id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
126200750|NCT01503229|454021747|FG000|Overall Study|Withdrew consent|1|||
126200751|NCT01524900|454021748|FG000|Overall Study|Lost to Follow-up|3|||
126200752|NCT01524900|454021749|FG001|Overall Study|Lost to Follow-up|12|||
126200753|NCT01524900|454021750|FG002|Overall Study|Lost to Follow-up|1|||
126200754|NCT01524900|454021751|FG003|Overall Study|Lost to Follow-up|0|||
126200755|NCT01524900|454021752|FG004|Overall Study|Lost to Follow-up|0|||
126200756|NCT01524900|454021748|FG000|Overall Study|Other reason than stated above|1|||
126200757|NCT01524900|454021749|FG001|Overall Study|Other reason than stated above|1|||
126200758|NCT01524900|454021750|FG002|Overall Study|Other reason than stated above|0|||
126200759|NCT01524900|454021751|FG003|Overall Study|Other reason than stated above|0|||
126200760|NCT01524900|454021752|FG004|Overall Study|Other reason than stated above|0|||
126200761|NCT01524900|454021748|FG000|Overall Study|No reason documented|2|||
126200762|NCT01524900|454021749|FG001|Overall Study|No reason documented|1|||
126200763|NCT01524900|454021750|FG002|Overall Study|No reason documented|0|||
126200764|NCT01524900|454021751|FG003|Overall Study|No reason documented|1|||
126200765|NCT01524900|454021752|FG004|Overall Study|No reason documented|0|||
126200766|NCT03824704|454021753|FG000|Overall Study|Study Terminated by Sponsor|1|||
126200767|NCT00298766|454021754|FG000|Overall Study|Adverse Event|18|||
126200768|NCT00298766|454021754|FG000|Overall Study|Death|2|||
126200769|NCT00298766|454021754|FG000|Overall Study|Withdrawal by Subject|9|||
126200770|NCT00298766|454021754|FG000|Overall Study|Treatment ongoing|4|||
126200771|NCT00298766|454021754|FG000|Overall Study|Progression of amyloid markers|4|||
126200772|NCT00298766|454021754|FG000|Overall Study|Deterioration in KPS and organ function|1|||
126200773|NCT00298766|454021754|FG000|Overall Study|Subjects overall condition deterioration|4|||
126200774|NCT00298766|454021754|FG000|Overall Study|Other|4|||
126200775|NCT02988115|454021756|FG000|Overall Study|Adverse Event|6|||
126200776|NCT02988115|454021757|FG001|Overall Study|Adverse Event|1|||
126200777|NCT02988115|454021756|FG000|Overall Study|Sponsor Decision|5|||
126200778|NCT02988115|454021757|FG001|Overall Study|Sponsor Decision|2|||
126200779|NCT02988115|454021756|FG000|Overall Study|Withdrawal by Subject|1|||
126200780|NCT02988115|454021757|FG001|Overall Study|Withdrawal by Subject|1|||
126200781|NCT02988115|454021756|FG000|Overall Study|Withdrawn by Mistake|1|||
126200782|NCT02988115|454021757|FG001|Overall Study|Withdrawn by Mistake|0|||
126200783|NCT02988115|454021756|FG000|Overall Study|Lost to Follow-up|1|||
126200784|NCT02988115|454021757|FG001|Overall Study|Lost to Follow-up|0|||
126200785|NCT01731951|454021758|FG000|Overall Study|Documented Disease Progression|1|||
126200786|NCT01731951|454021759|FG001|Overall Study|Documented Disease Progression|0|||
126200787|NCT01731951|454021760|FG002|Overall Study|Documented Disease Progression|0|||
126200788|NCT01731951|454021761|FG003|Overall Study|Documented Disease Progression|0|||
126200789|NCT01731951|454021762|FG004|Overall Study|Documented Disease Progression|0|||
126200790|NCT01731951|454021763|FG005|Overall Study|Documented Disease Progression|0|||
126200791|NCT01731951|454021758|FG000|Overall Study|Lost to Follow-up|2|||
126200792|NCT01731951|454021759|FG001|Overall Study|Lost to Follow-up|0|||
126200793|NCT01731951|454021760|FG002|Overall Study|Lost to Follow-up|0|||
126200794|NCT01731951|454021761|FG003|Overall Study|Lost to Follow-up|1|||
126200795|NCT01731951|454021762|FG004|Overall Study|Lost to Follow-up|3|||
126200796|NCT01731951|454021763|FG005|Overall Study|Lost to Follow-up|1|||
126200797|NCT01731951|454021758|FG000|Overall Study|Withdrawal of Consent|1|||
126200798|NCT01731951|454021759|FG001|Overall Study|Withdrawal of Consent|0|||
126200799|NCT01731951|454021760|FG002|Overall Study|Withdrawal of Consent|0|||
126200800|NCT01731951|454021761|FG003|Overall Study|Withdrawal of Consent|0|||
126200801|NCT01731951|454021762|FG004|Overall Study|Withdrawal of Consent|0|||
126200802|NCT01731951|454021763|FG005|Overall Study|Withdrawal of Consent|2|||
126200803|NCT01731951|454021758|FG000|Overall Study|Death|13|||
126200804|NCT01731951|454021759|FG001|Overall Study|Death|15|||
126200805|NCT01731951|454021760|FG002|Overall Study|Death|9|||
126200806|NCT01731951|454021761|FG003|Overall Study|Death|8|||
126200807|NCT01731951|454021762|FG004|Overall Study|Death|9|||
126200808|NCT01731951|454021763|FG005|Overall Study|Death|6|||
126200809|NCT00253747|454021764|FG000|Overall Study|Lost to Follow-up|13|||
126200810|NCT00253747|454021765|FG001|Overall Study|Lost to Follow-up|14|||
126200811|NCT00253747|454021764|FG000|Overall Study|Withdrawal by Subject|10|||
126200812|NCT00253747|454021765|FG001|Overall Study|Withdrawal by Subject|11|||
126200813|NCT00253747|454021764|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
126200814|NCT00253747|454021765|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
126200815|NCT01977651|454021766|FG000|4 Month Treatment Period|Adverse Event|34|||
126200816|NCT01977651|454021766|FG000|4 Month Treatment Period|Death|3|||
126200817|NCT01977651|454021766|FG000|4 Month Treatment Period|Progressive Disease|43|||
125977509|NCT01377480|453208124|FG000|Overall Study|Protocol Violation|0|||
126200818|NCT01977651|454021766|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
125977510|NCT01377480|453208125|FG001|Overall Study|Protocol Violation|0|||
125977511|NCT01377480|453208126|FG002|Overall Study|Protocol Violation|0|||
126200819|NCT01977651|454021766|FG000|4 Month Treatment Period|Physician Decision|4|||
126200820|NCT01977651|454021766|FG000|1 Year Extension Period|Adverse Event|14|||
126200821|NCT01977651|454021766|FG000|1 Year Extension Period|Death|10|||
126200822|NCT01977651|454021766|FG000|1 Year Extension Period|Lost to Follow-up|2|||
126200823|NCT01977651|454021766|FG000|1 Year Extension Period|Progressive Disease|86|||
126200824|NCT01977651|454021766|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
126200825|NCT01977651|454021766|FG000|1 Year Extension Period|Physician Decision|6|||
126200826|NCT01977651|454021766|FG000|1 Year Extension Period|Miscellaneous|1|||
126200827|NCT01977651|454021766|FG000|Post 1 Year Extension Period|Adverse Event|5|||
126200828|NCT01977651|454021766|FG000|Post 1 Year Extension Period|Death|13|||
126200829|NCT01977651|454021766|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
126200830|NCT01977651|454021766|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
126200831|NCT01977651|454021766|FG000|Post 1 Year Extension Period|Physician Decision|4|||
126200832|NCT01977651|454021766|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
126200833|NCT03287089|454021767|FG000|Overall Study|Lost to Follow-up|0|||
126200834|NCT03287089|454021768|FG001|Overall Study|Lost to Follow-up|2|||
126200835|NCT03287089|454021767|FG000|Overall Study|Physician Decision|0|||
125977512|NCT01377480|453208127|FG003|Overall Study|Protocol Violation|4|||
125977513|NCT01377480|453208124|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
125977514|NCT01377480|453208125|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
125977515|NCT01377480|453208126|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
125977516|NCT01377480|453208127|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
125977517|NCT01377480|453208124|FG000|Overall Study|Withdrawal by Subject|0|||
125977518|NCT01377480|453208125|FG001|Overall Study|Withdrawal by Subject|0|||
125977519|NCT01377480|453208126|FG002|Overall Study|Withdrawal by Subject|1|||
125977520|NCT01377480|453208127|FG003|Overall Study|Withdrawal by Subject|0|||
125977521|NCT01377480|453208124|FG000|Overall Study|Serious adverse event|0|||
125977522|NCT01377480|453208125|FG001|Overall Study|Serious adverse event|0|||
125977523|NCT01377480|453208126|FG002|Overall Study|Serious adverse event|1|||
125977524|NCT01377480|453208127|FG003|Overall Study|Serious adverse event|1|||
125977525|NCT01377480|453208124|FG000|Overall Study|Other|0|||
125977526|NCT01377480|453208125|FG001|Overall Study|Other|0|||
125977527|NCT01377480|453208126|FG002|Overall Study|Other|7|||
125977528|NCT01377480|453208127|FG003|Overall Study|Other|6|||
125977529|NCT01986881|453208128|FG000|Overall Study|Death|228|||
125977530|NCT01986881|453208129|FG001|Overall Study|Death|233|||
125977531|NCT01986881|453208130|FG002|Overall Study|Death|247|||
125977532|NCT01986881|453208128|FG000|Overall Study|Lost to Follow-up|51|||
125977533|NCT01986881|453208129|FG001|Overall Study|Lost to Follow-up|44|||
125977534|NCT01986881|453208130|FG002|Overall Study|Lost to Follow-up|55|||
125977535|NCT01986881|453208128|FG000|Overall Study|Physician Decision|7|||
125977536|NCT01986881|453208129|FG001|Overall Study|Physician Decision|4|||
125977537|NCT01986881|453208130|FG002|Overall Study|Physician Decision|6|||
125977538|NCT01986881|453208128|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
125977539|NCT01986881|453208129|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
125977540|NCT01986881|453208130|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
125977541|NCT01986881|453208128|FG000|Overall Study|Withdrawal by Subject|41|||
125977542|NCT01986881|453208129|FG001|Overall Study|Withdrawal by Subject|60|||
125977543|NCT01986881|453208130|FG002|Overall Study|Withdrawal by Subject|45|||
125977544|NCT01986881|453208128|FG000|Overall Study|Subject Moved|0|||
125977545|NCT01986881|453208129|FG001|Overall Study|Subject Moved|1|||
125977546|NCT01986881|453208130|FG002|Overall Study|Subject Moved|0|||
125977547|NCT01986881|453208128|FG000|Overall Study|Other|1|||
125977548|NCT01986881|453208129|FG001|Overall Study|Other|2|||
125977549|NCT01986881|453208130|FG002|Overall Study|Other|2|||
125977550|NCT03014674|453208133|FG000|Overall Study|Withdrawal by Subject|1|||
125977551|NCT03014674|453208134|FG001|Overall Study|Withdrawal by Subject|0|||
125977552|NCT03014674|453208135|FG002|Overall Study|Withdrawal by Subject|0|||
125977553|NCT03224182|453208140|FG000|Overall Study|Study Drug Not Instilled|6|||
125977554|NCT03224182|453208141|FG001|Overall Study|Study Drug Not Instilled|1|||
125977555|NCT03224182|453208140|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
125977556|NCT03224182|453208141|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
125977557|NCT03224182|453208140|FG000|Overall Study|Withdrew of Consent|4|||
125977558|NCT03224182|453208141|FG001|Overall Study|Withdrew of Consent|2|||
125977559|NCT03224182|453208140|FG000|Overall Study|Investigator Decision|3|||
125977560|NCT03224182|453208141|FG001|Overall Study|Investigator Decision|1|||
125977561|NCT03224182|453208140|FG000|Overall Study|Sponsor Decision|26|||
125977562|NCT03224182|453208141|FG001|Overall Study|Sponsor Decision|12|||
125977563|NCT03224182|453208140|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
125977564|NCT03224182|453208141|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
125977565|NCT03224182|453208140|FG000|Overall Study|Lost to Follow-up|1|||
125977566|NCT03224182|453208141|FG001|Overall Study|Lost to Follow-up|0|||
125977567|NCT03224182|453208140|FG000|Overall Study|Participant Had Recurrence|11|||
125977568|NCT03224182|453208141|FG001|Overall Study|Participant Had Recurrence|5|||
125977569|NCT03224182|453208140|FG000|Overall Study|Death|0|||
125977570|NCT03224182|453208141|FG001|Overall Study|Death|1|||
125977571|NCT03224182|453208140|FG000|Overall Study|Reason not Specified|3|||
125977572|NCT03224182|453208141|FG001|Overall Study|Reason not Specified|3|||
125977573|NCT03224182|453208140|FG000|Overall Study|Other|1|||
126200836|NCT03287089|454021768|FG001|Overall Study|Physician Decision|2|||
126200837|NCT03287089|454021767|FG000|Overall Study|Withdrawal by Subject|0|||
125977574|NCT03224182|453208141|FG001|Overall Study|Other|0|||
125977575|NCT04279314|453208142|FG000|Overall Study|Adverse Event|55|||
125977576|NCT04279314|453208142|FG000|Overall Study|Withdrawal by Subject|5|||
125977577|NCT04279314|453208142|FG000|Overall Study|Lack of Efficacy|5|||
125977578|NCT04279314|453208142|FG000|Overall Study|Protocol Violation|3|||
125977579|NCT04279314|453208142|FG000|Overall Study|Other (not COVID-19 related)|2|||
126200838|NCT03287089|454021768|FG001|Overall Study|Withdrawal by Subject|2|||
126200839|NCT00661362|454021769|FG000|Overall Study|Adverse Event|5|||
126200840|NCT00661362|454021770|FG001|Overall Study|Adverse Event|4|||
126200841|NCT00661362|454021769|FG000|Overall Study|Incorrect enrollment|2|||
126200842|NCT00661362|454021770|FG001|Overall Study|Incorrect enrollment|0|||
126200843|NCT00661362|454021769|FG000|Overall Study|Study specific discontinuation criteria|4|||
126200844|NCT00661362|454021770|FG001|Overall Study|Study specific discontinuation criteria|11|||
126200845|NCT00661362|454021769|FG000|Overall Study|Withdrawal by Subject|13|||
126200846|NCT00661362|454021770|FG001|Overall Study|Withdrawal by Subject|23|||
126200847|NCT00661362|454021769|FG000|Overall Study|Lost to Follow-up|3|||
126200848|NCT00661362|454021770|FG001|Overall Study|Lost to Follow-up|1|||
126200849|NCT00661362|454021769|FG000|Overall Study|Severe non-compliance to protocol|0|||
126200850|NCT00661362|454021770|FG001|Overall Study|Severe non-compliance to protocol|1|||
126200851|NCT00661362|454021769|FG000|Overall Study|Safety reasons|1|||
126422223|NCT03310723|454842545|FG000|Overall Study|Withdrawal by Subject|0|||
126422224|NCT03310723|454842546|FG001|Overall Study|Withdrawal by Subject|1|||
126422225|NCT03310723|454842545|FG000|Overall Study|Protocol Violation|0|||
126422226|NCT03310723|454842546|FG001|Overall Study|Protocol Violation|2|||
126422227|NCT02098746|454842547|FG000|Overall Study|Changes of Investigator|2|||
126422228|NCT02098746|454842547|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126422229|NCT02098746|454842547|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
126422230|NCT02098746|454842547|FG000|Overall Study|Data Not Available After Treatment|1|||
126422231|NCT01410890|454842548|FG000|Overall Study|Withdrawal by Subject|0|||
126422232|NCT01410890|454842549|FG001|Overall Study|Withdrawal by Subject|1|||
126422233|NCT00217425|454842550|FG000|Overall Study|Never started treatment|2|||
126422234|NCT00217425|454842550|FG000|Overall Study|Patient ineligible|5|||
126422235|NCT00217425|454842550|FG000|Overall Study|Lack of Efficacy|13|||
126422236|NCT00217425|454842550|FG000|Overall Study|Adverse Event|8|||
126422237|NCT00217425|454842550|FG000|Overall Study|Withdrawal by Subject|4|||
126422238|NCT00217425|454842550|FG000|Overall Study|Other complicating disease|1|||
126422239|NCT00217425|454842550|FG000|Overall Study|Other|4|||
126422240|NCT01121146|454842551|FG000|Overall Study|Death|17|||
126422241|NCT01121146|454842552|FG001|Overall Study|Death|15|||
126422242|NCT01121146|454842551|FG000|Overall Study|Adverse Event|2|||
126422243|NCT01121146|454842552|FG001|Overall Study|Adverse Event|11|||
126422244|NCT01121146|454842551|FG000|Overall Study|Lost to Follow-up|7|||
126422245|NCT01121146|454842552|FG001|Overall Study|Lost to Follow-up|16|||
126422246|NCT04640311|454842555|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
126422247|NCT04640311|454842556|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422248|NCT04640311|454842557|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422249|NCT04640311|454842558|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422250|NCT04640311|454842559|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422251|NCT04640311|454842560|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422252|NCT04640311|454842561|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422253|NCT04640311|454842562|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422254|NCT04640311|454842563|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422255|NCT04640311|454842564|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422256|NCT04640311|454842565|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422257|NCT04640311|454842566|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422258|NCT04640311|454842567|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422259|NCT04640311|454842555|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422260|NCT04640311|454842556|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
126422261|NCT04640311|454842557|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422262|NCT04640311|454842558|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422263|NCT04640311|454842559|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422264|NCT04640311|454842560|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422265|NCT04640311|454842561|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422266|NCT04640311|454842562|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422267|NCT04640311|454842563|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422268|NCT04640311|454842564|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422269|NCT04640311|454842565|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125977580|NCT02481310|453208143|FG000|Follow up|Still in follow up|0|||
125977581|NCT02481310|453208144|FG001|Follow up|Still in follow up|3|||
125977582|NCT02481310|453208145|FG002|Follow up|Still in follow up|0|||
126200852|NCT00661362|454021770|FG001|Overall Study|Safety reasons|0|||
125977583|NCT00160680|453208146|FG000|Overall Study|Adverse Event|0|||
125977584|NCT00160680|453208147|FG001|Overall Study|Adverse Event|1|||
125977585|NCT00160680|453208146|FG000|Overall Study|Lack of Efficacy|2|||
126200853|NCT00661362|454021769|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
126200854|NCT00661362|454021770|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
125977586|NCT00160680|453208147|FG001|Overall Study|Lack of Efficacy|1|||
126200855|NCT00775138|454021771|FG000|Overall Study|Withdrawal by Subject|0|||
126200856|NCT00775138|454021772|FG001|Overall Study|Withdrawal by Subject|0|||
126200857|NCT00775138|454021773|FG002|Overall Study|Withdrawal by Subject|2|||
125977587|NCT00160680|453208146|FG000|Overall Study|Lost to Follow-up|3|||
125977588|NCT00160680|453208147|FG001|Overall Study|Lost to Follow-up|2|||
125977589|NCT00160680|453208146|FG000|Overall Study|Withdrawal by Subject|4|||
125977590|NCT00160680|453208147|FG001|Overall Study|Withdrawal by Subject|9|||
125977591|NCT00985725|453208151|FG000|Overall Study|Adverse Event|4|||
125977592|NCT00985725|453208152|FG001|Overall Study|Adverse Event|1|||
125977593|NCT00985725|453208151|FG000|Overall Study|Protocol Violation|1|||
125977594|NCT00985725|453208152|FG001|Overall Study|Protocol Violation|3|||
125977595|NCT00985725|453208151|FG000|Overall Study|Withdrawal by Subject|4|||
125977596|NCT00985725|453208152|FG001|Overall Study|Withdrawal by Subject|4|||
126200858|NCT00775138|454021774|FG003|Overall Study|Withdrawal by Subject|2|||
126200859|NCT00775138|454021771|FG000|Overall Study|Adverse Event|0|||
126200860|NCT00775138|454021772|FG001|Overall Study|Adverse Event|0|||
126200861|NCT00775138|454021773|FG002|Overall Study|Adverse Event|1|||
126200862|NCT00775138|454021774|FG003|Overall Study|Adverse Event|0|||
126200863|NCT04880642|454021775|FG000|Randomization|Withdrawal by Subject|2|||
126200864|NCT04880642|454021776|FG001|Randomization|Withdrawal by Subject|3|||
126200865|NCT04880642|454021775|FG000|Treatment Period|Adverse Event|0|||
126200866|NCT04880642|454021776|FG001|Treatment Period|Adverse Event|1|||
126200867|NCT04880642|454021775|FG000|Treatment Period|Death|6|||
126200868|NCT04880642|454021776|FG001|Treatment Period|Death|6|||
126200869|NCT04880642|454021775|FG000|Treatment Period|Lost to Follow-up|1|||
125977597|NCT00985725|453208151|FG000|Overall Study|Lost to Follow-up|1|||
125977598|NCT00985725|453208152|FG001|Overall Study|Lost to Follow-up|1|||
126200870|NCT04880642|454021776|FG001|Treatment Period|Lost to Follow-up|0|||
126200871|NCT04880642|454021775|FG000|Treatment Period|Protocol Violation|0|||
126200872|NCT04880642|454021776|FG001|Treatment Period|Protocol Violation|1|||
126200873|NCT04880642|454021775|FG000|Treatment Period|Withdrawal by Subject|5|||
126200874|NCT04880642|454021776|FG001|Treatment Period|Withdrawal by Subject|3|||
126200875|NCT04880642|454021775|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
126200876|NCT04880642|454021776|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
126200877|NCT04880642|454021775|FG000|Follow-up|Death|4|||
126200878|NCT04880642|454021776|FG001|Follow-up|Death|3|||
126200879|NCT04880642|454021775|FG000|Follow-up|Withdrawal by Subject|1|||
126200880|NCT04880642|454021776|FG001|Follow-up|Withdrawal by Subject|0|||
126200881|NCT00104299|454021777|FG000|Overall Study|Adverse Event|3|||
126200882|NCT00104299|454021778|FG001|Overall Study|Adverse Event|1|||
126200883|NCT00104299|454021777|FG000|Overall Study|Death|2|||
126200884|NCT00104299|454021778|FG001|Overall Study|Death|2|||
126200885|NCT00104299|454021777|FG000|Overall Study|Withdrawal by Subject|2|||
126200886|NCT00104299|454021778|FG001|Overall Study|Withdrawal by Subject|6|||
126200887|NCT00104299|454021777|FG000|Overall Study|Physician Decision|1|||
125977599|NCT00985725|453208151|FG000|Overall Study|Lack of Efficacy|0|||
125977600|NCT00985725|453208152|FG001|Overall Study|Lack of Efficacy|1|||
125977601|NCT00985725|453208151|FG000|Overall Study|Non-compliance|1|||
126200888|NCT00104299|454021778|FG001|Overall Study|Physician Decision|1|||
126200889|NCT00104299|454021777|FG000|Overall Study|To have renal transplant|1|||
126200890|NCT00104299|454021778|FG001|Overall Study|To have renal transplant|0|||
126200891|NCT02906644|454021779|FG000|First 2 Weeks|Withdrawal by Subject|0|||
126200892|NCT02906644|454021780|FG001|First 2 Weeks|Withdrawal by Subject|2|||
126200893|NCT02906644|454021779|FG000|First 2 Weeks|Physician Decision|1|||
126200894|NCT02906644|454021780|FG001|First 2 Weeks|Physician Decision|1|||
126200895|NCT02906644|454021779|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
126200896|NCT02906644|454021780|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
126200897|NCT02906644|454021779|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
126200898|NCT02906644|454021780|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
126200899|NCT02452034|454021781|FG000|Overall Study|Adverse Event|0|||
125977602|NCT00985725|453208152|FG001|Overall Study|Non-compliance|2|||
125977603|NCT00985725|453208151|FG000|Overall Study|Out-of-window visits|0|||
125977604|NCT00985725|453208152|FG001|Overall Study|Out-of-window visits|1|||
125977605|NCT02723864|453208153|FG000|Overall Study|Refused further treatment|1|||
125977606|NCT02723864|453208154|FG001|Overall Study|Refused further treatment|0|||
126200900|NCT02452034|454021782|FG001|Overall Study|Adverse Event|0|||
125977607|NCT02723864|453208155|FG002|Overall Study|Refused further treatment|0|||
126200901|NCT02452034|454021783|FG002|Overall Study|Adverse Event|0|||
126200902|NCT02452034|454021784|FG003|Overall Study|Adverse Event|0|||
126200903|NCT02452034|454021785|FG004|Overall Study|Adverse Event|0|||
126200904|NCT02452034|454021786|FG005|Overall Study|Adverse Event|1|||
126200905|NCT02452034|454021781|FG000|Overall Study|Death|0|||
126200906|NCT02452034|454021782|FG001|Overall Study|Death|0|||
125977608|NCT02723864|453208156|FG003|Overall Study|Refused further treatment|0|||
126200907|NCT02452034|454021783|FG002|Overall Study|Death|0|||
126200908|NCT02452034|454021784|FG003|Overall Study|Death|0|||
126200909|NCT02452034|454021785|FG004|Overall Study|Death|1|||
126200910|NCT02452034|454021786|FG005|Overall Study|Death|1|||
126200911|NCT02452034|454021781|FG000|Overall Study|Physician Decision|0|||
126200912|NCT02452034|454021782|FG001|Overall Study|Physician Decision|1|||
126200913|NCT02452034|454021783|FG002|Overall Study|Physician Decision|1|||
126200914|NCT02452034|454021784|FG003|Overall Study|Physician Decision|0|||
126200915|NCT02452034|454021785|FG004|Overall Study|Physician Decision|0|||
126200916|NCT02452034|454021786|FG005|Overall Study|Physician Decision|0|||
126200917|NCT02452034|454021781|FG000|Overall Study|Protocol Violation|0|||
126200918|NCT02452034|454021782|FG001|Overall Study|Protocol Violation|0|||
126200919|NCT02452034|454021783|FG002|Overall Study|Protocol Violation|0|||
126200920|NCT02452034|454021784|FG003|Overall Study|Protocol Violation|0|||
126200921|NCT02452034|454021785|FG004|Overall Study|Protocol Violation|0|||
126200922|NCT02452034|454021786|FG005|Overall Study|Protocol Violation|1|||
126200923|NCT02452034|454021781|FG000|Overall Study|Screen Failure|1|||
126200924|NCT02452034|454021782|FG001|Overall Study|Screen Failure|0|||
126200925|NCT02452034|454021783|FG002|Overall Study|Screen Failure|0|||
126200926|NCT02452034|454021784|FG003|Overall Study|Screen Failure|1|||
126200927|NCT02452034|454021785|FG004|Overall Study|Screen Failure|0|||
126200928|NCT02452034|454021786|FG005|Overall Study|Screen Failure|0|||
126200929|NCT02452034|454021781|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
126200930|NCT02452034|454021782|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
126200931|NCT02452034|454021783|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
126200932|NCT02452034|454021784|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
126200933|NCT02452034|454021785|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
126200934|NCT02452034|454021786|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
126200935|NCT00561795|454021788|FG000|Overall Study|Adverse Event|3|||
126200936|NCT00561795|454021789|FG001|Overall Study|Adverse Event|3|||
126200937|NCT00561795|454021790|FG002|Overall Study|Adverse Event|0|||
126200938|NCT00561795|454021791|FG003|Overall Study|Adverse Event|0|||
126200939|NCT00561795|454021788|FG000|Overall Study|Study Closed/Terminated|0|||
126200940|NCT00561795|454021789|FG001|Overall Study|Study Closed/Terminated|3|||
126200941|NCT00561795|454021790|FG002|Overall Study|Study Closed/Terminated|0|||
126200942|NCT00561795|454021791|FG003|Overall Study|Study Closed/Terminated|0|||
126200943|NCT00561795|454021788|FG000|Overall Study|Physician Decision|1|||
126200944|NCT00561795|454021789|FG001|Overall Study|Physician Decision|0|||
126200945|NCT00561795|454021790|FG002|Overall Study|Physician Decision|0|||
126200946|NCT00561795|454021791|FG003|Overall Study|Physician Decision|0|||
126200947|NCT03672006|454021792|FG000|Overall Study|exclusion criteria met|0|||
126200948|NCT03672006|454021793|FG001|Overall Study|exclusion criteria met|1|||
126200949|NCT04235959|454021795|FG000|Overall Study|Protocol Violation|0|||
126200950|NCT04235959|454021796|FG001|Overall Study|Protocol Violation|1|||
126200951|NCT04235959|454021797|FG002|Overall Study|Protocol Violation|0|||
126200952|NCT04235959|454021795|FG000|Overall Study|Adverse Event|1|||
126200953|NCT04235959|454021796|FG001|Overall Study|Adverse Event|0|||
126200954|NCT04235959|454021797|FG002|Overall Study|Adverse Event|0|||
126200955|NCT00608426|454021798|FG000|Overall Study|Death|32|||
126200956|NCT00608426|454021799|FG001|Overall Study|Death|36|||
126200957|NCT00608426|454021798|FG000|Overall Study|Lost to Follow-up|485|||
126200958|NCT00608426|454021799|FG001|Overall Study|Lost to Follow-up|521|||
126200959|NCT00608426|454021798|FG000|Overall Study|refused, health issues, wrong address|319|||
126200960|NCT00608426|454021799|FG001|Overall Study|refused, health issues, wrong address|348|||
126200961|NCT02630459|454021803|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125977609|NCT02723864|453208157|FG004|Overall Study|Refused further treatment|1|||
125977610|NCT02723864|453208158|FG005|Overall Study|Refused further treatment|2|||
125977611|NCT02723864|453208159|FG006|Overall Study|Refused further treatment|0|||
125977612|NCT02723864|453208153|FG000|Overall Study|Exceed treatment hold time|0|||
125977613|NCT02723864|453208154|FG001|Overall Study|Exceed treatment hold time|1|||
125977614|NCT02723864|453208155|FG002|Overall Study|Exceed treatment hold time|0|||
125977615|NCT02723864|453208156|FG003|Overall Study|Exceed treatment hold time|0|||
125977616|NCT02723864|453208157|FG004|Overall Study|Exceed treatment hold time|0|||
125977617|NCT02723864|453208158|FG005|Overall Study|Exceed treatment hold time|0|||
125977618|NCT02723864|453208159|FG006|Overall Study|Exceed treatment hold time|0|||
125977619|NCT02723864|453208153|FG000|Overall Study|Clinical progression|0|||
126200962|NCT02630459|454021804|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
126200963|NCT02630459|454021805|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126200964|NCT02630459|454021806|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
126311178|NCT03339726|454429677|FG000|Overall Study|Withdrawal by Subject|1|||
126200965|NCT02630459|454021807|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126200966|NCT02630459|454021808|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126200967|NCT02630459|454021809|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126306045|NCT02553499|454408873|FG004|Overall Study|Lost to Follow-up|0|||
126200968|NCT02630459|454021810|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126200969|NCT02630459|454021803|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126200970|NCT02630459|454021804|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126200971|NCT02630459|454021805|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
126200972|NCT02630459|454021806|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126200973|NCT02630459|454021807|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126200974|NCT02630459|454021808|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126200975|NCT02630459|454021809|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126200976|NCT02630459|454021810|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126200977|NCT02630459|454021803|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
125977620|NCT02723864|453208154|FG001|Overall Study|Clinical progression|0|||
125977621|NCT02723864|453208155|FG002|Overall Study|Clinical progression|1|||
125977622|NCT02723864|453208156|FG003|Overall Study|Clinical progression|0|||
125977623|NCT02723864|453208157|FG004|Overall Study|Clinical progression|0|||
125977624|NCT02723864|453208158|FG005|Overall Study|Clinical progression|3|||
125977625|NCT02723864|453208159|FG006|Overall Study|Clinical progression|1|||
125977626|NCT02723864|453208153|FG000|Overall Study|Physician Decision|0|||
125977627|NCT02723864|453208154|FG001|Overall Study|Physician Decision|0|||
126200978|NCT02630459|454021804|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
126200979|NCT02630459|454021805|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
125977628|NCT02723864|453208155|FG002|Overall Study|Physician Decision|0|||
125977629|NCT02723864|453208156|FG003|Overall Study|Physician Decision|0|||
125977630|NCT02723864|453208157|FG004|Overall Study|Physician Decision|0|||
125977631|NCT02723864|453208158|FG005|Overall Study|Physician Decision|0|||
125977632|NCT02723864|453208159|FG006|Overall Study|Physician Decision|1|||
126200980|NCT02630459|454021806|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
126200981|NCT02630459|454021807|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
126200982|NCT02630459|454021808|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
126200983|NCT02630459|454021809|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
126200984|NCT02630459|454021810|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
126200985|NCT02630459|454021803|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
126200986|NCT02630459|454021804|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126200987|NCT02630459|454021805|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126200988|NCT02630459|454021806|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126200989|NCT02630459|454021807|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126200990|NCT02630459|454021808|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126200991|NCT02630459|454021809|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126200992|NCT02630459|454021810|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126200993|NCT02630459|454021803|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126200994|NCT02630459|454021804|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126200995|NCT02630459|454021805|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126200996|NCT02630459|454021806|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126200997|NCT02630459|454021807|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
126200998|NCT02630459|454021808|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
126200999|NCT02630459|454021809|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126201000|NCT02630459|454021810|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126201001|NCT02630459|454021803|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126201002|NCT02630459|454021804|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126201003|NCT02630459|454021805|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126201004|NCT02630459|454021806|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126201005|NCT02630459|454021807|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
126201006|NCT02630459|454021808|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
126201007|NCT02630459|454021809|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126201008|NCT02630459|454021810|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126201009|NCT02630459|454021803|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126201010|NCT02630459|454021804|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126201011|NCT02630459|454021805|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126201012|NCT02630459|454021806|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126306046|NCT02553499|454408874|FG005|Overall Study|Lost to Follow-up|0|||
126422270|NCT04640311|454842566|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422271|NCT04640311|454842567|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125977633|NCT02723864|453208153|FG000|Overall Study|Changes in patient condition|0|||
125977634|NCT02723864|453208154|FG001|Overall Study|Changes in patient condition|0|||
125977635|NCT02723864|453208155|FG002|Overall Study|Changes in patient condition|0|||
125977636|NCT02723864|453208156|FG003|Overall Study|Changes in patient condition|0|||
125977637|NCT02723864|453208157|FG004|Overall Study|Changes in patient condition|0|||
126201013|NCT02630459|454021807|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
126201014|NCT02630459|454021808|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126201015|NCT02630459|454021809|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126201016|NCT02630459|454021810|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126201017|NCT01453439|454021811|FG000|Treatment Phase|Withdrawal by Subject|13|||
126201018|NCT01453439|454021812|FG001|Treatment Phase|Withdrawal by Subject|10|||
126201019|NCT01453439|454021811|FG000|Treatment Phase|Suicidal Ideation|2|||
126201020|NCT01453439|454021812|FG001|Treatment Phase|Suicidal Ideation|0|||
126201021|NCT01453439|454021811|FG000|Treatment Phase|Need for higher level of care|1|||
126201022|NCT01453439|454021812|FG001|Treatment Phase|Need for higher level of care|1|||
126201023|NCT01453439|454021811|FG000|Treatment Phase|Therapist conflict of interest|1|||
126201024|NCT01453439|454021812|FG001|Treatment Phase|Therapist conflict of interest|0|||
126201025|NCT01453439|454021811|FG000|Follow-up|Withdrawal by Subject|0|||
126201026|NCT01453439|454021812|FG001|Follow-up|Withdrawal by Subject|1|||
126201027|NCT01453439|454021811|FG000|Follow-up|Lost to Follow-up|5|||
126201028|NCT01453439|454021812|FG001|Follow-up|Lost to Follow-up|10|||
126201029|NCT01014442|454021813|FG000|Overall Study|Adverse Event|0|||
126201030|NCT01014442|454021814|FG001|Overall Study|Adverse Event|8|||
126201031|NCT01014442|454021813|FG000|Overall Study|Withdrawal by Subject|4|||
126201032|NCT01014442|454021814|FG001|Overall Study|Withdrawal by Subject|4|||
126201033|NCT01014442|454021813|FG000|Overall Study|Protocol Violation|2|||
126201034|NCT01014442|454021814|FG001|Overall Study|Protocol Violation|5|||
126201035|NCT01014442|454021813|FG000|Overall Study|Lack of Compliance|0|||
126201036|NCT01014442|454021814|FG001|Overall Study|Lack of Compliance|1|||
126201037|NCT01014442|454021813|FG000|Overall Study|Unspecified Reason|1|||
126201038|NCT01014442|454021814|FG001|Overall Study|Unspecified Reason|1|||
126201039|NCT02135848|454021821|FG000|Overall Study|Adverse Event|2|||
126201040|NCT02135848|454021822|FG001|Overall Study|Adverse Event|0|||
126201041|NCT02135848|454021821|FG000|Overall Study|Withdrawal by Subject|1|||
126201042|NCT02135848|454021822|FG001|Overall Study|Withdrawal by Subject|1|||
126201043|NCT00699582|454021828|FG000|Overall Study|Adverse Event|4|||
126201044|NCT00699582|454021829|FG001|Overall Study|Adverse Event|11|||
126201045|NCT00699582|454021830|FG002|Overall Study|Adverse Event|23|||
126201046|NCT00699582|454021828|FG000|Overall Study|Withdrawal by Subject|6|||
126201047|NCT00699582|454021829|FG001|Overall Study|Withdrawal by Subject|7|||
126201048|NCT00699582|454021830|FG002|Overall Study|Withdrawal by Subject|4|||
126201049|NCT00699582|454021828|FG000|Overall Study|Lack of Efficacy|1|||
126201050|NCT00699582|454021829|FG001|Overall Study|Lack of Efficacy|0|||
126201051|NCT00699582|454021830|FG002|Overall Study|Lack of Efficacy|1|||
126201052|NCT00699582|454021828|FG000|Overall Study|Progressive Disease|1|||
126201053|NCT00699582|454021829|FG001|Overall Study|Progressive Disease|0|||
126201054|NCT00699582|454021830|FG002|Overall Study|Progressive Disease|0|||
126201055|NCT00699582|454021828|FG000|Overall Study|Administrative/Other|4|||
126201056|NCT00699582|454021829|FG001|Overall Study|Administrative/Other|3|||
126201057|NCT00699582|454021830|FG002|Overall Study|Administrative/Other|0|||
126201058|NCT00699582|454021828|FG000|Overall Study|Randomized, Not Treated|2|||
126201059|NCT00699582|454021829|FG001|Overall Study|Randomized, Not Treated|1|||
126201060|NCT00699582|454021830|FG002|Overall Study|Randomized, Not Treated|0|||
126201061|NCT04212221|454021831|FG000|Overall Study|Remained on Treatment|0|||
126201062|NCT04212221|454021832|FG001|Overall Study|Remained on Treatment|0|||
126201063|NCT04212221|454021833|FG002|Overall Study|Remained on Treatment|0|||
126201064|NCT04212221|454021834|FG003|Overall Study|Remained on Treatment|1|||
126201065|NCT04212221|454021835|FG004|Overall Study|Remained on Treatment|0|||
126201066|NCT04212221|454021836|FG005|Overall Study|Remained on Treatment|0|||
126201067|NCT04212221|454021837|FG006|Overall Study|Remained on Treatment|3|||
126201068|NCT04212221|454021838|FG007|Overall Study|Remained on Treatment|9|||
126201069|NCT04212221|454021831|FG000|Overall Study|Adverse Event|0|||
126201070|NCT04212221|454021832|FG001|Overall Study|Adverse Event|0|||
126201071|NCT04212221|454021833|FG002|Overall Study|Adverse Event|0|||
126201072|NCT04212221|454021834|FG003|Overall Study|Adverse Event|0|||
126201073|NCT04212221|454021835|FG004|Overall Study|Adverse Event|0|||
126201074|NCT04212221|454021836|FG005|Overall Study|Adverse Event|0|||
126201075|NCT04212221|454021837|FG006|Overall Study|Adverse Event|2|||
126201076|NCT04212221|454021838|FG007|Overall Study|Adverse Event|3|||
126201077|NCT04212221|454021831|FG000|Overall Study|Death|0|||
126201078|NCT04212221|454021832|FG001|Overall Study|Death|0|||
126201079|NCT04212221|454021833|FG002|Overall Study|Death|0|||
126201080|NCT04212221|454021834|FG003|Overall Study|Death|0|||
126201081|NCT04212221|454021835|FG004|Overall Study|Death|0|||
126201082|NCT04212221|454021836|FG005|Overall Study|Death|0|||
126201083|NCT04212221|454021837|FG006|Overall Study|Death|0|||
126201084|NCT04212221|454021838|FG007|Overall Study|Death|2|||
126201085|NCT04212221|454021831|FG000|Overall Study|Disease progression according to irRECIST|1|||
126201086|NCT04212221|454021832|FG001|Overall Study|Disease progression according to irRECIST|2|||
126201087|NCT04212221|454021833|FG002|Overall Study|Disease progression according to irRECIST|3|||
126201088|NCT04212221|454021834|FG003|Overall Study|Disease progression according to irRECIST|3|||
126201089|NCT04212221|454021835|FG004|Overall Study|Disease progression according to irRECIST|2|||
126201090|NCT04212221|454021836|FG005|Overall Study|Disease progression according to irRECIST|2|||
126201091|NCT04212221|454021837|FG006|Overall Study|Disease progression according to irRECIST|21|||
126201092|NCT04212221|454021838|FG007|Overall Study|Disease progression according to irRECIST|17|||
126201093|NCT04212221|454021831|FG000|Overall Study|Global Deterioration of Health Status|0|||
126201094|NCT04212221|454021832|FG001|Overall Study|Global Deterioration of Health Status|0|||
126201095|NCT04212221|454021833|FG002|Overall Study|Global Deterioration of Health Status|0|||
126201096|NCT04212221|454021834|FG003|Overall Study|Global Deterioration of Health Status|0|||
126201097|NCT04212221|454021835|FG004|Overall Study|Global Deterioration of Health Status|0|||
126201098|NCT04212221|454021836|FG005|Overall Study|Global Deterioration of Health Status|0|||
126201099|NCT04212221|454021837|FG006|Overall Study|Global Deterioration of Health Status|0|||
126201100|NCT04212221|454021838|FG007|Overall Study|Global Deterioration of Health Status|2|||
126201101|NCT04212221|454021831|FG000|Overall Study|Investigator's Decision|0|||
126201102|NCT04212221|454021832|FG001|Overall Study|Investigator's Decision|0|||
126201103|NCT04212221|454021833|FG002|Overall Study|Investigator's Decision|0|||
126201104|NCT04212221|454021834|FG003|Overall Study|Investigator's Decision|1|||
126201105|NCT04212221|454021835|FG004|Overall Study|Investigator's Decision|0|||
126201106|NCT04212221|454021836|FG005|Overall Study|Investigator's Decision|0|||
126201107|NCT04212221|454021837|FG006|Overall Study|Investigator's Decision|3|||
126201108|NCT04212221|454021838|FG007|Overall Study|Investigator's Decision|0|||
126201109|NCT04212221|454021831|FG000|Overall Study|Participant refused to continue treatment|0|||
126201110|NCT04212221|454021832|FG001|Overall Study|Participant refused to continue treatment|1|||
126201111|NCT04212221|454021833|FG002|Overall Study|Participant refused to continue treatment|0|||
126201112|NCT04212221|454021834|FG003|Overall Study|Participant refused to continue treatment|1|||
126201113|NCT04212221|454021835|FG004|Overall Study|Participant refused to continue treatment|1|||
126201114|NCT04212221|454021836|FG005|Overall Study|Participant refused to continue treatment|2|||
126201115|NCT04212221|454021837|FG006|Overall Study|Participant refused to continue treatment|4|||
126201116|NCT04212221|454021838|FG007|Overall Study|Participant refused to continue treatment|2|||
126201117|NCT04212221|454021831|FG000|Overall Study|Protocol Violation|0|||
126201118|NCT04212221|454021832|FG001|Overall Study|Protocol Violation|0|||
126201119|NCT04212221|454021833|FG002|Overall Study|Protocol Violation|0|||
126201120|NCT04212221|454021834|FG003|Overall Study|Protocol Violation|0|||
126201121|NCT04212221|454021835|FG004|Overall Study|Protocol Violation|0|||
126201122|NCT04212221|454021836|FG005|Overall Study|Protocol Violation|0|||
126201123|NCT04212221|454021837|FG006|Overall Study|Protocol Violation|0|||
126201124|NCT04212221|454021838|FG007|Overall Study|Protocol Violation|1|||
126201125|NCT00636506|454021847|FG000|Overall Study|Lost to Follow-up|8|||
126201126|NCT00636506|454021847|FG000|Overall Study|Explanted|1|||
126201127|NCT00636506|454021847|FG000|Overall Study|Withdrawal by Subject|6|||
126201128|NCT00636506|454021847|FG000|Overall Study|Procedure aborted|1|||
126201129|NCT03742271|454021848|FG000|Overall Study|Unsatisfactory Visual Response|1|||
126201130|NCT03742271|454021848|FG000|Overall Study|Withdrawal by Subject|3|||
126201131|NCT03742271|454021848|FG000|Overall Study|Lost to Follow-up|4|||
126201132|NCT03742271|454021848|FG000|Overall Study|Failed Insertion & removal|3|||
126201133|NCT03742271|454021848|FG000|Overall Study|Protocol Violation|1|||
126201134|NCT01624974|454021851|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
126201135|NCT01624974|454021852|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
126201136|NCT01624974|454021851|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
126201137|NCT01624974|454021852|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
126201138|NCT01624974|454021851|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
126201139|NCT01624974|454021852|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
126201140|NCT01624974|454021851|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
126201141|NCT01624974|454021852|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
126201142|NCT01624974|454021851|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
126201143|NCT01624974|454021852|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
126201144|NCT01624974|454021851|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
126201145|NCT01624974|454021852|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
126201146|NCT01624974|454021851|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
126201147|NCT01624974|454021852|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
126201148|NCT01624974|454021851|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
126201149|NCT01624974|454021852|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
126201150|NCT01624974|454021851|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
126201151|NCT01624974|454021852|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
126201152|NCT01624974|454021851|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
126201153|NCT01624974|454021852|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
126201154|NCT01624974|454021851|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
126201155|NCT01624974|454021852|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
126201156|NCT01624974|454021851|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
126201157|NCT01624974|454021852|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
126201158|NCT02646332|454021856|FG000|Overall Study|Lost to Follow-up|0|||
126201159|NCT02646332|454021857|FG001|Overall Study|Lost to Follow-up|3|||
126201160|NCT00252499|454021863|FG000|Overall Study|Lost to Follow-up|1|||
126201161|NCT00252499|454021864|FG001|Overall Study|Lost to Follow-up|0|||
126201162|NCT00252499|454021865|FG002|Overall Study|Lost to Follow-up|0|||
126201163|NCT04490499|454021866|FG000|Overall Study|Withdrawal by Subject|2|||
126201164|NCT01882439|454021867|FG000|Overall Study|Adverse event related to study drug|3|||
126201165|NCT01882439|454021868|FG001|Overall Study|Adverse event related to study drug|8|||
126201166|NCT01882439|454021869|FG002|Overall Study|Adverse event related to study drug|1|||
126201167|NCT01882439|454021870|FG003|Overall Study|Adverse event related to study drug|2|||
126201168|NCT01882439|454021867|FG000|Overall Study|Pregnancy|0|||
126201169|NCT01882439|454021868|FG001|Overall Study|Pregnancy|1|||
126201170|NCT01882439|454021869|FG002|Overall Study|Pregnancy|0|||
126201171|NCT01882439|454021870|FG003|Overall Study|Pregnancy|0|||
126201172|NCT01882439|454021867|FG000|Overall Study|Protocol Violation|2|||
126201173|NCT01882439|454021868|FG001|Overall Study|Protocol Violation|2|||
126201174|NCT01882439|454021869|FG002|Overall Study|Protocol Violation|0|||
126201175|NCT01882439|454021870|FG003|Overall Study|Protocol Violation|1|||
126201176|NCT01882439|454021867|FG000|Overall Study|No longer willing to participate|1|||
126201177|NCT01882439|454021868|FG001|Overall Study|No longer willing to participate|4|||
126201178|NCT01882439|454021869|FG002|Overall Study|No longer willing to participate|2|||
126201179|NCT01882439|454021870|FG003|Overall Study|No longer willing to participate|3|||
126201180|NCT01882439|454021867|FG000|Overall Study|Medication error with no associated AE|0|||
126201181|NCT01882439|454021868|FG001|Overall Study|Medication error with no associated AE|0|||
126201182|NCT01882439|454021869|FG002|Overall Study|Medication error with no associated AE|2|||
126201183|NCT01882439|454021870|FG003|Overall Study|Medication error with no associated AE|0|||
126201184|NCT01882439|454021867|FG000|Overall Study|Insufficient clinical response|1|||
126201185|NCT01882439|454021868|FG001|Overall Study|Insufficient clinical response|4|||
125977638|NCT02723864|453208158|FG005|Overall Study|Changes in patient condition|1|||
125977639|NCT02723864|453208159|FG006|Overall Study|Changes in patient condition|0|||
125977640|NCT02723864|453208153|FG000|Overall Study|Patient choice|0|||
125977641|NCT02723864|453208154|FG001|Overall Study|Patient choice|0|||
125977642|NCT02723864|453208155|FG002|Overall Study|Patient choice|0|||
125977643|NCT02723864|453208156|FG003|Overall Study|Patient choice|0|||
125977644|NCT02723864|453208157|FG004|Overall Study|Patient choice|0|||
125977645|NCT02723864|453208158|FG005|Overall Study|Patient choice|1|||
125977646|NCT02723864|453208159|FG006|Overall Study|Patient choice|0|||
125977647|NCT02723864|453208153|FG000|Overall Study|Adverse Event|0|||
125977648|NCT02723864|453208154|FG001|Overall Study|Adverse Event|0|||
125977649|NCT02723864|453208155|FG002|Overall Study|Adverse Event|0|||
125977650|NCT02723864|453208156|FG003|Overall Study|Adverse Event|0|||
125977651|NCT02723864|453208157|FG004|Overall Study|Adverse Event|0|||
125977652|NCT02723864|453208158|FG005|Overall Study|Adverse Event|1|||
125977653|NCT02723864|453208159|FG006|Overall Study|Adverse Event|0|||
125977654|NCT02723864|453208153|FG000|Overall Study|Started new treatment|0|||
125977655|NCT02723864|453208154|FG001|Overall Study|Started new treatment|0|||
125977656|NCT02723864|453208155|FG002|Overall Study|Started new treatment|0|||
125977657|NCT02723864|453208156|FG003|Overall Study|Started new treatment|0|||
125977658|NCT02723864|453208157|FG004|Overall Study|Started new treatment|0|||
125977659|NCT02723864|453208158|FG005|Overall Study|Started new treatment|1|||
125977660|NCT02723864|453208159|FG006|Overall Study|Started new treatment|0|||
125977661|NCT02723864|453208153|FG000|Overall Study|Switched to alternative treatment|0|||
125977662|NCT02723864|453208154|FG001|Overall Study|Switched to alternative treatment|0|||
125977663|NCT02723864|453208155|FG002|Overall Study|Switched to alternative treatment|0|||
125977664|NCT02723864|453208156|FG003|Overall Study|Switched to alternative treatment|0|||
125977665|NCT02723864|453208157|FG004|Overall Study|Switched to alternative treatment|0|||
125977666|NCT02723864|453208158|FG005|Overall Study|Switched to alternative treatment|1|||
125977667|NCT02723864|453208159|FG006|Overall Study|Switched to alternative treatment|0|||
125977668|NCT02723864|453208153|FG000|Overall Study|Late determination of ineligibility|0|||
125977669|NCT02723864|453208154|FG001|Overall Study|Late determination of ineligibility|0|||
125977670|NCT02723864|453208155|FG002|Overall Study|Late determination of ineligibility|0|||
125977671|NCT02723864|453208156|FG003|Overall Study|Late determination of ineligibility|0|||
125977672|NCT02723864|453208157|FG004|Overall Study|Late determination of ineligibility|0|||
125977673|NCT02723864|453208158|FG005|Overall Study|Late determination of ineligibility|1|||
125977674|NCT02723864|453208159|FG006|Overall Study|Late determination of ineligibility|0|||
125977675|NCT02548455|453208160|FG000|Overall Study|Withdrawal by Subject|27|||
125977676|NCT02548455|453208160|FG000|Overall Study|Death|26|||
125977677|NCT02548455|453208160|FG000|Overall Study|Lost to Follow-up|14|||
125977678|NCT02548455|453208160|FG000|Overall Study|Visit not completed|173|||
125977679|NCT02261493|453208161|FG000|Overall Study|Noncompliance|0|||
125977680|NCT02261493|453208162|FG001|Overall Study|Noncompliance|0|||
125977681|NCT02261493|453208163|FG002|Overall Study|Noncompliance|2|||
125977682|NCT02261493|453208161|FG000|Overall Study|Physician Decision|0|||
125977683|NCT02261493|453208162|FG001|Overall Study|Physician Decision|1|||
125977684|NCT02261493|453208163|FG002|Overall Study|Physician Decision|0|||
126201186|NCT01882439|454021869|FG002|Overall Study|Insufficient clinical response|4|||
126201187|NCT01882439|454021870|FG003|Overall Study|Insufficient clinical response|2|||
125977685|NCT02261493|453208161|FG000|Overall Study|Undisclosed alcohol abuse|0|||
126201188|NCT01882439|454021867|FG000|Overall Study|Adverse event unrelated to study drug|2|||
126201189|NCT01882439|454021868|FG001|Overall Study|Adverse event unrelated to study drug|2|||
126201190|NCT01882439|454021869|FG002|Overall Study|Adverse event unrelated to study drug|1|||
126201191|NCT01882439|454021870|FG003|Overall Study|Adverse event unrelated to study drug|1|||
126201192|NCT03125902|454021875|FG000|Overall Study|Adverse Event|0|||
126201193|NCT03125902|454021876|FG001|Overall Study|Adverse Event|1|||
126201194|NCT03125902|454021875|FG000|Overall Study|Death|119|||
126201195|NCT03125902|454021876|FG001|Overall Study|Death|229|||
126201196|NCT03125902|454021875|FG000|Overall Study|Lost to Follow-up|4|||
125977686|NCT02261493|453208162|FG001|Overall Study|Undisclosed alcohol abuse|1|||
125977687|NCT02261493|453208163|FG002|Overall Study|Undisclosed alcohol abuse|0|||
125977688|NCT02261493|453208161|FG000|Overall Study|Protocol Violation|1|||
125977689|NCT02261493|453208162|FG001|Overall Study|Protocol Violation|0|||
126201197|NCT03125902|454021876|FG001|Overall Study|Lost to Follow-up|13|||
126201198|NCT03125902|454021875|FG000|Overall Study|Other|0|||
126201199|NCT03125902|454021876|FG001|Overall Study|Other|4|||
126201200|NCT03125902|454021875|FG000|Overall Study|Physician Decision|2|||
126201201|NCT03125902|454021876|FG001|Overall Study|Physician Decision|1|||
126201202|NCT03125902|454021875|FG000|Overall Study|Progressive Disease|0|||
126201203|NCT03125902|454021876|FG001|Overall Study|Progressive Disease|3|||
126201204|NCT03125902|454021875|FG000|Overall Study|Study Terminated By Sponsor|74|||
126201205|NCT03125902|454021876|FG001|Overall Study|Study Terminated By Sponsor|143|||
126201206|NCT03125902|454021875|FG000|Overall Study|Withdrawal by Subject|21|||
126201207|NCT03125902|454021876|FG001|Overall Study|Withdrawal by Subject|37|||
126201208|NCT02269709|454021877|FG000|Time of Enrollment|Withdrawal by Subject|3|||
126201209|NCT02269709|454021877|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
126201210|NCT02269709|454021877|FG000|Six Month Follow-up|Lost to Follow-up|12|||
126201211|NCT02909504|454021878|FG000|Overall Study|Adverse Event|2|||
126201212|NCT02909504|454021878|FG000|Overall Study|Lack of Efficacy|3|||
126201213|NCT02909504|454021878|FG000|Overall Study|Withdrawal by Subject|4|||
126201214|NCT02909504|454021878|FG000|Overall Study|Pregnancy|1|||
125977690|NCT02261493|453208163|FG002|Overall Study|Protocol Violation|0|||
125977691|NCT02261493|453208161|FG000|Overall Study|Personal Reasons|14|||
125977692|NCT02261493|453208162|FG001|Overall Study|Personal Reasons|14|||
125977693|NCT02261493|453208163|FG002|Overall Study|Personal Reasons|16|||
125977694|NCT02261493|453208161|FG000|Overall Study|Lost to Follow-up|14|||
125977695|NCT02261493|453208162|FG001|Overall Study|Lost to Follow-up|27|||
126201215|NCT02909504|454021878|FG000|Overall Study|Subject moved|1|||
126201216|NCT02909504|454021878|FG000|Overall Study|Lost to Follow-up|1|||
126201217|NCT01843933|454021879|FG000|Overall Study|Data lost|6|||
126201218|NCT01843933|454021880|FG001|Overall Study|Data lost|4|||
126201219|NCT04411472|454021882|FG000|Overall Study|Adverse Event|5|||
126201220|NCT04411472|454021883|FG001|Overall Study|Adverse Event|10|||
126201221|NCT04411472|454021884|FG002|Overall Study|Adverse Event|1|||
126201222|NCT04411472|454021885|FG003|Overall Study|Adverse Event|0|||
126201223|NCT04411472|454021886|FG004|Overall Study|Adverse Event|0|||
126201224|NCT04411472|454021887|FG005|Overall Study|Adverse Event|0|||
125977696|NCT02261493|453208163|FG002|Overall Study|Lost to Follow-up|8|||
125977697|NCT02261493|453208161|FG000|Overall Study|Pregnancy|1|||
125977698|NCT02261493|453208162|FG001|Overall Study|Pregnancy|2|||
125977699|NCT02261493|453208163|FG002|Overall Study|Pregnancy|0|||
125977700|NCT02261493|453208161|FG000|Overall Study|Lack of Efficacy|0|||
125977701|NCT02261493|453208162|FG001|Overall Study|Lack of Efficacy|1|||
125977702|NCT02261493|453208163|FG002|Overall Study|Lack of Efficacy|0|||
125977703|NCT02261493|453208161|FG000|Overall Study|Adverse Event|0|||
125977704|NCT02261493|453208162|FG001|Overall Study|Adverse Event|1|||
126201225|NCT04411472|454021882|FG000|Overall Study|Protocol Violation|1|||
126201226|NCT04411472|454021883|FG001|Overall Study|Protocol Violation|0|||
126201227|NCT04411472|454021884|FG002|Overall Study|Protocol Violation|0|||
126201228|NCT04411472|454021885|FG003|Overall Study|Protocol Violation|0|||
126201229|NCT04411472|454021886|FG004|Overall Study|Protocol Violation|0|||
126201230|NCT04411472|454021887|FG005|Overall Study|Protocol Violation|0|||
125977705|NCT02261493|453208163|FG002|Overall Study|Adverse Event|0|||
125977706|NCT05711641|453208165|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
126201231|NCT04411472|454021882|FG000|Overall Study|Withdrawal by Subject|0|||
126201232|NCT04411472|454021883|FG001|Overall Study|Withdrawal by Subject|1|||
126311179|NCT03339726|454429678|FG001|Overall Study|Withdrawal by Subject|0|||
125977707|NCT05711641|453208166|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
125977708|NCT05711641|453208165|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
126046393|NCT02719574|453468202|FG001|Phase 2|Investigator Decision|0|||
126201233|NCT04411472|454021884|FG002|Overall Study|Withdrawal by Subject|0|||
126201234|NCT04411472|454021885|FG003|Overall Study|Withdrawal by Subject|1|||
126201235|NCT04411472|454021886|FG004|Overall Study|Withdrawal by Subject|0|||
126201236|NCT04411472|454021887|FG005|Overall Study|Withdrawal by Subject|0|||
126201237|NCT04411472|454021882|FG000|Overall Study|Physician Decision|1|||
126201238|NCT04411472|454021883|FG001|Overall Study|Physician Decision|0|||
126201239|NCT04411472|454021884|FG002|Overall Study|Physician Decision|0|||
126201240|NCT04411472|454021885|FG003|Overall Study|Physician Decision|0|||
126201241|NCT04411472|454021886|FG004|Overall Study|Physician Decision|0|||
126201242|NCT04411472|454021887|FG005|Overall Study|Physician Decision|0|||
126201243|NCT04411472|454021882|FG000|Overall Study|Study terminated by sponsor|17|||
126201244|NCT04411472|454021883|FG001|Overall Study|Study terminated by sponsor|20|||
126201245|NCT04411472|454021884|FG002|Overall Study|Study terminated by sponsor|3|||
126201246|NCT04411472|454021885|FG003|Overall Study|Study terminated by sponsor|0|||
126201247|NCT04411472|454021886|FG004|Overall Study|Study terminated by sponsor|0|||
126201248|NCT04411472|454021887|FG005|Overall Study|Study terminated by sponsor|0|||
126201249|NCT01747655|454021888|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
126201250|NCT01747655|454021889|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
126201251|NCT01747655|454021888|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
126201252|NCT01747655|454021889|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
126201253|NCT01747655|454021888|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
126201254|NCT01747655|454021889|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
126201255|NCT00982111|454021890|FG000|Overall Study|Adverse Event|1|||
126201256|NCT00982111|454021891|FG001|Overall Study|Adverse Event|1|||
126201257|NCT00982111|454021890|FG000|Overall Study|Progressive Disease|46|||
126201258|NCT00982111|454021891|FG001|Overall Study|Progressive Disease|39|||
126201259|NCT00982111|454021890|FG000|Overall Study|Lost to Follow-up|9|||
126201260|NCT00982111|454021891|FG001|Overall Study|Lost to Follow-up|6|||
126201261|NCT00982111|454021890|FG000|Overall Study|New Anti-Cancer Therapy|5|||
126201262|NCT00982111|454021891|FG001|Overall Study|New Anti-Cancer Therapy|5|||
126201263|NCT00982111|454021890|FG000|Overall Study|Medical Decision|1|||
126201264|NCT00982111|454021891|FG001|Overall Study|Medical Decision|0|||
126201265|NCT00982111|454021890|FG000|Overall Study|Withdrawal by Subject|17|||
126201266|NCT00982111|454021891|FG001|Overall Study|Withdrawal by Subject|19|||
126201267|NCT00982111|454021890|FG000|Overall Study|Global Study End|0|||
126201268|NCT00982111|454021891|FG001|Overall Study|Global Study End|1|||
126201269|NCT00982111|454021890|FG000|Overall Study|Sponsor's Decision|0|||
126201270|NCT00982111|454021891|FG001|Overall Study|Sponsor's Decision|1|||
126201271|NCT01482598|454021892|FG000|Overall Study|Death|7|||
126201272|NCT01482598|454021893|FG001|Overall Study|Death|10|||
126201273|NCT01482598|454021892|FG000|Overall Study|Physician Decision|0|||
126201274|NCT01482598|454021893|FG001|Overall Study|Physician Decision|3|||
126201275|NCT01482598|454021892|FG000|Overall Study|Withdrawal by Subject|4|||
126201276|NCT01482598|454021893|FG001|Overall Study|Withdrawal by Subject|5|||
126201277|NCT01482598|454021892|FG000|Overall Study|Lost to Follow-up|5|||
126201278|NCT01482598|454021893|FG001|Overall Study|Lost to Follow-up|4|||
126201279|NCT03769753|454021894|FG000|Overall Study|Not Treated|6|||
126201280|NCT03769753|454021894|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
126201281|NCT01373294|454021895|FG000|Overall Study|Adverse Event|1|||
126201282|NCT01373294|454021896|FG001|Overall Study|Adverse Event|0|||
126201283|NCT01657903|454021897|FG000|Overall Study|Lost to Follow-up|1|||
126201284|NCT01657903|454021897|FG000|Overall Study|Withdrawal by Subject|1|||
126201285|NCT01920061|454021901|FG000|Overall Study|Death|1|||
126201286|NCT01920061|454021902|FG001|Overall Study|Death|1|||
126201287|NCT01920061|454021903|FG002|Overall Study|Death|0|||
126201288|NCT01920061|454021904|FG003|Overall Study|Death|1|||
126201289|NCT01920061|454021905|FG004|Overall Study|Death|1|||
126201290|NCT01920061|454021906|FG005|Overall Study|Death|0|||
126201291|NCT01920061|454021907|FG006|Overall Study|Death|0|||
126201292|NCT01920061|454021908|FG007|Overall Study|Death|1|||
126201293|NCT01920061|454021909|FG008|Overall Study|Death|0|||
126201294|NCT01920061|454021910|FG009|Overall Study|Death|1|||
126201295|NCT01920061|454021911|FG010|Overall Study|Death|0|||
126201296|NCT01920061|454021912|FG011|Overall Study|Death|1|||
126201297|NCT01920061|454021913|FG012|Overall Study|Death|0|||
126201298|NCT01920061|454021914|FG013|Overall Study|Death|2|||
126201299|NCT01920061|454021915|FG014|Overall Study|Death|0|||
126201300|NCT01920061|454021916|FG015|Overall Study|Death|0|||
126201301|NCT01920061|454021917|FG016|Overall Study|Death|0|||
126201302|NCT01920061|454021918|FG017|Overall Study|Death|0|||
126201303|NCT01920061|454021919|FG018|Overall Study|Death|1|||
126201304|NCT01920061|454021920|FG019|Overall Study|Death|0|||
126201305|NCT01920061|454021901|FG000|Overall Study|Lost to Follow-up|0|||
126201306|NCT01920061|454021902|FG001|Overall Study|Lost to Follow-up|2|||
126201307|NCT01920061|454021903|FG002|Overall Study|Lost to Follow-up|0|||
126201308|NCT01920061|454021904|FG003|Overall Study|Lost to Follow-up|0|||
126201309|NCT01920061|454021905|FG004|Overall Study|Lost to Follow-up|0|||
126201310|NCT01920061|454021906|FG005|Overall Study|Lost to Follow-up|0|||
126201311|NCT01920061|454021907|FG006|Overall Study|Lost to Follow-up|1|||
126201312|NCT01920061|454021908|FG007|Overall Study|Lost to Follow-up|0|||
126201313|NCT01920061|454021909|FG008|Overall Study|Lost to Follow-up|0|||
126201314|NCT01920061|454021910|FG009|Overall Study|Lost to Follow-up|0|||
126201315|NCT01920061|454021911|FG010|Overall Study|Lost to Follow-up|3|||
126201316|NCT01920061|454021912|FG011|Overall Study|Lost to Follow-up|0|||
126201317|NCT01920061|454021913|FG012|Overall Study|Lost to Follow-up|0|||
126201318|NCT01920061|454021914|FG013|Overall Study|Lost to Follow-up|0|||
126201319|NCT01920061|454021915|FG014|Overall Study|Lost to Follow-up|0|||
126201320|NCT01920061|454021916|FG015|Overall Study|Lost to Follow-up|0|||
126201321|NCT01920061|454021917|FG016|Overall Study|Lost to Follow-up|0|||
126201322|NCT01920061|454021918|FG017|Overall Study|Lost to Follow-up|1|||
126201323|NCT01920061|454021919|FG018|Overall Study|Lost to Follow-up|4|||
126201324|NCT01920061|454021920|FG019|Overall Study|Lost to Follow-up|3|||
126201325|NCT01920061|454021901|FG000|Overall Study|Other|1|||
126201326|NCT01920061|454021902|FG001|Overall Study|Other|1|||
126201327|NCT01920061|454021903|FG002|Overall Study|Other|2|||
126201328|NCT01920061|454021904|FG003|Overall Study|Other|1|||
126201329|NCT01920061|454021905|FG004|Overall Study|Other|0|||
126201330|NCT01920061|454021906|FG005|Overall Study|Other|1|||
126201331|NCT01920061|454021907|FG006|Overall Study|Other|0|||
126201332|NCT01920061|454021908|FG007|Overall Study|Other|0|||
126201333|NCT01920061|454021909|FG008|Overall Study|Other|0|||
126201334|NCT01920061|454021910|FG009|Overall Study|Other|1|||
126201335|NCT01920061|454021911|FG010|Overall Study|Other|1|||
126201336|NCT01920061|454021912|FG011|Overall Study|Other|2|||
126201337|NCT01920061|454021913|FG012|Overall Study|Other|1|||
126201338|NCT01920061|454021914|FG013|Overall Study|Other|4|||
126201339|NCT01920061|454021915|FG014|Overall Study|Other|0|||
126201340|NCT01920061|454021916|FG015|Overall Study|Other|1|||
126201341|NCT01920061|454021917|FG016|Overall Study|Other|1|||
126201342|NCT01920061|454021918|FG017|Overall Study|Other|0|||
126201343|NCT01920061|454021919|FG018|Overall Study|Other|1|||
126201344|NCT01920061|454021920|FG019|Overall Study|Other|1|||
126201345|NCT01920061|454021901|FG000|Overall Study|Participant refused further follow-up|0|||
126201346|NCT01920061|454021902|FG001|Overall Study|Participant refused further follow-up|0|||
126201347|NCT01920061|454021903|FG002|Overall Study|Participant refused further follow-up|0|||
126201348|NCT01920061|454021904|FG003|Overall Study|Participant refused further follow-up|0|||
126201349|NCT01920061|454021905|FG004|Overall Study|Participant refused further follow-up|1|||
126311180|NCT03339726|454429679|FG002|Overall Study|Withdrawal by Subject|0|||
126311181|NCT03339726|454429677|FG000|Overall Study|Lost to Follow-up|0|||
126311182|NCT03339726|454429678|FG001|Overall Study|Lost to Follow-up|1|||
126311183|NCT03339726|454429679|FG002|Overall Study|Lost to Follow-up|0|||
126311184|NCT01275755|454429680|FG000|Double-blind Treatment Period|Adverse Event|0|||
126311185|NCT01275755|454429681|FG001|Double-blind Treatment Period|Adverse Event|2|||
126311186|NCT01275755|454429680|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
126311187|NCT01275755|454429681|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
126311188|NCT01275755|454429680|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126311189|NCT01275755|454429681|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126311190|NCT01275755|454429680|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
126311191|NCT01275755|454429681|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
126311192|NCT00636194|454429687|FG000|Overall Study|Study related symptoms and complaints|1|||
126311193|NCT00636194|454429688|FG001|Overall Study|Study related symptoms and complaints|0|||
126311194|NCT00636194|454429687|FG000|Overall Study|Protocol Violation|2|||
126311195|NCT00636194|454429688|FG001|Overall Study|Protocol Violation|0|||
126311196|NCT04934189|454429693|FG000|Overall Study|Lost to Follow-up|4|||
126311197|NCT04934189|454429693|FG000|Overall Study|Withdrawal by Subject|17|||
126311198|NCT03962790|454429694|FG000|Period 1|Adverse Event|0|||
126311199|NCT03962790|454429695|FG001|Period 1|Adverse Event|1|||
126311200|NCT03962790|454429694|FG000|Period 1|Failed to meet all eligibility criteria|1|||
126311201|NCT03962790|454429695|FG001|Period 1|Failed to meet all eligibility criteria|1|||
126311202|NCT03962790|454429694|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
126311203|NCT03962790|454429695|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
126311204|NCT03962790|454429694|FG000|Period 1|Withdrawal by Subject|1|||
126311205|NCT03962790|454429695|FG001|Period 1|Withdrawal by Subject|0|||
126311206|NCT01286168|454429697|FG000|Overall Study|Withdrawal by Subject|1|||
126311207|NCT01286168|454429697|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
126311208|NCT04598451|454429698|FG000|Overall Study|Adverse Event|3|||
126311209|NCT04598451|454429699|FG001|Overall Study|Adverse Event|2|||
126311210|NCT04598451|454429698|FG000|Overall Study|Withdrawal by Subject|3|||
126311211|NCT04598451|454429699|FG001|Overall Study|Withdrawal by Subject|7|||
126311212|NCT04598451|454429698|FG000|Overall Study|Lost to Follow-up|2|||
126311213|NCT04598451|454429699|FG001|Overall Study|Lost to Follow-up|0|||
126311214|NCT04598451|454429698|FG000|Overall Study|Physician Decision|4|||
126201350|NCT01920061|454021906|FG005|Overall Study|Participant refused further follow-up|1|||
126311215|NCT04598451|454429699|FG001|Overall Study|Physician Decision|1|||
126311216|NCT04598451|454429698|FG000|Overall Study|Requires Prohibited Medication|1|||
126311217|NCT04598451|454429699|FG001|Overall Study|Requires Prohibited Medication|0|||
126311218|NCT04598451|454429698|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
126311219|NCT04598451|454429699|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
126311220|NCT04594941|454429700|FG000|Overall Study|Other|0|||
126311221|NCT04594941|454429701|FG001|Overall Study|Other|3|||
126311222|NCT04594941|454429702|FG002|Overall Study|Other|1|||
126311223|NCT04594941|454429703|FG003|Overall Study|Other|0|||
126311224|NCT03535194|454429704|FG000|Induction Period|Adverse Event|2|||
126201351|NCT01920061|454021907|FG006|Overall Study|Participant refused further follow-up|0|||
126201352|NCT01920061|454021908|FG007|Overall Study|Participant refused further follow-up|0|||
126311225|NCT03535194|454429705|FG001|Induction Period|Adverse Event|2|||
126311226|NCT03535194|454429706|FG002|Induction Period|Adverse Event|1|||
126311227|NCT03535194|454429707|FG003|Induction Period|Adverse Event|3|||
126311228|NCT03535194|454429708|FG004|Induction Period|Adverse Event|0|||
126311229|NCT03535194|454429704|FG000|Induction Period|Death|0|||
126311230|NCT03535194|454429705|FG001|Induction Period|Death|1|||
126311231|NCT03535194|454429706|FG002|Induction Period|Death|0|||
126311232|NCT03535194|454429707|FG003|Induction Period|Death|0|||
126311233|NCT03535194|454429708|FG004|Induction Period|Death|0|||
126311234|NCT03535194|454429704|FG000|Induction Period|Lack of Efficacy|1|||
126311235|NCT03535194|454429705|FG001|Induction Period|Lack of Efficacy|3|||
126311236|NCT03535194|454429706|FG002|Induction Period|Lack of Efficacy|2|||
126311237|NCT03535194|454429707|FG003|Induction Period|Lack of Efficacy|2|||
126311238|NCT03535194|454429708|FG004|Induction Period|Lack of Efficacy|0|||
126311239|NCT03535194|454429704|FG000|Induction Period|Lost to Follow-up|3|||
126311240|NCT03535194|454429705|FG001|Induction Period|Lost to Follow-up|5|||
126311241|NCT03535194|454429706|FG002|Induction Period|Lost to Follow-up|2|||
126311242|NCT03535194|454429707|FG003|Induction Period|Lost to Follow-up|3|||
126311243|NCT03535194|454429708|FG004|Induction Period|Lost to Follow-up|0|||
126311244|NCT03535194|454429704|FG000|Induction Period|Physician Decision|1|||
126311245|NCT03535194|454429705|FG001|Induction Period|Physician Decision|1|||
126311246|NCT03535194|454429706|FG002|Induction Period|Physician Decision|0|||
126311247|NCT03535194|454429707|FG003|Induction Period|Physician Decision|0|||
126311248|NCT03535194|454429708|FG004|Induction Period|Physician Decision|0|||
126311249|NCT03535194|454429704|FG000|Induction Period|Protocol Violation|1|||
126311250|NCT03535194|454429705|FG001|Induction Period|Protocol Violation|0|||
126311251|NCT03535194|454429706|FG002|Induction Period|Protocol Violation|0|||
126311252|NCT03535194|454429707|FG003|Induction Period|Protocol Violation|1|||
126311253|NCT03535194|454429708|FG004|Induction Period|Protocol Violation|0|||
126311254|NCT03535194|454429704|FG000|Induction Period|Screen Failure|0|||
126311255|NCT03535194|454429705|FG001|Induction Period|Screen Failure|1|||
126311256|NCT03535194|454429706|FG002|Induction Period|Screen Failure|0|||
126311257|NCT03535194|454429707|FG003|Induction Period|Screen Failure|0|||
126311258|NCT03535194|454429708|FG004|Induction Period|Screen Failure|0|||
126311259|NCT03535194|454429704|FG000|Induction Period|Withdrawal by Subject|3|||
126311260|NCT03535194|454429705|FG001|Induction Period|Withdrawal by Subject|4|||
126311261|NCT03535194|454429706|FG002|Induction Period|Withdrawal by Subject|3|||
126311262|NCT03535194|454429707|FG003|Induction Period|Withdrawal by Subject|2|||
126311263|NCT03535194|454429708|FG004|Induction Period|Withdrawal by Subject|0|||
126311264|NCT03535194|454429704|FG000|Maintenance Period|Adverse Event|6|||
126311265|NCT03535194|454429705|FG001|Maintenance Period|Adverse Event|5|||
126311266|NCT03535194|454429706|FG002|Maintenance Period|Adverse Event|1|||
126311267|NCT03535194|454429707|FG003|Maintenance Period|Adverse Event|11|||
126311268|NCT03535194|454429708|FG004|Maintenance Period|Adverse Event|4|||
126311269|NCT03535194|454429704|FG000|Maintenance Period|Lack of Efficacy|3|||
126311270|NCT03535194|454429705|FG001|Maintenance Period|Lack of Efficacy|2|||
126311271|NCT03535194|454429706|FG002|Maintenance Period|Lack of Efficacy|5|||
126311272|NCT03535194|454429707|FG003|Maintenance Period|Lack of Efficacy|9|||
126311273|NCT03535194|454429708|FG004|Maintenance Period|Lack of Efficacy|0|||
126311274|NCT03535194|454429704|FG000|Maintenance Period|Lost to Follow-up|4|||
126311275|NCT03535194|454429705|FG001|Maintenance Period|Lost to Follow-up|2|||
126311276|NCT03535194|454429706|FG002|Maintenance Period|Lost to Follow-up|1|||
126311277|NCT03535194|454429707|FG003|Maintenance Period|Lost to Follow-up|5|||
126311278|NCT03535194|454429708|FG004|Maintenance Period|Lost to Follow-up|2|||
126311279|NCT03535194|454429704|FG000|Maintenance Period|Other|1|||
126311280|NCT03535194|454429705|FG001|Maintenance Period|Other|2|||
126311281|NCT03535194|454429706|FG002|Maintenance Period|Other|0|||
126311282|NCT03535194|454429707|FG003|Maintenance Period|Other|0|||
126311283|NCT03535194|454429708|FG004|Maintenance Period|Other|0|||
126311284|NCT03535194|454429704|FG000|Maintenance Period|Physician Decision|1|||
126311285|NCT03535194|454429705|FG001|Maintenance Period|Physician Decision|2|||
126201353|NCT01920061|454021909|FG008|Overall Study|Participant refused further follow-up|1|||
126201354|NCT01920061|454021910|FG009|Overall Study|Participant refused further follow-up|0|||
126201355|NCT01920061|454021911|FG010|Overall Study|Participant refused further follow-up|1|||
126311286|NCT03535194|454429706|FG002|Maintenance Period|Physician Decision|0|||
126311287|NCT03535194|454429707|FG003|Maintenance Period|Physician Decision|2|||
126311288|NCT03535194|454429708|FG004|Maintenance Period|Physician Decision|0|||
126311289|NCT03535194|454429704|FG000|Maintenance Period|Pregnancy|0|||
125977709|NCT05711641|453208166|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
126311290|NCT03535194|454429705|FG001|Maintenance Period|Pregnancy|0|||
126311291|NCT03535194|454429706|FG002|Maintenance Period|Pregnancy|0|||
126311292|NCT03535194|454429707|FG003|Maintenance Period|Pregnancy|2|||
126311293|NCT03535194|454429708|FG004|Maintenance Period|Pregnancy|0|||
126311294|NCT03535194|454429704|FG000|Maintenance Period|Protocol Violation|0|||
126311295|NCT03535194|454429705|FG001|Maintenance Period|Protocol Violation|1|||
126311296|NCT03535194|454429706|FG002|Maintenance Period|Protocol Violation|0|||
126311297|NCT03535194|454429707|FG003|Maintenance Period|Protocol Violation|0|||
126311298|NCT03535194|454429708|FG004|Maintenance Period|Protocol Violation|0|||
126311299|NCT03535194|454429704|FG000|Maintenance Period|Withdrawal by Subject|7|||
126311300|NCT03535194|454429705|FG001|Maintenance Period|Withdrawal by Subject|2|||
126311301|NCT03535194|454429706|FG002|Maintenance Period|Withdrawal by Subject|1|||
126311302|NCT03535194|454429707|FG003|Maintenance Period|Withdrawal by Subject|8|||
126311303|NCT03535194|454429708|FG004|Maintenance Period|Withdrawal by Subject|0|||
126311304|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Adverse Event|4|||
126311305|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Adverse Event|5|||
126311306|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Adverse Event|1|||
126311307|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Adverse Event|8|||
126311308|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Adverse Event|0|||
126311309|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
126311310|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
126311311|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
126311312|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
126311313|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
126311314|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
126311315|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
126311316|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
126311317|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
126311318|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
126311319|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Other|1|||
126311320|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Other|0|||
126311321|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Other|0|||
126311322|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Other|5|||
126311323|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Other|0|||
126311324|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Physician Decision|0|||
126311325|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Physician Decision|2|||
126311326|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Physician Decision|1|||
126311327|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Physician Decision|1|||
126311328|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Physician Decision|0|||
126311329|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
126311330|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
126311331|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
126311332|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
126311333|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126311334|NCT02091960|454429709|FG000|Overall Study|Death|7|||
126311335|NCT02091960|454429709|FG000|Overall Study|Withdrawal by Subject|1|||
126311336|NCT02091960|454429709|FG000|Overall Study|Miscellaneous Reasons|37|||
126311337|NCT02005692|454429724|FG000|Overall Study|Protocol Violation|1|||
126422272|NCT04640311|454842555|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422273|NCT04640311|454842556|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
126422274|NCT04640311|454842557|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422275|NCT04640311|454842558|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422276|NCT04640311|454842559|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422277|NCT04640311|454842560|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422278|NCT04640311|454842561|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422279|NCT04640311|454842562|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422280|NCT04640311|454842563|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422281|NCT04640311|454842564|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422282|NCT04640311|454842565|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422283|NCT04640311|454842566|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422284|NCT04640311|454842567|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422285|NCT04640311|454842555|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
126422286|NCT04640311|454842556|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
126422287|NCT04640311|454842557|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
126422288|NCT04640311|454842558|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422289|NCT04640311|454842559|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422290|NCT04640311|454842560|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422291|NCT04640311|454842561|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422292|NCT04640311|454842562|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422293|NCT04640311|454842563|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422294|NCT04640311|454842564|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422295|NCT04640311|454842565|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422296|NCT04640311|454842566|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422297|NCT04640311|454842567|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422298|NCT04640311|454842555|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422299|NCT04640311|454842556|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422300|NCT04640311|454842557|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
126422301|NCT04640311|454842558|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422302|NCT04640311|454842559|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422303|NCT04640311|454842560|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422304|NCT04640311|454842561|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422305|NCT04640311|454842562|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422306|NCT04640311|454842563|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422307|NCT04640311|454842564|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422308|NCT04640311|454842565|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422309|NCT04640311|454842566|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422310|NCT04640311|454842567|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422311|NCT04640311|454842555|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126311338|NCT02005692|454429724|FG000|Overall Study|Withdrawal by Subject|1|||
126422312|NCT04640311|454842556|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422313|NCT04640311|454842557|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422314|NCT04640311|454842558|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
126422315|NCT04640311|454842559|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422316|NCT04640311|454842560|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422317|NCT04640311|454842561|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
126422318|NCT04640311|454842562|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422319|NCT04640311|454842563|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422320|NCT04640311|454842564|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422321|NCT04640311|454842565|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422322|NCT04640311|454842566|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422323|NCT04640311|454842567|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422324|NCT04640311|454842555|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422325|NCT04640311|454842556|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422326|NCT04640311|454842557|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422327|NCT04640311|454842558|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422328|NCT04640311|454842559|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422329|NCT04640311|454842560|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
126422330|NCT04640311|454842561|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422331|NCT04640311|454842562|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422332|NCT04640311|454842563|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
126422333|NCT04640311|454842564|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422334|NCT04640311|454842565|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422335|NCT04640311|454842566|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422336|NCT04640311|454842567|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422337|NCT04640311|454842555|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422338|NCT04640311|454842556|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422339|NCT04640311|454842557|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422340|NCT04640311|454842558|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422341|NCT04640311|454842559|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422342|NCT04640311|454842560|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422343|NCT04640311|454842561|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
126422344|NCT04640311|454842562|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422345|NCT04640311|454842563|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422346|NCT04640311|454842564|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422347|NCT04640311|454842565|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
126422348|NCT04640311|454842566|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422349|NCT04640311|454842567|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422350|NCT04640311|454842555|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422351|NCT04640311|454842556|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422352|NCT04640311|454842557|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422353|NCT04640311|454842558|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126201356|NCT01920061|454021912|FG011|Overall Study|Participant refused further follow-up|0|||
126311339|NCT02005692|454429724|FG000|Overall Study|Discharged earlier than anticipated|5|||
126311340|NCT02091375|454429726|FG000|Overall Study|Adverse Event|8|||
126311341|NCT02091375|454429727|FG001|Overall Study|Adverse Event|1|||
126311342|NCT02091375|454429726|FG000|Overall Study|Lost to Follow-up|0|||
126311343|NCT02091375|454429727|FG001|Overall Study|Lost to Follow-up|1|||
126311344|NCT02091375|454429726|FG000|Overall Study|Withdrawal by Subject|0|||
126311345|NCT02091375|454429727|FG001|Overall Study|Withdrawal by Subject|1|||
126311346|NCT02091375|454429726|FG000|Overall Study|Withdrawn by the investigator|1|||
126311347|NCT02091375|454429727|FG001|Overall Study|Withdrawn by the investigator|0|||
126311348|NCT02682823|454429728|FG000|Overall Study|Withdrawal by Subject|0|||
126311349|NCT02682823|454429729|FG001|Overall Study|Withdrawal by Subject|0|||
126311350|NCT02682823|454429730|FG002|Overall Study|Withdrawal by Subject|1|||
126311351|NCT02682823|454429731|FG003|Overall Study|Withdrawal by Subject|0|||
126311352|NCT02682823|454429732|FG004|Overall Study|Withdrawal by Subject|1|||
126311353|NCT02682823|454429728|FG000|Overall Study|Protocol Deviation|0|||
126311354|NCT02682823|454429729|FG001|Overall Study|Protocol Deviation|1|||
126311355|NCT02682823|454429730|FG002|Overall Study|Protocol Deviation|0|||
126311356|NCT02682823|454429731|FG003|Overall Study|Protocol Deviation|0|||
126311357|NCT02682823|454429732|FG004|Overall Study|Protocol Deviation|0|||
126311358|NCT02682823|454429728|FG000|Overall Study|Adverse Event|0|||
126311359|NCT02682823|454429729|FG001|Overall Study|Adverse Event|0|||
126311360|NCT02682823|454429730|FG002|Overall Study|Adverse Event|0|||
126311361|NCT02682823|454429731|FG003|Overall Study|Adverse Event|1|||
126311362|NCT02682823|454429732|FG004|Overall Study|Adverse Event|0|||
126311363|NCT01938430|454429733|FG000|Overall Study|Randomized but Not Treated|0|||
126311364|NCT01938430|454429734|FG001|Overall Study|Randomized but Not Treated|0|||
126311365|NCT01938430|454429735|FG002|Overall Study|Randomized but Not Treated|0|||
126311366|NCT01938430|454429736|FG003|Overall Study|Randomized but Not Treated|0|||
126311367|NCT01938430|454429737|FG004|Overall Study|Randomized but Not Treated|0|||
126311368|NCT01938430|454429738|FG005|Overall Study|Randomized but Not Treated|0|||
126311369|NCT01938430|454429739|FG006|Overall Study|Randomized but Not Treated|0|||
126311370|NCT01938430|454429740|FG007|Overall Study|Randomized but Not Treated|0|||
126311371|NCT01938430|454429741|FG008|Overall Study|Randomized but Not Treated|0|||
126311372|NCT01938430|454429742|FG009|Overall Study|Randomized but Not Treated|0|||
126311373|NCT01938430|454429743|FG010|Overall Study|Randomized but Not Treated|1|||
126311374|NCT01938430|454429744|FG011|Overall Study|Randomized but Not Treated|0|||
126311375|NCT01938430|454429745|FG012|Overall Study|Randomized but Not Treated|0|||
126311376|NCT01938430|454429746|FG013|Overall Study|Randomized but Not Treated|1|||
126311377|NCT01938430|454429733|FG000|Overall Study|Adverse Event|0|||
126311378|NCT01938430|454429734|FG001|Overall Study|Adverse Event|0|||
126311379|NCT01938430|454429735|FG002|Overall Study|Adverse Event|0|||
126311380|NCT01938430|454429736|FG003|Overall Study|Adverse Event|0|||
126311381|NCT01938430|454429737|FG004|Overall Study|Adverse Event|0|||
126311382|NCT01938430|454429738|FG005|Overall Study|Adverse Event|0|||
126311383|NCT01938430|454429739|FG006|Overall Study|Adverse Event|1|||
126311384|NCT01938430|454429740|FG007|Overall Study|Adverse Event|0|||
126311385|NCT01938430|454429741|FG008|Overall Study|Adverse Event|0|||
126311386|NCT01938430|454429742|FG009|Overall Study|Adverse Event|0|||
126311387|NCT01938430|454429743|FG010|Overall Study|Adverse Event|0|||
126311388|NCT01938430|454429744|FG011|Overall Study|Adverse Event|0|||
126311389|NCT01938430|454429745|FG012|Overall Study|Adverse Event|0|||
126311390|NCT01938430|454429746|FG013|Overall Study|Adverse Event|0|||
126311391|NCT01938430|454429733|FG000|Overall Study|Death|1|||
126311392|NCT01938430|454429734|FG001|Overall Study|Death|2|||
126311393|NCT01938430|454429735|FG002|Overall Study|Death|2|||
126311394|NCT01938430|454429736|FG003|Overall Study|Death|1|||
126311395|NCT01938430|454429737|FG004|Overall Study|Death|0|||
126311396|NCT01938430|454429738|FG005|Overall Study|Death|0|||
126311397|NCT01938430|454429739|FG006|Overall Study|Death|1|||
126311398|NCT01938430|454429740|FG007|Overall Study|Death|1|||
126311399|NCT01938430|454429741|FG008|Overall Study|Death|2|||
126311400|NCT01938430|454429742|FG009|Overall Study|Death|3|||
126311401|NCT01938430|454429743|FG010|Overall Study|Death|0|||
126311402|NCT01938430|454429744|FG011|Overall Study|Death|0|||
126311403|NCT01938430|454429745|FG012|Overall Study|Death|0|||
126311404|NCT01938430|454429746|FG013|Overall Study|Death|0|||
126311405|NCT01938430|454429733|FG000|Overall Study|Investigator's Discretion|0|||
126311406|NCT01938430|454429734|FG001|Overall Study|Investigator's Discretion|0|||
126311407|NCT01938430|454429735|FG002|Overall Study|Investigator's Discretion|1|||
126311408|NCT01938430|454429736|FG003|Overall Study|Investigator's Discretion|0|||
126311409|NCT01938430|454429737|FG004|Overall Study|Investigator's Discretion|0|||
126311410|NCT01938430|454429738|FG005|Overall Study|Investigator's Discretion|0|||
126311411|NCT01938430|454429739|FG006|Overall Study|Investigator's Discretion|0|||
126311412|NCT01938430|454429740|FG007|Overall Study|Investigator's Discretion|0|||
126311413|NCT01938430|454429741|FG008|Overall Study|Investigator's Discretion|0|||
126311414|NCT01938430|454429742|FG009|Overall Study|Investigator's Discretion|0|||
126311415|NCT01938430|454429743|FG010|Overall Study|Investigator's Discretion|0|||
126311416|NCT01938430|454429744|FG011|Overall Study|Investigator's Discretion|0|||
126311417|NCT01938430|454429745|FG012|Overall Study|Investigator's Discretion|0|||
126311418|NCT01938430|454429746|FG013|Overall Study|Investigator's Discretion|0|||
126311419|NCT01938430|454429733|FG000|Overall Study|Lack of Efficacy|3|||
126311420|NCT01938430|454429734|FG001|Overall Study|Lack of Efficacy|1|||
126311421|NCT01938430|454429735|FG002|Overall Study|Lack of Efficacy|1|||
126311422|NCT01938430|454429736|FG003|Overall Study|Lack of Efficacy|1|||
126311423|NCT01938430|454429737|FG004|Overall Study|Lack of Efficacy|0|||
126311424|NCT01938430|454429738|FG005|Overall Study|Lack of Efficacy|0|||
126311425|NCT01938430|454429739|FG006|Overall Study|Lack of Efficacy|0|||
126311426|NCT01938430|454429740|FG007|Overall Study|Lack of Efficacy|0|||
126311427|NCT01938430|454429741|FG008|Overall Study|Lack of Efficacy|1|||
126311428|NCT01938430|454429742|FG009|Overall Study|Lack of Efficacy|0|||
126311429|NCT01938430|454429743|FG010|Overall Study|Lack of Efficacy|2|||
126311430|NCT01938430|454429744|FG011|Overall Study|Lack of Efficacy|1|||
126311431|NCT01938430|454429745|FG012|Overall Study|Lack of Efficacy|0|||
126311432|NCT01938430|454429746|FG013|Overall Study|Lack of Efficacy|0|||
126311433|NCT01938430|454429733|FG000|Overall Study|Lost to Follow-up|0|||
126311434|NCT01938430|454429734|FG001|Overall Study|Lost to Follow-up|0|||
126311435|NCT01938430|454429735|FG002|Overall Study|Lost to Follow-up|1|||
126311436|NCT01938430|454429736|FG003|Overall Study|Lost to Follow-up|0|||
126311437|NCT01938430|454429737|FG004|Overall Study|Lost to Follow-up|0|||
126311438|NCT01938430|454429738|FG005|Overall Study|Lost to Follow-up|1|||
126311439|NCT01938430|454429739|FG006|Overall Study|Lost to Follow-up|0|||
126311440|NCT01938430|454429740|FG007|Overall Study|Lost to Follow-up|0|||
126311441|NCT01938430|454429741|FG008|Overall Study|Lost to Follow-up|0|||
126311442|NCT01938430|454429742|FG009|Overall Study|Lost to Follow-up|0|||
126311443|NCT01938430|454429743|FG010|Overall Study|Lost to Follow-up|0|||
126311444|NCT01938430|454429744|FG011|Overall Study|Lost to Follow-up|0|||
126311445|NCT01938430|454429745|FG012|Overall Study|Lost to Follow-up|0|||
126311446|NCT01938430|454429746|FG013|Overall Study|Lost to Follow-up|0|||
126311447|NCT01938430|454429733|FG000|Overall Study|Withdrew Consent|0|||
126311448|NCT01938430|454429734|FG001|Overall Study|Withdrew Consent|0|||
126311449|NCT01938430|454429735|FG002|Overall Study|Withdrew Consent|0|||
126311450|NCT01938430|454429736|FG003|Overall Study|Withdrew Consent|0|||
126311451|NCT01938430|454429737|FG004|Overall Study|Withdrew Consent|0|||
126311452|NCT01938430|454429738|FG005|Overall Study|Withdrew Consent|0|||
126311453|NCT01938430|454429739|FG006|Overall Study|Withdrew Consent|0|||
126311454|NCT01938430|454429740|FG007|Overall Study|Withdrew Consent|0|||
126311455|NCT01938430|454429741|FG008|Overall Study|Withdrew Consent|1|||
126311456|NCT01938430|454429742|FG009|Overall Study|Withdrew Consent|0|||
126311457|NCT01938430|454429743|FG010|Overall Study|Withdrew Consent|0|||
126311458|NCT01938430|454429744|FG011|Overall Study|Withdrew Consent|0|||
126311459|NCT01938430|454429745|FG012|Overall Study|Withdrew Consent|0|||
126311460|NCT01938430|454429746|FG013|Overall Study|Withdrew Consent|0|||
126311461|NCT03875482|454429747|FG000|Overall Study|Adverse Event|0|||
126311462|NCT03875482|454429748|FG001|Overall Study|Adverse Event|1|||
126311463|NCT03875482|454429747|FG000|Overall Study|Withdrew consent|5|||
126311464|NCT03875482|454429748|FG001|Overall Study|Withdrew consent|6|||
126311465|NCT03875482|454429747|FG000|Overall Study|Lost to Follow-up|8|||
126311466|NCT03875482|454429748|FG001|Overall Study|Lost to Follow-up|2|||
126311467|NCT03875482|454429747|FG000|Overall Study|Lack of Efficacy|0|||
126311468|NCT03875482|454429748|FG001|Overall Study|Lack of Efficacy|11|||
126311469|NCT02738879|454429755|FG000|Overall Study|Adverse Event|1|||
126311470|NCT02738879|454429756|FG001|Overall Study|Adverse Event|1|||
126311471|NCT02738879|454429755|FG000|Overall Study|Death|0|||
126311472|NCT02738879|454429756|FG001|Overall Study|Death|2|||
126311473|NCT02738879|454429755|FG000|Overall Study|Lost to Follow-up|1|||
126311474|NCT02738879|454429756|FG001|Overall Study|Lost to Follow-up|5|||
126311475|NCT02738879|454429755|FG000|Overall Study|Protocol Violation|1|||
126311476|NCT02738879|454429756|FG001|Overall Study|Protocol Violation|3|||
126311477|NCT02738879|454429755|FG000|Overall Study|Physician Decision|3|||
126311478|NCT02738879|454429756|FG001|Overall Study|Physician Decision|4|||
126311479|NCT02738879|454429755|FG000|Overall Study|Pregnancy|0|||
126311480|NCT02738879|454429756|FG001|Overall Study|Pregnancy|1|||
126311481|NCT02738879|454429755|FG000|Overall Study|Screen Failure|1|||
126311482|NCT02738879|454429756|FG001|Overall Study|Screen Failure|2|||
126311483|NCT02738879|454429755|FG000|Overall Study|Site Discontinued Study Participation|1|||
126311484|NCT02738879|454429756|FG001|Overall Study|Site Discontinued Study Participation|0|||
126311485|NCT02738879|454429755|FG000|Overall Study|Withdrawal by Subject|5|||
126311486|NCT02738879|454429756|FG001|Overall Study|Withdrawal by Subject|7|||
126311487|NCT01438294|454429757|FG000|Overall Study|Lost to Follow-up|3|||
125977710|NCT00162370|453208167|FG000|Efficacy Population|Lost to Follow-up|51|||
126311488|NCT01438294|454429758|FG001|Overall Study|Lost to Follow-up|7|||
126311489|NCT01346189|454429761|FG000|Overall Study|Withdrawal by Subject|7|||
126311490|NCT01346189|454429762|FG001|Overall Study|Withdrawal by Subject|5|||
126311491|NCT01346189|454429763|FG002|Overall Study|Withdrawal by Subject|3|||
126311492|NCT01346189|454429764|FG003|Overall Study|Withdrawal by Subject|5|||
126311493|NCT01346189|454429761|FG000|Overall Study|Physician Decision|4|||
126311494|NCT01346189|454429762|FG001|Overall Study|Physician Decision|0|||
126311495|NCT01346189|454429763|FG002|Overall Study|Physician Decision|0|||
126422354|NCT04640311|454842559|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422355|NCT04640311|454842560|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422356|NCT04640311|454842561|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422357|NCT04640311|454842562|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422358|NCT04640311|454842563|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422359|NCT04640311|454842564|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126311496|NCT01346189|454429764|FG003|Overall Study|Physician Decision|0|||
126311497|NCT01346189|454429761|FG000|Overall Study|Moved|3|||
126311498|NCT01346189|454429762|FG001|Overall Study|Moved|0|||
126422360|NCT04640311|454842565|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422361|NCT04640311|454842566|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
126422362|NCT04640311|454842567|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422363|NCT00592904|454842568|FG000|Overall Study|Adverse Event|15|||
126422364|NCT00592904|454842569|FG001|Overall Study|Adverse Event|25|||
126422365|NCT00592904|454842570|FG002|Overall Study|Adverse Event|13|||
126422366|NCT00592904|454842571|FG003|Overall Study|Adverse Event|5|||
126422367|NCT00592904|454842568|FG000|Overall Study|Protocol Violation|1|||
126422368|NCT00592904|454842569|FG001|Overall Study|Protocol Violation|1|||
126422369|NCT00592904|454842570|FG002|Overall Study|Protocol Violation|0|||
126422370|NCT00592904|454842571|FG003|Overall Study|Protocol Violation|1|||
126422371|NCT00592904|454842568|FG000|Overall Study|Withdrawal by Subject|4|||
126422372|NCT00592904|454842569|FG001|Overall Study|Withdrawal by Subject|16|||
126422373|NCT00592904|454842570|FG002|Overall Study|Withdrawal by Subject|1|||
126422374|NCT00592904|454842571|FG003|Overall Study|Withdrawal by Subject|2|||
126422375|NCT00592904|454842568|FG000|Overall Study|Lack of Efficacy|2|||
126422376|NCT00592904|454842569|FG001|Overall Study|Lack of Efficacy|7|||
126422377|NCT00592904|454842570|FG002|Overall Study|Lack of Efficacy|2|||
126422378|NCT00592904|454842571|FG003|Overall Study|Lack of Efficacy|3|||
126422379|NCT00592904|454842568|FG000|Overall Study|Physician Decision|0|||
126422380|NCT00592904|454842569|FG001|Overall Study|Physician Decision|3|||
126422381|NCT00592904|454842570|FG002|Overall Study|Physician Decision|1|||
126422382|NCT00592904|454842571|FG003|Overall Study|Physician Decision|0|||
126422383|NCT00592904|454842568|FG000|Overall Study|Other|3|||
126422384|NCT00592904|454842569|FG001|Overall Study|Other|3|||
126422385|NCT00592904|454842570|FG002|Overall Study|Other|0|||
126422386|NCT00592904|454842571|FG003|Overall Study|Other|0|||
126422387|NCT03191630|454842572|FG000|Overall Study|Lost to Follow-up|7|||
126201357|NCT01920061|454021913|FG012|Overall Study|Participant refused further follow-up|1|||
126311499|NCT01346189|454429763|FG002|Overall Study|Moved|4|||
126311500|NCT01346189|454429764|FG003|Overall Study|Moved|0|||
126311501|NCT01346189|454429761|FG000|Overall Study|Other|2|||
126311502|NCT01346189|454429762|FG001|Overall Study|Other|4|||
126311503|NCT01346189|454429763|FG002|Overall Study|Other|7|||
126311504|NCT01346189|454429764|FG003|Overall Study|Other|3|||
126311505|NCT01346189|454429761|FG000|Overall Study|Death|0|||
126311506|NCT01346189|454429762|FG001|Overall Study|Death|3|||
126311507|NCT01346189|454429763|FG002|Overall Study|Death|0|||
126311508|NCT01346189|454429764|FG003|Overall Study|Death|0|||
126311509|NCT01346189|454429761|FG000|Overall Study|Non-health system primary care physician|0|||
126311510|NCT01346189|454429762|FG001|Overall Study|Non-health system primary care physician|5|||
126311511|NCT01346189|454429763|FG002|Overall Study|Non-health system primary care physician|0|||
126311512|NCT01346189|454429764|FG003|Overall Study|Non-health system primary care physician|0|||
126311513|NCT01346189|454429761|FG000|Overall Study|Travel|0|||
126311514|NCT01346189|454429762|FG001|Overall Study|Travel|0|||
126311515|NCT01346189|454429763|FG002|Overall Study|Travel|0|||
126311516|NCT01346189|454429764|FG003|Overall Study|Travel|3|||
126311517|NCT01730534|454429766|FG000|Overall Study|Withdrawal by Subject|97|||
126311518|NCT01730534|454429767|FG001|Overall Study|Withdrawal by Subject|127|||
126311519|NCT01730534|454429766|FG000|Overall Study|Lost to Follow-up|12|||
126311520|NCT01730534|454429767|FG001|Overall Study|Lost to Follow-up|18|||
126311521|NCT02256982|454429768|FG000|Overall Study|Disease Progression|0|||
126311522|NCT02256982|454429769|FG001|Overall Study|Disease Progression|1|||
126311523|NCT02658734|454429772|FG000|Overall Study|Adverse Event|2|||
126311524|NCT02658734|454429772|FG000|Overall Study|Death|4|||
126311525|NCT02658734|454429772|FG000|Overall Study|Lost to Follow-up|7|||
126311526|NCT02658734|454429772|FG000|Overall Study|Withdrawal of Consent|16|||
126311527|NCT02658734|454429772|FG000|Overall Study|Disease Progression|28|||
126311528|NCT00459706|454429773|FG000|Overall Study|Adverse Event|19|||
126311529|NCT00459706|454429774|FG001|Overall Study|Adverse Event|13|||
126422388|NCT03191630|454842573|FG001|Overall Study|Lost to Follow-up|7|||
126422389|NCT01367834|454842580|FG000|Overall Study|Withdrawal by Subject|2|||
126422390|NCT01367834|454842581|FG001|Overall Study|Withdrawal by Subject|2|||
126422391|NCT01367834|454842580|FG000|Overall Study|Study was ended.|0|||
126422392|NCT01367834|454842581|FG001|Overall Study|Study was ended.|1|||
126311530|NCT00459706|454429773|FG000|Overall Study|Withdrawal by Subject|1|||
126311531|NCT00459706|454429774|FG001|Overall Study|Withdrawal by Subject|6|||
126311532|NCT00459706|454429773|FG000|Overall Study|Physician Decision|2|||
126311533|NCT00459706|454429774|FG001|Overall Study|Physician Decision|0|||
126311534|NCT00459706|454429773|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
126311535|NCT00459706|454429774|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126311536|NCT00459706|454429773|FG000|Overall Study|Protocol Violation|2|||
126311537|NCT00459706|454429774|FG001|Overall Study|Protocol Violation|1|||
126311538|NCT00459706|454429773|FG000|Overall Study|Failed to Return|1|||
126311539|NCT00459706|454429774|FG001|Overall Study|Failed to Return|0|||
126311540|NCT00459706|454429773|FG000|Overall Study|Other|0|||
126311541|NCT00459706|454429774|FG001|Overall Study|Other|1|||
126311542|NCT03843632|454429778|FG000|Overall Study|Withdrawal by Subject|1|||
126311543|NCT03843632|454429779|FG001|Overall Study|Withdrawal by Subject|0|||
126311544|NCT03843632|454429780|FG002|Overall Study|Withdrawal by Subject|0|||
126311545|NCT03843632|454429781|FG003|Overall Study|Withdrawal by Subject|0|||
126311546|NCT05036668|454429785|FG000|Overall Study|lost to follow Up|0|||
126311547|NCT05036668|454429786|FG001|Overall Study|lost to follow Up|0|||
126311548|NCT05036668|454429787|FG002|Overall Study|lost to follow Up|1|||
126311549|NCT01190267|454429790|FG000|Overall Study|Adverse Event|10|||
126311550|NCT01190267|454429791|FG001|Overall Study|Adverse Event|0|||
126311551|NCT01190267|454429790|FG000|Overall Study|Treatment Failure|8|||
126311552|NCT01190267|454429791|FG001|Overall Study|Treatment Failure|2|||
126311553|NCT01190267|454429790|FG000|Overall Study|Lost to Follow-up|2|||
126311554|NCT01190267|454429791|FG001|Overall Study|Lost to Follow-up|0|||
126311555|NCT01190267|454429790|FG000|Overall Study|Withdrawal by Subject|13|||
126311556|NCT01190267|454429791|FG001|Overall Study|Withdrawal by Subject|1|||
126311557|NCT01190267|454429790|FG000|Overall Study|Protocol Violation|8|||
126311558|NCT01190267|454429791|FG001|Overall Study|Protocol Violation|1|||
126311559|NCT01901653|454429797|FG000|Overall Study|Death|2|||
126311560|NCT01901653|454429798|FG001|Overall Study|Death|1|||
126201358|NCT01920061|454021914|FG013|Overall Study|Participant refused further follow-up|0|||
126201359|NCT01920061|454021915|FG014|Overall Study|Participant refused further follow-up|1|||
126201360|NCT01920061|454021916|FG015|Overall Study|Participant refused further follow-up|2|||
126201361|NCT01920061|454021917|FG016|Overall Study|Participant refused further follow-up|1|||
126201362|NCT01920061|454021918|FG017|Overall Study|Participant refused further follow-up|1|||
126201363|NCT01920061|454021919|FG018|Overall Study|Participant refused further follow-up|0|||
126201364|NCT01920061|454021920|FG019|Overall Study|Participant refused further follow-up|0|||
126201365|NCT00517634|454021921|FG000|Second Treatment Period|Withdrawal by Subject|0|||
126201366|NCT00517634|454021922|FG001|Second Treatment Period|Withdrawal by Subject|0|||
126201367|NCT00517634|454021923|FG002|Second Treatment Period|Withdrawal by Subject|0|||
126201368|NCT00517634|454021924|FG003|Second Treatment Period|Withdrawal by Subject|0|||
126201369|NCT00517634|454021925|FG004|Second Treatment Period|Withdrawal by Subject|1|||
126201370|NCT00517634|454021926|FG005|Second Treatment Period|Withdrawal by Subject|0|||
126201371|NCT03091920|454021927|FG000|Overall Study|Adverse Event|0|||
126201372|NCT03091920|454021928|FG001|Overall Study|Adverse Event|1|||
126201373|NCT03091920|454021929|FG002|Overall Study|Adverse Event|0|||
126201374|NCT00453349|454021931|FG000|Randomized|Adverse Event|12|||
126201375|NCT00453349|454021932|FG001|Randomized|Adverse Event|11|||
126201376|NCT00453349|454021931|FG000|Randomized|Lack of Efficacy|2|||
126201377|NCT00453349|454021932|FG001|Randomized|Lack of Efficacy|1|||
126201378|NCT00453349|454021931|FG000|Randomized|Lost to Follow-up|7|||
126201379|NCT00453349|454021932|FG001|Randomized|Lost to Follow-up|5|||
126201380|NCT00453349|454021931|FG000|Randomized|Protocol Violation|1|||
126201381|NCT00453349|454021932|FG001|Randomized|Protocol Violation|1|||
126201382|NCT00453349|454021931|FG000|Randomized|Withdrawal by Subject|3|||
126201383|NCT00453349|454021932|FG001|Randomized|Withdrawal by Subject|5|||
126201384|NCT00453349|454021931|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
126201385|NCT00453349|454021932|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
126201386|NCT00453349|454021931|FG000|Completed Study|Adverse Event|12|||
126201387|NCT00453349|454021932|FG001|Completed Study|Adverse Event|11|||
126201388|NCT00453349|454021931|FG000|Completed Study|Lack of Efficacy|2|||
126201389|NCT00453349|454021932|FG001|Completed Study|Lack of Efficacy|1|||
126201390|NCT00453349|454021931|FG000|Completed Study|Lost to Follow-up|7|||
126201391|NCT00453349|454021932|FG001|Completed Study|Lost to Follow-up|5|||
126201392|NCT00453349|454021931|FG000|Completed Study|Protocol Violation|1|||
126201393|NCT00453349|454021932|FG001|Completed Study|Protocol Violation|1|||
126201394|NCT00453349|454021931|FG000|Completed Study|Withdrawal by Subject|3|||
126201395|NCT00453349|454021932|FG001|Completed Study|Withdrawal by Subject|5|||
126201396|NCT00453349|454021931|FG000|Completed Study|Lost to follow up after study treatment|2|||
125977711|NCT04040751|453208168|FG000|Overall Study|Withdrawal by Subject|2|||
125977712|NCT04040751|453208169|FG001|Overall Study|Withdrawal by Subject|0|||
126201397|NCT00453349|454021932|FG001|Completed Study|Lost to follow up after study treatment|11|||
126201398|NCT00695318|454021934|FG000|Overall Study|Lost to Follow-up|1|||
126201399|NCT00695318|454021935|FG001|Overall Study|Lost to Follow-up|0|||
126201400|NCT00695318|454021934|FG000|Overall Study|Withdrawal by Subject|2|||
126311561|NCT01901653|454429799|FG002|Overall Study|Death|8|||
126311562|NCT01901653|454429800|FG003|Overall Study|Death|3|||
126311563|NCT01901653|454429801|FG004|Overall Study|Death|2|||
126311564|NCT01901653|454429802|FG005|Overall Study|Death|2|||
126311565|NCT01901653|454429803|FG006|Overall Study|Death|6|||
126201401|NCT00695318|454021935|FG001|Overall Study|Withdrawal by Subject|0|||
126201402|NCT00695318|454021934|FG000|Overall Study|Death|1|||
126201403|NCT00695318|454021935|FG001|Overall Study|Death|1|||
126201404|NCT00695318|454021934|FG000|Overall Study|Study Terminated|1|||
126201405|NCT00695318|454021935|FG001|Overall Study|Study Terminated|0|||
126201406|NCT01078389|454023704|FG000|Overall Study|Adverse Event|10|||
126201407|NCT01078389|454023705|FG001|Overall Study|Adverse Event|6|||
126201408|NCT01078389|454023704|FG000|Overall Study|Major Protocol Deviation|2|||
126201409|NCT01078389|454023705|FG001|Overall Study|Major Protocol Deviation|0|||
126311566|NCT01901653|454429804|FG007|Overall Study|Death|9|||
126422393|NCT01020786|454842586|FG000|Induction Period|Entry Criteria Not Met|2|||
126422394|NCT01020786|454842586|FG000|Induction Period|Adverse Event|10|||
126422395|NCT01020786|454842586|FG000|Induction Period|Progressive Disease|31|||
126422396|NCT01020786|454842586|FG000|Induction Period|Investigator Decision|3|||
126422397|NCT01020786|454842586|FG000|Induction Period|Withdrawal by Subject|3|||
126422398|NCT01020786|454842586|FG000|Maintenance Period|Adverse Event|8|||
125977713|NCT04040751|453208170|FG002|Overall Study|Withdrawal by Subject|2|||
125977714|NCT04040751|453208171|FG003|Overall Study|Withdrawal by Subject|0|||
125977715|NCT03896035|453208172|FG000|Overall Study|Lost to Follow-up|2|||
125977716|NCT03896035|453208173|FG001|Overall Study|Lost to Follow-up|6|||
125977717|NCT03896035|453208172|FG000|Overall Study|Withdrawal by Subject|0|||
125977718|NCT03896035|453208173|FG001|Overall Study|Withdrawal by Subject|1|||
125977719|NCT03896035|453208172|FG000|Overall Study|Health/family health issues during COVID|0|||
125977720|NCT03896035|453208173|FG001|Overall Study|Health/family health issues during COVID|4|||
125977721|NCT02862457|453208174|FG000|Overall Study|Death|1|||
125977722|NCT02862457|453208175|FG001|Overall Study|Death|3|||
125977723|NCT02862457|453208176|FG002|Overall Study|Death|2|||
125977724|NCT02862457|453208177|FG003|Overall Study|Death|3|||
125977725|NCT02862457|453208178|FG004|Overall Study|Death|0|||
125977726|NCT02862457|453208179|FG005|Overall Study|Death|2|||
125977727|NCT02862457|453208180|FG006|Overall Study|Death|1|||
125977728|NCT02862457|453208174|FG000|Overall Study|Lost to Follow-up|1|||
125977729|NCT02862457|453208175|FG001|Overall Study|Lost to Follow-up|0|||
125977730|NCT02862457|453208176|FG002|Overall Study|Lost to Follow-up|0|||
125977731|NCT02862457|453208177|FG003|Overall Study|Lost to Follow-up|1|||
125977732|NCT02862457|453208178|FG004|Overall Study|Lost to Follow-up|0|||
125977733|NCT02862457|453208179|FG005|Overall Study|Lost to Follow-up|0|||
125977734|NCT02862457|453208180|FG006|Overall Study|Lost to Follow-up|0|||
125977735|NCT02862457|453208174|FG000|Overall Study|Withdrawal by Subject|0|||
125977736|NCT02862457|453208175|FG001|Overall Study|Withdrawal by Subject|0|||
125977737|NCT02862457|453208176|FG002|Overall Study|Withdrawal by Subject|1|||
125977738|NCT02862457|453208177|FG003|Overall Study|Withdrawal by Subject|0|||
125977739|NCT02862457|453208178|FG004|Overall Study|Withdrawal by Subject|0|||
125977740|NCT02862457|453208179|FG005|Overall Study|Withdrawal by Subject|1|||
125977741|NCT02862457|453208180|FG006|Overall Study|Withdrawal by Subject|0|||
125977742|NCT01388816|453208181|FG000|Overall Study|Adverse Event|0|||
125977743|NCT01388816|453208182|FG001|Overall Study|Adverse Event|2|||
125977744|NCT01388816|453208183|FG002|Overall Study|Adverse Event|0|||
125977745|NCT01388816|453208184|FG003|Overall Study|Adverse Event|0|||
125977746|NCT01388816|453208181|FG000|Overall Study|Lost to Follow-up|0|||
125977747|NCT01388816|453208182|FG001|Overall Study|Lost to Follow-up|1|||
125977748|NCT01388816|453208183|FG002|Overall Study|Lost to Follow-up|0|||
125977749|NCT01388816|453208184|FG003|Overall Study|Lost to Follow-up|0|||
125977750|NCT01388816|453208181|FG000|Overall Study|Withdrawal by Subject|2|||
125977751|NCT01388816|453208182|FG001|Overall Study|Withdrawal by Subject|1|||
125977752|NCT01388816|453208183|FG002|Overall Study|Withdrawal by Subject|1|||
125977753|NCT01388816|453208184|FG003|Overall Study|Withdrawal by Subject|0|||
125977754|NCT01388816|453208181|FG000|Overall Study|Protocol Violation|0|||
126422399|NCT01020786|454842586|FG000|Maintenance Period|Progressive Disease|43|||
125977755|NCT01388816|453208182|FG001|Overall Study|Protocol Violation|0|||
125977756|NCT01388816|453208183|FG002|Overall Study|Protocol Violation|2|||
125977757|NCT01388816|453208184|FG003|Overall Study|Protocol Violation|0|||
125977758|NCT00743366|453208185|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
125977759|NCT00743366|453208186|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
125977760|NCT03206203|453208187|FG000|Treatment|Death|38|||
125977761|NCT03206203|453208188|FG001|Treatment|Death|26|||
125977762|NCT03206203|453208189|FG002|Treatment|Death|0|||
125977763|NCT03206203|453208187|FG000|Treatment|Withdrawal by Subject|1|||
125977764|NCT03206203|453208188|FG001|Treatment|Withdrawal by Subject|0|||
126201410|NCT01078389|454023704|FG000|Overall Study|Lost to Follow-up|23|||
126201411|NCT01078389|454023705|FG001|Overall Study|Lost to Follow-up|23|||
126201412|NCT01078389|454023704|FG000|Overall Study|Voluntary Withdrawal|20|||
126201413|NCT01078389|454023705|FG001|Overall Study|Voluntary Withdrawal|36|||
126201414|NCT01078389|454023704|FG000|Overall Study|Other|9|||
126201415|NCT01078389|454023705|FG001|Overall Study|Other|2|||
126201416|NCT01002573|454023706|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
126201417|NCT01002573|454023707|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
126201418|NCT02028182|454023708|FG000|Overall Study|Protocol Violation|2|||
126201419|NCT02198040|454023709|FG000|Overall Study|Work reasons|0|||
125977765|NCT03206203|453208189|FG002|Treatment|Withdrawal by Subject|0|||
125977766|NCT03206203|453208187|FG000|Treatment|Lost to Follow-up|4|||
125977767|NCT03206203|453208188|FG001|Treatment|Lost to Follow-up|0|||
125977768|NCT03206203|453208189|FG002|Treatment|Lost to Follow-up|0|||
125977769|NCT03206203|453208187|FG000|Treatment|N/A in Follow-Up|8|||
125977770|NCT03206203|453208188|FG001|Treatment|N/A in Follow-Up|1|||
126201420|NCT02198040|454023710|FG001|Overall Study|Work reasons|1|||
126201421|NCT02198040|454023711|FG002|Overall Study|Work reasons|0|||
126201422|NCT02198040|454023709|FG000|Overall Study|Withdrawal by Subject|0|||
126201423|NCT02198040|454023710|FG001|Overall Study|Withdrawal by Subject|0|||
126201424|NCT02198040|454023711|FG002|Overall Study|Withdrawal by Subject|1|||
126201425|NCT00240331|454023712|FG000|Overall Study|Withdrawal by Subject|125|||
126201426|NCT00240331|454023713|FG001|Overall Study|Withdrawal by Subject|132|||
126311567|NCT01901653|454429805|FG008|Overall Study|Death|1|||
126311568|NCT01901653|454429806|FG009|Overall Study|Death|16|||
126311569|NCT01901653|454429807|FG010|Overall Study|Death|2|||
126311570|NCT01901653|454429808|FG011|Overall Study|Death|15|||
126422400|NCT01020786|454842586|FG000|Maintenance Period|Withdrawal by Subject|8|||
126422401|NCT01020786|454842586|FG000|Maintenance Period|Sponsor Decision|1|||
126422402|NCT01818596|454842595|FG000|Overall Study|Enrolled but Not Treated|4|||
126422403|NCT01818596|454842596|FG001|Overall Study|Enrolled but Not Treated|0|||
126422404|NCT01818596|454842595|FG000|Overall Study|Adverse Event|7|||
126422405|NCT01818596|454842596|FG001|Overall Study|Adverse Event|0|||
126422406|NCT01818596|454842595|FG000|Overall Study|Death|3|||
126422407|NCT01818596|454842596|FG001|Overall Study|Death|0|||
126422408|NCT01818596|454842595|FG000|Overall Study|Investigator's Discretion|4|||
126422409|NCT01818596|454842596|FG001|Overall Study|Investigator's Discretion|0|||
126422410|NCT01818596|454842595|FG000|Overall Study|Protocol Violation|1|||
126422411|NCT01818596|454842596|FG001|Overall Study|Protocol Violation|0|||
126422412|NCT01818596|454842595|FG000|Overall Study|Withdrew Consent|5|||
126422413|NCT01818596|454842596|FG001|Overall Study|Withdrew Consent|0|||
126422414|NCT01818596|454842595|FG000|Overall Study|Lost to Follow-up|7|||
126422415|NCT01818596|454842596|FG001|Overall Study|Lost to Follow-up|0|||
126422416|NCT03801174|454842597|FG000|Overall Study|Withdrawal by Subject|14|||
126422417|NCT03801174|454842598|FG001|Overall Study|Withdrawal by Subject|15|||
126422418|NCT03801174|454842597|FG000|Overall Study|Death|1|||
126422419|NCT03801174|454842598|FG001|Overall Study|Death|0|||
126422420|NCT03801174|454842597|FG000|Overall Study|Pregnancy|2|||
126422421|NCT03801174|454842598|FG001|Overall Study|Pregnancy|2|||
126422422|NCT03801174|454842597|FG000|Overall Study|Lost to Follow-up|19|||
126422423|NCT03801174|454842598|FG001|Overall Study|Lost to Follow-up|10|||
126422424|NCT03801174|454842597|FG000|Overall Study|Other|4|||
126422425|NCT03801174|454842598|FG001|Overall Study|Other|3|||
126422426|NCT03801174|454842597|FG000|Overall Study|Lack of Efficacy|4|||
126422427|NCT03801174|454842598|FG001|Overall Study|Lack of Efficacy|0|||
126422428|NCT03801174|454842597|FG000|Overall Study|Unwilling to complete activities|5|||
126422429|NCT03801174|454842598|FG001|Overall Study|Unwilling to complete activities|6|||
126422430|NCT03801174|454842597|FG000|Overall Study|Moved out of area|3|||
126422431|NCT03801174|454842598|FG001|Overall Study|Moved out of area|0|||
126311571|NCT01901653|454429809|FG012|Overall Study|Death|4|||
126311572|NCT01901653|454429797|FG000|Overall Study|Lost to Follow-up|1|||
126311573|NCT01901653|454429798|FG001|Overall Study|Lost to Follow-up|0|||
126311574|NCT01901653|454429799|FG002|Overall Study|Lost to Follow-up|2|||
126311575|NCT01901653|454429800|FG003|Overall Study|Lost to Follow-up|0|||
126311576|NCT01901653|454429801|FG004|Overall Study|Lost to Follow-up|0|||
126311577|NCT01901653|454429802|FG005|Overall Study|Lost to Follow-up|1|||
126311578|NCT01901653|454429803|FG006|Overall Study|Lost to Follow-up|0|||
126311579|NCT01901653|454429804|FG007|Overall Study|Lost to Follow-up|1|||
126311580|NCT01901653|454429805|FG008|Overall Study|Lost to Follow-up|0|||
126311581|NCT01901653|454429806|FG009|Overall Study|Lost to Follow-up|0|||
126311582|NCT01901653|454429807|FG010|Overall Study|Lost to Follow-up|0|||
126311583|NCT01901653|454429808|FG011|Overall Study|Lost to Follow-up|0|||
126311584|NCT01901653|454429809|FG012|Overall Study|Lost to Follow-up|0|||
126422432|NCT02915263|454842611|FG000|Overall Study|Covid|3|||
126422433|NCT02915263|454842612|FG001|Overall Study|Covid|2|||
126422434|NCT01879683|454842613|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
125977771|NCT03206203|453208189|FG002|Treatment|N/A in Follow-Up|0|||
125977772|NCT03206203|453208187|FG000|Treatment|Disease progression|0|||
126422435|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Progressive disease|50|||
126422436|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Progressive disease|110|||
126422437|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Progressive disease|0|||
126422438|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Progressive disease|0|||
126422439|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
126422440|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
125977773|NCT03206203|453208188|FG001|Treatment|Disease progression|1|||
125977774|NCT03206203|453208189|FG002|Treatment|Disease progression|0|||
126201427|NCT00240331|454023712|FG000|Overall Study|Option selected by investigator|1|||
126311585|NCT01901653|454429797|FG000|Overall Study|Withdrawal by Subject|0|||
126311586|NCT01901653|454429798|FG001|Overall Study|Withdrawal by Subject|0|||
126422441|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126422442|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126422443|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Adverse Event|7|||
126422444|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Adverse Event|7|||
126422445|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Adverse Event|0|||
126422446|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Adverse Event|0|||
126422447|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Other|1|||
126422448|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Other|3|||
126422449|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Other|0|||
125977775|NCT03206203|453208187|FG000|Treatment|Refused follow-up|0|||
125977776|NCT03206203|453208188|FG001|Treatment|Refused follow-up|1|||
125977777|NCT03206203|453208189|FG002|Treatment|Refused follow-up|0|||
125977778|NCT03206203|453208187|FG000|Treatment|Cross over to Arm 1|0|||
125977779|NCT03206203|453208188|FG001|Treatment|Cross over to Arm 1|19|||
125977780|NCT03206203|453208189|FG002|Treatment|Cross over to Arm 1|0|||
125977781|NCT03206203|453208187|FG000|Optional Cross-Over|Death|0|||
125977782|NCT03206203|453208188|FG001|Optional Cross-Over|Death|0|||
125977783|NCT03206203|453208189|FG002|Optional Cross-Over|Death|14|||
125977784|NCT03206203|453208187|FG000|Optional Cross-Over|Refused follow-up|0|||
125977785|NCT03206203|453208188|FG001|Optional Cross-Over|Refused follow-up|0|||
125977786|NCT03206203|453208189|FG002|Optional Cross-Over|Refused follow-up|2|||
125977787|NCT00335322|453208190|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
125977788|NCT00335322|453208191|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
125977789|NCT00335322|453208192|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
125977790|NCT01152580|453208195|FG000|Overall Study|Withdrawal by Subject|0|||
125977791|NCT01152580|453208196|FG001|Overall Study|Withdrawal by Subject|1|||
125977792|NCT03364751|453208197|FG000|Overall Study|Withdrawal by Subject|1|||
125977793|NCT03364751|453208198|FG001|Overall Study|Withdrawal by Subject|0|||
125977794|NCT03364751|453208199|FG002|Overall Study|Withdrawal by Subject|0|||
125977795|NCT03364751|453208200|FG003|Overall Study|Withdrawal by Subject|0|||
125977796|NCT03364751|453208197|FG000|Overall Study|Lost to Follow-up|0|||
125977797|NCT03364751|453208198|FG001|Overall Study|Lost to Follow-up|1|||
125977798|NCT03364751|453208199|FG002|Overall Study|Lost to Follow-up|0|||
125977799|NCT03364751|453208200|FG003|Overall Study|Lost to Follow-up|0|||
125977800|NCT00675766|453208201|FG000|Overall Study|Lost to Follow-up|6|||
125977801|NCT00675766|453208202|FG001|Overall Study|Lost to Follow-up|5|||
125977802|NCT00675766|453208203|FG002|Overall Study|Lost to Follow-up|21|||
125977803|NCT00675766|453208204|FG003|Overall Study|Lost to Follow-up|26|||
125977804|NCT02275065|453208206|FG000|Overall Study|Randomized but not treated|1|||
125977805|NCT02275065|453208207|FG001|Overall Study|Randomized but not treated|0|||
125977806|NCT02275065|453208208|FG002|Overall Study|Randomized but not treated|1|||
125977807|NCT02275065|453208209|FG003|Overall Study|Randomized but not treated|1|||
125977808|NCT02275065|453208210|FG004|Overall Study|Randomized but not treated|0|||
125977809|NCT03015402|453208211|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125977810|NCT03015402|453208212|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
125977811|NCT03015402|453208211|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
125977812|NCT03015402|453208212|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
125977813|NCT03213158|453208213|FG000|Overall Study|Withdrawal by Subject|1|||
125977814|NCT03213158|453208213|FG000|Overall Study|Physician Decision|2|||
125977815|NCT01995461|453208216|FG000|Overall Study|Death|1|||
125977816|NCT01995461|453208216|FG000|Overall Study|Lost to Follow-up|2|||
125977817|NCT01995461|453208216|FG000|Overall Study|Withdrawal by Subject|2|||
125977818|NCT01207102|453208221|FG000|Overall Study|Withdrawal by Subject|5|||
125977819|NCT01207102|453208221|FG000|Overall Study|Adverse Event|2|||
125977820|NCT01207102|453208221|FG000|Overall Study|progression|2|||
125977821|NCT01207102|453208221|FG000|Overall Study|Withdrawal by Treating Physician|1|||
125977822|NCT01777854|453208222|FG000|Overall Study|Physician Decision|3|||
125977823|NCT01777854|453208223|FG001|Overall Study|Physician Decision|3|||
125977824|NCT01239030|453208228|FG000|Double Blind|Adverse Event|0|||
125977825|NCT01239030|453208229|FG001|Double Blind|Adverse Event|1|||
126422450|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Other|0|||
125977826|NCT01239030|453208230|FG002|Double Blind|Adverse Event|0|||
125977827|NCT01239030|453208231|FG003|Double Blind|Adverse Event|2|||
125977828|NCT01239030|453208232|FG004|Double Blind|Adverse Event|0|||
125977829|NCT01239030|453208228|FG000|Double Blind|Withdrawal by Subject|0|||
125977830|NCT01239030|453208229|FG001|Double Blind|Withdrawal by Subject|1|||
125977831|NCT01239030|453208230|FG002|Double Blind|Withdrawal by Subject|1|||
125977832|NCT01239030|453208231|FG003|Double Blind|Withdrawal by Subject|0|||
125977833|NCT01239030|453208232|FG004|Double Blind|Withdrawal by Subject|1|||
125977834|NCT01239030|453208228|FG000|Double Blind|Lost to Follow-up|1|||
125977835|NCT01239030|453208229|FG001|Double Blind|Lost to Follow-up|1|||
126422451|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Physician Decision|6|||
126311587|NCT01901653|454429799|FG002|Overall Study|Withdrawal by Subject|0|||
125977836|NCT01239030|453208230|FG002|Double Blind|Lost to Follow-up|0|||
125977837|NCT01239030|453208231|FG003|Double Blind|Lost to Follow-up|0|||
125977838|NCT01239030|453208232|FG004|Double Blind|Lost to Follow-up|0|||
126422452|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Physician Decision|3|||
126422453|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Physician Decision|0|||
126422454|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Physician Decision|0|||
126422455|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Death|1|||
126422456|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Death|1|||
126422457|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Death|0|||
126422458|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Death|0|||
126422459|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
126422460|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
126422461|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
126422462|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
126422463|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
126422464|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
126422465|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
126422466|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
126422467|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
126422468|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
126422469|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
126422470|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
126422471|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
126422472|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
126422473|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
126422474|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
126422475|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Other|0|||
126422476|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Other|0|||
126422477|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Other|4|||
126311588|NCT01901653|454429800|FG003|Overall Study|Withdrawal by Subject|0|||
126311589|NCT01901653|454429801|FG004|Overall Study|Withdrawal by Subject|0|||
126311590|NCT01901653|454429802|FG005|Overall Study|Withdrawal by Subject|0|||
126422478|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Other|7|||
126422479|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
126422480|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
126422481|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
126422482|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
126422483|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Death|0|||
126422484|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Death|0|||
126422485|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Death|2|||
126422486|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Death|7|||
126422487|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
126422488|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
125977839|NCT01239030|453208228|FG000|Double Blind|Physician Decision|0|||
125977840|NCT01239030|453208229|FG001|Double Blind|Physician Decision|1|||
125977841|NCT01239030|453208230|FG002|Double Blind|Physician Decision|0|||
125977842|NCT01239030|453208231|FG003|Double Blind|Physician Decision|0|||
125977843|NCT01239030|453208232|FG004|Double Blind|Physician Decision|0|||
125977844|NCT01239030|453208228|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
125977845|NCT01239030|453208229|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
125977846|NCT01239030|453208230|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
125977847|NCT01239030|453208231|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
125977848|NCT01239030|453208232|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
125977849|NCT01239030|453208228|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
125977850|NCT01239030|453208229|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
125977851|NCT01239030|453208230|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
125977852|NCT01239030|453208231|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
125977853|NCT01239030|453208232|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
125977854|NCT01239030|453208228|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
125977855|NCT01239030|453208229|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
125977856|NCT01239030|453208230|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
125977857|NCT01239030|453208231|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
125977858|NCT01239030|453208232|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
125977859|NCT01239030|453208228|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
125977860|NCT01239030|453208229|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
125977861|NCT01239030|453208230|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
125977862|NCT01239030|453208231|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
125977863|NCT01239030|453208232|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
126311591|NCT01901653|454429803|FG006|Overall Study|Withdrawal by Subject|1|||
126311592|NCT01901653|454429804|FG007|Overall Study|Withdrawal by Subject|0|||
126311593|NCT01901653|454429805|FG008|Overall Study|Withdrawal by Subject|0|||
126311594|NCT01901653|454429806|FG009|Overall Study|Withdrawal by Subject|0|||
125977864|NCT01212770|453208233|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
125977865|NCT01212770|453208234|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
125977866|NCT01212770|453208235|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
125977867|NCT01212770|453208236|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125977868|NCT01212770|453208237|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125977869|NCT01212770|453208238|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125977870|NCT01212770|453208239|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125977871|NCT01212770|453208240|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125977872|NCT01212770|453208241|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125977873|NCT01212770|453208233|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
125977874|NCT01212770|453208234|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
125977875|NCT01212770|453208235|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
125977876|NCT01212770|453208236|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125977877|NCT01212770|453208237|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125977878|NCT01212770|453208238|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125977879|NCT01212770|453208239|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125977880|NCT01212770|453208240|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125977881|NCT01212770|453208241|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125977882|NCT01212770|453208233|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
126201428|NCT00240331|454023713|FG001|Overall Study|Option selected by investigator|2|||
126201429|NCT02551874|454023714|FG000|Overall Study|Lost to Follow-up|0|||
126201430|NCT02551874|454023715|FG001|Overall Study|Lost to Follow-up|2|||
126201431|NCT02551874|454023714|FG000|Overall Study|Pregnancy|0|||
126201432|NCT02551874|454023715|FG001|Overall Study|Pregnancy|1|||
126201433|NCT02551874|454023714|FG000|Overall Study|Reason not reported|10|||
126201434|NCT02551874|454023715|FG001|Overall Study|Reason not reported|4|||
126201435|NCT02551874|454023714|FG000|Overall Study|Did not receive randomized treatment|0|||
126201436|NCT02551874|454023715|FG001|Overall Study|Did not receive randomized treatment|7|||
126201437|NCT02551874|454023714|FG000|Overall Study|Did not enter long-term study|18|||
126201438|NCT02551874|454023715|FG001|Overall Study|Did not enter long-term study|25|||
126201439|NCT02491463|454023716|FG000|Overall Study|Withdrawal by Subject|1|||
126201440|NCT02491463|454023717|FG001|Overall Study|Withdrawal by Subject|2|||
126201441|NCT02491463|454023718|FG002|Overall Study|Withdrawal by Subject|0|||
126201442|NCT02491463|454023719|FG003|Overall Study|Withdrawal by Subject|0|||
126201443|NCT02491463|454023716|FG000|Overall Study|Migrated/moved from study area|1|||
126311595|NCT01901653|454429807|FG010|Overall Study|Withdrawal by Subject|0|||
126311596|NCT01901653|454429808|FG011|Overall Study|Withdrawal by Subject|0|||
126201444|NCT02491463|454023717|FG001|Overall Study|Migrated/moved from study area|5|||
126201445|NCT02491463|454023718|FG002|Overall Study|Migrated/moved from study area|1|||
126201446|NCT02491463|454023719|FG003|Overall Study|Migrated/moved from study area|1|||
126201447|NCT02491463|454023716|FG000|Overall Study|Lost to Follow-up|0|||
126201448|NCT02491463|454023717|FG001|Overall Study|Lost to Follow-up|3|||
126201449|NCT02491463|454023718|FG002|Overall Study|Lost to Follow-up|3|||
126311597|NCT01901653|454429809|FG012|Overall Study|Withdrawal by Subject|0|||
126311598|NCT01901653|454429797|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
126311599|NCT01901653|454429798|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
126311600|NCT01901653|454429799|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
126311601|NCT01901653|454429800|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
126311602|NCT01901653|454429801|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
126311603|NCT01901653|454429802|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
126311604|NCT01901653|454429803|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
126311605|NCT01901653|454429804|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
126311606|NCT01901653|454429805|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
126311607|NCT01901653|454429806|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
126311608|NCT01901653|454429807|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
126311609|NCT01901653|454429808|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
126311610|NCT01901653|454429809|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
126311611|NCT02091986|454429810|FG000|Overall Study|7 rand in error 1 patient decision|2|||
126311612|NCT02091986|454429811|FG001|Overall Study|7 rand in error 1 patient decision|3|||
126311613|NCT02091986|454429812|FG002|Overall Study|7 rand in error 1 patient decision|3|||
126311614|NCT02091986|454429810|FG000|Overall Study|Lost to Follow-up|1|||
126311615|NCT02091986|454429811|FG001|Overall Study|Lost to Follow-up|0|||
126311616|NCT02091986|454429812|FG002|Overall Study|Lost to Follow-up|0|||
126311617|NCT02091986|454429810|FG000|Overall Study|Withdrawal by Subject|4|||
126311618|NCT02091986|454429811|FG001|Overall Study|Withdrawal by Subject|8|||
126311619|NCT02091986|454429812|FG002|Overall Study|Withdrawal by Subject|3|||
126311620|NCT02091986|454429810|FG000|Overall Study|Adverse Event|0|||
126311621|NCT02091986|454429811|FG001|Overall Study|Adverse Event|0|||
126311622|NCT02091986|454429812|FG002|Overall Study|Adverse Event|2|||
126311623|NCT00957268|454429816|FG000|Overall Study|Voluntary Withdrawal|0|||
125977883|NCT01212770|453208234|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
125977884|NCT01212770|453208235|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
125977885|NCT01212770|453208236|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125977886|NCT01212770|453208237|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125977887|NCT01212770|453208238|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125977888|NCT01212770|453208239|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125977889|NCT01212770|453208240|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125977890|NCT01212770|453208241|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125977891|NCT01212770|453208233|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
125977892|NCT01212770|453208234|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125977893|NCT01212770|453208235|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
125977894|NCT01212770|453208236|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125977895|NCT01212770|453208237|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125977896|NCT01212770|453208238|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125977897|NCT01212770|453208239|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125977898|NCT01212770|453208240|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125977899|NCT01212770|453208241|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125977900|NCT01212770|453208233|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125977901|NCT01212770|453208234|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125977902|NCT01212770|453208235|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
125977903|NCT01212770|453208236|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125977904|NCT01212770|453208237|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125977905|NCT01212770|453208238|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125977906|NCT01212770|453208239|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125977907|NCT01212770|453208240|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125977908|NCT01212770|453208241|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125977909|NCT01212770|453208233|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
125977910|NCT01212770|453208234|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
125977911|NCT01212770|453208235|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
125977912|NCT01212770|453208236|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125977913|NCT01212770|453208237|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125977914|NCT01212770|453208238|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125977915|NCT01212770|453208239|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125977916|NCT01212770|453208240|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125977917|NCT01212770|453208241|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125977918|NCT01212770|453208233|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125977919|NCT01212770|453208234|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
125977920|NCT01212770|453208235|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
125977921|NCT01212770|453208236|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
125977922|NCT01212770|453208237|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125977923|NCT01212770|453208238|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125977924|NCT01212770|453208239|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
125977925|NCT01212770|453208240|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
126201450|NCT02491463|454023719|FG003|Overall Study|Lost to Follow-up|0|||
126201451|NCT01491802|454023720|FG000|Overall Study|Adverse Event|1|||
126201452|NCT01491802|454023721|FG001|Overall Study|Adverse Event|1|||
126201453|NCT01491802|454023720|FG000|Overall Study|Withdrawal by Subject|0|||
126201454|NCT01491802|454023721|FG001|Overall Study|Withdrawal by Subject|1|||
126201455|NCT04563845|454023722|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201456|NCT04563845|454023723|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201457|NCT04563845|454023724|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201458|NCT04563845|454023725|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201459|NCT04563845|454023726|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201460|NCT04563845|454023727|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201461|NCT04563845|454023728|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201462|NCT04563845|454023729|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
126201463|NCT04563845|454023730|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201464|NCT04563845|454023731|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201465|NCT04563845|454023732|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201466|NCT04563845|454023733|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201467|NCT04563845|454023734|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201468|NCT04563845|454023735|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126201469|NCT04563845|454023722|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201470|NCT04563845|454023723|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201471|NCT04563845|454023724|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126306047|NCT02553499|454408875|FG006|Overall Study|Lost to Follow-up|1|||
126201472|NCT04563845|454023725|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201473|NCT04563845|454023726|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
126201474|NCT04563845|454023727|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201475|NCT04563845|454023728|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201476|NCT04563845|454023729|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201477|NCT04563845|454023730|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201478|NCT04563845|454023731|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201479|NCT04563845|454023732|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201480|NCT04563845|454023733|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201481|NCT04563845|454023734|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201482|NCT04563845|454023735|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126201483|NCT02146274|454023736|FG000|Overall Study|Protocol Violation|73|||
126311624|NCT00957268|454429817|FG001|Overall Study|Voluntary Withdrawal|0|||
125977926|NCT01212770|453208241|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125977927|NCT01212770|453208233|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
125977928|NCT01212770|453208234|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
125977929|NCT01212770|453208235|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
125977930|NCT01212770|453208236|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
125977931|NCT01212770|453208237|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
125977932|NCT01212770|453208238|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
125977933|NCT01212770|453208239|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
125977934|NCT01212770|453208240|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
125977935|NCT01212770|453208241|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
125977936|NCT01212770|453208233|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
125977937|NCT01212770|453208234|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
125977938|NCT01212770|453208235|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
125977939|NCT01212770|453208236|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
125977940|NCT01212770|453208237|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
125977941|NCT01212770|453208238|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
125977942|NCT01212770|453208239|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
125977943|NCT01212770|453208240|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
125977944|NCT01212770|453208241|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
125977945|NCT01212770|453208233|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125977946|NCT01212770|453208234|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126201484|NCT01539720|454023737|FG000|Overall Study|Screen Fail|15|||
126201485|NCT01539720|454023738|FG001|Overall Study|Screen Fail|3|||
126201486|NCT01539720|454023737|FG000|Overall Study|Lost to Follow-up|14|||
126201487|NCT01539720|454023738|FG001|Overall Study|Lost to Follow-up|7|||
126201488|NCT00386152|454023743|FG000|Overall Study|Adverse Event|6|||
126201489|NCT00386152|454023744|FG001|Overall Study|Adverse Event|5|||
126201490|NCT00386152|454023745|FG002|Overall Study|Adverse Event|4|||
126201491|NCT00386152|454023743|FG000|Overall Study|Chang from original chemo stratification|4|||
126201492|NCT00386152|454023744|FG001|Overall Study|Chang from original chemo stratification|5|||
126201493|NCT00386152|454023745|FG002|Overall Study|Chang from original chemo stratification|6|||
126201494|NCT00386152|454023743|FG000|Overall Study|Death|3|||
126201495|NCT00386152|454023744|FG001|Overall Study|Death|0|||
126201496|NCT00386152|454023745|FG002|Overall Study|Death|1|||
126201497|NCT00386152|454023743|FG000|Overall Study|Disease progression|7|||
126201498|NCT00386152|454023744|FG001|Overall Study|Disease progression|4|||
126201499|NCT00386152|454023745|FG002|Overall Study|Disease progression|5|||
126201500|NCT00386152|454023743|FG000|Overall Study|Physician Decision|13|||
126201501|NCT00386152|454023744|FG001|Overall Study|Physician Decision|10|||
126201502|NCT00386152|454023745|FG002|Overall Study|Physician Decision|4|||
126201503|NCT00386152|454023743|FG000|Overall Study|Lost to Follow-up|1|||
126201504|NCT00386152|454023744|FG001|Overall Study|Lost to Follow-up|0|||
126201505|NCT00386152|454023745|FG002|Overall Study|Lost to Follow-up|0|||
126201506|NCT00386152|454023743|FG000|Overall Study|Completed chemotherapy|4|||
126201507|NCT00386152|454023744|FG001|Overall Study|Completed chemotherapy|5|||
126201508|NCT00386152|454023745|FG002|Overall Study|Completed chemotherapy|1|||
126201509|NCT00386152|454023743|FG000|Overall Study|Protocol Violation|3|||
126201510|NCT00386152|454023744|FG001|Overall Study|Protocol Violation|5|||
126201511|NCT00386152|454023745|FG002|Overall Study|Protocol Violation|2|||
126201512|NCT00386152|454023743|FG000|Overall Study|Withdrawal by Subject|3|||
126201513|NCT00386152|454023744|FG001|Overall Study|Withdrawal by Subject|6|||
126201514|NCT00386152|454023745|FG002|Overall Study|Withdrawal by Subject|10|||
126201515|NCT03938857|454023749|FG000|Overall Study|Physician Decision|1|||
126201516|NCT03938857|454023750|FG001|Overall Study|Physician Decision|0|||
126201517|NCT03938857|454023751|FG002|Overall Study|Physician Decision|0|||
126201518|NCT03938857|454023752|FG003|Overall Study|Physician Decision|0|||
126311625|NCT00957268|454429818|FG002|Overall Study|Voluntary Withdrawal|1|||
126311626|NCT00957268|454429819|FG003|Overall Study|Voluntary Withdrawal|0|||
125977947|NCT01212770|453208235|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
125977948|NCT01212770|453208236|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125977949|NCT01212770|453208237|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125977950|NCT01212770|453208238|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125977951|NCT01212770|453208239|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125977952|NCT01212770|453208240|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125977953|NCT01212770|453208241|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125977954|NCT01212770|453208233|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125977955|NCT01212770|453208234|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125977956|NCT01212770|453208235|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125977957|NCT01212770|453208236|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
125977958|NCT01212770|453208237|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125977959|NCT01212770|453208238|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125977960|NCT01212770|453208239|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125977961|NCT01212770|453208240|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125977962|NCT01212770|453208241|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125977963|NCT01212770|453208233|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125977964|NCT01212770|453208234|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125977965|NCT01212770|453208235|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
125977966|NCT01212770|453208236|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
125977967|NCT01212770|453208237|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125977968|NCT01212770|453208238|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125977969|NCT01212770|453208239|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125977970|NCT01212770|453208240|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125977971|NCT01212770|453208241|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125977972|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125977973|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
125977974|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
125977975|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125977976|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125977977|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125977978|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125977979|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125977980|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
125977981|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125977982|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
125977983|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
125977984|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126201519|NCT02577107|454023753|FG000|Overall Study|Protocol deviation|0|||
126201520|NCT02577107|454023754|FG001|Overall Study|Protocol deviation|1|||
126201521|NCT02516605|454023755|FG000|Overall Study|Protocol Violation|0|||
126201522|NCT02516605|454023756|FG001|Overall Study|Protocol Violation|0|||
126201523|NCT02516605|454023757|FG002|Overall Study|Protocol Violation|0|||
126201524|NCT02516605|454023758|FG003|Overall Study|Protocol Violation|0|||
126201525|NCT02516605|454023759|FG004|Overall Study|Protocol Violation|1|||
126201526|NCT02516605|454023755|FG000|Overall Study|Withdrawal by Subject|0|||
126201527|NCT02516605|454023756|FG001|Overall Study|Withdrawal by Subject|0|||
126201528|NCT02516605|454023757|FG002|Overall Study|Withdrawal by Subject|0|||
126201529|NCT02516605|454023758|FG003|Overall Study|Withdrawal by Subject|1|||
126201530|NCT02516605|454023759|FG004|Overall Study|Withdrawal by Subject|0|||
126201531|NCT00577382|454023760|FG000|Overall Study|Adverse Event|0|||
126201532|NCT00577382|454023761|FG001|Overall Study|Adverse Event|6|||
126201533|NCT00577382|454023760|FG000|Overall Study|Withdrawal by Subject|0|||
126201534|NCT00577382|454023761|FG001|Overall Study|Withdrawal by Subject|1|||
126201535|NCT00577382|454023760|FG000|Overall Study|Progressive Disease|17|||
126201536|NCT00577382|454023761|FG001|Overall Study|Progressive Disease|19|||
126201537|NCT00577382|454023760|FG000|Overall Study|Intercurrent Illness|1|||
126201538|NCT00577382|454023761|FG001|Overall Study|Intercurrent Illness|2|||
126201539|NCT00577382|454023760|FG000|Overall Study|Death|1|||
126201540|NCT00577382|454023761|FG001|Overall Study|Death|1|||
126201541|NCT00577382|454023760|FG000|Overall Study|Lost to Follow-up|2|||
126201542|NCT00577382|454023761|FG001|Overall Study|Lost to Follow-up|2|||
126201543|NCT02839330|454023762|FG000|Overall Study|Adverse Event|0|||
126201544|NCT02839330|454023763|FG001|Overall Study|Adverse Event|1|||
126201545|NCT02839330|454023764|FG002|Overall Study|Adverse Event|2|||
126201546|NCT02839330|454023765|FG003|Overall Study|Adverse Event|2|||
126201547|NCT02839330|454023762|FG000|Overall Study|Death|4|||
126201548|NCT02839330|454023763|FG001|Overall Study|Death|6|||
126201549|NCT02839330|454023764|FG002|Overall Study|Death|1|||
126201550|NCT02839330|454023765|FG003|Overall Study|Death|1|||
126201551|NCT02839330|454023762|FG000|Overall Study|Withdrawal by Subject|27|||
126201552|NCT02839330|454023763|FG001|Overall Study|Withdrawal by Subject|19|||
126201553|NCT02839330|454023764|FG002|Overall Study|Withdrawal by Subject|11|||
126201554|NCT02839330|454023765|FG003|Overall Study|Withdrawal by Subject|13|||
126201555|NCT02839330|454023762|FG000|Overall Study|Lost to Follow-up|22|||
126201556|NCT02839330|454023763|FG001|Overall Study|Lost to Follow-up|27|||
126201557|NCT02839330|454023764|FG002|Overall Study|Lost to Follow-up|29|||
126201558|NCT02839330|454023765|FG003|Overall Study|Lost to Follow-up|25|||
126201559|NCT02839330|454023762|FG000|Overall Study|Administrative Reason|0|||
126201560|NCT02839330|454023763|FG001|Overall Study|Administrative Reason|0|||
126201561|NCT02839330|454023764|FG002|Overall Study|Administrative Reason|0|||
126201562|NCT02839330|454023765|FG003|Overall Study|Administrative Reason|1|||
126201563|NCT02839330|454023762|FG000|Overall Study|Protocol Violation|1|||
126201564|NCT02839330|454023763|FG001|Overall Study|Protocol Violation|2|||
126201565|NCT02839330|454023764|FG002|Overall Study|Protocol Violation|2|||
126201566|NCT02839330|454023765|FG003|Overall Study|Protocol Violation|3|||
126201567|NCT02839330|454023762|FG000|Overall Study|Other reason, not specified|4|||
126201568|NCT02839330|454023763|FG001|Overall Study|Other reason, not specified|3|||
126201569|NCT02839330|454023764|FG002|Overall Study|Other reason, not specified|3|||
125977985|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125977986|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125977987|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125977988|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
126201570|NCT02839330|454023765|FG003|Overall Study|Other reason, not specified|6|||
126201571|NCT00508872|454023769|FG000|Overall Study|Lost to Follow-up|1|||
126201572|NCT00508872|454023769|FG000|Overall Study|Physician Decision|1|||
126201573|NCT03007472|454023770|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
126201574|NCT03007472|454023770|FG000|Overall Study|Death|2|||
126201575|NCT03007472|454023770|FG000|Overall Study|Loss to Follow Up|1|||
126201576|NCT01220024|454023779|FG000|Overall Study|Lost to Follow-up|1|||
126201577|NCT01220024|454023780|FG001|Overall Study|Lost to Follow-up|1|||
126201578|NCT00174460|454023781|FG000|Overall Study|Withdrawal by Subject|0|||
126201579|NCT00174460|454023782|FG001|Overall Study|Withdrawal by Subject|1|||
126201580|NCT00490815|454023785|FG000|Overall Study|Adverse Event|2|||
126201581|NCT00490815|454023786|FG001|Overall Study|Adverse Event|3|||
126201582|NCT00490815|454023785|FG000|Overall Study|Withdrawal by Subject|4|||
126201583|NCT00490815|454023786|FG001|Overall Study|Withdrawal by Subject|0|||
126201584|NCT00490815|454023785|FG000|Overall Study|Lost to Follow-up|1|||
126201585|NCT00490815|454023786|FG001|Overall Study|Lost to Follow-up|3|||
126201586|NCT00490815|454023785|FG000|Overall Study|Death|1|||
126201587|NCT00490815|454023786|FG001|Overall Study|Death|3|||
126201588|NCT00579059|454023788|FG000|Overall Study|Study Canceled at 1 Year|21|||
126201589|NCT00579059|454023789|FG001|Overall Study|Study Canceled at 1 Year|10|||
126201590|NCT04047472|454023790|FG000|Overall Study|Adverse Event|3|||
126201591|NCT04047472|454023791|FG001|Overall Study|Adverse Event|3|||
126201592|NCT04047472|454023790|FG000|Overall Study|Death|0|||
126201593|NCT04047472|454023791|FG001|Overall Study|Death|1|||
126201594|NCT04047472|454023790|FG000|Overall Study|Lost to Follow-up|1|||
126201595|NCT04047472|454023791|FG001|Overall Study|Lost to Follow-up|0|||
126201596|NCT04047472|454023790|FG000|Overall Study|Physician Decision|1|||
126201597|NCT04047472|454023791|FG001|Overall Study|Physician Decision|2|||
126201598|NCT04047472|454023790|FG000|Overall Study|Protocol Violation|1|||
126201599|NCT04047472|454023791|FG001|Overall Study|Protocol Violation|0|||
126201600|NCT04047472|454023790|FG000|Overall Study|Withdrawal by Subject|10|||
126201601|NCT04047472|454023791|FG001|Overall Study|Withdrawal by Subject|10|||
126201602|NCT02030067|454023792|FG000|Overall Study|Disease Progression|1|||
126201603|NCT02030067|454023793|FG001|Overall Study|Disease Progression|1|||
126201604|NCT02030067|454023794|FG002|Overall Study|Disease Progression|2|||
126201605|NCT02030067|454023795|FG003|Overall Study|Disease Progression|2|||
126201606|NCT02030067|454023796|FG004|Overall Study|Disease Progression|3|||
126201607|NCT02030067|454023797|FG005|Overall Study|Disease Progression|2|||
126201608|NCT02030067|454023798|FG006|Overall Study|Disease Progression|3|||
126201609|NCT02030067|454023799|FG007|Overall Study|Disease Progression|3|||
126201610|NCT02030067|454023800|FG008|Overall Study|Disease Progression|4|||
126201611|NCT02030067|454023801|FG009|Overall Study|Disease Progression|3|||
126201612|NCT02030067|454023802|FG010|Overall Study|Disease Progression|7|||
126201613|NCT02030067|454023803|FG011|Overall Study|Disease Progression|2|||
126201614|NCT02030067|454023804|FG012|Overall Study|Disease Progression|59|||
126201615|NCT02030067|454023792|FG000|Overall Study|Withdrawal by Subject|0|||
126201616|NCT02030067|454023793|FG001|Overall Study|Withdrawal by Subject|0|||
126201617|NCT02030067|454023794|FG002|Overall Study|Withdrawal by Subject|0|||
126201618|NCT02030067|454023795|FG003|Overall Study|Withdrawal by Subject|1|||
126201619|NCT02030067|454023796|FG004|Overall Study|Withdrawal by Subject|0|||
126201620|NCT02030067|454023797|FG005|Overall Study|Withdrawal by Subject|0|||
126201621|NCT02030067|454023798|FG006|Overall Study|Withdrawal by Subject|0|||
126201622|NCT02030067|454023799|FG007|Overall Study|Withdrawal by Subject|1|||
126201623|NCT02030067|454023800|FG008|Overall Study|Withdrawal by Subject|0|||
126201624|NCT02030067|454023801|FG009|Overall Study|Withdrawal by Subject|0|||
126201625|NCT02030067|454023802|FG010|Overall Study|Withdrawal by Subject|3|||
126201626|NCT02030067|454023803|FG011|Overall Study|Withdrawal by Subject|0|||
126201627|NCT02030067|454023804|FG012|Overall Study|Withdrawal by Subject|6|||
126201628|NCT02030067|454023792|FG000|Overall Study|Physician Decision|0|||
126201629|NCT02030067|454023793|FG001|Overall Study|Physician Decision|0|||
126201630|NCT02030067|454023794|FG002|Overall Study|Physician Decision|0|||
126201631|NCT02030067|454023795|FG003|Overall Study|Physician Decision|0|||
126201632|NCT02030067|454023796|FG004|Overall Study|Physician Decision|0|||
126201633|NCT02030067|454023797|FG005|Overall Study|Physician Decision|0|||
126201634|NCT02030067|454023798|FG006|Overall Study|Physician Decision|0|||
126201635|NCT02030067|454023799|FG007|Overall Study|Physician Decision|0|||
126201636|NCT02030067|454023800|FG008|Overall Study|Physician Decision|0|||
126201637|NCT02030067|454023801|FG009|Overall Study|Physician Decision|0|||
126201638|NCT02030067|454023802|FG010|Overall Study|Physician Decision|1|||
126201639|NCT02030067|454023803|FG011|Overall Study|Physician Decision|0|||
126201640|NCT02030067|454023804|FG012|Overall Study|Physician Decision|3|||
126201641|NCT02030067|454023792|FG000|Overall Study|other reasons|0|||
126201642|NCT02030067|454023793|FG001|Overall Study|other reasons|0|||
126201643|NCT02030067|454023794|FG002|Overall Study|other reasons|0|||
126201644|NCT02030067|454023795|FG003|Overall Study|other reasons|0|||
126201645|NCT02030067|454023796|FG004|Overall Study|other reasons|0|||
126201646|NCT02030067|454023797|FG005|Overall Study|other reasons|1|||
126201647|NCT02030067|454023798|FG006|Overall Study|other reasons|0|||
126201648|NCT02030067|454023799|FG007|Overall Study|other reasons|0|||
126201649|NCT02030067|454023800|FG008|Overall Study|other reasons|2|||
126201650|NCT02030067|454023801|FG009|Overall Study|other reasons|0|||
126201651|NCT02030067|454023802|FG010|Overall Study|other reasons|0|||
126201652|NCT02030067|454023803|FG011|Overall Study|other reasons|0|||
126201653|NCT02030067|454023804|FG012|Overall Study|other reasons|4|||
126201654|NCT02030067|454023792|FG000|Overall Study|Adverse Event|0|||
126201655|NCT02030067|454023793|FG001|Overall Study|Adverse Event|0|||
126201656|NCT02030067|454023794|FG002|Overall Study|Adverse Event|0|||
126201657|NCT02030067|454023795|FG003|Overall Study|Adverse Event|0|||
126201658|NCT02030067|454023796|FG004|Overall Study|Adverse Event|0|||
126201659|NCT02030067|454023797|FG005|Overall Study|Adverse Event|0|||
126201660|NCT02030067|454023798|FG006|Overall Study|Adverse Event|0|||
126201661|NCT02030067|454023799|FG007|Overall Study|Adverse Event|0|||
126201662|NCT02030067|454023800|FG008|Overall Study|Adverse Event|0|||
126201663|NCT02030067|454023801|FG009|Overall Study|Adverse Event|0|||
126201664|NCT02030067|454023802|FG010|Overall Study|Adverse Event|0|||
126201665|NCT02030067|454023803|FG011|Overall Study|Adverse Event|1|||
126201666|NCT02030067|454023804|FG012|Overall Study|Adverse Event|8|||
126201667|NCT01756846|454023805|FG000|Overall Study|Lost to Follow-up|5|||
126201668|NCT01756846|454023806|FG001|Overall Study|Lost to Follow-up|10|||
126201669|NCT01756846|454023805|FG000|Overall Study|Withdrawal by Subject|1|||
126201670|NCT01756846|454023806|FG001|Overall Study|Withdrawal by Subject|2|||
126201671|NCT01284127|454023807|FG000|Overall Study|Adverse Event|2|||
126201672|NCT01284127|454023807|FG000|Overall Study|Withdrawal by Subject|4|||
126201673|NCT01284127|454023807|FG000|Overall Study|Physician Decision|1|||
125977989|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
125977990|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125977991|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
125977992|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125977993|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125977994|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125977995|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125977996|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125977997|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125977998|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125977999|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125978000|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
125978001|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
125978002|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125978003|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125978004|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125978005|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125978006|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
126201674|NCT02853318|454023811|FG000|Overall Study|Withdrawal by Subject|1|||
126201675|NCT01997333|454023812|FG000|Randomization and Treatment|Disease Progression|70|||
126201676|NCT01997333|454023813|FG001|Randomization and Treatment|Disease Progression|159|||
126201677|NCT01997333|454023812|FG000|Randomization and Treatment|Adverse Event|10|||
126201678|NCT01997333|454023813|FG001|Randomization and Treatment|Adverse Event|32|||
126201679|NCT01997333|454023812|FG000|Randomization and Treatment|Physician Decision|0|||
126046394|NCT02719574|453468203|FG002|Phase 2|Investigator Decision|0|||
126201680|NCT01997333|454023813|FG001|Randomization and Treatment|Physician Decision|4|||
126201681|NCT01997333|454023812|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
126201682|NCT01997333|454023813|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
126201683|NCT01997333|454023812|FG000|Randomization and Treatment|Did not receive treatment|17|||
125978007|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
125978008|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125978009|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
125978010|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
125978011|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125978012|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125978013|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125978014|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125978015|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
125978016|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
125978017|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125978018|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
125978019|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125978020|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125978021|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125978022|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125978023|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125978024|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125978025|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125978026|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125978027|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
125978028|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
125978029|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125978030|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125978031|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125978032|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125978033|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
125978034|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
125978035|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125978036|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
125978037|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
125978038|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125978039|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125978040|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125978041|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125978042|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
125978043|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
125978044|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125978045|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
125978046|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
125978047|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125978048|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125978049|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125978050|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125978051|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
125978052|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
125978053|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125978054|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
125978055|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125978056|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125978057|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125978058|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125978059|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125978060|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125978061|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125978062|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125978063|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125978064|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125978065|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125978066|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125978067|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125978068|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125978069|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
125978070|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125978071|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125978072|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
126046395|NCT02719574|453468204|FG003|Phase 2|Investigator Decision|0|||
126201684|NCT01997333|454023813|FG001|Randomization and Treatment|Did not receive treatment|5|||
125978073|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125978074|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125978075|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125978076|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125978077|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125978078|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125978079|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125978080|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125978081|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
125978082|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
125978083|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125978084|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125978085|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125978086|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125978087|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125978088|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
126201685|NCT01997333|454023812|FG000|Survival Follow up|Withdrawal by Subject|15|||
126201686|NCT01997333|454023813|FG001|Survival Follow up|Withdrawal by Subject|6|||
125978089|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125978090|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
125978091|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
125978092|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125978093|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125978094|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126201687|NCT01997333|454023812|FG000|Survival Follow up|Lost to Follow-up|0|||
126201688|NCT01997333|454023813|FG001|Survival Follow up|Lost to Follow-up|6|||
125978095|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125978096|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
125978097|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125978098|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125978099|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
125978100|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
125978101|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125978102|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125978103|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125978104|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125978105|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
125978106|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125978107|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125978108|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
125978109|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
125978110|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125978111|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125978112|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125978113|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125978114|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125978115|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125978116|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125978117|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125978118|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
125978119|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125978120|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125978121|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125978122|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125978123|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125978124|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125978125|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125978126|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
125978127|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125978128|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125978129|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125978130|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125978131|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125978132|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125978133|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
125978134|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
125978135|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
125978136|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
126201689|NCT01997333|454023812|FG000|Survival Follow up|Various|1|||
125978137|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
125978138|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
125978139|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
125978140|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
125978141|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
125978142|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
125978143|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125978144|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125978145|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
125978146|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125978147|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125978148|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125978149|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125978150|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125978151|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125978152|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125978153|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125978154|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
125978155|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125978156|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125978157|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125978158|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125978159|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125978160|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
125978161|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125978162|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125978163|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
125978164|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125978165|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125978166|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125978167|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125978168|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125978169|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125978170|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125978171|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
125978172|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
125978173|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125978174|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125978175|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125978176|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125978177|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
125978178|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125978179|NCT01212770|453208233|FG000|Long-term Safety Phase (Year 5)|Death|0|||
125978180|NCT01212770|453208234|FG001|Long-term Safety Phase (Year 5)|Death|0|||
125978181|NCT01212770|453208235|FG002|Long-term Safety Phase (Year 5)|Death|0|||
125978182|NCT01212770|453208236|FG003|Long-term Safety Phase (Year 5)|Death|0|||
125978183|NCT01212770|453208237|FG004|Long-term Safety Phase (Year 5)|Death|0|||
125978184|NCT01212770|453208238|FG005|Long-term Safety Phase (Year 5)|Death|0|||
125978185|NCT01212770|453208239|FG006|Long-term Safety Phase (Year 5)|Death|0|||
125978186|NCT01212770|453208240|FG007|Long-term Safety Phase (Year 5)|Death|1|||
125978187|NCT01212770|453208241|FG008|Long-term Safety Phase (Year 5)|Death|0|||
125978188|NCT00829387|453208242|FG000|Overall Study|Withdrawal by Subject|2|||
125978189|NCT00829387|453208243|FG001|Overall Study|Withdrawal by Subject|3|||
125978190|NCT00829387|453208242|FG000|Overall Study|Disqualified by PI|1|||
125978191|NCT00829387|453208243|FG001|Overall Study|Disqualified by PI|0|||
125978192|NCT02747238|453208253|FG000|Overall Study|Lack of Efficacy|0|||
125978193|NCT02747238|453208254|FG001|Overall Study|Lack of Efficacy|1|||
125978194|NCT02747238|453208253|FG000|Overall Study|Data lost|3|||
125978195|NCT02747238|453208254|FG001|Overall Study|Data lost|5|||
125978196|NCT02085252|453208257|FG000|Overall Study|Withdrawal of Consent|1|||
125978197|NCT02085252|453208258|FG001|Overall Study|Withdrawal of Consent|0|||
125978198|NCT02085252|453208257|FG000|Overall Study|Adverse Event|0|||
125978199|NCT02085252|453208258|FG001|Overall Study|Adverse Event|1|||
125978200|NCT02085252|453208257|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
125978201|NCT02085252|453208258|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
125978202|NCT02085252|453208257|FG000|Overall Study|Reason Not Specified|0|||
125978203|NCT02085252|453208258|FG001|Overall Study|Reason Not Specified|1|||
125978204|NCT02085252|453208257|FG000|Overall Study|Reason Unknown|0|||
125978205|NCT02085252|453208258|FG001|Overall Study|Reason Unknown|1|||
125978206|NCT00951275|453208259|FG000|Overall Study|Administrative Reason|1|||
125978207|NCT00951275|453208259|FG000|Overall Study|Adverse Event|7|||
125978208|NCT00951275|453208259|FG000|Overall Study|Withdrawal by Subject|4|||
125978209|NCT00951275|453208259|FG000|Overall Study|Protocol Violation|1|||
125978210|NCT01112579|453208261|FG000|Overall Study|Missed Visit|1|||
125978211|NCT01112579|453208262|FG001|Overall Study|Missed Visit|1|||
125978212|NCT01112579|453208261|FG000|Overall Study|Death|0|||
125978213|NCT01112579|453208262|FG001|Overall Study|Death|2|||
125978214|NCT04304833|453208263|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
125978215|NCT04304833|453208264|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
125978216|NCT01951625|453208265|FG000|Treatment Period|Protocol Violation|2|||
125978217|NCT01951625|453208266|FG001|Treatment Period|Protocol Violation|0|||
125978218|NCT01951625|453208267|FG002|Treatment Period|Protocol Violation|1|||
125978219|NCT01951625|453208268|FG003|Treatment Period|Protocol Violation|3|||
125978220|NCT01951625|453208269|FG004|Treatment Period|Protocol Violation|2|||
125978221|NCT01951625|453208265|FG000|Treatment Period|Physician Decision|0|||
125978222|NCT01951625|453208266|FG001|Treatment Period|Physician Decision|0|||
125978223|NCT01951625|453208267|FG002|Treatment Period|Physician Decision|0|||
125978224|NCT01951625|453208268|FG003|Treatment Period|Physician Decision|0|||
125978225|NCT01951625|453208269|FG004|Treatment Period|Physician Decision|1|||
125978226|NCT01951625|453208265|FG000|Treatment Period|Protocol driven decision point|0|||
125978227|NCT01951625|453208266|FG001|Treatment Period|Protocol driven decision point|5|||
125978228|NCT01951625|453208267|FG002|Treatment Period|Protocol driven decision point|0|||
125978229|NCT01951625|453208268|FG003|Treatment Period|Protocol driven decision point|2|||
125978230|NCT01951625|453208269|FG004|Treatment Period|Protocol driven decision point|1|||
125978231|NCT01951625|453208265|FG000|Treatment Period|Non compliance with study drug|1|||
125978232|NCT01951625|453208266|FG001|Treatment Period|Non compliance with study drug|2|||
125978233|NCT01951625|453208267|FG002|Treatment Period|Non compliance with study drug|2|||
125978234|NCT01951625|453208268|FG003|Treatment Period|Non compliance with study drug|0|||
125978235|NCT01951625|453208269|FG004|Treatment Period|Non compliance with study drug|0|||
125978236|NCT01951625|453208265|FG000|Treatment Period|Death|3|||
125978237|NCT01951625|453208266|FG001|Treatment Period|Death|2|||
125978238|NCT01951625|453208267|FG002|Treatment Period|Death|2|||
125978239|NCT01951625|453208268|FG003|Treatment Period|Death|1|||
125978240|NCT01951625|453208269|FG004|Treatment Period|Death|2|||
125978241|NCT01951625|453208265|FG000|Treatment Period|Adverse Event|7|||
125978242|NCT01951625|453208266|FG001|Treatment Period|Adverse Event|10|||
125978243|NCT01951625|453208267|FG002|Treatment Period|Adverse Event|9|||
125978244|NCT01951625|453208268|FG003|Treatment Period|Adverse Event|8|||
125978245|NCT01951625|453208269|FG004|Treatment Period|Adverse Event|8|||
125978246|NCT01951625|453208265|FG000|Treatment Period|Withdrawal by Subject|5|||
125978247|NCT01951625|453208266|FG001|Treatment Period|Withdrawal by Subject|2|||
125978248|NCT01951625|453208267|FG002|Treatment Period|Withdrawal by Subject|1|||
125978249|NCT01951625|453208268|FG003|Treatment Period|Withdrawal by Subject|7|||
125978250|NCT01951625|453208269|FG004|Treatment Period|Withdrawal by Subject|3|||
125978251|NCT01951625|453208265|FG000|Treatment Period|Lost to Follow-up|1|||
125978252|NCT01951625|453208266|FG001|Treatment Period|Lost to Follow-up|0|||
125978253|NCT01951625|453208267|FG002|Treatment Period|Lost to Follow-up|0|||
125978254|NCT01951625|453208268|FG003|Treatment Period|Lost to Follow-up|1|||
125978255|NCT01951625|453208269|FG004|Treatment Period|Lost to Follow-up|0|||
125978256|NCT01951625|453208265|FG000|Follow Up Period|Non-compliance with study drug|1|||
125978257|NCT01951625|453208266|FG001|Follow Up Period|Non-compliance with study drug|0|||
125978258|NCT01951625|453208267|FG002|Follow Up Period|Non-compliance with study drug|0|||
125978259|NCT01951625|453208268|FG003|Follow Up Period|Non-compliance with study drug|0|||
125978260|NCT01951625|453208269|FG004|Follow Up Period|Non-compliance with study drug|0|||
125978261|NCT01951625|453208265|FG000|Follow Up Period|Death|1|||
125978262|NCT01951625|453208266|FG001|Follow Up Period|Death|3|||
125978263|NCT01951625|453208267|FG002|Follow Up Period|Death|2|||
125978264|NCT01951625|453208268|FG003|Follow Up Period|Death|2|||
125978265|NCT01951625|453208269|FG004|Follow Up Period|Death|1|||
125978266|NCT01951625|453208265|FG000|Follow Up Period|Logistical difficulties|1|||
125978267|NCT01951625|453208266|FG001|Follow Up Period|Logistical difficulties|2|||
125978268|NCT01951625|453208267|FG002|Follow Up Period|Logistical difficulties|0|||
125978269|NCT01951625|453208268|FG003|Follow Up Period|Logistical difficulties|0|||
126422489|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
126422490|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
126422491|NCT00684996|454842618|FG000|Overall Study|Adverse Event|1|||
125978270|NCT01951625|453208269|FG004|Follow Up Period|Logistical difficulties|0|||
125978271|NCT01951625|453208265|FG000|Follow Up Period|Adverse Event|0|||
125978272|NCT01951625|453208266|FG001|Follow Up Period|Adverse Event|3|||
125978273|NCT01951625|453208267|FG002|Follow Up Period|Adverse Event|2|||
125978274|NCT01951625|453208268|FG003|Follow Up Period|Adverse Event|3|||
125978275|NCT01951625|453208269|FG004|Follow Up Period|Adverse Event|5|||
125978276|NCT01951625|453208265|FG000|Follow Up Period|Withdrawal by Subject|4|||
125978277|NCT01951625|453208266|FG001|Follow Up Period|Withdrawal by Subject|1|||
125978278|NCT01951625|453208267|FG002|Follow Up Period|Withdrawal by Subject|0|||
125978279|NCT01951625|453208268|FG003|Follow Up Period|Withdrawal by Subject|5|||
126201690|NCT01997333|454023813|FG001|Survival Follow up|Various|2|||
125978280|NCT01951625|453208269|FG004|Follow Up Period|Withdrawal by Subject|3|||
125978281|NCT01951625|453208265|FG000|Follow Up Period|Lost to Follow-up|1|||
126422492|NCT00684996|454842618|FG000|Overall Study|Refusal unrelated to adverse event|1|||
126422493|NCT00684996|454842618|FG000|Overall Study|Progression/relapse|2|||
126422494|NCT00684996|454842618|FG000|Overall Study|Other reasons not protocol specified|1|||
126422495|NCT02491983|454842619|FG000|Overall Study|Physician Decision|1|||
126422496|NCT02491983|454842620|FG001|Overall Study|Physician Decision|0|||
126422497|NCT02491983|454842619|FG000|Overall Study|Not meet selection criteria|1|||
126422498|NCT02491983|454842620|FG001|Overall Study|Not meet selection criteria|0|||
126422499|NCT02491983|454842619|FG000|Overall Study|Withdrawal by Subject|0|||
126422500|NCT02491983|454842620|FG001|Overall Study|Withdrawal by Subject|1|||
125978282|NCT01951625|453208266|FG001|Follow Up Period|Lost to Follow-up|0|||
125978283|NCT01951625|453208267|FG002|Follow Up Period|Lost to Follow-up|0|||
125978284|NCT01951625|453208268|FG003|Follow Up Period|Lost to Follow-up|1|||
125978285|NCT01951625|453208269|FG004|Follow Up Period|Lost to Follow-up|1|||
125978286|NCT02459574|453208270|FG000|Overall Study|Withdrawal by Subject|6|||
125978287|NCT02459574|453208271|FG001|Overall Study|Withdrawal by Subject|6|||
125978288|NCT02459574|453208272|FG002|Overall Study|Withdrawal by Subject|2|||
125978289|NCT02459574|453208270|FG000|Overall Study|Lost to Follow-up|1|||
125978290|NCT02459574|453208271|FG001|Overall Study|Lost to Follow-up|1|||
125978291|NCT02459574|453208272|FG002|Overall Study|Lost to Follow-up|0|||
125978292|NCT02459574|453208270|FG000|Overall Study|Death|0|||
125978293|NCT02459574|453208271|FG001|Overall Study|Death|1|||
125978294|NCT02459574|453208272|FG002|Overall Study|Death|0|||
125978295|NCT00251745|453208273|FG000|Overall Study|Adverse Event|7|||
125978296|NCT00251745|453208274|FG001|Overall Study|Adverse Event|9|||
125978297|NCT00251745|453208275|FG002|Overall Study|Adverse Event|11|||
125978298|NCT00251745|453208273|FG000|Overall Study|Lost to Follow-up|4|||
125978299|NCT00251745|453208274|FG001|Overall Study|Lost to Follow-up|2|||
125978300|NCT00251745|453208275|FG002|Overall Study|Lost to Follow-up|5|||
125978301|NCT00251745|453208273|FG000|Overall Study|Withdrawal by Subject|13|||
125978302|NCT00251745|453208274|FG001|Overall Study|Withdrawal by Subject|7|||
125978303|NCT00251745|453208275|FG002|Overall Study|Withdrawal by Subject|3|||
125978304|NCT00251745|453208273|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
125978305|NCT00251745|453208274|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
125978306|NCT00251745|453208275|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
125978307|NCT00251745|453208273|FG000|Overall Study|Lack of Efficacy|3|||
125978308|NCT00251745|453208274|FG001|Overall Study|Lack of Efficacy|0|||
125978309|NCT00251745|453208275|FG002|Overall Study|Lack of Efficacy|0|||
125978310|NCT00251745|453208273|FG000|Overall Study|Noncompliant|0|||
125978311|NCT00251745|453208274|FG001|Overall Study|Noncompliant|2|||
125978312|NCT00251745|453208275|FG002|Overall Study|Noncompliant|2|||
125978313|NCT00251745|453208273|FG000|Overall Study|Pregnancy|0|||
125978314|NCT00251745|453208274|FG001|Overall Study|Pregnancy|1|||
125978315|NCT00251745|453208275|FG002|Overall Study|Pregnancy|0|||
125978316|NCT00251745|453208273|FG000|Overall Study|Per Subject Request|0|||
125978317|NCT00251745|453208274|FG001|Overall Study|Per Subject Request|0|||
125978318|NCT00251745|453208275|FG002|Overall Study|Per Subject Request|1|||
125978319|NCT00251745|453208273|FG000|Overall Study|Per Investigator Request|1|||
125978320|NCT00251745|453208274|FG001|Overall Study|Per Investigator Request|0|||
125978321|NCT00251745|453208275|FG002|Overall Study|Per Investigator Request|0|||
125978322|NCT04508699|453208278|FG000|Overall Study|Lack of Efficacy|2|||
125978323|NCT04508699|453208279|FG001|Overall Study|Lack of Efficacy|15|||
125978324|NCT04508699|453208278|FG000|Overall Study|Withdrawal by Subject|0|||
125978325|NCT04508699|453208279|FG001|Overall Study|Withdrawal by Subject|2|||
125978326|NCT04866017|453208280|FG000|Overall Study|Study Terminated by Sponsor|13|||
126201691|NCT01535638|454023814|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
126201692|NCT01535638|454023815|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
125978327|NCT04866017|453208281|FG001|Overall Study|Study Terminated by Sponsor|14|||
125978328|NCT04866017|453208282|FG002|Overall Study|Study Terminated by Sponsor|13|||
125978329|NCT04866017|453208280|FG000|Overall Study|Death|8|||
125978330|NCT04866017|453208281|FG001|Overall Study|Death|4|||
125978331|NCT04866017|453208282|FG002|Overall Study|Death|8|||
125978332|NCT04866017|453208280|FG000|Overall Study|Withdrawal by Subject|1|||
126422501|NCT02714569|454842621|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
126422502|NCT02714569|454842622|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
125978333|NCT04866017|453208281|FG001|Overall Study|Withdrawal by Subject|0|||
125978334|NCT04866017|453208282|FG002|Overall Study|Withdrawal by Subject|1|||
125978335|NCT04866017|453208280|FG000|Overall Study|Physician Decision|0|||
125978336|NCT04866017|453208281|FG001|Overall Study|Physician Decision|1|||
125978337|NCT04866017|453208282|FG002|Overall Study|Physician Decision|0|||
126422503|NCT02714569|454842623|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
125978338|NCT01475136|453208283|FG000|Overall Study|Sponsor Decision|0|||
125978339|NCT01475136|453208284|FG001|Overall Study|Sponsor Decision|1|||
125978340|NCT01475136|453208285|FG002|Overall Study|Sponsor Decision|0|||
125978341|NCT01475136|453208286|FG003|Overall Study|Sponsor Decision|0|||
126201693|NCT01535638|454023816|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
126422504|NCT02714569|454842624|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
125978342|NCT01475136|453208283|FG000|Overall Study|Entry Criteria Not Met|0|||
125978343|NCT01475136|453208284|FG001|Overall Study|Entry Criteria Not Met|2|||
125978344|NCT01475136|453208285|FG002|Overall Study|Entry Criteria Not Met|3|||
125978345|NCT01475136|453208286|FG003|Overall Study|Entry Criteria Not Met|1|||
125978346|NCT01475136|453208283|FG000|Overall Study|Withdrawal by Subject|0|||
125978347|NCT01475136|453208284|FG001|Overall Study|Withdrawal by Subject|0|||
125978348|NCT01475136|453208285|FG002|Overall Study|Withdrawal by Subject|0|||
125978349|NCT01475136|453208286|FG003|Overall Study|Withdrawal by Subject|2|||
125978350|NCT01475136|453208283|FG000|Overall Study|Adverse Event|1|||
125978351|NCT01475136|453208284|FG001|Overall Study|Adverse Event|0|||
125978352|NCT01475136|453208285|FG002|Overall Study|Adverse Event|0|||
125978353|NCT01475136|453208286|FG003|Overall Study|Adverse Event|1|||
125978354|NCT01475136|453208283|FG000|Overall Study|Death|0|||
125978355|NCT01475136|453208284|FG001|Overall Study|Death|0|||
125978356|NCT01475136|453208285|FG002|Overall Study|Death|0|||
125978357|NCT01475136|453208286|FG003|Overall Study|Death|1|||
125978358|NCT03355326|453208289|FG000|Overall Study|Protocol Violation|3|||
125978359|NCT03355326|453208290|FG001|Overall Study|Protocol Violation|3|||
126046396|NCT02719574|453468205|FG004|Phase 2|Investigator Decision|0|||
126046397|NCT02719574|453468206|FG005|Phase 2|Investigator Decision|0|||
126046398|NCT02719574|453468207|FG006|Phase 2|Investigator Decision|0|||
126046399|NCT02719574|453468208|FG007|Phase 2|Investigator Decision|0|||
126046400|NCT02719574|453468209|FG008|Phase 2|Investigator Decision|0|||
126046401|NCT02719574|453468210|FG009|Phase 2|Investigator Decision|6|||
126046402|NCT02719574|453468211|FG010|Phase 2|Investigator Decision|1|||
126046403|NCT02719574|453468212|FG011|Phase 2|Investigator Decision|2|||
126046404|NCT02719574|453468213|FG012|Phase 2|Investigator Decision|3|||
126046405|NCT02719574|453468214|FG013|Phase 2|Investigator Decision|1|||
126046406|NCT02719574|453468215|FG014|Phase 2|Investigator Decision|3|||
126046407|NCT02719574|453468216|FG015|Phase 2|Investigator Decision|2|||
126046408|NCT02719574|453468217|FG016|Phase 2|Investigator Decision|0|||
126046409|NCT02719574|453468201|FG000|Phase 2|Withdrawal by Subject|0|||
126046410|NCT02719574|453468202|FG001|Phase 2|Withdrawal by Subject|0|||
126046411|NCT02719574|453468203|FG002|Phase 2|Withdrawal by Subject|0|||
126046412|NCT02719574|453468204|FG003|Phase 2|Withdrawal by Subject|0|||
126046413|NCT02719574|453468205|FG004|Phase 2|Withdrawal by Subject|0|||
126046414|NCT02719574|453468206|FG005|Phase 2|Withdrawal by Subject|0|||
126046415|NCT02719574|453468207|FG006|Phase 2|Withdrawal by Subject|0|||
126046416|NCT02719574|453468208|FG007|Phase 2|Withdrawal by Subject|0|||
126046417|NCT02719574|453468209|FG008|Phase 2|Withdrawal by Subject|0|||
126046418|NCT02719574|453468210|FG009|Phase 2|Withdrawal by Subject|5|||
126046419|NCT02719574|453468211|FG010|Phase 2|Withdrawal by Subject|0|||
126046420|NCT02719574|453468212|FG011|Phase 2|Withdrawal by Subject|0|||
126046421|NCT02719574|453468213|FG012|Phase 2|Withdrawal by Subject|0|||
126046422|NCT02719574|453468214|FG013|Phase 2|Withdrawal by Subject|1|||
126422505|NCT02714569|454842625|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
126422506|NCT02714569|454842626|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
126422507|NCT02714569|454842627|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
126422508|NCT02714569|454842628|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
126422509|NCT02714569|454842629|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
126422510|NCT02714569|454842630|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
126422511|NCT02714569|454842631|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
126422512|NCT02714569|454842621|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422513|NCT02714569|454842622|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422514|NCT02714569|454842623|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422515|NCT02714569|454842624|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
126422516|NCT02714569|454842625|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422517|NCT02714569|454842626|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422518|NCT02714569|454842627|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422519|NCT02714569|454842628|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422520|NCT02714569|454842629|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422521|NCT02714569|454842630|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422522|NCT02714569|454842631|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422523|NCT02714569|454842621|FG000|Part A Third Intervention|Adverse Event|0|||
126422524|NCT02714569|454842622|FG001|Part A Third Intervention|Adverse Event|0|||
126046423|NCT02719574|453468215|FG014|Phase 2|Withdrawal by Subject|1|||
126046424|NCT02719574|453468216|FG015|Phase 2|Withdrawal by Subject|2|||
126046425|NCT02719574|453468217|FG016|Phase 2|Withdrawal by Subject|0|||
126046426|NCT02719574|453468201|FG000|Phase 2|Protocol Violation|0|||
126046427|NCT02719574|453468202|FG001|Phase 2|Protocol Violation|0|||
126046428|NCT02719574|453468203|FG002|Phase 2|Protocol Violation|0|||
126046429|NCT02719574|453468204|FG003|Phase 2|Protocol Violation|0|||
126046430|NCT02719574|453468205|FG004|Phase 2|Protocol Violation|0|||
126046431|NCT02719574|453468206|FG005|Phase 2|Protocol Violation|0|||
126046432|NCT02719574|453468207|FG006|Phase 2|Protocol Violation|0|||
126046433|NCT02719574|453468208|FG007|Phase 2|Protocol Violation|0|||
126046434|NCT02719574|453468209|FG008|Phase 2|Protocol Violation|0|||
126046435|NCT02719574|453468210|FG009|Phase 2|Protocol Violation|1|||
125978360|NCT00003508|453209717|FG000|Overall Study|Not evaluable|5|||
125978361|NCT03576768|453209719|FG000|Overall Study|Lost to Follow-up|3|||
125978362|NCT03576768|453209720|FG001|Overall Study|Lost to Follow-up|3|||
125978363|NCT03576768|453209721|FG002|Overall Study|Lost to Follow-up|0|||
125978364|NCT03576768|453209722|FG003|Overall Study|Lost to Follow-up|0|||
125978365|NCT04179175|453209729|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
125978366|NCT04179175|453209730|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
125978367|NCT04179175|453209731|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
125978368|NCT04179175|453209732|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
125978369|NCT04179175|453209733|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
125978370|NCT04179175|453209734|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
125978371|NCT04179175|453209729|FG000|Overall Study|Adverse Event|5|||
125978372|NCT04179175|453209730|FG001|Overall Study|Adverse Event|3|||
125978373|NCT04179175|453209731|FG002|Overall Study|Adverse Event|3|||
125978374|NCT04179175|453209732|FG003|Overall Study|Adverse Event|4|||
125978375|NCT04179175|453209733|FG004|Overall Study|Adverse Event|6|||
125978376|NCT04179175|453209734|FG005|Overall Study|Adverse Event|6|||
125978377|NCT04179175|453209729|FG000|Overall Study|Lack of Efficacy|5|||
125978378|NCT04179175|453209730|FG001|Overall Study|Lack of Efficacy|1|||
125978379|NCT04179175|453209731|FG002|Overall Study|Lack of Efficacy|3|||
125978380|NCT04179175|453209732|FG003|Overall Study|Lack of Efficacy|2|||
125978381|NCT04179175|453209733|FG004|Overall Study|Lack of Efficacy|18|||
125978382|NCT04179175|453209734|FG005|Overall Study|Lack of Efficacy|7|||
125978383|NCT04179175|453209729|FG000|Overall Study|Lost to Follow-up|5|||
125978384|NCT04179175|453209730|FG001|Overall Study|Lost to Follow-up|3|||
125978385|NCT04179175|453209731|FG002|Overall Study|Lost to Follow-up|2|||
125978386|NCT04179175|453209732|FG003|Overall Study|Lost to Follow-up|2|||
125978387|NCT04179175|453209733|FG004|Overall Study|Lost to Follow-up|4|||
125978388|NCT04179175|453209734|FG005|Overall Study|Lost to Follow-up|5|||
126201694|NCT01535638|454023817|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
126201695|NCT01535638|454023818|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
126201696|NCT01535638|454023819|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
126201697|NCT01535638|454023814|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
126201698|NCT01535638|454023815|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
126201699|NCT01535638|454023816|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
125978389|NCT04179175|453209729|FG000|Overall Study|Physician Decision|2|||
125978390|NCT04179175|453209730|FG001|Overall Study|Physician Decision|0|||
126089356|NCT04996004|453621394|FG000|Phase I|Death|1|||
126089357|NCT04996004|453621395|FG001|Phase I|Death|2|||
126089358|NCT04996004|453621396|FG002|Phase I|Death|1|||
126089359|NCT04996004|453621397|FG003|Phase I|Death|0|||
126089360|NCT04996004|453621398|FG004|Phase I|Death|0|||
126089361|NCT04996004|453621399|FG005|Phase I|Death|0|||
126089362|NCT04996004|453621394|FG000|Phase I|Study terminated by sponsor|2|||
126089363|NCT04996004|453621395|FG001|Phase I|Study terminated by sponsor|1|||
126089364|NCT04996004|453621396|FG002|Phase I|Study terminated by sponsor|2|||
126089365|NCT04996004|453621397|FG003|Phase I|Study terminated by sponsor|0|||
126089366|NCT04996004|453621398|FG004|Phase I|Study terminated by sponsor|0|||
126089367|NCT04996004|453621399|FG005|Phase I|Study terminated by sponsor|0|||
126089368|NCT04996004|453621394|FG000|Phase II|Study terminated by sponsor|0|||
126089369|NCT04996004|453621395|FG001|Phase II|Study terminated by sponsor|0|||
126089370|NCT04996004|453621396|FG002|Phase II|Study terminated by sponsor|0|||
126089371|NCT04996004|453621397|FG003|Phase II|Study terminated by sponsor|20|||
126089372|NCT04996004|453621398|FG004|Phase II|Study terminated by sponsor|10|||
126089373|NCT04996004|453621399|FG005|Phase II|Study terminated by sponsor|10|||
126089374|NCT04996004|453621394|FG000|Phase II|Withdrawal by Subject|0|||
126089375|NCT04996004|453621395|FG001|Phase II|Withdrawal by Subject|0|||
126089376|NCT04996004|453621396|FG002|Phase II|Withdrawal by Subject|0|||
126089377|NCT04996004|453621397|FG003|Phase II|Withdrawal by Subject|0|||
126089378|NCT04996004|453621398|FG004|Phase II|Withdrawal by Subject|1|||
126089379|NCT04996004|453621399|FG005|Phase II|Withdrawal by Subject|2|||
126089380|NCT04996004|453621394|FG000|Phase II|Death|0|||
126089381|NCT04996004|453621395|FG001|Phase II|Death|0|||
126089382|NCT04996004|453621396|FG002|Phase II|Death|0|||
126089383|NCT04996004|453621397|FG003|Phase II|Death|12|||
126089384|NCT04996004|453621398|FG004|Phase II|Death|2|||
126089385|NCT04996004|453621399|FG005|Phase II|Death|9|||
126089386|NCT04996004|453621394|FG000|Phase II|Other|0|||
126089387|NCT04996004|453621395|FG001|Phase II|Other|0|||
126089388|NCT04996004|453621396|FG002|Phase II|Other|0|||
126089389|NCT04996004|453621397|FG003|Phase II|Other|0|||
126089390|NCT04996004|453621398|FG004|Phase II|Other|0|||
126089391|NCT04996004|453621399|FG005|Phase II|Other|1|||
126089392|NCT02942277|453621400|FG000|Year 1|Withdrawal by Subject|0|||
126089393|NCT02942277|453621401|FG001|Year 1|Withdrawal by Subject|0|||
126089394|NCT02942277|453621402|FG002|Year 1|Withdrawal by Subject|0|||
126089395|NCT02942277|453621403|FG003|Year 1|Withdrawal by Subject|0|||
126089396|NCT02942277|453621404|FG004|Year 1|Withdrawal by Subject|1|||
126089397|NCT02942277|453621405|FG005|Year 1|Withdrawal by Subject|3|||
126089398|NCT02942277|453621406|FG006|Year 1|Withdrawal by Subject|0|||
125978391|NCT04179175|453209731|FG002|Overall Study|Physician Decision|2|||
125978392|NCT04179175|453209732|FG003|Overall Study|Physician Decision|3|||
125978393|NCT04179175|453209733|FG004|Overall Study|Physician Decision|1|||
125978394|NCT04179175|453209734|FG005|Overall Study|Physician Decision|1|||
125978395|NCT04179175|453209729|FG000|Overall Study|Pregnancy|3|||
125978396|NCT04179175|453209730|FG001|Overall Study|Pregnancy|0|||
125978397|NCT04179175|453209731|FG002|Overall Study|Pregnancy|3|||
125978398|NCT04179175|453209732|FG003|Overall Study|Pregnancy|0|||
125978399|NCT04179175|453209733|FG004|Overall Study|Pregnancy|1|||
125978400|NCT04179175|453209734|FG005|Overall Study|Pregnancy|2|||
125978401|NCT04179175|453209729|FG000|Overall Study|Withdrawal by Subject|22|||
125978402|NCT04179175|453209730|FG001|Overall Study|Withdrawal by Subject|10|||
125978403|NCT04179175|453209731|FG002|Overall Study|Withdrawal by Subject|12|||
125978404|NCT04179175|453209732|FG003|Overall Study|Withdrawal by Subject|8|||
125978405|NCT04179175|453209733|FG004|Overall Study|Withdrawal by Subject|23|||
125978406|NCT04179175|453209734|FG005|Overall Study|Withdrawal by Subject|31|||
125978407|NCT04179175|453209729|FG000|Overall Study|Technical problems|0|||
125978408|NCT04179175|453209730|FG001|Overall Study|Technical problems|0|||
125978409|NCT04179175|453209731|FG002|Overall Study|Technical problems|1|||
126201700|NCT01535638|454023817|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
126201701|NCT01535638|454023818|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
126201702|NCT01535638|454023819|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
126201703|NCT05060003|454023820|FG000|Overall Study|ctDNA negative|7|||
126201704|NCT00819052|454023821|FG000|Overall Study|Adverse Event|0|||
126201705|NCT00819052|454023822|FG001|Overall Study|Adverse Event|5|||
126201706|NCT00819052|454023821|FG000|Overall Study|Protocol Violation|1|||
126201707|NCT00819052|454023822|FG001|Overall Study|Protocol Violation|2|||
126201708|NCT00819052|454023821|FG000|Overall Study|Lost to Follow-up|1|||
126201709|NCT00819052|454023822|FG001|Overall Study|Lost to Follow-up|2|||
126201710|NCT00819052|454023821|FG000|Overall Study|Withdrawal by Subject|1|||
126201711|NCT00819052|454023822|FG001|Overall Study|Withdrawal by Subject|2|||
126201712|NCT00819052|454023821|FG000|Overall Study|Lack of Efficacy|1|||
126201713|NCT00819052|454023822|FG001|Overall Study|Lack of Efficacy|1|||
126201714|NCT00819052|454023821|FG000|Overall Study|Pregnancy|1|||
126201715|NCT00819052|454023822|FG001|Overall Study|Pregnancy|2|||
126201716|NCT00819052|454023821|FG000|Overall Study|Death or events leading to death|1|||
126201717|NCT00819052|454023822|FG001|Overall Study|Death or events leading to death|0|||
126201718|NCT01277666|454023827|FG000|Overall Study|Adverse Event|26|||
126201719|NCT01277666|454023828|FG001|Overall Study|Adverse Event|25|||
126201720|NCT01277666|454023829|FG002|Overall Study|Adverse Event|20|||
126201721|NCT01277666|454023827|FG000|Overall Study|Lack of Efficacy|8|||
126201722|NCT01277666|454023828|FG001|Overall Study|Lack of Efficacy|20|||
126201723|NCT01277666|454023829|FG002|Overall Study|Lack of Efficacy|12|||
126201724|NCT01277666|454023827|FG000|Overall Study|Protocol Violation|2|||
126201725|NCT01277666|454023828|FG001|Overall Study|Protocol Violation|3|||
126201726|NCT01277666|454023829|FG002|Overall Study|Protocol Violation|2|||
126201727|NCT01277666|454023827|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
126201728|NCT01277666|454023828|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
126201729|NCT01277666|454023829|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
126201730|NCT01277666|454023827|FG000|Overall Study|Lost to Follow-up|1|||
126201731|NCT01277666|454023828|FG001|Overall Study|Lost to Follow-up|1|||
126201732|NCT01277666|454023829|FG002|Overall Study|Lost to Follow-up|2|||
126201733|NCT01277666|454023827|FG000|Overall Study|Withdrawal by Subject|7|||
126311627|NCT00957268|454429820|FG004|Overall Study|Voluntary Withdrawal|0|||
126201734|NCT01277666|454023828|FG001|Overall Study|Withdrawal by Subject|8|||
126201735|NCT01277666|454023829|FG002|Overall Study|Withdrawal by Subject|6|||
126201736|NCT01277666|454023827|FG000|Overall Study|Death|0|||
126201737|NCT01277666|454023828|FG001|Overall Study|Death|0|||
126201738|NCT01277666|454023829|FG002|Overall Study|Death|1|||
126201739|NCT03702166|454023830|FG000|Overall Study|Lost to Follow-up|1|||
126201740|NCT03702166|454023830|FG000|Overall Study|Withdrawal by Subject|1|||
126201741|NCT00842829|454023833|FG000|Dose Titration Period|Adverse Event|11|||
126201742|NCT00842829|454023834|FG001|Dose Titration Period|Adverse Event|10|||
126201743|NCT00842829|454023835|FG002|Dose Titration Period|Adverse Event|0|||
126201744|NCT00842829|454023833|FG000|Dose Titration Period|Lack of Efficacy|4|||
126201745|NCT00842829|454023834|FG001|Dose Titration Period|Lack of Efficacy|1|||
126201746|NCT00842829|454023835|FG002|Dose Titration Period|Lack of Efficacy|0|||
126201747|NCT00842829|454023833|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
126201748|NCT00842829|454023834|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
126201749|NCT00842829|454023835|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
126201750|NCT00842829|454023833|FG000|Dose Titration Period|Withdrawal by Subject|2|||
126201751|NCT00842829|454023834|FG001|Dose Titration Period|Withdrawal by Subject|6|||
126201752|NCT00842829|454023835|FG002|Dose Titration Period|Withdrawal by Subject|0|||
126201753|NCT00842829|454023833|FG000|Dose Titration Period|Other|5|||
126201754|NCT00842829|454023834|FG001|Dose Titration Period|Other|4|||
126201755|NCT00842829|454023835|FG002|Dose Titration Period|Other|0|||
126201756|NCT00842829|454023833|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
126306048|NCT02553499|454408876|FG007|Overall Study|Lost to Follow-up|0|||
126201757|NCT00842829|454023834|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
126201758|NCT00842829|454023835|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
126201759|NCT00842829|454023833|FG000|Dose Titration Period|Non-compliance to study drug|2|||
126201760|NCT00842829|454023834|FG001|Dose Titration Period|Non-compliance to study drug|1|||
126201761|NCT00842829|454023835|FG002|Dose Titration Period|Non-compliance to study drug|0|||
126201762|NCT00842829|454023833|FG000|Treatment Period|Adverse Event|0|||
126201763|NCT00842829|454023834|FG001|Treatment Period|Adverse Event|0|||
126201764|NCT00842829|454023835|FG002|Treatment Period|Adverse Event|15|||
126201765|NCT00842829|454023833|FG000|Treatment Period|Lack of Efficacy|0|||
126201766|NCT00842829|454023834|FG001|Treatment Period|Lack of Efficacy|0|||
126201767|NCT00842829|454023835|FG002|Treatment Period|Lack of Efficacy|6|||
126201768|NCT00842829|454023833|FG000|Treatment Period|Unstable persistent cancer pain|0|||
126201769|NCT00842829|454023834|FG001|Treatment Period|Unstable persistent cancer pain|0|||
126201770|NCT00842829|454023835|FG002|Treatment Period|Unstable persistent cancer pain|5|||
126201771|NCT00842829|454023833|FG000|Treatment Period|Withdrawal by Subject|0|||
126201772|NCT00842829|454023834|FG001|Treatment Period|Withdrawal by Subject|0|||
126201773|NCT00842829|454023835|FG002|Treatment Period|Withdrawal by Subject|11|||
126201774|NCT00842829|454023833|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
126201775|NCT00842829|454023834|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
126201776|NCT00842829|454023835|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
126201777|NCT00842829|454023833|FG000|Treatment Period|Protocol Violation|0|||
126201778|NCT00842829|454023834|FG001|Treatment Period|Protocol Violation|0|||
126201779|NCT00842829|454023835|FG002|Treatment Period|Protocol Violation|2|||
126201780|NCT00842829|454023833|FG000|Treatment Period|Other|0|||
126201781|NCT00842829|454023834|FG001|Treatment Period|Other|0|||
126201782|NCT00842829|454023835|FG002|Treatment Period|Other|18|||
126201783|NCT00842829|454023833|FG000|Treatment Period|Non-compliance to study procedures|0|||
126201784|NCT00842829|454023834|FG001|Treatment Period|Non-compliance to study procedures|0|||
126201785|NCT00842829|454023835|FG002|Treatment Period|Non-compliance to study procedures|4|||
126201786|NCT00842829|454023833|FG000|Treatment Period|Unclear completion status|0|||
126201787|NCT00842829|454023834|FG001|Treatment Period|Unclear completion status|0|||
126201788|NCT00842829|454023835|FG002|Treatment Period|Unclear completion status|1|||
126201789|NCT00842829|454023833|FG000|Continuation Period|Adverse Event|0|||
126201790|NCT00842829|454023834|FG001|Continuation Period|Adverse Event|0|||
126201791|NCT00842829|454023835|FG002|Continuation Period|Adverse Event|32|||
126201792|NCT00842829|454023833|FG000|Continuation Period|Lack of Efficacy|0|||
126201793|NCT00842829|454023834|FG001|Continuation Period|Lack of Efficacy|0|||
126201794|NCT00842829|454023835|FG002|Continuation Period|Lack of Efficacy|6|||
126201795|NCT00842829|454023833|FG000|Continuation Period|Unstable persistent cancer pain|0|||
126311628|NCT00794040|454429821|FG000|Overall Study|Withdrawal by Subject|3|||
126311629|NCT00794040|454429822|FG001|Overall Study|Withdrawal by Subject|4|||
126311630|NCT00794040|454429821|FG000|Overall Study|Physician Decision|0|||
126311631|NCT00794040|454429822|FG001|Overall Study|Physician Decision|1|||
126311632|NCT02396420|454429823|FG000|Overall Study|Death|1|||
126311633|NCT01273623|454429824|FG000|Overall Study|did not meet IVUS criteria|29|||
126311634|NCT04064411|454429825|FG000|Overall Study|Adverse Event|29|||
126311635|NCT04064411|454429826|FG001|Overall Study|Adverse Event|19|||
126311636|NCT04064411|454429825|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
126311637|NCT04064411|454429826|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
126311638|NCT04064411|454429825|FG000|Overall Study|Protocol Deviation|0|||
126311639|NCT04064411|454429826|FG001|Overall Study|Protocol Deviation|2|||
126311640|NCT04064411|454429825|FG000|Overall Study|Withdrawal by Subject|25|||
126311641|NCT04064411|454429826|FG001|Overall Study|Withdrawal by Subject|29|||
126311642|NCT04064411|454429825|FG000|Overall Study|Lost to Follow-up|5|||
126311643|NCT04064411|454429826|FG001|Overall Study|Lost to Follow-up|2|||
126311644|NCT04064411|454429825|FG000|Overall Study|Other than Specified|4|||
126311645|NCT04064411|454429826|FG001|Overall Study|Other than Specified|1|||
126311646|NCT04064411|454429825|FG000|Overall Study|Death|1|||
126311647|NCT04064411|454429826|FG001|Overall Study|Death|0|||
126311648|NCT01970475|454429835|FG000|Overall Study|Withdrawal by Subject|11|||
126311649|NCT01970475|454429836|FG001|Overall Study|Withdrawal by Subject|6|||
126311650|NCT01970475|454429835|FG000|Overall Study|Adverse Event|7|||
126311651|NCT01970475|454429836|FG001|Overall Study|Adverse Event|3|||
126311652|NCT01970475|454429835|FG000|Overall Study|Lost to Follow-up|2|||
126311653|NCT01970475|454429836|FG001|Overall Study|Lost to Follow-up|2|||
126311654|NCT01970475|454429835|FG000|Overall Study|Protocol Violation|1|||
126311655|NCT01970475|454429836|FG001|Overall Study|Protocol Violation|0|||
126311656|NCT04413552|454429837|FG000|Overall Study|Adverse Event|0|||
126311657|NCT04413552|454429838|FG001|Overall Study|Adverse Event|0|||
126311658|NCT04413552|454429839|FG002|Overall Study|Adverse Event|0|||
126311659|NCT04413552|454429840|FG003|Overall Study|Adverse Event|0|||
126311660|NCT04413552|454429841|FG004|Overall Study|Adverse Event|0|||
126311661|NCT04413552|454429842|FG005|Overall Study|Adverse Event|0|||
126311662|NCT04413552|454429843|FG006|Overall Study|Adverse Event|1|||
126201796|NCT00842829|454023834|FG001|Continuation Period|Unstable persistent cancer pain|0|||
126201797|NCT00842829|454023835|FG002|Continuation Period|Unstable persistent cancer pain|3|||
126201798|NCT00842829|454023833|FG000|Continuation Period|Withdrawal by Subject|0|||
126201799|NCT00842829|454023834|FG001|Continuation Period|Withdrawal by Subject|0|||
126201800|NCT00842829|454023835|FG002|Continuation Period|Withdrawal by Subject|10|||
126201801|NCT00842829|454023833|FG000|Continuation Period|Other|0|||
126201802|NCT00842829|454023834|FG001|Continuation Period|Other|0|||
126201803|NCT00842829|454023835|FG002|Continuation Period|Other|7|||
126201804|NCT00842829|454023833|FG000|Continuation Period|Non-compliance to study procedures|0|||
126201805|NCT00842829|454023834|FG001|Continuation Period|Non-compliance to study procedures|0|||
126201806|NCT00842829|454023835|FG002|Continuation Period|Non-compliance to study procedures|2|||
126201807|NCT00842829|454023833|FG000|Continuation Period|Non-compliance to study drug|0|||
126201808|NCT00842829|454023834|FG001|Continuation Period|Non-compliance to study drug|0|||
126201809|NCT00842829|454023835|FG002|Continuation Period|Non-compliance to study drug|1|||
126201810|NCT03969589|454023836|FG000|Overall Study|Lost to Follow-up|3|||
126201811|NCT03969589|454023837|FG001|Overall Study|Lost to Follow-up|2|||
126201812|NCT03969589|454023836|FG000|Overall Study|Declined Follow-Up|0|||
126311663|NCT04413552|454429844|FG007|Overall Study|Adverse Event|0|||
126311664|NCT04413552|454429845|FG008|Overall Study|Adverse Event|0|||
126311665|NCT04413552|454429846|FG009|Overall Study|Adverse Event|0|||
126311666|NCT02100670|454429848|FG000|Overall Study|Adverse Event|10|||
126311667|NCT02100670|454429849|FG001|Overall Study|Adverse Event|3|||
126201813|NCT03969589|454023837|FG001|Overall Study|Declined Follow-Up|1|||
126201814|NCT03143855|454023840|FG000|Overall Study|Withdrawal by Subject|4|||
126201815|NCT03143855|454023841|FG001|Overall Study|Withdrawal by Subject|3|||
126201816|NCT03143855|454023840|FG000|Overall Study|Protocol Violation|1|||
126201817|NCT03143855|454023841|FG001|Overall Study|Protocol Violation|0|||
126201818|NCT03143855|454023840|FG000|Overall Study|Participant experienced withdrawal|0|||
126201819|NCT03143855|454023841|FG001|Overall Study|Participant experienced withdrawal|1|||
126201820|NCT04369742|454023842|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
126201821|NCT04369742|454023843|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
126311668|NCT02100670|454429850|FG002|Overall Study|Adverse Event|3|||
126311669|NCT02100670|454429851|FG003|Overall Study|Adverse Event|0|||
126311670|NCT02100670|454429848|FG000|Overall Study|Lost to Follow-up|1|||
126311671|NCT02100670|454429849|FG001|Overall Study|Lost to Follow-up|0|||
126311672|NCT02100670|454429850|FG002|Overall Study|Lost to Follow-up|0|||
126311673|NCT02100670|454429851|FG003|Overall Study|Lost to Follow-up|0|||
126311674|NCT02100670|454429848|FG000|Overall Study|Protocol Violation|0|||
126311675|NCT02100670|454429849|FG001|Overall Study|Protocol Violation|1|||
126311676|NCT02100670|454429850|FG002|Overall Study|Protocol Violation|0|||
126311677|NCT02100670|454429851|FG003|Overall Study|Protocol Violation|1|||
126311678|NCT02100670|454429848|FG000|Overall Study|Withdrawal of Consent|0|||
126311679|NCT02100670|454429849|FG001|Overall Study|Withdrawal of Consent|1|||
126311680|NCT02100670|454429850|FG002|Overall Study|Withdrawal of Consent|1|||
126311681|NCT02100670|454429851|FG003|Overall Study|Withdrawal of Consent|0|||
126311682|NCT02100670|454429848|FG000|Overall Study|No swelling no pain|1|||
126311683|NCT02100670|454429849|FG001|Overall Study|No swelling no pain|0|||
126311684|NCT02100670|454429850|FG002|Overall Study|No swelling no pain|0|||
126311685|NCT02100670|454429851|FG003|Overall Study|No swelling no pain|0|||
126201822|NCT04369742|454023842|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
126306049|NCT02553499|454408877|FG008|Overall Study|Lost to Follow-up|0|||
126311686|NCT02100670|454429848|FG000|Overall Study|Poor Efficacy|0|||
126311687|NCT02100670|454429849|FG001|Overall Study|Poor Efficacy|1|||
126311688|NCT02100670|454429850|FG002|Overall Study|Poor Efficacy|0|||
126311689|NCT02100670|454429851|FG003|Overall Study|Poor Efficacy|0|||
126311690|NCT02100670|454429848|FG000|Overall Study|Physician Decision|0|||
126311691|NCT02100670|454429849|FG001|Overall Study|Physician Decision|1|||
126311692|NCT02100670|454429850|FG002|Overall Study|Physician Decision|0|||
126311693|NCT02100670|454429851|FG003|Overall Study|Physician Decision|0|||
126311694|NCT02100670|454429848|FG000|Overall Study|Withdrawal by Subject|1|||
126311695|NCT02100670|454429849|FG001|Overall Study|Withdrawal by Subject|0|||
126311696|NCT02100670|454429850|FG002|Overall Study|Withdrawal by Subject|0|||
126311697|NCT02100670|454429851|FG003|Overall Study|Withdrawal by Subject|0|||
126311698|NCT04852679|454429852|FG000|Main Intervention Period|Withdrawal by Subject|3|||
126311699|NCT04852679|454429852|FG000|Main Intervention Period|Adverse Event|1|||
126311700|NCT04852679|454429852|FG000|Main Intervention Period|Progressive Disease|16|||
126311701|NCT04852679|454429852|FG000|Main Intervention Period|Refused study visit|1|||
126422525|NCT02714569|454842623|FG002|Part A Third Intervention|Adverse Event|1|||
126422526|NCT02714569|454842624|FG003|Part A Third Intervention|Adverse Event|0|||
126306050|NCT02553499|454408878|FG009|Overall Study|Lost to Follow-up|0|||
126306051|NCT02553499|454408879|FG010|Overall Study|Lost to Follow-up|0|||
126306052|NCT02553499|454408880|FG011|Overall Study|Lost to Follow-up|0|||
126306053|NCT02553499|454408881|FG012|Overall Study|Lost to Follow-up|0|||
126306054|NCT02553499|454408882|FG013|Overall Study|Lost to Follow-up|0|||
126311702|NCT04852679|454429852|FG000|Independent Injection Period|Missed study visit|1|||
126311703|NCT01294696|454429853|FG000|Overall Study|Screening failures|7|||
126311704|NCT01294696|454429853|FG000|Overall Study|Protocol Violation|8|||
126422527|NCT02714569|454842625|FG004|Part A Third Intervention|Adverse Event|0|||
126422528|NCT02714569|454842626|FG005|Part A Third Intervention|Adverse Event|0|||
126422529|NCT02714569|454842627|FG006|Part A Third Intervention|Adverse Event|0|||
126422530|NCT02714569|454842628|FG007|Part A Third Intervention|Adverse Event|0|||
126422531|NCT02714569|454842629|FG008|Part A Third Intervention|Adverse Event|0|||
126422532|NCT02714569|454842630|FG009|Part A Third Intervention|Adverse Event|0|||
126422533|NCT02714569|454842631|FG010|Part A Third Intervention|Adverse Event|0|||
126201823|NCT04369742|454023843|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
126201824|NCT03417999|454023846|FG000|Overall Study|Withdrawal by Subject|1|||
126201825|NCT03417999|454023847|FG001|Overall Study|Withdrawal by Subject|0|||
126201826|NCT03417999|454023848|FG002|Overall Study|Withdrawal by Subject|0|||
126201827|NCT03417999|454023846|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
126422534|NCT02714569|454842621|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
126422535|NCT02714569|454842622|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422536|NCT02714569|454842623|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422537|NCT02714569|454842624|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422538|NCT02714569|454842625|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126311705|NCT01294696|454429853|FG000|Overall Study|Missing BPI Response|7|||
126311706|NCT01294696|454429853|FG000|Overall Study|Site closure|52|||
126369306|NCT02090764|454648191|FG001|Overall Study|Intercurrent illness and other|1|||
126369307|NCT02090764|454648190|FG000|Overall Study|Lost to Follow-up|2|||
126369308|NCT02090764|454648191|FG001|Overall Study|Lost to Follow-up|2|||
126369309|NCT02300233|454648193|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
126369310|NCT02300233|454648194|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
126369311|NCT02300233|454648195|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
126422539|NCT02714569|454842626|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
126369312|NCT02300233|454648193|FG000|Overall Study|Withdrawal by Subject|1|||
126369313|NCT02300233|454648194|FG001|Overall Study|Withdrawal by Subject|0|||
126422540|NCT02714569|454842627|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422541|NCT02714569|454842628|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422542|NCT02714569|454842629|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422543|NCT02714569|454842630|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422544|NCT02714569|454842631|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126201828|NCT03417999|454023847|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
126201829|NCT03417999|454023848|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
126201830|NCT03417999|454023846|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
126201831|NCT03417999|454023847|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
126201832|NCT03417999|454023848|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
126201833|NCT03417999|454023846|FG000|Overall Study|Inadequate study staff available to process samples|0|||
126201834|NCT03417999|454023847|FG001|Overall Study|Inadequate study staff available to process samples|0|||
126201835|NCT03417999|454023848|FG002|Overall Study|Inadequate study staff available to process samples|1|||
126201836|NCT02098733|454023852|FG000|Overall Study|Data Not Available|5|||
126201837|NCT02098733|454023852|FG000|Overall Study|Lost to Follow-up|5|||
126201838|NCT00434876|454023855|FG000|Overall Study|Lost to Follow-up|1|||
126201839|NCT00434876|454023856|FG001|Overall Study|Lost to Follow-up|1|||
126201840|NCT04524663|454025764|FG000|Overall Study|Withdrawal by Subject|0|||
126201841|NCT04524663|454025765|FG001|Overall Study|Withdrawal by Subject|2|||
126369314|NCT02300233|454648195|FG002|Overall Study|Withdrawal by Subject|3|||
126369315|NCT02300233|454648193|FG000|Overall Study|Investigator Judgement|0|||
126369316|NCT02300233|454648194|FG001|Overall Study|Investigator Judgement|0|||
126369317|NCT02300233|454648195|FG002|Overall Study|Investigator Judgement|1|||
126369318|NCT02300233|454648193|FG000|Overall Study|Reason Not Specified|0|||
126369319|NCT02300233|454648194|FG001|Overall Study|Reason Not Specified|0|||
126369320|NCT02300233|454648195|FG002|Overall Study|Reason Not Specified|5|||
126369321|NCT00833690|454648196|FG000|Overall Study|Withdrawal by Subject|1|||
126369322|NCT00833690|454648197|FG001|Overall Study|Withdrawal by Subject|0|||
126369323|NCT00833690|454648198|FG002|Overall Study|Withdrawal by Subject|0|||
126369324|NCT00833690|454648196|FG000|Overall Study|Discontinued study drug|3|||
126369325|NCT00833690|454648197|FG001|Overall Study|Discontinued study drug|2|||
126369326|NCT00833690|454648198|FG002|Overall Study|Discontinued study drug|0|||
126369327|NCT02661815|454648199|FG000|Overall Study|Withdrawal by Subject|1|||
126369328|NCT02661815|454648200|FG001|Overall Study|Withdrawal by Subject|0|||
126422545|NCT02714569|454842621|FG000|Part B (Overall)|Lost to Follow-up|0|||
126422546|NCT02714569|454842622|FG001|Part B (Overall)|Lost to Follow-up|0|||
126422547|NCT02714569|454842623|FG002|Part B (Overall)|Lost to Follow-up|0|||
126201842|NCT00337935|454025766|FG000|Overall Study|Adverse Event|2|||
126201843|NCT00337935|454025767|FG001|Overall Study|Adverse Event|5|||
126201844|NCT00337935|454025766|FG000|Overall Study|Death|2|||
126201845|NCT00337935|454025767|FG001|Overall Study|Death|8|||
126369329|NCT02661815|454648201|FG002|Overall Study|Withdrawal by Subject|0|||
126369330|NCT02661815|454648202|FG003|Overall Study|Withdrawal by Subject|0|||
126201846|NCT00337935|454025766|FG000|Overall Study|Physician Decision|1|||
126201847|NCT00337935|454025767|FG001|Overall Study|Physician Decision|1|||
126201848|NCT00337935|454025766|FG000|Overall Study|Lost to Follow-up|0|||
126201849|NCT00337935|454025767|FG001|Overall Study|Lost to Follow-up|1|||
126311707|NCT00381238|454432080|FG000|Overall Study|Adverse Event|3|||
126311708|NCT00381238|454432080|FG000|Overall Study|Protocol Violation|1|||
126311709|NCT00381238|454432080|FG000|Overall Study|Withdrawal by Subject|4|||
126311710|NCT00381238|454432080|FG000|Overall Study|Lack of Efficacy|2|||
126311711|NCT00381238|454432080|FG000|Overall Study|Withdrew by physician|1|||
126311712|NCT00381238|454432080|FG000|Overall Study|Disease progression|1|||
126311713|NCT02086448|454432084|FG000|Overall Study|Withdrawal by Subject|1|||
126311714|NCT02086448|454432085|FG001|Overall Study|Withdrawal by Subject|0|||
126311715|NCT02086448|454432086|FG002|Overall Study|Withdrawal by Subject|0|||
126311716|NCT02086448|454432087|FG003|Overall Study|Withdrawal by Subject|2|||
126311717|NCT00843037|454432090|FG000|Overall Study|Lost to Follow-up|1|||
126311718|NCT01871402|454432093|FG000|Overall Study|Lost to Follow-up|1|||
126311719|NCT01871402|454432094|FG001|Overall Study|Lost to Follow-up|0|||
126311720|NCT01871402|454432093|FG000|Overall Study|Withdrawal by Subject|0|||
126311721|NCT01871402|454432094|FG001|Overall Study|Withdrawal by Subject|2|||
126311722|NCT01871402|454432093|FG000|Overall Study|Non-compliance|0|||
126311723|NCT01871402|454432094|FG001|Overall Study|Non-compliance|1|||
126311724|NCT02424630|454432095|FG000|Overall Study|No rotator cuff tear|1|||
126311725|NCT02424630|454432096|FG001|Overall Study|No rotator cuff tear|2|||
126311726|NCT02424630|454432095|FG000|Overall Study|Open procedure|0|||
126311727|NCT02424630|454432096|FG001|Overall Study|Open procedure|1|||
126311728|NCT02703272|454432097|FG000|Overall Study|Death|4|||
126201850|NCT00337935|454025766|FG000|Overall Study|Protocol Violation|4|||
126201851|NCT00337935|454025767|FG001|Overall Study|Protocol Violation|3|||
126201852|NCT00337935|454025766|FG000|Overall Study|Withdrawal by Subject|1|||
126201853|NCT00337935|454025767|FG001|Overall Study|Withdrawal by Subject|7|||
126201854|NCT00337935|454025766|FG000|Overall Study|Other|0|||
126201855|NCT00337935|454025767|FG001|Overall Study|Other|1|||
126201856|NCT00337935|454025766|FG000|Overall Study|Lack of Efficacy|0|||
126201857|NCT00337935|454025767|FG001|Overall Study|Lack of Efficacy|1|||
126201858|NCT01884675|454025768|FG000|Overall Study|Study closed/terminated|3|||
126201859|NCT01884675|454025769|FG001|Overall Study|Study closed/terminated|2|||
126201860|NCT02361307|454025770|FG000|Overall Study|Unstable medical condition.|0|||
126201861|NCT02361307|454025771|FG001|Overall Study|Unstable medical condition.|1|||
126201862|NCT00711009|454025772|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
126201863|NCT00711009|454025773|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
126201864|NCT00711009|454025772|FG000|Overall Study|Withdrawal by Subject|4|||
126311729|NCT02703272|454432098|FG001|Overall Study|Death|9|||
126311730|NCT02703272|454432099|FG002|Overall Study|Death|19|||
126311731|NCT02703272|454432100|FG003|Overall Study|Death|10|||
126311732|NCT02703272|454432097|FG000|Overall Study|Withdrawal by Subject|0|||
126311733|NCT02703272|454432098|FG001|Overall Study|Withdrawal by Subject|0|||
126311734|NCT02703272|454432099|FG002|Overall Study|Withdrawal by Subject|4|||
126201865|NCT00711009|454025773|FG001|Overall Study|Withdrawal by Subject|2|||
126201866|NCT00711009|454025772|FG000|Overall Study|Lost to Follow-up|3|||
126201867|NCT00711009|454025773|FG001|Overall Study|Lost to Follow-up|9|||
126201868|NCT00711009|454025772|FG000|Overall Study|Participant Noncompliant|0|||
126201869|NCT00711009|454025773|FG001|Overall Study|Participant Noncompliant|1|||
126201870|NCT00711009|454025772|FG000|Overall Study|Virologic Failure|2|||
126311735|NCT02703272|454432100|FG003|Overall Study|Withdrawal by Subject|2|||
126201871|NCT00711009|454025773|FG001|Overall Study|Virologic Failure|1|||
126201872|NCT00711009|454025772|FG000|Overall Study|Pregnancy|1|||
126201873|NCT00711009|454025773|FG001|Overall Study|Pregnancy|0|||
126201874|NCT00711009|454025772|FG000|Overall Study|Site closing|0|||
126201875|NCT00711009|454025773|FG001|Overall Study|Site closing|1|||
126201876|NCT00711009|454025772|FG000|Overall Study|Dose adjustment|1|||
126201877|NCT00711009|454025773|FG001|Overall Study|Dose adjustment|0|||
126201878|NCT03359811|454025774|FG000|Overall Study|Protocol Violation|2|||
126201879|NCT03359811|454025775|FG001|Overall Study|Protocol Violation|0|||
126201880|NCT01682876|454025776|FG000|Overall Study|Administrative reason|4|||
126201881|NCT01682876|454025777|FG001|Overall Study|Administrative reason|4|||
126201882|NCT01682876|454025778|FG002|Overall Study|Administrative reason|0|||
126201883|NCT01682876|454025779|FG003|Overall Study|Administrative reason|3|||
126201884|NCT01682876|454025776|FG000|Overall Study|Adverse Event|0|||
126201885|NCT01682876|454025777|FG001|Overall Study|Adverse Event|0|||
126201886|NCT01682876|454025778|FG002|Overall Study|Adverse Event|0|||
126201887|NCT01682876|454025779|FG003|Overall Study|Adverse Event|1|||
126311736|NCT02703272|454432097|FG000|Overall Study|Study Terminated by Sponsor|6|||
126311737|NCT02703272|454432098|FG001|Overall Study|Study Terminated by Sponsor|1|||
126311738|NCT02703272|454432099|FG002|Overall Study|Study Terminated by Sponsor|12|||
126311739|NCT02703272|454432100|FG003|Overall Study|Study Terminated by Sponsor|4|||
126311740|NCT02703272|454432097|FG000|Overall Study|Other|1|||
126311741|NCT02703272|454432098|FG001|Overall Study|Other|0|||
126311742|NCT02703272|454432099|FG002|Overall Study|Other|0|||
126311743|NCT02703272|454432100|FG003|Overall Study|Other|0|||
126201888|NCT01682876|454025776|FG000|Overall Study|Lost to Follow-up|11|||
126201889|NCT01682876|454025777|FG001|Overall Study|Lost to Follow-up|15|||
126201890|NCT01682876|454025778|FG002|Overall Study|Lost to Follow-up|9|||
126201891|NCT01682876|454025779|FG003|Overall Study|Lost to Follow-up|11|||
126201892|NCT01682876|454025776|FG000|Overall Study|Protocol Violation|1|||
126201893|NCT01682876|454025777|FG001|Overall Study|Protocol Violation|1|||
126201894|NCT01682876|454025778|FG002|Overall Study|Protocol Violation|1|||
126201895|NCT01682876|454025779|FG003|Overall Study|Protocol Violation|1|||
126201896|NCT01682876|454025776|FG000|Overall Study|Withdrawal by Subject|4|||
126201897|NCT01682876|454025777|FG001|Overall Study|Withdrawal by Subject|0|||
126201898|NCT01682876|454025778|FG002|Overall Study|Withdrawal by Subject|0|||
126201899|NCT01682876|454025779|FG003|Overall Study|Withdrawal by Subject|2|||
126201900|NCT01682876|454025776|FG000|Overall Study|Other|1|||
126201901|NCT01682876|454025777|FG001|Overall Study|Other|0|||
126201902|NCT01682876|454025778|FG002|Overall Study|Other|1|||
126201903|NCT01682876|454025779|FG003|Overall Study|Other|1|||
126201904|NCT02534324|454025781|FG000|Overall Study|Protocol Violation|4|||
126201905|NCT02534324|454025782|FG001|Overall Study|Protocol Violation|1|||
126201906|NCT02534324|454025781|FG000|Overall Study|Lost to Follow-up|20|||
126201907|NCT02534324|454025782|FG001|Overall Study|Lost to Follow-up|7|||
126201908|NCT02534324|454025781|FG000|Overall Study|Adverse Event|1|||
126201909|NCT02534324|454025782|FG001|Overall Study|Adverse Event|0|||
126201910|NCT01459016|454025785|FG000|Overall Study|Withdrawal by Subject|11|||
126201911|NCT01459016|454025785|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
126201912|NCT00303602|454025789|FG000|Overall Study|Adverse Event|2|||
126201913|NCT00303602|454025790|FG001|Overall Study|Adverse Event|2|||
126201914|NCT00303602|454025789|FG000|Overall Study|Withdrawal by Subject|5|||
126201915|NCT00303602|454025790|FG001|Overall Study|Withdrawal by Subject|6|||
126201916|NCT00303602|454025789|FG000|Overall Study|Lost to Follow-up|5|||
126201917|NCT00303602|454025790|FG001|Overall Study|Lost to Follow-up|2|||
126201918|NCT00303602|454025789|FG000|Overall Study|Protocol entry criteria not met|2|||
126201919|NCT00303602|454025790|FG001|Overall Study|Protocol entry criteria not met|2|||
126201920|NCT00303602|454025789|FG000|Overall Study|Physician Decision|2|||
126201921|NCT00303602|454025790|FG001|Overall Study|Physician Decision|1|||
126201922|NCT00303602|454025789|FG000|Overall Study|Noncompliance|2|||
126201923|NCT00303602|454025790|FG001|Overall Study|Noncompliance|2|||
126201924|NCT00303602|454025789|FG000|Overall Study|Protocol Violation|1|||
126201925|NCT00303602|454025790|FG001|Overall Study|Protocol Violation|0|||
126311744|NCT02637895|454432101|FG000|Overall Study|Lost to Follow-up|4|||
126311745|NCT02637895|454432102|FG001|Overall Study|Lost to Follow-up|0|||
126311746|NCT02637895|454432101|FG000|Overall Study|Protocol Violation|0|||
126311747|NCT02637895|454432102|FG001|Overall Study|Protocol Violation|1|||
126311748|NCT02637895|454432101|FG000|Overall Study|Lack of Efficacy|1|||
126311749|NCT02637895|454432102|FG001|Overall Study|Lack of Efficacy|0|||
126311750|NCT02637895|454432101|FG000|Overall Study|Withdrawal by Subject|1|||
126311751|NCT02637895|454432102|FG001|Overall Study|Withdrawal by Subject|1|||
126311752|NCT02637895|454432101|FG000|Overall Study|Abnormal baseline lab|0|||
126311753|NCT02637895|454432102|FG001|Overall Study|Abnormal baseline lab|1|||
126311754|NCT02222545|454432103|FG000|Overall Study|Adverse Event|1|||
126311755|NCT02222545|454432104|FG001|Overall Study|Adverse Event|0|||
126311756|NCT02222545|454432105|FG002|Overall Study|Adverse Event|2|||
126311757|NCT02222545|454432103|FG000|Overall Study|Death|0|||
126311758|NCT02222545|454432104|FG001|Overall Study|Death|0|||
126311759|NCT02222545|454432105|FG002|Overall Study|Death|9|||
126311760|NCT02222545|454432103|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
126311761|NCT02222545|454432104|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
126311762|NCT02222545|454432105|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
126311763|NCT02222545|454432103|FG000|Overall Study|Withdrawal by Subject|0|||
126311764|NCT02222545|454432104|FG001|Overall Study|Withdrawal by Subject|0|||
126311765|NCT02222545|454432105|FG002|Overall Study|Withdrawal by Subject|3|||
126311766|NCT02222545|454432103|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
126311767|NCT02222545|454432104|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
126201926|NCT00663208|454025795|FG000|Treatment Period|Lost to Follow-up|0|||
126201927|NCT00663208|454025796|FG001|Treatment Period|Lost to Follow-up|1|||
126201928|NCT00663208|454025797|FG002|Treatment Period|Lost to Follow-up|0|||
126201929|NCT00663208|454025798|FG003|Treatment Period|Lost to Follow-up|0|||
126311768|NCT02222545|454432105|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
126311769|NCT00761280|454432106|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
126311770|NCT00761280|454432107|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
126201930|NCT00663208|454025799|FG004|Treatment Period|Lost to Follow-up|0|||
126311771|NCT00761280|454432106|FG000|Randomization to First Dose|Sponsor decision|1|||
126311772|NCT00761280|454432107|FG001|Randomization to First Dose|Sponsor decision|0|||
126311773|NCT00761280|454432106|FG000|Randomization to First Dose|Other|1|||
126201931|NCT00663208|454025800|FG005|Treatment Period|Lost to Follow-up|0|||
126201932|NCT00663208|454025801|FG006|Treatment Period|Lost to Follow-up|0|||
126201933|NCT00663208|454025795|FG000|Follow-up Period|Lost to Follow-up|2|||
126201934|NCT00663208|454025796|FG001|Follow-up Period|Lost to Follow-up|0|||
126422548|NCT02714569|454842624|FG003|Part B (Overall)|Lost to Follow-up|0|||
126422549|NCT02714569|454842625|FG004|Part B (Overall)|Lost to Follow-up|0|||
126422550|NCT02714569|454842626|FG005|Part B (Overall)|Lost to Follow-up|0|||
126422551|NCT02714569|454842627|FG006|Part B (Overall)|Lost to Follow-up|1|||
126422552|NCT02714569|454842628|FG007|Part B (Overall)|Lost to Follow-up|0|||
126422553|NCT02714569|454842629|FG008|Part B (Overall)|Lost to Follow-up|0|||
126422554|NCT02714569|454842630|FG009|Part B (Overall)|Lost to Follow-up|0|||
126422555|NCT02714569|454842631|FG010|Part B (Overall)|Lost to Follow-up|0|||
126422556|NCT02714569|454842621|FG000|Part B (Overall)|Withdrawal by Subject|0|||
126422557|NCT02714569|454842622|FG001|Part B (Overall)|Withdrawal by Subject|0|||
126422558|NCT02714569|454842623|FG002|Part B (Overall)|Withdrawal by Subject|0|||
126422559|NCT02714569|454842624|FG003|Part B (Overall)|Withdrawal by Subject|0|||
126422560|NCT02714569|454842625|FG004|Part B (Overall)|Withdrawal by Subject|0|||
126201935|NCT00663208|454025797|FG002|Follow-up Period|Lost to Follow-up|3|||
125978410|NCT04179175|453209732|FG003|Overall Study|Technical problems|1|||
125978411|NCT04179175|453209733|FG004|Overall Study|Technical problems|0|||
125978412|NCT04179175|453209734|FG005|Overall Study|Technical problems|0|||
125978413|NCT02030015|453209738|FG000|Overall Study|Withdrawal by Subject|3|||
125978414|NCT02030015|453209738|FG000|Overall Study|Death|13|||
125978415|NCT02822222|453209748|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
125978416|NCT02822222|453209749|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
126422561|NCT02714569|454842626|FG005|Part B (Overall)|Withdrawal by Subject|0|||
126422562|NCT02714569|454842627|FG006|Part B (Overall)|Withdrawal by Subject|0|||
126422563|NCT02714569|454842628|FG007|Part B (Overall)|Withdrawal by Subject|1|||
126422564|NCT02714569|454842629|FG008|Part B (Overall)|Withdrawal by Subject|0|||
126422565|NCT02714569|454842630|FG009|Part B (Overall)|Withdrawal by Subject|1|||
126422566|NCT02714569|454842631|FG010|Part B (Overall)|Withdrawal by Subject|0|||
126422567|NCT02714569|454842621|FG000|Part B (Overall)|Adverse Event|0|||
126422568|NCT02714569|454842622|FG001|Part B (Overall)|Adverse Event|0|||
126422569|NCT02714569|454842623|FG002|Part B (Overall)|Adverse Event|0|||
126422570|NCT02714569|454842624|FG003|Part B (Overall)|Adverse Event|0|||
125978417|NCT03581981|453209753|FG000|Overall Study|Withdrawal by Subject|12|||
125978418|NCT03581981|453209754|FG001|Overall Study|Withdrawal by Subject|13|||
125978419|NCT03581981|453209753|FG000|Overall Study|Physician Decision|1|||
125978420|NCT03581981|453209754|FG001|Overall Study|Physician Decision|2|||
125978421|NCT03581981|453209753|FG000|Overall Study|Lost to Follow-up|0|||
125978422|NCT03581981|453209754|FG001|Overall Study|Lost to Follow-up|4|||
125978423|NCT02080871|453209755|FG000|Overall Study|Death|1|||
125978424|NCT02080871|453209755|FG000|Overall Study|Lost to Follow-up|1|||
125978425|NCT00234052|453209756|FG000|Treatment|Withdrawal by Subject|3|||
125978426|NCT00234052|453209756|FG000|Treatment|Adverse Event|5|||
125978427|NCT00234052|453209756|FG000|Treatment|Death|2|||
125978428|NCT00234052|453209756|FG000|Treatment|Progressive Disease|11|||
125978429|NCT00234052|453209756|FG000|Follow-up for 5 Years|Death|41|||
125978430|NCT00234052|453209756|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
125978431|NCT00234052|453209756|FG000|Follow-up for 5 Years|Other|7|||
125978432|NCT01410474|453209757|FG000|Overall Study|Withdrawal by Subject|0|||
125978433|NCT01410474|453209758|FG001|Overall Study|Withdrawal by Subject|1|||
125978434|NCT02428296|453209759|FG000|Overall Study|Adverse Event|7|||
125978435|NCT02428296|453209759|FG000|Overall Study|Withdrawal by Subject|2|||
125978436|NCT00828984|453209760|FG000|Overall Study|Adverse Event|2|||
125978437|NCT00828984|453209761|FG001|Overall Study|Adverse Event|3|||
125978438|NCT00828984|453209762|FG002|Overall Study|Adverse Event|0|||
125978439|NCT00828984|453209760|FG000|Overall Study|Lost to Follow-up|5|||
125978440|NCT00828984|453209761|FG001|Overall Study|Lost to Follow-up|3|||
126201936|NCT00663208|454025798|FG003|Follow-up Period|Lost to Follow-up|2|||
126201937|NCT00663208|454025799|FG004|Follow-up Period|Lost to Follow-up|0|||
126201938|NCT00663208|454025800|FG005|Follow-up Period|Lost to Follow-up|0|||
126201939|NCT00663208|454025801|FG006|Follow-up Period|Lost to Follow-up|0|||
126201940|NCT00663208|454025795|FG000|Follow-up Period|Other reason|1|||
126201941|NCT00663208|454025796|FG001|Follow-up Period|Other reason|0|||
126201942|NCT00663208|454025797|FG002|Follow-up Period|Other reason|0|||
126201943|NCT00663208|454025798|FG003|Follow-up Period|Other reason|0|||
126201944|NCT00663208|454025799|FG004|Follow-up Period|Other reason|0|||
126201945|NCT00663208|454025800|FG005|Follow-up Period|Other reason|0|||
126201946|NCT00663208|454025801|FG006|Follow-up Period|Other reason|1|||
126201947|NCT02927990|454025803|FG000|Overall Study|Protocol Violation|4|||
126201948|NCT02927990|454025803|FG000|Overall Study|Physician Decision|9|||
126201949|NCT02927990|454025803|FG000|Overall Study|Room switched and therefore no study device available|15|||
126422571|NCT02714569|454842625|FG004|Part B (Overall)|Adverse Event|0|||
126201950|NCT02927990|454025803|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
126422572|NCT02714569|454842626|FG005|Part B (Overall)|Adverse Event|0|||
126422573|NCT02714569|454842627|FG006|Part B (Overall)|Adverse Event|0|||
126422574|NCT02714569|454842628|FG007|Part B (Overall)|Adverse Event|0|||
126422575|NCT02714569|454842629|FG008|Part B (Overall)|Adverse Event|0|||
126422576|NCT02714569|454842630|FG009|Part B (Overall)|Adverse Event|1|||
126422577|NCT02714569|454842631|FG010|Part B (Overall)|Adverse Event|0|||
125978441|NCT00828984|453209762|FG002|Overall Study|Lost to Follow-up|1|||
126422578|NCT04915729|454842632|FG000|Overall Study|Lost to Follow-up|20|||
126201951|NCT00960323|454025804|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
126201952|NCT02719028|454025811|FG000|Overall Study|Adverse Event|2|||
125978442|NCT00828984|453209760|FG000|Overall Study|Withdrawal by Subject|4|||
125978443|NCT00828984|453209761|FG001|Overall Study|Withdrawal by Subject|4|||
125978444|NCT00828984|453209762|FG002|Overall Study|Withdrawal by Subject|4|||
125978445|NCT00828984|453209760|FG000|Overall Study|Ineligable|1|||
125978446|NCT00828984|453209761|FG001|Overall Study|Ineligable|2|||
125978447|NCT00828984|453209762|FG002|Overall Study|Ineligable|0|||
125978448|NCT00828984|453209760|FG000|Overall Study|Medical Contraindication|0|||
125978449|NCT00828984|453209761|FG001|Overall Study|Medical Contraindication|1|||
125978450|NCT00828984|453209762|FG002|Overall Study|Medical Contraindication|0|||
125978451|NCT00828984|453209760|FG000|Overall Study|Noncompliant|1|||
125978452|NCT00828984|453209761|FG001|Overall Study|Noncompliant|2|||
125978453|NCT00828984|453209762|FG002|Overall Study|Noncompliant|3|||
125978454|NCT00828984|453209760|FG000|Overall Study|ConMed|1|||
125978455|NCT00828984|453209761|FG001|Overall Study|ConMed|1|||
125978456|NCT00828984|453209762|FG002|Overall Study|ConMed|1|||
125978457|NCT01615328|453209765|FG000|Overall Study|Lost to Follow-up|3|||
125978458|NCT01615328|453209766|FG001|Overall Study|Lost to Follow-up|5|||
125978459|NCT03338894|453209767|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
125978460|NCT04465357|453209768|FG000|Overall Study|Adverse Event|2|||
125978461|NCT04465357|453209768|FG000|Overall Study|Lack of Efficacy|1|||
125978462|NCT04465357|453209768|FG000|Overall Study|Lost to Follow-up|2|||
125978463|NCT04465357|453209768|FG000|Overall Study|Withdrawal by Subject|6|||
125978464|NCT04465357|453209768|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
125978465|NCT00626028|453209771|FG000|Overall Study|Adverse Event|1|||
125978466|NCT00626028|453209772|FG001|Overall Study|Adverse Event|1|||
125978467|NCT00626028|453209771|FG000|Overall Study|Device Failure|0|||
125978468|NCT00626028|453209772|FG001|Overall Study|Device Failure|1|||
125978469|NCT00626028|453209771|FG000|Overall Study|Physician Decision|2|||
125978470|NCT00626028|453209772|FG001|Overall Study|Physician Decision|1|||
125978471|NCT00626028|453209771|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
125978472|NCT00626028|453209772|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
125978473|NCT00831779|453209773|FG000|Overall Study|Lost to Follow-up|1|||
125978474|NCT00831779|453209774|FG001|Overall Study|Lost to Follow-up|0|||
125978475|NCT00831779|453209773|FG000|Overall Study|No longer met criteria|0|||
125978476|NCT00831779|453209774|FG001|Overall Study|No longer met criteria|1|||
125978477|NCT02436330|453209775|FG000|Cohort 1|Lost to Follow-up|5|||
125978478|NCT02436330|453209776|FG001|Cohort 1|Lost to Follow-up|2|||
125978479|NCT02436330|453209775|FG000|Cohort 1|Withdrawal by Subject|0|||
125978480|NCT02436330|453209776|FG001|Cohort 1|Withdrawal by Subject|1|||
125978481|NCT02436330|453209775|FG000|Cohort 2|Lost to Follow-up|2|||
125978482|NCT02436330|453209776|FG001|Cohort 2|Lost to Follow-up|0|||
125978483|NCT02436330|453209775|FG000|Cohort 2|Withdrawal by Subject|2|||
125978484|NCT02436330|453209776|FG001|Cohort 2|Withdrawal by Subject|3|||
125978485|NCT02436330|453209775|FG000|Cohort 3|Lost to Follow-up|1|||
125978486|NCT02436330|453209776|FG001|Cohort 3|Lost to Follow-up|0|||
125978487|NCT02436330|453209775|FG000|Cohort 3|Withdrawal by Subject|4|||
125978488|NCT02436330|453209776|FG001|Cohort 3|Withdrawal by Subject|0|||
125978489|NCT02436330|453209775|FG000|Cohort 4|Lost to Follow-up|1|||
125978490|NCT02436330|453209776|FG001|Cohort 4|Lost to Follow-up|0|||
125978491|NCT02436330|453209775|FG000|Cohort 4|Withdrawal by Subject|1|||
125978492|NCT02436330|453209776|FG001|Cohort 4|Withdrawal by Subject|0|||
125978493|NCT02436330|453209775|FG000|Cohort 5|Lost to Follow-up|3|||
125978494|NCT02436330|453209776|FG001|Cohort 5|Lost to Follow-up|2|||
125978495|NCT02436330|453209775|FG000|Cohort 5|Withdrawal by Subject|3|||
125978496|NCT02436330|453209776|FG001|Cohort 5|Withdrawal by Subject|2|||
125978497|NCT02436330|453209775|FG000|Cohort 6|Lost to Follow-up|2|||
125978498|NCT02436330|453209776|FG001|Cohort 6|Lost to Follow-up|0|||
125978499|NCT02436330|453209775|FG000|Cohort 6|Withdrawal by Subject|1|||
125978500|NCT02436330|453209776|FG001|Cohort 6|Withdrawal by Subject|1|||
125978501|NCT02230956|453209777|FG000|Overall Study|Adverse Event|1|||
125978502|NCT02230956|453209778|FG001|Overall Study|Adverse Event|1|||
125978503|NCT02230956|453209779|FG002|Overall Study|Adverse Event|0|||
125978504|NCT02230956|453209777|FG000|Overall Study|Lack of Efficacy|1|||
125978505|NCT02230956|453209778|FG001|Overall Study|Lack of Efficacy|1|||
125978506|NCT02230956|453209779|FG002|Overall Study|Lack of Efficacy|1|||
126201953|NCT02719028|454025812|FG001|Overall Study|Adverse Event|1|||
126201954|NCT02719028|454025813|FG002|Overall Study|Adverse Event|4|||
126201955|NCT02719028|454025814|FG003|Overall Study|Adverse Event|8|||
126201956|NCT02719028|454025811|FG000|Overall Study|Physician Decision|0|||
126201957|NCT02719028|454025812|FG001|Overall Study|Physician Decision|1|||
126201958|NCT02719028|454025813|FG002|Overall Study|Physician Decision|1|||
126201959|NCT02719028|454025814|FG003|Overall Study|Physician Decision|1|||
125978507|NCT02230956|453209777|FG000|Overall Study|Lost to Follow-up|1|||
125978508|NCT02230956|453209778|FG001|Overall Study|Lost to Follow-up|1|||
125978509|NCT02230956|453209779|FG002|Overall Study|Lost to Follow-up|2|||
125978510|NCT02230956|453209777|FG000|Overall Study|Personal Reasons|2|||
126306055|NCT02553499|454408869|FG000|Overall Study|Physician Decision|0|||
126201960|NCT02719028|454025811|FG000|Overall Study|Use of prohibited medication|0|||
125978511|NCT02230956|453209778|FG001|Overall Study|Personal Reasons|1|||
125978512|NCT02230956|453209779|FG002|Overall Study|Personal Reasons|1|||
125978513|NCT02230956|453209777|FG000|Overall Study|Protocol Violation|0|||
125978514|NCT02230956|453209778|FG001|Overall Study|Protocol Violation|1|||
125978515|NCT02230956|453209779|FG002|Overall Study|Protocol Violation|1|||
125978516|NCT02230956|453209777|FG000|Overall Study|Other Miscellaneous Reason|0|||
125978517|NCT02230956|453209778|FG001|Overall Study|Other Miscellaneous Reason|1|||
125978518|NCT02230956|453209779|FG002|Overall Study|Other Miscellaneous Reason|2|||
125978519|NCT00338884|453209780|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
125978520|NCT00338884|453209780|FG000|Overall Study|Adverse Event|14|||
125978521|NCT00338884|453209780|FG000|Overall Study|Death|8|||
125978522|NCT00338884|453209780|FG000|Overall Study|Other|4|||
125978523|NCT00338884|453209780|FG000|Overall Study|Global Deterioration of Health Status|3|||
125978524|NCT00338884|453209780|FG000|Overall Study|Withdrawal by Subject|3|||
125978525|NCT00338884|453209780|FG000|Overall Study|Lost to Follow-up|1|||
125978526|NCT00338884|453209780|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
125978527|NCT01970982|453209782|FG000|Overall Study|Withdrawal by Subject|0|||
125978528|NCT01970982|453209783|FG001|Overall Study|Withdrawal by Subject|0|||
125978529|NCT01970982|453209784|FG002|Overall Study|Withdrawal by Subject|2|||
125978530|NCT04575051|453209790|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
125978531|NCT04575051|453209791|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
125978532|NCT04575051|453209792|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
125978533|NCT04575051|453209793|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
125978534|NCT04575051|453209794|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
125978535|NCT04575051|453209790|FG000|Time Period 1|Missing follow up|1|||
125978536|NCT04575051|453209791|FG001|Time Period 1|Missing follow up|3|||
125978537|NCT04575051|453209792|FG002|Time Period 1|Missing follow up|1|||
125978538|NCT04575051|453209793|FG003|Time Period 1|Missing follow up|3|||
125978539|NCT04575051|453209794|FG004|Time Period 1|Missing follow up|2|||
125978540|NCT04575051|453209790|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
125978541|NCT04575051|453209791|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
125978542|NCT04575051|453209792|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
125978543|NCT04575051|453209793|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
125978544|NCT04575051|453209794|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
125978545|NCT04575051|453209790|FG000|Time Period 2|Missing follow up|1|||
125978546|NCT04575051|453209791|FG001|Time Period 2|Missing follow up|8|||
125978547|NCT04575051|453209792|FG002|Time Period 2|Missing follow up|7|||
125978548|NCT04575051|453209793|FG003|Time Period 2|Missing follow up|0|||
125978549|NCT04575051|453209794|FG004|Time Period 2|Missing follow up|1|||
125978550|NCT04575051|453209790|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
125978551|NCT04575051|453209791|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
125978552|NCT04575051|453209792|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
125978553|NCT04575051|453209793|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
125978554|NCT04575051|453209794|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
125978555|NCT04575051|453209790|FG000|Time Period 3|Missing follow up|8|||
125978556|NCT04575051|453209791|FG001|Time Period 3|Missing follow up|6|||
125978557|NCT04575051|453209792|FG002|Time Period 3|Missing follow up|4|||
125978558|NCT04575051|453209793|FG003|Time Period 3|Missing follow up|3|||
125978559|NCT04575051|453209794|FG004|Time Period 3|Missing follow up|0|||
125978560|NCT04575051|453209790|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
125978561|NCT04575051|453209791|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
125978562|NCT04575051|453209792|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
125978563|NCT04575051|453209793|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
125978564|NCT04575051|453209794|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
125978565|NCT04575051|453209790|FG000|Time Period 4|Missing follow up|17|||
125978566|NCT04575051|453209791|FG001|Time Period 4|Missing follow up|3|||
125978567|NCT04575051|453209792|FG002|Time Period 4|Missing follow up|4|||
125978568|NCT04575051|453209793|FG003|Time Period 4|Missing follow up|2|||
125978569|NCT04575051|453209794|FG004|Time Period 4|Missing follow up|1|||
125978570|NCT04575051|453209790|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
125978571|NCT04575051|453209791|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
125978572|NCT04575051|453209792|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
125978573|NCT04575051|453209793|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
125978574|NCT04575051|453209794|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
125978575|NCT04575051|453209790|FG000|Time Period 5|Missing follow up|11|||
125978576|NCT04575051|453209791|FG001|Time Period 5|Missing follow up|8|||
125978577|NCT04575051|453209792|FG002|Time Period 5|Missing follow up|12|||
125978578|NCT04575051|453209793|FG003|Time Period 5|Missing follow up|3|||
125978579|NCT04575051|453209794|FG004|Time Period 5|Missing follow up|11|||
125978580|NCT03624504|453209795|FG000|Overall Study|Unsuccessful Implant|1|||
125978581|NCT00951483|453209798|FG000|Overall Study|Physician Decision|4|||
125978582|NCT00951483|453209799|FG001|Overall Study|Physician Decision|0|||
125978583|NCT00951483|453209798|FG000|Overall Study|Withdrawal by Subject|15|||
125978584|NCT00951483|453209799|FG001|Overall Study|Withdrawal by Subject|0|||
125978585|NCT03583554|453209800|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
125978586|NCT03583554|453209801|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
125978587|NCT03583554|453209802|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
125978588|NCT03178266|453209803|FG000|Overall Study|Death|0|||
125978589|NCT03178266|453209804|FG001|Overall Study|Death|1|||
125978590|NCT03178266|453209803|FG000|Overall Study|Disont. Early|0|||
125978591|NCT03178266|453209804|FG001|Overall Study|Disont. Early|1|||
125978592|NCT03178266|453209803|FG000|Overall Study|Withdrawal by Subject|0|||
125978593|NCT03178266|453209804|FG001|Overall Study|Withdrawal by Subject|2|||
125978594|NCT02342886|453209805|FG000|Overall Study|Treatment non-compliance|1|||
125978595|NCT02342886|453209806|FG001|Overall Study|Treatment non-compliance|0|||
125978596|NCT02342886|453209807|FG002|Overall Study|Treatment non-compliance|0|||
125978597|NCT02342886|453209808|FG003|Overall Study|Treatment non-compliance|1|||
125978598|NCT02342886|453209809|FG004|Overall Study|Treatment non-compliance|0|||
125978599|NCT02342886|453209805|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
125978600|NCT02342886|453209806|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
125978601|NCT02342886|453209807|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
125978602|NCT02342886|453209808|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
125978603|NCT02342886|453209809|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
125978604|NCT02342886|453209805|FG000|Overall Study|Adverse event/specific toxicity|4|||
125978605|NCT02342886|453209806|FG001|Overall Study|Adverse event/specific toxicity|3|||
125978606|NCT02342886|453209807|FG002|Overall Study|Adverse event/specific toxicity|11|||
125978607|NCT02342886|453209808|FG003|Overall Study|Adverse event/specific toxicity|2|||
125978608|NCT02342886|453209809|FG004|Overall Study|Adverse event/specific toxicity|1|||
125978609|NCT02342886|453209805|FG000|Overall Study|Lost to Follow-up|1|||
125978610|NCT02342886|453209806|FG001|Overall Study|Lost to Follow-up|0|||
125978611|NCT02342886|453209807|FG002|Overall Study|Lost to Follow-up|0|||
125978612|NCT02342886|453209808|FG003|Overall Study|Lost to Follow-up|0|||
125978613|NCT02342886|453209809|FG004|Overall Study|Lost to Follow-up|0|||
125978614|NCT02342886|453209805|FG000|Overall Study|Death|1|||
125978615|NCT02342886|453209806|FG001|Overall Study|Death|2|||
126311774|NCT00761280|454432107|FG001|Randomization to First Dose|Other|0|||
126311775|NCT00761280|454432106|FG000|First Dose to End of Study|End of trial|5|||
126311776|NCT00761280|454432107|FG001|First Dose to End of Study|End of trial|5|||
126311777|NCT00761280|454432106|FG000|First Dose to End of Study|Progressive disease|5|||
126311778|NCT00761280|454432107|FG001|First Dose to End of Study|Progressive disease|3|||
126311779|NCT00761280|454432106|FG000|First Dose to End of Study|Sponsor decision|1|||
126311780|NCT00761280|454432107|FG001|First Dose to End of Study|Sponsor decision|2|||
126311781|NCT00761280|454432106|FG000|First Dose to End of Study|Death|1|||
126311782|NCT00761280|454432107|FG001|First Dose to End of Study|Death|0|||
126311783|NCT00761280|454432106|FG000|First Dose to End of Study|Lost to Follow-up|0|||
126311784|NCT00761280|454432107|FG001|First Dose to End of Study|Lost to Follow-up|1|||
126311785|NCT02691013|454432109|FG000|Overall Study|Withdrawal by Subject|3|||
126311786|NCT02691013|454432110|FG001|Overall Study|Withdrawal by Subject|0|||
126311787|NCT02111785|454432114|FG000|Overall Study|Death|0|||
126311788|NCT02111785|454432115|FG001|Overall Study|Death|1|||
126311789|NCT02111785|454432116|FG002|Overall Study|Death|0|||
126311790|NCT02111785|454432117|FG003|Overall Study|Death|0|||
126311791|NCT01075646|454432120|FG000|Overall Study|Lost to Follow-up|4|||
126311792|NCT01075646|454432121|FG001|Overall Study|Lost to Follow-up|3|||
126311793|NCT01075646|454432122|FG002|Overall Study|Lost to Follow-up|1|||
126311794|NCT01075646|454432123|FG003|Overall Study|Lost to Follow-up|2|||
126311795|NCT01676896|454432127|FG000|Overall Study|Withdrawal by Subject|12|||
126311796|NCT01676896|454432128|FG001|Overall Study|Withdrawal by Subject|7|||
126311797|NCT01676896|454432129|FG002|Overall Study|Withdrawal by Subject|19|||
126311798|NCT01895608|454432130|FG000|Overall Study|change in health status|0|||
126311799|NCT01895608|454432131|FG001|Overall Study|change in health status|1|||
126311800|NCT01895608|454432132|FG002|Overall Study|change in health status|1|||
126311801|NCT01895608|454432133|FG003|Overall Study|change in health status|0|||
125978616|NCT02342886|453209807|FG002|Overall Study|Death|1|||
125978617|NCT02342886|453209808|FG003|Overall Study|Death|0|||
125978618|NCT02342886|453209809|FG004|Overall Study|Death|1|||
125978619|NCT02342886|453209805|FG000|Overall Study|Withdrawal by Subject|0|||
125978620|NCT02342886|453209806|FG001|Overall Study|Withdrawal by Subject|1|||
125978621|NCT02342886|453209807|FG002|Overall Study|Withdrawal by Subject|0|||
125978622|NCT02342886|453209808|FG003|Overall Study|Withdrawal by Subject|1|||
125978623|NCT02342886|453209809|FG004|Overall Study|Withdrawal by Subject|0|||
125978624|NCT02342886|453209805|FG000|Overall Study|Investigator/sponsor decision|0|||
126311802|NCT01895608|454432130|FG000|Overall Study|Withdrawal by Subject|0|||
126311803|NCT01895608|454432131|FG001|Overall Study|Withdrawal by Subject|0|||
126311804|NCT01895608|454432132|FG002|Overall Study|Withdrawal by Subject|2|||
125978625|NCT02342886|453209806|FG001|Overall Study|Investigator/sponsor decision|2|||
125978626|NCT02342886|453209807|FG002|Overall Study|Investigator/sponsor decision|0|||
125978627|NCT02342886|453209808|FG003|Overall Study|Investigator/sponsor decision|3|||
126311805|NCT01895608|454432133|FG003|Overall Study|Withdrawal by Subject|0|||
126311806|NCT03505593|454432134|FG000|Overall Study|Withdrawal by Subject|1|||
126311807|NCT03505593|454432134|FG000|Overall Study|Died before procedure|1|||
126311808|NCT03505593|454432134|FG000|Overall Study|Anatomical abnormality|1|||
126311809|NCT03505593|454432134|FG000|Overall Study|Unable to pass through esophagus|1|||
126311810|NCT03505593|454432134|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
126311811|NCT00738881|454432137|FG000|Overall Study|Withdrawal by Subject|0|||
126311812|NCT00738881|454432138|FG001|Overall Study|Withdrawal by Subject|2|||
126311813|NCT01044290|454432139|FG000|Follow-up 1|Death|3|||
126311814|NCT01044290|454432140|FG001|Follow-up 1|Death|3|||
126311815|NCT01044290|454432141|FG002|Follow-up 1|Death|1|||
126311816|NCT01044290|454432139|FG000|Follow-up 1|Withdrawal by Subject|2|||
126311817|NCT01044290|454432140|FG001|Follow-up 1|Withdrawal by Subject|2|||
126311818|NCT01044290|454432141|FG002|Follow-up 1|Withdrawal by Subject|0|||
126311819|NCT01044290|454432139|FG000|Follow-Up 2|Death|0|||
126311820|NCT01044290|454432140|FG001|Follow-Up 2|Death|1|||
126311821|NCT01044290|454432141|FG002|Follow-Up 2|Death|1|||
126311822|NCT01044290|454432139|FG000|Follow-Up 2|Withdrawal by Subject|0|||
126311823|NCT01044290|454432140|FG001|Follow-Up 2|Withdrawal by Subject|1|||
126311824|NCT01044290|454432141|FG002|Follow-Up 2|Withdrawal by Subject|1|||
126311825|NCT00348790|454432142|FG000|Completed Treatment|Withdrawal by Subject|4|||
126311826|NCT00348790|454432142|FG000|Completed Treatment|Disease progression|14|||
126311827|NCT00348790|454432142|FG000|Completed Treatment|Adverse Event|4|||
126311828|NCT00348790|454432142|FG000|Completed Treatment|Required surgery|2|||
126311829|NCT00348790|454432142|FG000|Completed Treatment|Unable to travel to study site|1|||
126311830|NCT00759785|454432148|FG000|Overall Study|Participant sample not evaluable|11|||
126311831|NCT00759785|454432149|FG001|Overall Study|Participant sample not evaluable|2|||
126311832|NCT00759785|454432148|FG000|Overall Study|Participant sample lost|0|||
126311833|NCT00759785|454432149|FG001|Overall Study|Participant sample lost|1|||
126311834|NCT00759785|454432148|FG000|Overall Study|Protocol Violation|1|||
126311835|NCT00759785|454432149|FG001|Overall Study|Protocol Violation|0|||
126311836|NCT00759785|454432148|FG000|Overall Study|Physician Decision|0|||
126311837|NCT00759785|454432149|FG001|Overall Study|Physician Decision|1|||
126311838|NCT00759785|454432148|FG000|Overall Study|Withdrawal by Subject|0|||
126311839|NCT00759785|454432149|FG001|Overall Study|Withdrawal by Subject|1|||
126311840|NCT04712019|454432150|FG000|Overall Study|Withdrawal by Subject|2|||
126311841|NCT04712019|454432151|FG001|Overall Study|Withdrawal by Subject|2|||
126311842|NCT04712019|454432150|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
126311843|NCT04712019|454432151|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
126311844|NCT01646021|454432152|FG000|Overall Study|Death|77|||
126311845|NCT01646021|454432153|FG001|Overall Study|Death|83|||
126311846|NCT01646021|454432152|FG000|Overall Study|Study Terminated by Sponsor|50|||
126311847|NCT01646021|454432153|FG001|Overall Study|Study Terminated by Sponsor|41|||
125978628|NCT02342886|453209809|FG004|Overall Study|Investigator/sponsor decision|1|||
125978629|NCT02342886|453209805|FG000|Overall Study|Pregnancy|0|||
125978630|NCT02342886|453209806|FG001|Overall Study|Pregnancy|0|||
125978631|NCT02342886|453209807|FG002|Overall Study|Pregnancy|2|||
125978632|NCT02342886|453209808|FG003|Overall Study|Pregnancy|0|||
125978633|NCT02342886|453209809|FG004|Overall Study|Pregnancy|0|||
125978634|NCT02342886|453209805|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
125978635|NCT02342886|453209806|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
125978636|NCT02342886|453209807|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
125978637|NCT02342886|453209808|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
125978638|NCT02342886|453209809|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
125978639|NCT02342886|453209805|FG000|Overall Study|Protocol Violation|0|||
125978640|NCT02342886|453209806|FG001|Overall Study|Protocol Violation|0|||
125978641|NCT02342886|453209807|FG002|Overall Study|Protocol Violation|0|||
125978642|NCT02342886|453209808|FG003|Overall Study|Protocol Violation|2|||
125978643|NCT02342886|453209809|FG004|Overall Study|Protocol Violation|0|||
125978644|NCT01328080|453209810|FG000|Overall Study|Lost to Follow-up|5|||
126201961|NCT02719028|454025812|FG001|Overall Study|Use of prohibited medication|0|||
126201962|NCT02719028|454025813|FG002|Overall Study|Use of prohibited medication|1|||
126201963|NCT02719028|454025814|FG003|Overall Study|Use of prohibited medication|0|||
126201964|NCT02719028|454025811|FG000|Overall Study|Protocol Violation|0|||
126201965|NCT02719028|454025812|FG001|Overall Study|Protocol Violation|0|||
126201966|NCT02719028|454025813|FG002|Overall Study|Protocol Violation|0|||
126201967|NCT02719028|454025814|FG003|Overall Study|Protocol Violation|1|||
126201968|NCT03287960|454025815|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
126201969|NCT03287960|454025815|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
126201970|NCT03730987|454025816|FG000|Overall Study|Lost to Follow-up|2|||
126201971|NCT03730987|454025817|FG001|Overall Study|Lost to Follow-up|0|||
126201972|NCT03730987|454025818|FG002|Overall Study|Lost to Follow-up|2|||
126311848|NCT01646021|454432152|FG000|Overall Study|Lost to Follow-up|2|||
126311849|NCT01646021|454432153|FG001|Overall Study|Lost to Follow-up|2|||
126311850|NCT01646021|454432152|FG000|Overall Study|Withdrawal by Subject|10|||
126311851|NCT01646021|454432153|FG001|Overall Study|Withdrawal by Subject|15|||
126311852|NCT01282164|454432154|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
126311853|NCT01282164|454432155|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
126311854|NCT04521621|454432156|FG000|Overall Study|Death|17|||
126311855|NCT04521621|454432157|FG001|Overall Study|Death|8|||
126311856|NCT04521621|454432158|FG002|Overall Study|Death|8|||
126311857|NCT04521621|454432159|FG003|Overall Study|Death|5|||
126311858|NCT04521621|454432160|FG004|Overall Study|Death|2|||
126311859|NCT04521621|454432161|FG005|Overall Study|Death|7|||
126311860|NCT04521621|454432162|FG006|Overall Study|Death|0|||
126311861|NCT04521621|454432163|FG007|Overall Study|Death|0|||
126311862|NCT04521621|454432156|FG000|Overall Study|Study Terminated by Sponsor|4|||
126311863|NCT04521621|454432157|FG001|Overall Study|Study Terminated by Sponsor|6|||
126311864|NCT04521621|454432158|FG002|Overall Study|Study Terminated by Sponsor|8|||
126311865|NCT04521621|454432159|FG003|Overall Study|Study Terminated by Sponsor|0|||
126311866|NCT04521621|454432160|FG004|Overall Study|Study Terminated by Sponsor|1|||
126311867|NCT04521621|454432161|FG005|Overall Study|Study Terminated by Sponsor|7|||
126311868|NCT04521621|454432162|FG006|Overall Study|Study Terminated by Sponsor|0|||
126311869|NCT04521621|454432163|FG007|Overall Study|Study Terminated by Sponsor|0|||
126311870|NCT04521621|454432156|FG000|Overall Study|Withdrawal by Subject|0|||
126311871|NCT04521621|454432157|FG001|Overall Study|Withdrawal by Subject|0|||
126311872|NCT04521621|454432158|FG002|Overall Study|Withdrawal by Subject|1|||
126311873|NCT04521621|454432159|FG003|Overall Study|Withdrawal by Subject|1|||
126311874|NCT04521621|454432160|FG004|Overall Study|Withdrawal by Subject|0|||
126311875|NCT04521621|454432161|FG005|Overall Study|Withdrawal by Subject|0|||
126311876|NCT04521621|454432162|FG006|Overall Study|Withdrawal by Subject|0|||
126311877|NCT04521621|454432163|FG007|Overall Study|Withdrawal by Subject|0|||
126311878|NCT04521621|454432156|FG000|Overall Study|Allocated in error without study intervention|1|||
126311879|NCT04521621|454432157|FG001|Overall Study|Allocated in error without study intervention|0|||
126311880|NCT04521621|454432158|FG002|Overall Study|Allocated in error without study intervention|0|||
126311881|NCT04521621|454432159|FG003|Overall Study|Allocated in error without study intervention|0|||
126311882|NCT04521621|454432160|FG004|Overall Study|Allocated in error without study intervention|0|||
126311883|NCT04521621|454432161|FG005|Overall Study|Allocated in error without study intervention|0|||
126311884|NCT04521621|454432162|FG006|Overall Study|Allocated in error without study intervention|0|||
126311885|NCT04521621|454432163|FG007|Overall Study|Allocated in error without study intervention|0|||
126311886|NCT01967706|454432178|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
126311887|NCT01967706|454432179|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
126311888|NCT01967706|454432180|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126311889|NCT01967706|454432181|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
126311890|NCT02777970|454432182|FG000|Overall Study|Lost to Follow-up|0|||
126311891|NCT02777970|454432183|FG001|Overall Study|Lost to Follow-up|1|||
126311892|NCT02777970|454432184|FG002|Overall Study|Lost to Follow-up|0|||
126311893|NCT02777970|454432182|FG000|Overall Study|Protocol Violation|1|||
126311894|NCT02777970|454432183|FG001|Overall Study|Protocol Violation|0|||
126311895|NCT02777970|454432184|FG002|Overall Study|Protocol Violation|0|||
126311896|NCT02347891|454432188|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
126311897|NCT02347891|454432189|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
126311898|NCT02347891|454432188|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
126311899|NCT02347891|454432189|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
126311900|NCT05845567|454432190|FG000|Overall Study|Withdrawal by Subject|1|||
126311901|NCT02541669|454432191|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
126311902|NCT02541669|454432192|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
126311903|NCT02541669|454432193|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
126311904|NCT02541669|454432194|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
126311905|NCT02541669|454432195|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
126311906|NCT00725608|454432196|FG000|Overall Study|Lost to Follow-up|60|||
126311907|NCT00725608|454432196|FG000|Overall Study|Adverse Event|14|||
126311908|NCT00725608|454432196|FG000|Overall Study|Individual reasons|86|||
126311909|NCT00725608|454432196|FG000|Overall Study|Other|7|||
126311910|NCT03409107|454432197|FG000|Overall Study|Withdrawal by Subject|4|||
126311911|NCT03409107|454432198|FG001|Overall Study|Withdrawal by Subject|2|||
126311912|NCT03409107|454432197|FG000|Overall Study|Physician Decision|1|||
126311913|NCT03409107|454432198|FG001|Overall Study|Physician Decision|0|||
126311914|NCT03409107|454432197|FG000|Overall Study|Lost to Follow-up|7|||
126311915|NCT03409107|454432198|FG001|Overall Study|Lost to Follow-up|2|||
126311916|NCT03409107|454432197|FG000|Overall Study|Adverse Event|5|||
126311917|NCT03409107|454432198|FG001|Overall Study|Adverse Event|3|||
126311918|NCT01084668|454432202|FG000|Overall Study|Lack of Efficacy|5|||
126311919|NCT01084668|454432202|FG000|Overall Study|Withdrawal by Subject|2|||
126311920|NCT01084668|454432202|FG000|Overall Study|Pregnancy|1|||
126311921|NCT01084668|454432202|FG000|Overall Study|Non-compliance|1|||
126311922|NCT01083186|454432204|FG000|Overall Study|Lost to Follow-up|48|||
126311923|NCT01083186|454432204|FG000|Overall Study|Consent Withdrawal|7|||
126311924|NCT01083186|454432204|FG000|Overall Study|Death|3|||
126311925|NCT01083186|454432204|FG000|Overall Study|Adverse Event|3|||
126311926|NCT01083186|454432204|FG000|Overall Study|Lack of Efficacy|2|||
126311927|NCT01083186|454432204|FG000|Overall Study|Hemodialysis Initiation|28|||
126311928|NCT01083186|454432204|FG000|Overall Study|Administrative Reasons|2|||
126311929|NCT01083186|454432204|FG000|Overall Study|Non-compliance to Study Treatment|1|||
126311930|NCT00655733|454432214|FG000|Overall Study|Lost to Follow-up|2|||
126311931|NCT00655733|454432215|FG001|Overall Study|Lost to Follow-up|2|||
126311932|NCT00655733|454432214|FG000|Overall Study|Adverse Event|2|||
126311933|NCT00655733|454432215|FG001|Overall Study|Adverse Event|2|||
126311934|NCT00655733|454432214|FG000|Overall Study|Withdrawal by Subject|3|||
126201973|NCT03730987|454025819|FG003|Overall Study|Lost to Follow-up|0|||
126201974|NCT01667731|454025825|FG000|Overall Study|Enrolled but not treated|0|||
126201975|NCT01667731|454025826|FG001|Overall Study|Enrolled but not treated|0|||
126201976|NCT01667731|454025827|FG002|Overall Study|Enrolled but not treated|0|||
126201977|NCT01667731|454025828|FG003|Overall Study|Enrolled but not treated|0|||
126201978|NCT01667731|454025829|FG004|Overall Study|Enrolled but not treated|1|||
126201979|NCT01667731|454025825|FG000|Overall Study|Efficacy Failure|1|||
126201980|NCT01667731|454025826|FG001|Overall Study|Efficacy Failure|12|||
126201981|NCT01667731|454025827|FG002|Overall Study|Efficacy Failure|0|||
126201982|NCT01667731|454025828|FG003|Overall Study|Efficacy Failure|1|||
126201983|NCT01667731|454025829|FG004|Overall Study|Efficacy Failure|24|||
126201984|NCT01667731|454025825|FG000|Overall Study|Lost to Follow-up|2|||
126201985|NCT01667731|454025826|FG001|Overall Study|Lost to Follow-up|3|||
126201986|NCT01667731|454025827|FG002|Overall Study|Lost to Follow-up|1|||
126201987|NCT01667731|454025828|FG003|Overall Study|Lost to Follow-up|1|||
126201988|NCT01667731|454025829|FG004|Overall Study|Lost to Follow-up|2|||
126201989|NCT01667731|454025825|FG000|Overall Study|Subject Withdrew Consent|2|||
126201990|NCT01667731|454025826|FG001|Overall Study|Subject Withdrew Consent|0|||
126201991|NCT01667731|454025827|FG002|Overall Study|Subject Withdrew Consent|1|||
126201992|NCT01667731|454025828|FG003|Overall Study|Subject Withdrew Consent|0|||
126201993|NCT01667731|454025829|FG004|Overall Study|Subject Withdrew Consent|1|||
126201994|NCT01667731|454025825|FG000|Overall Study|Death|0|||
126201995|NCT01667731|454025826|FG001|Overall Study|Death|1|||
126201996|NCT01667731|454025827|FG002|Overall Study|Death|0|||
126201997|NCT01667731|454025828|FG003|Overall Study|Death|0|||
126201998|NCT01667731|454025829|FG004|Overall Study|Death|0|||
126201999|NCT01425268|454025830|FG000|Overall Study|Withdrawal by Subject|2|||
126202000|NCT01425268|454025831|FG001|Overall Study|Withdrawal by Subject|0|||
126202001|NCT01425268|454025830|FG000|Overall Study|Sponsor Decision|5|||
126202002|NCT01425268|454025831|FG001|Overall Study|Sponsor Decision|0|||
126202003|NCT01425268|454025830|FG000|Overall Study|Physician Decision|1|||
126202004|NCT01425268|454025831|FG001|Overall Study|Physician Decision|0|||
126202005|NCT03633461|454025832|FG000|Overall Study|Lost to Follow-up|0|||
126202006|NCT03633461|454025833|FG001|Overall Study|Lost to Follow-up|1|||
126202007|NCT01345162|454025838|FG000|Overall Study|Protocol Violation|2|||
126202008|NCT01345162|454025839|FG001|Overall Study|Protocol Violation|4|||
126202009|NCT01871870|454025840|FG000|Overall Study|Hardware issues|7|||
126202010|NCT01871870|454025840|FG000|Overall Study|hyperglycemia|2|||
126202011|NCT00883896|454025842|FG000|Overall Study|Lost to Follow-up|0|||
126202012|NCT00883896|454025843|FG001|Overall Study|Lost to Follow-up|0|||
126202013|NCT00883896|454025844|FG002|Overall Study|Lost to Follow-up|0|||
126202014|NCT00883896|454025845|FG003|Overall Study|Lost to Follow-up|2|||
126202015|NCT00883896|454025842|FG000|Overall Study|Withdrawal by Subject|5|||
126202016|NCT00883896|454025843|FG001|Overall Study|Withdrawal by Subject|0|||
126311935|NCT00655733|454432215|FG001|Overall Study|Withdrawal by Subject|3|||
126311936|NCT00655733|454432214|FG000|Overall Study|Physician Decision|0|||
126311937|NCT00655733|454432215|FG001|Overall Study|Physician Decision|1|||
126311938|NCT02122770|454432216|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
126311939|NCT02122770|454432217|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
126311940|NCT02122770|454432218|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
126311941|NCT02122770|454432219|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
126311942|NCT02122770|454432220|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
126202017|NCT00883896|454025844|FG002|Overall Study|Withdrawal by Subject|1|||
126202018|NCT00883896|454025845|FG003|Overall Study|Withdrawal by Subject|3|||
126202019|NCT00883896|454025842|FG000|Overall Study|Lack of Efficacy|0|||
126202020|NCT00883896|454025843|FG001|Overall Study|Lack of Efficacy|0|||
126202021|NCT00883896|454025844|FG002|Overall Study|Lack of Efficacy|0|||
126202022|NCT00883896|454025845|FG003|Overall Study|Lack of Efficacy|2|||
126202023|NCT00883896|454025842|FG000|Overall Study|Other|1|||
126202024|NCT00883896|454025843|FG001|Overall Study|Other|0|||
126202025|NCT00883896|454025844|FG002|Overall Study|Other|0|||
126202026|NCT00883896|454025845|FG003|Overall Study|Other|0|||
126202027|NCT01856920|454025855|FG000|Overall Study|Disease Progression On Study|3|||
126202028|NCT01856920|454025856|FG001|Overall Study|Disease Progression On Study|4|||
126202029|NCT01856920|454025855|FG000|Overall Study|Disease Progression before Treatment|1|||
126202030|NCT01856920|454025856|FG001|Overall Study|Disease Progression before Treatment|0|||
126202031|NCT01856920|454025855|FG000|Overall Study|Ineligible|0|||
126202032|NCT01856920|454025856|FG001|Overall Study|Ineligible|1|||
126306056|NCT02553499|454408870|FG001|Overall Study|Physician Decision|1|||
126311943|NCT02122770|454432221|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
126311944|NCT02122770|454432216|FG000|Part A: Drug-drug Interaction 2|Other|0|||
126311945|NCT02122770|454432217|FG001|Part A: Drug-drug Interaction 2|Other|0|||
126311946|NCT02122770|454432218|FG002|Part A: Drug-drug Interaction 2|Other|1|||
126311947|NCT02122770|454432219|FG003|Part A: Drug-drug Interaction 2|Other|0|||
126311948|NCT02122770|454432220|FG004|Part A: Drug-drug Interaction 2|Other|0|||
126311949|NCT02122770|454432221|FG005|Part A: Drug-drug Interaction 2|Other|0|||
126311950|NCT02122770|454432216|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311951|NCT02122770|454432217|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
126311952|NCT02122770|454432218|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311953|NCT02122770|454432219|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311954|NCT02122770|454432220|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311955|NCT02122770|454432221|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311956|NCT02122770|454432216|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
126311957|NCT02122770|454432217|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
126311958|NCT02122770|454432218|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
126311959|NCT02122770|454432219|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
126311960|NCT02122770|454432220|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
126202033|NCT01856920|454025855|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
126202034|NCT01856920|454025856|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
126202035|NCT01856920|454025855|FG000|Overall Study|Refused further Treatment|5|||
126202036|NCT01856920|454025856|FG001|Overall Study|Refused further Treatment|1|||
126202037|NCT01856920|454025855|FG000|Overall Study|Other Reasons|0|||
126202038|NCT01856920|454025856|FG001|Overall Study|Other Reasons|1|||
126202039|NCT01856920|454025855|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
126202040|NCT01856920|454025856|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
126202041|NCT03802331|454025858|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
126202042|NCT03802331|454025859|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
126202043|NCT02074059|454025860|FG000|Overall Study|Death|0|||
126202044|NCT02074059|454025861|FG001|Overall Study|Death|0|||
126202045|NCT02074059|454025862|FG002|Overall Study|Death|0|||
126202046|NCT02074059|454025863|FG003|Overall Study|Death|0|||
126202047|NCT02074059|454025864|FG004|Overall Study|Death|1|||
126202048|NCT02074059|454025865|FG005|Overall Study|Death|1|||
126202049|NCT00779506|454025867|FG000|Overall Study|Screening Failed|2|||
126202050|NCT00779506|454025867|FG000|Overall Study|Adverse Event|4|||
126202051|NCT00779506|454025867|FG000|Overall Study|Lack of Efficacy|11|||
126202052|NCT00779506|454025867|FG000|Overall Study|Protocol Violation|5|||
126202053|NCT00779506|454025867|FG000|Overall Study|Withdrawal by Subject|6|||
126202054|NCT00779506|454025867|FG000|Overall Study|Lost to Follow-up|1|||
126202055|NCT01632345|454025870|FG000|Treatment: Part I|Adverse Event|1|||
126202056|NCT01632345|454025871|FG001|Treatment: Part I|Adverse Event|4|||
126202057|NCT01632345|454025872|FG002|Treatment: Part I|Adverse Event|2|||
126202058|NCT01632345|454025873|FG003|Treatment: Part I|Adverse Event|1|||
126202059|NCT01632345|454025874|FG004|Treatment: Part I|Adverse Event|3|||
126202060|NCT01632345|454025875|FG005|Treatment: Part I|Adverse Event|0|||
126202061|NCT01632345|454025876|FG006|Treatment: Part I|Adverse Event|0|||
126202062|NCT01632345|454025870|FG000|Treatment: Part I|Lack of Efficacy|0|||
126202063|NCT01632345|454025871|FG001|Treatment: Part I|Lack of Efficacy|1|||
126202064|NCT01632345|454025872|FG002|Treatment: Part I|Lack of Efficacy|0|||
126202065|NCT01632345|454025873|FG003|Treatment: Part I|Lack of Efficacy|1|||
126202066|NCT01632345|454025874|FG004|Treatment: Part I|Lack of Efficacy|1|||
126202067|NCT01632345|454025875|FG005|Treatment: Part I|Lack of Efficacy|0|||
126202068|NCT01632345|454025876|FG006|Treatment: Part I|Lack of Efficacy|0|||
126202069|NCT01632345|454025870|FG000|Treatment: Part I|Lost to Follow-up|3|||
126202070|NCT01632345|454025871|FG001|Treatment: Part I|Lost to Follow-up|2|||
126202071|NCT01632345|454025872|FG002|Treatment: Part I|Lost to Follow-up|1|||
126202072|NCT01632345|454025873|FG003|Treatment: Part I|Lost to Follow-up|3|||
126202073|NCT01632345|454025874|FG004|Treatment: Part I|Lost to Follow-up|4|||
126202074|NCT01632345|454025875|FG005|Treatment: Part I|Lost to Follow-up|0|||
126202075|NCT01632345|454025876|FG006|Treatment: Part I|Lost to Follow-up|0|||
126202076|NCT01632345|454025870|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
126202077|NCT01632345|454025871|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
126202078|NCT01632345|454025872|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
126202079|NCT01632345|454025873|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
126202080|NCT01632345|454025874|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
126202081|NCT01632345|454025875|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
126202082|NCT01632345|454025876|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
126202083|NCT01632345|454025870|FG000|Treatment: Part I|Physician Decision|2|||
126311961|NCT02122770|454432221|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
126311962|NCT02122770|454432216|FG000|Part B: Standard of Care|Adverse Event|0|||
126202084|NCT01632345|454025871|FG001|Treatment: Part I|Physician Decision|1|||
126202085|NCT01632345|454025872|FG002|Treatment: Part I|Physician Decision|0|||
126202086|NCT01632345|454025873|FG003|Treatment: Part I|Physician Decision|0|||
126202087|NCT01632345|454025874|FG004|Treatment: Part I|Physician Decision|1|||
126202088|NCT01632345|454025875|FG005|Treatment: Part I|Physician Decision|0|||
126202089|NCT01632345|454025876|FG006|Treatment: Part I|Physician Decision|0|||
126202090|NCT01632345|454025870|FG000|Treatment: Part I|Pregnancy|0|||
126202091|NCT01632345|454025871|FG001|Treatment: Part I|Pregnancy|1|||
126202092|NCT01632345|454025872|FG002|Treatment: Part I|Pregnancy|0|||
126202093|NCT01632345|454025873|FG003|Treatment: Part I|Pregnancy|0|||
126202094|NCT01632345|454025874|FG004|Treatment: Part I|Pregnancy|0|||
126202095|NCT01632345|454025875|FG005|Treatment: Part I|Pregnancy|0|||
126202096|NCT01632345|454025876|FG006|Treatment: Part I|Pregnancy|0|||
126202097|NCT01632345|454025870|FG000|Treatment: Part I|Protocol Deviation|0|||
126202098|NCT01632345|454025871|FG001|Treatment: Part I|Protocol Deviation|0|||
126202099|NCT01632345|454025872|FG002|Treatment: Part I|Protocol Deviation|1|||
126202100|NCT01632345|454025873|FG003|Treatment: Part I|Protocol Deviation|1|||
126202101|NCT01632345|454025874|FG004|Treatment: Part I|Protocol Deviation|0|||
126202102|NCT01632345|454025875|FG005|Treatment: Part I|Protocol Deviation|0|||
126202103|NCT01632345|454025876|FG006|Treatment: Part I|Protocol Deviation|0|||
126202104|NCT01632345|454025870|FG000|Treatment: Part I|Withdrawal by Subject|3|||
126202105|NCT01632345|454025871|FG001|Treatment: Part I|Withdrawal by Subject|4|||
126202106|NCT01632345|454025872|FG002|Treatment: Part I|Withdrawal by Subject|4|||
126202107|NCT01632345|454025873|FG003|Treatment: Part I|Withdrawal by Subject|1|||
126202108|NCT01632345|454025874|FG004|Treatment: Part I|Withdrawal by Subject|4|||
126202109|NCT01632345|454025875|FG005|Treatment: Part I|Withdrawal by Subject|0|||
126202110|NCT01632345|454025876|FG006|Treatment: Part I|Withdrawal by Subject|0|||
126202111|NCT01632345|454025870|FG000|Treatment: Part II|Adverse Event|0|||
126202112|NCT01632345|454025871|FG001|Treatment: Part II|Adverse Event|0|||
126202113|NCT01632345|454025872|FG002|Treatment: Part II|Adverse Event|0|||
126202114|NCT01632345|454025873|FG003|Treatment: Part II|Adverse Event|0|||
126202115|NCT01632345|454025874|FG004|Treatment: Part II|Adverse Event|0|||
126202116|NCT01632345|454025875|FG005|Treatment: Part II|Adverse Event|3|||
126202117|NCT01632345|454025876|FG006|Treatment: Part II|Adverse Event|8|||
126202118|NCT01632345|454025870|FG000|Treatment: Part II|Lost to Follow-up|0|||
126202119|NCT01632345|454025871|FG001|Treatment: Part II|Lost to Follow-up|0|||
126202120|NCT01632345|454025872|FG002|Treatment: Part II|Lost to Follow-up|0|||
126202121|NCT01632345|454025873|FG003|Treatment: Part II|Lost to Follow-up|0|||
126202122|NCT01632345|454025874|FG004|Treatment: Part II|Lost to Follow-up|0|||
126202123|NCT01632345|454025875|FG005|Treatment: Part II|Lost to Follow-up|3|||
126202124|NCT01632345|454025876|FG006|Treatment: Part II|Lost to Follow-up|1|||
126202125|NCT01632345|454025870|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
126202126|NCT01632345|454025871|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
126202127|NCT01632345|454025872|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
126202128|NCT01632345|454025873|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
126202129|NCT01632345|454025874|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
126202130|NCT01632345|454025875|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
126202131|NCT01632345|454025876|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
126202132|NCT01632345|454025870|FG000|Treatment: Part II|Withdrawal by Subject|0|||
126202133|NCT01632345|454025871|FG001|Treatment: Part II|Withdrawal by Subject|0|||
126202134|NCT01632345|454025872|FG002|Treatment: Part II|Withdrawal by Subject|0|||
126202135|NCT01632345|454025873|FG003|Treatment: Part II|Withdrawal by Subject|0|||
126202136|NCT01632345|454025874|FG004|Treatment: Part II|Withdrawal by Subject|0|||
126202137|NCT01632345|454025875|FG005|Treatment: Part II|Withdrawal by Subject|2|||
126202138|NCT01632345|454025876|FG006|Treatment: Part II|Withdrawal by Subject|2|||
126202139|NCT03370133|454025877|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
126202140|NCT03370133|454025878|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
126202141|NCT03370133|454025879|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
126202142|NCT03370133|454025880|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
126202143|NCT03370133|454025881|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
126202144|NCT03370133|454025882|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
126202145|NCT03370133|454025877|FG000|Initial Treatment Period (WK 16)|Death|1|||
126202146|NCT03370133|454025878|FG001|Initial Treatment Period (WK 16)|Death|1|||
126202147|NCT03370133|454025879|FG002|Initial Treatment Period (WK 16)|Death|1|||
126202148|NCT03370133|454025880|FG003|Initial Treatment Period (WK 16)|Death|0|||
126202149|NCT03370133|454025881|FG004|Initial Treatment Period (WK 16)|Death|0|||
126202150|NCT03370133|454025882|FG005|Initial Treatment Period (WK 16)|Death|0|||
126202151|NCT03370133|454025877|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
126202152|NCT03370133|454025878|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
126202153|NCT03370133|454025879|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
126202154|NCT03370133|454025880|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
126311963|NCT02122770|454432217|FG001|Part B: Standard of Care|Adverse Event|0|||
126202155|NCT03370133|454025881|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
126202156|NCT03370133|454025882|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
126202157|NCT03370133|454025877|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126311964|NCT02122770|454432218|FG002|Part B: Standard of Care|Adverse Event|0|||
126311965|NCT02122770|454432219|FG003|Part B: Standard of Care|Adverse Event|0|||
126202158|NCT03370133|454025878|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126202159|NCT03370133|454025879|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
126202160|NCT03370133|454025880|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126202161|NCT03370133|454025881|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126202162|NCT03370133|454025882|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126202163|NCT03370133|454025877|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126202164|NCT03370133|454025878|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
126202165|NCT03370133|454025879|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126202166|NCT03370133|454025880|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126202167|NCT03370133|454025881|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126202168|NCT03370133|454025882|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126202169|NCT03370133|454025877|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
126202170|NCT03370133|454025878|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
126202171|NCT03370133|454025879|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
126202172|NCT03370133|454025880|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
126202173|NCT03370133|454025881|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
126202174|NCT03370133|454025882|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
126202175|NCT03370133|454025877|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
126202176|NCT03370133|454025878|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
126202177|NCT03370133|454025879|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
126202178|NCT03370133|454025880|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
126202179|NCT03370133|454025881|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
126202180|NCT03370133|454025882|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
126202181|NCT03370133|454025877|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
126202182|NCT03370133|454025878|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
126202183|NCT03370133|454025879|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
126202184|NCT03370133|454025880|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
126202185|NCT03370133|454025881|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
126202186|NCT03370133|454025882|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
126202187|NCT03370133|454025877|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
126202188|NCT03370133|454025878|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
126202189|NCT03370133|454025879|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
126202190|NCT03370133|454025880|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
126202191|NCT03370133|454025881|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
126202192|NCT03370133|454025882|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
126202193|NCT03370133|454025877|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
126202194|NCT03370133|454025878|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
126202195|NCT03370133|454025879|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
126202196|NCT03370133|454025880|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
126202197|NCT03370133|454025881|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
126202198|NCT03370133|454025882|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
126202199|NCT03370133|454025877|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
126202200|NCT03370133|454025878|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
126202201|NCT03370133|454025879|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
126202202|NCT03370133|454025880|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
126202203|NCT03370133|454025881|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
126202204|NCT03370133|454025882|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
126202205|NCT03370133|454025877|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
126202206|NCT03370133|454025878|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
126202207|NCT03370133|454025879|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
126202208|NCT03370133|454025880|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
126202209|NCT03370133|454025881|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
126202210|NCT03370133|454025882|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
126202211|NCT03370133|454025877|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
126202212|NCT03370133|454025878|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
126202213|NCT03370133|454025879|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
126202214|NCT03370133|454025880|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
126202215|NCT03370133|454025881|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
126202216|NCT03370133|454025882|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
126202217|NCT03370133|454025877|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126202218|NCT03370133|454025878|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126202219|NCT03370133|454025879|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126202220|NCT03370133|454025880|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126202221|NCT03370133|454025881|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
126306057|NCT02553499|454408871|FG002|Overall Study|Physician Decision|1|||
126311966|NCT02122770|454432220|FG004|Part B: Standard of Care|Adverse Event|4|||
126202222|NCT03370133|454025882|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126202223|NCT03370133|454025877|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126202224|NCT03370133|454025878|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126202225|NCT03370133|454025879|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126202226|NCT03370133|454025880|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126202227|NCT03370133|454025881|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126202228|NCT03370133|454025882|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
126202229|NCT01365468|454025883|FG000|Overall Study|Physician Decision|1|||
126202230|NCT01365468|454025884|FG001|Overall Study|Physician Decision|0|||
126202231|NCT01365468|454025883|FG000|Overall Study|Disease progression|1|||
126202232|NCT01365468|454025884|FG001|Overall Study|Disease progression|0|||
126202233|NCT01365468|454025883|FG000|Overall Study|Lost to Follow-up|2|||
126202234|NCT01365468|454025884|FG001|Overall Study|Lost to Follow-up|0|||
126202235|NCT03524664|454025885|FG000|Overall Study|Withdrawal by Subject|1|||
126202236|NCT03524664|454025886|FG001|Overall Study|Withdrawal by Subject|2|||
126202237|NCT03524664|454025885|FG000|Overall Study|Lost to Follow-up|4|||
126202238|NCT03524664|454025886|FG001|Overall Study|Lost to Follow-up|13|||
126202239|NCT02694562|454025887|FG000|Overall Study|Death|8|||
126202240|NCT02694562|454025887|FG000|Overall Study|Protocol Violation|4|||
126202241|NCT02694562|454025887|FG000|Overall Study|Lost to Follow-up|3|||
126202242|NCT02694562|454025887|FG000|Overall Study|Screen Failure|2|||
126202243|NCT02694562|454025887|FG000|Overall Study|Physician Decision|1|||
126202244|NCT01333865|454025888|FG000|Overall Study|Adverse Event|2|||
126202245|NCT00684073|454025889|FG000|Selection|Selection/non-selection criteria|3|||
126202246|NCT00684073|454025889|FG000|Selection|Death|1|||
126202247|NCT00684073|454025889|FG000|Selection|noncompliance|1|||
126202248|NCT00684073|454025889|FG000|Selection|Lost to Follow-up|1|||
126202249|NCT00684073|454025889|FG000|Selection|request of the sponsor|1|||
126202250|NCT00684073|454025889|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
126202251|NCT00620815|454025890|FG000|Overall Study|Adverse Event|1|||
126202252|NCT00620815|454025891|FG001|Overall Study|Adverse Event|1|||
126202253|NCT00620815|454025892|FG002|Overall Study|Adverse Event|2|||
126202254|NCT00620815|454025890|FG000|Overall Study|Withdrawal by Subject|1|||
126202255|NCT00620815|454025891|FG001|Overall Study|Withdrawal by Subject|2|||
126202256|NCT00620815|454025892|FG002|Overall Study|Withdrawal by Subject|0|||
126202257|NCT00620815|454025890|FG000|Overall Study|Lost to Follow-up|1|||
126202258|NCT00620815|454025891|FG001|Overall Study|Lost to Follow-up|6|||
126202259|NCT00620815|454025892|FG002|Overall Study|Lost to Follow-up|3|||
126202260|NCT00620815|454025890|FG000|Overall Study|Inappropriate enrolment|0|||
126202261|NCT00620815|454025891|FG001|Overall Study|Inappropriate enrolment|0|||
126202262|NCT00620815|454025892|FG002|Overall Study|Inappropriate enrolment|1|||
126202263|NCT00620815|454025890|FG000|Overall Study|Protocol Violation|1|||
126202264|NCT00620815|454025891|FG001|Overall Study|Protocol Violation|2|||
126202265|NCT00620815|454025892|FG002|Overall Study|Protocol Violation|1|||
126202266|NCT01888367|454025895|FG000|Overall Study|Physician Decision|3|||
126202267|NCT01888367|454025896|FG001|Overall Study|Physician Decision|4|||
126202268|NCT01888367|454025897|FG002|Overall Study|Physician Decision|2|||
126202269|NCT01888367|454025895|FG000|Overall Study|Death|2|||
126202270|NCT01888367|454025896|FG001|Overall Study|Death|0|||
126202271|NCT01888367|454025897|FG002|Overall Study|Death|1|||
126202272|NCT01888367|454025895|FG000|Overall Study|Withdrawal by Subject|1|||
126202273|NCT01888367|454025896|FG001|Overall Study|Withdrawal by Subject|0|||
126202274|NCT01888367|454025897|FG002|Overall Study|Withdrawal by Subject|1|||
126202275|NCT01888367|454025895|FG000|Overall Study|Lost to Follow-up|1|||
126202276|NCT01888367|454025896|FG001|Overall Study|Lost to Follow-up|1|||
126202277|NCT01888367|454025897|FG002|Overall Study|Lost to Follow-up|0|||
126202278|NCT01888367|454025895|FG000|Overall Study|Protocol Violation|0|||
126202279|NCT01888367|454025896|FG001|Overall Study|Protocol Violation|0|||
126202280|NCT01888367|454025897|FG002|Overall Study|Protocol Violation|1|||
126202281|NCT01888367|454025895|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
126202282|NCT01888367|454025896|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
126202283|NCT01888367|454025897|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
126202284|NCT03590613|454025899|FG000|Period 2, 4 Days|Physician Decision|0|||
126202285|NCT03590613|454025900|FG001|Period 2, 4 Days|Physician Decision|0|||
126202286|NCT03590613|454025901|FG002|Period 2, 4 Days|Physician Decision|0|||
126202287|NCT03590613|454025902|FG003|Period 2, 4 Days|Physician Decision|1|||
126202288|NCT00280059|454025903|FG000|Efficacy Assessment Phase|Death|2|||
126202289|NCT00280059|454025904|FG001|Efficacy Assessment Phase|Death|0|||
126202290|NCT00280059|454025903|FG000|Efficacy Assessment Phase|Adverse Event|33|||
126202291|NCT00280059|454025904|FG001|Efficacy Assessment Phase|Adverse Event|31|||
126202292|NCT00280059|454025903|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
126202293|NCT00280059|454025904|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
125978645|NCT00862134|453209811|FG000|Overall Study|Death|1|||
126202294|NCT00280059|454025903|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
126202295|NCT00280059|454025904|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
125978646|NCT00862134|453209812|FG001|Overall Study|Death|0|||
126202296|NCT00280059|454025903|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
126202297|NCT00280059|454025904|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
126202298|NCT00280059|454025903|FG000|Efficacy Assessment Phase|Other|7|||
126202299|NCT00280059|454025904|FG001|Efficacy Assessment Phase|Other|8|||
126202300|NCT00280059|454025903|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
126202301|NCT00280059|454025904|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
126202302|NCT01130831|454025907|FG000|Overall Study|Withdrawal by Subject|7|||
126202303|NCT01130831|454025907|FG000|Overall Study|Death|4|||
126202304|NCT01130831|454025907|FG000|Overall Study|Information was missing|3|||
126202305|NCT00951912|454025908|FG000|Overall Study|Lack of Efficacy|1|||
126202306|NCT00951912|454025909|FG001|Overall Study|Lack of Efficacy|0|||
126202307|NCT00951912|454025910|FG002|Overall Study|Lack of Efficacy|0|||
126202308|NCT00951912|454025908|FG000|Overall Study|Adverse Event|0|||
126202309|NCT00951912|454025909|FG001|Overall Study|Adverse Event|1|||
126202310|NCT00951912|454025910|FG002|Overall Study|Adverse Event|1|||
126202311|NCT00951912|454025908|FG000|Overall Study|Lost to Follow-up|2|||
126202312|NCT00951912|454025909|FG001|Overall Study|Lost to Follow-up|2|||
126202313|NCT00951912|454025910|FG002|Overall Study|Lost to Follow-up|0|||
126202314|NCT00951912|454025908|FG000|Overall Study|Physician Decision|1|||
126202315|NCT00951912|454025909|FG001|Overall Study|Physician Decision|0|||
126202316|NCT00951912|454025910|FG002|Overall Study|Physician Decision|1|||
126202317|NCT00951912|454025908|FG000|Overall Study|Withdrawal by Subject|1|||
126202318|NCT00951912|454025909|FG001|Overall Study|Withdrawal by Subject|1|||
126202319|NCT00951912|454025910|FG002|Overall Study|Withdrawal by Subject|0|||
126202320|NCT00951912|454025908|FG000|Overall Study|Other:Depression|1|||
126202321|NCT00951912|454025909|FG001|Overall Study|Other:Depression|0|||
126202322|NCT00951912|454025910|FG002|Overall Study|Other:Depression|0|||
126202323|NCT00951912|454025908|FG000|Overall Study|Other: Colon cancer|1|||
126202324|NCT00951912|454025909|FG001|Overall Study|Other: Colon cancer|0|||
126202325|NCT00951912|454025910|FG002|Overall Study|Other: Colon cancer|0|||
126202326|NCT00951912|454025908|FG000|Overall Study|Other: Stroke|0|||
126202327|NCT00951912|454025909|FG001|Overall Study|Other: Stroke|1|||
126202328|NCT00951912|454025910|FG002|Overall Study|Other: Stroke|0|||
126202329|NCT00489216|454025914|FG000|Overall Study|Adverse Event|1|||
126202330|NCT02612194|454025919|FG000|Overall Study|Death|5|||
126202331|NCT02612194|454025920|FG001|Overall Study|Death|0|||
126202332|NCT02612194|454025921|FG002|Overall Study|Death|2|||
126202333|NCT02612194|454025919|FG000|Overall Study|Early Study Termination|1|||
126202334|NCT02612194|454025920|FG001|Overall Study|Early Study Termination|0|||
126202335|NCT02612194|454025921|FG002|Overall Study|Early Study Termination|0|||
126202336|NCT02539160|454025922|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
126202337|NCT02539160|454025923|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
126202338|NCT02539160|454025924|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
126202339|NCT02539160|454025925|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
126202340|NCT02539160|454025922|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
126202341|NCT02539160|454025923|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
126202342|NCT02539160|454025924|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
126202343|NCT02539160|454025925|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
126202344|NCT02539160|454025922|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
126202345|NCT02539160|454025923|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
126202346|NCT02539160|454025924|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
126202347|NCT02539160|454025925|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
126202348|NCT01681004|454025926|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
126202349|NCT01681004|454025927|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
126202350|NCT01681004|454025926|FG000|Study Completion|Lost to Follow-up|8|||
126202351|NCT01681004|454025927|FG001|Study Completion|Lost to Follow-up|3|||
126202352|NCT01681004|454025926|FG000|Study Completion|Physician Decision|1|||
126202353|NCT01681004|454025927|FG001|Study Completion|Physician Decision|3|||
126202354|NCT01681004|454025926|FG000|Study Completion|Site Termination|2|||
126202355|NCT01681004|454025927|FG001|Study Completion|Site Termination|1|||
126202356|NCT01681004|454025926|FG000|Study Completion|Death|1|||
126202357|NCT01681004|454025927|FG001|Study Completion|Death|1|||
126202358|NCT00372905|454025928|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
126202359|NCT00372905|454025929|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
126202360|NCT00372905|454025930|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
126202361|NCT00372905|454025931|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
126202362|NCT00372905|454025928|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
126202363|NCT00372905|454025929|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
126202364|NCT00372905|454025930|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
126202365|NCT00372905|454025931|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
126202366|NCT00372905|454025928|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
126202367|NCT00372905|454025929|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
126202368|NCT00372905|454025930|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
126202369|NCT00372905|454025931|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
126202370|NCT00372905|454025928|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
126202371|NCT00372905|454025929|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
126202372|NCT00372905|454025930|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
126202373|NCT00372905|454025931|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
126202374|NCT00372905|454025928|FG000|Follow up Until Relapse or Progression|Study closed|0|||
126202375|NCT00372905|454025929|FG001|Follow up Until Relapse or Progression|Study closed|0|||
126202376|NCT00372905|454025930|FG002|Follow up Until Relapse or Progression|Study closed|0|||
126202377|NCT00372905|454025931|FG003|Follow up Until Relapse or Progression|Study closed|3|||
126202378|NCT00372905|454025928|FG000|Follow up Until Relapse or Progression|Other|0|||
126202379|NCT00372905|454025929|FG001|Follow up Until Relapse or Progression|Other|1|||
126311967|NCT02122770|454432221|FG005|Part B: Standard of Care|Adverse Event|1|||
126311968|NCT02122770|454432216|FG000|Part B: Standard of Care|Other|0|||
126311969|NCT02122770|454432217|FG001|Part B: Standard of Care|Other|0|||
126311970|NCT02122770|454432218|FG002|Part B: Standard of Care|Other|0|||
126311971|NCT02122770|454432219|FG003|Part B: Standard of Care|Other|0|||
126311972|NCT02122770|454432220|FG004|Part B: Standard of Care|Other|0|||
126311973|NCT02122770|454432221|FG005|Part B: Standard of Care|Other|2|||
126311974|NCT02122770|454432216|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
126311975|NCT02122770|454432217|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
126311976|NCT02122770|454432218|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
126311977|NCT02122770|454432219|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
126311978|NCT02122770|454432220|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
126311979|NCT02122770|454432221|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
126311980|NCT02122770|454432216|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311981|NCT02122770|454432217|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311982|NCT02122770|454432218|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311983|NCT02122770|454432219|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311984|NCT02122770|454432220|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
126311985|NCT02122770|454432221|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311986|NCT02122770|454432216|FG000|Part B: Standard of Care|Progressive Disease|0|||
126311987|NCT02122770|454432217|FG001|Part B: Standard of Care|Progressive Disease|0|||
126311988|NCT02122770|454432218|FG002|Part B: Standard of Care|Progressive Disease|0|||
126311989|NCT02122770|454432219|FG003|Part B: Standard of Care|Progressive Disease|0|||
126311990|NCT02122770|454432220|FG004|Part B: Standard of Care|Progressive Disease|10|||
126311991|NCT02122770|454432221|FG005|Part B: Standard of Care|Progressive Disease|8|||
126311992|NCT00189306|454432223|FG000|Treatment Period|Withdrawal by Subject|2|||
126311993|NCT00189306|454432223|FG000|Treatment Period|Adverse Event|2|||
126311994|NCT00189306|454432223|FG000|Treatment Period|Protocol Violation|1|||
126311995|NCT00189306|454432223|FG000|Posttreatment Period|Death|1|||
126311996|NCT00189306|454432223|FG000|Posttreatment Period|Withdrawal by Subject|2|||
126311997|NCT00189306|454432223|FG000|Posttreatment Period|Noncompliance|1|||
126311998|NCT00189306|454432223|FG000|Posttreatment Period|Target lesion excised|1|||
126311999|NCT00189306|454432223|FG000|Posttreatment Period|Protocol Violation|1|||
126312000|NCT00189306|454432223|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
126312001|NCT00189306|454432223|FG000|Posttreatment Period|Local skin reaction/sign|1|||
126312002|NCT00189306|454432223|FG000|Long-Term Follow-up|Adverse Event|2|||
126312003|NCT00189306|454432223|FG000|Long-Term Follow-up|Death|4|||
126312004|NCT00189306|454432223|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
126312005|NCT00189306|454432223|FG000|Long-Term Follow-up|Intercurrent disease|2|||
126312006|NCT00189306|454432223|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
126312007|NCT00189306|454432223|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
126312008|NCT03640481|454432224|FG000|Overall Study|Death|14|||
126312009|NCT03640481|454432225|FG001|Overall Study|Death|14|||
126312010|NCT03640481|454432226|FG002|Overall Study|Death|0|||
126312011|NCT03640481|454432227|FG003|Overall Study|Death|0|||
126312012|NCT03640481|454432224|FG000|Overall Study|Lost to Follow-up|2|||
126312013|NCT03640481|454432225|FG001|Overall Study|Lost to Follow-up|0|||
126312014|NCT03640481|454432226|FG002|Overall Study|Lost to Follow-up|0|||
126312015|NCT03640481|454432227|FG003|Overall Study|Lost to Follow-up|0|||
126312016|NCT03640481|454432224|FG000|Overall Study|Site terminated by sponsor|1|||
126312017|NCT03640481|454432225|FG001|Overall Study|Site terminated by sponsor|3|||
126312018|NCT03640481|454432226|FG002|Overall Study|Site terminated by sponsor|0|||
126312019|NCT03640481|454432227|FG003|Overall Study|Site terminated by sponsor|0|||
126312020|NCT03640481|454432224|FG000|Overall Study|Study terminated by sponsor|29|||
126312021|NCT03640481|454432225|FG001|Overall Study|Study terminated by sponsor|42|||
126312022|NCT03640481|454432226|FG002|Overall Study|Study terminated by sponsor|1|||
126312023|NCT03640481|454432227|FG003|Overall Study|Study terminated by sponsor|0|||
126312024|NCT03640481|454432224|FG000|Overall Study|Withdrawal by Subject|5|||
126312025|NCT03640481|454432225|FG001|Overall Study|Withdrawal by Subject|4|||
126312026|NCT03640481|454432226|FG002|Overall Study|Withdrawal by Subject|0|||
126312027|NCT03640481|454432227|FG003|Overall Study|Withdrawal by Subject|1|||
126312028|NCT03640481|454432224|FG000|Overall Study|Other|26|||
126312029|NCT03640481|454432225|FG001|Overall Study|Other|12|||
126312030|NCT03640481|454432226|FG002|Overall Study|Other|1|||
126312031|NCT03640481|454432227|FG003|Overall Study|Other|0|||
126312032|NCT03640481|454432224|FG000|Overall Study|Randomized, but not treated|1|||
126312033|NCT03640481|454432225|FG001|Overall Study|Randomized, but not treated|3|||
126312034|NCT03640481|454432226|FG002|Overall Study|Randomized, but not treated|0|||
126312035|NCT03640481|454432227|FG003|Overall Study|Randomized, but not treated|0|||
126312036|NCT00535847|454432228|FG000|Overall Study|Adverse Event|5|||
126312037|NCT00535847|454432229|FG001|Overall Study|Adverse Event|3|||
126312038|NCT00535847|454432230|FG002|Overall Study|Adverse Event|2|||
126312039|NCT00535847|454432228|FG000|Overall Study|Non compliance|1|||
126312040|NCT00535847|454432229|FG001|Overall Study|Non compliance|1|||
126312041|NCT00535847|454432230|FG002|Overall Study|Non compliance|0|||
126312042|NCT00535847|454432228|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
126312043|NCT00535847|454432229|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
126312044|NCT00535847|454432230|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
126312045|NCT00727844|454432231|FG000|Initial Randomization|Physician Decision|2|||
126202380|NCT00372905|454025930|FG002|Follow up Until Relapse or Progression|Other|0|||
126202381|NCT00372905|454025931|FG003|Follow up Until Relapse or Progression|Other|0|||
126202382|NCT02312934|454025932|FG000|Overall Study|Lost to Follow-up|1|||
126202383|NCT02312934|454025933|FG001|Overall Study|Lost to Follow-up|0|||
126202384|NCT02312934|454025932|FG000|Overall Study|Physician Decision|1|||
126202385|NCT02312934|454025933|FG001|Overall Study|Physician Decision|0|||
126202386|NCT00701064|454025935|FG000|Overall Study|Protocol Violation|1|||
126202387|NCT00701064|454025936|FG001|Overall Study|Protocol Violation|1|||
126202388|NCT00701064|454025935|FG000|Overall Study|Withdrawal by Subject|1|||
126202389|NCT00701064|454025936|FG001|Overall Study|Withdrawal by Subject|1|||
126202390|NCT00701064|454025935|FG000|Overall Study|initiated other PTSD treatment|2|||
126202391|NCT00701064|454025936|FG001|Overall Study|initiated other PTSD treatment|2|||
126202392|NCT00689299|454025937|FG000|Overall Study|Adverse Event|2|||
126202393|NCT00689299|454025938|FG001|Overall Study|Adverse Event|1|||
126202394|NCT00689299|454025939|FG002|Overall Study|Adverse Event|1|||
126202395|NCT00689299|454025937|FG000|Overall Study|Lost to Follow-up|0|||
126312046|NCT00727844|454432232|FG001|Initial Randomization|Physician Decision|0|||
126312047|NCT00727844|454432233|FG002|Initial Randomization|Physician Decision|0|||
126312048|NCT00727844|454432234|FG003|Initial Randomization|Physician Decision|0|||
126312049|NCT04569968|454432235|FG000|Overall Study|Lost to Follow-up|2|||
126312050|NCT04569968|454432236|FG001|Overall Study|Lost to Follow-up|5|||
126312051|NCT04569968|454432235|FG000|Overall Study|Story of head and/or neck surgery|2|||
126312052|NCT04569968|454432236|FG001|Overall Study|Story of head and/or neck surgery|2|||
126312053|NCT04569968|454432235|FG000|Overall Study|Time of stroke onset|8|||
126312054|NCT04569968|454432236|FG001|Overall Study|Time of stroke onset|7|||
126312055|NCT04569968|454432235|FG000|Overall Study|Type of strokr|12|||
126312056|NCT04569968|454432236|FG001|Overall Study|Type of strokr|8|||
126312057|NCT04569968|454432235|FG000|Overall Study|Cooperation|8|||
126312058|NCT04569968|454432236|FG001|Overall Study|Cooperation|8|||
126312059|NCT04569968|454432235|FG000|Overall Study|Age interval|17|||
126312060|NCT04569968|454432236|FG001|Overall Study|Age interval|6|||
126312061|NCT04569968|454432235|FG000|Overall Study|Denial of participation to the study|0|||
126312062|NCT04569968|454432236|FG001|Overall Study|Denial of participation to the study|3|||
126312063|NCT04569968|454432235|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
126312064|NCT04569968|454432236|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
126312065|NCT04569968|454432235|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
126312066|NCT04569968|454432236|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
126312067|NCT04569968|454432235|FG000|Overall Study|Quarantine|1|||
126312068|NCT04569968|454432236|FG001|Overall Study|Quarantine|0|||
126312069|NCT04569968|454432235|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
126312070|NCT04569968|454432236|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
126312071|NCT04569968|454432235|FG000|Overall Study|Repetitive stroke|8|||
126312072|NCT04569968|454432236|FG001|Overall Study|Repetitive stroke|0|||
126312073|NCT04569968|454432235|FG000|Overall Study|Insufficient mastication|1|||
126312074|NCT04569968|454432236|FG001|Overall Study|Insufficient mastication|0|||
126312075|NCT04569968|454432235|FG000|Overall Study|Infection|1|||
126312076|NCT04569968|454432236|FG001|Overall Study|Infection|0|||
126312077|NCT00373958|454432237|FG000|Infant Series|Withdrawal by Subject|13|||
126312078|NCT00373958|454432238|FG001|Infant Series|Withdrawal by Subject|15|||
126312079|NCT00373958|454432237|FG000|Infant Series|Failed to return|8|||
126312080|NCT00373958|454432238|FG001|Infant Series|Failed to return|13|||
126312081|NCT00373958|454432237|FG000|Infant Series|Lost to Follow-up|6|||
126312082|NCT00373958|454432238|FG001|Infant Series|Lost to Follow-up|5|||
126312083|NCT00373958|454432237|FG000|Infant Series|Protocol Violation|3|||
126312084|NCT00373958|454432238|FG001|Infant Series|Protocol Violation|7|||
126312085|NCT00373958|454432237|FG000|Infant Series|Lost Kaiser coverage|4|||
126312086|NCT00373958|454432238|FG001|Infant Series|Lost Kaiser coverage|0|||
126312087|NCT00373958|454432237|FG000|Infant Series|Child relocated|1|||
126312088|NCT00373958|454432238|FG001|Infant Series|Child relocated|0|||
126202396|NCT00689299|454025938|FG001|Overall Study|Lost to Follow-up|1|||
126312089|NCT00373958|454432237|FG000|Infant Series|Consent was not received|1|||
126312090|NCT00373958|454432238|FG001|Infant Series|Consent was not received|0|||
126312091|NCT00373958|454432237|FG000|Infant Series|Adverse Event|3|||
126422579|NCT04915729|454842633|FG001|Overall Study|Lost to Follow-up|10|||
126202397|NCT00689299|454025939|FG002|Overall Study|Lost to Follow-up|1|||
126202398|NCT00689299|454025937|FG000|Overall Study|Withdrawal by Subject|4|||
126202399|NCT00689299|454025938|FG001|Overall Study|Withdrawal by Subject|1|||
126202400|NCT00689299|454025939|FG002|Overall Study|Withdrawal by Subject|3|||
126202401|NCT00689299|454025937|FG000|Overall Study|Protocol Violation|1|||
126202402|NCT00689299|454025938|FG001|Overall Study|Protocol Violation|0|||
126202403|NCT00689299|454025939|FG002|Overall Study|Protocol Violation|0|||
126202404|NCT00758394|454025942|FG000|2nd Intervention Order|Lost to Follow-up|0|||
126202405|NCT00758394|454025943|FG001|2nd Intervention Order|Lost to Follow-up|1|||
126202406|NCT00758394|454025944|FG002|2nd Intervention Order|Lost to Follow-up|0|||
126202407|NCT00758394|454025945|FG003|2nd Intervention Order|Lost to Follow-up|0|||
126202408|NCT00758394|454025942|FG000|3rd Intervention|Lost to Follow-up|1|||
126202409|NCT00758394|454025943|FG001|3rd Intervention|Lost to Follow-up|0|||
126202410|NCT00758394|454025944|FG002|3rd Intervention|Lost to Follow-up|0|||
126202411|NCT00758394|454025945|FG003|3rd Intervention|Lost to Follow-up|1|||
126202412|NCT01684930|454027458|FG000|Overall Study|Withdrawal by Subject|3|||
126202413|NCT01684930|454027459|FG001|Overall Study|Withdrawal by Subject|1|||
126202414|NCT00313716|454027469|FG000|Overall Study|Death|3|||
126202415|NCT00313716|454027470|FG001|Overall Study|Death|2|||
126202416|NCT00313716|454027471|FG002|Overall Study|Death|9|||
126202417|NCT00313716|454027472|FG003|Overall Study|Death|3|||
126202418|NCT00313716|454027473|FG004|Overall Study|Death|5|||
126202419|NCT00313716|454027474|FG005|Overall Study|Death|9|||
126202420|NCT00313716|454027469|FG000|Overall Study|Lost to Follow-up|2|||
126202421|NCT00313716|454027470|FG001|Overall Study|Lost to Follow-up|5|||
126202422|NCT00313716|454027471|FG002|Overall Study|Lost to Follow-up|2|||
126202423|NCT00313716|454027472|FG003|Overall Study|Lost to Follow-up|1|||
126202424|NCT00313716|454027473|FG004|Overall Study|Lost to Follow-up|0|||
126202425|NCT00313716|454027474|FG005|Overall Study|Lost to Follow-up|4|||
126202426|NCT00313716|454027469|FG000|Overall Study|Withdrawal by Subject|0|||
126202427|NCT00313716|454027470|FG001|Overall Study|Withdrawal by Subject|1|||
126202428|NCT00313716|454027471|FG002|Overall Study|Withdrawal by Subject|1|||
126202429|NCT00313716|454027472|FG003|Overall Study|Withdrawal by Subject|0|||
126202430|NCT00313716|454027473|FG004|Overall Study|Withdrawal by Subject|1|||
126202431|NCT00313716|454027474|FG005|Overall Study|Withdrawal by Subject|0|||
126202432|NCT00039377|454027476|FG000|Initial Registration|Adverse Event|2|||
126202433|NCT00039377|454027477|FG001|Initial Registration|Adverse Event|0|||
126202434|NCT00039377|454027478|FG002|Initial Registration|Adverse Event|0|||
126202435|NCT00039377|454027479|FG003|Initial Registration|Adverse Event|0|||
126202436|NCT00039377|454027476|FG000|Initial Registration|Relapsed|6|||
126202437|NCT00039377|454027477|FG001|Initial Registration|Relapsed|0|||
126202438|NCT00039377|454027478|FG002|Initial Registration|Relapsed|0|||
126202439|NCT00039377|454027479|FG003|Initial Registration|Relapsed|0|||
126202440|NCT00039377|454027476|FG000|Initial Registration|Received non-protocol therapy|11|||
126202441|NCT00039377|454027477|FG001|Initial Registration|Received non-protocol therapy|0|||
126202442|NCT00039377|454027478|FG002|Initial Registration|Received non-protocol therapy|0|||
126202443|NCT00039377|454027479|FG003|Initial Registration|Received non-protocol therapy|0|||
126202444|NCT00039377|454027476|FG000|Initial Registration|Withdrawal by Subject|3|||
126202445|NCT00039377|454027477|FG001|Initial Registration|Withdrawal by Subject|0|||
126202446|NCT00039377|454027478|FG002|Initial Registration|Withdrawal by Subject|0|||
126202447|NCT00039377|454027479|FG003|Initial Registration|Withdrawal by Subject|0|||
126202448|NCT04067310|454027483|FG000|Overall Study|Physician Decision|2|||
126202449|NCT04067310|454027484|FG001|Overall Study|Physician Decision|6|||
126202450|NCT04067310|454027483|FG000|Overall Study|Lost to Follow-up|0|||
126202451|NCT04067310|454027484|FG001|Overall Study|Lost to Follow-up|1|||
126202452|NCT04067310|454027483|FG000|Overall Study|Withdrawal by Subject|3|||
126202453|NCT04067310|454027484|FG001|Overall Study|Withdrawal by Subject|0|||
126202454|NCT01041027|454027485|FG000|Overall Study|Withdrawal by Subject|2|||
126202455|NCT01041027|454027485|FG000|Overall Study|Protocol Violation|1|||
126202456|NCT01041027|454027485|FG000|Overall Study|Delayed Radiation Therapy|1|||
126202457|NCT01041027|454027485|FG000|Overall Study|Adverse Event|4|||
126202458|NCT01347931|454027486|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
126202459|NCT01249404|454027487|FG000|Overall Study|Study treatment not received|0|||
126202460|NCT01249404|454027488|FG001|Overall Study|Study treatment not received|1|||
126202461|NCT01249404|454027489|FG002|Overall Study|Study treatment not received|2|||
126202462|NCT01249404|454027487|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
126202463|NCT01249404|454027488|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
126202464|NCT01249404|454027489|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
126202465|NCT01249404|454027487|FG000|Overall Study|Adverse Event|2|||
126202466|NCT01249404|454027488|FG001|Overall Study|Adverse Event|2|||
126202467|NCT01249404|454027489|FG002|Overall Study|Adverse Event|2|||
126202468|NCT01249404|454027487|FG000|Overall Study|Withdrawal by Subject|2|||
126422580|NCT04915729|454842632|FG000|Overall Study|Withdrawal by Subject|12|||
126202469|NCT01249404|454027488|FG001|Overall Study|Withdrawal by Subject|2|||
126202470|NCT01249404|454027489|FG002|Overall Study|Withdrawal by Subject|0|||
126202471|NCT01249404|454027487|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
126202472|NCT01249404|454027488|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
126202473|NCT01249404|454027489|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
126202474|NCT01249404|454027487|FG000|Overall Study|Non compliance to visit schedule|0|||
126312092|NCT00373958|454432238|FG001|Infant Series|Adverse Event|1|||
126312093|NCT00373958|454432237|FG000|Infant Series|Physician Decision|1|||
126312094|NCT00373958|454432238|FG001|Infant Series|Physician Decision|1|||
126312095|NCT00373958|454432237|FG000|Toddler Dose|Lost to Follow-up|5|||
126312096|NCT00373958|454432238|FG001|Toddler Dose|Lost to Follow-up|8|||
126312097|NCT00373958|454432237|FG000|Toddler Dose|Withdrawal by Subject|2|||
126312098|NCT00373958|454432238|FG001|Toddler Dose|Withdrawal by Subject|2|||
126312099|NCT00373958|454432237|FG000|Toddler Dose|Failed to return|1|||
126202475|NCT01249404|454027488|FG001|Overall Study|Non compliance to visit schedule|1|||
126202476|NCT01249404|454027489|FG002|Overall Study|Non compliance to visit schedule|0|||
126202477|NCT01020812|454027490|FG000|Overall Study|Physician Decision|1|||
126202478|NCT01020812|454027490|FG000|Overall Study|Withdrawal by Subject|1|||
126202479|NCT01020812|454027490|FG000|Overall Study|Protocol Violation|1|||
126202480|NCT02545270|454027491|FG000|Overall Study|technical difficulties|0|||
126202481|NCT02545270|454027492|FG001|Overall Study|technical difficulties|1|||
126202482|NCT02545270|454027493|FG002|Overall Study|technical difficulties|0|||
126312100|NCT00373958|454432238|FG001|Toddler Dose|Failed to return|2|||
126312101|NCT00373958|454432237|FG000|Toddler Dose|Protocol Violation|0|||
126312102|NCT00373958|454432238|FG001|Toddler Dose|Protocol Violation|1|||
126312103|NCT00373958|454432237|FG000|Toddler Dose|Withdrawn after infant series|22|||
126312104|NCT00373958|454432238|FG001|Toddler Dose|Withdrawn after infant series|25|||
126312105|NCT01552915|454432239|FG000|Overall Study|Adverse Event|3|||
126312106|NCT01552915|454432240|FG001|Overall Study|Adverse Event|14|||
126312107|NCT01552915|454432241|FG002|Overall Study|Adverse Event|3|||
126312108|NCT01552915|454432239|FG000|Overall Study|Lost to Follow-up|4|||
126312109|NCT01552915|454432240|FG001|Overall Study|Lost to Follow-up|6|||
126312110|NCT01552915|454432241|FG002|Overall Study|Lost to Follow-up|5|||
126312111|NCT01552915|454432239|FG000|Overall Study|Withdrawal by Subject|6|||
126312112|NCT01552915|454432240|FG001|Overall Study|Withdrawal by Subject|4|||
126312113|NCT01552915|454432241|FG002|Overall Study|Withdrawal by Subject|5|||
126312114|NCT01552915|454432239|FG000|Overall Study|Protocol Violation|0|||
126312115|NCT01552915|454432240|FG001|Overall Study|Protocol Violation|4|||
126312116|NCT01552915|454432241|FG002|Overall Study|Protocol Violation|4|||
126312117|NCT01552915|454432239|FG000|Overall Study|Lack of Efficacy|8|||
126312118|NCT01552915|454432240|FG001|Overall Study|Lack of Efficacy|1|||
126312119|NCT01552915|454432241|FG002|Overall Study|Lack of Efficacy|4|||
126312120|NCT01552915|454432239|FG000|Overall Study|Other|2|||
126312121|NCT01552915|454432240|FG001|Overall Study|Other|0|||
126312122|NCT01552915|454432241|FG002|Overall Study|Other|6|||
126312123|NCT02457832|454432242|FG000|Training|Lost to Follow-up|10|||
126312124|NCT02457832|454432243|FG001|Training|Lost to Follow-up|6|||
126312125|NCT02457832|454432244|FG002|Training|Lost to Follow-up|3|||
126312126|NCT02457832|454432242|FG000|One Month Washout|Lost to Follow-up|0|||
126312127|NCT02457832|454432243|FG001|One Month Washout|Lost to Follow-up|1|||
126312128|NCT02457832|454432244|FG002|One Month Washout|Lost to Follow-up|1|||
126312129|NCT03973918|454432249|FG000|Overall Study|Adverse Event|0|||
126312130|NCT03973918|454432250|FG001|Overall Study|Adverse Event|0|||
126312131|NCT03973918|454432251|FG002|Overall Study|Adverse Event|0|||
126312132|NCT03973918|454432252|FG003|Overall Study|Adverse Event|1|||
126312133|NCT03973918|454432249|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
126312134|NCT03973918|454432250|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
126312135|NCT03973918|454432251|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
126312136|NCT03973918|454432252|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
126202483|NCT02545270|454027491|FG000|Overall Study|Videos being too similar to other|0|||
126202484|NCT02545270|454027492|FG001|Overall Study|Videos being too similar to other|0|||
126202485|NCT02545270|454027493|FG002|Overall Study|Videos being too similar to other|2|||
126202486|NCT01716585|454027499|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
126202487|NCT01716585|454027500|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
126202488|NCT01716585|454027499|FG000|Double-blind Treatment|Adverse Event|2|||
126202489|NCT01716585|454027500|FG001|Double-blind Treatment|Adverse Event|1|||
126202490|NCT01716585|454027499|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
126312137|NCT02951533|454432253|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
126312138|NCT02951533|454432254|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
126312139|NCT02951533|454432255|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
126312140|NCT02951533|454432253|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
126312141|NCT02951533|454432254|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
126312142|NCT02951533|454432255|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
126202491|NCT01716585|454027500|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
126312143|NCT02951533|454432253|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
126312144|NCT02951533|454432254|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
126312145|NCT02951533|454432255|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
126312146|NCT02951533|454432253|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
126312147|NCT02951533|454432254|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
126312148|NCT02951533|454432255|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
126312149|NCT02951533|454432253|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
126312150|NCT02951533|454432254|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
126312151|NCT02951533|454432255|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
126312152|NCT02951533|454432253|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
126312153|NCT02951533|454432254|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
126312154|NCT02951533|454432255|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
126312155|NCT02951533|454432253|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
126312156|NCT02951533|454432254|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
126312157|NCT02951533|454432255|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
126312158|NCT02951533|454432253|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
126312159|NCT02951533|454432254|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
126312160|NCT02951533|454432255|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
126312161|NCT02951533|454432253|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
126312162|NCT02951533|454432254|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
126312163|NCT02951533|454432255|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
126312164|NCT02951533|454432253|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
126312165|NCT02951533|454432254|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
126312166|NCT02951533|454432255|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
126312167|NCT02951533|454432253|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
126312168|NCT02951533|454432254|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
126312169|NCT02951533|454432255|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
126312170|NCT00520481|454432256|FG000|Overall Study|Adverse Event|4|||
126312171|NCT00520481|454432257|FG001|Overall Study|Adverse Event|1|||
126312172|NCT00520481|454432256|FG000|Overall Study|Withdrawal by Subject|3|||
126312173|NCT00520481|454432257|FG001|Overall Study|Withdrawal by Subject|0|||
126312174|NCT00742508|454432265|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
126312175|NCT00742508|454432266|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
126312176|NCT00742508|454432265|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
126312177|NCT00742508|454432266|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
126312178|NCT00742508|454432265|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
126312179|NCT00742508|454432266|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
126312180|NCT00742508|454432265|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
126312181|NCT00742508|454432266|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
126312182|NCT00742508|454432265|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
126312183|NCT00742508|454432266|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
126312184|NCT04017832|454432267|FG000|Overall Study|Withdrawal by Subject|13|||
126312185|NCT04017832|454432268|FG001|Overall Study|Withdrawal by Subject|12|||
126312186|NCT04017832|454432269|FG002|Overall Study|Withdrawal by Subject|21|||
126312187|NCT04017832|454432270|FG003|Overall Study|Withdrawal by Subject|7|||
126312188|NCT04017832|454432267|FG000|Overall Study|Lost to Follow-up|0|||
126312189|NCT04017832|454432268|FG001|Overall Study|Lost to Follow-up|3|||
126312190|NCT04017832|454432269|FG002|Overall Study|Lost to Follow-up|3|||
126312191|NCT04017832|454432270|FG003|Overall Study|Lost to Follow-up|1|||
126312192|NCT04017832|454432267|FG000|Overall Study|Physician Decision|1|||
126312193|NCT04017832|454432268|FG001|Overall Study|Physician Decision|1|||
126312194|NCT04017832|454432269|FG002|Overall Study|Physician Decision|1|||
126312195|NCT04017832|454432270|FG003|Overall Study|Physician Decision|1|||
126312196|NCT04017832|454432267|FG000|Overall Study|Death|2|||
126312197|NCT04017832|454432268|FG001|Overall Study|Death|2|||
126312198|NCT04017832|454432269|FG002|Overall Study|Death|1|||
126312199|NCT04017832|454432270|FG003|Overall Study|Death|0|||
126312200|NCT00860249|454434145|FG000|Overall Study|trial was terminated prior to completion|21|||
126312201|NCT00860249|454434146|FG001|Overall Study|trial was terminated prior to completion|18|||
126312202|NCT00860249|454434147|FG002|Overall Study|trial was terminated prior to completion|21|||
126312203|NCT00174967|454434148|FG000|Overall Study|Adverse Event|1|||
126312204|NCT00174967|454434149|FG001|Overall Study|Adverse Event|2|||
126312205|NCT00174967|454434150|FG002|Overall Study|Adverse Event|2|||
126312206|NCT00174967|454434151|FG003|Overall Study|Adverse Event|1|||
126312207|NCT00174967|454434148|FG000|Overall Study|Gout Flare|0|||
126312208|NCT00174967|454434149|FG001|Overall Study|Gout Flare|0|||
126312209|NCT00174967|454434150|FG002|Overall Study|Gout Flare|0|||
126312210|NCT00174967|454434151|FG003|Overall Study|Gout Flare|1|||
126312211|NCT00174967|454434148|FG000|Overall Study|Other|0|||
126312212|NCT00174967|454434149|FG001|Overall Study|Other|1|||
126312213|NCT00174967|454434150|FG002|Overall Study|Other|0|||
126312214|NCT00174967|454434151|FG003|Overall Study|Other|0|||
126422581|NCT04915729|454842633|FG001|Overall Study|Withdrawal by Subject|5|||
126312215|NCT02031640|454434152|FG000|Screening Period|Adverse Event|1|||
126312216|NCT02031640|454434153|FG001|Screening Period|Adverse Event|0|||
126312217|NCT02031640|454434154|FG002|Screening Period|Adverse Event|0|||
126312218|NCT02031640|454434155|FG003|Screening Period|Adverse Event|0|||
126312219|NCT02031640|454434156|FG004|Screening Period|Adverse Event|0|||
126312220|NCT02031640|454434157|FG005|Screening Period|Adverse Event|0|||
126312221|NCT02031640|454434152|FG000|Screening Period|Withdrawal by Subject|29|||
126312222|NCT02031640|454434153|FG001|Screening Period|Withdrawal by Subject|0|||
126312223|NCT02031640|454434154|FG002|Screening Period|Withdrawal by Subject|0|||
126312224|NCT02031640|454434155|FG003|Screening Period|Withdrawal by Subject|0|||
126312225|NCT02031640|454434156|FG004|Screening Period|Withdrawal by Subject|0|||
126312226|NCT02031640|454434157|FG005|Screening Period|Withdrawal by Subject|0|||
126312227|NCT02031640|454434152|FG000|Screening Period|Inclusion criteria not met|312|||
126312228|NCT02031640|454434153|FG001|Screening Period|Inclusion criteria not met|0|||
126312229|NCT02031640|454434154|FG002|Screening Period|Inclusion criteria not met|0|||
126312230|NCT02031640|454434155|FG003|Screening Period|Inclusion criteria not met|0|||
126312231|NCT02031640|454434156|FG004|Screening Period|Inclusion criteria not met|0|||
126312232|NCT02031640|454434157|FG005|Screening Period|Inclusion criteria not met|0|||
126312233|NCT02031640|454434152|FG000|Screening Period|Exclusion criteria met|30|||
126312234|NCT02031640|454434153|FG001|Screening Period|Exclusion criteria met|0|||
126312235|NCT02031640|454434154|FG002|Screening Period|Exclusion criteria met|0|||
126312236|NCT02031640|454434155|FG003|Screening Period|Exclusion criteria met|0|||
126312237|NCT02031640|454434156|FG004|Screening Period|Exclusion criteria met|0|||
126312238|NCT02031640|454434157|FG005|Screening Period|Exclusion criteria met|0|||
126312239|NCT02031640|454434152|FG000|Screening Period|Lost to Follow-up|14|||
126312240|NCT02031640|454434153|FG001|Screening Period|Lost to Follow-up|0|||
126312241|NCT02031640|454434154|FG002|Screening Period|Lost to Follow-up|0|||
126312242|NCT02031640|454434155|FG003|Screening Period|Lost to Follow-up|0|||
126312243|NCT02031640|454434156|FG004|Screening Period|Lost to Follow-up|0|||
126312244|NCT02031640|454434157|FG005|Screening Period|Lost to Follow-up|0|||
126312245|NCT02031640|454434152|FG000|Screening Period|Enrollment closed|26|||
126312246|NCT02031640|454434153|FG001|Screening Period|Enrollment closed|0|||
126312247|NCT02031640|454434154|FG002|Screening Period|Enrollment closed|0|||
126312248|NCT02031640|454434155|FG003|Screening Period|Enrollment closed|0|||
126312249|NCT02031640|454434156|FG004|Screening Period|Enrollment closed|0|||
126312250|NCT02031640|454434157|FG005|Screening Period|Enrollment closed|0|||
126312251|NCT02031640|454434152|FG000|Run-In Period|Adverse Event|4|||
126312252|NCT02031640|454434153|FG001|Run-In Period|Adverse Event|0|||
126312253|NCT02031640|454434154|FG002|Run-In Period|Adverse Event|0|||
126312254|NCT02031640|454434155|FG003|Run-In Period|Adverse Event|0|||
126312255|NCT02031640|454434156|FG004|Run-In Period|Adverse Event|0|||
126312256|NCT02031640|454434157|FG005|Run-In Period|Adverse Event|0|||
126312257|NCT02031640|454434152|FG000|Run-In Period|Withdrawal by Subject|17|||
126312258|NCT02031640|454434153|FG001|Run-In Period|Withdrawal by Subject|0|||
126312259|NCT02031640|454434154|FG002|Run-In Period|Withdrawal by Subject|0|||
126312260|NCT02031640|454434155|FG003|Run-In Period|Withdrawal by Subject|0|||
126312261|NCT02031640|454434156|FG004|Run-In Period|Withdrawal by Subject|0|||
126312262|NCT02031640|454434157|FG005|Run-In Period|Withdrawal by Subject|0|||
126312263|NCT02031640|454434152|FG000|Run-In Period|Inclusion criteria not met|38|||
126312264|NCT02031640|454434153|FG001|Run-In Period|Inclusion criteria not met|0|||
126312265|NCT02031640|454434154|FG002|Run-In Period|Inclusion criteria not met|0|||
126312266|NCT02031640|454434155|FG003|Run-In Period|Inclusion criteria not met|0|||
126312267|NCT02031640|454434156|FG004|Run-In Period|Inclusion criteria not met|0|||
126312268|NCT02031640|454434157|FG005|Run-In Period|Inclusion criteria not met|0|||
126312269|NCT02031640|454434152|FG000|Run-In Period|Exclusion criteria met|8|||
126312270|NCT02031640|454434153|FG001|Run-In Period|Exclusion criteria met|0|||
126312271|NCT02031640|454434154|FG002|Run-In Period|Exclusion criteria met|0|||
126312272|NCT02031640|454434155|FG003|Run-In Period|Exclusion criteria met|0|||
126312273|NCT02031640|454434156|FG004|Run-In Period|Exclusion criteria met|0|||
126312274|NCT02031640|454434157|FG005|Run-In Period|Exclusion criteria met|0|||
126312275|NCT02031640|454434152|FG000|Run-In Period|Randomization criteria not met|85|||
126312276|NCT02031640|454434153|FG001|Run-In Period|Randomization criteria not met|0|||
126312277|NCT02031640|454434154|FG002|Run-In Period|Randomization criteria not met|0|||
126312278|NCT02031640|454434155|FG003|Run-In Period|Randomization criteria not met|0|||
126312279|NCT02031640|454434156|FG004|Run-In Period|Randomization criteria not met|0|||
126312280|NCT02031640|454434157|FG005|Run-In Period|Randomization criteria not met|0|||
126312281|NCT02031640|454434152|FG000|Run-In Period|Various administrative reasons|17|||
126312282|NCT02031640|454434153|FG001|Run-In Period|Various administrative reasons|0|||
126312283|NCT02031640|454434154|FG002|Run-In Period|Various administrative reasons|0|||
126312284|NCT02031640|454434155|FG003|Run-In Period|Various administrative reasons|0|||
126312285|NCT02031640|454434156|FG004|Run-In Period|Various administrative reasons|0|||
126312286|NCT02031640|454434157|FG005|Run-In Period|Various administrative reasons|0|||
126312287|NCT02031640|454434152|FG000|Double-blind Treatment Period|Protocol deviation|0|||
126312288|NCT02031640|454434153|FG001|Double-blind Treatment Period|Protocol deviation|2|||
126422582|NCT04915729|454842632|FG000|Overall Study|Death|34|||
126422583|NCT04915729|454842633|FG001|Overall Study|Death|44|||
126312289|NCT02031640|454434154|FG002|Double-blind Treatment Period|Protocol deviation|0|||
126312290|NCT02031640|454434155|FG003|Double-blind Treatment Period|Protocol deviation|1|||
126312291|NCT02031640|454434156|FG004|Double-blind Treatment Period|Protocol deviation|3|||
126312292|NCT02031640|454434157|FG005|Double-blind Treatment Period|Protocol deviation|1|||
126312293|NCT02031640|454434152|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126312294|NCT02031640|454434153|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
126312295|NCT02031640|454434154|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
126312296|NCT02031640|454434155|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
126312297|NCT02031640|454434156|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
126312298|NCT02031640|454434157|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
126312299|NCT02031640|454434152|FG000|Double-blind Treatment Period|Non-compliance|0|||
126312300|NCT02031640|454434153|FG001|Double-blind Treatment Period|Non-compliance|1|||
126312301|NCT02031640|454434154|FG002|Double-blind Treatment Period|Non-compliance|0|||
126312302|NCT02031640|454434155|FG003|Double-blind Treatment Period|Non-compliance|1|||
126312303|NCT02031640|454434156|FG004|Double-blind Treatment Period|Non-compliance|1|||
126312304|NCT02031640|454434157|FG005|Double-blind Treatment Period|Non-compliance|0|||
126312305|NCT02031640|454434152|FG000|Double-blind Treatment Period|Adverse Event|0|||
126312306|NCT02031640|454434153|FG001|Double-blind Treatment Period|Adverse Event|0|||
126312307|NCT02031640|454434154|FG002|Double-blind Treatment Period|Adverse Event|0|||
126312308|NCT02031640|454434155|FG003|Double-blind Treatment Period|Adverse Event|2|||
126312309|NCT02031640|454434156|FG004|Double-blind Treatment Period|Adverse Event|0|||
126312310|NCT02031640|454434157|FG005|Double-blind Treatment Period|Adverse Event|0|||
126312311|NCT02031640|454434152|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126312312|NCT02031640|454434153|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126312313|NCT02031640|454434154|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
126312314|NCT02031640|454434155|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
126312315|NCT02031640|454434156|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
126312316|NCT02031640|454434157|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
126312317|NCT02031640|454434152|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126312318|NCT02031640|454434153|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
126312319|NCT02031640|454434154|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126312320|NCT02031640|454434155|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126312321|NCT02031640|454434156|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
126312322|NCT02031640|454434157|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
126312323|NCT03085238|454434162|FG000|Overall Study|Adverse Event|2|||
126312324|NCT03085238|454434162|FG000|Overall Study|Death|2|||
126312325|NCT05896527|454434163|FG000|Overall Study|Withdrawal by Subject|11|||
126312326|NCT05896527|454434164|FG001|Overall Study|Withdrawal by Subject|10|||
126312327|NCT05896527|454434165|FG002|Overall Study|Withdrawal by Subject|4|||
126312328|NCT05896527|454434166|FG003|Overall Study|Withdrawal by Subject|3|||
126312329|NCT05896527|454434167|FG004|Overall Study|Withdrawal by Subject|2|||
126312330|NCT05896527|454434163|FG000|Overall Study|Lost to Follow-up|0|||
126312331|NCT05896527|454434164|FG001|Overall Study|Lost to Follow-up|2|||
126312332|NCT05896527|454434165|FG002|Overall Study|Lost to Follow-up|2|||
126312333|NCT05896527|454434166|FG003|Overall Study|Lost to Follow-up|2|||
126312334|NCT05896527|454434167|FG004|Overall Study|Lost to Follow-up|1|||
126312335|NCT05896527|454434163|FG000|Overall Study|Significant protocol noncompliance|0|||
126312336|NCT05896527|454434164|FG001|Overall Study|Significant protocol noncompliance|1|||
126312337|NCT05896527|454434165|FG002|Overall Study|Significant protocol noncompliance|0|||
126312338|NCT05896527|454434166|FG003|Overall Study|Significant protocol noncompliance|0|||
126312339|NCT05896527|454434167|FG004|Overall Study|Significant protocol noncompliance|0|||
126312340|NCT05896527|454434163|FG000|Overall Study|Eligibility criteria not met|1|||
126312341|NCT05896527|454434164|FG001|Overall Study|Eligibility criteria not met|0|||
126312342|NCT05896527|454434165|FG002|Overall Study|Eligibility criteria not met|0|||
126312343|NCT05896527|454434166|FG003|Overall Study|Eligibility criteria not met|0|||
126312344|NCT05896527|454434167|FG004|Overall Study|Eligibility criteria not met|0|||
126312345|NCT05896527|454434163|FG000|Overall Study|Sponsor's decision|0|||
126312346|NCT05896527|454434164|FG001|Overall Study|Sponsor's decision|0|||
126312347|NCT05896527|454434165|FG002|Overall Study|Sponsor's decision|0|||
126312348|NCT05896527|454434166|FG003|Overall Study|Sponsor's decision|1|||
126312349|NCT05896527|454434167|FG004|Overall Study|Sponsor's decision|0|||
126312350|NCT05896527|454434163|FG000|Overall Study|Investigator's decision|0|||
126312351|NCT05896527|454434164|FG001|Overall Study|Investigator's decision|1|||
126312352|NCT05896527|454434165|FG002|Overall Study|Investigator's decision|0|||
126312353|NCT05896527|454434166|FG003|Overall Study|Investigator's decision|0|||
126312354|NCT05896527|454434167|FG004|Overall Study|Investigator's decision|0|||
126422584|NCT04915729|454842632|FG000|Overall Study|not treated|3|||
126422585|NCT04915729|454842633|FG001|Overall Study|not treated|6|||
126422586|NCT04915729|454842632|FG000|Overall Study|Investigator removed subject|1|||
126422587|NCT04915729|454842633|FG001|Overall Study|Investigator removed subject|2|||
126312355|NCT05896527|454434163|FG000|Overall Study|Pregnancy of his partner|0|||
126312356|NCT05896527|454434164|FG001|Overall Study|Pregnancy of his partner|0|||
126312357|NCT05896527|454434165|FG002|Overall Study|Pregnancy of his partner|0|||
126312358|NCT05896527|454434166|FG003|Overall Study|Pregnancy of his partner|1|||
126312359|NCT05896527|454434167|FG004|Overall Study|Pregnancy of his partner|0|||
125978647|NCT00862134|453209811|FG000|Overall Study|Physician Decision|0|||
125978648|NCT00862134|453209812|FG001|Overall Study|Physician Decision|1|||
125978649|NCT00862134|453209811|FG000|Overall Study|Withdrawal by Subject|1|||
125978650|NCT00862134|453209812|FG001|Overall Study|Withdrawal by Subject|2|||
126312360|NCT01279070|454434168|FG000|Overall Study|Withdrawal by Subject|2|||
126312361|NCT01279070|454434169|FG001|Overall Study|Withdrawal by Subject|3|||
126312362|NCT01279070|454434168|FG000|Overall Study|Acute exacerbation|3|||
126312363|NCT01279070|454434169|FG001|Overall Study|Acute exacerbation|1|||
126312364|NCT03781583|454434170|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
126312365|NCT03781583|454434171|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
126312366|NCT03781583|454434172|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
126312367|NCT03781583|454434173|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
126312368|NCT03781583|454434170|FG000|Overall Study|Technology did not work for that person in that environment|1|||
126312369|NCT03781583|454434171|FG001|Overall Study|Technology did not work for that person in that environment|0|||
126312370|NCT03781583|454434172|FG002|Overall Study|Technology did not work for that person in that environment|0|||
126312371|NCT03781583|454434173|FG003|Overall Study|Technology did not work for that person in that environment|0|||
126312372|NCT03781583|454434170|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
126312373|NCT03781583|454434171|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
126312374|NCT03781583|454434172|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
126312375|NCT03781583|454434173|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
126312376|NCT03781583|454434170|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
126312377|NCT03781583|454434171|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
126312378|NCT03781583|454434172|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
126312379|NCT03781583|454434173|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
126312380|NCT05139303|454434174|FG000|Overall Study|Lost to Follow-up|3|||
126312381|NCT05139303|454434175|FG001|Overall Study|Lost to Follow-up|0|||
126312382|NCT05139303|454434174|FG000|Overall Study|Adverse Event|1|||
126312383|NCT05139303|454434175|FG001|Overall Study|Adverse Event|0|||
126312384|NCT02045862|454434176|FG000|Overall Study|Death|0|||
126312385|NCT02045862|454434177|FG001|Overall Study|Death|0|||
126312386|NCT02045862|454434178|FG002|Overall Study|Death|1|||
126312387|NCT02045862|454434176|FG000|Overall Study|Miscellaneous|5|||
126312388|NCT02045862|454434177|FG001|Overall Study|Miscellaneous|0|||
126312389|NCT02045862|454434178|FG002|Overall Study|Miscellaneous|8|||
126312390|NCT02045862|454434176|FG000|Overall Study|Withdrawal by Patient|18|||
126312391|NCT02045862|454434177|FG001|Overall Study|Withdrawal by Patient|27|||
126312392|NCT02045862|454434178|FG002|Overall Study|Withdrawal by Patient|57|||
126312393|NCT02045862|454434176|FG000|Overall Study|Protocol Violation|0|||
126312394|NCT02045862|454434177|FG001|Overall Study|Protocol Violation|0|||
126312395|NCT02045862|454434178|FG002|Overall Study|Protocol Violation|6|||
126312396|NCT02045862|454434176|FG000|Overall Study|Lack of Efficacy|8|||
126312397|NCT02045862|454434177|FG001|Overall Study|Lack of Efficacy|4|||
126312398|NCT02045862|454434178|FG002|Overall Study|Lack of Efficacy|13|||
126312399|NCT02045862|454434176|FG000|Overall Study|Randomized but not Received Study Drug|0|||
126312400|NCT02045862|454434177|FG001|Overall Study|Randomized but not Received Study Drug|2|||
126312401|NCT02045862|454434178|FG002|Overall Study|Randomized but not Received Study Drug|8|||
126312402|NCT02045862|454434176|FG000|Overall Study|Adverse Event|7|||
126312403|NCT02045862|454434177|FG001|Overall Study|Adverse Event|5|||
126422588|NCT04915729|454842632|FG000|Overall Study|questionnaire result not evaluated|1|||
126422589|NCT04915729|454842633|FG001|Overall Study|questionnaire result not evaluated|0|||
126422590|NCT04915729|454842632|FG000|Overall Study|refuse of hospital visit|1|||
126422591|NCT04915729|454842633|FG001|Overall Study|refuse of hospital visit|3|||
126422592|NCT04915729|454842632|FG000|Overall Study|Subject withdrew|1|||
126422593|NCT04915729|454842633|FG001|Overall Study|Subject withdrew|0|||
126422594|NCT02294058|454842644|FG000|Overall Study|Adverse Event|16|||
126422595|NCT02294058|454842645|FG001|Overall Study|Adverse Event|7|||
126422596|NCT02294058|454842646|FG002|Overall Study|Adverse Event|13|||
126422597|NCT02294058|454842644|FG000|Overall Study|Lack of Efficacy|3|||
126422598|NCT02294058|454842645|FG001|Overall Study|Lack of Efficacy|3|||
126422599|NCT02294058|454842646|FG002|Overall Study|Lack of Efficacy|0|||
126422600|NCT02294058|454842644|FG000|Overall Study|Lost to Follow-up|1|||
126422601|NCT02294058|454842645|FG001|Overall Study|Lost to Follow-up|0|||
126422602|NCT02294058|454842646|FG002|Overall Study|Lost to Follow-up|2|||
126422603|NCT02294058|454842644|FG000|Overall Study|Withdrawal by Subject|10|||
126422604|NCT02294058|454842645|FG001|Overall Study|Withdrawal by Subject|14|||
126422605|NCT02294058|454842646|FG002|Overall Study|Withdrawal by Subject|13|||
126422606|NCT02294058|454842644|FG000|Overall Study|Physician Decision|2|||
126422607|NCT02294058|454842645|FG001|Overall Study|Physician Decision|1|||
126422608|NCT02294058|454842646|FG002|Overall Study|Physician Decision|0|||
126312404|NCT02045862|454434178|FG002|Overall Study|Adverse Event|27|||
126312405|NCT02045862|454434176|FG000|Overall Study|Lost to Follow-up|1|||
126312406|NCT02045862|454434177|FG001|Overall Study|Lost to Follow-up|2|||
126312407|NCT02045862|454434178|FG002|Overall Study|Lost to Follow-up|6|||
126312408|NCT03164564|454434179|FG000|Overall Study|Death|3|||
126312409|NCT03164564|454434180|FG001|Overall Study|Death|0|||
126312410|NCT03164564|454434179|FG000|Overall Study|Withdrawal by Subject|20|||
126312411|NCT03164564|454434180|FG001|Overall Study|Withdrawal by Subject|15|||
126312412|NCT03164564|454434179|FG000|Overall Study|Lost to Follow-up|2|||
126312413|NCT03164564|454434180|FG001|Overall Study|Lost to Follow-up|0|||
126312414|NCT03164564|454434179|FG000|Overall Study|Physician Decision|0|||
126312415|NCT03164564|454434180|FG001|Overall Study|Physician Decision|1|||
126312416|NCT03164564|454434179|FG000|Overall Study|Adverse Event|0|||
126312417|NCT03164564|454434180|FG001|Overall Study|Adverse Event|1|||
126312418|NCT03164564|454434179|FG000|Overall Study|Ongoing|1586|||
126312419|NCT03164564|454434180|FG001|Overall Study|Ongoing|1586|||
126312420|NCT02822573|454434186|FG000|Overall Study|Lost to Follow-up|5|||
126312421|NCT02822573|454434187|FG001|Overall Study|Lost to Follow-up|3|||
126312422|NCT02822573|454434186|FG000|Overall Study|Physician Decision|1|||
126312423|NCT02822573|454434187|FG001|Overall Study|Physician Decision|1|||
126312424|NCT02822573|454434186|FG000|Overall Study|Withdrawal by Subject|9|||
126312425|NCT02822573|454434187|FG001|Overall Study|Withdrawal by Subject|5|||
126312426|NCT02822573|454434186|FG000|Overall Study|Protocol Violation|6|||
126312427|NCT02822573|454434187|FG001|Overall Study|Protocol Violation|4|||
126312428|NCT02822573|454434186|FG000|Overall Study|Too sick or ill|2|||
126312429|NCT02822573|454434187|FG001|Overall Study|Too sick or ill|1|||
126312430|NCT02822573|454434186|FG000|Overall Study|Disease Progression|1|||
126312431|NCT02822573|454434187|FG001|Overall Study|Disease Progression|1|||
126312432|NCT02822573|454434186|FG000|Overall Study|No reason given|6|||
126312433|NCT02822573|454434187|FG001|Overall Study|No reason given|4|||
126312434|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Adverse Event|6|||
126312435|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Adverse Event|14|||
126312436|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Death|3|||
126312437|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Death|1|||
126312438|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
126312439|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
126312440|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
126312441|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
126312442|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
126312443|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
126312444|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
126312445|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
126312446|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
126312447|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
126312448|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Physician Decision|2|||
126312449|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Physician Decision|4|||
126312450|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Pregnancy|2|||
126312451|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Pregnancy|1|||
126312452|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
126312453|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
126312454|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
126312455|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
126312456|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
126312457|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
126312458|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
126312459|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
126312460|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
126312461|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
126312462|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
126312463|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
126312464|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
126312465|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
126312466|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
126312467|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
126312468|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
126312469|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
126312470|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
126312471|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
126312472|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
126312473|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
126312474|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
126422609|NCT02294058|454842644|FG000|Overall Study|Miscellaneous|4|||
126046436|NCT02719574|453468211|FG010|Phase 2|Protocol Violation|0|||
126312475|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
126312476|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
126312477|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
126312478|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
126312479|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
126312480|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
126312481|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
126312482|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
126312483|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
126312484|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
126312485|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
126312486|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
126312487|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
126312488|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
126312489|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
126312490|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
126312491|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
126312492|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
126312493|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
126312494|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
126312495|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
126312496|NCT02855359|454434192|FG000|Overall Study|Death|2|||
126312497|NCT02855359|454434193|FG001|Overall Study|Death|2|||
126312498|NCT02855359|454434194|FG002|Overall Study|Death|0|||
126312499|NCT02855359|454434195|FG003|Overall Study|Death|0|||
126312500|NCT02855359|454434192|FG000|Overall Study|Study Termination by Sponsor|9|||
126312501|NCT02855359|454434193|FG001|Overall Study|Study Termination by Sponsor|11|||
126422610|NCT02294058|454842645|FG001|Overall Study|Miscellaneous|1|||
126422611|NCT02294058|454842646|FG002|Overall Study|Miscellaneous|1|||
126422612|NCT03575403|454842648|FG000|Overall Study|Adverse Event|1|||
126422613|NCT03575403|454842649|FG001|Overall Study|Adverse Event|0|||
126422614|NCT03575403|454842650|FG002|Overall Study|Adverse Event|0|||
126422615|NCT03575403|454842648|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
126422616|NCT03575403|454842649|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
126422617|NCT03575403|454842650|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
126422618|NCT02330055|454842651|FG000|Overall Study|technical issues|2|||
126422619|NCT02330055|454842652|FG001|Overall Study|technical issues|0|||
126422620|NCT02330055|454842651|FG000|Overall Study|participant forgot to wear device|5|||
126422621|NCT02330055|454842652|FG001|Overall Study|participant forgot to wear device|5|||
126422622|NCT02330055|454842651|FG000|Overall Study|data for less than 60 minutes|3|||
126422623|NCT02330055|454842652|FG001|Overall Study|data for less than 60 minutes|3|||
126422624|NCT02330055|454842651|FG000|Overall Study|participant did not sleep|0|||
126422625|NCT02330055|454842652|FG001|Overall Study|participant did not sleep|1|||
126422626|NCT02728089|454842654|FG000|Overall Study|Physician Decision|2|||
126422627|NCT02728089|454842654|FG000|Overall Study|Withdrawal by Subject|1|||
126422628|NCT03359174|454842657|FG000|Overall Study|Adverse Event|1|||
126422629|NCT01332994|454842661|FG000|Overall Study|Adverse Event|34|||
126422630|NCT01332994|454842661|FG000|Overall Study|Death|1|||
126422631|NCT01332994|454842661|FG000|Overall Study|Lack of Efficacy|1|||
126422632|NCT01332994|454842661|FG000|Overall Study|Lost to Follow-up|4|||
126422633|NCT01332994|454842661|FG000|Overall Study|Protocol Violation|6|||
126422634|NCT01332994|454842661|FG000|Overall Study|Withdrawal by Subject|15|||
126422635|NCT01332994|454842661|FG000|Overall Study|Administrative Problem|2|||
126422636|NCT01332994|454842661|FG000|Overall Study|Other|8|||
126312502|NCT02855359|454434194|FG002|Overall Study|Study Termination by Sponsor|0|||
126312503|NCT02855359|454434195|FG003|Overall Study|Study Termination by Sponsor|0|||
126312504|NCT00308087|454434196|FG000|Overall Study|Progressive Disease|19|||
126312505|NCT00308087|454434197|FG001|Overall Study|Progressive Disease|21|||
126312506|NCT00308087|454434196|FG000|Overall Study|Study Closure|11|||
126312507|NCT00308087|454434197|FG001|Overall Study|Study Closure|12|||
126312508|NCT00308087|454434196|FG000|Overall Study|Withdrawal by Subject|2|||
126312509|NCT00308087|454434197|FG001|Overall Study|Withdrawal by Subject|1|||
126312510|NCT00308087|454434196|FG000|Overall Study|Other|4|||
126312511|NCT00308087|454434197|FG001|Overall Study|Other|3|||
126312512|NCT05007041|454434204|FG000|Overall Study|Missing Diary Entries|0|||
126312513|NCT05007041|454434205|FG001|Overall Study|Missing Diary Entries|1|||
126312514|NCT02850016|454434206|FG000|Overall Study|Withdrawal by Subject|1|||
126312515|NCT02850016|454434207|FG001|Overall Study|Withdrawal by Subject|2|||
126312516|NCT00423189|454434210|FG000|Overall Study|Death|0|||
126312517|NCT00423189|454434211|FG001|Overall Study|Death|1|||
126312518|NCT00423189|454434212|FG002|Overall Study|Death|0|||
126312519|NCT01459718|454434217|FG000|Overall Study|Physician Decision|1|||
126312520|NCT01459718|454434217|FG000|Overall Study|Lost to Follow-up|1|||
126312521|NCT01459718|454434217|FG000|Overall Study|Adverse Event|1|||
126312522|NCT01258075|454434223|FG000|Overall Study|Adverse Event|8|||
126312523|NCT01258075|454434224|FG001|Overall Study|Adverse Event|3|||
126312524|NCT01258075|454434223|FG000|Overall Study|Lost to Follow-up|11|||
126312525|NCT01258075|454434224|FG001|Overall Study|Lost to Follow-up|6|||
126312526|NCT01258075|454434223|FG000|Overall Study|Withdrawal by Subject|10|||
126312527|NCT01258075|454434224|FG001|Overall Study|Withdrawal by Subject|7|||
126312528|NCT01258075|454434223|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
126312529|NCT01258075|454434224|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
126312530|NCT01258075|454434223|FG000|Overall Study|Other|12|||
126312531|NCT01258075|454434224|FG001|Overall Study|Other|5|||
126312532|NCT01500213|454434227|FG000|Overall Study|Adverse Event|35|||
126312533|NCT01500213|454434228|FG001|Overall Study|Adverse Event|35|||
126312534|NCT01500213|454434227|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
126312535|NCT01500213|454434228|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
126312536|NCT01500213|454434227|FG000|Overall Study|Withdrawal by Subject|28|||
126312537|NCT01500213|454434228|FG001|Overall Study|Withdrawal by Subject|37|||
126312538|NCT01500213|454434227|FG000|Overall Study|Death|7|||
126312539|NCT01500213|454434228|FG001|Overall Study|Death|3|||
126312540|NCT01500213|454434227|FG000|Overall Study|Disease Progression|13|||
126312541|NCT01500213|454434228|FG001|Overall Study|Disease Progression|21|||
126312542|NCT01500213|454434227|FG000|Overall Study|Protocol Violation|19|||
126312543|NCT01500213|454434228|FG001|Overall Study|Protocol Violation|19|||
126312544|NCT01500213|454434227|FG000|Overall Study|Physician Decision|12|||
126312545|NCT01500213|454434228|FG001|Overall Study|Physician Decision|10|||
126312546|NCT01500213|454434227|FG000|Overall Study|Lack of Efficacy|9|||
126312547|NCT01500213|454434228|FG001|Overall Study|Lack of Efficacy|7|||
126312548|NCT01500213|454434227|FG000|Overall Study|Lost to Follow-up|3|||
126312549|NCT01500213|454434228|FG001|Overall Study|Lost to Follow-up|6|||
126312550|NCT01500213|454434227|FG000|Overall Study|Other Reasons|7|||
126312551|NCT01500213|454434228|FG001|Overall Study|Other Reasons|5|||
126312552|NCT03197870|454434233|FG000|Overall Study|Adverse Event|9|||
126312553|NCT03197870|454434234|FG001|Overall Study|Adverse Event|4|||
126312554|NCT03197870|454434235|FG002|Overall Study|Adverse Event|6|||
126312555|NCT03197870|454434233|FG000|Overall Study|Withdrawal by Subject|2|||
126312556|NCT03197870|454434234|FG001|Overall Study|Withdrawal by Subject|3|||
126312557|NCT03197870|454434235|FG002|Overall Study|Withdrawal by Subject|0|||
126312558|NCT03197870|454434233|FG000|Overall Study|Lost to Follow-up|2|||
126312559|NCT03197870|454434234|FG001|Overall Study|Lost to Follow-up|2|||
126312560|NCT03197870|454434235|FG002|Overall Study|Lost to Follow-up|0|||
126312561|NCT03197870|454434233|FG000|Overall Study|data not available|1|||
126312562|NCT03197870|454434234|FG001|Overall Study|data not available|1|||
126312563|NCT03197870|454434235|FG002|Overall Study|data not available|0|||
126312564|NCT01618019|454434237|FG000|Overall Study|Withdrawal by Subject|14|||
126312565|NCT01618019|454434238|FG001|Overall Study|Withdrawal by Subject|14|||
126312566|NCT01542034|454434239|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
126312567|NCT01542034|454434240|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
126312568|NCT01542034|454434239|FG000|Overall Study|Administrative decision|0|||
126312569|NCT01542034|454434240|FG001|Overall Study|Administrative decision|3|||
126312570|NCT01542034|454434239|FG000|Overall Study|Subject Noncompliance|1|||
126312571|NCT01542034|454434240|FG001|Overall Study|Subject Noncompliance|0|||
126312572|NCT01542034|454434239|FG000|Overall Study|Adverse Event|2|||
126312573|NCT01542034|454434240|FG001|Overall Study|Adverse Event|2|||
126312574|NCT01542034|454434239|FG000|Overall Study|Lost to Follow-up|7|||
126312575|NCT01542034|454434240|FG001|Overall Study|Lost to Follow-up|6|||
126312576|NCT02612610|454434241|FG000|Overall Study|Withdrawal by Subject|1|||
126312577|NCT02612610|454434242|FG001|Overall Study|Withdrawal by Subject|1|||
126312578|NCT02612610|454434243|FG002|Overall Study|Withdrawal by Subject|0|||
126312579|NCT02612610|454434244|FG003|Overall Study|Withdrawal by Subject|2|||
126312580|NCT02612610|454434241|FG000|Overall Study|Adverse Event|2|||
126312581|NCT02612610|454434242|FG001|Overall Study|Adverse Event|2|||
126312582|NCT02612610|454434243|FG002|Overall Study|Adverse Event|3|||
126312583|NCT02612610|454434244|FG003|Overall Study|Adverse Event|10|||
126312584|NCT02612610|454434241|FG000|Overall Study|Lost to Follow-up|0|||
126312585|NCT02612610|454434242|FG001|Overall Study|Lost to Follow-up|1|||
126312586|NCT02612610|454434243|FG002|Overall Study|Lost to Follow-up|0|||
126312587|NCT02612610|454434244|FG003|Overall Study|Lost to Follow-up|0|||
126312588|NCT02612610|454434241|FG000|Overall Study|Protocol Violation|0|||
126312589|NCT02612610|454434242|FG001|Overall Study|Protocol Violation|1|||
126312590|NCT02612610|454434243|FG002|Overall Study|Protocol Violation|1|||
126312591|NCT02612610|454434244|FG003|Overall Study|Protocol Violation|0|||
126312592|NCT02612610|454434241|FG000|Overall Study|Lack of Efficacy|1|||
126312593|NCT02612610|454434242|FG001|Overall Study|Lack of Efficacy|2|||
126312594|NCT02612610|454434243|FG002|Overall Study|Lack of Efficacy|0|||
126312595|NCT02612610|454434244|FG003|Overall Study|Lack of Efficacy|1|||
126312596|NCT02612610|454434241|FG000|Overall Study|Physician Decision|0|||
126312597|NCT02612610|454434242|FG001|Overall Study|Physician Decision|1|||
126312598|NCT02612610|454434243|FG002|Overall Study|Physician Decision|0|||
126312599|NCT02612610|454434244|FG003|Overall Study|Physician Decision|0|||
126312600|NCT02612610|454434241|FG000|Overall Study|Noncompliance|1|||
126312601|NCT02612610|454434242|FG001|Overall Study|Noncompliance|0|||
126312602|NCT02612610|454434243|FG002|Overall Study|Noncompliance|0|||
126312603|NCT02612610|454434244|FG003|Overall Study|Noncompliance|0|||
126312604|NCT02612610|454434241|FG000|Overall Study|Cough Improvement|0|||
126312605|NCT02612610|454434242|FG001|Overall Study|Cough Improvement|0|||
126312606|NCT02612610|454434243|FG002|Overall Study|Cough Improvement|1|||
126312607|NCT02612610|454434244|FG003|Overall Study|Cough Improvement|0|||
126312608|NCT01801280|454434245|FG000|Period 1|Withdrawal by Subject|0|||
126312609|NCT01801280|454434246|FG001|Period 1|Withdrawal by Subject|1|||
126312610|NCT01801280|454434247|FG002|Period 1|Withdrawal by Subject|0|||
126312611|NCT01801280|454434248|FG003|Period 1|Withdrawal by Subject|0|||
126312612|NCT01801280|454434245|FG000|Period 2|Withdrawal by Subject|1|||
126312613|NCT01801280|454434246|FG001|Period 2|Withdrawal by Subject|0|||
126312614|NCT01801280|454434247|FG002|Period 2|Withdrawal by Subject|0|||
126312615|NCT01801280|454434248|FG003|Period 2|Withdrawal by Subject|0|||
126312616|NCT01801280|454434245|FG000|Period 4|Protocol Violation|0|||
126312617|NCT01801280|454434246|FG001|Period 4|Protocol Violation|0|||
126312618|NCT01801280|454434247|FG002|Period 4|Protocol Violation|1|||
126312619|NCT01801280|454434248|FG003|Period 4|Protocol Violation|0|||
126312620|NCT00176644|454434249|FG000|Overall Study|Withdrawal by Subject|1|||
126312621|NCT02783729|454434250|FG000|Overall Study|Lack of Efficacy|1|||
126312622|NCT02783729|454434251|FG001|Overall Study|Lack of Efficacy|0|||
126312623|NCT02783729|454434252|FG002|Overall Study|Lack of Efficacy|0|||
126312624|NCT02783729|454434253|FG003|Overall Study|Lack of Efficacy|0|||
126312625|NCT02783729|454434250|FG000|Overall Study|Adverse Event|2|||
126312626|NCT02783729|454434251|FG001|Overall Study|Adverse Event|6|||
126312627|NCT02783729|454434252|FG002|Overall Study|Adverse Event|2|||
126312628|NCT02783729|454434253|FG003|Overall Study|Adverse Event|3|||
126312629|NCT02783729|454434250|FG000|Overall Study|Other|1|||
126312630|NCT02783729|454434251|FG001|Overall Study|Other|6|||
126312631|NCT02783729|454434252|FG002|Overall Study|Other|2|||
126312632|NCT02783729|454434253|FG003|Overall Study|Other|3|||
126312633|NCT02783729|454434250|FG000|Overall Study|Withdrawal by Subject|2|||
126312634|NCT02783729|454434251|FG001|Overall Study|Withdrawal by Subject|3|||
126312635|NCT02783729|454434252|FG002|Overall Study|Withdrawal by Subject|1|||
126312636|NCT02783729|454434253|FG003|Overall Study|Withdrawal by Subject|2|||
126312637|NCT02783729|454434250|FG000|Overall Study|Participant's choice|2|||
126312638|NCT02783729|454434251|FG001|Overall Study|Participant's choice|1|||
126312639|NCT02783729|454434252|FG002|Overall Study|Participant's choice|2|||
126312640|NCT02783729|454434253|FG003|Overall Study|Participant's choice|1|||
126312641|NCT02783729|454434250|FG000|Overall Study|Lost to Follow-up|2|||
126312642|NCT02783729|454434251|FG001|Overall Study|Lost to Follow-up|1|||
126312643|NCT02783729|454434252|FG002|Overall Study|Lost to Follow-up|1|||
126312644|NCT02783729|454434253|FG003|Overall Study|Lost to Follow-up|0|||
126312645|NCT02693171|454434254|FG000|Overall Study|Adverse Event|1|||
126312646|NCT02693171|454434254|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
126312647|NCT01866657|454434262|FG000|Overall Study|Surgery canceled|2|||
126312648|NCT01866657|454434263|FG001|Overall Study|Surgery canceled|0|||
126312649|NCT04021121|454434271|FG000|Overall Study|Death|3|||
126312650|NCT04021121|454434272|FG001|Overall Study|Death|3|||
126312651|NCT04021121|454434273|FG002|Overall Study|Death|5|||
126312652|NCT04021121|454434274|FG003|Overall Study|Death|4|||
126312653|NCT02288091|454434275|FG000|Overall Study|Lost to Follow-up|1|||
126312654|NCT02288091|454434275|FG000|Overall Study|Screen fail|7|||
126312655|NCT00978250|454434280|FG000|Overall Study|Late determination of ineligibility|0|||
126312656|NCT00978250|454434281|FG001|Overall Study|Late determination of ineligibility|1|||
126312657|NCT00978250|454434282|FG002|Overall Study|Late determination of ineligibility|0|||
126312658|NCT00978250|454434283|FG003|Overall Study|Late determination of ineligibility|1|||
126312659|NCT05174949|454434288|FG000|Overall Study|Physician Decision|1|||
126312660|NCT05174949|454434289|FG001|Overall Study|Physician Decision|2|||
126312661|NCT05174949|454434290|FG002|Overall Study|Physician Decision|0|||
126312662|NCT05174949|454434291|FG003|Overall Study|Physician Decision|1|||
126312663|NCT05174949|454434292|FG004|Overall Study|Physician Decision|0|||
126312664|NCT05174949|454434293|FG005|Overall Study|Physician Decision|0|||
126312665|NCT05174949|454434288|FG000|Overall Study|Withdrawal by Subject|0|||
126312666|NCT05174949|454434289|FG001|Overall Study|Withdrawal by Subject|1|||
126312667|NCT05174949|454434290|FG002|Overall Study|Withdrawal by Subject|0|||
126312668|NCT05174949|454434291|FG003|Overall Study|Withdrawal by Subject|0|||
126202492|NCT01716585|454027499|FG000|Double-blind Treatment|Lost to Follow-up|2|||
126312669|NCT05174949|454434292|FG004|Overall Study|Withdrawal by Subject|0|||
126312670|NCT05174949|454434293|FG005|Overall Study|Withdrawal by Subject|0|||
126312671|NCT05174949|454434288|FG000|Overall Study|Lost to Follow-up|0|||
126312672|NCT05174949|454434289|FG001|Overall Study|Lost to Follow-up|0|||
126312673|NCT05174949|454434290|FG002|Overall Study|Lost to Follow-up|0|||
126312674|NCT05174949|454434291|FG003|Overall Study|Lost to Follow-up|1|||
126312675|NCT05174949|454434292|FG004|Overall Study|Lost to Follow-up|0|||
126312676|NCT05174949|454434293|FG005|Overall Study|Lost to Follow-up|0|||
126312677|NCT02029989|454434294|FG000|Overall Study|Withdrawal by Subject|1|||
126312678|NCT02029989|454434295|FG001|Overall Study|Withdrawal by Subject|0|||
126312679|NCT02029989|454434294|FG000|Overall Study|Withdrawal: Fear of needles|1|||
126312680|NCT02029989|454434295|FG001|Overall Study|Withdrawal: Fear of needles|0|||
126312681|NCT02029989|454434294|FG000|Overall Study|Change of location|2|||
126312682|NCT02029989|454434295|FG001|Overall Study|Change of location|3|||
126312683|NCT02029989|454434294|FG000|Overall Study|Physician Decision|2|||
126312684|NCT02029989|454434295|FG001|Overall Study|Physician Decision|0|||
126312685|NCT02029989|454434294|FG000|Overall Study|Lost to Follow-up|9|||
126312686|NCT02029989|454434295|FG001|Overall Study|Lost to Follow-up|7|||
126312687|NCT02029989|454434294|FG000|Overall Study|Death|0|||
126312688|NCT02029989|454434295|FG001|Overall Study|Death|1|||
126312689|NCT02029989|454434294|FG000|Overall Study|Protocol Violation|1|||
126312690|NCT02029989|454434295|FG001|Overall Study|Protocol Violation|0|||
126312691|NCT04351373|454434296|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
126312692|NCT02880865|454434298|FG000|Overall Study|Adverse Event|1|||
126312693|NCT02880865|454434299|FG001|Overall Study|Adverse Event|0|||
126422637|NCT02800863|454842662|FG000|Overall Study|Adverse Event|14|||
126422638|NCT02800863|454842662|FG000|Overall Study|Another Device Implanted|1|||
126422639|NCT02800863|454842662|FG000|Overall Study|Device Explanted|1|||
126422640|NCT02800863|454842662|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
126422641|NCT02800863|454842662|FG000|Overall Study|Health Issues|1|||
126422642|NCT02800863|454842662|FG000|Overall Study|Insurance Denial|8|||
126422643|NCT02800863|454842662|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
126422644|NCT02800863|454842662|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
126422645|NCT02800863|454842662|FG000|Overall Study|Screen Failure|1|||
126422646|NCT02800863|454842662|FG000|Overall Study|Sponsor Request|6|||
126422647|NCT02800863|454842662|FG000|Overall Study|Death|3|||
126422648|NCT02800863|454842662|FG000|Overall Study|Subject Implant at Another Facility|1|||
126422649|NCT02800863|454842662|FG000|Overall Study|Lost to Follow-up|26|||
126422650|NCT02800863|454842662|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
126422651|NCT02800863|454842662|FG000|Overall Study|Subject and/or Family Request|64|||
126422652|NCT02800863|454842662|FG000|Overall Study|Trial Failure|81|||
126422653|NCT02800863|454842662|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
126422654|NCT00279916|454842663|FG000|Overall Study|Withdrawal by Subject|4|||
126422655|NCT00279916|454842664|FG001|Overall Study|Withdrawal by Subject|3|||
126422656|NCT00279916|454842663|FG000|Overall Study|Lost to Follow-up|3|||
126422657|NCT00279916|454842664|FG001|Overall Study|Lost to Follow-up|2|||
126422658|NCT01807598|454842665|FG000|Overall Study|Withdrawal by Subject|4|||
126422659|NCT01807598|454842665|FG000|Overall Study|Adverse Event|1|||
126422660|NCT01807598|454842665|FG000|Overall Study|Other Physician Decision|1|||
126422661|NCT02717494|454842667|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
125885140|NCT00815659|452876786|FG000|Overall Study|Withdrawal by Subject|9|||
125885141|NCT00815659|452876786|FG000|Overall Study|Lost to Follow-up|4|||
125885142|NCT00815659|452876786|FG000|Overall Study|Protocol Violation|1|||
125885143|NCT02395471|452876787|FG000|Overall Study|Lost to Follow-up|2|||
125885144|NCT02395471|452876788|FG001|Overall Study|Lost to Follow-up|0|||
125885145|NCT02395471|452876787|FG000|Overall Study|Withdrawal by Subject|2|||
125885146|NCT02395471|452876788|FG001|Overall Study|Withdrawal by Subject|1|||
125885147|NCT02395471|452876787|FG000|Overall Study|Physician Decision|1|||
125885148|NCT02395471|452876788|FG001|Overall Study|Physician Decision|0|||
125885149|NCT02395471|452876787|FG000|Overall Study|Protocol Violation|0|||
125885150|NCT02395471|452876788|FG001|Overall Study|Protocol Violation|1|||
125885151|NCT02395471|452876787|FG000|Overall Study|Failure to swollow sponge twice|1|||
125885152|NCT02395471|452876788|FG001|Overall Study|Failure to swollow sponge twice|0|||
125885153|NCT02395471|452876787|FG000|Overall Study|Patient did not return for procedure|0|||
125885154|NCT02395471|452876788|FG001|Overall Study|Patient did not return for procedure|1|||
125885155|NCT02395471|452876787|FG000|Overall Study|Subject not eligible|1|||
125885156|NCT02395471|452876788|FG001|Overall Study|Subject not eligible|0|||
125885157|NCT03847896|452876789|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
126202493|NCT01716585|454027500|FG001|Double-blind Treatment|Lost to Follow-up|0|||
126202494|NCT01716585|454027499|FG000|Double-blind Treatment|Subject Noncompliant|1|||
126202495|NCT01716585|454027500|FG001|Double-blind Treatment|Subject Noncompliant|0|||
126202496|NCT01716585|454027499|FG000|Double-blind Treatment|Other|1|||
126202497|NCT01716585|454027500|FG001|Double-blind Treatment|Other|0|||
126202498|NCT01716585|454027499|FG000|Open-label Treatment|Adverse Event|0|||
126202499|NCT01716585|454027500|FG001|Open-label Treatment|Adverse Event|2|||
125885158|NCT03847896|452876790|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125885159|NCT03847896|452876791|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
125885160|NCT03847896|452876792|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125978651|NCT00862134|453209811|FG000|Overall Study|Sponsor terminated study|5|||
126306058|NCT02553499|454408872|FG003|Overall Study|Physician Decision|0|||
126312694|NCT02880865|454434298|FG000|Overall Study|Withdrawal by Subject|0|||
126312695|NCT02880865|454434299|FG001|Overall Study|Withdrawal by Subject|2|||
126312696|NCT02880865|454434298|FG000|Overall Study|Physician Decision|0|||
126312697|NCT02880865|454434299|FG001|Overall Study|Physician Decision|1|||
126312698|NCT01446237|454434302|FG000|Overall Study|Adverse Event|1|||
126312699|NCT01446237|454434302|FG000|Overall Study|Lost to Follow-up|2|||
126312700|NCT01446237|454434302|FG000|Overall Study|Withdrawal by Subject|7|||
126312701|NCT03634033|454435905|FG000|Overall Study|Did not have a post-assessment|384|||
126312702|NCT03634033|454435906|FG001|Overall Study|Did not have a post-assessment|291|||
126312703|NCT03634033|454435907|FG002|Overall Study|Did not have a post-assessment|114|||
126312704|NCT03634033|454435908|FG003|Overall Study|Did not have a post-assessment|161|||
126312705|NCT03634033|454435909|FG004|Overall Study|Did not have a post-assessment|5|||
126312706|NCT03634033|454435910|FG005|Overall Study|Did not have a post-assessment|0|||
126312707|NCT03634033|454435911|FG006|Overall Study|Did not have a post-assessment|0|||
126312708|NCT03634033|454435905|FG000|Overall Study|Death|0|||
126312709|NCT03634033|454435906|FG001|Overall Study|Death|0|||
126312710|NCT03634033|454435907|FG002|Overall Study|Death|0|||
126312711|NCT03634033|454435908|FG003|Overall Study|Death|0|||
126312712|NCT03634033|454435909|FG004|Overall Study|Death|0|||
126312713|NCT03634033|454435910|FG005|Overall Study|Death|7|||
126312714|NCT03634033|454435911|FG006|Overall Study|Death|7|||
126312715|NCT03634033|454435905|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312716|NCT03634033|454435906|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312717|NCT03634033|454435907|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312718|NCT03634033|454435908|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312719|NCT03634033|454435909|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312720|NCT03634033|454435910|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
126312721|NCT03634033|454435911|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
126312722|NCT03634033|454435905|FG000|Overall Study|Lost to Follow-up|0|||
126312723|NCT03634033|454435906|FG001|Overall Study|Lost to Follow-up|0|||
126312724|NCT03634033|454435907|FG002|Overall Study|Lost to Follow-up|0|||
126312725|NCT03634033|454435908|FG003|Overall Study|Lost to Follow-up|0|||
126312726|NCT03634033|454435909|FG004|Overall Study|Lost to Follow-up|0|||
126312727|NCT03634033|454435910|FG005|Overall Study|Lost to Follow-up|1|||
126312728|NCT03634033|454435911|FG006|Overall Study|Lost to Follow-up|2|||
126312729|NCT03634033|454435905|FG000|Overall Study|Withdrawal by Subject|0|||
126312730|NCT03634033|454435906|FG001|Overall Study|Withdrawal by Subject|0|||
126312731|NCT03634033|454435907|FG002|Overall Study|Withdrawal by Subject|0|||
126312732|NCT03634033|454435908|FG003|Overall Study|Withdrawal by Subject|0|||
126312733|NCT03634033|454435909|FG004|Overall Study|Withdrawal by Subject|0|||
126312734|NCT03634033|454435910|FG005|Overall Study|Withdrawal by Subject|0|||
126312735|NCT03634033|454435911|FG006|Overall Study|Withdrawal by Subject|1|||
126312736|NCT06366087|454435912|FG000|Overall Study|Withdrawal by Subject|0|||
126312737|NCT06366087|454435913|FG001|Overall Study|Withdrawal by Subject|1|||
126312738|NCT01944670|454435917|FG000|Overall Study|Lost to Follow-up|2|||
126312739|NCT00743288|454435918|FG000|Overall Study|Adverse Event|1|||
126312740|NCT00743288|454435919|FG001|Overall Study|Adverse Event|1|||
126312741|NCT00743288|454435920|FG002|Overall Study|Adverse Event|2|||
126312742|NCT00743288|454435921|FG003|Overall Study|Adverse Event|2|||
126312743|NCT00743288|454435922|FG004|Overall Study|Adverse Event|1|||
126312744|NCT00743288|454435923|FG005|Overall Study|Adverse Event|1|||
126312745|NCT00743288|454435924|FG006|Overall Study|Adverse Event|2|||
126312746|NCT00743288|454435918|FG000|Overall Study|Withdrawal by Subject|0|||
126312747|NCT00743288|454435919|FG001|Overall Study|Withdrawal by Subject|0|||
126312748|NCT00743288|454435920|FG002|Overall Study|Withdrawal by Subject|1|||
126312749|NCT00743288|454435921|FG003|Overall Study|Withdrawal by Subject|0|||
125978652|NCT00862134|453209812|FG001|Overall Study|Sponsor terminated study|7|||
125978653|NCT00862134|453209811|FG000|Overall Study|Adverse Event|2|||
125978654|NCT00862134|453209812|FG001|Overall Study|Adverse Event|2|||
125978655|NCT00862134|453209811|FG000|Overall Study|Withdrew prior to dosing|2|||
125978656|NCT00862134|453209812|FG001|Overall Study|Withdrew prior to dosing|0|||
125978657|NCT02191267|453209813|FG000|Overall Study|Withdrawal by Subject|1|||
125978658|NCT02191267|453209814|FG001|Overall Study|Withdrawal by Subject|0|||
125978659|NCT02191267|453209815|FG002|Overall Study|Withdrawal by Subject|0|||
125978660|NCT00765674|453209816|FG000|Overall Study|Adverse Event|7|||
125978661|NCT00765674|453209817|FG001|Overall Study|Adverse Event|2|||
125978662|NCT00765674|453209818|FG002|Overall Study|Adverse Event|8|||
125978663|NCT00765674|453209819|FG003|Overall Study|Adverse Event|11|||
125978664|NCT00765674|453209816|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
125978665|NCT00765674|453209817|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
125978666|NCT00765674|453209818|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
125978667|NCT00765674|453209819|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
126089399|NCT02942277|453621407|FG007|Year 1|Withdrawal by Subject|1|||
126089400|NCT02942277|453621408|FG008|Year 1|Withdrawal by Subject|0|||
126312750|NCT00743288|454435922|FG004|Overall Study|Withdrawal by Subject|0|||
126312751|NCT00743288|454435923|FG005|Overall Study|Withdrawal by Subject|1|||
126312752|NCT00743288|454435924|FG006|Overall Study|Withdrawal by Subject|1|||
126312753|NCT00743288|454435918|FG000|Overall Study|Progressive disease (PD)|2|||
126202500|NCT01716585|454027499|FG000|Open-label Treatment|Virologic Failure|0|||
126202501|NCT01716585|454027500|FG001|Open-label Treatment|Virologic Failure|2|||
126202502|NCT01716585|454027499|FG000|Open-label Treatment|Withdrawal by Subject|0|||
126202503|NCT01716585|454027500|FG001|Open-label Treatment|Withdrawal by Subject|3|||
126202504|NCT00761891|454027501|FG000|Overall Study|Withdrawal by Subject|10|||
126202505|NCT01707667|454027502|FG000|Period 1|expulsion of colonic sensor catheter|1|||
126202506|NCT01707667|454027503|FG001|Period 1|expulsion of colonic sensor catheter|0|||
126202507|NCT04382066|454027510|FG000|Overall Study|Adverse Event|1|||
126202508|NCT04382066|454027511|FG001|Overall Study|Adverse Event|0|||
126312754|NCT00743288|454435919|FG001|Overall Study|Progressive disease (PD)|0|||
126312755|NCT00743288|454435920|FG002|Overall Study|Progressive disease (PD)|1|||
126312756|NCT00743288|454435921|FG003|Overall Study|Progressive disease (PD)|4|||
126312757|NCT00743288|454435922|FG004|Overall Study|Progressive disease (PD)|5|||
126312758|NCT00743288|454435923|FG005|Overall Study|Progressive disease (PD)|3|||
126312759|NCT00743288|454435924|FG006|Overall Study|Progressive disease (PD)|6|||
126312760|NCT00743288|454435918|FG000|Overall Study|Worsening of condition (Not PD)|0|||
126312761|NCT00743288|454435919|FG001|Overall Study|Worsening of condition (Not PD)|2|||
126312762|NCT00743288|454435920|FG002|Overall Study|Worsening of condition (Not PD)|1|||
126312763|NCT00743288|454435921|FG003|Overall Study|Worsening of condition (Not PD)|1|||
126312764|NCT00743288|454435922|FG004|Overall Study|Worsening of condition (Not PD)|0|||
126312765|NCT00743288|454435923|FG005|Overall Study|Worsening of condition (Not PD)|0|||
126312766|NCT00743288|454435924|FG006|Overall Study|Worsening of condition (Not PD)|0|||
126312767|NCT05903924|454435925|FG000|Overall Study|Lost to Follow-up|1|||
126312768|NCT05903924|454435926|FG001|Overall Study|Lost to Follow-up|0|||
126312769|NCT05903924|454435927|FG002|Overall Study|Lost to Follow-up|0|||
126312770|NCT04338269|454435928|FG000|Overall Study|Death|86|||
126312771|NCT04338269|454435929|FG001|Overall Study|Death|89|||
126312772|NCT04338269|454435928|FG000|Overall Study|Lost to Follow-up|1|||
126312773|NCT04338269|454435929|FG001|Overall Study|Lost to Follow-up|2|||
126312774|NCT04338269|454435928|FG000|Overall Study|Physician Decision|1|||
126312775|NCT04338269|454435929|FG001|Overall Study|Physician Decision|0|||
126312776|NCT04338269|454435928|FG000|Overall Study|Withdrawal by Subject|14|||
126312777|NCT04338269|454435929|FG001|Overall Study|Withdrawal by Subject|11|||
126312778|NCT04166591|454435934|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
126312779|NCT04166591|454435935|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
126312780|NCT04166591|454435936|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126312781|NCT04166591|454435937|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126312782|NCT04166591|454435934|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
126312783|NCT04166591|454435935|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
126312784|NCT04166591|454435936|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126312785|NCT04166591|454435937|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126312786|NCT02730377|454435938|FG000|Overall Study|Other|5|||
126312787|NCT02730377|454435939|FG001|Overall Study|Other|4|||
126312788|NCT02730377|454435938|FG000|Overall Study|Death|1|||
126312789|NCT02730377|454435939|FG001|Overall Study|Death|8|||
126312790|NCT02730377|454435938|FG000|Overall Study|Inadequate glycaemic control|368|||
126312791|NCT02730377|454435939|FG001|Overall Study|Inadequate glycaemic control|473|||
126312792|NCT02730377|454435938|FG000|Overall Study|Adverse Event|79|||
126312793|NCT02730377|454435939|FG001|Overall Study|Adverse Event|41|||
126312794|NCT02730377|454435938|FG000|Overall Study|Protocol Violation|23|||
126312795|NCT02730377|454435939|FG001|Overall Study|Protocol Violation|30|||
126312796|NCT02730377|454435938|FG000|Overall Study|Lack of Efficacy|4|||
126312797|NCT02730377|454435939|FG001|Overall Study|Lack of Efficacy|13|||
126312798|NCT02730377|454435938|FG000|Overall Study|Pregnancy|0|||
126312799|NCT02730377|454435939|FG001|Overall Study|Pregnancy|1|||
126312800|NCT02730377|454435938|FG000|Overall Study|Withdrawal by Subject|45|||
126312801|NCT02730377|454435939|FG001|Overall Study|Withdrawal by Subject|42|||
126312802|NCT02730377|454435938|FG000|Overall Study|Lost to Follow-up|25|||
126312803|NCT02730377|454435939|FG001|Overall Study|Lost to Follow-up|21|||
126312804|NCT02203851|454435942|FG000|Overall Study|Lost to Follow-up|4|||
126312805|NCT02203851|454435942|FG000|Overall Study|Withdrawal by Subject|6|||
126312806|NCT02203851|454435942|FG000|Overall Study|Other|1|||
126202509|NCT04382066|454027512|FG002|Overall Study|Adverse Event|0|||
126202510|NCT04382066|454027510|FG000|Overall Study|Death|1|||
126312807|NCT04045132|454435945|FG000|Overall Study|Lost to Follow-up|3|||
126312808|NCT04045132|454435946|FG001|Overall Study|Lost to Follow-up|6|||
126312809|NCT01054300|454435956|FG000|Period 1|Adverse Event|1|||
126312810|NCT01054300|454435957|FG001|Period 1|Adverse Event|0|||
126312811|NCT01054300|454435958|FG002|Period 1|Adverse Event|0|||
126312812|NCT01054300|454435959|FG003|Period 1|Adverse Event|0|||
126312813|NCT01054300|454435956|FG000|Period 2|Withdrawal by Subject|0|||
126312814|NCT01054300|454435957|FG001|Period 2|Withdrawal by Subject|0|||
126312815|NCT01054300|454435958|FG002|Period 2|Withdrawal by Subject|1|||
126312816|NCT01054300|454435959|FG003|Period 2|Withdrawal by Subject|0|||
126312817|NCT04186806|454435967|FG000|Period 1: 7 Days|Adverse Event|1|||
126312818|NCT04186806|454435968|FG001|Period 1: 7 Days|Adverse Event|0|||
126312819|NCT00177307|454435969|FG000|Overall Study|Withdrawal by Subject|1|||
126312820|NCT02677038|454435973|FG000|Overall Study|Physician Decision|1|||
126312821|NCT02677038|454435973|FG000|Overall Study|Withdrawal by Subject|1|||
126312822|NCT03671564|454435974|FG000|Overall Study|Progressive Disease|3|||
126312823|NCT03671564|454435975|FG001|Overall Study|Progressive Disease|5|||
126312824|NCT03671564|454435976|FG002|Overall Study|Progressive Disease|3|||
126312825|NCT03671564|454435974|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
126422662|NCT02717494|454842668|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
126422663|NCT02717494|454842669|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
126422664|NCT02717494|454842667|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
126422665|NCT02717494|454842668|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
126422666|NCT02717494|454842669|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
126422667|NCT02717494|454842667|FG000|First Intervention (Step 1)|Death|0|||
126422668|NCT02717494|454842668|FG001|First Intervention (Step 1)|Death|0|||
126422669|NCT02717494|454842669|FG002|First Intervention (Step 1)|Death|1|||
126422670|NCT02717494|454842667|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
126422671|NCT02717494|454842668|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
126422672|NCT02717494|454842669|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
126422673|NCT00731679|454842672|FG000|Overall Study|Adverse Event|7|||
126422674|NCT00731679|454842673|FG001|Overall Study|Adverse Event|8|||
126422675|NCT00731679|454842672|FG000|Overall Study|Withdrawal by Subject|8|||
126422676|NCT00731679|454842673|FG001|Overall Study|Withdrawal by Subject|8|||
126422677|NCT00731679|454842672|FG000|Overall Study|Lost to Follow-up|7|||
126422678|NCT00731679|454842673|FG001|Overall Study|Lost to Follow-up|8|||
126422679|NCT00731679|454842672|FG000|Overall Study|Noncompliance|0|||
126422680|NCT00731679|454842673|FG001|Overall Study|Noncompliance|1|||
126422681|NCT00731679|454842672|FG000|Overall Study|Pregnancy|0|||
126422682|NCT00731679|454842673|FG001|Overall Study|Pregnancy|1|||
126422683|NCT02488005|454842674|FG000|Overall Study|Lost to Follow-up|2|||
126422684|NCT02326597|454842677|FG000|Overall Study|Lost to Follow-up|42|||
126422685|NCT02326597|454842678|FG001|Overall Study|Lost to Follow-up|32|||
126422686|NCT04089761|454842681|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
126422687|NCT04089761|454842681|FG000|"Run In Phase"|Lost to Follow-up|1|||
126422688|NCT04089761|454842681|FG000|"Treatment Phase"|No evaluable data|5|||
126422689|NCT04089761|454842681|FG000|"Treatment Phase"|Lost to Follow-up|1|||
126422690|NCT04739436|454842683|FG000|Overall Study|Lost to Follow-up|21|||
126422691|NCT04739436|454842684|FG001|Overall Study|Lost to Follow-up|23|||
126422692|NCT04739436|454842683|FG000|Overall Study|Withdrawal by Subject|4|||
126422693|NCT04739436|454842684|FG001|Overall Study|Withdrawal by Subject|6|||
126422694|NCT04739436|454842683|FG000|Overall Study|not randomized properly|1|||
126422695|NCT04739436|454842684|FG001|Overall Study|not randomized properly|0|||
126422696|NCT00428948|454842686|FG000|Overall Study|Lost to Follow-up|15|||
126422697|NCT00428948|454842687|FG001|Overall Study|Lost to Follow-up|8|||
126422698|NCT00428948|454842686|FG000|Overall Study|Adverse Event|148|||
126422699|NCT00428948|454842687|FG001|Overall Study|Adverse Event|24|||
126422700|NCT00428948|454842686|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
126422701|NCT00428948|454842687|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
126422702|NCT00428948|454842686|FG000|Overall Study|Investigator Withdrew Subject|3|||
126422703|NCT00428948|454842687|FG001|Overall Study|Investigator Withdrew Subject|4|||
126422704|NCT00428948|454842686|FG000|Overall Study|Subject Withdrew Consent|50|||
126422705|NCT00428948|454842687|FG001|Overall Study|Subject Withdrew Consent|30|||
126422706|NCT00428948|454842686|FG000|Overall Study|Protocol Deviation|1|||
126422707|NCT00428948|454842687|FG001|Overall Study|Protocol Deviation|1|||
126422708|NCT04965688|454842693|FG000|Overall Study|Withdrawal by Subject|2|||
126422709|NCT05864586|454842694|FG000|Overall Study|Ineligible|4|||
126422710|NCT05864586|454842695|FG001|Overall Study|Ineligible|12|||
126422711|NCT05864586|454842694|FG000|Overall Study|Pregnancy|0|||
126422712|NCT05864586|454842695|FG001|Overall Study|Pregnancy|1|||
126422713|NCT05864586|454842694|FG000|Overall Study|Withdrawal by Subject|0|||
126422714|NCT05864586|454842695|FG001|Overall Study|Withdrawal by Subject|1|||
126422715|NCT00319254|454842699|FG000|Overall Study|Withdrawal by Subject|4|||
126422716|NCT00319254|454842699|FG000|Overall Study|Death|46|||
126422717|NCT00319254|454842699|FG000|Overall Study|Lost to Follow-up|2|||
126422718|NCT00319254|454842699|FG000|Overall Study|Enrolled, Not Treated|2|||
126422719|NCT01505374|454842700|FG000|Overall Study|Lost to Follow-up|1|||
126422720|NCT01505374|454842701|FG001|Overall Study|Lost to Follow-up|0|||
126422721|NCT02452424|454842702|FG000|Overall Study|Death|2|||
126422722|NCT02452424|454842703|FG001|Overall Study|Death|2|||
126422723|NCT02452424|454842704|FG002|Overall Study|Death|2|||
126422724|NCT02452424|454842705|FG003|Overall Study|Death|6|||
126422725|NCT02452424|454842706|FG004|Overall Study|Death|2|||
126422726|NCT02452424|454842707|FG005|Overall Study|Death|0|||
126422727|NCT02452424|454842708|FG006|Overall Study|Death|5|||
126422728|NCT02452424|454842709|FG007|Overall Study|Death|1|||
126422729|NCT02452424|454842710|FG008|Overall Study|Death|3|||
126422730|NCT02452424|454842711|FG009|Overall Study|Death|1|||
126422731|NCT02452424|454842712|FG010|Overall Study|Death|0|||
126422732|NCT02452424|454842702|FG000|Overall Study|Lost to Follow-up|0|||
126422733|NCT02452424|454842703|FG001|Overall Study|Lost to Follow-up|1|||
126422734|NCT02452424|454842704|FG002|Overall Study|Lost to Follow-up|1|||
126422735|NCT02452424|454842705|FG003|Overall Study|Lost to Follow-up|0|||
126422736|NCT02452424|454842706|FG004|Overall Study|Lost to Follow-up|0|||
126422737|NCT02452424|454842707|FG005|Overall Study|Lost to Follow-up|0|||
126422738|NCT02452424|454842708|FG006|Overall Study|Lost to Follow-up|0|||
126422739|NCT02452424|454842709|FG007|Overall Study|Lost to Follow-up|0|||
126422740|NCT02452424|454842710|FG008|Overall Study|Lost to Follow-up|0|||
126422741|NCT02452424|454842711|FG009|Overall Study|Lost to Follow-up|0|||
126422742|NCT02452424|454842712|FG010|Overall Study|Lost to Follow-up|0|||
126422743|NCT02452424|454842702|FG000|Overall Study|Withdrawal by Subject|0|||
126422744|NCT02452424|454842703|FG001|Overall Study|Withdrawal by Subject|0|||
126422745|NCT02452424|454842704|FG002|Overall Study|Withdrawal by Subject|3|||
126422746|NCT02452424|454842705|FG003|Overall Study|Withdrawal by Subject|2|||
126422747|NCT02452424|454842706|FG004|Overall Study|Withdrawal by Subject|0|||
126422748|NCT02452424|454842707|FG005|Overall Study|Withdrawal by Subject|0|||
126422749|NCT02452424|454842708|FG006|Overall Study|Withdrawal by Subject|1|||
126422750|NCT02452424|454842709|FG007|Overall Study|Withdrawal by Subject|0|||
126422751|NCT02452424|454842710|FG008|Overall Study|Withdrawal by Subject|1|||
126422752|NCT02452424|454842711|FG009|Overall Study|Withdrawal by Subject|1|||
126422753|NCT02452424|454842712|FG010|Overall Study|Withdrawal by Subject|0|||
126422754|NCT02452424|454842702|FG000|Overall Study|Other|0|||
126422755|NCT02452424|454842703|FG001|Overall Study|Other|0|||
126422756|NCT02452424|454842704|FG002|Overall Study|Other|1|||
126422757|NCT02452424|454842705|FG003|Overall Study|Other|0|||
126422758|NCT02452424|454842706|FG004|Overall Study|Other|0|||
126422759|NCT02452424|454842707|FG005|Overall Study|Other|1|||
126422760|NCT02452424|454842708|FG006|Overall Study|Other|4|||
126422761|NCT02452424|454842709|FG007|Overall Study|Other|3|||
126422762|NCT02452424|454842710|FG008|Overall Study|Other|0|||
126422763|NCT02452424|454842711|FG009|Overall Study|Other|0|||
126422764|NCT02452424|454842712|FG010|Overall Study|Other|1|||
126422765|NCT02452424|454842702|FG000|Overall Study|Progressive disease (per RECIST)|0|||
126422766|NCT02452424|454842703|FG001|Overall Study|Progressive disease (per RECIST)|0|||
126422767|NCT02452424|454842704|FG002|Overall Study|Progressive disease (per RECIST)|0|||
126422768|NCT02452424|454842705|FG003|Overall Study|Progressive disease (per RECIST)|0|||
126422769|NCT02452424|454842706|FG004|Overall Study|Progressive disease (per RECIST)|0|||
126422770|NCT02452424|454842707|FG005|Overall Study|Progressive disease (per RECIST)|0|||
126422771|NCT02452424|454842708|FG006|Overall Study|Progressive disease (per RECIST)|0|||
126422772|NCT02452424|454842709|FG007|Overall Study|Progressive disease (per RECIST)|0|||
126422773|NCT02452424|454842710|FG008|Overall Study|Progressive disease (per RECIST)|2|||
126422774|NCT02452424|454842711|FG009|Overall Study|Progressive disease (per RECIST)|0|||
126422775|NCT02452424|454842712|FG010|Overall Study|Progressive disease (per RECIST)|0|||
126422776|NCT02452424|454842702|FG000|Overall Study|Adverse Event|0|||
126422777|NCT02452424|454842703|FG001|Overall Study|Adverse Event|0|||
126422778|NCT02452424|454842704|FG002|Overall Study|Adverse Event|0|||
126422779|NCT02452424|454842705|FG003|Overall Study|Adverse Event|0|||
126422780|NCT02452424|454842706|FG004|Overall Study|Adverse Event|0|||
126422781|NCT02452424|454842707|FG005|Overall Study|Adverse Event|0|||
126422782|NCT02452424|454842708|FG006|Overall Study|Adverse Event|0|||
126422783|NCT02452424|454842709|FG007|Overall Study|Adverse Event|0|||
126422784|NCT02452424|454842710|FG008|Overall Study|Adverse Event|0|||
126422785|NCT02452424|454842711|FG009|Overall Study|Adverse Event|0|||
126422786|NCT02452424|454842712|FG010|Overall Study|Adverse Event|1|||
126422787|NCT00543387|454842717|FG000|Panel 1 + Panel 2|Adverse Event|0|||
126422788|NCT00543387|454842718|FG001|Panel 1 + Panel 2|Adverse Event|1|||
126422789|NCT00543387|454842719|FG002|Panel 1 + Panel 2|Adverse Event|0|||
126422790|NCT00543387|454842720|FG003|Panel 1 + Panel 2|Adverse Event|0|||
126422791|NCT00543387|454842721|FG004|Panel 1 + Panel 2|Adverse Event|0|||
126422792|NCT00543387|454842722|FG005|Panel 1 + Panel 2|Adverse Event|0|||
126422793|NCT00543387|454842723|FG006|Panel 1 + Panel 2|Adverse Event|0|||
126422794|NCT00543387|454842724|FG007|Panel 1 + Panel 2|Adverse Event|1|||
126422795|NCT00543387|454842725|FG008|Panel 1 + Panel 2|Adverse Event|1|||
126422796|NCT00543387|454842726|FG009|Panel 1 + Panel 2|Adverse Event|0|||
126422797|NCT00543387|454842727|FG010|Panel 1 + Panel 2|Adverse Event|0|||
126422798|NCT00543387|454842717|FG000|Panel 1 + Panel 2|Physician Decision|0|||
126202511|NCT04382066|454027511|FG001|Overall Study|Death|0|||
126202512|NCT04382066|454027512|FG002|Overall Study|Death|1|||
126422799|NCT00543387|454842718|FG001|Panel 1 + Panel 2|Physician Decision|0|||
126422800|NCT00543387|454842719|FG002|Panel 1 + Panel 2|Physician Decision|1|||
126422801|NCT00543387|454842720|FG003|Panel 1 + Panel 2|Physician Decision|0|||
126202513|NCT00504595|454027513|FG000|Overall Study|Lack of Efficacy|1|||
126202514|NCT00504595|454027514|FG001|Overall Study|Lack of Efficacy|0|||
126422802|NCT00543387|454842721|FG004|Panel 1 + Panel 2|Physician Decision|0|||
126422803|NCT00543387|454842722|FG005|Panel 1 + Panel 2|Physician Decision|0|||
126202515|NCT00504595|454027515|FG002|Overall Study|Lack of Efficacy|0|||
126202516|NCT00504595|454027516|FG003|Overall Study|Lack of Efficacy|0|||
126202517|NCT00504595|454027513|FG000|Overall Study|Other|0|||
126422804|NCT00543387|454842723|FG006|Panel 1 + Panel 2|Physician Decision|0|||
126422805|NCT00543387|454842724|FG007|Panel 1 + Panel 2|Physician Decision|1|||
126422806|NCT00543387|454842725|FG008|Panel 1 + Panel 2|Physician Decision|0|||
126422807|NCT00543387|454842726|FG009|Panel 1 + Panel 2|Physician Decision|0|||
126422808|NCT00543387|454842727|FG010|Panel 1 + Panel 2|Physician Decision|0|||
126422809|NCT00543387|454842717|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
126422810|NCT00543387|454842718|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
126422811|NCT00543387|454842719|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
126422812|NCT00543387|454842720|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
126422813|NCT00543387|454842721|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
126422814|NCT00543387|454842722|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
126422815|NCT00543387|454842723|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
126422816|NCT00543387|454842724|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
126422817|NCT00543387|454842725|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
126422818|NCT00543387|454842726|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
126422819|NCT00543387|454842727|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
126422820|NCT00543387|454842717|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422821|NCT00543387|454842718|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422822|NCT00543387|454842719|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422823|NCT00543387|454842720|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422824|NCT00543387|454842721|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422825|NCT00543387|454842722|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422826|NCT00543387|454842723|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
126422827|NCT00543387|454842724|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422828|NCT00543387|454842725|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422829|NCT00543387|454842726|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422830|NCT00543387|454842727|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422831|NCT00543387|454842717|FG000|Crossover Participants|Progressive Disease|0|||
126422832|NCT00543387|454842718|FG001|Crossover Participants|Progressive Disease|0|||
126422833|NCT00543387|454842719|FG002|Crossover Participants|Progressive Disease|0|||
126422834|NCT00543387|454842720|FG003|Crossover Participants|Progressive Disease|0|||
126422835|NCT00543387|454842721|FG004|Crossover Participants|Progressive Disease|0|||
126422836|NCT00543387|454842722|FG005|Crossover Participants|Progressive Disease|0|||
126422837|NCT00543387|454842723|FG006|Crossover Participants|Progressive Disease|0|||
126422838|NCT00543387|454842724|FG007|Crossover Participants|Progressive Disease|0|||
126422839|NCT00543387|454842725|FG008|Crossover Participants|Progressive Disease|0|||
126422840|NCT00543387|454842726|FG009|Crossover Participants|Progressive Disease|1|||
126422841|NCT00543387|454842727|FG010|Crossover Participants|Progressive Disease|2|||
126422842|NCT00543387|454842717|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
126422843|NCT00543387|454842718|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
126422844|NCT00543387|454842719|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
126422845|NCT00543387|454842720|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
126422846|NCT00543387|454842721|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
126422847|NCT00543387|454842722|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
126422848|NCT00543387|454842723|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
126422849|NCT00543387|454842724|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
126422850|NCT00543387|454842725|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
126422851|NCT00543387|454842726|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
126422852|NCT00543387|454842727|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
126422853|NCT00940498|454842728|FG000|Overall Study|Death|2|||
126422854|NCT00940498|454842729|FG001|Overall Study|Death|0|||
126422855|NCT00940498|454842730|FG002|Overall Study|Death|0|||
126422856|NCT00940498|454842731|FG003|Overall Study|Death|1|||
126422857|NCT00940498|454842732|FG004|Overall Study|Death|5|||
126422858|NCT00940498|454842733|FG005|Overall Study|Death|0|||
126422859|NCT00940498|454842734|FG006|Overall Study|Death|1|||
126422860|NCT00940498|454842735|FG007|Overall Study|Death|0|||
126422861|NCT00940498|454842728|FG000|Overall Study|Lost to Follow-up|1|||
126422862|NCT00940498|454842729|FG001|Overall Study|Lost to Follow-up|1|||
126422863|NCT00940498|454842730|FG002|Overall Study|Lost to Follow-up|2|||
126422864|NCT00940498|454842731|FG003|Overall Study|Lost to Follow-up|0|||
126422865|NCT00940498|454842732|FG004|Overall Study|Lost to Follow-up|1|||
126422866|NCT00940498|454842733|FG005|Overall Study|Lost to Follow-up|0|||
126422867|NCT00940498|454842734|FG006|Overall Study|Lost to Follow-up|0|||
126422868|NCT00940498|454842735|FG007|Overall Study|Lost to Follow-up|1|||
126422869|NCT00940498|454842728|FG000|Overall Study|Disease Progression|0|||
126422870|NCT00940498|454842729|FG001|Overall Study|Disease Progression|0|||
126422871|NCT00940498|454842730|FG002|Overall Study|Disease Progression|1|||
126422872|NCT00940498|454842731|FG003|Overall Study|Disease Progression|1|||
126422873|NCT00940498|454842732|FG004|Overall Study|Disease Progression|0|||
126422874|NCT00940498|454842733|FG005|Overall Study|Disease Progression|1|||
126422875|NCT00940498|454842734|FG006|Overall Study|Disease Progression|0|||
126422876|NCT00940498|454842735|FG007|Overall Study|Disease Progression|0|||
126422877|NCT00940498|454842728|FG000|Overall Study|Physician Decision|0|||
126422878|NCT00940498|454842729|FG001|Overall Study|Physician Decision|0|||
126422879|NCT00940498|454842730|FG002|Overall Study|Physician Decision|0|||
126422880|NCT00940498|454842731|FG003|Overall Study|Physician Decision|0|||
126422881|NCT00940498|454842732|FG004|Overall Study|Physician Decision|2|||
126422882|NCT00940498|454842733|FG005|Overall Study|Physician Decision|0|||
126422883|NCT00940498|454842734|FG006|Overall Study|Physician Decision|0|||
126422884|NCT00940498|454842735|FG007|Overall Study|Physician Decision|0|||
126422885|NCT00940498|454842728|FG000|Overall Study|Not treated due to disease related pain|0|||
126422886|NCT00940498|454842729|FG001|Overall Study|Not treated due to disease related pain|0|||
126422887|NCT00940498|454842730|FG002|Overall Study|Not treated due to disease related pain|0|||
126422888|NCT00940498|454842731|FG003|Overall Study|Not treated due to disease related pain|0|||
126422889|NCT00940498|454842732|FG004|Overall Study|Not treated due to disease related pain|1|||
126422890|NCT00940498|454842733|FG005|Overall Study|Not treated due to disease related pain|0|||
126422891|NCT00940498|454842734|FG006|Overall Study|Not treated due to disease related pain|0|||
126422892|NCT00940498|454842735|FG007|Overall Study|Not treated due to disease related pain|0|||
126202518|NCT00504595|454027514|FG001|Overall Study|Other|0|||
126202519|NCT00504595|454027515|FG002|Overall Study|Other|2|||
126422893|NCT00330759|454844039|FG000|Overall Study|Death|316|||
126422894|NCT00330759|454844040|FG001|Overall Study|Death|310|||
126422895|NCT00330759|454844039|FG000|Overall Study|Disease progression|104|||
126422896|NCT00330759|454844040|FG001|Overall Study|Disease progression|126|||
126422897|NCT00330759|454844039|FG000|Overall Study|Withdrawal by Subject|143|||
126422898|NCT00330759|454844040|FG001|Overall Study|Withdrawal by Subject|124|||
126422899|NCT00330759|454844039|FG000|Overall Study|Adverse Event|48|||
126422900|NCT00330759|454844040|FG001|Overall Study|Adverse Event|36|||
126422901|NCT00330759|454844039|FG000|Overall Study|Participant request|31|||
126422902|NCT00330759|454844040|FG001|Overall Study|Participant request|22|||
126422903|NCT00330759|454844039|FG000|Overall Study|Lost to Follow-up|16|||
126422904|NCT00330759|454844040|FG001|Overall Study|Lost to Follow-up|22|||
126422905|NCT00330759|454844039|FG000|Overall Study|Noncompliance|15|||
126422906|NCT00330759|454844040|FG001|Overall Study|Noncompliance|17|||
126422907|NCT00330759|454844039|FG000|Overall Study|Physician Decision|1|||
126422908|NCT00330759|454844040|FG001|Overall Study|Physician Decision|2|||
126422909|NCT00330759|454844039|FG000|Overall Study|Protocol deviation|0|||
126422910|NCT00330759|454844040|FG001|Overall Study|Protocol deviation|2|||
126422911|NCT00330759|454844039|FG000|Overall Study|Ineligibility determined|2|||
126422912|NCT00330759|454844040|FG001|Overall Study|Ineligibility determined|1|||
126422913|NCT00330759|454844039|FG000|Overall Study|Other|36|||
126422914|NCT00330759|454844040|FG001|Overall Study|Other|44|||
126422915|NCT00997035|454844041|FG000|3-week Followup Visit|Lost to Follow-up|9|||
126422916|NCT00997035|454844042|FG001|3-week Followup Visit|Lost to Follow-up|6|||
126422917|NCT00997035|454844041|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
126422918|NCT00997035|454844042|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
126422919|NCT01380769|454844047|FG000|Overall Study|Withdrawal by Subject|7|||
126422920|NCT01380769|454844048|FG001|Overall Study|Withdrawal by Subject|11|||
126422921|NCT01380769|454844047|FG000|Overall Study|Physician Decision|1|||
126422922|NCT01380769|454844048|FG001|Overall Study|Physician Decision|1|||
126422923|NCT01380769|454844047|FG000|Overall Study|Adverse Event|1|||
126422924|NCT01380769|454844048|FG001|Overall Study|Adverse Event|1|||
126422925|NCT01380769|454844047|FG000|Overall Study|Protocol Violation|0|||
126422926|NCT01380769|454844048|FG001|Overall Study|Protocol Violation|1|||
126422927|NCT03654690|454844049|FG000|Overall Study|Withdrawal by Subject|1|||
126422928|NCT03654690|454844050|FG001|Overall Study|Withdrawal by Subject|0|||
126422929|NCT03654690|454844051|FG002|Overall Study|Withdrawal by Subject|0|||
126422930|NCT00742183|454844054|FG000|Overall Study|Adverse Event|2|||
126422931|NCT00742183|454844055|FG001|Overall Study|Adverse Event|2|||
126422932|NCT00742183|454844054|FG000|Overall Study|Death|1|||
126422933|NCT00742183|454844055|FG001|Overall Study|Death|0|||
126422934|NCT00742183|454844054|FG000|Overall Study|Physician Decision|0|||
126422935|NCT00742183|454844055|FG001|Overall Study|Physician Decision|2|||
126422936|NCT00742183|454844054|FG000|Overall Study|Lost to Follow-up|4|||
126422937|NCT00742183|454844055|FG001|Overall Study|Lost to Follow-up|4|||
126422938|NCT00742183|454844054|FG000|Overall Study|Required skin-graft|1|||
126422939|NCT00742183|454844055|FG001|Overall Study|Required skin-graft|1|||
126422940|NCT00742183|454844054|FG000|Overall Study|Withdrawal by Subject|1|||
126422941|NCT00742183|454844055|FG001|Overall Study|Withdrawal by Subject|0|||
126422942|NCT00742183|454844054|FG000|Overall Study|Lack of Efficacy|0|||
126422943|NCT00742183|454844055|FG001|Overall Study|Lack of Efficacy|3|||
126422944|NCT00786799|454844059|FG000|Overall Study|Lost to Follow-up|1|||
126422945|NCT00786799|454844060|FG001|Overall Study|Lost to Follow-up|1|||
126422946|NCT02544503|454844061|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
126422947|NCT02544503|454844062|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
126422948|NCT02544503|454844061|FG000|Overall Study|Lost to Follow-up|9|||
126422949|NCT02544503|454844062|FG001|Overall Study|Lost to Follow-up|0|||
126422950|NCT02544503|454844061|FG000|Overall Study|Withdrawal by Subject|1|||
126422951|NCT02544503|454844062|FG001|Overall Study|Withdrawal by Subject|0|||
126422952|NCT01080807|454844066|FG000|Overall Study|Adverse Event|9|||
126422953|NCT01080807|454844067|FG001|Overall Study|Adverse Event|1|||
126422954|NCT01080807|454844066|FG000|Overall Study|Lack of Efficacy|0|||
126422955|NCT01080807|454844067|FG001|Overall Study|Lack of Efficacy|1|||
126422956|NCT01080807|454844066|FG000|Overall Study|Withdrawal by Subject|7|||
126422957|NCT01080807|454844067|FG001|Overall Study|Withdrawal by Subject|2|||
126422958|NCT01080807|454844066|FG000|Overall Study|Protocol Violation|7|||
126422959|NCT01080807|454844067|FG001|Overall Study|Protocol Violation|6|||
126422960|NCT01080807|454844066|FG000|Overall Study|Lost to Follow-up|6|||
126202520|NCT00504595|454027516|FG003|Overall Study|Other|0|||
126422961|NCT01080807|454844067|FG001|Overall Study|Lost to Follow-up|4|||
126422962|NCT01080807|454844066|FG000|Overall Study|Noncompliance with drug administration|1|||
126422963|NCT01080807|454844067|FG001|Overall Study|Noncompliance with drug administration|1|||
126422964|NCT01080807|454844066|FG000|Overall Study|Noncompliance to study procedures|1|||
126306059|NCT02553499|454408873|FG004|Overall Study|Physician Decision|1|||
126422965|NCT01080807|454844067|FG001|Overall Study|Noncompliance to study procedures|1|||
126422966|NCT01080807|454844066|FG000|Overall Study|Began working day shift|0|||
126422967|NCT01080807|454844067|FG001|Overall Study|Began working day shift|2|||
126422968|NCT01080807|454844066|FG000|Overall Study|Laid off or terminated from job|1|||
126422969|NCT01080807|454844067|FG001|Overall Study|Laid off or terminated from job|2|||
126422970|NCT01080807|454844066|FG000|Overall Study|Stopped working consistent night shifts|0|||
126422971|NCT01080807|454844067|FG001|Overall Study|Stopped working consistent night shifts|1|||
126422972|NCT01080807|454844066|FG000|Overall Study|Work schedule changing|1|||
126422973|NCT01080807|454844067|FG001|Overall Study|Work schedule changing|1|||
126422974|NCT01080807|454844066|FG000|Overall Study|Work schedule and travel|0|||
126422975|NCT01080807|454844067|FG001|Overall Study|Work schedule and travel|1|||
126422976|NCT01080807|454844066|FG000|Overall Study|Switched to first shift|1|||
126422977|NCT01080807|454844067|FG001|Overall Study|Switched to first shift|0|||
126422978|NCT01080807|454844066|FG000|Overall Study|Moved away without notifying center|1|||
126422979|NCT01080807|454844067|FG001|Overall Study|Moved away without notifying center|0|||
126422980|NCT03922581|454844073|FG000|Overall Study|Lost to Follow-up|20|||
126422981|NCT03922581|454844074|FG001|Overall Study|Lost to Follow-up|9|||
126422982|NCT03922581|454844073|FG000|Overall Study|Physician Decision|1|||
126422983|NCT03922581|454844074|FG001|Overall Study|Physician Decision|1|||
126422984|NCT03922581|454844073|FG000|Overall Study|Withdrawal by Subject|1|||
126422985|NCT03922581|454844074|FG001|Overall Study|Withdrawal by Subject|0|||
126422986|NCT04685798|454844077|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
126422987|NCT02223715|454844078|FG000|Overall Study|Death|31|||
126422988|NCT02223715|454844078|FG000|Overall Study|Lost to Follow-up|73|||
126422989|NCT03956550|454844079|FG000|Overall Study|Sponsor decision|65|||
126422990|NCT03956550|454844080|FG001|Overall Study|Sponsor decision|66|||
126422991|NCT03956550|454844081|FG002|Overall Study|Sponsor decision|64|||
126422992|NCT03956550|454844079|FG000|Overall Study|Adverse Event|0|||
126422993|NCT03956550|454844080|FG001|Overall Study|Adverse Event|1|||
126422994|NCT03956550|454844081|FG002|Overall Study|Adverse Event|0|||
126422995|NCT03956550|454844079|FG000|Overall Study|Withdrawal by Subject|5|||
126422996|NCT03956550|454844080|FG001|Overall Study|Withdrawal by Subject|5|||
126422997|NCT03956550|454844081|FG002|Overall Study|Withdrawal by Subject|6|||
126422998|NCT01745367|454844084|FG000|Overall Study|Death|1|||
126422999|NCT01745367|454844085|FG001|Overall Study|Death|0|||
126423000|NCT01745367|454844084|FG000|Overall Study|Withdrawal by Subject|1|||
126423001|NCT01745367|454844085|FG001|Overall Study|Withdrawal by Subject|2|||
126423002|NCT01745367|454844084|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
126423003|NCT01745367|454844085|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
126423004|NCT01745367|454844084|FG000|Overall Study|Other Reasons Unspecified|0|||
126423005|NCT01745367|454844085|FG001|Overall Study|Other Reasons Unspecified|2|||
126423006|NCT00824473|454844087|FG000|Overall Study|Adverse Event|4|||
126423007|NCT00824473|454844088|FG001|Overall Study|Adverse Event|5|||
126423008|NCT00824473|454844087|FG000|Overall Study|Lack of Efficacy|2|||
126423009|NCT00824473|454844088|FG001|Overall Study|Lack of Efficacy|2|||
126423010|NCT00824473|454844087|FG000|Overall Study|Protocol Violation|2|||
126423011|NCT00824473|454844088|FG001|Overall Study|Protocol Violation|0|||
126423012|NCT00824473|454844087|FG000|Overall Study|Non-Compliance|4|||
126423013|NCT00824473|454844088|FG001|Overall Study|Non-Compliance|2|||
126423014|NCT00824473|454844087|FG000|Overall Study|Withdrawal by Subject|2|||
126423015|NCT00824473|454844088|FG001|Overall Study|Withdrawal by Subject|3|||
126423016|NCT00824473|454844087|FG000|Overall Study|Other|1|||
126423017|NCT00824473|454844088|FG001|Overall Study|Other|1|||
126423018|NCT01359904|454844089|FG000|Overall Study|Withdrawal by Subject|1|||
126423019|NCT01359904|454844090|FG001|Overall Study|Withdrawal by Subject|0|||
126423020|NCT02640547|454844091|FG000|Overall Study|Failure to Return|1|||
126423021|NCT02640547|454844091|FG000|Overall Study|Withdrawal by Subject|1|||
126423022|NCT02640547|454844091|FG000|Overall Study|Death|6|||
126423023|NCT02640547|454844091|FG000|Overall Study|Miscellaneous|3|||
126423024|NCT02525588|454844092|FG000|Overall Study|Death|3|||
126423025|NCT02525588|454844093|FG001|Overall Study|Death|1|||
126423026|NCT02525588|454844092|FG000|Overall Study|Lost to Follow-up|2|||
126423027|NCT02525588|454844093|FG001|Overall Study|Lost to Follow-up|0|||
126423028|NCT02525588|454844092|FG000|Overall Study|Withdrawal by Subject|1|||
126423029|NCT02525588|454844093|FG001|Overall Study|Withdrawal by Subject|1|||
126423030|NCT02525588|454844092|FG000|Overall Study|Adverse Event|0|||
126423031|NCT02525588|454844093|FG001|Overall Study|Adverse Event|1|||
126423032|NCT03369418|454844095|FG000|Overall Study|Withdrawal by Subject|3|||
126423033|NCT03369418|454844096|FG001|Overall Study|Withdrawal by Subject|3|||
126423034|NCT01485094|454844097|FG000|Overall Study|Adverse Event|1|||
126423035|NCT01485094|454844098|FG001|Overall Study|Adverse Event|1|||
126423036|NCT01485094|454844099|FG002|Overall Study|Adverse Event|1|||
126423037|NCT01485094|454844097|FG000|Overall Study|Lost to Follow-up|1|||
126423038|NCT01485094|454844098|FG001|Overall Study|Lost to Follow-up|0|||
126423039|NCT01485094|454844099|FG002|Overall Study|Lost to Follow-up|0|||
126423040|NCT01485094|454844097|FG000|Overall Study|Withdrawal by Subject|1|||
126423041|NCT01485094|454844098|FG001|Overall Study|Withdrawal by Subject|1|||
126423042|NCT01485094|454844099|FG002|Overall Study|Withdrawal by Subject|0|||
126423043|NCT02753946|454844113|FG000|Overall Study|Adverse Event|7|||
126423044|NCT02753946|454844114|FG001|Overall Study|Adverse Event|6|||
126423045|NCT02753946|454844113|FG000|Overall Study|Withdrawal by Subject|6|||
126423046|NCT02753946|454844114|FG001|Overall Study|Withdrawal by Subject|1|||
126423047|NCT02753946|454844113|FG000|Overall Study|Lack of Efficacy|1|||
126423048|NCT02753946|454844114|FG001|Overall Study|Lack of Efficacy|0|||
126423049|NCT02753946|454844113|FG000|Overall Study|Physician Decision|0|||
126423050|NCT02753946|454844114|FG001|Overall Study|Physician Decision|2|||
126423051|NCT02519439|454844115|FG000|Overall Study|Study Termination|19|||
126423052|NCT02519439|454844115|FG000|Overall Study|Withdrawal by Subject|1|||
126423053|NCT02519439|454844115|FG000|Overall Study|Adverse Event|1|||
126423054|NCT01539759|454844120|FG000|Overall Study|Lost to Follow-up|6|||
126423055|NCT01539759|454844121|FG001|Overall Study|Lost to Follow-up|8|||
126423056|NCT03901144|454844122|FG000|Overall Study|Lost to Follow-up|1|||
126423057|NCT03901144|454844123|FG001|Overall Study|Lost to Follow-up|1|||
126423058|NCT03901144|454844124|FG002|Overall Study|Lost to Follow-up|1|||
126423059|NCT03901144|454844125|FG003|Overall Study|Lost to Follow-up|1|||
126423060|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
126423061|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
126423062|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
126423063|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
126423064|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
126423065|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
126423066|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Death|7|||
126423067|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Death|5|||
126423068|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Death|6|||
126423069|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
126423070|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
126423071|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
126423072|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
126423073|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
126423074|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
126423075|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Other|1|||
126423076|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Other|0|||
126423077|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Other|0|||
126423078|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
126423079|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
126423080|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
126423081|NCT00104650|454844126|FG000|Follow-up Period|Physician Decision|1|||
126423082|NCT00104650|454844127|FG001|Follow-up Period|Physician Decision|1|||
126423083|NCT00104650|454844128|FG002|Follow-up Period|Physician Decision|0|||
125978668|NCT00765674|453209816|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125978669|NCT00765674|453209817|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
125978670|NCT00765674|453209818|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
125978671|NCT00765674|453209819|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
125978672|NCT00765674|453209816|FG000|Overall Study|Lack of Efficacy|2|||
125978673|NCT00765674|453209817|FG001|Overall Study|Lack of Efficacy|3|||
125978674|NCT00765674|453209818|FG002|Overall Study|Lack of Efficacy|1|||
125978675|NCT00765674|453209819|FG003|Overall Study|Lack of Efficacy|2|||
125978676|NCT00765674|453209816|FG000|Overall Study|Protocol Violation|2|||
125978677|NCT00765674|453209817|FG001|Overall Study|Protocol Violation|0|||
125978678|NCT00765674|453209818|FG002|Overall Study|Protocol Violation|1|||
125978679|NCT00765674|453209819|FG003|Overall Study|Protocol Violation|0|||
125978680|NCT00765674|453209816|FG000|Overall Study|Withdrawal by Subject|5|||
125978681|NCT00765674|453209817|FG001|Overall Study|Withdrawal by Subject|7|||
125978682|NCT00765674|453209818|FG002|Overall Study|Withdrawal by Subject|3|||
125978683|NCT00765674|453209819|FG003|Overall Study|Withdrawal by Subject|8|||
125978684|NCT00765674|453209816|FG000|Overall Study|Lost to Follow-up|4|||
125978685|NCT00765674|453209817|FG001|Overall Study|Lost to Follow-up|6|||
125978686|NCT00765674|453209818|FG002|Overall Study|Lost to Follow-up|2|||
125978687|NCT00765674|453209819|FG003|Overall Study|Lost to Follow-up|1|||
125978688|NCT00765674|453209816|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
125978689|NCT00765674|453209817|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
125978690|NCT00765674|453209818|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
125978691|NCT00765674|453209819|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
125978692|NCT01813474|453209820|FG000|Overall Study|Withdrawal by Subject|0|||
125978693|NCT01813474|453209821|FG001|Overall Study|Withdrawal by Subject|0|||
125978694|NCT01813474|453209822|FG002|Overall Study|Withdrawal by Subject|1|||
125978695|NCT01813474|453209820|FG000|Overall Study|Adverse Event|1|||
125978696|NCT01813474|453209821|FG001|Overall Study|Adverse Event|1|||
125978697|NCT01813474|453209822|FG002|Overall Study|Adverse Event|0|||
126306060|NCT02553499|454408874|FG005|Overall Study|Physician Decision|0|||
125978698|NCT01813474|453209820|FG000|Overall Study|Lack of Efficacy|2|||
125978699|NCT01813474|453209821|FG001|Overall Study|Lack of Efficacy|6|||
125978700|NCT01813474|453209822|FG002|Overall Study|Lack of Efficacy|9|||
125978701|NCT01813474|453209820|FG000|Overall Study|Death|0|||
125978702|NCT01813474|453209821|FG001|Overall Study|Death|0|||
125978703|NCT01813474|453209822|FG002|Overall Study|Death|1|||
125978704|NCT00316082|453209825|FG000|Overall Study|Lack of Efficacy|2|||
125978705|NCT00316082|453209826|FG001|Overall Study|Lack of Efficacy|3|||
126423084|NCT00104650|454844126|FG000|Follow-up Period|Adverse Event|1|||
126423085|NCT00104650|454844127|FG001|Follow-up Period|Adverse Event|0|||
126423086|NCT00104650|454844128|FG002|Follow-up Period|Adverse Event|1|||
126423087|NCT00104650|454844126|FG000|Follow-up Period|Withdrawal by Subject|0|||
126423088|NCT00104650|454844127|FG001|Follow-up Period|Withdrawal by Subject|3|||
126423089|NCT00104650|454844128|FG002|Follow-up Period|Withdrawal by Subject|3|||
126423090|NCT00104650|454844126|FG000|Follow-up Period|Death|6|||
126423091|NCT00104650|454844127|FG001|Follow-up Period|Death|6|||
126423092|NCT00104650|454844128|FG002|Follow-up Period|Death|4|||
126423093|NCT00104650|454844126|FG000|Follow-up Period|Disease progression|3|||
126423094|NCT00104650|454844127|FG001|Follow-up Period|Disease progression|1|||
126423095|NCT00104650|454844128|FG002|Follow-up Period|Disease progression|0|||
126423096|NCT00104650|454844126|FG000|Follow-up Period|Lost to Follow-up|0|||
126423097|NCT00104650|454844127|FG001|Follow-up Period|Lost to Follow-up|1|||
126423098|NCT00104650|454844128|FG002|Follow-up Period|Lost to Follow-up|2|||
126423099|NCT00104650|454844126|FG000|Follow-up Period|Other|0|||
126423100|NCT00104650|454844127|FG001|Follow-up Period|Other|1|||
126423101|NCT00104650|454844128|FG002|Follow-up Period|Other|0|||
126423102|NCT03384940|454844133|FG000|Overall Study|Progressive disease|36|||
126423103|NCT03384940|454844134|FG001|Overall Study|Progressive disease|11|||
126423104|NCT03384940|454844135|FG002|Overall Study|Progressive disease|13|||
126423105|NCT03384940|454844133|FG000|Overall Study|Clinical progression|4|||
126423106|NCT03384940|454844134|FG001|Overall Study|Clinical progression|0|||
126423107|NCT03384940|454844135|FG002|Overall Study|Clinical progression|3|||
126423108|NCT03384940|454844133|FG000|Overall Study|Adverse Event|7|||
126423109|NCT03384940|454844134|FG001|Overall Study|Adverse Event|1|||
126423110|NCT03384940|454844135|FG002|Overall Study|Adverse Event|1|||
126423111|NCT03384940|454844133|FG000|Overall Study|Withdrawal by Subject|3|||
126423112|NCT03384940|454844134|FG001|Overall Study|Withdrawal by Subject|1|||
126423113|NCT03384940|454844135|FG002|Overall Study|Withdrawal by Subject|0|||
126423114|NCT03384940|454844133|FG000|Overall Study|Physician Decision|1|||
126423115|NCT03384940|454844134|FG001|Overall Study|Physician Decision|1|||
126423116|NCT03384940|454844135|FG002|Overall Study|Physician Decision|0|||
126423117|NCT03384940|454844133|FG000|Overall Study|Death|2|||
126423118|NCT03384940|454844134|FG001|Overall Study|Death|1|||
126423119|NCT03384940|454844135|FG002|Overall Study|Death|0|||
126423120|NCT03384940|454844133|FG000|Overall Study|Other|0|||
126423121|NCT03384940|454844134|FG001|Overall Study|Other|0|||
126423122|NCT03384940|454844135|FG002|Overall Study|Other|1|||
126423123|NCT03089580|454844141|FG000|Overall Study|Lost to Follow-up|2|||
126423124|NCT03087513|454844142|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
126423125|NCT00770601|454844143|FG000|Overall Study|Withdrawal by Subject|1|||
126423126|NCT04417361|454844145|FG000|Overall Study|Withdrawal by Subject|1|||
126423127|NCT04417361|454844146|FG001|Overall Study|Withdrawal by Subject|0|||
126423128|NCT04417361|454844145|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
126423129|NCT04417361|454844146|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
126423130|NCT00801216|454844147|FG000|Overall Study|Screening Failure|2|||
126423131|NCT01463306|454844150|FG000|Overall Study|Adverse Event|6|||
126423132|NCT01463306|454844151|FG001|Overall Study|Adverse Event|9|||
126423133|NCT01463306|454844152|FG002|Overall Study|Adverse Event|3|||
126423134|NCT01463306|454844150|FG000|Overall Study|Death|3|||
126423135|NCT01463306|454844151|FG001|Overall Study|Death|3|||
126423136|NCT01463306|454844152|FG002|Overall Study|Death|0|||
126423137|NCT01463306|454844150|FG000|Overall Study|Lack of Efficacy|22|||
126423138|NCT01463306|454844151|FG001|Overall Study|Lack of Efficacy|16|||
126423139|NCT01463306|454844152|FG002|Overall Study|Lack of Efficacy|1|||
126423140|NCT01463306|454844150|FG000|Overall Study|Lost to Follow-up|5|||
126423141|NCT01463306|454844151|FG001|Overall Study|Lost to Follow-up|2|||
126423142|NCT01463306|454844152|FG002|Overall Study|Lost to Follow-up|0|||
126423143|NCT01463306|454844150|FG000|Overall Study|Protocol Violation|4|||
126423144|NCT01463306|454844151|FG001|Overall Study|Protocol Violation|0|||
126423145|NCT01463306|454844152|FG002|Overall Study|Protocol Violation|0|||
126423146|NCT01463306|454844150|FG000|Overall Study|Withdrawal by Subject|19|||
126423147|NCT01463306|454844151|FG001|Overall Study|Withdrawal by Subject|9|||
126423148|NCT01463306|454844152|FG002|Overall Study|Withdrawal by Subject|1|||
126423149|NCT01463306|454844150|FG000|Overall Study|Other|26|||
126423150|NCT01463306|454844151|FG001|Overall Study|Other|13|||
126423151|NCT01463306|454844152|FG002|Overall Study|Other|0|||
126423152|NCT01463306|454844150|FG000|Overall Study|Approval expiry at site|1|||
126423153|NCT01463306|454844151|FG001|Overall Study|Approval expiry at site|0|||
126423154|NCT01463306|454844152|FG002|Overall Study|Approval expiry at site|0|||
126423155|NCT02679287|454844153|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
126423156|NCT02679287|454844154|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
126423157|NCT02679287|454844153|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
126423158|NCT02679287|454844154|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
126423159|NCT02679287|454844153|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
126423160|NCT02679287|454844154|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
126423161|NCT02679287|454844153|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
126423162|NCT02679287|454844154|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
126423163|NCT02679287|454844153|FG000|Period 2|Work/Scheduling Conflict|1|||
126423164|NCT02679287|454844154|FG001|Period 2|Work/Scheduling Conflict|0|||
126423165|NCT02679287|454844153|FG000|Period 2|Disliked Mobile System|2|||
126423166|NCT02679287|454844154|FG001|Period 2|Disliked Mobile System|0|||
126423167|NCT02679287|454844153|FG000|Period 3|Work/Scheduling Conflict|0|||
126423168|NCT02679287|454844154|FG001|Period 3|Work/Scheduling Conflict|1|||
126423169|NCT00992459|454844159|FG000|Overall Study|Withdrawal by Subject|0|||
126423170|NCT00992459|454844160|FG001|Overall Study|Withdrawal by Subject|1|||
126423171|NCT00992459|454844159|FG000|Overall Study|Adverse Event|1|||
126423172|NCT00992459|454844160|FG001|Overall Study|Adverse Event|0|||
126423173|NCT01943591|454844161|FG000|Overall Study|Lost to Follow-up|3|||
126423174|NCT01943591|454844162|FG001|Overall Study|Lost to Follow-up|4|||
126423175|NCT01943591|454844161|FG000|Overall Study|Death|2|||
126423176|NCT01943591|454844162|FG001|Overall Study|Death|7|||
126423177|NCT00227721|454845588|FG000|Overall Study|On study, but never treated.|1|||
126423178|NCT01389882|454845597|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
126423179|NCT01389882|454845598|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
126423180|NCT01389882|454845597|FG000|Overall Study|Withdrawal by Subject|0|||
126423181|NCT01389882|454845598|FG001|Overall Study|Withdrawal by Subject|1|||
126423182|NCT00859547|454845613|FG000|Overall Study|Lost to Follow-up|1|||
126423183|NCT00859547|454845613|FG000|Overall Study|Parent withdrew consent|1|||
126423184|NCT01276639|454845627|FG000|Week 0 to 16|Death|1|||
126423185|NCT01276639|454845628|FG001|Week 0 to 16|Death|0|||
126423186|NCT01276639|454845629|FG002|Week 0 to 16|Death|0|||
126423187|NCT01276639|454845630|FG003|Week 0 to 16|Death|0|||
126423188|NCT01276639|454845631|FG004|Week 0 to 16|Death|0|||
126423189|NCT01276639|454845627|FG000|Week 0 to 16|Adverse Event|11|||
126423190|NCT01276639|454845628|FG001|Week 0 to 16|Adverse Event|8|||
126423191|NCT01276639|454845629|FG002|Week 0 to 16|Adverse Event|11|||
126423192|NCT01276639|454845630|FG003|Week 0 to 16|Adverse Event|0|||
126423193|NCT01276639|454845631|FG004|Week 0 to 16|Adverse Event|0|||
126423194|NCT01276639|454845627|FG000|Week 0 to 16|Lack of Efficacy|20|||
126423195|NCT01276639|454845628|FG001|Week 0 to 16|Lack of Efficacy|15|||
126423196|NCT01276639|454845629|FG002|Week 0 to 16|Lack of Efficacy|25|||
126423197|NCT01276639|454845630|FG003|Week 0 to 16|Lack of Efficacy|0|||
126423198|NCT01276639|454845631|FG004|Week 0 to 16|Lack of Efficacy|0|||
126423199|NCT01276639|454845627|FG000|Week 0 to 16|Lost to Follow-up|3|||
126423200|NCT01276639|454845628|FG001|Week 0 to 16|Lost to Follow-up|5|||
126423201|NCT01276639|454845629|FG002|Week 0 to 16|Lost to Follow-up|3|||
126423202|NCT01276639|454845630|FG003|Week 0 to 16|Lost to Follow-up|0|||
126423203|NCT01276639|454845631|FG004|Week 0 to 16|Lost to Follow-up|0|||
126423204|NCT01276639|454845627|FG000|Week 0 to 16|Withdrawal by Subject|8|||
126423205|NCT01276639|454845628|FG001|Week 0 to 16|Withdrawal by Subject|5|||
126423206|NCT01276639|454845629|FG002|Week 0 to 16|Withdrawal by Subject|4|||
126423207|NCT01276639|454845630|FG003|Week 0 to 16|Withdrawal by Subject|0|||
126423208|NCT01276639|454845631|FG004|Week 0 to 16|Withdrawal by Subject|0|||
126423209|NCT01276639|454845627|FG000|Week 0 to 16|Other|7|||
126423210|NCT01276639|454845628|FG001|Week 0 to 16|Other|7|||
126423211|NCT01276639|454845629|FG002|Week 0 to 16|Other|2|||
126423212|NCT01276639|454845630|FG003|Week 0 to 16|Other|0|||
126423213|NCT01276639|454845631|FG004|Week 0 to 16|Other|0|||
126423214|NCT01276639|454845627|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
126423215|NCT01276639|454845628|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
126423216|NCT01276639|454845629|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
126423217|NCT01276639|454845630|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
126423218|NCT01276639|454845631|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
126423219|NCT01276639|454845627|FG000|Week 16 to 52|Death|1|||
126423220|NCT01276639|454845628|FG001|Week 16 to 52|Death|0|||
126423221|NCT01276639|454845629|FG002|Week 16 to 52|Death|0|||
126423222|NCT01276639|454845630|FG003|Week 16 to 52|Death|0|||
126423223|NCT01276639|454845631|FG004|Week 16 to 52|Death|0|||
126423224|NCT01276639|454845627|FG000|Week 16 to 52|Adverse Event|10|||
126423225|NCT01276639|454845628|FG001|Week 16 to 52|Adverse Event|13|||
126423226|NCT01276639|454845629|FG002|Week 16 to 52|Adverse Event|0|||
126423227|NCT01276639|454845630|FG003|Week 16 to 52|Adverse Event|1|||
126423228|NCT01276639|454845631|FG004|Week 16 to 52|Adverse Event|3|||
126423229|NCT01276639|454845627|FG000|Week 16 to 52|Lack of Efficacy|99|||
126423230|NCT01276639|454845628|FG001|Week 16 to 52|Lack of Efficacy|71|||
126423231|NCT01276639|454845629|FG002|Week 16 to 52|Lack of Efficacy|0|||
126423232|NCT01276639|454845630|FG003|Week 16 to 52|Lack of Efficacy|14|||
126423233|NCT01276639|454845631|FG004|Week 16 to 52|Lack of Efficacy|13|||
126423234|NCT01276639|454845627|FG000|Week 16 to 52|Lost to Follow-up|3|||
126423235|NCT01276639|454845628|FG001|Week 16 to 52|Lost to Follow-up|1|||
126423236|NCT01276639|454845629|FG002|Week 16 to 52|Lost to Follow-up|0|||
126423237|NCT01276639|454845630|FG003|Week 16 to 52|Lost to Follow-up|0|||
126423238|NCT01276639|454845631|FG004|Week 16 to 52|Lost to Follow-up|1|||
126423239|NCT01276639|454845627|FG000|Week 16 to 52|Withdrawal by Subject|4|||
126423240|NCT01276639|454845628|FG001|Week 16 to 52|Withdrawal by Subject|4|||
126423241|NCT01276639|454845629|FG002|Week 16 to 52|Withdrawal by Subject|0|||
126423242|NCT01276639|454845630|FG003|Week 16 to 52|Withdrawal by Subject|0|||
126423243|NCT01276639|454845631|FG004|Week 16 to 52|Withdrawal by Subject|1|||
126423244|NCT01276639|454845627|FG000|Week 16 to 52|Other|10|||
126423245|NCT01276639|454845628|FG001|Week 16 to 52|Other|12|||
126423246|NCT01276639|454845629|FG002|Week 16 to 52|Other|0|||
126423247|NCT01276639|454845630|FG003|Week 16 to 52|Other|1|||
126423248|NCT01276639|454845631|FG004|Week 16 to 52|Other|3|||
126423249|NCT03018691|454845642|FG000|Overall Study|Adverse Event|1|||
126423250|NCT03018691|454845643|FG001|Overall Study|Adverse Event|1|||
126423251|NCT03018691|454845644|FG002|Overall Study|Adverse Event|4|||
126423252|NCT03018691|454845642|FG000|Overall Study|Lack of Efficacy|0|||
126423253|NCT03018691|454845643|FG001|Overall Study|Lack of Efficacy|0|||
126423254|NCT03018691|454845644|FG002|Overall Study|Lack of Efficacy|1|||
126423255|NCT03018691|454845642|FG000|Overall Study|Withdrawal by Subject|0|||
126423256|NCT03018691|454845643|FG001|Overall Study|Withdrawal by Subject|0|||
126423257|NCT03018691|454845644|FG002|Overall Study|Withdrawal by Subject|1|||
126423258|NCT03018691|454845642|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126423259|NCT03018691|454845643|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126423260|NCT03018691|454845644|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126423261|NCT00796666|454845646|FG000|Overall Study|Death|2|||
126423262|NCT00796666|454845647|FG001|Overall Study|Death|4|||
126423263|NCT00796666|454845646|FG000|Overall Study|Withdrawal by Subject|2|||
126423264|NCT00796666|454845647|FG001|Overall Study|Withdrawal by Subject|0|||
126423265|NCT00796666|454845646|FG000|Overall Study|Adverse Event|7|||
126423266|NCT00796666|454845647|FG001|Overall Study|Adverse Event|5|||
126423267|NCT00796666|454845646|FG000|Overall Study|Protocol Violation|1|||
126423268|NCT00796666|454845647|FG001|Overall Study|Protocol Violation|0|||
126423269|NCT00796666|454845646|FG000|Overall Study|Other|1|||
126423270|NCT00796666|454845647|FG001|Overall Study|Other|0|||
126423271|NCT00796666|454845646|FG000|Overall Study|Terminated by sponsor|53|||
126423272|NCT00796666|454845647|FG001|Overall Study|Terminated by sponsor|55|||
126423273|NCT00796666|454845646|FG000|Overall Study|Randomized and not treated|1|||
126423274|NCT00796666|454845647|FG001|Overall Study|Randomized and not treated|0|||
126423275|NCT02576639|454845648|FG000|Overall Study|Withdrawal by Subject|1|||
126423276|NCT02576639|454845649|FG001|Overall Study|Withdrawal by Subject|2|||
126423277|NCT02576639|454845650|FG002|Overall Study|Withdrawal by Subject|1|||
126423278|NCT02576639|454845651|FG003|Overall Study|Withdrawal by Subject|0|||
126423279|NCT02576639|454845652|FG004|Overall Study|Withdrawal by Subject|1|||
126423280|NCT02576639|454845648|FG000|Overall Study|Adverse Event|1|||
126423281|NCT02576639|454845649|FG001|Overall Study|Adverse Event|0|||
126423282|NCT02576639|454845650|FG002|Overall Study|Adverse Event|1|||
126423283|NCT02576639|454845651|FG003|Overall Study|Adverse Event|1|||
126423284|NCT02576639|454845652|FG004|Overall Study|Adverse Event|2|||
126423285|NCT02576639|454845648|FG000|Overall Study|Physician Decision|0|||
126423286|NCT02576639|454845649|FG001|Overall Study|Physician Decision|0|||
126423287|NCT02576639|454845650|FG002|Overall Study|Physician Decision|0|||
126423288|NCT02576639|454845651|FG003|Overall Study|Physician Decision|0|||
126423289|NCT02576639|454845652|FG004|Overall Study|Physician Decision|1|||
126423290|NCT00057863|454845654|FG000|Overall Study|Death|1|||
126423291|NCT00057863|454845654|FG000|Overall Study|Withdrawal by Subject|2|||
126423292|NCT01521507|454845655|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
126423293|NCT01521507|454845656|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
126423294|NCT01521507|454845655|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
126423295|NCT01521507|454845656|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
126423296|NCT01521507|454845655|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
126423297|NCT01521507|454845656|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
126423298|NCT01521507|454845655|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
126423299|NCT01521507|454845656|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
126423300|NCT01521507|454845655|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
126423301|NCT01521507|454845656|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
126423302|NCT01521507|454845655|FG000|Stage 2: Observational Design|Physician Decision|1|||
126423303|NCT01521507|454845656|FG001|Stage 2: Observational Design|Physician Decision|0|||
126423304|NCT02079038|454845657|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
126423305|NCT02079038|454845658|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
126423306|NCT02079038|454845657|FG000|Modified Intent to Treat Population|Death|1|||
126423307|NCT02079038|454845658|FG001|Modified Intent to Treat Population|Death|0|||
126423308|NCT02079038|454845657|FG000|Completed 6 Months|Lost to Follow-up|2|||
126423309|NCT02079038|454845658|FG001|Completed 6 Months|Lost to Follow-up|1|||
126423310|NCT02478463|454845659|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
126423311|NCT02478463|454845659|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
126423312|NCT02478463|454845659|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
126423313|NCT01358825|454845662|FG000|Overall Study|Blood sample not drawn|0|||
126423314|NCT01358825|454845663|FG001|Overall Study|Blood sample not drawn|1|||
126423315|NCT01479868|454845664|FG000|Overall Study|Adverse Event|1|||
126423316|NCT01479868|454845664|FG000|Overall Study|Lost to Follow-up|4|||
126423317|NCT01479868|454845664|FG000|Overall Study|Protocol Violation|1|||
126202521|NCT02764229|454027517|FG000|Overall Study|Withdrawal by Subject|15|||
126202522|NCT02764229|454027517|FG000|Overall Study|Adverse Event|9|||
126202523|NCT02764229|454027517|FG000|Overall Study|Physician Decision|5|||
126202524|NCT02764229|454027517|FG000|Overall Study|Lost to Follow-up|3|||
126202525|NCT02764229|454027517|FG000|Overall Study|Lack of Efficacy|1|||
126202526|NCT02764229|454027517|FG000|Overall Study|Study Stopped by Sponsor|69|||
126423318|NCT01479868|454845664|FG000|Overall Study|Withdrawal by Subject|1|||
126423319|NCT01479868|454845664|FG000|Overall Study|Sponsor's Decision|1|||
126423320|NCT01479868|454845664|FG000|Overall Study|Initiation of new HCV Therapy|1|||
126423321|NCT01508169|454845665|FG000|Overall Study|Adverse Event|1|||
126423322|NCT01508169|454845666|FG001|Overall Study|Adverse Event|0|||
126423323|NCT01508169|454845665|FG000|Overall Study|Withdrawal by Subject|1|||
126423324|NCT01508169|454845666|FG001|Overall Study|Withdrawal by Subject|0|||
126423325|NCT01508169|454845665|FG000|Overall Study|Lost to Follow-up|1|||
126423326|NCT01508169|454845666|FG001|Overall Study|Lost to Follow-up|2|||
126423327|NCT01292187|454845670|FG000|Overall Study|Adverse Event|10|||
126423328|NCT01292187|454845671|FG001|Overall Study|Adverse Event|5|||
126423329|NCT01292187|454845670|FG000|Overall Study|Withdrawal by Subject|6|||
126423330|NCT01292187|454845671|FG001|Overall Study|Withdrawal by Subject|5|||
126423331|NCT01292187|454845670|FG000|Overall Study|All other reasons|1|||
126423332|NCT01292187|454845671|FG001|Overall Study|All other reasons|3|||
126423333|NCT01814527|454845673|FG000|Overall Study|RTP greater than 30 days|6|||
126423334|NCT01814527|454845674|FG001|Overall Study|RTP greater than 30 days|1|||
126423335|NCT04524858|454845677|FG000|Overall Study|Adverse Event|1|||
126423336|NCT03571204|454845678|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
126423337|NCT03571204|454845679|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
126423338|NCT03571204|454845680|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
126423339|NCT03571204|454845678|FG000|Overall Study|Physician Decision|0|||
126423340|NCT03571204|454845679|FG001|Overall Study|Physician Decision|1|||
126423341|NCT03571204|454845680|FG002|Overall Study|Physician Decision|0|||
126423342|NCT02396212|454845681|FG000|Overall Study|Adverse Event|1|||
126423343|NCT02396212|454845681|FG000|Overall Study|Lack of Efficacy|2|||
126423344|NCT01363700|454845684|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
126423345|NCT01363700|454845685|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
126423346|NCT01363700|454845686|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
126423347|NCT01363700|454845687|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
126423348|NCT01363700|454845688|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
126202527|NCT00779142|454027518|FG000|Overall Study|Screen Failures|3|||
126423349|NCT00113841|454845696|FG000|Overall Study|Disease progression|0|||
126423350|NCT00113841|454845697|FG001|Overall Study|Disease progression|2|||
126423351|NCT00113841|454845696|FG000|Overall Study|Non-compliant|1|||
126423352|NCT00113841|454845697|FG001|Overall Study|Non-compliant|0|||
126423353|NCT01454596|454845698|FG000|Overall Study|Death|0|||
126423354|NCT01454596|454845699|FG001|Overall Study|Death|0|||
126423355|NCT01454596|454845700|FG002|Overall Study|Death|0|||
126423356|NCT01454596|454845701|FG003|Overall Study|Death|0|||
126423357|NCT01454596|454845702|FG004|Overall Study|Death|0|||
126423358|NCT01454596|454845703|FG005|Overall Study|Death|0|||
126423359|NCT01454596|454845704|FG006|Overall Study|Death|0|||
126423360|NCT01454596|454845705|FG007|Overall Study|Death|0|||
126423361|NCT01454596|454845706|FG008|Overall Study|Death|0|||
126423362|NCT01454596|454845707|FG009|Overall Study|Death|1|||
126423363|NCT01454596|454845708|FG010|Overall Study|Death|1|||
126423364|NCT01454596|454845709|FG011|Overall Study|Death|0|||
126423365|NCT02721875|454845711|FG000|Overall Study|Progressive disease/relapse|1|||
126423366|NCT02721875|454845712|FG001|Overall Study|Progressive disease/relapse|0|||
126423367|NCT00430716|454845713|FG000|Double Blind Phase|Death|1|||
126423368|NCT00430716|454845714|FG001|Double Blind Phase|Death|0|||
126423369|NCT00430716|454845715|FG002|Double Blind Phase|Death|0|||
126423370|NCT00430716|454845713|FG000|Double Blind Phase|No longer willing to participate|2|||
126423371|NCT00430716|454845714|FG001|Double Blind Phase|No longer willing to participate|1|||
126423372|NCT00430716|454845715|FG002|Double Blind Phase|No longer willing to participate|1|||
126202528|NCT00851721|454027522|FG000|Overall Study|planned surgery|1|||
126423373|NCT00430716|454845713|FG000|Double Blind Phase|Other|0|||
126423374|NCT00430716|454845714|FG001|Double Blind Phase|Other|2|||
126423375|NCT00430716|454845715|FG002|Double Blind Phase|Other|0|||
126423376|NCT00430716|454845713|FG000|Double Blind Phase|Study terminated by sponsor|1|||
126423377|NCT00430716|454845714|FG001|Double Blind Phase|Study terminated by sponsor|1|||
126423378|NCT00430716|454845715|FG002|Double Blind Phase|Study terminated by sponsor|2|||
126423379|NCT00430716|454845713|FG000|Double Blind Phase|Adverse Event|1|||
126423380|NCT00430716|454845714|FG001|Double Blind Phase|Adverse Event|1|||
126423381|NCT00430716|454845715|FG002|Double Blind Phase|Adverse Event|3|||
126423382|NCT00430716|454845713|FG000|Double Blind Phase|Not treated|1|||
126423383|NCT00430716|454845714|FG001|Double Blind Phase|Not treated|0|||
126423384|NCT00430716|454845715|FG002|Double Blind Phase|Not treated|0|||
126423385|NCT00430716|454845713|FG000|Open Label Phase|Lost to Follow-up|1|||
126423386|NCT00430716|454845714|FG001|Open Label Phase|Lost to Follow-up|0|||
126423387|NCT00430716|454845715|FG002|Open Label Phase|Lost to Follow-up|1|||
126423388|NCT00430716|454845713|FG000|Open Label Phase|No longer willing to participate|0|||
126423389|NCT00430716|454845714|FG001|Open Label Phase|No longer willing to participate|1|||
126423390|NCT00430716|454845715|FG002|Open Label Phase|No longer willing to participate|1|||
126423391|NCT00430716|454845713|FG000|Open Label Phase|Other|3|||
126423392|NCT00430716|454845714|FG001|Open Label Phase|Other|1|||
126423393|NCT00430716|454845715|FG002|Open Label Phase|Other|1|||
126423394|NCT00430716|454845713|FG000|Open Label Phase|Protocol Violation|1|||
126423395|NCT00430716|454845714|FG001|Open Label Phase|Protocol Violation|0|||
126423396|NCT00430716|454845715|FG002|Open Label Phase|Protocol Violation|0|||
126423397|NCT00430716|454845713|FG000|Open Label Phase|Study terminated by sponsor|4|||
126423398|NCT00430716|454845714|FG001|Open Label Phase|Study terminated by sponsor|5|||
126423399|NCT00430716|454845715|FG002|Open Label Phase|Study terminated by sponsor|4|||
126423400|NCT01433172|454845716|FG000|Overall Study|Withdrawal by Subject|0|||
126423401|NCT01433172|454845717|FG001|Overall Study|Withdrawal by Subject|1|||
126423402|NCT01433172|454845718|FG002|Overall Study|Withdrawal by Subject|0|||
126423403|NCT01433172|454845716|FG000|Overall Study|Disease Progression|0|||
126423404|NCT01433172|454845717|FG001|Overall Study|Disease Progression|0|||
126423405|NCT01433172|454845718|FG002|Overall Study|Disease Progression|1|||
126423406|NCT01433172|454845716|FG000|Overall Study|Death|0|||
126423407|NCT01433172|454845717|FG001|Overall Study|Death|2|||
126423408|NCT01433172|454845718|FG002|Overall Study|Death|0|||
126423409|NCT00773513|454845719|FG000|Overall Study|Renal Transplant|254|||
126423410|NCT00773513|454845720|FG001|Overall Study|Renal Transplant|263|||
126423411|NCT00773513|454845719|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
126423412|NCT00773513|454845720|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
126423413|NCT00773513|454845719|FG000|Overall Study|Withdrew Consent|68|||
126423414|NCT00773513|454845720|FG001|Overall Study|Withdrew Consent|69|||
126423415|NCT00773513|454845719|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
126423416|NCT00773513|454845720|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
126423417|NCT00773513|454845719|FG000|Overall Study|Failure to Return|22|||
126423418|NCT00773513|454845720|FG001|Overall Study|Failure to Return|8|||
126423419|NCT00773513|454845719|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126423420|NCT00773513|454845720|FG001|Overall Study|Insufficient Therapeutic Response|18|||
126423421|NCT00773513|454845719|FG000|Overall Study|Reason Not Specified|159|||
126423422|NCT00773513|454845720|FG001|Overall Study|Reason Not Specified|126|||
126423423|NCT00773513|454845719|FG000|Overall Study|Death|531|||
126423424|NCT00773513|454845720|FG001|Overall Study|Death|545|||
126423425|NCT03116685|454845725|FG000|Overall Study|Physician Decision|0|||
126423426|NCT03116685|454845726|FG001|Overall Study|Physician Decision|1|||
126423427|NCT05481359|454845727|FG000|Overall Study|Lost to Follow-up|3|||
126423428|NCT05481359|454845727|FG000|Overall Study|Withdrawal by Subject|1|||
126423429|NCT01712204|454845728|FG000|Overall Study|Adverse Event|3|||
126423430|NCT01712204|454845729|FG001|Overall Study|Adverse Event|1|||
126423431|NCT01712204|454845728|FG000|Overall Study|Withdrawal by Subject|3|||
126423432|NCT01712204|454845729|FG001|Overall Study|Withdrawal by Subject|3|||
126423433|NCT01712204|454845728|FG000|Overall Study|Lost to Follow-up|1|||
126423434|NCT01712204|454845729|FG001|Overall Study|Lost to Follow-up|0|||
126423435|NCT01712204|454845728|FG000|Overall Study|Protocol Violation|1|||
126423436|NCT01712204|454845729|FG001|Overall Study|Protocol Violation|1|||
126423437|NCT01045694|454845737|FG000|Overall Study|Withdrawal by Subject|2|||
126423438|NCT01150097|454845738|FG000|Months 24 to 36 Post-transplantation|Death|2|||
126423439|NCT01150097|454845739|FG001|Months 24 to 36 Post-transplantation|Death|0|||
126423440|NCT01150097|454845740|FG002|Months 24 to 36 Post-transplantation|Death|0|||
126423441|NCT01150097|454845738|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
126423442|NCT01150097|454845739|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
126423443|NCT01150097|454845740|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
126423444|NCT01150097|454845738|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
126423445|NCT01150097|454845739|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
126423446|NCT01150097|454845740|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
126423447|NCT01150097|454845738|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
126423448|NCT01150097|454845739|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
126423449|NCT01150097|454845740|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
126423450|NCT01150097|454845738|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
126423451|NCT01150097|454845739|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
126423452|NCT01150097|454845740|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
126423453|NCT01150097|454845738|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
126423454|NCT01150097|454845739|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
126423455|NCT01150097|454845740|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
126423456|NCT01150097|454845738|FG000|Months 24 to 48 Post-transplantation|Death|2|||
126423457|NCT01150097|454845739|FG001|Months 24 to 48 Post-transplantation|Death|0|||
126423458|NCT01150097|454845740|FG002|Months 24 to 48 Post-transplantation|Death|0|||
126423459|NCT01114828|454845743|FG000|Overall Study|Adverse Event|1|||
126423460|NCT01114828|454845744|FG001|Overall Study|Adverse Event|1|||
126423461|NCT01114828|454845743|FG000|Overall Study|Lack of Efficacy|0|||
126423462|NCT01114828|454845744|FG001|Overall Study|Lack of Efficacy|2|||
126423463|NCT01114828|454845743|FG000|Overall Study|Protocol Violation|2|||
126423464|NCT01114828|454845744|FG001|Overall Study|Protocol Violation|0|||
126423465|NCT01114828|454845743|FG000|Overall Study|Withdrawal by Subject|0|||
126423466|NCT01114828|454845744|FG001|Overall Study|Withdrawal by Subject|1|||
126423467|NCT00549445|454845745|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
126423468|NCT00549445|454845746|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
126423469|NCT02719171|454846968|FG000|Overall Study|Adverse Event|1|||
126423470|NCT02719171|454846969|FG001|Overall Study|Adverse Event|2|||
126423471|NCT02719171|454846970|FG002|Overall Study|Adverse Event|0|||
126423472|NCT02719171|454846971|FG003|Overall Study|Adverse Event|0|||
126423473|NCT02719171|454846972|FG004|Overall Study|Adverse Event|2|||
126423474|NCT02719171|454846968|FG000|Overall Study|Lost to Follow-up|0|||
126423475|NCT02719171|454846969|FG001|Overall Study|Lost to Follow-up|0|||
126423476|NCT02719171|454846970|FG002|Overall Study|Lost to Follow-up|1|||
126423477|NCT02719171|454846971|FG003|Overall Study|Lost to Follow-up|0|||
126423478|NCT02719171|454846972|FG004|Overall Study|Lost to Follow-up|0|||
126423479|NCT02719171|454846968|FG000|Overall Study|Subject Withdrawal|0|||
126423480|NCT02719171|454846969|FG001|Overall Study|Subject Withdrawal|2|||
126423481|NCT02719171|454846970|FG002|Overall Study|Subject Withdrawal|2|||
126423482|NCT02719171|454846971|FG003|Overall Study|Subject Withdrawal|1|||
126423483|NCT02719171|454846972|FG004|Overall Study|Subject Withdrawal|0|||
126423484|NCT02719171|454846968|FG000|Overall Study|Other|0|||
126423485|NCT02719171|454846969|FG001|Overall Study|Other|0|||
126423486|NCT02719171|454846970|FG002|Overall Study|Other|0|||
126423487|NCT02719171|454846971|FG003|Overall Study|Other|1|||
126423488|NCT02719171|454846972|FG004|Overall Study|Other|0|||
126423489|NCT02796677|454846973|FG000|Overall Study|Adverse Event|11|||
126423490|NCT02796677|454846974|FG001|Overall Study|Adverse Event|22|||
126423491|NCT02796677|454846975|FG002|Overall Study|Adverse Event|14|||
126423492|NCT02796677|454846976|FG003|Overall Study|Adverse Event|14|||
126423493|NCT02796677|454846973|FG000|Overall Study|Protocol Violation|7|||
126423494|NCT02796677|454846974|FG001|Overall Study|Protocol Violation|5|||
126423495|NCT02796677|454846975|FG002|Overall Study|Protocol Violation|4|||
126423496|NCT02796677|454846976|FG003|Overall Study|Protocol Violation|8|||
126423497|NCT02796677|454846973|FG000|Overall Study|Lost to Follow-up|1|||
126423498|NCT02796677|454846974|FG001|Overall Study|Lost to Follow-up|5|||
126423499|NCT02796677|454846975|FG002|Overall Study|Lost to Follow-up|2|||
126423500|NCT02796677|454846976|FG003|Overall Study|Lost to Follow-up|2|||
126423501|NCT02796677|454846973|FG000|Overall Study|Lack of Efficacy|7|||
126423502|NCT02796677|454846974|FG001|Overall Study|Lack of Efficacy|9|||
126423503|NCT02796677|454846975|FG002|Overall Study|Lack of Efficacy|14|||
126423504|NCT02796677|454846976|FG003|Overall Study|Lack of Efficacy|20|||
126423505|NCT02796677|454846973|FG000|Overall Study|Withdrawal by Subject|4|||
126423506|NCT02796677|454846974|FG001|Overall Study|Withdrawal by Subject|14|||
126423507|NCT02796677|454846975|FG002|Overall Study|Withdrawal by Subject|6|||
126423508|NCT02796677|454846976|FG003|Overall Study|Withdrawal by Subject|7|||
126423509|NCT02796677|454846973|FG000|Overall Study|Progressive disease|6|||
126423510|NCT02796677|454846974|FG001|Overall Study|Progressive disease|15|||
126423511|NCT02796677|454846975|FG002|Overall Study|Progressive disease|13|||
126423512|NCT02796677|454846976|FG003|Overall Study|Progressive disease|18|||
126423513|NCT02796677|454846973|FG000|Overall Study|Reason not mentioned|2|||
126423514|NCT02796677|454846974|FG001|Overall Study|Reason not mentioned|3|||
126423515|NCT02796677|454846975|FG002|Overall Study|Reason not mentioned|0|||
126423516|NCT02796677|454846976|FG003|Overall Study|Reason not mentioned|5|||
126423517|NCT00961181|454846977|FG000|Overall Study|Death|2|||
126423518|NCT00961181|454846977|FG000|Overall Study|Withdrawal by Subject|2|||
126423519|NCT00961181|454846977|FG000|Overall Study|Lost to Follow-up|1|||
126423520|NCT03811340|454846978|FG000|Overall Study|subjects did not complete the survey.|90|||
126423521|NCT01045967|454846979|FG000|Second Intervention|Protocol Violation|0|||
126423522|NCT01045967|454846980|FG001|Second Intervention|Protocol Violation|1|||
126423523|NCT00764361|454846983|FG000|Overall Study|Withdrawal by Subject|2|||
126423524|NCT00764361|454846984|FG001|Overall Study|Withdrawal by Subject|3|||
126423525|NCT00764361|454846983|FG000|Overall Study|Adverse Event|0|||
126423526|NCT00764361|454846984|FG001|Overall Study|Adverse Event|1|||
126423527|NCT02090426|454846985|FG000|Overall Study|Lost to Follow-up|12|||
126423528|NCT02090426|454846986|FG001|Overall Study|Lost to Follow-up|6|||
126423529|NCT01141712|454846990|FG000|Overall Study|Disease progression|3|||
126423530|NCT01308736|454846991|FG000|Overall Study|Did not attend a single session|6|||
126423531|NCT01308736|454846992|FG001|Overall Study|Did not attend a single session|5|||
126423532|NCT00296816|454846993|FG000|Overall Study|Disease Progression|37|||
126423533|NCT00296816|454846993|FG000|Overall Study|Adverse Event|18|||
126423534|NCT00296816|454846993|FG000|Overall Study|Investigator/Participant request|5|||
126423535|NCT00296816|454846993|FG000|Overall Study|Non-compliance|1|||
126423536|NCT00296816|454846993|FG000|Overall Study|Missing for end of treatment|4|||
126423537|NCT00296816|454846993|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
126423538|NCT00296816|454846993|FG000|Overall Study|Poor performance status|1|||
126423539|NCT00296816|454846993|FG000|Overall Study|Relocation to Florida|1|||
126423540|NCT00296816|454846993|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
126423541|NCT00296816|454846993|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
126423542|NCT00296816|454846993|FG000|Overall Study|Neuropathy/patient preference|1|||
126423543|NCT00296816|454846993|FG000|Overall Study|Proteinuria|1|||
126423544|NCT00296816|454846993|FG000|Overall Study|ineligibility due to radiation treatment|1|||
126423545|NCT00985465|454846999|FG000|Overall Study|Withdrawal by Subject|1|||
126423546|NCT00985465|454847000|FG001|Overall Study|Withdrawal by Subject|2|||
126423547|NCT00985465|454846999|FG000|Overall Study|Considered to be part of the other group|0|||
126423548|NCT00985465|454847000|FG001|Overall Study|Considered to be part of the other group|1|||
126423549|NCT04701333|454847001|FG000|Overall Study|Lost to Follow-up|3|||
126423550|NCT04701333|454847002|FG001|Overall Study|Lost to Follow-up|7|||
126423551|NCT04701333|454847001|FG000|Overall Study|Withdrawal by Subject|0|||
126423552|NCT04701333|454847002|FG001|Overall Study|Withdrawal by Subject|1|||
126423553|NCT01012258|454847003|FG000|Overall Study|Death|14|||
126423554|NCT01012258|454847003|FG000|Overall Study|Lost to Follow-up|1|||
126423555|NCT01012258|454847003|FG000|Overall Study|Adverse Event|1|||
126423556|NCT01012258|454847003|FG000|Overall Study|Progressive Disease (PD)|18|||
126423557|NCT01012258|454847003|FG000|Overall Study|Symptomatic Deterioration|1|||
126423558|NCT01012258|454847003|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
126423559|NCT01012258|454847003|FG000|Overall Study|Another Tumor Discovered|1|||
126423560|NCT01012258|454847003|FG000|Overall Study|Ongoing|29|||
126423561|NCT03600740|454847004|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
126423562|NCT01623115|454847005|FG000|Overall Study|Randomized but not treated|0|||
126423563|NCT01623115|454847006|FG001|Overall Study|Randomized but not treated|1|||
126423564|NCT01623115|454847005|FG000|Overall Study|Physician Decision|1|||
126423565|NCT01623115|454847006|FG001|Overall Study|Physician Decision|0|||
126423566|NCT01623115|454847005|FG000|Overall Study|Participants moved|1|||
126423567|NCT01623115|454847006|FG001|Overall Study|Participants moved|5|||
126423568|NCT01623115|454847005|FG000|Overall Study|Adverse Event|10|||
126423569|NCT01623115|454847006|FG001|Overall Study|Adverse Event|13|||
126423570|NCT01623115|454847005|FG000|Overall Study|Poor compliance to protocol|4|||
126423571|NCT01623115|454847006|FG001|Overall Study|Poor compliance to protocol|10|||
126423572|NCT01623115|454847005|FG000|Overall Study|Consent withdrawn by participant|2|||
126423573|NCT01623115|454847006|FG001|Overall Study|Consent withdrawn by participant|6|||
126423574|NCT01623115|454847005|FG000|Overall Study|Related to study drug administration|0|||
126423575|NCT01623115|454847006|FG001|Overall Study|Related to study drug administration|2|||
126423576|NCT01623115|454847005|FG000|Overall Study|Last visit outside protocol visit window|14|||
126423577|NCT01623115|454847006|FG001|Overall Study|Last visit outside protocol visit window|26|||
126423578|NCT01623115|454847005|FG000|Overall Study|Site closure|1|||
126423579|NCT01623115|454847006|FG001|Overall Study|Site closure|7|||
126423580|NCT01623115|454847005|FG000|Overall Study|Death|0|||
126423581|NCT01623115|454847006|FG001|Overall Study|Death|4|||
126423582|NCT01623115|454847005|FG000|Overall Study|Other than specified above|0|||
126423583|NCT01623115|454847006|FG001|Overall Study|Other than specified above|3|||
126423584|NCT00580723|454847012|FG000|Overall Study|Did not want to participate in extension|3|||
126423585|NCT00580723|454847012|FG000|Overall Study|Lost to Follow-up|5|||
126423586|NCT00148759|454847013|FG000|Overall Study|Withdrawal by Subject|1|||
126423587|NCT00148759|454847014|FG001|Overall Study|Withdrawal by Subject|1|||
126423588|NCT00148759|454847013|FG000|Overall Study|Lost to Follow-up|1|||
126423589|NCT00148759|454847014|FG001|Overall Study|Lost to Follow-up|0|||
126423590|NCT05202418|454847015|FG000|Overall Study|Withdrawal by Subject|2|||
126423591|NCT05202418|454847016|FG001|Overall Study|Withdrawal by Subject|1|||
126423592|NCT05202418|454847015|FG000|Overall Study|Lost to Follow-up|1|||
126423593|NCT05202418|454847016|FG001|Overall Study|Lost to Follow-up|1|||
126423594|NCT00857285|454847017|FG000|Overall Study|Adverse Event|4|||
126423595|NCT00857285|454847018|FG001|Overall Study|Adverse Event|2|||
126423596|NCT00857285|454847017|FG000|Overall Study|Lack of Efficacy|0|||
126423597|NCT00857285|454847018|FG001|Overall Study|Lack of Efficacy|2|||
126423598|NCT00857285|454847017|FG000|Overall Study|Protocol Violation|3|||
126423599|NCT00857285|454847018|FG001|Overall Study|Protocol Violation|1|||
126423600|NCT00857285|454847017|FG000|Overall Study|Withdrawal by Subject|4|||
126423601|NCT00857285|454847018|FG001|Overall Study|Withdrawal by Subject|0|||
126423602|NCT00857285|454847017|FG000|Overall Study|Randomization criteria not met|1|||
126423603|NCT00857285|454847018|FG001|Overall Study|Randomization criteria not met|1|||
126423604|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
126423605|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
126423606|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
126423607|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
126423608|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
126423609|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
126423610|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
126423611|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
126423612|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
126423613|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
126423614|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
126423615|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
126423616|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
126423617|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
126423618|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
126423619|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
126423620|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
126423621|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
126423622|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
126423623|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
126423624|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
126423625|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
126423626|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
126423627|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
126423628|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
126423629|NCT01329978|454847024|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
126423630|NCT01329978|454847025|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
126423631|NCT01329978|454847026|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
126423632|NCT01329978|454847027|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
126423633|NCT01329978|454847028|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
126423634|NCT01329978|454847024|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
126423635|NCT01329978|454847025|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
126423636|NCT01329978|454847026|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
126423637|NCT01329978|454847027|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
126423638|NCT01329978|454847028|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
126423639|NCT04170543|454847039|FG000|Overall Study|Death|1|||
126423640|NCT04170543|454847040|FG001|Overall Study|Death|1|||
126423641|NCT04170543|454847041|FG002|Overall Study|Death|1|||
126423642|NCT04170543|454847042|FG003|Overall Study|Death|1|||
126423643|NCT04170543|454847043|FG004|Overall Study|Death|1|||
126423644|NCT04170543|454847039|FG000|Overall Study|Lost to Follow-up|3|||
126423645|NCT04170543|454847040|FG001|Overall Study|Lost to Follow-up|3|||
126423646|NCT04170543|454847041|FG002|Overall Study|Lost to Follow-up|0|||
126423647|NCT04170543|454847042|FG003|Overall Study|Lost to Follow-up|3|||
126423648|NCT04170543|454847043|FG004|Overall Study|Lost to Follow-up|1|||
126423649|NCT04170543|454847039|FG000|Overall Study|Withdrawal by Subject|13|||
126423650|NCT04170543|454847040|FG001|Overall Study|Withdrawal by Subject|6|||
126423651|NCT04170543|454847041|FG002|Overall Study|Withdrawal by Subject|5|||
126423652|NCT04170543|454847042|FG003|Overall Study|Withdrawal by Subject|4|||
126423653|NCT04170543|454847043|FG004|Overall Study|Withdrawal by Subject|9|||
126423654|NCT04170543|454847039|FG000|Overall Study|Not able to transition to phase 2b|8|||
126423655|NCT04170543|454847040|FG001|Overall Study|Not able to transition to phase 2b|0|||
126423656|NCT04170543|454847041|FG002|Overall Study|Not able to transition to phase 2b|10|||
126423657|NCT04170543|454847042|FG003|Overall Study|Not able to transition to phase 2b|0|||
126423658|NCT04170543|454847043|FG004|Overall Study|Not able to transition to phase 2b|6|||
126423659|NCT04170543|454847039|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
126423660|NCT04170543|454847040|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
126423661|NCT04170543|454847041|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
126423662|NCT04170543|454847042|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
126423663|NCT04170543|454847043|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
126423664|NCT04170543|454847039|FG000|Overall Study|Not Treated|0|||
126423665|NCT04170543|454847040|FG001|Overall Study|Not Treated|0|||
126423666|NCT04170543|454847041|FG002|Overall Study|Not Treated|0|||
126423667|NCT04170543|454847042|FG003|Overall Study|Not Treated|0|||
126423668|NCT04170543|454847043|FG004|Overall Study|Not Treated|2|||
126423669|NCT04170543|454847039|FG000|Overall Study|(CRF)|16|||
126423670|NCT04170543|454847040|FG001|Overall Study|(CRF)|15|||
126423671|NCT04170543|454847041|FG002|Overall Study|(CRF)|12|||
126423672|NCT04170543|454847042|FG003|Overall Study|(CRF)|17|||
126202529|NCT00851721|454027523|FG001|Overall Study|planned surgery|0|||
126202530|NCT00851721|454027522|FG000|Overall Study|Death|1|||
125978706|NCT00316082|453209827|FG002|Overall Study|Lack of Efficacy|3|||
125978707|NCT00316082|453209828|FG003|Overall Study|Lack of Efficacy|4|||
125978708|NCT00316082|453209829|FG004|Overall Study|Lack of Efficacy|6|||
126202531|NCT00851721|454027523|FG001|Overall Study|Death|0|||
126202532|NCT00851721|454027522|FG000|Overall Study|Adverse Event|0|||
125978709|NCT00316082|453209825|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
125978710|NCT00316082|453209826|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
125978711|NCT00316082|453209827|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
125978712|NCT00316082|453209828|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
125978713|NCT00316082|453209829|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
125978714|NCT00316082|453209825|FG000|Overall Study|Lost to Follow-up|7|||
125978715|NCT00316082|453209826|FG001|Overall Study|Lost to Follow-up|6|||
125978716|NCT00316082|453209827|FG002|Overall Study|Lost to Follow-up|7|||
125978717|NCT00316082|453209828|FG003|Overall Study|Lost to Follow-up|8|||
126423673|NCT04170543|454847043|FG004|Overall Study|(CRF)|17|||
126423674|NCT04170543|454847039|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
126423675|NCT04170543|454847040|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
126423676|NCT04170543|454847041|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
126423677|NCT04170543|454847042|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
126423678|NCT04170543|454847043|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
126423679|NCT04303559|454847044|FG000|Overall Study|Study closed due to poor enrollment.|1|||
125978718|NCT00316082|453209829|FG004|Overall Study|Lost to Follow-up|6|||
125978719|NCT00316082|453209825|FG000|Overall Study|Poor/noncompliance|6|||
125978720|NCT00316082|453209826|FG001|Overall Study|Poor/noncompliance|1|||
125978721|NCT00316082|453209827|FG002|Overall Study|Poor/noncompliance|4|||
125978722|NCT00316082|453209828|FG003|Overall Study|Poor/noncompliance|1|||
125978723|NCT00316082|453209829|FG004|Overall Study|Poor/noncompliance|4|||
125978724|NCT00316082|453209825|FG000|Overall Study|Adverse Event|4|||
125978725|NCT00316082|453209826|FG001|Overall Study|Adverse Event|2|||
125978726|NCT00316082|453209827|FG002|Overall Study|Adverse Event|5|||
125978727|NCT00316082|453209828|FG003|Overall Study|Adverse Event|1|||
125978728|NCT00316082|453209829|FG004|Overall Study|Adverse Event|3|||
125978729|NCT00316082|453209825|FG000|Overall Study|Subject no longer meets study criteria|3|||
125978730|NCT00316082|453209826|FG001|Overall Study|Subject no longer meets study criteria|1|||
125978731|NCT00316082|453209827|FG002|Overall Study|Subject no longer meets study criteria|2|||
125978732|NCT00316082|453209828|FG003|Overall Study|Subject no longer meets study criteria|2|||
125978733|NCT00316082|453209829|FG004|Overall Study|Subject no longer meets study criteria|1|||
125978734|NCT00316082|453209825|FG000|Overall Study|Physician Decision|1|||
125978735|NCT00316082|453209826|FG001|Overall Study|Physician Decision|1|||
125978736|NCT00316082|453209827|FG002|Overall Study|Physician Decision|2|||
125978737|NCT00316082|453209828|FG003|Overall Study|Physician Decision|1|||
125978738|NCT00316082|453209829|FG004|Overall Study|Physician Decision|1|||
125978739|NCT00316082|453209825|FG000|Overall Study|Death|0|||
125978740|NCT00316082|453209826|FG001|Overall Study|Death|0|||
125978741|NCT00316082|453209827|FG002|Overall Study|Death|1|||
125978742|NCT00316082|453209828|FG003|Overall Study|Death|0|||
125978743|NCT00316082|453209829|FG004|Overall Study|Death|0|||
125978744|NCT00316082|453209825|FG000|Overall Study|Administrative reason by sponsor|0|||
125978745|NCT00316082|453209826|FG001|Overall Study|Administrative reason by sponsor|0|||
125978746|NCT00316082|453209827|FG002|Overall Study|Administrative reason by sponsor|1|||
125978747|NCT00316082|453209828|FG003|Overall Study|Administrative reason by sponsor|0|||
125978748|NCT00316082|453209829|FG004|Overall Study|Administrative reason by sponsor|0|||
125978749|NCT00528775|453209832|FG000|Overall Study|Other not specified|1|||
125978750|NCT00587964|453209836|FG000|Overall Study|Withdrawal by Subject|1|||
125978751|NCT00587964|453209836|FG000|Overall Study|Lost to Follow-up|1|||
125978752|NCT00587964|453209836|FG000|Overall Study|Patient found to be ineligible|1|||
125978753|NCT00587964|453209836|FG000|Overall Study|Patient did not receive intervention|5|||
125978754|NCT00587964|453209836|FG000|Overall Study|Progression of Disease|4|||
125978755|NCT00540124|453209837|FG000|Overall Study|Adverse Event|0|||
125978756|NCT00540124|453209838|FG001|Overall Study|Adverse Event|2|||
125978757|NCT00540124|453209839|FG002|Overall Study|Adverse Event|1|||
125978758|NCT00540124|453209837|FG000|Overall Study|Entry Criteria Not Met|2|||
125978759|NCT00540124|453209838|FG001|Overall Study|Entry Criteria Not Met|0|||
125978760|NCT00540124|453209839|FG002|Overall Study|Entry Criteria Not Met|0|||
125978761|NCT00540124|453209837|FG000|Overall Study|Lack of Efficacy|1|||
125978762|NCT00540124|453209838|FG001|Overall Study|Lack of Efficacy|0|||
126423680|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
126423681|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
126423682|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
126423683|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
126423684|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
126423685|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
126423686|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
126423687|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
126423688|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
126423689|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
126423690|NCT01987102|454847045|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
126423691|NCT01987102|454847046|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
126423692|NCT01236521|454847049|FG000|Overall Study|Withdrawal by Subject|12|||
125978763|NCT00540124|453209839|FG002|Overall Study|Lack of Efficacy|0|||
125978764|NCT00540124|453209837|FG000|Overall Study|Withdrawal by Subject|1|||
125978765|NCT00540124|453209838|FG001|Overall Study|Withdrawal by Subject|1|||
125978766|NCT00540124|453209839|FG002|Overall Study|Withdrawal by Subject|0|||
125978767|NCT01569438|453209843|FG000|Overall Study|Lack of Efficacy|1|||
125978768|NCT01569438|453209844|FG001|Overall Study|Lack of Efficacy|2|||
125978769|NCT01569438|453209843|FG000|Overall Study|Withdrawal by Subject|0|||
125978770|NCT01569438|453209844|FG001|Overall Study|Withdrawal by Subject|3|||
125978771|NCT01569438|453209843|FG000|Overall Study|Adverse Event|2|||
125978772|NCT01569438|453209844|FG001|Overall Study|Adverse Event|15|||
125978773|NCT01569438|453209843|FG000|Overall Study|Protocol Violation|2|||
125978774|NCT01569438|453209844|FG001|Overall Study|Protocol Violation|0|||
125978775|NCT01569438|453209843|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
125978776|NCT01569438|453209844|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
125978777|NCT01569438|453209843|FG000|Overall Study|Sponsor/Physician decision|1|||
125978778|NCT01569438|453209844|FG001|Overall Study|Sponsor/Physician decision|1|||
125978779|NCT01569438|453209843|FG000|Overall Study|Unable to adhere to study schedule|0|||
125978780|NCT01569438|453209844|FG001|Overall Study|Unable to adhere to study schedule|1|||
125978781|NCT03649230|453209846|FG000|Overall Study|Adverse Event|12|||
125978782|NCT03649230|453209846|FG000|Overall Study|Death|8|||
125978783|NCT03649230|453209846|FG000|Overall Study|Withdrawal by Subject|6|||
125978784|NCT03649230|453209846|FG000|Overall Study|Physician Decision|5|||
125978785|NCT03649230|453209846|FG000|Overall Study|Disease progression|5|||
125978786|NCT03649230|453209846|FG000|Overall Study|Switched to non-HEC|5|||
125978787|NCT03649230|453209846|FG000|Overall Study|Chemotherapy discontinued|4|||
125978788|NCT03649230|453209846|FG000|Overall Study|Received only 3 HEC cycles|4|||
125978789|NCT03649230|453209846|FG000|Overall Study|Screen Failure|3|||
125978790|NCT03649230|453209846|FG000|Overall Study|Patient stopped treatment|2|||
125978791|NCT03649230|453209846|FG000|Overall Study|Protocol Violation|1|||
125978792|NCT03649230|453209846|FG000|Overall Study|Non-compliance|1|||
125978793|NCT03649230|453209846|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
125978794|NCT01693068|453209850|FG000|Randomization Period|On-study|2|||
125978795|NCT01693068|453209851|FG001|Randomization Period|On-study|5|||
125978796|NCT01693068|453209852|FG002|Randomization Period|On-study|0|||
125978797|NCT01693068|453209850|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
125978798|NCT01693068|453209851|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
125978799|NCT01693068|453209852|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
125978800|NCT00977665|453209855|FG000|Overall Study|Withdrawal by Subject|1|||
125978801|NCT00977665|453209856|FG001|Overall Study|Withdrawal by Subject|3|||
125978802|NCT00977665|453209855|FG000|Overall Study|Physician Decision|2|||
125978803|NCT00977665|453209856|FG001|Overall Study|Physician Decision|1|||
125978804|NCT00977665|453209855|FG000|Overall Study|Sponsor requested withdrawal|0|||
125978805|NCT00977665|453209856|FG001|Overall Study|Sponsor requested withdrawal|1|||
125978806|NCT00977665|453209855|FG000|Overall Study|Lost to Follow-up|1|||
125978807|NCT00977665|453209856|FG001|Overall Study|Lost to Follow-up|0|||
125978808|NCT00977665|453209855|FG000|Overall Study|Death|3|||
125978809|NCT00977665|453209856|FG001|Overall Study|Death|2|||
125978810|NCT00977665|453209855|FG000|Overall Study|Adverse Event|14|||
125978811|NCT00977665|453209856|FG001|Overall Study|Adverse Event|7|||
125978812|NCT00977665|453209855|FG000|Overall Study|Treatment failure|0|||
125978813|NCT00977665|453209856|FG001|Overall Study|Treatment failure|1|||
125978814|NCT02432105|453209861|FG000|Overall Study|Lost to Follow-up|1|||
125978815|NCT02432105|453209862|FG001|Overall Study|Lost to Follow-up|1|||
125978816|NCT02432105|453209863|FG002|Overall Study|Lost to Follow-up|0|||
125978817|NCT02432105|453209861|FG000|Overall Study|Withdrawal by Subject|1|||
125978818|NCT02432105|453209862|FG001|Overall Study|Withdrawal by Subject|0|||
125978819|NCT02432105|453209863|FG002|Overall Study|Withdrawal by Subject|1|||
125978820|NCT02432105|453209861|FG000|Overall Study|Culture positive for yeast|0|||
125978821|NCT02432105|453209862|FG001|Overall Study|Culture positive for yeast|1|||
125978822|NCT02432105|453209863|FG002|Overall Study|Culture positive for yeast|0|||
125978823|NCT02432105|453209861|FG000|Overall Study|Randomized in error|0|||
125978824|NCT02432105|453209862|FG001|Overall Study|Randomized in error|0|||
125978825|NCT02432105|453209863|FG002|Overall Study|Randomized in error|2|||
125978826|NCT01400503|453209864|FG000|Overall Study|Withdrawal by Subject|1|||
125978827|NCT01400503|453209864|FG000|Overall Study|Study Terminated by Sponsor|58|||
125978828|NCT01400503|453209864|FG000|Overall Study|Other|1|||
125978829|NCT00058123|453209865|FG000|Overall Study|Wrong histology|9|||
125978830|NCT00058123|453209865|FG000|Overall Study|Received >3 prior treatments|1|||
125978831|NCT03053050|453209866|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
125978832|NCT03053050|453209867|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
125978833|NCT03053050|453209868|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
125978834|NCT03053050|453209869|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
125978835|NCT03053050|453209866|FG000|Randomized Phase|Withdrew Consent|16|||
125978836|NCT03053050|453209867|FG001|Randomized Phase|Withdrew Consent|8|||
125978837|NCT03053050|453209868|FG002|Randomized Phase|Withdrew Consent|9|||
125978838|NCT03053050|453209869|FG003|Randomized Phase|Withdrew Consent|0|||
125978839|NCT03053050|453209866|FG000|Randomized Phase|Investigator's Discretion|6|||
126202533|NCT00851721|454027523|FG001|Overall Study|Adverse Event|1|||
126202534|NCT01218477|454027525|FG000|Overall Study|Disease progression|2|||
126202535|NCT01218477|454027526|FG001|Overall Study|Disease progression|3|||
126202536|NCT01218477|454027527|FG002|Overall Study|Disease progression|6|||
126202537|NCT01218477|454027528|FG003|Overall Study|Disease progression|2|||
126202538|NCT01218477|454027525|FG000|Overall Study|Study drug toxicity|0|||
126202539|NCT01218477|454027526|FG001|Overall Study|Study drug toxicity|2|||
126202540|NCT01218477|454027527|FG002|Overall Study|Study drug toxicity|5|||
126202541|NCT01218477|454027528|FG003|Overall Study|Study drug toxicity|0|||
126202542|NCT01218477|454027525|FG000|Overall Study|No longer meets study criteria|1|||
126202543|NCT01218477|454027526|FG001|Overall Study|No longer meets study criteria|0|||
126202544|NCT01218477|454027527|FG002|Overall Study|No longer meets study criteria|0|||
126202545|NCT01218477|454027528|FG003|Overall Study|No longer meets study criteria|0|||
126202546|NCT01218477|454027525|FG000|Overall Study|Withdrawal by Subject|0|||
126202547|NCT01218477|454027526|FG001|Overall Study|Withdrawal by Subject|0|||
126202548|NCT01218477|454027527|FG002|Overall Study|Withdrawal by Subject|1|||
126202549|NCT01218477|454027528|FG003|Overall Study|Withdrawal by Subject|0|||
126202550|NCT01218477|454027525|FG000|Overall Study|Prepared for cell transplantation|0|||
126202551|NCT01218477|454027526|FG001|Overall Study|Prepared for cell transplantation|1|||
126202552|NCT01218477|454027527|FG002|Overall Study|Prepared for cell transplantation|1|||
126202553|NCT01218477|454027528|FG003|Overall Study|Prepared for cell transplantation|0|||
125978840|NCT03053050|453209867|FG001|Randomized Phase|Investigator's Discretion|6|||
125978841|NCT03053050|453209868|FG002|Randomized Phase|Investigator's Discretion|3|||
125978842|NCT03053050|453209869|FG003|Randomized Phase|Investigator's Discretion|0|||
126202554|NCT01218477|454027525|FG000|Overall Study|Administrative reason by sponsor|0|||
126202555|NCT01218477|454027526|FG001|Overall Study|Administrative reason by sponsor|0|||
126202556|NCT01218477|454027527|FG002|Overall Study|Administrative reason by sponsor|1|||
125978843|NCT03053050|453209866|FG000|Randomized Phase|Lost to Follow-up|5|||
125978844|NCT03053050|453209867|FG001|Randomized Phase|Lost to Follow-up|1|||
125978845|NCT03053050|453209868|FG002|Randomized Phase|Lost to Follow-up|1|||
125978846|NCT03053050|453209869|FG003|Randomized Phase|Lost to Follow-up|0|||
125978847|NCT03053050|453209866|FG000|Randomized Phase|Adverse Event|0|||
125978848|NCT03053050|453209867|FG001|Randomized Phase|Adverse Event|1|||
125978849|NCT03053050|453209868|FG002|Randomized Phase|Adverse Event|0|||
125978850|NCT03053050|453209869|FG003|Randomized Phase|Adverse Event|0|||
125978851|NCT03053050|453209866|FG000|Randomized Phase|Randomized but Never Treated|2|||
125978852|NCT03053050|453209867|FG001|Randomized Phase|Randomized but Never Treated|2|||
125978853|NCT03053050|453209868|FG002|Randomized Phase|Randomized but Never Treated|2|||
125978854|NCT03053050|453209869|FG003|Randomized Phase|Randomized but Never Treated|0|||
125978855|NCT03053050|453209866|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
125978856|NCT03053050|453209867|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
125978857|NCT03053050|453209868|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
125978858|NCT03053050|453209869|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
125978859|NCT03053050|453209866|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
125978860|NCT03053050|453209867|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
125978861|NCT03053050|453209868|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
125978862|NCT03053050|453209869|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
125978863|NCT03053050|453209866|FG000|Open-label Phase|Withdrew Consent|0|||
125978864|NCT03053050|453209867|FG001|Open-label Phase|Withdrew Consent|0|||
125978865|NCT03053050|453209868|FG002|Open-label Phase|Withdrew Consent|0|||
125978866|NCT03053050|453209869|FG003|Open-label Phase|Withdrew Consent|6|||
125978867|NCT03053050|453209866|FG000|Open-label Phase|Investigator's Discretion|0|||
125978868|NCT03053050|453209867|FG001|Open-label Phase|Investigator's Discretion|0|||
125978869|NCT03053050|453209868|FG002|Open-label Phase|Investigator's Discretion|0|||
125978870|NCT03053050|453209869|FG003|Open-label Phase|Investigator's Discretion|4|||
125978871|NCT03703466|453209870|FG000|Overall Study|Death|2|||
125978872|NCT03703466|453209871|FG001|Overall Study|Death|1|||
125978873|NCT03703466|453209872|FG002|Overall Study|Death|0|||
125978874|NCT03703466|453209870|FG000|Overall Study|Withdrawal by Subject|0|||
125978875|NCT03703466|453209871|FG001|Overall Study|Withdrawal by Subject|3|||
125978876|NCT03703466|453209872|FG002|Overall Study|Withdrawal by Subject|0|||
125978877|NCT03703466|453209870|FG000|Overall Study|Completed < 3 Cycles|2|||
125978878|NCT03703466|453209871|FG001|Overall Study|Completed < 3 Cycles|2|||
125978879|NCT03703466|453209872|FG002|Overall Study|Completed < 3 Cycles|2|||
125978880|NCT05338333|453209873|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
125978881|NCT05338333|453209874|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
125978882|NCT05073133|453209878|FG000|Overall Study|Death|2|||
126202557|NCT01218477|454027528|FG003|Overall Study|Administrative reason by sponsor|0|||
126202558|NCT01218477|454027525|FG000|Overall Study|Maximum clinical benefit|0|||
126202559|NCT01218477|454027526|FG001|Overall Study|Maximum clinical benefit|2|||
125978883|NCT00833560|453211510|FG000|Overall Study|Toxicity|13|||
125978884|NCT00833560|453211510|FG000|Overall Study|Adverse Event|11|||
125978885|NCT00833560|453211510|FG000|Overall Study|Protocol Violation|6|||
126202560|NCT01218477|454027527|FG002|Overall Study|Maximum clinical benefit|0|||
126202561|NCT01218477|454027528|FG003|Overall Study|Maximum clinical benefit|0|||
125978886|NCT00833560|453211510|FG000|Overall Study|Lack of Efficacy|4|||
125978887|NCT00833560|453211510|FG000|Overall Study|Death|2|||
125978888|NCT00833560|453211510|FG000|Overall Study|Pregression of other disease|1|||
125978889|NCT00833560|453211510|FG000|Overall Study|Other|5|||
125978890|NCT00643916|453211511|FG000|Overall Study|Protocol Violation|0|||
125978891|NCT00643916|453211512|FG001|Overall Study|Protocol Violation|1|||
125978892|NCT00643916|453211513|FG002|Overall Study|Protocol Violation|1|||
125978893|NCT00643916|453211514|FG003|Overall Study|Protocol Violation|1|||
125978894|NCT00643916|453211515|FG004|Overall Study|Protocol Violation|0|||
125978895|NCT00643916|453211516|FG005|Overall Study|Protocol Violation|0|||
125978896|NCT00643916|453211511|FG000|Overall Study|Lost to Follow-up|0|||
125978897|NCT00643916|453211512|FG001|Overall Study|Lost to Follow-up|1|||
125978898|NCT00643916|453211513|FG002|Overall Study|Lost to Follow-up|0|||
125978899|NCT00643916|453211514|FG003|Overall Study|Lost to Follow-up|0|||
125978900|NCT00643916|453211515|FG004|Overall Study|Lost to Follow-up|0|||
125978901|NCT00643916|453211516|FG005|Overall Study|Lost to Follow-up|0|||
125978902|NCT00643916|453211511|FG000|Overall Study|Withdrawal by Subject|2|||
125978903|NCT00643916|453211512|FG001|Overall Study|Withdrawal by Subject|2|||
125978904|NCT00643916|453211513|FG002|Overall Study|Withdrawal by Subject|2|||
125978905|NCT00643916|453211514|FG003|Overall Study|Withdrawal by Subject|1|||
125978906|NCT00643916|453211515|FG004|Overall Study|Withdrawal by Subject|0|||
125978907|NCT00643916|453211516|FG005|Overall Study|Withdrawal by Subject|1|||
125978908|NCT00643916|453211511|FG000|Overall Study|Not Vaccinated|2|||
125978909|NCT00643916|453211512|FG001|Overall Study|Not Vaccinated|2|||
125978910|NCT00643916|453211513|FG002|Overall Study|Not Vaccinated|3|||
125978911|NCT00643916|453211514|FG003|Overall Study|Not Vaccinated|0|||
125978912|NCT00643916|453211515|FG004|Overall Study|Not Vaccinated|2|||
125978913|NCT00643916|453211516|FG005|Overall Study|Not Vaccinated|0|||
125978914|NCT00499031|453211517|FG000|Overall Study|Improper pre-protocol treatment|1|||
125978915|NCT00499031|453211517|FG000|Overall Study|Required test not done|1|||
125978916|NCT00499031|453211517|FG000|Overall Study|Never treated|1|||
125978917|NCT03409666|453211523|FG000|Overall Study|Physician Decision|0|||
125978918|NCT03409666|453211524|FG001|Overall Study|Physician Decision|1|||
125978919|NCT03409666|453211523|FG000|Overall Study|Protocol Violation|0|||
125978920|NCT03409666|453211524|FG001|Overall Study|Protocol Violation|3|||
125978921|NCT01791725|453211525|FG000|Overall Study|Withdrawal by Subject|0|||
125978922|NCT01791725|453211526|FG001|Overall Study|Withdrawal by Subject|1|||
125978923|NCT01791725|453211527|FG002|Overall Study|Withdrawal by Subject|0|||
125978924|NCT00512148|453211528|FG000|Primay Study Period|Withdrawal by Subject|1|||
125978925|NCT00677833|453211529|FG000|Overall Study|Withdrawal by Subject|4|||
125978926|NCT00677833|453211530|FG001|Overall Study|Withdrawal by Subject|0|||
125978927|NCT00677833|453211531|FG002|Overall Study|Withdrawal by Subject|1|||
125978928|NCT00677833|453211532|FG003|Overall Study|Withdrawal by Subject|3|||
125978929|NCT00677833|453211529|FG000|Overall Study|Lost to Follow-up|0|||
125978930|NCT00677833|453211530|FG001|Overall Study|Lost to Follow-up|0|||
125978931|NCT00677833|453211531|FG002|Overall Study|Lost to Follow-up|1|||
125978932|NCT00677833|453211532|FG003|Overall Study|Lost to Follow-up|0|||
125978933|NCT02001194|453211538|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
125978934|NCT02001194|453211539|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
125978935|NCT02001194|453211540|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
125978936|NCT02001194|453211541|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
125978937|NCT02001194|453211538|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
125978938|NCT02001194|453211539|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
125978939|NCT02001194|453211540|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
125978940|NCT02001194|453211541|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
125978941|NCT02606279|453211542|FG000|Overall Study|Lost to Follow-up|0|||
125978942|NCT02606279|453211543|FG001|Overall Study|Lost to Follow-up|1|||
125978943|NCT02690974|453211545|FG000|Overall Study|Adverse Event|16|||
125978944|NCT02690974|453211545|FG000|Overall Study|Death|9|||
125978945|NCT02690974|453211545|FG000|Overall Study|Subject/guardian decision|4|||
125978946|NCT02690974|453211545|FG000|Overall Study|Lost to Follow-up|3|||
125978947|NCT02690974|453211545|FG000|Overall Study|Withdrawal of Informed Consent|3|||
125978948|NCT02690974|453211545|FG000|Overall Study|Physician Decision|2|||
125978949|NCT02690974|453211545|FG000|Overall Study|Non-compliance with study treatment|1|||
125978950|NCT02690974|453211545|FG000|Overall Study|Protocol-defined stopping criteria|1|||
125978951|NCT02690974|453211545|FG000|Overall Study|Protocol Deviation|1|||
125978952|NCT02184611|453211550|FG000|Overall Study|Lack of Efficacy|11|||
125978953|NCT02184611|453211551|FG001|Overall Study|Lack of Efficacy|15|||
125978954|NCT02184611|453211550|FG000|Overall Study|Withdrawal by Subject|5|||
125978955|NCT02184611|453211551|FG001|Overall Study|Withdrawal by Subject|6|||
125978956|NCT02184611|453211550|FG000|Overall Study|Adverse Event|4|||
125978957|NCT02184611|453211551|FG001|Overall Study|Adverse Event|5|||
125978958|NCT02184611|453211550|FG000|Overall Study|Protocol Violation|1|||
125978959|NCT02184611|453211551|FG001|Overall Study|Protocol Violation|1|||
125978960|NCT02184611|453211550|FG000|Overall Study|Protocol defined stopping criteria|0|||
125978961|NCT02184611|453211551|FG001|Overall Study|Protocol defined stopping criteria|1|||
125978962|NCT00522301|453211552|FG000|Overall Study|Withdrawal by Subject|1|||
125978963|NCT00522301|453211552|FG000|Overall Study|Adverse Event|5|||
125978964|NCT01666951|453211553|FG000|Overall Study|Not dosed|1|||
125978965|NCT01666951|453211554|FG001|Overall Study|Not dosed|1|||
125978966|NCT02366910|453211558|FG000|Overall Study|Withdrawal by Subject|2|||
125978967|NCT02366910|453211558|FG000|Overall Study|Screen Failure|3|||
125978968|NCT02623322|453211561|FG000|Overall Study|Lost to Follow-up|2|||
125978969|NCT02623322|453211562|FG001|Overall Study|Lost to Follow-up|1|||
125978970|NCT02623322|453211563|FG002|Overall Study|Lost to Follow-up|0|||
125978971|NCT03563716|453211564|FG000|Overall Study|Death|20|||
125978972|NCT03563716|453211565|FG001|Overall Study|Death|14|||
125978973|NCT03563716|453211564|FG000|Overall Study|Withdrawal by Subject|3|||
125978974|NCT03563716|453211565|FG001|Overall Study|Withdrawal by Subject|3|||
125978975|NCT03563716|453211564|FG000|Overall Study|Still on Study|45|||
125978976|NCT03563716|453211565|FG001|Overall Study|Still on Study|50|||
125978977|NCT04605978|453211569|FG000|Overall Study|Adverse Event|2|||
125978978|NCT04605978|453211570|FG001|Overall Study|Adverse Event|1|||
125978979|NCT04605978|453211569|FG000|Overall Study|Withdrawal nonmedical reason|1|||
125978980|NCT04605978|453211570|FG001|Overall Study|Withdrawal nonmedical reason|1|||
125978981|NCT03813238|453211571|FG000|Overall Study|Adverse Event|0|||
125978982|NCT03813238|453211572|FG001|Overall Study|Adverse Event|6|||
125978983|NCT03813238|453211571|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125978984|NCT03813238|453211572|FG001|Overall Study|Withdrawal by parent/guardian|2|||
125978985|NCT03813238|453211571|FG000|Overall Study|Lost to Follow-up|0|||
125978986|NCT03813238|453211572|FG001|Overall Study|Lost to Follow-up|1|||
125978987|NCT03813238|453211571|FG000|Overall Study|Other than specified|1|||
125978988|NCT03813238|453211572|FG001|Overall Study|Other than specified|2|||
125978989|NCT02583425|453211573|FG000|Screening|Did not meet entry criteria|12|||
125978990|NCT02583425|453211573|FG000|Baseline|Did not meet continued criteria|5|||
125978991|NCT02583425|453211573|FG000|Treatment Period|Adverse Event|1|||
125978992|NCT01690130|453211576|FG000|Overall Study|Subject have cancelled visit.|1|||
125978993|NCT01690130|453211577|FG001|Overall Study|Subject have cancelled visit.|0|||
125978994|NCT03318523|453211578|FG000|PC Period: Up to Year 1|Adverse Event|1|||
125978995|NCT03318523|453211579|FG001|PC Period: Up to Year 1|Adverse Event|0|||
125978996|NCT03318523|453211580|FG002|PC Period: Up to Year 1|Adverse Event|2|||
125978997|NCT03318523|453211581|FG003|PC Period: Up to Year 1|Adverse Event|0|||
125978998|NCT03318523|453211582|FG004|PC Period: Up to Year 1|Adverse Event|0|||
125978999|NCT03318523|453211583|FG005|PC Period: Up to Year 1|Adverse Event|0|||
125979000|NCT03318523|453211584|FG006|PC Period: Up to Year 1|Adverse Event|0|||
125979001|NCT03318523|453211585|FG007|PC Period: Up to Year 1|Adverse Event|0|||
125979002|NCT03318523|453211586|FG008|PC Period: Up to Year 1|Adverse Event|0|||
125979003|NCT03318523|453211587|FG009|PC Period: Up to Year 1|Adverse Event|0|||
125979004|NCT03318523|453211578|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
125979005|NCT03318523|453211579|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
125979006|NCT03318523|453211580|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
125979007|NCT03318523|453211581|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
125979008|NCT03318523|453211582|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
125979009|NCT03318523|453211583|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
125979010|NCT03318523|453211584|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
125979011|NCT03318523|453211585|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
125979012|NCT03318523|453211586|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
125979013|NCT03318523|453211587|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
125979014|NCT03318523|453211578|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125979015|NCT03318523|453211579|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125979016|NCT03318523|453211580|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125979017|NCT03318523|453211581|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125979018|NCT03318523|453211582|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
125979019|NCT03318523|453211583|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125979020|NCT03318523|453211584|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125979021|NCT03318523|453211585|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
125979022|NCT03318523|453211586|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125979023|NCT03318523|453211587|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
125979024|NCT03318523|453211578|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125979025|NCT03318523|453211579|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125979026|NCT03318523|453211580|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125979027|NCT03318523|453211581|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125979028|NCT03318523|453211582|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
125979029|NCT03318523|453211583|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125979030|NCT03318523|453211584|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125979031|NCT03318523|453211585|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
125979032|NCT03318523|453211586|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
125979033|NCT03318523|453211587|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
125979034|NCT03318523|453211578|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125979035|NCT03318523|453211579|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125979036|NCT03318523|453211580|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126202562|NCT03137433|454027529|FG000|Overall Study|Withdrawal by Subject|11|||
126202563|NCT03137433|454027530|FG001|Overall Study|Withdrawal by Subject|11|||
126202564|NCT03137433|454027529|FG000|Overall Study|Lost to Follow-up|5|||
126202565|NCT03137433|454027530|FG001|Overall Study|Lost to Follow-up|6|||
126202566|NCT03137433|454027529|FG000|Overall Study|Physician Decision|2|||
126202567|NCT03137433|454027530|FG001|Overall Study|Physician Decision|0|||
126202568|NCT03137433|454027529|FG000|Overall Study|Moved out of study area|1|||
126202569|NCT03137433|454027530|FG001|Overall Study|Moved out of study area|0|||
126202570|NCT03137433|454027529|FG000|Overall Study|Too far out of window due to COVID|0|||
126202571|NCT03137433|454027530|FG001|Overall Study|Too far out of window due to COVID|1|||
126202572|NCT00265382|454027532|FG000|Overall Study|Adverse Event|21|||
126202573|NCT00265382|454027532|FG000|Overall Study|Laboratory Abnormality|1|||
126202574|NCT00265382|454027532|FG000|Overall Study|Lost to Follow-up|3|||
126202575|NCT00265382|454027532|FG000|Overall Study|Lack of Efficacy|6|||
126202576|NCT00265382|454027532|FG000|Overall Study|Miscellaneous|6|||
126202577|NCT00265382|454027532|FG000|Overall Study|Withdrawal by Subject|13|||
126202578|NCT00265382|454027532|FG000|Overall Study|Study terminated by sponsor|94|||
126202579|NCT00265382|454027532|FG000|Overall Study|Death|1|||
126202580|NCT00760994|454027533|FG000|Overall Study|Lost to Follow-up|4|||
126202581|NCT00760994|454027534|FG001|Overall Study|Lost to Follow-up|4|||
126202582|NCT00760994|454027535|FG002|Overall Study|Lost to Follow-up|3|||
126202583|NCT01853397|454027536|FG000|Overall Study|Withdrawal by Subject|0|||
126202584|NCT01853397|454027537|FG001|Overall Study|Withdrawal by Subject|0|||
126202585|NCT01853397|454027538|FG002|Overall Study|Withdrawal by Subject|0|||
126202586|NCT01853397|454027539|FG003|Overall Study|Withdrawal by Subject|1|||
126202587|NCT01853397|454027536|FG000|Overall Study|Subject Noncompliance|0|||
126202588|NCT01853397|454027537|FG001|Overall Study|Subject Noncompliance|0|||
126202589|NCT01853397|454027538|FG002|Overall Study|Subject Noncompliance|0|||
126202590|NCT01853397|454027539|FG003|Overall Study|Subject Noncompliance|1|||
125979037|NCT03318523|453211581|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125979038|NCT03318523|453211582|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125979039|NCT03318523|453211583|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
125979040|NCT03318523|453211584|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125979041|NCT03318523|453211585|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125979042|NCT03318523|453211586|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125979043|NCT03318523|453211587|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125979044|NCT03318523|453211578|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126202591|NCT02132312|454027540|FG000|Overall Study|Adverse Event|2|||
126202592|NCT02132312|454027541|FG001|Overall Study|Adverse Event|0|||
126202593|NCT02132312|454027540|FG000|Overall Study|Physician Decision|1|||
126202594|NCT02132312|454027541|FG001|Overall Study|Physician Decision|1|||
126202595|NCT02132312|454027540|FG000|Overall Study|Protocol Violation|0|||
126202596|NCT02132312|454027541|FG001|Overall Study|Protocol Violation|1|||
126202597|NCT02132312|454027540|FG000|Overall Study|Withdrawal by Subject|1|||
126202598|NCT02132312|454027541|FG001|Overall Study|Withdrawal by Subject|0|||
126202599|NCT02132312|454027540|FG000|Overall Study|Lost to Follow-up|2|||
126202600|NCT02132312|454027541|FG001|Overall Study|Lost to Follow-up|1|||
126202601|NCT03451630|454027542|FG000|Overall Study|Death|15|||
126202602|NCT03451630|454027543|FG001|Overall Study|Death|16|||
126202603|NCT03451630|454027544|FG002|Overall Study|Death|11|||
126202604|NCT03451630|454027542|FG000|Overall Study|Lost to Follow-up|9|||
126202605|NCT03451630|454027543|FG001|Overall Study|Lost to Follow-up|0|||
126202606|NCT03451630|454027544|FG002|Overall Study|Lost to Follow-up|4|||
126202607|NCT03451630|454027542|FG000|Overall Study|Withdrawal by Subject|0|||
126202608|NCT03451630|454027543|FG001|Overall Study|Withdrawal by Subject|3|||
126202609|NCT03451630|454027544|FG002|Overall Study|Withdrawal by Subject|0|||
126202610|NCT03451630|454027542|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
126202611|NCT03451630|454027543|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
126202612|NCT03451630|454027544|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
126202613|NCT01724021|454027547|FG000|Overall Study|Adverse Event|11|||
126202614|NCT01724021|454027548|FG001|Overall Study|Adverse Event|6|||
126202615|NCT01724021|454027547|FG000|Overall Study|Death|46|||
126202616|NCT01724021|454027548|FG001|Overall Study|Death|58|||
125979045|NCT03318523|453211579|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126202617|NCT01724021|454027547|FG000|Overall Study|Participant request/ Withdrew consent|18|||
126202618|NCT01724021|454027548|FG001|Overall Study|Participant request/ Withdrew consent|14|||
126202619|NCT01724021|454027547|FG000|Overall Study|Lost to Follow-up|15|||
126202620|NCT01724021|454027548|FG001|Overall Study|Lost to Follow-up|15|||
126202621|NCT01724021|454027547|FG000|Overall Study|Reason Not Specified|36|||
126202622|NCT01724021|454027548|FG001|Overall Study|Reason Not Specified|39|||
126202623|NCT01724021|454027547|FG000|Overall Study|Missing|1|||
126202624|NCT01724021|454027548|FG001|Overall Study|Missing|1|||
126202625|NCT00486720|454027551|FG000|Overall Study|Adverse Event|1|||
126202626|NCT00486720|454027552|FG001|Overall Study|Adverse Event|2|||
126202627|NCT00486720|454027551|FG000|Overall Study|Lack of Efficacy|4|||
126202628|NCT00486720|454027552|FG001|Overall Study|Lack of Efficacy|6|||
126202629|NCT00486720|454027551|FG000|Overall Study|Physician Decision|1|||
126202630|NCT00486720|454027552|FG001|Overall Study|Physician Decision|2|||
126202631|NCT00486720|454027551|FG000|Overall Study|Protocol Violation|1|||
126202632|NCT00486720|454027552|FG001|Overall Study|Protocol Violation|0|||
126202633|NCT00486720|454027551|FG000|Overall Study|Withdrawal by Subject|3|||
126202634|NCT00486720|454027552|FG001|Overall Study|Withdrawal by Subject|1|||
126202635|NCT00486720|454027551|FG000|Overall Study|Progressive Disease|0|||
126202636|NCT00486720|454027552|FG001|Overall Study|Progressive Disease|1|||
126202637|NCT02452892|454027553|FG000|Week 1 Initial Randommization|Adverse Event|1|||
126202638|NCT02452892|454027554|FG001|Week 1 Initial Randommization|Adverse Event|0|||
126202639|NCT02452892|454027555|FG002|Week 1 Initial Randommization|Adverse Event|0|||
125979046|NCT03318523|453211580|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125979047|NCT03318523|453211581|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125979048|NCT03318523|453211582|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125979049|NCT03318523|453211583|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125979050|NCT03318523|453211584|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126202640|NCT02452892|454027556|FG003|Week 1 Initial Randommization|Adverse Event|0|||
126202641|NCT02452892|454027553|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
126202642|NCT02452892|454027554|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
126202643|NCT02452892|454027555|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
126202644|NCT02452892|454027556|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
126202645|NCT02452892|454027553|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
126202646|NCT02452892|454027554|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
126202647|NCT02452892|454027555|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
126202648|NCT02452892|454027556|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
125979051|NCT03318523|453211585|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125979052|NCT03318523|453211586|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125979053|NCT03318523|453211587|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
125979054|NCT03318523|453211578|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
125979055|NCT03318523|453211579|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
125979056|NCT03318523|453211580|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
125979057|NCT03318523|453211581|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
125979058|NCT03318523|453211582|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
125979059|NCT03318523|453211583|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
125979060|NCT03318523|453211584|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
125979061|NCT03318523|453211585|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
125979062|NCT03318523|453211586|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
125979063|NCT03318523|453211587|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
125979064|NCT03318523|453211578|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125979065|NCT03318523|453211579|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125979066|NCT03318523|453211580|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125979067|NCT03318523|453211581|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125979068|NCT03318523|453211582|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
125979069|NCT03318523|453211583|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125979070|NCT03318523|453211584|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125979071|NCT03318523|453211585|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
125979072|NCT03318523|453211586|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
125979073|NCT03318523|453211587|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125979074|NCT00430248|453211591|FG000|Overall Study|Adverse Event|49|||
125979075|NCT00430248|453211592|FG001|Overall Study|Adverse Event|61|||
125979076|NCT00430248|453211593|FG002|Overall Study|Adverse Event|64|||
125979077|NCT00430248|453211591|FG000|Overall Study|Protocol Violation|10|||
125979078|NCT00430248|453211592|FG001|Overall Study|Protocol Violation|2|||
125979079|NCT00430248|453211593|FG002|Overall Study|Protocol Violation|4|||
125979080|NCT00430248|453211591|FG000|Overall Study|Personal Reasons|12|||
125979081|NCT00430248|453211592|FG001|Overall Study|Personal Reasons|24|||
125979082|NCT00430248|453211593|FG002|Overall Study|Personal Reasons|9|||
125979083|NCT00430248|453211591|FG000|Overall Study|Lost to Follow-up|28|||
125979084|NCT00430248|453211592|FG001|Overall Study|Lost to Follow-up|33|||
125979085|NCT00430248|453211593|FG002|Overall Study|Lost to Follow-up|28|||
125979086|NCT00430248|453211591|FG000|Overall Study|Therapeutic Failure|1|||
125979087|NCT00430248|453211592|FG001|Overall Study|Therapeutic Failure|1|||
125979088|NCT00430248|453211593|FG002|Overall Study|Therapeutic Failure|1|||
125979089|NCT00430248|453211591|FG000|Overall Study|Withdrawal by Subject|14|||
125979090|NCT00430248|453211592|FG001|Overall Study|Withdrawal by Subject|20|||
125979091|NCT00430248|453211593|FG002|Overall Study|Withdrawal by Subject|16|||
125979092|NCT00430248|453211591|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126202649|NCT02452892|454027553|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
125979093|NCT00430248|453211592|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
125979094|NCT00430248|453211593|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125979095|NCT00430248|453211591|FG000|Overall Study|Gout Flare|3|||
126202650|NCT02452892|454027554|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
126202651|NCT02452892|454027555|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
126202652|NCT02452892|454027556|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
126202653|NCT02452892|454027553|FG000|Follow-up|Withdrawal by Subject|0|||
126202654|NCT02452892|454027554|FG001|Follow-up|Withdrawal by Subject|0|||
126202655|NCT02452892|454027555|FG002|Follow-up|Withdrawal by Subject|0|||
126202656|NCT02452892|454027556|FG003|Follow-up|Withdrawal by Subject|1|||
126202657|NCT02452892|454027553|FG000|Follow-up|Subject left town on Day 42|1|||
126202658|NCT02452892|454027554|FG001|Follow-up|Subject left town on Day 42|0|||
126202659|NCT02452892|454027555|FG002|Follow-up|Subject left town on Day 42|0|||
126202660|NCT02452892|454027556|FG003|Follow-up|Subject left town on Day 42|0|||
126202661|NCT01874288|454027568|FG000|Overall Study|Withdrawal by Subject|1|||
126202662|NCT01874288|454027569|FG001|Overall Study|Withdrawal by Subject|0|||
126202663|NCT01874288|454027570|FG002|Overall Study|Withdrawal by Subject|2|||
126202664|NCT01874288|454027571|FG003|Overall Study|Withdrawal by Subject|1|||
126202665|NCT01874288|454027572|FG004|Overall Study|Withdrawal by Subject|1|||
126202666|NCT01874288|454027568|FG000|Overall Study|Physician Decision|0|||
126202667|NCT01874288|454027569|FG001|Overall Study|Physician Decision|0|||
126202668|NCT01874288|454027570|FG002|Overall Study|Physician Decision|0|||
126202669|NCT01874288|454027571|FG003|Overall Study|Physician Decision|1|||
126202670|NCT01874288|454027572|FG004|Overall Study|Physician Decision|0|||
126202671|NCT01874288|454027568|FG000|Overall Study|Progressive disease|2|||
126202672|NCT01874288|454027569|FG001|Overall Study|Progressive disease|0|||
126202673|NCT01874288|454027570|FG002|Overall Study|Progressive disease|3|||
126202674|NCT01874288|454027571|FG003|Overall Study|Progressive disease|5|||
126202675|NCT01874288|454027572|FG004|Overall Study|Progressive disease|1|||
126202676|NCT00423267|454027573|FG000|Period A|Withdrawal by Subject|0|||
126202677|NCT00423267|454027574|FG001|Period A|Withdrawal by Subject|1|||
126202678|NCT00423267|454027573|FG000|Period A|Non-compliance with protocol|1|||
126202679|NCT00423267|454027574|FG001|Period A|Non-compliance with protocol|0|||
126202680|NCT00423267|454027573|FG000|Period A|Administrative|1|||
126202681|NCT00423267|454027574|FG001|Period A|Administrative|0|||
126202682|NCT00591786|454027577|FG000|Overall Study|Withdrawal of Informed Consent|0|||
126202683|NCT00591786|454027578|FG001|Overall Study|Withdrawal of Informed Consent|0|||
126202684|NCT00591786|454027579|FG002|Overall Study|Withdrawal of Informed Consent|1|||
125979096|NCT00430248|453211592|FG001|Overall Study|Gout Flare|7|||
125979097|NCT00430248|453211593|FG002|Overall Study|Gout Flare|2|||
125979098|NCT00430248|453211591|FG000|Overall Study|Reason Not Specified|8|||
125979099|NCT00430248|453211592|FG001|Overall Study|Reason Not Specified|8|||
125979100|NCT00430248|453211593|FG002|Overall Study|Reason Not Specified|11|||
125979101|NCT00002558|453211596|FG000|Overall Study|Withdrawal by Subject|0|||
125979102|NCT00002558|453211597|FG001|Overall Study|Withdrawal by Subject|1|||
125979103|NCT01754467|453211598|FG000|Overall Study|Lost to Follow-up|1|||
125979104|NCT02065336|453211599|FG000|Extension Phase|Study Terminated by Sponsor|0|||
125979105|NCT02065336|453211600|FG001|Extension Phase|Study Terminated by Sponsor|0|||
125979106|NCT02065336|453211601|FG002|Extension Phase|Study Terminated by Sponsor|0|||
125979107|NCT02065336|453211602|FG003|Extension Phase|Study Terminated by Sponsor|0|||
125979108|NCT02065336|453211603|FG004|Extension Phase|Study Terminated by Sponsor|0|||
125979109|NCT02065336|453211604|FG005|Extension Phase|Study Terminated by Sponsor|0|||
125979110|NCT02065336|453211605|FG006|Extension Phase|Study Terminated by Sponsor|0|||
125979111|NCT02065336|453211606|FG007|Extension Phase|Study Terminated by Sponsor|0|||
125979112|NCT02065336|453211607|FG008|Extension Phase|Study Terminated by Sponsor|2|||
125979113|NCT02065336|453211608|FG009|Extension Phase|Study Terminated by Sponsor|8|||
125979114|NCT01970462|453211609|FG000|Overall Study|Lost to Follow-up|0|||
125979115|NCT01970462|453211610|FG001|Overall Study|Lost to Follow-up|2|||
125979116|NCT01984684|453211612|FG000|Overall Study|Lost to Follow-up|25|||
125979117|NCT01984684|453211613|FG001|Overall Study|Lost to Follow-up|24|||
125979118|NCT01984684|453211612|FG000|Overall Study|Adverse Event|8|||
125979119|NCT01984684|453211613|FG001|Overall Study|Adverse Event|12|||
125979120|NCT01984684|453211612|FG000|Overall Study|Withdrawal by Subject|9|||
125979121|NCT01984684|453211613|FG001|Overall Study|Withdrawal by Subject|9|||
125979122|NCT01984684|453211612|FG000|Overall Study|Lack of Efficacy|3|||
125979123|NCT01984684|453211613|FG001|Overall Study|Lack of Efficacy|6|||
125979124|NCT01984684|453211612|FG000|Overall Study|Physician Decision|4|||
125979125|NCT01984684|453211613|FG001|Overall Study|Physician Decision|2|||
125979126|NCT01984684|453211612|FG000|Overall Study|Protocol Violation|4|||
125979127|NCT01984684|453211613|FG001|Overall Study|Protocol Violation|2|||
125979128|NCT01984684|453211612|FG000|Overall Study|Death|0|||
125979129|NCT01984684|453211613|FG001|Overall Study|Death|1|||
125979130|NCT01984684|453211612|FG000|Overall Study|Noncompliance with study drug|2|||
126046437|NCT02719574|453468212|FG011|Phase 2|Protocol Violation|0|||
126202685|NCT00591786|454027580|FG003|Overall Study|Withdrawal of Informed Consent|0|||
126202686|NCT00591786|454027581|FG004|Overall Study|Withdrawal of Informed Consent|0|||
126202687|NCT00591786|454027582|FG005|Overall Study|Withdrawal of Informed Consent|0|||
126202688|NCT00591786|454027583|FG006|Overall Study|Withdrawal of Informed Consent|0|||
126202689|NCT00591786|454027584|FG007|Overall Study|Withdrawal of Informed Consent|0|||
126202690|NCT00591786|454027585|FG008|Overall Study|Withdrawal of Informed Consent|0|||
126202691|NCT00591786|454027586|FG009|Overall Study|Withdrawal of Informed Consent|0|||
126202692|NCT00554229|454027587|FG000|Overall Study|Lost to Follow-up|3|||
126202693|NCT00554229|454027588|FG001|Overall Study|Lost to Follow-up|6|||
126202694|NCT00554229|454027587|FG000|Overall Study|Withdrawal by Subject|29|||
126202695|NCT00554229|454027588|FG001|Overall Study|Withdrawal by Subject|37|||
126202696|NCT00554229|454027587|FG000|Overall Study|Adverse Event|71|||
126202697|NCT00554229|454027588|FG001|Overall Study|Adverse Event|39|||
126202698|NCT00554229|454027587|FG000|Overall Study|Protocol Violation|3|||
126202699|NCT00554229|454027588|FG001|Overall Study|Protocol Violation|3|||
126202700|NCT00554229|454027587|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
126202701|NCT00554229|454027588|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
126202702|NCT00554229|454027587|FG000|Overall Study|Randomised but no treatment received|1|||
126202703|NCT00554229|454027588|FG001|Overall Study|Randomised but no treatment received|0|||
126202704|NCT00877929|454027589|FG000|Overall Study|Adverse Event|11|||
126202705|NCT00877929|454027590|FG001|Overall Study|Adverse Event|20|||
126202706|NCT00877929|454027589|FG000|Overall Study|Protocol Violation|3|||
126202707|NCT00877929|454027590|FG001|Overall Study|Protocol Violation|3|||
126202708|NCT00877929|454027589|FG000|Overall Study|Lost to Follow-up|0|||
126202709|NCT00877929|454027590|FG001|Overall Study|Lost to Follow-up|1|||
126202710|NCT00877929|454027589|FG000|Overall Study|Withdrawal by Subject|4|||
126202711|NCT00877929|454027590|FG001|Overall Study|Withdrawal by Subject|4|||
126202712|NCT00877929|454027589|FG000|Overall Study|Lack of Efficacy|0|||
126202713|NCT00877929|454027590|FG001|Overall Study|Lack of Efficacy|1|||
126202714|NCT00877929|454027589|FG000|Overall Study|Other reason (not specified)|2|||
126202715|NCT00877929|454027590|FG001|Overall Study|Other reason (not specified)|6|||
126202716|NCT01140646|454027591|FG000|Overall Study|Adverse Event|4|||
126202717|NCT01140646|454027591|FG000|Overall Study|Refused Further Treatment|5|||
125979131|NCT01984684|453211613|FG001|Overall Study|Noncompliance with study drug|1|||
125979132|NCT01984684|453211612|FG000|Overall Study|Subject incarcerated|1|||
125979133|NCT01984684|453211613|FG001|Overall Study|Subject incarcerated|0|||
125979134|NCT01984684|453211612|FG000|Overall Study|Study drug not available at site|1|||
125979135|NCT01984684|453211613|FG001|Overall Study|Study drug not available at site|1|||
125979136|NCT01984684|453211612|FG000|Overall Study|Subject had inadequate IV access|0|||
125979137|NCT01984684|453211613|FG001|Overall Study|Subject had inadequate IV access|1|||
125979138|NCT02472964|453211616|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
125979139|NCT02472964|453211617|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
125979140|NCT02472964|453211616|FG000|Part 1 (up to Week 24)|disease progression|58|||
125979141|NCT02472964|453211617|FG001|Part 1 (up to Week 24)|disease progression|47|||
125979142|NCT02472964|453211616|FG000|Part 1 (up to Week 24)|Death|3|||
125979143|NCT02472964|453211617|FG001|Part 1 (up to Week 24)|Death|6|||
125979144|NCT02472964|453211616|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
125979145|NCT02472964|453211617|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
125979146|NCT02472964|453211616|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
125979147|NCT02472964|453211617|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
125979148|NCT02472964|453211616|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
125979149|NCT02472964|453211617|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
125979150|NCT02472964|453211616|FG000|Part 1 (up to Week 24)|Other|2|||
125979151|NCT02472964|453211617|FG001|Part 1 (up to Week 24)|Other|1|||
125979152|NCT02472964|453211616|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
125979153|NCT02472964|453211617|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
125979154|NCT02472964|453211616|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
125979155|NCT02472964|453211617|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
125979156|NCT02472964|453211616|FG000|Part 2 (Week 24-week 48)|Death|0|||
125979157|NCT02472964|453211617|FG001|Part 2 (Week 24-week 48)|Death|1|||
125979158|NCT02472964|453211616|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
125979159|NCT02472964|453211617|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
125979160|NCT02472964|453211616|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
125979161|NCT02472964|453211617|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
125979162|NCT02472964|453211616|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
125979163|NCT02472964|453211617|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
125979164|NCT02472964|453211616|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
125979165|NCT02472964|453211617|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
125979166|NCT00689221|453211623|FG000|Overall Study|Ongoing at cut-off date|39|||
125979167|NCT00689221|453211624|FG001|Overall Study|Ongoing at cut-off date|36|||
125979168|NCT01749982|453211625|FG000|Overall Study|Physician Decision|0|||
125979169|NCT01749982|453211626|FG001|Overall Study|Physician Decision|0|||
125979170|NCT01749982|453211627|FG002|Overall Study|Physician Decision|0|||
126202718|NCT00689728|454027595|FG000|Double-Blind Treatment|Adverse Event|1|||
126202719|NCT00689728|454027596|FG001|Double-Blind Treatment|Adverse Event|0|||
126202720|NCT00689728|454027597|FG002|Double-Blind Treatment|Adverse Event|0|||
126202721|NCT00689728|454027595|FG000|Double-Blind Treatment|Protocol Violation|0|||
126202722|NCT00689728|454027596|FG001|Double-Blind Treatment|Protocol Violation|0|||
126202723|NCT00689728|454027597|FG002|Double-Blind Treatment|Protocol Violation|1|||
126202724|NCT00689728|454027595|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
126202725|NCT00689728|454027596|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
126202726|NCT00689728|454027597|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
126202727|NCT00689728|454027595|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
126202728|NCT00689728|454027596|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
126202729|NCT00689728|454027597|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
126202730|NCT00689728|454027595|FG000|Rescue|Adverse Event|0|||
126202731|NCT00689728|454027596|FG001|Rescue|Adverse Event|1|||
126202732|NCT00689728|454027597|FG002|Rescue|Adverse Event|0|||
126202733|NCT00689728|454027595|FG000|Rescue|Withdrawal by Subject|1|||
126202734|NCT00689728|454027596|FG001|Rescue|Withdrawal by Subject|1|||
126202735|NCT00689728|454027597|FG002|Rescue|Withdrawal by Subject|1|||
126202736|NCT00689728|454027595|FG000|Optional Follow-Up|Adverse Event|1|||
126202737|NCT00689728|454027596|FG001|Optional Follow-Up|Adverse Event|0|||
126202738|NCT00689728|454027597|FG002|Optional Follow-Up|Adverse Event|0|||
126202739|NCT00689728|454027595|FG000|Optional Follow-Up|Lack of Efficacy|0|||
126202740|NCT00689728|454027596|FG001|Optional Follow-Up|Lack of Efficacy|1|||
126202741|NCT00689728|454027597|FG002|Optional Follow-Up|Lack of Efficacy|1|||
126202742|NCT00689728|454027595|FG000|Optional Follow-Up|Lost to Follow-up|0|||
126202743|NCT00689728|454027596|FG001|Optional Follow-Up|Lost to Follow-up|1|||
126202744|NCT00689728|454027597|FG002|Optional Follow-Up|Lost to Follow-up|1|||
126202745|NCT00689728|454027595|FG000|Optional Follow-Up|Protocol Violation|0|||
126202746|NCT00689728|454027596|FG001|Optional Follow-Up|Protocol Violation|0|||
126202747|NCT00689728|454027597|FG002|Optional Follow-Up|Protocol Violation|1|||
126202748|NCT00689728|454027595|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
126202749|NCT00689728|454027596|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
126202750|NCT00689728|454027597|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
126202751|NCT00784836|454027602|FG000|Overall Study|Early Study Termination|3|||
126202752|NCT00660829|454027604|FG000|Overall Study|Adverse Event|3|||
126202753|NCT00660829|454027605|FG001|Overall Study|Adverse Event|4|||
126202754|NCT00660829|454027604|FG000|Overall Study|Lack of Efficacy|2|||
126202755|NCT00660829|454027605|FG001|Overall Study|Lack of Efficacy|3|||
126202756|NCT00660829|454027604|FG000|Overall Study|Non-Compliance|0|||
126202757|NCT00660829|454027605|FG001|Overall Study|Non-Compliance|4|||
126202758|NCT00660829|454027604|FG000|Overall Study|Withdrawal by Subject|1|||
126202759|NCT00660829|454027605|FG001|Overall Study|Withdrawal by Subject|2|||
126202760|NCT00660829|454027604|FG000|Overall Study|Lost to Follow-up|3|||
126202761|NCT00660829|454027605|FG001|Overall Study|Lost to Follow-up|2|||
126202762|NCT00660829|454027604|FG000|Overall Study|Other|9|||
126202763|NCT00660829|454027605|FG001|Overall Study|Other|4|||
126202764|NCT02127931|454027606|FG000|Overall Study|Glitch in Game|1|||
126202765|NCT01513460|454027607|FG000|Overall Study|Death|0|||
126202766|NCT01513460|454027608|FG001|Overall Study|Death|0|||
126202767|NCT01513460|454027609|FG002|Overall Study|Death|1|||
126202768|NCT01513460|454027607|FG000|Overall Study|Lost to Follow-up|0|||
126202769|NCT01513460|454027608|FG001|Overall Study|Lost to Follow-up|0|||
126202770|NCT01513460|454027609|FG002|Overall Study|Lost to Follow-up|2|||
126202771|NCT01513460|454027607|FG000|Overall Study|Abnormal laboratory value|1|||
126202772|NCT01513460|454027608|FG001|Overall Study|Abnormal laboratory value|0|||
126202773|NCT01513460|454027609|FG002|Overall Study|Abnormal laboratory value|1|||
126202774|NCT01513460|454027607|FG000|Overall Study|Lack of Efficacy|1|||
126202775|NCT01513460|454027608|FG001|Overall Study|Lack of Efficacy|2|||
126202776|NCT01513460|454027609|FG002|Overall Study|Lack of Efficacy|5|||
126202777|NCT01513460|454027607|FG000|Overall Study|Protocol deviations|3|||
126202778|NCT01513460|454027608|FG001|Overall Study|Protocol deviations|4|||
126202779|NCT01513460|454027609|FG002|Overall Study|Protocol deviations|3|||
126202780|NCT01513460|454027607|FG000|Overall Study|Withdrawal by Subject|7|||
126202781|NCT01513460|454027608|FG001|Overall Study|Withdrawal by Subject|8|||
126202782|NCT01513460|454027609|FG002|Overall Study|Withdrawal by Subject|21|||
126202783|NCT01513460|454027607|FG000|Overall Study|Adverse Event|16|||
126202784|NCT01513460|454027608|FG001|Overall Study|Adverse Event|18|||
126202785|NCT01513460|454027609|FG002|Overall Study|Adverse Event|23|||
126202786|NCT01513460|454027607|FG000|Overall Study|Abnormal test procedure|1|||
126202787|NCT01513460|454027608|FG001|Overall Study|Abnormal test procedure|0|||
126202788|NCT01513460|454027609|FG002|Overall Study|Abnormal test procedure|0|||
126202789|NCT00422942|454027610|FG000|Overall Study|Study terminated by Sponsor|3|||
126202790|NCT02828982|454027611|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126202791|NCT02828982|454027612|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126202792|NCT02613910|454027613|FG000|Overall Study|Termination of study|1|||
126202793|NCT03395704|454027614|FG000|Overall Study|Adverse Event|2|||
126202794|NCT03395704|454027615|FG001|Overall Study|Adverse Event|1|||
126202795|NCT03395704|454027614|FG000|Overall Study|Withdrawal by Subject|2|||
126202796|NCT03395704|454027615|FG001|Overall Study|Withdrawal by Subject|1|||
126202797|NCT03395704|454027614|FG000|Overall Study|Physician Decision|0|||
126202798|NCT03395704|454027615|FG001|Overall Study|Physician Decision|1|||
126202799|NCT04823494|454029152|FG000|Overall Study|Programming software malfunction.|1|||
126202800|NCT04823494|454029153|FG001|Overall Study|Programming software malfunction.|0|||
126202801|NCT04823494|454029152|FG000|Overall Study|Withdrawal by Subject|1|||
126202802|NCT04823494|454029153|FG001|Overall Study|Withdrawal by Subject|0|||
126202803|NCT04823494|454029152|FG000|Overall Study|Devices lost|0|||
126202804|NCT04823494|454029153|FG001|Overall Study|Devices lost|1|||
126202805|NCT03726320|454029154|FG000|Overall Study|Lost to Follow-up|2|||
126202806|NCT03726320|454029155|FG001|Overall Study|Lost to Follow-up|4|||
126202807|NCT03726320|454029156|FG002|Overall Study|Lost to Follow-up|0|||
126202808|NCT03726320|454029154|FG000|Overall Study|Time Constraints|4|||
126202809|NCT03726320|454029155|FG001|Overall Study|Time Constraints|1|||
126202810|NCT03726320|454029156|FG002|Overall Study|Time Constraints|0|||
126202811|NCT03726320|454029154|FG000|Overall Study|Ineligible after enrollment|3|||
126202812|NCT03726320|454029155|FG001|Overall Study|Ineligible after enrollment|3|||
126202813|NCT03726320|454029156|FG002|Overall Study|Ineligible after enrollment|0|||
126202814|NCT03726320|454029154|FG000|Overall Study|Clinic / insurance issue|2|||
126202815|NCT03726320|454029155|FG001|Overall Study|Clinic / insurance issue|0|||
126202816|NCT03726320|454029156|FG002|Overall Study|Clinic / insurance issue|0|||
126202817|NCT03726320|454029154|FG000|Overall Study|Language barrier|1|||
126202818|NCT03726320|454029155|FG001|Overall Study|Language barrier|0|||
126202819|NCT03726320|454029156|FG002|Overall Study|Language barrier|0|||
126202820|NCT03726320|454029154|FG000|Overall Study|Provider left the clinic|0|||
126202821|NCT03726320|454029155|FG001|Overall Study|Provider left the clinic|0|||
126202822|NCT03726320|454029156|FG002|Overall Study|Provider left the clinic|1|||
126202823|NCT03691831|454029159|FG000|Overall Study|Lost to Follow-up|16|||
126202824|NCT03691831|454029160|FG001|Overall Study|Lost to Follow-up|12|||
126202825|NCT03691831|454029159|FG000|Overall Study|Withdrawal by Subject|9|||
126202826|NCT03691831|454029160|FG001|Overall Study|Withdrawal by Subject|17|||
126202827|NCT03691831|454029159|FG000|Overall Study|Investigator Decision|2|||
126202828|NCT03691831|454029160|FG001|Overall Study|Investigator Decision|2|||
126202829|NCT03922945|454029161|FG000|Overall Study|Adverse Event|1|||
126202830|NCT03922945|454029162|FG001|Overall Study|Adverse Event|1|||
126202831|NCT03922945|454029163|FG002|Overall Study|Adverse Event|2|||
126202832|NCT03922945|454029161|FG000|Overall Study|Lost to Follow-up|13|||
126202833|NCT03922945|454029162|FG001|Overall Study|Lost to Follow-up|9|||
126202834|NCT03922945|454029163|FG002|Overall Study|Lost to Follow-up|20|||
126202835|NCT03922945|454029161|FG000|Overall Study|Lack of Efficacy|2|||
126202836|NCT03922945|454029162|FG001|Overall Study|Lack of Efficacy|0|||
126202837|NCT03922945|454029163|FG002|Overall Study|Lack of Efficacy|1|||
126202838|NCT03922945|454029161|FG000|Overall Study|Protocol Non-Compliance|0|||
126202839|NCT03922945|454029162|FG001|Overall Study|Protocol Non-Compliance|0|||
126202840|NCT03922945|454029163|FG002|Overall Study|Protocol Non-Compliance|1|||
126202841|NCT03922945|454029161|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
126202842|NCT03922945|454029162|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
126202843|NCT03922945|454029163|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
126202844|NCT03922945|454029161|FG000|Overall Study|All Other Personal Reasons|1|||
126202845|NCT03922945|454029162|FG001|Overall Study|All Other Personal Reasons|1|||
126202846|NCT03922945|454029163|FG002|Overall Study|All Other Personal Reasons|2|||
126202847|NCT02493712|454029164|FG000|Overall Study|Withdrawal by Subject|1|||
126202848|NCT02493712|454029165|FG001|Overall Study|Withdrawal by Subject|0|||
126202849|NCT02493712|454029166|FG002|Overall Study|Withdrawal by Subject|2|||
126202850|NCT02493712|454029164|FG000|Overall Study|Protocol Violation|0|||
126202851|NCT02493712|454029165|FG001|Overall Study|Protocol Violation|0|||
126202852|NCT02493712|454029166|FG002|Overall Study|Protocol Violation|1|||
126202853|NCT02493712|454029164|FG000|Overall Study|Lost to Follow-up|1|||
126202854|NCT02493712|454029165|FG001|Overall Study|Lost to Follow-up|0|||
126202855|NCT02493712|454029166|FG002|Overall Study|Lost to Follow-up|0|||
126202856|NCT02493712|454029164|FG000|Overall Study|Physician Decision|0|||
126202857|NCT02493712|454029165|FG001|Overall Study|Physician Decision|1|||
126202858|NCT02493712|454029166|FG002|Overall Study|Physician Decision|0|||
126202859|NCT02493712|454029164|FG000|Overall Study|Lack of Efficacy|0|||
126202860|NCT02493712|454029165|FG001|Overall Study|Lack of Efficacy|5|||
126202861|NCT02493712|454029166|FG002|Overall Study|Lack of Efficacy|3|||
126202862|NCT02528643|454029167|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
126202863|NCT02528643|454029168|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
126202864|NCT02528643|454029167|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
126202865|NCT02528643|454029168|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
126202866|NCT02528643|454029167|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
126202867|NCT02528643|454029168|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
126202868|NCT02528643|454029167|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
126202869|NCT02528643|454029168|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
126202870|NCT02528643|454029167|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
126202871|NCT02528643|454029168|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
126312826|NCT03671564|454435975|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
126202872|NCT02528643|454029167|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
126202873|NCT02528643|454029168|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
126202874|NCT02528643|454029167|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
126202875|NCT02528643|454029168|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
126202876|NCT04120116|454029169|FG000|Overall Study|Lost to Follow-up|0|||
126202877|NCT04120116|454029170|FG001|Overall Study|Lost to Follow-up|1|||
126202878|NCT04120116|454029171|FG002|Overall Study|Lost to Follow-up|0|||
126202879|NCT04120116|454029172|FG003|Overall Study|Lost to Follow-up|2|||
126202880|NCT04120116|454029169|FG000|Overall Study|Withdrawal by Subject|1|||
126202881|NCT04120116|454029170|FG001|Overall Study|Withdrawal by Subject|0|||
126202882|NCT04120116|454029171|FG002|Overall Study|Withdrawal by Subject|1|||
126202883|NCT04120116|454029172|FG003|Overall Study|Withdrawal by Subject|1|||
126202884|NCT04120116|454029169|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
126202885|NCT04120116|454029170|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
126202886|NCT04120116|454029171|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
126202887|NCT04120116|454029172|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
126202888|NCT02087085|454029173|FG000|Overall Study|Adverse Event|10|||
126202889|NCT02087085|454029174|FG001|Overall Study|Adverse Event|14|||
126202890|NCT02087085|454029173|FG000|Overall Study|Lack of Efficacy|4|||
126202891|NCT02087085|454029174|FG001|Overall Study|Lack of Efficacy|3|||
126202892|NCT02087085|454029173|FG000|Overall Study|Lost to Follow-up|6|||
126202893|NCT02087085|454029174|FG001|Overall Study|Lost to Follow-up|4|||
126202894|NCT02087085|454029173|FG000|Overall Study|Withdrawal by Subject|9|||
126202895|NCT02087085|454029174|FG001|Overall Study|Withdrawal by Subject|11|||
126202896|NCT02087085|454029173|FG000|Overall Study|Protocol Violation|1|||
126202897|NCT02087085|454029174|FG001|Overall Study|Protocol Violation|0|||
126202898|NCT02087085|454029173|FG000|Overall Study|Study Terminated by Sponsor|87|||
126202899|NCT02087085|454029174|FG001|Overall Study|Study Terminated by Sponsor|80|||
126202900|NCT02087085|454029173|FG000|Overall Study|Other Miscellaneous Reasons|3|||
126202901|NCT02087085|454029174|FG001|Overall Study|Other Miscellaneous Reasons|4|||
126202902|NCT01191190|454029175|FG000|Overall Study|Withdrawal by Subject|1|||
126202903|NCT03339999|454029183|FG000|Overall Study|Adverse Event|1|||
126202904|NCT03339999|454029184|FG001|Overall Study|Adverse Event|2|||
126202905|NCT03339999|454029185|FG002|Overall Study|Adverse Event|2|||
126202906|NCT03339999|454029186|FG003|Overall Study|Adverse Event|1|||
126202907|NCT03339999|454029183|FG000|Overall Study|Lack of Efficacy|0|||
126202908|NCT03339999|454029184|FG001|Overall Study|Lack of Efficacy|1|||
126202909|NCT03339999|454029185|FG002|Overall Study|Lack of Efficacy|0|||
126202910|NCT03339999|454029186|FG003|Overall Study|Lack of Efficacy|0|||
126202911|NCT03339999|454029183|FG000|Overall Study|Lost to Follow-up|0|||
126202912|NCT03339999|454029184|FG001|Overall Study|Lost to Follow-up|0|||
126202913|NCT03339999|454029185|FG002|Overall Study|Lost to Follow-up|0|||
126202914|NCT03339999|454029186|FG003|Overall Study|Lost to Follow-up|1|||
126202915|NCT03339999|454029183|FG000|Overall Study|Study Terminated by Sponsor|6|||
126202916|NCT03339999|454029184|FG001|Overall Study|Study Terminated by Sponsor|3|||
126202917|NCT03339999|454029185|FG002|Overall Study|Study Terminated by Sponsor|4|||
126202918|NCT03339999|454029186|FG003|Overall Study|Study Terminated by Sponsor|3|||
126202919|NCT01729559|454029190|FG000|Overall Study|Protocol Violation|31|||
126202920|NCT01729559|454029191|FG001|Overall Study|Protocol Violation|28|||
126202921|NCT03764813|454029196|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
126202922|NCT03764813|454029197|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
126202923|NCT03764813|454029198|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
126202924|NCT03764813|454029199|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
126202925|NCT03326323|454029207|FG000|Overall Study|Unable to receive ANH protocol|3|||
126202926|NCT04225026|454029209|FG000|Overall Study|Withdrawal by Subject|4|||
126202927|NCT04225026|454029209|FG000|Overall Study|Adverse Event|1|||
126202928|NCT04225026|454029209|FG000|Overall Study|Other|1|||
126202929|NCT04225026|454029209|FG000|Overall Study|Death|11|||
126202930|NCT04225026|454029209|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
126202931|NCT00672490|454029212|FG000|Overall Study|Withdrawal by Subject|8|||
126202932|NCT00672490|454029213|FG001|Overall Study|Withdrawal by Subject|8|||
126202933|NCT00672490|454029212|FG000|Overall Study|Lack of Compliance|2|||
126202934|NCT00672490|454029213|FG001|Overall Study|Lack of Compliance|7|||
126202935|NCT00672490|454029212|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
126202936|NCT00672490|454029213|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
126202937|NCT00672490|454029212|FG000|Overall Study|Adverse Event|5|||
126202938|NCT00672490|454029213|FG001|Overall Study|Adverse Event|8|||
126202939|NCT00672490|454029212|FG000|Overall Study|Violation of Concomitant Medicine|1|||
126202940|NCT00672490|454029213|FG001|Overall Study|Violation of Concomitant Medicine|0|||
126202941|NCT00672490|454029212|FG000|Overall Study|Intolerance|0|||
126202942|NCT00672490|454029213|FG001|Overall Study|Intolerance|2|||
126202943|NCT00672490|454029212|FG000|Overall Study|Lost to Follow-up|1|||
126202944|NCT00672490|454029213|FG001|Overall Study|Lost to Follow-up|5|||
126306061|NCT02553499|454408875|FG006|Overall Study|Physician Decision|0|||
126202945|NCT00672490|454029212|FG000|Overall Study|No reason was provided|6|||
126202946|NCT00672490|454029213|FG001|Overall Study|No reason was provided|2|||
126202947|NCT04738123|454029216|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
126202948|NCT04738123|454029217|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
126202949|NCT04738123|454029216|FG000|Overall Study|Progressive Disease|0|||
126202950|NCT04738123|454029217|FG001|Overall Study|Progressive Disease|4|||
126202951|NCT04738123|454029216|FG000|Overall Study|Adverse Event|8|||
126202952|NCT04738123|454029217|FG001|Overall Study|Adverse Event|7|||
126202953|NCT04738123|454029216|FG000|Overall Study|Other Reasons|0|||
126202954|NCT04738123|454029217|FG001|Overall Study|Other Reasons|1|||
126202955|NCT04738123|454029216|FG000|Overall Study|Suicidal or assaultive behavior|0|||
126202956|NCT04738123|454029217|FG001|Overall Study|Suicidal or assaultive behavior|2|||
126202957|NCT04738123|454029216|FG000|Overall Study|Protocol Violation|2|||
126202958|NCT04738123|454029217|FG001|Overall Study|Protocol Violation|2|||
126202959|NCT04738123|454029216|FG000|Overall Study|Consent Withdrawn|35|||
126202960|NCT04738123|454029217|FG001|Overall Study|Consent Withdrawn|22|||
126202961|NCT03604159|454029218|FG000|Overall Study|Lost to Follow-up|6|||
126202962|NCT03604159|454029219|FG001|Overall Study|Lost to Follow-up|7|||
126202963|NCT04533204|454029222|FG000|Overall Study|Unable to understand training instructions|1|||
126202964|NCT04533204|454029223|FG001|Overall Study|Unable to understand training instructions|1|||
126202965|NCT03982069|454029224|FG000|Overall Study|Lost to Follow-up|5|||
126202966|NCT03982069|454029225|FG001|Overall Study|Lost to Follow-up|5|||
126202967|NCT03982069|454029226|FG002|Overall Study|Lost to Follow-up|3|||
126202968|NCT03982069|454029227|FG003|Overall Study|Lost to Follow-up|5|||
126202969|NCT03982069|454029224|FG000|Overall Study|Physician Decision|0|||
126202970|NCT03982069|454029225|FG001|Overall Study|Physician Decision|1|||
126202971|NCT03982069|454029226|FG002|Overall Study|Physician Decision|0|||
126202972|NCT03982069|454029227|FG003|Overall Study|Physician Decision|0|||
126202973|NCT03982069|454029224|FG000|Overall Study|Withdrawal by Subject|2|||
126202974|NCT03982069|454029225|FG001|Overall Study|Withdrawal by Subject|1|||
126202975|NCT03982069|454029226|FG002|Overall Study|Withdrawal by Subject|5|||
126202976|NCT03982069|454029227|FG003|Overall Study|Withdrawal by Subject|2|||
126202977|NCT03982069|454029224|FG000|Overall Study|Specimen loss|3|||
126202978|NCT03982069|454029225|FG001|Overall Study|Specimen loss|3|||
126202979|NCT03982069|454029226|FG002|Overall Study|Specimen loss|1|||
126202980|NCT03982069|454029227|FG003|Overall Study|Specimen loss|1|||
126202981|NCT00787527|454029228|FG000|Overall Study|Toxicity|3|||
126202982|NCT00083616|454029231|FG000|Overall Study|Disease Progression|16|||
126202983|NCT00083616|454029231|FG000|Overall Study|Lost to Follow-up|1|||
126202984|NCT00083616|454029231|FG000|Overall Study|Physician Decision|2|||
126202985|NCT00083616|454029231|FG000|Overall Study|Withdrawal by Subject|3|||
126202986|NCT00083616|454029231|FG000|Overall Study|Ineligibility determined|2|||
126202987|NCT00083616|454029231|FG000|Overall Study|Non-compliance|1|||
126202988|NCT00083616|454029231|FG000|Overall Study|Other|6|||
126202989|NCT01474993|454029234|FG000|Overall Study|Lost to Follow-up|1|||
126202990|NCT01474993|454029235|FG001|Overall Study|Lost to Follow-up|2|||
126202991|NCT01474993|454029234|FG000|Overall Study|Adverse Event|0|||
126202992|NCT01474993|454029235|FG001|Overall Study|Adverse Event|1|||
126202993|NCT03258710|454029236|FG000|Overall Study|Adverse Event|1|||
126202994|NCT03258710|454029236|FG000|Overall Study|Protocol-defined stopping criteria|1|||
126202995|NCT03258710|454029236|FG000|Overall Study|Physician Decision|1|||
126202996|NCT02242305|454029237|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
126202997|NCT02242305|454029238|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
126202998|NCT02242305|454029237|FG000|Overall Study|Adverse Event|1|||
126202999|NCT02242305|454029238|FG001|Overall Study|Adverse Event|0|||
126203000|NCT02242305|454029237|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
126203001|NCT02242305|454029238|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
126203002|NCT02242305|454029237|FG000|Overall Study|Subject withdraws inform consent|0|||
126203003|NCT02242305|454029238|FG001|Overall Study|Subject withdraws inform consent|4|||
126203004|NCT02242305|454029237|FG000|Overall Study|Lost to Follow-up|2|||
126203005|NCT02242305|454029238|FG001|Overall Study|Lost to Follow-up|0|||
126203006|NCT00955682|454029239|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
126203007|NCT00955682|454029240|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
126203008|NCT02041533|454029242|FG000|Pre-Treatment Period|Disease Progression|1|||
126203009|NCT02041533|454029243|FG001|Pre-Treatment Period|Disease Progression|1|||
126203010|NCT02041533|454029242|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
126203011|NCT02041533|454029243|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
126203012|NCT02041533|454029242|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
126203013|NCT02041533|454029243|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
126203014|NCT02041533|454029242|FG000|Treatment Period|Disease progression|189|||
126203015|NCT02041533|454029243|FG001|Treatment Period|Disease progression|146|||
126203016|NCT02041533|454029242|FG000|Treatment Period|Study drug toxicity|30|||
126203017|NCT02041533|454029243|FG001|Treatment Period|Study drug toxicity|34|||
126203018|NCT02041533|454029242|FG000|Treatment Period|Death|1|||
126203019|NCT02041533|454029243|FG001|Treatment Period|Death|0|||
126203020|NCT02041533|454029242|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
126203021|NCT02041533|454029243|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
126203022|NCT02041533|454029242|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
126203023|NCT02041533|454029243|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
126203024|NCT02041533|454029242|FG000|Treatment Period|Participant withdrew consent|2|||
126203025|NCT02041533|454029243|FG001|Treatment Period|Participant withdrew consent|2|||
126203026|NCT02041533|454029242|FG000|Treatment Period|Maximum clinical benefit|0|||
126203027|NCT02041533|454029243|FG001|Treatment Period|Maximum clinical benefit|18|||
126203028|NCT02041533|454029242|FG000|Treatment Period|Poor/Non-compliance|1|||
126203029|NCT02041533|454029243|FG001|Treatment Period|Poor/Non-compliance|0|||
126203030|NCT02041533|454029242|FG000|Treatment Period|Administrative reason by sponsor|1|||
126203031|NCT02041533|454029243|FG001|Treatment Period|Administrative reason by sponsor|0|||
126203032|NCT02041533|454029242|FG000|Treatment Period|Other reasons|9|||
126203033|NCT02041533|454029243|FG001|Treatment Period|Other reasons|2|||
126203034|NCT02041533|454029242|FG000|Treatment Period|Not Reported|0|||
126203035|NCT02041533|454029243|FG001|Treatment Period|Not Reported|1|||
126203036|NCT02117024|454029244|FG000|Overall Study|Progressive Disease|26|||
126203037|NCT02117024|454029245|FG001|Overall Study|Progressive Disease|9|||
126312827|NCT03671564|454435976|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
126312828|NCT03671564|454435974|FG000|Overall Study|Withdrawal by Subject|1|||
126312829|NCT03671564|454435975|FG001|Overall Study|Withdrawal by Subject|1|||
126312830|NCT03671564|454435976|FG002|Overall Study|Withdrawal by Subject|0|||
126312831|NCT04739722|454435982|FG000|Overall Study|Lost to Follow-up|5301|||
126312832|NCT04739722|454435982|FG000|Overall Study|Withdrawal by Subject|42|||
126312833|NCT04739722|454435982|FG000|Overall Study|Non Average-risk|1157|||
126312834|NCT01185509|454435983|FG000|Overall Study|Progression/Relapse|9|||
126312835|NCT01185509|454435984|FG001|Overall Study|Progression/Relapse|15|||
126312836|NCT01185509|454435983|FG000|Overall Study|Physician Decision|2|||
126312837|NCT01185509|454435984|FG001|Overall Study|Physician Decision|2|||
126312838|NCT01185509|454435983|FG000|Overall Study|Withdrawal by Subject|0|||
126312839|NCT01185509|454435984|FG001|Overall Study|Withdrawal by Subject|1|||
126312840|NCT01185509|454435983|FG000|Overall Study|Death|0|||
126312841|NCT01185509|454435984|FG001|Overall Study|Death|1|||
126312842|NCT01185509|454435983|FG000|Overall Study|Intercurrent Illness|0|||
126312843|NCT01185509|454435984|FG001|Overall Study|Intercurrent Illness|1|||
126312844|NCT03687372|454435985|FG000|Overall Study|Lost to Follow-up|12|||
126312845|NCT03687372|454435986|FG001|Overall Study|Lost to Follow-up|21|||
126312846|NCT03687372|454435985|FG000|Overall Study|Withdrawal by Subject|4|||
126312847|NCT03687372|454435986|FG001|Overall Study|Withdrawal by Subject|17|||
126312848|NCT03687372|454435985|FG000|Overall Study|Investigator Decision|1|||
126312849|NCT03687372|454435986|FG001|Overall Study|Investigator Decision|1|||
126312850|NCT03419598|454435991|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
126312851|NCT02474589|454435992|FG000|Overall Study|Adverse Event|6|||
126312852|NCT02474589|454435993|FG001|Overall Study|Adverse Event|2|||
126312853|NCT02474589|454435992|FG000|Overall Study|Lost to Follow-up|6|||
126312854|NCT02474589|454435993|FG001|Overall Study|Lost to Follow-up|1|||
126312855|NCT02474589|454435992|FG000|Overall Study|Protocol Violation|4|||
126312856|NCT02474589|454435993|FG001|Overall Study|Protocol Violation|1|||
126312857|NCT02474589|454435992|FG000|Overall Study|Withdrawal by Subject|4|||
126312858|NCT02474589|454435993|FG001|Overall Study|Withdrawal by Subject|0|||
126312859|NCT02474589|454435992|FG000|Overall Study|Inability to complete study procedures|5|||
126312860|NCT02474589|454435993|FG001|Overall Study|Inability to complete study procedures|1|||
126312861|NCT01740128|454435994|FG000|Overall Study|Pregnancy|0|||
126312862|NCT01740128|454435995|FG001|Overall Study|Pregnancy|1|||
126312863|NCT01740128|454435994|FG000|Overall Study|Protocol Violation|1|||
126312864|NCT01740128|454435995|FG001|Overall Study|Protocol Violation|2|||
126312865|NCT01740128|454435994|FG000|Overall Study|Lost to Follow-up|2|||
126312866|NCT01740128|454435995|FG001|Overall Study|Lost to Follow-up|2|||
126312867|NCT01740128|454435994|FG000|Overall Study|Withdrawal by Subject|1|||
126312868|NCT01740128|454435995|FG001|Overall Study|Withdrawal by Subject|0|||
126312869|NCT01740128|454435994|FG000|Overall Study|Insufficient protocol compliance|2|||
126312870|NCT01740128|454435995|FG001|Overall Study|Insufficient protocol compliance|2|||
126312871|NCT02370667|454435998|FG000|Overall Study|Lost to Follow-up|0|||
126312872|NCT02370667|454435999|FG001|Overall Study|Lost to Follow-up|1|||
126312873|NCT02370667|454436000|FG002|Overall Study|Lost to Follow-up|0|||
126312874|NCT01546168|454436001|FG000|Overall Study|Lost to Follow-up|1|||
126312875|NCT01546168|454436002|FG001|Overall Study|Lost to Follow-up|0|||
126312876|NCT01546168|454436001|FG000|Overall Study|Withdrawal by Subject|1|||
126312877|NCT01546168|454436002|FG001|Overall Study|Withdrawal by Subject|0|||
126312878|NCT01546168|454436001|FG000|Overall Study|ineligible after signing consent|2|||
126312879|NCT01546168|454436002|FG001|Overall Study|ineligible after signing consent|0|||
126312880|NCT02954653|454436003|FG000|Overall Study|Death|3|||
126312881|NCT02954653|454436004|FG001|Overall Study|Death|1|||
126312882|NCT02954653|454436005|FG002|Overall Study|Death|0|||
126312883|NCT02954653|454436006|FG003|Overall Study|Death|0|||
126312884|NCT02954653|454436007|FG004|Overall Study|Death|0|||
126312885|NCT02954653|454436008|FG005|Overall Study|Death|0|||
126312886|NCT02954653|454436009|FG006|Overall Study|Death|0|||
125979171|NCT01749982|453211628|FG003|Overall Study|Physician Decision|1|||
125979172|NCT01749982|453211625|FG000|Overall Study|Lost to Follow-up|0|||
125979173|NCT01749982|453211626|FG001|Overall Study|Lost to Follow-up|0|||
125979174|NCT01749982|453211627|FG002|Overall Study|Lost to Follow-up|0|||
126203038|NCT02117024|454029244|FG000|Overall Study|Significant Clinical Progression|7|||
126203039|NCT02117024|454029245|FG001|Overall Study|Significant Clinical Progression|4|||
126203040|NCT02117024|454029244|FG000|Overall Study|Death|5|||
126203041|NCT02117024|454029245|FG001|Overall Study|Death|0|||
126203042|NCT02117024|454029244|FG000|Overall Study|Withdrawal by Subject|3|||
126203043|NCT02117024|454029245|FG001|Overall Study|Withdrawal by Subject|1|||
126203044|NCT02117024|454029244|FG000|Overall Study|Protocol Violation|1|||
126203045|NCT02117024|454029245|FG001|Overall Study|Protocol Violation|0|||
126203046|NCT02117024|454029244|FG000|Overall Study|Adverse Event|1|||
126203047|NCT02117024|454029245|FG001|Overall Study|Adverse Event|2|||
126203048|NCT02117024|454029244|FG000|Overall Study|Randomized in Error|1|||
126203049|NCT02117024|454029245|FG001|Overall Study|Randomized in Error|0|||
126203050|NCT02117024|454029244|FG000|Overall Study|Patient returned to primary oncologist|0|||
126203051|NCT02117024|454029245|FG001|Overall Study|Patient returned to primary oncologist|1|||
126203052|NCT02117024|454029244|FG000|Overall Study|Patient took treatment break|0|||
126203053|NCT02117024|454029245|FG001|Overall Study|Patient took treatment break|1|||
126203054|NCT02117024|454029244|FG000|Overall Study|Physician Decision|0|||
126203055|NCT02117024|454029245|FG001|Overall Study|Physician Decision|2|||
126203056|NCT00565721|454029248|FG000|Overall Study|Screen Failure|2|||
126203057|NCT00565721|454029248|FG000|Overall Study|Lost to Follow-up|6|||
126203058|NCT00565721|454029248|FG000|Overall Study|Technical Problems|1|||
126203059|NCT00565721|454029248|FG000|Overall Study|Physician Decision|2|||
126203060|NCT00565721|454029248|FG000|Overall Study|Other reasons|6|||
126203061|NCT02813681|454029249|FG000|Overall Study|Physician Decision|5|||
126203062|NCT02813681|454029250|FG001|Overall Study|Physician Decision|5|||
126203063|NCT02813681|454029251|FG002|Overall Study|Physician Decision|0|||
126203064|NCT02813681|454029249|FG000|Overall Study|Lost to Follow-up|0|||
126203065|NCT02813681|454029250|FG001|Overall Study|Lost to Follow-up|1|||
126203066|NCT02813681|454029251|FG002|Overall Study|Lost to Follow-up|0|||
126203067|NCT02500706|454029252|FG000|Overall Study|Adverse Event|0|||
126203068|NCT02500706|454029253|FG001|Overall Study|Adverse Event|0|||
126203069|NCT02500706|454029254|FG002|Overall Study|Adverse Event|1|||
126203070|NCT02500706|454029252|FG000|Overall Study|Lost to Follow-up|0|||
126203071|NCT02500706|454029253|FG001|Overall Study|Lost to Follow-up|1|||
126203072|NCT02500706|454029254|FG002|Overall Study|Lost to Follow-up|1|||
126203073|NCT02500706|454029252|FG000|Overall Study|Withdrawal by Subject|4|||
126203074|NCT02500706|454029253|FG001|Overall Study|Withdrawal by Subject|6|||
126203075|NCT02500706|454029254|FG002|Overall Study|Withdrawal by Subject|4|||
126203076|NCT02500706|454029252|FG000|Overall Study|Unclassified|0|||
126203077|NCT02500706|454029253|FG001|Overall Study|Unclassified|0|||
126203078|NCT02500706|454029254|FG002|Overall Study|Unclassified|1|||
126203079|NCT00529152|454029255|FG000|Overall Study|Adverse Event|2|||
126203080|NCT00529152|454029255|FG000|Overall Study|Withdrawal by Subject|2|||
126203081|NCT00529152|454029255|FG000|Overall Study|Lost to Follow-up|1|||
126203082|NCT01497899|454029260|FG000|Double-Blind Phase|Randomized but not Treated|1|||
126203083|NCT01497899|454029261|FG001|Double-Blind Phase|Randomized but not Treated|0|||
126203084|NCT01497899|454029262|FG002|Double-Blind Phase|Randomized but not Treated|0|||
126203085|NCT01497899|454029263|FG003|Double-Blind Phase|Randomized but not Treated|0|||
126203086|NCT01497899|454029260|FG000|Double-Blind Phase|Adverse Event|1|||
126203087|NCT01497899|454029261|FG001|Double-Blind Phase|Adverse Event|0|||
126203088|NCT01497899|454029262|FG002|Double-Blind Phase|Adverse Event|0|||
126203089|NCT01497899|454029263|FG003|Double-Blind Phase|Adverse Event|0|||
126203090|NCT01497899|454029260|FG000|Double-Blind Phase|Lack of Efficacy|0|||
126203091|NCT01497899|454029261|FG001|Double-Blind Phase|Lack of Efficacy|1|||
126203092|NCT01497899|454029262|FG002|Double-Blind Phase|Lack of Efficacy|0|||
126203093|NCT01497899|454029263|FG003|Double-Blind Phase|Lack of Efficacy|0|||
126203094|NCT01497899|454029260|FG000|Double-Blind Phase|Investigator's Discretion|1|||
126203095|NCT01497899|454029261|FG001|Double-Blind Phase|Investigator's Discretion|0|||
126203096|NCT01497899|454029262|FG002|Double-Blind Phase|Investigator's Discretion|0|||
126203097|NCT01497899|454029263|FG003|Double-Blind Phase|Investigator's Discretion|0|||
126203098|NCT01497899|454029260|FG000|Double-Blind Phase|Withdrew Consent|0|||
126203099|NCT01497899|454029261|FG001|Double-Blind Phase|Withdrew Consent|1|||
126203100|NCT01497899|454029262|FG002|Double-Blind Phase|Withdrew Consent|0|||
126203101|NCT01497899|454029263|FG003|Double-Blind Phase|Withdrew Consent|0|||
126203102|NCT01497899|454029260|FG000|Double-Blind Phase|Lost to Follow-up|3|||
126203103|NCT01497899|454029261|FG001|Double-Blind Phase|Lost to Follow-up|2|||
126203104|NCT01497899|454029262|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126203105|NCT01497899|454029263|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126203106|NCT01497899|454029260|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
126203107|NCT01497899|454029261|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
126203108|NCT01497899|454029262|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
126203109|NCT01497899|454029263|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
126203110|NCT01497899|454029260|FG000|Open-Label Extension Phase|Adverse Event|1|||
126312887|NCT02954653|454436010|FG007|Overall Study|Death|0|||
126312888|NCT02954653|454436011|FG008|Overall Study|Death|0|||
126312889|NCT02954653|454436003|FG000|Overall Study|Randomized but did not receive treatment|1|||
126312890|NCT02954653|454436004|FG001|Overall Study|Randomized but did not receive treatment|0|||
126312891|NCT02954653|454436005|FG002|Overall Study|Randomized but did not receive treatment|0|||
126312892|NCT02954653|454436006|FG003|Overall Study|Randomized but did not receive treatment|0|||
126312893|NCT02954653|454436007|FG004|Overall Study|Randomized but did not receive treatment|0|||
126312894|NCT02954653|454436008|FG005|Overall Study|Randomized but did not receive treatment|0|||
126312895|NCT02954653|454436009|FG006|Overall Study|Randomized but did not receive treatment|0|||
126312896|NCT02954653|454436010|FG007|Overall Study|Randomized but did not receive treatment|0|||
126312897|NCT02954653|454436011|FG008|Overall Study|Randomized but did not receive treatment|0|||
126312898|NCT02954653|454436003|FG000|Overall Study|Started another anti-cancer therapy|0|||
126312899|NCT02954653|454436004|FG001|Overall Study|Started another anti-cancer therapy|1|||
126312900|NCT02954653|454436005|FG002|Overall Study|Started another anti-cancer therapy|0|||
126312901|NCT02954653|454436006|FG003|Overall Study|Started another anti-cancer therapy|0|||
126312902|NCT02954653|454436007|FG004|Overall Study|Started another anti-cancer therapy|0|||
126312903|NCT02954653|454436008|FG005|Overall Study|Started another anti-cancer therapy|0|||
126312904|NCT02954653|454436009|FG006|Overall Study|Started another anti-cancer therapy|0|||
126312905|NCT02954653|454436010|FG007|Overall Study|Started another anti-cancer therapy|0|||
126312906|NCT02954653|454436011|FG008|Overall Study|Started another anti-cancer therapy|0|||
126312907|NCT02954653|454436003|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
126203111|NCT01497899|454029261|FG001|Open-Label Extension Phase|Adverse Event|0|||
126203112|NCT01497899|454029262|FG002|Open-Label Extension Phase|Adverse Event|0|||
126203113|NCT01497899|454029263|FG003|Open-Label Extension Phase|Adverse Event|0|||
126203114|NCT01497899|454029260|FG000|Open-Label Extension Phase|Death|1|||
126203115|NCT01497899|454029261|FG001|Open-Label Extension Phase|Death|0|||
126203116|NCT01497899|454029262|FG002|Open-Label Extension Phase|Death|0|||
126203117|NCT01497899|454029263|FG003|Open-Label Extension Phase|Death|0|||
126203118|NCT01497899|454029260|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
126203119|NCT01497899|454029261|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
126203120|NCT01497899|454029262|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
126203121|NCT01497899|454029263|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
126203122|NCT01497899|454029260|FG000|Open-Label Extension Phase|Pregnancy|0|||
126203123|NCT01497899|454029261|FG001|Open-Label Extension Phase|Pregnancy|1|||
126203124|NCT01497899|454029262|FG002|Open-Label Extension Phase|Pregnancy|1|||
126203125|NCT01497899|454029263|FG003|Open-Label Extension Phase|Pregnancy|0|||
126203126|NCT01497899|454029260|FG000|Open-Label Extension Phase|Protocol Violation|0|||
126203127|NCT01497899|454029261|FG001|Open-Label Extension Phase|Protocol Violation|0|||
126203128|NCT01497899|454029262|FG002|Open-Label Extension Phase|Protocol Violation|1|||
126203129|NCT01497899|454029263|FG003|Open-Label Extension Phase|Protocol Violation|0|||
126203130|NCT01497899|454029260|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
126203131|NCT01497899|454029261|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
126203132|NCT01497899|454029262|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
126203133|NCT01497899|454029263|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
126203134|NCT05047601|454029265|FG000|Overall Study|Lost to Follow-up|9|||
126203135|NCT05047601|454029266|FG001|Overall Study|Lost to Follow-up|11|||
126203136|NCT05047601|454029267|FG002|Overall Study|Lost to Follow-up|7|||
126203137|NCT05047601|454029265|FG000|Overall Study|Withdrawal by Subject|25|||
126203138|NCT05047601|454029266|FG001|Overall Study|Withdrawal by Subject|36|||
126203139|NCT05047601|454029267|FG002|Overall Study|Withdrawal by Subject|23|||
126203140|NCT05047601|454029265|FG000|Overall Study|Other|10|||
126203141|NCT05047601|454029266|FG001|Overall Study|Other|6|||
126203142|NCT05047601|454029267|FG002|Overall Study|Other|5|||
126203143|NCT00286234|454029268|FG000|Overall Study|Protocol Violation|1|||
126203144|NCT00286234|454029269|FG001|Overall Study|Protocol Violation|2|||
126203145|NCT00286234|454029270|FG002|Overall Study|Protocol Violation|0|||
126203146|NCT00286234|454029271|FG003|Overall Study|Protocol Violation|1|||
126203147|NCT00286234|454029268|FG000|Overall Study|Physician Decision|1|||
126203148|NCT00286234|454029269|FG001|Overall Study|Physician Decision|0|||
126203149|NCT00286234|454029270|FG002|Overall Study|Physician Decision|0|||
126203150|NCT00286234|454029271|FG003|Overall Study|Physician Decision|1|||
126203151|NCT00286234|454029268|FG000|Overall Study|Adverse Event|0|||
126203152|NCT00286234|454029269|FG001|Overall Study|Adverse Event|0|||
126203153|NCT00286234|454029270|FG002|Overall Study|Adverse Event|0|||
126203154|NCT00286234|454029271|FG003|Overall Study|Adverse Event|1|||
126203155|NCT00286234|454029268|FG000|Overall Study|Adverse Event|0|||
126203156|NCT00286234|454029269|FG001|Overall Study|Adverse Event|0|||
126203157|NCT00286234|454029270|FG002|Overall Study|Adverse Event|0|||
126203158|NCT00286234|454029271|FG003|Overall Study|Adverse Event|1|||
126203159|NCT00283062|454029274|FG000|Overall Study|Did not receive any study medication|5|||
126203160|NCT00283062|454029275|FG001|Overall Study|Did not receive any study medication|4|||
126203161|NCT00283062|454029276|FG002|Overall Study|Did not receive any study medication|36|||
126203162|NCT00283062|454029277|FG003|Overall Study|Did not receive any study medication|45|||
126203163|NCT00283062|454029274|FG000|Overall Study|Adverse Event|2|||
126203164|NCT00283062|454029275|FG001|Overall Study|Adverse Event|0|||
126203165|NCT00283062|454029276|FG002|Overall Study|Adverse Event|1|||
126203166|NCT00283062|454029277|FG003|Overall Study|Adverse Event|0|||
126203167|NCT00283062|454029274|FG000|Overall Study|Lost to Follow-up|1|||
126203168|NCT00283062|454029275|FG001|Overall Study|Lost to Follow-up|0|||
126203169|NCT00283062|454029276|FG002|Overall Study|Lost to Follow-up|1|||
126203170|NCT00283062|454029277|FG003|Overall Study|Lost to Follow-up|0|||
126203171|NCT00283062|454029274|FG000|Overall Study|Progressive disease|0|||
126203172|NCT00283062|454029275|FG001|Overall Study|Progressive disease|0|||
126203173|NCT00283062|454029276|FG002|Overall Study|Progressive disease|1|||
126203174|NCT00283062|454029277|FG003|Overall Study|Progressive disease|0|||
126203175|NCT00283062|454029274|FG000|Overall Study|Participant did not wish to continue|3|||
126203176|NCT00283062|454029275|FG001|Overall Study|Participant did not wish to continue|2|||
126203177|NCT00283062|454029276|FG002|Overall Study|Participant did not wish to continue|1|||
126203178|NCT00283062|454029277|FG003|Overall Study|Participant did not wish to continue|0|||
126203179|NCT00283062|454029274|FG000|Overall Study|Undefined|0|||
126203180|NCT00283062|454029275|FG001|Overall Study|Undefined|1|||
126203181|NCT00283062|454029276|FG002|Overall Study|Undefined|1|||
126203182|NCT00283062|454029277|FG003|Overall Study|Undefined|4|||
126203183|NCT00283062|454029274|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
126203184|NCT00283062|454029275|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
126203185|NCT00283062|454029276|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
126203186|NCT00283062|454029277|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
126312908|NCT02954653|454436004|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
126312909|NCT02954653|454436005|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
126312910|NCT02954653|454436006|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
126312911|NCT02954653|454436007|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
126312912|NCT02954653|454436008|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
126312913|NCT02954653|454436009|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
126312914|NCT02954653|454436010|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
126312915|NCT02954653|454436011|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
126312916|NCT03054064|454436012|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
126312917|NCT03054064|454436012|FG000|Overall Study|Investigator Decision|2|||
126312918|NCT03054064|454436012|FG000|Overall Study|Bladder Issue|1|||
126312919|NCT03054064|454436012|FG000|Overall Study|High Blood Pressure|1|||
126312920|NCT03054064|454436012|FG000|Overall Study|Change in Status|1|||
126312921|NCT00471718|454436025|FG000|Overall Study|Adverse Event|3|||
126312922|NCT00471718|454436025|FG000|Overall Study|other complicating disease|1|||
126312923|NCT00471718|454436025|FG000|Overall Study|disease progression|22|||
126312924|NCT00471718|454436025|FG000|Overall Study|Withdrawal by Subject|1|||
126312925|NCT04696354|454436032|FG000|Overall Study|Study termination|6|||
126312926|NCT04696354|454436033|FG001|Overall Study|Study termination|6|||
126312927|NCT00965341|454436034|FG000|Overall Study|Withdrew consent|1|||
126312928|NCT00965341|454436035|FG001|Overall Study|Withdrew consent|5|||
126312929|NCT00965341|454436034|FG000|Overall Study|Lost to Follow-up|1|||
126312930|NCT00965341|454436035|FG001|Overall Study|Lost to Follow-up|0|||
126312931|NCT00965341|454436034|FG000|Overall Study|Transportation issues|4|||
126203187|NCT03137173|454029278|FG000|Overall Study|Withdrawal by Subject|8|||
126203188|NCT03137173|454029279|FG001|Overall Study|Withdrawal by Subject|13|||
126203189|NCT03137173|454029278|FG000|Overall Study|Death|1|||
126203190|NCT03137173|454029279|FG001|Overall Study|Death|3|||
126312932|NCT00965341|454436035|FG001|Overall Study|Transportation issues|3|||
126312933|NCT03057054|454436041|FG000|Overall Study|Death|4|||
126312934|NCT03057054|454436042|FG001|Overall Study|Death|4|||
126312935|NCT03057054|454436041|FG000|Overall Study|Withdrawal by Subject|6|||
126312936|NCT03057054|454436042|FG001|Overall Study|Withdrawal by Subject|3|||
126312937|NCT03057054|454436041|FG000|Overall Study|Ineligible|1|||
126312938|NCT03057054|454436042|FG001|Overall Study|Ineligible|1|||
126312939|NCT00960986|454436043|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
126312940|NCT00960986|454436044|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
126312941|NCT00960986|454436045|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
126312942|NCT00960986|454436046|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
126312943|NCT00960986|454436043|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
126312944|NCT00960986|454436044|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
126312945|NCT00960986|454436045|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
126312946|NCT00960986|454436046|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
126312947|NCT00960986|454436043|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
126312948|NCT00960986|454436044|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
126312949|NCT00960986|454436045|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
126312950|NCT00960986|454436046|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
126203191|NCT03137173|454029278|FG000|Overall Study|Physician Decision|1|||
126203192|NCT03137173|454029279|FG001|Overall Study|Physician Decision|0|||
126203193|NCT03137173|454029278|FG000|Overall Study|Lost to Follow-up|13|||
126312951|NCT00960986|454436043|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
126312952|NCT00960986|454436044|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
126312953|NCT00960986|454436045|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
126312954|NCT00960986|454436046|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
126312955|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
125979175|NCT01749982|453211628|FG003|Overall Study|Lost to Follow-up|1|||
125979176|NCT01749982|453211625|FG000|Overall Study|Withdrawal by Subject|0|||
125979177|NCT01749982|453211626|FG001|Overall Study|Withdrawal by Subject|0|||
125979178|NCT01749982|453211627|FG002|Overall Study|Withdrawal by Subject|0|||
125979179|NCT01749982|453211628|FG003|Overall Study|Withdrawal by Subject|1|||
125979180|NCT01596582|453211630|FG000|Overall Study|Deemed ineligible after study visit|3|||
125979181|NCT01596582|453211631|FG001|Overall Study|Deemed ineligible after study visit|6|||
125979182|NCT01596582|453211630|FG000|Overall Study|Missing all outcome data|1|||
125979183|NCT01596582|453211631|FG001|Overall Study|Missing all outcome data|1|||
125979184|NCT04435665|453211632|FG000|Overall Study|Lost to Follow-up|0|||
125979185|NCT04435665|453211633|FG001|Overall Study|Lost to Follow-up|0|||
125979186|NCT04435665|453211634|FG002|Overall Study|Lost to Follow-up|0|||
125979187|NCT04435665|453211635|FG003|Overall Study|Lost to Follow-up|1|||
125979188|NCT04672941|453211636|FG000|Overall Study|Investigator decision|1|||
125979189|NCT04672941|453211636|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
125979190|NCT04672941|453211636|FG000|Overall Study|COVID-19 related but no adverse event|1|||
125979191|NCT04672941|453211636|FG000|Overall Study|Adverse Event|2|||
125979192|NCT04672941|453211636|FG000|Overall Study|Lost to Follow-up|2|||
125979193|NCT00765388|453211638|FG000|Period 1|Lack of Efficacy|1|||
125979194|NCT00765388|453211639|FG001|Period 1|Lack of Efficacy|2|||
125979195|NCT00765388|453211638|FG000|Period 1|Lost to Follow-up|0|||
125979196|NCT00765388|453211639|FG001|Period 1|Lost to Follow-up|1|||
125979197|NCT00765388|453211638|FG000|Period 1|Herpes Zoster|0|||
125979198|NCT00765388|453211639|FG001|Period 1|Herpes Zoster|1|||
125979199|NCT00765388|453211638|FG000|Period 1|Hip operation|0|||
125979200|NCT00765388|453211639|FG001|Period 1|Hip operation|1|||
125979201|NCT03923933|453211643|FG000|Overall Study|Lost to Follow-up|1|||
125979202|NCT03923933|453211644|FG001|Overall Study|Lost to Follow-up|0|||
125979203|NCT03923933|453211643|FG000|Overall Study|Withdrawal by Subject|0|||
125979204|NCT03923933|453211644|FG001|Overall Study|Withdrawal by Subject|1|||
125979205|NCT00419263|453211645|FG000|Overall Study|Lost to Follow-up|2|||
126203194|NCT03137173|454029279|FG001|Overall Study|Lost to Follow-up|18|||
126203195|NCT03137173|454029278|FG000|Overall Study|Other reasons|3|||
126203196|NCT03137173|454029279|FG001|Overall Study|Other reasons|2|||
126203197|NCT00827112|454029282|FG000|Overall Study|Adverse Event|2|||
126203198|NCT00827112|454029283|FG001|Overall Study|Adverse Event|0|||
126203199|NCT00827112|454029282|FG000|Overall Study|Lack of Efficacy|2|||
126203200|NCT00827112|454029283|FG001|Overall Study|Lack of Efficacy|0|||
126203201|NCT00827112|454029282|FG000|Overall Study|Lost to Follow-up|3|||
126203202|NCT00827112|454029283|FG001|Overall Study|Lost to Follow-up|2|||
126203203|NCT00827112|454029282|FG000|Overall Study|Pregnancy|0|||
126203204|NCT00827112|454029283|FG001|Overall Study|Pregnancy|1|||
126203205|NCT00827112|454029282|FG000|Overall Study|Protocol Violation|0|||
126203206|NCT00827112|454029283|FG001|Overall Study|Protocol Violation|2|||
126203207|NCT00827112|454029282|FG000|Overall Study|Withdrawal by Subject|2|||
126203208|NCT00827112|454029283|FG001|Overall Study|Withdrawal by Subject|1|||
126203209|NCT00827112|454029282|FG000|Overall Study|Randomized but not treated|5|||
126203210|NCT00827112|454029283|FG001|Overall Study|Randomized but not treated|3|||
126203211|NCT00827112|454029282|FG000|Overall Study|Other|1|||
126203212|NCT00827112|454029283|FG001|Overall Study|Other|3|||
126203213|NCT01475214|454029284|FG000|Overall Study|Lost to Follow-up|1|||
126203214|NCT01475214|454029285|FG001|Overall Study|Lost to Follow-up|0|||
126203215|NCT01475214|454029286|FG002|Overall Study|Lost to Follow-up|1|||
126203216|NCT01475214|454029284|FG000|Overall Study|Physician Decision|2|||
126203217|NCT01475214|454029285|FG001|Overall Study|Physician Decision|0|||
126203218|NCT01475214|454029286|FG002|Overall Study|Physician Decision|0|||
126203219|NCT01475214|454029284|FG000|Overall Study|Withdrawal by Subject|2|||
126203220|NCT01475214|454029285|FG001|Overall Study|Withdrawal by Subject|4|||
126203221|NCT01475214|454029286|FG002|Overall Study|Withdrawal by Subject|1|||
126203222|NCT03044730|454029299|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
126203223|NCT03044730|454029299|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
126203224|NCT03044730|454029299|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
126203225|NCT03044730|454029299|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
126203226|NCT03044730|454029299|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
126203227|NCT03044730|454029299|FG000|Cycles 4 and Beyond|Adverse Event|1|||
126203228|NCT03044730|454029299|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
126312956|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
126312957|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
126312958|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
126312959|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Death|0|||
126312960|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Death|0|||
126203229|NCT03044730|454029299|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
126312961|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Death|1|||
126203230|NCT03044730|454029299|FG000|On Follow-up for 2 Years|Death|17|||
126203231|NCT00690612|454030854|FG000|Overall Study|Adverse Event|1|||
126203232|NCT00690612|454030854|FG000|Overall Study|Withdrawal by Subject|2|||
126203233|NCT00911508|454030855|FG000|Overall Study|Lost to Follow-up|27|||
126203234|NCT00911508|454030856|FG001|Overall Study|Lost to Follow-up|18|||
126203235|NCT00911508|454030855|FG000|Overall Study|Withdrawal by Subject|79|||
126203236|NCT00911508|454030856|FG001|Overall Study|Withdrawal by Subject|112|||
126203237|NCT01409382|454030857|FG000|Overall Study|Lost to Follow-up|1|||
126203238|NCT01409382|454030858|FG001|Overall Study|Lost to Follow-up|1|||
126203239|NCT01409382|454030857|FG000|Overall Study|Protocol Violation|0|||
126203240|NCT01409382|454030858|FG001|Overall Study|Protocol Violation|3|||
126203241|NCT01409382|454030857|FG000|Overall Study|Multiple pregnancy|2|||
126203242|NCT01409382|454030858|FG001|Overall Study|Multiple pregnancy|4|||
126203243|NCT01409382|454030857|FG000|Overall Study|Still pregnant when study ended|13|||
126203244|NCT01409382|454030858|FG001|Overall Study|Still pregnant when study ended|2|||
126203245|NCT01409382|454030857|FG000|Overall Study|Did not manage to get pregnant|64|||
126203246|NCT01409382|454030858|FG001|Overall Study|Did not manage to get pregnant|70|||
126203247|NCT01409382|454030857|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
126203248|NCT01409382|454030858|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
126203249|NCT01233076|454030859|FG000|Period 2, One Week|Lost to Follow-up|1|||
126203250|NCT01233076|454030860|FG001|Period 2, One Week|Lost to Follow-up|0|||
126203251|NCT01786707|454030862|FG000|Overall Study|Lost to Follow-up|1|||
126203252|NCT01786707|454030863|FG001|Overall Study|Lost to Follow-up|1|||
126203253|NCT02058940|454030865|FG000|Overall Study|Discharged from Critical Care Unit|1|||
126312962|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Death|0|||
126312963|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
126312964|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
126312965|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
126312966|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
126312967|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
126312968|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
126312969|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
126312970|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
126312971|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
126312972|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
126312973|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
126312974|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
126312975|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
126312976|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
126312977|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
126312978|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
126312979|NCT01077739|454436047|FG000|Overall Study|Premature withdrawal|1|||
126312980|NCT01077739|454436048|FG001|Overall Study|Premature withdrawal|3|||
126312981|NCT01077739|454436047|FG000|Overall Study|Withdrawal by Subject|1|||
126312982|NCT01077739|454436048|FG001|Overall Study|Withdrawal by Subject|0|||
126312983|NCT01077739|454436047|FG000|Overall Study|Death|0|||
126312984|NCT01077739|454436048|FG001|Overall Study|Death|3|||
126312985|NCT01077739|454436047|FG000|Overall Study|Unacceptable toxicity|1|||
126312986|NCT01077739|454436048|FG001|Overall Study|Unacceptable toxicity|2|||
126312987|NCT01077739|454436047|FG000|Overall Study|Other|2|||
126312988|NCT01077739|454436048|FG001|Overall Study|Other|2|||
126312989|NCT00877071|454436049|FG000|Overall Study|disease progression|2|||
126312990|NCT01984892|454436050|FG000|Overall Study|Progressive disease|7|||
126312991|NCT04464720|454436051|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
126312992|NCT05723328|454436057|FG000|Overall Study|Investigator's Decision|5|||
126312993|NCT05723328|454436058|FG001|Overall Study|Investigator's Decision|2|||
126312994|NCT00954512|454436062|FG000|Overall Study|Withdrawal by Subject|0|||
126312995|NCT00954512|454436063|FG001|Overall Study|Withdrawal by Subject|0|||
126312996|NCT00954512|454436064|FG002|Overall Study|Withdrawal by Subject|0|||
126312997|NCT00954512|454436065|FG003|Overall Study|Withdrawal by Subject|0|||
126312998|NCT00954512|454436066|FG004|Overall Study|Withdrawal by Subject|0|||
126312999|NCT00954512|454436067|FG005|Overall Study|Withdrawal by Subject|1|||
126313000|NCT00954512|454436062|FG000|Overall Study|Adverse Event|0|||
126313001|NCT00954512|454436063|FG001|Overall Study|Adverse Event|0|||
126313002|NCT00954512|454436064|FG002|Overall Study|Adverse Event|0|||
126313003|NCT00954512|454436065|FG003|Overall Study|Adverse Event|0|||
126313004|NCT00954512|454436066|FG004|Overall Study|Adverse Event|1|||
126313005|NCT00954512|454436067|FG005|Overall Study|Adverse Event|2|||
126313006|NCT00954512|454436062|FG000|Overall Study|Physician Decision|0|||
126313007|NCT00954512|454436063|FG001|Overall Study|Physician Decision|1|||
126313008|NCT00954512|454436064|FG002|Overall Study|Physician Decision|0|||
126313009|NCT00954512|454436065|FG003|Overall Study|Physician Decision|1|||
126313010|NCT00954512|454436066|FG004|Overall Study|Physician Decision|0|||
126313011|NCT00954512|454436067|FG005|Overall Study|Physician Decision|0|||
126313012|NCT00954512|454436062|FG000|Overall Study|Symptomatic Deterioration|0|||
126313013|NCT00954512|454436063|FG001|Overall Study|Symptomatic Deterioration|1|||
126313014|NCT00954512|454436064|FG002|Overall Study|Symptomatic Deterioration|0|||
126313015|NCT00954512|454436065|FG003|Overall Study|Symptomatic Deterioration|0|||
126313016|NCT00954512|454436066|FG004|Overall Study|Symptomatic Deterioration|2|||
126313017|NCT00954512|454436067|FG005|Overall Study|Symptomatic Deterioration|0|||
126313018|NCT00954512|454436062|FG000|Overall Study|Progression of Disease|2|||
126313019|NCT00954512|454436063|FG001|Overall Study|Progression of Disease|1|||
126313020|NCT00954512|454436064|FG002|Overall Study|Progression of Disease|0|||
126313021|NCT00954512|454436065|FG003|Overall Study|Progression of Disease|1|||
126313022|NCT00954512|454436066|FG004|Overall Study|Progression of Disease|1|||
126313023|NCT00954512|454436067|FG005|Overall Study|Progression of Disease|1|||
126313024|NCT01794793|454436068|FG000|Treatment Period|Withdrawal by Subject|24|||
126313025|NCT01794793|454436068|FG000|Treatment Period|Lack of Efficacy|22|||
126313026|NCT01794793|454436068|FG000|Treatment Period|Adverse Event|17|||
126313027|NCT01794793|454436068|FG000|Treatment Period|Physician Decision|14|||
126313028|NCT01794793|454436068|FG000|Treatment Period|Lost to Follow-up|7|||
126313029|NCT01794793|454436068|FG000|Treatment Period|Death|6|||
126313030|NCT01794793|454436068|FG000|Treatment Period|Protocol Violation|5|||
126313031|NCT01794793|454436068|FG000|Treatment Period|administrative problem|3|||
126313032|NCT01794793|454436068|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
126313033|NCT01794793|454436068|FG000|Post-treatment Follow-up|Adverse Event|8|||
126313034|NCT01794793|454436068|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
126313035|NCT01794793|454436068|FG000|Post-treatment Follow-up|administrative problem|5|||
126313036|NCT01794793|454436068|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
126313037|NCT01794793|454436068|FG000|Post-treatment Follow-up|Protocol Violation|3|||
126313038|NCT03495154|454436069|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
126313039|NCT03495154|454436069|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
126313040|NCT03495154|454436069|FG000|Overall Study|Screen Failures During Surgery|6|||
126313041|NCT03495154|454436069|FG000|Overall Study|Death|2|||
126313042|NCT03495154|454436069|FG000|Overall Study|Lost to Follow-up|16|||
126313043|NCT03495154|454436069|FG000|Overall Study|Withdrawal by Subject|2|||
126313044|NCT03495154|454436069|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
126313045|NCT05685732|454436070|FG000|Overall Study|Withdrawal by Subject|2|||
126313046|NCT05685732|454436071|FG001|Overall Study|Withdrawal by Subject|0|||
126313047|NCT05685732|454436072|FG002|Overall Study|Withdrawal by Subject|2|||
126313048|NCT05685732|454436073|FG003|Overall Study|Withdrawal by Subject|3|||
126313049|NCT05685732|454436070|FG000|Overall Study|Protocol Violation|1|||
126313050|NCT05685732|454436071|FG001|Overall Study|Protocol Violation|2|||
126313051|NCT05685732|454436072|FG002|Overall Study|Protocol Violation|4|||
126313052|NCT05685732|454436073|FG003|Overall Study|Protocol Violation|1|||
126313053|NCT05685732|454436070|FG000|Overall Study|Lost to Follow-up|5|||
126313054|NCT05685732|454436071|FG001|Overall Study|Lost to Follow-up|1|||
126313055|NCT05685732|454436072|FG002|Overall Study|Lost to Follow-up|3|||
126313056|NCT05685732|454436073|FG003|Overall Study|Lost to Follow-up|1|||
126313057|NCT05685732|454436070|FG000|Overall Study|Adverse Event|2|||
126313058|NCT05685732|454436071|FG001|Overall Study|Adverse Event|1|||
126313059|NCT05685732|454436072|FG002|Overall Study|Adverse Event|0|||
126313060|NCT05685732|454436073|FG003|Overall Study|Adverse Event|0|||
126313061|NCT05685732|454436070|FG000|Overall Study|Physician Decision|1|||
126313062|NCT05685732|454436071|FG001|Overall Study|Physician Decision|0|||
126313063|NCT05685732|454436072|FG002|Overall Study|Physician Decision|0|||
126313064|NCT05685732|454436073|FG003|Overall Study|Physician Decision|0|||
126313065|NCT02640404|454436074|FG000|Overall Study|Protocol Violation|1|||
126313066|NCT02640404|454436075|FG001|Overall Study|Protocol Violation|0|||
126313067|NCT02640404|454436074|FG000|Overall Study|Withdrawal by Subject|1|||
126313068|NCT02640404|454436075|FG001|Overall Study|Withdrawal by Subject|0|||
126313069|NCT05397171|454436076|FG000|Overall Study|Death|2|||
126313070|NCT05397171|454436077|FG001|Overall Study|Death|3|||
126313071|NCT05397171|454436078|FG002|Overall Study|Death|3|||
126313072|NCT05397171|454436076|FG000|Overall Study|Study Terminated By Sponsor|1|||
126313073|NCT05397171|454436077|FG001|Overall Study|Study Terminated By Sponsor|2|||
126313074|NCT05397171|454436078|FG002|Overall Study|Study Terminated By Sponsor|3|||
126313075|NCT05397171|454436076|FG000|Overall Study|Withdrawal by Subject|0|||
126313076|NCT05397171|454436077|FG001|Overall Study|Withdrawal by Subject|1|||
126313077|NCT05397171|454436078|FG002|Overall Study|Withdrawal by Subject|1|||
126313078|NCT02234596|454436079|FG000|Overall Study|Participant not treated|2|||
126313079|NCT02143791|454437508|FG000|Enrolled|Withdrawal by Subject|4|||
126313080|NCT02143791|454437508|FG000|Trial Stimulation|Lack of Efficacy|21|||
126313081|NCT02143791|454437508|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
126313082|NCT02143791|454437508|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
126313083|NCT02143791|454437508|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
126313084|NCT02143791|454437508|FG000|Any Programming (3-6 Months)|Missing Data|1|||
126313085|NCT02143791|454437508|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
126313086|NCT00401544|454437509|FG000|Overall Study|Adverse Event|5|||
126313087|NCT00401544|454437510|FG001|Overall Study|Adverse Event|1|||
126313088|NCT00401544|454437511|FG002|Overall Study|Adverse Event|1|||
126313089|NCT00401544|454437512|FG003|Overall Study|Adverse Event|1|||
126313090|NCT00401544|454437509|FG000|Overall Study|Death|3|||
126313091|NCT00401544|454437510|FG001|Overall Study|Death|6|||
126313092|NCT00401544|454437511|FG002|Overall Study|Death|2|||
126313093|NCT00401544|454437512|FG003|Overall Study|Death|5|||
126313094|NCT00401544|454437509|FG000|Overall Study|Lost to Follow-up|2|||
126313095|NCT00401544|454437510|FG001|Overall Study|Lost to Follow-up|0|||
126313096|NCT00401544|454437511|FG002|Overall Study|Lost to Follow-up|1|||
126313097|NCT00401544|454437512|FG003|Overall Study|Lost to Follow-up|1|||
126313098|NCT00401544|454437509|FG000|Overall Study|Withdrawal by Subject|7|||
126313099|NCT00401544|454437510|FG001|Overall Study|Withdrawal by Subject|6|||
126313100|NCT00401544|454437511|FG002|Overall Study|Withdrawal by Subject|6|||
126313101|NCT00401544|454437512|FG003|Overall Study|Withdrawal by Subject|5|||
126313102|NCT00401544|454437509|FG000|Overall Study|Physician Decision|1|||
126313103|NCT00401544|454437510|FG001|Overall Study|Physician Decision|3|||
126313104|NCT00401544|454437511|FG002|Overall Study|Physician Decision|0|||
126313105|NCT00401544|454437512|FG003|Overall Study|Physician Decision|0|||
126313106|NCT00401544|454437509|FG000|Overall Study|Ineligibility determined|0|||
126313107|NCT00401544|454437510|FG001|Overall Study|Ineligibility determined|1|||
126313108|NCT00401544|454437511|FG002|Overall Study|Ineligibility determined|0|||
126313109|NCT00401544|454437512|FG003|Overall Study|Ineligibility determined|2|||
126313110|NCT00401544|454437509|FG000|Overall Study|Disease progression|0|||
126313111|NCT00401544|454437510|FG001|Overall Study|Disease progression|1|||
126313112|NCT00401544|454437511|FG002|Overall Study|Disease progression|0|||
126313113|NCT00401544|454437512|FG003|Overall Study|Disease progression|0|||
126313114|NCT00401544|454437509|FG000|Overall Study|Other|0|||
126313115|NCT00401544|454437510|FG001|Overall Study|Other|0|||
126313116|NCT00401544|454437511|FG002|Overall Study|Other|2|||
126313117|NCT00401544|454437512|FG003|Overall Study|Other|2|||
126313118|NCT00878969|454437520|FG000|Overall Study|Physician Decision|5|||
126313119|NCT00878969|454437521|FG001|Overall Study|Physician Decision|3|||
126313120|NCT00878969|454437522|FG002|Overall Study|Physician Decision|2|||
126313121|NCT00878969|454437520|FG000|Overall Study|Withdrawal by Subject|1|||
126313122|NCT00878969|454437521|FG001|Overall Study|Withdrawal by Subject|6|||
126313123|NCT00878969|454437522|FG002|Overall Study|Withdrawal by Subject|3|||
126313124|NCT00878969|454437520|FG000|Overall Study|kidney transplant|2|||
126313125|NCT00878969|454437521|FG001|Overall Study|kidney transplant|3|||
126313126|NCT00878969|454437522|FG002|Overall Study|kidney transplant|2|||
126313127|NCT00878969|454437520|FG000|Overall Study|Adverse Event|3|||
126313128|NCT00878969|454437521|FG001|Overall Study|Adverse Event|1|||
126313129|NCT00878969|454437522|FG002|Overall Study|Adverse Event|2|||
126313130|NCT00878969|454437520|FG000|Overall Study|Lost to Follow-up|2|||
126313131|NCT00878969|454437521|FG001|Overall Study|Lost to Follow-up|1|||
126313132|NCT00878969|454437522|FG002|Overall Study|Lost to Follow-up|0|||
126313133|NCT00878969|454437520|FG000|Overall Study|Protocol Violation|2|||
126313134|NCT00878969|454437521|FG001|Overall Study|Protocol Violation|0|||
126313135|NCT00878969|454437522|FG002|Overall Study|Protocol Violation|0|||
126313136|NCT00878969|454437520|FG000|Overall Study|Death|0|||
126313137|NCT00878969|454437521|FG001|Overall Study|Death|0|||
126313138|NCT00878969|454437522|FG002|Overall Study|Death|2|||
126313139|NCT00878969|454437520|FG000|Overall Study|Pregnancy|0|||
126313140|NCT00878969|454437521|FG001|Overall Study|Pregnancy|1|||
126313141|NCT00878969|454437522|FG002|Overall Study|Pregnancy|0|||
126313142|NCT02083185|454437523|FG000|Overall Study|Lost to Follow-up|0|||
126313143|NCT02083185|454437524|FG001|Overall Study|Lost to Follow-up|3|||
126313144|NCT02083185|454437525|FG002|Overall Study|Lost to Follow-up|0|||
126313145|NCT02083185|454437523|FG000|Overall Study|Withdrawal by Subject|9|||
126313146|NCT02083185|454437524|FG001|Overall Study|Withdrawal by Subject|15|||
126313147|NCT02083185|454437525|FG002|Overall Study|Withdrawal by Subject|1|||
126313148|NCT02083185|454437523|FG000|Overall Study|Death|2|||
126313149|NCT02083185|454437524|FG001|Overall Study|Death|2|||
126313150|NCT02083185|454437525|FG002|Overall Study|Death|1|||
126313151|NCT02083185|454437523|FG000|Overall Study|Reason not Specified|9|||
126313152|NCT02083185|454437524|FG001|Overall Study|Reason not Specified|6|||
126313153|NCT02083185|454437525|FG002|Overall Study|Reason not Specified|5|||
126313154|NCT02083185|454437523|FG000|Overall Study|Study Terminated by Sponsor|0|||
126313155|NCT02083185|454437524|FG001|Overall Study|Study Terminated by Sponsor|1|||
126313156|NCT02083185|454437525|FG002|Overall Study|Study Terminated by Sponsor|0|||
126313157|NCT02083185|454437523|FG000|Overall Study|Did not Receive Study Drug|0|||
126313158|NCT02083185|454437524|FG001|Overall Study|Did not Receive Study Drug|2|||
126313159|NCT02083185|454437525|FG002|Overall Study|Did not Receive Study Drug|0|||
126313160|NCT01041976|454437526|FG000|Overall Study|Withdrawal by Subject|3|||
126313161|NCT01041976|454437527|FG001|Overall Study|Withdrawal by Subject|0|||
126313162|NCT01041976|454437526|FG000|Overall Study|Incarceration|2|||
126313163|NCT01041976|454437527|FG001|Overall Study|Incarceration|0|||
126313164|NCT01041976|454437526|FG000|Overall Study|Death|0|||
126313165|NCT01041976|454437527|FG001|Overall Study|Death|4|||
126313166|NCT00380081|454437528|FG000|Overall Study|Withdrawal by Subject|0|||
126313167|NCT00380081|454437529|FG001|Overall Study|Withdrawal by Subject|0|||
126313168|NCT00380081|454437530|FG002|Overall Study|Withdrawal by Subject|0|||
126313169|NCT00380081|454437531|FG003|Overall Study|Withdrawal by Subject|0|||
126313170|NCT00380081|454437532|FG004|Overall Study|Withdrawal by Subject|1|||
126313171|NCT00380081|454437533|FG005|Overall Study|Withdrawal by Subject|0|||
126313172|NCT00380081|454437528|FG000|Overall Study|Family Emergency|0|||
126313173|NCT00380081|454437529|FG001|Overall Study|Family Emergency|0|||
126313174|NCT00380081|454437530|FG002|Overall Study|Family Emergency|0|||
126313175|NCT00380081|454437531|FG003|Overall Study|Family Emergency|0|||
126313176|NCT00380081|454437532|FG004|Overall Study|Family Emergency|0|||
126313177|NCT00380081|454437533|FG005|Overall Study|Family Emergency|1|||
126313178|NCT02231879|454437534|FG000|Overall Study|Adverse Event|2|||
126313179|NCT02231879|454437535|FG001|Overall Study|Adverse Event|1|||
126313180|NCT02231879|454437534|FG000|Overall Study|Lack of Efficacy|0|||
126313181|NCT02231879|454437535|FG001|Overall Study|Lack of Efficacy|1|||
126313182|NCT03787303|454437536|FG000|Overall Study|Death|1|||
126313183|NCT03787303|454437536|FG000|Overall Study|Premature Termination of Study|1|||
126313184|NCT01384019|454437537|FG000|Overall Study|Withdrawal by Subject|3|||
126313185|NCT01384019|454437538|FG001|Overall Study|Withdrawal by Subject|0|||
126313186|NCT01384019|454437537|FG000|Overall Study|Death|1|||
126313187|NCT01384019|454437538|FG001|Overall Study|Death|0|||
126313188|NCT01384019|454437537|FG000|Overall Study|MRI refusal|6|||
126313189|NCT01384019|454437538|FG001|Overall Study|MRI refusal|6|||
126313190|NCT04489381|454437545|FG000|Overall Study|Lost to Follow-up|2|||
126313191|NCT04489381|454437546|FG001|Overall Study|Lost to Follow-up|3|||
126313192|NCT04489381|454437545|FG000|Overall Study|Withdrawal by Subject|1|||
126313193|NCT04489381|454437546|FG001|Overall Study|Withdrawal by Subject|0|||
126313194|NCT00070018|454437547|FG000|Overall Study|Adverse Event|2|||
126313195|NCT00070018|454437547|FG000|Overall Study|Lack of Efficacy|1|||
126313196|NCT00070018|454437547|FG000|Overall Study|Withdrawal by Subject|1|||
126313197|NCT02543892|454437548|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
126313198|NCT02543892|454437549|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
126313199|NCT02543892|454437550|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
126423693|NCT01236521|454847050|FG001|Overall Study|Withdrawal by Subject|17|||
126423694|NCT01236521|454847049|FG000|Overall Study|Death|2|||
126313200|NCT02543892|454437551|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
126313201|NCT02543892|454437552|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
126313202|NCT02543892|454437553|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
126313203|NCT02543892|454437554|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
126313204|NCT02543892|454437555|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
126313205|NCT02543892|454437548|FG000|Received Vaccination 2|Physician Decision|0|||
126313206|NCT02543892|454437549|FG001|Received Vaccination 2|Physician Decision|0|||
126313207|NCT02543892|454437550|FG002|Received Vaccination 2|Physician Decision|0|||
126313208|NCT02543892|454437551|FG003|Received Vaccination 2|Physician Decision|0|||
126313209|NCT02543892|454437552|FG004|Received Vaccination 2|Physician Decision|0|||
126313210|NCT02543892|454437553|FG005|Received Vaccination 2|Physician Decision|1|||
126313211|NCT02543892|454437554|FG006|Received Vaccination 2|Physician Decision|0|||
126313212|NCT02543892|454437555|FG007|Received Vaccination 2|Physician Decision|0|||
126313213|NCT02543892|454437548|FG000|Received Vaccination 2|Adverse Event|0|||
126313214|NCT02543892|454437549|FG001|Received Vaccination 2|Adverse Event|1|||
126313215|NCT02543892|454437550|FG002|Received Vaccination 2|Adverse Event|0|||
126423695|NCT01236521|454847050|FG001|Overall Study|Death|1|||
126423696|NCT01236521|454847049|FG000|Overall Study|Lost to Follow-up|9|||
126423697|NCT01236521|454847050|FG001|Overall Study|Lost to Follow-up|7|||
126423698|NCT04037891|454847051|FG000|Open-label Period|Withdrawal by Subject|1|||
126423699|NCT04037891|454847052|FG001|Open-label Period|Withdrawal by Subject|0|||
126423700|NCT04037891|454847053|FG002|Open-label Period|Withdrawal by Subject|0|||
126423701|NCT04037891|454847051|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
126423702|NCT04037891|454847052|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
126423703|NCT04037891|454847053|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
126423704|NCT03446313|454847054|FG000|Overall Study|Lost to Follow-up|1|||
126423705|NCT03446313|454847055|FG001|Overall Study|Lost to Follow-up|2|||
126423706|NCT03446313|454847054|FG000|Overall Study|Failed primary screening|3|||
126423707|NCT03446313|454847055|FG001|Overall Study|Failed primary screening|0|||
126423708|NCT03446313|454847054|FG000|Overall Study|Diagnosed with terminal cancer|1|||
126423709|NCT03446313|454847055|FG001|Overall Study|Diagnosed with terminal cancer|0|||
126423710|NCT03446313|454847054|FG000|Overall Study|Excluded from analysis|1|||
126423711|NCT03446313|454847055|FG001|Overall Study|Excluded from analysis|1|||
126423712|NCT05274958|454847056|FG000|Overall Study|Only completed 1 set of PROMs|22|||
126423713|NCT05274958|454847057|FG001|Overall Study|Only completed 1 set of PROMs|35|||
126423714|NCT04491136|454847062|FG000|Overall Study|Patient withdraw informed consent|9|||
126423715|NCT04491136|454847062|FG000|Overall Study|Adverse Event|2|||
126423716|NCT04491136|454847062|FG000|Overall Study|Death|3|||
126423717|NCT04491136|454847062|FG000|Overall Study|Lost to Follow-up|3|||
126423718|NCT04491136|454847062|FG000|Overall Study|Physician Decision|45|||
126423719|NCT04491136|454847062|FG000|Overall Study|sponsor terminated the study early|16|||
126423720|NCT04491136|454847062|FG000|Overall Study|Patient/guardian's decision|1|||
126313216|NCT02543892|454437551|FG003|Received Vaccination 2|Adverse Event|0|||
126313217|NCT02543892|454437552|FG004|Received Vaccination 2|Adverse Event|0|||
126313218|NCT02543892|454437553|FG005|Received Vaccination 2|Adverse Event|0|||
126313219|NCT02543892|454437554|FG006|Received Vaccination 2|Adverse Event|0|||
126313220|NCT02543892|454437555|FG007|Received Vaccination 2|Adverse Event|0|||
126313221|NCT02543892|454437548|FG000|Had Immunology Data|Withdrawal by Subject|0|||
126313222|NCT02543892|454437549|FG001|Had Immunology Data|Withdrawal by Subject|0|||
126313223|NCT02543892|454437550|FG002|Had Immunology Data|Withdrawal by Subject|0|||
126313224|NCT02543892|454437551|FG003|Had Immunology Data|Withdrawal by Subject|0|||
126313225|NCT02543892|454437552|FG004|Had Immunology Data|Withdrawal by Subject|0|||
126313226|NCT02543892|454437553|FG005|Had Immunology Data|Withdrawal by Subject|0|||
126313227|NCT02543892|454437554|FG006|Had Immunology Data|Withdrawal by Subject|1|||
126313228|NCT02543892|454437555|FG007|Had Immunology Data|Withdrawal by Subject|0|||
126313229|NCT00525902|454437556|FG000|Overall Study|Lack of Efficacy|1|||
126313230|NCT00985959|454437557|FG000|Overall Study|Adverse Event|0|||
126313231|NCT00985959|454437558|FG001|Overall Study|Adverse Event|0|||
126313232|NCT00985959|454437559|FG002|Overall Study|Adverse Event|19|||
126313233|NCT00985959|454437557|FG000|Overall Study|Withdrawal by Subject|0|||
126313234|NCT00985959|454437558|FG001|Overall Study|Withdrawal by Subject|0|||
126313235|NCT00985959|454437559|FG002|Overall Study|Withdrawal by Subject|8|||
126313236|NCT00985959|454437557|FG000|Overall Study|Progressive disease|1|||
126313237|NCT00985959|454437558|FG001|Overall Study|Progressive disease|2|||
126313238|NCT00985959|454437559|FG002|Overall Study|Progressive disease|8|||
126313239|NCT00985959|454437557|FG000|Overall Study|Unrecovered toxicity|0|||
126313240|NCT00985959|454437558|FG001|Overall Study|Unrecovered toxicity|0|||
126313241|NCT00985959|454437559|FG002|Overall Study|Unrecovered toxicity|7|||
126313242|NCT00985959|454437557|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
126313243|NCT00985959|454437558|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
126313244|NCT00985959|454437559|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
126313245|NCT00985959|454437557|FG000|Overall Study|Complete response observed over 2 cycles|0|||
126313246|NCT00985959|454437558|FG001|Overall Study|Complete response observed over 2 cycles|1|||
126313247|NCT00985959|454437559|FG002|Overall Study|Complete response observed over 2 cycles|4|||
126313248|NCT00985959|454437557|FG000|Overall Study|Other|0|||
126313249|NCT00985959|454437558|FG001|Overall Study|Other|0|||
126313250|NCT00985959|454437559|FG002|Overall Study|Other|11|||
126313251|NCT00976209|454437560|FG000|Treatment Period 1|Protocol Violation|1|||
126313252|NCT00976209|454437561|FG001|Treatment Period 1|Protocol Violation|0|||
126313253|NCT00976209|454437560|FG000|Treatment Period 1|Lost to Follow-up|2|||
126313254|NCT00976209|454437561|FG001|Treatment Period 1|Lost to Follow-up|0|||
126313255|NCT00976209|454437560|FG000|Treatment Period 1|Other|0|||
126313256|NCT00976209|454437561|FG001|Treatment Period 1|Other|1|||
126313257|NCT00976209|454437560|FG000|Wash-out Period|Adverse Event|1|||
126313258|NCT00976209|454437561|FG001|Wash-out Period|Adverse Event|2|||
126313259|NCT00976209|454437560|FG000|Wash-out Period|Lost to Follow-up|1|||
126313260|NCT00976209|454437561|FG001|Wash-out Period|Lost to Follow-up|0|||
126313261|NCT00976209|454437560|FG000|Wash-out Period|Protocol Violation|1|||
126313262|NCT00976209|454437561|FG001|Wash-out Period|Protocol Violation|0|||
126313263|NCT00976209|454437560|FG000|Wash-out Period|Other|1|||
126313264|NCT00976209|454437561|FG001|Wash-out Period|Other|0|||
126313265|NCT00976209|454437560|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126313266|NCT00976209|454437561|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126313267|NCT00976209|454437560|FG000|Treatment Period 2|Lost to Follow-up|0|||
126313268|NCT00976209|454437561|FG001|Treatment Period 2|Lost to Follow-up|1|||
126313269|NCT00844480|454437568|FG000|Overall Study|Withdrawal by Subject|2|||
126313270|NCT00844480|454437569|FG001|Overall Study|Withdrawal by Subject|3|||
126313271|NCT02858180|454437570|FG000|Overall Study|Lost to Follow-up|0|||
126313272|NCT02858180|454437571|FG001|Overall Study|Lost to Follow-up|2|||
126313273|NCT00979420|454437572|FG000|Overall Study|Adverse Event|1|||
126313274|NCT00979420|454437573|FG001|Overall Study|Adverse Event|0|||
126313275|NCT00979420|454437574|FG002|Overall Study|Adverse Event|0|||
126313276|NCT00979420|454437575|FG003|Overall Study|Adverse Event|0|||
126313277|NCT00979420|454437572|FG000|Overall Study|Lack of Efficacy|3|||
126313278|NCT00979420|454437573|FG001|Overall Study|Lack of Efficacy|0|||
126313279|NCT00979420|454437574|FG002|Overall Study|Lack of Efficacy|1|||
126313280|NCT00979420|454437575|FG003|Overall Study|Lack of Efficacy|1|||
126313281|NCT00979420|454437572|FG000|Overall Study|Other reasons not related to Viramune|3|||
126313282|NCT00979420|454437573|FG001|Overall Study|Other reasons not related to Viramune|0|||
126313283|NCT00979420|454437574|FG002|Overall Study|Other reasons not related to Viramune|0|||
126313284|NCT00979420|454437575|FG003|Overall Study|Other reasons not related to Viramune|1|||
126313285|NCT00526331|454437576|FG000|Overall Study|Sponsor Termination|55|||
126313286|NCT00574249|454437577|FG000|Overall Study|Adverse Event|6|||
126313287|NCT00574249|454437578|FG001|Overall Study|Adverse Event|18|||
126313288|NCT00574249|454437577|FG000|Overall Study|Lack of Efficacy|5|||
126313289|NCT00574249|454437578|FG001|Overall Study|Lack of Efficacy|3|||
126313290|NCT00574249|454437577|FG000|Overall Study|Lost to Follow-up|4|||
126313291|NCT00574249|454437578|FG001|Overall Study|Lost to Follow-up|3|||
126313292|NCT00574249|454437577|FG000|Overall Study|Protocol Violation|5|||
126313293|NCT00574249|454437578|FG001|Overall Study|Protocol Violation|2|||
126313294|NCT00574249|454437577|FG000|Overall Study|History of carcinoma|1|||
126313295|NCT00574249|454437578|FG001|Overall Study|History of carcinoma|0|||
126313296|NCT00574249|454437577|FG000|Overall Study|Withdrawal by Subject|3|||
126313297|NCT00574249|454437578|FG001|Overall Study|Withdrawal by Subject|0|||
126313298|NCT00574249|454437577|FG000|Overall Study|Physician Decision|1|||
126313299|NCT00574249|454437578|FG001|Overall Study|Physician Decision|0|||
126313300|NCT00574249|454437577|FG000|Overall Study|Pregnancy|1|||
126313301|NCT00574249|454437578|FG001|Overall Study|Pregnancy|0|||
126313302|NCT00574249|454437577|FG000|Overall Study|Excluded by company|0|||
125979206|NCT00419263|453211646|FG001|Overall Study|Lost to Follow-up|1|||
125979207|NCT00419263|453211647|FG002|Overall Study|Lost to Follow-up|1|||
126313303|NCT00574249|454437578|FG001|Overall Study|Excluded by company|1|||
126313304|NCT00574249|454437577|FG000|Overall Study|PPD test taken twice|0|||
126313305|NCT00574249|454437578|FG001|Overall Study|PPD test taken twice|1|||
126313306|NCT01259375|454437579|FG000|Overall Study|Adverse Event|1|||
126313307|NCT00478699|454437582|FG000|Overall Study|Inclusion Error|1|||
126313308|NCT00478699|454437583|FG001|Overall Study|Inclusion Error|7|||
126313309|NCT00478699|454437582|FG000|Overall Study|Not receive study treatment|6|||
126423721|NCT01611194|454847065|FG000|Overall Study|Lost to Follow-up|0|||
126423722|NCT01611194|454847066|FG001|Overall Study|Lost to Follow-up|1|||
126423723|NCT01611194|454847065|FG000|Overall Study|Withdrawal by Subject|0|||
126423724|NCT01611194|454847066|FG001|Overall Study|Withdrawal by Subject|1|||
126423725|NCT01611194|454847065|FG000|Overall Study|drug use|0|||
126423726|NCT01611194|454847066|FG001|Overall Study|drug use|1|||
126423727|NCT00452790|454847067|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
126423728|NCT00452790|454847068|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
126423729|NCT00452790|454847067|FG000|Infant Series|Parent/legal guardian request|8|||
125979208|NCT00419263|453211645|FG000|Overall Study|Randomized in Error, Not Treated|1|||
126313310|NCT00478699|454437583|FG001|Overall Study|Not receive study treatment|30|||
126313311|NCT01043705|454437588|FG000|Overall Study|Death|28|||
126313312|NCT01043705|454437589|FG001|Overall Study|Death|60|||
126313313|NCT01043705|454437590|FG002|Overall Study|Death|26|||
126313314|NCT01043705|454437588|FG000|Overall Study|Lost to Follow-up|27|||
126313315|NCT01043705|454437589|FG001|Overall Study|Lost to Follow-up|12|||
126313316|NCT01043705|454437590|FG002|Overall Study|Lost to Follow-up|0|||
126313317|NCT01043705|454437588|FG000|Overall Study|Multiple Reasons|4|||
126313318|NCT01043705|454437589|FG001|Overall Study|Multiple Reasons|7|||
126313319|NCT01043705|454437590|FG002|Overall Study|Multiple Reasons|0|||
126313320|NCT01043705|454437588|FG000|Overall Study|Protocol Violation|2|||
126313321|NCT01043705|454437589|FG001|Overall Study|Protocol Violation|1|||
126313322|NCT01043705|454437590|FG002|Overall Study|Protocol Violation|0|||
126313323|NCT01043705|454437588|FG000|Overall Study|Withdrawal by Subject|8|||
126313324|NCT01043705|454437589|FG001|Overall Study|Withdrawal by Subject|6|||
126313325|NCT01043705|454437590|FG002|Overall Study|Withdrawal by Subject|0|||
126313326|NCT01043705|454437588|FG000|Overall Study|Site Closure|8|||
126313327|NCT01043705|454437589|FG001|Overall Study|Site Closure|0|||
126313328|NCT01043705|454437590|FG002|Overall Study|Site Closure|0|||
126313329|NCT01043705|454437588|FG000|Overall Study|Subsequent Procedure|9|||
126313330|NCT01043705|454437589|FG001|Overall Study|Subsequent Procedure|24|||
126313331|NCT01043705|454437590|FG002|Overall Study|Subsequent Procedure|29|||
126313332|NCT01043705|454437588|FG000|Overall Study|Adverse Event|0|||
126313333|NCT01043705|454437589|FG001|Overall Study|Adverse Event|2|||
126313334|NCT01043705|454437590|FG002|Overall Study|Adverse Event|0|||
126313335|NCT01043705|454437588|FG000|Overall Study|Screen Fail|21|||
126313336|NCT01043705|454437589|FG001|Overall Study|Screen Fail|0|||
126313337|NCT01043705|454437590|FG002|Overall Study|Screen Fail|0|||
126313338|NCT01043705|454437588|FG000|Overall Study|Other|0|||
126313339|NCT01043705|454437589|FG001|Overall Study|Other|19|||
126313340|NCT01043705|454437590|FG002|Overall Study|Other|25|||
126313341|NCT00581542|454437592|FG000|Overall Study|they met an exclusion criteria|2|||
126313342|NCT00581542|454437593|FG001|Overall Study|they met an exclusion criteria|2|||
126313343|NCT00581542|454437592|FG000|Overall Study|Lost to Follow-up|9|||
126313344|NCT00581542|454437593|FG001|Overall Study|Lost to Follow-up|21|||
126313345|NCT00656851|454437595|FG000|Overall Study|Withdrawal by Subject|0|||
126313346|NCT00656851|454437596|FG001|Overall Study|Withdrawal by Subject|4|||
126313347|NCT01123941|454437597|FG000|Overall Study|Lost to Follow-up|2|||
126313348|NCT01123941|454437598|FG001|Overall Study|Lost to Follow-up|1|||
126313349|NCT04601103|454437599|FG000|Overall Study|Needed crown & cleaning|0|||
126313350|NCT04601103|454437600|FG001|Overall Study|Needed crown & cleaning|0|||
126313351|NCT04601103|454437601|FG002|Overall Study|Needed crown & cleaning|1|||
126313352|NCT04601103|454437599|FG000|Overall Study|study was terminated|18|||
126313353|NCT04601103|454437600|FG001|Overall Study|study was terminated|18|||
126313354|NCT04601103|454437601|FG002|Overall Study|study was terminated|16|||
126313355|NCT06011161|454437605|FG000|Overall Study|Withdrawal by Subject|2|||
126313356|NCT06011161|454437605|FG000|Overall Study|Lost to Follow-up|5|||
126313357|NCT03099694|454437606|FG000|Overall Study|Withdrawal by Subject|11|||
126313358|NCT03099694|454437607|FG001|Overall Study|Withdrawal by Subject|13|||
126313359|NCT03099694|454437606|FG000|Overall Study|Lost to Follow-up|9|||
125979209|NCT00419263|453211646|FG001|Overall Study|Randomized in Error, Not Treated|1|||
125979210|NCT00419263|453211647|FG002|Overall Study|Randomized in Error, Not Treated|0|||
125979211|NCT00419263|453211645|FG000|Overall Study|Adverse Event|0|||
125979212|NCT00419263|453211646|FG001|Overall Study|Adverse Event|0|||
125979213|NCT00419263|453211647|FG002|Overall Study|Adverse Event|1|||
125979214|NCT00419263|453211645|FG000|Overall Study|Withdrawal by Subject|0|||
125979215|NCT00419263|453211646|FG001|Overall Study|Withdrawal by Subject|0|||
125979216|NCT00419263|453211647|FG002|Overall Study|Withdrawal by Subject|1|||
125979217|NCT01563536|453211650|FG000|Overall Study|Withdrawal by Subject|0|||
125979218|NCT01563536|453211651|FG001|Overall Study|Withdrawal by Subject|2|||
125979219|NCT01563536|453211650|FG000|Overall Study|Lost to Follow-up|1|||
125979220|NCT01563536|453211651|FG001|Overall Study|Lost to Follow-up|0|||
125979221|NCT00538590|453211654|FG000|Overall Study|Death|1|||
125979222|NCT00538590|453211655|FG001|Overall Study|Death|0|||
125979223|NCT01256567|453211656|FG000|Overall Study|Withdrawal by Subject|1|||
125979224|NCT00671931|453211662|FG000|Overall Study|Physician Decision|1|||
125979225|NCT00671931|453211663|FG001|Overall Study|Physician Decision|0|||
125979226|NCT00671931|453211664|FG002|Overall Study|Physician Decision|0|||
125979227|NCT00671931|453211665|FG003|Overall Study|Physician Decision|2|||
125979228|NCT00671931|453211666|FG004|Overall Study|Physician Decision|1|||
125979229|NCT03260868|453211667|FG000|Overall Study|Poor Compliance to Protocol|0|||
125979230|NCT03260868|453211668|FG001|Overall Study|Poor Compliance to Protocol|2|||
125979231|NCT03260868|453211667|FG000|Overall Study|Study Terminated By Sponsor|2|||
125979232|NCT03260868|453211668|FG001|Overall Study|Study Terminated By Sponsor|1|||
125979233|NCT03260868|453211667|FG000|Overall Study|Other than specified above|1|||
125979234|NCT03260868|453211668|FG001|Overall Study|Other than specified above|0|||
125979235|NCT02925676|453211669|FG000|Overall Study|Withdrawal by Subject|1|||
125979236|NCT01298999|453211670|FG000|Overall Study|Physician Decision|0|||
125979237|NCT01298999|453211671|FG001|Overall Study|Physician Decision|1|||
125979238|NCT01298999|453211670|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
125979239|NCT01298999|453211671|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
125979240|NCT00541450|453211672|FG000|Phase A|Adverse Event|3|||
125979241|NCT00541450|453211673|FG001|Phase A|Adverse Event|0|||
125979242|NCT00541450|453211672|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
125979243|NCT00541450|453211673|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
125979244|NCT00541450|453211672|FG000|Phase A|Hyperglycemia|0|||
125979245|NCT00541450|453211673|FG001|Phase A|Hyperglycemia|1|||
125979246|NCT00541450|453211672|FG000|Phase A|Lost to Follow-up|6|||
125979247|NCT00541450|453211673|FG001|Phase A|Lost to Follow-up|4|||
125979248|NCT00541450|453211672|FG000|Phase A|Physician Decision|2|||
125979249|NCT00541450|453211673|FG001|Phase A|Physician Decision|0|||
125979250|NCT00541450|453211672|FG000|Phase A|Protocol Violation|2|||
125979251|NCT00541450|453211673|FG001|Phase A|Protocol Violation|3|||
125979252|NCT00541450|453211672|FG000|Phase A|Withdrawal by Subject|7|||
125979253|NCT00541450|453211673|FG001|Phase A|Withdrawal by Subject|7|||
125979254|NCT00541450|453211672|FG000|Phase B|Adverse Event|6|||
125979255|NCT00541450|453211673|FG001|Phase B|Adverse Event|6|||
125979256|NCT00541450|453211672|FG000|Phase B|Hyperglycemia|10|||
125979257|NCT00541450|453211673|FG001|Phase B|Hyperglycemia|9|||
126313360|NCT03099694|454437607|FG001|Overall Study|Lost to Follow-up|5|||
126313361|NCT02291601|454437608|FG000|Abdomen|Did not qualify|333|||
126313362|NCT02291601|454437609|FG001|Abdomen|Did not qualify|54|||
126313363|NCT02291601|454437610|FG002|Abdomen|Did not qualify|339|||
126313364|NCT02291601|454437608|FG000|Groin|Did not qualify|183|||
126313365|NCT02291601|454437609|FG001|Groin|Did not qualify|30|||
126313366|NCT02291601|454437610|FG002|Groin|Did not qualify|177|||
126313367|NCT00381043|454437611|FG000|Overall Study|Lost to Follow-up|8|||
126313368|NCT00381043|454437612|FG001|Overall Study|Lost to Follow-up|6|||
126313369|NCT00381043|454437611|FG000|Overall Study|Withdrawal by Subject|3|||
126313370|NCT00381043|454437612|FG001|Overall Study|Withdrawal by Subject|1|||
126313371|NCT00381043|454437611|FG000|Overall Study|wanted more care|0|||
125979258|NCT00541450|453211672|FG000|Phase B|Lost to Follow-up|6|||
125979259|NCT00541450|453211673|FG001|Phase B|Lost to Follow-up|4|||
125979260|NCT00541450|453211672|FG000|Phase B|Physician Decision|4|||
126313372|NCT00381043|454437612|FG001|Overall Study|wanted more care|1|||
126313373|NCT00381043|454437611|FG000|Overall Study|incarcerated|1|||
126313374|NCT00381043|454437612|FG001|Overall Study|incarcerated|0|||
126313375|NCT03045276|454437615|FG000|Intervention Phase|Withdrawal by Subject|7|||
125979261|NCT00541450|453211673|FG001|Phase B|Physician Decision|2|||
125979262|NCT00541450|453211672|FG000|Phase B|Pregnancy|0|||
125979263|NCT00541450|453211673|FG001|Phase B|Pregnancy|1|||
125979264|NCT00541450|453211672|FG000|Phase B|Protocol Violation|3|||
125979265|NCT00541450|453211673|FG001|Phase B|Protocol Violation|3|||
125979266|NCT00541450|453211672|FG000|Phase B|Withdrawal by Subject|8|||
125979267|NCT00541450|453211673|FG001|Phase B|Withdrawal by Subject|6|||
125979268|NCT02151266|453211674|FG000|Overall Study|Lost to Follow-up|1|||
125979269|NCT02151266|453211675|FG001|Overall Study|Lost to Follow-up|4|||
126313376|NCT03045276|454437616|FG001|Intervention Phase|Withdrawal by Subject|2|||
126313377|NCT03045276|454437617|FG002|Intervention Phase|Withdrawal by Subject|3|||
126313378|NCT03045276|454437618|FG003|Intervention Phase|Withdrawal by Subject|7|||
126313379|NCT03045276|454437615|FG000|Intervention Phase|Developed exclusionary criteria|3|||
126313380|NCT03045276|454437616|FG001|Intervention Phase|Developed exclusionary criteria|3|||
126313381|NCT03045276|454437617|FG002|Intervention Phase|Developed exclusionary criteria|0|||
126313382|NCT03045276|454437618|FG003|Intervention Phase|Developed exclusionary criteria|0|||
126313383|NCT03045276|454437615|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
126313384|NCT03045276|454437616|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
126313385|NCT03045276|454437617|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
126313386|NCT03045276|454437618|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
126313387|NCT03045276|454437615|FG000|Follow-Up Phase|Lost to Follow-up|0|||
126313388|NCT03045276|454437616|FG001|Follow-Up Phase|Lost to Follow-up|1|||
126313389|NCT03045276|454437617|FG002|Follow-Up Phase|Lost to Follow-up|0|||
126313390|NCT03045276|454437618|FG003|Follow-Up Phase|Lost to Follow-up|1|||
126313391|NCT03045276|454437615|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
126313392|NCT03045276|454437616|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
126313393|NCT03045276|454437617|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
126313394|NCT03045276|454437618|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
126313395|NCT01597375|454437619|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
126313396|NCT01597375|454437620|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
126313397|NCT01597375|454437619|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
126313398|NCT01597375|454437620|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
126313399|NCT01597375|454437619|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
126313400|NCT01597375|454437620|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
125979270|NCT02151266|453211676|FG002|Overall Study|Lost to Follow-up|1|||
125979271|NCT02151266|453211674|FG000|Overall Study|Did NOT receive intervention|3|||
125979272|NCT02151266|453211675|FG001|Overall Study|Did NOT receive intervention|6|||
125979273|NCT02151266|453211676|FG002|Overall Study|Did NOT receive intervention|2|||
125979274|NCT02151266|453211674|FG000|Overall Study|Not able to exercise|4|||
125979275|NCT02151266|453211675|FG001|Overall Study|Not able to exercise|5|||
125979276|NCT02151266|453211676|FG002|Overall Study|Not able to exercise|4|||
125979277|NCT01169675|453211677|FG000|Overall Study|Progressive disease|13|||
125979278|NCT01169675|453211678|FG001|Overall Study|Progressive disease|2|||
125979279|NCT01169675|453211679|FG002|Overall Study|Progressive disease|5|||
125979280|NCT01169675|453211680|FG003|Overall Study|Progressive disease|15|||
125979281|NCT01169675|453211681|FG004|Overall Study|Progressive disease|1|||
125979282|NCT01169675|453211677|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125979283|NCT01169675|453211678|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125979284|NCT01169675|453211679|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125979285|NCT01169675|453211680|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125979286|NCT01169675|453211681|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125979287|NCT01169675|453211677|FG000|Overall Study|Adverse Event|5|||
125979288|NCT01169675|453211678|FG001|Overall Study|Adverse Event|1|||
125979289|NCT01169675|453211679|FG002|Overall Study|Adverse Event|2|||
125979290|NCT01169675|453211680|FG003|Overall Study|Adverse Event|0|||
125979291|NCT01169675|453211681|FG004|Overall Study|Adverse Event|0|||
125979292|NCT01169675|453211677|FG000|Overall Study|Withdrawal by Subject|1|||
125979293|NCT01169675|453211678|FG001|Overall Study|Withdrawal by Subject|0|||
125979294|NCT01169675|453211679|FG002|Overall Study|Withdrawal by Subject|0|||
125979295|NCT01169675|453211680|FG003|Overall Study|Withdrawal by Subject|1|||
125979296|NCT01169675|453211681|FG004|Overall Study|Withdrawal by Subject|2|||
125979297|NCT01169675|453211677|FG000|Overall Study|Other Reason Not Defined Above|0|||
125979298|NCT01169675|453211678|FG001|Overall Study|Other Reason Not Defined Above|0|||
125979299|NCT01169675|453211679|FG002|Overall Study|Other Reason Not Defined Above|0|||
125979300|NCT01169675|453211680|FG003|Overall Study|Other Reason Not Defined Above|1|||
125979301|NCT01169675|453211681|FG004|Overall Study|Other Reason Not Defined Above|1|||
125979302|NCT00803452|453211682|FG000|Overall Study|Adverse Event|0|||
125979303|NCT00803452|453211683|FG001|Overall Study|Adverse Event|2|||
125979304|NCT00803452|453211682|FG000|Overall Study|Lost to Follow-up|0|||
125979305|NCT00803452|453211683|FG001|Overall Study|Lost to Follow-up|3|||
125979306|NCT02816138|453211687|FG000|Overall Study|Adverse Event|1|||
125979307|NCT04839965|453211688|FG000|Overall Study|Death|6|||
126313401|NCT01597375|454437619|FG000|Washout (2 Weeks)|Adverse Event|1|||
126313402|NCT01597375|454437620|FG001|Washout (2 Weeks)|Adverse Event|0|||
126313403|NCT01597375|454437619|FG000|Second Intervention|Failed to react at both Aspirin|1|||
125979308|NCT04839965|453211689|FG001|Overall Study|Death|6|||
125979309|NCT04839965|453211688|FG000|Overall Study|Lost to Follow-up|1|||
125979310|NCT04839965|453211689|FG001|Overall Study|Lost to Follow-up|0|||
125979311|NCT02365519|453211690|FG000|Randomized and Treated|Adverse Event|0|||
125979312|NCT02365519|453211691|FG001|Randomized and Treated|Adverse Event|1|||
125979313|NCT02365519|453211692|FG002|Randomized and Treated|Adverse Event|0|||
125979314|NCT02365519|453211690|FG000|Randomized and Treated|Withdrawal by Subject|0|||
125979315|NCT02365519|453211691|FG001|Randomized and Treated|Withdrawal by Subject|1|||
125979316|NCT02365519|453211692|FG002|Randomized and Treated|Withdrawal by Subject|1|||
126313404|NCT01597375|454437620|FG001|Second Intervention|Failed to react at both Aspirin|1|||
126313405|NCT03379753|454437621|FG000|Overall Study|Withdrawal by Subject|2|||
125979317|NCT00981084|453211693|FG000|Post Intervention (Data Analysis)|poor effort|1|||
125979318|NCT00981084|453211694|FG001|Post Intervention (Data Analysis)|poor effort|1|||
125979319|NCT00981084|453211693|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
125979320|NCT00981084|453211694|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
125979321|NCT02291679|453211695|FG000|Overall Study|Adverse Event|2|||
125979322|NCT02291679|453211696|FG001|Overall Study|Adverse Event|12|||
125979323|NCT02291679|453211697|FG002|Overall Study|Adverse Event|19|||
125979324|NCT02291679|453211695|FG000|Overall Study|Protocol Violation|5|||
125979325|NCT02291679|453211696|FG001|Overall Study|Protocol Violation|1|||
125979326|NCT02291679|453211697|FG002|Overall Study|Protocol Violation|7|||
125979327|NCT02291679|453211695|FG000|Overall Study|Withdrew Consent|18|||
125979328|NCT02291679|453211696|FG001|Overall Study|Withdrew Consent|10|||
125979329|NCT02291679|453211697|FG002|Overall Study|Withdrew Consent|15|||
125979330|NCT02291679|453211695|FG000|Overall Study|Lost to Follow-up|12|||
125979331|NCT02291679|453211696|FG001|Overall Study|Lost to Follow-up|10|||
125979332|NCT02291679|453211697|FG002|Overall Study|Lost to Follow-up|9|||
125979333|NCT02291679|453211695|FG000|Overall Study|Insufficient Therapeutic Response|5|||
125979334|NCT02291679|453211696|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125979335|NCT02291679|453211697|FG002|Overall Study|Insufficient Therapeutic Response|7|||
125979336|NCT02291679|453211695|FG000|Overall Study|Other|2|||
125979337|NCT02291679|453211696|FG001|Overall Study|Other|4|||
125979338|NCT02291679|453211697|FG002|Overall Study|Other|2|||
125979339|NCT02048072|453211698|FG000|Overall Study|Adverse Event|3|||
125979340|NCT02048072|453211698|FG000|Overall Study|Lost to Follow-up|1|||
125979341|NCT00725296|453211699|FG000|Overall Study|Adverse Event|11|||
125979342|NCT00725296|453211699|FG000|Overall Study|Lack of Efficacy|7|||
125979343|NCT00725296|453211699|FG000|Overall Study|Withdrawal by Subject|3|||
125979344|NCT00725296|453211699|FG000|Overall Study|Non-Compliance|2|||
125979345|NCT00725296|453211699|FG000|Overall Study|Lost to Follow-up|1|||
125979346|NCT00725296|453211699|FG000|Overall Study|Other|38|||
125979347|NCT03360942|453211701|FG000|Overall Study|Device explanted|2|||
125979348|NCT03360942|453211701|FG000|Overall Study|Study closure|1|||
125979349|NCT03360942|453211701|FG000|Overall Study|Withdrawal by Subject|2|||
125979350|NCT00289887|453213216|FG000|Overall Study|Adverse Event|3|||
125979351|NCT00289887|453213217|FG001|Overall Study|Adverse Event|3|||
125979352|NCT00289887|453213216|FG000|Overall Study|Lack of Efficacy|3|||
125979353|NCT00289887|453213217|FG001|Overall Study|Lack of Efficacy|11|||
125979354|NCT00289887|453213216|FG000|Overall Study|Lost to Follow-up|3|||
125979355|NCT00289887|453213217|FG001|Overall Study|Lost to Follow-up|3|||
125979356|NCT00289887|453213216|FG000|Overall Study|Protocol Violation|3|||
125979357|NCT00289887|453213217|FG001|Overall Study|Protocol Violation|1|||
125979358|NCT00289887|453213216|FG000|Overall Study|Withdrawal by Subject|3|||
125979359|NCT00289887|453213217|FG001|Overall Study|Withdrawal by Subject|8|||
125979360|NCT00289887|453213216|FG000|Overall Study|Other|7|||
125979361|NCT00289887|453213217|FG001|Overall Study|Other|3|||
125979362|NCT01266850|453213218|FG000|Overall Study|Lost to Follow-up|19|||
125979363|NCT01266850|453213219|FG001|Overall Study|Lost to Follow-up|19|||
125979364|NCT01266850|453213220|FG002|Overall Study|Lost to Follow-up|13|||
125979365|NCT01266850|453213221|FG003|Overall Study|Lost to Follow-up|13|||
125979366|NCT01266850|453213222|FG004|Overall Study|Lost to Follow-up|12|||
125979367|NCT01266850|453213218|FG000|Overall Study|Withdrawal by Subject|8|||
125979368|NCT01266850|453213219|FG001|Overall Study|Withdrawal by Subject|9|||
125979369|NCT01266850|453213220|FG002|Overall Study|Withdrawal by Subject|6|||
125979370|NCT01266850|453213221|FG003|Overall Study|Withdrawal by Subject|9|||
125979371|NCT01266850|453213222|FG004|Overall Study|Withdrawal by Subject|12|||
125979372|NCT01266850|453213218|FG000|Overall Study|Physician Decision|3|||
125979373|NCT01266850|453213219|FG001|Overall Study|Physician Decision|6|||
125979374|NCT01266850|453213220|FG002|Overall Study|Physician Decision|4|||
125979375|NCT01266850|453213221|FG003|Overall Study|Physician Decision|4|||
125979376|NCT01266850|453213222|FG004|Overall Study|Physician Decision|3|||
125979377|NCT01266850|453213218|FG000|Overall Study|Protocol Violation|0|||
125979378|NCT01266850|453213219|FG001|Overall Study|Protocol Violation|1|||
125979379|NCT01266850|453213220|FG002|Overall Study|Protocol Violation|0|||
125979380|NCT01266850|453213221|FG003|Overall Study|Protocol Violation|1|||
125979381|NCT01266850|453213222|FG004|Overall Study|Protocol Violation|2|||
126313406|NCT03379753|454437622|FG001|Overall Study|Withdrawal by Subject|1|||
125979382|NCT01266850|453213218|FG000|Overall Study|Adverse Event|0|||
125979383|NCT01266850|453213219|FG001|Overall Study|Adverse Event|0|||
125979384|NCT01266850|453213220|FG002|Overall Study|Adverse Event|0|||
125979385|NCT01266850|453213221|FG003|Overall Study|Adverse Event|0|||
125979386|NCT01266850|453213222|FG004|Overall Study|Adverse Event|1|||
125979387|NCT01266850|453213218|FG000|Overall Study|Site Closure|0|||
125979388|NCT01266850|453213219|FG001|Overall Study|Site Closure|1|||
125979389|NCT01266850|453213220|FG002|Overall Study|Site Closure|1|||
125979390|NCT01266850|453213221|FG003|Overall Study|Site Closure|1|||
125979391|NCT01266850|453213222|FG004|Overall Study|Site Closure|0|||
125979392|NCT00437645|453213224|FG000|Overall Study|Adverse Event|15|||
125979393|NCT00437645|453213225|FG001|Overall Study|Adverse Event|84|||
125979394|NCT00437645|453213224|FG000|Overall Study|Withdrawal by Subject|10|||
125979395|NCT00437645|453213225|FG001|Overall Study|Withdrawal by Subject|22|||
125979396|NCT00437645|453213224|FG000|Overall Study|Protocol Violation|3|||
125979397|NCT00437645|453213225|FG001|Overall Study|Protocol Violation|3|||
125979398|NCT00437645|453213224|FG000|Overall Study|Lost to Follow-up|2|||
125979399|NCT00437645|453213225|FG001|Overall Study|Lost to Follow-up|3|||
125979400|NCT00437645|453213224|FG000|Overall Study|Administrative problems|2|||
125979401|NCT00437645|453213225|FG001|Overall Study|Administrative problems|1|||
125979402|NCT00437645|453213224|FG000|Overall Study|Lack of Efficacy|2|||
125979403|NCT00437645|453213225|FG001|Overall Study|Lack of Efficacy|1|||
125979404|NCT00437645|453213224|FG000|Overall Study|Condition no longer requires study drug|1|||
125979405|NCT00437645|453213225|FG001|Overall Study|Condition no longer requires study drug|1|||
125979406|NCT03751631|453213226|FG000|Overall Study|Withdrawal by Subject|0|||
125979407|NCT03751631|453213227|FG001|Overall Study|Withdrawal by Subject|0|||
125979408|NCT03751631|453213228|FG002|Overall Study|Withdrawal by Subject|1|||
125979409|NCT03751631|453213229|FG003|Overall Study|Withdrawal by Subject|1|||
125979410|NCT03751631|453213230|FG004|Overall Study|Withdrawal by Subject|0|||
125979411|NCT03751631|453213231|FG005|Overall Study|Withdrawal by Subject|0|||
125979412|NCT03382782|453213233|FG000|Cohort 1|Withdrawal by Subject|11|||
125979413|NCT03382782|453213234|FG001|Cohort 1|Withdrawal by Subject|5|||
125979414|NCT03382782|453213235|FG002|Cohort 1|Withdrawal by Subject|0|||
125979415|NCT03382782|453213233|FG000|Cohort 2|Withdrawal by Subject|1|||
125979416|NCT03382782|453213234|FG001|Cohort 2|Withdrawal by Subject|1|||
125979417|NCT03382782|453213235|FG002|Cohort 2|Withdrawal by Subject|0|||
125979418|NCT03382782|453213233|FG000|Cohort 3|Withdrawal by Subject|1|||
125979419|NCT03382782|453213234|FG001|Cohort 3|Withdrawal by Subject|2|||
125979420|NCT03382782|453213235|FG002|Cohort 3|Withdrawal by Subject|0|||
125979421|NCT00428090|453213238|FG000|Overall Study|Adverse Event|10|||
125979422|NCT00428090|453213239|FG001|Overall Study|Adverse Event|8|||
125979423|NCT00428090|453213240|FG002|Overall Study|Adverse Event|10|||
125979424|NCT00428090|453213241|FG003|Overall Study|Adverse Event|11|||
125979425|NCT00428090|453213238|FG000|Overall Study|Lost to Follow-up|3|||
125979426|NCT00428090|453213239|FG001|Overall Study|Lost to Follow-up|6|||
125979427|NCT00428090|453213240|FG002|Overall Study|Lost to Follow-up|1|||
125979428|NCT00428090|453213241|FG003|Overall Study|Lost to Follow-up|4|||
125979429|NCT00428090|453213238|FG000|Overall Study|Protocol Violation|3|||
125979430|NCT00428090|453213239|FG001|Overall Study|Protocol Violation|1|||
125979431|NCT00428090|453213240|FG002|Overall Study|Protocol Violation|3|||
125979432|NCT00428090|453213241|FG003|Overall Study|Protocol Violation|3|||
125979433|NCT00428090|453213238|FG000|Overall Study|Withdrawal by Subject|10|||
125979434|NCT00428090|453213239|FG001|Overall Study|Withdrawal by Subject|12|||
125979435|NCT00428090|453213240|FG002|Overall Study|Withdrawal by Subject|15|||
125979436|NCT00428090|453213241|FG003|Overall Study|Withdrawal by Subject|5|||
125979437|NCT00428090|453213238|FG000|Overall Study|Sponsor terminated study|0|||
125979438|NCT00428090|453213239|FG001|Overall Study|Sponsor terminated study|1|||
125979439|NCT00428090|453213240|FG002|Overall Study|Sponsor terminated study|0|||
125979440|NCT00428090|453213241|FG003|Overall Study|Sponsor terminated study|0|||
125979441|NCT00428090|453213238|FG000|Overall Study|Non-compliance|4|||
125979442|NCT00428090|453213239|FG001|Overall Study|Non-compliance|0|||
125979443|NCT00428090|453213240|FG002|Overall Study|Non-compliance|1|||
125979444|NCT00428090|453213241|FG003|Overall Study|Non-compliance|3|||
125979445|NCT00428090|453213238|FG000|Overall Study|Par. did not returned to visit|1|||
125979446|NCT00428090|453213239|FG001|Overall Study|Par. did not returned to visit|0|||
125979447|NCT00428090|453213240|FG002|Overall Study|Par. did not returned to visit|0|||
125979448|NCT00428090|453213241|FG003|Overall Study|Par. did not returned to visit|1|||
125979449|NCT00428090|453213238|FG000|Overall Study|Follow-Up visit not possible|1|||
125979450|NCT00428090|453213239|FG001|Overall Study|Follow-Up visit not possible|0|||
125979451|NCT00428090|453213240|FG002|Overall Study|Follow-Up visit not possible|0|||
125979452|NCT00428090|453213241|FG003|Overall Study|Follow-Up visit not possible|0|||
125979453|NCT00428090|453213238|FG000|Overall Study|Prohibited medication used for SAE|1|||
125979454|NCT00428090|453213239|FG001|Overall Study|Prohibited medication used for SAE|0|||
125979455|NCT00428090|453213240|FG002|Overall Study|Prohibited medication used for SAE|0|||
125979456|NCT00428090|453213241|FG003|Overall Study|Prohibited medication used for SAE|0|||
125979457|NCT00428090|453213238|FG000|Overall Study|Death of par.|1|||
125979458|NCT00428090|453213239|FG001|Overall Study|Death of par.|0|||
125979459|NCT00428090|453213240|FG002|Overall Study|Death of par.|1|||
125979460|NCT00428090|453213241|FG003|Overall Study|Death of par.|0|||
125979461|NCT00428090|453213238|FG000|Overall Study|Visit 7 exceed the visit window|0|||
125979462|NCT00428090|453213239|FG001|Overall Study|Visit 7 exceed the visit window|1|||
125979463|NCT00428090|453213240|FG002|Overall Study|Visit 7 exceed the visit window|0|||
125979464|NCT00428090|453213241|FG003|Overall Study|Visit 7 exceed the visit window|0|||
125979465|NCT00428090|453213238|FG000|Overall Study|Medical monitor terminated par.|0|||
125979466|NCT00428090|453213239|FG001|Overall Study|Medical monitor terminated par.|1|||
125979467|NCT00428090|453213240|FG002|Overall Study|Medical monitor terminated par.|0|||
125979468|NCT00428090|453213241|FG003|Overall Study|Medical monitor terminated par.|0|||
125979469|NCT00428090|453213238|FG000|Overall Study|Mental status of par. was|0|||
125979470|NCT00428090|453213239|FG001|Overall Study|Mental status of par. was|1|||
125979471|NCT00428090|453213240|FG002|Overall Study|Mental status of par. was|0|||
125979472|NCT00428090|453213241|FG003|Overall Study|Mental status of par. was|0|||
125979473|NCT00428090|453213238|FG000|Overall Study|Worsening of AD|0|||
125979474|NCT00428090|453213239|FG001|Overall Study|Worsening of AD|0|||
125979475|NCT00428090|453213240|FG002|Overall Study|Worsening of AD|1|||
125979476|NCT00428090|453213241|FG003|Overall Study|Worsening of AD|0|||
125979477|NCT00428090|453213238|FG000|Overall Study|Excluded for concerning QTc value|0|||
125979478|NCT00428090|453213239|FG001|Overall Study|Excluded for concerning QTc value|0|||
125979479|NCT00428090|453213240|FG002|Overall Study|Excluded for concerning QTc value|1|||
125979480|NCT00428090|453213241|FG003|Overall Study|Excluded for concerning QTc value|0|||
125979481|NCT00428090|453213238|FG000|Overall Study|Insufficient AD documentation|0|||
125979482|NCT00428090|453213239|FG001|Overall Study|Insufficient AD documentation|0|||
125979483|NCT00428090|453213240|FG002|Overall Study|Insufficient AD documentation|1|||
125979484|NCT00428090|453213241|FG003|Overall Study|Insufficient AD documentation|0|||
125979485|NCT00428090|453213238|FG000|Overall Study|High MMSE scores|0|||
125979486|NCT00428090|453213239|FG001|Overall Study|High MMSE scores|0|||
125979487|NCT00428090|453213240|FG002|Overall Study|High MMSE scores|1|||
125979488|NCT00428090|453213241|FG003|Overall Study|High MMSE scores|0|||
125979489|NCT00428090|453213238|FG000|Overall Study|Deterioration of cognitive status|0|||
125979490|NCT00428090|453213239|FG001|Overall Study|Deterioration of cognitive status|0|||
125979491|NCT00428090|453213240|FG002|Overall Study|Deterioration of cognitive status|1|||
125979492|NCT00428090|453213241|FG003|Overall Study|Deterioration of cognitive status|0|||
125979493|NCT00428090|453213238|FG000|Overall Study|Serious adverse event|0|||
125979494|NCT00428090|453213239|FG001|Overall Study|Serious adverse event|0|||
125979495|NCT00428090|453213240|FG002|Overall Study|Serious adverse event|1|||
125979496|NCT00428090|453213241|FG003|Overall Study|Serious adverse event|0|||
125979497|NCT00428090|453213238|FG000|Overall Study|Excluded for heart insufficiency|0|||
125979498|NCT00428090|453213239|FG001|Overall Study|Excluded for heart insufficiency|0|||
125979499|NCT00428090|453213240|FG002|Overall Study|Excluded for heart insufficiency|1|||
125979500|NCT00428090|453213241|FG003|Overall Study|Excluded for heart insufficiency|0|||
125979501|NCT00428090|453213238|FG000|Overall Study|Raised Creatinine Value|0|||
125979502|NCT00428090|453213239|FG001|Overall Study|Raised Creatinine Value|0|||
125979503|NCT00428090|453213240|FG002|Overall Study|Raised Creatinine Value|0|||
125979504|NCT00428090|453213241|FG003|Overall Study|Raised Creatinine Value|1|||
125979505|NCT03255824|453213245|FG000|Overall Study|Under-sedation|2|||
125979506|NCT03255824|453213246|FG001|Overall Study|Under-sedation|1|||
125979507|NCT03432364|453213249|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
125979508|NCT00337272|453213250|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
125979509|NCT00337272|453213251|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
125979510|NCT00337272|453213250|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
125979511|NCT00337272|453213251|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
125979512|NCT00337272|453213250|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
125979513|NCT00337272|453213251|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
125979514|NCT00337272|453213250|FG000|Treatment Period|Non-compliance|1|||
125979515|NCT00337272|453213251|FG001|Treatment Period|Non-compliance|1|||
125979516|NCT00337272|453213250|FG000|Treatment Period|Withdrawal by Subject|0|||
125979517|NCT00337272|453213251|FG001|Treatment Period|Withdrawal by Subject|1|||
125979518|NCT00337272|453213250|FG000|Withdrawal Period|Non-compliance|0|||
125979519|NCT00337272|453213251|FG001|Withdrawal Period|Non-compliance|1|||
125979520|NCT03320018|453213252|FG000|Treatment Period|Withdrawal by Subject|1|||
125979521|NCT03320018|453213253|FG001|Treatment Period|Withdrawal by Subject|0|||
125979522|NCT03320018|453213252|FG000|Day 90 Follow up|Death|0|||
125979523|NCT03320018|453213253|FG001|Day 90 Follow up|Death|1|||
125979524|NCT03284788|453213257|FG000|Overall Study|Withdrawal by Subject|2|||
125979525|NCT03104699|453213264|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
125979526|NCT03104699|453213265|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
125979527|NCT03104699|453213266|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
125979528|NCT03104699|453213267|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
125979529|NCT03104699|453213268|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
125979530|NCT03104699|453213269|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125979531|NCT03104699|453213264|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
125979532|NCT03104699|453213265|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
125979533|NCT03104699|453213266|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
125979534|NCT03104699|453213267|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
125979535|NCT03104699|453213268|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
125979536|NCT03104699|453213269|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
125979537|NCT03104699|453213264|FG000|Phase 1: Dose Escalation|Death|6|||
125979538|NCT03104699|453213265|FG001|Phase 1: Dose Escalation|Death|3|||
125979539|NCT03104699|453213266|FG002|Phase 1: Dose Escalation|Death|0|||
125979540|NCT03104699|453213267|FG003|Phase 1: Dose Escalation|Death|1|||
125979541|NCT03104699|453213268|FG004|Phase 1: Dose Escalation|Death|1|||
126203254|NCT01519700|454030866|FG000|Overall Study|Death|1|||
126203255|NCT01519700|454030867|FG001|Overall Study|Death|0|||
126203256|NCT01519700|454030868|FG002|Overall Study|Death|0|||
126313407|NCT03379753|454437621|FG000|Overall Study|not having correct procedure|1|||
126313408|NCT03379753|454437622|FG001|Overall Study|not having correct procedure|2|||
126313409|NCT03379753|454437621|FG000|Overall Study|No primary outcome|12|||
126313410|NCT03379753|454437622|FG001|Overall Study|No primary outcome|22|||
126313411|NCT00347919|454437623|FG000|Overall Study|Lost to Follow-up|11|||
126313412|NCT00347919|454437624|FG001|Overall Study|Lost to Follow-up|13|||
126313413|NCT00347919|454437625|FG002|Overall Study|Lost to Follow-up|0|||
126313414|NCT00347919|454437623|FG000|Overall Study|Withdrawal by Subject|6|||
126313415|NCT00347919|454437624|FG001|Overall Study|Withdrawal by Subject|8|||
126313416|NCT00347919|454437625|FG002|Overall Study|Withdrawal by Subject|0|||
126313417|NCT00347919|454437623|FG000|Overall Study|Physician Decision|1|||
126313418|NCT00347919|454437624|FG001|Overall Study|Physician Decision|1|||
126313419|NCT00347919|454437625|FG002|Overall Study|Physician Decision|0|||
126313420|NCT00347919|454437623|FG000|Overall Study|Sponsor terminated study|15|||
126313421|NCT00347919|454437624|FG001|Overall Study|Sponsor terminated study|10|||
126313422|NCT00347919|454437625|FG002|Overall Study|Sponsor terminated study|16|||
126313423|NCT00347919|454437623|FG000|Overall Study|Death|35|||
126313424|NCT00347919|454437624|FG001|Overall Study|Death|42|||
126313425|NCT00347919|454437625|FG002|Overall Study|Death|19|||
126313426|NCT00347919|454437623|FG000|Overall Study|Par. Started Other Treatment|1|||
126313427|NCT00347919|454437624|FG001|Overall Study|Par. Started Other Treatment|1|||
126313428|NCT00347919|454437625|FG002|Overall Study|Par. Started Other Treatment|1|||
126313429|NCT00347919|454437623|FG000|Overall Study|Missing|2|||
126313430|NCT00347919|454437624|FG001|Overall Study|Missing|1|||
126313431|NCT00347919|454437625|FG002|Overall Study|Missing|2|||
126313432|NCT01032239|454437626|FG000|Overall Study|Lost to Follow-up|3|||
126313433|NCT01032239|454437627|FG001|Overall Study|Lost to Follow-up|2|||
126313434|NCT01032239|454437626|FG000|Overall Study|Withdrawal by Subject|2|||
126313435|NCT01032239|454437627|FG001|Overall Study|Withdrawal by Subject|3|||
126313436|NCT01032239|454437626|FG000|Overall Study|Death|1|||
126313437|NCT01032239|454437627|FG001|Overall Study|Death|0|||
126313438|NCT01032239|454437626|FG000|Overall Study|Protocol Violation|1|||
126313439|NCT01032239|454437627|FG001|Overall Study|Protocol Violation|0|||
126313440|NCT01940900|454437632|FG000|Overall Study|Physician Decision|4|||
126313441|NCT01940900|454437633|FG001|Overall Study|Physician Decision|0|||
126313442|NCT01940900|454437632|FG000|Overall Study|Adverse Event|10|||
126313443|NCT01940900|454437633|FG001|Overall Study|Adverse Event|15|||
126313444|NCT01940900|454437632|FG000|Overall Study|Withdrawal by Subject|11|||
126313445|NCT01940900|454437633|FG001|Overall Study|Withdrawal by Subject|15|||
126313446|NCT01940900|454437632|FG000|Overall Study|Lost to Follow-up|1|||
126313447|NCT01940900|454437633|FG001|Overall Study|Lost to Follow-up|0|||
126313448|NCT01940900|454437632|FG000|Overall Study|Sponsor Decision|1|||
126313449|NCT01940900|454437633|FG001|Overall Study|Sponsor Decision|0|||
126313450|NCT01940900|454437632|FG000|Overall Study|subject non-compliance|1|||
126313451|NCT01940900|454437633|FG001|Overall Study|subject non-compliance|1|||
126313452|NCT01940900|454437632|FG000|Overall Study|other|1|||
126313453|NCT01940900|454437633|FG001|Overall Study|other|0|||
126313454|NCT02225366|454437636|FG000|Overall Study|Lack of Efficacy|1|||
126313455|NCT02225366|454437637|FG001|Overall Study|Lack of Efficacy|0|||
126313456|NCT04713592|454437642|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
126313457|NCT04713592|454437643|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
126313458|NCT04713592|454437644|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
126313459|NCT04713592|454437645|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
126313460|NCT04713592|454437642|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
126313461|NCT04713592|454437643|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
126313462|NCT04713592|454437644|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
126313463|NCT04713592|454437645|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
126313464|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
126313465|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
126313466|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
126313467|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
126313468|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126313469|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126313470|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
126313471|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
126313472|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
126313473|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
126313474|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
126313475|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
126313476|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126313477|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126313478|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
126313479|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
126313480|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
125979542|NCT03104699|453213269|FG005|Phase 1: Dose Escalation|Death|0|||
125979543|NCT03104699|453213264|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
125979544|NCT03104699|453213265|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
125979545|NCT03104699|453213266|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
125979546|NCT03104699|453213267|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
125979547|NCT03104699|453213268|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
125979548|NCT03104699|453213269|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
125979549|NCT03104699|453213264|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
125979550|NCT03104699|453213265|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
125979551|NCT03104699|453213266|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
125979552|NCT03104699|453213267|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
125979553|NCT03104699|453213268|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
125979554|NCT03104699|453213269|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
125979555|NCT03104699|453213264|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
125979556|NCT03104699|453213265|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
125979557|NCT03104699|453213266|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
125979558|NCT03104699|453213267|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
125979559|NCT03104699|453213268|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
125979560|NCT03104699|453213269|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
125979561|NCT03104699|453213264|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
125979562|NCT03104699|453213265|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
125979563|NCT03104699|453213266|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
125979564|NCT03104699|453213267|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
125979565|NCT03104699|453213268|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
125979566|NCT03104699|453213269|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
125979567|NCT03104699|453213264|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
125979568|NCT03104699|453213265|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
125979569|NCT03104699|453213266|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
125979570|NCT03104699|453213267|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
125979571|NCT03104699|453213268|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
125979572|NCT03104699|453213269|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
125979573|NCT03104699|453213264|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125979574|NCT03104699|453213265|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125979575|NCT03104699|453213266|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125979576|NCT03104699|453213267|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125979577|NCT03104699|453213268|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125979578|NCT03104699|453213269|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
125979579|NCT03104699|453213264|FG000|Phase 2: Dose Expansion|Death|0|||
125979580|NCT03104699|453213265|FG001|Phase 2: Dose Expansion|Death|0|||
125979581|NCT03104699|453213266|FG002|Phase 2: Dose Expansion|Death|0|||
125979582|NCT03104699|453213267|FG003|Phase 2: Dose Expansion|Death|0|||
125979583|NCT03104699|453213268|FG004|Phase 2: Dose Expansion|Death|0|||
125979584|NCT03104699|453213269|FG005|Phase 2: Dose Expansion|Death|107|||
125979585|NCT03104699|453213264|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125979586|NCT03104699|453213265|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125979587|NCT03104699|453213266|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125979588|NCT03104699|453213267|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125979589|NCT03104699|453213268|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125979590|NCT03104699|453213269|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
125979591|NCT03104699|453213264|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125979592|NCT03104699|453213265|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125979593|NCT03104699|453213266|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125979594|NCT03104699|453213267|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125979595|NCT03104699|453213268|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125979596|NCT03104699|453213269|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
125979597|NCT03104699|453213264|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125979598|NCT03104699|453213265|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125979599|NCT03104699|453213266|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125979600|NCT03104699|453213267|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125979601|NCT03104699|453213268|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125979602|NCT03104699|453213269|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
125979603|NCT03104699|453213264|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
125979604|NCT03104699|453213265|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
126313481|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
126313482|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
126313483|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
125979605|NCT03104699|453213266|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
125979606|NCT03104699|453213267|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
126313484|NCT03782298|454437646|FG000|Overall Study|Protocol Deviation|4|||
126313485|NCT01382225|454437656|FG000|Overall Study|Adverse Event|3|||
125979607|NCT03104699|453213268|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
125979608|NCT03104699|453213269|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
125979609|NCT00152464|453213270|FG000|Overall Study|Adverse Event|3|||
125979610|NCT00152464|453213271|FG001|Overall Study|Adverse Event|6|||
125979611|NCT00152464|453213270|FG000|Overall Study|Lost to Follow-up|8|||
125979612|NCT00152464|453213271|FG001|Overall Study|Lost to Follow-up|4|||
125979613|NCT00152464|453213270|FG000|Overall Study|Protocol Violation|3|||
125979614|NCT00152464|453213271|FG001|Overall Study|Protocol Violation|1|||
125979615|NCT00152464|453213270|FG000|Overall Study|Withdrawal by Subject|21|||
125979616|NCT00152464|453213271|FG001|Overall Study|Withdrawal by Subject|22|||
125979617|NCT00152464|453213270|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
125979618|NCT00152464|453213271|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
125979619|NCT00152464|453213270|FG000|Overall Study|Eczema deterioration|0|||
125979620|NCT00152464|453213271|FG001|Overall Study|Eczema deterioration|1|||
125979621|NCT00152464|453213270|FG000|Overall Study|Parent decision|1|||
125979622|NCT00152464|453213271|FG001|Overall Study|Parent decision|1|||
125979623|NCT00152464|453213270|FG000|Overall Study|Investigator decision|1|||
125979624|NCT00152464|453213271|FG001|Overall Study|Investigator decision|0|||
125979625|NCT00152464|453213270|FG000|Overall Study|Lack of Efficacy|1|||
125979626|NCT00152464|453213271|FG001|Overall Study|Lack of Efficacy|0|||
125979627|NCT00152464|453213270|FG000|Overall Study|Eczema poorly controlled|1|||
125979628|NCT00152464|453213271|FG001|Overall Study|Eczema poorly controlled|0|||
125979629|NCT00152464|453213270|FG000|Overall Study|Patient relocated|1|||
125979630|NCT00152464|453213271|FG001|Overall Study|Patient relocated|0|||
125979631|NCT01644734|453213272|FG000|Overall Study|Adverse Event|4|||
125979632|NCT01644734|453213272|FG000|Overall Study|Lost to Follow-up|17|||
125979633|NCT01644734|453213272|FG000|Overall Study|Reasons other than stated above|7|||
125979634|NCT01644734|453213272|FG000|Overall Study|Missing documentation|238|||
125979635|NCT05159622|453213273|FG000|Overall Study|Lost to Follow-up|4|||
125979636|NCT05159622|453213274|FG001|Overall Study|Lost to Follow-up|5|||
125979637|NCT00863655|453213279|FG000|Overall Study|Protocol Violation|4|||
125979638|NCT00863655|453213280|FG001|Overall Study|Protocol Violation|0|||
125979639|NCT00863655|453213279|FG000|Overall Study|Adverse Event|52|||
125979640|NCT00863655|453213280|FG001|Overall Study|Adverse Event|8|||
125979641|NCT00863655|453213279|FG000|Overall Study|Withdrawal by Subject|47|||
125979642|NCT00863655|453213280|FG001|Overall Study|Withdrawal by Subject|7|||
125979643|NCT00863655|453213279|FG000|Overall Study|Administrative problems|1|||
125979644|NCT00863655|453213280|FG001|Overall Study|Administrative problems|0|||
125979645|NCT00863655|453213279|FG000|Overall Study|Death|7|||
125979646|NCT00863655|453213280|FG001|Overall Study|Death|1|||
125979647|NCT00863655|453213279|FG000|Overall Study|New cancer therapy|5|||
125979648|NCT00863655|453213280|FG001|Overall Study|New cancer therapy|1|||
125979649|NCT00863655|453213279|FG000|Overall Study|Disease progression|364|||
125979650|NCT00863655|453213280|FG001|Overall Study|Disease progression|221|||
125979651|NCT00863655|453213279|FG000|Overall Study|Treatment completed as per protocol|5|||
125979652|NCT00863655|453213280|FG001|Overall Study|Treatment completed as per protocol|1|||
125979653|NCT02157779|453213281|FG000|Overall Study|Logistical|9|||
125979654|NCT02157779|453213282|FG001|Overall Study|Logistical|3|||
125979655|NCT02157779|453213281|FG000|Overall Study|Stopped attending, reason unknown|11|||
125979656|NCT02157779|453213282|FG001|Overall Study|Stopped attending, reason unknown|7|||
125979657|NCT02157779|453213281|FG000|Overall Study|No response to outreach after Baseline|1|||
125979658|NCT02157779|453213282|FG001|Overall Study|No response to outreach after Baseline|1|||
125979659|NCT02157779|453213281|FG000|Overall Study|Moved|1|||
125979660|NCT02157779|453213282|FG001|Overall Study|Moved|0|||
125979661|NCT02157779|453213281|FG000|Overall Study|Medical|1|||
125979662|NCT02157779|453213282|FG001|Overall Study|Medical|0|||
125979663|NCT02157779|453213281|FG000|Overall Study|Legal issue|1|||
125979664|NCT02157779|453213282|FG001|Overall Study|Legal issue|0|||
125979665|NCT00929162|453213283|FG000|Overall Study|Adverse Event|8|||
125979666|NCT00929162|453213284|FG001|Overall Study|Adverse Event|5|||
125979667|NCT00929162|453213283|FG000|Overall Study|Withdrawal by Subject|3|||
125979668|NCT00929162|453213284|FG001|Overall Study|Withdrawal by Subject|1|||
125979669|NCT00929162|453213283|FG000|Overall Study|Protocol Violation|32|||
125979670|NCT00929162|453213284|FG001|Overall Study|Protocol Violation|30|||
125979671|NCT00929162|453213283|FG000|Overall Study|Other termination reason|5|||
125979672|NCT00929162|453213284|FG001|Overall Study|Other termination reason|6|||
125979673|NCT01274182|453213285|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125979674|NCT01274182|453213286|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125979675|NCT01274182|453213287|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
125979676|NCT01274182|453213285|FG000|Overall Study|Adverse Event|4|||
125979677|NCT01274182|453213286|FG001|Overall Study|Adverse Event|5|||
125979678|NCT01274182|453213287|FG002|Overall Study|Adverse Event|3|||
125979679|NCT01274182|453213285|FG000|Overall Study|Withdrawal by Subject|5|||
125979680|NCT01274182|453213286|FG001|Overall Study|Withdrawal by Subject|5|||
125979681|NCT01274182|453213287|FG002|Overall Study|Withdrawal by Subject|3|||
125979682|NCT01274182|453213285|FG000|Overall Study|Lost to Follow-up|2|||
125979683|NCT01274182|453213286|FG001|Overall Study|Lost to Follow-up|3|||
125979684|NCT01274182|453213287|FG002|Overall Study|Lost to Follow-up|1|||
125979685|NCT01274182|453213285|FG000|Overall Study|Protocol Violation|3|||
125979686|NCT01274182|453213286|FG001|Overall Study|Protocol Violation|2|||
125979687|NCT01274182|453213287|FG002|Overall Study|Protocol Violation|0|||
125979688|NCT01274182|453213285|FG000|Overall Study|Death|1|||
125979689|NCT01274182|453213286|FG001|Overall Study|Death|0|||
125979690|NCT01274182|453213287|FG002|Overall Study|Death|1|||
125979691|NCT02355002|453213288|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
125979692|NCT02355002|453213289|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
125979693|NCT02355002|453213288|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
125979694|NCT02355002|453213289|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
125979695|NCT02355002|453213288|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
125979696|NCT02355002|453213289|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
125979697|NCT02355002|453213288|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
125979698|NCT02355002|453213289|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
125979699|NCT02355002|453213288|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
125979700|NCT02355002|453213289|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
125979701|NCT02355002|453213288|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
125979702|NCT02355002|453213289|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
125979703|NCT02355002|453213288|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
125979704|NCT02355002|453213289|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
125979705|NCT01375114|453213290|FG000|Overall Study|Lost to Follow-up|1|||
125979706|NCT01375114|453213291|FG001|Overall Study|Lost to Follow-up|0|||
125979707|NCT01375114|453213292|FG002|Overall Study|Lost to Follow-up|1|||
125979708|NCT01375114|453213290|FG000|Overall Study|Disease Progression|3|||
125979709|NCT01375114|453213291|FG001|Overall Study|Disease Progression|2|||
125979710|NCT01375114|453213292|FG002|Overall Study|Disease Progression|2|||
125979711|NCT01375114|453213290|FG000|Overall Study|Patient Changed Mind|0|||
125979712|NCT01375114|453213291|FG001|Overall Study|Patient Changed Mind|0|||
125979713|NCT01375114|453213292|FG002|Overall Study|Patient Changed Mind|2|||
125979714|NCT01375114|453213290|FG000|Overall Study|Pruritus|0|||
125979715|NCT01375114|453213291|FG001|Overall Study|Pruritus|0|||
125979716|NCT01375114|453213292|FG002|Overall Study|Pruritus|1|||
125979717|NCT01375114|453213290|FG000|Overall Study|Restlessness|0|||
125979718|NCT01375114|453213291|FG001|Overall Study|Restlessness|0|||
125979719|NCT01375114|453213292|FG002|Overall Study|Restlessness|1|||
125979720|NCT01375114|453213290|FG000|Overall Study|Diarrhea|0|||
125979721|NCT01375114|453213291|FG001|Overall Study|Diarrhea|0|||
125979722|NCT01375114|453213292|FG002|Overall Study|Diarrhea|1|||
125979723|NCT01375114|453213290|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
125979724|NCT01375114|453213291|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
125979725|NCT01375114|453213292|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
125979726|NCT01375114|453213290|FG000|Overall Study|Nausea|0|||
125979727|NCT01375114|453213291|FG001|Overall Study|Nausea|1|||
125979728|NCT01375114|453213292|FG002|Overall Study|Nausea|0|||
125979729|NCT01375114|453213290|FG000|Overall Study|Increased AST/ALT|0|||
125979730|NCT01375114|453213291|FG001|Overall Study|Increased AST/ALT|1|||
125979731|NCT01375114|453213292|FG002|Overall Study|Increased AST/ALT|0|||
125979732|NCT01375114|453213290|FG000|Overall Study|Vaginal Hemorrhage|0|||
125979733|NCT01375114|453213291|FG001|Overall Study|Vaginal Hemorrhage|1|||
125979734|NCT01375114|453213292|FG002|Overall Study|Vaginal Hemorrhage|0|||
125979735|NCT01375114|453213290|FG000|Overall Study|Family problem|0|||
125979736|NCT01375114|453213291|FG001|Overall Study|Family problem|1|||
125979737|NCT01375114|453213292|FG002|Overall Study|Family problem|0|||
125979738|NCT01375114|453213290|FG000|Overall Study|Protocol Violation|2|||
125979739|NCT01375114|453213291|FG001|Overall Study|Protocol Violation|0|||
125979740|NCT01375114|453213292|FG002|Overall Study|Protocol Violation|0|||
125979741|NCT02454101|453213296|FG000|Overall Study|Adverse Event|2|||
125979742|NCT02454101|453213297|FG001|Overall Study|Adverse Event|3|||
125979743|NCT02454101|453213296|FG000|Overall Study|Lost to Follow-up|3|||
125979744|NCT02454101|453213297|FG001|Overall Study|Lost to Follow-up|4|||
125979745|NCT03311373|453213298|FG000|Overall Study|Adverse Event|1|||
125979746|NCT03311373|453213298|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
125979747|NCT03311373|453213298|FG000|Overall Study|Lost to Follow-up|1|||
125979748|NCT03311373|453213298|FG000|Overall Study|Physician Decision|1|||
125979749|NCT03311373|453213298|FG000|Overall Study|Withdrawal by Subject|3|||
125979750|NCT00344461|453213325|FG000|Overall Study|Adverse Event|6|||
125979751|NCT00344461|453213325|FG000|Overall Study|Death|1|||
125979752|NCT00344461|453213325|FG000|Overall Study|Lack of Efficacy|2|||
125979753|NCT00344461|453213325|FG000|Overall Study|Lost to Follow-up|2|||
125979754|NCT00344461|453213325|FG000|Overall Study|Physician Decision|2|||
125979755|NCT00344461|453213325|FG000|Overall Study|Protocol Violation|6|||
125979756|NCT00344461|453213325|FG000|Overall Study|Withdrawal by Subject|2|||
125979757|NCT00636610|453213328|FG000|Overall Study|Adverse Event|4|||
125979758|NCT00636610|453213329|FG001|Overall Study|Adverse Event|4|||
125979759|NCT00636610|453213328|FG000|Overall Study|Death|6|||
125979760|NCT00636610|453213329|FG001|Overall Study|Death|3|||
125979761|NCT00636610|453213328|FG000|Overall Study|Physician decision to withdraw patient|15|||
125979762|NCT00636610|453213329|FG001|Overall Study|Physician decision to withdraw patient|9|||
125979763|NCT00636610|453213328|FG000|Overall Study|Subject decision to withdraw|15|||
125979764|NCT00636610|453213329|FG001|Overall Study|Subject decision to withdraw|11|||
125979765|NCT00636610|453213328|FG000|Overall Study|Disease progression - radiographic|41|||
125979766|NCT00636610|453213329|FG001|Overall Study|Disease progression - radiographic|51|||
125979767|NCT00636610|453213328|FG000|Overall Study|Disease progression - clinical|8|||
125979768|NCT00636610|453213329|FG001|Overall Study|Disease progression - clinical|3|||
125979769|NCT00636610|453213328|FG000|Overall Study|Reason for discontinuation not available|3|||
126089401|NCT02942277|453621409|FG009|Year 1|Withdrawal by Subject|0|||
125979770|NCT00636610|453213329|FG001|Overall Study|Reason for discontinuation not available|2|||
125979771|NCT00686881|453213337|FG000|Overall Study|Withdrawal by Subject|11|||
125979772|NCT00686881|453213338|FG001|Overall Study|Withdrawal by Subject|18|||
125979773|NCT00686881|453213337|FG000|Overall Study|Lost to Follow-up|0|||
125979774|NCT00686881|453213338|FG001|Overall Study|Lost to Follow-up|1|||
125979775|NCT00686881|453213337|FG000|Overall Study|Treatment-related adverse event|10|||
125979776|NCT00686881|453213338|FG001|Overall Study|Treatment-related adverse event|9|||
125979777|NCT00686881|453213337|FG000|Overall Study|Met discontinuation criteria|5|||
125979778|NCT00686881|453213338|FG001|Overall Study|Met discontinuation criteria|0|||
125979779|NCT00686881|453213337|FG000|Overall Study|Onset of malignant tumor|11|||
125979780|NCT00686881|453213338|FG001|Overall Study|Onset of malignant tumor|11|||
125979781|NCT00686881|453213337|FG000|Overall Study|Lack of Efficacy|4|||
125979782|NCT00686881|453213338|FG001|Overall Study|Lack of Efficacy|3|||
125979783|NCT00686881|453213337|FG000|Overall Study|Physician Decision|1|||
125979784|NCT00686881|453213338|FG001|Overall Study|Physician Decision|0|||
125979785|NCT00686881|453213337|FG000|Overall Study|Circumstances of site|1|||
125979786|NCT00686881|453213338|FG001|Overall Study|Circumstances of site|1|||
125979787|NCT00686881|453213337|FG000|Overall Study|Did not meet protocol eligibility|1|||
125979788|NCT00686881|453213338|FG001|Overall Study|Did not meet protocol eligibility|0|||
125979789|NCT00686881|453213337|FG000|Overall Study|Irregular visits|1|||
126089402|NCT02942277|453621410|FG010|Year 1|Withdrawal by Subject|3|||
126089403|NCT02942277|453621400|FG000|Year 1|Travel|0|||
126089404|NCT02942277|453621401|FG001|Year 1|Travel|1|||
126089405|NCT02942277|453621402|FG002|Year 1|Travel|0|||
125979790|NCT00686881|453213338|FG001|Overall Study|Irregular visits|0|||
125979791|NCT00686881|453213337|FG000|Overall Study|Study discontinuation|35|||
125979792|NCT00686881|453213338|FG001|Overall Study|Study discontinuation|32|||
125979793|NCT00686881|453213337|FG000|Overall Study|Never received study drug|2|||
125979794|NCT00686881|453213338|FG001|Overall Study|Never received study drug|6|||
125979795|NCT02355028|453213342|FG000|Overall Study|Adverse Event|2|||
125979796|NCT02355028|453213343|FG001|Overall Study|Adverse Event|0|||
125979797|NCT02355028|453213342|FG000|Overall Study|Withdrawal by Subject|1|||
125979798|NCT02355028|453213343|FG001|Overall Study|Withdrawal by Subject|1|||
125979799|NCT02355028|453213342|FG000|Overall Study|Deemed ineligible after randomization|8|||
125979800|NCT02355028|453213343|FG001|Overall Study|Deemed ineligible after randomization|4|||
125979801|NCT01971723|453213344|FG000|Overall Study|Withdrawal by Subject|1|||
125979802|NCT01971723|453213345|FG001|Overall Study|Withdrawal by Subject|1|||
125979803|NCT01971723|453213344|FG000|Overall Study|Protocol Violation|1|||
125979804|NCT01971723|453213345|FG001|Overall Study|Protocol Violation|2|||
125979805|NCT05899686|453213346|FG000|Overall Study|Protocol Violation|1|||
125979806|NCT03657277|453213348|FG000|Overall Study|Physician Decision|2|||
125979807|NCT03657277|453213348|FG000|Overall Study|Lost to Follow-up|1|||
126089406|NCT02942277|453621403|FG003|Year 1|Travel|0|||
126089407|NCT02942277|453621404|FG004|Year 1|Travel|4|||
126089408|NCT02942277|453621405|FG005|Year 1|Travel|5|||
126089409|NCT02942277|453621406|FG006|Year 1|Travel|0|||
126089410|NCT02942277|453621407|FG007|Year 1|Travel|0|||
126089411|NCT02942277|453621408|FG008|Year 1|Travel|0|||
126089412|NCT02942277|453621409|FG009|Year 1|Travel|0|||
126089413|NCT02942277|453621410|FG010|Year 1|Travel|8|||
126089414|NCT02942277|453621400|FG000|Year 1|Joined Army|0|||
126089415|NCT02942277|453621401|FG001|Year 1|Joined Army|1|||
126089416|NCT02942277|453621402|FG002|Year 1|Joined Army|0|||
126089417|NCT02942277|453621403|FG003|Year 1|Joined Army|0|||
126089418|NCT02942277|453621404|FG004|Year 1|Joined Army|0|||
126089419|NCT02942277|453621405|FG005|Year 1|Joined Army|0|||
126089420|NCT02942277|453621406|FG006|Year 1|Joined Army|0|||
126089421|NCT02942277|453621407|FG007|Year 1|Joined Army|0|||
126089422|NCT02942277|453621408|FG008|Year 1|Joined Army|0|||
126089423|NCT02942277|453621409|FG009|Year 1|Joined Army|0|||
126089424|NCT02942277|453621410|FG010|Year 1|Joined Army|0|||
126089425|NCT02942277|453621400|FG000|Year 1|Subject met withdrawal criteria|0|||
126089426|NCT02942277|453621401|FG001|Year 1|Subject met withdrawal criteria|0|||
126089427|NCT02942277|453621402|FG002|Year 1|Subject met withdrawal criteria|0|||
126089428|NCT02942277|453621403|FG003|Year 1|Subject met withdrawal criteria|1|||
126089429|NCT02942277|453621404|FG004|Year 1|Subject met withdrawal criteria|0|||
126089430|NCT02942277|453621405|FG005|Year 1|Subject met withdrawal criteria|0|||
126089431|NCT02942277|453621406|FG006|Year 1|Subject met withdrawal criteria|0|||
126089432|NCT02942277|453621407|FG007|Year 1|Subject met withdrawal criteria|0|||
126089433|NCT02942277|453621408|FG008|Year 1|Subject met withdrawal criteria|0|||
126089434|NCT02942277|453621409|FG009|Year 1|Subject met withdrawal criteria|0|||
126089435|NCT02942277|453621410|FG010|Year 1|Subject met withdrawal criteria|0|||
126089436|NCT02942277|453621400|FG000|Year 1|Lost to Follow-up|0|||
126089437|NCT02942277|453621401|FG001|Year 1|Lost to Follow-up|0|||
126089438|NCT02942277|453621402|FG002|Year 1|Lost to Follow-up|0|||
126089439|NCT02942277|453621403|FG003|Year 1|Lost to Follow-up|0|||
126089440|NCT02942277|453621404|FG004|Year 1|Lost to Follow-up|1|||
126089441|NCT02942277|453621405|FG005|Year 1|Lost to Follow-up|0|||
126089442|NCT02942277|453621406|FG006|Year 1|Lost to Follow-up|0|||
126089443|NCT02942277|453621407|FG007|Year 1|Lost to Follow-up|0|||
126089444|NCT02942277|453621408|FG008|Year 1|Lost to Follow-up|0|||
126089445|NCT02942277|453621409|FG009|Year 1|Lost to Follow-up|0|||
126089446|NCT02942277|453621410|FG010|Year 1|Lost to Follow-up|2|||
126089447|NCT02942277|453621400|FG000|Year 1|Protocol Violation|0|||
126089448|NCT02942277|453621401|FG001|Year 1|Protocol Violation|0|||
126089449|NCT02942277|453621402|FG002|Year 1|Protocol Violation|0|||
126089450|NCT02942277|453621403|FG003|Year 1|Protocol Violation|0|||
126089451|NCT02942277|453621404|FG004|Year 1|Protocol Violation|1|||
126089452|NCT02942277|453621405|FG005|Year 1|Protocol Violation|1|||
126313486|NCT01382225|454437657|FG001|Overall Study|Adverse Event|2|||
126313487|NCT01382225|454437656|FG000|Overall Study|Protocol Violation|2|||
126313488|NCT01382225|454437657|FG001|Overall Study|Protocol Violation|1|||
126313489|NCT01382225|454437656|FG000|Overall Study|Subject Withdrew Consent|5|||
126313490|NCT01382225|454437657|FG001|Overall Study|Subject Withdrew Consent|2|||
126313491|NCT01382225|454437656|FG000|Overall Study|Other|4|||
126313492|NCT01382225|454437657|FG001|Overall Study|Other|2|||
126313493|NCT01797081|454437658|FG000|Overall Study|Adverse Event|1|||
126313494|NCT01797081|454437659|FG001|Overall Study|Adverse Event|0|||
126313495|NCT01797081|454437660|FG002|Overall Study|Adverse Event|1|||
126313496|NCT01797081|454437661|FG003|Overall Study|Adverse Event|0|||
126313497|NCT01797081|454437658|FG000|Overall Study|Pregnancy|1|||
126313498|NCT01797081|454437659|FG001|Overall Study|Pregnancy|0|||
126313499|NCT01797081|454437660|FG002|Overall Study|Pregnancy|0|||
126313500|NCT01797081|454437661|FG003|Overall Study|Pregnancy|0|||
126313501|NCT01797081|454437658|FG000|Overall Study|Personal Reasons|12|||
126313502|NCT01797081|454437659|FG001|Overall Study|Personal Reasons|4|||
126313503|NCT01797081|454437660|FG002|Overall Study|Personal Reasons|4|||
126313504|NCT01797081|454437661|FG003|Overall Study|Personal Reasons|8|||
126313505|NCT01797081|454437658|FG000|Overall Study|Protocol Violation|0|||
126313506|NCT01797081|454437659|FG001|Overall Study|Protocol Violation|0|||
126313507|NCT01797081|454437660|FG002|Overall Study|Protocol Violation|0|||
126313508|NCT01797081|454437661|FG003|Overall Study|Protocol Violation|1|||
126313509|NCT02294175|454437669|FG000|Overall Study|Withdrawal by Subject|1|||
126313510|NCT02294175|454437670|FG001|Overall Study|Withdrawal by Subject|2|||
126313511|NCT02294175|454437669|FG000|Overall Study|pt taking excluded medication|3|||
126313512|NCT02294175|454437670|FG001|Overall Study|pt taking excluded medication|1|||
126313513|NCT02294175|454437669|FG000|Overall Study|Protocol Violation|1|||
126313514|NCT02294175|454437670|FG001|Overall Study|Protocol Violation|0|||
126313515|NCT02294175|454437669|FG000|Overall Study|Lost to Follow-up|0|||
126313516|NCT02294175|454437670|FG001|Overall Study|Lost to Follow-up|1|||
126313517|NCT02294175|454437669|FG000|Overall Study|wound healed|0|||
126313518|NCT02294175|454437670|FG001|Overall Study|wound healed|2|||
126313519|NCT02548351|454437671|FG000|Overall Study|Withdrawal by Subject|149|||
126313520|NCT02548351|454437672|FG001|Overall Study|Withdrawal by Subject|154|||
126313521|NCT02548351|454437673|FG002|Overall Study|Withdrawal by Subject|152|||
126313522|NCT02548351|454437671|FG000|Overall Study|Death|11|||
126313523|NCT02548351|454437672|FG001|Overall Study|Death|15|||
126313524|NCT02548351|454437673|FG002|Overall Study|Death|12|||
126313525|NCT02548351|454437671|FG000|Overall Study|Adverse Event|22|||
126313526|NCT02548351|454437672|FG001|Overall Study|Adverse Event|56|||
126313527|NCT02548351|454437673|FG002|Overall Study|Adverse Event|36|||
126313528|NCT02548351|454437671|FG000|Overall Study|Study Terminated by Sponsor|549|||
126089453|NCT02942277|453621406|FG006|Year 1|Protocol Violation|0|||
126089454|NCT02942277|453621407|FG007|Year 1|Protocol Violation|0|||
126089455|NCT02942277|453621408|FG008|Year 1|Protocol Violation|0|||
126313529|NCT02548351|454437672|FG001|Overall Study|Study Terminated by Sponsor|509|||
126313530|NCT02548351|454437673|FG002|Overall Study|Study Terminated by Sponsor|528|||
126313531|NCT02548351|454437671|FG000|Overall Study|Site Closure|14|||
126313532|NCT02548351|454437672|FG001|Overall Study|Site Closure|5|||
126313533|NCT02548351|454437673|FG002|Overall Study|Site Closure|7|||
126313534|NCT02548351|454437671|FG000|Overall Study|Non-compliance with Study Drug|4|||
126313535|NCT02548351|454437672|FG001|Overall Study|Non-compliance with Study Drug|2|||
126313536|NCT02548351|454437673|FG002|Overall Study|Non-compliance with Study Drug|0|||
126313537|NCT02548351|454437671|FG000|Overall Study|Protocol Violation|2|||
126089456|NCT02942277|453621409|FG009|Year 1|Protocol Violation|0|||
126089457|NCT02942277|453621410|FG010|Year 1|Protocol Violation|2|||
126313538|NCT02548351|454437672|FG001|Overall Study|Protocol Violation|1|||
126089458|NCT02942277|453621400|FG000|Year 1|Pregnancy|0|||
126089459|NCT02942277|453621401|FG001|Year 1|Pregnancy|0|||
126313539|NCT02548351|454437673|FG002|Overall Study|Protocol Violation|2|||
125979808|NCT03657277|453213348|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
125979809|NCT00657618|453213355|FG000|Overall Study|Adverse Event|32|||
125979810|NCT00657618|453213355|FG000|Overall Study|Withdrawal by Subject|8|||
125979811|NCT00657618|453213355|FG000|Overall Study|negative for leishmaniasis|2|||
125979812|NCT00657618|453213355|FG000|Overall Study|didn't start due to schedule conflicts|1|||
125979813|NCT01592370|453213363|FG000|Overall Study|Disease Progression|62|||
125979814|NCT01592370|453213364|FG001|Overall Study|Disease Progression|16|||
125979815|NCT01592370|453213365|FG002|Overall Study|Disease Progression|52|||
125979816|NCT01592370|453213366|FG003|Overall Study|Disease Progression|3|||
125979817|NCT01592370|453213367|FG004|Overall Study|Disease Progression|3|||
125979818|NCT01592370|453213368|FG005|Overall Study|Disease Progression|31|||
125979819|NCT01592370|453213369|FG006|Overall Study|Disease Progression|14|||
125979820|NCT01592370|453213363|FG000|Overall Study|Study Drug Toxicity|14|||
125979821|NCT01592370|453213364|FG001|Overall Study|Study Drug Toxicity|3|||
125979822|NCT01592370|453213365|FG002|Overall Study|Study Drug Toxicity|0|||
125979823|NCT01592370|453213366|FG003|Overall Study|Study Drug Toxicity|0|||
125979824|NCT01592370|453213367|FG004|Overall Study|Study Drug Toxicity|0|||
125979825|NCT01592370|453213368|FG005|Overall Study|Study Drug Toxicity|0|||
125979826|NCT01592370|453213369|FG006|Overall Study|Study Drug Toxicity|1|||
125979827|NCT01592370|453213363|FG000|Overall Study|AE unrelated to study drug|4|||
125979828|NCT01592370|453213364|FG001|Overall Study|AE unrelated to study drug|3|||
125979829|NCT01592370|453213365|FG002|Overall Study|AE unrelated to study drug|0|||
125979830|NCT01592370|453213366|FG003|Overall Study|AE unrelated to study drug|0|||
125979831|NCT01592370|453213367|FG004|Overall Study|AE unrelated to study drug|0|||
125979832|NCT01592370|453213368|FG005|Overall Study|AE unrelated to study drug|0|||
125979833|NCT01592370|453213369|FG006|Overall Study|AE unrelated to study drug|1|||
125979834|NCT01592370|453213363|FG000|Overall Study|Request to discontinue study treatment|5|||
125979835|NCT01592370|453213364|FG001|Overall Study|Request to discontinue study treatment|0|||
125979836|NCT01592370|453213365|FG002|Overall Study|Request to discontinue study treatment|2|||
125979837|NCT01592370|453213366|FG003|Overall Study|Request to discontinue study treatment|0|||
125979838|NCT01592370|453213367|FG004|Overall Study|Request to discontinue study treatment|1|||
125979839|NCT01592370|453213368|FG005|Overall Study|Request to discontinue study treatment|2|||
125979840|NCT01592370|453213369|FG006|Overall Study|Request to discontinue study treatment|0|||
125979841|NCT01592370|453213363|FG000|Overall Study|Withdrew consent|1|||
125979842|NCT01592370|453213364|FG001|Overall Study|Withdrew consent|2|||
125979843|NCT01592370|453213365|FG002|Overall Study|Withdrew consent|1|||
125979844|NCT01592370|453213366|FG003|Overall Study|Withdrew consent|1|||
125979845|NCT01592370|453213367|FG004|Overall Study|Withdrew consent|0|||
125979846|NCT01592370|453213368|FG005|Overall Study|Withdrew consent|0|||
125979847|NCT01592370|453213369|FG006|Overall Study|Withdrew consent|0|||
125979848|NCT01592370|453213363|FG000|Overall Study|Maximum clinical benefit|11|||
125979849|NCT01592370|453213364|FG001|Overall Study|Maximum clinical benefit|1|||
125979850|NCT01592370|453213365|FG002|Overall Study|Maximum clinical benefit|7|||
125979851|NCT01592370|453213366|FG003|Overall Study|Maximum clinical benefit|1|||
125979852|NCT01592370|453213367|FG004|Overall Study|Maximum clinical benefit|0|||
125979853|NCT01592370|453213368|FG005|Overall Study|Maximum clinical benefit|0|||
125979854|NCT01592370|453213369|FG006|Overall Study|Maximum clinical benefit|0|||
125979855|NCT01592370|453213363|FG000|Overall Study|No longer meets study criteria|1|||
125979856|NCT01592370|453213364|FG001|Overall Study|No longer meets study criteria|0|||
125979857|NCT01592370|453213365|FG002|Overall Study|No longer meets study criteria|0|||
125979858|NCT01592370|453213366|FG003|Overall Study|No longer meets study criteria|0|||
125979859|NCT01592370|453213367|FG004|Overall Study|No longer meets study criteria|0|||
125979860|NCT01592370|453213368|FG005|Overall Study|No longer meets study criteria|0|||
125979861|NCT01592370|453213369|FG006|Overall Study|No longer meets study criteria|0|||
125979862|NCT01592370|453213363|FG000|Overall Study|Other Reasons|6|||
125979863|NCT01592370|453213364|FG001|Overall Study|Other Reasons|0|||
125979864|NCT01592370|453213365|FG002|Overall Study|Other Reasons|10|||
125979865|NCT01592370|453213366|FG003|Overall Study|Other Reasons|0|||
125979866|NCT01592370|453213367|FG004|Overall Study|Other Reasons|0|||
125979867|NCT01592370|453213368|FG005|Overall Study|Other Reasons|1|||
125979868|NCT01592370|453213369|FG006|Overall Study|Other Reasons|0|||
125979869|NCT01735201|453215152|FG000|Overall Study|Adverse Event|1|||
125979870|NCT01735201|453215153|FG001|Overall Study|Adverse Event|1|||
125979871|NCT01735201|453215154|FG002|Overall Study|Adverse Event|0|||
125979872|NCT01735201|453215155|FG003|Overall Study|Adverse Event|1|||
125979873|NCT01735201|453215156|FG004|Overall Study|Adverse Event|1|||
125979874|NCT01735201|453215157|FG005|Overall Study|Adverse Event|3|||
125979875|NCT01735201|453215158|FG006|Overall Study|Adverse Event|2|||
125979876|NCT01735201|453215159|FG007|Overall Study|Adverse Event|1|||
125979877|NCT01735201|453215152|FG000|Overall Study|Personal Reasons|1|||
125979878|NCT01735201|453215153|FG001|Overall Study|Personal Reasons|0|||
125979879|NCT01735201|453215154|FG002|Overall Study|Personal Reasons|0|||
125979880|NCT01735201|453215155|FG003|Overall Study|Personal Reasons|0|||
125979881|NCT01735201|453215156|FG004|Overall Study|Personal Reasons|0|||
125979882|NCT01735201|453215157|FG005|Overall Study|Personal Reasons|0|||
125979883|NCT01735201|453215158|FG006|Overall Study|Personal Reasons|0|||
125979884|NCT01735201|453215159|FG007|Overall Study|Personal Reasons|0|||
125979885|NCT01735201|453215152|FG000|Overall Study|Protocol Violation|1|||
125979886|NCT01735201|453215153|FG001|Overall Study|Protocol Violation|0|||
125979887|NCT01735201|453215154|FG002|Overall Study|Protocol Violation|0|||
125979888|NCT01735201|453215155|FG003|Overall Study|Protocol Violation|0|||
125979889|NCT01735201|453215156|FG004|Overall Study|Protocol Violation|0|||
125979890|NCT01735201|453215157|FG005|Overall Study|Protocol Violation|0|||
125979891|NCT01735201|453215158|FG006|Overall Study|Protocol Violation|0|||
125979892|NCT01735201|453215159|FG007|Overall Study|Protocol Violation|0|||
125979893|NCT01735201|453215152|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125979894|NCT01735201|453215153|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125979895|NCT01735201|453215154|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125979896|NCT01735201|453215155|FG003|Overall Study|Other Miscellaneous Reasons|1|||
125979897|NCT01735201|453215156|FG004|Overall Study|Other Miscellaneous Reasons|0|||
125979898|NCT01735201|453215157|FG005|Overall Study|Other Miscellaneous Reasons|2|||
125979899|NCT01735201|453215158|FG006|Overall Study|Other Miscellaneous Reasons|1|||
125979900|NCT01735201|453215159|FG007|Overall Study|Other Miscellaneous Reasons|1|||
125979901|NCT01553318|453215160|FG000|Overall Study|Protocol Violation|3|||
125979902|NCT01553318|453215161|FG001|Overall Study|Protocol Violation|2|||
125979903|NCT02127372|453215162|FG000|Overall Study|Withdrawal by Subject|1|||
125979904|NCT02127372|453215163|FG001|Overall Study|Withdrawal by Subject|0|||
125979905|NCT01699022|453215170|FG000|Overall Study|Early discontinuation from the study|3|||
125979906|NCT02052310|453215171|FG000|Overall Study|Death|64|||
125979907|NCT02052310|453215172|FG001|Overall Study|Death|54|||
125979908|NCT02052310|453215171|FG000|Overall Study|Withdrawal by Subject|37|||
125979909|NCT02052310|453215172|FG001|Overall Study|Withdrawal by Subject|49|||
125979910|NCT02052310|453215171|FG000|Overall Study|Other than specified|32|||
125979911|NCT02052310|453215172|FG001|Overall Study|Other than specified|29|||
125979912|NCT02052310|453215171|FG000|Overall Study|Adverse Event|29|||
125979913|NCT02052310|453215172|FG001|Overall Study|Adverse Event|22|||
125979914|NCT02052310|453215171|FG000|Overall Study|Kidney Transplant|23|||
125979915|NCT02052310|453215172|FG001|Overall Study|Kidney Transplant|29|||
125979916|NCT02052310|453215171|FG000|Overall Study|Physician Decision|14|||
125979917|NCT02052310|453215172|FG001|Overall Study|Physician Decision|7|||
125979918|NCT02052310|453215171|FG000|Overall Study|Lack of Efficacy|6|||
125979919|NCT02052310|453215172|FG001|Overall Study|Lack of Efficacy|1|||
125979920|NCT02052310|453215171|FG000|Overall Study|Site Terminated by Sponsor|5|||
125979921|NCT02052310|453215172|FG001|Overall Study|Site Terminated by Sponsor|13|||
125979922|NCT02052310|453215171|FG000|Overall Study|Lost to Follow-up|4|||
125979923|NCT02052310|453215172|FG001|Overall Study|Lost to Follow-up|2|||
125979924|NCT02052310|453215171|FG000|Overall Study|Protocol Violation|1|||
125979925|NCT02052310|453215172|FG001|Overall Study|Protocol Violation|6|||
125979926|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
125979927|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
125979928|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
125979929|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
125979930|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
125979931|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
125979932|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
125979933|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
125979934|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Other|18|||
125979935|NCT02565914|453215175|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
125979936|NCT02565914|453215175|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
125979937|NCT02565914|453215175|FG000|Part B (Up to 96 Weeks)|Other|1|||
125979938|NCT02565914|453215175|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
125979939|NCT02565914|453215175|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
126089460|NCT02942277|453621402|FG002|Year 1|Pregnancy|0|||
126089461|NCT02942277|453621403|FG003|Year 1|Pregnancy|0|||
126089462|NCT02942277|453621404|FG004|Year 1|Pregnancy|0|||
126089463|NCT02942277|453621405|FG005|Year 1|Pregnancy|1|||
126089464|NCT02942277|453621406|FG006|Year 1|Pregnancy|0|||
126089465|NCT02942277|453621407|FG007|Year 1|Pregnancy|0|||
126089466|NCT02942277|453621408|FG008|Year 1|Pregnancy|0|||
126089467|NCT02942277|453621409|FG009|Year 1|Pregnancy|0|||
126089468|NCT02942277|453621410|FG010|Year 1|Pregnancy|0|||
126089469|NCT02942277|453621400|FG000|Year 2|Lost to Follow-up|0|||
126089470|NCT02942277|453621401|FG001|Year 2|Lost to Follow-up|0|||
126089471|NCT02942277|453621402|FG002|Year 2|Lost to Follow-up|0|||
126089472|NCT02942277|453621403|FG003|Year 2|Lost to Follow-up|0|||
126089473|NCT02942277|453621404|FG004|Year 2|Lost to Follow-up|2|||
126089474|NCT02942277|453621405|FG005|Year 2|Lost to Follow-up|1|||
126313540|NCT02548351|454437671|FG000|Overall Study|Physician Decision|11|||
126089475|NCT02942277|453621406|FG006|Year 2|Lost to Follow-up|0|||
126089476|NCT02942277|453621407|FG007|Year 2|Lost to Follow-up|0|||
126089477|NCT02942277|453621408|FG008|Year 2|Lost to Follow-up|0|||
126089478|NCT02942277|453621409|FG009|Year 2|Lost to Follow-up|0|||
126089479|NCT02942277|453621410|FG010|Year 2|Lost to Follow-up|0|||
126089480|NCT02942277|453621400|FG000|Year 2|Did not rescreen|0|||
126089481|NCT02942277|453621401|FG001|Year 2|Did not rescreen|0|||
126089482|NCT02942277|453621402|FG002|Year 2|Did not rescreen|1|||
126089483|NCT02942277|453621403|FG003|Year 2|Did not rescreen|1|||
126089484|NCT02942277|453621404|FG004|Year 2|Did not rescreen|9|||
126089485|NCT02942277|453621405|FG005|Year 2|Did not rescreen|6|||
126089486|NCT02942277|453621406|FG006|Year 2|Did not rescreen|0|||
126089487|NCT02942277|453621407|FG007|Year 2|Did not rescreen|1|||
126089488|NCT02942277|453621408|FG008|Year 2|Did not rescreen|0|||
125979940|NCT02565914|453215175|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
125979941|NCT02565914|453215175|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
125979942|NCT02565914|453215175|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
125979943|NCT02565914|453215175|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
125979944|NCT02565914|453215175|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
125979945|NCT02565914|453215175|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
125979946|NCT02565914|453215175|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
125979947|NCT02565914|453215175|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
125979948|NCT02565914|453215175|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
125979949|NCT02565914|453215175|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
125979950|NCT00754338|453215186|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
125979951|NCT00754338|453215187|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
125979952|NCT00754338|453215188|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
125979953|NCT00754338|453215189|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
125979954|NCT00754338|453215186|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
125979955|NCT00754338|453215187|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
125979956|NCT00754338|453215188|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
125979957|NCT00754338|453215189|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
125979958|NCT04020341|453215190|FG000|Overall Study|Adverse Event|8|||
125979959|NCT04020341|453215191|FG001|Overall Study|Adverse Event|6|||
125979960|NCT04020341|453215190|FG000|Overall Study|Lost to Follow-up|8|||
125979961|NCT04020341|453215191|FG001|Overall Study|Lost to Follow-up|2|||
125979962|NCT04020341|453215190|FG000|Overall Study|Withdrawal by Subject|16|||
125979963|NCT04020341|453215191|FG001|Overall Study|Withdrawal by Subject|16|||
125979964|NCT04020341|453215190|FG000|Overall Study|Participant not able to swallow the tablet|1|||
125979965|NCT04020341|453215191|FG001|Overall Study|Participant not able to swallow the tablet|0|||
125979966|NCT04020341|453215190|FG000|Overall Study|Physician Decision|0|||
125979967|NCT04020341|453215191|FG001|Overall Study|Physician Decision|2|||
125979968|NCT04020341|453215190|FG000|Overall Study|Protocol Deviation|0|||
125979969|NCT04020341|453215191|FG001|Overall Study|Protocol Deviation|2|||
125979970|NCT05763628|453215192|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
126089489|NCT02942277|453621409|FG009|Year 2|Did not rescreen|0|||
125979971|NCT05763628|453215193|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
125979972|NCT05763628|453215192|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
125979973|NCT05763628|453215193|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
125979974|NCT05763628|453215192|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
125979975|NCT05763628|453215193|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
125979976|NCT04683926|453215194|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
125979977|NCT04683926|453215195|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
125979978|NCT04683926|453215196|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
125979979|NCT04683926|453215197|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
125979980|NCT04385368|453215199|FG000|Overall Study|Death|5|||
125979981|NCT04385368|453215200|FG001|Overall Study|Death|5|||
125979982|NCT04385368|453215199|FG000|Overall Study|Physician Decision|3|||
125979983|NCT04385368|453215200|FG001|Overall Study|Physician Decision|0|||
125979984|NCT04385368|453215199|FG000|Overall Study|Withdrawal by Subject|4|||
125979985|NCT04385368|453215200|FG001|Overall Study|Withdrawal by Subject|3|||
125979986|NCT01256411|453215201|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
125979987|NCT01256411|453215202|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
125979988|NCT01256411|453215203|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
125979989|NCT01256411|453215204|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
125979990|NCT01256411|453215205|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
125979991|NCT01256411|453215206|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
125979992|NCT01256411|453215201|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
125979993|NCT01256411|453215202|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
125979994|NCT01256411|453215203|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
125979995|NCT01256411|453215204|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
125979996|NCT01256411|453215205|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
125979997|NCT01256411|453215206|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
125979998|NCT01256411|453215201|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
126089490|NCT02942277|453621410|FG010|Year 2|Did not rescreen|21|||
126089491|NCT02942277|453621400|FG000|Year 2|Met withdrawal criteria|0|||
126089492|NCT02942277|453621401|FG001|Year 2|Met withdrawal criteria|0|||
126089493|NCT02942277|453621402|FG002|Year 2|Met withdrawal criteria|0|||
126089494|NCT02942277|453621403|FG003|Year 2|Met withdrawal criteria|0|||
126089495|NCT02942277|453621404|FG004|Year 2|Met withdrawal criteria|1|||
126089496|NCT02942277|453621405|FG005|Year 2|Met withdrawal criteria|2|||
126089497|NCT02942277|453621406|FG006|Year 2|Met withdrawal criteria|0|||
126089498|NCT02942277|453621407|FG007|Year 2|Met withdrawal criteria|0|||
126089499|NCT02942277|453621408|FG008|Year 2|Met withdrawal criteria|0|||
126089500|NCT02942277|453621409|FG009|Year 2|Met withdrawal criteria|0|||
126089501|NCT02942277|453621410|FG010|Year 2|Met withdrawal criteria|1|||
126089502|NCT02942277|453621400|FG000|Year 2|Travel|0|||
126089503|NCT02942277|453621401|FG001|Year 2|Travel|1|||
126089504|NCT02942277|453621402|FG002|Year 2|Travel|0|||
126089505|NCT02942277|453621403|FG003|Year 2|Travel|0|||
126089506|NCT02942277|453621404|FG004|Year 2|Travel|0|||
126089507|NCT02942277|453621405|FG005|Year 2|Travel|1|||
126089508|NCT02942277|453621406|FG006|Year 2|Travel|0|||
126089509|NCT02942277|453621407|FG007|Year 2|Travel|0|||
126089510|NCT02942277|453621408|FG008|Year 2|Travel|0|||
126089511|NCT02942277|453621409|FG009|Year 2|Travel|1|||
126089512|NCT02942277|453621410|FG010|Year 2|Travel|3|||
126089513|NCT02942277|453621400|FG000|Year 2|Non-compliant|0|||
126089514|NCT02942277|453621401|FG001|Year 2|Non-compliant|0|||
126089515|NCT02942277|453621402|FG002|Year 2|Non-compliant|0|||
126089516|NCT02942277|453621403|FG003|Year 2|Non-compliant|0|||
126089517|NCT02942277|453621404|FG004|Year 2|Non-compliant|1|||
126089518|NCT02942277|453621405|FG005|Year 2|Non-compliant|1|||
126089519|NCT02942277|453621406|FG006|Year 2|Non-compliant|0|||
126089520|NCT02942277|453621407|FG007|Year 2|Non-compliant|0|||
126089521|NCT02942277|453621408|FG008|Year 2|Non-compliant|0|||
126089522|NCT02942277|453621409|FG009|Year 2|Non-compliant|0|||
126089523|NCT02942277|453621410|FG010|Year 2|Non-compliant|0|||
126089524|NCT02942277|453621400|FG000|Year 2|Withdrawal by Subject|0|||
126089525|NCT02942277|453621401|FG001|Year 2|Withdrawal by Subject|0|||
126089526|NCT02942277|453621402|FG002|Year 2|Withdrawal by Subject|0|||
126089527|NCT02942277|453621403|FG003|Year 2|Withdrawal by Subject|0|||
126089528|NCT02942277|453621404|FG004|Year 2|Withdrawal by Subject|0|||
126089529|NCT02942277|453621405|FG005|Year 2|Withdrawal by Subject|0|||
126089530|NCT02942277|453621406|FG006|Year 2|Withdrawal by Subject|1|||
126089531|NCT02942277|453621407|FG007|Year 2|Withdrawal by Subject|0|||
126089532|NCT02942277|453621408|FG008|Year 2|Withdrawal by Subject|0|||
126089533|NCT02942277|453621409|FG009|Year 2|Withdrawal by Subject|0|||
126089534|NCT02942277|453621410|FG010|Year 2|Withdrawal by Subject|0|||
126089535|NCT05577715|453621411|FG000|Overall Study|Withdrawal by Subject|1|||
126089536|NCT05577715|453621411|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
126089537|NCT05577715|453621411|FG000|Overall Study|Lost to Follow-up|1|||
126089538|NCT05577715|453621411|FG000|Overall Study|Death|6|||
125979999|NCT01256411|453215202|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
125980000|NCT01256411|453215203|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
125980001|NCT01256411|453215204|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
125980002|NCT01256411|453215205|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
125980003|NCT01256411|453215206|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
125980004|NCT01256411|453215201|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
125980005|NCT01256411|453215202|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
126089539|NCT00626197|453621418|FG000|Overall Study|Did not cooperate|2|||
126089540|NCT00626197|453621419|FG001|Overall Study|Did not cooperate|6|||
126089541|NCT00626197|453621420|FG002|Overall Study|Did not cooperate|1|||
126089542|NCT00626197|453621418|FG000|Overall Study|Failure to return|6|||
126089543|NCT00626197|453621419|FG001|Overall Study|Failure to return|5|||
126089544|NCT00626197|453621420|FG002|Overall Study|Failure to return|6|||
126089545|NCT00626197|453621418|FG000|Overall Study|Adverse event, serious fatal|3|||
126089546|NCT00626197|453621419|FG001|Overall Study|Adverse event, serious fatal|6|||
126089547|NCT00626197|453621420|FG002|Overall Study|Adverse event, serious fatal|6|||
126089548|NCT00626197|453621418|FG000|Overall Study|Adverse Event|1|||
126089549|NCT00626197|453621419|FG001|Overall Study|Adverse Event|1|||
126089550|NCT00626197|453621420|FG002|Overall Study|Adverse Event|2|||
125980006|NCT01256411|453215203|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
125980007|NCT01256411|453215204|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
125980008|NCT01256411|453215205|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
125980009|NCT01256411|453215206|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
125980010|NCT01256411|453215201|FG000|Extension by Maximum Treatment|Adverse Event|4|||
125980011|NCT01256411|453215202|FG001|Extension by Maximum Treatment|Adverse Event|2|||
125980012|NCT01256411|453215203|FG002|Extension by Maximum Treatment|Adverse Event|1|||
125980013|NCT01256411|453215204|FG003|Extension by Maximum Treatment|Adverse Event|0|||
125980014|NCT01256411|453215205|FG004|Extension by Maximum Treatment|Adverse Event|0|||
125980015|NCT01256411|453215206|FG005|Extension by Maximum Treatment|Adverse Event|0|||
125980016|NCT01256411|453215201|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
125980017|NCT01256411|453215202|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
125980018|NCT01256411|453215203|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
126089551|NCT00626197|453621418|FG000|Overall Study|Withdrawal by Subject|17|||
126089552|NCT00626197|453621419|FG001|Overall Study|Withdrawal by Subject|17|||
126089553|NCT00626197|453621420|FG002|Overall Study|Withdrawal by Subject|7|||
126089554|NCT00626197|453621418|FG000|Overall Study|Administrative reasons|15|||
125980019|NCT01256411|453215204|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
125980020|NCT01256411|453215205|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
125980021|NCT01256411|453215206|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
125980022|NCT01256411|453215201|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125980023|NCT01256411|453215202|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125980024|NCT01256411|453215203|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125980025|NCT01256411|453215204|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125980026|NCT01256411|453215205|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125980027|NCT01256411|453215206|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
125980028|NCT01256411|453215201|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125980029|NCT01256411|453215202|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125980030|NCT01256411|453215203|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125980031|NCT01256411|453215204|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125980032|NCT01256411|453215205|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
125980033|NCT01256411|453215206|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125980034|NCT01256411|453215201|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
125980035|NCT01256411|453215202|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
125980036|NCT01256411|453215203|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
125980037|NCT01256411|453215204|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
125980038|NCT01256411|453215205|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
125980039|NCT01256411|453215206|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
125980040|NCT01256411|453215201|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
125980041|NCT01256411|453215202|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
125980042|NCT01256411|453215203|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
125980043|NCT01256411|453215204|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
125980044|NCT01256411|453215205|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
125980045|NCT01256411|453215206|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
125980046|NCT02740049|453215207|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
125980047|NCT02123108|453215210|FG000|Overall Study|Death|2|||
125980048|NCT02123108|453215211|FG001|Overall Study|Death|3|||
125980049|NCT00716092|453215212|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
125980050|NCT00716092|453215213|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
125980051|NCT00716092|453215214|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
125980052|NCT02316769|453215215|FG000|Overall Study|Physician Decision|1|||
125980053|NCT02316769|453215216|FG001|Overall Study|Physician Decision|0|||
125980054|NCT02316769|453215215|FG000|Overall Study|Withdrawal by Subject|1|||
125980055|NCT02316769|453215216|FG001|Overall Study|Withdrawal by Subject|0|||
125980056|NCT01132326|453215217|FG000|Overall Study|Lack of Efficacy|25|||
125980057|NCT01132326|453215217|FG000|Overall Study|Adverse Event|37|||
125980058|NCT01132326|453215217|FG000|Overall Study|Protocol Violation|1|||
125980059|NCT01132326|453215217|FG000|Overall Study|Lost to Follow-up|16|||
125980060|NCT01132326|453215217|FG000|Overall Study|Withdrawal by Subject|40|||
125980061|NCT01132326|453215217|FG000|Overall Study|Physician Decision|10|||
125980062|NCT01132326|453215217|FG000|Overall Study|Study Termination|80|||
125980063|NCT01132326|453215217|FG000|Overall Study|Declining Health|1|||
125980064|NCT01132326|453215217|FG000|Overall Study|Pregnancy|1|||
125980065|NCT01132326|453215217|FG000|Overall Study|Caregiver Withdrew Consent|1|||
125980066|NCT01132326|453215217|FG000|Overall Study|Death|5|||
125980067|NCT01132326|453215217|FG000|Overall Study|Subject Unable to Come To Visits|1|||
125980068|NCT00677235|453215218|FG000|Overall Study|Withdrawal by Subject|1|||
125980069|NCT00677235|453215219|FG001|Overall Study|Withdrawal by Subject|1|||
125980070|NCT00677235|453215218|FG000|Overall Study|Lost to Follow-up|2|||
125980071|NCT00677235|453215219|FG001|Overall Study|Lost to Follow-up|1|||
125980072|NCT00677235|453215218|FG000|Overall Study|Death|37|||
125980073|NCT00677235|453215219|FG001|Overall Study|Death|36|||
125980074|NCT00677235|453215218|FG000|Overall Study|Adverse Experience|1|||
125980075|NCT00677235|453215219|FG001|Overall Study|Adverse Experience|0|||
125980076|NCT01040260|453215220|FG000|Overall Study|Withdrawal by Subject|12|||
125980077|NCT01040260|453215221|FG001|Overall Study|Withdrawal by Subject|6|||
125980078|NCT01040260|453215220|FG000|Overall Study|Lost to Follow-up|3|||
125980079|NCT01040260|453215221|FG001|Overall Study|Lost to Follow-up|5|||
125980080|NCT04570436|453215222|FG000|Overall Study|Adverse Event|0|||
125980081|NCT04570436|453215223|FG001|Overall Study|Adverse Event|0|||
125980082|NCT04570436|453215224|FG002|Overall Study|Adverse Event|1|||
126313541|NCT02548351|454437672|FG001|Overall Study|Physician Decision|18|||
125980083|NCT04570436|453215225|FG003|Overall Study|Adverse Event|0|||
125980084|NCT04570436|453215226|FG004|Overall Study|Adverse Event|0|||
125980085|NCT04570436|453215227|FG005|Overall Study|Adverse Event|0|||
125980086|NCT04570436|453215228|FG006|Overall Study|Adverse Event|0|||
125980087|NCT04570436|453215229|FG007|Overall Study|Adverse Event|0|||
125980088|NCT04570436|453215230|FG008|Overall Study|Adverse Event|0|||
125980089|NCT04570436|453215231|FG009|Overall Study|Adverse Event|0|||
125980090|NCT04570436|453215222|FG000|Overall Study|Physician Decision|1|||
125980091|NCT04570436|453215223|FG001|Overall Study|Physician Decision|0|||
125980092|NCT04570436|453215224|FG002|Overall Study|Physician Decision|0|||
125980093|NCT04570436|453215225|FG003|Overall Study|Physician Decision|0|||
125980094|NCT04570436|453215226|FG004|Overall Study|Physician Decision|0|||
125980095|NCT04570436|453215227|FG005|Overall Study|Physician Decision|0|||
125980096|NCT04570436|453215228|FG006|Overall Study|Physician Decision|0|||
125980097|NCT04570436|453215229|FG007|Overall Study|Physician Decision|0|||
125980098|NCT04570436|453215230|FG008|Overall Study|Physician Decision|0|||
125980099|NCT04570436|453215231|FG009|Overall Study|Physician Decision|0|||
125980100|NCT03205371|453215238|FG000|Overall Study|Withdrawal by Subject|4|||
125980101|NCT03205371|453215239|FG001|Overall Study|Withdrawal by Subject|1|||
125980102|NCT03205371|453215240|FG002|Overall Study|Withdrawal by Subject|0|||
125980103|NCT03205371|453215241|FG003|Overall Study|Withdrawal by Subject|0|||
125980104|NCT03205371|453215242|FG004|Overall Study|Withdrawal by Subject|0|||
125980105|NCT03205371|453215243|FG005|Overall Study|Withdrawal by Subject|0|||
125980106|NCT03205371|453215244|FG006|Overall Study|Withdrawal by Subject|4|||
125980107|NCT03205371|453215245|FG007|Overall Study|Withdrawal by Subject|0|||
125980108|NCT03205371|453215246|FG008|Overall Study|Withdrawal by Subject|2|||
125980109|NCT03205371|453215247|FG009|Overall Study|Withdrawal by Subject|0|||
125980110|NCT03205371|453215248|FG010|Overall Study|Withdrawal by Subject|0|||
125980111|NCT03205371|453215249|FG011|Overall Study|Withdrawal by Subject|1|||
125980112|NCT03205371|453215238|FG000|Overall Study|Lost to Follow-up|0|||
125980113|NCT03205371|453215239|FG001|Overall Study|Lost to Follow-up|0|||
125980114|NCT03205371|453215240|FG002|Overall Study|Lost to Follow-up|0|||
125980115|NCT03205371|453215241|FG003|Overall Study|Lost to Follow-up|0|||
125980116|NCT03205371|453215242|FG004|Overall Study|Lost to Follow-up|0|||
125980117|NCT03205371|453215243|FG005|Overall Study|Lost to Follow-up|0|||
125980118|NCT03205371|453215244|FG006|Overall Study|Lost to Follow-up|5|||
125980119|NCT03205371|453215245|FG007|Overall Study|Lost to Follow-up|2|||
125980120|NCT03205371|453215246|FG008|Overall Study|Lost to Follow-up|3|||
125980121|NCT03205371|453215247|FG009|Overall Study|Lost to Follow-up|0|||
125980122|NCT03205371|453215248|FG010|Overall Study|Lost to Follow-up|0|||
125980123|NCT03205371|453215249|FG011|Overall Study|Lost to Follow-up|0|||
125980124|NCT03205371|453215238|FG000|Overall Study|Protocol Violation|0|||
125980125|NCT03205371|453215239|FG001|Overall Study|Protocol Violation|0|||
125980126|NCT03205371|453215240|FG002|Overall Study|Protocol Violation|0|||
125980127|NCT03205371|453215241|FG003|Overall Study|Protocol Violation|0|||
125980128|NCT03205371|453215242|FG004|Overall Study|Protocol Violation|0|||
125980129|NCT03205371|453215243|FG005|Overall Study|Protocol Violation|0|||
125980130|NCT03205371|453215244|FG006|Overall Study|Protocol Violation|1|||
125980131|NCT03205371|453215245|FG007|Overall Study|Protocol Violation|0|||
125980132|NCT03205371|453215246|FG008|Overall Study|Protocol Violation|0|||
125980133|NCT03205371|453215247|FG009|Overall Study|Protocol Violation|0|||
125980134|NCT03205371|453215248|FG010|Overall Study|Protocol Violation|0|||
125980135|NCT03205371|453215249|FG011|Overall Study|Protocol Violation|0|||
125980136|NCT03205371|453215238|FG000|Overall Study|Adverse Event|0|||
125980137|NCT03205371|453215239|FG001|Overall Study|Adverse Event|0|||
125980138|NCT03205371|453215240|FG002|Overall Study|Adverse Event|0|||
125980139|NCT03205371|453215241|FG003|Overall Study|Adverse Event|0|||
125980140|NCT03205371|453215242|FG004|Overall Study|Adverse Event|0|||
125980141|NCT03205371|453215243|FG005|Overall Study|Adverse Event|0|||
125980142|NCT03205371|453215244|FG006|Overall Study|Adverse Event|0|||
125980143|NCT03205371|453215245|FG007|Overall Study|Adverse Event|1|||
125980144|NCT03205371|453215246|FG008|Overall Study|Adverse Event|0|||
125980145|NCT03205371|453215247|FG009|Overall Study|Adverse Event|0|||
125980146|NCT03205371|453215248|FG010|Overall Study|Adverse Event|0|||
125980147|NCT03205371|453215249|FG011|Overall Study|Adverse Event|0|||
125980148|NCT02835339|453215253|FG000|Overall Study|Did not receive allocated intervention|13|||
125980149|NCT02835339|453215254|FG001|Overall Study|Did not receive allocated intervention|16|||
125980150|NCT01077544|453215255|FG000|Overall Study|New Cancer Therapy|3|||
125980151|NCT01077544|453215256|FG001|Overall Study|New Cancer Therapy|3|||
125980152|NCT01077544|453215255|FG000|Overall Study|Adverse Event|0|||
125980153|NCT01077544|453215256|FG001|Overall Study|Adverse Event|1|||
126203257|NCT01519700|454030869|FG003|Overall Study|Death|0|||
126203258|NCT01519700|454030866|FG000|Overall Study|Lost to Follow-up|0|||
125980154|NCT01077544|453215255|FG000|Overall Study|Disease Progression|0|||
125980155|NCT01077544|453215256|FG001|Overall Study|Disease Progression|1|||
125980156|NCT03923959|453215257|FG000|Overall Study|Death|16|||
125980157|NCT03923959|453215258|FG001|Overall Study|Death|12|||
125980158|NCT03923959|453215257|FG000|Overall Study|Lost to Follow-up|56|||
125980159|NCT03923959|453215258|FG001|Overall Study|Lost to Follow-up|56|||
125980160|NCT03923959|453215257|FG000|Overall Study|Withdrawal by Subject|1|||
125980161|NCT03923959|453215258|FG001|Overall Study|Withdrawal by Subject|1|||
125980162|NCT03923959|453215257|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
125980163|NCT03923959|453215258|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
125980164|NCT04918147|453215259|FG000|Overall Study|Disease flare as defined in protocol|0|||
125980165|NCT04918147|453215260|FG001|Overall Study|Disease flare as defined in protocol|2|||
125980166|NCT02954354|453215262|FG000|Overall Study|Adverse Event|2|||
125980167|NCT02954354|453215263|FG001|Overall Study|Adverse Event|2|||
125980168|NCT02954354|453215264|FG002|Overall Study|Adverse Event|4|||
125980169|NCT02954354|453215262|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
125980170|NCT02954354|453215263|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
125980171|NCT02954354|453215264|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
125980172|NCT02954354|453215262|FG000|Overall Study|Lack of Efficacy|0|||
125980173|NCT02954354|453215263|FG001|Overall Study|Lack of Efficacy|2|||
125980174|NCT02954354|453215264|FG002|Overall Study|Lack of Efficacy|0|||
125980175|NCT02954354|453215262|FG000|Overall Study|Withdrawal by Subject|17|||
125980176|NCT02954354|453215263|FG001|Overall Study|Withdrawal by Subject|9|||
125980177|NCT02954354|453215264|FG002|Overall Study|Withdrawal by Subject|11|||
125980178|NCT02954354|453215262|FG000|Overall Study|Lost to Follow-up|12|||
125980179|NCT02954354|453215263|FG001|Overall Study|Lost to Follow-up|5|||
125980180|NCT02954354|453215264|FG002|Overall Study|Lost to Follow-up|0|||
125980181|NCT02954354|453215262|FG000|Overall Study|Miscellaneous|2|||
125980182|NCT02954354|453215263|FG001|Overall Study|Miscellaneous|2|||
125980183|NCT02954354|453215264|FG002|Overall Study|Miscellaneous|1|||
125980184|NCT03338829|453215265|FG000|Overall Study|Lost to Follow-up|4|||
125980185|NCT03338829|453215266|FG001|Overall Study|Lost to Follow-up|2|||
125980186|NCT03338829|453215267|FG002|Overall Study|Lost to Follow-up|4|||
125980187|NCT03338829|453215265|FG000|Overall Study|Pregnancy loss|1|||
125980188|NCT03338829|453215266|FG001|Overall Study|Pregnancy loss|1|||
125980189|NCT03338829|453215267|FG002|Overall Study|Pregnancy loss|0|||
125980190|NCT03338829|453215265|FG000|Overall Study|Protocol Violation|0|||
125980191|NCT03338829|453215266|FG001|Overall Study|Protocol Violation|1|||
125980192|NCT03338829|453215267|FG002|Overall Study|Protocol Violation|0|||
125980193|NCT03575325|453215268|FG000|Overall Study|Death|1|||
125980194|NCT04495179|453215269|FG000|Overall Study|Lost to Follow-up|0|||
125980195|NCT04495179|453215270|FG001|Overall Study|Lost to Follow-up|1|||
125980196|NCT04495179|453215269|FG000|Overall Study|Withdrawal by Subject|2|||
125980197|NCT04495179|453215270|FG001|Overall Study|Withdrawal by Subject|4|||
125980198|NCT04495179|453215269|FG000|Overall Study|Study terminated by sponsor|0|||
125980199|NCT04495179|453215270|FG001|Overall Study|Study terminated by sponsor|18|||
125980200|NCT04495179|453215269|FG000|Overall Study|Death|0|||
125980201|NCT04495179|453215270|FG001|Overall Study|Death|4|||
125980202|NCT04495179|453215269|FG000|Overall Study|Adverse Event|0|||
125980203|NCT04495179|453215270|FG001|Overall Study|Adverse Event|1|||
125980204|NCT02618967|453215274|FG000|Overall Study|Lost to Follow-up|0|||
125980205|NCT02618967|453215275|FG001|Overall Study|Lost to Follow-up|0|||
125980206|NCT02618967|453215276|FG002|Overall Study|Lost to Follow-up|1|||
125980207|NCT02618967|453215277|FG003|Overall Study|Lost to Follow-up|0|||
125980208|NCT02618967|453215278|FG004|Overall Study|Lost to Follow-up|2|||
125980209|NCT02618967|453215279|FG005|Overall Study|Lost to Follow-up|0|||
125980210|NCT02618967|453215280|FG006|Overall Study|Lost to Follow-up|0|||
125980211|NCT02618967|453215281|FG007|Overall Study|Lost to Follow-up|0|||
125980212|NCT02618967|453215274|FG000|Overall Study|Withdrawal by Subject|1|||
125980213|NCT02618967|453215275|FG001|Overall Study|Withdrawal by Subject|0|||
125980214|NCT02618967|453215276|FG002|Overall Study|Withdrawal by Subject|0|||
125980215|NCT02618967|453215277|FG003|Overall Study|Withdrawal by Subject|0|||
125980216|NCT02618967|453215278|FG004|Overall Study|Withdrawal by Subject|0|||
125980217|NCT02618967|453215279|FG005|Overall Study|Withdrawal by Subject|0|||
125980218|NCT02618967|453215280|FG006|Overall Study|Withdrawal by Subject|0|||
125980219|NCT02618967|453215281|FG007|Overall Study|Withdrawal by Subject|0|||
125980220|NCT01368965|453215282|FG000|Overall Study|Lost to Follow-up|12|||
125980221|NCT02355743|453215293|FG000|Overall Study|Withdrawal by Subject|1|||
125980222|NCT02355743|453215293|FG000|Overall Study|Lost to Follow-up|1|||
125980223|NCT04212091|453215294|FG000|Overall Study|Lost to Follow-up|0|||
125980224|NCT04212091|453215295|FG001|Overall Study|Lost to Follow-up|0|||
125980225|NCT04212091|453215296|FG002|Overall Study|Lost to Follow-up|0|||
125980226|NCT04212091|453215297|FG003|Overall Study|Lost to Follow-up|0|||
125980227|NCT04212091|453215298|FG004|Overall Study|Lost to Follow-up|1|||
125980228|NCT04212091|453215299|FG005|Overall Study|Lost to Follow-up|1|||
125980229|NCT04212091|453215294|FG000|Overall Study|Participant unable to adhere to visit|0|||
125980230|NCT04212091|453215295|FG001|Overall Study|Participant unable to adhere to visit|0|||
125980231|NCT04212091|453215296|FG002|Overall Study|Participant unable to adhere to visit|0|||
125980232|NCT04212091|453215297|FG003|Overall Study|Participant unable to adhere to visit|0|||
125980233|NCT04212091|453215298|FG004|Overall Study|Participant unable to adhere to visit|1|||
126313542|NCT02548351|454437673|FG002|Overall Study|Physician Decision|11|||
125980234|NCT04212091|453215299|FG005|Overall Study|Participant unable to adhere to visit|0|||
125980235|NCT02612311|453215300|FG000|Overall Study|Adverse Event|16|||
125980236|NCT02612311|453215301|FG001|Overall Study|Adverse Event|12|||
125980237|NCT02612311|453215302|FG002|Overall Study|Adverse Event|7|||
125980238|NCT02612311|453215303|FG003|Overall Study|Adverse Event|13|||
125980239|NCT02612311|453215300|FG000|Overall Study|Death|29|||
125980240|NCT02612311|453215301|FG001|Overall Study|Death|10|||
125980241|NCT02612311|453215302|FG002|Overall Study|Death|11|||
125980242|NCT02612311|453215303|FG003|Overall Study|Death|11|||
125980243|NCT02612311|453215300|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
125980244|NCT02612311|453215301|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
125980245|NCT02612311|453215302|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
125980246|NCT02612311|453215303|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
125980247|NCT02612311|453215300|FG000|Overall Study|Investigator's Decision|11|||
125980248|NCT02612311|453215301|FG001|Overall Study|Investigator's Decision|15|||
125980249|NCT02612311|453215302|FG002|Overall Study|Investigator's Decision|6|||
125980250|NCT02612311|453215303|FG003|Overall Study|Investigator's Decision|6|||
125980251|NCT02612311|453215300|FG000|Overall Study|Lack of Efficacy|0|||
125980252|NCT02612311|453215301|FG001|Overall Study|Lack of Efficacy|0|||
125980253|NCT02612311|453215302|FG002|Overall Study|Lack of Efficacy|1|||
125980254|NCT02612311|453215303|FG003|Overall Study|Lack of Efficacy|1|||
125980255|NCT02612311|453215300|FG000|Overall Study|Lost to Follow-up|2|||
125980256|NCT02612311|453215301|FG001|Overall Study|Lost to Follow-up|2|||
125980257|NCT02612311|453215302|FG002|Overall Study|Lost to Follow-up|1|||
125980258|NCT02612311|453215303|FG003|Overall Study|Lost to Follow-up|2|||
125980259|NCT02612311|453215300|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
125980260|NCT02612311|453215301|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
125980261|NCT02612311|453215302|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
125980262|NCT02612311|453215303|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
125980263|NCT02612311|453215300|FG000|Overall Study|Site Terminated by Sponsor|29|||
125980264|NCT02612311|453215301|FG001|Overall Study|Site Terminated by Sponsor|12|||
125980265|NCT02612311|453215302|FG002|Overall Study|Site Terminated by Sponsor|13|||
125980266|NCT02612311|453215303|FG003|Overall Study|Site Terminated by Sponsor|5|||
125980267|NCT02612311|453215300|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
125980268|NCT02612311|453215301|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
125980269|NCT02612311|453215302|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
125980270|NCT02612311|453215303|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
125980271|NCT02612311|453215300|FG000|Overall Study|Reason Not Specified|3|||
125980272|NCT02612311|453215301|FG001|Overall Study|Reason Not Specified|7|||
125980273|NCT02612311|453215302|FG002|Overall Study|Reason Not Specified|4|||
125980274|NCT02612311|453215303|FG003|Overall Study|Reason Not Specified|5|||
125980275|NCT02612311|453215300|FG000|Overall Study|Unknown/Missing|10|||
125980276|NCT02612311|453215301|FG001|Overall Study|Unknown/Missing|13|||
125980277|NCT02612311|453215302|FG002|Overall Study|Unknown/Missing|4|||
125980278|NCT02612311|453215303|FG003|Overall Study|Unknown/Missing|0|||
125980279|NCT02612311|453215300|FG000|Overall Study|Non-Compliance with Study|1|||
125980280|NCT02612311|453215301|FG001|Overall Study|Non-Compliance with Study|0|||
125980281|NCT02612311|453215302|FG002|Overall Study|Non-Compliance with Study|0|||
125980282|NCT02612311|453215303|FG003|Overall Study|Non-Compliance with Study|0|||
125980283|NCT00715429|453215304|FG000|Overall Study|Did not complete the study diary|0|||
125980284|NCT00715429|453215305|FG001|Overall Study|Did not complete the study diary|1|||
125980285|NCT04085328|453215306|FG000|Overall Study|Witihdrew Consent|16|||
125980286|NCT04085328|453215307|FG001|Overall Study|Witihdrew Consent|16|||
125980287|NCT04085328|453215306|FG000|Overall Study|Adverse Event|8|||
125980288|NCT04085328|453215307|FG001|Overall Study|Adverse Event|7|||
125980289|NCT04085328|453215306|FG000|Overall Study|Lost to Follow-up|7|||
125980290|NCT04085328|453215307|FG001|Overall Study|Lost to Follow-up|2|||
125980291|NCT04085328|453215306|FG000|Overall Study|Physician Decision|0|||
125980292|NCT04085328|453215307|FG001|Overall Study|Physician Decision|1|||
125980293|NCT04085328|453215306|FG000|Overall Study|Pregnancy|0|||
125980294|NCT04085328|453215307|FG001|Overall Study|Pregnancy|1|||
125980295|NCT04085328|453215306|FG000|Overall Study|Reasons Related to COVID-19|5|||
125980296|NCT04085328|453215307|FG001|Overall Study|Reasons Related to COVID-19|8|||
125980297|NCT04085328|453215306|FG000|Overall Study|Did not meet inclusion criteria|1|||
125980298|NCT04085328|453215307|FG001|Overall Study|Did not meet inclusion criteria|1|||
125980299|NCT04085328|453215306|FG000|Overall Study|Early termination|1|||
125980300|NCT04085328|453215307|FG001|Overall Study|Early termination|0|||
125980301|NCT00514735|453215308|FG000|Overall Study|Withdrawal by Subject|13|||
125980302|NCT00514735|453215309|FG001|Overall Study|Withdrawal by Subject|5|||
125980303|NCT00514735|453215308|FG000|Overall Study|Death|1|||
125980304|NCT00514735|453215309|FG001|Overall Study|Death|0|||
125980305|NCT00514735|453215308|FG000|Overall Study|Lost to Follow-up|0|||
125980306|NCT00514735|453215309|FG001|Overall Study|Lost to Follow-up|1|||
125980307|NCT04393441|453215310|FG000|Overall Study|Adverse Event|0|||
125980308|NCT04393441|453215311|FG001|Overall Study|Adverse Event|3|||
125980309|NCT04393441|453215310|FG000|Overall Study|Withdrawal by Subject|5|||
126203259|NCT01519700|454030867|FG001|Overall Study|Lost to Follow-up|0|||
126203260|NCT01519700|454030868|FG002|Overall Study|Lost to Follow-up|1|||
125980310|NCT04393441|453215311|FG001|Overall Study|Withdrawal by Subject|7|||
125980311|NCT04393441|453215310|FG000|Overall Study|Lost to Follow-up|0|||
125980312|NCT04393441|453215311|FG001|Overall Study|Lost to Follow-up|2|||
125980313|NCT04393441|453215310|FG000|Overall Study|Protocol Deviation|2|||
125980314|NCT04393441|453215311|FG001|Overall Study|Protocol Deviation|1|||
125980315|NCT04393441|453215310|FG000|Overall Study|Reason not Specified|1|||
125980316|NCT04393441|453215311|FG001|Overall Study|Reason not Specified|1|||
125980317|NCT01812655|453215312|FG000|Overall Study|Protocol Violation|1|||
125980318|NCT01812655|453215313|FG001|Overall Study|Protocol Violation|1|||
125980319|NCT01812655|453215314|FG002|Overall Study|Protocol Violation|0|||
125980320|NCT00553696|453215317|FG000|Overall Study|Adverse Event|2|||
125980321|NCT00553696|453215318|FG001|Overall Study|Adverse Event|4|||
125980322|NCT00553696|453215319|FG002|Overall Study|Adverse Event|0|||
125980323|NCT00553696|453215320|FG003|Overall Study|Adverse Event|1|||
125980324|NCT00553696|453215317|FG000|Overall Study|Global deterioration of health status|0|||
125980325|NCT00553696|453215318|FG001|Overall Study|Global deterioration of health status|2|||
125980326|NCT00553696|453215319|FG002|Overall Study|Global deterioration of health status|0|||
125980327|NCT00553696|453215320|FG003|Overall Study|Global deterioration of health status|0|||
125980328|NCT00553696|453215317|FG000|Overall Study|Objective progression or relapse|2|||
125980329|NCT00553696|453215318|FG001|Overall Study|Objective progression or relapse|9|||
125980330|NCT00553696|453215319|FG002|Overall Study|Objective progression or relapse|6|||
125980331|NCT00553696|453215320|FG003|Overall Study|Objective progression or relapse|0|||
125980332|NCT00553696|453215317|FG000|Overall Study|Withdrawal by Subject|0|||
125980333|NCT00553696|453215318|FG001|Overall Study|Withdrawal by Subject|1|||
125980334|NCT00553696|453215319|FG002|Overall Study|Withdrawal by Subject|0|||
125980335|NCT00553696|453215320|FG003|Overall Study|Withdrawal by Subject|0|||
125980336|NCT02276222|453215323|FG000|Overall Study|Adverse Event|62|||
125980337|NCT02276222|453215324|FG001|Overall Study|Adverse Event|11|||
125980338|NCT02276222|453215323|FG000|Overall Study|Death|3|||
125980339|NCT02276222|453215324|FG001|Overall Study|Death|4|||
125980340|NCT02276222|453215323|FG000|Overall Study|Lack of Efficacy|13|||
125980341|NCT02276222|453215324|FG001|Overall Study|Lack of Efficacy|3|||
125980342|NCT02276222|453215323|FG000|Overall Study|Protocol Violation|3|||
125980343|NCT02276222|453215324|FG001|Overall Study|Protocol Violation|2|||
125980344|NCT02276222|453215323|FG000|Overall Study|Withdrawal by Subject|79|||
125980345|NCT02276222|453215324|FG001|Overall Study|Withdrawal by Subject|33|||
125980346|NCT02276222|453215323|FG000|Overall Study|non compliance with study medication|6|||
125980347|NCT02276222|453215324|FG001|Overall Study|non compliance with study medication|2|||
125980348|NCT02276222|453215323|FG000|Overall Study|sponsor decision|0|||
125980349|NCT02276222|453215324|FG001|Overall Study|sponsor decision|3|||
125980350|NCT02276222|453215323|FG000|Overall Study|Lost to Follow-up|15|||
125980351|NCT02276222|453215324|FG001|Overall Study|Lost to Follow-up|5|||
125980352|NCT02276222|453215323|FG000|Overall Study|Physician Decision|2|||
125980353|NCT02276222|453215324|FG001|Overall Study|Physician Decision|1|||
125980354|NCT02276222|453215323|FG000|Overall Study|sheduling conflict|1|||
125980355|NCT02276222|453215324|FG001|Overall Study|sheduling conflict|0|||
125980356|NCT02276222|453215323|FG000|Overall Study|subject withdrew after randomization|1|||
125980357|NCT02276222|453215324|FG001|Overall Study|subject withdrew after randomization|0|||
125980358|NCT03645759|453215325|FG000|Overall Study|Lost to Follow-up|3|||
125980359|NCT03645759|453215326|FG001|Overall Study|Lost to Follow-up|2|||
125980360|NCT01648270|453215327|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
125980361|NCT02170025|453215328|FG000|Overall Study|Adverse Event|2|||
125980362|NCT02170025|453215329|FG001|Overall Study|Adverse Event|0|||
125980363|NCT00572195|453215330|FG000|Overall Study|Withdrawal by Subject|50|||
125980364|NCT00572195|453215330|FG000|Overall Study|Death|9|||
125980365|NCT00572195|453215330|FG000|Overall Study|Adverse Event|4|||
125980366|NCT00572195|453215330|FG000|Overall Study|Lost to Follow-up|5|||
125980367|NCT00902694|453215331|FG000|Overall Study|Death|1|||
125980368|NCT00902694|453215332|FG001|Overall Study|Death|3|||
125980369|NCT00902694|453215331|FG000|Overall Study|Lost to Follow-up|1|||
125980370|NCT00902694|453215332|FG001|Overall Study|Lost to Follow-up|0|||
125980371|NCT00902694|453215331|FG000|Overall Study|Censored per protocol|3|||
125980372|NCT00902694|453215332|FG001|Overall Study|Censored per protocol|1|||
125980373|NCT00902694|453215331|FG000|Overall Study|Pregnancy|1|||
125980374|NCT00902694|453215332|FG001|Overall Study|Pregnancy|1|||
125980375|NCT00902694|453215331|FG000|Overall Study|Incarceration|1|||
125980376|NCT00902694|453215332|FG001|Overall Study|Incarceration|0|||
125980377|NCT04969263|453215333|FG000|Overall Study|Death|1|||
125980378|NCT04969263|453215333|FG000|Overall Study|Lost to Follow-up|2|||
125980379|NCT04969263|453215333|FG000|Overall Study|Withdrawal by Subject|5|||
125980380|NCT04969263|453215333|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
125980381|NCT02693743|453215334|FG000|Overall Study|Physician Decision|1|||
125980382|NCT02693743|453215335|FG001|Overall Study|Physician Decision|0|||
125980383|NCT01024608|453215336|FG000|Overall Study|Adverse Event|1|||
125980384|NCT01024608|453215337|FG001|Overall Study|Adverse Event|0|||
125980385|NCT01024608|453215336|FG000|Overall Study|Withdrawal by Subject|1|||
125980386|NCT01024608|453215337|FG001|Overall Study|Withdrawal by Subject|0|||
125980387|NCT01024608|453215336|FG000|Overall Study|Lost to Follow-up|0|||
125980388|NCT01024608|453215337|FG001|Overall Study|Lost to Follow-up|1|||
125980389|NCT01024608|453215336|FG000|Overall Study|Protocol Violation|0|||
125980390|NCT01024608|453215337|FG001|Overall Study|Protocol Violation|3|||
125980391|NCT01024608|453215336|FG000|Overall Study|Never received study treatment|2|||
125980392|NCT01024608|453215337|FG001|Overall Study|Never received study treatment|0|||
125980393|NCT02412137|453215338|FG000|Overall Study|Withdrawal by Subject|2|||
125980394|NCT02412137|453215339|FG001|Overall Study|Withdrawal by Subject|0|||
125980395|NCT02412137|453215338|FG000|Overall Study|Lost to Follow-up|21|||
125980396|NCT02412137|453215339|FG001|Overall Study|Lost to Follow-up|14|||
125980397|NCT02412137|453215338|FG000|Overall Study|Physician Decision|28|||
125980398|NCT02412137|453215339|FG001|Overall Study|Physician Decision|9|||
125980399|NCT04981678|453215346|FG000|Overall Study|Lost to Follow-up|0|||
125980400|NCT04981678|453215347|FG001|Overall Study|Lost to Follow-up|1|||
125980401|NCT04922554|453215348|FG000|Overall Study|Adverse Event|4|||
125980402|NCT04922554|453215349|FG001|Overall Study|Adverse Event|0|||
125980403|NCT04922554|453215348|FG000|Overall Study|Withdrawal by Subject|1|||
125980404|NCT04922554|453215349|FG001|Overall Study|Withdrawal by Subject|0|||
125980405|NCT04128293|453217047|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
125980406|NCT04128293|453217048|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
125980407|NCT04128293|453217049|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
125980408|NCT04128293|453217050|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
125980409|NCT03597568|453217055|FG000|Overall Study|Withdrawal by Subject|1|||
125980410|NCT03597568|453217056|FG001|Overall Study|Withdrawal by Subject|1|||
125980411|NCT03597568|453217055|FG000|Overall Study|Unable to analyze vascular data|1|||
125980412|NCT03597568|453217056|FG001|Overall Study|Unable to analyze vascular data|1|||
125980413|NCT01357616|453217057|FG000|Overall Study|Adverse Event|1|||
125980414|NCT01357616|453217058|FG001|Overall Study|Adverse Event|1|||
125980415|NCT01357616|453217057|FG000|Overall Study|Lost to Follow-up|4|||
125980416|NCT01357616|453217058|FG001|Overall Study|Lost to Follow-up|3|||
125980417|NCT01357616|453217057|FG000|Overall Study|Protocol Violation|0|||
125980418|NCT01357616|453217058|FG001|Overall Study|Protocol Violation|2|||
125980419|NCT01357616|453217057|FG000|Overall Study|Inadequate Control of IOP|1|||
125980420|NCT01357616|453217058|FG001|Overall Study|Inadequate Control of IOP|2|||
125980421|NCT01357616|453217057|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
125980422|NCT01357616|453217058|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
125980423|NCT01357616|453217057|FG000|Overall Study|Withdrawal by Subject|1|||
125980424|NCT01357616|453217058|FG001|Overall Study|Withdrawal by Subject|0|||
125980425|NCT00420199|453217063|FG000|Overall Study|Participant no longer met study criteria|1|||
125980426|NCT00420199|453217064|FG001|Overall Study|Participant no longer met study criteria|0|||
125980427|NCT01197508|453217065|FG000|Overall Study|Withdrawal by Subject|8|||
125980428|NCT01197508|453217066|FG001|Overall Study|Withdrawal by Subject|7|||
125980429|NCT01197508|453217067|FG002|Overall Study|Withdrawal by Subject|15|||
125980430|NCT01197508|453217068|FG003|Overall Study|Withdrawal by Subject|4|||
125980431|NCT01197508|453217065|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
125980432|NCT01197508|453217066|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
125980433|NCT01197508|453217067|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
125980434|NCT01197508|453217068|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
125980435|NCT01197508|453217065|FG000|Overall Study|Adverse Event|10|||
125980436|NCT01197508|453217066|FG001|Overall Study|Adverse Event|13|||
125980437|NCT01197508|453217067|FG002|Overall Study|Adverse Event|23|||
125980438|NCT01197508|453217068|FG003|Overall Study|Adverse Event|3|||
125980439|NCT01197508|453217065|FG000|Overall Study|Severe non-compliance to protocol|0|||
125980440|NCT01197508|453217066|FG001|Overall Study|Severe non-compliance to protocol|3|||
125980441|NCT01197508|453217067|FG002|Overall Study|Severe non-compliance to protocol|1|||
125980442|NCT01197508|453217068|FG003|Overall Study|Severe non-compliance to protocol|3|||
125980443|NCT01197508|453217065|FG000|Overall Study|Condition under investigation worsened|1|||
125980444|NCT01197508|453217066|FG001|Overall Study|Condition under investigation worsened|1|||
125980445|NCT01197508|453217067|FG002|Overall Study|Condition under investigation worsened|1|||
125980446|NCT01197508|453217068|FG003|Overall Study|Condition under investigation worsened|1|||
125980447|NCT01197508|453217065|FG000|Overall Study|Lack of Efficacy|1|||
125980448|NCT01197508|453217066|FG001|Overall Study|Lack of Efficacy|2|||
125980449|NCT01197508|453217067|FG002|Overall Study|Lack of Efficacy|2|||
125980450|NCT01197508|453217068|FG003|Overall Study|Lack of Efficacy|1|||
125980451|NCT01197508|453217065|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125980452|NCT01197508|453217066|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125980453|NCT01197508|453217067|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125980454|NCT01197508|453217068|FG003|Overall Study|Study-specific withdrawal criteria|2|||
125980455|NCT01197508|453217065|FG000|Overall Study|Lost to Follow-up|1|||
125980456|NCT01197508|453217066|FG001|Overall Study|Lost to Follow-up|1|||
125980457|NCT01197508|453217067|FG002|Overall Study|Lost to Follow-up|2|||
125980458|NCT01197508|453217068|FG003|Overall Study|Lost to Follow-up|0|||
125980459|NCT01197508|453217065|FG000|Overall Study|Other|2|||
125980460|NCT01197508|453217066|FG001|Overall Study|Other|3|||
125980461|NCT01197508|453217067|FG002|Overall Study|Other|2|||
125980462|NCT01197508|453217068|FG003|Overall Study|Other|2|||
125980463|NCT00266825|453217069|FG000|Completed Follow-Up|Lost to Follow-up|14|||
125980464|NCT00266825|453217070|FG001|Completed Follow-Up|Lost to Follow-up|19|||
125980465|NCT00266825|453217069|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
125980466|NCT00266825|453217070|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
125980467|NCT01301391|453217073|FG000|Overall Study|Death|13|||
125980468|NCT01301391|453217073|FG000|Overall Study|Lost to Follow-up|3|||
125980469|NCT01301391|453217073|FG000|Overall Study|Physician Decision|2|||
125980470|NCT01301391|453217073|FG000|Overall Study|Sponsor's decision|8|||
125980471|NCT02799784|453217075|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
125980472|NCT02799784|453217076|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
125980473|NCT02799784|453217075|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
125980474|NCT02799784|453217076|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
125980475|NCT02799784|453217075|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
125980476|NCT02799784|453217076|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
125980477|NCT02799784|453217075|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
125980478|NCT02799784|453217076|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
125980479|NCT02799784|453217075|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
125980480|NCT02799784|453217076|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
125980481|NCT02799784|453217075|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
125980482|NCT02799784|453217076|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
125980483|NCT03466086|453217082|FG000|Period 1|Sponsor decision due to study timeline|1|||
125980484|NCT03466086|453217083|FG001|Period 1|Sponsor decision due to study timeline|0|||
125980485|NCT03466086|453217082|FG000|Period 1|Withdrawal by Subject|1|||
125980486|NCT03466086|453217083|FG001|Period 1|Withdrawal by Subject|0|||
125980487|NCT00595504|453217084|FG000|Overall Study|Withdrawal by Subject|1|||
125980488|NCT00595504|453217085|FG001|Overall Study|Withdrawal by Subject|3|||
125980489|NCT00595504|453217084|FG000|Overall Study|Physician Decision|1|||
125980490|NCT00595504|453217085|FG001|Overall Study|Physician Decision|0|||
125980491|NCT01949870|453217087|FG000|Overall Study|Lack of Efficacy|2|||
125980492|NCT01949870|453217087|FG000|Overall Study|Adverse Event|1|||
125980493|NCT01949870|453217087|FG000|Overall Study|Study termination|1|||
126089555|NCT00626197|453621419|FG001|Overall Study|Administrative reasons|19|||
126089556|NCT00626197|453621420|FG002|Overall Study|Administrative reasons|55|||
126089557|NCT04833127|453621421|FG000|Overall Study|Lost to Follow-up|1|||
126089558|NCT04833127|453621422|FG001|Overall Study|Lost to Follow-up|1|||
126089559|NCT04552899|453621425|FG000|Overall Study|Adverse Event|4|||
126089560|NCT04552899|453621426|FG001|Overall Study|Adverse Event|3|||
126089561|NCT04552899|453621425|FG000|Overall Study|Death|4|||
126089562|NCT04552899|453621426|FG001|Overall Study|Death|4|||
126089563|NCT04552899|453621425|FG000|Overall Study|Lost to Follow-up|8|||
126089564|NCT04552899|453621426|FG001|Overall Study|Lost to Follow-up|13|||
126089565|NCT04552899|453621425|FG000|Overall Study|Lung Transplant|4|||
126089566|NCT04552899|453621426|FG001|Overall Study|Lung Transplant|3|||
126089567|NCT04552899|453621425|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
126089568|NCT04552899|453621426|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
126089569|NCT04552899|453621425|FG000|Overall Study|Physician Decision|3|||
126089570|NCT04552899|453621426|FG001|Overall Study|Physician Decision|4|||
126089571|NCT04552899|453621425|FG000|Overall Study|Study Terminated By Sponsor|237|||
126089572|NCT04552899|453621426|FG001|Overall Study|Study Terminated By Sponsor|239|||
126089573|NCT04552899|453621425|FG000|Overall Study|Withdrawal by Subject|15|||
126089574|NCT04552899|453621426|FG001|Overall Study|Withdrawal by Subject|17|||
126089575|NCT05282121|453621427|FG000|Overall Study|Adverse Event|1|||
126089576|NCT05282121|453621428|FG001|Overall Study|Adverse Event|1|||
126089577|NCT05282121|453621429|FG002|Overall Study|Adverse Event|4|||
126089578|NCT05282121|453621430|FG003|Overall Study|Adverse Event|1|||
126089579|NCT05282121|453621427|FG000|Overall Study|Study Terminated by Sponsor|1|||
126089580|NCT05282121|453621428|FG001|Overall Study|Study Terminated by Sponsor|2|||
126089581|NCT05282121|453621429|FG002|Overall Study|Study Terminated by Sponsor|2|||
126089582|NCT05282121|453621430|FG003|Overall Study|Study Terminated by Sponsor|2|||
126089583|NCT05282121|453621427|FG000|Overall Study|Other than listed|0|||
126089584|NCT05282121|453621428|FG001|Overall Study|Other than listed|0|||
126089585|NCT05282121|453621429|FG002|Overall Study|Other than listed|1|||
126089586|NCT05282121|453621430|FG003|Overall Study|Other than listed|0|||
126089587|NCT05282121|453621427|FG000|Overall Study|No reason available|0|||
126089588|NCT05282121|453621428|FG001|Overall Study|No reason available|0|||
126089589|NCT05282121|453621429|FG002|Overall Study|No reason available|1|||
126089590|NCT05282121|453621430|FG003|Overall Study|No reason available|0|||
126089591|NCT00461981|453621434|FG000|Overall Study|Lost to Follow-up|9|||
126089592|NCT00461981|453621435|FG001|Overall Study|Lost to Follow-up|6|||
126089593|NCT00461981|453621434|FG000|Overall Study|Withdrawal by Subject|2|||
126089594|NCT00461981|453621435|FG001|Overall Study|Withdrawal by Subject|3|||
126089595|NCT00731133|453621439|FG000|Overall Study|Withdrawal by Subject|10|||
126089596|NCT03510455|453621440|FG000|Overall Study|Physician Decision|1|||
126089597|NCT04958642|453621447|FG000|Overall Study|Transferred to OLEX program|3|||
126089598|NCT04958642|453621448|FG001|Overall Study|Transferred to OLEX program|0|||
126089599|NCT04958642|453621449|FG002|Overall Study|Transferred to OLEX program|5|||
126089600|NCT04958642|453621447|FG000|Overall Study|Death|0|||
126089601|NCT04958642|453621448|FG001|Overall Study|Death|0|||
126089602|NCT04958642|453621449|FG002|Overall Study|Death|1|||
126089603|NCT04958642|453621447|FG000|Overall Study|Withdrawal by Subject|4|||
126089604|NCT04958642|453621448|FG001|Overall Study|Withdrawal by Subject|9|||
126089605|NCT04958642|453621449|FG002|Overall Study|Withdrawal by Subject|13|||
126089606|NCT04958642|453621447|FG000|Overall Study|Investigator's Decision|0|||
126089607|NCT04958642|453621448|FG001|Overall Study|Investigator's Decision|0|||
126089608|NCT04958642|453621449|FG002|Overall Study|Investigator's Decision|1|||
126089609|NCT04958642|453621447|FG000|Overall Study|Adverse Event|1|||
126089610|NCT04958642|453621448|FG001|Overall Study|Adverse Event|0|||
126089611|NCT04958642|453621449|FG002|Overall Study|Adverse Event|1|||
126089612|NCT04958642|453621447|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
126089613|NCT04958642|453621448|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
126089614|NCT04958642|453621449|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
126089615|NCT04958642|453621447|FG000|Overall Study|Lost to Follow-up|1|||
126089616|NCT04958642|453621448|FG001|Overall Study|Lost to Follow-up|0|||
126089617|NCT04958642|453621449|FG002|Overall Study|Lost to Follow-up|0|||
126089618|NCT04958642|453621447|FG000|Overall Study|Transferred to EAP following study termination|0|||
126089619|NCT04958642|453621448|FG001|Overall Study|Transferred to EAP following study termination|0|||
126089620|NCT04958642|453621449|FG002|Overall Study|Transferred to EAP following study termination|1|||
126089621|NCT04958642|453621447|FG000|Overall Study|Transferred to Expanded Access Program|1|||
126089622|NCT04958642|453621448|FG001|Overall Study|Transferred to Expanded Access Program|0|||
126089623|NCT04958642|453621449|FG002|Overall Study|Transferred to Expanded Access Program|0|||
126089624|NCT03853551|453621453|FG000|Overall Study|Death|2|||
126089625|NCT03853551|453621453|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
126089626|NCT02476175|453621454|FG000|Overall Study|Adverse Event|2|||
126089627|NCT01876901|453621456|FG000|Overall Study|Protocol Violation|10|||
126089628|NCT01876901|453621457|FG001|Overall Study|Protocol Violation|2|||
126089629|NCT01876901|453621456|FG000|Overall Study|No or other surgical intervention|7|||
126089630|NCT01876901|453621457|FG001|Overall Study|No or other surgical intervention|5|||
126089631|NCT02964325|453621460|FG000|Overall Study|Lost to Follow-up|3|||
126089632|NCT02964325|453621461|FG001|Overall Study|Lost to Follow-up|3|||
126089633|NCT02964325|453621460|FG000|Overall Study|Physician Decision|5|||
126089634|NCT02964325|453621461|FG001|Overall Study|Physician Decision|4|||
126089635|NCT02964325|453621460|FG000|Overall Study|Death|1|||
126089636|NCT02964325|453621461|FG001|Overall Study|Death|3|||
126089637|NCT02964325|453621460|FG000|Overall Study|Withdrawal by Subject|2|||
126089638|NCT02964325|453621461|FG001|Overall Study|Withdrawal by Subject|1|||
126089639|NCT02964325|453621460|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
126089640|NCT02964325|453621461|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
126089641|NCT02510040|453621462|FG000|Overall Study|Deemed no longer eligible|18|||
126089642|NCT02510040|453621463|FG001|Overall Study|Deemed no longer eligible|3|||
126089643|NCT02510040|453621464|FG002|Overall Study|Deemed no longer eligible|1|||
126089644|NCT00534495|453621471|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
126089645|NCT00534495|453621472|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
126089646|NCT00534495|453621473|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
126089647|NCT00534495|453621471|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
126089648|NCT00534495|453621472|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
126089649|NCT00534495|453621473|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
126089650|NCT00534495|453621471|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
126089651|NCT00534495|453621472|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
126089652|NCT00534495|453621473|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
126089653|NCT00534495|453621471|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
126089654|NCT00534495|453621472|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
126089655|NCT00534495|453621473|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
126089656|NCT00534495|453621471|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
126089657|NCT00534495|453621472|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
126089658|NCT00534495|453621473|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
126089659|NCT00534495|453621471|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
126089660|NCT00534495|453621472|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
126089661|NCT00534495|453621473|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
126089662|NCT00534495|453621471|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
126089663|NCT00534495|453621472|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
126089664|NCT00534495|453621473|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
126089665|NCT00534495|453621471|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
126089666|NCT00534495|453621472|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
126089667|NCT00534495|453621473|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
126089668|NCT00534495|453621471|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
126089669|NCT00534495|453621472|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
126089670|NCT00534495|453621473|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
126089671|NCT01068665|453621474|FG000|Overall Study|Adverse Event|5|||
126089672|NCT01068665|453621475|FG001|Overall Study|Adverse Event|4|||
126089673|NCT01068665|453621474|FG000|Overall Study|Lack of Efficacy|0|||
126089674|NCT01068665|453621475|FG001|Overall Study|Lack of Efficacy|2|||
126089675|NCT01068665|453621474|FG000|Overall Study|Protocol Violation|5|||
126089676|NCT01068665|453621475|FG001|Overall Study|Protocol Violation|2|||
126089677|NCT01068665|453621474|FG000|Overall Study|Withdrawal Criteria|3|||
126089678|NCT01068665|453621475|FG001|Overall Study|Withdrawal Criteria|9|||
126089679|NCT01068665|453621474|FG000|Overall Study|Other|17|||
126089680|NCT01068665|453621475|FG001|Overall Study|Other|12|||
126089681|NCT02202785|453621477|FG000|Overall Study|Study Terminated by Sponsor|1|||
126089682|NCT02202785|453621478|FG001|Overall Study|Study Terminated by Sponsor|6|||
126089683|NCT02202785|453621479|FG002|Overall Study|Study Terminated by Sponsor|4|||
126089684|NCT02202785|453621477|FG000|Overall Study|Withdrawal by Subject|0|||
126089685|NCT02202785|453621478|FG001|Overall Study|Withdrawal by Subject|1|||
126089686|NCT02202785|453621479|FG002|Overall Study|Withdrawal by Subject|0|||
126089687|NCT02202785|453621477|FG000|Overall Study|Lost to Follow-up|0|||
126089688|NCT02202785|453621478|FG001|Overall Study|Lost to Follow-up|1|||
126089689|NCT02202785|453621479|FG002|Overall Study|Lost to Follow-up|0|||
126089690|NCT02202785|453621477|FG000|Overall Study|Reason not Specified|10|||
126089691|NCT02202785|453621478|FG001|Overall Study|Reason not Specified|7|||
126089692|NCT02202785|453621479|FG002|Overall Study|Reason not Specified|13|||
126089693|NCT02180243|453621480|FG000|Overall Study|Withdrawal by Subject|12|||
126089694|NCT02180243|453621481|FG001|Overall Study|Withdrawal by Subject|12|||
126089695|NCT02180243|453621480|FG000|Overall Study|Lost to Follow-up|12|||
126089696|NCT02180243|453621481|FG001|Overall Study|Lost to Follow-up|2|||
126089697|NCT01137578|453621482|FG000|Overall Study|Participant requested to Discontinue|3|||
126089698|NCT01137578|453621483|FG001|Overall Study|Participant requested to Discontinue|0|||
126089699|NCT01137578|453621484|FG002|Overall Study|Participant requested to Discontinue|0|||
126089700|NCT01137578|453621482|FG000|Overall Study|Withdrawal by Subject|1|||
126089701|NCT01137578|453621483|FG001|Overall Study|Withdrawal by Subject|0|||
126089702|NCT01137578|453621484|FG002|Overall Study|Withdrawal by Subject|0|||
126089703|NCT01137578|453621482|FG000|Overall Study|Other|12|||
126089704|NCT01137578|453621483|FG001|Overall Study|Other|2|||
126089705|NCT01137578|453621484|FG002|Overall Study|Other|6|||
126089706|NCT04145700|453621486|FG000|Overall Study|Withdrawal by Subject|8|||
126089707|NCT04145700|453621487|FG001|Overall Study|Withdrawal by Subject|3|||
126089708|NCT00818779|453621488|FG000|Overall Study|Protocol Violation|1|||
126089709|NCT00818779|453621489|FG001|Overall Study|Protocol Violation|0|||
126089710|NCT00818779|453621488|FG000|Overall Study|Lost to Follow-up|1|||
126089711|NCT00818779|453621489|FG001|Overall Study|Lost to Follow-up|0|||
126089712|NCT00818779|453621488|FG000|Overall Study|Adverse Event|4|||
126089713|NCT00818779|453621489|FG001|Overall Study|Adverse Event|1|||
126089714|NCT04978493|453621490|FG000|Overall Study|No reason available|0|||
126089715|NCT04978493|453621491|FG001|Overall Study|No reason available|1|||
126089716|NCT04978493|453621490|FG000|Overall Study|Adverse Event|1|||
126089717|NCT04978493|453621491|FG001|Overall Study|Adverse Event|0|||
126089718|NCT01254747|453621492|FG000|Overall Study|Unacceptable subjective vision|0|||
126089719|NCT01254747|453621493|FG001|Overall Study|Unacceptable subjective vision|0|||
126089720|NCT01254747|453621494|FG002|Overall Study|Unacceptable subjective vision|0|||
126089721|NCT01254747|453621495|FG003|Overall Study|Unacceptable subjective vision|2|||
126089722|NCT01254747|453621492|FG000|Overall Study|Difficult removal handling|0|||
126089723|NCT01254747|453621493|FG001|Overall Study|Difficult removal handling|0|||
126089724|NCT01254747|453621494|FG002|Overall Study|Difficult removal handling|1|||
126089725|NCT01254747|453621495|FG003|Overall Study|Difficult removal handling|0|||
126089726|NCT01254747|453621492|FG000|Overall Study|Symptoms and problems|0|||
126089727|NCT01254747|453621493|FG001|Overall Study|Symptoms and problems|2|||
126089728|NCT01254747|453621494|FG002|Overall Study|Symptoms and problems|1|||
126089729|NCT01254747|453621495|FG003|Overall Study|Symptoms and problems|0|||
126089730|NCT01254747|453621492|FG000|Overall Study|Lost to Follow-up|0|||
126203261|NCT01519700|454030869|FG003|Overall Study|Lost to Follow-up|1|||
126203262|NCT01519700|454030866|FG000|Overall Study|Physician Decision|1|||
126089731|NCT01254747|453621493|FG001|Overall Study|Lost to Follow-up|0|||
126089732|NCT01254747|453621494|FG002|Overall Study|Lost to Follow-up|1|||
126089733|NCT01254747|453621495|FG003|Overall Study|Lost to Follow-up|0|||
126089734|NCT01254747|453621492|FG000|Overall Study|Biomicroscopy|0|||
126089735|NCT01254747|453621493|FG001|Overall Study|Biomicroscopy|0|||
126089736|NCT01254747|453621494|FG002|Overall Study|Biomicroscopy|1|||
126089737|NCT01254747|453621495|FG003|Overall Study|Biomicroscopy|0|||
126089738|NCT01254747|453621492|FG000|Overall Study|Discomfort|0|||
126089739|NCT01254747|453621493|FG001|Overall Study|Discomfort|4|||
126089740|NCT01254747|453621494|FG002|Overall Study|Discomfort|0|||
126089741|NCT01254747|453621495|FG003|Overall Study|Discomfort|0|||
126089742|NCT00245960|453621496|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
126089743|NCT00245960|453621497|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
126089744|NCT00245960|453621496|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
126089745|NCT00245960|453621497|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
126089746|NCT00245960|453621496|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
126089747|NCT00245960|453621497|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
126089748|NCT00245960|453621496|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
126089749|NCT00245960|453621497|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
126313543|NCT02548351|454437671|FG000|Overall Study|Lost to Follow-up|43|||
126089750|NCT00245960|453621496|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
126089751|NCT00245960|453621497|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
126089752|NCT00245960|453621496|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
126089753|NCT00245960|453621497|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
126089754|NCT00245960|453621496|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
126089755|NCT00245960|453621497|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
126089756|NCT00245960|453621496|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
126089757|NCT00245960|453621497|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
126089758|NCT00245960|453621496|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
126089759|NCT00245960|453621497|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
126089760|NCT00245960|453621496|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
126089761|NCT00245960|453621497|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
126089762|NCT00245960|453621496|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
126089763|NCT00245960|453621497|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
126089764|NCT00245960|453621496|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
126089765|NCT00245960|453621497|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
126089766|NCT00316017|453621502|FG000|Overall Study|Protocol Violation|11|||
126089767|NCT00316017|453621503|FG001|Overall Study|Protocol Violation|13|||
126089768|NCT00316017|453621504|FG002|Overall Study|Protocol Violation|19|||
126089769|NCT05235269|453621509|FG000|Overall Study|Adverse Event|1|||
126089770|NCT05235269|453621509|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
126089771|NCT05235269|453621509|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
126089772|NCT03570892|453621513|FG000|Overall Study|Death|51|||
126089773|NCT03570892|453621514|FG001|Overall Study|Death|45|||
126089774|NCT03570892|453621513|FG000|Overall Study|Subject decision|5|||
126089775|NCT03570892|453621514|FG001|Overall Study|Subject decision|3|||
126089776|NCT03570892|453621513|FG000|Overall Study|Protocol Violation|1|||
126089777|NCT03570892|453621514|FG001|Overall Study|Protocol Violation|4|||
126089778|NCT03570892|453621513|FG000|Overall Study|Physician Decision|0|||
126089779|NCT03570892|453621514|FG001|Overall Study|Physician Decision|2|||
126103424|NCT01831856|453672157|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
126103425|NCT01831856|453672158|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
126103426|NCT01718353|453672161|FG000|Overall Study|Lost to Follow-up|0|||
126103427|NCT01718353|453672162|FG001|Overall Study|Lost to Follow-up|1|||
126103428|NCT01718353|453672161|FG000|Overall Study|Principal Investigator's Decision|10|||
126103429|NCT01718353|453672162|FG001|Overall Study|Principal Investigator's Decision|4|||
126103430|NCT01718353|453672161|FG000|Overall Study|Randomized but not treated|2|||
126103431|NCT01718353|453672162|FG001|Overall Study|Randomized but not treated|0|||
126103432|NCT00455325|453672163|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
126103433|NCT00455325|453672164|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
126103434|NCT00455325|453672165|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
126103435|NCT00455325|453672166|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
126103436|NCT00455325|453672163|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
126103437|NCT00455325|453672164|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
126103438|NCT00455325|453672165|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
126103439|NCT00455325|453672166|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
126103440|NCT00455325|453672163|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
126103441|NCT00455325|453672164|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
126103442|NCT00455325|453672165|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
126103443|NCT00455325|453672166|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
126103444|NCT00455325|453672163|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
126103445|NCT00455325|453672164|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
126103446|NCT00455325|453672165|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
126103447|NCT00455325|453672166|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
126103448|NCT00455325|453672163|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
126103449|NCT00455325|453672164|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
126103450|NCT00455325|453672165|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
126103451|NCT00455325|453672166|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
126103452|NCT00455325|453672163|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
126103453|NCT00455325|453672164|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
126103454|NCT00455325|453672165|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
126103455|NCT00455325|453672166|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
126103456|NCT00455325|453672163|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
126313544|NCT02548351|454437672|FG001|Overall Study|Lost to Follow-up|50|||
126313545|NCT02548351|454437673|FG002|Overall Study|Lost to Follow-up|57|||
126313546|NCT02548351|454437671|FG000|Overall Study|Other|19|||
126103457|NCT00455325|453672164|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
126103458|NCT00455325|453672165|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
126103459|NCT00455325|453672166|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
126313547|NCT02548351|454437672|FG001|Overall Study|Other|16|||
126089780|NCT01876082|453623428|FG000|Overall Study|Withdrawal by Subject|0|||
126089781|NCT01876082|453623429|FG001|Overall Study|Withdrawal by Subject|2|||
126089782|NCT01876082|453623428|FG000|Overall Study|Protocol Violation|1|||
126089783|NCT01876082|453623429|FG001|Overall Study|Protocol Violation|0|||
126089784|NCT01876082|453623428|FG000|Overall Study|Adverse Event|1|||
126089785|NCT01876082|453623429|FG001|Overall Study|Adverse Event|1|||
126089786|NCT01876082|453623428|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
126089787|NCT01876082|453623429|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
126089788|NCT04427280|453623431|FG000|Overall Study|Withdrawal by Subject|0|||
126089789|NCT04427280|453623432|FG001|Overall Study|Withdrawal by Subject|2|||
126089790|NCT03829501|453623435|FG000|Overall Study|Withdrawal of Consent|2|||
126089791|NCT03829501|453623436|FG001|Overall Study|Withdrawal of Consent|0|||
126089792|NCT03829501|453623437|FG002|Overall Study|Withdrawal of Consent|3|||
126089793|NCT03829501|453623438|FG003|Overall Study|Withdrawal of Consent|0|||
126089794|NCT03829501|453623439|FG004|Overall Study|Withdrawal of Consent|1|||
126089795|NCT03829501|453623440|FG005|Overall Study|Withdrawal of Consent|1|||
126089796|NCT03829501|453623441|FG006|Overall Study|Withdrawal of Consent|0|||
126089797|NCT03829501|453623442|FG007|Overall Study|Withdrawal of Consent|10|||
126089798|NCT03829501|453623443|FG008|Overall Study|Withdrawal of Consent|10|||
126089799|NCT03829501|453623444|FG009|Overall Study|Withdrawal of Consent|3|||
126089800|NCT03829501|453623445|FG010|Overall Study|Withdrawal of Consent|4|||
126089801|NCT03829501|453623446|FG011|Overall Study|Withdrawal of Consent|4|||
126089802|NCT03829501|453623447|FG012|Overall Study|Withdrawal of Consent|4|||
126089803|NCT03829501|453623448|FG013|Overall Study|Withdrawal of Consent|0|||
126089804|NCT03829501|453623449|FG014|Overall Study|Withdrawal of Consent|3|||
126089805|NCT03829501|453623450|FG015|Overall Study|Withdrawal of Consent|0|||
126089806|NCT03829501|453623451|FG016|Overall Study|Withdrawal of Consent|1|||
126089807|NCT03829501|453623452|FG017|Overall Study|Withdrawal of Consent|1|||
126089808|NCT03829501|453623453|FG018|Overall Study|Withdrawal of Consent|0|||
126089809|NCT03829501|453623454|FG019|Overall Study|Withdrawal of Consent|0|||
126089810|NCT03829501|453623455|FG020|Overall Study|Withdrawal of Consent|3|||
126089811|NCT03829501|453623456|FG021|Overall Study|Withdrawal of Consent|0|||
126089812|NCT03829501|453623457|FG022|Overall Study|Withdrawal of Consent|1|||
126089813|NCT03829501|453623435|FG000|Overall Study|PD|0|||
126089814|NCT03829501|453623436|FG001|Overall Study|PD|0|||
126089815|NCT03829501|453623437|FG002|Overall Study|PD|0|||
126089816|NCT03829501|453623438|FG003|Overall Study|PD|2|||
126089817|NCT03829501|453623439|FG004|Overall Study|PD|0|||
126089818|NCT03829501|453623440|FG005|Overall Study|PD|0|||
126089819|NCT03829501|453623441|FG006|Overall Study|PD|0|||
126089820|NCT03829501|453623442|FG007|Overall Study|PD|0|||
126089821|NCT03829501|453623443|FG008|Overall Study|PD|0|||
126089822|NCT03829501|453623444|FG009|Overall Study|PD|0|||
126089823|NCT03829501|453623445|FG010|Overall Study|PD|0|||
126089824|NCT03829501|453623446|FG011|Overall Study|PD|0|||
126089825|NCT03829501|453623447|FG012|Overall Study|PD|0|||
126089826|NCT03829501|453623448|FG013|Overall Study|PD|0|||
126089827|NCT03829501|453623449|FG014|Overall Study|PD|0|||
126089828|NCT03829501|453623450|FG015|Overall Study|PD|1|||
126089829|NCT03829501|453623451|FG016|Overall Study|PD|0|||
126089830|NCT03829501|453623452|FG017|Overall Study|PD|0|||
126089831|NCT03829501|453623453|FG018|Overall Study|PD|0|||
126089832|NCT03829501|453623454|FG019|Overall Study|PD|0|||
126089833|NCT03829501|453623455|FG020|Overall Study|PD|1|||
126089834|NCT03829501|453623456|FG021|Overall Study|PD|0|||
126089835|NCT03829501|453623457|FG022|Overall Study|PD|0|||
126089836|NCT03829501|453623435|FG000|Overall Study|Study Terminated by Sponsor|0|||
126089837|NCT03829501|453623436|FG001|Overall Study|Study Terminated by Sponsor|0|||
126089838|NCT03829501|453623437|FG002|Overall Study|Study Terminated by Sponsor|0|||
126089839|NCT03829501|453623438|FG003|Overall Study|Study Terminated by Sponsor|0|||
126089840|NCT03829501|453623439|FG004|Overall Study|Study Terminated by Sponsor|0|||
126089841|NCT03829501|453623440|FG005|Overall Study|Study Terminated by Sponsor|0|||
126089842|NCT03829501|453623441|FG006|Overall Study|Study Terminated by Sponsor|0|||
126089843|NCT03829501|453623442|FG007|Overall Study|Study Terminated by Sponsor|3|||
126089844|NCT03829501|453623443|FG008|Overall Study|Study Terminated by Sponsor|1|||
126089845|NCT03829501|453623444|FG009|Overall Study|Study Terminated by Sponsor|0|||
126089846|NCT03829501|453623445|FG010|Overall Study|Study Terminated by Sponsor|0|||
126089847|NCT03829501|453623446|FG011|Overall Study|Study Terminated by Sponsor|0|||
126089848|NCT03829501|453623447|FG012|Overall Study|Study Terminated by Sponsor|0|||
126089849|NCT03829501|453623448|FG013|Overall Study|Study Terminated by Sponsor|0|||
126089850|NCT03829501|453623449|FG014|Overall Study|Study Terminated by Sponsor|3|||
126089851|NCT03829501|453623450|FG015|Overall Study|Study Terminated by Sponsor|2|||
126089852|NCT03829501|453623451|FG016|Overall Study|Study Terminated by Sponsor|2|||
126089853|NCT03829501|453623452|FG017|Overall Study|Study Terminated by Sponsor|0|||
126089854|NCT03829501|453623453|FG018|Overall Study|Study Terminated by Sponsor|0|||
126089855|NCT03829501|453623454|FG019|Overall Study|Study Terminated by Sponsor|0|||
126089856|NCT03829501|453623455|FG020|Overall Study|Study Terminated by Sponsor|1|||
126089857|NCT03829501|453623456|FG021|Overall Study|Study Terminated by Sponsor|0|||
126089858|NCT03829501|453623457|FG022|Overall Study|Study Terminated by Sponsor|3|||
126089859|NCT03829501|453623435|FG000|Overall Study|Lost to Follow Up|0|||
126089860|NCT03829501|453623436|FG001|Overall Study|Lost to Follow Up|0|||
126089861|NCT03829501|453623437|FG002|Overall Study|Lost to Follow Up|0|||
126089862|NCT03829501|453623438|FG003|Overall Study|Lost to Follow Up|0|||
126089863|NCT03829501|453623439|FG004|Overall Study|Lost to Follow Up|1|||
126089864|NCT03829501|453623440|FG005|Overall Study|Lost to Follow Up|0|||
126089865|NCT03829501|453623441|FG006|Overall Study|Lost to Follow Up|0|||
126089866|NCT03829501|453623442|FG007|Overall Study|Lost to Follow Up|2|||
126089867|NCT03829501|453623443|FG008|Overall Study|Lost to Follow Up|2|||
126089868|NCT03829501|453623444|FG009|Overall Study|Lost to Follow Up|0|||
126089869|NCT03829501|453623445|FG010|Overall Study|Lost to Follow Up|2|||
126089870|NCT03829501|453623446|FG011|Overall Study|Lost to Follow Up|1|||
126089871|NCT03829501|453623447|FG012|Overall Study|Lost to Follow Up|0|||
126089872|NCT03829501|453623448|FG013|Overall Study|Lost to Follow Up|1|||
126089873|NCT03829501|453623449|FG014|Overall Study|Lost to Follow Up|1|||
126089874|NCT03829501|453623450|FG015|Overall Study|Lost to Follow Up|0|||
126089875|NCT03829501|453623451|FG016|Overall Study|Lost to Follow Up|0|||
126089876|NCT03829501|453623452|FG017|Overall Study|Lost to Follow Up|0|||
126089877|NCT03829501|453623453|FG018|Overall Study|Lost to Follow Up|0|||
126089878|NCT03829501|453623454|FG019|Overall Study|Lost to Follow Up|0|||
126089879|NCT03829501|453623455|FG020|Overall Study|Lost to Follow Up|0|||
126089880|NCT03829501|453623456|FG021|Overall Study|Lost to Follow Up|0|||
126089881|NCT03829501|453623457|FG022|Overall Study|Lost to Follow Up|1|||
126089882|NCT03829501|453623435|FG000|Overall Study|Death|2|||
126089883|NCT03829501|453623436|FG001|Overall Study|Death|4|||
126089884|NCT03829501|453623437|FG002|Overall Study|Death|5|||
126089885|NCT03829501|453623438|FG003|Overall Study|Death|6|||
126089886|NCT03829501|453623439|FG004|Overall Study|Death|5|||
126089887|NCT03829501|453623440|FG005|Overall Study|Death|4|||
126089888|NCT03829501|453623441|FG006|Overall Study|Death|5|||
126089889|NCT03829501|453623442|FG007|Overall Study|Death|24|||
126089890|NCT03829501|453623443|FG008|Overall Study|Death|22|||
126089891|NCT03829501|453623444|FG009|Overall Study|Death|6|||
126089892|NCT03829501|453623445|FG010|Overall Study|Death|3|||
126089893|NCT03829501|453623446|FG011|Overall Study|Death|10|||
126089894|NCT03829501|453623447|FG012|Overall Study|Death|10|||
126089895|NCT03829501|453623448|FG013|Overall Study|Death|5|||
126089896|NCT03829501|453623449|FG014|Overall Study|Death|7|||
126089897|NCT03829501|453623450|FG015|Overall Study|Death|2|||
126089898|NCT03829501|453623451|FG016|Overall Study|Death|2|||
126089899|NCT03829501|453623452|FG017|Overall Study|Death|1|||
126089900|NCT03829501|453623453|FG018|Overall Study|Death|1|||
126089901|NCT03829501|453623454|FG019|Overall Study|Death|1|||
126089902|NCT03829501|453623455|FG020|Overall Study|Death|1|||
126089903|NCT03829501|453623456|FG021|Overall Study|Death|2|||
126089904|NCT03829501|453623457|FG022|Overall Study|Death|3|||
126089905|NCT03829501|453623435|FG000|Overall Study|Miscellaneous|0|||
126089906|NCT03829501|453623436|FG001|Overall Study|Miscellaneous|0|||
126089907|NCT03829501|453623437|FG002|Overall Study|Miscellaneous|1|||
126089908|NCT03829501|453623438|FG003|Overall Study|Miscellaneous|0|||
126089909|NCT03829501|453623439|FG004|Overall Study|Miscellaneous|0|||
126089910|NCT03829501|453623440|FG005|Overall Study|Miscellaneous|0|||
126089911|NCT03829501|453623441|FG006|Overall Study|Miscellaneous|0|||
126089912|NCT03829501|453623442|FG007|Overall Study|Miscellaneous|1|||
126089913|NCT03829501|453623443|FG008|Overall Study|Miscellaneous|0|||
126089914|NCT03829501|453623444|FG009|Overall Study|Miscellaneous|0|||
126089915|NCT03829501|453623445|FG010|Overall Study|Miscellaneous|0|||
126089916|NCT03829501|453623446|FG011|Overall Study|Miscellaneous|0|||
126089917|NCT03829501|453623447|FG012|Overall Study|Miscellaneous|0|||
126089918|NCT03829501|453623448|FG013|Overall Study|Miscellaneous|0|||
126089919|NCT03829501|453623449|FG014|Overall Study|Miscellaneous|0|||
126089920|NCT03829501|453623450|FG015|Overall Study|Miscellaneous|0|||
126089921|NCT03829501|453623451|FG016|Overall Study|Miscellaneous|0|||
126089922|NCT03829501|453623452|FG017|Overall Study|Miscellaneous|0|||
126089923|NCT03829501|453623453|FG018|Overall Study|Miscellaneous|0|||
126089924|NCT03829501|453623454|FG019|Overall Study|Miscellaneous|0|||
126089925|NCT03829501|453623455|FG020|Overall Study|Miscellaneous|0|||
126089926|NCT03829501|453623456|FG021|Overall Study|Miscellaneous|0|||
126089927|NCT03829501|453623457|FG022|Overall Study|Miscellaneous|1|||
126089928|NCT01123070|453623458|FG000|Part B Double Blind Period|Protocol Violation|0|||
126089929|NCT01123070|453623459|FG001|Part B Double Blind Period|Protocol Violation|0|||
126089930|NCT01123070|453623460|FG002|Part B Double Blind Period|Protocol Violation|0|||
126089931|NCT01123070|453623461|FG003|Part B Double Blind Period|Protocol Violation|1|||
126089932|NCT01123070|453623458|FG000|Part B Double Blind Period|Adverse Event|0|||
126089933|NCT01123070|453623459|FG001|Part B Double Blind Period|Adverse Event|0|||
126089934|NCT01123070|453623460|FG002|Part B Double Blind Period|Adverse Event|2|||
126089935|NCT01123070|453623461|FG003|Part B Double Blind Period|Adverse Event|0|||
126089936|NCT01123070|453623458|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
126089937|NCT01123070|453623459|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
126089938|NCT01123070|453623460|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
126089939|NCT01123070|453623461|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
126089940|NCT03284229|453623462|FG000|Overall Study|Lost to Follow-up|3|||
126089941|NCT01332630|453623463|FG000|Overall Study|Withdrawal by Subject|3|||
126089942|NCT03140280|453623464|FG000|Overall Study|Physician Decision|5|||
126089943|NCT01977677|453623477|FG000|Overall Study|Unrelated Adverse Event|0|||
126089944|NCT01977677|453623478|FG001|Overall Study|Unrelated Adverse Event|0|||
126089945|NCT01977677|453623479|FG002|Overall Study|Unrelated Adverse Event|1|||
126089946|NCT01498887|453623480|FG000|Overall Study|Administrative problems|1|||
126203263|NCT01519700|454030867|FG001|Overall Study|Physician Decision|1|||
126203264|NCT01519700|454030868|FG002|Overall Study|Physician Decision|3|||
126089947|NCT01498887|453623481|FG001|Overall Study|Administrative problems|0|||
126089948|NCT01498887|453623480|FG000|Overall Study|Lost to Follow-up|1|||
126089949|NCT01498887|453623481|FG001|Overall Study|Lost to Follow-up|1|||
126089950|NCT01498887|453623480|FG000|Overall Study|Withdrawal by Subject|1|||
126089951|NCT01498887|453623481|FG001|Overall Study|Withdrawal by Subject|0|||
126089952|NCT01498887|453623480|FG000|Overall Study|Protocol Violation|1|||
126203265|NCT01519700|454030869|FG003|Overall Study|Physician Decision|0|||
126203266|NCT01519700|454030866|FG000|Overall Study|Withdrawal by Subject|5|||
126203267|NCT01519700|454030867|FG001|Overall Study|Withdrawal by Subject|3|||
126203268|NCT01519700|454030868|FG002|Overall Study|Withdrawal by Subject|3|||
126203269|NCT01519700|454030869|FG003|Overall Study|Withdrawal by Subject|2|||
126203270|NCT01519700|454030866|FG000|Overall Study|Other Reason|2|||
126203271|NCT01519700|454030867|FG001|Overall Study|Other Reason|2|||
126203272|NCT01519700|454030868|FG002|Overall Study|Other Reason|0|||
126203273|NCT01519700|454030869|FG003|Overall Study|Other Reason|4|||
126203274|NCT01789476|454030879|FG000|Overall Study|Lack of Efficacy|6|||
126203275|NCT01789476|454030880|FG001|Overall Study|Lack of Efficacy|2|||
126203276|NCT01789476|454030879|FG000|Overall Study|Adverse Event|1|||
126203277|NCT01789476|454030880|FG001|Overall Study|Adverse Event|0|||
126203278|NCT01789476|454030879|FG000|Overall Study|Unable to get IV access|1|||
126203279|NCT01789476|454030880|FG001|Overall Study|Unable to get IV access|0|||
126203280|NCT00965458|454030881|FG000|Overall Study|Adverse Event|1|||
126203281|NCT00965458|454030882|FG001|Overall Study|Adverse Event|0|||
126203282|NCT00965458|454030881|FG000|Overall Study|Lost to Follow-up|1|||
126089953|NCT01498887|453623481|FG001|Overall Study|Protocol Violation|3|||
126089954|NCT01498887|453623480|FG000|Overall Study|Lack of Efficacy|5|||
126089955|NCT01498887|453623481|FG001|Overall Study|Lack of Efficacy|3|||
126089956|NCT01498887|453623480|FG000|Overall Study|Abnormal result from test procedure|1|||
126089957|NCT01498887|453623481|FG001|Overall Study|Abnormal result from test procedure|1|||
126089958|NCT01498887|453623480|FG000|Overall Study|Abnormal laboratory value|2|||
126089959|NCT01498887|453623481|FG001|Overall Study|Abnormal laboratory value|2|||
126089960|NCT01498887|453623480|FG000|Overall Study|Adverse Event|4|||
126089961|NCT01498887|453623481|FG001|Overall Study|Adverse Event|1|||
126089962|NCT00667225|453623484|FG000|Overall Study|Subject had no more lesions to treat.|1|||
126089963|NCT00667225|453623485|FG001|Overall Study|Subject had no more lesions to treat.|0|||
126089964|NCT00667225|453623484|FG000|Overall Study|Lost to Follow-up|0|||
126089965|NCT00667225|453623485|FG001|Overall Study|Lost to Follow-up|1|||
126089966|NCT02993406|453623486|FG000|Overall Study|Withdrawal by Subject|170|||
126089967|NCT02993406|453623487|FG001|Overall Study|Withdrawal by Subject|196|||
126089968|NCT02993406|453623486|FG000|Overall Study|Physician Decision|3|||
126089969|NCT02993406|453623487|FG001|Overall Study|Physician Decision|5|||
126089970|NCT02993406|453623486|FG000|Overall Study|Lost to Follow-up|12|||
126089971|NCT02993406|453623487|FG001|Overall Study|Lost to Follow-up|13|||
126203283|NCT00965458|454030882|FG001|Overall Study|Lost to Follow-up|3|||
126203284|NCT00965458|454030881|FG000|Overall Study|Withdrawal by Subject|0|||
126203285|NCT00965458|454030882|FG001|Overall Study|Withdrawal by Subject|1|||
126089972|NCT02993406|453623486|FG000|Overall Study|Unclassifiable Response|105|||
126089973|NCT02993406|453623487|FG001|Overall Study|Unclassifiable Response|139|||
126089974|NCT02993406|453623486|FG000|Overall Study|Administrative decision|1|||
126089975|NCT02993406|453623487|FG001|Overall Study|Administrative decision|0|||
126089976|NCT02993406|453623486|FG000|Overall Study|Sponsor decision|4|||
126089977|NCT02993406|453623487|FG001|Overall Study|Sponsor decision|5|||
126089978|NCT02248818|453623488|FG000|Screening|Protocol Violation|0|||
126089979|NCT02248818|453623489|FG001|Screening|Protocol Violation|0|||
126089980|NCT02248818|453623490|FG002|Screening|Protocol Violation|0|||
126089981|NCT02248818|453623491|FG003|Screening|Protocol Violation|0|||
126089982|NCT02248818|453623492|FG004|Screening|Protocol Violation|0|||
126089983|NCT02248818|453623493|FG005|Screening|Protocol Violation|0|||
126089984|NCT02248818|453623494|FG006|Screening|Protocol Violation|0|||
126089985|NCT02248818|453623495|FG007|Screening|Protocol Violation|0|||
126089986|NCT02248818|453623496|FG008|Screening|Protocol Violation|7|||
126089987|NCT02248818|453623488|FG000|Screening|Study fully enrolled|0|||
126089988|NCT02248818|453623489|FG001|Screening|Study fully enrolled|0|||
126089989|NCT02248818|453623490|FG002|Screening|Study fully enrolled|0|||
126089990|NCT02248818|453623491|FG003|Screening|Study fully enrolled|0|||
126089991|NCT02248818|453623492|FG004|Screening|Study fully enrolled|0|||
126089992|NCT02248818|453623493|FG005|Screening|Study fully enrolled|0|||
126089993|NCT02248818|453623494|FG006|Screening|Study fully enrolled|0|||
126203286|NCT04177862|454030889|FG000|Overall Study|Protocol Violation|2|||
126089994|NCT02248818|453623495|FG007|Screening|Study fully enrolled|0|||
126089995|NCT02248818|453623496|FG008|Screening|Study fully enrolled|14|||
126089996|NCT02248818|453623488|FG000|Screening|Physician Decision|0|||
126089997|NCT02248818|453623489|FG001|Screening|Physician Decision|0|||
126089998|NCT02248818|453623490|FG002|Screening|Physician Decision|0|||
126089999|NCT02248818|453623491|FG003|Screening|Physician Decision|0|||
126090000|NCT02248818|453623492|FG004|Screening|Physician Decision|0|||
126090001|NCT02248818|453623493|FG005|Screening|Physician Decision|0|||
126090002|NCT02248818|453623494|FG006|Screening|Physician Decision|0|||
126090003|NCT02248818|453623495|FG007|Screening|Physician Decision|0|||
126203287|NCT04177862|454030890|FG001|Overall Study|Protocol Violation|7|||
126203288|NCT00379639|454030891|FG000|Overall Study|Disease Progression|3|||
126203289|NCT00379639|454030892|FG001|Overall Study|Disease Progression|3|||
126203290|NCT00379639|454030893|FG002|Overall Study|Disease Progression|3|||
126203291|NCT00379639|454030894|FG003|Overall Study|Disease Progression|4|||
126203292|NCT00379639|454030895|FG004|Overall Study|Disease Progression|4|||
126090004|NCT02248818|453623496|FG008|Screening|Physician Decision|73|||
126090005|NCT02248818|453623488|FG000|Screening|Withdrawal by Subject|0|||
126090006|NCT02248818|453623489|FG001|Screening|Withdrawal by Subject|0|||
126090007|NCT02248818|453623490|FG002|Screening|Withdrawal by Subject|0|||
126090008|NCT02248818|453623491|FG003|Screening|Withdrawal by Subject|0|||
126090009|NCT02248818|453623492|FG004|Screening|Withdrawal by Subject|0|||
126090010|NCT02248818|453623493|FG005|Screening|Withdrawal by Subject|0|||
126090011|NCT02248818|453623494|FG006|Screening|Withdrawal by Subject|0|||
126090012|NCT02248818|453623495|FG007|Screening|Withdrawal by Subject|0|||
126090013|NCT02248818|453623496|FG008|Screening|Withdrawal by Subject|6|||
126090014|NCT02248818|453623488|FG000|Screening|Lost to Follow-up|0|||
126090015|NCT02248818|453623489|FG001|Screening|Lost to Follow-up|0|||
126090016|NCT02248818|453623490|FG002|Screening|Lost to Follow-up|0|||
126090017|NCT02248818|453623491|FG003|Screening|Lost to Follow-up|0|||
126090018|NCT02248818|453623492|FG004|Screening|Lost to Follow-up|0|||
126090019|NCT02248818|453623493|FG005|Screening|Lost to Follow-up|0|||
126090020|NCT02248818|453623494|FG006|Screening|Lost to Follow-up|0|||
126090021|NCT02248818|453623495|FG007|Screening|Lost to Follow-up|0|||
126090022|NCT02248818|453623496|FG008|Screening|Lost to Follow-up|7|||
126090023|NCT02248818|453623488|FG000|Randomised Study|Administrative - randomization error|0|||
126090024|NCT02248818|453623489|FG001|Randomised Study|Administrative - randomization error|0|||
126203293|NCT00379639|454030891|FG000|Overall Study|Physician Decision|0|||
126203294|NCT00379639|454030892|FG001|Overall Study|Physician Decision|2|||
126203295|NCT00379639|454030893|FG002|Overall Study|Physician Decision|1|||
126203296|NCT00379639|454030894|FG003|Overall Study|Physician Decision|1|||
126203297|NCT00379639|454030895|FG004|Overall Study|Physician Decision|0|||
126203298|NCT00379639|454030891|FG000|Overall Study|Symptomatic Deterioration|0|||
126203299|NCT00379639|454030892|FG001|Overall Study|Symptomatic Deterioration|0|||
126203300|NCT00379639|454030893|FG002|Overall Study|Symptomatic Deterioration|1|||
126203301|NCT00379639|454030894|FG003|Overall Study|Symptomatic Deterioration|0|||
126203302|NCT00379639|454030895|FG004|Overall Study|Symptomatic Deterioration|1|||
126203303|NCT00379639|454030891|FG000|Overall Study|Adverse Event|0|||
126203304|NCT00379639|454030892|FG001|Overall Study|Adverse Event|0|||
126203305|NCT00379639|454030893|FG002|Overall Study|Adverse Event|1|||
126203306|NCT00379639|454030894|FG003|Overall Study|Adverse Event|0|||
126203307|NCT00379639|454030895|FG004|Overall Study|Adverse Event|1|||
126203308|NCT00379639|454030891|FG000|Overall Study|Lost to Follow-up|0|||
126203309|NCT00379639|454030892|FG001|Overall Study|Lost to Follow-up|0|||
126203310|NCT00379639|454030893|FG002|Overall Study|Lost to Follow-up|0|||
126203311|NCT00379639|454030894|FG003|Overall Study|Lost to Follow-up|1|||
126203312|NCT00379639|454030895|FG004|Overall Study|Lost to Follow-up|0|||
126203313|NCT00379639|454030891|FG000|Overall Study|Other|0|||
126203314|NCT00379639|454030892|FG001|Overall Study|Other|0|||
126203315|NCT00379639|454030893|FG002|Overall Study|Other|3|||
126203316|NCT00379639|454030894|FG003|Overall Study|Other|0|||
126203317|NCT00379639|454030895|FG004|Overall Study|Other|0|||
126203318|NCT00594958|454030896|FG000|Overall Study|Withdrawal by Subject|1|||
126203319|NCT00594958|454030897|FG001|Overall Study|Withdrawal by Subject|0|||
126203320|NCT00594958|454030898|FG002|Overall Study|Withdrawal by Subject|1|||
126203321|NCT00594958|454030896|FG000|Overall Study|Adverse Event|4|||
126203322|NCT00594958|454030897|FG001|Overall Study|Adverse Event|1|||
126203323|NCT00594958|454030898|FG002|Overall Study|Adverse Event|2|||
126203324|NCT00594958|454030896|FG000|Overall Study|Pregnancy|0|||
126203325|NCT00594958|454030897|FG001|Overall Study|Pregnancy|2|||
126203326|NCT00594958|454030898|FG002|Overall Study|Pregnancy|0|||
126203327|NCT00594958|454030896|FG000|Overall Study|Protocol Violation|1|||
126203328|NCT00594958|454030897|FG001|Overall Study|Protocol Violation|0|||
126203329|NCT00594958|454030898|FG002|Overall Study|Protocol Violation|2|||
126203330|NCT00594958|454030896|FG000|Overall Study|Lost to Follow-up|5|||
126203331|NCT00594958|454030897|FG001|Overall Study|Lost to Follow-up|0|||
126090025|NCT02248818|453623490|FG002|Randomised Study|Administrative - randomization error|0|||
126203332|NCT00594958|454030898|FG002|Overall Study|Lost to Follow-up|3|||
126203333|NCT00594958|454030896|FG000|Overall Study|administrative|3|||
126203334|NCT00594958|454030897|FG001|Overall Study|administrative|0|||
126203335|NCT00594958|454030898|FG002|Overall Study|administrative|2|||
126203336|NCT05637515|454030899|FG000|Overall Study|Withdrawal by Subject|17|||
126203337|NCT05637515|454030900|FG001|Overall Study|Withdrawal by Subject|17|||
126203338|NCT03233009|454030901|FG000|Overall Study|Lost to Follow-up|1|||
126203339|NCT00278473|454030903|FG000|Overall Study|drop out|4|||
126203340|NCT00278473|454030904|FG001|Overall Study|drop out|3|||
126203341|NCT03039686|454030905|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
126203342|NCT03039686|454030906|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
126203343|NCT03039686|454030907|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
126203344|NCT03039686|454030905|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
126203345|NCT03039686|454030906|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
126203346|NCT03039686|454030907|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
126203347|NCT03039686|454030905|FG000|Double-blind Period|Withdrawal by Subject|2|||
126203348|NCT03039686|454030906|FG001|Double-blind Period|Withdrawal by Subject|2|||
126203349|NCT03039686|454030907|FG002|Double-blind Period|Withdrawal by Subject|1|||
126203350|NCT03039686|454030905|FG000|Double-blind Period|Death|0|||
126203351|NCT03039686|454030906|FG001|Double-blind Period|Death|0|||
126203352|NCT03039686|454030907|FG002|Double-blind Period|Death|1|||
126203353|NCT03039686|454030905|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
126203354|NCT03039686|454030906|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
126203355|NCT03039686|454030907|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
126203356|NCT03039686|454030905|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
126203357|NCT03039686|454030906|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
126203358|NCT03039686|454030907|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
126203359|NCT03039686|454030905|FG000|Open Label Period|Withdrawal by Subject|0|||
126203360|NCT03039686|454030906|FG001|Open Label Period|Withdrawal by Subject|3|||
126203361|NCT03039686|454030907|FG002|Open Label Period|Withdrawal by Subject|1|||
126203362|NCT02158949|454030908|FG000|Overall Study|Withdrawal by Subject|1|||
126203363|NCT02158949|454030909|FG001|Overall Study|Withdrawal by Subject|0|||
126203364|NCT02158949|454030908|FG000|Overall Study|Lost to Follow-up|5|||
126203365|NCT02158949|454030909|FG001|Overall Study|Lost to Follow-up|11|||
126203366|NCT02322866|454030910|FG000|Overall Study|Adverse Event|6|||
126203367|NCT02322866|454030911|FG001|Overall Study|Adverse Event|11|||
126203368|NCT02322866|454030910|FG000|Overall Study|Withdrawal of Consent|16|||
126203369|NCT02322866|454030911|FG001|Overall Study|Withdrawal of Consent|25|||
126203370|NCT02322866|454030910|FG000|Overall Study|Lost to Follow-up|36|||
126203371|NCT02322866|454030911|FG001|Overall Study|Lost to Follow-up|39|||
126203372|NCT02322866|454030910|FG000|Overall Study|Protocol Violation|1|||
126203373|NCT02322866|454030911|FG001|Overall Study|Protocol Violation|0|||
126203374|NCT02322866|454030910|FG000|Overall Study|Noncompliance with Treatment|3|||
126203375|NCT02322866|454030911|FG001|Overall Study|Noncompliance with Treatment|4|||
126203376|NCT02322866|454030910|FG000|Overall Study|Lack of Efficacy|3|||
126203377|NCT02322866|454030911|FG001|Overall Study|Lack of Efficacy|1|||
126203378|NCT02322866|454030910|FG000|Overall Study|Other Miscellaneous Reasons|6|||
126203379|NCT02322866|454030911|FG001|Overall Study|Other Miscellaneous Reasons|6|||
126203380|NCT02079077|454030916|FG000|Overall Study|Lost to Follow-up|5|||
126203381|NCT02079077|454030917|FG001|Overall Study|Lost to Follow-up|7|||
126203382|NCT02079077|454030916|FG000|Overall Study|Became STIs Positive|1|||
126203383|NCT02079077|454030917|FG001|Overall Study|Became STIs Positive|2|||
126203384|NCT00772031|454030919|FG000|Overall Study|Early termination of trial|12|||
126203385|NCT00772031|454030920|FG001|Overall Study|Early termination of trial|10|||
126203386|NCT00772031|454030919|FG000|Overall Study|Lost to Follow-up|20|||
126203387|NCT00772031|454030920|FG001|Overall Study|Lost to Follow-up|33|||
126203388|NCT00656136|454030924|FG000|Overall Study|Progressive disease|177|||
126203389|NCT00656136|454030925|FG001|Overall Study|Progressive disease|322|||
126203390|NCT00656136|454030924|FG000|Overall Study|Other Adverse Event|5|||
126203391|NCT00656136|454030925|FG001|Overall Study|Other Adverse Event|51|||
126203392|NCT00656136|454030924|FG000|Overall Study|Protocol Violation|2|||
126203393|NCT00656136|454030925|FG001|Overall Study|Protocol Violation|3|||
126203394|NCT00656136|454030924|FG000|Overall Study|Patient refused to take study medication|7|||
126203395|NCT00656136|454030925|FG001|Overall Study|Patient refused to take study medication|10|||
126203396|NCT00656136|454030924|FG000|Overall Study|Unknown and others|4|||
126203397|NCT00656136|454030925|FG001|Overall Study|Unknown and others|4|||
126203398|NCT02505945|454030926|FG000|Overall Study|Withdrawal by Subject|13|||
126203399|NCT02505945|454030927|FG001|Overall Study|Withdrawal by Subject|2|||
126203400|NCT02505945|454030926|FG000|Overall Study|Adverse Event|1|||
126203401|NCT02505945|454030927|FG001|Overall Study|Adverse Event|0|||
126203402|NCT02505945|454030926|FG000|Overall Study|Physician Decision|2|||
126203403|NCT02505945|454030927|FG001|Overall Study|Physician Decision|1|||
126203404|NCT02505945|454030926|FG000|Overall Study|Lost to Follow-up|6|||
126203405|NCT02505945|454030927|FG001|Overall Study|Lost to Follow-up|1|||
126203406|NCT00635804|454030928|FG000|Overall Study|Adverse Event|0|||
126203407|NCT00635804|454030929|FG001|Overall Study|Adverse Event|0|||
126313548|NCT02548351|454437673|FG002|Overall Study|Other|20|||
126313549|NCT02548351|454437671|FG000|Overall Study|Missing|1|||
126203408|NCT00635804|454030930|FG002|Overall Study|Adverse Event|0|||
126203409|NCT00635804|454030931|FG003|Overall Study|Adverse Event|0|||
126313550|NCT02548351|454437672|FG001|Overall Study|Missing|1|||
126313551|NCT02548351|454437673|FG002|Overall Study|Missing|0|||
126313552|NCT00125242|454437677|FG000|Overall Study|did not qualify|7|||
126313553|NCT00125242|454437678|FG001|Overall Study|did not qualify|2|||
126313554|NCT01664949|454437679|FG000|Overall Study|Adverse Event|11|||
126313555|NCT01664949|454437680|FG001|Overall Study|Adverse Event|12|||
126313556|NCT01664949|454437679|FG000|Overall Study|Lack of Efficacy|1|||
126313557|NCT01664949|454437680|FG001|Overall Study|Lack of Efficacy|1|||
126313558|NCT01664949|454437679|FG000|Overall Study|Lost to Follow-up|1|||
126313559|NCT01664949|454437680|FG001|Overall Study|Lost to Follow-up|2|||
126313560|NCT01664949|454437679|FG000|Overall Study|Personal Reasons|3|||
126313561|NCT01664949|454437680|FG001|Overall Study|Personal Reasons|4|||
126313562|NCT01664949|454437679|FG000|Overall Study|Protocol Violation|5|||
126313563|NCT01664949|454437680|FG001|Overall Study|Protocol Violation|5|||
126313564|NCT01664949|454437679|FG000|Overall Study|Other Miscellaneous Reasons|3|||
126313565|NCT01664949|454437680|FG001|Overall Study|Other Miscellaneous Reasons|1|||
126313566|NCT03003494|454437681|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
126313567|NCT05238025|454437682|FG000|Overall Study|Adverse Event|2|||
126313568|NCT05238025|454437683|FG001|Overall Study|Adverse Event|2|||
126313569|NCT05238025|454437682|FG000|Overall Study|Lost to Follow-up|334|||
126313570|NCT05238025|454437683|FG001|Overall Study|Lost to Follow-up|339|||
126313571|NCT05238025|454437682|FG000|Overall Study|Withdrawal by Subject|203|||
126313572|NCT05238025|454437683|FG001|Overall Study|Withdrawal by Subject|222|||
126313573|NCT05238025|454437682|FG000|Overall Study|Physician Decision|20|||
126313574|NCT05238025|454437683|FG001|Overall Study|Physician Decision|8|||
126313575|NCT05238025|454437682|FG000|Overall Study|Protocol Violation|6|||
126313576|NCT05238025|454437683|FG001|Overall Study|Protocol Violation|2|||
126313577|NCT05238025|454437682|FG000|Overall Study|Death|38|||
126313578|NCT05238025|454437683|FG001|Overall Study|Death|32|||
126313579|NCT05238025|454437682|FG000|Overall Study|Study terminated by Sponsor|6358|||
126313580|NCT05238025|454437683|FG001|Overall Study|Study terminated by Sponsor|6358|||
126313581|NCT05238025|454437682|FG000|Overall Study|Other Reason|669|||
126313582|NCT05238025|454437683|FG001|Overall Study|Other Reason|690|||
126313583|NCT03814720|454437685|FG000|Overall Study|Lost to Follow-up|0|||
126313584|NCT03814720|454437686|FG001|Overall Study|Lost to Follow-up|1|||
126313585|NCT03814720|454437687|FG002|Overall Study|Lost to Follow-up|0|||
126313586|NCT03814720|454437688|FG003|Overall Study|Lost to Follow-up|0|||
126313587|NCT03814720|454437689|FG004|Overall Study|Lost to Follow-up|0|||
126313588|NCT03197324|454437690|FG000|Overall Study|Adverse Event|0|||
126313589|NCT03197324|454437691|FG001|Overall Study|Adverse Event|1|||
126313590|NCT01632150|454439251|FG000|Overall Study|Disease progression|27|||
126313591|NCT01632150|454439251|FG000|Overall Study|Study drug toxicity|1|||
126313592|NCT01632150|454439251|FG000|Overall Study|Unrelated adverse event|7|||
126313593|NCT01632150|454439251|FG000|Overall Study|Withdrawal by Subject|2|||
126313594|NCT01632150|454439251|FG000|Overall Study|Patient underwent autologous transplant|1|||
126313595|NCT01632150|454439251|FG000|Overall Study|Moved to compassionate program|2|||
126313596|NCT02339155|454439257|FG000|Overall Study|Adverse Event|0|||
126313597|NCT02339155|454439258|FG001|Overall Study|Adverse Event|6|||
126313598|NCT02339155|454439257|FG000|Overall Study|Death|1|||
126313599|NCT02339155|454439258|FG001|Overall Study|Death|1|||
126313600|NCT02339155|454439257|FG000|Overall Study|Lost to Follow-up|8|||
126313601|NCT02339155|454439258|FG001|Overall Study|Lost to Follow-up|9|||
126313602|NCT02339155|454439257|FG000|Overall Study|Physician Decision|2|||
126313603|NCT02339155|454439258|FG001|Overall Study|Physician Decision|1|||
126313604|NCT02339155|454439257|FG000|Overall Study|Withdrawal by Subject|4|||
126313605|NCT02339155|454439258|FG001|Overall Study|Withdrawal by Subject|4|||
126313606|NCT01214252|454439259|FG000|Overall Study|Not eligible per protocol|82|||
126313607|NCT04327661|454439262|FG000|Overall Study|Withdrawal by Subject|1|||
126313608|NCT04327661|454439263|FG001|Overall Study|Withdrawal by Subject|0|||
126313609|NCT04327661|454439264|FG002|Overall Study|Withdrawal by Subject|0|||
126313610|NCT01877551|454439267|FG000|Overall Study|Physician Decision|0|||
126313611|NCT01877551|454439268|FG001|Overall Study|Physician Decision|1|||
126313612|NCT02659514|454439271|FG000|Overall Study|Adverse Event|3|||
126313613|NCT02659514|454439272|FG001|Overall Study|Adverse Event|12|||
126313614|NCT02659514|454439271|FG000|Overall Study|Disease Progression|23|||
126313615|NCT02659514|454439272|FG001|Overall Study|Disease Progression|13|||
126313616|NCT02659514|454439271|FG000|Overall Study|Withdrawal by Subject|0|||
126313617|NCT02659514|454439272|FG001|Overall Study|Withdrawal by Subject|4|||
126313618|NCT02659514|454439271|FG000|Overall Study|Lost to Follow-up|0|||
126313619|NCT02659514|454439272|FG001|Overall Study|Lost to Follow-up|1|||
126313620|NCT02659514|454439271|FG000|Overall Study|Death|6|||
126313621|NCT02659514|454439272|FG001|Overall Study|Death|1|||
126313622|NCT02659514|454439271|FG000|Overall Study|Reason Unspecified|0|||
126313623|NCT02659514|454439272|FG001|Overall Study|Reason Unspecified|3|||
126313624|NCT01968707|454439278|FG000|Overall Study|Did not meet treatment day baseline|49|||
126313625|NCT01968707|454439279|FG001|Overall Study|Did not meet treatment day baseline|12|||
126313626|NCT01968707|454439280|FG002|Overall Study|Did not meet treatment day baseline|41|||
126313627|NCT01968707|454439281|FG003|Overall Study|Did not meet treatment day baseline|44|||
126313628|NCT01968707|454439282|FG004|Overall Study|Did not meet treatment day baseline|36|||
126203410|NCT00635804|454030932|FG004|Overall Study|Adverse Event|0|||
126203411|NCT00635804|454030933|FG005|Overall Study|Adverse Event|1|||
126203412|NCT00635804|454030934|FG006|Overall Study|Adverse Event|0|||
126203413|NCT00635804|454030935|FG007|Overall Study|Adverse Event|0|||
126203414|NCT00635804|454030928|FG000|Overall Study|Withdrawal by Subject|1|||
126203415|NCT00635804|454030929|FG001|Overall Study|Withdrawal by Subject|0|||
126090026|NCT02248818|453623491|FG003|Randomised Study|Administrative - randomization error|0|||
126090027|NCT02248818|453623492|FG004|Randomised Study|Administrative - randomization error|0|||
126203416|NCT00635804|454030930|FG002|Overall Study|Withdrawal by Subject|0|||
126203417|NCT00635804|454030931|FG003|Overall Study|Withdrawal by Subject|0|||
126203418|NCT00635804|454030932|FG004|Overall Study|Withdrawal by Subject|0|||
126203419|NCT00635804|454030933|FG005|Overall Study|Withdrawal by Subject|0|||
126203420|NCT00635804|454030934|FG006|Overall Study|Withdrawal by Subject|0|||
126203421|NCT00635804|454030935|FG007|Overall Study|Withdrawal by Subject|0|||
126203422|NCT02718131|454030936|FG000|Overall Study|Withdrawal by Subject|1|||
126203423|NCT02718131|454030937|FG001|Overall Study|Withdrawal by Subject|0|||
126203424|NCT02718131|454030936|FG000|Overall Study|Adverse Event|1|||
126090028|NCT02248818|453623493|FG005|Randomised Study|Administrative - randomization error|8|||
126090029|NCT02248818|453623494|FG006|Randomised Study|Administrative - randomization error|0|||
126090030|NCT02248818|453623495|FG007|Randomised Study|Administrative - randomization error|0|||
126090031|NCT02248818|453623496|FG008|Randomised Study|Administrative - randomization error|0|||
126090032|NCT05262517|453623497|FG000|Overall Study|Randomized but not treated|5|||
126090033|NCT05262517|453623498|FG001|Overall Study|Randomized but not treated|11|||
126090034|NCT04325282|453623499|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
126090035|NCT04325282|453623500|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
126090036|NCT04325282|453623499|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
126090037|NCT04325282|453623500|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
126090038|NCT00527787|453623502|FG000|Overall Study|Adverse Event|14|||
126090039|NCT00527787|453623503|FG001|Overall Study|Adverse Event|24|||
126090040|NCT00527787|453623502|FG000|Overall Study|Withdrawal by Subject|13|||
126090041|NCT00527787|453623503|FG001|Overall Study|Withdrawal by Subject|25|||
126090042|NCT00527787|453623502|FG000|Overall Study|Lost to Follow-up|5|||
126090043|NCT00527787|453623503|FG001|Overall Study|Lost to Follow-up|2|||
126090044|NCT00527787|453623502|FG000|Overall Study|Duodenal Ulcer|1|||
126090045|NCT00527787|453623503|FG001|Overall Study|Duodenal Ulcer|10|||
126090046|NCT00527787|453623502|FG000|Overall Study|misc|5|||
126090047|NCT00527787|453623503|FG001|Overall Study|misc|2|||
126090048|NCT03330405|453623504|FG000|Overall Study|Other|1|||
126090049|NCT03330405|453623505|FG001|Overall Study|Other|3|||
126090050|NCT03330405|453623506|FG002|Overall Study|Other|1|||
126090051|NCT03330405|453623507|FG003|Overall Study|Other|0|||
126090052|NCT03330405|453623508|FG004|Overall Study|Other|2|||
126090053|NCT03330405|453623509|FG005|Overall Study|Other|0|||
126090054|NCT03330405|453623510|FG006|Overall Study|Other|1|||
126090055|NCT03330405|453623511|FG007|Overall Study|Other|0|||
126090056|NCT03330405|453623512|FG008|Overall Study|Other|0|||
126090057|NCT03330405|453623513|FG009|Overall Study|Other|0|||
126090058|NCT03330405|453623514|FG010|Overall Study|Other|0|||
126090059|NCT03330405|453623504|FG000|Overall Study|Progressive disease|8|||
126090060|NCT03330405|453623505|FG001|Overall Study|Progressive disease|27|||
126090061|NCT03330405|453623506|FG002|Overall Study|Progressive disease|4|||
126090062|NCT03330405|453623507|FG003|Overall Study|Progressive disease|18|||
126090063|NCT03330405|453623508|FG004|Overall Study|Progressive disease|16|||
126090064|NCT03330405|453623509|FG005|Overall Study|Progressive disease|14|||
126090065|NCT03330405|453623510|FG006|Overall Study|Progressive disease|7|||
126090066|NCT03330405|453623511|FG007|Overall Study|Progressive disease|29|||
126090067|NCT03330405|453623512|FG008|Overall Study|Progressive disease|9|||
126090068|NCT03330405|453623513|FG009|Overall Study|Progressive disease|11|||
126090069|NCT03330405|453623514|FG010|Overall Study|Progressive disease|5|||
126090070|NCT03330405|453623504|FG000|Overall Study|Withdrawal by Subject|1|||
126090071|NCT03330405|453623505|FG001|Overall Study|Withdrawal by Subject|4|||
126090072|NCT03330405|453623506|FG002|Overall Study|Withdrawal by Subject|0|||
126090073|NCT03330405|453623507|FG003|Overall Study|Withdrawal by Subject|1|||
126090074|NCT03330405|453623508|FG004|Overall Study|Withdrawal by Subject|1|||
126090075|NCT03330405|453623509|FG005|Overall Study|Withdrawal by Subject|1|||
126313629|NCT01968707|454439283|FG005|Overall Study|Did not meet treatment day baseline|11|||
126313630|NCT01968707|454439284|FG006|Overall Study|Did not meet treatment day baseline|34|||
126090076|NCT03330405|453623510|FG006|Overall Study|Withdrawal by Subject|0|||
126090077|NCT03330405|453623511|FG007|Overall Study|Withdrawal by Subject|2|||
126203425|NCT02718131|454030937|FG001|Overall Study|Adverse Event|0|||
126313631|NCT01968707|454439285|FG007|Overall Study|Did not meet treatment day baseline|35|||
126313632|NCT00916344|454439286|FG000|Overall Study|Death|2|||
126203426|NCT02718131|454030936|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
126203427|NCT02718131|454030937|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
126090078|NCT03330405|453623512|FG008|Overall Study|Withdrawal by Subject|2|||
126203428|NCT01097057|454030938|FG000|Overall Study|Physician Decision|3|||
126090079|NCT03330405|453623513|FG009|Overall Study|Withdrawal by Subject|1|||
126090080|NCT03330405|453623514|FG010|Overall Study|Withdrawal by Subject|1|||
126090081|NCT03330405|453623504|FG000|Overall Study|Global deterioration of health status|2|||
126090082|NCT03330405|453623505|FG001|Overall Study|Global deterioration of health status|3|||
126090083|NCT03330405|453623506|FG002|Overall Study|Global deterioration of health status|0|||
126090084|NCT03330405|453623507|FG003|Overall Study|Global deterioration of health status|2|||
126090085|NCT03330405|453623508|FG004|Overall Study|Global deterioration of health status|3|||
126090086|NCT03330405|453623509|FG005|Overall Study|Global deterioration of health status|3|||
126090087|NCT03330405|453623510|FG006|Overall Study|Global deterioration of health status|0|||
126090088|NCT03330405|453623511|FG007|Overall Study|Global deterioration of health status|2|||
126090089|NCT03330405|453623512|FG008|Overall Study|Global deterioration of health status|8|||
126090090|NCT03330405|453623513|FG009|Overall Study|Global deterioration of health status|4|||
126090091|NCT03330405|453623514|FG010|Overall Study|Global deterioration of health status|1|||
126090092|NCT03330405|453623504|FG000|Overall Study|Adverse Event|0|||
126090093|NCT03330405|453623505|FG001|Overall Study|Adverse Event|1|||
126090094|NCT03330405|453623506|FG002|Overall Study|Adverse Event|0|||
126090095|NCT03330405|453623507|FG003|Overall Study|Adverse Event|1|||
126090096|NCT03330405|453623508|FG004|Overall Study|Adverse Event|1|||
126090097|NCT03330405|453623509|FG005|Overall Study|Adverse Event|1|||
126090098|NCT03330405|453623510|FG006|Overall Study|Adverse Event|3|||
126090099|NCT03330405|453623511|FG007|Overall Study|Adverse Event|4|||
126090100|NCT03330405|453623512|FG008|Overall Study|Adverse Event|2|||
126090101|NCT03330405|453623513|FG009|Overall Study|Adverse Event|2|||
126090102|NCT03330405|453623514|FG010|Overall Study|Adverse Event|2|||
126090103|NCT03330405|453623504|FG000|Overall Study|Death|0|||
126090104|NCT03330405|453623505|FG001|Overall Study|Death|4|||
126090105|NCT03330405|453623506|FG002|Overall Study|Death|0|||
126090106|NCT03330405|453623507|FG003|Overall Study|Death|0|||
126090107|NCT03330405|453623508|FG004|Overall Study|Death|0|||
126090108|NCT03330405|453623509|FG005|Overall Study|Death|1|||
126090109|NCT03330405|453623510|FG006|Overall Study|Death|0|||
126090110|NCT03330405|453623511|FG007|Overall Study|Death|2|||
126090111|NCT03330405|453623512|FG008|Overall Study|Death|0|||
126090112|NCT03330405|453623513|FG009|Overall Study|Death|0|||
126090113|NCT03330405|453623514|FG010|Overall Study|Death|0|||
126090114|NCT03330405|453623504|FG000|Overall Study|Physician Decision|0|||
126090115|NCT03330405|453623505|FG001|Overall Study|Physician Decision|0|||
126090116|NCT03330405|453623506|FG002|Overall Study|Physician Decision|0|||
126090117|NCT03330405|453623507|FG003|Overall Study|Physician Decision|0|||
126090118|NCT03330405|453623508|FG004|Overall Study|Physician Decision|0|||
126090119|NCT03330405|453623509|FG005|Overall Study|Physician Decision|0|||
126090120|NCT03330405|453623510|FG006|Overall Study|Physician Decision|0|||
126090121|NCT03330405|453623511|FG007|Overall Study|Physician Decision|1|||
126090122|NCT03330405|453623512|FG008|Overall Study|Physician Decision|0|||
126090123|NCT03330405|453623513|FG009|Overall Study|Physician Decision|0|||
126090124|NCT03330405|453623514|FG010|Overall Study|Physician Decision|0|||
126090125|NCT02643303|453623515|FG000|Overall Study|Progressive Disease|4|||
126090126|NCT02643303|453623516|FG001|Overall Study|Progressive Disease|4|||
126090127|NCT02643303|453623517|FG002|Overall Study|Progressive Disease|1|||
126090128|NCT02643303|453623518|FG003|Overall Study|Progressive Disease|12|||
126090129|NCT02643303|453623519|FG004|Overall Study|Progressive Disease|6|||
126090130|NCT02643303|453623520|FG005|Overall Study|Progressive Disease|4|||
126090131|NCT02643303|453623521|FG006|Overall Study|Progressive Disease|8|||
126090132|NCT02643303|453623522|FG007|Overall Study|Progressive Disease|2|||
126090133|NCT02643303|453623523|FG008|Overall Study|Progressive Disease|6|||
126090134|NCT02643303|453623515|FG000|Overall Study|Adverse Event|0|||
126203429|NCT01101321|454030939|FG000|Period 1|Withdrawal by Subject|1|||
126203430|NCT01101321|454030940|FG001|Period 1|Withdrawal by Subject|1|||
126203431|NCT01101321|454030939|FG000|Period 1|Adverse Event|3|||
126203432|NCT01101321|454030940|FG001|Period 1|Adverse Event|3|||
126203433|NCT02681094|454030941|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
126203434|NCT02681094|454030942|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
126203435|NCT02681094|454030943|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
126203436|NCT02681094|454030941|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
126203437|NCT02681094|454030942|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
126203438|NCT02681094|454030943|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
126203439|NCT02681094|454030941|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
126203440|NCT02681094|454030942|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
126203441|NCT02681094|454030943|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
126313633|NCT00916344|454439286|FG000|Overall Study|ICD upgrade|1|||
126090135|NCT02643303|453623516|FG001|Overall Study|Adverse Event|1|||
126090136|NCT02643303|453623517|FG002|Overall Study|Adverse Event|0|||
126090137|NCT02643303|453623518|FG003|Overall Study|Adverse Event|0|||
126090138|NCT02643303|453623519|FG004|Overall Study|Adverse Event|1|||
126203442|NCT02681094|454030941|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
126090139|NCT02643303|453623520|FG005|Overall Study|Adverse Event|0|||
126090140|NCT02643303|453623521|FG006|Overall Study|Adverse Event|0|||
126203443|NCT02681094|454030942|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
126203444|NCT02681094|454030943|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
126203445|NCT02681094|454030941|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
126203446|NCT02681094|454030942|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
126203447|NCT02681094|454030943|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
126203448|NCT02681094|454030941|FG000|1 -Modified Enrolled Participants Set|Other|6|||
126203449|NCT02681094|454030942|FG001|1 -Modified Enrolled Participants Set|Other|6|||
126203450|NCT02681094|454030943|FG002|1 -Modified Enrolled Participants Set|Other|7|||
126203451|NCT02681094|454030941|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
126203452|NCT02681094|454030942|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
126203453|NCT02681094|454030943|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
126203454|NCT02681094|454030941|FG000|2 - Enrolled Participants Set|Participant decision|7|||
126203455|NCT02681094|454030942|FG001|2 - Enrolled Participants Set|Participant decision|10|||
126203456|NCT02681094|454030943|FG002|2 - Enrolled Participants Set|Participant decision|9|||
126203457|NCT02681094|454030941|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
126203458|NCT02681094|454030942|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
126203459|NCT02681094|454030943|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
126203460|NCT02681094|454030941|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
126203461|NCT02681094|454030942|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
126203462|NCT02681094|454030943|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
126203463|NCT02681094|454030941|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
126203464|NCT02681094|454030942|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
126203465|NCT02681094|454030943|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
126203466|NCT02681094|454030941|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
126203467|NCT02681094|454030942|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
126203468|NCT02681094|454030943|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
126203469|NCT02681094|454030941|FG000|2 - Enrolled Participants Set|Other|6|||
126203470|NCT02681094|454030942|FG001|2 - Enrolled Participants Set|Other|6|||
126203471|NCT02681094|454030943|FG002|2 - Enrolled Participants Set|Other|7|||
126203472|NCT02681094|454030941|FG000|2 - Enrolled Participants Set|No treatment given|0|||
126203473|NCT02681094|454030942|FG001|2 - Enrolled Participants Set|No treatment given|1|||
126203474|NCT02681094|454030943|FG002|2 - Enrolled Participants Set|No treatment given|1|||
126203475|NCT00310440|454030944|FG000|Overall Study|Lost to Follow-up|17|||
126203476|NCT00310440|454030945|FG001|Overall Study|Lost to Follow-up|8|||
126203477|NCT00310440|454030944|FG000|Overall Study|Withdrawal by Subject|2|||
126203478|NCT00310440|454030945|FG001|Overall Study|Withdrawal by Subject|1|||
126203479|NCT00310440|454030944|FG000|Overall Study|Missed 12 Month Visit|7|||
126203480|NCT00310440|454030945|FG001|Overall Study|Missed 12 Month Visit|4|||
126203481|NCT01098266|454030946|FG000|Overall Study|Physician Decision|1|||
126203482|NCT01098266|454030947|FG001|Overall Study|Physician Decision|0|||
126203483|NCT01098266|454030946|FG000|Overall Study|Death|3|||
126203484|NCT01098266|454030947|FG001|Overall Study|Death|2|||
126203485|NCT01098266|454030946|FG000|Overall Study|Withdrawal by Subject|3|||
126203486|NCT01098266|454030947|FG001|Overall Study|Withdrawal by Subject|5|||
126203487|NCT00525499|454030951|FG000|Overall Study|Lost to Follow-up|2|||
126203488|NCT00525499|454030952|FG001|Overall Study|Lost to Follow-up|4|||
126203489|NCT00525499|454030953|FG002|Overall Study|Lost to Follow-up|1|||
126203490|NCT00525499|454030954|FG003|Overall Study|Lost to Follow-up|4|||
126203491|NCT00525499|454030951|FG000|Overall Study|Adverse Event|0|||
126203492|NCT00525499|454030952|FG001|Overall Study|Adverse Event|1|||
126203493|NCT00525499|454030953|FG002|Overall Study|Adverse Event|0|||
126203494|NCT00525499|454030954|FG003|Overall Study|Adverse Event|1|||
126203495|NCT00525499|454030951|FG000|Overall Study|Withdrawal by Subject|5|||
126203496|NCT00525499|454030952|FG001|Overall Study|Withdrawal by Subject|1|||
126090141|NCT02643303|453623522|FG007|Overall Study|Adverse Event|0|||
126090142|NCT02643303|453623523|FG008|Overall Study|Adverse Event|0|||
126090143|NCT02643303|453623515|FG000|Overall Study|Withdrawal by Subject|0|||
126090144|NCT02643303|453623516|FG001|Overall Study|Withdrawal by Subject|0|||
126090145|NCT02643303|453623517|FG002|Overall Study|Withdrawal by Subject|0|||
126090146|NCT02643303|453623518|FG003|Overall Study|Withdrawal by Subject|1|||
126090147|NCT02643303|453623519|FG004|Overall Study|Withdrawal by Subject|0|||
126090148|NCT02643303|453623520|FG005|Overall Study|Withdrawal by Subject|0|||
126090149|NCT02643303|453623521|FG006|Overall Study|Withdrawal by Subject|1|||
126090150|NCT02643303|453623522|FG007|Overall Study|Withdrawal by Subject|1|||
126090151|NCT02643303|453623523|FG008|Overall Study|Withdrawal by Subject|1|||
126090152|NCT02383940|453623526|FG000|Overall Study|Adverse Event|1|||
126090153|NCT02383940|453623527|FG001|Overall Study|Adverse Event|0|||
126090154|NCT02383940|453623526|FG000|Overall Study|Lost to Follow-up|2|||
126090155|NCT02383940|453623527|FG001|Overall Study|Lost to Follow-up|2|||
126090156|NCT02383940|453623526|FG000|Overall Study|Physician Decision|2|||
126090157|NCT02383940|453623527|FG001|Overall Study|Physician Decision|0|||
126090158|NCT02383940|453623526|FG000|Overall Study|Withdrawal by Subject|1|||
126090159|NCT02383940|453623527|FG001|Overall Study|Withdrawal by Subject|1|||
126090160|NCT02383940|453623526|FG000|Overall Study|Randomized but not treated|2|||
126090161|NCT02383940|453623527|FG001|Overall Study|Randomized but not treated|0|||
126090162|NCT02383940|453623526|FG000|Overall Study|Other than specified above|1|||
126090163|NCT02383940|453623527|FG001|Overall Study|Other than specified above|0|||
126203497|NCT00525499|454030953|FG002|Overall Study|Withdrawal by Subject|5|||
126203498|NCT00525499|454030954|FG003|Overall Study|Withdrawal by Subject|2|||
126203499|NCT00525499|454030951|FG000|Overall Study|Protocol Violation|0|||
126203500|NCT00525499|454030952|FG001|Overall Study|Protocol Violation|1|||
126203501|NCT00525499|454030953|FG002|Overall Study|Protocol Violation|1|||
126203502|NCT00525499|454030954|FG003|Overall Study|Protocol Violation|0|||
126203503|NCT00438815|454030955|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
126203504|NCT00438815|454030955|FG000|Overall Study|3-month follow-up no longer required|12|||
126203505|NCT00438815|454030955|FG000|Overall Study|Noncompliance with protocol requirements|9|||
126090164|NCT02672852|453623529|FG000|Part A1|Disease Worsening|1|||
126203506|NCT00438815|454030955|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
126203507|NCT00438815|454030955|FG000|Overall Study|Lost to Follow-up|6|||
126203508|NCT00438815|454030955|FG000|Overall Study|Withdrawal by Subject|6|||
126203509|NCT00438815|454030955|FG000|Overall Study|Death|1|||
126203510|NCT01733758|454030956|FG000|Overall Study|Adverse Event|5|||
126203511|NCT01733758|454030957|FG001|Overall Study|Adverse Event|7|||
126203512|NCT01733758|454030958|FG002|Overall Study|Adverse Event|8|||
126203513|NCT01733758|454030959|FG003|Overall Study|Adverse Event|1|||
126203514|NCT01733758|454030956|FG000|Overall Study|Withdrawal by Subject|1|||
126203515|NCT01733758|454030957|FG001|Overall Study|Withdrawal by Subject|1|||
126203516|NCT01733758|454030958|FG002|Overall Study|Withdrawal by Subject|5|||
126203517|NCT01733758|454030959|FG003|Overall Study|Withdrawal by Subject|3|||
126203518|NCT01733758|454030956|FG000|Overall Study|Persistent Hyperglycemia|3|||
126203519|NCT01733758|454030957|FG001|Overall Study|Persistent Hyperglycemia|2|||
126203520|NCT01733758|454030958|FG002|Overall Study|Persistent Hyperglycemia|0|||
126203521|NCT01733758|454030959|FG003|Overall Study|Persistent Hyperglycemia|0|||
126203522|NCT01733758|454030956|FG000|Overall Study|Protocol Violation|0|||
126203523|NCT01733758|454030957|FG001|Overall Study|Protocol Violation|1|||
126203524|NCT01733758|454030958|FG002|Overall Study|Protocol Violation|2|||
126203525|NCT01733758|454030959|FG003|Overall Study|Protocol Violation|2|||
126203526|NCT01733758|454030956|FG000|Overall Study|Non-compliance|1|||
126203527|NCT01733758|454030957|FG001|Overall Study|Non-compliance|0|||
126203528|NCT01733758|454030958|FG002|Overall Study|Non-compliance|0|||
126203529|NCT01733758|454030959|FG003|Overall Study|Non-compliance|0|||
126203530|NCT01733758|454030956|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
126203531|NCT01733758|454030957|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
126203532|NCT01733758|454030958|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
126203533|NCT01733758|454030959|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
126203534|NCT01733758|454030956|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
126203535|NCT01733758|454030957|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
126203536|NCT01733758|454030958|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
126203537|NCT01733758|454030959|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
126203538|NCT03380091|454030967|FG000|Overall Study|Withdrawal by Subject|2|||
126203539|NCT03380091|454030968|FG001|Overall Study|Withdrawal by Subject|1|||
126203540|NCT05602818|454030969|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
126203541|NCT05602818|454030970|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
126203542|NCT05602818|454030971|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
126203543|NCT05602818|454030972|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
126090165|NCT02672852|453623530|FG001|Part A1|Disease Worsening|0|||
126090166|NCT02672852|453623531|FG002|Part A1|Disease Worsening|0|||
126090167|NCT02672852|453623532|FG003|Part A1|Disease Worsening|0|||
126090168|NCT02672852|453623533|FG004|Part A1|Disease Worsening|0|||
126090169|NCT02672852|453623534|FG005|Part A1|Disease Worsening|0|||
126090170|NCT02672852|453623535|FG006|Part A1|Disease Worsening|0|||
126090171|NCT02672852|453623529|FG000|Part A1|Adverse Event|0|||
126090172|NCT02672852|453623530|FG001|Part A1|Adverse Event|1|||
126090173|NCT02672852|453623531|FG002|Part A1|Adverse Event|0|||
126090174|NCT02672852|453623532|FG003|Part A1|Adverse Event|0|||
126090175|NCT02672852|453623533|FG004|Part A1|Adverse Event|0|||
126090176|NCT02672852|453623534|FG005|Part A1|Adverse Event|0|||
126090177|NCT02672852|453623535|FG006|Part A1|Adverse Event|0|||
126090178|NCT02672852|453623529|FG000|Part A1|Lost to Follow-up|1|||
126090179|NCT02672852|453623530|FG001|Part A1|Lost to Follow-up|2|||
126090180|NCT02672852|453623531|FG002|Part A1|Lost to Follow-up|0|||
126090181|NCT02672852|453623532|FG003|Part A1|Lost to Follow-up|0|||
126090182|NCT02672852|453623533|FG004|Part A1|Lost to Follow-up|0|||
126090183|NCT02672852|453623534|FG005|Part A1|Lost to Follow-up|0|||
126090184|NCT02672852|453623535|FG006|Part A1|Lost to Follow-up|0|||
126203544|NCT05602818|454030973|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
126203545|NCT05602818|454030974|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
126203546|NCT05602818|454030975|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
126203547|NCT05602818|454030976|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
126203548|NCT05602818|454030977|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
126203549|NCT05602818|454030978|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
126203550|NCT05602818|454030979|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
126203551|NCT05602818|454030980|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
126203552|NCT05602818|454030969|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
126203553|NCT05602818|454030970|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
126203554|NCT05602818|454030971|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203555|NCT05602818|454030972|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203556|NCT05602818|454030973|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203557|NCT05602818|454030974|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203558|NCT05602818|454030975|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203559|NCT05602818|454030976|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203560|NCT05602818|454030977|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203561|NCT05602818|454030978|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203562|NCT05602818|454030979|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203563|NCT05602818|454030980|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126203564|NCT05602818|454030969|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
126203565|NCT05602818|454030970|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203566|NCT05602818|454030971|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203567|NCT05602818|454030972|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203568|NCT05602818|454030973|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203569|NCT05602818|454030974|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203570|NCT05602818|454030975|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203571|NCT05602818|454030976|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203572|NCT05602818|454030977|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203573|NCT05602818|454030978|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203574|NCT05602818|454030979|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203575|NCT05602818|454030980|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126203576|NCT05602818|454030969|FG000|Qualification Phase (3 Days)|Other|1|||
126203577|NCT05602818|454030970|FG001|Qualification Phase (3 Days)|Other|0|||
126203578|NCT05602818|454030971|FG002|Qualification Phase (3 Days)|Other|0|||
126203579|NCT05602818|454030972|FG003|Qualification Phase (3 Days)|Other|0|||
126203580|NCT05602818|454030973|FG004|Qualification Phase (3 Days)|Other|0|||
126203581|NCT05602818|454030974|FG005|Qualification Phase (3 Days)|Other|0|||
126203582|NCT05602818|454030975|FG006|Qualification Phase (3 Days)|Other|0|||
126203583|NCT05602818|454030976|FG007|Qualification Phase (3 Days)|Other|0|||
126203584|NCT05602818|454030977|FG008|Qualification Phase (3 Days)|Other|0|||
126203585|NCT05602818|454030978|FG009|Qualification Phase (3 Days)|Other|0|||
126203586|NCT05602818|454030979|FG010|Qualification Phase (3 Days)|Other|0|||
126203587|NCT05602818|454030980|FG011|Qualification Phase (3 Days)|Other|0|||
126203588|NCT05602818|454030969|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203589|NCT05602818|454030970|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
126203590|NCT05602818|454030971|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203591|NCT05602818|454030972|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203592|NCT05602818|454030973|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203593|NCT05602818|454030974|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203594|NCT05602818|454030975|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203595|NCT05602818|454030976|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203596|NCT05602818|454030977|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203597|NCT05602818|454030978|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203598|NCT05602818|454030979|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203599|NCT05602818|454030980|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126203600|NCT05602818|454030969|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
126203601|NCT05602818|454030970|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
126203602|NCT05602818|454030971|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
126203603|NCT05602818|454030972|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
126203604|NCT05602818|454030973|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
126203605|NCT05602818|454030974|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
126203606|NCT05602818|454030975|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
126203607|NCT05602818|454030976|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
126203608|NCT05602818|454030977|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
126203609|NCT05602818|454030978|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
126203610|NCT05602818|454030979|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
126203611|NCT05602818|454030980|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
126306062|NCT02553499|454408876|FG007|Overall Study|Physician Decision|1|||
126306063|NCT02553499|454408877|FG008|Overall Study|Physician Decision|1|||
126203612|NCT05602818|454030969|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203613|NCT05602818|454030970|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203614|NCT05602818|454030971|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203615|NCT05602818|454030972|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203616|NCT05602818|454030973|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203617|NCT05602818|454030974|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203618|NCT05602818|454030975|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203619|NCT05602818|454030976|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203620|NCT05602818|454030977|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203621|NCT05602818|454030978|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126203622|NCT05602818|454030979|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
126203623|NCT05602818|454030980|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
126203624|NCT05602818|454030969|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
126203625|NCT05602818|454030970|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
126203626|NCT05602818|454030971|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
126203627|NCT05602818|454030972|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
126203628|NCT05602818|454030973|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
126203629|NCT05602818|454030974|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
126203630|NCT05602818|454030975|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
126203631|NCT05602818|454030976|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
126203632|NCT05602818|454030977|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
126203633|NCT05602818|454030978|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
126203634|NCT05602818|454030979|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
126203635|NCT05602818|454030980|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
126203636|NCT04594213|454030981|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
126203637|NCT04594213|454030982|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
126203638|NCT04594213|454030983|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
126203639|NCT04594213|454030984|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126203640|NCT04594213|454030985|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126313634|NCT00916344|454439286|FG000|Overall Study|Drop-out|5|||
126313635|NCT00108485|454439290|FG000|Overall Study|Withdrawal by Subject|3|||
126313636|NCT00108485|454439291|FG001|Overall Study|Withdrawal by Subject|0|||
126313637|NCT00108485|454439290|FG000|Overall Study|Lost to Follow-up|0|||
126313638|NCT00108485|454439291|FG001|Overall Study|Lost to Follow-up|2|||
126313639|NCT01097421|454439292|FG000|Overall Study|Adverse Event|8|||
126313640|NCT01097421|454439292|FG000|Overall Study|Protocol Violation|2|||
126313641|NCT01097421|454439292|FG000|Overall Study|Lost to Follow-up|1|||
126313642|NCT01097421|454439292|FG000|Overall Study|Withdrawal by Subject|3|||
126313643|NCT01701193|454439297|FG000|Overall Study|Withdrawal by Subject|2|||
126313644|NCT01701193|454439298|FG001|Overall Study|Withdrawal by Subject|2|||
126313645|NCT01701193|454439299|FG002|Overall Study|Withdrawal by Subject|1|||
126313646|NCT01701193|454439300|FG003|Overall Study|Withdrawal by Subject|2|||
126313647|NCT01701193|454439297|FG000|Overall Study|Adverse Event|1|||
126313648|NCT01701193|454439298|FG001|Overall Study|Adverse Event|0|||
126313649|NCT01701193|454439299|FG002|Overall Study|Adverse Event|0|||
126313650|NCT01701193|454439300|FG003|Overall Study|Adverse Event|0|||
126313651|NCT02062944|454439301|FG000|Overall Study|Lost to Follow-up|1|||
126313652|NCT02062944|454439301|FG000|Overall Study|New hemotological disorder identified|1|||
126313653|NCT02062944|454439301|FG000|Overall Study|Uncontrolled Hypertension|1|||
126313654|NCT02062944|454439301|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
126313655|NCT00278148|454439302|FG000|Phase II - Expansion Phase|Disease progression|0|||
126313656|NCT00278148|454439303|FG001|Phase II - Expansion Phase|Disease progression|0|||
126313657|NCT00278148|454439304|FG002|Phase II - Expansion Phase|Disease progression|4|||
126313658|NCT00278148|454439302|FG000|Phase II - Expansion Phase|Adverse Event|0|||
126313659|NCT00278148|454439303|FG001|Phase II - Expansion Phase|Adverse Event|0|||
126313660|NCT00278148|454439304|FG002|Phase II - Expansion Phase|Adverse Event|2|||
126313661|NCT02035748|454439305|FG000|Overall Study|Adverse Event|5|||
126313662|NCT02035748|454439305|FG000|Overall Study|Death|3|||
126313663|NCT02035748|454439305|FG000|Overall Study|Lost to Follow-up|2|||
126313664|NCT02035748|454439305|FG000|Overall Study|Physician Decision|3|||
126313665|NCT02035748|454439305|FG000|Overall Study|Withdrawal by Subject|6|||
126313666|NCT02035748|454439305|FG000|Overall Study|Progressive Disease|1|||
126313667|NCT01088243|454439307|FG000|Overall Study|Adverse Event|1|||
126313668|NCT01088243|454439308|FG001|Overall Study|Adverse Event|0|||
126313669|NCT01210495|454439309|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
126313670|NCT01210495|454439310|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
126313671|NCT01210495|454439311|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
126313672|NCT01210495|454439312|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
126313673|NCT01210495|454439309|FG000|Overall Study|Death|14|||
126313674|NCT01210495|454439310|FG001|Overall Study|Death|7|||
126423730|NCT00452790|454847068|FG001|Infant Series|Parent/legal guardian request|6|||
126313675|NCT01210495|454439311|FG002|Overall Study|Death|112|||
126313676|NCT01210495|454439312|FG003|Overall Study|Death|54|||
126203641|NCT04594213|454030986|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126203642|NCT04594213|454030981|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126203643|NCT04594213|454030982|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
126203644|NCT04594213|454030983|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126203645|NCT04594213|454030984|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126203646|NCT04594213|454030985|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126203647|NCT04594213|454030986|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126203648|NCT04594213|454030981|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
126203649|NCT04594213|454030982|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126203650|NCT04594213|454030983|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
126203651|NCT04594213|454030984|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126203652|NCT04594213|454030985|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126203653|NCT04594213|454030986|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126203654|NCT04594213|454030981|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126203655|NCT04594213|454030982|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126203656|NCT04594213|454030983|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126203657|NCT04594213|454030984|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126203658|NCT04594213|454030985|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
126203659|NCT04594213|454030986|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126203660|NCT04594213|454030981|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126203661|NCT04594213|454030982|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126203662|NCT04594213|454030983|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126203663|NCT04594213|454030984|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
126203664|NCT04594213|454030985|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
126203665|NCT04594213|454030986|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
126203666|NCT04594213|454030981|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126203667|NCT04594213|454030982|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126203668|NCT04594213|454030983|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126203669|NCT04594213|454030984|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126203670|NCT04594213|454030985|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126203671|NCT04594213|454030986|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
126203672|NCT04594213|454030981|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126203673|NCT04594213|454030982|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126203674|NCT04594213|454030983|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126203675|NCT04594213|454030984|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
126203676|NCT04594213|454030985|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126203677|NCT04594213|454030986|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126203678|NCT04594213|454030981|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126203679|NCT04594213|454030982|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126203680|NCT04594213|454030983|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126203681|NCT04594213|454030984|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
126203682|NCT04594213|454030985|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126203683|NCT04594213|454030986|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126203684|NCT04594213|454030981|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126203685|NCT04594213|454030982|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126203686|NCT04594213|454030983|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126203687|NCT04594213|454030984|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
126203688|NCT04594213|454030985|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
126203689|NCT04594213|454030986|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
126203690|NCT04594213|454030981|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126203691|NCT04594213|454030982|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126203692|NCT04594213|454030983|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126203693|NCT04594213|454030984|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
126203694|NCT04594213|454030985|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
126203695|NCT04594213|454030986|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
126203696|NCT04594213|454030981|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
126203697|NCT04594213|454030982|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
126203698|NCT04594213|454030983|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
126203699|NCT04594213|454030984|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
126203700|NCT04594213|454030985|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
126203701|NCT04594213|454030986|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
126203702|NCT03814499|454030992|FG000|Overall Study|Lost to Follow-up|3|||
126203703|NCT01589185|454030993|FG000|Overall Study|Death|1|||
126203704|NCT01589185|454030994|FG001|Overall Study|Death|2|||
126203705|NCT01589185|454030995|FG002|Overall Study|Death|2|||
126203706|NCT01589185|454030996|FG003|Overall Study|Death|0|||
126203707|NCT01589185|454030997|FG004|Overall Study|Death|1|||
126203708|NCT01589185|454030993|FG000|Overall Study|Lost to Follow-up|1|||
126203709|NCT01589185|454030994|FG001|Overall Study|Lost to Follow-up|0|||
126203710|NCT01589185|454030995|FG002|Overall Study|Lost to Follow-up|2|||
126313677|NCT01210495|454439309|FG000|Overall Study|Study Terminated by Sponsor|0|||
126313678|NCT01210495|454439310|FG001|Overall Study|Study Terminated by Sponsor|0|||
126313679|NCT01210495|454439311|FG002|Overall Study|Study Terminated by Sponsor|4|||
126313680|NCT01210495|454439312|FG003|Overall Study|Study Terminated by Sponsor|11|||
126203711|NCT01589185|454030996|FG003|Overall Study|Lost to Follow-up|3|||
126203712|NCT01589185|454030997|FG004|Overall Study|Lost to Follow-up|0|||
126203713|NCT02046993|454030998|FG000|Overall Study|Withdrawal by Subject|2|||
126203714|NCT02046993|454030999|FG001|Overall Study|Withdrawal by Subject|10|||
126203715|NCT02046993|454030998|FG000|Overall Study|Lost to Follow-up|1|||
126203716|NCT02046993|454030999|FG001|Overall Study|Lost to Follow-up|1|||
126203717|NCT00598442|454031002|FG000|Overall Study|Adverse Event|3|||
126203718|NCT00598442|454031003|FG001|Overall Study|Adverse Event|0|||
126203719|NCT00598442|454031004|FG002|Overall Study|Adverse Event|0|||
126203720|NCT00598442|454031002|FG000|Overall Study|Death|19|||
126203721|NCT00598442|454031003|FG001|Overall Study|Death|11|||
126203722|NCT00598442|454031004|FG002|Overall Study|Death|11|||
126203723|NCT00598442|454031002|FG000|Overall Study|Lost to Follow-up|4|||
126203724|NCT00598442|454031003|FG001|Overall Study|Lost to Follow-up|3|||
126203725|NCT00598442|454031004|FG002|Overall Study|Lost to Follow-up|3|||
126203726|NCT00598442|454031002|FG000|Overall Study|Physician Decision|2|||
126203727|NCT00598442|454031003|FG001|Overall Study|Physician Decision|1|||
126203728|NCT00598442|454031004|FG002|Overall Study|Physician Decision|1|||
126313681|NCT01210495|454439309|FG000|Overall Study|Lost to Follow-up|0|||
126313682|NCT01210495|454439310|FG001|Overall Study|Lost to Follow-up|0|||
126313683|NCT01210495|454439311|FG002|Overall Study|Lost to Follow-up|1|||
126313684|NCT01210495|454439312|FG003|Overall Study|Lost to Follow-up|1|||
126313685|NCT01210495|454439309|FG000|Overall Study|Other unspecified|0|||
126313686|NCT01210495|454439310|FG001|Overall Study|Other unspecified|0|||
126313687|NCT01210495|454439311|FG002|Overall Study|Other unspecified|6|||
126313688|NCT01210495|454439312|FG003|Overall Study|Other unspecified|0|||
126313689|NCT00454818|454439315|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
126313690|NCT00454818|454439316|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
126313691|NCT00454818|454439317|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
126313692|NCT00454818|454439318|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
126313693|NCT00454818|454439319|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
126313694|NCT00454818|454439315|FG000|Phase I: Open-label Dose-escalation|Death|0|||
126313695|NCT00454818|454439316|FG001|Phase I: Open-label Dose-escalation|Death|1|||
126313696|NCT00454818|454439317|FG002|Phase I: Open-label Dose-escalation|Death|0|||
126313697|NCT00454818|454439318|FG003|Phase I: Open-label Dose-escalation|Death|0|||
126313698|NCT00454818|454439319|FG004|Phase I: Open-label Dose-escalation|Death|0|||
126313699|NCT00454818|454439315|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
126313700|NCT00454818|454439316|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
126313701|NCT00454818|454439317|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
126313702|NCT00454818|454439318|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
126313703|NCT00454818|454439319|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
126313704|NCT00454818|454439315|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
126313705|NCT00454818|454439316|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
126313706|NCT00454818|454439317|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
126313707|NCT00454818|454439318|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
126313708|NCT00454818|454439319|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
126313709|NCT00454818|454439315|FG000|Phase 2: Randomized Double-blind|Death|0|||
126313710|NCT00454818|454439316|FG001|Phase 2: Randomized Double-blind|Death|1|||
126313711|NCT00454818|454439317|FG002|Phase 2: Randomized Double-blind|Death|0|||
126313712|NCT00454818|454439318|FG003|Phase 2: Randomized Double-blind|Death|0|||
126313713|NCT00454818|454439319|FG004|Phase 2: Randomized Double-blind|Death|1|||
126313714|NCT00454818|454439315|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
126313715|NCT00454818|454439316|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
126313716|NCT00454818|454439317|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
126313717|NCT00454818|454439318|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
126313718|NCT00454818|454439319|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
126313719|NCT00454818|454439315|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
126313720|NCT00454818|454439316|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
126313721|NCT00454818|454439317|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
126313722|NCT00454818|454439318|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
126313723|NCT00454818|454439319|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
126313724|NCT00767039|454439320|FG000|Overall Study|Death|5|||
126203729|NCT00598442|454031002|FG000|Overall Study|Withdrawal by Subject|8|||
126203730|NCT00598442|454031003|FG001|Overall Study|Withdrawal by Subject|16|||
126203731|NCT00598442|454031004|FG002|Overall Study|Withdrawal by Subject|6|||
126313725|NCT00767039|454439321|FG001|Overall Study|Death|2|||
126203732|NCT00598442|454031002|FG000|Overall Study|Noncompliance|0|||
126203733|NCT00598442|454031003|FG001|Overall Study|Noncompliance|2|||
126203734|NCT00598442|454031004|FG002|Overall Study|Noncompliance|1|||
126203735|NCT00598442|454031002|FG000|Overall Study|Relocation|1|||
126203736|NCT00598442|454031003|FG001|Overall Study|Relocation|4|||
126203737|NCT00598442|454031004|FG002|Overall Study|Relocation|0|||
126203738|NCT00598442|454031002|FG000|Overall Study|Renal transplant|0|||
126203739|NCT00598442|454031003|FG001|Overall Study|Renal transplant|0|||
126203740|NCT00598442|454031004|FG002|Overall Study|Renal transplant|1|||
126203741|NCT00598442|454031002|FG000|Overall Study|Site closed by sponsor|5|||
126203742|NCT00598442|454031003|FG001|Overall Study|Site closed by sponsor|2|||
126203743|NCT00598442|454031004|FG002|Overall Study|Site closed by sponsor|1|||
126203744|NCT00598442|454031002|FG000|Overall Study|Started dialysis|1|||
126203745|NCT00598442|454031003|FG001|Overall Study|Started dialysis|0|||
126203746|NCT00598442|454031004|FG002|Overall Study|Started dialysis|0|||
126203747|NCT00679354|454031008|FG000|Overall Study|Death|3|||
126203748|NCT00679354|454031008|FG000|Overall Study|Lack of Efficacy|22|||
126203749|NCT00679354|454031008|FG000|Overall Study|Physician Decision|4|||
126203750|NCT00679354|454031008|FG000|Overall Study|Ineligible|1|||
126203751|NCT01654666|454031013|FG000|Overall Study|Protocol Violation|7|||
126203752|NCT01654666|454031014|FG001|Overall Study|Protocol Violation|4|||
126203753|NCT01654666|454031015|FG002|Overall Study|Protocol Violation|8|||
126203754|NCT01654666|454031013|FG000|Overall Study|Lost to Follow-up|4|||
126203755|NCT01654666|454031014|FG001|Overall Study|Lost to Follow-up|5|||
126203756|NCT01654666|454031015|FG002|Overall Study|Lost to Follow-up|5|||
126203757|NCT01654666|454031013|FG000|Overall Study|Withdrawal by Subject|4|||
126203758|NCT01654666|454031014|FG001|Overall Study|Withdrawal by Subject|4|||
126203759|NCT01654666|454031015|FG002|Overall Study|Withdrawal by Subject|1|||
126203760|NCT00535262|454031018|FG000|Overall Study|No funding|3|||
126203761|NCT02898662|454031019|FG000|Overall Study|Adverse Event|1|||
126203762|NCT02898662|454031020|FG001|Overall Study|Adverse Event|0|||
126203763|NCT02898662|454031019|FG000|Overall Study|Loss of asthma control|23|||
126203764|NCT02898662|454031020|FG001|Overall Study|Loss of asthma control|24|||
126203765|NCT02898662|454031019|FG000|Overall Study|Withdrawal by Subject|4|||
126203766|NCT02898662|454031020|FG001|Overall Study|Withdrawal by Subject|1|||
126203767|NCT02898662|454031019|FG000|Overall Study|Technical issue|0|||
126203768|NCT02898662|454031020|FG001|Overall Study|Technical issue|1|||
126203769|NCT02898662|454031019|FG000|Overall Study|Randomized in error|0|||
126203770|NCT02898662|454031020|FG001|Overall Study|Randomized in error|1|||
126203771|NCT02898662|454031019|FG000|Overall Study|Subject decision|1|||
126203772|NCT02898662|454031020|FG001|Overall Study|Subject decision|0|||
126203773|NCT02898662|454031019|FG000|Overall Study|Other|0|||
126203774|NCT02898662|454031020|FG001|Overall Study|Other|1|||
126203775|NCT00917553|454031021|FG000|Overall Study|Lost to Follow-up|2|||
126203776|NCT00917553|454031022|FG001|Overall Study|Lost to Follow-up|1|||
126203777|NCT01616173|454031023|FG000|Overall Study|Lost to Follow-up|0|||
126203778|NCT01616173|454031024|FG001|Overall Study|Lost to Follow-up|2|||
126203779|NCT01616173|454031025|FG002|Overall Study|Lost to Follow-up|0|||
126203780|NCT03432819|454031028|FG000|Overall Study|Lost to Follow-up|2|||
126203781|NCT03432819|454031029|FG001|Overall Study|Lost to Follow-up|2|||
126203782|NCT03432819|454031028|FG000|Overall Study|Withdrawal by Subject|5|||
126203783|NCT03432819|454031029|FG001|Overall Study|Withdrawal by Subject|3|||
126203784|NCT01336647|454033164|FG000|Overall Study|Lost to Follow-up|4|||
126203785|NCT01336647|454033165|FG001|Overall Study|Lost to Follow-up|1|||
126203786|NCT01336647|454033166|FG002|Overall Study|Lost to Follow-up|3|||
126203787|NCT00151775|454033177|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
126203788|NCT00151775|454033178|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
126203789|NCT00151775|454033179|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203790|NCT00151775|454033180|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203791|NCT00151775|454033181|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203792|NCT00151775|454033182|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203793|NCT00151775|454033183|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126313726|NCT01826370|454439322|FG000|Overall Study|Protocol Violation|6|||
126313727|NCT01826370|454439322|FG000|Overall Study|Lost to Follow-up|12|||
126313728|NCT01826370|454439322|FG000|Overall Study|Other reason not defined above|2|||
126313729|NCT04416737|454439324|FG000|Week 1 (First Injection)|Physician Decision|0|||
126313730|NCT04416737|454439325|FG001|Week 1 (First Injection)|Physician Decision|1|||
126203794|NCT00151775|454033184|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203795|NCT00151775|454033185|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203796|NCT00151775|454033186|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203797|NCT00151775|454033187|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203798|NCT00151775|454033188|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126203799|NCT00151775|454033177|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
126203800|NCT00151775|454033178|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203801|NCT00151775|454033179|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203802|NCT00151775|454033180|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203803|NCT00151775|454033181|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203804|NCT00151775|454033182|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203805|NCT00151775|454033183|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
126203806|NCT00151775|454033184|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203807|NCT00151775|454033185|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203808|NCT00151775|454033186|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203809|NCT00151775|454033187|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
126203810|NCT00151775|454033188|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126203811|NCT00151775|454033177|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203812|NCT00151775|454033178|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
126203813|NCT00151775|454033179|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203814|NCT00151775|454033180|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203815|NCT00151775|454033181|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203816|NCT00151775|454033182|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203817|NCT00151775|454033183|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203818|NCT00151775|454033184|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203819|NCT00151775|454033185|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203820|NCT00151775|454033186|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203821|NCT00151775|454033187|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203822|NCT00151775|454033188|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126203823|NCT00151775|454033177|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
126203824|NCT00151775|454033178|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
126203825|NCT00151775|454033179|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
126203826|NCT00151775|454033180|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
126203827|NCT00151775|454033181|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
126203828|NCT00151775|454033182|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
126203829|NCT00151775|454033183|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
126203830|NCT00151775|454033184|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
126203831|NCT00151775|454033185|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
126203832|NCT00151775|454033186|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
126203833|NCT00151775|454033187|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
126203834|NCT00151775|454033188|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
126203835|NCT00151775|454033177|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203836|NCT00151775|454033178|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203837|NCT00151775|454033179|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203838|NCT00151775|454033180|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203839|NCT00151775|454033181|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203840|NCT00151775|454033182|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
126203841|NCT00151775|454033183|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203842|NCT00151775|454033184|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203843|NCT00151775|454033185|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203844|NCT00151775|454033186|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203845|NCT00151775|454033187|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203846|NCT00151775|454033188|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126203847|NCT00151775|454033177|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203848|NCT00151775|454033178|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203849|NCT00151775|454033179|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203850|NCT00151775|454033180|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203851|NCT00151775|454033181|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203852|NCT00151775|454033182|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
126203853|NCT00151775|454033183|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126306064|NCT02553499|454408878|FG009|Overall Study|Physician Decision|2|||
126306065|NCT02553499|454408879|FG010|Overall Study|Physician Decision|1|||
126306066|NCT02553499|454408880|FG011|Overall Study|Physician Decision|3|||
126306067|NCT02553499|454408881|FG012|Overall Study|Physician Decision|1|||
126306068|NCT02553499|454408882|FG013|Overall Study|Physician Decision|0|||
126306069|NCT02553499|454408869|FG000|Overall Study|Progressive Disease|0|||
126306070|NCT02553499|454408870|FG001|Overall Study|Progressive Disease|0|||
126306071|NCT02553499|454408871|FG002|Overall Study|Progressive Disease|0|||
126306072|NCT02553499|454408872|FG003|Overall Study|Progressive Disease|2|||
126306073|NCT02553499|454408873|FG004|Overall Study|Progressive Disease|1|||
126306074|NCT02553499|454408874|FG005|Overall Study|Progressive Disease|1|||
126306075|NCT02553499|454408875|FG006|Overall Study|Progressive Disease|1|||
126306076|NCT02553499|454408876|FG007|Overall Study|Progressive Disease|0|||
126306077|NCT02553499|454408877|FG008|Overall Study|Progressive Disease|0|||
126306078|NCT02553499|454408878|FG009|Overall Study|Progressive Disease|1|||
126306079|NCT02553499|454408879|FG010|Overall Study|Progressive Disease|0|||
126306080|NCT02553499|454408880|FG011|Overall Study|Progressive Disease|0|||
126313731|NCT03332628|454439326|FG000|Overall Study|Physician Decision|2|||
126313732|NCT01472757|454439327|FG000|Overall Study|Withdrawal by Subject|1|||
126313733|NCT01472757|454439328|FG001|Overall Study|Withdrawal by Subject|2|||
126313734|NCT01472757|454439329|FG002|Overall Study|Withdrawal by Subject|2|||
126313735|NCT01472757|454439330|FG003|Overall Study|Withdrawal by Subject|0|||
126313736|NCT01472757|454439327|FG000|Overall Study|Asthma exacerbation|4|||
126313737|NCT01472757|454439328|FG001|Overall Study|Asthma exacerbation|1|||
126313738|NCT01472757|454439329|FG002|Overall Study|Asthma exacerbation|2|||
126313739|NCT01472757|454439330|FG003|Overall Study|Asthma exacerbation|1|||
126203854|NCT00151775|454033184|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126313740|NCT01472757|454439327|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
126313741|NCT01472757|454439328|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
126313742|NCT01472757|454439329|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
126313743|NCT01472757|454439330|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
126313744|NCT01472757|454439327|FG000|Overall Study|Protocol Violation|3|||
126313745|NCT01472757|454439328|FG001|Overall Study|Protocol Violation|2|||
126313746|NCT01472757|454439329|FG002|Overall Study|Protocol Violation|4|||
126313747|NCT01472757|454439330|FG003|Overall Study|Protocol Violation|4|||
126313748|NCT01472757|454439327|FG000|Overall Study|Other reasons|1|||
126313749|NCT01472757|454439328|FG001|Overall Study|Other reasons|0|||
126313750|NCT01472757|454439329|FG002|Overall Study|Other reasons|2|||
126313751|NCT01472757|454439330|FG003|Overall Study|Other reasons|2|||
126313752|NCT02939716|454439336|FG000|Overall Study|scanner failure|0|||
126313753|NCT02939716|454439337|FG001|Overall Study|scanner failure|0|||
126313754|NCT02939716|454439338|FG002|Overall Study|scanner failure|0|||
126313755|NCT02939716|454439339|FG003|Overall Study|scanner failure|1|||
126203855|NCT00151775|454033185|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203856|NCT00151775|454033186|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203857|NCT00151775|454033187|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203858|NCT00151775|454033188|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126203859|NCT00151775|454033177|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203860|NCT00151775|454033178|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203861|NCT00151775|454033179|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203862|NCT00151775|454033180|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203863|NCT00151775|454033181|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203864|NCT00151775|454033182|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203865|NCT00151775|454033183|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
126203866|NCT00151775|454033184|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203867|NCT00151775|454033185|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203868|NCT00151775|454033186|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203869|NCT00151775|454033187|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203870|NCT00151775|454033188|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126203871|NCT00151775|454033177|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203872|NCT00151775|454033178|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203873|NCT00151775|454033179|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203874|NCT00151775|454033180|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203875|NCT00151775|454033181|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203876|NCT00151775|454033182|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
126203877|NCT00151775|454033183|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203878|NCT00151775|454033184|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203879|NCT00151775|454033185|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203880|NCT00151775|454033186|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203881|NCT00151775|454033187|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203882|NCT00151775|454033188|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126203883|NCT00151775|454033177|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
126203884|NCT00151775|454033178|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
126203885|NCT00151775|454033179|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
126203886|NCT00151775|454033180|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
126203887|NCT00151775|454033181|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
126203888|NCT00151775|454033182|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
126203889|NCT00151775|454033183|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
126203890|NCT00151775|454033184|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
126203891|NCT00151775|454033185|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
126203892|NCT00151775|454033186|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
126203893|NCT00151775|454033187|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
126203894|NCT00151775|454033188|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
126313756|NCT02939716|454439340|FG004|Overall Study|scanner failure|1|||
126313757|NCT02939716|454439341|FG005|Overall Study|scanner failure|1|||
126313758|NCT00785213|454439347|FG000|Quinine Sulfate Alone|Adverse Event|4|||
126313759|NCT00785213|454439347|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
126203895|NCT00151775|454033177|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203896|NCT00151775|454033178|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203897|NCT00151775|454033179|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203898|NCT00151775|454033180|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203899|NCT00151775|454033181|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203900|NCT00151775|454033182|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203901|NCT00151775|454033183|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
126203902|NCT00151775|454033184|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203903|NCT00151775|454033185|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203904|NCT00151775|454033186|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203905|NCT00151775|454033187|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203906|NCT00151775|454033188|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126203907|NCT00151775|454033177|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203908|NCT00151775|454033178|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203909|NCT00151775|454033179|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
126203910|NCT00151775|454033180|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203911|NCT00151775|454033181|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203912|NCT00151775|454033182|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203913|NCT00151775|454033183|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203914|NCT00151775|454033184|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203915|NCT00151775|454033185|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203916|NCT00151775|454033186|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203917|NCT00151775|454033187|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203918|NCT00151775|454033188|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126203919|NCT00151775|454033177|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203920|NCT00151775|454033178|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203921|NCT00151775|454033179|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
126203922|NCT00151775|454033180|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203923|NCT00151775|454033181|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203924|NCT00151775|454033182|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203925|NCT00151775|454033183|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203926|NCT00151775|454033184|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203927|NCT00151775|454033185|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203928|NCT00151775|454033186|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203929|NCT00151775|454033187|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203930|NCT00151775|454033188|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126203931|NCT00151775|454033177|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203932|NCT00151775|454033178|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203933|NCT00151775|454033179|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203934|NCT00151775|454033180|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203935|NCT00151775|454033181|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203936|NCT00151775|454033182|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203937|NCT00151775|454033183|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203938|NCT00151775|454033184|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203939|NCT00151775|454033185|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203940|NCT00151775|454033186|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203941|NCT00151775|454033187|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126203942|NCT00151775|454033188|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
126203943|NCT00151775|454033177|FG000|Period 4: Open Label|Increased blood pressure|0|||
126203944|NCT00151775|454033178|FG001|Period 4: Open Label|Increased blood pressure|0|||
126203945|NCT00151775|454033179|FG002|Period 4: Open Label|Increased blood pressure|0|||
126203946|NCT00151775|454033180|FG003|Period 4: Open Label|Increased blood pressure|0|||
126203947|NCT00151775|454033181|FG004|Period 4: Open Label|Increased blood pressure|1|||
126203948|NCT00151775|454033182|FG005|Period 4: Open Label|Increased blood pressure|0|||
126203949|NCT00151775|454033183|FG006|Period 4: Open Label|Increased blood pressure|0|||
126203950|NCT00151775|454033184|FG007|Period 4: Open Label|Increased blood pressure|0|||
126203951|NCT00151775|454033185|FG008|Period 4: Open Label|Increased blood pressure|0|||
126203952|NCT00151775|454033186|FG009|Period 4: Open Label|Increased blood pressure|1|||
126203953|NCT00151775|454033187|FG010|Period 4: Open Label|Increased blood pressure|0|||
126203954|NCT00151775|454033188|FG011|Period 4: Open Label|Increased blood pressure|0|||
126203955|NCT00151775|454033177|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
126203956|NCT00151775|454033178|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
126203957|NCT00151775|454033179|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
126203958|NCT00151775|454033180|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
126203959|NCT00151775|454033181|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
126203960|NCT00151775|454033182|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
126203961|NCT00151775|454033183|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
126313760|NCT02375555|454439358|FG000|Induction Period|Adverse Event|7|||
126313761|NCT02375555|454439358|FG000|Induction Period|Withdrawal by Subject|2|||
126313762|NCT02375555|454439358|FG000|Induction Period|Other|1|||
126313763|NCT02375555|454439358|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
126313764|NCT02375555|454439358|FG000|Maintenance Period|Adverse Event|2|||
126313765|NCT02375555|454439358|FG000|Maintenance Period|Withdrawal by Subject|4|||
126313766|NCT02375555|454439358|FG000|Maintenance Period|Death|1|||
126313767|NCT02375555|454439358|FG000|Maintenance Period|Disease Progression|5|||
126313768|NCT02375555|454439358|FG000|Maintenance Period|Patient Non-compliance|1|||
126313769|NCT02375555|454439358|FG000|Maintenance Period|Still on maintenance|16|||
126313770|NCT01744184|454439370|FG000|Overall Study|Adverse Event|1|||
126313771|NCT01744184|454439371|FG001|Overall Study|Adverse Event|0|||
126313772|NCT01744184|454439370|FG000|Overall Study|Withdrawal by Subject|0|||
126313773|NCT01744184|454439371|FG001|Overall Study|Withdrawal by Subject|1|||
126313774|NCT01263782|454439379|FG000|Overall Study|Death|0|||
126313775|NCT01263782|454439380|FG001|Overall Study|Death|0|||
126313776|NCT01263782|454439381|FG002|Overall Study|Death|1|||
126313777|NCT01263782|454439382|FG003|Overall Study|Death|0|||
126313778|NCT01263782|454439379|FG000|Overall Study|Progressive disease|0|||
126313779|NCT01263782|454439380|FG001|Overall Study|Progressive disease|0|||
126313780|NCT01263782|454439381|FG002|Overall Study|Progressive disease|0|||
126313781|NCT01263782|454439382|FG003|Overall Study|Progressive disease|1|||
126313782|NCT01263782|454439379|FG000|Overall Study|Too early|0|||
126313783|NCT01263782|454439380|FG001|Overall Study|Too early|0|||
126313784|NCT01263782|454439381|FG002|Overall Study|Too early|1|||
126313785|NCT01263782|454439382|FG003|Overall Study|Too early|0|||
126313786|NCT01263782|454439379|FG000|Overall Study|Inevaluable|0|||
126423731|NCT00452790|454847067|FG000|Infant Series|Failed to return|4|||
126423732|NCT00452790|454847068|FG001|Infant Series|Failed to return|1|||
126423733|NCT00452790|454847067|FG000|Infant Series|Protocol Violation|1|||
126423734|NCT00452790|454847068|FG001|Infant Series|Protocol Violation|3|||
126423735|NCT00452790|454847067|FG000|Infant Series|Lost to Follow-up|2|||
126423736|NCT00452790|454847068|FG001|Infant Series|Lost to Follow-up|2|||
126423737|NCT00452790|454847067|FG000|Infant Series|Adverse Event|1|||
126423738|NCT00452790|454847068|FG001|Infant Series|Adverse Event|2|||
126423739|NCT00452790|454847067|FG000|Infant Series|Other reasons|1|||
126423740|NCT00452790|454847068|FG001|Infant Series|Other reasons|2|||
126423741|NCT00452790|454847067|FG000|Infant Series|Investigator request|0|||
126423742|NCT00452790|454847068|FG001|Infant Series|Investigator request|1|||
126423743|NCT00452790|454847067|FG000|Infant Series|Death|0|||
126423744|NCT00452790|454847068|FG001|Infant Series|Death|1|||
126423745|NCT00452790|454847067|FG000|After Infant Series|Investigator request|10|||
126423746|NCT00452790|454847068|FG001|After Infant Series|Investigator request|10|||
126423747|NCT00452790|454847067|FG000|After Infant Series|Adverse Event|4|||
126423748|NCT00452790|454847068|FG001|After Infant Series|Adverse Event|1|||
126423749|NCT00452790|454847067|FG000|After Infant Series|Parent/legal guardian request|1|||
126423750|NCT00452790|454847068|FG001|After Infant Series|Parent/legal guardian request|3|||
126423751|NCT00452790|454847067|FG000|After Infant Series|Lost to Follow-up|4|||
126203962|NCT00151775|454033184|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
126203963|NCT00151775|454033185|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
126203964|NCT00151775|454033186|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
126203965|NCT00151775|454033187|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
126203966|NCT00151775|454033188|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
126203967|NCT00151775|454033177|FG000|Period 4: Open Label|Adverse Event|0|||
126203968|NCT00151775|454033178|FG001|Period 4: Open Label|Adverse Event|0|||
126203969|NCT00151775|454033179|FG002|Period 4: Open Label|Adverse Event|0|||
126423752|NCT00452790|454847068|FG001|After Infant Series|Lost to Follow-up|0|||
126423753|NCT00452790|454847067|FG000|After Infant Series|Failed to return|1|||
126423754|NCT00452790|454847068|FG001|After Infant Series|Failed to return|0|||
126423755|NCT00452790|454847067|FG000|After Infant Series|Other reasons|1|||
126423756|NCT00452790|454847068|FG001|After Infant Series|Other reasons|0|||
126423757|NCT00452790|454847067|FG000|Toddler Dose|Failed to return|0|||
126423758|NCT00452790|454847068|FG001|Toddler Dose|Failed to return|1|||
126423759|NCT00452790|454847067|FG000|Toddler Dose|Parent/legal guardian request|0|||
126423760|NCT00452790|454847068|FG001|Toddler Dose|Parent/legal guardian request|1|||
126423761|NCT00348673|454847081|FG000|Stage 1|Randomized but not Treated|0|||
126423762|NCT00348673|454847082|FG001|Stage 1|Randomized but not Treated|0|||
126423763|NCT00348673|454847083|FG002|Stage 1|Randomized but not Treated|1|||
126423764|NCT00348673|454847084|FG003|Stage 1|Randomized but not Treated|0|||
126423765|NCT00348673|454847085|FG004|Stage 1|Randomized but not Treated|0|||
126203970|NCT00151775|454033180|FG003|Period 4: Open Label|Adverse Event|0|||
126313787|NCT01263782|454439380|FG001|Overall Study|Inevaluable|0|||
126313788|NCT01263782|454439381|FG002|Overall Study|Inevaluable|1|||
126313789|NCT01263782|454439382|FG003|Overall Study|Inevaluable|0|||
126313790|NCT04545567|454439384|FG000|Overall Study|tested positive for SARS-co-V2|1|||
126423766|NCT00348673|454847086|FG005|Stage 1|Randomized but not Treated|0|||
126423767|NCT00348673|454847087|FG006|Stage 1|Randomized but not Treated|0|||
126423768|NCT00348673|454847088|FG007|Stage 1|Randomized but not Treated|0|||
126203971|NCT00151775|454033181|FG004|Period 4: Open Label|Adverse Event|1|||
126203972|NCT00151775|454033182|FG005|Period 4: Open Label|Adverse Event|0|||
126203973|NCT00151775|454033183|FG006|Period 4: Open Label|Adverse Event|0|||
126203974|NCT00151775|454033184|FG007|Period 4: Open Label|Adverse Event|0|||
126203975|NCT00151775|454033185|FG008|Period 4: Open Label|Adverse Event|0|||
126203976|NCT00151775|454033186|FG009|Period 4: Open Label|Adverse Event|2|||
126203977|NCT00151775|454033187|FG010|Period 4: Open Label|Adverse Event|0|||
126203978|NCT00151775|454033188|FG011|Period 4: Open Label|Adverse Event|0|||
126203979|NCT00151775|454033177|FG000|Period 4: Open Label|Lost to Follow-up|0|||
126203980|NCT00151775|454033178|FG001|Period 4: Open Label|Lost to Follow-up|0|||
126203981|NCT00151775|454033179|FG002|Period 4: Open Label|Lost to Follow-up|0|||
126203982|NCT00151775|454033180|FG003|Period 4: Open Label|Lost to Follow-up|0|||
126203983|NCT00151775|454033181|FG004|Period 4: Open Label|Lost to Follow-up|17|||
126203984|NCT00151775|454033182|FG005|Period 4: Open Label|Lost to Follow-up|0|||
126203985|NCT00151775|454033183|FG006|Period 4: Open Label|Lost to Follow-up|0|||
126203986|NCT00151775|454033184|FG007|Period 4: Open Label|Lost to Follow-up|0|||
126203987|NCT00151775|454033185|FG008|Period 4: Open Label|Lost to Follow-up|0|||
126203988|NCT00151775|454033186|FG009|Period 4: Open Label|Lost to Follow-up|7|||
126203989|NCT00151775|454033187|FG010|Period 4: Open Label|Lost to Follow-up|0|||
126203990|NCT00151775|454033188|FG011|Period 4: Open Label|Lost to Follow-up|0|||
126203991|NCT00151775|454033177|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
126203992|NCT00151775|454033178|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
126203993|NCT00151775|454033179|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
126203994|NCT00151775|454033180|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
126203995|NCT00151775|454033181|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
126203996|NCT00151775|454033182|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
126203997|NCT00151775|454033183|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
126203998|NCT00151775|454033184|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
126203999|NCT00151775|454033185|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
126204000|NCT00151775|454033186|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
126204001|NCT00151775|454033187|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
126204002|NCT00151775|454033188|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
126204003|NCT00151775|454033177|FG000|Period 4: Open Label|Other|0|||
126204004|NCT00151775|454033178|FG001|Period 4: Open Label|Other|0|||
126204005|NCT00151775|454033179|FG002|Period 4: Open Label|Other|0|||
126204006|NCT00151775|454033180|FG003|Period 4: Open Label|Other|0|||
126204007|NCT00151775|454033181|FG004|Period 4: Open Label|Other|1|||
126204008|NCT00151775|454033182|FG005|Period 4: Open Label|Other|0|||
126204009|NCT00151775|454033183|FG006|Period 4: Open Label|Other|0|||
126204010|NCT00151775|454033184|FG007|Period 4: Open Label|Other|0|||
126204011|NCT00151775|454033185|FG008|Period 4: Open Label|Other|0|||
126204012|NCT00151775|454033186|FG009|Period 4: Open Label|Other|3|||
126204013|NCT00151775|454033187|FG010|Period 4: Open Label|Other|0|||
126204014|NCT00151775|454033188|FG011|Period 4: Open Label|Other|0|||
126204015|NCT00151775|454033177|FG000|Period 4: Open Label|Physician Decision|0|||
126204016|NCT00151775|454033178|FG001|Period 4: Open Label|Physician Decision|0|||
126204017|NCT00151775|454033179|FG002|Period 4: Open Label|Physician Decision|0|||
126204018|NCT00151775|454033180|FG003|Period 4: Open Label|Physician Decision|0|||
126204019|NCT00151775|454033181|FG004|Period 4: Open Label|Physician Decision|0|||
126204020|NCT00151775|454033182|FG005|Period 4: Open Label|Physician Decision|0|||
126204021|NCT00151775|454033183|FG006|Period 4: Open Label|Physician Decision|0|||
126204022|NCT00151775|454033184|FG007|Period 4: Open Label|Physician Decision|0|||
126204023|NCT00151775|454033185|FG008|Period 4: Open Label|Physician Decision|0|||
126204024|NCT00151775|454033186|FG009|Period 4: Open Label|Physician Decision|2|||
126204025|NCT00151775|454033187|FG010|Period 4: Open Label|Physician Decision|0|||
126204026|NCT00151775|454033188|FG011|Period 4: Open Label|Physician Decision|0|||
126204027|NCT00151775|454033177|FG000|Period 4: Open Label|Protocol Violation|0|||
126204028|NCT00151775|454033178|FG001|Period 4: Open Label|Protocol Violation|0|||
126204029|NCT00151775|454033179|FG002|Period 4: Open Label|Protocol Violation|0|||
126204030|NCT00151775|454033180|FG003|Period 4: Open Label|Protocol Violation|0|||
126204031|NCT00151775|454033181|FG004|Period 4: Open Label|Protocol Violation|1|||
126204032|NCT00151775|454033182|FG005|Period 4: Open Label|Protocol Violation|0|||
126204033|NCT00151775|454033183|FG006|Period 4: Open Label|Protocol Violation|0|||
126204034|NCT00151775|454033184|FG007|Period 4: Open Label|Protocol Violation|0|||
126204035|NCT00151775|454033185|FG008|Period 4: Open Label|Protocol Violation|0|||
126204036|NCT00151775|454033186|FG009|Period 4: Open Label|Protocol Violation|0|||
126204037|NCT00151775|454033187|FG010|Period 4: Open Label|Protocol Violation|0|||
126204038|NCT00151775|454033188|FG011|Period 4: Open Label|Protocol Violation|0|||
126204039|NCT00474994|454033197|FG000|Overall Study|Patient Not treated|1|||
126204040|NCT00474994|454033197|FG000|Overall Study|Patient evaluable for toxicity only|3|||
126204041|NCT00474994|454033197|FG000|Overall Study|Patient found to be ineligible|1|||
126204042|NCT02181634|454033201|FG000|Overall Study|Lack of Efficacy|33|||
126204043|NCT02181634|454033201|FG000|Overall Study|Adverse Event|17|||
126204044|NCT02181634|454033201|FG000|Overall Study|Physician Decision|8|||
126204045|NCT02181634|454033201|FG000|Overall Study|Withdrawal by Subject|5|||
126423769|NCT00348673|454847089|FG008|Stage 1|Randomized but not Treated|0|||
126423770|NCT02614729|454849148|FG000|Overall Study|Withdrawal by Subject|1|||
126204046|NCT02181634|454033201|FG000|Overall Study|Death|2|||
126204047|NCT02181634|454033201|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
126204048|NCT02181634|454033201|FG000|Overall Study|Ineligible|1|||
126204049|NCT02181634|454033201|FG000|Overall Study|Max number of dose reduction|1|||
126204050|NCT02181634|454033201|FG000|Overall Study|Symptomatic progression|1|||
126204051|NCT02181634|454033201|FG000|Overall Study|Patient opted to proceed to surgery|1|||
126204052|NCT01928758|454033210|FG000|Overall Study|Lost to Follow-up|14|||
126204053|NCT01928758|454033211|FG001|Overall Study|Lost to Follow-up|9|||
126204054|NCT01928758|454033210|FG000|Overall Study|Withdrawal by Subject|5|||
126204055|NCT01928758|454033211|FG001|Overall Study|Withdrawal by Subject|2|||
126204056|NCT01928758|454033210|FG000|Overall Study|Adverse Event|3|||
126204057|NCT01928758|454033211|FG001|Overall Study|Adverse Event|5|||
126204058|NCT01928758|454033210|FG000|Overall Study|Protocol Violation|3|||
126204059|NCT01928758|454033211|FG001|Overall Study|Protocol Violation|4|||
126423771|NCT02614729|454849149|FG001|Overall Study|Withdrawal by Subject|0|||
126423772|NCT03790111|454849154|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
126423773|NCT03798717|454849159|FG000|Overall Study|Failed Screening|0|||
126423774|NCT03798717|454849160|FG001|Overall Study|Failed Screening|0|||
126423775|NCT03798717|454849161|FG002|Overall Study|Failed Screening|0|||
126204060|NCT00719706|454033212|FG000|Overall Study|Adverse Event|5|||
126204061|NCT00719706|454033213|FG001|Overall Study|Adverse Event|4|||
126204062|NCT00719706|454033212|FG000|Overall Study|Withdrawal by Subject|1|||
126204063|NCT00719706|454033213|FG001|Overall Study|Withdrawal by Subject|2|||
126204064|NCT00719706|454033212|FG000|Overall Study|Protocol Violation|3|||
126204065|NCT00719706|454033213|FG001|Overall Study|Protocol Violation|0|||
126204066|NCT01270139|454033216|FG000|Overall Study|Adverse Event|8|||
126204067|NCT01270139|454033217|FG001|Overall Study|Adverse Event|17|||
126204068|NCT01270139|454033218|FG002|Overall Study|Adverse Event|18|||
126204069|NCT01270139|454033216|FG000|Overall Study|Lost to Follow-up|10|||
126204070|NCT01270139|454033217|FG001|Overall Study|Lost to Follow-up|9|||
126204071|NCT01270139|454033218|FG002|Overall Study|Lost to Follow-up|2|||
126204072|NCT00134563|454033219|FG000|Overall Study|Not treated due to protocol violation|0|||
126204073|NCT00134563|454033220|FG001|Overall Study|Not treated due to protocol violation|1|||
126204074|NCT00134563|454033221|FG002|Overall Study|Not treated due to protocol violation|1|||
126204075|NCT00134563|454033219|FG000|Overall Study|Adverse Event|29|||
126423776|NCT03798717|454849162|FG003|Overall Study|Failed Screening|0|||
126423777|NCT03798717|454849163|FG004|Overall Study|Failed Screening|0|||
126046438|NCT02719574|453468213|FG012|Phase 2|Protocol Violation|0|||
126423778|NCT03798717|454849164|FG005|Overall Study|Failed Screening|1|||
126423779|NCT03798717|454849159|FG000|Overall Study|Physician Decision|1|||
126423780|NCT03798717|454849160|FG001|Overall Study|Physician Decision|0|||
126423781|NCT03798717|454849161|FG002|Overall Study|Physician Decision|1|||
126423782|NCT03798717|454849162|FG003|Overall Study|Physician Decision|0|||
126423783|NCT03798717|454849163|FG004|Overall Study|Physician Decision|0|||
126423784|NCT03798717|454849164|FG005|Overall Study|Physician Decision|0|||
126423785|NCT03798717|454849159|FG000|Overall Study|Withdrawal by Subject|0|||
126423786|NCT03798717|454849160|FG001|Overall Study|Withdrawal by Subject|0|||
126423787|NCT03798717|454849161|FG002|Overall Study|Withdrawal by Subject|0|||
126423788|NCT03798717|454849162|FG003|Overall Study|Withdrawal by Subject|1|||
126423789|NCT03798717|454849163|FG004|Overall Study|Withdrawal by Subject|0|||
126423790|NCT03798717|454849164|FG005|Overall Study|Withdrawal by Subject|0|||
126423791|NCT03798717|454849159|FG000|Overall Study|Lost to Follow-up|1|||
126423792|NCT03798717|454849160|FG001|Overall Study|Lost to Follow-up|0|||
126423793|NCT03798717|454849161|FG002|Overall Study|Lost to Follow-up|0|||
126423794|NCT03798717|454849162|FG003|Overall Study|Lost to Follow-up|1|||
126423795|NCT03798717|454849163|FG004|Overall Study|Lost to Follow-up|0|||
126423796|NCT03798717|454849164|FG005|Overall Study|Lost to Follow-up|0|||
126423797|NCT03798717|454849159|FG000|Overall Study|Adverse Event|0|||
126423798|NCT03798717|454849160|FG001|Overall Study|Adverse Event|1|||
126423799|NCT03798717|454849161|FG002|Overall Study|Adverse Event|0|||
126423800|NCT03798717|454849162|FG003|Overall Study|Adverse Event|0|||
126423801|NCT03798717|454849163|FG004|Overall Study|Adverse Event|0|||
126423802|NCT03798717|454849164|FG005|Overall Study|Adverse Event|0|||
126423803|NCT03798717|454849159|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423804|NCT03798717|454849160|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423805|NCT03798717|454849161|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423806|NCT03798717|454849162|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423807|NCT03798717|454849163|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
126423808|NCT03798717|454849164|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423809|NCT01777308|454849168|FG000|Overall Study|Withdrawal by Subject|5|||
126423810|NCT01777308|454849169|FG001|Overall Study|Withdrawal by Subject|1|||
126423811|NCT01777308|454849168|FG000|Overall Study|Migrated/moved from study area|1|||
126423812|NCT01777308|454849169|FG001|Overall Study|Migrated/moved from study area|0|||
126204076|NCT00134563|454033220|FG001|Overall Study|Adverse Event|37|||
126204077|NCT00134563|454033221|FG002|Overall Study|Adverse Event|38|||
126204078|NCT00134563|454033219|FG000|Overall Study|Lack of Efficacy|24|||
126204079|NCT00134563|454033220|FG001|Overall Study|Lack of Efficacy|14|||
126204080|NCT00134563|454033221|FG002|Overall Study|Lack of Efficacy|17|||
126204081|NCT00134563|454033219|FG000|Overall Study|Protocol Violation|3|||
126204082|NCT00134563|454033220|FG001|Overall Study|Protocol Violation|2|||
126204083|NCT00134563|454033221|FG002|Overall Study|Protocol Violation|5|||
126204084|NCT00134563|454033219|FG000|Overall Study|Lost to Follow-up|4|||
126204085|NCT00134563|454033220|FG001|Overall Study|Lost to Follow-up|0|||
126204086|NCT00134563|454033221|FG002|Overall Study|Lost to Follow-up|2|||
126204087|NCT00134563|454033219|FG000|Overall Study|progressive disease|11|||
126204088|NCT00134563|454033220|FG001|Overall Study|progressive disease|4|||
126204089|NCT00134563|454033221|FG002|Overall Study|progressive disease|2|||
126204090|NCT00134563|454033219|FG000|Overall Study|did not wish to continue|33|||
126204091|NCT00134563|454033220|FG001|Overall Study|did not wish to continue|32|||
126204092|NCT00134563|454033221|FG002|Overall Study|did not wish to continue|26|||
126204093|NCT00134563|454033219|FG000|Overall Study|Reason other than above|0|||
126204094|NCT00134563|454033220|FG001|Overall Study|Reason other than above|2|||
126204095|NCT00134563|454033221|FG002|Overall Study|Reason other than above|5|||
126204096|NCT02452320|454033225|FG000|Overall Study|Adverse Event|0|||
126204097|NCT02452320|454033226|FG001|Overall Study|Adverse Event|1|||
126204098|NCT02406586|454033227|FG000|Overall Study|Lost to Follow-up|0|||
126204099|NCT02406586|454033228|FG001|Overall Study|Lost to Follow-up|4|||
126204100|NCT02406586|454033229|FG002|Overall Study|Lost to Follow-up|2|||
126204101|NCT02406586|454033227|FG000|Overall Study|Withdrawal by Subject|1|||
126204102|NCT02406586|454033228|FG001|Overall Study|Withdrawal by Subject|0|||
126204103|NCT02406586|454033229|FG002|Overall Study|Withdrawal by Subject|0|||
126204104|NCT03382639|454033230|FG000|Overall Study|Adverse Event|2|||
126204105|NCT03382639|454033231|FG001|Overall Study|Adverse Event|0|||
126204106|NCT03382639|454033232|FG002|Overall Study|Adverse Event|1|||
126204107|NCT03382639|454033233|FG003|Overall Study|Adverse Event|1|||
126204108|NCT03382639|454033230|FG000|Overall Study|Lost to Follow-up|1|||
126204109|NCT03382639|454033231|FG001|Overall Study|Lost to Follow-up|0|||
126204110|NCT03382639|454033232|FG002|Overall Study|Lost to Follow-up|0|||
126204111|NCT03382639|454033233|FG003|Overall Study|Lost to Follow-up|0|||
126204112|NCT03382639|454033230|FG000|Overall Study|Withdrawal by Subject|4|||
126204113|NCT03382639|454033231|FG001|Overall Study|Withdrawal by Subject|3|||
126204114|NCT03382639|454033232|FG002|Overall Study|Withdrawal by Subject|2|||
126204115|NCT03382639|454033233|FG003|Overall Study|Withdrawal by Subject|3|||
126204116|NCT03382639|454033230|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
126204117|NCT03382639|454033231|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
126204118|NCT03382639|454033232|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
126204119|NCT03382639|454033233|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
126204120|NCT03382639|454033230|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
126204121|NCT03382639|454033231|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
126204122|NCT03382639|454033232|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
126204123|NCT03382639|454033233|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
126204124|NCT03382639|454033230|FG000|Overall Study|Other|2|||
126204125|NCT03382639|454033231|FG001|Overall Study|Other|0|||
126204126|NCT03382639|454033232|FG002|Overall Study|Other|0|||
126204127|NCT03382639|454033233|FG003|Overall Study|Other|3|||
126204128|NCT03198559|454033236|FG000|Overall Study|Adverse Event|2|||
126204129|NCT01072175|454033237|FG000|Part A (Drug-Drug Interaction)|Death|1|||
126204130|NCT01072175|454033238|FG001|Part A (Drug-Drug Interaction)|Death|0|||
126204131|NCT01072175|454033239|FG002|Part A (Drug-Drug Interaction)|Death|0|||
126204132|NCT01072175|454033240|FG003|Part A (Drug-Drug Interaction)|Death|0|||
126204133|NCT01072175|454033241|FG004|Part A (Drug-Drug Interaction)|Death|0|||
126204134|NCT01072175|454033242|FG005|Part A (Drug-Drug Interaction)|Death|0|||
126204135|NCT01072175|454033243|FG006|Part A (Drug-Drug Interaction)|Death|0|||
126204136|NCT01072175|454033244|FG007|Part A (Drug-Drug Interaction)|Death|0|||
126204137|NCT01072175|454033245|FG008|Part A (Drug-Drug Interaction)|Death|0|||
126204138|NCT01072175|454033246|FG009|Part A (Drug-Drug Interaction)|Death|0|||
126204139|NCT01072175|454033247|FG010|Part A (Drug-Drug Interaction)|Death|0|||
126204140|NCT01072175|454033248|FG011|Part A (Drug-Drug Interaction)|Death|0|||
126204141|NCT01072175|454033249|FG012|Part A (Drug-Drug Interaction)|Death|0|||
126204142|NCT01072175|454033237|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
126204143|NCT01072175|454033238|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204144|NCT01072175|454033239|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204145|NCT01072175|454033240|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204146|NCT01072175|454033241|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204147|NCT01072175|454033242|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204148|NCT01072175|454033243|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204149|NCT01072175|454033244|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126423813|NCT01777308|454849168|FG000|Overall Study|Lost to Follow-up|7|||
126423814|NCT01777308|454849169|FG001|Overall Study|Lost to Follow-up|2|||
126423815|NCT01777308|454849168|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
126423816|NCT01777308|454849169|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
126423817|NCT03212326|454849171|FG000|Overall Study|Physician Decision|4|||
126423818|NCT00985673|454849183|FG000|Overall Study|Lost to Follow-up|6|||
126423819|NCT00985673|454849184|FG001|Overall Study|Lost to Follow-up|7|||
126423820|NCT00985673|454849185|FG002|Overall Study|Lost to Follow-up|6|||
126423821|NCT00985673|454849186|FG003|Overall Study|Lost to Follow-up|10|||
126423822|NCT00985673|454849187|FG004|Overall Study|Lost to Follow-up|5|||
126423823|NCT00985673|454849188|FG005|Overall Study|Lost to Follow-up|3|||
126423824|NCT00985673|454849183|FG000|Overall Study|Withdrawal by Subject|0|||
126423825|NCT00985673|454849184|FG001|Overall Study|Withdrawal by Subject|4|||
126423826|NCT00985673|454849185|FG002|Overall Study|Withdrawal by Subject|5|||
126423827|NCT00985673|454849186|FG003|Overall Study|Withdrawal by Subject|2|||
126204150|NCT01072175|454033245|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204151|NCT01072175|454033246|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204152|NCT01072175|454033247|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204153|NCT01072175|454033248|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204154|NCT01072175|454033249|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126204155|NCT01072175|454033237|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
126204156|NCT01072175|454033238|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204157|NCT01072175|454033239|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204158|NCT01072175|454033240|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204159|NCT01072175|454033241|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204160|NCT01072175|454033242|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204161|NCT01072175|454033243|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204162|NCT01072175|454033244|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204163|NCT01072175|454033245|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204164|NCT01072175|454033246|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204165|NCT01072175|454033247|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204166|NCT01072175|454033248|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204167|NCT01072175|454033249|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126204168|NCT01072175|454033237|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
126204169|NCT01072175|454033238|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
126423828|NCT00985673|454849187|FG004|Overall Study|Withdrawal by Subject|2|||
126423829|NCT00985673|454849188|FG005|Overall Study|Withdrawal by Subject|3|||
126423830|NCT00985673|454849183|FG000|Overall Study|Other|1|||
126423831|NCT00985673|454849184|FG001|Overall Study|Other|0|||
126423832|NCT00985673|454849185|FG002|Overall Study|Other|1|||
126423833|NCT00985673|454849186|FG003|Overall Study|Other|0|||
126423834|NCT00985673|454849187|FG004|Overall Study|Other|1|||
126423835|NCT00985673|454849188|FG005|Overall Study|Other|0|||
126423836|NCT02252146|454849189|FG000|Overall Study|Lack of Efficacy|4|||
126204170|NCT01072175|454033239|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
126204171|NCT01072175|454033240|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
126204172|NCT01072175|454033241|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
126204173|NCT01072175|454033242|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
126204174|NCT01072175|454033243|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
126204175|NCT01072175|454033244|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
126204176|NCT01072175|454033245|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
126204177|NCT01072175|454033246|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
126204178|NCT01072175|454033247|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
126204179|NCT01072175|454033248|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
126204180|NCT01072175|454033249|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
126204181|NCT01072175|454033237|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204182|NCT01072175|454033238|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204183|NCT01072175|454033239|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
126204184|NCT01072175|454033240|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204185|NCT01072175|454033241|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
126204186|NCT01072175|454033242|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204187|NCT01072175|454033243|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204188|NCT01072175|454033244|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204189|NCT01072175|454033245|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204190|NCT01072175|454033246|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204191|NCT01072175|454033247|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204192|NCT01072175|454033248|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204193|NCT01072175|454033249|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126204194|NCT01072175|454033237|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204195|NCT01072175|454033238|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
126204196|NCT01072175|454033239|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204197|NCT01072175|454033240|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
126204198|NCT01072175|454033241|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
126204199|NCT01072175|454033242|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204200|NCT01072175|454033243|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204201|NCT01072175|454033244|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204202|NCT01072175|454033245|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204203|NCT01072175|454033246|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204204|NCT01072175|454033247|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204205|NCT01072175|454033248|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204206|NCT01072175|454033249|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126204207|NCT01072175|454033237|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204208|NCT01072175|454033238|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204209|NCT01072175|454033239|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
126204210|NCT01072175|454033240|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
126204211|NCT01072175|454033241|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
126204212|NCT01072175|454033242|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204213|NCT01072175|454033243|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204214|NCT01072175|454033244|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204215|NCT01072175|454033245|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204216|NCT01072175|454033246|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204217|NCT01072175|454033247|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204218|NCT01072175|454033248|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204219|NCT01072175|454033249|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126204220|NCT01072175|454033237|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204221|NCT01072175|454033238|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
126204222|NCT01072175|454033239|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204223|NCT01072175|454033240|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
126204224|NCT01072175|454033241|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
126204225|NCT01072175|454033242|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204226|NCT01072175|454033243|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204227|NCT01072175|454033244|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204228|NCT01072175|454033245|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204229|NCT01072175|454033246|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204230|NCT01072175|454033247|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204231|NCT01072175|454033248|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204232|NCT01072175|454033249|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126204233|NCT01072175|454033237|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
126204234|NCT01072175|454033238|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
126204235|NCT01072175|454033239|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
126204236|NCT01072175|454033240|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
126204237|NCT01072175|454033241|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
126204238|NCT01072175|454033242|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
126204239|NCT01072175|454033243|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
126204240|NCT01072175|454033244|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
126204241|NCT01072175|454033245|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
126204242|NCT01072175|454033246|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
126204243|NCT01072175|454033247|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
126204244|NCT01072175|454033248|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
126204245|NCT01072175|454033249|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
126204246|NCT01072175|454033237|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204247|NCT01072175|454033238|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204248|NCT01072175|454033239|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204249|NCT01072175|454033240|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204250|NCT01072175|454033241|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204251|NCT01072175|454033242|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
126204252|NCT01072175|454033243|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
126204253|NCT01072175|454033244|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
126204254|NCT01072175|454033245|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204255|NCT01072175|454033246|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204256|NCT01072175|454033247|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126423837|NCT02252146|454849189|FG000|Overall Study|Entered hospice care|1|||
126423838|NCT02252146|454849189|FG000|Overall Study|Inability to travel to study site|1|||
126423839|NCT00531284|454849192|FG000|Overall Study|Progressive Disease|1|||
126423840|NCT00531284|454849193|FG001|Overall Study|Progressive Disease|3|||
126423841|NCT00531284|454849194|FG002|Overall Study|Progressive Disease|5|||
126423842|NCT00531284|454849195|FG003|Overall Study|Progressive Disease|42|||
126423843|NCT00531284|454849196|FG004|Overall Study|Progressive Disease|4|||
126423844|NCT00531284|454849197|FG005|Overall Study|Progressive Disease|4|||
126423845|NCT00531284|454849198|FG006|Overall Study|Progressive Disease|3|||
126423846|NCT00531284|454849199|FG007|Overall Study|Progressive Disease|8|||
126423847|NCT00531284|454849200|FG008|Overall Study|Progressive Disease|6|||
126423848|NCT00531284|454849201|FG009|Overall Study|Progressive Disease|3|||
126423849|NCT00531284|454849202|FG010|Overall Study|Progressive Disease|3|||
126423850|NCT00531284|454849203|FG011|Overall Study|Progressive Disease|14|||
126423851|NCT00531284|454849204|FG012|Overall Study|Progressive Disease|2|||
126423852|NCT00531284|454849205|FG013|Overall Study|Progressive Disease|1|||
126204257|NCT01072175|454033248|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204258|NCT01072175|454033249|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126204259|NCT01072175|454033237|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204260|NCT01072175|454033238|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204261|NCT01072175|454033239|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204262|NCT01072175|454033240|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204263|NCT01072175|454033241|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204264|NCT01072175|454033242|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204265|NCT01072175|454033243|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
126204266|NCT01072175|454033244|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
126204267|NCT01072175|454033245|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204268|NCT01072175|454033246|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204269|NCT01072175|454033247|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204270|NCT01072175|454033248|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204271|NCT01072175|454033249|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126204272|NCT01072175|454033237|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126204273|NCT01072175|454033238|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126204274|NCT01072175|454033239|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126423853|NCT00531284|454849206|FG014|Overall Study|Progressive Disease|2|||
126423854|NCT00531284|454849207|FG015|Overall Study|Progressive Disease|11|||
126423855|NCT00531284|454849208|FG016|Overall Study|Progressive Disease|5|||
126423856|NCT00531284|454849192|FG000|Overall Study|Adverse Event|0|||
126204275|NCT01072175|454033240|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126204276|NCT01072175|454033241|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126423857|NCT00531284|454849193|FG001|Overall Study|Adverse Event|1|||
126423858|NCT00531284|454849194|FG002|Overall Study|Adverse Event|1|||
126423859|NCT00531284|454849195|FG003|Overall Study|Adverse Event|7|||
126423860|NCT00531284|454849196|FG004|Overall Study|Adverse Event|0|||
126423861|NCT00531284|454849197|FG005|Overall Study|Adverse Event|2|||
126423862|NCT00531284|454849198|FG006|Overall Study|Adverse Event|3|||
126423863|NCT00531284|454849199|FG007|Overall Study|Adverse Event|2|||
126423864|NCT00531284|454849200|FG008|Overall Study|Adverse Event|3|||
126423865|NCT00531284|454849201|FG009|Overall Study|Adverse Event|0|||
126423866|NCT00531284|454849202|FG010|Overall Study|Adverse Event|0|||
126204277|NCT01072175|454033242|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
126204278|NCT01072175|454033243|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
126204279|NCT01072175|454033244|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
126204280|NCT01072175|454033245|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126204281|NCT01072175|454033246|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126204282|NCT01072175|454033247|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126204283|NCT01072175|454033248|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126204284|NCT01072175|454033249|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126204285|NCT01072175|454033237|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204286|NCT01072175|454033238|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204287|NCT01072175|454033239|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204288|NCT01072175|454033240|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204289|NCT01072175|454033241|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204290|NCT01072175|454033242|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
126423867|NCT00531284|454849203|FG011|Overall Study|Adverse Event|5|||
126423868|NCT00531284|454849204|FG012|Overall Study|Adverse Event|0|||
126423869|NCT00531284|454849205|FG013|Overall Study|Adverse Event|1|||
126423870|NCT00531284|454849206|FG014|Overall Study|Adverse Event|1|||
126423871|NCT00531284|454849207|FG015|Overall Study|Adverse Event|0|||
126423872|NCT00531284|454849208|FG016|Overall Study|Adverse Event|2|||
126423873|NCT00531284|454849192|FG000|Overall Study|Withdrawal by Subject|1|||
126423874|NCT00531284|454849193|FG001|Overall Study|Withdrawal by Subject|0|||
126423875|NCT00531284|454849194|FG002|Overall Study|Withdrawal by Subject|0|||
126423876|NCT00531284|454849195|FG003|Overall Study|Withdrawal by Subject|4|||
126423877|NCT00531284|454849196|FG004|Overall Study|Withdrawal by Subject|0|||
126423878|NCT00531284|454849197|FG005|Overall Study|Withdrawal by Subject|0|||
126423879|NCT00531284|454849198|FG006|Overall Study|Withdrawal by Subject|0|||
126423880|NCT00531284|454849199|FG007|Overall Study|Withdrawal by Subject|0|||
126423881|NCT00531284|454849200|FG008|Overall Study|Withdrawal by Subject|0|||
126423882|NCT00531284|454849201|FG009|Overall Study|Withdrawal by Subject|0|||
126423883|NCT00531284|454849202|FG010|Overall Study|Withdrawal by Subject|0|||
126204291|NCT01072175|454033243|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
126204292|NCT01072175|454033244|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204293|NCT01072175|454033245|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204294|NCT01072175|454033246|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204295|NCT01072175|454033247|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204296|NCT01072175|454033248|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126204297|NCT01072175|454033249|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126423884|NCT00531284|454849203|FG011|Overall Study|Withdrawal by Subject|3|||
126423885|NCT00531284|454849204|FG012|Overall Study|Withdrawal by Subject|0|||
126423886|NCT00531284|454849205|FG013|Overall Study|Withdrawal by Subject|1|||
126423887|NCT00531284|454849206|FG014|Overall Study|Withdrawal by Subject|0|||
126423888|NCT00531284|454849207|FG015|Overall Study|Withdrawal by Subject|1|||
126423889|NCT00531284|454849208|FG016|Overall Study|Withdrawal by Subject|1|||
126423890|NCT00531284|454849192|FG000|Overall Study|Other|1|||
126423891|NCT00531284|454849193|FG001|Overall Study|Other|0|||
126423892|NCT00531284|454849194|FG002|Overall Study|Other|0|||
126423893|NCT00531284|454849195|FG003|Overall Study|Other|10|||
126423894|NCT00531284|454849196|FG004|Overall Study|Other|2|||
126423895|NCT00531284|454849197|FG005|Overall Study|Other|1|||
126423896|NCT00531284|454849198|FG006|Overall Study|Other|0|||
126423897|NCT00531284|454849199|FG007|Overall Study|Other|0|||
126423898|NCT00531284|454849200|FG008|Overall Study|Other|2|||
126423899|NCT00531284|454849201|FG009|Overall Study|Other|1|||
126423900|NCT00531284|454849202|FG010|Overall Study|Other|0|||
126423901|NCT00531284|454849203|FG011|Overall Study|Other|2|||
126423902|NCT00531284|454849204|FG012|Overall Study|Other|0|||
126423903|NCT00531284|454849205|FG013|Overall Study|Other|0|||
126423904|NCT00531284|454849206|FG014|Overall Study|Other|1|||
126423905|NCT00531284|454849207|FG015|Overall Study|Other|0|||
126423906|NCT00531284|454849208|FG016|Overall Study|Other|0|||
126423907|NCT02219464|454849210|FG000|Overall Study|Withdrawal by Subject|1|||
126423908|NCT02219464|454849211|FG001|Overall Study|Withdrawal by Subject|0|||
126423909|NCT02219464|454849210|FG000|Overall Study|case cancelled|1|||
126423910|NCT02219464|454849211|FG001|Overall Study|case cancelled|0|||
126423911|NCT02219464|454849210|FG000|Overall Study|catheter malfunction|1|||
126423912|NCT02219464|454849211|FG001|Overall Study|catheter malfunction|0|||
126423913|NCT00984256|454849212|FG000|Overall Study|Withdrawal by Subject|0|||
126423914|NCT00984256|454849213|FG001|Overall Study|Withdrawal by Subject|1|||
126423915|NCT03057496|454849214|FG000|Overall Study|Withdrawal by Subject|8|||
126423916|NCT03057496|454849214|FG000|Overall Study|Lost to Follow-up|5|||
126423917|NCT03057496|454849214|FG000|Overall Study|Did not use device during home trial|3|||
126423918|NCT03057496|454849214|FG000|Overall Study|Device failure|2|||
126423919|NCT00280917|454849220|FG000|Overall Study|Adverse Event|1|||
126423920|NCT00280917|454849221|FG001|Overall Study|Adverse Event|1|||
126423921|NCT00280917|454849222|FG002|Overall Study|Adverse Event|4|||
126423922|NCT00280917|454849223|FG003|Overall Study|Adverse Event|1|||
126423923|NCT00280917|454849220|FG000|Overall Study|Change Therapy|1|||
126423924|NCT00280917|454849221|FG001|Overall Study|Change Therapy|2|||
126423925|NCT00280917|454849222|FG002|Overall Study|Change Therapy|0|||
126423926|NCT00280917|454849223|FG003|Overall Study|Change Therapy|0|||
126423927|NCT00280917|454849220|FG000|Overall Study|Withdrawal by Subject|0|||
126423928|NCT00280917|454849221|FG001|Overall Study|Withdrawal by Subject|2|||
126423929|NCT00280917|454849222|FG002|Overall Study|Withdrawal by Subject|0|||
126204298|NCT01072175|454033237|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204299|NCT01072175|454033238|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204300|NCT01072175|454033239|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204301|NCT01072175|454033240|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204302|NCT01072175|454033241|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204303|NCT01072175|454033242|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204304|NCT01072175|454033243|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204305|NCT01072175|454033244|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126423930|NCT00280917|454849223|FG003|Overall Study|Withdrawal by Subject|1|||
126423931|NCT00280917|454849220|FG000|Overall Study|Noncompliance|0|||
126423932|NCT00280917|454849221|FG001|Overall Study|Noncompliance|1|||
126423933|NCT00280917|454849222|FG002|Overall Study|Noncompliance|2|||
126423934|NCT00280917|454849223|FG003|Overall Study|Noncompliance|0|||
126423935|NCT02544321|454849230|FG000|Overall Study|Withdrawal by Subject|1|||
126423936|NCT02544321|454849231|FG001|Overall Study|Withdrawal by Subject|2|||
126423937|NCT02544321|454849230|FG000|Overall Study|Adverse Event|1|||
126423938|NCT02544321|454849231|FG001|Overall Study|Adverse Event|1|||
126423939|NCT02544321|454849230|FG000|Overall Study|Protocol Violation|0|||
126204306|NCT01072175|454033245|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
126423940|NCT02544321|454849231|FG001|Overall Study|Protocol Violation|1|||
126423941|NCT01584232|454849232|FG000|Overall Study|Adverse Event|3|||
126423942|NCT01584232|454849233|FG001|Overall Study|Adverse Event|1|||
126423943|NCT01584232|454849232|FG000|Overall Study|Withdrawal by Subject|2|||
126423944|NCT01584232|454849233|FG001|Overall Study|Withdrawal by Subject|1|||
126423945|NCT01584232|454849232|FG000|Overall Study|Physician Decision|2|||
126204307|NCT01072175|454033246|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204308|NCT01072175|454033247|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204309|NCT01072175|454033248|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204310|NCT01072175|454033249|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126204311|NCT01072175|454033237|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204312|NCT01072175|454033238|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204313|NCT01072175|454033239|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204314|NCT01072175|454033240|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204315|NCT01072175|454033241|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204316|NCT01072175|454033242|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204317|NCT01072175|454033243|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204318|NCT01072175|454033244|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204319|NCT01072175|454033245|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
126204320|NCT01072175|454033246|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204321|NCT01072175|454033247|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204322|NCT01072175|454033248|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204323|NCT01072175|454033249|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126204324|NCT01072175|454033237|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204325|NCT01072175|454033238|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204326|NCT01072175|454033239|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204327|NCT01072175|454033240|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204328|NCT01072175|454033241|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204329|NCT01072175|454033242|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204330|NCT01072175|454033243|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204331|NCT01072175|454033244|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204332|NCT01072175|454033245|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
126204333|NCT01072175|454033246|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204334|NCT01072175|454033247|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204335|NCT01072175|454033248|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204336|NCT01072175|454033249|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126204337|NCT01072175|454033237|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204338|NCT01072175|454033238|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204339|NCT01072175|454033239|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204340|NCT01072175|454033240|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204341|NCT01072175|454033241|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204342|NCT01072175|454033242|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204343|NCT01072175|454033243|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204344|NCT01072175|454033244|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204345|NCT01072175|454033245|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
126204346|NCT01072175|454033246|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204347|NCT01072175|454033247|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204348|NCT01072175|454033248|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204349|NCT01072175|454033249|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126204350|NCT01072175|454033237|FG000|Part D (HPMC Capsules)|Death|0|||
126204351|NCT01072175|454033238|FG001|Part D (HPMC Capsules)|Death|0|||
126204352|NCT01072175|454033239|FG002|Part D (HPMC Capsules)|Death|0|||
126204353|NCT01072175|454033240|FG003|Part D (HPMC Capsules)|Death|0|||
126204354|NCT01072175|454033241|FG004|Part D (HPMC Capsules)|Death|0|||
126204355|NCT01072175|454033242|FG005|Part D (HPMC Capsules)|Death|0|||
126204356|NCT01072175|454033243|FG006|Part D (HPMC Capsules)|Death|0|||
126204357|NCT01072175|454033244|FG007|Part D (HPMC Capsules)|Death|0|||
126204358|NCT01072175|454033245|FG008|Part D (HPMC Capsules)|Death|0|||
126204359|NCT01072175|454033246|FG009|Part D (HPMC Capsules)|Death|10|||
126204360|NCT01072175|454033247|FG010|Part D (HPMC Capsules)|Death|12|||
126204361|NCT01072175|454033248|FG011|Part D (HPMC Capsules)|Death|28|||
126204362|NCT01072175|454033249|FG012|Part D (HPMC Capsules)|Death|26|||
126204363|NCT01072175|454033237|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
126204364|NCT01072175|454033238|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
126204365|NCT01072175|454033239|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
126204366|NCT01072175|454033240|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
126204367|NCT01072175|454033241|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
126204368|NCT01072175|454033242|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
126204369|NCT01072175|454033243|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
126204370|NCT01072175|454033244|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
126204371|NCT01072175|454033245|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
126204372|NCT01072175|454033246|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
126423946|NCT01584232|454849233|FG001|Overall Study|Physician Decision|1|||
126204373|NCT01072175|454033247|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
126423947|NCT01584232|454849232|FG000|Overall Study|Lost to Follow-up|1|||
126423948|NCT01584232|454849233|FG001|Overall Study|Lost to Follow-up|0|||
126423949|NCT01307319|454849234|FG000|Overall Study|Adverse Event|2|||
126423950|NCT01307319|454849235|FG001|Overall Study|Adverse Event|2|||
126423951|NCT01307319|454849236|FG002|Overall Study|Adverse Event|1|||
126423952|NCT01307319|454849234|FG000|Overall Study|Lost to Follow-up|1|||
126423953|NCT01307319|454849235|FG001|Overall Study|Lost to Follow-up|0|||
126423954|NCT01307319|454849236|FG002|Overall Study|Lost to Follow-up|1|||
126423955|NCT01307319|454849234|FG000|Overall Study|Protocol Violation|1|||
126423956|NCT01307319|454849235|FG001|Overall Study|Protocol Violation|1|||
126423957|NCT01307319|454849236|FG002|Overall Study|Protocol Violation|0|||
126423958|NCT01307319|454849234|FG000|Overall Study|Withdrawal by Subject|0|||
126423959|NCT01307319|454849235|FG001|Overall Study|Withdrawal by Subject|1|||
126423960|NCT01307319|454849236|FG002|Overall Study|Withdrawal by Subject|2|||
126423961|NCT01307319|454849234|FG000|Overall Study|Other|0|||
126423962|NCT01307319|454849235|FG001|Overall Study|Other|4|||
126423963|NCT01307319|454849236|FG002|Overall Study|Other|3|||
126423964|NCT03347123|454849238|FG000|Overall Study|Death|1|||
126423965|NCT03347123|454849239|FG001|Overall Study|Death|2|||
126423966|NCT03347123|454849240|FG002|Overall Study|Death|0|||
126423967|NCT03347123|454849241|FG003|Overall Study|Death|0|||
126423968|NCT03347123|454849242|FG004|Overall Study|Death|0|||
126423969|NCT03347123|454849243|FG005|Overall Study|Death|0|||
126423970|NCT03347123|454849244|FG006|Overall Study|Death|0|||
126423971|NCT03347123|454849238|FG000|Overall Study|Withdrawal by Subject|1|||
126423972|NCT03347123|454849239|FG001|Overall Study|Withdrawal by Subject|0|||
126423973|NCT03347123|454849240|FG002|Overall Study|Withdrawal by Subject|0|||
126423974|NCT03347123|454849241|FG003|Overall Study|Withdrawal by Subject|0|||
126423975|NCT03347123|454849242|FG004|Overall Study|Withdrawal by Subject|0|||
126423976|NCT03347123|454849243|FG005|Overall Study|Withdrawal by Subject|0|||
126423977|NCT03347123|454849244|FG006|Overall Study|Withdrawal by Subject|0|||
126423978|NCT03347123|454849238|FG000|Overall Study|Reason not Specified|3|||
126423979|NCT03347123|454849239|FG001|Overall Study|Reason not Specified|4|||
126423980|NCT03347123|454849240|FG002|Overall Study|Reason not Specified|0|||
126423981|NCT03347123|454849241|FG003|Overall Study|Reason not Specified|0|||
126423982|NCT03347123|454849242|FG004|Overall Study|Reason not Specified|0|||
126423983|NCT03347123|454849243|FG005|Overall Study|Reason not Specified|0|||
126423984|NCT03347123|454849244|FG006|Overall Study|Reason not Specified|0|||
126423985|NCT01132807|454849246|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
126423986|NCT01132807|454849247|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
126423987|NCT01132807|454849248|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
126423988|NCT01132807|454849246|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
126423989|NCT01132807|454849247|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
126423990|NCT01132807|454849248|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
126423991|NCT01731912|454849252|FG000|Overall Study|noncompliance|2|||
126423992|NCT02043938|454849253|FG000|Overall Study|Withdrawal by Subject|7|||
126204374|NCT01072175|454033248|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
126423993|NCT02043938|454849253|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
126204375|NCT01072175|454033249|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
126204376|NCT01072175|454033237|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204377|NCT01072175|454033238|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204378|NCT01072175|454033239|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204379|NCT01072175|454033240|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204380|NCT01072175|454033241|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204381|NCT01072175|454033242|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204382|NCT01072175|454033243|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204383|NCT01072175|454033244|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204384|NCT01072175|454033245|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204385|NCT01072175|454033246|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126204386|NCT01072175|454033247|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
126204387|NCT01072175|454033248|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
126204388|NCT01072175|454033249|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
126204389|NCT01072175|454033237|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204390|NCT01072175|454033238|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204391|NCT01072175|454033239|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204392|NCT01072175|454033240|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204393|NCT01072175|454033241|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204394|NCT01072175|454033242|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204395|NCT01072175|454033243|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204396|NCT01072175|454033244|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204397|NCT01072175|454033245|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
126204398|NCT01072175|454033246|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
126204399|NCT01072175|454033247|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
126204400|NCT01072175|454033248|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
126204401|NCT01072175|454033249|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
126204402|NCT01072175|454033237|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204403|NCT01072175|454033238|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204404|NCT01072175|454033239|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204405|NCT01072175|454033240|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204406|NCT01072175|454033241|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204407|NCT01072175|454033242|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204408|NCT01072175|454033243|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204409|NCT01072175|454033244|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204410|NCT01072175|454033245|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204411|NCT01072175|454033246|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204412|NCT01072175|454033247|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
126204413|NCT01072175|454033248|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
126204414|NCT01072175|454033249|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126204415|NCT00682539|454033250|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
126204416|NCT00682539|454033251|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
126204417|NCT00682539|454033252|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
126204418|NCT00682539|454033250|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
126204419|NCT00682539|454033251|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
126204420|NCT00682539|454033252|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
126204421|NCT02477215|454033255|FG000|Dose Escalation Phase|Physician Decision|1|||
126204422|NCT02477215|454033256|FG001|Dose Escalation Phase|Physician Decision|2|||
126204423|NCT02477215|454033257|FG002|Dose Escalation Phase|Physician Decision|0|||
126204424|NCT02477215|454033255|FG000|Fixed Dose Phase|Physician Decision|0|||
126204425|NCT02477215|454033256|FG001|Fixed Dose Phase|Physician Decision|7|||
126204426|NCT02477215|454033257|FG002|Fixed Dose Phase|Physician Decision|0|||
126204427|NCT01911546|454033260|FG000|Overall Study|Lost to Follow-up|1|||
126204428|NCT01911546|454033260|FG000|Overall Study|Everolimus was discontinued|5|||
126204429|NCT02210559|454033261|FG000|Overall Study|Progressive Disease|3|||
126204430|NCT02210559|454033262|FG001|Overall Study|Progressive Disease|2|||
126204431|NCT02210559|454033261|FG000|Overall Study|Adverse Event|2|||
126204432|NCT02210559|454033262|FG001|Overall Study|Adverse Event|2|||
126204433|NCT02210559|454033261|FG000|Overall Study|Physician Decision|1|||
126204434|NCT02210559|454033262|FG001|Overall Study|Physician Decision|0|||
126204435|NCT02210559|454033261|FG000|Overall Study|Withdrawal by Subject|0|||
126204436|NCT02210559|454033262|FG001|Overall Study|Withdrawal by Subject|1|||
126204437|NCT02210559|454033261|FG000|Overall Study|Other than specified|0|||
126204438|NCT02210559|454033262|FG001|Overall Study|Other than specified|1|||
126204439|NCT02546193|454033263|FG000|Overall Study|Withdrawal by Subject|2|||
126204440|NCT02546193|454033264|FG001|Overall Study|Withdrawal by Subject|0|||
126204441|NCT02546193|454033265|FG002|Overall Study|Withdrawal by Subject|1|||
126204442|NCT02546193|454033266|FG003|Overall Study|Withdrawal by Subject|0|||
126204443|NCT02546193|454033263|FG000|Overall Study|Not eligible at time of induction|4|||
126204444|NCT02546193|454033264|FG001|Overall Study|Not eligible at time of induction|6|||
126204445|NCT02546193|454033265|FG002|Overall Study|Not eligible at time of induction|1|||
126204446|NCT02546193|454033266|FG003|Overall Study|Not eligible at time of induction|0|||
126204447|NCT01474291|454033267|FG000|Overall Study|Not Evaluable for Efficacy|26|||
126204448|NCT01474291|454033267|FG000|Overall Study|Lack of Treatment Efficacy|88|||
126204449|NCT01474291|454033267|FG000|Overall Study|Adverse Event|53|||
126204450|NCT01474291|454033267|FG000|Overall Study|Lost to Follow-up|29|||
126204451|NCT01474291|454033267|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
126204452|NCT01474291|454033267|FG000|Overall Study|No Reason Reported|10|||
126204453|NCT01474291|454033267|FG000|Overall Study|Death|2|||
126204454|NCT01287403|454033268|FG000|1st Intervention (1 Day)|Adverse Event|1|||
126204455|NCT00148109|454033269|FG000|Overall Study|Lack of Efficacy|10|||
126204456|NCT00148109|454033270|FG001|Overall Study|Lack of Efficacy|18|||
126204457|NCT00148109|454033269|FG000|Overall Study|Adverse Event|0|||
126204458|NCT00148109|454033270|FG001|Overall Study|Adverse Event|2|||
126204459|NCT00148109|454033269|FG000|Overall Study|Withdrawal by Subject|2|||
126204460|NCT00148109|454033270|FG001|Overall Study|Withdrawal by Subject|0|||
126204461|NCT00665002|454033271|FG000|Overall Study|Progression/relapse during treatment|11|||
126204462|NCT00665002|454033271|FG000|Overall Study|Cytogenetic resistance|1|||
126204463|NCT00697255|454033272|FG000|Stage 1a|Insufficient ovarian response|1|||
126204464|NCT00697255|454033273|FG001|Stage 1a|Insufficient ovarian response|0|||
126204465|NCT00697255|454033272|FG000|Stage 1a|Multifollicular growth|1|||
126204466|NCT00697255|454033273|FG001|Stage 1a|Multifollicular growth|0|||
126204467|NCT00697255|454033272|FG000|Stage 1a|Not growing of dominant follicle|1|||
126204468|NCT00697255|454033273|FG001|Stage 1a|Not growing of dominant follicle|0|||
126204469|NCT00697255|454033272|FG000|Stage 1b|Not growing of dominant follicle|0|||
126204470|NCT00697255|454033273|FG001|Stage 1b|Not growing of dominant follicle|1|||
126204471|NCT00697255|454033272|FG000|Stage 1b|Insufficient ovarian response|0|||
126204472|NCT00697255|454033273|FG001|Stage 1b|Insufficient ovarian response|1|||
126204473|NCT01303159|454033281|FG000|Overall Study|Death|16|||
126204474|NCT01303159|454033281|FG000|Overall Study|Study Termination|7|||
126204475|NCT02243306|454033282|FG000|Overall Study|Adverse Event|0|||
126204476|NCT02243306|454033283|FG001|Overall Study|Adverse Event|1|||
126204477|NCT02243306|454033282|FG000|Overall Study|Other: Reached stopping criteria|0|||
126204478|NCT02243306|454033283|FG001|Overall Study|Other: Reached stopping criteria|1|||
126204479|NCT02243306|454033282|FG000|Overall Study|Physician Decision|0|||
126204480|NCT02243306|454033283|FG001|Overall Study|Physician Decision|1|||
126204481|NCT00496782|454033287|FG000|Overall Study|Protocol Violation|1|||
126204482|NCT00496782|454033288|FG001|Overall Study|Protocol Violation|2|||
126204483|NCT01005875|454033300|FG000|Overall Study|Death|3|||
126204484|NCT00242658|454033303|FG000|Overall Study|Lost to Follow-up|22|||
126204485|NCT00242658|454033304|FG001|Overall Study|Lost to Follow-up|19|||
126204486|NCT01815099|454033305|FG000|Overall Study|Lack of Efficacy|1|||
126204487|NCT01815099|454033305|FG000|Overall Study|unable to attend study visits|1|||
126204488|NCT00643851|454033306|FG000|Overall Study|Death|0|||
126204489|NCT00643851|454033307|FG001|Overall Study|Death|1|||
126204490|NCT00643851|454033308|FG002|Overall Study|Death|0|||
126204491|NCT00643851|454033306|FG000|Overall Study|Lack of Efficacy|0|||
126204492|NCT00643851|454033307|FG001|Overall Study|Lack of Efficacy|1|||
126204493|NCT00643851|454033308|FG002|Overall Study|Lack of Efficacy|0|||
126204494|NCT00643851|454033306|FG000|Overall Study|Adverse Event|2|||
126204495|NCT00643851|454033307|FG001|Overall Study|Adverse Event|6|||
126204496|NCT00643851|454033308|FG002|Overall Study|Adverse Event|6|||
126204497|NCT00643851|454033306|FG000|Overall Study|Lost to Follow-up|4|||
126204498|NCT00643851|454033307|FG001|Overall Study|Lost to Follow-up|6|||
126204499|NCT00643851|454033308|FG002|Overall Study|Lost to Follow-up|9|||
126204500|NCT00643851|454033306|FG000|Overall Study|Withdrawal by Subject|8|||
126204501|NCT00643851|454033307|FG001|Overall Study|Withdrawal by Subject|15|||
126204502|NCT00643851|454033308|FG002|Overall Study|Withdrawal by Subject|9|||
126204503|NCT00643851|454033306|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
126204504|NCT00643851|454033307|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
126204505|NCT00643851|454033308|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
126204506|NCT04806334|454033311|FG000|Overall Study|Withdrawal by Subject|1|||
126204507|NCT04557189|454033312|FG000|Overall Study|Adverse Event|0|||
126204508|NCT04557189|454033313|FG001|Overall Study|Adverse Event|1|||
126204509|NCT04557189|454033312|FG000|Overall Study|Lost to Follow-up|1|||
126204510|NCT04557189|454033313|FG001|Overall Study|Lost to Follow-up|1|||
126204511|NCT04557189|454033312|FG000|Overall Study|Withdrawal by Subject|2|||
126204512|NCT04557189|454033313|FG001|Overall Study|Withdrawal by Subject|1|||
126204513|NCT04557189|454033312|FG000|Overall Study|Reason not Specified|3|||
126204514|NCT04557189|454033313|FG001|Overall Study|Reason not Specified|6|||
126204515|NCT01731600|454033316|FG000|Overall Study|Adverse Event|2|||
126204516|NCT01731600|454033317|FG001|Overall Study|Adverse Event|0|||
126204517|NCT01731600|454033316|FG000|Overall Study|Withdrawal criteria|1|||
126204518|NCT01731600|454033317|FG001|Overall Study|Withdrawal criteria|0|||
126204519|NCT01731600|454033316|FG000|Overall Study|Other reasons|3|||
126204520|NCT01731600|454033317|FG001|Overall Study|Other reasons|0|||
126204521|NCT00465894|454033318|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
126204522|NCT00465894|454033319|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
126204523|NCT00465894|454033318|FG000|Treatment For 12 Weeks|Family Issues|1|||
126204524|NCT00465894|454033319|FG001|Treatment For 12 Weeks|Family Issues|1|||
126204525|NCT00465894|454033318|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
126204526|NCT00465894|454033319|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
126204527|NCT01636076|454033320|FG000|Overall Study|Terminated by sponsor|1|||
126204528|NCT01636076|454033321|FG001|Overall Study|Terminated by sponsor|1|||
126204529|NCT01636076|454033320|FG000|Overall Study|Lack of Efficacy|0|||
126204530|NCT01636076|454033321|FG001|Overall Study|Lack of Efficacy|1|||
126204531|NCT01636076|454033320|FG000|Overall Study|Lost to Follow-up|1|||
126204532|NCT01636076|454033321|FG001|Overall Study|Lost to Follow-up|0|||
126204533|NCT01636076|454033320|FG000|Overall Study|Physician Decision|1|||
126204534|NCT01636076|454033321|FG001|Overall Study|Physician Decision|1|||
126204535|NCT01636076|454033320|FG000|Overall Study|Non-compliance with study treatment|1|||
126204536|NCT01636076|454033321|FG001|Overall Study|Non-compliance with study treatment|1|||
126204537|NCT01636076|454033320|FG000|Overall Study|Adverse Event|6|||
126204538|NCT01636076|454033321|FG001|Overall Study|Adverse Event|11|||
126204539|NCT01636076|454033320|FG000|Overall Study|Withdrawal by Subject|7|||
126204540|NCT01636076|454033321|FG001|Overall Study|Withdrawal by Subject|10|||
126204541|NCT02173158|454033323|FG000|Efficacy Phase|Adverse Event|1|||
126204542|NCT01728454|454033335|FG000|Stage 1 and 2|Pregnancy|1|||
126204543|NCT01728454|454033336|FG001|Stage 1 and 2|Pregnancy|0|||
126204544|NCT01728454|454033337|FG002|Stage 1 and 2|Pregnancy|0|||
126204545|NCT01728454|454033335|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
126204546|NCT01728454|454033336|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
126204547|NCT01728454|454033337|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
126204548|NCT01728454|454033335|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
126204549|NCT01728454|454033336|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
126204550|NCT01728454|454033337|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
126204551|NCT01728454|454033335|FG000|Stage 1 and 2|Lost to Follow-up|1|||
126204552|NCT01728454|454033336|FG001|Stage 1 and 2|Lost to Follow-up|1|||
126204553|NCT01728454|454033337|FG002|Stage 1 and 2|Lost to Follow-up|0|||
126204554|NCT01728454|454033335|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
126204555|NCT01728454|454033336|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
126204556|NCT01728454|454033337|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
126204557|NCT01728454|454033335|FG000|Stage 3|Reason Missing|0|||
126204558|NCT01728454|454033336|FG001|Stage 3|Reason Missing|0|||
126204559|NCT01728454|454033337|FG002|Stage 3|Reason Missing|1|||
126204560|NCT01728454|454033335|FG000|Stage 3|Subject Required Other Treatment|0|||
126204561|NCT01728454|454033336|FG001|Stage 3|Subject Required Other Treatment|1|||
126204562|NCT01728454|454033337|FG002|Stage 3|Subject Required Other Treatment|0|||
126204563|NCT01728454|454033335|FG000|Stage 3|Pregnancy|1|||
126204564|NCT01728454|454033336|FG001|Stage 3|Pregnancy|0|||
126204565|NCT01728454|454033337|FG002|Stage 3|Pregnancy|0|||
126204566|NCT01728454|454033335|FG000|Stage 3|Withdrew Consent|1|||
126204567|NCT01728454|454033336|FG001|Stage 3|Withdrew Consent|0|||
126204568|NCT01728454|454033337|FG002|Stage 3|Withdrew Consent|1|||
126204569|NCT01728454|454033335|FG000|Stage 3|Non-compliance with Protocol|0|||
126204570|NCT01728454|454033336|FG001|Stage 3|Non-compliance with Protocol|0|||
126204571|NCT01728454|454033337|FG002|Stage 3|Non-compliance with Protocol|1|||
126204572|NCT01728454|454033335|FG000|Stage 3|Lost to Follow-up|0|||
126204573|NCT01728454|454033336|FG001|Stage 3|Lost to Follow-up|3|||
126204574|NCT01728454|454033337|FG002|Stage 3|Lost to Follow-up|1|||
126204575|NCT01728454|454033335|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
126204576|NCT01728454|454033336|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
126204577|NCT01728454|454033337|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
126204578|NCT01190839|454033338|FG000|Overall Study|Adverse Event|32|||
126204579|NCT01190839|454033339|FG001|Overall Study|Adverse Event|41|||
126204580|NCT01190839|454033338|FG000|Overall Study|Protocol Violation|2|||
126204581|NCT01190839|454033339|FG001|Overall Study|Protocol Violation|2|||
126204582|NCT01190839|454033338|FG000|Overall Study|Lost to Follow-up|7|||
126204583|NCT01190839|454033339|FG001|Overall Study|Lost to Follow-up|1|||
126204584|NCT01190839|454033338|FG000|Overall Study|Death|1|||
126204585|NCT01190839|454033339|FG001|Overall Study|Death|0|||
126204586|NCT01190839|454033338|FG000|Overall Study|Trial stopped by Sponsor|71|||
126204587|NCT01190839|454033339|FG001|Overall Study|Trial stopped by Sponsor|68|||
126204588|NCT01190839|454033338|FG000|Overall Study|Undefined|35|||
126204589|NCT01190839|454033339|FG001|Overall Study|Undefined|31|||
126204590|NCT01190839|454033338|FG000|Overall Study|Randomized but not treated|2|||
126204591|NCT01190839|454033339|FG001|Overall Study|Randomized but not treated|4|||
126204592|NCT03077646|454033343|FG000|Overall Study|Lost to Follow-up|29|||
126204593|NCT03077646|454033344|FG001|Overall Study|Lost to Follow-up|30|||
126204594|NCT03077646|454033345|FG002|Overall Study|Lost to Follow-up|31|||
126204595|NCT02058966|454033346|FG000|Open-Label Methamphetamine|Adverse Event|1|||
126204596|NCT02058966|454033346|FG000|First Intervention|Withdrawal by Subject|1|||
126204597|NCT00765726|454033347|FG000|Overall Study|Withdrawal by Subject|1|||
126204598|NCT00765726|454033347|FG000|Overall Study|Discontinuation of study by sponsor|8|||
126204599|NCT01265511|454033348|FG000|Overall Study|Lack of Efficacy|2|||
126204600|NCT01265511|454033349|FG001|Overall Study|Lack of Efficacy|1|||
126204601|NCT01265511|454033348|FG000|Overall Study|Met stopping rules|0|||
126204602|NCT01265511|454033349|FG001|Overall Study|Met stopping rules|2|||
126204603|NCT00323479|454033350|FG000|Overall Study|Adverse Event|2|||
126204604|NCT00323479|454033350|FG000|Overall Study|Withdrawal by Subject|2|||
126204605|NCT00323479|454033350|FG000|Overall Study|Protocol Violation|3|||
126204606|NCT00323479|454033350|FG000|Overall Study|house moving|1|||
126204607|NCT01362062|454033351|FG000|Overall Study|Adverse Event|1|||
126204608|NCT01362062|454033352|FG001|Overall Study|Adverse Event|0|||
126204609|NCT01362062|454033351|FG000|Overall Study|Lost to Follow-up|11|||
126204610|NCT01362062|454033352|FG001|Overall Study|Lost to Follow-up|0|||
126204611|NCT01362062|454033351|FG000|Overall Study|Withdrawal by Subject|2|||
126204612|NCT01362062|454033352|FG001|Overall Study|Withdrawal by Subject|0|||
126204613|NCT01362062|454033351|FG000|Overall Study|Non-compliant participant|2|||
126204614|NCT01362062|454033352|FG001|Overall Study|Non-compliant participant|0|||
126204615|NCT01362062|454033351|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
126204616|NCT01362062|454033352|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
126204617|NCT01362062|454033351|FG000|Overall Study|Had significant improvement|9|||
126204618|NCT01362062|454033352|FG001|Overall Study|Had significant improvement|0|||
126204619|NCT02545504|454033354|FG000|Overall Study|Death|174|||
126204620|NCT02545504|454033355|FG001|Overall Study|Death|168|||
126204621|NCT02545504|454033354|FG000|Overall Study|Unknown reason|30|||
126204622|NCT02545504|454033355|FG001|Overall Study|Unknown reason|32|||
126204623|NCT02545504|454033354|FG000|Overall Study|Withdrew consent|9|||
126204624|NCT02545504|454033355|FG001|Overall Study|Withdrew consent|11|||
126204625|NCT02545504|454033354|FG000|Overall Study|Investigator's discretion|3|||
126204626|NCT02545504|454033355|FG001|Overall Study|Investigator's discretion|1|||
126204627|NCT02545504|454033354|FG000|Overall Study|Lost to Follow-up|2|||
126204628|NCT02545504|454033355|FG001|Overall Study|Lost to Follow-up|2|||
126204629|NCT00967343|454033357|FG000|Overall Study|Study termination by sponsor|12|||
126204630|NCT00967343|454033357|FG000|Overall Study|Death|24|||
126204631|NCT00967343|454033357|FG000|Overall Study|Relapse|1|||
126204632|NCT00967343|454033357|FG000|Overall Study|Lost to Follow-up|1|||
126204633|NCT00950755|454033358|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
126204634|NCT00950755|454033358|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
126204635|NCT00950755|454033358|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
126204636|NCT00950755|454033358|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
126204637|NCT00950755|454033358|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
126204638|NCT00950755|454033358|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
126204639|NCT00950755|454033358|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
126204640|NCT00950755|454033358|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
126204641|NCT00950755|454033358|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
126204642|NCT00950755|454033358|FG000|Long-Term Follow-Up|Death|8|||
126204643|NCT00508820|454033359|FG000|Overall Study|Adverse Event|6|||
126204644|NCT00508820|454033360|FG001|Overall Study|Adverse Event|10|||
126204645|NCT00508820|454033359|FG000|Overall Study|Death|6|||
126204646|NCT00508820|454033360|FG001|Overall Study|Death|8|||
126204647|NCT00508820|454033359|FG000|Overall Study|Lost to Follow-up|1|||
126204648|NCT00508820|454033360|FG001|Overall Study|Lost to Follow-up|1|||
126204649|NCT00508820|454033359|FG000|Overall Study|Physician Decision|8|||
126204650|NCT00508820|454033360|FG001|Overall Study|Physician Decision|2|||
126204651|NCT00508820|454033359|FG000|Overall Study|Pregnancy|0|||
126204652|NCT00508820|454033360|FG001|Overall Study|Pregnancy|2|||
126204653|NCT00508820|454033359|FG000|Overall Study|Protocol Violation|2|||
126204654|NCT00508820|454033360|FG001|Overall Study|Protocol Violation|0|||
126204655|NCT00508820|454033359|FG000|Overall Study|Withdrawal by Subject|10|||
126204656|NCT00508820|454033360|FG001|Overall Study|Withdrawal by Subject|12|||
126204657|NCT00508820|454033359|FG000|Overall Study|Other|11|||
126204658|NCT00508820|454033360|FG001|Overall Study|Other|2|||
126204659|NCT00508820|454033359|FG000|Overall Study|Noncompliance|1|||
126204660|NCT00508820|454033360|FG001|Overall Study|Noncompliance|0|||
126204661|NCT00508820|454033359|FG000|Overall Study|Requirement for alternative therapy|7|||
126204662|NCT00508820|454033360|FG001|Overall Study|Requirement for alternative therapy|15|||
126204663|NCT00508820|454033359|FG000|Overall Study|Protocol-specified Criteria|3|||
126204664|NCT00508820|454033360|FG001|Overall Study|Protocol-specified Criteria|12|||
126204665|NCT01004822|454035056|FG000|Overall Study|Objective progression or relapse|3|||
126204666|NCT01004822|454035057|FG001|Overall Study|Objective progression or relapse|3|||
126204667|NCT01004822|454035058|FG002|Overall Study|Objective progression or relapse|0|||
126204668|NCT01004822|454035059|FG003|Overall Study|Objective progression or relapse|1|||
126204669|NCT01004822|454035060|FG004|Overall Study|Objective progression or relapse|2|||
126204670|NCT01004822|454035061|FG005|Overall Study|Objective progression or relapse|2|||
126204671|NCT01004822|454035062|FG006|Overall Study|Objective progression or relapse|1|||
126204672|NCT01004822|454035063|FG007|Overall Study|Objective progression or relapse|4|||
126204673|NCT01004822|454035056|FG000|Overall Study|Global deterioration of health status|0|||
126204674|NCT01004822|454035057|FG001|Overall Study|Global deterioration of health status|0|||
126204675|NCT01004822|454035058|FG002|Overall Study|Global deterioration of health status|0|||
126204676|NCT01004822|454035059|FG003|Overall Study|Global deterioration of health status|1|||
126204677|NCT01004822|454035060|FG004|Overall Study|Global deterioration of health status|0|||
126204678|NCT01004822|454035061|FG005|Overall Study|Global deterioration of health status|0|||
126204679|NCT01004822|454035062|FG006|Overall Study|Global deterioration of health status|1|||
126204680|NCT01004822|454035063|FG007|Overall Study|Global deterioration of health status|0|||
126204681|NCT01004822|454035056|FG000|Overall Study|No longer willing to continue|0|||
126204682|NCT01004822|454035057|FG001|Overall Study|No longer willing to continue|0|||
126204683|NCT01004822|454035058|FG002|Overall Study|No longer willing to continue|0|||
126204684|NCT01004822|454035059|FG003|Overall Study|No longer willing to continue|1|||
126204685|NCT01004822|454035060|FG004|Overall Study|No longer willing to continue|2|||
126204686|NCT01004822|454035061|FG005|Overall Study|No longer willing to continue|1|||
126204687|NCT01004822|454035062|FG006|Overall Study|No longer willing to continue|1|||
126204688|NCT01004822|454035063|FG007|Overall Study|No longer willing to continue|0|||
126204689|NCT01004822|454035056|FG000|Overall Study|Adverse Event|0|||
126204690|NCT01004822|454035057|FG001|Overall Study|Adverse Event|0|||
126204691|NCT01004822|454035058|FG002|Overall Study|Adverse Event|0|||
126204692|NCT01004822|454035059|FG003|Overall Study|Adverse Event|0|||
126204693|NCT01004822|454035060|FG004|Overall Study|Adverse Event|0|||
126204694|NCT01004822|454035061|FG005|Overall Study|Adverse Event|0|||
126204695|NCT01004822|454035062|FG006|Overall Study|Adverse Event|1|||
126204696|NCT01004822|454035063|FG007|Overall Study|Adverse Event|1|||
126204697|NCT01004822|454035056|FG000|Overall Study|Other|0|||
126204698|NCT01004822|454035057|FG001|Overall Study|Other|0|||
126204699|NCT01004822|454035058|FG002|Overall Study|Other|4|||
126204700|NCT01004822|454035059|FG003|Overall Study|Other|1|||
126204701|NCT01004822|454035060|FG004|Overall Study|Other|0|||
126204702|NCT01004822|454035061|FG005|Overall Study|Other|1|||
126204703|NCT01004822|454035062|FG006|Overall Study|Other|0|||
126204704|NCT01004822|454035063|FG007|Overall Study|Other|0|||
126204705|NCT01858701|454035064|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
126204706|NCT01858701|454035065|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
126204707|NCT01858701|454035064|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
126204708|NCT01858701|454035065|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
126204709|NCT01858701|454035064|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
126204710|NCT01858701|454035065|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
126204711|NCT01858701|454035064|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
126204712|NCT01858701|454035065|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
126204713|NCT01674010|454035066|FG000|Open Treatment Phase 1|Adverse Event|10|||
126204714|NCT01674010|454035067|FG001|Open Treatment Phase 1|Adverse Event|0|||
126204715|NCT01674010|454035068|FG002|Open Treatment Phase 1|Adverse Event|0|||
126204716|NCT01674010|454035066|FG000|Open Treatment Phase 1|Death|1|||
126204717|NCT01674010|454035067|FG001|Open Treatment Phase 1|Death|0|||
126204718|NCT01674010|454035068|FG002|Open Treatment Phase 1|Death|0|||
126204719|NCT01674010|454035066|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
126204720|NCT01674010|454035067|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
126204721|NCT01674010|454035068|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
126204722|NCT01674010|454035066|FG000|Open Treatment Phase 1|Physician Decision|9|||
126204723|NCT01674010|454035067|FG001|Open Treatment Phase 1|Physician Decision|0|||
126204724|NCT01674010|454035068|FG002|Open Treatment Phase 1|Physician Decision|0|||
126204725|NCT01674010|454035066|FG000|Open Treatment Phase 1|Protocol Violation|7|||
126204726|NCT01674010|454035067|FG001|Open Treatment Phase 1|Protocol Violation|0|||
126204727|NCT01674010|454035068|FG002|Open Treatment Phase 1|Protocol Violation|0|||
126204728|NCT01674010|454035066|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
126204729|NCT01674010|454035067|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
126204730|NCT01674010|454035068|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
126204731|NCT01674010|454035066|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
126204732|NCT01674010|454035067|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
126204733|NCT01674010|454035068|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
126204734|NCT01674010|454035066|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
126204735|NCT01674010|454035067|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
126204736|NCT01674010|454035068|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
126204737|NCT01674010|454035066|FG000|Randomization Phase 2|Adverse Event|0|||
126204738|NCT01674010|454035067|FG001|Randomization Phase 2|Adverse Event|1|||
126204739|NCT01674010|454035068|FG002|Randomization Phase 2|Adverse Event|1|||
126204740|NCT01674010|454035066|FG000|Randomization Phase 2|Lost to Follow-up|0|||
126204741|NCT01674010|454035067|FG001|Randomization Phase 2|Lost to Follow-up|1|||
126204742|NCT01674010|454035068|FG002|Randomization Phase 2|Lost to Follow-up|2|||
126204743|NCT01674010|454035066|FG000|Randomization Phase 2|Mood episode recurrence|0|||
126306081|NCT02553499|454408881|FG012|Overall Study|Progressive Disease|2|||
126204744|NCT01674010|454035067|FG001|Randomization Phase 2|Mood episode recurrence|8|||
126204745|NCT01674010|454035068|FG002|Randomization Phase 2|Mood episode recurrence|2|||
126204746|NCT01674010|454035066|FG000|Randomization Phase 2|Physician Decision|0|||
126204747|NCT01674010|454035067|FG001|Randomization Phase 2|Physician Decision|0|||
126204748|NCT01674010|454035068|FG002|Randomization Phase 2|Physician Decision|2|||
126204749|NCT01674010|454035066|FG000|Randomization Phase 2|Pregnancy|0|||
126204750|NCT01674010|454035067|FG001|Randomization Phase 2|Pregnancy|1|||
126204751|NCT01674010|454035068|FG002|Randomization Phase 2|Pregnancy|1|||
126204752|NCT01674010|454035066|FG000|Randomization Phase 2|Protocol Violation|0|||
126204753|NCT01674010|454035067|FG001|Randomization Phase 2|Protocol Violation|1|||
126204754|NCT01674010|454035068|FG002|Randomization Phase 2|Protocol Violation|1|||
126204755|NCT01674010|454035066|FG000|Randomization Phase 2|Sponsor Decision|0|||
126204756|NCT01674010|454035067|FG001|Randomization Phase 2|Sponsor Decision|42|||
126204757|NCT01674010|454035068|FG002|Randomization Phase 2|Sponsor Decision|45|||
126204758|NCT01674010|454035066|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
126313791|NCT04545567|454439385|FG001|Overall Study|tested positive for SARS-co-V2|1|||
126313792|NCT04545567|454439384|FG000|Overall Study|Withdrawal by Subject|0|||
126313793|NCT04545567|454439385|FG001|Overall Study|Withdrawal by Subject|1|||
126313794|NCT02419612|454439392|FG000|Short-term Treatment Period|Adverse Event|1|||
126313795|NCT02419612|454439393|FG001|Short-term Treatment Period|Adverse Event|1|||
126313796|NCT02419612|454439392|FG000|Short-term Treatment Period|Death|0|||
126313797|NCT02419612|454439393|FG001|Short-term Treatment Period|Death|2|||
126313798|NCT02419612|454439392|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
126313799|NCT02419612|454439393|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
126313800|NCT02419612|454439392|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
126313801|NCT02419612|454439393|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
126313802|NCT02419612|454439392|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
126313803|NCT02419612|454439393|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
126313804|NCT02419612|454439392|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
126313805|NCT02419612|454439393|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
126313806|NCT02419612|454439392|FG000|Short-term Treatment Period|Worsening of liver function|0|||
126313807|NCT02419612|454439393|FG001|Short-term Treatment Period|Worsening of liver function|1|||
126313808|NCT02419612|454439392|FG000|Short-term Treatment Period|Subject moved out of state|0|||
126313809|NCT02419612|454439393|FG001|Short-term Treatment Period|Subject moved out of state|1|||
126313810|NCT02419612|454439392|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
126313811|NCT02419612|454439393|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
126313812|NCT02419612|454439392|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
126313813|NCT02419612|454439393|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
126313814|NCT02419612|454439392|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
126313815|NCT02419612|454439393|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
126313816|NCT02419612|454439392|FG000|Long-term Treatment Period|Death|0|||
126313817|NCT02419612|454439393|FG001|Long-term Treatment Period|Death|1|||
126313818|NCT02419612|454439392|FG000|Long-term Treatment Period|Adverse Event|0|||
126313819|NCT02419612|454439393|FG001|Long-term Treatment Period|Adverse Event|5|||
126313820|NCT02419612|454439392|FG000|Long-term Treatment Period|Other|4|||
126313821|NCT02419612|454439393|FG001|Long-term Treatment Period|Other|4|||
126313822|NCT02419612|454439392|FG000|Long-term Treatment Period|Subject Decision|2|||
126313823|NCT02419612|454439393|FG001|Long-term Treatment Period|Subject Decision|4|||
126313824|NCT02419612|454439392|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
126313825|NCT02419612|454439393|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
126313826|NCT02135107|454439394|FG000|Treatment Period|Withdrawal by Subject|11|||
126313827|NCT02135107|454439395|FG001|Treatment Period|Withdrawal by Subject|0|||
126313828|NCT02135107|454439396|FG002|Treatment Period|Withdrawal by Subject|0|||
126313829|NCT02135107|454439397|FG003|Treatment Period|Withdrawal by Subject|0|||
126313830|NCT02135107|454439394|FG000|Treatment Period|Adverse Event|5|||
126313831|NCT02135107|454439395|FG001|Treatment Period|Adverse Event|2|||
126313832|NCT02135107|454439396|FG002|Treatment Period|Adverse Event|0|||
126313833|NCT02135107|454439397|FG003|Treatment Period|Adverse Event|0|||
126313834|NCT02135107|454439394|FG000|Treatment Period|Pregnancy|1|||
126313835|NCT02135107|454439395|FG001|Treatment Period|Pregnancy|0|||
126313836|NCT02135107|454439396|FG002|Treatment Period|Pregnancy|0|||
126313837|NCT02135107|454439397|FG003|Treatment Period|Pregnancy|0|||
126313838|NCT02135107|454439394|FG000|Treatment Period|Other|115|||
126313839|NCT02135107|454439395|FG001|Treatment Period|Other|24|||
126313840|NCT02135107|454439396|FG002|Treatment Period|Other|0|||
126313841|NCT02135107|454439397|FG003|Treatment Period|Other|0|||
126313842|NCT02135107|454439394|FG000|Maintenance Therapy Period|Adverse Event|0|||
126313843|NCT02135107|454439395|FG001|Maintenance Therapy Period|Adverse Event|0|||
126313844|NCT02135107|454439396|FG002|Maintenance Therapy Period|Adverse Event|3|||
126313845|NCT02135107|454439397|FG003|Maintenance Therapy Period|Adverse Event|7|||
126204759|NCT01674010|454035067|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
126204760|NCT01674010|454035068|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
126204761|NCT03159455|454035069|FG000|Overall Study|Adverse Event|0|||
126204762|NCT03159455|454035070|FG001|Overall Study|Adverse Event|0|||
126204763|NCT03159455|454035071|FG002|Overall Study|Adverse Event|0|||
126204764|NCT03159455|454035072|FG003|Overall Study|Adverse Event|0|||
126204765|NCT03159455|454035073|FG004|Overall Study|Adverse Event|0|||
126204766|NCT03159455|454035074|FG005|Overall Study|Adverse Event|1|||
126204767|NCT01801475|454035082|FG000|Overall Study|Withdrawal by Subject|0|||
126204768|NCT01801475|454035083|FG001|Overall Study|Withdrawal by Subject|0|||
126204769|NCT01801475|454035084|FG002|Overall Study|Withdrawal by Subject|0|||
126204770|NCT01801475|454035085|FG003|Overall Study|Withdrawal by Subject|0|||
126204771|NCT01801475|454035086|FG004|Overall Study|Withdrawal by Subject|1|||
126204772|NCT00421928|454035089|FG000|Overall Study|Adverse Event|61|||
126204773|NCT00421928|454035090|FG001|Overall Study|Adverse Event|140|||
126204774|NCT00421928|454035091|FG002|Overall Study|Adverse Event|22|||
126204775|NCT00421928|454035089|FG000|Overall Study|Lost to Follow-up|5|||
126204776|NCT00421928|454035090|FG001|Overall Study|Lost to Follow-up|0|||
126204777|NCT00421928|454035091|FG002|Overall Study|Lost to Follow-up|3|||
126204778|NCT00421928|454035089|FG000|Overall Study|Withdrawal by Subject|50|||
126204779|NCT00421928|454035090|FG001|Overall Study|Withdrawal by Subject|48|||
126204780|NCT00421928|454035091|FG002|Overall Study|Withdrawal by Subject|43|||
126204781|NCT00421928|454035089|FG000|Overall Study|Lack of Efficacy|15|||
126204782|NCT00421928|454035090|FG001|Overall Study|Lack of Efficacy|7|||
126204783|NCT00421928|454035091|FG002|Overall Study|Lack of Efficacy|35|||
126204784|NCT00421928|454035089|FG000|Overall Study|Study drug non-compliant|6|||
126204785|NCT00421928|454035090|FG001|Overall Study|Study drug non-compliant|7|||
126204786|NCT00421928|454035091|FG002|Overall Study|Study drug non-compliant|4|||
126204787|NCT00421928|454035089|FG000|Overall Study|All other|26|||
126204788|NCT00421928|454035090|FG001|Overall Study|All other|21|||
126204789|NCT00421928|454035091|FG002|Overall Study|All other|27|||
126204790|NCT00421928|454035089|FG000|Overall Study|Death|0|||
126204791|NCT00421928|454035090|FG001|Overall Study|Death|1|||
126204792|NCT00421928|454035091|FG002|Overall Study|Death|0|||
126204793|NCT05056311|454035098|FG000|Overall Study|Lost to Follow-up|14|||
126204794|NCT05056311|454035098|FG000|Overall Study|Withdrawal by Subject|1|||
126204795|NCT05056311|454035098|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
126204796|NCT02713490|454035101|FG000|Overall Study|Withdrawal by Subject|2|||
126204797|NCT02713490|454035102|FG001|Overall Study|Withdrawal by Subject|1|||
126204798|NCT02713490|454035101|FG000|Overall Study|Did not receive study drug|1|||
126204799|NCT02713490|454035102|FG001|Overall Study|Did not receive study drug|0|||
126204800|NCT02713490|454035101|FG000|Overall Study|Met exclusion criteria|0|||
126204801|NCT02713490|454035102|FG001|Overall Study|Met exclusion criteria|1|||
126204802|NCT00346775|454035103|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
126204803|NCT00346775|454035104|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
126204804|NCT00346775|454035103|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
126204805|NCT00346775|454035104|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
126204806|NCT00346775|454035103|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
126204807|NCT00346775|454035104|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
126204808|NCT03799198|454035105|FG000|Overall Study|Lost to Follow-up|4|||
126204809|NCT03799198|454035106|FG001|Overall Study|Lost to Follow-up|8|||
126204810|NCT03799198|454035105|FG000|Overall Study|Death|0|||
126204811|NCT03799198|454035106|FG001|Overall Study|Death|1|||
126204812|NCT00548340|454035109|FG000|Overall Study|Protocol Violation|2|||
126204813|NCT00548340|454035110|FG001|Overall Study|Protocol Violation|3|||
126204814|NCT00548340|454035111|FG002|Overall Study|Protocol Violation|3|||
126204815|NCT00548340|454035109|FG000|Overall Study|Adverse Event|2|||
126204816|NCT00548340|454035110|FG001|Overall Study|Adverse Event|2|||
126204817|NCT00548340|454035111|FG002|Overall Study|Adverse Event|2|||
126204818|NCT00548340|454035109|FG000|Overall Study|Lost to Follow-up|1|||
126204819|NCT00548340|454035110|FG001|Overall Study|Lost to Follow-up|1|||
126204820|NCT00548340|454035111|FG002|Overall Study|Lost to Follow-up|0|||
126204821|NCT00548340|454035109|FG000|Overall Study|Withdrawal by Subject|2|||
126204822|NCT00548340|454035110|FG001|Overall Study|Withdrawal by Subject|4|||
126204823|NCT00548340|454035111|FG002|Overall Study|Withdrawal by Subject|3|||
126204824|NCT00548340|454035109|FG000|Overall Study|Other|1|||
126204825|NCT00548340|454035110|FG001|Overall Study|Other|1|||
126204826|NCT00548340|454035111|FG002|Overall Study|Other|1|||
126204827|NCT01096017|454035112|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
126204828|NCT01096017|454035113|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
126204829|NCT00501969|454035114|FG000|Overall Study|Major Protocol Violation|4|||
126204830|NCT00501969|454035114|FG000|Overall Study|Lack of Efficacy|29|||
126204831|NCT00501969|454035114|FG000|Overall Study|Adverse Event|76|||
126204832|NCT00501969|454035114|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
126204833|NCT00501969|454035114|FG000|Overall Study|Subject withdrew consent|51|||
126204834|NCT00501969|454035114|FG000|Overall Study|Lost to Follow-up|4|||
126204835|NCT00501969|454035114|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
126204836|NCT00501969|454035114|FG000|Overall Study|Other: Sponsors Request|10|||
126204837|NCT00501969|454035114|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
126204838|NCT00501969|454035114|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
126204839|NCT00501969|454035114|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
126204840|NCT00501969|454035114|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
126204841|NCT00501969|454035114|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
126204842|NCT00501969|454035114|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
126204843|NCT00501969|454035114|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
126204844|NCT00501969|454035114|FG000|Overall Study|Other: As Required by Local EC|2|||
126204845|NCT00501969|454035114|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
126204846|NCT00501969|454035114|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
126204847|NCT00665366|454035115|FG000|Overall Study|Lack of Efficacy|11|||
126204848|NCT00665366|454035116|FG001|Overall Study|Lack of Efficacy|10|||
126204849|NCT00665366|454035115|FG000|Overall Study|Adverse Event|25|||
126204850|NCT00665366|454035116|FG001|Overall Study|Adverse Event|23|||
126204851|NCT00665366|454035115|FG000|Overall Study|Withdrawal by Subject|11|||
126204852|NCT00665366|454035116|FG001|Overall Study|Withdrawal by Subject|14|||
126204853|NCT00665366|454035115|FG000|Overall Study|Lost to Follow-up|3|||
126204854|NCT00665366|454035116|FG001|Overall Study|Lost to Follow-up|5|||
126204855|NCT00665366|454035115|FG000|Overall Study|Poor compliance/noncompliance|3|||
126204856|NCT00665366|454035116|FG001|Overall Study|Poor compliance/noncompliance|5|||
126204857|NCT00665366|454035115|FG000|Overall Study|Pregnancy|1|||
126204858|NCT00665366|454035116|FG001|Overall Study|Pregnancy|0|||
126204859|NCT00665366|454035115|FG000|Overall Study|No longer meets study criteria|0|||
126204860|NCT00665366|454035116|FG001|Overall Study|No longer meets study criteria|1|||
126204861|NCT00665366|454035115|FG000|Overall Study|Other reasons|4|||
126204862|NCT00665366|454035116|FG001|Overall Study|Other reasons|1|||
126204863|NCT05111548|454035117|FG000|Overall Study|Withdrawal by Subject|2|||
126204864|NCT05111548|454035118|FG001|Overall Study|Withdrawal by Subject|1|||
126204865|NCT05111548|454035117|FG000|Overall Study|Adverse Event|1|||
126204866|NCT05111548|454035118|FG001|Overall Study|Adverse Event|0|||
126204867|NCT04516291|454035119|FG000|Treatment Period (24 Weeks)|Other|1|||
126204868|NCT04516291|454035120|FG001|Treatment Period (24 Weeks)|Other|0|||
126204869|NCT04516291|454035121|FG002|Treatment Period (24 Weeks)|Other|0|||
126204870|NCT04516291|454035122|FG003|Treatment Period (24 Weeks)|Other|2|||
126204871|NCT04516291|454035123|FG004|Treatment Period (24 Weeks)|Other|2|||
126204872|NCT04516291|454035124|FG005|Treatment Period (24 Weeks)|Other|4|||
126204873|NCT04516291|454035125|FG006|Treatment Period (24 Weeks)|Other|2|||
126204874|NCT04516291|454035126|FG007|Treatment Period (24 Weeks)|Other|0|||
126204875|NCT04516291|454035119|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126204876|NCT04516291|454035120|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
126204877|NCT04516291|454035121|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126204878|NCT04516291|454035122|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126204879|NCT04516291|454035123|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126204880|NCT04516291|454035124|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126204881|NCT04516291|454035125|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126204882|NCT04516291|454035126|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126204883|NCT04516291|454035119|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
126204884|NCT04516291|454035120|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
126204885|NCT04516291|454035121|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
126204886|NCT04516291|454035122|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
126204887|NCT04516291|454035123|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
126204888|NCT04516291|454035124|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
126204889|NCT04516291|454035125|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
126204890|NCT04516291|454035126|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
126204891|NCT04516291|454035119|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126204892|NCT04516291|454035120|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126204893|NCT04516291|454035121|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126204894|NCT04516291|454035122|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126204895|NCT04516291|454035123|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126204896|NCT04516291|454035124|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126204897|NCT04516291|454035125|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126204898|NCT04516291|454035126|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126204899|NCT04516291|454035119|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
126204900|NCT04516291|454035120|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
126204901|NCT04516291|454035121|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
126204902|NCT04516291|454035122|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
126204903|NCT04516291|454035123|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
126204904|NCT04516291|454035124|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
126204905|NCT04516291|454035125|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
126204906|NCT04516291|454035126|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
126204907|NCT04516291|454035119|FG000|Follow-up Period (12 Weeks)|Other|0|||
126204908|NCT04516291|454035120|FG001|Follow-up Period (12 Weeks)|Other|1|||
126204909|NCT04516291|454035121|FG002|Follow-up Period (12 Weeks)|Other|0|||
126204910|NCT04516291|454035122|FG003|Follow-up Period (12 Weeks)|Other|2|||
126204911|NCT04516291|454035123|FG004|Follow-up Period (12 Weeks)|Other|0|||
126204912|NCT04516291|454035124|FG005|Follow-up Period (12 Weeks)|Other|0|||
126204913|NCT04516291|454035125|FG006|Follow-up Period (12 Weeks)|Other|0|||
126204914|NCT04516291|454035126|FG007|Follow-up Period (12 Weeks)|Other|0|||
126204915|NCT04516291|454035119|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126204916|NCT04516291|454035120|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126204917|NCT04516291|454035121|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126204918|NCT04516291|454035122|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126204919|NCT04516291|454035123|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
126204920|NCT04516291|454035124|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126204921|NCT04516291|454035125|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126204922|NCT04516291|454035126|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126204923|NCT04516291|454035119|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
126204924|NCT04516291|454035120|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
126204925|NCT04516291|454035121|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
126204926|NCT04516291|454035122|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
126204927|NCT04516291|454035123|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
126204928|NCT04516291|454035124|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
126204929|NCT04516291|454035125|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
126204930|NCT04516291|454035126|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
126204931|NCT00649220|454035127|FG000|Overall Study|Adverse Event|2|||
126204932|NCT00649220|454035127|FG000|Overall Study|Withdrawal by Subject|1|||
126204933|NCT01399619|454035128|FG000|Overall Study|Adverse Event|10|||
126204934|NCT01399619|454035129|FG001|Overall Study|Adverse Event|0|||
126204935|NCT01399619|454035130|FG002|Overall Study|Adverse Event|4|||
126204936|NCT01399619|454035131|FG003|Overall Study|Adverse Event|10|||
126204937|NCT01399619|454035128|FG000|Overall Study|Lack of Efficacy|9|||
126204938|NCT01399619|454035129|FG001|Overall Study|Lack of Efficacy|0|||
126204939|NCT01399619|454035130|FG002|Overall Study|Lack of Efficacy|5|||
126204940|NCT01399619|454035131|FG003|Overall Study|Lack of Efficacy|0|||
126204941|NCT01399619|454035128|FG000|Overall Study|Withdrawal by Subject|6|||
126204942|NCT01399619|454035129|FG001|Overall Study|Withdrawal by Subject|0|||
126204943|NCT01399619|454035130|FG002|Overall Study|Withdrawal by Subject|3|||
126204944|NCT01399619|454035131|FG003|Overall Study|Withdrawal by Subject|4|||
126204945|NCT01399619|454035128|FG000|Overall Study|Protocol Violation|0|||
126204946|NCT01399619|454035129|FG001|Overall Study|Protocol Violation|0|||
126204947|NCT01399619|454035130|FG002|Overall Study|Protocol Violation|0|||
126204948|NCT01399619|454035131|FG003|Overall Study|Protocol Violation|1|||
126204949|NCT01399619|454035128|FG000|Overall Study|Not treated|0|||
126204950|NCT01399619|454035129|FG001|Overall Study|Not treated|0|||
126204951|NCT01399619|454035130|FG002|Overall Study|Not treated|0|||
126204952|NCT01399619|454035131|FG003|Overall Study|Not treated|2|||
126204953|NCT02557308|454035132|FG000|Overall Study|Withdrawal by Subject|11|||
126204954|NCT02557308|454035133|FG001|Overall Study|Withdrawal by Subject|3|||
126204955|NCT02557308|454035134|FG002|Overall Study|Withdrawal by Subject|2|||
126204956|NCT02557308|454035135|FG003|Overall Study|Withdrawal by Subject|0|||
126204957|NCT02557308|454035136|FG004|Overall Study|Withdrawal by Subject|1|||
126204958|NCT02557308|454035137|FG005|Overall Study|Withdrawal by Subject|0|||
126204959|NCT02557308|454035138|FG006|Overall Study|Withdrawal by Subject|10|||
126204960|NCT02557308|454035139|FG007|Overall Study|Withdrawal by Subject|1|||
126204961|NCT02557308|454035132|FG000|Overall Study|Disease Progression|0|||
126204962|NCT02557308|454035133|FG001|Overall Study|Disease Progression|1|||
126204963|NCT02557308|454035134|FG002|Overall Study|Disease Progression|0|||
126204964|NCT02557308|454035135|FG003|Overall Study|Disease Progression|0|||
126204965|NCT02557308|454035136|FG004|Overall Study|Disease Progression|0|||
126204966|NCT02557308|454035137|FG005|Overall Study|Disease Progression|0|||
126204967|NCT02557308|454035138|FG006|Overall Study|Disease Progression|0|||
126204968|NCT02557308|454035139|FG007|Overall Study|Disease Progression|0|||
126204969|NCT02557308|454035132|FG000|Overall Study|Lack of Efficacy|3|||
126204970|NCT02557308|454035133|FG001|Overall Study|Lack of Efficacy|0|||
126204971|NCT02557308|454035134|FG002|Overall Study|Lack of Efficacy|0|||
126204972|NCT02557308|454035135|FG003|Overall Study|Lack of Efficacy|0|||
126204973|NCT02557308|454035136|FG004|Overall Study|Lack of Efficacy|0|||
126204974|NCT02557308|454035137|FG005|Overall Study|Lack of Efficacy|0|||
126204975|NCT02557308|454035138|FG006|Overall Study|Lack of Efficacy|1|||
126204976|NCT02557308|454035139|FG007|Overall Study|Lack of Efficacy|0|||
126204977|NCT02557308|454035132|FG000|Overall Study|Adverse Event|4|||
126204978|NCT02557308|454035133|FG001|Overall Study|Adverse Event|1|||
126204979|NCT02557308|454035134|FG002|Overall Study|Adverse Event|2|||
126204980|NCT02557308|454035135|FG003|Overall Study|Adverse Event|0|||
126204981|NCT02557308|454035136|FG004|Overall Study|Adverse Event|0|||
126204982|NCT02557308|454035137|FG005|Overall Study|Adverse Event|0|||
126204983|NCT02557308|454035138|FG006|Overall Study|Adverse Event|4|||
126204984|NCT02557308|454035139|FG007|Overall Study|Adverse Event|1|||
126090185|NCT02672852|453623529|FG000|Part A1|Withdrawal by Subject|1|||
126090186|NCT02672852|453623530|FG001|Part A1|Withdrawal by Subject|1|||
126090187|NCT02672852|453623531|FG002|Part A1|Withdrawal by Subject|0|||
126090188|NCT02672852|453623532|FG003|Part A1|Withdrawal by Subject|0|||
126090189|NCT02672852|453623533|FG004|Part A1|Withdrawal by Subject|0|||
126090190|NCT02672852|453623534|FG005|Part A1|Withdrawal by Subject|0|||
126090191|NCT02672852|453623535|FG006|Part A1|Withdrawal by Subject|0|||
126090192|NCT02672852|453623529|FG000|Part A2|Disease worsening|0|||
126090193|NCT02672852|453623530|FG001|Part A2|Disease worsening|0|||
126090194|NCT02672852|453623531|FG002|Part A2|Disease worsening|1|||
126090195|NCT02672852|453623532|FG003|Part A2|Disease worsening|0|||
126090196|NCT02672852|453623533|FG004|Part A2|Disease worsening|0|||
126090197|NCT02672852|453623534|FG005|Part A2|Disease worsening|0|||
126090198|NCT02672852|453623535|FG006|Part A2|Disease worsening|0|||
126090199|NCT02672852|453623529|FG000|Part A2|Adverse Event|0|||
126090200|NCT02672852|453623530|FG001|Part A2|Adverse Event|0|||
126090201|NCT02672852|453623531|FG002|Part A2|Adverse Event|3|||
126090202|NCT02672852|453623532|FG003|Part A2|Adverse Event|0|||
126090203|NCT02672852|453623533|FG004|Part A2|Adverse Event|0|||
126090204|NCT02672852|453623534|FG005|Part A2|Adverse Event|0|||
126090205|NCT02672852|453623535|FG006|Part A2|Adverse Event|0|||
126090206|NCT02672852|453623529|FG000|Part A2|Lost to Follow-up|0|||
126090207|NCT02672852|453623530|FG001|Part A2|Lost to Follow-up|0|||
126090208|NCT02672852|453623531|FG002|Part A2|Lost to Follow-up|2|||
126090209|NCT02672852|453623532|FG003|Part A2|Lost to Follow-up|0|||
126090210|NCT02672852|453623533|FG004|Part A2|Lost to Follow-up|0|||
126090211|NCT02672852|453623534|FG005|Part A2|Lost to Follow-up|0|||
126090212|NCT02672852|453623535|FG006|Part A2|Lost to Follow-up|0|||
126090213|NCT02672852|453623529|FG000|Part A2|Withdrawal by Subject|0|||
126090214|NCT02672852|453623530|FG001|Part A2|Withdrawal by Subject|0|||
126090215|NCT02672852|453623531|FG002|Part A2|Withdrawal by Subject|1|||
126090216|NCT02672852|453623532|FG003|Part A2|Withdrawal by Subject|0|||
126090217|NCT02672852|453623533|FG004|Part A2|Withdrawal by Subject|0|||
126090218|NCT02672852|453623534|FG005|Part A2|Withdrawal by Subject|0|||
126090219|NCT02672852|453623535|FG006|Part A2|Withdrawal by Subject|0|||
126090220|NCT02672852|453623529|FG000|Part A2|Other|0|||
126090221|NCT02672852|453623530|FG001|Part A2|Other|0|||
126090222|NCT02672852|453623531|FG002|Part A2|Other|3|||
126090223|NCT02672852|453623532|FG003|Part A2|Other|0|||
126090224|NCT02672852|453623533|FG004|Part A2|Other|0|||
126090225|NCT02672852|453623534|FG005|Part A2|Other|0|||
126090226|NCT02672852|453623535|FG006|Part A2|Other|0|||
126090227|NCT02672852|453623529|FG000|Part A2|Not entered in Part B|0|||
126090228|NCT02672852|453623530|FG001|Part A2|Not entered in Part B|0|||
126090229|NCT02672852|453623531|FG002|Part A2|Not entered in Part B|0|||
126090230|NCT02672852|453623532|FG003|Part A2|Not entered in Part B|4|||
126090231|NCT02672852|453623533|FG004|Part A2|Not entered in Part B|0|||
126090232|NCT02672852|453623534|FG005|Part A2|Not entered in Part B|0|||
126090233|NCT02672852|453623535|FG006|Part A2|Not entered in Part B|0|||
126090234|NCT02672852|453623529|FG000|Part B|Disease worsening|0|||
126090235|NCT02672852|453623530|FG001|Part B|Disease worsening|0|||
126090236|NCT02672852|453623531|FG002|Part B|Disease worsening|0|||
126090237|NCT02672852|453623532|FG003|Part B|Disease worsening|0|||
126090238|NCT02672852|453623533|FG004|Part B|Disease worsening|1|||
126090239|NCT02672852|453623534|FG005|Part B|Disease worsening|0|||
126090240|NCT02672852|453623535|FG006|Part B|Disease worsening|1|||
126090241|NCT02672852|453623529|FG000|Part B|Worsening pre-existing condition|0|||
126090242|NCT02672852|453623530|FG001|Part B|Worsening pre-existing condition|0|||
126090243|NCT02672852|453623531|FG002|Part B|Worsening pre-existing condition|0|||
126090244|NCT02672852|453623532|FG003|Part B|Worsening pre-existing condition|0|||
126090245|NCT02672852|453623533|FG004|Part B|Worsening pre-existing condition|0|||
126090246|NCT02672852|453623534|FG005|Part B|Worsening pre-existing condition|1|||
126090247|NCT02672852|453623535|FG006|Part B|Worsening pre-existing condition|0|||
126090248|NCT02672852|453623529|FG000|Part B|Other adverse event|0|||
126090249|NCT02672852|453623530|FG001|Part B|Other adverse event|0|||
126090250|NCT02672852|453623531|FG002|Part B|Other adverse event|0|||
126090251|NCT02672852|453623532|FG003|Part B|Other adverse event|0|||
126090252|NCT02672852|453623533|FG004|Part B|Other adverse event|3|||
126090253|NCT02672852|453623534|FG005|Part B|Other adverse event|5|||
126090254|NCT02672852|453623535|FG006|Part B|Other adverse event|1|||
126090255|NCT02672852|453623529|FG000|Part B|Lost to Follow-up|0|||
126090256|NCT02672852|453623530|FG001|Part B|Lost to Follow-up|0|||
126090257|NCT02672852|453623531|FG002|Part B|Lost to Follow-up|0|||
126090258|NCT02672852|453623532|FG003|Part B|Lost to Follow-up|0|||
126090259|NCT02672852|453623533|FG004|Part B|Lost to Follow-up|3|||
126090260|NCT02672852|453623534|FG005|Part B|Lost to Follow-up|4|||
126090261|NCT02672852|453623535|FG006|Part B|Lost to Follow-up|1|||
126090262|NCT02672852|453623529|FG000|Part B|Withdrawal by Subject|0|||
126090263|NCT02672852|453623530|FG001|Part B|Withdrawal by Subject|0|||
126090264|NCT02672852|453623531|FG002|Part B|Withdrawal by Subject|0|||
126204985|NCT02557308|454035132|FG000|Overall Study|Lost to Follow-up|2|||
126204986|NCT02557308|454035133|FG001|Overall Study|Lost to Follow-up|0|||
126204987|NCT02557308|454035134|FG002|Overall Study|Lost to Follow-up|1|||
126204988|NCT02557308|454035135|FG003|Overall Study|Lost to Follow-up|0|||
126204989|NCT02557308|454035136|FG004|Overall Study|Lost to Follow-up|0|||
126204990|NCT02557308|454035137|FG005|Overall Study|Lost to Follow-up|0|||
126204991|NCT02557308|454035138|FG006|Overall Study|Lost to Follow-up|2|||
126204992|NCT02557308|454035139|FG007|Overall Study|Lost to Follow-up|0|||
126204993|NCT02557308|454035132|FG000|Overall Study|Death|1|||
126204994|NCT02557308|454035133|FG001|Overall Study|Death|0|||
126204995|NCT02557308|454035134|FG002|Overall Study|Death|0|||
126204996|NCT02557308|454035135|FG003|Overall Study|Death|0|||
126204997|NCT02557308|454035136|FG004|Overall Study|Death|0|||
126204998|NCT02557308|454035137|FG005|Overall Study|Death|0|||
126204999|NCT02557308|454035138|FG006|Overall Study|Death|0|||
126205000|NCT02557308|454035139|FG007|Overall Study|Death|0|||
126205001|NCT02557308|454035132|FG000|Overall Study|Study Close|98|||
126205002|NCT02557308|454035133|FG001|Overall Study|Study Close|18|||
126205003|NCT02557308|454035134|FG002|Overall Study|Study Close|5|||
126205004|NCT02557308|454035135|FG003|Overall Study|Study Close|3|||
126205005|NCT02557308|454035136|FG004|Overall Study|Study Close|1|||
126205006|NCT02557308|454035137|FG005|Overall Study|Study Close|0|||
126205007|NCT02557308|454035138|FG006|Overall Study|Study Close|123|||
126205008|NCT02557308|454035139|FG007|Overall Study|Study Close|5|||
126205009|NCT02557308|454035132|FG000|Overall Study|Except for study close|5|||
126205010|NCT02557308|454035133|FG001|Overall Study|Except for study close|0|||
126205011|NCT02557308|454035134|FG002|Overall Study|Except for study close|0|||
126205012|NCT02557308|454035135|FG003|Overall Study|Except for study close|0|||
126205013|NCT02557308|454035136|FG004|Overall Study|Except for study close|3|||
126205014|NCT02557308|454035137|FG005|Overall Study|Except for study close|0|||
126205015|NCT02557308|454035138|FG006|Overall Study|Except for study close|6|||
126205016|NCT02557308|454035139|FG007|Overall Study|Except for study close|10|||
126205017|NCT00351611|454035142|FG000|Overall Study|Adverse Event|11|||
126205018|NCT00351611|454035143|FG001|Overall Study|Adverse Event|3|||
126205019|NCT00351611|454035142|FG000|Overall Study|Death|1|||
126205020|NCT00351611|454035143|FG001|Overall Study|Death|0|||
126205021|NCT00351611|454035142|FG000|Overall Study|Lost to Follow-up|1|||
126205022|NCT00351611|454035143|FG001|Overall Study|Lost to Follow-up|0|||
126205023|NCT00351611|454035142|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
126205024|NCT00351611|454035143|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
126205025|NCT00351611|454035142|FG000|Overall Study|Other|1|||
126205026|NCT00351611|454035143|FG001|Overall Study|Other|0|||
126205027|NCT00351611|454035142|FG000|Overall Study|Protocol Violation|0|||
126205028|NCT00351611|454035143|FG001|Overall Study|Protocol Violation|2|||
126205029|NCT00267202|454035144|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
126205030|NCT00267202|454035145|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126205031|NCT00267202|454035144|FG000|Overall Study|Withdrawal by Subject|12|||
126205032|NCT00267202|454035145|FG001|Overall Study|Withdrawal by Subject|15|||
126205033|NCT00267202|454035144|FG000|Overall Study|Adverse Event|13|||
126205034|NCT00267202|454035145|FG001|Overall Study|Adverse Event|7|||
126205035|NCT00267202|454035144|FG000|Overall Study|Protocol Violation|2|||
126205036|NCT00267202|454035145|FG001|Overall Study|Protocol Violation|3|||
126205037|NCT00267202|454035144|FG000|Overall Study|Administrative problems|2|||
126205038|NCT00267202|454035145|FG001|Overall Study|Administrative problems|1|||
126205039|NCT00267202|454035144|FG000|Overall Study|Lost to Follow-up|3|||
126205040|NCT00267202|454035145|FG001|Overall Study|Lost to Follow-up|0|||
126205041|NCT00368069|454035146|FG000|Overall Study|Adverse Event|5|||
126205042|NCT00368069|454035147|FG001|Overall Study|Adverse Event|2|||
126205043|NCT00368069|454035146|FG000|Overall Study|Lack of Efficacy|0|||
126205044|NCT00368069|454035147|FG001|Overall Study|Lack of Efficacy|1|||
126205045|NCT00368069|454035146|FG000|Overall Study|Lost to Follow-up|1|||
126205046|NCT00368069|454035147|FG001|Overall Study|Lost to Follow-up|0|||
126205047|NCT00368069|454035146|FG000|Overall Study|Protocol Violation|0|||
126205048|NCT00368069|454035147|FG001|Overall Study|Protocol Violation|2|||
126205049|NCT00368069|454035146|FG000|Overall Study|Withdrawal of Consent|2|||
126205050|NCT00368069|454035147|FG001|Overall Study|Withdrawal of Consent|1|||
126205051|NCT00368069|454035146|FG000|Overall Study|no blood sampling possible|0|||
126205052|NCT00368069|454035147|FG001|Overall Study|no blood sampling possible|1|||
126205053|NCT03907072|454035151|FG000|Overall Study|Study Terminated by Sponsor|2|||
126205054|NCT03907072|454035152|FG001|Overall Study|Study Terminated by Sponsor|2|||
126205055|NCT03907072|454035153|FG002|Overall Study|Study Terminated by Sponsor|2|||
126205056|NCT01430559|454035156|FG000|Overall Study|Adverse Event|7|||
126205057|NCT01430559|454035157|FG001|Overall Study|Adverse Event|3|||
126205058|NCT01430559|454035156|FG000|Overall Study|Entry criteria not met|1|||
126205059|NCT01430559|454035157|FG001|Overall Study|Entry criteria not met|1|||
126205060|NCT01430559|454035156|FG000|Overall Study|Lost to Follow-up|1|||
126205061|NCT01430559|454035157|FG001|Overall Study|Lost to Follow-up|0|||
126205062|NCT01430559|454035156|FG000|Overall Study|Medication error|1|||
126205063|NCT01430559|454035157|FG001|Overall Study|Medication error|0|||
126205064|NCT01430559|454035156|FG000|Overall Study|Withdrawal by Subject|3|||
126205065|NCT01430559|454035157|FG001|Overall Study|Withdrawal by Subject|2|||
126205066|NCT01430559|454035156|FG000|Overall Study|Protocol Violation|1|||
126205067|NCT01430559|454035157|FG001|Overall Study|Protocol Violation|0|||
126205068|NCT01430559|454035156|FG000|Overall Study|Other|3|||
126205069|NCT01430559|454035157|FG001|Overall Study|Other|3|||
126205070|NCT01430559|454035156|FG000|Overall Study|Randomized, Not Treated|3|||
126205071|NCT01430559|454035157|FG001|Overall Study|Randomized, Not Treated|3|||
126205072|NCT01177943|454035159|FG000|First Intervention|Withdrawal by Subject|2|||
126205073|NCT01177943|454035160|FG001|First Intervention|Withdrawal by Subject|0|||
126205074|NCT00808665|454035161|FG000|Overall Study|Withdrawal by Subject|1|||
126205075|NCT00808665|454035162|FG001|Overall Study|Withdrawal by Subject|0|||
126205076|NCT00808665|454035161|FG000|Overall Study|only required minimally invasive surgery|1|||
126205077|NCT00808665|454035162|FG001|Overall Study|only required minimally invasive surgery|0|||
126205078|NCT00808665|454035161|FG000|Overall Study|surgery cancelled|1|||
126205079|NCT00808665|454035162|FG001|Overall Study|surgery cancelled|0|||
126205080|NCT00808665|454035161|FG000|Overall Study|required an additional procedure|0|||
126205081|NCT00808665|454035162|FG001|Overall Study|required an additional procedure|1|||
126205082|NCT00808665|454035161|FG000|Overall Study|Physician Decision|3|||
126205083|NCT00808665|454035162|FG001|Overall Study|Physician Decision|1|||
126205084|NCT00808665|454035161|FG000|Overall Study|Medication stopped by resident|0|||
126205085|NCT00808665|454035162|FG001|Overall Study|Medication stopped by resident|1|||
126205086|NCT03319160|454035163|FG000|Overall Study|Data not available.|7|||
126205087|NCT03457701|454035169|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
126205088|NCT03457701|454035170|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
126205089|NCT03457701|454035169|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
126205090|NCT03457701|454035170|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
126205091|NCT01288911|454035171|FG000|Double-blind Period|Death|11|||
126205092|NCT01288911|454035172|FG001|Double-blind Period|Death|7|||
126205093|NCT01288911|454035171|FG000|Double-blind Period|Lost to Follow-up|0|||
126205094|NCT01288911|454035172|FG001|Double-blind Period|Lost to Follow-up|2|||
126205095|NCT01288911|454035171|FG000|Double-blind Period|Progressive Disease|75|||
126205096|NCT01288911|454035172|FG001|Double-blind Period|Progressive Disease|103|||
126205097|NCT01288911|454035171|FG000|Double-blind Period|Protocol Violation|1|||
126205098|NCT01288911|454035172|FG001|Double-blind Period|Protocol Violation|0|||
126205099|NCT01288911|454035171|FG000|Double-blind Period|Withdrawal by Subject|25|||
126205100|NCT01288911|454035172|FG001|Double-blind Period|Withdrawal by Subject|26|||
126205101|NCT01288911|454035171|FG000|Double-blind Period|Miscellaneous Reason|29|||
126205102|NCT01288911|454035172|FG001|Double-blind Period|Miscellaneous Reason|42|||
126205103|NCT01288911|454035171|FG000|Double-blind Period|Randomized but never received study drug|1|||
126205104|NCT01288911|454035172|FG001|Double-blind Period|Randomized but never received study drug|2|||
126205105|NCT01288911|454035171|FG000|Open-label Period (All Enzalutamide)|Death|0|||
126205106|NCT01288911|454035172|FG001|Open-label Period (All Enzalutamide)|Death|1|||
126205107|NCT01288911|454035171|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
126205108|NCT01288911|454035172|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
126205109|NCT01288911|454035171|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
126205110|NCT01288911|454035172|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
126205111|NCT01288911|454035171|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
126205112|NCT01288911|454035172|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
126205113|NCT01288911|454035171|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
126205114|NCT01288911|454035172|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
126205115|NCT01288911|454035171|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
126205116|NCT01288911|454035172|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
126205117|NCT02431559|454035173|FG000|Overall Study|Adverse Event|0|||
126205118|NCT02431559|454035174|FG001|Overall Study|Adverse Event|1|||
126205119|NCT02431559|454035175|FG002|Overall Study|Adverse Event|0|||
126205120|NCT02431559|454035176|FG003|Overall Study|Adverse Event|4|||
126205121|NCT02431559|454035173|FG000|Overall Study|Progressive disease|2|||
126205122|NCT02431559|454035174|FG001|Overall Study|Progressive disease|1|||
126205123|NCT02431559|454035175|FG002|Overall Study|Progressive disease|4|||
126205124|NCT02431559|454035176|FG003|Overall Study|Progressive disease|22|||
126205125|NCT02431559|454035173|FG000|Overall Study|Withdrawal by Subject|0|||
126205126|NCT02431559|454035174|FG001|Overall Study|Withdrawal by Subject|1|||
126205127|NCT02431559|454035175|FG002|Overall Study|Withdrawal by Subject|0|||
126205128|NCT02431559|454035176|FG003|Overall Study|Withdrawal by Subject|4|||
126205129|NCT02431559|454035173|FG000|Overall Study|Physician Decision|0|||
126205130|NCT02431559|454035174|FG001|Overall Study|Physician Decision|0|||
126205131|NCT02431559|454035175|FG002|Overall Study|Physician Decision|0|||
126205132|NCT02431559|454035176|FG003|Overall Study|Physician Decision|1|||
126205133|NCT02543918|454035177|FG000|Overall Study|Never treated|0|||
126205134|NCT02543918|454035178|FG001|Overall Study|Never treated|1|||
126205135|NCT02543918|454035177|FG000|Overall Study|Lost to Follow-up|1|||
126205136|NCT02543918|454035178|FG001|Overall Study|Lost to Follow-up|1|||
126205137|NCT02543918|454035177|FG000|Overall Study|Withdrawal by Subject|1|||
126205138|NCT02543918|454035178|FG001|Overall Study|Withdrawal by Subject|1|||
126205139|NCT02543918|454035177|FG000|Overall Study|Adverse Event|1|||
126205140|NCT02543918|454035178|FG001|Overall Study|Adverse Event|1|||
126205141|NCT01411917|454035184|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
126205142|NCT01411917|454035185|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
126205143|NCT00540228|454035192|FG000|Overall Study|Adverse Event|2|||
126205144|NCT00540228|454035193|FG001|Overall Study|Adverse Event|0|||
126205145|NCT00540228|454035194|FG002|Overall Study|Adverse Event|0|||
126205146|NCT00540228|454035195|FG003|Overall Study|Adverse Event|0|||
126205147|NCT00540228|454035196|FG004|Overall Study|Adverse Event|0|||
126205148|NCT00540228|454035192|FG000|Overall Study|Lost to Follow-up|1|||
126205149|NCT00540228|454035193|FG001|Overall Study|Lost to Follow-up|1|||
126205150|NCT00540228|454035194|FG002|Overall Study|Lost to Follow-up|0|||
126205151|NCT00540228|454035195|FG003|Overall Study|Lost to Follow-up|0|||
126205152|NCT00540228|454035196|FG004|Overall Study|Lost to Follow-up|0|||
126205153|NCT02451137|454035199|FG000|Overall Study|Randomized but not treated|19|||
126205154|NCT02451137|454035200|FG001|Overall Study|Randomized but not treated|27|||
126205155|NCT02451137|454035199|FG000|Overall Study|Adverse Event|43|||
126205156|NCT02451137|454035200|FG001|Overall Study|Adverse Event|42|||
126205157|NCT02451137|454035199|FG000|Overall Study|Lack of Efficacy|4|||
126205158|NCT02451137|454035200|FG001|Overall Study|Lack of Efficacy|9|||
126205159|NCT02451137|454035199|FG000|Overall Study|Participant decision:discontinue insulin|41|||
126205160|NCT02451137|454035200|FG001|Overall Study|Participant decision:discontinue insulin|43|||
126205161|NCT02451137|454035199|FG000|Overall Study|Hypoglycemia|2|||
126205162|NCT02451137|454035200|FG001|Overall Study|Hypoglycemia|1|||
126205163|NCT02451137|454035199|FG000|Overall Study|Investigator's decision|23|||
126205164|NCT02451137|454035200|FG001|Overall Study|Investigator's decision|19|||
126205165|NCT02451137|454035199|FG000|Overall Study|Lost to Follow-up|53|||
126205166|NCT02451137|454035200|FG001|Overall Study|Lost to Follow-up|61|||
126205167|NCT02451137|454035199|FG000|Overall Study|Physician Decision|6|||
126205168|NCT02451137|454035200|FG001|Overall Study|Physician Decision|5|||
126205169|NCT02451137|454035199|FG000|Overall Study|Sponsor decision|13|||
126205170|NCT02451137|454035200|FG001|Overall Study|Sponsor decision|25|||
126205171|NCT02451137|454035199|FG000|Overall Study|Withdrawal by Subject|40|||
126205172|NCT02451137|454035200|FG001|Overall Study|Withdrawal by Subject|63|||
126205173|NCT02451137|454035199|FG000|Overall Study|Other than specified above|2|||
126205174|NCT02451137|454035200|FG001|Overall Study|Other than specified above|3|||
126205175|NCT01977573|454035203|FG000|Overall Study|Adverse Event|7|||
126205176|NCT01977573|454035204|FG001|Overall Study|Adverse Event|0|||
126205177|NCT01977573|454035205|FG002|Overall Study|Adverse Event|2|||
126205178|NCT01977573|454035206|FG003|Overall Study|Adverse Event|1|||
126205179|NCT01977573|454035203|FG000|Overall Study|Lost to Follow-up|1|||
126205180|NCT01977573|454035204|FG001|Overall Study|Lost to Follow-up|0|||
126205181|NCT01977573|454035205|FG002|Overall Study|Lost to Follow-up|0|||
126205182|NCT01977573|454035206|FG003|Overall Study|Lost to Follow-up|1|||
126205183|NCT01977573|454035203|FG000|Overall Study|Physician Decision|1|||
126205184|NCT01977573|454035204|FG001|Overall Study|Physician Decision|0|||
126205185|NCT01977573|454035205|FG002|Overall Study|Physician Decision|0|||
126205186|NCT01977573|454035206|FG003|Overall Study|Physician Decision|0|||
126205187|NCT01977573|454035203|FG000|Overall Study|Protocol Violation|3|||
126205188|NCT01977573|454035204|FG001|Overall Study|Protocol Violation|1|||
126205189|NCT01977573|454035205|FG002|Overall Study|Protocol Violation|0|||
126205190|NCT01977573|454035206|FG003|Overall Study|Protocol Violation|0|||
126205191|NCT01977573|454035203|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
126205192|NCT01977573|454035204|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
126205193|NCT01977573|454035205|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
126205194|NCT01977573|454035206|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
126205195|NCT01977573|454035203|FG000|Overall Study|Withdrawal by Subject|6|||
126205196|NCT01977573|454035204|FG001|Overall Study|Withdrawal by Subject|1|||
126205197|NCT01977573|454035205|FG002|Overall Study|Withdrawal by Subject|1|||
126205198|NCT01977573|454035206|FG003|Overall Study|Withdrawal by Subject|1|||
126205199|NCT02993731|454035207|FG000|Overall Study|Study Termination|101|||
126205200|NCT02993731|454035208|FG001|Overall Study|Study Termination|105|||
126205201|NCT02926833|454036747|FG000|Overall Study|Death|1|||
126205202|NCT02926833|454036748|FG001|Overall Study|Death|1|||
126205203|NCT02926833|454036749|FG002|Overall Study|Death|2|||
126205204|NCT02926833|454036750|FG003|Overall Study|Death|13|||
126205205|NCT02926833|454036747|FG000|Overall Study|Lost to Follow-up|1|||
126205206|NCT02926833|454036748|FG001|Overall Study|Lost to Follow-up|2|||
126205207|NCT02926833|454036749|FG002|Overall Study|Lost to Follow-up|0|||
126205208|NCT02926833|454036750|FG003|Overall Study|Lost to Follow-up|3|||
126205209|NCT02926833|454036747|FG000|Overall Study|Full Consent Withdrawal|0|||
126205210|NCT02926833|454036748|FG001|Overall Study|Full Consent Withdrawal|0|||
126205211|NCT02926833|454036749|FG002|Overall Study|Full Consent Withdrawal|0|||
126205212|NCT02926833|454036750|FG003|Overall Study|Full Consent Withdrawal|2|||
126205213|NCT02926833|454036747|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
126205214|NCT02926833|454036748|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
126205215|NCT02926833|454036749|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
126205216|NCT02926833|454036750|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
126205217|NCT02926833|454036747|FG000|Overall Study|Investigator Decision|0|||
126205218|NCT02926833|454036748|FG001|Overall Study|Investigator Decision|1|||
126205219|NCT02926833|454036749|FG002|Overall Study|Investigator Decision|0|||
126205220|NCT02926833|454036750|FG003|Overall Study|Investigator Decision|0|||
126205221|NCT02926833|454036747|FG000|Overall Study|Adverse Event|0|||
126205222|NCT02926833|454036748|FG001|Overall Study|Adverse Event|0|||
126205223|NCT02926833|454036749|FG002|Overall Study|Adverse Event|1|||
126205224|NCT02926833|454036750|FG003|Overall Study|Adverse Event|0|||
126205225|NCT02926833|454036747|FG000|Overall Study|Partial Withdrawal of Consent|0|||
126205226|NCT02926833|454036748|FG001|Overall Study|Partial Withdrawal of Consent|0|||
126205227|NCT02926833|454036749|FG002|Overall Study|Partial Withdrawal of Consent|0|||
126205228|NCT02926833|454036750|FG003|Overall Study|Partial Withdrawal of Consent|1|||
126205229|NCT01189201|454036753|FG000|Overall Study|Adverse Event|1|||
126205230|NCT01277757|454036754|FG000|Overall Study|Disease Progression|1|||
126205231|NCT01277757|454036754|FG000|Overall Study|Withdrawal by Subject|1|||
126205232|NCT04308668|454036755|FG000|Overall Study|Lost to Follow-up|32|||
126205233|NCT04308668|454036756|FG001|Overall Study|Lost to Follow-up|38|||
126205234|NCT04308668|454036755|FG000|Overall Study|Withdrawal by Subject|4|||
126205235|NCT04308668|454036756|FG001|Overall Study|Withdrawal by Subject|4|||
126205236|NCT01266967|454036757|FG000|Overall Study|Death|69|||
126205237|NCT01266967|454036758|FG001|Overall Study|Death|61|||
126205238|NCT01266967|454036757|FG000|Overall Study|Study Closed/Terminated|15|||
126205239|NCT01266967|454036758|FG001|Overall Study|Study Closed/Terminated|17|||
126205240|NCT01266967|454036757|FG000|Overall Study|Lost to Follow-up|2|||
126205241|NCT01266967|454036758|FG001|Overall Study|Lost to Follow-up|1|||
126205242|NCT01266967|454036757|FG000|Overall Study|Physician Decision|0|||
126205243|NCT01266967|454036758|FG001|Overall Study|Physician Decision|1|||
126205244|NCT01266967|454036757|FG000|Overall Study|Withdrawal by Subject|3|||
126205245|NCT01266967|454036758|FG001|Overall Study|Withdrawal by Subject|3|||
126205246|NCT01945866|454036759|FG000|Overall Study|Eyes did not complete or were dropped|2|||
126205247|NCT01945866|454036760|FG001|Overall Study|Eyes did not complete or were dropped|0|||
126205248|NCT03808298|454036761|FG000|Overall Study|Adverse Event|3|||
126205249|NCT03808298|454036761|FG000|Overall Study|Physician Decision|1|||
126205250|NCT03808298|454036761|FG000|Overall Study|Withdrawal by Subject|1|||
126205251|NCT03808298|454036761|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
126205252|NCT04398030|454036762|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
126205253|NCT04398030|454036763|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
126205254|NCT04398030|454036762|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
126205255|NCT04398030|454036763|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
126205256|NCT02946515|454036766|FG000|Overall Study|Lost to Follow-up|2|||
126205257|NCT02946515|454036767|FG001|Overall Study|Lost to Follow-up|1|||
126205258|NCT00960869|454036768|FG000|Overall Study|Adverse Event|17|||
126205259|NCT00960869|454036769|FG001|Overall Study|Adverse Event|26|||
126205260|NCT00960869|454036768|FG000|Overall Study|Withdrawal by Subject|16|||
126205261|NCT00960869|454036769|FG001|Overall Study|Withdrawal by Subject|14|||
126205262|NCT00960869|454036768|FG000|Overall Study|Lost to Follow-up|1|||
126205263|NCT00960869|454036769|FG001|Overall Study|Lost to Follow-up|4|||
126205264|NCT00960869|454036768|FG000|Overall Study|Misc|19|||
126205265|NCT00960869|454036769|FG001|Overall Study|Misc|18|||
126205266|NCT01714726|454036770|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
126205267|NCT01714726|454036771|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
126205268|NCT01714726|454036772|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
126205269|NCT01714726|454036773|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
126205270|NCT01714726|454036770|FG000|Double-Blinded Induction Period|Adverse Event|0|||
126205271|NCT01714726|454036771|FG001|Double-Blinded Induction Period|Adverse Event|1|||
126205272|NCT01714726|454036772|FG002|Double-Blinded Induction Period|Adverse Event|0|||
126205273|NCT01714726|454036773|FG003|Double-Blinded Induction Period|Adverse Event|0|||
126205274|NCT01714726|454036770|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
126205275|NCT01714726|454036771|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
126205276|NCT01714726|454036772|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
126205277|NCT01714726|454036773|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
126205278|NCT01714726|454036770|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
126205279|NCT01714726|454036771|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
126205280|NCT01714726|454036772|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
126205281|NCT01714726|454036773|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
126205282|NCT01714726|454036770|FG000|Open-Label Period|Other|0|||
126205283|NCT01714726|454036771|FG001|Open-Label Period|Other|0|||
126205284|NCT01714726|454036772|FG002|Open-Label Period|Other|1|||
126205285|NCT01714726|454036773|FG003|Open-Label Period|Other|3|||
126205286|NCT01714726|454036770|FG000|Open-Label Period|Adverse Event|0|||
126205287|NCT01714726|454036771|FG001|Open-Label Period|Adverse Event|0|||
126205288|NCT01714726|454036772|FG002|Open-Label Period|Adverse Event|1|||
126205289|NCT01714726|454036773|FG003|Open-Label Period|Adverse Event|0|||
126205290|NCT01714726|454036770|FG000|Open-Label Period|Withdrawal by Subject|0|||
126205291|NCT01714726|454036771|FG001|Open-Label Period|Withdrawal by Subject|0|||
126205292|NCT01714726|454036772|FG002|Open-Label Period|Withdrawal by Subject|9|||
126205293|NCT01714726|454036773|FG003|Open-Label Period|Withdrawal by Subject|19|||
126205294|NCT01714726|454036770|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
126205295|NCT01714726|454036771|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
126205296|NCT01714726|454036772|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
126205297|NCT01714726|454036773|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
126205298|NCT01714726|454036770|FG000|Open-Label Period|Lost to Follow-up|0|||
126205299|NCT01714726|454036771|FG001|Open-Label Period|Lost to Follow-up|0|||
126205300|NCT01714726|454036772|FG002|Open-Label Period|Lost to Follow-up|3|||
126205301|NCT01714726|454036773|FG003|Open-Label Period|Lost to Follow-up|4|||
126205302|NCT02501642|454036774|FG000|Overall Study|Lost to Follow-up|7|||
126205303|NCT02501642|454036775|FG001|Overall Study|Lost to Follow-up|11|||
126205304|NCT02600559|454036789|FG000|Overall Study|Withdrawal by Subject|3|||
126205305|NCT02600559|454036789|FG000|Overall Study|Lost to Follow-up|20|||
126205306|NCT01545375|454036790|FG000|Overall Study|Adverse Event|2|||
126205307|NCT01545375|454036791|FG001|Overall Study|Adverse Event|1|||
126205308|NCT01545375|454036790|FG000|Overall Study|Lost to Follow-up|34|||
126205309|NCT01545375|454036791|FG001|Overall Study|Lost to Follow-up|31|||
126205310|NCT01545375|454036790|FG000|Overall Study|Protocol Violation|3|||
126205311|NCT01545375|454036791|FG001|Overall Study|Protocol Violation|3|||
126205312|NCT01545375|454036790|FG000|Overall Study|Withdrawal by Subject|58|||
126205313|NCT01545375|454036791|FG001|Overall Study|Withdrawal by Subject|55|||
126205314|NCT01846039|454036792|FG000|Overall Study|Protocol Violation|1|||
126205315|NCT01846039|454036792|FG000|Overall Study|Subject Withdrew Consent|1|||
126205316|NCT04854421|454036795|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
126205317|NCT04854421|454036796|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
126205318|NCT03472586|454036802|FG000|Overall Study|Physician Decision|6|||
126205319|NCT03472586|454036802|FG000|Overall Study|Death|6|||
126205320|NCT03472586|454036802|FG000|Overall Study|Adverse Event|1|||
126205321|NCT02528331|454036803|FG000|Overall Study|Withdrawal by Subject|2|||
126205322|NCT06045026|454036806|FG000|Overall Study|Lost to Follow-up|60|||
126205323|NCT06045026|454036806|FG000|Overall Study|Adverse Event|12|||
126205324|NCT06045026|454036806|FG000|Overall Study|Withdrawal by Subject|3|||
126205325|NCT06045026|454036806|FG000|Overall Study|Enrollment closed|1|||
126205326|NCT01980056|454036807|FG000|Overall Study|Death|1|||
126205327|NCT01980056|454036808|FG001|Overall Study|Death|1|||
126205328|NCT01980056|454036809|FG002|Overall Study|Death|0|||
126205329|NCT00408408|454036810|FG000|Overall Study|No follow up data|2|||
126205330|NCT00408408|454036811|FG001|Overall Study|No follow up data|3|||
126205331|NCT00408408|454036812|FG002|Overall Study|No follow up data|0|||
126205332|NCT00408408|454036813|FG003|Overall Study|No follow up data|7|||
126205333|NCT00408408|454036814|FG004|Overall Study|No follow up data|5|||
126205334|NCT00408408|454036815|FG005|Overall Study|No follow up data|3|||
126205335|NCT00399542|454036820|FG000|Overall Study|Adverse Event|18|||
126205336|NCT00399542|454036821|FG001|Overall Study|Adverse Event|15|||
126205337|NCT00399542|454036820|FG000|Overall Study|Protocol Violation|13|||
126205338|NCT00399542|454036821|FG001|Overall Study|Protocol Violation|3|||
126205339|NCT00399542|454036820|FG000|Overall Study|Withdrawal by Subject|28|||
126205340|NCT00399542|454036821|FG001|Overall Study|Withdrawal by Subject|10|||
126205341|NCT00399542|454036820|FG000|Overall Study|Lack of Efficacy|18|||
126205342|NCT00399542|454036821|FG001|Overall Study|Lack of Efficacy|8|||
126205343|NCT00399542|454036820|FG000|Overall Study|Lost to Follow-up|6|||
126205344|NCT00399542|454036821|FG001|Overall Study|Lost to Follow-up|6|||
126205345|NCT00399542|454036820|FG000|Overall Study|Other|1|||
126205346|NCT00399542|454036821|FG001|Overall Study|Other|0|||
126205347|NCT00399542|454036820|FG000|Overall Study|Physician Decision|0|||
126205348|NCT00399542|454036821|FG001|Overall Study|Physician Decision|1|||
126205349|NCT03172026|454036822|FG000|Overall Study|Withdrawal by Subject|1|||
126205350|NCT03172026|454036823|FG001|Overall Study|Withdrawal by Subject|0|||
126205351|NCT03172026|454036822|FG000|Overall Study|COVID restrictions|1|||
126205352|NCT03172026|454036823|FG001|Overall Study|COVID restrictions|0|||
126205353|NCT00265109|454036824|FG000|Overall Study|Withdrawal by Subject|5|||
126205354|NCT00265109|454036824|FG000|Overall Study|Adverse Event|1|||
126205355|NCT02463097|454036825|FG000|Overall Study|Withdrawal by Subject|1|||
126205356|NCT01757821|454036826|FG000|Overall Study|Adverse Event|1|||
126205357|NCT00334893|454036827|FG000|Overall Study|Not Treated|1|||
126205358|NCT00334893|454036828|FG001|Overall Study|Not Treated|0|||
126205359|NCT01552408|454036832|FG000|Overall Study|Lost to Follow-up|2|||
126205360|NCT01552408|454036833|FG001|Overall Study|Lost to Follow-up|0|||
126205361|NCT01552408|454036832|FG000|Overall Study|Relocation|0|||
126205362|NCT01552408|454036833|FG001|Overall Study|Relocation|1|||
126205363|NCT01552408|454036832|FG000|Overall Study|Withdrawal by Subject|2|||
126306082|NCT02553499|454408882|FG013|Overall Study|Progressive Disease|1|||
126205364|NCT01552408|454036833|FG001|Overall Study|Withdrawal by Subject|1|||
126205365|NCT00606931|454036835|FG000|Overall Study|Withdrawal by Subject|3|||
126205366|NCT02924129|454036849|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
126205367|NCT02924129|454036850|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
126205368|NCT02924129|454036849|FG000|Overall Study|Withdrawal by Subject|2|||
126205369|NCT02924129|454036850|FG001|Overall Study|Withdrawal by Subject|2|||
126205370|NCT02924129|454036849|FG000|Overall Study|Physician Decision|1|||
126205371|NCT02924129|454036850|FG001|Overall Study|Physician Decision|0|||
126205372|NCT02924129|454036849|FG000|Overall Study|Missed Visit|0|||
126205373|NCT02924129|454036850|FG001|Overall Study|Missed Visit|1|||
126205374|NCT01348828|454036852|FG000|Overall Study|Death|20|||
126205375|NCT01348828|454036852|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
126205376|NCT01348828|454036852|FG000|Overall Study|Conversion|2|||
126205377|NCT01348828|454036852|FG000|Overall Study|missed visit|1|||
126205378|NCT00302731|454036853|FG000|Overall Study|Lost to Follow-up|1|||
126205379|NCT00302731|454036854|FG001|Overall Study|Lost to Follow-up|2|||
126205380|NCT00302731|454036855|FG002|Overall Study|Lost to Follow-up|0|||
126205381|NCT00302731|454036856|FG003|Overall Study|Lost to Follow-up|0|||
126205382|NCT00302731|454036853|FG000|Overall Study|Adverse Event|0|||
126205383|NCT00302731|454036854|FG001|Overall Study|Adverse Event|2|||
126205384|NCT00302731|454036855|FG002|Overall Study|Adverse Event|2|||
126205385|NCT00302731|454036856|FG003|Overall Study|Adverse Event|0|||
126205386|NCT00302731|454036853|FG000|Overall Study|Withdrawal by Subject|1|||
126205387|NCT00302731|454036854|FG001|Overall Study|Withdrawal by Subject|1|||
126205388|NCT00302731|454036855|FG002|Overall Study|Withdrawal by Subject|0|||
126205389|NCT00302731|454036856|FG003|Overall Study|Withdrawal by Subject|0|||
126205390|NCT00302731|454036853|FG000|Overall Study|Protocol Violation|1|||
126205391|NCT00302731|454036854|FG001|Overall Study|Protocol Violation|0|||
126205392|NCT00302731|454036855|FG002|Overall Study|Protocol Violation|0|||
126205393|NCT00302731|454036856|FG003|Overall Study|Protocol Violation|0|||
126205394|NCT00302731|454036853|FG000|Overall Study|cancer unrelated to study discovered|1|||
126205395|NCT00302731|454036854|FG001|Overall Study|cancer unrelated to study discovered|0|||
126205396|NCT00302731|454036855|FG002|Overall Study|cancer unrelated to study discovered|1|||
126205397|NCT00302731|454036856|FG003|Overall Study|cancer unrelated to study discovered|0|||
126205398|NCT01000311|454036857|FG000|Overall Study|Adverse Event|2|||
126205399|NCT01000311|454036858|FG001|Overall Study|Adverse Event|5|||
126205400|NCT01000311|454036857|FG000|Overall Study|Withdrawal by Subject|16|||
126205401|NCT01000311|454036858|FG001|Overall Study|Withdrawal by Subject|24|||
126205402|NCT01000311|454036857|FG000|Overall Study|Lost to Follow-up|15|||
126205403|NCT01000311|454036858|FG001|Overall Study|Lost to Follow-up|24|||
126205404|NCT01000311|454036857|FG000|Overall Study|Protocol Violation|1|||
126205405|NCT01000311|454036858|FG001|Overall Study|Protocol Violation|2|||
126205406|NCT01000311|454036857|FG000|Overall Study|Inappropriate enrollment|2|||
126205407|NCT01000311|454036858|FG001|Overall Study|Inappropriate enrollment|0|||
126205408|NCT01000311|454036857|FG000|Overall Study|Administrative reason|9|||
126205409|NCT01000311|454036858|FG001|Overall Study|Administrative reason|15|||
126205410|NCT01610752|454036861|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
126205411|NCT01610752|454036862|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
126205412|NCT01610752|454036863|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
126205413|NCT02815670|454036864|FG000|Overall Study|Prematurely discontinued of the trial|1|||
126205414|NCT02354599|454036868|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126205415|NCT02354599|454036869|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
126205416|NCT02354599|454036870|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126205417|NCT02354599|454036871|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
126205418|NCT02354599|454036872|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
126205419|NCT02354599|454036873|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
126205420|NCT02354599|454036868|FG000|Overall Study|Withdrawal by Subject|1|||
126205421|NCT02354599|454036869|FG001|Overall Study|Withdrawal by Subject|1|||
126205422|NCT02354599|454036870|FG002|Overall Study|Withdrawal by Subject|0|||
126205423|NCT02354599|454036871|FG003|Overall Study|Withdrawal by Subject|0|||
126205424|NCT02354599|454036872|FG004|Overall Study|Withdrawal by Subject|0|||
126205425|NCT02354599|454036873|FG005|Overall Study|Withdrawal by Subject|0|||
126205426|NCT01087944|454036889|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
126205427|NCT01087944|454036890|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
126205428|NCT01087944|454036889|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
126205429|NCT01087944|454036890|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
126205430|NCT01159665|454036891|FG000|Overall Study|Withdrawal by Subject|0|||
126205431|NCT01159665|454036892|FG001|Overall Study|Withdrawal by Subject|1|||
126205432|NCT01159665|454036893|FG002|Overall Study|Withdrawal by Subject|0|||
126205433|NCT01159665|454036894|FG003|Overall Study|Withdrawal by Subject|0|||
126205434|NCT01159665|454036895|FG004|Overall Study|Withdrawal by Subject|0|||
126205435|NCT01159665|454036896|FG005|Overall Study|Withdrawal by Subject|0|||
126205436|NCT01377194|454036898|FG000|Overall Study|Adverse Event|3|||
126205437|NCT01377194|454036899|FG001|Overall Study|Adverse Event|12|||
126205438|NCT01377194|454036900|FG002|Overall Study|Adverse Event|19|||
126205439|NCT01377194|454036898|FG000|Overall Study|Lack of Efficacy|3|||
126205440|NCT01377194|454036899|FG001|Overall Study|Lack of Efficacy|3|||
126205441|NCT01377194|454036900|FG002|Overall Study|Lack of Efficacy|3|||
126205442|NCT01377194|454036898|FG000|Overall Study|Protocol Violation|4|||
126205443|NCT01377194|454036899|FG001|Overall Study|Protocol Violation|10|||
126205444|NCT01377194|454036900|FG002|Overall Study|Protocol Violation|6|||
126205445|NCT01377194|454036898|FG000|Overall Study|Withdrawal by Subject|8|||
126205446|NCT01377194|454036899|FG001|Overall Study|Withdrawal by Subject|10|||
126205447|NCT01377194|454036900|FG002|Overall Study|Withdrawal by Subject|7|||
126205448|NCT01377194|454036898|FG000|Overall Study|Lost to Follow-up|14|||
126205449|NCT01377194|454036899|FG001|Overall Study|Lost to Follow-up|8|||
126205450|NCT01377194|454036900|FG002|Overall Study|Lost to Follow-up|11|||
126205451|NCT01846442|454038703|FG000|Overall Study|Adverse Event|2|||
126205452|NCT01846442|454038704|FG001|Overall Study|Adverse Event|4|||
126205453|NCT01846442|454038705|FG002|Overall Study|Adverse Event|2|||
126205454|NCT01846442|454038706|FG003|Overall Study|Adverse Event|1|||
126205455|NCT01846442|454038703|FG000|Overall Study|Lost to Follow-up|0|||
126205456|NCT01846442|454038704|FG001|Overall Study|Lost to Follow-up|0|||
126205457|NCT01846442|454038705|FG002|Overall Study|Lost to Follow-up|1|||
126205458|NCT01846442|454038706|FG003|Overall Study|Lost to Follow-up|0|||
126205459|NCT01846442|454038703|FG000|Overall Study|Withdrawal by Subject|3|||
126205460|NCT01846442|454038704|FG001|Overall Study|Withdrawal by Subject|2|||
126205461|NCT01846442|454038705|FG002|Overall Study|Withdrawal by Subject|0|||
126205462|NCT01846442|454038706|FG003|Overall Study|Withdrawal by Subject|1|||
126205463|NCT01846442|454038703|FG000|Overall Study|Left the city/Lost medication|1|||
126205464|NCT01846442|454038704|FG001|Overall Study|Left the city/Lost medication|0|||
126205465|NCT01846442|454038705|FG002|Overall Study|Left the city/Lost medication|1|||
126205466|NCT01846442|454038706|FG003|Overall Study|Left the city/Lost medication|1|||
126205467|NCT01153971|454038709|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
126205468|NCT01153971|454038709|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
126205469|NCT01153971|454038709|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
126205470|NCT01153971|454038709|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
126205471|NCT01153971|454038709|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
126205472|NCT01153971|454038709|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
126205473|NCT01153971|454038709|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
126205474|NCT03410693|454038710|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
126205475|NCT03410693|454038711|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
126205476|NCT03410693|454038710|FG000|Overall Study|Disc trt: Lost to follow up|0|||
126205477|NCT03410693|454038711|FG001|Overall Study|Disc trt: Lost to follow up|1|||
126205478|NCT03410693|454038710|FG000|Overall Study|Disc trt: radiological progression|58|||
126205479|NCT03410693|454038711|FG001|Overall Study|Disc trt: radiological progression|50|||
126205480|NCT03410693|454038710|FG000|Overall Study|Disc trt: Other|1|||
126205481|NCT03410693|454038711|FG001|Overall Study|Disc trt: Other|0|||
126205482|NCT03410693|454038710|FG000|Overall Study|Study drug never administered|1|||
126205483|NCT03410693|454038711|FG001|Overall Study|Study drug never administered|6|||
126205484|NCT03410693|454038710|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
126205485|NCT03410693|454038711|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
126205486|NCT03410693|454038710|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
126205487|NCT03410693|454038711|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
126205488|NCT03410693|454038710|FG000|Overall Study|Disc trt: Physician decision|0|||
126205489|NCT03410693|454038711|FG001|Overall Study|Disc trt: Physician decision|5|||
126205490|NCT03410693|454038710|FG000|Overall Study|Disc trt: clinical progression|1|||
126205491|NCT03410693|454038711|FG001|Overall Study|Disc trt: clinical progression|5|||
126205492|NCT03410693|454038710|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
126205493|NCT03410693|454038711|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
126205494|NCT00953576|454038712|FG000|Overall Study|Adverse Event|0|||
126205495|NCT00953576|454038713|FG001|Overall Study|Adverse Event|1|||
126205496|NCT00953576|454038712|FG000|Overall Study|Ineligible after Consent|2|||
126205497|NCT00953576|454038713|FG001|Overall Study|Ineligible after Consent|0|||
126205498|NCT03628781|454038720|FG000|Overall Study|Lost to Follow-up|16|||
126205499|NCT03628781|454038721|FG001|Overall Study|Lost to Follow-up|8|||
126205500|NCT03628781|454038720|FG000|Overall Study|Withdrawal by Subject|16|||
126205501|NCT03628781|454038721|FG001|Overall Study|Withdrawal by Subject|1|||
126205502|NCT00656669|454038722|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
126205503|NCT00656669|454038722|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
126205504|NCT00656669|454038722|FG000|AC (Cycles 6-9)|Adverse Event|1|||
126205505|NCT00656669|454038722|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
126205506|NCT03778021|454038723|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
126205507|NCT03778021|454038724|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
126205508|NCT00679042|454038727|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
126205509|NCT00679042|454038727|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
126205510|NCT00679042|454038727|FG000|5-Year Follow Up|Death|1|||
126205511|NCT00679042|454038727|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
126205512|NCT00679042|454038727|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
126205513|NCT02687815|454038728|FG000|Overall Study|Lost to Follow-up|2|||
126205514|NCT02687815|454038729|FG001|Overall Study|Lost to Follow-up|4|||
126205515|NCT02687815|454038728|FG000|Overall Study|Withdrawal by Subject|2|||
126205516|NCT02687815|454038729|FG001|Overall Study|Withdrawal by Subject|4|||
126205517|NCT01224171|454038735|FG000|Overall Study|Adverse Event|8|||
126205518|NCT01224171|454038736|FG001|Overall Study|Adverse Event|4|||
126205519|NCT01224171|454038735|FG000|Overall Study|Protocol Violation|0|||
126205520|NCT01224171|454038736|FG001|Overall Study|Protocol Violation|1|||
126205521|NCT01224171|454038735|FG000|Overall Study|Lack of Efficacy|5|||
126205522|NCT01224171|454038736|FG001|Overall Study|Lack of Efficacy|1|||
126205523|NCT01224171|454038735|FG000|Overall Study|Withdrawal of Consent|2|||
126205524|NCT01224171|454038736|FG001|Overall Study|Withdrawal of Consent|4|||
126205525|NCT01224171|454038735|FG000|Overall Study|Lost to Follow-up|0|||
126205526|NCT01224171|454038736|FG001|Overall Study|Lost to Follow-up|3|||
126205527|NCT03737812|454038737|FG000|Overall Study|Withdrawal by Subject|1|||
126205528|NCT03737812|454038738|FG001|Overall Study|Withdrawal by Subject|2|||
126205529|NCT03737812|454038739|FG002|Overall Study|Withdrawal by Subject|1|||
126205530|NCT03737812|454038737|FG000|Overall Study|Sponsor Discontinued the Study|4|||
126205531|NCT03737812|454038738|FG001|Overall Study|Sponsor Discontinued the Study|3|||
126205532|NCT03737812|454038739|FG002|Overall Study|Sponsor Discontinued the Study|2|||
126205533|NCT03737812|454038737|FG000|Overall Study|Adverse Event|0|||
126205534|NCT03737812|454038738|FG001|Overall Study|Adverse Event|1|||
126205535|NCT03737812|454038739|FG002|Overall Study|Adverse Event|0|||
126205536|NCT03737812|454038737|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
126205537|NCT03737812|454038738|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
126205538|NCT03737812|454038739|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
126205539|NCT02624713|454038740|FG000|Overall Study|Lost to Follow-up|14|||
126205540|NCT02624713|454038741|FG001|Overall Study|Lost to Follow-up|0|||
126205541|NCT00285857|454038742|FG000|Overall Study|Withdrawal by Subject|2|||
126205542|NCT00285857|454038742|FG000|Overall Study|Inadequate initial breast cytology|1|||
126205543|NCT00285857|454038742|FG000|Overall Study|Adverse Event|1|||
126205544|NCT01161173|454038745|FG000|Overall Study|Protocol Violation|13|||
126205545|NCT01161173|454038745|FG000|Overall Study|Lost to Follow-up|7|||
126205546|NCT01161173|454038745|FG000|Overall Study|Progressive Disease|82|||
126205547|NCT01161173|454038745|FG000|Overall Study|Withdrawal of Consent|5|||
126205548|NCT01161173|454038745|FG000|Overall Study|Unacceptable Toxicity|21|||
126205549|NCT01161173|454038745|FG000|Overall Study|Death|194|||
126205550|NCT01161173|454038745|FG000|Overall Study|End of Study|2|||
126205551|NCT01161173|454038745|FG000|Overall Study|Reasons Not Specified|23|||
126205552|NCT00612456|454038751|FG000|Overall Study|Adverse Event|1|||
126205553|NCT00612456|454038752|FG001|Overall Study|Adverse Event|0|||
126205554|NCT00612456|454038753|FG002|Overall Study|Adverse Event|0|||
126205555|NCT00612456|454038751|FG000|Overall Study|Lack of Efficacy|1|||
126205556|NCT00612456|454038752|FG001|Overall Study|Lack of Efficacy|1|||
126205557|NCT00612456|454038753|FG002|Overall Study|Lack of Efficacy|0|||
126205558|NCT00612456|454038751|FG000|Overall Study|Withdrawal by Subject|0|||
126205559|NCT00612456|454038752|FG001|Overall Study|Withdrawal by Subject|1|||
126205560|NCT00612456|454038753|FG002|Overall Study|Withdrawal by Subject|0|||
126205561|NCT01258803|454038754|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
126205562|NCT01258803|454038755|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
126205563|NCT01258803|454038756|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
126205564|NCT01258803|454038757|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
126205565|NCT01258803|454038758|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
126205566|NCT01258803|454038759|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
126205567|NCT01258803|454038754|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126205568|NCT01258803|454038755|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
126205569|NCT01258803|454038756|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126205570|NCT01258803|454038757|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126205571|NCT01258803|454038758|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126205572|NCT01258803|454038759|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126205573|NCT01258803|454038754|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126205574|NCT01258803|454038755|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126205575|NCT01258803|454038756|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
126205576|NCT01258803|454038757|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126205577|NCT01258803|454038758|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126205578|NCT01258803|454038759|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126205579|NCT00920582|454038760|FG000|Overall Study|Lost to Follow-up|5|||
126205580|NCT00920582|454038761|FG001|Overall Study|Lost to Follow-up|1|||
126205581|NCT00920582|454038762|FG002|Overall Study|Lost to Follow-up|2|||
126205582|NCT00920582|454038763|FG003|Overall Study|Lost to Follow-up|0|||
126205583|NCT00920582|454038760|FG000|Overall Study|Withdrawal by Subject|5|||
126205584|NCT00920582|454038761|FG001|Overall Study|Withdrawal by Subject|4|||
126205585|NCT00920582|454038762|FG002|Overall Study|Withdrawal by Subject|6|||
126205586|NCT00920582|454038763|FG003|Overall Study|Withdrawal by Subject|3|||
126205587|NCT00920582|454038760|FG000|Overall Study|Protocol Violation|1|||
126205588|NCT00920582|454038761|FG001|Overall Study|Protocol Violation|0|||
126205589|NCT00920582|454038762|FG002|Overall Study|Protocol Violation|0|||
126205590|NCT00920582|454038763|FG003|Overall Study|Protocol Violation|0|||
126205591|NCT00920582|454038760|FG000|Overall Study|Other|2|||
126205592|NCT00920582|454038761|FG001|Overall Study|Other|1|||
126205593|NCT00920582|454038762|FG002|Overall Study|Other|3|||
126205594|NCT00920582|454038763|FG003|Overall Study|Other|2|||
126205595|NCT04652245|454038769|FG000|Wash-Out Period|Adverse Event|0|||
126205596|NCT04652245|454038770|FG001|Wash-Out Period|Adverse Event|2|||
126205597|NCT04652245|454038769|FG000|Wash-Out Period|Withdrawal by Subject|0|||
126205598|NCT04652245|454038770|FG001|Wash-Out Period|Withdrawal by Subject|2|||
126205599|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Adverse Event|6|||
126205600|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Adverse Event|6|||
126205601|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Death|14|||
126205602|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Death|11|||
126205603|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
126205604|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
126205605|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
126205606|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
126205607|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
126205608|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
126205609|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Disease Progression|1|||
126205610|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Disease Progression|0|||
126205611|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
126205612|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
126205613|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
126205614|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
126205615|NCT04419558|454038773|FG000|DB Period (48 Weeks)|Participant Decision|4|||
126205616|NCT04419558|454038774|FG001|DB Period (48 Weeks)|Participant Decision|3|||
126205617|NCT04419558|454038773|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
126205618|NCT04419558|454038774|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
126205619|NCT04419558|454038773|FG000|OLE Period (48 Weeks)|Death|4|||
126205620|NCT04419558|454038774|FG001|OLE Period (48 Weeks)|Death|6|||
126205621|NCT04419558|454038773|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
126205622|NCT04419558|454038774|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
126205623|NCT04419558|454038773|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
126205624|NCT04419558|454038774|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
126205625|NCT00903357|454038775|FG000|First Intervention|Withdrawal by Subject|5|||
126205626|NCT00903357|454038776|FG001|First Intervention|Withdrawal by Subject|3|||
126205627|NCT00903357|454038775|FG000|First Intervention|Flu|0|||
126205628|NCT00903357|454038776|FG001|First Intervention|Flu|1|||
126205629|NCT00903357|454038775|FG000|Wash Out Period of 2 Weeks|Flu|0|||
126205630|NCT00903357|454038776|FG001|Wash Out Period of 2 Weeks|Flu|1|||
126205631|NCT00903357|454038775|FG000|Second Intervention|Lost to Follow-up|1|||
126205632|NCT00903357|454038776|FG001|Second Intervention|Lost to Follow-up|0|||
126205633|NCT05146999|454038778|FG000|Overall Study|Withdrew consent|6|||
126205634|NCT05146999|454038779|FG001|Overall Study|Withdrew consent|1|||
126205635|NCT05146999|454038778|FG000|Overall Study|Lost to Follow-up|3|||
126205636|NCT05146999|454038779|FG001|Overall Study|Lost to Follow-up|2|||
126205637|NCT05146999|454038778|FG000|Overall Study|Other|1|||
126205638|NCT05146999|454038779|FG001|Overall Study|Other|3|||
126205639|NCT04668157|454038780|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
126205640|NCT04668157|454038781|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
126205641|NCT04668157|454038780|FG000|Treatment Period (52 Weeks)|Other|0|||
126205642|NCT04668157|454038781|FG001|Treatment Period (52 Weeks)|Other|2|||
126205643|NCT00383292|454038782|FG000|Overall Study|Adverse Event|4|||
126205644|NCT00383292|454038783|FG001|Overall Study|Adverse Event|1|||
126205645|NCT00383292|454038784|FG002|Overall Study|Adverse Event|2|||
126205646|NCT00383292|454038782|FG000|Overall Study|Death|3|||
126205647|NCT00383292|454038783|FG001|Overall Study|Death|3|||
126205648|NCT00383292|454038784|FG002|Overall Study|Death|3|||
126205649|NCT00383292|454038782|FG000|Overall Study|Physician Decision|4|||
126205650|NCT00383292|454038783|FG001|Overall Study|Physician Decision|0|||
126205651|NCT00383292|454038784|FG002|Overall Study|Physician Decision|1|||
126205652|NCT00383292|454038782|FG000|Overall Study|Withdrawal by Subject|3|||
126205653|NCT00383292|454038783|FG001|Overall Study|Withdrawal by Subject|2|||
126205654|NCT00383292|454038784|FG002|Overall Study|Withdrawal by Subject|2|||
126205655|NCT00383292|454038782|FG000|Overall Study|Other|1|||
126205656|NCT00383292|454038783|FG001|Overall Study|Other|0|||
126205657|NCT00383292|454038784|FG002|Overall Study|Other|0|||
126205658|NCT03329404|454038785|FG000|Overall Study|The study was suspended.|1|||
126205659|NCT03329404|454038786|FG001|Overall Study|The study was suspended.|4|||
126205660|NCT01016912|454038787|FG000|End of Treatment Period|Lack of Efficacy|0|||
126205661|NCT01016912|454038788|FG001|End of Treatment Period|Lack of Efficacy|1|||
126205662|NCT01016912|454038789|FG002|End of Treatment Period|Lack of Efficacy|0|||
126205663|NCT01016912|454038790|FG003|End of Treatment Period|Lack of Efficacy|4|||
126205664|NCT01016912|454038791|FG004|End of Treatment Period|Lack of Efficacy|4|||
126205665|NCT01016912|454038787|FG000|End of Treatment Period|Adverse Event|0|||
126205666|NCT01016912|454038788|FG001|End of Treatment Period|Adverse Event|1|||
126205667|NCT01016912|454038789|FG002|End of Treatment Period|Adverse Event|1|||
126205668|NCT01016912|454038790|FG003|End of Treatment Period|Adverse Event|0|||
126205669|NCT01016912|454038791|FG004|End of Treatment Period|Adverse Event|0|||
126205670|NCT01016912|454038787|FG000|End of Treatment Period|Completed double-blind period only|0|||
126205671|NCT01016912|454038788|FG001|End of Treatment Period|Completed double-blind period only|1|||
126205672|NCT01016912|454038789|FG002|End of Treatment Period|Completed double-blind period only|0|||
126205673|NCT01016912|454038790|FG003|End of Treatment Period|Completed double-blind period only|0|||
126205674|NCT01016912|454038791|FG004|End of Treatment Period|Completed double-blind period only|0|||
126205675|NCT01016912|454038787|FG000|Follow-up Period|Other reason|0|||
126205676|NCT01016912|454038788|FG001|Follow-up Period|Other reason|0|||
126205677|NCT01016912|454038789|FG002|Follow-up Period|Other reason|1|||
126205678|NCT01016912|454038790|FG003|Follow-up Period|Other reason|1|||
126205679|NCT01016912|454038791|FG004|Follow-up Period|Other reason|0|||
126205680|NCT02221882|454038792|FG000|Overall Study|Withdrawal by Subject|0|||
126205681|NCT02221882|454038793|FG001|Overall Study|Withdrawal by Subject|0|||
126205682|NCT02221882|454038794|FG002|Overall Study|Withdrawal by Subject|4|||
126205683|NCT02221882|454038795|FG003|Overall Study|Withdrawal by Subject|2|||
126205684|NCT02221882|454038796|FG004|Overall Study|Withdrawal by Subject|2|||
126205685|NCT02221882|454038797|FG005|Overall Study|Withdrawal by Subject|2|||
126205686|NCT02221882|454038792|FG000|Overall Study|Death|0|||
126205687|NCT02221882|454038793|FG001|Overall Study|Death|1|||
126205688|NCT02221882|454038794|FG002|Overall Study|Death|0|||
126205689|NCT02221882|454038795|FG003|Overall Study|Death|0|||
126205690|NCT02221882|454038796|FG004|Overall Study|Death|0|||
126205691|NCT02221882|454038797|FG005|Overall Study|Death|0|||
126205692|NCT00796367|454038798|FG000|Overall Study|Adverse Event|6|||
126205693|NCT00796367|454038799|FG001|Overall Study|Adverse Event|4|||
126205694|NCT00796367|454038800|FG002|Overall Study|Adverse Event|7|||
126205695|NCT00796367|454038798|FG000|Overall Study|Lost to Follow-up|5|||
126205696|NCT00796367|454038799|FG001|Overall Study|Lost to Follow-up|4|||
126205697|NCT00796367|454038800|FG002|Overall Study|Lost to Follow-up|21|||
126205698|NCT00796367|454038798|FG000|Overall Study|Withdrawal by Subject|9|||
126205699|NCT00796367|454038799|FG001|Overall Study|Withdrawal by Subject|11|||
126205700|NCT00796367|454038800|FG002|Overall Study|Withdrawal by Subject|12|||
126205701|NCT00796367|454038798|FG000|Overall Study|Lack of Efficacy|2|||
126205702|NCT00796367|454038799|FG001|Overall Study|Lack of Efficacy|1|||
126205703|NCT00796367|454038800|FG002|Overall Study|Lack of Efficacy|0|||
126205704|NCT00796367|454038798|FG000|Overall Study|non compliance|3|||
126205705|NCT00796367|454038799|FG001|Overall Study|non compliance|1|||
126205706|NCT00796367|454038800|FG002|Overall Study|non compliance|1|||
126205707|NCT00796367|454038798|FG000|Overall Study|Pregnancy|1|||
126205708|NCT00796367|454038799|FG001|Overall Study|Pregnancy|0|||
126205709|NCT00796367|454038800|FG002|Overall Study|Pregnancy|1|||
126205710|NCT00796367|454038798|FG000|Overall Study|Requirement for restricted medication|2|||
126205711|NCT00796367|454038799|FG001|Overall Study|Requirement for restricted medication|0|||
126205712|NCT00796367|454038800|FG002|Overall Study|Requirement for restricted medication|2|||
126205713|NCT00796367|454038798|FG000|Overall Study|other|2|||
126205714|NCT00796367|454038799|FG001|Overall Study|other|4|||
126205715|NCT00796367|454038800|FG002|Overall Study|other|3|||
126205716|NCT05664672|454038801|FG000|Overall Study|Adverse Event|0|||
126205717|NCT05664672|454038802|FG001|Overall Study|Adverse Event|0|||
126205718|NCT05664672|454038803|FG002|Overall Study|Adverse Event|0|||
126205719|NCT05664672|454038804|FG003|Overall Study|Adverse Event|0|||
126205720|NCT05664672|454038805|FG004|Overall Study|Adverse Event|0|||
126205721|NCT05664672|454038806|FG005|Overall Study|Adverse Event|1|||
126205722|NCT05664672|454038801|FG000|Overall Study|Withdrawal by Subject|0|||
126205723|NCT05664672|454038802|FG001|Overall Study|Withdrawal by Subject|1|||
126205724|NCT05664672|454038803|FG002|Overall Study|Withdrawal by Subject|3|||
126205725|NCT05664672|454038804|FG003|Overall Study|Withdrawal by Subject|0|||
126205726|NCT05664672|454038805|FG004|Overall Study|Withdrawal by Subject|5|||
126205727|NCT05664672|454038806|FG005|Overall Study|Withdrawal by Subject|6|||
126205728|NCT05664672|454038801|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
126205729|NCT05664672|454038802|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126205730|NCT05664672|454038803|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
126205731|NCT05664672|454038804|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
126205732|NCT05664672|454038805|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
126205733|NCT05664672|454038806|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
126205734|NCT05664672|454038801|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
126205735|NCT05664672|454038802|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126205736|NCT05664672|454038803|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126205737|NCT05664672|454038804|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126205738|NCT05664672|454038805|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126205739|NCT05664672|454038806|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126423994|NCT02043938|454849253|FG000|Overall Study|No show by subject|1|||
126423995|NCT02043938|454849253|FG000|Overall Study|Investigator decision|1|||
126090265|NCT02672852|453623532|FG003|Part B|Withdrawal by Subject|0|||
126090266|NCT02672852|453623533|FG004|Part B|Withdrawal by Subject|5|||
126090267|NCT02672852|453623534|FG005|Part B|Withdrawal by Subject|0|||
126090268|NCT02672852|453623535|FG006|Part B|Withdrawal by Subject|7|||
126090269|NCT02672852|453623529|FG000|Part B|Other|0|||
126090270|NCT02672852|453623530|FG001|Part B|Other|0|||
126090271|NCT02672852|453623531|FG002|Part B|Other|0|||
126090272|NCT02672852|453623532|FG003|Part B|Other|0|||
126090273|NCT02672852|453623533|FG004|Part B|Other|4|||
126090274|NCT02672852|453623534|FG005|Part B|Other|1|||
126090275|NCT02672852|453623535|FG006|Part B|Other|2|||
126090276|NCT04308590|453623536|FG000|Overall Study|Adverse Event|12|||
126090277|NCT04308590|453623537|FG001|Overall Study|Adverse Event|2|||
126090278|NCT04308590|453623536|FG000|Overall Study|Withdrawal by Subject|10|||
126090279|NCT04308590|453623537|FG001|Overall Study|Withdrawal by Subject|4|||
126090280|NCT04308590|453623536|FG000|Overall Study|Death|1|||
126090281|NCT04308590|453623537|FG001|Overall Study|Death|0|||
126090282|NCT04308590|453623536|FG000|Overall Study|Lost to Follow-up|1|||
126090283|NCT04308590|453623537|FG001|Overall Study|Lost to Follow-up|1|||
126090284|NCT04308590|453623536|FG000|Overall Study|Physician Decision|1|||
126090285|NCT04308590|453623537|FG001|Overall Study|Physician Decision|0|||
126090286|NCT04308590|453623536|FG000|Overall Study|Subject does not want to continue with Pi|0|||
126090287|NCT04308590|453623537|FG001|Overall Study|Subject does not want to continue with Pi|1|||
126090288|NCT05487586|453623538|FG000|Overall Study|Death|22|||
126090289|NCT05487586|453623538|FG000|Overall Study|Physician Decision|1|||
126090290|NCT05487586|453623538|FG000|Overall Study|Transfer to another hospital|4|||
126090291|NCT05487586|453623538|FG000|Overall Study|Other|1|||
126090292|NCT04798781|453623539|FG000|Overall Study|Withdrawal by Subject|1|||
126090293|NCT02175641|453623541|FG000|Overall Study|Death|3|||
126090294|NCT02175641|453623542|FG001|Overall Study|Death|4|||
126090295|NCT02175641|453623541|FG000|Overall Study|Lost to Follow-up|4|||
126090296|NCT02175641|453623542|FG001|Overall Study|Lost to Follow-up|4|||
126090297|NCT02175641|453623541|FG000|Overall Study|Withdrawal by Subject|7|||
126090298|NCT02175641|453623542|FG001|Overall Study|Withdrawal by Subject|4|||
126090299|NCT02175641|453623541|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
126090300|NCT02175641|453623542|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
126090301|NCT02175641|453623541|FG000|Overall Study|Developed Contraindicated Condition|8|||
126090302|NCT02175641|453623542|FG001|Overall Study|Developed Contraindicated Condition|0|||
126090303|NCT03921723|453623543|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
126090304|NCT03921723|453623543|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
126090305|NCT01598662|453623544|FG000|Overall Study|Lost to Follow-up|10|||
126090306|NCT01598662|453623545|FG001|Overall Study|Lost to Follow-up|17|||
126090307|NCT01598662|453623544|FG000|Overall Study|Physician Decision|1|||
126090308|NCT01598662|453623545|FG001|Overall Study|Physician Decision|2|||
126090309|NCT01598662|453623544|FG000|Overall Study|IUD expelled before month 6|0|||
126090310|NCT01598662|453623545|FG001|Overall Study|IUD expelled before month 6|2|||
126090311|NCT00643617|453623546|FG000|Overall Study|Death|6|||
126090312|NCT00643617|453623547|FG001|Overall Study|Death|9|||
126090313|NCT00643617|453623546|FG000|Overall Study|Lost to Follow-up|42|||
126090314|NCT00643617|453623547|FG001|Overall Study|Lost to Follow-up|51|||
126090315|NCT02683785|453623550|FG000|Overall Study|Withdrawal by Subject|1|||
126090316|NCT02683785|453623551|FG001|Overall Study|Withdrawal by Subject|1|||
126090317|NCT02683785|453623550|FG000|Overall Study|Lost to Follow-up|0|||
126090318|NCT02683785|453623551|FG001|Overall Study|Lost to Follow-up|1|||
126090319|NCT02683785|453623550|FG000|Overall Study|Adverse Event|0|||
126090320|NCT02683785|453623551|FG001|Overall Study|Adverse Event|2|||
126090321|NCT02233803|453623556|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
126090322|NCT02233803|453623557|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
126090323|NCT02233803|453623556|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
126090324|NCT02233803|453623557|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
126090325|NCT02233803|453623556|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
126090326|NCT02233803|453623557|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
126090327|NCT02233803|453623556|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
126090328|NCT02233803|453623557|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
126090329|NCT02233803|453623556|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
126090330|NCT02233803|453623557|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
126090331|NCT02233803|453623556|FG000|Washout Period (4-Wks)|Physician Decision|1|||
126090332|NCT02233803|453623557|FG001|Washout Period (4-Wks)|Physician Decision|0|||
126090333|NCT02233803|453623556|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
126090334|NCT02233803|453623557|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
126090335|NCT02233803|453623556|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
126090336|NCT02233803|453623557|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
126090337|NCT02233803|453623556|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
126090338|NCT02233803|453623557|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
126090339|NCT03635099|453623558|FG000|Period 1|Adverse Event|1|||
126090340|NCT03635099|453623559|FG001|Period 1|Adverse Event|0|||
126090341|NCT03635099|453623560|FG002|Period 1|Adverse Event|0|||
126205740|NCT04236986|454038817|FG000|Overall Study|Withdrawal by Subject|3|||
126205741|NCT04236986|454038818|FG001|Overall Study|Withdrawal by Subject|1|||
126205742|NCT04034225|454038819|FG000|Overall Study|Death|3|||
126205743|NCT04034225|454038819|FG000|Overall Study|Withdrawal by Subject|2|||
126205744|NCT04034225|454038819|FG000|Overall Study|Study termination by Sponsor|18|||
126205745|NCT04034225|454038819|FG000|Overall Study|Physician Decision|1|||
126205746|NCT04034225|454038819|FG000|Overall Study|Lack of Efficacy|1|||
126205747|NCT01326481|454038825|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
126205748|NCT00307736|454038826|FG000|Overall Study|Adverse Event|0|||
126205749|NCT00307736|454038827|FG001|Overall Study|Adverse Event|0|||
126205750|NCT00307736|454038828|FG002|Overall Study|Adverse Event|1|||
126205751|NCT00307736|454038829|FG003|Overall Study|Adverse Event|3|||
126205752|NCT00307736|454038826|FG000|Overall Study|Withdrawal by Subject|0|||
126205753|NCT00307736|454038827|FG001|Overall Study|Withdrawal by Subject|0|||
126205754|NCT00307736|454038828|FG002|Overall Study|Withdrawal by Subject|2|||
126205755|NCT00307736|454038829|FG003|Overall Study|Withdrawal by Subject|0|||
126205756|NCT02260791|454038832|FG000|Overall Study|Lost to Follow-up|4|||
126205757|NCT02260791|454038833|FG001|Overall Study|Lost to Follow-up|4|||
126205758|NCT02260791|454038832|FG000|Overall Study|Lack of Efficacy|2|||
126205759|NCT02260791|454038833|FG001|Overall Study|Lack of Efficacy|1|||
126205760|NCT02260791|454038832|FG000|Overall Study|Adverse Event|13|||
126205761|NCT02260791|454038833|FG001|Overall Study|Adverse Event|9|||
126205762|NCT02260791|454038832|FG000|Overall Study|Death|1|||
126205763|NCT02260791|454038833|FG001|Overall Study|Death|0|||
126205764|NCT02260791|454038832|FG000|Overall Study|Withdrawal by Subject|11|||
126205765|NCT02260791|454038833|FG001|Overall Study|Withdrawal by Subject|16|||
126205766|NCT02260791|454038832|FG000|Overall Study|Screen failure|0|||
126205767|NCT02260791|454038833|FG001|Overall Study|Screen failure|1|||
126205768|NCT02260791|454038832|FG000|Overall Study|Protocol deviation|2|||
126205769|NCT02260791|454038833|FG001|Overall Study|Protocol deviation|3|||
126205770|NCT04246996|454038836|FG000|Overall Study|Physician Decision|1|||
126205771|NCT04246996|454038837|FG001|Overall Study|Physician Decision|1|||
126205772|NCT04246996|454038836|FG000|Overall Study|Did not meet eligibility criteria|1|||
126205773|NCT04246996|454038837|FG001|Overall Study|Did not meet eligibility criteria|4|||
126205774|NCT02442284|454038838|FG000|Overall Study|Adverse Event|1|||
126205775|NCT02442284|454038838|FG000|Overall Study|Withdrew Consent|2|||
126205776|NCT02442284|454038838|FG000|Overall Study|Lost to Follow-up|3|||
126205777|NCT02442284|454038838|FG000|Overall Study|Other|1|||
126205778|NCT01365182|454038839|FG000|Overall Study|Withdrawal by Subject|10|||
126205779|NCT01365182|454038840|FG001|Overall Study|Withdrawal by Subject|13|||
126205780|NCT01365182|454038841|FG002|Overall Study|Withdrawal by Subject|12|||
126205781|NCT03039699|454038844|FG000|Overall Study|Incorrect inclusion|5|||
126205782|NCT03039699|454038845|FG001|Overall Study|Incorrect inclusion|4|||
126205783|NCT03039699|454038844|FG000|Overall Study|Lack of data to assess study endpoint|5|||
126205784|NCT03039699|454038845|FG001|Overall Study|Lack of data to assess study endpoint|3|||
126205785|NCT03039699|454038844|FG000|Overall Study|Bacterial infection|12|||
126205786|NCT03039699|454038845|FG001|Overall Study|Bacterial infection|28|||
126205787|NCT01230489|454038846|FG000|Overall Study|Death|2|||
126205788|NCT01230489|454038846|FG000|Overall Study|Adverse Event|2|||
126205789|NCT01230489|454038846|FG000|Overall Study|Treatment modality changed|1|||
126205790|NCT01791543|454038847|FG000|Overall Study|Lost to Follow-up|1|||
126205791|NCT01791543|454038847|FG000|Overall Study|Adverse Event|1|||
126205792|NCT02985541|454040141|FG000|Overall Study|Withdrawal by Subject|33|||
126205793|NCT02985541|454040141|FG000|Overall Study|Lost to Follow-up|26|||
126205794|NCT02985541|454040141|FG000|Overall Study|Adverse Event|27|||
126205795|NCT02985541|454040141|FG000|Overall Study|Physician Decision|2|||
126205796|NCT02985541|454040141|FG000|Overall Study|Pregnancy|2|||
126205797|NCT02985541|454040141|FG000|Overall Study|Wish for pregnancy|44|||
126205798|NCT02985541|454040141|FG000|Overall Study|Other reason|5|||
126205799|NCT02985541|454040141|FG000|Overall Study|Not valid for analysis|2|||
126205800|NCT00792467|454040149|FG000|Overall Study|progression of disease|17|||
126205801|NCT00792467|454040149|FG000|Overall Study|Adverse Event|1|||
126205802|NCT00792467|454040149|FG000|Overall Study|patient request|1|||
126205803|NCT00792467|454040149|FG000|Overall Study|Lost to Follow-up|1|||
126205804|NCT00792467|454040149|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
126205805|NCT00792467|454040149|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
126205806|NCT03911401|454040150|FG000|Overall Study|Adverse Event|1|||
126205807|NCT03911401|454040151|FG001|Overall Study|Adverse Event|2|||
126205808|NCT03911401|454040152|FG002|Overall Study|Adverse Event|5|||
126205809|NCT03911401|454040150|FG000|Overall Study|Lack of Efficacy|1|||
126205810|NCT03911401|454040151|FG001|Overall Study|Lack of Efficacy|1|||
126313846|NCT02135107|454439394|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
126205811|NCT03911401|454040152|FG002|Overall Study|Lack of Efficacy|8|||
126205812|NCT03911401|454040150|FG000|Overall Study|Physician Decision|0|||
126313847|NCT02135107|454439395|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
126205813|NCT03911401|454040151|FG001|Overall Study|Physician Decision|0|||
126205814|NCT03911401|454040152|FG002|Overall Study|Physician Decision|1|||
126205815|NCT03911401|454040150|FG000|Overall Study|Withdrawal by Subject|1|||
126205816|NCT03911401|454040151|FG001|Overall Study|Withdrawal by Subject|2|||
126205817|NCT03911401|454040152|FG002|Overall Study|Withdrawal by Subject|0|||
126205818|NCT03911401|454040150|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126205819|NCT03911401|454040151|FG001|Overall Study|Withdrawal by parent/guardian|4|||
126205820|NCT03911401|454040152|FG002|Overall Study|Withdrawal by parent/guardian|11|||
126205821|NCT00462501|454040153|FG000|Overall Study|Not treated|3|||
126205822|NCT00462501|454040153|FG000|Overall Study|Adverse Event|2|||
126205823|NCT00483574|454040154|FG000|Overall Study|Adverse Event|6|||
126205824|NCT00483574|454040155|FG001|Overall Study|Adverse Event|0|||
126205825|NCT00483574|454040154|FG000|Overall Study|Protocol Violation|28|||
126205826|NCT00483574|454040155|FG001|Overall Study|Protocol Violation|9|||
126205827|NCT00483574|454040154|FG000|Overall Study|Lost to Follow-up|16|||
126205828|NCT00483574|454040155|FG001|Overall Study|Lost to Follow-up|4|||
126205829|NCT00483574|454040154|FG000|Overall Study|Withdrawal by Subject|52|||
126205830|NCT00483574|454040155|FG001|Overall Study|Withdrawal by Subject|0|||
126205831|NCT00998166|454040156|FG000|Overall Study|Early Study Termination|8|||
126205832|NCT00933543|454040171|FG000|Overall Study|Adverse Event|2|||
126205833|NCT00933543|454040172|FG001|Overall Study|Adverse Event|1|||
126205834|NCT00933543|454040171|FG000|Overall Study|Lost to Follow-up|0|||
126205835|NCT00933543|454040172|FG001|Overall Study|Lost to Follow-up|1|||
126205836|NCT00933543|454040171|FG000|Overall Study|Withdrawal by Subject|0|||
126205837|NCT00933543|454040172|FG001|Overall Study|Withdrawal by Subject|1|||
126205838|NCT00933543|454040171|FG000|Overall Study|Lack of Efficacy|0|||
126205839|NCT00933543|454040172|FG001|Overall Study|Lack of Efficacy|3|||
126205840|NCT00933543|454040171|FG000|Overall Study|Other|1|||
126205841|NCT00933543|454040172|FG001|Overall Study|Other|1|||
126205842|NCT04988035|454040173|FG000|Overall Study|Death|19|||
126205843|NCT04988035|454040174|FG001|Overall Study|Death|13|||
126205844|NCT04988035|454040173|FG000|Overall Study|Lost to Follow-up|12|||
126205845|NCT04988035|454040174|FG001|Overall Study|Lost to Follow-up|6|||
126205846|NCT04988035|454040173|FG000|Overall Study|Protocol Violation|0|||
126205847|NCT04988035|454040174|FG001|Overall Study|Protocol Violation|1|||
126205848|NCT04988035|454040173|FG000|Overall Study|Withdrawal by Subject|2|||
126205849|NCT04988035|454040174|FG001|Overall Study|Withdrawal by Subject|4|||
126205850|NCT04988035|454040173|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
126205851|NCT04988035|454040174|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
126205852|NCT03602976|454040175|FG000|Overall Study|Withdrawal by Subject|1|||
126205853|NCT04837807|454040176|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
126205854|NCT04837807|454040177|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
126205855|NCT04626947|454040178|FG000|Overall Study|Study terminated|14|||
126205856|NCT01428882|454040179|FG000|Overall Study|Lack of Efficacy|2|||
126205857|NCT01428882|454040180|FG001|Overall Study|Lack of Efficacy|7|||
126205858|NCT01428882|454040179|FG000|Overall Study|Protocol Violation|4|||
126205859|NCT01428882|454040180|FG001|Overall Study|Protocol Violation|3|||
126205860|NCT00429026|454040183|FG000|Overall Study|Inevaluable for response.|40|||
126205861|NCT03831282|454040186|FG000|Overall Study|Could not place sensor|1|||
126205862|NCT03556202|454040189|FG000|Extension Treatment Period|Adverse Event|18|||
126205863|NCT03556202|454040190|FG001|Extension Treatment Period|Adverse Event|14|||
126205864|NCT03556202|454040191|FG002|Extension Treatment Period|Adverse Event|9|||
126205865|NCT03556202|454040189|FG000|Extension Treatment Period|Death|2|||
126205866|NCT03556202|454040190|FG001|Extension Treatment Period|Death|6|||
126205867|NCT03556202|454040191|FG002|Extension Treatment Period|Death|0|||
126205868|NCT03556202|454040189|FG000|Extension Treatment Period|Lack of Efficacy|5|||
126205869|NCT03556202|454040190|FG001|Extension Treatment Period|Lack of Efficacy|12|||
126205870|NCT03556202|454040191|FG002|Extension Treatment Period|Lack of Efficacy|18|||
126205871|NCT03556202|454040189|FG000|Extension Treatment Period|Lost to Follow-up|9|||
126205872|NCT03556202|454040190|FG001|Extension Treatment Period|Lost to Follow-up|20|||
126205873|NCT03556202|454040191|FG002|Extension Treatment Period|Lost to Follow-up|2|||
126205874|NCT03556202|454040189|FG000|Extension Treatment Period|Pregnancy|2|||
126205875|NCT03556202|454040190|FG001|Extension Treatment Period|Pregnancy|4|||
126205876|NCT03556202|454040191|FG002|Extension Treatment Period|Pregnancy|3|||
126205877|NCT03556202|454040189|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
126205878|NCT03556202|454040190|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
126205879|NCT03556202|454040191|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
126205880|NCT03556202|454040189|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
126205881|NCT03556202|454040190|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
126205882|NCT03556202|454040191|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
126205883|NCT03556202|454040189|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
126205884|NCT03556202|454040190|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
126205885|NCT03556202|454040191|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
126205886|NCT03556202|454040189|FG000|Extension Treatment Period|Physician Decision|0|||
126205887|NCT03556202|454040190|FG001|Extension Treatment Period|Physician Decision|8|||
126205888|NCT03556202|454040191|FG002|Extension Treatment Period|Physician Decision|2|||
126205889|NCT03556202|454040189|FG000|Extension Treatment Period|Protocol Violation|0|||
126205890|NCT03556202|454040190|FG001|Extension Treatment Period|Protocol Violation|1|||
126205891|NCT03556202|454040191|FG002|Extension Treatment Period|Protocol Violation|1|||
126205892|NCT03556202|454040189|FG000|Extension Treatment Period|Sponsor Decision|0|||
126205893|NCT03556202|454040190|FG001|Extension Treatment Period|Sponsor Decision|1|||
126205894|NCT03556202|454040191|FG002|Extension Treatment Period|Sponsor Decision|0|||
126205895|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
126205896|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
126313848|NCT02135107|454439396|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
126313849|NCT02135107|454439397|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
126313850|NCT02135107|454439394|FG000|Maintenance Therapy Period|Pregnancy|0|||
126313851|NCT02135107|454439395|FG001|Maintenance Therapy Period|Pregnancy|0|||
126313852|NCT02135107|454439396|FG002|Maintenance Therapy Period|Pregnancy|0|||
126313853|NCT02135107|454439397|FG003|Maintenance Therapy Period|Pregnancy|1|||
126313854|NCT02135107|454439394|FG000|Maintenance Therapy Period|Other|0|||
126313855|NCT02135107|454439395|FG001|Maintenance Therapy Period|Other|0|||
126313856|NCT02135107|454439396|FG002|Maintenance Therapy Period|Other|7|||
126313857|NCT02135107|454439397|FG003|Maintenance Therapy Period|Other|8|||
126313858|NCT00474045|454439398|FG000|Overall Study|Adverse Event|18|||
126313859|NCT00474045|454439399|FG001|Overall Study|Adverse Event|8|||
126313860|NCT00474045|454439398|FG000|Overall Study|Unclassified|1|||
126313861|NCT00474045|454439399|FG001|Overall Study|Unclassified|3|||
126313862|NCT00474045|454439398|FG000|Overall Study|Lack of Efficacy|0|||
126313863|NCT00474045|454439399|FG001|Overall Study|Lack of Efficacy|9|||
126313864|NCT00474045|454439398|FG000|Overall Study|Lost to Follow-up|1|||
126313865|NCT00474045|454439399|FG001|Overall Study|Lost to Follow-up|1|||
126313866|NCT00474045|454439398|FG000|Overall Study|Protocol Violation|10|||
126313867|NCT00474045|454439399|FG001|Overall Study|Protocol Violation|12|||
126313868|NCT00474045|454439398|FG000|Overall Study|Withdrawal by Subject|16|||
126313869|NCT00474045|454439399|FG001|Overall Study|Withdrawal by Subject|18|||
126313870|NCT00474045|454439398|FG000|Overall Study|Withdrawal criteria|60|||
126313871|NCT00474045|454439399|FG001|Overall Study|Withdrawal criteria|50|||
126313872|NCT01095978|454439400|FG000|Overall Study|Did not take Klacid SR|2|||
126313873|NCT01095978|454439400|FG000|Overall Study|Adverse Event|1|||
126313874|NCT02009397|454439408|FG000|Overall Study|Protocol Violation|6|||
126313875|NCT02009397|454439408|FG000|Overall Study|Death|8|||
126313876|NCT02009397|454439408|FG000|Overall Study|Lost to Follow-up|6|||
126313877|NCT02278120|454439410|FG000|Treatment Period|Progressive disease|234|||
126313878|NCT02278120|454439411|FG001|Treatment Period|Progressive disease|260|||
126313879|NCT02278120|454439410|FG000|Treatment Period|Subject/guardian decision|23|||
126313880|NCT02278120|454439411|FG001|Treatment Period|Subject/guardian decision|20|||
126313881|NCT02278120|454439410|FG000|Treatment Period|Adverse Event|16|||
126313882|NCT02278120|454439411|FG001|Treatment Period|Adverse Event|14|||
126313883|NCT02278120|454439410|FG000|Treatment Period|Physician Decision|14|||
126313884|NCT02278120|454439411|FG001|Treatment Period|Physician Decision|27|||
126313885|NCT02278120|454439410|FG000|Treatment Period|Death|3|||
126313886|NCT02278120|454439411|FG001|Treatment Period|Death|3|||
126313887|NCT02278120|454439410|FG000|Treatment Period|Lost to Follow-up|2|||
126313888|NCT02278120|454439411|FG001|Treatment Period|Lost to Follow-up|0|||
126313889|NCT02278120|454439410|FG000|Treatment Period|Protocol deviation|0|||
126313890|NCT02278120|454439411|FG001|Treatment Period|Protocol deviation|2|||
126313891|NCT02278120|454439410|FG000|Treatment Period|Study terminated as per protocol|43|||
126313892|NCT02278120|454439411|FG001|Treatment Period|Study terminated as per protocol|11|||
126313893|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Death|0|||
126313894|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Death|1|||
126313895|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
126313896|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
126313897|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
126313898|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
126313899|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
126313900|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
126313901|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126313902|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126313903|NCT00808639|454439417|FG000|Overall Study|Disease progression before surgery.|1|||
126313904|NCT01966068|454439418|FG000|Overall Study|Withdrawal by Subject|57|||
126313905|NCT01966068|454439418|FG000|Overall Study|Lost to Follow-up|81|||
126313906|NCT00191282|454439421|FG000|Overall Study|Adverse Event|5|||
126313907|NCT00191282|454439422|FG001|Overall Study|Adverse Event|6|||
126313908|NCT00191282|454439421|FG000|Overall Study|Death|51|||
126313909|NCT00191282|454439422|FG001|Overall Study|Death|51|||
126313910|NCT00191282|454439421|FG000|Overall Study|Lack of Efficacy|11|||
126205897|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
126205898|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Death|1|||
126205899|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Death|0|||
126205900|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Death|0|||
126205901|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
126205902|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
126205903|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
126205904|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
126205905|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
126205906|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
126205907|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
126205908|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
126205909|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
126205910|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
126205911|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
126205912|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
126205913|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
126205914|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
126205915|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
126205916|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
126205917|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
126205918|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
126205919|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
126205920|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
126205921|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
126205922|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
126205923|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
126205924|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
126205925|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
126205926|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
126205927|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
126205928|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
126205929|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
126205930|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
126205931|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
126205932|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
126205933|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
126205934|NCT03556202|454040189|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
126205935|NCT03556202|454040190|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
126205936|NCT03556202|454040191|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
126205937|NCT01539512|454040192|FG000|Overall Study|Adverse Event|9|||
126205938|NCT01539512|454040193|FG001|Overall Study|Adverse Event|7|||
126205939|NCT01539512|454040192|FG000|Overall Study|Physician Decision|1|||
126205940|NCT01539512|454040193|FG001|Overall Study|Physician Decision|1|||
126205941|NCT01539512|454040192|FG000|Overall Study|Withdrawal by Subject|12|||
126205942|NCT01539512|454040193|FG001|Overall Study|Withdrawal by Subject|5|||
126205943|NCT01539512|454040192|FG000|Overall Study|Richter's Transformation|1|||
126205944|NCT01539512|454040193|FG001|Overall Study|Richter's Transformation|0|||
126205945|NCT04479358|454040200|FG000|Overall Study|Withdrawal by Subject|0|||
126205946|NCT04479358|454040201|FG001|Overall Study|Withdrawal by Subject|0|||
126205947|NCT04479358|454040202|FG002|Overall Study|Withdrawal by Subject|1|||
126205948|NCT04479358|454040203|FG003|Overall Study|Withdrawal by Subject|0|||
126205949|NCT04479358|454040204|FG004|Overall Study|Withdrawal by Subject|0|||
126205950|NCT04479358|454040205|FG005|Overall Study|Withdrawal by Subject|1|||
126205951|NCT00764465|454040206|FG000|Overall Study|Adverse Event|2|||
126205952|NCT00764465|454040207|FG001|Overall Study|Adverse Event|0|||
126205953|NCT00764465|454040208|FG002|Overall Study|Adverse Event|0|||
126205954|NCT00764465|454040209|FG003|Overall Study|Adverse Event|1|||
126205955|NCT00764465|454040210|FG004|Overall Study|Adverse Event|1|||
126205956|NCT00764465|454040211|FG005|Overall Study|Adverse Event|1|||
126205957|NCT00764465|454040206|FG000|Overall Study|Withdrawal by Subject|0|||
126205958|NCT00764465|454040207|FG001|Overall Study|Withdrawal by Subject|1|||
126205959|NCT00764465|454040208|FG002|Overall Study|Withdrawal by Subject|1|||
126205960|NCT00764465|454040209|FG003|Overall Study|Withdrawal by Subject|0|||
126205961|NCT00764465|454040210|FG004|Overall Study|Withdrawal by Subject|0|||
126205962|NCT00764465|454040211|FG005|Overall Study|Withdrawal by Subject|0|||
126205963|NCT01333501|454040212|FG000|Overall Study|Adverse Event|3|||
126205964|NCT01333501|454040213|FG001|Overall Study|Adverse Event|1|||
126205965|NCT01333501|454040212|FG000|Overall Study|Abnormal laboratory value|2|||
126205966|NCT01333501|454040213|FG001|Overall Study|Abnormal laboratory value|1|||
126205967|NCT01333501|454040212|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126205968|NCT01333501|454040213|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
126205969|NCT01333501|454040212|FG000|Overall Study|Withdrawn consent|3|||
126205970|NCT01333501|454040213|FG001|Overall Study|Withdrawn consent|12|||
126205971|NCT00674440|454040214|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
126205972|NCT00674440|454040214|FG000|Overall Study|did not have surgery, so unevaluable|7|||
126205973|NCT00674440|454040214|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
126205974|NCT00914940|454040215|FG000|D0 to D100 Post-transplant|Death|2|||
126205975|NCT00914940|454040215|FG000|D101 to 2 Years Post-transplant|Death|8|||
126205976|NCT00914940|454040215|FG000|2 Years to 5 Years Post-transplant|Death|3|||
126205977|NCT04095039|454040217|FG000|Overall Study|Withdrawal by Subject|2|||
126205978|NCT04095039|454040218|FG001|Overall Study|Withdrawal by Subject|16|||
126205979|NCT04095039|454040217|FG000|Overall Study|Transplanted|21|||
126205980|NCT04095039|454040218|FG001|Overall Study|Transplanted|24|||
126205981|NCT04095039|454040217|FG000|Overall Study|Transferred to Non-study Facility|47|||
126205982|NCT04095039|454040218|FG001|Overall Study|Transferred to Non-study Facility|44|||
126205983|NCT04095039|454040217|FG000|Overall Study|Withdrawal from internvention target|0|||
126205984|NCT04095039|454040218|FG001|Overall Study|Withdrawal from internvention target|2|||
126205985|NCT04095039|454040217|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
126205986|NCT04095039|454040218|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
126205987|NCT04095039|454040217|FG000|Overall Study|Cacliphylaxis|0|||
126205988|NCT04095039|454040218|FG001|Overall Study|Cacliphylaxis|1|||
126205989|NCT04095039|454040217|FG000|Overall Study|Pregnancy|1|||
126205990|NCT04095039|454040218|FG001|Overall Study|Pregnancy|0|||
126205991|NCT02370173|454040219|FG000|Overall Study|Protocol Violation|1|||
126205992|NCT02370173|454040220|FG001|Overall Study|Protocol Violation|1|||
126205993|NCT02370173|454040219|FG000|Overall Study|Withdrawal by Subject|2|||
126205994|NCT02370173|454040220|FG001|Overall Study|Withdrawal by Subject|2|||
126205995|NCT01728194|454040223|FG000|Overall Study|Lost to Follow-up|4|||
126205996|NCT01728194|454040224|FG001|Overall Study|Lost to Follow-up|3|||
126205997|NCT01728194|454040223|FG000|Overall Study|Physician Decision|4|||
126205998|NCT01728194|454040224|FG001|Overall Study|Physician Decision|0|||
126205999|NCT01728194|454040223|FG000|Overall Study|Withdrawal by Subject|7|||
126206000|NCT01728194|454040224|FG001|Overall Study|Withdrawal by Subject|3|||
126206001|NCT01728194|454040223|FG000|Overall Study|Perceived Medication Side Effects|4|||
126206002|NCT01728194|454040224|FG001|Overall Study|Perceived Medication Side Effects|0|||
126206003|NCT01728194|454040223|FG000|Overall Study|Family Member Request|1|||
126206004|NCT01728194|454040224|FG001|Overall Study|Family Member Request|0|||
126206005|NCT02309372|454040225|FG000|Overall Study|Lost to Follow-up|3|||
126206006|NCT02309372|454040226|FG001|Overall Study|Lost to Follow-up|2|||
126206007|NCT04604015|454040228|FG000|Overall Study|Incomplete Data Collection|33|||
126206008|NCT02129192|454040229|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
126206009|NCT02129192|454040230|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
126206010|NCT01231620|454040232|FG000|Overall Study|Physician Decision|3|||
126206011|NCT01231620|454040233|FG001|Overall Study|Physician Decision|5|||
126206012|NCT01231620|454040234|FG002|Overall Study|Physician Decision|10|||
126206013|NCT01231620|454040232|FG000|Overall Study|Death|12|||
126206014|NCT01231620|454040233|FG001|Overall Study|Death|14|||
126206015|NCT01231620|454040234|FG002|Overall Study|Death|11|||
126206016|NCT01231620|454040232|FG000|Overall Study|Adverse Event|2|||
126206017|NCT01231620|454040233|FG001|Overall Study|Adverse Event|2|||
126206018|NCT01231620|454040234|FG002|Overall Study|Adverse Event|1|||
126206019|NCT01231620|454040232|FG000|Overall Study|Withdrawal by Subject|6|||
126206020|NCT01231620|454040233|FG001|Overall Study|Withdrawal by Subject|6|||
126206021|NCT01231620|454040234|FG002|Overall Study|Withdrawal by Subject|8|||
126206022|NCT01231620|454040232|FG000|Overall Study|Lost to Follow-up|3|||
126206023|NCT01231620|454040233|FG001|Overall Study|Lost to Follow-up|4|||
126206024|NCT01231620|454040234|FG002|Overall Study|Lost to Follow-up|9|||
126206025|NCT02400281|454040235|FG000|Overall Study|Adverse Event|0|||
126206026|NCT02400281|454040236|FG001|Overall Study|Adverse Event|0|||
126206027|NCT02400281|454040237|FG002|Overall Study|Adverse Event|1|||
126206028|NCT02400281|454040238|FG003|Overall Study|Adverse Event|0|||
126206029|NCT02400281|454040239|FG004|Overall Study|Adverse Event|1|||
126206030|NCT02400281|454040240|FG005|Overall Study|Adverse Event|0|||
126206031|NCT02400281|454040235|FG000|Overall Study|Physician Decision|0|||
126206032|NCT02400281|454040236|FG001|Overall Study|Physician Decision|0|||
126206033|NCT02400281|454040237|FG002|Overall Study|Physician Decision|1|||
126206034|NCT02400281|454040238|FG003|Overall Study|Physician Decision|0|||
126206035|NCT02400281|454040239|FG004|Overall Study|Physician Decision|0|||
126206036|NCT02400281|454040240|FG005|Overall Study|Physician Decision|0|||
126206037|NCT00412360|454040241|FG000|Overall Study|Lost to Follow-up|0|||
126206038|NCT00412360|454040242|FG001|Overall Study|Lost to Follow-up|1|||
126206039|NCT00412360|454040241|FG000|Overall Study|Not Transplanted|1|||
126206040|NCT00412360|454040242|FG001|Overall Study|Not Transplanted|2|||
126206041|NCT02576652|454040245|FG000|Overall Study|Withdrawal by Subject|2|||
126206042|NCT01078974|454040256|FG000|Overall Study|Adverse Event|3|||
126090342|NCT03635099|453623561|FG003|Period 1|Adverse Event|1|||
126090343|NCT03635099|453623562|FG004|Period 1|Adverse Event|0|||
126090344|NCT03635099|453623563|FG005|Period 1|Adverse Event|0|||
126090345|NCT03635099|453623564|FG006|Period 1|Adverse Event|0|||
126090346|NCT03635099|453623565|FG007|Period 1|Adverse Event|0|||
126090347|NCT03635099|453623558|FG000|Period 1|Protocol Violation|0|||
126090348|NCT03635099|453623559|FG001|Period 1|Protocol Violation|0|||
126090349|NCT03635099|453623560|FG002|Period 1|Protocol Violation|1|||
126090350|NCT03635099|453623561|FG003|Period 1|Protocol Violation|0|||
126090351|NCT03635099|453623562|FG004|Period 1|Protocol Violation|0|||
126090352|NCT03635099|453623563|FG005|Period 1|Protocol Violation|0|||
126090353|NCT03635099|453623564|FG006|Period 1|Protocol Violation|0|||
126090354|NCT03635099|453623565|FG007|Period 1|Protocol Violation|0|||
126090355|NCT03635099|453623558|FG000|Period 1|Lost to Follow-up|0|||
126090356|NCT03635099|453623559|FG001|Period 1|Lost to Follow-up|0|||
126090357|NCT03635099|453623560|FG002|Period 1|Lost to Follow-up|1|||
126090358|NCT03635099|453623561|FG003|Period 1|Lost to Follow-up|2|||
126090359|NCT03635099|453623562|FG004|Period 1|Lost to Follow-up|1|||
126090360|NCT03635099|453623563|FG005|Period 1|Lost to Follow-up|0|||
126090361|NCT03635099|453623564|FG006|Period 1|Lost to Follow-up|1|||
126090362|NCT03635099|453623565|FG007|Period 1|Lost to Follow-up|2|||
126090363|NCT03635099|453623558|FG000|Period 1|Withdrawal by Subject|3|||
126090364|NCT03635099|453623559|FG001|Period 1|Withdrawal by Subject|3|||
126090365|NCT03635099|453623560|FG002|Period 1|Withdrawal by Subject|5|||
126090366|NCT03635099|453623561|FG003|Period 1|Withdrawal by Subject|2|||
126090367|NCT03635099|453623562|FG004|Period 1|Withdrawal by Subject|2|||
126090368|NCT03635099|453623563|FG005|Period 1|Withdrawal by Subject|0|||
126090369|NCT03635099|453623564|FG006|Period 1|Withdrawal by Subject|3|||
126090370|NCT03635099|453623565|FG007|Period 1|Withdrawal by Subject|0|||
126090371|NCT03635099|453623558|FG000|Period 1|History of suicidal ideation|0|||
126090372|NCT03635099|453623559|FG001|Period 1|History of suicidal ideation|0|||
126090373|NCT03635099|453623560|FG002|Period 1|History of suicidal ideation|1|||
126090374|NCT03635099|453623561|FG003|Period 1|History of suicidal ideation|0|||
126090375|NCT03635099|453623562|FG004|Period 1|History of suicidal ideation|0|||
126090376|NCT03635099|453623563|FG005|Period 1|History of suicidal ideation|0|||
126090377|NCT03635099|453623564|FG006|Period 1|History of suicidal ideation|0|||
126090378|NCT03635099|453623565|FG007|Period 1|History of suicidal ideation|0|||
126090379|NCT03635099|453623558|FG000|Period 1|pursue other treatment options|0|||
126090380|NCT03635099|453623559|FG001|Period 1|pursue other treatment options|0|||
126090381|NCT03635099|453623560|FG002|Period 1|pursue other treatment options|0|||
126090382|NCT03635099|453623561|FG003|Period 1|pursue other treatment options|0|||
126090383|NCT03635099|453623562|FG004|Period 1|pursue other treatment options|0|||
126090384|NCT03635099|453623563|FG005|Period 1|pursue other treatment options|1|||
126090385|NCT03635099|453623564|FG006|Period 1|pursue other treatment options|0|||
126090386|NCT03635099|453623565|FG007|Period 1|pursue other treatment options|0|||
126090387|NCT03635099|453623558|FG000|Not Eligible for Period 2|Pregnancy|0|||
126090388|NCT03635099|453623559|FG001|Not Eligible for Period 2|Pregnancy|0|||
126090389|NCT03635099|453623560|FG002|Not Eligible for Period 2|Pregnancy|0|||
126090390|NCT03635099|453623561|FG003|Not Eligible for Period 2|Pregnancy|1|||
126090391|NCT03635099|453623562|FG004|Not Eligible for Period 2|Pregnancy|0|||
126090392|NCT03635099|453623563|FG005|Not Eligible for Period 2|Pregnancy|0|||
126090393|NCT03635099|453623564|FG006|Not Eligible for Period 2|Pregnancy|0|||
126090394|NCT03635099|453623565|FG007|Not Eligible for Period 2|Pregnancy|0|||
126090395|NCT03635099|453623558|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
126090396|NCT03635099|453623559|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
126090397|NCT03635099|453623560|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
126090398|NCT03635099|453623561|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
126090399|NCT03635099|453623562|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
126090400|NCT03635099|453623563|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
126090401|NCT03635099|453623564|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
126090402|NCT03635099|453623565|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
126090403|NCT03635099|453623558|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126090404|NCT03635099|453623559|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126090405|NCT03635099|453623560|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126090406|NCT03635099|453623561|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126090407|NCT03635099|453623562|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126090408|NCT03635099|453623563|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
126090409|NCT03635099|453623564|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
126090410|NCT03635099|453623565|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
126090411|NCT03635099|453623558|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
126090412|NCT03635099|453623559|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
126090413|NCT03635099|453623560|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
126090414|NCT03635099|453623561|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
126090415|NCT03635099|453623562|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
126206043|NCT00553319|454040257|FG000|Overall Study|Lost to Follow-up|10|||
126206044|NCT00553319|454040258|FG001|Overall Study|Lost to Follow-up|9|||
126206045|NCT00553319|454040259|FG002|Overall Study|Lost to Follow-up|5|||
126206046|NCT00553319|454040257|FG000|Overall Study|wanted treatment elsewhere|2|||
126206047|NCT00553319|454040258|FG001|Overall Study|wanted treatment elsewhere|1|||
126206048|NCT00553319|454040259|FG002|Overall Study|wanted treatment elsewhere|1|||
126206049|NCT00553319|454040257|FG000|Overall Study|non-compliance|0|||
126206050|NCT00553319|454040258|FG001|Overall Study|non-compliance|0|||
126206051|NCT00553319|454040259|FG002|Overall Study|non-compliance|2|||
126206052|NCT00553319|454040257|FG000|Overall Study|incarceration|1|||
126206053|NCT00553319|454040258|FG001|Overall Study|incarceration|0|||
126206054|NCT00553319|454040259|FG002|Overall Study|incarceration|0|||
126206055|NCT00553319|454040257|FG000|Overall Study|moved|1|||
126206056|NCT00553319|454040258|FG001|Overall Study|moved|0|||
126206057|NCT00553319|454040259|FG002|Overall Study|moved|1|||
126206058|NCT03575975|454040265|FG000|Overall Study|Lost to Follow-up|1|||
126206059|NCT03575975|454040266|FG001|Overall Study|Lost to Follow-up|0|||
126206060|NCT03575975|454040267|FG002|Overall Study|Lost to Follow-up|0|||
126206061|NCT00495794|454040268|FG000|Overall Study|Pharmacist did not activate patient|522|||
126206062|NCT00495794|454040269|FG001|Overall Study|Pharmacist did not activate patient|0|||
126206063|NCT00129220|454040271|FG000|Study Period II|Adverse Event|9|||
126206064|NCT00129220|454040272|FG001|Study Period II|Adverse Event|5|||
126206065|NCT00129220|454040273|FG002|Study Period II|Adverse Event|7|||
126206066|NCT00129220|454040271|FG000|Study Period II|Lack of Efficacy|15|||
126206067|NCT00129220|454040272|FG001|Study Period II|Lack of Efficacy|1|||
126206068|NCT00129220|454040273|FG002|Study Period II|Lack of Efficacy|28|||
126206069|NCT00129220|454040271|FG000|Study Period II|Entry Criteria Not Met|2|||
126206070|NCT00129220|454040272|FG001|Study Period II|Entry Criteria Not Met|0|||
126206071|NCT00129220|454040273|FG002|Study Period II|Entry Criteria Not Met|2|||
126206072|NCT00129220|454040271|FG000|Study Period II|Protocol Violation|4|||
126206073|NCT00129220|454040272|FG001|Study Period II|Protocol Violation|2|||
126206074|NCT00129220|454040273|FG002|Study Period II|Protocol Violation|1|||
126206075|NCT00129220|454040271|FG000|Study Period II|Physician Decision|0|||
126206076|NCT00129220|454040272|FG001|Study Period II|Physician Decision|1|||
126206077|NCT00129220|454040273|FG002|Study Period II|Physician Decision|0|||
126206078|NCT00129220|454040271|FG000|Study Period II|Withdrawal by Subject|1|||
126206079|NCT00129220|454040272|FG001|Study Period II|Withdrawal by Subject|3|||
126206080|NCT00129220|454040273|FG002|Study Period II|Withdrawal by Subject|4|||
126206081|NCT00129220|454040271|FG000|Study Period II|Reason Not Specified|2|||
126206082|NCT00129220|454040272|FG001|Study Period II|Reason Not Specified|0|||
126206083|NCT00129220|454040273|FG002|Study Period II|Reason Not Specified|5|||
126206084|NCT00129220|454040271|FG000|Study Period III|Adverse Event|1|||
126206085|NCT00129220|454040272|FG001|Study Period III|Adverse Event|0|||
126206086|NCT00129220|454040273|FG002|Study Period III|Adverse Event|3|||
126206087|NCT00129220|454040271|FG000|Study Period III|Protocol Violation|1|||
126206088|NCT00129220|454040272|FG001|Study Period III|Protocol Violation|1|||
126206089|NCT00129220|454040273|FG002|Study Period III|Protocol Violation|2|||
126206090|NCT00129220|454040271|FG000|Study Period III|Withdrawal by Subject|1|||
126206091|NCT00129220|454040272|FG001|Study Period III|Withdrawal by Subject|0|||
126206092|NCT00129220|454040273|FG002|Study Period III|Withdrawal by Subject|3|||
126206093|NCT00129220|454040271|FG000|Study Period III|Sponsor Decision|1|||
126206094|NCT00129220|454040272|FG001|Study Period III|Sponsor Decision|0|||
126206095|NCT00129220|454040273|FG002|Study Period III|Sponsor Decision|0|||
126206096|NCT00129220|454040271|FG000|Study Period III|Reason Not Specified|9|||
126206097|NCT00129220|454040272|FG001|Study Period III|Reason Not Specified|0|||
126206098|NCT00129220|454040273|FG002|Study Period III|Reason Not Specified|2|||
126206099|NCT01883362|454040274|FG000|Treatment|Adverse Event|1|||
126206100|NCT01883362|454040275|FG001|Treatment|Adverse Event|8|||
126206101|NCT01883362|454040274|FG000|Treatment|Withdrawal by Subject|6|||
126206102|NCT01883362|454040275|FG001|Treatment|Withdrawal by Subject|2|||
126206103|NCT01883362|454040274|FG000|Treatment|Administrative problems|4|||
126206104|NCT01883362|454040275|FG001|Treatment|Administrative problems|1|||
126206105|NCT01883362|454040274|FG000|Treatment|Relapse|4|||
126206106|NCT01883362|454040275|FG001|Treatment|Relapse|2|||
126206107|NCT01883362|454040274|FG000|Treatment|Randomized, not treated|1|||
126206108|NCT01883362|454040275|FG001|Treatment|Randomized, not treated|1|||
126206109|NCT01883362|454040274|FG000|Post Treatment Follow-up|Protocol Violation|0|||
126206110|NCT01883362|454040275|FG001|Post Treatment Follow-up|Protocol Violation|1|||
126206111|NCT01883362|454040274|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
126206112|NCT01883362|454040275|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
126206113|NCT01883362|454040274|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
126206114|NCT01883362|454040275|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
126206115|NCT01883362|454040274|FG000|Post Treatment Follow-up|Administrative problems|2|||
126206116|NCT01883362|454040275|FG001|Post Treatment Follow-up|Administrative problems|0|||
126206117|NCT01883362|454040274|FG000|Post Treatment Follow-up|Death|8|||
126206118|NCT01883362|454040275|FG001|Post Treatment Follow-up|Death|4|||
126206119|NCT01883362|454040274|FG000|Post Treatment Follow-up|Relapse|1|||
126206120|NCT01883362|454040275|FG001|Post Treatment Follow-up|Relapse|2|||
126206121|NCT02911285|454040276|FG000|Overall Study|Lost to Follow-up|8|||
126206122|NCT02911285|454040277|FG001|Overall Study|Lost to Follow-up|5|||
126206123|NCT02911285|454040276|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
126206124|NCT02911285|454040277|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
126206125|NCT03996694|454042162|FG000|First Washout (7 Days)|positive urine drug screen|0|||
126206126|NCT03996694|454042163|FG001|First Washout (7 Days)|positive urine drug screen|0|||
126206127|NCT03996694|454042164|FG002|First Washout (7 Days)|positive urine drug screen|1|||
126206128|NCT03996694|454042165|FG003|First Washout (7 Days)|positive urine drug screen|0|||
126206129|NCT03996694|454042166|FG004|First Washout (7 Days)|positive urine drug screen|0|||
126206130|NCT03996694|454042167|FG005|First Washout (7 Days)|positive urine drug screen|0|||
126206131|NCT03996694|454042162|FG000|First Washout (7 Days)|Adverse Event|0|||
126206132|NCT03996694|454042163|FG001|First Washout (7 Days)|Adverse Event|1|||
126206133|NCT03996694|454042164|FG002|First Washout (7 Days)|Adverse Event|0|||
126206134|NCT03996694|454042165|FG003|First Washout (7 Days)|Adverse Event|0|||
126206135|NCT03996694|454042166|FG004|First Washout (7 Days)|Adverse Event|0|||
126206136|NCT03996694|454042167|FG005|First Washout (7 Days)|Adverse Event|0|||
126206137|NCT03996694|454042162|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
126206138|NCT03996694|454042163|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
126206139|NCT03996694|454042164|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
126206140|NCT03996694|454042165|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
126206141|NCT03996694|454042166|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
126206142|NCT03996694|454042167|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
126206143|NCT03996694|454042162|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
126206144|NCT03996694|454042163|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
126206145|NCT03996694|454042164|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
126206146|NCT03996694|454042165|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
126206147|NCT03996694|454042166|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
126206148|NCT03996694|454042167|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
126206149|NCT00451191|454042173|FG000|Overall Study|withdrawal or received alternate tx|15|||
126206150|NCT00451191|454042174|FG001|Overall Study|withdrawal or received alternate tx|11|||
126206151|NCT00247416|454042177|FG000|Overall Study|3 patients were found to be ineligible|1|||
126206152|NCT00247416|454042178|FG001|Overall Study|3 patients were found to be ineligible|2|||
126206153|NCT00798161|454042179|FG000|Overall Study|Adverse Event|3|||
126206154|NCT00798161|454042180|FG001|Overall Study|Adverse Event|4|||
126206155|NCT00798161|454042181|FG002|Overall Study|Adverse Event|6|||
126206156|NCT00798161|454042182|FG003|Overall Study|Adverse Event|6|||
126206157|NCT00798161|454042183|FG004|Overall Study|Adverse Event|5|||
126206158|NCT00798161|454042184|FG005|Overall Study|Adverse Event|2|||
126206159|NCT00798161|454042185|FG006|Overall Study|Adverse Event|4|||
126206160|NCT00798161|454042179|FG000|Overall Study|Protocol Violation|2|||
126206161|NCT00798161|454042180|FG001|Overall Study|Protocol Violation|1|||
126206162|NCT00798161|454042181|FG002|Overall Study|Protocol Violation|3|||
126206163|NCT00798161|454042182|FG003|Overall Study|Protocol Violation|3|||
126206164|NCT00798161|454042183|FG004|Overall Study|Protocol Violation|3|||
126206165|NCT00798161|454042184|FG005|Overall Study|Protocol Violation|2|||
126206166|NCT00798161|454042185|FG006|Overall Study|Protocol Violation|0|||
126206167|NCT00798161|454042179|FG000|Overall Study|Lost to Follow-up|1|||
126206168|NCT00798161|454042180|FG001|Overall Study|Lost to Follow-up|3|||
126206169|NCT00798161|454042181|FG002|Overall Study|Lost to Follow-up|4|||
126206170|NCT00798161|454042182|FG003|Overall Study|Lost to Follow-up|3|||
126206171|NCT00798161|454042183|FG004|Overall Study|Lost to Follow-up|4|||
126206172|NCT00798161|454042184|FG005|Overall Study|Lost to Follow-up|0|||
126206173|NCT00798161|454042185|FG006|Overall Study|Lost to Follow-up|0|||
126206174|NCT00798161|454042179|FG000|Overall Study|Withdrawal by Subject|5|||
126206175|NCT00798161|454042180|FG001|Overall Study|Withdrawal by Subject|4|||
126206176|NCT00798161|454042181|FG002|Overall Study|Withdrawal by Subject|5|||
126206177|NCT00798161|454042182|FG003|Overall Study|Withdrawal by Subject|4|||
126206178|NCT00798161|454042183|FG004|Overall Study|Withdrawal by Subject|2|||
126206179|NCT00798161|454042184|FG005|Overall Study|Withdrawal by Subject|3|||
126206180|NCT00798161|454042185|FG006|Overall Study|Withdrawal by Subject|1|||
126206181|NCT00798161|454042179|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
126206182|NCT00798161|454042180|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
126206183|NCT00798161|454042181|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
126313911|NCT00191282|454439422|FG001|Overall Study|Lack of Efficacy|6|||
126313912|NCT00191282|454439421|FG000|Overall Study|Noncompliance|14|||
126206184|NCT00798161|454042182|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
126206185|NCT00798161|454042183|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
126206186|NCT00798161|454042184|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
126206187|NCT00798161|454042185|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
126206188|NCT00761761|454042186|FG000|Overall Study|Lost to Follow-up|3|||
126206189|NCT00761761|454042187|FG001|Overall Study|Lost to Follow-up|1|||
126206190|NCT00761761|454042186|FG000|Overall Study|Withdrawal by Subject|3|||
126206191|NCT00761761|454042187|FG001|Overall Study|Withdrawal by Subject|0|||
126206192|NCT02706327|454042189|FG000|Overall Study|Lost to Follow-up|1|||
126206193|NCT02706327|454042190|FG001|Overall Study|Lost to Follow-up|1|||
126206194|NCT02706327|454042191|FG002|Overall Study|Lost to Follow-up|2|||
126206195|NCT01982942|454042194|FG000|Overall Study|Adverse Event|10|||
126206196|NCT01982942|454042195|FG001|Overall Study|Adverse Event|5|||
126206197|NCT01982942|454042194|FG000|Overall Study|Lost to Follow-up|4|||
126206198|NCT01982942|454042195|FG001|Overall Study|Lost to Follow-up|3|||
126206199|NCT01982942|454042194|FG000|Overall Study|Multiple sclerosis progression|3|||
126206200|NCT01982942|454042195|FG001|Overall Study|Multiple sclerosis progression|2|||
126206201|NCT01982942|454042194|FG000|Overall Study|Wanted to try therapy not permitted|1|||
126206202|NCT01982942|454042195|FG001|Overall Study|Wanted to try therapy not permitted|0|||
126206203|NCT01982942|454042194|FG000|Overall Study|Subject declined future visits|0|||
126206204|NCT01982942|454042195|FG001|Overall Study|Subject declined future visits|1|||
126206205|NCT01982942|454042194|FG000|Overall Study|Left geographical area|2|||
126206206|NCT01982942|454042195|FG001|Overall Study|Left geographical area|0|||
126206207|NCT01982942|454042194|FG000|Overall Study|Too many pills|1|||
126206208|NCT01982942|454042195|FG001|Overall Study|Too many pills|0|||
126206209|NCT01982942|454042194|FG000|Overall Study|MS Relapse|0|||
126206210|NCT01982942|454042195|FG001|Overall Study|MS Relapse|1|||
126206211|NCT01982942|454042194|FG000|Overall Study|Chose to join a stem cell trial|0|||
126206212|NCT01982942|454042195|FG001|Overall Study|Chose to join a stem cell trial|1|||
126206213|NCT01982942|454042194|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
126206214|NCT01982942|454042195|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
126206215|NCT04511533|454042196|FG000|Treatment|Other|2|||
126206216|NCT04511533|454042196|FG000|Treatment|Withdrawal by Subject|11|||
126206217|NCT04511533|454042196|FG000|Treatment|Death|5|||
126206218|NCT04511533|454042196|FG000|Treatment|Physician Decision|1|||
126206219|NCT04511533|454042196|FG000|Treatment|Progressive Disease|61|||
126206220|NCT04511533|454042196|FG000|Follow-Up|Other|7|||
126206221|NCT04511533|454042196|FG000|Follow-Up|Withdrawal by Subject|5|||
126206222|NCT04511533|454042196|FG000|Follow-Up|Lost to Follow-up|2|||
126206223|NCT04511533|454042196|FG000|Follow-Up|Death|4|||
126206224|NCT02213666|454042197|FG000|Overall Study|Withdrawal by Subject|1|||
126206225|NCT02918968|454042200|FG000|1st Line AAT|Progressive disease|9|||
126206226|NCT02918968|454042201|FG001|1st Line AAT|Progressive disease|4|||
126206227|NCT02918968|454042200|FG000|1st Line AAT|Adverse Event|12|||
126206228|NCT02918968|454042201|FG001|1st Line AAT|Adverse Event|3|||
126206229|NCT02918968|454042200|FG000|1st Line AAT|Physician Decision|4|||
126206230|NCT02918968|454042201|FG001|1st Line AAT|Physician Decision|2|||
126206231|NCT02918968|454042200|FG000|1st Line AAT|Withdrawal by Subject|2|||
126206232|NCT02918968|454042201|FG001|1st Line AAT|Withdrawal by Subject|1|||
126206233|NCT02918968|454042200|FG000|1st Line AAT|Lost to Follow-up|0|||
126206234|NCT02918968|454042201|FG001|1st Line AAT|Lost to Follow-up|1|||
126206235|NCT02918968|454042200|FG000|1st Line AAT|Death|1|||
126206236|NCT02918968|454042201|FG001|1st Line AAT|Death|0|||
126206237|NCT02918968|454042200|FG000|1st Line AAT|Miscellaneous|1|||
126206238|NCT02918968|454042201|FG001|1st Line AAT|Miscellaneous|0|||
126206239|NCT02918968|454042200|FG000|2nd Line AAT|Progressive disease|21|||
126206240|NCT02918968|454042201|FG001|2nd Line AAT|Progressive disease|3|||
126206241|NCT02918968|454042200|FG000|2nd Line AAT|Adverse Event|2|||
126206242|NCT02918968|454042201|FG001|2nd Line AAT|Adverse Event|5|||
126046439|NCT02719574|453468214|FG013|Phase 2|Protocol Violation|0|||
126046440|NCT02719574|453468215|FG014|Phase 2|Protocol Violation|0|||
126046441|NCT02719574|453468216|FG015|Phase 2|Protocol Violation|0|||
126046442|NCT02719574|453468217|FG016|Phase 2|Protocol Violation|0|||
126090416|NCT03635099|453623563|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
126313913|NCT00191282|454439422|FG001|Overall Study|Noncompliance|17|||
126313914|NCT00191282|454439421|FG000|Overall Study|Patient moved|11|||
126313915|NCT00191282|454439422|FG001|Overall Study|Patient moved|14|||
126313916|NCT00191282|454439421|FG000|Overall Study|Withdrawal by Subject|59|||
126313917|NCT00191282|454439422|FG001|Overall Study|Withdrawal by Subject|44|||
126313918|NCT00191282|454439421|FG000|Overall Study|Physician Decision|18|||
126313919|NCT00191282|454439422|FG001|Overall Study|Physician Decision|15|||
126313920|NCT00191282|454439421|FG000|Overall Study|Protocol entry criteria not met|14|||
126313921|NCT00191282|454439422|FG001|Overall Study|Protocol entry criteria not met|9|||
126313922|NCT00191282|454439421|FG000|Overall Study|Protocol Violation|9|||
126313923|NCT00191282|454439422|FG001|Overall Study|Protocol Violation|12|||
126313924|NCT00191282|454439421|FG000|Overall Study|Severity of outcome|2|||
126313925|NCT00191282|454439422|FG001|Overall Study|Severity of outcome|5|||
126313926|NCT00191282|454439421|FG000|Overall Study|Sponsor's decision|2|||
126313927|NCT00191282|454439422|FG001|Overall Study|Sponsor's decision|2|||
126313928|NCT00191282|454439421|FG000|Overall Study|Lost to Follow-up|24|||
126313929|NCT00191282|454439422|FG001|Overall Study|Lost to Follow-up|31|||
126313930|NCT00102531|454439425|FG000|Overall Study|Adverse Event|0|||
126313931|NCT00102531|454439426|FG001|Overall Study|Adverse Event|1|||
126313932|NCT00102531|454439425|FG000|Overall Study|Disease Progression|5|||
126313933|NCT00102531|454439426|FG001|Overall Study|Disease Progression|9|||
126313934|NCT00102531|454439425|FG000|Overall Study|Physician Decision|0|||
126313935|NCT00102531|454439426|FG001|Overall Study|Physician Decision|1|||
126313936|NCT04756154|454439428|FG000|Overall Study|Did not meet treatment day baseline|30|||
126313937|NCT04756154|454439429|FG001|Overall Study|Did not meet treatment day baseline|28|||
126313938|NCT04756154|454439430|FG002|Overall Study|Did not meet treatment day baseline|7|||
126313939|NCT04756154|454439428|FG000|Overall Study|Did not return for final sample collection|1|||
126313940|NCT04756154|454439429|FG001|Overall Study|Did not return for final sample collection|1|||
126313941|NCT04756154|454439430|FG002|Overall Study|Did not return for final sample collection|0|||
126313942|NCT03055494|454440750|FG000|Overall Study|Lost to Follow-up|6|||
126313943|NCT03055494|454440751|FG001|Overall Study|Lost to Follow-up|0|||
126313944|NCT03055494|454440750|FG000|Overall Study|Physician Decision|2|||
126313945|NCT03055494|454440751|FG001|Overall Study|Physician Decision|0|||
126313946|NCT03055494|454440750|FG000|Overall Study|Withdrawal by Subject|1|||
126313947|NCT03055494|454440751|FG001|Overall Study|Withdrawal by Subject|0|||
126313948|NCT03055494|454440750|FG000|Overall Study|Adverse Event|0|||
126313949|NCT03055494|454440751|FG001|Overall Study|Adverse Event|1|||
126313950|NCT03055494|454440750|FG000|Overall Study|Non-compliance with study treatment|1|||
126313951|NCT03055494|454440751|FG001|Overall Study|Non-compliance with study treatment|0|||
126313952|NCT05079750|454440752|FG000|Overall Study|Lost to Follow-up|0|||
126313953|NCT05079750|454440753|FG001|Overall Study|Lost to Follow-up|0|||
126313954|NCT05079750|454440754|FG002|Overall Study|Lost to Follow-up|1|||
126313955|NCT05897827|454440755|FG000|Overall Study|Lost to Follow-up|33|||
126313956|NCT05897827|454440756|FG001|Overall Study|Lost to Follow-up|14|||
126313957|NCT05897827|454440755|FG000|Overall Study|Withdrawal by Subject|1|||
126313958|NCT05897827|454440756|FG001|Overall Study|Withdrawal by Subject|1|||
126313959|NCT00197002|454440757|FG000|Overall Study|Adverse Event|0|||
126313960|NCT00197002|454440758|FG001|Overall Study|Adverse Event|1|||
126313961|NCT00197002|454440759|FG002|Overall Study|Adverse Event|0|||
126313962|NCT00197002|454440757|FG000|Overall Study|Protocol Violation|1|||
126090417|NCT03635099|453623564|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
126090418|NCT03635099|453623565|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
126090419|NCT03635099|453623558|FG000|Period 2|Adverse Event|0|||
126206243|NCT02918968|454042200|FG000|2nd Line AAT|Physician Decision|0|||
126206244|NCT02918968|454042201|FG001|2nd Line AAT|Physician Decision|1|||
126206245|NCT02918968|454042200|FG000|2nd Line AAT|Withdrawal by Subject|2|||
126206246|NCT02918968|454042201|FG001|2nd Line AAT|Withdrawal by Subject|2|||
126206247|NCT02918968|454042200|FG000|2nd Line AAT|Death|0|||
126206248|NCT02918968|454042201|FG001|2nd Line AAT|Death|1|||
126206249|NCT00727246|454042206|FG000|Overall Study|could not complete MRI|0|||
126206250|NCT00727246|454042207|FG001|Overall Study|could not complete MRI|1|||
126206251|NCT00727246|454042208|FG002|Overall Study|could not complete MRI|0|||
126206252|NCT00727246|454042209|FG003|Overall Study|could not complete MRI|1|||
126206253|NCT00727246|454042206|FG000|Overall Study|incidental finding|0|||
126206254|NCT00727246|454042207|FG001|Overall Study|incidental finding|0|||
126206255|NCT00727246|454042208|FG002|Overall Study|incidental finding|0|||
126206256|NCT00727246|454042209|FG003|Overall Study|incidental finding|1|||
126206257|NCT00727246|454042206|FG000|Overall Study|withdrawn|0|||
126206258|NCT00727246|454042207|FG001|Overall Study|withdrawn|0|||
126206259|NCT00727246|454042208|FG002|Overall Study|withdrawn|1|||
126313963|NCT00197002|454440758|FG001|Overall Study|Protocol Violation|0|||
126090420|NCT03635099|453623559|FG001|Period 2|Adverse Event|0|||
126090421|NCT03635099|453623560|FG002|Period 2|Adverse Event|1|||
126090422|NCT03635099|453623561|FG003|Period 2|Adverse Event|0|||
126090423|NCT03635099|453623562|FG004|Period 2|Adverse Event|1|||
126090424|NCT03635099|453623563|FG005|Period 2|Adverse Event|0|||
126090425|NCT03635099|453623564|FG006|Period 2|Adverse Event|0|||
126090426|NCT03635099|453623565|FG007|Period 2|Adverse Event|0|||
126090427|NCT03635099|453623558|FG000|Period 2|Lost to Follow-up|0|||
126090428|NCT03635099|453623559|FG001|Period 2|Lost to Follow-up|0|||
126090429|NCT03635099|453623560|FG002|Period 2|Lost to Follow-up|1|||
126090430|NCT03635099|453623561|FG003|Period 2|Lost to Follow-up|0|||
126090431|NCT03635099|453623562|FG004|Period 2|Lost to Follow-up|4|||
126090432|NCT03635099|453623563|FG005|Period 2|Lost to Follow-up|0|||
126090433|NCT03635099|453623564|FG006|Period 2|Lost to Follow-up|0|||
126090434|NCT03635099|453623565|FG007|Period 2|Lost to Follow-up|0|||
126090435|NCT03635099|453623558|FG000|Period 2|Withdrawal by Subject|0|||
126090436|NCT03635099|453623559|FG001|Period 2|Withdrawal by Subject|0|||
126206260|NCT00727246|454042209|FG003|Overall Study|withdrawn|0|||
126206261|NCT02696382|454042211|FG000|Overall Study|Death|7|||
126206262|NCT02696382|454042212|FG001|Overall Study|Death|2|||
126206263|NCT02696382|454042211|FG000|Overall Study|Withdrawal by Subject|5|||
126206264|NCT02696382|454042212|FG001|Overall Study|Withdrawal by Subject|12|||
126206265|NCT02696382|454042211|FG000|Overall Study|Lost to Follow-up|4|||
126206266|NCT02696382|454042212|FG001|Overall Study|Lost to Follow-up|7|||
126206267|NCT03781167|454042219|FG000|Overall Study|Adverse Event|23|||
126206268|NCT03781167|454042220|FG001|Overall Study|Adverse Event|25|||
126206269|NCT03781167|454042219|FG000|Overall Study|Withdrew consent|16|||
126206270|NCT03781167|454042220|FG001|Overall Study|Withdrew consent|12|||
126206271|NCT03781167|454042219|FG000|Overall Study|Lost to Follow-up|0|||
126206272|NCT03781167|454042220|FG001|Overall Study|Lost to Follow-up|1|||
126206273|NCT03781167|454042219|FG000|Overall Study|Lack of Efficacy|4|||
126206274|NCT03781167|454042220|FG001|Overall Study|Lack of Efficacy|5|||
126206275|NCT03781167|454042219|FG000|Overall Study|Difficulty with drug delivery system|2|||
126206276|NCT03781167|454042220|FG001|Overall Study|Difficulty with drug delivery system|3|||
126206277|NCT03781167|454042219|FG000|Overall Study|Other, not specified|2|||
126206278|NCT03781167|454042220|FG001|Overall Study|Other, not specified|2|||
126206279|NCT01590628|454042228|FG000|Overall Study|Death|2|||
126206280|NCT01590628|454042229|FG001|Overall Study|Death|0|||
126206281|NCT00475657|454042230|FG000|Overall Study|Death|1|||
126206282|NCT00475657|454042230|FG000|Overall Study|Sponsor's Decision|3|||
126206283|NCT02992743|454042231|FG000|Overall Study|Withdrawal by Subject|1|||
126206284|NCT02992743|454042232|FG001|Overall Study|Withdrawal by Subject|1|||
126206285|NCT02992743|454042231|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
126206286|NCT02992743|454042232|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
126206287|NCT02992743|454042231|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
126206288|NCT02992743|454042232|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
126206289|NCT02992743|454042231|FG000|Overall Study|No measurable disease|1|||
126206290|NCT02992743|454042232|FG001|Overall Study|No measurable disease|0|||
126206291|NCT02992743|454042231|FG000|Overall Study|Lost to Follow-up|0|||
126206292|NCT02992743|454042232|FG001|Overall Study|Lost to Follow-up|1|||
126206293|NCT00761735|454042233|FG000|Overall Study|Lost to Follow-up|6|||
126206294|NCT00761735|454042233|FG000|Overall Study|Withdrawal by Subject|6|||
126206295|NCT00761735|454042233|FG000|Overall Study|Non-compliance with protocol|1|||
126206296|NCT00761735|454042233|FG000|Overall Study|Administrative|1|||
126206297|NCT00381680|454042236|FG000|Overall Study|Adverse Event|9|||
126206298|NCT00381680|454042237|FG001|Overall Study|Adverse Event|3|||
126206299|NCT00381680|454042236|FG000|Overall Study|Death|10|||
126206300|NCT00381680|454042237|FG001|Overall Study|Death|7|||
126206301|NCT00381680|454042236|FG000|Overall Study|Lost to Follow-up|3|||
126206302|NCT00381680|454042237|FG001|Overall Study|Lost to Follow-up|2|||
126206303|NCT00381680|454042236|FG000|Overall Study|Physician Decision|25|||
126206304|NCT00381680|454042237|FG001|Overall Study|Physician Decision|6|||
126206305|NCT00381680|454042236|FG000|Overall Study|Withdrawal by Subject|3|||
126206306|NCT00381680|454042237|FG001|Overall Study|Withdrawal by Subject|1|||
126206307|NCT00381680|454042236|FG000|Overall Study|Entry onto another COG Trial|1|||
126206308|NCT00381680|454042237|FG001|Overall Study|Entry onto another COG Trial|2|||
126206309|NCT00381680|454042236|FG000|Overall Study|Alternative Therapy|11|||
126206310|NCT00381680|454042237|FG001|Overall Study|Alternative Therapy|5|||
126206311|NCT00381680|454042236|FG000|Overall Study|Secondary Malignancy|3|||
126206312|NCT00381680|454042237|FG001|Overall Study|Secondary Malignancy|0|||
126206313|NCT00381680|454042236|FG000|Overall Study|Delay initiation|1|||
126206314|NCT00381680|454042237|FG001|Overall Study|Delay initiation|0|||
126206315|NCT00381680|454042236|FG000|Overall Study|Stem Cell Transplant|26|||
126206316|NCT00381680|454042237|FG001|Overall Study|Stem Cell Transplant|10|||
126206317|NCT00381680|454042236|FG000|Overall Study|Relapse|18|||
126206318|NCT00381680|454042237|FG001|Overall Study|Relapse|9|||
126206319|NCT00381680|454042236|FG000|Overall Study|Induction Failure|4|||
126206320|NCT00381680|454042237|FG001|Overall Study|Induction Failure|1|||
126206321|NCT00381680|454042236|FG000|Overall Study|Progression|1|||
126206322|NCT00381680|454042237|FG001|Overall Study|Progression|1|||
126206323|NCT00381680|454042236|FG000|Overall Study|Other not otherwise specified|7|||
126206324|NCT00381680|454042237|FG001|Overall Study|Other not otherwise specified|2|||
126206325|NCT00381680|454042236|FG000|Overall Study|Ineligible|3|||
126206326|NCT00381680|454042237|FG001|Overall Study|Ineligible|1|||
126206327|NCT03290131|454042238|FG000|Overall Study|Adverse Event|22|||
126206328|NCT03290131|454042239|FG001|Overall Study|Adverse Event|57|||
126206329|NCT03290131|454042240|FG002|Overall Study|Adverse Event|11|||
126206330|NCT03290131|454042238|FG000|Overall Study|Withdrawal by Subject|18|||
126206331|NCT03290131|454042239|FG001|Overall Study|Withdrawal by Subject|13|||
126206332|NCT03290131|454042240|FG002|Overall Study|Withdrawal by Subject|8|||
126206333|NCT03290131|454042238|FG000|Overall Study|MS Relapse|2|||
126206334|NCT03290131|454042239|FG001|Overall Study|MS Relapse|1|||
126206335|NCT03290131|454042240|FG002|Overall Study|MS Relapse|0|||
126206336|NCT03290131|454042238|FG000|Overall Study|Unknown reason|0|||
126206337|NCT03290131|454042239|FG001|Overall Study|Unknown reason|1|||
126206338|NCT03290131|454042240|FG002|Overall Study|Unknown reason|0|||
126206339|NCT03099096|454042243|FG000|Overall Study|Adverse Event|1|||
126206340|NCT03099096|454042243|FG000|Overall Study|Physician Decision|1|||
126206341|NCT04629534|454042250|FG000|Overall Study|Physician Decision|1|||
126206342|NCT04629534|454042251|FG001|Overall Study|Physician Decision|0|||
126206343|NCT04629534|454042250|FG000|Overall Study|Protocol Violation|0|||
126206344|NCT04629534|454042251|FG001|Overall Study|Protocol Violation|2|||
126206345|NCT02190604|454042252|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206346|NCT02190604|454042253|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206347|NCT02190604|454042254|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206348|NCT02190604|454042255|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206349|NCT02190604|454042256|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206350|NCT02190604|454042257|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206351|NCT02190604|454042258|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206352|NCT02190604|454042259|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206353|NCT02190604|454042260|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206354|NCT02190604|454042261|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206355|NCT02190604|454042262|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206356|NCT02190604|454042263|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206357|NCT02190604|454042264|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206358|NCT02190604|454042265|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206359|NCT02190604|454042266|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
126206360|NCT02190604|454042267|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206361|NCT02190604|454042268|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206362|NCT02190604|454042269|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206363|NCT02190604|454042270|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126206364|NCT02190604|454042252|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206365|NCT02190604|454042253|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206366|NCT02190604|454042254|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206367|NCT02190604|454042255|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206368|NCT02190604|454042256|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206369|NCT02190604|454042257|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206370|NCT02190604|454042258|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206371|NCT02190604|454042259|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206372|NCT02190604|454042260|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206373|NCT02190604|454042261|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206374|NCT02190604|454042262|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206375|NCT02190604|454042263|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206376|NCT02190604|454042264|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206377|NCT02190604|454042265|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
126206378|NCT02190604|454042266|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206379|NCT02190604|454042267|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206380|NCT02190604|454042268|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206381|NCT02190604|454042269|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206382|NCT02190604|454042270|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126206383|NCT02797951|454042271|FG000|Overall Study|Adverse Event|4|||
126206384|NCT02797951|454042271|FG000|Overall Study|Death|1|||
126206385|NCT02797951|454042271|FG000|Overall Study|Lack of Efficacy|19|||
126206386|NCT02797951|454042271|FG000|Overall Study|Lost to Follow-up|4|||
126206387|NCT02797951|454042271|FG000|Overall Study|Physician Decision|6|||
126206388|NCT02797951|454042271|FG000|Overall Study|Withdrawal by Subject|15|||
126206389|NCT03205605|454042272|FG000|Overall Study|Withdrawal by Subject|1|||
126206390|NCT00945815|454042275|FG000|Overall Study|Death|3|||
126206391|NCT00945815|454042275|FG000|Overall Study|Not protocol specified|1|||
126206392|NCT00945815|454042275|FG000|Overall Study|Ineligible|3|||
126206393|NCT00945815|454042275|FG000|Overall Study|Did not begin protocol therapy|1|||
126206394|NCT01990339|454042276|FG000|Overall Study|Data Not Available|49|||
126206395|NCT01990339|454042276|FG000|Overall Study|Voluntary Withdrawal|1402|||
126206396|NCT01990339|454042276|FG000|Overall Study|Lost to Follow-up|861|||
126206397|NCT01038609|454042277|FG000|Overall Study|Adverse Event|0|||
126206398|NCT01038609|454042278|FG001|Overall Study|Adverse Event|0|||
126206399|NCT01038609|454042279|FG002|Overall Study|Adverse Event|1|||
126206400|NCT01038609|454042280|FG003|Overall Study|Adverse Event|0|||
126206401|NCT01038609|454042281|FG004|Overall Study|Adverse Event|0|||
126206402|NCT01038609|454042277|FG000|Overall Study|Dosing Error|0|||
126206403|NCT01038609|454042278|FG001|Overall Study|Dosing Error|0|||
126206404|NCT01038609|454042279|FG002|Overall Study|Dosing Error|0|||
126206405|NCT01038609|454042280|FG003|Overall Study|Dosing Error|1|||
126206406|NCT01038609|454042281|FG004|Overall Study|Dosing Error|1|||
126206407|NCT01038609|454042277|FG000|Overall Study|Death in the Family|1|||
126313964|NCT00197002|454440759|FG002|Overall Study|Protocol Violation|2|||
126206408|NCT01038609|454042278|FG001|Overall Study|Death in the Family|0|||
126206409|NCT01038609|454042279|FG002|Overall Study|Death in the Family|0|||
126206410|NCT01038609|454042280|FG003|Overall Study|Death in the Family|0|||
126206411|NCT01038609|454042281|FG004|Overall Study|Death in the Family|0|||
126206412|NCT01038609|454042277|FG000|Overall Study|Refusal of Blood Draws|0|||
126206413|NCT01038609|454042278|FG001|Overall Study|Refusal of Blood Draws|1|||
126206414|NCT01038609|454042279|FG002|Overall Study|Refusal of Blood Draws|0|||
126206415|NCT01038609|454042280|FG003|Overall Study|Refusal of Blood Draws|0|||
126206416|NCT01038609|454042281|FG004|Overall Study|Refusal of Blood Draws|0|||
126206417|NCT01590810|454042283|FG000|Overall Study|Physician Decision|0|||
126206418|NCT01590810|454042284|FG001|Overall Study|Physician Decision|1|||
126206419|NCT01590810|454042285|FG002|Overall Study|Physician Decision|1|||
126206420|NCT01590810|454042286|FG003|Overall Study|Physician Decision|0|||
126206421|NCT01590810|454042287|FG004|Overall Study|Physician Decision|0|||
126206422|NCT03655951|454042288|FG000|Overall Study|Lost to Follow-up|39|||
126206423|NCT03655951|454042289|FG001|Overall Study|Lost to Follow-up|20|||
126206424|NCT03655951|454042288|FG000|Overall Study|Withdrawal by Subject|0|||
126206425|NCT03655951|454042289|FG001|Overall Study|Withdrawal by Subject|1|||
126206426|NCT02811640|454042290|FG000|Overall Study|Technology malfunction|2|||
126206427|NCT02441517|454042291|FG000|Overall Study|Lost to Follow-up|1|||
126206428|NCT02441517|454042291|FG000|Overall Study|Withdrawal by Subject|2|||
126206429|NCT02441517|454042291|FG000|Overall Study|Study Terminated by Sponsor|1|||
126206430|NCT01393444|454042292|FG000|Overall Study|Withdrawal by Subject|1|||
126206431|NCT01393444|454042292|FG000|Overall Study|Determined ineligible during screening.|2|||
126206432|NCT01349816|454042293|FG000|Overall Study|Withdrawal by Subject|4|||
126206433|NCT01349816|454042293|FG000|Overall Study|Physician Decision|1|||
126206434|NCT01349816|454042293|FG000|Overall Study|Adverse Event|14|||
126206435|NCT01349816|454042293|FG000|Overall Study|Lost to Follow-up|2|||
126206436|NCT01349816|454042293|FG000|Overall Study|Protocol Violation|1|||
126206437|NCT01349816|454042293|FG000|Overall Study|Protocol-specified criteria|8|||
126206438|NCT02569996|454042294|FG000|Overall Study|Adverse Event|6|||
126206439|NCT02569996|454042294|FG000|Overall Study|Physician Decision|3|||
126206440|NCT02569996|454042294|FG000|Overall Study|Progression of the disease|18|||
126206441|NCT02569996|454042294|FG000|Overall Study|New anti-lymphoma treatment|1|||
126206442|NCT02569996|454042294|FG000|Overall Study|Non-compliance|9|||
126206443|NCT02569996|454042294|FG000|Overall Study|Withdrawal by Subject|5|||
126206444|NCT02569996|454042294|FG000|Overall Study|Lost to Follow-up|5|||
126206445|NCT02569996|454042294|FG000|Overall Study|Complete remission|7|||
126206446|NCT02569996|454042294|FG000|Overall Study|Unknown reason|1|||
126206447|NCT01383317|454042295|FG000|Overall Study|Lost to Follow-up|2|||
126206448|NCT01383317|454042296|FG001|Overall Study|Lost to Follow-up|1|||
126206449|NCT01383317|454042295|FG000|Overall Study|Death|1|||
126206450|NCT01383317|454042296|FG001|Overall Study|Death|0|||
126206451|NCT01383317|454042295|FG000|Overall Study|Adverse Event|0|||
126206452|NCT01383317|454042296|FG001|Overall Study|Adverse Event|1|||
126206453|NCT01397409|454042301|FG000|Stage 2|Adverse Event|0|||
126206454|NCT01397409|454042302|FG001|Stage 2|Adverse Event|0|||
126206455|NCT01397409|454042303|FG002|Stage 2|Adverse Event|0|||
126206456|NCT01397409|454042304|FG003|Stage 2|Adverse Event|0|||
126206457|NCT01397409|454042305|FG004|Stage 2|Adverse Event|6|||
126206458|NCT01397409|454042306|FG005|Stage 2|Adverse Event|3|||
126206459|NCT01397409|454042307|FG006|Stage 2|Adverse Event|0|||
126206460|NCT01397409|454042308|FG007|Stage 2|Adverse Event|0|||
126206461|NCT01397409|454042309|FG008|Stage 2|Adverse Event|0|||
126206462|NCT01397409|454042310|FG009|Stage 2|Adverse Event|0|||
126206463|NCT01397409|454042301|FG000|Stage 2|Personal Reasons|0|||
126206464|NCT01397409|454042302|FG001|Stage 2|Personal Reasons|0|||
126206465|NCT01397409|454042303|FG002|Stage 2|Personal Reasons|0|||
126206466|NCT01397409|454042304|FG003|Stage 2|Personal Reasons|0|||
126206467|NCT01397409|454042305|FG004|Stage 2|Personal Reasons|1|||
126206468|NCT01397409|454042306|FG005|Stage 2|Personal Reasons|0|||
126206469|NCT01397409|454042307|FG006|Stage 2|Personal Reasons|0|||
126206470|NCT01397409|454042308|FG007|Stage 2|Personal Reasons|0|||
126206471|NCT01397409|454042309|FG008|Stage 2|Personal Reasons|0|||
126206472|NCT01397409|454042310|FG009|Stage 2|Personal Reasons|0|||
126206473|NCT01397409|454042301|FG000|Stage 2|Other Miscellaneous Reasons|0|||
126206474|NCT01397409|454042302|FG001|Stage 2|Other Miscellaneous Reasons|0|||
126206475|NCT01397409|454042303|FG002|Stage 2|Other Miscellaneous Reasons|0|||
126206476|NCT01397409|454042304|FG003|Stage 2|Other Miscellaneous Reasons|0|||
126206477|NCT01397409|454042305|FG004|Stage 2|Other Miscellaneous Reasons|1|||
126206478|NCT01397409|454042306|FG005|Stage 2|Other Miscellaneous Reasons|1|||
126206479|NCT01397409|454042307|FG006|Stage 2|Other Miscellaneous Reasons|0|||
126206480|NCT01397409|454042308|FG007|Stage 2|Other Miscellaneous Reasons|0|||
126206481|NCT01397409|454042309|FG008|Stage 2|Other Miscellaneous Reasons|0|||
126206482|NCT01397409|454042310|FG009|Stage 2|Other Miscellaneous Reasons|0|||
126206483|NCT01397409|454042301|FG000|Stage 3|Adverse Event|0|||
126206484|NCT01397409|454042302|FG001|Stage 3|Adverse Event|0|||
126206485|NCT01397409|454042303|FG002|Stage 3|Adverse Event|0|||
126206486|NCT01397409|454042304|FG003|Stage 3|Adverse Event|0|||
126206487|NCT01397409|454042305|FG004|Stage 3|Adverse Event|0|||
126206488|NCT01397409|454042306|FG005|Stage 3|Adverse Event|0|||
126206489|NCT01397409|454042307|FG006|Stage 3|Adverse Event|0|||
126206490|NCT01397409|454042308|FG007|Stage 3|Adverse Event|1|||
126206491|NCT01397409|454042309|FG008|Stage 3|Adverse Event|0|||
126206492|NCT01397409|454042310|FG009|Stage 3|Adverse Event|0|||
126206493|NCT01397409|454042301|FG000|Stage 3|Other Miscellaneous Reasons|0|||
126206494|NCT01397409|454042302|FG001|Stage 3|Other Miscellaneous Reasons|0|||
126206495|NCT01397409|454042303|FG002|Stage 3|Other Miscellaneous Reasons|0|||
126206496|NCT01397409|454042304|FG003|Stage 3|Other Miscellaneous Reasons|0|||
126206497|NCT01397409|454042305|FG004|Stage 3|Other Miscellaneous Reasons|0|||
126206498|NCT01397409|454042306|FG005|Stage 3|Other Miscellaneous Reasons|0|||
126206499|NCT01397409|454042307|FG006|Stage 3|Other Miscellaneous Reasons|0|||
126206500|NCT01397409|454042308|FG007|Stage 3|Other Miscellaneous Reasons|1|||
126206501|NCT01397409|454042309|FG008|Stage 3|Other Miscellaneous Reasons|0|||
126206502|NCT01397409|454042310|FG009|Stage 3|Other Miscellaneous Reasons|0|||
126206503|NCT01207427|454042311|FG000|Double-blind Treatment Period|Adverse Event|0|||
126206504|NCT01207427|454042312|FG001|Double-blind Treatment Period|Adverse Event|1|||
126206505|NCT01207427|454042313|FG002|Double-blind Treatment Period|Adverse Event|0|||
126206506|NCT01207427|454042311|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126206507|NCT01207427|454042312|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126206508|NCT01207427|454042313|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
126206509|NCT01207427|454042311|FG000|Double-blind Treatment Period|Protocol Violation|2|||
126206510|NCT01207427|454042312|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126206511|NCT01207427|454042313|FG002|Double-blind Treatment Period|Protocol Violation|1|||
126206512|NCT01207427|454042311|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126206513|NCT01207427|454042312|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126206514|NCT01207427|454042313|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126206515|NCT01790633|454042314|FG000|Overall Study|Protocol Violation|1|||
126206516|NCT01790633|454042315|FG001|Overall Study|Protocol Violation|2|||
126206517|NCT01790633|454042314|FG000|Overall Study|Did not have serology performed|47|||
126206518|NCT01790633|454042315|FG001|Overall Study|Did not have serology performed|0|||
126206519|NCT01790633|454042314|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
126206520|NCT01790633|454042315|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
126206521|NCT02930889|454043636|FG000|Overall Study|Lost to Follow-up|2|||
126206522|NCT02930889|454043636|FG000|Overall Study|Withdrawal by Subject|6|||
126206523|NCT02930889|454043636|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
126206524|NCT00198107|454043642|FG000|Double-Blind Period|Adverse Event|1|||
126206525|NCT00198107|454043643|FG001|Double-Blind Period|Adverse Event|1|||
126206526|NCT00198107|454043644|FG002|Double-Blind Period|Adverse Event|0|||
126206527|NCT00198107|454043642|FG000|Double-Blind Period|Lack of Efficacy|2|||
126206528|NCT00198107|454043643|FG001|Double-Blind Period|Lack of Efficacy|0|||
126206529|NCT00198107|454043644|FG002|Double-Blind Period|Lack of Efficacy|0|||
126206530|NCT00198107|454043642|FG000|Double-Blind Period|Lost to Follow-up|2|||
126206531|NCT00198107|454043643|FG001|Double-Blind Period|Lost to Follow-up|1|||
126206532|NCT00198107|454043644|FG002|Double-Blind Period|Lost to Follow-up|0|||
126206533|NCT00198107|454043642|FG000|Double-Blind Period|Physician Decision|1|||
126206534|NCT00198107|454043643|FG001|Double-Blind Period|Physician Decision|0|||
126206535|NCT00198107|454043644|FG002|Double-Blind Period|Physician Decision|0|||
126206536|NCT00198107|454043642|FG000|Double-Blind Period|Withdrawal by Subject|0|||
126206537|NCT00198107|454043643|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126206538|NCT00198107|454043644|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126206539|NCT00198107|454043642|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
126206540|NCT00198107|454043643|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
126206541|NCT00198107|454043644|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
126206542|NCT03575806|454043651|FG000|Overall Study|Withdrawal by Subject|0|||
126206543|NCT03575806|454043652|FG001|Overall Study|Withdrawal by Subject|2|||
126206544|NCT03575806|454043651|FG000|Overall Study|Protocol Violation|0|||
126206545|NCT03575806|454043652|FG001|Overall Study|Protocol Violation|2|||
126206546|NCT01458535|454043653|FG000|Overall Study|Other|0|||
126206547|NCT01458535|454043654|FG001|Overall Study|Other|0|||
126206548|NCT01458535|454043655|FG002|Overall Study|Other|0|||
126206549|NCT01458535|454043656|FG003|Overall Study|Other|0|||
126206550|NCT01458535|454043657|FG004|Overall Study|Other|1|||
126206551|NCT01458535|454043658|FG005|Overall Study|Other|1|||
126206552|NCT01458535|454043653|FG000|Overall Study|Withdrawal by Subject|0|||
126206553|NCT01458535|454043654|FG001|Overall Study|Withdrawal by Subject|0|||
126206554|NCT01458535|454043655|FG002|Overall Study|Withdrawal by Subject|2|||
126206555|NCT01458535|454043656|FG003|Overall Study|Withdrawal by Subject|0|||
126206556|NCT01458535|454043657|FG004|Overall Study|Withdrawal by Subject|1|||
126206557|NCT01458535|454043658|FG005|Overall Study|Withdrawal by Subject|1|||
126206558|NCT01458535|454043653|FG000|Overall Study|Lost to Follow-up|0|||
126206559|NCT01458535|454043654|FG001|Overall Study|Lost to Follow-up|2|||
126206560|NCT01458535|454043655|FG002|Overall Study|Lost to Follow-up|0|||
126206561|NCT01458535|454043656|FG003|Overall Study|Lost to Follow-up|3|||
126206562|NCT01458535|454043657|FG004|Overall Study|Lost to Follow-up|2|||
126206563|NCT01458535|454043658|FG005|Overall Study|Lost to Follow-up|2|||
126206564|NCT01458535|454043653|FG000|Overall Study|Adverse Event|0|||
126206565|NCT01458535|454043654|FG001|Overall Study|Adverse Event|0|||
126206566|NCT01458535|454043655|FG002|Overall Study|Adverse Event|0|||
126206567|NCT01458535|454043656|FG003|Overall Study|Adverse Event|1|||
126206568|NCT01458535|454043657|FG004|Overall Study|Adverse Event|0|||
126206569|NCT01458535|454043658|FG005|Overall Study|Adverse Event|0|||
126206570|NCT01238861|454043659|FG000|Overall Study|Lost to Follow-up|4|||
126206571|NCT01238861|454043660|FG001|Overall Study|Lost to Follow-up|2|||
126206572|NCT01238861|454043661|FG002|Overall Study|Lost to Follow-up|3|||
126206573|NCT01238861|454043662|FG003|Overall Study|Lost to Follow-up|1|||
126206574|NCT01238861|454043663|FG004|Overall Study|Lost to Follow-up|1|||
126206575|NCT01238861|454043664|FG005|Overall Study|Lost to Follow-up|2|||
126206576|NCT01238861|454043659|FG000|Overall Study|Unplanned surgery|1|||
126206577|NCT01238861|454043660|FG001|Overall Study|Unplanned surgery|0|||
126206578|NCT01238861|454043661|FG002|Overall Study|Unplanned surgery|0|||
126206579|NCT01238861|454043662|FG003|Overall Study|Unplanned surgery|0|||
126206580|NCT01238861|454043663|FG004|Overall Study|Unplanned surgery|0|||
126206581|NCT01238861|454043664|FG005|Overall Study|Unplanned surgery|0|||
126206582|NCT01238861|454043659|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
126206583|NCT01238861|454043660|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
126206584|NCT01238861|454043661|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
126206585|NCT01238861|454043662|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
126206586|NCT01238861|454043663|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
126206587|NCT01238861|454043664|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
126206588|NCT01238861|454043659|FG000|Overall Study|Incorrect enrollment/randomization|0|||
126206589|NCT01238861|454043660|FG001|Overall Study|Incorrect enrollment/randomization|0|||
126206590|NCT01238861|454043661|FG002|Overall Study|Incorrect enrollment/randomization|1|||
126206591|NCT01238861|454043662|FG003|Overall Study|Incorrect enrollment/randomization|0|||
126206592|NCT01238861|454043663|FG004|Overall Study|Incorrect enrollment/randomization|1|||
126206593|NCT01238861|454043664|FG005|Overall Study|Incorrect enrollment/randomization|0|||
126206594|NCT01238861|454043659|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
126206595|NCT01238861|454043660|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
126206596|NCT01238861|454043661|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
126206597|NCT01238861|454043662|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
126206598|NCT01238861|454043663|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
126206599|NCT01238861|454043664|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
126206600|NCT01238861|454043659|FG000|Overall Study|Subject moved out of state/area|0|||
126206601|NCT01238861|454043660|FG001|Overall Study|Subject moved out of state/area|0|||
126206602|NCT01238861|454043661|FG002|Overall Study|Subject moved out of state/area|1|||
126206603|NCT01238861|454043662|FG003|Overall Study|Subject moved out of state/area|1|||
126206604|NCT01238861|454043663|FG004|Overall Study|Subject moved out of state/area|0|||
126206605|NCT01238861|454043664|FG005|Overall Study|Subject moved out of state/area|0|||
126206606|NCT01238861|454043659|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
126206607|NCT01238861|454043660|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
126206608|NCT01238861|454043661|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
126206609|NCT01238861|454043662|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
126206610|NCT01238861|454043663|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
126206611|NCT01238861|454043664|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
126206612|NCT01238861|454043659|FG000|Overall Study|Personal problems|0|||
126206613|NCT01238861|454043660|FG001|Overall Study|Personal problems|0|||
126206614|NCT01238861|454043661|FG002|Overall Study|Personal problems|0|||
126206615|NCT01238861|454043662|FG003|Overall Study|Personal problems|1|||
126206616|NCT01238861|454043663|FG004|Overall Study|Personal problems|0|||
126206617|NCT01238861|454043664|FG005|Overall Study|Personal problems|0|||
126206618|NCT01238861|454043659|FG000|Overall Study|Unable to continue visits|0|||
126206619|NCT01238861|454043660|FG001|Overall Study|Unable to continue visits|0|||
126206620|NCT01238861|454043661|FG002|Overall Study|Unable to continue visits|0|||
126206621|NCT01238861|454043662|FG003|Overall Study|Unable to continue visits|1|||
126206622|NCT01238861|454043663|FG004|Overall Study|Unable to continue visits|0|||
126206623|NCT01238861|454043664|FG005|Overall Study|Unable to continue visits|1|||
126206624|NCT01238861|454043659|FG000|Overall Study|Serious adverse event|0|||
126206625|NCT01238861|454043660|FG001|Overall Study|Serious adverse event|0|||
126206626|NCT01238861|454043661|FG002|Overall Study|Serious adverse event|0|||
126206627|NCT01238861|454043662|FG003|Overall Study|Serious adverse event|0|||
126206628|NCT01238861|454043663|FG004|Overall Study|Serious adverse event|0|||
126206629|NCT01238861|454043664|FG005|Overall Study|Serious adverse event|1|||
126206630|NCT01238861|454043659|FG000|Overall Study|Lack of compliance|0|||
126206631|NCT01238861|454043660|FG001|Overall Study|Lack of compliance|0|||
126206632|NCT01238861|454043661|FG002|Overall Study|Lack of compliance|0|||
126206633|NCT01238861|454043662|FG003|Overall Study|Lack of compliance|0|||
126206634|NCT01238861|454043663|FG004|Overall Study|Lack of compliance|0|||
126206635|NCT01238861|454043664|FG005|Overall Study|Lack of compliance|1|||
126206636|NCT01238861|454043659|FG000|Overall Study|Adverse Event|0|||
126206637|NCT01238861|454043660|FG001|Overall Study|Adverse Event|1|||
126206638|NCT01238861|454043661|FG002|Overall Study|Adverse Event|0|||
126206639|NCT01238861|454043662|FG003|Overall Study|Adverse Event|0|||
126206640|NCT01238861|454043663|FG004|Overall Study|Adverse Event|0|||
126206641|NCT01238861|454043664|FG005|Overall Study|Adverse Event|0|||
126206642|NCT01238861|454043659|FG000|Overall Study|Withdrawal by Subject|6|||
126206643|NCT01238861|454043660|FG001|Overall Study|Withdrawal by Subject|5|||
126206644|NCT01238861|454043661|FG002|Overall Study|Withdrawal by Subject|4|||
126206645|NCT01238861|454043662|FG003|Overall Study|Withdrawal by Subject|8|||
126206646|NCT01238861|454043663|FG004|Overall Study|Withdrawal by Subject|10|||
126206647|NCT01238861|454043664|FG005|Overall Study|Withdrawal by Subject|9|||
126206648|NCT01269346|454043665|FG000|Treatment Phase|Disease progression|3|||
126206649|NCT01269346|454043665|FG000|Treatment Phase|Adverse Event|3|||
126206650|NCT01269346|454043665|FG000|Treatment Phase|Withdrawal by Subject|1|||
126206651|NCT01269346|454043665|FG000|Treatment Phase|Other|2|||
126206652|NCT01269346|454043665|FG000|Extension Phase|Adverse Event|6|||
126206653|NCT01269346|454043665|FG000|Extension Phase|Withdrawal by Subject|4|||
126206654|NCT01269346|454043665|FG000|Extension Phase|Disease progression|22|||
126206655|NCT01269346|454043665|FG000|Extension Phase|Physician decision or participant choice|9|||
126206656|NCT01269346|454043665|FG000|Extension Phase|Clinical progression|1|||
126206657|NCT01269346|454043665|FG000|Extension Phase|Started a prohibited con med|1|||
126206658|NCT01855607|454043666|FG000|Overall Study|Withdrawal by Subject|1|||
126206659|NCT01855607|454043666|FG000|Overall Study|Study was terminated|11|||
126206660|NCT04001790|454043671|FG000|Overall Study|Withdrawal by Subject|1|||
126206661|NCT04001790|454043672|FG001|Overall Study|Withdrawal by Subject|2|||
126206662|NCT04963231|454043677|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
126206663|NCT04963231|454043678|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
126206664|NCT04963231|454043679|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
126206665|NCT04963231|454043677|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
126206666|NCT04963231|454043678|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
126206667|NCT04963231|454043679|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
126206668|NCT04963231|454043677|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
126206669|NCT04963231|454043678|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
126206670|NCT04963231|454043679|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
126206671|NCT04963231|454043677|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
126206672|NCT04963231|454043678|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
126206673|NCT04963231|454043679|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
126206674|NCT04963231|454043677|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
126206675|NCT04963231|454043678|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
126206676|NCT04963231|454043679|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
126206677|NCT04963231|454043677|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
126206678|NCT04963231|454043678|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
126206679|NCT04963231|454043679|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
126206680|NCT04963231|454043677|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
126206681|NCT04963231|454043678|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
126206682|NCT04963231|454043679|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
126206683|NCT04576702|454043680|FG000|Overall Study|Death|1|||
126206684|NCT04576702|454043681|FG001|Overall Study|Death|0|||
126206685|NCT04576702|454043682|FG002|Overall Study|Death|0|||
126206686|NCT04576702|454043683|FG003|Overall Study|Death|0|||
126206687|NCT04576702|454043680|FG000|Overall Study|Withdrawal by Subject|0|||
126206688|NCT04576702|454043681|FG001|Overall Study|Withdrawal by Subject|2|||
126206689|NCT04576702|454043682|FG002|Overall Study|Withdrawal by Subject|1|||
126206690|NCT04576702|454043683|FG003|Overall Study|Withdrawal by Subject|0|||
126206691|NCT04576702|454043680|FG000|Overall Study|Lost to Follow-up|3|||
126206692|NCT04576702|454043681|FG001|Overall Study|Lost to Follow-up|3|||
126206693|NCT04576702|454043682|FG002|Overall Study|Lost to Follow-up|3|||
126206694|NCT04576702|454043683|FG003|Overall Study|Lost to Follow-up|4|||
126206695|NCT01319422|454043686|FG000|Overall Study|Withdrawal by Subject|1|||
126206696|NCT01319422|454043687|FG001|Overall Study|Withdrawal by Subject|0|||
126206697|NCT06104423|454043688|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
126206698|NCT06104423|454043689|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
126206699|NCT06104423|454043690|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
126206700|NCT06104423|454043688|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
126206701|NCT06104423|454043689|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
126206702|NCT06104423|454043690|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
126206703|NCT03417245|454043691|FG000|Overall Study|Adverse Event|1|||
126206704|NCT03417245|454043692|FG001|Overall Study|Adverse Event|0|||
126206705|NCT03417245|454043691|FG000|Overall Study|Protocol Violation|1|||
126206706|NCT03417245|454043692|FG001|Overall Study|Protocol Violation|0|||
126206707|NCT03417245|454043691|FG000|Overall Study|Withdrawal by Subject|1|||
126206708|NCT03417245|454043692|FG001|Overall Study|Withdrawal by Subject|1|||
126206709|NCT02708524|454043700|FG000|Overall Study|Adverse Event|0|||
126206710|NCT02708524|454043701|FG001|Overall Study|Adverse Event|1|||
126206711|NCT02708524|454043702|FG002|Overall Study|Adverse Event|0|||
126206712|NCT02708524|454043703|FG003|Overall Study|Adverse Event|0|||
126206713|NCT02708524|454043700|FG000|Overall Study|Lens Discomfort|1|||
126206714|NCT02708524|454043701|FG001|Overall Study|Lens Discomfort|0|||
126206715|NCT02708524|454043702|FG002|Overall Study|Lens Discomfort|1|||
126206716|NCT02708524|454043703|FG003|Overall Study|Lens Discomfort|0|||
126206717|NCT02708524|454043700|FG000|Overall Study|Lost to Follow-up|1|||
126206718|NCT02708524|454043701|FG001|Overall Study|Lost to Follow-up|1|||
126206719|NCT02708524|454043702|FG002|Overall Study|Lost to Follow-up|1|||
126206720|NCT02708524|454043703|FG003|Overall Study|Lost to Follow-up|0|||
126206721|NCT02708524|454043700|FG000|Overall Study|Protocol Violation|0|||
126206722|NCT02708524|454043701|FG001|Overall Study|Protocol Violation|1|||
126206723|NCT02708524|454043702|FG002|Overall Study|Protocol Violation|0|||
126206724|NCT02708524|454043703|FG003|Overall Study|Protocol Violation|0|||
126206725|NCT02708524|454043700|FG000|Overall Study|Withdrawal by Subject|1|||
126206726|NCT02708524|454043701|FG001|Overall Study|Withdrawal by Subject|1|||
126206727|NCT02708524|454043702|FG002|Overall Study|Withdrawal by Subject|0|||
126206728|NCT02708524|454043703|FG003|Overall Study|Withdrawal by Subject|0|||
126206729|NCT02708524|454043700|FG000|Overall Study|Dispensed incorrect study lens|0|||
126206730|NCT02708524|454043701|FG001|Overall Study|Dispensed incorrect study lens|1|||
126206731|NCT02708524|454043702|FG002|Overall Study|Dispensed incorrect study lens|1|||
126206732|NCT02708524|454043703|FG003|Overall Study|Dispensed incorrect study lens|0|||
126206733|NCT02708524|454043700|FG000|Overall Study|Did not wear lens at final visit|0|||
126206734|NCT02708524|454043701|FG001|Overall Study|Did not wear lens at final visit|1|||
126206735|NCT02708524|454043702|FG002|Overall Study|Did not wear lens at final visit|0|||
126206736|NCT02708524|454043703|FG003|Overall Study|Did not wear lens at final visit|0|||
126206737|NCT02708524|454043700|FG000|Overall Study|Subject lost study lens|1|||
126206738|NCT02708524|454043701|FG001|Overall Study|Subject lost study lens|0|||
126206739|NCT02708524|454043702|FG002|Overall Study|Subject lost study lens|0|||
126206740|NCT02708524|454043703|FG003|Overall Study|Subject lost study lens|0|||
126206741|NCT00229931|454043704|FG000|Overall Study|Death|1|||
126206742|NCT00229931|454043705|FG001|Overall Study|Death|0|||
126206743|NCT00229931|454043704|FG000|Overall Study|Lost to Follow-up|3|||
126206744|NCT00229931|454043705|FG001|Overall Study|Lost to Follow-up|2|||
126206745|NCT00465101|454043706|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
126206746|NCT00465101|454043706|FG000|Overall Study|Change in health precluded follow up|4|||
126206747|NCT00465101|454043706|FG000|Overall Study|Did not meet study criteria|4|||
126206748|NCT00465101|454043706|FG000|Overall Study|Lost to Follow-up|5|||
126206749|NCT00465101|454043706|FG000|Overall Study|Other|6|||
126206750|NCT00465101|454043706|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
126206751|NCT00465101|454043706|FG000|Overall Study|Patient postponed procedure|1|||
126206752|NCT00465101|454043706|FG000|Overall Study|Site closed due to IRB expiration|1|||
126206753|NCT00465101|454043706|FG000|Overall Study|Unable to obtain IRB approval|1|||
126206754|NCT00465101|454043706|FG000|Overall Study|Death|3|||
126206755|NCT00465101|454043706|FG000|Overall Study|Withdrawal by Subject|25|||
126206756|NCT00465101|454043706|FG000|Overall Study|Physician Decision|1|||
126206757|NCT00465101|454043706|FG000|Overall Study|Withdrew consent prior to procedure|3|||
126206758|NCT00361504|454043707|FG000|Overall Study|Withdrawal by Subject|94|||
126206759|NCT00361504|454043708|FG001|Overall Study|Withdrawal by Subject|31|||
126206760|NCT00361504|454043707|FG000|Overall Study|Lost to Follow-up|40|||
126206761|NCT00361504|454043708|FG001|Overall Study|Lost to Follow-up|7|||
126206762|NCT00361504|454043707|FG000|Overall Study|Adverse Event|203|||
126206763|NCT00361504|454043708|FG001|Overall Study|Adverse Event|82|||
126206764|NCT00361504|454043707|FG000|Overall Study|Lack of Efficacy|72|||
126206765|NCT00361504|454043708|FG001|Overall Study|Lack of Efficacy|7|||
126206766|NCT00361504|454043707|FG000|Overall Study|Resolution of Pain|2|||
126313965|NCT00197002|454440757|FG000|Overall Study|Withdrawal by Subject|9|||
126206767|NCT00361504|454043708|FG001|Overall Study|Resolution of Pain|0|||
126206768|NCT00361504|454043707|FG000|Overall Study|Study medication non compliant|42|||
126206769|NCT00361504|454043708|FG001|Overall Study|Study medication non compliant|15|||
126206770|NCT00361504|454043707|FG000|Overall Study|All other|28|||
126206771|NCT00361504|454043708|FG001|Overall Study|All other|3|||
126206772|NCT00450814|454043709|FG000|Overall Study|Failed to complete the initial therapy|0|||
126206773|NCT00450814|454043710|FG001|Overall Study|Failed to complete the initial therapy|0|||
126206774|NCT00450814|454043711|FG002|Overall Study|Failed to complete the initial therapy|0|||
126206775|NCT00450814|454043712|FG003|Overall Study|Failed to complete the initial therapy|1|||
126206776|NCT00450814|454043713|FG004|Overall Study|Failed to complete the initial therapy|1|||
126206777|NCT00450814|454043714|FG005|Overall Study|Failed to complete the initial therapy|1|||
126206778|NCT00450814|454043715|FG006|Overall Study|Failed to complete the initial therapy|0|||
126206779|NCT00450814|454043716|FG007|Overall Study|Failed to complete the initial therapy|0|||
126206780|NCT00450814|454043717|FG008|Overall Study|Failed to complete the initial therapy|0|||
126206781|NCT00450814|454043718|FG009|Overall Study|Failed to complete the initial therapy|0|||
126206782|NCT00450814|454043719|FG010|Overall Study|Failed to complete the initial therapy|0|||
126206783|NCT00450814|454043709|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
126206784|NCT00450814|454043710|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
126206785|NCT00450814|454043711|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
126206786|NCT00450814|454043712|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
126206787|NCT00450814|454043713|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
126206788|NCT00450814|454043714|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
126206789|NCT00450814|454043715|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
126206790|NCT00450814|454043716|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
126206791|NCT00450814|454043717|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
126206792|NCT00450814|454043718|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
126206793|NCT00450814|454043719|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
126206794|NCT02067728|454043720|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
126206795|NCT02067728|454043721|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
126206796|NCT02067728|454043720|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
126206797|NCT02067728|454043721|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
126206798|NCT02067728|454043720|FG000|6 Month Measurements|Unable to attend|114|||
126206799|NCT02067728|454043721|FG001|6 Month Measurements|Unable to attend|97|||
126206800|NCT03732534|454043725|FG000|Overall Study|Study terminated by Sponsor|6|||
126206801|NCT00814502|454043726|FG000|Overall Study|Adverse Event|1|||
126206802|NCT00814502|454043727|FG001|Overall Study|Adverse Event|0|||
126206803|NCT00814502|454043726|FG000|Overall Study|Withdrawal by Subject|0|||
126206804|NCT00814502|454043727|FG001|Overall Study|Withdrawal by Subject|2|||
126206805|NCT02369874|454043732|FG000|Overall Study|Lost to Follow-up|2|||
126206806|NCT02369874|454043733|FG001|Overall Study|Lost to Follow-up|2|||
126206807|NCT02369874|454043734|FG002|Overall Study|Lost to Follow-up|2|||
126206808|NCT02369874|454043732|FG000|Overall Study|Withdrawal by Subject|7|||
126206809|NCT02369874|454043733|FG001|Overall Study|Withdrawal by Subject|9|||
126206810|NCT02369874|454043734|FG002|Overall Study|Withdrawal by Subject|27|||
126206811|NCT02369874|454043732|FG000|Overall Study|Miscellaneous|1|||
126206812|NCT02369874|454043733|FG001|Overall Study|Miscellaneous|1|||
126206813|NCT02369874|454043734|FG002|Overall Study|Miscellaneous|0|||
126206814|NCT02369874|454043732|FG000|Overall Study|On Treatment/Off Study|34|||
126206815|NCT02369874|454043733|FG001|Overall Study|On Treatment/Off Study|45|||
126206816|NCT02369874|454043734|FG002|Overall Study|On Treatment/Off Study|32|||
126206817|NCT01012765|454043735|FG000|Treatment Period 1|Adverse Event|1|||
126206818|NCT01012765|454043736|FG001|Treatment Period 1|Adverse Event|0|||
126206819|NCT01012765|454043737|FG002|Treatment Period 1|Adverse Event|1|||
126206820|NCT01012765|454043738|FG003|Treatment Period 1|Adverse Event|0|||
126206821|NCT01012765|454043739|FG004|Treatment Period 1|Adverse Event|0|||
126206822|NCT01012765|454043740|FG005|Treatment Period 1|Adverse Event|0|||
126206823|NCT01012765|454043735|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126206824|NCT01012765|454043736|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126206825|NCT01012765|454043737|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126206826|NCT01012765|454043738|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126206827|NCT01012765|454043739|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126206828|NCT01012765|454043740|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126206829|NCT01012765|454043735|FG000|Treatment Period 1|Administrative problems|0|||
126206830|NCT01012765|454043736|FG001|Treatment Period 1|Administrative problems|0|||
126206831|NCT01012765|454043737|FG002|Treatment Period 1|Administrative problems|1|||
126206832|NCT01012765|454043738|FG003|Treatment Period 1|Administrative problems|1|||
126206833|NCT01012765|454043739|FG004|Treatment Period 1|Administrative problems|1|||
126206834|NCT01012765|454043740|FG005|Treatment Period 1|Administrative problems|0|||
126206835|NCT01012765|454043735|FG000|Treatment Period 1|Protocol Violation|0|||
126206836|NCT01012765|454043736|FG001|Treatment Period 1|Protocol Violation|0|||
126206837|NCT01012765|454043737|FG002|Treatment Period 1|Protocol Violation|0|||
126206838|NCT01012765|454043738|FG003|Treatment Period 1|Protocol Violation|2|||
126206839|NCT01012765|454043739|FG004|Treatment Period 1|Protocol Violation|1|||
126206840|NCT01012765|454043740|FG005|Treatment Period 1|Protocol Violation|0|||
126206841|NCT01012765|454043735|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126206842|NCT01012765|454043736|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126206843|NCT01012765|454043737|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126206844|NCT01012765|454043738|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126206845|NCT01012765|454043739|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
126206846|NCT01012765|454043740|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126206847|NCT01012765|454043735|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126206848|NCT01012765|454043736|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126206849|NCT01012765|454043737|FG002|Treatment Period 2|Withdrawal by Subject|1|||
126206850|NCT01012765|454043738|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126206851|NCT01012765|454043739|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126206852|NCT01012765|454043740|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126206853|NCT01012765|454043735|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
126206854|NCT01012765|454043736|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
126206855|NCT01012765|454043737|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
126206856|NCT01012765|454043738|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
126206857|NCT01012765|454043739|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
126206858|NCT01012765|454043740|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
126206859|NCT01012765|454043735|FG000|Treatment Period 2|Adverse Event|0|||
126206860|NCT01012765|454043736|FG001|Treatment Period 2|Adverse Event|1|||
126206861|NCT01012765|454043737|FG002|Treatment Period 2|Adverse Event|1|||
126206862|NCT01012765|454043738|FG003|Treatment Period 2|Adverse Event|0|||
126206863|NCT01012765|454043739|FG004|Treatment Period 2|Adverse Event|0|||
126206864|NCT01012765|454043740|FG005|Treatment Period 2|Adverse Event|0|||
126206865|NCT01012765|454043735|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
126206866|NCT01012765|454043736|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
126206867|NCT01012765|454043737|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
126206868|NCT01012765|454043738|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
126206869|NCT01012765|454043739|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
126206870|NCT01012765|454043740|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
126206871|NCT01326312|454043741|FG000|Overall Study|Adverse Event|11|||
126206872|NCT01326312|454043742|FG001|Overall Study|Adverse Event|11|||
126206873|NCT01326312|454043743|FG002|Overall Study|Adverse Event|1|||
126206874|NCT01326312|454043741|FG000|Overall Study|Withdrawal by Subject|1|||
126206875|NCT01326312|454043742|FG001|Overall Study|Withdrawal by Subject|2|||
126206876|NCT01326312|454043743|FG002|Overall Study|Withdrawal by Subject|1|||
126206877|NCT01326312|454043741|FG000|Overall Study|Protocol Violation|0|||
126206878|NCT01326312|454043742|FG001|Overall Study|Protocol Violation|1|||
126206879|NCT01326312|454043743|FG002|Overall Study|Protocol Violation|0|||
126206880|NCT01326312|454043741|FG000|Overall Study|Lack of Efficacy|13|||
126206881|NCT01326312|454043742|FG001|Overall Study|Lack of Efficacy|7|||
126206882|NCT01326312|454043743|FG002|Overall Study|Lack of Efficacy|1|||
126206883|NCT01326312|454043741|FG000|Overall Study|Death|1|||
126206884|NCT01326312|454043742|FG001|Overall Study|Death|0|||
126206885|NCT01326312|454043743|FG002|Overall Study|Death|1|||
126206886|NCT01326312|454043741|FG000|Overall Study|progressive disease|0|||
126206887|NCT01326312|454043742|FG001|Overall Study|progressive disease|1|||
126206888|NCT01326312|454043743|FG002|Overall Study|progressive disease|1|||
126206889|NCT01326312|454043741|FG000|Overall Study|Study terminated by Sponsor|8|||
126206890|NCT01326312|454043742|FG001|Overall Study|Study terminated by Sponsor|32|||
126206891|NCT01326312|454043743|FG002|Overall Study|Study terminated by Sponsor|46|||
126206892|NCT01326312|454043741|FG000|Overall Study|Treatment arm terminated|19|||
126206893|NCT01326312|454043742|FG001|Overall Study|Treatment arm terminated|0|||
126206894|NCT01326312|454043743|FG002|Overall Study|Treatment arm terminated|0|||
126206895|NCT01326312|454043741|FG000|Overall Study|QTc > 500|0|||
126206896|NCT01326312|454043742|FG001|Overall Study|QTc > 500|1|||
126206897|NCT01326312|454043743|FG002|Overall Study|QTc > 500|0|||
126206898|NCT02219477|454043744|FG000|Overall Study|Adverse Event|0|||
126206899|NCT02219477|454043745|FG001|Overall Study|Adverse Event|1|||
126206900|NCT02219477|454043746|FG002|Overall Study|Adverse Event|1|||
126206901|NCT02219477|454043744|FG000|Overall Study|Withdrawal by Subject|0|||
126206902|NCT02219477|454043745|FG001|Overall Study|Withdrawal by Subject|1|||
126206903|NCT02219477|454043746|FG002|Overall Study|Withdrawal by Subject|0|||
126206904|NCT00499694|454043751|FG000|Overall Study|Patient never received treatment.|1|||
126206905|NCT04338685|454043752|FG000|Overall Study|Death|3|||
126206906|NCT04338685|454043753|FG001|Overall Study|Death|4|||
126206907|NCT04338685|454043754|FG002|Overall Study|Death|2|||
126206908|NCT04338685|454043755|FG003|Overall Study|Death|4|||
126206909|NCT04338685|454043756|FG004|Overall Study|Death|4|||
126206910|NCT04338685|454043757|FG005|Overall Study|Death|8|||
126206911|NCT04338685|454043758|FG006|Overall Study|Death|1|||
126206912|NCT04338685|454043759|FG007|Overall Study|Death|0|||
126206913|NCT04338685|454043760|FG008|Overall Study|Death|0|||
126206914|NCT04338685|454043752|FG000|Overall Study|Study terminated by Sponsor|0|||
126206915|NCT04338685|454043753|FG001|Overall Study|Study terminated by Sponsor|0|||
126046443|NCT00113360|453468223|FG000|Overall Study|Adverse Event|3|||
126206916|NCT04338685|454043754|FG002|Overall Study|Study terminated by Sponsor|1|||
126206917|NCT04338685|454043755|FG003|Overall Study|Study terminated by Sponsor|4|||
126206918|NCT04338685|454043756|FG004|Overall Study|Study terminated by Sponsor|0|||
126206919|NCT04338685|454043757|FG005|Overall Study|Study terminated by Sponsor|5|||
126206920|NCT04338685|454043758|FG006|Overall Study|Study terminated by Sponsor|2|||
126206921|NCT04338685|454043759|FG007|Overall Study|Study terminated by Sponsor|4|||
126206922|NCT04338685|454043760|FG008|Overall Study|Study terminated by Sponsor|1|||
126206923|NCT04338685|454043752|FG000|Overall Study|Withdrawal by Subject|1|||
126206924|NCT04338685|454043753|FG001|Overall Study|Withdrawal by Subject|2|||
126206925|NCT04338685|454043754|FG002|Overall Study|Withdrawal by Subject|0|||
126206926|NCT04338685|454043755|FG003|Overall Study|Withdrawal by Subject|2|||
126206927|NCT04338685|454043756|FG004|Overall Study|Withdrawal by Subject|0|||
126206928|NCT04338685|454043757|FG005|Overall Study|Withdrawal by Subject|5|||
126206929|NCT04338685|454043758|FG006|Overall Study|Withdrawal by Subject|1|||
126206930|NCT04338685|454043759|FG007|Overall Study|Withdrawal by Subject|1|||
126206931|NCT04338685|454043760|FG008|Overall Study|Withdrawal by Subject|0|||
126206932|NCT00234533|454043761|FG000|Overall Study|Withdrawal by Subject|6|||
126206933|NCT00234533|454043761|FG000|Overall Study|Adverse Event|2|||
126206934|NCT00234533|454043761|FG000|Overall Study|Enrolled but not treated|3|||
126206935|NCT01484691|454043763|FG000|Overall Study|Withdrawal by Subject|1|||
126206936|NCT01484691|454043764|FG001|Overall Study|Withdrawal by Subject|1|||
126206937|NCT01484691|454043765|FG002|Overall Study|Withdrawal by Subject|1|||
126206938|NCT01484691|454043763|FG000|Overall Study|Physician Decision|0|||
126206939|NCT01484691|454043764|FG001|Overall Study|Physician Decision|2|||
126206940|NCT01484691|454043765|FG002|Overall Study|Physician Decision|1|||
126206941|NCT02500732|454043770|FG000|Overall Study|Physician Decision|0|||
126206942|NCT02500732|454043771|FG001|Overall Study|Physician Decision|1|||
126206943|NCT03328325|454043772|FG000|Overall Study|Lost to Follow-up|4|||
126206944|NCT03328325|454043772|FG000|Overall Study|Physician Decision|1|||
126206945|NCT03328325|454043772|FG000|Overall Study|Withdrawal by Subject|3|||
126206946|NCT03328325|454043772|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
126206947|NCT00736840|454043773|FG000|Overall Study|Lost to Follow-up|13|||
126206948|NCT01314261|454043776|FG000|Overall Study|Adverse Event|1|||
126206949|NCT01314261|454043777|FG001|Overall Study|Adverse Event|0|||
126206950|NCT01314261|454043778|FG002|Overall Study|Adverse Event|0|||
126206951|NCT01314261|454043779|FG003|Overall Study|Adverse Event|0|||
126206952|NCT01314261|454043776|FG000|Overall Study|Withdrawal by Subject|0|||
126206953|NCT01314261|454043777|FG001|Overall Study|Withdrawal by Subject|3|||
126206954|NCT01314261|454043778|FG002|Overall Study|Withdrawal by Subject|1|||
126206955|NCT01314261|454043779|FG003|Overall Study|Withdrawal by Subject|0|||
126206956|NCT01314261|454043776|FG000|Overall Study|Lost to Follow-up|1|||
126206957|NCT01314261|454043777|FG001|Overall Study|Lost to Follow-up|0|||
126206958|NCT01314261|454043778|FG002|Overall Study|Lost to Follow-up|2|||
126206959|NCT01314261|454043779|FG003|Overall Study|Lost to Follow-up|2|||
126206960|NCT01314261|454043776|FG000|Overall Study|Virologic Failure|0|||
126206961|NCT01314261|454043777|FG001|Overall Study|Virologic Failure|1|||
126206962|NCT01314261|454043778|FG002|Overall Study|Virologic Failure|0|||
126206963|NCT01314261|454043779|FG003|Overall Study|Virologic Failure|1|||
126206964|NCT04524507|454043780|FG000|Overall Study|Lost to Follow-up|2|||
126206965|NCT04524507|454043781|FG001|Overall Study|Lost to Follow-up|4|||
126206966|NCT04524507|454043780|FG000|Overall Study|Withdrawal by Subject|2|||
126206967|NCT04524507|454043781|FG001|Overall Study|Withdrawal by Subject|9|||
126206968|NCT04524507|454043780|FG000|Overall Study|Death|2|||
126206969|NCT04524507|454043781|FG001|Overall Study|Death|10|||
126206970|NCT02711306|454043782|FG000|Overall Study|Withdrawal by Subject|2|||
126206971|NCT02711306|454043783|FG001|Overall Study|Withdrawal by Subject|2|||
126206972|NCT00422227|454043784|FG000|Overall Study|Adverse Event|3|||
126206973|NCT00422227|454043785|FG001|Overall Study|Adverse Event|8|||
126206974|NCT00422227|454043784|FG000|Overall Study|Lost to Follow-up|1|||
126206975|NCT00422227|454043785|FG001|Overall Study|Lost to Follow-up|3|||
126206976|NCT00422227|454043784|FG000|Overall Study|Withdrawal by Subject|0|||
126206977|NCT00422227|454043785|FG001|Overall Study|Withdrawal by Subject|4|||
126206978|NCT01396434|454043786|FG000|Overall Study|Lost to Follow-up|1|||
126206979|NCT01396434|454043787|FG001|Overall Study|Lost to Follow-up|0|||
126206980|NCT01396434|454043788|FG002|Overall Study|Lost to Follow-up|0|||
126206981|NCT01396434|454043786|FG000|Overall Study|Other|10|||
126206982|NCT01396434|454043787|FG001|Overall Study|Other|0|||
126206983|NCT01396434|454043788|FG002|Overall Study|Other|0|||
126206984|NCT00157157|454043789|FG000|Overall Study|Withdrawal by Subject|6|||
126206985|NCT00157157|454043789|FG000|Overall Study|Physician Decision|1|||
126206986|NCT00157157|454043789|FG000|Overall Study|Lost to Follow-up|1|||
126090437|NCT03635099|453623560|FG002|Period 2|Withdrawal by Subject|7|||
126206987|NCT00157157|454043789|FG000|Overall Study|Enrolled in another study|1|||
126206988|NCT00157157|454043789|FG000|Overall Study|Met exclusion criteria|1|||
126206989|NCT00157157|454043789|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
126206990|NCT01018680|454045676|FG000|Overall Study|Adverse Event|23|||
126206991|NCT01018680|454045677|FG001|Overall Study|Adverse Event|40|||
126206992|NCT01018680|454045676|FG000|Overall Study|Withdrawal by Subject|10|||
126206993|NCT01018680|454045677|FG001|Overall Study|Withdrawal by Subject|10|||
126206994|NCT01018680|454045676|FG000|Overall Study|Protocol Violation|5|||
126206995|NCT01018680|454045677|FG001|Overall Study|Protocol Violation|8|||
126206996|NCT01018680|454045676|FG000|Overall Study|Sponsor Decision|6|||
126206997|NCT01018680|454045677|FG001|Overall Study|Sponsor Decision|7|||
126206998|NCT01018680|454045676|FG000|Overall Study|Lack of Efficacy|8|||
126206999|NCT01018680|454045677|FG001|Overall Study|Lack of Efficacy|2|||
126207000|NCT01018680|454045676|FG000|Overall Study|Lost to Follow-up|5|||
126207001|NCT01018680|454045677|FG001|Overall Study|Lost to Follow-up|3|||
126207002|NCT01018680|454045676|FG000|Overall Study|Entry Criteria Not Met|1|||
126207003|NCT01018680|454045677|FG001|Overall Study|Entry Criteria Not Met|4|||
126207004|NCT01018680|454045676|FG000|Overall Study|Physician Decision|3|||
126207005|NCT01018680|454045677|FG001|Overall Study|Physician Decision|1|||
126207006|NCT02383966|454045681|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
126207007|NCT02383966|454045682|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
126207008|NCT02383966|454045681|FG000|Overall Study|Randomized, but not treated|1|||
126207009|NCT02383966|454045682|FG001|Overall Study|Randomized, but not treated|3|||
126207010|NCT02163759|454045683|FG000|Overall Study|Withdrawal by Subject|1|||
126207011|NCT02163759|454045684|FG001|Overall Study|Withdrawal by Subject|5|||
126207012|NCT02163759|454045685|FG002|Overall Study|Withdrawal by Subject|1|||
126207013|NCT02163759|454045683|FG000|Overall Study|Adverse Event|0|||
126207014|NCT02163759|454045684|FG001|Overall Study|Adverse Event|0|||
126207015|NCT02163759|454045685|FG002|Overall Study|Adverse Event|1|||
126207016|NCT02163759|454045683|FG000|Overall Study|Death|0|||
126207017|NCT02163759|454045684|FG001|Overall Study|Death|0|||
126207018|NCT02163759|454045685|FG002|Overall Study|Death|1|||
126207019|NCT00219349|454045697|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
126207020|NCT00219349|454045697|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
126207021|NCT00219349|454045697|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
126207022|NCT00219349|454045697|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
126207023|NCT03471507|454045699|FG000|Overall Study|Lost to Follow-up|1|||
126207024|NCT03471507|454045700|FG001|Overall Study|Lost to Follow-up|3|||
126207025|NCT03471507|454045699|FG000|Overall Study|Physician Decision|0|||
126207026|NCT03471507|454045700|FG001|Overall Study|Physician Decision|1|||
126207027|NCT03471507|454045699|FG000|Overall Study|Withdrawal by Subject|2|||
126207028|NCT03471507|454045700|FG001|Overall Study|Withdrawal by Subject|1|||
126207029|NCT01151085|454045701|FG000|Overall Study|Lost to Follow-up|31|||
126207030|NCT01151085|454045701|FG000|Overall Study|Protocol Violation|25|||
126207031|NCT01308476|454045703|FG000|Overall Study|Lost to Follow-up|2|||
126207032|NCT01308476|454045704|FG001|Overall Study|Lost to Follow-up|2|||
126207033|NCT01308476|454045703|FG000|Overall Study|Other|1|||
126207034|NCT01308476|454045704|FG001|Overall Study|Other|0|||
126207035|NCT00750061|454045707|FG000|Overall Study|Adverse Event|2|||
126207036|NCT00750061|454045708|FG001|Overall Study|Adverse Event|0|||
126207037|NCT00750061|454045707|FG000|Overall Study|Withdrawal by Subject|0|||
126207038|NCT00750061|454045708|FG001|Overall Study|Withdrawal by Subject|1|||
126207039|NCT00750061|454045707|FG000|Overall Study|Physician Decision|0|||
126207040|NCT00750061|454045708|FG001|Overall Study|Physician Decision|1|||
126207041|NCT00812968|454045709|FG000|Overall Study|Relapse after erythroid response|6|||
126207042|NCT00812968|454045709|FG000|Overall Study|Disease progression|1|||
126207043|NCT00812968|454045709|FG000|Overall Study|No further treatment required|1|||
126207044|NCT00812968|454045709|FG000|Overall Study|Study closed due to marketing approval|3|||
126207045|NCT03246152|454045713|FG000|Overall Study|Lost to Follow-up|2|||
126207046|NCT03246152|454045713|FG000|Overall Study|Protocol Violation|1|||
126207047|NCT01243762|454045718|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
126207048|NCT01243762|454045719|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
126207049|NCT01243762|454045720|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
126207050|NCT01243762|454045721|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
126207051|NCT01243762|454045722|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
126207052|NCT01243762|454045723|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
126207053|NCT01243762|454045724|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
126207054|NCT01243762|454045718|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126090438|NCT03635099|453623561|FG003|Period 2|Withdrawal by Subject|4|||
126207055|NCT01243762|454045719|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
126207056|NCT01243762|454045720|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126207057|NCT01243762|454045721|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
126207058|NCT01243762|454045722|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126207059|NCT01243762|454045723|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126207060|NCT01243762|454045724|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126207061|NCT01243762|454045718|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
126207062|NCT01243762|454045719|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
126207063|NCT01243762|454045720|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
126207064|NCT01243762|454045721|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
126207065|NCT01243762|454045722|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
126207066|NCT01243762|454045723|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
126207067|NCT01243762|454045724|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
126207068|NCT01243762|454045718|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126207069|NCT01243762|454045719|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
126207070|NCT01243762|454045720|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126207071|NCT01243762|454045721|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126207072|NCT01243762|454045722|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126207073|NCT01243762|454045723|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126207074|NCT01243762|454045724|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126207075|NCT01243762|454045718|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126207076|NCT01243762|454045719|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
126207077|NCT01243762|454045720|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126207078|NCT01243762|454045721|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126207079|NCT01243762|454045722|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126207080|NCT01243762|454045723|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126207081|NCT01243762|454045724|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
126207082|NCT01243762|454045718|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
126207083|NCT01243762|454045719|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
126207084|NCT01243762|454045720|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
126207085|NCT01243762|454045721|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
126207086|NCT01243762|454045722|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
126207087|NCT01243762|454045723|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
126207088|NCT01243762|454045724|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
126207089|NCT01243762|454045718|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126207090|NCT01243762|454045719|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
126207091|NCT01243762|454045720|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126207092|NCT01243762|454045721|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126207093|NCT01243762|454045722|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
126207094|NCT01243762|454045723|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126207095|NCT01243762|454045724|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126207096|NCT01243762|454045718|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126207097|NCT01243762|454045719|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126207098|NCT01243762|454045720|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126207099|NCT01243762|454045721|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
126207100|NCT01243762|454045722|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
126207101|NCT01243762|454045723|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126207102|NCT01243762|454045724|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126207103|NCT02059265|454045725|FG000|Overall Study|Ineligible|4|||
126207104|NCT04753606|454045730|FG000|Overall Study|Adverse Event|1|||
126207105|NCT04753606|454045731|FG001|Overall Study|Adverse Event|0|||
126207106|NCT04753606|454045732|FG002|Overall Study|Adverse Event|0|||
126207107|NCT01374516|454045735|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
126207108|NCT01374516|454045736|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
126207109|NCT01374516|454045735|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
126207110|NCT01374516|454045736|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
126207111|NCT01374516|454045735|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
126207112|NCT01374516|454045736|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
126207113|NCT01374516|454045735|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
126207114|NCT01374516|454045736|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
126207115|NCT01374516|454045735|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
126207116|NCT01374516|454045736|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
126207117|NCT01374516|454045735|FG000|Surveillance Expansion Period|Protocol Violation|386|||
126207118|NCT01374516|454045736|FG001|Surveillance Expansion Period|Protocol Violation|217|||
126207119|NCT01374516|454045735|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
126207120|NCT01374516|454045736|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
126207121|NCT01374516|454045735|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
126207122|NCT01374516|454045736|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
126207123|NCT01374516|454045735|FG000|Surveillance Expansion Period|Serious adverse event|20|||
126207124|NCT01374516|454045736|FG001|Surveillance Expansion Period|Serious adverse event|5|||
126207125|NCT03219372|454045742|FG000|Overall Study|Withdrawal by Subject|1|||
126207126|NCT03219372|454045743|FG001|Overall Study|Withdrawal by Subject|0|||
126313966|NCT00197002|454440758|FG001|Overall Study|Withdrawal by Subject|5|||
126207127|NCT04145531|454045744|FG000|Part A|Adverse Event|2|||
126207128|NCT04145531|454045745|FG001|Part A|Adverse Event|12|||
126207129|NCT04145531|454045746|FG002|Part A|Adverse Event|6|||
126207130|NCT04145531|454045747|FG003|Part A|Adverse Event|0|||
126207131|NCT04145531|454045744|FG000|Part A|Death|1|||
126207132|NCT04145531|454045745|FG001|Part A|Death|2|||
126207133|NCT04145531|454045746|FG002|Part A|Death|0|||
126207134|NCT04145531|454045747|FG003|Part A|Death|0|||
126207135|NCT04145531|454045744|FG000|Part A|Physician Decision|2|||
126207136|NCT04145531|454045745|FG001|Part A|Physician Decision|5|||
126207137|NCT04145531|454045746|FG002|Part A|Physician Decision|2|||
126207138|NCT04145531|454045747|FG003|Part A|Physician Decision|0|||
126207139|NCT04145531|454045744|FG000|Part A|Progressive disease|0|||
126207140|NCT04145531|454045745|FG001|Part A|Progressive disease|2|||
126207141|NCT04145531|454045746|FG002|Part A|Progressive disease|1|||
126207142|NCT04145531|454045747|FG003|Part A|Progressive disease|0|||
126207143|NCT04145531|454045744|FG000|Part A|Protocol deviation|0|||
126207144|NCT04145531|454045745|FG001|Part A|Protocol deviation|0|||
126207145|NCT04145531|454045746|FG002|Part A|Protocol deviation|1|||
126207146|NCT04145531|454045747|FG003|Part A|Protocol deviation|0|||
126207147|NCT04145531|454045744|FG000|Part A|Withdrawal by parent or guardian|1|||
126207148|NCT04145531|454045745|FG001|Part A|Withdrawal by parent or guardian|0|||
126207149|NCT04145531|454045746|FG002|Part A|Withdrawal by parent or guardian|0|||
126207150|NCT04145531|454045747|FG003|Part A|Withdrawal by parent or guardian|0|||
126207151|NCT04145531|454045744|FG000|Part A|Withdrawal by participant|0|||
126207152|NCT04145531|454045745|FG001|Part A|Withdrawal by participant|0|||
126207153|NCT04145531|454045746|FG002|Part A|Withdrawal by participant|1|||
126207154|NCT04145531|454045747|FG003|Part A|Withdrawal by participant|0|||
126207155|NCT04145531|454045744|FG000|Part A|Other|0|||
126207156|NCT04145531|454045745|FG001|Part A|Other|0|||
126207157|NCT04145531|454045746|FG002|Part A|Other|1|||
126207158|NCT04145531|454045747|FG003|Part A|Other|0|||
126207159|NCT04145531|454045744|FG000|Part B|Adverse Event|0|||
126207160|NCT04145531|454045745|FG001|Part B|Adverse Event|0|||
126207161|NCT04145531|454045746|FG002|Part B|Adverse Event|0|||
126207162|NCT04145531|454045747|FG003|Part B|Adverse Event|21|||
126207163|NCT04145531|454045744|FG000|Part B|Physician Decision|0|||
126207164|NCT04145531|454045745|FG001|Part B|Physician Decision|0|||
126207165|NCT04145531|454045746|FG002|Part B|Physician Decision|0|||
126207166|NCT04145531|454045747|FG003|Part B|Physician Decision|7|||
126207167|NCT04145531|454045744|FG000|Part B|Progressive disease|0|||
126207168|NCT04145531|454045745|FG001|Part B|Progressive disease|0|||
126207169|NCT04145531|454045746|FG002|Part B|Progressive disease|0|||
126207170|NCT04145531|454045747|FG003|Part B|Progressive disease|1|||
126207171|NCT04145531|454045744|FG000|Part B|Recurrent disease|0|||
126207172|NCT04145531|454045745|FG001|Part B|Recurrent disease|0|||
126207173|NCT04145531|454045746|FG002|Part B|Recurrent disease|0|||
126207174|NCT04145531|454045747|FG003|Part B|Recurrent disease|1|||
126207175|NCT04145531|454045744|FG000|Part B|Withdrawal by parent or guardian|0|||
126207176|NCT04145531|454045745|FG001|Part B|Withdrawal by parent or guardian|0|||
126207177|NCT04145531|454045746|FG002|Part B|Withdrawal by parent or guardian|0|||
126207178|NCT04145531|454045747|FG003|Part B|Withdrawal by parent or guardian|3|||
126207179|NCT04145531|454045744|FG000|Part B|Withdrawal by participant|0|||
126207180|NCT04145531|454045745|FG001|Part B|Withdrawal by participant|0|||
126207181|NCT04145531|454045746|FG002|Part B|Withdrawal by participant|0|||
126207182|NCT04145531|454045747|FG003|Part B|Withdrawal by participant|1|||
126207183|NCT04145531|454045744|FG000|Part B|Other|0|||
126207184|NCT04145531|454045745|FG001|Part B|Other|0|||
126207185|NCT04145531|454045746|FG002|Part B|Other|0|||
126207186|NCT04145531|454045747|FG003|Part B|Other|1|||
126207187|NCT02985996|454045748|FG000|Overall Study|Withdrawal by Subject|0|||
126207188|NCT02985996|454045749|FG001|Overall Study|Withdrawal by Subject|0|||
126207189|NCT02985996|454045750|FG002|Overall Study|Withdrawal by Subject|1|||
126207190|NCT02985996|454045751|FG003|Overall Study|Withdrawal by Subject|0|||
126207191|NCT02985996|454045752|FG004|Overall Study|Withdrawal by Subject|0|||
126207192|NCT02985996|454045748|FG000|Overall Study|Protocol Violation|0|||
126207193|NCT02985996|454045749|FG001|Overall Study|Protocol Violation|1|||
126207194|NCT02985996|454045750|FG002|Overall Study|Protocol Violation|0|||
126207195|NCT02985996|454045751|FG003|Overall Study|Protocol Violation|0|||
126207196|NCT02985996|454045752|FG004|Overall Study|Protocol Violation|0|||
126207197|NCT00401726|454045753|FG000|Overall Study|Adverse Event|34|||
126207198|NCT00401726|454045754|FG001|Overall Study|Adverse Event|45|||
126207199|NCT00401726|454045753|FG000|Overall Study|Death|0|||
126207200|NCT00401726|454045754|FG001|Overall Study|Death|3|||
126207201|NCT00401726|454045753|FG000|Overall Study|Sponsor Request|0|||
126207202|NCT00401726|454045754|FG001|Overall Study|Sponsor Request|1|||
126207203|NCT00401726|454045753|FG000|Overall Study|Physician Decision|3|||
126207204|NCT00401726|454045754|FG001|Overall Study|Physician Decision|6|||
126207205|NCT00401726|454045753|FG000|Overall Study|Lost to Follow-up|23|||
126207206|NCT00401726|454045754|FG001|Overall Study|Lost to Follow-up|20|||
126207207|NCT00401726|454045753|FG000|Overall Study|Protocol Violation|6|||
126207208|NCT00401726|454045754|FG001|Overall Study|Protocol Violation|3|||
126207209|NCT00401726|454045753|FG000|Overall Study|Withdrawal by Subject|18|||
126207210|NCT00401726|454045754|FG001|Overall Study|Withdrawal by Subject|24|||
126207211|NCT00401726|454045753|FG000|Overall Study|Lack of Efficacy|4|||
126207212|NCT00401726|454045754|FG001|Overall Study|Lack of Efficacy|6|||
126207213|NCT00401726|454045753|FG000|Overall Study|Protocol Deviation|9|||
126207214|NCT00401726|454045754|FG001|Overall Study|Protocol Deviation|4|||
126207215|NCT00442572|454045755|FG000|Overall Study|Relapse|8|||
126207216|NCT00442572|454045756|FG001|Overall Study|Relapse|1|||
126207217|NCT00442572|454045755|FG000|Overall Study|Lost to Follow-up|0|||
126207218|NCT00442572|454045756|FG001|Overall Study|Lost to Follow-up|1|||
126207219|NCT00442572|454045755|FG000|Overall Study|Withdrawal by Subject|0|||
126207220|NCT00442572|454045756|FG001|Overall Study|Withdrawal by Subject|1|||
126207221|NCT03735849|454045760|FG000|Overall Study|Lost to Follow-up|1|||
126207222|NCT03735849|454045761|FG001|Overall Study|Lost to Follow-up|0|||
126207223|NCT03735849|454045762|FG002|Overall Study|Lost to Follow-up|0|||
126207224|NCT03735849|454045760|FG000|Overall Study|Participant unable to adhere to visit|1|||
126207225|NCT03735849|454045761|FG001|Overall Study|Participant unable to adhere to visit|0|||
126207226|NCT03735849|454045762|FG002|Overall Study|Participant unable to adhere to visit|0|||
126207227|NCT03735849|454045760|FG000|Overall Study|Not Randomized|0|||
126207228|NCT03735849|454045761|FG001|Overall Study|Not Randomized|0|||
126207229|NCT03735849|454045762|FG002|Overall Study|Not Randomized|4|||
126207230|NCT01050998|454045764|FG000|Overall Study|Adverse Event|1|||
126207231|NCT01050998|454045765|FG001|Overall Study|Adverse Event|0|||
126207232|NCT01050998|454045766|FG002|Overall Study|Adverse Event|1|||
126207233|NCT01050998|454045767|FG003|Overall Study|Adverse Event|0|||
126207234|NCT01050998|454045768|FG004|Overall Study|Adverse Event|2|||
126207235|NCT01050998|454045764|FG000|Overall Study|Withdrawal by Subject|0|||
126207236|NCT01050998|454045765|FG001|Overall Study|Withdrawal by Subject|0|||
126207237|NCT01050998|454045766|FG002|Overall Study|Withdrawal by Subject|0|||
126207238|NCT01050998|454045767|FG003|Overall Study|Withdrawal by Subject|1|||
126207239|NCT01050998|454045768|FG004|Overall Study|Withdrawal by Subject|3|||
126207240|NCT01050998|454045764|FG000|Overall Study|Other|3|||
126207241|NCT01050998|454045765|FG001|Overall Study|Other|2|||
126207242|NCT01050998|454045766|FG002|Overall Study|Other|1|||
126207243|NCT01050998|454045767|FG003|Overall Study|Other|1|||
126207244|NCT01050998|454045768|FG004|Overall Study|Other|5|||
126207245|NCT01050998|454045764|FG000|Overall Study|Data integrity issues|0|||
126207246|NCT01050998|454045765|FG001|Overall Study|Data integrity issues|0|||
126207247|NCT01050998|454045766|FG002|Overall Study|Data integrity issues|1|||
126207248|NCT01050998|454045767|FG003|Overall Study|Data integrity issues|1|||
126207249|NCT01050998|454045768|FG004|Overall Study|Data integrity issues|4|||
126207250|NCT04246593|454045775|FG000|Overall Study|Withdrawal by Subject|14|||
126207251|NCT04246593|454045776|FG001|Overall Study|Withdrawal by Subject|13|||
126207252|NCT04246593|454045775|FG000|Overall Study|Lost to Follow-up|124|||
126207253|NCT04246593|454045776|FG001|Overall Study|Lost to Follow-up|71|||
126207254|NCT04246593|454045775|FG000|Overall Study|Moved out of area/became ineligible|3|||
126207255|NCT04246593|454045776|FG001|Overall Study|Moved out of area/became ineligible|1|||
126207256|NCT04246593|454045775|FG000|Overall Study|Reason unknown|4|||
126207257|NCT04246593|454045776|FG001|Overall Study|Reason unknown|2|||
126207258|NCT02058849|454045779|FG000|Overall Study|Hospitalization|1|||
126207259|NCT02058849|454045780|FG001|Overall Study|Hospitalization|1|||
126207260|NCT02058849|454045779|FG000|Overall Study|Death|1|||
126207261|NCT02058849|454045780|FG001|Overall Study|Death|0|||
126207262|NCT02058849|454045779|FG000|Overall Study|Lost to Follow-up|1|||
126207263|NCT02058849|454045780|FG001|Overall Study|Lost to Follow-up|0|||
126207264|NCT02058849|454045779|FG000|Overall Study|Withdrawal by Subject|4|||
126207265|NCT02058849|454045780|FG001|Overall Study|Withdrawal by Subject|0|||
126207266|NCT02304484|454045785|FG000|Overall Study|Death|9|||
126207267|NCT02304484|454045785|FG000|Overall Study|Withdrawal by Subject|14|||
126207268|NCT02304484|454045785|FG000|Overall Study|Lost to Follow-up|2|||
126207269|NCT02967055|454045786|FG000|Overall Study|Excluded|40|||
126207270|NCT02967055|454045786|FG000|Overall Study|Screen fail|3|||
126207271|NCT02967055|454045786|FG000|Overall Study|Lost to Follow-up|2|||
126207272|NCT02967055|454045786|FG000|Overall Study|Stopped due to side effects|3|||
126207273|NCT02967055|454045786|FG000|Overall Study|Stopped due to drug cost|1|||
126207274|NCT00145795|454045787|FG000|Overall Study|Adverse Event|1|||
126207275|NCT00145795|454045788|FG001|Overall Study|Adverse Event|0|||
126207276|NCT00570492|454045789|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
126207277|NCT00570492|454045790|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
126207278|NCT00570492|454045791|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
126207279|NCT00570492|454045789|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
126207280|NCT00570492|454045790|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
126207281|NCT00570492|454045791|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
126207282|NCT00570492|454045789|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
126207283|NCT00570492|454045790|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
126207284|NCT00570492|454045791|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
126207285|NCT00570492|454045789|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
126207286|NCT00570492|454045790|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
126207287|NCT00570492|454045791|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
126207288|NCT00570492|454045789|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
126207289|NCT00570492|454045790|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
126207290|NCT00570492|454045791|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
126207291|NCT00570492|454045789|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
126207292|NCT00570492|454045790|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
126207293|NCT00570492|454045791|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
126207294|NCT00570492|454045789|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
126207295|NCT00570492|454045790|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
126207296|NCT00570492|454045791|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
126207297|NCT00570492|454045789|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126207298|NCT00570492|454045790|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
126207299|NCT00570492|454045791|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
126207300|NCT00570492|454045789|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
126207301|NCT00570492|454045790|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
126207302|NCT00570492|454045791|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
126207303|NCT00570492|454045789|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
126207304|NCT00570492|454045790|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
126207305|NCT00570492|454045791|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
126207306|NCT00570492|454045789|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
126207307|NCT00570492|454045790|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
126207308|NCT00570492|454045791|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
126207309|NCT00570492|454045789|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
126207310|NCT00570492|454045790|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
126207311|NCT00570492|454045791|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
126207312|NCT00570492|454045789|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
126207313|NCT00570492|454045790|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
126207314|NCT00570492|454045791|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
126207315|NCT00570492|454045789|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
126207316|NCT00570492|454045790|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
126207317|NCT00570492|454045791|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
126207318|NCT00976989|454045792|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
126207319|NCT00976989|454045793|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
126207320|NCT00976989|454045794|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
126207321|NCT00976989|454045792|FG000|Overall Study|Death|5|||
126207322|NCT00976989|454045793|FG001|Overall Study|Death|7|||
126207323|NCT00976989|454045794|FG002|Overall Study|Death|10|||
126207324|NCT00976989|454045792|FG000|Overall Study|Refused Treatment|4|||
126207325|NCT00976989|454045793|FG001|Overall Study|Refused Treatment|3|||
126207326|NCT00976989|454045794|FG002|Overall Study|Refused Treatment|5|||
126207327|NCT00976989|454045792|FG000|Overall Study|Failure to Return|2|||
126207328|NCT00976989|454045793|FG001|Overall Study|Failure to Return|1|||
126207329|NCT00976989|454045794|FG002|Overall Study|Failure to Return|0|||
126207330|NCT00976989|454045792|FG000|Overall Study|Recurrence of Disease|0|||
126207331|NCT00976989|454045793|FG001|Overall Study|Recurrence of Disease|1|||
126207332|NCT00976989|454045794|FG002|Overall Study|Recurrence of Disease|0|||
126207333|NCT00976989|454045792|FG000|Overall Study|Other|1|||
126207334|NCT00976989|454045793|FG001|Overall Study|Other|0|||
126207335|NCT00976989|454045794|FG002|Overall Study|Other|1|||
126207336|NCT03958045|454045795|FG000|Overall Study|Withdrawal by Subject|1|||
126207337|NCT02283411|454045796|FG000|Overall Study|Withdrawal by Subject|3|||
126207338|NCT02283411|454045796|FG000|Overall Study|Screen Failed|28|||
126207339|NCT04409262|454045798|FG000|Overall Study|Adverse Event|0|||
126207340|NCT04409262|454045799|FG001|Overall Study|Adverse Event|2|||
126207341|NCT04409262|454045798|FG000|Overall Study|Death|55|||
126207342|NCT04409262|454045799|FG001|Overall Study|Death|97|||
126207343|NCT04409262|454045798|FG000|Overall Study|Lost to Follow-up|12|||
126207344|NCT04409262|454045799|FG001|Overall Study|Lost to Follow-up|23|||
126207345|NCT04409262|454045798|FG000|Overall Study|Lack of Staff|0|||
126207346|NCT04409262|454045799|FG001|Overall Study|Lack of Staff|1|||
126207347|NCT04409262|454045798|FG000|Overall Study|Protocol Violation|3|||
126207348|NCT04409262|454045799|FG001|Overall Study|Protocol Violation|1|||
126207349|NCT04409262|454045798|FG000|Overall Study|Withdrawal by Subject|5|||
126207350|NCT04409262|454045799|FG001|Overall Study|Withdrawal by Subject|10|||
126207351|NCT03759340|454045801|FG000|Overall Study|Adverse Event|2|||
126207352|NCT03759340|454045801|FG000|Overall Study|Lost to Follow-up|1|||
126207353|NCT03759340|454045801|FG000|Overall Study|Withdrawal by Subject|15|||
126207354|NCT03759340|454045801|FG000|Overall Study|Study Terminated by Sponsor|38|||
126207355|NCT03289676|454045802|FG000|Overall Study|Withdrawal by Subject|2|||
126207356|NCT03289676|454045803|FG001|Overall Study|Withdrawal by Subject|0|||
126207357|NCT03289676|454045802|FG000|Overall Study|Protocol Violation|2|||
126207358|NCT03289676|454045803|FG001|Overall Study|Protocol Violation|0|||
126207359|NCT03289676|454045802|FG000|Overall Study|Lost to Follow-up|0|||
126207360|NCT03289676|454045803|FG001|Overall Study|Lost to Follow-up|1|||
126207361|NCT02260804|454045810|FG000|Induction Study Period|Protocol Violation|2|||
126207362|NCT02260804|454045811|FG001|Induction Study Period|Protocol Violation|0|||
126207363|NCT02260804|454045810|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
126207364|NCT02260804|454045811|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
126207365|NCT02260804|454045810|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
126207366|NCT02260804|454045811|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
126207367|NCT02260804|454045810|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
126207368|NCT02260804|454045811|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
126207369|NCT02260804|454045810|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
126207370|NCT02260804|454045811|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
126207371|NCT02260804|454045810|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
126207372|NCT02260804|454045811|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
126207373|NCT02260804|454045810|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
126207374|NCT02260804|454045811|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
126207375|NCT02260804|454045810|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
126207376|NCT02260804|454045811|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
126207377|NCT02260804|454045810|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
126207378|NCT02260804|454045811|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
126207379|NCT02260804|454045810|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
126207380|NCT02260804|454045811|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
126207381|NCT02260804|454045810|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
126207382|NCT02260804|454045811|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
126207383|NCT02207413|454045812|FG000|Overall Study|Withdrawal by Subject|1|||
126207384|NCT02207413|454045813|FG001|Overall Study|Withdrawal by Subject|0|||
126207385|NCT02207413|454045814|FG002|Overall Study|Withdrawal by Subject|0|||
126207386|NCT02207413|454045815|FG003|Overall Study|Withdrawal by Subject|0|||
126207387|NCT02207413|454045816|FG004|Overall Study|Withdrawal by Subject|3|||
126207388|NCT02207413|454045817|FG005|Overall Study|Withdrawal by Subject|7|||
126207389|NCT02207413|454045812|FG000|Overall Study|Lost to Follow-up|0|||
126207390|NCT02207413|454045813|FG001|Overall Study|Lost to Follow-up|0|||
126207391|NCT02207413|454045814|FG002|Overall Study|Lost to Follow-up|0|||
126207392|NCT02207413|454045815|FG003|Overall Study|Lost to Follow-up|1|||
126207393|NCT02207413|454045816|FG004|Overall Study|Lost to Follow-up|1|||
126207394|NCT02207413|454045817|FG005|Overall Study|Lost to Follow-up|5|||
126207395|NCT02207413|454045812|FG000|Overall Study|Adverse Event|0|||
126207396|NCT02207413|454045813|FG001|Overall Study|Adverse Event|0|||
126207397|NCT02207413|454045814|FG002|Overall Study|Adverse Event|0|||
126207398|NCT02207413|454045815|FG003|Overall Study|Adverse Event|0|||
126207399|NCT02207413|454045816|FG004|Overall Study|Adverse Event|2|||
126207400|NCT02207413|454045817|FG005|Overall Study|Adverse Event|1|||
126207401|NCT02207413|454045812|FG000|Overall Study|Migrated/moved from study area|0|||
126207402|NCT02207413|454045813|FG001|Overall Study|Migrated/moved from study area|0|||
126207403|NCT02207413|454045814|FG002|Overall Study|Migrated/moved from study area|0|||
126207404|NCT02207413|454045815|FG003|Overall Study|Migrated/moved from study area|0|||
126207405|NCT02207413|454045816|FG004|Overall Study|Migrated/moved from study area|1|||
126207406|NCT02207413|454045817|FG005|Overall Study|Migrated/moved from study area|0|||
126207407|NCT02777554|454047566|FG000|Overall Study|Adverse Event|4|||
126207408|NCT02777554|454047567|FG001|Overall Study|Adverse Event|4|||
126207409|NCT02777554|454047568|FG002|Overall Study|Adverse Event|0|||
126207410|NCT02777554|454047569|FG003|Overall Study|Adverse Event|1|||
126207411|NCT02777554|454047570|FG004|Overall Study|Adverse Event|0|||
126207412|NCT02777554|454047571|FG005|Overall Study|Adverse Event|0|||
126207413|NCT02777554|454047566|FG000|Overall Study|Withdrawal by Subject|3|||
126207414|NCT02777554|454047567|FG001|Overall Study|Withdrawal by Subject|1|||
126207415|NCT02777554|454047568|FG002|Overall Study|Withdrawal by Subject|1|||
126207416|NCT02777554|454047569|FG003|Overall Study|Withdrawal by Subject|0|||
126207417|NCT02777554|454047570|FG004|Overall Study|Withdrawal by Subject|0|||
126207418|NCT02777554|454047571|FG005|Overall Study|Withdrawal by Subject|0|||
126207419|NCT02777554|454047566|FG000|Overall Study|Discharged early due to hurricane|22|||
126207420|NCT02777554|454047567|FG001|Overall Study|Discharged early due to hurricane|20|||
126207421|NCT02777554|454047568|FG002|Overall Study|Discharged early due to hurricane|0|||
126207422|NCT02777554|454047569|FG003|Overall Study|Discharged early due to hurricane|0|||
126207423|NCT02777554|454047570|FG004|Overall Study|Discharged early due to hurricane|0|||
126207424|NCT02777554|454047571|FG005|Overall Study|Discharged early due to hurricane|0|||
126207425|NCT02777554|454047566|FG000|Overall Study|Other - Miscellaneous|1|||
126207426|NCT02777554|454047567|FG001|Overall Study|Other - Miscellaneous|0|||
126207427|NCT02777554|454047568|FG002|Overall Study|Other - Miscellaneous|0|||
126207428|NCT02777554|454047569|FG003|Overall Study|Other - Miscellaneous|0|||
126207429|NCT02777554|454047570|FG004|Overall Study|Other - Miscellaneous|0|||
126207430|NCT02777554|454047571|FG005|Overall Study|Other - Miscellaneous|0|||
126207431|NCT00270205|454047572|FG000|Overall Study|Lost to Follow-up|1|||
126207432|NCT00270205|454047573|FG001|Overall Study|Lost to Follow-up|0|||
126207433|NCT00270205|454047574|FG002|Overall Study|Lost to Follow-up|0|||
126207434|NCT00270205|454047575|FG003|Overall Study|Lost to Follow-up|1|||
126207435|NCT00066573|454047576|FG000|Overall Study|Did not received protocol treatment|28|||
126207436|NCT00066573|454047577|FG001|Overall Study|Did not received protocol treatment|28|||
126207437|NCT00869362|454047578|FG000|Overall Study|Death|0|||
126207438|NCT00869362|454047579|FG001|Overall Study|Death|2|||
126207439|NCT00869362|454047578|FG000|Overall Study|Lost to Follow-up|1|||
126207440|NCT00869362|454047579|FG001|Overall Study|Lost to Follow-up|3|||
126207441|NCT01241591|454047580|FG000|Overall Study|Lack of Efficacy|5|||
126207442|NCT01241591|454047581|FG001|Overall Study|Lack of Efficacy|2|||
126207443|NCT01241591|454047582|FG002|Overall Study|Lack of Efficacy|2|||
126207444|NCT01241591|454047583|FG003|Overall Study|Lack of Efficacy|3|||
126207445|NCT01241591|454047580|FG000|Overall Study|Protocol Violation|5|||
126207446|NCT01241591|454047581|FG001|Overall Study|Protocol Violation|2|||
126207447|NCT01241591|454047582|FG002|Overall Study|Protocol Violation|3|||
126207448|NCT01241591|454047583|FG003|Overall Study|Protocol Violation|0|||
126207449|NCT01241591|454047580|FG000|Overall Study|Lost to Follow-up|1|||
126207450|NCT01241591|454047581|FG001|Overall Study|Lost to Follow-up|2|||
126207451|NCT01241591|454047582|FG002|Overall Study|Lost to Follow-up|2|||
126207452|NCT01241591|454047583|FG003|Overall Study|Lost to Follow-up|2|||
126207453|NCT01241591|454047580|FG000|Overall Study|Screen Failure|3|||
126207454|NCT01241591|454047581|FG001|Overall Study|Screen Failure|2|||
126207455|NCT01241591|454047582|FG002|Overall Study|Screen Failure|1|||
126207456|NCT01241591|454047583|FG003|Overall Study|Screen Failure|0|||
126207457|NCT01241591|454047580|FG000|Overall Study|Withdrawal by Subject|6|||
126207458|NCT01241591|454047581|FG001|Overall Study|Withdrawal by Subject|4|||
126207459|NCT01241591|454047582|FG002|Overall Study|Withdrawal by Subject|2|||
126207460|NCT01241591|454047583|FG003|Overall Study|Withdrawal by Subject|2|||
126207461|NCT01241591|454047580|FG000|Overall Study|Other|0|||
126207462|NCT01241591|454047581|FG001|Overall Study|Other|1|||
126207463|NCT01241591|454047582|FG002|Overall Study|Other|0|||
126207464|NCT01241591|454047583|FG003|Overall Study|Other|1|||
126207465|NCT01241591|454047580|FG000|Overall Study|Adverse Event|3|||
126207466|NCT01241591|454047581|FG001|Overall Study|Adverse Event|11|||
126207467|NCT01241591|454047582|FG002|Overall Study|Adverse Event|12|||
126207468|NCT01241591|454047583|FG003|Overall Study|Adverse Event|4|||
126207469|NCT01945034|454047584|FG000|Overall Study|Medication Error|0|||
126207470|NCT01945034|454047585|FG001|Overall Study|Medication Error|1|||
126207471|NCT01945034|454047586|FG002|Overall Study|Medication Error|0|||
126207472|NCT01945034|454047584|FG000|Overall Study|Withdrawal by Subject|0|||
126207473|NCT01945034|454047585|FG001|Overall Study|Withdrawal by Subject|3|||
126207474|NCT01945034|454047586|FG002|Overall Study|Withdrawal by Subject|1|||
126207475|NCT01945034|454047584|FG000|Overall Study|Other|0|||
126207476|NCT01945034|454047585|FG001|Overall Study|Other|1|||
126207477|NCT01945034|454047586|FG002|Overall Study|Other|3|||
126207478|NCT01945034|454047584|FG000|Overall Study|Lost to Follow-up|0|||
126207479|NCT01945034|454047585|FG001|Overall Study|Lost to Follow-up|0|||
126207480|NCT01945034|454047586|FG002|Overall Study|Lost to Follow-up|2|||
126207481|NCT01945034|454047584|FG000|Overall Study|Protocol Violation|1|||
126207482|NCT01945034|454047585|FG001|Overall Study|Protocol Violation|0|||
126207483|NCT01945034|454047586|FG002|Overall Study|Protocol Violation|1|||
126207484|NCT03053102|454047587|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
126207485|NCT03053102|454047587|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
126207486|NCT02147132|454047588|FG000|Overall Study|Lost to Follow-up|1|||
126207487|NCT02147132|454047589|FG001|Overall Study|Lost to Follow-up|0|||
126207488|NCT02147132|454047590|FG002|Overall Study|Lost to Follow-up|0|||
126207489|NCT02147132|454047591|FG003|Overall Study|Lost to Follow-up|0|||
126207490|NCT01798056|454047592|FG000|Overall Study|Serious Adverse Event|13|||
126207491|NCT01798056|454047593|FG001|Overall Study|Serious Adverse Event|12|||
126207492|NCT01798056|454047592|FG000|Overall Study|Withdrawal by Subject|12|||
126207493|NCT01798056|454047593|FG001|Overall Study|Withdrawal by Subject|9|||
126207494|NCT01798056|454047592|FG000|Overall Study|Migrated/moved from study area|1|||
126207495|NCT01798056|454047593|FG001|Overall Study|Migrated/moved from study area|1|||
126207496|NCT01798056|454047592|FG000|Overall Study|Lost to Follow-up|1|||
126207497|NCT01798056|454047593|FG001|Overall Study|Lost to Follow-up|1|||
126207498|NCT01798056|454047592|FG000|Overall Study|Other|0|||
126207499|NCT01798056|454047593|FG001|Overall Study|Other|2|||
126207500|NCT02842736|454047596|FG000|Overall Study|Lost to Follow-up|13|||
126207501|NCT02842736|454047596|FG000|Overall Study|Intervention for menstrual bleeding|17|||
126207502|NCT02842736|454047596|FG000|Overall Study|Withdrawal by Subject|4|||
126207503|NCT02842736|454047596|FG000|Overall Study|Pregnancy|3|||
126207504|NCT02842736|454047596|FG000|Overall Study|Hysterectomy for fibroids|2|||
126207505|NCT02842736|454047596|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
126207506|NCT02842736|454047596|FG000|Overall Study|IUD: Mirena|1|||
126207507|NCT03323034|454047598|FG000|Overall Study|Lack of Efficacy|5|||
126207508|NCT03323034|454047599|FG001|Overall Study|Lack of Efficacy|5|||
126207509|NCT03323034|454047600|FG002|Overall Study|Lack of Efficacy|6|||
126207510|NCT03323034|454047601|FG003|Overall Study|Lack of Efficacy|5|||
126207511|NCT03323034|454047602|FG004|Overall Study|Lack of Efficacy|5|||
126207512|NCT03323034|454047598|FG000|Overall Study|Physician Decision|0|||
126207513|NCT03323034|454047599|FG001|Overall Study|Physician Decision|0|||
126207514|NCT03323034|454047600|FG002|Overall Study|Physician Decision|0|||
126207515|NCT03323034|454047601|FG003|Overall Study|Physician Decision|0|||
126207516|NCT03323034|454047602|FG004|Overall Study|Physician Decision|1|||
126207517|NCT03323034|454047598|FG000|Overall Study|Withdrawal by Subject|1|||
126207518|NCT03323034|454047599|FG001|Overall Study|Withdrawal by Subject|1|||
126207519|NCT03323034|454047600|FG002|Overall Study|Withdrawal by Subject|0|||
126207520|NCT03323034|454047601|FG003|Overall Study|Withdrawal by Subject|1|||
126207521|NCT03323034|454047602|FG004|Overall Study|Withdrawal by Subject|0|||
126207522|NCT02646566|454047603|FG000|Overall Study|Lost to Follow-up|5|||
126207523|NCT02646566|454047604|FG001|Overall Study|Lost to Follow-up|4|||
126207524|NCT02646566|454047605|FG002|Overall Study|Lost to Follow-up|5|||
126207525|NCT02646566|454047603|FG000|Overall Study|Treatment failure|1|||
126207526|NCT02646566|454047604|FG001|Overall Study|Treatment failure|0|||
126207527|NCT02646566|454047605|FG002|Overall Study|Treatment failure|0|||
126207528|NCT02815540|454047608|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
126207529|NCT02222246|454047609|FG000|Overall Study|No Emergency Department Visits|27|||
126207530|NCT02222246|454047610|FG001|Overall Study|No Emergency Department Visits|26|||
126207531|NCT02222246|454047609|FG000|Overall Study|Physician Decision|0|||
126207532|NCT02222246|454047610|FG001|Overall Study|Physician Decision|1|||
126207533|NCT02660489|454047611|FG000|Overall Study|Lost to Follow-up|1|||
126207534|NCT02660489|454047612|FG001|Overall Study|Lost to Follow-up|1|||
126207535|NCT02660489|454047611|FG000|Overall Study|Adverse Event|1|||
126207536|NCT02660489|454047612|FG001|Overall Study|Adverse Event|3|||
126207537|NCT02660489|454047611|FG000|Overall Study|no rhinovirus infection|4|||
126207538|NCT02660489|454047612|FG001|Overall Study|no rhinovirus infection|4|||
126207539|NCT02064231|454047613|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
126207540|NCT02064231|454047614|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
126207541|NCT02064231|454047615|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
126207542|NCT02064231|454047616|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
126207543|NCT02064231|454047613|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
126207544|NCT02064231|454047614|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
126207545|NCT02064231|454047615|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
126207546|NCT02064231|454047616|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
126207547|NCT02064231|454047613|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
126207548|NCT02064231|454047614|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
126207549|NCT02064231|454047615|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
126207550|NCT02064231|454047616|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
126207551|NCT02064231|454047613|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
126207552|NCT02064231|454047614|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
126207553|NCT02064231|454047615|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
126207554|NCT02064231|454047616|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
126207555|NCT04887922|454047617|FG000|1st Randomization|Decided not to have surgery|0|||
126207556|NCT04887922|454047618|FG001|1st Randomization|Decided not to have surgery|1|||
126207557|NCT04887922|454047619|FG002|1st Randomization|Decided not to have surgery|0|||
126207558|NCT04887922|454047620|FG003|1st Randomization|Decided not to have surgery|0|||
126207559|NCT04887922|454047621|FG004|1st Randomization|Decided not to have surgery|0|||
126207560|NCT00718809|454047622|FG000|Overall Study|Disease progression|9|||
126207561|NCT00718809|454047623|FG001|Overall Study|Disease progression|7|||
126207562|NCT00718809|454047622|FG000|Overall Study|Adverse Event|1|||
126207563|NCT00718809|454047623|FG001|Overall Study|Adverse Event|1|||
126207564|NCT00718809|454047622|FG000|Overall Study|Withdrawal by Subject|0|||
126207565|NCT00718809|454047623|FG001|Overall Study|Withdrawal by Subject|1|||
126207566|NCT00718809|454047622|FG000|Overall Study|Lost to Follow-up|1|||
126207567|NCT00718809|454047623|FG001|Overall Study|Lost to Follow-up|0|||
126207568|NCT00718809|454047622|FG000|Overall Study|Noncompliance|1|||
126207569|NCT00718809|454047623|FG001|Overall Study|Noncompliance|0|||
126207570|NCT00463385|454047624|FG000|Overall Study|Other|4|||
126207571|NCT00463385|454047625|FG001|Overall Study|Other|3|||
126207572|NCT00463385|454047626|FG002|Overall Study|Other|6|||
126207573|NCT00463385|454047627|FG003|Overall Study|Other|4|||
126207574|NCT00463385|454047624|FG000|Overall Study|Adverse Event|5|||
126207575|NCT00463385|454047625|FG001|Overall Study|Adverse Event|8|||
126207576|NCT00463385|454047626|FG002|Overall Study|Adverse Event|4|||
126207577|NCT00463385|454047627|FG003|Overall Study|Adverse Event|2|||
126207578|NCT00463385|454047624|FG000|Overall Study|Lack of Efficacy|6|||
126207579|NCT00463385|454047625|FG001|Overall Study|Lack of Efficacy|6|||
126207580|NCT00463385|454047626|FG002|Overall Study|Lack of Efficacy|7|||
126207581|NCT00463385|454047627|FG003|Overall Study|Lack of Efficacy|9|||
126207582|NCT00463385|454047624|FG000|Overall Study|Withdrawal by Subject|3|||
126207583|NCT00463385|454047625|FG001|Overall Study|Withdrawal by Subject|3|||
126207584|NCT00463385|454047626|FG002|Overall Study|Withdrawal by Subject|3|||
126207585|NCT00463385|454047627|FG003|Overall Study|Withdrawal by Subject|4|||
126207586|NCT00463385|454047624|FG000|Overall Study|Lost to Follow-up|0|||
126207587|NCT00463385|454047625|FG001|Overall Study|Lost to Follow-up|0|||
126207588|NCT00463385|454047626|FG002|Overall Study|Lost to Follow-up|0|||
126207589|NCT00463385|454047627|FG003|Overall Study|Lost to Follow-up|1|||
126207590|NCT00463385|454047624|FG000|Overall Study|Death|2|||
126207591|NCT00463385|454047625|FG001|Overall Study|Death|1|||
126207592|NCT00463385|454047626|FG002|Overall Study|Death|2|||
126207593|NCT00463385|454047627|FG003|Overall Study|Death|0|||
126207594|NCT00463385|454047624|FG000|Overall Study|Missing|2|||
126207595|NCT00463385|454047625|FG001|Overall Study|Missing|0|||
126207596|NCT00463385|454047626|FG002|Overall Study|Missing|0|||
126207597|NCT00463385|454047627|FG003|Overall Study|Missing|2|||
126207598|NCT00463385|454047624|FG000|Overall Study|1 participant received commercial drug|0|||
126207599|NCT00463385|454047625|FG001|Overall Study|1 participant received commercial drug|1|||
126207600|NCT00463385|454047626|FG002|Overall Study|1 participant received commercial drug|0|||
126207601|NCT00463385|454047627|FG003|Overall Study|1 participant received commercial drug|0|||
126207602|NCT00536991|454047630|FG000|Overall Study|Withdrawal by Subject|10|||
126207603|NCT00536991|454047630|FG000|Overall Study|Physician Decision|1|||
126207604|NCT00536991|454047630|FG000|Overall Study|patient ineligible|2|||
126207605|NCT01600755|454047631|FG000|Overall Study|Withdrawal by Subject|6|||
126207606|NCT04621227|454047636|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
126207607|NCT04621227|454047636|FG000|Period 3 (29 Days)|Adverse Event|1|||
126207608|NCT04621227|454047636|FG000|Period 8 (2 Days)|Adverse Event|1|||
126207609|NCT01548573|454047637|FG000|Overall Study|Death|3|||
126207610|NCT01548573|454047637|FG000|Overall Study|Withdrawal by Subject|2|||
126207611|NCT01366846|454047640|FG000|Overall Study|Withdrawal by Subject|2|||
126207612|NCT01366846|454047641|FG001|Overall Study|Withdrawal by Subject|0|||
126207613|NCT01366846|454047642|FG002|Overall Study|Withdrawal by Subject|0|||
126207614|NCT01366846|454047643|FG003|Overall Study|Withdrawal by Subject|0|||
126207615|NCT01366846|454047640|FG000|Overall Study|Communication Difficulties|1|||
126207616|NCT01366846|454047641|FG001|Overall Study|Communication Difficulties|4|||
126207617|NCT01366846|454047642|FG002|Overall Study|Communication Difficulties|0|||
126207618|NCT01366846|454047643|FG003|Overall Study|Communication Difficulties|1|||
126207619|NCT01366846|454047640|FG000|Overall Study|Scheduling Conflicts|0|||
126207620|NCT01366846|454047641|FG001|Overall Study|Scheduling Conflicts|0|||
126207621|NCT01366846|454047642|FG002|Overall Study|Scheduling Conflicts|1|||
126207622|NCT01366846|454047643|FG003|Overall Study|Scheduling Conflicts|0|||
126207623|NCT00558831|454047644|FG000|Overall Study|Lost to Follow-up|1|||
126207624|NCT00447265|454047645|FG000|Overall Study|Physician Decision|1|||
126207625|NCT00447265|454047646|FG001|Overall Study|Physician Decision|0|||
126207626|NCT02204449|454047647|FG000|Overall Study|Lost to Follow-up|7|||
126207627|NCT02204449|454047648|FG001|Overall Study|Lost to Follow-up|9|||
126207628|NCT02204449|454047647|FG000|Overall Study|Death|0|||
126207629|NCT02204449|454047648|FG001|Overall Study|Death|1|||
126207630|NCT02204449|454047647|FG000|Overall Study|Withdrawal by Subject|0|||
126207631|NCT02204449|454047648|FG001|Overall Study|Withdrawal by Subject|1|||
126207632|NCT00503035|454047649|FG000|Overall Study|Lost to Follow-up|2|||
126207633|NCT00503035|454047649|FG000|Overall Study|Physician Decision|3|||
126207634|NCT00503035|454047649|FG000|Overall Study|Ineligible|15|||
126207635|NCT01342445|454047650|FG000|Overall Study|Experienced side effects|0|||
126207636|NCT01342445|454047651|FG001|Overall Study|Experienced side effects|2|||
126207637|NCT05299359|454047652|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
126207638|NCT05299359|454047653|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
126207639|NCT05299359|454047652|FG000|Main Part: Day 1 up to Day 366|Other|2|||
126207640|NCT05299359|454047653|FG001|Main Part: Day 1 up to Day 366|Other|0|||
126207641|NCT05299359|454047652|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
126207642|NCT05299359|454047653|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
126207643|NCT05299359|454047652|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
126207644|NCT05299359|454047653|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
126207645|NCT05299359|454047652|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
126207646|NCT05299359|454047653|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
126207647|NCT05299359|454047652|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
126207648|NCT05299359|454047653|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
126207649|NCT05299359|454047652|FG000|Extension Part: Day 1 to Day 366|Other|0|||
126207650|NCT05299359|454047653|FG001|Extension Part: Day 1 to Day 366|Other|1|||
126207651|NCT02392078|454047654|FG000|Overall Study|Did not have procedure|32|||
126207652|NCT02392078|454047655|FG001|Overall Study|Did not have procedure|43|||
126207653|NCT02392078|454047656|FG002|Overall Study|Did not have procedure|20|||
126207654|NCT02392078|454047657|FG003|Overall Study|Did not have procedure|1|||
126207655|NCT02652793|454047660|FG000|Overall Study|Adverse Event|1|||
126207656|NCT02652793|454047660|FG000|Overall Study|Lost to Follow-up|2|||
126207657|NCT02652793|454047660|FG000|Overall Study|Withdrawal by Subject|1|||
126207658|NCT03868410|454047661|FG000|Overall Study|Physician Decision|0|||
126207659|NCT03868410|454047662|FG001|Overall Study|Physician Decision|1|||
126207660|NCT01059175|454047663|FG000|Overall Study|Death|17|||
126207661|NCT01059175|454047664|FG001|Overall Study|Death|17|||
126207662|NCT01059175|454047663|FG000|Overall Study|Adverse Event|4|||
126207663|NCT01059175|454047664|FG001|Overall Study|Adverse Event|2|||
126207664|NCT01059175|454047663|FG000|Overall Study|Lost to Follow-up|0|||
126207665|NCT01059175|454047664|FG001|Overall Study|Lost to Follow-up|1|||
126207666|NCT02957149|454047665|FG000|Overall Study|Withdrawal by Subject|5|||
126207667|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Adverse Event|4|||
126207668|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Adverse Event|3|||
126207669|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Adverse Event|0|||
126207670|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Adverse Event|0|||
126207671|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Death|24|||
126207672|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Death|9|||
126207673|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Death|0|||
126207674|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Death|0|||
126207675|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
126207676|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
126207677|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
126207678|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
126207679|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Physician Decision|4|||
126207680|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Physician Decision|1|||
126207681|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Physician Decision|0|||
126207682|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Physician Decision|0|||
126207683|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Progressive disease|1|||
126207684|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Progressive disease|0|||
126207685|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Progressive disease|0|||
126207686|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Progressive disease|0|||
126207687|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
126207688|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
126207689|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
126207690|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
126207691|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
126207692|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
126207693|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
126207694|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
126207695|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
126207696|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
126207697|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
126207698|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
126207699|NCT04579666|454047666|FG000|RTP (Up to Week 52)|Other|2|||
126207700|NCT04579666|454047667|FG001|RTP (Up to Week 52)|Other|0|||
126207701|NCT04579666|454047668|FG002|RTP (Up to Week 52)|Other|0|||
126207702|NCT04579666|454047669|FG003|RTP (Up to Week 52)|Other|0|||
126207703|NCT04579666|454047666|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
126207704|NCT04579666|454047667|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
126207705|NCT04579666|454047668|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
126207706|NCT04579666|454047669|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
126207707|NCT04579666|454047666|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
126207708|NCT04579666|454047667|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
126207709|NCT04579666|454047668|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
126207710|NCT04579666|454047669|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
126207711|NCT04579666|454047666|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
126207712|NCT04579666|454047667|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
126207713|NCT04579666|454047668|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
126207714|NCT04579666|454047669|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
126207715|NCT04579666|454047666|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
126207716|NCT04579666|454047667|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
126207717|NCT04579666|454047668|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
126207718|NCT04579666|454047669|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
126207719|NCT04579666|454047666|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
126207720|NCT04579666|454047667|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
126207721|NCT04579666|454047668|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
126207722|NCT04579666|454047669|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
126207723|NCT05450198|454047670|FG000|Overall Study|Withdrawal by Subject|1|||
126207724|NCT05450198|454047671|FG001|Overall Study|Withdrawal by Subject|1|||
126207725|NCT05450198|454047672|FG002|Overall Study|Withdrawal by Subject|2|||
126207726|NCT05450198|454047673|FG003|Overall Study|Withdrawal by Subject|0|||
126207727|NCT05450198|454047670|FG000|Overall Study|Lost to Follow-up|1|||
126207728|NCT05450198|454047671|FG001|Overall Study|Lost to Follow-up|0|||
126207729|NCT05450198|454047672|FG002|Overall Study|Lost to Follow-up|2|||
126207730|NCT05450198|454047673|FG003|Overall Study|Lost to Follow-up|1|||
126207731|NCT00643006|454047677|FG000|Overall Study|Lost to Follow-up|5|||
126207732|NCT00643006|454047678|FG001|Overall Study|Lost to Follow-up|4|||
126207733|NCT04359758|454047680|FG000|Overall Study|Protocol Violation|3|||
126207734|NCT04359758|454047681|FG001|Overall Study|Protocol Violation|2|||
126207735|NCT01748162|454047682|FG000|Overall Study|no additional croup episodes to evaluate|2|||
126207736|NCT01748162|454047683|FG001|Overall Study|no additional croup episodes to evaluate|2|||
126207737|NCT01748162|454047682|FG000|Overall Study|participant consented but did not begin|0|||
126207738|NCT01748162|454047683|FG001|Overall Study|participant consented but did not begin|1|||
126207739|NCT01748162|454047682|FG000|Overall Study|reasons not available|3|||
126207740|NCT01748162|454047683|FG001|Overall Study|reasons not available|2|||
126207741|NCT00505765|454047684|FG000|Overall Study|Withdrawal by Subject|1|||
126207742|NCT00505765|454047685|FG001|Overall Study|Withdrawal by Subject|0|||
126207743|NCT00505765|454047686|FG002|Overall Study|Withdrawal by Subject|0|||
126207744|NCT00505765|454047684|FG000|Overall Study|Adverse Event|1|||
126207745|NCT00505765|454047685|FG001|Overall Study|Adverse Event|2|||
126207746|NCT00505765|454047686|FG002|Overall Study|Adverse Event|0|||
126207747|NCT00505765|454047684|FG000|Overall Study|Noncompliance|0|||
126207748|NCT00505765|454047685|FG001|Overall Study|Noncompliance|1|||
126207749|NCT00505765|454047686|FG002|Overall Study|Noncompliance|3|||
126207750|NCT03841331|454047687|FG000|Overall Study|Withdrawal by Subject|4|||
126207751|NCT03841331|454047688|FG001|Overall Study|Withdrawal by Subject|9|||
126207752|NCT03841331|454047687|FG000|Overall Study|Lost to Follow-up|5|||
126207753|NCT03841331|454047688|FG001|Overall Study|Lost to Follow-up|1|||
126207754|NCT02743117|454047689|FG000|Overall Study|Lost to Follow-up|0|||
126207755|NCT02743117|454047690|FG001|Overall Study|Lost to Follow-up|1|||
126207756|NCT02743117|454047689|FG000|Overall Study|Other|1|||
126207757|NCT02743117|454047690|FG001|Overall Study|Other|0|||
126207758|NCT01207219|454047691|FG000|Overall Study|changed diagnosis during study period|5|||
126207759|NCT01207219|454047692|FG001|Overall Study|changed diagnosis during study period|3|||
126207760|NCT01207219|454047693|FG002|Overall Study|changed diagnosis during study period|1|||
126207761|NCT01207219|454047691|FG000|Overall Study|Lost to Follow-up|6|||
126207762|NCT01207219|454047692|FG001|Overall Study|Lost to Follow-up|8|||
126207763|NCT01207219|454047693|FG002|Overall Study|Lost to Follow-up|6|||
126207764|NCT03532048|454047695|FG000|Overall Study|Lost to Follow-up|12|||
126207765|NCT03532048|454047696|FG001|Overall Study|Lost to Follow-up|17|||
126207766|NCT03532048|454047695|FG000|Overall Study|Withdrawal by Subject|7|||
126207767|NCT03532048|454047696|FG001|Overall Study|Withdrawal by Subject|0|||
126207768|NCT01901393|454047699|FG000|Overall Study|Adverse Event|1|||
126207769|NCT01901393|454047700|FG001|Overall Study|Adverse Event|0|||
126207770|NCT04585906|454047701|FG000|Overall Study|Lost to Follow-up|8|||
126207771|NCT04585906|454047702|FG001|Overall Study|Lost to Follow-up|5|||
126207772|NCT00634933|454047707|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
126207773|NCT00634933|454047708|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
126207774|NCT00634933|454047709|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
126207775|NCT00634933|454047710|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
126207776|NCT00634933|454047711|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
126207777|NCT00634933|454047707|FG000|Part A: Baseline to Week 24|Death|1|||
126207778|NCT00634933|454047708|FG001|Part A: Baseline to Week 24|Death|0|||
126207779|NCT00634933|454047709|FG002|Part A: Baseline to Week 24|Death|0|||
126207780|NCT00634933|454047710|FG003|Part A: Baseline to Week 24|Death|0|||
126207781|NCT00634933|454047711|FG004|Part A: Baseline to Week 24|Death|0|||
126207782|NCT00634933|454047707|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
126207783|NCT00634933|454047708|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
126207784|NCT00634933|454047709|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
126207785|NCT00634933|454047710|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
126207786|NCT00634933|454047711|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
126207787|NCT00634933|454047707|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
126207788|NCT00634933|454047708|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
126207789|NCT00634933|454047709|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
126207790|NCT00634933|454047710|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
126207791|NCT00634933|454047711|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
126207792|NCT00634933|454047707|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
126207793|NCT00634933|454047708|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
126207794|NCT00634933|454047709|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
126207795|NCT00634933|454047710|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
126207796|NCT00634933|454047711|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
126207797|NCT00634933|454047707|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
126207798|NCT00634933|454047708|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
126207799|NCT00634933|454047709|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
126207800|NCT00634933|454047710|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
126207801|NCT00634933|454047711|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
126207802|NCT00634933|454047707|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
126207803|NCT00634933|454047708|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
126207804|NCT00634933|454047709|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
126207805|NCT00634933|454047710|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
126207806|NCT00634933|454047711|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
126207807|NCT00634933|454047707|FG000|Part A: Baseline to Week 24|Other|1|||
126207808|NCT00634933|454047708|FG001|Part A: Baseline to Week 24|Other|8|||
126207809|NCT00634933|454047709|FG002|Part A: Baseline to Week 24|Other|5|||
126207810|NCT00634933|454047710|FG003|Part A: Baseline to Week 24|Other|0|||
126207811|NCT00634933|454047711|FG004|Part A: Baseline to Week 24|Other|0|||
126207812|NCT00634933|454047707|FG000|Between Part A and Part B|Physician Decision|0|||
126207813|NCT00634933|454047708|FG001|Between Part A and Part B|Physician Decision|1|||
126207814|NCT00634933|454047709|FG002|Between Part A and Part B|Physician Decision|0|||
126207815|NCT00634933|454047710|FG003|Between Part A and Part B|Physician Decision|0|||
126207816|NCT00634933|454047711|FG004|Between Part A and Part B|Physician Decision|0|||
126207817|NCT00634933|454047707|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
126207818|NCT00634933|454047708|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
126207819|NCT00634933|454047709|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
126207820|NCT00634933|454047710|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
126207821|NCT00634933|454047711|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
126207822|NCT00634933|454047707|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
126207823|NCT00634933|454047708|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
126207824|NCT00634933|454047709|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
126207825|NCT00634933|454047710|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
126207826|NCT00634933|454047711|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
126207827|NCT00634933|454047707|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
126207828|NCT00634933|454047708|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
126207829|NCT00634933|454047709|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
126207830|NCT00634933|454047710|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
126207831|NCT00634933|454047711|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
126207832|NCT00634933|454047707|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
126207833|NCT00634933|454047708|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
126207834|NCT00634933|454047709|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
126207835|NCT00634933|454047710|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
126207836|NCT00634933|454047711|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
126207837|NCT00634933|454047707|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
126207838|NCT00634933|454047708|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
126207839|NCT00634933|454047709|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
126207840|NCT00634933|454047710|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
126207841|NCT00634933|454047711|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
126207842|NCT00634933|454047707|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
126207843|NCT00634933|454047708|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
126207844|NCT00634933|454047709|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
126207845|NCT00634933|454047710|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
126207846|NCT00634933|454047711|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
126207847|NCT00634933|454047707|FG000|Part B: Week 24 to Week 52|Other|0|||
126207848|NCT00634933|454047708|FG001|Part B: Week 24 to Week 52|Other|0|||
126207849|NCT00634933|454047709|FG002|Part B: Week 24 to Week 52|Other|5|||
126207850|NCT00634933|454047710|FG003|Part B: Week 24 to Week 52|Other|0|||
126207851|NCT00634933|454047711|FG004|Part B: Week 24 to Week 52|Other|1|||
126207852|NCT01049360|454047712|FG000|Period 1|Adverse Event|0|||
126207853|NCT01049360|454047713|FG001|Period 1|Adverse Event|1|||
126207854|NCT01049360|454047714|FG002|Period 1|Adverse Event|0|||
126207855|NCT01049360|454047715|FG003|Period 1|Adverse Event|1|||
126207856|NCT01049360|454047716|FG004|Period 1|Adverse Event|0|||
126207857|NCT01049360|454047717|FG005|Period 1|Adverse Event|0|||
126207858|NCT01049360|454047718|FG006|Period 1|Adverse Event|0|||
126207859|NCT01049360|454047719|FG007|Period 1|Adverse Event|1|||
126207860|NCT01049360|454047720|FG008|Period 1|Adverse Event|0|||
126207861|NCT01049360|454047721|FG009|Period 1|Adverse Event|0|||
126207862|NCT01049360|454047722|FG010|Period 1|Adverse Event|0|||
126207863|NCT01049360|454047723|FG011|Period 1|Adverse Event|0|||
126207864|NCT01049360|454047724|FG012|Period 1|Adverse Event|1|||
126207865|NCT01049360|454047725|FG013|Period 1|Adverse Event|1|||
126207866|NCT01049360|454047726|FG014|Period 1|Adverse Event|0|||
126207867|NCT01049360|454047727|FG015|Period 1|Adverse Event|0|||
126207868|NCT01049360|454047728|FG016|Period 1|Adverse Event|1|||
126207869|NCT01049360|454047729|FG017|Period 1|Adverse Event|0|||
126207870|NCT01049360|454047730|FG018|Period 1|Adverse Event|1|||
126207871|NCT01049360|454047731|FG019|Period 1|Adverse Event|0|||
126207872|NCT01049360|454047712|FG000|Period 1|Did not meet inc/exc criteria|0|||
126207873|NCT01049360|454047713|FG001|Period 1|Did not meet inc/exc criteria|0|||
126207874|NCT01049360|454047714|FG002|Period 1|Did not meet inc/exc criteria|0|||
126207875|NCT01049360|454047715|FG003|Period 1|Did not meet inc/exc criteria|0|||
126207876|NCT01049360|454047716|FG004|Period 1|Did not meet inc/exc criteria|0|||
126207877|NCT01049360|454047717|FG005|Period 1|Did not meet inc/exc criteria|0|||
126207878|NCT01049360|454047718|FG006|Period 1|Did not meet inc/exc criteria|0|||
126207879|NCT01049360|454047719|FG007|Period 1|Did not meet inc/exc criteria|1|||
126207880|NCT01049360|454047720|FG008|Period 1|Did not meet inc/exc criteria|1|||
126207881|NCT01049360|454047721|FG009|Period 1|Did not meet inc/exc criteria|0|||
126207882|NCT01049360|454047722|FG010|Period 1|Did not meet inc/exc criteria|0|||
126207883|NCT01049360|454047723|FG011|Period 1|Did not meet inc/exc criteria|0|||
126207884|NCT01049360|454047724|FG012|Period 1|Did not meet inc/exc criteria|0|||
126207885|NCT01049360|454047725|FG013|Period 1|Did not meet inc/exc criteria|0|||
126207886|NCT01049360|454047726|FG014|Period 1|Did not meet inc/exc criteria|0|||
126207887|NCT01049360|454047727|FG015|Period 1|Did not meet inc/exc criteria|0|||
126207888|NCT01049360|454047728|FG016|Period 1|Did not meet inc/exc criteria|0|||
126207889|NCT01049360|454047729|FG017|Period 1|Did not meet inc/exc criteria|0|||
126207890|NCT01049360|454047730|FG018|Period 1|Did not meet inc/exc criteria|0|||
126207891|NCT01049360|454047731|FG019|Period 1|Did not meet inc/exc criteria|0|||
126207892|NCT01049360|454047712|FG000|Period 1|Withdrawal by Subject|0|||
126207893|NCT01049360|454047713|FG001|Period 1|Withdrawal by Subject|0|||
126207894|NCT01049360|454047714|FG002|Period 1|Withdrawal by Subject|0|||
126207895|NCT01049360|454047715|FG003|Period 1|Withdrawal by Subject|0|||
126207896|NCT01049360|454047716|FG004|Period 1|Withdrawal by Subject|0|||
126207897|NCT01049360|454047717|FG005|Period 1|Withdrawal by Subject|0|||
126207898|NCT01049360|454047718|FG006|Period 1|Withdrawal by Subject|0|||
126207899|NCT01049360|454047719|FG007|Period 1|Withdrawal by Subject|0|||
126207900|NCT01049360|454047720|FG008|Period 1|Withdrawal by Subject|1|||
126207901|NCT01049360|454047721|FG009|Period 1|Withdrawal by Subject|0|||
126207902|NCT01049360|454047722|FG010|Period 1|Withdrawal by Subject|1|||
126207903|NCT01049360|454047723|FG011|Period 1|Withdrawal by Subject|0|||
126207904|NCT01049360|454047724|FG012|Period 1|Withdrawal by Subject|1|||
126207905|NCT01049360|454047725|FG013|Period 1|Withdrawal by Subject|0|||
126207906|NCT01049360|454047726|FG014|Period 1|Withdrawal by Subject|0|||
126207907|NCT01049360|454047727|FG015|Period 1|Withdrawal by Subject|0|||
126207908|NCT01049360|454047728|FG016|Period 1|Withdrawal by Subject|0|||
126207909|NCT01049360|454047729|FG017|Period 1|Withdrawal by Subject|0|||
126207910|NCT01049360|454047730|FG018|Period 1|Withdrawal by Subject|0|||
126207911|NCT01049360|454047731|FG019|Period 1|Withdrawal by Subject|0|||
126207912|NCT01049360|454047712|FG000|Period 2|Protocol Violation|0|||
126207913|NCT01049360|454047713|FG001|Period 2|Protocol Violation|0|||
126207914|NCT01049360|454047714|FG002|Period 2|Protocol Violation|0|||
126207915|NCT01049360|454047715|FG003|Period 2|Protocol Violation|1|||
126207916|NCT01049360|454047716|FG004|Period 2|Protocol Violation|0|||
126207917|NCT01049360|454047717|FG005|Period 2|Protocol Violation|0|||
126207918|NCT01049360|454047718|FG006|Period 2|Protocol Violation|0|||
126207919|NCT01049360|454047719|FG007|Period 2|Protocol Violation|0|||
126207920|NCT01049360|454047720|FG008|Period 2|Protocol Violation|0|||
126207921|NCT01049360|454047721|FG009|Period 2|Protocol Violation|0|||
126207922|NCT01049360|454047722|FG010|Period 2|Protocol Violation|0|||
126207923|NCT01049360|454047723|FG011|Period 2|Protocol Violation|0|||
126207924|NCT01049360|454047724|FG012|Period 2|Protocol Violation|0|||
126207925|NCT01049360|454047725|FG013|Period 2|Protocol Violation|0|||
126207926|NCT01049360|454047726|FG014|Period 2|Protocol Violation|1|||
126207927|NCT01049360|454047727|FG015|Period 2|Protocol Violation|1|||
126207928|NCT01049360|454047728|FG016|Period 2|Protocol Violation|0|||
126207929|NCT01049360|454047729|FG017|Period 2|Protocol Violation|0|||
126207930|NCT01049360|454047730|FG018|Period 2|Protocol Violation|0|||
126207931|NCT01049360|454047731|FG019|Period 2|Protocol Violation|0|||
126207932|NCT01049360|454047712|FG000|Period 2|Adverse Event|0|||
126207933|NCT01049360|454047713|FG001|Period 2|Adverse Event|1|||
126207934|NCT01049360|454047714|FG002|Period 2|Adverse Event|0|||
126207935|NCT01049360|454047715|FG003|Period 2|Adverse Event|0|||
126207936|NCT01049360|454047716|FG004|Period 2|Adverse Event|0|||
126207937|NCT01049360|454047717|FG005|Period 2|Adverse Event|0|||
126207938|NCT01049360|454047718|FG006|Period 2|Adverse Event|0|||
126207939|NCT01049360|454047719|FG007|Period 2|Adverse Event|0|||
126207940|NCT01049360|454047720|FG008|Period 2|Adverse Event|1|||
126207941|NCT01049360|454047721|FG009|Period 2|Adverse Event|0|||
126207942|NCT01049360|454047722|FG010|Period 2|Adverse Event|0|||
126207943|NCT01049360|454047723|FG011|Period 2|Adverse Event|0|||
126207944|NCT01049360|454047724|FG012|Period 2|Adverse Event|0|||
126207945|NCT01049360|454047725|FG013|Period 2|Adverse Event|0|||
126207946|NCT01049360|454047726|FG014|Period 2|Adverse Event|0|||
126207947|NCT01049360|454047727|FG015|Period 2|Adverse Event|0|||
126207948|NCT01049360|454047728|FG016|Period 2|Adverse Event|0|||
126207949|NCT01049360|454047729|FG017|Period 2|Adverse Event|0|||
126207950|NCT01049360|454047730|FG018|Period 2|Adverse Event|0|||
126207951|NCT01049360|454047731|FG019|Period 2|Adverse Event|1|||
126207952|NCT01049360|454047712|FG000|Period 2|Withdrawal by Subject|0|||
126207953|NCT01049360|454047713|FG001|Period 2|Withdrawal by Subject|0|||
126207954|NCT01049360|454047714|FG002|Period 2|Withdrawal by Subject|0|||
126313967|NCT00197002|454440759|FG002|Overall Study|Withdrawal by Subject|7|||
126313968|NCT00197002|454440757|FG000|Overall Study|Migrated/moved from study area|3|||
126313969|NCT00197002|454440758|FG001|Overall Study|Migrated/moved from study area|5|||
126313970|NCT00197002|454440759|FG002|Overall Study|Migrated/moved from study area|1|||
126313971|NCT00197002|454440757|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
126313972|NCT00197002|454440758|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
126313973|NCT00197002|454440759|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
126313974|NCT00197002|454440757|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
126313975|NCT00197002|454440758|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
126313976|NCT00197002|454440759|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
126313977|NCT00197002|454440757|FG000|Overall Study|Others|3|||
126313978|NCT00197002|454440758|FG001|Overall Study|Others|1|||
126313979|NCT00197002|454440759|FG002|Overall Study|Others|1|||
126313980|NCT02017717|454440760|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313981|NCT02017717|454440761|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313982|NCT02017717|454440762|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313983|NCT02017717|454440763|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313984|NCT02017717|454440764|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313985|NCT02017717|454440765|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313986|NCT02017717|454440766|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313987|NCT02017717|454440767|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
126313988|NCT02017717|454440768|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313989|NCT02017717|454440760|FG000|Before Treatment Period|Participant request to stop therapy|0|||
126313990|NCT02017717|454440761|FG001|Before Treatment Period|Participant request to stop therapy|0|||
126313991|NCT02017717|454440762|FG002|Before Treatment Period|Participant request to stop therapy|0|||
126313992|NCT02017717|454440763|FG003|Before Treatment Period|Participant request to stop therapy|0|||
126313993|NCT02017717|454440764|FG004|Before Treatment Period|Participant request to stop therapy|0|||
126313994|NCT02017717|454440765|FG005|Before Treatment Period|Participant request to stop therapy|0|||
126313995|NCT02017717|454440766|FG006|Before Treatment Period|Participant request to stop therapy|0|||
126313996|NCT02017717|454440767|FG007|Before Treatment Period|Participant request to stop therapy|0|||
126313997|NCT02017717|454440768|FG008|Before Treatment Period|Participant request to stop therapy|5|||
126090439|NCT03635099|453623562|FG004|Period 2|Withdrawal by Subject|7|||
126207955|NCT01049360|454047715|FG003|Period 2|Withdrawal by Subject|1|||
126207956|NCT01049360|454047716|FG004|Period 2|Withdrawal by Subject|0|||
126207957|NCT01049360|454047717|FG005|Period 2|Withdrawal by Subject|0|||
126207958|NCT01049360|454047718|FG006|Period 2|Withdrawal by Subject|0|||
126207959|NCT01049360|454047719|FG007|Period 2|Withdrawal by Subject|0|||
126207960|NCT01049360|454047720|FG008|Period 2|Withdrawal by Subject|0|||
126207961|NCT01049360|454047721|FG009|Period 2|Withdrawal by Subject|0|||
126207962|NCT01049360|454047722|FG010|Period 2|Withdrawal by Subject|0|||
126207963|NCT01049360|454047723|FG011|Period 2|Withdrawal by Subject|0|||
126207964|NCT01049360|454047724|FG012|Period 2|Withdrawal by Subject|0|||
126207965|NCT01049360|454047725|FG013|Period 2|Withdrawal by Subject|0|||
126207966|NCT01049360|454047726|FG014|Period 2|Withdrawal by Subject|1|||
126207967|NCT01049360|454047727|FG015|Period 2|Withdrawal by Subject|0|||
126207968|NCT01049360|454047728|FG016|Period 2|Withdrawal by Subject|0|||
126207969|NCT01049360|454047729|FG017|Period 2|Withdrawal by Subject|0|||
126207970|NCT01049360|454047730|FG018|Period 2|Withdrawal by Subject|0|||
126207971|NCT01049360|454047731|FG019|Period 2|Withdrawal by Subject|1|||
126207972|NCT01049360|454047712|FG000|Period 2|Lack of Efficacy|0|||
126207973|NCT01049360|454047713|FG001|Period 2|Lack of Efficacy|0|||
126207974|NCT01049360|454047714|FG002|Period 2|Lack of Efficacy|0|||
126207975|NCT01049360|454047715|FG003|Period 2|Lack of Efficacy|0|||
126207976|NCT01049360|454047716|FG004|Period 2|Lack of Efficacy|0|||
126207977|NCT01049360|454047717|FG005|Period 2|Lack of Efficacy|1|||
126207978|NCT01049360|454047718|FG006|Period 2|Lack of Efficacy|0|||
126207979|NCT01049360|454047719|FG007|Period 2|Lack of Efficacy|0|||
126207980|NCT01049360|454047720|FG008|Period 2|Lack of Efficacy|0|||
126207981|NCT01049360|454047721|FG009|Period 2|Lack of Efficacy|0|||
126207982|NCT01049360|454047722|FG010|Period 2|Lack of Efficacy|0|||
126207983|NCT01049360|454047723|FG011|Period 2|Lack of Efficacy|0|||
126207984|NCT01049360|454047724|FG012|Period 2|Lack of Efficacy|0|||
126207985|NCT01049360|454047725|FG013|Period 2|Lack of Efficacy|0|||
126207986|NCT01049360|454047726|FG014|Period 2|Lack of Efficacy|0|||
126207987|NCT01049360|454047727|FG015|Period 2|Lack of Efficacy|0|||
126207988|NCT01049360|454047728|FG016|Period 2|Lack of Efficacy|0|||
126207989|NCT01049360|454047729|FG017|Period 2|Lack of Efficacy|0|||
126207990|NCT01049360|454047730|FG018|Period 2|Lack of Efficacy|0|||
126207991|NCT01049360|454047731|FG019|Period 2|Lack of Efficacy|0|||
126207992|NCT01049360|454047712|FG000|Period 4|Protocol Violation|0|||
126207993|NCT01049360|454047713|FG001|Period 4|Protocol Violation|0|||
126207994|NCT01049360|454047714|FG002|Period 4|Protocol Violation|0|||
126207995|NCT01049360|454047715|FG003|Period 4|Protocol Violation|0|||
126207996|NCT01049360|454047716|FG004|Period 4|Protocol Violation|0|||
126207997|NCT01049360|454047717|FG005|Period 4|Protocol Violation|0|||
126207998|NCT01049360|454047718|FG006|Period 4|Protocol Violation|0|||
126207999|NCT01049360|454047719|FG007|Period 4|Protocol Violation|0|||
126208000|NCT01049360|454047720|FG008|Period 4|Protocol Violation|0|||
126208001|NCT01049360|454047721|FG009|Period 4|Protocol Violation|0|||
126208002|NCT01049360|454047722|FG010|Period 4|Protocol Violation|0|||
126208003|NCT01049360|454047723|FG011|Period 4|Protocol Violation|0|||
126208004|NCT01049360|454047724|FG012|Period 4|Protocol Violation|0|||
126208005|NCT01049360|454047725|FG013|Period 4|Protocol Violation|0|||
126208006|NCT01049360|454047726|FG014|Period 4|Protocol Violation|0|||
126208007|NCT01049360|454047727|FG015|Period 4|Protocol Violation|0|||
126208008|NCT01049360|454047728|FG016|Period 4|Protocol Violation|0|||
126208009|NCT01049360|454047729|FG017|Period 4|Protocol Violation|1|||
126208010|NCT01049360|454047730|FG018|Period 4|Protocol Violation|0|||
126208011|NCT01049360|454047731|FG019|Period 4|Protocol Violation|0|||
126208012|NCT01049360|454047712|FG000|Period 4|Withdrawal by Subject|0|||
126208013|NCT01049360|454047713|FG001|Period 4|Withdrawal by Subject|0|||
126208014|NCT01049360|454047714|FG002|Period 4|Withdrawal by Subject|0|||
126208015|NCT01049360|454047715|FG003|Period 4|Withdrawal by Subject|1|||
126208016|NCT01049360|454047716|FG004|Period 4|Withdrawal by Subject|0|||
126208017|NCT01049360|454047717|FG005|Period 4|Withdrawal by Subject|0|||
126208018|NCT01049360|454047718|FG006|Period 4|Withdrawal by Subject|0|||
126208019|NCT01049360|454047719|FG007|Period 4|Withdrawal by Subject|0|||
126208020|NCT01049360|454047720|FG008|Period 4|Withdrawal by Subject|0|||
126208021|NCT01049360|454047721|FG009|Period 4|Withdrawal by Subject|0|||
126208022|NCT01049360|454047722|FG010|Period 4|Withdrawal by Subject|0|||
126208023|NCT01049360|454047723|FG011|Period 4|Withdrawal by Subject|0|||
126208024|NCT01049360|454047724|FG012|Period 4|Withdrawal by Subject|0|||
126208025|NCT01049360|454047725|FG013|Period 4|Withdrawal by Subject|0|||
126208026|NCT01049360|454047726|FG014|Period 4|Withdrawal by Subject|0|||
126208027|NCT01049360|454047727|FG015|Period 4|Withdrawal by Subject|0|||
126208028|NCT01049360|454047728|FG016|Period 4|Withdrawal by Subject|0|||
126208029|NCT01049360|454047729|FG017|Period 4|Withdrawal by Subject|0|||
126208030|NCT01049360|454047730|FG018|Period 4|Withdrawal by Subject|0|||
126208031|NCT01049360|454047731|FG019|Period 4|Withdrawal by Subject|0|||
126208032|NCT01694849|454047732|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
126208033|NCT01694849|454047733|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
126208034|NCT01694849|454047734|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
126208035|NCT01694849|454047732|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
126208036|NCT01694849|454047733|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
126208037|NCT01694849|454047734|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
126208038|NCT01694849|454047732|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
126208039|NCT01694849|454047733|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
126208040|NCT01694849|454047734|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
126208041|NCT01694849|454047732|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
126208042|NCT01694849|454047733|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
126208043|NCT01694849|454047734|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
126208044|NCT01694849|454047732|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
126208045|NCT01694849|454047733|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
126208046|NCT01694849|454047734|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
126208047|NCT01694849|454047732|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
126208048|NCT01694849|454047733|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
126208049|NCT01694849|454047734|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
126208050|NCT01694849|454047732|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
126208051|NCT01694849|454047733|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
126208052|NCT01694849|454047734|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
126208053|NCT01694849|454047732|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
126208054|NCT01694849|454047733|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
126208055|NCT01694849|454047734|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
126208056|NCT00596466|454047737|FG000|Overall Study|Lack of Efficacy|5|||
126208057|NCT00596466|454047737|FG000|Overall Study|Adverse Event|4|||
126208058|NCT00596466|454047737|FG000|Overall Study|Withdrawal by Subject|2|||
126208059|NCT00596466|454047737|FG000|Overall Study|Protocol Violation|2|||
126208060|NCT00596466|454047737|FG000|Overall Study|Unpecified|2|||
126208061|NCT00596466|454047737|FG000|Overall Study|Enrolled, not treated|2|||
126208062|NCT00908375|454047738|FG000|Overall Study|Withdrawal by Subject|2|||
126208063|NCT00908375|454047739|FG001|Overall Study|Withdrawal by Subject|4|||
126208064|NCT00908375|454047738|FG000|Overall Study|Lost to Follow-up|8|||
126208065|NCT00908375|454047739|FG001|Overall Study|Lost to Follow-up|6|||
126208066|NCT00752206|454047740|FG000|Overall Study|Disease progression|8|||
126208067|NCT00752206|454047741|FG001|Overall Study|Disease progression|11|||
126313998|NCT02017717|454440760|FG000|Before Treatment Period|Participant withdrew consent|0|||
126313999|NCT02017717|454440761|FG001|Before Treatment Period|Participant withdrew consent|0|||
126314000|NCT02017717|454440762|FG002|Before Treatment Period|Participant withdrew consent|0|||
126314001|NCT02017717|454440763|FG003|Before Treatment Period|Participant withdrew consent|0|||
126314002|NCT02017717|454440764|FG004|Before Treatment Period|Participant withdrew consent|0|||
126314003|NCT02017717|454440765|FG005|Before Treatment Period|Participant withdrew consent|0|||
126314004|NCT02017717|454440766|FG006|Before Treatment Period|Participant withdrew consent|2|||
126314005|NCT02017717|454440767|FG007|Before Treatment Period|Participant withdrew consent|0|||
126314006|NCT02017717|454440768|FG008|Before Treatment Period|Participant withdrew consent|11|||
126314007|NCT02017717|454440760|FG000|Before Treatment Period|Lost to Follow-up|0|||
126314008|NCT02017717|454440761|FG001|Before Treatment Period|Lost to Follow-up|0|||
126314009|NCT02017717|454440762|FG002|Before Treatment Period|Lost to Follow-up|0|||
126314010|NCT02017717|454440763|FG003|Before Treatment Period|Lost to Follow-up|0|||
126314011|NCT02017717|454440764|FG004|Before Treatment Period|Lost to Follow-up|0|||
126208068|NCT00752206|454047740|FG000|Overall Study|Pregnancy|1|||
126208069|NCT00752206|454047741|FG001|Overall Study|Pregnancy|0|||
126208070|NCT00678652|454047742|FG000|Overall Study|Protocol Violation|2|||
126208071|NCT00678652|454047743|FG001|Overall Study|Protocol Violation|0|||
126208072|NCT00678652|454047744|FG002|Overall Study|Protocol Violation|0|||
126208073|NCT00678652|454047745|FG003|Overall Study|Protocol Violation|0|||
126208074|NCT00678652|454047742|FG000|Overall Study|Pregnancy|0|||
126208075|NCT00678652|454047743|FG001|Overall Study|Pregnancy|0|||
126208076|NCT00678652|454047744|FG002|Overall Study|Pregnancy|1|||
126208077|NCT00678652|454047745|FG003|Overall Study|Pregnancy|0|||
126208078|NCT00678652|454047742|FG000|Overall Study|Relocation|1|||
126208079|NCT00678652|454047743|FG001|Overall Study|Relocation|0|||
126314012|NCT02017717|454440765|FG005|Before Treatment Period|Lost to Follow-up|0|||
126314013|NCT02017717|454440766|FG006|Before Treatment Period|Lost to Follow-up|0|||
126314014|NCT02017717|454440767|FG007|Before Treatment Period|Lost to Follow-up|0|||
126314015|NCT02017717|454440768|FG008|Before Treatment Period|Lost to Follow-up|1|||
126314016|NCT02017717|454440760|FG000|Before Treatment Period|Participant no longer met criteria|0|||
126314017|NCT02017717|454440761|FG001|Before Treatment Period|Participant no longer met criteria|0|||
126314018|NCT02017717|454440762|FG002|Before Treatment Period|Participant no longer met criteria|0|||
126208080|NCT00678652|454047744|FG002|Overall Study|Relocation|0|||
126208081|NCT00678652|454047745|FG003|Overall Study|Relocation|0|||
126208082|NCT01013207|454049293|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
126208083|NCT04196023|454049300|FG000|Overall Study|Withdrawal by Subject|0|||
126208084|NCT04196023|454049301|FG001|Overall Study|Withdrawal by Subject|1|||
126208085|NCT04196023|454049300|FG000|Overall Study|Adverse Event|3|||
126208086|NCT04196023|454049301|FG001|Overall Study|Adverse Event|1|||
126208087|NCT04196023|454049300|FG000|Overall Study|Lost to Follow-up|0|||
126208088|NCT04196023|454049301|FG001|Overall Study|Lost to Follow-up|1|||
126208089|NCT03358407|454049302|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208090|NCT03358407|454049303|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208091|NCT03358407|454049304|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
126208092|NCT03358407|454049305|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208093|NCT03358407|454049306|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208094|NCT03358407|454049307|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208095|NCT03358407|454049308|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208096|NCT03358407|454049309|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208097|NCT03358407|454049310|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208098|NCT03358407|454049311|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126208099|NCT03358407|454049302|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208100|NCT03358407|454049303|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208101|NCT03358407|454049304|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208102|NCT03358407|454049305|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208103|NCT03358407|454049306|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
126208104|NCT03358407|454049307|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208105|NCT03358407|454049308|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208106|NCT03358407|454049309|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208107|NCT03358407|454049310|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208108|NCT03358407|454049311|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208109|NCT03358407|454049302|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126208110|NCT03358407|454049303|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126208111|NCT03358407|454049304|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126208112|NCT03358407|454049305|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126208113|NCT03358407|454049306|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126208114|NCT03358407|454049307|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
126208115|NCT03358407|454049308|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126208116|NCT03358407|454049309|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
126208117|NCT03358407|454049310|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126208118|NCT03358407|454049311|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126208119|NCT03358407|454049302|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126208120|NCT03358407|454049303|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126208121|NCT03358407|454049304|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126208122|NCT03358407|454049305|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126208123|NCT03358407|454049306|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126208124|NCT03358407|454049307|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
126208125|NCT03358407|454049308|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126208126|NCT03358407|454049309|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
126208127|NCT03358407|454049310|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126208128|NCT03358407|454049311|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126208129|NCT03358407|454049302|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208130|NCT03358407|454049303|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208131|NCT03358407|454049304|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208132|NCT03358407|454049305|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208133|NCT03358407|454049306|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208134|NCT03358407|454049307|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
126208135|NCT03358407|454049308|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
126208136|NCT03358407|454049309|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208137|NCT03358407|454049310|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208138|NCT03358407|454049311|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126208139|NCT03358407|454049302|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126208140|NCT03358407|454049303|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126208141|NCT03358407|454049304|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126208142|NCT03358407|454049305|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126208143|NCT03358407|454049306|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126208144|NCT03358407|454049307|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
126208145|NCT03358407|454049308|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
126208146|NCT03358407|454049309|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
126208147|NCT03358407|454049310|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126208148|NCT03358407|454049311|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126208149|NCT03605758|454049312|FG000|Overall Study|Lost to Follow-up|2|||
126208150|NCT03605758|454049313|FG001|Overall Study|Lost to Follow-up|1|||
126314019|NCT02017717|454440763|FG003|Before Treatment Period|Participant no longer met criteria|0|||
126314020|NCT02017717|454440764|FG004|Before Treatment Period|Participant no longer met criteria|0|||
126314021|NCT02017717|454440765|FG005|Before Treatment Period|Participant no longer met criteria|1|||
126314022|NCT02017717|454440766|FG006|Before Treatment Period|Participant no longer met criteria|0|||
126314023|NCT02017717|454440767|FG007|Before Treatment Period|Participant no longer met criteria|1|||
126314024|NCT02017717|454440768|FG008|Before Treatment Period|Participant no longer met criteria|2|||
126314025|NCT02017717|454440760|FG000|Before Treatment Period|other reason|0|||
126314026|NCT02017717|454440761|FG001|Before Treatment Period|other reason|0|||
126314027|NCT02017717|454440762|FG002|Before Treatment Period|other reason|0|||
126314028|NCT02017717|454440763|FG003|Before Treatment Period|other reason|0|||
126314029|NCT02017717|454440764|FG004|Before Treatment Period|other reason|0|||
126314030|NCT02017717|454440765|FG005|Before Treatment Period|other reason|0|||
126314031|NCT02017717|454440766|FG006|Before Treatment Period|other reason|0|||
126314032|NCT02017717|454440767|FG007|Before Treatment Period|other reason|0|||
126314033|NCT02017717|454440768|FG008|Before Treatment Period|other reason|1|||
126314034|NCT02017717|454440760|FG000|Treatment Period|Disease progression|7|||
126314035|NCT02017717|454440761|FG001|Treatment Period|Disease progression|9|||
126314036|NCT02017717|454440762|FG002|Treatment Period|Disease progression|12|||
126208151|NCT03605758|454049312|FG000|Overall Study|Illness|0|||
126208152|NCT03605758|454049313|FG001|Overall Study|Illness|1|||
126208153|NCT03605758|454049312|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
126208154|NCT03605758|454049313|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
126208155|NCT00489411|454049314|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
126208156|NCT00489411|454049315|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
126208157|NCT00489411|454049314|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
126208158|NCT00489411|454049315|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
126208159|NCT00489411|454049314|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
126208160|NCT00489411|454049315|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
126208161|NCT00489411|454049314|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
126208162|NCT00489411|454049315|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
126208163|NCT00489411|454049314|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
126208164|NCT00489411|454049315|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
126208165|NCT01283009|454049316|FG000|Overall Study|Death|83|||
126208166|NCT01283009|454049317|FG001|Overall Study|Death|78|||
126208167|NCT01283009|454049316|FG000|Overall Study|Study ended early|23|||
126208168|NCT01283009|454049317|FG001|Overall Study|Study ended early|26|||
126208169|NCT01283009|454049316|FG000|Overall Study|Withdrawal by Subject|10|||
126208170|NCT01283009|454049317|FG001|Overall Study|Withdrawal by Subject|8|||
126208171|NCT01283009|454049316|FG000|Overall Study|Physician Decision|1|||
126208172|NCT01283009|454049317|FG001|Overall Study|Physician Decision|1|||
126208173|NCT01283009|454049316|FG000|Overall Study|Lost to Follow-up|1|||
126208174|NCT01283009|454049317|FG001|Overall Study|Lost to Follow-up|0|||
126208175|NCT01283009|454049316|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
126208176|NCT01283009|454049317|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
126314037|NCT02017717|454440763|FG003|Treatment Period|Disease progression|20|||
126314038|NCT02017717|454440764|FG004|Treatment Period|Disease progression|26|||
126314039|NCT02017717|454440765|FG005|Treatment Period|Disease progression|16|||
126314040|NCT02017717|454440766|FG006|Treatment Period|Disease progression|22|||
126314041|NCT02017717|454440767|FG007|Treatment Period|Disease progression|165|||
126314042|NCT02017717|454440768|FG008|Treatment Period|Disease progression|135|||
126314043|NCT02017717|454440760|FG000|Treatment Period|Study drug toxicity|3|||
126314044|NCT02017717|454440761|FG001|Treatment Period|Study drug toxicity|0|||
126314045|NCT02017717|454440762|FG002|Treatment Period|Study drug toxicity|1|||
126314046|NCT02017717|454440763|FG003|Treatment Period|Study drug toxicity|4|||
126314047|NCT02017717|454440764|FG004|Treatment Period|Study drug toxicity|4|||
126314048|NCT02017717|454440765|FG005|Treatment Period|Study drug toxicity|5|||
126314049|NCT02017717|454440766|FG006|Treatment Period|Study drug toxicity|3|||
126314050|NCT02017717|454440767|FG007|Treatment Period|Study drug toxicity|7|||
126314051|NCT02017717|454440768|FG008|Treatment Period|Study drug toxicity|11|||
126314052|NCT02017717|454440760|FG000|Treatment Period|Death|0|||
126314053|NCT02017717|454440761|FG001|Treatment Period|Death|0|||
126314054|NCT02017717|454440762|FG002|Treatment Period|Death|1|||
126314055|NCT02017717|454440763|FG003|Treatment Period|Death|0|||
126314056|NCT02017717|454440764|FG004|Treatment Period|Death|0|||
126314057|NCT02017717|454440765|FG005|Treatment Period|Death|2|||
126314058|NCT02017717|454440766|FG006|Treatment Period|Death|0|||
126314059|NCT02017717|454440767|FG007|Treatment Period|Death|0|||
126314060|NCT02017717|454440768|FG008|Treatment Period|Death|0|||
126314061|NCT02017717|454440760|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
126314062|NCT02017717|454440761|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
126314063|NCT02017717|454440762|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
126314064|NCT02017717|454440763|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
126314065|NCT02017717|454440764|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
126314066|NCT02017717|454440765|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
126314067|NCT02017717|454440766|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
126314068|NCT02017717|454440767|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
126314069|NCT02017717|454440768|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
126314070|NCT02017717|454440760|FG000|Treatment Period|Participant request to stop therapy|0|||
126314071|NCT02017717|454440761|FG001|Treatment Period|Participant request to stop therapy|0|||
126314072|NCT02017717|454440762|FG002|Treatment Period|Participant request to stop therapy|3|||
126314073|NCT02017717|454440763|FG003|Treatment Period|Participant request to stop therapy|6|||
126314074|NCT02017717|454440764|FG004|Treatment Period|Participant request to stop therapy|0|||
126314075|NCT02017717|454440765|FG005|Treatment Period|Participant request to stop therapy|2|||
126314076|NCT02017717|454440766|FG006|Treatment Period|Participant request to stop therapy|1|||
126314077|NCT02017717|454440767|FG007|Treatment Period|Participant request to stop therapy|4|||
126314078|NCT02017717|454440768|FG008|Treatment Period|Participant request to stop therapy|7|||
126314079|NCT02017717|454440760|FG000|Treatment Period|Participant withdrew consent|0|||
126208177|NCT05770401|454049323|FG000|Overall Study|Lost to Follow-up|5|||
126208178|NCT05770401|454049324|FG001|Overall Study|Lost to Follow-up|4|||
126208179|NCT00402298|454049325|FG000|Overall Study|Withdrawal by Subject|1|||
126314080|NCT02017717|454440761|FG001|Treatment Period|Participant withdrew consent|0|||
126314081|NCT02017717|454440762|FG002|Treatment Period|Participant withdrew consent|1|||
126314082|NCT02017717|454440763|FG003|Treatment Period|Participant withdrew consent|0|||
126314083|NCT02017717|454440764|FG004|Treatment Period|Participant withdrew consent|0|||
126314084|NCT02017717|454440765|FG005|Treatment Period|Participant withdrew consent|2|||
126314085|NCT02017717|454440766|FG006|Treatment Period|Participant withdrew consent|0|||
126314086|NCT02017717|454440767|FG007|Treatment Period|Participant withdrew consent|1|||
126314087|NCT02017717|454440768|FG008|Treatment Period|Participant withdrew consent|4|||
126314088|NCT02017717|454440760|FG000|Treatment Period|Participant no longer met criteria|0|||
126314089|NCT02017717|454440761|FG001|Treatment Period|Participant no longer met criteria|0|||
126314090|NCT02017717|454440762|FG002|Treatment Period|Participant no longer met criteria|0|||
126314091|NCT02017717|454440763|FG003|Treatment Period|Participant no longer met criteria|0|||
126314092|NCT02017717|454440764|FG004|Treatment Period|Participant no longer met criteria|0|||
126314093|NCT02017717|454440765|FG005|Treatment Period|Participant no longer met criteria|0|||
126314094|NCT02017717|454440766|FG006|Treatment Period|Participant no longer met criteria|0|||
126208180|NCT00402298|454049326|FG001|Overall Study|Withdrawal by Subject|0|||
126208181|NCT00480077|454049327|FG000|Overall Study|Death|19|||
126208182|NCT00480077|454049328|FG001|Overall Study|Death|15|||
126208183|NCT00480077|454049327|FG000|Overall Study|early exit|12|||
126208184|NCT00480077|454049328|FG001|Overall Study|early exit|11|||
126208185|NCT04784455|454049329|FG000|Overall Study|Death|4|||
126208186|NCT04298229|454049334|FG000|Overall Study|Physician Decision|1|||
126208187|NCT04298229|454049335|FG001|Overall Study|Physician Decision|1|||
126208188|NCT04298229|454049334|FG000|Overall Study|Withdrawal by Subject|1|||
126208189|NCT04298229|454049335|FG001|Overall Study|Withdrawal by Subject|1|||
126314095|NCT02017717|454440767|FG007|Treatment Period|Participant no longer met criteria|0|||
126314096|NCT02017717|454440768|FG008|Treatment Period|Participant no longer met criteria|1|||
126314097|NCT02017717|454440760|FG000|Treatment Period|Other reasons|0|||
126314098|NCT02017717|454440761|FG001|Treatment Period|Other reasons|0|||
126314099|NCT02017717|454440762|FG002|Treatment Period|Other reasons|0|||
126314100|NCT02017717|454440763|FG003|Treatment Period|Other reasons|1|||
126314101|NCT02017717|454440764|FG004|Treatment Period|Other reasons|0|||
126314102|NCT02017717|454440765|FG005|Treatment Period|Other reasons|1|||
126314103|NCT02017717|454440766|FG006|Treatment Period|Other reasons|1|||
126314104|NCT02017717|454440767|FG007|Treatment Period|Other reasons|1|||
126314105|NCT02017717|454440768|FG008|Treatment Period|Other reasons|1|||
126314106|NCT02017717|454440760|FG000|Treatment Period|Maximum clinical benefit|0|||
126314107|NCT02017717|454440761|FG001|Treatment Period|Maximum clinical benefit|0|||
126314108|NCT02017717|454440762|FG002|Treatment Period|Maximum clinical benefit|0|||
126314109|NCT02017717|454440763|FG003|Treatment Period|Maximum clinical benefit|0|||
126314110|NCT02017717|454440764|FG004|Treatment Period|Maximum clinical benefit|0|||
126314111|NCT02017717|454440765|FG005|Treatment Period|Maximum clinical benefit|0|||
126314112|NCT02017717|454440766|FG006|Treatment Period|Maximum clinical benefit|0|||
126314113|NCT02017717|454440767|FG007|Treatment Period|Maximum clinical benefit|0|||
126314114|NCT02017717|454440768|FG008|Treatment Period|Maximum clinical benefit|1|||
126314115|NCT02017717|454440760|FG000|Treatment Period|Not reported|0|||
126314116|NCT02017717|454440761|FG001|Treatment Period|Not reported|1|||
126314117|NCT02017717|454440762|FG002|Treatment Period|Not reported|0|||
126314118|NCT02017717|454440763|FG003|Treatment Period|Not reported|0|||
126314119|NCT02017717|454440764|FG004|Treatment Period|Not reported|0|||
126314120|NCT02017717|454440765|FG005|Treatment Period|Not reported|0|||
126314121|NCT02017717|454440766|FG006|Treatment Period|Not reported|0|||
126314122|NCT02017717|454440767|FG007|Treatment Period|Not reported|0|||
126314123|NCT02017717|454440768|FG008|Treatment Period|Not reported|0|||
126314124|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
126314125|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
126314126|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
126314127|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
126314128|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
126314129|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
126314130|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
126314131|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
126314132|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
126314133|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
126314134|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
126314135|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
126314136|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
126314137|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
126314138|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
126208190|NCT04298229|454049334|FG000|Overall Study|Did not receive IV loop diuretics|2|||
126208191|NCT04298229|454049335|FG001|Overall Study|Did not receive IV loop diuretics|0|||
126208192|NCT00262119|454049337|FG000|Overall Study|Lost to Follow-up|38|||
126208193|NCT00262119|454049338|FG001|Overall Study|Lost to Follow-up|51|||
126208194|NCT00262119|454049339|FG002|Overall Study|Lost to Follow-up|42|||
126208195|NCT00262119|454049337|FG000|Overall Study|Death|20|||
126208196|NCT00262119|454049338|FG001|Overall Study|Death|19|||
126208197|NCT00262119|454049339|FG002|Overall Study|Death|16|||
126208198|NCT01683565|454049340|FG000|Overall Study|Lost to Follow-up|2|||
126208199|NCT01683565|454049341|FG001|Overall Study|Lost to Follow-up|0|||
126208200|NCT01683565|454049340|FG000|Overall Study|Discontinued Intervention|1|||
126208201|NCT01683565|454049341|FG001|Overall Study|Discontinued Intervention|1|||
126208202|NCT00859313|454049342|FG000|Overall Study|Lack of Efficacy|2|||
126208203|NCT00859313|454049342|FG000|Overall Study|Adverse Event|1|||
126208204|NCT00859313|454049342|FG000|Overall Study|staff error|1|||
126208205|NCT00071006|454049343|FG000|Overall Study|Lack of Efficacy|7|||
126208206|NCT00071006|454049343|FG000|Overall Study|Adverse Event|1|||
126208207|NCT00071006|454049343|FG000|Overall Study|Withdrawal by Subject|1|||
126208208|NCT00071006|454049343|FG000|Overall Study|Other|3|||
126208209|NCT05261126|454049344|FG000|Overall Study|Death|0|||
126208210|NCT05261126|454049345|FG001|Overall Study|Death|0|||
126208211|NCT05261126|454049346|FG002|Overall Study|Death|1|||
126208212|NCT05261126|454049347|FG003|Overall Study|Death|0|||
126208213|NCT05261126|454049348|FG004|Overall Study|Death|0|||
126208214|NCT05261126|454049344|FG000|Overall Study|Lost to Follow-up|0|||
126208215|NCT05261126|454049345|FG001|Overall Study|Lost to Follow-up|0|||
126208216|NCT05261126|454049346|FG002|Overall Study|Lost to Follow-up|0|||
126314139|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
126314140|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
126314141|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
126314142|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
126314143|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
126314144|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
126314145|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
126314146|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
126314147|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
126314148|NCT04488419|454440773|FG000|Primary Analysis Population|Adverse Event|6|||
126314149|NCT04488419|454440774|FG001|Primary Analysis Population|Adverse Event|9|||
126314150|NCT04488419|454440775|FG002|Primary Analysis Population|Adverse Event|0|||
126314151|NCT04488419|454440773|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
126314152|NCT04488419|454440774|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
126314153|NCT04488419|454440775|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
126314154|NCT04488419|454440773|FG000|Primary Analysis Population|Protocol Violation|1|||
126314155|NCT04488419|454440774|FG001|Primary Analysis Population|Protocol Violation|1|||
126314156|NCT04488419|454440775|FG002|Primary Analysis Population|Protocol Violation|0|||
126314157|NCT04488419|454440773|FG000|Primary Analysis Population|Undetermined|7|||
126314158|NCT04488419|454440774|FG001|Primary Analysis Population|Undetermined|3|||
126314159|NCT04488419|454440775|FG002|Primary Analysis Population|Undetermined|0|||
126314160|NCT04488419|454440773|FG000|Primary Analysis Population|>1 Reason|2|||
126314161|NCT04488419|454440774|FG001|Primary Analysis Population|>1 Reason|4|||
126314162|NCT04488419|454440775|FG002|Primary Analysis Population|>1 Reason|0|||
126314163|NCT02276053|454440778|FG000|Overall Study|Death|2|||
126314164|NCT02276053|454440778|FG000|Overall Study|Adverse Event|5|||
126314165|NCT02276053|454440778|FG000|Overall Study|Lack of Efficacy|2|||
126314166|NCT02276053|454440778|FG000|Overall Study|Withdrawal by Subject|1|||
126314167|NCT02276053|454440778|FG000|Overall Study|Patient does not meet selection criteria|3|||
126314168|NCT02276053|454440778|FG000|Overall Study|Patient needs to increase baseline AED|1|||
126314169|NCT04542499|454440781|FG000|Overall Study|Adverse Event|23|||
126314170|NCT04542499|454440782|FG001|Overall Study|Adverse Event|43|||
126314171|NCT04542499|454440781|FG000|Overall Study|Lack of Efficacy|5|||
126314172|NCT04542499|454440782|FG001|Overall Study|Lack of Efficacy|2|||
126314173|NCT04542499|454440781|FG000|Overall Study|Lost to Follow-up|3|||
126314174|NCT04542499|454440782|FG001|Overall Study|Lost to Follow-up|4|||
126314175|NCT04542499|454440781|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
126314176|NCT04542499|454440782|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
126090440|NCT03635099|453623563|FG005|Period 2|Withdrawal by Subject|0|||
126314177|NCT04542499|454440781|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
126314178|NCT04542499|454440782|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
126314179|NCT04542499|454440781|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126314180|NCT04542499|454440782|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126314181|NCT04542499|454440781|FG000|Overall Study|Physician Decision|0|||
126314182|NCT04542499|454440782|FG001|Overall Study|Physician Decision|1|||
126314183|NCT04542499|454440781|FG000|Overall Study|Site Terminated by Sponsor|3|||
126314184|NCT04542499|454440782|FG001|Overall Study|Site Terminated by Sponsor|5|||
126314185|NCT04542499|454440781|FG000|Overall Study|Withdrawal by Subject|12|||
126314186|NCT04542499|454440782|FG001|Overall Study|Withdrawal by Subject|33|||
126314187|NCT04542499|454440781|FG000|Overall Study|Other|2|||
126314188|NCT04542499|454440782|FG001|Overall Study|Other|2|||
126314189|NCT04161079|454440787|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
126314190|NCT03617861|454440790|FG000|Second Intervention (1 Day)|Adverse Event|0|||
126314191|NCT03617861|454440791|FG001|Second Intervention (1 Day)|Adverse Event|0|||
126314192|NCT03617861|454440792|FG002|Second Intervention (1 Day)|Adverse Event|1|||
126314193|NCT03617861|454440793|FG003|Second Intervention (1 Day)|Adverse Event|0|||
126314194|NCT00623597|454440794|FG000|Overall Study|Failed to return|1|||
126314195|NCT00623597|454440795|FG001|Overall Study|Failed to return|0|||
126314196|NCT02515994|454440796|FG000|Overall Study|Protocol Violation|3|||
126314197|NCT02515994|454440797|FG001|Overall Study|Protocol Violation|5|||
126314198|NCT02515994|454440796|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
126314199|NCT02515994|454440797|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
126314200|NCT02515994|454440796|FG000|Overall Study|Adverse Event|3|||
126314201|NCT02515994|454440797|FG001|Overall Study|Adverse Event|1|||
126314202|NCT02515994|454440796|FG000|Overall Study|Withdrawal by Subject|2|||
126314203|NCT02515994|454440797|FG001|Overall Study|Withdrawal by Subject|0|||
126314204|NCT01668966|454440807|FG000|Overall Study|Withdrawal by Subject|1|||
126314205|NCT01668966|454440807|FG000|Overall Study|Death|1|||
126314206|NCT01668966|454440807|FG000|Overall Study|Not treated|2|||
126314207|NCT03427268|454440811|FG000|Overall Study|Progressive disease|25|||
126314208|NCT03427268|454440811|FG000|Overall Study|Never treated|2|||
126314209|NCT03427268|454440811|FG000|Overall Study|Compassionate use|1|||
126314210|NCT03427268|454440811|FG000|Overall Study|Withdrawal by Subject|1|||
126314211|NCT03427268|454440811|FG000|Overall Study|Adverse Event|3|||
126314212|NCT00552032|454440813|FG000|Overall Study|Withdrawal by Subject|2|||
126314213|NCT00552032|454440814|FG001|Overall Study|Withdrawal by Subject|2|||
126314214|NCT00552032|454440813|FG000|Overall Study|Protocol Violation|7|||
126314215|NCT00552032|454440814|FG001|Overall Study|Protocol Violation|12|||
126314216|NCT00552032|454440813|FG000|Overall Study|Lost to Follow-up|8|||
126314217|NCT00552032|454440814|FG001|Overall Study|Lost to Follow-up|5|||
126314218|NCT00345878|454440815|FG000|Overall Study|Adverse Event|1|||
126314219|NCT00345878|454440816|FG001|Overall Study|Adverse Event|0|||
126314220|NCT00345878|454440815|FG000|Overall Study|Lost to Follow-up|2|||
126314221|NCT00345878|454440816|FG001|Overall Study|Lost to Follow-up|1|||
126314222|NCT00345878|454440815|FG000|Overall Study|Other|1|||
126314223|NCT00345878|454440816|FG001|Overall Study|Other|0|||
126314224|NCT03391232|454440817|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
126314225|NCT03391232|454440818|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
126314226|NCT03391232|454440817|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
126314227|NCT03391232|454440818|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
126314228|NCT01643798|454440819|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
126314229|NCT01643798|454440820|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
126314230|NCT01995175|454440826|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
126314231|NCT01995175|454440826|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
126314232|NCT01995175|454440826|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
126314233|NCT01995175|454440826|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
126314234|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
126314235|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
126314236|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
126314237|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
126314238|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
126314239|NCT00984061|454440827|FG000|Clarithromycin Alone|Protocol Violation|1|||
126314240|NCT00614120|454440832|FG000|Overall Study|Adverse Event|9|||
126314241|NCT00614120|454440833|FG001|Overall Study|Adverse Event|22|||
126314242|NCT00614120|454440834|FG002|Overall Study|Adverse Event|30|||
126314243|NCT00614120|454440835|FG003|Overall Study|Adverse Event|3|||
126314244|NCT00614120|454440832|FG000|Overall Study|Lack of Efficacy|3|||
126314245|NCT00614120|454440833|FG001|Overall Study|Lack of Efficacy|3|||
126314246|NCT00614120|454440834|FG002|Overall Study|Lack of Efficacy|2|||
126314247|NCT00614120|454440835|FG003|Overall Study|Lack of Efficacy|2|||
126314248|NCT00614120|454440832|FG000|Overall Study|Protocol Violation|2|||
126314249|NCT00614120|454440833|FG001|Overall Study|Protocol Violation|5|||
126314250|NCT00614120|454440834|FG002|Overall Study|Protocol Violation|3|||
126314251|NCT00614120|454440835|FG003|Overall Study|Protocol Violation|1|||
126314252|NCT00614120|454440832|FG000|Overall Study|Withdrawal criteria|1|||
126314253|NCT00614120|454440833|FG001|Overall Study|Withdrawal criteria|0|||
126314254|NCT00614120|454440834|FG002|Overall Study|Withdrawal criteria|0|||
126314255|NCT00614120|454440835|FG003|Overall Study|Withdrawal criteria|0|||
126314256|NCT00614120|454440832|FG000|Overall Study|Withdrawal by Subject|9|||
126314257|NCT00614120|454440833|FG001|Overall Study|Withdrawal by Subject|10|||
126314258|NCT00614120|454440834|FG002|Overall Study|Withdrawal by Subject|16|||
126314259|NCT00614120|454440835|FG003|Overall Study|Withdrawal by Subject|3|||
126314260|NCT00614120|454440832|FG000|Overall Study|Did not meet trial criteria|0|||
126314261|NCT00614120|454440833|FG001|Overall Study|Did not meet trial criteria|1|||
126314262|NCT00614120|454440834|FG002|Overall Study|Did not meet trial criteria|1|||
126314263|NCT00614120|454440835|FG003|Overall Study|Did not meet trial criteria|1|||
126314264|NCT00614120|454440832|FG000|Overall Study|hCG positive (not pregnant)|0|||
126314265|NCT00614120|454440833|FG001|Overall Study|hCG positive (not pregnant)|0|||
126314266|NCT00614120|454440834|FG002|Overall Study|hCG positive (not pregnant)|1|||
126314267|NCT00614120|454440835|FG003|Overall Study|hCG positive (not pregnant)|0|||
126314268|NCT00614120|454440832|FG000|Overall Study|Hypoglycaemia|0|||
126314269|NCT00614120|454440833|FG001|Overall Study|Hypoglycaemia|0|||
126314270|NCT00614120|454440834|FG002|Overall Study|Hypoglycaemia|0|||
126314271|NCT00614120|454440835|FG003|Overall Study|Hypoglycaemia|1|||
126314272|NCT00614120|454440832|FG000|Overall Study|Lack of trial product|3|||
126314273|NCT00614120|454440833|FG001|Overall Study|Lack of trial product|3|||
126314274|NCT00614120|454440834|FG002|Overall Study|Lack of trial product|2|||
126314275|NCT00614120|454440835|FG003|Overall Study|Lack of trial product|0|||
126314276|NCT00614120|454440832|FG000|Overall Study|Late syphilis, latent|1|||
126314277|NCT00614120|454440833|FG001|Overall Study|Late syphilis, latent|0|||
126314278|NCT00614120|454440834|FG002|Overall Study|Late syphilis, latent|0|||
126314279|NCT00614120|454440835|FG003|Overall Study|Late syphilis, latent|0|||
126314280|NCT00614120|454440832|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
126314281|NCT00614120|454440833|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
126314282|NCT00614120|454440834|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
126314283|NCT00614120|454440835|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
126314284|NCT00614120|454440832|FG000|Overall Study|Lost to Follow-up|1|||
126314285|NCT00614120|454440833|FG001|Overall Study|Lost to Follow-up|2|||
126314286|NCT00614120|454440834|FG002|Overall Study|Lost to Follow-up|3|||
126314287|NCT00614120|454440835|FG003|Overall Study|Lost to Follow-up|4|||
126314288|NCT03047720|454440836|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
126314289|NCT03047720|454440837|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
126314290|NCT03602391|454440844|FG000|Overall Study|COVID-19|7|||
126314291|NCT03602391|454440845|FG001|Overall Study|COVID-19|6|||
126314292|NCT03729570|454440852|FG000|Overall Study|Lost to Follow-up|16|||
126314293|NCT03729570|454440853|FG001|Overall Study|Lost to Follow-up|20|||
126314294|NCT03729570|454440852|FG000|Overall Study|Seroconversion|5|||
126314295|NCT03729570|454440853|FG001|Overall Study|Seroconversion|0|||
126314296|NCT03729570|454440852|FG000|Overall Study|Moved out of the city|1|||
126314297|NCT03729570|454440853|FG001|Overall Study|Moved out of the city|0|||
126314298|NCT03729570|454440852|FG000|Overall Study|Time Conflict|1|||
126314299|NCT03729570|454440853|FG001|Overall Study|Time Conflict|0|||
126314300|NCT03729570|454440852|FG000|Overall Study|Time Commitment|2|||
126314301|NCT03729570|454440853|FG001|Overall Study|Time Commitment|0|||
126314302|NCT03729570|454440852|FG000|Overall Study|Bad Experience|0|||
126314303|NCT03729570|454440853|FG001|Overall Study|Bad Experience|1|||
126314304|NCT03729570|454440852|FG000|Overall Study|No reason provided|2|||
126314305|NCT03729570|454440853|FG001|Overall Study|No reason provided|1|||
126314306|NCT03729570|454440852|FG000|Overall Study|Family Conflict|0|||
126314307|NCT03729570|454440853|FG001|Overall Study|Family Conflict|1|||
126314308|NCT03729570|454440852|FG000|Overall Study|Did not want to continue taking medications|0|||
126314309|NCT03729570|454440853|FG001|Overall Study|Did not want to continue taking medications|1|||
126314310|NCT03729570|454440852|FG000|Overall Study|Found another PrEP provider|1|||
126314311|NCT03729570|454440853|FG001|Overall Study|Found another PrEP provider|0|||
126314312|NCT03729570|454440852|FG000|Overall Study|Did not enjoy being in the control group|0|||
126314313|NCT03729570|454440853|FG001|Overall Study|Did not enjoy being in the control group|1|||
126314314|NCT04495816|454440857|FG000|Overall Study|Lost to Follow-up|10|||
126314315|NCT04495816|454440858|FG001|Overall Study|Lost to Follow-up|4|||
126314316|NCT04495816|454440857|FG000|Overall Study|Withdrawal by Subject|3|||
126314317|NCT04495816|454440858|FG001|Overall Study|Withdrawal by Subject|5|||
126314318|NCT00558896|454440859|FG000|Overall Study|Adverse Event|1|||
126314319|NCT00558896|454440860|FG001|Overall Study|Adverse Event|1|||
126314320|NCT00558896|454440861|FG002|Overall Study|Adverse Event|1|||
126314321|NCT00558896|454440862|FG003|Overall Study|Adverse Event|3|||
126314322|NCT00558896|454440863|FG004|Overall Study|Adverse Event|4|||
126314323|NCT00558896|454440864|FG005|Overall Study|Adverse Event|10|||
126314324|NCT00558896|454440865|FG006|Overall Study|Adverse Event|3|||
126314325|NCT00558896|454440859|FG000|Overall Study|Death|3|||
126314326|NCT00558896|454440860|FG001|Overall Study|Death|0|||
126314327|NCT00558896|454440861|FG002|Overall Study|Death|2|||
126314328|NCT00558896|454440862|FG003|Overall Study|Death|3|||
126314329|NCT00558896|454440863|FG004|Overall Study|Death|2|||
126314330|NCT00558896|454440864|FG005|Overall Study|Death|2|||
126314331|NCT00558896|454440865|FG006|Overall Study|Death|6|||
126314332|NCT00558896|454440859|FG000|Overall Study|Withdrawal by Subject|2|||
126314333|NCT00558896|454440860|FG001|Overall Study|Withdrawal by Subject|1|||
126314334|NCT00558896|454440861|FG002|Overall Study|Withdrawal by Subject|1|||
126314335|NCT00558896|454440862|FG003|Overall Study|Withdrawal by Subject|1|||
126314336|NCT00558896|454440863|FG004|Overall Study|Withdrawal by Subject|1|||
126314337|NCT00558896|454440864|FG005|Overall Study|Withdrawal by Subject|5|||
126314338|NCT00558896|454440865|FG006|Overall Study|Withdrawal by Subject|5|||
126314339|NCT00558896|454440859|FG000|Overall Study|Alternative Treatment|2|||
126314340|NCT00558896|454440860|FG001|Overall Study|Alternative Treatment|2|||
126314341|NCT00558896|454440861|FG002|Overall Study|Alternative Treatment|0|||
126314342|NCT00558896|454440862|FG003|Overall Study|Alternative Treatment|2|||
126314343|NCT00558896|454440863|FG004|Overall Study|Alternative Treatment|6|||
126314344|NCT00558896|454440864|FG005|Overall Study|Alternative Treatment|7|||
126314345|NCT00558896|454440865|FG006|Overall Study|Alternative Treatment|1|||
126314346|NCT00558896|454440859|FG000|Overall Study|Physician discretion|3|||
126314347|NCT00558896|454440860|FG001|Overall Study|Physician discretion|2|||
126314348|NCT00558896|454440861|FG002|Overall Study|Physician discretion|1|||
126314349|NCT00558896|454440862|FG003|Overall Study|Physician discretion|2|||
126314350|NCT00558896|454440863|FG004|Overall Study|Physician discretion|1|||
126314351|NCT00558896|454440864|FG005|Overall Study|Physician discretion|3|||
126314352|NCT00558896|454440865|FG006|Overall Study|Physician discretion|3|||
126314353|NCT00558896|454440859|FG000|Overall Study|Continues on treatment|10|||
126314354|NCT00558896|454440860|FG001|Overall Study|Continues on treatment|1|||
126314355|NCT00558896|454440861|FG002|Overall Study|Continues on treatment|0|||
126314356|NCT00558896|454440862|FG003|Overall Study|Continues on treatment|1|||
126314357|NCT00558896|454440863|FG004|Overall Study|Continues on treatment|9|||
126314358|NCT00558896|454440864|FG005|Overall Study|Continues on treatment|25|||
126314359|NCT00558896|454440865|FG006|Overall Study|Continues on treatment|6|||
126314360|NCT04329091|454440866|FG000|Overall Study|Physician Decision|5|||
126314361|NCT02484651|454440869|FG000|Overall Study|Patients' data files were corrupted.|1|||
126314362|NCT02484651|454440870|FG001|Overall Study|Patients' data files were corrupted.|1|||
126314363|NCT02484651|454440869|FG000|Overall Study|BIS monitoring failed.|1|||
126314364|NCT02484651|454440870|FG001|Overall Study|BIS monitoring failed.|1|||
126314365|NCT02484651|454440869|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
126314366|NCT02484651|454440870|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
126314367|NCT00150800|454440871|FG000|Overall Study|Adverse Event|89|||
126314368|NCT00150800|454440871|FG000|Overall Study|Death|18|||
126314369|NCT00150800|454440871|FG000|Overall Study|Lack of Efficacy|166|||
126314370|NCT00150800|454440871|FG000|Overall Study|Lost to Follow-up|58|||
126314371|NCT00150800|454440871|FG000|Overall Study|Subject's choice|90|||
126314372|NCT00150800|454440871|FG000|Overall Study|No compliance|18|||
126314373|NCT00150800|454440871|FG000|Overall Study|IP misshandling|1|||
126314374|NCT00150800|454440871|FG000|Overall Study|Site closure|24|||
126314375|NCT00150800|454440871|FG000|Overall Study|Protocol non-adherence|2|||
126314376|NCT00150800|454440871|FG000|Overall Study|Nobody to accompany patient|1|||
126314377|NCT00150800|454440871|FG000|Overall Study|Distance too long for patient|1|||
126314378|NCT00150800|454440871|FG000|Overall Study|Neurosurgery|2|||
126314379|NCT00150800|454440871|FG000|Overall Study|BRV monotherapy|1|||
126314380|NCT00150800|454440871|FG000|Overall Study|Visit refusal|3|||
126314381|NCT00150800|454440871|FG000|Overall Study|Sponsor's request|2|||
126314382|NCT00150800|454440871|FG000|Overall Study|Generalized Epilepsy|1|||
126314383|NCT00150800|454440871|FG000|Overall Study|Moved from area/country|8|||
126314384|NCT00150800|454440871|FG000|Overall Study|PI retiring|2|||
126314385|NCT00150800|454440871|FG000|Overall Study|PI leaving site|2|||
126314386|NCT00150800|454440871|FG000|Overall Study|Patient insurance|1|||
126314387|NCT00150800|454440871|FG000|Overall Study|Surgical intervention|4|||
126314388|NCT00150800|454440871|FG000|Overall Study|Pregnancy planned|1|||
126314389|NCT00150800|454440871|FG000|Overall Study|PI discontinuation request|1|||
126314390|NCT01790828|454440872|FG000|Overall Study|Other|34|||
126314391|NCT03026530|454440877|FG000|Overall Study|Lost to Follow-up|19|||
126314392|NCT03026530|454440878|FG001|Overall Study|Lost to Follow-up|24|||
126314393|NCT03026530|454440877|FG000|Overall Study|Protocol Violation|2|||
126314394|NCT03026530|454440878|FG001|Overall Study|Protocol Violation|5|||
126314395|NCT03721835|454440879|FG000|Overall Study|Participant not able to return|1|||
126314396|NCT03721835|454440879|FG000|Overall Study|Lost to Follow-up|1|||
126314397|NCT03721835|454440879|FG000|Overall Study|Revision of the components of the study device|2|||
126314398|NCT03721835|454440879|FG000|Overall Study|Sponsor terminated study|6|||
126314399|NCT03721835|454440879|FG000|Overall Study|Death|1|||
126314400|NCT03721835|454440879|FG000|Overall Study|Sponsor decision|1|||
126314401|NCT05072964|454440884|FG000|Overall Study|Withdrawal by Subject|4|||
126314402|NCT05072964|454440884|FG000|Overall Study|Death|1|||
126314403|NCT01390428|454442666|FG000|Overall Study|Elective Surgery|0|||
126314404|NCT01390428|454442667|FG001|Overall Study|Elective Surgery|0|||
126314405|NCT01390428|454442668|FG002|Overall Study|Elective Surgery|0|||
126314406|NCT01390428|454442669|FG003|Overall Study|Elective Surgery|0|||
126314407|NCT01390428|454442670|FG004|Overall Study|Elective Surgery|1|||
126314408|NCT01390428|454442671|FG005|Overall Study|Elective Surgery|0|||
126314409|NCT01390428|454442666|FG000|Overall Study|Withdrawal by Subject|0|||
126314410|NCT01390428|454442667|FG001|Overall Study|Withdrawal by Subject|0|||
126314411|NCT01390428|454442668|FG002|Overall Study|Withdrawal by Subject|1|||
126314412|NCT01390428|454442669|FG003|Overall Study|Withdrawal by Subject|0|||
126314413|NCT01390428|454442670|FG004|Overall Study|Withdrawal by Subject|0|||
126314414|NCT01390428|454442671|FG005|Overall Study|Withdrawal by Subject|0|||
126314415|NCT04322539|454442680|FG000|Overall Study|Adverse Event|2|||
126314416|NCT04322539|454442681|FG001|Overall Study|Adverse Event|0|||
126314417|NCT04322539|454442680|FG000|Overall Study|Death|411|||
126314418|NCT04322539|454442681|FG001|Overall Study|Death|203|||
126314419|NCT04322539|454442680|FG000|Overall Study|Lost to Follow-up|3|||
126314420|NCT04322539|454442681|FG001|Overall Study|Lost to Follow-up|1|||
126314421|NCT04322539|454442680|FG000|Overall Study|Withdrawal of consent|14|||
126314422|NCT04322539|454442681|FG001|Overall Study|Withdrawal of consent|8|||
126314423|NCT04322539|454442680|FG000|Overall Study|Radiological Disease Progression|6|||
126314424|NCT04322539|454442681|FG001|Overall Study|Radiological Disease Progression|0|||
126314425|NCT04322539|454442680|FG000|Overall Study|Sponsor Decision|19|||
126314426|NCT04322539|454442681|FG001|Overall Study|Sponsor Decision|14|||
125885163|NCT03847896|452876790|FG001|Overall Study|Withdrawal by Subject|10|||
126314427|NCT04322539|454442680|FG000|Overall Study|Other|6|||
126314428|NCT04322539|454442681|FG001|Overall Study|Other|4|||
126314429|NCT01702532|454442682|FG000|Overall Study|Adverse Event|0|||
126314430|NCT01702532|454442683|FG001|Overall Study|Adverse Event|1|||
126314431|NCT01451164|454442684|FG000|Overall Study|Adverse Event|19|||
126314432|NCT01451164|454442685|FG001|Overall Study|Adverse Event|12|||
126314433|NCT01451164|454442686|FG002|Overall Study|Adverse Event|18|||
126314434|NCT01451164|454442687|FG003|Overall Study|Adverse Event|21|||
126314435|NCT01451164|454442684|FG000|Overall Study|Withdrawal Criteria|1|||
126314436|NCT01451164|454442685|FG001|Overall Study|Withdrawal Criteria|1|||
126314437|NCT01451164|454442686|FG002|Overall Study|Withdrawal Criteria|1|||
126314438|NCT01451164|454442687|FG003|Overall Study|Withdrawal Criteria|1|||
126314439|NCT01451164|454442684|FG000|Overall Study|Physician Decision|2|||
126314440|NCT01451164|454442685|FG001|Overall Study|Physician Decision|0|||
126314441|NCT01451164|454442686|FG002|Overall Study|Physician Decision|1|||
126314442|NCT01451164|454442687|FG003|Overall Study|Physician Decision|0|||
126314443|NCT01451164|454442684|FG000|Overall Study|Withdrawal by Subject|14|||
126314444|NCT01451164|454442685|FG001|Overall Study|Withdrawal by Subject|11|||
126314445|NCT01451164|454442686|FG002|Overall Study|Withdrawal by Subject|16|||
126314446|NCT01451164|454442687|FG003|Overall Study|Withdrawal by Subject|17|||
126314447|NCT01451164|454442684|FG000|Overall Study|Protocol Violation|0|||
126314448|NCT01451164|454442685|FG001|Overall Study|Protocol Violation|1|||
126314449|NCT01451164|454442686|FG002|Overall Study|Protocol Violation|0|||
126314450|NCT01451164|454442687|FG003|Overall Study|Protocol Violation|0|||
126314451|NCT01451164|454442684|FG000|Overall Study|Lack of Efficacy|7|||
126314452|NCT01451164|454442685|FG001|Overall Study|Lack of Efficacy|9|||
126314453|NCT01451164|454442686|FG002|Overall Study|Lack of Efficacy|9|||
126314454|NCT01451164|454442687|FG003|Overall Study|Lack of Efficacy|7|||
126314455|NCT01846221|454442688|FG000|Overall Study|Catheter Failure|2|||
126314456|NCT01846221|454442689|FG001|Overall Study|Catheter Failure|0|||
126314457|NCT01846221|454442688|FG000|Overall Study|Age Exclusion|1|||
126314458|NCT01846221|454442689|FG001|Overall Study|Age Exclusion|0|||
126314459|NCT02879994|454442690|FG000|Overall Study|off treatment early|7|||
126314460|NCT02879994|454442690|FG000|Overall Study|Adverse Event|2|||
126314461|NCT02879994|454442690|FG000|Overall Study|Death|2|||
126314462|NCT01482962|454442693|FG000|Overall Study|Progressive Disease|65|||
126314463|NCT01482962|454442694|FG001|Overall Study|Progressive Disease|53|||
126314464|NCT01482962|454442693|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
126314465|NCT01482962|454442694|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
126314466|NCT01482962|454442693|FG000|Overall Study|Adverse Event|18|||
126314467|NCT01482962|454442694|FG001|Overall Study|Adverse Event|22|||
126314468|NCT01482962|454442693|FG000|Overall Study|Withdrawal by Participant|8|||
126314469|NCT01482962|454442694|FG001|Overall Study|Withdrawal by Participant|13|||
126314470|NCT01482962|454442693|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
126314471|NCT01482962|454442694|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
126314472|NCT01482962|454442693|FG000|Overall Study|Other Reason|1|||
126314473|NCT01482962|454442694|FG001|Overall Study|Other Reason|5|||
126314474|NCT01482962|454442693|FG000|Overall Study|Study Terminated by Sponsor|5|||
126314475|NCT01482962|454442694|FG001|Overall Study|Study Terminated by Sponsor|2|||
126314476|NCT01482962|454442693|FG000|Overall Study|Did not Receive Study Drug|1|||
126314477|NCT01482962|454442694|FG001|Overall Study|Did not Receive Study Drug|6|||
126314478|NCT02407457|454442695|FG000|1 Month|Death|3|||
126314479|NCT02407457|454442696|FG001|1 Month|Death|0|||
126314480|NCT02407457|454442695|FG000|1 Month|Lost to Follow-up|1|||
126314481|NCT02407457|454442696|FG001|1 Month|Lost to Follow-up|1|||
126314482|NCT02407457|454442695|FG000|1 Month|missed visit|2|||
126314483|NCT02407457|454442696|FG001|1 Month|missed visit|5|||
126314484|NCT02407457|454442695|FG000|6-Month|Death|2|||
126314485|NCT02407457|454442696|FG001|6-Month|Death|8|||
126314486|NCT02407457|454442695|FG000|6-Month|Lost to Follow-up|2|||
126314487|NCT02407457|454442696|FG001|6-Month|Lost to Follow-up|2|||
126314488|NCT02407457|454442695|FG000|6-Month|missed visit|16|||
126314489|NCT02407457|454442696|FG001|6-Month|missed visit|14|||
126314490|NCT02407457|454442695|FG000|6-Month|Open Repair|0|||
126314491|NCT02407457|454442696|FG001|6-Month|Open Repair|1|||
126314492|NCT02407457|454442695|FG000|1 Year|Death|6|||
126314493|NCT02407457|454442696|FG001|1 Year|Death|11|||
126314494|NCT02407457|454442695|FG000|1 Year|Lost to Follow-up|3|||
126314495|NCT02407457|454442696|FG001|1 Year|Lost to Follow-up|2|||
126314496|NCT02407457|454442695|FG000|1 Year|Missed Visit|24|||
126314497|NCT02407457|454442696|FG001|1 Year|Missed Visit|14|||
126314498|NCT02407457|454442695|FG000|1 Year|Open Repair|0|||
126314499|NCT02407457|454442696|FG001|1 Year|Open Repair|1|||
126314500|NCT02407457|454442695|FG000|2-year|Death|14|||
126314501|NCT02407457|454442696|FG001|2-year|Death|8|||
126314502|NCT02407457|454442695|FG000|2-year|Lost to Follow-up|7|||
126314503|NCT02407457|454442696|FG001|2-year|Lost to Follow-up|10|||
126314504|NCT02407457|454442695|FG000|2-year|Missed Visit|13|||
126090441|NCT03635099|453623564|FG006|Period 2|Withdrawal by Subject|0|||
126314505|NCT02407457|454442696|FG001|2-year|Missed Visit|15|||
126090442|NCT03635099|453623565|FG007|Period 2|Withdrawal by Subject|0|||
126208217|NCT05261126|454049347|FG003|Overall Study|Lost to Follow-up|0|||
126208218|NCT05261126|454049348|FG004|Overall Study|Lost to Follow-up|1|||
126314506|NCT02407457|454442695|FG000|2-year|Open Repair|0|||
126314507|NCT02407457|454442696|FG001|2-year|Open Repair|2|||
126314508|NCT02407457|454442695|FG000|3-year|Death|11|||
126314509|NCT02407457|454442696|FG001|3-year|Death|10|||
126314510|NCT02407457|454442695|FG000|3-year|Lost to Follow-up|9|||
126314511|NCT02407457|454442696|FG001|3-year|Lost to Follow-up|10|||
126314512|NCT02407457|454442695|FG000|3-year|Missed Visit|19|||
126314513|NCT02407457|454442696|FG001|3-year|Missed Visit|16|||
126314514|NCT02407457|454442695|FG000|4-year|Death|18|||
126314515|NCT02407457|454442696|FG001|4-year|Death|10|||
126314516|NCT02407457|454442695|FG000|4-year|Lost to Follow-up|10|||
126314517|NCT02407457|454442696|FG001|4-year|Lost to Follow-up|12|||
126314518|NCT02407457|454442695|FG000|4-year|Missed Visit|18|||
126314519|NCT02407457|454442696|FG001|4-year|Missed Visit|16|||
126314520|NCT02407457|454442695|FG000|5-year|Death|10|||
126314521|NCT02407457|454442696|FG001|5-year|Death|3|||
126314522|NCT02407457|454442695|FG000|5-year|Lost to Follow-up|22|||
126314523|NCT02407457|454442696|FG001|5-year|Lost to Follow-up|13|||
126314524|NCT02407457|454442695|FG000|5-year|Missed Visit|9|||
126314525|NCT02407457|454442696|FG001|5-year|Missed Visit|1|||
126314526|NCT02052596|454442697|FG000|Active Phase|Adverse Event|3|||
126314527|NCT02052596|454442698|FG001|Active Phase|Adverse Event|2|||
126314528|NCT02052596|454442697|FG000|Active Phase|Lost to Follow-up|8|||
126314529|NCT02052596|454442698|FG001|Active Phase|Lost to Follow-up|11|||
126314530|NCT02052596|454442697|FG000|Active Phase|Protocol Violation|1|||
126314531|NCT02052596|454442698|FG001|Active Phase|Protocol Violation|2|||
126314532|NCT02052596|454442697|FG000|Active Phase|Withdrawal by Subject|3|||
126314533|NCT02052596|454442698|FG001|Active Phase|Withdrawal by Subject|4|||
126314534|NCT02052596|454442697|FG000|Active Phase|Enrolled in error|1|||
126314535|NCT02052596|454442698|FG001|Active Phase|Enrolled in error|0|||
126314536|NCT02052596|454442697|FG000|Active Phase|Lost due to Crohn's disease|0|||
126314537|NCT02052596|454442698|FG001|Active Phase|Lost due to Crohn's disease|1|||
126314538|NCT02052596|454442697|FG000|Safety Phase|Adverse Event|6|||
126314539|NCT02052596|454442698|FG001|Safety Phase|Adverse Event|3|||
126314540|NCT02052596|454442697|FG000|Safety Phase|Lost to Follow-up|11|||
126314541|NCT02052596|454442698|FG001|Safety Phase|Lost to Follow-up|18|||
126314542|NCT02052596|454442697|FG000|Safety Phase|Protocol Violation|1|||
126314543|NCT02052596|454442698|FG001|Safety Phase|Protocol Violation|2|||
126314544|NCT02052596|454442697|FG000|Safety Phase|Withdrawal by Subject|8|||
126314545|NCT02052596|454442698|FG001|Safety Phase|Withdrawal by Subject|11|||
126314546|NCT02052596|454442697|FG000|Safety Phase|Enrolled in error|1|||
126314547|NCT02052596|454442698|FG001|Safety Phase|Enrolled in error|0|||
126314548|NCT02052596|454442697|FG000|Safety Phase|Lost due to Crohn's disease|0|||
126314549|NCT02052596|454442698|FG001|Safety Phase|Lost due to Crohn's disease|1|||
126314550|NCT00705718|454442699|FG000|Overall Study|Death|6|||
126314551|NCT00705718|454442700|FG001|Overall Study|Death|6|||
126314552|NCT00705718|454442699|FG000|Overall Study|Not due for Visit|0|||
126314553|NCT00705718|454442700|FG001|Overall Study|Not due for Visit|12|||
126314554|NCT00705718|454442699|FG000|Overall Study|Follow up not done|1|||
126314555|NCT00705718|454442700|FG001|Overall Study|Follow up not done|4|||
126314556|NCT06137703|454442702|FG000|Overall Study|Other|0|||
126314557|NCT06137703|454442703|FG001|Overall Study|Other|1|||
126314558|NCT06137703|454442704|FG002|Overall Study|Other|0|||
126314559|NCT06137703|454442705|FG003|Overall Study|Other|0|||
126314560|NCT06137703|454442702|FG000|Overall Study|Adverse Event|0|||
126314561|NCT06137703|454442703|FG001|Overall Study|Adverse Event|0|||
126314562|NCT06137703|454442704|FG002|Overall Study|Adverse Event|1|||
126314563|NCT06137703|454442705|FG003|Overall Study|Adverse Event|0|||
126314564|NCT00741091|454442710|FG000|Overall Study|Death|13|||
126314565|NCT00741091|454442710|FG000|Overall Study|Lost to Follow-up|16|||
126314566|NCT00741091|454442710|FG000|Overall Study|Withdrawal by Subject|6|||
126314567|NCT00741091|454442710|FG000|Overall Study|Missed Visit|22|||
126314568|NCT01801358|454442711|FG000|Overall Study|Adverse Event|0|||
126314569|NCT01801358|454442712|FG001|Overall Study|Adverse Event|2|||
126314570|NCT01801358|454442713|FG002|Overall Study|Adverse Event|1|||
126314571|NCT01801358|454442714|FG003|Overall Study|Adverse Event|0|||
126314572|NCT01801358|454442715|FG004|Overall Study|Adverse Event|0|||
126314573|NCT01801358|454442716|FG005|Overall Study|Adverse Event|1|||
126314574|NCT01801358|454442711|FG000|Overall Study|Physician Decision|0|||
126314575|NCT01801358|454442712|FG001|Overall Study|Physician Decision|0|||
126314576|NCT01801358|454442713|FG002|Overall Study|Physician Decision|1|||
126314577|NCT01801358|454442714|FG003|Overall Study|Physician Decision|0|||
126314578|NCT01801358|454442715|FG004|Overall Study|Physician Decision|0|||
126314579|NCT01801358|454442716|FG005|Overall Study|Physician Decision|0|||
126314580|NCT01801358|454442711|FG000|Overall Study|Progressive Disease|6|||
126314581|NCT01801358|454442712|FG001|Overall Study|Progressive Disease|4|||
126314582|NCT01801358|454442713|FG002|Overall Study|Progressive Disease|4|||
126314583|NCT01801358|454442714|FG003|Overall Study|Progressive Disease|5|||
126314584|NCT01801358|454442715|FG004|Overall Study|Progressive Disease|6|||
126314585|NCT01801358|454442716|FG005|Overall Study|Progressive Disease|5|||
126314586|NCT01801358|454442711|FG000|Overall Study|Withdrawal by Subject|0|||
126314587|NCT01801358|454442712|FG001|Overall Study|Withdrawal by Subject|0|||
126314588|NCT01801358|454442713|FG002|Overall Study|Withdrawal by Subject|0|||
126314589|NCT01801358|454442714|FG003|Overall Study|Withdrawal by Subject|1|||
126314590|NCT01801358|454442715|FG004|Overall Study|Withdrawal by Subject|0|||
126314591|NCT01801358|454442716|FG005|Overall Study|Withdrawal by Subject|2|||
126314592|NCT01527487|454442717|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
126314593|NCT01527487|454442718|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
126314594|NCT01527487|454442717|FG000|Overall Study|Disease Progression|4|||
126314595|NCT01527487|454442718|FG001|Overall Study|Disease Progression|1|||
126314596|NCT01527487|454442717|FG000|Overall Study|Adverse Event|1|||
126314597|NCT01527487|454442718|FG001|Overall Study|Adverse Event|1|||
126314598|NCT01527487|454442717|FG000|Overall Study|Death|0|||
126314599|NCT01527487|454442718|FG001|Overall Study|Death|1|||
126314600|NCT00723190|454442722|FG000|Overall Study|Withdrawal by Subject|45|||
126314601|NCT00723190|454442722|FG000|Overall Study|Lost to Follow-up|37|||
126314602|NCT00723190|454442722|FG000|Overall Study|Adverse Event|18|||
126314603|NCT00723190|454442722|FG000|Overall Study|Lack of Efficacy|16|||
126314604|NCT00723190|454442722|FG000|Overall Study|Protocol Violation|15|||
126314605|NCT00723190|454442722|FG000|Overall Study|Other-Premature Discontinuation|9|||
126314606|NCT00723190|454442722|FG000|Overall Study|Other-Not included in safety population|2|||
126314607|NCT03181503|454442723|FG000|Overall Study|Adverse Event|2|||
126314608|NCT03181503|454442724|FG001|Overall Study|Adverse Event|2|||
126314609|NCT03181503|454442723|FG000|Overall Study|Protocol Violation|1|||
126314610|NCT03181503|454442724|FG001|Overall Study|Protocol Violation|0|||
126314611|NCT03181503|454442723|FG000|Overall Study|Withdrawal by Subject|3|||
126314612|NCT03181503|454442724|FG001|Overall Study|Withdrawal by Subject|0|||
126314613|NCT03181503|454442723|FG000|Overall Study|Lost to Follow-up|1|||
126314614|NCT03181503|454442724|FG001|Overall Study|Lost to Follow-up|1|||
126314615|NCT02505334|454442735|FG000|Main Treatment Period|Adverse Event|3|||
126314616|NCT02505334|454442736|FG001|Main Treatment Period|Adverse Event|3|||
126314617|NCT02505334|454442735|FG000|Main Treatment Period|Lack of Efficacy|7|||
126314618|NCT02505334|454442736|FG001|Main Treatment Period|Lack of Efficacy|17|||
126314619|NCT02505334|454442735|FG000|Main Treatment Period|Protocol Violation|0|||
126314620|NCT02505334|454442736|FG001|Main Treatment Period|Protocol Violation|1|||
126314621|NCT02505334|454442735|FG000|Main Treatment Period|Withdrawal by Subject|1|||
126314622|NCT02505334|454442736|FG001|Main Treatment Period|Withdrawal by Subject|8|||
126314623|NCT02505334|454442735|FG000|Main Treatment Period|Unclassified|4|||
126314624|NCT02505334|454442736|FG001|Main Treatment Period|Unclassified|10|||
126314625|NCT02505334|454442735|FG000|Extension Treatment Period|Adverse Event|5|||
126314626|NCT02505334|454442736|FG001|Extension Treatment Period|Adverse Event|0|||
126314627|NCT02505334|454442735|FG000|Extension Treatment Period|Lack of Efficacy|4|||
126314628|NCT02505334|454442736|FG001|Extension Treatment Period|Lack of Efficacy|0|||
126314629|NCT02505334|454442735|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
126314630|NCT02505334|454442736|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126314631|NCT02505334|454442735|FG000|Extension Treatment Period|Unclassified|3|||
126314632|NCT02505334|454442736|FG001|Extension Treatment Period|Unclassified|0|||
126314633|NCT03199612|454442737|FG000|Overall Study|Adverse Event|1|||
126314634|NCT03199612|454442738|FG001|Overall Study|Adverse Event|0|||
126314635|NCT00081731|454442746|FG000|Overall Study|scientific integrity issue|8|||
126314636|NCT00081731|454442747|FG001|Overall Study|scientific integrity issue|8|||
126314637|NCT02386345|454442751|FG000|Overall Study|Not treated|14|||
126314638|NCT02386345|454442751|FG000|Overall Study|Lost to Follow-up|1|||
126314639|NCT02386345|454442751|FG000|Overall Study|Adverse Event|5|||
126314640|NCT02386345|454442751|FG000|Overall Study|Repeat Procedure|10|||
126314641|NCT02386345|454442751|FG000|Overall Study|Did not complete 12-month follow-up|72|||
126314642|NCT02258542|454442752|FG000|Overall Study|eg. not made to the visit|7|||
126314643|NCT02258542|454442753|FG001|Overall Study|eg. not made to the visit|4|||
126314644|NCT02258542|454442754|FG002|Overall Study|eg. not made to the visit|0|||
126314645|NCT02258542|454442755|FG003|Overall Study|eg. not made to the visit|1|||
126314646|NCT02258542|454442752|FG000|Overall Study|study specific discount. criteria|1|||
126314647|NCT02258542|454442753|FG001|Overall Study|study specific discount. criteria|1|||
126314648|NCT02258542|454442754|FG002|Overall Study|study specific discount. criteria|0|||
126314649|NCT02258542|454442755|FG003|Overall Study|study specific discount. criteria|0|||
126314650|NCT02258542|454442752|FG000|Overall Study|Withdrawal by Subject|20|||
126314651|NCT02258542|454442753|FG001|Overall Study|Withdrawal by Subject|20|||
126314652|NCT02258542|454442754|FG002|Overall Study|Withdrawal by Subject|7|||
126314653|NCT02258542|454442755|FG003|Overall Study|Withdrawal by Subject|1|||
126314654|NCT02258542|454442752|FG000|Overall Study|Lost to Follow-up|5|||
126314655|NCT02258542|454442753|FG001|Overall Study|Lost to Follow-up|12|||
126314656|NCT02258542|454442754|FG002|Overall Study|Lost to Follow-up|1|||
126314657|NCT02258542|454442755|FG003|Overall Study|Lost to Follow-up|2|||
126314658|NCT02258542|454442752|FG000|Overall Study|Death|5|||
126314659|NCT02258542|454442753|FG001|Overall Study|Death|4|||
126314660|NCT02258542|454442754|FG002|Overall Study|Death|0|||
126314661|NCT02258542|454442755|FG003|Overall Study|Death|1|||
126314662|NCT02258542|454442752|FG000|Overall Study|Adverse Event|3|||
126314663|NCT02258542|454442753|FG001|Overall Study|Adverse Event|4|||
126314664|NCT02258542|454442754|FG002|Overall Study|Adverse Event|0|||
126314665|NCT02258542|454442755|FG003|Overall Study|Adverse Event|0|||
126314666|NCT02258542|454442752|FG000|Overall Study|Protocol Violation|1|||
126314667|NCT02258542|454442753|FG001|Overall Study|Protocol Violation|2|||
126314668|NCT02258542|454442754|FG002|Overall Study|Protocol Violation|0|||
126314669|NCT02258542|454442755|FG003|Overall Study|Protocol Violation|0|||
126314670|NCT02258542|454442752|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126314671|NCT02258542|454442753|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
126314672|NCT02258542|454442754|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126314673|NCT02258542|454442755|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
126314674|NCT00986986|454442756|FG000|Overall Study|Lost to Follow-up|0|||
126314675|NCT00986986|454442757|FG001|Overall Study|Lost to Follow-up|1|||
126314676|NCT04050124|454442758|FG000|Overall Study|Death|1|||
126314677|NCT04050124|454442759|FG001|Overall Study|Death|0|||
126314678|NCT01537068|454442770|FG000|Overall Study|Lost to Follow-up|2|||
126314679|NCT01537068|454442771|FG001|Overall Study|Lost to Follow-up|1|||
126314680|NCT01537068|454442770|FG000|Overall Study|Adverse Event|0|||
126314681|NCT01537068|454442771|FG001|Overall Study|Adverse Event|1|||
126314682|NCT01537068|454442770|FG000|Overall Study|Withdrawal by Subject|1|||
126314683|NCT01537068|454442771|FG001|Overall Study|Withdrawal by Subject|1|||
126314684|NCT01537068|454442770|FG000|Overall Study|Lack of Efficacy|1|||
126314685|NCT01537068|454442771|FG001|Overall Study|Lack of Efficacy|0|||
126314686|NCT00483704|454442772|FG000|Randomization|Withdrawal by Subject|19|||
126314687|NCT00483704|454442773|FG001|Randomization|Withdrawal by Subject|28|||
126314688|NCT00483704|454442774|FG002|Randomization|Withdrawal by Subject|18|||
126314689|NCT00483704|454442772|FG000|Randomization|Protocol Violation|14|||
126314690|NCT00483704|454442773|FG001|Randomization|Protocol Violation|25|||
126314691|NCT00483704|454442774|FG002|Randomization|Protocol Violation|22|||
126314692|NCT00483704|454442772|FG000|Randomization|Lost to Follow-up|14|||
126314693|NCT00483704|454442773|FG001|Randomization|Lost to Follow-up|14|||
126314694|NCT00483704|454442774|FG002|Randomization|Lost to Follow-up|19|||
126314695|NCT00483704|454442772|FG000|Randomization|Pregnancy|1|||
126314696|NCT00483704|454442773|FG001|Randomization|Pregnancy|0|||
126314697|NCT00483704|454442774|FG002|Randomization|Pregnancy|0|||
126314698|NCT00483704|454442772|FG000|Randomization|Physician Decision|2|||
126314699|NCT00483704|454442773|FG001|Randomization|Physician Decision|4|||
126314700|NCT00483704|454442774|FG002|Randomization|Physician Decision|0|||
126314701|NCT00483704|454442772|FG000|Randomization|Progressive disease|0|||
126314702|NCT00483704|454442773|FG001|Randomization|Progressive disease|0|||
126314703|NCT00483704|454442774|FG002|Randomization|Progressive disease|1|||
126314704|NCT00483704|454442772|FG000|Randomization|Lack of qualifying migraines|21|||
126314705|NCT00483704|454442773|FG001|Randomization|Lack of qualifying migraines|25|||
126314706|NCT00483704|454442774|FG002|Randomization|Lack of qualifying migraines|31|||
126314707|NCT00483704|454442772|FG000|Treatment|Lack of qualifying migraines|101|||
126314708|NCT00483704|454442773|FG001|Treatment|Lack of qualifying migraines|99|||
126314709|NCT00483704|454442774|FG002|Treatment|Lack of qualifying migraines|116|||
126314710|NCT00483704|454442772|FG000|Treatment|Adverse Event|3|||
126314711|NCT00483704|454442773|FG001|Treatment|Adverse Event|5|||
126314712|NCT00483704|454442774|FG002|Treatment|Adverse Event|4|||
126314713|NCT00483704|454442772|FG000|Treatment|Withdrawal by Subject|16|||
126314714|NCT00483704|454442773|FG001|Treatment|Withdrawal by Subject|12|||
126314715|NCT00483704|454442774|FG002|Treatment|Withdrawal by Subject|21|||
126314716|NCT00483704|454442772|FG000|Treatment|Protocol Violation|6|||
126314717|NCT00483704|454442773|FG001|Treatment|Protocol Violation|3|||
126314718|NCT00483704|454442774|FG002|Treatment|Protocol Violation|5|||
126314719|NCT00483704|454442772|FG000|Treatment|Lost to Follow-up|2|||
126314720|NCT00483704|454442773|FG001|Treatment|Lost to Follow-up|7|||
126314721|NCT00483704|454442774|FG002|Treatment|Lost to Follow-up|5|||
126314722|NCT00483704|454442772|FG000|Treatment|Lack of Efficacy|1|||
126314723|NCT00483704|454442773|FG001|Treatment|Lack of Efficacy|1|||
126314724|NCT00483704|454442774|FG002|Treatment|Lack of Efficacy|1|||
126314725|NCT00483704|454442772|FG000|Treatment|Pregnancy|0|||
126314726|NCT00483704|454442773|FG001|Treatment|Pregnancy|1|||
126314727|NCT00483704|454442774|FG002|Treatment|Pregnancy|0|||
126314728|NCT00483704|454442772|FG000|Treatment|Physician Decision|0|||
126314729|NCT00483704|454442773|FG001|Treatment|Physician Decision|1|||
126314730|NCT00483704|454442774|FG002|Treatment|Physician Decision|4|||
126314731|NCT04442269|454442775|FG000|Overall Study|Adverse Event|1|||
126314732|NCT04442269|454442776|FG001|Overall Study|Adverse Event|0|||
126314733|NCT04442269|454442775|FG000|Overall Study|Death|0|||
126314734|NCT04442269|454442776|FG001|Overall Study|Death|1|||
126314735|NCT04442269|454442775|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
126314736|NCT04442269|454442776|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
126314737|NCT04442269|454442775|FG000|Overall Study|Lost to Follow-up|1|||
126314738|NCT04442269|454442776|FG001|Overall Study|Lost to Follow-up|0|||
126314739|NCT04442269|454442775|FG000|Overall Study|Withdrawal by Subject|3|||
126314740|NCT04442269|454442776|FG001|Overall Study|Withdrawal by Subject|2|||
126314741|NCT04442269|454442775|FG000|Overall Study|Protocol Deviation|0|||
126314742|NCT04442269|454442776|FG001|Overall Study|Protocol Deviation|1|||
126314743|NCT04442269|454442775|FG000|Overall Study|Travel Limitations|1|||
126314744|NCT04442269|454442776|FG001|Overall Study|Travel Limitations|1|||
126314745|NCT00819780|454442777|FG000|Overall Study|Did not receive study drug|3|||
126314746|NCT00819780|454442778|FG001|Overall Study|Did not receive study drug|4|||
126314747|NCT00819780|454442777|FG000|Overall Study|Still in treatment|25|||
126314748|NCT00819780|454442778|FG001|Overall Study|Still in treatment|17|||
126314749|NCT01793688|454442779|FG000|Overall Study|Protocol Violation|2|||
126314750|NCT01698879|454442782|FG000|Overall Study|Withdrawal by Subject|1|||
126314751|NCT01698879|454442783|FG001|Overall Study|Withdrawal by Subject|0|||
126314752|NCT01698879|454442784|FG002|Overall Study|Withdrawal by Subject|0|||
126314753|NCT04972968|454442785|FG000|Overall Study|Adverse Event|3|||
126314754|NCT04972968|454442786|FG001|Overall Study|Adverse Event|1|||
126314755|NCT04972968|454442787|FG002|Overall Study|Adverse Event|1|||
126314756|NCT04972968|454442788|FG003|Overall Study|Adverse Event|7|||
126314757|NCT04972968|454442785|FG000|Overall Study|Lack of Efficacy|2|||
126314758|NCT04972968|454442786|FG001|Overall Study|Lack of Efficacy|1|||
126314759|NCT04972968|454442787|FG002|Overall Study|Lack of Efficacy|0|||
126314760|NCT04972968|454442788|FG003|Overall Study|Lack of Efficacy|0|||
126314761|NCT04972968|454442785|FG000|Overall Study|Withdrawal by Subject|7|||
126314762|NCT04972968|454442786|FG001|Overall Study|Withdrawal by Subject|4|||
126314763|NCT04972968|454442787|FG002|Overall Study|Withdrawal by Subject|3|||
126314764|NCT04972968|454442788|FG003|Overall Study|Withdrawal by Subject|2|||
126314765|NCT04972968|454442785|FG000|Overall Study|Study Terminated by Sponsor|25|||
126314766|NCT04972968|454442786|FG001|Overall Study|Study Terminated by Sponsor|28|||
126314767|NCT04972968|454442787|FG002|Overall Study|Study Terminated by Sponsor|32|||
126314768|NCT04972968|454442788|FG003|Overall Study|Study Terminated by Sponsor|27|||
126314769|NCT04972968|454442785|FG000|Overall Study|Other|1|||
126314770|NCT04972968|454442786|FG001|Overall Study|Other|0|||
126314771|NCT04972968|454442787|FG002|Overall Study|Other|1|||
126314772|NCT04972968|454442788|FG003|Overall Study|Other|1|||
126314773|NCT03589976|454442793|FG000|Overall Study|Death|5|||
126314774|NCT03589976|454442794|FG001|Overall Study|Death|1|||
126314775|NCT03589976|454442793|FG000|Overall Study|Adverse Event|5|||
126314776|NCT03589976|454442794|FG001|Overall Study|Adverse Event|1|||
126314777|NCT03589976|454442793|FG000|Overall Study|Withdrawal by Subject|4|||
126314778|NCT03589976|454442794|FG001|Overall Study|Withdrawal by Subject|1|||
126314779|NCT03589976|454442793|FG000|Overall Study|Lost to Follow-up|1|||
126314780|NCT03589976|454442794|FG001|Overall Study|Lost to Follow-up|0|||
126314781|NCT03589976|454442793|FG000|Overall Study|Other|4|||
126314782|NCT03589976|454442794|FG001|Overall Study|Other|3|||
126314783|NCT00514904|454442797|FG000|Overall Study|Withdrawal by Subject|3|||
126314784|NCT00514904|454442798|FG001|Overall Study|Withdrawal by Subject|2|||
126314785|NCT00514904|454442797|FG000|Overall Study|Lost to Follow-up|21|||
126314786|NCT00514904|454442798|FG001|Overall Study|Lost to Follow-up|3|||
126314787|NCT00084318|454442800|FG000|Overall Study|Withdrawal by Subject|5|||
126314788|NCT00084318|454442801|FG001|Overall Study|Withdrawal by Subject|2|||
126314789|NCT00084318|454442800|FG000|Overall Study|Protocol Violation|15|||
126314790|NCT00084318|454442801|FG001|Overall Study|Protocol Violation|11|||
126314791|NCT00084318|454442800|FG000|Overall Study|No protocol treatment|2|||
126314792|NCT00084318|454442801|FG001|Overall Study|No protocol treatment|0|||
126314793|NCT03430895|454442802|FG000|Overall Study|Not Treated|2|||
126314794|NCT01317797|454442804|FG000|Overall Study|Other|0|||
126314795|NCT01317797|454442805|FG001|Overall Study|Other|1|||
126314796|NCT01317797|454442806|FG002|Overall Study|Other|0|||
126314797|NCT01317797|454442804|FG000|Overall Study|Withdrawal of Patient|0|||
126314798|NCT01317797|454442805|FG001|Overall Study|Withdrawal of Patient|0|||
126314799|NCT01317797|454442806|FG002|Overall Study|Withdrawal of Patient|1|||
126314800|NCT03197467|454444026|FG000|Overall Study|Withdrawal by Subject|1|||
126314801|NCT04599933|454444034|FG000|Overall Study|Adverse Event|4|||
126314802|NCT04599933|454444035|FG001|Overall Study|Adverse Event|1|||
126314803|NCT04599933|454444034|FG000|Overall Study|Withdrawal by Subject|4|||
126314804|NCT04599933|454444035|FG001|Overall Study|Withdrawal by Subject|2|||
126314805|NCT04599933|454444034|FG000|Overall Study|Lost to Follow-up|0|||
126314806|NCT04599933|454444035|FG001|Overall Study|Lost to Follow-up|1|||
126314807|NCT04599933|454444034|FG000|Overall Study|Physician Decision|0|||
126314808|NCT04599933|454444035|FG001|Overall Study|Physician Decision|1|||
126314809|NCT04599933|454444034|FG000|Overall Study|Screen Failure|1|||
126314810|NCT04599933|454444035|FG001|Overall Study|Screen Failure|2|||
126314811|NCT04392167|454444043|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
126314812|NCT04063657|454444044|FG000|Overall Study|Lost to Follow-up|1|||
126314813|NCT04063657|454444045|FG001|Overall Study|Lost to Follow-up|0|||
126314814|NCT03408444|454444046|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
126314815|NCT03408444|454444047|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
126314816|NCT03408444|454444048|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
126314817|NCT03408444|454444049|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
126314818|NCT03408444|454444046|FG000|Overall Study|Lens Discomfort|0|||
126314819|NCT03408444|454444047|FG001|Overall Study|Lens Discomfort|1|||
126314820|NCT03408444|454444048|FG002|Overall Study|Lens Discomfort|0|||
126314821|NCT03408444|454444049|FG003|Overall Study|Lens Discomfort|0|||
126314822|NCT03408444|454444046|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
126314823|NCT03408444|454444047|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
126314824|NCT03408444|454444048|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
126314825|NCT03408444|454444049|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
126314826|NCT03408444|454444046|FG000|Overall Study|Withdrawal by Subject|0|||
126314827|NCT03408444|454444047|FG001|Overall Study|Withdrawal by Subject|2|||
126314828|NCT03408444|454444048|FG002|Overall Study|Withdrawal by Subject|3|||
126314829|NCT03408444|454444049|FG003|Overall Study|Withdrawal by Subject|0|||
126314830|NCT03408444|454444046|FG000|Overall Study|Lost to Follow-up|0|||
126314831|NCT03408444|454444047|FG001|Overall Study|Lost to Follow-up|0|||
126314832|NCT03408444|454444048|FG002|Overall Study|Lost to Follow-up|1|||
126314833|NCT03408444|454444049|FG003|Overall Study|Lost to Follow-up|0|||
126314834|NCT03408444|454444046|FG000|Overall Study|Adverse Event|0|||
126314835|NCT03408444|454444047|FG001|Overall Study|Adverse Event|0|||
126314836|NCT03408444|454444048|FG002|Overall Study|Adverse Event|0|||
126314837|NCT03408444|454444049|FG003|Overall Study|Adverse Event|1|||
126314838|NCT03408444|454444046|FG000|Overall Study|Lens Handling Difficulties|0|||
126314839|NCT03408444|454444047|FG001|Overall Study|Lens Handling Difficulties|0|||
126314840|NCT03408444|454444048|FG002|Overall Study|Lens Handling Difficulties|1|||
126314841|NCT03408444|454444049|FG003|Overall Study|Lens Handling Difficulties|0|||
126314842|NCT03408444|454444046|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
126314843|NCT03408444|454444047|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
126314844|NCT03408444|454444048|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
126314845|NCT03408444|454444049|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
126314846|NCT04984681|454444050|FG000|Overall Study|Lost to Follow-up|3|||
126314847|NCT04984681|454444051|FG001|Overall Study|Lost to Follow-up|1|||
126314848|NCT01473394|454444052|FG000|Overall Study|Adverse Event|13|||
126314849|NCT01473394|454444053|FG001|Overall Study|Adverse Event|16|||
126314850|NCT01473394|454444052|FG000|Overall Study|Insufficient Therapeutic Response|4|||
126314851|NCT01473394|454444053|FG001|Overall Study|Insufficient Therapeutic Response|1|||
126314852|NCT01473394|454444052|FG000|Overall Study|Protocol Violation|7|||
126314853|NCT01473394|454444053|FG001|Overall Study|Protocol Violation|5|||
126314854|NCT01473394|454444052|FG000|Overall Study|Withdrew Consent|12|||
126314855|NCT01473394|454444053|FG001|Overall Study|Withdrew Consent|10|||
126314856|NCT01473394|454444052|FG000|Overall Study|Lost to Follow-up|9|||
126314857|NCT01473394|454444053|FG001|Overall Study|Lost to Follow-up|11|||
126314858|NCT03536949|454444056|FG000|Overall Study|Adverse Event|4|||
126314859|NCT03536949|454444057|FG001|Overall Study|Adverse Event|0|||
126314860|NCT03536949|454444056|FG000|Overall Study|Lost to Follow-up|2|||
126314861|NCT03536949|454444057|FG001|Overall Study|Lost to Follow-up|1|||
126314862|NCT03536949|454444056|FG000|Overall Study|Withdrawal by Subject|6|||
126314863|NCT03536949|454444057|FG001|Overall Study|Withdrawal by Subject|0|||
126314864|NCT03536949|454444056|FG000|Overall Study|Non-compliance|2|||
126314865|NCT03536949|454444057|FG001|Overall Study|Non-compliance|1|||
126314866|NCT00250458|454444061|FG000|Overall Study|Lost to Follow-up|4|||
126314867|NCT00250458|454444062|FG001|Overall Study|Lost to Follow-up|2|||
126314868|NCT00250458|454444061|FG000|Overall Study|Protocol Violation|0|||
126314869|NCT00250458|454444062|FG001|Overall Study|Protocol Violation|1|||
126314870|NCT00250458|454444061|FG000|Overall Study|Withdrawal by Subject|4|||
126314871|NCT00250458|454444062|FG001|Overall Study|Withdrawal by Subject|2|||
126314872|NCT00250458|454444061|FG000|Overall Study|Lack of Migraine Attack|20|||
126314873|NCT00250458|454444062|FG001|Overall Study|Lack of Migraine Attack|9|||
126314874|NCT00250458|454444061|FG000|Overall Study|Qualifying migraine but did not treat|3|||
126314875|NCT00250458|454444062|FG001|Overall Study|Qualifying migraine but did not treat|3|||
126314876|NCT00250458|454444061|FG000|Overall Study|Other|1|||
126314877|NCT00250458|454444062|FG001|Overall Study|Other|0|||
126314878|NCT01549041|454444063|FG000|Overall Study|Lack of Efficacy|2|||
126314879|NCT01549041|454444064|FG001|Overall Study|Lack of Efficacy|4|||
126314880|NCT01549041|454444063|FG000|Overall Study|Adverse Event|0|||
126314881|NCT01549041|454444064|FG001|Overall Study|Adverse Event|4|||
126314882|NCT00597506|454444065|FG000|Overall Study|Subject is being followed for survival|1|||
126314883|NCT02609724|454444066|FG000|Overall Study|Death|2|||
126314884|NCT02609724|454444067|FG001|Overall Study|Death|0|||
126314885|NCT02609724|454444068|FG002|Overall Study|Death|1|||
126314886|NCT02609724|454444066|FG000|Overall Study|Withdrawal by Subject|1|||
126314887|NCT02609724|454444067|FG001|Overall Study|Withdrawal by Subject|2|||
126314888|NCT02609724|454444068|FG002|Overall Study|Withdrawal by Subject|3|||
126314889|NCT02609724|454444066|FG000|Overall Study|Illness|2|||
126314890|NCT02609724|454444067|FG001|Overall Study|Illness|1|||
126314891|NCT02609724|454444068|FG002|Overall Study|Illness|0|||
126314892|NCT03077659|454444069|FG000|Overall Study|Withdrawal by Subject|0|||
126314893|NCT03077659|454444070|FG001|Overall Study|Withdrawal by Subject|0|||
126314894|NCT03077659|454444071|FG002|Overall Study|Withdrawal by Subject|1|||
126314895|NCT04272606|454444074|FG000|Overall Study|Protocol Violation|1|||
126314896|NCT04272606|454444075|FG001|Overall Study|Protocol Violation|1|||
126314897|NCT04272606|454444074|FG000|Overall Study|Physician Decision|0|||
126314898|NCT04272606|454444075|FG001|Overall Study|Physician Decision|1|||
126314899|NCT04450407|454444076|FG000|Overall Study|Withdrawal by Subject|10|||
126314900|NCT04450407|454444077|FG001|Overall Study|Withdrawal by Subject|1|||
126314901|NCT04450407|454444078|FG002|Overall Study|Withdrawal by Subject|4|||
126314902|NCT04450407|454444076|FG000|Overall Study|Adverse Event|0|||
126314903|NCT04450407|454444077|FG001|Overall Study|Adverse Event|0|||
126314904|NCT04450407|454444078|FG002|Overall Study|Adverse Event|1|||
126314905|NCT04450407|454444076|FG000|Overall Study|Lost to Follow-up|1|||
126314906|NCT04450407|454444077|FG001|Overall Study|Lost to Follow-up|0|||
126314907|NCT04450407|454444078|FG002|Overall Study|Lost to Follow-up|0|||
126314908|NCT04450407|454444076|FG000|Overall Study|Physician Decision|0|||
126314909|NCT04450407|454444077|FG001|Overall Study|Physician Decision|0|||
126314910|NCT04450407|454444078|FG002|Overall Study|Physician Decision|1|||
126314911|NCT04450407|454444076|FG000|Overall Study|Pregnancy|1|||
126314912|NCT04450407|454444077|FG001|Overall Study|Pregnancy|0|||
126314913|NCT04450407|454444078|FG002|Overall Study|Pregnancy|0|||
126314914|NCT04450407|454444076|FG000|Overall Study|Protocol Violation|2|||
126314915|NCT04450407|454444077|FG001|Overall Study|Protocol Violation|0|||
126314916|NCT04450407|454444078|FG002|Overall Study|Protocol Violation|0|||
126314917|NCT04450407|454444076|FG000|Overall Study|Investigational site terminated by sponsor|3|||
126314918|NCT04450407|454444077|FG001|Overall Study|Investigational site terminated by sponsor|0|||
126314919|NCT04450407|454444078|FG002|Overall Study|Investigational site terminated by sponsor|2|||
126314920|NCT02089334|454444079|FG000|Overall Study|Withdrawal by Subject|0|||
126314921|NCT02089334|454444080|FG001|Overall Study|Withdrawal by Subject|0|||
126314922|NCT02089334|454444081|FG002|Overall Study|Withdrawal by Subject|0|||
126314923|NCT02089334|454444082|FG003|Overall Study|Withdrawal by Subject|2|||
126314924|NCT02089334|454444079|FG000|Overall Study|Adverse Event|0|||
126314925|NCT02089334|454444080|FG001|Overall Study|Adverse Event|0|||
126314926|NCT02089334|454444081|FG002|Overall Study|Adverse Event|0|||
126314927|NCT02089334|454444082|FG003|Overall Study|Adverse Event|2|||
126314928|NCT02089334|454444079|FG000|Overall Study|Progressive disease|0|||
126314929|NCT02089334|454444080|FG001|Overall Study|Progressive disease|0|||
126314930|NCT02089334|454444081|FG002|Overall Study|Progressive disease|0|||
126314931|NCT02089334|454444082|FG003|Overall Study|Progressive disease|2|||
126314932|NCT02089334|454444079|FG000|Overall Study|Physician Decision|0|||
126314933|NCT02089334|454444080|FG001|Overall Study|Physician Decision|0|||
126314934|NCT02089334|454444081|FG002|Overall Study|Physician Decision|1|||
126314935|NCT02089334|454444082|FG003|Overall Study|Physician Decision|1|||
126314936|NCT02832375|454444083|FG000|Overall Study|Lost to Follow-up|1|||
126314937|NCT02832375|454444084|FG001|Overall Study|Lost to Follow-up|0|||
126314938|NCT02832375|454444083|FG000|Overall Study|Withdrawal of Consent|1|||
126314939|NCT02832375|454444084|FG001|Overall Study|Withdrawal of Consent|0|||
126314940|NCT01645891|454444087|FG000|Overall Study|Adverse Event|6|||
126314941|NCT01645891|454444088|FG001|Overall Study|Adverse Event|10|||
126314942|NCT01645891|454444087|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
126314943|NCT01645891|454444088|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
126314944|NCT01645891|454444087|FG000|Overall Study|Withdrawal by Subject|3|||
126314945|NCT01645891|454444088|FG001|Overall Study|Withdrawal by Subject|3|||
126314946|NCT01645891|454444087|FG000|Overall Study|Protocol Violation|4|||
126314947|NCT01645891|454444088|FG001|Overall Study|Protocol Violation|0|||
126314948|NCT01645891|454444087|FG000|Overall Study|Lost to Follow-up|4|||
126314949|NCT01645891|454444088|FG001|Overall Study|Lost to Follow-up|1|||
126314950|NCT01645891|454444087|FG000|Overall Study|Death|0|||
126314951|NCT01645891|454444088|FG001|Overall Study|Death|2|||
126314952|NCT00138073|454444091|FG000|Overall Study|lack of resources|55|||
126314953|NCT03301740|454444092|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
126314954|NCT03301740|454444093|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
126314955|NCT03301740|454444092|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
126314956|NCT03301740|454444093|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
126314957|NCT01037127|454444095|FG000|Overall Study|Lost to Follow-up|2|||
126314958|NCT01037127|454444096|FG001|Overall Study|Lost to Follow-up|4|||
126314959|NCT01037127|454444095|FG000|Overall Study|Physician Decision|1|||
126314960|NCT01037127|454444096|FG001|Overall Study|Physician Decision|0|||
126314961|NCT01037127|454444095|FG000|Overall Study|Study Closed Terminated|2|||
126314962|NCT01037127|454444096|FG001|Overall Study|Study Closed Terminated|17|||
126314963|NCT02637713|454444103|FG000|Overall Study|Screen Failure|2|||
126314964|NCT02847182|454444104|FG000|Overall Study|Withdrawal by Subject|0|||
126314965|NCT02847182|454444105|FG001|Overall Study|Withdrawal by Subject|1|||
126314966|NCT02345889|454444106|FG000|Overall Study|Inadequate Bowel Prep|17|||
126314967|NCT02345889|454444107|FG001|Overall Study|Inadequate Bowel Prep|16|||
126314968|NCT02345889|454444108|FG002|Overall Study|Inadequate Bowel Prep|18|||
126314969|NCT02345889|454444109|FG003|Overall Study|Inadequate Bowel Prep|14|||
126314970|NCT02345889|454444106|FG000|Overall Study|Polyposis identified during procedure|1|||
126314971|NCT02345889|454444107|FG001|Overall Study|Polyposis identified during procedure|1|||
126314972|NCT02345889|454444108|FG002|Overall Study|Polyposis identified during procedure|0|||
126314973|NCT02345889|454444109|FG003|Overall Study|Polyposis identified during procedure|1|||
126314974|NCT02345889|454444106|FG000|Overall Study|Recognized ineligible post-randomization|1|||
126314975|NCT02345889|454444107|FG001|Overall Study|Recognized ineligible post-randomization|0|||
126314976|NCT02345889|454444108|FG002|Overall Study|Recognized ineligible post-randomization|2|||
126314977|NCT02345889|454444109|FG003|Overall Study|Recognized ineligible post-randomization|1|||
126314978|NCT02345889|454444106|FG000|Overall Study|Ulcerative Colitis identified|1|||
126314979|NCT02345889|454444107|FG001|Overall Study|Ulcerative Colitis identified|0|||
126314980|NCT02345889|454444108|FG002|Overall Study|Ulcerative Colitis identified|0|||
126314981|NCT02345889|454444109|FG003|Overall Study|Ulcerative Colitis identified|0|||
126314982|NCT02345889|454444106|FG000|Overall Study|Cecum not intubated|1|||
126314983|NCT02345889|454444107|FG001|Overall Study|Cecum not intubated|0|||
126314984|NCT02345889|454444108|FG002|Overall Study|Cecum not intubated|0|||
126314985|NCT02345889|454444109|FG003|Overall Study|Cecum not intubated|0|||
126314986|NCT01173055|454444110|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
126314987|NCT01173055|454444111|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
126314988|NCT01173055|454444110|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
126314989|NCT01173055|454444111|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
126314990|NCT04325698|454444113|FG000|Overall Study|Study Terminated By Sponsor|1|||
126314991|NCT04325698|454444114|FG001|Overall Study|Study Terminated By Sponsor|1|||
126314992|NCT04325698|454444113|FG000|Overall Study|Withdrawal by Subject|0|||
126314993|NCT04325698|454444114|FG001|Overall Study|Withdrawal by Subject|2|||
126314994|NCT00962091|454444115|FG000|Overall Study|Withdrawal by Subject|1|||
126314995|NCT00962091|454444116|FG001|Overall Study|Withdrawal by Subject|2|||
126314996|NCT00962091|454444117|FG002|Overall Study|Withdrawal by Subject|1|||
126314997|NCT00962091|454444118|FG003|Overall Study|Withdrawal by Subject|1|||
126314998|NCT00962091|454444119|FG004|Overall Study|Withdrawal by Subject|0|||
126314999|NCT00962091|454444120|FG005|Overall Study|Withdrawal by Subject|1|||
126315000|NCT00962091|454444121|FG006|Overall Study|Withdrawal by Subject|0|||
126315001|NCT00962091|454444115|FG000|Overall Study|Adverse Event|0|||
126315002|NCT00962091|454444116|FG001|Overall Study|Adverse Event|0|||
126315003|NCT00962091|454444117|FG002|Overall Study|Adverse Event|0|||
126315004|NCT00962091|454444118|FG003|Overall Study|Adverse Event|0|||
126315005|NCT00962091|454444119|FG004|Overall Study|Adverse Event|0|||
126315006|NCT00962091|454444120|FG005|Overall Study|Adverse Event|0|||
126315007|NCT00962091|454444121|FG006|Overall Study|Adverse Event|1|||
126315008|NCT04253782|454444122|FG000|Overall Study|Death|2|||
126315009|NCT04253782|454444123|FG001|Overall Study|Death|0|||
126315010|NCT04216589|454444125|FG000|Overall Study|Withdrawal by Subject|2|||
126315011|NCT04216589|454444125|FG000|Overall Study|Protocol Violation|1|||
126315012|NCT04216589|454444125|FG000|Overall Study|Incarceration|1|||
126315013|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315014|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315015|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
126315016|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315017|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315018|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315019|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315020|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315021|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315022|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315023|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315024|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315025|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315026|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315027|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
126315028|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315029|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315030|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315031|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315032|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315033|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315034|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315035|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315036|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315037|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315038|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315039|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315040|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315041|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
126315042|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
126315043|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315044|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315045|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315046|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315047|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315048|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315049|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315050|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315051|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315052|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315053|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315054|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315055|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
126315056|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
126315057|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315058|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315059|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315060|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315061|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315062|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315063|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315064|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315065|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315066|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315067|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315068|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315069|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315070|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315071|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
126315072|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315073|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315074|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315075|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315076|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315077|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126090443|NCT04191616|453623567|FG000|Pre-assignment Period|Did not receive study treatment|2|||
126090444|NCT04191616|453623567|FG000|Treatment Period|Death|37|||
126315078|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315079|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315080|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315081|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315082|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315083|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315084|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315085|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315086|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315087|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315088|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126315089|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
126315090|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126315091|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126315092|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126315093|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315094|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315095|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315096|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315097|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315098|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315099|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315100|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315101|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315102|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
126315103|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
126315104|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315105|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
126315106|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315107|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315108|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315109|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315110|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315111|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315112|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315113|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315114|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315115|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315116|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
126315117|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315118|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315119|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315120|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315121|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315122|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315123|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315124|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315125|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315126|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315127|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315128|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315129|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315130|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315131|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
126315132|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315133|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315134|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315135|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315136|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315137|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315138|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315139|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315140|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315141|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315142|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315143|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315144|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315145|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315146|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
126315147|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315148|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315149|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315150|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315151|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315152|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315153|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315154|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315155|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315156|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315157|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315158|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315159|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
126315160|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
126315161|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315162|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315163|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315164|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315165|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315166|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315167|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315168|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315169|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315170|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315171|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315172|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315173|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315174|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
126315175|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315176|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315177|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315178|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315179|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315180|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315181|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315182|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315183|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315184|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315185|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315186|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
126315187|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315188|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315189|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315190|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315191|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315192|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315193|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315194|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315195|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
126315196|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
126315197|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
126315198|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
126315199|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
126315200|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
126315201|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
126315202|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
126315203|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
126315204|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
126315205|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
126315206|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
126315207|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
126315208|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
126315209|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315210|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315211|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315212|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315213|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315214|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315215|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315216|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315217|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315218|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315219|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315220|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
126315221|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
126315222|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315223|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315224|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315225|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315226|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315227|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315228|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315229|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315230|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315231|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315232|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315233|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315234|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126315235|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126315236|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315237|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315238|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315239|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315240|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315241|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315242|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315243|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315244|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315245|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315246|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315247|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315248|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315249|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315250|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
126315251|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315252|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315253|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315254|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315255|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315256|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315257|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315258|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315259|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315260|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315261|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315262|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
126315263|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
126315264|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
126315265|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315266|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315267|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315268|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315269|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315270|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315271|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315272|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315273|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315274|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315275|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315276|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
126315277|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
126315278|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
126315279|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315280|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315281|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315282|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315283|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315284|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315285|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315286|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315287|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315288|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315289|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315290|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
126315291|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
126315292|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
126315293|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315294|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315295|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315296|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315297|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315298|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
126315299|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315300|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315301|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315302|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315303|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315304|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
126315305|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Adverse Event|0|||
126315306|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Adverse Event|0|||
126315307|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Adverse Event|0|||
126315308|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Adverse Event|0|||
126315309|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Adverse Event|0|||
126315310|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Adverse Event|2|||
126315311|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315312|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315313|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315314|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315315|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315316|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
126315317|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315318|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315319|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315320|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315321|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315322|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
126315323|NCT03191864|454444145|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
126315324|NCT03191864|454444146|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
126315325|NCT03191864|454444147|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
126315326|NCT03191864|454444148|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
126315327|NCT03191864|454444149|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
126315328|NCT03191864|454444150|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
126315329|NCT03191864|454444145|FG000|Part 1 - Induction|Adverse Event|0|||
126315330|NCT03191864|454444146|FG001|Part 1 - Induction|Adverse Event|2|||
126315331|NCT03191864|454444147|FG002|Part 1 - Induction|Adverse Event|0|||
126315332|NCT03191864|454444148|FG003|Part 1 - Induction|Adverse Event|1|||
126315333|NCT03191864|454444149|FG004|Part 1 - Induction|Adverse Event|0|||
126315334|NCT03191864|454444150|FG005|Part 1 - Induction|Adverse Event|2|||
126315335|NCT03191864|454444145|FG000|Part 1 - Induction|Randomized but never dosed|0|||
126315336|NCT03191864|454444146|FG001|Part 1 - Induction|Randomized but never dosed|0|||
126315337|NCT03191864|454444147|FG002|Part 1 - Induction|Randomized but never dosed|1|||
126315338|NCT03191864|454444148|FG003|Part 1 - Induction|Randomized but never dosed|0|||
126315339|NCT03191864|454444149|FG004|Part 1 - Induction|Randomized but never dosed|0|||
126315340|NCT03191864|454444150|FG005|Part 1 - Induction|Randomized but never dosed|0|||
126315341|NCT03191864|454444145|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
126315342|NCT03191864|454444146|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
126315343|NCT03191864|454444147|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
126315344|NCT03191864|454444148|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
126315345|NCT03191864|454444149|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
126315346|NCT03191864|454444150|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
126315347|NCT03191864|454444145|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315348|NCT03191864|454444146|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315349|NCT03191864|454444147|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
126315350|NCT03191864|454444148|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315351|NCT03191864|454444149|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315352|NCT03191864|454444150|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315353|NCT03191864|454444145|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
126315354|NCT03191864|454444146|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315355|NCT03191864|454444147|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315356|NCT03191864|454444148|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315357|NCT03191864|454444149|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315358|NCT03191864|454444150|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315359|NCT03191864|454444145|FG000|Part 2 - Maintenance|Physician Decision|1|||
126315360|NCT03191864|454444146|FG001|Part 2 - Maintenance|Physician Decision|0|||
126315361|NCT03191864|454444147|FG002|Part 2 - Maintenance|Physician Decision|0|||
126315362|NCT03191864|454444148|FG003|Part 2 - Maintenance|Physician Decision|0|||
126315363|NCT03191864|454444149|FG004|Part 2 - Maintenance|Physician Decision|0|||
126315364|NCT03191864|454444150|FG005|Part 2 - Maintenance|Physician Decision|0|||
126315365|NCT03191864|454444145|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
126315366|NCT03191864|454444146|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
126315367|NCT03191864|454444147|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
126315368|NCT03191864|454444148|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
126315369|NCT03191864|454444149|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
126315370|NCT03191864|454444150|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
126315371|NCT03191864|454444145|FG000|Part 2 - Maintenance|Adverse Event|0|||
126315372|NCT03191864|454444146|FG001|Part 2 - Maintenance|Adverse Event|0|||
126315373|NCT03191864|454444147|FG002|Part 2 - Maintenance|Adverse Event|0|||
126315374|NCT03191864|454444148|FG003|Part 2 - Maintenance|Adverse Event|0|||
126315375|NCT03191864|454444149|FG004|Part 2 - Maintenance|Adverse Event|1|||
126315376|NCT03191864|454444150|FG005|Part 2 - Maintenance|Adverse Event|0|||
126315377|NCT03191864|454444145|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
126315378|NCT03191864|454444146|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
126315379|NCT03191864|454444147|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
126315380|NCT03191864|454444148|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
126315381|NCT03191864|454444149|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
126315382|NCT03191864|454444150|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
126315383|NCT03191864|454444145|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315384|NCT03191864|454444146|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315385|NCT03191864|454444147|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315386|NCT03191864|454444148|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315387|NCT03191864|454444149|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
126315388|NCT03191864|454444150|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315389|NCT02342548|454444153|FG000|Overall Study|Adverse Event|12|||
126315390|NCT02342548|454444154|FG001|Overall Study|Adverse Event|17|||
126315391|NCT02342548|454444155|FG002|Overall Study|Adverse Event|13|||
126315392|NCT02342548|454444153|FG000|Overall Study|Lost to Follow-up|0|||
126315393|NCT02342548|454444154|FG001|Overall Study|Lost to Follow-up|1|||
126315394|NCT02342548|454444155|FG002|Overall Study|Lost to Follow-up|0|||
126315395|NCT02342548|454444153|FG000|Overall Study|Study terminated by sponsor|20|||
126315396|NCT02342548|454444154|FG001|Overall Study|Study terminated by sponsor|39|||
126315397|NCT02342548|454444155|FG002|Overall Study|Study terminated by sponsor|25|||
126315398|NCT02342548|454444153|FG000|Overall Study|Protocol Violation|0|||
126315399|NCT02342548|454444154|FG001|Overall Study|Protocol Violation|1|||
126315400|NCT02342548|454444155|FG002|Overall Study|Protocol Violation|0|||
126315401|NCT02342548|454444153|FG000|Overall Study|Withdrawal by Subject|1|||
126315402|NCT02342548|454444154|FG001|Overall Study|Withdrawal by Subject|3|||
126315403|NCT02342548|454444155|FG002|Overall Study|Withdrawal by Subject|4|||
126315404|NCT02342548|454444153|FG000|Overall Study|Other|1|||
126315405|NCT02342548|454444154|FG001|Overall Study|Other|1|||
126315406|NCT02342548|454444155|FG002|Overall Study|Other|1|||
126315407|NCT01047332|454444156|FG000|Overall Study|SEMS Obstruction|11|||
126315408|NCT01047332|454444157|FG001|Overall Study|SEMS Obstruction|20|||
126315409|NCT01047332|454444156|FG000|Overall Study|Died Unobstructed|38|||
126315410|NCT01047332|454444157|FG001|Overall Study|Died Unobstructed|41|||
126315411|NCT01047332|454444156|FG000|Overall Study|Lost to Follow-up|8|||
126315412|NCT01047332|454444157|FG001|Overall Study|Lost to Follow-up|3|||
126315413|NCT03521817|454444162|FG000|Overall Study|Protocol Violation|0|||
126315414|NCT03521817|454444163|FG001|Overall Study|Protocol Violation|1|||
126315415|NCT02417961|454445454|FG000|Overall Study|Adverse Event|1|||
126315416|NCT02417961|454445454|FG000|Overall Study|Lost to Follow-up|1|||
126315417|NCT02417961|454445454|FG000|Overall Study|Withdrawal by Subject|2|||
126315418|NCT03666533|454445458|FG000|Overall Study|Lost to Follow-up|2|||
126315419|NCT03666533|454445459|FG001|Overall Study|Lost to Follow-up|2|||
126315420|NCT04240886|454445460|FG000|Treatment Phase|Death|4|||
126315421|NCT04240886|454445460|FG000|Treatment Phase|Discontinuation by Subject|1|||
126315422|NCT04240886|454445460|FG000|Treatment Phase|Adverse Event|5|||
126315423|NCT04240886|454445460|FG000|Follow-up Phase|Withdrawal by Subject|1|||
126315424|NCT04240886|454445460|FG000|Follow-up Phase|Discontinuation by Subject|1|||
126315425|NCT04240886|454445460|FG000|Follow-up Phase|Death|2|||
126315426|NCT04743804|454445461|FG000|Overall Study|Other|1|||
126315427|NCT04743804|454445462|FG001|Overall Study|Other|0|||
126315428|NCT04743804|454445461|FG000|Overall Study|Withdrawal by Subject|0|||
126315429|NCT04743804|454445462|FG001|Overall Study|Withdrawal by Subject|1|||
126315430|NCT04743804|454445461|FG000|Overall Study|Study Terminated by Sponsor|1|||
126315431|NCT04743804|454445462|FG001|Overall Study|Study Terminated by Sponsor|4|||
126315432|NCT04743804|454445461|FG000|Overall Study|Physician Decision|0|||
126315433|NCT04743804|454445462|FG001|Overall Study|Physician Decision|1|||
126315434|NCT04743804|454445461|FG000|Overall Study|Death|3|||
126315435|NCT04743804|454445462|FG001|Overall Study|Death|0|||
126315436|NCT01632904|454445463|FG000|Overall Study|Adverse Event|4|||
126315437|NCT01632904|454445464|FG001|Overall Study|Adverse Event|1|||
126315438|NCT01632904|454445463|FG000|Overall Study|Physician Decision|0|||
126315439|NCT01632904|454445464|FG001|Overall Study|Physician Decision|1|||
126315440|NCT01632904|454445463|FG000|Overall Study|Subject decision|3|||
126315441|NCT01632904|454445464|FG001|Overall Study|Subject decision|2|||
126315442|NCT01632904|454445463|FG000|Overall Study|Disease Progression|0|||
126315443|NCT01632904|454445464|FG001|Overall Study|Disease Progression|1|||
126315444|NCT01632904|454445463|FG000|Overall Study|Reason for discontinuation not available|0|||
126315445|NCT01632904|454445464|FG001|Overall Study|Reason for discontinuation not available|1|||
126315446|NCT02059434|454445465|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
126315447|NCT02059434|454445466|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
126315448|NCT02059434|454445467|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
126315449|NCT02059434|454445468|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
126315450|NCT02059434|454445469|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
126315451|NCT02059434|454445470|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
126315452|NCT02059434|454445471|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
126315453|NCT02059434|454445472|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
126315454|NCT02059434|454445473|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
126315455|NCT02059434|454445465|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
126315456|NCT02059434|454445466|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
126315457|NCT02059434|454445467|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
126315458|NCT02059434|454445468|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
126315459|NCT02059434|454445469|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
126315460|NCT02059434|454445470|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
126315461|NCT02059434|454445471|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
126315462|NCT02059434|454445472|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
126315463|NCT02059434|454445473|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
126315464|NCT02059434|454445465|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
126315465|NCT02059434|454445466|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
126315466|NCT02059434|454445467|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
126315467|NCT02059434|454445468|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
126315468|NCT02059434|454445469|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
126315469|NCT02059434|454445470|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
126315470|NCT02059434|454445471|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
126315471|NCT02059434|454445472|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
126315472|NCT02059434|454445473|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
126315473|NCT02059434|454445465|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
126315474|NCT02059434|454445466|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
126315475|NCT02059434|454445467|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
126315476|NCT02059434|454445468|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
126315477|NCT02059434|454445469|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
126315478|NCT02059434|454445470|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
126315479|NCT02059434|454445471|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
126315480|NCT02059434|454445472|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
126315481|NCT02059434|454445473|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
126315482|NCT02059434|454445465|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315483|NCT02059434|454445466|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315484|NCT02059434|454445467|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315485|NCT02059434|454445468|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315486|NCT02059434|454445469|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315487|NCT02059434|454445470|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315488|NCT02059434|454445471|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315489|NCT02059434|454445472|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315490|NCT02059434|454445473|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
126315491|NCT01004406|454445478|FG000|Overall Study|Withdrawal by Subject|2|||
126315492|NCT01004406|454445479|FG001|Overall Study|Withdrawal by Subject|0|||
126315493|NCT01004406|454445478|FG000|Overall Study|Lost to Follow-up|1|||
126315494|NCT01004406|454445479|FG001|Overall Study|Lost to Follow-up|0|||
126315495|NCT02928770|454445480|FG000|Overall Study|Withdrawal by Subject|2|||
126315496|NCT03201874|454445481|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
126315497|NCT03201874|454445482|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
126315498|NCT03201874|454445481|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
126315499|NCT03201874|454445482|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
126315500|NCT02907593|454445485|FG000|Overall Study|Withdrawal by Subject|0|||
126315501|NCT02907593|454445486|FG001|Overall Study|Withdrawal by Subject|0|||
126315502|NCT02907593|454445487|FG002|Overall Study|Withdrawal by Subject|1|||
126315503|NCT02907593|454445488|FG003|Overall Study|Withdrawal by Subject|0|||
126315504|NCT04618471|454445489|FG000|Overall Study|Screen Failure|62|||
126315505|NCT04618471|454445489|FG000|Overall Study|Withdrawal by Subject|6|||
126315506|NCT04618471|454445489|FG000|Overall Study|Physician Decision|2|||
126315507|NCT04618471|454445489|FG000|Overall Study|Lost to Follow-up|1|||
126315508|NCT04618471|454445489|FG000|Overall Study|Various other reasons|2|||
126315509|NCT04618471|454445489|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
126315510|NCT01752634|454445490|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
126315511|NCT01752634|454445491|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
126315512|NCT01752634|454445492|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
126315513|NCT01752634|454445493|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
126315514|NCT01752634|454445494|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
126315515|NCT01752634|454445495|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
126315516|NCT01752634|454445490|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315517|NCT01752634|454445491|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
126315518|NCT01752634|454445492|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315519|NCT01752634|454445493|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315520|NCT01752634|454445494|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315521|NCT01752634|454445495|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315522|NCT01752634|454445490|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
126315523|NCT01752634|454445491|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
126315524|NCT01752634|454445492|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
126315525|NCT01752634|454445493|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
126315526|NCT01752634|454445494|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
126315527|NCT01752634|454445495|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
126315528|NCT01752634|454445490|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
126315529|NCT01752634|454445491|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
126315530|NCT01752634|454445492|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
126315531|NCT01752634|454445493|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
126315532|NCT01752634|454445494|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
126315533|NCT01752634|454445495|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
126315534|NCT01752634|454445490|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
126315535|NCT01752634|454445491|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
126315536|NCT01752634|454445492|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
126315537|NCT01752634|454445493|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
126315538|NCT01752634|454445494|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
126315539|NCT01752634|454445495|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
126315540|NCT01752634|454445490|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
126315541|NCT01752634|454445491|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
126315542|NCT01752634|454445492|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
126315543|NCT01752634|454445493|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
126315544|NCT01752634|454445494|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
126315545|NCT01752634|454445495|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
126315546|NCT01752634|454445490|FG000|Week 24 to Week 260|Physician Decision|1|||
126315547|NCT01752634|454445491|FG001|Week 24 to Week 260|Physician Decision|2|||
126315548|NCT01752634|454445492|FG002|Week 24 to Week 260|Physician Decision|4|||
126315549|NCT01752634|454445493|FG003|Week 24 to Week 260|Physician Decision|2|||
126315550|NCT01752634|454445494|FG004|Week 24 to Week 260|Physician Decision|1|||
126315551|NCT01752634|454445495|FG005|Week 24 to Week 260|Physician Decision|0|||
126315552|NCT01752634|454445490|FG000|Week 24 to Week 260|Death|0|||
126315553|NCT01752634|454445491|FG001|Week 24 to Week 260|Death|1|||
126315554|NCT01752634|454445492|FG002|Week 24 to Week 260|Death|0|||
126315555|NCT01752634|454445493|FG003|Week 24 to Week 260|Death|0|||
126315556|NCT01752634|454445494|FG004|Week 24 to Week 260|Death|0|||
126315557|NCT01752634|454445495|FG005|Week 24 to Week 260|Death|0|||
126315558|NCT01752634|454445490|FG000|Week 24 to Week 260|Pregnancy|0|||
126315559|NCT01752634|454445491|FG001|Week 24 to Week 260|Pregnancy|0|||
126315560|NCT01752634|454445492|FG002|Week 24 to Week 260|Pregnancy|1|||
126208219|NCT05261126|454049344|FG000|Overall Study|Physician Decision|1|||
126208220|NCT05261126|454049345|FG001|Overall Study|Physician Decision|0|||
126208221|NCT05261126|454049346|FG002|Overall Study|Physician Decision|0|||
126208222|NCT05261126|454049347|FG003|Overall Study|Physician Decision|0|||
126208223|NCT05261126|454049348|FG004|Overall Study|Physician Decision|0|||
126208224|NCT05261126|454049344|FG000|Overall Study|Screen Failure|0|||
126208225|NCT05261126|454049345|FG001|Overall Study|Screen Failure|0|||
126208226|NCT05261126|454049346|FG002|Overall Study|Screen Failure|0|||
126208227|NCT05261126|454049347|FG003|Overall Study|Screen Failure|0|||
126208228|NCT05261126|454049348|FG004|Overall Study|Screen Failure|1|||
126208229|NCT05261126|454049344|FG000|Overall Study|Withdrawal by Subject|1|||
126208230|NCT05261126|454049345|FG001|Overall Study|Withdrawal by Subject|0|||
126208231|NCT05261126|454049346|FG002|Overall Study|Withdrawal by Subject|1|||
126208232|NCT05261126|454049347|FG003|Overall Study|Withdrawal by Subject|1|||
126208233|NCT05261126|454049348|FG004|Overall Study|Withdrawal by Subject|0|||
126208234|NCT05261126|454049344|FG000|Overall Study|Not Recorded|0|||
126208235|NCT05261126|454049345|FG001|Overall Study|Not Recorded|0|||
126208236|NCT05261126|454049346|FG002|Overall Study|Not Recorded|0|||
126208237|NCT05261126|454049347|FG003|Overall Study|Not Recorded|1|||
126208238|NCT05261126|454049348|FG004|Overall Study|Not Recorded|0|||
126208239|NCT03901274|454049349|FG000|Overall Study|Lost to Follow-up|120|||
126208240|NCT03901274|454049350|FG001|Overall Study|Lost to Follow-up|124|||
126208241|NCT03901274|454049349|FG000|Overall Study|Withdrawal by Subject|0|||
126208242|NCT03901274|454049350|FG001|Overall Study|Withdrawal by Subject|6|||
126208243|NCT05570604|454049351|FG000|Overall Study|Lost to Follow-up|1|||
126208244|NCT05570604|454049352|FG001|Overall Study|Lost to Follow-up|5|||
126208245|NCT05570604|454049351|FG000|Overall Study|Illness|2|||
126208246|NCT05570604|454049352|FG001|Overall Study|Illness|2|||
126208247|NCT00145119|454049355|FG000|Overall Study|Death|45|||
126208248|NCT04527380|454049356|FG000|Overall Study|Lack of Efficacy|0|||
126208249|NCT04527380|454049357|FG001|Overall Study|Lack of Efficacy|1|||
126315561|NCT01752634|454445493|FG003|Week 24 to Week 260|Pregnancy|0|||
126315562|NCT01752634|454445494|FG004|Week 24 to Week 260|Pregnancy|0|||
126315563|NCT01752634|454445495|FG005|Week 24 to Week 260|Pregnancy|0|||
126315564|NCT01752634|454445490|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315565|NCT01752634|454445491|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315566|NCT01752634|454445492|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
126315567|NCT01752634|454445493|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315568|NCT01752634|454445494|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315569|NCT01752634|454445495|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315570|NCT01752634|454445490|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
126315571|NCT01752634|454445491|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
126315572|NCT01752634|454445492|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
126315573|NCT01752634|454445493|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
126315574|NCT01752634|454445494|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
126315575|NCT01752634|454445495|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
126315576|NCT01752634|454445490|FG000|Week 24 to Week 260|Adverse Event|4|||
126315577|NCT01752634|454445491|FG001|Week 24 to Week 260|Adverse Event|8|||
126315578|NCT01752634|454445492|FG002|Week 24 to Week 260|Adverse Event|8|||
126315579|NCT01752634|454445493|FG003|Week 24 to Week 260|Adverse Event|4|||
126315580|NCT01752634|454445494|FG004|Week 24 to Week 260|Adverse Event|2|||
126315581|NCT01752634|454445495|FG005|Week 24 to Week 260|Adverse Event|0|||
126315582|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Adverse Event|0|||
126315583|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Adverse Event|1|||
126315584|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Adverse Event|0|||
126315585|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Adverse Event|0|||
126315586|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Adverse Event|0|||
126315587|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Adverse Event|0|||
126315588|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Death|0|||
126315589|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Death|0|||
126315590|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Death|1|||
126315591|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Death|0|||
126315592|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Death|0|||
126315593|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Death|0|||
126315594|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315595|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
126315596|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315597|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315598|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315599|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315600|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315601|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315602|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
126315603|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315604|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315605|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315606|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315607|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315608|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315609|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
126315610|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315611|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315612|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
126315613|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
126315614|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
126315615|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
126315616|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
126315617|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
126315618|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
126315619|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
126315620|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
126315621|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
126315622|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
126315623|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
126315624|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Death|0|||
126315625|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Death|0|||
126315626|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Death|0|||
126315627|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Death|0|||
126315628|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Death|0|||
126315629|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Death|1|||
126315630|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315631|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315632|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315633|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315634|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315635|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
126315636|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
126315637|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
126315638|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
126315639|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
126315640|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
126315641|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
126315642|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315643|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315644|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315645|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315646|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315647|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
126315648|NCT03117881|454445515|FG000|Baseline|Withdrawal by Subject|21|||
126315649|NCT03117881|454445516|FG001|Baseline|Withdrawal by Subject|10|||
126315650|NCT03117881|454445517|FG002|Baseline|Withdrawal by Subject|0|||
126315651|NCT03117881|454445515|FG000|Baseline|Lost to Follow-up|22|||
126315652|NCT03117881|454445516|FG001|Baseline|Lost to Follow-up|25|||
126315653|NCT03117881|454445517|FG002|Baseline|Lost to Follow-up|0|||
126208250|NCT04527380|454049356|FG000|Overall Study|Withdrawal by Subject|1|||
126208251|NCT04527380|454049357|FG001|Overall Study|Withdrawal by Subject|0|||
126208252|NCT05437211|454049364|FG000|Overall Study|Patient's decision|1|||
126208253|NCT05437211|454049365|FG001|Overall Study|Patient's decision|1|||
126208254|NCT04410991|454049367|FG000|Overall Study|Poor compliance to protocol|5|||
126208255|NCT04410991|454049368|FG001|Overall Study|Poor compliance to protocol|4|||
126208256|NCT04410991|454049367|FG000|Overall Study|Withdrawal by Subject|59|||
126208257|NCT04410991|454049368|FG001|Overall Study|Withdrawal by Subject|55|||
126208258|NCT04410991|454049367|FG000|Overall Study|Other|10|||
126208259|NCT04410991|454049368|FG001|Overall Study|Other|4|||
126208260|NCT01463631|454049378|FG000|Overall Study|Withdrawal by Subject|0|||
126208261|NCT01463631|454049379|FG001|Overall Study|Withdrawal by Subject|0|||
126208262|NCT01463631|454049380|FG002|Overall Study|Withdrawal by Subject|0|||
126208263|NCT01463631|454049381|FG003|Overall Study|Withdrawal by Subject|1|||
126208264|NCT01463631|454049378|FG000|Overall Study|Death|0|||
126208265|NCT01463631|454049379|FG001|Overall Study|Death|0|||
126208266|NCT01463631|454049380|FG002|Overall Study|Death|1|||
126208267|NCT01463631|454049381|FG003|Overall Study|Death|0|||
126208268|NCT01463631|454049378|FG000|Overall Study|Progressive Disease|0|||
126208269|NCT01463631|454049379|FG001|Overall Study|Progressive Disease|0|||
126208270|NCT01463631|454049380|FG002|Overall Study|Progressive Disease|0|||
126208271|NCT01463631|454049381|FG003|Overall Study|Progressive Disease|5|||
126208272|NCT05966129|454049383|FG000|Overall Study|Death|1|||
126208273|NCT05966129|454049384|FG001|Overall Study|Death|2|||
126208274|NCT05966129|454049383|FG000|Overall Study|Lost to Follow-up|63|||
126208275|NCT05966129|454049384|FG001|Overall Study|Lost to Follow-up|66|||
126208276|NCT05966129|454049383|FG000|Overall Study|Protocol Violation|1|||
126208277|NCT05966129|454049384|FG001|Overall Study|Protocol Violation|0|||
126208278|NCT05966129|454049383|FG000|Overall Study|Withdrawal by Subject|26|||
126208279|NCT05966129|454049384|FG001|Overall Study|Withdrawal by Subject|25|||
126208280|NCT05966129|454049383|FG000|Overall Study|Surgery not completed|63|||
126208281|NCT05966129|454049384|FG001|Overall Study|Surgery not completed|69|||
126315654|NCT03117881|454445515|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
126315655|NCT03117881|454445516|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
126315656|NCT03117881|454445517|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
126315657|NCT03117881|454445515|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
126315658|NCT03117881|454445516|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
126315659|NCT03117881|454445517|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
126315660|NCT03117881|454445515|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
126315661|NCT03117881|454445516|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
126315662|NCT03117881|454445517|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
126315663|NCT03117881|454445515|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
126315664|NCT03117881|454445516|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
126315665|NCT03117881|454445517|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
126315666|NCT03117881|454445515|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
126315667|NCT03117881|454445516|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
126315668|NCT03117881|454445517|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
126315669|NCT03117881|454445515|FG000|6-Month Follow-Up|Did not complete test|53|||
126315670|NCT03117881|454445516|FG001|6-Month Follow-Up|Did not complete test|25|||
126315671|NCT03117881|454445517|FG002|6-Month Follow-Up|Did not complete test|7|||
126315672|NCT03117881|454445515|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
126315673|NCT03117881|454445516|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
126315674|NCT03117881|454445517|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
126315675|NCT03117881|454445515|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
126315676|NCT03117881|454445516|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
126315677|NCT03117881|454445517|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
126315678|NCT03117881|454445515|FG000|12-Month Follow-Up|Did not complete test|40|||
126315679|NCT03117881|454445516|FG001|12-Month Follow-Up|Did not complete test|0|||
126315680|NCT03117881|454445517|FG002|12-Month Follow-Up|Did not complete test|0|||
126315681|NCT01027897|454445518|FG000|Overall Study|Protocol Violation|1|||
126315682|NCT01027897|454445518|FG000|Overall Study|Withdrawal by Subject|1|||
126315683|NCT01911780|454445519|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
126315684|NCT01911780|454445520|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
126315685|NCT01911780|454445519|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
126315686|NCT01911780|454445520|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
126315687|NCT01911780|454445519|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
126315688|NCT01911780|454445520|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
126315689|NCT01911780|454445519|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
126315690|NCT01911780|454445520|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
126315691|NCT01911780|454445519|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
126315692|NCT01911780|454445520|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
126315693|NCT01911780|454445519|FG000|Extension Period (52 Weeks)|Personal reason|1|||
126315694|NCT01911780|454445520|FG001|Extension Period (52 Weeks)|Personal reason|1|||
126315695|NCT02045732|454445523|FG000|Overall Study|At the discretion of the investigator|1|||
126315696|NCT02045732|454445524|FG001|Overall Study|At the discretion of the investigator|1|||
126315697|NCT00473824|454445525|FG000|Overall Study|Virologic Breakthrough|1|||
126315698|NCT00473824|454445526|FG001|Overall Study|Virologic Breakthrough|0|||
126315699|NCT00473824|454445525|FG000|Overall Study|Adverse Event|1|||
126315700|NCT00473824|454445526|FG001|Overall Study|Adverse Event|0|||
126315701|NCT00473824|454445525|FG000|Overall Study|Death|1|||
126315702|NCT00473824|454445526|FG001|Overall Study|Death|0|||
126315703|NCT00473824|454445525|FG000|Overall Study|Lost to Follow-up|1|||
126315704|NCT00473824|454445526|FG001|Overall Study|Lost to Follow-up|0|||
126315705|NCT00473824|454445525|FG000|Overall Study|Withdrawal by physician|1|||
126315706|NCT00473824|454445526|FG001|Overall Study|Withdrawal by physician|0|||
126315707|NCT02560623|454445527|FG000|Overall Study|Unable to swallow sponge|0|||
126315708|NCT02560623|454445528|FG001|Overall Study|Unable to swallow sponge|1|||
126315709|NCT02560623|454445529|FG002|Overall Study|Unable to swallow sponge|0|||
126315710|NCT02560623|454445530|FG003|Overall Study|Unable to swallow sponge|0|||
126315711|NCT02560623|454445527|FG000|Overall Study|Intervention prior to sponge administration|0|||
126315712|NCT02560623|454445528|FG001|Overall Study|Intervention prior to sponge administration|1|||
126315713|NCT02560623|454445529|FG002|Overall Study|Intervention prior to sponge administration|0|||
126315714|NCT02560623|454445530|FG003|Overall Study|Intervention prior to sponge administration|0|||
126315715|NCT05014815|454445531|FG000|Overall Study|Death|63|||
126315716|NCT05014815|454445532|FG001|Overall Study|Death|70|||
126315717|NCT05014815|454445531|FG000|Overall Study|Withdrawal by Subject|10|||
126315718|NCT05014815|454445532|FG001|Overall Study|Withdrawal by Subject|10|||
126315719|NCT05014815|454445531|FG000|Overall Study|Lost to Follow-up|4|||
126315720|NCT05014815|454445532|FG001|Overall Study|Lost to Follow-up|2|||
126315721|NCT05014815|454445531|FG000|Overall Study|Physician Decision|2|||
126315722|NCT05014815|454445532|FG001|Overall Study|Physician Decision|4|||
126315723|NCT04247880|454445533|FG000|Overall Study|Lost to Follow-up|24|||
126315724|NCT04247880|454445534|FG001|Overall Study|Lost to Follow-up|17|||
126315725|NCT04247880|454445533|FG000|Overall Study|Withdrawal by Subject|3|||
126315726|NCT04247880|454445534|FG001|Overall Study|Withdrawal by Subject|0|||
126315727|NCT06303167|454445538|FG000|Overall Study|Ineligible|1|||
126315728|NCT06303167|454445538|FG000|Overall Study|Never start protocol therapy|2|||
126315729|NCT06303167|454445538|FG000|Overall Study|Disease progression|16|||
126315730|NCT02453282|454445539|FG000|Overall Study|Death|275|||
126315731|NCT02453282|454445540|FG001|Overall Study|Death|277|||
126315732|NCT02453282|454445541|FG002|Overall Study|Death|296|||
126315733|NCT02453282|454445539|FG000|Overall Study|Lost to Follow-up|1|||
126315734|NCT02453282|454445540|FG001|Overall Study|Lost to Follow-up|0|||
126315735|NCT02453282|454445541|FG002|Overall Study|Lost to Follow-up|2|||
126315736|NCT02453282|454445539|FG000|Overall Study|Withdrawal by Subject|12|||
126315737|NCT02453282|454445540|FG001|Overall Study|Withdrawal by Subject|10|||
126315738|NCT02453282|454445541|FG002|Overall Study|Withdrawal by Subject|11|||
126315739|NCT02453282|454445539|FG000|Overall Study|Participants ongoing at data cut-off|85|||
126315740|NCT02453282|454445540|FG001|Overall Study|Participants ongoing at data cut-off|84|||
126315741|NCT02453282|454445541|FG002|Overall Study|Participants ongoing at data cut-off|62|||
126315742|NCT02453282|454445539|FG000|Overall Study|Other|1|||
126315743|NCT02453282|454445540|FG001|Overall Study|Other|1|||
126315744|NCT02453282|454445541|FG002|Overall Study|Other|1|||
126315745|NCT01661933|454445542|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
126315746|NCT01661933|454445542|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
126315747|NCT01120249|454445543|FG000|Overall Study|No protocol treatment received|21|||
126315748|NCT01120249|454445544|FG001|Overall Study|No protocol treatment received|15|||
126315749|NCT01120249|454445543|FG000|Overall Study|Disease recurrence|107|||
126315750|NCT01120249|454445544|FG001|Overall Study|Disease recurrence|57|||
126315751|NCT01120249|454445543|FG000|Overall Study|Death|1|||
126315752|NCT01120249|454445544|FG001|Overall Study|Death|0|||
126315753|NCT01120249|454445543|FG000|Overall Study|Adverse Event|40|||
126315754|NCT01120249|454445544|FG001|Overall Study|Adverse Event|276|||
126315755|NCT01120249|454445543|FG000|Overall Study|Participant refusal|34|||
126315756|NCT01120249|454445544|FG001|Overall Study|Participant refusal|42|||
126315757|NCT01120249|454445543|FG000|Overall Study|Other reasons, not protocol specified|29|||
126315758|NCT01120249|454445544|FG001|Overall Study|Other reasons, not protocol specified|22|||
126315759|NCT02720744|454445545|FG000|Overall Study|Protocol Violation|0|||
126315760|NCT02720744|454445546|FG001|Overall Study|Protocol Violation|2|||
126315761|NCT02720744|454445545|FG000|Overall Study|Pregnancy|2|||
126315762|NCT02720744|454445546|FG001|Overall Study|Pregnancy|0|||
126315763|NCT02720744|454445545|FG000|Overall Study|Lack of Efficacy|2|||
126315764|NCT02720744|454445546|FG001|Overall Study|Lack of Efficacy|8|||
126315765|NCT02720744|454445545|FG000|Overall Study|Adverse Event|21|||
126315766|NCT02720744|454445546|FG001|Overall Study|Adverse Event|3|||
126315767|NCT02720744|454445545|FG000|Overall Study|Withdrawal by Subject|11|||
126315768|NCT02720744|454445546|FG001|Overall Study|Withdrawal by Subject|11|||
126315769|NCT02720744|454445545|FG000|Overall Study|Lost to follow up|2|||
126315770|NCT02720744|454445546|FG001|Overall Study|Lost to follow up|0|||
126315771|NCT02720744|454445545|FG000|Overall Study|Non Compliance with Investigational Product|0|||
126315772|NCT02720744|454445546|FG001|Overall Study|Non Compliance with Investigational Product|1|||
126315773|NCT02720744|454445545|FG000|Overall Study|Excluded Concomitant Medication|0|||
126315774|NCT02720744|454445546|FG001|Overall Study|Excluded Concomitant Medication|1|||
126315775|NCT01447446|454445547|FG000|Overall Study|Death|6|||
126315776|NCT01447446|454445548|FG001|Overall Study|Death|3|||
126315777|NCT01447446|454445549|FG002|Overall Study|Death|2|||
126315778|NCT01447446|454445550|FG003|Overall Study|Death|1|||
126315779|NCT01447446|454445551|FG004|Overall Study|Death|7|||
126315780|NCT01447446|454445552|FG005|Overall Study|Death|0|||
126315781|NCT01447446|454445547|FG000|Overall Study|Adverse Event|3|||
126315782|NCT01447446|454445548|FG001|Overall Study|Adverse Event|0|||
126315783|NCT01447446|454445549|FG002|Overall Study|Adverse Event|1|||
126315784|NCT01447446|454445550|FG003|Overall Study|Adverse Event|0|||
126315785|NCT01447446|454445551|FG004|Overall Study|Adverse Event|2|||
126315786|NCT01447446|454445552|FG005|Overall Study|Adverse Event|0|||
126315787|NCT01447446|454445547|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
126315788|NCT01447446|454445548|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
126315789|NCT01447446|454445549|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
126315790|NCT01447446|454445550|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
126315791|NCT01447446|454445551|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
126315792|NCT01447446|454445552|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
126315793|NCT01447446|454445547|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
126315794|NCT01447446|454445548|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
126315795|NCT01447446|454445549|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
126315796|NCT01447446|454445550|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
126315797|NCT01447446|454445551|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
126315798|NCT01447446|454445552|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
126315799|NCT01447446|454445547|FG000|Overall Study|Administrative/Other|34|||
126315800|NCT01447446|454445548|FG001|Overall Study|Administrative/Other|9|||
126315801|NCT01447446|454445549|FG002|Overall Study|Administrative/Other|10|||
126315802|NCT01447446|454445550|FG003|Overall Study|Administrative/Other|2|||
126315803|NCT01447446|454445551|FG004|Overall Study|Administrative/Other|33|||
126315804|NCT01447446|454445552|FG005|Overall Study|Administrative/Other|4|||
126315805|NCT01447446|454445547|FG000|Overall Study|SVR12 Assessment|13|||
126315806|NCT01447446|454445548|FG001|Overall Study|SVR12 Assessment|1|||
126315807|NCT01447446|454445549|FG002|Overall Study|SVR12 Assessment|2|||
126315808|NCT01447446|454445550|FG003|Overall Study|SVR12 Assessment|1|||
126315809|NCT01447446|454445551|FG004|Overall Study|SVR12 Assessment|5|||
126315810|NCT01447446|454445552|FG005|Overall Study|SVR12 Assessment|5|||
126315811|NCT01447446|454445547|FG000|Overall Study|New Treatment Started|8|||
126315812|NCT01447446|454445548|FG001|Overall Study|New Treatment Started|2|||
126315813|NCT01447446|454445549|FG002|Overall Study|New Treatment Started|1|||
126315814|NCT01447446|454445550|FG003|Overall Study|New Treatment Started|0|||
126315815|NCT01447446|454445551|FG004|Overall Study|New Treatment Started|2|||
126315816|NCT01447446|454445552|FG005|Overall Study|New Treatment Started|0|||
126315817|NCT01447446|454445547|FG000|Overall Study|Reason not Specified|1|||
126315818|NCT01447446|454445548|FG001|Overall Study|Reason not Specified|1|||
126315819|NCT01447446|454445549|FG002|Overall Study|Reason not Specified|1|||
126315820|NCT01447446|454445550|FG003|Overall Study|Reason not Specified|1|||
126315821|NCT01447446|454445551|FG004|Overall Study|Reason not Specified|1|||
126315822|NCT01447446|454445552|FG005|Overall Study|Reason not Specified|0|||
126315823|NCT01892085|454445566|FG000|Overall Study|Death|4|||
126315824|NCT01892085|454445567|FG001|Overall Study|Death|1|||
126315825|NCT01892085|454445568|FG002|Overall Study|Death|3|||
126315826|NCT01892085|454445566|FG000|Overall Study|Withdrawal by Subject|2|||
126315827|NCT01892085|454445567|FG001|Overall Study|Withdrawal by Subject|0|||
126315828|NCT01892085|454445568|FG002|Overall Study|Withdrawal by Subject|2|||
126315829|NCT01629823|454445569|FG000|Trial Period|Missed visit|11|||
126315830|NCT01629823|454445570|FG001|Trial Period|Missed visit|9|||
126315831|NCT01629823|454445571|FG002|Trial Period|Missed visit|8|||
126315832|NCT01629823|454445569|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
126315833|NCT01629823|454445570|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
126315834|NCT01629823|454445571|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
126315835|NCT01629823|454445569|FG000|Trial Period|Pregnancy|1|||
126315836|NCT01629823|454445570|FG001|Trial Period|Pregnancy|0|||
126315837|NCT01629823|454445571|FG002|Trial Period|Pregnancy|0|||
126315838|NCT01629823|454445569|FG000|Trial Period|Adverse Event|0|||
126315839|NCT01629823|454445570|FG001|Trial Period|Adverse Event|1|||
126315840|NCT01629823|454445571|FG002|Trial Period|Adverse Event|0|||
126315841|NCT01629823|454445569|FG000|Trial Period|Out-of-window visit|0|||
126315842|NCT01629823|454445570|FG001|Trial Period|Out-of-window visit|2|||
126315843|NCT01629823|454445571|FG002|Trial Period|Out-of-window visit|0|||
126315844|NCT01629823|454445569|FG000|Trial Period|Failed to hold medication|0|||
126315845|NCT01629823|454445570|FG001|Trial Period|Failed to hold medication|0|||
126315846|NCT01629823|454445571|FG002|Trial Period|Failed to hold medication|1|||
126315847|NCT01629823|454445569|FG000|Washout Period|Safety|2|||
126315848|NCT01629823|454445570|FG001|Washout Period|Safety|5|||
126315849|NCT01629823|454445571|FG002|Washout Period|Safety|0|||
126315850|NCT01629823|454445569|FG000|Washout Period|Pregnancy|1|||
126315851|NCT01629823|454445570|FG001|Washout Period|Pregnancy|0|||
126315852|NCT01629823|454445571|FG002|Washout Period|Pregnancy|0|||
126315853|NCT01629823|454445569|FG000|Washout Period|Protocol Violation|0|||
126315854|NCT01629823|454445570|FG001|Washout Period|Protocol Violation|1|||
126315855|NCT01629823|454445571|FG002|Washout Period|Protocol Violation|0|||
126315856|NCT02844907|454445572|FG000|With Dexamethasone|No IV access|1|||
126315857|NCT02003963|454445575|FG000|Overall Study|Lost to Follow-up|2|||
126315858|NCT02003963|454445576|FG001|Overall Study|Lost to Follow-up|1|||
126315859|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
126315860|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
126315861|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
126315862|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
126315863|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
126315864|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
126315865|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
126315866|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
126315867|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
126315868|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
126315869|NCT00204477|454445583|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
126315870|NCT00204477|454445584|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
126315871|NCT00204477|454445583|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
126315872|NCT00204477|454445584|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
126315873|NCT00787917|454445586|FG000|Blinded Treatment|Adverse Event|1|||
126315874|NCT00787917|454445587|FG001|Blinded Treatment|Adverse Event|0|||
126315875|NCT00787917|454445586|FG000|Blinded Treatment|Lack of Efficacy|1|||
126315876|NCT00787917|454445587|FG001|Blinded Treatment|Lack of Efficacy|0|||
126315877|NCT00787917|454445586|FG000|Blinded Treatment|Administrative problems|3|||
126315878|NCT00787917|454445587|FG001|Blinded Treatment|Administrative problems|2|||
126315879|NCT00787917|454445586|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
126315880|NCT00787917|454445587|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
126315881|NCT00787917|454445586|FG000|Open Label|Administrative problems|3|||
126315882|NCT00787917|454445587|FG001|Open Label|Administrative problems|0|||
126315883|NCT00778102|454445588|FG000|Overall Study|Adverse Event|8|||
126315884|NCT00778102|454445589|FG001|Overall Study|Adverse Event|5|||
126315885|NCT00778102|454445588|FG000|Overall Study|Death|1|||
126315886|NCT00778102|454445589|FG001|Overall Study|Death|1|||
126315887|NCT00778102|454445588|FG000|Overall Study|Lost to Follow-up|1|||
126315888|NCT00778102|454445589|FG001|Overall Study|Lost to Follow-up|0|||
126315889|NCT00778102|454445588|FG000|Overall Study|Violation of Selection Criteria|1|||
126315890|NCT00778102|454445589|FG001|Overall Study|Violation of Selection Criteria|1|||
126315891|NCT00778102|454445588|FG000|Overall Study|Protocol Violation|0|||
126315892|NCT00778102|454445589|FG001|Overall Study|Protocol Violation|1|||
126315893|NCT00778102|454445588|FG000|Overall Study|Refused Treatment|2|||
126315894|NCT00778102|454445589|FG001|Overall Study|Refused Treatment|3|||
126315895|NCT00778102|454445588|FG000|Overall Study|Withdrawal by Subject|1|||
126315896|NCT00778102|454445589|FG001|Overall Study|Withdrawal by Subject|1|||
126315897|NCT00778102|454445588|FG000|Overall Study|Administrative Reason|7|||
126315898|NCT00778102|454445589|FG001|Overall Study|Administrative Reason|10|||
126315899|NCT01328548|454445590|FG000|Overall Study|Death|3|||
126315900|NCT01328548|454445591|FG001|Overall Study|Death|0|||
126315901|NCT01328548|454445590|FG000|Overall Study|Protocol Violation|1|||
126315902|NCT01328548|454445591|FG001|Overall Study|Protocol Violation|0|||
126315903|NCT00073983|454445592|FG000|Overall Study|not evaluable|1|||
126315904|NCT03800836|454445593|FG000|Overall Study|Other|2|||
126315905|NCT03800836|454445594|FG001|Overall Study|Other|1|||
126315906|NCT03800836|454445595|FG002|Overall Study|Other|0|||
126315907|NCT03800836|454445596|FG003|Overall Study|Other|2|||
126315908|NCT03800836|454445597|FG004|Overall Study|Other|0|||
126315909|NCT03800836|454445598|FG005|Overall Study|Other|1|||
126315910|NCT03800836|454445593|FG000|Overall Study|Lost to Follow-up|2|||
126315911|NCT03800836|454445594|FG001|Overall Study|Lost to Follow-up|0|||
126315912|NCT03800836|454445595|FG002|Overall Study|Lost to Follow-up|1|||
126315913|NCT03800836|454445596|FG003|Overall Study|Lost to Follow-up|1|||
126315914|NCT03800836|454445597|FG004|Overall Study|Lost to Follow-up|3|||
126315915|NCT03800836|454445598|FG005|Overall Study|Lost to Follow-up|0|||
126315916|NCT03800836|454445593|FG000|Overall Study|Withdrawal by Subject|1|||
126315917|NCT03800836|454445594|FG001|Overall Study|Withdrawal by Subject|0|||
126315918|NCT03800836|454445595|FG002|Overall Study|Withdrawal by Subject|0|||
126315919|NCT03800836|454445596|FG003|Overall Study|Withdrawal by Subject|0|||
126315920|NCT03800836|454445597|FG004|Overall Study|Withdrawal by Subject|0|||
126315921|NCT03800836|454445598|FG005|Overall Study|Withdrawal by Subject|0|||
126315922|NCT03800836|454445593|FG000|Overall Study|Physician Decision|31|||
126315923|NCT03800836|454445594|FG001|Overall Study|Physician Decision|3|||
126315924|NCT03800836|454445595|FG002|Overall Study|Physician Decision|6|||
126315925|NCT03800836|454445596|FG003|Overall Study|Physician Decision|4|||
126315926|NCT03800836|454445597|FG004|Overall Study|Physician Decision|4|||
126315927|NCT03800836|454445598|FG005|Overall Study|Physician Decision|5|||
126315928|NCT03800836|454445593|FG000|Overall Study|Death|34|||
126315929|NCT03800836|454445594|FG001|Overall Study|Death|16|||
126315930|NCT03800836|454445595|FG002|Overall Study|Death|5|||
126315931|NCT03800836|454445596|FG003|Overall Study|Death|5|||
126315932|NCT03800836|454445597|FG004|Overall Study|Death|10|||
126315933|NCT03800836|454445598|FG005|Overall Study|Death|0|||
126315934|NCT03800836|454445593|FG000|Overall Study|Symptomatic Deterioration|1|||
126315935|NCT03800836|454445594|FG001|Overall Study|Symptomatic Deterioration|0|||
126315936|NCT03800836|454445595|FG002|Overall Study|Symptomatic Deterioration|1|||
126315937|NCT03800836|454445596|FG003|Overall Study|Symptomatic Deterioration|0|||
126315938|NCT03800836|454445597|FG004|Overall Study|Symptomatic Deterioration|0|||
126315939|NCT03800836|454445598|FG005|Overall Study|Symptomatic Deterioration|0|||
126315940|NCT01250171|454447630|FG000|Overall Study|Administrative reasons|1|||
126315941|NCT01250171|454447631|FG001|Overall Study|Administrative reasons|0|||
126315942|NCT01250171|454447632|FG002|Overall Study|Administrative reasons|0|||
126315943|NCT04557124|454447637|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
126315944|NCT04557124|454447638|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
126315945|NCT04557124|454447637|FG000|Mid-point (1 Month)|Missed testing|5|||
126315946|NCT04557124|454447638|FG001|Mid-point (1 Month)|Missed testing|4|||
126315947|NCT04557124|454447637|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
126315948|NCT04557124|454447638|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
126315949|NCT04557124|454447637|FG000|Post-testing (2 Months)|Missed testing|1|||
126315950|NCT04557124|454447638|FG001|Post-testing (2 Months)|Missed testing|5|||
126315951|NCT04557124|454447637|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
126315952|NCT04557124|454447638|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
126315953|NCT04557124|454447637|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
126315954|NCT04557124|454447638|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
126315955|NCT04550832|454447639|FG000|Overall Study|Adverse Event|0|||
126315956|NCT04550832|454447640|FG001|Overall Study|Adverse Event|0|||
126315957|NCT04550832|454447641|FG002|Overall Study|Adverse Event|2|||
126315958|NCT04550832|454447642|FG003|Overall Study|Adverse Event|0|||
126315959|NCT04550832|454447643|FG004|Overall Study|Adverse Event|1|||
126315960|NCT04823130|454447644|FG000|Overall Study|Withdrawal by Subject|2|||
126315961|NCT04823130|454447645|FG001|Overall Study|Withdrawal by Subject|3|||
126315962|NCT04823130|454447644|FG000|Overall Study|Failure to meet inclusion criteria|6|||
126315963|NCT04823130|454447645|FG001|Overall Study|Failure to meet inclusion criteria|4|||
126315964|NCT04823130|454447644|FG000|Overall Study|Other-unspecified|1|||
126315965|NCT04823130|454447645|FG001|Overall Study|Other-unspecified|0|||
126315966|NCT03315455|454447646|FG000|Overall Study|Ongoing in the Study|13|||
126315967|NCT03315455|454447647|FG001|Overall Study|Ongoing in the Study|24|||
126315968|NCT03315455|454447648|FG002|Overall Study|Ongoing in the Study|17|||
126315969|NCT03315455|454447649|FG003|Overall Study|Ongoing in the Study|15|||
126315970|NCT03315455|454447646|FG000|Overall Study|Withdrawal by Subject|0|||
126315971|NCT03315455|454447647|FG001|Overall Study|Withdrawal by Subject|1|||
126315972|NCT03315455|454447648|FG002|Overall Study|Withdrawal by Subject|0|||
126315973|NCT03315455|454447649|FG003|Overall Study|Withdrawal by Subject|0|||
126315974|NCT03030118|454447653|FG000|Overall Study|Achieved SLE Diagnosis|11|||
126315975|NCT03030118|454447654|FG001|Overall Study|Achieved SLE Diagnosis|10|||
126315976|NCT03030118|454447653|FG000|Overall Study|Adverse Event|1|||
126315977|NCT03030118|454447654|FG001|Overall Study|Adverse Event|1|||
126315978|NCT03030118|454447653|FG000|Overall Study|Pregnancy|2|||
126315979|NCT03030118|454447654|FG001|Overall Study|Pregnancy|2|||
126315980|NCT03030118|454447653|FG000|Overall Study|Lost to Follow-up|5|||
126315981|NCT03030118|454447654|FG001|Overall Study|Lost to Follow-up|6|||
126315982|NCT03030118|454447653|FG000|Overall Study|Concomitant Medications|1|||
126315983|NCT03030118|454447654|FG001|Overall Study|Concomitant Medications|1|||
126315984|NCT03030118|454447653|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
126315985|NCT03030118|454447654|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
126315986|NCT03030118|454447653|FG000|Overall Study|Other|2|||
126315987|NCT03030118|454447654|FG001|Overall Study|Other|0|||
126315988|NCT03030118|454447653|FG000|Overall Study|Withdrawal by Subject|26|||
126315989|NCT03030118|454447654|FG001|Overall Study|Withdrawal by Subject|21|||
126315990|NCT03030118|454447653|FG000|Overall Study|Protocol Violation|1|||
126315991|NCT03030118|454447654|FG001|Overall Study|Protocol Violation|6|||
126315992|NCT03385304|454447656|FG000|Overall Study|Death|19|||
126315993|NCT03385304|454447657|FG001|Overall Study|Death|7|||
126315994|NCT03385304|454447656|FG000|Overall Study|Lost to Follow-up|17|||
126315995|NCT03385304|454447657|FG001|Overall Study|Lost to Follow-up|14|||
126315996|NCT03385304|454447656|FG000|Overall Study|Withdrawal by Subject|3|||
126315997|NCT03385304|454447657|FG001|Overall Study|Withdrawal by Subject|2|||
126315998|NCT03385304|454447656|FG000|Overall Study|Incarceration|2|||
126315999|NCT03385304|454447657|FG001|Overall Study|Incarceration|3|||
126316000|NCT00480493|454447664|FG000|Overall Study|moved|2|||
126316001|NCT00480493|454447665|FG001|Overall Study|moved|7|||
126316002|NCT01032070|454447666|FG000|Overall Study|Disease progression|13|||
126316003|NCT01032070|454447667|FG001|Overall Study|Disease progression|8|||
126316004|NCT01032070|454447666|FG000|Overall Study|Medical or ethical reasons|0|||
126316005|NCT01032070|454447667|FG001|Overall Study|Medical or ethical reasons|2|||
126316006|NCT01032070|454447666|FG000|Overall Study|Withdrawal by Subject|0|||
126316007|NCT01032070|454447667|FG001|Overall Study|Withdrawal by Subject|2|||
126316008|NCT00738062|454447668|FG000|Open Label Treatment|Lack of Efficacy|5|||
126316009|NCT00738062|454447669|FG001|Open Label Treatment|Lack of Efficacy|0|||
126316010|NCT00738062|454447670|FG002|Open Label Treatment|Lack of Efficacy|0|||
126316011|NCT00738062|454447668|FG000|Open Label Treatment|Adverse Event|11|||
126316012|NCT00738062|454447669|FG001|Open Label Treatment|Adverse Event|0|||
126316013|NCT00738062|454447670|FG002|Open Label Treatment|Adverse Event|0|||
126316014|NCT00738062|454447668|FG000|Open Label Treatment|Protocol Violation|2|||
126316015|NCT00738062|454447669|FG001|Open Label Treatment|Protocol Violation|0|||
126316016|NCT00738062|454447670|FG002|Open Label Treatment|Protocol Violation|0|||
126316017|NCT00738062|454447668|FG000|Open Label Treatment|Withdrawal by Subject|9|||
126316018|NCT00738062|454447669|FG001|Open Label Treatment|Withdrawal by Subject|0|||
126316019|NCT00738062|454447670|FG002|Open Label Treatment|Withdrawal by Subject|0|||
126316020|NCT00738062|454447668|FG000|Open Label Treatment|Investigator Decision|1|||
126316021|NCT00738062|454447669|FG001|Open Label Treatment|Investigator Decision|0|||
126316022|NCT00738062|454447670|FG002|Open Label Treatment|Investigator Decision|0|||
126316023|NCT00738062|454447668|FG000|Open-Label Extension|Adverse Event|5|||
126316024|NCT00738062|454447669|FG001|Open-Label Extension|Adverse Event|0|||
126316025|NCT00738062|454447670|FG002|Open-Label Extension|Adverse Event|0|||
126316026|NCT00738062|454447668|FG000|Open-Label Extension|Physician Decision|1|||
126316027|NCT00738062|454447669|FG001|Open-Label Extension|Physician Decision|0|||
126316028|NCT00738062|454447670|FG002|Open-Label Extension|Physician Decision|0|||
126316029|NCT00738062|454447668|FG000|Open-Label Extension|Lack of Efficacy|2|||
126316030|NCT00738062|454447669|FG001|Open-Label Extension|Lack of Efficacy|0|||
126316031|NCT00738062|454447670|FG002|Open-Label Extension|Lack of Efficacy|0|||
126316032|NCT00738062|454447668|FG000|Open-Label Extension|Withdrawal by Subject|6|||
126316033|NCT00738062|454447669|FG001|Open-Label Extension|Withdrawal by Subject|0|||
126316034|NCT00738062|454447670|FG002|Open-Label Extension|Withdrawal by Subject|0|||
126316035|NCT00738062|454447668|FG000|Open-Label Extension|Protocol Violation|1|||
126316036|NCT00738062|454447669|FG001|Open-Label Extension|Protocol Violation|0|||
126316037|NCT00738062|454447670|FG002|Open-Label Extension|Protocol Violation|0|||
126316038|NCT00738062|454447668|FG000|Open-Label Extension|Study Terminated|2|||
126316039|NCT00738062|454447669|FG001|Open-Label Extension|Study Terminated|0|||
126316040|NCT00738062|454447670|FG002|Open-Label Extension|Study Terminated|0|||
126316041|NCT00426660|454447671|FG000|Overall Study|Death|14|||
126316042|NCT00426660|454447671|FG000|Overall Study|Adverse Event|23|||
126316043|NCT00426660|454447671|FG000|Overall Study|Insufficient Clinical Response|22|||
126316044|NCT00426660|454447671|FG000|Overall Study|Lost to Follow-up|15|||
126316045|NCT00426660|454447671|FG000|Overall Study|Other|23|||
126316046|NCT00426660|454447671|FG000|Overall Study|Withdrawal by Subject|18|||
126316047|NCT00426660|454447671|FG000|Overall Study|Protocol Violation|1|||
126316048|NCT00426660|454447671|FG000|Overall Study|Enrolled Not Treated|15|||
126316049|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
126316050|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
126316051|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
126316052|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
126316053|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
126316054|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
126316055|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
126316056|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
126316057|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
126316058|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
126316059|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
126316060|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
126316061|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
126316062|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
126316063|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
126316064|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
126316065|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
126316066|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
126316067|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
126316068|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
126316069|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
126316070|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
126316071|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
126316072|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
126316073|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
126316074|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
126316075|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
126316076|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
126316077|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
126316078|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
126316079|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
126316080|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
126316081|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
126316082|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
126316083|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
126316084|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
126316085|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
126316086|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
126316087|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
126316088|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
126316089|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
126316090|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
126316091|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
126316092|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
126316093|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
126316094|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
126316095|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
126316096|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
126316097|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
126316098|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
126316099|NCT00980174|454447678|FG000|Overall Study|Withdrawal by Subject|1|||
126316100|NCT00980174|454447679|FG001|Overall Study|Withdrawal by Subject|4|||
126316101|NCT00980174|454447678|FG000|Overall Study|Adverse Event|0|||
126316102|NCT00980174|454447679|FG001|Overall Study|Adverse Event|3|||
126316103|NCT00980174|454447678|FG000|Overall Study|Ineligibility determined|2|||
126316104|NCT00980174|454447679|FG001|Overall Study|Ineligibility determined|1|||
126316105|NCT00980174|454447678|FG000|Overall Study|Death|1|||
126090445|NCT04191616|453623567|FG000|Treatment Period|Sponsor decision|11|||
126316106|NCT00980174|454447679|FG001|Overall Study|Death|1|||
126316107|NCT00980174|454447678|FG000|Overall Study|Other|0|||
126316108|NCT00980174|454447679|FG001|Overall Study|Other|1|||
126316109|NCT03488225|454447684|FG000|Overall Study|Off Protocol Therapy|2|||
126316110|NCT03488225|454447684|FG000|Overall Study|Stem Cell Transplant|2|||
126316111|NCT00894790|454447685|FG000|Overall Study|Protocol Violation|0|||
126316112|NCT00894790|454447686|FG001|Overall Study|Protocol Violation|1|||
126316113|NCT00894790|454447685|FG000|Overall Study|Lost to Follow-up|0|||
126316114|NCT00894790|454447686|FG001|Overall Study|Lost to Follow-up|1|||
126316115|NCT00894790|454447685|FG000|Overall Study|Did not meet entrance criteria|1|||
126316116|NCT00894790|454447686|FG001|Overall Study|Did not meet entrance criteria|0|||
126316117|NCT04093492|454447687|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
126316118|NCT04093492|454447688|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
126316119|NCT04093492|454447689|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
126316120|NCT04093492|454447690|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
126316121|NCT04093492|454447687|FG000|25 Weeks Gestational Age (GA)|No response|5|||
126316122|NCT04093492|454447688|FG001|25 Weeks Gestational Age (GA)|No response|5|||
126316123|NCT04093492|454447689|FG002|25 Weeks Gestational Age (GA)|No response|5|||
126316124|NCT04093492|454447690|FG003|25 Weeks Gestational Age (GA)|No response|2|||
126316125|NCT04093492|454447687|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
126316126|NCT04093492|454447688|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
126316127|NCT04093492|454447689|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
126316128|NCT04093492|454447690|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
126316129|NCT04093492|454447687|FG000|30 Weeks GA|Delivered before assessment|1|||
126316130|NCT04093492|454447688|FG001|30 Weeks GA|Delivered before assessment|2|||
126316131|NCT04093492|454447689|FG002|30 Weeks GA|Delivered before assessment|0|||
126316132|NCT04093492|454447690|FG003|30 Weeks GA|Delivered before assessment|0|||
126316133|NCT04093492|454447687|FG000|30 Weeks GA|No response|7|||
126316134|NCT04093492|454447688|FG001|30 Weeks GA|No response|5|||
126316135|NCT04093492|454447689|FG002|30 Weeks GA|No response|5|||
126316136|NCT04093492|454447690|FG003|30 Weeks GA|No response|2|||
126316137|NCT04093492|454447687|FG000|30 Weeks GA|Lost to Follow-up|0|||
126316138|NCT04093492|454447688|FG001|30 Weeks GA|Lost to Follow-up|1|||
126316139|NCT04093492|454447689|FG002|30 Weeks GA|Lost to Follow-up|0|||
126316140|NCT04093492|454447690|FG003|30 Weeks GA|Lost to Follow-up|0|||
126316141|NCT04093492|454447687|FG000|34 Weeks GA|Delivered before assessment|6|||
126316142|NCT04093492|454447688|FG001|34 Weeks GA|Delivered before assessment|3|||
126316143|NCT04093492|454447689|FG002|34 Weeks GA|Delivered before assessment|0|||
126316144|NCT04093492|454447690|FG003|34 Weeks GA|Delivered before assessment|0|||
126316145|NCT04093492|454447687|FG000|34 Weeks GA|No response|0|||
126316146|NCT04093492|454447688|FG001|34 Weeks GA|No response|7|||
126316147|NCT04093492|454447689|FG002|34 Weeks GA|No response|5|||
126316148|NCT04093492|454447690|FG003|34 Weeks GA|No response|3|||
126316149|NCT04093492|454447687|FG000|34 Weeks GA|Lost to Follow-up|0|||
126316150|NCT04093492|454447688|FG001|34 Weeks GA|Lost to Follow-up|1|||
126316151|NCT04093492|454447689|FG002|34 Weeks GA|Lost to Follow-up|0|||
126316152|NCT04093492|454447690|FG003|34 Weeks GA|Lost to Follow-up|0|||
126316153|NCT04631107|454447692|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
126316154|NCT04631107|454447692|FG000|Second Intervention (1 Night)|Adverse Event|1|||
126316155|NCT04631107|454447692|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
126316156|NCT04631107|454447692|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
126316157|NCT05385224|454447697|FG000|Overall Study|Unable to swallow capsule|2|||
126316158|NCT05385224|454447697|FG000|Overall Study|Withdrawal by Subject|2|||
126316159|NCT05385224|454447697|FG000|Overall Study|Did not meet study criteria|1|||
126316160|NCT00551161|454447698|FG000|Overall Study|Withdrawal by Subject|1|||
126316161|NCT01935128|454447699|FG000|Overall Study|Death|1|||
126316162|NCT01935128|454447699|FG000|Overall Study|Adverse Event|6|||
126316163|NCT00096993|454447700|FG000|Overall Study|Death|1|||
126316164|NCT00096993|454447701|FG001|Overall Study|Death|0|||
126316165|NCT00096993|454447700|FG000|Overall Study|Disease progression|56|||
126316166|NCT00096993|454447701|FG001|Overall Study|Disease progression|53|||
126316167|NCT00096993|454447700|FG000|Overall Study|Adverse Event|2|||
126316168|NCT00096993|454447701|FG001|Overall Study|Adverse Event|8|||
126316169|NCT00096993|454447700|FG000|Overall Study|Subject's decision|3|||
126316170|NCT00096993|454447701|FG001|Overall Study|Subject's decision|1|||
126316171|NCT00096993|454447700|FG000|Overall Study|Physician Decision|2|||
126316172|NCT00096993|454447701|FG001|Overall Study|Physician Decision|1|||
126316173|NCT00096993|454447700|FG000|Overall Study|Non-compliance|0|||
126316174|NCT00096993|454447701|FG001|Overall Study|Non-compliance|1|||
126316175|NCT00096993|454447700|FG000|Overall Study|Other unspecified|1|||
126316176|NCT00096993|454447701|FG001|Overall Study|Other unspecified|1|||
126316177|NCT00772005|454447702|FG000|Overall Study|Adverse Event|9|||
126316178|NCT00772005|454447703|FG001|Overall Study|Adverse Event|14|||
126316179|NCT00772005|454447704|FG002|Overall Study|Adverse Event|10|||
126316180|NCT00772005|454447705|FG003|Overall Study|Adverse Event|13|||
126316181|NCT00772005|454447702|FG000|Overall Study|Lack of Efficacy|0|||
126316182|NCT00772005|454447703|FG001|Overall Study|Lack of Efficacy|1|||
126316183|NCT00772005|454447704|FG002|Overall Study|Lack of Efficacy|0|||
126316184|NCT00772005|454447705|FG003|Overall Study|Lack of Efficacy|0|||
126316185|NCT00772005|454447702|FG000|Overall Study|Withdrawal by Subject|3|||
126316186|NCT00772005|454447703|FG001|Overall Study|Withdrawal by Subject|7|||
126316187|NCT00772005|454447704|FG002|Overall Study|Withdrawal by Subject|10|||
126316188|NCT00772005|454447705|FG003|Overall Study|Withdrawal by Subject|2|||
126316189|NCT00772005|454447702|FG000|Overall Study|Protocol Violation|2|||
126316190|NCT00772005|454447703|FG001|Overall Study|Protocol Violation|4|||
126316191|NCT00772005|454447704|FG002|Overall Study|Protocol Violation|1|||
126316192|NCT00772005|454447705|FG003|Overall Study|Protocol Violation|6|||
126316193|NCT00772005|454447702|FG000|Overall Study|Lost to Follow-up|7|||
126316194|NCT00772005|454447703|FG001|Overall Study|Lost to Follow-up|3|||
126316195|NCT00772005|454447704|FG002|Overall Study|Lost to Follow-up|6|||
126316196|NCT00772005|454447705|FG003|Overall Study|Lost to Follow-up|3|||
126316197|NCT00772005|454447702|FG000|Overall Study|Non-compliance with study procedures|1|||
126316198|NCT00772005|454447703|FG001|Overall Study|Non-compliance with study procedures|1|||
126316199|NCT00772005|454447704|FG002|Overall Study|Non-compliance with study procedures|0|||
126316200|NCT00772005|454447705|FG003|Overall Study|Non-compliance with study procedures|1|||
126316201|NCT00772005|454447702|FG000|Overall Study|Non-compliance with drug administration|3|||
126316202|NCT00772005|454447703|FG001|Overall Study|Non-compliance with drug administration|0|||
126316203|NCT00772005|454447704|FG002|Overall Study|Non-compliance with drug administration|1|||
126316204|NCT00772005|454447705|FG003|Overall Study|Non-compliance with drug administration|1|||
126316205|NCT01440569|454447709|FG000|Main Study|Enrolled but not treated|1|||
126316206|NCT01440569|454447710|FG001|Main Study|Enrolled but not treated|0|||
126316207|NCT01440569|454447709|FG000|Main Study|Adverse Event|9|||
126316208|NCT01440569|454447710|FG001|Main Study|Adverse Event|0|||
126316209|NCT01440569|454447709|FG000|Main Study|Pregnancy|1|||
126316210|NCT01440569|454447710|FG001|Main Study|Pregnancy|0|||
126316211|NCT01440569|454447709|FG000|Main Study|Investigator's Discretion|1|||
126316212|NCT01440569|454447710|FG001|Main Study|Investigator's Discretion|1|||
126316213|NCT01440569|454447709|FG000|Main Study|Withdrew Consent|7|||
126316214|NCT01440569|454447710|FG001|Main Study|Withdrew Consent|1|||
126316215|NCT01440569|454447709|FG000|Main Study|Lost to Follow-up|13|||
126316216|NCT01440569|454447710|FG001|Main Study|Lost to Follow-up|2|||
126316217|NCT01440569|454447709|FG000|Main Study|Subject Non-Compliance|3|||
126316218|NCT01440569|454447710|FG001|Main Study|Subject Non-Compliance|0|||
126316219|NCT01440569|454447709|FG000|Main Study|Protocol Violation|1|||
126316220|NCT01440569|454447710|FG001|Main Study|Protocol Violation|0|||
126316221|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Adverse Event|3|||
126316222|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Adverse Event|0|||
126316223|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Pregnancy|1|||
126316224|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Pregnancy|0|||
126316225|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
126316226|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
126316227|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
126316228|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
126316229|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
126316230|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
126316231|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
126316232|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
126316233|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
126316234|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
126316235|NCT05020366|454447711|FG000|Overall Study|Lost to Follow-up|2|||
126316236|NCT05020366|454447712|FG001|Overall Study|Lost to Follow-up|0|||
126316237|NCT05020366|454447711|FG000|Overall Study|Withdrawal by Subject|2|||
126316238|NCT05020366|454447712|FG001|Overall Study|Withdrawal by Subject|0|||
126316239|NCT00435487|454447726|FG000|Overall Study|Death|3|||
126316240|NCT00435487|454447727|FG001|Overall Study|Death|4|||
126316241|NCT00435487|454447726|FG000|Overall Study|Adverse Event|0|||
126316242|NCT00435487|454447727|FG001|Overall Study|Adverse Event|3|||
126316243|NCT00435487|454447726|FG000|Overall Study|Lost to Follow-up|2|||
126316244|NCT00435487|454447727|FG001|Overall Study|Lost to Follow-up|2|||
126316245|NCT00435487|454447726|FG000|Overall Study|Other|5|||
126316246|NCT00435487|454447727|FG001|Overall Study|Other|2|||
126316247|NCT00435487|454447726|FG000|Overall Study|Withdrawal by Subject|2|||
126316248|NCT00435487|454447727|FG001|Overall Study|Withdrawal by Subject|1|||
126316249|NCT00435487|454447726|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
126316250|NCT00435487|454447727|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
126316251|NCT00435487|454447726|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
126316252|NCT00435487|454447727|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
126316253|NCT03301844|454447728|FG000|Overall Study|suspected colon cancer|1|||
126316254|NCT03301844|454447729|FG001|Overall Study|suspected colon cancer|1|||
126316255|NCT05087966|454447730|FG000|Overall Study|Lost to Follow-up|1|||
126316256|NCT05087966|454447730|FG000|Overall Study|Withdrawal by Subject|5|||
126316257|NCT01267201|454447731|FG000|First Intervention Period|Withdrawal by Subject|1|||
126316258|NCT01267201|454447732|FG001|First Intervention Period|Withdrawal by Subject|0|||
126316259|NCT01267201|454447733|FG002|First Intervention Period|Withdrawal by Subject|0|||
126316260|NCT01267201|454447734|FG003|First Intervention Period|Withdrawal by Subject|0|||
126316261|NCT01267201|454447735|FG004|First Intervention Period|Withdrawal by Subject|0|||
126316262|NCT01267201|454447736|FG005|First Intervention Period|Withdrawal by Subject|0|||
126316263|NCT01267201|454447731|FG000|Second Intervention Period|Withdrawal by Subject|0|||
126316264|NCT01267201|454447732|FG001|Second Intervention Period|Withdrawal by Subject|1|||
126316265|NCT01267201|454447733|FG002|Second Intervention Period|Withdrawal by Subject|0|||
126316266|NCT01267201|454447734|FG003|Second Intervention Period|Withdrawal by Subject|0|||
126316267|NCT01267201|454447735|FG004|Second Intervention Period|Withdrawal by Subject|0|||
126316268|NCT01267201|454447736|FG005|Second Intervention Period|Withdrawal by Subject|0|||
126316269|NCT00501059|454447737|FG000|Overall Study|Protocol Violation|80|||
126316270|NCT00501059|454447738|FG001|Overall Study|Protocol Violation|69|||
126316271|NCT00501059|454447737|FG000|Overall Study|Death|140|||
126316272|NCT00501059|454447738|FG001|Overall Study|Death|137|||
126316273|NCT00501059|454447737|FG000|Overall Study|Other|236|||
126316274|NCT00501059|454447738|FG001|Overall Study|Other|239|||
126316275|NCT00501059|454447737|FG000|Overall Study|Missing end-of-study page|91|||
126316276|NCT00501059|454447738|FG001|Overall Study|Missing end-of-study page|92|||
126316277|NCT00501059|454447737|FG000|Overall Study|Clinical endpoint reached|110|||
126316278|NCT00501059|454447738|FG001|Overall Study|Clinical endpoint reached|123|||
126316279|NCT00501059|454447737|FG000|Overall Study|Insufficient therapeutic effect|4|||
126316280|NCT00501059|454447738|FG001|Overall Study|Insufficient therapeutic effect|5|||
126316281|NCT00501059|454447737|FG000|Overall Study|Consent withdrawn by subject|817|||
126316282|NCT00501059|454447738|FG001|Overall Study|Consent withdrawn by subject|873|||
126316283|NCT00501059|454447737|FG000|Overall Study|Non-compliant with study treatment|23|||
126316284|NCT00501059|454447738|FG001|Overall Study|Non-compliant with study treatment|16|||
126316285|NCT00501059|454447737|FG000|Overall Study|Reason not given|3|||
126316286|NCT00501059|454447738|FG001|Overall Study|Reason not given|1|||
126316287|NCT00501059|454447737|FG000|Overall Study|Adverse Event|129|||
126316288|NCT00501059|454447738|FG001|Overall Study|Adverse Event|122|||
126316289|NCT00501059|454447737|FG000|Overall Study|Lost to Follow-up|210|||
126316290|NCT00501059|454447738|FG001|Overall Study|Lost to Follow-up|198|||
126316291|NCT00501059|454447737|FG000|Overall Study|Not treated|25|||
126316292|NCT00501059|454447738|FG001|Overall Study|Not treated|17|||
126316293|NCT00955968|454447742|FG000|Overall Study|Death|2|||
126316294|NCT00955968|454447743|FG001|Overall Study|Death|4|||
126316295|NCT00955968|454447742|FG000|Overall Study|Withdrawal by Subject|35|||
126316296|NCT00955968|454447743|FG001|Overall Study|Withdrawal by Subject|31|||
126316297|NCT00955968|454447742|FG000|Overall Study|Lost to Follow-up|45|||
126316298|NCT00955968|454447743|FG001|Overall Study|Lost to Follow-up|39|||
126316299|NCT00955968|454447742|FG000|Overall Study|Site closed|55|||
126316300|NCT00955968|454447743|FG001|Overall Study|Site closed|52|||
126316301|NCT00430352|454447748|FG000|Overall Study|Disease progression|58|||
126316302|NCT00430352|454447748|FG000|Overall Study|Withdrawal by Subject|11|||
126316303|NCT00430352|454447748|FG000|Overall Study|Adverse Event|16|||
126316304|NCT00430352|454447748|FG000|Overall Study|Death|5|||
126316305|NCT00430352|454447748|FG000|Overall Study|Other|48|||
126316306|NCT04326439|454447751|FG000|Overall Study|Withdrawal by Subject|1|||
126316307|NCT04326439|454447752|FG001|Overall Study|Withdrawal by Subject|0|||
126316308|NCT04326439|454447751|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
126316309|NCT04326439|454447752|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
126316310|NCT04326439|454447751|FG000|Overall Study|Relapse after Induction 2|0|||
126316311|NCT04326439|454447752|FG001|Overall Study|Relapse after Induction 2|1|||
126316312|NCT04326439|454447751|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
126316313|NCT04326439|454447752|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
126316314|NCT01785849|454447755|FG000|Overall Study|Death|7|||
126316315|NCT01785849|454447756|FG001|Overall Study|Death|9|||
126316316|NCT01785849|454447755|FG000|Overall Study|Protocol Specified Criteria|29|||
126316317|NCT01785849|454447756|FG001|Overall Study|Protocol Specified Criteria|1|||
126316318|NCT01785849|454447755|FG000|Overall Study|Withdrawal by Subject|15|||
126316319|NCT01785849|454447756|FG001|Overall Study|Withdrawal by Subject|12|||
126316320|NCT01785849|454447755|FG000|Overall Study|Sponsor Decision|0|||
126316321|NCT01785849|454447756|FG001|Overall Study|Sponsor Decision|1|||
126316322|NCT01785849|454447755|FG000|Overall Study|Lost to Follow-up|10|||
126316323|NCT01785849|454447756|FG001|Overall Study|Lost to Follow-up|11|||
126316324|NCT04778059|454447757|FG000|Overall Study|Death|2|||
126316325|NCT04778059|454447758|FG001|Overall Study|Death|2|||
126316326|NCT04778059|454447759|FG002|Overall Study|Death|1|||
126316327|NCT04778059|454447760|FG003|Overall Study|Death|1|||
126316328|NCT04778059|454447761|FG004|Overall Study|Death|1|||
126316329|NCT04778059|454447757|FG000|Overall Study|Lost to Follow-up|0|||
126316330|NCT04778059|454447758|FG001|Overall Study|Lost to Follow-up|0|||
126316331|NCT04778059|454447759|FG002|Overall Study|Lost to Follow-up|0|||
126316332|NCT04778059|454447760|FG003|Overall Study|Lost to Follow-up|0|||
126316333|NCT04778059|454447761|FG004|Overall Study|Lost to Follow-up|1|||
126316334|NCT04778059|454447757|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
126316335|NCT04778059|454447758|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
126316336|NCT04778059|454447759|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
126316337|NCT04778059|454447760|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
126316338|NCT04778059|454447761|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
126316339|NCT01306045|454447768|FG000|Met General Eligibility Criteria|Screen failures|193|||
126316340|NCT01306045|454447769|FG001|Met General Eligibility Criteria|Screen failures|11|||
126316341|NCT01306045|454447770|FG002|Met General Eligibility Criteria|Screen failures|8|||
126316342|NCT02987972|454447771|FG000|Overall Study|Adverse Event|1|||
126316343|NCT02987972|454447772|FG001|Overall Study|Adverse Event|1|||
126316344|NCT02987972|454447773|FG002|Overall Study|Adverse Event|0|||
126316345|NCT02987972|454447771|FG000|Overall Study|Death|1|||
126316346|NCT02987972|454447772|FG001|Overall Study|Death|0|||
126316347|NCT02987972|454447773|FG002|Overall Study|Death|0|||
126316348|NCT02987972|454447771|FG000|Overall Study|Lack of Efficacy|9|||
126316349|NCT02987972|454447772|FG001|Overall Study|Lack of Efficacy|12|||
126316350|NCT02987972|454447773|FG002|Overall Study|Lack of Efficacy|12|||
126316351|NCT02987972|454447771|FG000|Overall Study|Lost to Follow-up|7|||
126316352|NCT02987972|454447772|FG001|Overall Study|Lost to Follow-up|8|||
126316353|NCT02987972|454447773|FG002|Overall Study|Lost to Follow-up|4|||
126316354|NCT02987972|454447771|FG000|Overall Study|Physician Decision|1|||
126316355|NCT02987972|454447772|FG001|Overall Study|Physician Decision|6|||
126316356|NCT02987972|454447773|FG002|Overall Study|Physician Decision|0|||
126316357|NCT02987972|454447771|FG000|Overall Study|Protocol Violation|2|||
126316358|NCT02987972|454447772|FG001|Overall Study|Protocol Violation|1|||
126316359|NCT02987972|454447773|FG002|Overall Study|Protocol Violation|5|||
126316360|NCT02987972|454447771|FG000|Overall Study|Withdrawal by Subject|22|||
126316361|NCT02987972|454447772|FG001|Overall Study|Withdrawal by Subject|17|||
126316362|NCT02987972|454447773|FG002|Overall Study|Withdrawal by Subject|21|||
126316363|NCT05128773|454449266|FG000|Overall Study|Sponsor decision to terminate study|3|||
126316364|NCT04250714|454449268|FG000|Overall Study|Treatment - withdrawal by subject|14|||
126316365|NCT04250714|454449268|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
126316366|NCT04250714|454449268|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
126316367|NCT04250714|454449268|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
126316368|NCT04250714|454449268|FG000|Overall Study|Treatment - Death|1|||
126316369|NCT04250714|454449268|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
126316370|NCT04250714|454449268|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
126316371|NCT04250714|454449268|FG000|Overall Study|Attempt|2|||
126316372|NCT04250714|454449268|FG000|Overall Study|Intent|7|||
126316373|NCT04676412|454449269|FG000|Overall Study|Death|28|||
126316374|NCT04676412|454449270|FG001|Overall Study|Death|31|||
126316375|NCT04676412|454449269|FG000|Overall Study|Lost to Follow-up|1|||
126316376|NCT04676412|454449270|FG001|Overall Study|Lost to Follow-up|2|||
126316377|NCT04676412|454449269|FG000|Overall Study|Sponsor Decision|20|||
126316378|NCT04676412|454449270|FG001|Overall Study|Sponsor Decision|23|||
126316379|NCT04676412|454449269|FG000|Overall Study|Withdrawal by Subject|0|||
126316380|NCT04676412|454449270|FG001|Overall Study|Withdrawal by Subject|2|||
126316381|NCT04697056|454449271|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
126316382|NCT04697056|454449272|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
126316383|NCT04439357|454449274|FG000|Overall Study|Disease Progression|4|||
126316384|NCT05906836|454449280|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
126316385|NCT05906836|454449280|FG000|Overall Study|Lost to Follow-up|1|||
126316386|NCT03747302|454449285|FG000|Overall Study|Withdrawal by Subject|1|||
126316387|NCT03747302|454449286|FG001|Overall Study|Withdrawal by Subject|2|||
126316388|NCT03769675|454449287|FG000|Overall Study|Lost to Follow-up|1|||
126316389|NCT00503997|454449290|FG000|Overall Study|disease progression|1|||
126316390|NCT00503997|454449290|FG000|Overall Study|Adverse Event|5|||
126316391|NCT00503997|454449290|FG000|Overall Study|Death|1|||
126316392|NCT00503997|454449290|FG000|Overall Study|Withdrawal by Subject|1|||
126316393|NCT01195844|454449291|FG000|Overall Study|Fecal sample not collected|40|||
126316394|NCT01432275|454449292|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
126316395|NCT01432275|454449293|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
126316396|NCT01432275|454449292|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
126316397|NCT01432275|454449293|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
126316398|NCT01432275|454449292|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
126316399|NCT01432275|454449293|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
126316400|NCT01432275|454449292|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
126316401|NCT01432275|454449293|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
126316402|NCT01432275|454449292|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
126316403|NCT01432275|454449293|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
126316404|NCT01432275|454449292|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
126316405|NCT01432275|454449293|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
126316406|NCT01432275|454449292|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
126316407|NCT01432275|454449293|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
126316408|NCT01432275|454449292|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
126316409|NCT01432275|454449293|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
126316410|NCT01432275|454449292|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
126316411|NCT01432275|454449293|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
126316412|NCT02565706|454449294|FG000|Overall Study|Withdrawal by Subject|5|||
126316413|NCT02565706|454449295|FG001|Overall Study|Withdrawal by Subject|7|||
126316414|NCT02565706|454449296|FG002|Overall Study|Withdrawal by Subject|7|||
126316415|NCT02565706|454449297|FG003|Overall Study|Withdrawal by Subject|11|||
126316416|NCT02565706|454449294|FG000|Overall Study|Lost to Follow-up|72|||
126316417|NCT02565706|454449295|FG001|Overall Study|Lost to Follow-up|75|||
126316418|NCT02565706|454449296|FG002|Overall Study|Lost to Follow-up|82|||
126316419|NCT02565706|454449297|FG003|Overall Study|Lost to Follow-up|74|||
126316420|NCT01935700|454449298|FG000|Overall Study|Withdrawal by Subject|1|||
126316421|NCT01935700|454449299|FG001|Overall Study|Withdrawal by Subject|0|||
126316422|NCT01935700|454449298|FG000|Overall Study|Physician Decision|4|||
126316423|NCT01935700|454449299|FG001|Overall Study|Physician Decision|0|||
126316424|NCT01606202|454449303|FG000|Overall Study|Adverse Event|5|||
126316425|NCT01606202|454449304|FG001|Overall Study|Adverse Event|0|||
126316426|NCT01606202|454449303|FG000|Overall Study|Withdrawal by Subject|2|||
126316427|NCT01606202|454449304|FG001|Overall Study|Withdrawal by Subject|1|||
126316428|NCT01606202|454449303|FG000|Overall Study|Personal problems|0|||
126316429|NCT01606202|454449304|FG001|Overall Study|Personal problems|1|||
126316430|NCT01606202|454449303|FG000|Overall Study|Problems with administration|0|||
126316431|NCT01606202|454449304|FG001|Overall Study|Problems with administration|1|||
126316432|NCT03802565|454449308|FG000|Overall Study|Adverse Event|0|||
126316433|NCT03802565|454449309|FG001|Overall Study|Adverse Event|1|||
126316434|NCT03802565|454449310|FG002|Overall Study|Adverse Event|2|||
126316435|NCT03802565|454449311|FG003|Overall Study|Adverse Event|1|||
126316436|NCT03802565|454449312|FG004|Overall Study|Adverse Event|1|||
126316437|NCT03802565|454449308|FG000|Overall Study|Withdrawal by Subject|2|||
126316438|NCT03802565|454449309|FG001|Overall Study|Withdrawal by Subject|2|||
126316439|NCT03802565|454449310|FG002|Overall Study|Withdrawal by Subject|2|||
126316440|NCT03802565|454449311|FG003|Overall Study|Withdrawal by Subject|0|||
126316441|NCT03802565|454449312|FG004|Overall Study|Withdrawal by Subject|1|||
126316442|NCT03802565|454449308|FG000|Overall Study|Protocol Violation|2|||
126316443|NCT03802565|454449309|FG001|Overall Study|Protocol Violation|1|||
126316444|NCT03802565|454449310|FG002|Overall Study|Protocol Violation|4|||
126316445|NCT03802565|454449311|FG003|Overall Study|Protocol Violation|5|||
126316446|NCT03802565|454449312|FG004|Overall Study|Protocol Violation|1|||
126316447|NCT03802565|454449308|FG000|Overall Study|Lost to Follow-up|0|||
126316448|NCT03802565|454449309|FG001|Overall Study|Lost to Follow-up|0|||
126316449|NCT03802565|454449310|FG002|Overall Study|Lost to Follow-up|1|||
126316450|NCT03802565|454449311|FG003|Overall Study|Lost to Follow-up|0|||
126316451|NCT03802565|454449312|FG004|Overall Study|Lost to Follow-up|0|||
126316452|NCT03802565|454449308|FG000|Overall Study|Subjects Related to Each Other|1|||
126316453|NCT03802565|454449309|FG001|Overall Study|Subjects Related to Each Other|0|||
126316454|NCT03802565|454449310|FG002|Overall Study|Subjects Related to Each Other|0|||
126316455|NCT03802565|454449311|FG003|Overall Study|Subjects Related to Each Other|2|||
126316456|NCT03802565|454449312|FG004|Overall Study|Subjects Related to Each Other|1|||
126316457|NCT03802565|454449308|FG000|Overall Study|Elevated Enzymes|0|||
126316458|NCT03802565|454449309|FG001|Overall Study|Elevated Enzymes|0|||
126316459|NCT03802565|454449310|FG002|Overall Study|Elevated Enzymes|0|||
126316460|NCT03802565|454449311|FG003|Overall Study|Elevated Enzymes|0|||
126316461|NCT03802565|454449312|FG004|Overall Study|Elevated Enzymes|2|||
126316462|NCT05020899|454449313|FG000|8 Week Follow-up|Lost to Follow-up|3|||
126316463|NCT05020899|454449314|FG001|8 Week Follow-up|Lost to Follow-up|6|||
126316464|NCT05020899|454449313|FG000|12 Week Follow-up|Lost to Follow-up|1|||
126316465|NCT05020899|454449314|FG001|12 Week Follow-up|Lost to Follow-up|0|||
126316466|NCT05020899|454449313|FG000|12 Week Follow-up|Death|0|||
126316467|NCT05020899|454449314|FG001|12 Week Follow-up|Death|1|||
126316468|NCT02124759|454449315|FG000|Overall Study|Withdrawal by Subject|3|||
126316469|NCT02124759|454449316|FG001|Overall Study|Withdrawal by Subject|1|||
126316470|NCT02124759|454449317|FG002|Overall Study|Withdrawal by Subject|1|||
126316471|NCT02124759|454449315|FG000|Overall Study|Screen Fail|2|||
126316472|NCT02124759|454449316|FG001|Overall Study|Screen Fail|2|||
126316473|NCT02124759|454449317|FG002|Overall Study|Screen Fail|3|||
126316474|NCT01068626|454449318|FG000|Overall Study|Adverse Event|3|||
126316475|NCT01068626|454449319|FG001|Overall Study|Adverse Event|0|||
126316476|NCT01068626|454449318|FG000|Overall Study|Withdrawal by Subject|0|||
126316477|NCT01068626|454449319|FG001|Overall Study|Withdrawal by Subject|2|||
126316478|NCT04340843|454449320|FG000|Overall Study|Adverse Event|0|||
126316479|NCT04340843|454449321|FG001|Overall Study|Adverse Event|2|||
126316480|NCT04340843|454449320|FG000|Overall Study|Withdrawal by Subject|0|||
126316481|NCT04340843|454449321|FG001|Overall Study|Withdrawal by Subject|2|||
126316482|NCT04249622|454449322|FG000|Overall Study|Withdrawal by Subject|1|||
126316483|NCT04249622|454449323|FG001|Overall Study|Withdrawal by Subject|1|||
126316484|NCT04249622|454449322|FG000|Overall Study|Alternative therapy|1|||
126316485|NCT04249622|454449323|FG001|Overall Study|Alternative therapy|0|||
126316486|NCT04249622|454449322|FG000|Overall Study|Discontinuation of pertuzumab|1|||
126316487|NCT04249622|454449323|FG001|Overall Study|Discontinuation of pertuzumab|0|||
126316488|NCT01294371|454449326|FG000|Overall Study|Adverse Event|1|||
126316489|NCT01294371|454449326|FG000|Overall Study|Withdrawal by Subject|12|||
126316490|NCT01294371|454449326|FG000|Overall Study|Lost to Follow-up|6|||
126316491|NCT01294371|454449326|FG000|Overall Study|Administrative Reason|1|||
126316492|NCT01294371|454449326|FG000|Overall Study|Other|14|||
126316493|NCT05619536|454449327|FG000|Overall Study|Withdrawal by Subject|0|||
126316494|NCT05619536|454449328|FG001|Overall Study|Withdrawal by Subject|1|||
126316495|NCT05619536|454449329|FG002|Overall Study|Withdrawal by Subject|0|||
126316496|NCT05619536|454449330|FG003|Overall Study|Withdrawal by Subject|1|||
126316497|NCT05619536|454449327|FG000|Overall Study|Lost to Follow-up|0|||
126316498|NCT05619536|454449328|FG001|Overall Study|Lost to Follow-up|1|||
126316499|NCT05619536|454449329|FG002|Overall Study|Lost to Follow-up|1|||
126316500|NCT05619536|454449330|FG003|Overall Study|Lost to Follow-up|0|||
126316501|NCT02923245|454449331|FG000|Overall Study|ultrasound order was cancelled|2|||
126316502|NCT02923245|454449332|FG001|Overall Study|ultrasound order was cancelled|1|||
126316503|NCT02520427|454449333|FG000|Overall Study|Decision by sponsor|0|||
126316504|NCT02520427|454449334|FG001|Overall Study|Decision by sponsor|0|||
126316505|NCT02520427|454449335|FG002|Overall Study|Decision by sponsor|0|||
126316506|NCT02520427|454449336|FG003|Overall Study|Decision by sponsor|0|||
126316507|NCT02520427|454449337|FG004|Overall Study|Decision by sponsor|0|||
126316508|NCT02520427|454449338|FG005|Overall Study|Decision by sponsor|0|||
126316509|NCT02520427|454449339|FG006|Overall Study|Decision by sponsor|0|||
126316510|NCT02520427|454449340|FG007|Overall Study|Decision by sponsor|0|||
126316511|NCT02520427|454449341|FG008|Overall Study|Decision by sponsor|1|||
126316512|NCT02520427|454449342|FG009|Overall Study|Decision by sponsor|1|||
126316513|NCT02520427|454449343|FG010|Overall Study|Decision by sponsor|0|||
126316514|NCT02520427|454449344|FG011|Overall Study|Decision by sponsor|0|||
126316515|NCT02520427|454449345|FG012|Overall Study|Decision by sponsor|0|||
126316516|NCT02520427|454449346|FG013|Overall Study|Decision by sponsor|0|||
126316517|NCT02520427|454449347|FG014|Overall Study|Decision by sponsor|0|||
126316518|NCT02520427|454449348|FG015|Overall Study|Decision by sponsor|0|||
126316519|NCT02520427|454449349|FG016|Overall Study|Decision by sponsor|0|||
126316520|NCT02520427|454449350|FG017|Overall Study|Decision by sponsor|0|||
126316521|NCT02520427|454449351|FG018|Overall Study|Decision by sponsor|0|||
126316522|NCT02520427|454449352|FG019|Overall Study|Decision by sponsor|0|||
126316523|NCT02520427|454449353|FG020|Overall Study|Decision by sponsor|0|||
126316524|NCT02520427|454449354|FG021|Overall Study|Decision by sponsor|0|||
126316525|NCT02520427|454449355|FG022|Overall Study|Decision by sponsor|0|||
126316526|NCT02520427|454449356|FG023|Overall Study|Decision by sponsor|0|||
126316527|NCT02520427|454449357|FG024|Overall Study|Decision by sponsor|0|||
126316528|NCT02520427|454449358|FG025|Overall Study|Decision by sponsor|0|||
126316529|NCT02520427|454449333|FG000|Overall Study|Withdrawal by Subject|0|||
126316530|NCT02520427|454449334|FG001|Overall Study|Withdrawal by Subject|0|||
126316531|NCT02520427|454449335|FG002|Overall Study|Withdrawal by Subject|1|||
126316532|NCT02520427|454449336|FG003|Overall Study|Withdrawal by Subject|0|||
126316533|NCT02520427|454449337|FG004|Overall Study|Withdrawal by Subject|0|||
126316534|NCT02520427|454449338|FG005|Overall Study|Withdrawal by Subject|0|||
126316535|NCT02520427|454449339|FG006|Overall Study|Withdrawal by Subject|0|||
126316536|NCT02520427|454449340|FG007|Overall Study|Withdrawal by Subject|0|||
126316537|NCT02520427|454449341|FG008|Overall Study|Withdrawal by Subject|0|||
126316538|NCT02520427|454449342|FG009|Overall Study|Withdrawal by Subject|0|||
126316539|NCT02520427|454449343|FG010|Overall Study|Withdrawal by Subject|0|||
126316540|NCT02520427|454449344|FG011|Overall Study|Withdrawal by Subject|0|||
126316541|NCT02520427|454449345|FG012|Overall Study|Withdrawal by Subject|1|||
126316542|NCT02520427|454449346|FG013|Overall Study|Withdrawal by Subject|1|||
126316543|NCT02520427|454449347|FG014|Overall Study|Withdrawal by Subject|1|||
126316544|NCT02520427|454449348|FG015|Overall Study|Withdrawal by Subject|0|||
126316545|NCT02520427|454449349|FG016|Overall Study|Withdrawal by Subject|1|||
126316546|NCT02520427|454449350|FG017|Overall Study|Withdrawal by Subject|0|||
126316547|NCT02520427|454449351|FG018|Overall Study|Withdrawal by Subject|0|||
126316548|NCT02520427|454449352|FG019|Overall Study|Withdrawal by Subject|3|||
126316549|NCT02520427|454449353|FG020|Overall Study|Withdrawal by Subject|2|||
126316550|NCT02520427|454449354|FG021|Overall Study|Withdrawal by Subject|0|||
126316551|NCT02520427|454449355|FG022|Overall Study|Withdrawal by Subject|0|||
126316552|NCT02520427|454449356|FG023|Overall Study|Withdrawal by Subject|0|||
126316553|NCT02520427|454449357|FG024|Overall Study|Withdrawal by Subject|0|||
126316554|NCT02520427|454449358|FG025|Overall Study|Withdrawal by Subject|0|||
126316555|NCT02520427|454449333|FG000|Overall Study|Death|1|||
126316556|NCT02520427|454449334|FG001|Overall Study|Death|0|||
126316557|NCT02520427|454449335|FG002|Overall Study|Death|0|||
126316558|NCT02520427|454449336|FG003|Overall Study|Death|0|||
126316559|NCT02520427|454449337|FG004|Overall Study|Death|0|||
126316560|NCT02520427|454449338|FG005|Overall Study|Death|0|||
126316561|NCT02520427|454449339|FG006|Overall Study|Death|0|||
126316562|NCT02520427|454449340|FG007|Overall Study|Death|0|||
126316563|NCT02520427|454449341|FG008|Overall Study|Death|0|||
126316564|NCT02520427|454449342|FG009|Overall Study|Death|0|||
126316565|NCT02520427|454449343|FG010|Overall Study|Death|0|||
126316566|NCT02520427|454449344|FG011|Overall Study|Death|0|||
126316567|NCT02520427|454449345|FG012|Overall Study|Death|0|||
126316568|NCT02520427|454449346|FG013|Overall Study|Death|0|||
126316569|NCT02520427|454449347|FG014|Overall Study|Death|0|||
126316570|NCT02520427|454449348|FG015|Overall Study|Death|0|||
126316571|NCT02520427|454449349|FG016|Overall Study|Death|2|||
126316572|NCT02520427|454449350|FG017|Overall Study|Death|1|||
126316573|NCT02520427|454449351|FG018|Overall Study|Death|3|||
126316574|NCT02520427|454449352|FG019|Overall Study|Death|2|||
126316575|NCT02520427|454449353|FG020|Overall Study|Death|0|||
126316576|NCT02520427|454449354|FG021|Overall Study|Death|0|||
126316577|NCT02520427|454449355|FG022|Overall Study|Death|1|||
126316578|NCT02520427|454449356|FG023|Overall Study|Death|0|||
126316579|NCT02520427|454449357|FG024|Overall Study|Death|1|||
126316580|NCT02520427|454449358|FG025|Overall Study|Death|0|||
126316581|NCT00793624|454449361|FG000|Overall Study|Adverse Event|18|||
126316582|NCT00793624|454449362|FG001|Overall Study|Adverse Event|16|||
126316583|NCT00793624|454449363|FG002|Overall Study|Adverse Event|15|||
126316584|NCT00793624|454449364|FG003|Overall Study|Adverse Event|20|||
126316585|NCT00793624|454449361|FG000|Overall Study|Lost to Follow-up|2|||
126316586|NCT00793624|454449362|FG001|Overall Study|Lost to Follow-up|2|||
126316587|NCT00793624|454449363|FG002|Overall Study|Lost to Follow-up|4|||
126316588|NCT00793624|454449364|FG003|Overall Study|Lost to Follow-up|0|||
126316589|NCT00793624|454449361|FG000|Overall Study|Withdrawal by Subject|20|||
126316590|NCT00793624|454449362|FG001|Overall Study|Withdrawal by Subject|9|||
126316591|NCT00793624|454449363|FG002|Overall Study|Withdrawal by Subject|11|||
126316592|NCT00793624|454449364|FG003|Overall Study|Withdrawal by Subject|14|||
126316593|NCT00793624|454449361|FG000|Overall Study|Lack of Efficacy|9|||
126316594|NCT00793624|454449362|FG001|Overall Study|Lack of Efficacy|2|||
126316595|NCT00793624|454449363|FG002|Overall Study|Lack of Efficacy|1|||
126316596|NCT00793624|454449364|FG003|Overall Study|Lack of Efficacy|3|||
126316597|NCT00793624|454449361|FG000|Overall Study|Non compliance with protocol|2|||
126316598|NCT00793624|454449362|FG001|Overall Study|Non compliance with protocol|3|||
126316599|NCT00793624|454449363|FG002|Overall Study|Non compliance with protocol|2|||
126316600|NCT00793624|454449364|FG003|Overall Study|Non compliance with protocol|3|||
126208282|NCT05966129|454049383|FG000|Overall Study|Surgery logistics issue|2|||
126208283|NCT05966129|454049384|FG001|Overall Study|Surgery logistics issue|1|||
126208284|NCT01298323|454049385|FG000|Overall Study|Adverse Event|2|||
126208285|NCT01298323|454049386|FG001|Overall Study|Adverse Event|4|||
126208286|NCT01298323|454049385|FG000|Overall Study|Death|11|||
126208287|NCT01298323|454049386|FG001|Overall Study|Death|16|||
126208288|NCT01298323|454049385|FG000|Overall Study|Lost to Follow-up|1|||
126208289|NCT01298323|454049386|FG001|Overall Study|Lost to Follow-up|0|||
126208290|NCT01298323|454049385|FG000|Overall Study|Withdrawal by Subject|6|||
126208291|NCT01298323|454049386|FG001|Overall Study|Withdrawal by Subject|3|||
126208292|NCT01298323|454049385|FG000|Overall Study|Protocol Violation|1|||
126208293|NCT01298323|454049386|FG001|Overall Study|Protocol Violation|0|||
126208294|NCT01298323|454049385|FG000|Overall Study|Other|10|||
126208295|NCT01298323|454049386|FG001|Overall Study|Other|9|||
126208296|NCT01298323|454049385|FG000|Overall Study|Ongoing|55|||
126208297|NCT01298323|454049386|FG001|Overall Study|Ongoing|55|||
126208298|NCT01298323|454049385|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126208299|NCT01298323|454049386|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126208300|NCT04089566|454049389|FG000|Overall Study|Death|0|||
126208301|NCT04089566|454049390|FG001|Overall Study|Death|6|||
126208302|NCT04089566|454049391|FG002|Overall Study|Death|10|||
126208303|NCT04089566|454049392|FG003|Overall Study|Death|0|||
126208304|NCT04089566|454049393|FG004|Overall Study|Death|0|||
126208305|NCT04089566|454049394|FG005|Overall Study|Death|0|||
126208306|NCT04089566|454049389|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
126208307|NCT04089566|454049390|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
126208308|NCT04089566|454049391|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
126208309|NCT04089566|454049392|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
126208310|NCT04089566|454049393|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
126208311|NCT04089566|454049394|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
126208312|NCT04089566|454049389|FG000|Overall Study|Reason not Specified|0|||
126208313|NCT04089566|454049390|FG001|Overall Study|Reason not Specified|4|||
126208314|NCT04089566|454049391|FG002|Overall Study|Reason not Specified|4|||
126208315|NCT04089566|454049392|FG003|Overall Study|Reason not Specified|1|||
126208316|NCT04089566|454049393|FG004|Overall Study|Reason not Specified|0|||
126208317|NCT04089566|454049394|FG005|Overall Study|Reason not Specified|0|||
126208318|NCT02396849|454049398|FG000|Overall Study|Lost to Follow-up|1|||
126208319|NCT02396849|454049399|FG001|Overall Study|Lost to Follow-up|1|||
126208320|NCT02396849|454049398|FG000|Overall Study|Did not tolerate intervention|1|||
126208321|NCT02396849|454049399|FG001|Overall Study|Did not tolerate intervention|1|||
126208322|NCT04794491|454049408|FG000|Overall Study|Adverse Event|1|||
126208323|NCT04794491|454049408|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
126208324|NCT04794491|454049408|FG000|Overall Study|Noncompliance With Study Intervention|1|||
126208325|NCT04794491|454049408|FG000|Overall Study|Withdrawal by Subject|2|||
126208326|NCT00931515|454049409|FG000|Overall Study|Lost to Follow-up|2|||
126208327|NCT00931515|454049410|FG001|Overall Study|Lost to Follow-up|5|||
126208328|NCT02950831|454049411|FG000|Overall Study|Lost to Follow-up|1|||
126208329|NCT02950831|454049411|FG000|Overall Study|Withdrawal by Subject|3|||
126208330|NCT02950831|454049411|FG000|Overall Study|stimulation trail failure|5|||
126208331|NCT01965600|454049412|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
126208332|NCT01965600|454049413|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
126208333|NCT01965600|454049414|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
126208334|NCT01965600|454049415|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
126208335|NCT01965600|454049412|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
126208336|NCT01965600|454049413|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
126208337|NCT01965600|454049414|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
126208338|NCT01965600|454049415|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
126208339|NCT01965600|454049412|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
126208340|NCT01965600|454049413|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
126208341|NCT01965600|454049414|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
126208342|NCT01965600|454049415|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
126208343|NCT01965600|454049412|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
126208344|NCT01965600|454049413|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
126208345|NCT01965600|454049414|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
126208346|NCT01965600|454049415|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
126208347|NCT01965600|454049412|FG000|Second Intervention|Study terminated by Sponsor|0|||
126316601|NCT00793624|454449361|FG000|Overall Study|Other reason not described above|6|||
126316602|NCT00793624|454449362|FG001|Overall Study|Other reason not described above|4|||
126316603|NCT00793624|454449363|FG002|Overall Study|Other reason not described above|6|||
126316604|NCT00793624|454449364|FG003|Overall Study|Other reason not described above|3|||
126316605|NCT00710684|454449365|FG000|Overall Study|Adverse Event|11|||
126316606|NCT00710684|454449366|FG001|Overall Study|Adverse Event|19|||
126316607|NCT00710684|454449367|FG002|Overall Study|Adverse Event|16|||
126316608|NCT00710684|454449365|FG000|Overall Study|Lack of Efficacy|4|||
126316609|NCT00710684|454449366|FG001|Overall Study|Lack of Efficacy|3|||
126316610|NCT00710684|454449367|FG002|Overall Study|Lack of Efficacy|5|||
126316611|NCT00710684|454449365|FG000|Overall Study|Protocol Violation|5|||
126316612|NCT00710684|454449366|FG001|Overall Study|Protocol Violation|5|||
126316613|NCT00710684|454449367|FG002|Overall Study|Protocol Violation|5|||
126316614|NCT00710684|454449365|FG000|Overall Study|Lost to Follow-up|4|||
126316615|NCT00710684|454449366|FG001|Overall Study|Lost to Follow-up|6|||
126316616|NCT00710684|454449367|FG002|Overall Study|Lost to Follow-up|7|||
126316617|NCT00710684|454449365|FG000|Overall Study|Physician Decision|0|||
126316618|NCT00710684|454449366|FG001|Overall Study|Physician Decision|2|||
126316619|NCT00710684|454449367|FG002|Overall Study|Physician Decision|4|||
126316620|NCT00710684|454449365|FG000|Overall Study|Withdrawal by Subject|24|||
126316621|NCT00710684|454449366|FG001|Overall Study|Withdrawal by Subject|18|||
126316622|NCT00710684|454449367|FG002|Overall Study|Withdrawal by Subject|11|||
125872702|NCT04245111|452828285|FG000|Overall Study|Lost to Follow-up|5|||
125872703|NCT04245111|452828286|FG001|Overall Study|Lost to Follow-up|1|||
125872704|NCT04245111|452828287|FG002|Overall Study|Lost to Follow-up|1|||
125872705|NCT03192176|452828288|FG000|Overall Study|Adverse Event|1|||
125872706|NCT03192176|452828289|FG001|Overall Study|Adverse Event|0|||
125872707|NCT03192176|452828290|FG002|Overall Study|Adverse Event|4|||
125872708|NCT03192176|452828291|FG003|Overall Study|Adverse Event|5|||
125872709|NCT03192176|452828292|FG004|Overall Study|Adverse Event|3|||
125872710|NCT03192176|452828293|FG005|Overall Study|Adverse Event|2|||
125872711|NCT03192176|452828294|FG006|Overall Study|Adverse Event|3|||
125872712|NCT03192176|452828295|FG007|Overall Study|Adverse Event|3|||
125872713|NCT03192176|452828288|FG000|Overall Study|Lost to Follow-up|0|||
125872714|NCT03192176|452828289|FG001|Overall Study|Lost to Follow-up|0|||
125872715|NCT03192176|452828290|FG002|Overall Study|Lost to Follow-up|1|||
125872716|NCT03192176|452828291|FG003|Overall Study|Lost to Follow-up|2|||
125872717|NCT03192176|452828292|FG004|Overall Study|Lost to Follow-up|3|||
125872718|NCT03192176|452828293|FG005|Overall Study|Lost to Follow-up|1|||
125872719|NCT03192176|452828294|FG006|Overall Study|Lost to Follow-up|1|||
125872720|NCT03192176|452828295|FG007|Overall Study|Lost to Follow-up|1|||
125872721|NCT03192176|452828288|FG000|Overall Study|Physician Decision|1|||
125872722|NCT03192176|452828289|FG001|Overall Study|Physician Decision|0|||
126208348|NCT01965600|454049413|FG001|Second Intervention|Study terminated by Sponsor|0|||
126208349|NCT01965600|454049414|FG002|Second Intervention|Study terminated by Sponsor|2|||
125872723|NCT03192176|452828290|FG002|Overall Study|Physician Decision|0|||
125872724|NCT03192176|452828291|FG003|Overall Study|Physician Decision|0|||
125872725|NCT03192176|452828292|FG004|Overall Study|Physician Decision|0|||
125872726|NCT03192176|452828293|FG005|Overall Study|Physician Decision|2|||
125872727|NCT03192176|452828294|FG006|Overall Study|Physician Decision|1|||
125872728|NCT03192176|452828295|FG007|Overall Study|Physician Decision|0|||
125872729|NCT03192176|452828288|FG000|Overall Study|Protocol Deviation|1|||
125872730|NCT03192176|452828289|FG001|Overall Study|Protocol Deviation|1|||
125872731|NCT03192176|452828290|FG002|Overall Study|Protocol Deviation|0|||
125872732|NCT03192176|452828291|FG003|Overall Study|Protocol Deviation|0|||
125872733|NCT03192176|452828292|FG004|Overall Study|Protocol Deviation|2|||
125872734|NCT03192176|452828293|FG005|Overall Study|Protocol Deviation|0|||
125872735|NCT03192176|452828294|FG006|Overall Study|Protocol Deviation|0|||
125872736|NCT03192176|452828295|FG007|Overall Study|Protocol Deviation|0|||
125872737|NCT03192176|452828288|FG000|Overall Study|Withdrawal by Subject|3|||
125872738|NCT03192176|452828289|FG001|Overall Study|Withdrawal by Subject|4|||
125872739|NCT03192176|452828290|FG002|Overall Study|Withdrawal by Subject|0|||
125872740|NCT03192176|452828291|FG003|Overall Study|Withdrawal by Subject|4|||
125872741|NCT03192176|452828292|FG004|Overall Study|Withdrawal by Subject|3|||
125872742|NCT03192176|452828293|FG005|Overall Study|Withdrawal by Subject|4|||
125872743|NCT03192176|452828294|FG006|Overall Study|Withdrawal by Subject|4|||
125872744|NCT03192176|452828295|FG007|Overall Study|Withdrawal by Subject|2|||
125872745|NCT03192176|452828288|FG000|Overall Study|Miscellaneous|1|||
125872746|NCT03192176|452828289|FG001|Overall Study|Miscellaneous|0|||
125872747|NCT03192176|452828290|FG002|Overall Study|Miscellaneous|1|||
125872748|NCT03192176|452828291|FG003|Overall Study|Miscellaneous|1|||
125872749|NCT03192176|452828292|FG004|Overall Study|Miscellaneous|1|||
125872750|NCT03192176|452828293|FG005|Overall Study|Miscellaneous|2|||
125872751|NCT03192176|452828294|FG006|Overall Study|Miscellaneous|0|||
125872752|NCT03192176|452828295|FG007|Overall Study|Miscellaneous|1|||
125872753|NCT03532542|452828298|FG000|Overall Study|Death|1|||
125872754|NCT03532542|452828299|FG001|Overall Study|Death|0|||
125872755|NCT03532542|452828298|FG000|Overall Study|Study Terminated by Sponsor|41|||
125872756|NCT03532542|452828299|FG001|Overall Study|Study Terminated by Sponsor|65|||
125872757|NCT03532542|452828298|FG000|Overall Study|Withdrawal by Subject|6|||
125872758|NCT03532542|452828299|FG001|Overall Study|Withdrawal by Subject|5|||
125872759|NCT01962441|452828300|FG000|Randomized Period|Randomized but Never Treated|4|||
125872760|NCT01962441|452828301|FG001|Randomized Period|Randomized but Never Treated|2|||
125872761|NCT01962441|452828302|FG002|Randomized Period|Randomized but Never Treated|3|||
125872762|NCT01962441|452828300|FG000|Randomized Period|Lost to Follow-up|2|||
125872763|NCT01962441|452828301|FG001|Randomized Period|Lost to Follow-up|4|||
125872764|NCT01962441|452828302|FG002|Randomized Period|Lost to Follow-up|4|||
125872765|NCT01962441|452828300|FG000|Randomized Period|Withdrew Consent|3|||
125872766|NCT01962441|452828301|FG001|Randomized Period|Withdrew Consent|3|||
125872767|NCT01962441|452828302|FG002|Randomized Period|Withdrew Consent|2|||
125872768|NCT01962441|452828300|FG000|Randomized Period|Adverse Event|1|||
125872769|NCT01962441|452828301|FG001|Randomized Period|Adverse Event|1|||
125872770|NCT01962441|452828302|FG002|Randomized Period|Adverse Event|0|||
125872771|NCT01962441|452828300|FG000|Randomized Period|Death|0|||
125872772|NCT01962441|452828301|FG001|Randomized Period|Death|0|||
125872773|NCT01962441|452828302|FG002|Randomized Period|Death|2|||
125872774|NCT01962441|452828300|FG000|Randomized Period|Protocol Violation|0|||
125872775|NCT01962441|452828301|FG001|Randomized Period|Protocol Violation|1|||
125872776|NCT01962441|452828302|FG002|Randomized Period|Protocol Violation|0|||
125872777|NCT01962441|452828300|FG000|Retreatment Substudy|Lack of Efficacy|1|||
125872778|NCT01962441|452828301|FG001|Retreatment Substudy|Lack of Efficacy|0|||
125872779|NCT01962441|452828302|FG002|Retreatment Substudy|Lack of Efficacy|0|||
125872780|NCT01962441|452828300|FG000|Retreatment Substudy|Lost to Follow-up|1|||
125872781|NCT01962441|452828301|FG001|Retreatment Substudy|Lost to Follow-up|0|||
125872782|NCT01962441|452828302|FG002|Retreatment Substudy|Lost to Follow-up|0|||
125872783|NCT02055898|452828303|FG000|First Intervention (5 Days)|Physician Decision|2|||
125872784|NCT02055898|452828304|FG001|First Intervention (5 Days)|Physician Decision|0|||
125872785|NCT02055898|452828303|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
125872786|NCT02055898|452828304|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
125872787|NCT02314052|452828308|FG000|Cycle One|Adverse Event|0|||
125872788|NCT02314052|452828309|FG001|Cycle One|Adverse Event|0|||
125872789|NCT02314052|452828310|FG002|Cycle One|Adverse Event|0|||
125872790|NCT02314052|452828311|FG003|Cycle One|Adverse Event|1|||
125872791|NCT02314052|452828312|FG004|Cycle One|Adverse Event|0|||
125872792|NCT02314052|452828313|FG005|Cycle One|Adverse Event|0|||
125872793|NCT00117637|452828314|FG000|First Intervention (Period 1)|Adverse Event|11|||
125872794|NCT00117637|452828315|FG001|First Intervention (Period 1)|Adverse Event|16|||
125872795|NCT00117637|452828314|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
125872796|NCT00117637|452828315|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
125872797|NCT00117637|452828314|FG000|First Intervention (Period 1)|Protocol Violation|1|||
125872798|NCT00117637|452828315|FG001|First Intervention (Period 1)|Protocol Violation|0|||
125872799|NCT00117637|452828314|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
125872800|NCT00117637|452828315|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
125872801|NCT00117637|452828314|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
125872802|NCT00117637|452828315|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
125872803|NCT00117637|452828314|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
125872804|NCT00117637|452828315|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
125872805|NCT00117637|452828314|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
125872806|NCT00117637|452828315|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
125872807|NCT00117637|452828314|FG000|First Intervention (Period 1)|reason not reported|0|||
125872808|NCT00117637|452828315|FG001|First Intervention (Period 1)|reason not reported|1|||
125872809|NCT00117637|452828314|FG000|Second Intervention (Period 2)|Adverse Event|0|||
125872810|NCT00117637|452828315|FG001|Second Intervention (Period 2)|Adverse Event|9|||
126316623|NCT00710684|454449365|FG000|Overall Study|Missing|1|||
125872811|NCT00117637|452828314|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
125872812|NCT00117637|452828315|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
125872813|NCT00117637|452828314|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
125872814|NCT00117637|452828315|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
125872815|NCT00117637|452828314|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
125872816|NCT00117637|452828315|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
125872817|NCT00117637|452828314|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
125872818|NCT00117637|452828315|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
125872819|NCT00117637|452828314|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
125872820|NCT00117637|452828315|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
125872821|NCT00117637|452828314|FG000|Second Intervention (Period 2)|reason not reported|1|||
125872822|NCT00117637|452828315|FG001|Second Intervention (Period 2)|reason not reported|0|||
125872823|NCT01620060|452828316|FG000|Overall Study|Adverse Event|9|||
125872824|NCT01620060|452828316|FG000|Overall Study|Protocol Violation|1|||
125872825|NCT01620060|452828316|FG000|Overall Study|Withdrawal by Subject|1|||
125872826|NCT01620060|452828316|FG000|Overall Study|Did not comply with Study Produre|1|||
125872827|NCT01620060|452828316|FG000|Overall Study|Family emergency|1|||
125872828|NCT01620060|452828316|FG000|Overall Study|Per Sponsor Decision|2|||
125872829|NCT01582061|452828317|FG000|Overall Study|Lack of Efficacy|3|||
125872830|NCT01582061|452828318|FG001|Overall Study|Lack of Efficacy|23|||
125872831|NCT01582061|452828317|FG000|Overall Study|Adverse Event|12|||
125872832|NCT01582061|452828318|FG001|Overall Study|Adverse Event|8|||
125872833|NCT01582061|452828317|FG000|Overall Study|Withdrawal by Subject|10|||
125872834|NCT01582061|452828318|FG001|Overall Study|Withdrawal by Subject|4|||
125872835|NCT01582061|452828317|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125872836|NCT01582061|452828318|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125872837|NCT01582061|452828317|FG000|Overall Study|Death|0|||
125872838|NCT01582061|452828318|FG001|Overall Study|Death|1|||
125872839|NCT01582061|452828317|FG000|Overall Study|condition no longer requires study drug|1|||
125872840|NCT01582061|452828318|FG001|Overall Study|condition no longer requires study drug|0|||
125872841|NCT01582061|452828317|FG000|Overall Study|Lost to Follow-up|1|||
125872842|NCT01582061|452828318|FG001|Overall Study|Lost to Follow-up|0|||
125872843|NCT00231777|452828319|FG000|Overall Study|Lost to Follow-up|3|||
125872844|NCT00231777|452828320|FG001|Overall Study|Lost to Follow-up|0|||
125872845|NCT00231777|452828319|FG000|Overall Study|Other|3|||
125872846|NCT00231777|452828320|FG001|Overall Study|Other|2|||
125872847|NCT04551989|452828323|FG000|Overall Study|Adverse Event|4|||
125872848|NCT04551989|452828323|FG000|Overall Study|Protocol Violation|3|||
125872849|NCT04551989|452828323|FG000|Overall Study|Lost to Follow-up|1|||
125872850|NCT04551989|452828323|FG000|Overall Study|Physician Decision|3|||
125872851|NCT04698343|452828324|FG000|Overall Study|Withdrawal by Subject|6|||
125872852|NCT04698343|452828324|FG000|Overall Study|Physician Decision|2|||
125872853|NCT04698343|452828324|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
125872854|NCT04698343|452828324|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
125872855|NCT04698343|452828324|FG000|Overall Study|Personal reasons|3|||
125872856|NCT04698343|452828324|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
125872857|NCT02756338|452828325|FG000|Overall Study|Withdrawn by Investigator|1|||
125872858|NCT02756338|452828325|FG000|Overall Study|Device Replaced with Pacemaker|4|||
125872859|NCT00088530|452828328|FG000|Overall Study|Progressive/Relapsed Disease|28|||
125872860|NCT00088530|452828329|FG001|Overall Study|Progressive/Relapsed Disease|39|||
125872861|NCT00088530|452828328|FG000|Overall Study|Adverse Event|15|||
125872862|NCT00088530|452828329|FG001|Overall Study|Adverse Event|9|||
125872863|NCT00088530|452828328|FG000|Overall Study|Withdrawal by Subject|2|||
125872864|NCT00088530|452828329|FG001|Overall Study|Withdrawal by Subject|5|||
125872865|NCT00088530|452828328|FG000|Overall Study|Lost to Follow-up|2|||
125872866|NCT00088530|452828329|FG001|Overall Study|Lost to Follow-up|0|||
125872867|NCT00088530|452828328|FG000|Overall Study|Physician Decision|2|||
125872868|NCT00088530|452828329|FG001|Overall Study|Physician Decision|0|||
125872869|NCT00088530|452828328|FG000|Overall Study|Sponsor decision|0|||
125872870|NCT00088530|452828329|FG001|Overall Study|Sponsor decision|1|||
125872871|NCT00088530|452828328|FG000|Overall Study|Patient never treated|1|||
125872872|NCT00088530|452828329|FG001|Overall Study|Patient never treated|0|||
125872873|NCT00300755|452828332|FG000|Overall Study|Adverse Event|1|||
125872874|NCT00300755|452828333|FG001|Overall Study|Adverse Event|2|||
125872875|NCT00300755|452828334|FG002|Overall Study|Adverse Event|1|||
125872876|NCT00300755|452828332|FG000|Overall Study|Withdrawal by Subject|0|||
125872877|NCT00300755|452828333|FG001|Overall Study|Withdrawal by Subject|2|||
126090446|NCT04191616|453623567|FG000|Treatment Period|Withdrawal by Subject|4|||
125872878|NCT00300755|452828334|FG002|Overall Study|Withdrawal by Subject|0|||
125872879|NCT00300755|452828332|FG000|Overall Study|Protocol Violation|0|||
125872880|NCT00300755|452828333|FG001|Overall Study|Protocol Violation|0|||
125872881|NCT00300755|452828334|FG002|Overall Study|Protocol Violation|1|||
125872882|NCT02694744|452828338|FG000|Overall Study|Adverse Event|2|||
125872883|NCT02694744|452828339|FG001|Overall Study|Adverse Event|1|||
125872884|NCT02694744|452828338|FG000|Overall Study|Withdrawal by Subject|2|||
125872885|NCT02694744|452828339|FG001|Overall Study|Withdrawal by Subject|1|||
125872886|NCT02694744|452828338|FG000|Overall Study|Physician Decision|1|||
125872887|NCT02694744|452828339|FG001|Overall Study|Physician Decision|2|||
125872888|NCT02694744|452828338|FG000|Overall Study|Lost to Follow-up|1|||
125872889|NCT02694744|452828339|FG001|Overall Study|Lost to Follow-up|0|||
125872890|NCT02694744|452828338|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
125872891|NCT02694744|452828339|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
125872892|NCT00686777|452828340|FG000|Overall Study|Adverse Event|2|||
125872893|NCT00686777|452828340|FG000|Overall Study|Pregnancy|1|||
125872894|NCT00686777|452828340|FG000|Overall Study|Withdrawal by Subject|2|||
125872895|NCT00686777|452828340|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
125872896|NCT00686777|452828340|FG000|Overall Study|No Visit|1|||
125872897|NCT01945021|452828341|FG000|Overall Study|Adverse Event|1|||
125872898|NCT01945021|452828341|FG000|Overall Study|Withdrawal of consent|12|||
125872899|NCT01945021|452828341|FG000|Overall Study|Lost to Follow-up|5|||
125872900|NCT01945021|452828341|FG000|Overall Study|Death|65|||
125872901|NCT03582215|452828342|FG000|Overall Study|Adverse Event|1|||
125872902|NCT03582215|452828343|FG001|Overall Study|Adverse Event|0|||
125872903|NCT03582215|452828344|FG002|Overall Study|Adverse Event|0|||
125872904|NCT03582215|452828345|FG003|Overall Study|Adverse Event|0|||
125872905|NCT03582215|452828346|FG004|Overall Study|Adverse Event|0|||
125872906|NCT03582215|452828347|FG005|Overall Study|Adverse Event|0|||
125872907|NCT03582215|452828348|FG006|Overall Study|Adverse Event|2|||
125872908|NCT03582215|452828349|FG007|Overall Study|Adverse Event|2|||
125872909|NCT02163902|452828350|FG000|Overall Study|Subject's Request|3|||
125872910|NCT02163902|452828351|FG001|Overall Study|Subject's Request|4|||
125872911|NCT02163902|452828350|FG000|Overall Study|Lost to Follow-up|6|||
125872912|NCT02163902|452828351|FG001|Overall Study|Lost to Follow-up|7|||
125872913|NCT02163902|452828350|FG000|Overall Study|Administrative Decision|2|||
125872914|NCT02163902|452828351|FG001|Overall Study|Administrative Decision|2|||
125872915|NCT03119259|452828352|FG000|Overall Study|Withdrawn as no longer eligible|1|||
125872916|NCT03119259|452828353|FG001|Overall Study|Withdrawn as no longer eligible|0|||
125872917|NCT03119259|452828352|FG000|Overall Study|Withdrawal by Subject|4|||
125872918|NCT03119259|452828353|FG001|Overall Study|Withdrawal by Subject|2|||
125872919|NCT03119259|452828352|FG000|Overall Study|Lost to Follow-up|0|||
125872920|NCT03119259|452828353|FG001|Overall Study|Lost to Follow-up|1|||
125872921|NCT04575155|452828356|FG000|2 Month|Withdrawal by Subject|1|||
125872922|NCT04575155|452828357|FG001|2 Month|Withdrawal by Subject|1|||
125872923|NCT04575155|452828356|FG000|2 Month|Lost to Follow-up|5|||
125872924|NCT04575155|452828357|FG001|2 Month|Lost to Follow-up|3|||
125872925|NCT04575155|452828356|FG000|2 Month|Ineligible|1|||
125872926|NCT04575155|452828357|FG001|2 Month|Ineligible|0|||
125872927|NCT02903160|452828360|FG000|Overall Study|Adverse Event|2|||
125872928|NCT02903160|452828360|FG000|Overall Study|Death|1|||
125872929|NCT02903160|452828360|FG000|Overall Study|Lost to Follow-up|2|||
125872930|NCT02903160|452828360|FG000|Overall Study|Withdrawal by Subject|1|||
125872931|NCT02903160|452828360|FG000|Overall Study|Medical Insurance Barriers|1|||
125872932|NCT01664910|452828363|FG000|Overall Study|Adverse Event|0|||
125872933|NCT01664910|452828364|FG001|Overall Study|Adverse Event|0|||
125872934|NCT01664910|452828365|FG002|Overall Study|Adverse Event|1|||
125872935|NCT00730158|452828369|FG000|Overall Study|Withdrawal by Subject|1|||
125872936|NCT00730158|452828370|FG001|Overall Study|Withdrawal by Subject|1|||
125872937|NCT04678115|452828371|FG000|Overall Study|Lost to Follow-up|1|||
125872938|NCT04678115|452828372|FG001|Overall Study|Lost to Follow-up|0|||
125872939|NCT01168349|452828373|FG000|Overall Study|Death|157|||
125872940|NCT01168349|452828373|FG000|Overall Study|Lost to Follow-up|34|||
125872941|NCT01168349|452828373|FG000|Overall Study|Withdrawal by Subject|9|||
125872942|NCT01168349|452828373|FG000|Overall Study|Kidney transplantation|3|||
126208350|NCT01965600|454049415|FG003|Second Intervention|Study terminated by Sponsor|2|||
126208351|NCT03418727|454049423|FG000|Overall Study|Adverse Event|1|||
126208352|NCT03418727|454049424|FG001|Overall Study|Adverse Event|2|||
126208353|NCT03418727|454049425|FG002|Overall Study|Adverse Event|0|||
126208354|NCT03418727|454049423|FG000|Overall Study|Withdrawal by Subject|0|||
126208355|NCT03418727|454049424|FG001|Overall Study|Withdrawal by Subject|0|||
126208356|NCT03418727|454049425|FG002|Overall Study|Withdrawal by Subject|2|||
125872943|NCT01168349|452828373|FG000|Overall Study|Other|22|||
125872944|NCT01168349|452828373|FG000|Overall Study|Protocol Violation|76|||
125872945|NCT03535974|452828374|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
125872946|NCT03535974|452828375|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
125872947|NCT03535974|452828376|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
125872948|NCT03535974|452828374|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
125872949|NCT03535974|452828375|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
125872950|NCT03535974|452828376|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
125872951|NCT04059549|452828377|FG000|Overall Study|Withdrawal by Subject|2|||
125872952|NCT04059549|452828378|FG001|Overall Study|Withdrawal by Subject|0|||
126208357|NCT00686894|454049430|FG000|Overall Study|Relapse|2|||
126208358|NCT00686894|454049430|FG000|Overall Study|Protocol Violation|4|||
125872953|NCT02678351|452828380|FG000|Overall Study|Withdrawal by Subject|1|||
125872954|NCT00988884|452828381|FG000|Overall Study|Adverse Event|0|||
125872955|NCT00988884|452828382|FG001|Overall Study|Adverse Event|1|||
125872956|NCT00988884|452828381|FG000|Overall Study|Lost to Follow-up|20|||
125872957|NCT00988884|452828382|FG001|Overall Study|Lost to Follow-up|16|||
125872958|NCT00988884|452828381|FG000|Overall Study|Protocol Violation|0|||
125872959|NCT00988884|452828382|FG001|Overall Study|Protocol Violation|1|||
125872960|NCT00988884|452828381|FG000|Overall Study|Withdrawal by Subject|15|||
125872961|NCT00988884|452828382|FG001|Overall Study|Withdrawal by Subject|18|||
125872962|NCT01919229|452828383|FG000|Overall Study|Subject/guardian decision|0|||
125872963|NCT01919229|452828384|FG001|Overall Study|Subject/guardian decision|0|||
125872964|NCT01919229|452828385|FG002|Overall Study|Subject/guardian decision|1|||
125872965|NCT01632020|452828386|FG000|Overall Study|Withdrawal by Subject|1|||
125872966|NCT01632020|452828387|FG001|Overall Study|Withdrawal by Subject|0|||
125872967|NCT01632020|452828386|FG000|Overall Study|Adverse Event|1|||
125872968|NCT01632020|452828387|FG001|Overall Study|Adverse Event|0|||
125872969|NCT01362348|452828389|FG000|Overall Study|Protocol-defined stopping criteria|9|||
125872970|NCT01362348|452828389|FG000|Overall Study|Study closed/terminated|5|||
125872971|NCT02898454|452828392|FG000|Overall Study|Adverse Event|4|||
125872972|NCT02898454|452828393|FG001|Overall Study|Adverse Event|1|||
125872973|NCT02898454|452828394|FG002|Overall Study|Adverse Event|2|||
125872974|NCT02898454|452828392|FG000|Overall Study|Protocol Violation|1|||
125872975|NCT02898454|452828393|FG001|Overall Study|Protocol Violation|0|||
125872976|NCT02898454|452828394|FG002|Overall Study|Protocol Violation|1|||
125872977|NCT02898454|452828392|FG000|Overall Study|Lack of Efficacy|4|||
125872978|NCT02898454|452828393|FG001|Overall Study|Lack of Efficacy|1|||
125872979|NCT02898454|452828394|FG002|Overall Study|Lack of Efficacy|0|||
125872980|NCT02898454|452828392|FG000|Overall Study|Withdrawal by Subject|6|||
125872981|NCT02898454|452828393|FG001|Overall Study|Withdrawal by Subject|3|||
125872982|NCT02898454|452828394|FG002|Overall Study|Withdrawal by Subject|3|||
125872983|NCT02898454|452828392|FG000|Overall Study|Lost to Follow-up|1|||
125872984|NCT02898454|452828393|FG001|Overall Study|Lost to Follow-up|0|||
125872985|NCT02898454|452828394|FG002|Overall Study|Lost to Follow-up|0|||
125872986|NCT02898454|452828392|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
125872987|NCT02898454|452828393|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
125872988|NCT02898454|452828394|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
125872989|NCT01601535|452828395|FG000|Phase 1|Adverse Event|1|||
125872990|NCT01601535|452828396|FG001|Phase 1|Adverse Event|0|||
125872991|NCT01601535|452828397|FG002|Phase 1|Adverse Event|2|||
125872992|NCT01601535|452828398|FG003|Phase 1|Adverse Event|1|||
125872993|NCT01601535|452828399|FG004|Phase 1|Adverse Event|0|||
125872994|NCT01601535|452828400|FG005|Phase 1|Adverse Event|0|||
125872995|NCT01601535|452828395|FG000|Phase 1|Withdrawal by Subject|2|||
125872996|NCT01601535|452828396|FG001|Phase 1|Withdrawal by Subject|1|||
125872997|NCT01601535|452828397|FG002|Phase 1|Withdrawal by Subject|1|||
125872998|NCT01601535|452828398|FG003|Phase 1|Withdrawal by Subject|2|||
125872999|NCT01601535|452828399|FG004|Phase 1|Withdrawal by Subject|0|||
125873000|NCT01601535|452828400|FG005|Phase 1|Withdrawal by Subject|0|||
125873001|NCT01601535|452828395|FG000|Phase 1|Progressive Disease|2|||
125873002|NCT01601535|452828396|FG001|Phase 1|Progressive Disease|3|||
125873003|NCT01601535|452828397|FG002|Phase 1|Progressive Disease|2|||
125873004|NCT01601535|452828398|FG003|Phase 1|Progressive Disease|1|||
125873005|NCT01601535|452828399|FG004|Phase 1|Progressive Disease|0|||
125873006|NCT01601535|452828400|FG005|Phase 1|Progressive Disease|0|||
125873007|NCT01601535|452828395|FG000|Phase 1|Started Another Treatment|1|||
125873008|NCT01601535|452828396|FG001|Phase 1|Started Another Treatment|2|||
125873009|NCT01601535|452828397|FG002|Phase 1|Started Another Treatment|0|||
125873010|NCT01601535|452828398|FG003|Phase 1|Started Another Treatment|0|||
125873011|NCT01601535|452828399|FG004|Phase 1|Started Another Treatment|0|||
125873012|NCT01601535|452828400|FG005|Phase 1|Started Another Treatment|0|||
125873013|NCT01601535|452828395|FG000|Phase 2|Adverse Event|0|||
125873014|NCT01601535|452828396|FG001|Phase 2|Adverse Event|0|||
125873015|NCT01601535|452828397|FG002|Phase 2|Adverse Event|0|||
125873016|NCT01601535|452828398|FG003|Phase 2|Adverse Event|0|||
125873017|NCT01601535|452828399|FG004|Phase 2|Adverse Event|5|||
125873018|NCT01601535|452828400|FG005|Phase 2|Adverse Event|1|||
125873019|NCT01601535|452828395|FG000|Phase 2|Withdrawal by Subject|0|||
125873020|NCT01601535|452828396|FG001|Phase 2|Withdrawal by Subject|0|||
125873021|NCT01601535|452828397|FG002|Phase 2|Withdrawal by Subject|0|||
125873022|NCT01601535|452828398|FG003|Phase 2|Withdrawal by Subject|0|||
125873023|NCT01601535|452828399|FG004|Phase 2|Withdrawal by Subject|8|||
125873024|NCT01601535|452828400|FG005|Phase 2|Withdrawal by Subject|2|||
125873025|NCT01601535|452828395|FG000|Phase 2|Progressive Disease|0|||
125873026|NCT01601535|452828396|FG001|Phase 2|Progressive Disease|0|||
125873027|NCT01601535|452828397|FG002|Phase 2|Progressive Disease|0|||
125873028|NCT01601535|452828398|FG003|Phase 2|Progressive Disease|0|||
125873029|NCT01601535|452828399|FG004|Phase 2|Progressive Disease|5|||
125873030|NCT01601535|452828400|FG005|Phase 2|Progressive Disease|7|||
125873031|NCT01601535|452828395|FG000|Phase 2|Started Another Treatment|0|||
125873032|NCT01601535|452828396|FG001|Phase 2|Started Another Treatment|0|||
125873033|NCT01601535|452828397|FG002|Phase 2|Started Another Treatment|0|||
125873034|NCT01601535|452828398|FG003|Phase 2|Started Another Treatment|0|||
125873035|NCT01601535|452828399|FG004|Phase 2|Started Another Treatment|1|||
125873036|NCT01601535|452828400|FG005|Phase 2|Started Another Treatment|2|||
125873037|NCT00647296|452828401|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125873038|NCT00647296|452828402|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125873039|NCT00647296|452828403|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125873040|NCT00647296|452828404|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
125873041|NCT00647296|452828401|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
125873042|NCT00647296|452828402|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
125873043|NCT00647296|452828403|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
125873044|NCT00647296|452828404|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
125873045|NCT00647296|452828401|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125873046|NCT00647296|452828402|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
125873047|NCT00647296|452828403|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125873048|NCT00647296|452828404|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125873049|NCT00647296|452828401|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
125873050|NCT00647296|452828402|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
125873051|NCT00647296|452828403|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
125873052|NCT00647296|452828404|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
125873053|NCT00647296|452828401|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
125873054|NCT00647296|452828402|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
125873055|NCT00647296|452828403|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
125873056|NCT00647296|452828404|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
125873057|NCT00647296|452828401|FG000|Part 2: 4-week Placebo Washout|Death|3|||
125873058|NCT00647296|452828402|FG001|Part 2: 4-week Placebo Washout|Death|0|||
125873059|NCT00647296|452828403|FG002|Part 2: 4-week Placebo Washout|Death|0|||
125873060|NCT00647296|452828404|FG003|Part 2: 4-week Placebo Washout|Death|0|||
125873061|NCT00647296|452828401|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
125873062|NCT00647296|452828402|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
125873063|NCT00647296|452828403|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
125873064|NCT00647296|452828404|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
125873065|NCT00647296|452828401|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
125873066|NCT00647296|452828402|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
125873067|NCT00647296|452828403|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
125873068|NCT00647296|452828404|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
125873069|NCT00647296|452828401|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125873070|NCT00647296|452828402|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
125873071|NCT00647296|452828403|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125873072|NCT00647296|452828404|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125873073|NCT00647296|452828401|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
125873074|NCT00647296|452828402|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
125873075|NCT00647296|452828403|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
125873076|NCT00647296|452828404|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
125873077|NCT00647296|452828401|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
125873078|NCT00647296|452828402|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
125873079|NCT00647296|452828403|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
125873080|NCT00647296|452828404|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
125873081|NCT01787461|452828405|FG000|Overall Study|Adverse Event|4|||
125873082|NCT01787461|452828406|FG001|Overall Study|Adverse Event|3|||
125873083|NCT01787461|452828405|FG000|Overall Study|Lost to Follow-up|3|||
125873084|NCT01787461|452828406|FG001|Overall Study|Lost to Follow-up|2|||
125873085|NCT01787461|452828405|FG000|Overall Study|No longer met eligibility criteria|1|||
125873086|NCT01787461|452828406|FG001|Overall Study|No longer met eligibility criteria|0|||
125873087|NCT01787461|452828405|FG000|Overall Study|Withdrawal by Subject|3|||
125873088|NCT01787461|452828406|FG001|Overall Study|Withdrawal by Subject|4|||
125873089|NCT01787461|452828405|FG000|Overall Study|Protocol Violation|3|||
125873090|NCT01787461|452828406|FG001|Overall Study|Protocol Violation|0|||
125873091|NCT03649074|452828407|FG000|Overall Study|Lost to Follow-up|2|||
125873092|NCT03649074|452828408|FG001|Overall Study|Lost to Follow-up|1|||
125873093|NCT03649074|452828407|FG000|Overall Study|Adverse Event|1|||
125873094|NCT03649074|452828408|FG001|Overall Study|Adverse Event|0|||
125873095|NCT03649074|452828407|FG000|Overall Study|Physician Decision|1|||
125873096|NCT03649074|452828408|FG001|Overall Study|Physician Decision|0|||
125873097|NCT03649074|452828407|FG000|Overall Study|Withdrawal by Subject|0|||
125873098|NCT03649074|452828408|FG001|Overall Study|Withdrawal by Subject|2|||
125873099|NCT03649074|452828407|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
125873100|NCT03649074|452828408|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
126316624|NCT00710684|454449366|FG001|Overall Study|Missing|0|||
126316625|NCT00710684|454449367|FG002|Overall Study|Missing|0|||
125873101|NCT03649074|452828407|FG000|Overall Study|Other|1|||
125873102|NCT03649074|452828408|FG001|Overall Study|Other|0|||
125873103|NCT00556894|452828409|FG000|Overall Study|Adverse Event|2|||
125873104|NCT00556894|452828410|FG001|Overall Study|Adverse Event|3|||
125873105|NCT00556894|452828411|FG002|Overall Study|Adverse Event|3|||
125873106|NCT00556894|452828409|FG000|Overall Study|Death|1|||
125873107|NCT00556894|452828410|FG001|Overall Study|Death|0|||
125873108|NCT00556894|452828411|FG002|Overall Study|Death|0|||
125873109|NCT00556894|452828409|FG000|Overall Study|regulatory decision in Bulgaria|10|||
125873110|NCT00556894|452828410|FG001|Overall Study|regulatory decision in Bulgaria|14|||
125873111|NCT00556894|452828411|FG002|Overall Study|regulatory decision in Bulgaria|13|||
125873112|NCT00556894|452828409|FG000|Overall Study|Change in therapy|2|||
125873113|NCT00556894|452828410|FG001|Overall Study|Change in therapy|1|||
125873114|NCT00556894|452828411|FG002|Overall Study|Change in therapy|2|||
125873115|NCT00556894|452828409|FG000|Overall Study|Withdrawal by Subject|1|||
125873116|NCT00556894|452828410|FG001|Overall Study|Withdrawal by Subject|1|||
125873117|NCT00556894|452828411|FG002|Overall Study|Withdrawal by Subject|1|||
125873118|NCT04750642|452828415|FG000|Overall Study|Adverse Event|1|||
125873119|NCT04750642|452828416|FG001|Overall Study|Adverse Event|0|||
125873120|NCT04750642|452828415|FG000|Overall Study|Withdrawal by Subject|0|||
125873121|NCT04750642|452828416|FG001|Overall Study|Withdrawal by Subject|1|||
125873122|NCT04750642|452828415|FG000|Overall Study|Protocol Violation|0|||
125873123|NCT04750642|452828416|FG001|Overall Study|Protocol Violation|1|||
125873124|NCT01519323|452829902|FG000|Overall Study|Death|3|||
125873125|NCT01519323|452829903|FG001|Overall Study|Death|2|||
125873126|NCT01519323|452829902|FG000|Overall Study|Study terminated by sponsor|0|||
125873127|NCT01519323|452829903|FG001|Overall Study|Study terminated by sponsor|1|||
125873128|NCT00383552|452829906|FG000|Overall Study|Adverse Event|7|||
125873129|NCT00383552|452829907|FG001|Overall Study|Adverse Event|6|||
125873130|NCT00383552|452829908|FG002|Overall Study|Adverse Event|9|||
125873131|NCT00383552|452829909|FG003|Overall Study|Adverse Event|6|||
125873132|NCT00383552|452829906|FG000|Overall Study|Lack of Efficacy|4|||
125873133|NCT00383552|452829907|FG001|Overall Study|Lack of Efficacy|13|||
125873134|NCT00383552|452829908|FG002|Overall Study|Lack of Efficacy|29|||
125873135|NCT00383552|452829909|FG003|Overall Study|Lack of Efficacy|42|||
125873136|NCT00383552|452829906|FG000|Overall Study|Lost to Follow-up|0|||
125873137|NCT00383552|452829907|FG001|Overall Study|Lost to Follow-up|1|||
125873138|NCT00383552|452829908|FG002|Overall Study|Lost to Follow-up|5|||
125873139|NCT00383552|452829909|FG003|Overall Study|Lost to Follow-up|1|||
125873140|NCT00383552|452829906|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
125873141|NCT00383552|452829907|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
125873142|NCT00383552|452829908|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
125873143|NCT00383552|452829909|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
125873144|NCT00383552|452829906|FG000|Overall Study|Did not wish to continue (related)|1|||
125873145|NCT00383552|452829907|FG001|Overall Study|Did not wish to continue (related)|0|||
125873146|NCT00383552|452829908|FG002|Overall Study|Did not wish to continue (related)|2|||
125873147|NCT00383552|452829909|FG003|Overall Study|Did not wish to continue (related)|3|||
125873148|NCT00383552|452829906|FG000|Overall Study|Noncompliance with the protocol|11|||
125873149|NCT00383552|452829907|FG001|Overall Study|Noncompliance with the protocol|6|||
125873150|NCT00383552|452829908|FG002|Overall Study|Noncompliance with the protocol|8|||
125873151|NCT00383552|452829909|FG003|Overall Study|Noncompliance with the protocol|10|||
125873152|NCT00383552|452829906|FG000|Overall Study|Did not meet protocol eligibility|8|||
125873153|NCT00383552|452829907|FG001|Overall Study|Did not meet protocol eligibility|6|||
125873154|NCT00383552|452829908|FG002|Overall Study|Did not meet protocol eligibility|2|||
125873155|NCT00383552|452829909|FG003|Overall Study|Did not meet protocol eligibility|3|||
125873156|NCT00383552|452829906|FG000|Overall Study|Administrative|1|||
125873157|NCT00383552|452829907|FG001|Overall Study|Administrative|0|||
125873158|NCT00383552|452829908|FG002|Overall Study|Administrative|1|||
125873159|NCT00383552|452829909|FG003|Overall Study|Administrative|1|||
125873160|NCT03096834|452829910|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
125873161|NCT03096834|452829911|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
125873162|NCT03096834|452829912|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
125873163|NCT03096834|452829913|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
125873164|NCT03096834|452829910|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
125873165|NCT03096834|452829911|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
125873166|NCT03096834|452829912|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
125873167|NCT03096834|452829913|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
125873168|NCT03096834|452829910|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
125873169|NCT03096834|452829911|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
125873170|NCT03096834|452829912|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
125873171|NCT03096834|452829913|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
125873172|NCT03096834|452829910|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
125873173|NCT03096834|452829911|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
125873174|NCT03096834|452829912|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
125873175|NCT03096834|452829913|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
125873176|NCT03096834|452829910|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
125873177|NCT03096834|452829911|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
125873178|NCT03096834|452829912|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
125873179|NCT03096834|452829913|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
125873180|NCT03096834|452829910|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
125873181|NCT03096834|452829911|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
125873182|NCT03096834|452829912|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
125873183|NCT03096834|452829913|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
125873184|NCT03096834|452829910|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
125873185|NCT03096834|452829911|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
125873186|NCT03096834|452829912|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
125873187|NCT03096834|452829913|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
125873188|NCT03096834|452829910|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
125873189|NCT03096834|452829911|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
125873190|NCT03096834|452829912|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
125873191|NCT03096834|452829913|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
125873192|NCT03096834|452829910|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
125873193|NCT03096834|452829911|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
125873194|NCT03096834|452829912|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
125873195|NCT03096834|452829913|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
125873196|NCT03096834|452829910|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
125873197|NCT03096834|452829911|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
125873198|NCT03096834|452829912|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
125873199|NCT03096834|452829913|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
125873200|NCT03096834|452829910|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
125873201|NCT03096834|452829911|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
125873202|NCT03096834|452829912|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
125873203|NCT03096834|452829913|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
125873204|NCT03096834|452829910|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125873205|NCT03096834|452829911|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125873206|NCT03096834|452829912|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
125873207|NCT03096834|452829913|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125873208|NCT00966654|452829914|FG000|Overall Study|Study was terminated,PI left institution|12|||
125873209|NCT04416204|452829917|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125873210|NCT04416204|452829918|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
125873211|NCT04416204|452829919|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125873212|NCT04416204|452829920|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125873213|NCT04456504|452829921|FG000|Overall Study|Lost to Follow-up|2|||
125873214|NCT01405768|452829922|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
125873215|NCT01405768|452829923|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
125873216|NCT01381016|452829928|FG000|Overall Study|Lost to Follow-up|1|||
125873217|NCT01381016|452829929|FG001|Overall Study|Lost to Follow-up|1|||
125873218|NCT01381016|452829928|FG000|Overall Study|Screen Failure|2|||
125873219|NCT01381016|452829929|FG001|Overall Study|Screen Failure|2|||
125873220|NCT01381016|452829928|FG000|Overall Study|Withdrawal by Subject|0|||
125873221|NCT01381016|452829929|FG001|Overall Study|Withdrawal by Subject|1|||
125873222|NCT01381016|452829928|FG000|Overall Study|Physician Decision|0|||
125873223|NCT01381016|452829929|FG001|Overall Study|Physician Decision|2|||
125873224|NCT01451723|452829931|FG000|Overall Study|study halted|6|||
125873225|NCT01451723|452829932|FG001|Overall Study|study halted|5|||
125873226|NCT01631435|452829933|FG000|Overall Study|Adverse Event|2|||
125873227|NCT01631435|452829933|FG000|Overall Study|Withdrawal by Subject|2|||
125873228|NCT01631435|452829933|FG000|Overall Study|incomplete study procedure|5|||
125873229|NCT01005251|452829942|FG000|Overall Study|Withdrawal by Subject|2|||
125873230|NCT01005251|452829943|FG001|Overall Study|Withdrawal by Subject|5|||
125873231|NCT01005251|452829944|FG002|Overall Study|Withdrawal by Subject|3|||
125873232|NCT01005251|452829945|FG003|Overall Study|Withdrawal by Subject|4|||
125873233|NCT01005251|452829946|FG004|Overall Study|Withdrawal by Subject|9|||
125873234|NCT01005251|452829942|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
125873235|NCT01005251|452829943|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125873236|NCT01005251|452829944|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
125873237|NCT01005251|452829945|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125873238|NCT01005251|452829946|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125873239|NCT01005251|452829942|FG000|Overall Study|Adverse Event|2|||
125873240|NCT01005251|452829943|FG001|Overall Study|Adverse Event|6|||
125873241|NCT01005251|452829944|FG002|Overall Study|Adverse Event|8|||
125873242|NCT01005251|452829945|FG003|Overall Study|Adverse Event|5|||
125873243|NCT01005251|452829946|FG004|Overall Study|Adverse Event|4|||
125873244|NCT01005251|452829942|FG000|Overall Study|Protocol Violation|1|||
125873245|NCT01005251|452829943|FG001|Overall Study|Protocol Violation|0|||
125873246|NCT01005251|452829944|FG002|Overall Study|Protocol Violation|0|||
125873247|NCT01005251|452829945|FG003|Overall Study|Protocol Violation|0|||
125873248|NCT01005251|452829946|FG004|Overall Study|Protocol Violation|2|||
126090447|NCT04230122|453623568|FG000|Overall Study|Lost to Follow-up|1|||
125873249|NCT01005251|452829942|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
125873250|NCT01005251|452829943|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
125873251|NCT01005251|452829944|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
125873252|NCT01005251|452829945|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
125873253|NCT01005251|452829946|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
125873254|NCT01005251|452829942|FG000|Overall Study|Lost to Follow-up|1|||
125873255|NCT01005251|452829943|FG001|Overall Study|Lost to Follow-up|4|||
125873256|NCT01005251|452829944|FG002|Overall Study|Lost to Follow-up|2|||
125873257|NCT01005251|452829945|FG003|Overall Study|Lost to Follow-up|0|||
125873258|NCT01005251|452829946|FG004|Overall Study|Lost to Follow-up|0|||
125873259|NCT01005251|452829942|FG000|Overall Study|Physician Decision|0|||
125873260|NCT01005251|452829943|FG001|Overall Study|Physician Decision|0|||
125873261|NCT01005251|452829944|FG002|Overall Study|Physician Decision|0|||
125873262|NCT01005251|452829945|FG003|Overall Study|Physician Decision|0|||
125873263|NCT01005251|452829946|FG004|Overall Study|Physician Decision|2|||
125873264|NCT01005251|452829942|FG000|Overall Study|Patient moved|1|||
125873265|NCT01005251|452829943|FG001|Overall Study|Patient moved|0|||
125873266|NCT01005251|452829944|FG002|Overall Study|Patient moved|0|||
125873267|NCT01005251|452829945|FG003|Overall Study|Patient moved|0|||
125873268|NCT01005251|452829946|FG004|Overall Study|Patient moved|0|||
125873269|NCT01005251|452829942|FG000|Overall Study|Wrong drug dispensed|0|||
125873270|NCT01005251|452829943|FG001|Overall Study|Wrong drug dispensed|1|||
125873271|NCT01005251|452829944|FG002|Overall Study|Wrong drug dispensed|0|||
125873272|NCT01005251|452829945|FG003|Overall Study|Wrong drug dispensed|0|||
125873273|NCT01005251|452829946|FG004|Overall Study|Wrong drug dispensed|0|||
125873274|NCT01005251|452829942|FG000|Overall Study|Randomized in error|0|||
125873275|NCT01005251|452829943|FG001|Overall Study|Randomized in error|0|||
125873276|NCT01005251|452829944|FG002|Overall Study|Randomized in error|1|||
125873277|NCT01005251|452829945|FG003|Overall Study|Randomized in error|1|||
125873278|NCT01005251|452829946|FG004|Overall Study|Randomized in error|0|||
125873279|NCT01005251|452829942|FG000|Overall Study|Lack of Efficacy|0|||
125873280|NCT01005251|452829943|FG001|Overall Study|Lack of Efficacy|0|||
125873281|NCT01005251|452829944|FG002|Overall Study|Lack of Efficacy|1|||
125873282|NCT01005251|452829945|FG003|Overall Study|Lack of Efficacy|1|||
125873283|NCT01005251|452829946|FG004|Overall Study|Lack of Efficacy|0|||
125873284|NCT00443040|452829947|FG000|Overall Study|Withdrawal by Subject|1|||
125873285|NCT00443040|452829948|FG001|Overall Study|Withdrawal by Subject|0|||
125873286|NCT00443040|452829949|FG002|Overall Study|Withdrawal by Subject|0|||
125873287|NCT00443040|452829947|FG000|Overall Study|Converted to an open laparotomy|3|||
125873288|NCT00443040|452829948|FG001|Overall Study|Converted to an open laparotomy|0|||
125873289|NCT00443040|452829949|FG002|Overall Study|Converted to an open laparotomy|1|||
125873290|NCT00435409|452829953|FG000|Overall Study|Protocol Violation|1|||
125873291|NCT00435409|452829954|FG001|Overall Study|Protocol Violation|2|||
125873292|NCT00435409|452829955|FG002|Overall Study|Protocol Violation|0|||
125873293|NCT00435409|452829953|FG000|Overall Study|Lost to Follow-up|1|||
125873294|NCT00435409|452829954|FG001|Overall Study|Lost to Follow-up|2|||
125873295|NCT00435409|452829955|FG002|Overall Study|Lost to Follow-up|0|||
125873296|NCT00435409|452829953|FG000|Overall Study|Death|8|||
125873297|NCT00435409|452829954|FG001|Overall Study|Death|6|||
125873298|NCT00435409|452829955|FG002|Overall Study|Death|6|||
125873299|NCT00435409|452829953|FG000|Overall Study|Objective progression or relapse|158|||
125873300|NCT00435409|452829954|FG001|Overall Study|Objective progression or relapse|93|||
125873301|NCT00435409|452829955|FG002|Overall Study|Objective progression or relapse|58|||
125873302|NCT00435409|452829953|FG000|Overall Study|Global deterioration of health status|0|||
125873303|NCT00435409|452829954|FG001|Overall Study|Global deterioration of health status|0|||
125873304|NCT00435409|452829955|FG002|Overall Study|Global deterioration of health status|4|||
125873305|NCT00435409|452829953|FG000|Overall Study|Withdrawal by Subject|8|||
125873306|NCT00435409|452829954|FG001|Overall Study|Withdrawal by Subject|7|||
125873307|NCT00435409|452829955|FG002|Overall Study|Withdrawal by Subject|1|||
125873308|NCT00435409|452829953|FG000|Overall Study|Other|45|||
125873309|NCT00435409|452829954|FG001|Overall Study|Other|30|||
125873310|NCT00435409|452829955|FG002|Overall Study|Other|1|||
125873311|NCT00435409|452829953|FG000|Overall Study|Adverse Event|0|||
125873312|NCT00435409|452829954|FG001|Overall Study|Adverse Event|0|||
125873313|NCT00435409|452829955|FG002|Overall Study|Adverse Event|8|||
125873314|NCT00435409|452829953|FG000|Overall Study|Sponsor decision|0|||
125873315|NCT00435409|452829954|FG001|Overall Study|Sponsor decision|3|||
125873316|NCT00435409|452829955|FG002|Overall Study|Sponsor decision|0|||
125873317|NCT03661723|452829957|FG000|Overall Study|Disease Progression|4|||
125873318|NCT03661723|452829958|FG001|Overall Study|Disease Progression|24|||
125873319|NCT03661723|452829959|FG002|Overall Study|Disease Progression|4|||
125873320|NCT03661723|452829960|FG003|Overall Study|Disease Progression|19|||
125873321|NCT03661723|452829957|FG000|Overall Study|Withdrawal by Subject|1|||
125873322|NCT03661723|452829958|FG001|Overall Study|Withdrawal by Subject|0|||
125873323|NCT03661723|452829959|FG002|Overall Study|Withdrawal by Subject|2|||
125873324|NCT03661723|452829960|FG003|Overall Study|Withdrawal by Subject|4|||
125873325|NCT03661723|452829957|FG000|Overall Study|Physician Decision|1|||
125873326|NCT03661723|452829958|FG001|Overall Study|Physician Decision|0|||
125873327|NCT03661723|452829959|FG002|Overall Study|Physician Decision|0|||
125873328|NCT03661723|452829960|FG003|Overall Study|Physician Decision|0|||
125873329|NCT03661723|452829957|FG000|Overall Study|Clinical Deterioration|0|||
125873330|NCT03661723|452829958|FG001|Overall Study|Clinical Deterioration|0|||
125873331|NCT03661723|452829959|FG002|Overall Study|Clinical Deterioration|0|||
125873332|NCT03661723|452829960|FG003|Overall Study|Clinical Deterioration|1|||
125873333|NCT00718510|452829963|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
125873334|NCT00718510|452829964|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125873335|NCT00718510|452829963|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
125873336|NCT00718510|452829964|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125873337|NCT00883779|452829965|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
125873338|NCT00883779|452829966|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
125873339|NCT00883779|452829965|FG000|Primary Study Treatment Phase|Disease progression|75|||
125873340|NCT00883779|452829966|FG001|Primary Study Treatment Phase|Disease progression|59|||
125873341|NCT00883779|452829965|FG000|Primary Study Treatment Phase|Adverse Event|16|||
125873342|NCT00883779|452829966|FG001|Primary Study Treatment Phase|Adverse Event|16|||
125873343|NCT00883779|452829965|FG000|Primary Study Treatment Phase|Death|2|||
125873344|NCT00883779|452829966|FG001|Primary Study Treatment Phase|Death|3|||
125873345|NCT00883779|452829965|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
125873346|NCT00883779|452829966|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
125873347|NCT00883779|452829965|FG000|Primary Study Treatment Phase|Other|3|||
125873348|NCT00883779|452829966|FG001|Primary Study Treatment Phase|Other|0|||
125873349|NCT00883779|452829965|FG000|Post-Study Treatment Phase|Adverse Event|2|||
125873350|NCT00883779|452829966|FG001|Post-Study Treatment Phase|Adverse Event|3|||
125873351|NCT00883779|452829965|FG000|Post-Study Treatment Phase|Death|1|||
125873352|NCT00883779|452829966|FG001|Post-Study Treatment Phase|Death|3|||
125873353|NCT00883779|452829965|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
125873354|NCT00883779|452829966|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
125873355|NCT00883779|452829965|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
125873356|NCT00883779|452829966|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
125873357|NCT00883779|452829965|FG000|Post-Study Treatment Phase|Disease progression|103|||
125873358|NCT00883779|452829966|FG001|Post-Study Treatment Phase|Disease progression|122|||
125873359|NCT00883779|452829965|FG000|Post-Study Treatment Phase|Other|3|||
125873360|NCT00883779|452829966|FG001|Post-Study Treatment Phase|Other|0|||
125873361|NCT00883779|452829965|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
125873362|NCT00883779|452829966|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
125873363|NCT00883779|452829965|FG000|Off-study Phase|Death|185|||
125873364|NCT00883779|452829966|FG001|Off-study Phase|Death|174|||
125873365|NCT00883779|452829965|FG000|Off-study Phase|Refused treatment|1|||
125873366|NCT00883779|452829966|FG001|Off-study Phase|Refused treatment|1|||
125873367|NCT00883779|452829965|FG000|Off-study Phase|Failure to return|5|||
125873368|NCT00883779|452829966|FG001|Off-study Phase|Failure to return|6|||
125873369|NCT00883779|452829965|FG000|Off-study Phase|Other|18|||
125873370|NCT00883779|452829966|FG001|Off-study Phase|Other|21|||
125873371|NCT00499681|452829967|FG000|Overall Study|toxicity|0|||
125873372|NCT00499681|452829968|FG001|Overall Study|toxicity|1|||
125873373|NCT00499681|452829967|FG000|Overall Study|disease progression|0|||
125873374|NCT00499681|452829968|FG001|Overall Study|disease progression|1|||
125873375|NCT02174731|452829969|FG000|Overall Study|Participant decision|67|||
125873376|NCT02174731|452829970|FG001|Overall Study|Participant decision|64|||
125873377|NCT02174731|452829969|FG000|Overall Study|Incorrect enrolment before randomization|0|||
126208359|NCT03145207|454049431|FG000|Overall Study|volunteer started taking allergy shots|1|||
126208360|NCT03145207|454049431|FG000|Overall Study|baseline blood pressure high|1|||
126208361|NCT04678557|454049434|FG000|Overall Study|Withdrawal by Subject|1|||
126208362|NCT04678557|454049435|FG001|Overall Study|Withdrawal by Subject|0|||
126208363|NCT04678557|454049434|FG000|Overall Study|Lack of Efficacy|0|||
126208364|NCT04678557|454049435|FG001|Overall Study|Lack of Efficacy|13|||
126208365|NCT04678557|454049434|FG000|Overall Study|Safety Evaluation|0|||
126208366|NCT04678557|454049435|FG001|Overall Study|Safety Evaluation|1|||
126208367|NCT00223990|454049436|FG000|Overall Study|Moved from area|2|||
126208368|NCT00223990|454049437|FG001|Overall Study|Moved from area|1|||
126208369|NCT00223990|454049436|FG000|Overall Study|Withdrawal by Subject|4|||
126208370|NCT00223990|454049437|FG001|Overall Study|Withdrawal by Subject|8|||
126208371|NCT00223990|454049436|FG000|Overall Study|Lost to Follow-up|1|||
126208372|NCT00223990|454049437|FG001|Overall Study|Lost to Follow-up|0|||
126208373|NCT02513732|454051319|FG000|Overall Study|Lost to Follow-up|11|||
126208374|NCT02513732|454051319|FG000|Overall Study|Death|9|||
126208375|NCT02513732|454051319|FG000|Overall Study|Changing hospital|2|||
126208376|NCT01740297|454051320|FG000|Overall Study|Withdrawal by Subject|4|||
125873378|NCT02174731|452829970|FG001|Overall Study|Incorrect enrolment before randomization|1|||
125873379|NCT02174731|452829969|FG000|Overall Study|Missing|2|||
125873380|NCT02174731|452829970|FG001|Overall Study|Missing|0|||
125873381|NCT00079040|452829971|FG000|Overall Study|Withdrew before treatment|1|||
125873382|NCT00079040|452829971|FG000|Overall Study|Ineligible|1|||
125873383|NCT00739401|452829974|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
125873384|NCT00739401|452829974|FG000|Overall Study|Death|3|||
125873385|NCT00739401|452829974|FG000|Overall Study|Withdrawal by Subject|4|||
125873386|NCT00467740|452829978|FG000|Overall Study|Adverse Event|0|||
125873387|NCT00467740|452829979|FG001|Overall Study|Adverse Event|0|||
125873388|NCT00467740|452829980|FG002|Overall Study|Adverse Event|1|||
125873389|NCT00467740|452829981|FG003|Overall Study|Adverse Event|0|||
125873390|NCT00467740|452829982|FG004|Overall Study|Adverse Event|0|||
125873391|NCT00467740|452829978|FG000|Overall Study|Protocol Violation|0|||
125873392|NCT00467740|452829979|FG001|Overall Study|Protocol Violation|0|||
125873393|NCT00467740|452829980|FG002|Overall Study|Protocol Violation|1|||
125873394|NCT00467740|452829981|FG003|Overall Study|Protocol Violation|0|||
125873395|NCT00467740|452829982|FG004|Overall Study|Protocol Violation|0|||
125873396|NCT00467740|452829978|FG000|Overall Study|Lost to Follow-up|0|||
125873397|NCT00467740|452829979|FG001|Overall Study|Lost to Follow-up|1|||
125873398|NCT00467740|452829980|FG002|Overall Study|Lost to Follow-up|0|||
125873399|NCT00467740|452829981|FG003|Overall Study|Lost to Follow-up|0|||
125873400|NCT00467740|452829982|FG004|Overall Study|Lost to Follow-up|0|||
125873401|NCT00467740|452829978|FG000|Overall Study|Withdrawal by Subject|1|||
125873402|NCT00467740|452829979|FG001|Overall Study|Withdrawal by Subject|1|||
125873403|NCT00467740|452829980|FG002|Overall Study|Withdrawal by Subject|0|||
126316626|NCT00710684|454449365|FG000|Overall Study|Did not continue after week 24|25|||
126316627|NCT00710684|454449366|FG001|Overall Study|Did not continue after week 24|21|||
125873404|NCT00467740|452829981|FG003|Overall Study|Withdrawal by Subject|1|||
125873405|NCT00467740|452829982|FG004|Overall Study|Withdrawal by Subject|0|||
125873406|NCT00467740|452829978|FG000|Overall Study|Lack of Efficacy|0|||
125873407|NCT00467740|452829979|FG001|Overall Study|Lack of Efficacy|1|||
125873408|NCT00467740|452829980|FG002|Overall Study|Lack of Efficacy|0|||
125873409|NCT00467740|452829981|FG003|Overall Study|Lack of Efficacy|0|||
125873410|NCT00467740|452829982|FG004|Overall Study|Lack of Efficacy|0|||
125873411|NCT00844376|452829983|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
125873412|NCT00844376|452829984|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
125873413|NCT00549640|452829985|FG000|Overall Study|Withdrawal by Subject|6|||
125873414|NCT00549640|452829986|FG001|Overall Study|Withdrawal by Subject|12|||
125873415|NCT00549640|452829985|FG000|Overall Study|Adverse Event|5|||
125873416|NCT00549640|452829986|FG001|Overall Study|Adverse Event|0|||
125873417|NCT00549640|452829985|FG000|Overall Study|Lost to Follow-up|7|||
125873418|NCT00549640|452829986|FG001|Overall Study|Lost to Follow-up|4|||
125873419|NCT04999839|452829995|FG000|Overall Study|Adverse Event|1|||
125873420|NCT04999839|452829996|FG001|Overall Study|Adverse Event|1|||
125873421|NCT04999839|452829997|FG002|Overall Study|Adverse Event|1|||
125873422|NCT04999839|452829998|FG003|Overall Study|Adverse Event|1|||
125873423|NCT04999839|452829999|FG004|Overall Study|Adverse Event|1|||
125873424|NCT04999839|452829995|FG000|Overall Study|Lost to Follow-up|2|||
125873425|NCT04999839|452829996|FG001|Overall Study|Lost to Follow-up|0|||
125873426|NCT04999839|452829997|FG002|Overall Study|Lost to Follow-up|2|||
125873427|NCT04999839|452829998|FG003|Overall Study|Lost to Follow-up|4|||
125873428|NCT04999839|452829999|FG004|Overall Study|Lost to Follow-up|1|||
125873429|NCT04999839|452829995|FG000|Overall Study|Withdrawal by Subject|6|||
125873430|NCT04999839|452829996|FG001|Overall Study|Withdrawal by Subject|5|||
125873431|NCT04999839|452829997|FG002|Overall Study|Withdrawal by Subject|3|||
125873432|NCT04999839|452829998|FG003|Overall Study|Withdrawal by Subject|2|||
125873433|NCT04999839|452829999|FG004|Overall Study|Withdrawal by Subject|2|||
125873434|NCT04999839|452829995|FG000|Overall Study|Lack of Efficacy|0|||
125873435|NCT04999839|452829996|FG001|Overall Study|Lack of Efficacy|1|||
125873436|NCT04999839|452829997|FG002|Overall Study|Lack of Efficacy|0|||
125873437|NCT04999839|452829998|FG003|Overall Study|Lack of Efficacy|0|||
125873438|NCT04999839|452829999|FG004|Overall Study|Lack of Efficacy|0|||
125873439|NCT04999839|452829995|FG000|Overall Study|Physician Decision|0|||
125873440|NCT04999839|452829996|FG001|Overall Study|Physician Decision|0|||
125873441|NCT04999839|452829997|FG002|Overall Study|Physician Decision|0|||
125873442|NCT04999839|452829998|FG003|Overall Study|Physician Decision|0|||
125873443|NCT04999839|452829999|FG004|Overall Study|Physician Decision|1|||
125873444|NCT04999839|452829995|FG000|Overall Study|Sponsor request|0|||
125873445|NCT04999839|452829996|FG001|Overall Study|Sponsor request|1|||
125873446|NCT04999839|452829997|FG002|Overall Study|Sponsor request|0|||
125873447|NCT04999839|452829998|FG003|Overall Study|Sponsor request|0|||
125873448|NCT04999839|452829999|FG004|Overall Study|Sponsor request|0|||
125873449|NCT04999839|452829995|FG000|Overall Study|Other|0|||
125873450|NCT04999839|452829996|FG001|Overall Study|Other|0|||
125873451|NCT04999839|452829997|FG002|Overall Study|Other|1|||
125873452|NCT04999839|452829998|FG003|Overall Study|Other|0|||
125873453|NCT04999839|452829999|FG004|Overall Study|Other|0|||
125873454|NCT00399516|452830000|FG000|Overall Study|Lost to Follow-up|2|||
125873455|NCT00660192|452830001|FG000|Overall Study|Lost to Follow-up|2|||
125873456|NCT00660192|452830002|FG001|Overall Study|Lost to Follow-up|3|||
125873457|NCT00982735|452830003|FG000|Overall Study|Lost to Follow-up|6|||
125873458|NCT00982735|452830003|FG000|Overall Study|Patient ineligible for trial|224|||
125873459|NCT02734693|452830004|FG000|Overall Study|Adverse Event|1|||
125873460|NCT02734693|452830005|FG001|Overall Study|Adverse Event|3|||
125873461|NCT02734693|452830006|FG002|Overall Study|Adverse Event|3|||
125873462|NCT02734693|452830004|FG000|Overall Study|Lack of Efficacy|1|||
125873463|NCT02734693|452830005|FG001|Overall Study|Lack of Efficacy|0|||
125873464|NCT02734693|452830006|FG002|Overall Study|Lack of Efficacy|0|||
125873465|NCT02734693|452830004|FG000|Overall Study|Lost to Follow-up|2|||
125873466|NCT02734693|452830005|FG001|Overall Study|Lost to Follow-up|0|||
125873467|NCT02734693|452830006|FG002|Overall Study|Lost to Follow-up|0|||
125873468|NCT02734693|452830004|FG000|Overall Study|Protocol Violation|1|||
125873469|NCT02734693|452830005|FG001|Overall Study|Protocol Violation|0|||
125873470|NCT02734693|452830006|FG002|Overall Study|Protocol Violation|0|||
125873471|NCT02734693|452830004|FG000|Overall Study|Withdrawal by Subject|1|||
125873472|NCT02734693|452830005|FG001|Overall Study|Withdrawal by Subject|0|||
125873473|NCT02734693|452830006|FG002|Overall Study|Withdrawal by Subject|0|||
125873474|NCT03740048|452830010|FG000|Overall Study|Withdrawal by Subject|1|||
125873475|NCT03740048|452830011|FG001|Overall Study|Withdrawal by Subject|1|||
125873476|NCT03740048|452830010|FG000|Overall Study|Death|1|||
125873477|NCT03740048|452830011|FG001|Overall Study|Death|6|||
125873478|NCT03740048|452830010|FG000|Overall Study|Switched to thrice-weekly HD|2|||
125873479|NCT03740048|452830011|FG001|Overall Study|Switched to thrice-weekly HD|0|||
125873480|NCT03740048|452830010|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
125873481|NCT03740048|452830011|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
125873482|NCT03740048|452830010|FG000|Overall Study|Lost to Follow-up|0|||
125873483|NCT03740048|452830011|FG001|Overall Study|Lost to Follow-up|1|||
125873484|NCT03740048|452830010|FG000|Overall Study|Non-compliance with HD|0|||
125873485|NCT03740048|452830011|FG001|Overall Study|Non-compliance with HD|1|||
125873486|NCT02675907|452830019|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
125873487|NCT02675907|452830020|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
125873488|NCT02675907|452830019|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
125873489|NCT02675907|452830020|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
125873490|NCT02675907|452830019|FG000|Study Overall|Lack of Efficacy|1|||
125873491|NCT02675907|452830020|FG001|Study Overall|Lack of Efficacy|0|||
125873492|NCT02675907|452830019|FG000|Study Overall|Withdrawal by Subject|2|||
125873493|NCT02675907|452830020|FG001|Study Overall|Withdrawal by Subject|2|||
125873494|NCT02675907|452830019|FG000|Study Overall|Lost to Follow-up|0|||
125873495|NCT02675907|452830020|FG001|Study Overall|Lost to Follow-up|2|||
125873496|NCT00539981|452830021|FG000|Overall Study|Adverse events (AE)|3|||
125873497|NCT00539981|452830022|FG001|Overall Study|Adverse events (AE)|3|||
125873498|NCT00539981|452830021|FG000|Overall Study|Lost to Follow-up|260|||
125873499|NCT00539981|452830022|FG001|Overall Study|Lost to Follow-up|251|||
125873500|NCT00539981|452830021|FG000|Overall Study|Withdrew consent|22|||
125873501|NCT00539981|452830022|FG001|Overall Study|Withdrew consent|14|||
125873502|NCT00539981|452830021|FG000|Overall Study|Death|1|||
125873503|NCT00539981|452830022|FG001|Overall Study|Death|1|||
125873504|NCT00539981|452830021|FG000|Overall Study|Other reason-unspecified|9|||
125873505|NCT00539981|452830022|FG001|Overall Study|Other reason-unspecified|13|||
125873506|NCT01611792|452830023|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
125873507|NCT01611792|452830024|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
125873508|NCT01611792|452830023|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
125873509|NCT01611792|452830024|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
125873510|NCT03289208|452830027|FG000|Overall Study|Adverse Event|1|||
125873511|NCT03289208|452830028|FG001|Overall Study|Adverse Event|0|||
125873512|NCT03289208|452830029|FG002|Overall Study|Adverse Event|0|||
125873513|NCT03353675|452830033|FG000|Overall Study|Adverse Event|4|||
125873514|NCT02025179|452830034|FG000|Overall Study|Lost to Follow-up|0|||
125873515|NCT02025179|452830035|FG001|Overall Study|Lost to Follow-up|0|||
125873516|NCT02025179|452830036|FG002|Overall Study|Lost to Follow-up|1|||
125873517|NCT02362724|452830037|FG000|Overall Study|Withdrawal by Subject|3|||
125873518|NCT02362724|452830038|FG001|Overall Study|Withdrawal by Subject|1|||
125873519|NCT02362724|452830037|FG000|Overall Study|Adverse Event|3|||
125873520|NCT02362724|452830038|FG001|Overall Study|Adverse Event|0|||
125873521|NCT00395746|452830039|FG000|Overall Study|Adverse Event|5|||
125873522|NCT00395746|452830040|FG001|Overall Study|Adverse Event|2|||
125873523|NCT00395746|452830041|FG002|Overall Study|Adverse Event|2|||
125873524|NCT00395746|452830039|FG000|Overall Study|Protocol Violation|0|||
125873525|NCT00395746|452830040|FG001|Overall Study|Protocol Violation|1|||
125873526|NCT00395746|452830041|FG002|Overall Study|Protocol Violation|0|||
125873527|NCT00395746|452830039|FG000|Overall Study|Lack of Efficacy|2|||
125873528|NCT00395746|452830040|FG001|Overall Study|Lack of Efficacy|0|||
126090448|NCT04230122|453623569|FG001|Overall Study|Lost to Follow-up|0|||
125873529|NCT00395746|452830041|FG002|Overall Study|Lack of Efficacy|17|||
125873530|NCT00395746|452830039|FG000|Overall Study|Hypoglycaemia|2|||
125873531|NCT00395746|452830040|FG001|Overall Study|Hypoglycaemia|1|||
125873532|NCT00395746|452830041|FG002|Overall Study|Hypoglycaemia|0|||
125873533|NCT00395746|452830039|FG000|Overall Study|Subject decision|0|||
125873534|NCT00395746|452830040|FG001|Overall Study|Subject decision|0|||
125873535|NCT00395746|452830041|FG002|Overall Study|Subject decision|1|||
125873536|NCT00395746|452830039|FG000|Overall Study|Withdrawal of consent|0|||
125873537|NCT00395746|452830040|FG001|Overall Study|Withdrawal of consent|0|||
125873538|NCT00395746|452830041|FG002|Overall Study|Withdrawal of consent|1|||
125873539|NCT00395746|452830039|FG000|Overall Study|Difficultulty in use of device|0|||
125873540|NCT00395746|452830040|FG001|Overall Study|Difficultulty in use of device|0|||
125873541|NCT00395746|452830041|FG002|Overall Study|Difficultulty in use of device|1|||
125873542|NCT00395746|452830039|FG000|Overall Study|Unable to visit site on schedule|1|||
125873543|NCT00395746|452830040|FG001|Overall Study|Unable to visit site on schedule|0|||
125873544|NCT00395746|452830041|FG002|Overall Study|Unable to visit site on schedule|0|||
125873545|NCT03137992|452830046|FG000|Washout Period 1|Adverse Event|1|||
125873546|NCT03137992|452830047|FG001|Washout Period 1|Adverse Event|1|||
125873547|NCT03137992|452830048|FG002|Washout Period 1|Adverse Event|0|||
125873548|NCT03137992|452830049|FG003|Washout Period 1|Adverse Event|0|||
125873549|NCT03137992|452830050|FG004|Washout Period 1|Adverse Event|0|||
126316628|NCT00710684|454449367|FG002|Overall Study|Did not continue after week 24|16|||
125873550|NCT03137992|452830051|FG005|Washout Period 1|Adverse Event|1|||
125873551|NCT03137992|452830046|FG000|Washout Period 1|Withdrawal by Subject|0|||
125873552|NCT03137992|452830047|FG001|Washout Period 1|Withdrawal by Subject|1|||
125873553|NCT03137992|452830048|FG002|Washout Period 1|Withdrawal by Subject|1|||
125873554|NCT03137992|452830049|FG003|Washout Period 1|Withdrawal by Subject|0|||
125873555|NCT03137992|452830050|FG004|Washout Period 1|Withdrawal by Subject|0|||
125873556|NCT03137992|452830051|FG005|Washout Period 1|Withdrawal by Subject|0|||
125873557|NCT03137992|452830046|FG000|Washout Period 1|Principal Investigator Discretion|0|||
125873558|NCT03137992|452830047|FG001|Washout Period 1|Principal Investigator Discretion|1|||
125873559|NCT03137992|452830048|FG002|Washout Period 1|Principal Investigator Discretion|0|||
125873560|NCT03137992|452830049|FG003|Washout Period 1|Principal Investigator Discretion|0|||
125873561|NCT03137992|452830050|FG004|Washout Period 1|Principal Investigator Discretion|0|||
125873562|NCT03137992|452830051|FG005|Washout Period 1|Principal Investigator Discretion|0|||
125873563|NCT03137992|452830046|FG000|Washout Period 1|COPD Exacerbation|1|||
125873564|NCT03137992|452830047|FG001|Washout Period 1|COPD Exacerbation|1|||
125873565|NCT03137992|452830048|FG002|Washout Period 1|COPD Exacerbation|1|||
125873566|NCT03137992|452830049|FG003|Washout Period 1|COPD Exacerbation|0|||
125873567|NCT03137992|452830050|FG004|Washout Period 1|COPD Exacerbation|1|||
125873568|NCT03137992|452830051|FG005|Washout Period 1|COPD Exacerbation|1|||
125873569|NCT03137992|452830046|FG000|Washout Period 1|Subject Noncompliance|1|||
125873570|NCT03137992|452830047|FG001|Washout Period 1|Subject Noncompliance|0|||
125873571|NCT03137992|452830048|FG002|Washout Period 1|Subject Noncompliance|0|||
125873572|NCT03137992|452830049|FG003|Washout Period 1|Subject Noncompliance|0|||
125873573|NCT03137992|452830050|FG004|Washout Period 1|Subject Noncompliance|1|||
125873574|NCT03137992|452830051|FG005|Washout Period 1|Subject Noncompliance|0|||
125873575|NCT03137992|452830046|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
125873576|NCT03137992|452830047|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
125873577|NCT03137992|452830048|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
125873578|NCT03137992|452830049|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
125873579|NCT03137992|452830050|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
125873580|NCT03137992|452830051|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
125873581|NCT03137992|452830046|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
125873582|NCT03137992|452830047|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
125873583|NCT03137992|452830048|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
125873584|NCT03137992|452830049|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
125873585|NCT03137992|452830050|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
125873586|NCT03137992|452830051|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
125873587|NCT03137992|452830046|FG000|Period 2 (Visit 3)|Adverse Event|0|||
125873588|NCT03137992|452830047|FG001|Period 2 (Visit 3)|Adverse Event|1|||
125873589|NCT03137992|452830048|FG002|Period 2 (Visit 3)|Adverse Event|0|||
125873590|NCT03137992|452830049|FG003|Period 2 (Visit 3)|Adverse Event|0|||
125873591|NCT03137992|452830050|FG004|Period 2 (Visit 3)|Adverse Event|0|||
125873592|NCT03137992|452830051|FG005|Period 2 (Visit 3)|Adverse Event|0|||
125873593|NCT03137992|452830046|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
125873594|NCT03137992|452830047|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
125873595|NCT03137992|452830048|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
125873596|NCT03137992|452830049|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
125873597|NCT03137992|452830050|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
125873598|NCT03137992|452830051|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
125873599|NCT03137992|452830046|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125873600|NCT03137992|452830047|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
125873601|NCT03137992|452830048|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125873602|NCT03137992|452830049|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125873603|NCT03137992|452830050|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
125873604|NCT03137992|452830051|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125873605|NCT03137992|452830046|FG000|Washout Period 2|COPD Exacerbation|1|||
125873606|NCT03137992|452830047|FG001|Washout Period 2|COPD Exacerbation|1|||
125873607|NCT03137992|452830048|FG002|Washout Period 2|COPD Exacerbation|0|||
125873608|NCT03137992|452830049|FG003|Washout Period 2|COPD Exacerbation|0|||
125873609|NCT03137992|452830050|FG004|Washout Period 2|COPD Exacerbation|1|||
125873610|NCT03137992|452830051|FG005|Washout Period 2|COPD Exacerbation|0|||
125873611|NCT03137992|452830046|FG000|Washout Period 2|Subject Non-compliance|0|||
125873612|NCT03137992|452830047|FG001|Washout Period 2|Subject Non-compliance|1|||
125873613|NCT03137992|452830048|FG002|Washout Period 2|Subject Non-compliance|0|||
125873614|NCT03137992|452830049|FG003|Washout Period 2|Subject Non-compliance|0|||
125873615|NCT03137992|452830050|FG004|Washout Period 2|Subject Non-compliance|0|||
125873616|NCT03137992|452830051|FG005|Washout Period 2|Subject Non-compliance|0|||
125873617|NCT03137992|452830046|FG000|Washout Period 2|Adverse Event|0|||
125873618|NCT03137992|452830047|FG001|Washout Period 2|Adverse Event|0|||
125873619|NCT03137992|452830048|FG002|Washout Period 2|Adverse Event|0|||
125873620|NCT03137992|452830049|FG003|Washout Period 2|Adverse Event|1|||
125873621|NCT03137992|452830050|FG004|Washout Period 2|Adverse Event|1|||
125873622|NCT03137992|452830051|FG005|Washout Period 2|Adverse Event|0|||
125873623|NCT03137992|452830046|FG000|Washout Period 2|Withdrawal by Subject|1|||
125873624|NCT03137992|452830047|FG001|Washout Period 2|Withdrawal by Subject|0|||
125873625|NCT03137992|452830048|FG002|Washout Period 2|Withdrawal by Subject|0|||
125873626|NCT03137992|452830049|FG003|Washout Period 2|Withdrawal by Subject|0|||
125873627|NCT03137992|452830050|FG004|Washout Period 2|Withdrawal by Subject|1|||
125873628|NCT03137992|452830051|FG005|Washout Period 2|Withdrawal by Subject|0|||
125873629|NCT03137992|452830046|FG000|Washout Period 2|Sponsor Decision|0|||
125873630|NCT03137992|452830047|FG001|Washout Period 2|Sponsor Decision|0|||
125873631|NCT03137992|452830048|FG002|Washout Period 2|Sponsor Decision|0|||
125873632|NCT03137992|452830049|FG003|Washout Period 2|Sponsor Decision|0|||
125873633|NCT03137992|452830050|FG004|Washout Period 2|Sponsor Decision|0|||
125873634|NCT03137992|452830051|FG005|Washout Period 2|Sponsor Decision|1|||
125873635|NCT03137992|452830046|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
125873636|NCT03137992|452830047|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
125873637|NCT03137992|452830048|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
125873638|NCT03137992|452830049|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
125873639|NCT03137992|452830050|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
125873640|NCT03137992|452830051|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
125873641|NCT03137992|452830046|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
125873642|NCT03137992|452830047|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
125873643|NCT03137992|452830048|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
125873644|NCT03137992|452830049|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
125873645|NCT03137992|452830050|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
125873646|NCT03137992|452830051|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
125873647|NCT03137992|452830046|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
125873648|NCT03137992|452830047|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125873649|NCT03137992|452830048|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
125873650|NCT03137992|452830049|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125873651|NCT03137992|452830050|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125873652|NCT03137992|452830051|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125873653|NCT03137992|452830046|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125873654|NCT03137992|452830047|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125873655|NCT03137992|452830048|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125873656|NCT03137992|452830049|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
125873657|NCT03137992|452830050|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125873658|NCT03137992|452830051|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125873659|NCT03137992|452830046|FG000|Part 2 (Open-label Extension)|Per study team|1|||
125873660|NCT03137992|452830047|FG001|Part 2 (Open-label Extension)|Per study team|0|||
125873661|NCT03137992|452830048|FG002|Part 2 (Open-label Extension)|Per study team|0|||
125873662|NCT03137992|452830049|FG003|Part 2 (Open-label Extension)|Per study team|0|||
125873663|NCT03137992|452830050|FG004|Part 2 (Open-label Extension)|Per study team|0|||
125873664|NCT03137992|452830051|FG005|Part 2 (Open-label Extension)|Per study team|0|||
125873665|NCT03137992|452830046|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125873666|NCT03137992|452830047|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125873667|NCT03137992|452830048|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125873668|NCT03137992|452830049|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125873669|NCT03137992|452830050|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125873670|NCT03137992|452830051|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
125873671|NCT02370420|452830052|FG000|Overall Study|Physician Decision|3|||
125873672|NCT02370420|452830053|FG001|Overall Study|Physician Decision|3|||
125873673|NCT02370420|452830052|FG000|Overall Study|Lost to Follow-up|11|||
125873674|NCT02370420|452830053|FG001|Overall Study|Lost to Follow-up|9|||
125873675|NCT03077542|452830054|FG000|Overall Study|Death|4|||
125873676|NCT03077542|452830055|FG001|Overall Study|Death|0|||
125873677|NCT03077542|452830054|FG000|Overall Study|Physician Decision|6|||
125873678|NCT03077542|452830055|FG001|Overall Study|Physician Decision|1|||
126316629|NCT00157248|454449368|FG000|Overall Study|Adverse Event|36|||
125873679|NCT03077542|452830054|FG000|Overall Study|Withdrawal by Subject|0|||
125873680|NCT03077542|452830055|FG001|Overall Study|Withdrawal by Subject|1|||
125873681|NCT00795704|452830056|FG000|Overall Study|Withdrawal by Subject|3|||
125873682|NCT00795704|452830057|FG001|Overall Study|Withdrawal by Subject|2|||
126316630|NCT00157248|454449369|FG001|Overall Study|Adverse Event|25|||
126316631|NCT00157248|454449370|FG002|Overall Study|Adverse Event|13|||
126316632|NCT00157248|454449371|FG003|Overall Study|Adverse Event|33|||
126316633|NCT00157248|454449368|FG000|Overall Study|Protocol Violation|4|||
126316634|NCT00157248|454449369|FG001|Overall Study|Protocol Violation|0|||
126316635|NCT00157248|454449370|FG002|Overall Study|Protocol Violation|2|||
126316636|NCT00157248|454449371|FG003|Overall Study|Protocol Violation|2|||
126316637|NCT00157248|454449368|FG000|Overall Study|Lost to Follow-up|0|||
126316638|NCT00157248|454449369|FG001|Overall Study|Lost to Follow-up|1|||
126316639|NCT00157248|454449370|FG002|Overall Study|Lost to Follow-up|0|||
126316640|NCT00157248|454449371|FG003|Overall Study|Lost to Follow-up|0|||
126316641|NCT00157248|454449368|FG000|Overall Study|Withdrawal by Subject|1|||
126316642|NCT00157248|454449369|FG001|Overall Study|Withdrawal by Subject|4|||
126316643|NCT00157248|454449370|FG002|Overall Study|Withdrawal by Subject|3|||
126316644|NCT00157248|454449371|FG003|Overall Study|Withdrawal by Subject|3|||
126316645|NCT00157248|454449368|FG000|Overall Study|site closures, subject moving|7|||
126316646|NCT00157248|454449369|FG001|Overall Study|site closures, subject moving|7|||
126316647|NCT00157248|454449370|FG002|Overall Study|site closures, subject moving|3|||
126316648|NCT00157248|454449371|FG003|Overall Study|site closures, subject moving|9|||
126316649|NCT02542293|454450736|FG000|Overall Study|Death|367|||
126316650|NCT02542293|454450737|FG001|Overall Study|Death|377|||
126316651|NCT02542293|454450736|FG000|Overall Study|Withdrawal by Subject|8|||
126316652|NCT02542293|454450737|FG001|Overall Study|Withdrawal by Subject|19|||
126316653|NCT04529850|454450738|FG000|Overall Study|Death|2|||
126316654|NCT04529850|454450738|FG000|Overall Study|Physician Decision|1|||
126316655|NCT04529850|454450738|FG000|Overall Study|Withdrawal by Subject|2|||
126316656|NCT01458951|454450739|FG000|Overall Study|Other|1|||
126316657|NCT01458951|454450740|FG001|Overall Study|Other|0|||
126316658|NCT01458951|454450741|FG002|Overall Study|Other|0|||
126316659|NCT01458951|454450739|FG000|Overall Study|Protocol Violation|5|||
126316660|NCT01458951|454450740|FG001|Overall Study|Protocol Violation|1|||
126316661|NCT01458951|454450741|FG002|Overall Study|Protocol Violation|0|||
126316662|NCT01458951|454450739|FG000|Overall Study|Withdrawal by Subject|2|||
126316663|NCT01458951|454450740|FG001|Overall Study|Withdrawal by Subject|0|||
126316664|NCT01458951|454450741|FG002|Overall Study|Withdrawal by Subject|2|||
126316665|NCT01458951|454450739|FG000|Overall Study|Adverse Event|7|||
126316666|NCT01458951|454450740|FG001|Overall Study|Adverse Event|0|||
126316667|NCT01458951|454450741|FG002|Overall Study|Adverse Event|2|||
126316668|NCT01458951|454450739|FG000|Overall Study|Insufficient Clinical Response|17|||
126316669|NCT01458951|454450740|FG001|Overall Study|Insufficient Clinical Response|0|||
126316670|NCT01458951|454450741|FG002|Overall Study|Insufficient Clinical Response|11|||
126316671|NCT02963558|454450742|FG000|Overall Study|Withdrawn by investigator|1|||
126316672|NCT02963558|454450743|FG001|Overall Study|Withdrawn by investigator|0|||
126316673|NCT02963558|454450742|FG000|Overall Study|Withdrawal by Subject|0|||
126316674|NCT02963558|454450743|FG001|Overall Study|Withdrawal by Subject|1|||
126316675|NCT03309696|454450744|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
126316676|NCT03309696|454450745|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
126316677|NCT03309696|454450746|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
126316678|NCT03309696|454450747|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
126316679|NCT01573767|454450748|FG000|Overall Study|Adverse Event|0|||
126316680|NCT01573767|454450749|FG001|Overall Study|Adverse Event|1|||
126316681|NCT01573767|454450750|FG002|Overall Study|Adverse Event|0|||
126316682|NCT01573767|454450751|FG003|Overall Study|Adverse Event|1|||
126316683|NCT01573767|454450748|FG000|Overall Study|Lack of Efficacy|18|||
126316684|NCT01573767|454450749|FG001|Overall Study|Lack of Efficacy|15|||
126316685|NCT01573767|454450750|FG002|Overall Study|Lack of Efficacy|12|||
126316686|NCT01573767|454450751|FG003|Overall Study|Lack of Efficacy|17|||
126316687|NCT01573767|454450748|FG000|Overall Study|Protocol Violation|3|||
126316688|NCT01573767|454450749|FG001|Overall Study|Protocol Violation|1|||
126316689|NCT01573767|454450750|FG002|Overall Study|Protocol Violation|1|||
126316690|NCT01573767|454450751|FG003|Overall Study|Protocol Violation|3|||
126316691|NCT01573767|454450748|FG000|Overall Study|Lost to Follow-up|0|||
126316692|NCT01573767|454450749|FG001|Overall Study|Lost to Follow-up|1|||
126316693|NCT01573767|454450750|FG002|Overall Study|Lost to Follow-up|1|||
126316694|NCT01573767|454450751|FG003|Overall Study|Lost to Follow-up|1|||
126316695|NCT01573767|454450748|FG000|Overall Study|Physician Decision|1|||
126316696|NCT01573767|454450749|FG001|Overall Study|Physician Decision|2|||
126316697|NCT01573767|454450750|FG002|Overall Study|Physician Decision|0|||
126316698|NCT01573767|454450751|FG003|Overall Study|Physician Decision|2|||
126316699|NCT01573767|454450748|FG000|Overall Study|Withdrawal by Subject|0|||
126316700|NCT01573767|454450749|FG001|Overall Study|Withdrawal by Subject|1|||
126316701|NCT01573767|454450750|FG002|Overall Study|Withdrawal by Subject|0|||
126316702|NCT01573767|454450751|FG003|Overall Study|Withdrawal by Subject|0|||
126316703|NCT01371877|454450754|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
126316704|NCT01371877|454450755|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
126316705|NCT00869557|454450756|FG000|Randomized Phase|Lost to Follow-up|2|||
126316706|NCT00869557|454450757|FG001|Randomized Phase|Lost to Follow-up|1|||
125873683|NCT00795704|452830056|FG000|Overall Study|Adverse Event|1|||
125873684|NCT00795704|452830057|FG001|Overall Study|Adverse Event|1|||
125873685|NCT03980730|452830058|FG000|Overall Study|Study Terminated by Sponsor|0|||
125873686|NCT03980730|452830059|FG001|Overall Study|Study Terminated by Sponsor|3|||
125873687|NCT03980730|452830058|FG000|Overall Study|Adverse Event|2|||
125873688|NCT03980730|452830059|FG001|Overall Study|Adverse Event|0|||
125873689|NCT03980730|452830058|FG000|Overall Study|Sponsor Request|0|||
125873690|NCT03980730|452830059|FG001|Overall Study|Sponsor Request|1|||
125873691|NCT01300728|452830060|FG000|Overall Study|Withdrawal by Subject|1|||
125873692|NCT01300728|452830061|FG001|Overall Study|Withdrawal by Subject|1|||
125873693|NCT01300728|452830060|FG000|Overall Study|Physician Decision|1|||
125873694|NCT01300728|452830061|FG001|Overall Study|Physician Decision|0|||
125873695|NCT00880620|452830064|FG000|Overall Study|Adverse Event|4|||
125873696|NCT00880620|452830065|FG001|Overall Study|Adverse Event|5|||
125873697|NCT00880620|452830066|FG002|Overall Study|Adverse Event|15|||
125873698|NCT00880620|452830067|FG003|Overall Study|Adverse Event|15|||
125873699|NCT00880620|452830064|FG000|Overall Study|Death|0|||
125873700|NCT00880620|452830065|FG001|Overall Study|Death|0|||
125873701|NCT00880620|452830066|FG002|Overall Study|Death|1|||
125873702|NCT00880620|452830067|FG003|Overall Study|Death|0|||
125873703|NCT00880620|452830064|FG000|Overall Study|Lack of Efficacy|12|||
125873704|NCT00880620|452830065|FG001|Overall Study|Lack of Efficacy|4|||
125873705|NCT00880620|452830066|FG002|Overall Study|Lack of Efficacy|0|||
125873706|NCT00880620|452830067|FG003|Overall Study|Lack of Efficacy|1|||
125873707|NCT00880620|452830064|FG000|Overall Study|Lost to Follow-up|0|||
125873708|NCT00880620|452830065|FG001|Overall Study|Lost to Follow-up|1|||
125873709|NCT00880620|452830066|FG002|Overall Study|Lost to Follow-up|1|||
125873710|NCT00880620|452830067|FG003|Overall Study|Lost to Follow-up|0|||
125873711|NCT00880620|452830064|FG000|Overall Study|Protocol Violation|0|||
125873712|NCT00880620|452830065|FG001|Overall Study|Protocol Violation|1|||
125873713|NCT00880620|452830066|FG002|Overall Study|Protocol Violation|0|||
125873714|NCT00880620|452830067|FG003|Overall Study|Protocol Violation|2|||
125873715|NCT00880620|452830064|FG000|Overall Study|Withdrawal by Subject|4|||
125873716|NCT00880620|452830065|FG001|Overall Study|Withdrawal by Subject|3|||
125873717|NCT00880620|452830066|FG002|Overall Study|Withdrawal by Subject|1|||
125873718|NCT00880620|452830067|FG003|Overall Study|Withdrawal by Subject|3|||
125873719|NCT00880620|452830064|FG000|Overall Study|Noncompliance|0|||
125873720|NCT00880620|452830065|FG001|Overall Study|Noncompliance|0|||
125873721|NCT00880620|452830066|FG002|Overall Study|Noncompliance|1|||
125873722|NCT00880620|452830067|FG003|Overall Study|Noncompliance|1|||
125873723|NCT00880620|452830064|FG000|Overall Study|Other|1|||
125873724|NCT00880620|452830065|FG001|Overall Study|Other|1|||
125873725|NCT00880620|452830066|FG002|Overall Study|Other|2|||
125873726|NCT00880620|452830067|FG003|Overall Study|Other|2|||
125873727|NCT03883581|452830069|FG000|Overall Study|Withdrawal by Subject|4|||
125873728|NCT04612725|452830070|FG000|Overall Study|Adverse Event|1|||
125873729|NCT04612725|452830071|FG001|Overall Study|Adverse Event|3|||
125873730|NCT04612725|452830072|FG002|Overall Study|Adverse Event|1|||
125873731|NCT04612725|452830073|FG003|Overall Study|Adverse Event|0|||
125873732|NCT04612725|452830074|FG004|Overall Study|Adverse Event|1|||
125873733|NCT04612725|452830070|FG000|Overall Study|Lost to Follow-up|0|||
125873734|NCT04612725|452830071|FG001|Overall Study|Lost to Follow-up|1|||
125873735|NCT04612725|452830072|FG002|Overall Study|Lost to Follow-up|0|||
125873736|NCT04612725|452830073|FG003|Overall Study|Lost to Follow-up|0|||
125873737|NCT04612725|452830074|FG004|Overall Study|Lost to Follow-up|0|||
125873738|NCT04612725|452830070|FG000|Overall Study|Physician Decision|2|||
125873739|NCT04612725|452830071|FG001|Overall Study|Physician Decision|0|||
125873740|NCT04612725|452830072|FG002|Overall Study|Physician Decision|0|||
125873741|NCT04612725|452830073|FG003|Overall Study|Physician Decision|0|||
125873742|NCT04612725|452830074|FG004|Overall Study|Physician Decision|0|||
125873743|NCT04612725|452830070|FG000|Overall Study|Study terminated by sponsor|3|||
125873744|NCT04612725|452830071|FG001|Overall Study|Study terminated by sponsor|1|||
125873745|NCT04612725|452830072|FG002|Overall Study|Study terminated by sponsor|2|||
125873746|NCT04612725|452830073|FG003|Overall Study|Study terminated by sponsor|4|||
125873747|NCT04612725|452830074|FG004|Overall Study|Study terminated by sponsor|5|||
125873748|NCT04612725|452830070|FG000|Overall Study|Withdrawal by Subject|8|||
125873749|NCT04612725|452830071|FG001|Overall Study|Withdrawal by Subject|3|||
125873750|NCT04612725|452830072|FG002|Overall Study|Withdrawal by Subject|5|||
125873751|NCT04612725|452830073|FG003|Overall Study|Withdrawal by Subject|1|||
125873752|NCT04612725|452830074|FG004|Overall Study|Withdrawal by Subject|9|||
125873753|NCT04612725|452830070|FG000|Overall Study|Other|0|||
125873754|NCT04612725|452830071|FG001|Overall Study|Other|0|||
125873755|NCT04612725|452830072|FG002|Overall Study|Other|0|||
125873756|NCT04612725|452830073|FG003|Overall Study|Other|0|||
125873757|NCT04612725|452830074|FG004|Overall Study|Other|1|||
125873758|NCT02354235|452830075|FG000|Overall Study|Adverse Event|2|||
125873759|NCT02354235|452830076|FG001|Overall Study|Adverse Event|2|||
125873760|NCT02354235|452830075|FG000|Overall Study|Physician Decision|0|||
125873761|NCT02354235|452830076|FG001|Overall Study|Physician Decision|1|||
125873762|NCT02354235|452830075|FG000|Overall Study|Withdrawal by Subject|1|||
125873763|NCT02354235|452830076|FG001|Overall Study|Withdrawal by Subject|3|||
125873764|NCT02354235|452830075|FG000|Overall Study|Conflict with the stopping criteria|0|||
125873765|NCT02354235|452830076|FG001|Overall Study|Conflict with the stopping criteria|1|||
125873766|NCT02926638|452830079|FG000|Overall Study|Progression|2|||
125873767|NCT02926638|452830080|FG001|Overall Study|Progression|5|||
125873768|NCT02926638|452830079|FG000|Overall Study|Ineligible|1|||
125873769|NCT02926638|452830080|FG001|Overall Study|Ineligible|0|||
125873770|NCT02926638|452830079|FG000|Overall Study|Not protocol specified|1|||
125873771|NCT02926638|452830080|FG001|Overall Study|Not protocol specified|0|||
125873772|NCT00644423|452831485|FG000|Overall Study|Lost to Follow-up|1|||
125873773|NCT00644423|452831486|FG001|Overall Study|Lost to Follow-up|1|||
125873774|NCT01908426|452831487|FG000|Overall Study|Adverse Event|98|||
125873775|NCT01908426|452831488|FG001|Overall Study|Adverse Event|11|||
125873776|NCT01908426|452831487|FG000|Overall Study|Clinical Deterioration|72|||
125873777|NCT01908426|452831488|FG001|Overall Study|Clinical Deterioration|38|||
125873778|NCT01908426|452831487|FG000|Overall Study|Lack of Efficacy|3|||
125873779|NCT01908426|452831488|FG001|Overall Study|Lack of Efficacy|0|||
125873780|NCT01908426|452831487|FG000|Overall Study|Lost to Follow-up|0|||
125873781|NCT01908426|452831488|FG001|Overall Study|Lost to Follow-up|1|||
125873782|NCT01908426|452831487|FG000|Overall Study|Physician Decision|3|||
125873783|NCT01908426|452831488|FG001|Overall Study|Physician Decision|3|||
125873784|NCT01908426|452831487|FG000|Overall Study|Withdrawal by Subject|11|||
125873785|NCT01908426|452831488|FG001|Overall Study|Withdrawal by Subject|6|||
125873786|NCT01908426|452831487|FG000|Overall Study|Progressive Disease|206|||
125873787|NCT01908426|452831488|FG001|Overall Study|Progressive Disease|152|||
125873788|NCT01908426|452831487|FG000|Overall Study|Protocol Violation|1|||
125873789|NCT01908426|452831488|FG001|Overall Study|Protocol Violation|0|||
125873790|NCT01908426|452831487|FG000|Overall Study|No Study Treatment Given|3|||
125873791|NCT01908426|452831488|FG001|Overall Study|No Study Treatment Given|0|||
125873792|NCT02426580|452831493|FG000|Overall Study|Death|2|||
125873793|NCT02426580|452831494|FG001|Overall Study|Death|2|||
125873794|NCT02426580|452831493|FG000|Overall Study|Lost to Follow-up|0|||
125873795|NCT02426580|452831494|FG001|Overall Study|Lost to Follow-up|9|||
125873796|NCT02426580|452831493|FG000|Overall Study|transfer to hemodialysis|5|||
125873797|NCT02426580|452831494|FG001|Overall Study|transfer to hemodialysis|5|||
125873798|NCT02426580|452831493|FG000|Overall Study|Kidney transplant|3|||
125873799|NCT02426580|452831494|FG001|Overall Study|Kidney transplant|0|||
125873800|NCT02426580|452831493|FG000|Overall Study|Allergic to egg white|1|||
125873801|NCT02426580|452831494|FG001|Overall Study|Allergic to egg white|0|||
125873802|NCT00445549|452831495|FG000|Overall Study|progressive disease|12|||
125873803|NCT00416624|452831504|FG000|Overall Study|Withdrawal by Subject|1|||
125873804|NCT00416624|452831505|FG001|Overall Study|Withdrawal by Subject|6|||
125873805|NCT00416624|452831506|FG002|Overall Study|Withdrawal by Subject|4|||
125873806|NCT00416624|452831507|FG003|Overall Study|Withdrawal by Subject|9|||
125873807|NCT00416624|452831504|FG000|Overall Study|Death|4|||
125873808|NCT00416624|452831505|FG001|Overall Study|Death|7|||
125873809|NCT00416624|452831506|FG002|Overall Study|Death|7|||
125873810|NCT00416624|452831507|FG003|Overall Study|Death|1|||
125873811|NCT00416624|452831504|FG000|Overall Study|Adverse Event|8|||
125873812|NCT00416624|452831505|FG001|Overall Study|Adverse Event|3|||
125873813|NCT00416624|452831506|FG002|Overall Study|Adverse Event|2|||
125873814|NCT00416624|452831507|FG003|Overall Study|Adverse Event|2|||
125873815|NCT00416624|452831504|FG000|Overall Study|Other|8|||
125873816|NCT00416624|452831505|FG001|Overall Study|Other|11|||
125873817|NCT00416624|452831506|FG002|Overall Study|Other|5|||
125873818|NCT00416624|452831507|FG003|Overall Study|Other|5|||
125873819|NCT00416624|452831504|FG000|Overall Study|Cancel|1|||
125873820|NCT00416624|452831505|FG001|Overall Study|Cancel|0|||
125873821|NCT00416624|452831506|FG002|Overall Study|Cancel|0|||
125873822|NCT00416624|452831507|FG003|Overall Study|Cancel|0|||
125873823|NCT00768989|452831510|FG000|Prior to Week 24|Withdrawal by Subject|1|||
125873824|NCT00768989|452831511|FG001|Prior to Week 24|Withdrawal by Subject|0|||
125873825|NCT00768989|452831510|FG000|Prior to Week 24|Adverse Event|3|||
125873826|NCT00768989|452831511|FG001|Prior to Week 24|Adverse Event|0|||
125873827|NCT00768989|452831510|FG000|Prior to Week 24|Lost to Follow-up|0|||
125873828|NCT00768989|452831511|FG001|Prior to Week 24|Lost to Follow-up|1|||
125873829|NCT00768989|452831510|FG000|Prior to Week 24|Protocol Violation|0|||
125873830|NCT00768989|452831511|FG001|Prior to Week 24|Protocol Violation|2|||
125873831|NCT00768989|452831510|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
125873832|NCT00768989|452831511|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
125873833|NCT00768989|452831510|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
125873834|NCT00768989|452831511|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
125873835|NCT00768989|452831510|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
125873836|NCT00768989|452831511|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
125873837|NCT00768989|452831510|FG000|On or After Week 36|Lack of Efficacy|1|||
125873838|NCT00768989|452831511|FG001|On or After Week 36|Lack of Efficacy|0|||
125873839|NCT00768989|452831510|FG000|On or After Week 36|Adverse Event|0|||
125873840|NCT00768989|452831511|FG001|On or After Week 36|Adverse Event|1|||
125873841|NCT00768989|452831510|FG000|On or After Week 36|Lost to Follow-up|1|||
125873842|NCT00768989|452831511|FG001|On or After Week 36|Lost to Follow-up|0|||
125873843|NCT00768989|452831510|FG000|On or After Week 36|Poor Compliance|1|||
125873844|NCT00768989|452831511|FG001|On or After Week 36|Poor Compliance|0|||
125873845|NCT00768989|452831510|FG000|On or After Week 36|Protocol Violation|1|||
125873846|NCT00768989|452831511|FG001|On or After Week 36|Protocol Violation|0|||
125873847|NCT00768989|452831510|FG000|On or After Week 36|Did not attend termination visit|2|||
125873848|NCT00768989|452831511|FG001|On or After Week 36|Did not attend termination visit|0|||
125873849|NCT00768989|452831510|FG000|On or After Week 36|Sponsor Termination|45|||
125873850|NCT00768989|452831511|FG001|On or After Week 36|Sponsor Termination|26|||
125873851|NCT00141453|452831518|FG000|Overall Study|Protocol Violation|6|||
126316707|NCT00869557|454450756|FG000|Randomized Phase|Investigator's Discretion|1|||
126316708|NCT00869557|454450757|FG001|Randomized Phase|Investigator's Discretion|0|||
126316709|NCT00869557|454450756|FG000|Randomized Phase|Withdrew Consent|0|||
126316710|NCT00869557|454450757|FG001|Randomized Phase|Withdrew Consent|1|||
126316711|NCT00869557|454450756|FG000|Extension Phase|Adverse Event|2|||
126316712|NCT00869557|454450757|FG001|Extension Phase|Adverse Event|2|||
126316713|NCT00869557|454450756|FG000|Extension Phase|Lack of Efficacy|1|||
126316714|NCT00869557|454450757|FG001|Extension Phase|Lack of Efficacy|0|||
125873852|NCT00141453|452831519|FG001|Overall Study|Protocol Violation|5|||
125873853|NCT00667888|452831527|FG000|Overall Study|Death|1|||
125873854|NCT00667888|452831528|FG001|Overall Study|Death|1|||
125873855|NCT00667888|452831527|FG000|Overall Study|Withdrawal by Subject|6|||
125873856|NCT00667888|452831528|FG001|Overall Study|Withdrawal by Subject|3|||
125873857|NCT00667888|452831527|FG000|Overall Study|Proceed with other treatment|3|||
125873858|NCT00667888|452831528|FG001|Overall Study|Proceed with other treatment|3|||
125873859|NCT00667888|452831527|FG000|Overall Study|Ineligible after SIM|0|||
125873860|NCT00667888|452831528|FG001|Overall Study|Ineligible after SIM|2|||
125873861|NCT00659061|452831529|FG000|Overall Study|Migration due to political unrest|21|||
125873862|NCT00659061|452831530|FG001|Overall Study|Migration due to political unrest|15|||
125873863|NCT01277744|452831531|FG000|Overall Study|Physician Decision|2|||
125873864|NCT00325897|452831532|FG000|Overall Study|Lost to Follow-up|12|||
125873865|NCT00325897|452831533|FG001|Overall Study|Lost to Follow-up|13|||
125873866|NCT03915717|452831534|FG000|Overall Study|EchoMark Not Implanted|6|||
125873867|NCT03748823|452831536|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
125873868|NCT03748823|452831537|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
125873869|NCT03748823|452831536|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
125873870|NCT03748823|452831537|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
125873871|NCT03748823|452831536|FG000|Extension Period|Withdrawal by Subject|9|||
125873872|NCT03748823|452831537|FG001|Extension Period|Withdrawal by Subject|12|||
125873873|NCT03748823|452831536|FG000|Extension Period|Death|2|||
125873874|NCT03748823|452831537|FG001|Extension Period|Death|2|||
125873875|NCT03748823|452831536|FG000|Extension Period|Other than Specified|0|||
125873876|NCT03748823|452831537|FG001|Extension Period|Other than Specified|1|||
125873877|NCT03748823|452831536|FG000|Extension Period|Protocol Violation|1|||
125873878|NCT03748823|452831537|FG001|Extension Period|Protocol Violation|0|||
125873879|NCT03748823|452831536|FG000|Extension Period|Lost to Follow-up|0|||
125873880|NCT03748823|452831537|FG001|Extension Period|Lost to Follow-up|1|||
125873881|NCT03748823|452831536|FG000|Extension Period|Lack of Efficacy|0|||
125873882|NCT03748823|452831537|FG001|Extension Period|Lack of Efficacy|1|||
125873883|NCT03748823|452831536|FG000|Extension Period|Physician Decision|1|||
125873884|NCT03748823|452831537|FG001|Extension Period|Physician Decision|2|||
125873885|NCT01011673|452831539|FG000|Randomized|Secondary headache|2|||
125873886|NCT01011673|452831540|FG001|Randomized|Secondary headache|1|||
125873887|NCT01011673|452831539|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
125873888|NCT01011673|452831540|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
125873889|NCT00626275|452831541|FG000|Part A - Treatment Period 1|Adverse Event|1|||
125873890|NCT00626275|452831542|FG001|Part A - Treatment Period 1|Adverse Event|0|||
125873891|NCT00626275|452831543|FG002|Part A - Treatment Period 1|Adverse Event|0|||
125873892|NCT00626275|452831544|FG003|Part A - Treatment Period 1|Adverse Event|0|||
125873893|NCT00626275|452831545|FG004|Part A - Treatment Period 1|Adverse Event|0|||
125873894|NCT00626275|452831546|FG005|Part A - Treatment Period 1|Adverse Event|0|||
125873895|NCT00626275|452831547|FG006|Part A - Treatment Period 1|Adverse Event|0|||
125873896|NCT00626275|452831548|FG007|Part A - Treatment Period 1|Adverse Event|0|||
125873897|NCT00626275|452831541|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125873898|NCT00626275|452831542|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125873899|NCT00626275|452831543|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
125873900|NCT00626275|452831544|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125873901|NCT00626275|452831545|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125873902|NCT00626275|452831546|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125873903|NCT00626275|452831547|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125873904|NCT00626275|452831548|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125873905|NCT00626275|452831541|FG000|Part B|Lost to Follow-up|0|||
125873906|NCT00626275|452831542|FG001|Part B|Lost to Follow-up|0|||
125873907|NCT00626275|452831543|FG002|Part B|Lost to Follow-up|0|||
125873908|NCT00626275|452831544|FG003|Part B|Lost to Follow-up|0|||
126090449|NCT01840410|453623572|FG000|Overall Study|Physician Decision|1|||
126316715|NCT00869557|454450756|FG000|Extension Phase|Lost to Follow-up|3|||
125873909|NCT00626275|452831545|FG004|Part B|Lost to Follow-up|0|||
125873910|NCT00626275|452831546|FG005|Part B|Lost to Follow-up|0|||
125873911|NCT00626275|452831547|FG006|Part B|Lost to Follow-up|1|||
125873912|NCT00626275|452831548|FG007|Part B|Lost to Follow-up|0|||
125873913|NCT00626275|452831541|FG000|Part B|Withdrawal by Subject|0|||
125873914|NCT00626275|452831542|FG001|Part B|Withdrawal by Subject|0|||
125873915|NCT00626275|452831543|FG002|Part B|Withdrawal by Subject|0|||
125873916|NCT00626275|452831544|FG003|Part B|Withdrawal by Subject|0|||
125873917|NCT00626275|452831545|FG004|Part B|Withdrawal by Subject|0|||
125873918|NCT00626275|452831546|FG005|Part B|Withdrawal by Subject|0|||
125873919|NCT00626275|452831547|FG006|Part B|Withdrawal by Subject|0|||
125873920|NCT00626275|452831548|FG007|Part B|Withdrawal by Subject|1|||
125873921|NCT01476722|452831549|FG000|Overall Study|Adverse Event|1|||
125873922|NCT03261336|452831550|FG000|Overall Study|Adverse Event|1|||
125873923|NCT01069484|452831553|FG000|Overall Study|Death-in-near-family|1|||
125873924|NCT01069484|452831554|FG001|Overall Study|Death-in-near-family|0|||
125873925|NCT01069484|452831553|FG000|Overall Study|No specific reason|8|||
125873926|NCT01069484|452831554|FG001|Overall Study|No specific reason|2|||
125873927|NCT01069484|452831553|FG000|Overall Study|Illness mother or child|3|||
125873928|NCT01069484|452831554|FG001|Overall Study|Illness mother or child|1|||
125873929|NCT00292942|452831555|FG000|Overall Study|Withdrawal by Subject|0|||
125873930|NCT00292942|452831556|FG001|Overall Study|Withdrawal by Subject|0|||
125873931|NCT00292942|452831557|FG002|Overall Study|Withdrawal by Subject|1|||
125873932|NCT00292942|452831558|FG003|Overall Study|Withdrawal by Subject|0|||
125873933|NCT00292942|452831555|FG000|Overall Study|Adverse Event|0|||
125873934|NCT00292942|452831556|FG001|Overall Study|Adverse Event|0|||
125873935|NCT00292942|452831557|FG002|Overall Study|Adverse Event|0|||
125873936|NCT00292942|452831558|FG003|Overall Study|Adverse Event|1|||
125873937|NCT00644358|452831559|FG000|Overall Study|Adverse Event|124|||
125873938|NCT00644358|452831559|FG000|Overall Study|Lost to Follow-up|105|||
125873939|NCT00644358|452831559|FG000|Overall Study|Consent Withdrawal|64|||
125873940|NCT00644358|452831559|FG000|Overall Study|Lack of Effectiveness|39|||
125873941|NCT00644358|452831559|FG000|Overall Study|Protocol Violation|5|||
125873942|NCT00644358|452831559|FG000|Overall Study|Noncompliance|14|||
125873943|NCT00644358|452831559|FG000|Overall Study|Other Unspecified|11|||
125873944|NCT00651924|452831566|FG000|Overall Study|Withdrawal by PI|0|||
125873945|NCT00651924|452831567|FG001|Overall Study|Withdrawal by PI|2|||
125873946|NCT00651924|452831566|FG000|Overall Study|Withdrawal by Subject|0|||
125873947|NCT00651924|452831567|FG001|Overall Study|Withdrawal by Subject|5|||
125873948|NCT00758771|452831568|FG000|Overall Study|Withdrawal by Subject|1|||
125873949|NCT00758771|452831569|FG001|Overall Study|Withdrawal by Subject|1|||
125873950|NCT00758771|452831568|FG000|Overall Study|Did not meet eligibility criteria|2|||
125873951|NCT00758771|452831569|FG001|Overall Study|Did not meet eligibility criteria|4|||
125873952|NCT00960063|452831570|FG000|Overall Study|Adverse Event|1|||
125873953|NCT00960063|452831571|FG001|Overall Study|Adverse Event|0|||
125873954|NCT00960063|452831572|FG002|Overall Study|Adverse Event|0|||
125873955|NCT00960063|452831570|FG000|Overall Study|Progression of Disease|0|||
125873956|NCT00960063|452831571|FG001|Overall Study|Progression of Disease|0|||
125873957|NCT00960063|452831572|FG002|Overall Study|Progression of Disease|3|||
125873958|NCT00771914|452831573|FG000|Overall Study|Physician Decision|0|||
125873959|NCT00771914|452831574|FG001|Overall Study|Physician Decision|0|||
125873960|NCT00771914|452831575|FG002|Overall Study|Physician Decision|0|||
125873961|NCT00771914|452831576|FG003|Overall Study|Physician Decision|1|||
125873962|NCT00771914|452831573|FG000|Overall Study|Lost to Follow-up|0|||
125873963|NCT00771914|452831574|FG001|Overall Study|Lost to Follow-up|0|||
125873964|NCT00771914|452831575|FG002|Overall Study|Lost to Follow-up|0|||
125873965|NCT00771914|452831576|FG003|Overall Study|Lost to Follow-up|1|||
125873966|NCT02978417|452831580|FG000|Overall Study|Lost to Follow-up|2|||
125873967|NCT02978417|452831581|FG001|Overall Study|Lost to Follow-up|2|||
125873968|NCT05083351|452831586|FG000|Overall Study|Adverse Event|3|||
125873969|NCT05083351|452831586|FG000|Overall Study|Did not meet data inclusion criteria|8|||
125873970|NCT05083351|452831586|FG000|Overall Study|Did not meet eligibility criteria|19|||
125873971|NCT05083351|452831586|FG000|Overall Study|Study Staff Decision|19|||
125873972|NCT01759420|452831592|FG000|Overall Study|Screen failure|5|||
125873973|NCT01759420|452831592|FG000|Overall Study|Inaccurate EKG machine readings|1|||
125873974|NCT01129622|452831595|FG000|Overall Study|Withdrawal by Subject|2|||
125873975|NCT00960375|452831598|FG000|Overall Study|Lost to Follow-up|20|||
125873976|NCT00960375|452831599|FG001|Overall Study|Lost to Follow-up|22|||
125873977|NCT00591006|452831600|FG000|Overall Study|Withdrawal by Subject|0|||
125873978|NCT00591006|452831601|FG001|Overall Study|Withdrawal by Subject|0|||
125873979|NCT00591006|452831602|FG002|Overall Study|Withdrawal by Subject|0|||
125873980|NCT00591006|452831603|FG003|Overall Study|Withdrawal by Subject|0|||
125873981|NCT00591006|452831604|FG004|Overall Study|Withdrawal by Subject|0|||
125873982|NCT00591006|452831605|FG005|Overall Study|Withdrawal by Subject|0|||
125873983|NCT00591006|452831606|FG006|Overall Study|Withdrawal by Subject|0|||
125873984|NCT00591006|452831607|FG007|Overall Study|Withdrawal by Subject|0|||
125873985|NCT00591006|452831608|FG008|Overall Study|Withdrawal by Subject|0|||
125873986|NCT00591006|452831609|FG009|Overall Study|Withdrawal by Subject|0|||
125873987|NCT00591006|452831610|FG010|Overall Study|Withdrawal by Subject|0|||
125873988|NCT00591006|452831611|FG011|Overall Study|Withdrawal by Subject|0|||
125873989|NCT00591006|452831612|FG012|Overall Study|Withdrawal by Subject|0|||
125873990|NCT00591006|452831613|FG013|Overall Study|Withdrawal by Subject|0|||
125873991|NCT00591006|452831614|FG014|Overall Study|Withdrawal by Subject|0|||
125873992|NCT00591006|452831615|FG015|Overall Study|Withdrawal by Subject|1|||
125873993|NCT00591006|452831616|FG016|Overall Study|Withdrawal by Subject|0|||
125873994|NCT00591006|452831617|FG017|Overall Study|Withdrawal by Subject|0|||
125873995|NCT00591006|452831618|FG018|Overall Study|Withdrawal by Subject|0|||
125873996|NCT00591006|452831619|FG019|Overall Study|Withdrawal by Subject|0|||
125873997|NCT00591006|452831620|FG020|Overall Study|Withdrawal by Subject|0|||
125873998|NCT00591006|452831621|FG021|Overall Study|Withdrawal by Subject|0|||
125873999|NCT00591006|452831622|FG022|Overall Study|Withdrawal by Subject|0|||
125874000|NCT00591006|452831623|FG023|Overall Study|Withdrawal by Subject|1|||
125874001|NCT00591006|452831600|FG000|Overall Study|Adverse Event|0|||
125874002|NCT00591006|452831601|FG001|Overall Study|Adverse Event|0|||
125874003|NCT00591006|452831602|FG002|Overall Study|Adverse Event|0|||
125874004|NCT00591006|452831603|FG003|Overall Study|Adverse Event|0|||
125874005|NCT00591006|452831604|FG004|Overall Study|Adverse Event|0|||
125874006|NCT00591006|452831605|FG005|Overall Study|Adverse Event|0|||
125874007|NCT00591006|452831606|FG006|Overall Study|Adverse Event|0|||
125874008|NCT00591006|452831607|FG007|Overall Study|Adverse Event|0|||
125874009|NCT00591006|452831608|FG008|Overall Study|Adverse Event|0|||
125874010|NCT00591006|452831609|FG009|Overall Study|Adverse Event|0|||
125874011|NCT00591006|452831610|FG010|Overall Study|Adverse Event|0|||
125874012|NCT00591006|452831611|FG011|Overall Study|Adverse Event|0|||
125874013|NCT00591006|452831612|FG012|Overall Study|Adverse Event|0|||
125874014|NCT00591006|452831613|FG013|Overall Study|Adverse Event|0|||
125874015|NCT00591006|452831614|FG014|Overall Study|Adverse Event|0|||
125874016|NCT00591006|452831615|FG015|Overall Study|Adverse Event|0|||
125874017|NCT00591006|452831616|FG016|Overall Study|Adverse Event|0|||
125874018|NCT00591006|452831617|FG017|Overall Study|Adverse Event|0|||
125874019|NCT00591006|452831618|FG018|Overall Study|Adverse Event|0|||
125874020|NCT00591006|452831619|FG019|Overall Study|Adverse Event|0|||
125874021|NCT00591006|452831620|FG020|Overall Study|Adverse Event|0|||
125874022|NCT00591006|452831621|FG021|Overall Study|Adverse Event|0|||
125874023|NCT00591006|452831622|FG022|Overall Study|Adverse Event|1|||
125874024|NCT00591006|452831623|FG023|Overall Study|Adverse Event|0|||
125874025|NCT00689390|452831624|FG000|Overall Study|Adverse Event|19|||
125874026|NCT00689390|452831625|FG001|Overall Study|Adverse Event|0|||
125874027|NCT00689390|452831624|FG000|Overall Study|Lost to Follow-up|179|||
125874028|NCT00689390|452831625|FG001|Overall Study|Lost to Follow-up|7|||
125874029|NCT00689390|452831624|FG000|Overall Study|Withdrawal by Subject|117|||
125874030|NCT00689390|452831625|FG001|Overall Study|Withdrawal by Subject|3|||
125874031|NCT00689390|452831624|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
125874032|NCT00689390|452831625|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
125874033|NCT00689390|452831624|FG000|Overall Study|Non-Compliance With Protocol|21|||
125874034|NCT00689390|452831625|FG001|Overall Study|Non-Compliance With Protocol|0|||
125874035|NCT00689390|452831624|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
125874036|NCT00689390|452831625|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
125874037|NCT00689390|452831624|FG000|Overall Study|Administrative|37|||
125874038|NCT00689390|452831625|FG001|Overall Study|Administrative|0|||
125874039|NCT02343263|452831626|FG000|Overall Study|Physician Decision|5|||
125874040|NCT02343263|452831627|FG001|Overall Study|Physician Decision|3|||
125874041|NCT02343263|452831628|FG002|Overall Study|Physician Decision|1|||
125874042|NCT00525512|452831642|FG000|Double-Blind Phase|Adverse Event|48|||
125874043|NCT00525512|452831643|FG001|Double-Blind Phase|Adverse Event|28|||
125874044|NCT00525512|452831644|FG002|Double-Blind Phase|Adverse Event|0|||
125874045|NCT00525512|452831645|FG003|Double-Blind Phase|Adverse Event|0|||
125874046|NCT00525512|452831642|FG000|Double-Blind Phase|Protocol Violation|3|||
125874047|NCT00525512|452831643|FG001|Double-Blind Phase|Protocol Violation|1|||
125874048|NCT00525512|452831644|FG002|Double-Blind Phase|Protocol Violation|0|||
125874049|NCT00525512|452831645|FG003|Double-Blind Phase|Protocol Violation|0|||
125874050|NCT00525512|452831642|FG000|Double-Blind Phase|Lost to Follow-up|3|||
125874051|NCT00525512|452831643|FG001|Double-Blind Phase|Lost to Follow-up|7|||
125874052|NCT00525512|452831644|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125874053|NCT00525512|452831645|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125874054|NCT00525512|452831642|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
125874055|NCT00525512|452831643|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
125874056|NCT00525512|452831644|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125874057|NCT00525512|452831645|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125874058|NCT00525512|452831642|FG000|Double-Blind Phase|Lack of Efficacy|13|||
125874059|NCT00525512|452831643|FG001|Double-Blind Phase|Lack of Efficacy|5|||
125874060|NCT00525512|452831644|FG002|Double-Blind Phase|Lack of Efficacy|0|||
125874061|NCT00525512|452831645|FG003|Double-Blind Phase|Lack of Efficacy|0|||
125874062|NCT00525512|452831642|FG000|Double-Blind Phase|Other reason (not specified)|12|||
126090450|NCT01840410|453623573|FG001|Overall Study|Physician Decision|2|||
125874063|NCT00525512|452831643|FG001|Double-Blind Phase|Other reason (not specified)|13|||
125874064|NCT00525512|452831644|FG002|Double-Blind Phase|Other reason (not specified)|0|||
125874065|NCT00525512|452831645|FG003|Double-Blind Phase|Other reason (not specified)|0|||
125874066|NCT00525512|452831642|FG000|Open-Label Phase|Adverse Event|0|||
125874067|NCT00525512|452831643|FG001|Open-Label Phase|Adverse Event|0|||
125874068|NCT00525512|452831644|FG002|Open-Label Phase|Adverse Event|1|||
125874069|NCT00525512|452831645|FG003|Open-Label Phase|Adverse Event|0|||
125874070|NCT00525512|452831642|FG000|Open-Label Phase|Lost to Follow-up|0|||
125874071|NCT00525512|452831643|FG001|Open-Label Phase|Lost to Follow-up|0|||
125874072|NCT00525512|452831644|FG002|Open-Label Phase|Lost to Follow-up|1|||
125874073|NCT00525512|452831645|FG003|Open-Label Phase|Lost to Follow-up|0|||
125874074|NCT00525512|452831642|FG000|Open-Label Phase|Other reason (not specified)|0|||
125874075|NCT00525512|452831643|FG001|Open-Label Phase|Other reason (not specified)|0|||
125874076|NCT00525512|452831644|FG002|Open-Label Phase|Other reason (not specified)|4|||
125874077|NCT00525512|452831645|FG003|Open-Label Phase|Other reason (not specified)|5|||
125874078|NCT00402168|452831652|FG000|Randomized|Lost to Follow-up|1|||
125874079|NCT00402168|452831653|FG001|Randomized|Lost to Follow-up|0|||
125874080|NCT00402168|452831652|FG000|Randomized|Withdrawal by Subject|0|||
125874081|NCT00402168|452831653|FG001|Randomized|Withdrawal by Subject|1|||
125874082|NCT00402168|452831652|FG000|Treatment (up to 12 Months)|Death|0|||
125874083|NCT00402168|452831653|FG001|Treatment (up to 12 Months)|Death|1|||
125874084|NCT00402168|452831652|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
125874085|NCT00402168|452831653|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
125874086|NCT00402168|452831652|FG000|Treatment (up to 12 Months)|non-specified|0|||
125874087|NCT00402168|452831653|FG001|Treatment (up to 12 Months)|non-specified|1|||
125874088|NCT00402168|452831652|FG000|Long Term (LT)|Adverse Event|1|||
125874089|NCT00402168|452831653|FG001|Long Term (LT)|Adverse Event|5|||
125874090|NCT00402168|452831652|FG000|Long Term (LT)|Withdrawal by Subject|4|||
125874091|NCT00402168|452831653|FG001|Long Term (LT)|Withdrawal by Subject|7|||
125874092|NCT00402168|452831652|FG000|Long Term (LT)|Pregnancy|0|||
125874093|NCT00402168|452831653|FG001|Long Term (LT)|Pregnancy|1|||
125874094|NCT00402168|452831652|FG000|Long Term (LT)|Lost to Follow-up|1|||
125874095|NCT00402168|452831653|FG001|Long Term (LT)|Lost to Follow-up|0|||
125874096|NCT00402168|452831652|FG000|Long Term (LT)|Death|4|||
125874097|NCT00402168|452831653|FG001|Long Term (LT)|Death|0|||
125874098|NCT00402168|452831652|FG000|Long Term (LT)|Lack of Efficacy|0|||
125874099|NCT00402168|452831653|FG001|Long Term (LT)|Lack of Efficacy|2|||
125874100|NCT00402168|452831652|FG000|Long Term (LT)|non-specified|1|||
125874101|NCT00402168|452831653|FG001|Long Term (LT)|non-specified|2|||
125874102|NCT00402168|452831652|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
125874103|NCT00402168|452831653|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
125874104|NCT00402168|452831652|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
125874105|NCT00402168|452831653|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
125874106|NCT00301808|452831659|FG000|Overall Study|Adverse Event|5|||
125874107|NCT00301808|452831659|FG000|Overall Study|Death|3|||
125874108|NCT00301808|452831659|FG000|Overall Study|Lack of Efficacy|4|||
125874109|NCT05893862|452831663|FG000|Overall Study|Physician Decision|0|||
125874110|NCT05893862|452831664|FG001|Overall Study|Physician Decision|1|||
125874111|NCT05893862|452831665|FG002|Overall Study|Physician Decision|0|||
125874112|NCT05893862|452831666|FG003|Overall Study|Physician Decision|0|||
125874113|NCT05893862|452831667|FG004|Overall Study|Physician Decision|1|||
125874114|NCT05893862|452831668|FG005|Overall Study|Physician Decision|0|||
125874115|NCT05893862|452831663|FG000|Overall Study|Withdrawal by Subject|1|||
125874116|NCT05893862|452831664|FG001|Overall Study|Withdrawal by Subject|7|||
125874117|NCT05893862|452831665|FG002|Overall Study|Withdrawal by Subject|1|||
125874118|NCT05893862|452831666|FG003|Overall Study|Withdrawal by Subject|3|||
125874119|NCT05893862|452831667|FG004|Overall Study|Withdrawal by Subject|3|||
125874120|NCT05893862|452831668|FG005|Overall Study|Withdrawal by Subject|2|||
125874121|NCT05893862|452831663|FG000|Overall Study|Adverse Event|1|||
125874122|NCT05893862|452831664|FG001|Overall Study|Adverse Event|4|||
125874123|NCT05893862|452831665|FG002|Overall Study|Adverse Event|2|||
125874124|NCT05893862|452831666|FG003|Overall Study|Adverse Event|2|||
125874125|NCT05893862|452831667|FG004|Overall Study|Adverse Event|1|||
125874126|NCT05893862|452831668|FG005|Overall Study|Adverse Event|0|||
125874127|NCT02429830|452831669|FG000|Overall Study|Lost to Follow-up|1|||
125874128|NCT02429830|452831669|FG000|Overall Study|Device Explant|2|||
125874129|NCT03346434|452833630|FG000|Overall Study|Randomized in Error|0|||
125874130|NCT03346434|452833631|FG001|Overall Study|Randomized in Error|0|||
125874131|NCT03346434|452833632|FG002|Overall Study|Randomized in Error|0|||
125874132|NCT03346434|452833633|FG003|Overall Study|Randomized in Error|0|||
125874133|NCT03346434|452833634|FG004|Overall Study|Randomized in Error|1|||
125874134|NCT03346434|452833635|FG005|Overall Study|Randomized in Error|0|||
125874135|NCT03346434|452833630|FG000|Overall Study|Withdrawal by Subject|0|||
125874136|NCT03346434|452833631|FG001|Overall Study|Withdrawal by Subject|0|||
125874137|NCT03346434|452833632|FG002|Overall Study|Withdrawal by Subject|1|||
125874138|NCT03346434|452833633|FG003|Overall Study|Withdrawal by Subject|0|||
125874139|NCT03346434|452833634|FG004|Overall Study|Withdrawal by Subject|1|||
125874140|NCT03346434|452833635|FG005|Overall Study|Withdrawal by Subject|0|||
125874141|NCT03346434|452833630|FG000|Overall Study|Lost to Follow-up|0|||
125874142|NCT03346434|452833631|FG001|Overall Study|Lost to Follow-up|0|||
125874143|NCT03346434|452833632|FG002|Overall Study|Lost to Follow-up|0|||
125874144|NCT03346434|452833633|FG003|Overall Study|Lost to Follow-up|0|||
125874145|NCT03346434|452833634|FG004|Overall Study|Lost to Follow-up|1|||
125874146|NCT03346434|452833635|FG005|Overall Study|Lost to Follow-up|1|||
125874147|NCT03346434|452833630|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125874148|NCT03346434|452833631|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125874149|NCT03346434|452833632|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125874150|NCT03346434|452833633|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125874151|NCT03346434|452833634|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
125874152|NCT03346434|452833635|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
125874153|NCT01419236|452833639|FG000|Overall Study|Adverse Event|1|||
126316716|NCT00869557|454450757|FG001|Extension Phase|Lost to Follow-up|1|||
126316717|NCT00869557|454450756|FG000|Extension Phase|Investigator's Discretion|2|||
126316718|NCT00869557|454450757|FG001|Extension Phase|Investigator's Discretion|0|||
126316719|NCT00869557|454450756|FG000|Extension Phase|Withdrew Consent|2|||
126316720|NCT00869557|454450757|FG001|Extension Phase|Withdrew Consent|0|||
126316721|NCT02368210|454450758|FG000|Overall Study|Withdrawal by Subject|1|||
126316722|NCT02368210|454450759|FG001|Overall Study|Withdrawal by Subject|0|||
125874154|NCT01419236|452833640|FG001|Overall Study|Adverse Event|0|||
125874155|NCT01419236|452833639|FG000|Overall Study|Lack of Efficacy|0|||
125874156|NCT01419236|452833640|FG001|Overall Study|Lack of Efficacy|1|||
125874157|NCT01419236|452833639|FG000|Overall Study|Lost to Follow-up|1|||
125874158|NCT01419236|452833640|FG001|Overall Study|Lost to Follow-up|0|||
125874159|NCT01419236|452833639|FG000|Overall Study|Physician Decision|1|||
125874160|NCT01419236|452833640|FG001|Overall Study|Physician Decision|0|||
125874161|NCT01419236|452833639|FG000|Overall Study|Withdrawal by Subject|1|||
125874162|NCT01419236|452833640|FG001|Overall Study|Withdrawal by Subject|4|||
125874163|NCT01419236|452833639|FG000|Overall Study|Entry Criteria Not Met|1|||
125874164|NCT01419236|452833640|FG001|Overall Study|Entry Criteria Not Met|0|||
125874165|NCT00762359|452833647|FG000|Overall Study|Adverse Event|20|||
125874166|NCT00762359|452833648|FG001|Overall Study|Adverse Event|23|||
125874167|NCT00762359|452833647|FG000|Overall Study|Protocol Violation|21|||
125874168|NCT00762359|452833648|FG001|Overall Study|Protocol Violation|13|||
125874169|NCT00762359|452833647|FG000|Overall Study|Withdrawal by Subject|13|||
125874170|NCT00762359|452833648|FG001|Overall Study|Withdrawal by Subject|10|||
125874171|NCT00762359|452833647|FG000|Overall Study|Lack of Efficacy|0|||
125874172|NCT00762359|452833648|FG001|Overall Study|Lack of Efficacy|4|||
125874173|NCT00762359|452833647|FG000|Overall Study|Institution closed|2|||
125874174|NCT00762359|452833648|FG001|Overall Study|Institution closed|3|||
125874175|NCT00762359|452833647|FG000|Overall Study|Physician Decision|2|||
125874176|NCT00762359|452833648|FG001|Overall Study|Physician Decision|3|||
125874177|NCT00762359|452833647|FG000|Overall Study|Removal|0|||
125874178|NCT00762359|452833648|FG001|Overall Study|Removal|1|||
125874179|NCT00762359|452833647|FG000|Overall Study|Withdrew consent|1|||
125874180|NCT00762359|452833648|FG001|Overall Study|Withdrew consent|0|||
125874181|NCT01453049|452833649|FG000|Overall Study|Protocol Violation|2|||
125874182|NCT01453049|452833650|FG001|Overall Study|Protocol Violation|5|||
125874183|NCT01453049|452833649|FG000|Overall Study|Lost to Follow-up|2|||
125874184|NCT01453049|452833650|FG001|Overall Study|Lost to Follow-up|1|||
125874185|NCT01453049|452833649|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
125874186|NCT01453049|452833650|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
125874187|NCT01453049|452833649|FG000|Overall Study|Withdrawal by Subject|1|||
125874188|NCT01453049|452833650|FG001|Overall Study|Withdrawal by Subject|0|||
125874189|NCT01453049|452833649|FG000|Overall Study|Randomized in Error|1|||
125874190|NCT01453049|452833650|FG001|Overall Study|Randomized in Error|0|||
125874191|NCT00882440|452833651|FG000|Overall Study|Adverse Event|2|||
125874192|NCT00882440|452833652|FG001|Overall Study|Adverse Event|2|||
125874193|NCT00882440|452833653|FG002|Overall Study|Adverse Event|2|||
125874194|NCT00882440|452833654|FG003|Overall Study|Adverse Event|1|||
125874195|NCT00882440|452833655|FG004|Overall Study|Adverse Event|1|||
125874196|NCT00882440|452833656|FG005|Overall Study|Adverse Event|4|||
125874197|NCT00882440|452833657|FG006|Overall Study|Adverse Event|2|||
125874198|NCT00882440|452833651|FG000|Overall Study|Lack of Efficacy|3|||
126316723|NCT02368210|454450758|FG000|Overall Study|Adverse Event|0|||
126316724|NCT02368210|454450759|FG001|Overall Study|Adverse Event|1|||
125874199|NCT00882440|452833652|FG001|Overall Study|Lack of Efficacy|5|||
126316725|NCT00078949|454450760|FG000|Overall Study|No treated|4|||
125874200|NCT00882440|452833653|FG002|Overall Study|Lack of Efficacy|2|||
125874201|NCT00882440|452833654|FG003|Overall Study|Lack of Efficacy|0|||
125874202|NCT00882440|452833655|FG004|Overall Study|Lack of Efficacy|0|||
125874203|NCT00882440|452833656|FG005|Overall Study|Lack of Efficacy|3|||
125874204|NCT00882440|452833657|FG006|Overall Study|Lack of Efficacy|0|||
125874205|NCT00882440|452833651|FG000|Overall Study|Lost to Follow-up|2|||
125874206|NCT00882440|452833652|FG001|Overall Study|Lost to Follow-up|0|||
126316726|NCT00078949|454450761|FG001|Overall Study|No treated|5|||
125874207|NCT00882440|452833653|FG002|Overall Study|Lost to Follow-up|1|||
125874208|NCT00882440|452833654|FG003|Overall Study|Lost to Follow-up|1|||
125874209|NCT00882440|452833655|FG004|Overall Study|Lost to Follow-up|1|||
125874210|NCT00882440|452833656|FG005|Overall Study|Lost to Follow-up|0|||
125874211|NCT00882440|452833657|FG006|Overall Study|Lost to Follow-up|1|||
125874212|NCT00882440|452833651|FG000|Overall Study|Protocol Violation|0|||
125874213|NCT00882440|452833652|FG001|Overall Study|Protocol Violation|0|||
125874214|NCT00882440|452833653|FG002|Overall Study|Protocol Violation|1|||
125874215|NCT00882440|452833654|FG003|Overall Study|Protocol Violation|1|||
125874216|NCT00882440|452833655|FG004|Overall Study|Protocol Violation|1|||
125874217|NCT00882440|452833656|FG005|Overall Study|Protocol Violation|0|||
125874218|NCT00882440|452833657|FG006|Overall Study|Protocol Violation|0|||
125874219|NCT00882440|452833651|FG000|Overall Study|Withdrawal by Subject|2|||
125874220|NCT00882440|452833652|FG001|Overall Study|Withdrawal by Subject|1|||
125874221|NCT00882440|452833653|FG002|Overall Study|Withdrawal by Subject|1|||
125874222|NCT00882440|452833654|FG003|Overall Study|Withdrawal by Subject|0|||
125874223|NCT00882440|452833655|FG004|Overall Study|Withdrawal by Subject|6|||
125874224|NCT00882440|452833656|FG005|Overall Study|Withdrawal by Subject|0|||
125874225|NCT00882440|452833657|FG006|Overall Study|Withdrawal by Subject|1|||
125874226|NCT00882440|452833651|FG000|Overall Study|Patient Uncooperative|2|||
125874227|NCT00882440|452833652|FG001|Overall Study|Patient Uncooperative|0|||
125874228|NCT00882440|452833653|FG002|Overall Study|Patient Uncooperative|0|||
125874229|NCT00882440|452833654|FG003|Overall Study|Patient Uncooperative|0|||
125874230|NCT00882440|452833655|FG004|Overall Study|Patient Uncooperative|1|||
125874231|NCT00882440|452833656|FG005|Overall Study|Patient Uncooperative|0|||
125874232|NCT00882440|452833657|FG006|Overall Study|Patient Uncooperative|0|||
125874233|NCT03287791|452833658|FG000|Overall Study|Insufficient Therapeutic Response|0|||
125874234|NCT03287791|452833659|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125874235|NCT03287791|452833660|FG002|Overall Study|Insufficient Therapeutic Response|1|||
125874236|NCT03287791|452833658|FG000|Overall Study|Adverse Event|0|||
125874237|NCT03287791|452833659|FG001|Overall Study|Adverse Event|4|||
125874238|NCT03287791|452833660|FG002|Overall Study|Adverse Event|3|||
125874239|NCT03287791|452833658|FG000|Overall Study|Withdrawal by Subject|12|||
125874240|NCT03287791|452833659|FG001|Overall Study|Withdrawal by Subject|12|||
125874241|NCT03287791|452833660|FG002|Overall Study|Withdrawal by Subject|17|||
125874242|NCT03287791|452833658|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
125874243|NCT03287791|452833659|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
125874244|NCT03287791|452833660|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
125874245|NCT03287791|452833658|FG000|Overall Study|Lost to Follow-up|8|||
125874246|NCT03287791|452833659|FG001|Overall Study|Lost to Follow-up|14|||
125874247|NCT03287791|452833660|FG002|Overall Study|Lost to Follow-up|11|||
125874248|NCT03287791|452833658|FG000|Overall Study|Protocol Violation|7|||
125874249|NCT03287791|452833659|FG001|Overall Study|Protocol Violation|2|||
125874250|NCT03287791|452833660|FG002|Overall Study|Protocol Violation|1|||
125874251|NCT03287791|452833658|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
125874252|NCT03287791|452833659|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
125874253|NCT03287791|452833660|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
125874254|NCT03287791|452833658|FG000|Overall Study|Too much time between 2 visits|0|||
125874255|NCT03287791|452833659|FG001|Overall Study|Too much time between 2 visits|1|||
125874256|NCT03287791|452833660|FG002|Overall Study|Too much time between 2 visits|0|||
125874257|NCT03287791|452833658|FG000|Overall Study|Non-compliance|0|||
125874258|NCT03287791|452833659|FG001|Overall Study|Non-compliance|1|||
125874259|NCT03287791|452833660|FG002|Overall Study|Non-compliance|0|||
125874260|NCT03287791|452833658|FG000|Overall Study|Did not meet inclusion criteria|1|||
125874261|NCT03287791|452833659|FG001|Overall Study|Did not meet inclusion criteria|0|||
125874262|NCT03287791|452833660|FG002|Overall Study|Did not meet inclusion criteria|0|||
125874263|NCT05482308|452833665|FG000|Overall Study|Withdrawal by Subject|1|||
125874264|NCT05482308|452833666|FG001|Overall Study|Withdrawal by Subject|0|||
125874265|NCT05482308|452833665|FG000|Overall Study|No longer meets eligibility criteria|0|||
125874266|NCT05482308|452833666|FG001|Overall Study|No longer meets eligibility criteria|1|||
126316727|NCT00078949|454450762|FG002|Overall Study|No treated|3|||
126316728|NCT00078949|454450763|FG003|Overall Study|No treated|3|||
126316729|NCT01143064|454450764|FG000|Overall Study|Death|109|||
126316730|NCT01143064|454450765|FG001|Overall Study|Death|91|||
125874267|NCT02250326|452833670|FG000|Treatment|Death|1|||
125874268|NCT02250326|452833671|FG001|Treatment|Death|13|||
125874269|NCT02250326|452833672|FG002|Treatment|Death|2|||
125874270|NCT02250326|452833670|FG000|Treatment|Adverse Event|8|||
125874271|NCT02250326|452833671|FG001|Treatment|Adverse Event|8|||
125874272|NCT02250326|452833672|FG002|Treatment|Adverse Event|9|||
125874273|NCT02250326|452833670|FG000|Treatment|Progressive Disease|42|||
125874274|NCT02250326|452833671|FG001|Treatment|Progressive Disease|40|||
125874275|NCT02250326|452833672|FG002|Treatment|Progressive Disease|47|||
125874276|NCT02250326|452833670|FG000|Treatment|Symptomatic Deterioration|9|||
126090451|NCT01840410|453623572|FG000|Overall Study|Pregnancy|1|||
126316731|NCT01143064|454450764|FG000|Overall Study|Adverse Event|0|||
125874277|NCT02250326|452833671|FG001|Treatment|Symptomatic Deterioration|4|||
126316732|NCT01143064|454450765|FG001|Overall Study|Adverse Event|1|||
125874278|NCT02250326|452833672|FG002|Treatment|Symptomatic Deterioration|10|||
125874279|NCT02250326|452833670|FG000|Treatment|Withdrawal by Subject|11|||
125874280|NCT02250326|452833671|FG001|Treatment|Withdrawal by Subject|6|||
125874281|NCT02250326|452833672|FG002|Treatment|Withdrawal by Subject|4|||
125874282|NCT02250326|452833670|FG000|Treatment|Other reasons|8|||
125874283|NCT02250326|452833671|FG001|Treatment|Other reasons|7|||
125874284|NCT02250326|452833672|FG002|Treatment|Other reasons|7|||
125874285|NCT02250326|452833670|FG000|Extension Period|Progressive Disease|0|||
125874286|NCT02250326|452833671|FG001|Extension Period|Progressive Disease|2|||
125874287|NCT02250326|452833672|FG002|Extension Period|Progressive Disease|0|||
125874288|NCT02250326|452833670|FG000|Extension Period|Withdrawal by Subject|0|||
125874289|NCT02250326|452833671|FG001|Extension Period|Withdrawal by Subject|1|||
125874290|NCT02250326|452833672|FG002|Extension Period|Withdrawal by Subject|0|||
125874291|NCT02250326|452833670|FG000|Extension Period|Withdrawal by investigator|0|||
125874292|NCT02250326|452833671|FG001|Extension Period|Withdrawal by investigator|1|||
125874293|NCT02250326|452833672|FG002|Extension Period|Withdrawal by investigator|0|||
125874294|NCT03924622|452833673|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
125874295|NCT03924622|452833674|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125874296|NCT03924622|452833675|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125874297|NCT03924622|452833676|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
125874298|NCT03924622|452833677|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125874299|NCT03924622|452833678|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125874300|NCT00866177|452833683|FG000|Overall Study|Withdrawal by Subject|1|||
125874301|NCT00866177|452833683|FG000|Overall Study|Not Treated|151|||
125874302|NCT03585660|452833684|FG000|Overall Study|operator error|1|||
125874303|NCT03585660|452833684|FG000|Overall Study|technical error|2|||
125874304|NCT03585660|452833684|FG000|Overall Study|hip prosthesis|2|||
125874305|NCT03585660|452833684|FG000|Overall Study|did not undergo biopsy|8|||
125874306|NCT03585660|452833684|FG000|Overall Study|scanner problem|2|||
125874307|NCT05635461|452833689|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125874308|NCT05635461|452833690|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125874309|NCT05635461|452833691|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125874310|NCT05635461|452833692|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125874311|NCT05635461|452833693|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
125874312|NCT05635461|452833694|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125874313|NCT05635461|452833689|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125874314|NCT05635461|452833690|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
125874315|NCT05635461|452833691|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125874316|NCT05635461|452833692|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125874317|NCT05635461|452833693|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125874318|NCT05635461|452833694|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125874319|NCT05635461|452833689|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125874320|NCT05635461|452833690|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125874321|NCT05635461|452833691|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125874322|NCT05635461|452833692|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
125874323|NCT05635461|452833693|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125874324|NCT05635461|452833694|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125874325|NCT03760029|452833697|FG000|Overall Study|Death|1|||
125874326|NCT03760029|452833698|FG001|Overall Study|Death|0|||
125874327|NCT03760029|452833699|FG002|Overall Study|Death|0|||
125874328|NCT03760029|452833697|FG000|Overall Study|Lost to Follow-up|0|||
125874329|NCT03760029|452833698|FG001|Overall Study|Lost to Follow-up|2|||
125874330|NCT03760029|452833699|FG002|Overall Study|Lost to Follow-up|1|||
125874331|NCT03760029|452833697|FG000|Overall Study|Withdrawal by Subject|1|||
125874332|NCT03760029|452833698|FG001|Overall Study|Withdrawal by Subject|4|||
125874333|NCT03760029|452833699|FG002|Overall Study|Withdrawal by Subject|1|||
125874334|NCT03760029|452833697|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125874335|NCT03760029|452833698|FG001|Overall Study|Withdrawal by parent/guardian|4|||
125874336|NCT03760029|452833699|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125874337|NCT03760029|452833697|FG000|Overall Study|Other|2|||
125874338|NCT03760029|452833698|FG001|Overall Study|Other|1|||
125874339|NCT03760029|452833699|FG002|Overall Study|Other|0|||
125874340|NCT04890652|452833703|FG000|Overall Study|Withdrawal by Subject|2|||
125874341|NCT00614575|452833708|FG000|Overall Study|Adverse Event|106|||
125874342|NCT00614575|452833708|FG000|Overall Study|Lost to Follow-up|55|||
125874343|NCT00614575|452833708|FG000|Overall Study|Lack of Efficacy|14|||
125874344|NCT00614575|452833708|FG000|Overall Study|Withdrawal by Subject|6|||
125874345|NCT00614575|452833708|FG000|Overall Study|Death|3|||
125874346|NCT00614575|452833708|FG000|Overall Study|Physician Decision|2|||
125874347|NCT00614575|452833708|FG000|Overall Study|No data were collected.|18|||
125874348|NCT00614575|452833708|FG000|Overall Study|Irregularly enrolled patients|23|||
125874349|NCT00614575|452833708|FG000|Overall Study|No treatment|1|||
125874350|NCT03452540|452833709|FG000|Overall Study|Adverse Event|1|||
125874351|NCT03452540|452833709|FG000|Overall Study|Withdrawal by Subject|1|||
125874352|NCT03452540|452833709|FG000|Overall Study|Other SAE and AE|2|||
125874353|NCT04664153|452833712|FG000|Overall Study|Lack of Efficacy|0|||
125874354|NCT04664153|452833713|FG001|Overall Study|Lack of Efficacy|0|||
125874355|NCT04664153|452833714|FG002|Overall Study|Lack of Efficacy|1|||
125874356|NCT04664153|452833715|FG003|Overall Study|Lack of Efficacy|0|||
125874357|NCT04664153|452833712|FG000|Overall Study|Physician Decision|0|||
125874358|NCT04664153|452833713|FG001|Overall Study|Physician Decision|0|||
125874359|NCT04664153|452833714|FG002|Overall Study|Physician Decision|1|||
125874360|NCT04664153|452833715|FG003|Overall Study|Physician Decision|0|||
125874361|NCT04664153|452833712|FG000|Overall Study|Withdrawal by Subject|3|||
125874362|NCT04664153|452833713|FG001|Overall Study|Withdrawal by Subject|2|||
125874363|NCT04664153|452833714|FG002|Overall Study|Withdrawal by Subject|1|||
125874364|NCT04664153|452833715|FG003|Overall Study|Withdrawal by Subject|2|||
125874365|NCT04664153|452833712|FG000|Overall Study|Other|0|||
125874366|NCT04664153|452833713|FG001|Overall Study|Other|1|||
125874367|NCT04664153|452833714|FG002|Overall Study|Other|0|||
125874368|NCT04664153|452833715|FG003|Overall Study|Other|0|||
125874369|NCT04664153|452833712|FG000|Overall Study|Adverse Event|4|||
125874370|NCT04664153|452833713|FG001|Overall Study|Adverse Event|0|||
125874371|NCT04664153|452833714|FG002|Overall Study|Adverse Event|1|||
125874372|NCT04664153|452833715|FG003|Overall Study|Adverse Event|0|||
125874373|NCT01045460|452833716|FG000|Overall Study|Physician Decision|3|||
125874374|NCT01045460|452833717|FG001|Overall Study|Physician Decision|2|||
125874375|NCT01045460|452833716|FG000|Overall Study|Lost to Follow-up|0|||
125874376|NCT01045460|452833717|FG001|Overall Study|Lost to Follow-up|1|||
125874377|NCT01045460|452833716|FG000|Overall Study|Lack of Efficacy|3|||
125874378|NCT01045460|452833717|FG001|Overall Study|Lack of Efficacy|0|||
125874379|NCT00524485|452833721|FG000|Overall Study|Withdrawal by Subject|5|||
125874380|NCT02140047|452833724|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125874381|NCT02140047|452833725|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125874382|NCT02140047|452833726|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125874383|NCT01046565|452833727|FG000|Overall Study|Adverse Event|2|||
125874384|NCT01046565|452833727|FG000|Overall Study|Withdrawal by Subject|7|||
125874385|NCT01650558|452833728|FG000|Overall Study|Migration out of study area|61|||
125874386|NCT01650558|452833729|FG001|Overall Study|Migration out of study area|71|||
125874387|NCT01650558|452833730|FG002|Overall Study|Migration out of study area|56|||
125874388|NCT01650558|452833728|FG000|Overall Study|Lost to Follow-up|10|||
125874389|NCT01650558|452833729|FG001|Overall Study|Lost to Follow-up|13|||
125874390|NCT01650558|452833730|FG002|Overall Study|Lost to Follow-up|6|||
125874391|NCT01650558|452833728|FG000|Overall Study|Death|10|||
125874392|NCT01650558|452833729|FG001|Overall Study|Death|6|||
125874393|NCT01650558|452833730|FG002|Overall Study|Death|8|||
125874394|NCT01650558|452833728|FG000|Overall Study|Withdrawal by Subject|1|||
125874395|NCT01650558|452833729|FG001|Overall Study|Withdrawal by Subject|1|||
125874396|NCT01650558|452833730|FG002|Overall Study|Withdrawal by Subject|3|||
125874397|NCT01650558|452833728|FG000|Overall Study|Non-compliant participant|1|||
125874398|NCT01650558|452833729|FG001|Overall Study|Non-compliant participant|0|||
125874399|NCT01650558|452833730|FG002|Overall Study|Non-compliant participant|2|||
125874400|NCT01650558|452833728|FG000|Overall Study|Physician Decision|0|||
125874401|NCT01650558|452833729|FG001|Overall Study|Physician Decision|1|||
125874402|NCT01650558|452833730|FG002|Overall Study|Physician Decision|0|||
125874403|NCT00528957|452833733|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
125874404|NCT00528957|452833734|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
125874405|NCT00528957|452833733|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
125874406|NCT00528957|452833734|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
125874407|NCT00528957|452833733|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
125874408|NCT00528957|452833734|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
125874409|NCT00528957|452833733|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
125874410|NCT00528957|452833734|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
125874411|NCT00528957|452833733|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
125874412|NCT00528957|452833734|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
125874413|NCT00528957|452833733|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
125874414|NCT00528957|452833734|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
125874415|NCT00528957|452833733|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
125874416|NCT00528957|452833734|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
125874417|NCT00528957|452833733|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
125874418|NCT00528957|452833734|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
125874419|NCT00528957|452833733|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
125874420|NCT00528957|452833734|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
125874421|NCT00528957|452833733|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
125874422|NCT00528957|452833734|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
125874423|NCT00528957|452833733|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
125874424|NCT00528957|452833734|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
125874425|NCT00528957|452833733|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
125874426|NCT00528957|452833734|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
125874427|NCT00528957|452833733|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
125874428|NCT00528957|452833734|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
125874429|NCT00528957|452833733|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
125874430|NCT00528957|452833734|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
125874431|NCT00528957|452833733|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
125874432|NCT00528957|452833734|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
125874433|NCT00528957|452833733|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
125874434|NCT00528957|452833734|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
125874435|NCT02051764|452833735|FG000|Overall Study|Study terminated by sponsor|0|||
125874436|NCT02051764|452833736|FG001|Overall Study|Study terminated by sponsor|7|||
125874437|NCT03624881|452833737|FG000|Overall Study|Screen Failure|14|||
125874438|NCT03624881|452833738|FG001|Overall Study|Screen Failure|0|||
125874439|NCT03624881|452833737|FG000|Overall Study|No Catheter Inserted|6|||
125874440|NCT03624881|452833738|FG001|Overall Study|No Catheter Inserted|1|||
125874441|NCT03624881|452833737|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
125874442|NCT03624881|452833738|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
125874443|NCT03624881|452833737|FG000|Overall Study|Death|2|||
125874444|NCT03624881|452833738|FG001|Overall Study|Death|0|||
125874445|NCT03624881|452833737|FG000|Overall Study|Lost to Follow-up|10|||
125874446|NCT03624881|452833738|FG001|Overall Study|Lost to Follow-up|4|||
125874447|NCT03624881|452833737|FG000|Overall Study|Withdrawal by Subject|12|||
125874448|NCT03624881|452833738|FG001|Overall Study|Withdrawal by Subject|1|||
125874449|NCT03557970|452833739|FG000|Overall Study|Study closure|1|||
125874450|NCT03557970|452833740|FG001|Overall Study|Study closure|0|||
125874451|NCT03557970|452833739|FG000|Overall Study|Physician Decision|0|||
125874452|NCT03557970|452833740|FG001|Overall Study|Physician Decision|1|||
125874453|NCT03557970|452833739|FG000|Overall Study|Death|0|||
125874454|NCT03557970|452833740|FG001|Overall Study|Death|1|||
125874455|NCT03155724|452833743|FG000|Overall Study|Death|3|||
125874456|NCT03155724|452833743|FG000|Overall Study|Physician Decision|1|||
125874457|NCT03155724|452833743|FG000|Overall Study|Study closure|7|||
125874458|NCT04258423|452833747|FG000|Overall Study|Study Closure|2|||
125874459|NCT04258423|452833748|FG001|Overall Study|Study Closure|2|||
125874460|NCT00321789|452833749|FG000|Overall Study|Lost to Follow-up|4|||
125874461|NCT00321789|452833750|FG001|Overall Study|Lost to Follow-up|7|||
125874462|NCT00321789|452833749|FG000|Overall Study|Withdrawal by Subject|6|||
125874463|NCT00321789|452833750|FG001|Overall Study|Withdrawal by Subject|6|||
125874464|NCT00321789|452833749|FG000|Overall Study|Protocol Violation|5|||
125874465|NCT00321789|452833750|FG001|Overall Study|Protocol Violation|3|||
125874466|NCT03309020|452833752|FG000|Overall Study|Death|1|||
125874467|NCT03309020|452833753|FG001|Overall Study|Death|0|||
125874468|NCT03309020|452833752|FG000|Overall Study|Did not undergo surgery|2|||
125874469|NCT03309020|452833753|FG001|Overall Study|Did not undergo surgery|1|||
125874470|NCT03095651|452835263|FG000|Overall Study|Lost to Follow-up|1|||
125874471|NCT03095651|452835264|FG001|Overall Study|Lost to Follow-up|1|||
125874472|NCT03095651|452835265|FG002|Overall Study|Lost to Follow-up|0|||
125874473|NCT03095651|452835266|FG003|Overall Study|Lost to Follow-up|1|||
125874474|NCT03095651|452835267|FG004|Overall Study|Lost to Follow-up|0|||
125874475|NCT03095651|452835268|FG005|Overall Study|Lost to Follow-up|0|||
125874476|NCT03095651|452835269|FG006|Overall Study|Lost to Follow-up|0|||
125874477|NCT03095651|452835270|FG007|Overall Study|Lost to Follow-up|0|||
125874478|NCT03095651|452835263|FG000|Overall Study|Withdrawal by Subject|0|||
125874479|NCT03095651|452835264|FG001|Overall Study|Withdrawal by Subject|0|||
125874480|NCT03095651|452835265|FG002|Overall Study|Withdrawal by Subject|0|||
125874481|NCT03095651|452835266|FG003|Overall Study|Withdrawal by Subject|0|||
125874482|NCT03095651|452835267|FG004|Overall Study|Withdrawal by Subject|0|||
125874483|NCT03095651|452835268|FG005|Overall Study|Withdrawal by Subject|1|||
125874484|NCT03095651|452835269|FG006|Overall Study|Withdrawal by Subject|0|||
125874485|NCT03095651|452835270|FG007|Overall Study|Withdrawal by Subject|0|||
125874486|NCT03284710|452835273|FG000|Overall Study|Withdrawal by Subject|1|||
125874487|NCT03284710|452835274|FG001|Overall Study|Withdrawal by Subject|0|||
125874488|NCT03284710|452835275|FG002|Overall Study|Withdrawal by Subject|1|||
125874489|NCT03284710|452835276|FG003|Overall Study|Withdrawal by Subject|6|||
125874490|NCT03284710|452835273|FG000|Overall Study|Lost to Follow-up|3|||
125874491|NCT03284710|452835274|FG001|Overall Study|Lost to Follow-up|3|||
125874492|NCT03284710|452835275|FG002|Overall Study|Lost to Follow-up|1|||
125874493|NCT03284710|452835276|FG003|Overall Study|Lost to Follow-up|0|||
125874494|NCT03284710|452835273|FG000|Overall Study|Physician Decision|1|||
125874495|NCT03284710|452835274|FG001|Overall Study|Physician Decision|0|||
125874496|NCT03284710|452835275|FG002|Overall Study|Physician Decision|0|||
125874497|NCT03284710|452835276|FG003|Overall Study|Physician Decision|0|||
125874498|NCT03284710|452835273|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
125874499|NCT03284710|452835274|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125874500|NCT03284710|452835275|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125874501|NCT03284710|452835276|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
125874502|NCT03284710|452835273|FG000|Overall Study|HIV Infection|0|||
125874503|NCT03284710|452835274|FG001|Overall Study|HIV Infection|2|||
125874504|NCT03284710|452835275|FG002|Overall Study|HIV Infection|2|||
125874505|NCT03284710|452835276|FG003|Overall Study|HIV Infection|1|||
125874506|NCT02412306|452835279|FG000|Overall Study|Lost to Follow-up|0|||
125874507|NCT02412306|452835280|FG001|Overall Study|Lost to Follow-up|1|||
125874508|NCT02412306|452835281|FG002|Overall Study|Lost to Follow-up|0|||
125874509|NCT02412306|452835282|FG003|Overall Study|Lost to Follow-up|0|||
125874510|NCT02412306|452835283|FG004|Overall Study|Lost to Follow-up|0|||
125874511|NCT02412306|452835279|FG000|Overall Study|Withdrawal by Subject|0|||
125874512|NCT02412306|452835280|FG001|Overall Study|Withdrawal by Subject|0|||
125874513|NCT02412306|452835281|FG002|Overall Study|Withdrawal by Subject|1|||
125874514|NCT02412306|452835282|FG003|Overall Study|Withdrawal by Subject|0|||
125874515|NCT02412306|452835283|FG004|Overall Study|Withdrawal by Subject|0|||
125874516|NCT02412306|452835279|FG000|Overall Study|Death|5|||
125874517|NCT02412306|452835280|FG001|Overall Study|Death|7|||
125874518|NCT02412306|452835281|FG002|Overall Study|Death|15|||
125874519|NCT02412306|452835282|FG003|Overall Study|Death|0|||
125874520|NCT02412306|452835283|FG004|Overall Study|Death|2|||
125874521|NCT01706458|452835287|FG000|Overall Study|Physician Decision|3|||
125874522|NCT01706458|452835288|FG001|Overall Study|Physician Decision|4|||
125874523|NCT04349891|452835294|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
125874524|NCT04349891|452835295|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
125874525|NCT04349891|452835294|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
125874526|NCT04349891|452835295|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
125874527|NCT04349891|452835294|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
125874528|NCT04349891|452835295|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
125874529|NCT04349891|452835294|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
125874530|NCT04349891|452835295|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
125874531|NCT02927301|452835298|FG000|Overall Study|Death|39|||
125874532|NCT02927301|452835298|FG000|Overall Study|Lost to Follow-up|8|||
125874533|NCT02927301|452835298|FG000|Overall Study|Physician Decision|2|||
125874534|NCT02927301|452835298|FG000|Overall Study|Withdrawal by Subject|12|||
125874535|NCT02927301|452835298|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
125874536|NCT04247347|452835303|FG000|Overall Study|Withdrawal by Subject|2|||
125874537|NCT04247347|452835304|FG001|Overall Study|Withdrawal by Subject|3|||
125874538|NCT04247347|452835305|FG002|Overall Study|Withdrawal by Subject|3|||
125874539|NCT04247347|452835303|FG000|Overall Study|Lost to Follow-up|1|||
125874540|NCT04247347|452835304|FG001|Overall Study|Lost to Follow-up|1|||
125874541|NCT04247347|452835305|FG002|Overall Study|Lost to Follow-up|1|||
125874542|NCT03562195|452835306|FG000|Overall Study|Adverse Event|0|||
125874543|NCT03562195|452835307|FG001|Overall Study|Adverse Event|6|||
125874544|NCT03562195|452835306|FG000|Overall Study|Lack of Efficacy|0|||
125874545|NCT03562195|452835307|FG001|Overall Study|Lack of Efficacy|5|||
125874546|NCT03562195|452835306|FG000|Overall Study|Protocol Violation|0|||
125874547|NCT03562195|452835307|FG001|Overall Study|Protocol Violation|1|||
125874548|NCT03562195|452835306|FG000|Overall Study|Lost to Follow-up|0|||
125874549|NCT03562195|452835307|FG001|Overall Study|Lost to Follow-up|1|||
125874550|NCT03562195|452835306|FG000|Overall Study|Physician Decision|1|||
125874551|NCT03562195|452835307|FG001|Overall Study|Physician Decision|0|||
125874552|NCT03562195|452835306|FG000|Overall Study|Withdrawal by Subject|3|||
125874553|NCT03562195|452835307|FG001|Overall Study|Withdrawal by Subject|0|||
125874554|NCT02529852|452835308|FG000|Overall Study|Withdrawal by Subject|2|||
125874555|NCT02269124|452835310|FG000|Overall Study|Lost to Follow-up|1|||
125874556|NCT02269124|452835311|FG001|Overall Study|Lost to Follow-up|0|||
125874557|NCT02269124|452835310|FG000|Overall Study|Withdrawal by Subject|0|||
125874558|NCT02269124|452835311|FG001|Overall Study|Withdrawal by Subject|2|||
125874559|NCT00097500|452835313|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
125874560|NCT00097500|452835314|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
125874561|NCT00097500|452835313|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
125874562|NCT00097500|452835314|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
125874563|NCT00097500|452835313|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
125874564|NCT00097500|452835314|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
125874565|NCT00097500|452835313|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125874566|NCT00097500|452835314|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
125874567|NCT00097500|452835313|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
125874568|NCT00097500|452835314|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
125874569|NCT00097500|452835313|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
125874570|NCT00097500|452835314|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
125874571|NCT00097500|452835313|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
125874572|NCT00097500|452835314|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
125874573|NCT01600885|452835315|FG000|First Period|Adverse Event|1|||
125874574|NCT01600885|452835316|FG001|First Period|Adverse Event|1|||
125874575|NCT01600885|452835315|FG000|First Period|moved out of area|1|||
125874576|NCT01600885|452835316|FG001|First Period|moved out of area|0|||
125874577|NCT00436332|452835317|FG000|Overall Study|Adverse Event|9|||
125874578|NCT00436332|452835317|FG000|Overall Study|Withdrawal by Subject|2|||
125874579|NCT00436332|452835317|FG000|Overall Study|Progression|59|||
125874580|NCT00436332|452835317|FG000|Overall Study|Death|2|||
125874581|NCT00436332|452835317|FG000|Overall Study|Not Protocol Specified|6|||
125874582|NCT00436332|452835317|FG000|Overall Study|Ineligible|2|||
125874583|NCT00436332|452835317|FG000|Overall Study|Never Received Treatment|3|||
125874584|NCT00472108|452835318|FG000|Overall Study|Lost to Follow-up|0|||
125874585|NCT00472108|452835319|FG001|Overall Study|Lost to Follow-up|1|||
125874586|NCT00642356|452835326|FG000|Overall Study|Adverse Event|1|||
125874587|NCT00642356|452835327|FG001|Overall Study|Adverse Event|0|||
125874588|NCT00642356|452835326|FG000|Overall Study|Protocol Violation|0|||
125874589|NCT00642356|452835327|FG001|Overall Study|Protocol Violation|3|||
125874590|NCT00642356|452835326|FG000|Overall Study|Lack of Efficacy|1|||
125874591|NCT00642356|452835327|FG001|Overall Study|Lack of Efficacy|0|||
125874592|NCT01009060|452835328|FG000|Overall Study|Adverse Event|1|||
125874593|NCT01009060|452835329|FG001|Overall Study|Adverse Event|2|||
125874594|NCT01009060|452835328|FG000|Overall Study|Protocol Violation|0|||
125874595|NCT01009060|452835329|FG001|Overall Study|Protocol Violation|1|||
125874596|NCT01009060|452835328|FG000|Overall Study|Lost to Follow-up|1|||
125874597|NCT01009060|452835329|FG001|Overall Study|Lost to Follow-up|0|||
125874598|NCT01009060|452835328|FG000|Overall Study|Physician Decision|1|||
125874599|NCT01009060|452835329|FG001|Overall Study|Physician Decision|1|||
125874600|NCT01009060|452835328|FG000|Overall Study|Withdrawal by Subject|1|||
125874601|NCT01009060|452835329|FG001|Overall Study|Withdrawal by Subject|1|||
125874602|NCT00005906|452835330|FG000|Overall Study|Lack of Efficacy|3|||
125874603|NCT00286442|452835335|FG000|Overall Study|Hyperglycemic Rescue|19|||
125874604|NCT00286442|452835336|FG001|Overall Study|Hyperglycemic Rescue|17|||
125874605|NCT00286442|452835337|FG002|Overall Study|Hyperglycemic Rescue|25|||
125874606|NCT00286442|452835335|FG000|Overall Study|Adverse Event|7|||
125874607|NCT00286442|452835336|FG001|Overall Study|Adverse Event|6|||
125874608|NCT00286442|452835337|FG002|Overall Study|Adverse Event|1|||
125874609|NCT00286442|452835335|FG000|Overall Study|Protocol Violation|2|||
125874610|NCT00286442|452835336|FG001|Overall Study|Protocol Violation|4|||
125874611|NCT00286442|452835337|FG002|Overall Study|Protocol Violation|2|||
125874612|NCT00286442|452835335|FG000|Overall Study|Lost to Follow-up|5|||
125874613|NCT00286442|452835336|FG001|Overall Study|Lost to Follow-up|2|||
125874614|NCT00286442|452835337|FG002|Overall Study|Lost to Follow-up|1|||
125874615|NCT00286442|452835335|FG000|Overall Study|Physician Decision|1|||
125874616|NCT00286442|452835336|FG001|Overall Study|Physician Decision|1|||
125874617|NCT00286442|452835337|FG002|Overall Study|Physician Decision|1|||
125874618|NCT00286442|452835335|FG000|Overall Study|Administrative Error|1|||
125874619|NCT00286442|452835336|FG001|Overall Study|Administrative Error|1|||
125874620|NCT00286442|452835337|FG002|Overall Study|Administrative Error|0|||
125874621|NCT00286442|452835335|FG000|Overall Study|Withdrawal by Subject|2|||
125874622|NCT00286442|452835336|FG001|Overall Study|Withdrawal by Subject|14|||
125874623|NCT00286442|452835337|FG002|Overall Study|Withdrawal by Subject|2|||
125874624|NCT02542865|452835340|FG000|Overall Study|Identified as screen failure|1|||
125874625|NCT02542865|452835341|FG001|Overall Study|Identified as screen failure|0|||
125874626|NCT02542865|452835340|FG000|Overall Study|Withdrawal by Subject|16|||
125874627|NCT02542865|452835341|FG001|Overall Study|Withdrawal by Subject|0|||
125874628|NCT01339689|452835344|FG000|Overall Study|Adverse Event|1|||
125874629|NCT01339689|452835345|FG001|Overall Study|Adverse Event|2|||
125874630|NCT01339689|452835344|FG000|Overall Study|Lost to Follow-up|9|||
125874631|NCT01339689|452835345|FG001|Overall Study|Lost to Follow-up|3|||
125874632|NCT01339689|452835344|FG000|Overall Study|Withdrawal by Subject|3|||
125874633|NCT01339689|452835345|FG001|Overall Study|Withdrawal by Subject|0|||
125874634|NCT01339689|452835344|FG000|Overall Study|Noncompliance|1|||
125874635|NCT01339689|452835345|FG001|Overall Study|Noncompliance|0|||
125874636|NCT01339689|452835344|FG000|Overall Study|Relocated out of area|0|||
125874637|NCT01339689|452835345|FG001|Overall Study|Relocated out of area|1|||
125874638|NCT01339689|452835344|FG000|Overall Study|Other|2|||
125874639|NCT01339689|452835345|FG001|Overall Study|Other|2|||
125874640|NCT01339689|452835344|FG000|Overall Study|multiple reasons|1|||
125874641|NCT01339689|452835345|FG001|Overall Study|multiple reasons|1|||
125874642|NCT04571944|452835346|FG000|Overall Study|Death|1|||
125874643|NCT04571944|452835347|FG001|Overall Study|Death|0|||
125874644|NCT04571944|452835346|FG000|Overall Study|Withdrawal by Subject|3|||
125874645|NCT04571944|452835347|FG001|Overall Study|Withdrawal by Subject|0|||
125874646|NCT04571944|452835346|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
125874647|NCT04571944|452835347|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
125874648|NCT04913610|452835350|FG000|Randomized Participants|Did Not Receive Treatment|0|||
125874649|NCT04913610|452835351|FG001|Randomized Participants|Did Not Receive Treatment|0|||
125874650|NCT04913610|452835352|FG002|Randomized Participants|Did Not Receive Treatment|1|||
125874651|NCT04913610|452835353|FG003|Randomized Participants|Did Not Receive Treatment|1|||
125874652|NCT04913610|452835354|FG004|Randomized Participants|Did Not Receive Treatment|0|||
125874653|NCT04913610|452835350|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
125874654|NCT04913610|452835351|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125874655|NCT04913610|452835352|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125874656|NCT04913610|452835353|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125874657|NCT04913610|452835354|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
125874658|NCT02358473|452835359|FG000|Overall Study|Disease Progession|6|||
125874659|NCT02358473|452835359|FG000|Overall Study|Adverse Event|3|||
125874660|NCT02358473|452835359|FG000|Overall Study|Withdrawal by Subject|2|||
125874661|NCT02358473|452835359|FG000|Overall Study|Physician Decision|2|||
125874662|NCT04819945|452835360|FG000|Overall Study|Lost to Follow-up|1|||
125874663|NCT04949191|452835361|FG000|Overall Study|Non-compliance with Study Drug|1|||
125874664|NCT04949191|452835362|FG001|Overall Study|Non-compliance with Study Drug|0|||
125874665|NCT04949191|452835363|FG002|Overall Study|Non-compliance with Study Drug|0|||
125874666|NCT04949191|452835364|FG003|Overall Study|Non-compliance with Study Drug|0|||
125874667|NCT04949191|452835361|FG000|Overall Study|Progressive Disease|0|||
125874668|NCT04949191|452835362|FG001|Overall Study|Progressive Disease|1|||
125874669|NCT04949191|452835363|FG002|Overall Study|Progressive Disease|0|||
125874670|NCT04949191|452835364|FG003|Overall Study|Progressive Disease|0|||
125874671|NCT04949191|452835361|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125874672|NCT04949191|452835362|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
125874673|NCT04949191|452835363|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125874674|NCT04949191|452835364|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125874675|NCT04949191|452835361|FG000|Overall Study|Sponsor Terminated Study|0|||
125874676|NCT04949191|452835362|FG001|Overall Study|Sponsor Terminated Study|0|||
125874677|NCT04949191|452835363|FG002|Overall Study|Sponsor Terminated Study|1|||
125874678|NCT04949191|452835364|FG003|Overall Study|Sponsor Terminated Study|1|||
125874679|NCT02913482|452835365|FG000|Overall Study|Death|0|||
125874680|NCT02913482|452835366|FG001|Overall Study|Death|2|||
125874681|NCT02913482|452835367|FG002|Overall Study|Death|2|||
125874682|NCT02913482|452835365|FG000|Overall Study|Progressive Disease|1|||
125874683|NCT02913482|452835366|FG001|Overall Study|Progressive Disease|1|||
125874684|NCT02913482|452835367|FG002|Overall Study|Progressive Disease|1|||
125874685|NCT02913482|452835365|FG000|Overall Study|Reason not specified|0|||
125874686|NCT02913482|452835366|FG001|Overall Study|Reason not specified|0|||
125874687|NCT02913482|452835367|FG002|Overall Study|Reason not specified|1|||
125874688|NCT02913482|452835365|FG000|Overall Study|Withdrawal by Subject|0|||
125874689|NCT02913482|452835366|FG001|Overall Study|Withdrawal by Subject|1|||
125874690|NCT02913482|452835367|FG002|Overall Study|Withdrawal by Subject|1|||
125874691|NCT00918385|452835370|FG000|Monotherapy|Adverse Event|1|||
125874692|NCT00918385|452835371|FG001|Monotherapy|Adverse Event|6|||
125874693|NCT00918385|452835370|FG000|Monotherapy|Complicating illness|1|||
125874694|NCT00918385|452835371|FG001|Monotherapy|Complicating illness|0|||
125874695|NCT00918385|452835370|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
125874696|NCT00918385|452835371|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
125874697|NCT00918385|452835370|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
125874698|NCT00918385|452835371|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
125874699|NCT00918385|452835370|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
125874700|NCT00918385|452835371|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
125874701|NCT00918385|452835370|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
125874702|NCT00918385|452835371|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
125874703|NCT00317473|452835373|FG000|Overall Study|Withdrawal by Subject|2|||
125874704|NCT00317473|452835374|FG001|Overall Study|Withdrawal by Subject|1|||
125874705|NCT00317473|452835375|FG002|Overall Study|Withdrawal by Subject|2|||
125874706|NCT00317473|452835376|FG003|Overall Study|Withdrawal by Subject|1|||
125874707|NCT00317473|452835377|FG004|Overall Study|Withdrawal by Subject|3|||
125874708|NCT00317473|452835378|FG005|Overall Study|Withdrawal by Subject|1|||
125874709|NCT00317473|452835373|FG000|Overall Study|Relocation|1|||
125874710|NCT00317473|452835374|FG001|Overall Study|Relocation|0|||
125874711|NCT00317473|452835375|FG002|Overall Study|Relocation|1|||
125874712|NCT00317473|452835376|FG003|Overall Study|Relocation|1|||
125874713|NCT00317473|452835377|FG004|Overall Study|Relocation|5|||
125874714|NCT00317473|452835378|FG005|Overall Study|Relocation|2|||
125874715|NCT00317473|452835373|FG000|Overall Study|Death|1|||
126316733|NCT01143064|454450764|FG000|Overall Study|Withdrawal by Subject|7|||
126316734|NCT01143064|454450765|FG001|Overall Study|Withdrawal by Subject|5|||
125874716|NCT00317473|452835374|FG001|Overall Study|Death|0|||
125874717|NCT00317473|452835375|FG002|Overall Study|Death|0|||
125874718|NCT00317473|452835376|FG003|Overall Study|Death|0|||
125874719|NCT00317473|452835377|FG004|Overall Study|Death|0|||
125874720|NCT00317473|452835378|FG005|Overall Study|Death|0|||
125874721|NCT00317473|452835373|FG000|Overall Study|Other|0|||
125874722|NCT00317473|452835374|FG001|Overall Study|Other|2|||
125874723|NCT00317473|452835375|FG002|Overall Study|Other|0|||
125874724|NCT00317473|452835376|FG003|Overall Study|Other|0|||
125874725|NCT00317473|452835377|FG004|Overall Study|Other|0|||
125874726|NCT00317473|452835378|FG005|Overall Study|Other|0|||
125874727|NCT01323582|452835382|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
125874728|NCT01323582|452835383|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
125874729|NCT01323582|452835382|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
125874730|NCT01323582|452835383|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
125874731|NCT01323582|452835382|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
125874732|NCT01323582|452835383|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
125874733|NCT03416868|452835384|FG000|Overall Study|Withdrawal by Subject|2|||
125874734|NCT03416868|452835384|FG000|Overall Study|Lost to Follow-up|1|||
125874735|NCT00083889|452835385|FG000|Overall Study|Adverse Event|76|||
125874736|NCT00083889|452835386|FG001|Overall Study|Adverse Event|86|||
125874737|NCT00083889|452835385|FG000|Overall Study|Protocol Violation|2|||
125874738|NCT00083889|452835386|FG001|Overall Study|Protocol Violation|2|||
125874739|NCT00083889|452835385|FG000|Overall Study|Withdrawal by Subject|22|||
125874740|NCT00083889|452835386|FG001|Overall Study|Withdrawal by Subject|24|||
125874741|NCT00083889|452835385|FG000|Overall Study|Lack of Efficacy|240|||
125874742|NCT00083889|452835386|FG001|Overall Study|Lack of Efficacy|219|||
125874743|NCT00083889|452835385|FG000|Overall Study|Decision of sponsor|32|||
125874744|NCT00083889|452835386|FG001|Overall Study|Decision of sponsor|4|||
125874745|NCT00083889|452835385|FG000|Overall Study|Randomized: did not take study drug|0|||
125874746|NCT00083889|452835386|FG001|Overall Study|Randomized: did not take study drug|15|||
125874747|NCT00083889|452835385|FG000|Overall Study|Completed on marketed sunitinub|3|||
125874748|NCT00083889|452835386|FG001|Overall Study|Completed on marketed sunitinub|0|||
125874749|NCT00083889|452835385|FG000|Overall Study|Crossover to SU011248|0|||
125874750|NCT00083889|452835386|FG001|Overall Study|Crossover to SU011248|25|||
125874751|NCT02919761|452835389|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
125874752|NCT02919761|452835390|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
125874753|NCT02919761|452835391|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
125874754|NCT02919761|452835389|FG000|Part 1: Open Label|Adverse Event|1|||
125874755|NCT02919761|452835390|FG001|Part 1: Open Label|Adverse Event|0|||
125874756|NCT02919761|452835391|FG002|Part 1: Open Label|Adverse Event|0|||
125874757|NCT02919761|452835389|FG000|Part 1: Open Label|Lost to Follow-up|1|||
125874758|NCT02919761|452835390|FG001|Part 1: Open Label|Lost to Follow-up|0|||
125874759|NCT02919761|452835391|FG002|Part 1: Open Label|Lost to Follow-up|0|||
125874760|NCT02919761|452835389|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
125874761|NCT02919761|452835390|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
125874762|NCT02919761|452835391|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
125874763|NCT02919761|452835389|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
125874764|NCT02919761|452835390|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
125874765|NCT02919761|452835391|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
125874766|NCT02919761|452835389|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
125874767|NCT02919761|452835390|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
125874768|NCT02919761|452835391|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
125874769|NCT02919761|452835389|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
125874770|NCT02919761|452835390|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
125874771|NCT02919761|452835391|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
125874772|NCT02919761|452835389|FG000|Part 1: Open Label|Termination by Sponsor|1|||
125874773|NCT02919761|452835390|FG001|Part 1: Open Label|Termination by Sponsor|0|||
125874774|NCT02919761|452835391|FG002|Part 1: Open Label|Termination by Sponsor|0|||
125874775|NCT02919761|452835389|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
125874776|NCT02919761|452835390|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
125874777|NCT02919761|452835391|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
125874778|NCT02919761|452835389|FG000|Part 2: Double-blind|Adverse Event|0|||
125874779|NCT02919761|452835390|FG001|Part 2: Double-blind|Adverse Event|1|||
125874780|NCT02919761|452835391|FG002|Part 2: Double-blind|Adverse Event|0|||
125874781|NCT02919761|452835389|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
125874782|NCT02919761|452835390|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
125874783|NCT02919761|452835391|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
125874784|NCT02919761|452835389|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
125874785|NCT02919761|452835390|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
125874786|NCT02919761|452835391|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
125874787|NCT02919761|452835389|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
125874788|NCT02919761|452835390|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
125874789|NCT02919761|452835391|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
125874790|NCT02919761|452835389|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
125874791|NCT02919761|452835390|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
125874792|NCT02919761|452835391|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
125874793|NCT02919761|452835389|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
125874794|NCT02919761|452835390|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
125874795|NCT02919761|452835391|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
125874796|NCT02919761|452835389|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
125874797|NCT02919761|452835390|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
125874798|NCT02919761|452835391|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
125874799|NCT00948064|452837448|FG000|Phase I|No treatment received|1|||
125874800|NCT00948064|452837449|FG001|Phase I|No treatment received|0|||
125874801|NCT00948064|452837450|FG002|Phase I|No treatment received|0|||
125874802|NCT00948064|452837448|FG000|Phase II|Physician Decision|0|||
125874803|NCT00948064|452837449|FG001|Phase II|Physician Decision|0|||
125874804|NCT00948064|452837450|FG002|Phase II|Physician Decision|1|||
125874805|NCT00948064|452837448|FG000|Phase II|Withdrawal by Subject|0|||
125874806|NCT00948064|452837449|FG001|Phase II|Withdrawal by Subject|1|||
125874807|NCT00948064|452837450|FG002|Phase II|Withdrawal by Subject|0|||
125874808|NCT03409796|452837464|FG000|Overall Study|Adverse Event|2|||
125874809|NCT03409796|452837465|FG001|Overall Study|Adverse Event|0|||
125874810|NCT03409796|452837464|FG000|Overall Study|Other|0|||
125874811|NCT03409796|452837465|FG001|Overall Study|Other|1|||
125874812|NCT00740220|452837466|FG000|Overall Study|screen failures (non-COPD patients)|9|||
125874813|NCT01602224|452837467|FG000|Overall Study|Adverse Event|0|||
125874814|NCT01602224|452837468|FG001|Overall Study|Adverse Event|1|||
125874815|NCT01602224|452837469|FG002|Overall Study|Adverse Event|0|||
125874816|NCT01602224|452837467|FG000|Overall Study|Investigator Decison|1|||
125874817|NCT01602224|452837468|FG001|Overall Study|Investigator Decison|0|||
125874818|NCT01602224|452837469|FG002|Overall Study|Investigator Decison|0|||
125874819|NCT01602224|452837467|FG000|Overall Study|Lost to Follow-up|0|||
125874820|NCT01602224|452837468|FG001|Overall Study|Lost to Follow-up|0|||
125874821|NCT01602224|452837469|FG002|Overall Study|Lost to Follow-up|1|||
125874822|NCT01602224|452837467|FG000|Overall Study|Protocol Violation|0|||
125874823|NCT01602224|452837468|FG001|Overall Study|Protocol Violation|1|||
125874824|NCT01602224|452837469|FG002|Overall Study|Protocol Violation|0|||
125874825|NCT01602224|452837467|FG000|Overall Study|Sponsor Decision|2|||
125874826|NCT01602224|452837468|FG001|Overall Study|Sponsor Decision|3|||
125874827|NCT01602224|452837469|FG002|Overall Study|Sponsor Decision|2|||
125874828|NCT01602224|452837467|FG000|Overall Study|Withdrawal by Subject|5|||
125874829|NCT01602224|452837468|FG001|Overall Study|Withdrawal by Subject|3|||
125874830|NCT01602224|452837469|FG002|Overall Study|Withdrawal by Subject|3|||
125874831|NCT01352117|452837470|FG000|Overall Study|Death|15|||
125874832|NCT01352117|452837471|FG001|Overall Study|Death|16|||
125874833|NCT01352117|452837470|FG000|Overall Study|Withdrawal by Subject|1|||
125874834|NCT01352117|452837471|FG001|Overall Study|Withdrawal by Subject|0|||
125874835|NCT01352117|452837470|FG000|Overall Study|Lost to Follow-up|2|||
125874836|NCT01352117|452837471|FG001|Overall Study|Lost to Follow-up|7|||
125874837|NCT01352117|452837470|FG000|Overall Study|Non-adherent to study requirements|1|||
125874838|NCT01352117|452837471|FG001|Overall Study|Non-adherent to study requirements|1|||
125874839|NCT01352117|452837470|FG000|Overall Study|Did not initiate study treatment|1|||
125874840|NCT01352117|452837471|FG001|Overall Study|Did not initiate study treatment|0|||
125874841|NCT01352117|452837470|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
125874842|NCT01352117|452837471|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
125874843|NCT00633477|452837472|FG000|Overall Study|Death|1|||
125874844|NCT00633477|452837473|FG001|Overall Study|Death|0|||
125874845|NCT00633477|452837472|FG000|Overall Study|Randomized but not treated|1|||
125874846|NCT00633477|452837473|FG001|Overall Study|Randomized but not treated|0|||
125874847|NCT00770653|452837477|FG000|Overall Study|Adverse Event|13|||
125874848|NCT00770653|452837478|FG001|Overall Study|Adverse Event|5|||
125874849|NCT00770653|452837477|FG000|Overall Study|Protocol Violation|8|||
125874850|NCT00770653|452837478|FG001|Overall Study|Protocol Violation|6|||
125874851|NCT00770653|452837477|FG000|Overall Study|Withdrawal by Subject|4|||
125874852|NCT00770653|452837478|FG001|Overall Study|Withdrawal by Subject|7|||
125874853|NCT00770653|452837477|FG000|Overall Study|Lack of Compliance|1|||
125874854|NCT00770653|452837478|FG001|Overall Study|Lack of Compliance|4|||
125874855|NCT00770653|452837477|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
125874856|NCT00770653|452837478|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
125874857|NCT00770653|452837477|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
125874858|NCT00770653|452837478|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
125874859|NCT00770653|452837477|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
125874860|NCT00770653|452837478|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
125874861|NCT00770653|452837477|FG000|Overall Study|Lost to Follow-up|1|||
125874862|NCT00770653|452837478|FG001|Overall Study|Lost to Follow-up|2|||
125874863|NCT00770653|452837477|FG000|Overall Study|Physician Decision|1|||
125874864|NCT00770653|452837478|FG001|Overall Study|Physician Decision|0|||
125874865|NCT04906499|452837484|FG000|Overall Study|Lack of time|1|||
125874866|NCT00179621|452837485|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
125874867|NCT00179621|452837486|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
125874868|NCT00179621|452837487|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
125874869|NCT00179621|452837488|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
125874870|NCT00179621|452837485|FG000|Double-Blind Period|Adverse Event|2|||
125874871|NCT00179621|452837486|FG001|Double-Blind Period|Adverse Event|7|||
125874872|NCT00179621|452837487|FG002|Double-Blind Period|Adverse Event|4|||
125874873|NCT00179621|452837488|FG003|Double-Blind Period|Adverse Event|0|||
125874874|NCT00179621|452837485|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125874875|NCT00179621|452837486|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125874876|NCT00179621|452837487|FG002|Double-Blind Period|Withdrawal by Subject|3|||
125874877|NCT00179621|452837488|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125874878|NCT00179621|452837485|FG000|Double-Blind Period|Death|0|||
125874879|NCT00179621|452837486|FG001|Double-Blind Period|Death|1|||
125874880|NCT00179621|452837487|FG002|Double-Blind Period|Death|2|||
125874881|NCT00179621|452837488|FG003|Double-Blind Period|Death|0|||
125874882|NCT00179621|452837485|FG000|Double-Blind Period|Protocol Violation|1|||
125874883|NCT00179621|452837486|FG001|Double-Blind Period|Protocol Violation|0|||
125874884|NCT00179621|452837487|FG002|Double-Blind Period|Protocol Violation|0|||
125874885|NCT00179621|452837488|FG003|Double-Blind Period|Protocol Violation|0|||
125874886|NCT00179621|452837485|FG000|Double-Blind Period|Other|0|||
125874887|NCT00179621|452837486|FG001|Double-Blind Period|Other|2|||
125874888|NCT00179621|452837487|FG002|Double-Blind Period|Other|2|||
125874889|NCT00179621|452837488|FG003|Double-Blind Period|Other|0|||
125874890|NCT00179621|452837485|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
125874891|NCT00179621|452837486|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
125874892|NCT00179621|452837487|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
125874893|NCT00179621|452837488|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
125874894|NCT00179621|452837485|FG000|Open-Label Period|Adverse Event|0|||
125874895|NCT00179621|452837486|FG001|Open-Label Period|Adverse Event|6|||
125874896|NCT00179621|452837487|FG002|Open-Label Period|Adverse Event|5|||
125874897|NCT00179621|452837488|FG003|Open-Label Period|Adverse Event|6|||
125874898|NCT00179621|452837485|FG000|Open-Label Period|Withdrawal by Subject|0|||
125874899|NCT00179621|452837486|FG001|Open-Label Period|Withdrawal by Subject|2|||
125874900|NCT00179621|452837487|FG002|Open-Label Period|Withdrawal by Subject|2|||
125874901|NCT00179621|452837488|FG003|Open-Label Period|Withdrawal by Subject|2|||
125874902|NCT00179621|452837485|FG000|Open-Label Period|Death|0|||
125874903|NCT00179621|452837486|FG001|Open-Label Period|Death|0|||
125874904|NCT00179621|452837487|FG002|Open-Label Period|Death|1|||
125874905|NCT00179621|452837488|FG003|Open-Label Period|Death|2|||
125874906|NCT00179621|452837485|FG000|Open-Label Period|Other|0|||
125874907|NCT00179621|452837486|FG001|Open-Label Period|Other|1|||
125874908|NCT00179621|452837487|FG002|Open-Label Period|Other|1|||
125874909|NCT00179621|452837488|FG003|Open-Label Period|Other|2|||
125874910|NCT03525444|452837495|FG000|Overall Study|Adverse Event|0|||
125874911|NCT03525444|452837496|FG001|Overall Study|Adverse Event|1|||
125874912|NCT03525444|452837495|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125874913|NCT03525444|452837496|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
125874914|NCT03525444|452837495|FG000|Overall Study|Other|0|||
125874915|NCT03525444|452837496|FG001|Overall Study|Other|1|||
125874916|NCT00262860|452837497|FG000|Overall Study|Adverse Event|2|||
125874917|NCT02741128|452837498|FG000|Overall Study|Protocol Violation|4|||
125874918|NCT02741128|452837499|FG001|Overall Study|Protocol Violation|1|||
125874919|NCT02741128|452837498|FG000|Overall Study|Withdrawal by Subject|2|||
125874920|NCT02741128|452837499|FG001|Overall Study|Withdrawal by Subject|0|||
125874921|NCT02741128|452837498|FG000|Overall Study|Lost to Follow-up|1|||
125874922|NCT02741128|452837499|FG001|Overall Study|Lost to Follow-up|0|||
125874923|NCT02973100|452837500|FG000|Overall Study|Adverse Event|1|||
125874924|NCT02973100|452837501|FG001|Overall Study|Adverse Event|2|||
125874925|NCT02973100|452837502|FG002|Overall Study|Adverse Event|1|||
125874926|NCT02973100|452837503|FG003|Overall Study|Adverse Event|2|||
125874927|NCT02973100|452837500|FG000|Overall Study|Lost to Follow-up|3|||
125874928|NCT02973100|452837501|FG001|Overall Study|Lost to Follow-up|1|||
125874929|NCT02973100|452837502|FG002|Overall Study|Lost to Follow-up|1|||
125874930|NCT02973100|452837503|FG003|Overall Study|Lost to Follow-up|0|||
125874931|NCT02973100|452837500|FG000|Overall Study|Withdrawal by Subject|3|||
125874932|NCT02973100|452837501|FG001|Overall Study|Withdrawal by Subject|5|||
125874933|NCT02973100|452837502|FG002|Overall Study|Withdrawal by Subject|1|||
125874934|NCT02973100|452837503|FG003|Overall Study|Withdrawal by Subject|4|||
126316735|NCT01143064|454450764|FG000|Overall Study|Lost to Follow-up|17|||
126316736|NCT01143064|454450765|FG001|Overall Study|Lost to Follow-up|14|||
125874935|NCT02973100|452837500|FG000|Overall Study|Notification of change in address|0|||
125874936|NCT02973100|452837501|FG001|Overall Study|Notification of change in address|0|||
125874937|NCT02973100|452837502|FG002|Overall Study|Notification of change in address|0|||
125874938|NCT02973100|452837503|FG003|Overall Study|Notification of change in address|1|||
125874939|NCT02973100|452837500|FG000|Overall Study|Failed to attend Safety followup period|0|||
125874940|NCT02973100|452837501|FG001|Overall Study|Failed to attend Safety followup period|0|||
125874941|NCT02973100|452837502|FG002|Overall Study|Failed to attend Safety followup period|1|||
125874942|NCT02973100|452837503|FG003|Overall Study|Failed to attend Safety followup period|0|||
125874943|NCT01419769|452837504|FG000|Overall Study|Did not receive the AXIOS stent|3|||
125874944|NCT01419769|452837504|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
125874945|NCT00878501|452837505|FG000|Overall Study|Adverse Event|11|||
125874946|NCT00878501|452837506|FG001|Overall Study|Adverse Event|3|||
125874947|NCT00878501|452837507|FG002|Overall Study|Adverse Event|3|||
125874948|NCT00878501|452837505|FG000|Overall Study|Lack of Efficacy|2|||
125874949|NCT00878501|452837506|FG001|Overall Study|Lack of Efficacy|1|||
125874950|NCT00878501|452837507|FG002|Overall Study|Lack of Efficacy|0|||
125874951|NCT00878501|452837505|FG000|Overall Study|Withdrawal by Subject|2|||
125874952|NCT00878501|452837506|FG001|Overall Study|Withdrawal by Subject|1|||
125874953|NCT00878501|452837507|FG002|Overall Study|Withdrawal by Subject|2|||
125874954|NCT00878501|452837505|FG000|Overall Study|Protocol Violation|0|||
125874955|NCT00878501|452837506|FG001|Overall Study|Protocol Violation|0|||
125874956|NCT00878501|452837507|FG002|Overall Study|Protocol Violation|1|||
125874957|NCT00878501|452837505|FG000|Overall Study|Incorrect enrolment|1|||
125874958|NCT00878501|452837506|FG001|Overall Study|Incorrect enrolment|2|||
125874959|NCT00878501|452837507|FG002|Overall Study|Incorrect enrolment|0|||
125874960|NCT00878501|452837505|FG000|Overall Study|Intake of prohibited concom. medication|0|||
125874961|NCT00878501|452837506|FG001|Overall Study|Intake of prohibited concom. medication|0|||
125874962|NCT00878501|452837507|FG002|Overall Study|Intake of prohibited concom. medication|1|||
125874963|NCT00878501|452837505|FG000|Overall Study|Mis-randomisation of patient|1|||
125874964|NCT00878501|452837506|FG001|Overall Study|Mis-randomisation of patient|0|||
125874965|NCT00878501|452837507|FG002|Overall Study|Mis-randomisation of patient|0|||
125874966|NCT00878501|452837505|FG000|Overall Study|Administrative|0|||
125874967|NCT00878501|452837506|FG001|Overall Study|Administrative|0|||
125874968|NCT00878501|452837507|FG002|Overall Study|Administrative|1|||
125874969|NCT00812708|452837510|FG000|Overall Study|Device could not be implanted|2|||
125874970|NCT00812708|452837510|FG000|Overall Study|Lack of medical insurance|1|||
125874971|NCT00812708|452837510|FG000|Overall Study|Switched to another study|1|||
125874972|NCT00812708|452837510|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
125874973|NCT00812708|452837510|FG000|Overall Study|Signed consent but later withdrew|3|||
125874974|NCT01959503|452837511|FG000|Overall Study|Death|2|||
125874975|NCT01959503|452837512|FG001|Overall Study|Death|1|||
125874976|NCT01959503|452837511|FG000|Overall Study|Randomized but not treated|1|||
125874977|NCT01959503|452837512|FG001|Overall Study|Randomized but not treated|1|||
125874978|NCT01600326|452837513|FG000|Overall Study|Lost to Follow-up|1|||
125874979|NCT01600326|452837514|FG001|Overall Study|Lost to Follow-up|1|||
125874980|NCT01131507|452837515|FG000|Overall Study|Adverse Event|1|||
125874981|NCT01131507|452837515|FG000|Overall Study|Lost to Follow-up|1|||
125874982|NCT01131507|452837515|FG000|Overall Study|Withdrawal by Subject|1|||
125874983|NCT01393158|452837516|FG000|Overall Study|Adverse Event|1|||
125874984|NCT01393158|452837517|FG001|Overall Study|Adverse Event|0|||
125874985|NCT03224130|452837518|FG000|Overall Study|consent issue|0|||
125874986|NCT03224130|452837519|FG001|Overall Study|consent issue|1|||
125874987|NCT02587520|452837523|FG000|Overall Study|Protocol Violation|2|||
125874988|NCT02587520|452837524|FG001|Overall Study|Protocol Violation|0|||
125874989|NCT02587520|452837525|FG002|Overall Study|Protocol Violation|0|||
125874990|NCT02587520|452837526|FG003|Overall Study|Protocol Violation|2|||
125874991|NCT02587520|452837527|FG004|Overall Study|Protocol Violation|0|||
125874992|NCT02587520|452837528|FG005|Overall Study|Protocol Violation|1|||
125874993|NCT02587520|452837529|FG006|Overall Study|Protocol Violation|1|||
125874994|NCT02587520|452837530|FG007|Overall Study|Protocol Violation|1|||
125874995|NCT02587520|452837531|FG008|Overall Study|Protocol Violation|3|||
125874996|NCT02587520|452837532|FG009|Overall Study|Protocol Violation|3|||
125874997|NCT02587520|452837533|FG010|Overall Study|Protocol Violation|1|||
125874998|NCT02587520|452837534|FG011|Overall Study|Protocol Violation|2|||
125874999|NCT02587520|452837535|FG012|Overall Study|Protocol Violation|0|||
125875000|NCT02587520|452837536|FG013|Overall Study|Protocol Violation|0|||
125875001|NCT02587520|452837537|FG014|Overall Study|Protocol Violation|0|||
125875002|NCT02587520|452837538|FG015|Overall Study|Protocol Violation|0|||
125875003|NCT02587520|452837539|FG016|Overall Study|Protocol Violation|0|||
125875004|NCT02587520|452837540|FG017|Overall Study|Protocol Violation|0|||
125875005|NCT02587520|452837523|FG000|Overall Study|Adverse Event|0|||
125875006|NCT02587520|452837524|FG001|Overall Study|Adverse Event|0|||
125875007|NCT02587520|452837525|FG002|Overall Study|Adverse Event|0|||
126316737|NCT01143064|454450764|FG000|Overall Study|Physician Decision|0|||
126316738|NCT01143064|454450765|FG001|Overall Study|Physician Decision|4|||
126316739|NCT01199822|454450771|FG000|Overall Study|Investigator discontinued therapy|0|||
126316740|NCT01199822|454450772|FG001|Overall Study|Investigator discontinued therapy|1|||
126316741|NCT01199822|454450773|FG002|Overall Study|Investigator discontinued therapy|0|||
126316742|NCT04027075|454450774|FG000|Overall Study|Lost to Follow-up|41|||
125875008|NCT02587520|452837526|FG003|Overall Study|Adverse Event|0|||
125875009|NCT02587520|452837527|FG004|Overall Study|Adverse Event|0|||
125875010|NCT02587520|452837528|FG005|Overall Study|Adverse Event|0|||
125875011|NCT02587520|452837529|FG006|Overall Study|Adverse Event|0|||
125875012|NCT02587520|452837530|FG007|Overall Study|Adverse Event|0|||
125875013|NCT02587520|452837531|FG008|Overall Study|Adverse Event|0|||
125875014|NCT02587520|452837532|FG009|Overall Study|Adverse Event|0|||
125875015|NCT02587520|452837533|FG010|Overall Study|Adverse Event|0|||
125875016|NCT02587520|452837534|FG011|Overall Study|Adverse Event|1|||
125875017|NCT02587520|452837535|FG012|Overall Study|Adverse Event|0|||
125875018|NCT02587520|452837536|FG013|Overall Study|Adverse Event|0|||
125875019|NCT02587520|452837537|FG014|Overall Study|Adverse Event|0|||
126316743|NCT04027075|454450775|FG001|Overall Study|Lost to Follow-up|22|||
125875020|NCT02587520|452837538|FG015|Overall Study|Adverse Event|0|||
125875021|NCT02587520|452837539|FG016|Overall Study|Adverse Event|0|||
125875022|NCT02587520|452837540|FG017|Overall Study|Adverse Event|0|||
126316744|NCT02772276|454450778|FG000|Overall Study|Lost to Follow-up|0|||
125875023|NCT02587520|452837523|FG000|Overall Study|Withdrawal by Subject|0|||
125875024|NCT02587520|452837524|FG001|Overall Study|Withdrawal by Subject|0|||
125875025|NCT02587520|452837525|FG002|Overall Study|Withdrawal by Subject|1|||
125875026|NCT02587520|452837526|FG003|Overall Study|Withdrawal by Subject|1|||
125875027|NCT02587520|452837527|FG004|Overall Study|Withdrawal by Subject|0|||
125875028|NCT02587520|452837528|FG005|Overall Study|Withdrawal by Subject|1|||
125875029|NCT02587520|452837529|FG006|Overall Study|Withdrawal by Subject|1|||
125875030|NCT02587520|452837530|FG007|Overall Study|Withdrawal by Subject|0|||
125875031|NCT02587520|452837531|FG008|Overall Study|Withdrawal by Subject|0|||
125875032|NCT02587520|452837532|FG009|Overall Study|Withdrawal by Subject|0|||
125875033|NCT02587520|452837533|FG010|Overall Study|Withdrawal by Subject|0|||
125875034|NCT02587520|452837534|FG011|Overall Study|Withdrawal by Subject|0|||
125875035|NCT02587520|452837535|FG012|Overall Study|Withdrawal by Subject|0|||
125875036|NCT02587520|452837536|FG013|Overall Study|Withdrawal by Subject|1|||
125875037|NCT02587520|452837537|FG014|Overall Study|Withdrawal by Subject|0|||
125875038|NCT02587520|452837538|FG015|Overall Study|Withdrawal by Subject|0|||
125875039|NCT02587520|452837539|FG016|Overall Study|Withdrawal by Subject|0|||
125875040|NCT02587520|452837540|FG017|Overall Study|Withdrawal by Subject|0|||
125875041|NCT02587520|452837523|FG000|Overall Study|Lost to Follow-up|0|||
125875042|NCT02587520|452837524|FG001|Overall Study|Lost to Follow-up|2|||
125875043|NCT02587520|452837525|FG002|Overall Study|Lost to Follow-up|0|||
125875044|NCT02587520|452837526|FG003|Overall Study|Lost to Follow-up|2|||
125875045|NCT02587520|452837527|FG004|Overall Study|Lost to Follow-up|0|||
125875046|NCT02587520|452837528|FG005|Overall Study|Lost to Follow-up|1|||
125875047|NCT02587520|452837529|FG006|Overall Study|Lost to Follow-up|1|||
125875048|NCT02587520|452837530|FG007|Overall Study|Lost to Follow-up|1|||
125875049|NCT02587520|452837531|FG008|Overall Study|Lost to Follow-up|0|||
125875050|NCT02587520|452837532|FG009|Overall Study|Lost to Follow-up|2|||
125875051|NCT02587520|452837533|FG010|Overall Study|Lost to Follow-up|2|||
125875052|NCT02587520|452837534|FG011|Overall Study|Lost to Follow-up|1|||
125875053|NCT02587520|452837535|FG012|Overall Study|Lost to Follow-up|0|||
125875054|NCT02587520|452837536|FG013|Overall Study|Lost to Follow-up|0|||
125875055|NCT02587520|452837537|FG014|Overall Study|Lost to Follow-up|0|||
125875056|NCT02587520|452837538|FG015|Overall Study|Lost to Follow-up|0|||
125875057|NCT02587520|452837539|FG016|Overall Study|Lost to Follow-up|0|||
125875058|NCT02587520|452837540|FG017|Overall Study|Lost to Follow-up|0|||
125875059|NCT01751061|452837541|FG000|Overall Study|Death|1|||
125875060|NCT01751061|452837542|FG001|Overall Study|Death|0|||
125875061|NCT01751061|452837541|FG000|Overall Study|patient death|5|||
125875062|NCT01751061|452837542|FG001|Overall Study|patient death|0|||
125875063|NCT01751061|452837541|FG000|Overall Study|Lost to Follow-up|40|||
125875064|NCT01751061|452837542|FG001|Overall Study|Lost to Follow-up|25|||
125875065|NCT01751061|452837541|FG000|Overall Study|patient regained decisional capacity|4|||
125875066|NCT01751061|452837542|FG001|Overall Study|patient regained decisional capacity|8|||
125875067|NCT01751061|452837541|FG000|Overall Study|Withdrawal by Subject|4|||
125875068|NCT01751061|452837542|FG001|Overall Study|Withdrawal by Subject|1|||
125875069|NCT01751061|452837541|FG000|Overall Study|Physician Decision|2|||
125875070|NCT01751061|452837542|FG001|Overall Study|Physician Decision|0|||
125875071|NCT01194830|452837544|FG000|Overall Study|Adverse Event|3|||
125875072|NCT01194830|452837545|FG001|Overall Study|Adverse Event|2|||
125875073|NCT01194830|452837544|FG000|Overall Study|Protocol Violation|5|||
125875074|NCT01194830|452837545|FG001|Overall Study|Protocol Violation|4|||
125875075|NCT01194830|452837544|FG000|Overall Study|Lost to Follow-up|9|||
125875076|NCT01194830|452837545|FG001|Overall Study|Lost to Follow-up|7|||
125875077|NCT01194830|452837544|FG000|Overall Study|Withdrawal by Subject|2|||
125875078|NCT01194830|452837545|FG001|Overall Study|Withdrawal by Subject|1|||
125875079|NCT01194830|452837544|FG000|Overall Study|Lack of Efficacy|1|||
125875080|NCT01194830|452837545|FG001|Overall Study|Lack of Efficacy|1|||
125875081|NCT01194830|452837544|FG000|Overall Study|Non-compliance issues|4|||
125875082|NCT01194830|452837545|FG001|Overall Study|Non-compliance issues|4|||
125875083|NCT01194830|452837544|FG000|Overall Study|Other Reason|12|||
125875084|NCT01194830|452837545|FG001|Overall Study|Other Reason|8|||
125875085|NCT01815918|452837548|FG000|Overall Study|Patient samples not analyzable|3|||
125875086|NCT01815918|452837549|FG001|Overall Study|Patient samples not analyzable|4|||
125875087|NCT01815918|452837548|FG000|Overall Study|Lack of Efficacy|15|||
126316745|NCT02772276|454450779|FG001|Overall Study|Lost to Follow-up|0|||
125875088|NCT01815918|452837549|FG001|Overall Study|Lack of Efficacy|15|||
125875089|NCT02814916|452837552|FG000|Overall Study|Withdrawal of consent|0|||
125875090|NCT02814916|452837553|FG001|Overall Study|Withdrawal of consent|2|||
125875091|NCT02814916|452837554|FG002|Overall Study|Withdrawal of consent|0|||
125875092|NCT02814916|452837552|FG000|Overall Study|Lost to Follow-up|0|||
125875093|NCT02814916|452837553|FG001|Overall Study|Lost to Follow-up|1|||
125875094|NCT02814916|452837554|FG002|Overall Study|Lost to Follow-up|0|||
125875095|NCT02814916|452837552|FG000|Overall Study|Other, not specified|0|||
125875096|NCT02814916|452837553|FG001|Overall Study|Other, not specified|1|||
125875097|NCT02814916|452837554|FG002|Overall Study|Other, not specified|0|||
125875098|NCT04750824|452837563|FG000|Overall Study|Toxicity/intolerability|3|||
125875099|NCT04750824|452837564|FG001|Overall Study|Toxicity/intolerability|1|||
125875100|NCT04750824|452837563|FG000|Overall Study|Death|1|||
125875101|NCT04750824|452837564|FG001|Overall Study|Death|3|||
125875102|NCT04750824|452837563|FG000|Overall Study|Scheduled duration of therapy complete|1|||
125875103|NCT04750824|452837564|FG001|Overall Study|Scheduled duration of therapy complete|9|||
125875104|NCT04750824|452837563|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
125875105|NCT04750824|452837564|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
125875106|NCT03547518|452837572|FG000|Overall Study|Lost to Follow-up|2|||
125875107|NCT03547518|452837573|FG001|Overall Study|Lost to Follow-up|0|||
125875108|NCT04739982|452837576|FG000|Overall Study|Lost to Follow-up|176|||
125875109|NCT04739982|452837577|FG001|Overall Study|Lost to Follow-up|65|||
125875110|NCT04739982|452837576|FG000|Overall Study|Withdrawal by Subject|19|||
125875111|NCT04739982|452837577|FG001|Overall Study|Withdrawal by Subject|0|||
125875112|NCT04739982|452837576|FG000|Overall Study|Protocol Violation|0|||
125875113|NCT04739982|452837577|FG001|Overall Study|Protocol Violation|5|||
125875114|NCT00702702|452837578|FG000|Overall Study|Study prematurely terminated|56|||
125875115|NCT02240485|452837579|FG000|3 Months Post-admission|Lost to Follow-up|1|||
125875116|NCT02240485|452837580|FG001|3 Months Post-admission|Lost to Follow-up|5|||
125875117|NCT02240485|452837579|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
125875118|NCT02240485|452837580|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
125875119|NCT02240485|452837579|FG000|9 Months Post-admission|Lost to Follow-up|3|||
125875120|NCT02240485|452837580|FG001|9 Months Post-admission|Lost to Follow-up|1|||
125875121|NCT02240485|452837579|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
125875122|NCT02240485|452837580|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
125875123|NCT02240485|452837579|FG000|18 Months Post-admission|Lost to Follow-up|1|||
125875124|NCT02240485|452837580|FG001|18 Months Post-admission|Lost to Follow-up|1|||
125875125|NCT02240485|452837579|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
125875126|NCT02240485|452837580|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
125875127|NCT00953667|452837581|FG000|Overall Study|Lost to Follow-up|11|||
125875128|NCT00953667|452837581|FG000|Overall Study|Physician Decision|35|||
125875129|NCT00953667|452837581|FG000|Overall Study|Withdrawal by Subject|63|||
125875130|NCT00953667|452837581|FG000|Overall Study|Adverse Event|10|||
125875131|NCT00953667|452837581|FG000|Overall Study|poor venous access,unable to draw blood|4|||
125875132|NCT00475670|452837582|FG000|Overall Study|Death|0|||
125875133|NCT00475670|452837583|FG001|Overall Study|Death|1|||
125875134|NCT00475670|452837582|FG000|Overall Study|Lack of Efficacy|3|||
125875135|NCT00475670|452837583|FG001|Overall Study|Lack of Efficacy|34|||
125875136|NCT00475670|452837582|FG000|Overall Study|Refused treatment|0|||
125875137|NCT00475670|452837583|FG001|Overall Study|Refused treatment|2|||
125875138|NCT00475670|452837582|FG000|Overall Study|Failure to Return|0|||
125875139|NCT00475670|452837583|FG001|Overall Study|Failure to Return|1|||
125875140|NCT00475670|452837582|FG000|Overall Study|Other|0|||
125875141|NCT00475670|452837583|FG001|Overall Study|Other|3|||
125875142|NCT00918281|452837586|FG000|Overall Study|Physician Decision|29|||
125875143|NCT00388349|452837587|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
125875144|NCT00388349|452837588|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
125875145|NCT00112736|452837589|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
125875146|NCT00112736|452837590|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
125875147|NCT05435339|452837591|FG000|Overall Study|Death|1|||
125875148|NCT05435339|452837592|FG001|Overall Study|Death|0|||
125875149|NCT05435339|452837593|FG002|Overall Study|Death|3|||
125875150|NCT05435339|452837594|FG003|Overall Study|Death|1|||
125875151|NCT05435339|452837595|FG004|Overall Study|Death|3|||
125875152|NCT05435339|452837596|FG005|Overall Study|Death|2|||
125875153|NCT05435339|452837597|FG006|Overall Study|Death|4|||
125875154|NCT05435339|452837598|FG007|Overall Study|Death|6|||
125875155|NCT05435339|452837591|FG000|Overall Study|Sponsor Decision|0|||
125875156|NCT05435339|452837592|FG001|Overall Study|Sponsor Decision|1|||
125875157|NCT05435339|452837593|FG002|Overall Study|Sponsor Decision|0|||
125875158|NCT05435339|452837594|FG003|Overall Study|Sponsor Decision|0|||
125875159|NCT05435339|452837595|FG004|Overall Study|Sponsor Decision|2|||
125875160|NCT05435339|452837596|FG005|Overall Study|Sponsor Decision|1|||
125875161|NCT05435339|452837597|FG006|Overall Study|Sponsor Decision|2|||
125875162|NCT05435339|452837598|FG007|Overall Study|Sponsor Decision|2|||
125875163|NCT05435339|452837591|FG000|Overall Study|Withdrawal by Subject|0|||
125875164|NCT05435339|452837592|FG001|Overall Study|Withdrawal by Subject|0|||
125875165|NCT05435339|452837593|FG002|Overall Study|Withdrawal by Subject|0|||
125875166|NCT05435339|452837594|FG003|Overall Study|Withdrawal by Subject|0|||
125875167|NCT05435339|452837595|FG004|Overall Study|Withdrawal by Subject|1|||
125875168|NCT05435339|452837596|FG005|Overall Study|Withdrawal by Subject|0|||
125875169|NCT05435339|452837597|FG006|Overall Study|Withdrawal by Subject|1|||
125875170|NCT05435339|452837598|FG007|Overall Study|Withdrawal by Subject|1|||
125875171|NCT00537394|452837602|FG000|First Year of Follow-up|Death|7|||
125875172|NCT00537394|452837603|FG001|First Year of Follow-up|Death|0|||
125875173|NCT00537394|452837604|FG002|First Year of Follow-up|Death|0|||
125875174|NCT00537394|452837602|FG000|First Year of Follow-up|Severe debilitation|1|||
125875175|NCT00537394|452837603|FG001|First Year of Follow-up|Severe debilitation|0|||
125875176|NCT00537394|452837604|FG002|First Year of Follow-up|Severe debilitation|1|||
125875177|NCT00537394|452837602|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
125875178|NCT00537394|452837603|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
125875179|NCT00537394|452837604|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
125875180|NCT00537394|452837602|FG000|First Year of Follow-up|Lost to Follow-up|1|||
125875181|NCT00537394|452837603|FG001|First Year of Follow-up|Lost to Follow-up|5|||
125875182|NCT00537394|452837604|FG002|First Year of Follow-up|Lost to Follow-up|1|||
125875183|NCT00537394|452837602|FG000|2nd Year of Follow-up|Death|4|||
125875184|NCT00537394|452837603|FG001|2nd Year of Follow-up|Death|1|||
125875185|NCT00537394|452837604|FG002|2nd Year of Follow-up|Death|2|||
125875186|NCT00537394|452837602|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
125875187|NCT00537394|452837603|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
125875188|NCT00537394|452837604|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
125875189|NCT00537394|452837602|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
125875190|NCT00537394|452837603|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
125875191|NCT00537394|452837604|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
125875192|NCT00537394|452837602|FG000|2nd Year of Follow-up|Clinic site closure|1|||
125875193|NCT00537394|452837603|FG001|2nd Year of Follow-up|Clinic site closure|0|||
125875194|NCT00537394|452837604|FG002|2nd Year of Follow-up|Clinic site closure|0|||
125875195|NCT03473236|452837609|FG000|Overall Study|Withdrawal by Subject|0|||
125875196|NCT03473236|452837610|FG001|Overall Study|Withdrawal by Subject|0|||
125875197|NCT03473236|452837611|FG002|Overall Study|Withdrawal by Subject|0|||
125875198|NCT03473236|452837612|FG003|Overall Study|Withdrawal by Subject|0|||
125875199|NCT03473236|452837613|FG004|Overall Study|Withdrawal by Subject|0|||
125875200|NCT03473236|452837614|FG005|Overall Study|Withdrawal by Subject|1|||
125875201|NCT03473236|452837615|FG006|Overall Study|Withdrawal by Subject|0|||
125875202|NCT03473236|452837616|FG007|Overall Study|Withdrawal by Subject|0|||
125875203|NCT03473236|452837617|FG008|Overall Study|Withdrawal by Subject|1|||
125875204|NCT03473236|452837618|FG009|Overall Study|Withdrawal by Subject|0|||
125875205|NCT00685165|452837619|FG000|Washout Period of 14 Days|Adverse Event|1|||
125875206|NCT00685165|452837620|FG001|Washout Period of 14 Days|Adverse Event|0|||
125875207|NCT00849940|452837621|FG000|Overall Study|Physician Decision|4|||
126316746|NCT02772276|454450780|FG002|Overall Study|Lost to Follow-up|0|||
125875208|NCT05135871|452837622|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
125875209|NCT05135871|452837623|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125875210|NCT05135871|452837624|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125875211|NCT05135871|452837625|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125875212|NCT04886154|452837631|FG000|Overall Study|Adverse Event|0|||
125875213|NCT04886154|452837632|FG001|Overall Study|Adverse Event|0|||
125875214|NCT04886154|452837633|FG002|Overall Study|Adverse Event|0|||
125875215|NCT04886154|452837634|FG003|Overall Study|Adverse Event|0|||
125875216|NCT04886154|452837635|FG004|Overall Study|Adverse Event|1|||
125875217|NCT04886154|452837636|FG005|Overall Study|Adverse Event|0|||
125875218|NCT04886154|452837637|FG006|Overall Study|Adverse Event|0|||
125875219|NCT04886154|452837638|FG007|Overall Study|Adverse Event|1|||
125875220|NCT04886154|452837639|FG008|Overall Study|Adverse Event|1|||
125875221|NCT04886154|452837640|FG009|Overall Study|Adverse Event|0|||
125875222|NCT04886154|452837641|FG010|Overall Study|Adverse Event|0|||
125875223|NCT04886154|452837642|FG011|Overall Study|Adverse Event|1|||
125875224|NCT04886154|452837643|FG012|Overall Study|Adverse Event|0|||
125875225|NCT04886154|452837644|FG013|Overall Study|Adverse Event|0|||
125875226|NCT04886154|452837645|FG014|Overall Study|Adverse Event|3|||
125875227|NCT04886154|452837631|FG000|Overall Study|Lost to Follow-up|1|||
125875228|NCT04886154|452837632|FG001|Overall Study|Lost to Follow-up|0|||
125875229|NCT04886154|452837633|FG002|Overall Study|Lost to Follow-up|2|||
125875230|NCT04886154|452837634|FG003|Overall Study|Lost to Follow-up|0|||
125875231|NCT04886154|452837635|FG004|Overall Study|Lost to Follow-up|17|||
125875232|NCT04886154|452837636|FG005|Overall Study|Lost to Follow-up|7|||
125875233|NCT04886154|452837637|FG006|Overall Study|Lost to Follow-up|8|||
125875234|NCT04886154|452837638|FG007|Overall Study|Lost to Follow-up|7|||
125875235|NCT04886154|452837639|FG008|Overall Study|Lost to Follow-up|8|||
125875236|NCT04886154|452837640|FG009|Overall Study|Lost to Follow-up|0|||
125875237|NCT04886154|452837641|FG010|Overall Study|Lost to Follow-up|2|||
125875238|NCT04886154|452837642|FG011|Overall Study|Lost to Follow-up|0|||
125875239|NCT04886154|452837643|FG012|Overall Study|Lost to Follow-up|0|||
125875240|NCT04886154|452837644|FG013|Overall Study|Lost to Follow-up|0|||
125875241|NCT04886154|452837645|FG014|Overall Study|Lost to Follow-up|0|||
125875242|NCT04886154|452837631|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875243|NCT04886154|452837632|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875244|NCT04886154|452837633|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875245|NCT04886154|452837634|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875246|NCT04886154|452837635|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875247|NCT04886154|452837636|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875248|NCT04886154|452837637|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
126090452|NCT01840410|453623573|FG001|Overall Study|Pregnancy|0|||
125875249|NCT04886154|452837638|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875250|NCT04886154|452837639|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875251|NCT04886154|452837640|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875252|NCT04886154|452837641|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875253|NCT04886154|452837642|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875254|NCT04886154|452837643|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875255|NCT04886154|452837644|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875256|NCT04886154|452837645|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125875257|NCT04886154|452837631|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875258|NCT04886154|452837632|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875259|NCT04886154|452837633|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875260|NCT04886154|452837634|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875261|NCT04886154|452837635|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125875262|NCT04886154|452837636|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875263|NCT04886154|452837637|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125875264|NCT04886154|452837638|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125875265|NCT04886154|452837639|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875266|NCT04886154|452837640|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875267|NCT04886154|452837641|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875268|NCT04886154|452837642|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875269|NCT04886154|452837643|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875270|NCT04886154|452837644|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125875271|NCT04886154|452837645|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125875272|NCT04886154|452837631|FG000|Overall Study|Other, Not Specified|0|||
125875273|NCT04886154|452837632|FG001|Overall Study|Other, Not Specified|0|||
125875274|NCT04886154|452837633|FG002|Overall Study|Other, Not Specified|0|||
125875275|NCT04886154|452837634|FG003|Overall Study|Other, Not Specified|0|||
125875276|NCT04886154|452837635|FG004|Overall Study|Other, Not Specified|11|||
125875277|NCT04886154|452837636|FG005|Overall Study|Other, Not Specified|8|||
125875278|NCT04886154|452837637|FG006|Overall Study|Other, Not Specified|9|||
125875279|NCT04886154|452837638|FG007|Overall Study|Other, Not Specified|10|||
125875280|NCT04886154|452837639|FG008|Overall Study|Other, Not Specified|6|||
125875281|NCT04886154|452837640|FG009|Overall Study|Other, Not Specified|1|||
125875282|NCT04886154|452837641|FG010|Overall Study|Other, Not Specified|1|||
125875283|NCT04886154|452837642|FG011|Overall Study|Other, Not Specified|2|||
125875284|NCT04886154|452837643|FG012|Overall Study|Other, Not Specified|1|||
125875285|NCT04886154|452837644|FG013|Overall Study|Other, Not Specified|2|||
125875286|NCT04886154|452837645|FG014|Overall Study|Other, Not Specified|3|||
125875287|NCT01400698|452837647|FG000|Overall Study|Lost to Follow-up|2|||
125875288|NCT01400698|452837648|FG001|Overall Study|Lost to Follow-up|5|||
125875289|NCT01400698|452837649|FG002|Overall Study|Lost to Follow-up|2|||
125875290|NCT01400698|452837650|FG003|Overall Study|Lost to Follow-up|1|||
125875291|NCT01400698|452837651|FG004|Overall Study|Lost to Follow-up|4|||
125875292|NCT01400698|452837652|FG005|Overall Study|Lost to Follow-up|3|||
125875293|NCT01400698|452837647|FG000|Overall Study|Withdrawal by Subject|8|||
125875294|NCT01400698|452837648|FG001|Overall Study|Withdrawal by Subject|2|||
125875295|NCT01400698|452837649|FG002|Overall Study|Withdrawal by Subject|0|||
125875296|NCT01400698|452837650|FG003|Overall Study|Withdrawal by Subject|4|||
125875297|NCT01400698|452837651|FG004|Overall Study|Withdrawal by Subject|1|||
125875298|NCT01400698|452837652|FG005|Overall Study|Withdrawal by Subject|3|||
125875299|NCT01400698|452837647|FG000|Overall Study|Protocol Violation|0|||
125875300|NCT01400698|452837648|FG001|Overall Study|Protocol Violation|1|||
125875301|NCT01400698|452837649|FG002|Overall Study|Protocol Violation|0|||
125875302|NCT01400698|452837650|FG003|Overall Study|Protocol Violation|0|||
125875303|NCT01400698|452837651|FG004|Overall Study|Protocol Violation|1|||
125875304|NCT01400698|452837652|FG005|Overall Study|Protocol Violation|0|||
125875305|NCT01400698|452837647|FG000|Overall Study|Non-compliance|0|||
125875306|NCT01400698|452837648|FG001|Overall Study|Non-compliance|1|||
125875307|NCT01400698|452837649|FG002|Overall Study|Non-compliance|0|||
125875308|NCT01400698|452837650|FG003|Overall Study|Non-compliance|1|||
125875309|NCT01400698|452837651|FG004|Overall Study|Non-compliance|0|||
125875310|NCT01400698|452837652|FG005|Overall Study|Non-compliance|0|||
125875311|NCT01400698|452837647|FG000|Overall Study|Adverse Event|1|||
125875312|NCT01400698|452837648|FG001|Overall Study|Adverse Event|0|||
125875313|NCT01400698|452837649|FG002|Overall Study|Adverse Event|0|||
125875314|NCT01400698|452837650|FG003|Overall Study|Adverse Event|0|||
125875315|NCT01400698|452837651|FG004|Overall Study|Adverse Event|0|||
125875316|NCT01400698|452837652|FG005|Overall Study|Adverse Event|0|||
125875317|NCT01400698|452837647|FG000|Overall Study|Other|4|||
125875318|NCT01400698|452837648|FG001|Overall Study|Other|2|||
125875319|NCT01400698|452837649|FG002|Overall Study|Other|0|||
125875320|NCT01400698|452837650|FG003|Overall Study|Other|2|||
126316747|NCT02772276|454450781|FG003|Overall Study|Lost to Follow-up|0|||
125875321|NCT01400698|452837651|FG004|Overall Study|Other|1|||
125875322|NCT01400698|452837652|FG005|Overall Study|Other|0|||
125875323|NCT02891174|452839318|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
125875324|NCT02891174|452839319|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
125875325|NCT02891174|452839318|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
125875326|NCT02891174|452839319|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
125875327|NCT02891174|452839318|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
125875328|NCT02891174|452839319|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
125875329|NCT02891174|452839318|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
125875330|NCT02891174|452839319|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
125875331|NCT02891174|452839318|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
125875332|NCT02891174|452839319|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
125875333|NCT02891174|452839318|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
125875334|NCT02891174|452839319|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
125875335|NCT02891174|452839318|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
125875336|NCT02891174|452839319|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
125875337|NCT04124939|452839320|FG000|Overall Study|Lost to Follow-up|1|||
125875338|NCT04124939|452839321|FG001|Overall Study|Lost to Follow-up|3|||
125875339|NCT04235140|452839322|FG000|Overall Study|Adverse Event|2|||
125875340|NCT04235140|452839322|FG000|Overall Study|Lost to Follow-up|1|||
125875341|NCT04235140|452839322|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
125875342|NCT04235140|452839322|FG000|Overall Study|Commercial drug is available for participants|7|||
125875343|NCT04516746|452839326|FG000|Overall Study|Randomized but not Treated|51|||
125875344|NCT04516746|452839327|FG001|Overall Study|Randomized but not Treated|19|||
125875345|NCT04516746|452839326|FG000|Overall Study|Adverse Event|0|||
125875346|NCT04516746|452839327|FG001|Overall Study|Adverse Event|1|||
125875347|NCT04516746|452839326|FG000|Overall Study|Death|62|||
125875348|NCT04516746|452839327|FG001|Overall Study|Death|32|||
125875349|NCT04516746|452839326|FG000|Overall Study|Lost to Follow-up|3431|||
125875350|NCT04516746|452839327|FG001|Overall Study|Lost to Follow-up|1831|||
125875351|NCT04516746|452839326|FG000|Overall Study|Withdrawal by Subject|1946|||
125875352|NCT04516746|452839327|FG001|Overall Study|Withdrawal by Subject|1696|||
125875353|NCT04516746|452839326|FG000|Overall Study|Physician Decision|10|||
125875354|NCT04516746|452839327|FG001|Overall Study|Physician Decision|8|||
125875355|NCT04516746|452839326|FG000|Overall Study|Other|35|||
125875356|NCT04516746|452839327|FG001|Overall Study|Other|16|||
125875357|NCT03115359|452839330|FG000|Overall Study|Withdrawal by Subject|29|||
125875358|NCT03115359|452839331|FG001|Overall Study|Withdrawal by Subject|39|||
125875359|NCT03115359|452839330|FG000|Overall Study|Scheduling conflict|25|||
125875360|NCT03115359|452839331|FG001|Overall Study|Scheduling conflict|23|||
125875361|NCT03115359|452839330|FG000|Overall Study|Personal reasons including health|12|||
125875362|NCT03115359|452839331|FG001|Overall Study|Personal reasons including health|9|||
125875363|NCT03115359|452839330|FG000|Overall Study|Transportation barriers|3|||
125875364|NCT03115359|452839331|FG001|Overall Study|Transportation barriers|0|||
125875365|NCT03115359|452839330|FG000|Overall Study|No longer interested|5|||
125875366|NCT03115359|452839331|FG001|Overall Study|No longer interested|4|||
125875367|NCT03115359|452839330|FG000|Overall Study|No reason provided|45|||
125875368|NCT03115359|452839331|FG001|Overall Study|No reason provided|47|||
125875369|NCT05543265|452839337|FG000|Overall Study|Lost to Follow-up|3|||
125875370|NCT05543265|452839338|FG001|Overall Study|Lost to Follow-up|3|||
125875371|NCT05543265|452839337|FG000|Overall Study|Withdrawal by Subject|0|||
125875372|NCT05543265|452839338|FG001|Overall Study|Withdrawal by Subject|1|||
125875373|NCT05316597|452839339|FG000|First Session|Withdrawal by Subject|0|||
125875374|NCT05316597|452839340|FG001|First Session|Withdrawal by Subject|1|||
125875375|NCT05316597|452839339|FG000|Washout Period|Lost to Follow-up|1|||
125875376|NCT05316597|452839340|FG001|Washout Period|Lost to Follow-up|2|||
125875377|NCT05316597|452839339|FG000|Washout Period|Physician Decision|1|||
125875378|NCT05316597|452839340|FG001|Washout Period|Physician Decision|1|||
125875379|NCT05316597|452839339|FG000|Washout Period|Excluded before second session|1|||
125875380|NCT05316597|452839340|FG001|Washout Period|Excluded before second session|1|||
125875381|NCT05316597|452839339|FG000|Washout Period|Withdrawal by Subject|0|||
125875382|NCT05316597|452839340|FG001|Washout Period|Withdrawal by Subject|4|||
125875383|NCT05526716|452839341|FG000|Overall Study|Death|1|||
125875384|NCT05526716|452839342|FG001|Overall Study|Death|2|||
125875385|NCT05526716|452839341|FG000|Overall Study|Lost to Follow-up|17|||
125875386|NCT05526716|452839342|FG001|Overall Study|Lost to Follow-up|15|||
125875387|NCT05526716|452839341|FG000|Overall Study|Physician Decision|0|||
125875388|NCT05526716|452839342|FG001|Overall Study|Physician Decision|1|||
125875389|NCT05526716|452839341|FG000|Overall Study|Randomized by mistake without study treatment|0|||
125875390|NCT05526716|452839342|FG001|Overall Study|Randomized by mistake without study treatment|1|||
125875391|NCT05526716|452839341|FG000|Overall Study|Withdrawal by Subject|12|||
125875392|NCT05526716|452839342|FG001|Overall Study|Withdrawal by Subject|12|||
125875393|NCT05526716|452839341|FG000|Overall Study|Not reported|0|||
125875394|NCT05526716|452839342|FG001|Overall Study|Not reported|2|||
125875395|NCT02384551|452839344|FG000|Overall Study|Lost to Follow-up|13|||
125875396|NCT02384551|452839345|FG001|Overall Study|Lost to Follow-up|14|||
125875397|NCT02384551|452839346|FG002|Overall Study|Lost to Follow-up|14|||
125875398|NCT02384551|452839347|FG003|Overall Study|Lost to Follow-up|14|||
125875399|NCT04742556|452839348|FG000|Overall Study|Withdrawal by Subject|0|||
125875400|NCT04742556|452839349|FG001|Overall Study|Withdrawal by Subject|1|||
125875401|NCT04742556|452839350|FG002|Overall Study|Withdrawal by Subject|0|||
125875402|NCT04742556|452839348|FG000|Overall Study|Adverse Event|0|||
125875403|NCT04742556|452839349|FG001|Overall Study|Adverse Event|0|||
125875404|NCT04742556|452839350|FG002|Overall Study|Adverse Event|2|||
125875405|NCT04742556|452839348|FG000|Overall Study|Clinical disease progression|0|||
125875406|NCT04742556|452839349|FG001|Overall Study|Clinical disease progression|1|||
125875407|NCT04742556|452839350|FG002|Overall Study|Clinical disease progression|2|||
125875408|NCT04742556|452839348|FG000|Overall Study|Objective disease progression|3|||
125875409|NCT04742556|452839349|FG001|Overall Study|Objective disease progression|2|||
125875410|NCT04742556|452839350|FG002|Overall Study|Objective disease progression|4|||
125875411|NCT03035032|452839353|FG000|Overall Study|Adverse Event|2|||
125875412|NCT03035032|452839353|FG000|Overall Study|Death|9|||
125875413|NCT03035032|452839353|FG000|Overall Study|Lost to Follow-up|1|||
125875414|NCT03035032|452839353|FG000|Overall Study|Progressive Disease|22|||
125875415|NCT03035032|452839353|FG000|Overall Study|Protocol Violation|2|||
125875416|NCT03035032|452839353|FG000|Overall Study|Withdrawal by Subject|2|||
125875417|NCT03035032|452839353|FG000|Overall Study|Physician Decision|5|||
125875418|NCT02201524|452839356|FG000|Overall Study|Adverse Event|0|||
125875419|NCT02201524|452839357|FG001|Overall Study|Adverse Event|2|||
125875420|NCT02201524|452839358|FG002|Overall Study|Adverse Event|1|||
125875421|NCT02201524|452839359|FG003|Overall Study|Adverse Event|0|||
125875422|NCT02201524|452839356|FG000|Overall Study|Insufficient clinical response|1|||
125875423|NCT02201524|452839357|FG001|Overall Study|Insufficient clinical response|0|||
125875424|NCT02201524|452839358|FG002|Overall Study|Insufficient clinical response|0|||
125875425|NCT02201524|452839359|FG003|Overall Study|Insufficient clinical response|0|||
125875426|NCT02201524|452839356|FG000|Overall Study|Lost to Follow-up|0|||
125875427|NCT02201524|452839357|FG001|Overall Study|Lost to Follow-up|0|||
125875428|NCT02201524|452839358|FG002|Overall Study|Lost to Follow-up|2|||
125875429|NCT02201524|452839359|FG003|Overall Study|Lost to Follow-up|0|||
125875430|NCT02201524|452839356|FG000|Overall Study|No longer meets eligibility criteria|0|||
125875431|NCT02201524|452839357|FG001|Overall Study|No longer meets eligibility criteria|0|||
125875432|NCT02201524|452839358|FG002|Overall Study|No longer meets eligibility criteria|0|||
125875433|NCT02201524|452839359|FG003|Overall Study|No longer meets eligibility criteria|2|||
125875434|NCT02201524|452839356|FG000|Overall Study|Protocol Violation|0|||
125875435|NCT02201524|452839357|FG001|Overall Study|Protocol Violation|0|||
125875436|NCT02201524|452839358|FG002|Overall Study|Protocol Violation|0|||
125875437|NCT02201524|452839359|FG003|Overall Study|Protocol Violation|1|||
125875438|NCT02201524|452839356|FG000|Overall Study|Withdrawal by Subject|0|||
125875439|NCT02201524|452839357|FG001|Overall Study|Withdrawal by Subject|0|||
125875440|NCT02201524|452839358|FG002|Overall Study|Withdrawal by Subject|1|||
125875441|NCT02201524|452839359|FG003|Overall Study|Withdrawal by Subject|1|||
125875442|NCT02201524|452839356|FG000|Overall Study|Other|1|||
125875443|NCT02201524|452839357|FG001|Overall Study|Other|1|||
125875444|NCT02201524|452839358|FG002|Overall Study|Other|0|||
125875445|NCT02201524|452839359|FG003|Overall Study|Other|0|||
125875446|NCT02914639|452839362|FG000|Overall Study|Withdrawal by Subject|0|||
125875447|NCT02914639|452839363|FG001|Overall Study|Withdrawal by Subject|2|||
125875448|NCT01018030|452839364|FG000|Overall Study|Adverse Event|10|||
125875449|NCT01018030|452839365|FG001|Overall Study|Adverse Event|5|||
125875450|NCT01018030|452839366|FG002|Overall Study|Adverse Event|5|||
125875451|NCT01018030|452839364|FG000|Overall Study|Withdrawal by Subject|2|||
125875452|NCT01018030|452839365|FG001|Overall Study|Withdrawal by Subject|2|||
125875453|NCT01018030|452839366|FG002|Overall Study|Withdrawal by Subject|4|||
125875454|NCT01018030|452839364|FG000|Overall Study|Lost to Follow-up|2|||
125875455|NCT01018030|452839365|FG001|Overall Study|Lost to Follow-up|0|||
125875456|NCT01018030|452839366|FG002|Overall Study|Lost to Follow-up|3|||
126316748|NCT02772276|454450782|FG004|Overall Study|Lost to Follow-up|0|||
126316749|NCT02772276|454450783|FG005|Overall Study|Lost to Follow-up|0|||
125875457|NCT01018030|452839364|FG000|Overall Study|Protocol Violation|2|||
125875458|NCT01018030|452839365|FG001|Overall Study|Protocol Violation|1|||
125875459|NCT01018030|452839366|FG002|Overall Study|Protocol Violation|0|||
125875460|NCT01018030|452839364|FG000|Overall Study|Physician Decision|1|||
125875461|NCT01018030|452839365|FG001|Overall Study|Physician Decision|0|||
125875462|NCT01018030|452839366|FG002|Overall Study|Physician Decision|1|||
125875463|NCT01018030|452839364|FG000|Overall Study|Lack of Efficacy|1|||
125875464|NCT01018030|452839365|FG001|Overall Study|Lack of Efficacy|0|||
125875465|NCT01018030|452839366|FG002|Overall Study|Lack of Efficacy|0|||
125875466|NCT01018030|452839364|FG000|Overall Study|Did Not Receive Study Drug|1|||
125875467|NCT01018030|452839365|FG001|Overall Study|Did Not Receive Study Drug|3|||
125875468|NCT01018030|452839366|FG002|Overall Study|Did Not Receive Study Drug|0|||
125875469|NCT03617172|452839369|FG000|Overall Study|Lost to Follow-up|1|||
125875470|NCT03617172|452839370|FG001|Overall Study|Lost to Follow-up|0|||
125875471|NCT00189540|452839371|FG000|Overall Study|Withdrawal by Subject|3|||
125875472|NCT00189540|452839372|FG001|Overall Study|Withdrawal by Subject|0|||
125875473|NCT00189540|452839371|FG000|Overall Study|Death|4|||
125875474|NCT00189540|452839372|FG001|Overall Study|Death|1|||
125875475|NCT01089504|452839373|FG000|Overall Study|Lost to Follow-up|1|||
125875476|NCT01089504|452839374|FG001|Overall Study|Lost to Follow-up|1|||
125875477|NCT01089504|452839373|FG000|Overall Study|Withdrawal by Subject|2|||
125875478|NCT01089504|452839374|FG001|Overall Study|Withdrawal by Subject|0|||
125875479|NCT00062439|452839375|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
125875480|NCT00062439|452839375|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
125875481|NCT00062439|452839375|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
125875482|NCT00062439|452839375|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
125875483|NCT00062439|452839375|FG000|Post Chemoradiation Assessment|Death|1|||
125875484|NCT00062439|452839375|FG000|Post Chemoradiation Assessment|Disease progression|2|||
125875485|NCT00062439|452839375|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
125875486|NCT00062439|452839375|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
125875487|NCT00062439|452839375|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
125875488|NCT00062439|452839375|FG000|Surgery|Physician Decision|4|||
125875489|NCT00062439|452839375|FG000|Surgery|Death|1|||
125875490|NCT00062439|452839375|FG000|Surgery|Adverse Event|2|||
125875491|NCT00062439|452839375|FG000|Consolidation Chemotherapy|Adverse Event|2|||
125875492|NCT01924845|452839376|FG000|Overall Study|Adverse Event|3|||
125875493|NCT01924845|452839376|FG000|Overall Study|Withdrawal by Subject|2|||
125875494|NCT01924845|452839376|FG000|Overall Study|Protocol Violation|1|||
125875495|NCT00001832|452839380|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
125875496|NCT00001832|452839381|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
125875497|NCT00001832|452839382|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
125875498|NCT00001832|452839383|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
125875499|NCT00001832|452839384|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
125875500|NCT00001832|452839385|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
125875501|NCT00001832|452839386|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
125875502|NCT00001832|452839387|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
125875503|NCT00001832|452839388|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
125875504|NCT00001832|452839389|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
125875505|NCT00001832|452839390|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
125875506|NCT00001832|452839391|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
125875507|NCT00001832|452839392|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
125875508|NCT00001832|452839393|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
125875509|NCT00001832|452839394|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
125875510|NCT00001832|452839380|FG000|Treatment Period|Death during treatment|0|||
125875511|NCT00001832|452839381|FG001|Treatment Period|Death during treatment|0|||
125875512|NCT00001832|452839382|FG002|Treatment Period|Death during treatment|0|||
125875513|NCT00001832|452839383|FG003|Treatment Period|Death during treatment|0|||
125875514|NCT00001832|452839384|FG004|Treatment Period|Death during treatment|0|||
125875515|NCT00001832|452839385|FG005|Treatment Period|Death during treatment|1|||
125875516|NCT00001832|452839386|FG006|Treatment Period|Death during treatment|0|||
125875517|NCT00001832|452839387|FG007|Treatment Period|Death during treatment|0|||
125875518|NCT00001832|452839388|FG008|Treatment Period|Death during treatment|0|||
125875519|NCT00001832|452839389|FG009|Treatment Period|Death during treatment|0|||
125875520|NCT00001832|452839390|FG010|Treatment Period|Death during treatment|0|||
125875521|NCT00001832|452839391|FG011|Treatment Period|Death during treatment|0|||
125875522|NCT00001832|452839392|FG012|Treatment Period|Death during treatment|0|||
125875523|NCT00001832|452839393|FG013|Treatment Period|Death during treatment|0|||
125875524|NCT00001832|452839394|FG014|Treatment Period|Death during treatment|0|||
125875525|NCT00001832|452839380|FG000|Treatment Period|Not treated|0|||
125875526|NCT00001832|452839381|FG001|Treatment Period|Not treated|0|||
125875527|NCT00001832|452839382|FG002|Treatment Period|Not treated|0|||
125875528|NCT00001832|452839383|FG003|Treatment Period|Not treated|0|||
125875529|NCT00001832|452839384|FG004|Treatment Period|Not treated|0|||
125875530|NCT00001832|452839385|FG005|Treatment Period|Not treated|0|||
125875531|NCT00001832|452839386|FG006|Treatment Period|Not treated|0|||
125875532|NCT00001832|452839387|FG007|Treatment Period|Not treated|1|||
125875533|NCT00001832|452839388|FG008|Treatment Period|Not treated|0|||
125875534|NCT00001832|452839389|FG009|Treatment Period|Not treated|0|||
125875535|NCT00001832|452839390|FG010|Treatment Period|Not treated|0|||
125875536|NCT00001832|452839391|FG011|Treatment Period|Not treated|0|||
125875537|NCT00001832|452839392|FG012|Treatment Period|Not treated|0|||
125875538|NCT00001832|452839393|FG013|Treatment Period|Not treated|0|||
125875539|NCT00001832|452839394|FG014|Treatment Period|Not treated|0|||
125875540|NCT05106959|452839395|FG000|Overall Study|Lost to Follow-up|1|||
125875541|NCT01292486|452839396|FG000|Overall Study|Protocol Violation|2|||
125875542|NCT01292486|452839396|FG000|Overall Study|Did not meet screening criteria|2|||
125875543|NCT01292486|452839396|FG000|Overall Study|Adverse Event|1|||
125875544|NCT01292486|452839396|FG000|Overall Study|Physician Decision|1|||
125875545|NCT04602390|452839401|FG000|Overall Study|Withdrawal by Subject|0|||
125875546|NCT04602390|452839402|FG001|Overall Study|Withdrawal by Subject|0|||
125875547|NCT04602390|452839403|FG002|Overall Study|Withdrawal by Subject|0|||
125875548|NCT04602390|452839404|FG003|Overall Study|Withdrawal by Subject|0|||
125875549|NCT04602390|452839405|FG004|Overall Study|Withdrawal by Subject|1|||
125875550|NCT04602390|452839406|FG005|Overall Study|Withdrawal by Subject|0|||
125875551|NCT04602390|452839401|FG000|Overall Study|Adverse Event|0|||
125875552|NCT04602390|452839402|FG001|Overall Study|Adverse Event|0|||
125875553|NCT04602390|452839403|FG002|Overall Study|Adverse Event|0|||
125875554|NCT04602390|452839404|FG003|Overall Study|Adverse Event|0|||
125875555|NCT04602390|452839405|FG004|Overall Study|Adverse Event|0|||
125875556|NCT04602390|452839406|FG005|Overall Study|Adverse Event|1|||
125875557|NCT00265564|452839407|FG000|Overall Study|Lost to Follow-up|5|||
125875558|NCT00265564|452839408|FG001|Overall Study|Lost to Follow-up|7|||
125875559|NCT00265564|452839407|FG000|Overall Study|met exclusion criteria|5|||
125875560|NCT00265564|452839408|FG001|Overall Study|met exclusion criteria|2|||
125875561|NCT01553084|452839409|FG000|Overall Study|Withdrawal by Subject|15|||
125875562|NCT01553084|452839410|FG001|Overall Study|Withdrawal by Subject|13|||
125875563|NCT01553084|452839411|FG002|Overall Study|Withdrawal by Subject|35|||
125875564|NCT03988400|452839412|FG000|Overall Study|Adverse Event|1|||
125875565|NCT03988400|452839413|FG001|Overall Study|Adverse Event|0|||
125875566|NCT03988400|452839412|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
125875567|NCT03988400|452839413|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
125875568|NCT03988400|452839412|FG000|Overall Study|Lost to Follow-up|0|||
125875569|NCT03988400|452839413|FG001|Overall Study|Lost to Follow-up|1|||
125875570|NCT01546857|452839415|FG000|Overall Study|Withdrawal by Subject|2|||
125875571|NCT01546857|452839416|FG001|Overall Study|Withdrawal by Subject|3|||
125875572|NCT01469221|452839417|FG000|Double Blind Phase|Protocol Violation|1|||
125875573|NCT01469221|452839418|FG001|Double Blind Phase|Protocol Violation|0|||
125875574|NCT01469221|452839419|FG002|Double Blind Phase|Protocol Violation|0|||
125875575|NCT01469221|452839417|FG000|Double Blind Phase|Physician Decision|1|||
125875576|NCT01469221|452839418|FG001|Double Blind Phase|Physician Decision|1|||
125875577|NCT01469221|452839419|FG002|Double Blind Phase|Physician Decision|0|||
125875578|NCT01469221|452839417|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
125875579|NCT01469221|452839418|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
125875580|NCT01469221|452839419|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
125875581|NCT02004236|452839427|FG000|Overall Study|Lack of Efficacy|0|||
125875582|NCT02004236|452839428|FG001|Overall Study|Lack of Efficacy|0|||
125875583|NCT02004236|452839429|FG002|Overall Study|Lack of Efficacy|16|||
125875584|NCT00168844|452839430|FG000|Overall Study|Adverse Event|31|||
125875585|NCT00168844|452839431|FG001|Overall Study|Adverse Event|32|||
125875586|NCT00168844|452839432|FG002|Overall Study|Adverse Event|48|||
125875587|NCT00168844|452839430|FG000|Overall Study|Lost to Follow-up|4|||
125875588|NCT00168844|452839431|FG001|Overall Study|Lost to Follow-up|5|||
125875589|NCT00168844|452839432|FG002|Overall Study|Lost to Follow-up|11|||
125875590|NCT00168844|452839430|FG000|Overall Study|Withdrawal by Subject|12|||
125875591|NCT00168844|452839431|FG001|Overall Study|Withdrawal by Subject|9|||
125875592|NCT00168844|452839432|FG002|Overall Study|Withdrawal by Subject|19|||
125875593|NCT00168844|452839430|FG000|Overall Study|Protocol Violation|2|||
125875594|NCT00168844|452839431|FG001|Overall Study|Protocol Violation|2|||
125875595|NCT00168844|452839432|FG002|Overall Study|Protocol Violation|4|||
125875596|NCT00168844|452839430|FG000|Overall Study|Other|6|||
125875597|NCT00168844|452839431|FG001|Overall Study|Other|7|||
125875598|NCT00168844|452839432|FG002|Overall Study|Other|9|||
125875599|NCT00601835|452839439|FG000|Overall Study|Withdrawal by Subject|9|||
125875600|NCT00601835|452839440|FG001|Overall Study|Withdrawal by Subject|6|||
125875601|NCT00601835|452839439|FG000|Overall Study|Physician Decision|1|||
125875602|NCT00601835|452839440|FG001|Overall Study|Physician Decision|0|||
125875603|NCT00601835|452839439|FG000|Overall Study|Lost to Follow-up|37|||
125875604|NCT00601835|452839440|FG001|Overall Study|Lost to Follow-up|5|||
125875605|NCT00601835|452839439|FG000|Overall Study|Adverse Event|1|||
125875606|NCT00601835|452839440|FG001|Overall Study|Adverse Event|1|||
125875607|NCT00601835|452839439|FG000|Overall Study|Relocate|12|||
125875608|NCT00601835|452839440|FG001|Overall Study|Relocate|2|||
125875609|NCT01927497|452839441|FG000|Overall Study|Death|0|||
125875610|NCT01927497|452839442|FG001|Overall Study|Death|1|||
125875611|NCT01927497|452839441|FG000|Overall Study|Protocol Violation|2|||
125875612|NCT01927497|452839442|FG001|Overall Study|Protocol Violation|0|||
125875613|NCT03914417|452839443|FG000|Overall Study|Withdrawal by Subject|2|||
125875614|NCT03361137|452839444|FG000|Overall Study|Reason not specified|1|||
125875615|NCT03361137|452839445|FG001|Overall Study|Reason not specified|0|||
125875616|NCT03361137|452839446|FG002|Overall Study|Reason not specified|0|||
125875617|NCT03361137|452839447|FG003|Overall Study|Reason not specified|0|||
125875618|NCT03361137|452839448|FG004|Overall Study|Reason not specified|0|||
125875619|NCT03009058|452839449|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
125875620|NCT01486966|452839452|FG000|Overall Study|Adverse Event|0|||
125875621|NCT01486966|452839453|FG001|Overall Study|Adverse Event|1|||
125875622|NCT01486966|452839452|FG000|Overall Study|Withdrawal by Subject|0|||
125875623|NCT01486966|452839453|FG001|Overall Study|Withdrawal by Subject|1|||
125875624|NCT00506350|452839454|FG000|Overall Study|Serious Adverse Event|1|||
125875625|NCT00506350|452839455|FG001|Overall Study|Serious Adverse Event|0|||
125875626|NCT00506350|452839456|FG002|Overall Study|Serious Adverse Event|0|||
125875627|NCT00506350|452839457|FG003|Overall Study|Serious Adverse Event|0|||
125875628|NCT00506350|452839458|FG004|Overall Study|Serious Adverse Event|0|||
125875629|NCT00506350|452839459|FG005|Overall Study|Serious Adverse Event|0|||
125875630|NCT00506350|452839460|FG006|Overall Study|Serious Adverse Event|0|||
125875631|NCT00506350|452839461|FG007|Overall Study|Serious Adverse Event|0|||
125875632|NCT00506350|452839462|FG008|Overall Study|Serious Adverse Event|0|||
125875633|NCT00506350|452839454|FG000|Overall Study|Adverse Event|0|||
125875634|NCT00506350|452839455|FG001|Overall Study|Adverse Event|0|||
125875635|NCT00506350|452839456|FG002|Overall Study|Adverse Event|0|||
125875636|NCT00506350|452839457|FG003|Overall Study|Adverse Event|0|||
125875637|NCT00506350|452839458|FG004|Overall Study|Adverse Event|0|||
125875638|NCT00506350|452839459|FG005|Overall Study|Adverse Event|0|||
125875639|NCT00506350|452839460|FG006|Overall Study|Adverse Event|0|||
125875640|NCT00506350|452839461|FG007|Overall Study|Adverse Event|1|||
125875641|NCT00506350|452839462|FG008|Overall Study|Adverse Event|1|||
125875642|NCT00506350|452839454|FG000|Overall Study|Protocol Violation|0|||
125875643|NCT00506350|452839455|FG001|Overall Study|Protocol Violation|0|||
125875644|NCT00506350|452839456|FG002|Overall Study|Protocol Violation|1|||
125875645|NCT00506350|452839457|FG003|Overall Study|Protocol Violation|0|||
125875646|NCT00506350|452839458|FG004|Overall Study|Protocol Violation|0|||
125875647|NCT00506350|452839459|FG005|Overall Study|Protocol Violation|0|||
125875648|NCT00506350|452839460|FG006|Overall Study|Protocol Violation|1|||
125875649|NCT00506350|452839461|FG007|Overall Study|Protocol Violation|0|||
126316750|NCT02772276|454450784|FG006|Overall Study|Lost to Follow-up|1|||
126316751|NCT02772276|454450785|FG007|Overall Study|Lost to Follow-up|0|||
126316752|NCT02772276|454450786|FG008|Overall Study|Lost to Follow-up|0|||
126316753|NCT02772276|454450787|FG009|Overall Study|Lost to Follow-up|0|||
126316754|NCT02772276|454450788|FG010|Overall Study|Lost to Follow-up|0|||
126316755|NCT02772276|454450789|FG011|Overall Study|Lost to Follow-up|0|||
125875650|NCT00506350|452839462|FG008|Overall Study|Protocol Violation|0|||
125875651|NCT00506350|452839454|FG000|Overall Study|Withdrawal by Subject|0|||
125875652|NCT00506350|452839455|FG001|Overall Study|Withdrawal by Subject|1|||
125875653|NCT00506350|452839456|FG002|Overall Study|Withdrawal by Subject|1|||
125875654|NCT00506350|452839457|FG003|Overall Study|Withdrawal by Subject|1|||
125875655|NCT00506350|452839458|FG004|Overall Study|Withdrawal by Subject|4|||
125875656|NCT00506350|452839459|FG005|Overall Study|Withdrawal by Subject|1|||
125875657|NCT00506350|452839460|FG006|Overall Study|Withdrawal by Subject|1|||
125875658|NCT00506350|452839461|FG007|Overall Study|Withdrawal by Subject|2|||
125875659|NCT00506350|452839462|FG008|Overall Study|Withdrawal by Subject|0|||
125875660|NCT00506350|452839454|FG000|Overall Study|Lost to Follow-up|1|||
125875661|NCT00506350|452839455|FG001|Overall Study|Lost to Follow-up|1|||
125875662|NCT00506350|452839456|FG002|Overall Study|Lost to Follow-up|1|||
125875663|NCT00506350|452839457|FG003|Overall Study|Lost to Follow-up|1|||
125875664|NCT00506350|452839458|FG004|Overall Study|Lost to Follow-up|2|||
125875665|NCT00506350|452839459|FG005|Overall Study|Lost to Follow-up|1|||
125875666|NCT00506350|452839460|FG006|Overall Study|Lost to Follow-up|0|||
125875667|NCT00506350|452839461|FG007|Overall Study|Lost to Follow-up|0|||
125875668|NCT00506350|452839462|FG008|Overall Study|Lost to Follow-up|2|||
125875669|NCT00506350|452839454|FG000|Overall Study|Medical Reason|0|||
125875670|NCT00506350|452839455|FG001|Overall Study|Medical Reason|0|||
125875671|NCT00506350|452839456|FG002|Overall Study|Medical Reason|0|||
125875672|NCT00506350|452839457|FG003|Overall Study|Medical Reason|0|||
125875673|NCT00506350|452839458|FG004|Overall Study|Medical Reason|1|||
125875674|NCT00506350|452839459|FG005|Overall Study|Medical Reason|0|||
125875675|NCT00506350|452839460|FG006|Overall Study|Medical Reason|0|||
125875676|NCT00506350|452839461|FG007|Overall Study|Medical Reason|0|||
125875677|NCT00506350|452839462|FG008|Overall Study|Medical Reason|0|||
125875678|NCT00506350|452839454|FG000|Overall Study|Other|1|||
125875679|NCT00506350|452839455|FG001|Overall Study|Other|1|||
125875680|NCT00506350|452839456|FG002|Overall Study|Other|3|||
125875681|NCT00506350|452839457|FG003|Overall Study|Other|0|||
125875682|NCT00506350|452839458|FG004|Overall Study|Other|3|||
125875683|NCT00506350|452839459|FG005|Overall Study|Other|0|||
125875684|NCT00506350|452839460|FG006|Overall Study|Other|0|||
125875685|NCT00506350|452839461|FG007|Overall Study|Other|2|||
126316756|NCT02772276|454450790|FG012|Overall Study|Lost to Follow-up|0|||
126316757|NCT02772276|454450778|FG000|Overall Study|Withdrew consent|0|||
126316758|NCT02772276|454450779|FG001|Overall Study|Withdrew consent|0|||
126316759|NCT02772276|454450780|FG002|Overall Study|Withdrew consent|0|||
126316760|NCT02772276|454450781|FG003|Overall Study|Withdrew consent|0|||
125875686|NCT00506350|452839462|FG008|Overall Study|Other|2|||
125875687|NCT01691794|452839463|FG000|Overall Study|Poor/Non-Compliance|1|||
125875688|NCT01691794|452839464|FG001|Overall Study|Poor/Non-Compliance|4|||
125875689|NCT01691794|452839465|FG002|Overall Study|Poor/Non-Compliance|1|||
125875690|NCT01691794|452839463|FG000|Overall Study|Death|0|||
125875691|NCT01691794|452839464|FG001|Overall Study|Death|0|||
126316761|NCT02772276|454450782|FG004|Overall Study|Withdrew consent|0|||
126316762|NCT02772276|454450783|FG005|Overall Study|Withdrew consent|0|||
125875692|NCT01691794|452839465|FG002|Overall Study|Death|1|||
125875693|NCT01691794|452839463|FG000|Overall Study|Lack of Efficacy|0|||
125875694|NCT01691794|452839464|FG001|Overall Study|Lack of Efficacy|7|||
125875695|NCT01691794|452839465|FG002|Overall Study|Lack of Efficacy|1|||
125875696|NCT01691794|452839463|FG000|Overall Study|Participant request to discontinue|0|||
125875697|NCT01691794|452839464|FG001|Overall Study|Participant request to discontinue|1|||
125875698|NCT01691794|452839465|FG002|Overall Study|Participant request to discontinue|0|||
125875699|NCT01691794|452839463|FG000|Overall Study|Adverse Event|0|||
125875700|NCT01691794|452839464|FG001|Overall Study|Adverse Event|1|||
125875701|NCT01691794|452839465|FG002|Overall Study|Adverse Event|1|||
125875702|NCT01691794|452839463|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
125875703|NCT01691794|452839464|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
125875704|NCT01691794|452839465|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
125875705|NCT01691794|452839463|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
125875706|NCT01691794|452839464|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
125875707|NCT01691794|452839465|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
125875708|NCT04972786|452839466|FG000|First Intervention (1 Day)|Adverse Event|1|||
125875709|NCT04972786|452839467|FG001|First Intervention (1 Day)|Adverse Event|0|||
125875710|NCT00844844|452839468|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
125875711|NCT00844844|452839468|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
125875712|NCT00844844|452839468|FG000|Extension Treatment Period|Adverse Event|2|||
125875713|NCT00844844|452839468|FG000|Post Treatment Period|Withdrawal by Subject|1|||
125875714|NCT05472090|452839471|FG000|Overall Study|Adverse Event|2|||
125875715|NCT05472090|452839472|FG001|Overall Study|Adverse Event|3|||
125875716|NCT05472090|452839471|FG000|Overall Study|Lack of Efficacy|1|||
125875717|NCT05472090|452839472|FG001|Overall Study|Lack of Efficacy|0|||
125875718|NCT05472090|452839471|FG000|Overall Study|Physician Decision|1|||
125875719|NCT05472090|452839472|FG001|Overall Study|Physician Decision|0|||
125875720|NCT05472090|452839471|FG000|Overall Study|Withdrawal by Subject|2|||
125875721|NCT05472090|452839472|FG001|Overall Study|Withdrawal by Subject|0|||
125875722|NCT05472090|452839471|FG000|Overall Study|Lost to Follow-up|0|||
125875723|NCT05472090|452839472|FG001|Overall Study|Lost to Follow-up|3|||
125875724|NCT01350999|452839474|FG000|Overall Study|Adverse Event|4|||
125875725|NCT01350999|452839475|FG001|Overall Study|Adverse Event|9|||
125875726|NCT01350999|452839476|FG002|Overall Study|Adverse Event|10|||
125875727|NCT01350999|452839474|FG000|Overall Study|Voluntary withdrawal|3|||
125875728|NCT01350999|452839475|FG001|Overall Study|Voluntary withdrawal|4|||
125875729|NCT01350999|452839476|FG002|Overall Study|Voluntary withdrawal|6|||
125875730|NCT01350999|452839474|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
125875731|NCT01350999|452839475|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
125875732|NCT01350999|452839476|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
125875733|NCT00089297|452841724|FG000|Overall Study|Adverse Event|9|||
125875734|NCT00089297|452841724|FG000|Overall Study|Death|1|||
125875735|NCT00089297|452841724|FG000|Overall Study|Withdrawal by Subject|12|||
125875736|NCT00089297|452841724|FG000|Overall Study|Disease progression|2|||
125875737|NCT00089297|452841724|FG000|Overall Study|Ineligible|11|||
125875738|NCT00089297|452841724|FG000|Overall Study|Secondary malignancy|1|||
125875739|NCT00089297|452841724|FG000|Overall Study|IRB approval not ready|1|||
125875740|NCT00089297|452841724|FG000|Overall Study|Non-compliance|1|||
125875741|NCT02177695|452841725|FG000|ITT Analysis|Ineligible|5|||
125875742|NCT02177695|452841726|FG001|ITT Analysis|Ineligible|5|||
125875743|NCT02177695|452841725|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
125875744|NCT02177695|452841726|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
125875745|NCT02177695|452841725|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
125875746|NCT02177695|452841726|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
125875747|NCT02177695|452841725|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
125875748|NCT02177695|452841726|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
125875749|NCT00419393|452841727|FG000|Overall Study|Adverse Event|5|||
125875750|NCT00419393|452841727|FG000|Overall Study|Protocol Violation|5|||
125875751|NCT00419393|452841727|FG000|Overall Study|Withdrawal by Subject|7|||
125875752|NCT00419393|452841727|FG000|Overall Study|Other: Sponsor request|3|||
125875753|NCT00419393|452841727|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
125875754|NCT00419393|452841727|FG000|Overall Study|Other: Site closure|1|||
125875755|NCT00419393|452841727|FG000|Overall Study|Other: Other health problems|1|||
125875756|NCT00419393|452841727|FG000|Overall Study|Other: Investigator decision|1|||
125875757|NCT00979901|452841728|FG000|Overall Study|Adverse Event|1|||
125875758|NCT00979901|452841729|FG001|Overall Study|Adverse Event|3|||
125875759|NCT00979901|452841730|FG002|Overall Study|Adverse Event|9|||
125875760|NCT00979901|452841731|FG003|Overall Study|Adverse Event|2|||
125875761|NCT00979901|452841728|FG000|Overall Study|Lack of Efficacy|8|||
125875762|NCT00979901|452841729|FG001|Overall Study|Lack of Efficacy|4|||
125875763|NCT00979901|452841730|FG002|Overall Study|Lack of Efficacy|9|||
125875764|NCT00979901|452841731|FG003|Overall Study|Lack of Efficacy|0|||
125875765|NCT00979901|452841728|FG000|Overall Study|Lost to Follow-up|1|||
125875766|NCT00979901|452841729|FG001|Overall Study|Lost to Follow-up|1|||
125875767|NCT00979901|452841730|FG002|Overall Study|Lost to Follow-up|2|||
125875768|NCT00979901|452841731|FG003|Overall Study|Lost to Follow-up|0|||
125875769|NCT00979901|452841728|FG000|Overall Study|Protocol Violation|2|||
125875770|NCT00979901|452841729|FG001|Overall Study|Protocol Violation|2|||
125875771|NCT00979901|452841730|FG002|Overall Study|Protocol Violation|7|||
125875772|NCT00979901|452841731|FG003|Overall Study|Protocol Violation|1|||
125875773|NCT00979901|452841728|FG000|Overall Study|Withdrawal by Subject|2|||
125875774|NCT00979901|452841729|FG001|Overall Study|Withdrawal by Subject|1|||
125875775|NCT00979901|452841730|FG002|Overall Study|Withdrawal by Subject|1|||
125875776|NCT00979901|452841731|FG003|Overall Study|Withdrawal by Subject|1|||
125875777|NCT00979901|452841728|FG000|Overall Study|Noncompliance|1|||
125875778|NCT00979901|452841729|FG001|Overall Study|Noncompliance|0|||
125875779|NCT00979901|452841730|FG002|Overall Study|Noncompliance|0|||
125875780|NCT00979901|452841731|FG003|Overall Study|Noncompliance|0|||
125875781|NCT00979901|452841728|FG000|Overall Study|out-of-state|1|||
125875782|NCT00979901|452841729|FG001|Overall Study|out-of-state|0|||
125875783|NCT00979901|452841730|FG002|Overall Study|out-of-state|0|||
125875784|NCT00979901|452841731|FG003|Overall Study|out-of-state|0|||
125875785|NCT00979901|452841728|FG000|Overall Study|vacation|1|||
125875786|NCT00979901|452841729|FG001|Overall Study|vacation|0|||
125875787|NCT00979901|452841730|FG002|Overall Study|vacation|0|||
125875788|NCT00979901|452841731|FG003|Overall Study|vacation|0|||
125875789|NCT00979901|452841728|FG000|Overall Study|elevated lab values pre-randomization|1|||
125875790|NCT00979901|452841729|FG001|Overall Study|elevated lab values pre-randomization|0|||
125875791|NCT00979901|452841730|FG002|Overall Study|elevated lab values pre-randomization|0|||
125875792|NCT00979901|452841731|FG003|Overall Study|elevated lab values pre-randomization|0|||
125875793|NCT00979901|452841728|FG000|Overall Study|Discontinued in Error|0|||
125875794|NCT00979901|452841729|FG001|Overall Study|Discontinued in Error|1|||
125875795|NCT00979901|452841730|FG002|Overall Study|Discontinued in Error|0|||
125875796|NCT00979901|452841731|FG003|Overall Study|Discontinued in Error|0|||
125875797|NCT00979901|452841728|FG000|Overall Study|Left Country|0|||
125875798|NCT00979901|452841729|FG001|Overall Study|Left Country|0|||
125875799|NCT00979901|452841730|FG002|Overall Study|Left Country|1|||
125875800|NCT00979901|452841731|FG003|Overall Study|Left Country|0|||
125875801|NCT00979901|452841728|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
125875802|NCT00979901|452841729|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
125875803|NCT00979901|452841730|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
125875804|NCT00979901|452841731|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
125875805|NCT00446849|452841733|FG000|Acute Phase|Lack of Efficacy|64|||
125875806|NCT00446849|452841733|FG000|Acute Phase|Protocol Violation|10|||
125875807|NCT00446849|452841733|FG000|Acute Phase|Consent withdrawn|4|||
125875808|NCT00446849|452841733|FG000|Acute Phase|Lost to Follow-up|2|||
125875809|NCT00446849|452841733|FG000|Acute Phase|Physician Decision|1|||
125875810|NCT00446849|452841733|FG000|Acute Phase|noncompliance|1|||
125875811|NCT00446849|452841733|FG000|Maintenance Phase|Lack of Efficacy|40|||
125875812|NCT00446849|452841733|FG000|Maintenance Phase|Protocol Violation|7|||
125875813|NCT00446849|452841733|FG000|Maintenance Phase|Adverse Event|6|||
125875814|NCT00446849|452841733|FG000|Maintenance Phase|Consent withdrawn|5|||
125875815|NCT00446849|452841733|FG000|Maintenance Phase|Lost to Follow-up|3|||
125875816|NCT00446849|452841733|FG000|Maintenance Phase|Pregnancy|1|||
125875817|NCT00446849|452841733|FG000|Maintenance Phase|noncompliance|2|||
125875818|NCT00446849|452841733|FG000|Maintenance Phase|prohibited medication use|2|||
125875819|NCT00446849|452841733|FG000|Maintenance Phase|antibiotic use|1|||
125875820|NCT00446849|452841733|FG000|Maintenance Phase|study closure|1|||
125875821|NCT00446849|452841733|FG000|Maintenance Phase|hydrocodone use|1|||
125875822|NCT00446849|452841733|FG000|Maintenance Phase|concomitant medication use|1|||
125875823|NCT01317472|452841736|FG000|Overall Study|Withdrawal by Subject|1|||
125875824|NCT01317472|452841737|FG001|Overall Study|Withdrawal by Subject|0|||
125875825|NCT01317472|452841736|FG000|Overall Study|Unrelated hospitalization|1|||
125875826|NCT01317472|452841737|FG001|Overall Study|Unrelated hospitalization|0|||
125875827|NCT05546476|452841738|FG000|Period 1: Part A|Adverse Event|2|||
125875828|NCT05546476|452841739|FG001|Period 1: Part A|Adverse Event|0|||
125875829|NCT05546476|452841740|FG002|Period 1: Part A|Adverse Event|0|||
125875830|NCT05546476|452841741|FG003|Period 1: Part A|Adverse Event|1|||
125875831|NCT05546476|452841738|FG000|Period 1: Part A|Death|4|||
125875832|NCT05546476|452841739|FG001|Period 1: Part A|Death|4|||
125875833|NCT05546476|452841740|FG002|Period 1: Part A|Death|5|||
125875834|NCT05546476|452841741|FG003|Period 1: Part A|Death|6|||
125875835|NCT05546476|452841738|FG000|Period 1: Part A|Lack of Efficacy|0|||
125875836|NCT05546476|452841739|FG001|Period 1: Part A|Lack of Efficacy|0|||
125875837|NCT05546476|452841740|FG002|Period 1: Part A|Lack of Efficacy|0|||
125875838|NCT05546476|452841741|FG003|Period 1: Part A|Lack of Efficacy|1|||
125875839|NCT05546476|452841738|FG000|Period 1: Part A|Lost to Follow-up|0|||
125875840|NCT05546476|452841739|FG001|Period 1: Part A|Lost to Follow-up|0|||
125875841|NCT05546476|452841740|FG002|Period 1: Part A|Lost to Follow-up|0|||
125875842|NCT05546476|452841741|FG003|Period 1: Part A|Lost to Follow-up|1|||
125875843|NCT05546476|452841738|FG000|Period 1: Part A|Physician Decision|1|||
125875844|NCT05546476|452841739|FG001|Period 1: Part A|Physician Decision|0|||
125875845|NCT05546476|452841740|FG002|Period 1: Part A|Physician Decision|0|||
125875846|NCT05546476|452841741|FG003|Period 1: Part A|Physician Decision|0|||
125875847|NCT05546476|452841738|FG000|Period 1: Part A|Progressive disease|3|||
125875848|NCT05546476|452841739|FG001|Period 1: Part A|Progressive disease|5|||
125875849|NCT05546476|452841740|FG002|Period 1: Part A|Progressive disease|0|||
125875850|NCT05546476|452841741|FG003|Period 1: Part A|Progressive disease|1|||
125875851|NCT05546476|452841738|FG000|Period 1: Part A|Withdrawal by Subject|1|||
125875852|NCT05546476|452841739|FG001|Period 1: Part A|Withdrawal by Subject|1|||
125875853|NCT05546476|452841740|FG002|Period 1: Part A|Withdrawal by Subject|1|||
125875854|NCT05546476|452841741|FG003|Period 1: Part A|Withdrawal by Subject|2|||
125875855|NCT05546476|452841738|FG000|Period 1: Part A|Global deterioration of health status|2|||
125875856|NCT05546476|452841739|FG001|Period 1: Part A|Global deterioration of health status|2|||
125875857|NCT05546476|452841740|FG002|Period 1: Part A|Global deterioration of health status|1|||
125875858|NCT05546476|452841741|FG003|Period 1: Part A|Global deterioration of health status|4|||
125875859|NCT05546476|452841738|FG000|Period 1: Part A|Other: Unspecified|0|||
125875860|NCT05546476|452841739|FG001|Period 1: Part A|Other: Unspecified|2|||
125875861|NCT05546476|452841740|FG002|Period 1: Part A|Other: Unspecified|0|||
125875862|NCT05546476|452841741|FG003|Period 1: Part A|Other: Unspecified|0|||
125875863|NCT05546476|452841738|FG000|Period 2: Part B|Ongoing|26|||
125875864|NCT05546476|452841739|FG001|Period 2: Part B|Ongoing|27|||
125875865|NCT05546476|452841740|FG002|Period 2: Part B|Ongoing|35|||
125875866|NCT05546476|452841741|FG003|Period 2: Part B|Ongoing|29|||
125875867|NCT00807911|452841746|FG000|Overall Study|Withdrawal by Subject|12|||
125875868|NCT00807911|452841747|FG001|Overall Study|Withdrawal by Subject|10|||
125875869|NCT00807911|452841746|FG000|Overall Study|Ineligible|0|||
125875870|NCT00807911|452841747|FG001|Overall Study|Ineligible|4|||
125875871|NCT02182895|452841748|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
125875872|NCT02182895|452841749|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
125875873|NCT02953652|452841750|FG000|Overall Study|Adverse Event|18|||
125875874|NCT02953652|452841750|FG000|Overall Study|Withdrawal by Subject|6|||
125875875|NCT02953652|452841750|FG000|Overall Study|Protocol Violation|1|||
125875876|NCT02953652|452841750|FG000|Overall Study|Disease Progression|27|||
125875877|NCT00836589|452841753|FG000|Overall Study|Lost to Follow-up|246|||
125875878|NCT00836589|452841753|FG000|Overall Study|Death|429|||
125875879|NCT00836589|452841753|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
125875880|NCT02399215|452841775|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
125875881|NCT02399215|452841775|FG000|Overall Study|Withdrawal by Subject|1|||
125875882|NCT00772538|452841776|FG000|Overall Study|Adverse Event|6|||
125875883|NCT00772538|452841777|FG001|Overall Study|Adverse Event|6|||
125875884|NCT00772538|452841776|FG000|Overall Study|Protocol Violation|3|||
125875885|NCT00772538|452841777|FG001|Overall Study|Protocol Violation|3|||
125875886|NCT00772538|452841776|FG000|Overall Study|Lost to Follow-up|1|||
125875887|NCT00772538|452841777|FG001|Overall Study|Lost to Follow-up|1|||
125875888|NCT00772538|452841776|FG000|Overall Study|Withdrawal by Subject|3|||
125875889|NCT00772538|452841777|FG001|Overall Study|Withdrawal by Subject|8|||
125875890|NCT00772538|452841776|FG000|Overall Study|Lack of Efficacy|0|||
125875891|NCT00772538|452841777|FG001|Overall Study|Lack of Efficacy|1|||
125875892|NCT00772538|452841776|FG000|Overall Study|Other|7|||
125875893|NCT00772538|452841777|FG001|Overall Study|Other|7|||
125875894|NCT00713609|452841778|FG000|Overall Study|Adverse Event|2|||
125875895|NCT00713609|452841779|FG001|Overall Study|Adverse Event|0|||
125875896|NCT00713609|452841780|FG002|Overall Study|Adverse Event|2|||
125875897|NCT00713609|452841781|FG003|Overall Study|Adverse Event|2|||
125875898|NCT00713609|452841782|FG004|Overall Study|Adverse Event|3|||
125875899|NCT00713609|452841783|FG005|Overall Study|Adverse Event|1|||
125875900|NCT00713609|452841778|FG000|Overall Study|Lost to Follow-up|5|||
125875901|NCT00713609|452841779|FG001|Overall Study|Lost to Follow-up|7|||
125875902|NCT00713609|452841780|FG002|Overall Study|Lost to Follow-up|5|||
125875903|NCT00713609|452841781|FG003|Overall Study|Lost to Follow-up|5|||
125875904|NCT00713609|452841782|FG004|Overall Study|Lost to Follow-up|7|||
125875905|NCT00713609|452841783|FG005|Overall Study|Lost to Follow-up|0|||
125875906|NCT00713609|452841778|FG000|Overall Study|Lack of Efficacy|1|||
125875907|NCT00713609|452841779|FG001|Overall Study|Lack of Efficacy|3|||
125875908|NCT00713609|452841780|FG002|Overall Study|Lack of Efficacy|0|||
125875909|NCT00713609|452841781|FG003|Overall Study|Lack of Efficacy|0|||
125875910|NCT00713609|452841782|FG004|Overall Study|Lack of Efficacy|1|||
125875911|NCT00713609|452841783|FG005|Overall Study|Lack of Efficacy|0|||
125875912|NCT00713609|452841778|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
125875913|NCT00713609|452841779|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
125875914|NCT00713609|452841780|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
125875915|NCT00713609|452841781|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
125875916|NCT00713609|452841782|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
125875917|NCT00713609|452841783|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
125875918|NCT00713609|452841778|FG000|Overall Study|Withdrawal by Subject|6|||
125875919|NCT00713609|452841779|FG001|Overall Study|Withdrawal by Subject|1|||
125875920|NCT00713609|452841780|FG002|Overall Study|Withdrawal by Subject|5|||
125875921|NCT00713609|452841781|FG003|Overall Study|Withdrawal by Subject|1|||
125875922|NCT00713609|452841782|FG004|Overall Study|Withdrawal by Subject|5|||
125875923|NCT00713609|452841783|FG005|Overall Study|Withdrawal by Subject|7|||
125875924|NCT00713609|452841778|FG000|Overall Study|Protocol Violation|6|||
125875925|NCT00713609|452841779|FG001|Overall Study|Protocol Violation|3|||
125875926|NCT00713609|452841780|FG002|Overall Study|Protocol Violation|1|||
125875927|NCT00713609|452841781|FG003|Overall Study|Protocol Violation|1|||
125875928|NCT00713609|452841782|FG004|Overall Study|Protocol Violation|2|||
125875929|NCT00713609|452841783|FG005|Overall Study|Protocol Violation|0|||
125875930|NCT01903356|452841784|FG000|Overall Study|Lost to Follow-up|7|||
125875931|NCT01903356|452841784|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
125875932|NCT01903356|452841784|FG000|Overall Study|Violated the dosage and administration|3|||
125875933|NCT04529083|452841785|FG000|Overall Study|Withdrawal by Subject|3|||
125875934|NCT03305666|452841786|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
125875935|NCT03305666|452841787|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
125875936|NCT04196686|452841789|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
125875937|NCT04196686|452841790|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
125875938|NCT02587221|452841794|FG000|Overall Study|Adverse Event|3|||
125875939|NCT02587221|452841795|FG001|Overall Study|Adverse Event|3|||
125875940|NCT02587221|452841794|FG000|Overall Study|Death|33|||
125875941|NCT02587221|452841795|FG001|Overall Study|Death|34|||
125875942|NCT02587221|452841794|FG000|Overall Study|Withdrawal by Subject|66|||
125875943|NCT02587221|452841795|FG001|Overall Study|Withdrawal by Subject|61|||
125875944|NCT02587221|452841794|FG000|Overall Study|Lost to Follow-up|21|||
125875945|NCT02587221|452841795|FG001|Overall Study|Lost to Follow-up|19|||
125875946|NCT02587221|452841794|FG000|Overall Study|Protocol Violation|6|||
125875947|NCT02587221|452841795|FG001|Overall Study|Protocol Violation|5|||
125875948|NCT02587221|452841794|FG000|Overall Study|Other Reason or Unspecified|2|||
125875949|NCT02587221|452841795|FG001|Overall Study|Other Reason or Unspecified|1|||
125875950|NCT02546609|452841796|FG000|Overall Study|Withdrawal by Subject|0|||
125875951|NCT02546609|452841797|FG001|Overall Study|Withdrawal by Subject|1|||
125875952|NCT02546609|452841798|FG002|Overall Study|Withdrawal by Subject|2|||
125875953|NCT02546609|452841796|FG000|Overall Study|Adverse Event|0|||
125875954|NCT02546609|452841797|FG001|Overall Study|Adverse Event|6|||
125875955|NCT02546609|452841798|FG002|Overall Study|Adverse Event|1|||
125875956|NCT02546609|452841796|FG000|Overall Study|Protocol Violation|0|||
125875957|NCT02546609|452841797|FG001|Overall Study|Protocol Violation|1|||
125875958|NCT02546609|452841798|FG002|Overall Study|Protocol Violation|1|||
125875959|NCT02546609|452841796|FG000|Overall Study|Lost to Follow-up|2|||
125875960|NCT02546609|452841797|FG001|Overall Study|Lost to Follow-up|3|||
125875961|NCT02546609|452841798|FG002|Overall Study|Lost to Follow-up|1|||
125875962|NCT02546609|452841796|FG000|Overall Study|travel or work schedule restriction|0|||
125875963|NCT02546609|452841797|FG001|Overall Study|travel or work schedule restriction|0|||
125875964|NCT02546609|452841798|FG002|Overall Study|travel or work schedule restriction|2|||
125875965|NCT00914849|452841799|FG000|Overall Study|Withdrawal by Subject|1|||
125875966|NCT00914849|452841800|FG001|Overall Study|Withdrawal by Subject|0|||
125875967|NCT00914849|452841799|FG000|Overall Study|Not eligible|0|||
125875968|NCT00914849|452841800|FG001|Overall Study|Not eligible|1|||
125875969|NCT01001221|452841801|FG000|Overall Study|Adverse Event|1|||
125875970|NCT01001221|452841802|FG001|Overall Study|Adverse Event|2|||
125875971|NCT01001221|452841803|FG002|Overall Study|Adverse Event|0|||
125875972|NCT01001221|452841804|FG003|Overall Study|Adverse Event|2|||
125875973|NCT01001221|452841805|FG004|Overall Study|Adverse Event|0|||
125875974|NCT01001221|452841801|FG000|Overall Study|Disease progression|3|||
125875975|NCT01001221|452841802|FG001|Overall Study|Disease progression|2|||
125875976|NCT01001221|452841803|FG002|Overall Study|Disease progression|2|||
125875977|NCT01001221|452841804|FG003|Overall Study|Disease progression|4|||
125875978|NCT01001221|452841805|FG004|Overall Study|Disease progression|0|||
125875979|NCT01001221|452841801|FG000|Overall Study|Other|1|||
125875980|NCT01001221|452841802|FG001|Overall Study|Other|1|||
125875981|NCT01001221|452841803|FG002|Overall Study|Other|0|||
125875982|NCT01001221|452841804|FG003|Overall Study|Other|0|||
125875983|NCT01001221|452841805|FG004|Overall Study|Other|0|||
125875984|NCT01001221|452841801|FG000|Overall Study|Not treated; protocol exclusion|0|||
125875985|NCT01001221|452841802|FG001|Overall Study|Not treated; protocol exclusion|0|||
126316763|NCT02772276|454450784|FG006|Overall Study|Withdrew consent|0|||
125875986|NCT01001221|452841803|FG002|Overall Study|Not treated; protocol exclusion|1|||
125875987|NCT01001221|452841804|FG003|Overall Study|Not treated; protocol exclusion|0|||
126316764|NCT02772276|454450785|FG007|Overall Study|Withdrew consent|1|||
125875988|NCT01001221|452841805|FG004|Overall Study|Not treated; protocol exclusion|0|||
125875989|NCT04201431|452841806|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
125875990|NCT04201431|452841807|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
125875991|NCT04201431|452841808|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
125875992|NCT01176032|452841809|FG000|Overall Study|Adverse Event|1|||
125875993|NCT01176032|452841810|FG001|Overall Study|Adverse Event|0|||
125875994|NCT01176032|452841809|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125875995|NCT01176032|452841810|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125875996|NCT01176032|452841809|FG000|Overall Study|Protocol Violation|1|||
125875997|NCT01176032|452841810|FG001|Overall Study|Protocol Violation|0|||
125875998|NCT01176032|452841809|FG000|Overall Study|Informed consent withdrawn|3|||
125875999|NCT01176032|452841810|FG001|Overall Study|Informed consent withdrawn|0|||
125876000|NCT01176032|452841809|FG000|Overall Study|Other|1|||
125876001|NCT01176032|452841810|FG001|Overall Study|Other|0|||
125876002|NCT01791244|452841813|FG000|Overall Study|Adverse Event|5|||
125876003|NCT01791244|452841814|FG001|Overall Study|Adverse Event|7|||
125876004|NCT01791244|452841813|FG000|Overall Study|Insufficient clinical response|10|||
125876005|NCT01791244|452841814|FG001|Overall Study|Insufficient clinical response|10|||
125876006|NCT01791244|452841813|FG000|Overall Study|Laboratory Abnormality|0|||
125876007|NCT01791244|452841814|FG001|Overall Study|Laboratory Abnormality|1|||
125876008|NCT01149096|452841815|FG000|Overall Study|Lost to Follow-up|0|||
125876009|NCT01149096|452841816|FG001|Overall Study|Lost to Follow-up|1|||
125876010|NCT04079296|452841817|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125876011|NCT04079296|452841818|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125876012|NCT04079296|452841819|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125876013|NCT04079296|452841820|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
125876014|NCT04079296|452841821|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
125876015|NCT04079296|452841817|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125876016|NCT04079296|452841818|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125876017|NCT04079296|452841819|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125876018|NCT04079296|452841820|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
125876019|NCT04079296|452841821|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
125876020|NCT04079296|452841817|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125876021|NCT04079296|452841818|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125876022|NCT04079296|452841819|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125876023|NCT04079296|452841820|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125876024|NCT04079296|452841821|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
125876025|NCT04079296|452841817|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125876026|NCT04079296|452841818|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125876027|NCT04079296|452841819|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125876028|NCT04079296|452841820|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125876029|NCT04079296|452841821|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
125876030|NCT04079296|452841817|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125876031|NCT04079296|452841818|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125876032|NCT04079296|452841819|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125876033|NCT04079296|452841820|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
125876034|NCT04079296|452841821|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125876035|NCT04079296|452841817|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125876036|NCT04079296|452841818|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125876037|NCT04079296|452841819|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125876038|NCT04079296|452841820|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
125876039|NCT04079296|452841821|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
125876040|NCT04079296|452841817|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125876041|NCT04079296|452841818|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125876042|NCT04079296|452841819|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125876043|NCT04079296|452841820|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
125876044|NCT04079296|452841821|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
125876045|NCT04079296|452841817|FG000|Dose Expansion Phase (168 Days)|Death|0|||
125876046|NCT04079296|452841818|FG001|Dose Expansion Phase (168 Days)|Death|0|||
125876047|NCT04079296|452841819|FG002|Dose Expansion Phase (168 Days)|Death|0|||
125876048|NCT04079296|452841820|FG003|Dose Expansion Phase (168 Days)|Death|1|||
125876049|NCT04079296|452841821|FG004|Dose Expansion Phase (168 Days)|Death|0|||
125876050|NCT01346358|452841834|FG000|Overall Study|Withdrawal by Subject|1|||
125876051|NCT01346358|452841835|FG001|Overall Study|Withdrawal by Subject|0|||
125876052|NCT01346358|452841836|FG002|Overall Study|Withdrawal by Subject|1|||
125876053|NCT01346358|452841837|FG003|Overall Study|Withdrawal by Subject|1|||
125876054|NCT01346358|452841838|FG004|Overall Study|Withdrawal by Subject|0|||
125876055|NCT01346358|452841839|FG005|Overall Study|Withdrawal by Subject|2|||
125876056|NCT01346358|452841840|FG006|Overall Study|Withdrawal by Subject|1|||
125876057|NCT01346358|452841841|FG007|Overall Study|Withdrawal by Subject|1|||
125876058|NCT01346358|452841842|FG008|Overall Study|Withdrawal by Subject|1|||
125876059|NCT01346358|452841834|FG000|Overall Study|Adverse Event|1|||
125876060|NCT01346358|452841835|FG001|Overall Study|Adverse Event|0|||
125876061|NCT01346358|452841836|FG002|Overall Study|Adverse Event|0|||
125876062|NCT01346358|452841837|FG003|Overall Study|Adverse Event|0|||
125876063|NCT01346358|452841838|FG004|Overall Study|Adverse Event|1|||
125876064|NCT01346358|452841839|FG005|Overall Study|Adverse Event|0|||
125876065|NCT01346358|452841840|FG006|Overall Study|Adverse Event|0|||
125876066|NCT01346358|452841841|FG007|Overall Study|Adverse Event|0|||
125876067|NCT01346358|452841842|FG008|Overall Study|Adverse Event|1|||
126316765|NCT02772276|454450786|FG008|Overall Study|Withdrew consent|0|||
126316766|NCT02772276|454450787|FG009|Overall Study|Withdrew consent|0|||
126316767|NCT02772276|454450788|FG010|Overall Study|Withdrew consent|0|||
126316768|NCT02772276|454450789|FG011|Overall Study|Withdrew consent|0|||
126316769|NCT02772276|454450790|FG012|Overall Study|Withdrew consent|0|||
126316770|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
126316771|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
126316772|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
126316773|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
126316774|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
125876068|NCT01346358|452841834|FG000|Overall Study|Non-Compliance|0|||
126316775|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
126316776|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
126316777|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
126316778|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
126316779|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
126316780|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|All other|33|||
126316781|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|All other|0|||
126316782|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
126316783|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
126316784|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
126316785|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
126316786|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
126316787|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
126316788|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
126316789|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
126316790|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
126316791|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
126316792|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
126316793|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
126316794|NCT03448939|454450794|FG000|Overall Study|Adverse Event|5|||
126316795|NCT03448939|454450795|FG001|Overall Study|Adverse Event|1|||
126316796|NCT03448939|454450794|FG000|Overall Study|Lost to Follow-up|6|||
126316797|NCT03448939|454450795|FG001|Overall Study|Lost to Follow-up|6|||
126316798|NCT03448939|454450794|FG000|Overall Study|Pregnancy|1|||
126316799|NCT03448939|454450795|FG001|Overall Study|Pregnancy|1|||
126316800|NCT03448939|454450794|FG000|Overall Study|Withdrawal by Subject|9|||
126316801|NCT03448939|454450795|FG001|Overall Study|Withdrawal by Subject|3|||
126316802|NCT01472965|454450796|FG000|Overall Study|Withdrawal by Subject|1|||
126316803|NCT01472965|454450797|FG001|Overall Study|Withdrawal by Subject|0|||
126316804|NCT00628095|454450798|FG000|Overall Study|Adverse Event|5|||
126316805|NCT00628095|454450799|FG001|Overall Study|Adverse Event|3|||
126316806|NCT00628095|454450798|FG000|Overall Study|Lack of Efficacy|0|||
126316807|NCT00628095|454450799|FG001|Overall Study|Lack of Efficacy|3|||
126316808|NCT00628095|454450798|FG000|Overall Study|Withdrawal by Subject|2|||
126316809|NCT00628095|454450799|FG001|Overall Study|Withdrawal by Subject|0|||
126316810|NCT00628095|454450798|FG000|Overall Study|Other|0|||
126316811|NCT00628095|454450799|FG001|Overall Study|Other|1|||
126316812|NCT03235115|454450803|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316813|NCT03235115|454450804|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316814|NCT03235115|454450805|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316815|NCT03235115|454450806|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316816|NCT03235115|454450807|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316817|NCT03235115|454450808|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
126316818|NCT00006305|454450809|FG000|Overall Study|Withdrawal by Subject|17|||
126316819|NCT00006305|454450810|FG001|Overall Study|Withdrawal by Subject|10|||
125876069|NCT01346358|452841835|FG001|Overall Study|Non-Compliance|0|||
125876070|NCT01346358|452841836|FG002|Overall Study|Non-Compliance|0|||
125876071|NCT01346358|452841837|FG003|Overall Study|Non-Compliance|0|||
125876072|NCT01346358|452841838|FG004|Overall Study|Non-Compliance|0|||
125876073|NCT01346358|452841839|FG005|Overall Study|Non-Compliance|0|||
125876074|NCT01346358|452841840|FG006|Overall Study|Non-Compliance|0|||
125876075|NCT01346358|452841841|FG007|Overall Study|Non-Compliance|2|||
125876076|NCT01346358|452841842|FG008|Overall Study|Non-Compliance|0|||
125876077|NCT01346358|452841834|FG000|Overall Study|Physician Decision|0|||
125876078|NCT01346358|452841835|FG001|Overall Study|Physician Decision|1|||
125876079|NCT01346358|452841836|FG002|Overall Study|Physician Decision|0|||
126316820|NCT00006305|454450811|FG002|Overall Study|Withdrawal by Subject|15|||
126316821|NCT00006305|454450812|FG003|Overall Study|Withdrawal by Subject|14|||
125876080|NCT01346358|452841837|FG003|Overall Study|Physician Decision|0|||
125876081|NCT01346358|452841838|FG004|Overall Study|Physician Decision|0|||
125876082|NCT01346358|452841839|FG005|Overall Study|Physician Decision|0|||
125876083|NCT01346358|452841840|FG006|Overall Study|Physician Decision|0|||
125876084|NCT01346358|452841841|FG007|Overall Study|Physician Decision|1|||
125876085|NCT01346358|452841842|FG008|Overall Study|Physician Decision|1|||
125876086|NCT05058365|452841845|FG000|Overall Study|Migration|1|||
125876087|NCT05058365|452841846|FG001|Overall Study|Migration|1|||
125876088|NCT04038359|452841847|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
125876089|NCT04038359|452841848|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
125876090|NCT04038359|452841847|FG000|Overall Study|Death|8|||
125876091|NCT04038359|452841848|FG001|Overall Study|Death|7|||
125876092|NCT04038359|452841847|FG000|Overall Study|Lost to Follow-up|3|||
125876093|NCT04038359|452841848|FG001|Overall Study|Lost to Follow-up|0|||
125876094|NCT04038359|452841847|FG000|Overall Study|Participant Moved|1|||
125876095|NCT04038359|452841848|FG001|Overall Study|Participant Moved|0|||
125876096|NCT04038359|452841847|FG000|Overall Study|Withdrawal by Subject|4|||
125876097|NCT04038359|452841848|FG001|Overall Study|Withdrawal by Subject|3|||
125876098|NCT04038359|452841847|FG000|Overall Study|Physician Decision|3|||
125876099|NCT04038359|452841848|FG001|Overall Study|Physician Decision|2|||
125876100|NCT04038359|452841847|FG000|Overall Study|Adverse Event|0|||
125876101|NCT04038359|452841848|FG001|Overall Study|Adverse Event|2|||
125876102|NCT04038359|452841847|FG000|Overall Study|Progressive Disease|0|||
125876103|NCT04038359|452841848|FG001|Overall Study|Progressive Disease|1|||
125876104|NCT00703014|452841849|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
125876105|NCT00703014|452841850|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
125876106|NCT00703014|452841851|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125876107|NCT00703014|452841852|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125876108|NCT00703014|452841849|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125876109|NCT00703014|452841850|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125876110|NCT00703014|452841851|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
125876111|NCT00703014|452841852|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
125876112|NCT05121766|452841853|FG000|Overall Study|Covid reinfection|3|||
125876113|NCT05121766|452841854|FG001|Overall Study|Covid reinfection|0|||
125876114|NCT05121766|452841853|FG000|Overall Study|Withdrawal by Subject|3|||
125876115|NCT05121766|452841854|FG001|Overall Study|Withdrawal by Subject|1|||
125876116|NCT05121766|452841853|FG000|Overall Study|Adverse Event|2|||
125876117|NCT05121766|452841854|FG001|Overall Study|Adverse Event|4|||
125876118|NCT05121766|452841853|FG000|Overall Study|Lost to Follow-up|0|||
125876119|NCT05121766|452841854|FG001|Overall Study|Lost to Follow-up|1|||
125876120|NCT01033240|452841858|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
125876121|NCT01033240|452841859|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
125876122|NCT01033240|452841860|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
125876123|NCT01033240|452841858|FG000|Overall Study|Death|2|||
125876124|NCT01033240|452841859|FG001|Overall Study|Death|0|||
125876125|NCT01033240|452841860|FG002|Overall Study|Death|0|||
125876126|NCT01033240|452841858|FG000|Overall Study|Withdrew Consent|2|||
125876127|NCT01033240|452841859|FG001|Overall Study|Withdrew Consent|9|||
125876128|NCT01033240|452841860|FG002|Overall Study|Withdrew Consent|2|||
125876129|NCT01033240|452841858|FG000|Overall Study|Disease Progression|35|||
125876130|NCT01033240|452841859|FG001|Overall Study|Disease Progression|32|||
125876131|NCT01033240|452841860|FG002|Overall Study|Disease Progression|41|||
125876132|NCT01033240|452841858|FG000|Overall Study|Investigator Discretion|0|||
125876133|NCT01033240|452841859|FG001|Overall Study|Investigator Discretion|0|||
125876134|NCT01033240|452841860|FG002|Overall Study|Investigator Discretion|2|||
125876135|NCT01033240|452841858|FG000|Overall Study|Other|0|||
125876136|NCT01033240|452841859|FG001|Overall Study|Other|1|||
125876137|NCT01033240|452841860|FG002|Overall Study|Other|2|||
125876138|NCT05468814|452841861|FG000|Overall Study|Lost to Follow-up|5|||
125876139|NCT05468814|452841862|FG001|Overall Study|Lost to Follow-up|6|||
125876140|NCT04716426|452841864|FG000|Overall Study|Vaccination|1|||
125876141|NCT04716426|452841865|FG001|Overall Study|Vaccination|1|||
125876142|NCT04716426|452841864|FG000|Overall Study|Contamination|1|||
125876143|NCT04716426|452841865|FG001|Overall Study|Contamination|0|||
125876144|NCT00551759|452841866|FG000|Overall Study|Adverse Event|7|||
125876145|NCT00551759|452841866|FG000|Overall Study|Death|5|||
125876146|NCT00551759|452841866|FG000|Overall Study|Ineligible|1|||
125876147|NCT02960217|452841867|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
125876148|NCT02960217|452841868|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
125876149|NCT02960217|452841867|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
125876150|NCT02960217|452841868|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
125876151|NCT02960217|452841867|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
125876152|NCT02960217|452841868|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
125876153|NCT02960217|452841867|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
125876154|NCT02960217|452841868|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
125876155|NCT02960217|452841867|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
125876156|NCT02960217|452841868|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
126090453|NCT01840410|453623572|FG000|Overall Study|Protocol deviation|1|||
125876157|NCT02960217|452841867|FG000|Open-Label Extension Phase|Adverse Event|1|||
125876158|NCT02960217|452841868|FG001|Open-Label Extension Phase|Adverse Event|0|||
125876159|NCT02960217|452841867|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
125876160|NCT02960217|452841868|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
125876161|NCT02960217|452841867|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
125876162|NCT02960217|452841868|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
125876163|NCT02960217|452841867|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
125876164|NCT02960217|452841868|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
126316822|NCT00662558|454450815|FG000|Overall Study|Adverse Event|21|||
126316823|NCT00662558|454450816|FG001|Overall Study|Adverse Event|59|||
126316824|NCT00662558|454450815|FG000|Overall Study|Lack of Efficacy|4|||
126316825|NCT00662558|454450816|FG001|Overall Study|Lack of Efficacy|7|||
126316826|NCT00662558|454450815|FG000|Overall Study|Lost to Follow-up|13|||
126316827|NCT00662558|454450816|FG001|Overall Study|Lost to Follow-up|10|||
126316828|NCT00662558|454450815|FG000|Overall Study|Other|9|||
126316829|NCT00662558|454450816|FG001|Overall Study|Other|14|||
126316830|NCT00662558|454450815|FG000|Overall Study|Withdrawal by Subject|7|||
126316831|NCT00662558|454450816|FG001|Overall Study|Withdrawal by Subject|12|||
126316832|NCT00662558|454450815|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
126316833|NCT00662558|454450816|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
126316834|NCT00329641|454450817|FG000|Overall Study|Did not start treatment|1|||
126316835|NCT00329641|454450817|FG000|Overall Study|Not eligible|1|||
126316836|NCT00329641|454450817|FG000|Overall Study|Adverse Event|3|||
126316837|NCT00329641|454450817|FG000|Overall Study|Other reason, not protocol specified|1|||
126316838|NCT00783224|454450818|FG000|Overall Study|Adverse Event|0|||
126316839|NCT00783224|454450819|FG001|Overall Study|Adverse Event|0|||
126316840|NCT00783224|454450820|FG002|Overall Study|Adverse Event|1|||
126316841|NCT00783224|454450821|FG003|Overall Study|Adverse Event|0|||
126316842|NCT00783224|454450818|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
126316843|NCT00783224|454450819|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
126316844|NCT00783224|454450820|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
126316845|NCT00783224|454450821|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
126316846|NCT00783224|454450818|FG000|Overall Study|Inappropriate as a study subject|0|||
126316847|NCT00783224|454450819|FG001|Overall Study|Inappropriate as a study subject|0|||
126316848|NCT00783224|454450820|FG002|Overall Study|Inappropriate as a study subject|0|||
126316849|NCT00783224|454450821|FG003|Overall Study|Inappropriate as a study subject|1|||
126316850|NCT01711619|454450822|FG000|Overall Study|Early study termination|10|||
126316851|NCT01711619|454450823|FG001|Overall Study|Early study termination|14|||
126316852|NCT01711619|454450822|FG000|Overall Study|Withdrawal by Subject|3|||
126316853|NCT01711619|454450823|FG001|Overall Study|Withdrawal by Subject|7|||
126316854|NCT01711619|454450822|FG000|Overall Study|Protocol Violation|2|||
126316855|NCT01711619|454450823|FG001|Overall Study|Protocol Violation|3|||
126316856|NCT01711619|454450822|FG000|Overall Study|Adverse Event|2|||
126316857|NCT01711619|454450823|FG001|Overall Study|Adverse Event|0|||
126316858|NCT01711619|454450822|FG000|Overall Study|Lost to Follow-up|1|||
126316859|NCT01711619|454450823|FG001|Overall Study|Lost to Follow-up|0|||
126316860|NCT00401960|454450830|FG000|Overall Study|Lost to Follow-up|3|||
126316861|NCT00401960|454450831|FG001|Overall Study|Lost to Follow-up|0|||
126316862|NCT00401960|454450830|FG000|Overall Study|Death|2|||
126316863|NCT00401960|454450831|FG001|Overall Study|Death|0|||
126316864|NCT02649426|454450832|FG000|Overall Study|Follow-up on going|1|||
126316865|NCT02649426|454450833|FG001|Overall Study|Follow-up on going|26|||
126316866|NCT02649426|454450834|FG002|Overall Study|Follow-up on going|28|||
126316867|NCT02649426|454450835|FG003|Overall Study|Follow-up on going|31|||
126316868|NCT02584959|454450836|FG000|Period 1|Withdrawn from study|3|||
125876165|NCT00625131|452841871|FG000|Overall Study|Lost to Follow-up|3|||
125876166|NCT00625131|452841872|FG001|Overall Study|Lost to Follow-up|2|||
125876167|NCT00625131|452841873|FG002|Overall Study|Lost to Follow-up|0|||
125876168|NCT00625131|452841871|FG000|Overall Study|Withdrawal by Subject|1|||
125876169|NCT00625131|452841872|FG001|Overall Study|Withdrawal by Subject|0|||
125876170|NCT00625131|452841873|FG002|Overall Study|Withdrawal by Subject|5|||
125876171|NCT02138890|452841878|FG000|Overall Study|Adverse Event|1|||
125876172|NCT02138890|452841879|FG001|Overall Study|Adverse Event|0|||
125876173|NCT01446159|452841880|FG000|Overall Study|Withdrawal by Subject|1|||
125876174|NCT01446159|452841881|FG001|Overall Study|Withdrawal by Subject|0|||
125876175|NCT01446159|452841882|FG002|Overall Study|Withdrawal by Subject|14|||
125876176|NCT01446159|452841883|FG003|Overall Study|Withdrawal by Subject|11|||
125876177|NCT01446159|452841880|FG000|Overall Study|Lost to Follow-up|0|||
125876178|NCT01446159|452841881|FG001|Overall Study|Lost to Follow-up|0|||
126316869|NCT02584959|454450837|FG001|Period 1|Withdrawn from study|4|||
126316870|NCT02584959|454450838|FG002|Period 1|Withdrawn from study|0|||
126316871|NCT02584959|454450836|FG000|Period 2|Withdrawn from study|6|||
126316872|NCT02584959|454450837|FG001|Period 2|Withdrawn from study|1|||
126316873|NCT02584959|454450838|FG002|Period 2|Withdrawn from study|2|||
125876179|NCT01446159|452841882|FG002|Overall Study|Lost to Follow-up|1|||
126316874|NCT00195494|454450841|FG000|Year 1|Adverse Event|0|||
126316875|NCT00195494|454450842|FG001|Year 1|Adverse Event|0|||
125876180|NCT01446159|452841883|FG003|Overall Study|Lost to Follow-up|2|||
125876181|NCT01446159|452841880|FG000|Overall Study|Death|2|||
125876182|NCT01446159|452841881|FG001|Overall Study|Death|3|||
125876183|NCT01446159|452841882|FG002|Overall Study|Death|43|||
125876184|NCT01446159|452841883|FG003|Overall Study|Death|36|||
125876185|NCT01446159|452841880|FG000|Overall Study|Other|0|||
125876186|NCT01446159|452841881|FG001|Overall Study|Other|0|||
125876187|NCT01446159|452841882|FG002|Overall Study|Other|13|||
125876188|NCT01446159|452841883|FG003|Overall Study|Other|13|||
125876189|NCT00795535|452841886|FG000|Overall Study|incomplete data and technical problems|20|||
125876190|NCT01420861|452841889|FG000|Overall Study|Adverse Event|2|||
125876191|NCT01420861|452841889|FG000|Overall Study|Study terminated by Sponsor|7|||
125876192|NCT01420861|452841889|FG000|Overall Study|Screen failure|7|||
125876193|NCT01420861|452841889|FG000|Overall Study|Randomized not Treated|2|||
125876194|NCT01247324|452841890|FG000|Overall Study|Death|6|||
125876195|NCT01247324|452841891|FG001|Overall Study|Death|10|||
125876196|NCT01247324|452841890|FG000|Overall Study|Physician Decision|2|||
125876197|NCT01247324|452841891|FG001|Overall Study|Physician Decision|3|||
125876198|NCT01247324|452841890|FG000|Overall Study|Non-compliance with study drug|3|||
125876199|NCT01247324|452841891|FG001|Overall Study|Non-compliance with study drug|0|||
125876200|NCT01247324|452841890|FG000|Overall Study|Lack of Efficacy|24|||
125876201|NCT01247324|452841891|FG001|Overall Study|Lack of Efficacy|14|||
125876202|NCT01247324|452841890|FG000|Overall Study|Non-compliance|3|||
125876203|NCT01247324|452841891|FG001|Overall Study|Non-compliance|2|||
125876204|NCT01247324|452841890|FG000|Overall Study|Pregnancy|5|||
125876205|NCT01247324|452841891|FG001|Overall Study|Pregnancy|10|||
125876206|NCT01247324|452841890|FG000|Overall Study|Protocol Violation|1|||
125876207|NCT01247324|452841891|FG001|Overall Study|Protocol Violation|1|||
125876208|NCT01247324|452841890|FG000|Overall Study|Reason not specified|42|||
125876209|NCT01247324|452841891|FG001|Overall Study|Reason not specified|32|||
125876210|NCT01247324|452841890|FG000|Overall Study|Consent withdrawn by participant|41|||
125876211|NCT01247324|452841891|FG001|Overall Study|Consent withdrawn by participant|56|||
125876212|NCT01247324|452841890|FG000|Overall Study|Adverse Event|49|||
125876213|NCT01247324|452841891|FG001|Overall Study|Adverse Event|35|||
125876214|NCT01247324|452841890|FG000|Overall Study|Lost to Follow-up|3|||
125876215|NCT01247324|452841891|FG001|Overall Study|Lost to Follow-up|6|||
125876216|NCT01247324|452841890|FG000|Overall Study|Study Terminated by Sponsor|4|||
125876217|NCT01247324|452841891|FG001|Overall Study|Study Terminated by Sponsor|1|||
125876218|NCT01247324|452841890|FG000|Overall Study|Missing|2|||
125876219|NCT01247324|452841891|FG001|Overall Study|Missing|1|||
125876220|NCT00668148|452841905|FG000|Overall Study|Adverse Event|5|||
125876221|NCT00668148|452841905|FG000|Overall Study|Subject Non-compliance|1|||
125876222|NCT00668148|452841905|FG000|Overall Study|Progressive Disease Before Treatment|2|||
125876223|NCT00668148|452841905|FG000|Overall Study|Withdrawal of Consent|2|||
125876224|NCT01766050|452843911|FG000|Overall Study|Adverse Event|1|||
125876225|NCT01766050|452843911|FG000|Overall Study|Lost to Follow-up|1|||
125876226|NCT01766050|452843911|FG000|Overall Study|Withdrawal by Subject|2|||
125876227|NCT01910298|452843917|FG000|Overall Study|Adverse Event|1|||
125876228|NCT01910298|452843918|FG001|Overall Study|Adverse Event|0|||
125876229|NCT01910298|452843917|FG000|Overall Study|Withdrawal by Subject|2|||
125876230|NCT01910298|452843918|FG001|Overall Study|Withdrawal by Subject|7|||
125876231|NCT01910298|452843917|FG000|Overall Study|Protocol Deviation|0|||
125876232|NCT01910298|452843918|FG001|Overall Study|Protocol Deviation|5|||
125876233|NCT01910298|452843917|FG000|Overall Study|Lost to Follow-up|1|||
125876234|NCT01910298|452843918|FG001|Overall Study|Lost to Follow-up|1|||
125876235|NCT01910298|452843917|FG000|Overall Study|Study Terminated by Sponsor|1|||
125876236|NCT01910298|452843918|FG001|Overall Study|Study Terminated by Sponsor|17|||
125876237|NCT01910298|452843917|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125876238|NCT01910298|452843918|FG001|Overall Study|Other Miscellaneous Reasons|2|||
125876239|NCT03037385|452843922|FG000|Overall Study|Adverse Event|0|||
125876240|NCT03037385|452843923|FG001|Overall Study|Adverse Event|0|||
125876241|NCT03037385|452843924|FG002|Overall Study|Adverse Event|1|||
125876242|NCT03037385|452843925|FG003|Overall Study|Adverse Event|0|||
125876243|NCT03037385|452843926|FG004|Overall Study|Adverse Event|0|||
125876244|NCT03037385|452843927|FG005|Overall Study|Adverse Event|0|||
125876245|NCT03037385|452843928|FG006|Overall Study|Adverse Event|0|||
125876246|NCT03037385|452843929|FG007|Overall Study|Adverse Event|0|||
125876247|NCT03037385|452843930|FG008|Overall Study|Adverse Event|0|||
125876248|NCT03037385|452843931|FG009|Overall Study|Adverse Event|6|||
125876249|NCT03037385|452843922|FG000|Overall Study|Death|1|||
125876250|NCT03037385|452843923|FG001|Overall Study|Death|4|||
125876251|NCT03037385|452843924|FG002|Overall Study|Death|2|||
125876252|NCT03037385|452843925|FG003|Overall Study|Death|2|||
125876253|NCT03037385|452843926|FG004|Overall Study|Death|5|||
125876254|NCT03037385|452843927|FG005|Overall Study|Death|2|||
125876255|NCT03037385|452843928|FG006|Overall Study|Death|1|||
125876256|NCT03037385|452843929|FG007|Overall Study|Death|4|||
126316876|NCT00195494|454450843|FG002|Year 1|Adverse Event|0|||
125876257|NCT03037385|452843930|FG008|Overall Study|Death|3|||
125876258|NCT03037385|452843931|FG009|Overall Study|Death|240|||
125876259|NCT03037385|452843922|FG000|Overall Study|Initiation of Another Therapy|1|||
125876260|NCT03037385|452843923|FG001|Overall Study|Initiation of Another Therapy|0|||
125876261|NCT03037385|452843924|FG002|Overall Study|Initiation of Another Therapy|0|||
125876262|NCT03037385|452843925|FG003|Overall Study|Initiation of Another Therapy|0|||
125876263|NCT03037385|452843926|FG004|Overall Study|Initiation of Another Therapy|0|||
125876264|NCT03037385|452843927|FG005|Overall Study|Initiation of Another Therapy|0|||
125876265|NCT03037385|452843928|FG006|Overall Study|Initiation of Another Therapy|0|||
125876266|NCT03037385|452843929|FG007|Overall Study|Initiation of Another Therapy|1|||
125876267|NCT03037385|452843930|FG008|Overall Study|Initiation of Another Therapy|0|||
125876268|NCT03037385|452843931|FG009|Overall Study|Initiation of Another Therapy|2|||
125876269|NCT03037385|452843922|FG000|Overall Study|Lost to Follow-up|0|||
125876270|NCT03037385|452843923|FG001|Overall Study|Lost to Follow-up|0|||
125876271|NCT03037385|452843924|FG002|Overall Study|Lost to Follow-up|0|||
125876272|NCT03037385|452843925|FG003|Overall Study|Lost to Follow-up|0|||
125876273|NCT03037385|452843926|FG004|Overall Study|Lost to Follow-up|0|||
125876274|NCT03037385|452843927|FG005|Overall Study|Lost to Follow-up|1|||
125876275|NCT03037385|452843928|FG006|Overall Study|Lost to Follow-up|0|||
125876276|NCT03037385|452843929|FG007|Overall Study|Lost to Follow-up|0|||
125876277|NCT03037385|452843930|FG008|Overall Study|Lost to Follow-up|0|||
125876278|NCT03037385|452843931|FG009|Overall Study|Lost to Follow-up|16|||
125876279|NCT03037385|452843922|FG000|Overall Study|Physician Decision|0|||
125876280|NCT03037385|452843923|FG001|Overall Study|Physician Decision|0|||
125876281|NCT03037385|452843924|FG002|Overall Study|Physician Decision|0|||
125876282|NCT03037385|452843925|FG003|Overall Study|Physician Decision|0|||
125876283|NCT03037385|452843926|FG004|Overall Study|Physician Decision|0|||
125876284|NCT03037385|452843927|FG005|Overall Study|Physician Decision|0|||
125876285|NCT03037385|452843928|FG006|Overall Study|Physician Decision|0|||
125876286|NCT03037385|452843929|FG007|Overall Study|Physician Decision|0|||
125876287|NCT03037385|452843930|FG008|Overall Study|Physician Decision|0|||
125876288|NCT03037385|452843931|FG009|Overall Study|Physician Decision|1|||
125876289|NCT03037385|452843922|FG000|Overall Study|Progressive Disease|0|||
125876290|NCT03037385|452843923|FG001|Overall Study|Progressive Disease|1|||
125876291|NCT03037385|452843924|FG002|Overall Study|Progressive Disease|1|||
125876292|NCT03037385|452843925|FG003|Overall Study|Progressive Disease|5|||
125876293|NCT03037385|452843926|FG004|Overall Study|Progressive Disease|2|||
125876294|NCT03037385|452843927|FG005|Overall Study|Progressive Disease|0|||
125876295|NCT03037385|452843928|FG006|Overall Study|Progressive Disease|1|||
125876296|NCT03037385|452843929|FG007|Overall Study|Progressive Disease|0|||
125876297|NCT03037385|452843930|FG008|Overall Study|Progressive Disease|0|||
125876298|NCT03037385|452843931|FG009|Overall Study|Progressive Disease|30|||
125876299|NCT03037385|452843922|FG000|Overall Study|Withdrawal by Subject|0|||
125876300|NCT03037385|452843923|FG001|Overall Study|Withdrawal by Subject|0|||
125876301|NCT03037385|452843924|FG002|Overall Study|Withdrawal by Subject|1|||
125876302|NCT03037385|452843925|FG003|Overall Study|Withdrawal by Subject|2|||
125876303|NCT03037385|452843926|FG004|Overall Study|Withdrawal by Subject|1|||
125876304|NCT03037385|452843927|FG005|Overall Study|Withdrawal by Subject|3|||
125876305|NCT03037385|452843928|FG006|Overall Study|Withdrawal by Subject|0|||
125876306|NCT03037385|452843929|FG007|Overall Study|Withdrawal by Subject|0|||
125876307|NCT03037385|452843930|FG008|Overall Study|Withdrawal by Subject|0|||
125876308|NCT03037385|452843931|FG009|Overall Study|Withdrawal by Subject|52|||
125876309|NCT03037385|452843922|FG000|Overall Study|Reason Not Specified|0|||
125876310|NCT03037385|452843923|FG001|Overall Study|Reason Not Specified|1|||
125876311|NCT03037385|452843924|FG002|Overall Study|Reason Not Specified|0|||
125876312|NCT03037385|452843925|FG003|Overall Study|Reason Not Specified|4|||
125876313|NCT03037385|452843926|FG004|Overall Study|Reason Not Specified|3|||
125876314|NCT03037385|452843927|FG005|Overall Study|Reason Not Specified|6|||
125876315|NCT03037385|452843928|FG006|Overall Study|Reason Not Specified|2|||
125876316|NCT03037385|452843929|FG007|Overall Study|Reason Not Specified|0|||
125876317|NCT03037385|452843930|FG008|Overall Study|Reason Not Specified|1|||
125876318|NCT03037385|452843931|FG009|Overall Study|Reason Not Specified|181|||
125876319|NCT04607668|452843939|FG000|Overall Study|Death|49|||
125876320|NCT04607668|452843940|FG001|Overall Study|Death|26|||
125876321|NCT04607668|452843939|FG000|Overall Study|Lost to Follow-up|3|||
125876322|NCT04607668|452843940|FG001|Overall Study|Lost to Follow-up|4|||
125876323|NCT04607668|452843939|FG000|Overall Study|Study terminated by Sponsor|92|||
125876324|NCT04607668|452843940|FG001|Overall Study|Study terminated by Sponsor|114|||
125876325|NCT04607668|452843939|FG000|Overall Study|Withdrawal by Subject|12|||
125876326|NCT04607668|452843940|FG001|Overall Study|Withdrawal by Subject|11|||
125876327|NCT04607668|452843939|FG000|Overall Study|Other, unspecified|8|||
125876328|NCT04607668|452843940|FG001|Overall Study|Other, unspecified|7|||
125876329|NCT01838694|452843941|FG000|Overall Study|Adverse Event|0|||
125876330|NCT01838694|452843942|FG001|Overall Study|Adverse Event|1|||
126208377|NCT01740297|454051321|FG001|Overall Study|Withdrawal by Subject|16|||
125876331|NCT00672555|452843943|FG000|Overall Study|Lost to Follow-up|4|||
125876332|NCT00672555|452843943|FG000|Overall Study|Did not want to answer questionnaire|2|||
125876333|NCT03623243|452843944|FG000|Overall Study|Adverse Event|15|||
125876334|NCT03623243|452843944|FG000|Overall Study|Guardian Decision|1|||
125876335|NCT03623243|452843944|FG000|Overall Study|New Therapy for Study Indication|1|||
125876336|NCT03623243|452843944|FG000|Overall Study|Protocol Deviation|3|||
125876337|NCT03623243|452843944|FG000|Overall Study|Physician Decision|4|||
125876338|NCT03623243|452843944|FG000|Overall Study|Patient Decision|15|||
125876339|NCT02153086|452843947|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
125876340|NCT02153086|452843947|FG000|Overall Study|Other|2|||
125876341|NCT03780452|452843951|FG000|Overall Study|Screening failure|2|||
125876342|NCT03186209|452843956|FG000|Overall Study|Withdrawal by Subject|11|||
125876343|NCT03186209|452843957|FG001|Overall Study|Withdrawal by Subject|22|||
125876344|NCT03186209|452843956|FG000|Overall Study|Pregnancy|1|||
125876345|NCT03186209|452843957|FG001|Overall Study|Pregnancy|0|||
125876346|NCT03186209|452843956|FG000|Overall Study|Adverse Event|4|||
125876347|NCT03186209|452843957|FG001|Overall Study|Adverse Event|0|||
125876348|NCT03186209|452843956|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
125876349|NCT03186209|452843957|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
125876350|NCT03186209|452843956|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
125876351|NCT03186209|452843957|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
125876352|NCT03186209|452843956|FG000|Overall Study|Fail to meet randomization criteria|0|||
125876353|NCT03186209|452843957|FG001|Overall Study|Fail to meet randomization criteria|1|||
125876354|NCT03186209|452843956|FG000|Overall Study|Lost to Follow-up|0|||
125876355|NCT03186209|452843957|FG001|Overall Study|Lost to Follow-up|1|||
125876356|NCT03796728|452843959|FG000|Overall Study|Lost to Follow-up|8|||
125876357|NCT03796728|452843959|FG000|Overall Study|Reason not Specified|16|||
125876358|NCT00333775|452843960|FG000|Overall Study|Death|144|||
125876359|NCT00333775|452843961|FG001|Overall Study|Death|149|||
125876360|NCT00333775|452843962|FG002|Overall Study|Death|143|||
125876361|NCT00333775|452843960|FG000|Overall Study|In Follow-up When Study Stopped|87|||
125876362|NCT00333775|452843961|FG001|Overall Study|In Follow-up When Study Stopped|92|||
125876363|NCT00333775|452843962|FG002|Overall Study|In Follow-up When Study Stopped|96|||
125876364|NCT00333775|452843960|FG000|Overall Study|Lost to Follow-up|10|||
125876365|NCT00333775|452843961|FG001|Overall Study|Lost to Follow-up|7|||
125876366|NCT00333775|452843962|FG002|Overall Study|Lost to Follow-up|8|||
125876367|NCT01383928|452843966|FG000|Overall Study|Initiation of ASCT|2|||
125876368|NCT01383928|452843967|FG001|Overall Study|Initiation of ASCT|1|||
125876369|NCT01383928|452843968|FG002|Overall Study|Initiation of ASCT|18|||
125876370|NCT01383928|452843966|FG000|Overall Study|Adverse Event|1|||
125876371|NCT01383928|452843967|FG001|Overall Study|Adverse Event|2|||
125876372|NCT01383928|452843968|FG002|Overall Study|Adverse Event|8|||
125876373|NCT01383928|452843966|FG000|Overall Study|Other|1|||
125876374|NCT01383928|452843967|FG001|Overall Study|Other|3|||
125876375|NCT01383928|452843968|FG002|Overall Study|Other|4|||
125876376|NCT01383928|452843966|FG000|Overall Study|Progressive Disease|1|||
125876377|NCT01383928|452843967|FG001|Overall Study|Progressive Disease|1|||
125876378|NCT01383928|452843968|FG002|Overall Study|Progressive Disease|5|||
125876379|NCT01383928|452843966|FG000|Overall Study|Withdrawal by Subject|0|||
125876380|NCT01383928|452843967|FG001|Overall Study|Withdrawal by Subject|0|||
125876381|NCT01383928|452843968|FG002|Overall Study|Withdrawal by Subject|4|||
125876382|NCT01383928|452843966|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
125876383|NCT01383928|452843967|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125876384|NCT01383928|452843968|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
125876385|NCT03651765|452843973|FG000|Overall Study|Adverse Event|6|||
125876386|NCT03651765|452843973|FG000|Overall Study|Lack of Efficacy|18|||
125876387|NCT03651765|452843973|FG000|Overall Study|Lost to Follow-up|5|||
125876388|NCT03651765|452843973|FG000|Overall Study|Non-Compliance with Study Drug|4|||
125876389|NCT03651765|452843973|FG000|Overall Study|Physician Decision|6|||
125876390|NCT03651765|452843973|FG000|Overall Study|Pregnancy|1|||
125876391|NCT03651765|452843973|FG000|Overall Study|Discontinued by Sponsor|40|||
125876392|NCT03651765|452843973|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
125876393|NCT03651765|452843973|FG000|Overall Study|Withdrawal by Subject|24|||
125876394|NCT03651765|452843973|FG000|Overall Study|Miscellaneous|6|||
125876395|NCT04842747|452843983|FG000|Overall Study|Withdrawal by Subject|6|||
125876396|NCT04842747|452843984|FG001|Overall Study|Withdrawal by Subject|2|||
125876397|NCT04842747|452843983|FG000|Overall Study|Lost to Follow-up|1|||
125876398|NCT04842747|452843984|FG001|Overall Study|Lost to Follow-up|2|||
125876399|NCT04842747|452843983|FG000|Overall Study|Physician Decision|1|||
125876400|NCT04842747|452843984|FG001|Overall Study|Physician Decision|0|||
125876401|NCT04842747|452843983|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
125876402|NCT04842747|452843984|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
125876403|NCT01743469|452843985|FG000|Active Treatment Phase|Adverse Event|10|||
125876404|NCT01743469|452843986|FG001|Active Treatment Phase|Adverse Event|5|||
125876405|NCT01743469|452843987|FG002|Active Treatment Phase|Adverse Event|8|||
125876406|NCT01743469|452843988|FG003|Active Treatment Phase|Adverse Event|1|||
125876407|NCT01743469|452843985|FG000|Active Treatment Phase|Disease Progression|40|||
125876408|NCT01743469|452843986|FG001|Active Treatment Phase|Disease Progression|47|||
125876409|NCT01743469|452843987|FG002|Active Treatment Phase|Disease Progression|30|||
125876410|NCT01743469|452843988|FG003|Active Treatment Phase|Disease Progression|20|||
125876411|NCT01743469|452843985|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
125876412|NCT01743469|452843986|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
126316877|NCT00195494|454450844|FG003|Year 1|Adverse Event|0|||
126316878|NCT00195494|454450845|FG004|Year 1|Adverse Event|34|||
126316879|NCT00195494|454450846|FG005|Year 1|Adverse Event|27|||
126316880|NCT00195494|454450841|FG000|Year 1|System Toxicity|0|||
126316881|NCT00195494|454450842|FG001|Year 1|System Toxicity|0|||
126316882|NCT00195494|454450843|FG002|Year 1|System Toxicity|0|||
126316883|NCT00195494|454450844|FG003|Year 1|System Toxicity|0|||
126316884|NCT00195494|454450845|FG004|Year 1|System Toxicity|0|||
126316885|NCT00195494|454450846|FG005|Year 1|System Toxicity|1|||
126316886|NCT00195494|454450841|FG000|Year 1|Lack of Efficacy|0|||
126316887|NCT00195494|454450842|FG001|Year 1|Lack of Efficacy|0|||
126316888|NCT00195494|454450843|FG002|Year 1|Lack of Efficacy|0|||
126316889|NCT00195494|454450844|FG003|Year 1|Lack of Efficacy|0|||
126316890|NCT00195494|454450845|FG004|Year 1|Lack of Efficacy|24|||
126316891|NCT00195494|454450846|FG005|Year 1|Lack of Efficacy|9|||
126316892|NCT00195494|454450841|FG000|Year 1|Compliance|0|||
126316893|NCT00195494|454450842|FG001|Year 1|Compliance|0|||
126316894|NCT00195494|454450843|FG002|Year 1|Compliance|0|||
126316895|NCT00195494|454450844|FG003|Year 1|Compliance|0|||
126316896|NCT00195494|454450845|FG004|Year 1|Compliance|5|||
126316897|NCT00195494|454450846|FG005|Year 1|Compliance|1|||
126316898|NCT00195494|454450841|FG000|Year 1|Lost to Follow-up|0|||
126316899|NCT00195494|454450842|FG001|Year 1|Lost to Follow-up|0|||
126316900|NCT00195494|454450843|FG002|Year 1|Lost to Follow-up|0|||
126316901|NCT00195494|454450844|FG003|Year 1|Lost to Follow-up|0|||
126316902|NCT00195494|454450845|FG004|Year 1|Lost to Follow-up|1|||
126316903|NCT00195494|454450846|FG005|Year 1|Lost to Follow-up|0|||
126316904|NCT00195494|454450841|FG000|Year 1|Missed >4 consecutive doses|0|||
126316905|NCT00195494|454450842|FG001|Year 1|Missed >4 consecutive doses|0|||
126316906|NCT00195494|454450843|FG002|Year 1|Missed >4 consecutive doses|0|||
126316907|NCT00195494|454450844|FG003|Year 1|Missed >4 consecutive doses|0|||
126316908|NCT00195494|454450845|FG004|Year 1|Missed >4 consecutive doses|3|||
126316909|NCT00195494|454450846|FG005|Year 1|Missed >4 consecutive doses|2|||
126316910|NCT00195494|454450841|FG000|Year 1|Protocol deviation|0|||
126316911|NCT00195494|454450842|FG001|Year 1|Protocol deviation|0|||
126316912|NCT00195494|454450843|FG002|Year 1|Protocol deviation|0|||
126316913|NCT00195494|454450844|FG003|Year 1|Protocol deviation|0|||
126316914|NCT00195494|454450845|FG004|Year 1|Protocol deviation|2|||
126316915|NCT00195494|454450846|FG005|Year 1|Protocol deviation|3|||
126316916|NCT00195494|454450841|FG000|Year 1|Physician Decision|0|||
126316917|NCT00195494|454450842|FG001|Year 1|Physician Decision|0|||
126316918|NCT00195494|454450843|FG002|Year 1|Physician Decision|0|||
126208378|NCT01740297|454051322|FG002|Overall Study|Withdrawal by Subject|17|||
126208379|NCT01740297|454051320|FG000|Overall Study|Death|8|||
126208380|NCT01740297|454051321|FG001|Overall Study|Death|46|||
126208381|NCT01740297|454051322|FG002|Overall Study|Death|40|||
126208382|NCT01740297|454051320|FG000|Overall Study|Lost to Follow-up|1|||
126208383|NCT01740297|454051321|FG001|Overall Study|Lost to Follow-up|2|||
126208384|NCT01740297|454051322|FG002|Overall Study|Lost to Follow-up|4|||
126208385|NCT00761462|454051327|FG000|Treatment|Subjects never received study medication|23|||
126208386|NCT00761462|454051328|FG001|Treatment|Subjects never received study medication|12|||
126208387|NCT00761462|454051327|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
126208388|NCT00761462|454051328|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
126208389|NCT00761462|454051327|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
126208390|NCT00761462|454051328|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
126208391|NCT00761462|454051327|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
126208392|NCT00761462|454051328|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
126208393|NCT01479777|454051329|FG000|Overall Study|Physician Decision|2|||
126208394|NCT01541644|454051338|FG000|Overall Study|Withdrawal by Subject|3|||
126208395|NCT02389621|454051341|FG000|Treatment Period|Withdrawal by Subject|1|||
126208396|NCT02389621|454051342|FG001|Treatment Period|Withdrawal by Subject|1|||
126208397|NCT02389621|454051341|FG000|Posttreatment Period|Adverse Event|3|||
126208398|NCT02389621|454051342|FG001|Posttreatment Period|Adverse Event|1|||
126208399|NCT02389621|454051341|FG000|Posttreatment Period|Withdrawal by Subject|3|||
126208400|NCT02389621|454051342|FG001|Posttreatment Period|Withdrawal by Subject|2|||
126316919|NCT00195494|454450844|FG003|Year 1|Physician Decision|0|||
126316920|NCT00195494|454450845|FG004|Year 1|Physician Decision|1|||
126316921|NCT00195494|454450846|FG005|Year 1|Physician Decision|0|||
126316922|NCT00195494|454450841|FG000|Year 1|Withdrawal by Subject|0|||
126316923|NCT00195494|454450842|FG001|Year 1|Withdrawal by Subject|0|||
126316924|NCT00195494|454450843|FG002|Year 1|Withdrawal by Subject|0|||
126316925|NCT00195494|454450844|FG003|Year 1|Withdrawal by Subject|0|||
126316926|NCT00195494|454450845|FG004|Year 1|Withdrawal by Subject|8|||
126316927|NCT00195494|454450846|FG005|Year 1|Withdrawal by Subject|9|||
126316928|NCT00195494|454450841|FG000|Year 1|Protocol Violation|0|||
126316929|NCT00195494|454450842|FG001|Year 1|Protocol Violation|0|||
126316930|NCT00195494|454450843|FG002|Year 1|Protocol Violation|0|||
126316931|NCT00195494|454450844|FG003|Year 1|Protocol Violation|0|||
126316932|NCT00195494|454450845|FG004|Year 1|Protocol Violation|1|||
126316933|NCT00195494|454450846|FG005|Year 1|Protocol Violation|1|||
126316934|NCT00195494|454450841|FG000|Year 2|Adverse Event|3|||
126316935|NCT00195494|454450842|FG001|Year 2|Adverse Event|7|||
126316936|NCT00195494|454450843|FG002|Year 2|Adverse Event|5|||
126316937|NCT00195494|454450844|FG003|Year 2|Adverse Event|9|||
126316938|NCT00195494|454450845|FG004|Year 2|Adverse Event|0|||
126316939|NCT00195494|454450846|FG005|Year 2|Adverse Event|0|||
126316940|NCT00195494|454450841|FG000|Year 2|Lack of Efficacy|0|||
126316941|NCT00195494|454450842|FG001|Year 2|Lack of Efficacy|1|||
126316942|NCT00195494|454450843|FG002|Year 2|Lack of Efficacy|7|||
126316943|NCT00195494|454450844|FG003|Year 2|Lack of Efficacy|7|||
126316944|NCT00195494|454450845|FG004|Year 2|Lack of Efficacy|0|||
126316945|NCT00195494|454450846|FG005|Year 2|Lack of Efficacy|0|||
126316946|NCT00195494|454450841|FG000|Year 2|Compliance|1|||
126316947|NCT00195494|454450842|FG001|Year 2|Compliance|0|||
126316948|NCT00195494|454450843|FG002|Year 2|Compliance|0|||
126316949|NCT00195494|454450844|FG003|Year 2|Compliance|2|||
126316950|NCT00195494|454450845|FG004|Year 2|Compliance|0|||
126316951|NCT00195494|454450846|FG005|Year 2|Compliance|0|||
126316952|NCT00195494|454450841|FG000|Year 2|Lost to Follow-up|0|||
126316953|NCT00195494|454450842|FG001|Year 2|Lost to Follow-up|0|||
126316954|NCT00195494|454450843|FG002|Year 2|Lost to Follow-up|1|||
126316955|NCT00195494|454450844|FG003|Year 2|Lost to Follow-up|1|||
126316956|NCT00195494|454450845|FG004|Year 2|Lost to Follow-up|0|||
126316957|NCT00195494|454450846|FG005|Year 2|Lost to Follow-up|0|||
126316958|NCT00195494|454450841|FG000|Year 2|Missed >4 consecutive doses|1|||
126316959|NCT00195494|454450842|FG001|Year 2|Missed >4 consecutive doses|1|||
126316960|NCT00195494|454450843|FG002|Year 2|Missed >4 consecutive doses|1|||
126316961|NCT00195494|454450844|FG003|Year 2|Missed >4 consecutive doses|0|||
126316962|NCT00195494|454450845|FG004|Year 2|Missed >4 consecutive doses|0|||
126316963|NCT00195494|454450846|FG005|Year 2|Missed >4 consecutive doses|0|||
126316964|NCT00195494|454450841|FG000|Year 2|Protocol deviation|0|||
126316965|NCT00195494|454450842|FG001|Year 2|Protocol deviation|1|||
126316966|NCT00195494|454450843|FG002|Year 2|Protocol deviation|0|||
126316967|NCT00195494|454450844|FG003|Year 2|Protocol deviation|0|||
126316968|NCT00195494|454450845|FG004|Year 2|Protocol deviation|0|||
126316969|NCT00195494|454450846|FG005|Year 2|Protocol deviation|0|||
126316970|NCT00195494|454450841|FG000|Year 2|Physician Decision|1|||
126316971|NCT00195494|454450842|FG001|Year 2|Physician Decision|1|||
126316972|NCT00195494|454450843|FG002|Year 2|Physician Decision|0|||
126316973|NCT00195494|454450844|FG003|Year 2|Physician Decision|0|||
126316974|NCT00195494|454450845|FG004|Year 2|Physician Decision|0|||
126316975|NCT00195494|454450846|FG005|Year 2|Physician Decision|0|||
126316976|NCT00195494|454450841|FG000|Year 2|Withdrawal by Subject|1|||
126316977|NCT00195494|454450842|FG001|Year 2|Withdrawal by Subject|5|||
126316978|NCT00195494|454450843|FG002|Year 2|Withdrawal by Subject|4|||
126316979|NCT00195494|454450844|FG003|Year 2|Withdrawal by Subject|3|||
126316980|NCT00195494|454450845|FG004|Year 2|Withdrawal by Subject|0|||
126316981|NCT00195494|454450846|FG005|Year 2|Withdrawal by Subject|0|||
126316982|NCT00195494|454450841|FG000|Year 2|System toxicity|0|||
126316983|NCT00195494|454450842|FG001|Year 2|System toxicity|0|||
126316984|NCT00195494|454450843|FG002|Year 2|System toxicity|0|||
126316985|NCT00195494|454450844|FG003|Year 2|System toxicity|1|||
126316986|NCT00195494|454450845|FG004|Year 2|System toxicity|0|||
126316987|NCT00195494|454450846|FG005|Year 2|System toxicity|0|||
126316988|NCT03008278|454450847|FG000|Overall Study|Progressive Disease|0|||
126316989|NCT03008278|454450848|FG001|Overall Study|Progressive Disease|0|||
126316990|NCT03008278|454450849|FG002|Overall Study|Progressive Disease|32|||
126316991|NCT03008278|454450847|FG000|Overall Study|Adverse Event|0|||
126316992|NCT03008278|454450848|FG001|Overall Study|Adverse Event|0|||
126316993|NCT03008278|454450849|FG002|Overall Study|Adverse Event|4|||
126316994|NCT03008278|454450847|FG000|Overall Study|Withdrawal by Subject|0|||
126316995|NCT03008278|454450848|FG001|Overall Study|Withdrawal by Subject|0|||
126316996|NCT03008278|454450849|FG002|Overall Study|Withdrawal by Subject|3|||
126316997|NCT03008278|454450847|FG000|Overall Study|Physician Decision|0|||
126316998|NCT03008278|454450848|FG001|Overall Study|Physician Decision|2|||
126316999|NCT03008278|454450849|FG002|Overall Study|Physician Decision|0|||
126317000|NCT01217385|454450854|FG000|Overall Study|Withdrawal by Subject|3|||
126317001|NCT01217385|454450854|FG000|Overall Study|DOSI not performed/not eval|12|||
126317002|NCT01217385|454450854|FG000|Overall Study|Central Path not Available|1|||
126317003|NCT01217385|454450854|FG000|Overall Study|Normal Breast TOI not available|10|||
126317004|NCT00835679|454450856|FG000|Overall Study|Withdrawal by Subject|1|||
126317005|NCT00835679|454450857|FG001|Overall Study|Withdrawal by Subject|0|||
126317006|NCT00835679|454450858|FG002|Overall Study|Withdrawal by Subject|0|||
126317007|NCT00835679|454450859|FG003|Overall Study|Withdrawal by Subject|0|||
126317008|NCT04769739|454450861|FG000|Overall Study|Colorectal cancer obstruction|2|||
126317009|NCT04769739|454450862|FG001|Overall Study|Colorectal cancer obstruction|0|||
126317010|NCT04769739|454450863|FG002|Overall Study|Colorectal cancer obstruction|0|||
126317011|NCT04769739|454450864|FG003|Overall Study|Colorectal cancer obstruction|0|||
126317012|NCT04769739|454450861|FG000|Overall Study|Failed cecal intubation|1|||
126317013|NCT04769739|454450862|FG001|Overall Study|Failed cecal intubation|0|||
126317014|NCT04769739|454450863|FG002|Overall Study|Failed cecal intubation|0|||
126317015|NCT04769739|454450864|FG003|Overall Study|Failed cecal intubation|1|||
126317016|NCT04769739|454450861|FG000|Overall Study|Poor bowel preparation|0|||
126317017|NCT04769739|454450862|FG001|Overall Study|Poor bowel preparation|0|||
126317018|NCT04769739|454450863|FG002|Overall Study|Poor bowel preparation|0|||
126317019|NCT04769739|454450864|FG003|Overall Study|Poor bowel preparation|1|||
126317020|NCT03689543|454450866|FG000|Overall Study|Adverse Event|0|||
126317021|NCT03689543|454450867|FG001|Overall Study|Adverse Event|0|||
126317022|NCT03689543|454450868|FG002|Overall Study|Adverse Event|1|||
126317023|NCT01634659|454450874|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
126317024|NCT01634659|454450875|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
126317025|NCT01634659|454450874|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
126317026|NCT01634659|454450875|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
126317027|NCT02431806|454450876|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
126317028|NCT02431806|454450877|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
126317029|NCT02431806|454450878|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
126317030|NCT02431806|454450879|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
126317031|NCT02431806|454450876|FG000|Double-blind Treatment Period|Adverse Event|4|||
126317032|NCT02431806|454450877|FG001|Double-blind Treatment Period|Adverse Event|7|||
126317033|NCT02431806|454450878|FG002|Double-blind Treatment Period|Adverse Event|11|||
126317034|NCT02431806|454450879|FG003|Double-blind Treatment Period|Adverse Event|7|||
126317035|NCT02431806|454450876|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
126317036|NCT02431806|454450877|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
126317037|NCT02431806|454450878|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
126317038|NCT02431806|454450879|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
126317039|NCT02431806|454450876|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
126317040|NCT02431806|454450877|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
126317041|NCT02431806|454450878|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
126317042|NCT02431806|454450879|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
126317043|NCT02431806|454450876|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
126317044|NCT02431806|454450877|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
126317045|NCT02431806|454450878|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
126317046|NCT02431806|454450879|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
126317047|NCT02431806|454450876|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
126317048|NCT02431806|454450877|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
126317049|NCT02431806|454450878|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
126317050|NCT02431806|454450879|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
126317051|NCT02431806|454450876|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
126317052|NCT02431806|454450877|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
126317053|NCT02431806|454450878|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
126317054|NCT02431806|454450879|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
126317055|NCT03627416|454450880|FG000|Overall Study|Adverse Event|0|||
126317056|NCT03627416|454450881|FG001|Overall Study|Adverse Event|1|||
126317057|NCT02968433|454450882|FG000|Overall Study|Withdrawal by Subject|1|||
126317058|NCT03619902|454450883|FG000|Overall Study|Termination of Study by Investigator|1|||
126317059|NCT03619902|454450883|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
126317060|NCT04506905|454450884|FG000|Overall Study|Lost to Follow-up|1|||
126317061|NCT04506905|454450885|FG001|Overall Study|Lost to Follow-up|0|||
126317062|NCT04506905|454450886|FG002|Overall Study|Lost to Follow-up|0|||
126317063|NCT04506905|454450887|FG003|Overall Study|Lost to Follow-up|1|||
126317064|NCT04506905|454450888|FG004|Overall Study|Lost to Follow-up|0|||
126317065|NCT04506905|454450889|FG005|Overall Study|Lost to Follow-up|0|||
125876413|NCT01743469|452843987|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
125876414|NCT01743469|452843988|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
125876415|NCT01743469|452843985|FG000|Active Treatment Phase|Missing|1|||
125876416|NCT01743469|452843986|FG001|Active Treatment Phase|Missing|0|||
125876417|NCT01743469|452843987|FG002|Active Treatment Phase|Missing|0|||
125876418|NCT01743469|452843988|FG003|Active Treatment Phase|Missing|0|||
125876419|NCT01743469|452843985|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
125876420|NCT01743469|452843986|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
125876421|NCT01743469|452843987|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
125876422|NCT01743469|452843988|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
125876423|NCT01743469|452843985|FG000|Follow-up Period - Post-Treatment|Death|43|||
125876424|NCT01743469|452843986|FG001|Follow-up Period - Post-Treatment|Death|47|||
125876425|NCT01743469|452843987|FG002|Follow-up Period - Post-Treatment|Death|22|||
125876426|NCT01743469|452843988|FG003|Follow-up Period - Post-Treatment|Death|16|||
125876427|NCT01743469|452843985|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
125876428|NCT01743469|452843986|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
125876429|NCT01743469|452843987|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
125876430|NCT01743469|452843988|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
125876431|NCT01451606|452843989|FG000|Overall Study|Withdrawal by Subject|4|||
125876432|NCT01451606|452843990|FG001|Overall Study|Withdrawal by Subject|3|||
125876433|NCT04011540|452843996|FG000|Overall Study|Lost to Follow-up|9|||
126317066|NCT04506905|454450890|FG006|Overall Study|Lost to Follow-up|0|||
126317067|NCT04506905|454450891|FG007|Overall Study|Lost to Follow-up|0|||
126317068|NCT04506905|454450892|FG008|Overall Study|Lost to Follow-up|0|||
126317069|NCT04506905|454450884|FG000|Overall Study|Withdrawal by Subject|0|||
126317070|NCT04506905|454450885|FG001|Overall Study|Withdrawal by Subject|0|||
126317071|NCT04506905|454450886|FG002|Overall Study|Withdrawal by Subject|0|||
126317072|NCT04506905|454450887|FG003|Overall Study|Withdrawal by Subject|2|||
126317073|NCT04506905|454450888|FG004|Overall Study|Withdrawal by Subject|0|||
126317074|NCT04506905|454450889|FG005|Overall Study|Withdrawal by Subject|0|||
126317075|NCT04506905|454450890|FG006|Overall Study|Withdrawal by Subject|0|||
126317076|NCT04506905|454450891|FG007|Overall Study|Withdrawal by Subject|0|||
126317077|NCT04506905|454450892|FG008|Overall Study|Withdrawal by Subject|0|||
126317078|NCT05072106|454452035|FG000|Overall Study|Progressive disease|3|||
126317079|NCT05072106|454452036|FG001|Overall Study|Progressive disease|3|||
126317080|NCT05072106|454452035|FG000|Overall Study|Compassionate use|3|||
126317081|NCT05072106|454452036|FG001|Overall Study|Compassionate use|1|||
126317082|NCT05072106|454452035|FG000|Overall Study|Withdrawal by Subject|1|||
126317083|NCT05072106|454452036|FG001|Overall Study|Withdrawal by Subject|0|||
126317084|NCT03839459|454452037|FG000|Overall Study|Withdrawal by Subject|2|||
126317085|NCT03839459|454452037|FG000|Overall Study|progression of disease|3|||
126317086|NCT05940077|454452038|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
126317087|NCT02304380|454452039|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317088|NCT02304380|454452040|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317089|NCT02304380|454452041|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317090|NCT02304380|454452042|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
126317091|NCT02304380|454452043|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317092|NCT02304380|454452044|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317093|NCT00328094|454452047|FG000|Overall Study|Physician Decision|3|||
126317094|NCT00328094|454452048|FG001|Overall Study|Physician Decision|3|||
126317095|NCT00590538|454452049|FG000|Overall Study|Study terminated before completed|2|||
126317096|NCT02309723|454452050|FG000|Overall Study|Withdrawal by Subject|24|||
126317097|NCT02309723|454452051|FG001|Overall Study|Withdrawal by Subject|23|||
126317098|NCT02309723|454452052|FG002|Overall Study|Withdrawal by Subject|24|||
126317099|NCT01125813|454452053|FG000|Overall Study|Death|1|||
126317100|NCT01125813|454452053|FG000|Overall Study|Withdrawal by Subject|1|||
126317101|NCT01125813|454452053|FG000|Overall Study|Screen Failures|4|||
126317102|NCT00985426|454452054|FG000|Overall Study|Adverse Event|0|||
126317103|NCT00985426|454452055|FG001|Overall Study|Adverse Event|1|||
125876434|NCT04011540|452843997|FG001|Overall Study|Lost to Follow-up|6|||
125876435|NCT03668873|452844000|FG000|Overall Study|Lost to Follow-up|6|||
125876436|NCT03668873|452844001|FG001|Overall Study|Lost to Follow-up|3|||
125876437|NCT02183675|452844002|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
125876438|NCT02183675|452844003|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
125876439|NCT02183675|452844004|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
125876440|NCT02183675|452844005|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
125876441|NCT02183675|452844006|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
125876442|NCT02183675|452844007|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
125876443|NCT01521117|452844008|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
125876444|NCT01521117|452844009|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125876445|NCT01521117|452844008|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
125876446|NCT01521117|452844009|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
125876447|NCT01521117|452844008|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125876448|NCT01521117|452844009|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
125876449|NCT04576988|452844012|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
125876450|NCT04576988|452844013|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
125876451|NCT04576988|452844012|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
125876452|NCT04576988|452844013|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
125876453|NCT04576988|452844012|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
125876454|NCT04576988|452844013|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
125876455|NCT04576988|452844012|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
125876456|NCT04576988|452844013|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
126317104|NCT00985426|454452054|FG000|Overall Study|Subject Non-Compliance|3|||
126317105|NCT00985426|454452055|FG001|Overall Study|Subject Non-Compliance|3|||
126317106|NCT00985426|454452054|FG000|Overall Study|Withdrawal by Subject|12|||
126317107|NCT00985426|454452055|FG001|Overall Study|Withdrawal by Subject|16|||
126317108|NCT00985426|454452054|FG000|Overall Study|Lost to Follow-up|8|||
126317109|NCT00985426|454452055|FG001|Overall Study|Lost to Follow-up|10|||
126317110|NCT00985426|454452054|FG000|Overall Study|Death|7|||
126317111|NCT00985426|454452055|FG001|Overall Study|Death|3|||
125876457|NCT04576988|452844012|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
126090454|NCT01840410|453623573|FG001|Overall Study|Protocol deviation|0|||
126317112|NCT00985426|454452054|FG000|Overall Study|Protocol Violation|2|||
126317113|NCT00985426|454452055|FG001|Overall Study|Protocol Violation|0|||
126317114|NCT00985426|454452054|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
126317115|NCT00985426|454452055|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
126317116|NCT02327013|454452056|FG000|Overall Study|Adverse Event|4|||
126317117|NCT02327013|454452057|FG001|Overall Study|Adverse Event|4|||
126317118|NCT02327013|454452058|FG002|Overall Study|Adverse Event|3|||
126317119|NCT02327013|454452059|FG003|Overall Study|Adverse Event|0|||
126317120|NCT02327013|454452060|FG004|Overall Study|Adverse Event|1|||
126317121|NCT02327013|454452056|FG000|Overall Study|Lack of Efficacy|2|||
126317122|NCT02327013|454452057|FG001|Overall Study|Lack of Efficacy|0|||
126317123|NCT02327013|454452058|FG002|Overall Study|Lack of Efficacy|5|||
126317124|NCT02327013|454452059|FG003|Overall Study|Lack of Efficacy|0|||
126317125|NCT02327013|454452060|FG004|Overall Study|Lack of Efficacy|1|||
126317126|NCT02327013|454452056|FG000|Overall Study|Non-compliance with IMP|1|||
126317127|NCT02327013|454452057|FG001|Overall Study|Non-compliance with IMP|2|||
126317128|NCT02327013|454452058|FG002|Overall Study|Non-compliance with IMP|7|||
126317129|NCT02327013|454452059|FG003|Overall Study|Non-compliance with IMP|0|||
126317130|NCT02327013|454452060|FG004|Overall Study|Non-compliance with IMP|0|||
126317131|NCT02327013|454452056|FG000|Overall Study|Withdrawal of Consent|1|||
126317132|NCT02327013|454452057|FG001|Overall Study|Withdrawal of Consent|0|||
126317133|NCT02327013|454452058|FG002|Overall Study|Withdrawal of Consent|3|||
126317134|NCT02327013|454452059|FG003|Overall Study|Withdrawal of Consent|0|||
126317135|NCT02327013|454452060|FG004|Overall Study|Withdrawal of Consent|0|||
126317136|NCT02327013|454452056|FG000|Overall Study|Lost to Follow-up|2|||
126317137|NCT02327013|454452057|FG001|Overall Study|Lost to Follow-up|4|||
126317138|NCT02327013|454452058|FG002|Overall Study|Lost to Follow-up|5|||
126317139|NCT02327013|454452059|FG003|Overall Study|Lost to Follow-up|0|||
126317140|NCT02327013|454452060|FG004|Overall Study|Lost to Follow-up|0|||
126317141|NCT02327013|454452056|FG000|Overall Study|Administrative or other reason(s)|1|||
126317142|NCT02327013|454452057|FG001|Overall Study|Administrative or other reason(s)|5|||
126317143|NCT02327013|454452058|FG002|Overall Study|Administrative or other reason(s)|11|||
126317144|NCT02327013|454452059|FG003|Overall Study|Administrative or other reason(s)|1|||
126317145|NCT02327013|454452060|FG004|Overall Study|Administrative or other reason(s)|1|||
126317146|NCT02327013|454452056|FG000|Overall Study|Protocol Violation|0|||
126317147|NCT02327013|454452057|FG001|Overall Study|Protocol Violation|0|||
126317148|NCT02327013|454452058|FG002|Overall Study|Protocol Violation|3|||
126317149|NCT02327013|454452059|FG003|Overall Study|Protocol Violation|0|||
126317150|NCT02327013|454452060|FG004|Overall Study|Protocol Violation|1|||
126317151|NCT02327013|454452056|FG000|Overall Study|Withdrawal before treatment|2|||
126317152|NCT02327013|454452057|FG001|Overall Study|Withdrawal before treatment|1|||
126317153|NCT02327013|454452058|FG002|Overall Study|Withdrawal before treatment|5|||
126317154|NCT02327013|454452059|FG003|Overall Study|Withdrawal before treatment|0|||
126317155|NCT02327013|454452060|FG004|Overall Study|Withdrawal before treatment|0|||
126317156|NCT01565668|454452061|FG000|Overall Study|Death|2|||
126317157|NCT01565668|454452062|FG001|Overall Study|Death|1|||
126317158|NCT01565668|454452061|FG000|Overall Study|Lack of Efficacy|4|||
126317159|NCT01565668|454452062|FG001|Overall Study|Lack of Efficacy|2|||
126317160|NCT01565668|454452061|FG000|Overall Study|Participant went on Hospice Care|1|||
126317161|NCT01565668|454452062|FG001|Overall Study|Participant went on Hospice Care|0|||
126317162|NCT01565668|454452061|FG000|Overall Study|Adverse Event|6|||
126317163|NCT01565668|454452062|FG001|Overall Study|Adverse Event|1|||
126317164|NCT01565668|454452061|FG000|Overall Study|Randomized, but never received drug|0|||
126317165|NCT01565668|454452062|FG001|Overall Study|Randomized, but never received drug|2|||
126317166|NCT01565668|454452061|FG000|Overall Study|Progressive disease|13|||
126317167|NCT01565668|454452062|FG001|Overall Study|Progressive disease|14|||
126317168|NCT01565668|454452061|FG000|Overall Study|Withdrawal by Subject|1|||
126317169|NCT01565668|454452062|FG001|Overall Study|Withdrawal by Subject|3|||
126317170|NCT01565668|454452061|FG000|Overall Study|HSCT Transplant|11|||
126317171|NCT01565668|454452062|FG001|Overall Study|HSCT Transplant|15|||
126317172|NCT02255552|454452063|FG000|Overall Study|Participants enrolled into another study|0|||
126317173|NCT02255552|454452064|FG001|Overall Study|Participants enrolled into another study|11|||
126317174|NCT02255552|454452063|FG000|Overall Study|Withdrawal by Subject|1|||
126317175|NCT02255552|454452064|FG001|Overall Study|Withdrawal by Subject|4|||
126317176|NCT02956057|454452070|FG000|Overall Study|Discontinued intervention|14|||
126317177|NCT02956057|454452071|FG001|Overall Study|Discontinued intervention|10|||
126317178|NCT02956057|454452072|FG002|Overall Study|Discontinued intervention|7|||
126317179|NCT02956057|454452073|FG003|Overall Study|Discontinued intervention|14|||
126317180|NCT02956057|454452074|FG004|Overall Study|Discontinued intervention|4|||
126317181|NCT02956057|454452075|FG005|Overall Study|Discontinued intervention|17|||
126317182|NCT02956057|454452070|FG000|Overall Study|Lost to Follow-up|0|||
126317183|NCT02956057|454452071|FG001|Overall Study|Lost to Follow-up|2|||
126317184|NCT02956057|454452072|FG002|Overall Study|Lost to Follow-up|1|||
126317185|NCT02956057|454452073|FG003|Overall Study|Lost to Follow-up|1|||
126317186|NCT02956057|454452074|FG004|Overall Study|Lost to Follow-up|1|||
126317187|NCT02956057|454452075|FG005|Overall Study|Lost to Follow-up|0|||
126317188|NCT03422159|454452081|FG000|Overall Study|Exclusion due to terminal disease|2|||
126317189|NCT03422159|454452082|FG001|Overall Study|Exclusion due to terminal disease|1|||
126317190|NCT00087126|454452086|FG000|Overall Study|Ineligible - second primary|1|||
126317191|NCT00087126|454452086|FG000|Overall Study|Never treated|1|||
126317192|NCT00934856|454452087|FG000|Feasibility Part|Progressive disease|4|||
126317193|NCT00934856|454452088|FG001|Feasibility Part|Progressive disease|4|||
126317194|NCT00934856|454452089|FG002|Feasibility Part|Progressive disease|2|||
126317195|NCT00934856|454452090|FG003|Feasibility Part|Progressive disease|3|||
126317196|NCT00934856|454452091|FG004|Feasibility Part|Progressive disease|0|||
126317197|NCT00934856|454452092|FG005|Feasibility Part|Progressive disease|0|||
126317198|NCT00934856|454452087|FG000|Feasibility Part|Physician Decision|0|||
126317199|NCT00934856|454452088|FG001|Feasibility Part|Physician Decision|0|||
126317200|NCT00934856|454452089|FG002|Feasibility Part|Physician Decision|1|||
126317201|NCT00934856|454452090|FG003|Feasibility Part|Physician Decision|0|||
126317202|NCT00934856|454452091|FG004|Feasibility Part|Physician Decision|0|||
126317203|NCT00934856|454452092|FG005|Feasibility Part|Physician Decision|0|||
126317204|NCT00934856|454452087|FG000|Feasibility Part|Adverse Event|1|||
126317205|NCT00934856|454452088|FG001|Feasibility Part|Adverse Event|1|||
126317206|NCT00934856|454452089|FG002|Feasibility Part|Adverse Event|0|||
126317207|NCT00934856|454452090|FG003|Feasibility Part|Adverse Event|1|||
126317208|NCT00934856|454452091|FG004|Feasibility Part|Adverse Event|0|||
126317209|NCT00934856|454452092|FG005|Feasibility Part|Adverse Event|2|||
126317210|NCT00934856|454452087|FG000|Feasibility Part|Withdrawal by Subject|0|||
126317211|NCT00934856|454452088|FG001|Feasibility Part|Withdrawal by Subject|0|||
126317212|NCT00934856|454452089|FG002|Feasibility Part|Withdrawal by Subject|0|||
126317213|NCT00934856|454452090|FG003|Feasibility Part|Withdrawal by Subject|1|||
126317214|NCT00934856|454452091|FG004|Feasibility Part|Withdrawal by Subject|0|||
126317215|NCT00934856|454452092|FG005|Feasibility Part|Withdrawal by Subject|1|||
126317216|NCT00934856|454452087|FG000|Extension Part|Adverse Event|0|||
126317217|NCT00934856|454452088|FG001|Extension Part|Adverse Event|0|||
126317218|NCT00934856|454452089|FG002|Extension Part|Adverse Event|0|||
126317219|NCT00934856|454452090|FG003|Extension Part|Adverse Event|1|||
126317220|NCT00934856|454452091|FG004|Extension Part|Adverse Event|4|||
126317221|NCT00934856|454452092|FG005|Extension Part|Adverse Event|4|||
126317222|NCT00934856|454452087|FG000|Extension Part|Progressive disease|0|||
126317223|NCT00934856|454452088|FG001|Extension Part|Progressive disease|0|||
126317224|NCT00934856|454452089|FG002|Extension Part|Progressive disease|0|||
126317225|NCT00934856|454452090|FG003|Extension Part|Progressive disease|1|||
126317226|NCT00934856|454452091|FG004|Extension Part|Progressive disease|0|||
126317227|NCT00934856|454452092|FG005|Extension Part|Progressive disease|0|||
126317228|NCT00934856|454452087|FG000|Extension Part|Non-compliance with drug|0|||
126317229|NCT00934856|454452088|FG001|Extension Part|Non-compliance with drug|0|||
126317230|NCT00934856|454452089|FG002|Extension Part|Non-compliance with drug|0|||
126317231|NCT00934856|454452090|FG003|Extension Part|Non-compliance with drug|0|||
126317232|NCT00934856|454452091|FG004|Extension Part|Non-compliance with drug|0|||
126317233|NCT00934856|454452092|FG005|Extension Part|Non-compliance with drug|1|||
126317234|NCT01256385|454452093|FG000|Overall Study|Physician Decision|1|||
126317235|NCT01256385|454452094|FG001|Overall Study|Physician Decision|1|||
126317236|NCT01256385|454452093|FG000|Overall Study|Withdrawal by Subject|2|||
126317237|NCT01256385|454452094|FG001|Overall Study|Withdrawal by Subject|2|||
126317238|NCT00513357|454452095|FG000|Overall Study|did not receive allocated placebo|2|||
126317239|NCT00513357|454452096|FG001|Overall Study|did not receive allocated placebo|3|||
126317240|NCT00513357|454452095|FG000|Overall Study|Adverse Event|4|||
126317241|NCT00513357|454452096|FG001|Overall Study|Adverse Event|2|||
126317242|NCT00513357|454452095|FG000|Overall Study|Death|2|||
126317243|NCT00513357|454452096|FG001|Overall Study|Death|0|||
126317244|NCT00513357|454452095|FG000|Overall Study|Withdrawal by Subject|5|||
126317245|NCT00513357|454452096|FG001|Overall Study|Withdrawal by Subject|4|||
126317246|NCT00513357|454452095|FG000|Overall Study|Disease Progression|2|||
126317247|NCT00513357|454452096|FG001|Overall Study|Disease Progression|1|||
126317248|NCT00090987|454452097|FG000|Overall Study|Adverse Event|5|||
126317249|NCT00090987|454452097|FG000|Overall Study|Lack of Efficacy|7|||
126317250|NCT00090987|454452097|FG000|Overall Study|Withdrawal by Subject|3|||
126317251|NCT00090987|454452097|FG000|Overall Study|alternative therapy|1|||
126317252|NCT00090987|454452097|FG000|Overall Study|Non-compliance|4|||
126317253|NCT00090987|454452097|FG000|Overall Study|Incarcerated|1|||
126317254|NCT02079636|454452110|FG000|Overall Study|Death|2|||
126317255|NCT02079636|454452111|FG001|Overall Study|Death|1|||
126317256|NCT02079636|454452112|FG002|Overall Study|Death|0|||
125876458|NCT04576988|452844013|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
125876459|NCT04576988|452844012|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
125876460|NCT04576988|452844013|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
126317257|NCT02079636|454452113|FG003|Overall Study|Death|5|||
126317258|NCT02079636|454452114|FG004|Overall Study|Death|1|||
126317259|NCT02079636|454452115|FG005|Overall Study|Death|2|||
126317260|NCT02079636|454452116|FG006|Overall Study|Death|1|||
126317261|NCT02079636|454452117|FG007|Overall Study|Death|0|||
126317262|NCT02079636|454452118|FG008|Overall Study|Death|0|||
126317263|NCT02079636|454452119|FG009|Overall Study|Death|0|||
126317264|NCT02079636|454452120|FG010|Overall Study|Death|0|||
126317265|NCT02079636|454452121|FG011|Overall Study|Death|1|||
126317266|NCT02079636|454452122|FG012|Overall Study|Death|1|||
126317267|NCT02079636|454452123|FG013|Overall Study|Death|0|||
126317268|NCT02079636|454452124|FG014|Overall Study|Death|2|||
126317269|NCT02079636|454452110|FG000|Overall Study|Adverse Event|1|||
126317270|NCT02079636|454452111|FG001|Overall Study|Adverse Event|1|||
126317271|NCT02079636|454452112|FG002|Overall Study|Adverse Event|0|||
126317272|NCT02079636|454452113|FG003|Overall Study|Adverse Event|1|||
126317273|NCT02079636|454452114|FG004|Overall Study|Adverse Event|1|||
126317274|NCT02079636|454452115|FG005|Overall Study|Adverse Event|2|||
126317275|NCT02079636|454452116|FG006|Overall Study|Adverse Event|0|||
126317276|NCT02079636|454452117|FG007|Overall Study|Adverse Event|0|||
126317277|NCT02079636|454452118|FG008|Overall Study|Adverse Event|0|||
126317278|NCT02079636|454452119|FG009|Overall Study|Adverse Event|0|||
126317279|NCT02079636|454452120|FG010|Overall Study|Adverse Event|0|||
126317280|NCT02079636|454452121|FG011|Overall Study|Adverse Event|0|||
126317281|NCT02079636|454452122|FG012|Overall Study|Adverse Event|0|||
126317282|NCT02079636|454452123|FG013|Overall Study|Adverse Event|0|||
126317283|NCT02079636|454452124|FG014|Overall Study|Adverse Event|0|||
126317284|NCT02079636|454452110|FG000|Overall Study|Progressive disease|0|||
126317285|NCT02079636|454452111|FG001|Overall Study|Progressive disease|0|||
126317286|NCT02079636|454452112|FG002|Overall Study|Progressive disease|0|||
126317287|NCT02079636|454452113|FG003|Overall Study|Progressive disease|2|||
126317288|NCT02079636|454452114|FG004|Overall Study|Progressive disease|0|||
126317289|NCT02079636|454452115|FG005|Overall Study|Progressive disease|0|||
126317290|NCT02079636|454452116|FG006|Overall Study|Progressive disease|0|||
126317291|NCT02079636|454452117|FG007|Overall Study|Progressive disease|0|||
126317292|NCT02079636|454452118|FG008|Overall Study|Progressive disease|0|||
126317293|NCT02079636|454452119|FG009|Overall Study|Progressive disease|0|||
126317294|NCT02079636|454452120|FG010|Overall Study|Progressive disease|0|||
126317295|NCT02079636|454452121|FG011|Overall Study|Progressive disease|0|||
126317296|NCT02079636|454452122|FG012|Overall Study|Progressive disease|1|||
126317297|NCT02079636|454452123|FG013|Overall Study|Progressive disease|0|||
126317298|NCT02079636|454452124|FG014|Overall Study|Progressive disease|0|||
126317299|NCT02079636|454452110|FG000|Overall Study|Withdrawal by Subject|0|||
126317300|NCT02079636|454452111|FG001|Overall Study|Withdrawal by Subject|0|||
126317301|NCT02079636|454452112|FG002|Overall Study|Withdrawal by Subject|0|||
126317302|NCT02079636|454452113|FG003|Overall Study|Withdrawal by Subject|4|||
126317303|NCT02079636|454452114|FG004|Overall Study|Withdrawal by Subject|0|||
126317304|NCT02079636|454452115|FG005|Overall Study|Withdrawal by Subject|1|||
126317305|NCT02079636|454452116|FG006|Overall Study|Withdrawal by Subject|0|||
126317306|NCT02079636|454452117|FG007|Overall Study|Withdrawal by Subject|0|||
126317307|NCT02079636|454452118|FG008|Overall Study|Withdrawal by Subject|0|||
126317308|NCT02079636|454452119|FG009|Overall Study|Withdrawal by Subject|2|||
126317309|NCT02079636|454452120|FG010|Overall Study|Withdrawal by Subject|1|||
126317310|NCT02079636|454452121|FG011|Overall Study|Withdrawal by Subject|1|||
126317311|NCT02079636|454452122|FG012|Overall Study|Withdrawal by Subject|1|||
126317312|NCT02079636|454452123|FG013|Overall Study|Withdrawal by Subject|0|||
126317313|NCT02079636|454452124|FG014|Overall Study|Withdrawal by Subject|2|||
126317314|NCT02079636|454452110|FG000|Overall Study|Physician Decision|0|||
126317315|NCT02079636|454452111|FG001|Overall Study|Physician Decision|0|||
126317316|NCT02079636|454452112|FG002|Overall Study|Physician Decision|0|||
126317317|NCT02079636|454452113|FG003|Overall Study|Physician Decision|0|||
126317318|NCT02079636|454452114|FG004|Overall Study|Physician Decision|0|||
126317319|NCT02079636|454452115|FG005|Overall Study|Physician Decision|1|||
126317320|NCT02079636|454452116|FG006|Overall Study|Physician Decision|0|||
126317321|NCT02079636|454452117|FG007|Overall Study|Physician Decision|0|||
125876461|NCT04576988|452844012|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
125876462|NCT04576988|452844013|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
126317322|NCT02079636|454452118|FG008|Overall Study|Physician Decision|0|||
126317323|NCT02079636|454452119|FG009|Overall Study|Physician Decision|1|||
125876463|NCT04576988|452844012|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
126317324|NCT02079636|454452120|FG010|Overall Study|Physician Decision|1|||
126317325|NCT02079636|454452121|FG011|Overall Study|Physician Decision|0|||
125876464|NCT04576988|452844013|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
125876465|NCT04576988|452844012|FG000|Long Term Double Blind (LTDB)|Death|2|||
125876466|NCT04576988|452844013|FG001|Long Term Double Blind (LTDB)|Death|1|||
126317326|NCT02079636|454452122|FG012|Overall Study|Physician Decision|0|||
126317327|NCT02079636|454452123|FG013|Overall Study|Physician Decision|0|||
126317328|NCT02079636|454452124|FG014|Overall Study|Physician Decision|1|||
126317329|NCT02079636|454452110|FG000|Overall Study|Lost to Follow-up|0|||
125876467|NCT04576988|452844012|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
126317330|NCT02079636|454452111|FG001|Overall Study|Lost to Follow-up|0|||
126317331|NCT02079636|454452112|FG002|Overall Study|Lost to Follow-up|0|||
126317332|NCT02079636|454452113|FG003|Overall Study|Lost to Follow-up|0|||
126317333|NCT02079636|454452114|FG004|Overall Study|Lost to Follow-up|0|||
126317334|NCT02079636|454452115|FG005|Overall Study|Lost to Follow-up|0|||
126317335|NCT02079636|454452116|FG006|Overall Study|Lost to Follow-up|0|||
126317336|NCT02079636|454452117|FG007|Overall Study|Lost to Follow-up|1|||
125876468|NCT04576988|452844013|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
125876469|NCT00617734|452844014|FG000|Overall Study|Withdrew Consent|2|||
125876470|NCT00617734|452844015|FG001|Overall Study|Withdrew Consent|0|||
125876471|NCT00617734|452844014|FG000|Overall Study|Adverse Event|4|||
125876472|NCT00617734|452844015|FG001|Overall Study|Adverse Event|1|||
125876473|NCT00617734|452844014|FG000|Overall Study|Protocol Violation|1|||
125876474|NCT00617734|452844015|FG001|Overall Study|Protocol Violation|0|||
125876475|NCT00617734|452844014|FG000|Overall Study|Found Ineligible After Randomization|1|||
125876476|NCT00617734|452844015|FG001|Overall Study|Found Ineligible After Randomization|4|||
125876477|NCT00617734|452844014|FG000|Overall Study|Lost to Follow-up|0|||
125876478|NCT00617734|452844015|FG001|Overall Study|Lost to Follow-up|1|||
125876479|NCT01844765|452844016|FG000|Overall Study|Adverse Event|6|||
125876480|NCT01844765|452844017|FG001|Overall Study|Adverse Event|8|||
125876481|NCT01844765|452844016|FG000|Overall Study|Withdrawal by Subject|2|||
125876482|NCT01844765|452844017|FG001|Overall Study|Withdrawal by Subject|3|||
125876483|NCT01844765|452844016|FG000|Overall Study|Disease progression|1|||
125876484|NCT01844765|452844017|FG001|Overall Study|Disease progression|0|||
125876485|NCT01844765|452844016|FG000|Overall Study|Administrative problems|3|||
125876486|NCT01844765|452844017|FG001|Overall Study|Administrative problems|4|||
125876487|NCT01844765|452844016|FG000|Overall Study|Protocol deviation|2|||
125876488|NCT01844765|452844017|FG001|Overall Study|Protocol deviation|0|||
125876489|NCT01844765|452844016|FG000|Overall Study|Untreated|1|||
125876490|NCT01844765|452844017|FG001|Overall Study|Untreated|0|||
125876491|NCT00556075|452844023|FG000|Overall Study|Lost to Follow-up|3|||
125876492|NCT00556075|452844024|FG001|Overall Study|Lost to Follow-up|0|||
125876493|NCT00556075|452844025|FG002|Overall Study|Lost to Follow-up|3|||
125876494|NCT00556075|452844023|FG000|Overall Study|Withdrawal by Subject|3|||
125876495|NCT00556075|452844024|FG001|Overall Study|Withdrawal by Subject|3|||
125876496|NCT00556075|452844025|FG002|Overall Study|Withdrawal by Subject|0|||
125876497|NCT00556075|452844023|FG000|Overall Study|Protocol Violation|1|||
125876498|NCT00556075|452844024|FG001|Overall Study|Protocol Violation|1|||
125876499|NCT00556075|452844025|FG002|Overall Study|Protocol Violation|3|||
125876500|NCT00556075|452844023|FG000|Overall Study|Not eligible|1|||
125876501|NCT00556075|452844024|FG001|Overall Study|Not eligible|1|||
125876502|NCT00556075|452844025|FG002|Overall Study|Not eligible|2|||
125876503|NCT00556075|452844023|FG000|Overall Study|Adverse Event|1|||
125876504|NCT00556075|452844024|FG001|Overall Study|Adverse Event|2|||
125876505|NCT00556075|452844025|FG002|Overall Study|Adverse Event|0|||
125876506|NCT00556075|452844023|FG000|Overall Study|Personal issues|4|||
125876507|NCT00556075|452844024|FG001|Overall Study|Personal issues|1|||
125876508|NCT00556075|452844025|FG002|Overall Study|Personal issues|0|||
125876509|NCT00556075|452844023|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
125876510|NCT00556075|452844024|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
125876511|NCT00556075|452844025|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
126208401|NCT02389621|454051341|FG000|Posttreatment Period|Lost to Follow-up|1|||
126208402|NCT02389621|454051342|FG001|Posttreatment Period|Lost to Follow-up|1|||
125876512|NCT02485691|452844026|FG000|Overall Study|Adverse Event|25|||
125876513|NCT02485691|452844027|FG001|Overall Study|Adverse Event|11|||
125876514|NCT02485691|452844026|FG000|Overall Study|Poor compliance to protocol|0|||
125876515|NCT02485691|452844027|FG001|Overall Study|Poor compliance to protocol|1|||
125876516|NCT02485691|452844026|FG000|Overall Study|Disease progression|57|||
125876517|NCT02485691|452844027|FG001|Overall Study|Disease progression|92|||
125876518|NCT02485691|452844026|FG000|Overall Study|Investigator's decision|23|||
125876519|NCT02485691|452844027|FG001|Overall Study|Investigator's decision|5|||
125876520|NCT02485691|452844026|FG000|Overall Study|Participant's request|13|||
125876521|NCT02485691|452844027|FG001|Overall Study|Participant's request|6|||
125876522|NCT02485691|452844026|FG000|Overall Study|Other reason|8|||
125876523|NCT02485691|452844027|FG001|Overall Study|Other reason|9|||
125876524|NCT02485691|452844026|FG000|Overall Study|Randomized and not treated|3|||
125876525|NCT02485691|452844027|FG001|Overall Study|Randomized and not treated|2|||
125876526|NCT00604565|452844028|FG000|Overall Study|Study terminated|0|||
125876527|NCT00604565|452844029|FG001|Overall Study|Study terminated|3|||
125876528|NCT04292535|452844030|FG000|Overall Study|Withdrawal by Subject|0|||
125876529|NCT04292535|452844031|FG001|Overall Study|Withdrawal by Subject|0|||
125876530|NCT04292535|452844032|FG002|Overall Study|Withdrawal by Subject|0|||
125876531|NCT04292535|452844033|FG003|Overall Study|Withdrawal by Subject|0|||
125876532|NCT04292535|452844034|FG004|Overall Study|Withdrawal by Subject|0|||
125876533|NCT04292535|452844035|FG005|Overall Study|Withdrawal by Subject|0|||
125876534|NCT04292535|452844036|FG006|Overall Study|Withdrawal by Subject|0|||
125876535|NCT04292535|452844037|FG007|Overall Study|Withdrawal by Subject|1|||
126317337|NCT02079636|454452118|FG008|Overall Study|Lost to Follow-up|0|||
125876536|NCT04292535|452844038|FG008|Overall Study|Withdrawal by Subject|0|||
125876537|NCT04292535|452844039|FG009|Overall Study|Withdrawal by Subject|0|||
125876538|NCT04292535|452844040|FG010|Overall Study|Withdrawal by Subject|0|||
125876539|NCT04292535|452844041|FG011|Overall Study|Withdrawal by Subject|0|||
125876540|NCT04292535|452844042|FG012|Overall Study|Withdrawal by Subject|0|||
125876541|NCT04292535|452844043|FG013|Overall Study|Withdrawal by Subject|0|||
126317338|NCT02079636|454452119|FG009|Overall Study|Lost to Follow-up|0|||
125876542|NCT04292535|452844030|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876543|NCT04292535|452844031|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876544|NCT04292535|452844032|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876545|NCT04292535|452844033|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876546|NCT04292535|452844034|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876547|NCT04292535|452844035|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876548|NCT04292535|452844036|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876549|NCT04292535|452844037|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125876550|NCT04292535|452844038|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876551|NCT04292535|452844039|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876552|NCT04292535|452844040|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876553|NCT04292535|452844041|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125876554|NCT04292535|452844042|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125876555|NCT04292535|452844043|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125876556|NCT04292535|452844030|FG000|Overall Study|Report of Dizziness|0|||
125876557|NCT04292535|452844031|FG001|Overall Study|Report of Dizziness|0|||
125876558|NCT04292535|452844032|FG002|Overall Study|Report of Dizziness|0|||
125876559|NCT04292535|452844033|FG003|Overall Study|Report of Dizziness|0|||
125876560|NCT04292535|452844034|FG004|Overall Study|Report of Dizziness|0|||
125876561|NCT04292535|452844035|FG005|Overall Study|Report of Dizziness|0|||
125876562|NCT04292535|452844036|FG006|Overall Study|Report of Dizziness|0|||
125876563|NCT04292535|452844037|FG007|Overall Study|Report of Dizziness|0|||
125876564|NCT04292535|452844038|FG008|Overall Study|Report of Dizziness|0|||
125876565|NCT04292535|452844039|FG009|Overall Study|Report of Dizziness|0|||
125876566|NCT04292535|452844040|FG010|Overall Study|Report of Dizziness|0|||
125876567|NCT04292535|452844041|FG011|Overall Study|Report of Dizziness|0|||
125876568|NCT04292535|452844042|FG012|Overall Study|Report of Dizziness|0|||
125876569|NCT04292535|452844043|FG013|Overall Study|Report of Dizziness|1|||
125876570|NCT04292535|452844030|FG000|Overall Study|Equipment Failure|0|||
125876571|NCT04292535|452844031|FG001|Overall Study|Equipment Failure|0|||
125876572|NCT04292535|452844032|FG002|Overall Study|Equipment Failure|0|||
125876573|NCT04292535|452844033|FG003|Overall Study|Equipment Failure|0|||
125876574|NCT04292535|452844034|FG004|Overall Study|Equipment Failure|0|||
125876575|NCT04292535|452844035|FG005|Overall Study|Equipment Failure|0|||
125876576|NCT04292535|452844036|FG006|Overall Study|Equipment Failure|0|||
125876577|NCT04292535|452844037|FG007|Overall Study|Equipment Failure|0|||
125876578|NCT04292535|452844038|FG008|Overall Study|Equipment Failure|0|||
125876579|NCT04292535|452844039|FG009|Overall Study|Equipment Failure|0|||
125876580|NCT04292535|452844040|FG010|Overall Study|Equipment Failure|0|||
125876581|NCT04292535|452844041|FG011|Overall Study|Equipment Failure|1|||
125876582|NCT04292535|452844042|FG012|Overall Study|Equipment Failure|0|||
125876583|NCT04292535|452844043|FG013|Overall Study|Equipment Failure|0|||
125876584|NCT03836625|452844044|FG000|Overall Study|Lost to Follow-up|9|||
125876585|NCT03836625|452844045|FG001|Overall Study|Lost to Follow-up|9|||
125876586|NCT03836625|452844044|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
125876587|NCT03836625|452844045|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
125876588|NCT03836625|452844044|FG000|Overall Study|Death|0|||
125876589|NCT03836625|452844045|FG001|Overall Study|Death|1|||
125876590|NCT03836625|452844044|FG000|Overall Study|Refused follow-up|0|||
125876591|NCT03836625|452844045|FG001|Overall Study|Refused follow-up|1|||
125876592|NCT03413891|452844048|FG000|Overall Study|Lost to Follow-up|2|||
125876593|NCT03413891|452844049|FG001|Overall Study|Lost to Follow-up|1|||
125876594|NCT03413891|452844048|FG000|Overall Study|Protocol Violation|0|||
125876595|NCT03413891|452844049|FG001|Overall Study|Protocol Violation|1|||
125876596|NCT04905134|452844052|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
125876597|NCT04905134|452844052|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
125876598|NCT03642873|452844053|FG000|Third Intervention (1 Day)|Screen failure|0|||
125876599|NCT03642873|452844054|FG001|Third Intervention (1 Day)|Screen failure|0|||
125876600|NCT03642873|452844055|FG002|Third Intervention (1 Day)|Screen failure|0|||
125876601|NCT03642873|452844056|FG003|Third Intervention (1 Day)|Screen failure|0|||
125876602|NCT03642873|452844057|FG004|Third Intervention (1 Day)|Screen failure|1|||
125876603|NCT03642873|452844058|FG005|Third Intervention (1 Day)|Screen failure|0|||
125876604|NCT05556265|452844059|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125876605|NCT05556265|452844060|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
125876606|NCT05556265|452844061|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125876607|NCT05556265|452844062|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125876608|NCT05556265|452844063|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125876609|NCT05556265|452844059|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125876610|NCT05556265|452844060|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
126317339|NCT02079636|454452120|FG010|Overall Study|Lost to Follow-up|0|||
125876611|NCT05556265|452844061|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125885164|NCT03847896|452876791|FG002|Overall Study|Withdrawal by Subject|5|||
126317340|NCT02079636|454452121|FG011|Overall Study|Lost to Follow-up|0|||
126317341|NCT02079636|454452122|FG012|Overall Study|Lost to Follow-up|0|||
126317342|NCT02079636|454452123|FG013|Overall Study|Lost to Follow-up|0|||
126317343|NCT02079636|454452124|FG014|Overall Study|Lost to Follow-up|0|||
126317344|NCT00875433|454452125|FG000|Overall Study|Progressive disease|41|||
126317345|NCT00875433|454452125|FG000|Overall Study|Other Adverse Event|14|||
125876612|NCT05556265|452844062|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125876613|NCT05556265|452844063|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125876614|NCT05556265|452844059|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125876615|NCT05556265|452844060|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
125876616|NCT05556265|452844061|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125876617|NCT05556265|452844062|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125876618|NCT05556265|452844063|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125876619|NCT05556265|452844059|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
125876620|NCT05556265|452844060|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
125876621|NCT05556265|452844061|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
125876622|NCT05556265|452844062|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
125876623|NCT05556265|452844063|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
125876624|NCT05556265|452844059|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
125876625|NCT05556265|452844060|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
125876626|NCT05556265|452844061|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
125876627|NCT05556265|452844062|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
125876628|NCT05556265|452844063|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
125876629|NCT05556265|452844059|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
125876630|NCT05556265|452844060|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
125876631|NCT05556265|452844061|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
125876632|NCT05556265|452844062|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
125876633|NCT05556265|452844063|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
125876634|NCT05556265|452844059|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125876635|NCT05556265|452844060|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
125876636|NCT05556265|452844061|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125876637|NCT05556265|452844062|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125876638|NCT05556265|452844063|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
125876639|NCT05556265|452844059|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125876640|NCT05556265|452844060|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125876641|NCT05556265|452844061|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
125876642|NCT05556265|452844062|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125876643|NCT05556265|452844063|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
125876644|NCT05556265|452844059|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125876645|NCT05556265|452844060|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125876646|NCT05556265|452844061|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
125876647|NCT05556265|452844062|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125876648|NCT05556265|452844063|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
125876649|NCT03221556|452844066|FG000|Allocation|post-randomization exclusion|0|||
125876650|NCT03221556|452844067|FG001|Allocation|post-randomization exclusion|1|||
125876651|NCT03221556|452844066|FG000|Follow-Up|Withdrawal by Subject|0|||
125876652|NCT03221556|452844067|FG001|Follow-Up|Withdrawal by Subject|1|||
125876653|NCT01253291|452844070|FG000|Overall Study|Withdrawal by Subject|1|||
125876654|NCT01253291|452844071|FG001|Overall Study|Withdrawal by Subject|1|||
125876655|NCT01253291|452844072|FG002|Overall Study|Withdrawal by Subject|0|||
125876656|NCT01253291|452844073|FG003|Overall Study|Withdrawal by Subject|0|||
125876657|NCT01253291|452844074|FG004|Overall Study|Withdrawal by Subject|0|||
125876658|NCT01253291|452844070|FG000|Overall Study|Adverse Event|0|||
125876659|NCT01253291|452844071|FG001|Overall Study|Adverse Event|1|||
125876660|NCT01253291|452844072|FG002|Overall Study|Adverse Event|0|||
125876661|NCT01253291|452844073|FG003|Overall Study|Adverse Event|0|||
125876662|NCT01253291|452844074|FG004|Overall Study|Adverse Event|0|||
125876663|NCT01253291|452844070|FG000|Overall Study|Lack of Efficacy|1|||
125876664|NCT01253291|452844071|FG001|Overall Study|Lack of Efficacy|0|||
125876665|NCT01253291|452844072|FG002|Overall Study|Lack of Efficacy|0|||
125876666|NCT01253291|452844073|FG003|Overall Study|Lack of Efficacy|0|||
125876667|NCT01253291|452844074|FG004|Overall Study|Lack of Efficacy|0|||
125876668|NCT01253291|452844070|FG000|Overall Study|Physician Decision|2|||
125876669|NCT01253291|452844071|FG001|Overall Study|Physician Decision|0|||
125876670|NCT01253291|452844072|FG002|Overall Study|Physician Decision|0|||
125876671|NCT01253291|452844073|FG003|Overall Study|Physician Decision|0|||
126317346|NCT00875433|454452125|FG000|Overall Study|Withdrawal by Subject|2|||
126317347|NCT00875433|454452125|FG000|Overall Study|Other|3|||
126317348|NCT00725101|454452126|FG000|Overall Study|Death|3|||
125876672|NCT01253291|452844074|FG004|Overall Study|Physician Decision|2|||
125876673|NCT02234843|452844075|FG000|Overall Study|Death|1|||
125876674|NCT02234843|452844076|FG001|Overall Study|Death|0|||
125876675|NCT02234843|452844077|FG002|Overall Study|Death|0|||
125876676|NCT02234843|452844078|FG003|Overall Study|Death|0|||
125876677|NCT02234843|452844079|FG004|Overall Study|Death|0|||
125876678|NCT02234843|452844080|FG005|Overall Study|Death|0|||
125876679|NCT02234843|452844081|FG006|Overall Study|Death|0|||
125876680|NCT02234843|452844082|FG007|Overall Study|Death|0|||
125876681|NCT02234843|452844083|FG008|Overall Study|Death|0|||
125876682|NCT02234843|452844084|FG009|Overall Study|Death|0|||
125876683|NCT02234843|452844075|FG000|Overall Study|Protocol Violation|1|||
125876684|NCT02234843|452844076|FG001|Overall Study|Protocol Violation|0|||
125876685|NCT02234843|452844077|FG002|Overall Study|Protocol Violation|1|||
125876686|NCT02234843|452844078|FG003|Overall Study|Protocol Violation|0|||
125876687|NCT02234843|452844079|FG004|Overall Study|Protocol Violation|0|||
125876688|NCT02234843|452844080|FG005|Overall Study|Protocol Violation|0|||
125876689|NCT02234843|452844081|FG006|Overall Study|Protocol Violation|0|||
125876690|NCT02234843|452844082|FG007|Overall Study|Protocol Violation|0|||
125876691|NCT02234843|452844083|FG008|Overall Study|Protocol Violation|0|||
125876692|NCT02234843|452844084|FG009|Overall Study|Protocol Violation|0|||
125876693|NCT02234843|452844075|FG000|Overall Study|Efficacy outcome reached|2|||
125876694|NCT02234843|452844076|FG001|Overall Study|Efficacy outcome reached|0|||
125876695|NCT02234843|452844077|FG002|Overall Study|Efficacy outcome reached|0|||
125876696|NCT02234843|452844078|FG003|Overall Study|Efficacy outcome reached|0|||
125876697|NCT02234843|452844079|FG004|Overall Study|Efficacy outcome reached|0|||
125876698|NCT02234843|452844080|FG005|Overall Study|Efficacy outcome reached|2|||
125876699|NCT02234843|452844081|FG006|Overall Study|Efficacy outcome reached|0|||
125876700|NCT02234843|452844082|FG007|Overall Study|Efficacy outcome reached|0|||
125876701|NCT02234843|452844083|FG008|Overall Study|Efficacy outcome reached|0|||
125876702|NCT02234843|452844084|FG009|Overall Study|Efficacy outcome reached|0|||
125876703|NCT02234843|452844075|FG000|Overall Study|Patient convenience|2|||
125876704|NCT02234843|452844076|FG001|Overall Study|Patient convenience|0|||
125876705|NCT02234843|452844077|FG002|Overall Study|Patient convenience|0|||
125876706|NCT02234843|452844078|FG003|Overall Study|Patient convenience|0|||
125876707|NCT02234843|452844079|FG004|Overall Study|Patient convenience|0|||
125876708|NCT02234843|452844080|FG005|Overall Study|Patient convenience|1|||
125876709|NCT02234843|452844081|FG006|Overall Study|Patient convenience|0|||
126317349|NCT00725101|454452126|FG000|Overall Study|Lost to Follow-up|353|||
126317350|NCT00725101|454452126|FG000|Overall Study|Protocol Violation|1|||
126317351|NCT00725101|454452126|FG000|Overall Study|Withdrawal by Subject|127|||
125876710|NCT02234843|452844082|FG007|Overall Study|Patient convenience|0|||
125876711|NCT02234843|452844083|FG008|Overall Study|Patient convenience|0|||
126317352|NCT00725101|454452126|FG000|Overall Study|not specified/no reason given|11|||
126317353|NCT00622336|454452127|FG000|Treatment Phase|Progression of Disease|181|||
125876712|NCT02234843|452844084|FG009|Overall Study|Patient convenience|0|||
125876713|NCT02234843|452844075|FG000|Overall Study|Withdrawal by Subject|5|||
125876714|NCT02234843|452844076|FG001|Overall Study|Withdrawal by Subject|1|||
125876715|NCT02234843|452844077|FG002|Overall Study|Withdrawal by Subject|1|||
125876716|NCT02234843|452844078|FG003|Overall Study|Withdrawal by Subject|0|||
125876717|NCT02234843|452844079|FG004|Overall Study|Withdrawal by Subject|0|||
125876718|NCT02234843|452844080|FG005|Overall Study|Withdrawal by Subject|7|||
125876719|NCT02234843|452844081|FG006|Overall Study|Withdrawal by Subject|0|||
125876720|NCT02234843|452844082|FG007|Overall Study|Withdrawal by Subject|0|||
125876721|NCT02234843|452844083|FG008|Overall Study|Withdrawal by Subject|0|||
125876722|NCT02234843|452844084|FG009|Overall Study|Withdrawal by Subject|0|||
126317354|NCT00622336|454452127|FG000|Treatment Phase|Adverse Event|46|||
126317355|NCT00622336|454452127|FG000|Treatment Phase|Other|40|||
126317356|NCT00622336|454452127|FG000|Treatment Phase|Death|14|||
126317357|NCT00622336|454452127|FG000|Treatment Phase|Lack of therapeutic effect|13|||
126317358|NCT00622336|454452127|FG000|Treatment Phase|Withdrawal by Subject|13|||
126317359|NCT00622336|454452127|FG000|Treatment Phase|Lost to Follow-up|2|||
125876723|NCT02234843|452844075|FG000|Overall Study|Recovery|1|||
125876724|NCT02234843|452844076|FG001|Overall Study|Recovery|0|||
125876725|NCT02234843|452844077|FG002|Overall Study|Recovery|0|||
125876726|NCT02234843|452844078|FG003|Overall Study|Recovery|0|||
125876727|NCT02234843|452844079|FG004|Overall Study|Recovery|0|||
125876728|NCT02234843|452844080|FG005|Overall Study|Recovery|0|||
126090455|NCT01840410|453623572|FG000|Overall Study|Lost to Follow-up|1|||
126317360|NCT00622336|454452127|FG000|Extension Phase|Adverse Event|2|||
126317361|NCT00622336|454452127|FG000|Extension Phase|Progressive Disease|6|||
125876729|NCT02234843|452844081|FG006|Overall Study|Recovery|0|||
125876730|NCT02234843|452844082|FG007|Overall Study|Recovery|0|||
125876731|NCT02234843|452844083|FG008|Overall Study|Recovery|0|||
125876732|NCT02234843|452844084|FG009|Overall Study|Recovery|0|||
125876733|NCT02234843|452844075|FG000|Overall Study|Other|0|||
125876734|NCT02234843|452844076|FG001|Overall Study|Other|2|||
125876735|NCT02234843|452844077|FG002|Overall Study|Other|0|||
125876736|NCT02234843|452844078|FG003|Overall Study|Other|1|||
125876737|NCT02234843|452844079|FG004|Overall Study|Other|0|||
125876738|NCT02234843|452844080|FG005|Overall Study|Other|1|||
125876739|NCT02234843|452844081|FG006|Overall Study|Other|0|||
125876740|NCT02234843|452844082|FG007|Overall Study|Other|1|||
125876741|NCT02234843|452844083|FG008|Overall Study|Other|0|||
125876742|NCT02234843|452844084|FG009|Overall Study|Other|0|||
125876743|NCT02234843|452844075|FG000|Overall Study|Physician Decision|4|||
125876744|NCT02234843|452844076|FG001|Overall Study|Physician Decision|1|||
125876745|NCT02234843|452844077|FG002|Overall Study|Physician Decision|0|||
125876746|NCT02234843|452844078|FG003|Overall Study|Physician Decision|1|||
125876747|NCT02234843|452844079|FG004|Overall Study|Physician Decision|0|||
125876748|NCT02234843|452844080|FG005|Overall Study|Physician Decision|0|||
125876749|NCT02234843|452844081|FG006|Overall Study|Physician Decision|0|||
125876750|NCT02234843|452844082|FG007|Overall Study|Physician Decision|1|||
125876751|NCT02234843|452844083|FG008|Overall Study|Physician Decision|0|||
125876752|NCT02234843|452844084|FG009|Overall Study|Physician Decision|0|||
125876753|NCT02234843|452844075|FG000|Overall Study|Adverse Event|5|||
125876754|NCT02234843|452844076|FG001|Overall Study|Adverse Event|1|||
125876755|NCT02234843|452844077|FG002|Overall Study|Adverse Event|1|||
125876756|NCT02234843|452844078|FG003|Overall Study|Adverse Event|3|||
125876757|NCT02234843|452844079|FG004|Overall Study|Adverse Event|2|||
125876758|NCT02234843|452844080|FG005|Overall Study|Adverse Event|1|||
125876759|NCT02234843|452844081|FG006|Overall Study|Adverse Event|0|||
125876760|NCT02234843|452844082|FG007|Overall Study|Adverse Event|0|||
125876761|NCT02234843|452844083|FG008|Overall Study|Adverse Event|1|||
125876762|NCT02234843|452844084|FG009|Overall Study|Adverse Event|0|||
125876763|NCT02234843|452844075|FG000|Overall Study|Non-compliance with study drug|1|||
125876764|NCT02234843|452844076|FG001|Overall Study|Non-compliance with study drug|0|||
125876765|NCT02234843|452844077|FG002|Overall Study|Non-compliance with study drug|0|||
125876766|NCT02234843|452844078|FG003|Overall Study|Non-compliance with study drug|0|||
125876767|NCT02234843|452844079|FG004|Overall Study|Non-compliance with study drug|0|||
126208403|NCT02389621|454051341|FG000|Posttreatment Period|Other - Miscellaneous|2|||
126208404|NCT02389621|454051342|FG001|Posttreatment Period|Other - Miscellaneous|0|||
126208405|NCT00953017|454051361|FG000|Overall Study|DId not show up for colonoscopy|4|||
126208406|NCT00953017|454051362|FG001|Overall Study|DId not show up for colonoscopy|4|||
126208407|NCT00953017|454051363|FG002|Overall Study|DId not show up for colonoscopy|5|||
126208408|NCT00953017|454051364|FG003|Overall Study|DId not show up for colonoscopy|4|||
126208409|NCT00953017|454051361|FG000|Overall Study|Incomplete data|1|||
126208410|NCT00953017|454051362|FG001|Overall Study|Incomplete data|1|||
126208411|NCT00953017|454051363|FG002|Overall Study|Incomplete data|0|||
126208412|NCT00953017|454051364|FG003|Overall Study|Incomplete data|0|||
126208413|NCT00953017|454051361|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
126208414|NCT00953017|454051362|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
126208415|NCT00953017|454051363|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
126208416|NCT00953017|454051364|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
126208417|NCT00953017|454051361|FG000|Overall Study|Brown stool prior to procedure|0|||
126208418|NCT00953017|454051362|FG001|Overall Study|Brown stool prior to procedure|0|||
126208419|NCT00953017|454051363|FG002|Overall Study|Brown stool prior to procedure|1|||
126208420|NCT00953017|454051364|FG003|Overall Study|Brown stool prior to procedure|0|||
126208421|NCT01473602|454051366|FG000|Overall Study|Adverse Event|1|||
126208422|NCT01473602|454051367|FG001|Overall Study|Adverse Event|2|||
126208423|NCT01473602|454051366|FG000|Overall Study|Death|0|||
126208424|NCT01473602|454051367|FG001|Overall Study|Death|1|||
126208425|NCT01473602|454051366|FG000|Overall Study|Lost to Follow-up|1|||
126208426|NCT01473602|454051367|FG001|Overall Study|Lost to Follow-up|1|||
126208427|NCT01473602|454051366|FG000|Overall Study|Withdrawal by Subject|5|||
126208428|NCT01473602|454051367|FG001|Overall Study|Withdrawal by Subject|4|||
126208429|NCT01473602|454051366|FG000|Overall Study|Physician Decision|1|||
126208430|NCT01473602|454051367|FG001|Overall Study|Physician Decision|0|||
126208431|NCT00449761|454051369|FG000|Overall Study|Disease progression|12|||
126208432|NCT00449761|454051369|FG000|Overall Study|Death|5|||
126208433|NCT00449761|454051369|FG000|Overall Study|New cancer therapy|1|||
126208434|NCT00344968|454051372|FG000|Overall Study|Adverse Event|5|||
126208435|NCT00344968|454051373|FG001|Overall Study|Adverse Event|4|||
126208436|NCT00344968|454051374|FG002|Overall Study|Adverse Event|15|||
126208437|NCT00344968|454051372|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126208438|NCT00344968|454051373|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126208439|NCT00344968|454051374|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126208440|NCT00344968|454051372|FG000|Overall Study|Protocol Violation|2|||
126208441|NCT00344968|454051373|FG001|Overall Study|Protocol Violation|2|||
126208442|NCT00344968|454051374|FG002|Overall Study|Protocol Violation|5|||
126208443|NCT00344968|454051372|FG000|Overall Study|Withdrawal by Subject|14|||
125876768|NCT02234843|452844080|FG005|Overall Study|Non-compliance with study drug|1|||
125876769|NCT02234843|452844081|FG006|Overall Study|Non-compliance with study drug|1|||
125876770|NCT02234843|452844082|FG007|Overall Study|Non-compliance with study drug|0|||
125876771|NCT02234843|452844083|FG008|Overall Study|Non-compliance with study drug|0|||
125876772|NCT02234843|452844084|FG009|Overall Study|Non-compliance with study drug|0|||
125876773|NCT02234843|452844075|FG000|Overall Study|Lost to Follow-up|0|||
125876774|NCT02234843|452844076|FG001|Overall Study|Lost to Follow-up|1|||
125876775|NCT02234843|452844077|FG002|Overall Study|Lost to Follow-up|0|||
125876776|NCT02234843|452844078|FG003|Overall Study|Lost to Follow-up|0|||
125876777|NCT02234843|452844079|FG004|Overall Study|Lost to Follow-up|0|||
125876778|NCT02234843|452844080|FG005|Overall Study|Lost to Follow-up|0|||
125876779|NCT02234843|452844081|FG006|Overall Study|Lost to Follow-up|1|||
125876780|NCT02234843|452844082|FG007|Overall Study|Lost to Follow-up|0|||
125876781|NCT02234843|452844083|FG008|Overall Study|Lost to Follow-up|0|||
125876782|NCT02234843|452844084|FG009|Overall Study|Lost to Follow-up|0|||
125876783|NCT03905096|452844085|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
125876784|NCT03905096|452844086|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
125876785|NCT02016781|452844087|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
125876786|NCT02016781|452844088|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
125876787|NCT02016781|452844087|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
125876788|NCT02016781|452844088|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
125876789|NCT02016781|452844087|FG000|Final Database Lock|Withdrawal by Subject|2|||
125876790|NCT02016781|452844088|FG001|Final Database Lock|Withdrawal by Subject|1|||
125876791|NCT02016781|452844087|FG000|Final Database Lock|Lost to Follow-up|11|||
125876792|NCT02016781|452844088|FG001|Final Database Lock|Lost to Follow-up|4|||
125876793|NCT02016781|452844087|FG000|Final Database Lock|Missing data|0|||
125876794|NCT02016781|452844088|FG001|Final Database Lock|Missing data|3|||
125876795|NCT02336282|452844089|FG000|Overall Study|Unrelated illness|1|||
125876796|NCT02336282|452844089|FG000|Overall Study|Uncomfortable with technology|1|||
125876797|NCT02336282|452844089|FG000|Overall Study|Lost to Follow-up|1|||
125876798|NCT02336282|452844089|FG000|Overall Study|Not enough time to complete sessions|2|||
125876799|NCT03724942|452844091|FG000|Overall Study|Adverse Event|20|||
125876800|NCT03724942|452844092|FG001|Overall Study|Adverse Event|14|||
125876801|NCT03724942|452844091|FG000|Overall Study|Lack of Efficacy|0|||
125876802|NCT03724942|452844092|FG001|Overall Study|Lack of Efficacy|1|||
125876803|NCT03724942|452844091|FG000|Overall Study|Physician Decision|5|||
125876804|NCT03724942|452844092|FG001|Overall Study|Physician Decision|2|||
125876805|NCT03724942|452844091|FG000|Overall Study|Protocol Violation|1|||
125876806|NCT03724942|452844092|FG001|Overall Study|Protocol Violation|0|||
125876807|NCT03724942|452844091|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
125876808|NCT03724942|452844092|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
125876809|NCT03724942|452844091|FG000|Overall Study|Withdrawal by Legal Representative|3|||
125876810|NCT03724942|452844092|FG001|Overall Study|Withdrawal by Legal Representative|0|||
125876811|NCT04875975|452844093|FG000|Overall Study|Adverse Event|1|||
125876812|NCT04875975|452844094|FG001|Overall Study|Adverse Event|2|||
125876813|NCT04875975|452844093|FG000|Overall Study|Lack of Efficacy|2|||
125876814|NCT04875975|452844094|FG001|Overall Study|Lack of Efficacy|2|||
125876815|NCT04875975|452844093|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
125876816|NCT04875975|452844094|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
125876817|NCT04875975|452844093|FG000|Overall Study|Relapse With Insults|0|||
125876818|NCT04875975|452844094|FG001|Overall Study|Relapse With Insults|1|||
125876819|NCT04875975|452844093|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
125876820|NCT04875975|452844094|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
125876821|NCT04515771|452845725|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
125876822|NCT04515771|452845726|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
125876823|NCT04515771|452845725|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
125876824|NCT04515771|452845726|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
125876825|NCT04515771|452845725|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
125876826|NCT04515771|452845726|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
125876827|NCT01021020|452845728|FG000|Period I|Protocol Violation|1|||
125876828|NCT01021020|452845728|FG000|Period I|Withdrawal by Subject|1|||
125876829|NCT01021020|452845728|FG000|14 Day Washout Period A|Physician Decision|1|||
125876830|NCT00948246|452845729|FG000|Overall Study|Lost to Follow-up|11|||
125876831|NCT00948246|452845729|FG000|Overall Study|Adverse Event|11|||
125876832|NCT00948246|452845729|FG000|Overall Study|Death|1|||
125876833|NCT00948246|452845729|FG000|Overall Study|Withdrawal by Subject|1|||
125876834|NCT03598036|452845730|FG000|Overall Study|Withdrawal by Subject|1|||
125876835|NCT03598036|452845731|FG001|Overall Study|Withdrawal by Subject|0|||
125876836|NCT04199351|452845734|FG000|Overall Study|Decision by sponsor|0|||
125876837|NCT04199351|452845735|FG001|Overall Study|Decision by sponsor|0|||
125876838|NCT04199351|452845736|FG002|Overall Study|Decision by sponsor|0|||
125876839|NCT04199351|452845737|FG003|Overall Study|Decision by sponsor|2|||
125876840|NCT04199351|452845738|FG004|Overall Study|Decision by sponsor|0|||
125876841|NCT04199351|452845739|FG005|Overall Study|Decision by sponsor|0|||
125876842|NCT04199351|452845740|FG006|Overall Study|Decision by sponsor|0|||
125876843|NCT04199351|452845741|FG007|Overall Study|Decision by sponsor|0|||
125876844|NCT04199351|452845742|FG008|Overall Study|Decision by sponsor|0|||
125876845|NCT04199351|452845743|FG009|Overall Study|Decision by sponsor|6|||
125876846|NCT04199351|452845734|FG000|Overall Study|Lost to Follow-up|0|||
125876847|NCT04199351|452845735|FG001|Overall Study|Lost to Follow-up|0|||
125876848|NCT04199351|452845736|FG002|Overall Study|Lost to Follow-up|1|||
125876849|NCT04199351|452845737|FG003|Overall Study|Lost to Follow-up|0|||
125876850|NCT04199351|452845738|FG004|Overall Study|Lost to Follow-up|0|||
125876851|NCT04199351|452845739|FG005|Overall Study|Lost to Follow-up|1|||
125876852|NCT04199351|452845740|FG006|Overall Study|Lost to Follow-up|0|||
125876853|NCT04199351|452845741|FG007|Overall Study|Lost to Follow-up|0|||
125876854|NCT04199351|452845742|FG008|Overall Study|Lost to Follow-up|0|||
125876855|NCT04199351|452845743|FG009|Overall Study|Lost to Follow-up|0|||
125876856|NCT04199351|452845734|FG000|Overall Study|Withdrawal by Subject|0|||
125876857|NCT04199351|452845735|FG001|Overall Study|Withdrawal by Subject|1|||
125876858|NCT04199351|452845736|FG002|Overall Study|Withdrawal by Subject|0|||
125876859|NCT04199351|452845737|FG003|Overall Study|Withdrawal by Subject|0|||
125876860|NCT04199351|452845738|FG004|Overall Study|Withdrawal by Subject|1|||
125876861|NCT04199351|452845739|FG005|Overall Study|Withdrawal by Subject|4|||
125876862|NCT04199351|452845740|FG006|Overall Study|Withdrawal by Subject|2|||
125876863|NCT04199351|452845741|FG007|Overall Study|Withdrawal by Subject|0|||
125876864|NCT04199351|452845742|FG008|Overall Study|Withdrawal by Subject|3|||
125876865|NCT04199351|452845743|FG009|Overall Study|Withdrawal by Subject|0|||
125876866|NCT00474487|452845747|FG000|Overall Study|Withdrawal by Subject|6|||
125876867|NCT00474487|452845748|FG001|Overall Study|Withdrawal by Subject|0|||
125876868|NCT00474487|452845749|FG002|Overall Study|Withdrawal by Subject|0|||
125876869|NCT00474487|452845750|FG003|Overall Study|Withdrawal by Subject|0|||
125876870|NCT00474487|452845747|FG000|Overall Study|Lost to Follow-up|20|||
125876871|NCT00474487|452845748|FG001|Overall Study|Lost to Follow-up|1|||
125876872|NCT00474487|452845749|FG002|Overall Study|Lost to Follow-up|7|||
125876873|NCT00474487|452845750|FG003|Overall Study|Lost to Follow-up|0|||
125876874|NCT00474487|452845747|FG000|Overall Study|Inappropriate enrollment|4|||
125876875|NCT00474487|452845748|FG001|Overall Study|Inappropriate enrollment|0|||
125876876|NCT00474487|452845749|FG002|Overall Study|Inappropriate enrollment|7|||
125876877|NCT00474487|452845750|FG003|Overall Study|Inappropriate enrollment|0|||
125876878|NCT00474487|452845747|FG000|Overall Study|Death|0|||
125876879|NCT00474487|452845748|FG001|Overall Study|Death|1|||
125876880|NCT00474487|452845749|FG002|Overall Study|Death|0|||
125876881|NCT00474487|452845750|FG003|Overall Study|Death|0|||
125876882|NCT01488045|452845751|FG000|Overall Study|Withdrawal by Subject|6|||
125876883|NCT01488045|452845752|FG001|Overall Study|Withdrawal by Subject|11|||
125876884|NCT01488045|452845751|FG000|Overall Study|Failure to present for colonoscopy|3|||
125876885|NCT01488045|452845752|FG001|Overall Study|Failure to present for colonoscopy|6|||
125876886|NCT01488045|452845751|FG000|Overall Study|Failure to report exclusion criteria|0|||
125876887|NCT01488045|452845752|FG001|Overall Study|Failure to report exclusion criteria|1|||
125876888|NCT02230410|452845759|FG000|Overall Study|Screen Failure|3|||
125876889|NCT02388269|452845766|FG000|Overall Study|Adverse Event|2|||
125876890|NCT02388269|452845767|FG001|Overall Study|Adverse Event|0|||
125876891|NCT02388269|452845768|FG002|Overall Study|Adverse Event|0|||
125876892|NCT02388269|452845766|FG000|Overall Study|Withdrawal by Subject|1|||
125876893|NCT02388269|452845767|FG001|Overall Study|Withdrawal by Subject|2|||
125876894|NCT02388269|452845768|FG002|Overall Study|Withdrawal by Subject|0|||
125876895|NCT02388269|452845766|FG000|Overall Study|less than 50% stimulations|1|||
125876896|NCT02388269|452845767|FG001|Overall Study|less than 50% stimulations|0|||
125876897|NCT02388269|452845768|FG002|Overall Study|less than 50% stimulations|0|||
125876898|NCT02388269|452845766|FG000|Overall Study|no diary data|3|||
125876899|NCT02388269|452845767|FG001|Overall Study|no diary data|0|||
125876900|NCT02388269|452845768|FG002|Overall Study|no diary data|0|||
125876901|NCT02388269|452845766|FG000|Overall Study|Protocol Violation|2|||
125876902|NCT02388269|452845767|FG001|Overall Study|Protocol Violation|0|||
125876903|NCT02388269|452845768|FG002|Overall Study|Protocol Violation|0|||
125876904|NCT02388269|452845766|FG000|Overall Study|Screen Failure|0|||
125876905|NCT02388269|452845767|FG001|Overall Study|Screen Failure|0|||
125876906|NCT02388269|452845768|FG002|Overall Study|Screen Failure|10|||
125876907|NCT03448406|452845769|FG000|Overall Study|Noncompliance of scheduled visits|1|||
125876908|NCT03448406|452845770|FG001|Overall Study|Noncompliance of scheduled visits|2|||
125876909|NCT03448406|452845769|FG000|Overall Study|Withdrawal by Subject|1|||
125876910|NCT03448406|452845770|FG001|Overall Study|Withdrawal by Subject|2|||
125876911|NCT03448406|452845769|FG000|Overall Study|Protocol Violation|1|||
125876912|NCT03448406|452845770|FG001|Overall Study|Protocol Violation|0|||
125876913|NCT03448406|452845769|FG000|Overall Study|Adverse Event|8|||
125876914|NCT03448406|452845770|FG001|Overall Study|Adverse Event|9|||
125876915|NCT03405792|452845771|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
125876916|NCT03405792|452845772|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
125876917|NCT03405792|452845771|FG000|Overall Study|o Did not receive pembrolizumab|1|||
125876918|NCT03405792|452845772|FG001|Overall Study|o Did not receive pembrolizumab|0|||
125876919|NCT03962491|452845773|FG000|Overall Study|Lost to Follow-up|4|||
125876920|NCT03962491|452845774|FG001|Overall Study|Lost to Follow-up|5|||
125876921|NCT03882021|452845775|FG000|Enrollment|Procedure aborted/cancelled|2|||
125876922|NCT03882021|452845775|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
125876923|NCT03882021|452845775|FG000|Enrollment to 3-Month|Death|1|||
125876924|NCT03882021|452845775|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
126317362|NCT00622336|454452127|FG000|Extension Phase|Lack of therapeutic effect|2|||
125876925|NCT03882021|452845775|FG000|Enrollment to 3-Month|Missed Visit|4|||
125876926|NCT03882021|452845775|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
125876927|NCT03882021|452845775|FG000|6-Month to 12-Month Visit|Death|1|||
125876928|NCT03882021|452845775|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
125876929|NCT01263769|452845776|FG000|Overall Study|Non-Compliant with treatment|1|||
125876930|NCT02242942|452845779|FG000|Overall Study|Death|17|||
125876931|NCT02242942|452845780|FG001|Overall Study|Death|20|||
125876932|NCT02242942|452845781|FG002|Overall Study|Death|2|||
125876933|NCT02242942|452845779|FG000|Overall Study|Physician Decision|1|||
125876934|NCT02242942|452845780|FG001|Overall Study|Physician Decision|0|||
125876935|NCT02242942|452845781|FG002|Overall Study|Physician Decision|0|||
125876936|NCT02242942|452845779|FG000|Overall Study|Withdrawal by Subject|8|||
125876937|NCT02242942|452845780|FG001|Overall Study|Withdrawal by Subject|10|||
125876938|NCT02242942|452845781|FG002|Overall Study|Withdrawal by Subject|0|||
125876939|NCT02242942|452845779|FG000|Overall Study|On-going in Study|190|||
125876940|NCT02242942|452845780|FG001|Overall Study|On-going in Study|186|||
125876941|NCT02242942|452845781|FG002|Overall Study|On-going in Study|11|||
125876942|NCT03259230|452845782|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
125876943|NCT03259230|452845783|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
125876944|NCT02559622|452845788|FG000|Overall Study|Progressive disease|0|||
125876945|NCT02559622|452845789|FG001|Overall Study|Progressive disease|1|||
125876946|NCT02559622|452845790|FG002|Overall Study|Progressive disease|0|||
125876947|NCT02559622|452845791|FG003|Overall Study|Progressive disease|0|||
125876948|NCT02559622|452845788|FG000|Overall Study|Adverse Event|0|||
125876949|NCT02559622|452845789|FG001|Overall Study|Adverse Event|2|||
125876950|NCT02559622|452845790|FG002|Overall Study|Adverse Event|2|||
125876951|NCT02559622|452845791|FG003|Overall Study|Adverse Event|2|||
125876952|NCT02559622|452845788|FG000|Overall Study|Patient/guardian decision|1|||
125876953|NCT02559622|452845789|FG001|Overall Study|Patient/guardian decision|2|||
125876954|NCT02559622|452845790|FG002|Overall Study|Patient/guardian decision|0|||
125876955|NCT02559622|452845791|FG003|Overall Study|Patient/guardian decision|1|||
125876956|NCT02163538|452845792|FG000|Overall Study|Protocol Violation|1|||
125876957|NCT02163538|452845793|FG001|Overall Study|Protocol Violation|0|||
125876958|NCT02163538|452845792|FG000|Overall Study|Physician Decision|0|||
125876959|NCT02163538|452845793|FG001|Overall Study|Physician Decision|1|||
125876960|NCT03019406|452845799|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
125876961|NCT03019406|452845800|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
125876962|NCT03019406|452845801|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
125876963|NCT03019406|452845802|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
125876964|NCT01339832|452845805|FG000|Overall Study|Lost to Follow-up|3|||
125876965|NCT01339832|452845805|FG000|Overall Study|Death|11|||
125876966|NCT00468169|452845806|FG000|Overall Study|Withdrawal by Subject|1|||
125876967|NCT00468169|452845807|FG001|Overall Study|Withdrawal by Subject|0|||
125876968|NCT00231816|452845808|FG000|Overall Study|Adverse Event|1|||
125876969|NCT00231816|452845809|FG001|Overall Study|Adverse Event|0|||
125876970|NCT00231816|452845808|FG000|Overall Study|Lost to Follow-up|8|||
125876971|NCT00231816|452845809|FG001|Overall Study|Lost to Follow-up|5|||
125876972|NCT00231816|452845808|FG000|Overall Study|Protocol Violation|2|||
125876973|NCT00231816|452845809|FG001|Overall Study|Protocol Violation|3|||
125876974|NCT00231816|452845808|FG000|Overall Study|Withdrawal by Subject|3|||
125876975|NCT00231816|452845809|FG001|Overall Study|Withdrawal by Subject|3|||
125876976|NCT00231816|452845808|FG000|Overall Study|Other|2|||
125876977|NCT00231816|452845809|FG001|Overall Study|Other|1|||
125876978|NCT01126749|452845814|FG000|Phase 1b|Other|0|||
125876979|NCT01126749|452845815|FG001|Phase 1b|Other|1|||
125876980|NCT01126749|452845816|FG002|Phase 1b|Other|0|||
125876981|NCT01126749|452845817|FG003|Phase 1b|Other|0|||
125876982|NCT01126749|452845814|FG000|Phase 1b|Withdrawal by Subject|0|||
126317363|NCT00622336|454452127|FG000|Extension Phase|Withdrawal by Subject|1|||
126317364|NCT00622336|454452127|FG000|Extension Phase|Lost to Follow-up|1|||
126317365|NCT00622336|454452127|FG000|Extension Phase|Other|9|||
125876983|NCT01126749|452845815|FG001|Phase 1b|Withdrawal by Subject|1|||
126317366|NCT04148287|454452129|FG000|Overall Study|Death|2|||
126317367|NCT03164265|454452130|FG000|Overall Study|Physician Decision|3|||
125876984|NCT01126749|452845816|FG002|Phase 1b|Withdrawal by Subject|0|||
125876985|NCT01126749|452845817|FG003|Phase 1b|Withdrawal by Subject|0|||
125876986|NCT01126749|452845814|FG000|Phase 1b|Death|3|||
125876987|NCT01126749|452845815|FG001|Phase 1b|Death|4|||
125876988|NCT01126749|452845816|FG002|Phase 1b|Death|0|||
126317368|NCT03912428|454452131|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
125876989|NCT01126749|452845817|FG003|Phase 1b|Death|0|||
125876990|NCT01126749|452845814|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
125876991|NCT01126749|452845815|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
125876992|NCT01126749|452845816|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
125876993|NCT01126749|452845817|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
125876994|NCT01126749|452845814|FG000|Phase 2|Study Termination by Sponsor|0|||
125876995|NCT01126749|452845815|FG001|Phase 2|Study Termination by Sponsor|0|||
125876996|NCT01126749|452845816|FG002|Phase 2|Study Termination by Sponsor|12|||
125876997|NCT01126749|452845817|FG003|Phase 2|Study Termination by Sponsor|6|||
125876998|NCT01126749|452845814|FG000|Phase 2|Other|0|||
125876999|NCT01126749|452845815|FG001|Phase 2|Other|0|||
125877000|NCT01126749|452845816|FG002|Phase 2|Other|4|||
125877001|NCT01126749|452845817|FG003|Phase 2|Other|2|||
125877002|NCT01126749|452845814|FG000|Phase 2|Withdrawal by Subject|0|||
125877003|NCT01126749|452845815|FG001|Phase 2|Withdrawal by Subject|0|||
125877004|NCT01126749|452845816|FG002|Phase 2|Withdrawal by Subject|0|||
125877005|NCT01126749|452845817|FG003|Phase 2|Withdrawal by Subject|2|||
125877006|NCT01126749|452845814|FG000|Phase 2|Lost to Follow-up|0|||
125877007|NCT01126749|452845815|FG001|Phase 2|Lost to Follow-up|0|||
125877008|NCT01126749|452845816|FG002|Phase 2|Lost to Follow-up|0|||
125877009|NCT01126749|452845817|FG003|Phase 2|Lost to Follow-up|1|||
125877010|NCT01126749|452845814|FG000|Phase 2|Death|0|||
125877011|NCT01126749|452845815|FG001|Phase 2|Death|0|||
125877012|NCT01126749|452845816|FG002|Phase 2|Death|22|||
125877013|NCT01126749|452845817|FG003|Phase 2|Death|22|||
125877014|NCT01126749|452845814|FG000|Phase 2|Adverse Event|0|||
125877015|NCT01126749|452845815|FG001|Phase 2|Adverse Event|0|||
125877016|NCT01126749|452845816|FG002|Phase 2|Adverse Event|0|||
125877017|NCT01126749|452845817|FG003|Phase 2|Adverse Event|1|||
125877018|NCT01283139|452845819|FG000|Overall Study|Lost to Follow-up|5|||
125877019|NCT01283139|452845820|FG001|Overall Study|Lost to Follow-up|2|||
125877020|NCT01283139|452845821|FG002|Overall Study|Lost to Follow-up|3|||
125877021|NCT01283139|452845822|FG003|Overall Study|Lost to Follow-up|1|||
125877022|NCT01283139|452845819|FG000|Overall Study|Withdrawal by Subject|8|||
125877023|NCT01283139|452845820|FG001|Overall Study|Withdrawal by Subject|8|||
125877024|NCT01283139|452845821|FG002|Overall Study|Withdrawal by Subject|6|||
125877025|NCT01283139|452845822|FG003|Overall Study|Withdrawal by Subject|8|||
125877026|NCT01283139|452845819|FG000|Overall Study|Death|2|||
125877027|NCT01283139|452845820|FG001|Overall Study|Death|0|||
125877028|NCT01283139|452845821|FG002|Overall Study|Death|2|||
125877029|NCT01283139|452845822|FG003|Overall Study|Death|2|||
125877030|NCT01283139|452845819|FG000|Overall Study|Lack of Efficacy|1|||
125877031|NCT01283139|452845820|FG001|Overall Study|Lack of Efficacy|2|||
125877032|NCT01283139|452845821|FG002|Overall Study|Lack of Efficacy|2|||
125877033|NCT01283139|452845822|FG003|Overall Study|Lack of Efficacy|1|||
125877034|NCT01283139|452845819|FG000|Overall Study|Early termination due to AE/SAE|1|||
125877035|NCT01283139|452845820|FG001|Overall Study|Early termination due to AE/SAE|1|||
125877036|NCT01283139|452845821|FG002|Overall Study|Early termination due to AE/SAE|0|||
125877037|NCT01283139|452845822|FG003|Overall Study|Early termination due to AE/SAE|0|||
125877038|NCT01283139|452845819|FG000|Overall Study|Participant's refusal to continue|0|||
125877039|NCT01283139|452845820|FG001|Overall Study|Participant's refusal to continue|3|||
125877040|NCT01283139|452845821|FG002|Overall Study|Participant's refusal to continue|1|||
125877041|NCT01283139|452845822|FG003|Overall Study|Participant's refusal to continue|1|||
125877042|NCT01283139|452845819|FG000|Overall Study|Pregnancy|0|||
125877043|NCT01283139|452845820|FG001|Overall Study|Pregnancy|1|||
125877044|NCT01283139|452845821|FG002|Overall Study|Pregnancy|1|||
125877045|NCT01283139|452845822|FG003|Overall Study|Pregnancy|0|||
125877046|NCT01283139|452845819|FG000|Overall Study|Missed follow-up visit|0|||
125877047|NCT01283139|452845820|FG001|Overall Study|Missed follow-up visit|1|||
125877048|NCT01283139|452845821|FG002|Overall Study|Missed follow-up visit|2|||
125877049|NCT01283139|452845822|FG003|Overall Study|Missed follow-up visit|2|||
125877050|NCT01283139|452845819|FG000|Overall Study|Participant randomized in error|0|||
125877051|NCT01283139|452845820|FG001|Overall Study|Participant randomized in error|0|||
125877052|NCT01283139|452845821|FG002|Overall Study|Participant randomized in error|1|||
125877053|NCT01283139|452845822|FG003|Overall Study|Participant randomized in error|0|||
125877054|NCT00627393|452845825|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
125877055|NCT00627393|452845826|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
125877056|NCT00627393|452845825|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
125877057|NCT00627393|452845826|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
125877058|NCT00627393|452845825|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
125877059|NCT00627393|452845826|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
125877060|NCT00627393|452845825|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
125877061|NCT00627393|452845826|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
125877062|NCT01056822|452845827|FG000|Overall Study|Adverse Event|0|||
125877063|NCT01056822|452845828|FG001|Overall Study|Adverse Event|1|||
125877064|NCT01056822|452845827|FG000|Overall Study|Protocol Violation|6|||
125877065|NCT01056822|452845828|FG001|Overall Study|Protocol Violation|5|||
125877066|NCT01056822|452845827|FG000|Overall Study|Withdrawal by Subject|1|||
125877067|NCT01056822|452845828|FG001|Overall Study|Withdrawal by Subject|1|||
125877068|NCT01056822|452845827|FG000|Overall Study|Lost to Follow-up|1|||
125877069|NCT01056822|452845828|FG001|Overall Study|Lost to Follow-up|0|||
125877070|NCT00784563|452845829|FG000|Years 1 & 2|Withdrawal by Subject|3|||
125877071|NCT00784563|452845830|FG001|Years 1 & 2|Withdrawal by Subject|2|||
125877072|NCT00784563|452845831|FG002|Years 1 & 2|Withdrawal by Subject|0|||
125877073|NCT00784563|452845829|FG000|Years 1 & 2|Adverse Event|0|||
125877074|NCT00784563|452845830|FG001|Years 1 & 2|Adverse Event|3|||
125877075|NCT00784563|452845831|FG002|Years 1 & 2|Adverse Event|0|||
125877076|NCT00784563|452845829|FG000|Year 3|Withdrawal by Subject|0|||
125877077|NCT00784563|452845830|FG001|Year 3|Withdrawal by Subject|0|||
125877078|NCT00784563|452845831|FG002|Year 3|Withdrawal by Subject|2|||
125877079|NCT00784563|452845829|FG000|Year 3|Adverse Event|0|||
125877080|NCT00784563|452845830|FG001|Year 3|Adverse Event|0|||
125877081|NCT00784563|452845831|FG002|Year 3|Adverse Event|1|||
125877082|NCT01614249|452845832|FG000|Overall Study|Lost to Follow-up|11|||
125877083|NCT01614249|452845833|FG001|Overall Study|Lost to Follow-up|23|||
125877084|NCT02954536|452845834|FG000|Overall Study|Adverse Event|2|||
125877085|NCT02954536|452845834|FG000|Overall Study|Death|12|||
125877086|NCT05498649|452845835|FG000|Overall Study|Lost to Follow-up|1|||
125877087|NCT02946580|452845839|FG000|Overall Study|Withdrawal by Subject|1|||
125877088|NCT02946580|452845840|FG001|Overall Study|Withdrawal by Subject|2|||
125877089|NCT02946580|452845839|FG000|Overall Study|Adverse Event|0|||
125877090|NCT02946580|452845840|FG001|Overall Study|Adverse Event|2|||
125877091|NCT02946580|452845839|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
125877092|NCT02946580|452845840|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
125877093|NCT02761330|452845845|FG000|Treatment Week 1|Withdrawal by Subject|0|||
125877094|NCT02761330|452845846|FG001|Treatment Week 1|Withdrawal by Subject|0|||
125877095|NCT02761330|452845847|FG002|Treatment Week 1|Withdrawal by Subject|0|||
125877096|NCT02761330|452845848|FG003|Treatment Week 1|Withdrawal by Subject|1|||
125877097|NCT02761330|452845849|FG004|Treatment Week 1|Withdrawal by Subject|0|||
125877098|NCT02761330|452845850|FG005|Treatment Week 1|Withdrawal by Subject|1|||
125877099|NCT03043313|452845853|FG000|Overall Study|Withdrawal by Subject|5|||
126317369|NCT03912428|454452132|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
125877100|NCT03043313|452845854|FG001|Overall Study|Withdrawal by Subject|1|||
125877101|NCT03043313|452845855|FG002|Overall Study|Withdrawal by Subject|1|||
125877102|NCT03043313|452845853|FG000|Overall Study|Lost to Follow-up|1|||
125877103|NCT03043313|452845854|FG001|Overall Study|Lost to Follow-up|1|||
125877104|NCT03043313|452845855|FG002|Overall Study|Lost to Follow-up|0|||
125877105|NCT03043313|452845853|FG000|Overall Study|Death|28|||
125877106|NCT03043313|452845854|FG001|Overall Study|Death|26|||
125877107|NCT03043313|452845855|FG002|Overall Study|Death|17|||
125877108|NCT03043313|452845853|FG000|Overall Study|Participation terminated by sponsor|11|||
125877109|NCT03043313|452845854|FG001|Overall Study|Participation terminated by sponsor|13|||
125877110|NCT03043313|452845855|FG002|Overall Study|Participation terminated by sponsor|13|||
125877111|NCT00980954|452845856|FG000|Overall Study|Protocol Violation|9|||
125877112|NCT00980954|452845857|FG001|Overall Study|Protocol Violation|15|||
125877113|NCT02657889|452845858|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
125877114|NCT02657889|452845859|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
125877115|NCT02657889|452845860|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
125877116|NCT02657889|452845861|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
125877117|NCT02657889|452845858|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
125877118|NCT02657889|452845859|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125877119|NCT02657889|452845860|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125877120|NCT02657889|452845861|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125877121|NCT02657889|452845858|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125877122|NCT02657889|452845859|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
125877123|NCT02657889|452845860|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125877124|NCT02657889|452845861|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125877125|NCT02657889|452845858|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125877126|NCT02657889|452845859|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
125877127|NCT02657889|452845860|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125877128|NCT02657889|452845861|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125877129|NCT02657889|452845858|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
125877130|NCT02657889|452845859|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
125877131|NCT02657889|452845860|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
125877132|NCT02657889|452845861|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
125877133|NCT02657889|452845858|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
125877134|NCT02657889|452845859|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
125877135|NCT02657889|452845860|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
125877136|NCT02657889|452845861|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
125877137|NCT02657889|452845858|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
125877138|NCT02657889|452845859|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
125877139|NCT02657889|452845860|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
125877140|NCT02657889|452845861|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
125877141|NCT02657889|452845858|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
125877142|NCT02657889|452845859|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
125877143|NCT02657889|452845860|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
125877144|NCT02657889|452845861|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
125877145|NCT02657889|452845858|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
125877146|NCT02657889|452845859|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
125877147|NCT02657889|452845860|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
125877148|NCT02657889|452845861|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
125877149|NCT02657889|452845858|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125877150|NCT02657889|452845859|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125877151|NCT02657889|452845860|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125877152|NCT02657889|452845861|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
125877153|NCT02657889|452845858|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
125877154|NCT02657889|452845859|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
125877155|NCT02657889|452845860|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
125877156|NCT02657889|452845861|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
125877157|NCT02657889|452845858|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125877158|NCT02657889|452845859|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125877159|NCT02657889|452845860|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125877160|NCT02657889|452845861|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
125877161|NCT00374140|452845862|FG000|Overall Study|Lost to Follow-up|1|||
125877162|NCT00374140|452845862|FG000|Overall Study|Protocol Violation|1|||
125877163|NCT01576341|452845863|FG000|Overall Study|Withdrawal by Subject|24|||
125877164|NCT01576341|452845863|FG000|Overall Study|Adverse Event|10|||
125877165|NCT01576341|452845863|FG000|Overall Study|Death|21|||
125877166|NCT01576341|452845863|FG000|Overall Study|Physician Decision|2|||
125877167|NCT01576341|452845863|FG000|Overall Study|Lost to Follow-up|2|||
125877168|NCT01576341|452845863|FG000|Overall Study|Kidney transplantation|10|||
125877169|NCT01576341|452845863|FG000|Overall Study|Protocol Violation|12|||
125877170|NCT01576341|452845863|FG000|Overall Study|Other|12|||
125877171|NCT00517296|452845867|FG000|Overall Study|Withdrawal by Subject|1|||
125877172|NCT00517296|452845868|FG001|Overall Study|Withdrawal by Subject|0|||
125877173|NCT04366349|452845869|FG000|Overall Study|Withdrawal by Subject|1|||
125877174|NCT04366349|452845870|FG001|Overall Study|Withdrawal by Subject|0|||
125877175|NCT04366349|452845871|FG002|Overall Study|Withdrawal by Subject|0|||
125877176|NCT04366349|452845872|FG003|Overall Study|Withdrawal by Subject|0|||
125877177|NCT04366349|452845873|FG004|Overall Study|Withdrawal by Subject|0|||
125877178|NCT04366349|452845874|FG005|Overall Study|Withdrawal by Subject|0|||
125877179|NCT04764162|452845875|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
125877180|NCT04764162|452845876|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
125877181|NCT03253393|452845882|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
125877182|NCT03253393|452845883|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
125877183|NCT03253393|452845884|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
125877184|NCT02443688|452847729|FG000|Overall Study|Adverse Event|2|||
125877185|NCT02443688|452847730|FG001|Overall Study|Adverse Event|3|||
125877186|NCT02443688|452847731|FG002|Overall Study|Adverse Event|2|||
125877187|NCT02443688|452847729|FG000|Overall Study|Lost to Follow-up|1|||
125877188|NCT02443688|452847730|FG001|Overall Study|Lost to Follow-up|0|||
125877189|NCT02443688|452847731|FG002|Overall Study|Lost to Follow-up|0|||
125877190|NCT02443688|452847729|FG000|Overall Study|Physician Decision|3|||
125877191|NCT02443688|452847730|FG001|Overall Study|Physician Decision|0|||
125877192|NCT02443688|452847731|FG002|Overall Study|Physician Decision|1|||
125877193|NCT02443688|452847729|FG000|Overall Study|Pregnancy|0|||
125877194|NCT02443688|452847730|FG001|Overall Study|Pregnancy|0|||
125877195|NCT02443688|452847731|FG002|Overall Study|Pregnancy|1|||
125877196|NCT02443688|452847729|FG000|Overall Study|Withdrawal by Subject|3|||
125877197|NCT02443688|452847730|FG001|Overall Study|Withdrawal by Subject|3|||
125877198|NCT02443688|452847731|FG002|Overall Study|Withdrawal by Subject|4|||
125877199|NCT02443688|452847729|FG000|Overall Study|Non-compliance with study drug|1|||
125877200|NCT02443688|452847730|FG001|Overall Study|Non-compliance with study drug|2|||
125877201|NCT02443688|452847731|FG002|Overall Study|Non-compliance with study drug|4|||
125877202|NCT02443688|452847729|FG000|Overall Study|Sponsor Request|2|||
125877203|NCT02443688|452847730|FG001|Overall Study|Sponsor Request|1|||
125877204|NCT02443688|452847731|FG002|Overall Study|Sponsor Request|0|||
125877205|NCT03182374|452847732|FG000|Overall Study|Lost to Follow-up|3|||
125877206|NCT03182374|452847733|FG001|Overall Study|Lost to Follow-up|2|||
125877207|NCT03182374|452847732|FG000|Overall Study|Lack of Efficacy|8|||
125877208|NCT03182374|452847733|FG001|Overall Study|Lack of Efficacy|14|||
125877209|NCT03182374|452847732|FG000|Overall Study|Withdrawal by Subject|1|||
125877210|NCT03182374|452847733|FG001|Overall Study|Withdrawal by Subject|1|||
125877211|NCT03182374|452847732|FG000|Overall Study|exit for non-compliance|1|||
126208444|NCT00344968|454051373|FG001|Overall Study|Withdrawal by Subject|31|||
125877212|NCT03182374|452847733|FG001|Overall Study|exit for non-compliance|1|||
125877213|NCT03182374|452847732|FG000|Overall Study|one subject was randomized but not treated|1|||
125877214|NCT03182374|452847733|FG001|Overall Study|one subject was randomized but not treated|0|||
125877215|NCT03182374|452847732|FG000|Overall Study|Other reasons|0|||
126317370|NCT03912428|454452133|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
126317371|NCT03912428|454452134|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
126317372|NCT03912428|454452131|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
126317373|NCT03912428|454452132|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
126317374|NCT03912428|454452133|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
126317375|NCT03912428|454452134|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
126317376|NCT03912428|454452131|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
126317377|NCT03912428|454452132|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
126317378|NCT03912428|454452133|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
126317379|NCT03912428|454452134|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
126317380|NCT02889835|454452135|FG000|Overall Study|Lost to Follow-up|13|||
126317381|NCT02889835|454452136|FG001|Overall Study|Lost to Follow-up|13|||
126317382|NCT02889835|454452137|FG002|Overall Study|Lost to Follow-up|13|||
126317383|NCT02889835|454452135|FG000|Overall Study|Withdrawal by Subject|2|||
126317384|NCT02889835|454452136|FG001|Overall Study|Withdrawal by Subject|2|||
126317385|NCT02889835|454452137|FG002|Overall Study|Withdrawal by Subject|2|||
126317386|NCT02889835|454452135|FG000|Overall Study|Protocol Violation|1|||
126317387|NCT02889835|454452136|FG001|Overall Study|Protocol Violation|1|||
126317388|NCT02889835|454452137|FG002|Overall Study|Protocol Violation|1|||
126317389|NCT02889835|454452135|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
126317390|NCT02889835|454452136|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
126317391|NCT02889835|454452137|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
126317392|NCT02889835|454452135|FG000|Overall Study|Death|1|||
126317393|NCT02889835|454452136|FG001|Overall Study|Death|1|||
126317394|NCT02889835|454452137|FG002|Overall Study|Death|1|||
126317395|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
126317396|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
126317397|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
126317398|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
126317399|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
126317400|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
126317401|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
126317402|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
126317403|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
126317404|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
126317405|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
126317406|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
126317407|NCT01777139|454453942|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
126317408|NCT01777139|454453943|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
126317409|NCT01777139|454453942|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
126317410|NCT01777139|454453943|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
126317411|NCT05625477|454453944|FG000|Overall Study|Lost to Follow-up|2|||
126317412|NCT05625477|454453945|FG001|Overall Study|Lost to Follow-up|2|||
126317413|NCT05625477|454453946|FG002|Overall Study|Lost to Follow-up|1|||
126317414|NCT05625477|454453947|FG003|Overall Study|Lost to Follow-up|1|||
125877216|NCT03182374|452847733|FG001|Overall Study|Other reasons|3|||
125877217|NCT03198715|452847741|FG000|Overall Study|Death|0|||
125877218|NCT03198715|452847742|FG001|Overall Study|Death|0|||
125877219|NCT03198715|452847743|FG002|Overall Study|Death|1|||
125877220|NCT03198715|452847744|FG003|Overall Study|Death|0|||
125877221|NCT03198715|452847745|FG004|Overall Study|Death|2|||
125877222|NCT03198715|452847741|FG000|Overall Study|Other|0|||
125877223|NCT03198715|452847742|FG001|Overall Study|Other|1|||
125877224|NCT03198715|452847743|FG002|Overall Study|Other|1|||
125877225|NCT03198715|452847744|FG003|Overall Study|Other|0|||
125877226|NCT03198715|452847745|FG004|Overall Study|Other|0|||
125877227|NCT00616759|452847746|FG000|Overall Study|Physician Decision|2|||
125877228|NCT00616759|452847747|FG001|Overall Study|Physician Decision|0|||
125877229|NCT00616759|452847746|FG000|Overall Study|Withdrawal by Subject|1|||
125877230|NCT00616759|452847747|FG001|Overall Study|Withdrawal by Subject|2|||
125877231|NCT02007096|452847748|FG000|Overall Study|medication not available|2|||
125877232|NCT02007096|452847749|FG001|Overall Study|medication not available|0|||
125877233|NCT02007096|452847748|FG000|Overall Study|did not inject saline|0|||
125877234|NCT02007096|452847749|FG001|Overall Study|did not inject saline|3|||
125877235|NCT02007096|452847748|FG000|Overall Study|did not follow postoperative protocol|8|||
125877236|NCT02007096|452847749|FG001|Overall Study|did not follow postoperative protocol|11|||
125877237|NCT02007096|452847748|FG000|Overall Study|converted to open surgery|1|||
125877238|NCT02007096|452847749|FG001|Overall Study|converted to open surgery|1|||
125877239|NCT02007096|452847748|FG000|Overall Study|no mesh placed|0|||
125877240|NCT02007096|452847749|FG001|Overall Study|no mesh placed|1|||
125877241|NCT02558894|452847754|FG000|Overall Study|Death; any cause, entire study duration|28|||
125877242|NCT02558894|452847755|FG001|Overall Study|Death; any cause, entire study duration|31|||
125877243|NCT02558894|452847754|FG000|Overall Study|Withdrawal by Subject|2|||
125877244|NCT02558894|452847755|FG001|Overall Study|Withdrawal by Subject|1|||
125877245|NCT02558894|452847754|FG000|Overall Study|Closure of Part A|2|||
125877246|NCT02558894|452847755|FG001|Overall Study|Closure of Part A|1|||
125877247|NCT02992288|452847756|FG000|Overall Study|Adverse Event|8|||
125877248|NCT02992288|452847757|FG001|Overall Study|Adverse Event|2|||
125877249|NCT02992288|452847758|FG002|Overall Study|Adverse Event|2|||
125877250|NCT02992288|452847759|FG003|Overall Study|Adverse Event|2|||
125877251|NCT02992288|452847760|FG004|Overall Study|Adverse Event|2|||
125877252|NCT02992288|452847761|FG005|Overall Study|Adverse Event|7|||
125877253|NCT02992288|452847756|FG000|Overall Study|Non-compliance with study drug|0|||
125877254|NCT02992288|452847757|FG001|Overall Study|Non-compliance with study drug|1|||
125877255|NCT02992288|452847758|FG002|Overall Study|Non-compliance with study drug|1|||
125877256|NCT02992288|452847759|FG003|Overall Study|Non-compliance with study drug|0|||
125877257|NCT02992288|452847760|FG004|Overall Study|Non-compliance with study drug|1|||
125877258|NCT02992288|452847761|FG005|Overall Study|Non-compliance with study drug|0|||
125877259|NCT02992288|452847756|FG000|Overall Study|Physician Decision|3|||
125877260|NCT02992288|452847757|FG001|Overall Study|Physician Decision|0|||
125877261|NCT02992288|452847758|FG002|Overall Study|Physician Decision|1|||
125877262|NCT02992288|452847759|FG003|Overall Study|Physician Decision|0|||
125877263|NCT02992288|452847760|FG004|Overall Study|Physician Decision|0|||
125877264|NCT02992288|452847761|FG005|Overall Study|Physician Decision|1|||
125877265|NCT02992288|452847756|FG000|Overall Study|Death|2|||
125877266|NCT02992288|452847757|FG001|Overall Study|Death|0|||
125877267|NCT02992288|452847758|FG002|Overall Study|Death|2|||
125877268|NCT02992288|452847759|FG003|Overall Study|Death|1|||
125877269|NCT02992288|452847760|FG004|Overall Study|Death|2|||
125877270|NCT02992288|452847761|FG005|Overall Study|Death|0|||
125877271|NCT02992288|452847756|FG000|Overall Study|Lost to Follow-up|0|||
125877272|NCT02992288|452847757|FG001|Overall Study|Lost to Follow-up|0|||
125877273|NCT02992288|452847758|FG002|Overall Study|Lost to Follow-up|0|||
125877274|NCT02992288|452847759|FG003|Overall Study|Lost to Follow-up|1|||
125877275|NCT02992288|452847760|FG004|Overall Study|Lost to Follow-up|0|||
125877276|NCT02992288|452847761|FG005|Overall Study|Lost to Follow-up|0|||
125877277|NCT02992288|452847756|FG000|Overall Study|Protocol Violation|0|||
125877278|NCT02992288|452847757|FG001|Overall Study|Protocol Violation|0|||
125877279|NCT02992288|452847758|FG002|Overall Study|Protocol Violation|0|||
126208445|NCT00344968|454051374|FG002|Overall Study|Withdrawal by Subject|27|||
126208446|NCT00344968|454051372|FG000|Overall Study|Lost to Follow-up|24|||
126208447|NCT00344968|454051373|FG001|Overall Study|Lost to Follow-up|37|||
126208448|NCT00344968|454051374|FG002|Overall Study|Lost to Follow-up|37|||
126208449|NCT00344968|454051372|FG000|Overall Study|Death|11|||
126208450|NCT00344968|454051373|FG001|Overall Study|Death|27|||
126208451|NCT00344968|454051374|FG002|Overall Study|Death|31|||
126208452|NCT00344968|454051372|FG000|Overall Study|Other|0|||
126208453|NCT00344968|454051373|FG001|Overall Study|Other|1|||
126208454|NCT00344968|454051374|FG002|Overall Study|Other|0|||
126208455|NCT03735680|454051375|FG000|Overall Study|Withdrawal by Subject|0|||
126208456|NCT03735680|454051376|FG001|Overall Study|Withdrawal by Subject|1|||
126208457|NCT03735680|454051377|FG002|Overall Study|Withdrawal by Subject|0|||
126208458|NCT03735680|454051378|FG003|Overall Study|Withdrawal by Subject|0|||
126208459|NCT03735680|454051379|FG004|Overall Study|Withdrawal by Subject|0|||
126208460|NCT03735680|454051380|FG005|Overall Study|Withdrawal by Subject|1|||
126208461|NCT03735680|454051375|FG000|Overall Study|Patient unable or unwilling to continue|0|||
126208462|NCT03735680|454051376|FG001|Overall Study|Patient unable or unwilling to continue|0|||
126208463|NCT03735680|454051377|FG002|Overall Study|Patient unable or unwilling to continue|1|||
126208464|NCT03735680|454051378|FG003|Overall Study|Patient unable or unwilling to continue|0|||
126208465|NCT03735680|454051379|FG004|Overall Study|Patient unable or unwilling to continue|0|||
126208466|NCT03735680|454051380|FG005|Overall Study|Patient unable or unwilling to continue|0|||
126208467|NCT01422876|454051382|FG000|Week 24|Lost to Follow-up|1|||
126208468|NCT01422876|454051383|FG001|Week 24|Lost to Follow-up|1|||
126208469|NCT01422876|454051384|FG002|Week 24|Lost to Follow-up|2|||
126208470|NCT01422876|454051385|FG003|Week 24|Lost to Follow-up|4|||
126208471|NCT01422876|454051386|FG004|Week 24|Lost to Follow-up|2|||
126208472|NCT01422876|454051387|FG005|Week 24|Lost to Follow-up|0|||
126208473|NCT01422876|454051388|FG006|Week 24|Lost to Follow-up|1|||
126208474|NCT01422876|454051389|FG007|Week 24|Lost to Follow-up|3|||
126208475|NCT01422876|454051390|FG008|Week 24|Lost to Follow-up|3|||
126208476|NCT01422876|454051391|FG009|Week 24|Lost to Follow-up|4|||
126208477|NCT01422876|454051382|FG000|Week 24|Consent withdrawn|5|||
126208478|NCT01422876|454051383|FG001|Week 24|Consent withdrawn|1|||
126208479|NCT01422876|454051384|FG002|Week 24|Consent withdrawn|3|||
125877280|NCT02992288|452847759|FG003|Overall Study|Protocol Violation|0|||
125877281|NCT02992288|452847760|FG004|Overall Study|Protocol Violation|0|||
125877282|NCT02992288|452847761|FG005|Overall Study|Protocol Violation|1|||
126208480|NCT01422876|454051385|FG003|Week 24|Consent withdrawn|4|||
125877283|NCT02992288|452847756|FG000|Overall Study|Withdrawal by Subject|4|||
125877284|NCT02992288|452847757|FG001|Overall Study|Withdrawal by Subject|2|||
125877285|NCT02992288|452847758|FG002|Overall Study|Withdrawal by Subject|1|||
125877286|NCT02992288|452847759|FG003|Overall Study|Withdrawal by Subject|5|||
125877287|NCT02992288|452847760|FG004|Overall Study|Withdrawal by Subject|3|||
125877288|NCT02992288|452847761|FG005|Overall Study|Withdrawal by Subject|4|||
125877289|NCT00656513|452847762|FG000|Overall Study|Protocol Violation|1|||
125877290|NCT00656513|452847763|FG001|Overall Study|Protocol Violation|0|||
125877291|NCT00656513|452847764|FG002|Overall Study|Protocol Violation|2|||
125877292|NCT00656513|452847762|FG000|Overall Study|Withdrawal by Subject|0|||
125877293|NCT00656513|452847763|FG001|Overall Study|Withdrawal by Subject|11|||
125877294|NCT00656513|452847764|FG002|Overall Study|Withdrawal by Subject|4|||
125877295|NCT00656513|452847762|FG000|Overall Study|Death|0|||
125877296|NCT00656513|452847763|FG001|Overall Study|Death|0|||
125877297|NCT00656513|452847764|FG002|Overall Study|Death|1|||
125877298|NCT00656513|452847762|FG000|Overall Study|Missing data|0|||
125877299|NCT00656513|452847763|FG001|Overall Study|Missing data|11|||
125877300|NCT00656513|452847764|FG002|Overall Study|Missing data|9|||
125877301|NCT00656513|452847762|FG000|Overall Study|Incomplete treatment|3|||
125877302|NCT00656513|452847763|FG001|Overall Study|Incomplete treatment|0|||
125877303|NCT00656513|452847764|FG002|Overall Study|Incomplete treatment|0|||
125877304|NCT00656513|452847762|FG000|Overall Study|Treatment completed outside of timeframe|0|||
125877305|NCT00656513|452847763|FG001|Overall Study|Treatment completed outside of timeframe|3|||
125877306|NCT00656513|452847764|FG002|Overall Study|Treatment completed outside of timeframe|1|||
125877307|NCT00656513|452847762|FG000|Overall Study|Missing baseline form|0|||
125877308|NCT00656513|452847763|FG001|Overall Study|Missing baseline form|5|||
125877309|NCT00656513|452847764|FG002|Overall Study|Missing baseline form|5|||
125877310|NCT02476617|452847771|FG000|Overall Study|Adverse Event|1|||
125877311|NCT02476617|452847771|FG000|Overall Study|Lost to Follow-up|1|||
125877312|NCT03486912|452847772|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125877313|NCT03486912|452847773|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
125877314|NCT03486912|452847774|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125877315|NCT03486912|452847775|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125877316|NCT03486912|452847772|FG000|Treatment Period|Withdrawal by Subject|3|||
125877317|NCT03486912|452847773|FG001|Treatment Period|Withdrawal by Subject|3|||
125877318|NCT03486912|452847774|FG002|Treatment Period|Withdrawal by Subject|3|||
125877319|NCT03486912|452847775|FG003|Treatment Period|Withdrawal by Subject|2|||
125877320|NCT03486912|452847772|FG000|Treatment Period|Other Reasons|0|||
125877321|NCT03486912|452847773|FG001|Treatment Period|Other Reasons|2|||
125877322|NCT03486912|452847774|FG002|Treatment Period|Other Reasons|1|||
125877323|NCT03486912|452847775|FG003|Treatment Period|Other Reasons|1|||
125877324|NCT03486912|452847772|FG000|Treatment Period|Adverse Event|0|||
125877325|NCT03486912|452847773|FG001|Treatment Period|Adverse Event|1|||
125877326|NCT03486912|452847774|FG002|Treatment Period|Adverse Event|1|||
125877327|NCT03486912|452847775|FG003|Treatment Period|Adverse Event|0|||
125877328|NCT03486912|452847772|FG000|Treatment Period|Lost to Follow-up|1|||
125877329|NCT03486912|452847773|FG001|Treatment Period|Lost to Follow-up|0|||
125877330|NCT03486912|452847774|FG002|Treatment Period|Lost to Follow-up|0|||
125877331|NCT03486912|452847775|FG003|Treatment Period|Lost to Follow-up|2|||
125877332|NCT02491684|452847776|FG000|Treatment Phase|Adverse Event|2|||
125877333|NCT02491684|452847777|FG001|Treatment Phase|Adverse Event|2|||
125877334|NCT02491684|452847776|FG000|Treatment Phase|Incorrect randomisation|1|||
125877335|NCT02491684|452847777|FG001|Treatment Phase|Incorrect randomisation|0|||
125877336|NCT02491684|452847776|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
125877337|NCT02491684|452847777|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
125877338|NCT00561652|452847779|FG000|Overall Study|Withdrawal by Subject|0|||
125877339|NCT00561652|452847780|FG001|Overall Study|Withdrawal by Subject|1|||
125877340|NCT00894803|452847781|FG000|Overall Study|Death|20|||
125877341|NCT00894803|452847782|FG001|Overall Study|Death|4|||
125877342|NCT00894803|452847781|FG000|Overall Study|Lost to Follow-up|0|||
125877343|NCT00894803|452847782|FG001|Overall Study|Lost to Follow-up|1|||
125877344|NCT04484961|452847783|FG000|Overall Study|Lost to Follow-up|9|||
125877345|NCT04484961|452847784|FG001|Overall Study|Lost to Follow-up|9|||
125877346|NCT01667900|452847785|FG000|Part B|Death|0|||
125877347|NCT01667900|452847786|FG001|Part B|Death|0|||
125877348|NCT01667900|452847787|FG002|Part B|Death|0|||
125877349|NCT01667900|452847788|FG003|Part B|Death|0|||
125877350|NCT01667900|452847789|FG004|Part B|Death|0|||
125877351|NCT01667900|452847790|FG005|Part B|Death|0|||
126317415|NCT05625477|454453948|FG004|Overall Study|Lost to Follow-up|0|||
125877352|NCT01667900|452847791|FG006|Part B|Death|0|||
125877353|NCT01667900|452847792|FG007|Part B|Death|0|||
125877354|NCT01667900|452847793|FG008|Part B|Death|0|||
125877355|NCT01667900|452847794|FG009|Part B|Death|0|||
125877356|NCT01667900|452847795|FG010|Part B|Death|0|||
125877357|NCT01667900|452847796|FG011|Part B|Death|0|||
125877358|NCT01667900|452847797|FG012|Part B|Death|0|||
125877359|NCT01667900|452847798|FG013|Part B|Death|0|||
125877360|NCT01667900|452847799|FG014|Part B|Death|0|||
125877361|NCT01667900|452847800|FG015|Part B|Death|0|||
125877362|NCT01667900|452847801|FG016|Part B|Death|1|||
125877363|NCT01667900|452847802|FG017|Part B|Death|0|||
125877364|NCT01667900|452847803|FG018|Part B|Death|0|||
125877365|NCT01667900|452847804|FG019|Part B|Death|0|||
125877366|NCT01075243|452847806|FG000|Overall Study|Lost to Follow-up|5|||
125877367|NCT01075243|452847807|FG001|Overall Study|Lost to Follow-up|2|||
125877368|NCT01075243|452847808|FG002|Overall Study|Lost to Follow-up|0|||
125877369|NCT01075243|452847806|FG000|Overall Study|Withdrawal by Subject|1|||
125877370|NCT01075243|452847807|FG001|Overall Study|Withdrawal by Subject|1|||
125877371|NCT01075243|452847808|FG002|Overall Study|Withdrawal by Subject|0|||
125877372|NCT00976274|452847809|FG000|Overall Study|Lost to Follow-up|5|||
125877373|NCT00976274|452847810|FG001|Overall Study|Lost to Follow-up|5|||
125877374|NCT00976274|452847809|FG000|Overall Study|Withdrawal by Subject|1|||
125877375|NCT00976274|452847810|FG001|Overall Study|Withdrawal by Subject|1|||
125877376|NCT00976274|452847809|FG000|Overall Study|Physician Decision|1|||
125877377|NCT00976274|452847810|FG001|Overall Study|Physician Decision|2|||
125877378|NCT00004563|452847813|FG000|Overall Study|Withdrawal by Subject|20|||
125877379|NCT00004563|452847814|FG001|Overall Study|Withdrawal by Subject|16|||
125877380|NCT00004563|452847813|FG000|Overall Study|Lack of Efficacy|3|||
125877381|NCT00004563|452847814|FG001|Overall Study|Lack of Efficacy|5|||
125877382|NCT00004563|452847813|FG000|Overall Study|Death|2|||
125877383|NCT00004563|452847814|FG001|Overall Study|Death|3|||
125877384|NCT00762164|452847819|FG000|Overall Study|Lost to Follow-up|1|||
126317416|NCT05625477|454453944|FG000|Overall Study|Covid quarantine|1|||
125877385|NCT00762164|452847820|FG001|Overall Study|Lost to Follow-up|1|||
125877386|NCT00762164|452847819|FG000|Overall Study|Discontinued medication|2|||
125877387|NCT00762164|452847820|FG001|Overall Study|Discontinued medication|0|||
125877388|NCT00762164|452847819|FG000|Overall Study|Withdrawal by Subject|0|||
125877389|NCT00762164|452847820|FG001|Overall Study|Withdrawal by Subject|1|||
125877390|NCT03094416|452847821|FG000|Run-in|Screening failure|8|||
125877391|NCT03094416|452847821|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
125877392|NCT03094416|452847821|FG000|Run-in|Withdrawal by Subject|3|||
125877393|NCT03094416|452847821|FG000|Treatment Period|Withdrawal by Subject|2|||
125877394|NCT04528641|452847822|FG000|Overall Study|Withdrawal by Subject|0|||
125877395|NCT04528641|452847823|FG001|Overall Study|Withdrawal by Subject|0|||
125877396|NCT04528641|452847824|FG002|Overall Study|Withdrawal by Subject|0|||
125877397|NCT04528641|452847825|FG003|Overall Study|Withdrawal by Subject|1|||
125877398|NCT04528641|452847826|FG004|Overall Study|Withdrawal by Subject|0|||
125877399|NCT04528641|452847827|FG005|Overall Study|Withdrawal by Subject|1|||
125877400|NCT00791934|452847828|FG000|Overall Study|Withdrawal by Subject|2|||
125877401|NCT00791934|452847828|FG000|Overall Study|Did not consent for extended follow-up|13|||
125877402|NCT02018562|452847829|FG000|Overall Study|Withdrawal by Subject|2|||
125877403|NCT02018562|452847830|FG001|Overall Study|Withdrawal by Subject|0|||
125877404|NCT02018562|452847829|FG000|Overall Study|Discharged prior to study completion|1|||
125877405|NCT02018562|452847830|FG001|Overall Study|Discharged prior to study completion|0|||
125877406|NCT05194124|452847831|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125877407|NCT05194124|452847832|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125877408|NCT05194124|452847833|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125877409|NCT05194124|452847834|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
125877410|NCT05194124|452847835|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125877411|NCT05194124|452847836|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
125877412|NCT05194124|452847837|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125877413|NCT05194124|452847838|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125877414|NCT05194124|452847839|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125877415|NCT05194124|452847840|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126317417|NCT05625477|454453945|FG001|Overall Study|Covid quarantine|0|||
126317418|NCT05625477|454453946|FG002|Overall Study|Covid quarantine|0|||
126317419|NCT05625477|454453947|FG003|Overall Study|Covid quarantine|0|||
126317420|NCT05625477|454453948|FG004|Overall Study|Covid quarantine|0|||
126317421|NCT02502266|454453949|FG000|Overall Study|Adverse Event|0|||
126317422|NCT02502266|454453950|FG001|Overall Study|Adverse Event|0|||
126317423|NCT02502266|454453951|FG002|Overall Study|Adverse Event|0|||
126317424|NCT02502266|454453952|FG003|Overall Study|Adverse Event|0|||
126317425|NCT02502266|454453953|FG004|Overall Study|Adverse Event|1|||
126317426|NCT02502266|454453954|FG005|Overall Study|Adverse Event|1|||
126317427|NCT02502266|454453955|FG006|Overall Study|Adverse Event|1|||
126317428|NCT02502266|454453949|FG000|Overall Study|Withdrawal by Subject|30|||
126317429|NCT02502266|454453950|FG001|Overall Study|Withdrawal by Subject|15|||
126317430|NCT02502266|454453951|FG002|Overall Study|Withdrawal by Subject|16|||
126317431|NCT02502266|454453952|FG003|Overall Study|Withdrawal by Subject|0|||
126317432|NCT02502266|454453953|FG004|Overall Study|Withdrawal by Subject|0|||
125877416|NCT05194124|452847831|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125877417|NCT05194124|452847832|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125877418|NCT05194124|452847833|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125877419|NCT05194124|452847834|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125877420|NCT05194124|452847835|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125877421|NCT05194124|452847836|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125877422|NCT05194124|452847837|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126090456|NCT01840410|453623573|FG001|Overall Study|Lost to Follow-up|0|||
125877423|NCT05194124|452847838|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125877424|NCT05194124|452847839|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125877425|NCT05194124|452847840|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
125877426|NCT04609319|452847841|FG000|Overall Study|Death|64|||
125877427|NCT04609319|452847842|FG001|Overall Study|Death|49|||
125877428|NCT04609319|452847843|FG002|Overall Study|Death|1|||
125877429|NCT04609319|452847841|FG000|Overall Study|Withdrawal of consent|15|||
125877430|NCT04609319|452847842|FG001|Overall Study|Withdrawal of consent|3|||
125877431|NCT04609319|452847843|FG002|Overall Study|Withdrawal of consent|0|||
125877432|NCT04609319|452847841|FG000|Overall Study|Lost to Follow-up|20|||
125877433|NCT04609319|452847842|FG001|Overall Study|Lost to Follow-up|33|||
125877434|NCT04609319|452847843|FG002|Overall Study|Lost to Follow-up|0|||
125877435|NCT04609319|452847841|FG000|Overall Study|Alive until end of follow-up|60|||
125877436|NCT04609319|452847842|FG001|Overall Study|Alive until end of follow-up|53|||
125877437|NCT04609319|452847843|FG002|Overall Study|Alive until end of follow-up|1|||
125877438|NCT03474588|452847854|FG000|Overall Study|Withdrawal by Subject|4|||
125877439|NCT03474588|452847855|FG001|Overall Study|Withdrawal by Subject|3|||
125877440|NCT03474588|452847854|FG000|Overall Study|Death|0|||
125877441|NCT03474588|452847855|FG001|Overall Study|Death|1|||
125877442|NCT03804528|452847857|FG000|Overall Study|Time Commitment|18|||
125877443|NCT03804528|452847857|FG000|Overall Study|Health Reasons|5|||
125877444|NCT01607957|452847858|FG000|Overall Study|Not treated|1|||
125877445|NCT01607957|452847859|FG001|Overall Study|Not treated|1|||
125877446|NCT01607957|452847858|FG000|Overall Study|Death|367|||
125877447|NCT01607957|452847859|FG001|Overall Study|Death|211|||
125877448|NCT01607957|452847858|FG000|Overall Study|Lost to Follow-up|3|||
125877449|NCT01607957|452847859|FG001|Overall Study|Lost to Follow-up|3|||
126317433|NCT02502266|454453954|FG005|Overall Study|Withdrawal by Subject|0|||
126317434|NCT02502266|454453955|FG006|Overall Study|Withdrawal by Subject|0|||
126317435|NCT02502266|454453949|FG000|Overall Study|Still on Treatment|0|||
126317436|NCT02502266|454453950|FG001|Overall Study|Still on Treatment|0|||
126317437|NCT02502266|454453951|FG002|Overall Study|Still on Treatment|1|||
126317438|NCT02502266|454453952|FG003|Overall Study|Still on Treatment|0|||
126317439|NCT02502266|454453953|FG004|Overall Study|Still on Treatment|0|||
126317440|NCT02502266|454453954|FG005|Overall Study|Still on Treatment|0|||
126317441|NCT02502266|454453955|FG006|Overall Study|Still on Treatment|0|||
126317442|NCT02502266|454453949|FG000|Overall Study|Other Reasons|19|||
125877450|NCT01607957|452847858|FG000|Overall Study|Participant refusal|1|||
125877451|NCT01607957|452847859|FG001|Overall Study|Participant refusal|0|||
125877452|NCT04607005|452847870|FG000|Overall Study|Adverse Event|0|||
125877453|NCT04607005|452847871|FG001|Overall Study|Adverse Event|1|||
125877454|NCT04607005|452847870|FG000|Overall Study|Lack of Efficacy|1|||
125877455|NCT04607005|452847871|FG001|Overall Study|Lack of Efficacy|6|||
125877456|NCT04607005|452847870|FG000|Overall Study|Withdrawal by Subject|4|||
125877457|NCT04607005|452847871|FG001|Overall Study|Withdrawal by Subject|9|||
125877458|NCT04607005|452847870|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
125877459|NCT04607005|452847871|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
125877460|NCT03919773|452847880|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
125877461|NCT03919773|452847881|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
125877462|NCT03919773|452847880|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
125877463|NCT03919773|452847881|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
125877464|NCT04659044|452847884|FG000|Induction|Physician Decision|1|||
125877465|NCT04659044|452847884|FG000|Induction|Adverse Event|2|||
125877466|NCT03589859|452847885|FG000|Overall Study|Withdrawal by Subject|0|||
125877467|NCT03589859|452847886|FG001|Overall Study|Withdrawal by Subject|6|||
125877468|NCT02331134|452847887|FG000|Overall Study|Withdrawal by Subject|1|||
125877469|NCT04966013|452847888|FG000|Overall Study|Withdrawal by Subject|0|||
125877470|NCT04966013|452847889|FG001|Overall Study|Withdrawal by Subject|2|||
125877471|NCT04966013|452847890|FG002|Overall Study|Withdrawal by Subject|1|||
125877472|NCT04966013|452847888|FG000|Overall Study|Adverse Event|2|||
125877473|NCT04966013|452847889|FG001|Overall Study|Adverse Event|1|||
126317443|NCT02502266|454453950|FG001|Overall Study|Other Reasons|6|||
126317444|NCT02502266|454453951|FG002|Overall Study|Other Reasons|14|||
126317445|NCT02502266|454453952|FG003|Overall Study|Other Reasons|0|||
125877474|NCT04966013|452847890|FG002|Overall Study|Adverse Event|1|||
125877475|NCT03518086|452847894|FG000|Overall Study|Adverse Event|23|||
125877476|NCT03518086|452847895|FG001|Overall Study|Adverse Event|15|||
125877477|NCT03518086|452847896|FG002|Overall Study|Adverse Event|3|||
125877478|NCT03518086|452847897|FG003|Overall Study|Adverse Event|2|||
125877479|NCT03518086|452847894|FG000|Overall Study|Withdrawal by Subject|8|||
125877480|NCT03518086|452847895|FG001|Overall Study|Withdrawal by Subject|5|||
125877481|NCT03518086|452847896|FG002|Overall Study|Withdrawal by Subject|1|||
125877482|NCT03518086|452847897|FG003|Overall Study|Withdrawal by Subject|0|||
125877483|NCT03518086|452847894|FG000|Overall Study|Lack of Efficacy|5|||
125877484|NCT03518086|452847895|FG001|Overall Study|Lack of Efficacy|5|||
126090457|NCT01840410|453623572|FG000|Overall Study|Withdrawal by Subject|2|||
126317446|NCT02502266|454453953|FG004|Overall Study|Other Reasons|1|||
126317447|NCT02502266|454453954|FG005|Overall Study|Other Reasons|1|||
126317448|NCT02502266|454453955|FG006|Overall Study|Other Reasons|0|||
126317449|NCT02502266|454453949|FG000|Overall Study|Arm 4 Discontinued|0|||
126317450|NCT02502266|454453950|FG001|Overall Study|Arm 4 Discontinued|0|||
126317451|NCT02502266|454453951|FG002|Overall Study|Arm 4 Discontinued|0|||
126317452|NCT02502266|454453952|FG003|Overall Study|Arm 4 Discontinued|52|||
126317453|NCT02502266|454453953|FG004|Overall Study|Arm 4 Discontinued|0|||
126317454|NCT02502266|454453954|FG005|Overall Study|Arm 4 Discontinued|0|||
126317455|NCT02502266|454453955|FG006|Overall Study|Arm 4 Discontinued|0|||
126317456|NCT02502266|454453949|FG000|Overall Study|Never treated|0|||
126317457|NCT02502266|454453950|FG001|Overall Study|Never treated|0|||
126317458|NCT02502266|454453951|FG002|Overall Study|Never treated|0|||
126317459|NCT02502266|454453952|FG003|Overall Study|Never treated|0|||
126317460|NCT02502266|454453953|FG004|Overall Study|Never treated|0|||
126317461|NCT02502266|454453954|FG005|Overall Study|Never treated|1|||
126317462|NCT02502266|454453955|FG006|Overall Study|Never treated|0|||
126317463|NCT02921750|454453956|FG000|Overall Study|Adverse Event|1|||
126317464|NCT02921750|454453957|FG001|Overall Study|Adverse Event|2|||
126317465|NCT02921750|454453956|FG000|Overall Study|Withdrawal by Subject|1|||
126317466|NCT02921750|454453957|FG001|Overall Study|Withdrawal by Subject|1|||
126317467|NCT02921750|454453956|FG000|Overall Study|Lost to Follow-up|3|||
126317468|NCT02921750|454453957|FG001|Overall Study|Lost to Follow-up|3|||
126317469|NCT02921750|454453956|FG000|Overall Study|Wound healed|3|||
125877485|NCT03518086|452847896|FG002|Overall Study|Lack of Efficacy|0|||
125877486|NCT03518086|452847897|FG003|Overall Study|Lack of Efficacy|2|||
125877487|NCT03518086|452847894|FG000|Overall Study|Protocol Violation|1|||
125877488|NCT03518086|452847895|FG001|Overall Study|Protocol Violation|5|||
125877489|NCT03518086|452847896|FG002|Overall Study|Protocol Violation|1|||
125877490|NCT03518086|452847897|FG003|Overall Study|Protocol Violation|3|||
125877491|NCT03518086|452847894|FG000|Overall Study|Lost to Follow-up|0|||
125877492|NCT03518086|452847895|FG001|Overall Study|Lost to Follow-up|3|||
125877493|NCT03518086|452847896|FG002|Overall Study|Lost to Follow-up|0|||
125877494|NCT03518086|452847897|FG003|Overall Study|Lost to Follow-up|0|||
125877495|NCT03518086|452847894|FG000|Overall Study|Insufficient Diary Data|0|||
125877496|NCT03518086|452847895|FG001|Overall Study|Insufficient Diary Data|2|||
125877497|NCT03518086|452847896|FG002|Overall Study|Insufficient Diary Data|0|||
125877498|NCT03518086|452847897|FG003|Overall Study|Insufficient Diary Data|0|||
125877499|NCT03518086|452847894|FG000|Overall Study|Non- compliance to Protocol|0|||
125877500|NCT03518086|452847895|FG001|Overall Study|Non- compliance to Protocol|1|||
125877501|NCT03518086|452847896|FG002|Overall Study|Non- compliance to Protocol|0|||
125877502|NCT03518086|452847897|FG003|Overall Study|Non- compliance to Protocol|0|||
125877503|NCT03518086|452847894|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
125877504|NCT03518086|452847895|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
125877505|NCT03518086|452847896|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
125877506|NCT03518086|452847897|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
125877507|NCT03518086|452847894|FG000|Overall Study|Site Terminated by Sponsor|0|||
125877508|NCT03518086|452847895|FG001|Overall Study|Site Terminated by Sponsor|1|||
125877509|NCT03518086|452847896|FG002|Overall Study|Site Terminated by Sponsor|0|||
125877510|NCT03518086|452847897|FG003|Overall Study|Site Terminated by Sponsor|0|||
125877511|NCT03518086|452847894|FG000|Overall Study|Pregnancy|0|||
125877512|NCT03518086|452847895|FG001|Overall Study|Pregnancy|0|||
125877513|NCT03518086|452847896|FG002|Overall Study|Pregnancy|0|||
125877514|NCT03518086|452847897|FG003|Overall Study|Pregnancy|2|||
125877515|NCT05967260|452847898|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
125877516|NCT05967260|452847899|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
125877517|NCT00626106|452847900|FG000|Overall Study|Withdrawal by Subject|2|||
125877518|NCT00626106|452847901|FG001|Overall Study|Withdrawal by Subject|1|||
125877519|NCT00626106|452847900|FG000|Overall Study|Lost to Follow-up|1|||
125877520|NCT00626106|452847901|FG001|Overall Study|Lost to Follow-up|4|||
125877521|NCT00626106|452847900|FG000|Overall Study|Death|64|||
125877522|NCT00626106|452847901|FG001|Overall Study|Death|19|||
125877523|NCT05417438|452847902|FG000|Overall Study|Withdrawal by Subject|3|||
125877524|NCT02994108|452849248|FG000|Intervention Messages|Withdrawal by Subject|2|||
125877525|NCT02994108|452849249|FG001|Intervention Messages|Withdrawal by Subject|0|||
125877526|NCT02994108|452849248|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
125877527|NCT02994108|452849249|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
125877528|NCT02994108|452849248|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
125877529|NCT02994108|452849249|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
125877530|NCT02994108|452849248|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
125877531|NCT02994108|452849249|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
125877532|NCT00781768|452849250|FG000|Overall Study|Not transplanted.|0|||
125877533|NCT00781768|452849251|FG001|Overall Study|Not transplanted.|2|||
125877534|NCT00079417|452849260|FG000|Overall Study|Physician Decision|2|||
125877535|NCT00079417|452849260|FG000|Overall Study|Ineligible|7|||
126317470|NCT02921750|454453957|FG001|Overall Study|Wound healed|3|||
126317471|NCT02921750|454453956|FG000|Overall Study|Serious Adverse Event|1|||
126317472|NCT02921750|454453957|FG001|Overall Study|Serious Adverse Event|2|||
126317473|NCT04258254|454453958|FG000|Overall Study|Withdrawal by Subject|0|||
126317474|NCT04258254|454453959|FG001|Overall Study|Withdrawal by Subject|1|||
126317475|NCT04258254|454453960|FG002|Overall Study|Withdrawal by Subject|0|||
126317476|NCT04829331|454453961|FG000|Overall Study|Lost to Follow-up|1|||
126317477|NCT04829331|454453962|FG001|Overall Study|Lost to Follow-up|0|||
126317478|NCT03570554|454453963|FG000|Overall Study|Non-compliance with study drug|0|||
126317479|NCT03570554|454453964|FG001|Overall Study|Non-compliance with study drug|0|||
126317480|NCT03570554|454453965|FG002|Overall Study|Non-compliance with study drug|1|||
126317481|NCT03570554|454453966|FG003|Overall Study|Non-compliance with study drug|0|||
126317482|NCT03570554|454453963|FG000|Overall Study|Adverse Event|0|||
126317483|NCT03570554|454453964|FG001|Overall Study|Adverse Event|0|||
126317484|NCT03570554|454453965|FG002|Overall Study|Adverse Event|0|||
126317485|NCT03570554|454453966|FG003|Overall Study|Adverse Event|1|||
126317486|NCT03435224|454453968|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
126317487|NCT02604550|454453971|FG000|Overall Study|Lost to Follow-up|7|||
126317488|NCT02604550|454453972|FG001|Overall Study|Lost to Follow-up|6|||
126317489|NCT02604550|454453971|FG000|Overall Study|Withdrawal by Subject|0|||
126317490|NCT02604550|454453972|FG001|Overall Study|Withdrawal by Subject|1|||
126317491|NCT02604550|454453971|FG000|Overall Study|Incomplete data using paper journal|18|||
126317492|NCT02604550|454453972|FG001|Overall Study|Incomplete data using paper journal|19|||
126317493|NCT01404208|454453973|FG000|Overall Study|Discontinued|3|||
126317494|NCT01404208|454453974|FG001|Overall Study|Discontinued|0|||
126317495|NCT01777295|454453977|FG000|Overall Study|Withdrawal by Subject|2|||
126317496|NCT01777295|454453978|FG001|Overall Study|Withdrawal by Subject|2|||
126317497|NCT01777295|454453977|FG000|Overall Study|Pregnancy|0|||
126317498|NCT01777295|454453978|FG001|Overall Study|Pregnancy|1|||
126317499|NCT01777295|454453977|FG000|Overall Study|Personal problem|1|||
126317500|NCT01777295|454453978|FG001|Overall Study|Personal problem|0|||
126317501|NCT01777295|454453977|FG000|Overall Study|Investigator call for AEs check|1|||
126317502|NCT01777295|454453978|FG001|Overall Study|Investigator call for AEs check|0|||
126317503|NCT04007107|454453979|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
126317504|NCT04007107|454453980|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
126317505|NCT04007107|454453981|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
126317506|NCT04007107|454453982|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
126317507|NCT04068688|454453983|FG000|Overall Study|Lost to Follow-up|1|||
126317508|NCT04068688|454453984|FG001|Overall Study|Lost to Follow-up|1|||
126317509|NCT04068688|454453985|FG002|Overall Study|Lost to Follow-up|0|||
126317510|NCT04068688|454453986|FG003|Overall Study|Lost to Follow-up|0|||
126317511|NCT04068688|454453987|FG004|Overall Study|Lost to Follow-up|5|||
126317512|NCT04068688|454453988|FG005|Overall Study|Lost to Follow-up|5|||
126317513|NCT04068688|454453989|FG006|Overall Study|Lost to Follow-up|0|||
126317514|NCT04068688|454453990|FG007|Overall Study|Lost to Follow-up|0|||
126317515|NCT04068688|454453991|FG008|Overall Study|Lost to Follow-up|1|||
126317516|NCT04068688|454453992|FG009|Overall Study|Lost to Follow-up|0|||
126317517|NCT04068688|454453983|FG000|Overall Study|Withdrawal by Subject|1|||
126317518|NCT04068688|454453984|FG001|Overall Study|Withdrawal by Subject|1|||
126317519|NCT04068688|454453985|FG002|Overall Study|Withdrawal by Subject|0|||
126317520|NCT04068688|454453986|FG003|Overall Study|Withdrawal by Subject|0|||
126317521|NCT04068688|454453987|FG004|Overall Study|Withdrawal by Subject|0|||
126317522|NCT04068688|454453988|FG005|Overall Study|Withdrawal by Subject|0|||
126317523|NCT04068688|454453989|FG006|Overall Study|Withdrawal by Subject|0|||
126317524|NCT04068688|454453990|FG007|Overall Study|Withdrawal by Subject|0|||
126317525|NCT04068688|454453991|FG008|Overall Study|Withdrawal by Subject|0|||
126317526|NCT04068688|454453992|FG009|Overall Study|Withdrawal by Subject|0|||
126317527|NCT04068688|454453983|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
126317528|NCT04068688|454453984|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
126317529|NCT04068688|454453985|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317530|NCT04068688|454453986|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317531|NCT04068688|454453987|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317532|NCT04068688|454453988|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317533|NCT04068688|454453989|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317534|NCT04068688|454453990|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317535|NCT04068688|454453991|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317536|NCT04068688|454453992|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317537|NCT04679051|454453993|FG000|Overall Study|felt tired after restricted time in bed|3|||
126317538|NCT04679051|454453994|FG001|Overall Study|felt tired after restricted time in bed|0|||
126317539|NCT04679051|454453993|FG000|Overall Study|discomfort with blood pressure cuff|2|||
126317540|NCT04679051|454453994|FG001|Overall Study|discomfort with blood pressure cuff|0|||
126317541|NCT04679051|454453993|FG000|Overall Study|scheduling conflict|1|||
126317542|NCT04679051|454453994|FG001|Overall Study|scheduling conflict|1|||
126317543|NCT04679051|454453993|FG000|Overall Study|Protocol Violation|0|||
126317544|NCT04679051|454453994|FG001|Overall Study|Protocol Violation|4|||
126317545|NCT02554318|454453995|FG000|Overall Study|Withdrawal by Subject|10|||
125877536|NCT02458313|452849261|FG000|Overall Study|Withdrawal by Subject|6|||
125877537|NCT02458313|452849262|FG001|Overall Study|Withdrawal by Subject|8|||
125877538|NCT02458313|452849261|FG000|Overall Study|Excluded for motion during MRI|1|||
125877539|NCT02458313|452849262|FG001|Overall Study|Excluded for motion during MRI|2|||
125877540|NCT02081677|452849263|FG000|Overall Study|Adverse Event|0|||
125877541|NCT02081677|452849264|FG001|Overall Study|Adverse Event|0|||
125877542|NCT02081677|452849265|FG002|Overall Study|Adverse Event|1|||
125877543|NCT02081677|452849266|FG003|Overall Study|Adverse Event|0|||
125877544|NCT02081677|452849263|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125877545|NCT02081677|452849264|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125877546|NCT02081677|452849265|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
125877547|NCT02081677|452849266|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125877548|NCT02081677|452849263|FG000|Overall Study|Not comfortable with lens care system|1|||
125877549|NCT02081677|452849264|FG001|Overall Study|Not comfortable with lens care system|0|||
125877550|NCT02081677|452849265|FG002|Overall Study|Not comfortable with lens care system|0|||
125877551|NCT02081677|452849266|FG003|Overall Study|Not comfortable with lens care system|0|||
125877552|NCT02081677|452849263|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125877553|NCT02081677|452849264|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125877554|NCT02081677|452849265|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
125877555|NCT02081677|452849266|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
125877556|NCT00904969|452849267|FG000|Overall Study|Lost to Follow-up|4|||
125877557|NCT00904969|452849267|FG000|Overall Study|Withdrawal by Subject|3|||
125877558|NCT00904969|452849267|FG000|Overall Study|Additional Treatments|11|||
125877559|NCT00904969|452849267|FG000|Overall Study|Case Aborted; Subject Exited|1|||
125877560|NCT01097668|452849268|FG000|Overall Study|Withdrawal by Subject|1|||
125877561|NCT01097668|452849269|FG001|Overall Study|Withdrawal by Subject|2|||
125877562|NCT01097668|452849268|FG000|Overall Study|Lost to Follow-up|1|||
125877563|NCT01097668|452849269|FG001|Overall Study|Lost to Follow-up|0|||
125877564|NCT00199381|452849276|FG000|Overall Study|Withdrawal by Subject|38|||
125877565|NCT00199381|452849276|FG000|Overall Study|Adverse Event|73|||
125877566|NCT00199381|452849276|FG000|Overall Study|Protocol Violation|6|||
125877567|NCT00199381|452849276|FG000|Overall Study|Lack of Efficacy|27|||
125877568|NCT00199381|452849276|FG000|Overall Study|Not including due to early termination|37|||
125877569|NCT00199381|452849276|FG000|Overall Study|Study termination by Sponsor|323|||
125877570|NCT03007966|452849279|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
125877571|NCT03007966|452849280|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
125877572|NCT01428258|452849281|FG000|Intervention 1|Withdrawal by Subject|2|||
125877573|NCT01428258|452849282|FG001|Intervention 1|Withdrawal by Subject|0|||
125877574|NCT00248625|452849283|FG000|Overall Study|Withdrawal by Subject|0|||
125877575|NCT00248625|452849284|FG001|Overall Study|Withdrawal by Subject|2|||
125877576|NCT03085095|452849285|FG000|Overall Study|Adverse Event|23|||
125877577|NCT03085095|452849286|FG001|Overall Study|Adverse Event|8|||
125877578|NCT03085095|452849285|FG000|Overall Study|Protocol Violation|0|||
125877579|NCT03085095|452849286|FG001|Overall Study|Protocol Violation|1|||
125877580|NCT03085095|452849285|FG000|Overall Study|Lost to Follow-up|2|||
126208481|NCT01422876|454051386|FG004|Week 24|Consent withdrawn|5|||
126208482|NCT01422876|454051387|FG005|Week 24|Consent withdrawn|6|||
126208483|NCT01422876|454051388|FG006|Week 24|Consent withdrawn|5|||
126208484|NCT01422876|454051389|FG007|Week 24|Consent withdrawn|4|||
126208485|NCT01422876|454051390|FG008|Week 24|Consent withdrawn|3|||
126208486|NCT01422876|454051391|FG009|Week 24|Consent withdrawn|6|||
126208487|NCT01422876|454051382|FG000|Week 24|Death|0|||
126208488|NCT01422876|454051383|FG001|Week 24|Death|1|||
126208489|NCT01422876|454051384|FG002|Week 24|Death|0|||
126208490|NCT01422876|454051385|FG003|Week 24|Death|0|||
126208491|NCT01422876|454051386|FG004|Week 24|Death|0|||
126208492|NCT01422876|454051387|FG005|Week 24|Death|0|||
126208493|NCT01422876|454051388|FG006|Week 24|Death|0|||
126208494|NCT01422876|454051389|FG007|Week 24|Death|0|||
126208495|NCT01422876|454051390|FG008|Week 24|Death|0|||
126208496|NCT01422876|454051391|FG009|Week 24|Death|0|||
126208497|NCT01422876|454051382|FG000|Week 52|Lost to Follow-up|3|||
126208498|NCT01422876|454051383|FG001|Week 52|Lost to Follow-up|5|||
126208499|NCT01422876|454051384|FG002|Week 52|Lost to Follow-up|7|||
126208500|NCT01422876|454051385|FG003|Week 52|Lost to Follow-up|5|||
126208501|NCT01422876|454051386|FG004|Week 52|Lost to Follow-up|8|||
126208502|NCT01422876|454051387|FG005|Week 52|Lost to Follow-up|5|||
125877581|NCT03085095|452849286|FG001|Overall Study|Lost to Follow-up|1|||
125877582|NCT03085095|452849285|FG000|Overall Study|Withdrawal by Subject|17|||
125877583|NCT03085095|452849286|FG001|Overall Study|Withdrawal by Subject|6|||
125877584|NCT03085095|452849285|FG000|Overall Study|Physician Decision|9|||
125877585|NCT03085095|452849286|FG001|Overall Study|Physician Decision|3|||
125877586|NCT03085095|452849285|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
125877587|NCT03085095|452849286|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
126208503|NCT01422876|454051388|FG006|Week 52|Lost to Follow-up|5|||
126208504|NCT01422876|454051389|FG007|Week 52|Lost to Follow-up|8|||
126208505|NCT01422876|454051390|FG008|Week 52|Lost to Follow-up|7|||
126208506|NCT01422876|454051391|FG009|Week 52|Lost to Follow-up|8|||
126208507|NCT01422876|454051382|FG000|Week 52|Consent withdrawn|9|||
125877588|NCT03085095|452849285|FG000|Overall Study|Did not Receive Study Drug|2|||
126317546|NCT02554318|454453996|FG001|Overall Study|Withdrawal by Subject|8|||
126317547|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
126317548|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
126317549|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
125877589|NCT03085095|452849286|FG001|Overall Study|Did not Receive Study Drug|2|||
125877590|NCT03085095|452849285|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
125877591|NCT03085095|452849286|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
125877592|NCT00408317|452849287|FG000|First Intervention Period|Adverse Event|0|||
125877593|NCT00408317|452849288|FG001|First Intervention Period|Adverse Event|1|||
125877594|NCT00408317|452849287|FG000|Second Intervention Period|Adverse Event|2|||
125877595|NCT00408317|452849288|FG001|Second Intervention Period|Adverse Event|0|||
125877596|NCT00408317|452849287|FG000|Second Intervention Period|Protocol Violation|0|||
125877597|NCT00408317|452849288|FG001|Second Intervention Period|Protocol Violation|1|||
125877598|NCT00408317|452849287|FG000|Second Intervention Period|Withdrawal of consent|0|||
125877599|NCT00408317|452849288|FG001|Second Intervention Period|Withdrawal of consent|1|||
125877600|NCT01074502|452849289|FG000|Overall Study|Withdrawal by Subject|1|||
125877601|NCT00726063|452849293|FG000|Overall Study|Adverse Event|9|||
125877602|NCT00726063|452849294|FG001|Overall Study|Adverse Event|7|||
125877603|NCT05176314|452849296|FG000|Overall Study|Lost to Follow-up|2|||
125877604|NCT05176314|452849296|FG000|Overall Study|Physician Decision|1|||
125877605|NCT05176314|452849296|FG000|Overall Study|Adverse Event|1|||
125877606|NCT01231984|452849297|FG000|Study Period 1|Withdrawal by Subject|0|||
125877607|NCT01231984|452849298|FG001|Study Period 1|Withdrawal by Subject|0|||
125877608|NCT01231984|452849299|FG002|Study Period 1|Withdrawal by Subject|0|||
125877609|NCT01231984|452849300|FG003|Study Period 1|Withdrawal by Subject|1|||
125877610|NCT01231984|452849297|FG000|Study Period 1|Lost to Follow-up|1|||
125877611|NCT01231984|452849298|FG001|Study Period 1|Lost to Follow-up|1|||
125877612|NCT01231984|452849299|FG002|Study Period 1|Lost to Follow-up|1|||
125877613|NCT01231984|452849300|FG003|Study Period 1|Lost to Follow-up|0|||
125877614|NCT01231984|452849297|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
125877615|NCT01231984|452849298|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
125877616|NCT01231984|452849299|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
125877617|NCT01231984|452849300|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
125877618|NCT01231984|452849297|FG000|Study Period 1|Screen Failure|0|||
125877619|NCT01231984|452849298|FG001|Study Period 1|Screen Failure|0|||
125877620|NCT01231984|452849299|FG002|Study Period 1|Screen Failure|0|||
125877621|NCT01231984|452849300|FG003|Study Period 1|Screen Failure|1|||
125877622|NCT01231984|452849297|FG000|Study Period 1|Non-compliance with study requirements|5|||
125877623|NCT01231984|452849298|FG001|Study Period 1|Non-compliance with study requirements|0|||
125877624|NCT01231984|452849299|FG002|Study Period 1|Non-compliance with study requirements|2|||
125877625|NCT01231984|452849300|FG003|Study Period 1|Non-compliance with study requirements|1|||
125877626|NCT01231984|452849297|FG000|Study Period 1|Protocol Violation|3|||
125877627|NCT01231984|452849298|FG001|Study Period 1|Protocol Violation|4|||
125877628|NCT01231984|452849299|FG002|Study Period 1|Protocol Violation|2|||
125877629|NCT01231984|452849300|FG003|Study Period 1|Protocol Violation|3|||
125877630|NCT01231984|452849297|FG000|Study Period 1|Adverse Event|1|||
125877631|NCT01231984|452849298|FG001|Study Period 1|Adverse Event|0|||
125877632|NCT01231984|452849299|FG002|Study Period 1|Adverse Event|0|||
125877633|NCT01231984|452849300|FG003|Study Period 1|Adverse Event|0|||
125877634|NCT01231984|452849297|FG000|Study Period 1|Other|0|||
125877635|NCT01231984|452849298|FG001|Study Period 1|Other|0|||
126317550|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
126317551|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Death|1|||
126317552|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Death|1|||
126317553|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
126317554|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
126317555|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
126317556|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
126317557|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
126317558|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
126317559|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
126317560|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
126317561|NCT00033657|454453997|FG000|Surgical Resection|not complete resection|0|||
126317562|NCT00033657|454453998|FG001|Surgical Resection|not complete resection|3|||
126317563|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
126317564|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
126317565|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
125877636|NCT01231984|452849299|FG002|Study Period 1|Other|0|||
125877637|NCT01231984|452849300|FG003|Study Period 1|Other|1|||
125877638|NCT01231984|452849297|FG000|Study Period 2|Withdrawal by Subject|1|||
125877639|NCT01231984|452849298|FG001|Study Period 2|Withdrawal by Subject|1|||
125877640|NCT01231984|452849299|FG002|Study Period 2|Withdrawal by Subject|0|||
125877641|NCT01231984|452849300|FG003|Study Period 2|Withdrawal by Subject|0|||
126317566|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
126317567|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Death|2|||
126317568|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Death|1|||
126317569|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
126317570|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
126317571|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
126317572|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
126317573|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Other|0|||
126317574|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Other|2|||
126317575|NCT02248974|454453999|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
126317576|NCT02248974|454454000|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
126317577|NCT02248974|454453999|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
126317578|NCT02248974|454454000|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
126317579|NCT02248974|454453999|FG000|1-Day Follow-Up|Enrolled in another study|1|||
126317580|NCT02248974|454454000|FG001|1-Day Follow-Up|Enrolled in another study|0|||
126317581|NCT02248974|454453999|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
126317582|NCT02248974|454454000|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
126317583|NCT02248974|454453999|FG000|1-Week Follow-Up|Enrolled in another study|1|||
126317584|NCT02248974|454454000|FG001|1-Week Follow-Up|Enrolled in another study|1|||
126317585|NCT02248974|454453999|FG000|1-Week Follow-Up|Transferred to another facility|1|||
126317586|NCT02248974|454454000|FG001|1-Week Follow-Up|Transferred to another facility|0|||
126317587|NCT02248974|454453999|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
126317588|NCT02248974|454454000|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
126317589|NCT02248974|454453999|FG000|1-Week Follow-Up|Death|1|||
126317590|NCT02248974|454454000|FG001|1-Week Follow-Up|Death|1|||
126317591|NCT02248974|454453999|FG000|1-Week Follow-Up|Excluded because of age|0|||
126317592|NCT02248974|454454000|FG001|1-Week Follow-Up|Excluded because of age|1|||
126317593|NCT02248974|454453999|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
126317594|NCT02248974|454454000|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
126317595|NCT02248974|454453999|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
126317596|NCT02248974|454454000|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
126317597|NCT02248974|454453999|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
126317598|NCT02248974|454454000|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
126317599|NCT02248974|454453999|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
126317600|NCT02248974|454454000|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
126317601|NCT02248974|454453999|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
126317602|NCT02248974|454454000|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
126317603|NCT02332239|454454001|FG000|Overall Study|Lost to Follow-up|4|||
126317604|NCT02332239|454454002|FG001|Overall Study|Lost to Follow-up|6|||
126317605|NCT00115037|454454003|FG000|Phase1|Lost to Follow-up|16|||
126317606|NCT00115037|454454004|FG001|Phase1|Lost to Follow-up|23|||
126317607|NCT00115037|454454005|FG002|Phase1|Lost to Follow-up|0|||
126317608|NCT00115037|454454006|FG003|Phase1|Lost to Follow-up|0|||
126317609|NCT00115037|454454007|FG004|Phase1|Lost to Follow-up|0|||
126317610|NCT00115037|454454008|FG005|Phase1|Lost to Follow-up|0|||
126317611|NCT00115037|454454003|FG000|Phase1|Withdrawal by Subject|9|||
125877642|NCT01231984|452849297|FG000|Study Period 2|Lost to Follow-up|1|||
125877643|NCT01231984|452849298|FG001|Study Period 2|Lost to Follow-up|0|||
125877644|NCT01231984|452849299|FG002|Study Period 2|Lost to Follow-up|0|||
125877645|NCT01231984|452849300|FG003|Study Period 2|Lost to Follow-up|3|||
125877646|NCT01231984|452849297|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
125877647|NCT01231984|452849298|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
125877648|NCT01231984|452849299|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
125877649|NCT01231984|452849300|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
125877650|NCT00286468|452849301|FG000|Overall Study|Hyperglycemic Rescue|28|||
125877651|NCT00286468|452849302|FG001|Overall Study|Hyperglycemic Rescue|30|||
125877652|NCT00286468|452849303|FG002|Overall Study|Hyperglycemic Rescue|31|||
125877653|NCT00286468|452849301|FG000|Overall Study|Adverse Event|2|||
125877654|NCT00286468|452849302|FG001|Overall Study|Adverse Event|6|||
125877655|NCT00286468|452849303|FG002|Overall Study|Adverse Event|4|||
125877656|NCT00286468|452849301|FG000|Overall Study|Protocol Violation|0|||
125877657|NCT00286468|452849302|FG001|Overall Study|Protocol Violation|3|||
125877658|NCT00286468|452849303|FG002|Overall Study|Protocol Violation|1|||
125877659|NCT00286468|452849301|FG000|Overall Study|Lost to Follow-up|1|||
125877660|NCT00286468|452849302|FG001|Overall Study|Lost to Follow-up|1|||
125877661|NCT00286468|452849303|FG002|Overall Study|Lost to Follow-up|2|||
125877662|NCT00286468|452849301|FG000|Overall Study|Withdrawal by Subject|3|||
125877663|NCT00286468|452849302|FG001|Overall Study|Withdrawal by Subject|8|||
125877664|NCT00286468|452849303|FG002|Overall Study|Withdrawal by Subject|11|||
125877665|NCT00286468|452849301|FG000|Overall Study|Physician Decision|3|||
125877666|NCT00286468|452849302|FG001|Overall Study|Physician Decision|2|||
125877667|NCT00286468|452849303|FG002|Overall Study|Physician Decision|1|||
125877668|NCT02923726|452849304|FG000|Overall Study|Death|196|||
126317612|NCT00115037|454454004|FG001|Phase1|Withdrawal by Subject|4|||
126317613|NCT00115037|454454005|FG002|Phase1|Withdrawal by Subject|0|||
126317614|NCT00115037|454454006|FG003|Phase1|Withdrawal by Subject|0|||
125877669|NCT02923726|452849305|FG001|Overall Study|Death|175|||
125877670|NCT02923726|452849304|FG000|Overall Study|Withdrawal by Subject|337|||
125877671|NCT02923726|452849305|FG001|Overall Study|Withdrawal by Subject|307|||
125877672|NCT00074711|452849307|FG000|Overall Study|Withdrawal by Subject|1|||
125877673|NCT00074711|452849308|FG001|Overall Study|Withdrawal by Subject|1|||
125877674|NCT00074711|452849307|FG000|Overall Study|Lost to Follow-up|10|||
125877675|NCT00074711|452849308|FG001|Overall Study|Lost to Follow-up|8|||
125877676|NCT00074711|452849307|FG000|Overall Study|Participant stopped study drug|4|||
125877677|NCT00074711|452849308|FG001|Overall Study|Participant stopped study drug|6|||
125877678|NCT03466658|452849309|FG000|Overall Study|Withdrawal by Subject|3|||
125877679|NCT05365217|452849310|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125877680|NCT05365217|452849311|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125877681|NCT00129402|452849314|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125877682|NCT00129402|452849315|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125877683|NCT00129402|452849316|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125877684|NCT00129402|452849317|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125877685|NCT00129402|452849318|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125877686|NCT00129402|452849319|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125877687|NCT00129402|452849320|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125877688|NCT00129402|452849314|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125877689|NCT00129402|452849315|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125877690|NCT00129402|452849316|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125877691|NCT00129402|452849317|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125877692|NCT00129402|452849318|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125877693|NCT00129402|452849319|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
125877694|NCT00129402|452849320|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125877695|NCT00129402|452849314|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125877696|NCT00129402|452849315|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125877697|NCT00129402|452849316|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125877698|NCT00129402|452849317|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
125877699|NCT00129402|452849318|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125877700|NCT00129402|452849319|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125877701|NCT00129402|452849320|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125877702|NCT00129402|452849314|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125877703|NCT00129402|452849315|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125877704|NCT00129402|452849316|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
125877705|NCT00129402|452849317|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125877706|NCT00129402|452849318|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
125877707|NCT00129402|452849319|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125877708|NCT00129402|452849320|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125877709|NCT00129402|452849314|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125877710|NCT00129402|452849315|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125877711|NCT00129402|452849316|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
125877712|NCT00129402|452849317|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125877713|NCT00129402|452849318|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125877714|NCT00129402|452849319|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125877715|NCT00129402|452849320|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125877716|NCT00129402|452849314|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125877717|NCT00129402|452849315|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125877718|NCT00129402|452849316|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
125877719|NCT00129402|452849317|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125877720|NCT00129402|452849318|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125877721|NCT00129402|452849319|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
125877722|NCT00129402|452849320|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125877723|NCT00129402|452849314|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125877724|NCT00129402|452849315|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125877725|NCT00129402|452849316|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
125877726|NCT00129402|452849317|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125877727|NCT00129402|452849318|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125877728|NCT00129402|452849319|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125877729|NCT00129402|452849320|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125877730|NCT00129402|452849314|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125877731|NCT00129402|452849315|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125877732|NCT00129402|452849316|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
125877733|NCT00129402|452849317|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125877734|NCT00129402|452849318|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
126208508|NCT01422876|454051383|FG001|Week 52|Consent withdrawn|4|||
125877735|NCT00129402|452849319|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
125877736|NCT00129402|452849320|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125877737|NCT00129402|452849314|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125877738|NCT00129402|452849315|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125877739|NCT00129402|452849316|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
125877740|NCT00129402|452849317|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125877741|NCT00129402|452849318|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125877742|NCT00129402|452849319|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
126317615|NCT00115037|454454007|FG004|Phase1|Withdrawal by Subject|0|||
126317616|NCT00115037|454454008|FG005|Phase1|Withdrawal by Subject|0|||
126317617|NCT00115037|454454003|FG000|Phase2|Death|0|||
126317618|NCT00115037|454454004|FG001|Phase2|Death|0|||
126317619|NCT00115037|454454005|FG002|Phase2|Death|1|||
126317620|NCT00115037|454454006|FG003|Phase2|Death|0|||
126317621|NCT00115037|454454007|FG004|Phase2|Death|0|||
126317622|NCT00115037|454454008|FG005|Phase2|Death|1|||
126317623|NCT00115037|454454003|FG000|Phase2|Withdrawal by Subject|0|||
126317624|NCT00115037|454454004|FG001|Phase2|Withdrawal by Subject|0|||
126317625|NCT00115037|454454005|FG002|Phase2|Withdrawal by Subject|2|||
126317626|NCT00115037|454454006|FG003|Phase2|Withdrawal by Subject|1|||
126317627|NCT00115037|454454007|FG004|Phase2|Withdrawal by Subject|2|||
126317628|NCT00115037|454454008|FG005|Phase2|Withdrawal by Subject|1|||
126317629|NCT00115037|454454003|FG000|Phase2|Lost to Follow-up|0|||
126317630|NCT00115037|454454004|FG001|Phase2|Lost to Follow-up|0|||
126317631|NCT00115037|454454005|FG002|Phase2|Lost to Follow-up|12|||
126317632|NCT00115037|454454006|FG003|Phase2|Lost to Follow-up|14|||
126317633|NCT00115037|454454007|FG004|Phase2|Lost to Follow-up|4|||
126317634|NCT00115037|454454008|FG005|Phase2|Lost to Follow-up|10|||
126317635|NCT00396877|454454011|FG000|Overall Study|Lost to Follow-up|2|||
126317636|NCT00396877|454454012|FG001|Overall Study|Lost to Follow-up|1|||
126317637|NCT00396877|454454011|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
126317638|NCT00396877|454454012|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
126317639|NCT02945254|454454013|FG000|Overall Study|Lost to Follow-up|1|||
126317640|NCT02945254|454454014|FG001|Overall Study|Lost to Follow-up|0|||
126317641|NCT02945254|454454013|FG000|Overall Study|Withdrawal by Subject|1|||
126317642|NCT02945254|454454014|FG001|Overall Study|Withdrawal by Subject|0|||
126317643|NCT03436199|454454019|FG000|Overall Study|Adverse Event|15|||
126317644|NCT03436199|454454020|FG001|Overall Study|Adverse Event|40|||
126317645|NCT03436199|454454021|FG002|Overall Study|Adverse Event|7|||
126317646|NCT03436199|454454019|FG000|Overall Study|Withdrawal by Subject|4|||
126317647|NCT03436199|454454020|FG001|Overall Study|Withdrawal by Subject|10|||
126317648|NCT03436199|454454021|FG002|Overall Study|Withdrawal by Subject|3|||
126317649|NCT03436199|454454019|FG000|Overall Study|Lost to Follow-up|1|||
126317650|NCT03436199|454454020|FG001|Overall Study|Lost to Follow-up|0|||
126317651|NCT03436199|454454021|FG002|Overall Study|Lost to Follow-up|2|||
126317652|NCT03436199|454454019|FG000|Overall Study|Protocol Violation|1|||
126317653|NCT03436199|454454020|FG001|Overall Study|Protocol Violation|1|||
126317654|NCT03436199|454454021|FG002|Overall Study|Protocol Violation|0|||
126317655|NCT03436199|454454019|FG000|Overall Study|Physician Decision|0|||
126317656|NCT03436199|454454020|FG001|Overall Study|Physician Decision|1|||
126317657|NCT03436199|454454021|FG002|Overall Study|Physician Decision|0|||
126317658|NCT03436199|454454019|FG000|Overall Study|Could not return to clinic|1|||
126317659|NCT03436199|454454020|FG001|Overall Study|Could not return to clinic|0|||
126317660|NCT03436199|454454021|FG002|Overall Study|Could not return to clinic|0|||
126317661|NCT03436199|454454019|FG000|Overall Study|Withdrawn per physician|0|||
126317662|NCT03436199|454454020|FG001|Overall Study|Withdrawn per physician|1|||
126317663|NCT03436199|454454021|FG002|Overall Study|Withdrawn per physician|0|||
126317664|NCT02631070|454454022|FG000|Overall Study|Withdrawal by Subject|35|||
126317665|NCT02631070|454454023|FG001|Overall Study|Withdrawal by Subject|13|||
126317666|NCT02631070|454454022|FG000|Overall Study|Death|45|||
126317667|NCT02631070|454454023|FG001|Overall Study|Death|24|||
125877743|NCT00129402|452849320|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125877744|NCT00129402|452849314|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
126317668|NCT02631070|454454022|FG000|Overall Study|Lost to Follow-up|5|||
126317669|NCT02631070|454454023|FG001|Overall Study|Lost to Follow-up|1|||
126317670|NCT02631070|454454022|FG000|Overall Study|Transition to rollover protocol|52|||
126317671|NCT02631070|454454023|FG001|Overall Study|Transition to rollover protocol|21|||
126317672|NCT02631070|454454022|FG000|Overall Study|Other reasons|12|||
126317673|NCT02631070|454454023|FG001|Overall Study|Other reasons|5|||
126317674|NCT00085098|454454025|FG000|Overall Study|Withdrawal by Subject|0|||
126317675|NCT00085098|454454026|FG001|Overall Study|Withdrawal by Subject|1|||
126317676|NCT00085098|454454025|FG000|Overall Study|Ineligible|1|||
126317677|NCT00085098|454454026|FG001|Overall Study|Ineligible|1|||
126317678|NCT01886781|454454029|FG000|Overall Study|Protocol Violation|5|||
126317679|NCT01886781|454454030|FG001|Overall Study|Protocol Violation|0|||
126317680|NCT01886781|454454029|FG000|Overall Study|Adverse Event|1|||
126317681|NCT01886781|454454030|FG001|Overall Study|Adverse Event|0|||
126317682|NCT01886781|454454029|FG000|Overall Study|Lost to Follow-up|5|||
125877745|NCT00129402|452849315|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125877746|NCT00129402|452849316|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125877747|NCT00129402|452849317|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125877748|NCT00129402|452849318|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125877749|NCT00129402|452849319|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125877750|NCT00129402|452849320|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
125877751|NCT00129402|452849314|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125877752|NCT00129402|452849315|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125877753|NCT00129402|452849316|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125877754|NCT00129402|452849317|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125877755|NCT00129402|452849318|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125877756|NCT00129402|452849319|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125877757|NCT00129402|452849320|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
125877758|NCT00129402|452849314|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125877759|NCT00129402|452849315|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125877760|NCT00129402|452849316|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125877761|NCT00129402|452849317|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125877762|NCT00129402|452849318|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125877763|NCT00129402|452849319|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125877764|NCT00129402|452849320|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
125877765|NCT00129402|452849314|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125877766|NCT00129402|452849315|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125877767|NCT00129402|452849316|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125877768|NCT00129402|452849317|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125877769|NCT00129402|452849318|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125877770|NCT00129402|452849319|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125877771|NCT00129402|452849320|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
125877772|NCT01527149|452849321|FG000|Overall Study|Death|2|||
125877773|NCT01680341|452849322|FG000|Overall Study|Adverse Event|3|||
125877774|NCT01680341|452849323|FG001|Overall Study|Adverse Event|2|||
125877775|NCT01680341|452849322|FG000|Overall Study|Unclassified|18|||
125877776|NCT01680341|452849323|FG001|Overall Study|Unclassified|15|||
125877777|NCT00481832|452849324|FG000|Enrollment|Physician Decision|8|||
125877778|NCT00481832|452849324|FG000|Enrollment|Unable to collect enough stem cells|2|||
125877779|NCT00481832|452849324|FG000|Inter-transplant Period|Adverse Event|4|||
125877780|NCT00481832|452849324|FG000|Inter-transplant Period|Death|3|||
125877781|NCT00481832|452849324|FG000|Inter-transplant Period|Physician Decision|4|||
125877782|NCT00481832|452849324|FG000|Inter-transplant Period|Disease relapse|11|||
125877783|NCT00481832|452849324|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
125877784|NCT02006472|452849328|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
125877785|NCT02006472|452849329|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
125877786|NCT02006472|452849330|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
125877787|NCT02006472|452849331|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
125877788|NCT02006472|452849332|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
125980494|NCT01949870|453217087|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
125980495|NCT02570126|453217091|FG000|Overall Study|Lost to Follow-up|2|||
126317683|NCT01886781|454454030|FG001|Overall Study|Lost to Follow-up|0|||
126317684|NCT01886781|454454029|FG000|Overall Study|Withdrawal by Subject|2|||
126317685|NCT01886781|454454030|FG001|Overall Study|Withdrawal by Subject|1|||
126317686|NCT01886781|454454029|FG000|Overall Study|Worsening of symptoms|1|||
126317687|NCT01886781|454454030|FG001|Overall Study|Worsening of symptoms|1|||
126317688|NCT01522235|454454031|FG000|Overall Study|Physician Decision|1|||
126317689|NCT01522235|454454032|FG001|Overall Study|Physician Decision|1|||
126317690|NCT00980018|454454033|FG000|Overall Study|Adverse Event|8|||
126317691|NCT00980018|454454033|FG000|Overall Study|Patient withdrew consent|3|||
126317692|NCT00980018|454454033|FG000|Overall Study|Lost to Follow-up|1|||
126317693|NCT03769194|454454034|FG000|Overall Study|Withdrawal by Subject|0|||
126317694|NCT03769194|454454035|FG001|Overall Study|Withdrawal by Subject|7|||
126317695|NCT03769194|454454036|FG002|Overall Study|Withdrawal by Subject|4|||
126317696|NCT03769194|454454037|FG003|Overall Study|Withdrawal by Subject|1|||
126317697|NCT03769194|454454034|FG000|Overall Study|moved from study area|0|||
126317698|NCT03769194|454454035|FG001|Overall Study|moved from study area|2|||
126317699|NCT03769194|454454036|FG002|Overall Study|moved from study area|1|||
126317700|NCT03769194|454454037|FG003|Overall Study|moved from study area|1|||
126317701|NCT03769194|454454034|FG000|Overall Study|Lost to Follow-up|3|||
126317702|NCT03769194|454454035|FG001|Overall Study|Lost to Follow-up|6|||
126317703|NCT03769194|454454036|FG002|Overall Study|Lost to Follow-up|3|||
126317704|NCT03769194|454454037|FG003|Overall Study|Lost to Follow-up|6|||
126317705|NCT03769194|454454034|FG000|Overall Study|other|1|||
126317706|NCT03769194|454454035|FG001|Overall Study|other|3|||
126317707|NCT03769194|454454036|FG002|Overall Study|other|0|||
125877789|NCT02006472|452849328|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125877790|NCT02006472|452849329|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125877791|NCT02006472|452849330|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
125877792|NCT02006472|452849331|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125877793|NCT02006472|452849332|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125877794|NCT02006472|452849328|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
125877795|NCT02006472|452849329|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
125877796|NCT02006472|452849330|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
125877797|NCT02006472|452849331|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
125877798|NCT02006472|452849332|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
125877799|NCT02006472|452849328|FG000|Period 1 (Through Week 26)|Other|1|||
125877800|NCT02006472|452849329|FG001|Period 1 (Through Week 26)|Other|5|||
125877801|NCT02006472|452849330|FG002|Period 1 (Through Week 26)|Other|0|||
125877802|NCT02006472|452849331|FG003|Period 1 (Through Week 26)|Other|2|||
125877803|NCT02006472|452849332|FG004|Period 1 (Through Week 26)|Other|3|||
125877804|NCT02006472|452849328|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
125877805|NCT02006472|452849329|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
125877806|NCT02006472|452849330|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
126317708|NCT03769194|454454037|FG003|Overall Study|other|1|||
126317709|NCT01832818|454454041|FG000|Overall Study|Lost to Follow-up|6|||
126317710|NCT01672294|454454048|FG000|Overall Study|Withdrawal by Subject|4|||
126317711|NCT01672294|454454049|FG001|Overall Study|Withdrawal by Subject|4|||
126317712|NCT01672294|454454050|FG002|Overall Study|Withdrawal by Subject|4|||
126317713|NCT01672294|454454051|FG003|Overall Study|Withdrawal by Subject|4|||
126317714|NCT01672294|454454048|FG000|Overall Study|Excluded by study|1|||
126317715|NCT01672294|454454049|FG001|Overall Study|Excluded by study|1|||
126317716|NCT01672294|454454050|FG002|Overall Study|Excluded by study|0|||
126317717|NCT01672294|454454051|FG003|Overall Study|Excluded by study|0|||
126317718|NCT01672294|454454048|FG000|Overall Study|Lost to Follow-up|1|||
126317719|NCT01672294|454454049|FG001|Overall Study|Lost to Follow-up|16|||
126317720|NCT01672294|454454050|FG002|Overall Study|Lost to Follow-up|7|||
126317721|NCT01672294|454454051|FG003|Overall Study|Lost to Follow-up|9|||
126317722|NCT01273155|454454052|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
126317723|NCT01273155|454454053|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
126317724|NCT01273155|454454054|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
126317725|NCT01273155|454454055|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
126317726|NCT01273155|454454056|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
126317727|NCT01273155|454454057|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
126317728|NCT01273155|454454058|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
126317729|NCT01273155|454454052|FG000|Overall Study|Change in liver function/no longer eval.|0|||
126317730|NCT01273155|454454053|FG001|Overall Study|Change in liver function/no longer eval.|1|||
126317731|NCT01273155|454454054|FG002|Overall Study|Change in liver function/no longer eval.|0|||
126317732|NCT01273155|454454055|FG003|Overall Study|Change in liver function/no longer eval.|0|||
126317733|NCT01273155|454454056|FG004|Overall Study|Change in liver function/no longer eval.|1|||
126317734|NCT01273155|454454057|FG005|Overall Study|Change in liver function/no longer eval.|0|||
126317735|NCT01273155|454454058|FG006|Overall Study|Change in liver function/no longer eval.|0|||
126317736|NCT01273155|454454052|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
126317737|NCT01273155|454454053|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
126317738|NCT01273155|454454054|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
126317739|NCT01273155|454454055|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
126317740|NCT01273155|454454056|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
126317741|NCT01273155|454454057|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
126317742|NCT01273155|454454058|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
126317743|NCT01273155|454454052|FG000|Overall Study|Died during Cycle 1|0|||
126317744|NCT01273155|454454053|FG001|Overall Study|Died during Cycle 1|0|||
126317745|NCT01273155|454454054|FG002|Overall Study|Died during Cycle 1|1|||
126317746|NCT01273155|454454055|FG003|Overall Study|Died during Cycle 1|1|||
126317747|NCT01273155|454454056|FG004|Overall Study|Died during Cycle 1|0|||
126317748|NCT01273155|454454057|FG005|Overall Study|Died during Cycle 1|2|||
126317749|NCT01273155|454454058|FG006|Overall Study|Died during Cycle 1|2|||
126317750|NCT01273155|454454052|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
126317751|NCT01273155|454454053|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
126317752|NCT01273155|454454054|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
126317753|NCT01273155|454454055|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
126317754|NCT01273155|454454056|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
126317755|NCT01273155|454454057|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
126317756|NCT01273155|454454058|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
126317757|NCT01438814|454454064|FG000|Overall Study|Adverse Event|3|||
125877807|NCT02006472|452849331|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
125877808|NCT02006472|452849332|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
125877809|NCT02006472|452849328|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125877810|NCT02006472|452849329|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
125877811|NCT02006472|452849330|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125877812|NCT02006472|452849331|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
125877813|NCT02006472|452849332|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125877814|NCT02006472|452849328|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125877815|NCT02006472|452849329|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
125877816|NCT02006472|452849330|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
125877817|NCT02006472|452849331|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125877818|NCT02006472|452849332|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125877819|NCT02006472|452849328|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
125877820|NCT02006472|452849329|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
125877821|NCT02006472|452849330|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
125877822|NCT02006472|452849331|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
125877823|NCT02006472|452849332|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
125877824|NCT02006472|452849328|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
125877825|NCT02006472|452849329|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
125877826|NCT02006472|452849330|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
125877827|NCT02006472|452849331|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
125877828|NCT02006472|452849332|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
125877829|NCT02006472|452849328|FG000|Period 2 (Through Week 52)|Other|0|||
125877830|NCT02006472|452849329|FG001|Period 2 (Through Week 52)|Other|1|||
125877831|NCT02006472|452849330|FG002|Period 2 (Through Week 52)|Other|0|||
125877832|NCT02006472|452849331|FG003|Period 2 (Through Week 52)|Other|1|||
125877833|NCT02006472|452849332|FG004|Period 2 (Through Week 52)|Other|0|||
125877834|NCT02006472|452849328|FG000|Period 2 (Through Week 52)|Not treated|0|||
125877835|NCT02006472|452849329|FG001|Period 2 (Through Week 52)|Not treated|0|||
125877836|NCT02006472|452849330|FG002|Period 2 (Through Week 52)|Not treated|2|||
125877837|NCT02006472|452849331|FG003|Period 2 (Through Week 52)|Not treated|0|||
125877838|NCT02006472|452849332|FG004|Period 2 (Through Week 52)|Not treated|0|||
125877839|NCT02006472|452849328|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
125877840|NCT02006472|452849329|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
125877841|NCT02006472|452849330|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
125877842|NCT02006472|452849331|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
125877843|NCT02006472|452849332|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
125877844|NCT02006472|452849328|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
125877845|NCT02006472|452849329|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
125877846|NCT02006472|452849330|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
125877847|NCT02006472|452849331|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
125877848|NCT02006472|452849332|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
125877849|NCT00499486|452849333|FG000|Overall Study|Withdrawal by Subject|16|||
125877850|NCT00087152|452849334|FG000|Overall Study|Ineligible|6|||
125877851|NCT01436149|452849337|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
125877852|NCT01436149|452849338|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
125877853|NCT01436149|452849339|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
125877854|NCT01436149|452849337|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
125877855|NCT01436149|452849338|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
125877856|NCT01436149|452849339|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
125877857|NCT01436149|452849337|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
125877858|NCT01436149|452849338|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125877859|NCT01436149|452849339|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125877860|NCT01436149|452849337|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
125877861|NCT01436149|452849338|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125877862|NCT01436149|452849339|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125877863|NCT01436149|452849337|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
125877864|NCT01436149|452849338|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
125877865|NCT01436149|452849339|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
125877866|NCT01436149|452849337|FG000|Antidepressant Lead-in Phase|Other|119|||
125877867|NCT01436149|452849338|FG001|Antidepressant Lead-in Phase|Other|0|||
125877868|NCT01436149|452849339|FG002|Antidepressant Lead-in Phase|Other|0|||
125980496|NCT02570126|453217092|FG001|Overall Study|Lost to Follow-up|0|||
125980497|NCT02570126|453217091|FG000|Overall Study|Unable To Arrange Visit 3|1|||
125980498|NCT02570126|453217092|FG001|Overall Study|Unable To Arrange Visit 3|0|||
125980499|NCT02570126|453217091|FG000|Overall Study|Violation Of Procedures GSK|0|||
125980500|NCT02570126|453217092|FG001|Overall Study|Violation Of Procedures GSK|1|||
125980501|NCT02570126|453217091|FG000|Overall Study|Protocol Violation|0|||
125980502|NCT02570126|453217092|FG001|Overall Study|Protocol Violation|1|||
125980503|NCT02570126|453217091|FG000|Overall Study|Withdrawal by Subject|3|||
125980504|NCT02570126|453217092|FG001|Overall Study|Withdrawal by Subject|7|||
125980505|NCT00917579|453217093|FG000|Washout >= 2 Weeks|Adverse Event|1|||
125980506|NCT00917579|453217094|FG001|Washout >= 2 Weeks|Adverse Event|0|||
126208509|NCT01422876|454051384|FG002|Week 52|Consent withdrawn|6|||
126208510|NCT01422876|454051385|FG003|Week 52|Consent withdrawn|12|||
125877869|NCT01436149|452849337|FG000|Randomized Phase|Adverse Event|9|||
125877870|NCT01436149|452849338|FG001|Randomized Phase|Adverse Event|10|||
126208511|NCT01422876|454051386|FG004|Week 52|Consent withdrawn|7|||
126317758|NCT01438814|454454065|FG001|Overall Study|Adverse Event|3|||
125877871|NCT01436149|452849339|FG002|Randomized Phase|Adverse Event|11|||
125877872|NCT01436149|452849337|FG000|Randomized Phase|Protocol Violation|4|||
126208512|NCT01422876|454051387|FG005|Week 52|Consent withdrawn|12|||
126208513|NCT01422876|454051388|FG006|Week 52|Consent withdrawn|10|||
126208514|NCT01422876|454051389|FG007|Week 52|Consent withdrawn|12|||
126208515|NCT01422876|454051390|FG008|Week 52|Consent withdrawn|13|||
126208516|NCT01422876|454051391|FG009|Week 52|Consent withdrawn|9|||
126208517|NCT01422876|454051382|FG000|Week 52|Death|0|||
126208518|NCT01422876|454051383|FG001|Week 52|Death|1|||
126208519|NCT01422876|454051384|FG002|Week 52|Death|0|||
126208520|NCT01422876|454051385|FG003|Week 52|Death|1|||
126208521|NCT01422876|454051386|FG004|Week 52|Death|0|||
126208522|NCT01422876|454051387|FG005|Week 52|Death|0|||
126208523|NCT01422876|454051388|FG006|Week 52|Death|1|||
126208524|NCT01422876|454051389|FG007|Week 52|Death|3|||
126208525|NCT01422876|454051390|FG008|Week 52|Death|1|||
126208526|NCT01422876|454051391|FG009|Week 52|Death|0|||
126208527|NCT00054639|454051401|FG000|Overall Study|Lack of Efficacy|1|||
126208528|NCT00054639|454051401|FG000|Overall Study|Physician Decision|1|||
126208529|NCT05028816|454051413|FG000|Overall Study|Lost to Follow-up|5|||
126208530|NCT05028816|454051414|FG001|Overall Study|Lost to Follow-up|3|||
126208531|NCT05028816|454051413|FG000|Overall Study|Withdrawal by Subject|4|||
126208532|NCT05028816|454051414|FG001|Overall Study|Withdrawal by Subject|1|||
126208533|NCT05028816|454051413|FG000|Overall Study|Physician Decision|1|||
126208534|NCT05028816|454051414|FG001|Overall Study|Physician Decision|0|||
126208535|NCT05064436|454051415|FG000|Overall Study|Other Reasons|1|||
126208536|NCT05064436|454051416|FG001|Overall Study|Other Reasons|0|||
126208537|NCT01711736|454051418|FG000|Overall Study|Lost to Follow-up|4|||
126208538|NCT01711736|454051419|FG001|Overall Study|Lost to Follow-up|1|||
126208539|NCT01711736|454051418|FG000|Overall Study|Withdrawal by Subject|6|||
126208540|NCT01711736|454051419|FG001|Overall Study|Withdrawal by Subject|6|||
126208541|NCT01711736|454051418|FG000|Overall Study|Migrated/moved from study area|2|||
126208542|NCT01711736|454051419|FG001|Overall Study|Migrated/moved from study area|1|||
126208543|NCT02506101|454051420|FG000|Overall Study|Transportation issues|1|||
126208544|NCT02506101|454051421|FG001|Overall Study|Transportation issues|0|||
126208545|NCT02506101|454051420|FG000|Overall Study|No enrollment and staff unavailability|1|||
126208546|NCT02506101|454051421|FG001|Overall Study|No enrollment and staff unavailability|0|||
126208547|NCT04640168|454051422|FG000|Overall Study|Withdrawal by Subject|8|||
126208548|NCT04640168|454051423|FG001|Overall Study|Withdrawal by Subject|7|||
126208549|NCT04640168|454051422|FG000|Overall Study|Lost to Follow-up|1|||
126208550|NCT04640168|454051423|FG001|Overall Study|Lost to Follow-up|0|||
126208551|NCT04640168|454051422|FG000|Overall Study|Enrolled but not treated|12|||
126208552|NCT04640168|454051423|FG001|Overall Study|Enrolled but not treated|12|||
126208553|NCT04366258|454051431|FG000|Baseline Assessments|Screen Failure|21|||
126208554|NCT04366258|454051431|FG000|Baseline Assessments|Early Termination|3|||
126208555|NCT01725217|454051432|FG000|Overall Study|Withdrawal by Subject|1|||
126208556|NCT01725217|454051433|FG001|Overall Study|Withdrawal by Subject|0|||
126208557|NCT01725217|454051434|FG002|Overall Study|Withdrawal by Subject|0|||
126208558|NCT00308555|454051435|FG000|Overall Study|Withdrawal by Subject|1|||
126208559|NCT00308555|454051436|FG001|Overall Study|Withdrawal by Subject|0|||
126208560|NCT00308555|454051435|FG000|Overall Study|Physician Decision|2|||
126208561|NCT00308555|454051436|FG001|Overall Study|Physician Decision|0|||
126208562|NCT00276458|454051437|FG000|Overall Study|Adverse Event|0|||
126208563|NCT00276458|454051438|FG001|Overall Study|Adverse Event|2|||
126208564|NCT00276458|454051437|FG000|Overall Study|Lost to Follow-up|2|||
126208565|NCT00276458|454051438|FG001|Overall Study|Lost to Follow-up|2|||
126208566|NCT00276458|454051437|FG000|Overall Study|Protocol Violation|4|||
126208567|NCT00276458|454051438|FG001|Overall Study|Protocol Violation|3|||
126208568|NCT02940392|454051441|FG000|Overall Study|Lost to Follow-up|3|||
126208569|NCT02940392|454051441|FG000|Overall Study|Retreatment|3|||
126208570|NCT02940392|454051441|FG000|Overall Study|Death|2|||
126208571|NCT00910000|454051445|FG000|Overall Study|Adverse Event|0|||
126208572|NCT00910000|454051446|FG001|Overall Study|Adverse Event|3|||
126208573|NCT00910000|454051447|FG002|Overall Study|Adverse Event|2|||
126208574|NCT00910000|454051448|FG003|Overall Study|Adverse Event|2|||
126208575|NCT00910000|454051449|FG004|Overall Study|Adverse Event|0|||
126208576|NCT00910000|454051450|FG005|Overall Study|Adverse Event|1|||
126208577|NCT00910000|454051445|FG000|Overall Study|Withdrawal by Subject|0|||
126208578|NCT00910000|454051446|FG001|Overall Study|Withdrawal by Subject|0|||
126208579|NCT00910000|454051447|FG002|Overall Study|Withdrawal by Subject|1|||
126208580|NCT00910000|454051448|FG003|Overall Study|Withdrawal by Subject|0|||
126208581|NCT00910000|454051449|FG004|Overall Study|Withdrawal by Subject|1|||
126208582|NCT00910000|454051450|FG005|Overall Study|Withdrawal by Subject|0|||
126208583|NCT04113746|454051451|FG000|Overall Study|Lost to Follow-up|4|||
126208584|NCT04113746|454051452|FG001|Overall Study|Lost to Follow-up|4|||
126208585|NCT01977625|454051453|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
126208586|NCT01977625|454051454|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126208587|NCT01977625|454051453|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126208588|NCT01977625|454051454|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126317759|NCT01438814|454454064|FG000|Overall Study|Protocol Violation|1|||
126317760|NCT01438814|454454065|FG001|Overall Study|Protocol Violation|2|||
126317761|NCT01438814|454454064|FG000|Overall Study|Lost to Follow-up|4|||
126317762|NCT01438814|454454065|FG001|Overall Study|Lost to Follow-up|3|||
126317763|NCT01438814|454454064|FG000|Overall Study|Withdrawal by Subject|4|||
126317764|NCT01438814|454454065|FG001|Overall Study|Withdrawal by Subject|2|||
126317765|NCT01438814|454454064|FG000|Overall Study|Other|2|||
126317766|NCT01438814|454454065|FG001|Overall Study|Other|4|||
126317767|NCT01870297|454454070|FG000|Overall Study|Adverse Event|0|||
126317768|NCT01870297|454454071|FG001|Overall Study|Adverse Event|0|||
126317769|NCT01870297|454454072|FG002|Overall Study|Adverse Event|0|||
126317770|NCT01870297|454454073|FG003|Overall Study|Adverse Event|0|||
126317771|NCT01870297|454454074|FG004|Overall Study|Adverse Event|2|||
126317772|NCT01870297|454454075|FG005|Overall Study|Adverse Event|0|||
126317773|NCT01870297|454454076|FG006|Overall Study|Adverse Event|0|||
126317774|NCT01870297|454454070|FG000|Overall Study|Lost to Follow-up|0|||
126317775|NCT01870297|454454071|FG001|Overall Study|Lost to Follow-up|1|||
126317776|NCT01870297|454454072|FG002|Overall Study|Lost to Follow-up|1|||
126317777|NCT01870297|454454073|FG003|Overall Study|Lost to Follow-up|0|||
126317778|NCT01870297|454454074|FG004|Overall Study|Lost to Follow-up|0|||
126317779|NCT01870297|454454075|FG005|Overall Study|Lost to Follow-up|0|||
126317780|NCT01870297|454454076|FG006|Overall Study|Lost to Follow-up|0|||
126317781|NCT01870297|454454070|FG000|Overall Study|Withdrawal by Subject|0|||
126317782|NCT01870297|454454071|FG001|Overall Study|Withdrawal by Subject|0|||
126317783|NCT01870297|454454072|FG002|Overall Study|Withdrawal by Subject|0|||
126317784|NCT01870297|454454073|FG003|Overall Study|Withdrawal by Subject|0|||
126317785|NCT01870297|454454074|FG004|Overall Study|Withdrawal by Subject|1|||
126317786|NCT01870297|454454075|FG005|Overall Study|Withdrawal by Subject|1|||
126317787|NCT01870297|454454076|FG006|Overall Study|Withdrawal by Subject|1|||
126317788|NCT01870297|454454070|FG000|Overall Study|Sponsor Decision|0|||
126317789|NCT01870297|454454071|FG001|Overall Study|Sponsor Decision|6|||
126317790|NCT01870297|454454072|FG002|Overall Study|Sponsor Decision|0|||
126317791|NCT01870297|454454073|FG003|Overall Study|Sponsor Decision|0|||
126317792|NCT01870297|454454074|FG004|Overall Study|Sponsor Decision|0|||
126317793|NCT01870297|454454075|FG005|Overall Study|Sponsor Decision|0|||
126317794|NCT01870297|454454076|FG006|Overall Study|Sponsor Decision|1|||
126317795|NCT00337779|454454077|FG000|Overall Study|Withdrawal by Subject|10|||
126317796|NCT00337779|454454078|FG001|Overall Study|Withdrawal by Subject|12|||
126317797|NCT00337779|454454077|FG000|Overall Study|Sponsor decision|1|||
126317798|NCT00337779|454454078|FG001|Overall Study|Sponsor decision|1|||
126317799|NCT00337779|454454077|FG000|Overall Study|Physician Decision|3|||
126317800|NCT00337779|454454078|FG001|Overall Study|Physician Decision|6|||
126317801|NCT00337779|454454077|FG000|Overall Study|Protocol Violation|1|||
126317802|NCT00337779|454454078|FG001|Overall Study|Protocol Violation|1|||
126317803|NCT00337779|454454077|FG000|Overall Study|Lost to Follow-up|6|||
126317804|NCT00337779|454454078|FG001|Overall Study|Lost to Follow-up|5|||
126317805|NCT00337779|454454077|FG000|Overall Study|Adverse Event|28|||
126317806|NCT00337779|454454078|FG001|Overall Study|Adverse Event|51|||
126317807|NCT00337779|454454077|FG000|Overall Study|Pregnancy|3|||
126317808|NCT00337779|454454078|FG001|Overall Study|Pregnancy|2|||
126317809|NCT00337779|454454077|FG000|Overall Study|Death|0|||
126317810|NCT00337779|454454078|FG001|Overall Study|Death|1|||
126317811|NCT01162122|454454079|FG000|Overall Study|Withdrawal by Subject|52|||
126317812|NCT01162122|454454080|FG001|Overall Study|Withdrawal by Subject|43|||
126317813|NCT01162122|454454079|FG000|Overall Study|Lost to Follow-up|73|||
126317814|NCT01162122|454454080|FG001|Overall Study|Lost to Follow-up|91|||
126317815|NCT01162122|454454079|FG000|Overall Study|Adverse Event|3|||
126317816|NCT01162122|454454080|FG001|Overall Study|Adverse Event|2|||
126317817|NCT01162122|454454079|FG000|Overall Study|Death|51|||
126317818|NCT01162122|454454080|FG001|Overall Study|Death|46|||
126317819|NCT01162122|454454079|FG000|Overall Study|Protocol Violation|2|||
126317820|NCT01162122|454454080|FG001|Overall Study|Protocol Violation|2|||
126317821|NCT01162122|454454079|FG000|Overall Study|Inappropriate enrollment|5|||
125877873|NCT01436149|452849338|FG001|Randomized Phase|Protocol Violation|5|||
125877874|NCT01436149|452849339|FG002|Randomized Phase|Protocol Violation|0|||
126317822|NCT01162122|454454080|FG001|Overall Study|Inappropriate enrollment|4|||
126317823|NCT01162122|454454079|FG000|Overall Study|Administrative reason|1|||
126317824|NCT01162122|454454080|FG001|Overall Study|Administrative reason|1|||
125877875|NCT01436149|452849337|FG000|Randomized Phase|Withdrawal by Subject|16|||
126090458|NCT01840410|453623573|FG001|Overall Study|Withdrawal by Subject|1|||
126317825|NCT01162122|454454079|FG000|Overall Study|Unable to classify|3|||
126317826|NCT01162122|454454080|FG001|Overall Study|Unable to classify|7|||
126317827|NCT01162122|454454079|FG000|Overall Study|Missing primary reason|1|||
126317828|NCT01162122|454454080|FG001|Overall Study|Missing primary reason|0|||
126317829|NCT02020512|454454081|FG000|Overall Study|Adverse Event|1|||
126317830|NCT02020512|454454081|FG000|Overall Study|Lost to Follow-up|3|||
126317831|NCT02020512|454454081|FG000|Overall Study|Protocol Violation|4|||
126317832|NCT00422422|454454085|FG000|Overall Study|Lack of Efficacy|1|||
126317833|NCT00422422|454454085|FG000|Overall Study|Protocol Violation|1|||
126317834|NCT00422422|454454085|FG000|Overall Study|Withdrawal by Subject|2|||
125877876|NCT01436149|452849338|FG001|Randomized Phase|Withdrawal by Subject|10|||
125877877|NCT01436149|452849339|FG002|Randomized Phase|Withdrawal by Subject|10|||
125877878|NCT01436149|452849337|FG000|Randomized Phase|Lost to Follow-up|34|||
125877879|NCT01436149|452849338|FG001|Randomized Phase|Lost to Follow-up|5|||
125877880|NCT01436149|452849339|FG002|Randomized Phase|Lost to Follow-up|6|||
125877881|NCT01436149|452849337|FG000|Randomized Phase|Lack of Efficacy|0|||
125877882|NCT01436149|452849338|FG001|Randomized Phase|Lack of Efficacy|0|||
125877883|NCT01436149|452849339|FG002|Randomized Phase|Lack of Efficacy|1|||
125877884|NCT01436149|452849337|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
125877885|NCT01436149|452849338|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
125877886|NCT01436149|452849339|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
125877887|NCT01436149|452849337|FG000|Randomized Phase|Other|12|||
125877888|NCT01436149|452849338|FG001|Randomized Phase|Other|5|||
125877889|NCT01436149|452849339|FG002|Randomized Phase|Other|11|||
125877890|NCT01643668|452849343|FG000|Overall Study|Death|1|||
126317835|NCT00422422|454454085|FG000|Overall Study|SAE, non-fatal|1|||
126317836|NCT00422422|454454085|FG000|Overall Study|AE, non-serious non-fatal|5|||
126317837|NCT03313310|454454086|FG000|Phase 2|Lost to Follow-up|4|||
125877891|NCT00322881|452849344|FG000|Overall Study|Death|2|||
125877892|NCT00322881|452849344|FG000|Overall Study|Adverse Event|1|||
125877893|NCT00322881|452849344|FG000|Overall Study|Disease Progression|2|||
125877894|NCT02285855|452849347|FG000|Overall Study|Withdrawal by Subject|2|||
125877895|NCT02285855|452849348|FG001|Overall Study|Withdrawal by Subject|1|||
125877896|NCT03253796|452849349|FG000|Period 1: Run-In|Adverse Event|4|||
125877897|NCT03253796|452849350|FG001|Period 1: Run-In|Adverse Event|0|||
125877898|NCT03253796|452849351|FG002|Period 1: Run-In|Adverse Event|0|||
125877899|NCT03253796|452849352|FG003|Period 1: Run-In|Adverse Event|0|||
125877900|NCT03253796|452849353|FG004|Period 1: Run-In|Adverse Event|0|||
125877901|NCT03253796|452849349|FG000|Period 1: Run-In|Lack of Efficacy|1|||
125877902|NCT03253796|452849350|FG001|Period 1: Run-In|Lack of Efficacy|0|||
125877903|NCT03253796|452849351|FG002|Period 1: Run-In|Lack of Efficacy|0|||
125877904|NCT03253796|452849352|FG003|Period 1: Run-In|Lack of Efficacy|0|||
125877905|NCT03253796|452849353|FG004|Period 1: Run-In|Lack of Efficacy|0|||
125877906|NCT03253796|452849349|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
125877907|NCT03253796|452849350|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
125877908|NCT03253796|452849351|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
125877909|NCT03253796|452849352|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
125877910|NCT03253796|452849353|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
125877911|NCT03253796|452849349|FG000|Period 1: Run-In|Protocol Violation|5|||
125877912|NCT03253796|452849350|FG001|Period 1: Run-In|Protocol Violation|0|||
125877913|NCT03253796|452849351|FG002|Period 1: Run-In|Protocol Violation|0|||
125877914|NCT03253796|452849352|FG003|Period 1: Run-In|Protocol Violation|0|||
125877915|NCT03253796|452849353|FG004|Period 1: Run-In|Protocol Violation|0|||
125877916|NCT03253796|452849349|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
125877917|NCT03253796|452849350|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
125877918|NCT03253796|452849351|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
125877919|NCT03253796|452849352|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
125877920|NCT03253796|452849353|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
125877921|NCT03253796|452849349|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125877922|NCT03253796|452849350|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125877923|NCT03253796|452849351|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
125877924|NCT03253796|452849352|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
126317838|NCT03313310|454454087|FG001|Phase 2|Lost to Follow-up|0|||
126317839|NCT03313310|454454086|FG000|Phase 3|Lost to Follow-up|0|||
126317840|NCT03313310|454454087|FG001|Phase 3|Lost to Follow-up|1|||
126317841|NCT00932451|454454090|FG000|Overall Study|Withdrawal by Subject|69|||
126317842|NCT00932451|454454090|FG000|Overall Study|Lost to Follow-up|22|||
126317843|NCT00932451|454454090|FG000|Overall Study|Death|726|||
126317844|NCT00932451|454454090|FG000|Overall Study|Other reasons|5|||
126317845|NCT03434249|454454093|FG000|Overall Study|Adverse Event|1|||
126317846|NCT03434249|454454094|FG001|Overall Study|Adverse Event|0|||
126317847|NCT03434249|454454093|FG000|Overall Study|Lost to Follow-up|0|||
126317848|NCT03434249|454454094|FG001|Overall Study|Lost to Follow-up|1|||
126317849|NCT03434249|454454093|FG000|Overall Study|Non-compliance of family|2|||
125877925|NCT03253796|452849353|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
126317850|NCT03434249|454454094|FG001|Overall Study|Non-compliance of family|1|||
126317851|NCT03434249|454454093|FG000|Overall Study|Difficulties in completing daily diary|2|||
126317852|NCT03434249|454454094|FG001|Overall Study|Difficulties in completing daily diary|1|||
125877926|NCT03253796|452849349|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125877927|NCT03253796|452849350|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125877928|NCT03253796|452849351|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
125877929|NCT03253796|452849352|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125877930|NCT03253796|452849353|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125877931|NCT03253796|452849349|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
126317853|NCT00561470|454454095|FG000|Overall Study|Adverse Event|74|||
126317854|NCT00561470|454454096|FG001|Overall Study|Adverse Event|163|||
125877932|NCT03253796|452849350|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
125877933|NCT03253796|452849351|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
125877934|NCT03253796|452849352|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
125877935|NCT03253796|452849353|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
125877936|NCT03253796|452849349|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125877937|NCT03253796|452849350|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125877938|NCT03253796|452849351|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
125877939|NCT03253796|452849352|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125877940|NCT03253796|452849353|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125877941|NCT03253796|452849349|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
125877942|NCT03253796|452849350|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
125877943|NCT03253796|452849351|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
125877944|NCT03253796|452849352|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
125877945|NCT03253796|452849353|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
125877946|NCT03253796|452849349|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125877947|NCT03253796|452849350|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125877948|NCT03253796|452849351|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125877949|NCT03253796|452849352|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125877950|NCT03253796|452849353|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
125877951|NCT00528112|452849354|FG000|Treatment up to 3 Years|Adverse Event|313|||
125877952|NCT00528112|452849355|FG001|Treatment up to 3 Years|Adverse Event|278|||
125877953|NCT00528112|452849354|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
125877954|NCT00528112|452849355|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
125877955|NCT00528112|452849354|FG000|Treatment up to 3 Years|Protocol Violation|16|||
125877956|NCT00528112|452849355|FG001|Treatment up to 3 Years|Protocol Violation|16|||
125877957|NCT00528112|452849354|FG000|Treatment up to 3 Years|Death|0|||
125877958|NCT00528112|452849355|FG001|Treatment up to 3 Years|Death|1|||
125877959|NCT00528112|452849354|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
125877960|NCT00528112|452849355|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
125877961|NCT00528112|452849354|FG000|Treatment up to 3 Years|Pregnancy|9|||
125877962|NCT00528112|452849355|FG001|Treatment up to 3 Years|Pregnancy|10|||
125877963|NCT00528112|452849354|FG000|Treatment up to 3 Years|Other reasons|186|||
125877964|NCT00528112|452849355|FG001|Treatment up to 3 Years|Other reasons|186|||
125877965|NCT00528112|452849354|FG000|Extension Phase|Withdrawal by Subject|0|||
125877966|NCT00528112|452849355|FG001|Extension Phase|Withdrawal by Subject|3|||
125877967|NCT00528112|452849354|FG000|Extension Phase|Other reasons|0|||
125877968|NCT00528112|452849355|FG001|Extension Phase|Other reasons|100|||
125877969|NCT00528112|452849354|FG000|Extension Phase|Pregnancy|0|||
125877970|NCT00528112|452849355|FG001|Extension Phase|Pregnancy|3|||
125877971|NCT00528112|452849354|FG000|Extension Phase|Lost to Follow-up|0|||
125877972|NCT00528112|452849355|FG001|Extension Phase|Lost to Follow-up|12|||
125877973|NCT00528112|452849354|FG000|Extension Phase|Death|0|||
125877974|NCT00528112|452849355|FG001|Extension Phase|Death|1|||
125877975|NCT00528112|452849354|FG000|Extension Phase|Adverse Event|0|||
125877976|NCT00528112|452849355|FG001|Extension Phase|Adverse Event|36|||
125877977|NCT00528112|452849354|FG000|Extension Phase|Protocol Violation|0|||
125877978|NCT00528112|452849355|FG001|Extension Phase|Protocol Violation|2|||
125877979|NCT02718898|452849356|FG000|Blinded Treatment Period|Adverse Event|5|||
125877980|NCT02718898|452849357|FG001|Blinded Treatment Period|Adverse Event|1|||
125877981|NCT02718898|452849358|FG002|Blinded Treatment Period|Adverse Event|0|||
125877982|NCT02718898|452849359|FG003|Blinded Treatment Period|Adverse Event|0|||
125877983|NCT02718898|452849360|FG004|Blinded Treatment Period|Adverse Event|0|||
125877984|NCT02718898|452849361|FG005|Blinded Treatment Period|Adverse Event|0|||
125877985|NCT02718898|452849362|FG006|Blinded Treatment Period|Adverse Event|0|||
125877986|NCT02718898|452849356|FG000|Blinded Treatment Period|Physician Decision|1|||
125877987|NCT02718898|452849357|FG001|Blinded Treatment Period|Physician Decision|0|||
125877988|NCT02718898|452849358|FG002|Blinded Treatment Period|Physician Decision|0|||
125877989|NCT02718898|452849359|FG003|Blinded Treatment Period|Physician Decision|0|||
125877990|NCT02718898|452849360|FG004|Blinded Treatment Period|Physician Decision|0|||
125877991|NCT02718898|452849361|FG005|Blinded Treatment Period|Physician Decision|0|||
125877992|NCT02718898|452849362|FG006|Blinded Treatment Period|Physician Decision|0|||
125877993|NCT02718898|452849356|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
125877994|NCT02718898|452849357|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
125877995|NCT02718898|452849358|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
125877996|NCT02718898|452849359|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
125877997|NCT02718898|452849360|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
125877998|NCT02718898|452849361|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
125877999|NCT02718898|452849362|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
125878000|NCT02718898|452849356|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
126090459|NCT01840410|453623572|FG000|Overall Study|Adverse Event|1|||
126317855|NCT00561470|454454095|FG000|Overall Study|Disease progression|437|||
126317856|NCT00561470|454454096|FG001|Overall Study|Disease progression|305|||
126317857|NCT00561470|454454095|FG000|Overall Study|poor compliance to protocol|4|||
126317858|NCT00561470|454454096|FG001|Overall Study|poor compliance to protocol|4|||
126317859|NCT00561470|454454095|FG000|Overall Study|Lost to Follow-up|2|||
126317860|NCT00561470|454454096|FG001|Overall Study|Lost to Follow-up|0|||
126317861|NCT00561470|454454095|FG000|Overall Study|Physician Decision|21|||
126317862|NCT00561470|454454096|FG001|Overall Study|Physician Decision|20|||
126317863|NCT00561470|454454095|FG000|Overall Study|Consent Withdrawn|2|||
126317864|NCT00561470|454454096|FG001|Overall Study|Consent Withdrawn|6|||
126317865|NCT00561470|454454095|FG000|Overall Study|Subject request|43|||
126317866|NCT00561470|454454096|FG001|Overall Study|Subject request|77|||
126317867|NCT00561470|454454095|FG000|Overall Study|Metastatic surgery|10|||
126317868|NCT00561470|454454096|FG001|Overall Study|Metastatic surgery|12|||
126317869|NCT00561470|454454095|FG000|Overall Study|Unauthorized procedure|3|||
126317870|NCT00561470|454454096|FG001|Overall Study|Unauthorized procedure|1|||
126317871|NCT00561470|454454095|FG000|Overall Study|Randomized but not treated|5|||
126317872|NCT00561470|454454096|FG001|Overall Study|Randomized but not treated|5|||
126317873|NCT00561470|454454095|FG000|Overall Study|Missed visit window|1|||
126317874|NCT00561470|454454096|FG001|Overall Study|Missed visit window|4|||
126090460|NCT01840410|453623573|FG001|Overall Study|Adverse Event|1|||
126090461|NCT02671500|453623587|FG000|Overall Study|Lack of Efficacy|12|||
126090462|NCT02671500|453623587|FG000|Overall Study|Lost to Follow-up|2|||
126090463|NCT00798434|453623590|FG000|Double-Blind|Adverse Event|22|||
126090464|NCT00798434|453623591|FG001|Double-Blind|Adverse Event|46|||
126090465|NCT00798434|453623590|FG000|Double-Blind|Death|0|||
126090466|NCT00798434|453623591|FG001|Double-Blind|Death|1|||
126090467|NCT00798434|453623590|FG000|Double-Blind|Lost to Follow-up|1|||
126090468|NCT00798434|453623591|FG001|Double-Blind|Lost to Follow-up|0|||
126090469|NCT00798434|453623590|FG000|Double-Blind|Lack of Efficacy|8|||
125878001|NCT02718898|452849357|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
125878002|NCT02718898|452849358|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
125878003|NCT02718898|452849359|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
125878004|NCT02718898|452849360|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
125878005|NCT02718898|452849361|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
125878006|NCT02718898|452849362|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
125878007|NCT02718898|452849356|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125878008|NCT02718898|452849357|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
126090470|NCT00798434|453623591|FG001|Double-Blind|Lack of Efficacy|12|||
126090471|NCT00798434|453623590|FG000|Double-Blind|Withdrawal by Subject|17|||
126090472|NCT00798434|453623591|FG001|Double-Blind|Withdrawal by Subject|14|||
126090473|NCT00798434|453623590|FG000|Double-Blind|Protocol Violation|1|||
126090474|NCT00798434|453623591|FG001|Double-Blind|Protocol Violation|4|||
126090475|NCT00798434|453623590|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
126090476|NCT00798434|453623591|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
126090477|NCT00798434|453623590|FG000|Double-Blind|Other|1|||
126090478|NCT00798434|453623591|FG001|Double-Blind|Other|0|||
126090479|NCT00798434|453623590|FG000|Double-Blind|Not Treated|3|||
126090480|NCT00798434|453623591|FG001|Double-Blind|Not Treated|6|||
126090481|NCT00798434|453623590|FG000|Open-Label|Adverse Event|33|||
126090482|NCT00798434|453623591|FG001|Open-Label|Adverse Event|11|||
126090483|NCT00798434|453623590|FG000|Open-Label|Lack of Efficacy|5|||
126090484|NCT00798434|453623591|FG001|Open-Label|Lack of Efficacy|11|||
126090485|NCT00798434|453623590|FG000|Open-Label|Withdrawal by Subject|2|||
126090486|NCT00798434|453623591|FG001|Open-Label|Withdrawal by Subject|7|||
126090487|NCT00798434|453623590|FG000|Open-Label|Protocol Violation|1|||
126090488|NCT00798434|453623591|FG001|Open-Label|Protocol Violation|0|||
126090489|NCT00798434|453623590|FG000|Open-Label|Other|1|||
126090490|NCT00798434|453623591|FG001|Open-Label|Other|2|||
126090491|NCT00798434|453623590|FG000|Open-Label|Not Treated|0|||
126090492|NCT00798434|453623591|FG001|Open-Label|Not Treated|1|||
126090493|NCT03898167|453623592|FG000|Overall Study|Terminated phone call early|7|||
126090494|NCT03898167|453623593|FG001|Overall Study|Terminated phone call early|0|||
126090495|NCT03898167|453623594|FG002|Overall Study|Terminated phone call early|0|||
125878009|NCT02718898|452849358|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
126090496|NCT03898167|453623592|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
126090497|NCT03898167|453623593|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
126090498|NCT03898167|453623594|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
125878010|NCT02718898|452849359|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
126090499|NCT05292586|453623595|FG000|Overall Study|Withdrawal by Subject|3|||
125878011|NCT02718898|452849360|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
126090500|NCT05292586|453623596|FG001|Overall Study|Withdrawal by Subject|10|||
126317875|NCT00561470|454454095|FG000|Overall Study|Planning surgery|1|||
126317876|NCT00561470|454454096|FG001|Overall Study|Planning surgery|1|||
126090501|NCT05292586|453623595|FG000|Overall Study|Randomization error|3|||
126090502|NCT05292586|453623596|FG001|Overall Study|Randomization error|7|||
126090503|NCT05292586|453623595|FG000|Overall Study|Adverse Event|3|||
126090504|NCT05292586|453623596|FG001|Overall Study|Adverse Event|0|||
126090505|NCT05292586|453623595|FG000|Overall Study|Lost to Follow-up|0|||
126090506|NCT05292586|453623596|FG001|Overall Study|Lost to Follow-up|1|||
126090507|NCT05292586|453623595|FG000|Overall Study|Patient refused treatment|1|||
125878012|NCT02718898|452849361|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125878013|NCT02718898|452849362|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125878014|NCT02718898|452849356|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125878015|NCT02718898|452849357|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125878016|NCT02718898|452849358|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125878017|NCT02718898|452849359|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
125878018|NCT02718898|452849360|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125878019|NCT02718898|452849361|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125878020|NCT02718898|452849362|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125878021|NCT02718898|452849356|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878022|NCT02718898|452849357|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126090508|NCT05292586|453623596|FG001|Overall Study|Patient refused treatment|0|||
126090509|NCT05292586|453623595|FG000|Overall Study|Patient could not travel to the study site|1|||
125878023|NCT02718898|452849358|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
125878024|NCT02718898|452849359|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
125878025|NCT02718898|452849360|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878026|NCT02718898|452849361|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878027|NCT02718898|452849362|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878028|NCT02718898|452849356|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125878029|NCT02718898|452849357|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125878030|NCT02718898|452849358|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
125878031|NCT02718898|452849359|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
125878032|NCT02718898|452849360|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125878033|NCT02718898|452849361|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125878034|NCT02718898|452849362|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125878035|NCT02718898|452849356|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125878036|NCT02718898|452849357|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125878037|NCT02718898|452849358|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125878038|NCT02718898|452849359|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
125878039|NCT02718898|452849360|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125878040|NCT02718898|452849361|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125878041|NCT02718898|452849362|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125878042|NCT02718898|452849356|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125878043|NCT02718898|452849357|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125878044|NCT02718898|452849358|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125878045|NCT02718898|452849359|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
125878046|NCT02718898|452849360|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125878047|NCT02718898|452849361|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125878048|NCT02718898|452849362|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125878049|NCT02718898|452849356|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
125878050|NCT02718898|452849357|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
125878051|NCT02718898|452849358|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
125878052|NCT02718898|452849359|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
125878053|NCT02718898|452849360|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
125878054|NCT02718898|452849361|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
125878055|NCT02718898|452849362|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
125878056|NCT02718898|452849356|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125878057|NCT02718898|452849357|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125878058|NCT02718898|452849358|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125878059|NCT02718898|452849359|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125878060|NCT02718898|452849360|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
126090510|NCT05292586|453623596|FG001|Overall Study|Patient could not travel to the study site|0|||
126090511|NCT05292586|453623595|FG000|Overall Study|Technical issues with the masterscope|0|||
126208589|NCT03125382|454051455|FG000|Randomization|screening failure|1|||
126208590|NCT03125382|454051456|FG001|Randomization|screening failure|4|||
126208591|NCT03125382|454051457|FG002|Randomization|screening failure|2|||
126208592|NCT03125382|454051458|FG003|Randomization|screening failure|0|||
126208593|NCT03125382|454051455|FG000|Follow-up|Death|1|||
126208594|NCT03125382|454051456|FG001|Follow-up|Death|2|||
126208595|NCT03125382|454051457|FG002|Follow-up|Death|1|||
126208596|NCT03125382|454051458|FG003|Follow-up|Death|2|||
126208597|NCT03125382|454051455|FG000|Follow-up|Lost to Follow-up|1|||
126208598|NCT03125382|454051456|FG001|Follow-up|Lost to Follow-up|4|||
126208599|NCT03125382|454051457|FG002|Follow-up|Lost to Follow-up|3|||
126208600|NCT03125382|454051458|FG003|Follow-up|Lost to Follow-up|1|||
126090512|NCT05292586|453623596|FG001|Overall Study|Technical issues with the masterscope|3|||
125878061|NCT02718898|452849361|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
125878062|NCT02718898|452849362|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
125878063|NCT02718898|452849356|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125878064|NCT02718898|452849357|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125878065|NCT02718898|452849358|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125878066|NCT02718898|452849359|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125878067|NCT02718898|452849360|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125878068|NCT02718898|452849361|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
125878069|NCT02718898|452849362|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
125878070|NCT03337308|452849364|FG000|Overall Study|Adverse Event|2|||
125878071|NCT03337308|452849365|FG001|Overall Study|Adverse Event|3|||
125878072|NCT03337308|452849366|FG002|Overall Study|Adverse Event|3|||
125878073|NCT03337308|452849367|FG003|Overall Study|Adverse Event|1|||
125878074|NCT03337308|452849364|FG000|Overall Study|Lost to Follow-up|1|||
125878075|NCT03337308|452849365|FG001|Overall Study|Lost to Follow-up|2|||
125878076|NCT03337308|452849366|FG002|Overall Study|Lost to Follow-up|0|||
125878077|NCT03337308|452849367|FG003|Overall Study|Lost to Follow-up|0|||
125878078|NCT03337308|452849364|FG000|Overall Study|Withdrawal by Subject|2|||
125878079|NCT03337308|452849365|FG001|Overall Study|Withdrawal by Subject|1|||
125878080|NCT03337308|452849366|FG002|Overall Study|Withdrawal by Subject|2|||
125878081|NCT03337308|452849367|FG003|Overall Study|Withdrawal by Subject|1|||
125878082|NCT03337308|452849364|FG000|Overall Study|Protocol Violation|0|||
125878083|NCT03337308|452849365|FG001|Overall Study|Protocol Violation|1|||
125878084|NCT03337308|452849366|FG002|Overall Study|Protocol Violation|0|||
125878085|NCT03337308|452849367|FG003|Overall Study|Protocol Violation|0|||
125878086|NCT03341299|452849371|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125878087|NCT03341299|452849372|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125878088|NCT03341299|452849373|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
125878089|NCT03341299|452849374|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125878090|NCT00945009|452849375|FG000|Overall Study|Lack of Efficacy|10|||
125878091|NCT00945009|452849376|FG001|Overall Study|Lack of Efficacy|0|||
125878092|NCT00945009|452849377|FG002|Overall Study|Lack of Efficacy|0|||
125878093|NCT00945009|452849375|FG000|Overall Study|Physician Decision|21|||
125878094|NCT00945009|452849376|FG001|Overall Study|Physician Decision|4|||
125878095|NCT00945009|452849377|FG002|Overall Study|Physician Decision|3|||
125878096|NCT00945009|452849375|FG000|Overall Study|Protocol Violation|6|||
125878097|NCT00945009|452849376|FG001|Overall Study|Protocol Violation|1|||
125878098|NCT00945009|452849377|FG002|Overall Study|Protocol Violation|0|||
125878099|NCT00945009|452849375|FG000|Overall Study|Withdrawal by Subject|1|||
125878100|NCT00945009|452849376|FG001|Overall Study|Withdrawal by Subject|0|||
125878101|NCT00945009|452849377|FG002|Overall Study|Withdrawal by Subject|0|||
125878102|NCT00945009|452849375|FG000|Overall Study|Ineligible|6|||
126090513|NCT05292586|453623595|FG000|Overall Study|Patient moved to a different state|0|||
126090514|NCT05292586|453623596|FG001|Overall Study|Patient moved to a different state|1|||
126090515|NCT05177354|453623597|FG000|Implant to 30-day Visit|Physician Decision|1|||
126090516|NCT05177354|453623597|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
126090517|NCT05177354|453623597|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
126090518|NCT05177354|453623597|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
126090519|NCT03548220|453623599|FG000|Overall Study|Lost to Follow-up|1|||
126090520|NCT03548220|453623600|FG001|Overall Study|Lost to Follow-up|0|||
126090521|NCT03548220|453623601|FG002|Overall Study|Lost to Follow-up|0|||
126090522|NCT03548220|453623602|FG003|Overall Study|Lost to Follow-up|0|||
126090523|NCT01099215|453624918|FG000|Overall Study|Withdrawal by Subject|1|||
126090524|NCT01099215|453624919|FG001|Overall Study|Withdrawal by Subject|0|||
126090525|NCT01099215|453624918|FG000|Overall Study|Adverse Event|0|||
126090526|NCT01099215|453624919|FG001|Overall Study|Adverse Event|1|||
126090527|NCT00747227|453624921|FG000|Overall Study|Death|3|||
126090528|NCT00747227|453624922|FG001|Overall Study|Death|1|||
126090529|NCT00747227|453624921|FG000|Overall Study|Withdrawal by Subject|1|||
126090530|NCT00747227|453624922|FG001|Overall Study|Withdrawal by Subject|0|||
126090531|NCT00747227|453624921|FG000|Overall Study|Lost to Follow-up|1|||
126090532|NCT00747227|453624922|FG001|Overall Study|Lost to Follow-up|2|||
126090533|NCT00747227|453624921|FG000|Overall Study|Illness|1|||
126090534|NCT00747227|453624922|FG001|Overall Study|Illness|1|||
126090535|NCT03554629|453624923|FG000|Overall Study|Inadequate data|6|||
126090536|NCT00515671|453624932|FG000|Overall Study|Lost to Follow-up|13|||
126090537|NCT00515671|453624933|FG001|Overall Study|Lost to Follow-up|10|||
125878103|NCT00945009|452849376|FG001|Overall Study|Ineligible|1|||
125878104|NCT00945009|452849377|FG002|Overall Study|Ineligible|0|||
125878105|NCT00945009|452849375|FG000|Overall Study|Inevaluable|0|||
125878106|NCT00945009|452849376|FG001|Overall Study|Inevaluable|1|||
125878107|NCT00945009|452849377|FG002|Overall Study|Inevaluable|0|||
125878108|NCT00945009|452849375|FG000|Overall Study|Refusal of further protocol|1|||
126090538|NCT00515671|453624932|FG000|Overall Study|Withdrawal by Subject|3|||
126090539|NCT00515671|453624933|FG001|Overall Study|Withdrawal by Subject|5|||
125878109|NCT00945009|452849376|FG001|Overall Study|Refusal of further protocol|0|||
125878110|NCT00945009|452849377|FG002|Overall Study|Refusal of further protocol|0|||
125878111|NCT00385671|452851198|FG000|Overall Study|Adverse Event|14|||
125878112|NCT00385671|452851199|FG001|Overall Study|Adverse Event|27|||
125878113|NCT00385671|452851200|FG002|Overall Study|Adverse Event|18|||
125878114|NCT00385671|452851198|FG000|Overall Study|Lack of Efficacy|5|||
125878115|NCT00385671|452851199|FG001|Overall Study|Lack of Efficacy|9|||
125878116|NCT00385671|452851200|FG002|Overall Study|Lack of Efficacy|5|||
125878117|NCT00385671|452851198|FG000|Overall Study|Lost to Follow-up|6|||
125878118|NCT00385671|452851199|FG001|Overall Study|Lost to Follow-up|6|||
125878119|NCT00385671|452851200|FG002|Overall Study|Lost to Follow-up|5|||
125878120|NCT00385671|452851198|FG000|Overall Study|Physician Decision|2|||
125878121|NCT00385671|452851199|FG001|Overall Study|Physician Decision|1|||
125878122|NCT00385671|452851200|FG002|Overall Study|Physician Decision|2|||
125878123|NCT00385671|452851198|FG000|Overall Study|Protocol Violation|5|||
125878124|NCT00385671|452851199|FG001|Overall Study|Protocol Violation|2|||
125878125|NCT00385671|452851200|FG002|Overall Study|Protocol Violation|1|||
125878126|NCT00385671|452851198|FG000|Overall Study|Sponsor Decision|2|||
125878127|NCT00385671|452851199|FG001|Overall Study|Sponsor Decision|2|||
125878128|NCT00385671|452851200|FG002|Overall Study|Sponsor Decision|1|||
125878129|NCT00385671|452851198|FG000|Overall Study|Withdrawal by Subject|4|||
125878130|NCT00385671|452851199|FG001|Overall Study|Withdrawal by Subject|4|||
125878131|NCT00385671|452851200|FG002|Overall Study|Withdrawal by Subject|4|||
125878132|NCT04944992|452851201|FG000|Overall Study|Lost to Follow-up|1|||
125878133|NCT04944992|452851202|FG001|Overall Study|Lost to Follow-up|1|||
125878134|NCT04944992|452851201|FG000|Overall Study|Physician Decision|1|||
125878135|NCT04944992|452851202|FG001|Overall Study|Physician Decision|0|||
125878136|NCT04944992|452851201|FG000|Overall Study|Withdrawal by Subject|6|||
125878137|NCT04944992|452851202|FG001|Overall Study|Withdrawal by Subject|1|||
125878138|NCT01295814|452851203|FG000|Overall Study|Lack of Efficacy|0|||
125878139|NCT01295814|452851204|FG001|Overall Study|Lack of Efficacy|2|||
125878140|NCT01295814|452851203|FG000|Overall Study|Withdrawal by Subject|2|||
125878141|NCT01295814|452851204|FG001|Overall Study|Withdrawal by Subject|0|||
125878142|NCT03414983|452851205|FG000|Pre-Treatment|Other reasons|1|||
125878143|NCT03414983|452851206|FG001|Pre-Treatment|Other reasons|0|||
125878144|NCT03414983|452851205|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125878145|NCT03414983|452851206|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
125878146|NCT03414983|452851205|FG000|Pre-Treatment|Participant withdrew consent|1|||
125878147|NCT03414983|452851206|FG001|Pre-Treatment|Participant withdrew consent|3|||
125878148|NCT03414983|452851205|FG000|Treatment|Participant withdrew consent|4|||
125878149|NCT03414983|452851206|FG001|Treatment|Participant withdrew consent|3|||
125878150|NCT03414983|452851205|FG000|Treatment|Participant request to discontinue study treatment|8|||
125878151|NCT03414983|452851206|FG001|Treatment|Participant request to discontinue study treatment|10|||
125878152|NCT03414983|452851205|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
125878153|NCT03414983|452851206|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
125878154|NCT03414983|452851205|FG000|Treatment|Death|0|||
125878155|NCT03414983|452851206|FG001|Treatment|Death|1|||
125878156|NCT03414983|452851205|FG000|Treatment|Study Drug Toxicity|10|||
125878157|NCT03414983|452851206|FG001|Treatment|Study Drug Toxicity|5|||
125878158|NCT03414983|452851205|FG000|Treatment|Disease Progression|75|||
125878159|NCT03414983|452851206|FG001|Treatment|Disease Progression|29|||
125878160|NCT03414983|452851205|FG000|Treatment|Not reported|1|||
125878161|NCT03414983|452851206|FG001|Treatment|Not reported|0|||
125878162|NCT03414983|452851205|FG000|Treatment|Other reasons|3|||
125878163|NCT03414983|452851206|FG001|Treatment|Other reasons|2|||
125878164|NCT03414983|452851205|FG000|Treatment|Poor/non-compliance|2|||
125878165|NCT03414983|452851206|FG001|Treatment|Poor/non-compliance|0|||
125878166|NCT03414983|452851205|FG000|Treatment|Maximum clinical benefit|5|||
125878167|NCT03414983|452851206|FG001|Treatment|Maximum clinical benefit|9|||
125878168|NCT03414983|452851205|FG000|Treatment|Lost to Follow-up|0|||
125878169|NCT03414983|452851206|FG001|Treatment|Lost to Follow-up|1|||
125878170|NCT03414983|452851205|FG000|Treatment|Administrative reasons by sponsor|1|||
125878171|NCT03414983|452851206|FG001|Treatment|Administrative reasons by sponsor|0|||
125878172|NCT01775501|452851209|FG000|Overall Study|Discontinued prior to treatment|1|||
125878173|NCT03780244|452851217|FG000|Overall Study|Lost to Follow-up|1|||
125878174|NCT03780244|452851218|FG001|Overall Study|Lost to Follow-up|0|||
125878175|NCT00804908|452851221|FG000|Overall Study|Other|115|||
125878176|NCT00804908|452851222|FG001|Overall Study|Other|116|||
125878177|NCT00804908|452851223|FG002|Overall Study|Other|114|||
125878178|NCT01280903|452851224|FG000|Overall Study|Lost to Follow-up|23|||
125878179|NCT01280903|452851225|FG001|Overall Study|Lost to Follow-up|16|||
125878180|NCT03453164|452851226|FG000|Overall Study|Lack of Efficacy|16|||
125878181|NCT03453164|452851226|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
125878182|NCT03822117|452851228|FG000|Overall Study|Death|18|||
125878183|NCT03822117|452851229|FG001|Overall Study|Death|17|||
125878184|NCT03822117|452851230|FG002|Overall Study|Death|12|||
125878185|NCT03822117|452851231|FG003|Overall Study|Death|4|||
125878186|NCT03822117|452851228|FG000|Overall Study|Lost to Follow-up|1|||
125878187|NCT03822117|452851229|FG001|Overall Study|Lost to Follow-up|2|||
125878188|NCT03822117|452851230|FG002|Overall Study|Lost to Follow-up|3|||
125878189|NCT03822117|452851231|FG003|Overall Study|Lost to Follow-up|0|||
125878190|NCT03822117|452851228|FG000|Overall Study|Study Terminated by Sponsor|25|||
125878191|NCT03822117|452851229|FG001|Overall Study|Study Terminated by Sponsor|11|||
125878192|NCT03822117|452851230|FG002|Overall Study|Study Terminated by Sponsor|6|||
125878193|NCT03822117|452851231|FG003|Overall Study|Study Terminated by Sponsor|0|||
125878194|NCT03822117|452851228|FG000|Overall Study|Withdrawal by Subject|4|||
125878195|NCT03822117|452851229|FG001|Overall Study|Withdrawal by Subject|0|||
125878196|NCT03822117|452851230|FG002|Overall Study|Withdrawal by Subject|3|||
125878197|NCT03822117|452851231|FG003|Overall Study|Withdrawal by Subject|0|||
125878198|NCT03822117|452851228|FG000|Overall Study|Disease Progression|1|||
125878199|NCT03822117|452851229|FG001|Overall Study|Disease Progression|2|||
125878200|NCT03822117|452851230|FG002|Overall Study|Disease Progression|1|||
125878201|NCT03822117|452851231|FG003|Overall Study|Disease Progression|0|||
125878202|NCT03822117|452851228|FG000|Overall Study|Never Returned to Hospital|0|||
125878203|NCT03822117|452851229|FG001|Overall Study|Never Returned to Hospital|0|||
125878204|NCT03822117|452851230|FG002|Overall Study|Never Returned to Hospital|1|||
125878205|NCT03822117|452851231|FG003|Overall Study|Never Returned to Hospital|0|||
125878206|NCT03459079|452851232|FG000|Overall Study|Adverse Event|4|||
125878207|NCT03459079|452851233|FG001|Overall Study|Adverse Event|2|||
125878208|NCT03459079|452851234|FG002|Overall Study|Adverse Event|0|||
125878209|NCT03459079|452851232|FG000|Overall Study|Withdrawal by Subject|2|||
125878210|NCT03459079|452851233|FG001|Overall Study|Withdrawal by Subject|2|||
125878211|NCT03459079|452851234|FG002|Overall Study|Withdrawal by Subject|0|||
125878212|NCT02766023|452851237|FG000|Overall Study|Lost to Follow-up|23|||
125878213|NCT02766023|452851238|FG001|Overall Study|Lost to Follow-up|11|||
125878214|NCT02766023|452851237|FG000|Overall Study|Pregnancy|1|||
125878215|NCT02766023|452851238|FG001|Overall Study|Pregnancy|0|||
125878216|NCT02766023|452851237|FG000|Overall Study|Adverse Event|1|||
125878217|NCT02766023|452851238|FG001|Overall Study|Adverse Event|0|||
125878218|NCT02766023|452851237|FG000|Overall Study|Withdrawal by Subject|4|||
125878219|NCT02766023|452851238|FG001|Overall Study|Withdrawal by Subject|5|||
125878220|NCT02766023|452851237|FG000|Overall Study|Physician Decision|1|||
125878221|NCT02766023|452851238|FG001|Overall Study|Physician Decision|0|||
125878222|NCT02766023|452851237|FG000|Overall Study|Not Eligible at Enrollment|0|||
125878223|NCT02766023|452851238|FG001|Overall Study|Not Eligible at Enrollment|1|||
125878224|NCT06271993|452851239|FG000|Overall Study|Not reactive to histamine|5|||
125878225|NCT06271993|452851240|FG001|Overall Study|Not reactive to histamine|5|||
125878226|NCT06271993|452851241|FG002|Overall Study|Not reactive to histamine|5|||
125878227|NCT04026113|452851246|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
125878228|NCT04026113|452851247|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
125878229|NCT04026113|452851248|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125878230|NCT04026113|452851249|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
125878231|NCT04026113|452851246|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
125878232|NCT04026113|452851247|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
125878233|NCT04026113|452851248|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
125878234|NCT04026113|452851249|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
125878235|NCT04026113|452851246|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
125878236|NCT04026113|452851247|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125878237|NCT04026113|452851248|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125878238|NCT04026113|452851249|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125878239|NCT04026113|452851246|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125878240|NCT04026113|452851247|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125878241|NCT04026113|452851248|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125878242|NCT04026113|452851249|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
125878243|NCT04026113|452851246|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
125878244|NCT04026113|452851247|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
125878245|NCT04026113|452851248|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
125878246|NCT04026113|452851249|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
125878247|NCT04026113|452851246|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
125878248|NCT04026113|452851247|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
125878249|NCT04026113|452851248|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125878250|NCT04026113|452851249|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125878251|NCT04026113|452851246|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
125878252|NCT04026113|452851247|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
125878253|NCT04026113|452851248|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
125878254|NCT04026113|452851249|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
125878255|NCT04026113|452851246|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125878256|NCT04026113|452851247|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
125878257|NCT04026113|452851248|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
126090540|NCT00515671|453624932|FG000|Overall Study|incarcerated|1|||
125878258|NCT04026113|452851249|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125878259|NCT04026113|452851246|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
125878260|NCT04026113|452851247|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
125878261|NCT04026113|452851248|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
125878262|NCT04026113|452851249|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
125878263|NCT04613362|452851251|FG000|3 Month Follow-up|Lost to Follow-up|1|||
125878264|NCT04613362|452851252|FG001|3 Month Follow-up|Lost to Follow-up|2|||
125878265|NCT04613362|452851251|FG000|6 Month Follow-up|Lost to Follow-up|0|||
125878266|NCT04613362|452851252|FG001|6 Month Follow-up|Lost to Follow-up|1|||
125878267|NCT02218372|452851253|FG000|Overall Study|Adverse Event|1|||
125878268|NCT02218372|452851254|FG001|Overall Study|Adverse Event|1|||
125878269|NCT02218372|452851253|FG000|Overall Study|Miscellaneous|2|||
125878270|NCT02218372|452851254|FG001|Overall Study|Miscellaneous|1|||
125878271|NCT02218372|452851253|FG000|Overall Study|Randomized but did not receive treatment|2|||
125878272|NCT02218372|452851254|FG001|Overall Study|Randomized but did not receive treatment|3|||
125878273|NCT02218372|452851253|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125878274|NCT02218372|452851254|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125878275|NCT00671658|452851263|FG000|Overall Study|Physician Decision|5|||
125878276|NCT01921205|452851264|FG000|Overall Study|Adverse Event|12|||
125878277|NCT01921205|452851265|FG001|Overall Study|Adverse Event|7|||
125878278|NCT01921205|452851264|FG000|Overall Study|Lack of Efficacy|1|||
125878279|NCT01921205|452851265|FG001|Overall Study|Lack of Efficacy|0|||
125878280|NCT01921205|452851264|FG000|Overall Study|Protocol Violation|1|||
125878281|NCT01921205|452851265|FG001|Overall Study|Protocol Violation|3|||
125878282|NCT01921205|452851264|FG000|Overall Study|Lost to Follow-up|1|||
125878283|NCT01921205|452851265|FG001|Overall Study|Lost to Follow-up|1|||
125878284|NCT01921205|452851264|FG000|Overall Study|Withdrawal by Subject|6|||
125878285|NCT01921205|452851265|FG001|Overall Study|Withdrawal by Subject|5|||
125878286|NCT01921205|452851264|FG000|Overall Study|Use Of Prohibited Medication|0|||
125878287|NCT01921205|452851265|FG001|Overall Study|Use Of Prohibited Medication|1|||
125878288|NCT01921205|452851264|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
125878289|NCT01921205|452851265|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
125878290|NCT01921205|452851264|FG000|Overall Study|Non Compliance Of The Parent|0|||
125878291|NCT01921205|452851265|FG001|Overall Study|Non Compliance Of The Parent|1|||
125878292|NCT01921205|452851264|FG000|Overall Study|Non Compliance Of Child|0|||
125878293|NCT01921205|452851265|FG001|Overall Study|Non Compliance Of Child|1|||
125878294|NCT00456846|452851267|FG000|Overall Study|Adverse Event|2|||
125878295|NCT00456846|452851268|FG001|Overall Study|Adverse Event|15|||
126208601|NCT02686749|454051459|FG000|Overall Study|terminated for poor enrollment|2|||
126208602|NCT02686749|454051460|FG001|Overall Study|terminated for poor enrollment|2|||
126208603|NCT05147311|454051463|FG000|Overall Study|Did not complete survey|2|||
126208604|NCT05147311|454051464|FG001|Overall Study|Did not complete survey|1|||
126208605|NCT05147311|454051463|FG000|Overall Study|Patient too sick|1|||
126208606|NCT05147311|454051464|FG001|Overall Study|Patient too sick|2|||
126208607|NCT05147311|454051463|FG000|Overall Study|Death|0|||
126208608|NCT05147311|454051464|FG001|Overall Study|Death|1|||
126208609|NCT05147311|454051463|FG000|Overall Study|Declined survey|1|||
126208610|NCT05147311|454051464|FG001|Overall Study|Declined survey|0|||
126208611|NCT04505592|454051466|FG000|Overall Study|Death|2|||
126208612|NCT04505592|454051467|FG001|Overall Study|Death|1|||
126208613|NCT01015118|454051472|FG000|Overall Study|Protocol Violation|5|||
126208614|NCT01015118|454051473|FG001|Overall Study|Protocol Violation|6|||
126208615|NCT01015118|454051472|FG000|Overall Study|Withdrawal by Subject|103|||
126208616|NCT01015118|454051473|FG001|Overall Study|Withdrawal by Subject|27|||
126208617|NCT01015118|454051472|FG000|Overall Study|Other Adverse Event (AE)|141|||
126208618|NCT01015118|454051473|FG001|Overall Study|Other Adverse Event (AE)|33|||
126208619|NCT01015118|454051472|FG000|Overall Study|Worsening or AE of underlying disease|5|||
126208620|NCT01015118|454051473|FG001|Overall Study|Worsening or AE of underlying disease|4|||
126208621|NCT01015118|454051472|FG000|Overall Study|Progressive disease|364|||
126208622|NCT01015118|454051473|FG001|Overall Study|Progressive disease|229|||
126208623|NCT01015118|454051472|FG000|Overall Study|Not treated|9|||
126208624|NCT01015118|454051473|FG001|Overall Study|Not treated|5|||
126208625|NCT01015118|454051472|FG000|Overall Study|Other than stated above|42|||
126208626|NCT01015118|454051473|FG001|Overall Study|Other than stated above|23|||
126208627|NCT03522506|454051474|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126208628|NCT03522506|454051475|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126208629|NCT03522506|454051476|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126208630|NCT03522506|454051477|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126208631|NCT03522506|454051474|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126208632|NCT03522506|454051475|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126208633|NCT03522506|454051476|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126208634|NCT03522506|454051477|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
126208635|NCT03480243|454051478|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
126208636|NCT03480243|454051478|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
125878296|NCT00456846|452851267|FG000|Overall Study|Physician Decision|11|||
125878297|NCT00456846|452851268|FG001|Overall Study|Physician Decision|6|||
125878298|NCT00456846|452851267|FG000|Overall Study|Protocol Deviation|2|||
125878299|NCT00456846|452851268|FG001|Overall Study|Protocol Deviation|0|||
125878300|NCT00456846|452851267|FG000|Overall Study|Participant Discretion|1|||
125878301|NCT00456846|452851268|FG001|Overall Study|Participant Discretion|5|||
125878302|NCT00456846|452851267|FG000|Overall Study|Other|0|||
125878303|NCT00456846|452851268|FG001|Overall Study|Other|2|||
125878304|NCT03379818|452851269|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
125878305|NCT03379818|452851270|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
125878306|NCT03379818|452851269|FG000|Overall Study|Withdrawal by Subject|2|||
125878307|NCT03379818|452851270|FG001|Overall Study|Withdrawal by Subject|3|||
125878308|NCT03379818|452851269|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
125878309|NCT03379818|452851270|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
125878310|NCT03125395|452851272|FG000|Overall Study|Adverse Event|2|||
125878311|NCT03125395|452851272|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125878312|NCT03125395|452851272|FG000|Overall Study|Physician Decision|2|||
125878313|NCT03125395|452851272|FG000|Overall Study|Commercial drug is available|5|||
125878314|NCT01668784|452851273|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
125878315|NCT01668784|452851274|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
125878316|NCT01668784|452851273|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
125878317|NCT01668784|452851274|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
125878318|NCT01668784|452851273|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
125878319|NCT01668784|452851274|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
125878320|NCT01668784|452851273|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
125878321|NCT01668784|452851274|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
125878322|NCT01668784|452851273|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
125878323|NCT01668784|452851274|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
125878324|NCT01668784|452851273|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
125878325|NCT01668784|452851274|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
125878326|NCT01668784|452851273|FG000|Treatment Period|Disease Progression|316|||
125878327|NCT01668784|452851274|FG001|Treatment Period|Disease Progression|293|||
125878328|NCT01668784|452851273|FG000|Treatment Period|Study Drug Toxicity|46|||
125878329|NCT01668784|452851274|FG001|Treatment Period|Study Drug Toxicity|53|||
125878330|NCT01668784|452851273|FG000|Treatment Period|Death|1|||
125878331|NCT01668784|452851274|FG001|Treatment Period|Death|1|||
125878332|NCT01668784|452851273|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
125878333|NCT01668784|452851274|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
125878334|NCT01668784|452851273|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
125878335|NCT01668784|452851274|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
125878336|NCT01668784|452851273|FG000|Treatment Period|Withdrawal by Subject|5|||
125878337|NCT01668784|452851274|FG001|Treatment Period|Withdrawal by Subject|3|||
125878338|NCT01668784|452851273|FG000|Treatment Period|Maximal Clinical Benefit|3|||
125878339|NCT01668784|452851274|FG001|Treatment Period|Maximal Clinical Benefit|3|||
125878340|NCT01668784|452851273|FG000|Treatment Period|Other|2|||
125878341|NCT01668784|452851274|FG001|Treatment Period|Other|8|||
125878342|NCT01668784|452851273|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
125878343|NCT01668784|452851274|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
125878344|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
125878345|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
125878346|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
125878347|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
125878348|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
125878349|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
125878350|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
125878351|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
125878352|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
125878353|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
125878354|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
125878355|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
125878356|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
125878357|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
125980507|NCT00917579|453217093|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
125980508|NCT00917579|453217094|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
125980509|NCT00677352|453217097|FG000|Treatment Phase|Adverse Event|14|||
125980510|NCT00677352|453217098|FG001|Treatment Phase|Adverse Event|22|||
125980511|NCT00677352|453217097|FG000|Treatment Phase|Lack of Efficacy|2|||
125980512|NCT00677352|453217098|FG001|Treatment Phase|Lack of Efficacy|3|||
125980513|NCT00677352|453217097|FG000|Treatment Phase|Lost to Follow-up|0|||
125980514|NCT00677352|453217098|FG001|Treatment Phase|Lost to Follow-up|1|||
125980515|NCT00677352|453217097|FG000|Treatment Phase|Withdrawal by Subject|7|||
125980516|NCT00677352|453217098|FG001|Treatment Phase|Withdrawal by Subject|7|||
125980517|NCT00677352|453217097|FG000|Treatment Phase|Physician Decision|1|||
125980518|NCT00677352|453217098|FG001|Treatment Phase|Physician Decision|0|||
125980519|NCT00677352|453217097|FG000|Treatment Phase|Pregnancy|0|||
125980520|NCT00677352|453217098|FG001|Treatment Phase|Pregnancy|1|||
125980521|NCT00677352|453217097|FG000|Treatment Phase|Protocol Violation|1|||
125980522|NCT00677352|453217098|FG001|Treatment Phase|Protocol Violation|1|||
125980523|NCT00677352|453217097|FG000|Treatment Phase|Transference or work related matter|0|||
125980524|NCT00677352|453217098|FG001|Treatment Phase|Transference or work related matter|5|||
125980525|NCT00677352|453217097|FG000|Treatment Phase|Not treated|0|||
125980526|NCT00677352|453217098|FG001|Treatment Phase|Not treated|2|||
125980527|NCT00677352|453217097|FG000|Tapering Phase|Adverse Event|1|||
125980528|NCT00677352|453217098|FG001|Tapering Phase|Adverse Event|5|||
125980529|NCT00677352|453217097|FG000|Tapering Phase|Withdrawal by Subject|5|||
125980530|NCT00677352|453217098|FG001|Tapering Phase|Withdrawal by Subject|3|||
125980531|NCT00677352|453217097|FG000|Tapering Phase|Pregnancy|0|||
125980532|NCT00677352|453217098|FG001|Tapering Phase|Pregnancy|1|||
125980533|NCT00677352|453217097|FG000|Tapering Phase|Job transfer|0|||
125980534|NCT00677352|453217098|FG001|Tapering Phase|Job transfer|1|||
125980535|NCT02182973|453217106|FG000|Overall Study|Withdrawal by Subject|3|||
125980536|NCT02182973|453217107|FG001|Overall Study|Withdrawal by Subject|0|||
125980537|NCT01235546|453217108|FG000|Overall Study|Staff error, medication not administered|1|||
125980538|NCT01235546|453217109|FG001|Overall Study|Staff error, medication not administered|0|||
125980539|NCT01235546|453217108|FG000|Overall Study|Protocol Violation|1|||
126090541|NCT00515671|453624933|FG001|Overall Study|incarcerated|2|||
126090542|NCT00288639|453624936|FG000|Overall Study|Adverse Event|5|||
126090543|NCT00288639|453624936|FG000|Overall Study|Lack of Efficacy|4|||
126090544|NCT00288639|453624936|FG000|Overall Study|Withdrawal by Subject|2|||
126090545|NCT00288639|453624936|FG000|Overall Study|Other|1|||
125980540|NCT01235546|453217109|FG001|Overall Study|Protocol Violation|1|||
126090546|NCT01014208|453624945|FG000|Overall Study|Lost to Follow-up|2|||
126090547|NCT01014208|453624946|FG001|Overall Study|Lost to Follow-up|5|||
126090548|NCT01014208|453624945|FG000|Overall Study|Participant Withdrew Consent|12|||
126090549|NCT01014208|453624946|FG001|Overall Study|Participant Withdrew Consent|12|||
126090550|NCT01014208|453624945|FG000|Overall Study|Did Not Receive Study Drug|2|||
126090551|NCT01014208|453624946|FG001|Overall Study|Did Not Receive Study Drug|0|||
126090552|NCT01014208|453624945|FG000|Overall Study|Study Closed/terminated|78|||
126090553|NCT01014208|453624946|FG001|Overall Study|Study Closed/terminated|83|||
126090554|NCT04165031|453624947|FG000|Overall Study|Adverse Event|1|||
126090555|NCT04165031|453624948|FG001|Overall Study|Adverse Event|1|||
126090556|NCT04165031|453624949|FG002|Overall Study|Adverse Event|0|||
126090557|NCT04165031|453624950|FG003|Overall Study|Adverse Event|0|||
126090558|NCT04165031|453624951|FG004|Overall Study|Adverse Event|0|||
126090559|NCT04165031|453624952|FG005|Overall Study|Adverse Event|0|||
126090560|NCT04165031|453624947|FG000|Overall Study|Withdrawal by Subject|0|||
126090561|NCT04165031|453624948|FG001|Overall Study|Withdrawal by Subject|0|||
126090562|NCT04165031|453624949|FG002|Overall Study|Withdrawal by Subject|1|||
126090563|NCT04165031|453624950|FG003|Overall Study|Withdrawal by Subject|0|||
126090564|NCT04165031|453624951|FG004|Overall Study|Withdrawal by Subject|0|||
126090565|NCT04165031|453624952|FG005|Overall Study|Withdrawal by Subject|0|||
126090566|NCT00663702|453624955|FG000|Overall Study|Adverse Event|8|||
126090567|NCT00663702|453624956|FG001|Overall Study|Adverse Event|4|||
126090568|NCT00663702|453624955|FG000|Overall Study|Withdrawal by Subject|3|||
126090569|NCT00663702|453624956|FG001|Overall Study|Withdrawal by Subject|1|||
126090570|NCT00663702|453624955|FG000|Overall Study|Pregnancy|0|||
126090571|NCT00663702|453624956|FG001|Overall Study|Pregnancy|1|||
126090572|NCT00663702|453624955|FG000|Overall Study|Lost to Follow-up|3|||
126090573|NCT00663702|453624956|FG001|Overall Study|Lost to Follow-up|0|||
126090574|NCT00663702|453624955|FG000|Overall Study|Death|1|||
126090575|NCT00663702|453624956|FG001|Overall Study|Death|1|||
126090576|NCT00663702|453624955|FG000|Overall Study|Lack of Efficacy|3|||
126090577|NCT00663702|453624956|FG001|Overall Study|Lack of Efficacy|3|||
126090578|NCT01283152|453624959|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
126090579|NCT01283152|453624960|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
126090580|NCT01283152|453624959|FG000|Overall Study|Refused HESA|1|||
125980541|NCT01123382|453217110|FG000|Overall Study|Withdrawal by Subject|1|||
125980542|NCT01123382|453217111|FG001|Overall Study|Withdrawal by Subject|4|||
126090581|NCT01283152|453624960|FG001|Overall Study|Refused HESA|0|||
126090582|NCT04020185|453624965|FG000|Overall Study|Death|0|||
126090583|NCT04020185|453624966|FG001|Overall Study|Death|0|||
125980543|NCT01123382|453217110|FG000|Overall Study|Lost to Follow-up|1|||
125980544|NCT01123382|453217111|FG001|Overall Study|Lost to Follow-up|2|||
125980545|NCT04721925|453217112|FG000|2-Month Assessment|Lost to Follow-up|5|||
125980546|NCT04721925|453217113|FG001|2-Month Assessment|Lost to Follow-up|3|||
125980547|NCT04721925|453217112|FG000|4-Month Assessment|Lost to Follow-up|3|||
126090584|NCT04020185|453624967|FG002|Overall Study|Death|1|||
126090585|NCT04020185|453624968|FG003|Overall Study|Death|2|||
126208637|NCT02388906|454051484|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
126208638|NCT02388906|454051485|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126208639|NCT02388906|454051484|FG000|Treatment Period|Disease progression|121|||
126208640|NCT02388906|454051485|FG001|Treatment Period|Disease progression|100|||
126208641|NCT02388906|454051484|FG000|Treatment Period|Study drug toxicity|41|||
125980548|NCT04721925|453217113|FG001|4-Month Assessment|Lost to Follow-up|6|||
126208642|NCT02388906|454051485|FG001|Treatment Period|Study drug toxicity|208|||
126208643|NCT02388906|454051484|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
126208644|NCT02388906|454051485|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
126208645|NCT02388906|454051484|FG000|Treatment Period|Participant request to stop treatment|5|||
126208646|NCT02388906|454051485|FG001|Treatment Period|Participant request to stop treatment|9|||
126208647|NCT02388906|454051484|FG000|Treatment Period|Participant withdrew consent|2|||
126208648|NCT02388906|454051485|FG001|Treatment Period|Participant withdrew consent|3|||
126208649|NCT02388906|454051484|FG000|Treatment Period|Poor/non-compliance|0|||
126208650|NCT02388906|454051485|FG001|Treatment Period|Poor/non-compliance|1|||
126208651|NCT02388906|454051484|FG000|Treatment Period|Participant no longer meets study criteria|0|||
126208652|NCT02388906|454051485|FG001|Treatment Period|Participant no longer meets study criteria|1|||
126208653|NCT02388906|454051484|FG000|Treatment Period|Other reasons|3|||
126208654|NCT02388906|454051485|FG001|Treatment Period|Other reasons|3|||
126208655|NCT04365387|454051494|FG000|Overall Study|Adverse Event|4|||
126208656|NCT04365387|454051495|FG001|Overall Study|Adverse Event|2|||
126208657|NCT04365387|454051494|FG000|Overall Study|Participants request|14|||
126208658|NCT04365387|454051495|FG001|Overall Study|Participants request|14|||
126208659|NCT04365387|454051494|FG000|Overall Study|Lost to Follow-up|8|||
126208660|NCT04365387|454051495|FG001|Overall Study|Lost to Follow-up|5|||
126208661|NCT04365387|454051494|FG000|Overall Study|Protocol deviation|3|||
126208662|NCT04365387|454051495|FG001|Overall Study|Protocol deviation|4|||
126208663|NCT04365387|454051494|FG000|Overall Study|Participant compliance with visit schedule|1|||
126208664|NCT04365387|454051495|FG001|Overall Study|Participant compliance with visit schedule|0|||
126208665|NCT04365387|454051494|FG000|Overall Study|Participant incarcerated|1|||
126208666|NCT04365387|454051495|FG001|Overall Study|Participant incarcerated|0|||
126208667|NCT04365387|454051494|FG000|Overall Study|Participant moved out of town (relocated)|0|||
126208668|NCT04365387|454051495|FG001|Overall Study|Participant moved out of town (relocated)|1|||
126208669|NCT04365387|454051494|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
126208670|NCT04365387|454051495|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
126208671|NCT04365387|454051494|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
126208672|NCT04365387|454051495|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
126208673|NCT03282123|454051496|FG000|Overall Study|Withdrawal by Subject|5|||
126208674|NCT00938366|454051497|FG000|Overall Study|Withdrawal by Subject|1|||
126208675|NCT00938366|454051498|FG001|Overall Study|Withdrawal by Subject|0|||
126208676|NCT05643573|454051500|FG000|Overall Study|Adverse Event|117|||
126208677|NCT05643573|454051501|FG001|Overall Study|Adverse Event|90|||
126208678|NCT05643573|454051500|FG000|Overall Study|Death|53|||
126208679|NCT05643573|454051501|FG001|Overall Study|Death|57|||
126208680|NCT05643573|454051500|FG000|Overall Study|Lost to Follow-up|6|||
126208681|NCT05643573|454051501|FG001|Overall Study|Lost to Follow-up|3|||
126208682|NCT05643573|454051500|FG000|Overall Study|Other|18|||
126208683|NCT05643573|454051501|FG001|Overall Study|Other|15|||
126208684|NCT05643573|454051500|FG000|Overall Study|Outcome event|64|||
126208685|NCT05643573|454051501|FG001|Overall Study|Outcome event|36|||
126208686|NCT05643573|454051500|FG000|Overall Study|Physician Decision|33|||
126208687|NCT05643573|454051501|FG001|Overall Study|Physician Decision|19|||
126208688|NCT05643573|454051500|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
126208689|NCT05643573|454051501|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
126208690|NCT05643573|454051500|FG000|Overall Study|Site terminated by sponsor|10|||
126208691|NCT05643573|454051501|FG001|Overall Study|Site terminated by sponsor|10|||
126208692|NCT05643573|454051500|FG000|Overall Study|Study terminated by sponsor|1|||
126208693|NCT05643573|454051501|FG001|Overall Study|Study terminated by sponsor|0|||
126208694|NCT05643573|454051500|FG000|Overall Study|Withdrawal by Subject|178|||
126208695|NCT05643573|454051501|FG001|Overall Study|Withdrawal by Subject|130|||
126208696|NCT04768881|454051504|FG000|Overall Study|Completed Study Follow-up|0|||
126208697|NCT04768881|454051505|FG001|Overall Study|Completed Study Follow-up|2|||
126208698|NCT04768881|454051504|FG000|Overall Study|Death|3|||
126208699|NCT04768881|454051505|FG001|Overall Study|Death|2|||
126208700|NCT04768881|454051504|FG000|Overall Study|Study Terminated by Sponsor|2|||
126208701|NCT04768881|454051505|FG001|Overall Study|Study Terminated by Sponsor|2|||
126208702|NCT04768881|454051504|FG000|Overall Study|Withdrawal by Subject|2|||
125980549|NCT00952367|453217114|FG000|Overall Study|Withdrawal by Subject|2|||
125980550|NCT00952367|453217114|FG000|Overall Study|Noncoordination|1|||
125980551|NCT00952367|453217114|FG000|Overall Study|Protocol Violation|3|||
125980552|NCT00781391|453217121|FG000|Overall Study|never received study drug|24|||
125980553|NCT00781391|453217122|FG001|Overall Study|never received study drug|23|||
125980554|NCT00781391|453217123|FG002|Overall Study|never received study drug|32|||
125980555|NCT00781391|453217121|FG000|Overall Study|Protocol Violation|19|||
125980556|NCT00781391|453217122|FG001|Overall Study|Protocol Violation|17|||
125980557|NCT00781391|453217123|FG002|Overall Study|Protocol Violation|20|||
125980558|NCT00781391|453217121|FG000|Overall Study|Death|789|||
125980559|NCT00781391|453217122|FG001|Overall Study|Death|730|||
125980560|NCT00781391|453217123|FG002|Overall Study|Death|706|||
125980561|NCT00781391|453217121|FG000|Overall Study|Withdrawal by Subject|47|||
125980562|NCT00781391|453217122|FG001|Overall Study|Withdrawal by Subject|37|||
125980563|NCT00781391|453217123|FG002|Overall Study|Withdrawal by Subject|25|||
125980564|NCT00781391|453217121|FG000|Overall Study|Lost to Follow-up|0|||
125980565|NCT00781391|453217122|FG001|Overall Study|Lost to Follow-up|0|||
125980566|NCT00781391|453217123|FG002|Overall Study|Lost to Follow-up|1|||
125980567|NCT04535947|453217124|FG000|Overall Study|Adverse Event|1|||
125980568|NCT04535947|453217125|FG001|Overall Study|Adverse Event|4|||
125980569|NCT04535947|453217124|FG000|Overall Study|Other reasons not specified|2|||
125980570|NCT04535947|453217125|FG001|Overall Study|Other reasons not specified|0|||
125980571|NCT04535947|453217124|FG000|Overall Study|Withdrawal by Subject|1|||
125980572|NCT04535947|453217125|FG001|Overall Study|Withdrawal by Subject|1|||
125980573|NCT03802123|453217127|FG000|Overall Study|Withdrawal by Subject|3|||
125980574|NCT03802123|453217127|FG000|Overall Study|Physician Decision|1|||
125980575|NCT03802123|453217127|FG000|Overall Study|Subject moved to hospice care|1|||
125980576|NCT03802123|453217127|FG000|Overall Study|technician error|1|||
125980577|NCT03802123|453217127|FG000|Overall Study|Death|3|||
125980578|NCT01822587|453217128|FG000|Overall Study|Lost to Follow-up|7|||
126090586|NCT04020185|453624969|FG004|Overall Study|Death|1|||
126208703|NCT04768881|454051505|FG001|Overall Study|Withdrawal by Subject|0|||
126208704|NCT04768881|454051504|FG000|Overall Study|Other|2|||
126208705|NCT04768881|454051505|FG001|Overall Study|Other|0|||
126208706|NCT01875731|454051507|FG000|Overall Study|Fail to obtain lab sample|1|||
126208707|NCT01875731|454051508|FG001|Overall Study|Fail to obtain lab sample|0|||
126208708|NCT00437294|454053070|FG000|Overall Study|Adverse Event|5|||
126208709|NCT00437294|454053071|FG001|Overall Study|Adverse Event|4|||
126208710|NCT00437294|454053070|FG000|Overall Study|Death|5|||
126208711|NCT00437294|454053071|FG001|Overall Study|Death|2|||
126208712|NCT00437294|454053070|FG000|Overall Study|Physician Decision|0|||
126208713|NCT00437294|454053071|FG001|Overall Study|Physician Decision|3|||
126208714|NCT00437294|454053070|FG000|Overall Study|Withdrawal by Subject|5|||
126208715|NCT00437294|454053071|FG001|Overall Study|Withdrawal by Subject|0|||
126208716|NCT00437294|454053070|FG000|Overall Study|Progressive Disease|19|||
126208717|NCT00437294|454053071|FG001|Overall Study|Progressive Disease|23|||
126208718|NCT00437294|454053070|FG000|Overall Study|Sponsor Decision|8|||
126208719|NCT00437294|454053071|FG001|Overall Study|Sponsor Decision|9|||
126208720|NCT00437294|454053070|FG000|Overall Study|Protocol Violation|0|||
126208721|NCT00437294|454053071|FG001|Overall Study|Protocol Violation|1|||
126208722|NCT00437294|454053070|FG000|Overall Study|Entry criteria not met|1|||
126208723|NCT00437294|454053071|FG001|Overall Study|Entry criteria not met|1|||
126208724|NCT00003526|454053073|FG000|Overall Study|Not evaluable|6|||
126208725|NCT00779857|454053074|FG000|Overall Study|Death|1|||
126208726|NCT00779857|454053074|FG000|Overall Study|Withdrawal by Subject|3|||
126208727|NCT00779857|454053074|FG000|Overall Study|Missed Visit|2|||
126208728|NCT00620776|454053075|FG000|Overall Study|Did not receive treatment|3|||
126208729|NCT00620776|454053076|FG001|Overall Study|Did not receive treatment|5|||
126208730|NCT00620776|454053075|FG000|Overall Study|Adverse Event|2|||
126208731|NCT00620776|454053076|FG001|Overall Study|Adverse Event|3|||
126208732|NCT00620776|454053075|FG000|Overall Study|Lack of Efficacy|2|||
126208733|NCT00620776|454053076|FG001|Overall Study|Lack of Efficacy|1|||
126208734|NCT00620776|454053075|FG000|Overall Study|Lost to Follow-up|2|||
126208735|NCT00620776|454053076|FG001|Overall Study|Lost to Follow-up|5|||
126208736|NCT00620776|454053075|FG000|Overall Study|Withdrawal by Subject|3|||
126208737|NCT00620776|454053076|FG001|Overall Study|Withdrawal by Subject|2|||
126208738|NCT03205046|454053078|FG000|Overall Study|Death|10|||
126208739|NCT03205046|454053079|FG001|Overall Study|Death|6|||
126208740|NCT03205046|454053078|FG000|Overall Study|Withdrawal by Subject|1|||
126208741|NCT03205046|454053079|FG001|Overall Study|Withdrawal by Subject|2|||
126208742|NCT03205046|454053078|FG000|Overall Study|Lost to Follow-up|0|||
126208743|NCT03205046|454053079|FG001|Overall Study|Lost to Follow-up|1|||
126208744|NCT03205046|454053078|FG000|Overall Study|Study terminated by sponsor|2|||
126208745|NCT03205046|454053079|FG001|Overall Study|Study terminated by sponsor|1|||
126208746|NCT01023815|454053080|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
126208747|NCT01023815|454053081|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
126208748|NCT01023815|454053082|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
126208749|NCT01023815|454053083|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
125980579|NCT01822587|453217129|FG001|Overall Study|Lost to Follow-up|9|||
125980580|NCT01822587|453217130|FG002|Overall Study|Lost to Follow-up|12|||
125980581|NCT01822587|453217128|FG000|Overall Study|Physician Decision|9|||
125980582|NCT01822587|453217129|FG001|Overall Study|Physician Decision|6|||
125980583|NCT01822587|453217130|FG002|Overall Study|Physician Decision|6|||
125980584|NCT00708916|453217132|FG000|Overall Study|Subject Noncompliance|2|||
125980585|NCT00708916|453217132|FG000|Overall Study|Adverse Event|2|||
126090587|NCT04020185|453624970|FG005|Overall Study|Death|0|||
126090588|NCT04020185|453624971|FG006|Overall Study|Death|1|||
126090589|NCT04020185|453624972|FG007|Overall Study|Death|0|||
126090590|NCT04020185|453624965|FG000|Overall Study|Consent withdrawn|1|||
126090591|NCT04020185|453624966|FG001|Overall Study|Consent withdrawn|0|||
126090592|NCT04020185|453624967|FG002|Overall Study|Consent withdrawn|0|||
126090593|NCT04020185|453624968|FG003|Overall Study|Consent withdrawn|0|||
126090594|NCT04020185|453624969|FG004|Overall Study|Consent withdrawn|2|||
126090595|NCT04020185|453624970|FG005|Overall Study|Consent withdrawn|0|||
126090596|NCT04020185|453624971|FG006|Overall Study|Consent withdrawn|1|||
126090597|NCT04020185|453624972|FG007|Overall Study|Consent withdrawn|1|||
126090598|NCT04020185|453624965|FG000|Overall Study|Patient in hospice|0|||
126090599|NCT04020185|453624966|FG001|Overall Study|Patient in hospice|1|||
126090600|NCT04020185|453624967|FG002|Overall Study|Patient in hospice|0|||
126090601|NCT04020185|453624968|FG003|Overall Study|Patient in hospice|0|||
126090602|NCT04020185|453624969|FG004|Overall Study|Patient in hospice|0|||
126090603|NCT04020185|453624970|FG005|Overall Study|Patient in hospice|0|||
126090604|NCT04020185|453624971|FG006|Overall Study|Patient in hospice|0|||
126090605|NCT04020185|453624972|FG007|Overall Study|Patient in hospice|0|||
126090606|NCT04020185|453624965|FG000|Overall Study|Continuing on expanded access|0|||
126090607|NCT04020185|453624966|FG001|Overall Study|Continuing on expanded access|0|||
126090608|NCT04020185|453624967|FG002|Overall Study|Continuing on expanded access|0|||
126090609|NCT04020185|453624968|FG003|Overall Study|Continuing on expanded access|0|||
126090610|NCT04020185|453624969|FG004|Overall Study|Continuing on expanded access|0|||
126090611|NCT04020185|453624970|FG005|Overall Study|Continuing on expanded access|0|||
126090612|NCT04020185|453624971|FG006|Overall Study|Continuing on expanded access|1|||
126090613|NCT04020185|453624972|FG007|Overall Study|Continuing on expanded access|1|||
126090614|NCT03433677|453624974|FG000|Period 1|Protocol Violation|1|||
126090615|NCT03433677|453624975|FG001|Period 1|Protocol Violation|0|||
126090616|NCT03433677|453624974|FG000|Period 2|Withdrawal by Subject|1|||
126090617|NCT03433677|453624975|FG001|Period 2|Withdrawal by Subject|1|||
126090618|NCT01499303|453624976|FG000|Overall Study|Ongoing|2|||
126090619|NCT01499303|453624977|FG001|Overall Study|Ongoing|1|||
126090620|NCT01499303|453624976|FG000|Overall Study|Withdrawal by Subject|0|||
126090621|NCT01499303|453624977|FG001|Overall Study|Withdrawal by Subject|1|||
126090622|NCT01499303|453624976|FG000|Overall Study|Adverse Event|1|||
126090623|NCT01499303|453624977|FG001|Overall Study|Adverse Event|4|||
126090624|NCT01499303|453624976|FG000|Overall Study|Other|0|||
126090625|NCT01499303|453624977|FG001|Overall Study|Other|1|||
126090626|NCT04939701|453624980|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
126090627|NCT04939701|453624981|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
126090628|NCT04939701|453624982|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
126090629|NCT04939701|453624980|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
126090630|NCT04939701|453624981|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
126090631|NCT04939701|453624982|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
126090632|NCT04939701|453624980|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
126090633|NCT04939701|453624981|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
126090634|NCT04939701|453624982|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
126090635|NCT04939701|453624980|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
126090636|NCT04939701|453624981|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
126090637|NCT04939701|453624982|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
126090638|NCT04939701|453624980|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
126090639|NCT04939701|453624981|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
126090640|NCT04939701|453624982|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
126090641|NCT04939701|453624980|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
126090642|NCT04939701|453624981|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
125980586|NCT00658567|453217134|FG000|Overall Study|Adverse Event|5|||
125980587|NCT00658567|453217135|FG001|Overall Study|Adverse Event|2|||
125980588|NCT00658567|453217136|FG002|Overall Study|Adverse Event|3|||
125980589|NCT00658567|453217134|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
125980590|NCT00658567|453217135|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
125980591|NCT00658567|453217136|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
125980592|NCT00658567|453217134|FG000|Overall Study|Physician Decision|0|||
126090643|NCT04939701|453624982|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
126090644|NCT04939701|453624980|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
126090645|NCT04939701|453624981|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
126090646|NCT04939701|453624982|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
126090647|NCT00565773|453624983|FG000|Overall Study|Withdrawal by Subject|1|||
126090648|NCT00565773|453624983|FG000|Overall Study|Physician Decision|1|||
126090649|NCT00702962|453624984|FG000|Overall Study|Progressive disease|0|||
126090650|NCT00702962|453624985|FG001|Overall Study|Progressive disease|1|||
125980593|NCT00658567|453217135|FG001|Overall Study|Physician Decision|1|||
125980594|NCT00658567|453217136|FG002|Overall Study|Physician Decision|0|||
125980595|NCT00658567|453217134|FG000|Overall Study|At Discretion of Sponsor|1|||
125980596|NCT00658567|453217135|FG001|Overall Study|At Discretion of Sponsor|1|||
125980597|NCT00658567|453217136|FG002|Overall Study|At Discretion of Sponsor|1|||
126090651|NCT00702962|453624984|FG000|Overall Study|Hospitalized for other health disorder|1|||
126090652|NCT00702962|453624985|FG001|Overall Study|Hospitalized for other health disorder|0|||
126090653|NCT01923467|453624987|FG000|Overall Study|Lost to Follow-up|62|||
126090654|NCT01923467|453624987|FG000|Overall Study|Subject non-interest|479|||
126090655|NCT03015129|453624988|FG000|Overall Study|Death|2|||
126090656|NCT03015129|453624989|FG001|Overall Study|Death|2|||
126090657|NCT03015129|453624988|FG000|Overall Study|Lost to Follow-up|0|||
126090658|NCT03015129|453624989|FG001|Overall Study|Lost to Follow-up|1|||
126090659|NCT03015129|453624988|FG000|Overall Study|Progression of disease|38|||
126090660|NCT03015129|453624989|FG001|Overall Study|Progression of disease|33|||
126090661|NCT03015129|453624988|FG000|Overall Study|Adverse Event|0|||
126090662|NCT03015129|453624989|FG001|Overall Study|Adverse Event|4|||
126090663|NCT02242097|453624990|FG000|Ibrutinib Treatment|Adverse Event|16|||
126317877|NCT00561470|454454095|FG000|Overall Study|Ongoing Treatment|11|||
126317878|NCT00561470|454454096|FG001|Overall Study|Ongoing Treatment|14|||
126317879|NCT00637806|454454097|FG000|Double-blind Phase|Study Discontinued|2|||
126317880|NCT00637806|454454098|FG001|Double-blind Phase|Study Discontinued|0|||
126090664|NCT02242097|453624990|FG000|Ibrutinib Treatment|Physician Decision|1|||
126090665|NCT02242097|453624990|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
126090666|NCT02242097|453624990|FG000|Ibrutinib Treatment|Death|1|||
126090667|NCT02242097|453624990|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
126090668|NCT02242097|453624990|FG000|Post Therapy Follow Up|Death|3|||
126090669|NCT02242097|453624990|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
126090670|NCT01075958|453624991|FG000|Overall Study|Blood sample could not be obtained|44|||
126090671|NCT03733314|453624993|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
126090672|NCT03733314|453624994|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
126090673|NCT03733314|453624993|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
126090674|NCT03733314|453624994|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
126090675|NCT03733314|453624993|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
126090676|NCT03733314|453624994|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
126090677|NCT03733314|453624993|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
126090678|NCT03733314|453624994|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
126090679|NCT03733314|453624993|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
126090680|NCT03733314|453624994|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
126090681|NCT03733314|453624993|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
126090682|NCT03733314|453624994|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
126090683|NCT01240915|453624995|FG000|Overall Study|Adverse Event|0|||
126090684|NCT01240915|453624996|FG001|Overall Study|Adverse Event|0|||
126090685|NCT01240915|453624997|FG002|Overall Study|Adverse Event|0|||
126090686|NCT01240915|453624998|FG003|Overall Study|Adverse Event|1|||
126090687|NCT01240915|453624999|FG004|Overall Study|Adverse Event|0|||
126090688|NCT01240915|453625000|FG005|Overall Study|Adverse Event|2|||
126090689|NCT01240915|453625001|FG006|Overall Study|Adverse Event|0|||
126090690|NCT01240915|453625002|FG007|Overall Study|Adverse Event|0|||
126090691|NCT01240915|453625003|FG008|Overall Study|Adverse Event|1|||
125980598|NCT01058304|453217145|FG000|Overall Study|Withdrawal by Subject|8|||
125980599|NCT01058304|453217146|FG001|Overall Study|Withdrawal by Subject|5|||
125980600|NCT01058304|453217145|FG000|Overall Study|Lost to Follow-up|13|||
125980601|NCT01058304|453217146|FG001|Overall Study|Lost to Follow-up|16|||
125980602|NCT01058304|453217145|FG000|Overall Study|Developed exclusion criterion|6|||
125980603|NCT01058304|453217146|FG001|Overall Study|Developed exclusion criterion|12|||
125980604|NCT01820559|453217147|FG000|Overall Study|Adverse Event|4|||
125980605|NCT01820559|453217148|FG001|Overall Study|Adverse Event|6|||
125980606|NCT01820559|453217149|FG002|Overall Study|Adverse Event|13|||
125980607|NCT01820559|453217147|FG000|Overall Study|Withdrawal by Subject|1|||
125980608|NCT01820559|453217148|FG001|Overall Study|Withdrawal by Subject|2|||
125980609|NCT01820559|453217149|FG002|Overall Study|Withdrawal by Subject|5|||
125980610|NCT01820559|453217147|FG000|Overall Study|Protocol Violation|2|||
125980611|NCT01820559|453217148|FG001|Overall Study|Protocol Violation|1|||
126090692|NCT01240915|453624995|FG000|Overall Study|Lost to Follow-up|0|||
126090693|NCT01240915|453624996|FG001|Overall Study|Lost to Follow-up|0|||
126090694|NCT01240915|453624997|FG002|Overall Study|Lost to Follow-up|0|||
126090695|NCT01240915|453624998|FG003|Overall Study|Lost to Follow-up|0|||
126090696|NCT01240915|453624999|FG004|Overall Study|Lost to Follow-up|1|||
126090697|NCT01240915|453625000|FG005|Overall Study|Lost to Follow-up|1|||
126090698|NCT01240915|453625001|FG006|Overall Study|Lost to Follow-up|0|||
126090699|NCT01240915|453625002|FG007|Overall Study|Lost to Follow-up|1|||
125980612|NCT01820559|453217149|FG002|Overall Study|Protocol Violation|3|||
125980613|NCT01820559|453217147|FG000|Overall Study|Subject's non-compliance|1|||
125980614|NCT01820559|453217148|FG001|Overall Study|Subject's non-compliance|0|||
125980615|NCT01820559|453217149|FG002|Overall Study|Subject's non-compliance|2|||
125980616|NCT01820559|453217147|FG000|Overall Study|Lost to Follow-up|3|||
125980617|NCT01820559|453217148|FG001|Overall Study|Lost to Follow-up|2|||
125980618|NCT01820559|453217149|FG002|Overall Study|Lost to Follow-up|2|||
125980619|NCT01820559|453217147|FG000|Overall Study|At sponsor request|0|||
125980620|NCT01820559|453217148|FG001|Overall Study|At sponsor request|0|||
125980621|NCT01820559|453217149|FG002|Overall Study|At sponsor request|1|||
125980622|NCT01820559|453217147|FG000|Overall Study|Lack of Efficacy|3|||
125980623|NCT01820559|453217148|FG001|Overall Study|Lack of Efficacy|2|||
125980624|NCT01820559|453217149|FG002|Overall Study|Lack of Efficacy|3|||
125980625|NCT02684006|453217150|FG000|Overall Study|Other|18|||
125980626|NCT02684006|453217151|FG001|Overall Study|Other|6|||
125980627|NCT02684006|453217150|FG000|Overall Study|Protocol Violation|2|||
125980628|NCT02684006|453217151|FG001|Overall Study|Protocol Violation|1|||
125980629|NCT02684006|453217150|FG000|Overall Study|Non-compliance with study drug|1|||
125980630|NCT02684006|453217151|FG001|Overall Study|Non-compliance with study drug|1|||
125980631|NCT02684006|453217150|FG000|Overall Study|No longer met eligibility criteria|6|||
125980632|NCT02684006|453217151|FG001|Overall Study|No longer met eligibility criteria|2|||
125980633|NCT02684006|453217150|FG000|Overall Study|Lost to Follow-up|0|||
125980634|NCT02684006|453217151|FG001|Overall Study|Lost to Follow-up|1|||
125980635|NCT02684006|453217150|FG000|Overall Study|Death|25|||
125980636|NCT02684006|453217151|FG001|Overall Study|Death|22|||
125980637|NCT02684006|453217150|FG000|Overall Study|Global deterioration of health status|18|||
125980638|NCT02684006|453217151|FG001|Overall Study|Global deterioration of health status|20|||
125980639|NCT02684006|453217150|FG000|Overall Study|Physician Decision|15|||
125980640|NCT02684006|453217151|FG001|Overall Study|Physician Decision|8|||
125980641|NCT02684006|453217150|FG000|Overall Study|Adverse Event|86|||
125980642|NCT02684006|453217151|FG001|Overall Study|Adverse Event|65|||
125980643|NCT02684006|453217150|FG000|Overall Study|Withdrawal by Subject|29|||
125980644|NCT02684006|453217151|FG001|Overall Study|Withdrawal by Subject|43|||
125980645|NCT02684006|453217150|FG000|Overall Study|Progressive disease|236|||
125980646|NCT02684006|453217151|FG001|Overall Study|Progressive disease|266|||
125980647|NCT02684006|453217150|FG000|Overall Study|Participation terminated by sponsor|6|||
125980648|NCT02684006|453217151|FG001|Overall Study|Participation terminated by sponsor|9|||
125980649|NCT03804710|453217158|FG000|Overall Study|Adverse Event|0|||
125980650|NCT03804710|453217159|FG001|Overall Study|Adverse Event|3|||
125980651|NCT03804710|453217158|FG000|Overall Study|Withdrawal by Subject|2|||
125980652|NCT03804710|453217159|FG001|Overall Study|Withdrawal by Subject|1|||
125980653|NCT03804710|453217158|FG000|Overall Study|Other|0|||
125980654|NCT03804710|453217159|FG001|Overall Study|Other|1|||
125980655|NCT02660827|453217163|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
125980656|NCT02660827|453217163|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
125980657|NCT02660827|453217163|FG000|From Study to End of Continued Access|Adverse Event|3|||
125980658|NCT02660827|453217163|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
125980659|NCT02660827|453217163|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
125980660|NCT02660827|453217163|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
125980661|NCT02660827|453217163|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
125980662|NCT02660827|453217163|FG000|Period 2: Continued Access Period|Adverse Event|3|||
125980663|NCT01428076|453217164|FG000|Overall Study|Adverse Event|0|||
125980664|NCT01428076|453217165|FG001|Overall Study|Adverse Event|1|||
125980665|NCT00045305|453217169|FG000|Overall Study|Lack of Efficacy|6|||
125980666|NCT00045305|453217169|FG000|Overall Study|Adverse Event|3|||
125980667|NCT00045305|453217169|FG000|Overall Study|Death|3|||
125980668|NCT00045305|453217169|FG000|Overall Study|site error|2|||
125980669|NCT02216773|453217175|FG000|Overall Study|Disease progression|4|||
125980670|NCT02216773|453217176|FG001|Overall Study|Disease progression|2|||
125980671|NCT02216773|453217175|FG000|Overall Study|Insufficient FLRV|4|||
125980672|NCT02216773|453217176|FG001|Overall Study|Insufficient FLRV|0|||
125980673|NCT02216773|453217175|FG000|Overall Study|Abandoned|4|||
125980674|NCT02216773|453217176|FG001|Overall Study|Abandoned|3|||
125980675|NCT04274894|453217177|FG000|Overall Study|Adverse Event|7|||
125980676|NCT04274894|453217177|FG000|Overall Study|Withdrew consent|5|||
125980677|NCT04274894|453217177|FG000|Overall Study|Lost to Follow-up|9|||
125980678|NCT04274894|453217177|FG000|Overall Study|COVID-19 infection|1|||
125980679|NCT04274894|453217177|FG000|Overall Study|Other, not specified|20|||
125980680|NCT01936857|453217178|FG000|Overall Study|Sent to prison or 06 center|11|||
125980681|NCT01936857|453217179|FG001|Overall Study|Sent to prison or 06 center|12|||
125980682|NCT01936857|453217178|FG000|Overall Study|Lost to Follow-up|10|||
125980683|NCT01936857|453217179|FG001|Overall Study|Lost to Follow-up|7|||
125980684|NCT01936857|453217178|FG000|Overall Study|Death|7|||
125980685|NCT01936857|453217179|FG001|Overall Study|Death|3|||
125980686|NCT01936857|453217178|FG000|Overall Study|Moved|2|||
125980687|NCT01936857|453217179|FG001|Overall Study|Moved|1|||
125980688|NCT01936857|453217178|FG000|Overall Study|Withdrawal by Subject|1|||
125980689|NCT01936857|453217179|FG001|Overall Study|Withdrawal by Subject|0|||
125980690|NCT01936857|453217178|FG000|Overall Study|Side effect of medication|1|||
125980691|NCT01936857|453217179|FG001|Overall Study|Side effect of medication|0|||
125980692|NCT01936857|453217178|FG000|Overall Study|Other|2|||
125980693|NCT01936857|453217179|FG001|Overall Study|Other|2|||
125980694|NCT03848403|453217180|FG000|Period 2 (Day 8)|Adverse Event|1|||
125980695|NCT03848403|453217181|FG001|Period 2 (Day 8)|Adverse Event|2|||
125980696|NCT03848403|453217182|FG002|Period 2 (Day 8)|Adverse Event|2|||
125980697|NCT03848403|453217180|FG000|Period 2 (Day 8)|Physician Decision|0|||
125980698|NCT03848403|453217181|FG001|Period 2 (Day 8)|Physician Decision|1|||
126317881|NCT00637806|454454099|FG002|Double-blind Phase|Study Discontinued|1|||
126317882|NCT00637806|454454100|FG003|Double-blind Phase|Study Discontinued|0|||
126317883|NCT00637806|454454097|FG000|Extension Phase|Study Discontinued|0|||
126317884|NCT00637806|454454098|FG001|Extension Phase|Study Discontinued|0|||
125980699|NCT03848403|453217182|FG002|Period 2 (Day 8)|Physician Decision|0|||
125980700|NCT03848403|453217180|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
125980701|NCT03848403|453217181|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
125980702|NCT03848403|453217182|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
126317885|NCT00637806|454454099|FG002|Extension Phase|Study Discontinued|0|||
126317886|NCT00637806|454454100|FG003|Extension Phase|Study Discontinued|1|||
126317887|NCT01731470|454454101|FG000|Overall Study|Withdrawal by Subject|1|||
126317888|NCT01731470|454454101|FG000|Overall Study|Did not meet study criteria|1|||
126317889|NCT04395274|454454102|FG000|Overall Study|Lost to Follow-up|20|||
126317890|NCT04395274|454454103|FG001|Overall Study|Lost to Follow-up|11|||
126317891|NCT04395274|454454102|FG000|Overall Study|Withdrawal by Subject|13|||
126317892|NCT04395274|454454103|FG001|Overall Study|Withdrawal by Subject|10|||
126317893|NCT04395274|454454102|FG000|Overall Study|Moved Abroad|0|||
126317894|NCT04395274|454454103|FG001|Overall Study|Moved Abroad|1|||
126317895|NCT01592292|454454106|FG000|Overall Study|Follow-up loss|3|||
126317896|NCT01592292|454454107|FG001|Overall Study|Follow-up loss|3|||
126317897|NCT01592292|454454108|FG002|Overall Study|Follow-up loss|1|||
126317898|NCT01592292|454454109|FG003|Overall Study|Follow-up loss|0|||
126317899|NCT01592292|454454106|FG000|Overall Study|Withdrew consent|2|||
126317900|NCT01592292|454454107|FG001|Overall Study|Withdrew consent|1|||
126317901|NCT01592292|454454108|FG002|Overall Study|Withdrew consent|0|||
126317902|NCT01592292|454454109|FG003|Overall Study|Withdrew consent|0|||
125980703|NCT02279043|453217183|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
125980704|NCT02279043|453217184|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
125980705|NCT02279043|453217185|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
125980706|NCT02279043|453217183|FG000|Overall Study|Lost to Follow-up|46|||
125980707|NCT02279043|453217184|FG001|Overall Study|Lost to Follow-up|88|||
125980708|NCT02279043|453217185|FG002|Overall Study|Lost to Follow-up|0|||
125980709|NCT02124265|453217186|FG000|Overall Study|Adverse Event|1|||
125980710|NCT01939548|453217187|FG000|Overall Study|Non compliance|0|||
125980711|NCT01939548|453217188|FG001|Overall Study|Non compliance|2|||
125980712|NCT01939548|453217189|FG002|Overall Study|Non compliance|0|||
126317903|NCT01592292|454454106|FG000|Overall Study|Other|1|||
126317904|NCT01592292|454454107|FG001|Overall Study|Other|1|||
126317905|NCT01592292|454454108|FG002|Overall Study|Other|2|||
126317906|NCT01592292|454454109|FG003|Overall Study|Other|1|||
126317907|NCT00335959|454454110|FG000|Overall Study|Adverse Event|2|||
126317908|NCT00335959|454454110|FG000|Overall Study|Ineligible|1|||
126317909|NCT02450552|454454112|FG000|Overall Study|Withdrawal by Subject|4|||
125980713|NCT01939548|453217187|FG000|Overall Study|Study Terminated by Sponsor|17|||
126090700|NCT01240915|453625003|FG008|Overall Study|Lost to Follow-up|1|||
126090701|NCT01240915|453624995|FG000|Overall Study|Withdrawal by Subject|2|||
126090702|NCT01240915|453624996|FG001|Overall Study|Withdrawal by Subject|1|||
126090703|NCT01240915|453624997|FG002|Overall Study|Withdrawal by Subject|0|||
126090704|NCT01240915|453624998|FG003|Overall Study|Withdrawal by Subject|2|||
126090705|NCT01240915|453624999|FG004|Overall Study|Withdrawal by Subject|0|||
126090706|NCT01240915|453625000|FG005|Overall Study|Withdrawal by Subject|4|||
126090707|NCT01240915|453625001|FG006|Overall Study|Withdrawal by Subject|2|||
126090708|NCT01240915|453625002|FG007|Overall Study|Withdrawal by Subject|3|||
126090709|NCT01240915|453625003|FG008|Overall Study|Withdrawal by Subject|3|||
126090710|NCT01240915|453624995|FG000|Overall Study|Other|0|||
126090711|NCT01240915|453624996|FG001|Overall Study|Other|0|||
126090712|NCT01240915|453624997|FG002|Overall Study|Other|0|||
126090713|NCT01240915|453624998|FG003|Overall Study|Other|0|||
126090714|NCT01240915|453624999|FG004|Overall Study|Other|2|||
126090715|NCT01240915|453625000|FG005|Overall Study|Other|0|||
126090716|NCT01240915|453625001|FG006|Overall Study|Other|0|||
125980714|NCT01939548|453217188|FG001|Overall Study|Study Terminated by Sponsor|19|||
125980715|NCT01939548|453217189|FG002|Overall Study|Study Terminated by Sponsor|12|||
125980716|NCT01939548|453217187|FG000|Overall Study|Insufficient Clinical Response|1|||
125980717|NCT01939548|453217188|FG001|Overall Study|Insufficient Clinical Response|0|||
125980718|NCT01939548|453217189|FG002|Overall Study|Insufficient Clinical Response|0|||
125980719|NCT01939548|453217187|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
125980720|NCT01939548|453217188|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
126090717|NCT01240915|453625002|FG007|Overall Study|Other|0|||
126090718|NCT01240915|453625003|FG008|Overall Study|Other|0|||
126090719|NCT01240915|453624995|FG000|Overall Study|Insufficient Clinical Response|0|||
126090720|NCT01240915|453624996|FG001|Overall Study|Insufficient Clinical Response|0|||
126090721|NCT01240915|453624997|FG002|Overall Study|Insufficient Clinical Response|0|||
126090722|NCT01240915|453624998|FG003|Overall Study|Insufficient Clinical Response|0|||
126090723|NCT01240915|453624999|FG004|Overall Study|Insufficient Clinical Response|1|||
126090724|NCT01240915|453625000|FG005|Overall Study|Insufficient Clinical Response|3|||
125980721|NCT01939548|453217189|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
126317910|NCT02450552|454454113|FG001|Overall Study|Withdrawal by Subject|0|||
125980722|NCT01939548|453217187|FG000|Overall Study|Withdrawal by Subject|4|||
125980723|NCT01939548|453217188|FG001|Overall Study|Withdrawal by Subject|4|||
125980724|NCT01939548|453217189|FG002|Overall Study|Withdrawal by Subject|1|||
125980725|NCT01939548|453217187|FG000|Overall Study|Protocol Violation|7|||
125980726|NCT01939548|453217188|FG001|Overall Study|Protocol Violation|6|||
125980727|NCT01939548|453217189|FG002|Overall Study|Protocol Violation|5|||
125980728|NCT01939548|453217187|FG000|Overall Study|Lost to Follow-up|5|||
125980729|NCT01939548|453217188|FG001|Overall Study|Lost to Follow-up|5|||
125980730|NCT01939548|453217189|FG002|Overall Study|Lost to Follow-up|3|||
125980731|NCT01939548|453217187|FG000|Overall Study|Adverse Event|2|||
125980732|NCT01939548|453217188|FG001|Overall Study|Adverse Event|9|||
125980733|NCT01939548|453217189|FG002|Overall Study|Adverse Event|7|||
125980734|NCT01939548|453217187|FG000|Overall Study|Death|0|||
125980735|NCT01939548|453217188|FG001|Overall Study|Death|0|||
125980736|NCT01939548|453217189|FG002|Overall Study|Death|1|||
125980737|NCT01939548|453217187|FG000|Overall Study|Participant dropped|0|||
125980738|NCT01939548|453217188|FG001|Overall Study|Participant dropped|0|||
125980739|NCT01939548|453217189|FG002|Overall Study|Participant dropped|1|||
125980740|NCT01939548|453217187|FG000|Overall Study|Participant unwilling to continue|0|||
125980741|NCT01939548|453217188|FG001|Overall Study|Participant unwilling to continue|1|||
125980742|NCT01939548|453217189|FG002|Overall Study|Participant unwilling to continue|0|||
125980743|NCT01939548|453217187|FG000|Overall Study|Participant withdrew consent|0|||
125980744|NCT01939548|453217188|FG001|Overall Study|Participant withdrew consent|2|||
125980745|NCT01939548|453217189|FG002|Overall Study|Participant withdrew consent|0|||
125980746|NCT01939548|453217187|FG000|Overall Study|Did not complete follow-up|0|||
125980747|NCT01939548|453217188|FG001|Overall Study|Did not complete follow-up|1|||
125980748|NCT01939548|453217189|FG002|Overall Study|Did not complete follow-up|0|||
125980749|NCT00490282|453217190|FG000|Overall Study|Withdrawal by Subject|3|||
125980750|NCT04510675|453217192|FG000|Overall Study|Withdrawal by Subject|5|||
125980751|NCT04198805|453217195|FG000|Overall Study|Death|0|||
125980752|NCT04198805|453217196|FG001|Overall Study|Death|0|||
125980753|NCT04198805|453217197|FG002|Overall Study|Death|0|||
125980754|NCT04198805|453217198|FG003|Overall Study|Death|1|||
125980755|NCT04198805|453217195|FG000|Overall Study|Early Termination|8|||
125980756|NCT04198805|453217196|FG001|Overall Study|Early Termination|4|||
125980757|NCT04198805|453217197|FG002|Overall Study|Early Termination|6|||
125980758|NCT04198805|453217198|FG003|Overall Study|Early Termination|9|||
125980759|NCT01330433|453217201|FG000|Overall Study|Death|1|||
125980760|NCT01330433|453217202|FG001|Overall Study|Death|3|||
125980761|NCT01330433|453217201|FG000|Overall Study|Lost to Follow-up|1|||
125980762|NCT01330433|453217202|FG001|Overall Study|Lost to Follow-up|0|||
125980763|NCT01323530|453219086|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
125980764|NCT01323530|453219087|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125980765|NCT01323530|453219088|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125980766|NCT01323530|453219089|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125980767|NCT01323530|453219090|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125980768|NCT01323530|453219091|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
125980769|NCT01323530|453219092|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125980770|NCT01323530|453219086|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
125980771|NCT01323530|453219087|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
125980772|NCT01323530|453219088|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
125980773|NCT01323530|453219089|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125980774|NCT01323530|453219090|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
125980775|NCT01323530|453219091|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125980776|NCT01323530|453219092|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125980777|NCT01323530|453219086|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
125980778|NCT01323530|453219087|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
125980779|NCT01323530|453219088|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
125980780|NCT01323530|453219089|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
125980781|NCT01323530|453219090|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
125980782|NCT01323530|453219091|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
125980783|NCT01323530|453219092|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
125980784|NCT01323530|453219086|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125980785|NCT01323530|453219087|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125980786|NCT01323530|453219088|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125980787|NCT01323530|453219089|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125980788|NCT01323530|453219090|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125980789|NCT01323530|453219091|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125980790|NCT01323530|453219092|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
125980791|NCT01323530|453219086|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125980792|NCT01323530|453219087|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125980793|NCT01323530|453219088|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125980794|NCT01323530|453219089|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
126090725|NCT01240915|453625001|FG006|Overall Study|Insufficient Clinical Response|6|||
126090726|NCT01240915|453625002|FG007|Overall Study|Insufficient Clinical Response|0|||
126090727|NCT01240915|453625003|FG008|Overall Study|Insufficient Clinical Response|3|||
126090728|NCT02574845|453625005|FG000|Overall Study|Consent withdrawn further participation|0|||
126090729|NCT02574845|453625006|FG001|Overall Study|Consent withdrawn further participation|0|||
126090730|NCT02574845|453625007|FG002|Overall Study|Consent withdrawn further participation|0|||
126090731|NCT02574845|453625008|FG003|Overall Study|Consent withdrawn further participation|0|||
126090732|NCT02574845|453625009|FG004|Overall Study|Consent withdrawn further participation|1|||
126090733|NCT02574845|453625010|FG005|Overall Study|Consent withdrawn further participation|0|||
126090734|NCT02574845|453625005|FG000|Overall Study|Adverse Event|0|||
126090735|NCT02574845|453625006|FG001|Overall Study|Adverse Event|1|||
126090736|NCT02574845|453625007|FG002|Overall Study|Adverse Event|0|||
126090737|NCT02574845|453625008|FG003|Overall Study|Adverse Event|0|||
126090738|NCT02574845|453625009|FG004|Overall Study|Adverse Event|0|||
126090739|NCT02574845|453625010|FG005|Overall Study|Adverse Event|1|||
126090740|NCT03435692|453625012|FG000|Overall Study|Lack of Efficacy|2|||
126090741|NCT03435692|453625013|FG001|Overall Study|Lack of Efficacy|2|||
126090742|NCT03435692|453625014|FG002|Overall Study|Lack of Efficacy|0|||
126090743|NCT00821587|453625019|FG000|Overall Study|Physician Decision|0|||
126090744|NCT00821587|453625020|FG001|Overall Study|Physician Decision|1|||
126090745|NCT02906007|453625023|FG000|Overall Study|Physician Decision|0|||
126090746|NCT02906007|453625024|FG001|Overall Study|Physician Decision|0|||
126090747|NCT02906007|453625025|FG002|Overall Study|Physician Decision|1|||
126090748|NCT02906007|453625023|FG000|Overall Study|Died|1|||
126090749|NCT02906007|453625024|FG001|Overall Study|Died|0|||
126090750|NCT02906007|453625025|FG002|Overall Study|Died|0|||
126090751|NCT01946529|453625028|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
126090752|NCT01946529|453625029|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
126090753|NCT01946529|453625030|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
126090754|NCT01946529|453625028|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
126090755|NCT01946529|453625029|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
126090756|NCT01946529|453625030|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
126090757|NCT06655558|453625034|FG000|Overall Study|Protocol Violation|1|||
126090758|NCT06748729|453625043|FG000|Overall Study|Withdrawal by Subject|1|||
126090759|NCT01253135|453626798|FG000|Original Protocol|Protocol Amendment|15|||
126090760|NCT01253135|453626798|FG000|Amended Protocol|Non-compliance|1|||
126090761|NCT01901432|453626803|FG000|Overall Study|Adverse Event|0|||
126090762|NCT01901432|453626804|FG001|Overall Study|Adverse Event|1|||
126090763|NCT01901432|453626805|FG002|Overall Study|Adverse Event|1|||
126090764|NCT01901432|453626806|FG003|Overall Study|Adverse Event|0|||
126090765|NCT01901432|453626807|FG004|Overall Study|Adverse Event|1|||
126090766|NCT01901432|453626803|FG000|Overall Study|Withdrawal by Subject|0|||
126090767|NCT01901432|453626804|FG001|Overall Study|Withdrawal by Subject|0|||
126090768|NCT01901432|453626805|FG002|Overall Study|Withdrawal by Subject|1|||
126090769|NCT01901432|453626806|FG003|Overall Study|Withdrawal by Subject|0|||
126317911|NCT02450552|454454114|FG002|Overall Study|Withdrawal by Subject|4|||
126317912|NCT02450552|454454112|FG000|Overall Study|Physician Decision|1|||
126317913|NCT02450552|454454113|FG001|Overall Study|Physician Decision|0|||
126317914|NCT02450552|454454114|FG002|Overall Study|Physician Decision|1|||
126090770|NCT01901432|453626807|FG004|Overall Study|Withdrawal by Subject|5|||
126090771|NCT01901432|453626803|FG000|Overall Study|Physician Decision|0|||
126090772|NCT01901432|453626804|FG001|Overall Study|Physician Decision|0|||
126208750|NCT01023815|454053080|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
126208751|NCT01023815|454053081|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
126208752|NCT01023815|454053082|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
126208753|NCT01023815|454053083|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
126208754|NCT01023815|454053080|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
126208755|NCT01023815|454053081|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
126208756|NCT01023815|454053082|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
126208757|NCT01023815|454053083|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
126208758|NCT01023815|454053080|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
126208759|NCT01023815|454053081|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
126208760|NCT01023815|454053082|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
126208761|NCT01023815|454053083|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
126208762|NCT01023815|454053080|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
126208763|NCT01023815|454053081|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
126090773|NCT01901432|453626805|FG002|Overall Study|Physician Decision|0|||
126090774|NCT01901432|453626806|FG003|Overall Study|Physician Decision|0|||
126090775|NCT01901432|453626807|FG004|Overall Study|Physician Decision|2|||
126090776|NCT01901432|453626803|FG000|Overall Study|Patient decision to stop study drug|0|||
126090777|NCT01901432|453626804|FG001|Overall Study|Patient decision to stop study drug|0|||
126090778|NCT01901432|453626805|FG002|Overall Study|Patient decision to stop study drug|0|||
126090779|NCT01901432|453626806|FG003|Overall Study|Patient decision to stop study drug|0|||
126317915|NCT01876979|454454115|FG000|Overall Study|Physician Decision|2|||
126317916|NCT01876979|454454116|FG001|Overall Study|Physician Decision|3|||
126317917|NCT00948506|454454117|FG000|Overall Study|Withdrawal by Subject|3|||
126317918|NCT00948506|454454118|FG001|Overall Study|Withdrawal by Subject|1|||
126317919|NCT03233204|454454121|FG000|Overall Study|Adverse Event|1|||
126317920|NCT03233204|454454121|FG000|Overall Study|Death|1|||
126317921|NCT03233204|454454121|FG000|Overall Study|Withdrawal by Subject|1|||
126317922|NCT03233204|454454121|FG000|Overall Study|Progressive Disease|3|||
126317923|NCT00721279|454454122|FG000|Overall Study|Lack of Efficacy|6|||
126317924|NCT00721279|454454123|FG001|Overall Study|Lack of Efficacy|3|||
126317925|NCT00721279|454454122|FG000|Overall Study|Tolerability insufficient|5|||
126317926|NCT00721279|454454123|FG001|Overall Study|Tolerability insufficient|2|||
126317927|NCT00721279|454454122|FG000|Overall Study|Withdrawal by Subject|13|||
126317928|NCT00721279|454454123|FG001|Overall Study|Withdrawal by Subject|3|||
126317929|NCT00721279|454454122|FG000|Overall Study|Other|12|||
126317930|NCT00721279|454454123|FG001|Overall Study|Other|16|||
126317931|NCT02680834|454454124|FG000|Overall Study|Physician Decision|5|||
126317932|NCT02680834|454454125|FG001|Overall Study|Physician Decision|2|||
126317933|NCT02680834|454454124|FG000|Overall Study|Withdrawal by Subject|6|||
126317934|NCT02680834|454454125|FG001|Overall Study|Withdrawal by Subject|0|||
126317935|NCT02680834|454454124|FG000|Overall Study|Lost to Follow-up|0|||
126317936|NCT02680834|454454125|FG001|Overall Study|Lost to Follow-up|1|||
126317937|NCT03467763|454454126|FG000|Overall Study|Lost to Follow-up|1|||
126317938|NCT03467763|454454126|FG000|Overall Study|Protocol Violation|2|||
126317939|NCT04918355|454454127|FG000|Overall Study|no qualifying health encounter|497|||
126317940|NCT04918355|454454128|FG001|Overall Study|no qualifying health encounter|192|||
126317941|NCT04918355|454454129|FG002|Overall Study|no qualifying health encounter|438|||
126317942|NCT04918355|454454130|FG003|Overall Study|no qualifying health encounter|424|||
126317943|NCT00224406|454455875|FG000|Overall Study|Re-transplant|0|||
126317944|NCT00224406|454455876|FG001|Overall Study|Re-transplant|2|||
126317945|NCT00224406|454455875|FG000|Overall Study|Death|0|||
126317946|NCT00224406|454455876|FG001|Overall Study|Death|1|||
126317947|NCT00224406|454455875|FG000|Overall Study|Transplant cancelled|0|||
126317948|NCT00224406|454455876|FG001|Overall Study|Transplant cancelled|4|||
126317949|NCT00224406|454455875|FG000|Overall Study|Drug not delivered|2|||
126317950|NCT00224406|454455876|FG001|Overall Study|Drug not delivered|0|||
126317951|NCT00224406|454455875|FG000|Overall Study|Other|4|||
126317952|NCT00224406|454455876|FG001|Overall Study|Other|0|||
126317953|NCT00224406|454455875|FG000|Overall Study|Transplant cancelled|3|||
126317954|NCT00224406|454455876|FG001|Overall Study|Transplant cancelled|0|||
126317955|NCT01556997|454455877|FG000|Overall Study|Adverse Event|10|||
126317956|NCT01556997|454455878|FG001|Overall Study|Adverse Event|12|||
126317957|NCT01556997|454455879|FG002|Overall Study|Adverse Event|12|||
126317958|NCT01556997|454455877|FG000|Overall Study|Lost to Follow-up|6|||
126317959|NCT01556997|454455878|FG001|Overall Study|Lost to Follow-up|6|||
126317960|NCT01556997|454455879|FG002|Overall Study|Lost to Follow-up|4|||
126317961|NCT01556997|454455877|FG000|Overall Study|Physician Decision|1|||
126317962|NCT01556997|454455878|FG001|Overall Study|Physician Decision|1|||
126317963|NCT01556997|454455879|FG002|Overall Study|Physician Decision|1|||
126317964|NCT01556997|454455877|FG000|Overall Study|Withdrawal by Subject|7|||
126317965|NCT01556997|454455878|FG001|Overall Study|Withdrawal by Subject|6|||
126317966|NCT01556997|454455879|FG002|Overall Study|Withdrawal by Subject|8|||
126317967|NCT01556997|454455877|FG000|Overall Study|Other|2|||
126317968|NCT01556997|454455878|FG001|Overall Study|Other|3|||
125980795|NCT01323530|453219090|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125980796|NCT01323530|453219091|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
126317969|NCT01556997|454455879|FG002|Overall Study|Other|7|||
126317970|NCT03605849|454455882|FG000|Overall Study|Adverse Event|20|||
126317971|NCT03605849|454455883|FG001|Overall Study|Adverse Event|21|||
126317972|NCT03605849|454455884|FG002|Overall Study|Adverse Event|29|||
126317973|NCT03605849|454455885|FG003|Overall Study|Adverse Event|11|||
126317974|NCT03605849|454455882|FG000|Overall Study|Lack of Efficacy|4|||
126317975|NCT03605849|454455883|FG001|Overall Study|Lack of Efficacy|7|||
126317976|NCT03605849|454455884|FG002|Overall Study|Lack of Efficacy|9|||
126317977|NCT03605849|454455885|FG003|Overall Study|Lack of Efficacy|2|||
126317978|NCT03605849|454455882|FG000|Overall Study|Lost to Follow-up|8|||
125980797|NCT01323530|453219092|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
126317979|NCT03605849|454455883|FG001|Overall Study|Lost to Follow-up|8|||
126317980|NCT03605849|454455884|FG002|Overall Study|Lost to Follow-up|14|||
126317981|NCT03605849|454455885|FG003|Overall Study|Lost to Follow-up|11|||
125980798|NCT01323530|453219086|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125980799|NCT01323530|453219087|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125980800|NCT01323530|453219088|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125980801|NCT01323530|453219089|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125980802|NCT01323530|453219090|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125980803|NCT01323530|453219091|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125980804|NCT01323530|453219092|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
126317982|NCT03605849|454455882|FG000|Overall Study|Non-compliance With IMP|6|||
126317983|NCT03605849|454455883|FG001|Overall Study|Non-compliance With IMP|5|||
126317984|NCT03605849|454455884|FG002|Overall Study|Non-compliance With IMP|2|||
126317985|NCT03605849|454455885|FG003|Overall Study|Non-compliance With IMP|1|||
126317986|NCT03605849|454455882|FG000|Overall Study|Protocol Deviation|1|||
126317987|NCT03605849|454455883|FG001|Overall Study|Protocol Deviation|2|||
126317988|NCT03605849|454455884|FG002|Overall Study|Protocol Deviation|1|||
126317989|NCT03605849|454455885|FG003|Overall Study|Protocol Deviation|3|||
126317990|NCT03605849|454455882|FG000|Overall Study|Withdrawal by Subject|33|||
126317991|NCT03605849|454455883|FG001|Overall Study|Withdrawal by Subject|28|||
126317992|NCT03605849|454455884|FG002|Overall Study|Withdrawal by Subject|30|||
126317993|NCT03605849|454455885|FG003|Overall Study|Withdrawal by Subject|28|||
126317994|NCT03605849|454455882|FG000|Overall Study|Site Terminated by Sponsor|0|||
126317995|NCT03605849|454455883|FG001|Overall Study|Site Terminated by Sponsor|0|||
126317996|NCT03605849|454455884|FG002|Overall Study|Site Terminated by Sponsor|0|||
126317997|NCT03605849|454455885|FG003|Overall Study|Site Terminated by Sponsor|1|||
126317998|NCT03605849|454455882|FG000|Overall Study|Physician Decision|2|||
126317999|NCT03605849|454455883|FG001|Overall Study|Physician Decision|1|||
126318000|NCT03605849|454455884|FG002|Overall Study|Physician Decision|2|||
126090780|NCT01901432|453626807|FG004|Overall Study|Patient decision to stop study drug|1|||
126090781|NCT00379288|453626810|FG000|Overall Study|Adverse Event|5|||
126090782|NCT00379288|453626811|FG001|Overall Study|Adverse Event|6|||
126090783|NCT00379288|453626812|FG002|Overall Study|Adverse Event|2|||
126090784|NCT00379288|453626813|FG003|Overall Study|Adverse Event|0|||
126090785|NCT00379288|453626810|FG000|Overall Study|Treatment Failure|0|||
126090786|NCT00379288|453626811|FG001|Overall Study|Treatment Failure|1|||
126090787|NCT00379288|453626812|FG002|Overall Study|Treatment Failure|0|||
126090788|NCT00379288|453626813|FG003|Overall Study|Treatment Failure|1|||
126090789|NCT00379288|453626810|FG000|Overall Study|Lost to Follow-up|3|||
126090790|NCT00379288|453626811|FG001|Overall Study|Lost to Follow-up|3|||
126318001|NCT03605849|454455885|FG003|Overall Study|Physician Decision|1|||
126318002|NCT03605849|454455882|FG000|Overall Study|Enrolled, but not Treated|2|||
126318003|NCT03605849|454455883|FG001|Overall Study|Enrolled, but not Treated|2|||
126318004|NCT03605849|454455884|FG002|Overall Study|Enrolled, but not Treated|3|||
126318005|NCT03605849|454455885|FG003|Overall Study|Enrolled, but not Treated|2|||
126318006|NCT03605849|454455882|FG000|Overall Study|Other (COVID-19 Related)|0|||
126318007|NCT03605849|454455883|FG001|Overall Study|Other (COVID-19 Related)|1|||
126318008|NCT03605849|454455884|FG002|Overall Study|Other (COVID-19 Related)|1|||
126318009|NCT03605849|454455885|FG003|Overall Study|Other (COVID-19 Related)|0|||
126318010|NCT03605849|454455882|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
126318011|NCT03605849|454455883|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
126318012|NCT03605849|454455884|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
126318013|NCT03605849|454455885|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
126318014|NCT01149421|454455887|FG000|Overall Study|Adverse Event|22|||
126318015|NCT01149421|454455888|FG001|Overall Study|Adverse Event|6|||
126318016|NCT01149421|454455889|FG002|Overall Study|Adverse Event|11|||
126318017|NCT01149421|454455887|FG000|Overall Study|Withdrawal by Subject|20|||
126318018|NCT01149421|454455888|FG001|Overall Study|Withdrawal by Subject|12|||
126318019|NCT01149421|454455889|FG002|Overall Study|Withdrawal by Subject|13|||
126318020|NCT01149421|454455887|FG000|Overall Study|Sponsor Decision|0|||
126318021|NCT01149421|454455888|FG001|Overall Study|Sponsor Decision|1|||
126318022|NCT01149421|454455889|FG002|Overall Study|Sponsor Decision|1|||
126318023|NCT01149421|454455887|FG000|Overall Study|Lost to Follow-up|2|||
126318024|NCT01149421|454455888|FG001|Overall Study|Lost to Follow-up|4|||
126318025|NCT01149421|454455889|FG002|Overall Study|Lost to Follow-up|5|||
126318026|NCT01149421|454455887|FG000|Overall Study|Physician Decision|5|||
126318027|NCT01149421|454455888|FG001|Overall Study|Physician Decision|3|||
126318028|NCT01149421|454455889|FG002|Overall Study|Physician Decision|6|||
126318029|NCT01149421|454455887|FG000|Overall Study|Entry Criteria Not Met|1|||
126318030|NCT01149421|454455888|FG001|Overall Study|Entry Criteria Not Met|1|||
126318031|NCT01149421|454455889|FG002|Overall Study|Entry Criteria Not Met|2|||
126318032|NCT01149421|454455887|FG000|Overall Study|Protocol Violation|2|||
126318033|NCT01149421|454455888|FG001|Overall Study|Protocol Violation|2|||
126318034|NCT01149421|454455889|FG002|Overall Study|Protocol Violation|6|||
126318035|NCT00616603|454455890|FG000|Overall Study|Physician Decision|2|||
126318036|NCT00616603|454455891|FG001|Overall Study|Physician Decision|0|||
126090791|NCT00379288|453626812|FG002|Overall Study|Lost to Follow-up|2|||
126090792|NCT00379288|453626813|FG003|Overall Study|Lost to Follow-up|0|||
126090793|NCT00379288|453626810|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
126090794|NCT00379288|453626811|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
126090795|NCT00379288|453626812|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
126090796|NCT00379288|453626813|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
126090797|NCT00379288|453626810|FG000|Overall Study|Subject withdrew-related to study drug|1|||
126318037|NCT00616603|454455892|FG002|Overall Study|Physician Decision|2|||
126318038|NCT03738800|454455895|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
126318039|NCT03738800|454455896|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126090798|NCT00379288|453626811|FG001|Overall Study|Subject withdrew-related to study drug|0|||
126090799|NCT00379288|453626812|FG002|Overall Study|Subject withdrew-related to study drug|0|||
126090800|NCT00379288|453626813|FG003|Overall Study|Subject withdrew-related to study drug|1|||
126090801|NCT00379288|453626810|FG000|Overall Study|Noncompliance with protocol|8|||
126090802|NCT00379288|453626811|FG001|Overall Study|Noncompliance with protocol|6|||
126090803|NCT00379288|453626812|FG002|Overall Study|Noncompliance with protocol|2|||
126090804|NCT00379288|453626813|FG003|Overall Study|Noncompliance with protocol|1|||
126090805|NCT00379288|453626810|FG000|Overall Study|Did not meet protocol eligibility|0|||
126090806|NCT00379288|453626811|FG001|Overall Study|Did not meet protocol eligibility|1|||
126090807|NCT00379288|453626812|FG002|Overall Study|Did not meet protocol eligibility|0|||
126090808|NCT00379288|453626813|FG003|Overall Study|Did not meet protocol eligibility|2|||
126090809|NCT00379288|453626810|FG000|Overall Study|Administrative|2|||
126090810|NCT00379288|453626811|FG001|Overall Study|Administrative|2|||
126090811|NCT00379288|453626812|FG002|Overall Study|Administrative|0|||
126090812|NCT00379288|453626813|FG003|Overall Study|Administrative|1|||
126090813|NCT00918879|453626814|FG000|Overall Study|Withdrawal by Subject|4|||
126090814|NCT00918879|453626815|FG001|Overall Study|Withdrawal by Subject|4|||
126090815|NCT00918879|453626814|FG000|Overall Study|Lost to Follow-up|1|||
126090816|NCT00918879|453626815|FG001|Overall Study|Lost to Follow-up|1|||
126090817|NCT00918879|453626814|FG000|Overall Study|Severe non-compliance to protocol|1|||
125980805|NCT01323530|453219086|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125980806|NCT01323530|453219087|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125980807|NCT01323530|453219088|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125980808|NCT01323530|453219089|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125980809|NCT01323530|453219090|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125980810|NCT01323530|453219091|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125980811|NCT01323530|453219092|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
125980812|NCT01323530|453219086|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125980813|NCT01323530|453219087|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125980814|NCT01323530|453219088|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125980815|NCT01323530|453219089|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125980816|NCT01323530|453219090|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125980817|NCT01323530|453219091|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125980818|NCT01323530|453219092|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
125980819|NCT01111123|453219093|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
125980820|NCT01111123|453219094|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
125980821|NCT01111123|453219093|FG000|Maintenance Phase|Lost to Follow-up|0|||
125980822|NCT01111123|453219094|FG001|Maintenance Phase|Lost to Follow-up|2|||
125980823|NCT00119405|453219095|FG000|Overall Study|Withdrawal by Subject|1|||
125980824|NCT01332227|453219104|FG000|Overall Study|Adverse Event|4|||
125980825|NCT01332227|453219105|FG001|Overall Study|Adverse Event|1|||
125980826|NCT01332227|453219104|FG000|Overall Study|Withdrawal by Subject|5|||
125980827|NCT01332227|453219105|FG001|Overall Study|Withdrawal by Subject|1|||
125980828|NCT01332227|453219104|FG000|Overall Study|Lost to Follow-up|2|||
125980829|NCT01332227|453219105|FG001|Overall Study|Lost to Follow-up|0|||
125980830|NCT01332227|453219104|FG000|Overall Study|Lack of Efficacy|3|||
125980831|NCT01332227|453219105|FG001|Overall Study|Lack of Efficacy|1|||
125980832|NCT01332227|453219104|FG000|Overall Study|Poor compliance/noncompliance|1|||
125980833|NCT01332227|453219105|FG001|Overall Study|Poor compliance/noncompliance|1|||
125980834|NCT01332227|453219104|FG000|Overall Study|Patient moved from area|1|||
125980835|NCT01332227|453219105|FG001|Overall Study|Patient moved from area|0|||
125980836|NCT01332227|453219104|FG000|Overall Study|Patient began prohibited medication|0|||
125980837|NCT01332227|453219105|FG001|Overall Study|Patient began prohibited medication|1|||
125980838|NCT00514943|453219106|FG000|Stage 1|Progressive disease|4|||
125980839|NCT00514943|453219107|FG001|Stage 1|Progressive disease|8|||
126090818|NCT00918879|453626815|FG001|Overall Study|Severe non-compliance to protocol|1|||
126090819|NCT00833261|453626818|FG000|Overall Study|Withdrawal by Subject|4|||
126090820|NCT00357110|453626819|FG000|Overall Study|Early study termination|5|||
126090821|NCT00357110|453626820|FG001|Overall Study|Early study termination|5|||
126090822|NCT05602727|453626823|FG000|Overall Study|Physician Decision|0|||
126090823|NCT05602727|453626824|FG001|Overall Study|Physician Decision|1|||
126090824|NCT05602727|453626825|FG002|Overall Study|Physician Decision|0|||
126090825|NCT05602727|453626823|FG000|Overall Study|Randomized by mistake without study medication|1|||
125980840|NCT00514943|453219106|FG000|Stage 1|Other Adverse Event|16|||
125980841|NCT00514943|453219107|FG001|Stage 1|Other Adverse Event|6|||
125980842|NCT00514943|453219106|FG000|Stage 1|Not treated|1|||
125980843|NCT00514943|453219107|FG001|Stage 1|Not treated|2|||
126090826|NCT05602727|453626824|FG001|Overall Study|Randomized by mistake without study medication|0|||
126090827|NCT05602727|453626825|FG002|Overall Study|Randomized by mistake without study medication|0|||
126090828|NCT05602727|453626823|FG000|Overall Study|Study termination by Sponsor|18|||
126090829|NCT05602727|453626824|FG001|Overall Study|Study termination by Sponsor|15|||
126090830|NCT05602727|453626825|FG002|Overall Study|Study termination by Sponsor|19|||
126090831|NCT05602727|453626823|FG000|Overall Study|Withdrawal by Subject|2|||
125980844|NCT00514943|453219106|FG000|Stage 1|Patient refused to continue study meds|8|||
125980845|NCT00514943|453219107|FG001|Stage 1|Patient refused to continue study meds|3|||
125980846|NCT00514943|453219106|FG000|Stage 1|Other than stated above|1|||
125980847|NCT00514943|453219107|FG001|Stage 1|Other than stated above|7|||
125980848|NCT00514943|453219106|FG000|Stage 2|Progressive disease|27|||
125980849|NCT00514943|453219107|FG001|Stage 2|Progressive disease|24|||
125980850|NCT00514943|453219106|FG000|Stage 2|Other Adverse Event|3|||
125980851|NCT00514943|453219107|FG001|Stage 2|Other Adverse Event|10|||
125980852|NCT00514943|453219106|FG000|Stage 2|Patient refused to continue study meds|2|||
125980853|NCT00514943|453219107|FG001|Stage 2|Patient refused to continue study meds|0|||
125980854|NCT00514943|453219106|FG000|Stage 2|Other than stated above|0|||
125980855|NCT00514943|453219107|FG001|Stage 2|Other than stated above|2|||
125980856|NCT02173548|453219112|FG000|Overall Study|Lost to Follow-up|0|||
125980857|NCT02173548|453219113|FG001|Overall Study|Lost to Follow-up|2|||
125980858|NCT02173548|453219112|FG000|Overall Study|Withdrawal by Subject|1|||
125980859|NCT02173548|453219113|FG001|Overall Study|Withdrawal by Subject|0|||
125980860|NCT02066402|453219116|FG000|Overall Study|Adverse Event|1|||
125980861|NCT02066402|453219117|FG001|Overall Study|Adverse Event|2|||
125980862|NCT02066402|453219116|FG000|Overall Study|Lost to Follow-up|11|||
125980863|NCT02066402|453219117|FG001|Overall Study|Lost to Follow-up|8|||
125980864|NCT02066402|453219116|FG000|Overall Study|Withdrawal by Subject|14|||
125980865|NCT02066402|453219117|FG001|Overall Study|Withdrawal by Subject|11|||
125980866|NCT02066402|453219116|FG000|Overall Study|Progressive disease-clinical progression|0|||
125980867|NCT02066402|453219117|FG001|Overall Study|Progressive disease-clinical progression|1|||
125980868|NCT02066402|453219116|FG000|Overall Study|Protocol driven decision point|0|||
125980869|NCT02066402|453219117|FG001|Overall Study|Protocol driven decision point|1|||
125980870|NCT01505387|453219118|FG000|Overall Study|Protocol Violation|1|||
125980871|NCT01505387|453219119|FG001|Overall Study|Protocol Violation|0|||
125980872|NCT01505387|453219118|FG000|Overall Study|Withdrawal by Subject|1|||
125980873|NCT01505387|453219119|FG001|Overall Study|Withdrawal by Subject|1|||
125980874|NCT04493931|453219121|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
125980875|NCT04493931|453219122|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125980876|NCT04493931|453219123|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125980877|NCT04493931|453219124|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125980878|NCT04493931|453219125|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
126090832|NCT05602727|453626824|FG001|Overall Study|Withdrawal by Subject|1|||
126090833|NCT05602727|453626825|FG002|Overall Study|Withdrawal by Subject|1|||
126090834|NCT05602727|453626823|FG000|Overall Study|Various reasons|1|||
126090835|NCT05602727|453626824|FG001|Overall Study|Various reasons|6|||
126090836|NCT05602727|453626825|FG002|Overall Study|Various reasons|1|||
126090837|NCT03889704|453626826|FG000|Overall Study|Study terminated due to pandemic|1|||
126090838|NCT03482466|453626827|FG000|Overall Study|Protocol Violation|2|||
126090839|NCT02060370|453626832|FG000|Overall Study|Physician Decision|1|||
126090840|NCT01493427|453626833|FG000|Overall Study|Adverse Event|10|||
126090841|NCT01493427|453626833|FG000|Overall Study|Personal Reasons|4|||
126090842|NCT01493427|453626833|FG000|Overall Study|Lost to Follow-up|2|||
126090843|NCT01493427|453626833|FG000|Overall Study|Inability to Follow Instructions|2|||
126090844|NCT01493427|453626833|FG000|Overall Study|Other|2|||
126090845|NCT01461811|453626834|FG000|Overall Study|Adverse Event|2|||
126090846|NCT01461811|453626835|FG001|Overall Study|Adverse Event|1|||
126090847|NCT01461811|453626834|FG000|Overall Study|Subject decision unrelated to an AE|1|||
126090848|NCT01461811|453626835|FG001|Overall Study|Subject decision unrelated to an AE|1|||
126090849|NCT01461811|453626834|FG000|Overall Study|Noncompliance|1|||
126090850|NCT01461811|453626835|FG001|Overall Study|Noncompliance|1|||
126090851|NCT02781090|453626836|FG000|3-Month Follow-Up|Missed Visit|20|||
126090852|NCT02781090|453626837|FG001|3-Month Follow-Up|Missed Visit|20|||
126318040|NCT03738800|454455897|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126318041|NCT03738800|454455895|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
125980879|NCT04493931|453219126|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
126090853|NCT02781090|453626836|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
126090854|NCT02781090|453626837|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
126090855|NCT02781090|453626836|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
126318042|NCT03738800|454455896|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
126318043|NCT03738800|454455897|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
126318044|NCT03738800|454455895|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
126318045|NCT03738800|454455896|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
126318046|NCT03738800|454455897|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
126318047|NCT00766467|454455907|FG000|Overall Study|Withdrawal by Subject|7|||
126318048|NCT00766467|454455908|FG001|Overall Study|Withdrawal by Subject|2|||
126318049|NCT00766467|454455907|FG000|Overall Study|Adverse Event|1|||
125980880|NCT04493931|453219127|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125980881|NCT04493931|453219121|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125980882|NCT04493931|453219122|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
126318050|NCT00766467|454455908|FG001|Overall Study|Adverse Event|1|||
126090856|NCT02781090|453626837|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
126090857|NCT02781090|453626836|FG000|3-Month Follow-Up|Death|1|||
126090858|NCT02781090|453626837|FG001|3-Month Follow-Up|Death|0|||
126090859|NCT02781090|453626836|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
126090860|NCT02781090|453626837|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
126090861|NCT02781090|453626836|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
126090862|NCT02781090|453626837|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
126090863|NCT02781090|453626836|FG000|6-Month Follow-Up|Death|0|||
126090864|NCT02781090|453626837|FG001|6-Month Follow-Up|Death|1|||
126090865|NCT01712061|453626838|FG000|Overall Study|Adverse Event|4|||
126090866|NCT01712061|453626839|FG001|Overall Study|Adverse Event|9|||
126090867|NCT01712061|453626840|FG002|Overall Study|Adverse Event|5|||
126090868|NCT01712061|453626838|FG000|Overall Study|Death|0|||
126090869|NCT01712061|453626839|FG001|Overall Study|Death|0|||
126090870|NCT01712061|453626840|FG002|Overall Study|Death|1|||
126090871|NCT01712061|453626838|FG000|Overall Study|Lost to Follow-up|1|||
126090872|NCT01712061|453626839|FG001|Overall Study|Lost to Follow-up|0|||
126090873|NCT01712061|453626840|FG002|Overall Study|Lost to Follow-up|1|||
126090874|NCT01712061|453626838|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
126090875|NCT01712061|453626839|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
126090876|NCT01712061|453626840|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
126090877|NCT01712061|453626838|FG000|Overall Study|Medication Error Without Associated AE|0|||
126090878|NCT01712061|453626839|FG001|Overall Study|Medication Error Without Associated AE|1|||
126090879|NCT01712061|453626840|FG002|Overall Study|Medication Error Without Associated AE|0|||
126090880|NCT01712061|453626838|FG000|Overall Study|Withdrawal by Subject|1|||
126090881|NCT01712061|453626839|FG001|Overall Study|Withdrawal by Subject|7|||
126090882|NCT01712061|453626840|FG002|Overall Study|Withdrawal by Subject|1|||
126090883|NCT01712061|453626838|FG000|Overall Study|Other|0|||
126090884|NCT01712061|453626839|FG001|Overall Study|Other|3|||
126090885|NCT01712061|453626840|FG002|Overall Study|Other|0|||
126090886|NCT00879775|453626843|FG000|Overall Study|Lost to Follow-up|2|||
126090887|NCT00879775|453626844|FG001|Overall Study|Lost to Follow-up|1|||
126090888|NCT01195623|453626845|FG000|Overall Study|Lost to Follow-up|35|||
126318051|NCT00766467|454455907|FG000|Overall Study|Protocol Violation|2|||
126318052|NCT00766467|454455908|FG001|Overall Study|Protocol Violation|4|||
126318053|NCT00766467|454455907|FG000|Overall Study|Tumor Progression on Study|0|||
126318054|NCT00766467|454455908|FG001|Overall Study|Tumor Progression on Study|1|||
126318055|NCT00766467|454455907|FG000|Overall Study|Physician Decision|1|||
126318056|NCT00766467|454455908|FG001|Overall Study|Physician Decision|0|||
126318057|NCT02223819|454455914|FG000|Overall Study|Lost to Follow-up|2|||
126318058|NCT01420679|454455921|FG000|Overall Study|Disease Progression|3|||
126318059|NCT01420679|454455922|FG001|Overall Study|Disease Progression|2|||
126318060|NCT01420679|454455921|FG000|Overall Study|Adverse Event|4|||
126318061|NCT01420679|454455922|FG001|Overall Study|Adverse Event|0|||
126318062|NCT01420679|454455921|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
126318063|NCT01420679|454455922|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
126318064|NCT01420679|454455921|FG000|Overall Study|Patient Decision|1|||
126318065|NCT01420679|454455922|FG001|Overall Study|Patient Decision|0|||
126318066|NCT01420679|454455921|FG000|Overall Study|Investigator Decision|1|||
126318067|NCT01420679|454455922|FG001|Overall Study|Investigator Decision|2|||
126318068|NCT01420679|454455921|FG000|Overall Study|Sponsor Decision|3|||
126318069|NCT01420679|454455922|FG001|Overall Study|Sponsor Decision|3|||
126318070|NCT01420679|454455921|FG000|Overall Study|Other|1|||
126318071|NCT01420679|454455922|FG001|Overall Study|Other|0|||
126318072|NCT00367484|454455923|FG000|Overall Study|Adverse Event|7|||
126318073|NCT00367484|454455923|FG000|Overall Study|Withdrew informed consent|5|||
126318074|NCT00367484|454455923|FG000|Overall Study|Travel to USA|1|||
126090889|NCT01195623|453626846|FG001|Overall Study|Lost to Follow-up|37|||
126090890|NCT01401153|453626848|FG000|First Test Day|Learning disabilities; illness|1|||
126090891|NCT01401153|453626849|FG001|First Test Day|Learning disabilities; illness|10|||
126090892|NCT01401153|453626848|FG000|Second Test Day|illness|0|||
126090893|NCT01401153|453626849|FG001|Second Test Day|illness|5|||
126318075|NCT00367484|454455923|FG000|Overall Study|Lost to Follow-up|1|||
126090894|NCT01677767|453626850|FG000|Overall Study|Adverse Event|1|||
126090895|NCT01677767|453626850|FG000|Overall Study|Death|4|||
126090896|NCT01677767|453626850|FG000|Overall Study|Protocol Violation|4|||
126090897|NCT01677767|453626850|FG000|Overall Study|Withdrawal by Subject|10|||
126090898|NCT01677767|453626850|FG000|Overall Study|Non-compliance by the participants|3|||
126090899|NCT00757627|453626851|FG000|Overall Study|Adverse Event|15|||
126090900|NCT00757627|453626851|FG000|Overall Study|Lack of Efficacy|10|||
126090901|NCT00757627|453626851|FG000|Overall Study|Lost to Follow-up|28|||
126090902|NCT00757627|453626851|FG000|Overall Study|Withdrawal by Subject|27|||
126090903|NCT00757627|453626851|FG000|Overall Study|Other|1|||
126090904|NCT03846453|453626852|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
126090905|NCT03846453|453626853|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
126090906|NCT03846453|453626854|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
126318076|NCT00367484|454455923|FG000|Overall Study|Protocol Violation|1|||
125980883|NCT04493931|453219123|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125980884|NCT04493931|453219124|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125980885|NCT04493931|453219125|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
126208764|NCT01023815|454053082|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
126208765|NCT01023815|454053083|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
126208766|NCT03253809|454053086|FG000|Overall Study|Unable to obtain study related data|14|||
126208767|NCT03992456|454053087|FG000|Overall Study|Withdrawal by Subject|1|||
126208768|NCT03992456|454053088|FG001|Overall Study|Withdrawal by Subject|0|||
126208769|NCT03992456|454053087|FG000|Overall Study|Disease progression|4|||
126208770|NCT03992456|454053088|FG001|Overall Study|Disease progression|5|||
126208771|NCT03992456|454053087|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
126208772|NCT03992456|454053088|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
126208773|NCT02594384|454053089|FG000|Overall Study|Disease Progression|3|||
126208774|NCT02594384|454053090|FG001|Overall Study|Disease Progression|7|||
126208775|NCT02594384|454053091|FG002|Overall Study|Disease Progression|0|||
126208776|NCT02594384|454053092|FG003|Overall Study|Disease Progression|2|||
126208777|NCT02594384|454053093|FG004|Overall Study|Disease Progression|2|||
126208778|NCT02594384|454053094|FG005|Overall Study|Disease Progression|12|||
126208779|NCT02594384|454053095|FG006|Overall Study|Disease Progression|5|||
126208780|NCT02594384|454053096|FG007|Overall Study|Disease Progression|5|||
126208781|NCT02594384|454053089|FG000|Overall Study|Adverse Event|0|||
126208782|NCT02594384|454053090|FG001|Overall Study|Adverse Event|1|||
126208783|NCT02594384|454053091|FG002|Overall Study|Adverse Event|4|||
126208784|NCT02594384|454053092|FG003|Overall Study|Adverse Event|1|||
126208785|NCT02594384|454053093|FG004|Overall Study|Adverse Event|0|||
126208786|NCT02594384|454053094|FG005|Overall Study|Adverse Event|6|||
126208787|NCT02594384|454053095|FG006|Overall Study|Adverse Event|1|||
126208788|NCT02594384|454053096|FG007|Overall Study|Adverse Event|1|||
126208789|NCT02594384|454053089|FG000|Overall Study|Withdrawal by Subject|0|||
126208790|NCT02594384|454053090|FG001|Overall Study|Withdrawal by Subject|0|||
126208791|NCT02594384|454053091|FG002|Overall Study|Withdrawal by Subject|0|||
126208792|NCT02594384|454053092|FG003|Overall Study|Withdrawal by Subject|1|||
126208793|NCT02594384|454053093|FG004|Overall Study|Withdrawal by Subject|0|||
126208794|NCT02594384|454053094|FG005|Overall Study|Withdrawal by Subject|0|||
126208795|NCT02594384|454053095|FG006|Overall Study|Withdrawal by Subject|0|||
126208796|NCT02594384|454053096|FG007|Overall Study|Withdrawal by Subject|1|||
126208797|NCT02594384|454053089|FG000|Overall Study|Physician Decision|0|||
126208798|NCT02594384|454053090|FG001|Overall Study|Physician Decision|0|||
126208799|NCT02594384|454053091|FG002|Overall Study|Physician Decision|0|||
126208800|NCT02594384|454053092|FG003|Overall Study|Physician Decision|0|||
126208801|NCT02594384|454053093|FG004|Overall Study|Physician Decision|0|||
126208802|NCT02594384|454053094|FG005|Overall Study|Physician Decision|1|||
126208803|NCT02594384|454053095|FG006|Overall Study|Physician Decision|2|||
126208804|NCT02594384|454053096|FG007|Overall Study|Physician Decision|0|||
126208805|NCT02594384|454053089|FG000|Overall Study|Progressive Leukocytosis|0|||
126208806|NCT02594384|454053090|FG001|Overall Study|Progressive Leukocytosis|0|||
126208807|NCT02594384|454053091|FG002|Overall Study|Progressive Leukocytosis|1|||
126208808|NCT02594384|454053092|FG003|Overall Study|Progressive Leukocytosis|0|||
126208809|NCT02594384|454053093|FG004|Overall Study|Progressive Leukocytosis|0|||
126208810|NCT02594384|454053094|FG005|Overall Study|Progressive Leukocytosis|0|||
126208811|NCT02594384|454053095|FG006|Overall Study|Progressive Leukocytosis|0|||
126208812|NCT02594384|454053096|FG007|Overall Study|Progressive Leukocytosis|0|||
126208813|NCT02594384|454053089|FG000|Overall Study|Lack of Efficacy|0|||
126208814|NCT02594384|454053090|FG001|Overall Study|Lack of Efficacy|0|||
126208815|NCT02594384|454053091|FG002|Overall Study|Lack of Efficacy|0|||
126208816|NCT02594384|454053092|FG003|Overall Study|Lack of Efficacy|0|||
126208817|NCT02594384|454053093|FG004|Overall Study|Lack of Efficacy|1|||
126208818|NCT02594384|454053094|FG005|Overall Study|Lack of Efficacy|0|||
126208819|NCT02594384|454053095|FG006|Overall Study|Lack of Efficacy|0|||
126208820|NCT02594384|454053096|FG007|Overall Study|Lack of Efficacy|0|||
126208821|NCT02594384|454053089|FG000|Overall Study|Substantial noncompliance|0|||
126208822|NCT02594384|454053090|FG001|Overall Study|Substantial noncompliance|0|||
125980886|NCT04493931|453219126|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
126208823|NCT02594384|454053091|FG002|Overall Study|Substantial noncompliance|0|||
126208824|NCT02594384|454053092|FG003|Overall Study|Substantial noncompliance|0|||
126208825|NCT02594384|454053093|FG004|Overall Study|Substantial noncompliance|0|||
126208826|NCT02594384|454053094|FG005|Overall Study|Substantial noncompliance|0|||
126208827|NCT02594384|454053095|FG006|Overall Study|Substantial noncompliance|1|||
126208828|NCT02594384|454053096|FG007|Overall Study|Substantial noncompliance|0|||
126208829|NCT03919669|454053099|FG000|Overall Study|Withdrawal by Subject|1|||
126208830|NCT03919669|454053100|FG001|Overall Study|Withdrawal by Subject|0|||
126208831|NCT03919669|454053101|FG002|Overall Study|Withdrawal by Subject|0|||
126208832|NCT04964960|454053102|FG000|Overall Study|Withdrawal by Subject|1|||
126208833|NCT02319642|454053103|FG000|Overall Study|Adverse Event|2|||
126208834|NCT02319642|454053104|FG001|Overall Study|Adverse Event|4|||
126208835|NCT02319642|454053103|FG000|Overall Study|Lack of Efficacy|1|||
126208836|NCT02319642|454053104|FG001|Overall Study|Lack of Efficacy|1|||
126090907|NCT03846453|453626852|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
126090908|NCT03846453|453626853|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
126090909|NCT03846453|453626854|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
126090910|NCT03846453|453626852|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
126090911|NCT03846453|453626853|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
126090912|NCT03846453|453626854|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
126090913|NCT03846453|453626852|FG000|Placebo Run-in (14 Days)|Other|2|||
126318077|NCT00367484|454455923|FG000|Overall Study|The choice of the patient|1|||
126318078|NCT00367484|454455923|FG000|Overall Study|Lack of Efficacy|1|||
126090914|NCT03846453|453626853|FG001|Placebo Run-in (14 Days)|Other|0|||
126090915|NCT03846453|453626854|FG002|Placebo Run-in (14 Days)|Other|0|||
126090916|NCT03846453|453626852|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
126090917|NCT03846453|453626853|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
125980887|NCT04493931|453219127|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125980888|NCT04493931|453219121|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125980889|NCT04493931|453219122|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
125980890|NCT04493931|453219123|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125980891|NCT04493931|453219124|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125980892|NCT04493931|453219125|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125980893|NCT04493931|453219126|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125980894|NCT04493931|453219127|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125980895|NCT04493931|453219121|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125980896|NCT04493931|453219122|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125980897|NCT04493931|453219123|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
125980898|NCT04493931|453219124|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125980899|NCT04493931|453219125|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125980900|NCT04493931|453219126|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125980901|NCT04493931|453219127|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125980902|NCT01281644|453219128|FG000|Overall Study|Lost to Follow-up|3|||
125980903|NCT01281644|453219128|FG000|Overall Study|Withdrawal by Subject|2|||
125980904|NCT00611858|453219129|FG000|Overall Study|Adverse Event|2|||
125980905|NCT00611858|453219129|FG000|Overall Study|Withdrawal by Subject|2|||
125980906|NCT01844284|453219130|FG000|Overall Study|Lost to Follow-up|12|||
125980907|NCT01844284|453219131|FG001|Overall Study|Lost to Follow-up|7|||
125980908|NCT02755597|453219132|FG000|Overall Study|Withdrew consent|27|||
125980909|NCT02755597|453219133|FG001|Overall Study|Withdrew consent|11|||
125980910|NCT02755597|453219132|FG000|Overall Study|Lost to Follow-up|1|||
125980911|NCT02755597|453219133|FG001|Overall Study|Lost to Follow-up|0|||
125980912|NCT02755597|453219132|FG000|Overall Study|Death|78|||
125980913|NCT02755597|453219133|FG001|Overall Study|Death|36|||
125980914|NCT02755597|453219132|FG000|Overall Study|Study terminated by Sponsor|67|||
125980915|NCT02755597|453219133|FG001|Overall Study|Study terminated by Sponsor|47|||
125980916|NCT02755597|453219132|FG000|Overall Study|Other, not specified|20|||
125980917|NCT02755597|453219133|FG001|Overall Study|Other, not specified|3|||
125980918|NCT02755597|453219132|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
125980919|NCT02755597|453219133|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
125980920|NCT00594854|453219135|FG000|Overall Study|Study terminated|7|||
126090918|NCT03846453|453626854|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
126090919|NCT03846453|453626852|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
126090920|NCT03846453|453626853|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
126090921|NCT03846453|453626854|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
126090922|NCT03846453|453626852|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
126090923|NCT03846453|453626853|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
126090924|NCT03846453|453626854|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
126090925|NCT03846453|453626852|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
126090926|NCT03846453|453626853|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
126090927|NCT03846453|453626854|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
126090928|NCT03846453|453626852|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
126090929|NCT03846453|453626853|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
126318079|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
126318080|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
126318081|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
126318082|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
126318083|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
126318084|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
126318085|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
126318086|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
125980921|NCT00594854|453219136|FG001|Overall Study|Study terminated|10|||
126318087|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
126318088|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
126318089|NCT03956615|454455925|FG000|Overall Study|No multiple myeloma confirmed|2|||
126318090|NCT03956615|454455925|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
126318091|NCT03956615|454455925|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
126318092|NCT03956615|454455925|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
126318093|NCT04472026|454455926|FG000|Overall Study|Lost to Follow-up|5|||
125980922|NCT03172702|453219137|FG000|Overall Study|Adverse Event|9|||
125980923|NCT03172702|453219137|FG000|Overall Study|Death|2|||
125980924|NCT03172702|453219137|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
125980925|NCT03172702|453219137|FG000|Overall Study|Withdrawal by Subject|5|||
125980926|NCT03172702|453219137|FG000|Overall Study|Other|2|||
125980927|NCT06134180|453219138|FG000|Overall Study|Lost to Follow-up|4|||
125980928|NCT02152982|453219139|FG000|Overall Study|Ineligible|4|||
125980929|NCT02152982|453219140|FG001|Overall Study|Ineligible|4|||
125980930|NCT02152982|453219139|FG000|Overall Study|Did not start treatment|12|||
125980931|NCT02152982|453219140|FG001|Overall Study|Did not start treatment|6|||
125980932|NCT02782169|453219146|FG000|Overall Study|Lost to Follow-up|1|||
125980933|NCT02782169|453219147|FG001|Overall Study|Lost to Follow-up|2|||
125980934|NCT02975973|453219148|FG000|Overall Study|Adverse Event|1|||
125980935|NCT02975973|453219149|FG001|Overall Study|Adverse Event|1|||
125980936|NCT02975973|453219150|FG002|Overall Study|Adverse Event|1|||
125980937|NCT02975973|453219151|FG003|Overall Study|Adverse Event|0|||
125980938|NCT00771810|453219152|FG000|Overall Study|Adverse Event|3|||
125980939|NCT00771810|453219153|FG001|Overall Study|Adverse Event|0|||
125980940|NCT00771810|453219154|FG002|Overall Study|Adverse Event|2|||
125980941|NCT00771810|453219152|FG000|Overall Study|Lost to Follow-up|0|||
125980942|NCT00771810|453219153|FG001|Overall Study|Lost to Follow-up|0|||
125980943|NCT00771810|453219154|FG002|Overall Study|Lost to Follow-up|1|||
125980944|NCT00771810|453219152|FG000|Overall Study|Physician Decision|1|||
125980945|NCT00771810|453219153|FG001|Overall Study|Physician Decision|2|||
125980946|NCT00771810|453219154|FG002|Overall Study|Physician Decision|2|||
125980947|NCT00771810|453219152|FG000|Overall Study|Protocol Violation|0|||
125980948|NCT00771810|453219153|FG001|Overall Study|Protocol Violation|1|||
125980949|NCT00771810|453219154|FG002|Overall Study|Protocol Violation|1|||
125980950|NCT00771810|453219152|FG000|Overall Study|Withdrawal by Subject|1|||
125980951|NCT00771810|453219153|FG001|Overall Study|Withdrawal by Subject|2|||
125980952|NCT00771810|453219154|FG002|Overall Study|Withdrawal by Subject|0|||
125980953|NCT00771810|453219152|FG000|Overall Study|Other|0|||
125980954|NCT00771810|453219153|FG001|Overall Study|Other|0|||
125980955|NCT00771810|453219154|FG002|Overall Study|Other|1|||
125980956|NCT04542018|453219157|FG000|Overall Study|Withdrawal by Subject|0|||
125980957|NCT04542018|453219158|FG001|Overall Study|Withdrawal by Subject|0|||
125980958|NCT04542018|453219159|FG002|Overall Study|Withdrawal by Subject|4|||
125980959|NCT04542018|453219157|FG000|Overall Study|Protocol Violation|0|||
125980960|NCT04542018|453219158|FG001|Overall Study|Protocol Violation|0|||
125980961|NCT04542018|453219159|FG002|Overall Study|Protocol Violation|2|||
125980962|NCT02953938|453219160|FG000|Overall Study|Adverse Event|0|||
125980963|NCT02953938|453219161|FG001|Overall Study|Adverse Event|1|||
125980964|NCT02953938|453219160|FG000|Overall Study|Withdrawal by Subject|1|||
125980965|NCT02953938|453219161|FG001|Overall Study|Withdrawal by Subject|1|||
125980966|NCT02114151|453219167|FG000|Overall Study|Death|1|||
125980967|NCT02114151|453219167|FG000|Overall Study|Lost to Follow-up|1|||
125980968|NCT02114151|453219167|FG000|Overall Study|Withdrawal by Subject|5|||
125980969|NCT01494584|453219168|FG000|Overall Study|Study Closed/Terminated|1|||
125980970|NCT01666808|453219169|FG000|Overall Study|Lost to Follow-up|9|||
125980971|NCT01666808|453219170|FG001|Overall Study|Lost to Follow-up|15|||
125980972|NCT01666808|453219169|FG000|Overall Study|Withdrawal by Subject|3|||
125980973|NCT01666808|453219170|FG001|Overall Study|Withdrawal by Subject|1|||
125980974|NCT01666808|453219169|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
125980975|NCT01666808|453219170|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
125980976|NCT01499082|453219171|FG000|Overall Study|Randomized but not Treated|0|||
125980977|NCT01499082|453219172|FG001|Overall Study|Randomized but not Treated|1|||
125980978|NCT01499082|453219171|FG000|Overall Study|Adverse Event|12|||
125980979|NCT01499082|453219172|FG001|Overall Study|Adverse Event|16|||
125980980|NCT01499082|453219171|FG000|Overall Study|Lack of Efficacy|1|||
125980981|NCT01499082|453219172|FG001|Overall Study|Lack of Efficacy|1|||
125980982|NCT01499082|453219171|FG000|Overall Study|Protocol Violation|6|||
125980983|NCT01499082|453219172|FG001|Overall Study|Protocol Violation|8|||
125980984|NCT01499082|453219171|FG000|Overall Study|Diverse Reasons|18|||
125980985|NCT01499082|453219172|FG001|Overall Study|Diverse Reasons|14|||
125980986|NCT01499082|453219171|FG000|Overall Study|Site Closure for Noncompliance|5|||
125980987|NCT01499082|453219172|FG001|Overall Study|Site Closure for Noncompliance|2|||
125980988|NCT01499082|453219171|FG000|Overall Study|Hypoglycemia|2|||
125980989|NCT01499082|453219172|FG001|Overall Study|Hypoglycemia|3|||
125980990|NCT01499082|453219171|FG000|Overall Study|Lost to Follow-up|1|||
125980991|NCT01499082|453219172|FG001|Overall Study|Lost to Follow-up|3|||
125980992|NCT03599349|453219173|FG000|Overall Study|Lost to Follow-up|1|||
125980993|NCT02638948|453219176|FG000|Overall Study|Withdrawal by Subject|4|||
125980994|NCT02638948|453219177|FG001|Overall Study|Withdrawal by Subject|5|||
125980995|NCT02638948|453219178|FG002|Overall Study|Withdrawal by Subject|3|||
125980996|NCT02638948|453219179|FG003|Overall Study|Withdrawal by Subject|1|||
125980997|NCT02638948|453219176|FG000|Overall Study|Administrative Reason by Sponsor|0|||
126090930|NCT03846453|453626854|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
125980998|NCT02638948|453219177|FG001|Overall Study|Administrative Reason by Sponsor|1|||
125980999|NCT02638948|453219178|FG002|Overall Study|Administrative Reason by Sponsor|0|||
125981000|NCT02638948|453219179|FG003|Overall Study|Administrative Reason by Sponsor|4|||
125981001|NCT02638948|453219176|FG000|Overall Study|Adverse Event|0|||
125981002|NCT02638948|453219177|FG001|Overall Study|Adverse Event|0|||
125981003|NCT02638948|453219178|FG002|Overall Study|Adverse Event|1|||
125981004|NCT02638948|453219179|FG003|Overall Study|Adverse Event|1|||
125981005|NCT02638948|453219176|FG000|Overall Study|Lack of Efficacy|1|||
125981006|NCT02638948|453219177|FG001|Overall Study|Lack of Efficacy|1|||
125981007|NCT02638948|453219178|FG002|Overall Study|Lack of Efficacy|0|||
125981008|NCT02638948|453219179|FG003|Overall Study|Lack of Efficacy|0|||
125981009|NCT02638948|453219176|FG000|Overall Study|Lost to Follow-up|0|||
125981010|NCT02638948|453219177|FG001|Overall Study|Lost to Follow-up|0|||
125981011|NCT02638948|453219178|FG002|Overall Study|Lost to Follow-up|1|||
125981012|NCT02638948|453219179|FG003|Overall Study|Lost to Follow-up|1|||
126090931|NCT00468143|453626855|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
126090932|NCT00468143|453626856|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
126090933|NCT00468143|453626855|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
126090934|NCT00468143|453626856|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
126090935|NCT01606670|453626859|FG000|Overall Study|Adverse Event|6|||
126090936|NCT01606670|453626859|FG000|Overall Study|Lack of Efficacy|2|||
126090937|NCT01606670|453626859|FG000|Overall Study|Lost to Follow-up|3|||
126090938|NCT01606670|453626859|FG000|Overall Study|Withdrawal by Subject|3|||
126090939|NCT01606670|453626859|FG000|Overall Study|Other Reason|2|||
126090940|NCT02636725|453626861|FG000|Overall Study|Adverse Event|1|||
126090941|NCT00403767|453626862|FG000|Overall Study|Adverse Event|993|||
126090942|NCT00403767|453626863|FG001|Overall Study|Adverse Event|919|||
126090943|NCT00403767|453626862|FG000|Overall Study|Non-compliant with study medication|134|||
126090944|NCT00403767|453626863|FG001|Overall Study|Non-compliant with study medication|164|||
126090945|NCT00403767|453626862|FG000|Overall Study|Consent withdrawn|671|||
126090946|NCT00403767|453626863|FG001|Overall Study|Consent withdrawn|673|||
126090947|NCT00403767|453626862|FG000|Overall Study|Investigator dec./not protocol-related|191|||
126090948|NCT00403767|453626863|FG001|Overall Study|Investigator dec./not protocol-related|178|||
126090949|NCT00403767|453626862|FG000|Overall Study|Lost to Follow-up|6|||
126090950|NCT00403767|453626863|FG001|Overall Study|Lost to Follow-up|8|||
126090951|NCT00403767|453626862|FG000|Overall Study|Protocol Violation|142|||
126318094|NCT01069419|454455927|FG000|Overall Study|Adverse Event|233|||
126318095|NCT01069419|454455927|FG000|Overall Study|Lack of Efficacy|332|||
126090952|NCT00403767|453626863|FG001|Overall Study|Protocol Violation|124|||
126090953|NCT00403767|453626862|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
126090954|NCT00403767|453626863|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
126090955|NCT00403767|453626862|FG000|Overall Study|Study terminated by sponsor|82|||
126090956|NCT00403767|453626863|FG001|Overall Study|Study terminated by sponsor|69|||
126090957|NCT00403767|453626862|FG000|Overall Study|Missing/incomplete data|1|||
126090958|NCT00403767|453626863|FG001|Overall Study|Missing/incomplete data|1|||
126090959|NCT05330676|453626864|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
126090960|NCT05330676|453626865|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
126090961|NCT00436605|453626866|FG000|Overall Study|Protocol Violation|3|||
126090962|NCT01559129|453626870|FG000|Treatment Phase|Adverse Event|0|||
126090963|NCT01559129|453626871|FG001|Treatment Phase|Adverse Event|2|||
126090964|NCT01559129|453626870|FG000|Treatment Phase|Progressive Disease|1|||
126090965|NCT01559129|453626871|FG001|Treatment Phase|Progressive Disease|1|||
126090966|NCT01559129|453626870|FG000|Treatment Phase|Lack of Efficacy|0|||
126090967|NCT01559129|453626871|FG001|Treatment Phase|Lack of Efficacy|1|||
126090968|NCT01559129|453626870|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
126090969|NCT01559129|453626871|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
126090970|NCT01559129|453626870|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
125981013|NCT02638948|453219176|FG000|Overall Study|Poor/Non-Compliance|0|||
125981014|NCT02638948|453219177|FG001|Overall Study|Poor/Non-Compliance|2|||
126090971|NCT01559129|453626871|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
126090972|NCT01559129|453626870|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
126090973|NCT01559129|453626871|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
126090974|NCT01559129|453626870|FG000|Open-label Extension Period|Adverse Event|1|||
126318096|NCT01069419|454455927|FG000|Overall Study|Lost to Follow-up|49|||
125981015|NCT02638948|453219178|FG002|Overall Study|Poor/Non-Compliance|1|||
125981016|NCT02638948|453219179|FG003|Overall Study|Poor/Non-Compliance|0|||
126090975|NCT01559129|453626871|FG001|Open-label Extension Period|Adverse Event|0|||
126090976|NCT01559129|453626870|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
126090977|NCT01559129|453626871|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
126090978|NCT00368927|453626872|FG000|Overall Study|Lost to Follow-up|2|||
126090979|NCT00368927|453626873|FG001|Overall Study|Lost to Follow-up|0|||
126318097|NCT01069419|454455927|FG000|Overall Study|Remission of disease|11|||
126318098|NCT01069419|454455927|FG000|Overall Study|Withdrawal by Subject|34|||
126318099|NCT01069419|454455927|FG000|Overall Study|Other Reason|43|||
126318100|NCT01069419|454455927|FG000|Overall Study|Missing termination information|13|||
126318101|NCT00908076|454455928|FG000|Overall Study|Lack of Efficacy|1|||
126318102|NCT00908076|454455929|FG001|Overall Study|Lack of Efficacy|1|||
126318103|NCT02382796|454455930|FG000|Overall Study|Global deterioration of health status|1|||
126318104|NCT02382796|454455930|FG000|Overall Study|Objective progression or relapse|3|||
126318105|NCT02382796|454455930|FG000|Overall Study|Commercial dacomitinib became available|3|||
126318106|NCT00334802|454455937|FG000|Overall Study|Progressive Disease|2|||
126318107|NCT00334802|454455938|FG001|Overall Study|Progressive Disease|24|||
126318108|NCT00334802|454455937|FG000|Overall Study|Toxicity|1|||
126318109|NCT00334802|454455938|FG001|Overall Study|Toxicity|5|||
126318110|NCT00334802|454455937|FG000|Overall Study|Lack of Efficacy|1|||
126318111|NCT00334802|454455938|FG001|Overall Study|Lack of Efficacy|3|||
126318112|NCT00334802|454455937|FG000|Overall Study|Patient Condition Aggrevated|1|||
126318113|NCT00334802|454455938|FG001|Overall Study|Patient Condition Aggrevated|0|||
126318114|NCT00334802|454455937|FG000|Overall Study|Physician Decision|1|||
126318115|NCT00334802|454455938|FG001|Overall Study|Physician Decision|0|||
126318116|NCT00334802|454455937|FG000|Overall Study|Withdrawal by Subject|0|||
126318117|NCT00334802|454455938|FG001|Overall Study|Withdrawal by Subject|4|||
126318118|NCT00334802|454455937|FG000|Overall Study|Adverse Event|0|||
126318119|NCT00334802|454455938|FG001|Overall Study|Adverse Event|3|||
126318120|NCT00334802|454455937|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
126318121|NCT00334802|454455938|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
126318122|NCT03515629|454455939|FG000|Overall Study|Death|0|||
126318123|NCT03515629|454455940|FG001|Overall Study|Death|1|||
126318124|NCT03515629|454455941|FG002|Overall Study|Death|1|||
126318125|NCT03515629|454455939|FG000|Overall Study|Progressive disease|0|||
126318126|NCT03515629|454455940|FG001|Overall Study|Progressive disease|1|||
125981017|NCT02638948|453219176|FG000|Overall Study|Participant no longer met study criteria|0|||
125981018|NCT02638948|453219177|FG001|Overall Study|Participant no longer met study criteria|1|||
126318127|NCT03515629|454455941|FG002|Overall Study|Progressive disease|0|||
126318128|NCT03887117|454455942|FG000|Overall Study|Discontinued prematurely|0|||
126318129|NCT03887117|454455943|FG001|Overall Study|Discontinued prematurely|1|||
126318130|NCT03887117|454455944|FG002|Overall Study|Discontinued prematurely|1|||
126318131|NCT03887117|454455945|FG003|Overall Study|Discontinued prematurely|2|||
126318132|NCT01739764|454455946|FG000|Overall Study|Adverse Event|0|||
126318133|NCT01739764|454455947|FG001|Overall Study|Adverse Event|3|||
126318134|NCT01739764|454455948|FG002|Overall Study|Adverse Event|4|||
126318135|NCT01739764|454455946|FG000|Overall Study|Death|4|||
126318136|NCT01739764|454455947|FG001|Overall Study|Death|6|||
126318137|NCT01739764|454455948|FG002|Overall Study|Death|38|||
126318138|NCT01739764|454455946|FG000|Overall Study|Lost to Follow-up|0|||
126318139|NCT01739764|454455947|FG001|Overall Study|Lost to Follow-up|0|||
126318140|NCT01739764|454455948|FG002|Overall Study|Lost to Follow-up|5|||
126318141|NCT01739764|454455946|FG000|Overall Study|Non-Compliance|0|||
126318142|NCT01739764|454455947|FG001|Overall Study|Non-Compliance|0|||
126318143|NCT01739764|454455948|FG002|Overall Study|Non-Compliance|1|||
125981019|NCT02638948|453219178|FG002|Overall Study|Participant no longer met study criteria|0|||
125981020|NCT02638948|453219179|FG003|Overall Study|Participant no longer met study criteria|0|||
125981021|NCT02638948|453219176|FG000|Overall Study|Other than specified above|4|||
125981022|NCT02638948|453219177|FG001|Overall Study|Other than specified above|1|||
125981023|NCT02638948|453219178|FG002|Overall Study|Other than specified above|1|||
125981024|NCT02638948|453219179|FG003|Overall Study|Other than specified above|1|||
125981025|NCT00810264|453219183|FG000|Overall Study|Lost to Follow-up|191|||
125981026|NCT00810264|453219183|FG000|Overall Study|Withdrawal by subject or physician|721|||
126318144|NCT01739764|454455946|FG000|Overall Study|Multiple Reasons|3|||
126318145|NCT01739764|454455947|FG001|Overall Study|Multiple Reasons|2|||
126318146|NCT01739764|454455948|FG002|Overall Study|Multiple Reasons|3|||
126318147|NCT01739764|454455946|FG000|Overall Study|Physician Decision|2|||
126318148|NCT01739764|454455947|FG001|Overall Study|Physician Decision|2|||
126318149|NCT01739764|454455948|FG002|Overall Study|Physician Decision|4|||
126318150|NCT01739764|454455946|FG000|Overall Study|Progressive Disease|3|||
126318151|NCT01739764|454455947|FG001|Overall Study|Progressive Disease|5|||
126318152|NCT01739764|454455948|FG002|Overall Study|Progressive Disease|16|||
126318153|NCT01739764|454455946|FG000|Overall Study|Protocol Violation|0|||
126318154|NCT01739764|454455947|FG001|Overall Study|Protocol Violation|0|||
126318155|NCT01739764|454455948|FG002|Overall Study|Protocol Violation|2|||
126318156|NCT01739764|454455946|FG000|Overall Study|Study Terminated by Sponsor|8|||
126318157|NCT01739764|454455947|FG001|Overall Study|Study Terminated by Sponsor|13|||
126318158|NCT01739764|454455948|FG002|Overall Study|Study Terminated by Sponsor|26|||
125981027|NCT00810264|453219183|FG000|Overall Study|Death|641|||
125981028|NCT01830127|453219184|FG000|Overall Study|Adverse Event|1|||
125981029|NCT01830127|453219185|FG001|Overall Study|Adverse Event|6|||
125981030|NCT01830127|453219184|FG000|Overall Study|Lack of Efficacy|3|||
125981031|NCT01830127|453219185|FG001|Overall Study|Lack of Efficacy|0|||
125981032|NCT01830127|453219184|FG000|Overall Study|Withdrawal by Subject|1|||
125981033|NCT01830127|453219185|FG001|Overall Study|Withdrawal by Subject|1|||
125981034|NCT01830127|453219184|FG000|Overall Study|Other reason not defined above|0|||
125981035|NCT01830127|453219185|FG001|Overall Study|Other reason not defined above|2|||
125981036|NCT06213701|453219186|FG000|Overall Study|Withdrawal by Subject|2|||
125981037|NCT06213701|453219187|FG001|Overall Study|Withdrawal by Subject|1|||
125981038|NCT06213701|453219188|FG002|Overall Study|Withdrawal by Subject|0|||
125981039|NCT00567190|453219189|FG000|Overall Study|Death|235|||
125981040|NCT00567190|453219190|FG001|Overall Study|Death|280|||
125981041|NCT00567190|453219189|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
125981042|NCT00567190|453219190|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
125981043|NCT02495025|453219195|FG000|Overall Study|Lost to Follow-up|21|||
125981044|NCT02495025|453219196|FG001|Overall Study|Lost to Follow-up|14|||
125981045|NCT02495025|453219195|FG000|Overall Study|Withdrawal by Subject|5|||
125981046|NCT02495025|453219196|FG001|Overall Study|Withdrawal by Subject|0|||
125981047|NCT00313820|453219198|FG000|Assigned to Treatment|Other|1|||
125981048|NCT00313820|453219199|FG001|Assigned to Treatment|Other|0|||
125981049|NCT00313820|453219198|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
125981050|NCT00313820|453219199|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
125981051|NCT00313820|453219198|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
125981052|NCT00313820|453219199|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
125981053|NCT00313820|453219198|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
125981054|NCT00313820|453219199|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
125981055|NCT00313820|453219198|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
125981056|NCT00313820|453219199|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
125981057|NCT00313820|453219198|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
125981058|NCT00313820|453219199|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
125981059|NCT00265889|453219205|FG000|Overall Study|Physician Decision|1|||
125981060|NCT00265889|453219205|FG000|Overall Study|Protocol Violation|1|||
125981061|NCT00265889|453219205|FG000|Overall Study|Insurance denied the request|3|||
125981062|NCT02134587|453219206|FG000|Overall Study|Did not completed all meetings|30|||
125981063|NCT01515748|453219210|FG000|Overall Study|Withdrawal by Subject|32|||
125981064|NCT01515748|453219211|FG001|Overall Study|Withdrawal by Subject|41|||
125981065|NCT01515748|453219210|FG000|Overall Study|Lost to Follow-up|2|||
125981066|NCT01515748|453219211|FG001|Overall Study|Lost to Follow-up|4|||
126090980|NCT00368927|453626872|FG000|Overall Study|Adverse Event|1|||
126208837|NCT02319642|454053103|FG000|Overall Study|Withdrawal by Subject|1|||
126208838|NCT02319642|454053104|FG001|Overall Study|Withdrawal by Subject|1|||
126208839|NCT00483119|454053105|FG000|Overall Study|Adverse Event|0|||
126208840|NCT00483119|454053106|FG001|Overall Study|Adverse Event|1|||
126208841|NCT00483119|454053105|FG000|Overall Study|Physician Decision|1|||
126208842|NCT00483119|454053106|FG001|Overall Study|Physician Decision|0|||
126208843|NCT04668066|454053107|FG000|Part 1: Treatment Phase|Adverse Event|0|||
126208844|NCT04668066|454053108|FG001|Part 1: Treatment Phase|Adverse Event|0|||
126208845|NCT04668066|454053109|FG002|Part 1: Treatment Phase|Adverse Event|0|||
126208846|NCT04668066|454053110|FG003|Part 1: Treatment Phase|Adverse Event|0|||
126208847|NCT04668066|454053111|FG004|Part 1: Treatment Phase|Adverse Event|0|||
126208848|NCT04668066|454053112|FG005|Part 1: Treatment Phase|Adverse Event|0|||
126208849|NCT04668066|454053113|FG006|Part 1: Treatment Phase|Adverse Event|0|||
126208850|NCT04668066|454053114|FG007|Part 1: Treatment Phase|Adverse Event|0|||
126208851|NCT04668066|454053115|FG008|Part 1: Treatment Phase|Adverse Event|0|||
126208852|NCT04668066|454053116|FG009|Part 1: Treatment Phase|Adverse Event|0|||
126208853|NCT04668066|454053117|FG010|Part 1: Treatment Phase|Adverse Event|0|||
126208854|NCT04668066|454053118|FG011|Part 1: Treatment Phase|Adverse Event|1|||
126208855|NCT04668066|454053119|FG012|Part 1: Treatment Phase|Adverse Event|1|||
126208856|NCT04668066|454053120|FG013|Part 1: Treatment Phase|Adverse Event|0|||
126208857|NCT04668066|454053121|FG014|Part 1: Treatment Phase|Adverse Event|0|||
126208858|NCT04668066|454053122|FG015|Part 1: Treatment Phase|Adverse Event|0|||
126208859|NCT04668066|454053123|FG016|Part 1: Treatment Phase|Adverse Event|0|||
126208860|NCT04668066|454053124|FG017|Part 1: Treatment Phase|Adverse Event|0|||
126208861|NCT04668066|454053125|FG018|Part 1: Treatment Phase|Adverse Event|0|||
126208862|NCT04668066|454053107|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208863|NCT04668066|454053108|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208864|NCT04668066|454053109|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
126208865|NCT04668066|454053110|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208866|NCT04668066|454053111|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208867|NCT04668066|454053112|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208868|NCT04668066|454053113|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208869|NCT04668066|454053114|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208870|NCT04668066|454053115|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
125981067|NCT01515748|453219210|FG000|Overall Study|Other than specified above|5|||
125981068|NCT01515748|453219211|FG001|Overall Study|Other than specified above|10|||
125981069|NCT03221387|453219214|FG000|Overall Study|Lost to Follow-up|1|||
125981070|NCT03221387|453219214|FG000|Overall Study|Lung transplant|1|||
125981071|NCT04102579|453219218|FG000|Overall Study|Withdrawal by Subject|3|||
125981072|NCT04102579|453219219|FG001|Overall Study|Withdrawal by Subject|4|||
125981073|NCT04102579|453219218|FG000|Overall Study|Lost to Follow-up|0|||
125981074|NCT04102579|453219219|FG001|Overall Study|Lost to Follow-up|1|||
125981075|NCT04102579|453219218|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
125981076|NCT04102579|453219219|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
125981077|NCT04102579|453219218|FG000|Overall Study|Other than Specified|1|||
125981078|NCT04102579|453219219|FG001|Overall Study|Other than Specified|0|||
125981079|NCT04102579|453219218|FG000|Overall Study|Not Dosed with Study Drug|0|||
125981080|NCT04102579|453219219|FG001|Overall Study|Not Dosed with Study Drug|1|||
125981081|NCT01525602|453219220|FG000|Overall Study|Adverse Event|1|||
125981082|NCT01525602|453219221|FG001|Overall Study|Adverse Event|0|||
125981083|NCT01525602|453219222|FG002|Overall Study|Adverse Event|1|||
125981084|NCT01525602|453219223|FG003|Overall Study|Adverse Event|1|||
125981085|NCT01525602|453219224|FG004|Overall Study|Adverse Event|3|||
125981086|NCT01525602|453219225|FG005|Overall Study|Adverse Event|3|||
125981087|NCT01525602|453219226|FG006|Overall Study|Adverse Event|0|||
126318159|NCT01739764|454455946|FG000|Overall Study|Withdrawal by Subject|6|||
126318160|NCT01739764|454455947|FG001|Overall Study|Withdrawal by Subject|5|||
126318161|NCT01739764|454455948|FG002|Overall Study|Withdrawal by Subject|27|||
126318162|NCT01389258|454455949|FG000|Overall Study|Lost to Follow-up|5|||
126318163|NCT00926536|454455950|FG000|Overall Study|Physician Decision|1|||
126318164|NCT00926536|454455951|FG001|Overall Study|Physician Decision|2|||
126318165|NCT00990665|454455952|FG000|Overall Study|Unsuccessful Implant|8|||
126318166|NCT00990665|454455952|FG000|Overall Study|Death|29|||
126318167|NCT00990665|454455952|FG000|Overall Study|Heart Transplant|1|||
126318168|NCT00990665|454455952|FG000|Overall Study|Withdrawal by Subject|6|||
126318169|NCT00990665|454455952|FG000|Overall Study|Lost to Follow-up|1|||
126318170|NCT00990665|454455952|FG000|Overall Study|System Explant|3|||
126318171|NCT01080391|454455953|FG000|Overall Study|Randomized but not treated|7|||
126318172|NCT01080391|454455954|FG001|Overall Study|Randomized but not treated|4|||
126318173|NCT00672841|454455955|FG000|Overall Study|Comfort care|1|||
126318174|NCT00672841|454455956|FG001|Overall Study|Comfort care|4|||
126318175|NCT00672841|454455955|FG000|Overall Study|icteric specimens|0|||
126318176|NCT00672841|454455956|FG001|Overall Study|icteric specimens|3|||
126318177|NCT00672841|454455955|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
126318178|NCT00672841|454455956|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
126318179|NCT00672841|454455955|FG000|Overall Study|Adverse Event|0|||
126318180|NCT00672841|454455956|FG001|Overall Study|Adverse Event|3|||
126318181|NCT00672841|454455955|FG000|Overall Study|Pregnancy|0|||
126318182|NCT00672841|454455956|FG001|Overall Study|Pregnancy|1|||
126318183|NCT03578146|454455957|FG000|Overall Study|Did Not Receive Treatment|1|||
126318184|NCT03578146|454455958|FG001|Overall Study|Did Not Receive Treatment|0|||
126318185|NCT03578146|454455959|FG002|Overall Study|Did Not Receive Treatment|0|||
126318186|NCT03578146|454455960|FG003|Overall Study|Did Not Receive Treatment|0|||
126318187|NCT03578146|454455961|FG004|Overall Study|Did Not Receive Treatment|0|||
126318188|NCT03578146|454455962|FG005|Overall Study|Did Not Receive Treatment|2|||
126318189|NCT03578146|454455957|FG000|Overall Study|Lost to Follow-up|0|||
126318190|NCT03578146|454455958|FG001|Overall Study|Lost to Follow-up|1|||
126318191|NCT03578146|454455959|FG002|Overall Study|Lost to Follow-up|1|||
126318192|NCT03578146|454455960|FG003|Overall Study|Lost to Follow-up|0|||
126318193|NCT03578146|454455961|FG004|Overall Study|Lost to Follow-up|0|||
126318194|NCT03578146|454455962|FG005|Overall Study|Lost to Follow-up|1|||
126318195|NCT01717391|454455963|FG000|Overall Study|Withdrawal by Subject|5|||
126318196|NCT01717391|454455963|FG000|Overall Study|Physician Decision|1|||
126318197|NCT01717391|454455963|FG000|Overall Study|FLT technical failure|3|||
126318198|NCT03677934|454455964|FG000|Overall Study|Adverse Event|1|||
126318199|NCT03677934|454455965|FG001|Overall Study|Adverse Event|1|||
126318200|NCT03677934|454455964|FG000|Overall Study|Death|8|||
126318201|NCT03677934|454455965|FG001|Overall Study|Death|4|||
126318202|NCT03677934|454455964|FG000|Overall Study|Lost to Follow-up|3|||
125981088|NCT01525602|453219227|FG007|Overall Study|Adverse Event|1|||
125981089|NCT01525602|453219220|FG000|Overall Study|Disease progression|6|||
125981090|NCT01525602|453219221|FG001|Overall Study|Disease progression|3|||
125981091|NCT01525602|453219222|FG002|Overall Study|Disease progression|2|||
125981092|NCT01525602|453219223|FG003|Overall Study|Disease progression|5|||
126318203|NCT03677934|454455965|FG001|Overall Study|Lost to Follow-up|0|||
126318204|NCT03677934|454455964|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126318205|NCT03677934|454455965|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126318206|NCT03677934|454455964|FG000|Overall Study|Physician Decision|0|||
126318207|NCT03677934|454455965|FG001|Overall Study|Physician Decision|1|||
126318208|NCT03677934|454455964|FG000|Overall Study|Withdrawal by Subject|1|||
126318209|NCT03677934|454455965|FG001|Overall Study|Withdrawal by Subject|7|||
126318210|NCT01260584|454455966|FG000|Period 1|Protocol Violation|0|||
125981093|NCT01525602|453219224|FG004|Overall Study|Disease progression|22|||
125981094|NCT01525602|453219225|FG005|Overall Study|Disease progression|2|||
125981095|NCT01525602|453219226|FG006|Overall Study|Disease progression|3|||
125981096|NCT01525602|453219227|FG007|Overall Study|Disease progression|3|||
125981097|NCT01525602|453219220|FG000|Overall Study|Clinical progression|2|||
125981098|NCT01525602|453219221|FG001|Overall Study|Clinical progression|0|||
125981099|NCT01525602|453219222|FG002|Overall Study|Clinical progression|0|||
125981100|NCT01525602|453219223|FG003|Overall Study|Clinical progression|0|||
125981101|NCT01525602|453219224|FG004|Overall Study|Clinical progression|0|||
125981102|NCT01525602|453219225|FG005|Overall Study|Clinical progression|0|||
125981103|NCT01525602|453219226|FG006|Overall Study|Clinical progression|1|||
125981104|NCT01525602|453219227|FG007|Overall Study|Clinical progression|1|||
125981105|NCT01525602|453219220|FG000|Overall Study|Non-compliance|0|||
125981106|NCT01525602|453219221|FG001|Overall Study|Non-compliance|0|||
125981107|NCT01525602|453219222|FG002|Overall Study|Non-compliance|0|||
125981108|NCT01525602|453219223|FG003|Overall Study|Non-compliance|0|||
125981109|NCT01525602|453219224|FG004|Overall Study|Non-compliance|1|||
125981110|NCT01525602|453219225|FG005|Overall Study|Non-compliance|0|||
125981111|NCT01525602|453219226|FG006|Overall Study|Non-compliance|0|||
125981112|NCT01525602|453219227|FG007|Overall Study|Non-compliance|0|||
125981113|NCT01525602|453219220|FG000|Overall Study|Withdrawal by Subject|0|||
125981114|NCT01525602|453219221|FG001|Overall Study|Withdrawal by Subject|0|||
125981115|NCT01525602|453219222|FG002|Overall Study|Withdrawal by Subject|0|||
125981116|NCT01525602|453219223|FG003|Overall Study|Withdrawal by Subject|0|||
125981117|NCT01525602|453219224|FG004|Overall Study|Withdrawal by Subject|3|||
125981118|NCT01525602|453219225|FG005|Overall Study|Withdrawal by Subject|1|||
125981119|NCT01525602|453219226|FG006|Overall Study|Withdrawal by Subject|0|||
125981120|NCT01525602|453219227|FG007|Overall Study|Withdrawal by Subject|1|||
125981121|NCT01525602|453219220|FG000|Overall Study|Physician Decision|0|||
125981122|NCT01525602|453219221|FG001|Overall Study|Physician Decision|0|||
125981123|NCT01525602|453219222|FG002|Overall Study|Physician Decision|0|||
125981124|NCT01525602|453219223|FG003|Overall Study|Physician Decision|0|||
125981125|NCT01525602|453219224|FG004|Overall Study|Physician Decision|3|||
125981126|NCT01525602|453219225|FG005|Overall Study|Physician Decision|0|||
125981127|NCT01525602|453219226|FG006|Overall Study|Physician Decision|1|||
125981128|NCT01525602|453219227|FG007|Overall Study|Physician Decision|0|||
125981129|NCT01525602|453219220|FG000|Overall Study|Death|0|||
125981130|NCT01525602|453219221|FG001|Overall Study|Death|0|||
125981131|NCT01525602|453219222|FG002|Overall Study|Death|0|||
125981132|NCT01525602|453219223|FG003|Overall Study|Death|0|||
125981133|NCT01525602|453219224|FG004|Overall Study|Death|1|||
125981134|NCT01525602|453219225|FG005|Overall Study|Death|1|||
125981135|NCT01525602|453219226|FG006|Overall Study|Death|0|||
125981136|NCT01525602|453219227|FG007|Overall Study|Death|0|||
125981137|NCT01525602|453219220|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
125981138|NCT01525602|453219221|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
125981139|NCT01525602|453219222|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
125981140|NCT01525602|453219223|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
125981141|NCT01525602|453219224|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
125981142|NCT01525602|453219225|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
125981143|NCT01525602|453219226|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
125981144|NCT01525602|453219227|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
125981145|NCT04349280|453219228|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
125981146|NCT04349280|453219229|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
125981147|NCT04349280|453219228|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
125981148|NCT04349280|453219229|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
125981149|NCT04349280|453219228|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
125981150|NCT04349280|453219229|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
125981151|NCT02532179|453221112|FG000|Overall Study|Lost to Follow-up|1|||
125981152|NCT02532179|453221112|FG000|Overall Study|Pregnancy|1|||
125981153|NCT02532179|453221112|FG000|Overall Study|Subject received depot steroid injection|1|||
125981154|NCT03076970|453221116|FG000|Washout Period 2|Adverse Event|0|||
125981155|NCT03076970|453221117|FG001|Washout Period 2|Adverse Event|0|||
125981156|NCT03076970|453221118|FG002|Washout Period 2|Adverse Event|0|||
125981157|NCT03076970|453221119|FG003|Washout Period 2|Adverse Event|0|||
125981158|NCT03076970|453221120|FG004|Washout Period 2|Adverse Event|1|||
125981159|NCT03076970|453221121|FG005|Washout Period 2|Adverse Event|0|||
125981160|NCT03076970|453221116|FG000|Period 3|Withdrawal by Subject|0|||
125981161|NCT03076970|453221117|FG001|Period 3|Withdrawal by Subject|0|||
125981162|NCT03076970|453221118|FG002|Period 3|Withdrawal by Subject|0|||
125981163|NCT03076970|453221119|FG003|Period 3|Withdrawal by Subject|0|||
125981164|NCT03076970|453221120|FG004|Period 3|Withdrawal by Subject|0|||
125981165|NCT03076970|453221121|FG005|Period 3|Withdrawal by Subject|1|||
125981166|NCT03076970|453221116|FG000|Period 3|Failure to meet I/E criteria|0|||
125981167|NCT03076970|453221117|FG001|Period 3|Failure to meet I/E criteria|0|||
125981168|NCT03076970|453221118|FG002|Period 3|Failure to meet I/E criteria|0|||
125981169|NCT03076970|453221119|FG003|Period 3|Failure to meet I/E criteria|0|||
125981170|NCT03076970|453221120|FG004|Period 3|Failure to meet I/E criteria|1|||
125981171|NCT03076970|453221121|FG005|Period 3|Failure to meet I/E criteria|0|||
125981172|NCT02543658|453221122|FG000|Overall Study|Lack of Efficacy|0|||
125981173|NCT02543658|453221123|FG001|Overall Study|Lack of Efficacy|4|||
125981174|NCT00789815|453221124|FG000|Overall Study|Protocol Violation|6|||
125981175|NCT00789815|453221125|FG001|Overall Study|Protocol Violation|1|||
125981176|NCT00789815|453221124|FG000|Overall Study|Intubation due to massive bleeding|1|||
125981177|NCT00789815|453221125|FG001|Overall Study|Intubation due to massive bleeding|0|||
125981178|NCT01203930|453221137|FG000|Overall Study|Disease Progression|0|||
125981179|NCT01203930|453221138|FG001|Overall Study|Disease Progression|4|||
125981180|NCT01203930|453221137|FG000|Overall Study|Death|3|||
125981181|NCT01203930|453221138|FG001|Overall Study|Death|1|||
125981182|NCT01203930|453221137|FG000|Overall Study|Withdrew Consent|1|||
125981183|NCT01203930|453221138|FG001|Overall Study|Withdrew Consent|10|||
125981184|NCT01203930|453221137|FG000|Overall Study|Investigator Request|0|||
125981185|NCT01203930|453221138|FG001|Overall Study|Investigator Request|8|||
125981186|NCT01203930|453221137|FG000|Overall Study|Study Terminated by Sponsor|0|||
125981187|NCT01203930|453221138|FG001|Overall Study|Study Terminated by Sponsor|12|||
125981188|NCT01203930|453221137|FG000|Overall Study|Poor tolerance of study drug|0|||
125981189|NCT01203930|453221138|FG001|Overall Study|Poor tolerance of study drug|1|||
125981190|NCT01203930|453221137|FG000|Overall Study|Adverse Event|17|||
125981191|NCT01203930|453221138|FG001|Overall Study|Adverse Event|5|||
125981192|NCT00662857|453221139|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
125981193|NCT00662857|453221140|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
125981194|NCT00662857|453221139|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
125981195|NCT00662857|453221140|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
125981196|NCT00662857|453221139|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
125981197|NCT00662857|453221140|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
125981198|NCT03966053|453221141|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
125981199|NCT00989092|453221144|FG000|Overall Study|Physician Decision|9|||
125981200|NCT00989092|453221145|FG001|Overall Study|Physician Decision|6|||
125981201|NCT00989092|453221144|FG000|Overall Study|Adverse Event|20|||
125981202|NCT00989092|453221145|FG001|Overall Study|Adverse Event|1|||
125981203|NCT00989092|453221144|FG000|Overall Study|Chemotherapy initiated|12|||
125981204|NCT00989092|453221145|FG001|Overall Study|Chemotherapy initiated|4|||
125981205|NCT00989092|453221144|FG000|Overall Study|Withdrawal by Subject|17|||
125981206|NCT00989092|453221145|FG001|Overall Study|Withdrawal by Subject|9|||
125981207|NCT00989092|453221144|FG000|Overall Study|Death|14|||
125981208|NCT00989092|453221145|FG001|Overall Study|Death|2|||
125981209|NCT00989092|453221144|FG000|Overall Study|Ineligibility determined|3|||
125981210|NCT00989092|453221145|FG001|Overall Study|Ineligibility determined|3|||
125981211|NCT00989092|453221144|FG000|Overall Study|Lost to Follow-up|6|||
125981212|NCT00989092|453221145|FG001|Overall Study|Lost to Follow-up|2|||
125981213|NCT00989092|453221144|FG000|Overall Study|Other|3|||
125981214|NCT00989092|453221145|FG001|Overall Study|Other|1|||
125981215|NCT00989092|453221144|FG000|Overall Study|Protocol deviation|2|||
125981216|NCT00989092|453221145|FG001|Overall Study|Protocol deviation|0|||
125981217|NCT00989092|453221144|FG000|Overall Study|Erythropoietin therapy initiated|2|||
125981218|NCT00989092|453221145|FG001|Overall Study|Erythropoietin therapy initiated|0|||
125981219|NCT00989092|453221144|FG000|Overall Study|Did not receive study drug|2|||
125981220|NCT00989092|453221145|FG001|Overall Study|Did not receive study drug|0|||
125981221|NCT04098406|453221146|FG000|Overall Study|Adverse Event|2|||
125981222|NCT04098406|453221147|FG001|Overall Study|Adverse Event|1|||
125981223|NCT04098406|453221146|FG000|Overall Study|Withdrawal by Subject|1|||
125981224|NCT04098406|453221147|FG001|Overall Study|Withdrawal by Subject|0|||
125981225|NCT01783418|453221151|FG000|Overall Study|Withdrawal by Subject|1|||
125981226|NCT01783418|453221152|FG001|Overall Study|Withdrawal by Subject|0|||
125981227|NCT04791761|453221153|FG000|Overall Study|Lost to Follow-up|8|||
125981228|NCT04791761|453221154|FG001|Overall Study|Lost to Follow-up|6|||
125981229|NCT04791761|453221155|FG002|Overall Study|Lost to Follow-up|10|||
125981230|NCT04791761|453221153|FG000|Overall Study|Withdrawal by Subject|0|||
125981231|NCT04791761|453221154|FG001|Overall Study|Withdrawal by Subject|1|||
125981232|NCT04791761|453221155|FG002|Overall Study|Withdrawal by Subject|1|||
125981233|NCT04791761|453221153|FG000|Overall Study|Protocol Violation|0|||
125981234|NCT04791761|453221154|FG001|Overall Study|Protocol Violation|1|||
125981235|NCT04791761|453221155|FG002|Overall Study|Protocol Violation|1|||
125981236|NCT03548207|453221156|FG000|Overall Study|Death|10|||
125981237|NCT03548207|453221157|FG001|Overall Study|Death|23|||
125981238|NCT03548207|453221158|FG002|Overall Study|Death|3|||
125981239|NCT03548207|453221156|FG000|Overall Study|Lost to Follow-up|0|||
125981240|NCT03548207|453221157|FG001|Overall Study|Lost to Follow-up|2|||
125981241|NCT03548207|453221158|FG002|Overall Study|Lost to Follow-up|0|||
125981242|NCT03548207|453221156|FG000|Overall Study|Withdrawal by Subject|0|||
125981243|NCT03548207|453221157|FG001|Overall Study|Withdrawal by Subject|3|||
125981244|NCT03548207|453221158|FG002|Overall Study|Withdrawal by Subject|0|||
125981245|NCT03548207|453221156|FG000|Overall Study|Sponsor decision|19|||
125981246|NCT03548207|453221157|FG001|Overall Study|Sponsor decision|40|||
125981247|NCT03548207|453221158|FG002|Overall Study|Sponsor decision|6|||
125981248|NCT03548207|453221156|FG000|Overall Study|Randomized but not treated|6|||
125981249|NCT03548207|453221157|FG001|Overall Study|Randomized but not treated|10|||
125981250|NCT03548207|453221158|FG002|Overall Study|Randomized but not treated|4|||
125981251|NCT01756352|453221159|FG000|Overall Study|moved away and lost to followup|1|||
125981252|NCT00415610|453221160|FG000|Overall Study|Death|3|||
125981253|NCT00415610|453221161|FG001|Overall Study|Death|2|||
125981254|NCT00415610|453221162|FG002|Overall Study|Death|5|||
125981255|NCT00999466|453221165|FG000|Main Part|Withdrawal by Subject|0|||
125981256|NCT00999466|453221166|FG001|Main Part|Withdrawal by Subject|0|||
125981257|NCT00999466|453221167|FG002|Main Part|Withdrawal by Subject|2|||
125981258|NCT00999466|453221165|FG000|Main Part|Adverse Event|0|||
125981259|NCT00999466|453221166|FG001|Main Part|Adverse Event|4|||
125981260|NCT00999466|453221167|FG002|Main Part|Adverse Event|2|||
125981261|NCT03040713|453221168|FG000|Overall Study|Positive amyloid scan|3|||
125981262|NCT04539821|453221169|FG000|Overall Study|Withdrawal by Subject|2|||
125981263|NCT04539821|453221169|FG000|Overall Study|continued care with their physician|20|||
125981264|NCT04539821|453221169|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
125981265|NCT02691182|453221170|FG000|Overall Study|Withdrawal by Subject|4|||
125981266|NCT02691182|453221171|FG001|Overall Study|Withdrawal by Subject|7|||
125981267|NCT02691182|453221172|FG002|Overall Study|Withdrawal by Subject|6|||
125981268|NCT02691182|453221173|FG003|Overall Study|Withdrawal by Subject|8|||
125981269|NCT02691182|453221170|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
125981270|NCT02691182|453221171|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
125981271|NCT02691182|453221172|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
125981272|NCT02691182|453221173|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
125981273|NCT02691182|453221170|FG000|Overall Study|Lost to Follow-up|8|||
125981274|NCT02691182|453221171|FG001|Overall Study|Lost to Follow-up|33|||
125981275|NCT02691182|453221172|FG002|Overall Study|Lost to Follow-up|19|||
125981276|NCT02691182|453221173|FG003|Overall Study|Lost to Follow-up|22|||
125981277|NCT02691182|453221170|FG000|Overall Study|Adverse Event|3|||
125981278|NCT02691182|453221171|FG001|Overall Study|Adverse Event|10|||
125981279|NCT02691182|453221172|FG002|Overall Study|Adverse Event|10|||
126318211|NCT01260584|454455967|FG001|Period 1|Protocol Violation|0|||
126318212|NCT01260584|454455968|FG002|Period 1|Protocol Violation|1|||
126318213|NCT01260584|454455969|FG003|Period 1|Protocol Violation|1|||
126318214|NCT01260584|454455966|FG000|Period 1|Adverse Event|0|||
126318215|NCT01260584|454455967|FG001|Period 1|Adverse Event|0|||
126318216|NCT01260584|454455968|FG002|Period 1|Adverse Event|1|||
126318217|NCT01260584|454455969|FG003|Period 1|Adverse Event|0|||
125981280|NCT02691182|453221173|FG003|Overall Study|Adverse Event|11|||
125981281|NCT02691182|453221170|FG000|Overall Study|Physician Decision|3|||
125981282|NCT02691182|453221171|FG001|Overall Study|Physician Decision|7|||
125981283|NCT02691182|453221172|FG002|Overall Study|Physician Decision|14|||
125981284|NCT02691182|453221173|FG003|Overall Study|Physician Decision|8|||
125981285|NCT02691182|453221170|FG000|Overall Study|Lack of Efficacy|0|||
125981286|NCT02691182|453221171|FG001|Overall Study|Lack of Efficacy|0|||
125981287|NCT02691182|453221172|FG002|Overall Study|Lack of Efficacy|0|||
125981288|NCT02691182|453221173|FG003|Overall Study|Lack of Efficacy|4|||
125981289|NCT02691182|453221170|FG000|Overall Study|Protocol Violation|2|||
125981290|NCT02691182|453221171|FG001|Overall Study|Protocol Violation|6|||
125981291|NCT02691182|453221172|FG002|Overall Study|Protocol Violation|6|||
125981292|NCT02691182|453221173|FG003|Overall Study|Protocol Violation|8|||
125981293|NCT02691182|453221170|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
125981294|NCT02691182|453221171|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
125981295|NCT02691182|453221172|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
125981296|NCT02691182|453221173|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
126318218|NCT01260584|454455966|FG000|Period 2|Protocol Violation|0|||
126318219|NCT01260584|454455967|FG001|Period 2|Protocol Violation|2|||
126318220|NCT01260584|454455968|FG002|Period 2|Protocol Violation|3|||
126318221|NCT01260584|454455969|FG003|Period 2|Protocol Violation|1|||
125981297|NCT02691182|453221170|FG000|Overall Study|Missing|0|||
125981298|NCT02691182|453221171|FG001|Overall Study|Missing|5|||
125981299|NCT02691182|453221172|FG002|Overall Study|Missing|1|||
125981300|NCT02691182|453221173|FG003|Overall Study|Missing|5|||
125981301|NCT02563002|453221174|FG000|Overall Study|Death|72|||
125981302|NCT02563002|453221175|FG001|Overall Study|Death|87|||
125981303|NCT02563002|453221174|FG000|Overall Study|Lost to Follow-up|5|||
125981304|NCT02563002|453221175|FG001|Overall Study|Lost to Follow-up|0|||
125981305|NCT02563002|453221174|FG000|Overall Study|Physician Decision|0|||
125981306|NCT02563002|453221175|FG001|Overall Study|Physician Decision|2|||
126318222|NCT01260584|454455966|FG000|Period 2|Adverse Event|1|||
126318223|NCT01260584|454455967|FG001|Period 2|Adverse Event|0|||
126318224|NCT01260584|454455968|FG002|Period 2|Adverse Event|2|||
125981307|NCT02563002|453221174|FG000|Overall Study|Withdrawal by Subject|2|||
125981308|NCT02563002|453221175|FG001|Overall Study|Withdrawal by Subject|10|||
125981309|NCT02563002|453221174|FG000|Overall Study|Sponsor decision|74|||
126318225|NCT01260584|454455969|FG003|Period 2|Adverse Event|0|||
126318226|NCT01260584|454455966|FG000|Period 2|Withdrawal by Subject|0|||
126318227|NCT01260584|454455967|FG001|Period 2|Withdrawal by Subject|1|||
126318228|NCT01260584|454455968|FG002|Period 2|Withdrawal by Subject|0|||
126318229|NCT01260584|454455969|FG003|Period 2|Withdrawal by Subject|0|||
126318230|NCT02918552|454455972|FG000|Overall Study|Failed Pharmacokinetics|1|||
126318231|NCT02918552|454455973|FG001|Overall Study|Failed Pharmacokinetics|0|||
126318232|NCT02918552|454455972|FG000|Overall Study|Withdrawal by Subject|0|||
126318233|NCT02918552|454455973|FG001|Overall Study|Withdrawal by Subject|1|||
126318234|NCT02918552|454455972|FG000|Overall Study|Lost to Follow-up|0|||
126318235|NCT02918552|454455973|FG001|Overall Study|Lost to Follow-up|1|||
126318236|NCT03325894|454455974|FG000|Overall Study|Adverse Event|2|||
126318237|NCT03325894|454455975|FG001|Overall Study|Adverse Event|3|||
126318238|NCT03325894|454455974|FG000|Overall Study|Protocol Violation|1|||
126318239|NCT03325894|454455975|FG001|Overall Study|Protocol Violation|2|||
126318240|NCT03325894|454455974|FG000|Overall Study|Withdrawal by Subject|10|||
126318241|NCT03325894|454455975|FG001|Overall Study|Withdrawal by Subject|6|||
126318242|NCT03325894|454455974|FG000|Overall Study|Lost to Follow-up|4|||
126318243|NCT03325894|454455975|FG001|Overall Study|Lost to Follow-up|9|||
126318244|NCT03325894|454455974|FG000|Overall Study|Lack of Efficacy|8|||
126318245|NCT03325894|454455975|FG001|Overall Study|Lack of Efficacy|14|||
126318246|NCT03325894|454455974|FG000|Overall Study|Study Terminated by Sponsor|38|||
126318247|NCT03325894|454455975|FG001|Overall Study|Study Terminated by Sponsor|43|||
126318248|NCT03325894|454455974|FG000|Overall Study|Other (Not received Treatment)|1|||
126318249|NCT03325894|454455975|FG001|Overall Study|Other (Not received Treatment)|0|||
126318250|NCT00824382|454455979|FG000|Overall Study|Adverse Event|4|||
126318251|NCT00824382|454455980|FG001|Overall Study|Adverse Event|1|||
126318252|NCT00824382|454455981|FG002|Overall Study|Adverse Event|1|||
126318253|NCT00824382|454455982|FG003|Overall Study|Adverse Event|4|||
126318254|NCT00824382|454455979|FG000|Overall Study|Protocol Violation|1|||
126318255|NCT00824382|454455980|FG001|Overall Study|Protocol Violation|0|||
126318256|NCT00824382|454455981|FG002|Overall Study|Protocol Violation|0|||
126318257|NCT00824382|454455982|FG003|Overall Study|Protocol Violation|1|||
126318258|NCT00824382|454455979|FG000|Overall Study|Investigator's decision|0|||
126318259|NCT00824382|454455980|FG001|Overall Study|Investigator's decision|1|||
126318260|NCT00824382|454455981|FG002|Overall Study|Investigator's decision|2|||
126318261|NCT00824382|454455982|FG003|Overall Study|Investigator's decision|0|||
126318262|NCT01362244|454455983|FG000|Overall Study|Adverse Event|3|||
126318263|NCT01362244|454455984|FG001|Overall Study|Adverse Event|5|||
126318264|NCT01362244|454455983|FG000|Overall Study|Lack of Efficacy|5|||
126318265|NCT01362244|454455984|FG001|Overall Study|Lack of Efficacy|11|||
126318266|NCT01362244|454455983|FG000|Overall Study|Lost to Follow-up|0|||
126318267|NCT01362244|454455984|FG001|Overall Study|Lost to Follow-up|2|||
126318268|NCT01362244|454455983|FG000|Overall Study|Protocol Violation|5|||
126318269|NCT01362244|454455984|FG001|Overall Study|Protocol Violation|1|||
126318270|NCT01362244|454455983|FG000|Overall Study|Withdrawal by Subject|2|||
126318271|NCT01362244|454455984|FG001|Overall Study|Withdrawal by Subject|1|||
126318272|NCT01362244|454455983|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
126318273|NCT01362244|454455984|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
126318274|NCT01362244|454455983|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
126318275|NCT01362244|454455984|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
126318276|NCT05153148|454455985|FG000|Overall Study|Adverse Event|1|||
126318277|NCT05153148|454455986|FG001|Overall Study|Adverse Event|0|||
126318278|NCT05153148|454455987|FG002|Overall Study|Adverse Event|3|||
126318279|NCT05153148|454455988|FG003|Overall Study|Adverse Event|5|||
126318280|NCT05153148|454455985|FG000|Overall Study|Lost to Follow-up|1|||
126318281|NCT05153148|454455986|FG001|Overall Study|Lost to Follow-up|1|||
126318282|NCT05153148|454455987|FG002|Overall Study|Lost to Follow-up|2|||
125981310|NCT02563002|453221175|FG001|Overall Study|Sponsor decision|55|||
126318283|NCT05153148|454455988|FG003|Overall Study|Lost to Follow-up|0|||
126318284|NCT05153148|454455985|FG000|Overall Study|Withdrawal by Subject|6|||
126318285|NCT05153148|454455986|FG001|Overall Study|Withdrawal by Subject|8|||
126318286|NCT05153148|454455987|FG002|Overall Study|Withdrawal by Subject|6|||
126318287|NCT05153148|454455988|FG003|Overall Study|Withdrawal by Subject|8|||
126318288|NCT05153148|454455985|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
126318289|NCT05153148|454455986|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
126318290|NCT05153148|454455987|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
126318291|NCT05153148|454455988|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
126318292|NCT05153148|454455985|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
126318293|NCT05153148|454455986|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
126318294|NCT05153148|454455987|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
126318295|NCT05153148|454455988|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
126318296|NCT05153148|454455985|FG000|Overall Study|Reason not Specified|1|||
126318297|NCT05153148|454455986|FG001|Overall Study|Reason not Specified|1|||
126318298|NCT05153148|454455987|FG002|Overall Study|Reason not Specified|1|||
126318299|NCT05153148|454455988|FG003|Overall Study|Reason not Specified|1|||
126318300|NCT01712334|454455991|FG000|Treatment Period 1|Randomized in Error|0|||
126318301|NCT01712334|454455992|FG001|Treatment Period 1|Randomized in Error|2|||
125981311|NCT02054806|453221177|FG000|Overall Study|Sponsor Decision|31|||
125981312|NCT02054806|453221177|FG000|Overall Study|Withdrawal by Subject|43|||
125981313|NCT02054806|453221177|FG000|Overall Study|Protocol Violation|2|||
125981314|NCT02054806|453221177|FG000|Overall Study|Lost to Follow-up|10|||
125981315|NCT02054806|453221177|FG000|Overall Study|Death|391|||
125981316|NCT01113502|453221180|FG000|Overall Study|Withdrawal by Subject|1|||
125981317|NCT01113502|453221181|FG001|Overall Study|Withdrawal by Subject|0|||
125981318|NCT01113502|453221182|FG002|Overall Study|Withdrawal by Subject|1|||
125981319|NCT01113502|453221183|FG003|Overall Study|Withdrawal by Subject|1|||
125981320|NCT01113502|453221184|FG004|Overall Study|Withdrawal by Subject|0|||
125981321|NCT01113502|453221180|FG000|Overall Study|Adverse Event|0|||
125981322|NCT01113502|453221181|FG001|Overall Study|Adverse Event|0|||
125981323|NCT01113502|453221182|FG002|Overall Study|Adverse Event|3|||
125981324|NCT01113502|453221183|FG003|Overall Study|Adverse Event|2|||
125981325|NCT01113502|453221184|FG004|Overall Study|Adverse Event|0|||
125981326|NCT03002610|453221193|FG000|Overall Study|Withdrawal by Subject|6|||
125981327|NCT03002610|453221194|FG001|Overall Study|Withdrawal by Subject|25|||
125981328|NCT03002610|453221195|FG002|Overall Study|Withdrawal by Subject|13|||
125981329|NCT00645164|453221198|FG000|Overall Study|Lost to Follow-up|2|||
125981330|NCT00645164|453221198|FG000|Overall Study|Withdrawal by Subject|4|||
125981331|NCT00645164|453221198|FG000|Overall Study|Protocol Violation|1|||
125981332|NCT01362439|453221201|FG000|Overall Study|Adverse Event|1|||
125981333|NCT01362439|453221201|FG000|Overall Study|Lack of Efficacy|3|||
125981334|NCT01362439|453221201|FG000|Overall Study|Lost to Follow-up|2|||
125981335|NCT01362439|453221201|FG000|Overall Study|Study medication non-compliant|1|||
125981336|NCT01362439|453221201|FG000|Overall Study|Participant who withdrew consent|8|||
125981337|NCT01755702|453221203|FG000|Wash Out Period I|Other Reason|3|||
125981338|NCT01755702|453221203|FG000|Washout Period II|Other Reason|5|||
125981339|NCT00691938|453221204|FG000|Overall Study|QTc prolongation|1|||
125981340|NCT00691938|453221205|FG001|Overall Study|QTc prolongation|0|||
125981341|NCT00691938|453221206|FG002|Overall Study|QTc prolongation|0|||
125981342|NCT00691938|453221207|FG003|Overall Study|QTc prolongation|0|||
125981343|NCT00691938|453221208|FG004|Overall Study|QTc prolongation|0|||
125981344|NCT00691938|453221209|FG005|Overall Study|QTc prolongation|0|||
125981345|NCT00691938|453221210|FG006|Overall Study|QTc prolongation|0|||
125981346|NCT04860518|453221211|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
125981347|NCT04860518|453221212|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
125981348|NCT03641313|453221224|FG000|Overall Study|Death|1|||
125981349|NCT03641313|453221224|FG000|Overall Study|Withdrawal by Subject|2|||
125981350|NCT03641313|453221224|FG000|Overall Study|Declining health|1|||
125981351|NCT03641313|453221224|FG000|Overall Study|Adverse Event|1|||
125981352|NCT04642898|453221225|FG000|Overall Study|Withdrawal by Subject|2|||
125981353|NCT04642898|453221226|FG001|Overall Study|Withdrawal by Subject|4|||
125981354|NCT04642898|453221227|FG002|Overall Study|Withdrawal by Subject|4|||
125981355|NCT04642898|453221228|FG003|Overall Study|Withdrawal by Subject|6|||
125981356|NCT04642898|453221229|FG004|Overall Study|Withdrawal by Subject|2|||
125981357|NCT04642898|453221230|FG005|Overall Study|Withdrawal by Subject|6|||
125981358|NCT04642898|453221225|FG000|Overall Study|Lost to Follow-up|0|||
125981359|NCT04642898|453221226|FG001|Overall Study|Lost to Follow-up|0|||
125981360|NCT04642898|453221227|FG002|Overall Study|Lost to Follow-up|0|||
125981361|NCT04642898|453221228|FG003|Overall Study|Lost to Follow-up|2|||
125981362|NCT04642898|453221229|FG004|Overall Study|Lost to Follow-up|0|||
125981363|NCT04642898|453221230|FG005|Overall Study|Lost to Follow-up|1|||
125981364|NCT04642898|453221225|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
125981365|NCT04642898|453221226|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
125981366|NCT04642898|453221227|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
125981367|NCT04642898|453221228|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
125981368|NCT04642898|453221229|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
125981369|NCT04642898|453221230|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
125981370|NCT04642898|453221225|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125981371|NCT04642898|453221226|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125981372|NCT04642898|453221227|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125981373|NCT04642898|453221228|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125981374|NCT04642898|453221229|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
125981375|NCT04642898|453221230|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125981376|NCT03574597|453221231|FG000|Overall Study|Withdrawal by Subject|67|||
125981377|NCT03574597|453221232|FG001|Overall Study|Withdrawal by Subject|96|||
125981378|NCT03574597|453221231|FG000|Overall Study|Lost to Follow-up|192|||
125981379|NCT03574597|453221232|FG001|Overall Study|Lost to Follow-up|188|||
125981380|NCT03434678|453221233|FG000|Overall Study|Withdrawal by Subject|13|||
125981381|NCT03434678|453221234|FG001|Overall Study|Withdrawal by Subject|13|||
125981382|NCT03434678|453221233|FG000|Overall Study|Found to be ineligible post randomization|2|||
125981383|NCT03434678|453221234|FG001|Overall Study|Found to be ineligible post randomization|1|||
125981384|NCT06060457|453221237|FG000|Overall Study|Adverse Event|1|||
125981385|NCT06060457|453221238|FG001|Overall Study|Adverse Event|1|||
125981386|NCT06060457|453221237|FG000|Overall Study|Death|2|||
125981387|NCT06060457|453221238|FG001|Overall Study|Death|2|||
125981388|NCT06060457|453221237|FG000|Overall Study|Lost to Follow-up|17|||
125981389|NCT06060457|453221238|FG001|Overall Study|Lost to Follow-up|19|||
125981390|NCT06060457|453221237|FG000|Overall Study|Physician Decision|0|||
125981391|NCT06060457|453221238|FG001|Overall Study|Physician Decision|1|||
125981392|NCT06060457|453221237|FG000|Overall Study|Protocol Violation|1|||
125981393|NCT06060457|453221238|FG001|Overall Study|Protocol Violation|1|||
125981394|NCT06060457|453221237|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
125981395|NCT06060457|453221238|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
125981396|NCT06060457|453221237|FG000|Overall Study|Withdrawal by Subject|12|||
125981397|NCT06060457|453221238|FG001|Overall Study|Withdrawal by Subject|15|||
125981398|NCT06060457|453221237|FG000|Overall Study|Other Than Specified|2|||
125981399|NCT06060457|453221238|FG001|Overall Study|Other Than Specified|1|||
125981400|NCT02061202|453221239|FG000|Overall Study|Lost to Follow-up|1|||
125981401|NCT02061202|453221240|FG001|Overall Study|Lost to Follow-up|1|||
125981402|NCT00569582|453221244|FG000|Overall Study|Withdrawal by Subject|5|||
125981403|NCT00569582|453221244|FG000|Overall Study|Death|2|||
125981404|NCT00569582|453221244|FG000|Overall Study|Adverse Event|7|||
125981405|NCT00569582|453221244|FG000|Overall Study|Subject was too ill to travel.|1|||
125981406|NCT00569582|453221244|FG000|Overall Study|Subject was non-compliant.|1|||
125981407|NCT01533493|453221245|FG000|Overall Study|Adverse Event|2|||
125981408|NCT01533493|453221246|FG001|Overall Study|Adverse Event|1|||
125981409|NCT01533493|453221245|FG000|Overall Study|Withdrawal by Subject|1|||
125981410|NCT01533493|453221246|FG001|Overall Study|Withdrawal by Subject|2|||
125981411|NCT01533493|453221245|FG000|Overall Study|Lost to Follow-up|2|||
125981412|NCT01533493|453221246|FG001|Overall Study|Lost to Follow-up|0|||
125981413|NCT03419364|453221247|FG000|Overall Study|Delivery due to maternal condition|2|||
125981414|NCT03419364|453221248|FG001|Overall Study|Delivery due to maternal condition|0|||
125981415|NCT03419364|453221249|FG002|Overall Study|Delivery due to maternal condition|0|||
125981416|NCT01338025|453221253|FG000|Overall Study|Unexpected closure of study|10|||
125981417|NCT01338025|453221254|FG001|Overall Study|Unexpected closure of study|9|||
125981418|NCT01338025|453221253|FG000|Overall Study|Withdrawal by Subject|0|||
125981419|NCT01338025|453221254|FG001|Overall Study|Withdrawal by Subject|2|||
125981420|NCT01338025|453221253|FG000|Overall Study|Found ineligible after starting|1|||
125981421|NCT01338025|453221254|FG001|Overall Study|Found ineligible after starting|0|||
125981422|NCT04120233|453221255|FG000|Overall Study|Adverse Event|0|||
125981423|NCT04120233|453221256|FG001|Overall Study|Adverse Event|0|||
125981424|NCT04120233|453221257|FG002|Overall Study|Adverse Event|0|||
125981425|NCT04120233|453221258|FG003|Overall Study|Adverse Event|0|||
125981426|NCT04120233|453221259|FG004|Overall Study|Adverse Event|1|||
125981427|NCT04120233|453221260|FG005|Overall Study|Adverse Event|0|||
125981428|NCT03779906|453221261|FG000|Overall Study|Lost to Follow-up|7|||
125981429|NCT03779906|453221261|FG000|Overall Study|COVID pandemic|1|||
125981430|NCT01194570|453222253|FG000|Overall Study|Adverse Event|22|||
125981431|NCT01194570|453222254|FG001|Overall Study|Adverse Event|40|||
125981432|NCT01194570|453222253|FG000|Overall Study|Death|6|||
125981433|NCT01194570|453222254|FG001|Overall Study|Death|20|||
125981434|NCT01194570|453222253|FG000|Overall Study|Lack of Efficacy|32|||
125981435|NCT01194570|453222254|FG001|Overall Study|Lack of Efficacy|33|||
125981436|NCT01194570|453222253|FG000|Overall Study|Lost to Follow-up|4|||
125981437|NCT01194570|453222254|FG001|Overall Study|Lost to Follow-up|15|||
125981438|NCT01194570|453222253|FG000|Overall Study|Non-Compliance|2|||
125981439|NCT01194570|453222254|FG001|Overall Study|Non-Compliance|2|||
125981440|NCT01194570|453222253|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125981441|NCT01194570|453222254|FG001|Overall Study|Non-Compliance With Study Drug|2|||
125981442|NCT01194570|453222253|FG000|Overall Study|Other|18|||
125981443|NCT01194570|453222254|FG001|Overall Study|Other|47|||
125981444|NCT01194570|453222253|FG000|Overall Study|Physician Decision|10|||
125981445|NCT01194570|453222254|FG001|Overall Study|Physician Decision|25|||
125981446|NCT01194570|453222253|FG000|Overall Study|Protocol Violation|1|||
125981447|NCT01194570|453222254|FG001|Overall Study|Protocol Violation|2|||
125981448|NCT01194570|453222253|FG000|Overall Study|Study Terminated By Sponsor|0|||
125981449|NCT01194570|453222254|FG001|Overall Study|Study Terminated By Sponsor|1|||
125981450|NCT01194570|453222253|FG000|Overall Study|Withdrawal by Subject|57|||
125981451|NCT01194570|453222254|FG001|Overall Study|Withdrawal by Subject|82|||
125981452|NCT01194570|453222253|FG000|Overall Study|Pregnancy|1|||
125981453|NCT01194570|453222254|FG001|Overall Study|Pregnancy|1|||
125981454|NCT01337674|453222255|FG000|Treatment Period 1|Adverse Event|0|||
125981455|NCT01337674|453222256|FG001|Treatment Period 1|Adverse Event|1|||
125981456|NCT01337674|453222257|FG002|Treatment Period 1|Adverse Event|0|||
125981457|NCT01337674|453222258|FG003|Treatment Period 1|Adverse Event|0|||
125981458|NCT01337674|453222255|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
125981459|NCT01337674|453222256|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
125981460|NCT01337674|453222257|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
125981461|NCT01337674|453222258|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
125981462|NCT01337674|453222255|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125981463|NCT01337674|453222256|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125981464|NCT01337674|453222257|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125981465|NCT01337674|453222258|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126318302|NCT00232596|454455993|FG000|6-Week Titration Phase|Adverse Event|6|||
125981466|NCT00939484|453222262|FG000|Overall Study|Progression/Relapse|8|||
125981467|NCT00939484|453222263|FG001|Overall Study|Progression/Relapse|20|||
125981468|NCT00939484|453222264|FG002|Overall Study|Progression/Relapse|3|||
125981469|NCT01224925|453222265|FG000|Overall Study|Lost to Follow-up|3|||
125981470|NCT01224925|453222266|FG001|Overall Study|Lost to Follow-up|2|||
125981471|NCT02178059|453222267|FG000|Washout|Physician Decision|1|||
125981472|NCT02178059|453222268|FG001|Washout|Physician Decision|0|||
125981473|NCT05178121|453222269|FG000|Overall Study|Other|4|||
125981474|NCT05178121|453222269|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
126318303|NCT00232596|454455994|FG001|6-Week Titration Phase|Adverse Event|19|||
126318304|NCT00232596|454455993|FG000|6-Week Titration Phase|Failed to Return|2|||
126318305|NCT00232596|454455994|FG001|6-Week Titration Phase|Failed to Return|1|||
126318306|NCT00232596|454455993|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
126318307|NCT00232596|454455994|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
126318308|NCT00232596|454455993|FG000|6-Week Titration Phase|Protocol Violation|1|||
126318309|NCT00232596|454455994|FG001|6-Week Titration Phase|Protocol Violation|3|||
126318310|NCT00232596|454455993|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
126318311|NCT00232596|454455994|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
126318312|NCT00232596|454455993|FG000|6-Week Titration Phase|Other|3|||
126318313|NCT00232596|454455994|FG001|6-Week Titration Phase|Other|3|||
126318314|NCT00232596|454455993|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
126318315|NCT00232596|454455994|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
126318316|NCT00232596|454455993|FG000|12-Week Maintenance Phase|Adverse Event|7|||
126318317|NCT00232596|454455994|FG001|12-Week Maintenance Phase|Adverse Event|22|||
126318318|NCT00232596|454455993|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
126318319|NCT00232596|454455994|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
126318320|NCT00232596|454455993|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
126318321|NCT00232596|454455994|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
126318322|NCT00232596|454455993|FG000|12-Week Maintenance Phase|Other|1|||
126318323|NCT00232596|454455994|FG001|12-Week Maintenance Phase|Other|3|||
126318324|NCT01732471|454455995|FG000|Overall Study|Withdrawal by Subject|1|||
126318325|NCT01253174|454455996|FG000|Period 1|Randomized but not treated|0|||
126318326|NCT01253174|454455997|FG001|Period 1|Randomized but not treated|1|||
126318327|NCT01253174|454455998|FG002|Period 1|Randomized but not treated|1|||
126318328|NCT01253174|454455999|FG003|Period 1|Randomized but not treated|0|||
126318329|NCT01253174|454456000|FG004|Period 1|Randomized but not treated|1|||
126318330|NCT01253174|454456001|FG005|Period 1|Randomized but not treated|0|||
126318331|NCT01253174|454455996|FG000|Period 2|Adverse Event|0|||
126318332|NCT01253174|454455997|FG001|Period 2|Adverse Event|0|||
126318333|NCT01253174|454455998|FG002|Period 2|Adverse Event|1|||
126318334|NCT01253174|454455999|FG003|Period 2|Adverse Event|0|||
126318335|NCT01253174|454456000|FG004|Period 2|Adverse Event|0|||
126318336|NCT01253174|454456001|FG005|Period 2|Adverse Event|0|||
126318337|NCT01253174|454455996|FG000|Period 3|Withdrawal by Subject|0|||
126318338|NCT01253174|454455997|FG001|Period 3|Withdrawal by Subject|1|||
125878358|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
125878359|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
125878360|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
125878361|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
125878362|NCT03605667|452851282|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
125878363|NCT03605667|452851283|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
125878364|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
125878365|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
125878366|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Other|6|||
126318339|NCT01253174|454455998|FG002|Period 3|Withdrawal by Subject|0|||
126318340|NCT01253174|454455999|FG003|Period 3|Withdrawal by Subject|0|||
126318341|NCT01253174|454456000|FG004|Period 3|Withdrawal by Subject|1|||
126318342|NCT01253174|454456001|FG005|Period 3|Withdrawal by Subject|0|||
126318343|NCT01253174|454455996|FG000|Period 3|Pregnancy|0|||
126318344|NCT01253174|454455997|FG001|Period 3|Pregnancy|0|||
126318345|NCT01253174|454455998|FG002|Period 3|Pregnancy|1|||
126318346|NCT01253174|454455999|FG003|Period 3|Pregnancy|0|||
126318347|NCT01253174|454456000|FG004|Period 3|Pregnancy|0|||
126318348|NCT01253174|454456001|FG005|Period 3|Pregnancy|0|||
126318349|NCT03426436|454456002|FG000|Overall Study|Incorrect lead placement|12|||
126318350|NCT03426436|454456002|FG000|Overall Study|Withdrawal by Subject|2|||
126318351|NCT03426436|454456002|FG000|Overall Study|Consent issue|1|||
125981475|NCT00245102|453222270|FG000|Overall Study|Not Treated|1|||
125981476|NCT00245102|453222271|FG001|Overall Study|Not Treated|0|||
125981477|NCT00245102|453222272|FG002|Overall Study|Not Treated|1|||
126318352|NCT03426436|454456002|FG000|Overall Study|ECGs not saved|4|||
126318353|NCT02892513|454456003|FG000|Overall Study|Withdrawal by Subject|0|||
125981478|NCT00245102|453222273|FG003|Overall Study|Not Treated|0|||
125981479|NCT00245102|453222274|FG004|Overall Study|Not Treated|0|||
125981480|NCT00245102|453222275|FG005|Overall Study|Not Treated|0|||
125981481|NCT00245102|453222270|FG000|Overall Study|Protocol Violation|1|||
125981482|NCT00245102|453222271|FG001|Overall Study|Protocol Violation|0|||
125981483|NCT00245102|453222272|FG002|Overall Study|Protocol Violation|0|||
125981484|NCT00245102|453222273|FG003|Overall Study|Protocol Violation|0|||
125981485|NCT00245102|453222274|FG004|Overall Study|Protocol Violation|0|||
125981486|NCT00245102|453222275|FG005|Overall Study|Protocol Violation|0|||
125981487|NCT00245102|453222270|FG000|Overall Study|Death|0|||
125981488|NCT00245102|453222271|FG001|Overall Study|Death|0|||
125981489|NCT00245102|453222272|FG002|Overall Study|Death|0|||
125981490|NCT00245102|453222273|FG003|Overall Study|Death|1|||
125981491|NCT00245102|453222274|FG004|Overall Study|Death|0|||
125981492|NCT00245102|453222275|FG005|Overall Study|Death|0|||
125981493|NCT00245102|453222270|FG000|Overall Study|Adverse Event|4|||
125981494|NCT00245102|453222271|FG001|Overall Study|Adverse Event|2|||
125981495|NCT00245102|453222272|FG002|Overall Study|Adverse Event|5|||
125981496|NCT00245102|453222273|FG003|Overall Study|Adverse Event|1|||
125981497|NCT00245102|453222274|FG004|Overall Study|Adverse Event|0|||
125981498|NCT00245102|453222275|FG005|Overall Study|Adverse Event|2|||
125981499|NCT00245102|453222270|FG000|Overall Study|Decline in performance|0|||
125981500|NCT00245102|453222271|FG001|Overall Study|Decline in performance|2|||
125981501|NCT00245102|453222272|FG002|Overall Study|Decline in performance|0|||
125981502|NCT00245102|453222273|FG003|Overall Study|Decline in performance|1|||
125981503|NCT00245102|453222274|FG004|Overall Study|Decline in performance|0|||
125981504|NCT00245102|453222275|FG005|Overall Study|Decline in performance|2|||
125981505|NCT00245102|453222270|FG000|Overall Study|Participant needed surgery|0|||
125981506|NCT00245102|453222271|FG001|Overall Study|Participant needed surgery|0|||
125981507|NCT00245102|453222272|FG002|Overall Study|Participant needed surgery|1|||
125981508|NCT00245102|453222273|FG003|Overall Study|Participant needed surgery|0|||
125981509|NCT00245102|453222274|FG004|Overall Study|Participant needed surgery|0|||
125981510|NCT00245102|453222275|FG005|Overall Study|Participant needed surgery|0|||
125981511|NCT00245102|453222270|FG000|Overall Study|Clinical progression|1|||
125981512|NCT00245102|453222271|FG001|Overall Study|Clinical progression|0|||
125981513|NCT00245102|453222272|FG002|Overall Study|Clinical progression|0|||
125981514|NCT00245102|453222273|FG003|Overall Study|Clinical progression|0|||
125981515|NCT00245102|453222274|FG004|Overall Study|Clinical progression|0|||
125981516|NCT00245102|453222275|FG005|Overall Study|Clinical progression|0|||
125981517|NCT02035332|453222278|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
125981518|NCT00838682|453222279|FG000|Overall Study|Lost to Follow-up|21|||
125981519|NCT00838682|453222280|FG001|Overall Study|Lost to Follow-up|14|||
125981520|NCT00838682|453222279|FG000|Overall Study|detection of exclusion criteria|4|||
125981521|NCT00838682|453222280|FG001|Overall Study|detection of exclusion criteria|3|||
125981522|NCT00838682|453222279|FG000|Overall Study|Protocol Violation|0|||
125981523|NCT00838682|453222280|FG001|Overall Study|Protocol Violation|1|||
125981524|NCT00838682|453222279|FG000|Overall Study|Withdrawal by Subject|0|||
125981525|NCT00838682|453222280|FG001|Overall Study|Withdrawal by Subject|1|||
125981526|NCT03315143|453222283|FG000|Overall Study|Death|240|||
125981527|NCT03315143|453222284|FG001|Overall Study|Death|246|||
125981528|NCT03315143|453222283|FG000|Overall Study|Withdrawal by Subject|57|||
125981529|NCT03315143|453222284|FG001|Overall Study|Withdrawal by Subject|68|||
125981530|NCT03315143|453222283|FG000|Overall Study|Site Terminated by Sponsor|256|||
125981531|NCT03315143|453222284|FG001|Overall Study|Site Terminated by Sponsor|282|||
125981532|NCT03315143|453222283|FG000|Overall Study|Study Terminated by Sponsor|4723|||
125981533|NCT03315143|453222284|FG001|Overall Study|Study Terminated by Sponsor|4664|||
125981534|NCT03315143|453222283|FG000|Overall Study|Reason not Specified|16|||
125981535|NCT03315143|453222284|FG001|Overall Study|Reason not Specified|32|||
125981536|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
125981537|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
125981538|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
125981539|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
125981540|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
125981541|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
125981542|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
125981543|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
126208871|NCT04668066|454053116|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208872|NCT04668066|454053117|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208873|NCT04668066|454053118|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208874|NCT04668066|454053119|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208875|NCT04668066|454053120|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208876|NCT04668066|454053121|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208877|NCT04668066|454053122|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208878|NCT04668066|454053123|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208879|NCT04668066|454053124|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
126208880|NCT04668066|454053125|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
126318354|NCT02892513|454456004|FG001|Overall Study|Withdrawal by Subject|1|||
126318355|NCT02919267|454456005|FG000|Overall Study|Protocol Violation|0|||
126318356|NCT02919267|454456006|FG001|Overall Study|Protocol Violation|3|||
126318357|NCT02919267|454456007|FG002|Overall Study|Protocol Violation|3|||
126318358|NCT02919267|454456008|FG003|Overall Study|Protocol Violation|4|||
126318359|NCT02407054|454456009|FG000|Overall Study|Adverse Event|1|||
126318360|NCT02407054|454456010|FG001|Overall Study|Adverse Event|4|||
126318361|NCT02407054|454456011|FG002|Overall Study|Adverse Event|1|||
126318362|NCT02407054|454456009|FG000|Overall Study|Non-compliance with Study|0|||
126318363|NCT02407054|454456010|FG001|Overall Study|Non-compliance with Study|2|||
126318364|NCT02407054|454456011|FG002|Overall Study|Non-compliance with Study|1|||
126318365|NCT02407054|454456009|FG000|Overall Study|Physician Decision|1|||
126318366|NCT02407054|454456010|FG001|Overall Study|Physician Decision|3|||
126318367|NCT02407054|454456011|FG002|Overall Study|Physician Decision|3|||
126318368|NCT02407054|454456009|FG000|Overall Study|Withdrawal by Subject|5|||
126318369|NCT02407054|454456010|FG001|Overall Study|Withdrawal by Subject|9|||
126318370|NCT02407054|454456011|FG002|Overall Study|Withdrawal by Subject|2|||
126318371|NCT00131365|454456012|FG000|Overall Study|Withdrawal by Subject|1|||
126318372|NCT00131365|454456012|FG000|Overall Study|Alternative treatment|3|||
126318373|NCT04608344|454456013|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
126318374|NCT04608344|454456014|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
126318375|NCT04608344|454456013|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
126318376|NCT04608344|454456014|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
126318377|NCT02044874|454456015|FG000|Overall Study|Adverse Event|5|||
126318378|NCT02044874|454456016|FG001|Overall Study|Adverse Event|6|||
126318379|NCT02044874|454456017|FG002|Overall Study|Adverse Event|6|||
126318380|NCT02044874|454456015|FG000|Overall Study|Withdrawal by Subject|8|||
126318381|NCT02044874|454456016|FG001|Overall Study|Withdrawal by Subject|16|||
126318382|NCT02044874|454456017|FG002|Overall Study|Withdrawal by Subject|23|||
126318383|NCT02044874|454456015|FG000|Overall Study|Physician Decision|0|||
126318384|NCT02044874|454456016|FG001|Overall Study|Physician Decision|2|||
126318385|NCT02044874|454456017|FG002|Overall Study|Physician Decision|1|||
126318386|NCT02044874|454456015|FG000|Overall Study|Lost to Follow-up|10|||
126318387|NCT02044874|454456016|FG001|Overall Study|Lost to Follow-up|27|||
126318388|NCT02044874|454456017|FG002|Overall Study|Lost to Follow-up|21|||
126318389|NCT02044874|454456015|FG000|Overall Study|Sponsor Decision|0|||
126318390|NCT02044874|454456016|FG001|Overall Study|Sponsor Decision|1|||
126318391|NCT02044874|454456017|FG002|Overall Study|Sponsor Decision|1|||
125981544|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
125981545|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
125981546|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
125981547|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
125981548|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
125981549|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
125981550|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
125981551|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
125981552|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
125981553|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
125981554|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
125981555|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
125981556|NCT00549757|453222285|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
125981557|NCT00549757|453222286|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
125981558|NCT00549757|453222285|FG000|Extension Period (in Average 9 Months)|Death|143|||
125981559|NCT00549757|453222286|FG001|Extension Period (in Average 9 Months)|Death|136|||
125981560|NCT00549757|453222285|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
125981561|NCT00549757|453222286|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
125981562|NCT00549757|453222285|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
125981563|NCT00549757|453222286|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
125981564|NCT00549757|453222285|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
125981565|NCT00549757|453222286|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
125981566|NCT02641392|453222287|FG000|Overall Study|Lost to Follow-up|0|||
125981567|NCT02641392|453222288|FG001|Overall Study|Lost to Follow-up|0|||
125981568|NCT02641392|453222289|FG002|Overall Study|Lost to Follow-up|2|||
125981569|NCT02641392|453222287|FG000|Overall Study|Withdrawal by Subject|0|||
125981570|NCT02641392|453222288|FG001|Overall Study|Withdrawal by Subject|0|||
125981571|NCT02641392|453222289|FG002|Overall Study|Withdrawal by Subject|17|||
126318392|NCT02044874|454456015|FG000|Overall Study|Other|7|||
126318393|NCT02044874|454456016|FG001|Overall Study|Other|3|||
126318394|NCT02044874|454456017|FG002|Overall Study|Other|8|||
126318395|NCT00415597|454456018|FG000|Enrollment|Withdrawal by Subject|1|||
126318396|NCT00415597|454456018|FG000|Enrollment|Protocol Violation|1|||
126318397|NCT00415597|454456018|FG000|Treatment|Adverse Event|110|||
126318398|NCT00415597|454456018|FG000|Treatment|Lack of Efficacy|39|||
126318399|NCT00415597|454456018|FG000|Treatment|Protocol Violation|67|||
125981572|NCT02641392|453222287|FG000|Overall Study|Adverse Event|0|||
125981573|NCT02641392|453222288|FG001|Overall Study|Adverse Event|1|||
125981574|NCT02641392|453222289|FG002|Overall Study|Adverse Event|25|||
125981575|NCT02641392|453222287|FG000|Overall Study|Study Terminated by Sponsor|4|||
125981576|NCT02641392|453222288|FG001|Overall Study|Study Terminated by Sponsor|12|||
125981577|NCT02641392|453222289|FG002|Overall Study|Study Terminated by Sponsor|144|||
125981578|NCT02641392|453222287|FG000|Overall Study|Lack of Efficacy|0|||
125981579|NCT02641392|453222288|FG001|Overall Study|Lack of Efficacy|0|||
125981580|NCT02641392|453222289|FG002|Overall Study|Lack of Efficacy|101|||
125981581|NCT02641392|453222287|FG000|Overall Study|Miscellaneous|0|||
125981582|NCT02641392|453222288|FG001|Overall Study|Miscellaneous|0|||
125981583|NCT02641392|453222289|FG002|Overall Study|Miscellaneous|3|||
125981584|NCT02641392|453222287|FG000|Overall Study|Death|0|||
125981585|NCT02641392|453222288|FG001|Overall Study|Death|0|||
125981586|NCT02641392|453222289|FG002|Overall Study|Death|1|||
125981587|NCT02227875|453222294|FG000|Overall Study|Protocol Violation|10|||
125981588|NCT02227875|453222295|FG001|Overall Study|Protocol Violation|7|||
125981589|NCT02227875|453222294|FG000|Overall Study|Other|1|||
125981590|NCT02227875|453222295|FG001|Overall Study|Other|3|||
125981591|NCT02227875|453222294|FG000|Overall Study|Physician Decision|1|||
125981592|NCT02227875|453222295|FG001|Overall Study|Physician Decision|0|||
125981593|NCT02227875|453222294|FG000|Overall Study|Adverse Event|3|||
125981594|NCT02227875|453222295|FG001|Overall Study|Adverse Event|0|||
125981595|NCT02227875|453222294|FG000|Overall Study|Withdrawal by Subject|12|||
125981596|NCT02227875|453222295|FG001|Overall Study|Withdrawal by Subject|13|||
125981597|NCT02227875|453222294|FG000|Overall Study|Lost to Follow-up|10|||
125981598|NCT02227875|453222295|FG001|Overall Study|Lost to Follow-up|10|||
125981599|NCT03033225|453222296|FG000|Overall Study|Withdrawal by Subject|5|||
125981600|NCT05163522|453222299|FG000|Overall Study|Withdrawal by Subject|0|||
125981601|NCT05163522|453222300|FG001|Overall Study|Withdrawal by Subject|0|||
125981602|NCT05163522|453222301|FG002|Overall Study|Withdrawal by Subject|1|||
125981603|NCT05163522|453222302|FG003|Overall Study|Withdrawal by Subject|0|||
125981604|NCT05163522|453222303|FG004|Overall Study|Withdrawal by Subject|0|||
125981605|NCT05163522|453222304|FG005|Overall Study|Withdrawal by Subject|0|||
125981606|NCT05163522|453222305|FG006|Overall Study|Withdrawal by Subject|0|||
125981607|NCT05163522|453222306|FG007|Overall Study|Withdrawal by Subject|0|||
125981608|NCT05163522|453222307|FG008|Overall Study|Withdrawal by Subject|0|||
125981609|NCT05163522|453222308|FG009|Overall Study|Withdrawal by Subject|0|||
125981610|NCT05163522|453222309|FG010|Overall Study|Withdrawal by Subject|0|||
125981611|NCT03412396|453222310|FG000|Overall Study|Withdrawal by Subject|2|||
125981612|NCT03412396|453222310|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
125981613|NCT03412396|453222310|FG000|Overall Study|Did not undergo RP|2|||
125981614|NCT02753595|453222318|FG000|Overall Study|Sponsor termination|2|||
125981615|NCT02753595|453222319|FG001|Overall Study|Sponsor termination|2|||
125981616|NCT01570868|453222320|FG000|Overall Study|Adverse Event|8|||
125981617|NCT01570868|453222321|FG001|Overall Study|Adverse Event|1|||
125981618|NCT01570868|453222320|FG000|Overall Study|FDA Recommendation|23|||
125981619|NCT01570868|453222321|FG001|Overall Study|FDA Recommendation|3|||
125981620|NCT01570868|453222320|FG000|Overall Study|Physician Decision|10|||
125981621|NCT01570868|453222321|FG001|Overall Study|Physician Decision|4|||
125981622|NCT01570868|453222320|FG000|Overall Study|Lost to Follow-up|1|||
125981623|NCT01570868|453222321|FG001|Overall Study|Lost to Follow-up|0|||
125981624|NCT01570868|453222320|FG000|Overall Study|Withdrawal by Subject|1|||
125981625|NCT01570868|453222321|FG001|Overall Study|Withdrawal by Subject|0|||
125981626|NCT02515279|453222325|FG000|Overall Study|Adverse Event|7|||
125981627|NCT02515279|453222325|FG000|Overall Study|Lack of Efficacy|31|||
125981628|NCT02515279|453222325|FG000|Overall Study|Lost to Follow-up|9|||
125981629|NCT02515279|453222325|FG000|Overall Study|Withdrawal by Subject|18|||
125981630|NCT02515279|453222325|FG000|Overall Study|End-of-treatment visit not attended|17|||
125981631|NCT02515279|453222325|FG000|Overall Study|Other|22|||
125981632|NCT01800968|453222326|FG000|Overall Study|Death|23|||
125981633|NCT01800968|453222327|FG001|Overall Study|Death|16|||
125981634|NCT01800968|453222326|FG000|Overall Study|Lost to Follow-up|5|||
125981635|NCT01800968|453222327|FG001|Overall Study|Lost to Follow-up|7|||
125981636|NCT01800968|453222326|FG000|Overall Study|Withdrawal by Subject|7|||
125981637|NCT01800968|453222327|FG001|Overall Study|Withdrawal by Subject|9|||
125981638|NCT01800968|453222326|FG000|Overall Study|Physician Decision|1|||
125981639|NCT01800968|453222327|FG001|Overall Study|Physician Decision|0|||
125981640|NCT03266770|453222328|FG000|Overall Study|Physician Decision|3|||
125981641|NCT03266770|453222328|FG000|Overall Study|Insufficient study supplies|1|||
125981642|NCT03266770|453222328|FG000|Overall Study|Adverse Event|1|||
125981643|NCT02657031|453222329|FG000|Overall Study|Adverse Event|1|||
125981644|NCT02657031|453222330|FG001|Overall Study|Adverse Event|2|||
125981645|NCT03078816|453222331|FG000|Overall Study|Withdrawal by Subject|1|||
125981646|NCT05007392|453222332|FG000|Overall Study|Randomized but not treated|1|||
125981647|NCT05007392|453222333|FG001|Overall Study|Randomized but not treated|2|||
125981648|NCT05007392|453222332|FG000|Overall Study|Other|5|||
125981649|NCT05007392|453222333|FG001|Overall Study|Other|4|||
125981650|NCT05007392|453222332|FG000|Overall Study|Lost to Follow-up|1|||
125981651|NCT05007392|453222333|FG001|Overall Study|Lost to Follow-up|2|||
125981652|NCT05007392|453222332|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
125981653|NCT05007392|453222333|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
125981654|NCT05007392|453222332|FG000|Overall Study|Use of prohibited concomitant drug|1|||
125981655|NCT05007392|453222333|FG001|Overall Study|Use of prohibited concomitant drug|1|||
125981656|NCT05007392|453222332|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
125981657|NCT05007392|453222333|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
125981658|NCT05007392|453222332|FG000|Overall Study|Adverse Event|10|||
125981659|NCT05007392|453222333|FG001|Overall Study|Adverse Event|6|||
125981660|NCT05007392|453222332|FG000|Overall Study|Participant choice|5|||
125981661|NCT05007392|453222333|FG001|Overall Study|Participant choice|10|||
125981662|NCT05007392|453222332|FG000|Overall Study|Withdrawal of consent|5|||
125981663|NCT05007392|453222333|FG001|Overall Study|Withdrawal of consent|4|||
125981664|NCT01218126|453222336|FG000|Overall Study|Adverse Event|8|||
125981665|NCT01218126|453222337|FG001|Overall Study|Adverse Event|10|||
125981666|NCT01218126|453222338|FG002|Overall Study|Adverse Event|12|||
125981667|NCT01218126|453222339|FG003|Overall Study|Adverse Event|16|||
125981668|NCT01218126|453222336|FG000|Overall Study|Lack of Efficacy|7|||
125981669|NCT01218126|453222337|FG001|Overall Study|Lack of Efficacy|2|||
125981670|NCT01218126|453222338|FG002|Overall Study|Lack of Efficacy|2|||
125981671|NCT01218126|453222339|FG003|Overall Study|Lack of Efficacy|6|||
125981672|NCT01218126|453222336|FG000|Overall Study|Protocol Violation|5|||
125981673|NCT01218126|453222337|FG001|Overall Study|Protocol Violation|2|||
125981674|NCT01218126|453222338|FG002|Overall Study|Protocol Violation|2|||
125981675|NCT01218126|453222339|FG003|Overall Study|Protocol Violation|3|||
125981676|NCT01218126|453222336|FG000|Overall Study|Protocol-defined stopping criteria|1|||
125981677|NCT01218126|453222337|FG001|Overall Study|Protocol-defined stopping criteria|1|||
125981678|NCT01218126|453222338|FG002|Overall Study|Protocol-defined stopping criteria|0|||
125981679|NCT01218126|453222339|FG003|Overall Study|Protocol-defined stopping criteria|0|||
125981680|NCT01218126|453222336|FG000|Overall Study|Lost to Follow-up|0|||
125981681|NCT01218126|453222337|FG001|Overall Study|Lost to Follow-up|0|||
125981682|NCT01218126|453222338|FG002|Overall Study|Lost to Follow-up|0|||
125981683|NCT01218126|453222339|FG003|Overall Study|Lost to Follow-up|2|||
125981684|NCT01218126|453222336|FG000|Overall Study|Physician Decision|1|||
125981685|NCT01218126|453222337|FG001|Overall Study|Physician Decision|2|||
125981686|NCT01218126|453222338|FG002|Overall Study|Physician Decision|4|||
125981687|NCT01218126|453222339|FG003|Overall Study|Physician Decision|2|||
125981688|NCT01218126|453222336|FG000|Overall Study|Withdrawal by Subject|2|||
125981689|NCT01218126|453222337|FG001|Overall Study|Withdrawal by Subject|5|||
125981690|NCT01218126|453222338|FG002|Overall Study|Withdrawal by Subject|4|||
125981691|NCT01218126|453222339|FG003|Overall Study|Withdrawal by Subject|6|||
125981692|NCT01860703|453222341|FG000|Overall Study|Adverse Event|1|||
125981693|NCT01860703|453222342|FG001|Overall Study|Adverse Event|4|||
125981694|NCT01860703|453222343|FG002|Overall Study|Adverse Event|0|||
125981695|NCT01860703|453222344|FG003|Overall Study|Adverse Event|2|||
125981696|NCT01860703|453222341|FG000|Overall Study|Withdrawal by Subject|0|||
125981697|NCT01860703|453222342|FG001|Overall Study|Withdrawal by Subject|1|||
125981698|NCT01860703|453222343|FG002|Overall Study|Withdrawal by Subject|0|||
125981699|NCT01860703|453222344|FG003|Overall Study|Withdrawal by Subject|0|||
125981700|NCT01860703|453222341|FG000|Overall Study|Personal reason|1|||
125981701|NCT01860703|453222342|FG001|Overall Study|Personal reason|0|||
125981702|NCT01860703|453222343|FG002|Overall Study|Personal reason|1|||
125981703|NCT01860703|453222344|FG003|Overall Study|Personal reason|0|||
125981704|NCT02453685|453222346|FG000|Overall Study|Adverse Event|0|||
125981705|NCT02453685|453222347|FG001|Overall Study|Adverse Event|1|||
125981706|NCT02453685|453222346|FG000|Overall Study|Protocol Violation|7|||
125981707|NCT02453685|453222347|FG001|Overall Study|Protocol Violation|4|||
125981708|NCT02453685|453222346|FG000|Overall Study|Lost to Follow-up|0|||
125981709|NCT02453685|453222347|FG001|Overall Study|Lost to Follow-up|1|||
125981710|NCT02453685|453222346|FG000|Overall Study|Withdrawal by Subject|8|||
125981711|NCT02453685|453222347|FG001|Overall Study|Withdrawal by Subject|4|||
125981712|NCT02453685|453222346|FG000|Overall Study|Unclassified|4|||
125981713|NCT02453685|453222347|FG001|Overall Study|Unclassified|2|||
125981714|NCT00552084|453222352|FG000|Overall Study|Adverse Event|2|||
125981715|NCT00552084|453222353|FG001|Overall Study|Adverse Event|3|||
125981716|NCT00552084|453222352|FG000|Overall Study|Withdrawal by Subject|4|||
125981717|NCT00552084|453222353|FG001|Overall Study|Withdrawal by Subject|5|||
125981718|NCT00552084|453222352|FG000|Overall Study|Protocol Violation|1|||
125981719|NCT00552084|453222353|FG001|Overall Study|Protocol Violation|0|||
125981720|NCT00552084|453222352|FG000|Overall Study|change in anti-arrythmic drug|1|||
125981721|NCT00552084|453222353|FG001|Overall Study|change in anti-arrythmic drug|1|||
125981722|NCT02553460|453222359|FG000|Overall Study|Death|3|||
126318400|NCT00415597|454456018|FG000|Treatment|Physician Decision|3|||
125981723|NCT02553460|453222359|FG000|Overall Study|Withdrawal by Subject|1|||
125981724|NCT02553460|453222359|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
125981725|NCT02553460|453222359|FG000|Overall Study|Relapse or Transplant|14|||
125981726|NCT02553460|453222359|FG000|Overall Study|No response to treatment|2|||
125981727|NCT02553460|453222359|FG000|Overall Study|CAR T cells|2|||
125981728|NCT04814368|453222360|FG000|Overall Study|Study Terminated by Sponsor|0|||
125981729|NCT04814368|453222361|FG001|Overall Study|Study Terminated by Sponsor|3|||
125981730|NCT04814368|453222362|FG002|Overall Study|Study Terminated by Sponsor|0|||
125981731|NCT04814368|453222363|FG003|Overall Study|Study Terminated by Sponsor|2|||
125981732|NCT04814368|453222360|FG000|Overall Study|Subject Decision|1|||
125981733|NCT04814368|453222361|FG001|Overall Study|Subject Decision|2|||
125981734|NCT04814368|453222362|FG002|Overall Study|Subject Decision|0|||
125981735|NCT04814368|453222363|FG003|Overall Study|Subject Decision|0|||
125981736|NCT04067401|453223750|FG000|Overall Study|Withdrawal by Subject|7|||
125981737|NCT04067401|453223751|FG001|Overall Study|Withdrawal by Subject|0|||
125981738|NCT04067401|453223750|FG000|Overall Study|no data provided|1|||
125981739|NCT04067401|453223751|FG001|Overall Study|no data provided|0|||
125981740|NCT01662063|453223752|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
125981741|NCT01662063|453223753|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
125981742|NCT01662063|453223754|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
125981743|NCT01662063|453223752|FG000|Overall Study|Lack of Efficacy|1|||
125981744|NCT01662063|453223753|FG001|Overall Study|Lack of Efficacy|6|||
125981745|NCT01662063|453223754|FG002|Overall Study|Lack of Efficacy|0|||
125981746|NCT01662063|453223752|FG000|Overall Study|Lost to Follow-up|0|||
125981747|NCT01662063|453223753|FG001|Overall Study|Lost to Follow-up|4|||
125981748|NCT01662063|453223754|FG002|Overall Study|Lost to Follow-up|0|||
125981749|NCT01662063|453223752|FG000|Overall Study|Protocol Violation|1|||
125981750|NCT01662063|453223753|FG001|Overall Study|Protocol Violation|0|||
125981751|NCT01662063|453223754|FG002|Overall Study|Protocol Violation|0|||
125981752|NCT01662063|453223752|FG000|Overall Study|Withdrawal by Subject|2|||
125981753|NCT01662063|453223753|FG001|Overall Study|Withdrawal by Subject|4|||
125981754|NCT01662063|453223754|FG002|Overall Study|Withdrawal by Subject|1|||
125981755|NCT01662063|453223752|FG000|Overall Study|Physician Decision|0|||
125981756|NCT01662063|453223753|FG001|Overall Study|Physician Decision|2|||
125981757|NCT01662063|453223754|FG002|Overall Study|Physician Decision|0|||
125981758|NCT01662063|453223752|FG000|Overall Study|Other|0|||
125981759|NCT01662063|453223753|FG001|Overall Study|Other|1|||
125981760|NCT01662063|453223754|FG002|Overall Study|Other|0|||
125981761|NCT02313909|453223756|FG000|Overall Study|Consent withdrawn by participant|33|||
125981762|NCT02313909|453223757|FG001|Overall Study|Consent withdrawn by participant|33|||
125981763|NCT02313909|453223756|FG000|Overall Study|Lost to Follow-up|24|||
125981764|NCT02313909|453223757|FG001|Overall Study|Lost to Follow-up|17|||
125981765|NCT00293267|453223763|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
125981766|NCT00293267|453223764|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
125981767|NCT00293267|453223763|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
125981768|NCT00293267|453223764|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
125981769|NCT00293267|453223763|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
125981770|NCT00293267|453223764|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
125981771|NCT00293267|453223763|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
125981772|NCT00293267|453223764|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
125981773|NCT00293267|453223763|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
125981774|NCT00293267|453223764|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
125981775|NCT00293267|453223763|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
125981776|NCT00293267|453223764|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
125981777|NCT00293267|453223763|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
125981778|NCT00293267|453223764|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
125981779|NCT00293267|453223763|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
125981780|NCT00293267|453223764|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
125981781|NCT00293267|453223763|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
125981782|NCT00293267|453223764|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
125981783|NCT00293267|453223763|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
125981784|NCT00293267|453223764|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
125981785|NCT00293267|453223763|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
125981786|NCT00293267|453223764|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
125981787|NCT00293267|453223763|FG000|Extension - Double-Blind Week 49-156|Death|3|||
125981788|NCT00293267|453223764|FG001|Extension - Double-Blind Week 49-156|Death|0|||
125981789|NCT00293267|453223763|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
125981790|NCT00293267|453223764|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
125981791|NCT00293267|453223763|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
125981792|NCT00293267|453223764|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
125981793|NCT00293267|453223763|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
125981794|NCT00293267|453223764|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
125981795|NCT00293267|453223763|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
125981796|NCT00293267|453223764|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
126090981|NCT00368927|453626873|FG001|Overall Study|Adverse Event|1|||
125981797|NCT00293267|453223763|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
125981798|NCT00293267|453223764|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
125981799|NCT00293267|453223763|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
125981800|NCT00293267|453223764|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
125981801|NCT00293267|453223763|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
125981802|NCT00293267|453223764|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
125981803|NCT00293267|453223763|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
125981804|NCT00293267|453223764|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
125981805|NCT00293267|453223763|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
125981806|NCT00293267|453223764|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
125981807|NCT00293267|453223763|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
125981808|NCT00293267|453223764|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
125981809|NCT00293267|453223763|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
125981810|NCT00293267|453223764|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
125981811|NCT00293267|453223763|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
125981812|NCT00293267|453223764|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
125981813|NCT00293267|453223763|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
125981814|NCT00293267|453223764|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
125981815|NCT00293267|453223763|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
125981816|NCT00293267|453223764|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
125981817|NCT00293267|453223763|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
125981818|NCT00293267|453223764|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
125981819|NCT00293267|453223763|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
125981820|NCT00293267|453223764|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
125981821|NCT01477853|453223765|FG000|Phase A|Adverse Event|1|||
125981822|NCT01477853|453223766|FG001|Phase A|Adverse Event|2|||
125981823|NCT01477853|453223767|FG002|Phase A|Adverse Event|2|||
125981824|NCT01477853|453223765|FG000|Phase A|Lost to Follow-up|4|||
125981825|NCT01477853|453223766|FG001|Phase A|Lost to Follow-up|3|||
125981826|NCT01477853|453223767|FG002|Phase A|Lost to Follow-up|2|||
125981827|NCT01477853|453223765|FG000|Phase A|Physician Decision|1|||
125981828|NCT01477853|453223766|FG001|Phase A|Physician Decision|0|||
125981829|NCT01477853|453223767|FG002|Phase A|Physician Decision|1|||
125981830|NCT01477853|453223765|FG000|Phase A|Study terminated by sponsor|37|||
125981831|NCT01477853|453223766|FG001|Phase A|Study terminated by sponsor|40|||
125981832|NCT01477853|453223767|FG002|Phase A|Study terminated by sponsor|39|||
125981833|NCT01477853|453223765|FG000|Phase B|Lost to Follow-up|0|||
125981834|NCT01477853|453223766|FG001|Phase B|Lost to Follow-up|1|||
125981835|NCT01477853|453223767|FG002|Phase B|Lost to Follow-up|0|||
125981836|NCT01477853|453223765|FG000|Phase B|Study terminated by sponsor|12|||
125981837|NCT01477853|453223766|FG001|Phase B|Study terminated by sponsor|10|||
125981838|NCT01477853|453223767|FG002|Phase B|Study terminated by sponsor|11|||
125981839|NCT01050816|453223768|FG000|Overall Study|Lost to Follow-up|2|||
125981840|NCT01050816|453223768|FG000|Overall Study|patient's refusal|2|||
125981841|NCT03086330|453223769|FG000|Overall Study|Withdrawal by Subject|3|||
125981842|NCT03086330|453223770|FG001|Overall Study|Withdrawal by Subject|2|||
125981843|NCT03086330|453223769|FG000|Overall Study|Lost to Follow-up|1|||
125981844|NCT03086330|453223770|FG001|Overall Study|Lost to Follow-up|2|||
125981845|NCT00948974|453223775|FG000|Overall Study|Lost to Follow-up|23|||
125981846|NCT00948974|453223776|FG001|Overall Study|Lost to Follow-up|20|||
125981847|NCT00238433|453223778|FG000|Overall Study|Screen failure|1|||
125981848|NCT00238433|453223778|FG000|Overall Study|Lost to Follow-up|1|||
125981849|NCT00238433|453223778|FG000|Overall Study|Death|1|||
125981850|NCT01814748|453223781|FG000|Overall Study|Lost to Follow-up|1|||
125981851|NCT01814748|453223782|FG001|Overall Study|Lost to Follow-up|2|||
125981852|NCT01814748|453223781|FG000|Overall Study|Study site terminated by sponsor|1|||
125981853|NCT01814748|453223782|FG001|Overall Study|Study site terminated by sponsor|1|||
125981854|NCT01814748|453223781|FG000|Overall Study|Withdrawal by Subject|6|||
125981855|NCT01814748|453223782|FG001|Overall Study|Withdrawal by Subject|4|||
125981856|NCT04044456|453223783|FG000|Overall Study|Lost to Follow-up|4|||
125981857|NCT04044456|453223784|FG001|Overall Study|Lost to Follow-up|1|||
125981858|NCT04044456|453223783|FG000|Overall Study|Withdrawal by Subject|1|||
125981859|NCT04044456|453223784|FG001|Overall Study|Withdrawal by Subject|0|||
125981860|NCT01972529|453223785|FG000|Overall Study|Adverse Event|0|||
125981861|NCT01972529|453223786|FG001|Overall Study|Adverse Event|1|||
125981862|NCT01972529|453223787|FG002|Overall Study|Adverse Event|0|||
125981863|NCT01972529|453223788|FG003|Overall Study|Adverse Event|0|||
125981864|NCT01972529|453223785|FG000|Overall Study|Lost to Follow-up|1|||
125981865|NCT01972529|453223786|FG001|Overall Study|Lost to Follow-up|0|||
125981866|NCT01972529|453223787|FG002|Overall Study|Lost to Follow-up|0|||
125981867|NCT01972529|453223788|FG003|Overall Study|Lost to Follow-up|0|||
125981868|NCT01972529|453223785|FG000|Overall Study|Participant Choice|0|||
125981869|NCT01972529|453223786|FG001|Overall Study|Participant Choice|1|||
125981870|NCT01972529|453223787|FG002|Overall Study|Participant Choice|0|||
125981871|NCT01972529|453223788|FG003|Overall Study|Participant Choice|0|||
125981872|NCT01972529|453223785|FG000|Overall Study|Withdrawl of Consent|1|||
125981873|NCT01972529|453223786|FG001|Overall Study|Withdrawl of Consent|2|||
125981874|NCT01972529|453223787|FG002|Overall Study|Withdrawl of Consent|0|||
125981875|NCT01972529|453223788|FG003|Overall Study|Withdrawl of Consent|1|||
125981876|NCT01972529|453223785|FG000|Overall Study|Other|0|||
125981877|NCT01972529|453223786|FG001|Overall Study|Other|0|||
125981878|NCT01972529|453223787|FG002|Overall Study|Other|0|||
125981879|NCT01972529|453223788|FG003|Overall Study|Other|2|||
125981880|NCT01972529|453223785|FG000|Overall Study|Not treated|0|||
125981881|NCT01972529|453223786|FG001|Overall Study|Not treated|1|||
125981882|NCT01972529|453223787|FG002|Overall Study|Not treated|2|||
125981883|NCT01972529|453223788|FG003|Overall Study|Not treated|1|||
125981884|NCT02274857|453223789|FG000|Overall Study|Adverse Event|1|||
125981885|NCT02274857|453223790|FG001|Overall Study|Adverse Event|0|||
125981886|NCT02274857|453223789|FG000|Overall Study|Death|1|||
125981887|NCT02274857|453223790|FG001|Overall Study|Death|2|||
125981888|NCT02274857|453223789|FG000|Overall Study|Lost to Follow-up|3|||
125981889|NCT02274857|453223790|FG001|Overall Study|Lost to Follow-up|0|||
125981890|NCT02274857|453223789|FG000|Overall Study|Physician Decision|2|||
125981891|NCT02274857|453223790|FG001|Overall Study|Physician Decision|0|||
125981892|NCT02274857|453223789|FG000|Overall Study|Trial screen failure|0|||
125981893|NCT02274857|453223790|FG001|Overall Study|Trial screen failure|2|||
125981894|NCT02274857|453223789|FG000|Overall Study|Withdrawal by Subject|11|||
125981895|NCT02274857|453223790|FG001|Overall Study|Withdrawal by Subject|2|||
125981896|NCT02274857|453223789|FG000|Overall Study|Other|2|||
125981897|NCT02274857|453223790|FG001|Overall Study|Other|0|||
125981898|NCT00330174|453223793|FG000|Overall Study|Withdrawal by Subject|7|||
125981899|NCT00330174|453223794|FG001|Overall Study|Withdrawal by Subject|7|||
125981900|NCT00330174|453223793|FG000|Overall Study|Lost to Follow-up|4|||
125981901|NCT00330174|453223794|FG001|Overall Study|Lost to Follow-up|1|||
125981902|NCT00330174|453223793|FG000|Overall Study|Clinical deterioration|1|||
125981903|NCT00330174|453223794|FG001|Overall Study|Clinical deterioration|2|||
125981904|NCT00330174|453223793|FG000|Overall Study|Excessive missed visits|3|||
125981905|NCT00330174|453223794|FG001|Overall Study|Excessive missed visits|8|||
125981906|NCT00330174|453223793|FG000|Overall Study|Miscellaneous reasons|7|||
125981907|NCT00330174|453223794|FG001|Overall Study|Miscellaneous reasons|1|||
125981908|NCT02403180|453223796|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
125981909|NCT02403180|453223797|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
125981910|NCT02403180|453223796|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
125981911|NCT02403180|453223797|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
125981912|NCT00118716|453223802|FG000|Overall Study|Adverse Event|2|||
125981913|NCT00118716|453223803|FG001|Overall Study|Adverse Event|7|||
125981914|NCT00118716|453223802|FG000|Overall Study|Protocol Violation|5|||
125981915|NCT00118716|453223803|FG001|Overall Study|Protocol Violation|4|||
125981916|NCT00118716|453223802|FG000|Overall Study|Withdrawal by Subject|0|||
125981917|NCT00118716|453223803|FG001|Overall Study|Withdrawal by Subject|1|||
125981918|NCT00118716|453223802|FG000|Overall Study|Exacerbation|2|||
125981919|NCT00118716|453223803|FG001|Overall Study|Exacerbation|2|||
125981920|NCT00118716|453223802|FG000|Overall Study|Discontinued by sponsor|1|||
125981921|NCT00118716|453223803|FG001|Overall Study|Discontinued by sponsor|1|||
125981922|NCT00118716|453223802|FG000|Overall Study|Non-compliance|1|||
125981923|NCT00118716|453223803|FG001|Overall Study|Non-compliance|3|||
125981924|NCT00118716|453223802|FG000|Overall Study|misrandomized|1|||
125981925|NCT00118716|453223803|FG001|Overall Study|misrandomized|1|||
125981926|NCT00118716|453223802|FG000|Overall Study|Expired drug use|1|||
125981927|NCT00118716|453223803|FG001|Overall Study|Expired drug use|2|||
125981928|NCT00118716|453223802|FG000|Overall Study|Investigator discretion|0|||
125981929|NCT00118716|453223803|FG001|Overall Study|Investigator discretion|1|||
125981930|NCT01445652|453223805|FG000|Overall Study|Not comfortable in lenses|5|||
125981931|NCT01445652|453223806|FG001|Overall Study|Not comfortable in lenses|0|||
125981932|NCT01445652|453223805|FG000|Overall Study|Failed to attend scheduled visit|2|||
125981933|NCT01445652|453223806|FG001|Overall Study|Failed to attend scheduled visit|3|||
125981934|NCT01445652|453223805|FG000|Overall Study|Failed teach session|2|||
125981935|NCT01445652|453223806|FG001|Overall Study|Failed teach session|0|||
125981936|NCT01445652|453223805|FG000|Overall Study|Adverse Event|1|||
125981937|NCT01445652|453223806|FG001|Overall Study|Adverse Event|0|||
125981938|NCT00454571|453223807|FG000|Overall Study|Adverse Event|2|||
125981939|NCT00454571|453223808|FG001|Overall Study|Adverse Event|0|||
125981940|NCT00454571|453223807|FG000|Overall Study|Physician Decision|0|||
125981941|NCT00454571|453223808|FG001|Overall Study|Physician Decision|1|||
125981942|NCT00454571|453223807|FG000|Overall Study|Protocol Violation|1|||
125981943|NCT00454571|453223808|FG001|Overall Study|Protocol Violation|0|||
125981944|NCT00454571|453223807|FG000|Overall Study|Withdrawal by Subject|10|||
125981945|NCT00454571|453223808|FG001|Overall Study|Withdrawal by Subject|5|||
125981946|NCT02436811|453223809|FG000|Overall Study|Lost to Follow-up|2|||
125981947|NCT02436811|453223810|FG001|Overall Study|Lost to Follow-up|9|||
125981948|NCT02436811|453223811|FG002|Overall Study|Lost to Follow-up|7|||
125981949|NCT03595332|453223812|FG000|Overall Study|Lost to Follow-up|16|||
125981950|NCT03595332|453223813|FG001|Overall Study|Lost to Follow-up|22|||
125981951|NCT03595332|453223812|FG000|Overall Study|Unable to retrieve ID from school|0|||
125981952|NCT03595332|453223813|FG001|Overall Study|Unable to retrieve ID from school|2|||
125981953|NCT04209725|453223814|FG000|Overall Study|Adverse Event|1|||
125981954|NCT01201811|453223817|FG000|Overall Study|Adverse Event|6|||
125981955|NCT01201811|453223817|FG000|Overall Study|Disease progression|3|||
125981956|NCT01201811|453223817|FG000|Overall Study|Withdrawal by Subject|3|||
125981957|NCT01201811|453223817|FG000|Overall Study|Death|4|||
125981958|NCT01201811|453223817|FG000|Overall Study|Treatment Failure|2|||
125981959|NCT01201811|453223817|FG000|Overall Study|Physician Decision|1|||
125981960|NCT02657317|453223818|FG000|Overall Study|Withdrawal by Subject|2|||
125981961|NCT02657317|453223819|FG001|Overall Study|Withdrawal by Subject|0|||
125981962|NCT02657317|453223818|FG000|Overall Study|Lost to Follow-up|3|||
125981963|NCT02657317|453223819|FG001|Overall Study|Lost to Follow-up|3|||
125981964|NCT00117676|453223820|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
125981965|NCT00117676|453223821|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
125981966|NCT00117676|453223820|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
125981967|NCT00117676|453223821|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
125981968|NCT00117676|453223820|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
125981969|NCT00117676|453223821|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
125981970|NCT00117676|453223820|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
125981971|NCT00117676|453223821|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
125981972|NCT00117676|453223820|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
125981973|NCT00117676|453223821|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
125981974|NCT00117676|453223820|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
125981975|NCT00117676|453223821|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
125981976|NCT00117676|453223820|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
125981977|NCT00117676|453223821|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
125981978|NCT00117676|453223820|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
125981979|NCT00117676|453223821|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
125981980|NCT00117676|453223820|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
125981981|NCT00117676|453223821|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
125981982|NCT00117676|453223820|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
125981983|NCT00117676|453223821|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
125981984|NCT00117676|453223820|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
125981985|NCT00117676|453223821|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
125981986|NCT00117676|453223820|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
125981987|NCT00117676|453223821|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
125981988|NCT00117676|453223820|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
125981989|NCT00117676|453223821|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
125981990|NCT00117676|453223820|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
125981991|NCT00117676|453223821|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
125981992|NCT00117676|453223820|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
125981993|NCT00117676|453223821|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
125981994|NCT00117676|453223820|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
125981995|NCT00117676|453223821|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
125981996|NCT00117676|453223820|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
125981997|NCT00117676|453223821|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
125981998|NCT00117676|453223820|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
125981999|NCT00117676|453223821|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
125982000|NCT00117676|453223820|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
125982001|NCT00117676|453223821|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
125982002|NCT00117676|453223820|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
125982003|NCT00117676|453223821|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
125982004|NCT00117676|453223820|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
125982005|NCT00117676|453223821|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
125982006|NCT00117676|453223820|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
125982007|NCT00117676|453223821|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
125982008|NCT00117676|453223820|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
125982009|NCT00117676|453223821|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
125982010|NCT00117676|453223820|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
125982011|NCT00117676|453223821|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
125982012|NCT00117676|453223820|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
125982013|NCT00117676|453223821|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
125982014|NCT00117676|453223820|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
126208881|NCT04668066|454053107|FG000|Part 1: Treatment Phase|Other|0|||
126318401|NCT00415597|454456018|FG000|Treatment|Withdrawal by Subject|51|||
126318402|NCT00415597|454456018|FG000|Treatment|Lost to Follow-up|28|||
126318403|NCT00415597|454456018|FG000|Treatment|Drug Screen|2|||
126318404|NCT00415597|454456018|FG000|Treatment|Administrative|3|||
126318405|NCT00415597|454456018|FG000|Treatment|Sponsor Decision|1|||
126318406|NCT00415597|454456018|FG000|Treatment|Multiple Reasons|1|||
126318407|NCT01447927|454456019|FG000|Overall Study|Adverse Event|4|||
125982015|NCT00117676|453223821|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
125982016|NCT00117676|453223820|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
125982017|NCT00117676|453223821|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
125982018|NCT00117676|453223820|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
125982019|NCT00117676|453223821|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
125982020|NCT00117676|453223820|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
125982021|NCT00117676|453223821|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
125982022|NCT00117676|453223820|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
125982023|NCT00117676|453223821|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
125982024|NCT00117676|453223820|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
125982025|NCT00117676|453223821|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
125982026|NCT00117676|453223820|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
125982027|NCT00117676|453223821|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
125982028|NCT00117676|453223820|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
125982029|NCT00117676|453223821|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
125982030|NCT00117676|453223820|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
125982031|NCT00117676|453223821|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
125982032|NCT00117676|453223820|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
125982033|NCT00117676|453223821|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
125982034|NCT00952822|453223822|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
125982035|NCT00952822|453223823|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
125982036|NCT00952822|453223824|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
125982037|NCT00952822|453223825|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
125982038|NCT00952822|453223822|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
125982039|NCT00952822|453223823|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
125982040|NCT00952822|453223824|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
125982041|NCT00952822|453223825|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
125982042|NCT04555096|453223829|FG000|Overall Study|Death|4|||
125982043|NCT04555096|453223830|FG001|Overall Study|Death|4|||
125982044|NCT04555096|453223829|FG000|Overall Study|Withdrawal by Subject|1|||
125982045|NCT04555096|453223830|FG001|Overall Study|Withdrawal by Subject|0|||
125982046|NCT04555096|453223829|FG000|Overall Study|Other|0|||
125982047|NCT04555096|453223830|FG001|Overall Study|Other|1|||
125982048|NCT04899245|453223853|FG000|Overall Study|Withdrawal by Subject|3|||
125982049|NCT04899245|453223854|FG001|Overall Study|Withdrawal by Subject|5|||
125982050|NCT04899245|453223855|FG002|Overall Study|Withdrawal by Subject|2|||
125982051|NCT04899245|453223853|FG000|Overall Study|No longer eligible - Left staff position|0|||
125982052|NCT04899245|453223854|FG001|Overall Study|No longer eligible - Left staff position|0|||
125982053|NCT04899245|453223855|FG002|Overall Study|No longer eligible - Left staff position|1|||
125982054|NCT04899245|453223853|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
125982055|NCT04899245|453223854|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
125982056|NCT04899245|453223855|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
125982057|NCT04899245|453223853|FG000|Overall Study|No longer eligible - Moved away from area|2|||
125982058|NCT04899245|453223854|FG001|Overall Study|No longer eligible - Moved away from area|2|||
125982059|NCT04899245|453223855|FG002|Overall Study|No longer eligible - Moved away from area|0|||
125982060|NCT02220894|453223865|FG000|Overall Study|Adverse Event|127|||
125982061|NCT02220894|453223866|FG001|Overall Study|Adverse Event|74|||
125982062|NCT02220894|453223865|FG000|Overall Study|Death|418|||
125982063|NCT02220894|453223866|FG001|Overall Study|Death|508|||
125982064|NCT02220894|453223865|FG000|Overall Study|Lost to Follow-up|0|||
125982065|NCT02220894|453223866|FG001|Overall Study|Lost to Follow-up|4|||
125982066|NCT02220894|453223865|FG000|Overall Study|Site Terminated by Sponsor|2|||
125982067|NCT02220894|453223866|FG001|Overall Study|Site Terminated by Sponsor|0|||
125982068|NCT02220894|453223865|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
125982069|NCT02220894|453223866|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
125982070|NCT02220894|453223865|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125982071|NCT02220894|453223866|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125982072|NCT02220894|453223865|FG000|Overall Study|Withdrawal by Subject|10|||
125982073|NCT02220894|453223866|FG001|Overall Study|Withdrawal by Subject|9|||
125982074|NCT00453986|453223868|FG000|Overall Study|Lost to Follow-up|6|||
125982075|NCT00453986|453223869|FG001|Overall Study|Lost to Follow-up|5|||
126318408|NCT01447927|454456020|FG001|Overall Study|Adverse Event|3|||
126318409|NCT01447927|454456019|FG000|Overall Study|Withdrawal by Subject|1|||
125982076|NCT00453986|453223870|FG002|Overall Study|Lost to Follow-up|6|||
125982077|NCT00453986|453223871|FG003|Overall Study|Lost to Follow-up|2|||
125982078|NCT00453986|453223872|FG004|Overall Study|Lost to Follow-up|0|||
125982079|NCT02778100|453223875|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
125982080|NCT02778100|453223876|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
126318410|NCT01447927|454456020|FG001|Overall Study|Withdrawal by Subject|0|||
126318411|NCT04102865|454456022|FG000|Overall Study|Adverse Event|4|||
126318412|NCT04102865|454456023|FG001|Overall Study|Adverse Event|0|||
126318413|NCT04102865|454456022|FG000|Overall Study|Lost to Follow-up|1|||
126318414|NCT04102865|454456023|FG001|Overall Study|Lost to Follow-up|0|||
126318415|NCT04102865|454456022|FG000|Overall Study|Withdrawal by Subject|2|||
126318416|NCT04102865|454456023|FG001|Overall Study|Withdrawal by Subject|0|||
126318417|NCT01764997|454456024|FG000|Run-in Period|Adverse Event|15|||
126318418|NCT01764997|454456025|FG001|Run-in Period|Adverse Event|0|||
126318419|NCT01764997|454456026|FG002|Run-in Period|Adverse Event|0|||
126318420|NCT01764997|454456027|FG003|Run-in Period|Adverse Event|0|||
126318421|NCT01764997|454456028|FG004|Run-in Period|Adverse Event|0|||
126318422|NCT01764997|454456024|FG000|Run-in Period|Lack of Efficacy|5|||
126318423|NCT01764997|454456025|FG001|Run-in Period|Lack of Efficacy|0|||
126318424|NCT01764997|454456026|FG002|Run-in Period|Lack of Efficacy|0|||
126318425|NCT01764997|454456027|FG003|Run-in Period|Lack of Efficacy|0|||
126318426|NCT01764997|454456028|FG004|Run-in Period|Lack of Efficacy|0|||
126318427|NCT01764997|454456024|FG000|Run-in Period|Poor compliance to protocol|1|||
126318428|NCT01764997|454456025|FG001|Run-in Period|Poor compliance to protocol|0|||
126318429|NCT01764997|454456026|FG002|Run-in Period|Poor compliance to protocol|0|||
126318430|NCT01764997|454456027|FG003|Run-in Period|Poor compliance to protocol|0|||
126318431|NCT01764997|454456028|FG004|Run-in Period|Poor compliance to protocol|0|||
126318432|NCT01764997|454456024|FG000|Run-in Period|Other than specified above|17|||
126318433|NCT01764997|454456025|FG001|Run-in Period|Other than specified above|0|||
126318434|NCT01764997|454456026|FG002|Run-in Period|Other than specified above|0|||
126318435|NCT01764997|454456027|FG003|Run-in Period|Other than specified above|0|||
126318436|NCT01764997|454456028|FG004|Run-in Period|Other than specified above|0|||
126318437|NCT01764997|454456024|FG000|Study Drug Treatment Period|Adverse Event|0|||
126318438|NCT01764997|454456025|FG001|Study Drug Treatment Period|Adverse Event|1|||
126318439|NCT01764997|454456026|FG002|Study Drug Treatment Period|Adverse Event|0|||
126318440|NCT01764997|454456027|FG003|Study Drug Treatment Period|Adverse Event|0|||
126318441|NCT01764997|454456028|FG004|Study Drug Treatment Period|Adverse Event|24|||
126318442|NCT01764997|454456024|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
126318443|NCT01764997|454456025|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
126318444|NCT01764997|454456026|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
126318445|NCT01764997|454456027|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
126318446|NCT01764997|454456028|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
126318447|NCT01764997|454456024|FG000|Study Drug Treatment Period|Other than specified above|0|||
126318448|NCT01764997|454456025|FG001|Study Drug Treatment Period|Other than specified above|0|||
126318449|NCT01764997|454456026|FG002|Study Drug Treatment Period|Other than specified above|0|||
126318450|NCT01764997|454456027|FG003|Study Drug Treatment Period|Other than specified above|0|||
126318451|NCT01764997|454456028|FG004|Study Drug Treatment Period|Other than specified above|10|||
126318452|NCT04438499|454456037|FG000|Overall Study|Lack of Efficacy|3|||
126318453|NCT04683939|454456038|FG000|Overall Study|Study termination by the sponsor|0|||
126318454|NCT04683939|454456039|FG001|Overall Study|Study termination by the sponsor|1|||
126318455|NCT04683939|454456040|FG002|Overall Study|Study termination by the sponsor|2|||
126318456|NCT04683939|454456041|FG003|Overall Study|Study termination by the sponsor|2|||
126318457|NCT04683939|454456038|FG000|Overall Study|Death|1|||
126318458|NCT04683939|454456039|FG001|Overall Study|Death|1|||
126318459|NCT04683939|454456040|FG002|Overall Study|Death|2|||
126318460|NCT04683939|454456041|FG003|Overall Study|Death|1|||
126318461|NCT04683939|454456038|FG000|Overall Study|Withdrawal by Subject|1|||
125982081|NCT00522626|453223877|FG000|Overall Study|Lost to Follow-up|7|||
125982082|NCT03017079|453223880|FG000|Overall Study|Physician Decision|1|||
125982083|NCT03017079|453223881|FG001|Overall Study|Physician Decision|1|||
126318462|NCT04683939|454456039|FG001|Overall Study|Withdrawal by Subject|0|||
126318463|NCT04683939|454456040|FG002|Overall Study|Withdrawal by Subject|0|||
126318464|NCT04683939|454456041|FG003|Overall Study|Withdrawal by Subject|0|||
126318465|NCT04683939|454456038|FG000|Overall Study|Physician Decision|1|||
126318466|NCT04683939|454456039|FG001|Overall Study|Physician Decision|0|||
126318467|NCT04683939|454456040|FG002|Overall Study|Physician Decision|0|||
126318468|NCT04683939|454456041|FG003|Overall Study|Physician Decision|0|||
126318469|NCT04683939|454456038|FG000|Overall Study|Lost to Follow-up|0|||
126318470|NCT04683939|454456039|FG001|Overall Study|Lost to Follow-up|1|||
126318471|NCT04683939|454456040|FG002|Overall Study|Lost to Follow-up|0|||
126318472|NCT04683939|454456041|FG003|Overall Study|Lost to Follow-up|0|||
125982084|NCT03017079|453223880|FG000|Overall Study|Death|3|||
125982085|NCT03017079|453223881|FG001|Overall Study|Death|2|||
125982086|NCT03017079|453223880|FG000|Overall Study|Lack of Efficacy|2|||
126318473|NCT01172808|454457923|FG000|Overall Study|Adverse Event|8|||
125982087|NCT03017079|453223881|FG001|Overall Study|Lack of Efficacy|2|||
125982088|NCT03017079|453223880|FG000|Overall Study|Protocol Violation|0|||
125982089|NCT03017079|453223881|FG001|Overall Study|Protocol Violation|1|||
125982090|NCT03538951|453223882|FG000|Overall Study|Withdrawal by Subject|1|||
125982091|NCT03538951|453223883|FG001|Overall Study|Withdrawal by Subject|2|||
125982092|NCT01953003|453225639|FG000|Overall Study|Not treated|0|||
125982093|NCT01953003|453225640|FG001|Overall Study|Not treated|1|||
125982094|NCT01953003|453225639|FG000|Overall Study|Progressive disease|35|||
125982095|NCT01953003|453225640|FG001|Overall Study|Progressive disease|45|||
125982096|NCT01953003|453225639|FG000|Overall Study|Related Adverse events|7|||
125982097|NCT01953003|453225640|FG001|Overall Study|Related Adverse events|2|||
125982098|NCT01953003|453225639|FG000|Overall Study|Non-related adverse events|0|||
125982099|NCT01953003|453225640|FG001|Overall Study|Non-related adverse events|2|||
125982100|NCT01953003|453225639|FG000|Overall Study|Protocol Violation|0|||
125982101|NCT01953003|453225640|FG001|Overall Study|Protocol Violation|1|||
125982102|NCT01953003|453225639|FG000|Overall Study|Withdrawal by Subject|14|||
125982103|NCT01953003|453225640|FG001|Overall Study|Withdrawal by Subject|4|||
125982104|NCT03092375|453225641|FG000|Overall Study|Lack of Efficacy|0|||
125982105|NCT03092375|453225642|FG001|Overall Study|Lack of Efficacy|1|||
125982106|NCT03092375|453225643|FG002|Overall Study|Lack of Efficacy|1|||
125982107|NCT03092375|453225644|FG003|Overall Study|Lack of Efficacy|0|||
125982108|NCT00553501|453225649|FG000|Overall Study|Adverse Event|2|||
125982109|NCT00553501|453225649|FG000|Overall Study|Death|1|||
125982110|NCT00553501|453225649|FG000|Overall Study|Progression|1|||
125982111|NCT02293395|453225650|FG000|Overall Study|Lost to Follow-up|1|||
125982112|NCT02293395|453225651|FG001|Overall Study|Lost to Follow-up|0|||
125982113|NCT02293395|453225650|FG000|Overall Study|Withdrawal by Subject|8|||
125982114|NCT02293395|453225651|FG001|Overall Study|Withdrawal by Subject|7|||
125982115|NCT01464021|453225653|FG000|Overall Study|Withdrawal by Subject|13|||
125982116|NCT01464021|453225653|FG000|Overall Study|Lost to Follow-up|1|||
125982117|NCT01464021|453225653|FG000|Overall Study|Lack of Efficacy|1|||
125982118|NCT01464021|453225653|FG000|Overall Study|various|11|||
125982119|NCT00224770|453225659|FG000|Overall Study|Lost to Follow-up|4|||
125982120|NCT00224770|453225660|FG001|Overall Study|Lost to Follow-up|2|||
125982121|NCT00224770|453225661|FG002|Overall Study|Lost to Follow-up|0|||
125982122|NCT01106430|453225662|FG000|Overall Study|Adverse Event|8|||
125982123|NCT01106430|453225663|FG001|Overall Study|Adverse Event|10|||
125982124|NCT01106430|453225662|FG000|Overall Study|Lack of Efficacy|2|||
125982125|NCT01106430|453225663|FG001|Overall Study|Lack of Efficacy|13|||
125982126|NCT01106430|453225662|FG000|Overall Study|Lost to Follow-up|5|||
125982127|NCT01106430|453225663|FG001|Overall Study|Lost to Follow-up|1|||
125982128|NCT01106430|453225662|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
125982129|NCT01106430|453225663|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
125982130|NCT01106430|453225662|FG000|Overall Study|Moved Out Of State|0|||
125982131|NCT01106430|453225663|FG001|Overall Study|Moved Out Of State|1|||
125982132|NCT01106430|453225662|FG000|Overall Study|Refused To Take Medication|0|||
125982133|NCT01106430|453225663|FG001|Overall Study|Refused To Take Medication|1|||
125982134|NCT01106430|453225662|FG000|Overall Study|Noncompliance|0|||
125982135|NCT01106430|453225663|FG001|Overall Study|Noncompliance|1|||
125982136|NCT01106430|453225662|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
125982137|NCT01106430|453225663|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
125982138|NCT01106430|453225662|FG000|Overall Study|Previous Use Of Marijuana|1|||
125982139|NCT01106430|453225663|FG001|Overall Study|Previous Use Of Marijuana|0|||
125982140|NCT01106430|453225662|FG000|Overall Study|Protocol Violation|7|||
125982141|NCT01106430|453225663|FG001|Overall Study|Protocol Violation|2|||
125982142|NCT01106430|453225662|FG000|Overall Study|Withdrawal by Subject|8|||
125982143|NCT01106430|453225663|FG001|Overall Study|Withdrawal by Subject|4|||
125982144|NCT00861614|453225664|FG000|Overall Study|Disease Progression|182|||
125982145|NCT00861614|453225665|FG001|Overall Study|Disease Progression|263|||
125982146|NCT00861614|453225664|FG000|Overall Study|Study Drug Toxicity|79|||
125982147|NCT00861614|453225665|FG001|Overall Study|Study Drug Toxicity|6|||
125982148|NCT00861614|453225664|FG000|Overall Study|Death|32|||
125982149|NCT00861614|453225665|FG001|Overall Study|Death|19|||
125982150|NCT00861614|453225664|FG000|Overall Study|Adverse Event|27|||
125982151|NCT00861614|453225665|FG001|Overall Study|Adverse Event|23|||
125982152|NCT00861614|453225664|FG000|Overall Study|Withdrawal by Subject|34|||
125982153|NCT00861614|453225665|FG001|Overall Study|Withdrawal by Subject|35|||
125982154|NCT00861614|453225664|FG000|Overall Study|Other|17|||
125982155|NCT00861614|453225665|FG001|Overall Study|Other|22|||
125982156|NCT03391765|453225666|FG000|Overall Study|Adverse Event|2|||
125982157|NCT03391765|453225667|FG001|Overall Study|Adverse Event|0|||
125982158|NCT03391765|453225668|FG002|Overall Study|Adverse Event|0|||
125982159|NCT03391765|453225669|FG003|Overall Study|Adverse Event|2|||
125982160|NCT03391765|453225666|FG000|Overall Study|Withdrew consent|5|||
125982161|NCT03391765|453225667|FG001|Overall Study|Withdrew consent|7|||
125982162|NCT03391765|453225668|FG002|Overall Study|Withdrew consent|2|||
125982163|NCT03391765|453225669|FG003|Overall Study|Withdrew consent|5|||
125982164|NCT03391765|453225666|FG000|Overall Study|Other, not specified|44|||
125982165|NCT03391765|453225667|FG001|Overall Study|Other, not specified|38|||
125982166|NCT03391765|453225668|FG002|Overall Study|Other, not specified|21|||
125982167|NCT03391765|453225669|FG003|Overall Study|Other, not specified|16|||
125982168|NCT01255592|453225670|FG000|Overall Study|Adverse Event|5|||
125982169|NCT01255592|453225671|FG001|Overall Study|Adverse Event|0|||
125982170|NCT01255592|453225670|FG000|Overall Study|Withdrawal by Subject|1|||
125982171|NCT01255592|453225671|FG001|Overall Study|Withdrawal by Subject|0|||
125982172|NCT01255592|453225670|FG000|Overall Study|Other|0|||
125982173|NCT01255592|453225671|FG001|Overall Study|Other|1|||
125982174|NCT01777321|453225673|FG000|Overall Study|Withdrawal by Subject|0|||
125982175|NCT01777321|453225674|FG001|Overall Study|Withdrawal by Subject|1|||
125982176|NCT00089141|453225678|FG000|Overall Study|Termination of trial|18|||
125982177|NCT00089141|453225679|FG001|Overall Study|Termination of trial|24|||
125982178|NCT00508261|453225680|FG000|Overall Study|Other|0|||
125982179|NCT00508261|453225681|FG001|Overall Study|Other|1|||
125982180|NCT00508261|453225682|FG002|Overall Study|Other|1|||
125982181|NCT00508261|453225683|FG003|Overall Study|Other|0|||
125982182|NCT00508261|453225680|FG000|Overall Study|Serious Adverse Event|0|||
125982183|NCT00508261|453225681|FG001|Overall Study|Serious Adverse Event|1|||
125982184|NCT00508261|453225682|FG002|Overall Study|Serious Adverse Event|0|||
125982185|NCT00508261|453225683|FG003|Overall Study|Serious Adverse Event|0|||
125982186|NCT00508261|453225680|FG000|Overall Study|Withdrawal by Subject|3|||
125982187|NCT00508261|453225681|FG001|Overall Study|Withdrawal by Subject|4|||
125982188|NCT00508261|453225682|FG002|Overall Study|Withdrawal by Subject|4|||
125982189|NCT00508261|453225683|FG003|Overall Study|Withdrawal by Subject|0|||
125982190|NCT00508261|453225680|FG000|Overall Study|Migrated/ moved from study area|0|||
125982191|NCT00508261|453225681|FG001|Overall Study|Migrated/ moved from study area|1|||
125982192|NCT00508261|453225682|FG002|Overall Study|Migrated/ moved from study area|0|||
125982193|NCT00508261|453225683|FG003|Overall Study|Migrated/ moved from study area|0|||
125982194|NCT00508261|453225680|FG000|Overall Study|Lost to Follow-up|0|||
125982195|NCT00508261|453225681|FG001|Overall Study|Lost to Follow-up|1|||
125982196|NCT00508261|453225682|FG002|Overall Study|Lost to Follow-up|1|||
125982197|NCT00508261|453225683|FG003|Overall Study|Lost to Follow-up|1|||
125982198|NCT00180479|453225684|FG000|Overall Study|Death|4|||
125982199|NCT00180479|453225685|FG001|Overall Study|Death|2|||
125982200|NCT00180479|453225684|FG000|Overall Study|Lost to Follow-up|9|||
125982201|NCT00180479|453225685|FG001|Overall Study|Lost to Follow-up|7|||
125982202|NCT00180479|453225684|FG000|Overall Study|Withdrawal by Subject|3|||
125982203|NCT00180479|453225685|FG001|Overall Study|Withdrawal by Subject|3|||
125982204|NCT00180479|453225684|FG000|Overall Study|Informed consent not signed|0|||
125982205|NCT00180479|453225685|FG001|Overall Study|Informed consent not signed|1|||
125982206|NCT00526630|453225694|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
125982207|NCT00526630|453225695|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
125982208|NCT00526630|453225694|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
125982209|NCT00526630|453225695|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
125982210|NCT03518125|453225697|FG000|Overall Study|Lost to Follow-up|0|||
125982211|NCT03518125|453225698|FG001|Overall Study|Lost to Follow-up|2|||
125982212|NCT03518125|453225699|FG002|Overall Study|Lost to Follow-up|0|||
125982213|NCT03518125|453225700|FG003|Overall Study|Lost to Follow-up|0|||
125982214|NCT03518125|453225701|FG004|Overall Study|Lost to Follow-up|3|||
125982215|NCT03518125|453225702|FG005|Overall Study|Lost to Follow-up|5|||
125982216|NCT03518125|453225697|FG000|Overall Study|Physician Decision|0|||
125982217|NCT03518125|453225698|FG001|Overall Study|Physician Decision|1|||
125982218|NCT03518125|453225699|FG002|Overall Study|Physician Decision|0|||
125982219|NCT03518125|453225700|FG003|Overall Study|Physician Decision|0|||
125982220|NCT03518125|453225701|FG004|Overall Study|Physician Decision|0|||
125982221|NCT03518125|453225702|FG005|Overall Study|Physician Decision|0|||
125982222|NCT03518125|453225697|FG000|Overall Study|Withdrawal by Subject|1|||
125982223|NCT03518125|453225698|FG001|Overall Study|Withdrawal by Subject|1|||
125982224|NCT03518125|453225699|FG002|Overall Study|Withdrawal by Subject|0|||
125982225|NCT03518125|453225700|FG003|Overall Study|Withdrawal by Subject|1|||
125982226|NCT03518125|453225701|FG004|Overall Study|Withdrawal by Subject|1|||
125982227|NCT03518125|453225702|FG005|Overall Study|Withdrawal by Subject|3|||
125982228|NCT03518125|453225697|FG000|Overall Study|Missed Day 394 Visit|1|||
125982229|NCT03518125|453225698|FG001|Overall Study|Missed Day 394 Visit|0|||
125982230|NCT03518125|453225699|FG002|Overall Study|Missed Day 394 Visit|0|||
125982231|NCT03518125|453225700|FG003|Overall Study|Missed Day 394 Visit|0|||
125982232|NCT03518125|453225701|FG004|Overall Study|Missed Day 394 Visit|0|||
125982233|NCT03518125|453225702|FG005|Overall Study|Missed Day 394 Visit|0|||
125982234|NCT01424930|453225703|FG000|Overall Study|Adverse Event|0|||
125982235|NCT01424930|453225704|FG001|Overall Study|Adverse Event|1|||
125982236|NCT01424930|453225703|FG000|Overall Study|Death|1|||
125982237|NCT01424930|453225704|FG001|Overall Study|Death|0|||
125982238|NCT01424930|453225703|FG000|Overall Study|Progressive Disease|3|||
125982239|NCT01424930|453225704|FG001|Overall Study|Progressive Disease|6|||
125982240|NCT01424930|453225703|FG000|Overall Study|Screen Failure|0|||
125982241|NCT01424930|453225704|FG001|Overall Study|Screen Failure|1|||
125982242|NCT01424930|453225703|FG000|Overall Study|Reason not specified|0|||
125982243|NCT01424930|453225704|FG001|Overall Study|Reason not specified|6|||
125982244|NCT03286751|453225705|FG000|Washout Period 1|Withdrawal by Subject|0|||
125982245|NCT03286751|453225706|FG001|Washout Period 1|Withdrawal by Subject|0|||
126318474|NCT01172808|454457924|FG001|Overall Study|Adverse Event|4|||
126318475|NCT01172808|454457925|FG002|Overall Study|Adverse Event|8|||
126318476|NCT01172808|454457926|FG003|Overall Study|Adverse Event|3|||
126318477|NCT01172808|454457923|FG000|Overall Study|Lack of Efficacy|1|||
126318478|NCT01172808|454457924|FG001|Overall Study|Lack of Efficacy|0|||
126318479|NCT01172808|454457925|FG002|Overall Study|Lack of Efficacy|0|||
126318480|NCT01172808|454457926|FG003|Overall Study|Lack of Efficacy|0|||
126318481|NCT01172808|454457923|FG000|Overall Study|Protocol Violation|2|||
125982246|NCT03286751|453225707|FG002|Washout Period 1|Withdrawal by Subject|0|||
125982247|NCT03286751|453225708|FG003|Washout Period 1|Withdrawal by Subject|0|||
125982248|NCT03286751|453225709|FG004|Washout Period 1|Withdrawal by Subject|1|||
125982249|NCT03286751|453225710|FG005|Washout Period 1|Withdrawal by Subject|0|||
125982250|NCT03286751|453225705|FG000|Washout Period 2|Personal Reasons|0|||
125982251|NCT03286751|453225706|FG001|Washout Period 2|Personal Reasons|1|||
125982252|NCT03286751|453225707|FG002|Washout Period 2|Personal Reasons|0|||
125982253|NCT03286751|453225708|FG003|Washout Period 2|Personal Reasons|0|||
125982254|NCT03286751|453225709|FG004|Washout Period 2|Personal Reasons|0|||
125982255|NCT03286751|453225710|FG005|Washout Period 2|Personal Reasons|0|||
125982256|NCT03286751|453225705|FG000|Washout Period 5|Adverse Event|0|||
125982257|NCT03286751|453225706|FG001|Washout Period 5|Adverse Event|0|||
125982258|NCT03286751|453225707|FG002|Washout Period 5|Adverse Event|0|||
125982259|NCT03286751|453225708|FG003|Washout Period 5|Adverse Event|0|||
125982260|NCT03286751|453225709|FG004|Washout Period 5|Adverse Event|1|||
125982261|NCT03286751|453225710|FG005|Washout Period 5|Adverse Event|0|||
125982262|NCT01078155|453225711|FG000|Overall Study|Adverse Event|7|||
125982263|NCT01078155|453225711|FG000|Overall Study|Lack of Efficacy|16|||
125982264|NCT01078155|453225711|FG000|Overall Study|Participant's Decision|6|||
125982265|NCT01078155|453225711|FG000|Overall Study|Lost to Follow-up|15|||
125982266|NCT01621880|453225712|FG000|Overall Study|Adverse Event|5|||
125982267|NCT01621880|453225713|FG001|Overall Study|Adverse Event|1|||
125982268|NCT01621880|453225712|FG000|Overall Study|Withdrawal by Subject|5|||
125982269|NCT01621880|453225713|FG001|Overall Study|Withdrawal by Subject|4|||
125982270|NCT01127646|453225714|FG000|Overall Study|Entry Criteria Not Met|1|||
125982271|NCT01127646|453225715|FG001|Overall Study|Entry Criteria Not Met|0|||
125982272|NCT01127646|453225714|FG000|Overall Study|Protocol Violation|0|||
125982273|NCT01127646|453225715|FG001|Overall Study|Protocol Violation|1|||
125982274|NCT00106184|453225718|FG000|Overall Study|Withdrawal by Subject|3|||
125982275|NCT00106184|453225719|FG001|Overall Study|Withdrawal by Subject|2|||
125982276|NCT00409682|453225728|FG000|Open-label Induction Period|Adverse Event|1|||
125982277|NCT00409682|453225729|FG001|Open-label Induction Period|Adverse Event|0|||
125982278|NCT00409682|453225730|FG002|Open-label Induction Period|Adverse Event|0|||
125982279|NCT00409682|453225728|FG000|Open-label Induction Period|Lack of Efficacy|1|||
125982280|NCT00409682|453225729|FG001|Open-label Induction Period|Lack of Efficacy|0|||
125982281|NCT00409682|453225730|FG002|Open-label Induction Period|Lack of Efficacy|0|||
125982282|NCT00409682|453225728|FG000|Open-label Induction Period|Protocol Violation|1|||
125982283|NCT00409682|453225729|FG001|Open-label Induction Period|Protocol Violation|0|||
125982284|NCT00409682|453225730|FG002|Open-label Induction Period|Protocol Violation|0|||
125982285|NCT00409682|453225728|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
125982286|NCT00409682|453225729|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
125982287|NCT00409682|453225730|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
125982288|NCT00409682|453225728|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
125982289|NCT00409682|453225729|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
125982290|NCT00409682|453225730|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
125982291|NCT00409682|453225728|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
125982292|NCT00409682|453225729|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
125982293|NCT00409682|453225730|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
125982294|NCT00409682|453225728|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
125982295|NCT00409682|453225729|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
125982296|NCT00409682|453225730|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
126318482|NCT01172808|454457924|FG001|Overall Study|Protocol Violation|2|||
126318483|NCT01172808|454457925|FG002|Overall Study|Protocol Violation|2|||
126318484|NCT01172808|454457926|FG003|Overall Study|Protocol Violation|0|||
125982297|NCT00409682|453225728|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
125982298|NCT00409682|453225729|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
126318485|NCT01172808|454457923|FG000|Overall Study|Lost to Follow-up|0|||
125982299|NCT00409682|453225730|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
125982300|NCT00409682|453225728|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
125982301|NCT00409682|453225729|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
125982302|NCT00409682|453225730|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
125982303|NCT00409682|453225728|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
125982304|NCT00409682|453225729|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
125982305|NCT00409682|453225730|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
126318486|NCT01172808|454457924|FG001|Overall Study|Lost to Follow-up|1|||
126318487|NCT01172808|454457925|FG002|Overall Study|Lost to Follow-up|1|||
125982306|NCT01089374|453225735|FG000|Overall Study|Lost to Follow-up|3|||
125982307|NCT01089374|453225736|FG001|Overall Study|Lost to Follow-up|0|||
125982308|NCT01089374|453225735|FG000|Overall Study|Withdrawal by Subject|1|||
125982309|NCT01089374|453225736|FG001|Overall Study|Withdrawal by Subject|0|||
125982310|NCT01089374|453225735|FG000|Overall Study|Study closed early - low accrual|6|||
125982311|NCT01089374|453225736|FG001|Overall Study|Study closed early - low accrual|0|||
125982312|NCT02856113|453225737|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125982313|NCT02856113|453225738|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125982314|NCT02856113|453225737|FG000|Overall Study|Significant Protocol Deviation|1|||
125982315|NCT02856113|453225738|FG001|Overall Study|Significant Protocol Deviation|0|||
125982316|NCT02856113|453225737|FG000|Overall Study|Lost to Follow-up|3|||
125982317|NCT02856113|453225738|FG001|Overall Study|Lost to Follow-up|5|||
125982318|NCT02856113|453225737|FG000|Overall Study|Voluntary Withdrawal|3|||
125982319|NCT02856113|453225738|FG001|Overall Study|Voluntary Withdrawal|5|||
125982320|NCT02856113|453225737|FG000|Overall Study|Pregnancy|0|||
125982321|NCT02856113|453225738|FG001|Overall Study|Pregnancy|1|||
125982322|NCT02856113|453225737|FG000|Overall Study|Principal Investigator Discretion|2|||
125982323|NCT02856113|453225738|FG001|Overall Study|Principal Investigator Discretion|1|||
125982324|NCT02856113|453225737|FG000|Overall Study|Randomized but not Treated|1|||
125982325|NCT02856113|453225738|FG001|Overall Study|Randomized but not Treated|0|||
125982326|NCT02856113|453225737|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
125982327|NCT02856113|453225738|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
125982328|NCT03185481|453225740|FG000|Overall Study|Adverse Event|1|||
125982329|NCT03185481|453225740|FG000|Overall Study|Study Terminated by Sponsor|4|||
125982330|NCT01422408|453225741|FG000|Overall Study|Adverse Event|1|||
125982331|NCT01422408|453225741|FG000|Overall Study|Withdrawal by Subject|3|||
125982332|NCT03371940|453225746|FG000|Overall Study|Withdrawal by Subject|8|||
125982333|NCT03371940|453225747|FG001|Overall Study|Withdrawal by Subject|1|||
125982334|NCT03371940|453225748|FG002|Overall Study|Withdrawal by Subject|3|||
125982335|NCT03371940|453225749|FG003|Overall Study|Withdrawal by Subject|4|||
125982336|NCT05099926|453225757|FG000|Overall Study|Lost to Follow-up|1|||
125982337|NCT00724152|453225758|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
125982338|NCT00724152|453225759|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
125982339|NCT00724152|453225760|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
125982340|NCT00724152|453225758|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
125982341|NCT00724152|453225759|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
125982342|NCT00724152|453225760|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
125982343|NCT00031486|453225766|FG000|Overall Study|Adverse Event|1|||
125982344|NCT00031486|453225767|FG001|Overall Study|Adverse Event|0|||
125982345|NCT00031486|453225766|FG000|Overall Study|Lost to Follow-up|0|||
125982346|NCT00031486|453225767|FG001|Overall Study|Lost to Follow-up|1|||
125982347|NCT00031486|453225766|FG000|Overall Study|Withdrawal by Subject|3|||
125982348|NCT00031486|453225767|FG001|Overall Study|Withdrawal by Subject|2|||
125982349|NCT00031486|453225766|FG000|Overall Study|Death|0|||
125982350|NCT00031486|453225767|FG001|Overall Study|Death|3|||
125982351|NCT00031486|453225766|FG000|Overall Study|Non-compliant|0|||
125982352|NCT00031486|453225767|FG001|Overall Study|Non-compliant|4|||
125982353|NCT00031486|453225766|FG000|Overall Study|Did not meet eligibility requirement|2|||
125982354|NCT00031486|453225767|FG001|Overall Study|Did not meet eligibility requirement|1|||
125982355|NCT00031486|453225766|FG000|Overall Study|Other|1|||
125982356|NCT00031486|453225767|FG001|Overall Study|Other|1|||
125982357|NCT03685591|453225768|FG000|Overall Study|Global Deterioration of Health Status|0|||
125982358|NCT03685591|453225769|FG001|Overall Study|Global Deterioration of Health Status|0|||
125982359|NCT03685591|453225770|FG002|Overall Study|Global Deterioration of Health Status|0|||
125982360|NCT03685591|453225771|FG003|Overall Study|Global Deterioration of Health Status|1|||
125982361|NCT03685591|453225772|FG004|Overall Study|Global Deterioration of Health Status|2|||
125982362|NCT03685591|453225773|FG005|Overall Study|Global Deterioration of Health Status|4|||
125982363|NCT03685591|453225774|FG006|Overall Study|Global Deterioration of Health Status|1|||
125982364|NCT03685591|453225775|FG007|Overall Study|Global Deterioration of Health Status|1|||
125982365|NCT03685591|453225776|FG008|Overall Study|Global Deterioration of Health Status|0|||
125982366|NCT03685591|453225768|FG000|Overall Study|Progressive Disease|1|||
125982367|NCT03685591|453225769|FG001|Overall Study|Progressive Disease|1|||
125982368|NCT03685591|453225770|FG002|Overall Study|Progressive Disease|0|||
125982369|NCT03685591|453225771|FG003|Overall Study|Progressive Disease|3|||
125982370|NCT03685591|453225772|FG004|Overall Study|Progressive Disease|5|||
125982371|NCT03685591|453225773|FG005|Overall Study|Progressive Disease|4|||
125982372|NCT03685591|453225774|FG006|Overall Study|Progressive Disease|3|||
125982373|NCT03685591|453225775|FG007|Overall Study|Progressive Disease|2|||
125982374|NCT03685591|453225776|FG008|Overall Study|Progressive Disease|1|||
125982375|NCT03685591|453225768|FG000|Overall Study|Other|0|||
125982376|NCT03685591|453225769|FG001|Overall Study|Other|0|||
125982377|NCT03685591|453225770|FG002|Overall Study|Other|1|||
125982378|NCT03685591|453225771|FG003|Overall Study|Other|0|||
125982379|NCT03685591|453225772|FG004|Overall Study|Other|2|||
125982380|NCT03685591|453225773|FG005|Overall Study|Other|3|||
126318488|NCT01172808|454457926|FG003|Overall Study|Lost to Follow-up|3|||
126318489|NCT01172808|454457923|FG000|Overall Study|Withdrawal by Subject|4|||
126318490|NCT01172808|454457924|FG001|Overall Study|Withdrawal by Subject|1|||
126318491|NCT01172808|454457925|FG002|Overall Study|Withdrawal by Subject|3|||
126318492|NCT01172808|454457926|FG003|Overall Study|Withdrawal by Subject|2|||
125982381|NCT03685591|453225774|FG006|Overall Study|Other|0|||
125982382|NCT03685591|453225775|FG007|Overall Study|Other|0|||
126318493|NCT01172808|454457923|FG000|Overall Study|Other|6|||
126318494|NCT01172808|454457924|FG001|Overall Study|Other|5|||
126318495|NCT01172808|454457925|FG002|Overall Study|Other|9|||
126318496|NCT01172808|454457926|FG003|Overall Study|Other|7|||
126318497|NCT01937715|454457938|FG000|Overall Study|Death|0|||
126318498|NCT01937715|454457939|FG001|Overall Study|Death|0|||
126318499|NCT01937715|454457940|FG002|Overall Study|Death|0|||
126318500|NCT01937715|454457941|FG003|Overall Study|Death|1|||
126318501|NCT01937715|454457942|FG004|Overall Study|Death|0|||
126318502|NCT01937715|454457938|FG000|Overall Study|Withdrawal by Subject|0|||
126318503|NCT01937715|454457939|FG001|Overall Study|Withdrawal by Subject|1|||
126318504|NCT01937715|454457940|FG002|Overall Study|Withdrawal by Subject|0|||
126318505|NCT01937715|454457941|FG003|Overall Study|Withdrawal by Subject|0|||
126318506|NCT01937715|454457942|FG004|Overall Study|Withdrawal by Subject|2|||
126318507|NCT01937715|454457938|FG000|Overall Study|Other|0|||
126318508|NCT01937715|454457939|FG001|Overall Study|Other|0|||
126318509|NCT01937715|454457940|FG002|Overall Study|Other|0|||
126318510|NCT01937715|454457941|FG003|Overall Study|Other|3|||
126318511|NCT01937715|454457942|FG004|Overall Study|Other|0|||
126318512|NCT05459558|454457943|FG000|Overall Study|Adverse Event|1|||
126318513|NCT05459558|454457944|FG001|Overall Study|Adverse Event|0|||
126318514|NCT05459558|454457945|FG002|Overall Study|Adverse Event|0|||
126318515|NCT05459558|454457943|FG000|Overall Study|Scheduling issue|0|||
126318516|NCT05459558|454457944|FG001|Overall Study|Scheduling issue|1|||
126318517|NCT05459558|454457945|FG002|Overall Study|Scheduling issue|3|||
126318518|NCT05459558|454457943|FG000|Overall Study|Withdrawal by Subject|0|||
126318519|NCT05459558|454457944|FG001|Overall Study|Withdrawal by Subject|0|||
126318520|NCT05459558|454457945|FG002|Overall Study|Withdrawal by Subject|2|||
126318521|NCT01092637|454457947|FG000|Overall Study|Death|47|||
126318522|NCT01092637|454457948|FG001|Overall Study|Death|49|||
126318523|NCT03292458|454457950|FG000|Period 1|Adverse Event|2|||
126318524|NCT03292458|454457951|FG001|Period 1|Adverse Event|0|||
126318525|NCT00593606|454457952|FG000|Overall Study|Adverse Event|13|||
126318526|NCT00593606|454457952|FG000|Overall Study|Withdrawal by Subject|1|||
126318527|NCT00593606|454457952|FG000|Overall Study|Protocol Violation|3|||
126318528|NCT00593606|454457952|FG000|Overall Study|Lost to Follow-up|2|||
126318529|NCT00593606|454457952|FG000|Overall Study|Run-In Failure|5|||
126318530|NCT00593606|454457952|FG000|Overall Study|Screen Failure|3|||
126318531|NCT02278367|454457953|FG000|Overall Study|Physician Decision|5|||
126318532|NCT02278367|454457954|FG001|Overall Study|Physician Decision|0|||
126318533|NCT02278367|454457953|FG000|Overall Study|Withdrawal by Subject|5|||
126318534|NCT02278367|454457954|FG001|Overall Study|Withdrawal by Subject|0|||
126318535|NCT04643964|454457956|FG000|Overall Study|Lost to Follow-up|55|||
126318536|NCT04643964|454457957|FG001|Overall Study|Lost to Follow-up|59|||
126318537|NCT04643964|454457958|FG002|Overall Study|Lost to Follow-up|54|||
126318538|NCT04643964|454457959|FG003|Overall Study|Lost to Follow-up|129|||
126318539|NCT04643964|454457960|FG004|Overall Study|Lost to Follow-up|48|||
126318540|NCT04643964|454457956|FG000|Overall Study|Failed attention check|1|||
126318541|NCT04643964|454457957|FG001|Overall Study|Failed attention check|8|||
126318542|NCT04643964|454457958|FG002|Overall Study|Failed attention check|2|||
126318543|NCT04643964|454457959|FG003|Overall Study|Failed attention check|14|||
126318544|NCT04643964|454457960|FG004|Overall Study|Failed attention check|11|||
126318545|NCT05932225|454457961|FG000|Overall Study|Lost to Follow-up|0|||
126318546|NCT05932225|454457962|FG001|Overall Study|Lost to Follow-up|1|||
126318547|NCT05932225|454457963|FG002|Overall Study|Lost to Follow-up|0|||
126318548|NCT05932225|454457961|FG000|Overall Study|Withdrawal by Subject|1|||
125982383|NCT03685591|453225776|FG008|Overall Study|Other|0|||
126318549|NCT05932225|454457962|FG001|Overall Study|Withdrawal by Subject|0|||
126318550|NCT05932225|454457963|FG002|Overall Study|Withdrawal by Subject|0|||
126318551|NCT05932225|454457961|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
126318552|NCT05932225|454457962|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
126318553|NCT05932225|454457963|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
126318554|NCT02638129|454457964|FG000|Overall Study|Study terminated|28|||
126318555|NCT02638129|454457965|FG001|Overall Study|Study terminated|30|||
126318556|NCT02949908|454457966|FG000|Overall Study|Study termination|2|||
126318557|NCT01472939|454457967|FG000|Overall Study|Adverse Event|3|||
125982384|NCT03685591|453225768|FG000|Overall Study|Withdrawal by Subject|0|||
126318558|NCT01472939|454457968|FG001|Overall Study|Adverse Event|7|||
126318559|NCT01472939|454457969|FG002|Overall Study|Adverse Event|7|||
126318560|NCT01472939|454457970|FG003|Overall Study|Adverse Event|14|||
126318561|NCT01472939|454457967|FG000|Overall Study|Lack of Efficacy|1|||
126318562|NCT01472939|454457968|FG001|Overall Study|Lack of Efficacy|0|||
126318563|NCT01472939|454457969|FG002|Overall Study|Lack of Efficacy|0|||
126318564|NCT01472939|454457970|FG003|Overall Study|Lack of Efficacy|1|||
126318565|NCT01472939|454457967|FG000|Overall Study|Lost to Follow-up|3|||
126318566|NCT01472939|454457968|FG001|Overall Study|Lost to Follow-up|0|||
126318567|NCT01472939|454457969|FG002|Overall Study|Lost to Follow-up|2|||
126318568|NCT01472939|454457970|FG003|Overall Study|Lost to Follow-up|0|||
126318569|NCT01472939|454457967|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
126318570|NCT01472939|454457968|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
126318571|NCT01472939|454457969|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
126318572|NCT01472939|454457970|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
126318573|NCT01472939|454457967|FG000|Overall Study|Prohibited Medication|0|||
126318574|NCT01472939|454457968|FG001|Overall Study|Prohibited Medication|1|||
126318575|NCT01472939|454457969|FG002|Overall Study|Prohibited Medication|0|||
126318576|NCT01472939|454457970|FG003|Overall Study|Prohibited Medication|0|||
126318577|NCT01472939|454457967|FG000|Overall Study|Withdrawal By PI|1|||
126318578|NCT01472939|454457968|FG001|Overall Study|Withdrawal By PI|0|||
126318579|NCT01472939|454457969|FG002|Overall Study|Withdrawal By PI|0|||
126318580|NCT01472939|454457970|FG003|Overall Study|Withdrawal By PI|0|||
126318581|NCT01472939|454457967|FG000|Overall Study|Protocol Violation|3|||
126318582|NCT01472939|454457968|FG001|Overall Study|Protocol Violation|3|||
126318583|NCT01472939|454457969|FG002|Overall Study|Protocol Violation|0|||
126318584|NCT01472939|454457970|FG003|Overall Study|Protocol Violation|1|||
126318585|NCT01472939|454457967|FG000|Overall Study|Withdrawal by Subject|9|||
126318586|NCT01472939|454457968|FG001|Overall Study|Withdrawal by Subject|3|||
126318587|NCT01472939|454457969|FG002|Overall Study|Withdrawal by Subject|1|||
126318588|NCT01472939|454457970|FG003|Overall Study|Withdrawal by Subject|4|||
126318589|NCT00114738|454457971|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
126318590|NCT00114738|454457972|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
126318591|NCT00114738|454457973|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
126318592|NCT00114738|454457971|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
126318593|NCT00114738|454457972|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
126318594|NCT00114738|454457973|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
126318595|NCT00114738|454457971|FG000|Screening for Randomization|Neuropathy|17|||
126318596|NCT00114738|454457972|FG001|Screening for Randomization|Neuropathy|0|||
126318597|NCT00114738|454457973|FG002|Screening for Randomization|Neuropathy|0|||
126318598|NCT00114738|454457971|FG000|Screening for Randomization|Progressive disease|2|||
126318599|NCT00114738|454457972|FG001|Screening for Randomization|Progressive disease|0|||
126318600|NCT00114738|454457973|FG002|Screening for Randomization|Progressive disease|0|||
126318601|NCT00114738|454457971|FG000|Screening for Randomization|CNS Hemorrhage|1|||
126318602|NCT00114738|454457972|FG001|Screening for Randomization|CNS Hemorrhage|0|||
126318603|NCT00114738|454457973|FG002|Screening for Randomization|CNS Hemorrhage|0|||
126318604|NCT00114738|454457971|FG000|Screening for Randomization|Other|1|||
126318605|NCT00114738|454457972|FG001|Screening for Randomization|Other|0|||
126318606|NCT00114738|454457973|FG002|Screening for Randomization|Other|0|||
126318607|NCT00308750|454457978|FG000|Overall Study|Adverse Event|9|||
126318608|NCT00308750|454457979|FG001|Overall Study|Adverse Event|9|||
126318609|NCT00308750|454457980|FG002|Overall Study|Adverse Event|13|||
125982385|NCT03685591|453225769|FG001|Overall Study|Withdrawal by Subject|0|||
125982386|NCT03685591|453225770|FG002|Overall Study|Withdrawal by Subject|0|||
125982387|NCT03685591|453225771|FG003|Overall Study|Withdrawal by Subject|0|||
125982388|NCT03685591|453225772|FG004|Overall Study|Withdrawal by Subject|3|||
125982389|NCT03685591|453225773|FG005|Overall Study|Withdrawal by Subject|2|||
125982390|NCT03685591|453225774|FG006|Overall Study|Withdrawal by Subject|0|||
125982391|NCT03685591|453225775|FG007|Overall Study|Withdrawal by Subject|0|||
125982392|NCT03685591|453225776|FG008|Overall Study|Withdrawal by Subject|1|||
125982393|NCT03685591|453225768|FG000|Overall Study|Adverse Event|0|||
125982394|NCT03685591|453225769|FG001|Overall Study|Adverse Event|0|||
125982395|NCT03685591|453225770|FG002|Overall Study|Adverse Event|0|||
125982396|NCT03685591|453225771|FG003|Overall Study|Adverse Event|1|||
125982397|NCT03685591|453225772|FG004|Overall Study|Adverse Event|1|||
125982398|NCT03685591|453225773|FG005|Overall Study|Adverse Event|4|||
125982399|NCT03685591|453225774|FG006|Overall Study|Adverse Event|0|||
126318610|NCT00308750|454457978|FG000|Overall Study|Withdrawal by Subject|6|||
126318611|NCT00308750|454457979|FG001|Overall Study|Withdrawal by Subject|2|||
126318612|NCT00308750|454457980|FG002|Overall Study|Withdrawal by Subject|3|||
126318613|NCT00308750|454457978|FG000|Overall Study|Physician Decision|3|||
126318614|NCT00308750|454457979|FG001|Overall Study|Physician Decision|4|||
126318615|NCT00308750|454457980|FG002|Overall Study|Physician Decision|3|||
125982400|NCT03685591|453225775|FG007|Overall Study|Adverse Event|1|||
125982401|NCT03685591|453225776|FG008|Overall Study|Adverse Event|1|||
125982402|NCT00500903|453225777|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
126318616|NCT00308750|454457978|FG000|Overall Study|Sponsor Decision|1|||
126318617|NCT00308750|454457979|FG001|Overall Study|Sponsor Decision|0|||
125982403|NCT00500903|453225778|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
125982404|NCT00500903|453225779|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
126318618|NCT00308750|454457980|FG002|Overall Study|Sponsor Decision|0|||
126318619|NCT00308750|454457978|FG000|Overall Study|Disease Progression|47|||
126318620|NCT00308750|454457979|FG001|Overall Study|Disease Progression|24|||
126318621|NCT00308750|454457980|FG002|Overall Study|Disease Progression|28|||
126318622|NCT00308750|454457978|FG000|Overall Study|Unrelated Complication|3|||
126318623|NCT00308750|454457979|FG001|Overall Study|Unrelated Complication|0|||
126318624|NCT00308750|454457980|FG002|Overall Study|Unrelated Complication|1|||
126318625|NCT00308750|454457978|FG000|Overall Study|Death|1|||
126318626|NCT00308750|454457979|FG001|Overall Study|Death|0|||
126318627|NCT00308750|454457980|FG002|Overall Study|Death|1|||
126318628|NCT00308750|454457978|FG000|Overall Study|Protocol Violation|1|||
126318629|NCT00308750|454457979|FG001|Overall Study|Protocol Violation|0|||
126318630|NCT00308750|454457980|FG002|Overall Study|Protocol Violation|0|||
126318631|NCT00308750|454457978|FG000|Overall Study|New Primary Disease Identified|1|||
126318632|NCT00308750|454457979|FG001|Overall Study|New Primary Disease Identified|1|||
126318633|NCT00308750|454457980|FG002|Overall Study|New Primary Disease Identified|0|||
126318634|NCT01358578|454457981|FG000|Induction Period|Adverse Event|2|||
126318635|NCT01358578|454457982|FG001|Induction Period|Adverse Event|4|||
126318636|NCT01358578|454457983|FG002|Induction Period|Adverse Event|2|||
126318637|NCT01358578|454457984|FG003|Induction Period|Adverse Event|6|||
126318638|NCT01358578|454457985|FG004|Induction Period|Adverse Event|0|||
126318639|NCT01358578|454457986|FG005|Induction Period|Adverse Event|0|||
125982405|NCT00500903|453225777|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
125982406|NCT00500903|453225778|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125982407|NCT00500903|453225779|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125982408|NCT00500903|453225777|FG000|Overall Study|Progressive Disease|41|||
125982409|NCT00500903|453225778|FG001|Overall Study|Progressive Disease|2|||
125982410|NCT00500903|453225779|FG002|Overall Study|Progressive Disease|15|||
125982411|NCT00500903|453225777|FG000|Overall Study|Patient Declined Further Treatment|0|||
125982412|NCT00500903|453225778|FG001|Overall Study|Patient Declined Further Treatment|0|||
125982413|NCT00500903|453225779|FG002|Overall Study|Patient Declined Further Treatment|3|||
125982414|NCT00500903|453225777|FG000|Overall Study|Symptomatic Deterioration|2|||
125982415|NCT00500903|453225778|FG001|Overall Study|Symptomatic Deterioration|0|||
125982416|NCT00500903|453225779|FG002|Overall Study|Symptomatic Deterioration|0|||
125982417|NCT00500903|453225777|FG000|Overall Study|Reason Not Specified|10|||
125982418|NCT00500903|453225778|FG001|Overall Study|Reason Not Specified|0|||
126318640|NCT01358578|454457981|FG000|Induction Period|Lack of Efficacy|0|||
126318641|NCT01358578|454457982|FG001|Induction Period|Lack of Efficacy|0|||
126318642|NCT01358578|454457983|FG002|Induction Period|Lack of Efficacy|9|||
126318643|NCT01358578|454457984|FG003|Induction Period|Lack of Efficacy|1|||
126318644|NCT01358578|454457985|FG004|Induction Period|Lack of Efficacy|0|||
126318645|NCT01358578|454457986|FG005|Induction Period|Lack of Efficacy|0|||
125982419|NCT00500903|453225779|FG002|Overall Study|Reason Not Specified|2|||
125982420|NCT00696410|453225782|FG000|Overall Study|Lost to Follow-up|2|||
125982421|NCT00696410|453225783|FG001|Overall Study|Lost to Follow-up|0|||
125982422|NCT00696410|453225782|FG000|Overall Study|Withdrawal by Subject|8|||
126318646|NCT01358578|454457981|FG000|Induction Period|Lost to Follow-up|0|||
125878367|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Other|8|||
125878368|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
125878369|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
125878370|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
125878371|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
125878372|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
125878373|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
125878374|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
125878375|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
125878376|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
125878377|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
125878378|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
125878379|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
125878380|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Death|0|||
125878381|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Death|2|||
125878382|NCT03605667|452851282|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
125878383|NCT03605667|452851283|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
125982423|NCT00696410|453225783|FG001|Overall Study|Withdrawal by Subject|0|||
125982424|NCT00696410|453225782|FG000|Overall Study|Physician Decision|3|||
125982425|NCT00696410|453225783|FG001|Overall Study|Physician Decision|0|||
125878384|NCT02783690|452851291|FG000|Overall Study|Withdrawal by Subject|3|||
125878385|NCT02783690|452851292|FG001|Overall Study|Withdrawal by Subject|3|||
125878386|NCT03312231|452851296|FG000|Overall Study|Lost to Follow-up|2|||
125878387|NCT03312231|452851297|FG001|Overall Study|Lost to Follow-up|6|||
125982426|NCT01951638|453225785|FG000|Treatment Period|Protocol Violation|0|||
125982427|NCT01951638|453225786|FG001|Treatment Period|Protocol Violation|0|||
125982428|NCT01951638|453225787|FG002|Treatment Period|Protocol Violation|0|||
126318647|NCT01358578|454457982|FG001|Induction Period|Lost to Follow-up|0|||
126318648|NCT01358578|454457983|FG002|Induction Period|Lost to Follow-up|1|||
126318649|NCT01358578|454457984|FG003|Induction Period|Lost to Follow-up|4|||
126318650|NCT01358578|454457985|FG004|Induction Period|Lost to Follow-up|0|||
125982429|NCT01951638|453225788|FG003|Treatment Period|Protocol Violation|2|||
125982430|NCT01951638|453225789|FG004|Treatment Period|Protocol Violation|0|||
125982431|NCT01951638|453225785|FG000|Treatment Period|Protocol-driven decision point|1|||
125982432|NCT01951638|453225786|FG001|Treatment Period|Protocol-driven decision point|3|||
125982433|NCT01951638|453225787|FG002|Treatment Period|Protocol-driven decision point|0|||
125982434|NCT01951638|453225788|FG003|Treatment Period|Protocol-driven decision point|0|||
125982435|NCT01951638|453225789|FG004|Treatment Period|Protocol-driven decision point|0|||
125982436|NCT01951638|453225785|FG000|Treatment Period|Logistical difficulties|0|||
125982437|NCT01951638|453225786|FG001|Treatment Period|Logistical difficulties|1|||
125982438|NCT01951638|453225787|FG002|Treatment Period|Logistical difficulties|1|||
125982439|NCT01951638|453225788|FG003|Treatment Period|Logistical difficulties|0|||
125982440|NCT01951638|453225789|FG004|Treatment Period|Logistical difficulties|0|||
125982441|NCT01951638|453225785|FG000|Treatment Period|Withdrawal by Subject|9|||
125982442|NCT01951638|453225786|FG001|Treatment Period|Withdrawal by Subject|6|||
125982443|NCT01951638|453225787|FG002|Treatment Period|Withdrawal by Subject|4|||
125982444|NCT01951638|453225788|FG003|Treatment Period|Withdrawal by Subject|5|||
125982445|NCT01951638|453225789|FG004|Treatment Period|Withdrawal by Subject|4|||
125982446|NCT01951638|453225785|FG000|Treatment Period|Death|0|||
125982447|NCT01951638|453225786|FG001|Treatment Period|Death|0|||
125982448|NCT01951638|453225787|FG002|Treatment Period|Death|0|||
125982449|NCT01951638|453225788|FG003|Treatment Period|Death|3|||
125982450|NCT01951638|453225789|FG004|Treatment Period|Death|1|||
125982451|NCT01951638|453225785|FG000|Treatment Period|Adverse Event|3|||
125982452|NCT01951638|453225786|FG001|Treatment Period|Adverse Event|4|||
125982453|NCT01951638|453225787|FG002|Treatment Period|Adverse Event|8|||
125982454|NCT01951638|453225788|FG003|Treatment Period|Adverse Event|6|||
125982455|NCT01951638|453225789|FG004|Treatment Period|Adverse Event|5|||
125982456|NCT01951638|453225785|FG000|Follow-up Period|Protocol Violation|0|||
125982457|NCT01951638|453225786|FG001|Follow-up Period|Protocol Violation|0|||
125982458|NCT01951638|453225787|FG002|Follow-up Period|Protocol Violation|0|||
125982459|NCT01951638|453225788|FG003|Follow-up Period|Protocol Violation|1|||
125982460|NCT01951638|453225789|FG004|Follow-up Period|Protocol Violation|0|||
125982461|NCT01951638|453225785|FG000|Follow-up Period|Logistical difficulties|0|||
125982462|NCT01951638|453225786|FG001|Follow-up Period|Logistical difficulties|2|||
125982463|NCT01951638|453225787|FG002|Follow-up Period|Logistical difficulties|0|||
125982464|NCT01951638|453225788|FG003|Follow-up Period|Logistical difficulties|0|||
125982465|NCT01951638|453225789|FG004|Follow-up Period|Logistical difficulties|1|||
125982466|NCT01951638|453225785|FG000|Follow-up Period|Withdrawal by Subject|1|||
125982467|NCT01951638|453225786|FG001|Follow-up Period|Withdrawal by Subject|5|||
125982468|NCT01951638|453225787|FG002|Follow-up Period|Withdrawal by Subject|2|||
125982469|NCT01951638|453225788|FG003|Follow-up Period|Withdrawal by Subject|1|||
125982470|NCT01951638|453225789|FG004|Follow-up Period|Withdrawal by Subject|2|||
125982471|NCT01951638|453225785|FG000|Follow-up Period|Lost to Follow-up|0|||
125982472|NCT01951638|453225786|FG001|Follow-up Period|Lost to Follow-up|1|||
125982473|NCT01951638|453225787|FG002|Follow-up Period|Lost to Follow-up|0|||
125982474|NCT01951638|453225788|FG003|Follow-up Period|Lost to Follow-up|1|||
125982475|NCT01951638|453225789|FG004|Follow-up Period|Lost to Follow-up|0|||
125982476|NCT01951638|453225785|FG000|Follow-up Period|Death|1|||
125982477|NCT01951638|453225786|FG001|Follow-up Period|Death|0|||
125982478|NCT01951638|453225787|FG002|Follow-up Period|Death|1|||
125982479|NCT01951638|453225788|FG003|Follow-up Period|Death|4|||
125982480|NCT01951638|453225789|FG004|Follow-up Period|Death|1|||
125982481|NCT01951638|453225785|FG000|Follow-up Period|Adverse Event|0|||
125982482|NCT01951638|453225786|FG001|Follow-up Period|Adverse Event|1|||
125982483|NCT01951638|453225787|FG002|Follow-up Period|Adverse Event|2|||
125982484|NCT01951638|453225788|FG003|Follow-up Period|Adverse Event|1|||
125982485|NCT01951638|453225789|FG004|Follow-up Period|Adverse Event|1|||
125982486|NCT00944658|453226863|FG000|Treatment 12 Weeks|Adverse Event|0|||
125982487|NCT00944658|453226864|FG001|Treatment 12 Weeks|Adverse Event|2|||
125982488|NCT03704584|453226865|FG000|Overall Study|Withdrawal by Subject|1|||
125982489|NCT03704584|453226866|FG001|Overall Study|Withdrawal by Subject|0|||
125982490|NCT01083641|453226867|FG000|Overall Study|Withdrawal by Subject|2|||
125982491|NCT03439189|453226868|FG000|Overall Study|Protocol Violation|19|||
125982492|NCT03439189|453226868|FG000|Overall Study|Lack of Efficacy|63|||
125982493|NCT01493687|453226869|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
125982494|NCT01493687|453226870|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
125982495|NCT01493687|453226869|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
125982496|NCT01493687|453226870|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
125982497|NCT01493687|453226869|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
125982498|NCT01493687|453226870|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
125982499|NCT01493687|453226869|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
125982500|NCT01493687|453226870|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
125982501|NCT01493687|453226869|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
125982502|NCT01493687|453226870|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
125982503|NCT01493687|453226869|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
125982504|NCT01493687|453226870|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
126318651|NCT01358578|454457986|FG005|Induction Period|Lost to Follow-up|0|||
126318652|NCT01358578|454457981|FG000|Induction Period|Physician Decision|2|||
126318653|NCT01358578|454457982|FG001|Induction Period|Physician Decision|1|||
126318654|NCT01358578|454457983|FG002|Induction Period|Physician Decision|2|||
126318655|NCT01358578|454457984|FG003|Induction Period|Physician Decision|0|||
126318656|NCT01358578|454457985|FG004|Induction Period|Physician Decision|0|||
126318657|NCT01358578|454457986|FG005|Induction Period|Physician Decision|0|||
126318658|NCT01358578|454457981|FG000|Induction Period|Protocol Deviation|3|||
126318659|NCT01358578|454457982|FG001|Induction Period|Protocol Deviation|5|||
126318660|NCT01358578|454457983|FG002|Induction Period|Protocol Deviation|0|||
126318661|NCT01358578|454457984|FG003|Induction Period|Protocol Deviation|3|||
126318662|NCT01358578|454457985|FG004|Induction Period|Protocol Deviation|0|||
126318663|NCT01358578|454457986|FG005|Induction Period|Protocol Deviation|0|||
126318664|NCT01358578|454457981|FG000|Induction Period|technical problems|0|||
126318665|NCT01358578|454457982|FG001|Induction Period|technical problems|0|||
126318666|NCT01358578|454457983|FG002|Induction Period|technical problems|1|||
126318667|NCT01358578|454457984|FG003|Induction Period|technical problems|1|||
126318668|NCT01358578|454457985|FG004|Induction Period|technical problems|0|||
126318669|NCT01358578|454457986|FG005|Induction Period|technical problems|0|||
126318670|NCT01358578|454457981|FG000|Induction Period|Withdrawal by Subject|5|||
126318671|NCT01358578|454457982|FG001|Induction Period|Withdrawal by Subject|5|||
126318672|NCT01358578|454457983|FG002|Induction Period|Withdrawal by Subject|10|||
126318673|NCT01358578|454457984|FG003|Induction Period|Withdrawal by Subject|6|||
126318674|NCT01358578|454457985|FG004|Induction Period|Withdrawal by Subject|0|||
126318675|NCT01358578|454457986|FG005|Induction Period|Withdrawal by Subject|0|||
126318676|NCT01358578|454457981|FG000|Maintenance Period|Adverse Event|2|||
126318677|NCT01358578|454457982|FG001|Maintenance Period|Adverse Event|7|||
126318678|NCT01358578|454457983|FG002|Maintenance Period|Adverse Event|0|||
125982505|NCT01493687|453226869|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
125982506|NCT01493687|453226870|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
125982507|NCT01493687|453226869|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
125982508|NCT01493687|453226870|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
125982509|NCT01493687|453226869|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
125982510|NCT01493687|453226870|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
125982511|NCT01493687|453226869|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
125982512|NCT01493687|453226870|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
125982513|NCT01493687|453226869|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
125982514|NCT01493687|453226870|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
125982515|NCT01493687|453226869|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
125982516|NCT01493687|453226870|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
125982517|NCT01493687|453226869|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
125982518|NCT01493687|453226870|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
125982519|NCT01493687|453226869|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
125982520|NCT01493687|453226870|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
125982521|NCT01493687|453226869|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
125982522|NCT01493687|453226870|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
125982523|NCT02323646|453226871|FG000|Treatment Course 1|Adverse Event|1|||
125982524|NCT02323646|453226872|FG001|Treatment Course 1|Adverse Event|0|||
125982525|NCT02323646|453226873|FG002|Treatment Course 1|Adverse Event|1|||
125982526|NCT02323646|453226871|FG000|Treatment Course 1|Heavy Bleeding|1|||
125982527|NCT02323646|453226872|FG001|Treatment Course 1|Heavy Bleeding|1|||
125982528|NCT02323646|453226873|FG002|Treatment Course 1|Heavy Bleeding|0|||
125982529|NCT02323646|453226871|FG000|Treatment Course 1|Lost to Follow-up|1|||
125982530|NCT02323646|453226872|FG001|Treatment Course 1|Lost to Follow-up|0|||
125982531|NCT02323646|453226873|FG002|Treatment Course 1|Lost to Follow-up|2|||
125982532|NCT02323646|453226871|FG000|Treatment Course 1|Withdrawal by Subject|0|||
125982533|NCT02323646|453226872|FG001|Treatment Course 1|Withdrawal by Subject|2|||
125982534|NCT02323646|453226873|FG002|Treatment Course 1|Withdrawal by Subject|0|||
125982535|NCT02323646|453226871|FG000|Treatment Course 2|Adverse Event|1|||
125982536|NCT02323646|453226872|FG001|Treatment Course 2|Adverse Event|0|||
125982537|NCT02323646|453226873|FG002|Treatment Course 2|Adverse Event|1|||
125982538|NCT02323646|453226871|FG000|Treatment Course 2|Lost to Follow-up|0|||
125982539|NCT02323646|453226872|FG001|Treatment Course 2|Lost to Follow-up|0|||
125982540|NCT02323646|453226873|FG002|Treatment Course 2|Lost to Follow-up|1|||
126318679|NCT01358578|454457984|FG003|Maintenance Period|Adverse Event|6|||
125982541|NCT02323646|453226871|FG000|Treatment Course 2|Non-compliance|0|||
126318680|NCT01358578|454457985|FG004|Maintenance Period|Adverse Event|4|||
126318681|NCT01358578|454457986|FG005|Maintenance Period|Adverse Event|3|||
126318682|NCT01358578|454457981|FG000|Maintenance Period|Lack of Efficacy|10|||
126318683|NCT01358578|454457982|FG001|Maintenance Period|Lack of Efficacy|2|||
125982542|NCT02323646|453226872|FG001|Treatment Course 2|Non-compliance|1|||
125982543|NCT02323646|453226873|FG002|Treatment Course 2|Non-compliance|1|||
125982544|NCT05131165|453226878|FG000|Overall Study|Death|1|||
125982545|NCT05131165|453226879|FG001|Overall Study|Death|1|||
126318684|NCT01358578|454457983|FG002|Maintenance Period|Lack of Efficacy|0|||
126318685|NCT01358578|454457984|FG003|Maintenance Period|Lack of Efficacy|11|||
126318686|NCT01358578|454457985|FG004|Maintenance Period|Lack of Efficacy|3|||
126318687|NCT01358578|454457986|FG005|Maintenance Period|Lack of Efficacy|0|||
126318688|NCT01358578|454457981|FG000|Maintenance Period|Lost to Follow-up|4|||
126318689|NCT01358578|454457982|FG001|Maintenance Period|Lost to Follow-up|0|||
126318690|NCT01358578|454457983|FG002|Maintenance Period|Lost to Follow-up|0|||
126318691|NCT01358578|454457984|FG003|Maintenance Period|Lost to Follow-up|5|||
126318692|NCT01358578|454457985|FG004|Maintenance Period|Lost to Follow-up|1|||
126318693|NCT01358578|454457986|FG005|Maintenance Period|Lost to Follow-up|1|||
126318694|NCT01358578|454457981|FG000|Maintenance Period|Non-compliance with study treatment|3|||
126318695|NCT01358578|454457982|FG001|Maintenance Period|Non-compliance with study treatment|1|||
126318696|NCT01358578|454457983|FG002|Maintenance Period|Non-compliance with study treatment|0|||
126318697|NCT01358578|454457984|FG003|Maintenance Period|Non-compliance with study treatment|2|||
126318698|NCT01358578|454457985|FG004|Maintenance Period|Non-compliance with study treatment|1|||
126318699|NCT01358578|454457986|FG005|Maintenance Period|Non-compliance with study treatment|2|||
126318700|NCT01358578|454457981|FG000|Maintenance Period|Physician Decision|0|||
126318701|NCT01358578|454457982|FG001|Maintenance Period|Physician Decision|1|||
126318702|NCT01358578|454457983|FG002|Maintenance Period|Physician Decision|0|||
126318703|NCT01358578|454457984|FG003|Maintenance Period|Physician Decision|1|||
126318704|NCT01358578|454457985|FG004|Maintenance Period|Physician Decision|0|||
126318705|NCT01358578|454457986|FG005|Maintenance Period|Physician Decision|0|||
126318706|NCT01358578|454457981|FG000|Maintenance Period|Pregnancy|1|||
125982546|NCT05131165|453226880|FG002|Overall Study|Death|0|||
125982547|NCT05131165|453226878|FG000|Overall Study|Lost to Follow-up|2|||
125982548|NCT05131165|453226879|FG001|Overall Study|Lost to Follow-up|2|||
125982549|NCT05131165|453226880|FG002|Overall Study|Lost to Follow-up|5|||
125982550|NCT05131165|453226878|FG000|Overall Study|Transferred out of clinic|1|||
125982551|NCT05131165|453226879|FG001|Overall Study|Transferred out of clinic|0|||
125982552|NCT05131165|453226880|FG002|Overall Study|Transferred out of clinic|3|||
125982553|NCT05131165|453226878|FG000|Overall Study|Dropped out|1|||
125982554|NCT05131165|453226879|FG001|Overall Study|Dropped out|2|||
125982555|NCT05131165|453226880|FG002|Overall Study|Dropped out|0|||
125982556|NCT02459262|453226886|FG000|Overall Study|Withdrawal by Subject|0|||
125982557|NCT02459262|453226887|FG001|Overall Study|Withdrawal by Subject|0|||
125982558|NCT02459262|453226888|FG002|Overall Study|Withdrawal by Subject|0|||
125982559|NCT02459262|453226889|FG003|Overall Study|Withdrawal by Subject|0|||
125982560|NCT02459262|453226890|FG004|Overall Study|Withdrawal by Subject|0|||
125982561|NCT02459262|453226891|FG005|Overall Study|Withdrawal by Subject|0|||
125982562|NCT02459262|453226892|FG006|Overall Study|Withdrawal by Subject|0|||
125982563|NCT02459262|453226893|FG007|Overall Study|Withdrawal by Subject|0|||
125982564|NCT02459262|453226894|FG008|Overall Study|Withdrawal by Subject|0|||
125982565|NCT02459262|453226895|FG009|Overall Study|Withdrawal by Subject|1|||
125982566|NCT02459262|453226896|FG010|Overall Study|Withdrawal by Subject|0|||
125982567|NCT05168579|453226897|FG000|Overall Study|Lack of Consent|1|||
125982568|NCT05168579|453226898|FG001|Overall Study|Lack of Consent|0|||
125982569|NCT05168579|453226897|FG000|Overall Study|Conflicts with time|2|||
125982570|NCT05168579|453226898|FG001|Overall Study|Conflicts with time|0|||
125982571|NCT05168579|453226897|FG000|Overall Study|Time slots were full|3|||
125982572|NCT05168579|453226898|FG001|Overall Study|Time slots were full|0|||
125982573|NCT05168579|453226897|FG000|Overall Study|Lost to Follow-up|0|||
125982574|NCT05168579|453226898|FG001|Overall Study|Lost to Follow-up|15|||
125982575|NCT01242748|453226899|FG000|Overall Study|Adverse Event|10|||
125982576|NCT01242748|453226900|FG001|Overall Study|Adverse Event|5|||
125982577|NCT01242748|453226899|FG000|Overall Study|Lost to Follow-up|6|||
125982578|NCT01242748|453226900|FG001|Overall Study|Lost to Follow-up|2|||
126318707|NCT01358578|454457982|FG001|Maintenance Period|Pregnancy|0|||
126318708|NCT01358578|454457983|FG002|Maintenance Period|Pregnancy|0|||
125982579|NCT01242748|453226899|FG000|Overall Study|Physician Decision|3|||
125982580|NCT01242748|453226900|FG001|Overall Study|Physician Decision|2|||
125982581|NCT01242748|453226899|FG000|Overall Study|Protocol Violation|1|||
125982582|NCT01242748|453226900|FG001|Overall Study|Protocol Violation|0|||
125982583|NCT01242748|453226899|FG000|Overall Study|Withdrawal by Subject|10|||
126318709|NCT01358578|454457984|FG003|Maintenance Period|Pregnancy|0|||
125982584|NCT01242748|453226900|FG001|Overall Study|Withdrawal by Subject|2|||
126318710|NCT01358578|454457985|FG004|Maintenance Period|Pregnancy|0|||
126318711|NCT01358578|454457986|FG005|Maintenance Period|Pregnancy|0|||
125982585|NCT01242748|453226899|FG000|Overall Study|Miscellaneous reasons|8|||
125982586|NCT01242748|453226900|FG001|Overall Study|Miscellaneous reasons|3|||
125982587|NCT00840801|453226901|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
125982588|NCT00840801|453226902|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
125982589|NCT00840801|453226903|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
125982590|NCT00840801|453226901|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
126318712|NCT01358578|454457981|FG000|Maintenance Period|Protocol deviation|7|||
126318713|NCT01358578|454457982|FG001|Maintenance Period|Protocol deviation|4|||
126318714|NCT01358578|454457983|FG002|Maintenance Period|Protocol deviation|0|||
126318715|NCT01358578|454457984|FG003|Maintenance Period|Protocol deviation|2|||
126318716|NCT01358578|454457985|FG004|Maintenance Period|Protocol deviation|2|||
126318717|NCT01358578|454457986|FG005|Maintenance Period|Protocol deviation|2|||
126318718|NCT01358578|454457981|FG000|Maintenance Period|Withdrawal by Subject|12|||
126318719|NCT01358578|454457982|FG001|Maintenance Period|Withdrawal by Subject|7|||
126318720|NCT01358578|454457983|FG002|Maintenance Period|Withdrawal by Subject|2|||
126318721|NCT01358578|454457984|FG003|Maintenance Period|Withdrawal by Subject|15|||
126318722|NCT01358578|454457985|FG004|Maintenance Period|Withdrawal by Subject|6|||
126318723|NCT01358578|454457986|FG005|Maintenance Period|Withdrawal by Subject|3|||
126318724|NCT01358578|454457981|FG000|Follow-up Period|Adverse Event|1|||
126318725|NCT01358578|454457982|FG001|Follow-up Period|Adverse Event|1|||
126318726|NCT01358578|454457983|FG002|Follow-up Period|Adverse Event|0|||
126318727|NCT01358578|454457984|FG003|Follow-up Period|Adverse Event|0|||
126318728|NCT01358578|454457985|FG004|Follow-up Period|Adverse Event|0|||
126318729|NCT01358578|454457986|FG005|Follow-up Period|Adverse Event|0|||
126318730|NCT01358578|454457981|FG000|Follow-up Period|Lack of Efficacy|3|||
126318731|NCT01358578|454457982|FG001|Follow-up Period|Lack of Efficacy|0|||
126318732|NCT01358578|454457983|FG002|Follow-up Period|Lack of Efficacy|4|||
126318733|NCT01358578|454457984|FG003|Follow-up Period|Lack of Efficacy|1|||
126318734|NCT01358578|454457985|FG004|Follow-up Period|Lack of Efficacy|0|||
126318735|NCT01358578|454457986|FG005|Follow-up Period|Lack of Efficacy|0|||
126318736|NCT01358578|454457981|FG000|Follow-up Period|Lost to Follow-up|0|||
126318737|NCT01358578|454457982|FG001|Follow-up Period|Lost to Follow-up|1|||
126318738|NCT01358578|454457983|FG002|Follow-up Period|Lost to Follow-up|0|||
126318739|NCT01358578|454457984|FG003|Follow-up Period|Lost to Follow-up|4|||
126318740|NCT01358578|454457985|FG004|Follow-up Period|Lost to Follow-up|0|||
126318741|NCT01358578|454457986|FG005|Follow-up Period|Lost to Follow-up|0|||
126318742|NCT01358578|454457981|FG000|Follow-up Period|non- compliance with study treatment|1|||
126318743|NCT01358578|454457982|FG001|Follow-up Period|non- compliance with study treatment|0|||
126318744|NCT01358578|454457983|FG002|Follow-up Period|non- compliance with study treatment|0|||
126318745|NCT01358578|454457984|FG003|Follow-up Period|non- compliance with study treatment|0|||
126318746|NCT01358578|454457985|FG004|Follow-up Period|non- compliance with study treatment|0|||
126318747|NCT01358578|454457986|FG005|Follow-up Period|non- compliance with study treatment|0|||
126318748|NCT01358578|454457981|FG000|Follow-up Period|Pregnancy|1|||
126318749|NCT01358578|454457982|FG001|Follow-up Period|Pregnancy|0|||
126318750|NCT01358578|454457983|FG002|Follow-up Period|Pregnancy|0|||
126318751|NCT01358578|454457984|FG003|Follow-up Period|Pregnancy|0|||
126318752|NCT01358578|454457985|FG004|Follow-up Period|Pregnancy|0|||
126318753|NCT01358578|454457986|FG005|Follow-up Period|Pregnancy|0|||
126318754|NCT01358578|454457981|FG000|Follow-up Period|Withdrawal by Subject|3|||
126318755|NCT01358578|454457982|FG001|Follow-up Period|Withdrawal by Subject|3|||
126318756|NCT01358578|454457983|FG002|Follow-up Period|Withdrawal by Subject|1|||
126318757|NCT01358578|454457984|FG003|Follow-up Period|Withdrawal by Subject|12|||
126318758|NCT01358578|454457985|FG004|Follow-up Period|Withdrawal by Subject|0|||
126318759|NCT01358578|454457986|FG005|Follow-up Period|Withdrawal by Subject|0|||
126318760|NCT01358578|454457981|FG000|Follow-up Period|Physician Decision|1|||
126318761|NCT01358578|454457982|FG001|Follow-up Period|Physician Decision|1|||
126318762|NCT01358578|454457983|FG002|Follow-up Period|Physician Decision|0|||
126318763|NCT01358578|454457984|FG003|Follow-up Period|Physician Decision|2|||
126318764|NCT01358578|454457985|FG004|Follow-up Period|Physician Decision|0|||
126318765|NCT01358578|454457986|FG005|Follow-up Period|Physician Decision|0|||
126318766|NCT00388297|454457987|FG000|Overall Study|Lost to Follow-up|16|||
126318767|NCT00388297|454457988|FG001|Overall Study|Lost to Follow-up|12|||
126318768|NCT00388297|454457989|FG002|Overall Study|Lost to Follow-up|11|||
126318769|NCT00388297|454457990|FG003|Overall Study|Lost to Follow-up|8|||
126318770|NCT02607280|454457991|FG000|Overall Study|Adverse Event|4|||
126318771|NCT02607280|454457992|FG001|Overall Study|Adverse Event|0|||
126318772|NCT02607280|454457991|FG000|Overall Study|Decrease in CrCl <15|0|||
126318773|NCT02607280|454457992|FG001|Overall Study|Decrease in CrCl <15|1|||
126318774|NCT00577005|454457993|FG000|Overall Study|Lost to Follow-up|3|||
126318775|NCT00577005|454457994|FG001|Overall Study|Lost to Follow-up|2|||
126318776|NCT00577005|454457993|FG000|Overall Study|Withdrawal by Subject|2|||
126318777|NCT00577005|454457994|FG001|Overall Study|Withdrawal by Subject|1|||
126318778|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
126318779|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
126318780|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
126318781|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
126318782|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
126318783|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
126318784|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
126318785|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
126318786|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
126318787|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
126318788|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
126318789|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
126318790|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
126318791|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
126318792|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
126318793|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
126318794|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
126318795|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
126318796|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
126318797|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
126318798|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
126318799|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
126318800|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
126318801|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
126318802|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
126318803|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
126318804|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
126318805|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
126318806|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
126318807|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
126318808|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
126318809|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
126318810|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
126318811|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
126318812|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
126318813|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
126318814|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
126318815|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
126318816|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
126318817|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
126318818|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
126318819|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
126318820|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
126318821|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
126318822|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
126318823|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
126318824|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
126318825|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
126318826|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
126318827|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
126318828|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
126318829|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
126318830|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
126318831|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
126318832|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
126318833|NCT01004432|454457995|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
126318834|NCT01004432|454457996|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
126318835|NCT01004432|454457997|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
126318836|NCT01004432|454457998|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
126318837|NCT01004432|454457999|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
126318838|NCT01004432|454457995|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
126318839|NCT01004432|454457996|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
126318840|NCT01004432|454457997|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125982591|NCT00840801|453226902|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
125982592|NCT00840801|453226903|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
125982593|NCT00840801|453226901|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
125982594|NCT00840801|453226902|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
125982595|NCT00840801|453226903|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
125982596|NCT00840801|453226901|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
125982597|NCT00840801|453226902|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
125982598|NCT00840801|453226903|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
125982599|NCT01896869|453226910|FG000|Overall Study|Withdrawal by Subject|0|||
125982600|NCT01896869|453226911|FG001|Overall Study|Withdrawal by Subject|6|||
126318841|NCT01004432|454457998|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
126318842|NCT01004432|454457999|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
126318843|NCT01004432|454457995|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125982601|NCT01896869|453226910|FG000|Overall Study|Lost to Follow-up|1|||
125982602|NCT01896869|453226911|FG001|Overall Study|Lost to Follow-up|0|||
125982603|NCT03494166|453226915|FG000|Overall Study|Death|0|||
125982604|NCT03494166|453226916|FG001|Overall Study|Death|0|||
125982605|NCT03494166|453226917|FG002|Overall Study|Death|0|||
125982606|NCT03494166|453226918|FG003|Overall Study|Death|1|||
125982607|NCT03494166|453226919|FG004|Overall Study|Death|3|||
125982608|NCT03494166|453226920|FG005|Overall Study|Death|0|||
125982609|NCT03494166|453226915|FG000|Overall Study|Lost to Follow-up|2|||
125982610|NCT03494166|453226916|FG001|Overall Study|Lost to Follow-up|2|||
125982611|NCT03494166|453226917|FG002|Overall Study|Lost to Follow-up|2|||
125982612|NCT03494166|453226918|FG003|Overall Study|Lost to Follow-up|2|||
125982613|NCT03494166|453226919|FG004|Overall Study|Lost to Follow-up|14|||
125982614|NCT03494166|453226920|FG005|Overall Study|Lost to Follow-up|0|||
125982615|NCT03494166|453226915|FG000|Overall Study|Withdrawal by Subject|10|||
125982616|NCT03494166|453226916|FG001|Overall Study|Withdrawal by Subject|7|||
125982617|NCT03494166|453226917|FG002|Overall Study|Withdrawal by Subject|0|||
125982618|NCT03494166|453226918|FG003|Overall Study|Withdrawal by Subject|5|||
125982619|NCT03494166|453226919|FG004|Overall Study|Withdrawal by Subject|3|||
125982620|NCT03494166|453226920|FG005|Overall Study|Withdrawal by Subject|17|||
125982621|NCT03494166|453226915|FG000|Overall Study|Screen failure|1|||
125982622|NCT03494166|453226916|FG001|Overall Study|Screen failure|0|||
125982623|NCT03494166|453226917|FG002|Overall Study|Screen failure|0|||
125982624|NCT03494166|453226918|FG003|Overall Study|Screen failure|0|||
125982625|NCT03494166|453226919|FG004|Overall Study|Screen failure|1|||
125982626|NCT03494166|453226920|FG005|Overall Study|Screen failure|0|||
125982627|NCT02857426|453226921|FG000|Overall Study|Disease progression|34|||
125982628|NCT02857426|453226922|FG001|Overall Study|Disease progression|13|||
125982629|NCT02857426|453226921|FG000|Overall Study|Study drug toxicity|4|||
125982630|NCT02857426|453226922|FG001|Overall Study|Study drug toxicity|1|||
125982631|NCT02857426|453226921|FG000|Overall Study|Death|1|||
125982632|NCT02857426|453226922|FG001|Overall Study|Death|0|||
125982633|NCT02857426|453226921|FG000|Overall Study|Adverse event unrelated to study drug|6|||
125982634|NCT02857426|453226922|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125982635|NCT02857426|453226921|FG000|Overall Study|Participant withdrew consent|1|||
125982636|NCT02857426|453226922|FG001|Overall Study|Participant withdrew consent|1|||
125982637|NCT02857426|453226921|FG000|Overall Study|Maximum clinical benefit|1|||
125982638|NCT02857426|453226922|FG001|Overall Study|Maximum clinical benefit|0|||
125982639|NCT02857426|453226921|FG000|Overall Study|Completed treatment|0|||
125982640|NCT02857426|453226922|FG001|Overall Study|Completed treatment|2|||
125982641|NCT02110901|453226926|FG000|Overall Study|Death|6|||
125982642|NCT02110901|453226927|FG001|Overall Study|Death|3|||
125982643|NCT02110901|453226926|FG000|Overall Study|Lost to Follow-up|12|||
125982644|NCT02110901|453226927|FG001|Overall Study|Lost to Follow-up|8|||
125982645|NCT02110901|453226926|FG000|Overall Study|Withdrawal by Subject|7|||
125982646|NCT02110901|453226927|FG001|Overall Study|Withdrawal by Subject|3|||
125982647|NCT02110901|453226926|FG000|Overall Study|received a kidney transplant|5|||
125982648|NCT02110901|453226927|FG001|Overall Study|received a kidney transplant|0|||
125982649|NCT00758459|453226928|FG000|Overall Study|Adverse Event|3|||
125982650|NCT00758459|453226929|FG001|Overall Study|Adverse Event|2|||
125982651|NCT00758459|453226928|FG000|Overall Study|Protocol Violation|0|||
125982652|NCT00758459|453226929|FG001|Overall Study|Protocol Violation|1|||
125982653|NCT00758459|453226928|FG000|Overall Study|Withdrawal by Subject|0|||
125982654|NCT00758459|453226929|FG001|Overall Study|Withdrawal by Subject|1|||
125982655|NCT02831257|453226931|FG000|Overall Study|Lack of Efficacy|3|||
125982656|NCT02831257|453226931|FG000|Overall Study|Adverse Event|2|||
125982657|NCT02831257|453226931|FG000|Overall Study|Physician Decision|1|||
125982658|NCT02831257|453226931|FG000|Overall Study|Withdrawal by Subject|6|||
125982659|NCT01780935|453226932|FG000|Overall Study|Admin problems due to early termination|321|||
125982660|NCT01780935|453226933|FG001|Overall Study|Admin problems due to early termination|309|||
125982661|NCT01780935|453226932|FG000|Overall Study|Adverse Event|2|||
125982662|NCT01780935|453226933|FG001|Overall Study|Adverse Event|4|||
125982663|NCT01780935|453226932|FG000|Overall Study|Death|1|||
125982664|NCT01780935|453226933|FG001|Overall Study|Death|6|||
125982665|NCT01780935|453226932|FG000|Overall Study|Lost to Follow-up|2|||
125982666|NCT01780935|453226933|FG001|Overall Study|Lost to Follow-up|6|||
125982667|NCT01780935|453226932|FG000|Overall Study|Physician Decision|1|||
125982668|NCT01780935|453226933|FG001|Overall Study|Physician Decision|1|||
125982669|NCT01780935|453226932|FG000|Overall Study|Protocol deviation|0|||
125982670|NCT01780935|453226933|FG001|Overall Study|Protocol deviation|1|||
125982671|NCT01780935|453226932|FG000|Overall Study|Patient withdrew consent|8|||
125982672|NCT01780935|453226933|FG001|Overall Study|Patient withdrew consent|9|||
125982673|NCT00855595|453226934|FG000|Overall Study|Withdrawal by Subject|1|||
125982674|NCT00855595|453226935|FG001|Overall Study|Withdrawal by Subject|2|||
125982675|NCT00855595|453226934|FG000|Overall Study|Lost to Follow-up|3|||
125982676|NCT00855595|453226935|FG001|Overall Study|Lost to Follow-up|3|||
125982677|NCT00855595|453226934|FG000|Overall Study|Adverse Event|1|||
125982678|NCT00855595|453226935|FG001|Overall Study|Adverse Event|1|||
125982679|NCT00855595|453226934|FG000|Overall Study|patient moved out of state|1|||
126318844|NCT01004432|454457996|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
126318845|NCT01004432|454457997|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
126318846|NCT01004432|454457998|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
126318847|NCT01004432|454457999|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
126318848|NCT01004432|454457995|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
126318849|NCT01004432|454457996|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
126318850|NCT01004432|454457997|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
126318851|NCT01004432|454457998|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
126318852|NCT01004432|454457999|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
126318853|NCT02667626|454458000|FG000|Overall Study|Withdrawal by Subject|0|||
126318854|NCT02667626|454458001|FG001|Overall Study|Withdrawal by Subject|1|||
126318855|NCT02696434|454458003|FG000|Overall Study|Adverse Event|3|||
126318856|NCT02696434|454458004|FG001|Overall Study|Adverse Event|1|||
126318857|NCT02696434|454458003|FG000|Overall Study|Lost to Follow-up|5|||
126318858|NCT02696434|454458004|FG001|Overall Study|Lost to Follow-up|4|||
126318859|NCT02696434|454458003|FG000|Overall Study|Withdrawal by Subject|14|||
126318860|NCT02696434|454458004|FG001|Overall Study|Withdrawal by Subject|12|||
126318861|NCT02696434|454458003|FG000|Overall Study|Physician Decision|0|||
126318862|NCT02696434|454458004|FG001|Overall Study|Physician Decision|1|||
126318863|NCT02539134|454458005|FG000|Overall Study|Lost to Follow-up|1|||
126318864|NCT02539134|454458006|FG001|Overall Study|Lost to Follow-up|0|||
126318865|NCT02539134|454458007|FG002|Overall Study|Lost to Follow-up|0|||
126318866|NCT02539134|454458008|FG003|Overall Study|Lost to Follow-up|0|||
126318867|NCT02539134|454458009|FG004|Overall Study|Lost to Follow-up|0|||
126318868|NCT02539134|454458010|FG005|Overall Study|Lost to Follow-up|0|||
126318869|NCT02971800|454458013|FG000|Overall Study|Protocol Violation|1|||
126318870|NCT02971800|454458013|FG000|Overall Study|Withdrawal by Subject|1|||
126318871|NCT02971800|454458013|FG000|Overall Study|Exclusion criteria prior intervention|1|||
126318872|NCT02971800|454458013|FG000|Overall Study|Number evaluable participant already reached|4|||
126318873|NCT05323994|454458014|FG000|Overall Study|Protocol Violation|1|||
126318874|NCT04526574|454458020|FG000|Overall Study|Protocol Violation|3|||
126318875|NCT04526574|454458021|FG001|Overall Study|Protocol Violation|1|||
126318876|NCT04526574|454458020|FG000|Overall Study|Withdrawal by Subject|12|||
126318877|NCT04526574|454458021|FG001|Overall Study|Withdrawal by Subject|9|||
126318878|NCT04526574|454458020|FG000|Overall Study|Other|1|||
126318879|NCT04526574|454458021|FG001|Overall Study|Other|2|||
126318880|NCT04526574|454458020|FG000|Overall Study|Adverse Event|1|||
126318881|NCT04526574|454458021|FG001|Overall Study|Adverse Event|1|||
126318882|NCT04526574|454458020|FG000|Overall Study|Death|2|||
126318883|NCT04526574|454458021|FG001|Overall Study|Death|3|||
126318884|NCT04526574|454458020|FG000|Overall Study|Lost to Follow-up|9|||
126318885|NCT04526574|454458021|FG001|Overall Study|Lost to Follow-up|9|||
126318886|NCT04526574|454458020|FG000|Overall Study|No longer meets eligibility criteria|8|||
126318887|NCT04526574|454458021|FG001|Overall Study|No longer meets eligibility criteria|8|||
126318888|NCT01534208|454458029|FG000|Overall Study|Lost to Follow-up|19|||
126318889|NCT01534208|454458030|FG001|Overall Study|Lost to Follow-up|14|||
126318890|NCT01534208|454458029|FG000|Overall Study|Withdrawal by Subject|6|||
126318891|NCT01534208|454458030|FG001|Overall Study|Withdrawal by Subject|20|||
126318892|NCT01534208|454458029|FG000|Overall Study|Adverse Event|15|||
126318893|NCT01534208|454458030|FG001|Overall Study|Adverse Event|8|||
126318894|NCT01534208|454458029|FG000|Overall Study|Physician Decision|2|||
126318895|NCT01534208|454458030|FG001|Overall Study|Physician Decision|0|||
126318896|NCT01534208|454458029|FG000|Overall Study|Lack of Efficacy|0|||
125982680|NCT00855595|453226935|FG001|Overall Study|patient moved out of state|0|||
125982681|NCT00855595|453226934|FG000|Overall Study|patient left country|0|||
125982682|NCT00855595|453226935|FG001|Overall Study|patient left country|1|||
125982683|NCT01281202|453226936|FG000|Overall Study|Adverse Event|2|||
125982684|NCT01281202|453226937|FG001|Overall Study|Adverse Event|0|||
125982685|NCT01281202|453226936|FG000|Overall Study|Withdrawal by Subject|2|||
125982686|NCT01281202|453226937|FG001|Overall Study|Withdrawal by Subject|2|||
125982687|NCT01281202|453226936|FG000|Overall Study|Protocol Violation|11|||
125982688|NCT01281202|453226937|FG001|Overall Study|Protocol Violation|10|||
125982689|NCT01281202|453226936|FG000|Overall Study|Administrative|2|||
125982690|NCT01281202|453226937|FG001|Overall Study|Administrative|8|||
125982691|NCT01281202|453226936|FG000|Overall Study|Lost to Follow-up|11|||
125982692|NCT01281202|453226937|FG001|Overall Study|Lost to Follow-up|13|||
125982693|NCT01281202|453226936|FG000|Overall Study|Incarceration|0|||
126318897|NCT01534208|454458030|FG001|Overall Study|Lack of Efficacy|3|||
126318898|NCT01534208|454458029|FG000|Overall Study|Protocol Violation|2|||
126318899|NCT01534208|454458030|FG001|Overall Study|Protocol Violation|2|||
126318900|NCT01534208|454458029|FG000|Overall Study|Sponsor decision|4|||
126318901|NCT01534208|454458030|FG001|Overall Study|Sponsor decision|1|||
126318902|NCT01534208|454458029|FG000|Overall Study|Subject relocation|2|||
126318903|NCT01534208|454458030|FG001|Overall Study|Subject relocation|0|||
126318904|NCT01534208|454458029|FG000|Overall Study|Lab assessment|2|||
126318905|NCT01534208|454458030|FG001|Overall Study|Lab assessment|1|||
126318906|NCT01534208|454458029|FG000|Overall Study|Eligibility error|3|||
126318907|NCT01534208|454458030|FG001|Overall Study|Eligibility error|0|||
126318908|NCT01534208|454458029|FG000|Overall Study|PCP decision|1|||
126318909|NCT01534208|454458030|FG001|Overall Study|PCP decision|0|||
126318910|NCT01534208|454458029|FG000|Overall Study|Needed prohibited meds|1|||
126318911|NCT01534208|454458030|FG001|Overall Study|Needed prohibited meds|0|||
126318912|NCT01904903|454458031|FG000|Overall Study|Withdrawal by Subject|1|||
126318913|NCT00045734|454458032|FG000|Overall Study|Protocol Violation|1|||
126318914|NCT03482167|454458035|FG000|Allocated to Intervention|Physician Decision|1|||
126318915|NCT03482167|454458036|FG001|Allocated to Intervention|Physician Decision|2|||
126318916|NCT03482167|454458035|FG000|Received Intervention|Adverse Event|3|||
126318917|NCT03482167|454458036|FG001|Received Intervention|Adverse Event|1|||
126318918|NCT03482167|454458035|FG000|Received Intervention|Physician Decision|1|||
126318919|NCT03482167|454458036|FG001|Received Intervention|Physician Decision|1|||
126318920|NCT03482167|454458035|FG000|Received Intervention|Withdrawal by Subject|1|||
126318921|NCT03482167|454458036|FG001|Received Intervention|Withdrawal by Subject|0|||
126318922|NCT01001598|454458038|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
126318923|NCT01001598|454458038|FG000|Overall Study|Adverse Event|1|||
126318924|NCT05079230|454458054|FG000|Overall Study|Study Terminated by Sponsor|101|||
126318925|NCT05079230|454458055|FG001|Overall Study|Study Terminated by Sponsor|102|||
126318926|NCT05079230|454458054|FG000|Overall Study|Death|72|||
126318927|NCT05079230|454458055|FG001|Overall Study|Death|66|||
126318928|NCT05079230|454458054|FG000|Overall Study|Withdrew Consent|16|||
126318929|NCT05079230|454458055|FG001|Overall Study|Withdrew Consent|18|||
126318930|NCT05079230|454458054|FG000|Overall Study|Lost to Follow-up|0|||
126318931|NCT05079230|454458055|FG001|Overall Study|Lost to Follow-up|3|||
126318932|NCT01524783|454458056|FG000|Blinded Period|Adverse Event|64|||
126318933|NCT01524783|454458057|FG001|Blinded Period|Adverse Event|7|||
126318934|NCT01524783|454458058|FG002|Blinded Period|Adverse Event|0|||
126318935|NCT01524783|454458056|FG000|Blinded Period|Disease Progression|89|||
126318936|NCT01524783|454458057|FG001|Blinded Period|Disease Progression|75|||
126318937|NCT01524783|454458058|FG002|Blinded Period|Disease Progression|0|||
126318938|NCT01524783|454458056|FG000|Blinded Period|Withdrawal by Subject|19|||
126318939|NCT01524783|454458057|FG001|Blinded Period|Withdrawal by Subject|6|||
126318940|NCT01524783|454458058|FG002|Blinded Period|Withdrawal by Subject|0|||
126318941|NCT01524783|454458056|FG000|Blinded Period|Protocol deviation|2|||
126318942|NCT01524783|454458057|FG001|Blinded Period|Protocol deviation|1|||
126318943|NCT01524783|454458058|FG002|Blinded Period|Protocol deviation|0|||
126318944|NCT01524783|454458056|FG000|Blinded Period|Death|5|||
126318945|NCT01524783|454458057|FG001|Blinded Period|Death|2|||
126318946|NCT01524783|454458058|FG002|Blinded Period|Death|0|||
126318947|NCT01524783|454458056|FG000|Open-label Period|Disease progression|13|||
126318948|NCT01524783|454458057|FG001|Open-label Period|Disease progression|0|||
126318949|NCT01524783|454458058|FG002|Open-label Period|Disease progression|2|||
126318950|NCT01524783|454458056|FG000|Open-label Period|Administrative problems|5|||
126318951|NCT01524783|454458057|FG001|Open-label Period|Administrative problems|0|||
126318952|NCT01524783|454458058|FG002|Open-label Period|Administrative problems|2|||
126318953|NCT01524783|454458056|FG000|Open-label Period|Adverse Event|5|||
126318954|NCT01524783|454458057|FG001|Open-label Period|Adverse Event|0|||
126318955|NCT01524783|454458058|FG002|Open-label Period|Adverse Event|1|||
126318956|NCT01524783|454458056|FG000|Open-label Period|Withdrawal by Subject|2|||
126318957|NCT01524783|454458057|FG001|Open-label Period|Withdrawal by Subject|0|||
126318958|NCT01524783|454458058|FG002|Open-label Period|Withdrawal by Subject|1|||
126318959|NCT01524783|454458056|FG000|Open-label Period|Protocol deviation|1|||
126318960|NCT01524783|454458057|FG001|Open-label Period|Protocol deviation|0|||
126318961|NCT01524783|454458058|FG002|Open-label Period|Protocol deviation|0|||
126318962|NCT02920177|454458060|FG000|Overall Study|Withdrawal by Subject|1|||
126318963|NCT02920177|454458061|FG001|Overall Study|Withdrawal by Subject|1|||
126318964|NCT02920177|454458060|FG000|Overall Study|Physician Decision|1|||
126318965|NCT02920177|454458061|FG001|Overall Study|Physician Decision|0|||
126318966|NCT02920177|454458060|FG000|Overall Study|Lost to Follow-up|0|||
126318967|NCT02920177|454458061|FG001|Overall Study|Lost to Follow-up|1|||
126318968|NCT02054910|454458062|FG000|Overall Study|Lost to Follow-up|4|||
126318969|NCT02054910|454458063|FG001|Overall Study|Lost to Follow-up|1|||
126318970|NCT01096589|454458069|FG000|Overall Study|Adverse Event|2|||
126318971|NCT01096589|454458070|FG001|Overall Study|Adverse Event|1|||
125878388|NCT03312231|452851298|FG002|Overall Study|Lost to Follow-up|1|||
125878389|NCT03312231|452851299|FG003|Overall Study|Lost to Follow-up|3|||
125878390|NCT03312231|452851300|FG004|Overall Study|Lost to Follow-up|1|||
125878391|NCT03312231|452851296|FG000|Overall Study|Withdrawal by Subject|0|||
125878392|NCT03312231|452851297|FG001|Overall Study|Withdrawal by Subject|3|||
125878393|NCT03312231|452851298|FG002|Overall Study|Withdrawal by Subject|1|||
125878394|NCT03312231|452851299|FG003|Overall Study|Withdrawal by Subject|0|||
125878395|NCT03312231|452851300|FG004|Overall Study|Withdrawal by Subject|0|||
125878396|NCT03312231|452851296|FG000|Overall Study|Death|0|||
125878397|NCT03312231|452851297|FG001|Overall Study|Death|1|||
125878398|NCT03312231|452851298|FG002|Overall Study|Death|1|||
125878399|NCT03312231|452851299|FG003|Overall Study|Death|0|||
125878400|NCT03312231|452851300|FG004|Overall Study|Death|0|||
125982694|NCT01281202|453226937|FG001|Overall Study|Incarceration|3|||
125982695|NCT00166296|453226938|FG000|Overall Study|Withdrawal by Subject|1|||
125982696|NCT00166296|453226939|FG001|Overall Study|Withdrawal by Subject|3|||
125982697|NCT00166296|453226938|FG000|Overall Study|Adverse Event|2|||
125982698|NCT00166296|453226939|FG001|Overall Study|Adverse Event|4|||
125982699|NCT00166296|453226938|FG000|Overall Study|Lost to Follow-up|4|||
125982700|NCT00166296|453226939|FG001|Overall Study|Lost to Follow-up|2|||
125982701|NCT04035200|453226940|FG000|Overall Study|Lost to Follow-up|0|||
125982702|NCT04035200|453226941|FG001|Overall Study|Lost to Follow-up|1|||
125982703|NCT04035200|453226942|FG002|Overall Study|Lost to Follow-up|0|||
125982704|NCT04035200|453226940|FG000|Overall Study|Withdrawal by Subject|1|||
125982705|NCT04035200|453226941|FG001|Overall Study|Withdrawal by Subject|4|||
125982706|NCT04035200|453226942|FG002|Overall Study|Withdrawal by Subject|4|||
125982707|NCT04035200|453226940|FG000|Overall Study|COVID-19|1|||
125982708|NCT04035200|453226941|FG001|Overall Study|COVID-19|0|||
125982709|NCT04035200|453226942|FG002|Overall Study|COVID-19|0|||
125982710|NCT04035200|453226940|FG000|Overall Study|Early Termination|0|||
125982711|NCT04035200|453226941|FG001|Overall Study|Early Termination|1|||
125982712|NCT04035200|453226942|FG002|Overall Study|Early Termination|0|||
125982713|NCT04035200|453226940|FG000|Overall Study|Non-compliance|0|||
125982714|NCT04035200|453226941|FG001|Overall Study|Non-compliance|1|||
125982715|NCT04035200|453226942|FG002|Overall Study|Non-compliance|0|||
125982716|NCT00946296|453226943|FG000|Overall Study|Physician Decision|3|||
125982717|NCT00946296|453226944|FG001|Overall Study|Physician Decision|0|||
125982718|NCT00701038|453226949|FG000|Overall Study|study amended pilot group of patients|4|||
125982719|NCT00701038|453226950|FG001|Overall Study|study amended pilot group of patients|4|||
125982720|NCT00386022|453226952|FG000|Plus Estrogen|Lost to Follow-up|2|||
125982721|NCT00386022|453226953|FG001|Plus Estrogen|Lost to Follow-up|0|||
125982722|NCT00386022|453226952|FG000|Plus Estrogen|Adverse Event|0|||
126318972|NCT01096589|454458071|FG002|Overall Study|Adverse Event|2|||
126318973|NCT01096589|454458072|FG003|Overall Study|Adverse Event|1|||
126318974|NCT01096589|454458069|FG000|Overall Study|Withdrawal by Subject|2|||
125982723|NCT00386022|453226953|FG001|Plus Estrogen|Adverse Event|1|||
125982724|NCT01064297|453226957|FG000|Overall Study|Lost to Follow-up|791|||
125982725|NCT01064297|453226958|FG001|Overall Study|Lost to Follow-up|48|||
125982726|NCT01064297|453226959|FG002|Overall Study|Lost to Follow-up|133|||
125982727|NCT00168038|453226965|FG000|Overall Study|Adverse Event|1|||
126318975|NCT01096589|454458070|FG001|Overall Study|Withdrawal by Subject|1|||
126318976|NCT01096589|454458071|FG002|Overall Study|Withdrawal by Subject|1|||
126318977|NCT01096589|454458072|FG003|Overall Study|Withdrawal by Subject|1|||
126318978|NCT01096589|454458069|FG000|Overall Study|Compliance with protocol|0|||
126318979|NCT01096589|454458070|FG001|Overall Study|Compliance with protocol|0|||
126318980|NCT01096589|454458071|FG002|Overall Study|Compliance with protocol|1|||
126318981|NCT01096589|454458072|FG003|Overall Study|Compliance with protocol|0|||
126318982|NCT01096589|454458069|FG000|Overall Study|found treatment exhausting|0|||
126318983|NCT01096589|454458070|FG001|Overall Study|found treatment exhausting|0|||
126318984|NCT01096589|454458071|FG002|Overall Study|found treatment exhausting|0|||
126318985|NCT01096589|454458072|FG003|Overall Study|found treatment exhausting|1|||
126318986|NCT03673345|454458074|FG000|Overall Study|Lost to Follow-up|1|||
126318987|NCT03673345|454458075|FG001|Overall Study|Lost to Follow-up|0|||
126318988|NCT03673345|454458076|FG002|Overall Study|Lost to Follow-up|3|||
126318989|NCT03673345|454458077|FG003|Overall Study|Lost to Follow-up|3|||
126318990|NCT03673345|454458078|FG004|Overall Study|Lost to Follow-up|2|||
126318991|NCT03673345|454458079|FG005|Overall Study|Lost to Follow-up|1|||
126318992|NCT03673345|454458080|FG006|Overall Study|Lost to Follow-up|0|||
126318993|NCT03673345|454458081|FG007|Overall Study|Lost to Follow-up|0|||
126318994|NCT03673345|454458074|FG000|Overall Study|Withdrawal by Subject|1|||
126318995|NCT03673345|454458075|FG001|Overall Study|Withdrawal by Subject|0|||
126318996|NCT03673345|454458076|FG002|Overall Study|Withdrawal by Subject|4|||
125982728|NCT00168038|453226965|FG000|Overall Study|Therapy failure|1|||
125982729|NCT01685138|453226968|FG000|Overall Study|Lost to Follow-up|1|||
125982730|NCT01685138|453226968|FG000|Overall Study|Protocol Violation|1|||
125982731|NCT01685138|453226968|FG000|Overall Study|No longer requires treatment|1|||
125982732|NCT01685138|453226968|FG000|Overall Study|Subject/guardian decision|2|||
125982733|NCT01685138|453226968|FG000|Overall Study|Physician Decision|6|||
125982734|NCT01685138|453226968|FG000|Overall Study|Death|10|||
125982735|NCT01685138|453226968|FG000|Overall Study|Adverse Event|18|||
126318997|NCT03673345|454458077|FG003|Overall Study|Withdrawal by Subject|2|||
126318998|NCT03673345|454458078|FG004|Overall Study|Withdrawal by Subject|0|||
126318999|NCT03673345|454458079|FG005|Overall Study|Withdrawal by Subject|0|||
126319000|NCT03673345|454458080|FG006|Overall Study|Withdrawal by Subject|0|||
126319001|NCT03673345|454458081|FG007|Overall Study|Withdrawal by Subject|0|||
126319002|NCT03673345|454458074|FG000|Overall Study|Physician Decision|0|||
126319003|NCT03673345|454458075|FG001|Overall Study|Physician Decision|0|||
126319004|NCT03673345|454458076|FG002|Overall Study|Physician Decision|2|||
126319005|NCT03673345|454458077|FG003|Overall Study|Physician Decision|0|||
126319006|NCT03673345|454458078|FG004|Overall Study|Physician Decision|0|||
125982736|NCT01685138|453226968|FG000|Overall Study|Progressive disease|53|||
125982737|NCT02068495|453226973|FG000|Overall Study|Case Report Forms Uncollected|60|||
126319007|NCT03673345|454458079|FG005|Overall Study|Physician Decision|0|||
126319008|NCT03673345|454458080|FG006|Overall Study|Physician Decision|0|||
126319009|NCT03673345|454458081|FG007|Overall Study|Physician Decision|0|||
126319010|NCT02267135|454458082|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
126319011|NCT02267135|454458083|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
126319012|NCT02267135|454458082|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
126319013|NCT02267135|454458083|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
126319014|NCT02267135|454458082|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
126319015|NCT02267135|454458083|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
126319016|NCT02267135|454458082|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
126319017|NCT02267135|454458083|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
126319018|NCT02267135|454458082|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
126319019|NCT02267135|454458083|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
126319020|NCT03806231|454458084|FG000|Overall Study|Physician Decision|1|||
126319021|NCT03806231|454458085|FG001|Overall Study|Physician Decision|0|||
126319022|NCT03806231|454458084|FG000|Overall Study|Withdrawal by Subject|1|||
126319023|NCT03806231|454458085|FG001|Overall Study|Withdrawal by Subject|0|||
126319024|NCT00900731|454458086|FG000|Overall Study|Adverse Event|31|||
126319025|NCT00900731|454458087|FG001|Overall Study|Adverse Event|27|||
126319026|NCT00900731|454458086|FG000|Overall Study|Withdrawal by Subject|8|||
126319027|NCT00900731|454458087|FG001|Overall Study|Withdrawal by Subject|7|||
126319028|NCT00900731|454458086|FG000|Overall Study|Protocol Deviation|8|||
126319029|NCT00900731|454458087|FG001|Overall Study|Protocol Deviation|11|||
126319030|NCT00900731|454458086|FG000|Overall Study|Administrative Problems|5|||
126319031|NCT00900731|454458087|FG001|Overall Study|Administrative Problems|4|||
126319032|NCT00900731|454458086|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
126319033|NCT00900731|454458087|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126319034|NCT00900731|454458086|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
126319035|NCT00900731|454458087|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
126319036|NCT00900731|454458086|FG000|Overall Study|Lost to Follow-up|2|||
126319037|NCT00900731|454458087|FG001|Overall Study|Lost to Follow-up|3|||
126319038|NCT00900731|454458086|FG000|Overall Study|Lack of Efficacy|1|||
126319039|NCT00900731|454458087|FG001|Overall Study|Lack of Efficacy|3|||
126319040|NCT00900731|454458086|FG000|Overall Study|Death|0|||
126319041|NCT00900731|454458087|FG001|Overall Study|Death|2|||
126319042|NCT01764659|454458088|FG000|Overall Study|Death|1|||
126319043|NCT01764659|454458088|FG000|Overall Study|Physician Decision|1|||
126319044|NCT01210352|454458089|FG000|Overall Study|Adverse Event|0|||
126319045|NCT01210352|454458090|FG001|Overall Study|Adverse Event|0|||
126319046|NCT01210352|454458091|FG002|Overall Study|Adverse Event|0|||
126319047|NCT01210352|454458092|FG003|Overall Study|Adverse Event|0|||
126319048|NCT01210352|454458093|FG004|Overall Study|Adverse Event|0|||
126319049|NCT01210352|454458094|FG005|Overall Study|Adverse Event|0|||
126319050|NCT01210352|454458095|FG006|Overall Study|Adverse Event|0|||
126319051|NCT01210352|454458096|FG007|Overall Study|Adverse Event|2|||
126319052|NCT01210352|454458097|FG008|Overall Study|Adverse Event|1|||
126319053|NCT01210352|454458089|FG000|Overall Study|Lack of Efficacy|0|||
126319054|NCT01210352|454458090|FG001|Overall Study|Lack of Efficacy|0|||
126319055|NCT01210352|454458091|FG002|Overall Study|Lack of Efficacy|0|||
126319056|NCT01210352|454458092|FG003|Overall Study|Lack of Efficacy|0|||
126319057|NCT01210352|454458093|FG004|Overall Study|Lack of Efficacy|0|||
126319058|NCT01210352|454458094|FG005|Overall Study|Lack of Efficacy|0|||
126319059|NCT01210352|454458095|FG006|Overall Study|Lack of Efficacy|1|||
126319060|NCT01210352|454458096|FG007|Overall Study|Lack of Efficacy|0|||
126319061|NCT01210352|454458097|FG008|Overall Study|Lack of Efficacy|0|||
126319062|NCT01210352|454458089|FG000|Overall Study|Physician Decision|0|||
126319063|NCT01210352|454458090|FG001|Overall Study|Physician Decision|0|||
126319064|NCT01210352|454458091|FG002|Overall Study|Physician Decision|0|||
126319065|NCT01210352|454458092|FG003|Overall Study|Physician Decision|0|||
126319066|NCT01210352|454458093|FG004|Overall Study|Physician Decision|0|||
126319067|NCT01210352|454458094|FG005|Overall Study|Physician Decision|0|||
125982738|NCT02068495|453226973|FG000|Overall Study|Protocol Deviation|49|||
125982739|NCT00689026|453226974|FG000|Overall Study|Withdrawal by Subject|13|||
126319068|NCT01210352|454458095|FG006|Overall Study|Physician Decision|0|||
125982740|NCT00689026|453226975|FG001|Overall Study|Withdrawal by Subject|6|||
126319069|NCT01210352|454458096|FG007|Overall Study|Physician Decision|1|||
126319070|NCT01210352|454458097|FG008|Overall Study|Physician Decision|2|||
126319071|NCT01210352|454458089|FG000|Overall Study|Withdrawal by Subject|0|||
125982741|NCT02703922|453226979|FG000|Overall Study|Death|5|||
125982742|NCT02703922|453226980|FG001|Overall Study|Death|8|||
125982743|NCT02703922|453226979|FG000|Overall Study|Lost to Follow-up|10|||
126319072|NCT01210352|454458090|FG001|Overall Study|Withdrawal by Subject|0|||
126319073|NCT01210352|454458091|FG002|Overall Study|Withdrawal by Subject|1|||
126319074|NCT01210352|454458092|FG003|Overall Study|Withdrawal by Subject|0|||
126319075|NCT01210352|454458093|FG004|Overall Study|Withdrawal by Subject|0|||
126319076|NCT01210352|454458094|FG005|Overall Study|Withdrawal by Subject|0|||
126319077|NCT01210352|454458095|FG006|Overall Study|Withdrawal by Subject|1|||
126319078|NCT01210352|454458096|FG007|Overall Study|Withdrawal by Subject|0|||
126319079|NCT01210352|454458097|FG008|Overall Study|Withdrawal by Subject|1|||
126319080|NCT01210352|454458089|FG000|Overall Study|Patient Discharged Early|0|||
126319081|NCT01210352|454458090|FG001|Overall Study|Patient Discharged Early|0|||
126319082|NCT01210352|454458091|FG002|Overall Study|Patient Discharged Early|1|||
126319083|NCT01210352|454458092|FG003|Overall Study|Patient Discharged Early|0|||
126319084|NCT01210352|454458093|FG004|Overall Study|Patient Discharged Early|0|||
126319085|NCT01210352|454458094|FG005|Overall Study|Patient Discharged Early|0|||
126319086|NCT01210352|454458095|FG006|Overall Study|Patient Discharged Early|0|||
126319087|NCT01210352|454458096|FG007|Overall Study|Patient Discharged Early|0|||
126319088|NCT01210352|454458097|FG008|Overall Study|Patient Discharged Early|0|||
126319089|NCT00628927|454458098|FG000|Overall Study|Problems performing blood draw|6|||
126319090|NCT00628927|454458099|FG001|Overall Study|Problems performing blood draw|0|||
126319091|NCT00628927|454458098|FG000|Overall Study|Lost to Follow-up|1|||
126319092|NCT00628927|454458099|FG001|Overall Study|Lost to Follow-up|0|||
126319093|NCT00628927|454458098|FG000|Overall Study|Equipment failure|1|||
126319094|NCT00628927|454458099|FG001|Overall Study|Equipment failure|0|||
126319095|NCT01298141|454458100|FG000|Overall Study|Adverse Event|3|||
126319096|NCT01298141|454458100|FG000|Overall Study|Refusal of Required Study Procedures|1|||
126319097|NCT01298141|454458100|FG000|Overall Study|Withdrawal by Subject|6|||
126319098|NCT01298141|454458100|FG000|Overall Study|Termination of Study by the Investigator|5|||
126319099|NCT01298141|454458100|FG000|Overall Study|Other|5|||
126319100|NCT01298141|454458100|FG000|Overall Study|Lost to Follow-up|1|||
126319101|NCT01298141|454458100|FG000|Overall Study|Death|6|||
126319102|NCT01298141|454458100|FG000|Overall Study|Not treated|4|||
126319103|NCT02093390|454458104|FG000|Overall Study|Withdrawal by Subject|0|||
126319104|NCT02093390|454458105|FG001|Overall Study|Withdrawal by Subject|1|||
126319105|NCT02000882|454459654|FG000|Overall Study|Adverse Event|3|||
126319106|NCT02000882|454459654|FG000|Overall Study|Physician Decision|2|||
126319107|NCT02000882|454459654|FG000|Overall Study|Withdrawal by Subject|1|||
126319108|NCT00549601|454459655|FG000|Randomized|Protocol Violation|0|||
126319109|NCT00549601|454459656|FG001|Randomized|Protocol Violation|0|||
126319110|NCT00549601|454459657|FG002|Randomized|Protocol Violation|1|||
126319111|NCT00549601|454459655|FG000|Randomized|Withdrawal by Subject|0|||
126319112|NCT00549601|454459656|FG001|Randomized|Withdrawal by Subject|1|||
126319113|NCT00549601|454459657|FG002|Randomized|Withdrawal by Subject|1|||
126319114|NCT00549601|454459655|FG000|Received Study Drug|Adverse Event|2|||
126319115|NCT00549601|454459656|FG001|Received Study Drug|Adverse Event|5|||
126319116|NCT00549601|454459657|FG002|Received Study Drug|Adverse Event|1|||
126319117|NCT00549601|454459655|FG000|Received Study Drug|Death|0|||
126319118|NCT00549601|454459656|FG001|Received Study Drug|Death|1|||
126319119|NCT00549601|454459657|FG002|Received Study Drug|Death|0|||
126319120|NCT00549601|454459655|FG000|Received Study Drug|Lost to Follow-up|0|||
126319121|NCT00549601|454459656|FG001|Received Study Drug|Lost to Follow-up|1|||
126319122|NCT00549601|454459657|FG002|Received Study Drug|Lost to Follow-up|1|||
126319123|NCT00549601|454459655|FG000|Received Study Drug|Protocol Violation|3|||
126319124|NCT00549601|454459656|FG001|Received Study Drug|Protocol Violation|4|||
126319125|NCT00549601|454459657|FG002|Received Study Drug|Protocol Violation|1|||
126319126|NCT00549601|454459655|FG000|Received Study Drug|Withdrawal by Subject|2|||
126319127|NCT00549601|454459656|FG001|Received Study Drug|Withdrawal by Subject|0|||
126319128|NCT00549601|454459657|FG002|Received Study Drug|Withdrawal by Subject|1|||
126319129|NCT00908596|454459661|FG000|Overall Study|Other reasons|46|||
126319130|NCT00908596|454459662|FG001|Overall Study|Other reasons|6|||
126319131|NCT00908596|454459663|FG002|Overall Study|Other reasons|2|||
126319132|NCT00908596|454459664|FG003|Overall Study|Other reasons|0|||
126319133|NCT00908596|454459661|FG000|Overall Study|Lost to Follow-up|0|||
126319134|NCT00908596|454459662|FG001|Overall Study|Lost to Follow-up|1|||
126319135|NCT00908596|454459663|FG002|Overall Study|Lost to Follow-up|12|||
126319136|NCT00908596|454459664|FG003|Overall Study|Lost to Follow-up|4|||
126319137|NCT00908596|454459661|FG000|Overall Study|Death|0|||
126319138|NCT00908596|454459662|FG001|Overall Study|Death|5|||
126319139|NCT00908596|454459663|FG002|Overall Study|Death|57|||
126319140|NCT00908596|454459664|FG003|Overall Study|Death|32|||
126319141|NCT00908596|454459661|FG000|Overall Study|Protocol Violation|1|||
126319142|NCT00908596|454459662|FG001|Overall Study|Protocol Violation|0|||
125878401|NCT03312231|452851296|FG000|Overall Study|Study Vaccination not Received|1|||
125878402|NCT03312231|452851297|FG001|Overall Study|Study Vaccination not Received|1|||
125878403|NCT03312231|452851298|FG002|Overall Study|Study Vaccination not Received|1|||
125878404|NCT03312231|452851299|FG003|Overall Study|Study Vaccination not Received|0|||
125878405|NCT03312231|452851300|FG004|Overall Study|Study Vaccination not Received|0|||
125878406|NCT03157830|452851304|FG000|Overall Study|Lost to Follow-up|1|||
125878407|NCT03157830|452851304|FG000|Overall Study|Withdrawal by Subject|1|||
125878408|NCT00400179|452851307|FG000|Overall Study|Adverse Event|2|||
126319143|NCT00908596|454459663|FG002|Overall Study|Protocol Violation|0|||
126319144|NCT00908596|454459664|FG003|Overall Study|Protocol Violation|0|||
126319145|NCT00908596|454459661|FG000|Overall Study|Withdrawal by Subject|0|||
126319146|NCT00908596|454459662|FG001|Overall Study|Withdrawal by Subject|1|||
126319147|NCT00908596|454459663|FG002|Overall Study|Withdrawal by Subject|3|||
126319148|NCT00908596|454459664|FG003|Overall Study|Withdrawal by Subject|1|||
126319149|NCT02437188|454459667|FG000|Overall Study|Randomized but did not receive surgery|4|||
126319150|NCT02437188|454459668|FG001|Overall Study|Randomized but did not receive surgery|8|||
126319151|NCT02437188|454459667|FG000|Overall Study|Adverse Event|0|||
126319152|NCT02437188|454459668|FG001|Overall Study|Adverse Event|1|||
126319153|NCT02661061|454459671|FG000|Overall Study|Lack of Efficacy|1|||
126319154|NCT02661061|454459672|FG001|Overall Study|Lack of Efficacy|1|||
126319155|NCT02661061|454459671|FG000|Overall Study|Withdrawal by Subject|1|||
126319156|NCT02661061|454459672|FG001|Overall Study|Withdrawal by Subject|1|||
126319157|NCT03246061|454459673|FG000|Overall Study|Still in follow-up|15|||
126319158|NCT03246061|454459674|FG001|Overall Study|Still in follow-up|21|||
126319159|NCT01492101|454459676|FG000|Overall Study|Death|323|||
126319160|NCT01492101|454459677|FG001|Overall Study|Death|322|||
126319161|NCT01492101|454459676|FG000|Overall Study|Withdrawal by Subject|14|||
126319162|NCT01492101|454459677|FG001|Overall Study|Withdrawal by Subject|18|||
126319163|NCT01492101|454459676|FG000|Overall Study|Lost to Follow-up|0|||
126319164|NCT01492101|454459677|FG001|Overall Study|Lost to Follow-up|2|||
126319165|NCT01675154|454459678|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
126319166|NCT01675154|454459679|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
126319167|NCT01675154|454459680|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
126319168|NCT01675154|454459681|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
126319169|NCT00460265|454459682|FG000|Overall Study|Lost to Follow-up|14|||
126319170|NCT00460265|454459683|FG001|Overall Study|Lost to Follow-up|15|||
125878409|NCT00400179|452851308|FG001|Overall Study|Adverse Event|2|||
125878410|NCT00400179|452851307|FG000|Overall Study|Death|1|||
125878411|NCT00400179|452851308|FG001|Overall Study|Death|2|||
125878412|NCT00400179|452851307|FG000|Overall Study|Withdrew Consent|1|||
125878413|NCT00400179|452851308|FG001|Overall Study|Withdrew Consent|5|||
125878414|NCT00400179|452851307|FG000|Overall Study|Disease progression|1|||
125878415|NCT00400179|452851308|FG001|Overall Study|Disease progression|1|||
125878416|NCT00400179|452851307|FG000|Overall Study|Intercurrent illness|0|||
125878417|NCT00400179|452851308|FG001|Overall Study|Intercurrent illness|1|||
125878418|NCT00400179|452851307|FG000|Overall Study|Investigator judgment|0|||
125878419|NCT00400179|452851308|FG001|Overall Study|Investigator judgment|1|||
125878420|NCT00400179|452851307|FG000|Overall Study|Randomization error/patient ineligible|1|||
125878421|NCT00400179|452851308|FG001|Overall Study|Randomization error/patient ineligible|6|||
125878422|NCT05138653|452851309|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
125878423|NCT05138653|452851310|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878424|NCT05138653|452851311|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878425|NCT05138653|452851312|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878426|NCT05138653|452851313|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878427|NCT05138653|452851314|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878428|NCT05138653|452851315|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878429|NCT05138653|452851316|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878430|NCT05138653|452851317|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878431|NCT05138653|452851318|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878432|NCT05138653|452851319|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878433|NCT05138653|452851320|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878434|NCT05138653|452851321|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878435|NCT05138653|452851322|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878436|NCT05138653|452851323|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878437|NCT05138653|452851324|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125878438|NCT05138653|452851309|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878439|NCT05138653|452851310|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
125878440|NCT05138653|452851311|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878441|NCT05138653|452851312|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878442|NCT05138653|452851313|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878443|NCT05138653|452851314|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878444|NCT05138653|452851315|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878445|NCT05138653|452851316|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878446|NCT05138653|452851317|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
125878447|NCT05138653|452851318|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878448|NCT05138653|452851319|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878449|NCT05138653|452851320|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878450|NCT05138653|452851321|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878451|NCT05138653|452851322|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878452|NCT05138653|452851323|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878453|NCT05138653|452851324|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125878454|NCT05138653|452851309|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126319171|NCT00460265|454459682|FG000|Overall Study|Physician Decision|1|||
126319172|NCT00460265|454459683|FG001|Overall Study|Physician Decision|2|||
126319173|NCT00460265|454459682|FG000|Overall Study|Withdrawal by Subject|10|||
126319174|NCT00460265|454459683|FG001|Overall Study|Withdrawal by Subject|25|||
126319175|NCT00460265|454459682|FG000|Overall Study|Ongoing|60|||
126319176|NCT00460265|454459683|FG001|Overall Study|Ongoing|47|||
126319177|NCT02719353|454459684|FG000|First Intervention|Physician Decision|0|||
126319178|NCT02719353|454459685|FG001|First Intervention|Physician Decision|1|||
126319179|NCT01917344|454459689|FG000|Overall Study|Withdrawal by Subject|1|||
126319180|NCT00717275|454459691|FG000|Overall Study|Premature study termination.|3|||
126319181|NCT00424021|454459692|FG000|NCT00046319 Study Period|Adverse Event|1|||
126319182|NCT00424021|454459693|FG001|NCT00046319 Study Period|Adverse Event|0|||
126319183|NCT00424021|454459694|FG002|NCT00046319 Study Period|Adverse Event|1|||
126319184|NCT00424021|454459695|FG003|NCT00046319 Study Period|Adverse Event|1|||
126319185|NCT00424021|454459692|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
126319186|NCT00424021|454459693|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
126319187|NCT00424021|454459694|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
126319188|NCT00424021|454459695|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
126319189|NCT00424021|454459692|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
126319190|NCT00424021|454459693|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
126319191|NCT00424021|454459694|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
126319192|NCT00424021|454459695|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
126319193|NCT00424021|454459692|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
126319194|NCT00424021|454459693|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
126319195|NCT00424021|454459694|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
126319196|NCT00424021|454459695|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
126319197|NCT00424021|454459692|FG000|AMB-220-E Study Period|Adverse Event|1|||
126319198|NCT00424021|454459693|FG001|AMB-220-E Study Period|Adverse Event|1|||
126319199|NCT00424021|454459694|FG002|AMB-220-E Study Period|Adverse Event|3|||
126319200|NCT00424021|454459695|FG003|AMB-220-E Study Period|Adverse Event|7|||
126319201|NCT00424021|454459692|FG000|AMB-220-E Study Period|Death|0|||
126319202|NCT00424021|454459693|FG001|AMB-220-E Study Period|Death|0|||
126319203|NCT00424021|454459694|FG002|AMB-220-E Study Period|Death|1|||
126319204|NCT00424021|454459695|FG003|AMB-220-E Study Period|Death|1|||
126319205|NCT00424021|454459692|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
126319206|NCT00424021|454459693|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
126319207|NCT00424021|454459694|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
126319208|NCT00424021|454459695|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
126319209|NCT00424021|454459692|FG000|AMB-220-E Study Period|Physician Decision|0|||
126319210|NCT00424021|454459693|FG001|AMB-220-E Study Period|Physician Decision|0|||
126319211|NCT00424021|454459694|FG002|AMB-220-E Study Period|Physician Decision|0|||
126319212|NCT00424021|454459695|FG003|AMB-220-E Study Period|Physician Decision|1|||
126319213|NCT03000530|454459696|FG000|Overall Study|Adverse Event|0|||
126319214|NCT03000530|454459697|FG001|Overall Study|Adverse Event|0|||
126319215|NCT03000530|454459698|FG002|Overall Study|Adverse Event|2|||
126319216|NCT03000530|454459696|FG000|Overall Study|Lost to Follow-up|0|||
126319217|NCT03000530|454459697|FG001|Overall Study|Lost to Follow-up|3|||
126319218|NCT03000530|454459698|FG002|Overall Study|Lost to Follow-up|1|||
126319219|NCT03000530|454459696|FG000|Overall Study|Withdrawal by Subject|0|||
126319220|NCT03000530|454459697|FG001|Overall Study|Withdrawal by Subject|2|||
126319221|NCT03000530|454459698|FG002|Overall Study|Withdrawal by Subject|1|||
126319222|NCT00312572|454459702|FG000|Overall Study|Adverse Event|10|||
126319223|NCT00312572|454459703|FG001|Overall Study|Adverse Event|16|||
126319224|NCT00312572|454459702|FG000|Overall Study|Lost to Follow-up|1|||
126319225|NCT00312572|454459703|FG001|Overall Study|Lost to Follow-up|1|||
126319226|NCT00312572|454459702|FG000|Overall Study|Administrative|4|||
126319227|NCT00312572|454459703|FG001|Overall Study|Administrative|2|||
126319228|NCT00312572|454459702|FG000|Overall Study|Lack of Efficacy|1|||
126319229|NCT00312572|454459703|FG001|Overall Study|Lack of Efficacy|2|||
126319230|NCT03597022|454459704|FG000|Overall Study|Premature termination of the study|7|||
126319231|NCT03597022|454459705|FG001|Overall Study|Premature termination of the study|7|||
126319232|NCT03597022|454459706|FG002|Overall Study|Premature termination of the study|8|||
126319233|NCT03597022|454459704|FG000|Overall Study|Serious adverse event|1|||
126319234|NCT03597022|454459705|FG001|Overall Study|Serious adverse event|1|||
126319235|NCT03597022|454459706|FG002|Overall Study|Serious adverse event|0|||
126319236|NCT02614131|454459707|FG000|Overall Study|Withdrawal by Subject|1|||
126090982|NCT00368927|453626872|FG000|Overall Study|Withdrawal by Subject|1|||
126319237|NCT02614131|454459708|FG001|Overall Study|Withdrawal by Subject|0|||
126319238|NCT02614131|454459709|FG002|Overall Study|Withdrawal by Subject|0|||
126319239|NCT02614131|454459710|FG003|Overall Study|Withdrawal by Subject|0|||
126319240|NCT02614131|454459711|FG004|Overall Study|Withdrawal by Subject|0|||
126319241|NCT02614131|454459712|FG005|Overall Study|Withdrawal by Subject|0|||
126319242|NCT02614131|454459713|FG006|Overall Study|Withdrawal by Subject|0|||
126319243|NCT02614131|454459707|FG000|Overall Study|Adverse Event|0|||
126319244|NCT02614131|454459708|FG001|Overall Study|Adverse Event|0|||
126319245|NCT02614131|454459709|FG002|Overall Study|Adverse Event|0|||
126319246|NCT02614131|454459710|FG003|Overall Study|Adverse Event|0|||
126319247|NCT02614131|454459711|FG004|Overall Study|Adverse Event|0|||
126319248|NCT02614131|454459712|FG005|Overall Study|Adverse Event|0|||
126319249|NCT02614131|454459713|FG006|Overall Study|Adverse Event|1|||
126319250|NCT01285492|454459718|FG000|Overall Study|Adverse Event|11|||
126319251|NCT01285492|454459719|FG001|Overall Study|Adverse Event|0|||
126319252|NCT01285492|454459718|FG000|Overall Study|Protocol Violation|3|||
126319253|NCT01285492|454459719|FG001|Overall Study|Protocol Violation|0|||
126319254|NCT01285492|454459718|FG000|Overall Study|Withdrawal by Subject|2|||
126319255|NCT01285492|454459719|FG001|Overall Study|Withdrawal by Subject|1|||
126319256|NCT01285492|454459718|FG000|Overall Study|Death|1|||
126319257|NCT01285492|454459719|FG001|Overall Study|Death|0|||
126319258|NCT01797094|454459720|FG000|Overall Study|Adverse Event|1|||
126319259|NCT01797094|454459721|FG001|Overall Study|Adverse Event|1|||
126319260|NCT01797094|454459720|FG000|Overall Study|Personal Reasons|4|||
126319261|NCT01797094|454459721|FG001|Overall Study|Personal Reasons|0|||
126319262|NCT01797094|454459720|FG000|Overall Study|Protocol Violation|0|||
126319263|NCT01797094|454459721|FG001|Overall Study|Protocol Violation|1|||
126319264|NCT01797094|454459720|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126319265|NCT01797094|454459721|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126319266|NCT03217968|454459726|FG000|Overall Study|Withdrawal by Subject|4|||
126319267|NCT03217968|454459726|FG000|Overall Study|Lost to Follow-up|1|||
126319268|NCT03217968|454459726|FG000|Overall Study|Protocol Violation|6|||
126319269|NCT01887678|454459730|FG000|Overall Study|Adverse Event|4|||
126319270|NCT01887678|454459731|FG001|Overall Study|Adverse Event|6|||
126319271|NCT01887678|454459730|FG000|Overall Study|Exceeded rescue medication dosage|4|||
126319272|NCT01887678|454459731|FG001|Overall Study|Exceeded rescue medication dosage|5|||
126319273|NCT01887678|454459730|FG000|Overall Study|Withdrawal of consent|3|||
126319274|NCT01887678|454459731|FG001|Overall Study|Withdrawal of consent|4|||
126319275|NCT01887678|454459730|FG000|Overall Study|Lost to Follow-up|4|||
126319276|NCT01887678|454459731|FG001|Overall Study|Lost to Follow-up|2|||
126319277|NCT01887678|454459730|FG000|Overall Study|Deterioration of clinical condition|0|||
126319278|NCT01887678|454459731|FG001|Overall Study|Deterioration of clinical condition|4|||
126319279|NCT01887678|454459730|FG000|Overall Study|Lack of Efficacy|1|||
126319280|NCT01887678|454459731|FG001|Overall Study|Lack of Efficacy|2|||
126319281|NCT01887678|454459730|FG000|Overall Study|Non-compliance|0|||
126319282|NCT01887678|454459731|FG001|Overall Study|Non-compliance|3|||
126319283|NCT01887678|454459730|FG000|Overall Study|Specified|1|||
126319284|NCT01887678|454459731|FG001|Overall Study|Specified|2|||
126319285|NCT03013985|454459732|FG000|Overall Study|Protocol Violation|2|||
126319286|NCT03013985|454459733|FG001|Overall Study|Protocol Violation|2|||
126319287|NCT03013985|454459732|FG000|Overall Study|Withdrawal by Subject|14|||
126319288|NCT03013985|454459733|FG001|Overall Study|Withdrawal by Subject|17|||
126319289|NCT00791492|454459736|FG000|Overall Study|Withdrawal by Subject|1|||
126319290|NCT00791492|454459737|FG001|Overall Study|Withdrawal by Subject|2|||
126319291|NCT00791492|454459736|FG000|Overall Study|Liver transplantation|5|||
126319292|NCT00791492|454459737|FG001|Overall Study|Liver transplantation|1|||
126319293|NCT00634049|454459752|FG000|Overall Study|Never received study drug|1|||
126319294|NCT00634049|454459752|FG000|Overall Study|Died prior to receiving study drug|1|||
126319295|NCT00634049|454459752|FG000|Overall Study|Screening failure|1|||
126319296|NCT00314132|454459754|FG000|Overall Study|Lost to Follow-up|3|||
126319297|NCT00314132|454459755|FG001|Overall Study|Lost to Follow-up|13|||
126319298|NCT00314132|454459754|FG000|Overall Study|Withdrawal by Subject|3|||
126319299|NCT00314132|454459755|FG001|Overall Study|Withdrawal by Subject|5|||
126319300|NCT00314132|454459754|FG000|Overall Study|Adverse Event|1|||
126319301|NCT00314132|454459755|FG001|Overall Study|Adverse Event|0|||
126319302|NCT00314132|454459754|FG000|Overall Study|Physician Decision|1|||
126319303|NCT00314132|454459755|FG001|Overall Study|Physician Decision|0|||
126319304|NCT01380691|454459757|FG000|Washout (7 Days)|Protocol Violation|0|||
126319305|NCT01380691|454459758|FG001|Washout (7 Days)|Protocol Violation|0|||
126319306|NCT01380691|454459759|FG002|Washout (7 Days)|Protocol Violation|0|||
126319307|NCT01380691|454459760|FG003|Washout (7 Days)|Protocol Violation|1|||
126319308|NCT01380691|454459757|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
126319309|NCT01380691|454459758|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
125878455|NCT05138653|452851310|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
125982744|NCT02703922|453226980|FG001|Overall Study|Lost to Follow-up|10|||
126319310|NCT01380691|454459759|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
126319311|NCT01380691|454459760|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
126319312|NCT01987232|454459763|FG000|Overall Study|Ongoing in Study|0|||
126319313|NCT01987232|454459764|FG001|Overall Study|Ongoing in Study|0|||
126319314|NCT01987232|454459765|FG002|Overall Study|Ongoing in Study|0|||
126319315|NCT01987232|454459766|FG003|Overall Study|Ongoing in Study|1|||
126319316|NCT01987232|454459767|FG004|Overall Study|Ongoing in Study|0|||
126319317|NCT00586508|454459768|FG000|Overall Study|Progressive disease|52|||
126319318|NCT00586508|454459769|FG001|Overall Study|Progressive disease|8|||
126319319|NCT00586508|454459768|FG000|Overall Study|Death|0|||
126319320|NCT00586508|454459769|FG001|Overall Study|Death|1|||
126319321|NCT00586508|454459768|FG000|Overall Study|Adverse Event|12|||
126319322|NCT00586508|454459769|FG001|Overall Study|Adverse Event|4|||
126319323|NCT00586508|454459768|FG000|Overall Study|Withdrawal by Subject|4|||
126319324|NCT00586508|454459769|FG001|Overall Study|Withdrawal by Subject|0|||
126319325|NCT00932698|454459770|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
126319326|NCT00932698|454459771|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
126319327|NCT00932698|454459772|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
126319328|NCT00932698|454459773|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
126319329|NCT00932698|454459774|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
126319330|NCT00932698|454459775|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
126319331|NCT00932698|454459776|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
126319332|NCT00932698|454459777|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
126319333|NCT00932698|454459778|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
126319334|NCT00932698|454459779|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
126319335|NCT00932698|454459780|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
126319336|NCT00932698|454459770|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319337|NCT00932698|454459771|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
126319338|NCT00932698|454459772|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319339|NCT00932698|454459773|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
126319340|NCT00932698|454459774|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319341|NCT00932698|454459775|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
126319342|NCT00932698|454459776|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
126319343|NCT00932698|454459777|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319344|NCT00932698|454459778|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319345|NCT00932698|454459779|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319346|NCT00932698|454459780|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319347|NCT00932698|454459770|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
126319348|NCT00932698|454459771|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
126319349|NCT00932698|454459772|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
126319350|NCT00932698|454459773|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
126319351|NCT00932698|454459774|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
126319352|NCT00932698|454459775|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
126319353|NCT00932698|454459776|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
126319354|NCT00932698|454459777|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
126319355|NCT00932698|454459778|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
126319356|NCT00932698|454459779|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
126319357|NCT00932698|454459780|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
126319358|NCT00932698|454459770|FG000|Part 1 (Dose Escalation)|Other|0|||
126319359|NCT00932698|454459771|FG001|Part 1 (Dose Escalation)|Other|0|||
126319360|NCT00932698|454459772|FG002|Part 1 (Dose Escalation)|Other|1|||
126319361|NCT00932698|454459773|FG003|Part 1 (Dose Escalation)|Other|0|||
126319362|NCT00932698|454459774|FG004|Part 1 (Dose Escalation)|Other|0|||
126319363|NCT00932698|454459775|FG005|Part 1 (Dose Escalation)|Other|0|||
126319364|NCT00932698|454459776|FG006|Part 1 (Dose Escalation)|Other|1|||
126319365|NCT00932698|454459777|FG007|Part 1 (Dose Escalation)|Other|0|||
126319366|NCT00932698|454459778|FG008|Part 1 (Dose Escalation)|Other|0|||
126319367|NCT00932698|454459779|FG009|Part 1 (Dose Escalation)|Other|0|||
126319368|NCT00932698|454459780|FG010|Part 1 (Dose Escalation)|Other|0|||
126319369|NCT00932698|454459770|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319370|NCT00932698|454459771|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319371|NCT00932698|454459772|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
125982745|NCT00394355|453226982|FG000|Overall Study|Adverse Event|10|||
125982746|NCT00394355|453226983|FG001|Overall Study|Adverse Event|6|||
125982747|NCT00394355|453226984|FG002|Overall Study|Adverse Event|7|||
125982748|NCT00394355|453226985|FG003|Overall Study|Adverse Event|8|||
125982749|NCT00394355|453226982|FG000|Overall Study|Did not meet protocol eligibility|1|||
126319372|NCT00932698|454459773|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319373|NCT00932698|454459774|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319374|NCT00932698|454459775|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319375|NCT00932698|454459776|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319376|NCT00932698|454459777|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
126319377|NCT00932698|454459778|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
125878456|NCT05138653|452851311|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878457|NCT05138653|452851312|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878458|NCT05138653|452851313|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
125878459|NCT05138653|452851314|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878460|NCT05138653|452851315|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878461|NCT05138653|452851316|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878462|NCT05138653|452851317|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878463|NCT05138653|452851318|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878464|NCT05138653|452851319|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126319378|NCT00932698|454459779|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
126319379|NCT00932698|454459780|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
126319380|NCT00932698|454459770|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319381|NCT00932698|454459771|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319382|NCT00932698|454459772|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319383|NCT00932698|454459773|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319384|NCT00932698|454459774|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319385|NCT00932698|454459775|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319386|NCT00932698|454459776|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319387|NCT00932698|454459777|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
126319388|NCT00932698|454459778|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
126319389|NCT00932698|454459779|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
126319390|NCT00932698|454459780|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319391|NCT00932698|454459770|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
126319392|NCT00932698|454459771|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
126319393|NCT00932698|454459772|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
126319394|NCT00932698|454459773|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
126319395|NCT00932698|454459774|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
126319396|NCT00932698|454459775|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
126319397|NCT00932698|454459776|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
126319398|NCT00932698|454459777|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
126319399|NCT00932698|454459778|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
126319400|NCT00932698|454459779|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
126319401|NCT00932698|454459780|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
126319402|NCT00655681|454459781|FG000|Overall Study|Lost to Follow-up|1|||
126319403|NCT00655681|454459782|FG001|Overall Study|Lost to Follow-up|1|||
126319404|NCT02429310|454459783|FG000|Overall Study|Lost to Follow-up|1|||
126319405|NCT02429310|454459784|FG001|Overall Study|Lost to Follow-up|2|||
126319406|NCT02429310|454459783|FG000|Overall Study|Protocol Violation|1|||
126319407|NCT02429310|454459784|FG001|Overall Study|Protocol Violation|1|||
126319408|NCT00394433|454459785|FG000|Overall Study|Adverse Event|2|||
126319409|NCT00394433|454459785|FG000|Overall Study|Alternative Therapy|1|||
126319410|NCT01554176|454459786|FG000|Treatment Phase|Protocol Violation|1|||
126319411|NCT01554176|454459787|FG001|Treatment Phase|Protocol Violation|2|||
126319412|NCT01554176|454459788|FG002|Treatment Phase|Protocol Violation|0|||
126319413|NCT01554176|454459789|FG003|Treatment Phase|Protocol Violation|0|||
126319414|NCT01554176|454459790|FG004|Treatment Phase|Protocol Violation|0|||
126319415|NCT01554176|454459786|FG000|Treatment Phase|Physician Decision|1|||
126319416|NCT01554176|454459787|FG001|Treatment Phase|Physician Decision|1|||
126319417|NCT01554176|454459788|FG002|Treatment Phase|Physician Decision|0|||
126319418|NCT01554176|454459789|FG003|Treatment Phase|Physician Decision|0|||
126319419|NCT01554176|454459790|FG004|Treatment Phase|Physician Decision|0|||
126319420|NCT01554176|454459786|FG000|Treatment Phase|Lack of Efficacy|0|||
126319421|NCT01554176|454459787|FG001|Treatment Phase|Lack of Efficacy|1|||
126319422|NCT01554176|454459788|FG002|Treatment Phase|Lack of Efficacy|0|||
126319423|NCT01554176|454459789|FG003|Treatment Phase|Lack of Efficacy|0|||
126319424|NCT01554176|454459790|FG004|Treatment Phase|Lack of Efficacy|0|||
126319425|NCT01554176|454459786|FG000|Treatment Phase|Adverse event, non-fatal|1|||
126319426|NCT01554176|454459787|FG001|Treatment Phase|Adverse event, non-fatal|1|||
126319427|NCT01554176|454459788|FG002|Treatment Phase|Adverse event, non-fatal|0|||
126319428|NCT01554176|454459789|FG003|Treatment Phase|Adverse event, non-fatal|0|||
126319429|NCT01554176|454459790|FG004|Treatment Phase|Adverse event, non-fatal|0|||
126319430|NCT01554176|454459786|FG000|Treatment Phase|Non-compliance with study drug|1|||
126319431|NCT01554176|454459787|FG001|Treatment Phase|Non-compliance with study drug|0|||
126319432|NCT01554176|454459788|FG002|Treatment Phase|Non-compliance with study drug|0|||
126319433|NCT01554176|454459789|FG003|Treatment Phase|Non-compliance with study drug|0|||
126319434|NCT01554176|454459790|FG004|Treatment Phase|Non-compliance with study drug|0|||
125878465|NCT05138653|452851320|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878466|NCT05138653|452851321|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878467|NCT05138653|452851322|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125878468|NCT05138653|452851323|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126319435|NCT01554176|454459786|FG000|Treatment Phase|Withdrawal by Subject|1|||
126319436|NCT01554176|454459787|FG001|Treatment Phase|Withdrawal by Subject|0|||
125878469|NCT05138653|452851324|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126319437|NCT01554176|454459788|FG002|Treatment Phase|Withdrawal by Subject|0|||
126319438|NCT01554176|454459789|FG003|Treatment Phase|Withdrawal by Subject|0|||
126319439|NCT01554176|454459790|FG004|Treatment Phase|Withdrawal by Subject|0|||
125878470|NCT05138653|452851309|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126319440|NCT01554176|454459786|FG000|Treatment Phase|Lost to Follow-up|3|||
126319441|NCT01554176|454459787|FG001|Treatment Phase|Lost to Follow-up|0|||
126319442|NCT01554176|454459788|FG002|Treatment Phase|Lost to Follow-up|0|||
126319443|NCT01554176|454459789|FG003|Treatment Phase|Lost to Follow-up|0|||
126319444|NCT01554176|454459790|FG004|Treatment Phase|Lost to Follow-up|0|||
126319445|NCT01554176|454459786|FG000|Run-out Phase|Protocol Violation|0|||
126319446|NCT01554176|454459787|FG001|Run-out Phase|Protocol Violation|0|||
126319447|NCT01554176|454459788|FG002|Run-out Phase|Protocol Violation|0|||
126319448|NCT01554176|454459789|FG003|Run-out Phase|Protocol Violation|1|||
126319449|NCT01554176|454459790|FG004|Run-out Phase|Protocol Violation|0|||
126208882|NCT04668066|454053108|FG001|Part 1: Treatment Phase|Other|0|||
126208883|NCT04668066|454053109|FG002|Part 1: Treatment Phase|Other|0|||
126208884|NCT04668066|454053110|FG003|Part 1: Treatment Phase|Other|0|||
126208885|NCT04668066|454053111|FG004|Part 1: Treatment Phase|Other|0|||
126208886|NCT04668066|454053112|FG005|Part 1: Treatment Phase|Other|0|||
126208887|NCT04668066|454053113|FG006|Part 1: Treatment Phase|Other|0|||
126208888|NCT04668066|454053114|FG007|Part 1: Treatment Phase|Other|0|||
126208889|NCT04668066|454053115|FG008|Part 1: Treatment Phase|Other|0|||
126208890|NCT04668066|454053116|FG009|Part 1: Treatment Phase|Other|0|||
126208891|NCT04668066|454053117|FG010|Part 1: Treatment Phase|Other|0|||
126208892|NCT04668066|454053118|FG011|Part 1: Treatment Phase|Other|1|||
126208893|NCT04668066|454053119|FG012|Part 1: Treatment Phase|Other|0|||
126208894|NCT04668066|454053120|FG013|Part 1: Treatment Phase|Other|0|||
126208895|NCT04668066|454053121|FG014|Part 1: Treatment Phase|Other|0|||
126208896|NCT04668066|454053122|FG015|Part 1: Treatment Phase|Other|0|||
126208897|NCT04668066|454053123|FG016|Part 1: Treatment Phase|Other|0|||
126208898|NCT04668066|454053124|FG017|Part 1: Treatment Phase|Other|0|||
126208899|NCT04668066|454053125|FG018|Part 1: Treatment Phase|Other|0|||
126208900|NCT04668066|454053107|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208901|NCT04668066|454053108|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208902|NCT04668066|454053109|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208903|NCT04668066|454053110|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208904|NCT04668066|454053111|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208905|NCT04668066|454053112|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208906|NCT04668066|454053113|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208907|NCT04668066|454053114|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208908|NCT04668066|454053115|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208909|NCT04668066|454053116|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208910|NCT04668066|454053117|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208911|NCT04668066|454053118|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208912|NCT04668066|454053119|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
126208913|NCT04668066|454053120|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208914|NCT04668066|454053121|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208915|NCT04668066|454053122|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
126208916|NCT04668066|454053123|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208917|NCT04668066|454053124|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208918|NCT04668066|454053125|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126208919|NCT04668066|454053107|FG000|Part 1: Follow-Up|Adverse Event|0|||
126208920|NCT04668066|454053108|FG001|Part 1: Follow-Up|Adverse Event|0|||
126208921|NCT04668066|454053109|FG002|Part 1: Follow-Up|Adverse Event|0|||
126208922|NCT04668066|454053110|FG003|Part 1: Follow-Up|Adverse Event|0|||
126208923|NCT04668066|454053111|FG004|Part 1: Follow-Up|Adverse Event|0|||
126208924|NCT04668066|454053112|FG005|Part 1: Follow-Up|Adverse Event|0|||
126208925|NCT04668066|454053113|FG006|Part 1: Follow-Up|Adverse Event|0|||
126208926|NCT04668066|454053114|FG007|Part 1: Follow-Up|Adverse Event|0|||
126208927|NCT04668066|454053115|FG008|Part 1: Follow-Up|Adverse Event|0|||
126208928|NCT04668066|454053116|FG009|Part 1: Follow-Up|Adverse Event|0|||
126208929|NCT04668066|454053117|FG010|Part 1: Follow-Up|Adverse Event|0|||
126208930|NCT04668066|454053118|FG011|Part 1: Follow-Up|Adverse Event|1|||
126208931|NCT04668066|454053119|FG012|Part 1: Follow-Up|Adverse Event|0|||
126208932|NCT04668066|454053120|FG013|Part 1: Follow-Up|Adverse Event|0|||
126208933|NCT04668066|454053121|FG014|Part 1: Follow-Up|Adverse Event|0|||
126208934|NCT04668066|454053122|FG015|Part 1: Follow-Up|Adverse Event|0|||
126208935|NCT04668066|454053123|FG016|Part 1: Follow-Up|Adverse Event|0|||
126208936|NCT04668066|454053124|FG017|Part 1: Follow-Up|Adverse Event|0|||
126208937|NCT04668066|454053125|FG018|Part 1: Follow-Up|Adverse Event|0|||
126208938|NCT04668066|454053107|FG000|Part 1: Follow-Up|Other|0|||
126208939|NCT04668066|454053108|FG001|Part 1: Follow-Up|Other|0|||
126208940|NCT04668066|454053109|FG002|Part 1: Follow-Up|Other|0|||
126208941|NCT04668066|454053110|FG003|Part 1: Follow-Up|Other|0|||
126208942|NCT04668066|454053111|FG004|Part 1: Follow-Up|Other|0|||
126208943|NCT04668066|454053112|FG005|Part 1: Follow-Up|Other|0|||
126208944|NCT04668066|454053113|FG006|Part 1: Follow-Up|Other|0|||
126208945|NCT04668066|454053114|FG007|Part 1: Follow-Up|Other|0|||
126208946|NCT04668066|454053115|FG008|Part 1: Follow-Up|Other|0|||
126208947|NCT04668066|454053116|FG009|Part 1: Follow-Up|Other|0|||
126208948|NCT04668066|454053117|FG010|Part 1: Follow-Up|Other|0|||
126208949|NCT04668066|454053118|FG011|Part 1: Follow-Up|Other|1|||
126208950|NCT04668066|454053119|FG012|Part 1: Follow-Up|Other|1|||
126208951|NCT04668066|454053120|FG013|Part 1: Follow-Up|Other|0|||
126208952|NCT04668066|454053121|FG014|Part 1: Follow-Up|Other|0|||
126208953|NCT04668066|454053122|FG015|Part 1: Follow-Up|Other|0|||
126208954|NCT04668066|454053123|FG016|Part 1: Follow-Up|Other|0|||
126208955|NCT04668066|454053124|FG017|Part 1: Follow-Up|Other|0|||
126208956|NCT04668066|454053125|FG018|Part 1: Follow-Up|Other|0|||
126208957|NCT04668066|454053107|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208958|NCT04668066|454053108|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
126319450|NCT01085136|454459791|FG000|Part A|Other Adverse event|223|||
126319451|NCT01085136|454459792|FG001|Part A|Other Adverse event|0|||
126319452|NCT01085136|454459793|FG002|Part A|Other Adverse event|0|||
126319453|NCT01085136|454459791|FG000|Part A|Protocol Violation|3|||
126319454|NCT01085136|454459792|FG001|Part A|Protocol Violation|0|||
126319455|NCT01085136|454459793|FG002|Part A|Protocol Violation|0|||
126319456|NCT01085136|454459791|FG000|Part A|Lost to Follow-up|3|||
126319457|NCT01085136|454459792|FG001|Part A|Lost to Follow-up|0|||
126319458|NCT01085136|454459793|FG002|Part A|Lost to Follow-up|0|||
126319459|NCT01085136|454459791|FG000|Part A|Refusal to continue trial medication|64|||
126319460|NCT01085136|454459792|FG001|Part A|Refusal to continue trial medication|0|||
126319461|NCT01085136|454459793|FG002|Part A|Refusal to continue trial medication|0|||
126319462|NCT01085136|454459791|FG000|Part A|Other reason not defined above|30|||
126319463|NCT01085136|454459792|FG001|Part A|Other reason not defined above|0|||
126319464|NCT01085136|454459793|FG002|Part A|Other reason not defined above|0|||
126319465|NCT01085136|454459791|FG000|Part B|Other AE|0|||
126319466|NCT01085136|454459792|FG001|Part B|Other AE|29|||
126319467|NCT01085136|454459793|FG002|Part B|Other AE|8|||
126319468|NCT01085136|454459791|FG000|Part B|Refusal to continue trial medication|0|||
126319469|NCT01085136|454459792|FG001|Part B|Refusal to continue trial medication|12|||
126319470|NCT01085136|454459793|FG002|Part B|Refusal to continue trial medication|7|||
126319471|NCT01085136|454459791|FG000|Part B|Not treated|0|||
126319472|NCT01085136|454459792|FG001|Part B|Not treated|4|||
126319473|NCT01085136|454459793|FG002|Part B|Not treated|8|||
126319474|NCT01085136|454459791|FG000|Part B|Other reason not defined above|0|||
126319475|NCT01085136|454459792|FG001|Part B|Other reason not defined above|6|||
126319476|NCT01085136|454459793|FG002|Part B|Other reason not defined above|3|||
126319477|NCT01854879|454459796|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
126319478|NCT01854879|454459796|FG000|Overall Study|screen fail|3|||
126319479|NCT01854879|454459796|FG000|Overall Study|incomplete data set|1|||
126319480|NCT01709864|454461424|FG000|Overall Study|Physician Decision|0|||
126319481|NCT01709864|454461425|FG001|Overall Study|Physician Decision|1|||
126319482|NCT01709864|454461424|FG000|Overall Study|subject/guardian decision|5|||
126319483|NCT01709864|454461425|FG001|Overall Study|subject/guardian decision|6|||
126319484|NCT01709864|454461424|FG000|Overall Study|Lost to Follow-up|1|||
126319485|NCT01709864|454461425|FG001|Overall Study|Lost to Follow-up|0|||
126319486|NCT01709864|454461424|FG000|Overall Study|non-compliance with study treatment|1|||
126319487|NCT01709864|454461425|FG001|Overall Study|non-compliance with study treatment|1|||
126319488|NCT01709864|454461424|FG000|Overall Study|Adverse Event|0|||
126319489|NCT01709864|454461425|FG001|Overall Study|Adverse Event|2|||
126319490|NCT01709864|454461424|FG000|Overall Study|Death|0|||
126319491|NCT01709864|454461425|FG001|Overall Study|Death|1|||
126319492|NCT00316914|454461446|FG000|Overall Study|Withdrawal by Subject|5|||
126319493|NCT00316914|454461447|FG001|Overall Study|Withdrawal by Subject|3|||
126319494|NCT00316914|454461446|FG000|Overall Study|Adverse Event|8|||
126319495|NCT00316914|454461447|FG001|Overall Study|Adverse Event|7|||
126319496|NCT00316914|454461446|FG000|Overall Study|Other Problems|6|||
126319497|NCT00316914|454461447|FG001|Overall Study|Other Problems|11|||
126319498|NCT00316914|454461446|FG000|Overall Study|Missing end of treatment documentation|14|||
126319499|NCT00316914|454461447|FG001|Overall Study|Missing end of treatment documentation|15|||
126319500|NCT04105010|454461448|FG000|Overall Study|Death|3|||
126319501|NCT04105010|454461449|FG001|Overall Study|Death|1|||
126319502|NCT04105010|454461450|FG002|Overall Study|Death|1|||
126319503|NCT04105010|454461451|FG003|Overall Study|Death|54|||
126319504|NCT04105010|454461448|FG000|Overall Study|Lost to Follow-up|0|||
126319505|NCT04105010|454461449|FG001|Overall Study|Lost to Follow-up|0|||
126319506|NCT04105010|454461450|FG002|Overall Study|Lost to Follow-up|0|||
126319507|NCT04105010|454461451|FG003|Overall Study|Lost to Follow-up|4|||
126319508|NCT04105010|454461448|FG000|Overall Study|Withdrawal by Subject|8|||
126319509|NCT04105010|454461449|FG001|Overall Study|Withdrawal by Subject|1|||
126319510|NCT04105010|454461450|FG002|Overall Study|Withdrawal by Subject|1|||
126319511|NCT04105010|454461451|FG003|Overall Study|Withdrawal by Subject|4|||
125878471|NCT05138653|452851310|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878472|NCT05138653|452851311|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126319512|NCT04105010|454461448|FG000|Overall Study|Other reason|4|||
126319513|NCT04105010|454461449|FG001|Overall Study|Other reason|7|||
126319514|NCT04105010|454461450|FG002|Overall Study|Other reason|0|||
126319515|NCT04105010|454461451|FG003|Overall Study|Other reason|19|||
126319516|NCT00427999|454461452|FG000|Overall Study|Adverse Event|6|||
126319517|NCT00427999|454461452|FG000|Overall Study|Abnormal laboratory values|1|||
126319518|NCT00427999|454461452|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
126319519|NCT00427999|454461452|FG000|Overall Study|Protocol Violation|2|||
126319520|NCT00427999|454461452|FG000|Overall Study|Withdrawal by Subject|9|||
126319521|NCT00427999|454461452|FG000|Overall Study|Death|1|||
126319522|NCT02380859|454461453|FG000|Overall Study|Withdrawal by Subject|2|||
126319523|NCT02380859|454461454|FG001|Overall Study|Withdrawal by Subject|0|||
126319524|NCT02284568|454461455|FG000|Overall Study|Adverse Event|2|||
126319525|NCT02284568|454461456|FG001|Overall Study|Adverse Event|9|||
126319526|NCT02284568|454461457|FG002|Overall Study|Adverse Event|4|||
126319527|NCT02284568|454461455|FG000|Overall Study|Withdrawal by Subject|22|||
126319528|NCT02284568|454461456|FG001|Overall Study|Withdrawal by Subject|21|||
126319529|NCT02284568|454461457|FG002|Overall Study|Withdrawal by Subject|1|||
126319530|NCT02284568|454461455|FG000|Overall Study|Noncompliance with study drug admin|1|||
126319531|NCT02284568|454461456|FG001|Overall Study|Noncompliance with study drug admin|2|||
126319532|NCT02284568|454461457|FG002|Overall Study|Noncompliance with study drug admin|0|||
126319533|NCT02284568|454461455|FG000|Overall Study|Noncompliance|1|||
126319534|NCT02284568|454461456|FG001|Overall Study|Noncompliance|0|||
126319535|NCT02284568|454461457|FG002|Overall Study|Noncompliance|0|||
126319536|NCT02284568|454461455|FG000|Overall Study|Protocol Violation|0|||
126319537|NCT02284568|454461456|FG001|Overall Study|Protocol Violation|1|||
126319538|NCT02284568|454461457|FG002|Overall Study|Protocol Violation|0|||
126319539|NCT02284568|454461455|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
126319540|NCT02284568|454461456|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
126319541|NCT02284568|454461457|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
126319542|NCT02284568|454461455|FG000|Overall Study|Lost to Follow-up|0|||
126319543|NCT02284568|454461456|FG001|Overall Study|Lost to Follow-up|3|||
126319544|NCT02284568|454461457|FG002|Overall Study|Lost to Follow-up|0|||
126319545|NCT02284568|454461455|FG000|Overall Study|Lack of Efficacy|4|||
126319546|NCT02284568|454461456|FG001|Overall Study|Lack of Efficacy|7|||
126319547|NCT02284568|454461457|FG002|Overall Study|Lack of Efficacy|0|||
126319548|NCT02284568|454461455|FG000|Overall Study|Other|1|||
126319549|NCT02284568|454461456|FG001|Overall Study|Other|2|||
126319550|NCT02284568|454461457|FG002|Overall Study|Other|0|||
126319551|NCT02284568|454461455|FG000|Overall Study|Withdrew before taking study drug|0|||
126319552|NCT02284568|454461456|FG001|Overall Study|Withdrew before taking study drug|1|||
126319553|NCT02284568|454461457|FG002|Overall Study|Withdrew before taking study drug|0|||
126319554|NCT00412217|454461458|FG000|Overall Study|Insufficient Data Available|8|||
126319555|NCT00412217|454461459|FG001|Overall Study|Insufficient Data Available|3|||
126319556|NCT00412217|454461458|FG000|Overall Study|Death|5|||
126319557|NCT00412217|454461459|FG001|Overall Study|Death|4|||
126319558|NCT00412217|454461458|FG000|Overall Study|Disease Progression|2|||
126319559|NCT00412217|454461459|FG001|Overall Study|Disease Progression|3|||
126319560|NCT00412217|454461458|FG000|Overall Study|Investigator Decision|1|||
126319561|NCT00412217|454461459|FG001|Overall Study|Investigator Decision|0|||
126319562|NCT00412217|454461458|FG000|Overall Study|Withdrawal by Subject|2|||
126319563|NCT00412217|454461459|FG001|Overall Study|Withdrawal by Subject|0|||
126319564|NCT00412217|454461458|FG000|Overall Study|Lost to Follow-up|1|||
126319565|NCT00412217|454461459|FG001|Overall Study|Lost to Follow-up|4|||
126319566|NCT00412217|454461458|FG000|Overall Study|Study Terminated by Sponsor|26|||
126319567|NCT00412217|454461459|FG001|Overall Study|Study Terminated by Sponsor|33|||
126319568|NCT00412217|454461458|FG000|Overall Study|Other|1|||
126319569|NCT00412217|454461459|FG001|Overall Study|Other|1|||
126319570|NCT03114657|454461461|FG000|Overall Study|Adverse Event|9|||
126319571|NCT03114657|454461462|FG001|Overall Study|Adverse Event|6|||
126319572|NCT03114657|454461461|FG000|Overall Study|Death|4|||
126319573|NCT03114657|454461462|FG001|Overall Study|Death|0|||
126319574|NCT03114657|454461461|FG000|Overall Study|Multiple Reasons|1|||
126319575|NCT03114657|454461462|FG001|Overall Study|Multiple Reasons|2|||
126319576|NCT03114657|454461461|FG000|Overall Study|Physician Decision|2|||
126319577|NCT03114657|454461462|FG001|Overall Study|Physician Decision|2|||
126319578|NCT03114657|454461461|FG000|Overall Study|Study Terminated By Sponsor|355|||
126319579|NCT03114657|454461462|FG001|Overall Study|Study Terminated By Sponsor|374|||
126319580|NCT03114657|454461461|FG000|Overall Study|Symptomatic Deterioration|0|||
126319581|NCT03114657|454461462|FG001|Overall Study|Symptomatic Deterioration|1|||
126319582|NCT03114657|454461461|FG000|Overall Study|Withdrawal by Subject|28|||
126319583|NCT03114657|454461462|FG001|Overall Study|Withdrawal by Subject|22|||
126319584|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
126319585|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
126319586|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
126319587|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
126208959|NCT04668066|454053109|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208960|NCT04668066|454053110|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
126319588|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
126319589|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
126319590|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
126208961|NCT04668066|454053111|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208962|NCT04668066|454053112|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208963|NCT04668066|454053113|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208964|NCT04668066|454053114|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208965|NCT04668066|454053115|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208966|NCT04668066|454053116|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208967|NCT04668066|454053117|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208968|NCT04668066|454053118|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208969|NCT04668066|454053119|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
126208970|NCT04668066|454053120|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208971|NCT04668066|454053121|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
126319591|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
126319592|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
126319593|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
126319594|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
126319595|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
126319596|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Death|0|||
126319597|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Death|0|||
126319598|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Death|1|||
126319599|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Death|0|||
126319600|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
126319601|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
126319602|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
126319603|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
126319604|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
126319605|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
126319606|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
126319607|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
126319608|NCT01179737|454461463|FG000|Extension|The study was terminated|3|||
126319609|NCT01179737|454461464|FG001|Extension|The study was terminated|0|||
126319610|NCT01179737|454461465|FG002|Extension|The study was terminated|0|||
126319611|NCT01179737|454461466|FG003|Extension|The study was terminated|0|||
126319612|NCT01546038|454461467|FG000|Overall Study|Death|15|||
126319613|NCT01546038|454461468|FG001|Overall Study|Death|6|||
126319614|NCT01546038|454461469|FG002|Overall Study|Death|4|||
126319615|NCT01546038|454461470|FG003|Overall Study|Death|2|||
126319616|NCT01546038|454461471|FG004|Overall Study|Death|9|||
126319617|NCT01546038|454461472|FG005|Overall Study|Death|3|||
126319618|NCT01546038|454461473|FG006|Overall Study|Death|46|||
126319619|NCT01546038|454461474|FG007|Overall Study|Death|76|||
126319620|NCT01546038|454461475|FG008|Overall Study|Death|39|||
126319621|NCT01546038|454461467|FG000|Overall Study|Lost to Follow-up|0|||
126319622|NCT01546038|454461468|FG001|Overall Study|Lost to Follow-up|0|||
126319623|NCT01546038|454461469|FG002|Overall Study|Lost to Follow-up|0|||
126319624|NCT01546038|454461470|FG003|Overall Study|Lost to Follow-up|0|||
126319625|NCT01546038|454461471|FG004|Overall Study|Lost to Follow-up|1|||
126319626|NCT01546038|454461472|FG005|Overall Study|Lost to Follow-up|0|||
126319627|NCT01546038|454461473|FG006|Overall Study|Lost to Follow-up|2|||
126319628|NCT01546038|454461474|FG007|Overall Study|Lost to Follow-up|1|||
126319629|NCT01546038|454461475|FG008|Overall Study|Lost to Follow-up|0|||
126319630|NCT01546038|454461467|FG000|Overall Study|Withdrawal by Subject|1|||
126319631|NCT01546038|454461468|FG001|Overall Study|Withdrawal by Subject|0|||
126319632|NCT01546038|454461469|FG002|Overall Study|Withdrawal by Subject|0|||
126319633|NCT01546038|454461470|FG003|Overall Study|Withdrawal by Subject|1|||
126319634|NCT01546038|454461471|FG004|Overall Study|Withdrawal by Subject|0|||
126319635|NCT01546038|454461472|FG005|Overall Study|Withdrawal by Subject|1|||
126319636|NCT01546038|454461473|FG006|Overall Study|Withdrawal by Subject|3|||
126319637|NCT01546038|454461474|FG007|Overall Study|Withdrawal by Subject|3|||
126319638|NCT01546038|454461475|FG008|Overall Study|Withdrawal by Subject|1|||
126319639|NCT01546038|454461467|FG000|Overall Study|: Randomized, not treated|0|||
126319640|NCT01546038|454461468|FG001|Overall Study|: Randomized, not treated|0|||
126319641|NCT01546038|454461469|FG002|Overall Study|: Randomized, not treated|0|||
126319642|NCT01546038|454461470|FG003|Overall Study|: Randomized, not treated|0|||
126319643|NCT01546038|454461471|FG004|Overall Study|: Randomized, not treated|0|||
126319644|NCT01546038|454461472|FG005|Overall Study|: Randomized, not treated|0|||
126319645|NCT01546038|454461473|FG006|Overall Study|: Randomized, not treated|2|||
126319646|NCT01546038|454461474|FG007|Overall Study|: Randomized, not treated|4|||
126319647|NCT01546038|454461475|FG008|Overall Study|: Randomized, not treated|3|||
126319648|NCT03329248|454461479|FG000|Overall Study|Progressive Disease|6|||
126319649|NCT01254721|454461480|FG000|Overall Study|Lost to Follow-up|0|||
126319650|NCT01254721|454461481|FG001|Overall Study|Lost to Follow-up|4|||
126319651|NCT01254721|454461480|FG000|Overall Study|Lack of Efficacy|4|||
126319652|NCT01254721|454461481|FG001|Overall Study|Lack of Efficacy|2|||
126319653|NCT01254721|454461480|FG000|Overall Study|Death|0|||
125878473|NCT05138653|452851312|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126319654|NCT01254721|454461481|FG001|Overall Study|Death|1|||
126319655|NCT01254721|454461480|FG000|Overall Study|technical problum|1|||
126319656|NCT01254721|454461481|FG001|Overall Study|technical problum|0|||
126319657|NCT01254721|454461480|FG000|Overall Study|Adverse Event|2|||
126319658|NCT01254721|454461481|FG001|Overall Study|Adverse Event|3|||
126319659|NCT01254721|454461480|FG000|Overall Study|Withdrawal by Subject|8|||
126319660|NCT01254721|454461481|FG001|Overall Study|Withdrawal by Subject|11|||
126319661|NCT01254721|454461480|FG000|Overall Study|Wrongly randomization|0|||
126319662|NCT01254721|454461481|FG001|Overall Study|Wrongly randomization|1|||
126319663|NCT00987402|454461482|FG000|Overall Study|Insufficient data entry|86|||
126319664|NCT00987402|454461483|FG001|Overall Study|Insufficient data entry|98|||
126319665|NCT01362517|454461488|FG000|Overall Study|Protocol Violation|1|||
126319666|NCT01362517|454461488|FG000|Overall Study|Lost to Follow-up|1|||
126319667|NCT03209518|454461491|FG000|Overall Study|Case Report Forms Uncollected|1|||
126319668|NCT03209518|454461491|FG000|Overall Study|Protocol Deviation|1|||
126319669|NCT00236899|454461492|FG000|Overall Study|Adverse Event (Study Related)|1|||
126319670|NCT00236899|454461493|FG001|Overall Study|Adverse Event (Study Related)|1|||
126319671|NCT00236899|454461494|FG002|Overall Study|Adverse Event (Study Related)|2|||
126319672|NCT00236899|454461495|FG003|Overall Study|Adverse Event (Study Related)|1|||
126319673|NCT00236899|454461492|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
126319674|NCT00236899|454461493|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
126319675|NCT00236899|454461494|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
126319676|NCT00236899|454461495|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
126319677|NCT00236899|454461492|FG000|Overall Study|Death (Study Disease)|1|||
126319678|NCT00236899|454461493|FG001|Overall Study|Death (Study Disease)|4|||
126319679|NCT00236899|454461494|FG002|Overall Study|Death (Study Disease)|0|||
126319680|NCT00236899|454461495|FG003|Overall Study|Death (Study Disease)|0|||
126319681|NCT00236899|454461492|FG000|Overall Study|Death (Not Study Related)|2|||
126319682|NCT00236899|454461493|FG001|Overall Study|Death (Not Study Related)|0|||
126319683|NCT00236899|454461494|FG002|Overall Study|Death (Not Study Related)|0|||
126319684|NCT00236899|454461495|FG003|Overall Study|Death (Not Study Related)|0|||
126319685|NCT00236899|454461492|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
126319686|NCT00236899|454461493|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
126319687|NCT00236899|454461494|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
126319688|NCT00236899|454461495|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
126319689|NCT00236899|454461492|FG000|Overall Study|Lost to Follow-up|0|||
126319690|NCT00236899|454461493|FG001|Overall Study|Lost to Follow-up|1|||
126319691|NCT00236899|454461494|FG002|Overall Study|Lost to Follow-up|0|||
126319692|NCT00236899|454461495|FG003|Overall Study|Lost to Follow-up|0|||
126319693|NCT00236899|454461492|FG000|Overall Study|Entry Criteria Exclusion|0|||
126319694|NCT00236899|454461493|FG001|Overall Study|Entry Criteria Exclusion|1|||
126319695|NCT00236899|454461494|FG002|Overall Study|Entry Criteria Exclusion|1|||
126319696|NCT00236899|454461495|FG003|Overall Study|Entry Criteria Exclusion|0|||
126319697|NCT00236899|454461492|FG000|Overall Study|Protocol Violation|1|||
126319698|NCT00236899|454461493|FG001|Overall Study|Protocol Violation|0|||
126319699|NCT00236899|454461494|FG002|Overall Study|Protocol Violation|0|||
126319700|NCT00236899|454461495|FG003|Overall Study|Protocol Violation|0|||
126319701|NCT00236899|454461492|FG000|Overall Study|Withdrawal by Subject|6|||
126319702|NCT00236899|454461493|FG001|Overall Study|Withdrawal by Subject|4|||
126319703|NCT00236899|454461494|FG002|Overall Study|Withdrawal by Subject|5|||
126319704|NCT00236899|454461495|FG003|Overall Study|Withdrawal by Subject|2|||
126319705|NCT00236899|454461492|FG000|Overall Study|Physician Decision|7|||
126319706|NCT00236899|454461493|FG001|Overall Study|Physician Decision|8|||
126319707|NCT00236899|454461494|FG002|Overall Study|Physician Decision|7|||
126319708|NCT00236899|454461495|FG003|Overall Study|Physician Decision|6|||
126319709|NCT00236899|454461492|FG000|Overall Study|Satisfactory Response|2|||
126319710|NCT00236899|454461493|FG001|Overall Study|Satisfactory Response|0|||
126319711|NCT00236899|454461494|FG002|Overall Study|Satisfactory Response|0|||
126319712|NCT00236899|454461495|FG003|Overall Study|Satisfactory Response|1|||
126319713|NCT00236899|454461492|FG000|Overall Study|Lack of Efficacy|18|||
126319714|NCT00236899|454461493|FG001|Overall Study|Lack of Efficacy|18|||
126319715|NCT00236899|454461494|FG002|Overall Study|Lack of Efficacy|25|||
126319716|NCT00236899|454461495|FG003|Overall Study|Lack of Efficacy|23|||
126319717|NCT03379792|454461497|FG000|Overall Study|Physician Decision|0|||
126319718|NCT03379792|454461498|FG001|Overall Study|Physician Decision|0|||
126319719|NCT03379792|454461499|FG002|Overall Study|Physician Decision|0|||
126319720|NCT03379792|454461500|FG003|Overall Study|Physician Decision|1|||
126319721|NCT03379792|454461501|FG004|Overall Study|Physician Decision|0|||
126319722|NCT03379792|454461502|FG005|Overall Study|Physician Decision|0|||
126319723|NCT03379792|454461497|FG000|Overall Study|Withdrawal by Subject|0|||
126319724|NCT03379792|454461498|FG001|Overall Study|Withdrawal by Subject|0|||
126319725|NCT03379792|454461499|FG002|Overall Study|Withdrawal by Subject|0|||
126319726|NCT03379792|454461500|FG003|Overall Study|Withdrawal by Subject|0|||
126319727|NCT03379792|454461501|FG004|Overall Study|Withdrawal by Subject|1|||
126319728|NCT03379792|454461502|FG005|Overall Study|Withdrawal by Subject|1|||
126319729|NCT01121536|454461503|FG000|Overall Study|Adverse Event|63|||
126319730|NCT01121536|454461503|FG000|Overall Study|Lack of Efficacy|35|||
125982750|NCT00394355|453226983|FG001|Overall Study|Did not meet protocol eligibility|5|||
125982751|NCT00394355|453226984|FG002|Overall Study|Did not meet protocol eligibility|4|||
126319731|NCT01121536|454461503|FG000|Overall Study|Withdrawal by Subject|65|||
126319732|NCT01121536|454461503|FG000|Overall Study|Protocol Violation|20|||
126319733|NCT01121536|454461503|FG000|Overall Study|Noncompliance with study medication|12|||
126319734|NCT01121536|454461503|FG000|Overall Study|Noncompliance with study procedures|9|||
126319735|NCT01121536|454461503|FG000|Overall Study|Lost to Follow-up|39|||
126319736|NCT01121536|454461503|FG000|Overall Study|Other|118|||
126319737|NCT02854605|454461504|FG000|Overall Study|Adverse Event|1|||
126319738|NCT02854605|454461505|FG001|Overall Study|Adverse Event|5|||
126319739|NCT02854605|454461506|FG002|Overall Study|Adverse Event|2|||
126319740|NCT02854605|454461504|FG000|Overall Study|Lost to Follow-up|0|||
126319741|NCT02854605|454461505|FG001|Overall Study|Lost to Follow-up|2|||
126319742|NCT02854605|454461506|FG002|Overall Study|Lost to Follow-up|0|||
126319743|NCT02854605|454461504|FG000|Overall Study|Withdrew Consent|1|||
126319744|NCT02854605|454461505|FG001|Overall Study|Withdrew Consent|0|||
126319745|NCT02854605|454461506|FG002|Overall Study|Withdrew Consent|1|||
126319746|NCT02854605|454461504|FG000|Overall Study|Investigator's Discretion|1|||
126319747|NCT02854605|454461505|FG001|Overall Study|Investigator's Discretion|0|||
125982752|NCT00394355|453226985|FG003|Overall Study|Did not meet protocol eligibility|2|||
125982753|NCT00394355|453226982|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
125982754|NCT00394355|453226983|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
125982755|NCT00394355|453226984|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
125982756|NCT00394355|453226985|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
125982757|NCT00394355|453226982|FG000|Overall Study|Subject withdrawal - related to drug|1|||
125982758|NCT00394355|453226983|FG001|Overall Study|Subject withdrawal - related to drug|0|||
125982759|NCT00394355|453226984|FG002|Overall Study|Subject withdrawal - related to drug|0|||
125982760|NCT00394355|453226985|FG003|Overall Study|Subject withdrawal - related to drug|0|||
125982761|NCT00394355|453226982|FG000|Overall Study|Lost to Follow-up|7|||
125982762|NCT00394355|453226983|FG001|Overall Study|Lost to Follow-up|5|||
125982763|NCT00394355|453226984|FG002|Overall Study|Lost to Follow-up|4|||
125982764|NCT00394355|453226985|FG003|Overall Study|Lost to Follow-up|3|||
125982765|NCT00394355|453226982|FG000|Overall Study|Noncompliance with protocol|4|||
125982766|NCT00394355|453226983|FG001|Overall Study|Noncompliance with protocol|3|||
125982767|NCT00394355|453226984|FG002|Overall Study|Noncompliance with protocol|10|||
125982768|NCT00394355|453226985|FG003|Overall Study|Noncompliance with protocol|8|||
125982769|NCT00394355|453226982|FG000|Overall Study|Administrative|0|||
125982770|NCT00394355|453226983|FG001|Overall Study|Administrative|1|||
125982771|NCT00394355|453226984|FG002|Overall Study|Administrative|1|||
126319748|NCT02854605|454461506|FG002|Overall Study|Investigator's Discretion|0|||
126319749|NCT02854605|454461504|FG000|Overall Study|Protocol Violation|0|||
126319750|NCT02854605|454461505|FG001|Overall Study|Protocol Violation|0|||
126319751|NCT02854605|454461506|FG002|Overall Study|Protocol Violation|1|||
126319752|NCT00568334|454461511|FG000|Overall Study|Withdrawal by Subject|0|||
126319753|NCT00568334|454461512|FG001|Overall Study|Withdrawal by Subject|1|||
126319754|NCT00568334|454461511|FG000|Overall Study|Lost to Follow-up|1|||
126319755|NCT00568334|454461512|FG001|Overall Study|Lost to Follow-up|0|||
126319756|NCT01897571|454461513|FG000|Overall Study|Lost to Follow-up|3|||
126319757|NCT01897571|454461514|FG001|Overall Study|Lost to Follow-up|0|||
126319758|NCT01897571|454461515|FG002|Overall Study|Lost to Follow-up|0|||
126319759|NCT01897571|454461516|FG003|Overall Study|Lost to Follow-up|0|||
126319760|NCT01897571|454461517|FG004|Overall Study|Lost to Follow-up|2|||
126319761|NCT01897571|454461518|FG005|Overall Study|Lost to Follow-up|0|||
126319762|NCT01897571|454461519|FG006|Overall Study|Lost to Follow-up|0|||
126319763|NCT01897571|454461520|FG007|Overall Study|Lost to Follow-up|0|||
126319764|NCT01897571|454461521|FG008|Overall Study|Lost to Follow-up|1|||
126319765|NCT01897571|454461522|FG009|Overall Study|Lost to Follow-up|2|||
126319766|NCT01897571|454461523|FG010|Overall Study|Lost to Follow-up|4|||
126319767|NCT01897571|454461513|FG000|Overall Study|Withdrawal by Subject|0|||
126319768|NCT01897571|454461514|FG001|Overall Study|Withdrawal by Subject|0|||
126319769|NCT01897571|454461515|FG002|Overall Study|Withdrawal by Subject|0|||
126319770|NCT01897571|454461516|FG003|Overall Study|Withdrawal by Subject|0|||
126319771|NCT01897571|454461517|FG004|Overall Study|Withdrawal by Subject|0|||
126319772|NCT01897571|454461518|FG005|Overall Study|Withdrawal by Subject|0|||
126319773|NCT01897571|454461519|FG006|Overall Study|Withdrawal by Subject|0|||
126319774|NCT01897571|454461520|FG007|Overall Study|Withdrawal by Subject|1|||
126319775|NCT01897571|454461521|FG008|Overall Study|Withdrawal by Subject|4|||
126319776|NCT01897571|454461522|FG009|Overall Study|Withdrawal by Subject|3|||
126319777|NCT01897571|454461523|FG010|Overall Study|Withdrawal by Subject|1|||
126319778|NCT01897571|454461513|FG000|Overall Study|Other|1|||
126319779|NCT01897571|454461514|FG001|Overall Study|Other|0|||
126319780|NCT01897571|454461515|FG002|Overall Study|Other|0|||
126319781|NCT01897571|454461516|FG003|Overall Study|Other|3|||
126319782|NCT01897571|454461517|FG004|Overall Study|Other|3|||
126319783|NCT01897571|454461518|FG005|Overall Study|Other|4|||
126319784|NCT01897571|454461519|FG006|Overall Study|Other|7|||
126319785|NCT01897571|454461520|FG007|Overall Study|Other|0|||
126319786|NCT01897571|454461521|FG008|Overall Study|Other|0|||
125982772|NCT00394355|453226985|FG003|Overall Study|Administrative|1|||
125982773|NCT00394355|453226982|FG000|Overall Study|Lack of Efficacy|0|||
126319787|NCT01897571|454461522|FG009|Overall Study|Other|0|||
126319788|NCT01897571|454461523|FG010|Overall Study|Other|0|||
126319789|NCT01897571|454461513|FG000|Overall Study|Enrolled in rollover study|0|||
126319790|NCT01897571|454461514|FG001|Overall Study|Enrolled in rollover study|0|||
126319791|NCT01897571|454461515|FG002|Overall Study|Enrolled in rollover study|0|||
126319792|NCT01897571|454461516|FG003|Overall Study|Enrolled in rollover study|0|||
126319793|NCT01897571|454461517|FG004|Overall Study|Enrolled in rollover study|0|||
126319794|NCT01897571|454461518|FG005|Overall Study|Enrolled in rollover study|0|||
126319795|NCT01897571|454461519|FG006|Overall Study|Enrolled in rollover study|0|||
126319796|NCT01897571|454461520|FG007|Overall Study|Enrolled in rollover study|9|||
126319797|NCT01897571|454461521|FG008|Overall Study|Enrolled in rollover study|7|||
125982774|NCT00394355|453226983|FG001|Overall Study|Lack of Efficacy|0|||
126319798|NCT01897571|454461522|FG009|Overall Study|Enrolled in rollover study|9|||
126319799|NCT01897571|454461523|FG010|Overall Study|Enrolled in rollover study|1|||
126319800|NCT01897571|454461513|FG000|Overall Study|Death|2|||
126319801|NCT01897571|454461514|FG001|Overall Study|Death|2|||
126319802|NCT01897571|454461515|FG002|Overall Study|Death|3|||
126319803|NCT01897571|454461516|FG003|Overall Study|Death|6|||
126319804|NCT01897571|454461517|FG004|Overall Study|Death|7|||
126319805|NCT01897571|454461518|FG005|Overall Study|Death|9|||
126319806|NCT01897571|454461519|FG006|Overall Study|Death|5|||
126319807|NCT01897571|454461520|FG007|Overall Study|Death|22|||
126319808|NCT01897571|454461521|FG008|Overall Study|Death|23|||
126319809|NCT01897571|454461522|FG009|Overall Study|Death|129|||
126319810|NCT01897571|454461523|FG010|Overall Study|Death|59|||
126319811|NCT00306787|454461525|FG000|Overall Study|Discontinued without taking study drug|208|||
126319812|NCT00306787|454461526|FG001|Overall Study|Discontinued without taking study drug|215|||
126319813|NCT00306787|454461525|FG000|Overall Study|Adverse Event|1|||
126319814|NCT00306787|454461526|FG001|Overall Study|Adverse Event|1|||
126319815|NCT00306787|454461525|FG000|Overall Study|Lack of Efficacy|1|||
126319816|NCT00306787|454461526|FG001|Overall Study|Lack of Efficacy|0|||
126319817|NCT00306787|454461525|FG000|Overall Study|Protocol Violation|8|||
126319818|NCT00306787|454461526|FG001|Overall Study|Protocol Violation|10|||
126319819|NCT00306787|454461525|FG000|Overall Study|Withdrawal by Subject|2|||
126319820|NCT00306787|454461526|FG001|Overall Study|Withdrawal by Subject|9|||
126319821|NCT00306787|454461525|FG000|Overall Study|Lost to Follow-up|9|||
126319822|NCT00306787|454461526|FG001|Overall Study|Lost to Follow-up|6|||
126319823|NCT00306787|454461525|FG000|Overall Study|Administrative problems|4|||
126319824|NCT00306787|454461526|FG001|Overall Study|Administrative problems|0|||
126319825|NCT00306787|454461525|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126319826|NCT00306787|454461526|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126319827|NCT02273908|454461527|FG000|Overall Study|Adverse Event|16|||
126319828|NCT02273908|454461528|FG001|Overall Study|Adverse Event|0|||
126319829|NCT02273908|454461527|FG000|Overall Study|Lost to Follow-up|10|||
126319830|NCT02273908|454461528|FG001|Overall Study|Lost to Follow-up|1|||
126319831|NCT02273908|454461527|FG000|Overall Study|Did not meet entrance criteria|3|||
126319832|NCT02273908|454461528|FG001|Overall Study|Did not meet entrance criteria|2|||
126319833|NCT02273908|454461527|FG000|Overall Study|Withdrawal by Subject|4|||
126319834|NCT02273908|454461528|FG001|Overall Study|Withdrawal by Subject|2|||
126319835|NCT04908475|454461529|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
126319836|NCT04908475|454461530|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319837|NCT04908475|454461531|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319838|NCT04908475|454461532|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319839|NCT04908475|454461533|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319840|NCT04908475|454461534|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319841|NCT04908475|454461529|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
126319842|NCT04908475|454461530|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319843|NCT04908475|454461531|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319844|NCT04908475|454461532|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319845|NCT04908475|454461533|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319846|NCT04908475|454461534|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319847|NCT04908475|454461529|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
126319848|NCT04908475|454461530|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319849|NCT04908475|454461531|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319850|NCT04908475|454461532|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319851|NCT04908475|454461533|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319852|NCT04908475|454461534|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319853|NCT04908475|454461529|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126319854|NCT04908475|454461530|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
126319855|NCT04908475|454461531|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
126319856|NCT04908475|454461532|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
126319857|NCT04908475|454461533|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126319858|NCT04908475|454461534|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126319859|NCT04908475|454461529|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
126319860|NCT04908475|454461530|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
126319861|NCT04908475|454461531|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
126319862|NCT04908475|454461532|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
126319863|NCT04908475|454461533|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
126319864|NCT04908475|454461534|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
126319865|NCT04908475|454461529|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
126319866|NCT04908475|454461530|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
126319867|NCT04908475|454461531|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
126319868|NCT04908475|454461532|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
126319869|NCT04908475|454461533|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
126319870|NCT04908475|454461534|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
126319871|NCT03913104|454461537|FG000|Overall Study|Lost to Follow-up|20|||
125982775|NCT00394355|453226984|FG002|Overall Study|Lack of Efficacy|2|||
125982776|NCT00394355|453226985|FG003|Overall Study|Lack of Efficacy|3|||
125982777|NCT01648348|453226988|FG000|Overall Study|Cancel|1|||
125982778|NCT01648348|453226989|FG001|Overall Study|Cancel|0|||
125982779|NCT01648348|453226990|FG002|Overall Study|Cancel|0|||
126319872|NCT03913104|454461537|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
126319873|NCT03913104|454461537|FG000|Overall Study|Withdrawal by Subject|2|||
126319874|NCT00089635|454461538|FG000|Overall Study|Adverse Event|2|||
126319875|NCT00089635|454461538|FG000|Overall Study|Death|17|||
126319876|NCT00089635|454461538|FG000|Overall Study|Disease Progression|12|||
126319877|NCT00089635|454461538|FG000|Overall Study|Lost to Follow-up|3|||
126319878|NCT00089635|454461538|FG000|Overall Study|Withdrawal by Subject|6|||
126319879|NCT00089635|454461538|FG000|Overall Study|Ineligibility determined|1|||
126319880|NCT00089635|454461538|FG000|Overall Study|Other|2|||
126319881|NCT01593254|454461542|FG000|Overall Study|Disease progression|2|||
126319882|NCT01593254|454461543|FG001|Overall Study|Disease progression|7|||
126319883|NCT01593254|454461542|FG000|Overall Study|Study drug toxicity|6|||
126319884|NCT01593254|454461543|FG001|Overall Study|Study drug toxicity|20|||
126319885|NCT01593254|454461542|FG000|Overall Study|Death|3|||
126319886|NCT01593254|454461543|FG001|Overall Study|Death|3|||
126319887|NCT01593254|454461542|FG000|Overall Study|AE unrelated to study drug|0|||
126319888|NCT01593254|454461543|FG001|Overall Study|AE unrelated to study drug|1|||
126319889|NCT01593254|454461542|FG000|Overall Study|participant request to discontinue study treatment|1|||
126319890|NCT01593254|454461543|FG001|Overall Study|participant request to discontinue study treatment|3|||
126319891|NCT01593254|454461542|FG000|Overall Study|participant withdrew consent|0|||
126319892|NCT01593254|454461543|FG001|Overall Study|participant withdrew consent|9|||
126319893|NCT01593254|454461542|FG000|Overall Study|lost to follow up|1|||
126319894|NCT01593254|454461543|FG001|Overall Study|lost to follow up|6|||
126319895|NCT01593254|454461542|FG000|Overall Study|maximum clinical benefit|1|||
126319896|NCT01593254|454461543|FG001|Overall Study|maximum clinical benefit|2|||
126319897|NCT01593254|454461542|FG000|Overall Study|Poor/non compliance|1|||
126319898|NCT01593254|454461543|FG001|Overall Study|Poor/non compliance|1|||
126319899|NCT01593254|454461542|FG000|Overall Study|Pregnancy|0|||
126319900|NCT01593254|454461543|FG001|Overall Study|Pregnancy|3|||
126319901|NCT01593254|454461542|FG000|Overall Study|participant no longer meets study criteria|1|||
126319902|NCT01593254|454461543|FG001|Overall Study|participant no longer meets study criteria|1|||
126319903|NCT01593254|454461542|FG000|Overall Study|Admin reason by sponsor|7|||
126319904|NCT01593254|454461543|FG001|Overall Study|Admin reason by sponsor|3|||
126319905|NCT01593254|454461542|FG000|Overall Study|Imatinib treatment failure|2|||
126319906|NCT01593254|454461543|FG001|Overall Study|Imatinib treatment failure|0|||
126319907|NCT01593254|454461542|FG000|Overall Study|Other Reasons|61|||
126319908|NCT01593254|454461543|FG001|Overall Study|Other Reasons|115|||
126319909|NCT00076999|454461548|FG000|Overall Study|Adverse Event|2|||
126319910|NCT00076999|454461549|FG001|Overall Study|Adverse Event|8|||
126319911|NCT00076999|454461550|FG002|Overall Study|Adverse Event|6|||
126319912|NCT00076999|454461551|FG003|Overall Study|Adverse Event|0|||
126319913|NCT00076999|454461552|FG004|Overall Study|Adverse Event|2|||
126319914|NCT00076999|454461548|FG000|Overall Study|Protocol Violation|0|||
126319915|NCT00076999|454461549|FG001|Overall Study|Protocol Violation|3|||
126319916|NCT00076999|454461550|FG002|Overall Study|Protocol Violation|4|||
126319917|NCT00076999|454461551|FG003|Overall Study|Protocol Violation|0|||
126319918|NCT00076999|454461552|FG004|Overall Study|Protocol Violation|9|||
126319919|NCT00076999|454461548|FG000|Overall Study|Lost to Follow-up|2|||
126319920|NCT00076999|454461549|FG001|Overall Study|Lost to Follow-up|1|||
126319921|NCT00076999|454461550|FG002|Overall Study|Lost to Follow-up|0|||
126319922|NCT00076999|454461551|FG003|Overall Study|Lost to Follow-up|0|||
126319923|NCT00076999|454461552|FG004|Overall Study|Lost to Follow-up|0|||
126319924|NCT00076999|454461548|FG000|Overall Study|Withdrawal by Subject|0|||
126319925|NCT00076999|454461549|FG001|Overall Study|Withdrawal by Subject|4|||
126319926|NCT00076999|454461550|FG002|Overall Study|Withdrawal by Subject|3|||
126319927|NCT00076999|454461551|FG003|Overall Study|Withdrawal by Subject|0|||
126319928|NCT00076999|454461552|FG004|Overall Study|Withdrawal by Subject|1|||
125982780|NCT01648348|453226991|FG003|Overall Study|Cancel|0|||
125982781|NCT01648348|453226992|FG004|Overall Study|Cancel|3|||
125982782|NCT01648348|453226993|FG005|Overall Study|Cancel|6|||
126319929|NCT00076999|454461548|FG000|Overall Study|Other reason (not specified)|8|||
126319930|NCT00076999|454461549|FG001|Overall Study|Other reason (not specified)|8|||
126319931|NCT00076999|454461550|FG002|Overall Study|Other reason (not specified)|4|||
126319932|NCT00076999|454461551|FG003|Overall Study|Other reason (not specified)|1|||
126319933|NCT00076999|454461552|FG004|Overall Study|Other reason (not specified)|13|||
126319934|NCT01857102|454461554|FG000|Period 1|No longer meets Eligibility Criteria|0|||
126319935|NCT01857102|454461555|FG001|Period 1|No longer meets Eligibility Criteria|2|||
126319936|NCT01857102|454461554|FG000|Period 1|Lost to Follow-up|0|||
126319937|NCT01857102|454461555|FG001|Period 1|Lost to Follow-up|3|||
126319938|NCT01857102|454461554|FG000|Period 1|Unsatisfactory Lens Fit|1|||
126319939|NCT01857102|454461555|FG001|Period 1|Unsatisfactory Lens Fit|0|||
126319940|NCT01857102|454461554|FG000|Period 1|Unsatisfactory Visual Response|1|||
126319941|NCT01857102|454461555|FG001|Period 1|Unsatisfactory Visual Response|0|||
126319942|NCT01857102|454461554|FG000|Period 1|Physician Decision|1|||
126319943|NCT01857102|454461555|FG001|Period 1|Physician Decision|0|||
126319944|NCT01857102|454461554|FG000|Period 2|Lens Discomfort|1|||
126319945|NCT01857102|454461555|FG001|Period 2|Lens Discomfort|0|||
126319946|NCT01857102|454461554|FG000|Period 2|Unsatisfactory Lens Fit|1|||
126319947|NCT01857102|454461555|FG001|Period 2|Unsatisfactory Lens Fit|0|||
126319948|NCT02603562|454461560|FG000|Overall Study|Lost to Follow-up|1|||
126319949|NCT03564795|454461572|FG000|Overall Study|Withdrawal by Subject|3|||
126319950|NCT03564795|454461572|FG000|Overall Study|Lost to Follow-up|6|||
126319951|NCT03564795|454461572|FG000|Overall Study|Physician Decision|2|||
126319952|NCT02906033|454461577|FG000|Baseline|Protocol Violation|37|||
126319953|NCT02906033|454461578|FG001|Baseline|Protocol Violation|33|||
126319954|NCT02906033|454461577|FG000|Follow-up|Lost to Follow-up|46|||
126319955|NCT02906033|454461578|FG001|Follow-up|Lost to Follow-up|62|||
126319956|NCT00386425|454461580|FG000|Overall Study|Physician Decision|3|||
126319957|NCT00386425|454461581|FG001|Overall Study|Physician Decision|0|||
126319958|NCT00386425|454461582|FG002|Overall Study|Physician Decision|0|||
126319959|NCT00386425|454461580|FG000|Overall Study|Withdrawal by Subject|0|||
126319960|NCT00386425|454461581|FG001|Overall Study|Withdrawal by Subject|1|||
126319961|NCT00386425|454461582|FG002|Overall Study|Withdrawal by Subject|0|||
126319962|NCT02678000|454461583|FG000|PART 2|Adverse Event|0|||
126319963|NCT02678000|454461584|FG001|PART 2|Adverse Event|0|||
126319964|NCT02678000|454461585|FG002|PART 2|Adverse Event|2|||
126319965|NCT02678000|454461586|FG003|PART 2|Adverse Event|1|||
126319966|NCT02678000|454461587|FG004|PART 2|Adverse Event|0|||
126319967|NCT02678000|454461583|FG000|PART 2|Withdrawal by Subject|0|||
126319968|NCT02678000|454461584|FG001|PART 2|Withdrawal by Subject|0|||
126319969|NCT02678000|454461585|FG002|PART 2|Withdrawal by Subject|1|||
126319970|NCT02678000|454461586|FG003|PART 2|Withdrawal by Subject|0|||
126319971|NCT02678000|454461587|FG004|PART 2|Withdrawal by Subject|0|||
126319972|NCT01324570|454461589|FG000|Overall Study|Adverse Event|4|||
126319973|NCT01324570|454461590|FG001|Overall Study|Adverse Event|7|||
126319974|NCT01324570|454461589|FG000|Overall Study|Withdrawal by Subject|0|||
126319975|NCT01324570|454461590|FG001|Overall Study|Withdrawal by Subject|3|||
126319976|NCT01324570|454461589|FG000|Overall Study|Lack of Efficacy|0|||
126319977|NCT01324570|454461590|FG001|Overall Study|Lack of Efficacy|1|||
126319978|NCT01324570|454461589|FG000|Overall Study|Confirmed or suspected diversion|0|||
126319979|NCT01324570|454461590|FG001|Overall Study|Confirmed or suspected diversion|1|||
126319980|NCT01324570|454461589|FG000|Overall Study|Administrative|0|||
126319981|NCT01324570|454461590|FG001|Overall Study|Administrative|2|||
126319982|NCT02360475|454461593|FG000|Overall Study|Lost to Follow-up|4|||
126319983|NCT02360475|454461594|FG001|Overall Study|Lost to Follow-up|12|||
126319984|NCT02360475|454461595|FG002|Overall Study|Lost to Follow-up|6|||
126319985|NCT02360475|454461596|FG003|Overall Study|Lost to Follow-up|4|||
126319986|NCT02360475|454461593|FG000|Overall Study|Withdrawal by Subject|0|||
126319987|NCT02360475|454461594|FG001|Overall Study|Withdrawal by Subject|1|||
126319988|NCT02360475|454461595|FG002|Overall Study|Withdrawal by Subject|2|||
126319989|NCT02360475|454461596|FG003|Overall Study|Withdrawal by Subject|0|||
126319990|NCT02360475|454461593|FG000|Overall Study|Migrated/moved from study area|0|||
126319991|NCT02360475|454461594|FG001|Overall Study|Migrated/moved from study area|0|||
126319992|NCT02360475|454461595|FG002|Overall Study|Migrated/moved from study area|0|||
126319993|NCT02360475|454461596|FG003|Overall Study|Migrated/moved from study area|1|||
126319994|NCT00207727|454461597|FG000|Overall Study|Withdrawal by Subject|0|||
126319995|NCT00207727|454461598|FG001|Overall Study|Withdrawal by Subject|0|||
126319996|NCT00207727|454461599|FG002|Overall Study|Withdrawal by Subject|0|||
126319997|NCT00207727|454461600|FG003|Overall Study|Withdrawal by Subject|0|||
126319998|NCT00207727|454461601|FG004|Overall Study|Withdrawal by Subject|1|||
126319999|NCT00207727|454461597|FG000|Overall Study|Lost to Follow-up|0|||
126320000|NCT00207727|454461598|FG001|Overall Study|Lost to Follow-up|1|||
126320001|NCT00207727|454461599|FG002|Overall Study|Lost to Follow-up|0|||
126320002|NCT00207727|454461600|FG003|Overall Study|Lost to Follow-up|0|||
126320003|NCT00207727|454461601|FG004|Overall Study|Lost to Follow-up|0|||
126320004|NCT00207727|454461597|FG000|Overall Study|Other|38|||
126320005|NCT00207727|454461598|FG001|Overall Study|Other|41|||
126320006|NCT00207727|454461599|FG002|Overall Study|Other|41|||
126320007|NCT00207727|454461600|FG003|Overall Study|Other|37|||
126320008|NCT00207727|454461601|FG004|Overall Study|Other|33|||
126320009|NCT00435019|454461606|FG000|Overall Study|Adverse Event|1|||
126320010|NCT00435019|454461607|FG001|Overall Study|Adverse Event|0|||
126320011|NCT00435019|454461606|FG000|Overall Study|Lack of Efficacy|1|||
126320012|NCT00435019|454461607|FG001|Overall Study|Lack of Efficacy|2|||
126320013|NCT00435019|454461606|FG000|Overall Study|Protocol Violation|3|||
126320014|NCT00435019|454461607|FG001|Overall Study|Protocol Violation|1|||
126320015|NCT00435019|454461606|FG000|Overall Study|Personal reasons for withdrawal|8|||
126320016|NCT00435019|454461607|FG001|Overall Study|Personal reasons for withdrawal|7|||
126320017|NCT02440854|454461611|FG000|Overall Study|Relocation of patient|1|||
126320018|NCT02440854|454461611|FG000|Overall Study|Death|6|||
126320019|NCT02440854|454461611|FG000|Overall Study|Lost to Follow-up|10|||
126320020|NCT02440854|454461611|FG000|Overall Study|Afatinib discontinuation|46|||
125982783|NCT01648348|453226988|FG000|Overall Study|Replaced for MTD analysis|1|||
125982784|NCT01648348|453226989|FG001|Overall Study|Replaced for MTD analysis|0|||
125982785|NCT01648348|453226990|FG002|Overall Study|Replaced for MTD analysis|1|||
125982786|NCT01648348|453226991|FG003|Overall Study|Replaced for MTD analysis|0|||
125982787|NCT01648348|453226992|FG004|Overall Study|Replaced for MTD analysis|0|||
125982788|NCT01648348|453226993|FG005|Overall Study|Replaced for MTD analysis|0|||
125982789|NCT00459342|453226995|FG000|Overall Study|Not eligible|1|||
125982790|NCT02686034|453226996|FG000|Run-In Period 1|Eligibility|12|||
125982791|NCT02686034|453226997|FG001|Run-In Period 1|Eligibility|10|||
125982792|NCT02686034|453226996|FG000|Run-In Period 1|Withdrawal by Subject|4|||
125982793|NCT02686034|453226997|FG001|Run-In Period 1|Withdrawal by Subject|3|||
125982794|NCT02686034|453226996|FG000|Run-In Period 1|Lost to Follow-up|4|||
125982795|NCT02686034|453226997|FG001|Run-In Period 1|Lost to Follow-up|4|||
125982796|NCT02686034|453226996|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
125982797|NCT02686034|453226997|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
125982798|NCT02686034|453226996|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
125982799|NCT02686034|453226997|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
125982800|NCT02686034|453226996|FG000|Randomized Controlled Period 2|Adverse Event|0|||
125982801|NCT02686034|453226997|FG001|Randomized Controlled Period 2|Adverse Event|2|||
125982802|NCT02686034|453226996|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
125982803|NCT02686034|453226997|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
125982804|NCT02686034|453226996|FG000|Open Label Period 3|Lost to Follow-up|0|||
125982805|NCT02686034|453226997|FG001|Open Label Period 3|Lost to Follow-up|1|||
125982806|NCT00766675|453228196|FG000|Overall Study|Adverse Event|16|||
125982807|NCT00766675|453228196|FG000|Overall Study|Lost to Follow-up|2|||
125982808|NCT00766675|453228196|FG000|Overall Study|Withdrawal by Subject|11|||
125982809|NCT00766675|453228196|FG000|Overall Study|Protocol Violation|8|||
125982810|NCT00766675|453228196|FG000|Overall Study|Participant took prohibited medication|1|||
125982811|NCT00766675|453228196|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
125982812|NCT00766675|453228196|FG000|Overall Study|Insufficient therapy|1|||
125982813|NCT02240108|453228197|FG000|Overall Study|Other than specified|8|||
125982814|NCT02240108|453228198|FG001|Overall Study|Other than specified|6|||
125982815|NCT02240108|453228197|FG000|Overall Study|Adverse Event|1|||
125982816|NCT02240108|453228198|FG001|Overall Study|Adverse Event|9|||
125982817|NCT02240108|453228197|FG000|Overall Study|Pregnancy|1|||
125982818|NCT02240108|453228198|FG001|Overall Study|Pregnancy|0|||
125982819|NCT02240108|453228197|FG000|Overall Study|Withdrawal by Subject|4|||
125982820|NCT02240108|453228198|FG001|Overall Study|Withdrawal by Subject|9|||
125982821|NCT02240108|453228197|FG000|Overall Study|StudyTerminated by Sponsor|0|||
125982822|NCT02240108|453228198|FG001|Overall Study|StudyTerminated by Sponsor|1|||
125982823|NCT01345630|453228199|FG000|Overall Study|Adverse Event|22|||
125982824|NCT01345630|453228200|FG001|Overall Study|Adverse Event|23|||
125982825|NCT01345630|453228199|FG000|Overall Study|Lost to Follow-up|17|||
125982826|NCT01345630|453228200|FG001|Overall Study|Lost to Follow-up|16|||
125982827|NCT01345630|453228199|FG000|Overall Study|Protocol Violation|4|||
125982828|NCT01345630|453228200|FG001|Overall Study|Protocol Violation|1|||
125982829|NCT01345630|453228199|FG000|Overall Study|Medication error without associated AE|0|||
125982830|NCT01345630|453228200|FG001|Overall Study|Medication error without associated AE|1|||
125982831|NCT01345630|453228199|FG000|Overall Study|Study terminated by sponsor|254|||
125982832|NCT01345630|453228200|FG001|Overall Study|Study terminated by sponsor|285|||
125982833|NCT01345630|453228199|FG000|Overall Study|Other reasons|6|||
125982834|NCT01345630|453228200|FG001|Overall Study|Other reasons|8|||
125982835|NCT01345630|453228199|FG000|Overall Study|Withdrawn due to pregnancy|1|||
125982836|NCT01345630|453228200|FG001|Overall Study|Withdrawn due to pregnancy|2|||
125982837|NCT01345630|453228199|FG000|Overall Study|No longer willing to participate|9|||
125982838|NCT01345630|453228200|FG001|Overall Study|No longer willing to participate|12|||
125982839|NCT01345630|453228199|FG000|Overall Study|Insufficient clinical response|48|||
125982840|NCT01345630|453228200|FG001|Overall Study|Insufficient clinical response|11|||
125982841|NCT04233372|453228201|FG000|Overall Study|Lost to Follow-up|104|||
125982842|NCT04233372|453228201|FG000|Overall Study|Adverse Event|8|||
126320021|NCT02440854|454461611|FG000|Overall Study|stopped study at earlier timepoint|14|||
125982843|NCT04233372|453228201|FG000|Overall Study|Withdrawal by Subject|2|||
125982844|NCT03938454|453228202|FG000|Overall Study|Protocol Violation|1|||
125982845|NCT03938454|453228202|FG000|Overall Study|Withdrawal by Subject|2|||
125982846|NCT03938454|453228202|FG000|Overall Study|Lost to Follow-up|3|||
126320022|NCT02440854|454461611|FG000|Overall Study|Study medication not received|1|||
125982847|NCT01090310|453228203|FG000|Core Study|Adverse Event|2|||
125982848|NCT01090310|453228204|FG001|Core Study|Adverse Event|2|||
125982849|NCT01090310|453228205|FG002|Core Study|Adverse Event|1|||
125982850|NCT01090310|453228206|FG003|Core Study|Adverse Event|1|||
125982851|NCT01090310|453228203|FG000|Core Study|Subject withdrew consent|0|||
125982852|NCT01090310|453228204|FG001|Core Study|Subject withdrew consent|3|||
125982853|NCT01090310|453228205|FG002|Core Study|Subject withdrew consent|1|||
125982854|NCT01090310|453228206|FG003|Core Study|Subject withdrew consent|1|||
125982855|NCT01090310|453228203|FG000|Core Study|Abnormal test procedure result|0|||
126320023|NCT02440854|454461611|FG000|Overall Study|Violation of inclusion criteria|2|||
126320024|NCT02669082|454461612|FG000|Overall Study|Adverse Event|1|||
126320025|NCT04852276|454461613|FG000|Overall Study|Death|2|||
126320026|NCT04852276|454461614|FG001|Overall Study|Death|0|||
126320027|NCT04852276|454461613|FG000|Overall Study|Lost to Follow-up|15|||
126320028|NCT04852276|454461614|FG001|Overall Study|Lost to Follow-up|9|||
126320029|NCT04852276|454461613|FG000|Overall Study|Withdrawal by Subject|26|||
126320030|NCT04852276|454461614|FG001|Overall Study|Withdrawal by Subject|6|||
126320031|NCT02824562|454463942|FG000|Overall Study|Lost to Follow-up|3|||
126320032|NCT02824562|454463943|FG001|Overall Study|Lost to Follow-up|4|||
126320033|NCT02824562|454463942|FG000|Overall Study|Death|0|||
126320034|NCT02824562|454463943|FG001|Overall Study|Death|1|||
126320035|NCT05243563|454463944|FG000|Overall Study|Withdrawal by Subject|1|||
126320036|NCT05243563|454463945|FG001|Overall Study|Withdrawal by Subject|0|||
126320037|NCT05243563|454463944|FG000|Overall Study|Physician Decision|1|||
126320038|NCT05243563|454463945|FG001|Overall Study|Physician Decision|0|||
126320039|NCT03774394|454463946|FG000|Overall Study|Withdrawal by Subject|2|||
126320040|NCT03774394|454463947|FG001|Overall Study|Withdrawal by Subject|0|||
126320041|NCT02864316|454463950|FG000|Overall Study|Progressive Disease|2|||
126320042|NCT02864316|454463951|FG001|Overall Study|Progressive Disease|1|||
126320043|NCT02864316|454463950|FG000|Overall Study|Adverse Event|0|||
126320044|NCT02864316|454463951|FG001|Overall Study|Adverse Event|1|||
126320045|NCT00298363|454463952|FG000|Overall Study|Lost to Follow-up|0|||
126320046|NCT00298363|454463953|FG001|Overall Study|Lost to Follow-up|0|||
126320047|NCT00298363|454463954|FG002|Overall Study|Lost to Follow-up|1|||
126320048|NCT00298363|454463952|FG000|Overall Study|Physician Decision|4|||
126320049|NCT00298363|454463953|FG001|Overall Study|Physician Decision|1|||
126320050|NCT00298363|454463954|FG002|Overall Study|Physician Decision|0|||
126320051|NCT00298363|454463952|FG000|Overall Study|Protocol Violation|1|||
125982856|NCT01090310|453228204|FG001|Core Study|Abnormal test procedure result|0|||
125982857|NCT01090310|453228205|FG002|Core Study|Abnormal test procedure result|1|||
125982858|NCT01090310|453228206|FG003|Core Study|Abnormal test procedure result|0|||
126320052|NCT00298363|454463953|FG001|Overall Study|Protocol Violation|1|||
126320053|NCT00298363|454463954|FG002|Overall Study|Protocol Violation|0|||
126320054|NCT00298363|454463952|FG000|Overall Study|Withdrawal by Subject|5|||
126320055|NCT00298363|454463953|FG001|Overall Study|Withdrawal by Subject|1|||
126320056|NCT00298363|454463954|FG002|Overall Study|Withdrawal by Subject|3|||
126320057|NCT00298363|454463952|FG000|Overall Study|Adverse Event|5|||
126320058|NCT00298363|454463953|FG001|Overall Study|Adverse Event|2|||
126320059|NCT00298363|454463954|FG002|Overall Study|Adverse Event|2|||
126320060|NCT00298363|454463952|FG000|Overall Study|Lack of Efficacy|2|||
126320061|NCT00298363|454463953|FG001|Overall Study|Lack of Efficacy|3|||
126320062|NCT00298363|454463954|FG002|Overall Study|Lack of Efficacy|0|||
126320063|NCT04710368|454463955|FG000|Overall Study|Withdrawal by Subject|9|||
126320064|NCT04710368|454463955|FG000|Overall Study|Lost to Follow-up|4|||
126320065|NCT04710368|454463955|FG000|Overall Study|Death|2|||
126320066|NCT04710368|454463955|FG000|Overall Study|Patient preference|11|||
126320067|NCT04710368|454463955|FG000|Overall Study|Treatment discontinuation|1|||
126320068|NCT00135356|454463956|FG000|Overall Study|Adverse Event|6|||
126320069|NCT00135356|454463957|FG001|Overall Study|Adverse Event|2|||
126320070|NCT00135356|454463956|FG000|Overall Study|Lack of Efficacy|2|||
126320071|NCT00135356|454463957|FG001|Overall Study|Lack of Efficacy|0|||
126320072|NCT00135356|454463956|FG000|Overall Study|Lost to Follow-up|3|||
126320073|NCT00135356|454463957|FG001|Overall Study|Lost to Follow-up|1|||
126320074|NCT00135356|454463956|FG000|Overall Study|Surgery for abdominal fat|1|||
126320075|NCT00135356|454463957|FG001|Overall Study|Surgery for abdominal fat|0|||
126320076|NCT00135356|454463956|FG000|Overall Study|Change in antiviral regimen|0|||
126320077|NCT00135356|454463957|FG001|Overall Study|Change in antiviral regimen|1|||
126320078|NCT00135356|454463956|FG000|Overall Study|Poor/noncompliance|1|||
126320079|NCT00135356|454463957|FG001|Overall Study|Poor/noncompliance|1|||
126320080|NCT00135356|454463956|FG000|Overall Study|No longer meets study criteria|2|||
125982859|NCT01090310|453228203|FG000|Core Study|Administrative reasons|5|||
126320081|NCT00135356|454463957|FG001|Overall Study|No longer meets study criteria|0|||
126320082|NCT00135356|454463956|FG000|Overall Study|Withdrawal by Subject|2|||
126320083|NCT00135356|454463957|FG001|Overall Study|Withdrawal by Subject|4|||
126320084|NCT00153816|454463958|FG000|Overall Study|Death|6|||
126320085|NCT00153816|454463959|FG001|Overall Study|Death|5|||
126320086|NCT00153816|454463960|FG002|Overall Study|Death|4|||
126320087|NCT00153816|454463961|FG003|Overall Study|Death|6|||
126320088|NCT00153816|454463962|FG004|Overall Study|Death|0|||
125982860|NCT01090310|453228204|FG001|Core Study|Administrative reasons|6|||
125982861|NCT01090310|453228205|FG002|Core Study|Administrative reasons|4|||
126320089|NCT00153816|454463963|FG005|Overall Study|Death|2|||
125982862|NCT01090310|453228206|FG003|Core Study|Administrative reasons|4|||
126320090|NCT00153816|454463958|FG000|Overall Study|Lost to Follow-up|7|||
126320091|NCT00153816|454463959|FG001|Overall Study|Lost to Follow-up|8|||
126320092|NCT00153816|454463960|FG002|Overall Study|Lost to Follow-up|5|||
126320093|NCT00153816|454463961|FG003|Overall Study|Lost to Follow-up|8|||
126320094|NCT00153816|454463962|FG004|Overall Study|Lost to Follow-up|7|||
126320095|NCT00153816|454463963|FG005|Overall Study|Lost to Follow-up|9|||
126320096|NCT00153816|454463958|FG000|Overall Study|Withdrawal by Subject|9|||
126320097|NCT00153816|454463959|FG001|Overall Study|Withdrawal by Subject|9|||
126320098|NCT00153816|454463960|FG002|Overall Study|Withdrawal by Subject|9|||
126320099|NCT00153816|454463961|FG003|Overall Study|Withdrawal by Subject|4|||
126320100|NCT00153816|454463962|FG004|Overall Study|Withdrawal by Subject|1|||
126320101|NCT00153816|454463963|FG005|Overall Study|Withdrawal by Subject|5|||
126320102|NCT00153816|454463958|FG000|Overall Study|Follow-up exam not done|8|||
126320103|NCT00153816|454463959|FG001|Overall Study|Follow-up exam not done|7|||
126320104|NCT00153816|454463960|FG002|Overall Study|Follow-up exam not done|11|||
126320105|NCT00153816|454463961|FG003|Overall Study|Follow-up exam not done|10|||
126320106|NCT00153816|454463962|FG004|Overall Study|Follow-up exam not done|8|||
126320107|NCT00153816|454463963|FG005|Overall Study|Follow-up exam not done|9|||
126320108|NCT00153816|454463958|FG000|Overall Study|Follow-up exam done, histology missing|2|||
126320109|NCT00153816|454463959|FG001|Overall Study|Follow-up exam done, histology missing|3|||
126320110|NCT00153816|454463960|FG002|Overall Study|Follow-up exam done, histology missing|3|||
126320111|NCT00153816|454463961|FG003|Overall Study|Follow-up exam done, histology missing|3|||
126320112|NCT00153816|454463962|FG004|Overall Study|Follow-up exam done, histology missing|1|||
126320113|NCT00153816|454463963|FG005|Overall Study|Follow-up exam done, histology missing|2|||
126320114|NCT01887288|454463968|FG000|Overall Study|The study was terminated and the PI has|16|||
126320115|NCT00253370|454463971|FG000|Overall Study|Adverse Event|18|||
126320116|NCT00253370|454463971|FG000|Overall Study|Disease progression|13|||
126320117|NCT00253370|454463971|FG000|Overall Study|Death|2|||
126320118|NCT00253370|454463971|FG000|Overall Study|Withdrawal by Subject|6|||
126320119|NCT00253370|454463971|FG000|Overall Study|Non-protocol therapy|1|||
126320120|NCT00253370|454463971|FG000|Overall Study|Physician Decision|1|||
126320121|NCT00253370|454463971|FG000|Overall Study|Protocol Violation|1|||
126320122|NCT00253370|454463971|FG000|Overall Study|Abdominal pain due to disease|1|||
126320123|NCT05916131|454463972|FG000|Overall Study|Lost to Follow-up|0|||
126320124|NCT05916131|454463973|FG001|Overall Study|Lost to Follow-up|0|||
126320125|NCT05916131|454463974|FG002|Overall Study|Lost to Follow-up|1|||
126320126|NCT05916131|454463975|FG003|Overall Study|Lost to Follow-up|0|||
126320127|NCT01211483|454463985|FG000|Phase 1b|Death|6|||
126320128|NCT01211483|454463986|FG001|Phase 1b|Death|0|||
126320129|NCT01211483|454463987|FG002|Phase 1b|Death|0|||
126320130|NCT01211483|454463988|FG003|Phase 1b|Death|0|||
126320131|NCT01211483|454463985|FG000|Phase 1b|Withdrawal by Subject|1|||
126320132|NCT01211483|454463986|FG001|Phase 1b|Withdrawal by Subject|0|||
126320133|NCT01211483|454463987|FG002|Phase 1b|Withdrawal by Subject|0|||
126320134|NCT01211483|454463988|FG003|Phase 1b|Withdrawal by Subject|0|||
126320135|NCT01211483|454463985|FG000|Phase 2|Lost to Follow-up|0|||
126320136|NCT01211483|454463986|FG001|Phase 2|Lost to Follow-up|1|||
126320137|NCT01211483|454463987|FG002|Phase 2|Lost to Follow-up|1|||
126320138|NCT01211483|454463988|FG003|Phase 2|Lost to Follow-up|2|||
126320139|NCT01211483|454463985|FG000|Phase 2|Death|0|||
126320140|NCT01211483|454463986|FG001|Phase 2|Death|64|||
126320141|NCT01211483|454463987|FG002|Phase 2|Death|53|||
126320142|NCT01211483|454463988|FG003|Phase 2|Death|53|||
126320143|NCT01211483|454463985|FG000|Phase 2|Withdrawal by Subject|0|||
126320144|NCT01211483|454463986|FG001|Phase 2|Withdrawal by Subject|1|||
126320145|NCT01211483|454463987|FG002|Phase 2|Withdrawal by Subject|10|||
126320146|NCT01211483|454463988|FG003|Phase 2|Withdrawal by Subject|5|||
126320147|NCT01211483|454463985|FG000|Phase 2|Study terminated by Sponsor|0|||
126320148|NCT01211483|454463986|FG001|Phase 2|Study terminated by Sponsor|6|||
126320149|NCT01211483|454463987|FG002|Phase 2|Study terminated by Sponsor|8|||
126320150|NCT01211483|454463988|FG003|Phase 2|Study terminated by Sponsor|11|||
126320151|NCT01398410|454463990|FG000|Overall Study|Adverse Event|12|||
126320152|NCT01398410|454463991|FG001|Overall Study|Adverse Event|16|||
126320153|NCT01398410|454463990|FG000|Overall Study|Participants Choice|8|||
126320154|NCT01398410|454463991|FG001|Overall Study|Participants Choice|11|||
126320155|NCT01398410|454463990|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
126320156|NCT01398410|454463991|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
126320157|NCT01398410|454463990|FG000|Overall Study|Other|36|||
126320158|NCT01398410|454463991|FG001|Overall Study|Other|29|||
126320159|NCT04245202|454463992|FG000|Overall Study|Lack of Efficacy|10|||
126320160|NCT04245202|454463993|FG001|Overall Study|Lack of Efficacy|1|||
126320161|NCT02470403|454463994|FG000|Overall Study|Adverse Event|1|||
126320162|NCT02470403|454463995|FG001|Overall Study|Adverse Event|0|||
126320163|NCT02470403|454463996|FG002|Overall Study|Adverse Event|0|||
126320164|NCT02470403|454463997|FG003|Overall Study|Adverse Event|0|||
126320165|NCT02470403|454463998|FG004|Overall Study|Adverse Event|0|||
125878474|NCT05138653|452851313|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878475|NCT05138653|452851314|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126320166|NCT02470403|454463994|FG000|Overall Study|Lost to Follow-up|0|||
126320167|NCT02470403|454463995|FG001|Overall Study|Lost to Follow-up|1|||
126320168|NCT02470403|454463996|FG002|Overall Study|Lost to Follow-up|0|||
126320169|NCT02470403|454463997|FG003|Overall Study|Lost to Follow-up|0|||
126320170|NCT02470403|454463998|FG004|Overall Study|Lost to Follow-up|0|||
126320171|NCT02470403|454463994|FG000|Overall Study|Subject/guardian decision|1|||
126320172|NCT02470403|454463995|FG001|Overall Study|Subject/guardian decision|0|||
126320173|NCT02470403|454463996|FG002|Overall Study|Subject/guardian decision|0|||
126320174|NCT02470403|454463997|FG003|Overall Study|Subject/guardian decision|4|||
126320175|NCT02470403|454463998|FG004|Overall Study|Subject/guardian decision|0|||
126320176|NCT00904839|454464005|FG000|Overall Study|Adverse Event|0|||
126320177|NCT00904839|454464006|FG001|Overall Study|Adverse Event|5|||
126320178|NCT00904839|454464007|FG002|Overall Study|Adverse Event|4|||
126320179|NCT00904839|454464005|FG000|Overall Study|Protocol Violation|0|||
126320180|NCT00904839|454464006|FG001|Overall Study|Protocol Violation|1|||
126320181|NCT00904839|454464007|FG002|Overall Study|Protocol Violation|1|||
126320182|NCT00904839|454464005|FG000|Overall Study|Lost to Follow-up|0|||
126320183|NCT00904839|454464006|FG001|Overall Study|Lost to Follow-up|1|||
126320184|NCT00904839|454464007|FG002|Overall Study|Lost to Follow-up|2|||
126320185|NCT00904839|454464005|FG000|Overall Study|Withdrawal by Subject|0|||
126320186|NCT00904839|454464006|FG001|Overall Study|Withdrawal by Subject|2|||
126320187|NCT00904839|454464007|FG002|Overall Study|Withdrawal by Subject|0|||
126320188|NCT00904839|454464005|FG000|Overall Study|Not treated|1|||
126320189|NCT00904839|454464006|FG001|Overall Study|Not treated|0|||
126320190|NCT00904839|454464007|FG002|Overall Study|Not treated|1|||
126320191|NCT00904839|454464005|FG000|Overall Study|Other than above|0|||
126320192|NCT00904839|454464006|FG001|Overall Study|Other than above|9|||
126320193|NCT00904839|454464007|FG002|Overall Study|Other than above|7|||
126320194|NCT01430624|454464008|FG000|Overall Study|Lost to Follow-up|23|||
126320195|NCT01430624|454464009|FG001|Overall Study|Lost to Follow-up|29|||
126320196|NCT01430624|454464010|FG002|Overall Study|Lost to Follow-up|27|||
126320197|NCT01430624|454464008|FG000|Overall Study|technical or eligibility|5|||
126320198|NCT01430624|454464009|FG001|Overall Study|technical or eligibility|5|||
126320199|NCT01430624|454464010|FG002|Overall Study|technical or eligibility|2|||
126320200|NCT01167634|454464015|FG000|Overall Study|Lost to Follow-up|1|||
126320201|NCT01167634|454464016|FG001|Overall Study|Lost to Follow-up|3|||
126320202|NCT01167634|454464017|FG002|Overall Study|Lost to Follow-up|3|||
126320203|NCT01167634|454464018|FG003|Overall Study|Lost to Follow-up|4|||
126320204|NCT01167634|454464015|FG000|Overall Study|Withdrawal by Subject|1|||
126320205|NCT01167634|454464016|FG001|Overall Study|Withdrawal by Subject|1|||
126320206|NCT01167634|454464017|FG002|Overall Study|Withdrawal by Subject|0|||
126320207|NCT01167634|454464018|FG003|Overall Study|Withdrawal by Subject|0|||
126320208|NCT00553358|454464019|FG000|Overall Study|Randomized but did not receive treatment|3|||
126320209|NCT00553358|454464020|FG001|Overall Study|Randomized but did not receive treatment|3|||
126320210|NCT00553358|454464021|FG002|Overall Study|Randomized but did not receive treatment|1|||
126320211|NCT00553358|454464019|FG000|Overall Study|Lost to Follow-up|22|||
126320212|NCT00553358|454464020|FG001|Overall Study|Lost to Follow-up|26|||
126320213|NCT00553358|454464021|FG002|Overall Study|Lost to Follow-up|18|||
126320214|NCT00553358|454464019|FG000|Overall Study|Withdrew completely|23|||
126320215|NCT00553358|454464020|FG001|Overall Study|Withdrew completely|33|||
126320216|NCT00553358|454464021|FG002|Overall Study|Withdrew completely|34|||
126320217|NCT00553358|454464019|FG000|Overall Study|Died during clinical follow-up|25|||
126320218|NCT00553358|454464020|FG001|Overall Study|Died during clinical follow-up|29|||
126320219|NCT00553358|454464021|FG002|Overall Study|Died during clinical follow-up|32|||
126320220|NCT00553358|454464019|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
126320221|NCT00553358|454464020|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
126320222|NCT00553358|454464021|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
126320223|NCT00553358|454464019|FG000|Overall Study|Died after clinical follow-up ended|1|||
126320224|NCT00553358|454464020|FG001|Overall Study|Died after clinical follow-up ended|2|||
126320225|NCT00553358|454464021|FG002|Overall Study|Died after clinical follow-up ended|0|||
126320226|NCT00553358|454464019|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
126320227|NCT00553358|454464020|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
126320228|NCT00553358|454464021|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
126320229|NCT05268016|454464023|FG000|Overall Study|Unacceptable toxicity or AE|2|||
126320230|NCT05268016|454464024|FG001|Overall Study|Unacceptable toxicity or AE|2|||
126320231|NCT05268016|454464025|FG002|Overall Study|Unacceptable toxicity or AE|4|||
126320232|NCT05268016|454464026|FG003|Overall Study|Unacceptable toxicity or AE|3|||
126320233|NCT05268016|454464027|FG004|Overall Study|Unacceptable toxicity or AE|1|||
126320234|NCT05268016|454464023|FG000|Overall Study|Withdrawal by Subject|1|||
126320235|NCT05268016|454464024|FG001|Overall Study|Withdrawal by Subject|3|||
126320236|NCT05268016|454464025|FG002|Overall Study|Withdrawal by Subject|2|||
126320237|NCT05268016|454464026|FG003|Overall Study|Withdrawal by Subject|2|||
126320238|NCT05268016|454464027|FG004|Overall Study|Withdrawal by Subject|1|||
126320239|NCT05268016|454464023|FG000|Overall Study|Lost to Follow-up|4|||
126320240|NCT05268016|454464024|FG001|Overall Study|Lost to Follow-up|7|||
126320241|NCT05268016|454464025|FG002|Overall Study|Lost to Follow-up|1|||
126320242|NCT05268016|454464026|FG003|Overall Study|Lost to Follow-up|3|||
126320243|NCT05268016|454464027|FG004|Overall Study|Lost to Follow-up|5|||
126320244|NCT05268016|454464023|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
126320245|NCT05268016|454464024|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
126320246|NCT05268016|454464025|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
126320247|NCT05268016|454464026|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
126320248|NCT05268016|454464027|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
126320249|NCT05268016|454464023|FG000|Overall Study|Lack of Efficacy|0|||
126320250|NCT05268016|454464024|FG001|Overall Study|Lack of Efficacy|0|||
126320251|NCT05268016|454464025|FG002|Overall Study|Lack of Efficacy|0|||
126320252|NCT05268016|454464026|FG003|Overall Study|Lack of Efficacy|0|||
126320253|NCT05268016|454464027|FG004|Overall Study|Lack of Efficacy|4|||
126320254|NCT05268016|454464023|FG000|Overall Study|Physician Decision|0|||
126320255|NCT05268016|454464024|FG001|Overall Study|Physician Decision|0|||
126320256|NCT05268016|454464025|FG002|Overall Study|Physician Decision|0|||
126320257|NCT05268016|454464026|FG003|Overall Study|Physician Decision|1|||
126320258|NCT05268016|454464027|FG004|Overall Study|Physician Decision|0|||
126320259|NCT05268016|454464023|FG000|Overall Study|Other|1|||
126320260|NCT05268016|454464024|FG001|Overall Study|Other|0|||
126320261|NCT05268016|454464025|FG002|Overall Study|Other|1|||
126320262|NCT05268016|454464026|FG003|Overall Study|Other|2|||
126320263|NCT05268016|454464027|FG004|Overall Study|Other|0|||
126320264|NCT00404924|454464028|FG000|Overall Study|Adverse Event|75|||
126320265|NCT00404924|454464029|FG001|Overall Study|Adverse Event|16|||
126320266|NCT00404924|454464028|FG000|Overall Study|Condition under investigation worsened|475|||
126320267|NCT00404924|454464029|FG001|Overall Study|Condition under investigation worsened|264|||
126320268|NCT00404924|454464028|FG000|Overall Study|Lost to Follow-up|1|||
126320269|NCT00404924|454464029|FG001|Overall Study|Lost to Follow-up|1|||
126320270|NCT00404924|454464028|FG000|Overall Study|Withdrawal by Subject|26|||
126320271|NCT00404924|454464029|FG001|Overall Study|Withdrawal by Subject|13|||
126320272|NCT00404924|454464028|FG000|Overall Study|Other|25|||
126320273|NCT00404924|454464029|FG001|Overall Study|Other|11|||
126320274|NCT00404924|454464028|FG000|Overall Study|Randomised but not received treatment|1|||
126320275|NCT00404924|454464029|FG001|Overall Study|Randomised but not received treatment|1|||
126320276|NCT01074255|454464034|FG000|Overall Study|Did not receive EMEND|2|||
126320277|NCT02943785|454464036|FG000|Overall Study|Adverse Event|112|||
126320278|NCT02943785|454464037|FG001|Overall Study|Adverse Event|97|||
126320279|NCT02943785|454464036|FG000|Overall Study|Withdrawal by Subject|63|||
126320280|NCT02943785|454464037|FG001|Overall Study|Withdrawal by Subject|126|||
126320281|NCT02943785|454464036|FG000|Overall Study|Physician Decision|23|||
126320282|NCT02943785|454464037|FG001|Overall Study|Physician Decision|47|||
126320283|NCT02943785|454464036|FG000|Overall Study|Death|46|||
126320284|NCT02943785|454464037|FG001|Overall Study|Death|46|||
126320285|NCT02943785|454464036|FG000|Overall Study|Lost to Follow-up|1|||
126320286|NCT02943785|454464037|FG001|Overall Study|Lost to Follow-up|0|||
126320287|NCT02943785|454464036|FG000|Overall Study|Other|16|||
126320288|NCT02943785|454464037|FG001|Overall Study|Other|19|||
126320289|NCT02943785|454464036|FG000|Overall Study|Did not receive any study medication|21|||
126320290|NCT02943785|454464037|FG001|Overall Study|Did not receive any study medication|28|||
126320291|NCT00821015|454464040|FG000|Overall Study|Lost to Follow-up|12|||
126320292|NCT01281956|454464041|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
126320293|NCT01281956|454464042|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
126320294|NCT03170609|454464043|FG000|Overall Study|Death|0|||
126320295|NCT03170609|454464044|FG001|Overall Study|Death|0|||
126320296|NCT03170609|454464045|FG002|Overall Study|Death|1|||
126320297|NCT03170609|454464046|FG003|Overall Study|Death|0|||
126320298|NCT03170609|454464047|FG004|Overall Study|Death|0|||
126320299|NCT03170609|454464048|FG005|Overall Study|Death|0|||
126320300|NCT03170609|454464049|FG006|Overall Study|Death|0|||
126320301|NCT03170609|454464043|FG000|Overall Study|Withdrawal by Subject|1|||
126320302|NCT03170609|454464044|FG001|Overall Study|Withdrawal by Subject|2|||
126320303|NCT03170609|454464045|FG002|Overall Study|Withdrawal by Subject|0|||
126320304|NCT03170609|454464046|FG003|Overall Study|Withdrawal by Subject|0|||
126320305|NCT03170609|454464047|FG004|Overall Study|Withdrawal by Subject|0|||
126320306|NCT03170609|454464048|FG005|Overall Study|Withdrawal by Subject|0|||
126320307|NCT03170609|454464049|FG006|Overall Study|Withdrawal by Subject|1|||
126320308|NCT03170609|454464043|FG000|Overall Study|Lost to Follow-up|1|||
126320309|NCT03170609|454464044|FG001|Overall Study|Lost to Follow-up|0|||
126320310|NCT03170609|454464045|FG002|Overall Study|Lost to Follow-up|5|||
126320311|NCT03170609|454464046|FG003|Overall Study|Lost to Follow-up|2|||
126320312|NCT03170609|454464047|FG004|Overall Study|Lost to Follow-up|1|||
126320313|NCT03170609|454464048|FG005|Overall Study|Lost to Follow-up|1|||
126320314|NCT03170609|454464049|FG006|Overall Study|Lost to Follow-up|0|||
126320315|NCT03170609|454464043|FG000|Overall Study|Other|1|||
126320316|NCT03170609|454464044|FG001|Overall Study|Other|0|||
126320317|NCT03170609|454464045|FG002|Overall Study|Other|0|||
126320318|NCT03170609|454464046|FG003|Overall Study|Other|0|||
126320319|NCT03170609|454464047|FG004|Overall Study|Other|0|||
126320320|NCT03170609|454464048|FG005|Overall Study|Other|1|||
126320321|NCT03170609|454464049|FG006|Overall Study|Other|0|||
126320322|NCT01490697|454464057|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
126320323|NCT01490697|454464058|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
126320324|NCT00090584|454464059|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
125982863|NCT01090310|453228203|FG000|Core Study|Protocol deviation|1|||
125982864|NCT01090310|453228204|FG001|Core Study|Protocol deviation|0|||
125982865|NCT01090310|453228205|FG002|Core Study|Protocol deviation|0|||
126320325|NCT00090584|454464060|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
126320326|NCT00090584|454464059|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
126320327|NCT00090584|454464060|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
126320328|NCT00270231|454464061|FG000|First Intervention|Lost to Follow-up|1|||
126320329|NCT00270231|454464062|FG001|First Intervention|Lost to Follow-up|1|||
126320330|NCT00270231|454464061|FG000|Washout Period|Lost to Follow-up|1|||
126320331|NCT00270231|454464062|FG001|Washout Period|Lost to Follow-up|0|||
126320332|NCT00270231|454464061|FG000|Second Intervention|Lost to Follow-up|0|||
126320333|NCT00270231|454464062|FG001|Second Intervention|Lost to Follow-up|1|||
126320334|NCT02117713|454464072|FG000|Week 48|Adverse Event|4|||
126320335|NCT02117713|454464072|FG000|Week 48|Withdrawal by caregiver|2|||
126320336|NCT02117713|454464072|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
126320337|NCT02117713|454464072|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
126320338|NCT02117713|454464072|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
126320339|NCT02117713|454464072|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
126320340|NCT00574795|454464073|FG000|Infant Series|Withdrawal by Subject|2|||
126320341|NCT00574795|454464073|FG000|Infant Series|Protocol Violation|2|||
126320342|NCT00574795|454464073|FG000|Infant Series|Adverse Event|1|||
126320343|NCT00574795|454464073|FG000|After Infant Series|Withdrawal by Subject|1|||
126320344|NCT00574795|454464073|FG000|After Infant Series|Adverse Event|2|||
126320345|NCT00574795|454464073|FG000|Toddler Dose|Withdrawal by Subject|1|||
126320346|NCT01333956|454464081|FG000|Overall Study|Lost to Follow-up|1|||
126320347|NCT01333956|454464082|FG001|Overall Study|Lost to Follow-up|2|||
126320348|NCT01333956|454464083|FG002|Overall Study|Lost to Follow-up|0|||
126320349|NCT01333956|454464084|FG003|Overall Study|Lost to Follow-up|1|||
126320350|NCT01333956|454464081|FG000|Overall Study|Unable to complete study procedure|1|||
126320351|NCT01333956|454464082|FG001|Overall Study|Unable to complete study procedure|0|||
126320352|NCT01333956|454464083|FG002|Overall Study|Unable to complete study procedure|0|||
126320353|NCT01333956|454464084|FG003|Overall Study|Unable to complete study procedure|1|||
126320354|NCT01333956|454464081|FG000|Overall Study|Withdrawal by Subject|0|||
126320355|NCT01333956|454464082|FG001|Overall Study|Withdrawal by Subject|2|||
126320356|NCT01333956|454464083|FG002|Overall Study|Withdrawal by Subject|1|||
126320357|NCT01333956|454464084|FG003|Overall Study|Withdrawal by Subject|0|||
126320358|NCT00432276|454464087|FG000|Overall Study|Hyperglycemic Rescue|44|||
126320359|NCT00432276|454464088|FG001|Overall Study|Hyperglycemic Rescue|87|||
126320360|NCT00432276|454464087|FG000|Overall Study|Adverse Event|13|||
126320361|NCT00432276|454464088|FG001|Overall Study|Adverse Event|16|||
126320362|NCT00432276|454464087|FG000|Overall Study|Protocol Violation|25|||
126320363|NCT00432276|454464088|FG001|Overall Study|Protocol Violation|20|||
126320364|NCT00432276|454464087|FG000|Overall Study|Lost to Follow-up|6|||
126320365|NCT00432276|454464088|FG001|Overall Study|Lost to Follow-up|2|||
126320366|NCT00432276|454464087|FG000|Overall Study|Withdrawal by Subject|25|||
126320367|NCT00432276|454464088|FG001|Overall Study|Withdrawal by Subject|20|||
126320368|NCT00432276|454464087|FG000|Overall Study|Physician Decision|6|||
126320369|NCT00432276|454464088|FG001|Overall Study|Physician Decision|8|||
126320370|NCT00432276|454464087|FG000|Overall Study|Other|2|||
126320371|NCT00432276|454464088|FG001|Overall Study|Other|3|||
126320372|NCT00467961|454464089|FG000|Overall Study|Technical Failures|5|||
126320373|NCT00467961|454464089|FG000|Overall Study|Disease Progression|2|||
126320374|NCT05249127|454464090|FG000|Overall Study|Protocol Violation|13|||
126320375|NCT05249127|454464090|FG000|Overall Study|Physician Decision|4|||
126320376|NCT05249127|454464090|FG000|Overall Study|Withdrawal by Subject|2|||
126320377|NCT05249127|454464090|FG000|Overall Study|Participant Non-compliance|1|||
126320378|NCT02073565|454464091|FG000|Cohort A|Withdrawal by Subject|1|||
126320379|NCT02073565|454464092|FG001|Cohort A|Withdrawal by Subject|0|||
126320380|NCT02073565|454464091|FG000|Cohort B|Withdrawal by Subject|1|||
126320381|NCT02073565|454464092|FG001|Cohort B|Withdrawal by Subject|2|||
126320382|NCT02073565|454464091|FG000|Cohort C|Withdrawal by Subject|0|||
126320383|NCT02073565|454464092|FG001|Cohort C|Withdrawal by Subject|2|||
126320384|NCT02073565|454464091|FG000|Cohort C|Lost to Follow-up|0|||
126320385|NCT02073565|454464092|FG001|Cohort C|Lost to Follow-up|2|||
126320386|NCT03646305|454464093|FG000|Overall Study|Lost to Follow-up|4|||
126320387|NCT03646305|454464094|FG001|Overall Study|Lost to Follow-up|2|||
126320388|NCT03646305|454464095|FG002|Overall Study|Lost to Follow-up|2|||
126320389|NCT03646305|454464096|FG003|Overall Study|Lost to Follow-up|1|||
126320390|NCT03646305|454464093|FG000|Overall Study|Withdrawal by Subject|1|||
126320391|NCT03646305|454464094|FG001|Overall Study|Withdrawal by Subject|0|||
126320392|NCT03646305|454464095|FG002|Overall Study|Withdrawal by Subject|0|||
126320393|NCT03646305|454464096|FG003|Overall Study|Withdrawal by Subject|1|||
126320394|NCT03417024|454464097|FG000|Overall Study|Study Termination prior to follow-up|11|||
126320395|NCT03417024|454464097|FG000|Overall Study|Physician Decision|2|||
126320396|NCT03168919|454464098|FG000|Overall Study|Withdrawal by Subject|2|||
126320397|NCT04015518|454464099|FG000|Overall Study|Adverse Event|6|||
126320398|NCT04015518|454464100|FG001|Overall Study|Adverse Event|1|||
126320399|NCT04015518|454464101|FG002|Overall Study|Adverse Event|1|||
126320400|NCT04015518|454464102|FG003|Overall Study|Adverse Event|3|||
126320401|NCT04015518|454464103|FG004|Overall Study|Adverse Event|3|||
126320402|NCT04015518|454464099|FG000|Overall Study|Lack of Efficacy|1|||
126320403|NCT04015518|454464100|FG001|Overall Study|Lack of Efficacy|0|||
126320404|NCT04015518|454464101|FG002|Overall Study|Lack of Efficacy|1|||
126320405|NCT04015518|454464102|FG003|Overall Study|Lack of Efficacy|0|||
126320406|NCT04015518|454464103|FG004|Overall Study|Lack of Efficacy|4|||
126320407|NCT04015518|454464099|FG000|Overall Study|Lost to Follow-up|0|||
126320408|NCT04015518|454464100|FG001|Overall Study|Lost to Follow-up|0|||
126320409|NCT04015518|454464101|FG002|Overall Study|Lost to Follow-up|0|||
126320410|NCT04015518|454464102|FG003|Overall Study|Lost to Follow-up|0|||
126320411|NCT04015518|454464103|FG004|Overall Study|Lost to Follow-up|1|||
126320412|NCT04015518|454464099|FG000|Overall Study|Withdrawal by Subject|0|||
126320413|NCT04015518|454464100|FG001|Overall Study|Withdrawal by Subject|1|||
126320414|NCT04015518|454464101|FG002|Overall Study|Withdrawal by Subject|0|||
126320415|NCT04015518|454464102|FG003|Overall Study|Withdrawal by Subject|1|||
126320416|NCT04015518|454464103|FG004|Overall Study|Withdrawal by Subject|1|||
126320417|NCT04015518|454464099|FG000|Overall Study|Patient did not come for consecutive visits|0|||
126320418|NCT04015518|454464100|FG001|Overall Study|Patient did not come for consecutive visits|1|||
126320419|NCT04015518|454464101|FG002|Overall Study|Patient did not come for consecutive visits|0|||
126320420|NCT04015518|454464102|FG003|Overall Study|Patient did not come for consecutive visits|0|||
126320421|NCT04015518|454464103|FG004|Overall Study|Patient did not come for consecutive visits|0|||
126320422|NCT04015518|454464099|FG000|Overall Study|not willing to travel due to Covid-19|0|||
126320423|NCT04015518|454464100|FG001|Overall Study|not willing to travel due to Covid-19|0|||
126320424|NCT04015518|454464101|FG002|Overall Study|not willing to travel due to Covid-19|1|||
126320425|NCT04015518|454464102|FG003|Overall Study|not willing to travel due to Covid-19|0|||
126320426|NCT04015518|454464103|FG004|Overall Study|not willing to travel due to Covid-19|0|||
126320427|NCT04015518|454464099|FG000|Overall Study|Patient wants to discontinue treatment|0|||
126320428|NCT04015518|454464100|FG001|Overall Study|Patient wants to discontinue treatment|0|||
126320429|NCT04015518|454464101|FG002|Overall Study|Patient wants to discontinue treatment|0|||
126320430|NCT04015518|454464102|FG003|Overall Study|Patient wants to discontinue treatment|1|||
126320431|NCT04015518|454464103|FG004|Overall Study|Patient wants to discontinue treatment|0|||
126320432|NCT04015518|454464099|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
126320433|NCT04015518|454464100|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
126320434|NCT04015518|454464101|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
126320435|NCT04015518|454464102|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
126320436|NCT04015518|454464103|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
126320437|NCT04015518|454464099|FG000|Overall Study|Pregnancy|0|||
126320438|NCT04015518|454464100|FG001|Overall Study|Pregnancy|0|||
126320439|NCT04015518|454464101|FG002|Overall Study|Pregnancy|0|||
126320440|NCT04015518|454464102|FG003|Overall Study|Pregnancy|0|||
126320441|NCT04015518|454464103|FG004|Overall Study|Pregnancy|1|||
126320442|NCT04015518|454464099|FG000|Overall Study|Personal reasons|1|||
126320443|NCT04015518|454464100|FG001|Overall Study|Personal reasons|0|||
126320444|NCT04015518|454464101|FG002|Overall Study|Personal reasons|0|||
126320445|NCT04015518|454464102|FG003|Overall Study|Personal reasons|0|||
126320446|NCT04015518|454464103|FG004|Overall Study|Personal reasons|1|||
126320447|NCT04015518|454464099|FG000|Overall Study|Withdrew consent|1|||
126320448|NCT04015518|454464100|FG001|Overall Study|Withdrew consent|0|||
126320449|NCT04015518|454464101|FG002|Overall Study|Withdrew consent|0|||
126320450|NCT04015518|454464102|FG003|Overall Study|Withdrew consent|0|||
126320451|NCT04015518|454464103|FG004|Overall Study|Withdrew consent|0|||
126320452|NCT04015518|454464099|FG000|Overall Study|Prostate carcinoma|1|||
126320453|NCT04015518|454464100|FG001|Overall Study|Prostate carcinoma|0|||
125982866|NCT01090310|453228206|FG003|Core Study|Protocol deviation|1|||
125982867|NCT01090310|453228203|FG000|Extension Study|Aministrative problems|13|||
126320454|NCT04015518|454464101|FG002|Overall Study|Prostate carcinoma|0|||
126320455|NCT04015518|454464102|FG003|Overall Study|Prostate carcinoma|0|||
126320456|NCT04015518|454464103|FG004|Overall Study|Prostate carcinoma|0|||
126320457|NCT04015518|454464099|FG000|Overall Study|Could not keep appointments due to work|1|||
126320458|NCT04015518|454464100|FG001|Overall Study|Could not keep appointments due to work|0|||
126320459|NCT04015518|454464101|FG002|Overall Study|Could not keep appointments due to work|0|||
126320460|NCT04015518|454464102|FG003|Overall Study|Could not keep appointments due to work|0|||
126320461|NCT04015518|454464103|FG004|Overall Study|Could not keep appointments due to work|0|||
126320462|NCT02195427|454464104|FG000|Overall Study|Did not consent to study extension|13|||
126320463|NCT02195427|454464105|FG001|Overall Study|Did not consent to study extension|9|||
126320464|NCT02195427|454464104|FG000|Overall Study|Withdrawal by Subject|4|||
126320465|NCT02195427|454464105|FG001|Overall Study|Withdrawal by Subject|2|||
126320466|NCT02195427|454464104|FG000|Overall Study|Lost to Follow-up|0|||
125982868|NCT01090310|453228204|FG001|Extension Study|Aministrative problems|15|||
125982869|NCT01090310|453228205|FG002|Extension Study|Aministrative problems|14|||
126320467|NCT02195427|454464105|FG001|Overall Study|Lost to Follow-up|1|||
126320468|NCT02195427|454464104|FG000|Overall Study|Protocol Violation|7|||
126320469|NCT02195427|454464105|FG001|Overall Study|Protocol Violation|14|||
126320470|NCT02195427|454464104|FG000|Overall Study|Conditional re-treatment at W52|2|||
126320471|NCT02195427|454464105|FG001|Overall Study|Conditional re-treatment at W52|1|||
126320472|NCT03053427|454464106|FG000|Overall Study|Adverse Event|4|||
126320473|NCT03053427|454464107|FG001|Overall Study|Adverse Event|4|||
126320474|NCT03053427|454464106|FG000|Overall Study|Lack of Efficacy|1|||
126320475|NCT03053427|454464107|FG001|Overall Study|Lack of Efficacy|3|||
126320476|NCT03053427|454464106|FG000|Overall Study|Lost to Follow-up|2|||
126320477|NCT03053427|454464107|FG001|Overall Study|Lost to Follow-up|2|||
126320478|NCT03053427|454464106|FG000|Overall Study|Worsening of the target disease|0|||
126320479|NCT03053427|454464107|FG001|Overall Study|Worsening of the target disease|1|||
126320480|NCT03053427|454464106|FG000|Overall Study|Protocol Deviation|3|||
126320481|NCT03053427|454464107|FG001|Overall Study|Protocol Deviation|3|||
126320482|NCT03053427|454464106|FG000|Overall Study|Withdrawal by Subject|3|||
126320483|NCT03053427|454464107|FG001|Overall Study|Withdrawal by Subject|2|||
126320484|NCT03053427|454464106|FG000|Overall Study|Miscellaneous|0|||
126320485|NCT03053427|454464107|FG001|Overall Study|Miscellaneous|1|||
126320486|NCT02172040|454464113|FG000|Overall Study|Adverse Event|0|||
126320487|NCT02172040|454464114|FG001|Overall Study|Adverse Event|2|||
126320488|NCT02172040|454464115|FG002|Overall Study|Adverse Event|0|||
126320489|NCT02172040|454464116|FG003|Overall Study|Adverse Event|0|||
126320490|NCT02172040|454464113|FG000|Overall Study|Protocol Violation|0|||
126320491|NCT02172040|454464114|FG001|Overall Study|Protocol Violation|1|||
126320492|NCT02172040|454464115|FG002|Overall Study|Protocol Violation|0|||
126320493|NCT02172040|454464116|FG003|Overall Study|Protocol Violation|0|||
126320494|NCT02172040|454464113|FG000|Overall Study|Withdrawal by Subject|0|||
126320495|NCT02172040|454464114|FG001|Overall Study|Withdrawal by Subject|0|||
126320496|NCT02172040|454464115|FG002|Overall Study|Withdrawal by Subject|1|||
126320497|NCT02172040|454464116|FG003|Overall Study|Withdrawal by Subject|0|||
126320498|NCT02172040|454464113|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
126320499|NCT02172040|454464114|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
126320500|NCT02172040|454464115|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
126320501|NCT02172040|454464116|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
126320502|NCT02172040|454464113|FG000|Overall Study|Family emergency abroad|0|||
126320503|NCT02172040|454464114|FG001|Overall Study|Family emergency abroad|0|||
126320504|NCT02172040|454464115|FG002|Overall Study|Family emergency abroad|0|||
126320505|NCT02172040|454464116|FG003|Overall Study|Family emergency abroad|1|||
126320506|NCT02607306|454464121|FG000|Overall Study|Adverse Event|8|||
126320507|NCT02607306|454464122|FG001|Overall Study|Adverse Event|6|||
126320508|NCT02607306|454464123|FG002|Overall Study|Adverse Event|6|||
126320509|NCT02607306|454464121|FG000|Overall Study|Unclassified|1|||
126320510|NCT02607306|454464122|FG001|Overall Study|Unclassified|4|||
126320511|NCT02607306|454464123|FG002|Overall Study|Unclassified|0|||
126320512|NCT02607306|454464121|FG000|Overall Study|Withdrawal by Subject|8|||
126320513|NCT02607306|454464122|FG001|Overall Study|Withdrawal by Subject|10|||
126320514|NCT02607306|454464123|FG002|Overall Study|Withdrawal by Subject|2|||
126320515|NCT02607306|454464121|FG000|Overall Study|Lack of Efficacy|0|||
126320516|NCT02607306|454464122|FG001|Overall Study|Lack of Efficacy|1|||
126320517|NCT02607306|454464123|FG002|Overall Study|Lack of Efficacy|1|||
126320518|NCT02607306|454464121|FG000|Overall Study|Protocol Violation|4|||
126320519|NCT02607306|454464122|FG001|Overall Study|Protocol Violation|2|||
126320520|NCT02607306|454464123|FG002|Overall Study|Protocol Violation|1|||
126320521|NCT03759366|454464124|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
126320522|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
126320523|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
126320524|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
126320525|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
125982870|NCT01090310|453228206|FG003|Extension Study|Aministrative problems|18|||
125982871|NCT01090310|453228203|FG000|Extension Study|Adverse Event|0|||
125982872|NCT01090310|453228204|FG001|Extension Study|Adverse Event|0|||
125982873|NCT01090310|453228205|FG002|Extension Study|Adverse Event|0|||
125982874|NCT01090310|453228206|FG003|Extension Study|Adverse Event|1|||
125982875|NCT01090310|453228203|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
125982876|NCT01090310|453228204|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
125982877|NCT01090310|453228205|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
126320526|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
126320527|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
126320528|NCT04226495|454464125|FG000|Overall Study|Withdrawal by Subject|3|||
126320529|NCT04226495|454464126|FG001|Overall Study|Withdrawal by Subject|3|||
126320530|NCT04226495|454464125|FG000|Overall Study|PI discretion|3|||
126320531|NCT04226495|454464126|FG001|Overall Study|PI discretion|4|||
126320532|NCT00539032|454464127|FG000|Overall Study|Withdrawal by Subject|2|||
126320533|NCT00539032|454464128|FG001|Overall Study|Withdrawal by Subject|1|||
126320534|NCT02168777|454466253|FG000|Overall Study|Withdrawal by Subject|1|||
126320535|NCT02168777|454466254|FG001|Overall Study|Withdrawal by Subject|0|||
126320536|NCT02168777|454466255|FG002|Overall Study|Withdrawal by Subject|2|||
126320537|NCT02168777|454466253|FG000|Overall Study|Adverse Event|1|||
126320538|NCT02168777|454466254|FG001|Overall Study|Adverse Event|0|||
126320539|NCT02168777|454466255|FG002|Overall Study|Adverse Event|1|||
126320540|NCT02168777|454466253|FG000|Overall Study|Disease recurrence|0|||
126320541|NCT02168777|454466254|FG001|Overall Study|Disease recurrence|0|||
126320542|NCT02168777|454466255|FG002|Overall Study|Disease recurrence|1|||
126320543|NCT02168777|454466253|FG000|Overall Study|Radiological disease progression|0|||
126320544|NCT02168777|454466254|FG001|Overall Study|Radiological disease progression|5|||
126320545|NCT02168777|454466255|FG002|Overall Study|Radiological disease progression|5|||
126320546|NCT02168777|454466253|FG000|Overall Study|Clinical disease progression|0|||
126320547|NCT02168777|454466254|FG001|Overall Study|Clinical disease progression|1|||
126320548|NCT02168777|454466255|FG002|Overall Study|Clinical disease progression|2|||
126320549|NCT02168777|454466253|FG000|Overall Study|Other reason|0|||
126320550|NCT02168777|454466254|FG001|Overall Study|Other reason|1|||
126320551|NCT02168777|454466255|FG002|Overall Study|Other reason|0|||
126320552|NCT03334422|454466257|FG000|Overall Study|Adverse Event|1|||
126320553|NCT03334422|454466258|FG001|Overall Study|Adverse Event|3|||
126320554|NCT03334422|454466259|FG002|Overall Study|Adverse Event|2|||
126320555|NCT03334422|454466260|FG003|Overall Study|Adverse Event|2|||
126320556|NCT03334422|454466257|FG000|Overall Study|Lack of Efficacy|10|||
126320557|NCT03334422|454466258|FG001|Overall Study|Lack of Efficacy|2|||
126320558|NCT03334422|454466259|FG002|Overall Study|Lack of Efficacy|7|||
126320559|NCT03334422|454466260|FG003|Overall Study|Lack of Efficacy|3|||
126320560|NCT03334422|454466257|FG000|Overall Study|Withdrawal by Subject|8|||
126320561|NCT03334422|454466258|FG001|Overall Study|Withdrawal by Subject|3|||
126320562|NCT03334422|454466259|FG002|Overall Study|Withdrawal by Subject|1|||
126320563|NCT03334422|454466260|FG003|Overall Study|Withdrawal by Subject|0|||
126320564|NCT03334422|454466257|FG000|Overall Study|Lost to Follow-up|0|||
126320565|NCT03334422|454466258|FG001|Overall Study|Lost to Follow-up|0|||
126320566|NCT03334422|454466259|FG002|Overall Study|Lost to Follow-up|0|||
126320567|NCT03334422|454466260|FG003|Overall Study|Lost to Follow-up|1|||
126320568|NCT03334422|454466257|FG000|Overall Study|Inability to obtain laboratory samples|0|||
126320569|NCT03334422|454466258|FG001|Overall Study|Inability to obtain laboratory samples|1|||
126320570|NCT03334422|454466259|FG002|Overall Study|Inability to obtain laboratory samples|0|||
126320571|NCT03334422|454466260|FG003|Overall Study|Inability to obtain laboratory samples|0|||
126320572|NCT03334422|454466257|FG000|Overall Study|Pregnancy|0|||
126320573|NCT03334422|454466258|FG001|Overall Study|Pregnancy|1|||
126320574|NCT03334422|454466259|FG002|Overall Study|Pregnancy|0|||
126320575|NCT03334422|454466260|FG003|Overall Study|Pregnancy|0|||
126320576|NCT02697916|454466261|FG000|Overall Study|Death|357|||
126320577|NCT02697916|454466262|FG001|Overall Study|Death|315|||
126320578|NCT02697916|454466261|FG000|Overall Study|Withdrawal by Subject|221|||
126320579|NCT02697916|454466262|FG001|Overall Study|Withdrawal by Subject|393|||
126320580|NCT01698268|454466263|FG000|Overall Study|Physician Decision|2|||
126320581|NCT01698268|454466264|FG001|Overall Study|Physician Decision|1|||
126320582|NCT01533688|454466265|FG000|Overall Study|Withdrawal by Subject|5|||
126320583|NCT01533688|454466266|FG001|Overall Study|Withdrawal by Subject|4|||
126320584|NCT01533688|454466267|FG002|Overall Study|Withdrawal by Subject|3|||
126320585|NCT01533688|454466265|FG000|Overall Study|Medically unstable|1|||
126320586|NCT01533688|454466266|FG001|Overall Study|Medically unstable|3|||
126320587|NCT01533688|454466267|FG002|Overall Study|Medically unstable|3|||
126320588|NCT01533688|454466265|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
126320589|NCT01533688|454466266|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
126320590|NCT01533688|454466267|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
126320591|NCT04591015|454466268|FG000|Overall Study|Death|6|||
126320592|NCT04591015|454466269|FG001|Overall Study|Death|4|||
126320593|NCT04591015|454466268|FG000|Overall Study|Withdrawal by Subject|6|||
126320594|NCT04591015|454466269|FG001|Overall Study|Withdrawal by Subject|3|||
126320595|NCT04591015|454466268|FG000|Overall Study|Lost to Follow-up|16|||
126320596|NCT04591015|454466269|FG001|Overall Study|Lost to Follow-up|11|||
126320597|NCT02509078|454466270|FG000|Overall Study|Protocol Violation|1|||
126320598|NCT02509078|454466271|FG001|Overall Study|Protocol Violation|1|||
126320599|NCT02686814|454466272|FG000|Overall Study|Physician Decision|14|||
126320600|NCT02686814|454466272|FG000|Overall Study|Withdrawal by Subject|4|||
126320601|NCT02686814|454466272|FG000|Overall Study|Death|1|||
126320602|NCT00290693|454466273|FG000|Overall Study|Withdrawal by Subject|2|||
126320603|NCT02907619|454466274|FG000|Overall Study|Study terminated by sponsor|18|||
126320604|NCT02907619|454466275|FG001|Overall Study|Study terminated by sponsor|18|||
126320605|NCT02907619|454466276|FG002|Overall Study|Study terminated by sponsor|19|||
126320606|NCT02907619|454466274|FG000|Overall Study|Death|0|||
126320607|NCT02907619|454466275|FG001|Overall Study|Death|0|||
126320608|NCT02907619|454466276|FG002|Overall Study|Death|1|||
126320609|NCT02907619|454466274|FG000|Overall Study|Withdrawal by Subject|1|||
126320610|NCT02907619|454466275|FG001|Overall Study|Withdrawal by Subject|1|||
126320611|NCT02907619|454466276|FG002|Overall Study|Withdrawal by Subject|0|||
126320612|NCT02907619|454466274|FG000|Overall Study|Other|0|||
126320613|NCT02907619|454466275|FG001|Overall Study|Other|1|||
126320614|NCT02907619|454466276|FG002|Overall Study|Other|0|||
126320615|NCT02603107|454466277|FG000|Randomized Phase|Withdrew consent|8|||
126320616|NCT02603107|454466278|FG001|Randomized Phase|Withdrew consent|15|||
126320617|NCT02603107|454466277|FG000|Randomized Phase|Lost to Follow-up|1|||
126320618|NCT02603107|454466278|FG001|Randomized Phase|Lost to Follow-up|3|||
126320619|NCT02603107|454466277|FG000|Randomized Phase|Adverse Event|2|||
126320620|NCT02603107|454466278|FG001|Randomized Phase|Adverse Event|0|||
126320621|NCT02603107|454466277|FG000|Randomized Phase|Death|1|||
126320622|NCT02603107|454466278|FG001|Randomized Phase|Death|1|||
126320623|NCT02603107|454466277|FG000|Randomized Phase|Non-compliance with study drug|1|||
126320624|NCT02603107|454466278|FG001|Randomized Phase|Non-compliance with study drug|1|||
126320625|NCT02603107|454466277|FG000|Randomized Phase|Investigator's discretion|0|||
126320626|NCT02603107|454466278|FG001|Randomized Phase|Investigator's discretion|1|||
126320627|NCT02603107|454466277|FG000|Randomized Phase|Lack of Efficacy|1|||
126320628|NCT02603107|454466278|FG001|Randomized Phase|Lack of Efficacy|0|||
126320629|NCT02603107|454466277|FG000|Randomized Phase|Protocol Violation|1|||
126320630|NCT02603107|454466278|FG001|Randomized Phase|Protocol Violation|0|||
126320631|NCT02603107|454466277|FG000|Optional Extension Phase|Lost to Follow-up|3|||
126320632|NCT02603107|454466278|FG001|Optional Extension Phase|Lost to Follow-up|3|||
126320633|NCT02603107|454466277|FG000|Optional Extension Phase|Withdrew consent|3|||
126320634|NCT02603107|454466278|FG001|Optional Extension Phase|Withdrew consent|2|||
126320635|NCT02603107|454466277|FG000|Optional Extension Phase|Investigator's discretion|2|||
126320636|NCT02603107|454466278|FG001|Optional Extension Phase|Investigator's discretion|2|||
126320637|NCT02603107|454466277|FG000|Optional Extension Phase|Pregnancy|0|||
126320638|NCT02603107|454466278|FG001|Optional Extension Phase|Pregnancy|3|||
126320639|NCT02603107|454466277|FG000|Optional Extension Phase|Adverse Event|0|||
126320640|NCT02603107|454466278|FG001|Optional Extension Phase|Adverse Event|2|||
126320641|NCT02603107|454466277|FG000|Optional Extension Phase|Not treated in extension phase|0|||
126320642|NCT02603107|454466278|FG001|Optional Extension Phase|Not treated in extension phase|1|||
126320643|NCT02603107|454466277|FG000|Optional Extension Phase|Protocol Violation|1|||
126320644|NCT02603107|454466278|FG001|Optional Extension Phase|Protocol Violation|0|||
126320645|NCT03411902|454466279|FG000|Overall Study|Lost to Follow-up|3|||
126320646|NCT03411902|454466280|FG001|Overall Study|Lost to Follow-up|0|||
126320647|NCT00419159|454466281|FG000|Overall Study|Adverse Event|7|||
126320648|NCT00419159|454466282|FG001|Overall Study|Adverse Event|15|||
126320649|NCT00419159|454466281|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126320650|NCT00419159|454466282|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126320651|NCT00419159|454466281|FG000|Overall Study|Subject's no longer requires study drug|0|||
126320652|NCT00419159|454466282|FG001|Overall Study|Subject's no longer requires study drug|1|||
126320653|NCT00419159|454466281|FG000|Overall Study|Protocol Violation|1|||
126320654|NCT00419159|454466282|FG001|Overall Study|Protocol Violation|0|||
126320655|NCT00419159|454466281|FG000|Overall Study|Withdrawal by Subject|10|||
126320656|NCT00419159|454466282|FG001|Overall Study|Withdrawal by Subject|3|||
126320657|NCT00419159|454466281|FG000|Overall Study|Lost to Follow-up|0|||
126320658|NCT00419159|454466282|FG001|Overall Study|Lost to Follow-up|1|||
126320659|NCT00419159|454466281|FG000|Overall Study|Death|2|||
126320660|NCT00419159|454466282|FG001|Overall Study|Death|2|||
126320661|NCT00419159|454466281|FG000|Overall Study|Disease progression|79|||
126320662|NCT00419159|454466282|FG001|Overall Study|Disease progression|76|||
126320663|NCT00187278|454466283|FG000|Overall Study|Protocol Violation|10|||
126320664|NCT00187278|454466284|FG001|Overall Study|Protocol Violation|13|||
126320665|NCT00803205|454466285|FG000|Overall Study|Adverse Event|7|||
126320666|NCT00803205|454466286|FG001|Overall Study|Adverse Event|2|||
126320667|NCT00803205|454466285|FG000|Overall Study|Lost to Follow-up|1|||
126320668|NCT00803205|454466286|FG001|Overall Study|Lost to Follow-up|0|||
126320669|NCT00803205|454466285|FG000|Overall Study|Withdrawal by Subject|9|||
126320670|NCT00803205|454466286|FG001|Overall Study|Withdrawal by Subject|9|||
126320671|NCT00803205|454466285|FG000|Overall Study|Physician Decision|1|||
126320672|NCT00803205|454466286|FG001|Overall Study|Physician Decision|0|||
126320673|NCT00803205|454466285|FG000|Overall Study|Protocol Violation|1|||
126320674|NCT00803205|454466286|FG001|Overall Study|Protocol Violation|1|||
126320675|NCT00803205|454466285|FG000|Overall Study|Medical Monitor Decision|1|||
126320676|NCT00803205|454466286|FG001|Overall Study|Medical Monitor Decision|0|||
126320677|NCT00803205|454466285|FG000|Overall Study|Acquired a Lung Infection|0|||
126320678|NCT00803205|454466286|FG001|Overall Study|Acquired a Lung Infection|1|||
126320679|NCT00803205|454466285|FG000|Overall Study|Sponsor Decision|0|||
126320680|NCT00803205|454466286|FG001|Overall Study|Sponsor Decision|1|||
126320681|NCT02735096|454466287|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
126320682|NCT00379808|454466288|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
126320683|NCT00379808|454466289|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
126320684|NCT04299048|454466294|FG000|Overall Study|Death|1|||
125878476|NCT05138653|452851315|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
126320685|NCT04299048|454466294|FG000|Overall Study|Global deterioration of health status|2|||
126320686|NCT04299048|454466294|FG000|Overall Study|Enrolled and not treated|1|||
126320687|NCT01706575|454466295|FG000|Overall Study|Participant Withdrew Consent|4|||
126320688|NCT01706575|454466295|FG000|Overall Study|Lost to Follow-up|2|||
126320689|NCT01706575|454466295|FG000|Overall Study|Started but not Treated|6|||
126320690|NCT02536781|454466312|FG000|Overall Study|Lost to Follow-up|2|||
126320691|NCT02536781|454466313|FG001|Overall Study|Lost to Follow-up|0|||
126320692|NCT02069093|454466314|FG000|Overall Study|Disease progression|14|||
126320693|NCT02069093|454466314|FG000|Overall Study|New cancer therapy|1|||
126320694|NCT02069093|454466314|FG000|Overall Study|Death|1|||
126320695|NCT02069093|454466314|FG000|Overall Study|Administrative problems|1|||
126320696|NCT02069093|454466314|FG000|Overall Study|Withdrawal by Subject|2|||
126320697|NCT02069093|454466314|FG000|Overall Study|Abnormal laboratory values|1|||
126320698|NCT02069093|454466314|FG000|Overall Study|Adverse Event|10|||
126320699|NCT02028169|454466315|FG000|Overall Study|Lost to Follow-up|21|||
126320700|NCT02028169|454466315|FG000|Overall Study|Lack of Efficacy|2|||
126320701|NCT02028169|454466315|FG000|Overall Study|Withdrawal by Subject|2|||
126320702|NCT02028169|454466315|FG000|Overall Study|Adverse Event|1|||
126320703|NCT02028169|454466315|FG000|Overall Study|Cessation of Drug|1|||
126320704|NCT02028169|454466315|FG000|Overall Study|Concomitant Medication Usage|1|||
126320705|NCT02258334|454466316|FG000|Overall Study|Adverse Event|1|||
126320706|NCT02258334|454466317|FG001|Overall Study|Adverse Event|0|||
126320707|NCT02258334|454466318|FG002|Overall Study|Adverse Event|0|||
126320708|NCT02258334|454466319|FG003|Overall Study|Adverse Event|0|||
126320709|NCT01969084|454466320|FG000|Overall Study|Adverse Event|0|||
126320710|NCT01969084|454466321|FG001|Overall Study|Adverse Event|1|||
126320711|NCT00862459|454466322|FG000|Overall Study|Lost to Follow-up|1|||
126320712|NCT00862459|454466323|FG001|Overall Study|Lost to Follow-up|2|||
126320713|NCT00862459|454466324|FG002|Overall Study|Lost to Follow-up|2|||
126320714|NCT00862459|454466322|FG000|Overall Study|Protocol Violation|1|||
126320715|NCT00862459|454466323|FG001|Overall Study|Protocol Violation|0|||
125982878|NCT01090310|453228206|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
126320716|NCT00862459|454466324|FG002|Overall Study|Protocol Violation|0|||
126320717|NCT00862459|454466322|FG000|Overall Study|Withdrawal by Subject|1|||
126320718|NCT00862459|454466323|FG001|Overall Study|Withdrawal by Subject|1|||
126320719|NCT00862459|454466324|FG002|Overall Study|Withdrawal by Subject|3|||
126320720|NCT00862459|454466322|FG000|Overall Study|Adverse Event|0|||
126320721|NCT00862459|454466323|FG001|Overall Study|Adverse Event|1|||
126320722|NCT00862459|454466324|FG002|Overall Study|Adverse Event|0|||
126320723|NCT00862459|454466322|FG000|Overall Study|Personal reasons|1|||
126320724|NCT00862459|454466323|FG001|Overall Study|Personal reasons|0|||
126320725|NCT00862459|454466324|FG002|Overall Study|Personal reasons|0|||
126320726|NCT00862459|454466322|FG000|Overall Study|Operation|1|||
126320727|NCT00862459|454466323|FG001|Overall Study|Operation|1|||
126320728|NCT00862459|454466324|FG002|Overall Study|Operation|0|||
126320729|NCT00862459|454466322|FG000|Overall Study|Intravenous (IV) site problems|1|||
126320730|NCT00862459|454466323|FG001|Overall Study|Intravenous (IV) site problems|0|||
126320731|NCT00862459|454466324|FG002|Overall Study|Intravenous (IV) site problems|1|||
126320732|NCT00862459|454466322|FG000|Overall Study|Unable to hold still for imaging|0|||
126320733|NCT00862459|454466323|FG001|Overall Study|Unable to hold still for imaging|1|||
126320734|NCT00862459|454466324|FG002|Overall Study|Unable to hold still for imaging|0|||
126320735|NCT00862459|454466322|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
126320736|NCT00862459|454466323|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
126320737|NCT00862459|454466324|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
126320738|NCT00862459|454466322|FG000|Overall Study|Administrative problems|0|||
126320739|NCT00862459|454466323|FG001|Overall Study|Administrative problems|1|||
126320740|NCT00862459|454466324|FG002|Overall Study|Administrative problems|0|||
126320741|NCT04907227|454466331|FG000|Overall Study|Death|12|||
126320742|NCT04907227|454466332|FG001|Overall Study|Death|8|||
126320743|NCT04907227|454466331|FG000|Overall Study|Withdrawal by Subject|2|||
126320744|NCT04907227|454466332|FG001|Overall Study|Withdrawal by Subject|2|||
125982879|NCT01090310|453228203|FG000|Extension Study|Subject withdrew consent|0|||
126320745|NCT04907227|454466331|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
126320746|NCT04907227|454466332|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
126320747|NCT04907227|454466331|FG000|Overall Study|Sponsor Decision|25|||
126320748|NCT04907227|454466332|FG001|Overall Study|Sponsor Decision|30|||
126320749|NCT04907227|454466331|FG000|Overall Study|Physician Decision|1|||
126320750|NCT04907227|454466332|FG001|Overall Study|Physician Decision|0|||
126320751|NCT02240069|454466333|FG000|Overall Study|Withdrawal by Subject|5|||
126320752|NCT02240069|454466334|FG001|Overall Study|Withdrawal by Subject|5|||
126320753|NCT02240069|454466335|FG002|Overall Study|Withdrawal by Subject|2|||
126320754|NCT03723070|454466336|FG000|Overall Study|Lost to Follow-up|2|||
126320755|NCT03723070|454466336|FG000|Overall Study|Physician Decision|1|||
126320756|NCT03723070|454466336|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
126320757|NCT02208050|454466337|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
126320758|NCT02208050|454466338|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
126320759|NCT02134353|454466339|FG000|Overall Study|Adverse Event|10|||
126320760|NCT02134353|454466340|FG001|Overall Study|Adverse Event|6|||
126320761|NCT02134353|454466339|FG000|Overall Study|Lost to Follow-up|1|||
125982880|NCT01090310|453228204|FG001|Extension Study|Subject withdrew consent|1|||
126320762|NCT02134353|454466340|FG001|Overall Study|Lost to Follow-up|1|||
126320763|NCT02134353|454466339|FG000|Overall Study|Lack of Efficacy|2|||
126320764|NCT02134353|454466340|FG001|Overall Study|Lack of Efficacy|1|||
126320765|NCT02134353|454466339|FG000|Overall Study|Withdrawal by Subject|12|||
126320766|NCT02134353|454466340|FG001|Overall Study|Withdrawal by Subject|13|||
126320767|NCT02134353|454466339|FG000|Overall Study|Death|0|||
126320768|NCT02134353|454466340|FG001|Overall Study|Death|1|||
126320769|NCT02134353|454466339|FG000|Overall Study|Pregnancy|0|||
126320770|NCT02134353|454466340|FG001|Overall Study|Pregnancy|1|||
126320771|NCT02134353|454466339|FG000|Overall Study|Relocation|1|||
126320772|NCT02134353|454466340|FG001|Overall Study|Relocation|0|||
126320773|NCT02134353|454466339|FG000|Overall Study|Other - Patient's Choice|0|||
126320774|NCT02134353|454466340|FG001|Overall Study|Other - Patient's Choice|1|||
126320775|NCT00474786|454466342|FG000|Overall Study|Not Meeting Study Criteria|0|||
126320776|NCT00474786|454466343|FG001|Overall Study|Not Meeting Study Criteria|1|||
126320777|NCT00474786|454466342|FG000|Overall Study|Investigator Request|2|||
126320778|NCT00474786|454466343|FG001|Overall Study|Investigator Request|1|||
126320779|NCT00474786|454466342|FG000|Overall Study|Death|189|||
126320780|NCT00474786|454466343|FG001|Overall Study|Death|170|||
126320781|NCT00474786|454466342|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
126320782|NCT00474786|454466343|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
126320783|NCT00474786|454466342|FG000|Overall Study|Lost to Follow-up|4|||
126320784|NCT00474786|454466343|FG001|Overall Study|Lost to Follow-up|7|||
126320785|NCT00474786|454466342|FG000|Overall Study|Protocol Violation|2|||
126320786|NCT00474786|454466343|FG001|Overall Study|Protocol Violation|0|||
126320787|NCT00474786|454466342|FG000|Overall Study|Withdrawal by Subject|15|||
126320788|NCT00474786|454466343|FG001|Overall Study|Withdrawal by Subject|15|||
126320789|NCT00474786|454466342|FG000|Overall Study|Other|5|||
126320790|NCT00474786|454466343|FG001|Overall Study|Other|0|||
126320791|NCT00358956|454466344|FG000|Overall Study|Adverse Event|3|||
126320792|NCT00358956|454466344|FG000|Overall Study|condition under investigation worsened|4|||
126320793|NCT00358956|454466344|FG000|Overall Study|Withdrawal by Subject|1|||
126320794|NCT04776018|454466345|FG000|Overall Study|Death|0|||
126320795|NCT04776018|454466346|FG001|Overall Study|Death|1|||
126320796|NCT04776018|454466347|FG002|Overall Study|Death|4|||
126320797|NCT04776018|454466348|FG003|Overall Study|Death|1|||
126320798|NCT04776018|454466349|FG004|Overall Study|Death|4|||
126320799|NCT04776018|454466350|FG005|Overall Study|Death|0|||
126320800|NCT04776018|454466351|FG006|Overall Study|Death|0|||
126320801|NCT04776018|454466345|FG000|Overall Study|Study terminated by sponsor|2|||
126320802|NCT04776018|454466346|FG001|Overall Study|Study terminated by sponsor|1|||
126320803|NCT04776018|454466347|FG002|Overall Study|Study terminated by sponsor|4|||
126320804|NCT04776018|454466348|FG003|Overall Study|Study terminated by sponsor|0|||
126320805|NCT04776018|454466349|FG004|Overall Study|Study terminated by sponsor|3|||
126320806|NCT04776018|454466350|FG005|Overall Study|Study terminated by sponsor|0|||
126320807|NCT04776018|454466351|FG006|Overall Study|Study terminated by sponsor|0|||
126320808|NCT04776018|454466345|FG000|Overall Study|Withdrawal by Subject|1|||
126320809|NCT04776018|454466346|FG001|Overall Study|Withdrawal by Subject|0|||
126320810|NCT04776018|454466347|FG002|Overall Study|Withdrawal by Subject|0|||
126320811|NCT04776018|454466348|FG003|Overall Study|Withdrawal by Subject|2|||
126320812|NCT04776018|454466349|FG004|Overall Study|Withdrawal by Subject|1|||
126320813|NCT04776018|454466350|FG005|Overall Study|Withdrawal by Subject|0|||
126320814|NCT04776018|454466351|FG006|Overall Study|Withdrawal by Subject|0|||
126320815|NCT04776018|454466345|FG000|Overall Study|Other|0|||
126320816|NCT04776018|454466346|FG001|Overall Study|Other|1|||
126320817|NCT04776018|454466347|FG002|Overall Study|Other|1|||
126320818|NCT04776018|454466348|FG003|Overall Study|Other|0|||
126320819|NCT04776018|454466349|FG004|Overall Study|Other|0|||
126320820|NCT04776018|454466350|FG005|Overall Study|Other|0|||
126320821|NCT04776018|454466351|FG006|Overall Study|Other|0|||
126320822|NCT04776018|454466345|FG000|Overall Study|Lost to Follow-up|0|||
126320823|NCT04776018|454466346|FG001|Overall Study|Lost to Follow-up|0|||
126320824|NCT04776018|454466347|FG002|Overall Study|Lost to Follow-up|1|||
126320825|NCT04776018|454466348|FG003|Overall Study|Lost to Follow-up|0|||
126320826|NCT04776018|454466349|FG004|Overall Study|Lost to Follow-up|0|||
126320827|NCT04776018|454466350|FG005|Overall Study|Lost to Follow-up|0|||
125982881|NCT01090310|453228205|FG002|Extension Study|Subject withdrew consent|0|||
125982882|NCT01090310|453228206|FG003|Extension Study|Subject withdrew consent|0|||
125982883|NCT00695786|453228207|FG000|Overall Study|Adverse Event|0|||
125982884|NCT00695786|453228208|FG001|Overall Study|Adverse Event|3|||
126320828|NCT04776018|454466351|FG006|Overall Study|Lost to Follow-up|0|||
126320829|NCT02908074|454466353|FG000|Overall Study|sponsor/ICON decision|0|||
126320830|NCT02908074|454466354|FG001|Overall Study|sponsor/ICON decision|0|||
126320831|NCT02908074|454466355|FG002|Overall Study|sponsor/ICON decision|1|||
125982885|NCT00695786|453228209|FG002|Overall Study|Adverse Event|4|||
125982886|NCT00695786|453228210|FG003|Overall Study|Adverse Event|2|||
125982887|NCT00695786|453228207|FG000|Overall Study|Lost to Follow-up|0|||
126320832|NCT02908074|454466356|FG003|Overall Study|sponsor/ICON decision|0|||
126320833|NCT02908074|454466357|FG004|Overall Study|sponsor/ICON decision|0|||
126320834|NCT02908074|454466358|FG005|Overall Study|sponsor/ICON decision|0|||
126320835|NCT02908074|454466353|FG000|Overall Study|Protocol Violation|0|||
126320836|NCT02908074|454466354|FG001|Overall Study|Protocol Violation|1|||
126320837|NCT02908074|454466355|FG002|Overall Study|Protocol Violation|0|||
126320838|NCT02908074|454466356|FG003|Overall Study|Protocol Violation|0|||
126320839|NCT02908074|454466357|FG004|Overall Study|Protocol Violation|0|||
126320840|NCT02908074|454466358|FG005|Overall Study|Protocol Violation|0|||
126320841|NCT02908074|454466353|FG000|Overall Study|Adverse Event|5|||
126320842|NCT02908074|454466354|FG001|Overall Study|Adverse Event|2|||
126320843|NCT02908074|454466355|FG002|Overall Study|Adverse Event|0|||
126320844|NCT02908074|454466356|FG003|Overall Study|Adverse Event|0|||
126320845|NCT02908074|454466357|FG004|Overall Study|Adverse Event|1|||
126320846|NCT02908074|454466358|FG005|Overall Study|Adverse Event|0|||
126320847|NCT02908074|454466353|FG000|Overall Study|AESI|1|||
126320848|NCT02908074|454466354|FG001|Overall Study|AESI|0|||
126320849|NCT02908074|454466355|FG002|Overall Study|AESI|1|||
126320850|NCT02908074|454466356|FG003|Overall Study|AESI|0|||
126320851|NCT02908074|454466357|FG004|Overall Study|AESI|1|||
126320852|NCT02908074|454466358|FG005|Overall Study|AESI|0|||
126320853|NCT02908074|454466353|FG000|Overall Study|Discontinuation criteria per protocol|0|||
126320854|NCT02908074|454466354|FG001|Overall Study|Discontinuation criteria per protocol|0|||
126320855|NCT02908074|454466355|FG002|Overall Study|Discontinuation criteria per protocol|1|||
126320856|NCT02908074|454466356|FG003|Overall Study|Discontinuation criteria per protocol|0|||
126320857|NCT02908074|454466357|FG004|Overall Study|Discontinuation criteria per protocol|0|||
126320858|NCT02908074|454466358|FG005|Overall Study|Discontinuation criteria per protocol|1|||
126320859|NCT02908074|454466353|FG000|Overall Study|Withdrawal by Subject|3|||
126320860|NCT02908074|454466354|FG001|Overall Study|Withdrawal by Subject|2|||
126320861|NCT02908074|454466355|FG002|Overall Study|Withdrawal by Subject|2|||
126320862|NCT02908074|454466356|FG003|Overall Study|Withdrawal by Subject|2|||
126320863|NCT02908074|454466357|FG004|Overall Study|Withdrawal by Subject|2|||
126320864|NCT02908074|454466358|FG005|Overall Study|Withdrawal by Subject|2|||
126320865|NCT02908074|454466353|FG000|Overall Study|Lost to Follow-up|0|||
126320866|NCT02908074|454466354|FG001|Overall Study|Lost to Follow-up|1|||
126320867|NCT02908074|454466355|FG002|Overall Study|Lost to Follow-up|1|||
126320868|NCT02908074|454466356|FG003|Overall Study|Lost to Follow-up|1|||
126320869|NCT02908074|454466357|FG004|Overall Study|Lost to Follow-up|0|||
126320870|NCT02908074|454466358|FG005|Overall Study|Lost to Follow-up|1|||
126320871|NCT02655419|454466363|FG000|Overall Study|Enrolled but not treated|1|||
126320872|NCT02655419|454466364|FG001|Overall Study|Enrolled but not treated|5|||
126320873|NCT02655419|454466363|FG000|Overall Study|Withdrawal by Subject|4|||
126320874|NCT02655419|454466364|FG001|Overall Study|Withdrawal by Subject|1|||
126320875|NCT02655419|454466363|FG000|Overall Study|Other|0|||
126320876|NCT02655419|454466364|FG001|Overall Study|Other|1|||
126320877|NCT03403621|454466365|FG000|Overall Study|Withdrawal by Subject|2|||
126320878|NCT03403621|454466366|FG001|Overall Study|Withdrawal by Subject|2|||
126320879|NCT00583102|454466367|FG000|Overall Study|Adverse Event|3|||
126320880|NCT00505661|454466370|FG000|Overall Study|Not Eligible|4|||
126320881|NCT03611582|454466371|FG000|Overall Study|Adverse Event|26|||
126320882|NCT03611582|454466372|FG001|Overall Study|Adverse Event|6|||
126320883|NCT03611582|454466371|FG000|Overall Study|Protocol Violation|0|||
126320884|NCT03611582|454466372|FG001|Overall Study|Protocol Violation|1|||
126320885|NCT03611582|454466371|FG000|Overall Study|Pregnancy|1|||
126320886|NCT03611582|454466372|FG001|Overall Study|Pregnancy|2|||
126320887|NCT03611582|454466371|FG000|Overall Study|Lack of Efficacy|0|||
126320888|NCT03611582|454466372|FG001|Overall Study|Lack of Efficacy|1|||
126320889|NCT03611582|454466371|FG000|Overall Study|At the discretion of the investigator|1|||
126320890|NCT03611582|454466372|FG001|Overall Study|At the discretion of the investigator|0|||
126320891|NCT03611582|454466371|FG000|Overall Study|Safety concern as judged by the investigator|1|||
126320892|NCT03611582|454466372|FG001|Overall Study|Safety concern as judged by the investigator|2|||
126320893|NCT03611582|454466371|FG000|Overall Study|Withdrawal by Subject|4|||
126320894|NCT03611582|454466372|FG001|Overall Study|Withdrawal by Subject|3|||
125982888|NCT00695786|453228208|FG001|Overall Study|Lost to Follow-up|5|||
126320895|NCT03611582|454466371|FG000|Overall Study|Lost to Follow-up|18|||
126320896|NCT03611582|454466372|FG001|Overall Study|Lost to Follow-up|7|||
126320897|NCT03611582|454466371|FG000|Overall Study|other|17|||
126320898|NCT03611582|454466372|FG001|Overall Study|other|16|||
126320899|NCT04459598|454466373|FG000|Overall Study|Adverse Event|1|||
126320900|NCT04459598|454466374|FG001|Overall Study|Adverse Event|1|||
126320901|NCT01078298|454466375|FG000|Overall Study|Lost to Follow-up|12|||
126320902|NCT01078298|454466376|FG001|Overall Study|Lost to Follow-up|13|||
125982889|NCT00695786|453228209|FG002|Overall Study|Lost to Follow-up|1|||
126320903|NCT01078298|454466375|FG000|Overall Study|Withdrawal by Subject|31|||
126320904|NCT01078298|454466376|FG001|Overall Study|Withdrawal by Subject|33|||
126320905|NCT01078298|454466375|FG000|Overall Study|Protocol Violation|6|||
126320906|NCT01078298|454466376|FG001|Overall Study|Protocol Violation|6|||
126320907|NCT01078298|454466375|FG000|Overall Study|Adverse Event|6|||
126320908|NCT01078298|454466376|FG001|Overall Study|Adverse Event|5|||
126320909|NCT01078298|454466375|FG000|Overall Study|Death|2|||
126320910|NCT01078298|454466376|FG001|Overall Study|Death|0|||
125982890|NCT00695786|453228210|FG003|Overall Study|Lost to Follow-up|1|||
126320911|NCT01078298|454466375|FG000|Overall Study|Did not meet entrance criteria|0|||
126320912|NCT01078298|454466376|FG001|Overall Study|Did not meet entrance criteria|1|||
126320913|NCT01078298|454466375|FG000|Overall Study|Other|24|||
126320914|NCT01078298|454466376|FG001|Overall Study|Other|32|||
126320915|NCT00463840|454466377|FG000|Overall Study|Disease progression|7|||
126320916|NCT00463840|454466377|FG000|Overall Study|Withdrawal by Subject|2|||
126320917|NCT00463840|454466377|FG000|Overall Study|Adverse Event|3|||
126320918|NCT00866333|454466378|FG000|Overall Study|Withdrawal of consent|0|||
126320919|NCT00866333|454466379|FG001|Overall Study|Withdrawal of consent|1|||
126320920|NCT00866333|454466380|FG002|Overall Study|Withdrawal of consent|2|||
126320921|NCT00866333|454466378|FG000|Overall Study|Reason not Specified|3|||
126320922|NCT00866333|454466379|FG001|Overall Study|Reason not Specified|1|||
126320923|NCT00866333|454466380|FG002|Overall Study|Reason not Specified|1|||
126320924|NCT00866333|454466378|FG000|Overall Study|Study Terminated by Sponsor|2|||
126320925|NCT00866333|454466379|FG001|Overall Study|Study Terminated by Sponsor|5|||
126320926|NCT00866333|454466380|FG002|Overall Study|Study Terminated by Sponsor|9|||
126320927|NCT01653327|454466381|FG000|Overall Study|Withdrawal by Subject|1|||
126320928|NCT01738191|454466382|FG000|Overall Study|Withdrawal by Subject|4|||
126320929|NCT01738191|454466383|FG001|Overall Study|Withdrawal by Subject|1|||
126320930|NCT00422292|454466384|FG000|Overall Study|Serious adverse events|1|||
126320931|NCT00422292|454466385|FG001|Overall Study|Serious adverse events|4|||
126320932|NCT00422292|454466386|FG002|Overall Study|Serious adverse events|0|||
126320933|NCT00422292|454466387|FG003|Overall Study|Serious adverse events|0|||
126320934|NCT00422292|454466384|FG000|Overall Study|Adverse Event|1|||
126320935|NCT00422292|454466385|FG001|Overall Study|Adverse Event|0|||
126320936|NCT00422292|454466386|FG002|Overall Study|Adverse Event|1|||
126320937|NCT00422292|454466387|FG003|Overall Study|Adverse Event|0|||
126320938|NCT00422292|454466384|FG000|Overall Study|Protocol Violation|4|||
126320939|NCT00422292|454466385|FG001|Overall Study|Protocol Violation|25|||
126320940|NCT00422292|454466386|FG002|Overall Study|Protocol Violation|8|||
126320941|NCT00422292|454466387|FG003|Overall Study|Protocol Violation|5|||
126320942|NCT00422292|454466384|FG000|Overall Study|Lost to Follow-up|6|||
126320943|NCT00422292|454466385|FG001|Overall Study|Lost to Follow-up|12|||
126320944|NCT00422292|454466386|FG002|Overall Study|Lost to Follow-up|6|||
126320945|NCT00422292|454466387|FG003|Overall Study|Lost to Follow-up|6|||
126320946|NCT00422292|454466384|FG000|Overall Study|Withdrawal by Subject|6|||
126320947|NCT00422292|454466385|FG001|Overall Study|Withdrawal by Subject|25|||
126320948|NCT00422292|454466386|FG002|Overall Study|Withdrawal by Subject|7|||
126320949|NCT00422292|454466387|FG003|Overall Study|Withdrawal by Subject|13|||
126320950|NCT02243046|454466388|FG000|Overall Study|Lost to Follow-up|1|||
126320951|NCT02243046|454466389|FG001|Overall Study|Lost to Follow-up|1|||
126320952|NCT02243046|454466390|FG002|Overall Study|Lost to Follow-up|4|||
126320953|NCT03338569|454466391|FG000|Overall Study|Physician Decision|8|||
126320954|NCT03338569|454466392|FG001|Overall Study|Physician Decision|3|||
126320955|NCT03338569|454466391|FG000|Overall Study|Withdrawal by Subject|0|||
126320956|NCT03338569|454466392|FG001|Overall Study|Withdrawal by Subject|1|||
126320957|NCT03338569|454466391|FG000|Overall Study|Lost to Follow-up|0|||
126320958|NCT03338569|454466392|FG001|Overall Study|Lost to Follow-up|1|||
126320959|NCT04607980|454466393|FG000|Overall Study|Adverse Event|3|||
126320960|NCT04607980|454466394|FG001|Overall Study|Adverse Event|4|||
126320961|NCT04607980|454466393|FG000|Overall Study|Death|0|||
126320962|NCT04607980|454466394|FG001|Overall Study|Death|1|||
126320963|NCT04607980|454466393|FG000|Overall Study|Withdrawal by Subject|2|||
126320964|NCT04607980|454466394|FG001|Overall Study|Withdrawal by Subject|5|||
126320965|NCT04607980|454466393|FG000|Overall Study|Lost to Follow-up|4|||
126320966|NCT04607980|454466394|FG001|Overall Study|Lost to Follow-up|8|||
126320967|NCT04607980|454466393|FG000|Overall Study|Protocol Violation|0|||
126320968|NCT04607980|454466394|FG001|Overall Study|Protocol Violation|3|||
126320969|NCT04607980|454466393|FG000|Overall Study|Other|3|||
126320970|NCT04607980|454466394|FG001|Overall Study|Other|0|||
126320971|NCT02109445|454466397|FG000|Overall Study|Symptomatic deterioration|2|||
126320972|NCT02109445|454466397|FG000|Overall Study|Adverse Event|1|||
126320973|NCT00441363|454467602|FG000|Overall Study|Adverse Event|4|||
126320974|NCT00441363|454467603|FG001|Overall Study|Adverse Event|2|||
126320975|NCT00441363|454467602|FG000|Overall Study|Withdrawal by Subject|3|||
126320976|NCT00441363|454467603|FG001|Overall Study|Withdrawal by Subject|4|||
125982891|NCT00695786|453228207|FG000|Overall Study|Withdrawal by Subject|0|||
126320977|NCT00441363|454467602|FG000|Overall Study|Physician Decision|6|||
126320978|NCT00441363|454467603|FG001|Overall Study|Physician Decision|7|||
126320979|NCT00441363|454467602|FG000|Overall Study|Lost to Follow-up|2|||
126320980|NCT00441363|454467603|FG001|Overall Study|Lost to Follow-up|2|||
126320981|NCT00441363|454467602|FG000|Overall Study|Other|2|||
126320982|NCT00441363|454467603|FG001|Overall Study|Other|0|||
126320983|NCT02474355|454467609|FG000|Overall Study|Other|43|||
126320984|NCT02474355|454467609|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
126320985|NCT02474355|454467609|FG000|Overall Study|Lost to Follow-up|98|||
126320986|NCT02474355|454467609|FG000|Overall Study|Withdrawal by Subject|124|||
126320987|NCT02474355|454467609|FG000|Overall Study|Death|1361|||
126320988|NCT01066793|454467610|FG000|Overall Study|Death|4|||
126320989|NCT01066793|454467611|FG001|Overall Study|Death|1|||
126320990|NCT01066793|454467612|FG002|Overall Study|Death|1|||
126320991|NCT01066793|454467613|FG003|Overall Study|Death|0|||
126320992|NCT01066793|454467614|FG004|Overall Study|Death|0|||
126320993|NCT01066793|454467615|FG005|Overall Study|Death|0|||
126320994|NCT01066793|454467610|FG000|Overall Study|Lack of Efficacy|2|||
126320995|NCT01066793|454467611|FG001|Overall Study|Lack of Efficacy|1|||
126320996|NCT01066793|454467612|FG002|Overall Study|Lack of Efficacy|0|||
126320997|NCT01066793|454467613|FG003|Overall Study|Lack of Efficacy|0|||
126320998|NCT01066793|454467614|FG004|Overall Study|Lack of Efficacy|0|||
126320999|NCT01066793|454467615|FG005|Overall Study|Lack of Efficacy|0|||
126321000|NCT01066793|454467610|FG000|Overall Study|Lost to Follow-up|180|||
126321001|NCT01066793|454467611|FG001|Overall Study|Lost to Follow-up|39|||
126321002|NCT01066793|454467612|FG002|Overall Study|Lost to Follow-up|82|||
126321003|NCT01066793|454467613|FG003|Overall Study|Lost to Follow-up|16|||
126321004|NCT01066793|454467614|FG004|Overall Study|Lost to Follow-up|0|||
126321005|NCT01066793|454467615|FG005|Overall Study|Lost to Follow-up|1|||
126321006|NCT01066793|454467610|FG000|Overall Study|Physician Decision|3|||
126321007|NCT01066793|454467611|FG001|Overall Study|Physician Decision|0|||
126321008|NCT01066793|454467612|FG002|Overall Study|Physician Decision|0|||
126321009|NCT01066793|454467613|FG003|Overall Study|Physician Decision|0|||
126321010|NCT01066793|454467614|FG004|Overall Study|Physician Decision|0|||
126321011|NCT01066793|454467615|FG005|Overall Study|Physician Decision|0|||
126321012|NCT01066793|454467610|FG000|Overall Study|Protocol Violation|3|||
126321013|NCT01066793|454467611|FG001|Overall Study|Protocol Violation|2|||
126321014|NCT01066793|454467612|FG002|Overall Study|Protocol Violation|2|||
126321015|NCT01066793|454467613|FG003|Overall Study|Protocol Violation|0|||
126321016|NCT01066793|454467614|FG004|Overall Study|Protocol Violation|0|||
126321017|NCT01066793|454467615|FG005|Overall Study|Protocol Violation|0|||
126321018|NCT01066793|454467610|FG000|Overall Study|Withdrawal by Subject|7|||
126321019|NCT01066793|454467611|FG001|Overall Study|Withdrawal by Subject|4|||
126321020|NCT01066793|454467612|FG002|Overall Study|Withdrawal by Subject|1|||
126321021|NCT01066793|454467613|FG003|Overall Study|Withdrawal by Subject|0|||
126321022|NCT01066793|454467614|FG004|Overall Study|Withdrawal by Subject|0|||
126321023|NCT01066793|454467615|FG005|Overall Study|Withdrawal by Subject|0|||
126321024|NCT01066793|454467610|FG000|Overall Study|Early Termination|3|||
126321025|NCT01066793|454467611|FG001|Overall Study|Early Termination|0|||
126321026|NCT01066793|454467612|FG002|Overall Study|Early Termination|0|||
126321027|NCT01066793|454467613|FG003|Overall Study|Early Termination|0|||
126321028|NCT01066793|454467614|FG004|Overall Study|Early Termination|0|||
126321029|NCT01066793|454467615|FG005|Overall Study|Early Termination|0|||
126321030|NCT01066793|454467610|FG000|Overall Study|Lab test not done|7|||
126321031|NCT01066793|454467611|FG001|Overall Study|Lab test not done|0|||
126321032|NCT01066793|454467612|FG002|Overall Study|Lab test not done|0|||
126321033|NCT01066793|454467613|FG003|Overall Study|Lab test not done|1|||
126321034|NCT01066793|454467614|FG004|Overall Study|Lab test not done|0|||
126321035|NCT01066793|454467615|FG005|Overall Study|Lab test not done|0|||
126321036|NCT01066793|454467610|FG000|Overall Study|Miscellaneous|4|||
126321037|NCT01066793|454467611|FG001|Overall Study|Miscellaneous|5|||
126321038|NCT01066793|454467612|FG002|Overall Study|Miscellaneous|6|||
126321039|NCT01066793|454467613|FG003|Overall Study|Miscellaneous|0|||
126321040|NCT01066793|454467614|FG004|Overall Study|Miscellaneous|0|||
126321041|NCT01066793|454467615|FG005|Overall Study|Miscellaneous|0|||
126321042|NCT01066793|454467610|FG000|Overall Study|Non-responders|104|||
126321043|NCT01066793|454467611|FG001|Overall Study|Non-responders|5|||
126321044|NCT01066793|454467612|FG002|Overall Study|Non-responders|11|||
126321045|NCT01066793|454467613|FG003|Overall Study|Non-responders|25|||
126321046|NCT01066793|454467614|FG004|Overall Study|Non-responders|0|||
126321047|NCT01066793|454467615|FG005|Overall Study|Non-responders|0|||
126321048|NCT01066793|454467610|FG000|Overall Study|Other|15|||
126321049|NCT01066793|454467611|FG001|Overall Study|Other|5|||
126321050|NCT01066793|454467612|FG002|Overall Study|Other|6|||
126321051|NCT01066793|454467613|FG003|Overall Study|Other|2|||
126321052|NCT01066793|454467614|FG004|Overall Study|Other|0|||
126321053|NCT01066793|454467615|FG005|Overall Study|Other|0|||
126321054|NCT01066793|454467610|FG000|Overall Study|Relapse|20|||
126321055|NCT01066793|454467611|FG001|Overall Study|Relapse|8|||
126321056|NCT01066793|454467612|FG002|Overall Study|Relapse|2|||
126321057|NCT01066793|454467613|FG003|Overall Study|Relapse|3|||
126321058|NCT01066793|454467614|FG004|Overall Study|Relapse|0|||
126321059|NCT01066793|454467615|FG005|Overall Study|Relapse|0|||
126321060|NCT01066793|454467610|FG000|Overall Study|Result Not Available|1|||
126321061|NCT01066793|454467611|FG001|Overall Study|Result Not Available|0|||
126321062|NCT01066793|454467612|FG002|Overall Study|Result Not Available|0|||
126321063|NCT01066793|454467613|FG003|Overall Study|Result Not Available|0|||
126321064|NCT01066793|454467614|FG004|Overall Study|Result Not Available|0|||
126321065|NCT01066793|454467615|FG005|Overall Study|Result Not Available|0|||
126321066|NCT01066793|454467610|FG000|Overall Study|Treatment Interrupted|1|||
126321067|NCT01066793|454467611|FG001|Overall Study|Treatment Interrupted|1|||
126321068|NCT01066793|454467612|FG002|Overall Study|Treatment Interrupted|0|||
126321069|NCT01066793|454467613|FG003|Overall Study|Treatment Interrupted|0|||
126321070|NCT01066793|454467614|FG004|Overall Study|Treatment Interrupted|0|||
126321071|NCT01066793|454467615|FG005|Overall Study|Treatment Interrupted|0|||
126321072|NCT01066793|454467610|FG000|Overall Study|Treatment Never Started|18|||
126321073|NCT01066793|454467611|FG001|Overall Study|Treatment Never Started|5|||
126321074|NCT01066793|454467612|FG002|Overall Study|Treatment Never Started|4|||
126321075|NCT01066793|454467613|FG003|Overall Study|Treatment Never Started|1|||
126321076|NCT01066793|454467614|FG004|Overall Study|Treatment Never Started|0|||
126321077|NCT01066793|454467615|FG005|Overall Study|Treatment Never Started|0|||
126321078|NCT01066793|454467610|FG000|Overall Study|Treatment Stopped|2|||
126321079|NCT01066793|454467611|FG001|Overall Study|Treatment Stopped|1|||
126321080|NCT01066793|454467612|FG002|Overall Study|Treatment Stopped|0|||
126321081|NCT01066793|454467613|FG003|Overall Study|Treatment Stopped|1|||
126321082|NCT01066793|454467614|FG004|Overall Study|Treatment Stopped|0|||
126321083|NCT01066793|454467615|FG005|Overall Study|Treatment Stopped|0|||
126321084|NCT01911793|454467616|FG000|Overall Study|Physician Decision|1|||
126321085|NCT01911793|454467617|FG001|Overall Study|Physician Decision|5|||
126321086|NCT01313221|454467620|FG000|Overall Study|Protocol Violation|0|||
126321087|NCT01313221|454467621|FG001|Overall Study|Protocol Violation|1|||
126321088|NCT01313221|454467622|FG002|Overall Study|Protocol Violation|1|||
126321089|NCT01313221|454467620|FG000|Overall Study|Non-compliance|3|||
126321090|NCT01313221|454467621|FG001|Overall Study|Non-compliance|0|||
126321091|NCT01313221|454467622|FG002|Overall Study|Non-compliance|2|||
126321092|NCT01313221|454467620|FG000|Overall Study|Withdrawal by Subject|2|||
126321093|NCT01313221|454467621|FG001|Overall Study|Withdrawal by Subject|3|||
126321094|NCT01313221|454467622|FG002|Overall Study|Withdrawal by Subject|5|||
126321095|NCT01313221|454467620|FG000|Overall Study|Requirement for alternative therapy|0|||
126321096|NCT01313221|454467621|FG001|Overall Study|Requirement for alternative therapy|1|||
126321097|NCT01313221|454467622|FG002|Overall Study|Requirement for alternative therapy|1|||
126321098|NCT01313221|454467620|FG000|Overall Study|Lost to Follow-up|6|||
126321099|NCT01313221|454467621|FG001|Overall Study|Lost to Follow-up|3|||
126321100|NCT01313221|454467622|FG002|Overall Study|Lost to Follow-up|1|||
126321101|NCT01313221|454467620|FG000|Overall Study|Other|1|||
126321102|NCT01313221|454467621|FG001|Overall Study|Other|0|||
126321103|NCT01313221|454467622|FG002|Overall Study|Other|0|||
126321104|NCT01313221|454467620|FG000|Overall Study|Adverse Event|0|||
126321105|NCT01313221|454467621|FG001|Overall Study|Adverse Event|0|||
126321106|NCT01313221|454467622|FG002|Overall Study|Adverse Event|7|||
126321107|NCT01313221|454467620|FG000|Overall Study|Disease progression|0|||
126321108|NCT01313221|454467621|FG001|Overall Study|Disease progression|0|||
126321109|NCT01313221|454467622|FG002|Overall Study|Disease progression|2|||
126321110|NCT01313221|454467620|FG000|Overall Study|Physician Decision|0|||
126321111|NCT01313221|454467621|FG001|Overall Study|Physician Decision|0|||
126321112|NCT01313221|454467622|FG002|Overall Study|Physician Decision|2|||
126321113|NCT01313221|454467620|FG000|Overall Study|Pregnancy|0|||
126321114|NCT01313221|454467621|FG001|Overall Study|Pregnancy|0|||
126321115|NCT01313221|454467622|FG002|Overall Study|Pregnancy|2|||
126321116|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
126321117|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
126321118|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
126321119|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
126321120|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
126321121|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
126321122|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
126321123|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
126321124|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
126321125|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
126321126|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
126321127|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
126321128|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
126321129|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
126321130|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
126321131|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
126321132|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
125982892|NCT00695786|453228208|FG001|Overall Study|Withdrawal by Subject|4|||
126321133|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
126321134|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
126321135|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
126321136|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
126321137|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
126321138|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
126321139|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
126321140|NCT02636699|454467634|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
126321141|NCT02636699|454467635|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
126321142|NCT02636699|454467636|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
126321143|NCT02636699|454467634|FG000|Screening Period|Withdrawal by Subject|0|||
126321144|NCT02636699|454467635|FG001|Screening Period|Withdrawal by Subject|0|||
126321145|NCT02636699|454467636|FG002|Screening Period|Withdrawal by Subject|23|||
126321146|NCT02636699|454467634|FG000|Screening Period|Adverse Event|0|||
126321147|NCT02636699|454467635|FG001|Screening Period|Adverse Event|0|||
126321148|NCT02636699|454467636|FG002|Screening Period|Adverse Event|1|||
126321149|NCT02636699|454467634|FG000|Screening Period|Other not specified|0|||
126321150|NCT02636699|454467635|FG001|Screening Period|Other not specified|0|||
126321151|NCT02636699|454467636|FG002|Screening Period|Other not specified|3|||
126321152|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
126321153|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
126321154|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
126321155|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
126321156|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
126321157|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
126321158|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
126321159|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
126321160|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
126321161|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
126321162|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
126321163|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
126321164|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
126321165|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
126321166|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
126321167|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Other|3|||
126321168|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Other|1|||
126321169|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Other|0|||
126321170|NCT02305446|454467645|FG000|Overall Study|Adverse Event|1|||
126321171|NCT01636947|454467646|FG000|Overall Study|Not Treated|2|||
126321172|NCT01636947|454467647|FG001|Overall Study|Not Treated|2|||
126321173|NCT01636947|454467646|FG000|Overall Study|Lost to Follow-up|4|||
126321174|NCT01636947|454467647|FG001|Overall Study|Lost to Follow-up|0|||
126321175|NCT01636947|454467646|FG000|Overall Study|Protocol Violation|1|||
126321176|NCT01636947|454467647|FG001|Overall Study|Protocol Violation|1|||
126321177|NCT01636947|454467646|FG000|Overall Study|Withdrawal by Subject|3|||
126321178|NCT01636947|454467647|FG001|Overall Study|Withdrawal by Subject|3|||
126321179|NCT01636947|454467646|FG000|Overall Study|Adverse Event|1|||
126321180|NCT01636947|454467647|FG001|Overall Study|Adverse Event|1|||
126321181|NCT01636947|454467646|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
126321182|NCT01636947|454467647|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
126321183|NCT00957424|454467648|FG000|Overall Study|Lost to Follow-up|19|||
126321184|NCT00957424|454467648|FG000|Overall Study|Protocol Violation|3|||
126321185|NCT00957424|454467648|FG000|Overall Study|Withdrawal by Subject|1|||
126321186|NCT05182606|454467656|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
126321187|NCT01955109|454467659|FG000|Overall Study|Adverse Event|2|||
126321188|NCT01955109|454467660|FG001|Overall Study|Adverse Event|0|||
126321189|NCT01955109|454467659|FG000|Overall Study|Participant unwilling to continue|35|||
126321190|NCT01955109|454467660|FG001|Overall Study|Participant unwilling to continue|7|||
126321191|NCT01955109|454467659|FG000|Overall Study|Physician Decision|2|||
126321192|NCT01955109|454467660|FG001|Overall Study|Physician Decision|0|||
126321193|NCT01955109|454467659|FG000|Overall Study|Lost to Follow-up|3|||
126321194|NCT01955109|454467660|FG001|Overall Study|Lost to Follow-up|1|||
126321195|NCT01955109|454467659|FG000|Overall Study|Non-compliance|3|||
126321196|NCT01955109|454467660|FG001|Overall Study|Non-compliance|1|||
126321197|NCT01618916|454467662|FG000|Overall Study|Adverse Event|1|||
126321198|NCT01618916|454467663|FG001|Overall Study|Adverse Event|0|||
126321199|NCT01618916|454467664|FG002|Overall Study|Adverse Event|0|||
126321200|NCT01618916|454467665|FG003|Overall Study|Adverse Event|0|||
126321201|NCT01618916|454467666|FG004|Overall Study|Adverse Event|0|||
126321202|NCT01618916|454467667|FG005|Overall Study|Adverse Event|0|||
126321203|NCT01618916|454467662|FG000|Overall Study|Withdrawal by Subject|0|||
126321204|NCT01618916|454467663|FG001|Overall Study|Withdrawal by Subject|1|||
126321205|NCT01618916|454467664|FG002|Overall Study|Withdrawal by Subject|1|||
126321206|NCT01618916|454467665|FG003|Overall Study|Withdrawal by Subject|0|||
125982893|NCT00695786|453228209|FG002|Overall Study|Withdrawal by Subject|3|||
125982894|NCT00695786|453228210|FG003|Overall Study|Withdrawal by Subject|1|||
126321207|NCT01618916|454467666|FG004|Overall Study|Withdrawal by Subject|1|||
126321208|NCT01618916|454467667|FG005|Overall Study|Withdrawal by Subject|0|||
126321209|NCT01618916|454467662|FG000|Overall Study|Lost to Follow-up|1|||
126321210|NCT01618916|454467663|FG001|Overall Study|Lost to Follow-up|0|||
126321211|NCT01618916|454467664|FG002|Overall Study|Lost to Follow-up|0|||
126321212|NCT01618916|454467665|FG003|Overall Study|Lost to Follow-up|2|||
126321213|NCT01618916|454467666|FG004|Overall Study|Lost to Follow-up|0|||
126321214|NCT01618916|454467667|FG005|Overall Study|Lost to Follow-up|0|||
126321215|NCT04521114|454467668|FG000|Overall Study|Lost to Follow-up|1|||
126321216|NCT04521114|454467669|FG001|Overall Study|Lost to Follow-up|2|||
126321217|NCT04521114|454467670|FG002|Overall Study|Lost to Follow-up|0|||
126321218|NCT04521114|454467668|FG000|Overall Study|Withdrawal by Subject|1|||
126321219|NCT04521114|454467669|FG001|Overall Study|Withdrawal by Subject|2|||
126321220|NCT04521114|454467670|FG002|Overall Study|Withdrawal by Subject|2|||
126321221|NCT04521114|454467668|FG000|Overall Study|Adverse Event|1|||
126321222|NCT04521114|454467669|FG001|Overall Study|Adverse Event|0|||
126321223|NCT04521114|454467670|FG002|Overall Study|Adverse Event|0|||
126321224|NCT04521114|454467668|FG000|Overall Study|Sponsor Wish|1|||
126321225|NCT04521114|454467669|FG001|Overall Study|Sponsor Wish|0|||
126321226|NCT04521114|454467670|FG002|Overall Study|Sponsor Wish|0|||
126321227|NCT04521114|454467668|FG000|Overall Study|Withdrawal of Consent|2|||
126321228|NCT04521114|454467669|FG001|Overall Study|Withdrawal of Consent|2|||
126321229|NCT04521114|454467670|FG002|Overall Study|Withdrawal of Consent|0|||
126321230|NCT01133288|454467673|FG000|Eligibility Assessment|met exclusion criteria|5|||
126321231|NCT01133288|454467673|FG000|Intervention Allocation|study terminated|2|||
126321232|NCT00438256|454467674|FG000|Overall Study|Ineligible for Resection|2|||
126321233|NCT00438256|454467675|FG001|Overall Study|Ineligible for Resection|1|||
126321234|NCT00438256|454467676|FG002|Overall Study|Ineligible for Resection|1|||
126321235|NCT00438256|454467677|FG003|Overall Study|Ineligible for Resection|7|||
126321236|NCT00438256|454467674|FG000|Overall Study|Excluded final Diagnosis|0|||
126321237|NCT00438256|454467675|FG001|Overall Study|Excluded final Diagnosis|0|||
126321238|NCT00438256|454467676|FG002|Overall Study|Excluded final Diagnosis|0|||
126321239|NCT00438256|454467677|FG003|Overall Study|Excluded final Diagnosis|2|||
126321240|NCT00369161|454467686|FG000|Overall Study|Adverse Event|15|||
126321241|NCT00369161|454467687|FG001|Overall Study|Adverse Event|13|||
126321242|NCT00369161|454467686|FG000|Overall Study|Abnormal laboratory value|0|||
126321243|NCT00369161|454467687|FG001|Overall Study|Abnormal laboratory value|1|||
126321244|NCT00369161|454467686|FG000|Overall Study|Lack of Efficacy|3|||
126321245|NCT00369161|454467687|FG001|Overall Study|Lack of Efficacy|1|||
126321246|NCT00369161|454467686|FG000|Overall Study|Protocol Violation|0|||
126321247|NCT00369161|454467687|FG001|Overall Study|Protocol Violation|2|||
126321248|NCT00369161|454467686|FG000|Overall Study|Withdrawal by Subject|2|||
126321249|NCT00369161|454467687|FG001|Overall Study|Withdrawal by Subject|3|||
126321250|NCT00369161|454467686|FG000|Overall Study|Death|1|||
126321251|NCT00369161|454467687|FG001|Overall Study|Death|2|||
126321252|NCT00369161|454467686|FG000|Overall Study|Graft loss|4|||
126321253|NCT00369161|454467687|FG001|Overall Study|Graft loss|0|||
126321254|NCT00369161|454467686|FG000|Overall Study|Administrative Problem|2|||
126321255|NCT00369161|454467687|FG001|Overall Study|Administrative Problem|2|||
126321256|NCT00750919|454467688|FG000|Overall Study|Adverse Event|9|||
126321257|NCT00750919|454467688|FG000|Overall Study|Withdrawal by Subject|1|||
126321258|NCT00750919|454467688|FG000|Overall Study|Lack of Efficacy|8|||
126321259|NCT00750919|454467688|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
126321260|NCT00750919|454467688|FG000|Overall Study|Other|36|||
126321261|NCT02147067|454467691|FG000|Overall Study|Withdrawal by Subject|2|||
126321262|NCT02147067|454467692|FG001|Overall Study|Withdrawal by Subject|2|||
126321263|NCT01404949|454467693|FG000|Overall Study|Not Treated|1|||
126321264|NCT01017601|454467696|FG000|Overall Study|Disease Progression|12|||
126321265|NCT01017601|454467697|FG001|Overall Study|Disease Progression|12|||
126321266|NCT01017601|454467696|FG000|Overall Study|Withdrawal by Subject|0|||
126321267|NCT01017601|454467697|FG001|Overall Study|Withdrawal by Subject|1|||
126321268|NCT02638259|454467702|FG000|Treatment Period 1|Adverse Event|1|||
126321269|NCT02638259|454467703|FG001|Treatment Period 1|Adverse Event|5|||
126321270|NCT02638259|454467702|FG000|Treatment Period 1|Death|0|||
126321271|NCT02638259|454467703|FG001|Treatment Period 1|Death|1|||
126321272|NCT02638259|454467702|FG000|Treatment Period 1|Lack of Efficacy|0|||
126321273|NCT02638259|454467703|FG001|Treatment Period 1|Lack of Efficacy|1|||
126321274|NCT02638259|454467702|FG000|Treatment Period 1|Protocol Violation|0|||
125982895|NCT00695786|453228207|FG000|Overall Study|Deemed Ineligible|1|||
125982896|NCT00695786|453228208|FG001|Overall Study|Deemed Ineligible|0|||
125982897|NCT00695786|453228209|FG002|Overall Study|Deemed Ineligible|0|||
125982898|NCT00695786|453228210|FG003|Overall Study|Deemed Ineligible|0|||
126321275|NCT02638259|454467703|FG001|Treatment Period 1|Protocol Violation|3|||
126321276|NCT02638259|454467702|FG000|Treatment Period 1|Withdrawal by Subject|4|||
126321277|NCT02638259|454467703|FG001|Treatment Period 1|Withdrawal by Subject|6|||
126321278|NCT02638259|454467702|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
125982899|NCT00695786|453228207|FG000|Overall Study|Lack of Efficacy|0|||
126321279|NCT02638259|454467703|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
126321280|NCT02638259|454467702|FG000|Treatment Period 2|Adverse Event|5|||
126321281|NCT02638259|454467703|FG001|Treatment Period 2|Adverse Event|4|||
126321282|NCT02638259|454467702|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126321283|NCT02638259|454467703|FG001|Treatment Period 2|Withdrawal by Subject|7|||
126321284|NCT01094782|454467704|FG000|Overall Study|Withdrawal by Subject|5|||
126321285|NCT01094782|454467705|FG001|Overall Study|Withdrawal by Subject|5|||
126321286|NCT01094782|454467706|FG002|Overall Study|Withdrawal by Subject|1|||
126321287|NCT01094782|454467707|FG003|Overall Study|Withdrawal by Subject|5|||
126321288|NCT01094782|454467708|FG004|Overall Study|Withdrawal by Subject|5|||
126321289|NCT01094782|454467709|FG005|Overall Study|Withdrawal by Subject|0|||
126321290|NCT01094782|454467704|FG000|Overall Study|Lost to Follow-up|1|||
126321291|NCT01094782|454467705|FG001|Overall Study|Lost to Follow-up|0|||
126321292|NCT01094782|454467706|FG002|Overall Study|Lost to Follow-up|0|||
126321293|NCT01094782|454467707|FG003|Overall Study|Lost to Follow-up|2|||
126321294|NCT01094782|454467708|FG004|Overall Study|Lost to Follow-up|1|||
126321295|NCT01094782|454467709|FG005|Overall Study|Lost to Follow-up|4|||
126321296|NCT01094782|454467704|FG000|Overall Study|Positive Drug Screen|2|||
126321297|NCT01094782|454467705|FG001|Overall Study|Positive Drug Screen|2|||
126321298|NCT01094782|454467706|FG002|Overall Study|Positive Drug Screen|1|||
126321299|NCT01094782|454467707|FG003|Overall Study|Positive Drug Screen|1|||
126321300|NCT01094782|454467708|FG004|Overall Study|Positive Drug Screen|3|||
126321301|NCT01094782|454467709|FG005|Overall Study|Positive Drug Screen|2|||
126321302|NCT01094782|454467704|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
126321303|NCT01094782|454467705|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
126321304|NCT01094782|454467706|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
126321305|NCT01094782|454467707|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
126321306|NCT01094782|454467708|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
126321307|NCT01094782|454467709|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
126321308|NCT01094782|454467704|FG000|Overall Study|Unable to Complete Questionnaires|0|||
126321309|NCT01094782|454467705|FG001|Overall Study|Unable to Complete Questionnaires|1|||
126321310|NCT01094782|454467706|FG002|Overall Study|Unable to Complete Questionnaires|0|||
126321311|NCT01094782|454467707|FG003|Overall Study|Unable to Complete Questionnaires|0|||
126321312|NCT01094782|454467708|FG004|Overall Study|Unable to Complete Questionnaires|0|||
126321313|NCT01094782|454467709|FG005|Overall Study|Unable to Complete Questionnaires|0|||
126321314|NCT01094782|454467704|FG000|Overall Study|Healthy Subject Had Pain|0|||
126321315|NCT01094782|454467705|FG001|Overall Study|Healthy Subject Had Pain|1|||
126321316|NCT01094782|454467706|FG002|Overall Study|Healthy Subject Had Pain|0|||
126321317|NCT01094782|454467707|FG003|Overall Study|Healthy Subject Had Pain|0|||
126321318|NCT01094782|454467708|FG004|Overall Study|Healthy Subject Had Pain|0|||
126321319|NCT01094782|454467709|FG005|Overall Study|Healthy Subject Had Pain|0|||
126321320|NCT01094782|454467704|FG000|Overall Study|Hypertension|0|||
126321321|NCT01094782|454467705|FG001|Overall Study|Hypertension|0|||
126321322|NCT01094782|454467706|FG002|Overall Study|Hypertension|1|||
126321323|NCT01094782|454467707|FG003|Overall Study|Hypertension|0|||
126321324|NCT01094782|454467708|FG004|Overall Study|Hypertension|0|||
126321325|NCT01094782|454467709|FG005|Overall Study|Hypertension|0|||
126321326|NCT01094782|454467704|FG000|Overall Study|Wrong Pain Condition|0|||
126321327|NCT01094782|454467705|FG001|Overall Study|Wrong Pain Condition|0|||
126321328|NCT01094782|454467706|FG002|Overall Study|Wrong Pain Condition|0|||
126321329|NCT01094782|454467707|FG003|Overall Study|Wrong Pain Condition|2|||
126321330|NCT01094782|454467708|FG004|Overall Study|Wrong Pain Condition|1|||
126321331|NCT01094782|454467709|FG005|Overall Study|Wrong Pain Condition|1|||
126321332|NCT01094782|454467704|FG000|Overall Study|Recent Interventional Injection|0|||
126321333|NCT01094782|454467705|FG001|Overall Study|Recent Interventional Injection|0|||
126321334|NCT01094782|454467706|FG002|Overall Study|Recent Interventional Injection|0|||
126321335|NCT01094782|454467707|FG003|Overall Study|Recent Interventional Injection|0|||
126321336|NCT01094782|454467708|FG004|Overall Study|Recent Interventional Injection|0|||
126321337|NCT01094782|454467709|FG005|Overall Study|Recent Interventional Injection|1|||
126321338|NCT01094782|454467704|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321339|NCT01094782|454467705|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321340|NCT01094782|454467706|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321341|NCT01094782|454467707|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321342|NCT01094782|454467708|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
126321343|NCT01094782|454467709|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321344|NCT01094782|454467704|FG000|Overall Study|Noncompliance With Study Schedule|0|||
126321345|NCT01094782|454467705|FG001|Overall Study|Noncompliance With Study Schedule|0|||
126321346|NCT01094782|454467706|FG002|Overall Study|Noncompliance With Study Schedule|0|||
126321347|NCT01094782|454467707|FG003|Overall Study|Noncompliance With Study Schedule|1|||
126321348|NCT01094782|454467708|FG004|Overall Study|Noncompliance With Study Schedule|0|||
126321349|NCT01094782|454467709|FG005|Overall Study|Noncompliance With Study Schedule|0|||
126321350|NCT00957905|454467710|FG000|Part B|Not Treated|0|||
126321351|NCT00957905|454467711|FG001|Part B|Not Treated|1|||
126321352|NCT00957905|454467710|FG000|Part B|Physician Decision|0|||
126321353|NCT00957905|454467711|FG001|Part B|Physician Decision|1|||
126321354|NCT00957905|454467710|FG000|Part B|Death|0|||
126321355|NCT00957905|454467711|FG001|Part B|Death|1|||
126321356|NCT00957905|454467710|FG000|Part B|Protocol Violation|0|||
126321357|NCT00957905|454467711|FG001|Part B|Protocol Violation|1|||
126321358|NCT02073656|454467712|FG000|Primary Study|Lost to Follow-up|6|||
126321359|NCT02073656|454467712|FG000|Primary Study|Death|1|||
126321360|NCT02073656|454467712|FG000|Primary Study|Withdrew Consent|1|||
126321361|NCT03423147|454467716|FG000|Overall Study|Lost to Follow-up|5|||
126321362|NCT03423147|454467717|FG001|Overall Study|Lost to Follow-up|8|||
126321363|NCT03423147|454467716|FG000|Overall Study|Withdrawal by Subject|1|||
125982900|NCT00695786|453228208|FG001|Overall Study|Lack of Efficacy|0|||
125982901|NCT00695786|453228209|FG002|Overall Study|Lack of Efficacy|0|||
125982902|NCT00695786|453228210|FG003|Overall Study|Lack of Efficacy|4|||
125982903|NCT01364922|453228211|FG000|Open-label (OL) Period|Adverse Event|7|||
125982904|NCT01364922|453228212|FG001|Open-label (OL) Period|Adverse Event|0|||
126208972|NCT04668066|454053122|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
126208973|NCT04668066|454053123|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208974|NCT04668066|454053124|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208975|NCT04668066|454053125|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
126208976|NCT04668066|454053107|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208977|NCT04668066|454053108|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208978|NCT04668066|454053109|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208979|NCT04668066|454053110|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208980|NCT04668066|454053111|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208981|NCT04668066|454053112|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208982|NCT04668066|454053113|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208983|NCT04668066|454053114|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208984|NCT04668066|454053115|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208985|NCT04668066|454053116|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208986|NCT04668066|454053117|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208987|NCT04668066|454053118|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208988|NCT04668066|454053119|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208989|NCT04668066|454053120|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208990|NCT04668066|454053121|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208991|NCT04668066|454053122|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208992|NCT04668066|454053123|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208993|NCT04668066|454053124|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126208994|NCT04668066|454053125|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
126208995|NCT04668066|454053107|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
126208996|NCT04668066|454053108|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
126208997|NCT04668066|454053109|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
126208998|NCT04668066|454053110|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
126208999|NCT04668066|454053111|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209000|NCT04668066|454053112|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209001|NCT04668066|454053113|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209002|NCT04668066|454053114|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209003|NCT04668066|454053115|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209004|NCT04668066|454053116|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209005|NCT04668066|454053117|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209006|NCT04668066|454053118|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209007|NCT04668066|454053119|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209008|NCT04668066|454053120|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209009|NCT04668066|454053121|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209010|NCT04668066|454053122|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209011|NCT04668066|454053123|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209012|NCT04668066|454053124|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
126209013|NCT04668066|454053125|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
126209014|NCT04668066|454053107|FG000|Part 2: Treatment Phase|Other|0|||
126209015|NCT04668066|454053108|FG001|Part 2: Treatment Phase|Other|0|||
126209016|NCT04668066|454053109|FG002|Part 2: Treatment Phase|Other|0|||
126209017|NCT04668066|454053110|FG003|Part 2: Treatment Phase|Other|0|||
126209018|NCT04668066|454053111|FG004|Part 2: Treatment Phase|Other|0|||
126209019|NCT04668066|454053112|FG005|Part 2: Treatment Phase|Other|0|||
126209020|NCT04668066|454053113|FG006|Part 2: Treatment Phase|Other|0|||
126209021|NCT04668066|454053114|FG007|Part 2: Treatment Phase|Other|0|||
126209022|NCT04668066|454053115|FG008|Part 2: Treatment Phase|Other|0|||
126209023|NCT04668066|454053116|FG009|Part 2: Treatment Phase|Other|0|||
126209024|NCT04668066|454053117|FG010|Part 2: Treatment Phase|Other|0|||
126209025|NCT04668066|454053118|FG011|Part 2: Treatment Phase|Other|0|||
126209026|NCT04668066|454053119|FG012|Part 2: Treatment Phase|Other|0|||
126209027|NCT04668066|454053120|FG013|Part 2: Treatment Phase|Other|0|||
126209028|NCT04668066|454053121|FG014|Part 2: Treatment Phase|Other|0|||
126209029|NCT04668066|454053122|FG015|Part 2: Treatment Phase|Other|0|||
126209030|NCT04668066|454053123|FG016|Part 2: Treatment Phase|Other|0|||
126209031|NCT04668066|454053124|FG017|Part 2: Treatment Phase|Other|0|||
126209032|NCT04668066|454053125|FG018|Part 2: Treatment Phase|Other|1|||
126209033|NCT04668066|454053107|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
126321364|NCT03423147|454467717|FG001|Overall Study|Withdrawal by Subject|0|||
125982905|NCT01364922|453228213|FG002|Open-label (OL) Period|Adverse Event|0|||
125982906|NCT01364922|453228211|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
126209034|NCT04668066|454053108|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209035|NCT04668066|454053109|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209036|NCT04668066|454053110|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
126321365|NCT03423147|454467716|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
126321366|NCT03423147|454467717|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
126321367|NCT03423147|454467716|FG000|Overall Study|Age < 18|1|||
126321368|NCT03423147|454467717|FG001|Overall Study|Age < 18|0|||
126321369|NCT03423147|454467716|FG000|Overall Study|No Trial of Labor|0|||
126321370|NCT03423147|454467717|FG001|Overall Study|No Trial of Labor|1|||
126321371|NCT01048099|454467718|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
126321372|NCT01048099|454467718|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
126321373|NCT00508157|454467719|FG000|Overall Study|Adverse Event|0|||
126321374|NCT00508157|454467720|FG001|Overall Study|Adverse Event|1|||
126321375|NCT00508157|454467719|FG000|Overall Study|Subject Withdrew Consent|1|||
126321376|NCT00508157|454467720|FG001|Overall Study|Subject Withdrew Consent|0|||
126321377|NCT00508157|454467719|FG000|Overall Study|Lost to Follow-up|1|||
126321378|NCT00508157|454467720|FG001|Overall Study|Lost to Follow-up|0|||
126321379|NCT00508157|454467719|FG000|Overall Study|Subject no longer met study criteria|0|||
126321380|NCT00508157|454467720|FG001|Overall Study|Subject no longer met study criteria|1|||
126321381|NCT00508157|454467719|FG000|Overall Study|Other known cause|0|||
126321382|NCT00508157|454467720|FG001|Overall Study|Other known cause|1|||
126321383|NCT03089853|454469322|FG000|Overall Study|Lost to Follow-up|2|||
126321384|NCT03089853|454469323|FG001|Overall Study|Lost to Follow-up|1|||
126321385|NCT04114656|454469324|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
126321386|NCT04114656|454469325|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
126321387|NCT04114656|454469324|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
126321388|NCT04114656|454469325|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
126321389|NCT04114656|454469324|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
126321390|NCT04114656|454469325|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
126321391|NCT04114656|454469324|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
126321392|NCT04114656|454469325|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
126321393|NCT04114656|454469324|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
126321394|NCT04114656|454469325|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
126321395|NCT02578940|454469326|FG000|Overall Study|Screening failure|5|||
126321396|NCT02578940|454469326|FG000|Overall Study|Lost to Follow-up|1|||
126321397|NCT03326518|454469334|FG000|Overall Study|Protocol Violation|1|||
126321398|NCT03326518|454469335|FG001|Overall Study|Protocol Violation|0|||
126321399|NCT03326518|454469336|FG002|Overall Study|Protocol Violation|0|||
126321400|NCT03326518|454469334|FG000|Overall Study|Withdrawal by Subject|1|||
126321401|NCT03326518|454469335|FG001|Overall Study|Withdrawal by Subject|0|||
126321402|NCT03326518|454469336|FG002|Overall Study|Withdrawal by Subject|0|||
126321403|NCT03326518|454469334|FG000|Overall Study|Lost to Follow-up|1|||
126321404|NCT03326518|454469335|FG001|Overall Study|Lost to Follow-up|0|||
126321405|NCT03326518|454469336|FG002|Overall Study|Lost to Follow-up|1|||
126321406|NCT01375374|454469339|FG000|Overall Study|Adverse Event|1|||
126321407|NCT01908582|454469340|FG000|Period 2|Physician Decision|1|||
126321408|NCT01908582|454469340|FG000|Period 2|Withdrawal by Subject|1|||
126321409|NCT01108237|454469342|FG000|Overall Study|No alignment data|2|||
126321410|NCT01108237|454469343|FG001|Overall Study|No alignment data|15|||
126321411|NCT01108237|454469342|FG000|Overall Study|Did not meet criteria for analysis|7|||
126321412|NCT01108237|454469343|FG001|Overall Study|Did not meet criteria for analysis|0|||
126321413|NCT02065518|454469345|FG000|Overall Study|Lost to Follow-up|3|||
126321414|NCT02065518|454469346|FG001|Overall Study|Lost to Follow-up|4|||
126321415|NCT02065518|454469347|FG002|Overall Study|Lost to Follow-up|0|||
126321416|NCT02065518|454469348|FG003|Overall Study|Lost to Follow-up|3|||
126321417|NCT02065518|454469345|FG000|Overall Study|Withdrawal by Subject|3|||
126321418|NCT02065518|454469346|FG001|Overall Study|Withdrawal by Subject|4|||
126321419|NCT02065518|454469347|FG002|Overall Study|Withdrawal by Subject|9|||
126321420|NCT02065518|454469348|FG003|Overall Study|Withdrawal by Subject|2|||
126321421|NCT03484403|454469351|FG000|Overall Study|Withdrawal by Subject|6|||
125982907|NCT01364922|453228212|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
125982908|NCT01364922|453228213|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
125982909|NCT01364922|453228211|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
125982910|NCT01364922|453228212|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
125982911|NCT01364922|453228213|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
125982912|NCT01364922|453228211|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
125982913|NCT01364922|453228212|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
125982914|NCT01364922|453228213|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
125982915|NCT01364922|453228211|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
125982916|NCT01364922|453228212|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
125982917|NCT01364922|453228213|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
125982918|NCT01364922|453228211|FG000|Open-label (OL) Period|Other, Unspecified|1|||
125982919|NCT01364922|453228212|FG001|Open-label (OL) Period|Other, Unspecified|0|||
125982920|NCT01364922|453228213|FG002|Open-label (OL) Period|Other, Unspecified|0|||
125982921|NCT01364922|453228211|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
125982922|NCT01364922|453228212|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
125982923|NCT01364922|453228213|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
126321422|NCT03484403|454469352|FG001|Overall Study|Withdrawal by Subject|4|||
126321423|NCT02173379|454469353|FG000|Overall Study|Lost to Follow-up|89|||
126321424|NCT02173379|454469354|FG001|Overall Study|Lost to Follow-up|81|||
126321425|NCT02173379|454469353|FG000|Overall Study|Withdrawal by Subject|24|||
126321426|NCT02173379|454469354|FG001|Overall Study|Withdrawal by Subject|29|||
126321427|NCT02173379|454469353|FG000|Overall Study|Physician Decision|8|||
126321428|NCT02173379|454469354|FG001|Overall Study|Physician Decision|8|||
126321429|NCT02173379|454469353|FG000|Overall Study|Death|75|||
126321430|NCT02173379|454469354|FG001|Overall Study|Death|72|||
126321431|NCT02173379|454469353|FG000|Overall Study|Other Reason|1|||
126321432|NCT02173379|454469354|FG001|Overall Study|Other Reason|0|||
126321433|NCT06226649|454469358|FG000|Overall Study|Withdrawal by Subject|4|||
126321434|NCT06226649|454469359|FG001|Overall Study|Withdrawal by Subject|1|||
126321435|NCT04767529|454469364|FG000|Overall Study|Adverse Event|0|||
126321436|NCT04767529|454469365|FG001|Overall Study|Adverse Event|4|||
126321437|NCT04767529|454469366|FG002|Overall Study|Adverse Event|3|||
126321438|NCT04767529|454469364|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
126321439|NCT04767529|454469365|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
126321440|NCT04767529|454469366|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
126321441|NCT04767529|454469364|FG000|Overall Study|Required use of a prohibited medication|0|||
126321442|NCT04767529|454469365|FG001|Overall Study|Required use of a prohibited medication|1|||
126321443|NCT04767529|454469366|FG002|Overall Study|Required use of a prohibited medication|0|||
126321444|NCT04767529|454469364|FG000|Overall Study|Withdrawal by Subject|7|||
126321445|NCT04767529|454469365|FG001|Overall Study|Withdrawal by Subject|5|||
126321446|NCT04767529|454469366|FG002|Overall Study|Withdrawal by Subject|4|||
126321447|NCT04767529|454469364|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
126321448|NCT04767529|454469365|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
126321449|NCT04767529|454469366|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
126321450|NCT04767529|454469364|FG000|Overall Study|Lost to Follow-up|0|||
126321451|NCT04767529|454469365|FG001|Overall Study|Lost to Follow-up|2|||
126321452|NCT04767529|454469366|FG002|Overall Study|Lost to Follow-up|3|||
126321453|NCT04942210|454469374|FG000|Overall Study|Adverse Event|0|||
126321454|NCT04942210|454469375|FG001|Overall Study|Adverse Event|1|||
126321455|NCT04942210|454469374|FG000|Overall Study|Protocol Deviation|4|||
126321456|NCT04942210|454469375|FG001|Overall Study|Protocol Deviation|1|||
126321457|NCT04942210|454469374|FG000|Overall Study|Withdrawal by Subject|5|||
126321458|NCT04942210|454469375|FG001|Overall Study|Withdrawal by Subject|2|||
126321459|NCT04942210|454469374|FG000|Overall Study|Lost to Follow-up|16|||
126321460|NCT04942210|454469375|FG001|Overall Study|Lost to Follow-up|7|||
126321461|NCT04942210|454469374|FG000|Overall Study|Ongoing at the time of DBL date|60|||
126321462|NCT04942210|454469375|FG001|Overall Study|Ongoing at the time of DBL date|25|||
126321463|NCT04942210|454469374|FG000|Overall Study|Randomized but did not receive vaccination|3|||
126321464|NCT04942210|454469375|FG001|Overall Study|Randomized but did not receive vaccination|0|||
126321465|NCT05697627|454469378|FG000|Overall Study|Adverse Event|1|||
126321466|NCT02570750|454469379|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
126321467|NCT02570750|454469380|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
126321468|NCT02570750|454469379|FG000|Overall Study|Protocol deviation|4|||
126321469|NCT02570750|454469380|FG001|Overall Study|Protocol deviation|2|||
126321470|NCT02570750|454469379|FG000|Overall Study|Withdrawal by Subject|5|||
126321471|NCT02570750|454469380|FG001|Overall Study|Withdrawal by Subject|0|||
126321472|NCT02570750|454469379|FG000|Overall Study|Lost to Follow-up|2|||
126321473|NCT02570750|454469380|FG001|Overall Study|Lost to Follow-up|2|||
126321474|NCT02570750|454469379|FG000|Overall Study|Adverse Event|2|||
126321475|NCT02570750|454469380|FG001|Overall Study|Adverse Event|1|||
126321476|NCT04122625|454469381|FG000|Part A (up to 2.92 Years)|Death|2|||
126321477|NCT04122625|454469382|FG001|Part A (up to 2.92 Years)|Death|4|||
126321478|NCT04122625|454469383|FG002|Part A (up to 2.92 Years)|Death|0|||
125982924|NCT01364922|453228211|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
125982925|NCT01364922|453228212|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
125982926|NCT01364922|453228213|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
125982927|NCT01364922|453228211|FG000|Double-Blind (DB) Period|Adverse Event|0|||
125982928|NCT01364922|453228212|FG001|Double-Blind (DB) Period|Adverse Event|0|||
125982929|NCT01364922|453228213|FG002|Double-Blind (DB) Period|Adverse Event|1|||
125982930|NCT01364922|453228211|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
125982931|NCT01364922|453228212|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
126321479|NCT04122625|454469384|FG003|Part A (up to 2.92 Years)|Death|0|||
126321480|NCT04122625|454469385|FG004|Part A (up to 2.92 Years)|Death|0|||
126321481|NCT04122625|454469386|FG005|Part A (up to 2.92 Years)|Death|0|||
126321482|NCT04122625|454469381|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
126321483|NCT04122625|454469382|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
126321484|NCT04122625|454469383|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
126321485|NCT04122625|454469384|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
126321486|NCT04122625|454469385|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
126321487|NCT04122625|454469386|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
126321488|NCT04122625|454469381|FG000|Part B (up to 2.33 Years)|Death|0|||
126321489|NCT04122625|454469382|FG001|Part B (up to 2.33 Years)|Death|0|||
126321490|NCT04122625|454469383|FG002|Part B (up to 2.33 Years)|Death|5|||
126321491|NCT04122625|454469384|FG003|Part B (up to 2.33 Years)|Death|7|||
126321492|NCT04122625|454469385|FG004|Part B (up to 2.33 Years)|Death|6|||
126321493|NCT04122625|454469386|FG005|Part B (up to 2.33 Years)|Death|7|||
126321494|NCT04348500|454469387|FG000|Overall Study|Death|2|||
126321495|NCT04348500|454469388|FG001|Overall Study|Death|2|||
126321496|NCT04348500|454469387|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
126321497|NCT04348500|454469388|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
126321498|NCT01410240|454469389|FG000|Overall Study|Physician Decision|0|||
126321499|NCT01410240|454469390|FG001|Overall Study|Physician Decision|0|||
126321500|NCT01410240|454469391|FG002|Overall Study|Physician Decision|1|||
126321501|NCT01410240|454469389|FG000|Overall Study|Missed week 6 assessments|1|||
126321502|NCT01410240|454469390|FG001|Overall Study|Missed week 6 assessments|1|||
126321503|NCT01410240|454469391|FG002|Overall Study|Missed week 6 assessments|1|||
126321504|NCT02776670|454469392|FG000|Overall Study|Adverse Event|0|||
126321505|NCT02776670|454469393|FG001|Overall Study|Adverse Event|2|||
126321506|NCT02776670|454469392|FG000|Overall Study|Protocol Violation|0|||
126321507|NCT02776670|454469393|FG001|Overall Study|Protocol Violation|2|||
126321508|NCT02776670|454469392|FG000|Overall Study|Withdrawal by Subject|0|||
126321509|NCT02776670|454469393|FG001|Overall Study|Withdrawal by Subject|1|||
126321510|NCT02776670|454469392|FG000|Overall Study|Other - Reason not given|0|||
126321511|NCT02776670|454469393|FG001|Overall Study|Other - Reason not given|1|||
126321512|NCT01937884|454469398|FG000|Overall Study|Withdrawal by Subject|1|||
126321513|NCT01937884|454469399|FG001|Overall Study|Withdrawal by Subject|0|||
126321514|NCT00004088|454469400|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
126321515|NCT00004088|454469400|FG000|Overall Study|Withdrawal by Subject|1|||
126321516|NCT00004088|454469400|FG000|Overall Study|Protocol Violation|3|||
125982932|NCT01364922|453228213|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
125982933|NCT04244396|453228217|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
125982934|NCT04244396|453228217|FG000|Overall Study|Withdrawal by Subject|2|||
125982935|NCT04244396|453228217|FG000|Overall Study|Study termination|37|||
125982936|NCT01787097|453228218|FG000|Overall Study|Withdrawal by Subject|1|||
125982937|NCT01787097|453228219|FG001|Overall Study|Withdrawal by Subject|0|||
125982938|NCT01787097|453228220|FG002|Overall Study|Withdrawal by Subject|0|||
125982939|NCT01787097|453228221|FG003|Overall Study|Withdrawal by Subject|0|||
125982940|NCT00949884|453228222|FG000|Overall Study|Adverse Event|14|||
125982941|NCT00949884|453228223|FG001|Overall Study|Adverse Event|3|||
125982942|NCT00949884|453228224|FG002|Overall Study|Adverse Event|12|||
125982943|NCT00949884|453228222|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
125982944|NCT00949884|453228223|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
125982945|NCT00949884|453228224|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
125982946|NCT00949884|453228222|FG000|Overall Study|Lost to Follow-up|7|||
125982947|NCT00949884|453228223|FG001|Overall Study|Lost to Follow-up|5|||
125982948|NCT00949884|453228224|FG002|Overall Study|Lost to Follow-up|5|||
125982949|NCT00949884|453228222|FG000|Overall Study|Physician Decision|5|||
125982950|NCT00949884|453228223|FG001|Overall Study|Physician Decision|0|||
125982951|NCT00949884|453228224|FG002|Overall Study|Physician Decision|6|||
125982952|NCT00949884|453228222|FG000|Overall Study|Treatment non-compliance|5|||
125982953|NCT00949884|453228223|FG001|Overall Study|Treatment non-compliance|0|||
125982954|NCT00949884|453228224|FG002|Overall Study|Treatment non-compliance|8|||
125982955|NCT00949884|453228222|FG000|Overall Study|Withdrawal by Subject|13|||
125982956|NCT00949884|453228223|FG001|Overall Study|Withdrawal by Subject|4|||
125982957|NCT00949884|453228224|FG002|Overall Study|Withdrawal by Subject|16|||
125982958|NCT00949884|453228222|FG000|Overall Study|Lack of Efficacy|4|||
125982959|NCT00949884|453228223|FG001|Overall Study|Lack of Efficacy|2|||
125982960|NCT00949884|453228224|FG002|Overall Study|Lack of Efficacy|7|||
125982961|NCT00949884|453228222|FG000|Overall Study|Study terminated by sponsor|0|||
125982962|NCT00949884|453228223|FG001|Overall Study|Study terminated by sponsor|0|||
125982963|NCT00949884|453228224|FG002|Overall Study|Study terminated by sponsor|1|||
125982964|NCT02832622|453228237|FG000|Overall Study|MPP not programmed|1259|||
125982965|NCT02832622|453228237|FG000|Overall Study|Withdrawal by Subject|123|||
125982966|NCT02832622|453228237|FG000|Overall Study|Death|119|||
125982967|NCT02832622|453228237|FG000|Overall Study|Unsuccessful CRT implant|93|||
125982968|NCT02832622|453228237|FG000|Overall Study|Lost to Follow-up|45|||
125982969|NCT02832622|453228237|FG000|Overall Study|Patient non-compliance|42|||
125982970|NCT02832622|453228237|FG000|Overall Study|Withdrawal by other reasons|25|||
125982971|NCT02832622|453228237|FG000|Overall Study|System explant|24|||
125982972|NCT02832622|453228237|FG000|Overall Study|Physician Decision|6|||
125982973|NCT02243280|453228238|FG000|Treated|Adverse Event|1|||
126321517|NCT00004088|454469400|FG000|Overall Study|Physician Decision|1|||
126321518|NCT02722746|454469401|FG000|Overall Study|Withdrawal by Subject|0|||
125982974|NCT02243280|453228239|FG001|Treated|Adverse Event|0|||
125982975|NCT02243280|453228240|FG002|Treated|Adverse Event|0|||
126321519|NCT02722746|454469402|FG001|Overall Study|Withdrawal by Subject|1|||
126321520|NCT02722746|454469403|FG002|Overall Study|Withdrawal by Subject|0|||
126321521|NCT02722746|454469401|FG000|Overall Study|Protocol Violation|8|||
126321522|NCT02722746|454469402|FG001|Overall Study|Protocol Violation|4|||
126321523|NCT02722746|454469403|FG002|Overall Study|Protocol Violation|6|||
126321524|NCT00981058|454469408|FG000|Overall Study|Progressive Disease|38|||
126321525|NCT00981058|454469409|FG001|Overall Study|Progressive Disease|31|||
126321526|NCT00981058|454469408|FG000|Overall Study|Lost to Follow-up|3|||
126321527|NCT00981058|454469409|FG001|Overall Study|Lost to Follow-up|2|||
126321528|NCT00981058|454469408|FG000|Overall Study|Physician Decision|4|||
126321529|NCT00981058|454469409|FG001|Overall Study|Physician Decision|5|||
126321530|NCT00981058|454469408|FG000|Overall Study|Randomization Error|0|||
126321531|NCT00981058|454469409|FG001|Overall Study|Randomization Error|1|||
126321532|NCT00981058|454469408|FG000|Overall Study|Withdrawal by Subject|24|||
126321533|NCT00981058|454469409|FG001|Overall Study|Withdrawal by Subject|22|||
126321534|NCT02667587|454469410|FG000|Pre-Treatment|Not reported|1|||
126321535|NCT02667587|454469411|FG001|Pre-Treatment|Not reported|0|||
126321536|NCT02667587|454469410|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
126321537|NCT02667587|454469411|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
126321538|NCT02667587|454469410|FG000|Pre-Treatment|Participant withdrew consent|0|||
126321539|NCT02667587|454469411|FG001|Pre-Treatment|Participant withdrew consent|1|||
126321540|NCT02667587|454469410|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
126321541|NCT02667587|454469411|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
126321542|NCT02667587|454469410|FG000|End of Treatment|Disease Progression|193|||
126321543|NCT02667587|454469411|FG001|End of Treatment|Disease Progression|226|||
126321544|NCT02667587|454469410|FG000|End of Treatment|Study Drug Toxicity|75|||
126321545|NCT02667587|454469411|FG001|End of Treatment|Study Drug Toxicity|19|||
126321546|NCT02667587|454469410|FG000|End of Treatment|Death|2|||
126321547|NCT02667587|454469411|FG001|End of Treatment|Death|1|||
125982976|NCT02243280|453228241|FG003|Treated|Adverse Event|0|||
125982977|NCT02243280|453228242|FG004|Treated|Adverse Event|0|||
125982978|NCT02243280|453228243|FG005|Treated|Adverse Event|0|||
125982979|NCT02243280|453228244|FG006|Treated|Adverse Event|0|||
125982980|NCT02243280|453228245|FG007|Treated|Adverse Event|0|||
126321548|NCT02667587|454469410|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
126321549|NCT02667587|454469411|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
126321550|NCT02667587|454469410|FG000|End of Treatment|participant request to discontinue treatment|33|||
126321551|NCT02667587|454469411|FG001|End of Treatment|participant request to discontinue treatment|35|||
126321552|NCT02667587|454469410|FG000|End of Treatment|participant withdrew consent|5|||
126321553|NCT02667587|454469411|FG001|End of Treatment|participant withdrew consent|6|||
126321554|NCT02667587|454469410|FG000|End of Treatment|Lost to Follow-up|1|||
126321555|NCT02667587|454469411|FG001|End of Treatment|Lost to Follow-up|2|||
126321556|NCT02667587|454469410|FG000|End of Treatment|maximum clinical benefit|4|||
126321557|NCT02667587|454469411|FG001|End of Treatment|maximum clinical benefit|4|||
126321558|NCT02667587|454469410|FG000|End of Treatment|poor or non compliant|0|||
126321559|NCT02667587|454469411|FG001|End of Treatment|poor or non compliant|1|||
126321560|NCT02667587|454469410|FG000|End of Treatment|participant no longer meets study criteria|1|||
126321561|NCT02667587|454469411|FG001|End of Treatment|participant no longer meets study criteria|1|||
126321562|NCT02667587|454469410|FG000|End of Treatment|administrative reason by sponsor|1|||
126321563|NCT02667587|454469411|FG001|End of Treatment|administrative reason by sponsor|29|||
125982981|NCT02243280|453228246|FG008|Treated|Adverse Event|0|||
125982982|NCT02243280|453228247|FG009|Treated|Adverse Event|0|||
125982983|NCT02243280|453228248|FG010|Treated|Adverse Event|1|||
125982984|NCT02243280|453228238|FG000|Treated|Lost to Follow-up|0|||
125982985|NCT02243280|453228239|FG001|Treated|Lost to Follow-up|0|||
125982986|NCT02243280|453228240|FG002|Treated|Lost to Follow-up|0|||
125982987|NCT02243280|453228241|FG003|Treated|Lost to Follow-up|0|||
125982988|NCT02243280|453228242|FG004|Treated|Lost to Follow-up|0|||
125982989|NCT02243280|453228243|FG005|Treated|Lost to Follow-up|0|||
125982990|NCT02243280|453228244|FG006|Treated|Lost to Follow-up|0|||
125982991|NCT02243280|453228245|FG007|Treated|Lost to Follow-up|0|||
125982992|NCT02243280|453228246|FG008|Treated|Lost to Follow-up|1|||
125982993|NCT02243280|453228247|FG009|Treated|Lost to Follow-up|0|||
125982994|NCT02243280|453228248|FG010|Treated|Lost to Follow-up|2|||
125982995|NCT02472652|453228249|FG000|Overall Study|Lost to Follow-up|1|||
126321564|NCT02667587|454469410|FG000|End of Treatment|other reasonse|21|||
126321565|NCT02667587|454469411|FG001|End of Treatment|other reasonse|10|||
126321566|NCT01134263|454469412|FG000|Overall Study|Serious adverse event|2|||
125982996|NCT00998400|453228254|FG000|Overall Study|Lack of interest/motivation|1|||
125982997|NCT00998400|453228255|FG001|Overall Study|Lack of interest/motivation|2|||
126321567|NCT01134263|454469413|FG001|Overall Study|Serious adverse event|1|||
126321568|NCT01134263|454469414|FG002|Overall Study|Serious adverse event|1|||
125982998|NCT00998400|453228254|FG000|Overall Study|Logistical problems|1|||
125982999|NCT00998400|453228255|FG001|Overall Study|Logistical problems|0|||
125983000|NCT03185832|453228256|FG000|Overall Study|Death|9|||
125983001|NCT03185832|453228257|FG001|Overall Study|Death|14|||
125983002|NCT03185832|453228258|FG002|Overall Study|Death|9|||
125983003|NCT03185832|453228259|FG003|Overall Study|Death|7|||
125983004|NCT03185832|453228256|FG000|Overall Study|Withdrawn - vital status available|0|||
126321569|NCT01134263|454469415|FG003|Overall Study|Serious adverse event|1|||
125983005|NCT03185832|453228257|FG001|Overall Study|Withdrawn - vital status available|1|||
125983006|NCT03185832|453228258|FG002|Overall Study|Withdrawn - vital status available|1|||
125983007|NCT03185832|453228259|FG003|Overall Study|Withdrawn - vital status available|4|||
125983008|NCT01807156|453228260|FG000|Overall Study|Physician Decision|1|||
125983009|NCT03122119|453228263|FG000|Overall Study|Did not meet eligibility critria|1|||
125983010|NCT02364180|453228268|FG000|Overall Study|Screen Fail|1|||
125983011|NCT00521144|453228269|FG000|Overall Study|Not Treated|0|||
125983012|NCT00521144|453228270|FG001|Overall Study|Not Treated|0|||
125983013|NCT00521144|453228271|FG002|Overall Study|Not Treated|0|||
125983014|NCT00521144|453228272|FG003|Overall Study|Not Treated|1|||
125983015|NCT00521144|453228273|FG004|Overall Study|Not Treated|0|||
125983016|NCT00521144|453228269|FG000|Overall Study|Adverse Event|0|||
125983017|NCT00521144|453228270|FG001|Overall Study|Adverse Event|1|||
125983018|NCT00521144|453228271|FG002|Overall Study|Adverse Event|0|||
125983019|NCT00521144|453228272|FG003|Overall Study|Adverse Event|0|||
125983020|NCT00521144|453228273|FG004|Overall Study|Adverse Event|1|||
125983021|NCT00521144|453228269|FG000|Overall Study|Progressive Disease|4|||
125983022|NCT00521144|453228270|FG001|Overall Study|Progressive Disease|2|||
125983023|NCT00521144|453228271|FG002|Overall Study|Progressive Disease|2|||
125983024|NCT00521144|453228272|FG003|Overall Study|Progressive Disease|0|||
125983025|NCT00521144|453228273|FG004|Overall Study|Progressive Disease|6|||
125983026|NCT01370525|453228274|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
125983027|NCT01370525|453228275|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
125983028|NCT01370525|453228274|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125983029|NCT01370525|453228275|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125983030|NCT01370525|453228274|FG000|Overall Study|Adverse Event|0|||
125983031|NCT01370525|453228275|FG001|Overall Study|Adverse Event|1|||
125983032|NCT01370525|453228274|FG000|Overall Study|Protocol Violation|2|||
125983033|NCT01370525|453228275|FG001|Overall Study|Protocol Violation|1|||
125983034|NCT01370525|453228274|FG000|Overall Study|Lost to follow up|2|||
125983035|NCT01370525|453228275|FG001|Overall Study|Lost to follow up|6|||
125983036|NCT02093663|453228278|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
125983037|NCT02093663|453228279|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
125983038|NCT02093663|453228280|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
125983039|NCT02093663|453228281|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
125983040|NCT02093663|453228282|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
125983041|NCT02093663|453228278|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
125983042|NCT02093663|453228279|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125983043|NCT02093663|453228280|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125983044|NCT02093663|453228281|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125983045|NCT02093663|453228282|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125983046|NCT02093663|453228278|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
125983047|NCT02093663|453228279|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
125983048|NCT02093663|453228280|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
125983049|NCT02093663|453228281|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
125983050|NCT02093663|453228282|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
125983051|NCT02093663|453228278|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
125983052|NCT02093663|453228279|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
125983053|NCT02093663|453228280|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
125983054|NCT02093663|453228281|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
125983055|NCT02093663|453228282|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
125983056|NCT02093663|453228278|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125983057|NCT02093663|453228279|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125983058|NCT02093663|453228280|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
125983059|NCT02093663|453228281|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125983060|NCT02093663|453228282|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125983061|NCT02093663|453228278|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
125983062|NCT02093663|453228279|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
125983063|NCT02093663|453228280|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
126321570|NCT01134263|454469416|FG004|Overall Study|Serious adverse event|1|||
126321571|NCT01134263|454469412|FG000|Overall Study|Other adverse event|1|||
126321572|NCT01134263|454469413|FG001|Overall Study|Other adverse event|2|||
126321573|NCT01134263|454469414|FG002|Overall Study|Other adverse event|5|||
125983064|NCT02093663|453228281|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
125983065|NCT02093663|453228282|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
125983066|NCT02093663|453228278|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
126321574|NCT01134263|454469415|FG003|Overall Study|Other adverse event|3|||
126321575|NCT01134263|454469416|FG004|Overall Study|Other adverse event|0|||
126321576|NCT01134263|454469412|FG000|Overall Study|Protocol Violation|8|||
125983067|NCT02093663|453228279|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
125983068|NCT02093663|453228280|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
125983069|NCT02093663|453228281|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
126321577|NCT01134263|454469413|FG001|Overall Study|Protocol Violation|7|||
126321578|NCT01134263|454469414|FG002|Overall Study|Protocol Violation|2|||
126321579|NCT01134263|454469415|FG003|Overall Study|Protocol Violation|4|||
126321580|NCT01134263|454469416|FG004|Overall Study|Protocol Violation|2|||
126321581|NCT01134263|454469412|FG000|Overall Study|Lost to Follow-up|4|||
126321582|NCT01134263|454469413|FG001|Overall Study|Lost to Follow-up|3|||
126321583|NCT01134263|454469414|FG002|Overall Study|Lost to Follow-up|5|||
126321584|NCT01134263|454469415|FG003|Overall Study|Lost to Follow-up|3|||
126321585|NCT01134263|454469416|FG004|Overall Study|Lost to Follow-up|1|||
126321586|NCT01134263|454469412|FG000|Overall Study|Withdrawal by Subject|8|||
126321587|NCT01134263|454469413|FG001|Overall Study|Withdrawal by Subject|6|||
126321588|NCT01134263|454469414|FG002|Overall Study|Withdrawal by Subject|16|||
126321589|NCT01134263|454469415|FG003|Overall Study|Withdrawal by Subject|7|||
126321590|NCT01134263|454469416|FG004|Overall Study|Withdrawal by Subject|5|||
126321591|NCT01134263|454469412|FG000|Overall Study|Enrolled, but not treated|1|||
126321592|NCT01134263|454469413|FG001|Overall Study|Enrolled, but not treated|1|||
126321593|NCT01134263|454469414|FG002|Overall Study|Enrolled, but not treated|0|||
126321594|NCT01134263|454469415|FG003|Overall Study|Enrolled, but not treated|1|||
126321595|NCT01134263|454469416|FG004|Overall Study|Enrolled, but not treated|0|||
126321596|NCT04165135|454469417|FG000|Overall Study|Protocol Violation|10|||
126321597|NCT04165135|454469417|FG000|Overall Study|Participants withdrawal of consent|5|||
126321598|NCT02886884|454469426|FG000|Follow-up|Withdrawal by Subject|0|||
126321599|NCT02886884|454469427|FG001|Follow-up|Withdrawal by Subject|0|||
126321600|NCT02886884|454469428|FG002|Follow-up|Withdrawal by Subject|0|||
126321601|NCT02886884|454469429|FG003|Follow-up|Withdrawal by Subject|1|||
126321602|NCT00575510|454469432|FG000|Overall Study|Lost to Follow-up|4|||
126321603|NCT00575510|454469433|FG001|Overall Study|Lost to Follow-up|6|||
126321604|NCT00575510|454469434|FG002|Overall Study|Lost to Follow-up|9|||
126321605|NCT00575510|454469432|FG000|Overall Study|Withdrawal by Subject|1|||
126321606|NCT00575510|454469433|FG001|Overall Study|Withdrawal by Subject|0|||
126321607|NCT00575510|454469434|FG002|Overall Study|Withdrawal by Subject|0|||
126321608|NCT00575510|454469432|FG000|Overall Study|Clinic Called Patient|7|||
126321609|NCT00575510|454469433|FG001|Overall Study|Clinic Called Patient|7|||
126321610|NCT00575510|454469434|FG002|Overall Study|Clinic Called Patient|7|||
126321611|NCT00575510|454469432|FG000|Overall Study|Pregnancy|0|||
126321612|NCT00575510|454469433|FG001|Overall Study|Pregnancy|0|||
126321613|NCT00575510|454469434|FG002|Overall Study|Pregnancy|1|||
126321614|NCT00380718|454469438|FG000|Overall Study|Adverse Event|1|||
126321615|NCT00380718|454469438|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
126321616|NCT02912455|454469439|FG000|Overall Study|Withdrawal by Subject|0|||
126321617|NCT02912455|454469440|FG001|Overall Study|Withdrawal by Subject|1|||
126321618|NCT02912455|454469439|FG000|Overall Study|Lack of Efficacy|0|||
126321619|NCT02912455|454469440|FG001|Overall Study|Lack of Efficacy|1|||
126321620|NCT02912455|454469439|FG000|Overall Study|Lost to Follow-up|2|||
126321621|NCT02912455|454469440|FG001|Overall Study|Lost to Follow-up|1|||
126321622|NCT01625689|454469443|FG000|Overall Study|Migration|2|||
126321623|NCT01625689|454469444|FG001|Overall Study|Migration|1|||
126321624|NCT01810783|454469447|FG000|Overall Study|Adverse Event|32|||
126321625|NCT01810783|454469447|FG000|Overall Study|Withdrawal by Subject|22|||
126321626|NCT01810783|454469447|FG000|Overall Study|Lack of Efficacy|12|||
126321627|NCT01810783|454469447|FG000|Overall Study|Lost to Follow-up|10|||
126321628|NCT01810783|454469447|FG000|Overall Study|Protocol Violation|5|||
126321629|NCT01810783|454469447|FG000|Overall Study|Non-compliance with IMP|4|||
126321630|NCT01810783|454469447|FG000|Overall Study|Adminstrative or other reason(s)|23|||
126321631|NCT01810783|454469447|FG000|Overall Study|Enrolled, not treated|1|||
126321632|NCT00477607|454469448|FG000|Overall Study|Lost to Follow-up|7|||
126321633|NCT00477607|454469449|FG001|Overall Study|Lost to Follow-up|7|||
126321634|NCT00564278|454470662|FG000|Overall Study|Lost to Follow-up|35|||
126321635|NCT00564278|454470663|FG001|Overall Study|Lost to Follow-up|33|||
126321636|NCT00564278|454470662|FG000|Overall Study|Physician Decision|1|||
126321637|NCT00564278|454470663|FG001|Overall Study|Physician Decision|2|||
126321638|NCT00564278|454470662|FG000|Overall Study|Withdrawal by Subject|11|||
125983070|NCT02093663|453228282|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
125983071|NCT02093663|453228278|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
126321639|NCT00564278|454470663|FG001|Overall Study|Withdrawal by Subject|7|||
126321640|NCT06439095|454470664|FG000|Overall Study|Lost to Follow-up|2|||
126321641|NCT03341936|454470665|FG000|Overall Study|Ineligible|1|||
125983072|NCT02093663|453228279|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
126209037|NCT04668066|454053111|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
126321642|NCT03341936|454470665|FG000|Overall Study|Disease Progression|2|||
126321643|NCT03341936|454470665|FG000|Overall Study|Withdrew Consent|4|||
126321644|NCT03341936|454470665|FG000|Overall Study|Non-Compliance|1|||
126321645|NCT03341936|454470665|FG000|Overall Study|Physician Decision|1|||
126321646|NCT03341936|454470665|FG000|Overall Study|Withdrawal by Subject|1|||
126321647|NCT03341936|454470665|FG000|Overall Study|Other|1|||
126321648|NCT02368886|454470666|FG000|Overall Study|Cancel|1|||
126321649|NCT02368886|454470667|FG001|Overall Study|Cancel|1|||
126321650|NCT02368886|454470668|FG002|Overall Study|Cancel|1|||
126321651|NCT02368886|454470669|FG003|Overall Study|Cancel|3|||
125983073|NCT02093663|453228280|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
125983074|NCT02093663|453228281|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
125983075|NCT02093663|453228282|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
125983076|NCT02093663|453228278|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
125983077|NCT02093663|453228279|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
125983078|NCT02093663|453228280|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
125983079|NCT02093663|453228281|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
125983080|NCT02093663|453228282|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
125983081|NCT01960725|453228286|FG000|Overall Study|Lost to Follow-up|4|||
125983082|NCT01960725|453228287|FG001|Overall Study|Lost to Follow-up|3|||
125983083|NCT01960725|453228286|FG000|Overall Study|Withdrawal by Subject|1|||
125983084|NCT01960725|453228287|FG001|Overall Study|Withdrawal by Subject|0|||
125983085|NCT01960725|453228286|FG000|Overall Study|unable to obtain blood sample|1|||
125983086|NCT01960725|453228287|FG001|Overall Study|unable to obtain blood sample|2|||
125983087|NCT02277990|453228291|FG000|Overall Study|Death|170|||
125983088|NCT02277990|453228292|FG001|Overall Study|Death|188|||
125983089|NCT02277990|453228291|FG000|Overall Study|Withdrawal by Subject|64|||
125983090|NCT02277990|453228292|FG001|Overall Study|Withdrawal by Subject|53|||
125983091|NCT02277990|453228291|FG000|Overall Study|Physician Decision|40|||
126321652|NCT02368886|454470666|FG000|Overall Study|Ineligible|0|||
126321653|NCT02368886|454470667|FG001|Overall Study|Ineligible|0|||
126321654|NCT02368886|454470668|FG002|Overall Study|Ineligible|0|||
126321655|NCT02368886|454470669|FG003|Overall Study|Ineligible|1|||
126321656|NCT04849416|454470671|FG000|Overall Study|Ongoing Treatment|12|||
126321657|NCT04849416|454470672|FG001|Overall Study|Ongoing Treatment|5|||
126321658|NCT04849416|454470673|FG002|Overall Study|Ongoing Treatment|3|||
125983092|NCT02277990|453228292|FG001|Overall Study|Physician Decision|34|||
125983093|NCT02277990|453228291|FG000|Overall Study|Lost to Follow-up|66|||
126321659|NCT04849416|454470671|FG000|Overall Study|On Post-Treatment Follow-up|8|||
125983094|NCT02277990|453228292|FG001|Overall Study|Lost to Follow-up|69|||
125983095|NCT02277990|453228291|FG000|Overall Study|Had other reason|26|||
125983096|NCT02277990|453228292|FG001|Overall Study|Had other reason|32|||
125983097|NCT04711603|453228293|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
125983098|NCT04711603|453228294|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
125983099|NCT04711603|453228295|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
125983100|NCT04711603|453228296|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
125983101|NCT04711603|453228293|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
125983102|NCT04711603|453228294|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
125983103|NCT04711603|453228295|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
125983104|NCT04711603|453228296|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
125983105|NCT04711603|453228293|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
125983106|NCT04711603|453228294|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
125983107|NCT04711603|453228295|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
126321660|NCT04849416|454470672|FG001|Overall Study|On Post-Treatment Follow-up|9|||
126321661|NCT04849416|454470673|FG002|Overall Study|On Post-Treatment Follow-up|10|||
126321662|NCT04849416|454470671|FG000|Overall Study|Withdrawal by Subject|0|||
126321663|NCT04849416|454470672|FG001|Overall Study|Withdrawal by Subject|0|||
126321664|NCT04849416|454470673|FG002|Overall Study|Withdrawal by Subject|1|||
126321665|NCT04849416|454470671|FG000|Overall Study|Lost to Follow-up|1|||
126321666|NCT04849416|454470672|FG001|Overall Study|Lost to Follow-up|0|||
126321667|NCT04849416|454470673|FG002|Overall Study|Lost to Follow-up|0|||
126321668|NCT02131636|454470678|FG000|Overall Study|Personal Reasons|4|||
126321669|NCT02131636|454470679|FG001|Overall Study|Personal Reasons|4|||
126321670|NCT02131636|454470678|FG000|Overall Study|Lost to Follow-up|4|||
126321671|NCT02131636|454470679|FG001|Overall Study|Lost to Follow-up|0|||
126321672|NCT02131636|454470678|FG000|Overall Study|Adverse Event|4|||
126321673|NCT02131636|454470679|FG001|Overall Study|Adverse Event|1|||
126321674|NCT04847232|454470682|FG000|Overall Study|Death|123|||
126321675|NCT04847232|454470683|FG001|Overall Study|Death|115|||
126321676|NCT04847232|454470682|FG000|Overall Study|Lost to Follow-up|3|||
125983108|NCT04711603|453228296|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
125983109|NCT04711603|453228293|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
125983110|NCT04711603|453228294|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
125983111|NCT04711603|453228295|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
125983112|NCT04711603|453228296|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
125983113|NCT04711603|453228293|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
125983114|NCT04711603|453228294|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
126321677|NCT04847232|454470683|FG001|Overall Study|Lost to Follow-up|10|||
126321678|NCT04847232|454470682|FG000|Overall Study|Withdrawal by Subject|73|||
126321679|NCT04847232|454470683|FG001|Overall Study|Withdrawal by Subject|101|||
126321680|NCT04847232|454470682|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
126321681|NCT04847232|454470683|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
126321682|NCT02290925|454470689|FG000|First Period of Three Months|Lost to Follow-up|2|||
126321683|NCT02290925|454470690|FG001|First Period of Three Months|Lost to Follow-up|1|||
126321684|NCT02290925|454470689|FG000|First Period of Three Months|Death|1|||
126321685|NCT02290925|454470690|FG001|First Period of Three Months|Death|0|||
126321686|NCT02290925|454470689|FG000|First Period of Three Months|Insulin Started|1|||
126321687|NCT02290925|454470690|FG001|First Period of Three Months|Insulin Started|1|||
126321688|NCT02290925|454470689|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
126321689|NCT02290925|454470690|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
126321690|NCT02290925|454470689|FG000|Second Period of 3 Months|insulin started|0|||
126321691|NCT02290925|454470690|FG001|Second Period of 3 Months|insulin started|1|||
126321692|NCT01716520|454470691|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
126321693|NCT01716520|454470692|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321694|NCT01716520|454470693|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321695|NCT01716520|454470694|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321696|NCT01716520|454470695|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321697|NCT01716520|454470696|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321698|NCT01716520|454470691|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
126321699|NCT01716520|454470692|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321700|NCT01716520|454470693|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
126321701|NCT01716520|454470694|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
126321702|NCT01716520|454470695|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321703|NCT01716520|454470696|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
126321704|NCT01716520|454470691|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321705|NCT01716520|454470692|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126321706|NCT01716520|454470693|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321707|NCT01716520|454470694|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321708|NCT01716520|454470695|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321709|NCT01716520|454470696|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321710|NCT01716520|454470691|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321711|NCT01716520|454470692|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
126321712|NCT01716520|454470693|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321713|NCT01716520|454470694|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321714|NCT01716520|454470695|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321715|NCT01716520|454470696|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321716|NCT01716520|454470691|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321717|NCT01716520|454470692|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321718|NCT01716520|454470693|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321719|NCT01716520|454470694|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321720|NCT01716520|454470695|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321721|NCT01716520|454470696|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
126321722|NCT01716520|454470691|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
126321723|NCT01716520|454470692|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
126321724|NCT01716520|454470693|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
126321725|NCT01716520|454470694|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
126321726|NCT01716520|454470695|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
126321727|NCT01716520|454470696|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
126321728|NCT01716520|454470691|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321729|NCT01716520|454470692|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321730|NCT01716520|454470693|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321731|NCT01716520|454470694|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321732|NCT01716520|454470695|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
126321733|NCT01716520|454470696|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321734|NCT01716520|454470691|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321735|NCT01716520|454470692|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321736|NCT01716520|454470693|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321737|NCT01716520|454470694|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321738|NCT01716520|454470695|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126321739|NCT01716520|454470696|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321740|NCT01716520|454470691|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125878477|NCT05138653|452851316|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878478|NCT05138653|452851317|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878479|NCT05138653|452851318|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878480|NCT05138653|452851319|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878481|NCT05138653|452851320|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878482|NCT05138653|452851321|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878483|NCT05138653|452851322|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878484|NCT05138653|452851323|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878485|NCT05138653|452851324|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125878486|NCT05138653|452851309|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126321741|NCT01716520|454470692|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321742|NCT01716520|454470693|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321743|NCT01716520|454470694|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
126321744|NCT01716520|454470695|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321745|NCT01716520|454470696|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321746|NCT01716520|454470691|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
126321747|NCT01716520|454470692|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
126321748|NCT01716520|454470693|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
126321749|NCT01716520|454470694|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
126321750|NCT01716520|454470695|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
126321751|NCT01716520|454470696|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
126321752|NCT01716520|454470691|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
126321753|NCT01716520|454470692|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321754|NCT01716520|454470693|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321755|NCT01716520|454470694|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321756|NCT01716520|454470695|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321757|NCT01716520|454470696|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321758|NCT01716520|454470691|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321759|NCT01716520|454470692|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321760|NCT01716520|454470693|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321761|NCT01716520|454470694|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321762|NCT01716520|454470695|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321763|NCT01716520|454470696|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
126321764|NCT01716520|454470691|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126321765|NCT01716520|454470692|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
126321766|NCT01716520|454470693|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125983115|NCT04711603|453228295|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
125983116|NCT04711603|453228296|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
125983117|NCT04711603|453228293|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
125983118|NCT04711603|453228294|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
125983119|NCT04711603|453228295|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
126321767|NCT01716520|454470694|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126321768|NCT01716520|454470695|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126321769|NCT01716520|454470696|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126321770|NCT01716520|454470691|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321771|NCT01716520|454470692|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321772|NCT01716520|454470693|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321773|NCT01716520|454470694|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321774|NCT01716520|454470695|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321775|NCT01716520|454470696|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
126321776|NCT01716520|454470691|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126321777|NCT01716520|454470692|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126321778|NCT01716520|454470693|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
126321779|NCT01716520|454470694|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125983120|NCT04711603|453228296|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
125983121|NCT04711603|453228293|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
125983122|NCT04711603|453228294|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
125983123|NCT04711603|453228295|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
125983124|NCT04711603|453228296|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
125983125|NCT04711603|453228293|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
125983126|NCT04711603|453228294|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
125983127|NCT04711603|453228295|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
125983128|NCT04711603|453228296|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
125983129|NCT04711603|453228293|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
125983130|NCT04711603|453228294|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
125983131|NCT04711603|453228295|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
125983132|NCT04711603|453228296|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
125983133|NCT04711603|453228293|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
125983134|NCT04711603|453228294|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
125983135|NCT04711603|453228295|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
126321780|NCT01716520|454470695|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126321781|NCT01716520|454470696|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126321782|NCT03699540|454470697|FG000|Overall Study|Lost to Follow-up|1|||
126321783|NCT02697591|454470702|FG000|Overall Study|Lost to Follow-up|0|||
126321784|NCT02697591|454470703|FG001|Overall Study|Lost to Follow-up|0|||
126321785|NCT02697591|454470704|FG002|Overall Study|Lost to Follow-up|0|||
126321786|NCT02697591|454470705|FG003|Overall Study|Lost to Follow-up|0|||
126321787|NCT02697591|454470706|FG004|Overall Study|Lost to Follow-up|0|||
126321788|NCT02697591|454470707|FG005|Overall Study|Lost to Follow-up|1|||
126321789|NCT02697591|454470708|FG006|Overall Study|Lost to Follow-up|1|||
126321790|NCT02697591|454470709|FG007|Overall Study|Lost to Follow-up|0|||
126321791|NCT02697591|454470710|FG008|Overall Study|Lost to Follow-up|0|||
125983136|NCT04711603|453228296|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
125983137|NCT04711603|453228293|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
125983138|NCT04711603|453228294|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
125983139|NCT04711603|453228295|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
125983140|NCT04711603|453228296|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
125983141|NCT04711603|453228293|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
125983142|NCT04711603|453228294|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
125983143|NCT04711603|453228295|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
125983144|NCT04711603|453228296|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
125983145|NCT03138733|453228297|FG000|Overall Study|Death|17|||
125983146|NCT03138733|453228298|FG001|Overall Study|Death|18|||
125983147|NCT03138733|453228297|FG000|Overall Study|Withdrawal by Subject|11|||
125983148|NCT03138733|453228298|FG001|Overall Study|Withdrawal by Subject|6|||
125983149|NCT03138733|453228297|FG000|Overall Study|Lost to Follow-up|3|||
125983150|NCT03138733|453228298|FG001|Overall Study|Lost to Follow-up|2|||
125983151|NCT03138733|453228297|FG000|Overall Study|Adverse Event|1|||
125983152|NCT03138733|453228298|FG001|Overall Study|Adverse Event|0|||
125983153|NCT03138733|453228297|FG000|Overall Study|Protocol Violation|1|||
125983154|NCT03138733|453228298|FG001|Overall Study|Protocol Violation|3|||
125983155|NCT03138733|453228297|FG000|Overall Study|Administrative or logistical reason|1|||
125983156|NCT03138733|453228298|FG001|Overall Study|Administrative or logistical reason|0|||
125983157|NCT03138733|453228297|FG000|Overall Study|The patient was transferred to another hospital|1|||
125983158|NCT03138733|453228298|FG001|Overall Study|The patient was transferred to another hospital|0|||
125983159|NCT04252742|453228302|FG000|Overall Study|Decision by sponsor|0|||
125983160|NCT04252742|453228303|FG001|Overall Study|Decision by sponsor|2|||
125983161|NCT04252742|453228302|FG000|Overall Study|Withdrawal by Subject|15|||
125983162|NCT04252742|453228303|FG001|Overall Study|Withdrawal by Subject|9|||
125983163|NCT04252742|453228302|FG000|Overall Study|Lost to Follow-up|0|||
125983164|NCT04252742|453228303|FG001|Overall Study|Lost to Follow-up|1|||
125983165|NCT04270747|453228306|FG000|Through Week 16|Adverse Event|1|||
125983166|NCT04270747|453228307|FG001|Through Week 16|Adverse Event|2|||
125983167|NCT04270747|453228308|FG002|Through Week 16|Adverse Event|0|||
125983168|NCT04270747|453228306|FG000|Through Week 16|Death|0|||
125983169|NCT04270747|453228307|FG001|Through Week 16|Death|2|||
125983170|NCT04270747|453228308|FG002|Through Week 16|Death|0|||
125983171|NCT04270747|453228306|FG000|Through Week 16|Consent Withdrawn|3|||
125983172|NCT04270747|453228307|FG001|Through Week 16|Consent Withdrawn|3|||
125983173|NCT04270747|453228308|FG002|Through Week 16|Consent Withdrawn|0|||
125983174|NCT04270747|453228306|FG000|Through Week 16|Physician Decision|1|||
125983175|NCT04270747|453228307|FG001|Through Week 16|Physician Decision|1|||
125983176|NCT04270747|453228308|FG002|Through Week 16|Physician Decision|0|||
125983177|NCT04270747|453228306|FG000|Through Week 16|Lost to Follow-up|2|||
125983178|NCT04270747|453228307|FG001|Through Week 16|Lost to Follow-up|0|||
125983179|NCT04270747|453228308|FG002|Through Week 16|Lost to Follow-up|0|||
125983180|NCT04270747|453228306|FG000|Through Week 16|Protocol Violation|1|||
125983181|NCT04270747|453228307|FG001|Through Week 16|Protocol Violation|2|||
125983182|NCT04270747|453228308|FG002|Through Week 16|Protocol Violation|0|||
125983183|NCT04270747|453228306|FG000|Through Week 16|Protocol Specified Criteria|6|||
125983184|NCT04270747|453228307|FG001|Through Week 16|Protocol Specified Criteria|7|||
125983185|NCT04270747|453228308|FG002|Through Week 16|Protocol Specified Criteria|0|||
125983186|NCT04270747|453228306|FG000|Through Week 16|Miscellaneous|1|||
125983187|NCT04270747|453228307|FG001|Through Week 16|Miscellaneous|1|||
125983188|NCT04270747|453228308|FG002|Through Week 16|Miscellaneous|0|||
125983189|NCT04270747|453228306|FG000|Post Week 16|Adverse Event|7|||
126321792|NCT02697591|454470711|FG009|Overall Study|Lost to Follow-up|1|||
126321793|NCT02697591|454470702|FG000|Overall Study|Withdrawal by Subject|1|||
125983190|NCT04270747|453228307|FG001|Post Week 16|Adverse Event|5|||
126321794|NCT02697591|454470703|FG001|Overall Study|Withdrawal by Subject|1|||
125983191|NCT04270747|453228308|FG002|Post Week 16|Adverse Event|1|||
126321795|NCT02697591|454470704|FG002|Overall Study|Withdrawal by Subject|2|||
126321796|NCT02697591|454470705|FG003|Overall Study|Withdrawal by Subject|1|||
126321797|NCT02697591|454470706|FG004|Overall Study|Withdrawal by Subject|7|||
125983192|NCT04270747|453228306|FG000|Post Week 16|Death|2|||
125983193|NCT04270747|453228307|FG001|Post Week 16|Death|0|||
125983194|NCT04270747|453228308|FG002|Post Week 16|Death|2|||
125983195|NCT04270747|453228306|FG000|Post Week 16|Consent Withdrawn|4|||
125983196|NCT04270747|453228307|FG001|Post Week 16|Consent Withdrawn|3|||
126321798|NCT02697591|454470707|FG005|Overall Study|Withdrawal by Subject|6|||
126321799|NCT02697591|454470708|FG006|Overall Study|Withdrawal by Subject|9|||
125983197|NCT04270747|453228308|FG002|Post Week 16|Consent Withdrawn|6|||
125983198|NCT04270747|453228306|FG000|Post Week 16|Physician Decision|3|||
125983199|NCT04270747|453228307|FG001|Post Week 16|Physician Decision|1|||
125983200|NCT04270747|453228308|FG002|Post Week 16|Physician Decision|1|||
125983201|NCT04270747|453228306|FG000|Post Week 16|Lost to Follow-up|2|||
125983202|NCT04270747|453228307|FG001|Post Week 16|Lost to Follow-up|1|||
125983203|NCT04270747|453228308|FG002|Post Week 16|Lost to Follow-up|0|||
125983204|NCT04270747|453228306|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
125983205|NCT04270747|453228307|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
125983206|NCT04270747|453228308|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
125983207|NCT04270747|453228306|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
125983208|NCT04270747|453228307|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
125983209|NCT04270747|453228308|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
125983210|NCT04270747|453228306|FG000|Post Week 16|Miscellaneous|1|||
125983211|NCT04270747|453228307|FG001|Post Week 16|Miscellaneous|0|||
125983212|NCT04270747|453228308|FG002|Post Week 16|Miscellaneous|1|||
125983213|NCT01784068|453228312|FG000|NTCS Phase|Adverse Event|5|||
125983214|NCT01784068|453228313|FG001|NTCS Phase|Adverse Event|0|||
125983215|NCT01784068|453228312|FG000|NTCS Phase|Physician Decision|2|||
125983216|NCT01784068|453228313|FG001|NTCS Phase|Physician Decision|0|||
125983217|NCT01784068|453228312|FG000|NTCS Phase|Patient/guardian decision|3|||
125983218|NCT01784068|453228313|FG001|NTCS Phase|Patient/guardian decision|0|||
125983219|NCT01784068|453228312|FG000|NTCS Phase|Death|2|||
125983220|NCT01784068|453228313|FG001|NTCS Phase|Death|0|||
125983221|NCT01784068|453228312|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
125983222|NCT01784068|453228313|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
125983223|NCT01784068|453228312|FG000|TFR Phase|Physician Decision|0|||
125983224|NCT01784068|453228313|FG001|TFR Phase|Physician Decision|1|||
125983225|NCT01784068|453228312|FG000|TFR Phase|Patient/guardian decision|0|||
125983226|NCT01784068|453228313|FG001|TFR Phase|Patient/guardian decision|3|||
125983227|NCT01784068|453228312|FG000|TFR Phase|Death|0|||
125983228|NCT01784068|453228313|FG001|TFR Phase|Death|1|||
125983229|NCT01784068|453228312|FG000|TFR Phase|Lack of Efficacy|0|||
125983230|NCT01784068|453228313|FG001|TFR Phase|Lack of Efficacy|88|||
125983231|NCT05614089|453228314|FG000|Overall Study|Pregnancy|5|||
125983232|NCT05614089|453228315|FG001|Overall Study|Pregnancy|2|||
125983233|NCT05614089|453228314|FG000|Overall Study|Lost to Follow-up|5|||
125983234|NCT05614089|453228315|FG001|Overall Study|Lost to Follow-up|1|||
125983235|NCT05614089|453228314|FG000|Overall Study|Death|0|||
125983236|NCT05614089|453228315|FG001|Overall Study|Death|1|||
125983237|NCT05614089|453228314|FG000|Overall Study|Adverse Event|1|||
125983238|NCT05614089|453228315|FG001|Overall Study|Adverse Event|0|||
125983239|NCT02612064|453228326|FG000|Overall Study|Withdrawal by Subject|1|||
125983240|NCT02612064|453228327|FG001|Overall Study|Withdrawal by Subject|1|||
125983241|NCT02612064|453228326|FG000|Overall Study|Other|0|||
125983242|NCT02612064|453228327|FG001|Overall Study|Other|2|||
125983243|NCT01669798|453228328|FG000|Overall Study|Physician Decision|5|||
125983244|NCT00717860|453228330|FG000|Overall Study|Clinical adverse experience|5|||
125983245|NCT00717860|453228331|FG001|Overall Study|Clinical adverse experience|9|||
125983246|NCT00717860|453228330|FG000|Overall Study|Laboratory adverse experience|2|||
125983247|NCT00717860|453228331|FG001|Overall Study|Laboratory adverse experience|2|||
125983248|NCT00717860|453228330|FG000|Overall Study|Lack of Efficacy|7|||
125983249|NCT00717860|453228331|FG001|Overall Study|Lack of Efficacy|13|||
125983250|NCT00717860|453228330|FG000|Overall Study|Discontinued for other reason|6|||
125983251|NCT00717860|453228331|FG001|Overall Study|Discontinued for other reason|1|||
125983252|NCT00717860|453228330|FG000|Overall Study|Withdrew consent|7|||
125983253|NCT00717860|453228331|FG001|Overall Study|Withdrew consent|3|||
125983254|NCT04058353|453228335|FG000|Overall Study|Adverse Event|2|||
125983255|NCT04058353|453228336|FG001|Overall Study|Adverse Event|1|||
125983256|NCT04058353|453228335|FG000|Overall Study|Physician Decision|1|||
125983257|NCT04058353|453228336|FG001|Overall Study|Physician Decision|0|||
125983258|NCT04058353|453228335|FG000|Overall Study|Other|1|||
125983259|NCT04058353|453228336|FG001|Overall Study|Other|0|||
125983260|NCT00698646|453228337|FG000|Overall Study|Adverse Event|8|||
125983261|NCT00698646|453228338|FG001|Overall Study|Adverse Event|7|||
125983262|NCT00698646|453228339|FG002|Overall Study|Adverse Event|8|||
125983263|NCT00698646|453228337|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
125983264|NCT00698646|453228338|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
125983265|NCT00698646|453228339|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
125983266|NCT00698646|453228337|FG000|Overall Study|Protocol Deviation|6|||
125983267|NCT00698646|453228338|FG001|Overall Study|Protocol Deviation|2|||
125983268|NCT00698646|453228339|FG002|Overall Study|Protocol Deviation|3|||
125983269|NCT00698646|453228337|FG000|Overall Study|Withdrawal by Subject|10|||
125983270|NCT00698646|453228338|FG001|Overall Study|Withdrawal by Subject|11|||
125983271|NCT00698646|453228339|FG002|Overall Study|Withdrawal by Subject|8|||
125983272|NCT00698646|453228337|FG000|Overall Study|Lost to Follow-up|0|||
125983273|NCT00698646|453228338|FG001|Overall Study|Lost to Follow-up|0|||
125983274|NCT00698646|453228339|FG002|Overall Study|Lost to Follow-up|2|||
126321800|NCT02697591|454470709|FG007|Overall Study|Withdrawal by Subject|1|||
126321801|NCT02697591|454470710|FG008|Overall Study|Withdrawal by Subject|6|||
126321802|NCT02697591|454470711|FG009|Overall Study|Withdrawal by Subject|10|||
126321803|NCT02697591|454470702|FG000|Overall Study|Physician Decision|1|||
126321804|NCT02697591|454470703|FG001|Overall Study|Physician Decision|0|||
126321805|NCT02697591|454470704|FG002|Overall Study|Physician Decision|0|||
126321806|NCT02697591|454470705|FG003|Overall Study|Physician Decision|0|||
126321807|NCT02697591|454470706|FG004|Overall Study|Physician Decision|1|||
126321808|NCT02697591|454470707|FG005|Overall Study|Physician Decision|2|||
126321809|NCT02697591|454470708|FG006|Overall Study|Physician Decision|0|||
126321810|NCT02697591|454470709|FG007|Overall Study|Physician Decision|0|||
126321811|NCT02697591|454470710|FG008|Overall Study|Physician Decision|1|||
126321812|NCT02697591|454470711|FG009|Overall Study|Physician Decision|1|||
126321813|NCT02697591|454470702|FG000|Overall Study|Death|2|||
126321814|NCT02697591|454470703|FG001|Overall Study|Death|3|||
126321815|NCT02697591|454470704|FG002|Overall Study|Death|1|||
126321816|NCT02697591|454470705|FG003|Overall Study|Death|1|||
126321817|NCT02697591|454470706|FG004|Overall Study|Death|4|||
126321818|NCT02697591|454470707|FG005|Overall Study|Death|5|||
126321819|NCT02697591|454470708|FG006|Overall Study|Death|3|||
126321820|NCT02697591|454470709|FG007|Overall Study|Death|1|||
126321821|NCT02697591|454470710|FG008|Overall Study|Death|1|||
126321822|NCT02697591|454470711|FG009|Overall Study|Death|5|||
126321823|NCT02697591|454470702|FG000|Overall Study|Reason not Specified|0|||
126321824|NCT02697591|454470703|FG001|Overall Study|Reason not Specified|0|||
126321825|NCT02697591|454470704|FG002|Overall Study|Reason not Specified|0|||
126321826|NCT02697591|454470705|FG003|Overall Study|Reason not Specified|1|||
126321827|NCT02697591|454470706|FG004|Overall Study|Reason not Specified|1|||
126321828|NCT02697591|454470707|FG005|Overall Study|Reason not Specified|2|||
126321829|NCT02697591|454470708|FG006|Overall Study|Reason not Specified|3|||
126321830|NCT02697591|454470709|FG007|Overall Study|Reason not Specified|1|||
126321831|NCT02697591|454470710|FG008|Overall Study|Reason not Specified|1|||
126321832|NCT02697591|454470711|FG009|Overall Study|Reason not Specified|3|||
126321833|NCT01038752|454470713|FG000|Overall Study|Tumor Progression|2|||
126321834|NCT01038752|454470714|FG001|Overall Study|Tumor Progression|2|||
126321835|NCT01038752|454470713|FG000|Overall Study|Lost to Follow-up|3|||
126321836|NCT01038752|454470714|FG001|Overall Study|Lost to Follow-up|3|||
126321837|NCT00530790|454470715|FG000|Overall Study|Adverse Event|2|||
126321838|NCT00530790|454470715|FG000|Overall Study|Withdrawal by Subject|2|||
126321839|NCT00530790|454470715|FG000|Overall Study|Physician Decision|1|||
126321840|NCT01084538|454470718|FG000|Overall Study|Drug not available|30|||
126321841|NCT01084538|454470718|FG000|Overall Study|Adverse Event|9|||
126321842|NCT01084538|454470718|FG000|Overall Study|Kidney transplant|6|||
126321843|NCT01084538|454470718|FG000|Overall Study|Serious Adverse Event|3|||
126321844|NCT01084538|454470718|FG000|Overall Study|Lack of effectiveness|2|||
126321845|NCT01084538|454470718|FG000|Overall Study|Patient noncompliance|2|||
126321846|NCT01084538|454470718|FG000|Overall Study|Hyperphosphatemia|2|||
126321847|NCT01084538|454470718|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
126321848|NCT01084538|454470718|FG000|Overall Study|Change of residence|2|||
126321849|NCT01084538|454470718|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
126321850|NCT01084538|454470718|FG000|Overall Study|Reason unknown|8|||
126321851|NCT02279745|454470719|FG000|Overall Study|Adverse Event|7|||
126321852|NCT02279745|454470719|FG000|Overall Study|Death|6|||
125878487|NCT05138653|452851310|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878488|NCT05138653|452851311|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878489|NCT05138653|452851312|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878490|NCT05138653|452851313|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878491|NCT05138653|452851314|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878492|NCT05138653|452851315|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878493|NCT05138653|452851316|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878494|NCT05138653|452851317|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878495|NCT05138653|452851318|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878496|NCT05138653|452851319|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125878497|NCT05138653|452851320|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878498|NCT05138653|452851321|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125878499|NCT05138653|452851322|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878500|NCT05138653|452851323|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125878501|NCT05138653|452851324|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125878502|NCT05138653|452851309|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126321853|NCT02279745|454470719|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
126321854|NCT02279745|454470719|FG000|Overall Study|Withdrawal by Subject|2|||
126321855|NCT02279745|454470719|FG000|Overall Study|Pregnancy|1|||
126321856|NCT02279745|454470719|FG000|Overall Study|Study Non-compliance|1|||
126321857|NCT02279745|454470719|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
126321858|NCT00106639|454470728|FG000|Overall Study|Adverse Event|3|||
126321859|NCT00106639|454470729|FG001|Overall Study|Adverse Event|4|||
125983275|NCT00698646|453228337|FG000|Overall Study|Administrative problems|1|||
125983276|NCT00698646|453228338|FG001|Overall Study|Administrative problems|0|||
125983277|NCT00698646|453228339|FG002|Overall Study|Administrative problems|1|||
125983278|NCT02618616|453228340|FG000|Overall Study|Lack of Efficacy|4|||
125983279|NCT02618616|453228341|FG001|Overall Study|Lack of Efficacy|0|||
125983280|NCT02618616|453228340|FG000|Overall Study|Pregnancy|0|||
125983281|NCT02618616|453228341|FG001|Overall Study|Pregnancy|1|||
125983282|NCT02618616|453228340|FG000|Overall Study|Adverse Event|8|||
125983283|NCT02618616|453228341|FG001|Overall Study|Adverse Event|0|||
125983284|NCT02618616|453228340|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
125983285|NCT02618616|453228341|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
125983286|NCT02618616|453228340|FG000|Overall Study|Consent withdrawn by subject|8|||
125983287|NCT02618616|453228341|FG001|Overall Study|Consent withdrawn by subject|5|||
125983288|NCT02618616|453228340|FG000|Overall Study|Lost to Follow-up|0|||
125983289|NCT02618616|453228341|FG001|Overall Study|Lost to Follow-up|1|||
125983290|NCT02027402|453228342|FG000|Overall Study|Withdrawal by Subject|4|||
125983291|NCT02027402|453228343|FG001|Overall Study|Withdrawal by Subject|1|||
125983292|NCT04225988|453228344|FG000|Overall Study|Withdrawal by Subject|2|||
125983293|NCT04225988|453228345|FG001|Overall Study|Withdrawal by Subject|0|||
125983294|NCT01142388|453229884|FG000|Overall Study|Lack of Efficacy|21|||
125983295|NCT01142388|453229885|FG001|Overall Study|Lack of Efficacy|31|||
125983296|NCT01142388|453229884|FG000|Overall Study|Adverse Event|9|||
125983297|NCT01142388|453229885|FG001|Overall Study|Adverse Event|5|||
125983298|NCT01142388|453229884|FG000|Overall Study|Death|3|||
125983299|NCT01142388|453229885|FG001|Overall Study|Death|2|||
125983300|NCT01142388|453229884|FG000|Overall Study|Withdrawal by Subject|5|||
125983301|NCT01142388|453229885|FG001|Overall Study|Withdrawal by Subject|3|||
125983302|NCT01142388|453229884|FG000|Overall Study|Alternative therapy|1|||
125983303|NCT01142388|453229885|FG001|Overall Study|Alternative therapy|0|||
125983304|NCT01142388|453229884|FG000|Overall Study|Other complications|0|||
125983305|NCT01142388|453229885|FG001|Overall Study|Other complications|2|||
125983306|NCT01142388|453229884|FG000|Overall Study|Other|1|||
125983307|NCT01142388|453229885|FG001|Overall Study|Other|1|||
125983308|NCT01142388|453229884|FG000|Overall Study|Never started therapy|7|||
125983309|NCT01142388|453229885|FG001|Overall Study|Never started therapy|3|||
125983310|NCT00335452|453229892|FG000|Overall Study|Death|156|||
125983311|NCT00335452|453229893|FG001|Overall Study|Death|144|||
125983312|NCT00335452|453229894|FG002|Overall Study|Death|158|||
125983313|NCT00335452|453229895|FG003|Overall Study|Death|129|||
125983314|NCT00335452|453229892|FG000|Overall Study|Lost to Follow-up|2|||
125983315|NCT00335452|453229893|FG001|Overall Study|Lost to Follow-up|3|||
125983316|NCT00335452|453229894|FG002|Overall Study|Lost to Follow-up|1|||
125983317|NCT00335452|453229895|FG003|Overall Study|Lost to Follow-up|2|||
125983318|NCT01750879|453229909|FG000|Overall Study|Adverse Event|8|||
125983319|NCT01750879|453229910|FG001|Overall Study|Adverse Event|0|||
125983320|NCT01750879|453229909|FG000|Overall Study|Lack of Efficacy|1|||
125983321|NCT01750879|453229910|FG001|Overall Study|Lack of Efficacy|0|||
125983322|NCT01750879|453229909|FG000|Overall Study|Withdrawal by Subject|1|||
125983323|NCT01750879|453229910|FG001|Overall Study|Withdrawal by Subject|0|||
125983324|NCT01750879|453229909|FG000|Overall Study|Did not complete per protocol|0|||
125983325|NCT01750879|453229910|FG001|Overall Study|Did not complete per protocol|3|||
125983326|NCT02421666|453229913|FG000|6-month Follow-up|Lost to Follow-up|8|||
125983327|NCT02421666|453229914|FG001|6-month Follow-up|Lost to Follow-up|7|||
125983328|NCT02421666|453229913|FG000|6-month Follow-up|Withdrawal by Subject|5|||
125983329|NCT02421666|453229914|FG001|6-month Follow-up|Withdrawal by Subject|6|||
125983330|NCT02421666|453229913|FG000|12-month Follow-up|Lost to Follow-up|5|||
125983331|NCT02421666|453229914|FG001|12-month Follow-up|Lost to Follow-up|5|||
125983332|NCT02421666|453229913|FG000|12-month Follow-up|Withdrawal by Subject|6|||
125983333|NCT02421666|453229914|FG001|12-month Follow-up|Withdrawal by Subject|11|||
125983334|NCT00508404|453229919|FG000|Overall Study|Ongoing at Data Cut-off|12|||
125983335|NCT00508404|453229919|FG000|Overall Study|Adverse Event|2|||
125983336|NCT00508404|453229919|FG000|Overall Study|Death|16|||
125983337|NCT00508404|453229919|FG000|Overall Study|Physician Decision|2|||
125983338|NCT00508404|453229919|FG000|Overall Study|Withdrawal by Subject|3|||
125983339|NCT00508404|453229919|FG000|Overall Study|Protocol-specified Criteria|2|||
125983340|NCT00508404|453229919|FG000|Overall Study|Lost to Follow-up|2|||
125983341|NCT00508404|453229919|FG000|Overall Study|Other - Not Specified|3|||
125983342|NCT01119768|453229925|FG000|Treatment Period|Lack of Efficacy|18|||
125983343|NCT01119768|453229926|FG001|Treatment Period|Lack of Efficacy|25|||
125983344|NCT01059643|453229927|FG000|Overall Study|Adverse Event|3|||
125983345|NCT01059643|453229927|FG000|Overall Study|Withdrawal by Subject|2|||
125983346|NCT01059643|453229927|FG000|Overall Study|Physician Decision|1|||
125983347|NCT00643123|453229940|FG000|Overall Study|Lost to Follow-up|4|||
125983348|NCT00643123|453229941|FG001|Overall Study|Lost to Follow-up|0|||
125983349|NCT00643123|453229940|FG000|Overall Study|Withdrawal by Subject|1|||
125983350|NCT00643123|453229941|FG001|Overall Study|Withdrawal by Subject|1|||
125983351|NCT02923739|453229942|FG000|Overall Study|Withdrawal by Subject|2|||
125983352|NCT02923739|453229943|FG001|Overall Study|Withdrawal by Subject|0|||
126321860|NCT00106639|454470730|FG002|Overall Study|Adverse Event|1|||
126321861|NCT00106639|454470728|FG000|Overall Study|Protocol Violation|0|||
126321862|NCT00106639|454470729|FG001|Overall Study|Protocol Violation|1|||
126321863|NCT00106639|454470730|FG002|Overall Study|Protocol Violation|0|||
126321864|NCT00106639|454470728|FG000|Overall Study|Withdrawal by Subject|0|||
126321865|NCT00106639|454470729|FG001|Overall Study|Withdrawal by Subject|1|||
126321866|NCT00106639|454470730|FG002|Overall Study|Withdrawal by Subject|0|||
126321867|NCT00106639|454470728|FG000|Overall Study|Participant defaulted|0|||
126321868|NCT00106639|454470729|FG001|Overall Study|Participant defaulted|1|||
126321869|NCT00106639|454470730|FG002|Overall Study|Participant defaulted|1|||
126321870|NCT00594386|454470732|FG000|Overall Study|Major protocol violation|2|||
126321871|NCT00594386|454470732|FG000|Overall Study|Lack of Efficacy|12|||
126321872|NCT00594386|454470732|FG000|Overall Study|Adverse Event|68|||
126321873|NCT00594386|454470732|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
126321874|NCT00594386|454470732|FG000|Overall Study|Subject withdrew consent|35|||
126321875|NCT00594386|454470732|FG000|Overall Study|Study ended per sponsor|115|||
126321876|NCT00594386|454470732|FG000|Overall Study|Lost to Follow-up|6|||
126321877|NCT00594386|454470732|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
126321878|NCT00594386|454470732|FG000|Overall Study|Other: Subject moved to Seattle|1|||
126321879|NCT00594386|454470732|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
126321880|NCT00594386|454470732|FG000|Overall Study|Other: Study terminated per investigator|2|||
126321881|NCT00594386|454470732|FG000|Overall Study|Other: Sponsor closure of study|1|||
126321882|NCT00594386|454470732|FG000|Overall Study|Other: Site terminated participation|1|||
126321883|NCT00594386|454470732|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
126321884|NCT00594386|454470732|FG000|Overall Study|Other: Loss of drivers license|1|||
126321885|NCT01210144|454470733|FG000|Overall Study|Lack of ovarian response|1|||
126321886|NCT01210144|454470734|FG001|Overall Study|Lack of ovarian response|0|||
126321887|NCT01210144|454470733|FG000|Overall Study|No fertilization|1|||
126321888|NCT01210144|454470734|FG001|Overall Study|No fertilization|0|||
126321889|NCT01210144|454470733|FG000|Overall Study|No transfer|1|||
126321890|NCT01210144|454470734|FG001|Overall Study|No transfer|0|||
126321891|NCT00094536|454470741|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
126321892|NCT00094536|454470741|FG000|Treatment and Follow-up|Adverse Event|4|||
126321893|NCT00094536|454470741|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
126321894|NCT00094536|454470741|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
126321895|NCT00094536|454470741|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
126321896|NCT00094536|454470741|FG000|Treatment and Follow-up|Subject non-compliance|9|||
126321897|NCT00094536|454470741|FG000|Treatment and Follow-up|Unable to attend visits|1|||
126321898|NCT00494221|454470742|FG000|Overall Study|Death|15|||
126321899|NCT00494221|454470743|FG001|Overall Study|Death|9|||
126321900|NCT00494221|454470744|FG002|Overall Study|Death|14|||
126321901|NCT00494221|454470742|FG000|Overall Study|Withdrawal by Subject|1|||
126321902|NCT00494221|454470743|FG001|Overall Study|Withdrawal by Subject|2|||
126321903|NCT00494221|454470744|FG002|Overall Study|Withdrawal by Subject|0|||
126321904|NCT01900431|454470746|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
126321905|NCT01900431|454470747|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
126321906|NCT01900431|454470748|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
126321907|NCT01900431|454470746|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
126321908|NCT01900431|454470747|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
126321909|NCT01900431|454470748|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
126321910|NCT01900431|454470746|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
126321911|NCT01900431|454470747|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
126321912|NCT01900431|454470748|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
126321913|NCT01900431|454470746|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
126321914|NCT01900431|454470747|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
126321915|NCT01900431|454470748|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
126321916|NCT01900431|454470746|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
126321917|NCT01900431|454470747|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
125983353|NCT02923739|453229944|FG002|Overall Study|Withdrawal by Subject|0|||
125983354|NCT02923739|453229945|FG003|Overall Study|Withdrawal by Subject|0|||
125983355|NCT02923739|453229942|FG000|Overall Study|Failed Screening|3|||
125983356|NCT02923739|453229943|FG001|Overall Study|Failed Screening|0|||
125983357|NCT02923739|453229944|FG002|Overall Study|Failed Screening|0|||
125983358|NCT02923739|453229945|FG003|Overall Study|Failed Screening|0|||
126321918|NCT01900431|454470748|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
126321919|NCT01900431|454470746|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
126321920|NCT01900431|454470747|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
126321921|NCT01900431|454470748|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
126321922|NCT01900431|454470746|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
126321923|NCT01900431|454470747|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
126321924|NCT01900431|454470748|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
125983359|NCT01591382|453229950|FG000|Overall Study|Discharged Prior to Study Completion|2|||
125983360|NCT01591382|453229951|FG001|Overall Study|Discharged Prior to Study Completion|1|||
126321925|NCT01900431|454470746|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
126321926|NCT01900431|454470747|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
126321927|NCT01900431|454470748|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
126321928|NCT01900431|454470746|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
126321929|NCT01900431|454470747|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
126321930|NCT01900431|454470748|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
126321931|NCT03172364|454470752|FG000|Overall Study|Adverse Event|1|||
126321932|NCT03172364|454470753|FG001|Overall Study|Adverse Event|1|||
126321933|NCT03172364|454470752|FG000|Overall Study|Protocol Violation|1|||
126321934|NCT03172364|454470753|FG001|Overall Study|Protocol Violation|0|||
126321935|NCT03755518|454470754|FG000|Overall Study|Lack of Efficacy|10|||
126321936|NCT03755518|454470754|FG000|Overall Study|Adverse Event|7|||
126321937|NCT03755518|454470754|FG000|Overall Study|Study Terminated by Sponsor|5|||
126321938|NCT03755518|454470754|FG000|Overall Study|Death|1|||
126321939|NCT03755518|454470754|FG000|Overall Study|Withdrawal by Subject|3|||
126321940|NCT03755518|454470754|FG000|Overall Study|Progressive Disease|4|||
126321941|NCT03755518|454470754|FG000|Overall Study|Bone Marrow Transplant|4|||
126321942|NCT03755518|454470754|FG000|Overall Study|Physicians Decision|1|||
126321943|NCT03755518|454470754|FG000|Overall Study|Relapse|1|||
126321944|NCT03755518|454470754|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
126321945|NCT03755518|454470754|FG000|Overall Study|Withdrawal by PI|1|||
126321946|NCT01714609|454470755|FG000|Overall Study|Protocol Violation|1|||
126321947|NCT01714609|454470756|FG001|Overall Study|Protocol Violation|0|||
126321948|NCT00630747|454470757|FG000|Overall Study|Death|1|||
126321949|NCT00630747|454470757|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
126321950|NCT00630747|454470757|FG000|Overall Study|Returned to country of origin|1|||
126321951|NCT04503668|454470760|FG000|Overall Study|Incomplete data|4|||
126321952|NCT04503668|454470761|FG001|Overall Study|Incomplete data|3|||
126321953|NCT04503668|454470760|FG000|Overall Study|Withdrawal by Subject|1|||
126321954|NCT04503668|454470761|FG001|Overall Study|Withdrawal by Subject|1|||
126321955|NCT04503668|454470760|FG000|Overall Study|Adverse Event|2|||
126321956|NCT04503668|454470761|FG001|Overall Study|Adverse Event|0|||
126321957|NCT02306694|454470762|FG000|Overall Study|Withdrawal by Subject|3|||
126321958|NCT02306694|454470762|FG000|Overall Study|Lost to Follow-up|1|||
126321959|NCT00603382|454470763|FG000|Overall Study|Adverse Event|0|||
126321960|NCT00603382|454470764|FG001|Overall Study|Adverse Event|1|||
126321961|NCT00603382|454470765|FG002|Overall Study|Adverse Event|1|||
126321962|NCT00603382|454470766|FG003|Overall Study|Adverse Event|2|||
126321963|NCT00603382|454470767|FG004|Overall Study|Adverse Event|1|||
126321964|NCT00603382|454470768|FG005|Overall Study|Adverse Event|2|||
126321965|NCT00603382|454470763|FG000|Overall Study|Lack of Efficacy|14|||
126321966|NCT00603382|454470764|FG001|Overall Study|Lack of Efficacy|9|||
126321967|NCT00603382|454470765|FG002|Overall Study|Lack of Efficacy|3|||
126321968|NCT00603382|454470766|FG003|Overall Study|Lack of Efficacy|6|||
126321969|NCT00603382|454470767|FG004|Overall Study|Lack of Efficacy|6|||
126321970|NCT00603382|454470768|FG005|Overall Study|Lack of Efficacy|11|||
126321971|NCT00603382|454470763|FG000|Overall Study|Protocol Violation|1|||
126321972|NCT00603382|454470764|FG001|Overall Study|Protocol Violation|0|||
126321973|NCT00603382|454470765|FG002|Overall Study|Protocol Violation|1|||
126321974|NCT00603382|454470766|FG003|Overall Study|Protocol Violation|2|||
126321975|NCT00603382|454470767|FG004|Overall Study|Protocol Violation|1|||
126321976|NCT00603382|454470768|FG005|Overall Study|Protocol Violation|0|||
126321977|NCT00603382|454470763|FG000|Overall Study|Lost to Follow-up|0|||
126321978|NCT00603382|454470764|FG001|Overall Study|Lost to Follow-up|1|||
126321979|NCT00603382|454470765|FG002|Overall Study|Lost to Follow-up|1|||
126321980|NCT00603382|454470766|FG003|Overall Study|Lost to Follow-up|1|||
126321981|NCT00603382|454470767|FG004|Overall Study|Lost to Follow-up|0|||
126321982|NCT00603382|454470768|FG005|Overall Study|Lost to Follow-up|1|||
126321983|NCT00603382|454470763|FG000|Overall Study|Physician Decision|0|||
126321984|NCT00603382|454470764|FG001|Overall Study|Physician Decision|0|||
126321985|NCT00603382|454470765|FG002|Overall Study|Physician Decision|2|||
126321986|NCT00603382|454470766|FG003|Overall Study|Physician Decision|0|||
126321987|NCT00603382|454470767|FG004|Overall Study|Physician Decision|1|||
125983361|NCT01591382|453229950|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
125983362|NCT01591382|453229951|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
126321988|NCT00603382|454470768|FG005|Overall Study|Physician Decision|3|||
126321989|NCT00603382|454470763|FG000|Overall Study|Withdrawal by Subject|3|||
126321990|NCT00603382|454470764|FG001|Overall Study|Withdrawal by Subject|3|||
126321991|NCT00603382|454470765|FG002|Overall Study|Withdrawal by Subject|1|||
126321992|NCT00603382|454470766|FG003|Overall Study|Withdrawal by Subject|1|||
126321993|NCT00603382|454470767|FG004|Overall Study|Withdrawal by Subject|0|||
126321994|NCT00603382|454470768|FG005|Overall Study|Withdrawal by Subject|1|||
126321995|NCT03782974|454470769|FG000|Overall Study|Withdrawal by Subject|7|||
126321996|NCT03782974|454470770|FG001|Overall Study|Withdrawal by Subject|7|||
126321997|NCT03782974|454470769|FG000|Overall Study|Pregnancy|1|||
126321998|NCT03782974|454470770|FG001|Overall Study|Pregnancy|0|||
126321999|NCT02012959|454470771|FG000|Treatment Phase A|Adverse Event|2|||
126322000|NCT02012959|454470772|FG001|Treatment Phase A|Adverse Event|0|||
126322001|NCT02012959|454470773|FG002|Treatment Phase A|Adverse Event|0|||
126322002|NCT02012959|454470774|FG003|Treatment Phase A|Adverse Event|0|||
126322003|NCT02012959|454470775|FG004|Treatment Phase A|Adverse Event|0|||
126322004|NCT00395642|454470776|FG000|Overall Study|Death|4|||
126322005|NCT00395642|454470776|FG000|Overall Study|Lost to Follow-up|1|||
126322006|NCT00395642|454470776|FG000|Overall Study|Physician Decision|7|||
126322007|NCT00395642|454470776|FG000|Overall Study|Withdrawal by Subject|1|||
126322008|NCT01783821|454470779|FG000|Overall Study|Screen Failure|1|||
126322009|NCT01783821|454470780|FG001|Overall Study|Screen Failure|1|||
126322010|NCT02333383|454470783|FG000|Overall Study|Adalimumab discontinuation|21|||
126322011|NCT02333383|454470783|FG000|Overall Study|Lost to Follow-up|15|||
126322012|NCT02333383|454470783|FG000|Overall Study|Withdrawal by Subject|3|||
125983363|NCT01059630|453229957|FG000|Overall Study|Death|100|||
125983364|NCT01059630|453229958|FG001|Overall Study|Death|84|||
125983365|NCT01059630|453229957|FG000|Overall Study|Lost to Follow-up|4|||
125983366|NCT01059630|453229958|FG001|Overall Study|Lost to Follow-up|1|||
125983367|NCT01059630|453229957|FG000|Overall Study|Physician Decision|2|||
125983368|NCT01059630|453229958|FG001|Overall Study|Physician Decision|4|||
125983369|NCT01059630|453229957|FG000|Overall Study|Withdrawal by Subject|21|||
125983370|NCT01059630|453229958|FG001|Overall Study|Withdrawal by Subject|14|||
125983371|NCT03170375|453229959|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
125983372|NCT03170375|453229960|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
125983373|NCT03170375|453229961|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
125983374|NCT03170375|453229959|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
125983375|NCT03170375|453229960|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
125983376|NCT03170375|453229961|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
125983377|NCT00855062|453229962|FG000|Step1|Early Study Closure|5|||
125983378|NCT00855062|453229963|FG001|Step1|Early Study Closure|7|||
125983379|NCT00855062|453229962|FG000|Step1|Adverse Event|1|||
125983380|NCT00855062|453229963|FG001|Step1|Adverse Event|1|||
125983381|NCT00855062|453229962|FG000|Step1|Protocol Violation|1|||
125983382|NCT00855062|453229963|FG001|Step1|Protocol Violation|0|||
125983383|NCT00855062|453229962|FG000|Step1|Pregnancy|1|||
125983384|NCT00855062|453229963|FG001|Step1|Pregnancy|0|||
125983385|NCT00855062|453229962|FG000|Step1|Withdrawal by Subject|2|||
125983386|NCT00855062|453229963|FG001|Step1|Withdrawal by Subject|3|||
125983387|NCT00855062|453229962|FG000|Step2|Early Study Closure|6|||
125983388|NCT00855062|453229963|FG001|Step2|Early Study Closure|2|||
125983389|NCT00855062|453229962|FG000|Step2|Adverse Event|0|||
125983390|NCT00855062|453229963|FG001|Step2|Adverse Event|3|||
125983391|NCT00855062|453229962|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
125983392|NCT00855062|453229963|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
125983393|NCT00763958|453229966|FG000|Overall Study|did not meet final criteria|4|||
125983394|NCT00763958|453229967|FG001|Overall Study|did not meet final criteria|4|||
125983395|NCT00763958|453229966|FG000|Overall Study|Lost to Follow-up|10|||
125983396|NCT00763958|453229967|FG001|Overall Study|Lost to Follow-up|2|||
125983397|NCT00763958|453229966|FG000|Overall Study|Believed they were receiving placebo|0|||
125983398|NCT00763958|453229967|FG001|Overall Study|Believed they were receiving placebo|5|||
125983399|NCT01376323|453229969|FG000|Overall Study|Adverse Event|1|||
125983400|NCT01376323|453229970|FG001|Overall Study|Adverse Event|0|||
125983401|NCT01376323|453229971|FG002|Overall Study|Adverse Event|0|||
125983402|NCT01376323|453229972|FG003|Overall Study|Adverse Event|2|||
125983403|NCT01376323|453229973|FG004|Overall Study|Adverse Event|0|||
125983404|NCT01376323|453229969|FG000|Overall Study|Lost to Follow-up|0|||
125983405|NCT01376323|453229970|FG001|Overall Study|Lost to Follow-up|0|||
125983406|NCT01376323|453229971|FG002|Overall Study|Lost to Follow-up|0|||
125983407|NCT01376323|453229972|FG003|Overall Study|Lost to Follow-up|2|||
125983408|NCT01376323|453229973|FG004|Overall Study|Lost to Follow-up|0|||
125983409|NCT01376323|453229969|FG000|Overall Study|Physician Decision|1|||
125983410|NCT01376323|453229970|FG001|Overall Study|Physician Decision|0|||
125983411|NCT01376323|453229971|FG002|Overall Study|Physician Decision|2|||
125983412|NCT01376323|453229972|FG003|Overall Study|Physician Decision|1|||
126322013|NCT02333383|454470783|FG000|Overall Study|Transfer to another hospital|2|||
126322014|NCT01907217|454470784|FG000|Overall Study|Withdrawal by Subject|0|||
126322015|NCT01907217|454470785|FG001|Overall Study|Withdrawal by Subject|2|||
126322016|NCT00659776|454470794|FG000|Overall Study|Withdrawal by Subject|12|||
125983413|NCT01376323|453229973|FG004|Overall Study|Physician Decision|1|||
125983414|NCT01376323|453229969|FG000|Overall Study|Withdrawal by Subject|0|||
125983415|NCT01376323|453229970|FG001|Overall Study|Withdrawal by Subject|1|||
125983416|NCT01376323|453229971|FG002|Overall Study|Withdrawal by Subject|1|||
125983417|NCT01376323|453229972|FG003|Overall Study|Withdrawal by Subject|0|||
126322017|NCT00659776|454470795|FG001|Overall Study|Withdrawal by Subject|2|||
126322018|NCT00659776|454470796|FG002|Overall Study|Withdrawal by Subject|0|||
125983418|NCT01376323|453229973|FG004|Overall Study|Withdrawal by Subject|0|||
125983419|NCT04681729|453229974|FG000|Overall Study|Lack of Efficacy|2|||
125983420|NCT04681729|453229975|FG001|Overall Study|Lack of Efficacy|2|||
125983421|NCT04681729|453229974|FG000|Overall Study|Withdrawal by Subject|8|||
125983422|NCT04681729|453229975|FG001|Overall Study|Withdrawal by Subject|9|||
126322019|NCT01180049|454470797|FG000|Overall Study|Other|9|||
126322020|NCT01180049|454470798|FG001|Overall Study|Other|7|||
126322021|NCT01180049|454470797|FG000|Overall Study|Lost to Follow-up|8|||
125983423|NCT02535364|453229977|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
125983424|NCT02535364|453229977|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
125983425|NCT02535364|453229977|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
125983426|NCT02535364|453229977|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
125983427|NCT02535364|453229977|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
125983428|NCT02535364|453229977|FG000|Part B Screening|Death|2|||
125983429|NCT02535364|453229977|FG000|Part B Screening|Physician Decision|1|||
125983430|NCT02535364|453229977|FG000|Part B Screening|Withdrawal by Subject|1|||
125983431|NCT02535364|453229977|FG000|Part B Screening|Adverse Event|1|||
125983432|NCT02535364|453229977|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
125983433|NCT02535364|453229977|FG000|Study Treatment|Death|1|||
125983434|NCT02535364|453229977|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
125983435|NCT02535364|453229977|FG000|12-Month Follow-up Period|Disease progression|22|||
126322022|NCT01180049|454470798|FG001|Overall Study|Lost to Follow-up|6|||
126322023|NCT01180049|454470797|FG000|Overall Study|Death|36|||
126322024|NCT01180049|454470798|FG001|Overall Study|Death|35|||
126322025|NCT01687283|454471968|FG000|Overall Study|Adverse Event|11|||
126322026|NCT01687283|454471969|FG001|Overall Study|Adverse Event|4|||
126322027|NCT01687283|454471968|FG000|Overall Study|Lack of Efficacy|3|||
126322028|NCT01687283|454471969|FG001|Overall Study|Lack of Efficacy|1|||
126322029|NCT01687283|454471968|FG000|Overall Study|Protocol Violation|1|||
126322030|NCT01687283|454471969|FG001|Overall Study|Protocol Violation|3|||
126322031|NCT01687283|454471968|FG000|Overall Study|protocol defined stopping criteria|8|||
126322032|NCT01687283|454471969|FG001|Overall Study|protocol defined stopping criteria|10|||
126322033|NCT01687283|454471968|FG000|Overall Study|Lost to Follow-up|1|||
126322034|NCT01687283|454471969|FG001|Overall Study|Lost to Follow-up|1|||
126322035|NCT01687283|454471968|FG000|Overall Study|Investigator discretion|2|||
126322036|NCT01687283|454471969|FG001|Overall Study|Investigator discretion|0|||
126322037|NCT01687283|454471968|FG000|Overall Study|Withdrawal by Subject|9|||
126322038|NCT01687283|454471969|FG001|Overall Study|Withdrawal by Subject|8|||
126322039|NCT00642954|454471970|FG000|Overall Study|Progressive Disease|3|||
126322040|NCT00642954|454471971|FG001|Overall Study|Progressive Disease|3|||
126322041|NCT00642954|454471972|FG002|Overall Study|Progressive Disease|3|||
126322042|NCT00642954|454471973|FG003|Overall Study|Progressive Disease|3|||
126322043|NCT00642954|454471974|FG004|Overall Study|Progressive Disease|9|||
126322044|NCT00642954|454471970|FG000|Overall Study|Withdrawal by Subject|0|||
126322045|NCT00642954|454471971|FG001|Overall Study|Withdrawal by Subject|0|||
126322046|NCT00642954|454471972|FG002|Overall Study|Withdrawal by Subject|0|||
126322047|NCT00642954|454471973|FG003|Overall Study|Withdrawal by Subject|0|||
126322048|NCT00642954|454471974|FG004|Overall Study|Withdrawal by Subject|1|||
126322049|NCT00642954|454471970|FG000|Overall Study|Adverse Event|1|||
126322050|NCT00642954|454471971|FG001|Overall Study|Adverse Event|1|||
126322051|NCT00642954|454471972|FG002|Overall Study|Adverse Event|0|||
126322052|NCT00642954|454471973|FG003|Overall Study|Adverse Event|0|||
126322053|NCT00642954|454471974|FG004|Overall Study|Adverse Event|6|||
126322054|NCT01663857|454471975|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
126322055|NCT01663857|454471976|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
126322056|NCT01663857|454471977|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
126322057|NCT01663857|454471978|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
126322058|NCT01663857|454471975|FG000|Overall Study|Lost to Follow-up|0|||
126322059|NCT01663857|454471976|FG001|Overall Study|Lost to Follow-up|0|||
126322060|NCT01663857|454471977|FG002|Overall Study|Lost to Follow-up|3|||
126322061|NCT01663857|454471978|FG003|Overall Study|Lost to Follow-up|1|||
126322062|NCT03041467|454471979|FG000|Overall Study|Death|46|||
126322063|NCT03041467|454471980|FG001|Overall Study|Death|39|||
126322064|NCT03041467|454471979|FG000|Overall Study|Withdrawal by Subject|36|||
126322065|NCT03041467|454471980|FG001|Overall Study|Withdrawal by Subject|37|||
126322066|NCT03041467|454471979|FG000|Overall Study|Lost to Follow-up|6|||
126322067|NCT03041467|454471980|FG001|Overall Study|Lost to Follow-up|8|||
126322068|NCT03041467|454471979|FG000|Overall Study|Declined consent for study extension|21|||
126322069|NCT03041467|454471980|FG001|Overall Study|Declined consent for study extension|33|||
126322070|NCT03041467|454471979|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
126322071|NCT03041467|454471980|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
126322072|NCT02732015|454471981|FG000|Overall Study|Lost to Follow-up|0|||
126322073|NCT02732015|454471982|FG001|Overall Study|Lost to Follow-up|1|||
126322074|NCT03052920|454471983|FG000|Overall Study|Withdrawal by Subject|1|||
126322075|NCT01980628|454471984|FG000|Overall Study|Adverse Event|12|||
126322076|NCT01980628|454471984|FG000|Overall Study|Physician Decision|5|||
126322077|NCT01980628|454471984|FG000|Overall Study|Withdrawal by Subject|4|||
126322078|NCT01980628|454471984|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
126322079|NCT03015194|454471985|FG000|Overall Study|Death|10|||
126322080|NCT03015194|454471985|FG000|Overall Study|Withdrawal by Subject|2|||
126322081|NCT02469168|454471988|FG000|Overall Study|Trial closed|1|||
126322082|NCT02469168|454471989|FG001|Overall Study|Trial closed|0|||
126322083|NCT00433017|454471990|FG000|Overall Study|Adverse Event|5|||
126322084|NCT00433017|454471991|FG001|Overall Study|Adverse Event|3|||
126322085|NCT00433017|454471990|FG000|Overall Study|Withdrawal by Subject|4|||
126322086|NCT00433017|454471991|FG001|Overall Study|Withdrawal by Subject|5|||
126322087|NCT00433017|454471990|FG000|Overall Study|Lost to Follow-up|3|||
126322088|NCT00433017|454471991|FG001|Overall Study|Lost to Follow-up|4|||
126322089|NCT00433017|454471990|FG000|Overall Study|Administrative problems|80|||
126322090|NCT00433017|454471991|FG001|Overall Study|Administrative problems|86|||
126322091|NCT00433017|454471990|FG000|Overall Study|Protocol Violation|1|||
126322092|NCT00433017|454471991|FG001|Overall Study|Protocol Violation|0|||
126322093|NCT00433017|454471990|FG000|Overall Study|Death|2|||
126322094|NCT00433017|454471991|FG001|Overall Study|Death|2|||
126322095|NCT00433017|454471990|FG000|Overall Study|Subject no longer requires study drug|1|||
126322096|NCT00433017|454471991|FG001|Overall Study|Subject no longer requires study drug|1|||
126322097|NCT00255840|454471994|FG000|Overall Study|Lost to Follow-up|10|||
126322098|NCT00255840|454471995|FG001|Overall Study|Lost to Follow-up|14|||
126322099|NCT00255840|454471994|FG000|Overall Study|Discontinued intervention|53|||
126322100|NCT00255840|454471995|FG001|Overall Study|Discontinued intervention|56|||
126322101|NCT00715520|454471996|FG000|Overall Study|Screen failure|8|||
126322102|NCT00715520|454471997|FG001|Overall Study|Screen failure|1|||
126322103|NCT00715520|454471998|FG002|Overall Study|Screen failure|1|||
126322104|NCT00715520|454471996|FG000|Overall Study|Withdrawal by Subject|2|||
126322105|NCT00715520|454471997|FG001|Overall Study|Withdrawal by Subject|0|||
126322106|NCT00715520|454471998|FG002|Overall Study|Withdrawal by Subject|1|||
126322107|NCT03332095|454471999|FG000|Overall Study|Lost to Follow-up|1|||
126322108|NCT03332095|454472000|FG001|Overall Study|Lost to Follow-up|0|||
126322109|NCT03332095|454471999|FG000|Overall Study|Pregnancy|0|||
126322110|NCT03332095|454472000|FG001|Overall Study|Pregnancy|1|||
126322111|NCT00624832|454472005|FG000|Overall Study|Adverse Event|0|||
126322112|NCT00624832|454472006|FG001|Overall Study|Adverse Event|1|||
126322113|NCT00624832|454472007|FG002|Overall Study|Adverse Event|0|||
126322114|NCT00624832|454472008|FG003|Overall Study|Adverse Event|1|||
126322115|NCT00624832|454472005|FG000|Overall Study|Abnormal Laboratory Value|2|||
126322116|NCT00624832|454472006|FG001|Overall Study|Abnormal Laboratory Value|0|||
126322117|NCT00624832|454472007|FG002|Overall Study|Abnormal Laboratory Value|0|||
126322118|NCT00624832|454472008|FG003|Overall Study|Abnormal Laboratory Value|0|||
126322119|NCT04379700|454472009|FG000|Overall Study|Withdrawal by Subject|10|||
126322120|NCT04379700|454472009|FG000|Overall Study|Screen Fail|4|||
126322121|NCT04379700|454472009|FG000|Overall Study|Lost to Follow-up|3|||
126322122|NCT00592592|454472010|FG000|Overall Study|Patient found ineligible upon chart review|1|||
126322123|NCT05053035|454472013|FG000|Overall Study|Withdrawal by Subject|1|||
126322124|NCT05053035|454472014|FG001|Overall Study|Withdrawal by Subject|0|||
126322125|NCT03003000|454472019|FG000|Overall Study|Adverse Event|1|||
126322126|NCT03003000|454472020|FG001|Overall Study|Adverse Event|2|||
126322127|NCT03003000|454472021|FG002|Overall Study|Adverse Event|3|||
126322128|NCT03003000|454472019|FG000|Overall Study|Lack of Efficacy|1|||
126322129|NCT03003000|454472020|FG001|Overall Study|Lack of Efficacy|0|||
126322130|NCT03003000|454472021|FG002|Overall Study|Lack of Efficacy|0|||
126322131|NCT03003000|454472019|FG000|Overall Study|Non-compliant with protocol|0|||
126322132|NCT03003000|454472020|FG001|Overall Study|Non-compliant with protocol|1|||
126322133|NCT03003000|454472021|FG002|Overall Study|Non-compliant with protocol|1|||
126322134|NCT03003000|454472019|FG000|Overall Study|Refused to continue medication|2|||
126322135|NCT03003000|454472020|FG001|Overall Study|Refused to continue medication|0|||
126322136|NCT03003000|454472021|FG002|Overall Study|Refused to continue medication|0|||
126322137|NCT03003000|454472019|FG000|Overall Study|Other than listed|1|||
126322138|NCT03003000|454472020|FG001|Overall Study|Other than listed|1|||
126322139|NCT03003000|454472021|FG002|Overall Study|Other than listed|1|||
126322140|NCT02191046|454472024|FG000|Overall Study|low compliance|5|||
126322141|NCT02191046|454472025|FG001|Overall Study|low compliance|1|||
126322142|NCT00048997|454472028|FG000|Overall Study|Protocol Violation|7|||
126322143|NCT00048997|454472029|FG001|Overall Study|Protocol Violation|2|||
125983436|NCT02535364|453229977|FG000|12-Month Follow-up Period|Death|5|||
126322144|NCT00048997|454472028|FG000|Overall Study|Withdrawal by Subject|6|||
125983437|NCT02535364|453229977|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
125983438|NCT02535364|453229977|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
126322145|NCT00048997|454472029|FG001|Overall Study|Withdrawal by Subject|1|||
125983439|NCT02535364|453229977|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
125983440|NCT02634788|453229978|FG000|Overall Study|Adverse Event|0|||
126322146|NCT02819440|454472030|FG000|Overall Study|Adverse Event|3|||
126322147|NCT02819440|454472031|FG001|Overall Study|Adverse Event|1|||
126322148|NCT02819440|454472030|FG000|Overall Study|Lost to Follow-up|1|||
126322149|NCT02819440|454472031|FG001|Overall Study|Lost to Follow-up|3|||
126322150|NCT02819440|454472030|FG000|Overall Study|Withdrawal by Subject|9|||
126322151|NCT02819440|454472031|FG001|Overall Study|Withdrawal by Subject|8|||
126322152|NCT02007278|454472032|FG000|Overall Study|Failure to comply with an eligibility|0|||
125983441|NCT02634788|453229979|FG001|Overall Study|Adverse Event|8|||
126322153|NCT02007278|454472033|FG001|Overall Study|Failure to comply with an eligibility|1|||
126322154|NCT02007278|454472032|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
126322155|NCT02007278|454472033|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
126322156|NCT02007278|454472032|FG000|Overall Study|Incorrect medication administration|1|||
126322157|NCT02007278|454472033|FG001|Overall Study|Incorrect medication administration|0|||
126322158|NCT02007278|454472032|FG000|Overall Study|Mis-randomization|1|||
126322159|NCT02007278|454472033|FG001|Overall Study|Mis-randomization|1|||
126322160|NCT00435188|454472035|FG000|Overall Study|Death|1|||
126322161|NCT00435188|454472036|FG001|Overall Study|Death|6|||
126322162|NCT00435188|454472035|FG000|Overall Study|Withdrawal by Subject|16|||
126322163|NCT00435188|454472036|FG001|Overall Study|Withdrawal by Subject|11|||
126322164|NCT00435188|454472035|FG000|Overall Study|Lost to Follow-up|5|||
126322165|NCT00435188|454472036|FG001|Overall Study|Lost to Follow-up|6|||
126322166|NCT00055497|454472041|FG000|Overall Study|Adverse Event|1|||
126322167|NCT00055497|454472042|FG001|Overall Study|Adverse Event|1|||
126322168|NCT00055497|454472043|FG002|Overall Study|Adverse Event|1|||
126322169|NCT00055497|454472044|FG003|Overall Study|Adverse Event|28|||
126322170|NCT00055497|454472041|FG000|Overall Study|Withdrawal by Subject|3|||
126322171|NCT00055497|454472042|FG001|Overall Study|Withdrawal by Subject|1|||
126322172|NCT00055497|454472043|FG002|Overall Study|Withdrawal by Subject|1|||
126322173|NCT00055497|454472044|FG003|Overall Study|Withdrawal by Subject|15|||
126322174|NCT00055497|454472041|FG000|Overall Study|Lost to Follow-up|0|||
126322175|NCT00055497|454472042|FG001|Overall Study|Lost to Follow-up|1|||
126322176|NCT00055497|454472043|FG002|Overall Study|Lost to Follow-up|0|||
126322177|NCT00055497|454472044|FG003|Overall Study|Lost to Follow-up|5|||
126322178|NCT00055497|454472041|FG000|Overall Study|Protocol Violation|0|||
126322179|NCT00055497|454472042|FG001|Overall Study|Protocol Violation|0|||
126322180|NCT00055497|454472043|FG002|Overall Study|Protocol Violation|0|||
126322181|NCT00055497|454472044|FG003|Overall Study|Protocol Violation|3|||
126322182|NCT00055497|454472041|FG000|Overall Study|Lack of Efficacy|1|||
126322183|NCT00055497|454472042|FG001|Overall Study|Lack of Efficacy|0|||
126322184|NCT00055497|454472043|FG002|Overall Study|Lack of Efficacy|0|||
126322185|NCT00055497|454472044|FG003|Overall Study|Lack of Efficacy|27|||
126322186|NCT00055497|454472041|FG000|Overall Study|Administrative Reasons|0|||
126322187|NCT00055497|454472042|FG001|Overall Study|Administrative Reasons|0|||
126322188|NCT00055497|454472043|FG002|Overall Study|Administrative Reasons|0|||
126322189|NCT00055497|454472044|FG003|Overall Study|Administrative Reasons|1|||
126322190|NCT00055497|454472041|FG000|Overall Study|Other|0|||
126322191|NCT00055497|454472042|FG001|Overall Study|Other|0|||
126322192|NCT00055497|454472043|FG002|Overall Study|Other|0|||
126322193|NCT00055497|454472044|FG003|Overall Study|Other|11|||
126322194|NCT00048165|454472045|FG000|Completed 6 Months Study|Administration/Other|8|||
126322195|NCT00048165|454472046|FG001|Completed 6 Months Study|Administration/Other|8|||
126322196|NCT00048165|454472045|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
126322197|NCT00048165|454472046|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
126322198|NCT00048165|454472045|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
126322199|NCT00048165|454472046|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
126322200|NCT00048165|454472045|FG000|Completed 6 Months Study|Death|12|||
126322201|NCT00048165|454472046|FG001|Completed 6 Months Study|Death|6|||
126322202|NCT00048165|454472045|FG000|Completed 6 Months Study|Insufficient therapy|1|||
126322203|NCT00048165|454472046|FG001|Completed 6 Months Study|Insufficient therapy|4|||
126322204|NCT00048165|454472045|FG000|Completed 6 Months Study|Other violation|4|||
126322205|NCT00048165|454472046|FG001|Completed 6 Months Study|Other violation|6|||
126322206|NCT00048165|454472045|FG000|Completed 6 Months Study|Refused treatment|5|||
126322207|NCT00048165|454472046|FG001|Completed 6 Months Study|Refused treatment|5|||
126322208|NCT00048165|454472045|FG000|Completed 6 Months Study|Violation criteria|0|||
126322209|NCT00048165|454472046|FG001|Completed 6 Months Study|Violation criteria|2|||
126322210|NCT00048165|454472045|FG000|Completed 6 Months Study|Did not receive study drug|6|||
126322211|NCT00048165|454472046|FG001|Completed 6 Months Study|Did not receive study drug|6|||
126322212|NCT00048165|454472045|FG000|Completed 12 Months Study|Administration/Other|0|||
126322213|NCT00048165|454472046|FG001|Completed 12 Months Study|Administration/Other|2|||
126322214|NCT00048165|454472045|FG000|Completed 12 Months Study|Death|2|||
126322215|NCT00048165|454472046|FG001|Completed 12 Months Study|Death|1|||
126322216|NCT00048165|454472045|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
126322217|NCT00048165|454472046|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
126322218|NCT00731731|454472047|FG000|Overall Study|Protocol Violation|0|||
126322219|NCT00731731|454472048|FG001|Overall Study|Protocol Violation|0|||
126322220|NCT00731731|454472049|FG002|Overall Study|Protocol Violation|1|||
126322221|NCT00731731|454472047|FG000|Overall Study|Cancel prior to treatment|0|||
126322222|NCT00731731|454472048|FG001|Overall Study|Cancel prior to treatment|0|||
126322223|NCT00731731|454472049|FG002|Overall Study|Cancel prior to treatment|2|||
126322224|NCT03970200|454472050|FG000|Overall Study|Death|2|||
126322225|NCT03970200|454472051|FG001|Overall Study|Death|2|||
126322226|NCT03970200|454472052|FG002|Overall Study|Death|1|||
126322227|NCT03970200|454472050|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
126322228|NCT03970200|454472051|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
126322229|NCT03970200|454472052|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
126322230|NCT02112877|454472053|FG000|Overall Study|Withdrawal by Subject|1|||
126322231|NCT02112877|454472054|FG001|Overall Study|Withdrawal by Subject|7|||
126322232|NCT02112877|454472053|FG000|Overall Study|Visit Missed|1|||
126322233|NCT02112877|454472054|FG001|Overall Study|Visit Missed|6|||
126322234|NCT01693185|454472055|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
126322235|NCT01693185|454472056|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
126322236|NCT01606748|454472061|FG000|Overall Study|Adverse Event|1|||
126322237|NCT01606748|454472062|FG001|Overall Study|Adverse Event|0|||
126322238|NCT01606748|454472061|FG000|Overall Study|Progressive Disease|1|||
126322239|NCT01606748|454472062|FG001|Overall Study|Progressive Disease|0|||
126322240|NCT01606748|454472061|FG000|Overall Study|Withdrawal by Subject|1|||
126322241|NCT01606748|454472062|FG001|Overall Study|Withdrawal by Subject|0|||
126322242|NCT03742258|454472064|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
126322243|NCT03742258|454472065|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
125983442|NCT02634788|453229980|FG002|Overall Study|Adverse Event|3|||
125983443|NCT02634788|453229981|FG003|Overall Study|Adverse Event|1|||
125983444|NCT02634788|453229978|FG000|Overall Study|Lack of Efficacy|4|||
125983445|NCT02634788|453229979|FG001|Overall Study|Lack of Efficacy|0|||
125983446|NCT02634788|453229980|FG002|Overall Study|Lack of Efficacy|1|||
125983447|NCT02634788|453229981|FG003|Overall Study|Lack of Efficacy|4|||
125983448|NCT02634788|453229978|FG000|Overall Study|Lost to Follow-up|0|||
125983449|NCT02634788|453229979|FG001|Overall Study|Lost to Follow-up|1|||
125983450|NCT02634788|453229980|FG002|Overall Study|Lost to Follow-up|0|||
125983451|NCT02634788|453229981|FG003|Overall Study|Lost to Follow-up|0|||
125983452|NCT02634788|453229978|FG000|Overall Study|Withdrawal by Subject|0|||
125983453|NCT02634788|453229979|FG001|Overall Study|Withdrawal by Subject|1|||
125983454|NCT02634788|453229980|FG002|Overall Study|Withdrawal by Subject|1|||
125983455|NCT02634788|453229981|FG003|Overall Study|Withdrawal by Subject|0|||
125983456|NCT04766086|453229986|FG000|Overall Study|Lost to Follow-up|3|||
125983457|NCT04766086|453229987|FG001|Overall Study|Lost to Follow-up|5|||
125983458|NCT04766086|453229988|FG002|Overall Study|Lost to Follow-up|3|||
125983459|NCT04766086|453229986|FG000|Overall Study|Withdrawal by Subject|1|||
125983460|NCT04766086|453229987|FG001|Overall Study|Withdrawal by Subject|1|||
125983461|NCT04766086|453229988|FG002|Overall Study|Withdrawal by Subject|2|||
125983462|NCT04766086|453229986|FG000|Overall Study|Other|0|||
125983463|NCT04766086|453229987|FG001|Overall Study|Other|0|||
125983464|NCT04766086|453229988|FG002|Overall Study|Other|1|||
125983465|NCT02496767|453230000|FG000|Open-label Lead-in Phase|Adverse Event|176|||
125983466|NCT02496767|453230001|FG001|Open-label Lead-in Phase|Adverse Event|0|||
125983467|NCT02496767|453230002|FG002|Open-label Lead-in Phase|Adverse Event|0|||
125983468|NCT02496767|453230003|FG003|Open-label Lead-in Phase|Adverse Event|0|||
125983469|NCT02496767|453230004|FG004|Open-label Lead-in Phase|Adverse Event|0|||
125983470|NCT02496767|453230005|FG005|Open-label Lead-in Phase|Adverse Event|0|||
125983471|NCT02496767|453230006|FG006|Open-label Lead-in Phase|Adverse Event|0|||
125983472|NCT02496767|453230007|FG007|Open-label Lead-in Phase|Adverse Event|0|||
125983473|NCT02496767|453230000|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
125983474|NCT02496767|453230001|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
125983475|NCT02496767|453230002|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
125983476|NCT02496767|453230003|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
125983477|NCT02496767|453230004|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
125983478|NCT02496767|453230005|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
125983479|NCT02496767|453230006|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
125983480|NCT02496767|453230007|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
125983481|NCT02496767|453230000|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
125983482|NCT02496767|453230001|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
125983483|NCT02496767|453230002|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
125983484|NCT02496767|453230003|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
125983485|NCT02496767|453230004|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
125983486|NCT02496767|453230005|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
125983487|NCT02496767|453230006|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
125983488|NCT02496767|453230007|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
125983489|NCT02496767|453230000|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125983490|NCT02496767|453230001|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
125983491|NCT02496767|453230002|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
125983492|NCT02496767|453230003|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
125983493|NCT02496767|453230004|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
126322244|NCT03742258|454472066|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
125983494|NCT02496767|453230005|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125983495|NCT02496767|453230006|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125983496|NCT02496767|453230007|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125983497|NCT02496767|453230000|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
126322245|NCT03742258|454472064|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
126322246|NCT03742258|454472065|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
126322247|NCT03742258|454472066|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
126322248|NCT03742258|454472064|FG000|Survival Follow-Up|Still in Follow-up|0|||
126322249|NCT03742258|454472065|FG001|Survival Follow-Up|Still in Follow-up|0|||
126322250|NCT03742258|454472066|FG002|Survival Follow-Up|Still in Follow-up|2|||
126322251|NCT02083653|454472069|FG000|Overall Study|Randomized but not Treated|0|||
126322252|NCT02083653|454472070|FG001|Overall Study|Randomized but not Treated|2|||
126322253|NCT02083653|454472071|FG002|Overall Study|Randomized but not Treated|7|||
126322254|NCT02083653|454472069|FG000|Overall Study|Adverse Event|12|||
126322255|NCT02083653|454472070|FG001|Overall Study|Adverse Event|5|||
126322256|NCT02083653|454472071|FG002|Overall Study|Adverse Event|4|||
126322257|NCT02083653|454472069|FG000|Overall Study|Lost to Follow-up|1|||
126322258|NCT02083653|454472070|FG001|Overall Study|Lost to Follow-up|0|||
126322259|NCT02083653|454472071|FG002|Overall Study|Lost to Follow-up|0|||
126322260|NCT02083653|454472069|FG000|Overall Study|Death|2|||
126322261|NCT02083653|454472070|FG001|Overall Study|Death|2|||
126322262|NCT02083653|454472071|FG002|Overall Study|Death|2|||
126322263|NCT02083653|454472069|FG000|Overall Study|Progressive Disease|65|||
126322264|NCT02083653|454472070|FG001|Overall Study|Progressive Disease|73|||
126322265|NCT02083653|454472071|FG002|Overall Study|Progressive Disease|63|||
126322266|NCT02083653|454472069|FG000|Overall Study|Withdrawal by Subject|2|||
126322267|NCT02083653|454472070|FG001|Overall Study|Withdrawal by Subject|1|||
126322268|NCT02083653|454472071|FG002|Overall Study|Withdrawal by Subject|2|||
126322269|NCT02083653|454472069|FG000|Overall Study|Other Events|0|||
126322270|NCT02083653|454472070|FG001|Overall Study|Other Events|2|||
126322271|NCT02083653|454472071|FG002|Overall Study|Other Events|2|||
126322272|NCT02083653|454472069|FG000|Overall Study|Reason Missing|0|||
126322273|NCT02083653|454472070|FG001|Overall Study|Reason Missing|0|||
126322274|NCT02083653|454472071|FG002|Overall Study|Reason Missing|4|||
126322275|NCT03084315|454472072|FG000|Overall Study|Lost to Follow-up|8|||
126322276|NCT03084315|454472073|FG001|Overall Study|Lost to Follow-up|7|||
126322277|NCT03084315|454472072|FG000|Overall Study|Withdrawal by Subject|2|||
126322278|NCT03084315|454472073|FG001|Overall Study|Withdrawal by Subject|2|||
126322279|NCT01952080|454472074|FG000|Overall Study|Withdrawal by Subject|0|||
126322280|NCT01952080|454472075|FG001|Overall Study|Withdrawal by Subject|0|||
126322281|NCT01952080|454472076|FG002|Overall Study|Withdrawal by Subject|0|||
126322282|NCT01952080|454472077|FG003|Overall Study|Withdrawal by Subject|1|||
126322283|NCT01952080|454472074|FG000|Overall Study|Protocol Non-compliance|0|||
126322284|NCT01952080|454472075|FG001|Overall Study|Protocol Non-compliance|1|||
126322285|NCT01952080|454472076|FG002|Overall Study|Protocol Non-compliance|0|||
126322286|NCT01952080|454472077|FG003|Overall Study|Protocol Non-compliance|0|||
126322287|NCT02732327|454472078|FG000|Overall Study|Protocol Violation|0|||
126322288|NCT02732327|454472079|FG001|Overall Study|Protocol Violation|1|||
126322289|NCT00350779|454472080|FG000|Overall Study|Adverse Event|4|||
126322290|NCT00350779|454472081|FG001|Overall Study|Adverse Event|2|||
126322291|NCT00350779|454472080|FG000|Overall Study|Lack of Efficacy|0|||
126322292|NCT00350779|454472081|FG001|Overall Study|Lack of Efficacy|4|||
126322293|NCT00350779|454472080|FG000|Overall Study|Lost to Follow-up|2|||
126322294|NCT00350779|454472081|FG001|Overall Study|Lost to Follow-up|0|||
126322295|NCT00350779|454472080|FG000|Overall Study|Physician Decision|2|||
126322296|NCT00350779|454472081|FG001|Overall Study|Physician Decision|4|||
126322297|NCT00350779|454472080|FG000|Overall Study|Protocol Violation|3|||
126322298|NCT00350779|454472081|FG001|Overall Study|Protocol Violation|1|||
126322299|NCT00350779|454472080|FG000|Overall Study|Withdrawal by Subject|9|||
126322300|NCT00350779|454472081|FG001|Overall Study|Withdrawal by Subject|8|||
126322301|NCT00350779|454472080|FG000|Overall Study|Patient Moved|2|||
126322302|NCT00350779|454472081|FG001|Overall Study|Patient Moved|1|||
126322303|NCT00350779|454472080|FG000|Overall Study|Non-compliance with study procedures|0|||
126322304|NCT00350779|454472081|FG001|Overall Study|Non-compliance with study procedures|1|||
126322305|NCT01905592|454472083|FG000|Overall Study|Disease Progression|51|||
126322306|NCT01905592|454472084|FG001|Overall Study|Disease Progression|110|||
126322307|NCT01905592|454472083|FG000|Overall Study|Toxicity|1|||
126322308|NCT01905592|454472084|FG001|Overall Study|Toxicity|16|||
126322309|NCT01905592|454472083|FG000|Overall Study|Physician Decision|0|||
126322310|NCT01905592|454472084|FG001|Overall Study|Physician Decision|2|||
126322311|NCT01905592|454472083|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
126322312|NCT01905592|454472084|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
126322313|NCT01905592|454472083|FG000|Overall Study|Protocol Violation|0|||
126322314|NCT01905592|454472084|FG001|Overall Study|Protocol Violation|1|||
125878503|NCT05138653|452851310|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126322315|NCT01905592|454472083|FG000|Overall Study|Sponsor's decision|1|||
126322316|NCT01905592|454472084|FG001|Overall Study|Sponsor's decision|1|||
126322317|NCT01905592|454472083|FG000|Overall Study|Not treated|7|||
126322318|NCT01905592|454472084|FG001|Overall Study|Not treated|3|||
126322319|NCT01905592|454472083|FG000|Overall Study|Withdrawal by Subject|10|||
126322320|NCT01905592|454472084|FG001|Overall Study|Withdrawal by Subject|2|||
126322321|NCT02227368|454474029|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
126322322|NCT02227368|454474030|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
126322323|NCT02227368|454474029|FG000|Overall Study|Lost to Follow-up|1|||
126322324|NCT02227368|454474030|FG001|Overall Study|Lost to Follow-up|0|||
126322325|NCT02227368|454474029|FG000|Overall Study|Adverse Event|1|||
126322326|NCT02227368|454474030|FG001|Overall Study|Adverse Event|0|||
126322327|NCT04494425|454474031|FG000|Overall Study|Death|160|||
126322328|NCT04494425|454474032|FG001|Overall Study|Death|166|||
126322329|NCT04494425|454474031|FG000|Overall Study|Withdrawal by Subject|10|||
126322330|NCT04494425|454474032|FG001|Overall Study|Withdrawal by Subject|40|||
126322331|NCT04494425|454474031|FG000|Overall Study|Other|1|||
126322332|NCT04494425|454474032|FG001|Overall Study|Other|1|||
126322333|NCT04494425|454474031|FG000|Overall Study|Ongoing at the time of PCD|265|||
126322334|NCT04494425|454474032|FG001|Overall Study|Ongoing at the time of PCD|223|||
126322335|NCT01760447|454474034|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
126322336|NCT01760447|454474035|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
126322337|NCT01760447|454474036|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
126322338|NCT01760447|454474037|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
126322339|NCT01760447|454474034|FG000|Weeks 0-20|Withdrawal by Subject|2|||
126322340|NCT01760447|454474035|FG001|Weeks 0-20|Withdrawal by Subject|0|||
126322341|NCT01760447|454474036|FG002|Weeks 0-20|Withdrawal by Subject|1|||
126322342|NCT01760447|454474037|FG003|Weeks 0-20|Withdrawal by Subject|0|||
126322343|NCT01760447|454474034|FG000|Weeks 0-20|Lost to Follow-up|1|||
126322344|NCT01760447|454474035|FG001|Weeks 0-20|Lost to Follow-up|0|||
126322345|NCT01760447|454474036|FG002|Weeks 0-20|Lost to Follow-up|1|||
126322346|NCT01760447|454474037|FG003|Weeks 0-20|Lost to Follow-up|1|||
126322347|NCT01760447|454474034|FG000|Weeks 0-20|Randomized but not treated|0|||
126322348|NCT01760447|454474035|FG001|Weeks 0-20|Randomized but not treated|0|||
126322349|NCT01760447|454474036|FG002|Weeks 0-20|Randomized but not treated|2|||
126322350|NCT01760447|454474037|FG003|Weeks 0-20|Randomized but not treated|0|||
126322351|NCT01760447|454474034|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
126322352|NCT01760447|454474035|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
126322353|NCT01760447|454474036|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
126322354|NCT01760447|454474037|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
126322355|NCT01760447|454474034|FG000|Weeks 20-54|Withdrawal by Subject|2|||
126322356|NCT01760447|454474035|FG001|Weeks 20-54|Withdrawal by Subject|1|||
126322357|NCT01760447|454474036|FG002|Weeks 20-54|Withdrawal by Subject|1|||
126322358|NCT01760447|454474037|FG003|Weeks 20-54|Withdrawal by Subject|2|||
126322359|NCT01760447|454474034|FG000|Weeks 20-54|Lost to Follow-up|0|||
126322360|NCT01760447|454474035|FG001|Weeks 20-54|Lost to Follow-up|0|||
126322361|NCT01760447|454474036|FG002|Weeks 20-54|Lost to Follow-up|1|||
126322362|NCT01760447|454474037|FG003|Weeks 20-54|Lost to Follow-up|2|||
126322363|NCT01641471|454474038|FG000|Overall Study|Withdrawal by Subject|19|||
126322364|NCT01641471|454474039|FG001|Overall Study|Withdrawal by Subject|19|||
126322365|NCT01641471|454474038|FG000|Overall Study|Lost to Follow-up|2|||
126322366|NCT01641471|454474039|FG001|Overall Study|Lost to Follow-up|4|||
126322367|NCT01641471|454474038|FG000|Overall Study|Protocol Violation|2|||
126322368|NCT01641471|454474039|FG001|Overall Study|Protocol Violation|4|||
126322369|NCT04575584|454474040|FG000|Overall Study|Death|6|||
126322370|NCT04575584|454474041|FG001|Overall Study|Death|4|||
126322371|NCT04575584|454474042|FG002|Overall Study|Death|6|||
126322372|NCT04575584|454474043|FG003|Overall Study|Death|2|||
126322373|NCT04575584|454474044|FG004|Overall Study|Death|0|||
126322374|NCT04575584|454474045|FG005|Overall Study|Death|0|||
126322375|NCT04575584|454474040|FG000|Overall Study|Lost to Follow-up|1|||
126322376|NCT04575584|454474041|FG001|Overall Study|Lost to Follow-up|1|||
126322377|NCT04575584|454474042|FG002|Overall Study|Lost to Follow-up|1|||
126322378|NCT04575584|454474043|FG003|Overall Study|Lost to Follow-up|1|||
126322379|NCT04575584|454474044|FG004|Overall Study|Lost to Follow-up|0|||
126322380|NCT04575584|454474045|FG005|Overall Study|Lost to Follow-up|0|||
126322381|NCT04575584|454474040|FG000|Overall Study|Physician Decision|0|||
126322382|NCT04575584|454474041|FG001|Overall Study|Physician Decision|1|||
126322383|NCT04575584|454474042|FG002|Overall Study|Physician Decision|1|||
126322384|NCT04575584|454474043|FG003|Overall Study|Physician Decision|1|||
126322385|NCT04575584|454474044|FG004|Overall Study|Physician Decision|0|||
126322386|NCT04575584|454474045|FG005|Overall Study|Physician Decision|0|||
126322387|NCT04575584|454474040|FG000|Overall Study|Withdrawal by Subject|7|||
126322388|NCT04575584|454474041|FG001|Overall Study|Withdrawal by Subject|9|||
126322389|NCT04575584|454474042|FG002|Overall Study|Withdrawal by Subject|5|||
126322390|NCT04575584|454474043|FG003|Overall Study|Withdrawal by Subject|3|||
126322391|NCT04575584|454474044|FG004|Overall Study|Withdrawal by Subject|0|||
126322392|NCT04575584|454474045|FG005|Overall Study|Withdrawal by Subject|0|||
126322393|NCT04575584|454474040|FG000|Overall Study|Not recorded|0|||
126090983|NCT00368927|453626873|FG001|Overall Study|Withdrawal by Subject|2|||
126090984|NCT00368927|453626872|FG000|Overall Study|Physician Decision|1|||
126322394|NCT04575584|454474041|FG001|Overall Study|Not recorded|0|||
126322395|NCT04575584|454474042|FG002|Overall Study|Not recorded|0|||
126322396|NCT04575584|454474043|FG003|Overall Study|Not recorded|1|||
126322397|NCT04575584|454474044|FG004|Overall Study|Not recorded|0|||
126322398|NCT04575584|454474045|FG005|Overall Study|Not recorded|0|||
126322399|NCT03488563|454474046|FG000|Overall Study|Lost to Follow-up|7|||
126322400|NCT03488563|454474047|FG001|Overall Study|Lost to Follow-up|6|||
126322401|NCT03488563|454474048|FG002|Overall Study|Lost to Follow-up|7|||
125983498|NCT02496767|453230001|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
125983499|NCT02496767|453230002|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
125983500|NCT02496767|453230003|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
125983501|NCT02496767|453230004|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
125983502|NCT02496767|453230005|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
125983503|NCT02496767|453230006|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
125983504|NCT02496767|453230007|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
125983505|NCT02496767|453230000|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
125983506|NCT02496767|453230001|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
125983507|NCT02496767|453230002|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
125983508|NCT02496767|453230003|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
125983509|NCT02496767|453230004|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
125983510|NCT02496767|453230005|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
125983511|NCT02496767|453230006|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
125983512|NCT02496767|453230007|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
125983513|NCT02496767|453230000|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
125983514|NCT02496767|453230001|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
125983515|NCT02496767|453230002|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
125983516|NCT02496767|453230003|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
125983517|NCT02496767|453230004|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
125983518|NCT02496767|453230005|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
125983519|NCT02496767|453230006|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
125983520|NCT02496767|453230007|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
125983521|NCT02496767|453230000|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125983522|NCT02496767|453230001|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
125983523|NCT02496767|453230002|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
125983524|NCT02496767|453230003|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
125983525|NCT02496767|453230004|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
125983526|NCT02496767|453230005|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125983527|NCT02496767|453230006|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125983528|NCT02496767|453230007|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125983529|NCT02496767|453230000|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125983530|NCT02496767|453230001|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
125983531|NCT02496767|453230002|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
125983532|NCT02496767|453230003|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125983533|NCT02496767|453230004|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125983534|NCT02496767|453230005|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125983535|NCT02496767|453230006|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125983536|NCT02496767|453230007|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125983537|NCT02496767|453230000|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125983538|NCT02496767|453230001|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
125983539|NCT02496767|453230002|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125983540|NCT02496767|453230003|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
125983541|NCT02496767|453230004|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
125983542|NCT02496767|453230005|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125983543|NCT02496767|453230006|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125983544|NCT02496767|453230007|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125983545|NCT02496767|453230000|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125983546|NCT02496767|453230001|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
125983547|NCT02496767|453230002|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125983548|NCT02496767|453230003|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125983549|NCT02496767|453230004|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125983550|NCT02496767|453230005|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125983551|NCT02496767|453230006|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125983552|NCT02496767|453230007|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125983553|NCT02496767|453230000|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
125983554|NCT02496767|453230001|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
125983555|NCT02496767|453230002|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
125983556|NCT02496767|453230003|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
125983557|NCT02496767|453230004|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
125983558|NCT02496767|453230005|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
125983559|NCT02496767|453230006|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
126322402|NCT03488563|454474046|FG000|Overall Study|Withdrawal by Subject|8|||
126322403|NCT03488563|454474047|FG001|Overall Study|Withdrawal by Subject|7|||
125983560|NCT02496767|453230007|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
126322404|NCT03488563|454474048|FG002|Overall Study|Withdrawal by Subject|7|||
126322405|NCT03488563|454474046|FG000|Overall Study|Physician Decision|0|||
126322406|NCT03488563|454474047|FG001|Overall Study|Physician Decision|0|||
126322407|NCT03488563|454474048|FG002|Overall Study|Physician Decision|1|||
126322408|NCT03488563|454474046|FG000|Overall Study|Protocol Violation|3|||
126322409|NCT03488563|454474047|FG001|Overall Study|Protocol Violation|2|||
126322410|NCT03488563|454474048|FG002|Overall Study|Protocol Violation|6|||
126322411|NCT03488563|454474046|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
126322412|NCT03488563|454474047|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
126322413|NCT03488563|454474048|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
126322414|NCT03488563|454474046|FG000|Overall Study|Use of prohibited medication|2|||
126322415|NCT03488563|454474047|FG001|Overall Study|Use of prohibited medication|0|||
126322416|NCT03488563|454474048|FG002|Overall Study|Use of prohibited medication|0|||
126322417|NCT03488563|454474046|FG000|Overall Study|Adverse Event|1|||
126322418|NCT03488563|454474047|FG001|Overall Study|Adverse Event|0|||
126322419|NCT03488563|454474048|FG002|Overall Study|Adverse Event|1|||
126322420|NCT03488563|454474046|FG000|Overall Study|Subject returned for ET visit|0|||
126322421|NCT03488563|454474047|FG001|Overall Study|Subject returned for ET visit|1|||
126322422|NCT03488563|454474048|FG002|Overall Study|Subject returned for ET visit|0|||
126322423|NCT03488563|454474046|FG000|Overall Study|Sponsor's decision|0|||
126322424|NCT03488563|454474047|FG001|Overall Study|Sponsor's decision|0|||
126322425|NCT03488563|454474048|FG002|Overall Study|Sponsor's decision|1|||
126322426|NCT02815267|454474056|FG000|Double-Blind Phase|Adverse Event|0|||
125983561|NCT02496767|453230000|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
126322427|NCT02815267|454474057|FG001|Double-Blind Phase|Adverse Event|3|||
126322428|NCT02815267|454474056|FG000|Double-Blind Phase|Lost to Follow-up|17|||
126322429|NCT02815267|454474057|FG001|Double-Blind Phase|Lost to Follow-up|9|||
126322430|NCT02815267|454474056|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
126322431|NCT02815267|454474057|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
126322432|NCT02815267|454474056|FG000|Double-Blind Phase|Protocol Violation|3|||
126322433|NCT02815267|454474057|FG001|Double-Blind Phase|Protocol Violation|2|||
126322434|NCT02815267|454474056|FG000|Double-Blind Phase|Site withdrawal|1|||
126322435|NCT02815267|454474057|FG001|Double-Blind Phase|Site withdrawal|6|||
126322436|NCT02815267|454474056|FG000|Double-Blind Phase|Received a disallowed medication|1|||
126322437|NCT02815267|454474057|FG001|Double-Blind Phase|Received a disallowed medication|1|||
126322438|NCT02815267|454474056|FG000|Open-Label Phase|Adverse Event|1|||
126322439|NCT02815267|454474057|FG001|Open-Label Phase|Adverse Event|1|||
126322440|NCT02815267|454474056|FG000|Open-Label Phase|Lost to Follow-up|23|||
126322441|NCT02815267|454474057|FG001|Open-Label Phase|Lost to Follow-up|9|||
126322442|NCT02815267|454474056|FG000|Open-Label Phase|Withdrawal by Subject|24|||
126322443|NCT02815267|454474057|FG001|Open-Label Phase|Withdrawal by Subject|13|||
125983562|NCT02496767|453230001|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
125983563|NCT02496767|453230002|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
125983564|NCT02496767|453230003|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
125983565|NCT02496767|453230004|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
125983566|NCT02496767|453230005|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
125983567|NCT02496767|453230006|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
125983568|NCT02496767|453230007|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
125983569|NCT02496767|453230000|FG000|Double-blind, Withdrawal Phase|Death|0|||
125983570|NCT02496767|453230001|FG001|Double-blind, Withdrawal Phase|Death|0|||
125983571|NCT02496767|453230002|FG002|Double-blind, Withdrawal Phase|Death|0|||
125983572|NCT02496767|453230003|FG003|Double-blind, Withdrawal Phase|Death|0|||
125983573|NCT02496767|453230004|FG004|Double-blind, Withdrawal Phase|Death|0|||
125983574|NCT02496767|453230005|FG005|Double-blind, Withdrawal Phase|Death|0|||
125983575|NCT02496767|453230006|FG006|Double-blind, Withdrawal Phase|Death|1|||
125983576|NCT02496767|453230007|FG007|Double-blind, Withdrawal Phase|Death|2|||
125983577|NCT02496767|453230000|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125983578|NCT02496767|453230001|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125983579|NCT02496767|453230002|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125983580|NCT02496767|453230003|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125983581|NCT02496767|453230004|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125983582|NCT02496767|453230005|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
125983583|NCT02496767|453230006|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
126322444|NCT02815267|454474056|FG000|Open-Label Phase|Protocol Violation|0|||
126322445|NCT02815267|454474057|FG001|Open-Label Phase|Protocol Violation|1|||
126322446|NCT02815267|454474056|FG000|Open-Label Phase|Administrative|21|||
126322447|NCT02815267|454474057|FG001|Open-Label Phase|Administrative|12|||
126322448|NCT02815267|454474056|FG000|Open-Label Phase|Other|2|||
126322449|NCT02815267|454474057|FG001|Open-Label Phase|Other|5|||
126322450|NCT03594955|454474060|FG000|Overall Study|Adverse Event|1|||
126322451|NCT03594955|454474060|FG000|Overall Study|Progressive disease|5|||
126322452|NCT03594955|454474060|FG000|Overall Study|Sponsor's decision|1|||
125983584|NCT02496767|453230007|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
126322453|NCT04278924|454474063|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
126322454|NCT04278924|454474064|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
126322455|NCT04278924|454474065|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
126322456|NCT04278924|454474066|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
126322457|NCT04278924|454474067|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
126322458|NCT04278924|454474068|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
126322459|NCT04278924|454474069|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
126322460|NCT04278924|454474063|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322461|NCT04278924|454474064|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
126322462|NCT04278924|454474065|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322463|NCT04278924|454474066|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322464|NCT04278924|454474067|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322465|NCT04278924|454474068|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322466|NCT04278924|454474069|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322467|NCT05600036|454474070|FG000|Overall Study|Adverse Event|0|||
126322468|NCT05600036|454474071|FG001|Overall Study|Adverse Event|2|||
126322469|NCT05600036|454474072|FG002|Overall Study|Adverse Event|1|||
126322470|NCT05600036|454474073|FG003|Overall Study|Adverse Event|0|||
126322471|NCT05600036|454474074|FG004|Overall Study|Adverse Event|1|||
126322472|NCT05600036|454474075|FG005|Overall Study|Adverse Event|0|||
126322473|NCT05600036|454474070|FG000|Overall Study|Lost to Follow-up|0|||
126322474|NCT05600036|454474071|FG001|Overall Study|Lost to Follow-up|2|||
126322475|NCT05600036|454474072|FG002|Overall Study|Lost to Follow-up|1|||
126322476|NCT05600036|454474073|FG003|Overall Study|Lost to Follow-up|1|||
126322477|NCT05600036|454474074|FG004|Overall Study|Lost to Follow-up|0|||
126322478|NCT05600036|454474075|FG005|Overall Study|Lost to Follow-up|0|||
126322479|NCT05600036|454474070|FG000|Overall Study|Protocol Violation|0|||
126322480|NCT05600036|454474071|FG001|Overall Study|Protocol Violation|0|||
126322481|NCT05600036|454474072|FG002|Overall Study|Protocol Violation|2|||
126322482|NCT05600036|454474073|FG003|Overall Study|Protocol Violation|0|||
126322483|NCT05600036|454474074|FG004|Overall Study|Protocol Violation|0|||
126322484|NCT05600036|454474075|FG005|Overall Study|Protocol Violation|0|||
126322485|NCT05600036|454474070|FG000|Overall Study|Withdrawal by Subject|0|||
126322486|NCT05600036|454474071|FG001|Overall Study|Withdrawal by Subject|1|||
126322487|NCT05600036|454474072|FG002|Overall Study|Withdrawal by Subject|2|||
126322488|NCT05600036|454474073|FG003|Overall Study|Withdrawal by Subject|0|||
126322489|NCT05600036|454474074|FG004|Overall Study|Withdrawal by Subject|3|||
126322490|NCT05600036|454474075|FG005|Overall Study|Withdrawal by Subject|5|||
126322491|NCT05600036|454474070|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322492|NCT05600036|454474071|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322493|NCT05600036|454474072|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322494|NCT05600036|454474073|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
126322495|NCT05600036|454474074|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322496|NCT05600036|454474075|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322497|NCT05600036|454474070|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322498|NCT05600036|454474071|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
126322499|NCT05600036|454474072|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322500|NCT05600036|454474073|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322501|NCT05600036|454474074|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322502|NCT05600036|454474075|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322503|NCT05600036|454474070|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322504|NCT05600036|454474071|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322505|NCT05600036|454474072|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322506|NCT05600036|454474073|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
126322507|NCT05600036|454474074|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322508|NCT05600036|454474075|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322509|NCT01006590|454474076|FG000|Overall Study|Adverse Event|2|||
126322510|NCT01006590|454474077|FG001|Overall Study|Adverse Event|3|||
126322511|NCT01006590|454474076|FG000|Overall Study|Death|1|||
126322512|NCT01006590|454474077|FG001|Overall Study|Death|1|||
126322513|NCT01006590|454474076|FG000|Overall Study|Lost to Follow-up|1|||
126322514|NCT01006590|454474077|FG001|Overall Study|Lost to Follow-up|1|||
126322515|NCT01006590|454474076|FG000|Overall Study|Protocol Violation|1|||
126322516|NCT01006590|454474077|FG001|Overall Study|Protocol Violation|0|||
126322517|NCT01006590|454474076|FG000|Overall Study|Withdrawal by Subject|4|||
126322518|NCT01006590|454474077|FG001|Overall Study|Withdrawal by Subject|2|||
126322519|NCT01006590|454474076|FG000|Overall Study|Study specific discontinuation criteria|16|||
126322520|NCT01006590|454474077|FG001|Overall Study|Study specific discontinuation criteria|23|||
126322521|NCT01006590|454474076|FG000|Overall Study|Other|3|||
126322522|NCT01006590|454474077|FG001|Overall Study|Other|2|||
126322523|NCT00329745|454474078|FG000|Overall Study|Protocol Violation|1|||
126322524|NCT00329745|454474079|FG001|Overall Study|Protocol Violation|0|||
126322525|NCT00329745|454474078|FG000|Overall Study|Withdrawal by Subject|0|||
126322526|NCT00329745|454474079|FG001|Overall Study|Withdrawal by Subject|1|||
126322527|NCT00329745|454474078|FG000|Overall Study|Lost to Follow-up|86|||
126322528|NCT00329745|454474079|FG001|Overall Study|Lost to Follow-up|101|||
126322529|NCT02700698|454474080|FG000|Overall Study|Withdrawal by Subject|1|||
126322530|NCT02700698|454474081|FG001|Overall Study|Withdrawal by Subject|0|||
126322531|NCT00703118|454474084|FG000|Overall Study|Adverse Event|1|||
126322532|NCT00703118|454474085|FG001|Overall Study|Adverse Event|2|||
126322533|NCT00703118|454474086|FG002|Overall Study|Adverse Event|2|||
126322534|NCT00703118|454474084|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
126322535|NCT00703118|454474085|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
126322536|NCT00703118|454474086|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
126322537|NCT00703118|454474084|FG000|Overall Study|Lost to Follow-up|6|||
126322538|NCT00703118|454474085|FG001|Overall Study|Lost to Follow-up|4|||
126322539|NCT00703118|454474086|FG002|Overall Study|Lost to Follow-up|4|||
126322540|NCT00703118|454474084|FG000|Overall Study|Withdrawal by Subject|8|||
126322541|NCT00703118|454474085|FG001|Overall Study|Withdrawal by Subject|7|||
126322542|NCT00703118|454474086|FG002|Overall Study|Withdrawal by Subject|13|||
126322543|NCT00703118|454474084|FG000|Overall Study|Other|0|||
126322544|NCT00703118|454474085|FG001|Overall Study|Other|0|||
126322545|NCT00703118|454474086|FG002|Overall Study|Other|1|||
126322546|NCT01204918|454474089|FG000|Overall Study|Withdrawal by Subject|4|||
125983585|NCT02889133|453230008|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
126322547|NCT01204918|454474090|FG001|Overall Study|Withdrawal by Subject|10|||
126322548|NCT01204918|454474091|FG002|Overall Study|Withdrawal by Subject|5|||
126322549|NCT02005627|454474096|FG000|Overall Study|Lost to Follow-up|1|||
126322550|NCT02005627|454474097|FG001|Overall Study|Lost to Follow-up|2|||
126322551|NCT02005627|454474096|FG000|Overall Study|Withdrawal by Subject|1|||
126322552|NCT02005627|454474097|FG001|Overall Study|Withdrawal by Subject|2|||
126322553|NCT00938587|454474098|FG000|Overall Study|Adverse Event|2|||
126322554|NCT00938587|454474099|FG001|Overall Study|Adverse Event|0|||
126322555|NCT00938587|454474100|FG002|Overall Study|Adverse Event|0|||
126322556|NCT00938587|454474101|FG003|Overall Study|Adverse Event|2|||
126322557|NCT00938587|454474098|FG000|Overall Study|Did not meet entrance criteria|0|||
126322558|NCT00938587|454474099|FG001|Overall Study|Did not meet entrance criteria|0|||
126322559|NCT00938587|454474100|FG002|Overall Study|Did not meet entrance criteria|1|||
126322560|NCT00938587|454474101|FG003|Overall Study|Did not meet entrance criteria|0|||
126322561|NCT00938587|454474098|FG000|Overall Study|Withdrawal by Subject|1|||
126322562|NCT00938587|454474099|FG001|Overall Study|Withdrawal by Subject|1|||
126322563|NCT00938587|454474100|FG002|Overall Study|Withdrawal by Subject|0|||
126322564|NCT00938587|454474101|FG003|Overall Study|Withdrawal by Subject|0|||
126322565|NCT00849290|454474102|FG000|Overall Study|Adverse Event|3|||
126322566|NCT00849290|454474102|FG000|Overall Study|Death|14|||
126322567|NCT00849290|454474102|FG000|Overall Study|Withdrawal by Subject|11|||
126322568|NCT00849290|454474102|FG000|Overall Study|Lost to Follow-up|2|||
126322569|NCT00849290|454474102|FG000|Overall Study|Protocol Violation|5|||
126322570|NCT00849290|454474102|FG000|Overall Study|Disease Progression|20|||
126322571|NCT00548249|454474103|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
125983586|NCT02889133|453230009|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
125983587|NCT02889133|453230008|FG000|Completed Primary Outcome|Manufacturing error|3|||
125983588|NCT02889133|453230009|FG001|Completed Primary Outcome|Manufacturing error|8|||
125983589|NCT02889133|453230008|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
125983590|NCT02889133|453230009|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
125983591|NCT02889133|453230008|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
125983592|NCT02889133|453230009|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
125983593|NCT02889133|453230008|FG000|Completed Primary Outcome|Protocol Violation|1|||
125983594|NCT02889133|453230009|FG001|Completed Primary Outcome|Protocol Violation|0|||
125983595|NCT02889133|453230008|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
125983596|NCT02889133|453230009|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
125983597|NCT02889133|453230008|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
125983598|NCT02889133|453230009|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
125983599|NCT02889133|453230008|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
125983600|NCT02889133|453230009|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
125983601|NCT02889133|453230008|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
126322572|NCT00548249|454474104|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
126322573|NCT00548249|454474105|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
126322574|NCT00548249|454474106|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
126322575|NCT00548249|454474107|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
126090985|NCT00368927|453626873|FG001|Overall Study|Physician Decision|0|||
126322576|NCT00548249|454474103|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
126322577|NCT00548249|454474104|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
126322578|NCT00548249|454474105|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
126322579|NCT00548249|454474106|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
126322580|NCT00548249|454474107|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
126322581|NCT00548249|454474103|FG000|Overall Study|Protocol Violation|1|||
126322582|NCT00548249|454474104|FG001|Overall Study|Protocol Violation|1|||
126322583|NCT00548249|454474105|FG002|Overall Study|Protocol Violation|4|||
126322584|NCT00548249|454474106|FG003|Overall Study|Protocol Violation|0|||
126322585|NCT00548249|454474107|FG004|Overall Study|Protocol Violation|3|||
126322586|NCT00548249|454474103|FG000|Overall Study|Miscellaneous|2|||
126322587|NCT00548249|454474104|FG001|Overall Study|Miscellaneous|3|||
126322588|NCT00548249|454474105|FG002|Overall Study|Miscellaneous|2|||
126322589|NCT00548249|454474106|FG003|Overall Study|Miscellaneous|0|||
126322590|NCT00548249|454474107|FG004|Overall Study|Miscellaneous|2|||
126322591|NCT00548249|454474103|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
126322592|NCT00548249|454474104|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
126322593|NCT00548249|454474105|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
126322594|NCT00548249|454474106|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
126322595|NCT00548249|454474107|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
126322596|NCT00548249|454474103|FG000|Overall Study|Adverse Event|2|||
126322597|NCT00548249|454474104|FG001|Overall Study|Adverse Event|2|||
126322598|NCT00548249|454474105|FG002|Overall Study|Adverse Event|0|||
126322599|NCT00548249|454474106|FG003|Overall Study|Adverse Event|1|||
126322600|NCT00548249|454474107|FG004|Overall Study|Adverse Event|1|||
126322601|NCT00548249|454474103|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
126322602|NCT00548249|454474104|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
126322603|NCT00548249|454474105|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
126322604|NCT00548249|454474106|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
126322605|NCT00548249|454474107|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
126322606|NCT00548249|454474103|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
126322607|NCT00548249|454474104|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
126322608|NCT00548249|454474105|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
126322609|NCT00548249|454474106|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
126322610|NCT00548249|454474107|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
126322611|NCT00548249|454474103|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
126322612|NCT00548249|454474104|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
126322613|NCT00548249|454474105|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
126322614|NCT00548249|454474106|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
126322615|NCT00548249|454474107|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
126322616|NCT00548249|454474103|FG000|Overall Study|Prolonged hospitalization|0|||
126322617|NCT00548249|454474104|FG001|Overall Study|Prolonged hospitalization|0|||
126322618|NCT00548249|454474105|FG002|Overall Study|Prolonged hospitalization|2|||
126322619|NCT00548249|454474106|FG003|Overall Study|Prolonged hospitalization|1|||
126322620|NCT00548249|454474107|FG004|Overall Study|Prolonged hospitalization|0|||
126322621|NCT00548249|454474103|FG000|Overall Study|Withdrawal by Subject|2|||
126322622|NCT00548249|454474104|FG001|Overall Study|Withdrawal by Subject|0|||
126322623|NCT00548249|454474105|FG002|Overall Study|Withdrawal by Subject|0|||
126322624|NCT00548249|454474106|FG003|Overall Study|Withdrawal by Subject|0|||
126322625|NCT00548249|454474107|FG004|Overall Study|Withdrawal by Subject|0|||
126322626|NCT00548249|454474103|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
126322627|NCT00548249|454474104|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
126322628|NCT00548249|454474105|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
126322629|NCT00548249|454474106|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
126322630|NCT00548249|454474107|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
126322631|NCT00548249|454474103|FG000|Overall Study|Sponsor's request|0|||
126322632|NCT00548249|454474104|FG001|Overall Study|Sponsor's request|0|||
126322633|NCT00548249|454474105|FG002|Overall Study|Sponsor's request|0|||
126322634|NCT00548249|454474106|FG003|Overall Study|Sponsor's request|1|||
126322635|NCT00548249|454474107|FG004|Overall Study|Sponsor's request|0|||
126322636|NCT04933617|454474110|FG000|Dose Escalation|Early closure of study|0|||
126322637|NCT04933617|454474111|FG001|Dose Escalation|Early closure of study|3|||
125983602|NCT02889133|453230009|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
125983603|NCT02889133|453230008|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
126322638|NCT04933617|454474112|FG002|Dose Escalation|Early closure of study|0|||
125983604|NCT02889133|453230009|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
126322639|NCT04933617|454474113|FG003|Dose Escalation|Early closure of study|0|||
125983605|NCT05687032|453230010|FG000|Treatment Phase|Adverse Event|13|||
126322640|NCT04933617|454474114|FG004|Dose Escalation|Early closure of study|0|||
126322641|NCT03760458|454474116|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
126322642|NCT03760458|454474117|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
126322643|NCT03760458|454474118|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
126322644|NCT03760458|454474119|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
125983606|NCT05687032|453230010|FG000|Treatment Phase|Death|1|||
126322645|NCT03760458|454474120|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
126322646|NCT00002525|454474132|FG000|Overall Study|Adverse Event|36|||
126322647|NCT00002525|454474133|FG001|Overall Study|Adverse Event|0|||
126322648|NCT00002525|454474132|FG000|Overall Study|Death|5|||
126322649|NCT00002525|454474133|FG001|Overall Study|Death|0|||
126322650|NCT00002525|454474132|FG000|Overall Study|Withdrawal by Subject|11|||
126322651|NCT00002525|454474133|FG001|Overall Study|Withdrawal by Subject|0|||
126322652|NCT00002525|454474132|FG000|Overall Study|Start non-protocol therapy|1|||
126322653|NCT00002525|454474133|FG001|Overall Study|Start non-protocol therapy|0|||
126322654|NCT00002525|454474132|FG000|Overall Study|Other complicating disease|1|||
126322655|NCT00002525|454474133|FG001|Overall Study|Other complicating disease|0|||
126322656|NCT00002525|454474132|FG000|Overall Study|Duke's A, B1, D disease|92|||
126322657|NCT00002525|454474133|FG001|Overall Study|Duke's A, B1, D disease|0|||
126322658|NCT00002525|454474132|FG000|Overall Study|Error|6|||
126322659|NCT00002525|454474133|FG001|Overall Study|Error|0|||
126322660|NCT00002525|454474132|FG000|Overall Study|Other|26|||
126322661|NCT00002525|454474133|FG001|Overall Study|Other|0|||
126322662|NCT00002525|454474132|FG000|Overall Study|Never start protocol therapy|8|||
126322663|NCT00002525|454474133|FG001|Overall Study|Never start protocol therapy|0|||
126322664|NCT03230838|454474134|FG000|Overall Study|Withdrawal by Subject|3|||
126322665|NCT03230838|454474135|FG001|Overall Study|Withdrawal by Subject|0|||
126322666|NCT03230838|454474134|FG000|Overall Study|Temperature excursion|1|||
126322667|NCT03230838|454474135|FG001|Overall Study|Temperature excursion|0|||
126322668|NCT01915771|454474138|FG000|Day 1|Withdrawal by Subject|1|||
126322669|NCT01915771|454474138|FG000|Day 15|Withdrawal by Subject|1|||
126322670|NCT03420222|454474139|FG000|Overall Study|Withdrawal by Subject|5|||
126322671|NCT03420222|454474140|FG001|Overall Study|Withdrawal by Subject|0|||
126322672|NCT03420222|454474139|FG000|Overall Study|Physician Decision|0|||
126322673|NCT03420222|454474140|FG001|Overall Study|Physician Decision|1|||
126322674|NCT02697734|454474141|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
126322675|NCT02697734|454474142|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
126322676|NCT02697734|454474141|FG000|Core Phase - up to Week 48|Adverse Event|1|||
126322677|NCT02697734|454474142|FG001|Core Phase - up to Week 48|Adverse Event|2|||
126322678|NCT02697734|454474141|FG000|Core Phase - up to Week 48|Physician Decision|1|||
126322679|NCT02697734|454474142|FG001|Core Phase - up to Week 48|Physician Decision|0|||
126322680|NCT02697734|454474141|FG000|Optional Extension Phase|Adverse Event|5|||
126322681|NCT02697734|454474142|FG001|Optional Extension Phase|Adverse Event|1|||
126322682|NCT02697734|454474141|FG000|Optional Extension Phase|Physician Decision|0|||
126322683|NCT02697734|454474142|FG001|Optional Extension Phase|Physician Decision|1|||
126322684|NCT02334384|454474143|FG000|Overall Study|Lost to Follow-up|1|||
126322685|NCT02334384|454474144|FG001|Overall Study|Lost to Follow-up|1|||
126322686|NCT02651688|454474145|FG000|Overall Study|Non-compliance|0|||
126322687|NCT02651688|454474146|FG001|Overall Study|Non-compliance|0|||
126322688|NCT02651688|454474147|FG002|Overall Study|Non-compliance|1|||
126322689|NCT02651688|454474145|FG000|Overall Study|Principal Investigator (PI) decision|0|||
126322690|NCT02651688|454474146|FG001|Overall Study|Principal Investigator (PI) decision|2|||
126322691|NCT02651688|454474147|FG002|Overall Study|Principal Investigator (PI) decision|0|||
126322692|NCT02651688|454474145|FG000|Overall Study|Lost to Follow-up|1|||
126322693|NCT02651688|454474146|FG001|Overall Study|Lost to Follow-up|3|||
126322694|NCT02651688|454474147|FG002|Overall Study|Lost to Follow-up|0|||
126322695|NCT02651688|454474145|FG000|Overall Study|Withdrawal by Subject|1|||
126322696|NCT02651688|454474146|FG001|Overall Study|Withdrawal by Subject|0|||
126322697|NCT02651688|454474147|FG002|Overall Study|Withdrawal by Subject|2|||
126322698|NCT01429441|454474148|FG000|Overall Study|Adverse Event|5|||
126322699|NCT01429441|454474149|FG001|Overall Study|Adverse Event|1|||
126322700|NCT01429441|454474148|FG000|Overall Study|Death|0|||
126322701|NCT01429441|454474149|FG001|Overall Study|Death|2|||
125983607|NCT05687032|453230010|FG000|Treatment Phase|Physician Decision|3|||
125983608|NCT05687032|453230010|FG000|Treatment Phase|Progressive disease|9|||
125983609|NCT05687032|453230010|FG000|Treatment Phase|Withdrawal by Subject|5|||
125983610|NCT05687032|453230010|FG000|Follow-Up Phase|Death|16|||
126209038|NCT04668066|454053112|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
126322702|NCT01429441|454474148|FG000|Overall Study|Lost to Follow-up|5|||
126322703|NCT01429441|454474149|FG001|Overall Study|Lost to Follow-up|2|||
126322704|NCT01429441|454474148|FG000|Overall Study|Physician Decision|1|||
126322705|NCT01429441|454474149|FG001|Overall Study|Physician Decision|0|||
126322706|NCT01429441|454474148|FG000|Overall Study|Withdrawal by Subject|27|||
126322707|NCT01429441|454474149|FG001|Overall Study|Withdrawal by Subject|18|||
126322708|NCT00621517|454474155|FG000|Overall Study|Lost to Follow-up|3|||
126322709|NCT00621517|454474156|FG001|Overall Study|Lost to Follow-up|3|||
126322710|NCT00621517|454474155|FG000|Overall Study|Withdrawal by Subject|3|||
126322711|NCT00621517|454474156|FG001|Overall Study|Withdrawal by Subject|4|||
126322712|NCT00621517|454474155|FG000|Overall Study|Adverse Event|1|||
126322713|NCT00621517|454474156|FG001|Overall Study|Adverse Event|0|||
125983611|NCT05687032|453230010|FG000|Follow-Up Phase|Ongoing|26|||
126322714|NCT02155322|454474158|FG000|Overall Study|Adverse Event|1|||
126322715|NCT02155322|454474158|FG000|Overall Study|Physician Decision|1|||
126322716|NCT02155322|454474158|FG000|Overall Study|Relapse/Recurrence|8|||
126322717|NCT02155322|454474158|FG000|Overall Study|Withdrawal by Subject|4|||
126322718|NCT00073008|454474159|FG000|Overall Study|Missing|6|||
126322719|NCT00073008|454474160|FG001|Overall Study|Missing|6|||
126322720|NCT00073008|454474159|FG000|Overall Study|Withdrawal by Subject|2|||
126322721|NCT00073008|454474160|FG001|Overall Study|Withdrawal by Subject|2|||
126322722|NCT00073008|454474159|FG000|Overall Study|Lost to Follow-up|1|||
126322723|NCT00073008|454474160|FG001|Overall Study|Lost to Follow-up|3|||
126322724|NCT00073008|454474159|FG000|Overall Study|Death|46|||
126322725|NCT00073008|454474160|FG001|Overall Study|Death|47|||
126322726|NCT00073008|454474159|FG000|Overall Study|"Other selected on Case Report Form"|7|||
126322727|NCT00073008|454474160|FG001|Overall Study|"Other selected on Case Report Form"|5|||
126322728|NCT00913770|454474161|FG000|Overall Study|Unable to contact|24|||
126322729|NCT00913770|454474162|FG001|Overall Study|Unable to contact|19|||
126322730|NCT00913770|454474163|FG002|Overall Study|Unable to contact|13|||
126322731|NCT00913770|454474161|FG000|Overall Study|Refused|11|||
126322732|NCT00913770|454474162|FG001|Overall Study|Refused|10|||
126322733|NCT00913770|454474163|FG002|Overall Study|Refused|8|||
126322734|NCT03337048|454474167|FG000|Overall Study|Withdrawal by Subject|2|||
126322735|NCT03337048|454474168|FG001|Overall Study|Withdrawal by Subject|0|||
126322736|NCT03337048|454474169|FG002|Overall Study|Withdrawal by Subject|0|||
126322737|NCT02791438|454474172|FG000|Treatment Period|Adverse Event|1|||
126322738|NCT02791438|454474173|FG001|Treatment Period|Adverse Event|0|||
126322739|NCT02791438|454474172|FG000|Treatment Period|Withdrawal by Subject|0|||
126322740|NCT02791438|454474173|FG001|Treatment Period|Withdrawal by Subject|1|||
126322741|NCT02791438|454474172|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
126322742|NCT02791438|454474173|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
126322743|NCT02669667|454474175|FG000|Overall Study|Lost to Follow-up|0|||
126322744|NCT02669667|454474176|FG001|Overall Study|Lost to Follow-up|0|||
126322745|NCT02669667|454474177|FG002|Overall Study|Lost to Follow-up|0|||
126322746|NCT02669667|454474178|FG003|Overall Study|Lost to Follow-up|0|||
126322747|NCT02669667|454474179|FG004|Overall Study|Lost to Follow-up|0|||
126322748|NCT02669667|454474180|FG005|Overall Study|Lost to Follow-up|1|||
126322749|NCT02669667|454474181|FG006|Overall Study|Lost to Follow-up|0|||
126322750|NCT02839876|454474182|FG000|Overall Study|Protocol Violation|10|||
126322751|NCT02839876|454474183|FG001|Overall Study|Protocol Violation|11|||
126322752|NCT00564395|454474187|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
126322753|NCT00564395|454474188|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
126322754|NCT00564395|454474187|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
126322755|NCT00564395|454474188|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
126322756|NCT01428115|454474189|FG000|Overall Study|Lack of Efficacy|3|||
126322757|NCT01428115|454474189|FG000|Overall Study|Lost to Follow-up|10|||
126322758|NCT01428115|454474189|FG000|Overall Study|Pregnancy|1|||
126322759|NCT01428115|454474189|FG000|Overall Study|Protocol Violation|3|||
126322760|NCT01428115|454474189|FG000|Overall Study|Withdrawal by Subject|4|||
126322761|NCT02071082|454474194|FG000|Overall Study|Enrolled and Never Treated|1|||
126322762|NCT02071082|454474195|FG001|Overall Study|Enrolled and Never Treated|1|||
126322763|NCT02071082|454474194|FG000|Overall Study|Adverse Event|0|||
126322764|NCT02071082|454474195|FG001|Overall Study|Adverse Event|1|||
126322765|NCT02071082|454474194|FG000|Overall Study|Withdrew Consent|0|||
126322766|NCT02071082|454474195|FG001|Overall Study|Withdrew Consent|4|||
126322767|NCT02071082|454474194|FG000|Overall Study|Lost to Follow-up|1|||
126322768|NCT02071082|454474195|FG001|Overall Study|Lost to Follow-up|1|||
126322769|NCT02494401|454474199|FG000|Overall Study|Lost to Follow-up|22|||
126322770|NCT02494401|454474200|FG001|Overall Study|Lost to Follow-up|25|||
126322771|NCT02494401|454474199|FG000|Overall Study|Withdrawal by Subject|3|||
126322772|NCT02494401|454474200|FG001|Overall Study|Withdrawal by Subject|2|||
126322773|NCT00966355|454474201|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
126322774|NCT00966355|454474202|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
126322775|NCT00966355|454474203|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
126322776|NCT00966355|454474201|FG000|Overall Study|newly diagnosed advanced HCC|11|||
126322777|NCT00966355|454474202|FG001|Overall Study|newly diagnosed advanced HCC|12|||
126322778|NCT00966355|454474203|FG002|Overall Study|newly diagnosed advanced HCC|10|||
126322779|NCT00966355|454474201|FG000|Overall Study|Lost to Follow-up|5|||
126322780|NCT00966355|454474202|FG001|Overall Study|Lost to Follow-up|4|||
126322781|NCT00966355|454474203|FG002|Overall Study|Lost to Follow-up|3|||
126322782|NCT00958412|454474204|FG000|Overall Study|Study prematurely terminated|18|||
126322783|NCT02510820|454476117|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126322784|NCT02510820|454476118|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126322785|NCT02510820|454476117|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126322786|NCT02510820|454476118|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126322787|NCT03046056|454476119|FG000|Overall Study|Non-responder at Week 10|6|||
126322788|NCT03046056|454476120|FG001|Overall Study|Non-responder at Week 10|6|||
125878504|NCT05138653|452851311|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126322789|NCT03046056|454476121|FG002|Overall Study|Non-responder at Week 10|4|||
126322790|NCT03046056|454476119|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
126322791|NCT03046056|454476120|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
126322792|NCT03046056|454476121|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
126322793|NCT03046056|454476119|FG000|Overall Study|Adverse Event|1|||
126322794|NCT03046056|454476120|FG001|Overall Study|Adverse Event|5|||
126322795|NCT03046056|454476121|FG002|Overall Study|Adverse Event|0|||
126322796|NCT03046056|454476119|FG000|Overall Study|Non-compliance With Study Drug|0|||
126322797|NCT03046056|454476120|FG001|Overall Study|Non-compliance With Study Drug|0|||
126322798|NCT03046056|454476121|FG002|Overall Study|Non-compliance With Study Drug|2|||
126322799|NCT03046056|454476119|FG000|Overall Study|Protocol Violation|1|||
126322800|NCT03046056|454476120|FG001|Overall Study|Protocol Violation|1|||
126322801|NCT03046056|454476121|FG002|Overall Study|Protocol Violation|0|||
126322802|NCT03046056|454476119|FG000|Overall Study|Investigator's Discretion|0|||
126322803|NCT03046056|454476120|FG001|Overall Study|Investigator's Discretion|1|||
126322804|NCT03046056|454476121|FG002|Overall Study|Investigator's Discretion|0|||
126322805|NCT03046056|454476119|FG000|Overall Study|Withdrew Consent|1|||
126322806|NCT03046056|454476120|FG001|Overall Study|Withdrew Consent|0|||
126322807|NCT03046056|454476121|FG002|Overall Study|Withdrew Consent|0|||
126322808|NCT02913105|454476122|FG000|Overall Study|Adverse Event|11|||
126322809|NCT02913105|454476123|FG001|Overall Study|Adverse Event|0|||
126322810|NCT02913105|454476124|FG002|Overall Study|Adverse Event|4|||
126322811|NCT02913105|454476122|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126322812|NCT02913105|454476123|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126322813|NCT02913105|454476124|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126322814|NCT02913105|454476122|FG000|Overall Study|Reason Not Specified|3|||
126322815|NCT02913105|454476123|FG001|Overall Study|Reason Not Specified|1|||
126322816|NCT02913105|454476124|FG002|Overall Study|Reason Not Specified|1|||
126322817|NCT02913105|454476122|FG000|Overall Study|Physician Decision|1|||
126322818|NCT02913105|454476123|FG001|Overall Study|Physician Decision|1|||
126322819|NCT02913105|454476124|FG002|Overall Study|Physician Decision|0|||
126322820|NCT02913105|454476122|FG000|Overall Study|Withdrawal by Subject|0|||
126322821|NCT02913105|454476123|FG001|Overall Study|Withdrawal by Subject|3|||
126322822|NCT02913105|454476124|FG002|Overall Study|Withdrawal by Subject|1|||
126322823|NCT01317004|454476125|FG000|Overall Study|Withdrawal by Subject|1|||
126322824|NCT01317004|454476126|FG001|Overall Study|Withdrawal by Subject|4|||
126322825|NCT01317004|454476125|FG000|Overall Study|Protocol Violation|0|||
126322826|NCT01317004|454476126|FG001|Overall Study|Protocol Violation|2|||
126322827|NCT01317004|454476125|FG000|Overall Study|Adverse Event|3|||
126322828|NCT01317004|454476126|FG001|Overall Study|Adverse Event|3|||
126322829|NCT01344759|454476130|FG000|Overall Study|Patients failed to reach sedation level|0|||
126322830|NCT01344759|454476131|FG001|Overall Study|Patients failed to reach sedation level|2|||
126322831|NCT01153009|454476132|FG000|Overall Study|Adverse Event|4|||
126322832|NCT01153009|454476133|FG001|Overall Study|Adverse Event|14|||
126322833|NCT01153009|454476134|FG002|Overall Study|Adverse Event|14|||
126322834|NCT01153009|454476135|FG003|Overall Study|Adverse Event|10|||
126322835|NCT01153009|454476132|FG000|Overall Study|Lack of Efficacy|9|||
126322836|NCT01153009|454476133|FG001|Overall Study|Lack of Efficacy|0|||
126322837|NCT01153009|454476134|FG002|Overall Study|Lack of Efficacy|2|||
126322838|NCT01153009|454476135|FG003|Overall Study|Lack of Efficacy|1|||
126322839|NCT01153009|454476132|FG000|Overall Study|Noncompliance with Study Medication|1|||
126322840|NCT01153009|454476133|FG001|Overall Study|Noncompliance with Study Medication|3|||
126322841|NCT01153009|454476134|FG002|Overall Study|Noncompliance with Study Medication|4|||
126322842|NCT01153009|454476135|FG003|Overall Study|Noncompliance with Study Medication|1|||
126322843|NCT01153009|454476132|FG000|Overall Study|Protocol Deviations|4|||
126322844|NCT01153009|454476133|FG001|Overall Study|Protocol Deviations|3|||
126322845|NCT01153009|454476134|FG002|Overall Study|Protocol Deviations|3|||
126322846|NCT01153009|454476135|FG003|Overall Study|Protocol Deviations|2|||
126322847|NCT01153009|454476132|FG000|Overall Study|Withdrawal of Consent|5|||
126322848|NCT01153009|454476133|FG001|Overall Study|Withdrawal of Consent|5|||
126322849|NCT01153009|454476134|FG002|Overall Study|Withdrawal of Consent|4|||
126322850|NCT01153009|454476135|FG003|Overall Study|Withdrawal of Consent|6|||
126322851|NCT01153009|454476132|FG000|Overall Study|Lost to Follow-up|8|||
126322852|NCT01153009|454476133|FG001|Overall Study|Lost to Follow-up|8|||
126322853|NCT01153009|454476134|FG002|Overall Study|Lost to Follow-up|11|||
126322854|NCT01153009|454476135|FG003|Overall Study|Lost to Follow-up|15|||
126322855|NCT01153009|454476132|FG000|Overall Study|Other|1|||
126322856|NCT01153009|454476133|FG001|Overall Study|Other|1|||
126322857|NCT01153009|454476134|FG002|Overall Study|Other|3|||
126322858|NCT01153009|454476135|FG003|Overall Study|Other|2|||
126322859|NCT04003623|454476139|FG000|Overall Study|Withdrawal by Subject|1|||
126322860|NCT04003623|454476140|FG001|Overall Study|Withdrawal by Subject|0|||
126322861|NCT00703326|454476142|FG000|Overall Study|Lost to Follow-up|47|||
126322862|NCT00703326|454476143|FG001|Overall Study|Lost to Follow-up|18|||
126322863|NCT00703326|454476142|FG000|Overall Study|Withdrawal by Subject|54|||
126322864|NCT00703326|454476143|FG001|Overall Study|Withdrawal by Subject|20|||
126322865|NCT00703326|454476142|FG000|Overall Study|Adverse Event|1|||
126322866|NCT00703326|454476143|FG001|Overall Study|Adverse Event|0|||
126209039|NCT04668066|454053113|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
125983612|NCT00279201|453230016|FG000|Initiation|Death|1|||
126322867|NCT01744483|454476147|FG000|Overall Study|Death|9|||
126322868|NCT01744483|454476148|FG001|Overall Study|Death|4|||
126322869|NCT01744483|454476149|FG002|Overall Study|Death|11|||
126322870|NCT01744483|454476147|FG000|Overall Study|Lost to Follow-up|8|||
126322871|NCT01744483|454476148|FG001|Overall Study|Lost to Follow-up|9|||
126322872|NCT01744483|454476149|FG002|Overall Study|Lost to Follow-up|11|||
126322873|NCT01744483|454476147|FG000|Overall Study|Protocol Violation|1|||
126322874|NCT01744483|454476148|FG001|Overall Study|Protocol Violation|2|||
126322875|NCT01744483|454476149|FG002|Overall Study|Protocol Violation|1|||
126322876|NCT01744483|454476147|FG000|Overall Study|Withdrawal by Subject|4|||
126322877|NCT01744483|454476148|FG001|Overall Study|Withdrawal by Subject|6|||
126322878|NCT01744483|454476149|FG002|Overall Study|Withdrawal by Subject|2|||
126322879|NCT01744483|454476147|FG000|Overall Study|No ICU Admit|5|||
126322880|NCT01744483|454476148|FG001|Overall Study|No ICU Admit|1|||
126322881|NCT01744483|454476149|FG002|Overall Study|No ICU Admit|2|||
126322882|NCT01744483|454476147|FG000|Overall Study|Routed to OSH|2|||
126322883|NCT01744483|454476148|FG001|Overall Study|Routed to OSH|0|||
126322884|NCT01744483|454476149|FG002|Overall Study|Routed to OSH|1|||
126322885|NCT01190189|454476150|FG000|Overall Study|Lost to Follow-up|4|||
126322886|NCT01190189|454476150|FG000|Overall Study|Withdrawal by Subject|1|||
126322887|NCT01190189|454476150|FG000|Overall Study|Migrated/moved from study area|1|||
126322888|NCT03214679|454476152|FG000|Overall Study|Lost to Follow-up|12|||
126322889|NCT03214679|454476153|FG001|Overall Study|Lost to Follow-up|14|||
126322890|NCT03214679|454476152|FG000|Overall Study|not eligible|2|||
126322891|NCT03214679|454476153|FG001|Overall Study|not eligible|0|||
126322892|NCT01754766|454476166|FG000|Overall Study|Personal reasons|1|||
126322893|NCT01754766|454476167|FG001|Overall Study|Personal reasons|1|||
126322894|NCT01754766|454476168|FG002|Overall Study|Personal reasons|0|||
126322895|NCT01709409|454476171|FG000|Overall Study|Protocol Violation|1|||
126322896|NCT01709409|454476172|FG001|Overall Study|Protocol Violation|0|||
126322897|NCT02412878|454476173|FG000|Overall Study|Withdrawal by Subject|19|||
126322898|NCT02412878|454476174|FG001|Overall Study|Withdrawal by Subject|10|||
126322899|NCT02412878|454476173|FG000|Overall Study|Lost to Follow-up|2|||
126322900|NCT02412878|454476174|FG001|Overall Study|Lost to Follow-up|3|||
126322901|NCT02190721|454476175|FG000|Overall Study|Patient was out of the city|0|||
126322902|NCT02190721|454476176|FG001|Overall Study|Patient was out of the city|1|||
126322903|NCT02190721|454476177|FG002|Overall Study|Patient was out of the city|0|||
126322904|NCT04571385|454476178|FG000|Overall Study|Participant non-compliance|1|||
126322905|NCT04571385|454476179|FG001|Overall Study|Participant non-compliance|0|||
126322906|NCT04571385|454476180|FG002|Overall Study|Participant non-compliance|0|||
126322907|NCT04571385|454476178|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
126322908|NCT04571385|454476179|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
126322909|NCT04571385|454476180|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
126322910|NCT04571385|454476178|FG000|Overall Study|Screen failure|0|||
126322911|NCT04571385|454476179|FG001|Overall Study|Screen failure|0|||
126322912|NCT04571385|454476180|FG002|Overall Study|Screen failure|1|||
126322913|NCT02263729|454476182|FG000|Overall Study|Lost to Follow-up|1|||
126322914|NCT02263729|454476183|FG001|Overall Study|Lost to Follow-up|1|||
126322915|NCT05025332|454476184|FG000|Screening|Screen failure|12|||
126322916|NCT05025332|454476184|FG000|Treatment & Follow Up|Protocol Violation|1|||
126322917|NCT05025332|454476184|FG000|Treatment & Follow Up|Adverse Event|4|||
126322918|NCT01212159|454476185|FG000|Overall Study|Withdrawal by Subject|12|||
126322919|NCT01212159|454476186|FG001|Overall Study|Withdrawal by Subject|12|||
126322920|NCT01306214|454476187|FG000|Overall Study|Death|0|||
126322921|NCT01306214|454476188|FG001|Overall Study|Death|0|||
126322922|NCT01306214|454476189|FG002|Overall Study|Death|1|||
126322923|NCT01306214|454476187|FG000|Overall Study|Lost to Follow-up|3|||
126322924|NCT01306214|454476188|FG001|Overall Study|Lost to Follow-up|5|||
126322925|NCT01306214|454476189|FG002|Overall Study|Lost to Follow-up|4|||
125983613|NCT00279201|453230017|FG001|Initiation|Death|5|||
125983614|NCT00279201|453230018|FG002|Initiation|Death|0|||
125983615|NCT00279201|453230019|FG003|Initiation|Death|0|||
126322926|NCT01306214|454476187|FG000|Overall Study|Withdrawal by Subject|24|||
126322927|NCT01306214|454476188|FG001|Overall Study|Withdrawal by Subject|22|||
126322928|NCT01306214|454476189|FG002|Overall Study|Withdrawal by Subject|16|||
126322929|NCT01306214|454476187|FG000|Overall Study|Not treated|1|||
126322930|NCT01306214|454476188|FG001|Overall Study|Not treated|1|||
126322931|NCT01306214|454476189|FG002|Overall Study|Not treated|1|||
126322932|NCT01928199|454476192|FG000|Overall Study|Lost to Follow-up|2|||
126322933|NCT01928199|454476193|FG001|Overall Study|Lost to Follow-up|1|||
126322934|NCT01928199|454476192|FG000|Overall Study|Withdrawal by Subject|3|||
126322935|NCT01928199|454476193|FG001|Overall Study|Withdrawal by Subject|5|||
126322936|NCT01502956|454476200|FG000|Overall Study|Death|0|||
126322937|NCT01502956|454476201|FG001|Overall Study|Death|2|||
126322938|NCT01502956|454476200|FG000|Overall Study|Lost to Follow-up|14|||
126322939|NCT01502956|454476201|FG001|Overall Study|Lost to Follow-up|11|||
125983616|NCT00279201|453230020|FG004|Initiation|Death|0|||
125983617|NCT00279201|453230021|FG005|Initiation|Death|0|||
126322940|NCT01502956|454476200|FG000|Overall Study|Physician Decision|2|||
126322941|NCT01502956|454476201|FG001|Overall Study|Physician Decision|3|||
126322942|NCT01502956|454476200|FG000|Overall Study|Withdrawal by Subject|8|||
126322943|NCT01502956|454476201|FG001|Overall Study|Withdrawal by Subject|10|||
126322944|NCT03959488|454476202|FG000|Season 1|Other|6|||
126322945|NCT03959488|454476203|FG001|Season 1|Other|7|||
126322946|NCT03959488|454476204|FG002|Season 1|Other|0|||
125983618|NCT00279201|453230016|FG000|Initiation|Adverse Event|6|||
125983619|NCT00279201|453230017|FG001|Initiation|Adverse Event|15|||
125983620|NCT00279201|453230018|FG002|Initiation|Adverse Event|0|||
125983621|NCT00279201|453230019|FG003|Initiation|Adverse Event|0|||
125983622|NCT00279201|453230020|FG004|Initiation|Adverse Event|0|||
125983623|NCT00279201|453230021|FG005|Initiation|Adverse Event|0|||
126322947|NCT03959488|454476205|FG003|Season 1|Other|0|||
126322948|NCT03959488|454476206|FG004|Season 1|Other|0|||
126322949|NCT03959488|454476202|FG000|Season 1|Withdrawal by parent/guardian|43|||
126322950|NCT03959488|454476203|FG001|Season 1|Withdrawal by parent/guardian|28|||
126322951|NCT03959488|454476204|FG002|Season 1|Withdrawal by parent/guardian|0|||
126322952|NCT03959488|454476205|FG003|Season 1|Withdrawal by parent/guardian|0|||
126322953|NCT03959488|454476206|FG004|Season 1|Withdrawal by parent/guardian|0|||
126322954|NCT03959488|454476202|FG000|Season 1|Due to COVID-19 pandemic|2|||
126322955|NCT03959488|454476203|FG001|Season 1|Due to COVID-19 pandemic|3|||
126322956|NCT03959488|454476204|FG002|Season 1|Due to COVID-19 pandemic|0|||
126322957|NCT03959488|454476205|FG003|Season 1|Due to COVID-19 pandemic|0|||
126322958|NCT03959488|454476206|FG004|Season 1|Due to COVID-19 pandemic|0|||
126322959|NCT03959488|454476202|FG000|Season 1|Lost to Follow-up|17|||
126322960|NCT03959488|454476203|FG001|Season 1|Lost to Follow-up|7|||
126322961|NCT03959488|454476204|FG002|Season 1|Lost to Follow-up|0|||
126322962|NCT03959488|454476205|FG003|Season 1|Lost to Follow-up|0|||
126322963|NCT03959488|454476206|FG004|Season 1|Lost to Follow-up|0|||
126322964|NCT03959488|454476202|FG000|Season 1|Death|5|||
126322965|NCT03959488|454476203|FG001|Season 1|Death|1|||
126322966|NCT03959488|454476204|FG002|Season 1|Death|0|||
126322967|NCT03959488|454476205|FG003|Season 1|Death|0|||
126322968|NCT03959488|454476206|FG004|Season 1|Death|0|||
126322969|NCT03959488|454476202|FG000|Season 2|Other|0|||
126322970|NCT03959488|454476203|FG001|Season 2|Other|0|||
126322971|NCT03959488|454476204|FG002|Season 2|Other|2|||
126322972|NCT03959488|454476205|FG003|Season 2|Other|0|||
125983624|NCT00279201|453230016|FG000|Initiation|Lost to Follow-up|42|||
125983625|NCT00279201|453230017|FG001|Initiation|Lost to Follow-up|41|||
125983626|NCT00279201|453230018|FG002|Initiation|Lost to Follow-up|0|||
125983627|NCT00279201|453230019|FG003|Initiation|Lost to Follow-up|0|||
125983628|NCT00279201|453230020|FG004|Initiation|Lost to Follow-up|0|||
125983629|NCT00279201|453230021|FG005|Initiation|Lost to Follow-up|0|||
125983630|NCT00279201|453230016|FG000|Initiation|Entry Criteria Exclusion|7|||
125983631|NCT00279201|453230017|FG001|Initiation|Entry Criteria Exclusion|9|||
125983632|NCT00279201|453230018|FG002|Initiation|Entry Criteria Exclusion|0|||
125983633|NCT00279201|453230019|FG003|Initiation|Entry Criteria Exclusion|0|||
125983634|NCT00279201|453230020|FG004|Initiation|Entry Criteria Exclusion|0|||
125983635|NCT00279201|453230021|FG005|Initiation|Entry Criteria Exclusion|0|||
125983636|NCT00279201|453230016|FG000|Initiation|Protocol Violation|9|||
125983637|NCT00279201|453230017|FG001|Initiation|Protocol Violation|10|||
125983638|NCT00279201|453230018|FG002|Initiation|Protocol Violation|0|||
125983639|NCT00279201|453230019|FG003|Initiation|Protocol Violation|0|||
125983640|NCT00279201|453230020|FG004|Initiation|Protocol Violation|0|||
125983641|NCT00279201|453230021|FG005|Initiation|Protocol Violation|0|||
126209040|NCT04668066|454053114|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209041|NCT04668066|454053115|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209042|NCT04668066|454053116|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
126322973|NCT03959488|454476206|FG004|Season 2|Other|0|||
126322974|NCT03959488|454476202|FG000|Season 2|Withdrawal by parent/guardian|0|||
126322975|NCT03959488|454476203|FG001|Season 2|Withdrawal by parent/guardian|0|||
126322976|NCT03959488|454476204|FG002|Season 2|Withdrawal by parent/guardian|3|||
126322977|NCT03959488|454476205|FG003|Season 2|Withdrawal by parent/guardian|1|||
126322978|NCT03959488|454476206|FG004|Season 2|Withdrawal by parent/guardian|1|||
126322979|NCT03959488|454476202|FG000|Season 2|Lost to Follow-up|0|||
126322980|NCT03959488|454476203|FG001|Season 2|Lost to Follow-up|0|||
126322981|NCT03959488|454476204|FG002|Season 2|Lost to Follow-up|1|||
126322982|NCT03959488|454476205|FG003|Season 2|Lost to Follow-up|0|||
126322983|NCT03959488|454476206|FG004|Season 2|Lost to Follow-up|1|||
126322984|NCT01026818|454476209|FG000|Screening Period|Entry Criteria Not Met|105|||
126322985|NCT01026818|454476210|FG001|Screening Period|Entry Criteria Not Met|0|||
126322986|NCT01026818|454476211|FG002|Screening Period|Entry Criteria Not Met|0|||
125983642|NCT00279201|453230016|FG000|Initiation|Withdrawal by Subject|35|||
125983643|NCT00279201|453230017|FG001|Initiation|Withdrawal by Subject|41|||
125983644|NCT00279201|453230018|FG002|Initiation|Withdrawal by Subject|0|||
125983645|NCT00279201|453230019|FG003|Initiation|Withdrawal by Subject|0|||
125983646|NCT00279201|453230020|FG004|Initiation|Withdrawal by Subject|0|||
125983647|NCT00279201|453230021|FG005|Initiation|Withdrawal by Subject|0|||
125983648|NCT00279201|453230016|FG000|Initiation|Physician Decision|15|||
126322987|NCT01026818|454476212|FG003|Screening Period|Entry Criteria Not Met|0|||
126322988|NCT01026818|454476209|FG000|Screening Period|Withdrawal by Subject|49|||
125983649|NCT00279201|453230017|FG001|Initiation|Physician Decision|18|||
125983650|NCT00279201|453230018|FG002|Initiation|Physician Decision|0|||
125983651|NCT00279201|453230019|FG003|Initiation|Physician Decision|0|||
125983652|NCT00279201|453230020|FG004|Initiation|Physician Decision|0|||
126322989|NCT01026818|454476210|FG001|Screening Period|Withdrawal by Subject|0|||
126322990|NCT01026818|454476211|FG002|Screening Period|Withdrawal by Subject|0|||
126322991|NCT01026818|454476212|FG003|Screening Period|Withdrawal by Subject|0|||
126322992|NCT01026818|454476209|FG000|Screening Period|Protocol Deviation|3|||
126322993|NCT01026818|454476210|FG001|Screening Period|Protocol Deviation|0|||
126322994|NCT01026818|454476211|FG002|Screening Period|Protocol Deviation|0|||
126322995|NCT01026818|454476212|FG003|Screening Period|Protocol Deviation|0|||
126322996|NCT01026818|454476209|FG000|Screening Period|Adverse Event|2|||
126322997|NCT01026818|454476210|FG001|Screening Period|Adverse Event|0|||
126322998|NCT01026818|454476211|FG002|Screening Period|Adverse Event|0|||
126322999|NCT01026818|454476212|FG003|Screening Period|Adverse Event|0|||
126323000|NCT01026818|454476209|FG000|Screening Period|Physician Decision|1|||
126323001|NCT01026818|454476210|FG001|Screening Period|Physician Decision|0|||
126323002|NCT01026818|454476211|FG002|Screening Period|Physician Decision|0|||
126323003|NCT01026818|454476212|FG003|Screening Period|Physician Decision|0|||
126323004|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
126323005|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
126323006|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
126323007|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
126323008|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
126323009|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
126323010|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
126323011|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
126323012|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
126323013|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
126323014|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
126323015|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
126323016|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
126323017|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
126323018|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
126323019|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
126323020|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
126323021|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
126323022|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
126323023|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
126323024|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
126323025|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
126323026|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
126323027|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
126323028|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
126323029|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
125983653|NCT00279201|453230021|FG005|Initiation|Physician Decision|0|||
125983654|NCT00279201|453230016|FG000|Initiation|Sponsor Decision|13|||
125983655|NCT00279201|453230017|FG001|Initiation|Sponsor Decision|5|||
125983656|NCT00279201|453230018|FG002|Initiation|Sponsor Decision|0|||
125983657|NCT00279201|453230019|FG003|Initiation|Sponsor Decision|0|||
125983658|NCT00279201|453230020|FG004|Initiation|Sponsor Decision|0|||
125983659|NCT00279201|453230021|FG005|Initiation|Sponsor Decision|0|||
125983660|NCT00279201|453230016|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125983661|NCT00279201|453230017|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
125983662|NCT00279201|453230018|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125983663|NCT00279201|453230019|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125983664|NCT00279201|453230020|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125983665|NCT00279201|453230021|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125983666|NCT00279201|453230016|FG000|Maintenance|Lack of Efficacy|32|||
125983667|NCT00279201|453230017|FG001|Maintenance|Lack of Efficacy|30|||
125983668|NCT00279201|453230018|FG002|Maintenance|Lack of Efficacy|0|||
126323030|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
126323031|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
126323032|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
126323033|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
126323034|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
126323035|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
125983669|NCT00279201|453230019|FG003|Maintenance|Lack of Efficacy|0|||
125983670|NCT00279201|453230020|FG004|Maintenance|Lack of Efficacy|0|||
125983671|NCT00279201|453230021|FG005|Maintenance|Lack of Efficacy|0|||
126090986|NCT03525392|453626874|FG000|Overall Study|Adverse Event|1|||
125983672|NCT00279201|453230016|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
125983673|NCT00279201|453230017|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
125983674|NCT00279201|453230018|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
125983675|NCT00279201|453230019|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
125983676|NCT00279201|453230020|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
125983677|NCT00279201|453230021|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
125983678|NCT00279201|453230016|FG000|Maintenance|Adverse Event|4|||
125983679|NCT00279201|453230017|FG001|Maintenance|Adverse Event|4|||
125983680|NCT00279201|453230018|FG002|Maintenance|Adverse Event|0|||
125983681|NCT00279201|453230019|FG003|Maintenance|Adverse Event|0|||
125983682|NCT00279201|453230020|FG004|Maintenance|Adverse Event|0|||
125983683|NCT00279201|453230021|FG005|Maintenance|Adverse Event|0|||
125983684|NCT00279201|453230016|FG000|Maintenance|Death|4|||
125983685|NCT00279201|453230017|FG001|Maintenance|Death|4|||
125983686|NCT00279201|453230018|FG002|Maintenance|Death|0|||
125983687|NCT00279201|453230019|FG003|Maintenance|Death|0|||
125983688|NCT00279201|453230020|FG004|Maintenance|Death|0|||
125983689|NCT00279201|453230021|FG005|Maintenance|Death|0|||
125983690|NCT00279201|453230016|FG000|Maintenance|Lost to Follow-up|17|||
125983691|NCT00279201|453230017|FG001|Maintenance|Lost to Follow-up|13|||
125983692|NCT00279201|453230018|FG002|Maintenance|Lost to Follow-up|0|||
125983693|NCT00279201|453230019|FG003|Maintenance|Lost to Follow-up|0|||
125983694|NCT00279201|453230020|FG004|Maintenance|Lost to Follow-up|0|||
125983695|NCT00279201|453230021|FG005|Maintenance|Lost to Follow-up|0|||
126323036|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
126323037|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
126323038|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
126323039|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
126323040|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
126323041|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
126323042|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
126323043|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
126323044|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
126323045|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
126323046|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
126323047|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
126323048|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
126323049|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
126323050|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
126323051|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
126323052|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
126323053|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
126323054|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
126323055|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
126323056|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
126323057|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
126323058|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
126323059|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
126323060|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
126323061|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
126323062|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
126323063|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
126323064|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
126323065|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
126323066|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
126323067|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
126323068|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
126323069|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
126323070|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
126323071|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
126323072|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
126323073|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
126323074|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
126323075|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
125983696|NCT00279201|453230016|FG000|Maintenance|Entry Criteria Exclusion|1|||
125983697|NCT00279201|453230017|FG001|Maintenance|Entry Criteria Exclusion|4|||
125983698|NCT00279201|453230018|FG002|Maintenance|Entry Criteria Exclusion|0|||
125983699|NCT00279201|453230019|FG003|Maintenance|Entry Criteria Exclusion|0|||
125983700|NCT00279201|453230020|FG004|Maintenance|Entry Criteria Exclusion|0|||
125983701|NCT00279201|453230021|FG005|Maintenance|Entry Criteria Exclusion|0|||
125983702|NCT00279201|453230016|FG000|Maintenance|Protocol Violation|16|||
126323076|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
126323077|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
126323078|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
126323079|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
126323080|NCT03300050|454476215|FG000|Overall Study|Lost to Follow-up|2|||
126323081|NCT03300050|454476216|FG001|Overall Study|Lost to Follow-up|1|||
126323082|NCT03300050|454476217|FG002|Overall Study|Lost to Follow-up|0|||
126323083|NCT03300050|454476218|FG003|Overall Study|Lost to Follow-up|0|||
126323084|NCT03300050|454476219|FG004|Overall Study|Lost to Follow-up|1|||
126323085|NCT03300050|454476215|FG000|Overall Study|Withdrawal by Subject|1|||
126323086|NCT03300050|454476216|FG001|Overall Study|Withdrawal by Subject|1|||
126323087|NCT03300050|454476217|FG002|Overall Study|Withdrawal by Subject|1|||
126323088|NCT03300050|454476218|FG003|Overall Study|Withdrawal by Subject|0|||
126323089|NCT03300050|454476219|FG004|Overall Study|Withdrawal by Subject|0|||
126323090|NCT03300050|454476215|FG000|Overall Study|Death|0|||
126323091|NCT03300050|454476216|FG001|Overall Study|Death|0|||
126323092|NCT03300050|454476217|FG002|Overall Study|Death|1|||
126323093|NCT03300050|454476218|FG003|Overall Study|Death|0|||
126323094|NCT03300050|454476219|FG004|Overall Study|Death|0|||
126323095|NCT03300050|454476215|FG000|Overall Study|Not Eligible at Randomization|0|||
126323096|NCT03300050|454476216|FG001|Overall Study|Not Eligible at Randomization|0|||
126323097|NCT03300050|454476217|FG002|Overall Study|Not Eligible at Randomization|1|||
126323098|NCT03300050|454476218|FG003|Overall Study|Not Eligible at Randomization|1|||
126323099|NCT03300050|454476219|FG004|Overall Study|Not Eligible at Randomization|0|||
126323100|NCT00631163|454476222|FG000|Number of Participants in Year 1|Adverse Event|12|||
126323101|NCT00631163|454476222|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
126323102|NCT00631163|454476222|FG000|Number of Participants in Year 1|Death|6|||
126323103|NCT00631163|454476222|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
126323104|NCT00631163|454476222|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
126323105|NCT00631163|454476222|FG000|Number of Participants in Year 1|Administrative problems|6|||
126323106|NCT00631163|454476222|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
126323107|NCT00631163|454476222|FG000|Number of Participants in Year 2|Adverse Event|1|||
126323108|NCT00631163|454476222|FG000|Number of Participants in Year 2|Protocol Violation|1|||
126323109|NCT00631163|454476222|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
126323110|NCT02714036|454476223|FG000|Overall Study|Adverse Event|9|||
126323111|NCT02714036|454476224|FG001|Overall Study|Adverse Event|2|||
126323112|NCT02714036|454476223|FG000|Overall Study|Withdrawal by Subject|3|||
126323113|NCT02714036|454476224|FG001|Overall Study|Withdrawal by Subject|2|||
126323114|NCT01597492|454476226|FG000|Overall Study|Withdrawal by Subject|1|||
126323115|NCT01597492|454476227|FG001|Overall Study|Withdrawal by Subject|2|||
126323116|NCT01597492|454476226|FG000|Overall Study|Adverse Event|3|||
126323117|NCT01597492|454476227|FG001|Overall Study|Adverse Event|0|||
126323118|NCT01597492|454476226|FG000|Overall Study|Lost to Follow-up|0|||
126323119|NCT01597492|454476227|FG001|Overall Study|Lost to Follow-up|2|||
126323120|NCT01597492|454476226|FG000|Overall Study|Other Reason|2|||
126323121|NCT01597492|454476227|FG001|Overall Study|Other Reason|0|||
126323122|NCT03517449|454476237|FG000|Overall Study|Death|184|||
126323123|NCT03517449|454476238|FG001|Overall Study|Death|236|||
126323124|NCT03517449|454476237|FG000|Overall Study|Lost to Follow-up|0|||
126323125|NCT03517449|454476238|FG001|Overall Study|Lost to Follow-up|2|||
126323126|NCT03517449|454476237|FG000|Overall Study|Withdrawal by Subject|7|||
126323127|NCT03517449|454476238|FG001|Overall Study|Withdrawal by Subject|26|||
126323128|NCT03517449|454476237|FG000|Overall Study|Participants Ongoing|220|||
126323129|NCT03517449|454476238|FG001|Overall Study|Participants Ongoing|152|||
126323130|NCT01853696|454476239|FG000|Overall Study|Withdrawal by Subject|1|||
126323131|NCT01853696|454476240|FG001|Overall Study|Withdrawal by Subject|1|||
126323132|NCT01853696|454476239|FG000|Overall Study|Lost to Follow-up|5|||
126323133|NCT01853696|454476240|FG001|Overall Study|Lost to Follow-up|4|||
126323134|NCT00431067|454476243|FG000|Overall Study|Other Adverse Event|9|||
126323135|NCT00431067|454476243|FG000|Overall Study|Progressive disease|30|||
126323136|NCT00431067|454476243|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
126323137|NCT03304184|454476248|FG000|Overall Study|Withdrawal by Subject|1|||
126323138|NCT03304184|454476249|FG001|Overall Study|Withdrawal by Subject|2|||
126323139|NCT04527978|454476256|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
126323140|NCT04527978|454476257|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
126323141|NCT01578499|454476258|FG000|Overall Study|Reason not Specified|0|||
126323142|NCT01578499|454476259|FG001|Overall Study|Reason not Specified|1|||
126323143|NCT01578499|454476258|FG000|Overall Study|Lost to Follow-up|2|||
126323144|NCT01578499|454476259|FG001|Overall Study|Lost to Follow-up|1|||
126323145|NCT01578499|454476258|FG000|Overall Study|Withdrawal by Subject|10|||
126323146|NCT01578499|454476259|FG001|Overall Study|Withdrawal by Subject|16|||
126323147|NCT01578499|454476258|FG000|Overall Study|Death|20|||
126323148|NCT01578499|454476259|FG001|Overall Study|Death|25|||
126323149|NCT01578499|454476258|FG000|Overall Study|Died and End of Study Page not Completed|2|||
126323150|NCT01578499|454476259|FG001|Overall Study|Died and End of Study Page not Completed|0|||
126323151|NCT00830518|454476260|FG000|Overall Study|Progressive Disease|18|||
126323152|NCT00830518|454476261|FG001|Overall Study|Progressive Disease|8|||
126323153|NCT00830518|454476260|FG000|Overall Study|Symptomatic Deterioration|4|||
126323154|NCT00830518|454476261|FG001|Overall Study|Symptomatic Deterioration|1|||
126323155|NCT00830518|454476260|FG000|Overall Study|Adverse Event|14|||
126323156|NCT00830518|454476261|FG001|Overall Study|Adverse Event|1|||
126323157|NCT00830518|454476260|FG000|Overall Study|Withdrawal by Patient|2|||
126323158|NCT00830518|454476261|FG001|Overall Study|Withdrawal by Patient|0|||
126323159|NCT00830518|454476260|FG000|Overall Study|Reason not Specified|8|||
126323160|NCT00830518|454476261|FG001|Overall Study|Reason not Specified|1|||
126323161|NCT01156051|454476269|FG000|Overall Study|Lost to Follow-up|1|||
126323162|NCT01156051|454476270|FG001|Overall Study|Lost to Follow-up|0|||
126323163|NCT01156051|454476269|FG000|Overall Study|patient not compliant with protocol|0|||
126323164|NCT01156051|454476270|FG001|Overall Study|patient not compliant with protocol|1|||
126323165|NCT01926197|454476273|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
126323166|NCT01926197|454476274|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
126323167|NCT01926197|454476273|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
126323168|NCT01926197|454476274|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
126323169|NCT02620384|454476276|FG000|Overall Study|Adverse Event|2|||
126323170|NCT02620384|454476277|FG001|Overall Study|Adverse Event|1|||
126323171|NCT02620384|454476276|FG000|Overall Study|Discharged prior to 2nd dose|2|||
126323172|NCT02620384|454476277|FG001|Overall Study|Discharged prior to 2nd dose|5|||
126323173|NCT02620384|454476276|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
126323174|NCT02620384|454476277|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
126323175|NCT02101359|454476278|FG000|Overall Study|Not included|23|||
126323176|NCT02101359|454476279|FG001|Overall Study|Not included|13|||
126323177|NCT02101359|454476278|FG000|Overall Study|Withdrawal by Subject|5|||
126323178|NCT02101359|454476279|FG001|Overall Study|Withdrawal by Subject|4|||
126323179|NCT02101359|454476278|FG000|Overall Study|Lost to Follow-up|1|||
126323180|NCT02101359|454476279|FG001|Overall Study|Lost to Follow-up|0|||
126323181|NCT02101359|454476278|FG000|Overall Study|Protocol Violation|0|||
126323182|NCT02101359|454476279|FG001|Overall Study|Protocol Violation|2|||
126323183|NCT00723697|454476281|FG000|Overall Study|Physician questionnaires not received|2|||
126323184|NCT00723697|454476281|FG000|Overall Study|Missing Informed Consent Form|10|||
126323185|NCT00723697|454476281|FG000|Overall Study|Other exclusion criteria applied|6|||
126323186|NCT01483599|454476282|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
126323187|NCT01483599|454476283|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323188|NCT01483599|454476284|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323189|NCT01483599|454476285|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
126323190|NCT01483599|454476286|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
126323191|NCT01483599|454476287|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
126323192|NCT01483599|454476288|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
126323193|NCT01483599|454476289|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323194|NCT01483599|454476290|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323195|NCT01483599|454476291|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323196|NCT01483599|454476292|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323197|NCT01483599|454476293|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323198|NCT01483599|454476294|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323199|NCT01483599|454476295|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323200|NCT01483599|454476282|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323201|NCT01483599|454476283|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
126323202|NCT01483599|454476284|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323203|NCT01483599|454476285|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
126323204|NCT01483599|454476286|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323205|NCT01483599|454476287|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323206|NCT01483599|454476288|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
126323207|NCT01483599|454476289|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323208|NCT01483599|454476290|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323209|NCT01483599|454476291|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323210|NCT01483599|454476292|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323211|NCT01483599|454476293|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323212|NCT01483599|454476294|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323213|NCT01483599|454476295|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323214|NCT01483599|454476282|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
126209043|NCT04668066|454053117|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209044|NCT04668066|454053118|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209045|NCT04668066|454053119|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209046|NCT04668066|454053120|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209047|NCT04668066|454053121|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209048|NCT04668066|454053122|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
126209049|NCT04668066|454053123|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
126323215|NCT01483599|454476283|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323216|NCT01483599|454476284|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323217|NCT01483599|454476285|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323218|NCT01483599|454476286|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323219|NCT01483599|454476287|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323220|NCT01483599|454476288|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323221|NCT01483599|454476289|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323222|NCT01483599|454476290|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323223|NCT01483599|454476291|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323224|NCT01483599|454476292|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323225|NCT01483599|454476293|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323226|NCT01483599|454476294|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323227|NCT01483599|454476295|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323228|NCT01483599|454476282|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
126323229|NCT01483599|454476283|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
126323230|NCT01483599|454476284|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
126323231|NCT01483599|454476285|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
126323232|NCT01483599|454476286|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
126323233|NCT01483599|454476287|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
126323234|NCT01483599|454476288|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
126323235|NCT01483599|454476289|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
126323236|NCT01483599|454476290|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
126323237|NCT01483599|454476291|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
126323238|NCT01483599|454476292|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
126323239|NCT01483599|454476293|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
126323240|NCT01483599|454476294|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
126323241|NCT01483599|454476295|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
125983703|NCT00279201|453230017|FG001|Maintenance|Protocol Violation|24|||
125983704|NCT00279201|453230018|FG002|Maintenance|Protocol Violation|0|||
125983705|NCT00279201|453230019|FG003|Maintenance|Protocol Violation|0|||
125983706|NCT00279201|453230020|FG004|Maintenance|Protocol Violation|0|||
125983707|NCT00279201|453230021|FG005|Maintenance|Protocol Violation|0|||
125983708|NCT00279201|453230016|FG000|Maintenance|Withdrawal by Subject|18|||
125983709|NCT00279201|453230017|FG001|Maintenance|Withdrawal by Subject|18|||
125983710|NCT00279201|453230018|FG002|Maintenance|Withdrawal by Subject|0|||
125983711|NCT00279201|453230019|FG003|Maintenance|Withdrawal by Subject|0|||
125983712|NCT00279201|453230020|FG004|Maintenance|Withdrawal by Subject|0|||
125983713|NCT00279201|453230021|FG005|Maintenance|Withdrawal by Subject|0|||
125983714|NCT00279201|453230016|FG000|Maintenance|Physician Decision|9|||
125983715|NCT00279201|453230017|FG001|Maintenance|Physician Decision|9|||
125983716|NCT00279201|453230018|FG002|Maintenance|Physician Decision|0|||
125983717|NCT00279201|453230019|FG003|Maintenance|Physician Decision|0|||
125983718|NCT00279201|453230020|FG004|Maintenance|Physician Decision|0|||
125983719|NCT00279201|453230021|FG005|Maintenance|Physician Decision|0|||
125983720|NCT00279201|453230016|FG000|Maintenance|Sponsor Decision|4|||
125983721|NCT00279201|453230017|FG001|Maintenance|Sponsor Decision|0|||
125983722|NCT00279201|453230018|FG002|Maintenance|Sponsor Decision|0|||
125983723|NCT00279201|453230019|FG003|Maintenance|Sponsor Decision|0|||
125983724|NCT00279201|453230020|FG004|Maintenance|Sponsor Decision|0|||
125983725|NCT00279201|453230021|FG005|Maintenance|Sponsor Decision|0|||
125983726|NCT00279201|453230016|FG000|Maintenance|HbA1c>7.5%|123|||
125983727|NCT00279201|453230017|FG001|Maintenance|HbA1c>7.5%|126|||
125983728|NCT00279201|453230018|FG002|Maintenance|HbA1c>7.5%|0|||
125983729|NCT00279201|453230019|FG003|Maintenance|HbA1c>7.5%|0|||
125983730|NCT00279201|453230020|FG004|Maintenance|HbA1c>7.5%|0|||
125983731|NCT00279201|453230021|FG005|Maintenance|HbA1c>7.5%|0|||
125983732|NCT00279201|453230016|FG000|Intensification Addendum|Withdrawal by Subject|0|||
125983733|NCT00279201|453230017|FG001|Intensification Addendum|Withdrawal by Subject|0|||
125983734|NCT00279201|453230018|FG002|Intensification Addendum|Withdrawal by Subject|12|||
125983735|NCT00279201|453230019|FG003|Intensification Addendum|Withdrawal by Subject|14|||
125983736|NCT00279201|453230020|FG004|Intensification Addendum|Withdrawal by Subject|9|||
125983737|NCT00279201|453230021|FG005|Intensification Addendum|Withdrawal by Subject|18|||
125983738|NCT00279201|453230016|FG000|Intensification Addendum|Lost to Follow-up|0|||
125983739|NCT00279201|453230017|FG001|Intensification Addendum|Lost to Follow-up|0|||
125983740|NCT00279201|453230018|FG002|Intensification Addendum|Lost to Follow-up|4|||
125983741|NCT00279201|453230019|FG003|Intensification Addendum|Lost to Follow-up|6|||
125983742|NCT00279201|453230020|FG004|Intensification Addendum|Lost to Follow-up|7|||
125983743|NCT00279201|453230021|FG005|Intensification Addendum|Lost to Follow-up|7|||
125983744|NCT00279201|453230016|FG000|Intensification Addendum|Protocol Violation|0|||
125983745|NCT00279201|453230017|FG001|Intensification Addendum|Protocol Violation|0|||
125983746|NCT00279201|453230018|FG002|Intensification Addendum|Protocol Violation|2|||
125983747|NCT00279201|453230019|FG003|Intensification Addendum|Protocol Violation|2|||
125983748|NCT00279201|453230020|FG004|Intensification Addendum|Protocol Violation|6|||
125983749|NCT00279201|453230021|FG005|Intensification Addendum|Protocol Violation|6|||
126323242|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
126323243|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
126323244|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
126323245|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
126323246|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
126323247|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
126323248|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
126323249|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
126323250|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
126323251|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
126323252|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
126323253|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
126323254|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
126323255|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
126323256|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323257|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323258|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323259|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323260|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323261|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323262|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323263|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
126323264|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
126323265|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323266|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323267|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323268|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
126323269|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
126323270|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323271|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323272|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323273|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323274|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323275|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323276|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323277|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323278|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
126323279|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323280|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323281|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
126323282|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323283|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
126323284|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323285|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323286|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323287|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323288|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323289|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323290|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125983750|NCT00279201|453230016|FG000|Intensification Addendum|Adverse Event|0|||
125983751|NCT00279201|453230017|FG001|Intensification Addendum|Adverse Event|0|||
125983752|NCT00279201|453230018|FG002|Intensification Addendum|Adverse Event|0|||
125983753|NCT00279201|453230019|FG003|Intensification Addendum|Adverse Event|4|||
125983754|NCT00279201|453230020|FG004|Intensification Addendum|Adverse Event|1|||
125983755|NCT00279201|453230021|FG005|Intensification Addendum|Adverse Event|3|||
125983756|NCT00279201|453230016|FG000|Intensification Addendum|Physician Decision|0|||
125983757|NCT00279201|453230017|FG001|Intensification Addendum|Physician Decision|0|||
125983758|NCT00279201|453230018|FG002|Intensification Addendum|Physician Decision|4|||
125983759|NCT00279201|453230019|FG003|Intensification Addendum|Physician Decision|1|||
125983760|NCT00279201|453230020|FG004|Intensification Addendum|Physician Decision|3|||
125983761|NCT00279201|453230021|FG005|Intensification Addendum|Physician Decision|2|||
125983762|NCT00279201|453230016|FG000|Intensification Addendum|Sponsor Decision|0|||
125983763|NCT00279201|453230017|FG001|Intensification Addendum|Sponsor Decision|0|||
125983764|NCT00279201|453230018|FG002|Intensification Addendum|Sponsor Decision|0|||
125983765|NCT00279201|453230019|FG003|Intensification Addendum|Sponsor Decision|0|||
126323291|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323292|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
126323293|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323294|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
126323295|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323296|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323297|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
126323298|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323299|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323300|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323301|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323302|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323303|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323304|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323305|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323306|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
126323307|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323308|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323309|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323310|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
126323311|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
126323312|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
126323313|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
126323314|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
126323315|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
126323316|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
126323317|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
126323318|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
126323319|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
126323320|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
126323321|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
126323322|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
126323323|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
126323324|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
126323325|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
126323326|NCT01270321|454477811|FG000|Overall Study|Death|3|||
126323327|NCT01270321|454477812|FG001|Overall Study|Death|1|||
126323328|NCT01270321|454477813|FG002|Overall Study|Death|4|||
126323329|NCT01270321|454477811|FG000|Overall Study|Adverse Event|7|||
126323330|NCT01270321|454477812|FG001|Overall Study|Adverse Event|9|||
126323331|NCT01270321|454477813|FG002|Overall Study|Adverse Event|5|||
126323332|NCT01393106|454477815|FG000|Overall Study|Adverse Event|3|||
126323333|NCT01393106|454477815|FG000|Overall Study|Withdrawal by Subject|1|||
126323334|NCT01393106|454477815|FG000|Overall Study|Lack of Efficacy|1|||
126323335|NCT05437640|454477816|FG000|Washout (1 Week)|Adverse Event|1|||
126323336|NCT05437640|454477817|FG001|Washout (1 Week)|Adverse Event|0|||
126323337|NCT00904917|454477818|FG000|Overall Study|Lost to Follow-up|2|||
126323338|NCT00904917|454477819|FG001|Overall Study|Lost to Follow-up|2|||
126323339|NCT00904917|454477820|FG002|Overall Study|Lost to Follow-up|2|||
126323340|NCT00904917|454477821|FG003|Overall Study|Lost to Follow-up|2|||
125983766|NCT00279201|453230020|FG004|Intensification Addendum|Sponsor Decision|1|||
125983767|NCT00279201|453230021|FG005|Intensification Addendum|Sponsor Decision|1|||
125983768|NCT00279201|453230016|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
125983769|NCT00279201|453230017|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
125983770|NCT00279201|453230018|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
125983771|NCT00279201|453230019|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
125983772|NCT00279201|453230020|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
125983773|NCT00279201|453230021|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
125983774|NCT00279201|453230016|FG000|Intensification Addendum|Lack of Efficacy|0|||
125983775|NCT00279201|453230017|FG001|Intensification Addendum|Lack of Efficacy|0|||
125983776|NCT00279201|453230018|FG002|Intensification Addendum|Lack of Efficacy|0|||
125983777|NCT00279201|453230019|FG003|Intensification Addendum|Lack of Efficacy|1|||
125983778|NCT00279201|453230020|FG004|Intensification Addendum|Lack of Efficacy|1|||
125983779|NCT00279201|453230021|FG005|Intensification Addendum|Lack of Efficacy|0|||
125983780|NCT00279201|453230016|FG000|Intensification Addendum|Death|0|||
125983781|NCT00279201|453230017|FG001|Intensification Addendum|Death|0|||
126323341|NCT04228965|454477824|FG000|Overall Study|Lost to Follow-up|26|||
126323342|NCT04228965|454477825|FG001|Overall Study|Lost to Follow-up|11|||
125983782|NCT00279201|453230018|FG002|Intensification Addendum|Death|0|||
125983783|NCT00279201|453230019|FG003|Intensification Addendum|Death|0|||
125983784|NCT00279201|453230020|FG004|Intensification Addendum|Death|1|||
125983785|NCT00279201|453230021|FG005|Intensification Addendum|Death|0|||
126323343|NCT04228965|454477824|FG000|Overall Study|Withdrawal by Subject|18|||
126323344|NCT04228965|454477825|FG001|Overall Study|Withdrawal by Subject|5|||
126323345|NCT00734656|454477828|FG000|Lab Session 1|Withdrawal by Subject|2|||
126323346|NCT00734656|454477829|FG001|Lab Session 1|Withdrawal by Subject|0|||
126323347|NCT00734656|454477830|FG002|Lab Session 1|Withdrawal by Subject|0|||
126323348|NCT00734656|454477831|FG003|Lab Session 1|Withdrawal by Subject|0|||
126323349|NCT00734656|454477828|FG000|Washout 1|Withdrawal by Subject|1|||
126323350|NCT00734656|454477829|FG001|Washout 1|Withdrawal by Subject|5|||
126323351|NCT00734656|454477830|FG002|Washout 1|Withdrawal by Subject|2|||
126323352|NCT00734656|454477831|FG003|Washout 1|Withdrawal by Subject|3|||
126323353|NCT00734656|454477828|FG000|Lab Session 2|Withdrawal by Subject|1|||
126323354|NCT00734656|454477829|FG001|Lab Session 2|Withdrawal by Subject|0|||
126323355|NCT00734656|454477830|FG002|Lab Session 2|Withdrawal by Subject|0|||
126323356|NCT00734656|454477831|FG003|Lab Session 2|Withdrawal by Subject|1|||
126323357|NCT00734656|454477828|FG000|Washout 2|Withdrawal by Subject|1|||
126323358|NCT00734656|454477829|FG001|Washout 2|Withdrawal by Subject|1|||
126323359|NCT00734656|454477830|FG002|Washout 2|Withdrawal by Subject|1|||
126323360|NCT00734656|454477831|FG003|Washout 2|Withdrawal by Subject|0|||
126323361|NCT00734656|454477828|FG000|Washout 3|Withdrawal by Subject|1|||
126323362|NCT00734656|454477829|FG001|Washout 3|Withdrawal by Subject|0|||
126323363|NCT00734656|454477830|FG002|Washout 3|Withdrawal by Subject|0|||
126323364|NCT00734656|454477831|FG003|Washout 3|Withdrawal by Subject|1|||
126323365|NCT00734656|454477828|FG000|Lab Session 4|Withdrawal by Subject|0|||
126323366|NCT00734656|454477829|FG001|Lab Session 4|Withdrawal by Subject|0|||
126323367|NCT00734656|454477830|FG002|Lab Session 4|Withdrawal by Subject|0|||
126323368|NCT00734656|454477831|FG003|Lab Session 4|Withdrawal by Subject|1|||
126323369|NCT03915626|454477832|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
126323370|NCT04676152|454477833|FG000|Overall Study|screen fail|9|||
125983786|NCT00316173|453230022|FG000|Run-in Phase|Adverse Event|1|||
125983787|NCT00316173|453230023|FG001|Run-in Phase|Adverse Event|0|||
125983788|NCT00316173|453230022|FG000|Run-in Phase|Protocol Violation|1|||
125983789|NCT00316173|453230023|FG001|Run-in Phase|Protocol Violation|0|||
125983790|NCT00316173|453230022|FG000|Run-in Phase|Study Follow-up Stopped|5|||
125983791|NCT00316173|453230023|FG001|Run-in Phase|Study Follow-up Stopped|0|||
125983792|NCT00316173|453230022|FG000|Treatment Phase|Adverse Event|0|||
125983793|NCT00316173|453230023|FG001|Treatment Phase|Adverse Event|1|||
125983794|NCT00316173|453230022|FG000|Treatment Phase|Lack of Efficacy|0|||
125983795|NCT00316173|453230023|FG001|Treatment Phase|Lack of Efficacy|3|||
125983796|NCT00316173|453230022|FG000|Treatment Phase|Lost to Follow-up|0|||
125983797|NCT00316173|453230023|FG001|Treatment Phase|Lost to Follow-up|3|||
125983798|NCT00316173|453230022|FG000|Treatment Phase|Withdrawal by Subject|0|||
125983799|NCT00316173|453230023|FG001|Treatment Phase|Withdrawal by Subject|1|||
125983800|NCT00316173|453230022|FG000|Treatment Phase|Study Follow-up Stopped|0|||
125983801|NCT00316173|453230023|FG001|Treatment Phase|Study Follow-up Stopped|34|||
125983802|NCT02390531|453230024|FG000|Overall Study|Death|0|||
125983803|NCT02390531|453230025|FG001|Overall Study|Death|2|||
125983804|NCT02390531|453230026|FG002|Overall Study|Death|0|||
125983805|NCT02390531|453230027|FG003|Overall Study|Death|1|||
125983806|NCT02390531|453230028|FG004|Overall Study|Death|0|||
125983807|NCT02390531|453230029|FG005|Overall Study|Death|0|||
125983808|NCT02390531|453230030|FG006|Overall Study|Death|0|||
125983809|NCT02390531|453230031|FG007|Overall Study|Death|1|||
125983810|NCT02390531|453230024|FG000|Overall Study|Protocol Violation|0|||
125983811|NCT02390531|453230025|FG001|Overall Study|Protocol Violation|0|||
125983812|NCT02390531|453230026|FG002|Overall Study|Protocol Violation|0|||
125983813|NCT02390531|453230027|FG003|Overall Study|Protocol Violation|0|||
125983814|NCT02390531|453230028|FG004|Overall Study|Protocol Violation|1|||
125983815|NCT02390531|453230029|FG005|Overall Study|Protocol Violation|0|||
126323371|NCT02626000|454477838|FG000|Overall Study|Decision by Sponsor|1|||
126323372|NCT02626000|454477838|FG000|Overall Study|Death|29|||
126323373|NCT02335346|454477857|FG000|Overall Study|Adverse Event|11|||
126323374|NCT02335346|454477857|FG000|Overall Study|Withdrawal by Subject|1|||
125983816|NCT02390531|453230030|FG006|Overall Study|Protocol Violation|2|||
126323375|NCT02769312|454477861|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
126323376|NCT02769312|454477862|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
126323377|NCT02769312|454477861|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
126323378|NCT02769312|454477862|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
126323379|NCT02769312|454477861|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
126323380|NCT02769312|454477862|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
125983817|NCT02390531|453230031|FG007|Overall Study|Protocol Violation|0|||
125983818|NCT00511875|453230032|FG000|Overall Study|Lost to Follow-up|4|||
125983819|NCT00511875|453230033|FG001|Overall Study|Lost to Follow-up|0|||
125983820|NCT00511875|453230032|FG000|Overall Study|Missing variables|1|||
125983821|NCT00511875|453230033|FG001|Overall Study|Missing variables|0|||
125983822|NCT00696384|453230035|FG000|Open Label Phase|Adverse Event|27|||
125983823|NCT00696384|453230036|FG001|Open Label Phase|Adverse Event|0|||
125983824|NCT00696384|453230037|FG002|Open Label Phase|Adverse Event|0|||
125983825|NCT00696384|453230035|FG000|Open Label Phase|Protocol Violation|18|||
126323381|NCT02769312|454477861|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
126323382|NCT02769312|454477862|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
126323383|NCT02769312|454477861|FG000|Follow-up|Lost to Follow-up|1|||
126323384|NCT02769312|454477862|FG001|Follow-up|Lost to Follow-up|1|||
126323385|NCT02178358|454477863|FG000|Overall Study|Withdrawal by Subject|0|||
126323386|NCT02178358|454477864|FG001|Overall Study|Withdrawal by Subject|2|||
126323387|NCT02178358|454477865|FG002|Overall Study|Withdrawal by Subject|2|||
126323388|NCT02178358|454477863|FG000|Overall Study|Lost to Follow-up|1|||
126323389|NCT02178358|454477864|FG001|Overall Study|Lost to Follow-up|0|||
126323390|NCT02178358|454477865|FG002|Overall Study|Lost to Follow-up|0|||
126323391|NCT01066663|454477866|FG000|Overall Study|Adverse Event|0|||
126323392|NCT01066663|454477867|FG001|Overall Study|Adverse Event|0|||
126323393|NCT01066663|454477868|FG002|Overall Study|Adverse Event|1|||
126323394|NCT01090050|454477869|FG000|Overall Study|Lost to Follow-up|0|||
126323395|NCT01090050|454477870|FG001|Overall Study|Lost to Follow-up|1|||
126323396|NCT01090050|454477869|FG000|Overall Study|Lack of Efficacy|1|||
126323397|NCT01090050|454477870|FG001|Overall Study|Lack of Efficacy|5|||
126323398|NCT01090050|454477869|FG000|Overall Study|Physician Decision|0|||
126323399|NCT01090050|454477870|FG001|Overall Study|Physician Decision|1|||
126323400|NCT03539484|454477871|FG000|Overall Study|Death|1|||
126323401|NCT03539484|454477872|FG001|Overall Study|Death|0|||
126323402|NCT03539484|454477873|FG002|Overall Study|Death|0|||
126323403|NCT03539484|454477874|FG003|Overall Study|Death|2|||
126323404|NCT03539484|454477875|FG004|Overall Study|Death|8|||
126323405|NCT03539484|454477876|FG005|Overall Study|Death|3|||
126323406|NCT03539484|454477877|FG006|Overall Study|Death|0|||
126323407|NCT03539484|454477871|FG000|Overall Study|Lost to Follow-up|0|||
126323408|NCT03539484|454477872|FG001|Overall Study|Lost to Follow-up|1|||
126323409|NCT03539484|454477873|FG002|Overall Study|Lost to Follow-up|0|||
126323410|NCT03539484|454477874|FG003|Overall Study|Lost to Follow-up|0|||
126323411|NCT03539484|454477875|FG004|Overall Study|Lost to Follow-up|1|||
126323412|NCT03539484|454477876|FG005|Overall Study|Lost to Follow-up|0|||
126323413|NCT03539484|454477877|FG006|Overall Study|Lost to Follow-up|0|||
126323414|NCT03539484|454477871|FG000|Overall Study|Withdrawal by Subject|0|||
126323415|NCT03539484|454477872|FG001|Overall Study|Withdrawal by Subject|0|||
126323416|NCT03539484|454477873|FG002|Overall Study|Withdrawal by Subject|0|||
126323417|NCT03539484|454477874|FG003|Overall Study|Withdrawal by Subject|0|||
126323418|NCT03539484|454477875|FG004|Overall Study|Withdrawal by Subject|2|||
126323419|NCT03539484|454477876|FG005|Overall Study|Withdrawal by Subject|0|||
126323420|NCT03539484|454477877|FG006|Overall Study|Withdrawal by Subject|1|||
126323421|NCT03539484|454477871|FG000|Overall Study|Study Terminated by Sponsor|0|||
126323422|NCT03539484|454477872|FG001|Overall Study|Study Terminated by Sponsor|0|||
126323423|NCT03539484|454477873|FG002|Overall Study|Study Terminated by Sponsor|1|||
126323424|NCT03539484|454477874|FG003|Overall Study|Study Terminated by Sponsor|1|||
126323425|NCT03539484|454477875|FG004|Overall Study|Study Terminated by Sponsor|2|||
126323426|NCT03539484|454477876|FG005|Overall Study|Study Terminated by Sponsor|2|||
126323427|NCT03539484|454477877|FG006|Overall Study|Study Terminated by Sponsor|1|||
126323428|NCT02232061|454477878|FG000|Overall Study|Administrative problems|1|||
126323429|NCT02232061|454477878|FG000|Overall Study|Withdrawal by Subject|1|||
126323430|NCT00560703|454477880|FG000|Overall Study|Adverse Event|0|||
126323431|NCT00560703|454477881|FG001|Overall Study|Adverse Event|2|||
126323432|NCT00560703|454477880|FG000|Overall Study|Protocol Violation|0|||
126323433|NCT00560703|454477881|FG001|Overall Study|Protocol Violation|2|||
126323434|NCT00560703|454477880|FG000|Overall Study|Withdrawal by Subject|0|||
126323435|NCT00560703|454477881|FG001|Overall Study|Withdrawal by Subject|1|||
126323436|NCT00560703|454477880|FG000|Overall Study|non-compliance|0|||
126323437|NCT00560703|454477881|FG001|Overall Study|non-compliance|1|||
126323438|NCT00339833|454477891|FG000|Overall Study|Withdrawal by Subject|1|||
126323439|NCT00339833|454477892|FG001|Overall Study|Withdrawal by Subject|2|||
126323440|NCT00339833|454477891|FG000|Overall Study|toothache|0|||
126323441|NCT00339833|454477892|FG001|Overall Study|toothache|1|||
126323442|NCT00339833|454477891|FG000|Overall Study|indigestion|0|||
126323443|NCT00339833|454477892|FG001|Overall Study|indigestion|1|||
126323444|NCT00339833|454477891|FG000|Overall Study|Chest pain|0|||
126323445|NCT00339833|454477892|FG001|Overall Study|Chest pain|1|||
126323446|NCT00339833|454477891|FG000|Overall Study|minor infection|0|||
126323447|NCT00339833|454477892|FG001|Overall Study|minor infection|1|||
126323448|NCT00339833|454477891|FG000|Overall Study|Poor venous access|2|||
126323449|NCT00339833|454477892|FG001|Overall Study|Poor venous access|2|||
126323450|NCT00339833|454477891|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
126323451|NCT00339833|454477892|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
126323452|NCT00339833|454477891|FG000|Overall Study|Error in data records|1|||
126323453|NCT00339833|454477892|FG001|Overall Study|Error in data records|0|||
126323454|NCT03077607|454477893|FG000|Period 1 (15 Days)|Adverse Event|1|||
126323455|NCT03077607|454477894|FG001|Period 1 (15 Days)|Adverse Event|0|||
126323456|NCT03077607|454477893|FG000|Period 1 (15 Days)|Death|1|||
126323457|NCT03077607|454477894|FG001|Period 1 (15 Days)|Death|0|||
126323458|NCT03077607|454477893|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
126323459|NCT03077607|454477894|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
126323460|NCT03077607|454477893|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
126323461|NCT03077607|454477894|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
126323462|NCT02476916|454477895|FG000|Core Period|Adverse Event|2|||
126323463|NCT02476916|454477896|FG001|Core Period|Adverse Event|2|||
126323464|NCT02476916|454477895|FG000|Core Period|Investigator decision|1|||
126323465|NCT02476916|454477896|FG001|Core Period|Investigator decision|1|||
126323466|NCT02476916|454477895|FG000|Core Period|Withdrawal by Subject|3|||
126323467|NCT02476916|454477896|FG001|Core Period|Withdrawal by Subject|0|||
126323468|NCT02476916|454477895|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
126323469|NCT02476916|454477896|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
126323470|NCT02476916|454477895|FG000|Extension Period|On Treatment|12|||
126323471|NCT02476916|454477896|FG001|Extension Period|On Treatment|17|||
126323472|NCT06010732|454477897|FG000|Crossover Period 1|Protocol Violation|0|||
126323473|NCT06010732|454477898|FG001|Crossover Period 1|Protocol Violation|0|||
126323474|NCT06010732|454477899|FG002|Crossover Period 1|Protocol Violation|1|||
126323475|NCT06010732|454477900|FG003|Crossover Period 1|Protocol Violation|0|||
126323476|NCT06010732|454477901|FG004|Crossover Period 1|Protocol Violation|1|||
126323477|NCT06010732|454477902|FG005|Crossover Period 1|Protocol Violation|0|||
126323478|NCT06010732|454477897|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323479|NCT06010732|454477898|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
126323480|NCT06010732|454477899|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323481|NCT06010732|454477900|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323482|NCT06010732|454477901|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323483|NCT06010732|454477902|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323484|NCT06010732|454477897|FG000|Crossover Period 2|Adverse Event|0|||
126323485|NCT06010732|454477898|FG001|Crossover Period 2|Adverse Event|1|||
126323486|NCT06010732|454477899|FG002|Crossover Period 2|Adverse Event|0|||
126323487|NCT06010732|454477900|FG003|Crossover Period 2|Adverse Event|0|||
126323488|NCT06010732|454477901|FG004|Crossover Period 2|Adverse Event|0|||
126323489|NCT06010732|454477902|FG005|Crossover Period 2|Adverse Event|0|||
126323490|NCT06010732|454477897|FG000|Crossover Period 2|broken denture|0|||
126323491|NCT06010732|454477898|FG001|Crossover Period 2|broken denture|0|||
126323492|NCT06010732|454477899|FG002|Crossover Period 2|broken denture|1|||
126323493|NCT06010732|454477900|FG003|Crossover Period 2|broken denture|0|||
126323494|NCT06010732|454477901|FG004|Crossover Period 2|broken denture|0|||
126323495|NCT06010732|454477902|FG005|Crossover Period 2|broken denture|0|||
126323496|NCT04401202|454477903|FG000|Overall Study|Lost to Follow-up|2|||
126323497|NCT04401202|454477904|FG001|Overall Study|Lost to Follow-up|2|||
126323498|NCT04401202|454477903|FG000|Overall Study|Adverse Event|0|||
126323499|NCT04401202|454477904|FG001|Overall Study|Adverse Event|1|||
126323500|NCT04401202|454477903|FG000|Overall Study|Hospitalized|4|||
126323501|NCT04401202|454477904|FG001|Overall Study|Hospitalized|1|||
126323502|NCT03624569|454477908|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126323503|NCT03624569|454477909|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
126323504|NCT03624569|454477908|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
126323505|NCT03624569|454477909|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
126323506|NCT03004924|454477914|FG000|Overall Study|Adverse Event|6|||
126323507|NCT03004924|454477915|FG001|Overall Study|Adverse Event|5|||
126323508|NCT03004924|454477916|FG002|Overall Study|Adverse Event|10|||
126323509|NCT03004924|454477914|FG000|Overall Study|Protocol Violation|4|||
126323510|NCT03004924|454477915|FG001|Overall Study|Protocol Violation|0|||
125983826|NCT00696384|453230036|FG001|Open Label Phase|Protocol Violation|0|||
125983827|NCT00696384|453230037|FG002|Open Label Phase|Protocol Violation|0|||
125983828|NCT00696384|453230035|FG000|Open Label Phase|Lost to Follow-up|24|||
125983829|NCT00696384|453230036|FG001|Open Label Phase|Lost to Follow-up|0|||
126323511|NCT03004924|454477916|FG002|Overall Study|Protocol Violation|1|||
126323512|NCT03004924|454477914|FG000|Overall Study|Withdrawal by Subject|5|||
126323513|NCT03004924|454477915|FG001|Overall Study|Withdrawal by Subject|3|||
126323514|NCT03004924|454477916|FG002|Overall Study|Withdrawal by Subject|5|||
126323515|NCT03004924|454477914|FG000|Overall Study|Lost to Follow-up|6|||
126323516|NCT03004924|454477915|FG001|Overall Study|Lost to Follow-up|1|||
126323517|NCT03004924|454477916|FG002|Overall Study|Lost to Follow-up|4|||
126323518|NCT03004924|454477914|FG000|Overall Study|Lack of Efficacy|2|||
126323519|NCT03004924|454477915|FG001|Overall Study|Lack of Efficacy|4|||
126323520|NCT03004924|454477916|FG002|Overall Study|Lack of Efficacy|2|||
126323521|NCT03004924|454477914|FG000|Overall Study|Physician Decision|1|||
126323522|NCT03004924|454477915|FG001|Overall Study|Physician Decision|0|||
126323523|NCT03004924|454477916|FG002|Overall Study|Physician Decision|1|||
126323524|NCT03004924|454477914|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126323525|NCT03004924|454477915|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126323526|NCT03004924|454477916|FG002|Overall Study|Withdrawal by parent/guardian|2|||
126323527|NCT03004924|454477914|FG000|Overall Study|Screen Failure|1|||
126323528|NCT03004924|454477915|FG001|Overall Study|Screen Failure|0|||
126323529|NCT03004924|454477916|FG002|Overall Study|Screen Failure|0|||
125983830|NCT00696384|453230037|FG002|Open Label Phase|Lost to Follow-up|0|||
126323530|NCT03004924|454477914|FG000|Overall Study|Pregnancy|0|||
126323531|NCT03004924|454477915|FG001|Overall Study|Pregnancy|1|||
126323532|NCT03004924|454477916|FG002|Overall Study|Pregnancy|0|||
125983831|NCT00696384|453230035|FG000|Open Label Phase|Withdrawal by Subject|37|||
125983832|NCT00696384|453230036|FG001|Open Label Phase|Withdrawal by Subject|0|||
125983833|NCT00696384|453230037|FG002|Open Label Phase|Withdrawal by Subject|0|||
125983834|NCT00696384|453230035|FG000|Open Label Phase|Other|6|||
125983835|NCT00696384|453230036|FG001|Open Label Phase|Other|0|||
125983836|NCT00696384|453230037|FG002|Open Label Phase|Other|0|||
125983837|NCT00696384|453230035|FG000|Open Label Phase|Lack of Efficacy|3|||
125983838|NCT00696384|453230036|FG001|Open Label Phase|Lack of Efficacy|0|||
125983839|NCT00696384|453230037|FG002|Open Label Phase|Lack of Efficacy|0|||
125983840|NCT00696384|453230035|FG000|Open Label Phase|Physician Decision|4|||
125983841|NCT00696384|453230036|FG001|Open Label Phase|Physician Decision|0|||
125983842|NCT00696384|453230037|FG002|Open Label Phase|Physician Decision|0|||
125983843|NCT00696384|453230035|FG000|Double Blind Phase|Adverse Event|0|||
125983844|NCT00696384|453230036|FG001|Double Blind Phase|Adverse Event|2|||
125983845|NCT00696384|453230037|FG002|Double Blind Phase|Adverse Event|2|||
125983846|NCT00696384|453230035|FG000|Double Blind Phase|Lost to Follow-up|0|||
125983847|NCT00696384|453230036|FG001|Double Blind Phase|Lost to Follow-up|2|||
125983848|NCT00696384|453230037|FG002|Double Blind Phase|Lost to Follow-up|1|||
125983849|NCT00696384|453230035|FG000|Double Blind Phase|Withdrawal by Subject|0|||
125983850|NCT00696384|453230036|FG001|Double Blind Phase|Withdrawal by Subject|4|||
125983851|NCT00696384|453230037|FG002|Double Blind Phase|Withdrawal by Subject|3|||
125983852|NCT00696384|453230035|FG000|Double Blind Phase|Lack of Efficacy|0|||
125983853|NCT00696384|453230036|FG001|Double Blind Phase|Lack of Efficacy|1|||
125983854|NCT00696384|453230037|FG002|Double Blind Phase|Lack of Efficacy|0|||
125983855|NCT00696384|453230035|FG000|Double Blind Phase|Physician Decision|0|||
125983856|NCT00696384|453230036|FG001|Double Blind Phase|Physician Decision|2|||
125983857|NCT00696384|453230037|FG002|Double Blind Phase|Physician Decision|0|||
125983858|NCT04179721|453230044|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
125983859|NCT04179721|453230045|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
125983860|NCT04179721|453230044|FG000|Overall Study|Lost to Follow-up|0|||
125983861|NCT04179721|453230045|FG001|Overall Study|Lost to Follow-up|1|||
125983862|NCT03444376|453230048|FG000|Part A|Disease relapse or Progression|1|||
125983863|NCT03444376|453230048|FG000|Part A|Withdrawal by Subject|2|||
125983864|NCT03444376|453230048|FG000|Part A|Adverse Event|1|||
125983865|NCT03444376|453230048|FG000|Part B|Disease relapse or Progression|18|||
125983866|NCT03444376|453230048|FG000|Part B|Withdrawal by Subject|2|||
125983867|NCT03444376|453230048|FG000|Part B|Adverse Event|2|||
125983868|NCT03444376|453230048|FG000|Part B|Physician Decision|1|||
125983869|NCT03444376|453230048|FG000|Part C|Disease relapse or Progression|43|||
125983870|NCT03444376|453230048|FG000|Part C|Withdrawal by Subject|5|||
125983871|NCT03444376|453230048|FG000|Part C|Adverse Event|2|||
125983872|NCT03444376|453230048|FG000|Part C|Physician Decision|2|||
125983873|NCT03444376|453230048|FG000|Part C|Death|1|||
125983874|NCT01984697|453231353|FG000|Overall Study|Adverse Event|0|||
125983875|NCT01984697|453231354|FG001|Overall Study|Adverse Event|0|||
125983876|NCT01984697|453231355|FG002|Overall Study|Adverse Event|2|||
126323533|NCT03004924|454477914|FG000|Overall Study|Terminated by Sponsor|0|||
126323534|NCT03004924|454477915|FG001|Overall Study|Terminated by Sponsor|0|||
126323535|NCT03004924|454477916|FG002|Overall Study|Terminated by Sponsor|1|||
126323536|NCT03004924|454477914|FG000|Overall Study|Missed Study Visit|0|||
126323537|NCT03004924|454477915|FG001|Overall Study|Missed Study Visit|0|||
126323538|NCT03004924|454477916|FG002|Overall Study|Missed Study Visit|2|||
126323539|NCT03004924|454477914|FG000|Overall Study|HSV1 Positive|1|||
126323540|NCT03004924|454477915|FG001|Overall Study|HSV1 Positive|0|||
126323541|NCT03004924|454477916|FG002|Overall Study|HSV1 Positive|0|||
126323542|NCT00269477|454477917|FG000|Overall Study|Protocol Violation|5|||
126323543|NCT00269477|454477918|FG001|Overall Study|Protocol Violation|5|||
126323544|NCT00269477|454477919|FG002|Overall Study|Protocol Violation|1|||
126323545|NCT00269477|454477920|FG003|Overall Study|Protocol Violation|0|||
126323546|NCT00269477|454477917|FG000|Overall Study|Missed post-vaccination blood draw|0|||
126323547|NCT00269477|454477918|FG001|Overall Study|Missed post-vaccination blood draw|1|||
126323548|NCT00269477|454477919|FG002|Overall Study|Missed post-vaccination blood draw|0|||
126323549|NCT00269477|454477920|FG003|Overall Study|Missed post-vaccination blood draw|0|||
126323550|NCT01119846|454477921|FG000|Overall Study|Adverse Event|1|||
125983877|NCT01984697|453231356|FG003|Overall Study|Adverse Event|0|||
125983878|NCT01984697|453231357|FG004|Overall Study|Adverse Event|0|||
125983879|NCT01984697|453231353|FG000|Overall Study|Lost to Follow-up|14|||
125983880|NCT01984697|453231354|FG001|Overall Study|Lost to Follow-up|5|||
125983881|NCT01984697|453231355|FG002|Overall Study|Lost to Follow-up|10|||
125983882|NCT01984697|453231356|FG003|Overall Study|Lost to Follow-up|6|||
125983883|NCT01984697|453231357|FG004|Overall Study|Lost to Follow-up|21|||
125983884|NCT01984697|453231353|FG000|Overall Study|Physician Decision|3|||
125983885|NCT01984697|453231354|FG001|Overall Study|Physician Decision|0|||
125983886|NCT01984697|453231355|FG002|Overall Study|Physician Decision|0|||
125983887|NCT01984697|453231356|FG003|Overall Study|Physician Decision|1|||
125983888|NCT01984697|453231357|FG004|Overall Study|Physician Decision|0|||
125983889|NCT01984697|453231353|FG000|Overall Study|Protocol Violation|8|||
126323551|NCT01119846|454477922|FG001|Overall Study|Adverse Event|0|||
125983890|NCT01984697|453231354|FG001|Overall Study|Protocol Violation|5|||
125983891|NCT01984697|453231355|FG002|Overall Study|Protocol Violation|3|||
125983892|NCT01984697|453231356|FG003|Overall Study|Protocol Violation|2|||
125983893|NCT01984697|453231357|FG004|Overall Study|Protocol Violation|0|||
125983894|NCT01984697|453231353|FG000|Overall Study|Withdrawal by Subject|15|||
125983895|NCT01984697|453231354|FG001|Overall Study|Withdrawal by Subject|21|||
125983896|NCT01984697|453231355|FG002|Overall Study|Withdrawal by Subject|13|||
125983897|NCT01984697|453231356|FG003|Overall Study|Withdrawal by Subject|11|||
125983898|NCT01984697|453231357|FG004|Overall Study|Withdrawal by Subject|13|||
125983899|NCT01984697|453231353|FG000|Overall Study|Missed last follow-up visit|1|||
125983900|NCT01984697|453231354|FG001|Overall Study|Missed last follow-up visit|0|||
125983901|NCT01984697|453231355|FG002|Overall Study|Missed last follow-up visit|0|||
125983902|NCT01984697|453231356|FG003|Overall Study|Missed last follow-up visit|0|||
125983903|NCT01984697|453231357|FG004|Overall Study|Missed last follow-up visit|0|||
125983904|NCT01984697|453231353|FG000|Overall Study|Death|0|||
125983905|NCT01984697|453231354|FG001|Overall Study|Death|0|||
125983906|NCT01984697|453231355|FG002|Overall Study|Death|0|||
125983907|NCT01984697|453231356|FG003|Overall Study|Death|1|||
125983908|NCT01984697|453231357|FG004|Overall Study|Death|0|||
125983909|NCT01984697|453231353|FG000|Overall Study|Pregnancy|2|||
125983910|NCT01984697|453231354|FG001|Overall Study|Pregnancy|0|||
125983911|NCT01984697|453231355|FG002|Overall Study|Pregnancy|1|||
125983912|NCT01984697|453231356|FG003|Overall Study|Pregnancy|0|||
125983913|NCT01984697|453231357|FG004|Overall Study|Pregnancy|1|||
125983914|NCT03308825|453231358|FG000|Overall Study|Lost to Follow-up|2|||
125983915|NCT03308825|453231359|FG001|Overall Study|Lost to Follow-up|2|||
125983916|NCT03308825|453231360|FG002|Overall Study|Lost to Follow-up|1|||
125983917|NCT03308825|453231361|FG003|Overall Study|Lost to Follow-up|0|||
125983918|NCT03308825|453231358|FG000|Overall Study|Protocol Violation|0|||
125983919|NCT03308825|453231359|FG001|Overall Study|Protocol Violation|2|||
125983920|NCT03308825|453231360|FG002|Overall Study|Protocol Violation|0|||
125983921|NCT03308825|453231361|FG003|Overall Study|Protocol Violation|0|||
125983922|NCT04737109|453231362|FG000|Study Treatment|Disease Progression|5|||
125983923|NCT04737109|453231363|FG001|Study Treatment|Disease Progression|0|||
125983924|NCT04737109|453231364|FG002|Study Treatment|Disease Progression|0|||
125983925|NCT04737109|453231365|FG003|Study Treatment|Disease Progression|0|||
125983926|NCT04737109|453231362|FG000|Study Treatment|Death on study|1|||
125983927|NCT04737109|453231363|FG001|Study Treatment|Death on study|0|||
125983928|NCT04737109|453231364|FG002|Study Treatment|Death on study|0|||
125983929|NCT04737109|453231365|FG003|Study Treatment|Death on study|0|||
125983930|NCT02259517|453231369|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
125983931|NCT02259517|453231370|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
125983932|NCT02259517|453231371|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
125983933|NCT02259517|453231369|FG000|Overall Study|Withdrawal by Subject|0|||
125983934|NCT02259517|453231370|FG001|Overall Study|Withdrawal by Subject|0|||
125983935|NCT02259517|453231371|FG002|Overall Study|Withdrawal by Subject|3|||
125983936|NCT01289418|453231372|FG000|Day 8 Survey|email address invalid|283|||
125983937|NCT01289418|453231372|FG000|Day 8 Survey|participants did not complete the survey|1935|||
125983938|NCT01289418|453231372|FG000|Day 29 Survey|email address invalid|283|||
125983939|NCT01289418|453231372|FG000|Day 29 Survey|participants did not complete the survey|2185|||
125983940|NCT01352585|453231373|FG000|Overall Study|Adverse Event|2|||
125983941|NCT01352585|453231374|FG001|Overall Study|Adverse Event|1|||
125983942|NCT01352585|453231373|FG000|Overall Study|Lost to Follow-up|1|||
125983943|NCT01352585|453231374|FG001|Overall Study|Lost to Follow-up|0|||
125983944|NCT01352585|453231373|FG000|Overall Study|Other|5|||
125983945|NCT01352585|453231374|FG001|Overall Study|Other|2|||
125983946|NCT02276066|453231379|FG000|Overall Study|Lost to Follow-up|21|||
125983947|NCT02276066|453231380|FG001|Overall Study|Lost to Follow-up|11|||
125983948|NCT05050578|453231381|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
125983949|NCT05050578|453231382|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
125983950|NCT05050578|453231381|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
125983951|NCT05050578|453231382|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
125983952|NCT05050578|453231381|FG000|Period 2, 30 Days|Protocol Violation|0|||
126323552|NCT01119846|454477923|FG002|Overall Study|Adverse Event|6|||
125983953|NCT05050578|453231382|FG001|Period 2, 30 Days|Protocol Violation|1|||
125983954|NCT03386032|453231389|FG000|Overall Study|Lack of Efficacy|6|||
125983955|NCT03386032|453231390|FG001|Overall Study|Lack of Efficacy|2|||
125983956|NCT03386032|453231391|FG002|Overall Study|Lack of Efficacy|0|||
125983957|NCT03386032|453231389|FG000|Overall Study|Adverse Event|2|||
125983958|NCT03386032|453231390|FG001|Overall Study|Adverse Event|2|||
125983959|NCT03386032|453231391|FG002|Overall Study|Adverse Event|0|||
125983960|NCT03386032|453231389|FG000|Overall Study|Withdrawal by Subject|1|||
126090987|NCT03525392|453626875|FG001|Overall Study|Adverse Event|0|||
125983961|NCT03386032|453231390|FG001|Overall Study|Withdrawal by Subject|0|||
125983962|NCT03386032|453231391|FG002|Overall Study|Withdrawal by Subject|0|||
125983963|NCT03386032|453231389|FG000|Overall Study|Lost to Follow-up|9|||
125983964|NCT03386032|453231390|FG001|Overall Study|Lost to Follow-up|3|||
125983965|NCT03386032|453231391|FG002|Overall Study|Lost to Follow-up|0|||
125983966|NCT02901626|453231404|FG000|Overall Study|Lost to Follow-up|1|||
126323553|NCT01119846|454477921|FG000|Overall Study|Physician Decision|1|||
126323554|NCT01119846|454477922|FG001|Overall Study|Physician Decision|0|||
126323555|NCT01119846|454477923|FG002|Overall Study|Physician Decision|0|||
126323556|NCT01119846|454477921|FG000|Overall Study|Protocol Violation|0|||
126323557|NCT01119846|454477922|FG001|Overall Study|Protocol Violation|0|||
126323558|NCT01119846|454477923|FG002|Overall Study|Protocol Violation|1|||
126323559|NCT01119846|454477921|FG000|Overall Study|Withdrawal by Subject|0|||
126323560|NCT01119846|454477922|FG001|Overall Study|Withdrawal by Subject|0|||
126323561|NCT01119846|454477923|FG002|Overall Study|Withdrawal by Subject|4|||
126323562|NCT01370616|454477927|FG000|Overall Study|Adverse Event|11|||
126323563|NCT01370616|454477928|FG001|Overall Study|Adverse Event|16|||
126323564|NCT01370616|454477927|FG000|Overall Study|Death|1|||
125983967|NCT02901626|453231405|FG001|Overall Study|Lost to Follow-up|1|||
125983968|NCT00331344|453231406|FG000|Phase I|Adverse Event|0|||
125983969|NCT00331344|453231407|FG001|Phase I|Adverse Event|0|||
125983970|NCT00331344|453231408|FG002|Phase I|Adverse Event|0|||
125983971|NCT00331344|453231409|FG003|Phase I|Adverse Event|1|||
125983972|NCT00331344|453231410|FG004|Phase I|Adverse Event|2|||
126323565|NCT01370616|454477928|FG001|Overall Study|Death|0|||
126323566|NCT01370616|454477927|FG000|Overall Study|Lack of Efficacy|6|||
126323567|NCT01370616|454477928|FG001|Overall Study|Lack of Efficacy|2|||
126323568|NCT01370616|454477927|FG000|Overall Study|Lost to Follow-up|0|||
126323569|NCT01370616|454477928|FG001|Overall Study|Lost to Follow-up|3|||
126323570|NCT01370616|454477927|FG000|Overall Study|Physician Decision|6|||
126323571|NCT01370616|454477928|FG001|Overall Study|Physician Decision|6|||
126323572|NCT01370616|454477927|FG000|Overall Study|Progressive Disease|0|||
126323573|NCT01370616|454477928|FG001|Overall Study|Progressive Disease|1|||
126323574|NCT01370616|454477927|FG000|Overall Study|Recovery|1|||
125983973|NCT00331344|453231411|FG005|Phase I|Adverse Event|2|||
125983974|NCT00331344|453231412|FG006|Phase I|Adverse Event|0|||
125983975|NCT00331344|453231413|FG007|Phase I|Adverse Event|1|||
125983976|NCT00331344|453231414|FG008|Phase I|Adverse Event|0|||
125983977|NCT00331344|453231406|FG000|Phase II|Death|0|||
125983978|NCT00331344|453231407|FG001|Phase II|Death|0|||
125983979|NCT00331344|453231408|FG002|Phase II|Death|0|||
125983980|NCT00331344|453231409|FG003|Phase II|Death|0|||
125983981|NCT00331344|453231410|FG004|Phase II|Death|0|||
125983982|NCT00331344|453231411|FG005|Phase II|Death|0|||
125983983|NCT00331344|453231412|FG006|Phase II|Death|0|||
125983984|NCT00331344|453231413|FG007|Phase II|Death|0|||
125983985|NCT00331344|453231414|FG008|Phase II|Death|4|||
125983986|NCT01373931|453231417|FG000|Lead-in Period|Adverse Event|2|||
125983987|NCT01373931|453231418|FG001|Lead-in Period|Adverse Event|0|||
125983988|NCT01373931|453231417|FG000|Period 1|Adverse Event|2|||
125983989|NCT01373931|453231418|FG001|Period 1|Adverse Event|0|||
125983990|NCT01373931|453231417|FG000|Period 1|Withdrawal by Subject|0|||
125983991|NCT01373931|453231418|FG001|Period 1|Withdrawal by Subject|2|||
125983992|NCT02940574|453231419|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
125983993|NCT02940574|453231420|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
125983994|NCT02940574|453231419|FG000|1-year Follow-up|Lost to Follow-up|3|||
125983995|NCT02940574|453231420|FG001|1-year Follow-up|Lost to Follow-up|4|||
125983996|NCT00387894|453231421|FG000|Overall Study|Withdrawal by Subject|1|||
125983997|NCT00261495|453231422|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
125983998|NCT00261495|453231423|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
125983999|NCT00261495|453231422|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
125984000|NCT00261495|453231423|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
126323575|NCT01370616|454477928|FG001|Overall Study|Recovery|0|||
126323576|NCT01370616|454477927|FG000|Overall Study|Technical Problems|3|||
126323577|NCT01370616|454477928|FG001|Overall Study|Technical Problems|5|||
126323578|NCT01370616|454477927|FG000|Overall Study|Withdrawal by Subject|34|||
126323579|NCT01370616|454477928|FG001|Overall Study|Withdrawal by Subject|34|||
126323580|NCT02324699|454477929|FG000|Overall Study|study terminated|1|||
126323581|NCT01605825|454477934|FG000|Overall Study|Adverse Event|4|||
126323582|NCT01605825|454477935|FG001|Overall Study|Adverse Event|2|||
126323583|NCT01605825|454477934|FG000|Overall Study|Withdrawal by Subject|0|||
125984001|NCT00261495|453231422|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
125984002|NCT00261495|453231423|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
125984003|NCT00261495|453231422|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
125984004|NCT00261495|453231423|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
125984005|NCT00261495|453231422|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
125984006|NCT00261495|453231423|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
125984007|NCT00261495|453231422|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
126323584|NCT01605825|454477935|FG001|Overall Study|Withdrawal by Subject|1|||
126323585|NCT01605825|454477934|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
126323586|NCT01605825|454477935|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
126323587|NCT01605825|454477934|FG000|Overall Study|Non-Compliance with Protocol|3|||
126323588|NCT01605825|454477935|FG001|Overall Study|Non-Compliance with Protocol|0|||
125984008|NCT00261495|453231423|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
126323589|NCT02670382|454477942|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
125984009|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
125984010|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
125984011|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
125984012|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
125984013|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
125984014|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
125984015|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
125984016|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
125984017|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
125984018|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
125984019|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
125984020|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
125984021|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
125984022|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
125984023|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
125984024|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
125984025|NCT00261495|453231422|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
125984026|NCT00261495|453231423|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
125984027|NCT00261495|453231422|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
125984028|NCT00261495|453231423|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
125984029|NCT00261495|453231422|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
125984030|NCT00261495|453231423|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125984031|NCT00261495|453231422|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
125984032|NCT00261495|453231423|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
125984033|NCT00261495|453231422|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125984034|NCT00261495|453231423|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
125984035|NCT00261495|453231422|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
125984036|NCT00261495|453231423|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
125984037|NCT00261495|453231422|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
125984038|NCT00261495|453231423|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125984039|NCT00642902|453231424|FG000|Overall Study|Adverse Event|0|||
125984040|NCT00642902|453231425|FG001|Overall Study|Adverse Event|1|||
125984041|NCT00642902|453231426|FG002|Overall Study|Adverse Event|3|||
125984042|NCT00642902|453231427|FG003|Overall Study|Adverse Event|1|||
125984043|NCT00642902|453231424|FG000|Overall Study|Lost to Follow-up|1|||
125984044|NCT00642902|453231425|FG001|Overall Study|Lost to Follow-up|1|||
125984045|NCT00642902|453231426|FG002|Overall Study|Lost to Follow-up|0|||
125984046|NCT00642902|453231427|FG003|Overall Study|Lost to Follow-up|0|||
125984047|NCT00642902|453231424|FG000|Overall Study|Lack of Efficacy|0|||
125984048|NCT00642902|453231425|FG001|Overall Study|Lack of Efficacy|3|||
125984049|NCT00642902|453231426|FG002|Overall Study|Lack of Efficacy|3|||
125984050|NCT00642902|453231427|FG003|Overall Study|Lack of Efficacy|0|||
125984051|NCT00642902|453231424|FG000|Overall Study|Death|1|||
125984052|NCT00642902|453231425|FG001|Overall Study|Death|0|||
125984053|NCT00642902|453231426|FG002|Overall Study|Death|0|||
125984054|NCT00642902|453231427|FG003|Overall Study|Death|0|||
125984055|NCT00642902|453231424|FG000|Overall Study|Premature termination of clinical trial|37|||
125984056|NCT00642902|453231425|FG001|Overall Study|Premature termination of clinical trial|32|||
125984057|NCT00642902|453231426|FG002|Overall Study|Premature termination of clinical trial|35|||
125984058|NCT00642902|453231427|FG003|Overall Study|Premature termination of clinical trial|35|||
125984059|NCT00642902|453231424|FG000|Overall Study|Randomized, but not treated|0|||
125984060|NCT00642902|453231425|FG001|Overall Study|Randomized, but not treated|0|||
125984061|NCT00642902|453231426|FG002|Overall Study|Randomized, but not treated|1|||
125984062|NCT00642902|453231427|FG003|Overall Study|Randomized, but not treated|0|||
125984063|NCT00642902|453231424|FG000|Overall Study|Other|1|||
125984064|NCT00642902|453231425|FG001|Overall Study|Other|5|||
125984065|NCT00642902|453231426|FG002|Overall Study|Other|1|||
125984066|NCT00642902|453231427|FG003|Overall Study|Other|4|||
125984067|NCT03953898|453231428|FG000|Overall Study|Lack of Efficacy|8|||
125984068|NCT03953898|453231428|FG000|Overall Study|Death|3|||
125984069|NCT03953898|453231428|FG000|Overall Study|Withdrawal by Subject|2|||
125984070|NCT03953898|453231428|FG000|Overall Study|Adverse Event|1|||
125984071|NCT01932697|453231429|FG000|Overall Study|Received a different amount of tx|1|||
125984072|NCT01932697|453231430|FG001|Overall Study|Received a different amount of tx|0|||
125984073|NCT01932697|453231429|FG000|Overall Study|Ineligible|1|||
125984074|NCT01932697|453231430|FG001|Overall Study|Ineligible|0|||
125984075|NCT01538472|453231431|FG000|Overall Study|Disease Progression|3|||
125984076|NCT01538472|453231431|FG000|Overall Study|Death|1|||
125984077|NCT05479604|453231432|FG000|Overall Study|Lost to Follow-up|1|||
125984078|NCT05479604|453231433|FG001|Overall Study|Lost to Follow-up|5|||
125984079|NCT03759834|453231438|FG000|Overall Study|Withdrawal by Subject|1|||
125984080|NCT05701995|453231439|FG000|Pre-Treatment|Randomization Error|1|||
125984081|NCT05701995|453231440|FG001|Pre-Treatment|Randomization Error|1|||
125984082|NCT05701995|453231439|FG000|Treatment|Withdrawal by Subject|8|||
125984083|NCT05701995|453231440|FG001|Treatment|Withdrawal by Subject|4|||
125984084|NCT05701995|453231439|FG000|Treatment|Lost to Follow-up|2|||
125984085|NCT05701995|453231440|FG001|Treatment|Lost to Follow-up|3|||
125984086|NCT05701995|453231439|FG000|Treatment|Adverse Event|3|||
125984087|NCT05701995|453231440|FG001|Treatment|Adverse Event|1|||
125984088|NCT05701995|453231439|FG000|Treatment|Other Reason|1|||
125984089|NCT05701995|453231440|FG001|Treatment|Other Reason|1|||
125984090|NCT05701995|453231439|FG000|Treatment|Death|1|||
126323590|NCT02670382|454477943|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
126323591|NCT03244618|454477944|FG000|Overall Study|Lost to Follow-up|3|||
126323592|NCT03244618|454477945|FG001|Overall Study|Lost to Follow-up|4|||
126323593|NCT03244618|454477944|FG000|Overall Study|Protocol Violation|4|||
126323594|NCT03244618|454477945|FG001|Overall Study|Protocol Violation|3|||
125984091|NCT05701995|453231440|FG001|Treatment|Death|0|||
125984092|NCT05701995|453231439|FG000|Treatment|Physician Decision|0|||
125984093|NCT05701995|453231440|FG001|Treatment|Physician Decision|1|||
125984094|NCT04987762|453231444|FG000|Overall Study|Study was Terminated by Sponsor|103|||
125984095|NCT04803214|453231447|FG000|Overall Study|Adverse Event|1|||
125984096|NCT04803214|453231448|FG001|Overall Study|Adverse Event|0|||
125984097|NCT04803214|453231447|FG000|Overall Study|Withdrawal by Subject|1|||
125984098|NCT04803214|453231448|FG001|Overall Study|Withdrawal by Subject|2|||
125984099|NCT04803214|453231447|FG000|Overall Study|Lost to Follow-up|2|||
125984100|NCT04803214|453231448|FG001|Overall Study|Lost to Follow-up|4|||
125984101|NCT04803214|453231447|FG000|Overall Study|Physician Decision|1|||
125984102|NCT04803214|453231448|FG001|Overall Study|Physician Decision|1|||
125984103|NCT04803214|453231447|FG000|Overall Study|Missed 12 month visit|0|||
125984104|NCT04803214|453231448|FG001|Overall Study|Missed 12 month visit|3|||
125984105|NCT00504426|453231449|FG000|Overall Study|Adverse Event|0|||
125984106|NCT00504426|453231450|FG001|Overall Study|Adverse Event|0|||
125984107|NCT00504426|453231451|FG002|Overall Study|Adverse Event|2|||
125984108|NCT00504426|453231452|FG003|Overall Study|Adverse Event|0|||
125984109|NCT00504426|453231449|FG000|Overall Study|Protocol Violation|1|||
125984110|NCT00504426|453231450|FG001|Overall Study|Protocol Violation|1|||
125984111|NCT00504426|453231451|FG002|Overall Study|Protocol Violation|2|||
125984112|NCT00504426|453231452|FG003|Overall Study|Protocol Violation|0|||
125984113|NCT00504426|453231449|FG000|Overall Study|Withdrawal by Subject|2|||
125984114|NCT00504426|453231450|FG001|Overall Study|Withdrawal by Subject|0|||
125984115|NCT00504426|453231451|FG002|Overall Study|Withdrawal by Subject|0|||
125984116|NCT00504426|453231452|FG003|Overall Study|Withdrawal by Subject|0|||
125984117|NCT03988166|453231453|FG000|Overall Study|Lost to Follow-up|2|||
125984118|NCT03988166|453231453|FG000|Overall Study|Death|1|||
125984119|NCT03248375|453231454|FG000|Overall Study|Lost to Follow-up|5|||
126323595|NCT03244618|454477944|FG000|Overall Study|Withdrawal by Subject|0|||
125984120|NCT04992546|453231455|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
125984121|NCT04992546|453231455|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
125984122|NCT04992546|453231455|FG000|Open-Label Treatment Period|Adverse Event|3|||
125984123|NCT04992546|453231455|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
125984124|NCT00633464|453231457|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
125984125|NCT00633464|453231458|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
125984126|NCT00633464|453231457|FG000|Overall Study|Never Treated (Randomized in error)|0|||
125984127|NCT00633464|453231458|FG001|Overall Study|Never Treated (Randomized in error)|1|||
126323596|NCT03244618|454477945|FG001|Overall Study|Withdrawal by Subject|2|||
126323597|NCT03469999|454477948|FG000|Overall Study|Lost to Follow-up|2|||
126323598|NCT00394771|454477949|FG000|Overall Study|Did not meet protocol requirements|1|||
126323599|NCT00394771|454477950|FG001|Overall Study|Did not meet protocol requirements|0|||
126323600|NCT00394771|454477951|FG002|Overall Study|Did not meet protocol requirements|2|||
126323601|NCT00394771|454477952|FG003|Overall Study|Did not meet protocol requirements|0|||
126323602|NCT00394771|454477949|FG000|Overall Study|Protocol Violation|2|||
126323603|NCT00394771|454477950|FG001|Overall Study|Protocol Violation|4|||
126323604|NCT00394771|454477951|FG002|Overall Study|Protocol Violation|9|||
126323605|NCT00394771|454477952|FG003|Overall Study|Protocol Violation|7|||
126323606|NCT00394771|454477949|FG000|Overall Study|Withdrawal by Subject|10|||
126323607|NCT00394771|454477950|FG001|Overall Study|Withdrawal by Subject|6|||
126323608|NCT00394771|454477951|FG002|Overall Study|Withdrawal by Subject|8|||
126323609|NCT00394771|454477952|FG003|Overall Study|Withdrawal by Subject|12|||
126323610|NCT00394771|454477949|FG000|Overall Study|Adverse Event|10|||
125984128|NCT00542880|453231461|FG000|Period 1|Eligibility criteria not fulfilled|2|||
126323611|NCT00394771|454477950|FG001|Overall Study|Adverse Event|5|||
126323612|NCT00394771|454477951|FG002|Overall Study|Adverse Event|12|||
126323613|NCT00394771|454477952|FG003|Overall Study|Adverse Event|8|||
126323614|NCT00394771|454477949|FG000|Overall Study|Participant pregnant|0|||
126323615|NCT00394771|454477950|FG001|Overall Study|Participant pregnant|1|||
126323616|NCT00394771|454477951|FG002|Overall Study|Participant pregnant|2|||
125984129|NCT00542880|453231462|FG001|Period 1|Eligibility criteria not fulfilled|6|||
125984130|NCT00542880|453231461|FG000|Period 1|Adverse Event|2|||
125984131|NCT00542880|453231462|FG001|Period 1|Adverse Event|2|||
125984132|NCT00542880|453231461|FG000|Period 1|Development of study-specific criteria|1|||
125984133|NCT00542880|453231462|FG001|Period 1|Development of study-specific criteria|2|||
125984134|NCT00542880|453231461|FG000|Period 1|Withdrawal by Subject|1|||
125984135|NCT00542880|453231462|FG001|Period 1|Withdrawal by Subject|1|||
125984136|NCT00542880|453231461|FG000|Period 1|Protocol Violation|0|||
125984137|NCT00542880|453231462|FG001|Period 1|Protocol Violation|1|||
125984138|NCT00542880|453231461|FG000|Period 2|Adverse Event|5|||
125984139|NCT00542880|453231462|FG001|Period 2|Adverse Event|7|||
125984140|NCT00542880|453231461|FG000|Period 2|Eligibility not fulfilled|0|||
125984141|NCT00542880|453231462|FG001|Period 2|Eligibility not fulfilled|1|||
125984142|NCT00542880|453231461|FG000|Period 2|Discontinuation criteria|2|||
125984143|NCT00542880|453231462|FG001|Period 2|Discontinuation criteria|0|||
125984144|NCT00542880|453231461|FG000|Period 2|Severe non-compliance|0|||
125984145|NCT00542880|453231462|FG001|Period 2|Severe non-compliance|1|||
125984146|NCT00542880|453231461|FG000|Period 2|Other|0|||
125984147|NCT00542880|453231462|FG001|Period 2|Other|1|||
125984148|NCT00542880|453231461|FG000|Period 3|Adverse Event|0|||
125984149|NCT00542880|453231462|FG001|Period 3|Adverse Event|2|||
125984150|NCT01678131|453231463|FG000|Overall Study|Adverse Event|0|||
125984151|NCT01678131|453231464|FG001|Overall Study|Adverse Event|1|||
125984152|NCT01678131|453231465|FG002|Overall Study|Adverse Event|0|||
125984153|NCT01678131|453231463|FG000|Overall Study|Withdrawal by Subject|0|||
125984154|NCT01678131|453231464|FG001|Overall Study|Withdrawal by Subject|0|||
125984155|NCT01678131|453231465|FG002|Overall Study|Withdrawal by Subject|2|||
125984156|NCT00941798|453231466|FG000|Overall Study|Withdrawal by Subject|72|||
125984157|NCT00941798|453231467|FG001|Overall Study|Withdrawal by Subject|74|||
125984158|NCT00941798|453231466|FG000|Overall Study|Adverse Event|43|||
125984159|NCT00941798|453231467|FG001|Overall Study|Adverse Event|23|||
125984160|NCT00941798|453231466|FG000|Overall Study|Lost to Follow-up|29|||
125984161|NCT00941798|453231467|FG001|Overall Study|Lost to Follow-up|23|||
125984162|NCT00941798|453231466|FG000|Overall Study|Protocol Violation|17|||
125984163|NCT00941798|453231467|FG001|Overall Study|Protocol Violation|20|||
125984164|NCT00941798|453231466|FG000|Overall Study|Administrative problems|13|||
125984165|NCT00941798|453231467|FG001|Overall Study|Administrative problems|23|||
125984166|NCT00941798|453231466|FG000|Overall Study|Lack of Efficacy|10|||
125984167|NCT00941798|453231467|FG001|Overall Study|Lack of Efficacy|17|||
125984168|NCT00941798|453231466|FG000|Overall Study|Patient's inability to use device|6|||
125984169|NCT00941798|453231467|FG001|Overall Study|Patient's inability to use device|1|||
125984170|NCT00941798|453231466|FG000|Overall Study|Abnormal test procedure results|3|||
125984171|NCT00941798|453231467|FG001|Overall Study|Abnormal test procedure results|1|||
125984172|NCT00941798|453231466|FG000|Overall Study|Abnormal laboratory values|1|||
125984173|NCT00941798|453231467|FG001|Overall Study|Abnormal laboratory values|2|||
125984174|NCT00941798|453231466|FG000|Overall Study|Death|0|||
125984175|NCT00941798|453231467|FG001|Overall Study|Death|1|||
125984176|NCT00112580|453231468|FG000|Overall Study|Adverse Event|1|||
125984177|NCT00112580|453231469|FG001|Overall Study|Adverse Event|2|||
125984178|NCT00112580|453231468|FG000|Overall Study|Disease progression|5|||
125984179|NCT00112580|453231469|FG001|Overall Study|Disease progression|16|||
125984180|NCT00112580|453231468|FG000|Overall Study|Participant withdrew consent|2|||
125984181|NCT00112580|453231469|FG001|Overall Study|Participant withdrew consent|1|||
125984182|NCT05597722|453231470|FG000|Overall Study|Study was terminated|6|||
125984183|NCT05597722|453231471|FG001|Overall Study|Study was terminated|1|||
125984184|NCT04108000|453231472|FG000|Overall Study|Death of patient|1|||
125984185|NCT04108000|453231473|FG001|Overall Study|Death of patient|0|||
125984186|NCT04108000|453231474|FG002|Overall Study|Death of patient|1|||
125984187|NCT04108000|453231475|FG003|Overall Study|Death of patient|0|||
125984188|NCT04108000|453231472|FG000|Overall Study|Withdrawal by Subject|2|||
125984189|NCT04108000|453231473|FG001|Overall Study|Withdrawal by Subject|2|||
125984190|NCT04108000|453231474|FG002|Overall Study|Withdrawal by Subject|0|||
125984191|NCT04108000|453231475|FG003|Overall Study|Withdrawal by Subject|0|||
125984192|NCT04108000|453231472|FG000|Overall Study|Death of surrogate partner|0|||
125984193|NCT04108000|453231473|FG001|Overall Study|Death of surrogate partner|1|||
125984194|NCT04108000|453231474|FG002|Overall Study|Death of surrogate partner|0|||
125984195|NCT04108000|453231475|FG003|Overall Study|Death of surrogate partner|1|||
125984196|NCT05619003|453231477|FG000|Overall Study|Adverse Event|1|||
125984197|NCT00685945|453233409|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
125984198|NCT03183388|453233410|FG000|Overall Study|Lost to Follow-up|3|||
125984199|NCT03183388|453233411|FG001|Overall Study|Lost to Follow-up|5|||
125984200|NCT03183388|453233410|FG000|Overall Study|Physician Decision|1|||
125984201|NCT03183388|453233411|FG001|Overall Study|Physician Decision|4|||
125984202|NCT03183388|453233410|FG000|Overall Study|Withdrawal by Subject|4|||
125984203|NCT03183388|453233411|FG001|Overall Study|Withdrawal by Subject|1|||
125984204|NCT03183388|453233410|FG000|Overall Study|Moved|1|||
125984205|NCT03183388|453233411|FG001|Overall Study|Moved|0|||
125984206|NCT03183388|453233410|FG000|Overall Study|Met Exclusion Criteria|2|||
125984207|NCT03183388|453233411|FG001|Overall Study|Met Exclusion Criteria|2|||
125984208|NCT03183388|453233410|FG000|Overall Study|COVID Pandemic Related|2|||
125984209|NCT03183388|453233411|FG001|Overall Study|COVID Pandemic Related|4|||
125984210|NCT00847405|453233412|FG000|First Intervention|Adverse Event|0|||
125984211|NCT00847405|453233413|FG001|First Intervention|Adverse Event|1|||
125984212|NCT00847405|453233412|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125984213|NCT00847405|453233413|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125984214|NCT01728792|453233414|FG000|Overall Study|Withdrawal of Consent|1|||
125984215|NCT01728792|453233415|FG001|Overall Study|Withdrawal of Consent|1|||
125984216|NCT01728792|453233416|FG002|Overall Study|Withdrawal of Consent|0|||
125984217|NCT01728792|453233417|FG003|Overall Study|Withdrawal of Consent|1|||
125984218|NCT01728792|453233418|FG004|Overall Study|Withdrawal of Consent|0|||
125984219|NCT01728792|453233414|FG000|Overall Study|Lost to Follow-up|2|||
125984220|NCT01728792|453233415|FG001|Overall Study|Lost to Follow-up|1|||
125984221|NCT01728792|453233416|FG002|Overall Study|Lost to Follow-up|4|||
125984222|NCT01728792|453233417|FG003|Overall Study|Lost to Follow-up|2|||
125984223|NCT01728792|453233418|FG004|Overall Study|Lost to Follow-up|0|||
125984224|NCT04277455|453233421|FG000|Overall Study|Lost to Follow-up|1|||
125984225|NCT00949715|453233422|FG000|Overall Study|Physician Decision|1|||
125984226|NCT00949715|453233423|FG001|Overall Study|Physician Decision|0|||
125984227|NCT00949715|453233422|FG000|Overall Study|Lost to Follow-up|1|||
125984228|NCT00949715|453233423|FG001|Overall Study|Lost to Follow-up|0|||
125984229|NCT00949715|453233422|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
125984230|NCT00949715|453233423|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
125984231|NCT03928028|453233425|FG000|Overall Study|Physician Decision|9|||
125984232|NCT03928028|453233426|FG001|Overall Study|Physician Decision|6|||
125984233|NCT03928028|453233427|FG002|Overall Study|Physician Decision|3|||
125984234|NCT03928028|453233425|FG000|Overall Study|Withdrawal by Subject|12|||
125984235|NCT03928028|453233426|FG001|Overall Study|Withdrawal by Subject|3|||
125984236|NCT03928028|453233427|FG002|Overall Study|Withdrawal by Subject|3|||
125984237|NCT02710292|453233432|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
125984238|NCT02710292|453233433|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
125984239|NCT02710292|453233432|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
125984240|NCT02710292|453233433|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
125984241|NCT04525547|453233434|FG000|Overall Study|Not treated with Ofev|2|||
125984242|NCT04525547|453233434|FG000|Overall Study|Off-label use|2|||
125984243|NCT04525547|453233434|FG000|Overall Study|Lost to Follow-up|1|||
125984244|NCT00800202|453233435|FG000|Overall Study|Adverse Event|7|||
125984245|NCT00800202|453233436|FG001|Overall Study|Adverse Event|6|||
125984246|NCT00800202|453233435|FG000|Overall Study|Death|1|||
125984247|NCT00800202|453233436|FG001|Overall Study|Death|0|||
125984248|NCT00800202|453233435|FG000|Overall Study|Other|5|||
125984249|NCT00800202|453233436|FG001|Overall Study|Other|0|||
125984250|NCT00800202|453233435|FG000|Overall Study|Disease Progression|54|||
125984251|NCT00800202|453233436|FG001|Overall Study|Disease Progression|18|||
125984252|NCT04425902|453233437|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
125984253|NCT04669600|453233443|FG000|Overall Study|Withdrawal by Subject|1|||
125984254|NCT04669600|453233443|FG000|Overall Study|Other|6|||
125984255|NCT00710606|453233446|FG000|Overall Study|Adverse Event|0|||
125984256|NCT00710606|453233447|FG001|Overall Study|Adverse Event|2|||
125984257|NCT00514683|453233448|FG000|Overall Study|Not treated|2|||
125984258|NCT00514683|453233449|FG001|Overall Study|Not treated|1|||
125984259|NCT00514683|453233450|FG002|Overall Study|Not treated|0|||
125984260|NCT00514683|453233451|FG003|Overall Study|Not treated|0|||
125984261|NCT00514683|453233452|FG004|Overall Study|Not treated|1|||
125984262|NCT00514683|453233448|FG000|Overall Study|Adverse Event|21|||
125984263|NCT00514683|453233449|FG001|Overall Study|Adverse Event|20|||
125984264|NCT00514683|453233450|FG002|Overall Study|Adverse Event|15|||
125984265|NCT00514683|453233451|FG003|Overall Study|Adverse Event|13|||
125984266|NCT00514683|453233452|FG004|Overall Study|Adverse Event|27|||
125984267|NCT00514683|453233448|FG000|Overall Study|Protocol Violation|1|||
125984268|NCT00514683|453233449|FG001|Overall Study|Protocol Violation|1|||
125984269|NCT00514683|453233450|FG002|Overall Study|Protocol Violation|0|||
125984270|NCT00514683|453233451|FG003|Overall Study|Protocol Violation|1|||
125984271|NCT00514683|453233452|FG004|Overall Study|Protocol Violation|0|||
125984272|NCT00514683|453233448|FG000|Overall Study|Withdrawal by Subject|2|||
125984273|NCT00514683|453233449|FG001|Overall Study|Withdrawal by Subject|2|||
125984274|NCT00514683|453233450|FG002|Overall Study|Withdrawal by Subject|1|||
125984275|NCT00514683|453233451|FG003|Overall Study|Withdrawal by Subject|0|||
125984276|NCT00514683|453233452|FG004|Overall Study|Withdrawal by Subject|4|||
125984277|NCT00514683|453233448|FG000|Overall Study|Reason other than listed above|0|||
125984278|NCT00514683|453233449|FG001|Overall Study|Reason other than listed above|1|||
125984279|NCT00514683|453233450|FG002|Overall Study|Reason other than listed above|2|||
125984280|NCT00514683|453233451|FG003|Overall Study|Reason other than listed above|0|||
125984281|NCT00514683|453233452|FG004|Overall Study|Reason other than listed above|1|||
125984282|NCT02736825|453233453|FG000|Overall Study|Lost to Follow-up|10|||
125984283|NCT02736825|453233454|FG001|Overall Study|Lost to Follow-up|11|||
125984284|NCT02736825|453233453|FG000|Overall Study|Early Termination|0|||
125984285|NCT02736825|453233454|FG001|Overall Study|Early Termination|1|||
125984286|NCT00790452|453233455|FG000|Overall Study|Drug supply issue|1|||
125984287|NCT00790452|453233456|FG001|Overall Study|Drug supply issue|0|||
125984288|NCT01564368|453233457|FG000|Overall Study|Ineligible|18|||
125984289|NCT01564368|453233457|FG000|Overall Study|Not Randomized in Parent study|116|||
125984290|NCT01564368|453233457|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
125984291|NCT01564368|453233457|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
125984292|NCT04082884|453233458|FG000|Overall Study|Withdrawal by Subject|1|||
125984293|NCT04857034|453233459|FG000|Placebo-Controlled Period|Request to discontinue|2|||
125984294|NCT04857034|453233460|FG001|Placebo-Controlled Period|Request to discontinue|2|||
125984295|NCT04857034|453233461|FG002|Placebo-Controlled Period|Request to discontinue|0|||
125984296|NCT04857034|453233462|FG003|Placebo-Controlled Period|Request to discontinue|0|||
125984297|NCT04857034|453233463|FG004|Placebo-Controlled Period|Request to discontinue|0|||
125984298|NCT04857034|453233459|FG000|Placebo-Controlled Period|withdrew consent|1|||
125984299|NCT04857034|453233460|FG001|Placebo-Controlled Period|withdrew consent|1|||
125984300|NCT04857034|453233461|FG002|Placebo-Controlled Period|withdrew consent|2|||
125984301|NCT04857034|453233462|FG003|Placebo-Controlled Period|withdrew consent|0|||
125984302|NCT04857034|453233463|FG004|Placebo-Controlled Period|withdrew consent|0|||
125984303|NCT04857034|453233459|FG000|Placebo-Controlled Period|Pregnancy|1|||
125984304|NCT04857034|453233460|FG001|Placebo-Controlled Period|Pregnancy|1|||
125984305|NCT04857034|453233461|FG002|Placebo-Controlled Period|Pregnancy|0|||
125984306|NCT04857034|453233462|FG003|Placebo-Controlled Period|Pregnancy|0|||
125984307|NCT04857034|453233463|FG004|Placebo-Controlled Period|Pregnancy|0|||
125984308|NCT04857034|453233459|FG000|Placebo-Controlled Period|Ongoing study period|0|||
125984309|NCT04857034|453233460|FG001|Placebo-Controlled Period|Ongoing study period|1|||
125984310|NCT04857034|453233461|FG002|Placebo-Controlled Period|Ongoing study period|0|||
125984311|NCT04857034|453233462|FG003|Placebo-Controlled Period|Ongoing study period|0|||
126323617|NCT00394771|454477952|FG003|Overall Study|Participant pregnant|2|||
126323618|NCT00394771|454477949|FG000|Overall Study|Lost to Follow-up|15|||
126323619|NCT00394771|454477950|FG001|Overall Study|Lost to Follow-up|15|||
126323620|NCT00394771|454477951|FG002|Overall Study|Lost to Follow-up|13|||
126323621|NCT00394771|454477952|FG003|Overall Study|Lost to Follow-up|10|||
126323622|NCT00394771|454477949|FG000|Overall Study|Other|3|||
126323623|NCT00394771|454477950|FG001|Overall Study|Other|3|||
126323624|NCT00394771|454477951|FG002|Overall Study|Other|1|||
126323625|NCT00394771|454477952|FG003|Overall Study|Other|0|||
126323626|NCT03597139|454477953|FG000|Overall Study|Adverse Event|3|||
126323627|NCT03597139|454477954|FG001|Overall Study|Adverse Event|0|||
126323628|NCT03597139|454477953|FG000|Overall Study|Protocol Non-compliance|1|||
126323629|NCT03597139|454477954|FG001|Overall Study|Protocol Non-compliance|0|||
126323630|NCT00520767|454477956|FG000|Overall Study|Death|2|||
126323631|NCT00382109|454477957|FG000|Overall Study|Adverse Event|3|||
126323632|NCT00382109|454477958|FG001|Overall Study|Adverse Event|0|||
126323633|NCT00382109|454477957|FG000|Overall Study|Physician Decision|6|||
126323634|NCT00382109|454477958|FG001|Overall Study|Physician Decision|1|||
126323635|NCT00382109|454477957|FG000|Overall Study|Withdrawal by Subject|1|||
126323636|NCT00382109|454477958|FG001|Overall Study|Withdrawal by Subject|0|||
126323637|NCT00382109|454477957|FG000|Overall Study|ineligible|2|||
126323638|NCT00382109|454477958|FG001|Overall Study|ineligible|0|||
126323639|NCT00382109|454477957|FG000|Overall Study|Other|0|||
126323640|NCT00382109|454477958|FG001|Overall Study|Other|2|||
126323641|NCT00382109|454477957|FG000|Overall Study|consent withdrawal|0|||
126323642|NCT00382109|454477958|FG001|Overall Study|consent withdrawal|1|||
126323643|NCT00248833|454477959|FG000|Overall Study|Adverse Event|2|||
126323644|NCT00248833|454477960|FG001|Overall Study|Adverse Event|0|||
126323645|NCT00248833|454477961|FG002|Overall Study|Adverse Event|0|||
126323646|NCT00248833|454477959|FG000|Overall Study|Withdrawal by Subject|0|||
126323647|NCT00248833|454477960|FG001|Overall Study|Withdrawal by Subject|1|||
126323648|NCT00248833|454477961|FG002|Overall Study|Withdrawal by Subject|1|||
126323649|NCT00248833|454477959|FG000|Overall Study|Lost to Follow-up|1|||
126323650|NCT00248833|454477960|FG001|Overall Study|Lost to Follow-up|1|||
126323651|NCT00248833|454477961|FG002|Overall Study|Lost to Follow-up|1|||
126323652|NCT00248833|454477959|FG000|Overall Study|Other|0|||
126323653|NCT00248833|454477960|FG001|Overall Study|Other|1|||
126323654|NCT00248833|454477961|FG002|Overall Study|Other|0|||
126323655|NCT01900899|454477962|FG000|Overall Study|Withdrawal by Subject|7|||
126323656|NCT01900899|454477963|FG001|Overall Study|Withdrawal by Subject|1|||
126323657|NCT01900899|454477962|FG000|Overall Study|Migrated from study area|2|||
125984312|NCT04857034|453233463|FG004|Placebo-Controlled Period|Ongoing study period|0|||
125984313|NCT04857034|453233459|FG000|Active Treatment Period|Lack of Efficacy|1|||
125984314|NCT04857034|453233460|FG001|Active Treatment Period|Lack of Efficacy|0|||
125984315|NCT04857034|453233461|FG002|Active Treatment Period|Lack of Efficacy|0|||
126323658|NCT01900899|454477963|FG001|Overall Study|Migrated from study area|0|||
126323659|NCT01859949|454479761|FG000|Overall Study|Family Matters|0|||
126323660|NCT01859949|454479762|FG001|Overall Study|Family Matters|1|||
126323661|NCT01859949|454479761|FG000|Overall Study|Physician Decision|2|||
126323662|NCT01859949|454479762|FG001|Overall Study|Physician Decision|4|||
126323663|NCT01859949|454479761|FG000|Overall Study|Withdrawal by Subject|11|||
126323664|NCT01859949|454479762|FG001|Overall Study|Withdrawal by Subject|10|||
126323665|NCT01859949|454479761|FG000|Overall Study|Protocol Violation|1|||
126323666|NCT01859949|454479762|FG001|Overall Study|Protocol Violation|1|||
126323667|NCT01859949|454479761|FG000|Overall Study|Adverse Event|0|||
126323668|NCT01859949|454479762|FG001|Overall Study|Adverse Event|1|||
126323669|NCT01890759|454479763|FG000|Overall Study|Protocol Violation|0|||
126323670|NCT01890759|454479764|FG001|Overall Study|Protocol Violation|2|||
126323671|NCT01890759|454479763|FG000|Overall Study|Lost to Follow-up|0|||
126323672|NCT01890759|454479764|FG001|Overall Study|Lost to Follow-up|2|||
126323673|NCT01890759|454479763|FG000|Overall Study|Withdrawal by Subject|2|||
125984316|NCT04857034|453233462|FG003|Active Treatment Period|Lack of Efficacy|0|||
126323674|NCT01890759|454479764|FG001|Overall Study|Withdrawal by Subject|8|||
126323675|NCT00385827|454479765|FG000|Part 1|Adverse Event|1|||
126323676|NCT00385827|454479766|FG001|Part 1|Adverse Event|0|||
126323677|NCT00385827|454479767|FG002|Part 1|Adverse Event|0|||
126323678|NCT00385827|454479765|FG000|Part 1|Death|2|||
126323679|NCT00385827|454479766|FG001|Part 1|Death|0|||
126323680|NCT00385827|454479767|FG002|Part 1|Death|0|||
126323681|NCT00385827|454479765|FG000|Part 1|Lack of Efficacy|5|||
126323682|NCT00385827|454479766|FG001|Part 1|Lack of Efficacy|0|||
126323683|NCT00385827|454479767|FG002|Part 1|Lack of Efficacy|0|||
126323684|NCT00385827|454479765|FG000|Part 1|Other|1|||
126323685|NCT00385827|454479766|FG001|Part 1|Other|0|||
126323686|NCT00385827|454479767|FG002|Part 1|Other|0|||
126323687|NCT00385827|454479765|FG000|Part 2|Adverse Event|0|||
126323688|NCT00385827|454479766|FG001|Part 2|Adverse Event|6|||
126323689|NCT00385827|454479767|FG002|Part 2|Adverse Event|10|||
126323690|NCT00385827|454479765|FG000|Part 2|Death|0|||
126323691|NCT00385827|454479766|FG001|Part 2|Death|0|||
126323692|NCT00385827|454479767|FG002|Part 2|Death|2|||
126323693|NCT00385827|454479765|FG000|Part 2|Lack of Efficacy|0|||
126323694|NCT00385827|454479766|FG001|Part 2|Lack of Efficacy|14|||
126323695|NCT00385827|454479767|FG002|Part 2|Lack of Efficacy|13|||
126323696|NCT00385827|454479765|FG000|Part 2|Randomized but not treated|0|||
126323697|NCT00385827|454479766|FG001|Part 2|Randomized but not treated|2|||
126323698|NCT00385827|454479767|FG002|Part 2|Randomized but not treated|2|||
126323699|NCT00385827|454479765|FG000|Part 2|Other|0|||
126323700|NCT00385827|454479766|FG001|Part 2|Other|11|||
126323701|NCT00385827|454479767|FG002|Part 2|Other|21|||
126323702|NCT00410072|454479768|FG000|Day 1 to Week 48|Adverse Event|1|||
126323703|NCT00410072|454479769|FG001|Day 1 to Week 48|Adverse Event|2|||
126323704|NCT00410072|454479768|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
126323705|NCT00410072|454479769|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
126323706|NCT00410072|454479768|FG000|Day 1 to Week 48|Other|0|||
126323707|NCT00410072|454479769|FG001|Day 1 to Week 48|Other|1|||
126323708|NCT00410072|454479768|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
126323709|NCT00410072|454479769|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
126323710|NCT00410072|454479768|FG000|Day 1 to Week 48|Pregnancy|0|||
125984317|NCT04857034|453233463|FG004|Active Treatment Period|Lack of Efficacy|0|||
125984318|NCT04857034|453233459|FG000|Active Treatment Period|request to discontinue|0|||
125984319|NCT04857034|453233460|FG001|Active Treatment Period|request to discontinue|1|||
125984320|NCT04857034|453233461|FG002|Active Treatment Period|request to discontinue|0|||
125984321|NCT04857034|453233462|FG003|Active Treatment Period|request to discontinue|1|||
125984322|NCT04857034|453233463|FG004|Active Treatment Period|request to discontinue|0|||
125984323|NCT04857034|453233459|FG000|Active Treatment Period|administrative reason by sponsor|1|||
125984324|NCT04857034|453233460|FG001|Active Treatment Period|administrative reason by sponsor|5|||
125984325|NCT04857034|453233461|FG002|Active Treatment Period|administrative reason by sponsor|0|||
125984326|NCT04857034|453233462|FG003|Active Treatment Period|administrative reason by sponsor|2|||
125984327|NCT04857034|453233463|FG004|Active Treatment Period|administrative reason by sponsor|2|||
125984328|NCT04857034|453233459|FG000|Active Treatment Period|other reasons|1|||
125984329|NCT04857034|453233460|FG001|Active Treatment Period|other reasons|1|||
125984330|NCT04857034|453233461|FG002|Active Treatment Period|other reasons|0|||
125984331|NCT04857034|453233462|FG003|Active Treatment Period|other reasons|0|||
125984332|NCT04857034|453233463|FG004|Active Treatment Period|other reasons|1|||
125984333|NCT04857034|453233459|FG000|Active Treatment Period|Ongoing Study Period|2|||
126323711|NCT00410072|454479769|FG001|Day 1 to Week 48|Pregnancy|2|||
125984334|NCT04857034|453233460|FG001|Active Treatment Period|Ongoing Study Period|4|||
126323712|NCT00410072|454479768|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
126323713|NCT00410072|454479769|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
125984335|NCT04857034|453233461|FG002|Active Treatment Period|Ongoing Study Period|0|||
125984336|NCT04857034|453233462|FG003|Active Treatment Period|Ongoing Study Period|1|||
126323714|NCT00410072|454479768|FG000|After Week 48 to Week 96|Adverse Event|1|||
126323715|NCT00410072|454479769|FG001|After Week 48 to Week 96|Adverse Event|2|||
126323716|NCT00410072|454479768|FG000|After Week 48 to Week 96|Death|0|||
126323717|NCT00410072|454479769|FG001|After Week 48 to Week 96|Death|1|||
126323718|NCT00410072|454479768|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
126323719|NCT00410072|454479769|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
126323720|NCT00410072|454479768|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
126323721|NCT00410072|454479769|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
126323722|NCT00410072|454479768|FG000|After Week 48 to Week 96|Other|2|||
126323723|NCT00410072|454479769|FG001|After Week 48 to Week 96|Other|0|||
126323724|NCT00410072|454479768|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
126323725|NCT00410072|454479769|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
126323726|NCT00410072|454479768|FG000|After Week 48 to Week 96|Pregnancy|0|||
125984337|NCT04857034|453233463|FG004|Active Treatment Period|Ongoing Study Period|0|||
125984338|NCT00659490|453233464|FG000|Overall Study|Lost to Follow-up|2|||
125984339|NCT00659490|453233465|FG001|Overall Study|Lost to Follow-up|0|||
125984340|NCT00659490|453233466|FG002|Overall Study|Lost to Follow-up|1|||
125984341|NCT05674890|453233471|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
125984342|NCT05674890|453233472|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
125984343|NCT05674890|453233471|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
125984344|NCT05674890|453233472|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
125984345|NCT05674890|453233471|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
125984346|NCT05674890|453233472|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
125984347|NCT00827541|453233473|FG000|Overall Study|Exitus|1|||
125984348|NCT00827541|453233474|FG001|Overall Study|Exitus|8|||
125984349|NCT00827541|453233473|FG000|Overall Study|Other|1|||
125984350|NCT00827541|453233474|FG001|Overall Study|Other|3|||
125984351|NCT00827541|453233473|FG000|Overall Study|Pathogen not susceptible|1|||
125984352|NCT00827541|453233474|FG001|Overall Study|Pathogen not susceptible|0|||
125984353|NCT00827541|453233473|FG000|Overall Study|Lack of effectiveness|1|||
125984354|NCT00827541|453233474|FG001|Overall Study|Lack of effectiveness|0|||
125984355|NCT01649232|453233475|FG000|Overall Study|Physician Decision|2|||
125984356|NCT01649232|453233476|FG001|Overall Study|Physician Decision|0|||
125984357|NCT02228967|453233477|FG000|Overall Study|Lost to Follow-up|146|||
125984358|NCT02228967|453233478|FG001|Overall Study|Lost to Follow-up|142|||
125984359|NCT02228967|453233477|FG000|Overall Study|Withdrawal by Subject|13|||
125984360|NCT02228967|453233478|FG001|Overall Study|Withdrawal by Subject|18|||
125984361|NCT00520975|453233479|FG000|Overall Study|Disease progression|31|||
125984362|NCT00520975|453233480|FG001|Overall Study|Disease progression|23|||
125984363|NCT00520975|453233479|FG000|Overall Study|Adverse Event|7|||
125984364|NCT00520975|453233480|FG001|Overall Study|Adverse Event|10|||
125984365|NCT00520975|453233479|FG000|Overall Study|Death|0|||
125984366|NCT00520975|453233480|FG001|Overall Study|Death|2|||
125984367|NCT00520975|453233479|FG000|Overall Study|Withdrawal by Subject|3|||
125984368|NCT00520975|453233480|FG001|Overall Study|Withdrawal by Subject|5|||
125984369|NCT00520975|453233479|FG000|Overall Study|Other therapy|2|||
125984370|NCT00520975|453233480|FG001|Overall Study|Other therapy|4|||
125984371|NCT00520975|453233479|FG000|Overall Study|Other reasons|4|||
125984372|NCT00520975|453233480|FG001|Overall Study|Other reasons|2|||
125984373|NCT00520975|453233479|FG000|Overall Study|Not start protocol therapy|1|||
125984374|NCT00520975|453233480|FG001|Overall Study|Not start protocol therapy|2|||
125984375|NCT04810221|453233481|FG000|Overall Study|Physician Decision|3|||
125984376|NCT03642938|453233482|FG000|Overall Study|Withdrawal by Subject|0|||
125984377|NCT03642938|453233483|FG001|Overall Study|Withdrawal by Subject|0|||
125984378|NCT03642938|453233484|FG002|Overall Study|Withdrawal by Subject|0|||
125984379|NCT03642938|453233485|FG003|Overall Study|Withdrawal by Subject|1|||
125984380|NCT00105235|453233486|FG000|Overall Study|Death|4|||
125984381|NCT00105235|453233486|FG000|Overall Study|Physician Decision|1|||
125984382|NCT00105235|453233486|FG000|Overall Study|Withdrawal by Subject|2|||
125984383|NCT01964326|453233487|FG000|Overall Study|Adverse Event|48|||
125984384|NCT01964326|453233487|FG000|Overall Study|Death|2|||
125984385|NCT01964326|453233487|FG000|Overall Study|Protocol Violation|4|||
125984386|NCT01964326|453233487|FG000|Overall Study|Lost to Follow-up|88|||
125984387|NCT01964326|453233487|FG000|Overall Study|Withdrawal by Subject|87|||
125984388|NCT01964326|453233487|FG000|Overall Study|Pregnancy|1|||
125984389|NCT01964326|453233487|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
125984390|NCT01964326|453233487|FG000|Overall Study|Physician Decision|55|||
125984391|NCT01964326|453233487|FG000|Overall Study|Investigator Discretion|1|||
125984392|NCT01964326|453233487|FG000|Overall Study|Other|9|||
125984393|NCT01964326|453233487|FG000|Overall Study|Did not meet eligibility criteria|1|||
125984394|NCT02347657|453233488|FG000|Overall Study|Physician Decision|0|||
125984395|NCT02347657|453233489|FG001|Overall Study|Physician Decision|1|||
125984396|NCT02347657|453233488|FG000|Overall Study|Adverse Event|8|||
125984397|NCT02347657|453233489|FG001|Overall Study|Adverse Event|4|||
125984398|NCT02347657|453233488|FG000|Overall Study|Withdrawal by Subject|6|||
125984399|NCT02347657|453233489|FG001|Overall Study|Withdrawal by Subject|7|||
125984400|NCT02347657|453233488|FG000|Overall Study|Randomized but not treated|1|||
125984401|NCT02347657|453233489|FG001|Overall Study|Randomized but not treated|0|||
125984402|NCT02347657|453233488|FG000|Overall Study|Other|3|||
125984403|NCT02347657|453233489|FG001|Overall Study|Other|3|||
125984404|NCT01995539|453233490|FG000|Overall Study|Screening Failure|1|||
125984405|NCT01995539|453233490|FG000|Overall Study|Withdrawal by Investigator|15|||
125984406|NCT01995539|453233490|FG000|Overall Study|Withdrawal by Subject|11|||
125984407|NCT01995539|453233490|FG000|Overall Study|Lost to Follow-up|5|||
125984408|NCT01995539|453233490|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
125984409|NCT02309112|453233493|FG000|Overall Study|Withdrawal by Subject|1|||
125984410|NCT02309112|453233494|FG001|Overall Study|Withdrawal by Subject|0|||
125984411|NCT02309112|453233495|FG002|Overall Study|Withdrawal by Subject|1|||
125984412|NCT02309112|453233493|FG000|Overall Study|Lost to Follow-up|0|||
125984413|NCT02309112|453233494|FG001|Overall Study|Lost to Follow-up|1|||
125984414|NCT02309112|453233495|FG002|Overall Study|Lost to Follow-up|0|||
125984415|NCT00621543|453233496|FG000|Overall Study|Lost to Follow-up|23|||
125984416|NCT00499863|453233501|FG000|Overall Study|Lack of Efficacy|21|||
125984417|NCT00499863|453233502|FG001|Overall Study|Lack of Efficacy|27|||
125984418|NCT00499863|453233501|FG000|Overall Study|Protocol Violation|12|||
125984419|NCT00499863|453233502|FG001|Overall Study|Protocol Violation|7|||
125984420|NCT00499863|453233501|FG000|Overall Study|Withdrawal by Subject|6|||
125984421|NCT00499863|453233502|FG001|Overall Study|Withdrawal by Subject|4|||
125984422|NCT00499863|453233501|FG000|Overall Study|Adverse Event|8|||
125984423|NCT00499863|453233502|FG001|Overall Study|Adverse Event|2|||
125984424|NCT00499863|453233501|FG000|Overall Study|Sponsor decision|2|||
125984425|NCT00499863|453233502|FG001|Overall Study|Sponsor decision|2|||
125984426|NCT00499863|453233501|FG000|Overall Study|Lost to Follow-up|1|||
125984427|NCT00499863|453233502|FG001|Overall Study|Lost to Follow-up|1|||
125984428|NCT00571701|453233503|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
125984429|NCT00571701|453233504|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
125984430|NCT00571701|453233503|FG000|First Intervention 12 Months|Death|1|||
125984431|NCT00571701|453233504|FG001|First Intervention 12 Months|Death|0|||
125984432|NCT00571701|453233503|FG000|Second Intervention 12 Months|Adverse Event|0|||
125984433|NCT00571701|453233504|FG001|Second Intervention 12 Months|Adverse Event|1|||
125984434|NCT00571701|453233503|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
125984435|NCT00571701|453233504|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
125984436|NCT03351738|453233509|FG000|Overall Study|Withdrawal by Subject|0|||
125984437|NCT03351738|453233510|FG001|Overall Study|Withdrawal by Subject|1|||
125984438|NCT03351738|453233511|FG002|Overall Study|Withdrawal by Subject|0|||
125984439|NCT03351738|453233512|FG003|Overall Study|Withdrawal by Subject|1|||
125984440|NCT03351738|453233513|FG004|Overall Study|Withdrawal by Subject|0|||
125984441|NCT03351738|453233514|FG005|Overall Study|Withdrawal by Subject|0|||
125984442|NCT01375205|453233517|FG000|Overall Study|Lost to Follow-up|15|||
125984443|NCT01375205|453233518|FG001|Overall Study|Lost to Follow-up|12|||
125984444|NCT01375205|453233517|FG000|Overall Study|Withdrawal by Subject|6|||
125984445|NCT01375205|453233518|FG001|Overall Study|Withdrawal by Subject|1|||
125984446|NCT03056534|453233520|FG000|Overall Study|Participant withdrew consent|8|||
125984447|NCT03056534|453233520|FG000|Overall Study|Participant not able to return|6|||
125984448|NCT03056534|453233520|FG000|Overall Study|Lost to Follow-up|37|||
126323727|NCT00410072|454479769|FG001|After Week 48 to Week 96|Pregnancy|2|||
126323728|NCT00410072|454479768|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
125984449|NCT03056534|453233520|FG000|Overall Study|Investigator judgment|1|||
125984450|NCT03056534|453233520|FG000|Overall Study|Death|4|||
125984451|NCT03056534|453233520|FG000|Overall Study|Adverse Event|1|||
125984452|NCT03056534|453233520|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
125984453|NCT03815019|453233521|FG000|Overall Study|Withdrawal by Subject|6|||
125984454|NCT03815019|453233522|FG001|Overall Study|Withdrawal by Subject|8|||
125984455|NCT02063828|453233523|FG000|Overall Study|Withdrawal by Subject|4|||
125984456|NCT02063828|453233524|FG001|Overall Study|Withdrawal by Subject|6|||
125984457|NCT02063828|453233525|FG002|Overall Study|Withdrawal by Subject|3|||
125984458|NCT02063828|453233523|FG000|Overall Study|Death|0|||
125984459|NCT02063828|453233524|FG001|Overall Study|Death|0|||
125984460|NCT02063828|453233525|FG002|Overall Study|Death|1|||
125984461|NCT03937219|453233526|FG000|Overall Study|Death|223|||
125984462|NCT03937219|453233527|FG001|Overall Study|Death|211|||
125984463|NCT03937219|453233526|FG000|Overall Study|Withdrawal by Subject|17|||
125984464|NCT03937219|453233527|FG001|Overall Study|Withdrawal by Subject|25|||
125984465|NCT03937219|453233526|FG000|Overall Study|Lost to Follow-up|3|||
125984466|NCT03937219|453233527|FG001|Overall Study|Lost to Follow-up|4|||
125984467|NCT03483038|453233528|FG000|Overall Study|Subjects still in follow-up|18|||
125984468|NCT02134925|453233529|FG000|Overall Study|Withdrawal by Subject|1|||
125984469|NCT02134925|453233530|FG001|Overall Study|Withdrawal by Subject|0|||
125984470|NCT02134925|453233529|FG000|Overall Study|Cancel|1|||
125984471|NCT02134925|453233530|FG001|Overall Study|Cancel|6|||
125984472|NCT00654901|453233535|FG000|Overall Study|Lost to Follow-up|1|||
125984473|NCT00654901|453233536|FG001|Overall Study|Lost to Follow-up|0|||
125984474|NCT00654901|453233537|FG002|Overall Study|Lost to Follow-up|1|||
125984475|NCT00654901|453233538|FG003|Overall Study|Lost to Follow-up|0|||
125984476|NCT00654901|453233535|FG000|Overall Study|Withdrawal by Subject|3|||
125984477|NCT00654901|453233536|FG001|Overall Study|Withdrawal by Subject|0|||
125984478|NCT00654901|453233537|FG002|Overall Study|Withdrawal by Subject|1|||
125984479|NCT00654901|453233538|FG003|Overall Study|Withdrawal by Subject|0|||
126323729|NCT00410072|454479769|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
125984480|NCT02332590|453233539|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
125984481|NCT02332590|453233540|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
125984482|NCT02332590|453233539|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
126323730|NCT01421147|454479774|FG000|Treatment Period|Adverse Event|2|||
125984483|NCT02332590|453233540|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
125984484|NCT02332590|453233539|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
125984485|NCT02332590|453233540|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
125984486|NCT02332590|453233539|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
125984487|NCT02332590|453233540|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
125984488|NCT02332590|453233539|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
125984489|NCT02332590|453233540|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
125984490|NCT02332590|453233539|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
125984491|NCT02332590|453233540|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
125984492|NCT02332590|453233539|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
125984493|NCT02332590|453233540|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
125984494|NCT02332590|453233539|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
125984495|NCT02332590|453233540|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
125984496|NCT02332590|453233539|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
125984497|NCT02332590|453233540|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
125984498|NCT03764072|453233543|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125984499|NCT03764072|453233544|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125984500|NCT03764072|453233545|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
125984501|NCT03764072|453233546|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125984502|NCT03764072|453233547|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125984503|NCT03764072|453233548|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125984504|NCT03764072|453233543|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
125984505|NCT03764072|453233544|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
125984506|NCT03764072|453233545|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
125984507|NCT03764072|453233546|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
125984508|NCT03764072|453233547|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
125984509|NCT03764072|453233548|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
125984510|NCT03764072|453233543|FG000|Overall Study|Lost to Follow-up|0|||
125984511|NCT03764072|453233544|FG001|Overall Study|Lost to Follow-up|0|||
125984512|NCT03764072|453233545|FG002|Overall Study|Lost to Follow-up|0|||
125984513|NCT03764072|453233546|FG003|Overall Study|Lost to Follow-up|0|||
125984514|NCT03764072|453233547|FG004|Overall Study|Lost to Follow-up|1|||
125984515|NCT03764072|453233548|FG005|Overall Study|Lost to Follow-up|0|||
125984516|NCT00558064|453233553|FG000|Overall Study|Adverse Event|3|||
125984517|NCT00558064|453233554|FG001|Overall Study|Adverse Event|2|||
125984518|NCT00558064|453233553|FG000|Overall Study|Lack of Efficacy|0|||
125984519|NCT00558064|453233554|FG001|Overall Study|Lack of Efficacy|1|||
125984520|NCT00558064|453233553|FG000|Overall Study|Protocol Violation|1|||
125984521|NCT00558064|453233554|FG001|Overall Study|Protocol Violation|0|||
125984522|NCT00558064|453233553|FG000|Overall Study|Lost to Follow-up|0|||
125984523|NCT00558064|453233554|FG001|Overall Study|Lost to Follow-up|1|||
125984524|NCT00558064|453233553|FG000|Overall Study|Withdrawal by Subject|0|||
125984525|NCT00558064|453233554|FG001|Overall Study|Withdrawal by Subject|1|||
125984526|NCT00558064|453233553|FG000|Overall Study|No visit within allowance period|1|||
125984527|NCT00558064|453233554|FG001|Overall Study|No visit within allowance period|0|||
125984528|NCT01582789|453234477|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
125984529|NCT01582789|453234478|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
125984530|NCT01191840|453234486|FG000|Overall Study|withdrew consent|2|||
125984531|NCT01191840|453234487|FG001|Overall Study|withdrew consent|1|||
125984532|NCT01191840|453234486|FG000|Overall Study|Subject discontinued treatment|1|||
125984533|NCT01191840|453234487|FG001|Overall Study|Subject discontinued treatment|2|||
125984534|NCT01191840|453234486|FG000|Overall Study|Lost to Follow-up|4|||
125984535|NCT01191840|453234487|FG001|Overall Study|Lost to Follow-up|6|||
125984536|NCT01191840|453234486|FG000|Overall Study|Non Staph Infection|4|||
125984537|NCT01191840|453234487|FG001|Overall Study|Non Staph Infection|3|||
125984538|NCT01191840|453234486|FG000|Overall Study|ineligible at enrollment|1|||
125984539|NCT01191840|453234487|FG001|Overall Study|ineligible at enrollment|0|||
125984540|NCT01191840|453234486|FG000|Overall Study|IRB approval lapse|0|||
125984541|NCT01191840|453234487|FG001|Overall Study|IRB approval lapse|2|||
125984542|NCT01191840|453234486|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
125984543|NCT01191840|453234487|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
125984544|NCT01191840|453234486|FG000|Overall Study|Withdrawal by Subject|2|||
125984545|NCT01191840|453234487|FG001|Overall Study|Withdrawal by Subject|0|||
125984546|NCT01392300|453234488|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
125984547|NCT01392300|453234489|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
125984548|NCT01392300|453234490|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
125984549|NCT01392300|453234488|FG000|Main Period (MP)|Withdrawal by Subject|5|||
125984550|NCT01392300|453234489|FG001|Main Period (MP)|Withdrawal by Subject|1|||
125984551|NCT01392300|453234490|FG002|Main Period (MP)|Withdrawal by Subject|0|||
125984552|NCT01392300|453234488|FG000|Main Period (MP)|Lost to Follow-up|3|||
125984553|NCT01392300|453234489|FG001|Main Period (MP)|Lost to Follow-up|3|||
125984554|NCT01392300|453234490|FG002|Main Period (MP)|Lost to Follow-up|0|||
125984555|NCT01392300|453234488|FG000|Main Period (MP)|Non-compliance|1|||
125984556|NCT01392300|453234489|FG001|Main Period (MP)|Non-compliance|0|||
125984557|NCT01392300|453234490|FG002|Main Period (MP)|Non-compliance|0|||
125984558|NCT01392300|453234488|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
125984559|NCT01392300|453234489|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
125984560|NCT01392300|453234490|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
125984561|NCT01392300|453234488|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
125984562|NCT01392300|453234489|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
125984563|NCT01392300|453234490|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
125984564|NCT01392300|453234488|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
125984565|NCT01392300|453234489|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
125984566|NCT01392300|453234490|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
125984567|NCT01392300|453234488|FG000|Open Label Extension (OLEX) Period|Death|0|||
125984568|NCT01392300|453234489|FG001|Open Label Extension (OLEX) Period|Death|0|||
125984569|NCT01392300|453234490|FG002|Open Label Extension (OLEX) Period|Death|4|||
125984570|NCT01392300|453234488|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
125984571|NCT01392300|453234489|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
125984572|NCT01392300|453234490|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
125984573|NCT01392300|453234488|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
125984574|NCT01392300|453234489|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
126323731|NCT01421147|454479775|FG001|Treatment Period|Adverse Event|3|||
126323732|NCT01421147|454479774|FG000|Treatment Period|Lost to Follow-up|2|||
126323733|NCT01421147|454479775|FG001|Treatment Period|Lost to Follow-up|1|||
126323734|NCT01421147|454479774|FG000|Treatment Period|Physician Decision|2|||
126323735|NCT01421147|454479775|FG001|Treatment Period|Physician Decision|2|||
126323736|NCT01421147|454479774|FG000|Treatment Period|Withdrawal by Subject|10|||
126323737|NCT01421147|454479775|FG001|Treatment Period|Withdrawal by Subject|5|||
126323738|NCT01421147|454479774|FG000|Extension Period|Adverse Event|0|||
126323739|NCT01421147|454479775|FG001|Extension Period|Adverse Event|2|||
126323740|NCT01421147|454479774|FG000|Extension Period|Death|0|||
126323741|NCT01421147|454479775|FG001|Extension Period|Death|1|||
126323742|NCT01421147|454479774|FG000|Extension Period|Lost to Follow-up|2|||
126323743|NCT01421147|454479775|FG001|Extension Period|Lost to Follow-up|5|||
126323744|NCT01421147|454479774|FG000|Extension Period|Physician Decision|1|||
126323745|NCT01421147|454479775|FG001|Extension Period|Physician Decision|0|||
126323746|NCT01421147|454479774|FG000|Extension Period|Withdrawal by Subject|5|||
126323747|NCT01421147|454479775|FG001|Extension Period|Withdrawal by Subject|3|||
126323748|NCT03307837|454479777|FG000|Overall Study|Withdrawal by Subject|0|||
126323749|NCT03307837|454479778|FG001|Overall Study|Withdrawal by Subject|0|||
126323750|NCT03307837|454479779|FG002|Overall Study|Withdrawal by Subject|1|||
125984575|NCT01392300|453234490|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
125984576|NCT01392300|453234488|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
125984577|NCT01392300|453234489|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
125984578|NCT01392300|453234490|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
125984579|NCT01802437|453234495|FG000|Overall Study|Lost to Follow-up|1|||
125984580|NCT01802437|453234496|FG001|Overall Study|Lost to Follow-up|0|||
125984581|NCT01802437|453234495|FG000|Overall Study|Withdrawal by Subject|3|||
125984582|NCT01802437|453234496|FG001|Overall Study|Withdrawal by Subject|4|||
125984583|NCT01682213|453234504|FG000|Overall Study|Withdrawal by Subject|2|||
125984584|NCT00742079|453234505|FG000|Overall Study|Lost to Follow-up|0|||
125984585|NCT00742079|453234506|FG001|Overall Study|Lost to Follow-up|1|||
125984586|NCT01181726|453234507|FG000|First Intervention|Adverse Event|1|||
125984587|NCT01181726|453234508|FG001|First Intervention|Adverse Event|0|||
125984588|NCT01264380|453234509|FG000|Period C|Disease Progression|0|||
125984589|NCT01264380|453234510|FG001|Period C|Disease Progression|0|||
125984590|NCT01264380|453234511|FG002|Period C|Disease Progression|4|||
125984591|NCT01264380|453234509|FG000|Period C|Death|0|||
125984592|NCT01264380|453234510|FG001|Period C|Death|0|||
125984593|NCT01264380|453234511|FG002|Period C|Death|2|||
125984594|NCT01264380|453234509|FG000|Period C|Follow-up for survival status|0|||
125984595|NCT01264380|453234510|FG001|Period C|Follow-up for survival status|0|||
125984596|NCT01264380|453234511|FG002|Period C|Follow-up for survival status|6|||
126323751|NCT03307837|454479780|FG003|Overall Study|Withdrawal by Subject|0|||
125984597|NCT01264380|453234509|FG000|Period C|Withdrawal by Subject|0|||
125984598|NCT01264380|453234510|FG001|Period C|Withdrawal by Subject|0|||
125984599|NCT01264380|453234511|FG002|Period C|Withdrawal by Subject|1|||
125984600|NCT01264380|453234509|FG000|Period C|Adverse Event|0|||
125984601|NCT01264380|453234510|FG001|Period C|Adverse Event|0|||
125984602|NCT01264380|453234511|FG002|Period C|Adverse Event|1|||
125984603|NCT01147822|453234512|FG000|Overall Study|Lost to Follow-up|14|||
125984604|NCT01147822|453234513|FG001|Overall Study|Lost to Follow-up|6|||
125984605|NCT01147822|453234512|FG000|Overall Study|Withdrawal by Subject|10|||
126323752|NCT03307837|454479781|FG004|Overall Study|Withdrawal by Subject|0|||
126323753|NCT03307837|454479782|FG005|Overall Study|Withdrawal by Subject|1|||
126323754|NCT03307837|454479777|FG000|Overall Study|Lost to Follow-up|1|||
126323755|NCT03307837|454479778|FG001|Overall Study|Lost to Follow-up|1|||
126323756|NCT03307837|454479779|FG002|Overall Study|Lost to Follow-up|0|||
126323757|NCT03307837|454479780|FG003|Overall Study|Lost to Follow-up|0|||
126323758|NCT03307837|454479781|FG004|Overall Study|Lost to Follow-up|0|||
126323759|NCT03307837|454479782|FG005|Overall Study|Lost to Follow-up|1|||
126323760|NCT00171158|454479783|FG000|Core Study|Death|27|||
126323761|NCT00171158|454479783|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
126323762|NCT00171158|454479783|FG000|Core Study|Protocol Violation|4|||
126323763|NCT00171158|454479783|FG000|Core Study|Administrative problems|1|||
126323764|NCT00171158|454479783|FG000|Core Study|Adverse event, non-fatal|21|||
126323765|NCT00171158|454479783|FG000|Core Study|Consent withdrawn by subject|6|||
126323766|NCT00171158|454479783|FG000|Core Study|No longer required drug (BMT)|14|||
126323767|NCT00171158|454479783|FG000|Core Study|Abnormal Laboratory Values|2|||
126323768|NCT00171158|454479783|FG000|Core Study|Lost to Follow-up|1|||
126323769|NCT00171158|454479783|FG000|E2 Extension|Other|7|||
126323770|NCT03536663|454479788|FG000|Endexo|Protocol Violation|1|||
126323771|NCT01031004|454479791|FG000|Overall Study|Protocol Violation|0|||
126323772|NCT01031004|454479792|FG001|Overall Study|Protocol Violation|1|||
126323773|NCT01031004|454479791|FG000|Overall Study|Lost to Follow-up|1|||
126323774|NCT01031004|454479792|FG001|Overall Study|Lost to Follow-up|0|||
126323775|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
126323776|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
126323777|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
126323778|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
126323779|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
126323780|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
126323781|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
126323782|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
126323783|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
126323784|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
126323785|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
126323786|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
126323787|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
126323788|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
126323789|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
126323790|NCT02634801|454479793|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
126323791|NCT02634801|454479794|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
126323792|NCT02634801|454479795|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
126323793|NCT02634801|454479793|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
126323794|NCT02634801|454479794|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
126323795|NCT02634801|454479795|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
126323796|NCT02634801|454479793|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
126323797|NCT02634801|454479794|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
126323798|NCT02634801|454479795|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
126323799|NCT02634801|454479793|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
126323800|NCT02634801|454479794|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
126323801|NCT02634801|454479795|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
126323802|NCT02634801|454479793|FG000|Follow-up Period|Lost to Follow-up|3|||
126323803|NCT02634801|454479794|FG001|Follow-up Period|Lost to Follow-up|1|||
126323804|NCT02634801|454479795|FG002|Follow-up Period|Lost to Follow-up|2|||
126323805|NCT02634801|454479793|FG000|Follow-up Period|Physician Decision|0|||
126323806|NCT02634801|454479794|FG001|Follow-up Period|Physician Decision|0|||
126323807|NCT02634801|454479795|FG002|Follow-up Period|Physician Decision|1|||
126323808|NCT02634801|454479793|FG000|Follow-up Period|Withdrawal by Subject|1|||
126323809|NCT02634801|454479794|FG001|Follow-up Period|Withdrawal by Subject|2|||
126323810|NCT02634801|454479795|FG002|Follow-up Period|Withdrawal by Subject|5|||
126323811|NCT02634801|454479793|FG000|Follow-up Period|Adverse Event|1|||
126323812|NCT02634801|454479794|FG001|Follow-up Period|Adverse Event|5|||
126323813|NCT02634801|454479795|FG002|Follow-up Period|Adverse Event|0|||
126323814|NCT00582426|454479808|FG000|Overall Study|Lost to Follow-up|0|||
126323815|NCT00582426|454479809|FG001|Overall Study|Lost to Follow-up|2|||
125984606|NCT01147822|453234513|FG001|Overall Study|Withdrawal by Subject|16|||
125984607|NCT01147822|453234512|FG000|Overall Study|Physician Decision|9|||
125984608|NCT01147822|453234513|FG001|Overall Study|Physician Decision|8|||
125984609|NCT01147822|453234512|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
125984610|NCT01147822|453234513|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
126323816|NCT00582426|454479808|FG000|Overall Study|Adverse Event|4|||
126323817|NCT00582426|454479809|FG001|Overall Study|Adverse Event|2|||
126323818|NCT00582426|454479808|FG000|Overall Study|Protocol Violation|6|||
126323819|NCT00582426|454479809|FG001|Overall Study|Protocol Violation|2|||
126323820|NCT00582426|454479808|FG000|Overall Study|Death|4|||
125984611|NCT01147822|453234512|FG000|Overall Study|Protocol Violation|1|||
125984612|NCT01147822|453234513|FG001|Overall Study|Protocol Violation|1|||
125984613|NCT00429663|453234516|FG000|Overall Study|Lost to Follow-up|24|||
126323821|NCT00582426|454479809|FG001|Overall Study|Death|3|||
125984614|NCT00429663|453234517|FG001|Overall Study|Lost to Follow-up|31|||
125984615|NCT00429663|453234516|FG000|Overall Study|Physician Decision|6|||
125984616|NCT00429663|453234517|FG001|Overall Study|Physician Decision|3|||
125984617|NCT00429663|453234516|FG000|Overall Study|Withdrawal by Subject|2|||
126323822|NCT00582426|454479808|FG000|Overall Study|Withdrawal by Subject|3|||
126323823|NCT00582426|454479809|FG001|Overall Study|Withdrawal by Subject|2|||
126323824|NCT00582426|454479808|FG000|Overall Study|Disease Progression|2|||
126323825|NCT00582426|454479809|FG001|Overall Study|Disease Progression|2|||
126323826|NCT00582426|454479808|FG000|Overall Study|Use of illicit drugs|1|||
126323827|NCT00582426|454479809|FG001|Overall Study|Use of illicit drugs|0|||
126323828|NCT02164318|454479810|FG000|Overall Study|Withdrawal by Subject|0|||
126323829|NCT02164318|454479811|FG001|Overall Study|Withdrawal by Subject|1|||
126323830|NCT02164318|454479812|FG002|Overall Study|Withdrawal by Subject|0|||
126323831|NCT02164318|454479813|FG003|Overall Study|Withdrawal by Subject|1|||
126323832|NCT04126317|454479834|FG000|Overall Study|Adverse Event|0|||
126323833|NCT04126317|454479835|FG001|Overall Study|Adverse Event|1|||
126323834|NCT04126317|454479834|FG000|Overall Study|Withdrawal by Subject|4|||
126323835|NCT04126317|454479835|FG001|Overall Study|Withdrawal by Subject|1|||
126323836|NCT02985021|454479837|FG000|Overall Study|Inability to comply with study procedures|1|||
126323837|NCT02756819|454479838|FG000|Overall Study|Lost for observation|23|||
126323838|NCT02756819|454479838|FG000|Overall Study|Patient's unwillingness|16|||
126323839|NCT02756819|454479838|FG000|Overall Study|Insufficient efficacy|2|||
126323840|NCT02756819|454479838|FG000|Overall Study|Adverse Event|2|||
126323841|NCT02756819|454479838|FG000|Overall Study|Reason not Specified|9|||
126323842|NCT00264290|454479839|FG000|Intervention (8 Weeks)|Adverse Event|1|||
126323843|NCT00264290|454479840|FG001|Intervention (8 Weeks)|Adverse Event|0|||
126323844|NCT01939223|454479841|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
126323845|NCT01939223|454479842|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
126323846|NCT01939223|454479841|FG000|Overall Study|Disease recurrence (radiological)|1|||
126323847|NCT01939223|454479842|FG001|Overall Study|Disease recurrence (radiological)|3|||
126323848|NCT01939223|454479841|FG000|Overall Study|Study stopped by Sponsor|5|||
126323849|NCT01939223|454479842|FG001|Overall Study|Study stopped by Sponsor|7|||
126323850|NCT01939223|454479841|FG000|Overall Study|Withdrawal by Subject|6|||
126323851|NCT01939223|454479842|FG001|Overall Study|Withdrawal by Subject|0|||
126323852|NCT01557517|454479843|FG000|Overall Study|Death|1|||
126323853|NCT01557517|454479844|FG001|Overall Study|Death|0|||
126323854|NCT01557517|454479843|FG000|Overall Study|Refused further treatment|0|||
126323855|NCT01557517|454479844|FG001|Overall Study|Refused further treatment|2|||
126323856|NCT01557517|454479843|FG000|Overall Study|Adverse Event|0|||
126323857|NCT01557517|454479844|FG001|Overall Study|Adverse Event|2|||
126323858|NCT01557517|454479843|FG000|Overall Study|Pt declined before treatment started|1|||
126323859|NCT01557517|454479844|FG001|Overall Study|Pt declined before treatment started|0|||
126323860|NCT00162097|454479845|FG000|Overall Study|Participant no longer met study criteria|0|||
126323861|NCT00162097|454479846|FG001|Overall Study|Participant no longer met study criteria|0|||
125984618|NCT00429663|453234517|FG001|Overall Study|Withdrawal by Subject|5|||
125984619|NCT00429663|453234516|FG000|Overall Study|Death|4|||
126323862|NCT00162097|454479847|FG002|Overall Study|Participant no longer met study criteria|0|||
126323863|NCT00162097|454479848|FG003|Overall Study|Participant no longer met study criteria|1|||
126323864|NCT03585712|454479851|FG000|Treatment Period 1|Protocol Violation|1|||
126323865|NCT03585712|454479852|FG001|Treatment Period 1|Protocol Violation|0|||
126323866|NCT03585712|454479853|FG002|Treatment Period 1|Protocol Violation|0|||
126323867|NCT03585712|454479851|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
126323868|NCT03585712|454479852|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
126323869|NCT03585712|454479853|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
125984620|NCT00429663|453234517|FG001|Overall Study|Death|0|||
125984621|NCT01226511|453234518|FG000|Acute Treatment Period|Adverse Event|7|||
125984622|NCT01226511|453234519|FG001|Acute Treatment Period|Adverse Event|6|||
125984623|NCT01226511|453234518|FG000|Acute Treatment Period|Lack of Efficacy|2|||
125984624|NCT01226511|453234519|FG001|Acute Treatment Period|Lack of Efficacy|1|||
125984625|NCT01226511|453234518|FG000|Acute Treatment Period|Lost to Follow-up|3|||
126323870|NCT03585712|454479851|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
125984626|NCT01226511|453234519|FG001|Acute Treatment Period|Lost to Follow-up|6|||
125984627|NCT01226511|453234518|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
125984628|NCT01226511|453234519|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
125984629|NCT01226511|453234518|FG000|Acute Treatment Period|Protocol Violation|5|||
126209050|NCT04668066|454053124|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
126323871|NCT03585712|454479852|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
126323872|NCT03585712|454479853|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
126323873|NCT03585712|454479851|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
126323874|NCT03585712|454479852|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
126323875|NCT03585712|454479853|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
126323876|NCT01280682|454479860|FG000|Overall Study|Lost to Follow-up|0|||
125984630|NCT01226511|453234519|FG001|Acute Treatment Period|Protocol Violation|5|||
126209051|NCT04668066|454053125|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
125984631|NCT01226511|453234518|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
125984632|NCT01226511|453234519|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
125984633|NCT01226511|453234518|FG000|Extension Treatment Period|Adverse Event|8|||
125984634|NCT01226511|453234519|FG001|Extension Treatment Period|Adverse Event|8|||
125984635|NCT01226511|453234518|FG000|Extension Treatment Period|Lack of Efficacy|3|||
125984636|NCT01226511|453234519|FG001|Extension Treatment Period|Lack of Efficacy|2|||
125984637|NCT01226511|453234518|FG000|Extension Treatment Period|Lost to Follow-up|4|||
125984638|NCT01226511|453234519|FG001|Extension Treatment Period|Lost to Follow-up|3|||
125984639|NCT01226511|453234518|FG000|Extension Treatment Period|Protocol Violation|2|||
125984640|NCT01226511|453234519|FG001|Extension Treatment Period|Protocol Violation|2|||
125984641|NCT01226511|453234518|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
125984642|NCT01226511|453234519|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
125984643|NCT01226511|453234518|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
125984644|NCT01226511|453234519|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
125984645|NCT01226511|453234518|FG000|Extension Treatment Period|Sponsor Decision|1|||
125984646|NCT01226511|453234519|FG001|Extension Treatment Period|Sponsor Decision|1|||
125984647|NCT01226511|453234518|FG000|Taper Period|Adverse Event|1|||
125984648|NCT01226511|453234519|FG001|Taper Period|Adverse Event|0|||
125984649|NCT01226511|453234518|FG000|Taper Period|Lost to Follow-up|2|||
125984650|NCT01226511|453234519|FG001|Taper Period|Lost to Follow-up|2|||
125984651|NCT01226511|453234518|FG000|Taper Period|Protocol Violation|1|||
125984652|NCT01226511|453234519|FG001|Taper Period|Protocol Violation|0|||
125984653|NCT01226511|453234518|FG000|Taper Period|Parent/Caregiver Decision|1|||
126323877|NCT01280682|454479861|FG001|Overall Study|Lost to Follow-up|6|||
126323878|NCT01280682|454479860|FG000|Overall Study|Withdrawal by Subject|0|||
126323879|NCT01280682|454479861|FG001|Overall Study|Withdrawal by Subject|7|||
126323880|NCT01964716|454479870|FG000|Overall Study|Withdrawal by Subject|2|||
126323881|NCT01964716|454479871|FG001|Overall Study|Withdrawal by Subject|3|||
126323882|NCT01964716|454479870|FG000|Overall Study|Lost to Follow-up|1|||
126323883|NCT01964716|454479871|FG001|Overall Study|Lost to Follow-up|2|||
126323884|NCT01964716|454479870|FG000|Overall Study|No longer met eligibility criteria|1|||
126323885|NCT01964716|454479871|FG001|Overall Study|No longer met eligibility criteria|1|||
126323886|NCT01964716|454479870|FG000|Overall Study|Death|1|||
126323887|NCT01964716|454479871|FG001|Overall Study|Death|0|||
126323888|NCT01464619|454479876|FG000|Overall Study|Lost to Follow-up|3|||
126323889|NCT01464619|454479877|FG001|Overall Study|Lost to Follow-up|4|||
126323890|NCT01863732|454479878|FG000|Overall Study|Adverse Event|2|||
126323891|NCT01863732|454479879|FG001|Overall Study|Adverse Event|0|||
126323892|NCT01863732|454479880|FG002|Overall Study|Adverse Event|3|||
126323893|NCT01863732|454479881|FG003|Overall Study|Adverse Event|3|||
126323894|NCT01863732|454479878|FG000|Overall Study|Lack of Efficacy|1|||
126323895|NCT01863732|454479879|FG001|Overall Study|Lack of Efficacy|0|||
126323896|NCT01863732|454479880|FG002|Overall Study|Lack of Efficacy|2|||
126323897|NCT01863732|454479881|FG003|Overall Study|Lack of Efficacy|1|||
126323898|NCT01863732|454479878|FG000|Overall Study|Lost to Follow-up|2|||
126323899|NCT01863732|454479879|FG001|Overall Study|Lost to Follow-up|2|||
126323900|NCT01863732|454479880|FG002|Overall Study|Lost to Follow-up|1|||
126323901|NCT01863732|454479881|FG003|Overall Study|Lost to Follow-up|1|||
126323902|NCT01863732|454479878|FG000|Overall Study|Physician Decision|1|||
126323903|NCT01863732|454479879|FG001|Overall Study|Physician Decision|0|||
126323904|NCT01863732|454479880|FG002|Overall Study|Physician Decision|1|||
126323905|NCT01863732|454479881|FG003|Overall Study|Physician Decision|0|||
126323906|NCT01863732|454479878|FG000|Overall Study|Pregnancy|0|||
126323907|NCT01863732|454479879|FG001|Overall Study|Pregnancy|0|||
126323908|NCT01863732|454479880|FG002|Overall Study|Pregnancy|0|||
126323909|NCT01863732|454479881|FG003|Overall Study|Pregnancy|1|||
126323910|NCT01863732|454479878|FG000|Overall Study|Technical problems|0|||
126323911|NCT01863732|454479879|FG001|Overall Study|Technical problems|1|||
126323912|NCT01863732|454479880|FG002|Overall Study|Technical problems|1|||
126323913|NCT01863732|454479881|FG003|Overall Study|Technical problems|0|||
126323914|NCT01863732|454479878|FG000|Overall Study|Subject/guardian decision|6|||
126323915|NCT01863732|454479879|FG001|Overall Study|Subject/guardian decision|9|||
126323916|NCT01863732|454479880|FG002|Overall Study|Subject/guardian decision|3|||
126323917|NCT01863732|454479881|FG003|Overall Study|Subject/guardian decision|1|||
125984654|NCT01226511|453234519|FG001|Taper Period|Parent/Caregiver Decision|1|||
125984655|NCT01337986|453234521|FG000|Overall Study|Adverse Event|2|||
126323918|NCT01863732|454479878|FG000|Overall Study|Death|1|||
126323919|NCT01863732|454479879|FG001|Overall Study|Death|0|||
126209052|NCT05048875|454053131|FG000|Overall Study|Withdrawal by Subject|1|||
126323920|NCT01863732|454479880|FG002|Overall Study|Death|0|||
126323921|NCT01863732|454479881|FG003|Overall Study|Death|1|||
126323922|NCT01603394|454479886|FG000|Overall Study|Adverse Event|1|||
126323923|NCT00840034|454479888|FG000|Acute Treatment Phase|Adverse Event|6|||
126323924|NCT00840034|454479889|FG001|Acute Treatment Phase|Adverse Event|8|||
126323925|NCT00840034|454479888|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
126323926|NCT00840034|454479889|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
126323927|NCT00840034|454479888|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
126323928|NCT00840034|454479889|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
125984656|NCT01337986|453234522|FG001|Overall Study|Adverse Event|2|||
125984657|NCT01337986|453234521|FG000|Overall Study|Lost to Follow-up|1|||
125984658|NCT01337986|453234522|FG001|Overall Study|Lost to Follow-up|0|||
125984659|NCT01337986|453234521|FG000|Overall Study|Protocol Violation|0|||
125984660|NCT01337986|453234522|FG001|Overall Study|Protocol Violation|3|||
125984661|NCT00532155|453234531|FG000|Overall Study|Adverse Event|66|||
125984662|NCT00532155|453234532|FG001|Overall Study|Adverse Event|123|||
125984663|NCT00532155|453234531|FG000|Overall Study|Lack of Efficacy|332|||
125984664|NCT00532155|453234532|FG001|Overall Study|Lack of Efficacy|255|||
125984665|NCT00532155|453234531|FG000|Overall Study|Protocol Violation|1|||
125984666|NCT00532155|453234532|FG001|Overall Study|Protocol Violation|3|||
125984667|NCT00532155|453234531|FG000|Overall Study|Lost to Follow-up|2|||
125984668|NCT00532155|453234532|FG001|Overall Study|Lost to Follow-up|0|||
125984669|NCT00532155|453234531|FG000|Overall Study|Physician Decision|16|||
125984670|NCT00532155|453234532|FG001|Overall Study|Physician Decision|15|||
125984671|NCT00532155|453234531|FG000|Overall Study|Withdrawal by Subject|23|||
125984672|NCT00532155|453234532|FG001|Overall Study|Withdrawal by Subject|44|||
125984673|NCT00532155|453234531|FG000|Overall Study|Consent withdrawn|5|||
125984674|NCT00532155|453234532|FG001|Overall Study|Consent withdrawn|7|||
125984675|NCT00532155|453234531|FG000|Overall Study|Moved|1|||
125984676|NCT00532155|453234532|FG001|Overall Study|Moved|0|||
125984677|NCT00532155|453234531|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
126323929|NCT00840034|454479888|FG000|Acute Treatment Phase|Physician Decision|0|||
126323930|NCT00840034|454479889|FG001|Acute Treatment Phase|Physician Decision|1|||
126323931|NCT00840034|454479888|FG000|Acute Treatment Phase|Protocol Violation|2|||
126323932|NCT00840034|454479889|FG001|Acute Treatment Phase|Protocol Violation|4|||
126323933|NCT00840034|454479888|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
126323934|NCT00840034|454479889|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
126323935|NCT00840034|454479888|FG000|Taper Phase|Adverse Event|1|||
126323936|NCT00840034|454479889|FG001|Taper Phase|Adverse Event|0|||
126323937|NCT00840034|454479888|FG000|Taper Phase|Lost to Follow-up|1|||
126323938|NCT00840034|454479889|FG001|Taper Phase|Lost to Follow-up|1|||
126323939|NCT00840034|454479888|FG000|Taper Phase|Withdrawal by Subject|1|||
126323940|NCT00840034|454479889|FG001|Taper Phase|Withdrawal by Subject|1|||
126323941|NCT01215435|454479890|FG000|Overall Study|Adverse Event|1|||
126323942|NCT01215435|454479891|FG001|Overall Study|Adverse Event|0|||
126323943|NCT01215435|454479890|FG000|Overall Study|Protocol Violation|2|||
126323944|NCT01215435|454479891|FG001|Overall Study|Protocol Violation|0|||
126323945|NCT01215435|454479890|FG000|Overall Study|Withdrawal Criteria|8|||
126323946|NCT01215435|454479891|FG001|Overall Study|Withdrawal Criteria|11|||
126323947|NCT01215435|454479890|FG000|Overall Study|Lost to Follow-up|3|||
126323948|NCT01215435|454479891|FG001|Overall Study|Lost to Follow-up|0|||
126323949|NCT01215435|454479890|FG000|Overall Study|Unclassified|5|||
126323950|NCT01215435|454479891|FG001|Overall Study|Unclassified|5|||
126323951|NCT00586898|454479900|FG000|Overall Study|Adverse Event|1|||
126323952|NCT00586898|454479900|FG000|Overall Study|Patiemt Non-compliance|1|||
126323953|NCT00586898|454479900|FG000|Overall Study|Evaluable for Toxicity Only|5|||
126323954|NCT03816007|454479901|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
126323955|NCT03816007|454479902|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
126323956|NCT03816007|454479901|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
126323957|NCT03816007|454479902|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
126323958|NCT03816007|454479901|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
126323959|NCT03816007|454479902|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
126323960|NCT02179749|454479904|FG000|Overall Study|Adverse Event|0|||
126323961|NCT02179749|454479905|FG001|Overall Study|Adverse Event|0|||
126323962|NCT02179749|454479906|FG002|Overall Study|Adverse Event|1|||
126323963|NCT02179749|454479904|FG000|Overall Study|Withdrawal by Subject|0|||
126323964|NCT02179749|454479905|FG001|Overall Study|Withdrawal by Subject|0|||
126323965|NCT02179749|454479906|FG002|Overall Study|Withdrawal by Subject|1|||
126323966|NCT02756364|454479907|FG000|Overall Study|Site Terminated by Sponsor|24|||
126323967|NCT02756364|454479908|FG001|Overall Study|Site Terminated by Sponsor|30|||
126323968|NCT02756364|454479909|FG002|Overall Study|Site Terminated by Sponsor|21|||
126323969|NCT02756364|454479907|FG000|Overall Study|Death|20|||
125984678|NCT00532155|453234532|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
125984679|NCT00532155|453234531|FG000|Overall Study|Occurence of a second cancer|0|||
125984680|NCT00532155|453234532|FG001|Overall Study|Occurence of a second cancer|1|||
125984681|NCT00532155|453234531|FG000|Overall Study|Occurence of a secondary cancer|0|||
125984682|NCT00532155|453234532|FG001|Overall Study|Occurence of a secondary cancer|1|||
126090988|NCT03525392|453626876|FG002|Overall Study|Adverse Event|2|||
126090989|NCT03525392|453626877|FG003|Overall Study|Adverse Event|0|||
126323970|NCT02756364|454479908|FG001|Overall Study|Death|15|||
126323971|NCT02756364|454479909|FG002|Overall Study|Death|18|||
126323972|NCT02756364|454479907|FG000|Overall Study|Withdrawal by Patient|2|||
126323973|NCT02756364|454479908|FG001|Overall Study|Withdrawal by Patient|1|||
126323974|NCT02756364|454479909|FG002|Overall Study|Withdrawal by Patient|8|||
126323975|NCT02756364|454479907|FG000|Overall Study|Lost to Follow-up|0|||
126323976|NCT02756364|454479908|FG001|Overall Study|Lost to Follow-up|1|||
126323977|NCT02756364|454479909|FG002|Overall Study|Lost to Follow-up|1|||
126323978|NCT02655016|454479910|FG000|Overall Study|Disease progression|6|||
126323979|NCT02655016|454479911|FG001|Overall Study|Disease progression|4|||
126323980|NCT02655016|454479910|FG000|Overall Study|Site closed|0|||
126323981|NCT02655016|454479911|FG001|Overall Study|Site closed|1|||
126323982|NCT02655016|454479910|FG000|Overall Study|Death|30|||
126323983|NCT02655016|454479911|FG001|Overall Study|Death|48|||
126323984|NCT02655016|454479910|FG000|Overall Study|Lost to Follow-up|1|||
126323985|NCT02655016|454479911|FG001|Overall Study|Lost to Follow-up|1|||
126323986|NCT02655016|454479910|FG000|Overall Study|Withdrawal by Subject|18|||
126323987|NCT02655016|454479911|FG001|Overall Study|Withdrawal by Subject|36|||
126323988|NCT02223364|454479912|FG000|Overall Study|Protocol Violation|3|||
126323989|NCT02223364|454479913|FG001|Overall Study|Protocol Violation|0|||
126323990|NCT02223364|454479914|FG002|Overall Study|Protocol Violation|3|||
126323991|NCT02223364|454479912|FG000|Overall Study|subject expired before surgery|1|||
126323992|NCT02223364|454479913|FG001|Overall Study|subject expired before surgery|0|||
126323993|NCT02223364|454479914|FG002|Overall Study|subject expired before surgery|0|||
126323994|NCT02223364|454479912|FG000|Overall Study|Physician Decision|1|||
126323995|NCT02223364|454479913|FG001|Overall Study|Physician Decision|0|||
126323996|NCT02223364|454479914|FG002|Overall Study|Physician Decision|0|||
126323997|NCT00793546|454479915|FG000|Overall Study|Death|3|||
126323998|NCT00793546|454479916|FG001|Overall Study|Death|0|||
126323999|NCT00793546|454479915|FG000|Overall Study|Lost to Follow-up|1|||
126324000|NCT00793546|454479916|FG001|Overall Study|Lost to Follow-up|0|||
126324001|NCT00793546|454479915|FG000|Overall Study|Withdrawal by Subject|1|||
126324002|NCT00793546|454479916|FG001|Overall Study|Withdrawal by Subject|1|||
126324003|NCT00793546|454479915|FG000|Overall Study|Study Terminated by Sponsor|8|||
126324004|NCT00793546|454479916|FG001|Overall Study|Study Terminated by Sponsor|27|||
126324005|NCT00793546|454479915|FG000|Overall Study|Other|1|||
126324006|NCT00793546|454479916|FG001|Overall Study|Other|0|||
126324007|NCT01841567|454479917|FG000|Overall Study|Adverse Event|3|||
126324008|NCT01416155|454479918|FG000|Overall Study|Adverse Event|8|||
126324009|NCT01416155|454479918|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
126324010|NCT01416155|454479918|FG000|Overall Study|Withdrawal by Subject|33|||
126324011|NCT01416155|454479918|FG000|Overall Study|Investigator decision|8|||
126324012|NCT01416155|454479918|FG000|Overall Study|Other|7|||
126324013|NCT02984267|454479923|FG000|Overall Study|Protocol Violation|1|||
126324014|NCT02984267|454479924|FG001|Overall Study|Protocol Violation|0|||
126324015|NCT02984267|454479923|FG000|Overall Study|Withdrawal by Subject|0|||
126324016|NCT02984267|454479924|FG001|Overall Study|Withdrawal by Subject|1|||
126324017|NCT00742027|454479925|FG000|Overall Study|Disease Progression|76|||
126324018|NCT00742027|454479925|FG000|Overall Study|New Cancer Therapy|19|||
126324019|NCT00742027|454479925|FG000|Overall Study|Withdrawal by Subject|18|||
126324020|NCT00742027|454479925|FG000|Overall Study|Death|7|||
126324021|NCT00742027|454479925|FG000|Overall Study|Lost to Follow-up|4|||
126324022|NCT00742027|454479925|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
126324023|NCT00742027|454479925|FG000|Overall Study|Missing|2|||
126324024|NCT00742027|454479925|FG000|Overall Study|Administrative Problems|1|||
126324025|NCT01249833|454479928|FG000|Overall Study|Lost to Follow-up|0|||
126324026|NCT01249833|454479929|FG001|Overall Study|Lost to Follow-up|1|||
126324027|NCT03796676|454479930|FG000|Overall Study|Adverse Event|2|||
126324028|NCT03796676|454479931|FG001|Overall Study|Adverse Event|1|||
126324029|NCT03796676|454479932|FG002|Overall Study|Adverse Event|2|||
126324030|NCT03796676|454479930|FG000|Overall Study|Lost to Follow-up|2|||
126324031|NCT03796676|454479931|FG001|Overall Study|Lost to Follow-up|1|||
126324032|NCT03796676|454479932|FG002|Overall Study|Lost to Follow-up|0|||
126324033|NCT03796676|454479930|FG000|Overall Study|Protocol Violation|0|||
126324034|NCT03796676|454479931|FG001|Overall Study|Protocol Violation|0|||
125984683|NCT00532155|453234531|FG000|Overall Study|Promotor ended study|1|||
125984684|NCT00532155|453234532|FG001|Overall Study|Promotor ended study|0|||
125984685|NCT00532155|453234531|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
125984686|NCT00532155|453234532|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
125984687|NCT00532155|453234531|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
125984688|NCT00532155|453234532|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
125984689|NCT00532155|453234531|FG000|Overall Study|Study stopped|1|||
125984690|NCT00532155|453234532|FG001|Overall Study|Study stopped|0|||
126324035|NCT03796676|454479932|FG002|Overall Study|Protocol Violation|1|||
126324036|NCT03796676|454479930|FG000|Overall Study|Withdrawal by Subject|1|||
126324037|NCT03796676|454479931|FG001|Overall Study|Withdrawal by Subject|1|||
126324038|NCT03796676|454479932|FG002|Overall Study|Withdrawal by Subject|0|||
126324039|NCT03796676|454479930|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
126324040|NCT03796676|454479931|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
126324041|NCT03796676|454479932|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
126324042|NCT02442206|454481998|FG000|Period 1|Adverse Event|1|||
126324043|NCT02442206|454481999|FG001|Period 1|Adverse Event|1|||
125984691|NCT00532155|453234531|FG000|Overall Study|Study terminated by sponsor|1|||
126324044|NCT02442206|454481998|FG000|Period 1|withdrew consent|0|||
126324045|NCT02442206|454481999|FG001|Period 1|withdrew consent|1|||
126324046|NCT02442206|454481998|FG000|Period 1|COPD exacerbation|0|||
126324047|NCT02442206|454481999|FG001|Period 1|COPD exacerbation|1|||
126324048|NCT02442206|454481998|FG000|Period 2|Adverse Event|1|||
126324049|NCT02442206|454481999|FG001|Period 2|Adverse Event|0|||
126324050|NCT00497146|454482000|FG000|Treatment Period|Adverse Event|6|||
126324051|NCT00497146|454482001|FG001|Treatment Period|Adverse Event|2|||
126324052|NCT00497146|454482000|FG000|Treatment Period|Withdrawal by Subject|5|||
126324053|NCT00497146|454482001|FG001|Treatment Period|Withdrawal by Subject|9|||
126324054|NCT00497146|454482000|FG000|Treatment Period|Lost to Follow-up|1|||
126324055|NCT00497146|454482001|FG001|Treatment Period|Lost to Follow-up|3|||
126324056|NCT00497146|454482000|FG000|Treatment Period|Required dialysis|4|||
126324057|NCT00497146|454482001|FG001|Treatment Period|Required dialysis|1|||
126324058|NCT00497146|454482000|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
126324059|NCT00497146|454482001|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
126324060|NCT00497146|454482000|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
126324061|NCT00497146|454482001|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
126324062|NCT00497146|454482000|FG000|Treatment Period|Other Reason|2|||
126324063|NCT00497146|454482001|FG001|Treatment Period|Other Reason|3|||
126324064|NCT00497146|454482000|FG000|Long-term Follow-up Period|Adverse Event|2|||
126324065|NCT00497146|454482001|FG001|Long-term Follow-up Period|Adverse Event|2|||
126324066|NCT00497146|454482000|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
126324067|NCT00497146|454482001|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
126324068|NCT00497146|454482000|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
126324069|NCT00497146|454482001|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
126324070|NCT00497146|454482000|FG000|Long-term Follow-up Period|Other|0|||
126324071|NCT00497146|454482001|FG001|Long-term Follow-up Period|Other|1|||
126324072|NCT01471444|454482002|FG000|Overall Study|Physician Decision|3|||
126324073|NCT01471444|454482003|FG001|Overall Study|Physician Decision|2|||
126324074|NCT01471444|454482002|FG000|Overall Study|Withdrawal by Subject|0|||
126324075|NCT01471444|454482003|FG001|Overall Study|Withdrawal by Subject|1|||
126324076|NCT02155309|454482004|FG000|Overall Study|Protocol Violation|0|||
126324077|NCT02155309|454482005|FG001|Overall Study|Protocol Violation|0|||
126324078|NCT02155309|454482006|FG002|Overall Study|Protocol Violation|1|||
126324079|NCT00662311|454482007|FG000|Overall Study|Respiratory Infection|1|||
126324080|NCT00662311|454482008|FG001|Overall Study|Respiratory Infection|0|||
126324081|NCT00662311|454482009|FG002|Overall Study|Respiratory Infection|0|||
126324082|NCT01467271|454482010|FG000|Overall Study|Death|84|||
126324083|NCT01467271|454482010|FG000|Overall Study|Lost to Follow-up|83|||
126324084|NCT01467271|454482010|FG000|Overall Study|Retraction of patient's consent|21|||
126324085|NCT01467271|454482010|FG000|Overall Study|Other reason|14|||
126324086|NCT01548768|454482011|FG000|Overall Study|Withdrawal by Subject|0|||
126324087|NCT01548768|454482012|FG001|Overall Study|Withdrawal by Subject|2|||
126324088|NCT01548768|454482013|FG002|Overall Study|Withdrawal by Subject|1|||
126324089|NCT01548768|454482014|FG003|Overall Study|Withdrawal by Subject|0|||
125984692|NCT00532155|453234532|FG001|Overall Study|Study terminated by sponsor|0|||
125984693|NCT00532155|453234531|FG000|Overall Study|Study termination stop further treatment|4|||
125984694|NCT00532155|453234532|FG001|Overall Study|Study termination stop further treatment|0|||
125984695|NCT00532155|453234531|FG000|Overall Study|Did not receive study medication|2|||
125984696|NCT00532155|453234532|FG001|Overall Study|Did not receive study medication|6|||
125984697|NCT04241094|453234542|FG000|Overall Study|Dropped out of treatment|4|||
125984698|NCT04241094|453234542|FG000|Overall Study|Ineligible after clinical assessment|2|||
125984699|NCT04241094|453234542|FG000|Overall Study|Lost to Follow-up|2|||
125984700|NCT00982930|453234547|FG000|Overall Study|Adverse Event|1|||
125984701|NCT00982930|453234547|FG000|Overall Study|Withdrawal by Subject|1|||
125984702|NCT00982930|453234547|FG000|Overall Study|Administrative Problems|2|||
125984703|NCT01489189|453234548|FG000|Overall Study|Withdrawal by Subject|20|||
125984704|NCT01489189|453234549|FG001|Overall Study|Withdrawal by Subject|23|||
125984705|NCT01489189|453234548|FG000|Overall Study|Death|10|||
125984706|NCT01489189|453234549|FG001|Overall Study|Death|8|||
125984707|NCT01489189|453234548|FG000|Overall Study|Missed Visit|1|||
125984708|NCT01489189|453234549|FG001|Overall Study|Missed Visit|4|||
125984709|NCT03750006|453234552|FG000|Overall Study|Withdrawal by Subject|8|||
125984710|NCT03750006|453234552|FG000|Overall Study|COVID PANDEMIC|11|||
125984711|NCT04739761|453234554|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
125984712|NCT04739761|453234555|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
126324090|NCT01548768|454482011|FG000|Overall Study|Physician Decision|1|||
126324091|NCT01548768|454482012|FG001|Overall Study|Physician Decision|0|||
126209053|NCT05048875|454053132|FG001|Overall Study|Withdrawal by Subject|0|||
126324092|NCT01548768|454482013|FG002|Overall Study|Physician Decision|0|||
126324093|NCT01548768|454482014|FG003|Overall Study|Physician Decision|0|||
125984713|NCT04739761|453234554|FG000|Overall Study|By complete response from the participant|1|||
126209054|NCT05048875|454053133|FG002|Overall Study|Withdrawal by Subject|0|||
126324094|NCT01548768|454482011|FG000|Overall Study|Adverse Event|0|||
126324095|NCT01548768|454482012|FG001|Overall Study|Adverse Event|0|||
125984714|NCT04739761|453234555|FG001|Overall Study|By complete response from the participant|0|||
125984715|NCT04739761|453234554|FG000|Overall Study|Lost to Follow-up|3|||
125984716|NCT04739761|453234555|FG001|Overall Study|Lost to Follow-up|3|||
125984717|NCT04739761|453234554|FG000|Overall Study|Death|13|||
125984718|NCT04739761|453234555|FG001|Overall Study|Death|13|||
125984719|NCT04739761|453234554|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
125984720|NCT04739761|453234555|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
125984721|NCT04739761|453234554|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
125984722|NCT04739761|453234555|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
125984723|NCT04739761|453234554|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
125984724|NCT04739761|453234555|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
125984725|NCT04739761|453234554|FG000|Overall Study|Adverse Event|0|||
125984726|NCT04739761|453234555|FG001|Overall Study|Adverse Event|3|||
125984727|NCT04739761|453234554|FG000|Overall Study|Participant decision|1|||
125984728|NCT04739761|453234555|FG001|Overall Study|Participant decision|0|||
125984729|NCT04739761|453234554|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
125984730|NCT04739761|453234555|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
125984731|NCT04739761|453234554|FG000|Overall Study|Participant immediately started next line of treatment|1|||
125984732|NCT04739761|453234555|FG001|Overall Study|Participant immediately started next line of treatment|0|||
125984733|NCT04739761|453234554|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
125984734|NCT04739761|453234555|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
125984735|NCT04739761|453234554|FG000|Overall Study|Lack of clinical benefit|1|||
125984736|NCT04739761|453234555|FG001|Overall Study|Lack of clinical benefit|0|||
125984737|NCT04739761|453234554|FG000|Overall Study|Disease progression|5|||
125984738|NCT04739761|453234555|FG001|Overall Study|Disease progression|5|||
125984739|NCT04739761|453234554|FG000|Overall Study|Withdrawal by Subject|14|||
125984740|NCT04739761|453234555|FG001|Overall Study|Withdrawal by Subject|13|||
125984741|NCT04739761|453234554|FG000|Overall Study|Protocol Violation|1|||
125984742|NCT04739761|453234555|FG001|Overall Study|Protocol Violation|0|||
125984743|NCT04739761|453234554|FG000|Overall Study|Physician Decision|2|||
125984744|NCT04739761|453234555|FG001|Overall Study|Physician Decision|0|||
125984745|NCT03881696|453234559|FG000|Overall Study|Adverse Event|2|||
125984746|NCT03881696|453234560|FG001|Overall Study|Adverse Event|0|||
125984747|NCT03881696|453234559|FG000|Overall Study|Withdrawal by Subject|2|||
125984748|NCT03881696|453234560|FG001|Overall Study|Withdrawal by Subject|0|||
125984749|NCT03881696|453234559|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
125984750|NCT03881696|453234560|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
125984751|NCT03881696|453234559|FG000|Overall Study|Failure to meet continuation criteria|1|||
125984752|NCT03881696|453234560|FG001|Overall Study|Failure to meet continuation criteria|0|||
125984753|NCT02044848|453236069|FG000|Overall Study|Administrative Problems|2|||
125984754|NCT02044848|453236070|FG001|Overall Study|Administrative Problems|3|||
125984755|NCT03237858|453236071|FG000|Overall Study|Death|19|||
125984756|NCT03237858|453236071|FG000|Overall Study|Withdrawal by Subject|37|||
125984757|NCT04858802|453236072|FG000|Overall Study|Lost to Follow-up|1|||
125984758|NCT04858802|453236073|FG001|Overall Study|Lost to Follow-up|1|||
125984759|NCT04858802|453236072|FG000|Overall Study|Withdrawal by Subject|1|||
125984760|NCT04858802|453236073|FG001|Overall Study|Withdrawal by Subject|1|||
125984761|NCT04382924|453236075|FG000|Overall Study|Death|2|||
125984762|NCT04382924|453236076|FG001|Overall Study|Death|5|||
125984763|NCT04382924|453236077|FG002|Overall Study|Death|4|||
125984764|NCT04382924|453236075|FG000|Overall Study|Protocol Violation|0|||
125984765|NCT04382924|453236076|FG001|Overall Study|Protocol Violation|1|||
125984766|NCT04382924|453236077|FG002|Overall Study|Protocol Violation|1|||
125984767|NCT04382924|453236075|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
125984768|NCT04382924|453236076|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
125984769|NCT04382924|453236077|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
125984770|NCT04382924|453236075|FG000|Overall Study|Withdrawal by Subject|6|||
125984771|NCT04382924|453236076|FG001|Overall Study|Withdrawal by Subject|3|||
125984772|NCT04382924|453236077|FG002|Overall Study|Withdrawal by Subject|6|||
125984773|NCT02013388|453236078|FG000|Overall Study|work emergency|1|||
125984774|NCT02013388|453236079|FG001|Overall Study|work emergency|0|||
125984775|NCT02013388|453236080|FG002|Overall Study|work emergency|0|||
125984776|NCT02013388|453236081|FG003|Overall Study|work emergency|0|||
125984777|NCT02013388|453236082|FG004|Overall Study|work emergency|1|||
125984778|NCT02013388|453236083|FG005|Overall Study|work emergency|0|||
125984779|NCT02013388|453236084|FG006|Overall Study|work emergency|0|||
125984780|NCT02013388|453236085|FG007|Overall Study|work emergency|0|||
125984781|NCT04207840|453236086|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
125984782|NCT04207840|453236087|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
125984783|NCT04207840|453236088|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
125984784|NCT04207840|453236086|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
125984785|NCT04207840|453236087|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
125984786|NCT04207840|453236088|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
125984787|NCT03243422|453236089|FG000|Overall Study|Death|20|||
125984788|NCT03243422|453236090|FG001|Overall Study|Death|21|||
125984789|NCT03243422|453236089|FG000|Overall Study|Lost to Follow-up|9|||
125984790|NCT03243422|453236090|FG001|Overall Study|Lost to Follow-up|21|||
125984791|NCT03243422|453236089|FG000|Overall Study|Withdrawal by Subject|22|||
125984792|NCT03243422|453236090|FG001|Overall Study|Withdrawal by Subject|8|||
125984793|NCT03261271|453236094|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
125984794|NCT03261271|453236095|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
125984795|NCT02173054|453236096|FG000|Overall Study|lack of compliance|1|||
125984796|NCT02173054|453236097|FG001|Overall Study|lack of compliance|0|||
125984797|NCT02173054|453236098|FG002|Overall Study|lack of compliance|0|||
125984798|NCT02173054|453236096|FG000|Overall Study|Withdrawal by Subject|0|||
125984799|NCT02173054|453236097|FG001|Overall Study|Withdrawal by Subject|0|||
125984800|NCT02173054|453236098|FG002|Overall Study|Withdrawal by Subject|1|||
125984801|NCT01559454|453236099|FG000|Overall Study|Lost to Follow-up|3|||
125984802|NCT01559454|453236100|FG001|Overall Study|Lost to Follow-up|2|||
125984803|NCT01559454|453236099|FG000|Overall Study|Withdrawal by Subject|0|||
125984804|NCT01559454|453236100|FG001|Overall Study|Withdrawal by Subject|1|||
125984805|NCT01559454|453236099|FG000|Overall Study|Physician Decision|0|||
125984806|NCT01559454|453236100|FG001|Overall Study|Physician Decision|1|||
125984807|NCT01559454|453236099|FG000|Overall Study|Protocol Violation|0|||
125984808|NCT01559454|453236100|FG001|Overall Study|Protocol Violation|1|||
125984809|NCT01559454|453236099|FG000|Overall Study|Lack of Efficacy|0|||
125984810|NCT01559454|453236100|FG001|Overall Study|Lack of Efficacy|1|||
125984811|NCT01114204|453236103|FG000|Overall Study|Adverse Event|3|||
125984812|NCT01114204|453236104|FG001|Overall Study|Adverse Event|2|||
125984813|NCT01114204|453236103|FG000|Overall Study|Lost to Follow-up|1|||
125984814|NCT01114204|453236104|FG001|Overall Study|Lost to Follow-up|0|||
125984815|NCT01114204|453236103|FG000|Overall Study|Withdrawal by Subject|10|||
125984816|NCT01114204|453236104|FG001|Overall Study|Withdrawal by Subject|6|||
125984817|NCT01114204|453236103|FG000|Overall Study|Death|1|||
125984818|NCT01114204|453236104|FG001|Overall Study|Death|0|||
125984819|NCT01114204|453236103|FG000|Overall Study|Other-Personal reasons|2|||
125984820|NCT01114204|453236104|FG001|Overall Study|Other-Personal reasons|0|||
126324096|NCT01548768|454482013|FG002|Overall Study|Adverse Event|0|||
126324097|NCT01548768|454482014|FG003|Overall Study|Adverse Event|1|||
126324098|NCT01548768|454482011|FG000|Overall Study|Non-Compliance|0|||
126324099|NCT01548768|454482012|FG001|Overall Study|Non-Compliance|0|||
126324100|NCT01548768|454482013|FG002|Overall Study|Non-Compliance|0|||
125984821|NCT01114204|453236103|FG000|Overall Study|Other-Medical monitor request|1|||
125984822|NCT01114204|453236104|FG001|Overall Study|Other-Medical monitor request|0|||
125984823|NCT01114204|453236103|FG000|Overall Study|Other-Participant request|2|||
125984824|NCT01114204|453236104|FG001|Overall Study|Other-Participant request|0|||
125984825|NCT01114204|453236103|FG000|Overall Study|Other-Protocol Violation|1|||
125984826|NCT01114204|453236104|FG001|Overall Study|Other-Protocol Violation|0|||
125984827|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
125984828|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
125984829|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
125984830|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
125984831|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
125984832|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
125984833|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
125984834|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
125984835|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
125984836|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
125984837|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
125984838|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
125984839|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125984840|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125984841|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125984842|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
125984843|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
125984844|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125984845|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125984846|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125984847|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Death|2|||
125984848|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Death|2|||
125984849|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Death|0|||
125984850|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Death|0|||
125984851|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Death|0|||
125984852|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
126209055|NCT05048875|454053134|FG003|Overall Study|Withdrawal by Subject|0|||
125984853|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
126209056|NCT05048875|454053135|FG004|Overall Study|Withdrawal by Subject|0|||
125984854|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
125984855|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
126324101|NCT01548768|454482014|FG003|Overall Study|Non-Compliance|3|||
126324102|NCT03084302|454482015|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
126324103|NCT03084302|454482015|FG000|Overall Study|No valid objective monitor data|6|||
126324104|NCT00929994|454482016|FG000|Overall Study|Withdrawal by Subject|1|||
126324105|NCT00929994|454482016|FG000|Overall Study|medical issue unrelated to intervention|4|||
126324106|NCT00929994|454482016|FG000|Overall Study|employment|1|||
126324107|NCT01214668|454482017|FG000|Overall Study|Adverse Event|0|||
126324108|NCT01214668|454482018|FG001|Overall Study|Adverse Event|1|||
126324109|NCT01214668|454482019|FG002|Overall Study|Adverse Event|0|||
126324110|NCT01214668|454482020|FG003|Overall Study|Adverse Event|2|||
126324111|NCT01214668|454482021|FG004|Overall Study|Adverse Event|1|||
126324112|NCT01214668|454482022|FG005|Overall Study|Adverse Event|1|||
126324113|NCT01214668|454482017|FG000|Overall Study|Death|0|||
126324114|NCT01214668|454482018|FG001|Overall Study|Death|0|||
126324115|NCT01214668|454482019|FG002|Overall Study|Death|1|||
126324116|NCT01214668|454482020|FG003|Overall Study|Death|0|||
126324117|NCT01214668|454482021|FG004|Overall Study|Death|0|||
126324118|NCT01214668|454482022|FG005|Overall Study|Death|0|||
126324119|NCT01214668|454482017|FG000|Overall Study|Progressive Disease|4|||
126324120|NCT01214668|454482018|FG001|Overall Study|Progressive Disease|2|||
126324121|NCT01214668|454482019|FG002|Overall Study|Progressive Disease|5|||
126324122|NCT01214668|454482020|FG003|Overall Study|Progressive Disease|4|||
126324123|NCT01214668|454482021|FG004|Overall Study|Progressive Disease|4|||
126324124|NCT01214668|454482022|FG005|Overall Study|Progressive Disease|5|||
126324125|NCT01214668|454482017|FG000|Overall Study|Withdrawal by Subject|0|||
126324126|NCT01214668|454482018|FG001|Overall Study|Withdrawal by Subject|0|||
126324127|NCT01214668|454482019|FG002|Overall Study|Withdrawal by Subject|0|||
126324128|NCT01214668|454482020|FG003|Overall Study|Withdrawal by Subject|0|||
126324129|NCT01214668|454482021|FG004|Overall Study|Withdrawal by Subject|1|||
126324130|NCT01214668|454482022|FG005|Overall Study|Withdrawal by Subject|0|||
126324131|NCT01964989|454482023|FG000|Overall Study|Protocol Violation|3|||
126324132|NCT01964989|454482024|FG001|Overall Study|Protocol Violation|4|||
126324133|NCT01964989|454482023|FG000|Overall Study|Administrative Reason|103|||
126324134|NCT01964989|454482024|FG001|Overall Study|Administrative Reason|95|||
126324135|NCT01964989|454482023|FG000|Overall Study|Adverse Event|0|||
126324136|NCT01964989|454482024|FG001|Overall Study|Adverse Event|1|||
126324137|NCT01964989|454482023|FG000|Overall Study|Death|1|||
126324138|NCT01964989|454482024|FG001|Overall Study|Death|3|||
126324139|NCT01964989|454482023|FG000|Overall Study|Withdrawal by Subject|156|||
126324140|NCT01964989|454482024|FG001|Overall Study|Withdrawal by Subject|160|||
126324141|NCT01964989|454482023|FG000|Overall Study|Lost to Follow-up|254|||
126324142|NCT01964989|454482024|FG001|Overall Study|Lost to Follow-up|232|||
126324143|NCT01964989|454482023|FG000|Overall Study|Other|267|||
126324144|NCT01964989|454482024|FG001|Overall Study|Other|252|||
126324145|NCT00424593|454482025|FG000|Acute Double-Blind Period|Adverse Event|16|||
126324146|NCT00424593|454482026|FG001|Acute Double-Blind Period|Adverse Event|7|||
126324147|NCT00424593|454482025|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
126324148|NCT00424593|454482026|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
126324149|NCT00424593|454482025|FG000|Acute Double-Blind Period|Protocol Violation|2|||
126324150|NCT00424593|454482026|FG001|Acute Double-Blind Period|Protocol Violation|2|||
126324151|NCT00424593|454482025|FG000|Acute Double-Blind Period|Physician Decision|1|||
126324152|NCT00424593|454482026|FG001|Acute Double-Blind Period|Physician Decision|2|||
126324153|NCT00424593|454482025|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
126324154|NCT00424593|454482026|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
126324155|NCT00424593|454482025|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
126324156|NCT00424593|454482026|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
126324157|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
126324158|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
126324159|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Adverse Event|18|||
126324160|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Adverse Event|0|||
126324161|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
126324162|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
126324163|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
126324164|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
126324165|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
126324166|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
125984856|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
125984857|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
125984858|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
125984859|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
126324167|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Physician Decision|3|||
126324168|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Physician Decision|0|||
126324169|NCT01796301|454482027|FG000|Overall Study|Withdrawal by Subject|15|||
126324170|NCT01796301|454482028|FG001|Overall Study|Withdrawal by Subject|15|||
126324171|NCT01796301|454482027|FG000|Overall Study|Lost to Follow-up|3|||
126324172|NCT01796301|454482028|FG001|Overall Study|Lost to Follow-up|3|||
126324173|NCT01796301|454482027|FG000|Overall Study|Death|0|||
125984860|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
125984861|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
125984862|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
125984863|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
125984864|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
126324174|NCT01796301|454482028|FG001|Overall Study|Death|1|||
126324175|NCT01796301|454482027|FG000|Overall Study|Decision by Sponsor|0|||
126324176|NCT01796301|454482028|FG001|Overall Study|Decision by Sponsor|1|||
126324177|NCT00667563|454482029|FG000|Overall Study|Protocol Violation|24|||
126324178|NCT00790556|454482030|FG000|Treatment Period 1|Physician Decision|1|||
126324179|NCT00790556|454482031|FG001|Treatment Period 1|Physician Decision|0|||
126324180|NCT00790556|454482030|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126324181|NCT00790556|454482031|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126324182|NCT00217581|454482034|FG000|Overall Study|Withdrawal by Subject|1|||
126324183|NCT04399889|454482035|FG000|Overall Study|Death|5|||
126324184|NCT04399889|454482036|FG001|Overall Study|Death|1|||
126324185|NCT04399889|454482037|FG002|Overall Study|Death|1|||
126324186|NCT01005901|454482042|FG000|Overall Study|Withdrawal by Subject|38|||
126324187|NCT01005901|454482043|FG001|Overall Study|Withdrawal by Subject|14|||
126324188|NCT01005901|454482042|FG000|Overall Study|Adverse Event|30|||
126324189|NCT01005901|454482043|FG001|Overall Study|Adverse Event|16|||
126324190|NCT01005901|454482042|FG000|Overall Study|Administrative problems|21|||
126324191|NCT01005901|454482043|FG001|Overall Study|Administrative problems|13|||
126324192|NCT01005901|454482042|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126324193|NCT01005901|454482043|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
126324194|NCT01005901|454482042|FG000|Overall Study|Protocol Violation|4|||
126324195|NCT01005901|454482043|FG001|Overall Study|Protocol Violation|3|||
126324196|NCT01005901|454482042|FG000|Overall Study|Death|2|||
126324197|NCT01005901|454482043|FG001|Overall Study|Death|3|||
126324198|NCT01005901|454482042|FG000|Overall Study|Lost to Follow-up|1|||
126324199|NCT01005901|454482043|FG001|Overall Study|Lost to Follow-up|2|||
126324200|NCT01005901|454482042|FG000|Overall Study|Patient's inability to use the device|1|||
126324201|NCT01005901|454482043|FG001|Overall Study|Patient's inability to use the device|1|||
126324202|NCT01005901|454482042|FG000|Overall Study|No longer requires study drug|0|||
126324203|NCT01005901|454482043|FG001|Overall Study|No longer requires study drug|1|||
126324204|NCT00760487|454482044|FG000|Overall Study|Unilateral implantation|3|||
126324205|NCT06360588|454482045|FG000|Overall Study|Adverse Event|3|||
126324206|NCT06360588|454482045|FG000|Overall Study|Death|2|||
126324207|NCT06360588|454482045|FG000|Overall Study|Disease Progression|14|||
126324208|NCT06360588|454482045|FG000|Overall Study|Withdrawal by Subject|1|||
126324209|NCT06360588|454482045|FG000|Overall Study|Lack of Efficacy|1|||
126324210|NCT06360588|454482045|FG000|Overall Study|Ineligible|1|||
126324211|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
126324212|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
126324213|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
126324214|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
126324215|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
126324216|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
126324217|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
126324218|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
126324219|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
126324220|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
126324221|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
126324222|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
126324223|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
126324224|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
126324225|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
126324226|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
126324227|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
126324228|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
126324229|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
126324230|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
125984865|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
126324231|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
126324232|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
126324233|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
126324234|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
126324235|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
126324236|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
126324237|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
126324238|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
126324239|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
126324240|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
126324241|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
126324242|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
126324243|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
126324244|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
126324245|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
126324246|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
126324247|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
126324248|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
126324249|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
126324250|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
126324251|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
126324252|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
126324253|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
126324254|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
126324255|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
126324256|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
125984866|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
125984867|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
125984868|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
125984869|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
125984870|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
125984871|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
125984872|NCT03420781|453236112|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
125984873|NCT03420781|453236113|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
125984874|NCT03420781|453236114|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
125984875|NCT03420781|453236115|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
125984876|NCT03420781|453236116|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
125984877|NCT03420781|453236112|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125984878|NCT03420781|453236113|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125984879|NCT03420781|453236114|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125984880|NCT03420781|453236115|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
125984881|NCT03420781|453236116|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125984882|NCT03420781|453236112|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125984883|NCT03420781|453236113|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125984884|NCT03420781|453236114|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125984885|NCT03420781|453236115|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125984886|NCT03420781|453236116|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
125984887|NCT03420781|453236112|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
125984888|NCT03420781|453236113|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
125984889|NCT03420781|453236114|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
125984890|NCT03420781|453236115|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
125984891|NCT03420781|453236116|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
125984892|NCT00215540|453236127|FG000|Overall Study|Withdrew from study medication|1|||
125984893|NCT00215540|453236128|FG001|Overall Study|Withdrew from study medication|0|||
125984894|NCT00215540|453236129|FG002|Overall Study|Withdrew from study medication|0|||
125984895|NCT02799472|453236136|FG000|Overall Study|Withdrawal by Subject|2|||
125984896|NCT02799472|453236137|FG001|Overall Study|Withdrawal by Subject|4|||
125984897|NCT02799472|453236136|FG000|Overall Study|Lack of Efficacy|2|||
125984898|NCT02799472|453236137|FG001|Overall Study|Lack of Efficacy|0|||
125984899|NCT02799472|453236136|FG000|Overall Study|Lost to Follow-up|0|||
125984900|NCT02799472|453236137|FG001|Overall Study|Lost to Follow-up|1|||
125984901|NCT00674570|453236138|FG000|Overall Study|Withdrawal by Subject|0|||
125984902|NCT00674570|453236139|FG001|Overall Study|Withdrawal by Subject|2|||
125984903|NCT00674570|453236140|FG002|Overall Study|Withdrawal by Subject|0|||
125984904|NCT04461795|453236142|FG000|Overall Study|Lost to Follow-up|2|||
125984905|NCT04461795|453236142|FG000|Overall Study|Withdrawal by Subject|2|||
125984906|NCT04461795|453236142|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
126324257|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
126324258|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
126324259|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
126324260|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
126324261|NCT03836209|454482052|FG000|Overall Study|Adverse Event|5|||
125984907|NCT00058422|453236143|FG000|Overall Study|Not treated|2|||
125984908|NCT00185640|453236144|FG000|Overall Study|Not Eligible|4|||
126324262|NCT03836209|454482053|FG001|Overall Study|Adverse Event|2|||
126324263|NCT03836209|454482052|FG000|Overall Study|Death|4|||
126324264|NCT03836209|454482053|FG001|Overall Study|Death|1|||
126324265|NCT03836209|454482052|FG000|Overall Study|Lack of Efficacy|7|||
126324266|NCT03836209|454482053|FG001|Overall Study|Lack of Efficacy|10|||
126324267|NCT03836209|454482052|FG000|Overall Study|Physician Decision|7|||
126324268|NCT03836209|454482053|FG001|Overall Study|Physician Decision|11|||
126324269|NCT03836209|454482052|FG000|Overall Study|Protocol Violation|0|||
126324270|NCT03836209|454482053|FG001|Overall Study|Protocol Violation|3|||
126324271|NCT03836209|454482052|FG000|Overall Study|Withdrawal by Subject|2|||
126324272|NCT03836209|454482053|FG001|Overall Study|Withdrawal by Subject|10|||
126324273|NCT03836209|454482052|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
126324274|NCT03836209|454482053|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
126324275|NCT03739710|454482054|FG000|Overall Study|Screen Failed|81|||
126324276|NCT01424241|454482055|FG000|Overall Study|Withdrawal by Subject|1|||
126324277|NCT01424241|454482055|FG000|Overall Study|Time constraints|2|||
126324278|NCT05259917|454482056|FG000|Overall Study|Protocol Violation|0|||
126324279|NCT05259917|454482057|FG001|Overall Study|Protocol Violation|0|||
126324280|NCT05259917|454482058|FG002|Overall Study|Protocol Violation|1|||
125984909|NCT00185640|453236144|FG000|Overall Study|Withdrawal by Subject|3|||
125984910|NCT00185640|453236144|FG000|Overall Study|Death|138|||
125984911|NCT01520402|453236145|FG000|Overall Study|Withdrawal by Subject|2|||
125984912|NCT01520402|453236145|FG000|Overall Study|Physician Decision|3|||
125984913|NCT01722162|453236146|FG000|Overall Study|Withdrawal by Subject|1|||
125984914|NCT01722162|453236147|FG001|Overall Study|Withdrawal by Subject|1|||
125984915|NCT01722162|453236146|FG000|Overall Study|Found ineligible|1|||
125984916|NCT01722162|453236147|FG001|Overall Study|Found ineligible|0|||
125984917|NCT01722162|453236146|FG000|Overall Study|Unrelated to study adverse event|2|||
125984918|NCT01722162|453236147|FG001|Overall Study|Unrelated to study adverse event|2|||
125984919|NCT01722162|453236146|FG000|Overall Study|Adverse Event|1|||
125984920|NCT01722162|453236147|FG001|Overall Study|Adverse Event|1|||
125984921|NCT01722162|453236146|FG000|Overall Study|Insurance denial post enrollment|0|||
125984922|NCT01722162|453236147|FG001|Overall Study|Insurance denial post enrollment|1|||
125984923|NCT01722162|453236146|FG000|Overall Study|Noncompliance|0|||
125984924|NCT01722162|453236147|FG001|Overall Study|Noncompliance|1|||
125984925|NCT03124199|453236148|FG000|Overall Study|Lost to Follow-up|4|||
125984926|NCT03086018|453236149|FG000|Final Testing for End of Trial|Adverse Event|1|||
125984927|NCT03086018|453236149|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
125984928|NCT02748694|453236150|FG000|Overall Study|Voluntary Withdrawal|0|||
125984929|NCT02748694|453236151|FG001|Overall Study|Voluntary Withdrawal|0|||
125984930|NCT02748694|453236152|FG002|Overall Study|Voluntary Withdrawal|0|||
125984931|NCT02748694|453236153|FG003|Overall Study|Voluntary Withdrawal|0|||
125984932|NCT02748694|453236154|FG004|Overall Study|Voluntary Withdrawal|0|||
125984933|NCT02748694|453236155|FG005|Overall Study|Voluntary Withdrawal|0|||
125984934|NCT02748694|453236156|FG006|Overall Study|Voluntary Withdrawal|0|||
125984935|NCT02748694|453236157|FG007|Overall Study|Voluntary Withdrawal|0|||
125984936|NCT02748694|453236158|FG008|Overall Study|Voluntary Withdrawal|0|||
125984937|NCT02748694|453236159|FG009|Overall Study|Voluntary Withdrawal|0|||
125984938|NCT02748694|453236160|FG010|Overall Study|Voluntary Withdrawal|0|||
125984939|NCT02748694|453236161|FG011|Overall Study|Voluntary Withdrawal|0|||
125984940|NCT02748694|453236162|FG012|Overall Study|Voluntary Withdrawal|0|||
125984941|NCT02748694|453236163|FG013|Overall Study|Voluntary Withdrawal|0|||
125984942|NCT02748694|453236164|FG014|Overall Study|Voluntary Withdrawal|2|||
125984943|NCT00077064|453236165|FG000|Overall Study|Adverse Event|0|||
125984944|NCT00077064|453236166|FG001|Overall Study|Adverse Event|4|||
125984945|NCT00077064|453236165|FG000|Overall Study|Patient refusal|0|||
125984946|NCT00077064|453236166|FG001|Overall Study|Patient refusal|2|||
125984947|NCT02192970|453236170|FG000|Overall Study|Lost to Follow-up|6|||
125984948|NCT02192970|453236171|FG001|Overall Study|Lost to Follow-up|0|||
125984949|NCT04074590|453236172|FG000|Overall Study|Adverse Event|1|||
125984950|NCT04074590|453236173|FG001|Overall Study|Adverse Event|0|||
125984951|NCT04074590|453236172|FG000|Overall Study|Physician Decision|1|||
125984952|NCT04074590|453236173|FG001|Overall Study|Physician Decision|0|||
125984953|NCT04074590|453236172|FG000|Overall Study|Withdrawal by Subject|2|||
125984954|NCT04074590|453236173|FG001|Overall Study|Withdrawal by Subject|0|||
126324281|NCT05259917|454482059|FG003|Overall Study|Protocol Violation|0|||
126324282|NCT05259917|454482060|FG004|Overall Study|Protocol Violation|0|||
126324283|NCT05259917|454482061|FG005|Overall Study|Protocol Violation|0|||
126324284|NCT05259917|454482056|FG000|Overall Study|Lost to Follow-up|0|||
126324285|NCT05259917|454482057|FG001|Overall Study|Lost to Follow-up|0|||
125984955|NCT02709005|453236174|FG000|Overall Study|Lost to Follow-up|1|||
125984956|NCT02709005|453236175|FG001|Overall Study|Lost to Follow-up|1|||
125984957|NCT02709005|453236174|FG000|Overall Study|Withdrawal by Subject|3|||
125984958|NCT02709005|453236175|FG001|Overall Study|Withdrawal by Subject|0|||
125984959|NCT00691132|453236176|FG000|Overall Study|Adverse Event|2|||
125984960|NCT00691132|453236177|FG001|Overall Study|Adverse Event|3|||
125984961|NCT00691132|453236176|FG000|Overall Study|Withdrawal by Subject|10|||
125984962|NCT00691132|453236177|FG001|Overall Study|Withdrawal by Subject|10|||
125984963|NCT01959347|453236178|FG000|Overall Study|Protocol Violation|9|||
125984964|NCT01959347|453236179|FG001|Overall Study|Protocol Violation|7|||
125984965|NCT03954743|453236180|FG000|Overall Study|Adverse Event|1|||
125984966|NCT03954743|453236181|FG001|Overall Study|Adverse Event|0|||
125984967|NCT03954743|453236180|FG000|Overall Study|Lost to Follow-up|6|||
125984968|NCT03954743|453236181|FG001|Overall Study|Lost to Follow-up|4|||
125984969|NCT03954743|453236180|FG000|Overall Study|Protocol Violation|1|||
125984970|NCT03954743|453236181|FG001|Overall Study|Protocol Violation|0|||
126324286|NCT05259917|454482058|FG002|Overall Study|Lost to Follow-up|1|||
126324287|NCT05259917|454482059|FG003|Overall Study|Lost to Follow-up|0|||
126324288|NCT05259917|454482060|FG004|Overall Study|Lost to Follow-up|0|||
126324289|NCT05259917|454482061|FG005|Overall Study|Lost to Follow-up|1|||
126324290|NCT05259917|454482056|FG000|Overall Study|Physician Decision|0|||
126324291|NCT05259917|454482057|FG001|Overall Study|Physician Decision|1|||
126324292|NCT05259917|454482058|FG002|Overall Study|Physician Decision|0|||
126324293|NCT05259917|454482059|FG003|Overall Study|Physician Decision|0|||
126324294|NCT05259917|454482060|FG004|Overall Study|Physician Decision|0|||
126324295|NCT05259917|454482061|FG005|Overall Study|Physician Decision|0|||
126324296|NCT05259917|454482056|FG000|Overall Study|Withdrawal by Subject|0|||
126324297|NCT05259917|454482057|FG001|Overall Study|Withdrawal by Subject|1|||
126324298|NCT05259917|454482058|FG002|Overall Study|Withdrawal by Subject|0|||
126324299|NCT05259917|454482059|FG003|Overall Study|Withdrawal by Subject|0|||
126324300|NCT05259917|454482060|FG004|Overall Study|Withdrawal by Subject|1|||
126324301|NCT05259917|454482061|FG005|Overall Study|Withdrawal by Subject|1|||
126324302|NCT05259917|454482056|FG000|Overall Study|Trial Termination by Sponsor|7|||
126324303|NCT05259917|454482057|FG001|Overall Study|Trial Termination by Sponsor|2|||
126324304|NCT05259917|454482058|FG002|Overall Study|Trial Termination by Sponsor|3|||
126324305|NCT05259917|454482059|FG003|Overall Study|Trial Termination by Sponsor|5|||
126324306|NCT05259917|454482060|FG004|Overall Study|Trial Termination by Sponsor|11|||
126324307|NCT05259917|454482061|FG005|Overall Study|Trial Termination by Sponsor|4|||
126324308|NCT05259917|454482056|FG000|Overall Study|Other|1|||
126324309|NCT05259917|454482057|FG001|Overall Study|Other|0|||
126324310|NCT05259917|454482058|FG002|Overall Study|Other|2|||
126324311|NCT05259917|454482059|FG003|Overall Study|Other|0|||
126324312|NCT05259917|454482060|FG004|Overall Study|Other|0|||
126324313|NCT05259917|454482061|FG005|Overall Study|Other|0|||
126324314|NCT00482170|454482062|FG000|Overall Study|Adverse Event|5|||
126324315|NCT00482170|454482063|FG001|Overall Study|Adverse Event|14|||
126324316|NCT00482170|454482062|FG000|Overall Study|Withdrawal by Subject|6|||
126324317|NCT00482170|454482063|FG001|Overall Study|Withdrawal by Subject|1|||
126324318|NCT00482170|454482062|FG000|Overall Study|Protocol Violation|2|||
126324319|NCT00482170|454482063|FG001|Overall Study|Protocol Violation|3|||
126324320|NCT00482170|454482062|FG000|Overall Study|Lost to Follow-up|2|||
126324321|NCT00482170|454482063|FG001|Overall Study|Lost to Follow-up|0|||
126324322|NCT00482170|454482062|FG000|Overall Study|Unspecified reason|0|||
126324323|NCT00482170|454482063|FG001|Overall Study|Unspecified reason|2|||
126324324|NCT01658904|454482064|FG000|Overall Study|Principal Investigator discretion|2|||
126324325|NCT01658904|454482065|FG001|Overall Study|Principal Investigator discretion|0|||
126324326|NCT01658904|454482066|FG002|Overall Study|Principal Investigator discretion|0|||
126324327|NCT00080483|454482067|FG000|Overall Study|Lost to Follow-up|1|||
126324328|NCT00080483|454482068|FG001|Overall Study|Lost to Follow-up|1|||
126324329|NCT00080483|454482067|FG000|Overall Study|Physician Decision|1|||
126324330|NCT00080483|454482068|FG001|Overall Study|Physician Decision|1|||
126324331|NCT00460746|454482076|FG000|Overall Study|Adverse Event|1|||
126324332|NCT00460746|454482076|FG000|Overall Study|Lost to Follow-up|1|||
126324333|NCT04399538|454482081|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
126324334|NCT04399538|454482082|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
126324335|NCT04399538|454482083|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
126324336|NCT04399538|454482084|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
126324337|NCT04399538|454482085|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
126324338|NCT04399538|454482081|FG000|Double-Blind Treatment|Adverse Event|0|||
126324339|NCT04399538|454482082|FG001|Double-Blind Treatment|Adverse Event|0|||
125984971|NCT03954743|453236180|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
125984972|NCT03954743|453236181|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
125984973|NCT03954743|453236180|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
125984974|NCT03954743|453236181|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125984975|NCT02387996|453236184|FG000|Overall Study|Disease Progression|167|||
125984976|NCT02387996|453236184|FG000|Overall Study|Study Drug Toxicity|31|||
126324340|NCT04399538|454482083|FG002|Double-Blind Treatment|Adverse Event|0|||
126324341|NCT04399538|454482084|FG003|Double-Blind Treatment|Adverse Event|0|||
126324342|NCT04399538|454482085|FG004|Double-Blind Treatment|Adverse Event|1|||
126324343|NCT04399538|454482081|FG000|Follow-Up|Adverse Event|0|||
125984977|NCT02387996|453236184|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
126324344|NCT04399538|454482082|FG001|Follow-Up|Adverse Event|0|||
126324345|NCT04399538|454482083|FG002|Follow-Up|Adverse Event|0|||
126324346|NCT04399538|454482084|FG003|Follow-Up|Adverse Event|0|||
125984978|NCT02387996|453236184|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
126324347|NCT04399538|454482085|FG004|Follow-Up|Adverse Event|1|||
125984979|NCT02387996|453236184|FG000|Overall Study|Subject Withdrew Consent|5|||
125984980|NCT02387996|453236184|FG000|Overall Study|Lost to Follow-up|1|||
125984981|NCT02387996|453236184|FG000|Overall Study|Poor/Non-Compliance|1|||
125984982|NCT02387996|453236184|FG000|Overall Study|Other Reasons|5|||
125984983|NCT02387996|453236184|FG000|Overall Study|Death|1|||
125984984|NCT05375955|453236195|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
125984985|NCT05375955|453236196|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
125984986|NCT05375955|453236197|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
125984987|NCT05375955|453236198|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
125984988|NCT05375955|453236199|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
125984989|NCT05375955|453236200|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
125984990|NCT05375955|453236201|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
125984991|NCT05375955|453236195|FG000|Treatment (12 Weeks)|Physician Decision|4|||
125984992|NCT05375955|453236196|FG001|Treatment (12 Weeks)|Physician Decision|1|||
125984993|NCT05375955|453236197|FG002|Treatment (12 Weeks)|Physician Decision|3|||
125984994|NCT05375955|453236198|FG003|Treatment (12 Weeks)|Physician Decision|0|||
125984995|NCT05375955|453236199|FG004|Treatment (12 Weeks)|Physician Decision|0|||
125984996|NCT05375955|453236200|FG005|Treatment (12 Weeks)|Physician Decision|1|||
125984997|NCT05375955|453236201|FG006|Treatment (12 Weeks)|Physician Decision|0|||
125984998|NCT05375955|453236195|FG000|Treatment (12 Weeks)|Other|0|||
125984999|NCT05375955|453236196|FG001|Treatment (12 Weeks)|Other|1|||
125985000|NCT05375955|453236197|FG002|Treatment (12 Weeks)|Other|0|||
125985001|NCT05375955|453236198|FG003|Treatment (12 Weeks)|Other|0|||
125985002|NCT05375955|453236199|FG004|Treatment (12 Weeks)|Other|0|||
125985003|NCT05375955|453236200|FG005|Treatment (12 Weeks)|Other|0|||
125985004|NCT05375955|453236201|FG006|Treatment (12 Weeks)|Other|0|||
125985005|NCT05375955|453236195|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125985006|NCT05375955|453236196|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125985007|NCT05375955|453236197|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125985008|NCT05375955|453236198|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125985009|NCT05375955|453236199|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125985010|NCT05375955|453236200|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125985011|NCT05375955|453236201|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
125985012|NCT05375955|453236195|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
125985013|NCT05375955|453236196|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
125985014|NCT05375955|453236197|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
125985015|NCT05375955|453236198|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
125985016|NCT05375955|453236199|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
125985017|NCT05375955|453236200|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
125985018|NCT05375955|453236201|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
125985019|NCT05375955|453236195|FG000|Treatment (12 Weeks)|Pregnancy|0|||
125985020|NCT05375955|453236196|FG001|Treatment (12 Weeks)|Pregnancy|0|||
125985021|NCT05375955|453236197|FG002|Treatment (12 Weeks)|Pregnancy|1|||
125985022|NCT05375955|453236198|FG003|Treatment (12 Weeks)|Pregnancy|0|||
125985023|NCT05375955|453236199|FG004|Treatment (12 Weeks)|Pregnancy|0|||
125985024|NCT05375955|453236200|FG005|Treatment (12 Weeks)|Pregnancy|0|||
125985025|NCT05375955|453236201|FG006|Treatment (12 Weeks)|Pregnancy|0|||
125985026|NCT05375955|453236195|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125985027|NCT05375955|453236196|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125985028|NCT05375955|453236197|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
125985029|NCT05375955|453236198|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125985030|NCT05375955|453236199|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125985031|NCT05375955|453236200|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125985032|NCT05375955|453236201|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125985033|NCT05375955|453236195|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
125985034|NCT05375955|453236196|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
125985035|NCT05375955|453236197|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
125985036|NCT05375955|453236198|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
126324348|NCT04399538|454482081|FG000|Follow-Up|Withdrawal by Subject|0|||
126324349|NCT04399538|454482082|FG001|Follow-Up|Withdrawal by Subject|0|||
126324350|NCT04399538|454482083|FG002|Follow-Up|Withdrawal by Subject|0|||
126324351|NCT04399538|454482084|FG003|Follow-Up|Withdrawal by Subject|2|||
126324352|NCT04399538|454482085|FG004|Follow-Up|Withdrawal by Subject|0|||
126324353|NCT00636961|454482090|FG000|Period 1|Administrative problems|1|||
125985037|NCT05375955|453236199|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
125985038|NCT05375955|453236200|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
125985039|NCT05375955|453236201|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
125985040|NCT05375955|453236195|FG000|Follow-up (up to 5 Weeks)|Other|0|||
125985041|NCT05375955|453236196|FG001|Follow-up (up to 5 Weeks)|Other|1|||
125985042|NCT05375955|453236197|FG002|Follow-up (up to 5 Weeks)|Other|0|||
125985043|NCT05375955|453236198|FG003|Follow-up (up to 5 Weeks)|Other|0|||
125985044|NCT05375955|453236199|FG004|Follow-up (up to 5 Weeks)|Other|0|||
125985045|NCT05375955|453236200|FG005|Follow-up (up to 5 Weeks)|Other|0|||
126324354|NCT00636961|454482091|FG001|Period 1|Administrative problems|1|||
126324355|NCT00636961|454482090|FG000|Period 2|Adverse Event|1|||
126324356|NCT00636961|454482091|FG001|Period 2|Adverse Event|0|||
126324357|NCT01573754|454482093|FG000|Overall Study|Noncompliance or remission not achieved|3|||
126324358|NCT01573754|454482094|FG001|Overall Study|Noncompliance or remission not achieved|15|||
126324359|NCT00829829|454482096|FG000|Overall Study|Protocol Violation|0|||
126324360|NCT00829829|454482097|FG001|Overall Study|Protocol Violation|3|||
126324361|NCT00829829|454482098|FG002|Overall Study|Protocol Violation|0|||
126324362|NCT00829829|454482096|FG000|Overall Study|Adverse Event|4|||
126324363|NCT00829829|454482097|FG001|Overall Study|Adverse Event|4|||
126324364|NCT00829829|454482098|FG002|Overall Study|Adverse Event|3|||
126324365|NCT00829829|454482096|FG000|Overall Study|Withdrawal by Subject|8|||
126324366|NCT00829829|454482097|FG001|Overall Study|Withdrawal by Subject|4|||
126324367|NCT00829829|454482098|FG002|Overall Study|Withdrawal by Subject|2|||
126324368|NCT00829829|454482096|FG000|Overall Study|Decision by the Sponsor|1|||
126324369|NCT00829829|454482097|FG001|Overall Study|Decision by the Sponsor|0|||
126324370|NCT00829829|454482098|FG002|Overall Study|Decision by the Sponsor|2|||
126324371|NCT00829829|454482096|FG000|Overall Study|Lost to Follow-up|7|||
126324372|NCT00829829|454482097|FG001|Overall Study|Lost to Follow-up|3|||
126324373|NCT00829829|454482098|FG002|Overall Study|Lost to Follow-up|3|||
126324374|NCT00829829|454482096|FG000|Overall Study|Other than specified above|2|||
126324375|NCT00829829|454482097|FG001|Overall Study|Other than specified above|2|||
126324376|NCT00829829|454482098|FG002|Overall Study|Other than specified above|1|||
126324377|NCT02685072|454482099|FG000|Treatment Period|Lost to Follow-up|12|||
126324378|NCT02685072|454482100|FG001|Treatment Period|Lost to Follow-up|6|||
126324379|NCT02685072|454482099|FG000|Treatment Period|Withdrawal by Subject|1|||
126324380|NCT02685072|454482100|FG001|Treatment Period|Withdrawal by Subject|3|||
126324381|NCT02685072|454482099|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
126324382|NCT02685072|454482100|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
126324383|NCT02634710|454482101|FG000|Overall Study|Death|4|||
126324384|NCT02717442|454482103|FG000|Overall Study|Study Terminated by Sponsor|31|||
126324385|NCT02717442|454482104|FG001|Overall Study|Study Terminated by Sponsor|29|||
126324386|NCT02717442|454482103|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
126324387|NCT02717442|454482104|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
126324388|NCT02717442|454482103|FG000|Overall Study|Other - Not Specified|2|||
126324389|NCT02717442|454482104|FG001|Overall Study|Other - Not Specified|0|||
126324390|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
126324391|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324392|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324393|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324394|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324395|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324396|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324397|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324398|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324399|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
126324400|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
126324401|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
126324402|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
126324403|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
126324404|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
126324405|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
126324406|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
126324407|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
126324408|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
126324409|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
126324410|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
126324411|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
126324412|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
126324413|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
126324414|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
126324415|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
126324416|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
126324417|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
126324418|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
126324419|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
126324420|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
126324421|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
126324422|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
126324423|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
126324424|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
125985046|NCT05375955|453236201|FG006|Follow-up (up to 5 Weeks)|Other|0|||
125985047|NCT05375955|453236195|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
125985048|NCT05375955|453236196|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
126324425|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
126324426|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324427|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324428|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324429|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
126324430|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324431|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
126324432|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324433|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324434|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324435|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
126324436|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324437|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
126324438|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324439|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324440|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
126324441|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324442|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324443|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324444|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
126324445|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324446|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324447|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
126324448|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324449|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324450|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324451|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
126324452|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324453|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
126324454|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
126324455|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
126324456|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
126324457|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
126324458|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
126324459|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
126324460|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
126324461|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
126324462|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
126324463|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
126324464|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
126324465|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
126324466|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
126324467|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
126324468|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
126324469|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
126324470|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
126324471|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
126324472|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
126324473|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
126324474|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
126324475|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
126324476|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
126324477|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
126324478|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
126324479|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
126324480|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
126324481|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
126324482|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
126324483|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
125985049|NCT05375955|453236197|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
125985050|NCT05375955|453236198|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
126324484|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
126324485|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
126324486|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
126324487|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
126324488|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
126324489|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324490|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
126324491|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
126324492|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
126324493|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324494|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324495|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
126324496|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324497|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324498|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324499|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324500|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125985051|NCT05375955|453236199|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
125985052|NCT05375955|453236200|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
125985053|NCT05375955|453236201|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
125985054|NCT05375955|453236195|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
125985055|NCT05375955|453236196|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
125985056|NCT05375955|453236197|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
125985057|NCT05375955|453236198|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
125985058|NCT05375955|453236199|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
126324501|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324502|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
126324503|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
126324504|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125985059|NCT05375955|453236200|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
125985060|NCT05375955|453236201|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
125985061|NCT01320943|453236202|FG000|Overall Study|Lost to Follow-up|1|||
125985062|NCT01320943|453236203|FG001|Overall Study|Lost to Follow-up|0|||
125985063|NCT01320943|453236202|FG000|Overall Study|Physician Decision|0|||
125985064|NCT01320943|453236203|FG001|Overall Study|Physician Decision|1|||
125985065|NCT01320943|453236202|FG000|Overall Study|Randomized but not Treated|0|||
125985066|NCT01320943|453236203|FG001|Overall Study|Randomized but not Treated|1|||
125985067|NCT02158884|453236208|FG000|Baseline Assessment|Missed performance assessment|3|||
125985068|NCT02158884|453236208|FG000|Baseline Assessment|Missed SMFA|1|||
125985069|NCT02158884|453236208|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
125985070|NCT02158884|453236208|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
125985071|NCT02158884|453236208|FG000|6 Month Assessment|Missed SMFA|20|||
125985072|NCT02158884|453236208|FG000|12 Month Assessment|Missed SMFA|17|||
125985073|NCT01313286|453236209|FG000|Period 1|Withdrawal by Subject|2|||
125985074|NCT01313286|453236210|FG001|Period 1|Withdrawal by Subject|0|||
125985075|NCT02034708|453236211|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
125985076|NCT02034708|453236212|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
125985077|NCT02034708|453236211|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
125985078|NCT02034708|453236212|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
125985079|NCT02034708|453236211|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
125985080|NCT02034708|453236212|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
125985081|NCT02034708|453236211|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
125985082|NCT02034708|453236212|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
125985083|NCT00733980|453236215|FG000|Overall Study|Adverse Event|5|||
125985084|NCT00733980|453236216|FG001|Overall Study|Adverse Event|2|||
125985085|NCT00733980|453236215|FG000|Overall Study|Lack of Efficacy|0|||
125985086|NCT00733980|453236216|FG001|Overall Study|Lack of Efficacy|1|||
125985087|NCT00733980|453236215|FG000|Overall Study|Protocol Violation|2|||
125985088|NCT00733980|453236216|FG001|Overall Study|Protocol Violation|1|||
125985089|NCT00733980|453236215|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
125985090|NCT00733980|453236216|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
125985091|NCT00733980|453236215|FG000|Overall Study|Lost to Follow-up|6|||
126324505|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324506|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324507|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125985092|NCT00733980|453236216|FG001|Overall Study|Lost to Follow-up|11|||
125985093|NCT00733980|453236215|FG000|Overall Study|Physician Decision|2|||
125985094|NCT00733980|453236216|FG001|Overall Study|Physician Decision|3|||
126324508|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
126324509|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324510|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324511|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324512|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324513|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
126324514|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324515|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
126324516|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
126324517|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
126324518|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
126324519|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
126324520|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
126324521|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
126324522|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
126324523|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
126324524|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
126324525|NCT02772809|454482117|FG000|Overall Study|not completed some tasks|6|||
126324526|NCT02774005|454482123|FG000|Overall Study|Adverse Event|8|||
126324527|NCT02774005|454482123|FG000|Overall Study|Withdrawal by Subject|23|||
126324528|NCT02774005|454482123|FG000|Overall Study|Lost to Follow-up|7|||
126324529|NCT02774005|454482123|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
126324530|NCT02774005|454482123|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
126324531|NCT02774005|454482123|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
126324532|NCT02774005|454482123|FG000|Overall Study|Death|1|||
126324533|NCT02774005|454482123|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
126324534|NCT02774005|454482123|FG000|Overall Study|Lack of compliance with study medication|4|||
126324535|NCT02774005|454482123|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
126324536|NCT02774005|454482123|FG000|Overall Study|another study|1|||
126324537|NCT02774005|454482123|FG000|Overall Study|cardiologist imposed travel restriction|1|||
126324538|NCT00534105|454482124|FG000|Overall Study|Lost to Follow-up|23|||
126324539|NCT00534105|454482125|FG001|Overall Study|Lost to Follow-up|39|||
126324540|NCT03275389|454482129|FG000|Overall Study|Lost to Follow-up|10|||
126324541|NCT03275389|454482130|FG001|Overall Study|Lost to Follow-up|10|||
126324542|NCT03275389|454482131|FG002|Overall Study|Lost to Follow-up|19|||
126324543|NCT03275389|454482132|FG003|Overall Study|Lost to Follow-up|12|||
126324544|NCT03275389|454482133|FG004|Overall Study|Lost to Follow-up|11|||
126324545|NCT03275389|454482134|FG005|Overall Study|Lost to Follow-up|12|||
126324546|NCT03275389|454482135|FG006|Overall Study|Lost to Follow-up|21|||
126324547|NCT03275389|454482136|FG007|Overall Study|Lost to Follow-up|15|||
126324548|NCT03275389|454482137|FG008|Overall Study|Lost to Follow-up|12|||
126324549|NCT03275389|454482138|FG009|Overall Study|Lost to Follow-up|14|||
126324550|NCT03275389|454482129|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324551|NCT03275389|454482130|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324552|NCT03275389|454482131|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324553|NCT03275389|454482132|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324554|NCT03275389|454482133|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324555|NCT03275389|454482134|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
126324556|NCT03275389|454482135|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324557|NCT03275389|454482136|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324558|NCT03275389|454482137|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324559|NCT03275389|454482138|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
126324560|NCT03275389|454482129|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
126324561|NCT03275389|454482130|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126324562|NCT03275389|454482131|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126324563|NCT03275389|454482132|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
126324564|NCT03275389|454482133|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
126324565|NCT03275389|454482134|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
126324566|NCT03275389|454482135|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
126324567|NCT03275389|454482136|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
126324568|NCT03275389|454482137|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
126324569|NCT03275389|454482138|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
126324570|NCT03275389|454482129|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324571|NCT03275389|454482130|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126324572|NCT03275389|454482131|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324573|NCT03275389|454482132|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
125985095|NCT00733980|453236215|FG000|Overall Study|Withdrawal by Subject|6|||
125985096|NCT00733980|453236216|FG001|Overall Study|Withdrawal by Subject|2|||
125985097|NCT00779779|453236217|FG000|Overall Study|Adverse Event|1|||
125985098|NCT00779779|453236217|FG000|Overall Study|Protocol Violation|14|||
125985099|NCT00779779|453236217|FG000|Overall Study|Withdrawal by Subject|4|||
125985100|NCT00779779|453236217|FG000|Overall Study|Lost to Follow-up|5|||
125985101|NCT02719990|453236218|FG000|Overall Study|Physician Decision|2|||
125985102|NCT02719990|453236218|FG000|Overall Study|Withdrawal by Subject|2|||
125985103|NCT02719990|453236218|FG000|Overall Study|Study Terminated By Sponsor|32|||
125985104|NCT02010632|453236219|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
125985105|NCT02010632|453236220|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
125985106|NCT06387472|453236229|FG000|Overall Study|Withdrawal by Subject|1|||
125985107|NCT06387472|453236229|FG000|Overall Study|Lost to Follow-up|2|||
125985108|NCT06387472|453236229|FG000|Overall Study|Physician Decision|1|||
125985109|NCT00404495|453236231|FG000|Overall Study|Death|37|||
125985110|NCT00404495|453236232|FG001|Overall Study|Death|11|||
125985111|NCT00404495|453236231|FG000|Overall Study|Lost to Follow-up|5|||
125985112|NCT00404495|453236232|FG001|Overall Study|Lost to Follow-up|0|||
125985113|NCT00404495|453236231|FG000|Overall Study|Other|1|||
125985114|NCT00404495|453236232|FG001|Overall Study|Other|0|||
125985115|NCT00404495|453236231|FG000|Overall Study|Withdrawal by Subject|1|||
125985116|NCT00404495|453236232|FG001|Overall Study|Withdrawal by Subject|0|||
125985117|NCT01061333|453236233|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
125985118|NCT01061333|453236234|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
125985119|NCT00045708|453237887|FG000|Phase 1|early progressive disease|0|||
125985120|NCT00045708|453237888|FG001|Phase 1|early progressive disease|1|||
125985121|NCT00045708|453237889|FG002|Phase 1|early progressive disease|0|||
125985122|NCT01679236|453237890|FG000|Overall Study|Lost to Follow-up|15|||
125985123|NCT01679236|453237891|FG001|Overall Study|Lost to Follow-up|15|||
125985124|NCT01160484|453237895|FG000|Overall Study|Lack of Efficacy|9|||
125985125|NCT01160484|453237895|FG000|Overall Study|Adverse Event|6|||
125985126|NCT01160484|453237895|FG000|Overall Study|Withdrawal by Subject|2|||
125985127|NCT01160484|453237895|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
125985128|NCT00803101|453237896|FG000|Overall Study|Death / Serious Adverse Event|4|||
125985129|NCT00803101|453237897|FG001|Overall Study|Death / Serious Adverse Event|6|||
125985130|NCT00803101|453237896|FG000|Overall Study|Withdrawal by Subject|6|||
125985131|NCT00803101|453237897|FG001|Overall Study|Withdrawal by Subject|4|||
125985132|NCT00803101|453237896|FG000|Overall Study|Lost to Follow-up|2|||
125985133|NCT00803101|453237897|FG001|Overall Study|Lost to Follow-up|2|||
125985134|NCT00803101|453237896|FG000|Overall Study|Protocol Violation|1|||
125985135|NCT00803101|453237897|FG001|Overall Study|Protocol Violation|7|||
125985136|NCT00803101|453237896|FG000|Overall Study|Surgery finished outside protocol window|1|||
125985137|NCT00803101|453237897|FG001|Overall Study|Surgery finished outside protocol window|1|||
125985138|NCT00803101|453237896|FG000|Overall Study|Patient died outside SAE report period|1|||
125985139|NCT00803101|453237897|FG001|Overall Study|Patient died outside SAE report period|0|||
125985140|NCT00803101|453237896|FG000|Overall Study|Patient did not attend scheduled visit|2|||
125985141|NCT00803101|453237897|FG001|Overall Study|Patient did not attend scheduled visit|1|||
125985142|NCT00803101|453237896|FG000|Overall Study|Patient did not have surgery|1|||
125985143|NCT00803101|453237897|FG001|Overall Study|Patient did not have surgery|1|||
125985144|NCT01782742|453237898|FG000|Double-blind Treatment Phase|Adverse Event|1|||
125985145|NCT01782742|453237899|FG001|Double-blind Treatment Phase|Adverse Event|0|||
125985146|NCT01679301|453237902|FG000|Screening Period|screen failure|3|||
125985147|NCT01679301|453237903|FG001|Screening Period|screen failure|0|||
125985148|NCT01679301|453237904|FG002|Screening Period|screen failure|0|||
125985149|NCT02026232|453237905|FG000|Overall Study|incomplete visit/missing data|3|||
126324574|NCT03275389|454482133|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324575|NCT03275389|454482134|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324576|NCT03275389|454482135|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126324577|NCT03275389|454482136|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324578|NCT03275389|454482137|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324579|NCT03275389|454482138|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324580|NCT03275389|454482129|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324581|NCT03275389|454482130|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324582|NCT03275389|454482131|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
126324583|NCT03275389|454482132|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324584|NCT03275389|454482133|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324585|NCT03275389|454482134|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324586|NCT03275389|454482135|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324587|NCT03275389|454482136|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125985150|NCT02026232|453237906|FG001|Overall Study|incomplete visit/missing data|2|||
125985151|NCT01529008|453237907|FG000|Bone Marrow Harvesting|Physician Decision|1|||
125985152|NCT01529008|453237908|FG001|Bone Marrow Harvesting|Physician Decision|1|||
125985153|NCT01529008|453237907|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
125985154|NCT01529008|453237908|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
126324588|NCT03275389|454482137|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324589|NCT03275389|454482138|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
126324590|NCT03275389|454482129|FG000|Overall Study|Other|0|||
126324591|NCT03275389|454482130|FG001|Overall Study|Other|4|||
126324592|NCT03275389|454482131|FG002|Overall Study|Other|3|||
126324593|NCT03275389|454482132|FG003|Overall Study|Other|2|||
126324594|NCT03275389|454482133|FG004|Overall Study|Other|2|||
126324595|NCT03275389|454482134|FG005|Overall Study|Other|2|||
126324596|NCT03275389|454482135|FG006|Overall Study|Other|0|||
126324597|NCT03275389|454482136|FG007|Overall Study|Other|0|||
126324598|NCT03275389|454482137|FG008|Overall Study|Other|1|||
126324599|NCT03275389|454482138|FG009|Overall Study|Other|0|||
126324600|NCT02432144|454482139|FG000|Overall Study|Participant Non-Compliance|1|||
126324601|NCT00978341|454482140|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
126324602|NCT00978341|454482141|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
126324603|NCT03035916|454482142|FG000|Overall Study|Puncture failed|0|||
126324604|NCT03035916|454482143|FG001|Overall Study|Puncture failed|2|||
126324605|NCT03035916|454482144|FG002|Overall Study|Puncture failed|0|||
126324606|NCT00448812|454482145|FG000|Year 2|Missed visit but remained in study|4|||
126324607|NCT00448812|454482146|FG001|Year 2|Missed visit but remained in study|1|||
126324608|NCT00448812|454482145|FG000|Year 3|Withdrawal by Subject|1|||
126324609|NCT00448812|454482146|FG001|Year 3|Withdrawal by Subject|3|||
126324610|NCT00448812|454482145|FG000|Year 3|Lost to Follow-up|1|||
126324611|NCT00448812|454482146|FG001|Year 3|Lost to Follow-up|0|||
126324612|NCT00448812|454482145|FG000|Year 3|Missed visit but remained in study|2|||
126324613|NCT00448812|454482146|FG001|Year 3|Missed visit but remained in study|0|||
126324614|NCT00448812|454482145|FG000|Year 5|Missed visit but remained in study|1|||
126324615|NCT00448812|454482146|FG001|Year 5|Missed visit but remained in study|0|||
126324616|NCT03885999|454482147|FG000|Overall Study|Adverse Event|1|||
126324617|NCT02452554|454482148|FG000|Overall Study|Death|2|||
126324618|NCT02452554|454482149|FG001|Overall Study|Death|1|||
126324619|NCT02452554|454482150|FG002|Overall Study|Death|0|||
126324620|NCT02452554|454482151|FG003|Overall Study|Death|0|||
126324621|NCT02452554|454482152|FG004|Overall Study|Death|0|||
126324622|NCT02452554|454482153|FG005|Overall Study|Death|0|||
126324623|NCT02452554|454482148|FG000|Overall Study|Lack of Efficacy|13|||
126324624|NCT02452554|454482149|FG001|Overall Study|Lack of Efficacy|14|||
126324625|NCT02452554|454482150|FG002|Overall Study|Lack of Efficacy|9|||
126324626|NCT02452554|454482151|FG003|Overall Study|Lack of Efficacy|1|||
126324627|NCT02452554|454482152|FG004|Overall Study|Lack of Efficacy|5|||
126324628|NCT02452554|454482153|FG005|Overall Study|Lack of Efficacy|8|||
126324629|NCT02452554|454482148|FG000|Overall Study|Physician Decision|0|||
126324630|NCT02452554|454482149|FG001|Overall Study|Physician Decision|1|||
126324631|NCT02452554|454482150|FG002|Overall Study|Physician Decision|0|||
126324632|NCT02452554|454482151|FG003|Overall Study|Physician Decision|0|||
126324633|NCT02452554|454482152|FG004|Overall Study|Physician Decision|0|||
126324634|NCT02452554|454482153|FG005|Overall Study|Physician Decision|0|||
126324635|NCT02452554|454482148|FG000|Overall Study|Withdrawal by Subject|1|||
126324636|NCT02452554|454482149|FG001|Overall Study|Withdrawal by Subject|0|||
126324637|NCT02452554|454482150|FG002|Overall Study|Withdrawal by Subject|2|||
126324638|NCT02452554|454482151|FG003|Overall Study|Withdrawal by Subject|0|||
126324639|NCT02452554|454482152|FG004|Overall Study|Withdrawal by Subject|0|||
126324640|NCT02452554|454482153|FG005|Overall Study|Withdrawal by Subject|1|||
126324641|NCT02452554|454482148|FG000|Overall Study|Ineligible|0|||
126324642|NCT02452554|454482149|FG001|Overall Study|Ineligible|1|||
126324643|NCT02452554|454482150|FG002|Overall Study|Ineligible|0|||
126324644|NCT02452554|454482151|FG003|Overall Study|Ineligible|0|||
126324645|NCT02452554|454482152|FG004|Overall Study|Ineligible|0|||
126324646|NCT02452554|454482153|FG005|Overall Study|Ineligible|0|||
126324647|NCT02452554|454482148|FG000|Overall Study|Never Received Treatment|1|||
126324648|NCT02452554|454482149|FG001|Overall Study|Never Received Treatment|0|||
126324649|NCT02452554|454482150|FG002|Overall Study|Never Received Treatment|0|||
126324650|NCT02452554|454482151|FG003|Overall Study|Never Received Treatment|0|||
126324651|NCT02452554|454482152|FG004|Overall Study|Never Received Treatment|0|||
126324652|NCT02452554|454482153|FG005|Overall Study|Never Received Treatment|0|||
126324653|NCT02636439|454482156|FG000|Overall Study|Adverse Event|2|||
126324654|NCT02636439|454482157|FG001|Overall Study|Adverse Event|2|||
126324655|NCT02636439|454482156|FG000|Overall Study|Lost to Follow-up|1|||
126324656|NCT02636439|454482157|FG001|Overall Study|Lost to Follow-up|0|||
126324657|NCT02636439|454482156|FG000|Overall Study|Non-compliance|1|||
126324658|NCT02636439|454482157|FG001|Overall Study|Non-compliance|1|||
126324659|NCT02636439|454482156|FG000|Overall Study|Personal reasons|2|||
126324660|NCT02636439|454482157|FG001|Overall Study|Personal reasons|0|||
126324661|NCT05188729|454482158|FG000|Overall Study|Withdrawal by Subject|0|||
126324662|NCT05188729|454482159|FG001|Overall Study|Withdrawal by Subject|0|||
126324663|NCT05188729|454482160|FG002|Overall Study|Withdrawal by Subject|0|||
126324664|NCT05188729|454482161|FG003|Overall Study|Withdrawal by Subject|0|||
126324665|NCT05188729|454482162|FG004|Overall Study|Withdrawal by Subject|0|||
126324666|NCT05188729|454482163|FG005|Overall Study|Withdrawal by Subject|0|||
126324667|NCT05188729|454482164|FG006|Overall Study|Withdrawal by Subject|0|||
126324668|NCT05188729|454482165|FG007|Overall Study|Withdrawal by Subject|0|||
126324669|NCT05188729|454482166|FG008|Overall Study|Withdrawal by Subject|0|||
126324670|NCT05188729|454482167|FG009|Overall Study|Withdrawal by Subject|1|||
126324671|NCT05188729|454482168|FG010|Overall Study|Withdrawal by Subject|0|||
126324672|NCT05188729|454482169|FG011|Overall Study|Withdrawal by Subject|0|||
126324673|NCT05188729|454482170|FG012|Overall Study|Withdrawal by Subject|0|||
126324674|NCT05188729|454482158|FG000|Overall Study|Lost to Follow-up|0|||
126324675|NCT05188729|454482159|FG001|Overall Study|Lost to Follow-up|0|||
126324676|NCT05188729|454482160|FG002|Overall Study|Lost to Follow-up|0|||
126324677|NCT05188729|454482161|FG003|Overall Study|Lost to Follow-up|0|||
126324678|NCT05188729|454482162|FG004|Overall Study|Lost to Follow-up|0|||
126324679|NCT05188729|454482163|FG005|Overall Study|Lost to Follow-up|0|||
126324680|NCT05188729|454482164|FG006|Overall Study|Lost to Follow-up|0|||
126324681|NCT05188729|454482165|FG007|Overall Study|Lost to Follow-up|0|||
126324682|NCT05188729|454482166|FG008|Overall Study|Lost to Follow-up|0|||
126324683|NCT05188729|454482167|FG009|Overall Study|Lost to Follow-up|0|||
126324684|NCT05188729|454482168|FG010|Overall Study|Lost to Follow-up|1|||
126324685|NCT05188729|454482169|FG011|Overall Study|Lost to Follow-up|1|||
126324686|NCT05188729|454482170|FG012|Overall Study|Lost to Follow-up|0|||
126324687|NCT02552888|454482171|FG000|Overall Study|Lost to Follow-up|1|||
126324688|NCT02552888|454482172|FG001|Overall Study|Lost to Follow-up|1|||
126324689|NCT00762034|454483734|FG000|Induction Period|Protocol Violation|1|||
126324690|NCT00762034|454483735|FG001|Induction Period|Protocol Violation|2|||
126324691|NCT00762034|454483734|FG000|Induction Period|Entry Criterion Not Met|12|||
126324692|NCT00762034|454483735|FG001|Induction Period|Entry Criterion Not Met|11|||
126324693|NCT00762034|454483734|FG000|Induction Period|Adverse Event|27|||
126324694|NCT00762034|454483735|FG001|Induction Period|Adverse Event|38|||
126324695|NCT00762034|454483734|FG000|Induction Period|Lost to Follow-up|1|||
126324696|NCT00762034|454483735|FG001|Induction Period|Lost to Follow-up|1|||
126324697|NCT00762034|454483734|FG000|Induction Period|Progressive Disease|73|||
126324698|NCT00762034|454483735|FG001|Induction Period|Progressive Disease|55|||
126324699|NCT00762034|454483734|FG000|Induction Period|Physician Decision|21|||
126324700|NCT00762034|454483735|FG001|Induction Period|Physician Decision|20|||
126324701|NCT00762034|454483734|FG000|Induction Period|Withdrawal by Subject|15|||
126324702|NCT00762034|454483735|FG001|Induction Period|Withdrawal by Subject|19|||
126324703|NCT00762034|454483734|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
126324704|NCT00762034|454483735|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
126324705|NCT00762034|454483734|FG000|Induction Period|Deaths Due to Study Disease|9|||
126324706|NCT00762034|454483735|FG001|Induction Period|Deaths Due to Study Disease|9|||
126324707|NCT00762034|454483734|FG000|Maintenance Period|Protocol Violation|1|||
126324708|NCT00762034|454483735|FG001|Maintenance Period|Protocol Violation|3|||
126324709|NCT00762034|454483734|FG000|Maintenance Period|Entry Criterion Not Met|0|||
126324710|NCT00762034|454483735|FG001|Maintenance Period|Entry Criterion Not Met|2|||
126324711|NCT00762034|454483734|FG000|Maintenance Period|Adverse Event|42|||
126324712|NCT00762034|454483735|FG001|Maintenance Period|Adverse Event|26|||
126324713|NCT00762034|454483734|FG000|Maintenance Period|Progressive Disease|186|||
126324714|NCT00762034|454483735|FG001|Maintenance Period|Progressive Disease|224|||
126324715|NCT00762034|454483734|FG000|Maintenance Period|Physician Decision|25|||
126324716|NCT00762034|454483735|FG001|Maintenance Period|Physician Decision|20|||
126324717|NCT00762034|454483734|FG000|Maintenance Period|Withdrawal by Subject|34|||
126324718|NCT00762034|454483735|FG001|Maintenance Period|Withdrawal by Subject|14|||
126324719|NCT00762034|454483734|FG000|Maintenance Period|Death not due to study disease|2|||
126324720|NCT00762034|454483735|FG001|Maintenance Period|Death not due to study disease|5|||
126324721|NCT00762034|454483734|FG000|Maintenance Period|Death due to study disease|3|||
126324722|NCT00762034|454483735|FG001|Maintenance Period|Death due to study disease|3|||
126324723|NCT00762034|454483734|FG000|Maintenance Period|Other|1|||
126324724|NCT00762034|454483735|FG001|Maintenance Period|Other|1|||
126324725|NCT01299896|454483738|FG000|Overall Study|Withdrawal by Subject|1|||
126324726|NCT01299896|454483739|FG001|Overall Study|Withdrawal by Subject|7|||
126324727|NCT01299896|454483738|FG000|Overall Study|Lost to Follow-up|0|||
126324728|NCT01299896|454483739|FG001|Overall Study|Lost to Follow-up|11|||
126324729|NCT02107313|454483740|FG000|Overall Study|One participant did not do the FED cohor|0|||
126324730|NCT02107313|454483741|FG001|Overall Study|One participant did not do the FED cohor|1|||
126324731|NCT02090283|454483746|FG000|Overall Study|Withdrawal by Subject|6|||
126324732|NCT02090283|454483747|FG001|Overall Study|Withdrawal by Subject|6|||
126324733|NCT02090283|454483748|FG002|Overall Study|Withdrawal by Subject|6|||
126324734|NCT02090283|454483746|FG000|Overall Study|Sponsor Terminated Study|6|||
126324735|NCT02090283|454483747|FG001|Overall Study|Sponsor Terminated Study|6|||
126324736|NCT02090283|454483748|FG002|Overall Study|Sponsor Terminated Study|1|||
126324737|NCT02090283|454483746|FG000|Overall Study|Lost to Follow-up|2|||
126324738|NCT02090283|454483747|FG001|Overall Study|Lost to Follow-up|2|||
126324739|NCT02090283|454483748|FG002|Overall Study|Lost to Follow-up|3|||
126324740|NCT02090283|454483746|FG000|Overall Study|Adverse Event|1|||
126324741|NCT02090283|454483747|FG001|Overall Study|Adverse Event|1|||
126324742|NCT02090283|454483748|FG002|Overall Study|Adverse Event|0|||
126324743|NCT02090283|454483746|FG000|Overall Study|Protocol Violation|2|||
126324744|NCT02090283|454483747|FG001|Overall Study|Protocol Violation|0|||
125985155|NCT01529008|453237907|FG000|Treatment|Adverse Event|6|||
125985156|NCT01529008|453237908|FG001|Treatment|Adverse Event|0|||
125985157|NCT01529008|453237907|FG000|Treatment|Other|3|||
125985158|NCT01529008|453237908|FG001|Treatment|Other|1|||
125985159|NCT01529008|453237907|FG000|Efficacy Analysis|Protocol Violation|2|||
125985160|NCT01529008|453237908|FG001|Efficacy Analysis|Protocol Violation|0|||
125985161|NCT01529008|453237907|FG000|Efficacy Analysis|Physician Decision|0|||
125985162|NCT01529008|453237908|FG001|Efficacy Analysis|Physician Decision|1|||
125985163|NCT01529008|453237907|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
126324745|NCT02090283|454483748|FG002|Overall Study|Protocol Violation|0|||
126324746|NCT01411319|454483752|FG000|Overall Study|Lost to Follow-up|1|||
126324747|NCT05205005|454483767|FG000|Overall Study|Withdrawal by Subject|1|||
126324748|NCT05205005|454483768|FG001|Overall Study|Withdrawal by Subject|0|||
126324749|NCT05205005|454483767|FG000|Overall Study|Adverse Event|1|||
126324750|NCT05205005|454483768|FG001|Overall Study|Adverse Event|0|||
126324751|NCT02187029|454483770|FG000|Overall Study|Adverse Event|0|||
126324752|NCT02187029|454483771|FG001|Overall Study|Adverse Event|1|||
126324753|NCT02187029|454483772|FG002|Overall Study|Adverse Event|1|||
126324754|NCT02187029|454483773|FG003|Overall Study|Adverse Event|0|||
126324755|NCT02187029|454483770|FG000|Overall Study|Study Terminated by Sponsor|0|||
126324756|NCT02187029|454483771|FG001|Overall Study|Study Terminated by Sponsor|0|||
126324757|NCT02187029|454483772|FG002|Overall Study|Study Terminated by Sponsor|10|||
126324758|NCT02187029|454483773|FG003|Overall Study|Study Terminated by Sponsor|3|||
126324759|NCT02187029|454483770|FG000|Overall Study|Withdrawal by Subject|1|||
126324760|NCT02187029|454483771|FG001|Overall Study|Withdrawal by Subject|0|||
126324761|NCT02187029|454483772|FG002|Overall Study|Withdrawal by Subject|0|||
126324762|NCT02187029|454483773|FG003|Overall Study|Withdrawal by Subject|0|||
126324763|NCT03042910|454483774|FG000|Overall Study|Adverse Event|1|||
126324764|NCT03042910|454483774|FG000|Overall Study|Disease Progression|2|||
126324765|NCT03042910|454483774|FG000|Overall Study|Withdrawal by Subject|3|||
126324766|NCT03042910|454483774|FG000|Overall Study|Enrolled but not treated|1|||
126324767|NCT01491841|454483779|FG000|Overall Study|Screen Failure|10|||
126324768|NCT01491841|454483779|FG000|Overall Study|Withdrawal by Subject|1|||
126324769|NCT02933528|454483780|FG000|Overall Study|Lost to Follow-up|2|||
126324770|NCT04472494|454483782|FG000|Pre-treatment|Other reasons|2|||
126324771|NCT04472494|454483783|FG001|Pre-treatment|Other reasons|0|||
126324772|NCT04472494|454483782|FG000|Treatment|Death|5|||
126324773|NCT04472494|454483783|FG001|Treatment|Death|2|||
126324774|NCT04472494|454483782|FG000|Treatment|Hospital discharge|1|||
126324775|NCT04472494|454483783|FG001|Treatment|Hospital discharge|1|||
126324776|NCT01308463|454483784|FG000|Overall Study|Study Discontinued|23|||
126324777|NCT01308463|454483784|FG000|Overall Study|Death|4|||
126324778|NCT01308463|454483784|FG000|Overall Study|Revision|2|||
126324779|NCT03297021|454483785|FG000|Overall Study|Incomplete/illegible data sheet|4|||
126324780|NCT03297021|454483786|FG001|Overall Study|Incomplete/illegible data sheet|2|||
126324781|NCT03297021|454483787|FG002|Overall Study|Incomplete/illegible data sheet|3|||
126324782|NCT03297021|454483785|FG000|Overall Study|Missing Post-Op Data|1|||
126324783|NCT03297021|454483786|FG001|Overall Study|Missing Post-Op Data|2|||
126324784|NCT03297021|454483787|FG002|Overall Study|Missing Post-Op Data|1|||
126324785|NCT02784288|454483788|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
126324786|NCT02734862|454483789|FG000|Part A|Death|3|||
126324787|NCT02734862|454483790|FG001|Part A|Death|4|||
126324788|NCT02734862|454483791|FG002|Part A|Death|6|||
126324789|NCT02734862|454483789|FG000|Part A|Lost to Follow-up|2|||
126324790|NCT02734862|454483790|FG001|Part A|Lost to Follow-up|1|||
126324791|NCT02734862|454483791|FG002|Part A|Lost to Follow-up|1|||
126324792|NCT02734862|454483789|FG000|Part A|Withdrawal by Subject|1|||
126324793|NCT02734862|454483790|FG001|Part A|Withdrawal by Subject|1|||
126324794|NCT02734862|454483791|FG002|Part A|Withdrawal by Subject|2|||
126324795|NCT02734862|454483789|FG000|Part A|Physician Decision|2|||
126324796|NCT02734862|454483790|FG001|Part A|Physician Decision|0|||
126324797|NCT02734862|454483791|FG002|Part A|Physician Decision|1|||
126324798|NCT02734862|454483789|FG000|Part A|Adverse Event|2|||
126324799|NCT02734862|454483790|FG001|Part A|Adverse Event|0|||
125985164|NCT01529008|453237908|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
126324800|NCT02734862|454483791|FG002|Part A|Adverse Event|1|||
126324801|NCT02734862|454483789|FG000|Part A|Noncompliance|1|||
126324802|NCT02734862|454483790|FG001|Part A|Noncompliance|1|||
126324803|NCT02734862|454483791|FG002|Part A|Noncompliance|0|||
126324804|NCT02734862|454483789|FG000|Part A|Other|1|||
126324805|NCT02734862|454483790|FG001|Part A|Other|1|||
126324806|NCT02734862|454483791|FG002|Part A|Other|3|||
125985165|NCT02305381|453237909|FG000|Overall Study|Unclassified|5|||
126324807|NCT02734862|454483789|FG000|Part B|Death|8|||
126324808|NCT02734862|454483790|FG001|Part B|Death|3|||
126324809|NCT02734862|454483791|FG002|Part B|Death|5|||
126324810|NCT02734862|454483789|FG000|Part B|Lost to Follow-up|2|||
126324811|NCT02734862|454483790|FG001|Part B|Lost to Follow-up|2|||
126324812|NCT02734862|454483791|FG002|Part B|Lost to Follow-up|0|||
126324813|NCT02734862|454483789|FG000|Part B|Withdrawal by Subject|3|||
126324814|NCT02734862|454483790|FG001|Part B|Withdrawal by Subject|1|||
126324815|NCT02734862|454483791|FG002|Part B|Withdrawal by Subject|0|||
126324816|NCT02734862|454483789|FG000|Part B|Other|0|||
125985166|NCT02305381|453237910|FG001|Overall Study|Unclassified|5|||
125985167|NCT02305381|453237911|FG002|Overall Study|Unclassified|7|||
126324817|NCT02734862|454483790|FG001|Part B|Other|1|||
126324818|NCT02734862|454483791|FG002|Part B|Other|0|||
126324819|NCT02757625|454483792|FG000|Overall Study|Investigator's discretion|0|||
126324820|NCT02757625|454483793|FG001|Overall Study|Investigator's discretion|0|||
126324821|NCT02757625|454483794|FG002|Overall Study|Investigator's discretion|1|||
126324822|NCT02757625|454483795|FG003|Overall Study|Investigator's discretion|0|||
126324823|NCT02757625|454483792|FG000|Overall Study|Adverse Event|0|||
126324824|NCT02757625|454483793|FG001|Overall Study|Adverse Event|0|||
126324825|NCT02757625|454483794|FG002|Overall Study|Adverse Event|1|||
126324826|NCT02757625|454483795|FG003|Overall Study|Adverse Event|0|||
126324827|NCT04854057|454483796|FG000|Overall Study|Adverse Event|0|||
126324828|NCT04854057|454483797|FG001|Overall Study|Adverse Event|1|||
126324829|NCT02131233|454483798|FG000|Overall Study|Not Treated|2|||
126324830|NCT02131233|454483799|FG001|Overall Study|Not Treated|3|||
126324831|NCT02131233|454483798|FG000|Overall Study|Adverse Event|7|||
126324832|NCT02131233|454483799|FG001|Overall Study|Adverse Event|6|||
126324833|NCT02131233|454483798|FG000|Overall Study|Death|0|||
126324834|NCT02131233|454483799|FG001|Overall Study|Death|1|||
126324835|NCT02131233|454483798|FG000|Overall Study|Lack of Efficacy|6|||
126324836|NCT02131233|454483799|FG001|Overall Study|Lack of Efficacy|3|||
126324837|NCT02131233|454483798|FG000|Overall Study|Lost to Follow-up|14|||
126324838|NCT02131233|454483799|FG001|Overall Study|Lost to Follow-up|13|||
126324839|NCT02131233|454483798|FG000|Overall Study|Non-Compliance With Study Drug|8|||
126324840|NCT02131233|454483799|FG001|Overall Study|Non-Compliance With Study Drug|5|||
126324841|NCT02131233|454483798|FG000|Overall Study|Physician Decision|7|||
126324842|NCT02131233|454483799|FG001|Overall Study|Physician Decision|0|||
126324843|NCT02131233|454483798|FG000|Overall Study|Pregnancy|4|||
126324844|NCT02131233|454483799|FG001|Overall Study|Pregnancy|0|||
126324845|NCT02131233|454483798|FG000|Overall Study|Withdrawal by Subject|18|||
126324846|NCT02131233|454483799|FG001|Overall Study|Withdrawal by Subject|11|||
126324847|NCT03519919|454483800|FG000|Overall Study|Withdrawal by Subject|1|||
126324848|NCT03519919|454483800|FG000|Overall Study|Lack of Efficacy|1|||
126324849|NCT03519919|454483800|FG000|Overall Study|Screen Failure|1|||
126324850|NCT02095197|454483801|FG000|Overall Study|Lost to Follow-up|0|||
126324851|NCT02095197|454483802|FG001|Overall Study|Lost to Follow-up|3|||
125985168|NCT05056870|453237917|FG000|Period 1|Site COVID-19 Related|3|||
125985169|NCT05056870|453237918|FG001|Period 1|Site COVID-19 Related|3|||
125985170|NCT05056870|453237917|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125985171|NCT05056870|453237918|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
125985172|NCT05056870|453237917|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
125985173|NCT05056870|453237918|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125985174|NCT05056870|453237917|FG000|Period 2|COVID-19 Related|1|||
125985175|NCT05056870|453237918|FG001|Period 2|COVID-19 Related|0|||
125985176|NCT05056870|453237917|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
125985177|NCT05056870|453237918|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
125985178|NCT02487498|453237919|FG000|Period: Period 1|Adverse Event|2|||
125985179|NCT02487498|453237920|FG001|Period: Period 1|Adverse Event|4|||
125985180|NCT02487498|453237919|FG000|Period: Period 1|Subject/guardian decision|2|||
125985181|NCT02487498|453237920|FG001|Period: Period 1|Subject/guardian decision|4|||
125985182|NCT02487498|453237919|FG000|Period: Period 1|Lost to Follow-up|0|||
125985183|NCT02487498|453237920|FG001|Period: Period 1|Lost to Follow-up|2|||
125985184|NCT02487498|453237919|FG000|Period: Period 1|Lack of Efficacy|1|||
125985185|NCT02487498|453237920|FG001|Period: Period 1|Lack of Efficacy|0|||
125985186|NCT02487498|453237919|FG000|Period: Period 1|Physician Decision|0|||
125985187|NCT02487498|453237920|FG001|Period: Period 1|Physician Decision|1|||
125985188|NCT02487498|453237919|FG000|Period: Period 1|Protocol deviation|1|||
125985189|NCT02487498|453237920|FG001|Period: Period 1|Protocol deviation|0|||
125985190|NCT02487498|453237919|FG000|Period: Washout|Subject/guardian decision|0|||
125985191|NCT02487498|453237920|FG001|Period: Washout|Subject/guardian decision|5|||
125985192|NCT02487498|453237919|FG000|Period: Washout|Lack of Efficacy|1|||
125985193|NCT02487498|453237920|FG001|Period: Washout|Lack of Efficacy|1|||
125985194|NCT02487498|453237919|FG000|Period: Washout|Physician Decision|1|||
125985195|NCT02487498|453237920|FG001|Period: Washout|Physician Decision|0|||
125985196|NCT02487498|453237919|FG000|Period: Washout|Non-compliance with study treatment|0|||
125985197|NCT02487498|453237920|FG001|Period: Washout|Non-compliance with study treatment|1|||
126324852|NCT02829047|454483803|FG000|Overall Study|Withdrawal by Subject|1|||
126324853|NCT01909973|454483804|FG000|Overall Study|Lost to Follow-up|1|||
126324854|NCT01909973|454483805|FG001|Overall Study|Lost to Follow-up|0|||
126324855|NCT00460239|454483806|FG000|Overall Study|Physician Decision|0|||
126324856|NCT00460239|454483807|FG001|Overall Study|Physician Decision|1|||
126324857|NCT00460239|454483808|FG002|Overall Study|Physician Decision|0|||
126324858|NCT00460239|454483809|FG003|Overall Study|Physician Decision|0|||
126324859|NCT00460239|454483810|FG004|Overall Study|Physician Decision|0|||
126324860|NCT00460239|454483811|FG005|Overall Study|Physician Decision|2|||
126324861|NCT00460239|454483812|FG006|Overall Study|Physician Decision|0|||
125985198|NCT02487498|453237919|FG000|Period: Period 2|Adverse Event|2|||
125985199|NCT02487498|453237920|FG001|Period: Period 2|Adverse Event|2|||
125985200|NCT02487498|453237919|FG000|Period: Period 2|Subject/guardian decision|2|||
125985201|NCT02487498|453237920|FG001|Period: Period 2|Subject/guardian decision|1|||
125985202|NCT02487498|453237919|FG000|Period: Period 2|Lost to Follow-up|1|||
125985203|NCT02487498|453237920|FG001|Period: Period 2|Lost to Follow-up|1|||
125985204|NCT02487498|453237919|FG000|Period: Period 2|Death|0|||
125985205|NCT02487498|453237920|FG001|Period: Period 2|Death|1|||
125985206|NCT02487498|453237919|FG000|Period: Period 2|Physician Decision|1|||
125985207|NCT02487498|453237920|FG001|Period: Period 2|Physician Decision|0|||
125985208|NCT00676130|453237921|FG000|Overall Study|Lost to Follow-up|0|||
125985209|NCT00676130|453237922|FG001|Overall Study|Lost to Follow-up|1|||
125985210|NCT00676130|453237921|FG000|Overall Study|Found ineligible|3|||
125985211|NCT00676130|453237922|FG001|Overall Study|Found ineligible|2|||
125985212|NCT00676130|453237921|FG000|Overall Study|Withdrawal by Subject|0|||
125985213|NCT00676130|453237922|FG001|Overall Study|Withdrawal by Subject|1|||
125985214|NCT05044325|453237925|FG000|Part A:Treatment Period 1|Adverse Event|0|||
125985215|NCT05044325|453237926|FG001|Part A:Treatment Period 1|Adverse Event|0|||
125985216|NCT05044325|453237927|FG002|Part A:Treatment Period 1|Adverse Event|0|||
125985217|NCT05044325|453237928|FG003|Part A:Treatment Period 1|Adverse Event|0|||
125985218|NCT05044325|453237929|FG004|Part A:Treatment Period 1|Adverse Event|0|||
125985219|NCT05044325|453237930|FG005|Part A:Treatment Period 1|Adverse Event|1|||
125985220|NCT05044325|453237931|FG006|Part A:Treatment Period 1|Adverse Event|0|||
125985221|NCT05044325|453237932|FG007|Part A:Treatment Period 1|Adverse Event|1|||
125985222|NCT05044325|453237933|FG008|Part A:Treatment Period 1|Adverse Event|0|||
125985223|NCT05044325|453237934|FG009|Part A:Treatment Period 1|Adverse Event|0|||
125985224|NCT05044325|453237925|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125985225|NCT05044325|453237926|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125985226|NCT05044325|453237927|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125985227|NCT05044325|453237928|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
125985228|NCT05044325|453237929|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
125985229|NCT05044325|453237930|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
125985230|NCT05044325|453237931|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125985231|NCT05044325|453237932|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125985232|NCT05044325|453237933|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125985233|NCT05044325|453237934|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125985234|NCT05044325|453237925|FG000|Part A:Treatment Period 1|Physician Decision|0|||
125985235|NCT05044325|453237926|FG001|Part A:Treatment Period 1|Physician Decision|0|||
125985236|NCT05044325|453237927|FG002|Part A:Treatment Period 1|Physician Decision|0|||
125985237|NCT05044325|453237928|FG003|Part A:Treatment Period 1|Physician Decision|0|||
125985238|NCT05044325|453237929|FG004|Part A:Treatment Period 1|Physician Decision|0|||
125985239|NCT05044325|453237930|FG005|Part A:Treatment Period 1|Physician Decision|0|||
125985240|NCT05044325|453237931|FG006|Part A:Treatment Period 1|Physician Decision|1|||
125985241|NCT05044325|453237932|FG007|Part A:Treatment Period 1|Physician Decision|0|||
125985242|NCT05044325|453237933|FG008|Part A:Treatment Period 1|Physician Decision|0|||
125985243|NCT05044325|453237934|FG009|Part A:Treatment Period 1|Physician Decision|0|||
126324862|NCT00460239|454483813|FG007|Overall Study|Physician Decision|0|||
126324863|NCT00460239|454483814|FG008|Overall Study|Physician Decision|0|||
126324864|NCT00460239|454483806|FG000|Overall Study|Withdrawal by Subject|0|||
126324865|NCT00460239|454483807|FG001|Overall Study|Withdrawal by Subject|0|||
126324866|NCT00460239|454483808|FG002|Overall Study|Withdrawal by Subject|0|||
126324867|NCT00460239|454483809|FG003|Overall Study|Withdrawal by Subject|0|||
126324868|NCT00460239|454483810|FG004|Overall Study|Withdrawal by Subject|0|||
126324869|NCT00460239|454483811|FG005|Overall Study|Withdrawal by Subject|1|||
126324870|NCT00460239|454483812|FG006|Overall Study|Withdrawal by Subject|0|||
126324871|NCT00460239|454483813|FG007|Overall Study|Withdrawal by Subject|0|||
126324872|NCT00460239|454483814|FG008|Overall Study|Withdrawal by Subject|0|||
126324873|NCT04217317|454483843|FG000|Overall Study|Lack of Efficacy|4|||
126324874|NCT04217317|454483843|FG000|Overall Study|Physician Decision|1|||
126324875|NCT01690299|454483844|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
126324876|NCT01690299|454483845|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
126324877|NCT01690299|454483846|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
125985244|NCT05044325|453237925|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125985245|NCT05044325|453237926|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125985246|NCT05044325|453237927|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
125985247|NCT05044325|453237928|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125985248|NCT05044325|453237929|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125985249|NCT05044325|453237930|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126324878|NCT01690299|454483847|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
126324879|NCT01690299|454483848|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
126324880|NCT01690299|454483849|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
125985250|NCT05044325|453237931|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125985251|NCT05044325|453237932|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125985252|NCT05044325|453237933|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125985253|NCT05044325|453237934|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125985254|NCT05044325|453237925|FG000|Part A:Treatment Period 2|Adverse Event|0|||
125985255|NCT05044325|453237926|FG001|Part A:Treatment Period 2|Adverse Event|1|||
125985256|NCT05044325|453237927|FG002|Part A:Treatment Period 2|Adverse Event|0|||
125985257|NCT05044325|453237928|FG003|Part A:Treatment Period 2|Adverse Event|0|||
125985258|NCT05044325|453237929|FG004|Part A:Treatment Period 2|Adverse Event|1|||
125985259|NCT05044325|453237930|FG005|Part A:Treatment Period 2|Adverse Event|1|||
125985260|NCT05044325|453237931|FG006|Part A:Treatment Period 2|Adverse Event|0|||
125985261|NCT05044325|453237932|FG007|Part A:Treatment Period 2|Adverse Event|0|||
125985262|NCT05044325|453237933|FG008|Part A:Treatment Period 2|Adverse Event|0|||
125985263|NCT05044325|453237934|FG009|Part A:Treatment Period 2|Adverse Event|0|||
125985264|NCT05044325|453237925|FG000|Part A:Treatment Period 2|Physician Decision|0|||
125985265|NCT05044325|453237926|FG001|Part A:Treatment Period 2|Physician Decision|0|||
125985266|NCT05044325|453237927|FG002|Part A:Treatment Period 2|Physician Decision|0|||
125985267|NCT05044325|453237928|FG003|Part A:Treatment Period 2|Physician Decision|0|||
125985268|NCT05044325|453237929|FG004|Part A:Treatment Period 2|Physician Decision|0|||
125985269|NCT05044325|453237930|FG005|Part A:Treatment Period 2|Physician Decision|1|||
125985270|NCT05044325|453237931|FG006|Part A:Treatment Period 2|Physician Decision|0|||
125985271|NCT05044325|453237932|FG007|Part A:Treatment Period 2|Physician Decision|0|||
125985272|NCT05044325|453237933|FG008|Part A:Treatment Period 2|Physician Decision|0|||
125985273|NCT05044325|453237934|FG009|Part A:Treatment Period 2|Physician Decision|0|||
125985274|NCT05044325|453237925|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125985275|NCT05044325|453237926|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125985276|NCT05044325|453237927|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125985277|NCT05044325|453237928|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
125985278|NCT05044325|453237929|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
126324881|NCT01690299|454483844|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
126324882|NCT01690299|454483845|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324883|NCT01690299|454483846|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324884|NCT01690299|454483847|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324885|NCT01690299|454483848|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324886|NCT01690299|454483849|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324887|NCT01690299|454483844|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
126324888|NCT01690299|454483845|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
126324889|NCT01690299|454483846|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126324890|NCT01690299|454483847|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126324891|NCT01690299|454483848|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126324892|NCT01690299|454483849|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126324893|NCT01690299|454483844|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
126324894|NCT01690299|454483845|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
126324895|NCT01690299|454483846|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
126324896|NCT01690299|454483847|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
126324897|NCT01690299|454483848|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
126324898|NCT01690299|454483849|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
126324899|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
126324900|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
126324901|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
126324902|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
126324903|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
126324904|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
126324905|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
126324906|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
126324907|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
126324908|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
126324909|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
126324910|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
126324911|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
126324912|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
126324913|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
126324914|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
126324915|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
125985279|NCT05044325|453237930|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125985280|NCT05044325|453237931|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126324916|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
125985281|NCT05044325|453237932|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125985282|NCT05044325|453237933|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125985283|NCT05044325|453237934|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125985284|NCT00755222|453237935|FG000|Overall Study|Withdrawal by Subject|4|||
125985285|NCT00755222|453237936|FG001|Overall Study|Withdrawal by Subject|2|||
125985286|NCT00755222|453237935|FG000|Overall Study|Adverse Event|2|||
126324917|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
126324918|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
126324919|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
126324920|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
126324921|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
126324922|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
126324923|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
126324924|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
126324925|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
126324926|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
126324927|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
126324928|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
126324929|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324930|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324931|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324932|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324933|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324934|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
126324935|NCT01753115|454483850|FG000|Overall Study|Lost to Follow-up|3|||
126324936|NCT01753115|454483851|FG001|Overall Study|Lost to Follow-up|6|||
126324937|NCT01753115|454483852|FG002|Overall Study|Lost to Follow-up|8|||
126324938|NCT01753115|454483850|FG000|Overall Study|Withdrawal by Subject|6|||
126324939|NCT01753115|454483851|FG001|Overall Study|Withdrawal by Subject|5|||
126324940|NCT01753115|454483852|FG002|Overall Study|Withdrawal by Subject|6|||
126324941|NCT01753115|454483850|FG000|Overall Study|Subject non-compliant|3|||
125985287|NCT00755222|453237936|FG001|Overall Study|Adverse Event|0|||
125985288|NCT00755222|453237935|FG000|Overall Study|Protocol Violation|2|||
125985289|NCT00755222|453237936|FG001|Overall Study|Protocol Violation|0|||
125985290|NCT02243202|453237942|FG000|Overall Study|Adverse Event|5|||
125985291|NCT02243202|453237943|FG001|Overall Study|Adverse Event|6|||
125985292|NCT02243202|453237944|FG002|Overall Study|Adverse Event|10|||
125985293|NCT02243202|453237945|FG003|Overall Study|Adverse Event|4|||
125985294|NCT02243202|453237942|FG000|Overall Study|Lost to Follow-up|9|||
125985295|NCT02243202|453237943|FG001|Overall Study|Lost to Follow-up|9|||
125985296|NCT02243202|453237944|FG002|Overall Study|Lost to Follow-up|14|||
125985297|NCT02243202|453237945|FG003|Overall Study|Lost to Follow-up|11|||
125985298|NCT02243202|453237942|FG000|Overall Study|Protocol Violation|3|||
125985299|NCT02243202|453237943|FG001|Overall Study|Protocol Violation|1|||
125985300|NCT02243202|453237944|FG002|Overall Study|Protocol Violation|2|||
125985301|NCT02243202|453237945|FG003|Overall Study|Protocol Violation|1|||
125985302|NCT02243202|453237942|FG000|Overall Study|Withdrawal by Subject|7|||
125985303|NCT02243202|453237943|FG001|Overall Study|Withdrawal by Subject|6|||
125985304|NCT02243202|453237944|FG002|Overall Study|Withdrawal by Subject|4|||
125985305|NCT02243202|453237945|FG003|Overall Study|Withdrawal by Subject|4|||
125985306|NCT02243202|453237942|FG000|Overall Study|Other|1|||
125985307|NCT02243202|453237943|FG001|Overall Study|Other|3|||
125985308|NCT02243202|453237944|FG002|Overall Study|Other|1|||
125985309|NCT02243202|453237945|FG003|Overall Study|Other|2|||
125985310|NCT02243202|453237942|FG000|Overall Study|Randomized but not received treatment|0|||
125985311|NCT02243202|453237943|FG001|Overall Study|Randomized but not received treatment|0|||
125985312|NCT02243202|453237944|FG002|Overall Study|Randomized but not received treatment|0|||
125985313|NCT02243202|453237945|FG003|Overall Study|Randomized but not received treatment|1|||
125985314|NCT00991341|453237952|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
125985315|NCT00991341|453237953|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
125985316|NCT00991341|453237952|FG000|Overall Study|Death|3|||
125985317|NCT00991341|453237953|FG001|Overall Study|Death|0|||
126324942|NCT01753115|454483851|FG001|Overall Study|Subject non-compliant|3|||
125985318|NCT00991341|453237952|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
125985319|NCT00991341|453237953|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
125985320|NCT00991341|453237952|FG000|Overall Study|Physician Decision|1|||
125985321|NCT00991341|453237953|FG001|Overall Study|Physician Decision|2|||
125985322|NCT00991341|453237952|FG000|Overall Study|Withdrawal by Subject|3|||
125985323|NCT00991341|453237953|FG001|Overall Study|Withdrawal by Subject|4|||
125985324|NCT01330316|453237959|FG000|Overall Study|Adverse Event|2|||
126324943|NCT01753115|454483852|FG002|Overall Study|Subject non-compliant|0|||
126324944|NCT01753115|454483850|FG000|Overall Study|Used excluded drug|0|||
125985325|NCT01330316|453237960|FG001|Overall Study|Adverse Event|2|||
125985326|NCT01330316|453237959|FG000|Overall Study|Lack of Efficacy|0|||
125985327|NCT01330316|453237960|FG001|Overall Study|Lack of Efficacy|10|||
125985328|NCT01330316|453237959|FG000|Overall Study|Lost to Follow-up|0|||
125985329|NCT01330316|453237960|FG001|Overall Study|Lost to Follow-up|1|||
125985330|NCT01330316|453237959|FG000|Overall Study|Withdrawal by Subject|0|||
125985331|NCT01330316|453237960|FG001|Overall Study|Withdrawal by Subject|1|||
125985332|NCT01330316|453237959|FG000|Overall Study|other than above|0|||
125985333|NCT01330316|453237960|FG001|Overall Study|other than above|1|||
125985334|NCT03010462|453237961|FG000|Overall Study|Withdrawal by Subject|3|||
125985335|NCT03010462|453237962|FG001|Overall Study|Withdrawal by Subject|1|||
125985336|NCT02207725|453237963|FG000|Overall Study|Did Not Receive Treatment|0|||
125985337|NCT02207725|453237964|FG001|Overall Study|Did Not Receive Treatment|1|||
125985338|NCT02207725|453237965|FG002|Overall Study|Did Not Receive Treatment|1|||
125985339|NCT02207725|453237966|FG003|Overall Study|Did Not Receive Treatment|1|||
125985340|NCT03145766|453237967|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
125985341|NCT03145766|453237968|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
125985342|NCT03145766|453237969|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
125985343|NCT03145766|453237970|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
125985344|NCT03145766|453237971|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
125985345|NCT03145766|453237967|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
125985346|NCT03145766|453237968|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
125985347|NCT03145766|453237969|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
125985348|NCT03145766|453237970|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
125985349|NCT03145766|453237971|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
125985350|NCT03145766|453237967|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
125985351|NCT03145766|453237968|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
125985352|NCT03145766|453237969|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
125985353|NCT03145766|453237970|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
125985354|NCT03145766|453237971|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
125985355|NCT03145766|453237967|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
125985356|NCT03145766|453237968|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
125985357|NCT03145766|453237969|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
125985358|NCT03145766|453237970|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
125985359|NCT03145766|453237971|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
125985360|NCT03145766|453237967|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
125985361|NCT03145766|453237968|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
125985362|NCT03145766|453237969|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
125985363|NCT03145766|453237970|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
125985364|NCT03145766|453237971|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
125985365|NCT03145766|453237967|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
125985366|NCT03145766|453237968|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
125985367|NCT03145766|453237969|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
125985368|NCT03145766|453237970|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
125985369|NCT03145766|453237971|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
125985370|NCT03145766|453237967|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
125985371|NCT03145766|453237968|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
125985372|NCT03145766|453237969|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
125985373|NCT03145766|453237970|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
125985374|NCT03145766|453237971|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
125985375|NCT00246337|453237972|FG000|Overall Study|Lost to Follow-up|3|||
125985376|NCT00246337|453237973|FG001|Overall Study|Lost to Follow-up|0|||
125985377|NCT00246337|453237974|FG002|Overall Study|Lost to Follow-up|0|||
126324945|NCT01753115|454483851|FG001|Overall Study|Used excluded drug|1|||
126324946|NCT01753115|454483852|FG002|Overall Study|Used excluded drug|0|||
126324947|NCT04313400|454483856|FG000|Overall Study|Withdrawal by Subject|0|||
126324948|NCT04313400|454483857|FG001|Overall Study|Withdrawal by Subject|0|||
126324949|NCT04313400|454483858|FG002|Overall Study|Withdrawal by Subject|0|||
126324950|NCT04313400|454483859|FG003|Overall Study|Withdrawal by Subject|0|||
126324951|NCT04313400|454483860|FG004|Overall Study|Withdrawal by Subject|0|||
126324952|NCT04313400|454483861|FG005|Overall Study|Withdrawal by Subject|4|||
126324953|NCT04313400|454483862|FG006|Overall Study|Withdrawal by Subject|1|||
126324954|NCT04313400|454483856|FG000|Overall Study|Adverse Event|0|||
126324955|NCT04313400|454483857|FG001|Overall Study|Adverse Event|0|||
126324956|NCT04313400|454483858|FG002|Overall Study|Adverse Event|0|||
126324957|NCT04313400|454483859|FG003|Overall Study|Adverse Event|0|||
126324958|NCT04313400|454483860|FG004|Overall Study|Adverse Event|0|||
126324959|NCT04313400|454483861|FG005|Overall Study|Adverse Event|1|||
125985378|NCT00246337|453237975|FG003|Overall Study|Lost to Follow-up|0|||
125985379|NCT00246337|453237976|FG004|Overall Study|Lost to Follow-up|2|||
125985380|NCT00246337|453237977|FG005|Overall Study|Lost to Follow-up|2|||
125985381|NCT00246337|453237978|FG006|Overall Study|Lost to Follow-up|1|||
126324960|NCT04313400|454483862|FG006|Overall Study|Adverse Event|0|||
126324961|NCT04313400|454483856|FG000|Overall Study|Lost to Follow-up|0|||
126324962|NCT04313400|454483857|FG001|Overall Study|Lost to Follow-up|0|||
126324963|NCT04313400|454483858|FG002|Overall Study|Lost to Follow-up|0|||
126324964|NCT04313400|454483859|FG003|Overall Study|Lost to Follow-up|0|||
126324965|NCT04313400|454483860|FG004|Overall Study|Lost to Follow-up|0|||
126324966|NCT04313400|454483861|FG005|Overall Study|Lost to Follow-up|1|||
126324967|NCT04313400|454483862|FG006|Overall Study|Lost to Follow-up|0|||
126324968|NCT00496587|454483867|FG000|Overall Study|Adverse Event|2|||
126324969|NCT00496587|454483867|FG000|Overall Study|Progressive Disease|24|||
126324970|NCT00496587|454483867|FG000|Overall Study|Withdrawal by Subject|2|||
125985382|NCT00246337|453237979|FG007|Overall Study|Lost to Follow-up|2|||
125985383|NCT00246337|453237980|FG008|Overall Study|Lost to Follow-up|0|||
125985384|NCT00246337|453237972|FG000|Overall Study|Protocol Violation|1|||
125985385|NCT00246337|453237973|FG001|Overall Study|Protocol Violation|0|||
125985386|NCT00246337|453237974|FG002|Overall Study|Protocol Violation|0|||
125985387|NCT00246337|453237975|FG003|Overall Study|Protocol Violation|0|||
125985388|NCT00246337|453237976|FG004|Overall Study|Protocol Violation|1|||
125985389|NCT00246337|453237977|FG005|Overall Study|Protocol Violation|0|||
125985390|NCT00246337|453237978|FG006|Overall Study|Protocol Violation|1|||
125985391|NCT00246337|453237979|FG007|Overall Study|Protocol Violation|1|||
125985392|NCT00246337|453237980|FG008|Overall Study|Protocol Violation|0|||
125985393|NCT00246337|453237972|FG000|Overall Study|Withdrawal by Subject|2|||
125985394|NCT00246337|453237973|FG001|Overall Study|Withdrawal by Subject|0|||
125985395|NCT00246337|453237974|FG002|Overall Study|Withdrawal by Subject|0|||
125985396|NCT00246337|453237975|FG003|Overall Study|Withdrawal by Subject|0|||
125985397|NCT00246337|453237976|FG004|Overall Study|Withdrawal by Subject|0|||
125985398|NCT00246337|453237977|FG005|Overall Study|Withdrawal by Subject|0|||
125985399|NCT00246337|453237978|FG006|Overall Study|Withdrawal by Subject|1|||
125985400|NCT00246337|453237979|FG007|Overall Study|Withdrawal by Subject|1|||
126324971|NCT00496587|454483867|FG000|Overall Study|Death|1|||
126324972|NCT00496587|454483867|FG000|Overall Study|Complications unrelated|2|||
126324973|NCT01808222|454483870|FG000|Overall Study|mpMR scan was not performed|1|||
126324974|NCT02383355|454483871|FG000|Overall Study|Adverse Event|2|||
126324975|NCT02383355|454483872|FG001|Overall Study|Adverse Event|0|||
126324976|NCT01146561|454483874|FG000|Overall Study|Withdrawal by Subject|1|||
126324977|NCT01146561|454483874|FG000|Overall Study|Lost to Follow-up|1|||
126324978|NCT01778751|454483876|FG000|Overall Study|Lost to Follow-up|1|||
126324979|NCT01778751|454483877|FG001|Overall Study|Lost to Follow-up|0|||
126324980|NCT01778751|454483876|FG000|Overall Study|Withdrawal by Subject|0|||
126324981|NCT01778751|454483877|FG001|Overall Study|Withdrawal by Subject|2|||
126324982|NCT01778751|454483876|FG000|Overall Study|Transfered care|1|||
126324983|NCT01778751|454483877|FG001|Overall Study|Transfered care|0|||
126324984|NCT03628716|454483880|FG000|Overall Study|Adverse Event|1|||
126324985|NCT03628716|454483881|FG001|Overall Study|Adverse Event|1|||
126324986|NCT03628716|454483880|FG000|Overall Study|Death|1|||
126324987|NCT03628716|454483881|FG001|Overall Study|Death|0|||
126324988|NCT03628716|454483880|FG000|Overall Study|Lack of Efficacy|15|||
126324989|NCT03628716|454483881|FG001|Overall Study|Lack of Efficacy|20|||
126324990|NCT03628716|454483880|FG000|Overall Study|Withdrawal by Subject|1|||
126324991|NCT03628716|454483881|FG001|Overall Study|Withdrawal by Subject|2|||
126324992|NCT03628716|454483880|FG000|Overall Study|Study Terminated by Sponsor|1|||
126324993|NCT03628716|454483881|FG001|Overall Study|Study Terminated by Sponsor|0|||
126324994|NCT01994902|454483882|FG000|Test Period 1|Withdrawal by Subject|3|||
126324995|NCT01994902|454483883|FG001|Test Period 1|Withdrawal by Subject|0|||
126324996|NCT01994902|454483882|FG000|Test Period 1|device deficiency with adverse event|0|||
126324997|NCT01994902|454483883|FG001|Test Period 1|device deficiency with adverse event|1|||
126324998|NCT01994902|454483882|FG000|Test Period 1|Adverse Event|2|||
126324999|NCT01994902|454483883|FG001|Test Period 1|Adverse Event|1|||
126325000|NCT01994902|454483882|FG000|Test Period 1|Lack of Efficacy|0|||
126325001|NCT01994902|454483883|FG001|Test Period 1|Lack of Efficacy|1|||
126325002|NCT01994902|454483882|FG000|Test Period 1|bag too small|1|||
126325003|NCT01994902|454483883|FG001|Test Period 1|bag too small|0|||
126325004|NCT01994902|454483882|FG000|Test Period 2|Withdrawal by Subject|0|||
125985401|NCT00246337|453237980|FG008|Overall Study|Withdrawal by Subject|0|||
125985402|NCT00246337|453237972|FG000|Overall Study|Lack of Qualifying Event|8|||
125985403|NCT00246337|453237973|FG001|Overall Study|Lack of Qualifying Event|2|||
126325005|NCT01994902|454483883|FG001|Test Period 2|Withdrawal by Subject|2|||
126325006|NCT01994902|454483882|FG000|Test Period 2|Lack of Efficacy|0|||
126325007|NCT01994902|454483883|FG001|Test Period 2|Lack of Efficacy|1|||
126325008|NCT01994902|454483882|FG000|Test Period 2|Other|0|||
126325009|NCT01994902|454483883|FG001|Test Period 2|Other|3|||
126325010|NCT00467558|454483884|FG000|Overall Study|Lost to Follow-up|2|||
125985404|NCT00246337|453237974|FG002|Overall Study|Lack of Qualifying Event|1|||
125985405|NCT00246337|453237975|FG003|Overall Study|Lack of Qualifying Event|1|||
125985406|NCT00246337|453237976|FG004|Overall Study|Lack of Qualifying Event|1|||
125985407|NCT00246337|453237977|FG005|Overall Study|Lack of Qualifying Event|3|||
125985408|NCT00246337|453237978|FG006|Overall Study|Lack of Qualifying Event|3|||
125985409|NCT00246337|453237979|FG007|Overall Study|Lack of Qualifying Event|2|||
125985410|NCT00246337|453237980|FG008|Overall Study|Lack of Qualifying Event|5|||
125985411|NCT00246337|453237972|FG000|Overall Study|Site Terminated|10|||
125985412|NCT00246337|453237973|FG001|Overall Study|Site Terminated|0|||
125985413|NCT00246337|453237974|FG002|Overall Study|Site Terminated|0|||
125985414|NCT00246337|453237975|FG003|Overall Study|Site Terminated|0|||
125985415|NCT00246337|453237976|FG004|Overall Study|Site Terminated|0|||
125985416|NCT00246337|453237977|FG005|Overall Study|Site Terminated|7|||
125985417|NCT00246337|453237978|FG006|Overall Study|Site Terminated|1|||
125985418|NCT00246337|453237979|FG007|Overall Study|Site Terminated|6|||
125985419|NCT00246337|453237980|FG008|Overall Study|Site Terminated|2|||
125985420|NCT00246337|453237972|FG000|Overall Study|Abnormal baseline lab values|7|||
125985421|NCT00246337|453237973|FG001|Overall Study|Abnormal baseline lab values|0|||
125985422|NCT00246337|453237974|FG002|Overall Study|Abnormal baseline lab values|2|||
125985423|NCT00246337|453237975|FG003|Overall Study|Abnormal baseline lab values|0|||
125985424|NCT00246337|453237976|FG004|Overall Study|Abnormal baseline lab values|0|||
125985425|NCT00246337|453237977|FG005|Overall Study|Abnormal baseline lab values|2|||
125985426|NCT00246337|453237978|FG006|Overall Study|Abnormal baseline lab values|2|||
125985427|NCT00246337|453237979|FG007|Overall Study|Abnormal baseline lab values|0|||
125985428|NCT00246337|453237980|FG008|Overall Study|Abnormal baseline lab values|4|||
125985429|NCT00246337|453237972|FG000|Overall Study|Overwhelmed|0|||
125985430|NCT00246337|453237973|FG001|Overall Study|Overwhelmed|0|||
125985431|NCT00246337|453237974|FG002|Overall Study|Overwhelmed|0|||
125985432|NCT00246337|453237975|FG003|Overall Study|Overwhelmed|0|||
125985433|NCT00246337|453237976|FG004|Overall Study|Overwhelmed|0|||
125985434|NCT00246337|453237977|FG005|Overall Study|Overwhelmed|1|||
125985435|NCT00246337|453237978|FG006|Overall Study|Overwhelmed|0|||
125985436|NCT00246337|453237979|FG007|Overall Study|Overwhelmed|0|||
125985437|NCT00246337|453237980|FG008|Overall Study|Overwhelmed|0|||
125985438|NCT00246337|453237972|FG000|Overall Study|Protocol Violator|1|||
125985439|NCT00246337|453237973|FG001|Overall Study|Protocol Violator|0|||
125985440|NCT00246337|453237974|FG002|Overall Study|Protocol Violator|0|||
125985441|NCT00246337|453237975|FG003|Overall Study|Protocol Violator|0|||
125985442|NCT00246337|453237976|FG004|Overall Study|Protocol Violator|0|||
126325011|NCT00467558|454483885|FG001|Overall Study|Lost to Follow-up|0|||
126325012|NCT00376532|454485447|FG000|Overall Study|Lack sufficient blood sample|6|||
126325013|NCT00376532|454485448|FG001|Overall Study|Lack sufficient blood sample|6|||
126325014|NCT04227405|454485449|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
126325015|NCT04227405|454485450|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
126325016|NCT04227405|454485449|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
126325017|NCT04227405|454485450|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
126325018|NCT04227405|454485449|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
126325019|NCT04227405|454485450|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
126325020|NCT02757352|454485453|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
126325021|NCT02757352|454485454|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325022|NCT02757352|454485455|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
126325023|NCT02757352|454485456|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325024|NCT02757352|454485457|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325025|NCT02757352|454485458|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325026|NCT02757352|454485459|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325027|NCT02757352|454485460|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325028|NCT02757352|454485461|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325029|NCT02757352|454485462|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325030|NCT02757352|454485453|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325031|NCT02757352|454485454|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325032|NCT02757352|454485455|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
126325033|NCT02757352|454485456|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125985443|NCT00246337|453237977|FG005|Overall Study|Protocol Violator|0|||
126325034|NCT02757352|454485457|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325035|NCT02757352|454485458|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125985444|NCT00246337|453237978|FG006|Overall Study|Protocol Violator|0|||
125985445|NCT00246337|453237979|FG007|Overall Study|Protocol Violator|0|||
125985446|NCT00246337|453237980|FG008|Overall Study|Protocol Violator|0|||
125985447|NCT00246337|453237972|FG000|Overall Study|Reported as completing trial in error|0|||
125985448|NCT00246337|453237973|FG001|Overall Study|Reported as completing trial in error|0|||
125985449|NCT00246337|453237974|FG002|Overall Study|Reported as completing trial in error|0|||
125985450|NCT00246337|453237975|FG003|Overall Study|Reported as completing trial in error|0|||
125985451|NCT00246337|453237976|FG004|Overall Study|Reported as completing trial in error|0|||
125985452|NCT00246337|453237977|FG005|Overall Study|Reported as completing trial in error|0|||
126325036|NCT02757352|454485459|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325037|NCT02757352|454485460|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325038|NCT02757352|454485461|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325039|NCT02757352|454485462|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325040|NCT02757352|454485453|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
126325041|NCT02757352|454485454|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
126325042|NCT02757352|454485455|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
125985453|NCT00246337|453237978|FG006|Overall Study|Reported as completing trial in error|0|||
125985454|NCT00246337|453237979|FG007|Overall Study|Reported as completing trial in error|1|||
125985455|NCT00246337|453237980|FG008|Overall Study|Reported as completing trial in error|0|||
125985456|NCT01966003|453237984|FG000|Overall Study|Death|43|||
125985457|NCT01966003|453237985|FG001|Overall Study|Death|36|||
125985458|NCT01966003|453237984|FG000|Overall Study|Protocol Violation|6|||
125985459|NCT01966003|453237985|FG001|Overall Study|Protocol Violation|4|||
125985460|NCT01966003|453237984|FG000|Overall Study|Lost to Follow-up|4|||
125985461|NCT01966003|453237985|FG001|Overall Study|Lost to Follow-up|3|||
125985462|NCT01966003|453237984|FG000|Overall Study|Physician Decision|12|||
125985463|NCT01966003|453237985|FG001|Overall Study|Physician Decision|13|||
125985464|NCT01966003|453237984|FG000|Overall Study|Withdrawal by Subject|29|||
125985465|NCT01966003|453237985|FG001|Overall Study|Withdrawal by Subject|19|||
125985466|NCT01966003|453237984|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
125985467|NCT01966003|453237985|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
125985468|NCT01966003|453237984|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
125985469|NCT01966003|453237985|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
125985470|NCT01966003|453237984|FG000|Overall Study|Other|1|||
125985471|NCT01966003|453237985|FG001|Overall Study|Other|1|||
125985472|NCT03633929|453237987|FG000|Overall Study|Lost to Follow-up|1|||
125985473|NCT03633929|453237987|FG000|Overall Study|Did not login to software. Did not participate|3|||
125985474|NCT02287584|453237991|FG000|the Double-blind Phase|Adverse Event|17|||
125985475|NCT02287584|453237992|FG001|the Double-blind Phase|Adverse Event|17|||
125985476|NCT02287584|453237993|FG002|the Double-blind Phase|Adverse Event|12|||
125985477|NCT02287584|453237994|FG003|the Double-blind Phase|Adverse Event|0|||
125985478|NCT02287584|453237995|FG004|the Double-blind Phase|Adverse Event|0|||
125985479|NCT02287584|453237996|FG005|the Double-blind Phase|Adverse Event|0|||
125985480|NCT02287584|453237991|FG000|the Double-blind Phase|Lack of Efficacy|18|||
125985481|NCT02287584|453237992|FG001|the Double-blind Phase|Lack of Efficacy|8|||
125985482|NCT02287584|453237993|FG002|the Double-blind Phase|Lack of Efficacy|8|||
125985483|NCT02287584|453237994|FG003|the Double-blind Phase|Lack of Efficacy|0|||
125985484|NCT02287584|453237995|FG004|the Double-blind Phase|Lack of Efficacy|0|||
125985485|NCT02287584|453237996|FG005|the Double-blind Phase|Lack of Efficacy|0|||
125985486|NCT02287584|453237991|FG000|the Double-blind Phase|Lost to Follow-up|0|||
125985487|NCT02287584|453237992|FG001|the Double-blind Phase|Lost to Follow-up|1|||
125985488|NCT02287584|453237993|FG002|the Double-blind Phase|Lost to Follow-up|1|||
125985489|NCT02287584|453237994|FG003|the Double-blind Phase|Lost to Follow-up|0|||
125985490|NCT02287584|453237995|FG004|the Double-blind Phase|Lost to Follow-up|0|||
125985491|NCT02287584|453237996|FG005|the Double-blind Phase|Lost to Follow-up|0|||
125985492|NCT02287584|453237991|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
125985493|NCT02287584|453237992|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
125985494|NCT02287584|453237993|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
125985495|NCT02287584|453237994|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
125985496|NCT02287584|453237995|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
125985497|NCT02287584|453237996|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
125985498|NCT02287584|453237991|FG000|the Double-blind Phase|Pregnancy|0|||
125985499|NCT02287584|453237992|FG001|the Double-blind Phase|Pregnancy|1|||
125985500|NCT02287584|453237993|FG002|the Double-blind Phase|Pregnancy|0|||
125985501|NCT02287584|453237994|FG003|the Double-blind Phase|Pregnancy|0|||
125985502|NCT02287584|453237995|FG004|the Double-blind Phase|Pregnancy|0|||
125985503|NCT02287584|453237996|FG005|the Double-blind Phase|Pregnancy|0|||
125985504|NCT02287584|453237991|FG000|the Double-blind Phase|Protocol Violation|0|||
125985505|NCT02287584|453237992|FG001|the Double-blind Phase|Protocol Violation|3|||
125985506|NCT02287584|453237993|FG002|the Double-blind Phase|Protocol Violation|0|||
126325043|NCT02757352|454485456|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325044|NCT02757352|454485457|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325045|NCT02757352|454485458|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125985507|NCT02287584|453237994|FG003|the Double-blind Phase|Protocol Violation|0|||
125985508|NCT02287584|453237995|FG004|the Double-blind Phase|Protocol Violation|0|||
126325046|NCT02757352|454485459|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125985509|NCT02287584|453237996|FG005|the Double-blind Phase|Protocol Violation|0|||
125985510|NCT02287584|453237991|FG000|the Double-blind Phase|other reasons|0|||
125985511|NCT02287584|453237992|FG001|the Double-blind Phase|other reasons|0|||
125985512|NCT02287584|453237993|FG002|the Double-blind Phase|other reasons|1|||
125985513|NCT02287584|453237994|FG003|the Double-blind Phase|other reasons|0|||
125985514|NCT02287584|453237995|FG004|the Double-blind Phase|other reasons|0|||
126325047|NCT02757352|454485460|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325048|NCT02757352|454485461|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325049|NCT02757352|454485462|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325050|NCT02757352|454485453|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325051|NCT02757352|454485454|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
126325052|NCT02757352|454485455|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325053|NCT02757352|454485456|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325054|NCT02757352|454485457|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325055|NCT02757352|454485458|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325056|NCT02757352|454485459|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325057|NCT02757352|454485460|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325058|NCT02757352|454485461|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325059|NCT02757352|454485462|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325060|NCT02757352|454485453|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325061|NCT02757352|454485454|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
126325062|NCT02757352|454485455|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325063|NCT02757352|454485456|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325064|NCT02757352|454485457|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325065|NCT02757352|454485458|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325066|NCT02757352|454485459|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325067|NCT02757352|454485460|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325068|NCT02757352|454485461|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325069|NCT02757352|454485462|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325070|NCT02757352|454485453|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
126325071|NCT02757352|454485454|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
126325072|NCT02757352|454485455|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
126325073|NCT02757352|454485456|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325074|NCT02757352|454485457|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125985515|NCT02287584|453237996|FG005|the Double-blind Phase|other reasons|0|||
125985516|NCT02287584|453237991|FG000|the Open-label Phase|Did not receive drug|0|||
125985517|NCT02287584|453237992|FG001|the Open-label Phase|Did not receive drug|0|||
125985518|NCT02287584|453237993|FG002|the Open-label Phase|Did not receive drug|0|||
125985519|NCT02287584|453237994|FG003|the Open-label Phase|Did not receive drug|7|||
125985520|NCT02287584|453237995|FG004|the Open-label Phase|Did not receive drug|6|||
125985521|NCT02287584|453237996|FG005|the Open-label Phase|Did not receive drug|4|||
125985522|NCT02287584|453237991|FG000|the Open-label Phase|Adverse Event|0|||
125985523|NCT02287584|453237992|FG001|the Open-label Phase|Adverse Event|0|||
125985524|NCT02287584|453237993|FG002|the Open-label Phase|Adverse Event|0|||
125985525|NCT02287584|453237994|FG003|the Open-label Phase|Adverse Event|15|||
125985526|NCT02287584|453237995|FG004|the Open-label Phase|Adverse Event|12|||
125985527|NCT02287584|453237996|FG005|the Open-label Phase|Adverse Event|16|||
125985528|NCT02287584|453237991|FG000|the Open-label Phase|Lack of Efficacy|0|||
125985529|NCT02287584|453237992|FG001|the Open-label Phase|Lack of Efficacy|0|||
125985530|NCT02287584|453237993|FG002|the Open-label Phase|Lack of Efficacy|0|||
125985531|NCT02287584|453237994|FG003|the Open-label Phase|Lack of Efficacy|8|||
125985532|NCT02287584|453237995|FG004|the Open-label Phase|Lack of Efficacy|3|||
125985533|NCT02287584|453237996|FG005|the Open-label Phase|Lack of Efficacy|7|||
125985534|NCT02287584|453237991|FG000|the Open-label Phase|Lost to Follow-up|0|||
125985535|NCT02287584|453237992|FG001|the Open-label Phase|Lost to Follow-up|0|||
125985536|NCT02287584|453237993|FG002|the Open-label Phase|Lost to Follow-up|0|||
125985537|NCT02287584|453237994|FG003|the Open-label Phase|Lost to Follow-up|4|||
125985538|NCT02287584|453237995|FG004|the Open-label Phase|Lost to Follow-up|1|||
125985539|NCT02287584|453237996|FG005|the Open-label Phase|Lost to Follow-up|2|||
125985540|NCT02287584|453237991|FG000|the Open-label Phase|Withdrawal by Subject|0|||
125985541|NCT02287584|453237992|FG001|the Open-label Phase|Withdrawal by Subject|0|||
125985542|NCT02287584|453237993|FG002|the Open-label Phase|Withdrawal by Subject|0|||
125985543|NCT02287584|453237994|FG003|the Open-label Phase|Withdrawal by Subject|18|||
125985544|NCT02287584|453237995|FG004|the Open-label Phase|Withdrawal by Subject|29|||
125985545|NCT02287584|453237996|FG005|the Open-label Phase|Withdrawal by Subject|21|||
125985546|NCT02287584|453237991|FG000|the Open-label Phase|non-compliance|0|||
125985547|NCT02287584|453237992|FG001|the Open-label Phase|non-compliance|0|||
126325075|NCT02757352|454485458|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325076|NCT02757352|454485459|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325077|NCT02757352|454485460|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125985548|NCT02287584|453237993|FG002|the Open-label Phase|non-compliance|0|||
125985549|NCT02287584|453237994|FG003|the Open-label Phase|non-compliance|2|||
125985550|NCT02287584|453237995|FG004|the Open-label Phase|non-compliance|5|||
125985551|NCT02287584|453237996|FG005|the Open-label Phase|non-compliance|1|||
125985552|NCT02287584|453237991|FG000|the Open-label Phase|other reasons|0|||
126325078|NCT02757352|454485461|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325079|NCT02757352|454485462|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325080|NCT02757352|454485453|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
126325081|NCT02757352|454485454|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
126325082|NCT02757352|454485455|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
126325083|NCT02757352|454485456|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325084|NCT02757352|454485457|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325085|NCT02757352|454485458|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325086|NCT02757352|454485459|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325087|NCT02757352|454485460|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325088|NCT02757352|454485461|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325089|NCT02757352|454485462|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325090|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325091|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325092|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325093|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
126325094|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325095|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
126325096|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325097|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325098|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325099|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325100|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325101|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325102|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325103|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
126325104|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
126325105|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
126325106|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325107|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325108|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325109|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325110|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325111|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325112|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325113|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325114|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
126325115|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325116|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325117|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325118|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325119|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325120|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325121|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325122|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325123|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325124|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325125|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
126325126|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325127|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325128|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325129|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325130|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325131|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325132|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325133|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
126325134|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
126325135|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
126325136|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325137|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325138|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325139|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125985553|NCT02287584|453237992|FG001|the Open-label Phase|other reasons|0|||
125985554|NCT02287584|453237993|FG002|the Open-label Phase|other reasons|0|||
125985555|NCT02287584|453237994|FG003|the Open-label Phase|other reasons|3|||
125985556|NCT02287584|453237995|FG004|the Open-label Phase|other reasons|6|||
125985557|NCT02287584|453237996|FG005|the Open-label Phase|other reasons|6|||
125985558|NCT01492686|453238000|FG000|Double-blind Phase|Adverse Event|0|||
125985559|NCT01492686|453238001|FG001|Double-blind Phase|Adverse Event|2|||
125985560|NCT01492686|453238000|FG000|Double-blind Phase|Physician Decision|0|||
125985561|NCT01492686|453238001|FG001|Double-blind Phase|Physician Decision|1|||
125985562|NCT01492686|453238000|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125985563|NCT01492686|453238001|FG001|Double-blind Phase|Withdrawal by Subject|2|||
125985564|NCT01492686|453238000|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
125985565|NCT01492686|453238001|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
125985566|NCT01492686|453238000|FG000|Open-label Phase|Adverse Event|1|||
125985567|NCT01492686|453238001|FG001|Open-label Phase|Adverse Event|2|||
125985568|NCT01492686|453238000|FG000|Open-label Phase|Physician Decision|1|||
125985569|NCT01492686|453238001|FG001|Open-label Phase|Physician Decision|0|||
125985570|NCT01492686|453238000|FG000|Open-label Phase|Withdrawal by Subject|6|||
125985571|NCT01492686|453238001|FG001|Open-label Phase|Withdrawal by Subject|7|||
125985572|NCT01492686|453238000|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
125985573|NCT01492686|453238001|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
125985574|NCT02487810|453238005|FG000|Overall Study|Withdrawal by Subject|1|||
125985575|NCT02487810|453238006|FG001|Overall Study|Withdrawal by Subject|0|||
125985576|NCT01889186|453238007|FG000|Overall Study|Adverse event- not related to progression|18|||
125985577|NCT01889186|453238008|FG001|Overall Study|Adverse event- not related to progression|5|||
125985578|NCT01889186|453238007|FG000|Overall Study|Adverse event- related to progression|7|||
125985579|NCT01889186|453238008|FG001|Overall Study|Adverse event- related to progression|2|||
125985580|NCT01889186|453238007|FG000|Overall Study|COVID-19 logistical restrictions|1|||
125985581|NCT01889186|453238008|FG001|Overall Study|COVID-19 logistical restrictions|0|||
125985582|NCT01889186|453238007|FG000|Overall Study|Investigator request|1|||
125985583|NCT01889186|453238008|FG001|Overall Study|Investigator request|1|||
125985584|NCT01889186|453238007|FG000|Overall Study|Progressive disease- Richter's|12|||
125985585|NCT01889186|453238008|FG001|Overall Study|Progressive disease- Richter's|7|||
125985586|NCT01889186|453238007|FG000|Overall Study|Progressive disease per protocol|46|||
125985587|NCT01889186|453238008|FG001|Overall Study|Progressive disease per protocol|17|||
125985588|NCT01889186|453238007|FG000|Overall Study|Stem cell transplant|2|||
125985589|NCT01889186|453238008|FG001|Overall Study|Stem cell transplant|1|||
125985590|NCT01889186|453238007|FG000|Overall Study|Withdrew consent|2|||
125985591|NCT01889186|453238008|FG001|Overall Study|Withdrew consent|3|||
125985592|NCT01889186|453238007|FG000|Overall Study|Other, not specified|18|||
125985593|NCT01889186|453238008|FG001|Overall Study|Other, not specified|15|||
125985594|NCT02569437|453238013|FG000|Overall Study|Lost to Follow-up|12|||
125985595|NCT02569437|453238014|FG001|Overall Study|Lost to Follow-up|14|||
125985596|NCT00441701|453238015|FG000|Overall Study|Adverse Event|3|||
125985597|NCT00441701|453238016|FG001|Overall Study|Adverse Event|2|||
125985598|NCT00441701|453238017|FG002|Overall Study|Adverse Event|1|||
125985599|NCT00441701|453238018|FG003|Overall Study|Adverse Event|0|||
125985600|NCT00441701|453238019|FG004|Overall Study|Adverse Event|2|||
125985601|NCT00441701|453238020|FG005|Overall Study|Adverse Event|2|||
125985602|NCT00441701|453238021|FG006|Overall Study|Adverse Event|0|||
125985603|NCT00441701|453238022|FG007|Overall Study|Adverse Event|0|||
125985604|NCT00441701|453238023|FG008|Overall Study|Adverse Event|0|||
125985605|NCT00441701|453238024|FG009|Overall Study|Adverse Event|0|||
125985606|NCT00441701|453238015|FG000|Overall Study|Lack of Efficacy|2|||
125985607|NCT00441701|453238016|FG001|Overall Study|Lack of Efficacy|0|||
125985608|NCT00441701|453238017|FG002|Overall Study|Lack of Efficacy|2|||
125985609|NCT00441701|453238018|FG003|Overall Study|Lack of Efficacy|2|||
125985610|NCT00441701|453238019|FG004|Overall Study|Lack of Efficacy|0|||
125985611|NCT00441701|453238020|FG005|Overall Study|Lack of Efficacy|1|||
125985612|NCT00441701|453238021|FG006|Overall Study|Lack of Efficacy|0|||
125985613|NCT00441701|453238022|FG007|Overall Study|Lack of Efficacy|0|||
125985614|NCT00441701|453238023|FG008|Overall Study|Lack of Efficacy|0|||
125985615|NCT00441701|453238024|FG009|Overall Study|Lack of Efficacy|0|||
125985616|NCT00441701|453238015|FG000|Overall Study|Withdrawal by Subject|0|||
125985617|NCT00441701|453238016|FG001|Overall Study|Withdrawal by Subject|2|||
125985618|NCT00441701|453238017|FG002|Overall Study|Withdrawal by Subject|1|||
125985619|NCT00441701|453238018|FG003|Overall Study|Withdrawal by Subject|1|||
125985620|NCT00441701|453238019|FG004|Overall Study|Withdrawal by Subject|0|||
125985621|NCT00441701|453238020|FG005|Overall Study|Withdrawal by Subject|0|||
125985622|NCT00441701|453238021|FG006|Overall Study|Withdrawal by Subject|0|||
125985623|NCT00441701|453238022|FG007|Overall Study|Withdrawal by Subject|0|||
125985624|NCT00441701|453238023|FG008|Overall Study|Withdrawal by Subject|0|||
125985625|NCT00441701|453238024|FG009|Overall Study|Withdrawal by Subject|0|||
125985626|NCT04710927|453238028|FG000|Overall Study|Lost to Follow-up|7|||
125985627|NCT04710927|453238029|FG001|Overall Study|Lost to Follow-up|6|||
125985628|NCT04710927|453238030|FG002|Overall Study|Lost to Follow-up|5|||
125985629|NCT02007434|453238032|FG000|Overall Study|Lost to Follow-up|0|||
125985630|NCT02007434|453238033|FG001|Overall Study|Lost to Follow-up|1|||
126325140|NCT02757352|454485453|FG000|Follow-Up Period|Adverse Event|0|||
126325141|NCT02757352|454485454|FG001|Follow-Up Period|Adverse Event|0|||
126325142|NCT02757352|454485455|FG002|Follow-Up Period|Adverse Event|0|||
125985631|NCT02007434|453238034|FG002|Overall Study|Lost to Follow-up|0|||
125985632|NCT02007434|453238035|FG003|Overall Study|Lost to Follow-up|0|||
126325143|NCT02757352|454485456|FG003|Follow-Up Period|Adverse Event|0|||
126325144|NCT02757352|454485457|FG004|Follow-Up Period|Adverse Event|0|||
126325145|NCT02757352|454485458|FG005|Follow-Up Period|Adverse Event|0|||
126325146|NCT02757352|454485459|FG006|Follow-Up Period|Adverse Event|1|||
126325147|NCT02757352|454485460|FG007|Follow-Up Period|Adverse Event|0|||
126325148|NCT02757352|454485461|FG008|Follow-Up Period|Adverse Event|2|||
126325149|NCT02757352|454485462|FG009|Follow-Up Period|Adverse Event|0|||
126325150|NCT02757352|454485453|FG000|Follow-Up Period|Lost to Follow-up|0|||
126325151|NCT02757352|454485454|FG001|Follow-Up Period|Lost to Follow-up|0|||
126325152|NCT02757352|454485455|FG002|Follow-Up Period|Lost to Follow-up|0|||
126325153|NCT02757352|454485456|FG003|Follow-Up Period|Lost to Follow-up|0|||
126325154|NCT02757352|454485457|FG004|Follow-Up Period|Lost to Follow-up|0|||
126325155|NCT02757352|454485458|FG005|Follow-Up Period|Lost to Follow-up|0|||
126325156|NCT02757352|454485459|FG006|Follow-Up Period|Lost to Follow-up|0|||
126325157|NCT02757352|454485460|FG007|Follow-Up Period|Lost to Follow-up|0|||
126325158|NCT02757352|454485461|FG008|Follow-Up Period|Lost to Follow-up|1|||
126325159|NCT02757352|454485462|FG009|Follow-Up Period|Lost to Follow-up|0|||
126325160|NCT02757352|454485453|FG000|Follow-Up Period|Lack of Efficacy|0|||
126325161|NCT02757352|454485454|FG001|Follow-Up Period|Lack of Efficacy|0|||
126325162|NCT02757352|454485455|FG002|Follow-Up Period|Lack of Efficacy|0|||
126325163|NCT02757352|454485456|FG003|Follow-Up Period|Lack of Efficacy|0|||
126325164|NCT02757352|454485457|FG004|Follow-Up Period|Lack of Efficacy|0|||
126325165|NCT02757352|454485458|FG005|Follow-Up Period|Lack of Efficacy|0|||
126325166|NCT02757352|454485459|FG006|Follow-Up Period|Lack of Efficacy|0|||
126325167|NCT02757352|454485460|FG007|Follow-Up Period|Lack of Efficacy|0|||
126325168|NCT02757352|454485461|FG008|Follow-Up Period|Lack of Efficacy|1|||
126325169|NCT02757352|454485462|FG009|Follow-Up Period|Lack of Efficacy|1|||
126325170|NCT02757352|454485453|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126325171|NCT02757352|454485454|FG001|Follow-Up Period|Withdrawal by Subject|0|||
126325172|NCT02757352|454485455|FG002|Follow-Up Period|Withdrawal by Subject|0|||
126325173|NCT02757352|454485456|FG003|Follow-Up Period|Withdrawal by Subject|0|||
126325174|NCT02757352|454485457|FG004|Follow-Up Period|Withdrawal by Subject|0|||
126325175|NCT02757352|454485458|FG005|Follow-Up Period|Withdrawal by Subject|0|||
126325176|NCT02757352|454485459|FG006|Follow-Up Period|Withdrawal by Subject|0|||
126325177|NCT02757352|454485460|FG007|Follow-Up Period|Withdrawal by Subject|1|||
126325178|NCT02757352|454485461|FG008|Follow-Up Period|Withdrawal by Subject|6|||
126325179|NCT02757352|454485462|FG009|Follow-Up Period|Withdrawal by Subject|2|||
126325180|NCT00802672|454485463|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
126325181|NCT00802672|454485464|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
126325182|NCT00802672|454485465|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
126325183|NCT00802672|454485463|FG000|Overall Study|Adverse Event|1|||
126325184|NCT00802672|454485464|FG001|Overall Study|Adverse Event|1|||
126325185|NCT00802672|454485465|FG002|Overall Study|Adverse Event|1|||
126325186|NCT00802672|454485463|FG000|Overall Study|Protocol Violation|2|||
126325187|NCT00802672|454485464|FG001|Overall Study|Protocol Violation|1|||
126325188|NCT00802672|454485465|FG002|Overall Study|Protocol Violation|1|||
126325189|NCT00802672|454485463|FG000|Overall Study|Lost to Follow-up|5|||
126325190|NCT00802672|454485464|FG001|Overall Study|Lost to Follow-up|5|||
126325191|NCT00802672|454485465|FG002|Overall Study|Lost to Follow-up|3|||
126325192|NCT00802672|454485463|FG000|Overall Study|Withdrawal by Subject|1|||
126325193|NCT00802672|454485464|FG001|Overall Study|Withdrawal by Subject|1|||
126325194|NCT00802672|454485465|FG002|Overall Study|Withdrawal by Subject|2|||
126325195|NCT00802672|454485463|FG000|Overall Study|other|3|||
126325196|NCT00802672|454485464|FG001|Overall Study|other|1|||
125985633|NCT02007434|453238036|FG004|Overall Study|Lost to Follow-up|0|||
126325197|NCT00802672|454485465|FG002|Overall Study|other|2|||
126325198|NCT02499263|454485466|FG000|Overall Study|Lost to Follow-up|9|||
125985634|NCT02007434|453238037|FG005|Overall Study|Lost to Follow-up|0|||
125985635|NCT02007434|453238038|FG006|Overall Study|Lost to Follow-up|0|||
126325199|NCT02499263|454485466|FG000|Overall Study|Participant's withdrawal of consent|4|||
126325200|NCT02499263|454485466|FG000|Overall Study|Lack of Efficacy|22|||
126325201|NCT02499263|454485466|FG000|Overall Study|investigator's judgment|12|||
126325202|NCT02499263|454485466|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
126325203|NCT02499263|454485466|FG000|Overall Study|Participant's decision|3|||
126325204|NCT02499263|454485466|FG000|Overall Study|Pregnancy|1|||
126325205|NCT02075008|454485471|FG000|Overall Study|Technical problems|1|||
126325206|NCT02075008|454485471|FG000|Overall Study|Pregnancy|1|||
126325207|NCT02075008|454485471|FG000|Overall Study|Physician Decision|1|||
125985636|NCT02007434|453238039|FG007|Overall Study|Lost to Follow-up|0|||
125985637|NCT02007434|453238032|FG000|Overall Study|Non-compliance|1|||
126325208|NCT02075008|454485471|FG000|Overall Study|Lost to Follow-up|1|||
126325209|NCT02075008|454485471|FG000|Overall Study|Lack of Efficacy|1|||
126325210|NCT02075008|454485471|FG000|Overall Study|Death|1|||
125985638|NCT02007434|453238033|FG001|Overall Study|Non-compliance|0|||
125985639|NCT02007434|453238034|FG002|Overall Study|Non-compliance|1|||
125985640|NCT02007434|453238035|FG003|Overall Study|Non-compliance|0|||
125985641|NCT02007434|453238036|FG004|Overall Study|Non-compliance|0|||
125985642|NCT02007434|453238037|FG005|Overall Study|Non-compliance|0|||
125985643|NCT02007434|453238038|FG006|Overall Study|Non-compliance|0|||
125985644|NCT02007434|453238039|FG007|Overall Study|Non-compliance|0|||
125985645|NCT01287611|453238040|FG000|Overall Study|Lost to Follow-up|29|||
125985646|NCT01287611|453238041|FG001|Overall Study|Lost to Follow-up|16|||
126325211|NCT02075008|454485471|FG000|Overall Study|Adverse Event|5|||
126325212|NCT02075008|454485471|FG000|Overall Study|Withdrawal by Subject|6|||
126325213|NCT02075008|454485471|FG000|Overall Study|Study terminated by Sponsor|159|||
126325214|NCT00660595|454485472|FG000|Overall Study|Lost to Follow-up|0|||
126325215|NCT00660595|454485473|FG001|Overall Study|Lost to Follow-up|1|||
126325216|NCT00660595|454485472|FG000|Overall Study|Did not consent to participate in study|12|||
126325217|NCT00660595|454485473|FG001|Overall Study|Did not consent to participate in study|8|||
126325218|NCT00660595|454485472|FG000|Overall Study|Participant left hospital|1|||
126325219|NCT00660595|454485473|FG001|Overall Study|Participant left hospital|0|||
126325220|NCT00660595|454485472|FG000|Overall Study|Non Specified reasons|5|||
126325221|NCT00660595|454485473|FG001|Overall Study|Non Specified reasons|0|||
126325222|NCT01301079|454485480|FG000|Overall Study|Lost to Follow-up|2|||
126325223|NCT01301079|454485481|FG001|Overall Study|Lost to Follow-up|2|||
126325224|NCT02496039|454485484|FG000|Overall Study|Adverse Event|3|||
126325225|NCT02496039|454485484|FG000|Overall Study|Protocol Violation|1|||
126325226|NCT00571103|454485485|FG000|Overall Study|Withdrawal by Subject|1|||
126325227|NCT00571103|454485485|FG000|Overall Study|Lost to Follow-up|1|||
126325228|NCT00948922|454485488|FG000|Overall Study|Did not start study treatment|2|||
126325229|NCT00948922|454485489|FG001|Overall Study|Did not start study treatment|5|||
126325230|NCT00948922|454485490|FG002|Overall Study|Did not start study treatment|0|||
126325231|NCT00948922|454485488|FG000|Overall Study|Withdrawal by Subject|0|||
126325232|NCT00948922|454485489|FG001|Overall Study|Withdrawal by Subject|2|||
126325233|NCT00948922|454485490|FG002|Overall Study|Withdrawal by Subject|1|||
126325234|NCT00948922|454485488|FG000|Overall Study|Death|3|||
126325235|NCT00948922|454485489|FG001|Overall Study|Death|0|||
126325236|NCT00948922|454485490|FG002|Overall Study|Death|0|||
126325237|NCT00948922|454485488|FG000|Overall Study|Disease progression|0|||
126325238|NCT00948922|454485489|FG001|Overall Study|Disease progression|1|||
126325239|NCT00948922|454485490|FG002|Overall Study|Disease progression|0|||
126325240|NCT00948922|454485488|FG000|Overall Study|Insurance issues|1|||
126325241|NCT00948922|454485489|FG001|Overall Study|Insurance issues|0|||
126325242|NCT00948922|454485490|FG002|Overall Study|Insurance issues|0|||
126325243|NCT00948922|454485488|FG000|Overall Study|Transplant eligibility issues|2|||
126325244|NCT00948922|454485489|FG001|Overall Study|Transplant eligibility issues|3|||
126325245|NCT00948922|454485490|FG002|Overall Study|Transplant eligibility issues|0|||
126325246|NCT00948922|454485488|FG000|Overall Study|Not evaluable at time of analysis|0|||
126325247|NCT00948922|454485489|FG001|Overall Study|Not evaluable at time of analysis|3|||
126325248|NCT00948922|454485490|FG002|Overall Study|Not evaluable at time of analysis|0|||
126325249|NCT00645671|454485491|FG000|Overall Study|Protocol Violation|1|||
126325250|NCT00645671|454485492|FG001|Overall Study|Protocol Violation|0|||
126325251|NCT00645671|454485491|FG000|Overall Study|Withdrawal by Subject|0|||
126325252|NCT00645671|454485492|FG001|Overall Study|Withdrawal by Subject|4|||
126325253|NCT00645671|454485491|FG000|Overall Study|Adverse Event|0|||
126325254|NCT00645671|454485492|FG001|Overall Study|Adverse Event|1|||
126325255|NCT00645671|454485491|FG000|Overall Study|Physician Decision|0|||
126325256|NCT00645671|454485492|FG001|Overall Study|Physician Decision|1|||
126325257|NCT05114564|454485493|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
126325258|NCT05114564|454485494|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
126325259|NCT05114564|454485493|FG000|First Intervention|Adverse Event|0|||
126325260|NCT05114564|454485494|FG001|First Intervention|Adverse Event|1|||
126325261|NCT00493311|454485495|FG000|Overall Study|Need for rescue medication|2|||
125985647|NCT01287611|453238040|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
125985648|NCT01287611|453238041|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
126325262|NCT00493311|454485496|FG001|Overall Study|Need for rescue medication|2|||
126325263|NCT02779075|454485497|FG000|Overall Study|Withdrawal by Subject|1|||
126325264|NCT02779075|454485498|FG001|Overall Study|Withdrawal by Subject|3|||
125985649|NCT03299686|453238054|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
125985650|NCT03299686|453238055|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
126325265|NCT02779075|454485497|FG000|Overall Study|IV lost during 2nd study|1|||
126325266|NCT02779075|454485498|FG001|Overall Study|IV lost during 2nd study|0|||
126325267|NCT01951573|454485499|FG000|Washout Period|Adverse Event|0|||
126325268|NCT01951573|454485500|FG001|Washout Period|Adverse Event|1|||
126325269|NCT03959527|454485501|FG000|Overall Study|Withdrawal by Subject|8|||
126325270|NCT03959527|454485502|FG001|Overall Study|Withdrawal by Subject|3|||
126325271|NCT03959527|454485501|FG000|Overall Study|Lost to Follow-up|31|||
126325272|NCT03959527|454485502|FG001|Overall Study|Lost to Follow-up|15|||
125985651|NCT03299686|453238054|FG000|Treatment Epoch|Physician Decision|1|||
125985652|NCT03299686|453238055|FG001|Treatment Epoch|Physician Decision|0|||
125985653|NCT03299686|453238054|FG000|Treatment Epoch|Adverse Event|8|||
125985654|NCT03299686|453238055|FG001|Treatment Epoch|Adverse Event|4|||
125985655|NCT03299686|453238054|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
125985656|NCT03299686|453238055|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
125985657|NCT03745222|453238056|FG000|Overall Study|Withdrawal by Subject|0|||
125985658|NCT03745222|453238057|FG001|Overall Study|Withdrawal by Subject|1|||
125985659|NCT03745222|453238058|FG002|Overall Study|Withdrawal by Subject|0|||
125985660|NCT00860067|453238059|FG000|Overall Study|Lost to Follow-up|46|||
125985661|NCT00860067|453238060|FG001|Overall Study|Lost to Follow-up|9|||
125985662|NCT00860067|453238061|FG002|Overall Study|Lost to Follow-up|9|||
125985663|NCT00860067|453238059|FG000|Overall Study|Withdrawal by Subject|4|||
125985664|NCT00860067|453238060|FG001|Overall Study|Withdrawal by Subject|0|||
125985665|NCT00860067|453238061|FG002|Overall Study|Withdrawal by Subject|0|||
125985666|NCT00860067|453238059|FG000|Overall Study|Pregnancy|1|||
126325273|NCT03959527|454485501|FG000|Overall Study|Did not meet eligibility criteria|1|||
126325274|NCT03959527|454485502|FG001|Overall Study|Did not meet eligibility criteria|1|||
126325275|NCT03959527|454485501|FG000|Overall Study|Protocol Violation|10|||
126325276|NCT03959527|454485502|FG001|Overall Study|Protocol Violation|5|||
126325277|NCT00707980|454485503|FG000|Overall Study|Adverse Event|49|||
126325278|NCT00707980|454485503|FG000|Overall Study|Lack of Efficacy|35|||
126325279|NCT00707980|454485503|FG000|Overall Study|Non-Compliance with Study Drug|28|||
126325280|NCT00707980|454485503|FG000|Overall Study|Protocol Deviations|19|||
126325281|NCT00707980|454485503|FG000|Overall Study|Withdrawal of Consent|81|||
126325282|NCT00707980|454485503|FG000|Overall Study|Lost to Follow-up|59|||
126325283|NCT00707980|454485503|FG000|Overall Study|Other|39|||
126325284|NCT01152996|454485504|FG000|Overall Study|Withdrawal by Subject|142|||
126325285|NCT01152996|454485504|FG000|Overall Study|Adverse Event|115|||
126325286|NCT01152996|454485504|FG000|Overall Study|Lost to Follow-up|112|||
126325287|NCT01152996|454485504|FG000|Overall Study|Lack of Efficacy|68|||
126325288|NCT01152996|454485504|FG000|Overall Study|Noncompliance|41|||
126325289|NCT01152996|454485504|FG000|Overall Study|Other|36|||
126325290|NCT01152996|454485504|FG000|Overall Study|Protocol Violation|22|||
126325291|NCT01152996|454485504|FG000|Overall Study|Elevated liver enzymes|1|||
126325292|NCT02072941|454485506|FG000|Overall Study|Withdrawal by Subject|29|||
126325293|NCT02072941|454485507|FG001|Overall Study|Withdrawal by Subject|21|||
126325294|NCT02072941|454485506|FG000|Overall Study|Lost to Follow-up|4|||
126325295|NCT02072941|454485507|FG001|Overall Study|Lost to Follow-up|4|||
126325296|NCT02072941|454485506|FG000|Overall Study|Death|3|||
126325297|NCT02072941|454485507|FG001|Overall Study|Death|2|||
126325298|NCT02072941|454485506|FG000|Overall Study|Removed by Study Staff|2|||
126325299|NCT02072941|454485507|FG001|Overall Study|Removed by Study Staff|2|||
126325300|NCT02020889|454485508|FG000|Overall Study|Adverse Event|0|||
126325301|NCT02020889|454485509|FG001|Overall Study|Adverse Event|1|||
126325302|NCT02020889|454485508|FG000|Overall Study|Lack of Efficacy|1|||
126325303|NCT02020889|454485509|FG001|Overall Study|Lack of Efficacy|0|||
126325304|NCT02020889|454485508|FG000|Overall Study|Lost to Follow-up|1|||
126325305|NCT02020889|454485509|FG001|Overall Study|Lost to Follow-up|0|||
126325306|NCT02020889|454485508|FG000|Overall Study|Physician Decision|2|||
126325307|NCT02020889|454485509|FG001|Overall Study|Physician Decision|0|||
126325308|NCT02020889|454485508|FG000|Overall Study|Withdrawal by Subject|3|||
126325309|NCT02020889|454485509|FG001|Overall Study|Withdrawal by Subject|2|||
126325310|NCT03146741|454485510|FG000|Overall Study|Txp with non-HCV+ heart|4|||
126325311|NCT03146741|454485510|FG000|Overall Study|Listeted for MOT|2|||
126325312|NCT03146741|454485510|FG000|Overall Study|Physician Decision|2|||
126325313|NCT03146741|454485510|FG000|Overall Study|Awaiting txp|2|||
126325314|NCT03224624|454485511|FG000|Overall Study|Lost to Follow-up|9|||
126325315|NCT03224624|454485512|FG001|Overall Study|Lost to Follow-up|4|||
126325316|NCT03224624|454485511|FG000|Overall Study|Death|1|||
126325317|NCT03224624|454485512|FG001|Overall Study|Death|0|||
126325318|NCT01884545|454485513|FG000|Overall Study|Lost to Follow-up|6|||
126325319|NCT01884545|454485514|FG001|Overall Study|Lost to Follow-up|4|||
125985667|NCT00860067|453238060|FG001|Overall Study|Pregnancy|0|||
125985668|NCT00860067|453238061|FG002|Overall Study|Pregnancy|0|||
125985669|NCT01282801|453238062|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
125985670|NCT01282801|453238063|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
126325320|NCT01884545|454485515|FG002|Overall Study|Lost to Follow-up|9|||
126325321|NCT01884545|454485516|FG003|Overall Study|Lost to Follow-up|4|||
126325322|NCT01884545|454485513|FG000|Overall Study|Patient withdrawn|7|||
125985671|NCT01060553|453238066|FG000|Overall Study|Lost to Follow-up|3|||
125985672|NCT01060553|453238067|FG001|Overall Study|Lost to Follow-up|5|||
125985673|NCT01060553|453238066|FG000|Overall Study|Withdrawal by Subject|5|||
126325323|NCT01884545|454485514|FG001|Overall Study|Patient withdrawn|12|||
125985674|NCT01060553|453238067|FG001|Overall Study|Withdrawal by Subject|5|||
126325324|NCT01884545|454485515|FG002|Overall Study|Patient withdrawn|5|||
126325325|NCT01884545|454485516|FG003|Overall Study|Patient withdrawn|5|||
126325326|NCT01884545|454485513|FG000|Overall Study|Non-adherence|0|||
126325327|NCT01884545|454485514|FG001|Overall Study|Non-adherence|2|||
125985675|NCT01060553|453238066|FG000|Overall Study|Lack of Efficacy|1|||
125985676|NCT01060553|453238067|FG001|Overall Study|Lack of Efficacy|0|||
125985677|NCT04707196|453238069|FG000|Overall Study|Withdrawal by Subject|9|||
125985678|NCT04707196|453238070|FG001|Overall Study|Withdrawal by Subject|6|||
125985679|NCT04707196|453238069|FG000|Overall Study|Lost to Follow-up|1|||
125985680|NCT04707196|453238070|FG001|Overall Study|Lost to Follow-up|0|||
126325328|NCT01884545|454485515|FG002|Overall Study|Non-adherence|0|||
126325329|NCT01884545|454485516|FG003|Overall Study|Non-adherence|0|||
126325330|NCT00524680|454485526|FG000|Overall Study|progression|0|||
126325331|NCT00524680|454485527|FG001|Overall Study|progression|0|||
126325332|NCT00524680|454485528|FG002|Overall Study|progression|0|||
126325333|NCT00524680|454485529|FG003|Overall Study|progression|1|||
126325334|NCT00524680|454485526|FG000|Overall Study|Adverse Event|2|||
125985681|NCT04707196|453238069|FG000|Overall Study|Protocol Violation|4|||
126325335|NCT00524680|454485527|FG001|Overall Study|Adverse Event|0|||
126325336|NCT00524680|454485528|FG002|Overall Study|Adverse Event|0|||
126325337|NCT00524680|454485529|FG003|Overall Study|Adverse Event|1|||
126325338|NCT00524680|454485526|FG000|Overall Study|Other|0|||
126325339|NCT00524680|454485527|FG001|Overall Study|Other|1|||
126325340|NCT00524680|454485528|FG002|Overall Study|Other|2|||
126325341|NCT00524680|454485529|FG003|Overall Study|Other|3|||
126325342|NCT00524680|454485526|FG000|Overall Study|Withdrawal by Subject|1|||
126325343|NCT00524680|454485527|FG001|Overall Study|Withdrawal by Subject|0|||
126325344|NCT00524680|454485528|FG002|Overall Study|Withdrawal by Subject|1|||
126325345|NCT00524680|454485529|FG003|Overall Study|Withdrawal by Subject|1|||
126325346|NCT01607346|454485530|FG000|Overall Study|Adverse Event|3|||
125985682|NCT04707196|453238070|FG001|Overall Study|Protocol Violation|1|||
126325347|NCT01098162|454485531|FG000|Overall Study|Adverse Event|37|||
126325348|NCT01098162|454485531|FG000|Overall Study|Lack of Efficacy|4|||
126325349|NCT01098162|454485531|FG000|Overall Study|Wish of Patient|7|||
126325350|NCT01098162|454485531|FG000|Overall Study|Lost to Follow-up|9|||
126325351|NCT01098162|454485531|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
126325352|NCT01098162|454485531|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
126325353|NCT01098162|454485531|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
126325354|NCT01098162|454485531|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
126325355|NCT01098162|454485531|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
126325356|NCT01098162|454485531|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
126325357|NCT01098162|454485531|FG000|Overall Study|Other Reason|1|||
126325358|NCT01098162|454485531|FG000|Overall Study|Reason Unknown|26|||
126325359|NCT00625183|454485532|FG000|Overall Study|Disease Progression|1|||
126325360|NCT00856843|454485534|FG000|Overall Study|Withdrawal by Subject|1|||
126325361|NCT00856843|454485535|FG001|Overall Study|Withdrawal by Subject|5|||
126325362|NCT00856843|454485534|FG000|Overall Study|Lack of Efficacy|1|||
126325363|NCT00856843|454485535|FG001|Overall Study|Lack of Efficacy|0|||
126325364|NCT01366638|454485539|FG000|Overall Study|Withdrawal by Subject|0|||
126325365|NCT01366638|454485540|FG001|Overall Study|Withdrawal by Subject|0|||
126325366|NCT01366638|454485541|FG002|Overall Study|Withdrawal by Subject|6|||
126325367|NCT01366638|454485539|FG000|Overall Study|Other|1|||
126325368|NCT01366638|454485540|FG001|Overall Study|Other|0|||
126325369|NCT01366638|454485541|FG002|Overall Study|Other|0|||
126325370|NCT01451554|454485542|FG000|Overall Study|Withdrawal by Subject|14|||
126325371|NCT01451554|454485543|FG001|Overall Study|Withdrawal by Subject|9|||
126325372|NCT01402986|454485544|FG000|Overall Study|Withdrawal by Subject|7|||
126325373|NCT01402986|454485545|FG001|Overall Study|Withdrawal by Subject|10|||
125985683|NCT04707196|453238069|FG000|Overall Study|Adverse Event|2|||
125985684|NCT04707196|453238070|FG001|Overall Study|Adverse Event|2|||
125985685|NCT04707196|453238069|FG000|Overall Study|Death|3|||
125985686|NCT04707196|453238070|FG001|Overall Study|Death|1|||
125985687|NCT04707196|453238069|FG000|Overall Study|Non-compliance with study drug|1|||
125985688|NCT04707196|453238070|FG001|Overall Study|Non-compliance with study drug|0|||
125985689|NCT04707196|453238069|FG000|Overall Study|Progressive disease|9|||
125985690|NCT04707196|453238070|FG001|Overall Study|Progressive disease|10|||
125985691|NCT01862796|453238071|FG000|Overall Study|Prohibited medications|0|||
125985692|NCT01862796|453238072|FG001|Overall Study|Prohibited medications|0|||
125985693|NCT01862796|453238073|FG002|Overall Study|Prohibited medications|1|||
126325374|NCT01402986|454485546|FG002|Overall Study|Withdrawal by Subject|7|||
126325375|NCT01402986|454485547|FG003|Overall Study|Withdrawal by Subject|13|||
126325376|NCT01402986|454485544|FG000|Overall Study|Death|0|||
126325377|NCT01402986|454485545|FG001|Overall Study|Death|0|||
126325378|NCT01402986|454485546|FG002|Overall Study|Death|0|||
126325379|NCT01402986|454485547|FG003|Overall Study|Death|2|||
126325380|NCT01402986|454485544|FG000|Overall Study|Lost to Follow-up|0|||
126325381|NCT01402986|454485545|FG001|Overall Study|Lost to Follow-up|0|||
126325382|NCT01402986|454485546|FG002|Overall Study|Lost to Follow-up|0|||
125985694|NCT01493960|453240392|FG000|Overall Study|Adverse Event|0|||
125985695|NCT01493960|453240393|FG001|Overall Study|Adverse Event|1|||
125985696|NCT01493960|453240392|FG000|Overall Study|Lack of Efficacy|15|||
126325383|NCT01402986|454485547|FG003|Overall Study|Lost to Follow-up|1|||
126325384|NCT01402986|454485544|FG000|Overall Study|Other|2|||
126325385|NCT01402986|454485545|FG001|Overall Study|Other|5|||
125985697|NCT01493960|453240393|FG001|Overall Study|Lack of Efficacy|9|||
126325386|NCT01402986|454485546|FG002|Overall Study|Other|1|||
126325387|NCT01402986|454485547|FG003|Overall Study|Other|6|||
126325388|NCT02427802|454485548|FG000|Overall Study|Adverse Event|11|||
126325389|NCT02427802|454485549|FG001|Overall Study|Adverse Event|3|||
126325390|NCT02427802|454485550|FG002|Overall Study|Adverse Event|7|||
126325391|NCT02427802|454485548|FG000|Overall Study|Death|0|||
126325392|NCT02427802|454485549|FG001|Overall Study|Death|4|||
126325393|NCT02427802|454485550|FG002|Overall Study|Death|1|||
126325394|NCT02427802|454485548|FG000|Overall Study|Lost to Follow-up|13|||
126325395|NCT02427802|454485549|FG001|Overall Study|Lost to Follow-up|8|||
126325396|NCT02427802|454485550|FG002|Overall Study|Lost to Follow-up|8|||
126325397|NCT02427802|454485548|FG000|Overall Study|Physician Decision|4|||
126325398|NCT02427802|454485549|FG001|Overall Study|Physician Decision|2|||
126325399|NCT02427802|454485550|FG002|Overall Study|Physician Decision|4|||
126325400|NCT02427802|454485548|FG000|Overall Study|Withdrawal by Subject|10|||
126325401|NCT02427802|454485549|FG001|Overall Study|Withdrawal by Subject|5|||
126325402|NCT02427802|454485550|FG002|Overall Study|Withdrawal by Subject|11|||
126325403|NCT02427802|454485548|FG000|Overall Study|Protocol Violation|3|||
126325404|NCT02427802|454485549|FG001|Overall Study|Protocol Violation|1|||
126325405|NCT02427802|454485550|FG002|Overall Study|Protocol Violation|1|||
126325406|NCT02427802|454485548|FG000|Overall Study|protocol specific treatment unrelated|18|||
126325407|NCT02427802|454485549|FG001|Overall Study|protocol specific treatment unrelated|11|||
126325408|NCT02427802|454485550|FG002|Overall Study|protocol specific treatment unrelated|11|||
126325409|NCT01085084|454485551|FG000|Overall Study|Withdrawal by Subject|1|||
126325410|NCT01085084|454485552|FG001|Overall Study|Withdrawal by Subject|0|||
126325411|NCT01085084|454485553|FG002|Overall Study|Withdrawal by Subject|0|||
126325412|NCT01085084|454485551|FG000|Overall Study|Lost to Follow-up|2|||
126325413|NCT01085084|454485552|FG001|Overall Study|Lost to Follow-up|1|||
126325414|NCT01085084|454485553|FG002|Overall Study|Lost to Follow-up|1|||
126325415|NCT01085084|454485551|FG000|Overall Study|Adverse Event|4|||
126325416|NCT01085084|454485552|FG001|Overall Study|Adverse Event|3|||
126325417|NCT01085084|454485553|FG002|Overall Study|Adverse Event|6|||
126325418|NCT01085084|454485551|FG000|Overall Study|Treatment Failure|0|||
126325419|NCT01085084|454485552|FG001|Overall Study|Treatment Failure|1|||
126325420|NCT01085084|454485553|FG002|Overall Study|Treatment Failure|2|||
126325421|NCT02749799|454485554|FG000|Overall Study|Adverse Event|2|||
126325422|NCT02749799|454485554|FG000|Overall Study|Lost to Follow-up|4|||
126325423|NCT02749799|454485554|FG000|Overall Study|Protocol Violation|1|||
126325424|NCT02749799|454485554|FG000|Overall Study|Withdrawal by Subject|1|||
125985698|NCT01493960|453240392|FG000|Overall Study|Protocol Violation|3|||
125985699|NCT01493960|453240393|FG001|Overall Study|Protocol Violation|0|||
125985700|NCT01493960|453240392|FG000|Overall Study|Withdrawal by Subject|10|||
125985701|NCT01493960|453240393|FG001|Overall Study|Withdrawal by Subject|4|||
126325425|NCT02634983|454485555|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
126325426|NCT02634983|454485556|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
126325427|NCT02070978|454485557|FG000|Overall Study|Adverse Event|6|||
126325428|NCT02070978|454485558|FG001|Overall Study|Adverse Event|2|||
126325429|NCT02070978|454485559|FG002|Overall Study|Adverse Event|0|||
126325430|NCT02070978|454485557|FG000|Overall Study|Lost to Follow-up|1|||
126325431|NCT02070978|454485558|FG001|Overall Study|Lost to Follow-up|3|||
126325432|NCT02070978|454485559|FG002|Overall Study|Lost to Follow-up|4|||
126325433|NCT02070978|454485557|FG000|Overall Study|Withdrawal by Subject|3|||
125985702|NCT01493960|453240392|FG000|Overall Study|Non-specified|4|||
125985703|NCT01493960|453240393|FG001|Overall Study|Non-specified|4|||
125985704|NCT00284141|453240398|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
125985705|NCT00284141|453240398|FG000|Overall Study|Adverse Event|19|||
125985706|NCT00284141|453240398|FG000|Overall Study|Participant's request|9|||
125985707|NCT00284141|453240398|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
125985708|NCT00284141|453240398|FG000|Overall Study|Clinical deterioration / death|2|||
125985709|NCT00284141|453240398|FG000|Overall Study|General decline|1|||
125985710|NCT00284141|453240398|FG000|Overall Study|Pneumonia|1|||
126325434|NCT02070978|454485558|FG001|Overall Study|Withdrawal by Subject|5|||
126325435|NCT02070978|454485559|FG002|Overall Study|Withdrawal by Subject|3|||
126325436|NCT02070978|454485557|FG000|Overall Study|Protocol Violation|1|||
126325437|NCT02070978|454485558|FG001|Overall Study|Protocol Violation|0|||
126325438|NCT02070978|454485559|FG002|Overall Study|Protocol Violation|3|||
126325439|NCT02070978|454485557|FG000|Overall Study|Lack of Efficacy|0|||
125985711|NCT00284141|453240398|FG000|Overall Study|Did not take study medication|2|||
125985712|NCT00284141|453240398|FG000|Overall Study|Ongoing treatment|2|||
126325440|NCT02070978|454485558|FG001|Overall Study|Lack of Efficacy|1|||
126325441|NCT02070978|454485559|FG002|Overall Study|Lack of Efficacy|0|||
126325442|NCT02070978|454485557|FG000|Overall Study|Death|0|||
126325443|NCT02070978|454485558|FG001|Overall Study|Death|0|||
126325444|NCT02070978|454485559|FG002|Overall Study|Death|2|||
126325445|NCT02070978|454485557|FG000|Overall Study|Un-specified|3|||
126325446|NCT02070978|454485558|FG001|Overall Study|Un-specified|2|||
126325447|NCT02070978|454485559|FG002|Overall Study|Un-specified|2|||
126325448|NCT02070978|454485557|FG000|Overall Study|Terminated by Sponsor|33|||
126325449|NCT02070978|454485558|FG001|Overall Study|Terminated by Sponsor|40|||
126325450|NCT02070978|454485559|FG002|Overall Study|Terminated by Sponsor|39|||
126325451|NCT03749109|454485560|FG000|Overall Study|Adverse Event|2|||
126325452|NCT03749109|454485561|FG001|Overall Study|Adverse Event|0|||
126325453|NCT03951753|454485562|FG000|Overall Study|Adverse Event|1|||
126325454|NCT03951753|454485563|FG001|Overall Study|Adverse Event|0|||
126325455|NCT03951753|454485564|FG002|Overall Study|Adverse Event|3|||
126325456|NCT03951753|454485562|FG000|Overall Study|Withdrawal by Subject|3|||
126325457|NCT03951753|454485563|FG001|Overall Study|Withdrawal by Subject|1|||
126325458|NCT03951753|454485564|FG002|Overall Study|Withdrawal by Subject|0|||
126325459|NCT03951753|454485562|FG000|Overall Study|Lost to Follow-up|0|||
126325460|NCT03951753|454485563|FG001|Overall Study|Lost to Follow-up|0|||
126325461|NCT03951753|454485564|FG002|Overall Study|Lost to Follow-up|1|||
126325462|NCT03178851|454485565|FG000|Overall Study|Death|48|||
126325463|NCT03178851|454485566|FG001|Overall Study|Death|2|||
126325464|NCT03178851|454485567|FG002|Overall Study|Death|25|||
126325465|NCT03178851|454485565|FG000|Overall Study|Withdrawal by Subject|8|||
126325466|NCT03178851|454485566|FG001|Overall Study|Withdrawal by Subject|0|||
126325467|NCT03178851|454485567|FG002|Overall Study|Withdrawal by Subject|0|||
126325468|NCT03178851|454485565|FG000|Overall Study|Lost to Follow-up|5|||
126325469|NCT03178851|454485566|FG001|Overall Study|Lost to Follow-up|2|||
126325470|NCT03178851|454485567|FG002|Overall Study|Lost to Follow-up|0|||
126325471|NCT03178851|454485565|FG000|Overall Study|Adverse Event|0|||
125985713|NCT00975221|453240399|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
125985714|NCT00975221|453240400|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
125985715|NCT00975221|453240399|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
125985716|NCT00975221|453240400|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
125985717|NCT00975221|453240399|FG000|Titration Phase (Weeks 1-12)|Other|0|||
125985718|NCT00975221|453240400|FG001|Titration Phase (Weeks 1-12)|Other|1|||
126325472|NCT03178851|454485566|FG001|Overall Study|Adverse Event|0|||
126325473|NCT03178851|454485567|FG002|Overall Study|Adverse Event|1|||
125985719|NCT00975221|453240399|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
125985720|NCT00975221|453240400|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
125985721|NCT00975221|453240399|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
125985722|NCT00975221|453240400|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
125985723|NCT00975221|453240399|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
125985724|NCT00975221|453240400|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
125985725|NCT03935217|453240403|FG000|Overall Study|Adverse Event|1|||
125985726|NCT03935217|453240404|FG001|Overall Study|Adverse Event|0|||
125985727|NCT03935217|453240403|FG000|Overall Study|Lost to Follow-up|0|||
125985728|NCT03935217|453240404|FG001|Overall Study|Lost to Follow-up|1|||
125985729|NCT03935217|453240403|FG000|Overall Study|Withdrawal by Subject|0|||
125985730|NCT03935217|453240404|FG001|Overall Study|Withdrawal by Subject|2|||
125985731|NCT03559218|453240405|FG000|Overall Study|Withdrawal by Subject|1|||
125985732|NCT03559218|453240406|FG001|Overall Study|Withdrawal by Subject|0|||
125985733|NCT00332332|453240408|FG000|Overall Study|Adverse Event|13|||
125985734|NCT00332332|453240408|FG000|Overall Study|Death|1|||
125985735|NCT00332332|453240408|FG000|Overall Study|Withdrawal by Subject|8|||
125985736|NCT00332332|453240408|FG000|Overall Study|Physician Decision|1|||
125985737|NCT00332332|453240408|FG000|Overall Study|Lost to Follow-up|3|||
125985738|NCT00332332|453240408|FG000|Overall Study|Protocol deviation|4|||
125985739|NCT00332332|453240408|FG000|Overall Study|Noncompliance|2|||
125985740|NCT00332332|453240408|FG000|Overall Study|Disease progression|2|||
125985741|NCT00332332|453240408|FG000|Overall Study|Other|18|||
125985742|NCT00332332|453240408|FG000|Overall Study|Did not receive study treatment|16|||
125985743|NCT01108458|453240409|FG000|Overall Study|Withdrawal by Subject|1|||
125985744|NCT01382602|453240410|FG000|Overall Study|Protocol Violation|0|||
125985745|NCT01382602|453240411|FG001|Overall Study|Protocol Violation|3|||
125985746|NCT01382602|453240410|FG000|Overall Study|Withdrawal by Subject|0|||
125985747|NCT01382602|453240411|FG001|Overall Study|Withdrawal by Subject|1|||
125985748|NCT02790073|453240412|FG000|Overall Study|Death|1|||
125985749|NCT02790073|453240412|FG000|Overall Study|Withdrawal from HD|1|||
126325474|NCT03178851|454485565|FG000|Overall Study|Study Termination by Sponsor|31|||
126325475|NCT03178851|454485566|FG001|Overall Study|Study Termination by Sponsor|7|||
126325476|NCT03178851|454485567|FG002|Overall Study|Study Termination by Sponsor|26|||
126325477|NCT02226120|454485570|FG000|Overall Study|Adverse Event|60|||
126325478|NCT02226120|454485570|FG000|Overall Study|Death|172|||
125985750|NCT02790073|453240412|FG000|Overall Study|Withdrawal by Subject|1|||
125985751|NCT04170686|453240413|FG000|Screening|Physician Decision|12|||
125985752|NCT04170686|453240414|FG001|Screening|Physician Decision|13|||
125985753|NCT04170686|453240413|FG000|Randomization and Treatment|Lost to Follow-up|26|||
125985754|NCT04170686|453240414|FG001|Randomization and Treatment|Lost to Follow-up|15|||
125985755|NCT03328143|453240415|FG000|Overall Study|Declined|3|||
125985756|NCT03328143|453240415|FG000|Overall Study|Required increased sedation|4|||
126325479|NCT02226120|454485570|FG000|Overall Study|Study terminated by sponsor|1|||
126325480|NCT02226120|454485570|FG000|Overall Study|Technical problems|4|||
125985757|NCT03328143|453240415|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
125985758|NCT03328143|453240415|FG000|Overall Study|Surgery cancelled|1|||
125985759|NCT02801669|453240416|FG000|Overall Study|Death|66|||
125985760|NCT02801669|453240417|FG001|Overall Study|Death|69|||
125985761|NCT02801669|453240416|FG000|Overall Study|Withdrawal by Subject|81|||
125985762|NCT02801669|453240417|FG001|Overall Study|Withdrawal by Subject|77|||
125985763|NCT02801669|453240416|FG000|Overall Study|Other|4|||
125985764|NCT02801669|453240417|FG001|Overall Study|Other|6|||
125985765|NCT02696564|453240418|FG000|Overall Study|Death|1|||
125985766|NCT02696564|453240419|FG001|Overall Study|Death|2|||
125985767|NCT02696564|453240418|FG000|Overall Study|Withdrawal by Subject|3|||
125985768|NCT02696564|453240419|FG001|Overall Study|Withdrawal by Subject|2|||
125985769|NCT02696564|453240418|FG000|Overall Study|Lost to Follow-up|3|||
125985770|NCT02696564|453240419|FG001|Overall Study|Lost to Follow-up|3|||
126325481|NCT02226120|454485570|FG000|Overall Study|Lost to Follow-up|13|||
126325482|NCT02226120|454485570|FG000|Overall Study|Physician Decision|21|||
126325483|NCT02226120|454485570|FG000|Overall Study|Withdrawal by parent/guardian|36|||
126325484|NCT02226120|454485570|FG000|Overall Study|Non-compliance with study drug|10|||
126325485|NCT02226120|454485570|FG000|Overall Study|Protocol deviation|1|||
125985771|NCT02696564|453240418|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
125985772|NCT02696564|453240419|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
125985773|NCT02696564|453240418|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
125985774|NCT02696564|453240419|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
125985775|NCT02696564|453240418|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
126325486|NCT02226120|454485570|FG000|Overall Study|missing treatment disposition pages|2|||
126325487|NCT02669043|454485573|FG000|Overall Study|Didn't meet I/E criteria|4|||
126325488|NCT00401193|454488203|FG000|Overall Study|Adverse Event|1|||
126325489|NCT00401193|454488204|FG001|Overall Study|Adverse Event|3|||
126325490|NCT00401193|454488205|FG002|Overall Study|Adverse Event|1|||
126325491|NCT00401193|454488203|FG000|Overall Study|Protocol Violation|3|||
126325492|NCT00401193|454488204|FG001|Overall Study|Protocol Violation|1|||
126325493|NCT00401193|454488205|FG002|Overall Study|Protocol Violation|1|||
126325494|NCT00401193|454488203|FG000|Overall Study|Lost to Follow-up|6|||
126325495|NCT00401193|454488204|FG001|Overall Study|Lost to Follow-up|5|||
126325496|NCT00401193|454488205|FG002|Overall Study|Lost to Follow-up|1|||
126325497|NCT00401193|454488203|FG000|Overall Study|Withdrawal by Subject|2|||
126325498|NCT00401193|454488204|FG001|Overall Study|Withdrawal by Subject|0|||
126325499|NCT00401193|454488205|FG002|Overall Study|Withdrawal by Subject|1|||
126325500|NCT00401193|454488203|FG000|Overall Study|Other Event|3|||
126325501|NCT00401193|454488204|FG001|Overall Study|Other Event|2|||
126325502|NCT00401193|454488205|FG002|Overall Study|Other Event|2|||
126325503|NCT00398216|454488206|FG000|Overall Study|Adverse Event|4|||
126325504|NCT00398216|454488207|FG001|Overall Study|Adverse Event|2|||
126325505|NCT00398216|454488208|FG002|Overall Study|Adverse Event|5|||
126325506|NCT00398216|454488209|FG003|Overall Study|Adverse Event|7|||
126325507|NCT00398216|454488210|FG004|Overall Study|Adverse Event|2|||
126325508|NCT00398216|454488206|FG000|Overall Study|Protocol Violation|2|||
126325509|NCT00398216|454488207|FG001|Overall Study|Protocol Violation|4|||
126325510|NCT00398216|454488208|FG002|Overall Study|Protocol Violation|5|||
126325511|NCT00398216|454488209|FG003|Overall Study|Protocol Violation|7|||
126325512|NCT00398216|454488210|FG004|Overall Study|Protocol Violation|5|||
126325513|NCT00398216|454488206|FG000|Overall Study|Lost to Follow-up|1|||
126325514|NCT00398216|454488207|FG001|Overall Study|Lost to Follow-up|6|||
126325515|NCT00398216|454488208|FG002|Overall Study|Lost to Follow-up|4|||
126325516|NCT00398216|454488209|FG003|Overall Study|Lost to Follow-up|4|||
126325517|NCT00398216|454488210|FG004|Overall Study|Lost to Follow-up|1|||
126325518|NCT00398216|454488206|FG000|Overall Study|Death|0|||
126325519|NCT00398216|454488207|FG001|Overall Study|Death|3|||
126325520|NCT00398216|454488208|FG002|Overall Study|Death|0|||
126325521|NCT00398216|454488209|FG003|Overall Study|Death|0|||
126325522|NCT00398216|454488210|FG004|Overall Study|Death|0|||
126325523|NCT00398216|454488206|FG000|Overall Study|Withdrawal by Subject|1|||
126325524|NCT00398216|454488207|FG001|Overall Study|Withdrawal by Subject|0|||
126325525|NCT00398216|454488208|FG002|Overall Study|Withdrawal by Subject|3|||
126325526|NCT00398216|454488209|FG003|Overall Study|Withdrawal by Subject|1|||
126325527|NCT00398216|454488210|FG004|Overall Study|Withdrawal by Subject|2|||
126325528|NCT00398216|454488206|FG000|Overall Study|administrative reasons|3|||
126325529|NCT00398216|454488207|FG001|Overall Study|administrative reasons|4|||
126325530|NCT00398216|454488208|FG002|Overall Study|administrative reasons|4|||
126325531|NCT00398216|454488209|FG003|Overall Study|administrative reasons|3|||
125985776|NCT02696564|453240419|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
125985777|NCT02696564|453240418|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
126325532|NCT00398216|454488210|FG004|Overall Study|administrative reasons|3|||
126325533|NCT00398216|454488206|FG000|Overall Study|entrance criteria|0|||
125985778|NCT02696564|453240419|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
126325534|NCT00398216|454488207|FG001|Overall Study|entrance criteria|0|||
125985779|NCT02696564|453240418|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
125985780|NCT02696564|453240419|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
125985781|NCT00615264|453240421|FG000|Overall Study|Withdrawal by Subject|17|||
125985782|NCT00615264|453240422|FG001|Overall Study|Withdrawal by Subject|19|||
125985783|NCT00615264|453240421|FG000|Overall Study|Lost to Follow-up|6|||
125985784|NCT00615264|453240422|FG001|Overall Study|Lost to Follow-up|13|||
125985785|NCT00615264|453240421|FG000|Overall Study|Adverse Event|8|||
126325535|NCT00398216|454488208|FG002|Overall Study|entrance criteria|0|||
126325536|NCT00398216|454488209|FG003|Overall Study|entrance criteria|0|||
126325537|NCT00398216|454488210|FG004|Overall Study|entrance criteria|2|||
126325538|NCT01048944|454488211|FG000|Overall Study|Protocol Violation|8|||
126325539|NCT01048944|454488212|FG001|Overall Study|Protocol Violation|10|||
126325540|NCT01048944|454488213|FG002|Overall Study|Protocol Violation|10|||
126325541|NCT01048944|454488214|FG003|Overall Study|Protocol Violation|2|||
126325542|NCT01844817|454488215|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
126325543|NCT01844817|454488216|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
126325544|NCT01844817|454488215|FG000|Treatment|Progressive Disease|27|||
126325545|NCT01844817|454488216|FG001|Treatment|Progressive Disease|36|||
126325546|NCT01844817|454488215|FG000|Treatment|Adverse Event|17|||
126325547|NCT01844817|454488216|FG001|Treatment|Adverse Event|9|||
126325548|NCT01844817|454488215|FG000|Treatment|Withdrawal by Subject|10|||
126325549|NCT01844817|454488216|FG001|Treatment|Withdrawal by Subject|6|||
126325550|NCT01844817|454488215|FG000|Treatment|Death|10|||
126325551|NCT01844817|454488216|FG001|Treatment|Death|8|||
126325552|NCT01844817|454488215|FG000|Treatment|Lost to Follow-up|0|||
126325553|NCT01844817|454488216|FG001|Treatment|Lost to Follow-up|1|||
126325554|NCT01844817|454488215|FG000|Treatment|Other|0|||
126325555|NCT01844817|454488216|FG001|Treatment|Other|3|||
126325556|NCT02207400|454488217|FG000|Overall Study|Adverse Event|1|||
126325557|NCT02207400|454488218|FG001|Overall Study|Adverse Event|1|||
126325558|NCT02207400|454488217|FG000|Overall Study|Lost to Follow-up|6|||
126325559|NCT02207400|454488218|FG001|Overall Study|Lost to Follow-up|7|||
126325560|NCT02207400|454488217|FG000|Overall Study|Protocol Violation|1|||
126325561|NCT02207400|454488218|FG001|Overall Study|Protocol Violation|1|||
126325562|NCT02207400|454488217|FG000|Overall Study|Withdrawal by Subject|8|||
126325563|NCT02207400|454488218|FG001|Overall Study|Withdrawal by Subject|4|||
126325564|NCT02207400|454488217|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
126325565|NCT02207400|454488218|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
126325566|NCT03396822|454488219|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
126325567|NCT03396822|454488219|FG000|Overall Study|Physician Decision|1|||
126325568|NCT03638466|454488220|FG000|Overall Study|Early Termination|0|||
125985786|NCT00615264|453240422|FG001|Overall Study|Adverse Event|5|||
125985787|NCT00615264|453240421|FG000|Overall Study|Death|1|||
125985788|NCT00615264|453240422|FG001|Overall Study|Death|1|||
125985789|NCT00615264|453240421|FG000|Overall Study|Protocol Violation|11|||
126325569|NCT03638466|454488221|FG001|Overall Study|Early Termination|1|||
126325570|NCT03251482|454488222|FG000|Overall Study|Withdrawal by Subject|0|||
126325571|NCT03251482|454488223|FG001|Overall Study|Withdrawal by Subject|1|||
126325572|NCT03251482|454488224|FG002|Overall Study|Withdrawal by Subject|0|||
126325573|NCT03251482|454488225|FG003|Overall Study|Withdrawal by Subject|0|||
126325574|NCT03251482|454488226|FG004|Overall Study|Withdrawal by Subject|0|||
126325575|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
126325576|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
126325577|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
126325578|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
126325579|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
126325580|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
126325581|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
126325582|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
126325583|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
126325584|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
126325585|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
125985790|NCT00615264|453240422|FG001|Overall Study|Protocol Violation|7|||
125985791|NCT00615264|453240421|FG000|Overall Study|Not defined|7|||
125985792|NCT00615264|453240422|FG001|Overall Study|Not defined|4|||
126325586|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
126325587|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
126325588|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
126325589|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
126325590|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
126325591|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
126325592|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
126325593|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
126325594|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
125985793|NCT00615264|453240421|FG000|Overall Study|Dermal Hypersensitivity|0|||
125985794|NCT00615264|453240422|FG001|Overall Study|Dermal Hypersensitivity|3|||
126325595|NCT02362425|454488227|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
126325596|NCT02362425|454488228|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
126325597|NCT02362425|454488229|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
126325598|NCT02362425|454488230|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
126325599|NCT02362425|454488227|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
126325600|NCT02362425|454488228|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
126325601|NCT02362425|454488229|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
126325602|NCT02362425|454488230|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
126325603|NCT02362425|454488227|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
126325604|NCT02362425|454488228|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
126325605|NCT02362425|454488229|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
126325606|NCT02362425|454488230|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
126325607|NCT02579382|454488235|FG000|Main Study Phase|Lost to Follow-up|0|||
126325608|NCT02579382|454488236|FG001|Main Study Phase|Lost to Follow-up|0|||
126325609|NCT02579382|454488237|FG002|Main Study Phase|Lost to Follow-up|2|||
126325610|NCT02579382|454488238|FG003|Main Study Phase|Lost to Follow-up|0|||
126325611|NCT02579382|454488235|FG000|Main Study Phase|Withdrew Consent|0|||
126325612|NCT02579382|454488236|FG001|Main Study Phase|Withdrew Consent|0|||
126325613|NCT02579382|454488237|FG002|Main Study Phase|Withdrew Consent|0|||
126325614|NCT02579382|454488238|FG003|Main Study Phase|Withdrew Consent|2|||
126325615|NCT02579382|454488235|FG000|Main Study Phase|Lack of Efficacy|0|||
126325616|NCT02579382|454488236|FG001|Main Study Phase|Lack of Efficacy|0|||
126325617|NCT02579382|454488237|FG002|Main Study Phase|Lack of Efficacy|0|||
126325618|NCT02579382|454488238|FG003|Main Study Phase|Lack of Efficacy|1|||
126325619|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
126325620|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
126325621|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
126325622|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
126325623|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
126325624|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
126325625|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
126325626|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
126325627|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
126325628|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
126325629|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
126325630|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
126325631|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
126325632|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
126325633|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
126325634|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
126325635|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
126325636|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
126325637|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
126325638|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
126325639|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
126325640|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
126325641|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
126325642|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
126325643|NCT03026283|454488240|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
126325644|NCT03026283|454488241|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
126325645|NCT03026283|454488242|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
126325646|NCT03026283|454488243|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
126325647|NCT03026283|454488244|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
126325648|NCT03026283|454488245|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
126325649|NCT03026283|454488246|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
126325650|NCT03026283|454488247|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
126325651|NCT03026283|454488240|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
126325652|NCT03026283|454488241|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
126325653|NCT03026283|454488242|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
126325654|NCT03026283|454488243|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
126325655|NCT03026283|454488244|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
126325656|NCT03026283|454488245|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
126325657|NCT03026283|454488246|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
126325658|NCT03026283|454488247|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
126325659|NCT03026283|454488240|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125985795|NCT03430063|453240432|FG000|Overall Study|Adverse Event|0|||
125985796|NCT03430063|453240433|FG001|Overall Study|Adverse Event|1|||
125985797|NCT03430063|453240434|FG002|Overall Study|Adverse Event|0|||
125985798|NCT03430063|453240432|FG000|Overall Study|Death|3|||
125985799|NCT03430063|453240433|FG001|Overall Study|Death|2|||
125985800|NCT03430063|453240434|FG002|Overall Study|Death|3|||
125985801|NCT03430063|453240432|FG000|Overall Study|Lost to Follow-up|0|||
125985802|NCT03430063|453240433|FG001|Overall Study|Lost to Follow-up|1|||
125985803|NCT03430063|453240434|FG002|Overall Study|Lost to Follow-up|0|||
125985804|NCT03430063|453240432|FG000|Overall Study|Withdrawal by Subject|0|||
126325660|NCT03026283|454488241|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
126325661|NCT03026283|454488242|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325662|NCT03026283|454488243|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325663|NCT03026283|454488244|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325664|NCT03026283|454488245|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325665|NCT03026283|454488246|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325666|NCT03026283|454488247|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325667|NCT03026283|454488240|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325668|NCT03026283|454488241|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125985805|NCT03430063|453240433|FG001|Overall Study|Withdrawal by Subject|0|||
125985806|NCT03430063|453240434|FG002|Overall Study|Withdrawal by Subject|1|||
125985807|NCT03430063|453240432|FG000|Overall Study|Withdrawal of consent|3|||
125985808|NCT03430063|453240433|FG001|Overall Study|Withdrawal of consent|1|||
125985809|NCT03430063|453240434|FG002|Overall Study|Withdrawal of consent|2|||
125985810|NCT03430063|453240432|FG000|Overall Study|Progressive disease|1|||
125985811|NCT03430063|453240433|FG001|Overall Study|Progressive disease|2|||
125985812|NCT03430063|453240434|FG002|Overall Study|Progressive disease|1|||
125985813|NCT03430063|453240432|FG000|Overall Study|Other un-specified|1|||
125985814|NCT03430063|453240433|FG001|Overall Study|Other un-specified|1|||
125985815|NCT03430063|453240434|FG002|Overall Study|Other un-specified|0|||
126325669|NCT03026283|454488242|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
126325670|NCT03026283|454488243|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325671|NCT03026283|454488244|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325672|NCT03026283|454488245|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325673|NCT03026283|454488246|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325674|NCT03026283|454488247|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325675|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325676|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325677|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325678|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
126325679|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
126325680|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325681|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325682|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325683|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325684|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325685|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325686|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
126325687|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
126325688|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
126325689|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325690|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325691|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325692|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325693|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325694|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
126325695|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325696|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
126325697|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325698|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325699|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325700|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325701|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325702|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
125985816|NCT03430063|453240432|FG000|Overall Study|Randomized, but never treated|0|||
125985817|NCT03430063|453240433|FG001|Overall Study|Randomized, but never treated|0|||
125985818|NCT03430063|453240434|FG002|Overall Study|Randomized, but never treated|1|||
125985819|NCT02798211|453240435|FG000|Period 1|Adverse Event|1|||
125985820|NCT02798211|453240436|FG001|Period 1|Adverse Event|1|||
125985821|NCT02798211|453240437|FG002|Period 1|Adverse Event|0|||
126325703|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325704|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325705|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325706|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325707|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325708|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325709|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325710|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325711|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
126325712|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
126325713|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325714|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325715|NCT03782571|454488248|FG000|Period 1|Withdrawal by Subject|1|||
126325716|NCT03782571|454488249|FG001|Period 1|Withdrawal by Subject|0|||
126325717|NCT03782571|454488250|FG002|Period 1|Withdrawal by Subject|0|||
126325718|NCT03782571|454488251|FG003|Period 1|Withdrawal by Subject|0|||
126325719|NCT03782571|454488248|FG000|Period 3|Subject Unable to Attend V5|1|||
126325720|NCT03782571|454488249|FG001|Period 3|Subject Unable to Attend V5|0|||
126325721|NCT03782571|454488250|FG002|Period 3|Subject Unable to Attend V5|0|||
126325722|NCT03782571|454488251|FG003|Period 3|Subject Unable to Attend V5|0|||
126325723|NCT03782571|454488248|FG000|Period 3|Adverse Event|1|||
126325724|NCT03782571|454488249|FG001|Period 3|Adverse Event|0|||
126325725|NCT03782571|454488250|FG002|Period 3|Adverse Event|0|||
126325726|NCT03782571|454488251|FG003|Period 3|Adverse Event|0|||
126325727|NCT02213380|454488263|FG000|Underwent Randomization|Withdrawal by Subject|2|||
126325728|NCT02213380|454488264|FG001|Underwent Randomization|Withdrawal by Subject|0|||
126325729|NCT02213380|454488263|FG000|Underwent Randomization|Not treated|3|||
126325730|NCT02213380|454488264|FG001|Underwent Randomization|Not treated|3|||
126325731|NCT02213380|454488263|FG000|Per-protocol Analysis|Protocol Violation|32|||
126325732|NCT02213380|454488264|FG001|Per-protocol Analysis|Protocol Violation|36|||
126325733|NCT03498313|454488267|FG000|Experimental Period 1|Adverse Event|1|||
126325734|NCT03498313|454488268|FG001|Experimental Period 1|Adverse Event|0|||
126325735|NCT03498313|454488269|FG002|Experimental Period 1|Adverse Event|0|||
126325736|NCT03498313|454488270|FG003|Experimental Period 1|Adverse Event|1|||
126325737|NCT03498313|454488271|FG004|Experimental Period 1|Adverse Event|0|||
126325738|NCT03498313|454488272|FG005|Experimental Period 1|Adverse Event|0|||
126325739|NCT03498313|454488267|FG000|Experimental Period 1|Withdrawal by Subject|0|||
126325740|NCT03498313|454488268|FG001|Experimental Period 1|Withdrawal by Subject|1|||
126325741|NCT03498313|454488269|FG002|Experimental Period 1|Withdrawal by Subject|0|||
126325742|NCT03498313|454488270|FG003|Experimental Period 1|Withdrawal by Subject|0|||
126325743|NCT03498313|454488271|FG004|Experimental Period 1|Withdrawal by Subject|0|||
126325744|NCT03498313|454488272|FG005|Experimental Period 1|Withdrawal by Subject|0|||
126325745|NCT03498313|454488267|FG000|Washout Period 1|Anovulation|1|||
126325746|NCT03498313|454488268|FG001|Washout Period 1|Anovulation|0|||
126325747|NCT03498313|454488269|FG002|Washout Period 1|Anovulation|0|||
126325748|NCT03498313|454488270|FG003|Washout Period 1|Anovulation|0|||
126325749|NCT03498313|454488271|FG004|Washout Period 1|Anovulation|0|||
125985822|NCT02798211|453240438|FG003|Period 1|Adverse Event|0|||
125985823|NCT02798211|453240439|FG004|Period 1|Adverse Event|0|||
125985824|NCT02798211|453240440|FG005|Period 1|Adverse Event|0|||
125985825|NCT02798211|453240435|FG000|Period 1|Lost to Follow-up|2|||
125985826|NCT02798211|453240436|FG001|Period 1|Lost to Follow-up|1|||
125985827|NCT02798211|453240437|FG002|Period 1|Lost to Follow-up|0|||
125985828|NCT02798211|453240438|FG003|Period 1|Lost to Follow-up|0|||
125985829|NCT02798211|453240439|FG004|Period 1|Lost to Follow-up|0|||
125985830|NCT02798211|453240440|FG005|Period 1|Lost to Follow-up|0|||
125985831|NCT02798211|453240435|FG000|Period 1|Protocol Violation|0|||
125985832|NCT02798211|453240436|FG001|Period 1|Protocol Violation|0|||
125985833|NCT02798211|453240437|FG002|Period 1|Protocol Violation|2|||
125985834|NCT02798211|453240438|FG003|Period 1|Protocol Violation|0|||
126325750|NCT03498313|454488272|FG005|Washout Period 1|Anovulation|0|||
126325751|NCT03498313|454488267|FG000|Washout Period 1|Withdrawal by Subject|0|||
126325752|NCT03498313|454488268|FG001|Washout Period 1|Withdrawal by Subject|3|||
126325753|NCT03498313|454488269|FG002|Washout Period 1|Withdrawal by Subject|0|||
125985835|NCT02798211|453240439|FG004|Period 1|Protocol Violation|0|||
125985836|NCT02798211|453240440|FG005|Period 1|Protocol Violation|0|||
125985837|NCT02798211|453240435|FG000|Period 1|Withdrawal by Subject|1|||
125985838|NCT02798211|453240436|FG001|Period 1|Withdrawal by Subject|1|||
125985839|NCT02798211|453240437|FG002|Period 1|Withdrawal by Subject|0|||
125985840|NCT02798211|453240438|FG003|Period 1|Withdrawal by Subject|0|||
126325754|NCT03498313|454488270|FG003|Washout Period 1|Withdrawal by Subject|1|||
126325755|NCT03498313|454488271|FG004|Washout Period 1|Withdrawal by Subject|0|||
126325756|NCT03498313|454488272|FG005|Washout Period 1|Withdrawal by Subject|1|||
125985841|NCT02798211|453240439|FG004|Period 1|Withdrawal by Subject|0|||
126325757|NCT03498313|454488267|FG000|Experimental Period 2|Adverse Event|0|||
126325758|NCT03498313|454488268|FG001|Experimental Period 2|Adverse Event|0|||
126325759|NCT03498313|454488269|FG002|Experimental Period 2|Adverse Event|0|||
126325760|NCT03498313|454488270|FG003|Experimental Period 2|Adverse Event|0|||
126325761|NCT03498313|454488271|FG004|Experimental Period 2|Adverse Event|1|||
126325762|NCT03498313|454488272|FG005|Experimental Period 2|Adverse Event|2|||
126325763|NCT03498313|454488267|FG000|Washout Period 2|Physician Decision|1|||
126325764|NCT03498313|454488268|FG001|Washout Period 2|Physician Decision|0|||
126325765|NCT03498313|454488269|FG002|Washout Period 2|Physician Decision|0|||
126325766|NCT03498313|454488270|FG003|Washout Period 2|Physician Decision|1|||
126325767|NCT03498313|454488271|FG004|Washout Period 2|Physician Decision|0|||
126325768|NCT03498313|454488272|FG005|Washout Period 2|Physician Decision|1|||
126325769|NCT03498313|454488267|FG000|Washout Period 2|Withdrawal by Subject|3|||
126325770|NCT03498313|454488268|FG001|Washout Period 2|Withdrawal by Subject|2|||
126325771|NCT03498313|454488269|FG002|Washout Period 2|Withdrawal by Subject|0|||
126325772|NCT03498313|454488270|FG003|Washout Period 2|Withdrawal by Subject|0|||
126325773|NCT03498313|454488271|FG004|Washout Period 2|Withdrawal by Subject|2|||
126325774|NCT03498313|454488272|FG005|Washout Period 2|Withdrawal by Subject|0|||
126325775|NCT03498313|454488267|FG000|Washout Period 2|Anovulation|0|||
126325776|NCT03498313|454488268|FG001|Washout Period 2|Anovulation|0|||
126325777|NCT03498313|454488269|FG002|Washout Period 2|Anovulation|0|||
126325778|NCT03498313|454488270|FG003|Washout Period 2|Anovulation|0|||
126325779|NCT03498313|454488271|FG004|Washout Period 2|Anovulation|0|||
126325780|NCT03498313|454488272|FG005|Washout Period 2|Anovulation|1|||
126325781|NCT00184002|454488275|FG000|Overall Study|Adverse Event|9|||
126325782|NCT00184002|454488275|FG000|Overall Study|Death|3|||
126325783|NCT00184002|454488275|FG000|Overall Study|Physician Decision|1|||
126325784|NCT00184002|454488275|FG000|Overall Study|Withdrawal by Subject|4|||
126325785|NCT02171429|454488276|FG000|Overall Study|Other|0|||
126325786|NCT02171429|454488277|FG001|Overall Study|Other|1|||
126325787|NCT02171429|454488278|FG002|Overall Study|Other|1|||
126325788|NCT02171429|454488276|FG000|Overall Study|Non-Compliance|0|||
126325789|NCT02171429|454488277|FG001|Overall Study|Non-Compliance|0|||
126325790|NCT02171429|454488278|FG002|Overall Study|Non-Compliance|1|||
126325791|NCT02171429|454488276|FG000|Overall Study|Physician Decision|0|||
125985842|NCT02798211|453240440|FG005|Period 1|Withdrawal by Subject|0|||
125985843|NCT02798211|453240435|FG000|Period 1|Death|0|||
126325792|NCT02171429|454488277|FG001|Overall Study|Physician Decision|0|||
126325793|NCT02171429|454488278|FG002|Overall Study|Physician Decision|1|||
126325794|NCT02171429|454488276|FG000|Overall Study|Withdrawal by Subject|1|||
125985844|NCT02798211|453240436|FG001|Period 1|Death|0|||
125985845|NCT02798211|453240437|FG002|Period 1|Death|1|||
125985846|NCT02798211|453240438|FG003|Period 1|Death|0|||
125985847|NCT02798211|453240439|FG004|Period 1|Death|0|||
125985848|NCT02798211|453240440|FG005|Period 1|Death|0|||
125985849|NCT02798211|453240435|FG000|Period 1|Withdrawal of Informed Consent|2|||
125985850|NCT02798211|453240436|FG001|Period 1|Withdrawal of Informed Consent|7|||
125985851|NCT02798211|453240437|FG002|Period 1|Withdrawal of Informed Consent|3|||
125985852|NCT02798211|453240438|FG003|Period 1|Withdrawal of Informed Consent|0|||
125985853|NCT02798211|453240439|FG004|Period 1|Withdrawal of Informed Consent|0|||
125985854|NCT02798211|453240440|FG005|Period 1|Withdrawal of Informed Consent|0|||
125985855|NCT02798211|453240435|FG000|Period 2|Withdrawal by Subject|2|||
125985856|NCT02798211|453240436|FG001|Period 2|Withdrawal by Subject|0|||
125985857|NCT02798211|453240437|FG002|Period 2|Withdrawal by Subject|0|||
125985858|NCT02798211|453240438|FG003|Period 2|Withdrawal by Subject|0|||
125985859|NCT02798211|453240439|FG004|Period 2|Withdrawal by Subject|2|||
125985860|NCT02798211|453240440|FG005|Period 2|Withdrawal by Subject|2|||
125985861|NCT02798211|453240435|FG000|Period 2|Adverse Event|5|||
125985862|NCT02798211|453240436|FG001|Period 2|Adverse Event|0|||
125985863|NCT02798211|453240437|FG002|Period 2|Adverse Event|0|||
125985864|NCT02798211|453240438|FG003|Period 2|Adverse Event|0|||
125985865|NCT02798211|453240439|FG004|Period 2|Adverse Event|1|||
125985866|NCT02798211|453240440|FG005|Period 2|Adverse Event|0|||
125985867|NCT02798211|453240435|FG000|Period 2|Lack of Efficacy|1|||
125985868|NCT02798211|453240436|FG001|Period 2|Lack of Efficacy|0|||
125985869|NCT02798211|453240437|FG002|Period 2|Lack of Efficacy|0|||
126325795|NCT02171429|454488277|FG001|Overall Study|Withdrawal by Subject|1|||
126325796|NCT02171429|454488278|FG002|Overall Study|Withdrawal by Subject|1|||
126325797|NCT02171429|454488276|FG000|Overall Study|Lost to Follow-up|0|||
126325798|NCT02171429|454488277|FG001|Overall Study|Lost to Follow-up|1|||
126325799|NCT02171429|454488278|FG002|Overall Study|Lost to Follow-up|0|||
126325800|NCT02171429|454488276|FG000|Overall Study|Death|0|||
125985870|NCT02798211|453240438|FG003|Period 2|Lack of Efficacy|1|||
125985871|NCT02798211|453240439|FG004|Period 2|Lack of Efficacy|0|||
125985872|NCT02798211|453240440|FG005|Period 2|Lack of Efficacy|1|||
125985873|NCT02798211|453240435|FG000|Period 2|Lost to Follow-up|3|||
125985874|NCT02798211|453240436|FG001|Period 2|Lost to Follow-up|0|||
126325801|NCT02171429|454488277|FG001|Overall Study|Death|0|||
126325802|NCT02171429|454488278|FG002|Overall Study|Death|1|||
125985875|NCT02798211|453240437|FG002|Period 2|Lost to Follow-up|0|||
125985876|NCT02798211|453240438|FG003|Period 2|Lost to Follow-up|0|||
125985877|NCT02798211|453240439|FG004|Period 2|Lost to Follow-up|2|||
125985878|NCT02798211|453240440|FG005|Period 2|Lost to Follow-up|0|||
125985879|NCT02798211|453240435|FG000|Period 2|Physician Decision|1|||
125985880|NCT02798211|453240436|FG001|Period 2|Physician Decision|0|||
125985881|NCT02798211|453240437|FG002|Period 2|Physician Decision|0|||
125985882|NCT02798211|453240438|FG003|Period 2|Physician Decision|1|||
125985883|NCT02798211|453240439|FG004|Period 2|Physician Decision|1|||
125985884|NCT02798211|453240440|FG005|Period 2|Physician Decision|0|||
125985885|NCT02798211|453240435|FG000|Period 2|Pregnancy|0|||
125985886|NCT02798211|453240436|FG001|Period 2|Pregnancy|0|||
125985887|NCT02798211|453240437|FG002|Period 2|Pregnancy|0|||
125985888|NCT02798211|453240438|FG003|Period 2|Pregnancy|2|||
126325803|NCT01148459|454488283|FG000|Overall Study|Serious Adverse Event|5|||
126325804|NCT01148459|454488284|FG001|Overall Study|Serious Adverse Event|4|||
126325805|NCT01148459|454488283|FG000|Overall Study|Withdrawal by Subject|1|||
125985889|NCT02798211|453240439|FG004|Period 2|Pregnancy|0|||
125985890|NCT02798211|453240440|FG005|Period 2|Pregnancy|0|||
125985891|NCT02798211|453240435|FG000|Period 2|Technical problems|1|||
125985892|NCT02798211|453240436|FG001|Period 2|Technical problems|0|||
125985893|NCT02798211|453240437|FG002|Period 2|Technical problems|0|||
125985894|NCT02798211|453240438|FG003|Period 2|Technical problems|1|||
125985895|NCT02798211|453240439|FG004|Period 2|Technical problems|0|||
125985896|NCT02798211|453240440|FG005|Period 2|Technical problems|0|||
125985897|NCT02798211|453240435|FG000|Period 2|Withdrawal of Informed Consent|1|||
125985898|NCT02798211|453240436|FG001|Period 2|Withdrawal of Informed Consent|0|||
125985899|NCT02798211|453240437|FG002|Period 2|Withdrawal of Informed Consent|0|||
125985900|NCT02798211|453240438|FG003|Period 2|Withdrawal of Informed Consent|2|||
125985901|NCT02798211|453240439|FG004|Period 2|Withdrawal of Informed Consent|2|||
125985902|NCT02798211|453240440|FG005|Period 2|Withdrawal of Informed Consent|3|||
125985903|NCT01982435|453240441|FG000|Overall Study|Adverse Event|1|||
125985904|NCT01982435|453240442|FG001|Overall Study|Adverse Event|0|||
125985905|NCT05292534|453240443|FG000|Overall Study|Protocol Violation|3|||
125985906|NCT05292534|453240444|FG001|Overall Study|Protocol Violation|4|||
125985907|NCT05292534|453240443|FG000|Overall Study|Withdrawal by Subject|0|||
125985908|NCT05292534|453240444|FG001|Overall Study|Withdrawal by Subject|1|||
125985909|NCT04887948|453240445|FG000|Overall Study|Death|1|||
125985910|NCT04887948|453240446|FG001|Overall Study|Death|0|||
125985911|NCT04887948|453240447|FG002|Overall Study|Death|0|||
125985912|NCT04887948|453240445|FG000|Overall Study|Lost to Follow-up|1|||
125985913|NCT04887948|453240446|FG001|Overall Study|Lost to Follow-up|0|||
125985914|NCT04887948|453240447|FG002|Overall Study|Lost to Follow-up|3|||
125985915|NCT04887948|453240445|FG000|Overall Study|Physician Decision|0|||
125985916|NCT04887948|453240446|FG001|Overall Study|Physician Decision|4|||
125985917|NCT04887948|453240447|FG002|Overall Study|Physician Decision|1|||
125985918|NCT04887948|453240445|FG000|Overall Study|Protocol Violation|1|||
125985919|NCT04887948|453240446|FG001|Overall Study|Protocol Violation|1|||
125985920|NCT04887948|453240447|FG002|Overall Study|Protocol Violation|0|||
125985921|NCT04887948|453240445|FG000|Overall Study|Withdrawal by Subject|0|||
125985922|NCT04887948|453240446|FG001|Overall Study|Withdrawal by Subject|6|||
125985923|NCT04887948|453240447|FG002|Overall Study|Withdrawal by Subject|1|||
125985924|NCT04887948|453240445|FG000|Overall Study|No longer met eligibility criteria|1|||
125985925|NCT04887948|453240446|FG001|Overall Study|No longer met eligibility criteria|2|||
125985926|NCT04887948|453240447|FG002|Overall Study|No longer met eligibility criteria|1|||
125985927|NCT04887948|453240445|FG000|Overall Study|Other|2|||
125985928|NCT04887948|453240446|FG001|Overall Study|Other|1|||
125985929|NCT04887948|453240447|FG002|Overall Study|Other|1|||
126325806|NCT01148459|454488284|FG001|Overall Study|Withdrawal by Subject|0|||
126325807|NCT01148459|454488283|FG000|Overall Study|Migrated/moved from study area|3|||
125985930|NCT01782872|453240452|FG000|Overall Study|Protocol Violation|0|||
125985931|NCT01782872|453240453|FG001|Overall Study|Protocol Violation|0|||
125985932|NCT01782872|453240454|FG002|Overall Study|Protocol Violation|0|||
125985933|NCT01782872|453240455|FG003|Overall Study|Protocol Violation|1|||
125985934|NCT01782872|453240452|FG000|Overall Study|Withdrawal by Subject|0|||
126325808|NCT01148459|454488284|FG001|Overall Study|Migrated/moved from study area|6|||
126325809|NCT01148459|454488283|FG000|Overall Study|Lost to Follow-up|2|||
126325810|NCT01148459|454488284|FG001|Overall Study|Lost to Follow-up|0|||
125985935|NCT01782872|453240453|FG001|Overall Study|Withdrawal by Subject|1|||
125985936|NCT01782872|453240454|FG002|Overall Study|Withdrawal by Subject|0|||
125985937|NCT01782872|453240455|FG003|Overall Study|Withdrawal by Subject|0|||
125985938|NCT01892345|453240456|FG000|Overall Study|Adverse Event|0|||
125985939|NCT01892345|453240457|FG001|Overall Study|Adverse Event|2|||
125985940|NCT01892345|453240456|FG000|Overall Study|Death|1|||
125985941|NCT01892345|453240457|FG001|Overall Study|Death|0|||
125985942|NCT01892345|453240456|FG000|Overall Study|Lost to Follow-up|3|||
125985943|NCT01892345|453240457|FG001|Overall Study|Lost to Follow-up|0|||
125985944|NCT01892345|453240456|FG000|Overall Study|Withdrawal by Subject|12|||
125985945|NCT01892345|453240457|FG001|Overall Study|Withdrawal by Subject|1|||
125985946|NCT00638235|453240458|FG000|Overall Study|Lost to Follow-up|31|||
125985947|NCT00638235|453240459|FG001|Overall Study|Lost to Follow-up|3|||
126325811|NCT01148459|454488283|FG000|Overall Study|Refusal|1|||
125985948|NCT00638235|453240460|FG002|Overall Study|Lost to Follow-up|18|||
125985949|NCT00638235|453240461|FG003|Overall Study|Lost to Follow-up|10|||
125985950|NCT00638235|453240462|FG004|Overall Study|Lost to Follow-up|13|||
125985951|NCT00638235|453240463|FG005|Overall Study|Lost to Follow-up|26|||
125985952|NCT00638235|453240464|FG006|Overall Study|Lost to Follow-up|0|||
125985953|NCT00638235|453240465|FG007|Overall Study|Lost to Follow-up|1|||
125985954|NCT00638235|453240466|FG008|Overall Study|Lost to Follow-up|18|||
125985955|NCT01473381|453240467|FG000|Overall Study|Adverse Event|8|||
125985956|NCT01473381|453240468|FG001|Overall Study|Adverse Event|20|||
125985957|NCT01473381|453240469|FG002|Overall Study|Adverse Event|25|||
125985958|NCT01473381|453240470|FG003|Overall Study|Adverse Event|17|||
125985959|NCT01473381|453240467|FG000|Overall Study|Insufficient Therapeutic Response|10|||
125985960|NCT01473381|453240468|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125985961|NCT01473381|453240469|FG002|Overall Study|Insufficient Therapeutic Response|2|||
125985962|NCT01473381|453240470|FG003|Overall Study|Insufficient Therapeutic Response|3|||
125985963|NCT01473381|453240467|FG000|Overall Study|Protocol Violation|17|||
125985964|NCT01473381|453240468|FG001|Overall Study|Protocol Violation|23|||
125985965|NCT01473381|453240469|FG002|Overall Study|Protocol Violation|19|||
125985966|NCT01473381|453240470|FG003|Overall Study|Protocol Violation|17|||
125985967|NCT01473381|453240467|FG000|Overall Study|Withdrawal of Consent|20|||
125985968|NCT01473381|453240468|FG001|Overall Study|Withdrawal of Consent|21|||
125985969|NCT01473381|453240469|FG002|Overall Study|Withdrawal of Consent|20|||
125985970|NCT01473381|453240470|FG003|Overall Study|Withdrawal of Consent|26|||
125985971|NCT01473381|453240467|FG000|Overall Study|Lost to Follow-up|25|||
125985972|NCT01473381|453240468|FG001|Overall Study|Lost to Follow-up|28|||
126325812|NCT01148459|454488284|FG001|Overall Study|Refusal|0|||
126325813|NCT01148459|454488283|FG000|Overall Study|Failure to comply with study procedures|0|||
126325814|NCT01148459|454488284|FG001|Overall Study|Failure to comply with study procedures|1|||
126325815|NCT00694356|454488285|FG000|Overall Study|Adverse Event|1|||
126325816|NCT00694356|454488286|FG001|Overall Study|Adverse Event|0|||
126325817|NCT00694356|454488287|FG002|Overall Study|Adverse Event|0|||
126325818|NCT00694356|454488285|FG000|Overall Study|Progressive Disease|2|||
126325819|NCT00694356|454488286|FG001|Overall Study|Progressive Disease|6|||
126325820|NCT00694356|454488287|FG002|Overall Study|Progressive Disease|6|||
126325821|NCT01763203|454488288|FG000|Overall Study|Death|4|||
126325822|NCT01763203|454488289|FG001|Overall Study|Death|7|||
126325823|NCT01763203|454488288|FG000|Overall Study|Lost to Follow-up|12|||
126325824|NCT01763203|454488289|FG001|Overall Study|Lost to Follow-up|12|||
126325825|NCT01763203|454488288|FG000|Overall Study|Withdrawal by Subject|8|||
126325826|NCT01763203|454488289|FG001|Overall Study|Withdrawal by Subject|12|||
126325827|NCT01763203|454488288|FG000|Overall Study|Moved out of study region|7|||
126325828|NCT01763203|454488289|FG001|Overall Study|Moved out of study region|10|||
126325829|NCT01763203|454488288|FG000|Overall Study|Physician Decision|2|||
126325830|NCT01763203|454488289|FG001|Overall Study|Physician Decision|1|||
126325831|NCT02187861|454488290|FG000|Overall Study|Adverse Event|2|||
126325832|NCT02187861|454488291|FG001|Overall Study|Adverse Event|1|||
126325833|NCT02187861|454488292|FG002|Overall Study|Adverse Event|2|||
126325834|NCT02187861|454488293|FG003|Overall Study|Adverse Event|1|||
126325835|NCT02187861|454488290|FG000|Overall Study|Death|0|||
126325836|NCT02187861|454488291|FG001|Overall Study|Death|3|||
126325837|NCT02187861|454488292|FG002|Overall Study|Death|1|||
126325838|NCT02187861|454488293|FG003|Overall Study|Death|2|||
126325839|NCT02187861|454488290|FG000|Overall Study|Physician Decision|0|||
126325840|NCT02187861|454488291|FG001|Overall Study|Physician Decision|1|||
126325841|NCT02187861|454488292|FG002|Overall Study|Physician Decision|0|||
126325842|NCT02187861|454488293|FG003|Overall Study|Physician Decision|3|||
126325843|NCT02187861|454488290|FG000|Overall Study|Progressive Disease|4|||
126325844|NCT02187861|454488291|FG001|Overall Study|Progressive Disease|42|||
126325845|NCT02187861|454488292|FG002|Overall Study|Progressive Disease|19|||
126325846|NCT02187861|454488293|FG003|Overall Study|Progressive Disease|22|||
126325847|NCT02187861|454488290|FG000|Overall Study|Withdrawal by Subject|0|||
126325848|NCT02187861|454488291|FG001|Overall Study|Withdrawal by Subject|0|||
126325849|NCT02187861|454488292|FG002|Overall Study|Withdrawal by Subject|3|||
126325850|NCT02187861|454488293|FG003|Overall Study|Withdrawal by Subject|3|||
126325851|NCT02187861|454488290|FG000|Overall Study|Other|0|||
126325852|NCT02187861|454488291|FG001|Overall Study|Other|1|||
126325853|NCT02187861|454488292|FG002|Overall Study|Other|7|||
126325854|NCT02187861|454488293|FG003|Overall Study|Other|1|||
126325855|NCT02768792|454488297|FG000|Overall Study|Adverse Event|1|||
126325856|NCT05980013|454488298|FG000|Overall Study|Withdrawal by Subject|0|||
125985973|NCT01473381|453240469|FG002|Overall Study|Lost to Follow-up|35|||
125985974|NCT01473381|453240470|FG003|Overall Study|Lost to Follow-up|23|||
125985975|NCT01473381|453240467|FG000|Overall Study|Other Reasons|0|||
125985976|NCT01473381|453240468|FG001|Overall Study|Other Reasons|0|||
125985977|NCT01473381|453240469|FG002|Overall Study|Other Reasons|1|||
125985978|NCT01473381|453240470|FG003|Overall Study|Other Reasons|3|||
125985979|NCT04026165|453240473|FG000|Run-in Placebo Period|Enrollment Error|13|||
125985980|NCT04026165|453240474|FG001|Run-in Placebo Period|Enrollment Error|0|||
126325857|NCT05980013|454488299|FG001|Overall Study|Withdrawal by Subject|1|||
126325858|NCT05980013|454488298|FG000|Overall Study|Device Error|0|||
126325859|NCT05980013|454488299|FG001|Overall Study|Device Error|1|||
126325860|NCT01768559|454488302|FG000|Overall Study|Randomized but not treated|0|||
126325861|NCT01768559|454488303|FG001|Overall Study|Randomized but not treated|0|||
126325862|NCT01768559|454488304|FG002|Overall Study|Randomized but not treated|1|||
126325863|NCT01768559|454488302|FG000|Overall Study|Adverse Event|15|||
126325864|NCT01768559|454488303|FG001|Overall Study|Adverse Event|2|||
126325865|NCT01768559|454488304|FG002|Overall Study|Adverse Event|5|||
126325866|NCT01768559|454488302|FG000|Overall Study|Lack of Efficacy|6|||
126325867|NCT01768559|454488303|FG001|Overall Study|Lack of Efficacy|4|||
126325868|NCT01768559|454488304|FG002|Overall Study|Lack of Efficacy|0|||
126325869|NCT01768559|454488302|FG000|Overall Study|Poor compliance to protocol|0|||
126325870|NCT01768559|454488303|FG001|Overall Study|Poor compliance to protocol|3|||
126325871|NCT01768559|454488304|FG002|Overall Study|Poor compliance to protocol|2|||
126325872|NCT01768559|454488302|FG000|Overall Study|Other than specified|9|||
126325873|NCT01768559|454488303|FG001|Overall Study|Other than specified|8|||
126325874|NCT01768559|454488304|FG002|Overall Study|Other than specified|5|||
126325875|NCT02782377|454488305|FG000|Overall Study|Physician Decision|5|||
126325876|NCT02521792|454488306|FG000|Overall Study|Study Terminated|6|||
126325877|NCT00303472|454488307|FG000|Treatment Period|Adverse Event|0|||
126325878|NCT00303472|454488308|FG001|Treatment Period|Adverse Event|0|||
126325879|NCT00303472|454488309|FG002|Treatment Period|Adverse Event|0|||
126325880|NCT00303472|454488310|FG003|Treatment Period|Adverse Event|0|||
126325881|NCT00303472|454488311|FG004|Treatment Period|Adverse Event|1|||
126325882|NCT00303472|454488312|FG005|Treatment Period|Adverse Event|0|||
126325883|NCT00303472|454488313|FG006|Treatment Period|Adverse Event|0|||
126325884|NCT00303472|454488307|FG000|Treatment Period|Death|0|||
126325885|NCT00303472|454488308|FG001|Treatment Period|Death|0|||
126325886|NCT00303472|454488309|FG002|Treatment Period|Death|0|||
126325887|NCT00303472|454488310|FG003|Treatment Period|Death|1|||
126325888|NCT00303472|454488311|FG004|Treatment Period|Death|0|||
126325889|NCT00303472|454488312|FG005|Treatment Period|Death|0|||
126325890|NCT00303472|454488313|FG006|Treatment Period|Death|1|||
126325891|NCT00303472|454488307|FG000|Treatment Period|Withdrawal by Subject|0|||
126325892|NCT00303472|454488308|FG001|Treatment Period|Withdrawal by Subject|0|||
126325893|NCT00303472|454488309|FG002|Treatment Period|Withdrawal by Subject|0|||
126325894|NCT00303472|454488310|FG003|Treatment Period|Withdrawal by Subject|1|||
126325895|NCT00303472|454488311|FG004|Treatment Period|Withdrawal by Subject|0|||
126325896|NCT00303472|454488312|FG005|Treatment Period|Withdrawal by Subject|1|||
126325897|NCT00303472|454488313|FG006|Treatment Period|Withdrawal by Subject|0|||
126325898|NCT00303472|454488307|FG000|Treatment Period|Other|0|||
126325899|NCT00303472|454488308|FG001|Treatment Period|Other|0|||
126325900|NCT00303472|454488309|FG002|Treatment Period|Other|0|||
126325901|NCT00303472|454488310|FG003|Treatment Period|Other|0|||
126325902|NCT00303472|454488311|FG004|Treatment Period|Other|1|||
126325903|NCT00303472|454488312|FG005|Treatment Period|Other|0|||
126325904|NCT00303472|454488313|FG006|Treatment Period|Other|1|||
126325905|NCT00303472|454488307|FG000|Treatment Period|Disease Progression (to AML)|0|||
126325906|NCT00303472|454488308|FG001|Treatment Period|Disease Progression (to AML)|0|||
125985981|NCT04026165|453240475|FG002|Run-in Placebo Period|Enrollment Error|0|||
125985982|NCT04026165|453240476|FG003|Run-in Placebo Period|Enrollment Error|0|||
125985983|NCT04026165|453240473|FG000|Run-in Placebo Period|Run-in Failure|4|||
125985984|NCT04026165|453240474|FG001|Run-in Placebo Period|Run-in Failure|0|||
125985985|NCT04026165|453240475|FG002|Run-in Placebo Period|Run-in Failure|0|||
125985986|NCT04026165|453240476|FG003|Run-in Placebo Period|Run-in Failure|0|||
125985987|NCT04026165|453240473|FG000|Run-in Placebo Period|Protocol Violation|2|||
125985988|NCT04026165|453240474|FG001|Run-in Placebo Period|Protocol Violation|0|||
125985989|NCT04026165|453240475|FG002|Run-in Placebo Period|Protocol Violation|0|||
125985990|NCT04026165|453240476|FG003|Run-in Placebo Period|Protocol Violation|0|||
125985991|NCT04026165|453240473|FG000|Run-in Placebo Period|Withdrew Consent|2|||
125985992|NCT04026165|453240474|FG001|Run-in Placebo Period|Withdrew Consent|0|||
125985993|NCT04026165|453240475|FG002|Run-in Placebo Period|Withdrew Consent|0|||
126325907|NCT00303472|454488309|FG002|Treatment Period|Disease Progression (to AML)|0|||
126325908|NCT00303472|454488310|FG003|Treatment Period|Disease Progression (to AML)|0|||
126325909|NCT00303472|454488311|FG004|Treatment Period|Disease Progression (to AML)|1|||
126325910|NCT00303472|454488312|FG005|Treatment Period|Disease Progression (to AML)|0|||
126325911|NCT00303472|454488313|FG006|Treatment Period|Disease Progression (to AML)|0|||
126325912|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Adverse Event|1|||
126325913|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Adverse Event|0|||
125985994|NCT04026165|453240476|FG003|Run-in Placebo Period|Withdrew Consent|0|||
125985995|NCT04026165|453240473|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
125985996|NCT04026165|453240474|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
125985997|NCT04026165|453240475|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
126325914|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Adverse Event|1|||
126325915|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Adverse Event|0|||
126325916|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Adverse Event|0|||
126325917|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Adverse Event|0|||
126325918|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Adverse Event|0|||
126325919|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Death|2|||
126325920|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Death|0|||
126325921|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Death|1|||
126325922|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Death|0|||
126325923|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Death|0|||
126325924|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Death|0|||
126325925|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Death|0|||
126325926|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325927|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325928|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325929|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
126325930|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325931|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325932|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325933|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Physician Decision|0|||
126325934|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Physician Decision|4|||
126325935|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Physician Decision|2|||
126325936|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Physician Decision|3|||
126325937|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Physician Decision|2|||
126325938|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Physician Decision|0|||
126325939|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Physician Decision|0|||
126325940|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
126325941|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
126325942|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
126325943|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
126325944|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
126325945|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
126325946|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
126325947|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Other|0|||
126325948|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Other|2|||
126325949|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Other|4|||
126325950|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Other|2|||
126325951|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Other|1|||
126325952|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Other|0|||
126325953|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Other|0|||
126325954|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
126325955|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126325956|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126325957|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125985998|NCT04026165|453240476|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
125985999|NCT04026165|453240473|FG000|Run-in SEL Period|Run-in Failure|0|||
125986000|NCT04026165|453240474|FG001|Run-in SEL Period|Run-in Failure|26|||
125986001|NCT04026165|453240475|FG002|Run-in SEL Period|Run-in Failure|0|||
125986002|NCT04026165|453240476|FG003|Run-in SEL Period|Run-in Failure|0|||
125986003|NCT04026165|453240473|FG000|Run-in SEL Period|Withdrew Consent|0|||
126325958|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126325959|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
126325960|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126325961|NCT02937636|454488315|FG000|Overall Study|Other (Not specified)|3|||
126325962|NCT02937636|454488316|FG001|Overall Study|Other (Not specified)|2|||
126325963|NCT00770913|454488321|FG000|Overall Study|Adverse Event|1|||
126325964|NCT00770913|454488322|FG001|Overall Study|Adverse Event|3|||
126325965|NCT00770913|454488323|FG002|Overall Study|Adverse Event|6|||
126325966|NCT00770913|454488321|FG000|Overall Study|Refusal to continue participation|6|||
126325967|NCT00770913|454488322|FG001|Overall Study|Refusal to continue participation|4|||
126325968|NCT00770913|454488323|FG002|Overall Study|Refusal to continue participation|5|||
126325969|NCT00770913|454488321|FG000|Overall Study|Physician Decision|0|||
126325970|NCT00770913|454488322|FG001|Overall Study|Physician Decision|1|||
126325971|NCT00770913|454488323|FG002|Overall Study|Physician Decision|1|||
126325972|NCT00770913|454488321|FG000|Overall Study|Protocol Violation|3|||
126325973|NCT00770913|454488322|FG001|Overall Study|Protocol Violation|0|||
126325974|NCT00770913|454488323|FG002|Overall Study|Protocol Violation|1|||
126325975|NCT00770913|454488321|FG000|Overall Study|Incorrect drug was allocated|1|||
126325976|NCT00770913|454488322|FG001|Overall Study|Incorrect drug was allocated|0|||
126325977|NCT00770913|454488323|FG002|Overall Study|Incorrect drug was allocated|0|||
126325978|NCT00359294|454488327|FG000|Overall Study|Progressive disease|1|||
126325979|NCT00359294|454488328|FG001|Overall Study|Progressive disease|1|||
126325980|NCT00359294|454488329|FG002|Overall Study|Progressive disease|2|||
126325981|NCT00359294|454488330|FG003|Overall Study|Progressive disease|3|||
126325982|NCT00359294|454488331|FG004|Overall Study|Progressive disease|2|||
125986004|NCT04026165|453240474|FG001|Run-in SEL Period|Withdrew Consent|10|||
125986005|NCT04026165|453240475|FG002|Run-in SEL Period|Withdrew Consent|0|||
126325983|NCT00359294|454488327|FG000|Overall Study|Withdrawal by Subject|0|||
126325984|NCT00359294|454488328|FG001|Overall Study|Withdrawal by Subject|0|||
126325985|NCT00359294|454488329|FG002|Overall Study|Withdrawal by Subject|0|||
125986006|NCT04026165|453240476|FG003|Run-in SEL Period|Withdrew Consent|0|||
125986007|NCT04026165|453240473|FG000|Run-in SEL Period|Enrollment Error|0|||
125986008|NCT04026165|453240474|FG001|Run-in SEL Period|Enrollment Error|4|||
125986009|NCT04026165|453240475|FG002|Run-in SEL Period|Enrollment Error|0|||
125986010|NCT04026165|453240476|FG003|Run-in SEL Period|Enrollment Error|0|||
125986011|NCT04026165|453240473|FG000|Run-in SEL Period|Protocol Violation|0|||
125986012|NCT04026165|453240474|FG001|Run-in SEL Period|Protocol Violation|3|||
125986013|NCT04026165|453240475|FG002|Run-in SEL Period|Protocol Violation|0|||
125986014|NCT04026165|453240476|FG003|Run-in SEL Period|Protocol Violation|0|||
125986015|NCT04026165|453240473|FG000|Run-in SEL Period|Investigator's Discretion|0|||
125986016|NCT04026165|453240474|FG001|Run-in SEL Period|Investigator's Discretion|2|||
125986017|NCT04026165|453240475|FG002|Run-in SEL Period|Investigator's Discretion|0|||
125986018|NCT04026165|453240476|FG003|Run-in SEL Period|Investigator's Discretion|0|||
125986019|NCT04026165|453240473|FG000|Run-in SEL Period|Death|0|||
125986020|NCT04026165|453240474|FG001|Run-in SEL Period|Death|1|||
125986021|NCT04026165|453240475|FG002|Run-in SEL Period|Death|0|||
125986022|NCT04026165|453240476|FG003|Run-in SEL Period|Death|0|||
125986023|NCT04026165|453240473|FG000|Randomized Period|Withdrew Consent|0|||
125986024|NCT04026165|453240474|FG001|Randomized Period|Withdrew Consent|0|||
125986025|NCT04026165|453240475|FG002|Randomized Period|Withdrew Consent|5|||
125986026|NCT04026165|453240476|FG003|Randomized Period|Withdrew Consent|8|||
125986027|NCT04026165|453240473|FG000|Randomized Period|Death|0|||
125986028|NCT04026165|453240474|FG001|Randomized Period|Death|0|||
125986029|NCT04026165|453240475|FG002|Randomized Period|Death|5|||
125986030|NCT04026165|453240476|FG003|Randomized Period|Death|7|||
125986031|NCT04026165|453240473|FG000|Randomized Period|Investigator's Discretion|0|||
125986032|NCT04026165|453240474|FG001|Randomized Period|Investigator's Discretion|0|||
125986033|NCT04026165|453240475|FG002|Randomized Period|Investigator's Discretion|2|||
125986034|NCT04026165|453240476|FG003|Randomized Period|Investigator's Discretion|2|||
125986035|NCT04026165|453240473|FG000|Randomized Period|Lost to Follow-up|0|||
125986036|NCT04026165|453240474|FG001|Randomized Period|Lost to Follow-up|0|||
125986037|NCT04026165|453240475|FG002|Randomized Period|Lost to Follow-up|2|||
125986038|NCT04026165|453240476|FG003|Randomized Period|Lost to Follow-up|2|||
125986039|NCT00985985|453240477|FG000|Overall Study|Adverse Event|4|||
125986040|NCT00985985|453240478|FG001|Overall Study|Adverse Event|2|||
125986041|NCT00985985|453240479|FG002|Overall Study|Adverse Event|2|||
125986042|NCT00985985|453240480|FG003|Overall Study|Adverse Event|2|||
125986043|NCT00985985|453240477|FG000|Overall Study|Lost to Follow-up|4|||
125986044|NCT00985985|453240478|FG001|Overall Study|Lost to Follow-up|11|||
125986045|NCT00985985|453240479|FG002|Overall Study|Lost to Follow-up|2|||
125986046|NCT00985985|453240480|FG003|Overall Study|Lost to Follow-up|3|||
125986047|NCT00985985|453240477|FG000|Overall Study|Protocol Violation|1|||
125986048|NCT00985985|453240478|FG001|Overall Study|Protocol Violation|2|||
125986049|NCT00985985|453240479|FG002|Overall Study|Protocol Violation|0|||
125986050|NCT00985985|453240480|FG003|Overall Study|Protocol Violation|1|||
125986051|NCT00985985|453240477|FG000|Overall Study|Lack of Efficacy|5|||
125986052|NCT00985985|453240478|FG001|Overall Study|Lack of Efficacy|6|||
125986053|NCT00985985|453240479|FG002|Overall Study|Lack of Efficacy|1|||
125986054|NCT00985985|453240480|FG003|Overall Study|Lack of Efficacy|3|||
125986055|NCT00985985|453240477|FG000|Overall Study|Withdrawal by Subject|4|||
125986056|NCT00985985|453240478|FG001|Overall Study|Withdrawal by Subject|2|||
125986057|NCT00985985|453240479|FG002|Overall Study|Withdrawal by Subject|2|||
125986058|NCT00985985|453240480|FG003|Overall Study|Withdrawal by Subject|2|||
126325986|NCT00359294|454488330|FG003|Overall Study|Withdrawal by Subject|0|||
126325987|NCT00359294|454488331|FG004|Overall Study|Withdrawal by Subject|1|||
126325988|NCT00359294|454488327|FG000|Overall Study|Not treated|0|||
126325989|NCT00359294|454488328|FG001|Overall Study|Not treated|0|||
126325990|NCT00359294|454488329|FG002|Overall Study|Not treated|0|||
126325991|NCT00359294|454488330|FG003|Overall Study|Not treated|1|||
126325992|NCT00359294|454488331|FG004|Overall Study|Not treated|0|||
126325993|NCT00359294|454488327|FG000|Overall Study|Physician Decision|0|||
125986059|NCT00985985|453240477|FG000|Overall Study|Other Reason|6|||
125986060|NCT00985985|453240478|FG001|Overall Study|Other Reason|1|||
125986061|NCT00985985|453240479|FG002|Overall Study|Other Reason|4|||
125986062|NCT00985985|453240480|FG003|Overall Study|Other Reason|2|||
125986063|NCT02255357|453240481|FG000|Overall Study|Physician Decision|10|||
125986064|NCT02255357|453240482|FG001|Overall Study|Physician Decision|24|||
125986065|NCT05061537|453240483|FG000|Treatment Phase|Progressive disease|0|||
125986066|NCT05061537|453240484|FG001|Treatment Phase|Progressive disease|1|||
125986067|NCT05061537|453240485|FG002|Treatment Phase|Progressive disease|2|||
125986068|NCT05061537|453240486|FG003|Treatment Phase|Progressive disease|0|||
125986069|NCT05061537|453240487|FG004|Treatment Phase|Progressive disease|0|||
125986070|NCT05061537|453240483|FG000|Treatment Phase|Adverse Event|0|||
126325994|NCT00359294|454488328|FG001|Overall Study|Physician Decision|0|||
126325995|NCT00359294|454488329|FG002|Overall Study|Physician Decision|1|||
126325996|NCT00359294|454488330|FG003|Overall Study|Physician Decision|0|||
126325997|NCT00359294|454488331|FG004|Overall Study|Physician Decision|0|||
126325998|NCT02347072|454488332|FG000|Overall Study|Adverse Event|2|||
126325999|NCT02347072|454488332|FG000|Overall Study|Withdrawal by Subject|6|||
126326000|NCT02347072|454488332|FG000|Overall Study|Physician Decision|1|||
126326001|NCT02347072|454488332|FG000|Overall Study|Lost to Follow-up|2|||
126326002|NCT02347072|454488332|FG000|Overall Study|Protocol Violation|1|||
126326003|NCT02347072|454488332|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
126326004|NCT03148067|454488335|FG000|Overall Study|Lost to Follow-up|3|||
126326005|NCT03148067|454488335|FG000|Overall Study|Death|1|||
126326006|NCT03124537|454488337|FG000|Overall Study|Lost to Follow-up|3|||
126326007|NCT03124537|454488338|FG001|Overall Study|Lost to Follow-up|5|||
126326008|NCT03124537|454488337|FG000|Overall Study|App Crash, Incomplete Data|7|||
126326009|NCT03124537|454488338|FG001|Overall Study|App Crash, Incomplete Data|8|||
126326010|NCT03681184|454488341|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
126326011|NCT03681184|454488342|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
126326012|NCT04318132|454488345|FG000|Overall Study|Protocol Violation|0|||
126326013|NCT04318132|454488346|FG001|Overall Study|Protocol Violation|0|||
126326014|NCT04318132|454488347|FG002|Overall Study|Protocol Violation|3|||
126326015|NCT04318132|454488348|FG003|Overall Study|Protocol Violation|0|||
126326016|NCT04424914|454488349|FG000|Overall Study|Other|0|||
126326017|NCT04424914|454488350|FG001|Overall Study|Other|0|||
126326018|NCT04424914|454488351|FG002|Overall Study|Other|28|||
126326019|NCT04424914|454488349|FG000|Overall Study|Withdrawal by Subject|3|||
126326020|NCT04424914|454488350|FG001|Overall Study|Withdrawal by Subject|0|||
126326021|NCT04424914|454488351|FG002|Overall Study|Withdrawal by Subject|0|||
126326022|NCT04424914|454488349|FG000|Overall Study|Study terminated by sponsor|23|||
126326023|NCT04424914|454488350|FG001|Overall Study|Study terminated by sponsor|7|||
126326024|NCT04424914|454488351|FG002|Overall Study|Study terminated by sponsor|0|||
126326025|NCT04424914|454488349|FG000|Overall Study|Lost to Follow-up|0|||
126326026|NCT04424914|454488350|FG001|Overall Study|Lost to Follow-up|0|||
126326027|NCT04424914|454488351|FG002|Overall Study|Lost to Follow-up|1|||
126326028|NCT04424914|454488349|FG000|Overall Study|Death|3|||
126326029|NCT04424914|454488350|FG001|Overall Study|Death|1|||
125986071|NCT05061537|453240484|FG001|Treatment Phase|Adverse Event|0|||
125986072|NCT05061537|453240485|FG002|Treatment Phase|Adverse Event|2|||
126326030|NCT04424914|454488351|FG002|Overall Study|Death|0|||
126326031|NCT03383692|454488360|FG000|Overall Study|Progressive disease as per RECIST|3|||
126326032|NCT03383692|454488361|FG001|Overall Study|Progressive disease as per RECIST|3|||
126326033|NCT03383692|454488360|FG000|Overall Study|Clinical progression|0|||
126326034|NCT03383692|454488361|FG001|Overall Study|Clinical progression|1|||
126326035|NCT03383692|454488360|FG000|Overall Study|Adverse Event|3|||
126326036|NCT03383692|454488361|FG001|Overall Study|Adverse Event|0|||
126326037|NCT00893971|454488362|FG000|Overall Study|Physician Decision|3|||
126326038|NCT00492232|454488363|FG000|Placebo Run-in|Adverse Event|0|||
126326039|NCT00492232|454488364|FG001|Placebo Run-in|Adverse Event|2|||
126326040|NCT00492232|454488363|FG000|Placebo Run-in|Protocol Violation|0|||
126326041|NCT00492232|454488364|FG001|Placebo Run-in|Protocol Violation|3|||
126326042|NCT00492232|454488363|FG000|Placebo Run-in|Lost to Follow-up|0|||
126326043|NCT00492232|454488364|FG001|Placebo Run-in|Lost to Follow-up|3|||
126326044|NCT00492232|454488363|FG000|Placebo Run-in|Withdrawal by Subject|0|||
126326045|NCT00492232|454488364|FG001|Placebo Run-in|Withdrawal by Subject|8|||
126326046|NCT00492232|454488363|FG000|Placebo Run-in|Pregnancy|0|||
126326047|NCT00492232|454488364|FG001|Placebo Run-in|Pregnancy|1|||
126326048|NCT00492232|454488363|FG000|Placebo Run-in|Entrance criteria not met|0|||
126326049|NCT00492232|454488364|FG001|Placebo Run-in|Entrance criteria not met|45|||
126326050|NCT00492232|454488363|FG000|Placebo Run-in|Other|0|||
126326051|NCT00492232|454488364|FG001|Placebo Run-in|Other|6|||
126326052|NCT00492232|454488363|FG000|Placebo Run-in|Missing|0|||
126326053|NCT00492232|454488364|FG001|Placebo Run-in|Missing|2|||
126326054|NCT00492232|454488363|FG000|Double-Blind Treatment|Adverse Event|1|||
126326055|NCT00492232|454488364|FG001|Double-Blind Treatment|Adverse Event|2|||
126326056|NCT00492232|454488363|FG000|Double-Blind Treatment|Protocol Violation|3|||
126326057|NCT00492232|454488364|FG001|Double-Blind Treatment|Protocol Violation|7|||
126326058|NCT00492232|454488363|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
126326059|NCT00492232|454488364|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
126326060|NCT00492232|454488363|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
126326061|NCT00492232|454488364|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
126326062|NCT00492232|454488363|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
126326063|NCT00492232|454488364|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
126326064|NCT00492232|454488363|FG000|Double-Blind Treatment|Other|6|||
126326065|NCT00492232|454488364|FG001|Double-Blind Treatment|Other|5|||
125986073|NCT05061537|453240486|FG003|Treatment Phase|Adverse Event|0|||
126326066|NCT00492232|454488363|FG000|Double-Blind Treatment|Randomized not treated|1|||
126326067|NCT00492232|454488364|FG001|Double-Blind Treatment|Randomized not treated|0|||
125986074|NCT05061537|453240487|FG004|Treatment Phase|Adverse Event|0|||
125986075|NCT05061537|453240483|FG000|Treatment Phase|Global deterioration of health status|0|||
126326068|NCT00492232|454488363|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
126326069|NCT00492232|454488364|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
126326070|NCT02453256|454488365|FG000|Double Blind Period|Death|1|||
126326071|NCT02453256|454488366|FG001|Double Blind Period|Death|1|||
126326072|NCT02453256|454488365|FG000|Double Blind Period|Adverse Event|3|||
126326073|NCT02453256|454488366|FG001|Double Blind Period|Adverse Event|2|||
126326074|NCT02453256|454488365|FG000|Double Blind Period|Withdrawal by Subject|9|||
126326075|NCT02453256|454488366|FG001|Double Blind Period|Withdrawal by Subject|5|||
126326076|NCT02453256|454488365|FG000|Double Blind Period|Other|0|||
126326077|NCT02453256|454488366|FG001|Double Blind Period|Other|1|||
126326078|NCT02453256|454488365|FG000|Open Label Period|Adverse Event|1|||
126326079|NCT02453256|454488366|FG001|Open Label Period|Adverse Event|3|||
126326080|NCT02453256|454488365|FG000|Open Label Period|Death|0|||
126326081|NCT02453256|454488366|FG001|Open Label Period|Death|1|||
126326082|NCT02453256|454488365|FG000|Open Label Period|Lost to Follow-up|1|||
126326083|NCT02453256|454488366|FG001|Open Label Period|Lost to Follow-up|0|||
126326084|NCT02453256|454488365|FG000|Open Label Period|Other|0|||
126326085|NCT02453256|454488366|FG001|Open Label Period|Other|2|||
126326086|NCT02453256|454488365|FG000|Open Label Period|Withdrawal by Subject|5|||
126326087|NCT02453256|454488366|FG001|Open Label Period|Withdrawal by Subject|1|||
126326088|NCT01216332|454488367|FG000|Overall Study|Withdrawal by Subject|4|||
126326089|NCT01216332|454488368|FG001|Overall Study|Withdrawal by Subject|0|||
126326090|NCT00636636|454488369|FG000|Overall Study|Other reason|4|||
126326091|NCT00636636|454488370|FG001|Overall Study|Other reason|6|||
126326092|NCT00636636|454488369|FG000|Overall Study|Adverse Event|19|||
126326093|NCT00636636|454488370|FG001|Overall Study|Adverse Event|8|||
126326094|NCT00636636|454488369|FG000|Overall Study|Lack of Efficacy|7|||
126326095|NCT00636636|454488370|FG001|Overall Study|Lack of Efficacy|12|||
126326096|NCT00636636|454488369|FG000|Overall Study|Protocol Violation|2|||
126326097|NCT00636636|454488370|FG001|Overall Study|Protocol Violation|2|||
126326098|NCT00636636|454488369|FG000|Overall Study|Lost to Follow-up|0|||
126326099|NCT00636636|454488370|FG001|Overall Study|Lost to Follow-up|1|||
126326100|NCT00636636|454488369|FG000|Overall Study|Death|0|||
126326101|NCT00636636|454488370|FG001|Overall Study|Death|1|||
126326102|NCT00636636|454488369|FG000|Overall Study|Withdrawal by Subject|4|||
126326103|NCT00636636|454488370|FG001|Overall Study|Withdrawal by Subject|9|||
126326104|NCT01237327|454488371|FG000|Overall Study|Protocol Violation: Core Study|1|||
126326105|NCT01237327|454488372|FG001|Overall Study|Protocol Violation: Core Study|0|||
126326106|NCT01237327|454488371|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
126326107|NCT01237327|454488372|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
125986076|NCT05061537|453240484|FG001|Treatment Phase|Global deterioration of health status|1|||
125986077|NCT05061537|453240485|FG002|Treatment Phase|Global deterioration of health status|0|||
125986078|NCT05061537|453240486|FG003|Treatment Phase|Global deterioration of health status|0|||
125986079|NCT05061537|453240487|FG004|Treatment Phase|Global deterioration of health status|0|||
125986080|NCT05061537|453240483|FG000|Follow up|Other|2|||
125986081|NCT05061537|453240484|FG001|Follow up|Other|0|||
125986082|NCT05061537|453240485|FG002|Follow up|Other|2|||
125986083|NCT05061537|453240486|FG003|Follow up|Other|0|||
125986084|NCT05061537|453240487|FG004|Follow up|Other|0|||
125986085|NCT05061537|453240483|FG000|Follow up|Study terminated by sponsor|0|||
125986086|NCT05061537|453240484|FG001|Follow up|Study terminated by sponsor|0|||
126326108|NCT01237327|454488371|FG000|Overall Study|Progression of Disease: Core Study|18|||
126326109|NCT01237327|454488372|FG001|Overall Study|Progression of Disease: Core Study|22|||
126326110|NCT01237327|454488371|FG000|Overall Study|Progression of Disease: Extension Study|15|||
126326111|NCT01237327|454488372|FG001|Overall Study|Progression of Disease: Extension Study|13|||
126326112|NCT01237327|454488371|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
126326113|NCT01237327|454488372|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
126326114|NCT01237327|454488371|FG000|Overall Study|Withdrawal by Subject|1|||
126326115|NCT01237327|454488372|FG001|Overall Study|Withdrawal by Subject|3|||
126326116|NCT01237327|454488371|FG000|Overall Study|Lost to Follow-up|3|||
126326117|NCT01237327|454488372|FG001|Overall Study|Lost to Follow-up|0|||
126326118|NCT00524173|454488373|FG000|Overall Study|Lost to Follow-up|0|||
126326119|NCT00524173|454488374|FG001|Overall Study|Lost to Follow-up|1|||
126326120|NCT00524173|454488373|FG000|Overall Study|Death|1|||
125986087|NCT05061537|453240485|FG002|Follow up|Study terminated by sponsor|2|||
126326121|NCT00524173|454488374|FG001|Overall Study|Death|0|||
126326122|NCT00524173|454488373|FG000|Overall Study|Had not reached endpoint at study close|4|||
126326123|NCT00524173|454488374|FG001|Overall Study|Had not reached endpoint at study close|1|||
126326124|NCT02483572|454488377|FG000|Overall Study|Withdrawal by Subject|1|||
125986088|NCT05061537|453240486|FG003|Follow up|Study terminated by sponsor|0|||
125986089|NCT05061537|453240487|FG004|Follow up|Study terminated by sponsor|0|||
125986090|NCT05061537|453240483|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
125986091|NCT05061537|453240484|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
126326125|NCT02483572|454488378|FG001|Overall Study|Withdrawal by Subject|0|||
126326126|NCT02483572|454488377|FG000|Overall Study|Lost to Follow-up|1|||
126326127|NCT02483572|454488378|FG001|Overall Study|Lost to Follow-up|0|||
126326128|NCT02483572|454488377|FG000|Overall Study|Physician Decision|0|||
126326129|NCT02483572|454488378|FG001|Overall Study|Physician Decision|1|||
126326130|NCT04811664|454488379|FG000|Overall Study|Lost to Follow-up|78|||
126326131|NCT04811664|454488380|FG001|Overall Study|Lost to Follow-up|125|||
126326132|NCT04811664|454488381|FG002|Overall Study|Lost to Follow-up|46|||
126326133|NCT04811664|454488379|FG000|Overall Study|Withdrawal by Subject|39|||
126326134|NCT04811664|454488380|FG001|Overall Study|Withdrawal by Subject|76|||
126326135|NCT04811664|454488381|FG002|Overall Study|Withdrawal by Subject|12|||
126326136|NCT04811664|454488379|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
126326137|NCT04811664|454488380|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
126326138|NCT04811664|454488381|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
126326139|NCT04811664|454488379|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
126326140|NCT04811664|454488380|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
126326141|NCT04811664|454488381|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
126326142|NCT04811664|454488379|FG000|Overall Study|Protocol Violation|0|||
126326143|NCT04811664|454488380|FG001|Overall Study|Protocol Violation|5|||
126326144|NCT04811664|454488381|FG002|Overall Study|Protocol Violation|11|||
126326145|NCT04811664|454488379|FG000|Overall Study|Study Terminated by Sponsor|4|||
126326146|NCT04811664|454488380|FG001|Overall Study|Study Terminated by Sponsor|3|||
126326147|NCT04811664|454488381|FG002|Overall Study|Study Terminated by Sponsor|34|||
126326148|NCT04811664|454488379|FG000|Overall Study|Early Study Closure|3|||
126326149|NCT04811664|454488380|FG001|Overall Study|Early Study Closure|7|||
126326150|NCT04811664|454488381|FG002|Overall Study|Early Study Closure|79|||
126326151|NCT04811664|454488379|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
126326152|NCT04811664|454488380|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
126326153|NCT04811664|454488381|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
126326154|NCT05052697|454488382|FG000|Substudy A|Lost to Follow-up|0|||
126326155|NCT05052697|454488383|FG001|Substudy A|Lost to Follow-up|0|||
126326156|NCT05052697|454488384|FG002|Substudy A|Lost to Follow-up|0|||
126326157|NCT05052697|454488385|FG003|Substudy A|Lost to Follow-up|0|||
126326158|NCT05052697|454488386|FG004|Substudy A|Lost to Follow-up|0|||
126326159|NCT05052697|454488387|FG005|Substudy A|Lost to Follow-up|1|||
126326160|NCT05052697|454488388|FG006|Substudy A|Lost to Follow-up|0|||
126326161|NCT05052697|454488389|FG007|Substudy A|Lost to Follow-up|0|||
126326162|NCT05052697|454488390|FG008|Substudy A|Lost to Follow-up|0|||
126326163|NCT05052697|454488391|FG009|Substudy A|Lost to Follow-up|0|||
126326164|NCT05052697|454488392|FG010|Substudy A|Lost to Follow-up|0|||
126326165|NCT05052697|454488393|FG011|Substudy A|Lost to Follow-up|0|||
126326166|NCT05052697|454488394|FG012|Substudy A|Lost to Follow-up|0|||
126326167|NCT05052697|454488395|FG013|Substudy A|Lost to Follow-up|0|||
126326168|NCT05052697|454488396|FG014|Substudy A|Lost to Follow-up|0|||
126326169|NCT05052697|454488397|FG015|Substudy A|Lost to Follow-up|2|||
126326170|NCT05052697|454488398|FG016|Substudy A|Lost to Follow-up|0|||
126326171|NCT05052697|454488399|FG017|Substudy A|Lost to Follow-up|0|||
126326172|NCT05052697|454488400|FG018|Substudy A|Lost to Follow-up|0|||
126326173|NCT05052697|454488401|FG019|Substudy A|Lost to Follow-up|0|||
126326174|NCT05052697|454488402|FG020|Substudy A|Lost to Follow-up|0|||
126326175|NCT05052697|454488403|FG021|Substudy A|Lost to Follow-up|0|||
126326176|NCT05052697|454488404|FG022|Substudy A|Lost to Follow-up|0|||
126326177|NCT05052697|454488405|FG023|Substudy A|Lost to Follow-up|0|||
126326178|NCT05052697|454488406|FG024|Substudy A|Lost to Follow-up|0|||
126326179|NCT05052697|454488407|FG025|Substudy A|Lost to Follow-up|0|||
126326180|NCT05052697|454488408|FG026|Substudy A|Lost to Follow-up|0|||
126326181|NCT05052697|454488409|FG027|Substudy A|Lost to Follow-up|0|||
126326182|NCT05052697|454488410|FG028|Substudy A|Lost to Follow-up|0|||
126326183|NCT05052697|454488411|FG029|Substudy A|Lost to Follow-up|0|||
126326184|NCT05052697|454488412|FG030|Substudy A|Lost to Follow-up|0|||
126326185|NCT05052697|454488413|FG031|Substudy A|Lost to Follow-up|0|||
126326186|NCT05052697|454488414|FG032|Substudy A|Lost to Follow-up|0|||
126326187|NCT05052697|454488415|FG033|Substudy A|Lost to Follow-up|0|||
126326188|NCT05052697|454488382|FG000|Substudy A|No longer met eligibility criteria|0|||
126326189|NCT05052697|454488383|FG001|Substudy A|No longer met eligibility criteria|0|||
126326190|NCT05052697|454488384|FG002|Substudy A|No longer met eligibility criteria|0|||
126326191|NCT05052697|454488385|FG003|Substudy A|No longer met eligibility criteria|0|||
126326192|NCT05052697|454488386|FG004|Substudy A|No longer met eligibility criteria|0|||
126326193|NCT05052697|454488387|FG005|Substudy A|No longer met eligibility criteria|0|||
126326194|NCT05052697|454488388|FG006|Substudy A|No longer met eligibility criteria|0|||
126326195|NCT05052697|454488389|FG007|Substudy A|No longer met eligibility criteria|0|||
126326196|NCT05052697|454488390|FG008|Substudy A|No longer met eligibility criteria|0|||
126326197|NCT05052697|454488391|FG009|Substudy A|No longer met eligibility criteria|0|||
126326198|NCT05052697|454488392|FG010|Substudy A|No longer met eligibility criteria|0|||
126326199|NCT05052697|454488393|FG011|Substudy A|No longer met eligibility criteria|0|||
126326200|NCT05052697|454488394|FG012|Substudy A|No longer met eligibility criteria|0|||
126326201|NCT05052697|454488395|FG013|Substudy A|No longer met eligibility criteria|1|||
126326202|NCT05052697|454488396|FG014|Substudy A|No longer met eligibility criteria|0|||
126326203|NCT05052697|454488397|FG015|Substudy A|No longer met eligibility criteria|0|||
126326204|NCT05052697|454488398|FG016|Substudy A|No longer met eligibility criteria|0|||
125986092|NCT05061537|453240485|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
125986093|NCT05061537|453240486|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
125986094|NCT05061537|453240487|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
125986095|NCT05061537|453240483|FG000|Long-term Follow-up|Death|0|||
125986096|NCT05061537|453240484|FG001|Long-term Follow-up|Death|1|||
125986097|NCT05061537|453240485|FG002|Long-term Follow-up|Death|0|||
125986098|NCT05061537|453240486|FG003|Long-term Follow-up|Death|0|||
125986099|NCT05061537|453240487|FG004|Long-term Follow-up|Death|0|||
125986100|NCT01674621|453240498|FG000|Overall Study|Adverse Event|3|||
125986101|NCT01674621|453240499|FG001|Overall Study|Adverse Event|2|||
125986102|NCT01674621|453240500|FG002|Overall Study|Adverse Event|5|||
125986103|NCT01674621|453240501|FG003|Overall Study|Adverse Event|5|||
125986104|NCT01674621|453240502|FG004|Overall Study|Adverse Event|1|||
125986105|NCT01674621|453240498|FG000|Overall Study|Inability to Complete Study Procedures|0|||
125986106|NCT01674621|453240499|FG001|Overall Study|Inability to Complete Study Procedures|0|||
125986107|NCT01674621|453240500|FG002|Overall Study|Inability to Complete Study Procedures|0|||
125986108|NCT01674621|453240501|FG003|Overall Study|Inability to Complete Study Procedures|0|||
125986109|NCT01674621|453240502|FG004|Overall Study|Inability to Complete Study Procedures|2|||
125986110|NCT01674621|453240498|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
125986111|NCT01674621|453240499|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
125986112|NCT01674621|453240500|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
125986113|NCT01674621|453240501|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
126326205|NCT05052697|454488399|FG017|Substudy A|No longer met eligibility criteria|0|||
126326206|NCT05052697|454488400|FG018|Substudy A|No longer met eligibility criteria|0|||
126326207|NCT05052697|454488401|FG019|Substudy A|No longer met eligibility criteria|0|||
126326208|NCT05052697|454488402|FG020|Substudy A|No longer met eligibility criteria|0|||
126326209|NCT05052697|454488403|FG021|Substudy A|No longer met eligibility criteria|0|||
126326210|NCT05052697|454488404|FG022|Substudy A|No longer met eligibility criteria|0|||
126326211|NCT05052697|454488405|FG023|Substudy A|No longer met eligibility criteria|0|||
126326212|NCT05052697|454488406|FG024|Substudy A|No longer met eligibility criteria|0|||
126326213|NCT05052697|454488407|FG025|Substudy A|No longer met eligibility criteria|0|||
126326214|NCT05052697|454488408|FG026|Substudy A|No longer met eligibility criteria|0|||
126326215|NCT05052697|454488409|FG027|Substudy A|No longer met eligibility criteria|0|||
126326216|NCT05052697|454488410|FG028|Substudy A|No longer met eligibility criteria|0|||
126326217|NCT05052697|454488411|FG029|Substudy A|No longer met eligibility criteria|0|||
126326218|NCT05052697|454488412|FG030|Substudy A|No longer met eligibility criteria|0|||
126326219|NCT05052697|454488413|FG031|Substudy A|No longer met eligibility criteria|0|||
126326220|NCT05052697|454488414|FG032|Substudy A|No longer met eligibility criteria|0|||
126326221|NCT05052697|454488415|FG033|Substudy A|No longer met eligibility criteria|0|||
126326222|NCT05052697|454488382|FG000|Substudy A|Not vaccinated|0|||
126326223|NCT05052697|454488383|FG001|Substudy A|Not vaccinated|0|||
126326224|NCT05052697|454488384|FG002|Substudy A|Not vaccinated|0|||
126326225|NCT05052697|454488385|FG003|Substudy A|Not vaccinated|1|||
126326226|NCT05052697|454488386|FG004|Substudy A|Not vaccinated|0|||
126326227|NCT05052697|454488387|FG005|Substudy A|Not vaccinated|0|||
126326228|NCT05052697|454488388|FG006|Substudy A|Not vaccinated|0|||
126326229|NCT05052697|454488389|FG007|Substudy A|Not vaccinated|0|||
126326230|NCT05052697|454488390|FG008|Substudy A|Not vaccinated|1|||
126326231|NCT05052697|454488391|FG009|Substudy A|Not vaccinated|0|||
126326232|NCT05052697|454488392|FG010|Substudy A|Not vaccinated|0|||
126209057|NCT05048875|454053136|FG005|Overall Study|Withdrawal by Subject|0|||
126209058|NCT05048875|454053137|FG006|Overall Study|Withdrawal by Subject|0|||
126209059|NCT05048875|454053138|FG007|Overall Study|Withdrawal by Subject|0|||
126209060|NCT05048875|454053131|FG000|Overall Study|Adverse Event|0|||
126209061|NCT05048875|454053132|FG001|Overall Study|Adverse Event|0|||
126209062|NCT05048875|454053133|FG002|Overall Study|Adverse Event|0|||
126209063|NCT05048875|454053134|FG003|Overall Study|Adverse Event|1|||
126326233|NCT05052697|454488393|FG011|Substudy A|Not vaccinated|0|||
126326234|NCT05052697|454488394|FG012|Substudy A|Not vaccinated|0|||
126326235|NCT05052697|454488395|FG013|Substudy A|Not vaccinated|0|||
126326236|NCT05052697|454488396|FG014|Substudy A|Not vaccinated|0|||
126326237|NCT05052697|454488397|FG015|Substudy A|Not vaccinated|0|||
126326238|NCT05052697|454488398|FG016|Substudy A|Not vaccinated|0|||
126326239|NCT05052697|454488399|FG017|Substudy A|Not vaccinated|0|||
126326240|NCT05052697|454488400|FG018|Substudy A|Not vaccinated|0|||
125986114|NCT01674621|453240502|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
126209064|NCT05048875|454053135|FG004|Overall Study|Adverse Event|0|||
126209065|NCT05048875|454053136|FG005|Overall Study|Adverse Event|0|||
126326241|NCT05052697|454488401|FG019|Substudy A|Not vaccinated|0|||
125986115|NCT01674621|453240498|FG000|Overall Study|Withdrawal by Subject|2|||
125986116|NCT01674621|453240499|FG001|Overall Study|Withdrawal by Subject|5|||
125986117|NCT01674621|453240500|FG002|Overall Study|Withdrawal by Subject|2|||
125986118|NCT01674621|453240501|FG003|Overall Study|Withdrawal by Subject|0|||
126326242|NCT05052697|454488402|FG020|Substudy A|Not vaccinated|0|||
126326243|NCT05052697|454488403|FG021|Substudy A|Not vaccinated|0|||
126326244|NCT05052697|454488404|FG022|Substudy A|Not vaccinated|0|||
126326245|NCT05052697|454488405|FG023|Substudy A|Not vaccinated|0|||
125986119|NCT01674621|453240502|FG004|Overall Study|Withdrawal by Subject|1|||
125986120|NCT01674621|453240498|FG000|Overall Study|Other than specified|0|||
126326246|NCT05052697|454488406|FG024|Substudy A|Not vaccinated|0|||
126326247|NCT05052697|454488407|FG025|Substudy A|Not vaccinated|0|||
125986121|NCT01674621|453240499|FG001|Overall Study|Other than specified|1|||
125986122|NCT01674621|453240500|FG002|Overall Study|Other than specified|0|||
125986123|NCT01674621|453240501|FG003|Overall Study|Other than specified|0|||
126326248|NCT05052697|454488408|FG026|Substudy A|Not vaccinated|0|||
126326249|NCT05052697|454488409|FG027|Substudy A|Not vaccinated|0|||
126326250|NCT05052697|454488410|FG028|Substudy A|Not vaccinated|0|||
126326251|NCT05052697|454488411|FG029|Substudy A|Not vaccinated|0|||
125986124|NCT01674621|453240502|FG004|Overall Study|Other than specified|2|||
125986125|NCT01859793|453240503|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
125986126|NCT01859793|453240504|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
125986127|NCT01859793|453240503|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
125986128|NCT01859793|453240504|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
125986129|NCT01859793|453240503|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125986130|NCT01859793|453240504|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126326252|NCT05052697|454488412|FG030|Substudy A|Not vaccinated|0|||
126326253|NCT05052697|454488413|FG031|Substudy A|Not vaccinated|0|||
126326254|NCT05052697|454488414|FG032|Substudy A|Not vaccinated|0|||
126326255|NCT05052697|454488415|FG033|Substudy A|Not vaccinated|0|||
126326256|NCT05052697|454488382|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326257|NCT05052697|454488383|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326258|NCT05052697|454488384|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326259|NCT05052697|454488385|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125986131|NCT01859793|453240503|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
125986132|NCT01859793|453240504|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
125986133|NCT01735396|453240505|FG000|Overall Study|not evaluable|1|||
125986134|NCT01148862|453240506|FG000|Second Intervention|Withdrawal by Subject|0|||
125986135|NCT01148862|453240507|FG001|Second Intervention|Withdrawal by Subject|2|||
125986136|NCT00895622|453240509|FG000|Overall Study|Protocol Violation|5|||
126326260|NCT05052697|454488386|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326261|NCT05052697|454488387|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326262|NCT05052697|454488388|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326263|NCT05052697|454488389|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326264|NCT05052697|454488390|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326265|NCT05052697|454488391|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326266|NCT05052697|454488392|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326267|NCT05052697|454488393|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326268|NCT05052697|454488394|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326269|NCT05052697|454488395|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326270|NCT05052697|454488396|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326271|NCT05052697|454488397|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326272|NCT05052697|454488398|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326273|NCT05052697|454488399|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326274|NCT05052697|454488400|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
126326275|NCT05052697|454488401|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
126326276|NCT05052697|454488402|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326277|NCT05052697|454488403|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
126326278|NCT05052697|454488404|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
126326279|NCT05052697|454488405|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326280|NCT05052697|454488406|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326281|NCT05052697|454488407|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326282|NCT05052697|454488408|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326283|NCT05052697|454488409|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326284|NCT05052697|454488410|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326285|NCT05052697|454488411|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326286|NCT05052697|454488412|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326287|NCT05052697|454488413|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326288|NCT05052697|454488414|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326289|NCT05052697|454488415|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125986137|NCT00895622|453240510|FG001|Overall Study|Protocol Violation|4|||
125986138|NCT00895622|453240511|FG002|Overall Study|Protocol Violation|4|||
126326290|NCT05052697|454488382|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
125986139|NCT03724396|453240512|FG000|Overall Study|Lost to Follow-up|1|||
125986140|NCT03724396|453240513|FG001|Overall Study|Lost to Follow-up|1|||
125986141|NCT03724396|453240512|FG000|Overall Study|Withdrawal by Subject|1|||
125986142|NCT03724396|453240513|FG001|Overall Study|Withdrawal by Subject|0|||
125986143|NCT01490125|453240514|FG000|Period I|Adverse Event|4|||
125986144|NCT01490125|453240515|FG001|Period I|Adverse Event|1|||
126326291|NCT05052697|454488383|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326292|NCT05052697|454488384|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326293|NCT05052697|454488385|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326294|NCT05052697|454488386|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326295|NCT05052697|454488387|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326296|NCT05052697|454488388|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326297|NCT05052697|454488389|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326298|NCT05052697|454488390|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326299|NCT05052697|454488391|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326300|NCT05052697|454488392|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326301|NCT05052697|454488393|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326302|NCT05052697|454488394|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326303|NCT05052697|454488395|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326304|NCT05052697|454488396|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326305|NCT05052697|454488397|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326306|NCT05052697|454488398|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326307|NCT05052697|454488399|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
126326308|NCT05052697|454488400|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326309|NCT05052697|454488401|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326310|NCT05052697|454488402|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326311|NCT05052697|454488403|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326312|NCT05052697|454488404|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326313|NCT05052697|454488405|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326314|NCT05052697|454488406|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326315|NCT05052697|454488407|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326316|NCT05052697|454488408|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326317|NCT05052697|454488409|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326318|NCT05052697|454488410|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326319|NCT05052697|454488411|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326320|NCT05052697|454488412|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326321|NCT05052697|454488413|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326322|NCT05052697|454488414|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326323|NCT05052697|454488415|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326324|NCT05052697|454488382|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326325|NCT05052697|454488383|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326326|NCT05052697|454488384|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326327|NCT05052697|454488385|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326328|NCT05052697|454488386|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326329|NCT05052697|454488387|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326330|NCT05052697|454488388|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326331|NCT05052697|454488389|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326332|NCT05052697|454488390|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326333|NCT05052697|454488391|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326334|NCT05052697|454488392|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326335|NCT05052697|454488393|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326336|NCT05052697|454488394|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326337|NCT05052697|454488395|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326338|NCT05052697|454488396|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326339|NCT05052697|454488397|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326340|NCT05052697|454488398|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326341|NCT05052697|454488399|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326342|NCT05052697|454488400|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326343|NCT05052697|454488401|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
126326344|NCT05052697|454488402|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326345|NCT05052697|454488403|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326346|NCT05052697|454488404|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326347|NCT05052697|454488405|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326348|NCT05052697|454488406|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326349|NCT05052697|454488407|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326350|NCT05052697|454488408|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326351|NCT05052697|454488409|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326352|NCT05052697|454488410|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326353|NCT05052697|454488411|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326354|NCT05052697|454488412|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326355|NCT05052697|454488413|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326356|NCT05052697|454488414|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326357|NCT05052697|454488415|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326358|NCT05052697|454488382|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326359|NCT05052697|454488383|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326360|NCT05052697|454488384|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326361|NCT05052697|454488385|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326362|NCT05052697|454488386|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326363|NCT05052697|454488387|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326364|NCT05052697|454488388|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326365|NCT05052697|454488389|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326366|NCT05052697|454488390|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326367|NCT05052697|454488391|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326368|NCT05052697|454488392|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326369|NCT05052697|454488393|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326370|NCT05052697|454488394|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326371|NCT05052697|454488395|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326372|NCT05052697|454488396|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326373|NCT05052697|454488397|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326374|NCT05052697|454488398|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326375|NCT05052697|454488399|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
126326376|NCT05052697|454488400|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326377|NCT05052697|454488401|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326378|NCT05052697|454488402|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326379|NCT05052697|454488403|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326380|NCT05052697|454488404|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326381|NCT05052697|454488405|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326382|NCT05052697|454488406|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326383|NCT05052697|454488407|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
126326384|NCT05052697|454488408|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326385|NCT05052697|454488409|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
126326386|NCT05052697|454488410|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326387|NCT05052697|454488411|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326388|NCT05052697|454488412|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326389|NCT05052697|454488413|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326390|NCT05052697|454488414|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326391|NCT05052697|454488415|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326392|NCT05052697|454488382|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326393|NCT05052697|454488383|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326394|NCT05052697|454488384|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326395|NCT05052697|454488385|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326396|NCT05052697|454488386|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326397|NCT05052697|454488387|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326398|NCT05052697|454488388|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326399|NCT05052697|454488389|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326400|NCT05052697|454488390|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326401|NCT05052697|454488391|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326402|NCT05052697|454488392|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326403|NCT05052697|454488393|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326404|NCT05052697|454488394|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326405|NCT05052697|454488395|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326406|NCT05052697|454488396|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326407|NCT05052697|454488397|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125986145|NCT01490125|453240516|FG002|Period I|Adverse Event|1|||
125986146|NCT01490125|453240517|FG003|Period I|Adverse Event|3|||
125986147|NCT01490125|453240518|FG004|Period I|Adverse Event|2|||
125986148|NCT01490125|453240519|FG005|Period I|Adverse Event|4|||
125986149|NCT01490125|453240514|FG000|Period I|Protocol Violation|1|||
125986150|NCT01490125|453240515|FG001|Period I|Protocol Violation|1|||
125986151|NCT01490125|453240516|FG002|Period I|Protocol Violation|1|||
125986152|NCT01490125|453240517|FG003|Period I|Protocol Violation|1|||
125986153|NCT01490125|453240518|FG004|Period I|Protocol Violation|0|||
125986154|NCT01490125|453240519|FG005|Period I|Protocol Violation|0|||
125986155|NCT01490125|453240514|FG000|Period I|Withdrawal by Subject|1|||
125986156|NCT01490125|453240515|FG001|Period I|Withdrawal by Subject|3|||
125986157|NCT01490125|453240516|FG002|Period I|Withdrawal by Subject|2|||
125986158|NCT01490125|453240517|FG003|Period I|Withdrawal by Subject|1|||
126326408|NCT05052697|454488398|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326409|NCT05052697|454488399|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326410|NCT05052697|454488400|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326411|NCT05052697|454488401|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326412|NCT05052697|454488402|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125986159|NCT01490125|453240518|FG004|Period I|Withdrawal by Subject|2|||
125986160|NCT01490125|453240519|FG005|Period I|Withdrawal by Subject|1|||
125986161|NCT01490125|453240514|FG000|Period II|Adverse Event|2|||
125986162|NCT01490125|453240515|FG001|Period II|Adverse Event|3|||
125986163|NCT01490125|453240516|FG002|Period II|Adverse Event|2|||
125986164|NCT01490125|453240517|FG003|Period II|Adverse Event|2|||
125986165|NCT01490125|453240518|FG004|Period II|Adverse Event|4|||
125986166|NCT01490125|453240519|FG005|Period II|Adverse Event|2|||
125986167|NCT01490125|453240514|FG000|Period II|Protocol Violation|0|||
125986168|NCT01490125|453240515|FG001|Period II|Protocol Violation|0|||
125986169|NCT01490125|453240516|FG002|Period II|Protocol Violation|1|||
125986170|NCT01490125|453240517|FG003|Period II|Protocol Violation|1|||
125986171|NCT01490125|453240518|FG004|Period II|Protocol Violation|0|||
125986172|NCT01490125|453240519|FG005|Period II|Protocol Violation|0|||
125986173|NCT01490125|453240514|FG000|Period II|Lost to Follow-up|0|||
125986174|NCT01490125|453240515|FG001|Period II|Lost to Follow-up|1|||
125986175|NCT01490125|453240516|FG002|Period II|Lost to Follow-up|0|||
125986176|NCT01490125|453240517|FG003|Period II|Lost to Follow-up|0|||
125986177|NCT01490125|453240518|FG004|Period II|Lost to Follow-up|0|||
125986178|NCT01490125|453240519|FG005|Period II|Lost to Follow-up|0|||
125986179|NCT01490125|453240514|FG000|Period II|Withdrawal by Subject|1|||
125986180|NCT01490125|453240515|FG001|Period II|Withdrawal by Subject|0|||
125986181|NCT01490125|453240516|FG002|Period II|Withdrawal by Subject|0|||
125986182|NCT01490125|453240517|FG003|Period II|Withdrawal by Subject|0|||
125986183|NCT01490125|453240518|FG004|Period II|Withdrawal by Subject|0|||
125986184|NCT01490125|453240519|FG005|Period II|Withdrawal by Subject|0|||
125986185|NCT01490125|453240514|FG000|Period III|Adverse Event|3|||
125986186|NCT01490125|453240515|FG001|Period III|Adverse Event|1|||
125986187|NCT01490125|453240516|FG002|Period III|Adverse Event|0|||
125986188|NCT01490125|453240517|FG003|Period III|Adverse Event|1|||
125986189|NCT01490125|453240518|FG004|Period III|Adverse Event|0|||
125986190|NCT01490125|453240519|FG005|Period III|Adverse Event|0|||
125986191|NCT01490125|453240514|FG000|Period III|Death|0|||
125986192|NCT01490125|453240515|FG001|Period III|Death|0|||
125986193|NCT01490125|453240516|FG002|Period III|Death|0|||
125986194|NCT01490125|453240517|FG003|Period III|Death|1|||
125986195|NCT01490125|453240518|FG004|Period III|Death|0|||
125986196|NCT01490125|453240519|FG005|Period III|Death|0|||
125986197|NCT01490125|453240514|FG000|Period III|Lack of Efficacy|0|||
125986198|NCT01490125|453240515|FG001|Period III|Lack of Efficacy|0|||
125986199|NCT01490125|453240516|FG002|Period III|Lack of Efficacy|0|||
125986200|NCT01490125|453240517|FG003|Period III|Lack of Efficacy|0|||
125986201|NCT01490125|453240518|FG004|Period III|Lack of Efficacy|1|||
125986202|NCT01490125|453240519|FG005|Period III|Lack of Efficacy|0|||
125986203|NCT02237508|453240521|FG000|Overall Study|Withdrawal by Subject|0|||
125986204|NCT02237508|453240522|FG001|Overall Study|Withdrawal by Subject|2|||
125986205|NCT02237508|453240523|FG002|Overall Study|Withdrawal by Subject|0|||
125986206|NCT02237508|453240524|FG003|Overall Study|Withdrawal by Subject|1|||
125986207|NCT02237508|453240525|FG004|Overall Study|Withdrawal by Subject|0|||
125986208|NCT02237508|453240526|FG005|Overall Study|Withdrawal by Subject|1|||
125986209|NCT02237508|453240527|FG006|Overall Study|Withdrawal by Subject|1|||
125986210|NCT02237508|453240528|FG007|Overall Study|Withdrawal by Subject|0|||
125986211|NCT02237508|453240529|FG008|Overall Study|Withdrawal by Subject|1|||
125986212|NCT02237508|453240530|FG009|Overall Study|Withdrawal by Subject|0|||
125986213|NCT02237508|453240521|FG000|Overall Study|Physician Decision|0|||
125986214|NCT02237508|453240522|FG001|Overall Study|Physician Decision|1|||
125986215|NCT02237508|453240523|FG002|Overall Study|Physician Decision|0|||
125986216|NCT02237508|453240524|FG003|Overall Study|Physician Decision|0|||
125986217|NCT02237508|453240525|FG004|Overall Study|Physician Decision|0|||
125986218|NCT02237508|453240526|FG005|Overall Study|Physician Decision|0|||
125986219|NCT02237508|453240527|FG006|Overall Study|Physician Decision|0|||
125986220|NCT02237508|453240528|FG007|Overall Study|Physician Decision|0|||
125986221|NCT02237508|453240529|FG008|Overall Study|Physician Decision|0|||
125986222|NCT02237508|453240530|FG009|Overall Study|Physician Decision|0|||
125986223|NCT02237508|453240521|FG000|Overall Study|Protocol Violation|0|||
126326413|NCT05052697|454488403|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326414|NCT05052697|454488404|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326415|NCT05052697|454488405|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326416|NCT05052697|454488406|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125986224|NCT02237508|453240522|FG001|Overall Study|Protocol Violation|0|||
125986225|NCT02237508|453240523|FG002|Overall Study|Protocol Violation|1|||
125986226|NCT02237508|453240524|FG003|Overall Study|Protocol Violation|0|||
125986227|NCT02237508|453240525|FG004|Overall Study|Protocol Violation|0|||
125986228|NCT02237508|453240526|FG005|Overall Study|Protocol Violation|0|||
125986229|NCT02237508|453240527|FG006|Overall Study|Protocol Violation|0|||
125986230|NCT02237508|453240528|FG007|Overall Study|Protocol Violation|0|||
125986231|NCT02237508|453240529|FG008|Overall Study|Protocol Violation|0|||
125986232|NCT02237508|453240530|FG009|Overall Study|Protocol Violation|0|||
125986233|NCT04954586|453240531|FG000|Overall Study|Withdrawal by Subject|5|||
125986234|NCT04000594|453240532|FG000|Overall Study|Withdrawal by Subject|1|||
125986235|NCT04000594|453240533|FG001|Overall Study|Withdrawal by Subject|0|||
125986236|NCT04000594|453240534|FG002|Overall Study|Withdrawal by Subject|0|||
125986237|NCT04522180|453240535|FG000|Overall Study|Investigator judgement|3|||
125986238|NCT04522180|453240536|FG001|Overall Study|Investigator judgement|4|||
125986239|NCT04522180|453240535|FG000|Overall Study|Voluntary withdrawal|1|||
125986240|NCT04522180|453240536|FG001|Overall Study|Voluntary withdrawal|0|||
125986241|NCT04522180|453240535|FG000|Overall Study|Pregnancy|0|||
125986242|NCT04522180|453240536|FG001|Overall Study|Pregnancy|1|||
125986243|NCT04522180|453240535|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
125986244|NCT04522180|453240536|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
125986245|NCT04522180|453240535|FG000|Overall Study|Reason not specified|8|||
125986246|NCT04522180|453240536|FG001|Overall Study|Reason not specified|5|||
125986247|NCT01905046|453240537|FG000|Months 13-24|Withdrawal by Subject|10|||
125986248|NCT01905046|453240538|FG001|Months 13-24|Withdrawal by Subject|10|||
125986249|NCT01905046|453240537|FG000|Months 13-24|Adverse Event|3|||
125986250|NCT01905046|453240538|FG001|Months 13-24|Adverse Event|2|||
125986251|NCT01905046|453240537|FG000|Months 13-24|Protocol Violation|3|||
126326417|NCT05052697|454488407|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326418|NCT05052697|454488408|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326419|NCT05052697|454488409|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326420|NCT05052697|454488410|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
126326421|NCT05052697|454488411|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326422|NCT05052697|454488412|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
125986252|NCT01905046|453240538|FG001|Months 13-24|Protocol Violation|3|||
125986253|NCT01905046|453240537|FG000|Months 13-24|Physician Decision|1|||
125986254|NCT01905046|453240538|FG001|Months 13-24|Physician Decision|0|||
125986255|NCT03489057|453240543|FG000|Overall Study|Lost to Follow-up|16|||
125986256|NCT03489057|453240544|FG001|Overall Study|Lost to Follow-up|16|||
125986257|NCT03489057|453240545|FG002|Overall Study|Lost to Follow-up|14|||
125986258|NCT03489057|453240546|FG003|Overall Study|Lost to Follow-up|14|||
125986259|NCT03489057|453240543|FG000|Overall Study|Withdrawal by Subject|12|||
126326423|NCT05052697|454488413|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
126326424|NCT05052697|454488414|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
126326425|NCT05052697|454488415|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326426|NCT05052697|454488382|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326427|NCT05052697|454488383|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326428|NCT05052697|454488384|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326429|NCT05052697|454488385|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326430|NCT05052697|454488386|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326431|NCT05052697|454488387|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326432|NCT05052697|454488388|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326433|NCT05052697|454488389|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326434|NCT05052697|454488390|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326435|NCT05052697|454488391|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326436|NCT05052697|454488392|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326437|NCT05052697|454488393|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326438|NCT05052697|454488394|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326439|NCT05052697|454488395|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326440|NCT05052697|454488396|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326441|NCT05052697|454488397|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326442|NCT05052697|454488398|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326443|NCT05052697|454488399|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326444|NCT05052697|454488400|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326445|NCT05052697|454488401|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326446|NCT05052697|454488402|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326447|NCT05052697|454488403|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326448|NCT05052697|454488404|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326449|NCT05052697|454488405|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326450|NCT05052697|454488406|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326451|NCT05052697|454488407|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326452|NCT05052697|454488408|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326453|NCT05052697|454488409|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326454|NCT05052697|454488410|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
126326455|NCT05052697|454488411|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
126326456|NCT05052697|454488412|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
126326457|NCT05052697|454488413|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
126326458|NCT05052697|454488414|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
126326459|NCT05052697|454488415|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326460|NCT05052697|454488382|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326461|NCT05052697|454488383|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326462|NCT05052697|454488384|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986260|NCT03489057|453240544|FG001|Overall Study|Withdrawal by Subject|12|||
125986261|NCT03489057|453240545|FG002|Overall Study|Withdrawal by Subject|8|||
125986262|NCT03489057|453240546|FG003|Overall Study|Withdrawal by Subject|8|||
125986263|NCT03489057|453240543|FG000|Overall Study|Protocol Violation|7|||
125986264|NCT03489057|453240544|FG001|Overall Study|Protocol Violation|7|||
125986265|NCT03489057|453240545|FG002|Overall Study|Protocol Violation|2|||
125986266|NCT03489057|453240546|FG003|Overall Study|Protocol Violation|2|||
125986267|NCT01368900|453240549|FG000|Overall Study|Lost to Follow-up|7|||
125986268|NCT04027348|453240552|FG000|Overall Study|Adverse Event|2|||
125986269|NCT02487472|453240553|FG000|Overall Study|Did not complete telephonic interviews|9|||
125986270|NCT02487472|453240553|FG000|Overall Study|Other|2|||
125986271|NCT02277743|453240554|FG000|Overall Study|Protocol Violation|1|||
125986272|NCT02277743|453240555|FG001|Overall Study|Protocol Violation|1|||
125986273|NCT02277743|453240556|FG002|Overall Study|Protocol Violation|1|||
125986274|NCT02277743|453240554|FG000|Overall Study|Adverse Event|10|||
125986275|NCT02277743|453240555|FG001|Overall Study|Adverse Event|6|||
125986276|NCT02277743|453240556|FG002|Overall Study|Adverse Event|6|||
125986277|NCT02277743|453240554|FG000|Overall Study|Lack of Efficacy|11|||
125986278|NCT02277743|453240555|FG001|Overall Study|Lack of Efficacy|4|||
125986279|NCT02277743|453240556|FG002|Overall Study|Lack of Efficacy|3|||
125986280|NCT02277743|453240554|FG000|Overall Study|Other than specified above|18|||
125986281|NCT02277743|453240555|FG001|Overall Study|Other than specified above|5|||
125986282|NCT02277743|453240556|FG002|Overall Study|Other than specified above|16|||
126326463|NCT05052697|454488385|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326464|NCT05052697|454488386|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326465|NCT05052697|454488387|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326466|NCT05052697|454488388|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326467|NCT05052697|454488389|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986283|NCT01224158|453240557|FG000|Overall Study|Withdrawal by Subject|1|||
125986284|NCT01224158|453240558|FG001|Overall Study|Withdrawal by Subject|0|||
125986285|NCT03976466|453240561|FG000|Overall Study|Lost to Follow-up|1|||
125986286|NCT03976466|453240562|FG001|Overall Study|Lost to Follow-up|3|||
125986287|NCT02055157|453240563|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
125986288|NCT02055157|453240564|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
125986289|NCT02055157|453240565|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
125986290|NCT02055157|453240566|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
125986291|NCT02055157|453240563|FG000|Initial 6 Months|Adverse Event|0|||
125986292|NCT02055157|453240564|FG001|Initial 6 Months|Adverse Event|0|||
125986293|NCT02055157|453240565|FG002|Initial 6 Months|Adverse Event|0|||
125986294|NCT02055157|453240566|FG003|Initial 6 Months|Adverse Event|1|||
125986295|NCT02055157|453240563|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
125986296|NCT02055157|453240564|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
125986297|NCT02055157|453240565|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
125986298|NCT02055157|453240566|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
125986299|NCT02055157|453240563|FG000|18-month Extension|Investigator decision|0|||
125986300|NCT02055157|453240564|FG001|18-month Extension|Investigator decision|1|||
125986301|NCT02055157|453240565|FG002|18-month Extension|Investigator decision|0|||
125986302|NCT02055157|453240566|FG003|18-month Extension|Investigator decision|0|||
125986303|NCT02055157|453240563|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
125986304|NCT02055157|453240564|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
125986305|NCT02055157|453240565|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
125986306|NCT02055157|453240566|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
125986307|NCT00733499|453240567|FG000|Pre-operative|Protocol Violation|0|||
125986308|NCT00733499|453240568|FG001|Pre-operative|Protocol Violation|1|||
125986309|NCT00733499|453240567|FG000|3 Months Follow-up|Death|1|||
125986310|NCT00733499|453240568|FG001|3 Months Follow-up|Death|2|||
125986311|NCT00733499|453240567|FG000|6 Months Follow-up|Death|0|||
125986312|NCT00733499|453240568|FG001|6 Months Follow-up|Death|2|||
125986313|NCT00733499|453240567|FG000|6 Months Follow-up|Adverse Event|0|||
125986314|NCT00733499|453240568|FG001|6 Months Follow-up|Adverse Event|1|||
125986315|NCT00733499|453240567|FG000|12 Months Follow-up|Death|2|||
125986316|NCT00733499|453240568|FG001|12 Months Follow-up|Death|1|||
125986317|NCT00733499|453240567|FG000|24 Months Follow-up|Death|0|||
125986318|NCT00733499|453240568|FG001|24 Months Follow-up|Death|1|||
125986319|NCT00733499|453240567|FG000|5 Year Followup|Adverse Event|2|||
125986320|NCT00733499|453240568|FG001|5 Year Followup|Adverse Event|2|||
125986321|NCT00733499|453240567|FG000|5 Year Followup|Non device related AE|0|||
125986322|NCT00733499|453240568|FG001|5 Year Followup|Non device related AE|1|||
125986323|NCT00733499|453240567|FG000|5 Year Followup|Revision of Study Implant|0|||
125986324|NCT00733499|453240568|FG001|5 Year Followup|Revision of Study Implant|1|||
125986325|NCT00733499|453240567|FG000|5 Year Followup|Lost to Follow-up|2|||
125986326|NCT00733499|453240568|FG001|5 Year Followup|Lost to Follow-up|0|||
125986327|NCT00733499|453240567|FG000|5 Year Followup|Death|13|||
125986328|NCT00733499|453240568|FG001|5 Year Followup|Death|19|||
125986329|NCT00733499|453240567|FG000|5 Year Followup|missing, unable to locate|0|||
125986330|NCT00733499|453240568|FG001|5 Year Followup|missing, unable to locate|1|||
125986331|NCT00733499|453240567|FG000|5 Year Followup|Withdrawal by Subject|4|||
125986332|NCT00733499|453240568|FG001|5 Year Followup|Withdrawal by Subject|1|||
126326468|NCT05052697|454488390|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986333|NCT00733499|453240567|FG000|10 Year Followup|Death|9|||
125986334|NCT00733499|453240568|FG001|10 Year Followup|Death|7|||
125986335|NCT00733499|453240567|FG000|10 Year Followup|Adverse Event|3|||
125986336|NCT00733499|453240568|FG001|10 Year Followup|Adverse Event|3|||
125986337|NCT00733499|453240567|FG000|10 Year Followup|Lost to Follow-up|3|||
125986338|NCT00733499|453240568|FG001|10 Year Followup|Lost to Follow-up|2|||
125986339|NCT00733499|453240567|FG000|10 Year Followup|Withdrawal by Subject|5|||
125986340|NCT00733499|453240568|FG001|10 Year Followup|Withdrawal by Subject|5|||
125986341|NCT00733499|453240567|FG000|10 Year Followup|missing, unable to locate|0|||
125986342|NCT00733499|453240568|FG001|10 Year Followup|missing, unable to locate|2|||
125986343|NCT03929562|453240569|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
125986344|NCT03929562|453240570|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
125986345|NCT03929562|453240569|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
125986346|NCT03929562|453240570|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
125986347|NCT03929562|453240569|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
125986348|NCT03929562|453240570|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
125986349|NCT01552954|453240571|FG000|Overall Study|Adverse Event|1|||
125986350|NCT01552954|453240572|FG001|Overall Study|Adverse Event|2|||
125986351|NCT01552954|453240571|FG000|Overall Study|Lost to Follow-up|1|||
125986352|NCT01552954|453240572|FG001|Overall Study|Lost to Follow-up|1|||
125986353|NCT01552954|453240571|FG000|Overall Study|Withdrawal by Subject|1|||
125986354|NCT01552954|453240572|FG001|Overall Study|Withdrawal by Subject|1|||
125986355|NCT01552954|453240571|FG000|Overall Study|Protocol Violation|1|||
125986356|NCT01552954|453240572|FG001|Overall Study|Protocol Violation|2|||
125986357|NCT01552954|453240571|FG000|Overall Study|diagnosed DM|1|||
125986358|NCT01552954|453240572|FG001|Overall Study|diagnosed DM|0|||
125986359|NCT04843930|453240573|FG000|Randomization|Withdrawal by Subject|6|||
125986360|NCT04843930|453240574|FG001|Randomization|Withdrawal by Subject|6|||
125986361|NCT04843930|453240575|FG002|Randomization|Withdrawal by Subject|0|||
125986362|NCT04843930|453240576|FG003|Randomization|Withdrawal by Subject|0|||
125986363|NCT04843930|453240573|FG000|Week 6 Assessment|Adverse Event|3|||
125986364|NCT04843930|453240574|FG001|Week 6 Assessment|Adverse Event|0|||
125986365|NCT04843930|453240575|FG002|Week 6 Assessment|Adverse Event|0|||
125986366|NCT04843930|453240576|FG003|Week 6 Assessment|Adverse Event|0|||
125986367|NCT04843930|453240573|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
125986368|NCT04843930|453240574|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
125986369|NCT04843930|453240575|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
125986370|NCT04843930|453240576|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
125986371|NCT04843930|453240573|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
125986372|NCT04843930|453240574|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
125986373|NCT04843930|453240575|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
125986374|NCT04843930|453240576|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
125986375|NCT00652938|453240580|FG000|Overall Study|Adverse Event|1|||
125986376|NCT00652938|453240581|FG001|Overall Study|Adverse Event|0|||
125986377|NCT00652938|453240582|FG002|Overall Study|Adverse Event|2|||
125986378|NCT00652938|453240580|FG000|Overall Study|Withdrawal by Subject|0|||
125986379|NCT00652938|453240581|FG001|Overall Study|Withdrawal by Subject|6|||
126209066|NCT05048875|454053137|FG006|Overall Study|Adverse Event|0|||
126209067|NCT05048875|454053138|FG007|Overall Study|Adverse Event|0|||
126209068|NCT02255422|454053143|FG000|Overall Study|Withdrawal by Subject|0|||
126209069|NCT02255422|454053144|FG001|Overall Study|Withdrawal by Subject|0|||
126209070|NCT02255422|454053145|FG002|Overall Study|Withdrawal by Subject|0|||
126209071|NCT02255422|454053146|FG003|Overall Study|Withdrawal by Subject|0|||
125986380|NCT00652938|453240582|FG002|Overall Study|Withdrawal by Subject|1|||
125986381|NCT00652938|453240580|FG000|Overall Study|Lost to Follow-up|0|||
125986382|NCT00652938|453240581|FG001|Overall Study|Lost to Follow-up|0|||
125986383|NCT00652938|453240582|FG002|Overall Study|Lost to Follow-up|2|||
125986384|NCT00652938|453240580|FG000|Overall Study|fear of blood sampling|0|||
125986385|NCT00652938|453240581|FG001|Overall Study|fear of blood sampling|1|||
125986386|NCT00652938|453240582|FG002|Overall Study|fear of blood sampling|0|||
125986387|NCT01547299|453240583|FG000|Overall Study|Withdrawal by Subject|2|||
125986388|NCT01547299|453240584|FG001|Overall Study|Withdrawal by Subject|2|||
125986389|NCT01833143|453240589|FG000|Overall Study|Not Treated|1|||
125986390|NCT03995784|453240590|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
125986391|NCT01862991|453242969|FG000|Overall Study|Lost to Follow-up|2|||
125986392|NCT01862991|453242970|FG001|Overall Study|Lost to Follow-up|1|||
125986393|NCT01862991|453242971|FG002|Overall Study|Lost to Follow-up|1|||
125986394|NCT01862991|453242969|FG000|Overall Study|Protocol Violation|1|||
125986395|NCT01862991|453242970|FG001|Overall Study|Protocol Violation|0|||
125986396|NCT01862991|453242971|FG002|Overall Study|Protocol Violation|0|||
125986397|NCT02228395|453242974|FG000|First Intervention Period|No longer willing to participate|1|||
125986398|NCT02228395|453242975|FG001|First Intervention Period|No longer willing to participate|0|||
125986399|NCT02228395|453242976|FG002|First Intervention Period|No longer willing to participate|0|||
125986400|NCT02228395|453242974|FG000|First Intervention Period|Unable to comply with study dates|0|||
126090990|NCT03525392|453626878|FG004|Overall Study|Adverse Event|0|||
126209072|NCT02255422|454053147|FG004|Overall Study|Withdrawal by Subject|0|||
126209073|NCT02255422|454053148|FG005|Overall Study|Withdrawal by Subject|0|||
126209074|NCT02255422|454053149|FG006|Overall Study|Withdrawal by Subject|2|||
125986401|NCT02228395|453242975|FG001|First Intervention Period|Unable to comply with study dates|1|||
125986402|NCT02228395|453242976|FG002|First Intervention Period|Unable to comply with study dates|1|||
125986403|NCT00509236|453242977|FG000|Overall Study|Adverse Event|7|||
125986404|NCT00509236|453242978|FG001|Overall Study|Adverse Event|9|||
125986405|NCT00509236|453242977|FG000|Overall Study|Withdrawal by Subject|5|||
125986406|NCT00509236|453242978|FG001|Overall Study|Withdrawal by Subject|10|||
125986407|NCT00509236|453242977|FG000|Overall Study|Protocol Violation|3|||
125986408|NCT00509236|453242978|FG001|Overall Study|Protocol Violation|0|||
125986409|NCT00509236|453242977|FG000|Overall Study|Excluded Medication|1|||
125986410|NCT00509236|453242978|FG001|Overall Study|Excluded Medication|1|||
125986411|NCT00509236|453242977|FG000|Overall Study|Scheduled Kidney Transplant|1|||
125986412|NCT00509236|453242978|FG001|Overall Study|Scheduled Kidney Transplant|0|||
125986413|NCT00792103|453242979|FG000|Overall Study|Enrolled, not treated|15|||
125986414|NCT00792103|453242979|FG000|Overall Study|Lost to Follow-up|17|||
125986415|NCT00792103|453242979|FG000|Overall Study|Adverse Event|25|||
125986416|NCT00792103|453242979|FG000|Overall Study|Withdrawal by Subject|52|||
125986417|NCT00792103|453242979|FG000|Overall Study|Protocol Violation|10|||
125986418|NCT00792103|453242979|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
125986419|NCT01572389|453242981|FG000|Overall Study|Death|1|||
125986420|NCT01572389|453242982|FG001|Overall Study|Death|3|||
125986421|NCT01572389|453242981|FG000|Overall Study|Withdrawal by Subject|14|||
125986422|NCT01572389|453242982|FG001|Overall Study|Withdrawal by Subject|2|||
125986423|NCT01572389|453242981|FG000|Overall Study|Lost to Follow-up|25|||
125986424|NCT01572389|453242982|FG001|Overall Study|Lost to Follow-up|14|||
125986425|NCT01572389|453242981|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
125986426|NCT01572389|453242982|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
125986427|NCT01287520|453242983|FG000|Overall Study|Adverse Event|2|||
125986428|NCT01287520|453242984|FG001|Overall Study|Adverse Event|2|||
125986429|NCT01287520|453242985|FG002|Overall Study|Adverse Event|2|||
125986430|NCT01287520|453242986|FG003|Overall Study|Adverse Event|1|||
125986431|NCT01287520|453242987|FG004|Overall Study|Adverse Event|1|||
125986432|NCT01287520|453242988|FG005|Overall Study|Adverse Event|2|||
125986433|NCT01287520|453242989|FG006|Overall Study|Adverse Event|0|||
125986434|NCT01287520|453242990|FG007|Overall Study|Adverse Event|2|||
125986435|NCT01287520|453242991|FG008|Overall Study|Adverse Event|0|||
125986436|NCT01287520|453242983|FG000|Overall Study|Physician Decision|1|||
125986437|NCT01287520|453242984|FG001|Overall Study|Physician Decision|1|||
125986438|NCT01287520|453242985|FG002|Overall Study|Physician Decision|2|||
125986439|NCT01287520|453242986|FG003|Overall Study|Physician Decision|0|||
125986440|NCT01287520|453242987|FG004|Overall Study|Physician Decision|1|||
125986441|NCT01287520|453242988|FG005|Overall Study|Physician Decision|1|||
125986442|NCT01287520|453242989|FG006|Overall Study|Physician Decision|0|||
125986443|NCT01287520|453242990|FG007|Overall Study|Physician Decision|1|||
125986444|NCT01287520|453242991|FG008|Overall Study|Physician Decision|0|||
125986445|NCT01287520|453242983|FG000|Overall Study|Progressive disease|0|||
125986446|NCT01287520|453242984|FG001|Overall Study|Progressive disease|4|||
125986447|NCT01287520|453242985|FG002|Overall Study|Progressive disease|1|||
125986448|NCT01287520|453242986|FG003|Overall Study|Progressive disease|6|||
125986449|NCT01287520|453242987|FG004|Overall Study|Progressive disease|1|||
125986450|NCT01287520|453242988|FG005|Overall Study|Progressive disease|0|||
125986451|NCT01287520|453242989|FG006|Overall Study|Progressive disease|2|||
125986452|NCT01287520|453242990|FG007|Overall Study|Progressive disease|2|||
125986453|NCT01287520|453242991|FG008|Overall Study|Progressive disease|4|||
125986454|NCT01287520|453242983|FG000|Overall Study|Withdrawal by Subject|0|||
125986455|NCT01287520|453242984|FG001|Overall Study|Withdrawal by Subject|0|||
125986456|NCT01287520|453242985|FG002|Overall Study|Withdrawal by Subject|0|||
125986457|NCT01287520|453242986|FG003|Overall Study|Withdrawal by Subject|0|||
125986458|NCT01287520|453242987|FG004|Overall Study|Withdrawal by Subject|0|||
125986459|NCT01287520|453242988|FG005|Overall Study|Withdrawal by Subject|1|||
125986460|NCT01287520|453242989|FG006|Overall Study|Withdrawal by Subject|0|||
125986461|NCT01287520|453242990|FG007|Overall Study|Withdrawal by Subject|0|||
125986462|NCT01287520|453242991|FG008|Overall Study|Withdrawal by Subject|1|||
125986463|NCT03587142|453242992|FG000|Overall Study|Lost to Follow-up|5|||
125986464|NCT03587142|453242993|FG001|Overall Study|Lost to Follow-up|3|||
125986465|NCT03587142|453242992|FG000|Overall Study|Did not complete the f4 visit|3|||
125986466|NCT03587142|453242993|FG001|Overall Study|Did not complete the f4 visit|7|||
125986467|NCT02768662|453242994|FG000|Overall Study|Adverse Event|1|||
125986468|NCT02768662|453242994|FG000|Overall Study|Lost to Follow-up|4|||
125986469|NCT02768662|453242994|FG000|Overall Study|Withdrawal by Subject|3|||
125986470|NCT02768662|453242994|FG000|Overall Study|Study terminated by Sponsor|78|||
125986471|NCT03673462|453242995|FG000|Overall Study|Adverse Event|11|||
125986472|NCT03673462|453242996|FG001|Overall Study|Adverse Event|1|||
125986473|NCT03673462|453242995|FG000|Overall Study|Protocol Violation|25|||
125986474|NCT03673462|453242996|FG001|Overall Study|Protocol Violation|11|||
125986475|NCT03673462|453242995|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
125986476|NCT03673462|453242996|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
125986477|NCT03673462|453242995|FG000|Overall Study|Lost to Follow-up|102|||
125986478|NCT03673462|453242996|FG001|Overall Study|Lost to Follow-up|19|||
125986479|NCT00708435|453242997|FG000|Overall Study|Death / Serious Adverse Event|10|||
125986480|NCT00708435|453242998|FG001|Overall Study|Death / Serious Adverse Event|5|||
125986481|NCT00708435|453242997|FG000|Overall Study|Lost to Follow-up|9|||
125986482|NCT00708435|453242998|FG001|Overall Study|Lost to Follow-up|4|||
125986483|NCT00708435|453242997|FG000|Overall Study|Withdrawal by Subject|3|||
125986484|NCT00708435|453242998|FG001|Overall Study|Withdrawal by Subject|7|||
125986485|NCT00708435|453242997|FG000|Overall Study|Adverse Event|1|||
125986486|NCT00708435|453242998|FG001|Overall Study|Adverse Event|0|||
125986487|NCT00708435|453242997|FG000|Overall Study|Protocol Violation|0|||
125986488|NCT00708435|453242998|FG001|Overall Study|Protocol Violation|1|||
125986489|NCT00708435|453242997|FG000|Overall Study|Intervention by primary care physician|1|||
125986490|NCT00708435|453242998|FG001|Overall Study|Intervention by primary care physician|0|||
125986491|NCT00708435|453242997|FG000|Overall Study|Refused hospitalization|1|||
125986492|NCT00708435|453242998|FG001|Overall Study|Refused hospitalization|0|||
125986493|NCT03502616|453243001|FG000|Up to Week 16|Withdrawal by Subject|1|||
125986494|NCT03502616|453243002|FG001|Up to Week 16|Withdrawal by Subject|2|||
125986495|NCT03502616|453243001|FG000|Up to Week 16|Lost to Follow-up|0|||
125986496|NCT03502616|453243002|FG001|Up to Week 16|Lost to Follow-up|1|||
125986497|NCT03502616|453243001|FG000|Up to Week 16|Randomized, but not treated|1|||
125986498|NCT03502616|453243002|FG001|Up to Week 16|Randomized, but not treated|0|||
125986499|NCT03502616|453243001|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
125986500|NCT03502616|453243002|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
125986501|NCT03502616|453243001|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
125986502|NCT03502616|453243002|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
125986503|NCT00770432|453243007|FG000|Overall Study|Other|4|||
125986504|NCT00770432|453243008|FG001|Overall Study|Other|6|||
125986505|NCT00770432|453243007|FG000|Overall Study|Non-compliance|0|||
125986506|NCT00770432|453243008|FG001|Overall Study|Non-compliance|1|||
125986507|NCT00988221|453243011|FG000|Part I|Adverse Event|0|||
125986508|NCT00988221|453243012|FG001|Part I|Adverse Event|1|||
125986509|NCT00988221|453243013|FG002|Part I|Adverse Event|2|||
125986510|NCT00988221|453243014|FG003|Part I|Adverse Event|0|||
125986511|NCT00988221|453243011|FG000|Part I|Insufficient Therapeutic Response|4|||
125986512|NCT00988221|453243012|FG001|Part I|Insufficient Therapeutic Response|6|||
125986513|NCT00988221|453243013|FG002|Part I|Insufficient Therapeutic Response|5|||
125986514|NCT00988221|453243014|FG003|Part I|Insufficient Therapeutic Response|0|||
125986515|NCT00988221|453243011|FG000|Part I|Refused Treatment|0|||
125986516|NCT00988221|453243012|FG001|Part I|Refused Treatment|2|||
125986517|NCT00988221|453243013|FG002|Part I|Refused Treatment|1|||
125986518|NCT00988221|453243014|FG003|Part I|Refused Treatment|0|||
125986519|NCT00988221|453243011|FG000|Part I|Lost to Follow-up|0|||
125986520|NCT00988221|453243012|FG001|Part I|Lost to Follow-up|1|||
125986521|NCT00988221|453243013|FG002|Part I|Lost to Follow-up|0|||
125986522|NCT00988221|453243014|FG003|Part I|Lost to Follow-up|0|||
125986523|NCT00988221|453243011|FG000|Part II|Adverse Event|1|||
125986524|NCT00988221|453243012|FG001|Part II|Adverse Event|0|||
125986525|NCT00988221|453243013|FG002|Part II|Adverse Event|0|||
125986526|NCT00988221|453243014|FG003|Part II|Adverse Event|1|||
125986527|NCT00988221|453243011|FG000|Part II|Withdrawal by Subject|0|||
125986528|NCT00988221|453243012|FG001|Part II|Withdrawal by Subject|0|||
125986529|NCT00988221|453243013|FG002|Part II|Withdrawal by Subject|2|||
125986530|NCT00988221|453243014|FG003|Part II|Withdrawal by Subject|2|||
125986531|NCT00988221|453243011|FG000|Part II|Reason not Specified|0|||
125986532|NCT00988221|453243012|FG001|Part II|Reason not Specified|0|||
125986533|NCT00988221|453243013|FG002|Part II|Reason not Specified|1|||
125986534|NCT00988221|453243014|FG003|Part II|Reason not Specified|0|||
125986535|NCT00988221|453243011|FG000|Part III|Adverse Event|1|||
125986536|NCT00988221|453243012|FG001|Part III|Adverse Event|0|||
125986537|NCT00988221|453243013|FG002|Part III|Adverse Event|1|||
125986538|NCT00988221|453243014|FG003|Part III|Adverse Event|0|||
125986539|NCT00988221|453243011|FG000|Part III|Insufficient Therapeutic Response|0|||
125986540|NCT00988221|453243012|FG001|Part III|Insufficient Therapeutic Response|1|||
125986541|NCT00988221|453243013|FG002|Part III|Insufficient Therapeutic Response|1|||
125986542|NCT00988221|453243014|FG003|Part III|Insufficient Therapeutic Response|0|||
125986543|NCT00988221|453243011|FG000|Part III|Refused Treatment|0|||
125986544|NCT00988221|453243012|FG001|Part III|Refused Treatment|0|||
125986545|NCT00988221|453243013|FG002|Part III|Refused Treatment|1|||
125986546|NCT00988221|453243014|FG003|Part III|Refused Treatment|0|||
126326469|NCT05052697|454488391|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986547|NCT02756832|453243017|FG000|Overall Study|Lost for Observation after Baseline|6|||
125986548|NCT02756832|453243017|FG000|Overall Study|Lost for Observation|13|||
125986549|NCT02756832|453243017|FG000|Overall Study|Patient's Unwillingness|12|||
125986550|NCT02756832|453243017|FG000|Overall Study|Insufficient Efficacy|2|||
125986551|NCT02756832|453243017|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
125986552|NCT02756832|453243017|FG000|Overall Study|Reason not Specified|9|||
125986553|NCT02756832|453243017|FG000|Overall Study|Protocol Deviation|10|||
125986554|NCT01364597|453243018|FG000|Overall Study|Adverse Event|4|||
125986555|NCT01364597|453243019|FG001|Overall Study|Adverse Event|5|||
125986556|NCT01364597|453243020|FG002|Overall Study|Adverse Event|16|||
125986557|NCT01364597|453243021|FG003|Overall Study|Adverse Event|7|||
125986558|NCT01364597|453243018|FG000|Overall Study|Lack of Efficacy|4|||
125986559|NCT01364597|453243019|FG001|Overall Study|Lack of Efficacy|4|||
125986560|NCT01364597|453243020|FG002|Overall Study|Lack of Efficacy|23|||
125986561|NCT01364597|453243021|FG003|Overall Study|Lack of Efficacy|8|||
125986562|NCT01364597|453243018|FG000|Overall Study|Protocol Violation|0|||
125986563|NCT01364597|453243019|FG001|Overall Study|Protocol Violation|0|||
125986564|NCT01364597|453243020|FG002|Overall Study|Protocol Violation|2|||
125986565|NCT01364597|453243021|FG003|Overall Study|Protocol Violation|0|||
125986566|NCT01364597|453243018|FG000|Overall Study|Lost to Follow-up|0|||
125986567|NCT01364597|453243019|FG001|Overall Study|Lost to Follow-up|0|||
125986568|NCT01364597|453243020|FG002|Overall Study|Lost to Follow-up|5|||
125986569|NCT01364597|453243021|FG003|Overall Study|Lost to Follow-up|3|||
125986570|NCT01364597|453243018|FG000|Overall Study|Withdrawal by Subject|4|||
125986571|NCT01364597|453243019|FG001|Overall Study|Withdrawal by Subject|1|||
125986572|NCT01364597|453243020|FG002|Overall Study|Withdrawal by Subject|18|||
125986573|NCT01364597|453243021|FG003|Overall Study|Withdrawal by Subject|6|||
125986574|NCT01364597|453243018|FG000|Overall Study|Non compliance|1|||
125986575|NCT01364597|453243019|FG001|Overall Study|Non compliance|0|||
125986576|NCT01364597|453243020|FG002|Overall Study|Non compliance|1|||
125986577|NCT01364597|453243021|FG003|Overall Study|Non compliance|0|||
125986578|NCT01364597|453243018|FG000|Overall Study|Lack of compliance|1|||
125986579|NCT01364597|453243019|FG001|Overall Study|Lack of compliance|0|||
125986580|NCT01364597|453243020|FG002|Overall Study|Lack of compliance|0|||
125986581|NCT01364597|453243021|FG003|Overall Study|Lack of compliance|0|||
125986582|NCT01364597|453243018|FG000|Overall Study|End of treatment epilepsy|1|||
125986583|NCT01364597|453243019|FG001|Overall Study|End of treatment epilepsy|0|||
125986584|NCT01364597|453243020|FG002|Overall Study|End of treatment epilepsy|0|||
125986585|NCT01364597|453243021|FG003|Overall Study|End of treatment epilepsy|0|||
125986586|NCT01364597|453243018|FG000|Overall Study|No Seizures|1|||
125986587|NCT01364597|453243019|FG001|Overall Study|No Seizures|0|||
125986588|NCT01364597|453243020|FG002|Overall Study|No Seizures|0|||
125986589|NCT01364597|453243021|FG003|Overall Study|No Seizures|0|||
125986590|NCT01364597|453243018|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
125986591|NCT01364597|453243019|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
125986592|NCT01364597|453243020|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
125986593|NCT01364597|453243021|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
125986594|NCT01364597|453243018|FG000|Overall Study|Cure|1|||
125986595|NCT01364597|453243019|FG001|Overall Study|Cure|0|||
125986596|NCT01364597|453243020|FG002|Overall Study|Cure|0|||
125986597|NCT01364597|453243021|FG003|Overall Study|Cure|0|||
125986598|NCT01364597|453243018|FG000|Overall Study|Patient was moving|0|||
125986599|NCT01364597|453243019|FG001|Overall Study|Patient was moving|1|||
125986600|NCT01364597|453243020|FG002|Overall Study|Patient was moving|0|||
125986601|NCT01364597|453243021|FG003|Overall Study|Patient was moving|0|||
125986602|NCT01364597|453243018|FG000|Overall Study|Seizures resolved|0|||
125986603|NCT01364597|453243019|FG001|Overall Study|Seizures resolved|0|||
125986604|NCT01364597|453243020|FG002|Overall Study|Seizures resolved|1|||
125986605|NCT01364597|453243021|FG003|Overall Study|Seizures resolved|0|||
125986606|NCT01364597|453243018|FG000|Overall Study|Patient became seizure-free after surgery|0|||
125986607|NCT01364597|453243019|FG001|Overall Study|Patient became seizure-free after surgery|0|||
125986608|NCT01364597|453243020|FG002|Overall Study|Patient became seizure-free after surgery|1|||
125986609|NCT01364597|453243021|FG003|Overall Study|Patient became seizure-free after surgery|0|||
125986610|NCT01364597|453243018|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
125986611|NCT01364597|453243019|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
125986612|NCT01364597|453243020|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
125986613|NCT01364597|453243021|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
125986614|NCT01364597|453243018|FG000|Overall Study|Patient cured from Epilepsy|0|||
125986615|NCT01364597|453243019|FG001|Overall Study|Patient cured from Epilepsy|0|||
125986616|NCT01364597|453243020|FG002|Overall Study|Patient cured from Epilepsy|1|||
126326470|NCT05052697|454488392|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326471|NCT05052697|454488393|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986617|NCT01364597|453243021|FG003|Overall Study|Patient cured from Epilepsy|0|||
125986618|NCT01364597|453243018|FG000|Overall Study|Investigator decision|0|||
125986619|NCT01364597|453243019|FG001|Overall Study|Investigator decision|0|||
125986620|NCT01364597|453243020|FG002|Overall Study|Investigator decision|1|||
125986621|NCT01364597|453243021|FG003|Overall Study|Investigator decision|0|||
125986622|NCT01364597|453243018|FG000|Overall Study|Sponsor recommended discontinuation|0|||
125986623|NCT01364597|453243019|FG001|Overall Study|Sponsor recommended discontinuation|0|||
125986624|NCT01364597|453243020|FG002|Overall Study|Sponsor recommended discontinuation|0|||
125986625|NCT01364597|453243021|FG003|Overall Study|Sponsor recommended discontinuation|1|||
126209075|NCT02255422|454053143|FG000|Overall Study|Lost to Follow-up|0|||
126326472|NCT05052697|454488394|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986626|NCT01364597|453243018|FG000|Overall Study|Parents went abroad with the patient|0|||
125986627|NCT01364597|453243019|FG001|Overall Study|Parents went abroad with the patient|0|||
125986628|NCT01364597|453243020|FG002|Overall Study|Parents went abroad with the patient|1|||
125986629|NCT01364597|453243021|FG003|Overall Study|Parents went abroad with the patient|0|||
125986630|NCT01364597|453243018|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
125986631|NCT01364597|453243019|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
125986632|NCT01364597|453243020|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
125986633|NCT01364597|453243021|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
125986634|NCT01364597|453243018|FG000|Overall Study|BRV administration dropout|0|||
125986635|NCT01364597|453243019|FG001|Overall Study|BRV administration dropout|0|||
125986636|NCT01364597|453243020|FG002|Overall Study|BRV administration dropout|1|||
125986637|NCT01364597|453243021|FG003|Overall Study|BRV administration dropout|0|||
125986638|NCT01364597|453243018|FG000|Overall Study|Dropout|0|||
125986639|NCT01364597|453243019|FG001|Overall Study|Dropout|0|||
125986640|NCT01364597|453243020|FG002|Overall Study|Dropout|3|||
125986641|NCT01364597|453243021|FG003|Overall Study|Dropout|1|||
125986642|NCT01364597|453243018|FG000|Overall Study|Unreliable subject|0|||
125986643|NCT01364597|453243019|FG001|Overall Study|Unreliable subject|0|||
125986644|NCT01364597|453243020|FG002|Overall Study|Unreliable subject|0|||
125986645|NCT01364597|453243021|FG003|Overall Study|Unreliable subject|1|||
125986646|NCT01364597|453243018|FG000|Overall Study|Other|0|||
125986647|NCT01364597|453243019|FG001|Overall Study|Other|0|||
125986648|NCT01364597|453243020|FG002|Overall Study|Other|0|||
125986649|NCT01364597|453243021|FG003|Overall Study|Other|1|||
125986650|NCT01498822|453243022|FG000|Overall Study|Protocol Violation|8|||
125986651|NCT01498822|453243023|FG001|Overall Study|Protocol Violation|4|||
125986652|NCT01498822|453243022|FG000|Overall Study|Other Reason|5|||
125986653|NCT01498822|453243023|FG001|Overall Study|Other Reason|2|||
125986654|NCT01498822|453243022|FG000|Overall Study|Lack of Efficacy|7|||
125986655|NCT01498822|453243023|FG001|Overall Study|Lack of Efficacy|2|||
125986656|NCT01498822|453243022|FG000|Overall Study|AE, non-serious non-fatal|8|||
125986657|NCT01498822|453243023|FG001|Overall Study|AE, non-serious non-fatal|17|||
125986658|NCT01498822|453243022|FG000|Overall Study|SAE, non-fatal|2|||
125986659|NCT01498822|453243023|FG001|Overall Study|SAE, non-fatal|2|||
125986660|NCT01498822|453243022|FG000|Overall Study|Adverse Event, serious fatal|1|||
125986661|NCT01498822|453243023|FG001|Overall Study|Adverse Event, serious fatal|1|||
125986662|NCT01498822|453243022|FG000|Overall Study|Withdrawal by Subject|15|||
125986663|NCT01498822|453243023|FG001|Overall Study|Withdrawal by Subject|25|||
125986664|NCT01498822|453243022|FG000|Overall Study|Lost to Follow-up|8|||
125986665|NCT01498822|453243023|FG001|Overall Study|Lost to Follow-up|3|||
125986666|NCT03579290|453243031|FG000|Overall Study|Lost to Follow-up|9|||
125986667|NCT03131960|453243034|FG000|Overall Study|Adverse Event|0|||
125986668|NCT03131960|453243035|FG001|Overall Study|Adverse Event|1|||
125986669|NCT01781390|453243036|FG000|Overall Study|Withdrawal of Consent|0|||
125986670|NCT01781390|453243037|FG001|Overall Study|Withdrawal of Consent|3|||
125986671|NCT01781390|453243038|FG002|Overall Study|Withdrawal of Consent|1|||
125986672|NCT01781390|453243036|FG000|Overall Study|Lost to Follow-up|1|||
125986673|NCT01781390|453243037|FG001|Overall Study|Lost to Follow-up|1|||
125986674|NCT01781390|453243038|FG002|Overall Study|Lost to Follow-up|1|||
125986675|NCT01781390|453243036|FG000|Overall Study|Adverse Event|1|||
125986676|NCT01781390|453243037|FG001|Overall Study|Adverse Event|2|||
125986677|NCT01781390|453243038|FG002|Overall Study|Adverse Event|1|||
125986678|NCT01781390|453243036|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
125986679|NCT01781390|453243037|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
125986680|NCT01781390|453243038|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
125986681|NCT04404478|453243040|FG000|Overall Study|Withdrawal by Subject|1|||
125986682|NCT04404478|453243041|FG001|Overall Study|Withdrawal by Subject|3|||
125986683|NCT02904902|453243042|FG000|Overall Study|Withdrawal by Subject|1|||
125986684|NCT01216163|453243046|FG000|Overall Study|Withdrawal by Subject|1|||
125986685|NCT01216163|453243047|FG001|Overall Study|Withdrawal by Subject|1|||
125986686|NCT01216163|453243048|FG002|Overall Study|Withdrawal by Subject|0|||
125986687|NCT02002182|453243051|FG000|Overall Study|Withdraw from study|3|||
125986688|NCT02002182|453243052|FG001|Overall Study|Withdraw from study|1|||
125986689|NCT02002182|453243051|FG000|Overall Study|Health Reasons|1|||
125986690|NCT02002182|453243052|FG001|Overall Study|Health Reasons|0|||
125986691|NCT02002182|453243051|FG000|Overall Study|Death|1|||
125986692|NCT02002182|453243052|FG001|Overall Study|Death|0|||
125986693|NCT01597505|453243055|FG000|Overall Study|Physician Decision|5|||
126326473|NCT05052697|454488395|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326474|NCT05052697|454488396|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986694|NCT01597505|453243056|FG001|Overall Study|Physician Decision|0|||
125986695|NCT01597505|453243055|FG000|Overall Study|Adverse Event|19|||
125986696|NCT01597505|453243056|FG001|Overall Study|Adverse Event|7|||
125986697|NCT01597505|453243055|FG000|Overall Study|Lost to Follow-up|4|||
125986698|NCT01597505|453243056|FG001|Overall Study|Lost to Follow-up|2|||
125986699|NCT01597505|453243055|FG000|Overall Study|Withdrawal by Subject|10|||
125986700|NCT01597505|453243056|FG001|Overall Study|Withdrawal by Subject|18|||
125986701|NCT01597505|453243055|FG000|Overall Study|Other|5|||
125986702|NCT01597505|453243056|FG001|Overall Study|Other|6|||
125986703|NCT01597505|453243055|FG000|Overall Study|Missing|1|||
125986704|NCT01597505|453243056|FG001|Overall Study|Missing|0|||
125986705|NCT03879408|453243066|FG000|Overall Study|Lost to Follow-up|0|||
125986706|NCT03879408|453243067|FG001|Overall Study|Lost to Follow-up|3|||
125986707|NCT03879408|453243068|FG002|Overall Study|Lost to Follow-up|2|||
125986708|NCT03879408|453243069|FG003|Overall Study|Lost to Follow-up|1|||
125986709|NCT03879408|453243070|FG004|Overall Study|Lost to Follow-up|0|||
125986710|NCT03879408|453243066|FG000|Overall Study|Withdrawal by Subject|2|||
125986711|NCT03879408|453243067|FG001|Overall Study|Withdrawal by Subject|1|||
125986712|NCT03879408|453243068|FG002|Overall Study|Withdrawal by Subject|1|||
125986713|NCT03879408|453243069|FG003|Overall Study|Withdrawal by Subject|0|||
125986714|NCT03879408|453243070|FG004|Overall Study|Withdrawal by Subject|1|||
125986715|NCT00728962|453243071|FG000|Implant Placement Surgery|Adverse Event|8|||
125986716|NCT00728962|453243071|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
125986717|NCT00728962|453243071|FG000|Implant Placement Surgery|Protocol Violation|1|||
125986718|NCT00728962|453243071|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
125986719|NCT00728962|453243071|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
125986720|NCT05807919|453243072|FG000|Overall Study|Received antibiotics - excluded|0|||
125986721|NCT05807919|453243073|FG001|Overall Study|Received antibiotics - excluded|1|||
125986722|NCT05807919|453243072|FG000|Overall Study|Withdrawal by Subject|0|||
125986723|NCT05807919|453243073|FG001|Overall Study|Withdrawal by Subject|3|||
125986724|NCT05807919|453243072|FG000|Overall Study|Adverse Event|1|||
125986725|NCT05807919|453243073|FG001|Overall Study|Adverse Event|1|||
125986726|NCT02739347|453243078|FG000|Overall Study|Adverse Event|3|||
125986727|NCT02739347|453243079|FG001|Overall Study|Adverse Event|0|||
125986728|NCT02739347|453243078|FG000|Overall Study|Protocol Violation|0|||
125986729|NCT02739347|453243079|FG001|Overall Study|Protocol Violation|1|||
125986730|NCT02739347|453243078|FG000|Overall Study|Lost to Follow-up|0|||
125986731|NCT02739347|453243079|FG001|Overall Study|Lost to Follow-up|2|||
125986732|NCT01931735|453243080|FG000|Randomized Phase|Lost to Follow-up|2|||
125986733|NCT01931735|453243081|FG001|Randomized Phase|Lost to Follow-up|2|||
125986734|NCT01931735|453243082|FG002|Randomized Phase|Lost to Follow-up|5|||
125986735|NCT01931735|453243083|FG003|Randomized Phase|Lost to Follow-up|0|||
125986736|NCT01931735|453243080|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
125986737|NCT01931735|453243081|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
125986738|NCT01931735|453243082|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
125986739|NCT01931735|453243083|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
125986740|NCT01931735|453243080|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
125986741|NCT01931735|453243081|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
125986742|NCT01931735|453243082|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
125986743|NCT01931735|453243083|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
125986744|NCT02552238|453243088|FG000|Overall Study|Withdrawal by Subject|2|||
125986745|NCT02552238|453243088|FG000|Overall Study|Adverse Event|2|||
125986746|NCT05158296|453243089|FG000|Overall Study|Sponsor Decision|2|||
125986747|NCT05158296|453243090|FG001|Overall Study|Sponsor Decision|3|||
125986748|NCT05158296|453243091|FG002|Overall Study|Sponsor Decision|2|||
125986749|NCT02036645|453243094|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986750|NCT02036645|453243095|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986751|NCT02036645|453243096|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986752|NCT02036645|453243097|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986753|NCT02036645|453243098|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986754|NCT02036645|453243099|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986755|NCT02036645|453243100|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
125986756|NCT02036645|453243101|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986757|NCT02036645|453243102|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986758|NCT02036645|453243103|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986759|NCT02036645|453243104|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986760|NCT02036645|453243105|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125986761|NCT02036645|453243094|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986762|NCT02036645|453243095|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986763|NCT02036645|453243096|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986764|NCT02036645|453243097|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
125986765|NCT02036645|453243098|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986766|NCT02036645|453243099|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986767|NCT02036645|453243100|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986768|NCT02036645|453243101|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986769|NCT02036645|453243102|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986770|NCT02036645|453243103|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986771|NCT02036645|453243104|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986772|NCT02036645|453243105|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125986773|NCT01778556|453243109|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
125986774|NCT01778556|453243110|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
126090991|NCT03525392|453626874|FG000|Overall Study|Progressive disease|0|||
126326475|NCT05052697|454488397|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326476|NCT05052697|454488398|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326477|NCT05052697|454488399|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326478|NCT05052697|454488400|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326479|NCT05052697|454488401|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326480|NCT05052697|454488402|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986775|NCT01778556|453243109|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125986776|NCT01778556|453243110|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
125986777|NCT01778556|453243109|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
125986778|NCT01778556|453243110|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
125986779|NCT01778556|453243109|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
125986780|NCT01778556|453243110|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
125986781|NCT02404389|453243111|FG000|Overall Study|Adverse Event|1|||
125986782|NCT02404389|453243112|FG001|Overall Study|Adverse Event|0|||
125986783|NCT02404389|453243113|FG002|Overall Study|Adverse Event|1|||
125986784|NCT02404389|453243114|FG003|Overall Study|Adverse Event|0|||
125986785|NCT02404389|453243115|FG004|Overall Study|Adverse Event|2|||
125986786|NCT02404389|453243111|FG000|Overall Study|Subject/guardian decision|1|||
125986787|NCT02404389|453243112|FG001|Overall Study|Subject/guardian decision|0|||
125986788|NCT02404389|453243113|FG002|Overall Study|Subject/guardian decision|0|||
125986789|NCT02404389|453243114|FG003|Overall Study|Subject/guardian decision|1|||
125986790|NCT02404389|453243115|FG004|Overall Study|Subject/guardian decision|1|||
125986791|NCT03324880|453243116|FG000|Overall Study|Adverse Event|0|||
125986792|NCT03324880|453243117|FG001|Overall Study|Adverse Event|2|||
125986793|NCT03324880|453243116|FG000|Overall Study|Withdrawal by Subject|2|||
125986794|NCT03324880|453243117|FG001|Overall Study|Withdrawal by Subject|2|||
125986795|NCT03324880|453243116|FG000|Overall Study|Lost to Follow-up|0|||
125986796|NCT03324880|453243117|FG001|Overall Study|Lost to Follow-up|1|||
125986797|NCT03324880|453243116|FG000|Overall Study|Product Recall|0|||
125986798|NCT03324880|453243117|FG001|Overall Study|Product Recall|1|||
125986799|NCT01412801|453243121|FG000|Overall Study|Death|0|||
125986800|NCT01412801|453243122|FG001|Overall Study|Death|1|||
125986801|NCT01412801|453243123|FG002|Overall Study|Death|0|||
125986802|NCT01412801|453243124|FG003|Overall Study|Death|4|||
125986803|NCT01412801|453243125|FG004|Overall Study|Death|2|||
125986804|NCT01412801|453243126|FG005|Overall Study|Death|2|||
125986805|NCT01412801|453243121|FG000|Overall Study|Lost to Follow-up|1|||
125986806|NCT01412801|453243122|FG001|Overall Study|Lost to Follow-up|2|||
125986807|NCT01412801|453243123|FG002|Overall Study|Lost to Follow-up|4|||
125986808|NCT01412801|453243124|FG003|Overall Study|Lost to Follow-up|0|||
125986809|NCT01412801|453243125|FG004|Overall Study|Lost to Follow-up|1|||
125986810|NCT01412801|453243126|FG005|Overall Study|Lost to Follow-up|1|||
125986811|NCT01412801|453243121|FG000|Overall Study|Withdrawal by Subject|3|||
125986812|NCT01412801|453243122|FG001|Overall Study|Withdrawal by Subject|2|||
125986813|NCT01412801|453243123|FG002|Overall Study|Withdrawal by Subject|1|||
125986814|NCT01412801|453243124|FG003|Overall Study|Withdrawal by Subject|0|||
125986815|NCT01412801|453243125|FG004|Overall Study|Withdrawal by Subject|0|||
125986816|NCT01412801|453243126|FG005|Overall Study|Withdrawal by Subject|0|||
125986817|NCT01412801|453243121|FG000|Overall Study|Relocated to another area|0|||
125986818|NCT01412801|453243122|FG001|Overall Study|Relocated to another area|0|||
125986819|NCT01412801|453243123|FG002|Overall Study|Relocated to another area|2|||
125986820|NCT01412801|453243124|FG003|Overall Study|Relocated to another area|0|||
125986821|NCT01412801|453243125|FG004|Overall Study|Relocated to another area|0|||
125986822|NCT01412801|453243126|FG005|Overall Study|Relocated to another area|0|||
125986823|NCT03300570|453243127|FG000|Overall Study|Adverse Event|0|||
125986824|NCT03300570|453243128|FG001|Overall Study|Adverse Event|1|||
125986825|NCT03300570|453243127|FG000|Overall Study|Withdrawal by Subject|1|||
125986826|NCT03300570|453243128|FG001|Overall Study|Withdrawal by Subject|0|||
125986827|NCT03300570|453243127|FG000|Overall Study|Inadequate bowel prep|1|||
125986828|NCT03300570|453243128|FG001|Overall Study|Inadequate bowel prep|0|||
125986829|NCT00116272|453243129|FG000|Overall Study|Lost to Follow-up|11|||
125986830|NCT00116272|453243130|FG001|Overall Study|Lost to Follow-up|6|||
125986831|NCT03188120|453243132|FG000|Overall Study|Adverse Event|4|||
125986832|NCT03188120|453243132|FG000|Overall Study|Insufficient Effectiveness|8|||
125986833|NCT03188120|453243132|FG000|Overall Study|Improved|12|||
125986834|NCT03188120|453243132|FG000|Overall Study|Lost to Follow-up|7|||
125986835|NCT03188120|453243132|FG000|Overall Study|Other than specified|3|||
125986836|NCT03188120|453243132|FG000|Overall Study|No visit after the first visit|13|||
125986837|NCT01235403|453243135|FG000|Overall Study|Adverse Event|14|||
125986838|NCT01235403|453243135|FG000|Overall Study|Lost to Follow-up|2|||
125986839|NCT01235403|453243135|FG000|Overall Study|Withdrawal by Subject|4|||
125986840|NCT01235403|453243135|FG000|Overall Study|Lack of Efficacy|2|||
125986841|NCT01235403|453243135|FG000|Overall Study|Other reasons for premature termination|4|||
125986842|NCT02296190|453243136|FG000|Overall Study|Lost to Follow-up|0|||
125986843|NCT02296190|453243137|FG001|Overall Study|Lost to Follow-up|0|||
125986844|NCT02296190|453243138|FG002|Overall Study|Lost to Follow-up|0|||
125986845|NCT02296190|453243139|FG003|Overall Study|Lost to Follow-up|0|||
125986846|NCT02296190|453243140|FG004|Overall Study|Lost to Follow-up|1|||
125986847|NCT02296190|453243141|FG005|Overall Study|Lost to Follow-up|0|||
125986848|NCT02296190|453243136|FG000|Overall Study|Failure to induce PSVT|6|||
125986849|NCT02296190|453243137|FG001|Overall Study|Failure to induce PSVT|10|||
125986850|NCT02296190|453243138|FG002|Overall Study|Failure to induce PSVT|5|||
125986851|NCT02296190|453243139|FG003|Overall Study|Failure to induce PSVT|13|||
125986852|NCT02296190|453243140|FG004|Overall Study|Failure to induce PSVT|8|||
125986853|NCT02296190|453243141|FG005|Overall Study|Failure to induce PSVT|0|||
125986854|NCT02296190|453243136|FG000|Overall Study|Physician Decision|1|||
125986855|NCT02296190|453243137|FG001|Overall Study|Physician Decision|1|||
125986856|NCT02296190|453243138|FG002|Overall Study|Physician Decision|0|||
125986857|NCT02296190|453243139|FG003|Overall Study|Physician Decision|1|||
125986858|NCT02296190|453243140|FG004|Overall Study|Physician Decision|2|||
125986859|NCT02296190|453243141|FG005|Overall Study|Physician Decision|0|||
125986860|NCT02296190|453243136|FG000|Overall Study|Withdrawal by Subject|0|||
125986861|NCT02296190|453243137|FG001|Overall Study|Withdrawal by Subject|1|||
125986862|NCT02296190|453243138|FG002|Overall Study|Withdrawal by Subject|0|||
125986863|NCT02296190|453243139|FG003|Overall Study|Withdrawal by Subject|0|||
125986864|NCT02296190|453243140|FG004|Overall Study|Withdrawal by Subject|0|||
125986865|NCT02296190|453243141|FG005|Overall Study|Withdrawal by Subject|0|||
125986866|NCT02296190|453243136|FG000|Overall Study|PSVT < 5 minutes|5|||
125986867|NCT02296190|453243137|FG001|Overall Study|PSVT < 5 minutes|6|||
125986868|NCT02296190|453243138|FG002|Overall Study|PSVT < 5 minutes|6|||
125986869|NCT02296190|453243139|FG003|Overall Study|PSVT < 5 minutes|6|||
125986870|NCT02296190|453243140|FG004|Overall Study|PSVT < 5 minutes|5|||
125986871|NCT02296190|453243141|FG005|Overall Study|PSVT < 5 minutes|0|||
125986872|NCT02296190|453243136|FG000|Overall Study|Patient was given Propofol|0|||
125986873|NCT02296190|453243137|FG001|Overall Study|Patient was given Propofol|1|||
125986874|NCT02296190|453243138|FG002|Overall Study|Patient was given Propofol|0|||
125986875|NCT02296190|453243139|FG003|Overall Study|Patient was given Propofol|1|||
125986876|NCT02296190|453243140|FG004|Overall Study|Patient was given Propofol|0|||
125986877|NCT02296190|453243141|FG005|Overall Study|Patient was given Propofol|0|||
125986878|NCT02296190|453243136|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
125986879|NCT02296190|453243137|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
125986880|NCT02296190|453243138|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
125986881|NCT02296190|453243139|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
125986882|NCT02296190|453243140|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
125986883|NCT02296190|453243141|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
125986884|NCT02296190|453243136|FG000|Overall Study|Blood pressure <100 after sedation|0|||
125986885|NCT02296190|453243137|FG001|Overall Study|Blood pressure <100 after sedation|0|||
125986886|NCT02296190|453243138|FG002|Overall Study|Blood pressure <100 after sedation|0|||
125986887|NCT02296190|453243139|FG003|Overall Study|Blood pressure <100 after sedation|1|||
125986888|NCT02296190|453243140|FG004|Overall Study|Blood pressure <100 after sedation|0|||
125986889|NCT02296190|453243141|FG005|Overall Study|Blood pressure <100 after sedation|0|||
125986890|NCT02296190|453243136|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125986891|NCT02296190|453243137|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
125986892|NCT02296190|453243138|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
125986893|NCT02296190|453243139|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125986894|NCT02296190|453243140|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125986895|NCT02296190|453243141|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125986896|NCT02296190|453243136|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
125986897|NCT02296190|453243137|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
125986898|NCT02296190|453243138|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
125986899|NCT02296190|453243139|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
125986900|NCT02296190|453243140|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
125986901|NCT02296190|453243141|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
125986902|NCT02296190|453243136|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125986903|NCT02296190|453243137|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
125986904|NCT02296190|453243138|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125986905|NCT02296190|453243139|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125986906|NCT02296190|453243140|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125986907|NCT02296190|453243141|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125986908|NCT02296190|453243136|FG000|Overall Study|Lab result not available in time|1|||
125986909|NCT02296190|453243137|FG001|Overall Study|Lab result not available in time|0|||
125986910|NCT02296190|453243138|FG002|Overall Study|Lab result not available in time|0|||
125986911|NCT02296190|453243139|FG003|Overall Study|Lab result not available in time|0|||
125986912|NCT02296190|453243140|FG004|Overall Study|Lab result not available in time|0|||
125986913|NCT02296190|453243141|FG005|Overall Study|Lab result not available in time|0|||
125986914|NCT02978443|453243142|FG000|Overall Study|Withdrawal by Subject|1|||
125986915|NCT02978443|453243142|FG000|Overall Study|Adverse Event|3|||
126326481|NCT05052697|454488403|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125986916|NCT02978443|453243142|FG000|Overall Study|Disease Progression on study|6|||
125986917|NCT02978443|453243142|FG000|Overall Study|Death|1|||
125986918|NCT02978443|453243142|FG000|Overall Study|Physician Decision|1|||
125986919|NCT02978443|453243142|FG000|Overall Study|Switch to alternative therapy|1|||
125986920|NCT02978443|453243142|FG000|Overall Study|Refused further treatment|1|||
125986921|NCT00782496|453243143|FG000|Overall Study|Lost to Follow-up|14|||
125986922|NCT00782496|453243144|FG001|Overall Study|Lost to Follow-up|15|||
125986923|NCT01987817|453243147|FG000|Overall Study|Adverse Event|4|||
125986924|NCT01987817|453243148|FG001|Overall Study|Adverse Event|0|||
125986925|NCT01987817|453243147|FG000|Overall Study|Withdrawal by Subject|1|||
125986926|NCT01987817|453243148|FG001|Overall Study|Withdrawal by Subject|1|||
125986927|NCT01987817|453243147|FG000|Overall Study|Physician Decision|1|||
125986928|NCT01987817|453243148|FG001|Overall Study|Physician Decision|0|||
125986929|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
125986930|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
125986931|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
125986932|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
125986933|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
125986934|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
125986935|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
125986936|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
125986937|NCT01336621|453243149|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
125986938|NCT01336621|453243149|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
125986939|NCT01336621|453243149|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
125986940|NCT01336621|453243149|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
125986941|NCT01336621|453243149|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
125986942|NCT01336621|453243149|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
125986943|NCT01576718|453243150|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
125986944|NCT01576718|453243151|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125986945|NCT01576718|453243152|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125986946|NCT01576718|453243153|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125986947|NCT01576718|453243154|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125986948|NCT01576718|453243155|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125986949|NCT01576718|453243156|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125986950|NCT01576718|453243150|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
125986951|NCT01576718|453243151|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125986952|NCT01576718|453243152|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125986953|NCT01576718|453243153|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125986954|NCT01576718|453243154|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125986955|NCT01576718|453243155|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125986956|NCT01576718|453243156|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125986957|NCT01576718|453243150|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
125986958|NCT01576718|453243151|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125986959|NCT01576718|453243152|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126209076|NCT02255422|454053144|FG001|Overall Study|Lost to Follow-up|0|||
126209077|NCT02255422|454053145|FG002|Overall Study|Lost to Follow-up|1|||
126326482|NCT05052697|454488404|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326483|NCT05052697|454488405|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326484|NCT05052697|454488406|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326485|NCT05052697|454488407|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326486|NCT05052697|454488408|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326487|NCT05052697|454488409|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326488|NCT05052697|454488410|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326489|NCT05052697|454488411|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326490|NCT05052697|454488412|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326491|NCT05052697|454488413|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326492|NCT05052697|454488414|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
126326493|NCT05052697|454488415|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326494|NCT05052697|454488382|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326495|NCT05052697|454488383|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326496|NCT05052697|454488384|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326497|NCT05052697|454488385|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326498|NCT05052697|454488386|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326499|NCT05052697|454488387|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326500|NCT05052697|454488388|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326501|NCT05052697|454488389|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326502|NCT05052697|454488390|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326503|NCT05052697|454488391|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326504|NCT05052697|454488392|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326505|NCT05052697|454488393|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326506|NCT05052697|454488394|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326507|NCT05052697|454488395|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326508|NCT05052697|454488396|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326509|NCT05052697|454488397|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326510|NCT05052697|454488398|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326511|NCT05052697|454488399|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326512|NCT05052697|454488400|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326513|NCT05052697|454488401|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326514|NCT05052697|454488402|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326515|NCT05052697|454488403|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326516|NCT05052697|454488404|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326517|NCT05052697|454488405|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326518|NCT05052697|454488406|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326519|NCT05052697|454488407|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326520|NCT05052697|454488408|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326521|NCT05052697|454488409|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326522|NCT05052697|454488410|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
126326523|NCT05052697|454488411|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
126326524|NCT05052697|454488412|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
126326525|NCT05052697|454488413|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326526|NCT05052697|454488414|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326527|NCT05052697|454488415|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326528|NCT01289574|454488416|FG000|Overall Study|Lack of Efficacy|4|||
126326529|NCT01289574|454488417|FG001|Overall Study|Lack of Efficacy|0|||
126326530|NCT01289574|454488418|FG002|Overall Study|Lack of Efficacy|1|||
126326531|NCT01289574|454488416|FG000|Overall Study|Lost to Follow-up|2|||
126326532|NCT01289574|454488417|FG001|Overall Study|Lost to Follow-up|0|||
126326533|NCT01289574|454488418|FG002|Overall Study|Lost to Follow-up|1|||
126326534|NCT01289574|454488416|FG000|Overall Study|Withdrawal by Subject|1|||
126326535|NCT01289574|454488417|FG001|Overall Study|Withdrawal by Subject|1|||
126326536|NCT01289574|454488418|FG002|Overall Study|Withdrawal by Subject|1|||
126326537|NCT01289574|454488416|FG000|Overall Study|Adverse Event|0|||
126326538|NCT01289574|454488417|FG001|Overall Study|Adverse Event|1|||
126326539|NCT01289574|454488418|FG002|Overall Study|Adverse Event|0|||
126326540|NCT01289574|454488416|FG000|Overall Study|Subject wanted alternate treatment|0|||
126326541|NCT01289574|454488417|FG001|Overall Study|Subject wanted alternate treatment|1|||
126326542|NCT01289574|454488418|FG002|Overall Study|Subject wanted alternate treatment|0|||
126326543|NCT00262002|454488419|FG000|Overall Study|Adverse Event|2|||
126326544|NCT00262002|454488420|FG001|Overall Study|Adverse Event|1|||
126326545|NCT00262002|454488421|FG002|Overall Study|Adverse Event|0|||
126326546|NCT00262002|454488422|FG003|Overall Study|Adverse Event|0|||
126326547|NCT00262002|454488423|FG004|Overall Study|Adverse Event|0|||
126326548|NCT00262002|454488424|FG005|Overall Study|Adverse Event|1|||
126326549|NCT00262002|454488425|FG006|Overall Study|Adverse Event|0|||
126326550|NCT00262002|454488419|FG000|Overall Study|Withdrawal by Subject|4|||
126326551|NCT00262002|454488420|FG001|Overall Study|Withdrawal by Subject|2|||
126326552|NCT00262002|454488421|FG002|Overall Study|Withdrawal by Subject|0|||
126326553|NCT00262002|454488422|FG003|Overall Study|Withdrawal by Subject|1|||
126326554|NCT00262002|454488423|FG004|Overall Study|Withdrawal by Subject|2|||
126326555|NCT00262002|454488424|FG005|Overall Study|Withdrawal by Subject|2|||
126326556|NCT00262002|454488425|FG006|Overall Study|Withdrawal by Subject|2|||
126326557|NCT00262002|454488419|FG000|Overall Study|Lost to Follow-up|2|||
126326558|NCT00262002|454488420|FG001|Overall Study|Lost to Follow-up|0|||
126326559|NCT00262002|454488421|FG002|Overall Study|Lost to Follow-up|0|||
126326560|NCT00262002|454488422|FG003|Overall Study|Lost to Follow-up|2|||
126326561|NCT00262002|454488423|FG004|Overall Study|Lost to Follow-up|0|||
126326562|NCT00262002|454488424|FG005|Overall Study|Lost to Follow-up|1|||
126326563|NCT00262002|454488425|FG006|Overall Study|Lost to Follow-up|0|||
126326564|NCT00262002|454488419|FG000|Overall Study|Inapropriate enrollment|0|||
126326565|NCT00262002|454488420|FG001|Overall Study|Inapropriate enrollment|1|||
126326566|NCT00262002|454488421|FG002|Overall Study|Inapropriate enrollment|0|||
126326567|NCT00262002|454488422|FG003|Overall Study|Inapropriate enrollment|0|||
126326568|NCT00262002|454488423|FG004|Overall Study|Inapropriate enrollment|0|||
126326569|NCT00262002|454488424|FG005|Overall Study|Inapropriate enrollment|0|||
126326570|NCT00262002|454488425|FG006|Overall Study|Inapropriate enrollment|0|||
126326571|NCT00262002|454488419|FG000|Overall Study|Protocol Violation|3|||
126326572|NCT00262002|454488420|FG001|Overall Study|Protocol Violation|2|||
126326573|NCT00262002|454488421|FG002|Overall Study|Protocol Violation|0|||
126326574|NCT00262002|454488422|FG003|Overall Study|Protocol Violation|2|||
126326575|NCT00262002|454488423|FG004|Overall Study|Protocol Violation|5|||
126326576|NCT00262002|454488424|FG005|Overall Study|Protocol Violation|3|||
126326577|NCT00262002|454488425|FG006|Overall Study|Protocol Violation|2|||
126326578|NCT00262002|454488419|FG000|Overall Study|Unable to classify|0|||
126326579|NCT00262002|454488420|FG001|Overall Study|Unable to classify|0|||
126326580|NCT00262002|454488421|FG002|Overall Study|Unable to classify|0|||
126326581|NCT00262002|454488422|FG003|Overall Study|Unable to classify|0|||
126326582|NCT00262002|454488423|FG004|Overall Study|Unable to classify|0|||
126326583|NCT00262002|454488424|FG005|Overall Study|Unable to classify|0|||
126326584|NCT00262002|454488425|FG006|Overall Study|Unable to classify|2|||
126326585|NCT01790516|454488426|FG000|Overall Study|Physician Decision|1|||
126326586|NCT01790516|454488427|FG001|Overall Study|Physician Decision|0|||
126326587|NCT01554163|454488428|FG000|Overall Study|Adverse Event|3|||
126326588|NCT01554163|454488429|FG001|Overall Study|Adverse Event|0|||
126326589|NCT01554163|454488428|FG000|Overall Study|Lack of Efficacy|1|||
126326590|NCT01554163|454488429|FG001|Overall Study|Lack of Efficacy|0|||
126326591|NCT01554163|454488428|FG000|Overall Study|Lost to Follow-up|1|||
126326592|NCT01554163|454488429|FG001|Overall Study|Lost to Follow-up|0|||
126326593|NCT01554163|454488428|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126326594|NCT01554163|454488429|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126326595|NCT01554163|454488428|FG000|Overall Study|Protocol Violation|0|||
126326596|NCT01554163|454488429|FG001|Overall Study|Protocol Violation|4|||
126326597|NCT01554163|454488428|FG000|Overall Study|Withdrawal by Subject|1|||
126326598|NCT01554163|454488429|FG001|Overall Study|Withdrawal by Subject|5|||
126326599|NCT01554163|454488428|FG000|Overall Study|Not Treated|1|||
126326600|NCT01554163|454488429|FG001|Overall Study|Not Treated|0|||
126326601|NCT03034135|454488430|FG000|Overall Study|Withdrawal by Subject|2|||
126326602|NCT01972464|454488434|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
126326603|NCT01972464|454488435|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
126326604|NCT01972464|454488434|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
126326605|NCT01972464|454488435|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
126326606|NCT01972464|454488434|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
126326607|NCT01972464|454488435|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
126326608|NCT01972464|454488434|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
126326609|NCT01972464|454488435|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
126326610|NCT01133704|454490002|FG000|Overall Study|Death|44|||
126326611|NCT01133704|454490003|FG001|Overall Study|Death|26|||
126326612|NCT01133704|454490002|FG000|Overall Study|Patient refused to continue|4|||
126326613|NCT01133704|454490003|FG001|Overall Study|Patient refused to continue|0|||
126326614|NCT01133704|454490002|FG000|Overall Study|Study Closure|1|||
126326615|NCT01133704|454490003|FG001|Overall Study|Study Closure|0|||
126326616|NCT04985942|454490006|FG000|Overall Study|Adverse Event|14|||
126326617|NCT04985942|454490007|FG001|Overall Study|Adverse Event|2|||
126326618|NCT04985942|454490006|FG000|Overall Study|Lack of Efficacy|0|||
126326619|NCT04985942|454490007|FG001|Overall Study|Lack of Efficacy|3|||
126326620|NCT04985942|454490006|FG000|Overall Study|Lost to Follow-up|1|||
126326621|NCT04985942|454490007|FG001|Overall Study|Lost to Follow-up|1|||
126326622|NCT04985942|454490006|FG000|Overall Study|Protocol Violation|1|||
126326623|NCT04985942|454490007|FG001|Overall Study|Protocol Violation|1|||
126326624|NCT04985942|454490006|FG000|Overall Study|Withdrawal by Subject|5|||
126326625|NCT04985942|454490007|FG001|Overall Study|Withdrawal by Subject|4|||
126326626|NCT02849704|454490009|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
126326627|NCT02849704|454490010|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
126326628|NCT02849704|454490009|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
126326629|NCT02849704|454490010|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
126326630|NCT02849704|454490009|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
126326631|NCT02849704|454490010|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
126326632|NCT02447328|454490015|FG000|Overall Study|Withdrawal by Subject|1|||
126326633|NCT01128400|454490016|FG000|Overall Study|Lost to Follow-up|1|||
126326634|NCT01128400|454490017|FG001|Overall Study|Lost to Follow-up|0|||
126326635|NCT01128400|454490018|FG002|Overall Study|Lost to Follow-up|1|||
126326636|NCT01128400|454490016|FG000|Overall Study|Screening failure|1|||
126326637|NCT01128400|454490017|FG001|Overall Study|Screening failure|0|||
126326638|NCT01128400|454490018|FG002|Overall Study|Screening failure|0|||
126209078|NCT02255422|454053146|FG003|Overall Study|Lost to Follow-up|0|||
126326639|NCT01128400|454490016|FG000|Overall Study|were not invited to participate on taste|0|||
126326640|NCT01128400|454490017|FG001|Overall Study|were not invited to participate on taste|0|||
126326641|NCT01128400|454490018|FG002|Overall Study|were not invited to participate on taste|15|||
126326642|NCT01128400|454490016|FG000|Overall Study|Excluded due to sinus problems|0|||
126326643|NCT01128400|454490017|FG001|Overall Study|Excluded due to sinus problems|1|||
126326644|NCT01128400|454490018|FG002|Overall Study|Excluded due to sinus problems|0|||
126326645|NCT00314808|454490022|FG000|Overall Study|Disease Progression without AE|4|||
126326646|NCT00314808|454490022|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
126326647|NCT04304508|454490023|FG000|Overall Study|Subject Decision|29|||
126326648|NCT04304508|454490024|FG001|Overall Study|Subject Decision|39|||
126326649|NCT04304508|454490025|FG002|Overall Study|Subject Decision|37|||
126326650|NCT04304508|454490026|FG003|Overall Study|Subject Decision|48|||
126326651|NCT04304508|454490023|FG000|Overall Study|Death|6|||
126326652|NCT04304508|454490024|FG001|Overall Study|Death|1|||
126326653|NCT04304508|454490025|FG002|Overall Study|Death|8|||
126326654|NCT04304508|454490026|FG003|Overall Study|Death|5|||
126326655|NCT04304508|454490023|FG000|Overall Study|Non-compliance With Study Drug|3|||
126326656|NCT04304508|454490024|FG001|Overall Study|Non-compliance With Study Drug|1|||
126326657|NCT04304508|454490025|FG002|Overall Study|Non-compliance With Study Drug|2|||
126326658|NCT04304508|454490026|FG003|Overall Study|Non-compliance With Study Drug|0|||
126326659|NCT04304508|454490023|FG000|Overall Study|Switching To Other Therapy|1|||
126326660|NCT04304508|454490024|FG001|Overall Study|Switching To Other Therapy|1|||
126326661|NCT04304508|454490025|FG002|Overall Study|Switching To Other Therapy|1|||
126326662|NCT04304508|454490026|FG003|Overall Study|Switching To Other Therapy|2|||
126326663|NCT04304508|454490023|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
126326664|NCT04304508|454490024|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
126326665|NCT04304508|454490025|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
126326666|NCT04304508|454490026|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
126326667|NCT04304508|454490023|FG000|Overall Study|Withdrawal by Subject|7|||
126326668|NCT04304508|454490024|FG001|Overall Study|Withdrawal by Subject|5|||
126326669|NCT04304508|454490025|FG002|Overall Study|Withdrawal by Subject|11|||
126326670|NCT04304508|454490026|FG003|Overall Study|Withdrawal by Subject|6|||
126326671|NCT04304508|454490023|FG000|Overall Study|Logistical Difficulties|2|||
126326672|NCT04304508|454490024|FG001|Overall Study|Logistical Difficulties|2|||
126326673|NCT04304508|454490025|FG002|Overall Study|Logistical Difficulties|3|||
126326674|NCT04304508|454490026|FG003|Overall Study|Logistical Difficulties|2|||
126326675|NCT04304508|454490023|FG000|Overall Study|Missing Information|1|||
126326676|NCT04304508|454490024|FG001|Overall Study|Missing Information|2|||
126326677|NCT04304508|454490025|FG002|Overall Study|Missing Information|1|||
126326678|NCT04304508|454490026|FG003|Overall Study|Missing Information|3|||
126326679|NCT04304508|454490023|FG000|Overall Study|Other|7|||
126326680|NCT04304508|454490024|FG001|Overall Study|Other|6|||
126326681|NCT04304508|454490025|FG002|Overall Study|Other|5|||
125986960|NCT01576718|453243153|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126326682|NCT04304508|454490026|FG003|Overall Study|Other|4|||
126326683|NCT04304508|454490023|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
126326684|NCT04304508|454490024|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
126326685|NCT04304508|454490025|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
126326686|NCT04304508|454490026|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
126326687|NCT04304508|454490023|FG000|Overall Study|Physician Decision|3|||
126326688|NCT04304508|454490024|FG001|Overall Study|Physician Decision|4|||
126326689|NCT04304508|454490025|FG002|Overall Study|Physician Decision|9|||
126326690|NCT04304508|454490026|FG003|Overall Study|Physician Decision|7|||
126326691|NCT04304508|454490023|FG000|Overall Study|Study drug never administered|10|||
126326692|NCT04304508|454490024|FG001|Overall Study|Study drug never administered|4|||
126326693|NCT04304508|454490025|FG002|Overall Study|Study drug never administered|4|||
126326694|NCT04304508|454490026|FG003|Overall Study|Study drug never administered|4|||
126326695|NCT04304508|454490023|FG000|Overall Study|Adverse Event|49|||
126326696|NCT04304508|454490024|FG001|Overall Study|Adverse Event|50|||
126326697|NCT04304508|454490025|FG002|Overall Study|Adverse Event|51|||
126326698|NCT04304508|454490026|FG003|Overall Study|Adverse Event|56|||
126326699|NCT04304508|454490023|FG000|Overall Study|Lost to Follow-up|1|||
126326700|NCT04304508|454490024|FG001|Overall Study|Lost to Follow-up|5|||
126326701|NCT04304508|454490025|FG002|Overall Study|Lost to Follow-up|2|||
126326702|NCT04304508|454490026|FG003|Overall Study|Lost to Follow-up|3|||
126326703|NCT02688764|454490033|FG000|Overall Study|Adverse Event|3|||
126326704|NCT02688764|454490034|FG001|Overall Study|Adverse Event|3|||
126326705|NCT02688764|454490033|FG000|Overall Study|AE/Kidney transplant|1|||
126326706|NCT02688764|454490034|FG001|Overall Study|AE/Kidney transplant|0|||
126326707|NCT02688764|454490033|FG000|Overall Study|AE/Lack of efficacy|1|||
126326708|NCT02688764|454490034|FG001|Overall Study|AE/Lack of efficacy|0|||
126326709|NCT02688764|454490033|FG000|Overall Study|AE/Non-compl.|1|||
126326710|NCT02688764|454490034|FG001|Overall Study|AE/Non-compl.|0|||
126326711|NCT02688764|454490033|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
126326712|NCT02688764|454490034|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
126326713|NCT02688764|454490033|FG000|Overall Study|AE/Other|0|||
126326714|NCT02688764|454490034|FG001|Overall Study|AE/Other|1|||
126326715|NCT02688764|454490033|FG000|Overall Study|AE/Physician decision|1|||
126326716|NCT02688764|454490034|FG001|Overall Study|AE/Physician decision|0|||
126326717|NCT02688764|454490033|FG000|Overall Study|AE/Withd. parent|3|||
126326718|NCT02688764|454490034|FG001|Overall Study|AE/Withd. parent|0|||
126326719|NCT02688764|454490033|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
126326720|NCT02688764|454490034|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
126326721|NCT02688764|454490033|FG000|Overall Study|AE/Withd. subject|1|||
126326722|NCT02688764|454490034|FG001|Overall Study|AE/Withd. subject|0|||
126326723|NCT02688764|454490033|FG000|Overall Study|Kidney transplant|10|||
126326724|NCT02688764|454490034|FG001|Overall Study|Kidney transplant|4|||
126326725|NCT02688764|454490033|FG000|Overall Study|Lack of Efficacy|3|||
126326726|NCT02688764|454490034|FG001|Overall Study|Lack of Efficacy|2|||
126326727|NCT02688764|454490033|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
126326728|NCT02688764|454490034|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
126326729|NCT02688764|454490033|FG000|Overall Study|Non-compliance with study drug|4|||
126326730|NCT02688764|454490034|FG001|Overall Study|Non-compliance with study drug|0|||
126326731|NCT02688764|454490033|FG000|Overall Study|Non-compl./Physician decision|2|||
126326732|NCT02688764|454490034|FG001|Overall Study|Non-compl./Physician decision|0|||
126326733|NCT02688764|454490033|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
126326734|NCT02688764|454490034|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
126326735|NCT02688764|454490033|FG000|Overall Study|Non-compl./Withd. subject|0|||
126326736|NCT02688764|454490034|FG001|Overall Study|Non-compl./Withd. subject|2|||
126326737|NCT02688764|454490033|FG000|Overall Study|Phosphorus level outside safe range|0|||
126326738|NCT02688764|454490034|FG001|Overall Study|Phosphorus level outside safe range|1|||
126326739|NCT02688764|454490033|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
126326740|NCT02688764|454490034|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
126326741|NCT02688764|454490033|FG000|Overall Study|Study drug taste/Withd. parent|1|||
126326742|NCT02688764|454490034|FG001|Overall Study|Study drug taste/Withd. parent|0|||
126326743|NCT02688764|454490033|FG000|Overall Study|Subject moving out|2|||
126326744|NCT02688764|454490034|FG001|Overall Study|Subject moving out|0|||
126326745|NCT02688764|454490033|FG000|Overall Study|Subject taken off dialysis|1|||
126326746|NCT02688764|454490034|FG001|Overall Study|Subject taken off dialysis|0|||
126326747|NCT02688764|454490033|FG000|Overall Study|Withdrawal by parent|3|||
126326748|NCT02688764|454490034|FG001|Overall Study|Withdrawal by parent|0|||
126326749|NCT02113007|454490035|FG000|Overall Study|Progressive disease|2|||
126326750|NCT00885378|454490036|FG000|Overall Study|Lack of Efficacy|2|||
126326751|NCT00885378|454490037|FG001|Overall Study|Lack of Efficacy|2|||
126326752|NCT00885378|454490036|FG000|Overall Study|Withdrawal by Subject|1|||
126326753|NCT00885378|454490037|FG001|Overall Study|Withdrawal by Subject|2|||
126326754|NCT00885378|454490036|FG000|Overall Study|Lost to Follow-up|1|||
126326755|NCT00885378|454490037|FG001|Overall Study|Lost to Follow-up|2|||
126326756|NCT00885378|454490036|FG000|Overall Study|Poor/Noncompliance|2|||
126326757|NCT00885378|454490037|FG001|Overall Study|Poor/Noncompliance|2|||
126326758|NCT00885378|454490036|FG000|Overall Study|Protocol Violation|2|||
126326759|NCT00885378|454490037|FG001|Overall Study|Protocol Violation|0|||
126326760|NCT04750278|454490039|FG000|Overall Study|Death|9|||
126326761|NCT04750278|454490040|FG001|Overall Study|Death|10|||
126326762|NCT04750278|454490041|FG002|Overall Study|Death|10|||
126326763|NCT04750278|454490039|FG000|Overall Study|Withdrawal by Subject|4|||
126326764|NCT04750278|454490040|FG001|Overall Study|Withdrawal by Subject|1|||
126326765|NCT04750278|454490041|FG002|Overall Study|Withdrawal by Subject|2|||
126326766|NCT04750278|454490039|FG000|Overall Study|Lost to Follow-up|1|||
126326767|NCT04750278|454490040|FG001|Overall Study|Lost to Follow-up|1|||
126326768|NCT04750278|454490041|FG002|Overall Study|Lost to Follow-up|1|||
126326769|NCT04750278|454490039|FG000|Overall Study|Pregnancy|1|||
126326770|NCT04750278|454490040|FG001|Overall Study|Pregnancy|0|||
126326771|NCT04750278|454490041|FG002|Overall Study|Pregnancy|0|||
126326772|NCT04750278|454490039|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
126326773|NCT04750278|454490040|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
126326774|NCT04750278|454490041|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
126326775|NCT04750278|454490039|FG000|Overall Study|Non-compliance|0|||
126326776|NCT04750278|454490040|FG001|Overall Study|Non-compliance|0|||
126326777|NCT04750278|454490041|FG002|Overall Study|Non-compliance|1|||
126326778|NCT04750278|454490039|FG000|Overall Study|Transfer to Outside Facility|0|||
126326779|NCT04750278|454490040|FG001|Overall Study|Transfer to Outside Facility|2|||
126326780|NCT04750278|454490041|FG002|Overall Study|Transfer to Outside Facility|1|||
126326781|NCT04750278|454490039|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
126326782|NCT04750278|454490040|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
126326783|NCT04750278|454490041|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
126326784|NCT04750278|454490039|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
126326785|NCT04750278|454490040|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
126326786|NCT04750278|454490041|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
126326787|NCT01775787|454490042|FG000|First 7-10 Days|Adverse Event|0|||
126326788|NCT01775787|454490043|FG001|First 7-10 Days|Adverse Event|1|||
126326789|NCT01775787|454490042|FG000|First 7-10 Days|family emergency|0|||
126326790|NCT01775787|454490043|FG001|First 7-10 Days|family emergency|1|||
126326791|NCT01775787|454490042|FG000|First 7-10 Days|time commitment|0|||
126326792|NCT01775787|454490043|FG001|First 7-10 Days|time commitment|2|||
126090992|NCT03525392|453626875|FG001|Overall Study|Progressive disease|1|||
126326793|NCT01775787|454490042|FG000|First 7-10 Days|concerns with using IV|1|||
126326794|NCT01775787|454490043|FG001|First 7-10 Days|concerns with using IV|2|||
126326795|NCT01775787|454490042|FG000|Second 7-10 Days|time commitment|0|||
126326796|NCT01775787|454490043|FG001|Second 7-10 Days|time commitment|1|||
126326797|NCT01775787|454490042|FG000|Second 7-10 Days|concerns with using IV|0|||
126326798|NCT01775787|454490043|FG001|Second 7-10 Days|concerns with using IV|1|||
126326799|NCT01616758|454490048|FG000|Overall Study|Adverse Event|1|||
126326800|NCT01616758|454490048|FG000|Overall Study|Withdrawal by Subject|2|||
126326801|NCT01616758|454490048|FG000|Overall Study|Disease progression|18|||
126326802|NCT01616758|454490048|FG000|Overall Study|Study termination by Sponsor|1|||
126326803|NCT04076319|454490053|FG000|Overall Study|Withdrawal by Subject|2|||
126326804|NCT04076319|454490054|FG001|Overall Study|Withdrawal by Subject|0|||
126326805|NCT04076319|454490053|FG000|Overall Study|Death|1|||
126326806|NCT04076319|454490054|FG001|Overall Study|Death|0|||
126326807|NCT01054222|454490055|FG000|Overall Study|Lack of Efficacy|1|||
126326808|NCT01054222|454490055|FG000|Overall Study|Lost to Follow-up|4|||
126326809|NCT01054222|454490055|FG000|Overall Study|Withdrawal by Subject|6|||
126326810|NCT00824655|454490056|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
126326811|NCT00824655|454490057|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
126326812|NCT00824655|454490056|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
126326813|NCT00824655|454490057|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
126326814|NCT03252145|454490058|FG000|Overall Study|Withdrawal by Subject|1|||
126326815|NCT03252145|454490059|FG001|Overall Study|Withdrawal by Subject|0|||
126326816|NCT03252145|454490058|FG000|Overall Study|Complicating Disease|1|||
126326817|NCT03252145|454490059|FG001|Overall Study|Complicating Disease|2|||
126326818|NCT03504189|454490060|FG000|Overall Study|Withdrawal by Subject|1|||
126326819|NCT03504189|454490060|FG000|Overall Study|Screening Failure|1|||
126326820|NCT03504189|454490060|FG000|Overall Study|Device Failure|2|||
126326821|NCT03091738|454490061|FG000|Overall Study|Adverse Event|1|||
126326822|NCT03091738|454490061|FG000|Overall Study|Lost to Follow-up|1|||
126326823|NCT04336475|454490062|FG000|Overall Study|pain|1|||
126326824|NCT04336475|454490063|FG001|Overall Study|pain|0|||
126326825|NCT04336475|454490062|FG000|Overall Study|upper respiratory infection|1|||
126326826|NCT04336475|454490063|FG001|Overall Study|upper respiratory infection|0|||
126326827|NCT04336475|454490062|FG000|Overall Study|Lost to Follow-up|0|||
126326828|NCT04336475|454490063|FG001|Overall Study|Lost to Follow-up|2|||
126326829|NCT00199849|454490072|FG000|Overall Study|Unrelated illness or complication|0|||
126326830|NCT00199849|454490073|FG001|Overall Study|Unrelated illness or complication|1|||
126326831|NCT00199849|454490074|FG002|Overall Study|Unrelated illness or complication|0|||
126326832|NCT00199849|454490072|FG000|Overall Study|Progressive disease requiring intervention|0|||
126326833|NCT00199849|454490073|FG001|Overall Study|Progressive disease requiring intervention|0|||
126326834|NCT00199849|454490074|FG002|Overall Study|Progressive disease requiring intervention|1|||
126326835|NCT00199849|454490072|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
126326836|NCT00199849|454490073|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
126326837|NCT00199849|454490074|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
126326838|NCT00398047|454490084|FG000|Overall Study|all patient progressed before completion|3|||
126326839|NCT01188668|454490085|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
126326840|NCT01188668|454490085|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
126326841|NCT01188668|454490085|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
126326842|NCT00902746|454490086|FG000|Overall Study|Protocol Violation|7|||
126326843|NCT00902746|454490086|FG000|Overall Study|Withdrawal by Subject|16|||
126326844|NCT00902746|454490086|FG000|Overall Study|Adverse Event|8|||
126326845|NCT00902746|454490086|FG000|Overall Study|Lost to Follow-up|3|||
126326846|NCT00902746|454490086|FG000|Overall Study|Physician Decision|2|||
126326847|NCT02081001|454490087|FG000|Overall Study|Adverse Event|0|||
126326848|NCT02081001|454490088|FG001|Overall Study|Adverse Event|0|||
126326849|NCT02081001|454490089|FG002|Overall Study|Adverse Event|0|||
126326850|NCT02081001|454490090|FG003|Overall Study|Adverse Event|0|||
126326851|NCT02081001|454490091|FG004|Overall Study|Adverse Event|1|||
126326852|NCT02081001|454490092|FG005|Overall Study|Adverse Event|0|||
126326853|NCT02081001|454490093|FG006|Overall Study|Adverse Event|0|||
126326854|NCT02081001|454490094|FG007|Overall Study|Adverse Event|0|||
126326855|NCT02081001|454490095|FG008|Overall Study|Adverse Event|0|||
126326856|NCT02081001|454490096|FG009|Overall Study|Adverse Event|0|||
126326857|NCT02081001|454490097|FG010|Overall Study|Adverse Event|0|||
126326858|NCT02081001|454490098|FG011|Overall Study|Adverse Event|0|||
126326859|NCT02588092|454490107|FG000|Overall Study|Death|4|||
126326860|NCT02588092|454490108|FG001|Overall Study|Death|3|||
126326861|NCT02588092|454490109|FG002|Overall Study|Death|3|||
126326862|NCT02588092|454490110|FG003|Overall Study|Death|3|||
126326863|NCT02588092|454490111|FG004|Overall Study|Death|2|||
126326864|NCT02588092|454490112|FG005|Overall Study|Death|2|||
126326865|NCT02588092|454490113|FG006|Overall Study|Death|2|||
126326866|NCT02588092|454490114|FG007|Overall Study|Death|1|||
126326867|NCT02588092|454490115|FG008|Overall Study|Death|5|||
126326868|NCT02588092|454490116|FG009|Overall Study|Death|2|||
126326869|NCT02588092|454490107|FG000|Overall Study|Withdrawal by Subject|0|||
126326870|NCT02588092|454490108|FG001|Overall Study|Withdrawal by Subject|0|||
126326871|NCT02588092|454490109|FG002|Overall Study|Withdrawal by Subject|0|||
126326872|NCT02588092|454490110|FG003|Overall Study|Withdrawal by Subject|0|||
126326873|NCT02588092|454490111|FG004|Overall Study|Withdrawal by Subject|0|||
126326874|NCT02588092|454490112|FG005|Overall Study|Withdrawal by Subject|1|||
126326875|NCT02588092|454490113|FG006|Overall Study|Withdrawal by Subject|1|||
126326876|NCT02588092|454490114|FG007|Overall Study|Withdrawal by Subject|2|||
126326877|NCT02588092|454490115|FG008|Overall Study|Withdrawal by Subject|0|||
126326878|NCT02588092|454490116|FG009|Overall Study|Withdrawal by Subject|0|||
126326879|NCT02588092|454490107|FG000|Overall Study|Started Another Treatment|0|||
126326880|NCT02588092|454490108|FG001|Overall Study|Started Another Treatment|0|||
126326881|NCT02588092|454490109|FG002|Overall Study|Started Another Treatment|0|||
126326882|NCT02588092|454490110|FG003|Overall Study|Started Another Treatment|0|||
126326883|NCT02588092|454490111|FG004|Overall Study|Started Another Treatment|1|||
126326884|NCT02588092|454490112|FG005|Overall Study|Started Another Treatment|0|||
126326885|NCT02588092|454490113|FG006|Overall Study|Started Another Treatment|0|||
126326886|NCT02588092|454490114|FG007|Overall Study|Started Another Treatment|1|||
126326887|NCT02588092|454490115|FG008|Overall Study|Started Another Treatment|0|||
126326888|NCT02588092|454490116|FG009|Overall Study|Started Another Treatment|0|||
126326889|NCT02588092|454490107|FG000|Overall Study|Sponsor Decision|0|||
126326890|NCT02588092|454490108|FG001|Overall Study|Sponsor Decision|0|||
126326891|NCT02588092|454490109|FG002|Overall Study|Sponsor Decision|0|||
126326892|NCT02588092|454490110|FG003|Overall Study|Sponsor Decision|0|||
126326893|NCT02588092|454490111|FG004|Overall Study|Sponsor Decision|0|||
126326894|NCT02588092|454490112|FG005|Overall Study|Sponsor Decision|0|||
126326895|NCT02588092|454490113|FG006|Overall Study|Sponsor Decision|0|||
126326896|NCT02588092|454490114|FG007|Overall Study|Sponsor Decision|0|||
126326897|NCT02588092|454490115|FG008|Overall Study|Sponsor Decision|1|||
126326898|NCT02588092|454490116|FG009|Overall Study|Sponsor Decision|1|||
126326899|NCT01030718|454490117|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
126326900|NCT01030718|454490118|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
126326901|NCT01030718|454490119|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
126326902|NCT01030718|454490117|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
126326903|NCT01030718|454490118|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
126326904|NCT01030718|454490119|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
126326905|NCT01030718|454490117|FG000|Studies CA180-031 and -036 Combined|Death|0|||
126326906|NCT01030718|454490118|FG001|Studies CA180-031 and -036 Combined|Death|1|||
126326907|NCT01030718|454490119|FG002|Studies CA180-031 and -036 Combined|Death|0|||
126326908|NCT01030718|454490117|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
126326909|NCT01030718|454490118|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
126326910|NCT01030718|454490119|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
126326911|NCT01030718|454490117|FG000|Study CA180-036 Only|insufficient effect|1|||
126326912|NCT01030718|454490118|FG001|Study CA180-036 Only|insufficient effect|1|||
126326913|NCT01030718|454490119|FG002|Study CA180-036 Only|insufficient effect|5|||
126326914|NCT01030718|454490117|FG000|Study CA180-036 Only|Adverse Event|2|||
126326915|NCT01030718|454490118|FG001|Study CA180-036 Only|Adverse Event|3|||
126326916|NCT01030718|454490119|FG002|Study CA180-036 Only|Adverse Event|0|||
126326917|NCT01030718|454490117|FG000|Study CA180-036 Only|Death|0|||
126326918|NCT01030718|454490118|FG001|Study CA180-036 Only|Death|1|||
126326919|NCT01030718|454490119|FG002|Study CA180-036 Only|Death|0|||
126326920|NCT01030718|454490117|FG000|Study CA180-036 Only|Other Reasons|0|||
126326921|NCT01030718|454490118|FG001|Study CA180-036 Only|Other Reasons|2|||
126326922|NCT01030718|454490119|FG002|Study CA180-036 Only|Other Reasons|0|||
126326923|NCT00423813|454490122|FG000|Overall Study|Adverse Event|11|||
126326924|NCT00423813|454490123|FG001|Overall Study|Adverse Event|30|||
126326925|NCT00423813|454490124|FG002|Overall Study|Adverse Event|40|||
126326926|NCT00423813|454490122|FG000|Overall Study|Withdrawal by Subject|6|||
126326927|NCT00423813|454490123|FG001|Overall Study|Withdrawal by Subject|8|||
126326928|NCT00423813|454490124|FG002|Overall Study|Withdrawal by Subject|5|||
126326929|NCT00423813|454490122|FG000|Overall Study|Lost to Follow-up|5|||
126326930|NCT00423813|454490123|FG001|Overall Study|Lost to Follow-up|4|||
126326931|NCT00423813|454490124|FG002|Overall Study|Lost to Follow-up|4|||
126326932|NCT00423813|454490122|FG000|Overall Study|Lack of Efficacy|23|||
126326933|NCT00423813|454490123|FG001|Overall Study|Lack of Efficacy|18|||
126326934|NCT00423813|454490124|FG002|Overall Study|Lack of Efficacy|19|||
126326935|NCT00423813|454490122|FG000|Overall Study|Physician Decision|2|||
126326936|NCT00423813|454490123|FG001|Overall Study|Physician Decision|0|||
126326937|NCT00423813|454490124|FG002|Overall Study|Physician Decision|0|||
126326938|NCT00423813|454490122|FG000|Overall Study|Sponsor Decision|0|||
126326939|NCT00423813|454490123|FG001|Overall Study|Sponsor Decision|1|||
126326940|NCT00423813|454490124|FG002|Overall Study|Sponsor Decision|0|||
126326941|NCT00423813|454490122|FG000|Overall Study|Protocol Violation|9|||
126326942|NCT00423813|454490123|FG001|Overall Study|Protocol Violation|4|||
126326943|NCT00423813|454490124|FG002|Overall Study|Protocol Violation|4|||
126326944|NCT00423813|454490122|FG000|Overall Study|Pregnancy|0|||
126326945|NCT00423813|454490123|FG001|Overall Study|Pregnancy|0|||
126326946|NCT00423813|454490124|FG002|Overall Study|Pregnancy|1|||
126326947|NCT00423813|454490122|FG000|Overall Study|Subject started night shift work|1|||
126326948|NCT00423813|454490123|FG001|Overall Study|Subject started night shift work|0|||
126326949|NCT00423813|454490124|FG002|Overall Study|Subject started night shift work|0|||
126326950|NCT00423813|454490122|FG000|Overall Study|Will start exclusionary medications|0|||
126326951|NCT00423813|454490123|FG001|Overall Study|Will start exclusionary medications|1|||
126326952|NCT00423813|454490124|FG002|Overall Study|Will start exclusionary medications|0|||
126326953|NCT00423813|454490122|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
126326954|NCT00423813|454490123|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
126326955|NCT00423813|454490124|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
126326956|NCT01386944|454490126|FG000|Overall Study|Adverse Event|26|||
126326957|NCT01386944|454490126|FG000|Overall Study|Lack of Efficacy|14|||
126326958|NCT01386944|454490126|FG000|Overall Study|Lost to Follow-up|8|||
126326959|NCT01386944|454490126|FG000|Overall Study|Unspecified reason|8|||
126326960|NCT03853291|454490127|FG000|Overall Study|Lost to Follow-up|1|||
126326961|NCT03853291|454490128|FG001|Overall Study|Lost to Follow-up|2|||
126326962|NCT03853291|454490129|FG002|Overall Study|Lost to Follow-up|0|||
126326963|NCT03853291|454490130|FG003|Overall Study|Lost to Follow-up|0|||
126326964|NCT03853291|454490131|FG004|Overall Study|Lost to Follow-up|0|||
126326965|NCT03853291|454490132|FG005|Overall Study|Lost to Follow-up|0|||
126326966|NCT03853291|454490127|FG000|Overall Study|Determined to be ineligible|1|||
126326967|NCT03853291|454490128|FG001|Overall Study|Determined to be ineligible|1|||
126326968|NCT03853291|454490129|FG002|Overall Study|Determined to be ineligible|0|||
126326969|NCT03853291|454490130|FG003|Overall Study|Determined to be ineligible|0|||
126326970|NCT03853291|454490131|FG004|Overall Study|Determined to be ineligible|0|||
126326971|NCT03853291|454490132|FG005|Overall Study|Determined to be ineligible|0|||
126326972|NCT03883477|454490133|FG000|Overall Study|Death|1|||
126326973|NCT03883477|454490134|FG001|Overall Study|Death|0|||
126326974|NCT03883477|454490133|FG000|Overall Study|Protocol Violation|0|||
126326975|NCT03883477|454490134|FG001|Overall Study|Protocol Violation|1|||
126326976|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
126326977|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
126326978|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
126326979|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
126326980|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
126326981|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
126326982|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
126326983|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
126326984|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
126326985|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
126326986|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
126326987|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
126326988|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
126326989|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
126326990|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
126326991|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
126326992|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
126326993|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
126326994|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
126326995|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
126326996|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
126326997|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
126326998|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
126326999|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
126327000|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
126327001|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
126327002|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
126327003|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
126327004|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
126327005|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
126327006|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
126327007|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
126327008|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
126327009|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
126327010|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
126327011|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
126327012|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
126327013|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
126327014|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
126327015|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
126327016|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
126327017|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
126327018|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
126327019|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
126327020|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
126327021|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
126327022|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
126327023|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
126327024|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
126327025|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
126327026|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
126327027|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
126327028|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
126327029|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
126327030|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
126327031|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
126327032|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
126327033|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
126327034|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
126327035|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
126327036|NCT03762681|454490145|FG000|Part 1|Withdrawal by Subject|0|||
126327037|NCT03762681|454490146|FG001|Part 1|Withdrawal by Subject|0|||
126327038|NCT03762681|454490147|FG002|Part 1|Withdrawal by Subject|0|||
126327039|NCT03762681|454490148|FG003|Part 1|Withdrawal by Subject|1|||
126327040|NCT03762681|454490149|FG004|Part 1|Withdrawal by Subject|0|||
126327041|NCT03762681|454490150|FG005|Part 1|Withdrawal by Subject|0|||
126327042|NCT03762681|454490151|FG006|Part 1|Withdrawal by Subject|0|||
125986961|NCT01576718|453243154|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125986962|NCT01576718|453243155|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126327043|NCT03762681|454490152|FG007|Part 1|Withdrawal by Subject|0|||
126327044|NCT03762681|454490145|FG000|Part 2a|Pandemic Travel Restrictions|0|||
126327045|NCT03762681|454490146|FG001|Part 2a|Pandemic Travel Restrictions|0|||
126327046|NCT03762681|454490147|FG002|Part 2a|Pandemic Travel Restrictions|0|||
126327047|NCT03762681|454490148|FG003|Part 2a|Pandemic Travel Restrictions|0|||
126327048|NCT03762681|454490149|FG004|Part 2a|Pandemic Travel Restrictions|0|||
126327049|NCT03762681|454490150|FG005|Part 2a|Pandemic Travel Restrictions|0|||
126327050|NCT03762681|454490151|FG006|Part 2a|Pandemic Travel Restrictions|0|||
126327051|NCT03762681|454490152|FG007|Part 2a|Pandemic Travel Restrictions|1|||
125986963|NCT01576718|453243156|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125986964|NCT01576718|453243150|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
125986965|NCT01576718|453243151|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125986966|NCT01576718|453243152|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125986967|NCT01576718|453243153|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125986968|NCT01576718|453243154|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125986969|NCT01576718|453243155|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125986970|NCT01576718|453243156|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125986971|NCT01576718|453243150|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
125986972|NCT01576718|453243151|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125986973|NCT01576718|453243152|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125986974|NCT01576718|453243153|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125986975|NCT01576718|453243154|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125986976|NCT01576718|453243155|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125986977|NCT01576718|453243156|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125986978|NCT01576718|453243150|FG000|Treatment Period|Adverse Event|0|||
125986979|NCT01576718|453243151|FG001|Treatment Period|Adverse Event|1|||
125986980|NCT01576718|453243152|FG002|Treatment Period|Adverse Event|1|||
125986981|NCT01576718|453243153|FG003|Treatment Period|Adverse Event|1|||
125986982|NCT01576718|453243154|FG004|Treatment Period|Adverse Event|1|||
125986983|NCT01576718|453243155|FG005|Treatment Period|Adverse Event|1|||
125986984|NCT01576718|453243156|FG006|Treatment Period|Adverse Event|0|||
125986985|NCT01576718|453243150|FG000|Treatment Period|Withdrawal by Subject|0|||
125986986|NCT01576718|453243151|FG001|Treatment Period|Withdrawal by Subject|1|||
125986987|NCT01576718|453243152|FG002|Treatment Period|Withdrawal by Subject|1|||
125986988|NCT01576718|453243153|FG003|Treatment Period|Withdrawal by Subject|0|||
125986989|NCT01576718|453243154|FG004|Treatment Period|Withdrawal by Subject|2|||
125986990|NCT01576718|453243155|FG005|Treatment Period|Withdrawal by Subject|4|||
125986991|NCT01576718|453243156|FG006|Treatment Period|Withdrawal by Subject|2|||
125986992|NCT01576718|453243150|FG000|Treatment Period|Physician Decision|0|||
125986993|NCT01576718|453243151|FG001|Treatment Period|Physician Decision|1|||
125986994|NCT01576718|453243152|FG002|Treatment Period|Physician Decision|1|||
125986995|NCT01576718|453243153|FG003|Treatment Period|Physician Decision|1|||
125986996|NCT01576718|453243154|FG004|Treatment Period|Physician Decision|1|||
125986997|NCT01576718|453243155|FG005|Treatment Period|Physician Decision|0|||
125986998|NCT01576718|453243156|FG006|Treatment Period|Physician Decision|0|||
125986999|NCT01576718|453243150|FG000|Treatment Period|Protocol Violation|0|||
125987000|NCT01576718|453243151|FG001|Treatment Period|Protocol Violation|5|||
126327052|NCT00003896|454490159|FG000|Overall Study|Adverse Event|16|||
126327053|NCT00003896|454490159|FG000|Overall Study|Withdrawal by Subject|1|||
126327054|NCT00003896|454490159|FG000|Overall Study|Lack of Efficacy|1|||
126327055|NCT00003896|454490159|FG000|Overall Study|Death|3|||
126327056|NCT00003896|454490159|FG000|Overall Study|not protocol specified|3|||
126327057|NCT00003896|454490159|FG000|Overall Study|ineligible|5|||
126327058|NCT01398358|454490160|FG000|Overall Study|Lost to Follow-up|11|||
125987001|NCT01576718|453243152|FG002|Treatment Period|Protocol Violation|4|||
125987002|NCT01576718|453243153|FG003|Treatment Period|Protocol Violation|10|||
125987003|NCT01576718|453243154|FG004|Treatment Period|Protocol Violation|6|||
125987004|NCT01576718|453243155|FG005|Treatment Period|Protocol Violation|8|||
125987005|NCT01576718|453243156|FG006|Treatment Period|Protocol Violation|12|||
125987006|NCT01576718|453243150|FG000|Treatment Period|Sponsor request|0|||
125987007|NCT01576718|453243151|FG001|Treatment Period|Sponsor request|1|||
126327059|NCT01398358|454490161|FG001|Overall Study|Lost to Follow-up|21|||
126327060|NCT01398358|454490162|FG002|Overall Study|Lost to Follow-up|18|||
126327061|NCT01398358|454490160|FG000|Overall Study|Withdrawal by Subject|3|||
126327062|NCT01398358|454490161|FG001|Overall Study|Withdrawal by Subject|2|||
126327063|NCT01398358|454490162|FG002|Overall Study|Withdrawal by Subject|2|||
125987008|NCT01576718|453243152|FG002|Treatment Period|Sponsor request|0|||
125987009|NCT01576718|453243153|FG003|Treatment Period|Sponsor request|0|||
125987010|NCT01576718|453243154|FG004|Treatment Period|Sponsor request|0|||
125987011|NCT01576718|453243155|FG005|Treatment Period|Sponsor request|1|||
125987012|NCT01576718|453243156|FG006|Treatment Period|Sponsor request|0|||
125987013|NCT01576718|453243150|FG000|Treatment Period|Met stopping criteria|0|||
125987014|NCT01576718|453243151|FG001|Treatment Period|Met stopping criteria|16|||
125987015|NCT01576718|453243152|FG002|Treatment Period|Met stopping criteria|13|||
126327064|NCT01398358|454490160|FG000|Overall Study|no longer eligible|1|||
126327065|NCT01398358|454490161|FG001|Overall Study|no longer eligible|0|||
126327066|NCT01398358|454490162|FG002|Overall Study|no longer eligible|1|||
126327067|NCT00985686|454490164|FG000|Overall Study|Lost to Follow-up|1|||
125987016|NCT01576718|453243153|FG003|Treatment Period|Met stopping criteria|19|||
125987017|NCT01576718|453243154|FG004|Treatment Period|Met stopping criteria|16|||
125987018|NCT01576718|453243155|FG005|Treatment Period|Met stopping criteria|33|||
125987019|NCT01576718|453243156|FG006|Treatment Period|Met stopping criteria|15|||
126327068|NCT00985686|454490165|FG001|Overall Study|Lost to Follow-up|1|||
126327069|NCT00985686|454490166|FG002|Overall Study|Lost to Follow-up|0|||
126327070|NCT00985686|454490167|FG003|Overall Study|Lost to Follow-up|2|||
126327071|NCT01670045|454490168|FG000|Overall Study|Withdrawal by Subject|3|||
126327072|NCT01670045|454490168|FG000|Overall Study|Adverse Event|1|||
125987020|NCT01576718|453243150|FG000|Treatment Period|Lost to Follow-up|0|||
125987021|NCT01576718|453243151|FG001|Treatment Period|Lost to Follow-up|0|||
125987022|NCT01576718|453243152|FG002|Treatment Period|Lost to Follow-up|0|||
126327073|NCT01670045|454490168|FG000|Overall Study|Death|1|||
126327074|NCT01670045|454490168|FG000|Overall Study|Lost to Follow-up|11|||
126327075|NCT02559570|454490170|FG000|Overall Study|Adverse Event|0|||
126327076|NCT02559570|454490171|FG001|Overall Study|Adverse Event|2|||
126327077|NCT02559570|454490172|FG002|Overall Study|Adverse Event|0|||
126327078|NCT02559570|454490173|FG003|Overall Study|Adverse Event|1|||
126327079|NCT02559570|454490174|FG004|Overall Study|Adverse Event|0|||
126327080|NCT02559570|454490170|FG000|Overall Study|Withdrawal of Consent|0|||
126327081|NCT02559570|454490171|FG001|Overall Study|Withdrawal of Consent|0|||
126327082|NCT02559570|454490172|FG002|Overall Study|Withdrawal of Consent|1|||
126327083|NCT02559570|454490173|FG003|Overall Study|Withdrawal of Consent|2|||
126327084|NCT02559570|454490174|FG004|Overall Study|Withdrawal of Consent|1|||
126327085|NCT02559570|454490170|FG000|Overall Study|Lost to Follow-up|1|||
126327086|NCT02559570|454490171|FG001|Overall Study|Lost to Follow-up|0|||
126327087|NCT02559570|454490172|FG002|Overall Study|Lost to Follow-up|0|||
126327088|NCT02559570|454490173|FG003|Overall Study|Lost to Follow-up|0|||
126327089|NCT02559570|454490174|FG004|Overall Study|Lost to Follow-up|0|||
126327090|NCT02559570|454490170|FG000|Overall Study|Protocol Violation|1|||
126327091|NCT02559570|454490171|FG001|Overall Study|Protocol Violation|0|||
126327092|NCT02559570|454490172|FG002|Overall Study|Protocol Violation|0|||
126327093|NCT02559570|454490173|FG003|Overall Study|Protocol Violation|0|||
126327094|NCT02559570|454490174|FG004|Overall Study|Protocol Violation|1|||
126327095|NCT02559570|454490170|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126327096|NCT02559570|454490171|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126327097|NCT02559570|454490172|FG002|Overall Study|Other Miscellaneous Reasons|1|||
126327098|NCT02559570|454490173|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125987023|NCT01576718|453243153|FG003|Treatment Period|Lost to Follow-up|0|||
125987024|NCT01576718|453243154|FG004|Treatment Period|Lost to Follow-up|1|||
125987025|NCT01576718|453243155|FG005|Treatment Period|Lost to Follow-up|0|||
126327099|NCT02559570|454490174|FG004|Overall Study|Other Miscellaneous Reasons|0|||
126327100|NCT00396383|454490177|FG000|Overall Study|Death|2|||
126327101|NCT00396383|454490177|FG000|Overall Study|Lost to Follow-up|1|||
126327102|NCT00585325|454490178|FG000|Overall Study|Withdrawal by Subject|1|||
126327103|NCT00585325|454490179|FG001|Overall Study|Withdrawal by Subject|1|||
126327104|NCT00334295|454490180|FG000|Overall Study|Patients received fewer than 3 injection|5|||
126327105|NCT02526160|454492305|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
126327106|NCT02526160|454492306|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
126327107|NCT02526160|454492305|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
126327108|NCT02526160|454492306|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
126327109|NCT02526160|454492305|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
126327110|NCT02526160|454492306|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
126327111|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period I|Death|0|||
126327112|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period I|Death|1|||
126327113|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
126327114|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
126327115|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
126327116|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
126327117|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
126327118|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
126327119|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
126327120|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
126327121|NCT02576977|454492307|FG000|Overall Study|Adverse Event|13|||
126327122|NCT02576977|454492308|FG001|Overall Study|Adverse Event|2|||
126327123|NCT02576977|454492307|FG000|Overall Study|Death|73|||
126327124|NCT02576977|454492308|FG001|Overall Study|Death|60|||
126327125|NCT02576977|454492307|FG000|Overall Study|Screen failure|1|||
126327126|NCT02576977|454492308|FG001|Overall Study|Screen failure|0|||
126327127|NCT02576977|454492307|FG000|Overall Study|Study Terminated at Selected Sites|27|||
126327128|NCT02576977|454492308|FG001|Overall Study|Study Terminated at Selected Sites|50|||
126327129|NCT02576977|454492307|FG000|Overall Study|Withdrawal by Subject|11|||
126327130|NCT02576977|454492308|FG001|Overall Study|Withdrawal by Subject|11|||
126327131|NCT02576977|454492307|FG000|Overall Study|Final Disposition Unknown|0|||
126327132|NCT02576977|454492308|FG001|Overall Study|Final Disposition Unknown|1|||
126327133|NCT02576977|454492307|FG000|Overall Study|Lost to Follow-up|1|||
126327134|NCT02576977|454492308|FG001|Overall Study|Lost to Follow-up|0|||
126327135|NCT02576977|454492307|FG000|Overall Study|Progressive Disease|0|||
126327136|NCT02576977|454492308|FG001|Overall Study|Progressive Disease|1|||
126327137|NCT04727528|454492309|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
126327138|NCT04727528|454492310|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
126327139|NCT04727528|454492309|FG000|Open-label Period|Randomized who did not receive treatment|1|||
126327140|NCT04727528|454492310|FG001|Open-label Period|Randomized who did not receive treatment|0|||
126327141|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Adverse Event|0|||
126327142|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Adverse Event|1|||
126327143|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Death|0|||
126327144|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Death|1|||
126327145|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
126327146|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
126327147|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
126327148|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
126327149|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Physician Decision|0|||
126327150|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Physician Decision|1|||
126327151|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
126327152|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126327153|NCT01763827|454492311|FG000|Overall Study|Withdrawal by Subject|1|||
126327154|NCT01763827|454492312|FG001|Overall Study|Withdrawal by Subject|0|||
126327155|NCT01763827|454492313|FG002|Overall Study|Withdrawal by Subject|0|||
126327156|NCT01763827|454492314|FG003|Overall Study|Withdrawal by Subject|0|||
126327157|NCT01763827|454492315|FG004|Overall Study|Withdrawal by Subject|2|||
126327158|NCT01763827|454492316|FG005|Overall Study|Withdrawal by Subject|0|||
126327159|NCT01763827|454492311|FG000|Overall Study|Decision by sponsor|2|||
126327160|NCT01763827|454492312|FG001|Overall Study|Decision by sponsor|0|||
126327161|NCT01763827|454492313|FG002|Overall Study|Decision by sponsor|3|||
126327162|NCT01763827|454492314|FG003|Overall Study|Decision by sponsor|0|||
126327163|NCT01763827|454492315|FG004|Overall Study|Decision by sponsor|2|||
126327164|NCT01763827|454492316|FG005|Overall Study|Decision by sponsor|1|||
126327165|NCT01763827|454492311|FG000|Overall Study|Lost to Follow-up|0|||
126327166|NCT01763827|454492312|FG001|Overall Study|Lost to Follow-up|1|||
126327167|NCT01763827|454492313|FG002|Overall Study|Lost to Follow-up|1|||
126327168|NCT01763827|454492314|FG003|Overall Study|Lost to Follow-up|1|||
126327169|NCT01763827|454492315|FG004|Overall Study|Lost to Follow-up|2|||
126327170|NCT01763827|454492316|FG005|Overall Study|Lost to Follow-up|1|||
126327171|NCT02906579|454492317|FG000|Overall Study|Adverse Event|1|||
126327172|NCT02906579|454492317|FG000|Overall Study|Physician Decision|1|||
126327173|NCT01826981|454492318|FG000|Overall Study|Lack of Efficacy|0|||
126327174|NCT01826981|454492319|FG001|Overall Study|Lack of Efficacy|1|||
126327175|NCT01826981|454492320|FG002|Overall Study|Lack of Efficacy|0|||
126327176|NCT01826981|454492321|FG003|Overall Study|Lack of Efficacy|0|||
126327177|NCT01826981|454492322|FG004|Overall Study|Lack of Efficacy|5|||
126327178|NCT01826981|454492323|FG005|Overall Study|Lack of Efficacy|0|||
126327179|NCT01826981|454492324|FG006|Overall Study|Lack of Efficacy|0|||
126327180|NCT01826981|454492325|FG007|Overall Study|Lack of Efficacy|8|||
126327181|NCT01826981|454492326|FG008|Overall Study|Lack of Efficacy|7|||
126327182|NCT01826981|454492327|FG009|Overall Study|Lack of Efficacy|0|||
126327183|NCT01826981|454492328|FG010|Overall Study|Lack of Efficacy|1|||
126327184|NCT01826981|454492329|FG011|Overall Study|Lack of Efficacy|0|||
126327185|NCT01826981|454492330|FG012|Overall Study|Lack of Efficacy|0|||
126327186|NCT01826981|454492331|FG013|Overall Study|Lack of Efficacy|3|||
126327187|NCT01826981|454492332|FG014|Overall Study|Lack of Efficacy|0|||
126327188|NCT01826981|454492318|FG000|Overall Study|Lost to Follow-up|0|||
126327189|NCT01826981|454492319|FG001|Overall Study|Lost to Follow-up|0|||
126327190|NCT01826981|454492320|FG002|Overall Study|Lost to Follow-up|0|||
126327191|NCT01826981|454492321|FG003|Overall Study|Lost to Follow-up|0|||
126327192|NCT01826981|454492322|FG004|Overall Study|Lost to Follow-up|1|||
126327193|NCT01826981|454492323|FG005|Overall Study|Lost to Follow-up|1|||
126327194|NCT01826981|454492324|FG006|Overall Study|Lost to Follow-up|0|||
126327195|NCT01826981|454492325|FG007|Overall Study|Lost to Follow-up|1|||
126327196|NCT01826981|454492326|FG008|Overall Study|Lost to Follow-up|0|||
126327197|NCT01826981|454492327|FG009|Overall Study|Lost to Follow-up|1|||
126327198|NCT01826981|454492328|FG010|Overall Study|Lost to Follow-up|1|||
126327199|NCT01826981|454492329|FG011|Overall Study|Lost to Follow-up|1|||
126327200|NCT01826981|454492330|FG012|Overall Study|Lost to Follow-up|1|||
126327201|NCT01826981|454492331|FG013|Overall Study|Lost to Follow-up|0|||
126327202|NCT01826981|454492332|FG014|Overall Study|Lost to Follow-up|0|||
126209079|NCT02255422|454053147|FG004|Overall Study|Lost to Follow-up|0|||
126209080|NCT02255422|454053148|FG005|Overall Study|Lost to Follow-up|0|||
126209081|NCT02255422|454053149|FG006|Overall Study|Lost to Follow-up|0|||
126209082|NCT04411641|454053150|FG000|DB Period|Other|7|||
126209083|NCT04411641|454053151|FG001|DB Period|Other|27|||
126209084|NCT04411641|454053152|FG002|DB Period|Other|0|||
126209085|NCT04411641|454053153|FG003|DB Period|Other|0|||
126209086|NCT04411641|454053150|FG000|DB Period|Withdrawal by Subject|67|||
126209087|NCT04411641|454053151|FG001|DB Period|Withdrawal by Subject|122|||
126209088|NCT04411641|454053152|FG002|DB Period|Withdrawal by Subject|0|||
126209089|NCT04411641|454053153|FG003|DB Period|Withdrawal by Subject|0|||
126209090|NCT04411641|454053150|FG000|DB Period|Progressive disease|76|||
126209091|NCT04411641|454053151|FG001|DB Period|Progressive disease|116|||
126209092|NCT04411641|454053152|FG002|DB Period|Progressive disease|0|||
126209093|NCT04411641|454053153|FG003|DB Period|Progressive disease|0|||
126209094|NCT04411641|454053150|FG000|DB Period|Poor compliance to protocol|1|||
126209095|NCT04411641|454053151|FG001|DB Period|Poor compliance to protocol|5|||
126209096|NCT04411641|454053152|FG002|DB Period|Poor compliance to protocol|0|||
126209097|NCT04411641|454053153|FG003|DB Period|Poor compliance to protocol|0|||
126209098|NCT04411641|454053150|FG000|DB Period|Lack of Efficacy|19|||
126209099|NCT04411641|454053151|FG001|DB Period|Lack of Efficacy|19|||
126209100|NCT04411641|454053152|FG002|DB Period|Lack of Efficacy|0|||
126209101|NCT04411641|454053153|FG003|DB Period|Lack of Efficacy|0|||
126209102|NCT04411641|454053150|FG000|DB Period|Adverse Event|13|||
126209103|NCT04411641|454053151|FG001|DB Period|Adverse Event|29|||
126209104|NCT04411641|454053152|FG002|DB Period|Adverse Event|0|||
126209105|NCT04411641|454053153|FG003|DB Period|Adverse Event|0|||
126209106|NCT04411641|454053150|FG000|DB Period|Randomized and not treated|2|||
126209107|NCT04411641|454053151|FG001|DB Period|Randomized and not treated|2|||
126209108|NCT04411641|454053152|FG002|DB Period|Randomized and not treated|0|||
126209109|NCT04411641|454053153|FG003|DB Period|Randomized and not treated|0|||
126209110|NCT04411641|454053150|FG000|OL|Withdrawal by Subject|0|||
126209111|NCT04411641|454053151|FG001|OL|Withdrawal by Subject|0|||
126209112|NCT04411641|454053152|FG002|OL|Withdrawal by Subject|6|||
126209113|NCT04411641|454053153|FG003|OL|Withdrawal by Subject|17|||
126209114|NCT04411641|454053150|FG000|OL|Progressive disease|0|||
126209115|NCT04411641|454053151|FG001|OL|Progressive disease|0|||
126209116|NCT04411641|454053152|FG002|OL|Progressive disease|1|||
126209117|NCT04411641|454053153|FG003|OL|Progressive disease|2|||
126209118|NCT04411641|454053150|FG000|OL|Poor compliance to protocol|0|||
126209119|NCT04411641|454053151|FG001|OL|Poor compliance to protocol|0|||
126209120|NCT04411641|454053152|FG002|OL|Poor compliance to protocol|1|||
126209121|NCT04411641|454053153|FG003|OL|Poor compliance to protocol|0|||
126327203|NCT01826981|454492318|FG000|Overall Study|Withdrew Consent|0|||
126327204|NCT01826981|454492319|FG001|Overall Study|Withdrew Consent|0|||
126327205|NCT01826981|454492320|FG002|Overall Study|Withdrew Consent|0|||
126327206|NCT01826981|454492321|FG003|Overall Study|Withdrew Consent|0|||
126327207|NCT01826981|454492322|FG004|Overall Study|Withdrew Consent|0|||
126209122|NCT04411641|454053150|FG000|OL|Adverse Event|0|||
126209123|NCT04411641|454053151|FG001|OL|Adverse Event|0|||
126209124|NCT04411641|454053152|FG002|OL|Adverse Event|1|||
126209125|NCT04411641|454053153|FG003|OL|Adverse Event|0|||
126209126|NCT04411641|454053150|FG000|OL|Other|0|||
126209127|NCT04411641|454053151|FG001|OL|Other|0|||
126209128|NCT04411641|454053152|FG002|OL|Other|0|||
126209129|NCT04411641|454053153|FG003|OL|Other|6|||
126209130|NCT01195662|454053158|FG000|Double Blind Treatment Period|Adverse Event|4|||
126209131|NCT01195662|454053159|FG001|Double Blind Treatment Period|Adverse Event|1|||
126209132|NCT01195662|454053160|FG002|Double Blind Treatment Period|Adverse Event|2|||
126209133|NCT01195662|454053158|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
126327208|NCT01826981|454492323|FG005|Overall Study|Withdrew Consent|0|||
126327209|NCT01826981|454492324|FG006|Overall Study|Withdrew Consent|1|||
126327210|NCT01826981|454492325|FG007|Overall Study|Withdrew Consent|1|||
126327211|NCT01826981|454492326|FG008|Overall Study|Withdrew Consent|0|||
126327212|NCT01826981|454492327|FG009|Overall Study|Withdrew Consent|0|||
126327213|NCT01826981|454492328|FG010|Overall Study|Withdrew Consent|0|||
126327214|NCT01826981|454492329|FG011|Overall Study|Withdrew Consent|1|||
126327215|NCT01826981|454492330|FG012|Overall Study|Withdrew Consent|0|||
126327216|NCT01826981|454492331|FG013|Overall Study|Withdrew Consent|1|||
126327217|NCT01826981|454492332|FG014|Overall Study|Withdrew Consent|0|||
126327218|NCT01826981|454492318|FG000|Overall Study|Adverse Event|0|||
126327219|NCT01826981|454492319|FG001|Overall Study|Adverse Event|0|||
126327220|NCT01826981|454492320|FG002|Overall Study|Adverse Event|0|||
126327221|NCT01826981|454492321|FG003|Overall Study|Adverse Event|0|||
126327222|NCT01826981|454492322|FG004|Overall Study|Adverse Event|1|||
126327223|NCT01826981|454492323|FG005|Overall Study|Adverse Event|0|||
126327224|NCT01826981|454492324|FG006|Overall Study|Adverse Event|0|||
126327225|NCT01826981|454492325|FG007|Overall Study|Adverse Event|0|||
126327226|NCT01826981|454492326|FG008|Overall Study|Adverse Event|0|||
126327227|NCT01826981|454492327|FG009|Overall Study|Adverse Event|0|||
126209134|NCT01195662|454053159|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
126209135|NCT01195662|454053160|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
126209136|NCT01195662|454053158|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
126209137|NCT01195662|454053159|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
126209138|NCT01195662|454053160|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
126209139|NCT01195662|454053158|FG000|Double Blind Treatment Period|Administrative reason|2|||
126209140|NCT01195662|454053159|FG001|Double Blind Treatment Period|Administrative reason|1|||
126209141|NCT01195662|454053160|FG002|Double Blind Treatment Period|Administrative reason|1|||
126209142|NCT01195662|454053158|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
126209143|NCT01195662|454053159|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
126209144|NCT01195662|454053160|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
126209145|NCT01195662|454053158|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
126209146|NCT01195662|454053159|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
126209147|NCT01195662|454053160|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
126209148|NCT01195662|454053158|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
126209149|NCT01195662|454053159|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
126209150|NCT01195662|454053160|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
126209151|NCT01195662|454053158|FG000|Double Blind Treatment Period|Non-specified|3|||
126209152|NCT01195662|454053159|FG001|Double Blind Treatment Period|Non-specified|0|||
126209153|NCT01195662|454053160|FG002|Double Blind Treatment Period|Non-specified|0|||
126209154|NCT01195662|454053158|FG000|Double Blind Treatment Period|Missing disposition information|0|||
126209155|NCT01195662|454053159|FG001|Double Blind Treatment Period|Missing disposition information|1|||
126209156|NCT01195662|454053160|FG002|Double Blind Treatment Period|Missing disposition information|1|||
126209157|NCT01195662|454053158|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
126209158|NCT01195662|454053159|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
126209159|NCT01195662|454053160|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
126209160|NCT01195662|454053158|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
126209161|NCT01195662|454053159|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
126209162|NCT01195662|454053160|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
126209163|NCT01215968|454053161|FG000|Overall Study|Adverse Event|0|||
126209164|NCT01215968|454053162|FG001|Overall Study|Adverse Event|2|||
126209165|NCT01215968|454053161|FG000|Overall Study|Protocol Violation|2|||
126209166|NCT01215968|454053162|FG001|Overall Study|Protocol Violation|4|||
126209167|NCT01215968|454053161|FG000|Overall Study|Not received study drug|0|||
126209168|NCT01215968|454053162|FG001|Overall Study|Not received study drug|1|||
126209169|NCT01250418|454053169|FG000|Overall Study|monitor data failure|1|||
126209170|NCT01250418|454053170|FG001|Overall Study|monitor data failure|1|||
126209171|NCT01761565|454053171|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
126209172|NCT05182840|454053173|FG000|Run-in Period|Not treated|0|||
126209173|NCT05182840|454053174|FG001|Run-in Period|Not treated|1|||
126209174|NCT05182840|454053175|FG002|Run-in Period|Not treated|0|||
126209175|NCT05182840|454053176|FG003|Run-in Period|Not treated|0|||
126209176|NCT05182840|454053177|FG004|Run-in Period|Not treated|0|||
126209177|NCT05182840|454053178|FG005|Run-in Period|Not treated|0|||
126209178|NCT05182840|454053179|FG006|Run-in Period|Not treated|0|||
126209179|NCT05182840|454053180|FG007|Run-in Period|Not treated|0|||
126327228|NCT01826981|454492328|FG010|Overall Study|Adverse Event|0|||
126327229|NCT01826981|454492329|FG011|Overall Study|Adverse Event|0|||
126327230|NCT01826981|454492330|FG012|Overall Study|Adverse Event|0|||
126327231|NCT01826981|454492331|FG013|Overall Study|Adverse Event|0|||
126327232|NCT01826981|454492332|FG014|Overall Study|Adverse Event|0|||
126209180|NCT05182840|454053181|FG008|Run-in Period|Not treated|0|||
126209181|NCT05182840|454053182|FG009|Run-in Period|Not treated|0|||
126209182|NCT05182840|454053173|FG000|Run-in Period|Other reason but not sponsor termination|14|||
126209183|NCT05182840|454053174|FG001|Run-in Period|Other reason but not sponsor termination|18|||
126327233|NCT01826981|454492318|FG000|Overall Study|Upper G-I Haemorrhage|0|||
126327234|NCT01826981|454492319|FG001|Overall Study|Upper G-I Haemorrhage|0|||
126327235|NCT01826981|454492320|FG002|Overall Study|Upper G-I Haemorrhage|0|||
126327236|NCT01826981|454492321|FG003|Overall Study|Upper G-I Haemorrhage|0|||
126327237|NCT01826981|454492322|FG004|Overall Study|Upper G-I Haemorrhage|0|||
126327238|NCT01826981|454492323|FG005|Overall Study|Upper G-I Haemorrhage|0|||
126327239|NCT01826981|454492324|FG006|Overall Study|Upper G-I Haemorrhage|0|||
126327240|NCT01826981|454492325|FG007|Overall Study|Upper G-I Haemorrhage|0|||
126327241|NCT01826981|454492326|FG008|Overall Study|Upper G-I Haemorrhage|0|||
126327242|NCT01826981|454492327|FG009|Overall Study|Upper G-I Haemorrhage|0|||
126327243|NCT01826981|454492328|FG010|Overall Study|Upper G-I Haemorrhage|0|||
126327244|NCT01826981|454492329|FG011|Overall Study|Upper G-I Haemorrhage|0|||
126327245|NCT01826981|454492330|FG012|Overall Study|Upper G-I Haemorrhage|0|||
126327246|NCT01826981|454492331|FG013|Overall Study|Upper G-I Haemorrhage|1|||
126327247|NCT01826981|454492332|FG014|Overall Study|Upper G-I Haemorrhage|0|||
126327248|NCT01826981|454492318|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327249|NCT01826981|454492319|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327250|NCT01826981|454492320|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327251|NCT01826981|454492321|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327252|NCT01826981|454492322|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327253|NCT01826981|454492323|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327254|NCT01826981|454492324|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327255|NCT01826981|454492325|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
126327256|NCT01826981|454492326|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327257|NCT01826981|454492327|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327258|NCT01826981|454492328|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327259|NCT01826981|454492329|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327260|NCT01826981|454492330|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327261|NCT01826981|454492331|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327262|NCT01826981|454492332|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327263|NCT02030119|454492337|FG000|Overall Study|Withdrawal by Subject|3|||
126327264|NCT02030119|454492338|FG001|Overall Study|Withdrawal by Subject|1|||
126327265|NCT02030119|454492339|FG002|Overall Study|Withdrawal by Subject|5|||
126327266|NCT02030119|454492340|FG003|Overall Study|Withdrawal by Subject|3|||
126327267|NCT02030119|454492337|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
126327268|NCT02030119|454492338|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
126327269|NCT02030119|454492339|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
126327270|NCT02030119|454492340|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
126327271|NCT00759655|454492341|FG000|Overall Study|Termination of the study by sponsor|1|||
126327272|NCT02793947|454492342|FG000|Overall Study|Death|1|||
126327273|NCT02793947|454492343|FG001|Overall Study|Death|0|||
126327274|NCT02793947|454492342|FG000|Overall Study|Physician Decision|1|||
126327275|NCT02793947|454492343|FG001|Overall Study|Physician Decision|5|||
126327276|NCT03746405|454492351|FG000|Overall Study|Withdrawal by Subject|3|||
126327277|NCT03746405|454492352|FG001|Overall Study|Withdrawal by Subject|0|||
126327278|NCT03746405|454492351|FG000|Overall Study|technical difficulties|0|||
126327279|NCT03746405|454492352|FG001|Overall Study|technical difficulties|2|||
126327280|NCT03479008|454492353|FG000|Overall Study|Withdrawal by Subject|3|||
126327281|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
126327282|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
126327283|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
126327284|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
126327285|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Other|1|||
126327286|NCT00412932|454492354|FG000|Olmesartan 40 mg|Adverse Event|4|||
126327287|NCT00412932|454492354|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
126327288|NCT00412932|454492354|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
126327289|NCT00412932|454492354|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
126327290|NCT00412932|454492354|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
126327291|NCT00412932|454492354|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
126327292|NCT00412932|454492354|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
126327293|NCT02753816|454492356|FG000|Overall Study|Protocol Violation|0|||
126327294|NCT02753816|454492357|FG001|Overall Study|Protocol Violation|1|||
126327295|NCT02753816|454492358|FG002|Overall Study|Protocol Violation|0|||
126327296|NCT01465230|454492359|FG000|Overall Study|Withdrawal by Subject|2|||
126327297|NCT00547248|454492364|FG000|Overall Study|Protocol Violation|0|||
126327298|NCT00547248|454492365|FG001|Overall Study|Protocol Violation|0|||
126327299|NCT00547248|454492366|FG002|Overall Study|Protocol Violation|1|||
126327300|NCT00547248|454492367|FG003|Overall Study|Protocol Violation|1|||
126327301|NCT00547248|454492364|FG000|Overall Study|Migrated/moved from study area|0|||
126327302|NCT00547248|454492365|FG001|Overall Study|Migrated/moved from study area|0|||
126327303|NCT00547248|454492366|FG002|Overall Study|Migrated/moved from study area|2|||
126327304|NCT00547248|454492367|FG003|Overall Study|Migrated/moved from study area|0|||
126327305|NCT00547248|454492364|FG000|Overall Study|Withdrawal by Subject|0|||
126209184|NCT05182840|454053175|FG002|Run-in Period|Other reason but not sponsor termination|0|||
126327306|NCT00547248|454492365|FG001|Overall Study|Withdrawal by Subject|0|||
126327307|NCT00547248|454492366|FG002|Overall Study|Withdrawal by Subject|7|||
126327308|NCT00547248|454492367|FG003|Overall Study|Withdrawal by Subject|1|||
126327309|NCT00534248|454492368|FG000|Overall Study|Adverse Event|19|||
126327310|NCT00534248|454492369|FG001|Overall Study|Adverse Event|29|||
126327311|NCT00534248|454492368|FG000|Overall Study|Lost to Follow-up|353|||
126327312|NCT00534248|454492369|FG001|Overall Study|Lost to Follow-up|375|||
126327313|NCT00534248|454492368|FG000|Overall Study|Other protocol specified criteria|13|||
126327314|NCT00534248|454492369|FG001|Overall Study|Other protocol specified criteria|3|||
126327315|NCT00534248|454492368|FG000|Overall Study|Physician Decision|10|||
126327316|NCT00534248|454492369|FG001|Overall Study|Physician Decision|7|||
126327317|NCT00534248|454492368|FG000|Overall Study|Protocol Violation|3|||
126327318|NCT00534248|454492369|FG001|Overall Study|Protocol Violation|4|||
126327319|NCT00534248|454492368|FG000|Overall Study|Withdrawal by Subject|263|||
126327320|NCT00534248|454492369|FG001|Overall Study|Withdrawal by Subject|255|||
126327321|NCT02849171|454492372|FG000|Overall Study|Withdrawal by Subject|1|||
126327322|NCT02849171|454492372|FG000|Overall Study|Not treated|1|||
126327323|NCT02532257|454492373|FG000|Overall Study|Adverse Event|2|||
126327324|NCT02532257|454492373|FG000|Overall Study|Physician Decision|4|||
126327325|NCT02532257|454492373|FG000|Overall Study|Withdrawal by Subject|3|||
126327326|NCT02532257|454492373|FG000|Overall Study|Progressive Disease|10|||
126327327|NCT02259400|454492376|FG000|Overall Study|Death|0|||
126327328|NCT02259400|454492377|FG001|Overall Study|Death|2|||
126327329|NCT00697593|454492379|FG000|Overall Study|Adverse Event|3|||
126327330|NCT00697593|454492379|FG000|Overall Study|Protocol Violation|1|||
126327331|NCT00697593|454492379|FG000|Overall Study|Lack of Efficacy|3|||
126327332|NCT00697593|454492379|FG000|Overall Study|Suspension of the study by sponsor|12|||
126327333|NCT02964338|454492380|FG000|Overall Study|Sponsor terminated study for futility|12|||
126327334|NCT02964338|454492381|FG001|Overall Study|Sponsor terminated study for futility|15|||
126327335|NCT02964338|454492382|FG002|Overall Study|Sponsor terminated study for futility|14|||
126327336|NCT02964338|454492380|FG000|Overall Study|Lack of Efficacy|0|||
126327337|NCT02964338|454492381|FG001|Overall Study|Lack of Efficacy|3|||
126327338|NCT02964338|454492382|FG002|Overall Study|Lack of Efficacy|0|||
126327339|NCT02964338|454492380|FG000|Overall Study|Lost to Follow-up|1|||
126327340|NCT02964338|454492381|FG001|Overall Study|Lost to Follow-up|0|||
126327341|NCT02964338|454492382|FG002|Overall Study|Lost to Follow-up|3|||
126327342|NCT02964338|454492380|FG000|Overall Study|Protocol Violation|0|||
126327343|NCT02964338|454492381|FG001|Overall Study|Protocol Violation|1|||
126327344|NCT02964338|454492382|FG002|Overall Study|Protocol Violation|0|||
126327345|NCT02964338|454492380|FG000|Overall Study|Withdrawal by Subject|1|||
126327346|NCT02964338|454492381|FG001|Overall Study|Withdrawal by Subject|3|||
126327347|NCT02964338|454492382|FG002|Overall Study|Withdrawal by Subject|1|||
126327348|NCT02964338|454492380|FG000|Overall Study|Adverse Event|2|||
126327349|NCT02964338|454492381|FG001|Overall Study|Adverse Event|1|||
126327350|NCT02964338|454492382|FG002|Overall Study|Adverse Event|1|||
126327351|NCT02964338|454492380|FG000|Overall Study|Non-compliant with e-diary|0|||
126327352|NCT02964338|454492381|FG001|Overall Study|Non-compliant with e-diary|1|||
126327353|NCT02964338|454492382|FG002|Overall Study|Non-compliant with e-diary|0|||
126327354|NCT02964338|454492380|FG000|Overall Study|Did not meet criteria|1|||
126327355|NCT02964338|454492381|FG001|Overall Study|Did not meet criteria|0|||
126327356|NCT02964338|454492382|FG002|Overall Study|Did not meet criteria|0|||
126327357|NCT02372383|454492386|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
126327358|NCT02372383|454492387|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
126327359|NCT02372383|454492388|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
126327360|NCT01704755|454492392|FG000|Overall Study|Adverse Event|4|||
126327361|NCT01704755|454492393|FG001|Overall Study|Adverse Event|1|||
126327362|NCT01704755|454492392|FG000|Overall Study|Lost to Follow-up|3|||
126327363|NCT01704755|454492393|FG001|Overall Study|Lost to Follow-up|4|||
126327364|NCT01704755|454492392|FG000|Overall Study|Withdrew consent|1|||
126327365|NCT01704755|454492393|FG001|Overall Study|Withdrew consent|1|||
126327366|NCT01704755|454492392|FG000|Overall Study|Other (not specified)|3|||
126327367|NCT01704755|454492393|FG001|Overall Study|Other (not specified)|1|||
126327368|NCT01704755|454492392|FG000|Overall Study|Withdrew consent and personal issues|1|||
126327369|NCT01704755|454492393|FG001|Overall Study|Withdrew consent and personal issues|0|||
126327370|NCT04105842|454492394|FG000|Overall Study|Withdrawal by Subject|2|||
126327371|NCT01639703|454492395|FG000|Overall Study|Withdrawal by Subject|5|||
126327372|NCT01639703|454492395|FG000|Overall Study|Other reason|7|||
126327373|NCT02087670|454492396|FG000|Overall Study|Withdrawal by Subject|3|||
126327374|NCT02087670|454492397|FG001|Overall Study|Withdrawal by Subject|2|||
126327375|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
126327376|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
126327377|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
126327378|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
126327379|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
126327380|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
126327381|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
126327382|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
126327383|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
126327384|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
126327385|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
126327386|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
126327387|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
126327388|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
126327389|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
126327390|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
126327391|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
126327392|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
126327393|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
126327394|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
126327395|NCT01042392|454492398|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
126327396|NCT01042392|454492399|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
126327397|NCT01042392|454492400|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
126327398|NCT01042392|454492401|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
126327399|NCT01042392|454492398|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
126327400|NCT01042392|454492399|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
126327401|NCT01042392|454492400|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
126327402|NCT01042392|454492401|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
126327403|NCT01042392|454492398|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
126327404|NCT01042392|454492399|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
126327405|NCT01042392|454492400|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
126327406|NCT01042392|454492401|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
126327407|NCT01042392|454492398|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
126327408|NCT01042392|454492399|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
126327409|NCT01042392|454492400|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
126327410|NCT01042392|454492401|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
126327411|NCT00587795|454492402|FG000|Overall Study|Withdrawal by Subject|1|||
126327412|NCT00587795|454492403|FG001|Overall Study|Withdrawal by Subject|0|||
126327413|NCT02869893|454492408|FG000|Overall Study|participant aversion to IV|5|||
126327414|NCT02869893|454492408|FG000|Overall Study|participant fear of MRI scanner|2|||
126327415|NCT00551525|454492413|FG000|Overall Study|Protocol Violation|5|||
126327416|NCT04676724|454492414|FG000|Overall Study|Adverse Event|2|||
126327417|NCT04676724|454492415|FG001|Overall Study|Adverse Event|0|||
126327418|NCT04676724|454492414|FG000|Overall Study|Lost to Follow-up|1|||
126327419|NCT04676724|454492415|FG001|Overall Study|Lost to Follow-up|0|||
126327420|NCT04676724|454492414|FG000|Overall Study|Physician Decision|0|||
126327421|NCT04676724|454492415|FG001|Overall Study|Physician Decision|1|||
126327422|NCT04676724|454492414|FG000|Overall Study|Withdrawal by Subject|3|||
126327423|NCT04676724|454492415|FG001|Overall Study|Withdrawal by Subject|2|||
126327424|NCT00099632|454492428|FG000|Overall Study|Lost to Follow-up|1|||
126327425|NCT00099632|454492429|FG001|Overall Study|Lost to Follow-up|0|||
126327426|NCT00099632|454492430|FG002|Overall Study|Lost to Follow-up|3|||
126327427|NCT00099632|454492431|FG003|Overall Study|Lost to Follow-up|1|||
126327428|NCT00099632|454492432|FG004|Overall Study|Lost to Follow-up|1|||
126327429|NCT00099632|454492433|FG005|Overall Study|Lost to Follow-up|0|||
126327430|NCT00099632|454492428|FG000|Overall Study|Withdrawal by Subject|0|||
126327431|NCT00099632|454492429|FG001|Overall Study|Withdrawal by Subject|1|||
126327432|NCT00099632|454492430|FG002|Overall Study|Withdrawal by Subject|0|||
126327433|NCT00099632|454492431|FG003|Overall Study|Withdrawal by Subject|0|||
126327434|NCT00099632|454492432|FG004|Overall Study|Withdrawal by Subject|0|||
126327435|NCT00099632|454492433|FG005|Overall Study|Withdrawal by Subject|1|||
126327436|NCT00099632|454492428|FG000|Overall Study|Protocol Violation|0|||
126327437|NCT00099632|454492429|FG001|Overall Study|Protocol Violation|0|||
126327438|NCT00099632|454492430|FG002|Overall Study|Protocol Violation|0|||
126327439|NCT00099632|454492431|FG003|Overall Study|Protocol Violation|0|||
126327440|NCT00099632|454492432|FG004|Overall Study|Protocol Violation|0|||
126327441|NCT00099632|454492433|FG005|Overall Study|Protocol Violation|1|||
126327442|NCT02710084|454492441|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
126327443|NCT02710084|454492442|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
126327444|NCT05305989|454492443|FG000|Overall Study|Other|3|||
126327445|NCT05305989|454492444|FG001|Overall Study|Other|2|||
126327446|NCT05305989|454492445|FG002|Overall Study|Other|0|||
126327447|NCT05305989|454492443|FG000|Overall Study|Sponsor decision|2|||
126327448|NCT05305989|454492444|FG001|Overall Study|Sponsor decision|1|||
126327449|NCT05305989|454492445|FG002|Overall Study|Sponsor decision|0|||
126327450|NCT05305989|454492443|FG000|Overall Study|Protocol Violation|0|||
126327451|NCT05305989|454492444|FG001|Overall Study|Protocol Violation|1|||
126327452|NCT05305989|454492445|FG002|Overall Study|Protocol Violation|0|||
126327453|NCT05305989|454492443|FG000|Overall Study|Investigator decision|1|||
126327454|NCT05305989|454492444|FG001|Overall Study|Investigator decision|2|||
126327455|NCT05305989|454492445|FG002|Overall Study|Investigator decision|0|||
126327456|NCT05305989|454492443|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
126327457|NCT05305989|454492444|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
126327458|NCT05305989|454492445|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
126327459|NCT05305989|454492443|FG000|Overall Study|Adverse Event|1|||
126327460|NCT05305989|454492444|FG001|Overall Study|Adverse Event|1|||
126327461|NCT05305989|454492445|FG002|Overall Study|Adverse Event|0|||
126327462|NCT05305989|454492443|FG000|Overall Study|Enrolled but never dosed|3|||
126327463|NCT05305989|454492444|FG001|Overall Study|Enrolled but never dosed|2|||
126327464|NCT05305989|454492445|FG002|Overall Study|Enrolled but never dosed|1|||
126327465|NCT00282152|454492446|FG000|Overall Study|Withdrawal by Subject|1|||
126327466|NCT00282152|454492447|FG001|Overall Study|Withdrawal by Subject|0|||
126327467|NCT03301831|454492448|FG000|Overall Study|Lost to Follow-up|5|||
126327468|NCT03301831|454492449|FG001|Overall Study|Lost to Follow-up|3|||
126327469|NCT03301831|454492448|FG000|Overall Study|Protocol Violation|4|||
126327470|NCT03301831|454492449|FG001|Overall Study|Protocol Violation|0|||
126327471|NCT03301831|454492448|FG000|Overall Study|Withdrawal by Subject|11|||
126327472|NCT03301831|454492449|FG001|Overall Study|Withdrawal by Subject|0|||
126327473|NCT02182830|454492451|FG000|Overall Study|Not Treated|1|||
126327474|NCT02182830|454492452|FG001|Overall Study|Not Treated|1|||
126327475|NCT02182830|454492451|FG000|Overall Study|Trial stopped, reason missing|3|||
126327476|NCT02182830|454492452|FG001|Overall Study|Trial stopped, reason missing|3|||
126327477|NCT02182830|454492451|FG000|Overall Study|Consent withdrawn|8|||
126327478|NCT02182830|454492452|FG001|Overall Study|Consent withdrawn|8|||
126327479|NCT02182830|454492451|FG000|Overall Study|Lost to Follow-up|3|||
126327480|NCT02182830|454492452|FG001|Overall Study|Lost to Follow-up|3|||
126327481|NCT02348008|454492453|FG000|Overall Study|Adverse Event|2|||
126327482|NCT02348008|454492454|FG001|Overall Study|Adverse Event|3|||
126327483|NCT02348008|454492455|FG002|Overall Study|Adverse Event|3|||
126327484|NCT02348008|454492453|FG000|Overall Study|Disease Progression|1|||
126327485|NCT02348008|454492454|FG001|Overall Study|Disease Progression|5|||
126327486|NCT02348008|454492455|FG002|Overall Study|Disease Progression|16|||
126327487|NCT02348008|454492453|FG000|Overall Study|Withdrawal by Subject|0|||
126327488|NCT02348008|454492454|FG001|Overall Study|Withdrawal by Subject|1|||
126327489|NCT02348008|454492455|FG002|Overall Study|Withdrawal by Subject|0|||
126327490|NCT02348008|454492453|FG000|Overall Study|Symptomatic Deterioration|0|||
126327491|NCT02348008|454492454|FG001|Overall Study|Symptomatic Deterioration|1|||
126327492|NCT02348008|454492455|FG002|Overall Study|Symptomatic Deterioration|0|||
126327493|NCT03268005|454492460|FG000|Overall Study|Death|2|||
126327494|NCT03268005|454492461|FG001|Overall Study|Death|1|||
126327495|NCT03268005|454492460|FG000|Overall Study|Lost to Follow-up|2|||
126327496|NCT03268005|454492461|FG001|Overall Study|Lost to Follow-up|2|||
126327497|NCT03268005|454492460|FG000|Overall Study|Withdrawal by Subject|11|||
126327498|NCT03268005|454492461|FG001|Overall Study|Withdrawal by Subject|11|||
126327499|NCT00792116|454492464|FG000|Overall Study|Lost to Follow-up|0|||
126327500|NCT00792116|454492465|FG001|Overall Study|Lost to Follow-up|1|||
126327501|NCT00792116|454492464|FG000|Overall Study|Discontnued intervention|1|||
126327502|NCT00792116|454492465|FG001|Overall Study|Discontnued intervention|0|||
126327503|NCT00845676|454492468|FG000|Overall Study|Virologic breakthrough at week 20|1|||
126327504|NCT00845676|454492468|FG000|Overall Study|Adverse Event|1|||
126327505|NCT00481767|454492469|FG000|Overall Study|Withdrawal by Subject|16|||
126327506|NCT00481767|454492470|FG001|Overall Study|Withdrawal by Subject|11|||
126327507|NCT00481767|454492469|FG000|Overall Study|Lost to Follow-up|16|||
126327508|NCT00481767|454492470|FG001|Overall Study|Lost to Follow-up|10|||
126327509|NCT03630705|454494052|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
126327510|NCT03630705|454494053|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
126327511|NCT03630705|454494054|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
126327512|NCT03630705|454494055|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126327513|NCT03630705|454494052|FG000|Overall Study|Lost to Follow-up|1|||
126327514|NCT03630705|454494053|FG001|Overall Study|Lost to Follow-up|2|||
126327515|NCT03630705|454494054|FG002|Overall Study|Lost to Follow-up|0|||
126327516|NCT03630705|454494055|FG003|Overall Study|Lost to Follow-up|0|||
126327517|NCT01310127|454494056|FG000|Overall Study|Protocol Violation|1|||
126209185|NCT05182840|454053176|FG003|Run-in Period|Other reason but not sponsor termination|0|||
126327518|NCT01310127|454494057|FG001|Overall Study|Protocol Violation|1|||
126327519|NCT01310127|454494056|FG000|Overall Study|advanced psc cataract outlier|1|||
126327520|NCT01310127|454494057|FG001|Overall Study|advanced psc cataract outlier|0|||
126327521|NCT01490840|454494058|FG000|Phase 1|Lost to Follow-up|1|||
126327522|NCT01490840|454494059|FG001|Phase 1|Lost to Follow-up|0|||
126327523|NCT01490840|454494058|FG000|Phase 1|Adverse Event|2|||
126327524|NCT01490840|454494059|FG001|Phase 1|Adverse Event|1|||
126327525|NCT01490840|454494058|FG000|Phase 1|Withdrawal by Subject|6|||
126327526|NCT01490840|454494059|FG001|Phase 1|Withdrawal by Subject|5|||
126327527|NCT01490840|454494058|FG000|Phase 1|Visit 6a omitted|1|||
126327528|NCT01490840|454494059|FG001|Phase 1|Visit 6a omitted|0|||
126327529|NCT01490840|454494058|FG000|Phase 2|Withdrawal by Subject|4|||
126327530|NCT01490840|454494059|FG001|Phase 2|Withdrawal by Subject|3|||
126327531|NCT01490840|454494058|FG000|Phase 2|Permanent interruption of fingolimod|0|||
126327532|NCT01490840|454494059|FG001|Phase 2|Permanent interruption of fingolimod|1|||
126327533|NCT01490840|454494058|FG000|Phase 2|Lost to Follow-up|1|||
126327534|NCT01490840|454494059|FG001|Phase 2|Lost to Follow-up|1|||
126327535|NCT01490840|454494058|FG000|Phase 2|Adverse Event|1|||
126327536|NCT01490840|454494059|FG001|Phase 2|Adverse Event|1|||
126327537|NCT01025284|454494060|FG000|Overall Study|Investigator Decision|0|||
126327538|NCT01025284|454494061|FG001|Overall Study|Investigator Decision|1|||
126327539|NCT01025284|454494062|FG002|Overall Study|Investigator Decision|0|||
126327540|NCT01025284|454494060|FG000|Overall Study|Withdrawal by Subject|0|||
126327541|NCT01025284|454494061|FG001|Overall Study|Withdrawal by Subject|1|||
126327542|NCT01025284|454494062|FG002|Overall Study|Withdrawal by Subject|0|||
126327543|NCT00905567|454494063|FG000|Washout|Withdrawal by Subject|0|||
126327544|NCT00905567|454494064|FG001|Washout|Withdrawal by Subject|1|||
126327545|NCT02542397|454494065|FG000|Overall Study|Death|2|||
126327546|NCT02542397|454494065|FG000|Overall Study|Physician Decision|6|||
126327547|NCT02542397|454494065|FG000|Overall Study|Withdrawal by Subject|6|||
126327548|NCT02542397|454494065|FG000|Overall Study|Lost to Follow-up|2|||
126327549|NCT01738919|454494071|FG000|Overall Study|Lost to Follow-up|1|||
126327550|NCT01738919|454494072|FG001|Overall Study|Lost to Follow-up|0|||
126327551|NCT01738919|454494071|FG000|Overall Study|Immigrated|0|||
126327552|NCT01738919|454494072|FG001|Overall Study|Immigrated|1|||
126327553|NCT01738919|454494071|FG000|Overall Study|Withdrawal by Subject|0|||
126327554|NCT01738919|454494072|FG001|Overall Study|Withdrawal by Subject|1|||
126327555|NCT01738919|454494071|FG000|Overall Study|Not treated in accordance to guidelines|0|||
126327556|NCT01738919|454494072|FG001|Overall Study|Not treated in accordance to guidelines|1|||
126327557|NCT01473940|454494073|FG000|Induction Therapy|Death|0|||
126327558|NCT01473940|454494074|FG001|Induction Therapy|Death|0|||
126327559|NCT01473940|454494075|FG002|Induction Therapy|Death|1|||
126327560|NCT01473940|454494076|FG003|Induction Therapy|Death|1|||
126327561|NCT01473940|454494073|FG000|Induction Therapy|Progressive Disease|0|||
126327562|NCT01473940|454494074|FG001|Induction Therapy|Progressive Disease|1|||
126327563|NCT01473940|454494075|FG002|Induction Therapy|Progressive Disease|1|||
126327564|NCT01473940|454494076|FG003|Induction Therapy|Progressive Disease|0|||
126327565|NCT01473940|454494073|FG000|Maintenance Therapy|Progressive Disease|1|||
126327566|NCT01473940|454494074|FG001|Maintenance Therapy|Progressive Disease|2|||
126327567|NCT01473940|454494075|FG002|Maintenance Therapy|Progressive Disease|1|||
126327568|NCT01473940|454494076|FG003|Maintenance Therapy|Progressive Disease|4|||
126327569|NCT00741598|454494077|FG000|Overall Study|Lost to Follow-up|3|||
126327570|NCT00741598|454494078|FG001|Overall Study|Lost to Follow-up|4|||
126327571|NCT00741598|454494077|FG000|Overall Study|Lack of Efficacy|1|||
126327572|NCT00741598|454494078|FG001|Overall Study|Lack of Efficacy|2|||
126327573|NCT00741598|454494077|FG000|Overall Study|Physician Decision|1|||
126327574|NCT00741598|454494078|FG001|Overall Study|Physician Decision|1|||
126327575|NCT00741598|454494077|FG000|Overall Study|Pregnancy|1|||
126327576|NCT00741598|454494078|FG001|Overall Study|Pregnancy|0|||
126327577|NCT00741598|454494077|FG000|Overall Study|Withdrawal by Subject|3|||
126327578|NCT00741598|454494078|FG001|Overall Study|Withdrawal by Subject|2|||
126327579|NCT00435461|454494081|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
126327580|NCT00435461|454494082|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
126327581|NCT00435461|454494083|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
126327582|NCT00435461|454494081|FG000|Overall Study|Protocol Violation|6|||
126327583|NCT00435461|454494082|FG001|Overall Study|Protocol Violation|9|||
126327584|NCT00435461|454494083|FG002|Overall Study|Protocol Violation|10|||
126327585|NCT00435461|454494081|FG000|Overall Study|Participant randomized(inadequate score)|1|||
126327586|NCT00435461|454494082|FG001|Overall Study|Participant randomized(inadequate score)|0|||
126327587|NCT00435461|454494083|FG002|Overall Study|Participant randomized(inadequate score)|0|||
126327588|NCT00435461|454494081|FG000|Overall Study|Compliance less than 80 percent|1|||
126327589|NCT00435461|454494082|FG001|Overall Study|Compliance less than 80 percent|0|||
126327590|NCT00435461|454494083|FG002|Overall Study|Compliance less than 80 percent|0|||
126327591|NCT00435461|454494081|FG000|Overall Study|In error, two study medications switched|1|||
126327592|NCT00435461|454494082|FG001|Overall Study|In error, two study medications switched|0|||
126327593|NCT00435461|454494083|FG002|Overall Study|In error, two study medications switched|0|||
126327594|NCT00435461|454494081|FG000|Overall Study|Lack of Efficacy|2|||
126327595|NCT00435461|454494082|FG001|Overall Study|Lack of Efficacy|1|||
126327596|NCT00435461|454494083|FG002|Overall Study|Lack of Efficacy|0|||
126327597|NCT00435461|454494081|FG000|Overall Study|Withdrawal by Subject|1|||
126327598|NCT00435461|454494082|FG001|Overall Study|Withdrawal by Subject|0|||
126327599|NCT00435461|454494083|FG002|Overall Study|Withdrawal by Subject|2|||
126327600|NCT00435461|454494081|FG000|Overall Study|Randomized in error|1|||
126327601|NCT00435461|454494082|FG001|Overall Study|Randomized in error|0|||
126327602|NCT00435461|454494083|FG002|Overall Study|Randomized in error|0|||
126327603|NCT00435461|454494081|FG000|Overall Study|Participant could not tolerate symptoms|0|||
126327604|NCT00435461|454494082|FG001|Overall Study|Participant could not tolerate symptoms|0|||
126327605|NCT00435461|454494083|FG002|Overall Study|Participant could not tolerate symptoms|1|||
126327606|NCT00435461|454494081|FG000|Overall Study|Participant could not swallow capsule|0|||
126327607|NCT00435461|454494082|FG001|Overall Study|Participant could not swallow capsule|0|||
126327608|NCT00435461|454494083|FG002|Overall Study|Participant could not swallow capsule|1|||
126327609|NCT00435461|454494081|FG000|Overall Study|Pregnancy|2|||
126327610|NCT00435461|454494082|FG001|Overall Study|Pregnancy|0|||
126327611|NCT00435461|454494083|FG002|Overall Study|Pregnancy|0|||
126327612|NCT00435461|454494081|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
126327613|NCT00435461|454494082|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
126327614|NCT00435461|454494083|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
126327615|NCT00435461|454494081|FG000|Overall Study|Participant ended study one day early|1|||
126327616|NCT00435461|454494082|FG001|Overall Study|Participant ended study one day early|0|||
126327617|NCT00435461|454494083|FG002|Overall Study|Participant ended study one day early|0|||
126327618|NCT00435461|454494081|FG000|Overall Study|Noncompliance with study requirements|1|||
126327619|NCT00435461|454494082|FG001|Overall Study|Noncompliance with study requirements|1|||
126327620|NCT00435461|454494083|FG002|Overall Study|Noncompliance with study requirements|1|||
126327621|NCT00435461|454494081|FG000|Overall Study|Adverse Event|1|||
126327622|NCT00435461|454494082|FG001|Overall Study|Adverse Event|2|||
126327623|NCT00435461|454494083|FG002|Overall Study|Adverse Event|6|||
126327624|NCT00435461|454494081|FG000|Overall Study|Non-Compliance of diary|2|||
126327625|NCT00435461|454494082|FG001|Overall Study|Non-Compliance of diary|0|||
126327626|NCT00435461|454494083|FG002|Overall Study|Non-Compliance of diary|1|||
126327627|NCT00435461|454494081|FG000|Overall Study|Lost to Follow-up|1|||
126327628|NCT00435461|454494082|FG001|Overall Study|Lost to Follow-up|1|||
126327629|NCT00435461|454494083|FG002|Overall Study|Lost to Follow-up|2|||
126327630|NCT00837967|454494084|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
126327631|NCT00837967|454494085|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
126327632|NCT05446142|454494101|FG000|Period 2|Adverse Event|1|||
126327633|NCT05446142|454494102|FG001|Period 2|Adverse Event|0|||
126327634|NCT05446142|454494103|FG002|Period 2|Adverse Event|0|||
126327635|NCT05446142|454494104|FG003|Period 2|Adverse Event|0|||
126327636|NCT05446142|454494105|FG004|Period 2|Adverse Event|0|||
126327637|NCT05446142|454494106|FG005|Period 2|Adverse Event|0|||
126327638|NCT02098395|454494107|FG000|Overall Study|Protocol Violation|2|||
126327639|NCT02098395|454494108|FG001|Overall Study|Protocol Violation|2|||
126327640|NCT02098395|454494109|FG002|Overall Study|Protocol Violation|0|||
126327641|NCT02098395|454494110|FG003|Overall Study|Protocol Violation|7|||
126327642|NCT02098395|454494107|FG000|Overall Study|Withdrawal by Subject|10|||
126327643|NCT02098395|454494108|FG001|Overall Study|Withdrawal by Subject|10|||
126327644|NCT02098395|454494109|FG002|Overall Study|Withdrawal by Subject|5|||
126327645|NCT02098395|454494110|FG003|Overall Study|Withdrawal by Subject|13|||
126327646|NCT02098395|454494107|FG000|Overall Study|Adverse Event|12|||
126327647|NCT02098395|454494108|FG001|Overall Study|Adverse Event|19|||
126327648|NCT02098395|454494109|FG002|Overall Study|Adverse Event|34|||
126327649|NCT02098395|454494110|FG003|Overall Study|Adverse Event|2|||
126327650|NCT02098395|454494107|FG000|Overall Study|Lost to Follow-up|2|||
126327651|NCT02098395|454494108|FG001|Overall Study|Lost to Follow-up|1|||
126327652|NCT02098395|454494109|FG002|Overall Study|Lost to Follow-up|0|||
126327653|NCT02098395|454494110|FG003|Overall Study|Lost to Follow-up|3|||
126327654|NCT02098395|454494107|FG000|Overall Study|Unclassified|0|||
126327655|NCT02098395|454494108|FG001|Overall Study|Unclassified|0|||
126327656|NCT02098395|454494109|FG002|Overall Study|Unclassified|3|||
126327657|NCT02098395|454494110|FG003|Overall Study|Unclassified|2|||
126327658|NCT00547157|454494113|FG000|Overall Study|Other|1|||
126327659|NCT00547157|454494114|FG001|Overall Study|Other|0|||
126327660|NCT00547157|454494113|FG000|Overall Study|Death|38|||
126327661|NCT00547157|454494114|FG001|Overall Study|Death|18|||
126327662|NCT00547157|454494113|FG000|Overall Study|Withdrawal by Subject|3|||
126327663|NCT00547157|454494114|FG001|Overall Study|Withdrawal by Subject|1|||
126327664|NCT00547157|454494113|FG000|Overall Study|Administrative decision|3|||
126327665|NCT00547157|454494114|FG001|Overall Study|Administrative decision|2|||
126327666|NCT00547157|454494113|FG000|Overall Study|Lost to Follow-up|4|||
126327667|NCT00547157|454494114|FG001|Overall Study|Lost to Follow-up|2|||
126327668|NCT00110357|454494115|FG000|Overall Study|Deterioration without progression|2|||
126327669|NCT00110357|454494116|FG001|Overall Study|Deterioration without progression|0|||
126327670|NCT00110357|454494115|FG000|Overall Study|Disease progression/relapse|20|||
126327671|NCT00110357|454494116|FG001|Overall Study|Disease progression/relapse|15|||
126327672|NCT00110357|454494115|FG000|Overall Study|Study Closure|1|||
126327673|NCT00110357|454494116|FG001|Overall Study|Study Closure|0|||
126327674|NCT00110357|454494115|FG000|Overall Study|Study Drug Toxicity|1|||
126327675|NCT00110357|454494116|FG001|Overall Study|Study Drug Toxicity|3|||
126327676|NCT00110357|454494115|FG000|Overall Study|Withdrawal by Subject|3|||
126327677|NCT00110357|454494116|FG001|Overall Study|Withdrawal by Subject|1|||
126327678|NCT03382418|454494117|FG000|Overall Study|Withdrawal by Subject|1|||
126327679|NCT03382418|454494118|FG001|Overall Study|Withdrawal by Subject|0|||
126327680|NCT03382418|454494119|FG002|Overall Study|Withdrawal by Subject|0|||
126327681|NCT03382418|454494117|FG000|Overall Study|Lost to Follow-up|2|||
126327682|NCT03382418|454494118|FG001|Overall Study|Lost to Follow-up|3|||
126327683|NCT03382418|454494119|FG002|Overall Study|Lost to Follow-up|0|||
126327684|NCT04633226|454494120|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126327685|NCT04633226|454494120|FG000|Overall Study|Randomized by mistake without study treatment|1|||
126327686|NCT01151345|454494122|FG000|First Intervention Period|Protocol Violation|0|||
126327687|NCT01151345|454494123|FG001|First Intervention Period|Protocol Violation|1|||
126327688|NCT01348100|454494125|FG000|Overall Study|Subject Withdrew Consent|0|||
126327689|NCT01348100|454494126|FG001|Overall Study|Subject Withdrew Consent|0|||
126327690|NCT01348100|454494127|FG002|Overall Study|Subject Withdrew Consent|2|||
126327691|NCT01348100|454494128|FG003|Overall Study|Subject Withdrew Consent|0|||
126327692|NCT01348100|454494129|FG004|Overall Study|Subject Withdrew Consent|1|||
126327693|NCT01348100|454494130|FG005|Overall Study|Subject Withdrew Consent|0|||
126327694|NCT01348100|454494131|FG006|Overall Study|Subject Withdrew Consent|1|||
126327695|NCT01348100|454494125|FG000|Overall Study|Protocol Deviation|0|||
126327696|NCT01348100|454494126|FG001|Overall Study|Protocol Deviation|0|||
126327697|NCT01348100|454494127|FG002|Overall Study|Protocol Deviation|0|||
126327698|NCT01348100|454494128|FG003|Overall Study|Protocol Deviation|1|||
126327699|NCT01348100|454494129|FG004|Overall Study|Protocol Deviation|0|||
126327700|NCT01348100|454494130|FG005|Overall Study|Protocol Deviation|0|||
126327701|NCT01348100|454494131|FG006|Overall Study|Protocol Deviation|0|||
126327702|NCT01348100|454494125|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327703|NCT01348100|454494126|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327704|NCT01348100|454494127|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327705|NCT01348100|454494128|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327706|NCT01348100|454494129|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327707|NCT01348100|454494130|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126327708|NCT01348100|454494131|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327709|NCT01348100|454494125|FG000|Overall Study|Lost to Follow-up|0|||
126327710|NCT01348100|454494126|FG001|Overall Study|Lost to Follow-up|0|||
126327711|NCT01348100|454494127|FG002|Overall Study|Lost to Follow-up|0|||
126327712|NCT01348100|454494128|FG003|Overall Study|Lost to Follow-up|0|||
126327713|NCT01348100|454494129|FG004|Overall Study|Lost to Follow-up|0|||
126327714|NCT01348100|454494130|FG005|Overall Study|Lost to Follow-up|0|||
126327715|NCT01348100|454494131|FG006|Overall Study|Lost to Follow-up|1|||
126327716|NCT01348100|454494125|FG000|Overall Study|Administrative Problems|0|||
126327717|NCT01348100|454494126|FG001|Overall Study|Administrative Problems|0|||
126327718|NCT01348100|454494127|FG002|Overall Study|Administrative Problems|0|||
126327719|NCT01348100|454494128|FG003|Overall Study|Administrative Problems|0|||
126327720|NCT01348100|454494129|FG004|Overall Study|Administrative Problems|0|||
126327721|NCT01348100|454494130|FG005|Overall Study|Administrative Problems|1|||
126327722|NCT01348100|454494131|FG006|Overall Study|Administrative Problems|1|||
126327723|NCT03882957|454494134|FG000|Overall Study|Did not complete all three arms|1|||
126327724|NCT04186221|454494139|FG000|Overall Study|Death|1|||
126209186|NCT05182840|454053177|FG004|Run-in Period|Other reason but not sponsor termination|0|||
126209187|NCT05182840|454053178|FG005|Run-in Period|Other reason but not sponsor termination|0|||
126209188|NCT05182840|454053179|FG006|Run-in Period|Other reason but not sponsor termination|0|||
126209189|NCT05182840|454053180|FG007|Run-in Period|Other reason but not sponsor termination|0|||
126209190|NCT05182840|454053181|FG008|Run-in Period|Other reason but not sponsor termination|0|||
126209191|NCT05182840|454053182|FG009|Run-in Period|Other reason but not sponsor termination|0|||
126209192|NCT05182840|454053173|FG000|Run-in Period|No reason available|2|||
126209193|NCT05182840|454053174|FG001|Run-in Period|No reason available|2|||
126209194|NCT05182840|454053175|FG002|Run-in Period|No reason available|0|||
126209195|NCT05182840|454053176|FG003|Run-in Period|No reason available|0|||
126209196|NCT05182840|454053177|FG004|Run-in Period|No reason available|0|||
126209197|NCT05182840|454053178|FG005|Run-in Period|No reason available|0|||
126209198|NCT05182840|454053179|FG006|Run-in Period|No reason available|0|||
126209199|NCT05182840|454053180|FG007|Run-in Period|No reason available|0|||
126209200|NCT05182840|454053181|FG008|Run-in Period|No reason available|0|||
126209201|NCT05182840|454053182|FG009|Run-in Period|No reason available|0|||
126209202|NCT05182840|454053173|FG000|Run-in Period|Burden of study procedures|2|||
126209203|NCT05182840|454053174|FG001|Run-in Period|Burden of study procedures|2|||
126209204|NCT05182840|454053175|FG002|Run-in Period|Burden of study procedures|0|||
126209205|NCT05182840|454053176|FG003|Run-in Period|Burden of study procedures|0|||
126209206|NCT05182840|454053177|FG004|Run-in Period|Burden of study procedures|0|||
126209207|NCT05182840|454053178|FG005|Run-in Period|Burden of study procedures|0|||
126209208|NCT05182840|454053179|FG006|Run-in Period|Burden of study procedures|0|||
126209209|NCT05182840|454053180|FG007|Run-in Period|Burden of study procedures|0|||
126209210|NCT05182840|454053181|FG008|Run-in Period|Burden of study procedures|0|||
126209211|NCT05182840|454053182|FG009|Run-in Period|Burden of study procedures|0|||
126209212|NCT05182840|454053173|FG000|Run-in Period|Change of residence|1|||
126209213|NCT05182840|454053174|FG001|Run-in Period|Change of residence|0|||
126327725|NCT01134393|454494140|FG000|Overall Study|Adverse Event|18|||
126327726|NCT01134393|454494140|FG000|Overall Study|Lack of Efficacy|2|||
126327727|NCT01134393|454494140|FG000|Overall Study|Protocol Violation|12|||
126327728|NCT01134393|454494140|FG000|Overall Study|Lost to Follow-up|3|||
126327729|NCT01134393|454494140|FG000|Overall Study|Withdrawal by Subject|11|||
126327730|NCT01134393|454494140|FG000|Overall Study|Other|6|||
126327731|NCT00531947|454494141|FG000|Overall Study|Adverse Event|5|||
126327732|NCT00531947|454494142|FG001|Overall Study|Adverse Event|10|||
126327733|NCT00531947|454494141|FG000|Overall Study|Lost to Follow-up|12|||
126327734|NCT00531947|454494142|FG001|Overall Study|Lost to Follow-up|9|||
126327735|NCT00531947|454494141|FG000|Overall Study|Withdrawal by Subject|14|||
126327736|NCT00531947|454494142|FG001|Overall Study|Withdrawal by Subject|19|||
126327737|NCT00531947|454494141|FG000|Overall Study|Protocol Violation|2|||
126327738|NCT00531947|454494142|FG001|Overall Study|Protocol Violation|1|||
126327739|NCT00531947|454494141|FG000|Overall Study|Non-Compliance|4|||
126327740|NCT00531947|454494142|FG001|Overall Study|Non-Compliance|7|||
126327741|NCT00531947|454494141|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
126327742|NCT00531947|454494142|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
126327743|NCT03134911|454494147|FG000|Overall Study|Screen failure|31|||
126327744|NCT03134911|454494147|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
126327745|NCT01087203|454494148|FG000|Overall Study|Lost to Follow-up|2|||
126327746|NCT01087203|454494149|FG001|Overall Study|Lost to Follow-up|0|||
126327747|NCT01087203|454494148|FG000|Overall Study|Withdrawal by Subject|2|||
126327748|NCT01087203|454494149|FG001|Overall Study|Withdrawal by Subject|6|||
126327749|NCT01087203|454494148|FG000|Overall Study|Lack of Efficacy|1|||
126327750|NCT01087203|454494149|FG001|Overall Study|Lack of Efficacy|2|||
126327751|NCT01087203|454494148|FG000|Overall Study|Study terminated by sponsor|27|||
126327752|NCT01087203|454494149|FG001|Overall Study|Study terminated by sponsor|27|||
126327753|NCT00420628|454494154|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
126327754|NCT00420628|454494155|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
126327755|NCT00420628|454494154|FG000|Overall Study|Lost to Follow-up|3|||
126327756|NCT00420628|454494155|FG001|Overall Study|Lost to Follow-up|2|||
126327757|NCT00420628|454494154|FG000|Overall Study|Adverse Event|1|||
126327758|NCT00420628|454494155|FG001|Overall Study|Adverse Event|0|||
126327759|NCT02903420|454494161|FG000|Overall Study|Death|3|||
126327760|NCT02787083|454494163|FG000|Overall Study|Adverse Event|1|||
126327761|NCT02787083|454494164|FG001|Overall Study|Adverse Event|0|||
126327762|NCT02787083|454494163|FG000|Overall Study|Withdrawal by Subject|2|||
126327763|NCT02787083|454494164|FG001|Overall Study|Withdrawal by Subject|2|||
126327764|NCT03162328|454494165|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
126327765|NCT03162328|454494166|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
126327766|NCT03162328|454494167|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
126327767|NCT03162328|454494165|FG000|Screening Period|Withdrawal by Subject|1|||
126327768|NCT03162328|454494166|FG001|Screening Period|Withdrawal by Subject|0|||
126327769|NCT03162328|454494167|FG002|Screening Period|Withdrawal by Subject|0|||
126327770|NCT03162328|454494165|FG000|Study Period|Withdrawal by Subject|0|||
126327771|NCT03162328|454494166|FG001|Study Period|Withdrawal by Subject|0|||
126327772|NCT03162328|454494167|FG002|Study Period|Withdrawal by Subject|1|||
126327773|NCT03092791|454494168|FG000|Overall Study|Lost to Follow-up|0|||
126327774|NCT03092791|454494169|FG001|Overall Study|Lost to Follow-up|0|||
126327775|NCT03092791|454494170|FG002|Overall Study|Lost to Follow-up|0|||
126327776|NCT03092791|454494171|FG003|Overall Study|Lost to Follow-up|0|||
126327777|NCT03092791|454494172|FG004|Overall Study|Lost to Follow-up|0|||
126327778|NCT03092791|454494173|FG005|Overall Study|Lost to Follow-up|0|||
126327779|NCT03092791|454494174|FG006|Overall Study|Lost to Follow-up|1|||
126327780|NCT03092791|454494175|FG007|Overall Study|Lost to Follow-up|0|||
126327781|NCT03092791|454494168|FG000|Overall Study|Withdrawal of Consent|0|||
126327782|NCT03092791|454494169|FG001|Overall Study|Withdrawal of Consent|0|||
126327783|NCT03092791|454494170|FG002|Overall Study|Withdrawal of Consent|0|||
126327784|NCT03092791|454494171|FG003|Overall Study|Withdrawal of Consent|0|||
126327785|NCT03092791|454494172|FG004|Overall Study|Withdrawal of Consent|4|||
126327786|NCT03092791|454494173|FG005|Overall Study|Withdrawal of Consent|12|||
126327787|NCT03092791|454494174|FG006|Overall Study|Withdrawal of Consent|6|||
126327788|NCT03092791|454494175|FG007|Overall Study|Withdrawal of Consent|4|||
126327789|NCT03092791|454494168|FG000|Overall Study|Study Termination|0|||
126327790|NCT03092791|454494169|FG001|Overall Study|Study Termination|0|||
126327791|NCT03092791|454494170|FG002|Overall Study|Study Termination|0|||
126327792|NCT03092791|454494171|FG003|Overall Study|Study Termination|0|||
126327793|NCT03092791|454494172|FG004|Overall Study|Study Termination|55|||
126327794|NCT03092791|454494173|FG005|Overall Study|Study Termination|46|||
126327795|NCT03092791|454494174|FG006|Overall Study|Study Termination|53|||
126327796|NCT03092791|454494175|FG007|Overall Study|Study Termination|55|||
126327797|NCT03092791|454494168|FG000|Overall Study|Death|0|||
126327798|NCT03092791|454494169|FG001|Overall Study|Death|0|||
126327799|NCT03092791|454494170|FG002|Overall Study|Death|0|||
126327800|NCT03092791|454494171|FG003|Overall Study|Death|0|||
126327801|NCT03092791|454494172|FG004|Overall Study|Death|0|||
126327802|NCT03092791|454494173|FG005|Overall Study|Death|1|||
126327803|NCT03092791|454494174|FG006|Overall Study|Death|0|||
126327804|NCT03092791|454494175|FG007|Overall Study|Death|1|||
126327805|NCT03092791|454494168|FG000|Overall Study|Reason Not Specified|0|||
126327806|NCT03092791|454494169|FG001|Overall Study|Reason Not Specified|0|||
126327807|NCT03092791|454494170|FG002|Overall Study|Reason Not Specified|0|||
126327808|NCT03092791|454494171|FG003|Overall Study|Reason Not Specified|0|||
126327809|NCT03092791|454494172|FG004|Overall Study|Reason Not Specified|1|||
126327810|NCT03092791|454494173|FG005|Overall Study|Reason Not Specified|1|||
126327811|NCT03092791|454494174|FG006|Overall Study|Reason Not Specified|0|||
126327812|NCT03092791|454494175|FG007|Overall Study|Reason Not Specified|0|||
126327813|NCT00154375|454494176|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
126327814|NCT00154375|454494177|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
126327815|NCT00154375|454494176|FG000|Overall Study|Adverse Event|18|||
126327816|NCT00154375|454494177|FG001|Overall Study|Adverse Event|20|||
126327817|NCT00154375|454494176|FG000|Overall Study|Withdrawal by Subject|14|||
126327818|NCT00154375|454494177|FG001|Overall Study|Withdrawal by Subject|10|||
126327819|NCT00154375|454494176|FG000|Overall Study|Death|5|||
126327820|NCT00154375|454494177|FG001|Overall Study|Death|13|||
126327821|NCT00154375|454494176|FG000|Overall Study|Study drug no longer required|5|||
126327822|NCT00154375|454494177|FG001|Overall Study|Study drug no longer required|3|||
126327823|NCT00154375|454494176|FG000|Overall Study|Lost to Follow-up|2|||
126327824|NCT00154375|454494177|FG001|Overall Study|Lost to Follow-up|1|||
126327825|NCT00154375|454494176|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126327826|NCT00154375|454494177|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126327827|NCT00154375|454494176|FG000|Overall Study|Protocol Violation|0|||
126327828|NCT00154375|454494177|FG001|Overall Study|Protocol Violation|1|||
126327829|NCT00154375|454494176|FG000|Overall Study|Suspected progression of disease|44|||
126327830|NCT00154375|454494177|FG001|Overall Study|Suspected progression of disease|30|||
126327831|NCT00980655|454494178|FG000|Overall Study|Adverse Event|13|||
126327832|NCT00980655|454494179|FG001|Overall Study|Adverse Event|31|||
126327833|NCT00980655|454494178|FG000|Overall Study|Death|0|||
126327834|NCT00980655|454494179|FG001|Overall Study|Death|7|||
126327835|NCT00980655|454494178|FG000|Overall Study|Protocol Violation|2|||
126327836|NCT00980655|454494179|FG001|Overall Study|Protocol Violation|7|||
126327837|NCT00980655|454494178|FG000|Overall Study|Withdrawal by Subject|0|||
126327838|NCT00980655|454494179|FG001|Overall Study|Withdrawal by Subject|4|||
126327839|NCT00980655|454494178|FG000|Overall Study|Lost to Follow-up|0|||
126327840|NCT00980655|454494179|FG001|Overall Study|Lost to Follow-up|1|||
126327841|NCT00980655|454494178|FG000|Overall Study|Parent/legal guardian request|1|||
126327842|NCT00980655|454494179|FG001|Overall Study|Parent/legal guardian request|0|||
126327843|NCT00980655|454494178|FG000|Overall Study|Other|0|||
126327844|NCT00980655|454494179|FG001|Overall Study|Other|1|||
126327845|NCT01941537|454494184|FG000|Overall Study|Lack of Efficacy|1|||
126327846|NCT01941537|454494185|FG001|Overall Study|Lack of Efficacy|2|||
126327847|NCT01941537|454494184|FG000|Overall Study|Lost to Follow-up|1|||
126327848|NCT01941537|454494185|FG001|Overall Study|Lost to Follow-up|0|||
126327849|NCT01941537|454494184|FG000|Overall Study|Pregnancy|1|||
126327850|NCT01941537|454494185|FG001|Overall Study|Pregnancy|0|||
126327851|NCT01941537|454494184|FG000|Overall Study|Adverse Event|1|||
126327852|NCT01941537|454494185|FG001|Overall Study|Adverse Event|0|||
126327853|NCT01941537|454494184|FG000|Overall Study|Withdrawal by Subject|0|||
126327854|NCT01941537|454494185|FG001|Overall Study|Withdrawal by Subject|1|||
126327855|NCT02557516|454494187|FG000|Overall Study|Adverse Event|1|||
126327856|NCT02557516|454494188|FG001|Overall Study|Adverse Event|0|||
126327857|NCT02557516|454494189|FG002|Overall Study|Adverse Event|2|||
126327858|NCT02557516|454494190|FG003|Overall Study|Adverse Event|1|||
126327859|NCT02557516|454494187|FG000|Overall Study|Disease progression|0|||
126327860|NCT02557516|454494188|FG001|Overall Study|Disease progression|2|||
126327861|NCT02557516|454494189|FG002|Overall Study|Disease progression|0|||
126327862|NCT02557516|454494190|FG003|Overall Study|Disease progression|0|||
126327863|NCT02557516|454494187|FG000|Overall Study|Physician Decision|0|||
126327864|NCT02557516|454494188|FG001|Overall Study|Physician Decision|2|||
126327865|NCT02557516|454494189|FG002|Overall Study|Physician Decision|0|||
126327866|NCT02557516|454494190|FG003|Overall Study|Physician Decision|0|||
126327867|NCT02557516|454494187|FG000|Overall Study|Sponsor decision|0|||
126327868|NCT02557516|454494188|FG001|Overall Study|Sponsor decision|1|||
126327869|NCT02557516|454494189|FG002|Overall Study|Sponsor decision|2|||
126327870|NCT02557516|454494190|FG003|Overall Study|Sponsor decision|8|||
126327871|NCT04378569|454496025|FG000|Overall Study|Adverse Event|0|||
126327872|NCT04378569|454496026|FG001|Overall Study|Adverse Event|0|||
126327873|NCT04378569|454496027|FG002|Overall Study|Adverse Event|2|||
126327874|NCT04378569|454496028|FG003|Overall Study|Adverse Event|0|||
126327875|NCT04378569|454496029|FG004|Overall Study|Adverse Event|3|||
126327876|NCT04378569|454496030|FG005|Overall Study|Adverse Event|3|||
126327877|NCT04378569|454496025|FG000|Overall Study|Lost to Follow-up|0|||
126327878|NCT04378569|454496026|FG001|Overall Study|Lost to Follow-up|3|||
126327879|NCT04378569|454496027|FG002|Overall Study|Lost to Follow-up|1|||
126327880|NCT04378569|454496028|FG003|Overall Study|Lost to Follow-up|0|||
126327881|NCT04378569|454496029|FG004|Overall Study|Lost to Follow-up|1|||
126327882|NCT04378569|454496030|FG005|Overall Study|Lost to Follow-up|1|||
126327883|NCT04378569|454496025|FG000|Overall Study|Protocol Violation|0|||
126327884|NCT04378569|454496026|FG001|Overall Study|Protocol Violation|0|||
126327885|NCT04378569|454496027|FG002|Overall Study|Protocol Violation|0|||
126327886|NCT04378569|454496028|FG003|Overall Study|Protocol Violation|0|||
126327887|NCT04378569|454496029|FG004|Overall Study|Protocol Violation|0|||
126327888|NCT04378569|454496030|FG005|Overall Study|Protocol Violation|1|||
126327889|NCT04378569|454496025|FG000|Overall Study|Withdrawal by Subject|0|||
126327890|NCT04378569|454496026|FG001|Overall Study|Withdrawal by Subject|6|||
126327891|NCT04378569|454496027|FG002|Overall Study|Withdrawal by Subject|7|||
126327892|NCT04378569|454496028|FG003|Overall Study|Withdrawal by Subject|4|||
126327893|NCT04378569|454496029|FG004|Overall Study|Withdrawal by Subject|5|||
126327894|NCT04378569|454496030|FG005|Overall Study|Withdrawal by Subject|4|||
126327895|NCT04378569|454496025|FG000|Overall Study|Lack of response|0|||
126327896|NCT04378569|454496026|FG001|Overall Study|Lack of response|0|||
126327897|NCT04378569|454496027|FG002|Overall Study|Lack of response|1|||
126327898|NCT04378569|454496028|FG003|Overall Study|Lack of response|0|||
126327899|NCT04378569|454496029|FG004|Overall Study|Lack of response|1|||
126327900|NCT04378569|454496030|FG005|Overall Study|Lack of response|1|||
126327901|NCT01962948|454496031|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
126327902|NCT01962948|454496032|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
126327903|NCT01962948|454496033|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
126327904|NCT01962948|454496034|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
126327905|NCT02239640|454496046|FG000|Overall Study|Withdrawal by Subject|3|||
126327906|NCT02239640|454496046|FG000|Overall Study|Lost to Follow-up|72|||
126327907|NCT02239640|454496046|FG000|Overall Study|Death|142|||
126327908|NCT02630563|454496049|FG000|Overall Study|Administrative|1|||
126327909|NCT02061813|454496050|FG000|Overall Study|Withdrawal by Subject|1|||
126327910|NCT02061813|454496050|FG000|Overall Study|Protocol Violation|2|||
126327911|NCT01724177|454496053|FG000|Overall Study|Adverse Event|8|||
126327912|NCT01724177|454496053|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
126327913|NCT01724177|454496053|FG000|Overall Study|Nervous participant|1|||
126327914|NCT01724177|454496053|FG000|Overall Study|Serious Adverse Event Related|1|||
126327915|NCT01705080|454496054|FG000|Overall Study|Missed visit|10|||
126327916|NCT01705080|454496055|FG001|Overall Study|Missed visit|4|||
126327917|NCT01705080|454496056|FG002|Overall Study|Missed visit|1|||
126327918|NCT01705080|454496054|FG000|Overall Study|Death|4|||
126327919|NCT01705080|454496055|FG001|Overall Study|Death|4|||
126327920|NCT01705080|454496056|FG002|Overall Study|Death|6|||
126327921|NCT01705080|454496054|FG000|Overall Study|Withdrawal by Subject|61|||
126327922|NCT01705080|454496055|FG001|Overall Study|Withdrawal by Subject|44|||
126327923|NCT01705080|454496056|FG002|Overall Study|Withdrawal by Subject|9|||
126327924|NCT00206427|454496059|FG000|Overall Study|Adverse Event|2|||
126327925|NCT00281697|454496063|FG000|Overall Study|> 60 days since last dose of study drug|4|||
126327926|NCT00281697|454496064|FG001|Overall Study|> 60 days since last dose of study drug|4|||
126327927|NCT00281697|454496063|FG000|Overall Study|Adverse Event|54|||
126327928|NCT00281697|454496064|FG001|Overall Study|Adverse Event|15|||
126327929|NCT00281697|454496063|FG000|Overall Study|Death|8|||
126327930|NCT00281697|454496064|FG001|Overall Study|Death|3|||
126327931|NCT00281697|454496063|FG000|Overall Study|Disease progression|279|||
126327932|NCT00281697|454496064|FG001|Overall Study|Disease progression|149|||
126327933|NCT00281697|454496063|FG000|Overall Study|Other|5|||
126327934|NCT00281697|454496064|FG001|Overall Study|Other|6|||
126327935|NCT00281697|454496063|FG000|Overall Study|Physician's decision to withdraw|15|||
126327936|NCT00281697|454496064|FG001|Overall Study|Physician's decision to withdraw|12|||
126327937|NCT00281697|454496063|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
126327938|NCT00281697|454496064|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
126327939|NCT00281697|454496063|FG000|Overall Study|Did not receive study drug|3|||
126327940|NCT00281697|454496064|FG001|Overall Study|Did not receive study drug|2|||
126327941|NCT03130959|454496077|FG000|Overall Study|Disease progression|19|||
126327942|NCT03130959|454496078|FG001|Overall Study|Disease progression|7|||
126327943|NCT03130959|454496079|FG002|Overall Study|Disease progression|12|||
126327944|NCT03130959|454496080|FG003|Overall Study|Disease progression|7|||
126327945|NCT03130959|454496081|FG004|Overall Study|Disease progression|12|||
126327946|NCT03130959|454496082|FG005|Overall Study|Disease progression|3|||
126327947|NCT03130959|454496083|FG006|Overall Study|Disease progression|6|||
126327948|NCT03130959|454496084|FG007|Overall Study|Disease progression|3|||
126327949|NCT03130959|454496085|FG008|Overall Study|Disease progression|15|||
126327950|NCT03130959|454496086|FG009|Overall Study|Disease progression|8|||
126327951|NCT03130959|454496077|FG000|Overall Study|Study drug toxicity|2|||
126327952|NCT03130959|454496078|FG001|Overall Study|Study drug toxicity|2|||
126327953|NCT03130959|454496079|FG002|Overall Study|Study drug toxicity|1|||
126327954|NCT03130959|454496080|FG003|Overall Study|Study drug toxicity|2|||
126327955|NCT03130959|454496081|FG004|Overall Study|Study drug toxicity|1|||
126327956|NCT03130959|454496082|FG005|Overall Study|Study drug toxicity|1|||
126327957|NCT03130959|454496083|FG006|Overall Study|Study drug toxicity|3|||
126327958|NCT03130959|454496084|FG007|Overall Study|Study drug toxicity|0|||
126327959|NCT03130959|454496085|FG008|Overall Study|Study drug toxicity|3|||
126327960|NCT03130959|454496086|FG009|Overall Study|Study drug toxicity|3|||
126327961|NCT03130959|454496077|FG000|Overall Study|Other reasons|0|||
126327962|NCT03130959|454496078|FG001|Overall Study|Other reasons|0|||
126327963|NCT03130959|454496079|FG002|Overall Study|Other reasons|0|||
126327964|NCT03130959|454496080|FG003|Overall Study|Other reasons|0|||
126327965|NCT03130959|454496081|FG004|Overall Study|Other reasons|0|||
126327966|NCT03130959|454496082|FG005|Overall Study|Other reasons|1|||
126327967|NCT03130959|454496083|FG006|Overall Study|Other reasons|1|||
126327968|NCT03130959|454496084|FG007|Overall Study|Other reasons|0|||
126327969|NCT03130959|454496085|FG008|Overall Study|Other reasons|0|||
126327970|NCT03130959|454496086|FG009|Overall Study|Other reasons|0|||
126327971|NCT03130959|454496077|FG000|Overall Study|Subject request to discontinue therapy|0|||
126327972|NCT03130959|454496078|FG001|Overall Study|Subject request to discontinue therapy|0|||
126327973|NCT03130959|454496079|FG002|Overall Study|Subject request to discontinue therapy|1|||
126327974|NCT03130959|454496080|FG003|Overall Study|Subject request to discontinue therapy|1|||
126327975|NCT03130959|454496081|FG004|Overall Study|Subject request to discontinue therapy|0|||
126327976|NCT03130959|454496082|FG005|Overall Study|Subject request to discontinue therapy|0|||
126327977|NCT03130959|454496083|FG006|Overall Study|Subject request to discontinue therapy|1|||
126327978|NCT03130959|454496084|FG007|Overall Study|Subject request to discontinue therapy|1|||
126327979|NCT03130959|454496085|FG008|Overall Study|Subject request to discontinue therapy|0|||
126327980|NCT03130959|454496086|FG009|Overall Study|Subject request to discontinue therapy|0|||
126327981|NCT03130959|454496077|FG000|Overall Study|Not reported|0|||
126327982|NCT03130959|454496078|FG001|Overall Study|Not reported|0|||
126327983|NCT03130959|454496079|FG002|Overall Study|Not reported|0|||
126327984|NCT03130959|454496080|FG003|Overall Study|Not reported|1|||
126327985|NCT03130959|454496081|FG004|Overall Study|Not reported|0|||
126327986|NCT03130959|454496082|FG005|Overall Study|Not reported|1|||
126327987|NCT03130959|454496083|FG006|Overall Study|Not reported|0|||
126327988|NCT03130959|454496084|FG007|Overall Study|Not reported|0|||
126327989|NCT03130959|454496085|FG008|Overall Study|Not reported|0|||
126327990|NCT03130959|454496086|FG009|Overall Study|Not reported|1|||
126327991|NCT03130959|454496077|FG000|Overall Study|Adverse Event unrelated to drug|0|||
126327992|NCT03130959|454496078|FG001|Overall Study|Adverse Event unrelated to drug|0|||
126327993|NCT03130959|454496079|FG002|Overall Study|Adverse Event unrelated to drug|1|||
126327994|NCT03130959|454496080|FG003|Overall Study|Adverse Event unrelated to drug|1|||
126327995|NCT03130959|454496081|FG004|Overall Study|Adverse Event unrelated to drug|1|||
126327996|NCT03130959|454496082|FG005|Overall Study|Adverse Event unrelated to drug|0|||
126327997|NCT03130959|454496083|FG006|Overall Study|Adverse Event unrelated to drug|1|||
126327998|NCT03130959|454496084|FG007|Overall Study|Adverse Event unrelated to drug|0|||
126327999|NCT03130959|454496085|FG008|Overall Study|Adverse Event unrelated to drug|1|||
126328000|NCT03130959|454496086|FG009|Overall Study|Adverse Event unrelated to drug|1|||
126328001|NCT03130959|454496077|FG000|Overall Study|Participant withdrew consent|0|||
126328002|NCT03130959|454496078|FG001|Overall Study|Participant withdrew consent|1|||
126328003|NCT03130959|454496079|FG002|Overall Study|Participant withdrew consent|0|||
126328004|NCT03130959|454496080|FG003|Overall Study|Participant withdrew consent|2|||
126328005|NCT03130959|454496081|FG004|Overall Study|Participant withdrew consent|1|||
126328006|NCT03130959|454496082|FG005|Overall Study|Participant withdrew consent|0|||
126328007|NCT03130959|454496083|FG006|Overall Study|Participant withdrew consent|0|||
126328008|NCT03130959|454496084|FG007|Overall Study|Participant withdrew consent|0|||
126328009|NCT03130959|454496085|FG008|Overall Study|Participant withdrew consent|0|||
126328010|NCT03130959|454496086|FG009|Overall Study|Participant withdrew consent|2|||
126328011|NCT03130959|454496077|FG000|Overall Study|Administrative reason by sponsor|1|||
126328012|NCT03130959|454496078|FG001|Overall Study|Administrative reason by sponsor|0|||
126328013|NCT03130959|454496079|FG002|Overall Study|Administrative reason by sponsor|1|||
126328014|NCT03130959|454496080|FG003|Overall Study|Administrative reason by sponsor|0|||
126328015|NCT03130959|454496081|FG004|Overall Study|Administrative reason by sponsor|0|||
126328016|NCT03130959|454496082|FG005|Overall Study|Administrative reason by sponsor|0|||
126328017|NCT03130959|454496083|FG006|Overall Study|Administrative reason by sponsor|0|||
126328018|NCT03130959|454496084|FG007|Overall Study|Administrative reason by sponsor|0|||
126328019|NCT03130959|454496085|FG008|Overall Study|Administrative reason by sponsor|0|||
126328020|NCT03130959|454496086|FG009|Overall Study|Administrative reason by sponsor|0|||
126328021|NCT03130959|454496077|FG000|Overall Study|Lost to Follow-up|1|||
126328022|NCT03130959|454496078|FG001|Overall Study|Lost to Follow-up|0|||
126328023|NCT03130959|454496079|FG002|Overall Study|Lost to Follow-up|0|||
126328024|NCT03130959|454496080|FG003|Overall Study|Lost to Follow-up|0|||
126328025|NCT03130959|454496081|FG004|Overall Study|Lost to Follow-up|0|||
126328026|NCT03130959|454496082|FG005|Overall Study|Lost to Follow-up|0|||
126328027|NCT03130959|454496083|FG006|Overall Study|Lost to Follow-up|0|||
126328028|NCT03130959|454496084|FG007|Overall Study|Lost to Follow-up|0|||
126328029|NCT03130959|454496085|FG008|Overall Study|Lost to Follow-up|0|||
126328030|NCT03130959|454496086|FG009|Overall Study|Lost to Follow-up|0|||
126328031|NCT00313586|454496087|FG000|Overall Study|Disease progression|14|||
126328032|NCT00313586|454496088|FG001|Overall Study|Disease progression|19|||
126328033|NCT00313586|454496089|FG002|Overall Study|Disease progression|10|||
126328034|NCT00313586|454496090|FG003|Overall Study|Disease progression|3|||
126328035|NCT00313586|454496087|FG000|Overall Study|Adverse Event|12|||
126328036|NCT00313586|454496088|FG001|Overall Study|Adverse Event|18|||
126328037|NCT00313586|454496089|FG002|Overall Study|Adverse Event|3|||
126328038|NCT00313586|454496090|FG003|Overall Study|Adverse Event|10|||
126328039|NCT00313586|454496087|FG000|Overall Study|Death|11|||
126328040|NCT00313586|454496088|FG001|Overall Study|Death|8|||
126328041|NCT00313586|454496089|FG002|Overall Study|Death|1|||
126328042|NCT00313586|454496090|FG003|Overall Study|Death|7|||
126328043|NCT00313586|454496087|FG000|Overall Study|Withdrawal by Subject|13|||
126328044|NCT00313586|454496088|FG001|Overall Study|Withdrawal by Subject|6|||
126328045|NCT00313586|454496089|FG002|Overall Study|Withdrawal by Subject|6|||
126328046|NCT00313586|454496090|FG003|Overall Study|Withdrawal by Subject|2|||
126328047|NCT00313586|454496087|FG000|Overall Study|Alternative therapy|3|||
126328048|NCT00313586|454496088|FG001|Overall Study|Alternative therapy|6|||
126328049|NCT00313586|454496089|FG002|Overall Study|Alternative therapy|2|||
126328050|NCT00313586|454496090|FG003|Overall Study|Alternative therapy|0|||
126328051|NCT00313586|454496087|FG000|Overall Study|Other complicating disease|2|||
126328052|NCT00313586|454496088|FG001|Overall Study|Other complicating disease|2|||
126328053|NCT00313586|454496089|FG002|Overall Study|Other complicating disease|0|||
126328054|NCT00313586|454496090|FG003|Overall Study|Other complicating disease|0|||
126328055|NCT00313586|454496087|FG000|Overall Study|Did not achieve HI-major/better response|10|||
126328056|NCT00313586|454496088|FG001|Overall Study|Did not achieve HI-major/better response|7|||
126328057|NCT00313586|454496089|FG002|Overall Study|Did not achieve HI-major/better response|2|||
126328058|NCT00313586|454496090|FG003|Overall Study|Did not achieve HI-major/better response|1|||
126328059|NCT00313586|454496087|FG000|Overall Study|Physician Decision|2|||
126328060|NCT00313586|454496088|FG001|Overall Study|Physician Decision|1|||
126328061|NCT00313586|454496089|FG002|Overall Study|Physician Decision|0|||
126328062|NCT00313586|454496090|FG003|Overall Study|Physician Decision|0|||
126328063|NCT00313586|454496087|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
126328064|NCT00313586|454496088|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
126328065|NCT00313586|454496089|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
126328066|NCT00313586|454496090|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
126328067|NCT00313586|454496087|FG000|Overall Study|Lost insurance|0|||
126328068|NCT00313586|454496088|FG001|Overall Study|Lost insurance|1|||
126328069|NCT00313586|454496089|FG002|Overall Study|Lost insurance|0|||
126328070|NCT00313586|454496090|FG003|Overall Study|Lost insurance|0|||
126328071|NCT00313586|454496087|FG000|Overall Study|Moved|0|||
126328072|NCT00313586|454496088|FG001|Overall Study|Moved|1|||
126328073|NCT00313586|454496089|FG002|Overall Study|Moved|0|||
126328074|NCT00313586|454496090|FG003|Overall Study|Moved|0|||
126328075|NCT00313586|454496087|FG000|Overall Study|Death before starting treatment|1|||
126328076|NCT00313586|454496088|FG001|Overall Study|Death before starting treatment|0|||
126328077|NCT00313586|454496089|FG002|Overall Study|Death before starting treatment|0|||
126328078|NCT00313586|454496090|FG003|Overall Study|Death before starting treatment|0|||
126328079|NCT03076996|454496091|FG000|Overall Study|Withdrawal by Subject|2|||
126328080|NCT03076996|454496091|FG000|Overall Study|Lost to Follow-up|3|||
126328081|NCT03076996|454496091|FG000|Overall Study|Literacy precluded participation|1|||
126328082|NCT03117361|454496093|FG000|Overall Study|Progressive disease|5|||
126328083|NCT03117361|454496093|FG000|Overall Study|Death|1|||
126328084|NCT03117361|454496093|FG000|Overall Study|Physician Decision|2|||
126328085|NCT03117361|454496093|FG000|Overall Study|On study treatment at the end of study|1|||
126328086|NCT03117361|454496093|FG000|Overall Study|Treatment-related adverse event|1|||
126328087|NCT03280056|454496097|FG000|Overall Study|Withdrawal by Subject|12|||
126328088|NCT03280056|454496098|FG001|Overall Study|Withdrawal by Subject|14|||
126328089|NCT03280056|454496097|FG000|Overall Study|Death|9|||
126328090|NCT03280056|454496098|FG001|Overall Study|Death|2|||
126328091|NCT03280056|454496097|FG000|Overall Study|Adverse Event|1|||
126328092|NCT03280056|454496098|FG001|Overall Study|Adverse Event|3|||
126328093|NCT03280056|454496097|FG000|Overall Study|Lost to Follow-up|1|||
126328094|NCT03280056|454496098|FG001|Overall Study|Lost to Follow-up|1|||
126328095|NCT03280056|454496097|FG000|Overall Study|Physician Decision|0|||
126328096|NCT03280056|454496098|FG001|Overall Study|Physician Decision|1|||
126328097|NCT03280056|454496097|FG000|Overall Study|Early Discontinuation|1|||
126328098|NCT03280056|454496098|FG001|Overall Study|Early Discontinuation|0|||
126328099|NCT02144077|454496099|FG000|Overall Study|Withdrawal by Subject|3|||
126328100|NCT02144077|454496100|FG001|Overall Study|Withdrawal by Subject|3|||
126328101|NCT02144077|454496099|FG000|Overall Study|Adverse Event|2|||
126328102|NCT02144077|454496100|FG001|Overall Study|Adverse Event|3|||
126328103|NCT02144077|454496099|FG000|Overall Study|Lost to Follow-up|2|||
126328104|NCT02144077|454496100|FG001|Overall Study|Lost to Follow-up|2|||
126328105|NCT02144077|454496099|FG000|Overall Study|Protocol Violation|1|||
126328106|NCT02144077|454496100|FG001|Overall Study|Protocol Violation|2|||
126328107|NCT02144077|454496099|FG000|Overall Study|Death|0|||
126328108|NCT02144077|454496100|FG001|Overall Study|Death|1|||
126328109|NCT02144077|454496099|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
126328110|NCT02144077|454496100|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
126328111|NCT00610168|454496101|FG000|Overall Study|Withdrawal by Subject|2|||
126328112|NCT00610168|454496102|FG001|Overall Study|Withdrawal by Subject|0|||
126328113|NCT00943592|454496103|FG000|Overall Study|Death|3|||
126328114|NCT01247350|454496104|FG000|Overall Study|Adverse Event|0|||
126328115|NCT01247350|454496105|FG001|Overall Study|Adverse Event|0|||
126328116|NCT01247350|454496106|FG002|Overall Study|Adverse Event|1|||
126328117|NCT01247350|454496107|FG003|Overall Study|Adverse Event|0|||
126328118|NCT01247350|454496108|FG004|Overall Study|Adverse Event|0|||
126328119|NCT01247350|454496104|FG000|Overall Study|Withdrawal by Subject|0|||
126328120|NCT01247350|454496105|FG001|Overall Study|Withdrawal by Subject|0|||
126328121|NCT01247350|454496106|FG002|Overall Study|Withdrawal by Subject|0|||
126209214|NCT05182840|454053175|FG002|Run-in Period|Change of residence|0|||
126209215|NCT05182840|454053176|FG003|Run-in Period|Change of residence|0|||
126209216|NCT05182840|454053177|FG004|Run-in Period|Change of residence|0|||
126209217|NCT05182840|454053178|FG005|Run-in Period|Change of residence|0|||
126209218|NCT05182840|454053179|FG006|Run-in Period|Change of residence|0|||
126209219|NCT05182840|454053180|FG007|Run-in Period|Change of residence|0|||
126209220|NCT05182840|454053181|FG008|Run-in Period|Change of residence|0|||
126209221|NCT05182840|454053182|FG009|Run-in Period|Change of residence|0|||
126209222|NCT05182840|454053173|FG000|Run-in Period|Adverse Event|5|||
126209223|NCT05182840|454053174|FG001|Run-in Period|Adverse Event|5|||
126209224|NCT05182840|454053175|FG002|Run-in Period|Adverse Event|0|||
126209225|NCT05182840|454053176|FG003|Run-in Period|Adverse Event|0|||
126209226|NCT05182840|454053177|FG004|Run-in Period|Adverse Event|0|||
126209227|NCT05182840|454053178|FG005|Run-in Period|Adverse Event|0|||
126209228|NCT05182840|454053179|FG006|Run-in Period|Adverse Event|0|||
126209229|NCT05182840|454053180|FG007|Run-in Period|Adverse Event|0|||
126209230|NCT05182840|454053181|FG008|Run-in Period|Adverse Event|0|||
126209231|NCT05182840|454053182|FG009|Run-in Period|Adverse Event|0|||
126209232|NCT05182840|454053173|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
126209233|NCT05182840|454053174|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
126209234|NCT05182840|454053175|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126209235|NCT05182840|454053176|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126209236|NCT05182840|454053177|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126209237|NCT05182840|454053178|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126209238|NCT05182840|454053179|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126209239|NCT05182840|454053180|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126209240|NCT05182840|454053181|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126209241|NCT05182840|454053182|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126209242|NCT05182840|454053173|FG000|Treatment Period|Reason missing|0|||
126209243|NCT05182840|454053174|FG001|Treatment Period|Reason missing|0|||
126209244|NCT05182840|454053175|FG002|Treatment Period|Reason missing|1|||
126209245|NCT05182840|454053176|FG003|Treatment Period|Reason missing|0|||
126209246|NCT05182840|454053177|FG004|Treatment Period|Reason missing|0|||
126209247|NCT05182840|454053178|FG005|Treatment Period|Reason missing|0|||
126209248|NCT05182840|454053179|FG006|Treatment Period|Reason missing|0|||
126209249|NCT05182840|454053180|FG007|Treatment Period|Reason missing|0|||
126209250|NCT05182840|454053181|FG008|Treatment Period|Reason missing|0|||
126209251|NCT05182840|454053182|FG009|Treatment Period|Reason missing|0|||
126209252|NCT05182840|454053173|FG000|Treatment Period|Other but not sponsor termination|0|||
126209253|NCT05182840|454053174|FG001|Treatment Period|Other but not sponsor termination|0|||
126209254|NCT05182840|454053175|FG002|Treatment Period|Other but not sponsor termination|8|||
126209255|NCT05182840|454053176|FG003|Treatment Period|Other but not sponsor termination|6|||
126209256|NCT05182840|454053177|FG004|Treatment Period|Other but not sponsor termination|6|||
126209257|NCT05182840|454053178|FG005|Treatment Period|Other but not sponsor termination|7|||
126209258|NCT05182840|454053179|FG006|Treatment Period|Other but not sponsor termination|5|||
126209259|NCT05182840|454053180|FG007|Treatment Period|Other but not sponsor termination|8|||
126209260|NCT05182840|454053181|FG008|Treatment Period|Other but not sponsor termination|7|||
126209261|NCT05182840|454053182|FG009|Treatment Period|Other but not sponsor termination|2|||
126209262|NCT05182840|454053173|FG000|Treatment Period|Protocol deviation|0|||
126209263|NCT05182840|454053174|FG001|Treatment Period|Protocol deviation|0|||
126209264|NCT05182840|454053175|FG002|Treatment Period|Protocol deviation|0|||
126209265|NCT05182840|454053176|FG003|Treatment Period|Protocol deviation|0|||
126209266|NCT05182840|454053177|FG004|Treatment Period|Protocol deviation|0|||
126209267|NCT05182840|454053178|FG005|Treatment Period|Protocol deviation|0|||
126209268|NCT05182840|454053179|FG006|Treatment Period|Protocol deviation|0|||
126209269|NCT05182840|454053180|FG007|Treatment Period|Protocol deviation|0|||
126209270|NCT05182840|454053181|FG008|Treatment Period|Protocol deviation|1|||
126328122|NCT01247350|454496107|FG003|Overall Study|Withdrawal by Subject|1|||
126328123|NCT01247350|454496108|FG004|Overall Study|Withdrawal by Subject|0|||
126328124|NCT01247350|454496104|FG000|Overall Study|Entry criteria not met|0|||
126328125|NCT01247350|454496105|FG001|Overall Study|Entry criteria not met|0|||
126328126|NCT01247350|454496106|FG002|Overall Study|Entry criteria not met|0|||
126328127|NCT01247350|454496107|FG003|Overall Study|Entry criteria not met|0|||
126328128|NCT01247350|454496108|FG004|Overall Study|Entry criteria not met|1|||
126328129|NCT00169104|454496109|FG000|Overall Study|Withdrawal by Subject|2|||
126328130|NCT00169104|454496110|FG001|Overall Study|Withdrawal by Subject|0|||
126328131|NCT00169104|454496109|FG000|Overall Study|Protocol Violation|0|||
126328132|NCT00169104|454496110|FG001|Overall Study|Protocol Violation|1|||
126328133|NCT00169104|454496109|FG000|Overall Study|Physician Decision|0|||
126328134|NCT00169104|454496110|FG001|Overall Study|Physician Decision|1|||
126328135|NCT01540981|454496116|FG000|Overall Study|Withdrawal by Subject|1|||
126328136|NCT01540981|454496117|FG001|Overall Study|Withdrawal by Subject|0|||
126328137|NCT00141518|454496120|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
126328138|NCT00141518|454496121|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
126328139|NCT00141518|454496122|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
126328140|NCT00141518|454496120|FG000|Overall Study|Adverse Event|7|||
126328141|NCT00141518|454496121|FG001|Overall Study|Adverse Event|5|||
126328142|NCT00141518|454496122|FG002|Overall Study|Adverse Event|2|||
126328143|NCT00141518|454496120|FG000|Overall Study|Withdrawal by Subject|2|||
126328144|NCT00141518|454496121|FG001|Overall Study|Withdrawal by Subject|0|||
126328145|NCT00141518|454496122|FG002|Overall Study|Withdrawal by Subject|2|||
126328146|NCT00141518|454496120|FG000|Overall Study|Protocol Violation|1|||
126328147|NCT00141518|454496121|FG001|Overall Study|Protocol Violation|1|||
126328148|NCT00141518|454496122|FG002|Overall Study|Protocol Violation|2|||
126328149|NCT00141518|454496120|FG000|Overall Study|Lack of Efficacy|5|||
126328150|NCT00141518|454496121|FG001|Overall Study|Lack of Efficacy|0|||
126328151|NCT00141518|454496122|FG002|Overall Study|Lack of Efficacy|0|||
126328152|NCT02091414|454496125|FG000|Overall Study|Withdrawal by Subject|2|||
126328153|NCT02091414|454496125|FG000|Overall Study|Death|2|||
126328154|NCT03231306|454496126|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
126328155|NCT03231306|454496126|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
126328156|NCT03231306|454496126|FG000|Overall Study|Treatment delay > 21 days|2|||
126328157|NCT03231306|454496126|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
126328158|NCT03231306|454496126|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
126328159|NCT03231306|454496126|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
126328160|NCT03231306|454496126|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
126328161|NCT03231306|454496126|FG000|Overall Study|More than 1 Reason|2|||
126328162|NCT02306850|454496127|FG000|Overall Study|Lack of Efficacy|2|||
126328163|NCT00237692|454496128|FG000|Overall Study|Lost to Follow-up|9|||
126328164|NCT00237692|454496129|FG001|Overall Study|Lost to Follow-up|3|||
126328165|NCT00237692|454496130|FG002|Overall Study|Lost to Follow-up|5|||
126328166|NCT00237692|454496131|FG003|Overall Study|Lost to Follow-up|3|||
126328167|NCT00237692|454496128|FG000|Overall Study|Death|1|||
126328168|NCT00237692|454496129|FG001|Overall Study|Death|2|||
126328169|NCT00237692|454496130|FG002|Overall Study|Death|2|||
126328170|NCT00237692|454496131|FG003|Overall Study|Death|3|||
126328171|NCT00237692|454496128|FG000|Overall Study|Excluded - did not meet criteria|4|||
126328172|NCT00237692|454496129|FG001|Overall Study|Excluded - did not meet criteria|3|||
126328173|NCT00237692|454496130|FG002|Overall Study|Excluded - did not meet criteria|5|||
126328174|NCT00237692|454496131|FG003|Overall Study|Excluded - did not meet criteria|9|||
126328175|NCT00237692|454496128|FG000|Overall Study|Withdrawal by Subject|4|||
126328176|NCT00237692|454496129|FG001|Overall Study|Withdrawal by Subject|6|||
126328177|NCT00237692|454496130|FG002|Overall Study|Withdrawal by Subject|10|||
126328178|NCT00237692|454496131|FG003|Overall Study|Withdrawal by Subject|4|||
126328179|NCT00685360|454496134|FG000|Overall Study|Lost to Follow-up|0|||
126328180|NCT00685360|454496135|FG001|Overall Study|Lost to Follow-up|1|||
126328181|NCT00685360|454496136|FG002|Overall Study|Lost to Follow-up|2|||
126328182|NCT00685360|454496134|FG000|Overall Study|Adverse Event|4|||
126328183|NCT00685360|454496135|FG001|Overall Study|Adverse Event|6|||
126328184|NCT00685360|454496136|FG002|Overall Study|Adverse Event|4|||
126328185|NCT00685360|454496134|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
126328186|NCT00685360|454496135|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
126328187|NCT00685360|454496136|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
126328188|NCT00685360|454496134|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
126328189|NCT00685360|454496135|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
126328190|NCT00685360|454496136|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
126328191|NCT00685360|454496134|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
126328192|NCT00685360|454496135|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
126328193|NCT00685360|454496136|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
126328194|NCT00685360|454496134|FG000|Overall Study|Protocol Deviation|0|||
126328195|NCT00685360|454496135|FG001|Overall Study|Protocol Deviation|1|||
126328196|NCT00685360|454496136|FG002|Overall Study|Protocol Deviation|1|||
126328197|NCT04865419|454496137|FG000|Overall Study|Other|1|||
126328198|NCT04865419|454496138|FG001|Overall Study|Other|2|||
126328199|NCT04865419|454496139|FG002|Overall Study|Other|2|||
126328200|NCT04865419|454496140|FG003|Overall Study|Other|1|||
126328201|NCT04865419|454496141|FG004|Overall Study|Other|3|||
126328202|NCT04865419|454496142|FG005|Overall Study|Other|0|||
126328203|NCT04865419|454496143|FG006|Overall Study|Other|0|||
126328204|NCT04865419|454496144|FG007|Overall Study|Other|1|||
126328205|NCT04865419|454496145|FG008|Overall Study|Other|0|||
126328206|NCT04865419|454496146|FG009|Overall Study|Other|0|||
126328207|NCT04865419|454496147|FG010|Overall Study|Other|0|||
126328208|NCT04865419|454496137|FG000|Overall Study|Withdrawal by Subject|0|||
126328209|NCT04865419|454496138|FG001|Overall Study|Withdrawal by Subject|1|||
126328210|NCT04865419|454496139|FG002|Overall Study|Withdrawal by Subject|1|||
126328211|NCT04865419|454496140|FG003|Overall Study|Withdrawal by Subject|0|||
126328212|NCT04865419|454496141|FG004|Overall Study|Withdrawal by Subject|0|||
126328213|NCT04865419|454496142|FG005|Overall Study|Withdrawal by Subject|0|||
126328214|NCT04865419|454496143|FG006|Overall Study|Withdrawal by Subject|0|||
126328215|NCT04865419|454496144|FG007|Overall Study|Withdrawal by Subject|1|||
126328216|NCT04865419|454496145|FG008|Overall Study|Withdrawal by Subject|2|||
126328217|NCT04865419|454496146|FG009|Overall Study|Withdrawal by Subject|1|||
126328218|NCT04865419|454496147|FG010|Overall Study|Withdrawal by Subject|0|||
126328219|NCT04865419|454496137|FG000|Overall Study|Study terminated by Sponsor|0|||
126328220|NCT04865419|454496138|FG001|Overall Study|Study terminated by Sponsor|0|||
126328221|NCT04865419|454496139|FG002|Overall Study|Study terminated by Sponsor|0|||
126328222|NCT04865419|454496140|FG003|Overall Study|Study terminated by Sponsor|2|||
126328223|NCT04865419|454496141|FG004|Overall Study|Study terminated by Sponsor|2|||
126328224|NCT04865419|454496142|FG005|Overall Study|Study terminated by Sponsor|0|||
126328225|NCT04865419|454496143|FG006|Overall Study|Study terminated by Sponsor|0|||
126328226|NCT04865419|454496144|FG007|Overall Study|Study terminated by Sponsor|0|||
126328227|NCT04865419|454496145|FG008|Overall Study|Study terminated by Sponsor|0|||
126328228|NCT04865419|454496146|FG009|Overall Study|Study terminated by Sponsor|0|||
126328229|NCT04865419|454496147|FG010|Overall Study|Study terminated by Sponsor|1|||
126328230|NCT04865419|454496137|FG000|Overall Study|Death|3|||
126328231|NCT04865419|454496138|FG001|Overall Study|Death|1|||
126328232|NCT04865419|454496139|FG002|Overall Study|Death|4|||
126328233|NCT04865419|454496140|FG003|Overall Study|Death|2|||
126328234|NCT04865419|454496141|FG004|Overall Study|Death|5|||
126328235|NCT04865419|454496142|FG005|Overall Study|Death|2|||
126328236|NCT04865419|454496143|FG006|Overall Study|Death|1|||
126328237|NCT04865419|454496144|FG007|Overall Study|Death|1|||
126328238|NCT04865419|454496145|FG008|Overall Study|Death|2|||
126328239|NCT04865419|454496146|FG009|Overall Study|Death|2|||
126328240|NCT04865419|454496147|FG010|Overall Study|Death|1|||
126328241|NCT04865419|454496137|FG000|Overall Study|Lost to Follow-up|0|||
126328242|NCT04865419|454496138|FG001|Overall Study|Lost to Follow-up|0|||
126328243|NCT04865419|454496139|FG002|Overall Study|Lost to Follow-up|0|||
126328244|NCT04865419|454496140|FG003|Overall Study|Lost to Follow-up|0|||
126328245|NCT04865419|454496141|FG004|Overall Study|Lost to Follow-up|0|||
126328246|NCT04865419|454496142|FG005|Overall Study|Lost to Follow-up|0|||
126328247|NCT04865419|454496143|FG006|Overall Study|Lost to Follow-up|0|||
126328248|NCT04865419|454496144|FG007|Overall Study|Lost to Follow-up|0|||
126328249|NCT04865419|454496145|FG008|Overall Study|Lost to Follow-up|0|||
126328250|NCT04865419|454496146|FG009|Overall Study|Lost to Follow-up|1|||
126328251|NCT04865419|454496147|FG010|Overall Study|Lost to Follow-up|0|||
126328252|NCT04208412|454496148|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
126328253|NCT04208412|454496149|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
126328254|NCT04208412|454496148|FG000|Overall Study|Withdrawal by Subject|1|||
126328255|NCT04208412|454496149|FG001|Overall Study|Withdrawal by Subject|0|||
126328256|NCT04208412|454496148|FG000|Overall Study|Lost to Follow-up|0|||
126328257|NCT04208412|454496149|FG001|Overall Study|Lost to Follow-up|1|||
126328258|NCT05415462|454496152|FG000|Overall Study|Death|18|||
126328259|NCT05415462|454496153|FG001|Overall Study|Death|10|||
126328260|NCT05415462|454496152|FG000|Overall Study|Lost to Follow-up|72|||
126328261|NCT05415462|454496153|FG001|Overall Study|Lost to Follow-up|64|||
126328262|NCT05415462|454496152|FG000|Overall Study|Physician Decision|5|||
126328263|NCT05415462|454496153|FG001|Overall Study|Physician Decision|5|||
126328264|NCT05415462|454496152|FG000|Overall Study|Protocol Deviation|1|||
126328265|NCT05415462|454496153|FG001|Overall Study|Protocol Deviation|0|||
126328266|NCT05415462|454496152|FG000|Overall Study|Withdrawal by Subject|129|||
126328267|NCT05415462|454496153|FG001|Overall Study|Withdrawal by Subject|101|||
126328268|NCT05415462|454496152|FG000|Overall Study|Other Than Specified|8|||
126328269|NCT05415462|454496153|FG001|Overall Study|Other Than Specified|8|||
126328270|NCT05095311|454496161|FG000|Overall Study|Lost to Follow-up|7|||
126328271|NCT05095311|454496162|FG001|Overall Study|Lost to Follow-up|0|||
126328272|NCT05095311|454496163|FG002|Overall Study|Lost to Follow-up|0|||
126328273|NCT02588664|454496166|FG000|Overall Study|Death|56|||
126328274|NCT02588664|454496167|FG001|Overall Study|Death|55|||
126328275|NCT02588664|454496166|FG000|Overall Study|Lost to Follow-up|1305|||
126328276|NCT02588664|454496167|FG001|Overall Study|Lost to Follow-up|990|||
126328277|NCT01429298|454496168|FG000|Overall Study|Protocol Violation|4|||
126328278|NCT01429298|454496169|FG001|Overall Study|Protocol Violation|6|||
126328279|NCT01124292|454496171|FG000|Overall Study|Lost to Follow-up|2|||
126328280|NCT01124292|454496172|FG001|Overall Study|Lost to Follow-up|4|||
126328281|NCT01124292|454496173|FG002|Overall Study|Lost to Follow-up|3|||
126328282|NCT01124292|454496171|FG000|Overall Study|Physician Decision|0|||
126328283|NCT01124292|454496172|FG001|Overall Study|Physician Decision|3|||
126328284|NCT01124292|454496173|FG002|Overall Study|Physician Decision|2|||
126328285|NCT01124292|454496171|FG000|Overall Study|Withdrawal by Subject|0|||
126328286|NCT01124292|454496172|FG001|Overall Study|Withdrawal by Subject|6|||
126328287|NCT01124292|454496173|FG002|Overall Study|Withdrawal by Subject|2|||
126328288|NCT01124292|454496171|FG000|Overall Study|medical issue unrelated to the study|0|||
126328289|NCT01124292|454496172|FG001|Overall Study|medical issue unrelated to the study|0|||
126328290|NCT01124292|454496173|FG002|Overall Study|medical issue unrelated to the study|2|||
126328291|NCT01124292|454496171|FG000|Overall Study|piercing track closed|0|||
126328292|NCT01124292|454496172|FG001|Overall Study|piercing track closed|2|||
126328293|NCT01124292|454496173|FG002|Overall Study|piercing track closed|1|||
126328294|NCT03373461|454496174|FG000|Part 2|Adverse Event|0|||
126328295|NCT03373461|454496175|FG001|Part 2|Adverse Event|1|||
126328296|NCT03373461|454496176|FG002|Part 2|Adverse Event|0|||
126328297|NCT03373461|454496177|FG003|Part 2|Adverse Event|0|||
126328298|NCT03373461|454496178|FG004|Part 2|Adverse Event|1|||
126328299|NCT03300180|454496179|FG000|Baseline|Withdrawal by Subject|4|||
126328300|NCT03300180|454496180|FG001|Baseline|Withdrawal by Subject|6|||
126328301|NCT03300180|454496181|FG002|Baseline|Withdrawal by Subject|4|||
126328302|NCT03300180|454496179|FG000|6 Month Outcome|Withdrawal by Subject|12|||
126328303|NCT03300180|454496180|FG001|6 Month Outcome|Withdrawal by Subject|12|||
126328304|NCT03300180|454496181|FG002|6 Month Outcome|Withdrawal by Subject|19|||
126328305|NCT03300180|454496179|FG000|6 Month Outcome|Death|2|||
126328306|NCT03300180|454496180|FG001|6 Month Outcome|Death|4|||
126328307|NCT03300180|454496181|FG002|6 Month Outcome|Death|3|||
126328308|NCT03300180|454496179|FG000|6 Month Outcome|Missed Assessment|43|||
126328309|NCT03300180|454496180|FG001|6 Month Outcome|Missed Assessment|52|||
126328310|NCT03300180|454496181|FG002|6 Month Outcome|Missed Assessment|46|||
126328311|NCT03300180|454496179|FG000|12 Month Outcome|Withdrawal by Subject|3|||
126328312|NCT03300180|454496180|FG001|12 Month Outcome|Withdrawal by Subject|6|||
126328313|NCT03300180|454496181|FG002|12 Month Outcome|Withdrawal by Subject|6|||
126328314|NCT03300180|454496179|FG000|12 Month Outcome|Death|9|||
126328315|NCT03300180|454496180|FG001|12 Month Outcome|Death|6|||
126328316|NCT03300180|454496181|FG002|12 Month Outcome|Death|6|||
126328317|NCT03300180|454496179|FG000|12 Month Outcome|Missed Assessment|62|||
126328318|NCT03300180|454496180|FG001|12 Month Outcome|Missed Assessment|59|||
126328319|NCT03300180|454496181|FG002|12 Month Outcome|Missed Assessment|58|||
126328320|NCT03300180|454496179|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
126328321|NCT03300180|454496180|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
126328322|NCT03300180|454496181|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
126328323|NCT03300180|454496179|FG000|18 Month Outcome Assessment|Death|8|||
126328324|NCT03300180|454496180|FG001|18 Month Outcome Assessment|Death|5|||
126328325|NCT03300180|454496181|FG002|18 Month Outcome Assessment|Death|5|||
126328326|NCT03300180|454496179|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
126328327|NCT03300180|454496180|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
126328328|NCT03300180|454496181|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
126328329|NCT03300180|454496179|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
126328330|NCT03300180|454496180|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
126328331|NCT03300180|454496181|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
126328332|NCT03300180|454496179|FG000|24 Month Outcome Assessment|Death|13|||
126328333|NCT03300180|454496180|FG001|24 Month Outcome Assessment|Death|13|||
126328334|NCT03300180|454496181|FG002|24 Month Outcome Assessment|Death|3|||
126328335|NCT03300180|454496179|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
126328336|NCT03300180|454496180|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
126328337|NCT03300180|454496181|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
126328338|NCT00588146|454497866|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
126328339|NCT00588146|454497867|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
126328340|NCT02823470|454497868|FG000|Overall Study|Adverse Event|1|||
126328341|NCT02823470|454497869|FG001|Overall Study|Adverse Event|0|||
126328342|NCT02823470|454497868|FG000|Overall Study|Study terminated by sponsor|8|||
126328343|NCT02823470|454497869|FG001|Overall Study|Study terminated by sponsor|15|||
126328344|NCT00463801|454497872|FG000|Overall Study|Protocol Violation|1|||
126328345|NCT00463801|454497872|FG000|Overall Study|Lack of Efficacy|2|||
126328346|NCT00463801|454497872|FG000|Overall Study|Adverse Event|4|||
126328347|NCT00463801|454497872|FG000|Overall Study|Lost to Follow-up|5|||
126328348|NCT00463801|454497872|FG000|Overall Study|No longer require therapy|1|||
126328349|NCT02315664|454497873|FG000|Overall Study|Lost to Follow-up|1|||
126328350|NCT02315664|454497874|FG001|Overall Study|Lost to Follow-up|1|||
126328351|NCT02315664|454497873|FG000|Overall Study|Withdrawal by Subject|0|||
126328352|NCT02315664|454497874|FG001|Overall Study|Withdrawal by Subject|3|||
126328353|NCT02501161|454497877|FG000|Overall Study|Adverse Event|2|||
126328354|NCT02501161|454497878|FG001|Overall Study|Adverse Event|6|||
126328355|NCT02501161|454497877|FG000|Overall Study|Lost to Follow-up|7|||
126328356|NCT02501161|454497878|FG001|Overall Study|Lost to Follow-up|4|||
126328357|NCT02501161|454497877|FG000|Overall Study|Withdrawal by Subject|10|||
126328358|NCT02501161|454497878|FG001|Overall Study|Withdrawal by Subject|15|||
126328359|NCT02501161|454497877|FG000|Overall Study|Other|3|||
126328360|NCT02501161|454497878|FG001|Overall Study|Other|0|||
126328361|NCT01990573|454497879|FG000|Overall Study|Physician Decision|0|||
126328362|NCT01990573|454497880|FG001|Overall Study|Physician Decision|0|||
126328363|NCT01990573|454497881|FG002|Overall Study|Physician Decision|1|||
126328364|NCT03335813|454497882|FG000|Overall Study|Withdrawal by Subject|1|||
126328365|NCT01957579|454497883|FG000|Overall Study|Withdrawal of concent|0|||
126328366|NCT01957579|454497884|FG001|Overall Study|Withdrawal of concent|1|||
126328367|NCT01957579|454497885|FG002|Overall Study|Withdrawal of concent|0|||
126328368|NCT01957579|454497886|FG003|Overall Study|Withdrawal of concent|0|||
126328369|NCT01957579|454497883|FG000|Overall Study|Death|0|||
126328370|NCT01957579|454497884|FG001|Overall Study|Death|0|||
126328371|NCT01957579|454497885|FG002|Overall Study|Death|2|||
126328372|NCT01957579|454497886|FG003|Overall Study|Death|0|||
126328373|NCT01639144|454497887|FG000|Overall Study|Withdrawal by Subject|4|||
126328374|NCT01639144|454497888|FG001|Overall Study|Withdrawal by Subject|2|||
126328375|NCT01639144|454497887|FG000|Overall Study|Physician Decision|2|||
126328376|NCT01639144|454497888|FG001|Overall Study|Physician Decision|0|||
126328377|NCT01639144|454497887|FG000|Overall Study|Met postoperative exclusion criteria|4|||
126328378|NCT01639144|454497888|FG001|Overall Study|Met postoperative exclusion criteria|3|||
126328379|NCT01000974|454497889|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
126328380|NCT01000974|454497890|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
126328381|NCT01000974|454497891|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
126328382|NCT01000974|454497889|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
126328383|NCT01000974|454497890|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
126328384|NCT01000974|454497891|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
126328385|NCT01000974|454497889|FG000|Primary Vaccination Phase|Protocol Violation|40|||
126328386|NCT01000974|454497890|FG001|Primary Vaccination Phase|Protocol Violation|3|||
126328387|NCT01000974|454497891|FG002|Primary Vaccination Phase|Protocol Violation|2|||
126328388|NCT01000974|454497889|FG000|Primary Vaccination Phase|Adverse Event|14|||
126328389|NCT01000974|454497890|FG001|Primary Vaccination Phase|Adverse Event|2|||
126328390|NCT01000974|454497891|FG002|Primary Vaccination Phase|Adverse Event|2|||
126328391|NCT01000974|454497889|FG000|Primary Vaccination Phase|Other|4|||
126328392|NCT01000974|454497890|FG001|Primary Vaccination Phase|Other|9|||
126328393|NCT01000974|454497891|FG002|Primary Vaccination Phase|Other|12|||
126328394|NCT01000974|454497889|FG000|Booster Vaccination Phase|Protocol Violation|0|||
126328395|NCT01000974|454497890|FG001|Booster Vaccination Phase|Protocol Violation|0|||
126328396|NCT01000974|454497891|FG002|Booster Vaccination Phase|Protocol Violation|2|||
126328397|NCT01000974|454497889|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
126328398|NCT01000974|454497890|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
126328399|NCT01000974|454497891|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
126328400|NCT01000974|454497889|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
126328401|NCT01000974|454497890|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
126328402|NCT01000974|454497891|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
126328403|NCT01000974|454497889|FG000|Booster Vaccination Phase|Other|24|||
126328404|NCT01000974|454497890|FG001|Booster Vaccination Phase|Other|6|||
126328405|NCT01000974|454497891|FG002|Booster Vaccination Phase|Other|4|||
126328406|NCT02750332|454497892|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126328407|NCT02750332|454497893|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126328408|NCT02485483|454497900|FG000|Overall Study|Depression at baseline|15|||
126328409|NCT02485483|454497901|FG001|Overall Study|Depression at baseline|0|||
126328410|NCT02485483|454497900|FG000|Overall Study|Discontinued after baseline|39|||
126328411|NCT02485483|454497901|FG001|Overall Study|Discontinued after baseline|0|||
126328412|NCT00621257|454497902|FG000|Overall Study|Lost to Follow-up|4|||
126328413|NCT00621257|454497903|FG001|Overall Study|Lost to Follow-up|0|||
126328414|NCT00621257|454497904|FG002|Overall Study|Lost to Follow-up|2|||
126328415|NCT00621257|454497905|FG003|Overall Study|Lost to Follow-up|4|||
126328416|NCT00621257|454497906|FG004|Overall Study|Lost to Follow-up|7|||
126328417|NCT00621257|454497902|FG000|Overall Study|Adverse Event|0|||
126328418|NCT00621257|454497903|FG001|Overall Study|Adverse Event|1|||
126328419|NCT00621257|454497904|FG002|Overall Study|Adverse Event|1|||
126328420|NCT00621257|454497905|FG003|Overall Study|Adverse Event|0|||
126328421|NCT00621257|454497906|FG004|Overall Study|Adverse Event|0|||
126328422|NCT00621257|454497902|FG000|Overall Study|Physician Decision|0|||
126328423|NCT00621257|454497903|FG001|Overall Study|Physician Decision|2|||
126328424|NCT00621257|454497904|FG002|Overall Study|Physician Decision|0|||
126328425|NCT00621257|454497905|FG003|Overall Study|Physician Decision|1|||
126328426|NCT00621257|454497906|FG004|Overall Study|Physician Decision|1|||
126328427|NCT00621257|454497902|FG000|Overall Study|Withdrawal by Subject|0|||
126328428|NCT00621257|454497903|FG001|Overall Study|Withdrawal by Subject|0|||
126328429|NCT00621257|454497904|FG002|Overall Study|Withdrawal by Subject|0|||
126328430|NCT00621257|454497905|FG003|Overall Study|Withdrawal by Subject|1|||
126328431|NCT00621257|454497906|FG004|Overall Study|Withdrawal by Subject|1|||
126328432|NCT01255904|454497907|FG000|Overall Study|Physician Decision|1|||
126328433|NCT01255904|454497908|FG001|Overall Study|Physician Decision|4|||
126328434|NCT00632125|454497913|FG000|Overall Study|Death|82|||
126328435|NCT00632125|454497913|FG000|Overall Study|Withdrawal by Subject|44|||
126328436|NCT00632125|454497913|FG000|Overall Study|Adverse Event|36|||
126328437|NCT00632125|454497913|FG000|Overall Study|Renal transplantation|17|||
126328438|NCT00632125|454497913|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
126328439|NCT00632125|454497913|FG000|Overall Study|Non-compliance|8|||
126328440|NCT00632125|454497913|FG000|Overall Study|Development of uncontrolled hypertension|5|||
126328441|NCT00632125|454497913|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
126328442|NCT02384538|454497914|FG000|Overall Study|Adverse Event|1|||
126328443|NCT02384538|454497915|FG001|Overall Study|Adverse Event|4|||
126328444|NCT02384538|454497914|FG000|Overall Study|Lack of Efficacy|4|||
126328445|NCT02384538|454497915|FG001|Overall Study|Lack of Efficacy|4|||
126328446|NCT02384538|454497914|FG000|Overall Study|Withdrew Consent|0|||
126328447|NCT02384538|454497915|FG001|Overall Study|Withdrew Consent|4|||
126328448|NCT02384538|454497914|FG000|Overall Study|Other|1|||
126328449|NCT02384538|454497915|FG001|Overall Study|Other|3|||
126328450|NCT04446429|454497918|FG000|Overall Study|Lost to Follow-up|6|||
126328451|NCT04446429|454497919|FG001|Overall Study|Lost to Follow-up|0|||
126328452|NCT02256917|454497920|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
126328453|NCT02256917|454497920|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
126328454|NCT02256917|454497920|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
126328455|NCT02256917|454497920|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
126328456|NCT02256917|454497920|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
126328457|NCT00540644|454497921|FG000|Overall Study|Adverse Event|3|||
126328458|NCT00540644|454497922|FG001|Overall Study|Adverse Event|1|||
126328459|NCT00540644|454497921|FG000|Overall Study|Disease Progression|3|||
126328460|NCT00540644|454497922|FG001|Overall Study|Disease Progression|1|||
126328461|NCT00540644|454497921|FG000|Overall Study|Physician Decision|0|||
126328462|NCT00540644|454497922|FG001|Overall Study|Physician Decision|5|||
126328463|NCT00540644|454497921|FG000|Overall Study|Withdrawal by Subject|2|||
126328464|NCT00540644|454497922|FG001|Overall Study|Withdrawal by Subject|2|||
126328465|NCT00540644|454497921|FG000|Overall Study|Noncomplilance|1|||
126328466|NCT00540644|454497922|FG001|Overall Study|Noncomplilance|0|||
126328467|NCT00809094|454497923|FG000|Overall Study|Lost to Follow-up|0|||
126328468|NCT00809094|454497924|FG001|Overall Study|Lost to Follow-up|1|||
126328469|NCT00397189|454497926|FG000|3 Weeks Period|Lost to Follow-up|5|||
126328470|NCT00397189|454497927|FG001|3 Weeks Period|Lost to Follow-up|4|||
126328471|NCT00397189|454497926|FG000|3 Weeks Period|Adverse Event|3|||
126328472|NCT00397189|454497927|FG001|3 Weeks Period|Adverse Event|2|||
126328473|NCT00397189|454497926|FG000|3 Weeks Period|Withdrawal by Subject|13|||
126328474|NCT00397189|454497927|FG001|3 Weeks Period|Withdrawal by Subject|9|||
126328475|NCT00397189|454497926|FG000|3 Weeks Period|Physician Decision|0|||
126328476|NCT00397189|454497927|FG001|3 Weeks Period|Physician Decision|2|||
126328477|NCT00397189|454497926|FG000|3 Weeks Period|Protocol Violation|0|||
126328478|NCT00397189|454497927|FG001|3 Weeks Period|Protocol Violation|3|||
126328479|NCT00397189|454497926|FG000|3 Weeks Period|Other|0|||
126328480|NCT00397189|454497927|FG001|3 Weeks Period|Other|2|||
126328481|NCT01535443|454497928|FG000|Overall Study|Physician Decision|3|||
126328482|NCT00232557|454497931|FG000|Overall Study|Lost to Follow-up|3|||
126328483|NCT00232557|454497932|FG001|Overall Study|Lost to Follow-up|5|||
126328484|NCT01059773|454497933|FG000|Overall Study|Adverse Event|2|||
126328485|NCT01059773|454497934|FG001|Overall Study|Adverse Event|2|||
126328486|NCT01059773|454497933|FG000|Overall Study|Withdrawal by Subject|1|||
126328487|NCT01059773|454497934|FG001|Overall Study|Withdrawal by Subject|5|||
126328488|NCT01059773|454497933|FG000|Overall Study|Lost to Follow-up|1|||
126328489|NCT01059773|454497934|FG001|Overall Study|Lost to Follow-up|1|||
126328490|NCT01059773|454497933|FG000|Overall Study|Pregnancy|1|||
126328491|NCT01059773|454497934|FG001|Overall Study|Pregnancy|1|||
126328492|NCT01059773|454497933|FG000|Overall Study|Protocol Violation|6|||
126328493|NCT01059773|454497934|FG001|Overall Study|Protocol Violation|2|||
126328494|NCT01059773|454497933|FG000|Overall Study|Physician Decision|5|||
126328495|NCT01059773|454497934|FG001|Overall Study|Physician Decision|4|||
126328496|NCT01059773|454497933|FG000|Overall Study|Lack of Efficacy|3|||
126328497|NCT01059773|454497934|FG001|Overall Study|Lack of Efficacy|3|||
126328498|NCT01059773|454497933|FG000|Overall Study|Death|0|||
126328499|NCT01059773|454497934|FG001|Overall Study|Death|1|||
126328500|NCT01059773|454497933|FG000|Overall Study|Malignancy including squamous cell skin|0|||
126328501|NCT01059773|454497934|FG001|Overall Study|Malignancy including squamous cell skin|1|||
126328502|NCT01059773|454497933|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
126328503|NCT01059773|454497934|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
126328504|NCT01059773|454497933|FG000|Overall Study|Other|1|||
126328505|NCT01059773|454497934|FG001|Overall Study|Other|3|||
126328506|NCT01806168|454497937|FG000|Overall Study|Adverse Event|1|||
126328507|NCT01806168|454497938|FG001|Overall Study|Adverse Event|0|||
126328508|NCT01806168|454497939|FG002|Overall Study|Adverse Event|0|||
126328509|NCT01806168|454497937|FG000|Overall Study|Withdrawal by Subject|0|||
126328510|NCT01806168|454497938|FG001|Overall Study|Withdrawal by Subject|1|||
126328511|NCT01806168|454497939|FG002|Overall Study|Withdrawal by Subject|2|||
126328512|NCT01806168|454497937|FG000|Overall Study|Protocol Violation|0|||
126328513|NCT01806168|454497938|FG001|Overall Study|Protocol Violation|0|||
126328514|NCT01806168|454497939|FG002|Overall Study|Protocol Violation|1|||
126328515|NCT01029262|454497942|FG000|Overall Study|Adverse Event|9|||
126328516|NCT01029262|454497943|FG001|Overall Study|Adverse Event|52|||
126328517|NCT01029262|454497942|FG000|Overall Study|Lack of therapeutic effect|57|||
126328518|NCT01029262|454497943|FG001|Overall Study|Lack of therapeutic effect|76|||
126328519|NCT01029262|454497942|FG000|Overall Study|Withdrawal by Subject|10|||
126328520|NCT01029262|454497943|FG001|Overall Study|Withdrawal by Subject|17|||
126328521|NCT01029262|454497942|FG000|Overall Study|Protocol Violation|2|||
126328522|NCT01029262|454497943|FG001|Overall Study|Protocol Violation|3|||
126328523|NCT01029262|454497942|FG000|Overall Study|Miscellaneous|1|||
126328524|NCT01029262|454497943|FG001|Overall Study|Miscellaneous|9|||
126328525|NCT01029262|454497942|FG000|Overall Study|Death|0|||
126328526|NCT01029262|454497943|FG001|Overall Study|Death|3|||
126328527|NCT03410992|454497944|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328528|NCT03410992|454497945|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
126328529|NCT03410992|454497946|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328530|NCT03410992|454497947|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328531|NCT03410992|454497948|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328532|NCT03410992|454497949|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328533|NCT03410992|454497950|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328534|NCT03410992|454497951|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328535|NCT03410992|454497952|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328536|NCT03410992|454497953|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328537|NCT03410992|454497954|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328538|NCT03410992|454497944|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
126328539|NCT03410992|454497945|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
126328540|NCT03410992|454497946|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328541|NCT03410992|454497947|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328542|NCT03410992|454497948|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328543|NCT03410992|454497949|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328544|NCT03410992|454497950|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328545|NCT03410992|454497951|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328546|NCT03410992|454497952|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328547|NCT03410992|454497953|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328548|NCT03410992|454497954|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328549|NCT03410992|454497944|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
126328550|NCT03410992|454497945|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
126328551|NCT03410992|454497946|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328552|NCT03410992|454497947|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328553|NCT03410992|454497948|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328554|NCT03410992|454497949|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328555|NCT03410992|454497950|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328556|NCT03410992|454497951|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328557|NCT03410992|454497952|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328558|NCT03410992|454497953|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328559|NCT03410992|454497954|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328560|NCT03410992|454497944|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
126328561|NCT03410992|454497945|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328562|NCT03410992|454497946|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328563|NCT03410992|454497947|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328564|NCT03410992|454497948|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328565|NCT03410992|454497949|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328566|NCT03410992|454497950|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328567|NCT03410992|454497951|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328568|NCT03410992|454497952|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328569|NCT03410992|454497953|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328570|NCT03410992|454497954|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328571|NCT03410992|454497944|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
126328572|NCT03410992|454497945|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
126328573|NCT03410992|454497946|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328574|NCT03410992|454497947|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328575|NCT03410992|454497948|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328576|NCT03410992|454497949|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328577|NCT03410992|454497950|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328578|NCT03410992|454497951|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328579|NCT03410992|454497952|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328580|NCT03410992|454497953|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328581|NCT03410992|454497954|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328582|NCT03410992|454497944|FG000|Week 16 Assessment|Incorrect escapers|0|||
126328583|NCT03410992|454497945|FG001|Week 16 Assessment|Incorrect escapers|6|||
126328584|NCT03410992|454497946|FG002|Week 16 Assessment|Incorrect escapers|0|||
126328585|NCT03410992|454497947|FG003|Week 16 Assessment|Incorrect escapers|0|||
126328586|NCT03410992|454497948|FG004|Week 16 Assessment|Incorrect escapers|0|||
126328587|NCT03410992|454497949|FG005|Week 16 Assessment|Incorrect escapers|0|||
126328588|NCT03410992|454497950|FG006|Week 16 Assessment|Incorrect escapers|0|||
126328589|NCT03410992|454497951|FG007|Week 16 Assessment|Incorrect escapers|0|||
126328590|NCT03410992|454497952|FG008|Week 16 Assessment|Incorrect escapers|0|||
126328591|NCT03410992|454497953|FG009|Week 16 Assessment|Incorrect escapers|0|||
126328592|NCT03410992|454497954|FG010|Week 16 Assessment|Incorrect escapers|0|||
126328593|NCT03410992|454497944|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328594|NCT03410992|454497945|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328595|NCT03410992|454497946|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328596|NCT03410992|454497947|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
126328597|NCT03410992|454497948|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
126328598|NCT03410992|454497949|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328599|NCT03410992|454497950|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328600|NCT03410992|454497951|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328601|NCT03410992|454497952|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328602|NCT03410992|454497953|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328603|NCT03410992|454497954|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328604|NCT03410992|454497944|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328605|NCT03410992|454497945|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328606|NCT03410992|454497946|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328607|NCT03410992|454497947|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
126328608|NCT03410992|454497948|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
126328609|NCT03410992|454497949|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
126328610|NCT03410992|454497950|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328611|NCT03410992|454497951|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328612|NCT03410992|454497952|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328613|NCT03410992|454497953|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328614|NCT03410992|454497954|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328615|NCT03410992|454497944|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328616|NCT03410992|454497945|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328617|NCT03410992|454497946|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328618|NCT03410992|454497947|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328619|NCT03410992|454497948|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328620|NCT03410992|454497949|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
126328621|NCT03410992|454497950|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328622|NCT03410992|454497951|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328623|NCT03410992|454497952|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328624|NCT03410992|454497953|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328625|NCT03410992|454497954|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328626|NCT03410992|454497944|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328627|NCT03410992|454497945|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328628|NCT03410992|454497946|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328629|NCT03410992|454497947|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
126328630|NCT03410992|454497948|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
126328631|NCT03410992|454497949|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
126328632|NCT03410992|454497950|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328633|NCT03410992|454497951|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328634|NCT03410992|454497952|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328635|NCT03410992|454497953|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328636|NCT03410992|454497954|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328637|NCT03410992|454497944|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328638|NCT03410992|454497945|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328639|NCT03410992|454497946|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328640|NCT03410992|454497947|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328641|NCT03410992|454497948|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328642|NCT03410992|454497949|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328643|NCT03410992|454497950|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328644|NCT03410992|454497951|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
126328645|NCT03410992|454497952|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328646|NCT03410992|454497953|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328647|NCT03410992|454497954|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328648|NCT03410992|454497944|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328649|NCT03410992|454497945|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328650|NCT03410992|454497946|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328651|NCT03410992|454497947|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328652|NCT03410992|454497948|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328653|NCT03410992|454497949|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328654|NCT03410992|454497950|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328655|NCT03410992|454497951|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328656|NCT03410992|454497952|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
126328657|NCT03410992|454497953|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328658|NCT03410992|454497954|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328659|NCT02438280|454497955|FG000|Overall Study|Physician Decision|1|||
126328660|NCT02438280|454497956|FG001|Overall Study|Physician Decision|0|||
126328661|NCT02260817|454497957|FG000|Overall Study|Lost to Follow-up|0|||
126328662|NCT02260817|454497958|FG001|Overall Study|Lost to Follow-up|14|||
126328663|NCT02260817|454497957|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
126328664|NCT02260817|454497958|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
126328665|NCT02260817|454497957|FG000|Overall Study|Observation, no biopsy|0|||
126328666|NCT02260817|454497958|FG001|Overall Study|Observation, no biopsy|1|||
126328667|NCT02260817|454497957|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
126328668|NCT02260817|454497958|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
126328669|NCT02260817|454497957|FG000|Overall Study|Protocol Violation|0|||
126328670|NCT02260817|454497958|FG001|Overall Study|Protocol Violation|14|||
126328671|NCT03299101|454497959|FG000|Overall Study|Lost to Follow-up|1|||
126328672|NCT03299101|454497959|FG000|Overall Study|Withdrawal by Subject|5|||
126328673|NCT03299101|454497959|FG000|Overall Study|Surgery was changed|3|||
126328674|NCT03299101|454497959|FG000|Overall Study|Not enough time to complete prehab|1|||
126328675|NCT03066778|454497963|FG000|Overall Study|Death|195|||
126328676|NCT03066778|454497964|FG001|Overall Study|Death|205|||
126328677|NCT03066778|454497963|FG000|Overall Study|Withdrawal by Subject|5|||
126328678|NCT03066778|454497964|FG001|Overall Study|Withdrawal by Subject|7|||
126328679|NCT02328937|454497965|FG000|Period 1|Lost to Follow-up|0|||
126328680|NCT02328937|454497966|FG001|Period 1|Lost to Follow-up|0|||
126328681|NCT02328937|454497967|FG002|Period 1|Lost to Follow-up|0|||
126328682|NCT02328937|454497968|FG003|Period 1|Lost to Follow-up|1|||
126328683|NCT02328937|454497969|FG004|Period 1|Lost to Follow-up|0|||
126328684|NCT02328937|454497970|FG005|Period 1|Lost to Follow-up|0|||
126328685|NCT02328937|454497965|FG000|Period 2|Adverse Event|0|||
126328686|NCT02328937|454497966|FG001|Period 2|Adverse Event|0|||
126328687|NCT02328937|454497967|FG002|Period 2|Adverse Event|1|||
126328688|NCT02328937|454497968|FG003|Period 2|Adverse Event|0|||
126328689|NCT02328937|454497969|FG004|Period 2|Adverse Event|0|||
126328690|NCT02328937|454497970|FG005|Period 2|Adverse Event|0|||
126328691|NCT03665077|454497973|FG000|Overall Study|Lost to Follow-up|2|||
126328692|NCT03665077|454497973|FG000|Overall Study|Physician Decision|2|||
126328693|NCT02420262|454497976|FG000|Overall Study|Adverse Event|1|||
126328694|NCT02420262|454497977|FG001|Overall Study|Adverse Event|0|||
126328695|NCT02420262|454497976|FG000|Overall Study|Withdrawal by Subject|1|||
126328696|NCT02420262|454497977|FG001|Overall Study|Withdrawal by Subject|4|||
126328697|NCT02420262|454497976|FG000|Overall Study|Unclassified|0|||
126328698|NCT02420262|454497977|FG001|Overall Study|Unclassified|1|||
126328699|NCT01904032|454497981|FG000|Overall Study|Adverse Event|3|||
126328700|NCT01904032|454497982|FG001|Overall Study|Adverse Event|1|||
126328701|NCT01904032|454497981|FG000|Overall Study|Lost to Follow-up|4|||
126328702|NCT01904032|454497982|FG001|Overall Study|Lost to Follow-up|2|||
126328703|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
126328704|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
126328705|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
126328706|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
126328707|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
126328708|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
126328709|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
126328710|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
126328711|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
126328712|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
126328713|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
126328714|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
126328715|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
126328716|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
126328717|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
126328718|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
126328719|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
126328720|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
126328721|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
126328722|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
126328723|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328724|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328725|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
126328726|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328727|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328728|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328729|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328730|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328731|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328732|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328733|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328734|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328735|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328736|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328737|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328738|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
126328739|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328740|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
126328741|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328742|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125987026|NCT01576718|453243156|FG006|Treatment Period|Lost to Follow-up|0|||
125987027|NCT01576718|453243150|FG000|Treatment Period|Noncompliance to study medication|0|||
125987028|NCT01576718|453243151|FG001|Treatment Period|Noncompliance to study medication|0|||
125987029|NCT01576718|453243152|FG002|Treatment Period|Noncompliance to study medication|0|||
126328743|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
126328744|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
126328745|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
126328746|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328747|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
126328748|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
126328749|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328750|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328751|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328752|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328753|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328754|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
126328755|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
126328756|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
126328757|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328758|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
126328759|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328760|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328761|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328762|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328763|NCT04074330|454497995|FG000|Dose Expansion (up to 42 Months)|Death|0|||
126328764|NCT04074330|454497996|FG001|Dose Expansion (up to 42 Months)|Death|0|||
126328765|NCT04074330|454497997|FG002|Dose Expansion (up to 42 Months)|Death|0|||
126328766|NCT04074330|454497998|FG003|Dose Expansion (up to 42 Months)|Death|0|||
126328767|NCT04074330|454497999|FG004|Dose Expansion (up to 42 Months)|Death|0|||
126328768|NCT04074330|454498000|FG005|Dose Expansion (up to 42 Months)|Death|0|||
126328769|NCT04074330|454498001|FG006|Dose Expansion (up to 42 Months)|Death|0|||
126328770|NCT04074330|454498002|FG007|Dose Expansion (up to 42 Months)|Death|0|||
126328771|NCT04074330|454498003|FG008|Dose Expansion (up to 42 Months)|Death|1|||
126328772|NCT04074330|454498004|FG009|Dose Expansion (up to 42 Months)|Death|0|||
126328773|NCT04074330|454497995|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328774|NCT04074330|454497996|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328775|NCT04074330|454497997|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328776|NCT04074330|454497998|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125987030|NCT01576718|453243153|FG003|Treatment Period|Noncompliance to study medication|0|||
126328777|NCT04074330|454497999|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328778|NCT04074330|454498000|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328779|NCT04074330|454498001|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328780|NCT04074330|454498002|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328781|NCT04074330|454498003|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
126328782|NCT04074330|454498004|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
126328783|NCT01903993|454498005|FG000|Overall Study|Death|118|||
126328784|NCT01903993|454498006|FG001|Overall Study|Death|121|||
126328785|NCT01903993|454498005|FG000|Overall Study|Withdrawal by Subject|15|||
126328786|NCT01903993|454498006|FG001|Overall Study|Withdrawal by Subject|4|||
126328787|NCT01903993|454498005|FG000|Overall Study|Lost to Follow-up|2|||
126328788|NCT01903993|454498006|FG001|Overall Study|Lost to Follow-up|3|||
126328789|NCT01903993|454498005|FG000|Overall Study|Study Terminated by Sponsor|8|||
126328790|NCT01903993|454498006|FG001|Overall Study|Study Terminated by Sponsor|14|||
126328791|NCT01903993|454498005|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
126328792|NCT01903993|454498006|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
126328793|NCT00184093|454498007|FG000|Overall Study|Adverse Event|3|||
126328794|NCT00184093|454498007|FG000|Overall Study|Lost to Follow-up|3|||
126328795|NCT00184093|454498007|FG000|Overall Study|Physician Decision|1|||
126328796|NCT00184093|454498007|FG000|Overall Study|Withdrawal by Subject|2|||
126328797|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
126328798|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
126328799|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
126328800|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
126328801|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
126328802|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
126328803|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
126328804|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
126328805|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
126328806|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
126328807|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
126328808|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
126328809|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
126328810|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
126328811|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
126328812|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
126328813|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
126328814|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
126328815|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
125987031|NCT01576718|453243154|FG004|Treatment Period|Noncompliance to study medication|0|||
125987032|NCT01576718|453243155|FG005|Treatment Period|Noncompliance to study medication|1|||
125987033|NCT01576718|453243156|FG006|Treatment Period|Noncompliance to study medication|1|||
125987034|NCT00682643|453243157|FG000|Overall Study|Adverse Event|12|||
125987035|NCT00682643|453243158|FG001|Overall Study|Adverse Event|23|||
125987036|NCT00682643|453243157|FG000|Overall Study|Lack of Efficacy|2|||
125987037|NCT00682643|453243158|FG001|Overall Study|Lack of Efficacy|0|||
125987038|NCT00682643|453243157|FG000|Overall Study|Protocol Violation|38|||
125987039|NCT00682643|453243158|FG001|Overall Study|Protocol Violation|76|||
125987040|NCT00682643|453243157|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
125987041|NCT00682643|453243158|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
126328816|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
126328817|NCT01868165|454498012|FG000|Overall Study|Withdrawal by Subject|36|||
126328818|NCT01868165|454498012|FG000|Overall Study|Physician Decision|2|||
126328819|NCT01868165|454498012|FG000|Overall Study|Lost to Follow-up|3|||
126328820|NCT01868165|454498012|FG000|Overall Study|Death|4|||
126328821|NCT02282163|454498015|FG000|Overall Study|Protocol Violation|1|||
126328822|NCT01603407|454498016|FG000|Overall Study|Adverse Event|1|||
126328823|NCT01603407|454498017|FG001|Overall Study|Adverse Event|1|||
126328824|NCT01603407|454498018|FG002|Overall Study|Adverse Event|1|||
126328825|NCT01603407|454498016|FG000|Overall Study|Protocol Violation|2|||
126328826|NCT01603407|454498017|FG001|Overall Study|Protocol Violation|2|||
126328827|NCT01603407|454498018|FG002|Overall Study|Protocol Violation|0|||
126328828|NCT01603407|454498016|FG000|Overall Study|Withdrawal by Subject|8|||
126328829|NCT01603407|454498017|FG001|Overall Study|Withdrawal by Subject|5|||
126328830|NCT01603407|454498018|FG002|Overall Study|Withdrawal by Subject|7|||
126328831|NCT01603407|454498016|FG000|Overall Study|Lost to Follow-up|0|||
126328832|NCT01603407|454498017|FG001|Overall Study|Lost to Follow-up|3|||
125987042|NCT00682643|453243157|FG000|Overall Study|Lost to Follow-up|1|||
126328833|NCT01603407|454498018|FG002|Overall Study|Lost to Follow-up|2|||
126328834|NCT02500719|454498019|FG000|Overall Study|Lost to Follow-up|2|||
126328835|NCT02500719|454498020|FG001|Overall Study|Lost to Follow-up|3|||
126328836|NCT02500719|454498019|FG000|Overall Study|Trauma history|1|||
126328837|NCT02500719|454498020|FG001|Overall Study|Trauma history|0|||
126328838|NCT02500719|454498019|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
126328839|NCT02500719|454498020|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
126328840|NCT02500719|454498019|FG000|Overall Study|Did not meet criteria for PTSD|0|||
126328841|NCT02500719|454498020|FG001|Overall Study|Did not meet criteria for PTSD|1|||
126328842|NCT02500719|454498019|FG000|Overall Study|Claustrophobia|0|||
126328843|NCT02500719|454498020|FG001|Overall Study|Claustrophobia|1|||
126328844|NCT02500719|454498019|FG000|Overall Study|History of head trauma|0|||
126328845|NCT02500719|454498020|FG001|Overall Study|History of head trauma|1|||
126328846|NCT01990768|454498021|FG000|Intervention Started|Found to be ineligible|14|||
126328847|NCT01990768|454498022|FG001|Intervention Started|Found to be ineligible|13|||
126328848|NCT01990768|454498023|FG002|Intervention Started|Found to be ineligible|11|||
126328849|NCT01990768|454498021|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
126328850|NCT01990768|454498022|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
126328851|NCT01990768|454498023|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
126328852|NCT01990768|454498021|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
126328853|NCT01990768|454498022|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
126328854|NCT01990768|454498023|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
126328855|NCT01990768|454498021|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
126328856|NCT01990768|454498022|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
126328857|NCT01990768|454498023|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
126328858|NCT01990768|454498021|FG000|Intervention Started|Patient care priority|1|||
126328859|NCT01990768|454498022|FG001|Intervention Started|Patient care priority|2|||
126328860|NCT01990768|454498023|FG002|Intervention Started|Patient care priority|3|||
126328861|NCT01990768|454498021|FG000|Intervention Started|IV lost|2|||
126328862|NCT01990768|454498022|FG001|Intervention Started|IV lost|2|||
126328863|NCT01990768|454498023|FG002|Intervention Started|IV lost|2|||
126328864|NCT01990768|454498021|FG000|Intervention Started|Required CPR|1|||
125987043|NCT00682643|453243158|FG001|Overall Study|Lost to Follow-up|6|||
125987044|NCT00682643|453243157|FG000|Overall Study|Physician Decision|2|||
126328865|NCT01990768|454498022|FG001|Intervention Started|Required CPR|1|||
126328866|NCT01990768|454498023|FG002|Intervention Started|Required CPR|0|||
126328867|NCT01990768|454498021|FG000|Intervention Started|Seizure or hx of seizure|0|||
126328868|NCT01990768|454498022|FG001|Intervention Started|Seizure or hx of seizure|0|||
126328869|NCT01990768|454498023|FG002|Intervention Started|Seizure or hx of seizure|2|||
126328870|NCT01990768|454498021|FG000|Intervention Started|Discovered to be pregnant|0|||
126328871|NCT01990768|454498022|FG001|Intervention Started|Discovered to be pregnant|1|||
126328872|NCT01990768|454498023|FG002|Intervention Started|Discovered to be pregnant|0|||
126328873|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
126328874|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
126328875|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
126328876|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
126328877|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
126328878|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
126328879|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
126328880|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
126328881|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
126328882|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
126328883|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
126328884|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
126328885|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Death|3|||
126328886|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Death|1|||
126328887|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Death|1|||
126328888|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Discharged|2|||
126328889|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Discharged|1|||
126328890|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Discharged|0|||
126328891|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
126328892|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
126328893|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
126328894|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
126328895|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
126328896|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
126328897|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
126328898|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
126328899|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
126328900|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
126328901|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
126328902|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
126328903|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
125987045|NCT00682643|453243158|FG001|Overall Study|Physician Decision|6|||
126328904|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
126328905|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
126328906|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
126328907|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
126328908|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
126328909|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
126328910|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
126328911|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
126328912|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
126328913|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
126328914|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
126328915|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
126328916|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
126328917|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
126328918|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
126328919|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
126328920|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
126328921|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
126328922|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
126328923|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
126328924|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
126328925|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
126328926|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
126328927|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
126328928|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
126328929|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
126328930|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
126328931|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
126328932|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
126328933|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
126328934|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
126328935|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
126328936|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
126328937|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
126328938|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
126328939|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
126328940|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
126328941|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
126328942|NCT01990768|454498021|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
126328943|NCT01990768|454498022|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
126328944|NCT01990768|454498023|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
126328945|NCT01990768|454498021|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
126328946|NCT01990768|454498022|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
126328947|NCT01990768|454498023|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
126328948|NCT01990768|454498021|FG000|6-Month Follow-up|No contact information|5|||
126328949|NCT01990768|454498022|FG001|6-Month Follow-up|No contact information|6|||
126328950|NCT01990768|454498023|FG002|6-Month Follow-up|No contact information|5|||
126328951|NCT01990768|454498021|FG000|6-Month Follow-up|Homeless|4|||
126328952|NCT01990768|454498022|FG001|6-Month Follow-up|Homeless|3|||
126328953|NCT01990768|454498023|FG002|6-Month Follow-up|Homeless|6|||
126328954|NCT01990768|454498021|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
126328955|NCT01990768|454498022|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
126328956|NCT01990768|454498023|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
126328957|NCT01990768|454498021|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
126328958|NCT01990768|454498022|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
126328959|NCT01990768|454498023|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
126328960|NCT01990768|454498021|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
126328961|NCT01990768|454498022|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
126328962|NCT01990768|454498023|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
126328963|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
126328964|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
126328965|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
126328966|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
126328967|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
126328968|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
126328969|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
126328970|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
126328971|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
126328972|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
126328973|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
126328974|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
126328975|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
126328976|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
126328977|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
126328978|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
126328979|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
126328980|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
126328981|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
126328982|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
126328983|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
126328984|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
126328985|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
126328986|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
126328987|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
126328988|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
126328989|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
126328990|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
126328991|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
126328992|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
126328993|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
126328994|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
126328995|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
126328996|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
125987046|NCT00682643|453243157|FG000|Overall Study|Withdrawal by Subject|19|||
125987047|NCT00682643|453243158|FG001|Overall Study|Withdrawal by Subject|53|||
125987048|NCT00682643|453243157|FG000|Overall Study|Did Not Receive Study Drug|1|||
125987049|NCT00682643|453243158|FG001|Overall Study|Did Not Receive Study Drug|1|||
125987050|NCT00263328|453243162|FG000|Overall Study|Death|0|||
125987051|NCT00263328|453243163|FG001|Overall Study|Death|0|||
125987052|NCT00263328|453243164|FG002|Overall Study|Death|1|||
125987053|NCT00263328|453243162|FG000|Overall Study|Lost to Follow-up|1|||
125987054|NCT00263328|453243163|FG001|Overall Study|Lost to Follow-up|1|||
125987055|NCT00263328|453243164|FG002|Overall Study|Lost to Follow-up|0|||
125987056|NCT00263328|453243162|FG000|Overall Study|Withdrawal by Subject|3|||
126328997|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
126328998|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
126328999|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
126329000|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
126329001|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
126329002|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
126329003|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
126329004|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
126329005|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
126329006|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
126329007|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
126329008|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
126329009|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
126329010|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
126329011|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
126329012|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
126329013|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
126329014|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
125987057|NCT00263328|453243163|FG001|Overall Study|Withdrawal by Subject|0|||
125987058|NCT00263328|453243164|FG002|Overall Study|Withdrawal by Subject|1|||
125987059|NCT00263328|453243162|FG000|Overall Study|Other|3|||
126329015|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
125987060|NCT00263328|453243163|FG001|Overall Study|Other|0|||
125987061|NCT00263328|453243164|FG002|Overall Study|Other|1|||
125987062|NCT00263328|453243162|FG000|Overall Study|Adverse Event|1|||
125987063|NCT00263328|453243163|FG001|Overall Study|Adverse Event|1|||
125987064|NCT00263328|453243164|FG002|Overall Study|Adverse Event|4|||
126329016|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
125987065|NCT00622180|453243165|FG000|Overall Study|Lost to Follow-up|1|||
125987066|NCT00622180|453243166|FG001|Overall Study|Lost to Follow-up|2|||
125987067|NCT04512066|453243169|FG000|Double-blind Treatment Period|Adverse Event|6|||
125987068|NCT04512066|453243170|FG001|Double-blind Treatment Period|Adverse Event|4|||
125987069|NCT04512066|453243171|FG002|Double-blind Treatment Period|Adverse Event|5|||
125987070|NCT04512066|453243172|FG003|Double-blind Treatment Period|Adverse Event|1|||
125987071|NCT04512066|453243173|FG004|Double-blind Treatment Period|Adverse Event|0|||
125987072|NCT04512066|453243174|FG005|Double-blind Treatment Period|Adverse Event|0|||
125987073|NCT04512066|453243169|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
126329017|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
126329018|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
126329019|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
126329020|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
126329021|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
126329022|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
126329023|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
126329024|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
126329025|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
126329026|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
126329027|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
126329028|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
126329029|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
126329030|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
126329031|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
126329032|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
126329033|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
126329034|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
126329035|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329036|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
126329037|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329038|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329039|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
126329040|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
126329041|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
126329042|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
126329043|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
126329044|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
126329045|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
126329046|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
126329047|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
126329048|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
126329049|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
126329050|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
126329051|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
126329052|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
126329053|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
126329054|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
126329055|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
126329056|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
126329057|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
126329058|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
126329059|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
126329060|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
126329061|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
126329062|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
126329063|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
126329064|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
126329065|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
126329066|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
126329067|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
125987074|NCT04512066|453243170|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
125987075|NCT04512066|453243171|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
126329068|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
126329069|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
126329070|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
126329071|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329072|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329073|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
126329074|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
126329075|NCT01588405|454498028|FG000|Overall Study|Adverse Event|1|||
126329076|NCT01588405|454498028|FG000|Overall Study|Clinical Worsening|1|||
126329077|NCT02029274|454498030|FG000|Overall Study|Adverse Event|1|||
126329078|NCT02029274|454498031|FG001|Overall Study|Adverse Event|0|||
126329079|NCT02029274|454498032|FG002|Overall Study|Adverse Event|2|||
126329080|NCT02029274|454498033|FG003|Overall Study|Adverse Event|2|||
126329081|NCT03654729|454499979|FG000|Overall Study|Death|9|||
126329082|NCT03654729|454499980|FG001|Overall Study|Death|9|||
126329083|NCT03654729|454499981|FG002|Overall Study|Death|16|||
126329084|NCT03654729|454499979|FG000|Overall Study|Withdrawal by Subject|8|||
126329085|NCT03654729|454499980|FG001|Overall Study|Withdrawal by Subject|6|||
126329086|NCT03654729|454499981|FG002|Overall Study|Withdrawal by Subject|4|||
126329087|NCT03654729|454499979|FG000|Overall Study|Study terminated by Sponsor|3|||
126329088|NCT03654729|454499980|FG001|Overall Study|Study terminated by Sponsor|5|||
126329089|NCT03654729|454499981|FG002|Overall Study|Study terminated by Sponsor|4|||
126329090|NCT03654729|454499979|FG000|Overall Study|Not reported|2|||
126329091|NCT03654729|454499980|FG001|Overall Study|Not reported|4|||
126329092|NCT03654729|454499981|FG002|Overall Study|Not reported|5|||
126329093|NCT03654729|454499979|FG000|Overall Study|Progressive disease|3|||
126329094|NCT03654729|454499980|FG001|Overall Study|Progressive disease|0|||
126329095|NCT03654729|454499981|FG002|Overall Study|Progressive disease|0|||
126329096|NCT03654729|454499979|FG000|Overall Study|Lost to Follow-up|2|||
126329097|NCT03654729|454499980|FG001|Overall Study|Lost to Follow-up|0|||
126329098|NCT03654729|454499981|FG002|Overall Study|Lost to Follow-up|0|||
126329099|NCT03654729|454499979|FG000|Overall Study|Physician Decision|2|||
126329100|NCT03654729|454499980|FG001|Overall Study|Physician Decision|0|||
126329101|NCT03654729|454499981|FG002|Overall Study|Physician Decision|0|||
126329102|NCT03654729|454499979|FG000|Overall Study|Protocol Violation|1|||
126329103|NCT03654729|454499980|FG001|Overall Study|Protocol Violation|1|||
126329104|NCT03654729|454499981|FG002|Overall Study|Protocol Violation|0|||
126329105|NCT03654729|454499979|FG000|Overall Study|Non-compliance with study drug|0|||
126329106|NCT03654729|454499980|FG001|Overall Study|Non-compliance with study drug|1|||
126329107|NCT03654729|454499981|FG002|Overall Study|Non-compliance with study drug|0|||
126329108|NCT03654729|454499979|FG000|Overall Study|Site terminated by Sponsor|1|||
126329109|NCT03654729|454499980|FG001|Overall Study|Site terminated by Sponsor|0|||
126329110|NCT03654729|454499981|FG002|Overall Study|Site terminated by Sponsor|0|||
126329111|NCT01919164|454499989|FG000|Overall Study|Adverse Event|6|||
126329112|NCT01919164|454499990|FG001|Overall Study|Adverse Event|4|||
126329113|NCT01919164|454499991|FG002|Overall Study|Adverse Event|9|||
126329114|NCT01919164|454499992|FG003|Overall Study|Adverse Event|3|||
126329115|NCT01919164|454499993|FG004|Overall Study|Adverse Event|2|||
126329116|NCT01919164|454499989|FG000|Overall Study|Lost to Follow-up|2|||
126329117|NCT01919164|454499990|FG001|Overall Study|Lost to Follow-up|2|||
126329118|NCT01919164|454499991|FG002|Overall Study|Lost to Follow-up|2|||
126329119|NCT01919164|454499992|FG003|Overall Study|Lost to Follow-up|0|||
126329120|NCT01919164|454499993|FG004|Overall Study|Lost to Follow-up|4|||
126329121|NCT01919164|454499989|FG000|Overall Study|Death|1|||
126329122|NCT01919164|454499990|FG001|Overall Study|Death|0|||
126329123|NCT01919164|454499991|FG002|Overall Study|Death|0|||
126329124|NCT01919164|454499992|FG003|Overall Study|Death|0|||
126329125|NCT01919164|454499993|FG004|Overall Study|Death|0|||
126329126|NCT01919164|454499989|FG000|Overall Study|Protocol Violation|6|||
126329127|NCT01919164|454499990|FG001|Overall Study|Protocol Violation|0|||
126329128|NCT01919164|454499991|FG002|Overall Study|Protocol Violation|3|||
126329129|NCT01919164|454499992|FG003|Overall Study|Protocol Violation|2|||
126329130|NCT01919164|454499993|FG004|Overall Study|Protocol Violation|2|||
126329131|NCT01919164|454499989|FG000|Overall Study|Disease progression|2|||
126329132|NCT01919164|454499990|FG001|Overall Study|Disease progression|2|||
126329133|NCT01919164|454499991|FG002|Overall Study|Disease progression|1|||
126329134|NCT01919164|454499992|FG003|Overall Study|Disease progression|2|||
126329135|NCT01919164|454499993|FG004|Overall Study|Disease progression|1|||
126329136|NCT01919164|454499989|FG000|Overall Study|Withdrew consent|13|||
126329137|NCT01919164|454499990|FG001|Overall Study|Withdrew consent|13|||
126329138|NCT01919164|454499991|FG002|Overall Study|Withdrew consent|14|||
126329139|NCT01919164|454499992|FG003|Overall Study|Withdrew consent|14|||
126329140|NCT01919164|454499993|FG004|Overall Study|Withdrew consent|9|||
126329141|NCT01919164|454499989|FG000|Overall Study|Other Un-specified|13|||
126329142|NCT01919164|454499990|FG001|Overall Study|Other Un-specified|9|||
126329143|NCT01919164|454499991|FG002|Overall Study|Other Un-specified|8|||
126329144|NCT01919164|454499992|FG003|Overall Study|Other Un-specified|7|||
126329145|NCT01919164|454499993|FG004|Overall Study|Other Un-specified|15|||
126329146|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
126329147|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
126329148|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
126329149|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
126329150|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
126329151|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
126329152|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
126329153|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
126329154|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
126329155|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
126329156|NCT00667992|454499996|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
126329157|NCT00667992|454499997|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
126329158|NCT00667992|454499996|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
126329159|NCT00667992|454499997|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
126329160|NCT00667992|454499996|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
126329161|NCT00667992|454499997|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
126329162|NCT00667992|454499996|FG000|Wash-out|Not within one doubling dilution|4|||
126329163|NCT00667992|454499997|FG001|Wash-out|Not within one doubling dilution|3|||
126329164|NCT00667992|454499996|FG000|Wash-out|Failure to wash-out|2|||
126329165|NCT00667992|454499997|FG001|Wash-out|Failure to wash-out|2|||
126329166|NCT00667992|454499996|FG000|Wash-out|Withdrawal by Subject|1|||
126329167|NCT00667992|454499997|FG001|Wash-out|Withdrawal by Subject|0|||
126329168|NCT00667992|454499996|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
126329169|NCT00667992|454499997|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
126329170|NCT00667992|454499996|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
126329171|NCT00667992|454499997|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
126329172|NCT02748057|454500001|FG000|Overall Study|Adverse Event|1|||
126329173|NCT02748057|454500002|FG001|Overall Study|Adverse Event|0|||
126329174|NCT02748057|454500001|FG000|Overall Study|Physician Decision|0|||
126329175|NCT02748057|454500002|FG001|Overall Study|Physician Decision|1|||
126329176|NCT02748057|454500001|FG000|Overall Study|Protocol Violation|2|||
126329177|NCT02748057|454500002|FG001|Overall Study|Protocol Violation|1|||
126329178|NCT02748057|454500001|FG000|Overall Study|Participant Moved|1|||
126329179|NCT02748057|454500002|FG001|Overall Study|Participant Moved|0|||
126329180|NCT02748057|454500001|FG000|Overall Study|Withdrawal by Subject|1|||
126329181|NCT02748057|454500002|FG001|Overall Study|Withdrawal by Subject|0|||
126329182|NCT00524771|454500017|FG000|Overall Study|Protocol Violation|220|||
126329183|NCT00524771|454500018|FG001|Overall Study|Protocol Violation|585|||
126329184|NCT01266824|454500019|FG000|Overall Study|Study terminated prior to completion|2|||
126329185|NCT01266824|454500020|FG001|Overall Study|Study terminated prior to completion|3|||
126329186|NCT04435808|454500021|FG000|Overall Study|Study stopped by DSMB|0|||
126329187|NCT04435808|454500022|FG001|Overall Study|Study stopped by DSMB|1|||
126329188|NCT02982863|454500023|FG000|Overall Study|Not eligible patients|809|||
126329189|NCT02982863|454500024|FG001|Overall Study|Not eligible patients|4261|||
126329190|NCT02982863|454500025|FG002|Overall Study|Not eligible patients|1852|||
126329191|NCT02982863|454500026|FG003|Overall Study|Not eligible patients|1400|||
126329192|NCT02982863|454500027|FG004|Overall Study|Not eligible patients|492|||
126329193|NCT02457195|454500028|FG000|Overall Study|Adverse Event|3|||
126329194|NCT02457195|454500028|FG000|Overall Study|Protocol Violation|2|||
126329195|NCT02457195|454500028|FG000|Overall Study|Withdrawal by Subject|4|||
126329196|NCT01896193|454500029|FG000|Overall Study|Lack of Efficacy|20|||
126329197|NCT01896193|454500030|FG001|Overall Study|Lack of Efficacy|11|||
126329198|NCT01896193|454500029|FG000|Overall Study|Protocol Violation|0|||
125987076|NCT04512066|453243172|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
125987077|NCT04512066|453243173|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
125987078|NCT04512066|453243174|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
126329199|NCT01896193|454500030|FG001|Overall Study|Protocol Violation|1|||
126329200|NCT01896193|454500029|FG000|Overall Study|Withdrew Consent|1|||
126329201|NCT01896193|454500030|FG001|Overall Study|Withdrew Consent|0|||
126329202|NCT01300247|454500032|FG000|Overall Study|Death|1|||
126329203|NCT01300247|454500033|FG001|Overall Study|Death|1|||
126329204|NCT01300247|454500032|FG000|Overall Study|Lost to Follow-up|2|||
126329205|NCT01300247|454500033|FG001|Overall Study|Lost to Follow-up|0|||
126329206|NCT01300247|454500032|FG000|Overall Study|Withdrawal by Subject|1|||
126329207|NCT01300247|454500033|FG001|Overall Study|Withdrawal by Subject|0|||
126329208|NCT01300247|454500032|FG000|Overall Study|Non-Compliance|0|||
126329209|NCT01300247|454500033|FG001|Overall Study|Non-Compliance|1|||
126329210|NCT04819438|454500034|FG000|Overall Study|Withdrawal by Subject|1|||
126329211|NCT04819438|454500035|FG001|Overall Study|Withdrawal by Subject|0|||
126329212|NCT04819438|454500034|FG000|Overall Study|Adverse Event|0|||
125987079|NCT04512066|453243169|FG000|Double-blind Treatment Period|Physician Decision|1|||
126329213|NCT04819438|454500035|FG001|Overall Study|Adverse Event|1|||
126329214|NCT04819438|454500034|FG000|Overall Study|Protocol Violation|0|||
126329215|NCT04819438|454500035|FG001|Overall Study|Protocol Violation|1|||
126329216|NCT03465709|454500037|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
126329217|NCT03465709|454500037|FG000|Overall Study|Withdrawal by Subject|3|||
126329218|NCT05359952|454500038|FG000|Overall Study|Lost to Follow-up|1|||
126329219|NCT05359952|454500039|FG001|Overall Study|Lost to Follow-up|0|||
126329220|NCT04892446|454500040|FG000|Overall Study|Death|4|||
126329221|NCT04892446|454500041|FG001|Overall Study|Death|4|||
126329222|NCT04892446|454500042|FG002|Overall Study|Death|0|||
126329223|NCT04892446|454500040|FG000|Overall Study|Withdrew consent|3|||
126329224|NCT04892446|454500041|FG001|Overall Study|Withdrew consent|0|||
126329225|NCT04892446|454500042|FG002|Overall Study|Withdrew consent|1|||
126329226|NCT04892446|454500040|FG000|Overall Study|Investigator's discretion|1|||
126329227|NCT04892446|454500041|FG001|Overall Study|Investigator's discretion|1|||
126329228|NCT04892446|454500042|FG002|Overall Study|Investigator's discretion|0|||
126329229|NCT04892446|454500040|FG000|Overall Study|Study terminated by sponsor|0|||
126329230|NCT04892446|454500041|FG001|Overall Study|Study terminated by sponsor|0|||
126329231|NCT04892446|454500042|FG002|Overall Study|Study terminated by sponsor|2|||
126329232|NCT03060291|454500043|FG000|3-month Follow-up|Declined to respond|8|||
126329233|NCT03060291|454500044|FG001|3-month Follow-up|Declined to respond|10|||
126329234|NCT03060291|454500045|FG002|3-month Follow-up|Declined to respond|2|||
126329235|NCT03060291|454500043|FG000|6-month Follow-up|Declined to respond|7|||
126329236|NCT03060291|454500044|FG001|6-month Follow-up|Declined to respond|13|||
126329237|NCT03060291|454500045|FG002|6-month Follow-up|Declined to respond|4|||
126329238|NCT03060291|454500043|FG000|12-month Follow-up|Declined to respond|7|||
126329239|NCT03060291|454500044|FG001|12-month Follow-up|Declined to respond|16|||
126329240|NCT03060291|454500045|FG002|12-month Follow-up|Declined to respond|6|||
126329241|NCT01556932|454500046|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
126329242|NCT01556932|454500047|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
126329243|NCT01882803|454500048|FG000|Overall Study|Disease Progression|1|||
126329244|NCT01882803|454500048|FG000|Overall Study|Withdrawal by Subject|9|||
126329245|NCT01882803|454500048|FG000|Overall Study|Death|68|||
126329246|NCT01882803|454500048|FG000|Overall Study|Physician Decision|3|||
126329247|NCT01882803|454500048|FG000|Overall Study|Lost to Follow-up|3|||
126329248|NCT01882803|454500048|FG000|Overall Study|Follow-up Completed|39|||
126329249|NCT01882803|454500048|FG000|Overall Study|Study Terminated by the Sponsor|6|||
126329250|NCT01563913|454500049|FG000|Overall Study|Physician Decision|1|||
126329251|NCT01563913|454500050|FG001|Overall Study|Physician Decision|0|||
126329252|NCT01563913|454500049|FG000|Overall Study|Spouse Passed Away|1|||
126329253|NCT01563913|454500050|FG001|Overall Study|Spouse Passed Away|0|||
126329254|NCT00705341|454500051|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
126329255|NCT00705341|454500052|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
126329256|NCT00705341|454500053|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
126329257|NCT00705341|454500054|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
126329258|NCT00705341|454500051|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
126329259|NCT00705341|454500052|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
126329260|NCT00705341|454500053|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
126329261|NCT00705341|454500054|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
126329262|NCT00791700|454500055|FG000|Overall Study|Insufficient clinical response|1|||
126329263|NCT00791700|454500056|FG001|Overall Study|Insufficient clinical response|4|||
126329264|NCT00791700|454500057|FG002|Overall Study|Insufficient clinical response|1|||
126329265|NCT00791700|454500058|FG003|Overall Study|Insufficient clinical response|8|||
126329266|NCT00791700|454500055|FG000|Overall Study|No longer willing to participate|1|||
126329267|NCT00791700|454500056|FG001|Overall Study|No longer willing to participate|1|||
126329268|NCT00791700|454500057|FG002|Overall Study|No longer willing to participate|0|||
126329269|NCT00791700|454500058|FG003|Overall Study|No longer willing to participate|8|||
126329270|NCT00791700|454500055|FG000|Overall Study|Non-compliance with study treatment|0|||
126329271|NCT00791700|454500056|FG001|Overall Study|Non-compliance with study treatment|2|||
126329272|NCT00791700|454500057|FG002|Overall Study|Non-compliance with study treatment|0|||
126329273|NCT00791700|454500058|FG003|Overall Study|Non-compliance with study treatment|4|||
126329274|NCT00791700|454500055|FG000|Overall Study|Withdrawn due to pregnancy|0|||
126329275|NCT00791700|454500056|FG001|Overall Study|Withdrawn due to pregnancy|0|||
126329276|NCT00791700|454500057|FG002|Overall Study|Withdrawn due to pregnancy|0|||
126329277|NCT00791700|454500058|FG003|Overall Study|Withdrawn due to pregnancy|1|||
126329278|NCT00791700|454500055|FG000|Overall Study|Other|0|||
126329279|NCT00791700|454500056|FG001|Overall Study|Other|1|||
126329280|NCT00791700|454500057|FG002|Overall Study|Other|0|||
126329281|NCT00791700|454500058|FG003|Overall Study|Other|1|||
126329282|NCT00791700|454500055|FG000|Overall Study|Death|0|||
126329283|NCT00791700|454500056|FG001|Overall Study|Death|0|||
126329284|NCT00791700|454500057|FG002|Overall Study|Death|0|||
126329285|NCT00791700|454500058|FG003|Overall Study|Death|1|||
126329286|NCT00791700|454500055|FG000|Overall Study|Lost to Follow-up|4|||
126329287|NCT00791700|454500056|FG001|Overall Study|Lost to Follow-up|3|||
126329288|NCT00791700|454500057|FG002|Overall Study|Lost to Follow-up|4|||
126329289|NCT00791700|454500058|FG003|Overall Study|Lost to Follow-up|6|||
126329290|NCT00791700|454500055|FG000|Overall Study|Adverse Event|0|||
126329291|NCT00791700|454500056|FG001|Overall Study|Adverse Event|0|||
126329292|NCT00791700|454500057|FG002|Overall Study|Adverse Event|1|||
126329293|NCT00791700|454500058|FG003|Overall Study|Adverse Event|1|||
126329294|NCT01720524|454500065|FG000|Part A|Insufficient Clinical Response|2|||
126329295|NCT01720524|454500066|FG001|Part A|Insufficient Clinical Response|4|||
126329296|NCT01720524|454500065|FG000|Part A|Adverse Event|2|||
126329297|NCT01720524|454500066|FG001|Part A|Adverse Event|2|||
126329298|NCT01720524|454500065|FG000|Part A|Death|2|||
126329299|NCT01720524|454500066|FG001|Part A|Death|1|||
126329300|NCT01720524|454500065|FG000|Part A|Lost to Follow-up|0|||
125987080|NCT04512066|453243170|FG001|Double-blind Treatment Period|Physician Decision|0|||
125987081|NCT04512066|453243171|FG002|Double-blind Treatment Period|Physician Decision|1|||
125987082|NCT04512066|453243172|FG003|Double-blind Treatment Period|Physician Decision|0|||
125987083|NCT04512066|453243173|FG004|Double-blind Treatment Period|Physician Decision|0|||
125987084|NCT04512066|453243174|FG005|Double-blind Treatment Period|Physician Decision|0|||
125987085|NCT04512066|453243169|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
125987086|NCT04512066|453243170|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
125987087|NCT04512066|453243171|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
125987088|NCT04512066|453243172|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
125987089|NCT04512066|453243173|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
125987090|NCT04512066|453243174|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
125987091|NCT04512066|453243169|FG000|Extension Period|Adverse Event|0|||
125987092|NCT04512066|453243170|FG001|Extension Period|Adverse Event|1|||
125987093|NCT04512066|453243171|FG002|Extension Period|Adverse Event|4|||
125987094|NCT04512066|453243172|FG003|Extension Period|Adverse Event|3|||
125987095|NCT04512066|453243173|FG004|Extension Period|Adverse Event|1|||
125987096|NCT04512066|453243174|FG005|Extension Period|Adverse Event|3|||
126329301|NCT01720524|454500066|FG001|Part A|Lost to Follow-up|1|||
126329302|NCT01720524|454500065|FG000|Part A|Missed 28 day follow-up visit|1|||
126329303|NCT01720524|454500066|FG001|Part A|Missed 28 day follow-up visit|1|||
126329304|NCT01720524|454500065|FG000|Part A|Withdrawal by Subject|0|||
126329305|NCT01720524|454500066|FG001|Part A|Withdrawal by Subject|1|||
126329306|NCT01720524|454500065|FG000|Part A|Other|0|||
126329307|NCT01720524|454500066|FG001|Part A|Other|1|||
126329308|NCT01720524|454500065|FG000|Part A|Lost to Follow-up|0|||
126329309|NCT01720524|454500066|FG001|Part A|Lost to Follow-up|1|||
126329310|NCT01720524|454500065|FG000|Part B|No longer willing to participate in study|1|||
126329311|NCT01720524|454500066|FG001|Part B|No longer willing to participate in study|4|||
126329312|NCT01720524|454500065|FG000|Part B|Other|2|||
126329313|NCT01720524|454500066|FG001|Part B|Other|0|||
126329314|NCT01720524|454500065|FG000|Part B|Lost to Follow-up|2|||
126329315|NCT01720524|454500066|FG001|Part B|Lost to Follow-up|3|||
126329316|NCT01720524|454500065|FG000|Part B|Death|0|||
126329317|NCT01720524|454500066|FG001|Part B|Death|2|||
126329318|NCT00996034|454500067|FG000|Overall Study|Lost to Follow-up|2|||
126329319|NCT00996034|454500067|FG000|Overall Study|withdrawn by PI|1|||
126329320|NCT00527826|454500071|FG000|Overall Study|Adverse Event|10|||
126329321|NCT00527826|454500072|FG001|Overall Study|Adverse Event|10|||
126329322|NCT00527826|454500071|FG000|Overall Study|Lost to Follow-up|3|||
126329323|NCT00527826|454500072|FG001|Overall Study|Lost to Follow-up|2|||
126329324|NCT00527826|454500071|FG000|Overall Study|Withdrawal by Subject|5|||
126329325|NCT00527826|454500072|FG001|Overall Study|Withdrawal by Subject|8|||
126329326|NCT00527826|454500071|FG000|Overall Study|Inclusion Criteria Not Met|3|||
126329327|NCT00527826|454500072|FG001|Overall Study|Inclusion Criteria Not Met|3|||
126329328|NCT00527826|454500071|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
126329329|NCT00527826|454500072|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
126329330|NCT00527826|454500071|FG000|Overall Study|Additional Intake of Viani forte|0|||
126329331|NCT00527826|454500072|FG001|Overall Study|Additional Intake of Viani forte|1|||
126329332|NCT00527826|454500071|FG000|Overall Study|Participant moved away|0|||
126329333|NCT00527826|454500072|FG001|Overall Study|Participant moved away|1|||
126329334|NCT00158262|454500073|FG000|Overall Study|Lost to Follow-up|1|||
126329335|NCT00158262|454500074|FG001|Overall Study|Lost to Follow-up|1|||
126329336|NCT02105285|454500077|FG000|Overall Study|Adverse Event|1|||
126329337|NCT02105285|454500078|FG001|Overall Study|Adverse Event|1|||
126329338|NCT02105285|454500079|FG002|Overall Study|Adverse Event|0|||
126329339|NCT02105285|454500077|FG000|Overall Study|Protocol Violation|0|||
126329340|NCT02105285|454500078|FG001|Overall Study|Protocol Violation|1|||
126329341|NCT02105285|454500079|FG002|Overall Study|Protocol Violation|0|||
126329342|NCT02105285|454500077|FG000|Overall Study|Withdrawal by Subject|1|||
126329343|NCT02105285|454500078|FG001|Overall Study|Withdrawal by Subject|0|||
126329344|NCT02105285|454500079|FG002|Overall Study|Withdrawal by Subject|0|||
126329345|NCT01421641|454500080|FG000|Overall Study|Protocol Violation|2|||
126329346|NCT01421641|454500081|FG001|Overall Study|Protocol Violation|2|||
126329347|NCT02959918|454500083|FG000|Overall Study|Adverse Event|1|||
126329348|NCT02959918|454500084|FG001|Overall Study|Adverse Event|1|||
126329349|NCT02959918|454500085|FG002|Overall Study|Adverse Event|2|||
126329350|NCT02959918|454500086|FG003|Overall Study|Adverse Event|0|||
126329351|NCT02959918|454500087|FG004|Overall Study|Adverse Event|0|||
126329352|NCT02959918|454500088|FG005|Overall Study|Adverse Event|2|||
126329353|NCT02959918|454500089|FG006|Overall Study|Adverse Event|2|||
126329354|NCT02959918|454500090|FG007|Overall Study|Adverse Event|1|||
126329355|NCT02959918|454500091|FG008|Overall Study|Adverse Event|2|||
126329356|NCT02959918|454500092|FG009|Overall Study|Adverse Event|1|||
126329357|NCT02959918|454500093|FG010|Overall Study|Adverse Event|1|||
126329358|NCT02959918|454500094|FG011|Overall Study|Adverse Event|3|||
126329359|NCT02959918|454500095|FG012|Overall Study|Adverse Event|2|||
126329360|NCT02959918|454500096|FG013|Overall Study|Adverse Event|4|||
126329361|NCT02959918|454500083|FG000|Overall Study|Lost to Follow-up|0|||
126329362|NCT02959918|454500084|FG001|Overall Study|Lost to Follow-up|0|||
126329363|NCT02959918|454500085|FG002|Overall Study|Lost to Follow-up|0|||
126329364|NCT02959918|454500086|FG003|Overall Study|Lost to Follow-up|0|||
126329365|NCT02959918|454500087|FG004|Overall Study|Lost to Follow-up|0|||
126329366|NCT02959918|454500088|FG005|Overall Study|Lost to Follow-up|0|||
126329367|NCT02959918|454500089|FG006|Overall Study|Lost to Follow-up|0|||
126329368|NCT02959918|454500090|FG007|Overall Study|Lost to Follow-up|0|||
126329369|NCT02959918|454500091|FG008|Overall Study|Lost to Follow-up|0|||
126329370|NCT02959918|454500092|FG009|Overall Study|Lost to Follow-up|1|||
126329371|NCT02959918|454500093|FG010|Overall Study|Lost to Follow-up|0|||
126329372|NCT02959918|454500094|FG011|Overall Study|Lost to Follow-up|0|||
126329373|NCT02959918|454500095|FG012|Overall Study|Lost to Follow-up|1|||
126329374|NCT02959918|454500096|FG013|Overall Study|Lost to Follow-up|0|||
126329375|NCT02959918|454500083|FG000|Overall Study|Withdrawal by Subject|0|||
126329376|NCT02959918|454500084|FG001|Overall Study|Withdrawal by Subject|0|||
126329377|NCT02959918|454500085|FG002|Overall Study|Withdrawal by Subject|1|||
126329378|NCT02959918|454500086|FG003|Overall Study|Withdrawal by Subject|2|||
126329379|NCT02959918|454500087|FG004|Overall Study|Withdrawal by Subject|0|||
126329380|NCT02959918|454500088|FG005|Overall Study|Withdrawal by Subject|0|||
126329381|NCT02959918|454500089|FG006|Overall Study|Withdrawal by Subject|1|||
126329382|NCT02959918|454500090|FG007|Overall Study|Withdrawal by Subject|0|||
126329383|NCT02959918|454500091|FG008|Overall Study|Withdrawal by Subject|1|||
126329384|NCT02959918|454500092|FG009|Overall Study|Withdrawal by Subject|1|||
126329385|NCT02959918|454500093|FG010|Overall Study|Withdrawal by Subject|2|||
126329386|NCT02959918|454500094|FG011|Overall Study|Withdrawal by Subject|3|||
126329387|NCT02959918|454500095|FG012|Overall Study|Withdrawal by Subject|1|||
126329388|NCT02959918|454500096|FG013|Overall Study|Withdrawal by Subject|1|||
126329389|NCT02959918|454500083|FG000|Overall Study|Protocol Violation|0|||
126329390|NCT02959918|454500084|FG001|Overall Study|Protocol Violation|0|||
126329391|NCT02959918|454500085|FG002|Overall Study|Protocol Violation|1|||
126329392|NCT02959918|454500086|FG003|Overall Study|Protocol Violation|0|||
126329393|NCT02959918|454500087|FG004|Overall Study|Protocol Violation|0|||
126329394|NCT02959918|454500088|FG005|Overall Study|Protocol Violation|1|||
126329395|NCT02959918|454500089|FG006|Overall Study|Protocol Violation|0|||
126329396|NCT02959918|454500090|FG007|Overall Study|Protocol Violation|0|||
126329397|NCT02959918|454500091|FG008|Overall Study|Protocol Violation|2|||
126329398|NCT02959918|454500092|FG009|Overall Study|Protocol Violation|1|||
126329399|NCT02959918|454500093|FG010|Overall Study|Protocol Violation|0|||
126329400|NCT02959918|454500094|FG011|Overall Study|Protocol Violation|1|||
126329401|NCT02959918|454500095|FG012|Overall Study|Protocol Violation|1|||
126329402|NCT02959918|454500096|FG013|Overall Study|Protocol Violation|0|||
126329403|NCT02959918|454500083|FG000|Overall Study|Stopping Rule Met|1|||
126329404|NCT02959918|454500084|FG001|Overall Study|Stopping Rule Met|0|||
126329405|NCT02959918|454500085|FG002|Overall Study|Stopping Rule Met|3|||
126329406|NCT02959918|454500086|FG003|Overall Study|Stopping Rule Met|4|||
126329407|NCT02959918|454500087|FG004|Overall Study|Stopping Rule Met|5|||
126329408|NCT02959918|454500088|FG005|Overall Study|Stopping Rule Met|3|||
126329409|NCT02959918|454500089|FG006|Overall Study|Stopping Rule Met|2|||
126329410|NCT02959918|454500090|FG007|Overall Study|Stopping Rule Met|4|||
126329411|NCT02959918|454500091|FG008|Overall Study|Stopping Rule Met|1|||
126329412|NCT02959918|454500092|FG009|Overall Study|Stopping Rule Met|1|||
126329413|NCT02959918|454500093|FG010|Overall Study|Stopping Rule Met|3|||
126329414|NCT02959918|454500094|FG011|Overall Study|Stopping Rule Met|5|||
125987097|NCT04512066|453243169|FG000|Extension Period|Death|0|||
126329415|NCT02959918|454500095|FG012|Overall Study|Stopping Rule Met|2|||
126329416|NCT02959918|454500096|FG013|Overall Study|Stopping Rule Met|1|||
126329417|NCT02959918|454500083|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
126329418|NCT02959918|454500084|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
126329419|NCT02959918|454500085|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
126329420|NCT02959918|454500086|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
126329421|NCT02959918|454500087|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329422|NCT02959918|454500088|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329423|NCT02959918|454500089|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329424|NCT02959918|454500090|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329425|NCT02959918|454500091|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125987098|NCT04512066|453243170|FG001|Extension Period|Death|0|||
126329426|NCT02959918|454500092|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329427|NCT02959918|454500093|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125987099|NCT04512066|453243171|FG002|Extension Period|Death|0|||
125987100|NCT04512066|453243172|FG003|Extension Period|Death|0|||
125987101|NCT04512066|453243173|FG004|Extension Period|Death|0|||
125987102|NCT04512066|453243174|FG005|Extension Period|Death|1|||
125987103|NCT04512066|453243169|FG000|Extension Period|Lack of Efficacy|0|||
125987104|NCT04512066|453243170|FG001|Extension Period|Lack of Efficacy|4|||
126329428|NCT02959918|454500094|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329429|NCT02959918|454500095|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329430|NCT02959918|454500096|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329431|NCT02959918|454500083|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329432|NCT02959918|454500084|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329433|NCT02959918|454500085|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329434|NCT02959918|454500086|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329435|NCT02959918|454500087|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329436|NCT02959918|454500088|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125987105|NCT04512066|453243171|FG002|Extension Period|Lack of Efficacy|4|||
125987106|NCT04512066|453243172|FG003|Extension Period|Lack of Efficacy|1|||
125987107|NCT04512066|453243173|FG004|Extension Period|Lack of Efficacy|3|||
125987108|NCT04512066|453243174|FG005|Extension Period|Lack of Efficacy|3|||
126329437|NCT02959918|454500089|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329438|NCT02959918|454500090|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
126329439|NCT02959918|454500091|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329440|NCT02959918|454500092|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329441|NCT02959918|454500093|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329442|NCT02959918|454500094|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329443|NCT02959918|454500095|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329444|NCT02959918|454500096|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329445|NCT02959918|454500083|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329446|NCT02959918|454500084|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329447|NCT02959918|454500085|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329448|NCT02959918|454500086|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329449|NCT02959918|454500087|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329450|NCT02959918|454500088|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329451|NCT02959918|454500089|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329452|NCT02959918|454500090|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329453|NCT02959918|454500091|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
126329454|NCT02959918|454500092|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329455|NCT02959918|454500093|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329456|NCT02959918|454500094|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329457|NCT02959918|454500095|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329458|NCT02959918|454500096|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329459|NCT02959918|454500083|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329460|NCT02959918|454500084|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125987109|NCT04512066|453243169|FG000|Extension Period|Lost to Follow-up|0|||
125987110|NCT04512066|453243170|FG001|Extension Period|Lost to Follow-up|1|||
125987111|NCT04512066|453243171|FG002|Extension Period|Lost to Follow-up|5|||
126329461|NCT02959918|454500085|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329462|NCT02959918|454500086|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329463|NCT02959918|454500087|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329464|NCT02959918|454500088|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329465|NCT02959918|454500089|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329466|NCT02959918|454500090|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329467|NCT02959918|454500091|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329468|NCT02959918|454500092|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
126329469|NCT02959918|454500093|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125987112|NCT04512066|453243172|FG003|Extension Period|Lost to Follow-up|2|||
125987113|NCT04512066|453243173|FG004|Extension Period|Lost to Follow-up|3|||
125987114|NCT04512066|453243174|FG005|Extension Period|Lost to Follow-up|2|||
125987115|NCT04512066|453243169|FG000|Extension Period|Non-compliance with study drug|0|||
125987116|NCT04512066|453243170|FG001|Extension Period|Non-compliance with study drug|1|||
125987117|NCT04512066|453243171|FG002|Extension Period|Non-compliance with study drug|0|||
125987118|NCT04512066|453243172|FG003|Extension Period|Non-compliance with study drug|0|||
125987119|NCT04512066|453243173|FG004|Extension Period|Non-compliance with study drug|0|||
125987120|NCT04512066|453243174|FG005|Extension Period|Non-compliance with study drug|1|||
125987121|NCT04512066|453243169|FG000|Extension Period|Other|0|||
125987122|NCT04512066|453243170|FG001|Extension Period|Other|2|||
125987123|NCT04512066|453243171|FG002|Extension Period|Other|0|||
125987124|NCT04512066|453243172|FG003|Extension Period|Other|0|||
125987125|NCT04512066|453243173|FG004|Extension Period|Other|0|||
125987126|NCT04512066|453243174|FG005|Extension Period|Other|0|||
126329470|NCT02959918|454500094|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329471|NCT02959918|454500095|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329472|NCT02959918|454500096|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329473|NCT02585713|454500098|FG000|Overall Study|Withdrew prior to treatment|2|||
126329474|NCT02585713|454500099|FG001|Overall Study|Withdrew prior to treatment|7|||
126329475|NCT02585713|454500098|FG000|Overall Study|Other|3|||
126329476|NCT02585713|454500099|FG001|Overall Study|Other|1|||
126329477|NCT03173456|454500104|FG000|Baseline|Medication dispensing system malfunction'|0|||
126329478|NCT03173456|454500105|FG001|Baseline|Medication dispensing system malfunction'|1|||
126329479|NCT03173456|454500106|FG002|Baseline|Medication dispensing system malfunction'|0|||
126329480|NCT03173456|454500107|FG003|Baseline|Medication dispensing system malfunction'|0|||
126329481|NCT03173456|454500108|FG004|Baseline|Medication dispensing system malfunction'|2|||
126329482|NCT03173456|454500104|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
126329483|NCT03173456|454500105|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
126329484|NCT03173456|454500106|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
126329485|NCT03173456|454500107|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
126329486|NCT03173456|454500108|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
126329487|NCT01733121|454500109|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
126329488|NCT01733121|454500110|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
126329489|NCT01733121|454500109|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
126329490|NCT01733121|454500110|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
126329491|NCT01733121|454500109|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
126329492|NCT01733121|454500110|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
126329493|NCT01733121|454500109|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
126329494|NCT01733121|454500110|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
126329495|NCT03061188|454500119|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
126329496|NCT03061188|454500120|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
126329497|NCT03061188|454500121|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
126329498|NCT03061188|454500122|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
126329499|NCT03061188|454500119|FG000|On Follow-up for 3 Years|Death|0|||
126329500|NCT03061188|454500120|FG001|On Follow-up for 3 Years|Death|3|||
126329501|NCT03061188|454500121|FG002|On Follow-up for 3 Years|Death|5|||
126329502|NCT03061188|454500122|FG003|On Follow-up for 3 Years|Death|4|||
126329503|NCT03061188|454500119|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
126329504|NCT03061188|454500120|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
126329505|NCT03061188|454500121|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
126329506|NCT03061188|454500122|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
126329507|NCT04501952|454500123|FG000|Overall Study|Adverse Event|0|||
126329508|NCT04501952|454500124|FG001|Overall Study|Adverse Event|3|||
126329509|NCT04501952|454500123|FG000|Overall Study|Investigator's Discretion|0|||
126329510|NCT04501952|454500124|FG001|Overall Study|Investigator's Discretion|1|||
126329511|NCT04501952|454500123|FG000|Overall Study|Protocol Violation|1|||
126329512|NCT04501952|454500124|FG001|Overall Study|Protocol Violation|1|||
126329513|NCT04501952|454500123|FG000|Overall Study|Withdrew Consent|5|||
126329514|NCT04501952|454500124|FG001|Overall Study|Withdrew Consent|4|||
126329515|NCT04501952|454500123|FG000|Overall Study|Lost to Follow-up|7|||
126329516|NCT04501952|454500124|FG001|Overall Study|Lost to Follow-up|2|||
126329517|NCT04501952|454500123|FG000|Overall Study|Randomized and Never Treated|13|||
126329518|NCT04501952|454500124|FG001|Overall Study|Randomized and Never Treated|9|||
126329519|NCT00436826|454500125|FG000|Double Blind Period (DBP)|Adverse Event|2|||
126329520|NCT00436826|454500126|FG001|Double Blind Period (DBP)|Adverse Event|0|||
125987127|NCT04512066|453243169|FG000|Extension Period|Physician Decision|0|||
125987128|NCT04512066|453243170|FG001|Extension Period|Physician Decision|2|||
125987129|NCT04512066|453243171|FG002|Extension Period|Physician Decision|0|||
125987130|NCT04512066|453243172|FG003|Extension Period|Physician Decision|1|||
125987131|NCT04512066|453243173|FG004|Extension Period|Physician Decision|1|||
125987132|NCT04512066|453243174|FG005|Extension Period|Physician Decision|0|||
125987133|NCT04512066|453243169|FG000|Extension Period|Withdrawal by Subject|0|||
125987134|NCT04512066|453243170|FG001|Extension Period|Withdrawal by Subject|3|||
126329521|NCT00436826|454500127|FG002|Double Blind Period (DBP)|Adverse Event|0|||
126329522|NCT00436826|454500128|FG003|Double Blind Period (DBP)|Adverse Event|0|||
126329523|NCT00436826|454500129|FG004|Double Blind Period (DBP)|Adverse Event|0|||
125987135|NCT04512066|453243171|FG002|Extension Period|Withdrawal by Subject|7|||
125987136|NCT04512066|453243172|FG003|Extension Period|Withdrawal by Subject|11|||
125987137|NCT04512066|453243173|FG004|Extension Period|Withdrawal by Subject|8|||
125987138|NCT04512066|453243174|FG005|Extension Period|Withdrawal by Subject|4|||
126329524|NCT00436826|454500130|FG005|Double Blind Period (DBP)|Adverse Event|0|||
126329525|NCT00436826|454500125|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
126329526|NCT00436826|454500126|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
126329527|NCT00436826|454500127|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
126329528|NCT00436826|454500128|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
126329529|NCT00436826|454500129|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
126329530|NCT00436826|454500130|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
126329531|NCT00436826|454500125|FG000|Double Blind Period (DBP)|Other|10|||
126329532|NCT00436826|454500126|FG001|Double Blind Period (DBP)|Other|11|||
126329533|NCT00436826|454500127|FG002|Double Blind Period (DBP)|Other|0|||
126329534|NCT00436826|454500128|FG003|Double Blind Period (DBP)|Other|0|||
126329535|NCT00436826|454500129|FG004|Double Blind Period (DBP)|Other|0|||
126329536|NCT00436826|454500130|FG005|Double Blind Period (DBP)|Other|0|||
126329537|NCT00436826|454500125|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329538|NCT00436826|454500126|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329539|NCT00436826|454500127|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329540|NCT00436826|454500128|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
126329541|NCT00436826|454500129|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329542|NCT00436826|454500130|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329543|NCT00436826|454500125|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
126329544|NCT00436826|454500126|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
126329545|NCT00436826|454500127|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
126329546|NCT00436826|454500128|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
126329547|NCT00436826|454500129|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
126329548|NCT00436826|454500130|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
126329549|NCT00436826|454500125|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
126329550|NCT00436826|454500126|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
126329551|NCT00436826|454500127|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
126329552|NCT00436826|454500128|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
126329553|NCT00436826|454500129|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
126329554|NCT00436826|454500130|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
126329555|NCT00784719|454500131|FG000|Overall Study|Adverse Event|0|||
126329556|NCT00784719|454500132|FG001|Overall Study|Adverse Event|2|||
126329557|NCT00784719|454500133|FG002|Overall Study|Adverse Event|0|||
126329558|NCT00784719|454500134|FG003|Overall Study|Adverse Event|0|||
126329559|NCT00784719|454500135|FG004|Overall Study|Adverse Event|1|||
126329560|NCT00784719|454500136|FG005|Overall Study|Adverse Event|1|||
126329561|NCT00784719|454500137|FG006|Overall Study|Adverse Event|1|||
126329562|NCT00784719|454500131|FG000|Overall Study|Lost to Follow-up|0|||
126329563|NCT00784719|454500132|FG001|Overall Study|Lost to Follow-up|0|||
126329564|NCT00784719|454500133|FG002|Overall Study|Lost to Follow-up|0|||
126329565|NCT00784719|454500134|FG003|Overall Study|Lost to Follow-up|0|||
126329566|NCT00784719|454500135|FG004|Overall Study|Lost to Follow-up|1|||
126329567|NCT00784719|454500136|FG005|Overall Study|Lost to Follow-up|1|||
126329568|NCT00784719|454500137|FG006|Overall Study|Lost to Follow-up|0|||
126329569|NCT00784719|454500131|FG000|Overall Study|Other|2|||
126329570|NCT00784719|454500132|FG001|Overall Study|Other|1|||
126329571|NCT00784719|454500133|FG002|Overall Study|Other|1|||
126329572|NCT00784719|454500134|FG003|Overall Study|Other|0|||
126329573|NCT00784719|454500135|FG004|Overall Study|Other|2|||
126329574|NCT00784719|454500136|FG005|Overall Study|Other|1|||
126329575|NCT00784719|454500137|FG006|Overall Study|Other|3|||
126329576|NCT00784719|454500131|FG000|Overall Study|Withdrawal by Subject|1|||
126329577|NCT00784719|454500132|FG001|Overall Study|Withdrawal by Subject|0|||
126329578|NCT00784719|454500133|FG002|Overall Study|Withdrawal by Subject|0|||
126329579|NCT00784719|454500134|FG003|Overall Study|Withdrawal by Subject|0|||
126329580|NCT00784719|454500135|FG004|Overall Study|Withdrawal by Subject|2|||
126329581|NCT00784719|454500136|FG005|Overall Study|Withdrawal by Subject|0|||
126329582|NCT00784719|454500137|FG006|Overall Study|Withdrawal by Subject|1|||
126329583|NCT05464420|454500140|FG000|Overall Study|Death|0|||
126329584|NCT05464420|454500141|FG001|Overall Study|Death|0|||
126329585|NCT05464420|454500142|FG002|Overall Study|Death|0|||
126329586|NCT05464420|454500143|FG003|Overall Study|Death|1|||
126329587|NCT05464420|454500140|FG000|Overall Study|Lost to Follow-up|16|||
126329588|NCT05464420|454500141|FG001|Overall Study|Lost to Follow-up|11|||
126329589|NCT05464420|454500142|FG002|Overall Study|Lost to Follow-up|11|||
126329590|NCT05464420|454500143|FG003|Overall Study|Lost to Follow-up|11|||
126329591|NCT05464420|454500140|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
126329592|NCT05464420|454500141|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
126329593|NCT05464420|454500142|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
126329594|NCT05464420|454500143|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
126329595|NCT05464420|454500140|FG000|Overall Study|Withdrawal by Subject|4|||
126329596|NCT05464420|454500141|FG001|Overall Study|Withdrawal by Subject|8|||
126329597|NCT05464420|454500142|FG002|Overall Study|Withdrawal by Subject|3|||
126329598|NCT05464420|454500143|FG003|Overall Study|Withdrawal by Subject|1|||
126329599|NCT05464420|454500140|FG000|Overall Study|Protocol Violation|0|||
126329600|NCT05464420|454500141|FG001|Overall Study|Protocol Violation|0|||
126329601|NCT05464420|454500142|FG002|Overall Study|Protocol Violation|1|||
126329602|NCT05464420|454500143|FG003|Overall Study|Protocol Violation|1|||
126329603|NCT05464420|454500140|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
126329604|NCT05464420|454500141|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
126329605|NCT05464420|454500142|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
126329606|NCT05464420|454500143|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
126329607|NCT01383018|454500144|FG000|Overall Study|Adverse Event|14|||
126329608|NCT01383018|454500144|FG000|Overall Study|Death|10|||
126329609|NCT01383018|454500144|FG000|Overall Study|Lost to Follow-up|5|||
126329610|NCT01383018|454500144|FG000|Overall Study|Physician Decision|5|||
126329611|NCT01383018|454500144|FG000|Overall Study|Withdrawal by Subject|9|||
126329612|NCT01383018|454500144|FG000|Overall Study|Subject not implanted|76|||
126329613|NCT01383018|454500144|FG000|Overall Study|Missed Visit|247|||
126329614|NCT01383018|454500144|FG000|Overall Study|Site closed early-not compliance related|7|||
126329615|NCT01383018|454500144|FG000|Overall Study|Patient moved away from site|1|||
126329616|NCT01383018|454500144|FG000|Overall Study|Subject Incarcerated|1|||
126329617|NCT03131687|454500147|FG000|Overall Study|Adverse Event|0|||
126329618|NCT03131687|454500148|FG001|Overall Study|Adverse Event|1|||
125987139|NCT03610737|453245388|FG000|Overall Study|Withdrawal by Subject|1|||
125987140|NCT03610737|453245389|FG001|Overall Study|Withdrawal by Subject|5|||
125987141|NCT03610737|453245388|FG000|Overall Study|Death|1|||
125987142|NCT03610737|453245389|FG001|Overall Study|Death|0|||
125987143|NCT03610737|453245388|FG000|Overall Study|Not treated|5|||
125987144|NCT03610737|453245389|FG001|Overall Study|Not treated|2|||
126329619|NCT03131687|454500149|FG002|Overall Study|Adverse Event|0|||
126329620|NCT03131687|454500150|FG003|Overall Study|Adverse Event|1|||
126329621|NCT03131687|454500151|FG004|Overall Study|Adverse Event|2|||
126329622|NCT03131687|454500152|FG005|Overall Study|Adverse Event|2|||
125987145|NCT03610737|453245388|FG000|Overall Study|Missed Visit|1|||
125987146|NCT03610737|453245389|FG001|Overall Study|Missed Visit|2|||
125987147|NCT02991482|453245390|FG000|Overall Study|Disease progression|56|||
126329623|NCT03131687|454500147|FG000|Overall Study|Death|1|||
126329624|NCT03131687|454500148|FG001|Overall Study|Death|0|||
126329625|NCT03131687|454500149|FG002|Overall Study|Death|0|||
125987148|NCT02991482|453245391|FG001|Overall Study|Disease progression|47|||
125987149|NCT02991482|453245390|FG000|Overall Study|Death|4|||
125987150|NCT02991482|453245391|FG001|Overall Study|Death|4|||
125987151|NCT02991482|453245390|FG000|Overall Study|Adverse Event|1|||
125987152|NCT02991482|453245391|FG001|Overall Study|Adverse Event|6|||
125987153|NCT02991482|453245390|FG000|Overall Study|Patient decision|1|||
125987154|NCT02991482|453245391|FG001|Overall Study|Patient decision|1|||
125987155|NCT02991482|453245390|FG000|Overall Study|Physician Decision|0|||
126329626|NCT03131687|454500150|FG003|Overall Study|Death|0|||
126329627|NCT03131687|454500151|FG004|Overall Study|Death|0|||
126329628|NCT03131687|454500152|FG005|Overall Study|Death|0|||
126329629|NCT03131687|454500147|FG000|Overall Study|Withdrawal by Subject|3|||
126329630|NCT03131687|454500148|FG001|Overall Study|Withdrawal by Subject|3|||
126329631|NCT03131687|454500149|FG002|Overall Study|Withdrawal by Subject|3|||
126329632|NCT03131687|454500150|FG003|Overall Study|Withdrawal by Subject|1|||
126329633|NCT03131687|454500151|FG004|Overall Study|Withdrawal by Subject|2|||
126329634|NCT03131687|454500152|FG005|Overall Study|Withdrawal by Subject|1|||
126329635|NCT03131687|454500147|FG000|Overall Study|Lost to Follow-up|1|||
126329636|NCT03131687|454500148|FG001|Overall Study|Lost to Follow-up|4|||
126329637|NCT03131687|454500149|FG002|Overall Study|Lost to Follow-up|0|||
126329638|NCT03131687|454500150|FG003|Overall Study|Lost to Follow-up|1|||
126329639|NCT03131687|454500151|FG004|Overall Study|Lost to Follow-up|4|||
126329640|NCT03131687|454500152|FG005|Overall Study|Lost to Follow-up|2|||
126329641|NCT03131687|454500147|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
126329642|NCT03131687|454500148|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
126329643|NCT03131687|454500149|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
126329644|NCT03131687|454500150|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
126329645|NCT03131687|454500151|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
126329646|NCT03131687|454500152|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
126329647|NCT03131687|454500147|FG000|Overall Study|Principle Investigator Decision|0|||
126329648|NCT03131687|454500148|FG001|Overall Study|Principle Investigator Decision|1|||
126329649|NCT03131687|454500149|FG002|Overall Study|Principle Investigator Decision|0|||
126329650|NCT03131687|454500150|FG003|Overall Study|Principle Investigator Decision|0|||
126329651|NCT03131687|454500151|FG004|Overall Study|Principle Investigator Decision|0|||
126329652|NCT03131687|454500152|FG005|Overall Study|Principle Investigator Decision|0|||
125987156|NCT02991482|453245391|FG001|Overall Study|Physician Decision|6|||
126329653|NCT03131687|454500147|FG000|Overall Study|Inadvertent Enrollment|0|||
126329654|NCT03131687|454500148|FG001|Overall Study|Inadvertent Enrollment|0|||
126329655|NCT03131687|454500149|FG002|Overall Study|Inadvertent Enrollment|0|||
126329656|NCT03131687|454500150|FG003|Overall Study|Inadvertent Enrollment|1|||
125987157|NCT02991482|453245390|FG000|Overall Study|Clinical deterioration|1|||
125987158|NCT02991482|453245391|FG001|Overall Study|Clinical deterioration|0|||
125987159|NCT02991482|453245390|FG000|Overall Study|Patient feeling too unwell|1|||
125987160|NCT02991482|453245391|FG001|Overall Study|Patient feeling too unwell|0|||
125987161|NCT02991482|453245390|FG000|Overall Study|Worsening of performance status|0|||
125987162|NCT02991482|453245391|FG001|Overall Study|Worsening of performance status|1|||
125987163|NCT02991482|453245390|FG000|Overall Study|Death prior to study drug initiation|1|||
125987164|NCT02991482|453245391|FG001|Overall Study|Death prior to study drug initiation|0|||
126329657|NCT03131687|454500151|FG004|Overall Study|Inadvertent Enrollment|0|||
126329658|NCT03131687|454500152|FG005|Overall Study|Inadvertent Enrollment|0|||
125987165|NCT02991482|453245390|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
125987166|NCT02991482|453245391|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
126329659|NCT06597084|454500162|FG000|Overall Study|Withdrawal by Subject|4|||
126329660|NCT06597084|454500163|FG001|Overall Study|Withdrawal by Subject|9|||
126329661|NCT06597084|454500162|FG000|Overall Study|Consent was not given by the patient until V2|0|||
126329662|NCT06597084|454500163|FG001|Overall Study|Consent was not given by the patient until V2|3|||
126329663|NCT06597084|454500162|FG000|Overall Study|Physician Decision|1|||
126329664|NCT06597084|454500163|FG001|Overall Study|Physician Decision|0|||
126329665|NCT06597084|454500162|FG000|Overall Study|Adverse Event|3|||
126329666|NCT06597084|454500163|FG001|Overall Study|Adverse Event|2|||
126329667|NCT06597084|454500162|FG000|Overall Study|Death|4|||
126329668|NCT06597084|454500163|FG001|Overall Study|Death|0|||
126329669|NCT06597084|454500162|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
126329670|NCT06597084|454500163|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
126329671|NCT06597084|454500162|FG000|Overall Study|Lost to Follow-up|4|||
126329672|NCT06597084|454500163|FG001|Overall Study|Lost to Follow-up|2|||
126329673|NCT06597084|454500162|FG000|Overall Study|Other. Not specified|1|||
126329674|NCT06597084|454500163|FG001|Overall Study|Other. Not specified|0|||
126329675|NCT01243177|454500170|FG000|Overall Study|Lack of Efficacy|47|||
126329676|NCT01243177|454500171|FG001|Overall Study|Lack of Efficacy|31|||
126329677|NCT01243177|454500170|FG000|Overall Study|Protocol Violation|11|||
126329678|NCT01243177|454500171|FG001|Overall Study|Protocol Violation|10|||
126329679|NCT01243177|454500170|FG000|Overall Study|Lost to Follow-up|15|||
126329680|NCT01243177|454500171|FG001|Overall Study|Lost to Follow-up|18|||
126329681|NCT01243177|454500170|FG000|Overall Study|Withdrawal by Subject|46|||
126329682|NCT01243177|454500171|FG001|Overall Study|Withdrawal by Subject|38|||
126329683|NCT01243177|454500170|FG000|Overall Study|AE, serious fatal|0|||
126329684|NCT01243177|454500171|FG001|Overall Study|AE, serious fatal|1|||
126329685|NCT01243177|454500170|FG000|Overall Study|SAE, non-fatal|7|||
126329686|NCT01243177|454500171|FG001|Overall Study|SAE, non-fatal|9|||
126329687|NCT01243177|454500170|FG000|Overall Study|AE, non-serious non-fatal|40|||
126329688|NCT01243177|454500171|FG001|Overall Study|AE, non-serious non-fatal|58|||
126329689|NCT01243177|454500170|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
126329690|NCT01243177|454500171|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
126329691|NCT01243177|454500170|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
126329692|NCT01243177|454500171|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
126329693|NCT01243177|454500170|FG000|Overall Study|Other Reason|11|||
126329694|NCT01243177|454500171|FG001|Overall Study|Other Reason|12|||
126329695|NCT05251233|454501666|FG000|Overall Study|Disease progression - did not start treatment|0|||
126329696|NCT05251233|454501667|FG001|Overall Study|Disease progression - did not start treatment|0|||
126329697|NCT05251233|454501668|FG002|Overall Study|Disease progression - did not start treatment|5|||
126329698|NCT05251233|454501666|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
126329699|NCT05251233|454501667|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
126329700|NCT05251233|454501668|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
126329701|NCT05251233|454501666|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
126329702|NCT05251233|454501667|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
126329703|NCT05251233|454501668|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
126329704|NCT05251233|454501666|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
126329705|NCT05251233|454501667|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
126329706|NCT05251233|454501668|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
126329707|NCT05251233|454501666|FG000|Overall Study|Death - did not start treatment|3|||
126329708|NCT05251233|454501667|FG001|Overall Study|Death - did not start treatment|0|||
126329709|NCT05251233|454501668|FG002|Overall Study|Death - did not start treatment|0|||
126329710|NCT05251233|454501666|FG000|Overall Study|Withdrawal by Subject|2|||
126329711|NCT05251233|454501667|FG001|Overall Study|Withdrawal by Subject|2|||
126329712|NCT05251233|454501668|FG002|Overall Study|Withdrawal by Subject|0|||
126329713|NCT05251233|454501666|FG000|Overall Study|Other complicating disease|2|||
126329714|NCT05251233|454501667|FG001|Overall Study|Other complicating disease|1|||
126329715|NCT05251233|454501668|FG002|Overall Study|Other complicating disease|0|||
126329716|NCT05251233|454501666|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
126329717|NCT05251233|454501667|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
126329718|NCT05251233|454501668|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
126329719|NCT05251233|454501666|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
126329720|NCT05251233|454501667|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
126329721|NCT05251233|454501668|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
126329722|NCT02781818|454501669|FG000|Overall Study|Lost to Follow-up|4|||
126329723|NCT02781818|454501670|FG001|Overall Study|Lost to Follow-up|2|||
126329724|NCT02781818|454501671|FG002|Overall Study|Lost to Follow-up|1|||
126329725|NCT01223404|454501672|FG000|First Intervention (1 Day)|Adverse Event|0|||
126329726|NCT01223404|454501673|FG001|First Intervention (1 Day)|Adverse Event|0|||
126329727|NCT01223404|454501674|FG002|First Intervention (1 Day)|Adverse Event|0|||
126329728|NCT01223404|454501675|FG003|First Intervention (1 Day)|Adverse Event|1|||
126329729|NCT01223404|454501676|FG004|First Intervention (1 Day)|Adverse Event|0|||
126329730|NCT01223404|454501677|FG005|First Intervention (1 Day)|Adverse Event|0|||
125987167|NCT00871403|453245392|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
126329731|NCT01223404|454501672|FG000|Second Intervention (1 Day)|Adverse Event|1|||
126329732|NCT01223404|454501673|FG001|Second Intervention (1 Day)|Adverse Event|0|||
125987168|NCT00871403|453245393|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
126329733|NCT01223404|454501674|FG002|Second Intervention (1 Day)|Adverse Event|0|||
126329734|NCT01223404|454501675|FG003|Second Intervention (1 Day)|Adverse Event|0|||
126329735|NCT01223404|454501676|FG004|Second Intervention (1 Day)|Adverse Event|0|||
126329736|NCT01223404|454501677|FG005|Second Intervention (1 Day)|Adverse Event|0|||
126329737|NCT01223404|454501672|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329738|NCT01223404|454501673|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329739|NCT01223404|454501674|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329740|NCT01223404|454501675|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
126329741|NCT01223404|454501676|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329742|NCT01223404|454501677|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329743|NCT02492165|454501678|FG000|Overall Study|Withdrawal by Subject|0|||
126329744|NCT02492165|454501679|FG001|Overall Study|Withdrawal by Subject|1|||
125987169|NCT00871403|453245394|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
125987170|NCT00871403|453245392|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
126329745|NCT02492165|454501680|FG002|Overall Study|Withdrawal by Subject|0|||
126329746|NCT02492165|454501681|FG003|Overall Study|Withdrawal by Subject|0|||
126329747|NCT00707057|454501682|FG000|Overall Study|Withdrawal by Subject|8|||
126329748|NCT00707057|454501683|FG001|Overall Study|Withdrawal by Subject|3|||
126329749|NCT00707057|454501682|FG000|Overall Study|Dosed incorrectly|0|||
126329750|NCT00707057|454501683|FG001|Overall Study|Dosed incorrectly|1|||
126329751|NCT02915159|454501689|FG000|Overall Study|Participant no longer meets criteria|2|||
126329752|NCT02915159|454501690|FG001|Overall Study|Participant no longer meets criteria|0|||
126329753|NCT02915159|454501689|FG000|Overall Study|poor/non-compliance|1|||
125987171|NCT00871403|453245393|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
125987172|NCT00871403|453245394|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
125987173|NCT00871403|453245392|FG000|Combination Treatment Phase|Adverse Event|0|||
125987174|NCT00871403|453245393|FG001|Combination Treatment Phase|Adverse Event|17|||
125987175|NCT00871403|453245394|FG002|Combination Treatment Phase|Adverse Event|2|||
125987176|NCT00871403|453245392|FG000|Combination Treatment Phase|Disease Progression|0|||
125987177|NCT00871403|453245393|FG001|Combination Treatment Phase|Disease Progression|8|||
125987178|NCT00871403|453245394|FG002|Combination Treatment Phase|Disease Progression|5|||
125987179|NCT00871403|453245392|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
125987180|NCT00871403|453245393|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
125987181|NCT00871403|453245394|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
125987182|NCT00871403|453245392|FG000|Combination Treatment Phase|Physician Decision|0|||
126329754|NCT02915159|454501690|FG001|Overall Study|poor/non-compliance|0|||
126329755|NCT02915159|454501689|FG000|Overall Study|Participant withdrew consent|5|||
126329756|NCT02915159|454501690|FG001|Overall Study|Participant withdrew consent|1|||
126329757|NCT02915159|454501689|FG000|Overall Study|Request to discontinue treatment|1|||
126329758|NCT02915159|454501690|FG001|Overall Study|Request to discontinue treatment|2|||
126329759|NCT02915159|454501689|FG000|Overall Study|Adverse Event|2|||
126329760|NCT02915159|454501690|FG001|Overall Study|Adverse Event|2|||
126329761|NCT02915159|454501689|FG000|Overall Study|Lack of Efficacy|0|||
125987183|NCT00871403|453245393|FG001|Combination Treatment Phase|Physician Decision|1|||
126329762|NCT02915159|454501690|FG001|Overall Study|Lack of Efficacy|3|||
125987184|NCT00871403|453245394|FG002|Combination Treatment Phase|Physician Decision|3|||
126329763|NCT02821416|454501693|FG000|Overall Study|Adverse Event|0|||
126329764|NCT02821416|454501694|FG001|Overall Study|Adverse Event|1|||
126329765|NCT02821416|454501693|FG000|Overall Study|Withdrawal by Subject|2|||
126329766|NCT02821416|454501694|FG001|Overall Study|Withdrawal by Subject|0|||
126329767|NCT02821416|454501693|FG000|Overall Study|Lost to Follow-up|1|||
126329768|NCT02821416|454501694|FG001|Overall Study|Lost to Follow-up|0|||
126329769|NCT01001520|454501701|FG000|Medication Period 1|Withdrawal by Subject|2|||
126329770|NCT01001520|454501702|FG001|Medication Period 1|Withdrawal by Subject|2|||
126329771|NCT01001520|454501701|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
126329772|NCT01001520|454501702|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
125987185|NCT00871403|453245392|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
125987186|NCT00871403|453245393|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
125987187|NCT00871403|453245394|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
125987188|NCT00871403|453245392|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
125987189|NCT00871403|453245393|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
125987190|NCT00871403|453245394|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
125987191|NCT00787319|453245395|FG000|Overall Study|Lost to Follow-up|2|||
125987192|NCT00787319|453245395|FG000|Overall Study|Withdrawal by Subject|15|||
125987193|NCT00787319|453245395|FG000|Overall Study|Adverse Event|3|||
125987194|NCT00787319|453245395|FG000|Overall Study|Objective progression or relapse|30|||
125987195|NCT00787319|453245395|FG000|Overall Study|Lack of Efficacy|1|||
125987196|NCT00787319|453245395|FG000|Overall Study|Budget exhausted/exceeded|1|||
125987197|NCT00787319|453245395|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
125987198|NCT00787319|453245395|FG000|Overall Study|No health insurance reimbursement|2|||
125987199|NCT00787319|453245395|FG000|Overall Study|Stabilized disease findings|3|||
125987200|NCT00787319|453245395|FG000|Overall Study|Inactive disease|5|||
125987201|NCT01932294|453245396|FG000|Overall Study|Death|43|||
125987202|NCT01932294|453245396|FG000|Overall Study|Lost to Follow-up|8|||
125987203|NCT01932294|453245396|FG000|Overall Study|VAD Implantation|20|||
126329773|NCT01001520|454501701|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
126329774|NCT01001520|454501702|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
125987204|NCT01932294|453245396|FG000|Overall Study|Heart Transplantation|16|||
125987205|NCT01932294|453245396|FG000|Overall Study|Transferred to other hospitals|12|||
125987206|NCT00659984|453245400|FG000|Overall Study|Adverse Event|1|||
125987207|NCT00927355|453245401|FG000|Overall Study|Adverse Event|1|||
125987208|NCT00927355|453245402|FG001|Overall Study|Adverse Event|1|||
125987209|NCT01800201|453245403|FG000|Overall Study|Withdrawal by Subject|2|||
125987210|NCT01800201|453245404|FG001|Overall Study|Withdrawal by Subject|0|||
125987211|NCT01800201|453245403|FG000|Overall Study|patient privacy concerns|1|||
125987212|NCT01800201|453245404|FG001|Overall Study|patient privacy concerns|1|||
125987213|NCT01800201|453245403|FG000|Overall Study|did not want to use device|0|||
125987214|NCT01800201|453245404|FG001|Overall Study|did not want to use device|1|||
125987215|NCT01800201|453245403|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
125987216|NCT01800201|453245404|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
125987217|NCT01691521|453245408|FG000|Overall Study|Adverse Event|4|||
125987218|NCT01691521|453245409|FG001|Overall Study|Adverse Event|0|||
125987219|NCT01691521|453245410|FG002|Overall Study|Adverse Event|1|||
125987220|NCT01691521|453245408|FG000|Overall Study|Lack of Efficacy|1|||
125987221|NCT01691521|453245409|FG001|Overall Study|Lack of Efficacy|1|||
125987222|NCT01691521|453245410|FG002|Overall Study|Lack of Efficacy|2|||
125987223|NCT01691521|453245408|FG000|Overall Study|Protocol Violation|0|||
125987224|NCT01691521|453245409|FG001|Overall Study|Protocol Violation|3|||
125987225|NCT01691521|453245410|FG002|Overall Study|Protocol Violation|0|||
125987226|NCT01691521|453245408|FG000|Overall Study|Lost to Follow-up|0|||
125987227|NCT01691521|453245409|FG001|Overall Study|Lost to Follow-up|2|||
125987228|NCT01691521|453245410|FG002|Overall Study|Lost to Follow-up|2|||
125987229|NCT01691521|453245408|FG000|Overall Study|Physician Decision|2|||
125987230|NCT01691521|453245409|FG001|Overall Study|Physician Decision|1|||
125987231|NCT01691521|453245410|FG002|Overall Study|Physician Decision|0|||
125987232|NCT01691521|453245408|FG000|Overall Study|Withdrawal by Subject|5|||
125987233|NCT01691521|453245409|FG001|Overall Study|Withdrawal by Subject|9|||
125987234|NCT01691521|453245410|FG002|Overall Study|Withdrawal by Subject|4|||
126329775|NCT01001520|454501701|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
126329776|NCT01001520|454501702|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
126329777|NCT01001520|454501701|FG000|Washout Period|Withdrawal by Subject|2|||
126329778|NCT01001520|454501702|FG001|Washout Period|Withdrawal by Subject|1|||
126329779|NCT01001520|454501701|FG000|Medication Period 2|Withdrawal by Subject|0|||
125987235|NCT01480596|453245411|FG000|Overall Study|Adverse Event|3|||
125987236|NCT01480596|453245412|FG001|Overall Study|Adverse Event|0|||
125987237|NCT01480596|453245411|FG000|Overall Study|MG exacerbation or change in medication|2|||
125987238|NCT01480596|453245412|FG001|Overall Study|MG exacerbation or change in medication|2|||
125987239|NCT04503096|453245413|FG000|Overall Study|Withdrawal by Subject|3|||
125987240|NCT02343003|453245414|FG000|Overall Study|Withdrawal by Subject|9|||
125987241|NCT02343003|453245415|FG001|Overall Study|Withdrawal by Subject|4|||
125987242|NCT02343003|453245414|FG000|Overall Study|Lost to Follow-up|5|||
125987243|NCT02343003|453245415|FG001|Overall Study|Lost to Follow-up|1|||
125987244|NCT02343003|453245414|FG000|Overall Study|Protocol Violation|1|||
125987245|NCT02343003|453245415|FG001|Overall Study|Protocol Violation|0|||
125987246|NCT02343003|453245414|FG000|Overall Study|Death|0|||
125987247|NCT02343003|453245415|FG001|Overall Study|Death|1|||
125987248|NCT02343003|453245414|FG000|Overall Study|exclusion criteria met|1|||
125987249|NCT02343003|453245415|FG001|Overall Study|exclusion criteria met|1|||
125987250|NCT02343003|453245414|FG000|Overall Study|terminated by sponsor|2|||
125987251|NCT02343003|453245415|FG001|Overall Study|terminated by sponsor|0|||
125987252|NCT01153269|453245418|FG000|Overall Study|Withdrawal by Subject|1|||
126329780|NCT01001520|454501702|FG001|Medication Period 2|Withdrawal by Subject|3|||
126329781|NCT00878800|454501715|FG000|Overall Study|Adverse Event|0|||
126329782|NCT00878800|454501716|FG001|Overall Study|Adverse Event|0|||
126329783|NCT00878800|454501717|FG002|Overall Study|Adverse Event|2|||
126329784|NCT00878800|454501718|FG003|Overall Study|Adverse Event|0|||
126329785|NCT00878800|454501719|FG004|Overall Study|Adverse Event|1|||
126329786|NCT00878800|454501715|FG000|Overall Study|Progressive disease|1|||
126329787|NCT00878800|454501716|FG001|Overall Study|Progressive disease|5|||
126329788|NCT00878800|454501717|FG002|Overall Study|Progressive disease|6|||
126329789|NCT00878800|454501718|FG003|Overall Study|Progressive disease|5|||
126329790|NCT00878800|454501719|FG004|Overall Study|Progressive disease|13|||
126329791|NCT00878800|454501715|FG000|Overall Study|Withdrew consent|1|||
125987253|NCT01153269|453245418|FG000|Overall Study|Antiretroviral therapy break|1|||
125987254|NCT03541044|453245419|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
125987255|NCT03541044|453245420|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
125987256|NCT03541044|453245419|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
125987257|NCT03541044|453245420|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
125987258|NCT02635724|453245421|FG000|Overall Study|Withdrawal by Subject|0|||
125987259|NCT02635724|453245422|FG001|Overall Study|Withdrawal by Subject|1|||
125987260|NCT02635724|453245423|FG002|Overall Study|Withdrawal by Subject|0|||
125987261|NCT01446796|453245430|FG000|Overall Study|Withdrawal by Subject|1|||
125987262|NCT01446796|453245431|FG001|Overall Study|Withdrawal by Subject|0|||
125987263|NCT02424591|453245432|FG000|Overall Study|Protocol Violation|2|||
125987264|NCT02424591|453245433|FG001|Overall Study|Protocol Violation|3|||
125987265|NCT00312702|453245434|FG000|Immunization Phase|Lost to Follow-up|0|||
125987266|NCT00312702|453245435|FG001|Immunization Phase|Lost to Follow-up|1|||
125987267|NCT00312702|453245436|FG002|Immunization Phase|Lost to Follow-up|0|||
125987268|NCT04581200|453245439|FG000|Overall Study|Lost to Follow-up|6|||
125987269|NCT04581200|453245440|FG001|Overall Study|Lost to Follow-up|5|||
125987270|NCT04296890|453245448|FG000|Overall Study|Withdrawal by Subject|1|||
125987271|NCT04296890|453245448|FG000|Overall Study|Death|62|||
125987272|NCT04296890|453245448|FG000|Overall Study|Lost to Follow-up|3|||
125987273|NCT04296890|453245448|FG000|Overall Study|Other than specified|2|||
125987274|NCT05400746|453245449|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
125987275|NCT05400746|453245450|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
125987276|NCT05400746|453245451|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
125987277|NCT05454410|453245452|FG000|Overall Study|Withdrawal by Subject|0|||
125987278|NCT05454410|453245453|FG001|Overall Study|Withdrawal by Subject|0|||
125987279|NCT05454410|453245454|FG002|Overall Study|Withdrawal by Subject|1|||
125987280|NCT05454410|453245455|FG003|Overall Study|Withdrawal by Subject|1|||
125987281|NCT05004688|453245457|FG000|Overall Study|Protocol Violation|7|||
125987282|NCT05004688|453245457|FG000|Overall Study|Physician Decision|2|||
125987283|NCT05004688|453245457|FG000|Overall Study|Withdrawal by Subject|2|||
125987284|NCT03682705|453245461|FG000|Overall Study|Adverse Event|1|||
125987285|NCT03682705|453245462|FG001|Overall Study|Adverse Event|1|||
125987286|NCT03682705|453245463|FG002|Overall Study|Adverse Event|1|||
125987287|NCT03682705|453245464|FG003|Overall Study|Adverse Event|0|||
125987288|NCT03682705|453245465|FG004|Overall Study|Adverse Event|1|||
125987289|NCT03682705|453245466|FG005|Overall Study|Adverse Event|1|||
125987290|NCT03682705|453245461|FG000|Overall Study|Withdrawal by Subject|1|||
125987291|NCT03682705|453245462|FG001|Overall Study|Withdrawal by Subject|3|||
125987292|NCT03682705|453245463|FG002|Overall Study|Withdrawal by Subject|2|||
125987293|NCT03682705|453245464|FG003|Overall Study|Withdrawal by Subject|4|||
125987294|NCT03682705|453245465|FG004|Overall Study|Withdrawal by Subject|0|||
125987295|NCT03682705|453245466|FG005|Overall Study|Withdrawal by Subject|1|||
125987296|NCT03682705|453245461|FG000|Overall Study|Other, not specified|0|||
125987297|NCT03682705|453245462|FG001|Overall Study|Other, not specified|0|||
125987298|NCT03682705|453245463|FG002|Overall Study|Other, not specified|0|||
125987299|NCT03682705|453245464|FG003|Overall Study|Other, not specified|1|||
125987300|NCT03682705|453245465|FG004|Overall Study|Other, not specified|2|||
125987301|NCT03682705|453245466|FG005|Overall Study|Other, not specified|0|||
125987302|NCT03682705|453245461|FG000|Overall Study|Lost to Follow-up|0|||
125987303|NCT03682705|453245462|FG001|Overall Study|Lost to Follow-up|0|||
125987304|NCT03682705|453245463|FG002|Overall Study|Lost to Follow-up|0|||
125987305|NCT03682705|453245464|FG003|Overall Study|Lost to Follow-up|0|||
125987306|NCT03682705|453245465|FG004|Overall Study|Lost to Follow-up|3|||
125987307|NCT03682705|453245466|FG005|Overall Study|Lost to Follow-up|0|||
126329792|NCT00878800|454501716|FG001|Overall Study|Withdrew consent|1|||
125987308|NCT00990340|453245467|FG000|First 14-day Treatment|Not Compliant|2|||
125987309|NCT00990340|453245468|FG001|First 14-day Treatment|Not Compliant|1|||
125987310|NCT00990340|453245467|FG000|First 14-day Treatment|Lost to Follow-up|2|||
125987311|NCT00990340|453245468|FG001|First 14-day Treatment|Lost to Follow-up|1|||
125987312|NCT00990340|453245467|FG000|First 14-day Treatment|Protocol Violation|2|||
125987313|NCT00990340|453245468|FG001|First 14-day Treatment|Protocol Violation|2|||
126329793|NCT00878800|454501717|FG002|Overall Study|Withdrew consent|0|||
125987314|NCT04615182|453245470|FG000|Overall Study|Re-transplanted|2|||
126329794|NCT00878800|454501718|FG003|Overall Study|Withdrew consent|1|||
125987315|NCT04615182|453245470|FG000|Overall Study|Protocol Violation|6|||
125987316|NCT04615182|453245470|FG000|Overall Study|Death|6|||
125987317|NCT04615182|453245470|FG000|Overall Study|Death and protocol violation|1|||
125987318|NCT01874145|453245473|FG000|Core Period|Non-compliance|1|||
125987319|NCT01874145|453245474|FG001|Core Period|Non-compliance|0|||
125987320|NCT01874145|453245473|FG000|Core Period|Protocol Violation|1|||
125987321|NCT01874145|453245474|FG001|Core Period|Protocol Violation|1|||
125987322|NCT01874145|453245473|FG000|Core Period|Physician Decision|1|||
125987323|NCT01874145|453245474|FG001|Core Period|Physician Decision|1|||
125987324|NCT01874145|453245473|FG000|Core Period|Adverse Event|0|||
125987325|NCT01874145|453245474|FG001|Core Period|Adverse Event|1|||
125987326|NCT01874145|453245473|FG000|Core Period|Withdrawal by Subject|0|||
125987327|NCT01874145|453245474|FG001|Core Period|Withdrawal by Subject|4|||
125987328|NCT01874145|453245473|FG000|Extension Period|Adverse Event|3|||
125987329|NCT01874145|453245474|FG001|Extension Period|Adverse Event|2|||
125987330|NCT01874145|453245473|FG000|Extension Period|Withdrawal by Subject|2|||
125987331|NCT01874145|453245474|FG001|Extension Period|Withdrawal by Subject|1|||
125987332|NCT01874145|453245473|FG000|Extension Period|Lost to Follow-up|1|||
125987333|NCT01874145|453245474|FG001|Extension Period|Lost to Follow-up|1|||
125987334|NCT00402337|453245479|FG000|Overall Study|Adverse Event|0|||
125987335|NCT00402337|453245480|FG001|Overall Study|Adverse Event|2|||
125987336|NCT00402337|453245481|FG002|Overall Study|Adverse Event|2|||
125987337|NCT00402337|453245482|FG003|Overall Study|Adverse Event|3|||
125987338|NCT00402337|453245483|FG004|Overall Study|Adverse Event|2|||
125987339|NCT00402337|453245479|FG000|Overall Study|Noncompliance|0|||
125987340|NCT00402337|453245480|FG001|Overall Study|Noncompliance|0|||
125987341|NCT00402337|453245481|FG002|Overall Study|Noncompliance|0|||
125987342|NCT00402337|453245482|FG003|Overall Study|Noncompliance|0|||
125987343|NCT00402337|453245483|FG004|Overall Study|Noncompliance|2|||
125987344|NCT00402337|453245479|FG000|Overall Study|Withdrawal by Subject|5|||
126329795|NCT00878800|454501719|FG004|Overall Study|Withdrew consent|1|||
126329796|NCT00878800|454501715|FG000|Overall Study|Death|0|||
126329797|NCT00878800|454501716|FG001|Overall Study|Death|0|||
126329798|NCT00878800|454501717|FG002|Overall Study|Death|1|||
126329799|NCT00878800|454501718|FG003|Overall Study|Death|0|||
126329800|NCT00878800|454501719|FG004|Overall Study|Death|0|||
126329801|NCT00878800|454501715|FG000|Overall Study|Other|1|||
126329802|NCT00878800|454501716|FG001|Overall Study|Other|1|||
126329803|NCT00878800|454501717|FG002|Overall Study|Other|0|||
126329804|NCT00878800|454501718|FG003|Overall Study|Other|0|||
126329805|NCT00878800|454501719|FG004|Overall Study|Other|1|||
126329806|NCT00613821|454501720|FG000|Overall Study|Withdrawal by Subject|1|||
126329807|NCT00613821|454501721|FG001|Overall Study|Withdrawal by Subject|0|||
126329808|NCT00613821|454501720|FG000|Overall Study|Physician Decision|1|||
126329809|NCT00613821|454501721|FG001|Overall Study|Physician Decision|1|||
126329810|NCT02302846|454501722|FG000|Overall Study|Withdrawal by Subject|1|||
126329811|NCT00715299|454501724|FG000|Overall Study|Withdrawal by Subject|1|||
126329812|NCT00715299|454501724|FG000|Overall Study|Adverse Event|3|||
126329813|NCT00715299|454501724|FG000|Overall Study|failed the pre-screen exercise test|2|||
126329814|NCT00411450|454501725|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
126329815|NCT00872521|454501726|FG000|Completed PAD Induction|Patient choice|0|||
126329816|NCT00872521|454501727|FG001|Completed PAD Induction|Patient choice|1|||
126329817|NCT00872521|454501728|FG002|Completed PAD Induction|Patient choice|0|||
126329818|NCT00872521|454501726|FG000|Completed PAD Induction|Disease progression|0|||
126329819|NCT00872521|454501727|FG001|Completed PAD Induction|Disease progression|2|||
126329820|NCT00872521|454501728|FG002|Completed PAD Induction|Disease progression|0|||
126329821|NCT00872521|454501726|FG000|Completed PAD Induction|Adverse Event|4|||
126329822|NCT00872521|454501727|FG001|Completed PAD Induction|Adverse Event|0|||
126329823|NCT00872521|454501728|FG002|Completed PAD Induction|Adverse Event|0|||
126329824|NCT00872521|454501726|FG000|Completed PAD Induction|Death|1|||
126329825|NCT00872521|454501727|FG001|Completed PAD Induction|Death|1|||
126329826|NCT00872521|454501728|FG002|Completed PAD Induction|Death|0|||
126329827|NCT00872521|454501726|FG000|Primary Endpoint Analysis|Other|1|||
126329828|NCT00872521|454501727|FG001|Primary Endpoint Analysis|Other|2|||
126329829|NCT00872521|454501728|FG002|Primary Endpoint Analysis|Other|0|||
125987345|NCT00402337|453245480|FG001|Overall Study|Withdrawal by Subject|3|||
125987346|NCT00402337|453245481|FG002|Overall Study|Withdrawal by Subject|1|||
125987347|NCT00402337|453245482|FG003|Overall Study|Withdrawal by Subject|6|||
125987348|NCT00402337|453245483|FG004|Overall Study|Withdrawal by Subject|4|||
125987349|NCT00402337|453245479|FG000|Overall Study|Lost to Follow-up|0|||
125987350|NCT00402337|453245480|FG001|Overall Study|Lost to Follow-up|0|||
126209271|NCT05182840|454053182|FG009|Treatment Period|Protocol deviation|0|||
126329830|NCT00872521|454501726|FG000|Primary Endpoint Analysis|Patient choice|0|||
126329831|NCT00872521|454501727|FG001|Primary Endpoint Analysis|Patient choice|1|||
126329832|NCT00872521|454501728|FG002|Primary Endpoint Analysis|Patient choice|0|||
126329833|NCT00872521|454501726|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
126329834|NCT00872521|454501727|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
126329835|NCT00872521|454501728|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
125987351|NCT00402337|453245481|FG002|Overall Study|Lost to Follow-up|1|||
125987352|NCT00402337|453245482|FG003|Overall Study|Lost to Follow-up|2|||
125987353|NCT00402337|453245483|FG004|Overall Study|Lost to Follow-up|0|||
125987354|NCT00402337|453245479|FG000|Overall Study|Physician Decision|0|||
125987355|NCT00402337|453245480|FG001|Overall Study|Physician Decision|0|||
125987356|NCT00402337|453245481|FG002|Overall Study|Physician Decision|0|||
125987357|NCT00402337|453245482|FG003|Overall Study|Physician Decision|1|||
125987358|NCT00402337|453245483|FG004|Overall Study|Physician Decision|0|||
125987359|NCT00402337|453245479|FG000|Overall Study|Other Reason|0|||
125987360|NCT00402337|453245480|FG001|Overall Study|Other Reason|1|||
125987361|NCT00402337|453245481|FG002|Overall Study|Other Reason|0|||
125987362|NCT00402337|453245482|FG003|Overall Study|Other Reason|0|||
125987363|NCT00402337|453245483|FG004|Overall Study|Other Reason|0|||
125987364|NCT02178566|453245484|FG000|Overall Study|patient did not complete due to noncompliance|0|||
125987365|NCT02178566|453245485|FG001|Overall Study|patient did not complete due to noncompliance|1|||
125987366|NCT02070484|453245492|FG000|Overall Study|Withdrawal by Subject|1|||
125987367|NCT02070484|453245493|FG001|Overall Study|Withdrawal by Subject|0|||
125987368|NCT02658630|453245494|FG000|Overall Study|Withdrawal by Subject|4|||
125987369|NCT02821819|453245495|FG000|Overall Study|Protocol Violation|1|||
125987370|NCT03565068|453245496|FG000|Overall Study|Protocol Violation|0|||
125987371|NCT03565068|453245497|FG001|Overall Study|Protocol Violation|0|||
125987372|NCT03565068|453245498|FG002|Overall Study|Protocol Violation|0|||
125987373|NCT03565068|453245499|FG003|Overall Study|Protocol Violation|0|||
125987374|NCT03565068|453245500|FG004|Overall Study|Protocol Violation|1|||
125987375|NCT03565068|453245501|FG005|Overall Study|Protocol Violation|0|||
125987376|NCT03565068|453245502|FG006|Overall Study|Protocol Violation|0|||
125987377|NCT03565068|453245503|FG007|Overall Study|Protocol Violation|1|||
125987378|NCT03565068|453245504|FG008|Overall Study|Protocol Violation|0|||
125987379|NCT03565068|453245496|FG000|Overall Study|Sponsor decision|0|||
126090993|NCT03525392|453626876|FG002|Overall Study|Progressive disease|1|||
126090994|NCT03525392|453626877|FG003|Overall Study|Progressive disease|3|||
126090995|NCT03525392|453626878|FG004|Overall Study|Progressive disease|1|||
126090996|NCT03284203|453626881|FG000|Overall Study|Lost to Follow-up|3|||
126090997|NCT02229851|453626882|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
126090998|NCT02229851|453626883|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
126090999|NCT02229851|453626884|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
126091000|NCT02229851|453626885|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
126091001|NCT02229851|453626886|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
126091002|NCT02229851|453626887|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
126091003|NCT02229851|453626888|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
126091004|NCT02229851|453626882|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126091005|NCT02229851|453626883|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
126091006|NCT02229851|453626884|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126091007|NCT02229851|453626885|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126091008|NCT02229851|453626886|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126091009|NCT02229851|453626887|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126091010|NCT02229851|453626888|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126091011|NCT02229851|453626882|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
126091012|NCT02229851|453626883|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
126091013|NCT02229851|453626884|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
126091014|NCT02229851|453626885|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
126091015|NCT02229851|453626886|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
126091016|NCT02229851|453626887|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
126091017|NCT02229851|453626888|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
126091018|NCT02229851|453626882|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126091019|NCT02229851|453626883|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126091020|NCT02229851|453626884|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
126091021|NCT02229851|453626885|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126091022|NCT02229851|453626886|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126091023|NCT02229851|453626887|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126091024|NCT02229851|453626888|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126091025|NCT02229851|453626882|FG000|Main Phase (Double-blind Phase)|Death|1|||
126091026|NCT02229851|453626883|FG001|Main Phase (Double-blind Phase)|Death|1|||
126091027|NCT02229851|453626884|FG002|Main Phase (Double-blind Phase)|Death|0|||
126091028|NCT02229851|453626885|FG003|Main Phase (Double-blind Phase)|Death|0|||
126091029|NCT02229851|453626886|FG004|Main Phase (Double-blind Phase)|Death|0|||
126091030|NCT02229851|453626887|FG005|Main Phase (Double-blind Phase)|Death|0|||
126091031|NCT02229851|453626888|FG006|Main Phase (Double-blind Phase)|Death|0|||
126091032|NCT02229851|453626882|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
126091033|NCT02229851|453626883|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
126091034|NCT02229851|453626884|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
126091035|NCT02229851|453626885|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
125987380|NCT03565068|453245497|FG001|Overall Study|Sponsor decision|0|||
125987381|NCT03565068|453245498|FG002|Overall Study|Sponsor decision|0|||
126329836|NCT00872521|454501726|FG000|Primary Endpoint Analysis|Patient response missing|0|||
126329837|NCT00872521|454501727|FG001|Primary Endpoint Analysis|Patient response missing|0|||
126329838|NCT00872521|454501728|FG002|Primary Endpoint Analysis|Patient response missing|1|||
126329839|NCT00872521|454501726|FG000|Completed 3-month Follow up|Other|0|||
126329840|NCT00872521|454501727|FG001|Completed 3-month Follow up|Other|2|||
126329841|NCT00872521|454501728|FG002|Completed 3-month Follow up|Other|0|||
126329842|NCT00872521|454501726|FG000|Completed 3-month Follow up|Physician Decision|0|||
126329843|NCT00872521|454501727|FG001|Completed 3-month Follow up|Physician Decision|1|||
126329844|NCT00872521|454501728|FG002|Completed 3-month Follow up|Physician Decision|0|||
126329845|NCT00872521|454501726|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
126329846|NCT00872521|454501727|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
126329847|NCT00872521|454501728|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
126329848|NCT00614874|454501729|FG000|Overall Study|Protocol Violation|1|||
126329849|NCT00614874|454501729|FG000|Overall Study|Withdrawal by Subject|1|||
126329850|NCT01468454|454501730|FG000|Overall Study|Did not have surgery after PET|9|||
126329851|NCT02620787|454501731|FG000|Overall Study|Adverse Event|1|||
126329852|NCT02620787|454501732|FG001|Overall Study|Adverse Event|0|||
126329853|NCT02620787|454501731|FG000|Overall Study|Eligibility Criteria Not Met|1|||
126329854|NCT02620787|454501732|FG001|Overall Study|Eligibility Criteria Not Met|0|||
126329855|NCT00807612|454501734|FG000|Overall Study|Death|8|||
126329856|NCT00807612|454501734|FG000|Overall Study|Study early termination|5|||
126329857|NCT00807612|454501734|FG000|Overall Study|Withdrawal by Subject|1|||
126329858|NCT02028507|454501735|FG000|Overall Study|Progressive Disease|122|||
126329859|NCT02028507|454501736|FG001|Overall Study|Progressive Disease|90|||
126329860|NCT02028507|454501737|FG002|Overall Study|Progressive Disease|102|||
126329861|NCT02028507|454501738|FG003|Overall Study|Progressive Disease|89|||
126329862|NCT02028507|454501735|FG000|Overall Study|Adverse Event|8|||
126329863|NCT02028507|454501736|FG001|Overall Study|Adverse Event|25|||
126329864|NCT02028507|454501737|FG002|Overall Study|Adverse Event|3|||
126329865|NCT02028507|454501738|FG003|Overall Study|Adverse Event|16|||
126329866|NCT02028507|454501735|FG000|Overall Study|Withdrawal by Subject|6|||
126329867|NCT02028507|454501736|FG001|Overall Study|Withdrawal by Subject|8|||
126329868|NCT02028507|454501737|FG002|Overall Study|Withdrawal by Subject|5|||
126091036|NCT02229851|453626886|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
126091037|NCT02229851|453626887|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
126329869|NCT02028507|454501738|FG003|Overall Study|Withdrawal by Subject|9|||
126329870|NCT02028507|454501735|FG000|Overall Study|Protocol Violation|2|||
126329871|NCT02028507|454501736|FG001|Overall Study|Protocol Violation|4|||
126329872|NCT02028507|454501737|FG002|Overall Study|Protocol Violation|1|||
126329873|NCT02028507|454501738|FG003|Overall Study|Protocol Violation|3|||
126329874|NCT02028507|454501735|FG000|Overall Study|Physician Decision|0|||
126329875|NCT02028507|454501736|FG001|Overall Study|Physician Decision|4|||
126329876|NCT02028507|454501737|FG002|Overall Study|Physician Decision|0|||
126329877|NCT02028507|454501738|FG003|Overall Study|Physician Decision|0|||
126329878|NCT02028507|454501735|FG000|Overall Study|Death|1|||
126329879|NCT02028507|454501736|FG001|Overall Study|Death|0|||
126329880|NCT02028507|454501737|FG002|Overall Study|Death|1|||
126329881|NCT02028507|454501738|FG003|Overall Study|Death|3|||
126329882|NCT02028507|454501735|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
126329883|NCT02028507|454501736|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
126329884|NCT02028507|454501737|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
126329885|NCT02028507|454501738|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
126329886|NCT02028507|454501735|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
126329887|NCT02028507|454501736|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
126329888|NCT02028507|454501737|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
126329889|NCT02028507|454501738|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
126209272|NCT05182840|454053173|FG000|Treatment Period|No reason available|0|||
126209273|NCT05182840|454053174|FG001|Treatment Period|No reason available|0|||
126209274|NCT05182840|454053175|FG002|Treatment Period|No reason available|0|||
126209275|NCT05182840|454053176|FG003|Treatment Period|No reason available|1|||
126209276|NCT05182840|454053177|FG004|Treatment Period|No reason available|0|||
126209277|NCT05182840|454053178|FG005|Treatment Period|No reason available|2|||
126329890|NCT02028507|454501735|FG000|Overall Study|Randomized But Not Treated|3|||
126329891|NCT02028507|454501736|FG001|Overall Study|Randomized But Not Treated|6|||
126329892|NCT02028507|454501737|FG002|Overall Study|Randomized But Not Treated|0|||
126329893|NCT02028507|454501738|FG003|Overall Study|Randomized But Not Treated|4|||
126329894|NCT02028507|454501735|FG000|Overall Study|Enzyme defect|0|||
126329895|NCT02028507|454501736|FG001|Overall Study|Enzyme defect|0|||
126329896|NCT02028507|454501737|FG002|Overall Study|Enzyme defect|0|||
126329897|NCT02028507|454501738|FG003|Overall Study|Enzyme defect|1|||
126329898|NCT02028507|454501735|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
126329899|NCT02028507|454501736|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
126329900|NCT02028507|454501737|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
126329901|NCT02028507|454501738|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
126209278|NCT05182840|454053179|FG006|Treatment Period|No reason available|0|||
126209279|NCT05182840|454053180|FG007|Treatment Period|No reason available|1|||
126209280|NCT05182840|454053181|FG008|Treatment Period|No reason available|0|||
126209281|NCT05182840|454053182|FG009|Treatment Period|No reason available|0|||
126209282|NCT05182840|454053173|FG000|Treatment Period|Burden of study procedures|0|||
126209283|NCT05182840|454053174|FG001|Treatment Period|Burden of study procedures|0|||
126209284|NCT05182840|454053175|FG002|Treatment Period|Burden of study procedures|0|||
126209285|NCT05182840|454053176|FG003|Treatment Period|Burden of study procedures|0|||
126209286|NCT05182840|454053177|FG004|Treatment Period|Burden of study procedures|1|||
126209287|NCT05182840|454053178|FG005|Treatment Period|Burden of study procedures|0|||
126209288|NCT05182840|454053179|FG006|Treatment Period|Burden of study procedures|0|||
126209289|NCT05182840|454053180|FG007|Treatment Period|Burden of study procedures|0|||
126209290|NCT05182840|454053181|FG008|Treatment Period|Burden of study procedures|0|||
126209291|NCT05182840|454053182|FG009|Treatment Period|Burden of study procedures|0|||
126091038|NCT02229851|453626888|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
126091039|NCT02229851|453626882|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
126091040|NCT02229851|453626883|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
126091041|NCT02229851|453626884|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
126091042|NCT02229851|453626885|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
126091043|NCT02229851|453626886|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
126091044|NCT02229851|453626887|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
126091045|NCT02229851|453626888|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
126091046|NCT02229851|453626882|FG000|Extension Phase (Open-label Phase)|Death|0|||
126091047|NCT02229851|453626883|FG001|Extension Phase (Open-label Phase)|Death|0|||
126091048|NCT02229851|453626884|FG002|Extension Phase (Open-label Phase)|Death|0|||
126091049|NCT02229851|453626885|FG003|Extension Phase (Open-label Phase)|Death|1|||
126091050|NCT02229851|453626886|FG004|Extension Phase (Open-label Phase)|Death|0|||
126091051|NCT02229851|453626887|FG005|Extension Phase (Open-label Phase)|Death|1|||
126091052|NCT02229851|453626888|FG006|Extension Phase (Open-label Phase)|Death|1|||
126091053|NCT01111240|453626889|FG000|Overall Study|Adverse Event|190|||
126091054|NCT01111240|453626889|FG000|Overall Study|Lack of Efficacy|545|||
126091055|NCT01111240|453626889|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
126091056|NCT01111240|453626889|FG000|Overall Study|Other|312|||
126091057|NCT02206061|453626890|FG000|Overall Study|Withdrawal by Subject|4|||
126091058|NCT02206061|453626891|FG001|Overall Study|Withdrawal by Subject|7|||
126091059|NCT02206061|453626892|FG002|Overall Study|Withdrawal by Subject|1|||
126091060|NCT02206061|453626890|FG000|Overall Study|Lost to Follow-up|14|||
126091061|NCT02206061|453626891|FG001|Overall Study|Lost to Follow-up|7|||
126091062|NCT02206061|453626892|FG002|Overall Study|Lost to Follow-up|20|||
126091063|NCT04187326|453626893|FG000|Overall Study|Lost to Follow-up|2|||
126091064|NCT04187326|453626894|FG001|Overall Study|Lost to Follow-up|1|||
126209292|NCT05182840|454053173|FG000|Treatment Period|Change of residence|0|||
126209293|NCT05182840|454053174|FG001|Treatment Period|Change of residence|0|||
125987382|NCT03565068|453245499|FG003|Overall Study|Sponsor decision|0|||
125987383|NCT03565068|453245500|FG004|Overall Study|Sponsor decision|1|||
125987384|NCT03565068|453245501|FG005|Overall Study|Sponsor decision|1|||
125987385|NCT03565068|453245502|FG006|Overall Study|Sponsor decision|0|||
125987386|NCT03565068|453245503|FG007|Overall Study|Sponsor decision|0|||
125987387|NCT03565068|453245504|FG008|Overall Study|Sponsor decision|0|||
125987388|NCT03565068|453245496|FG000|Overall Study|Withdrawal by Subject|0|||
125987389|NCT03565068|453245497|FG001|Overall Study|Withdrawal by Subject|0|||
125987390|NCT03565068|453245498|FG002|Overall Study|Withdrawal by Subject|1|||
125987391|NCT03565068|453245499|FG003|Overall Study|Withdrawal by Subject|0|||
125987392|NCT03565068|453245500|FG004|Overall Study|Withdrawal by Subject|2|||
125987393|NCT03565068|453245501|FG005|Overall Study|Withdrawal by Subject|0|||
125987394|NCT03565068|453245502|FG006|Overall Study|Withdrawal by Subject|1|||
125987395|NCT03565068|453245503|FG007|Overall Study|Withdrawal by Subject|5|||
125987396|NCT03565068|453245504|FG008|Overall Study|Withdrawal by Subject|1|||
125987397|NCT03565068|453245496|FG000|Overall Study|Physician Decision|0|||
125987398|NCT03565068|453245497|FG001|Overall Study|Physician Decision|0|||
125987399|NCT03565068|453245498|FG002|Overall Study|Physician Decision|0|||
125987400|NCT03565068|453245499|FG003|Overall Study|Physician Decision|0|||
125987401|NCT03565068|453245500|FG004|Overall Study|Physician Decision|0|||
125987402|NCT03565068|453245501|FG005|Overall Study|Physician Decision|0|||
125987403|NCT03565068|453245502|FG006|Overall Study|Physician Decision|0|||
125987404|NCT03565068|453245503|FG007|Overall Study|Physician Decision|1|||
125987405|NCT03565068|453245504|FG008|Overall Study|Physician Decision|0|||
125987406|NCT03565068|453245496|FG000|Overall Study|Lost to Follow-up|0|||
125987407|NCT03565068|453245497|FG001|Overall Study|Lost to Follow-up|0|||
125987408|NCT03565068|453245498|FG002|Overall Study|Lost to Follow-up|0|||
125987409|NCT03565068|453245499|FG003|Overall Study|Lost to Follow-up|0|||
125987410|NCT03565068|453245500|FG004|Overall Study|Lost to Follow-up|0|||
125987411|NCT03565068|453245501|FG005|Overall Study|Lost to Follow-up|0|||
125987412|NCT03565068|453245502|FG006|Overall Study|Lost to Follow-up|0|||
125987413|NCT03565068|453245503|FG007|Overall Study|Lost to Follow-up|1|||
125987414|NCT03565068|453245504|FG008|Overall Study|Lost to Follow-up|0|||
125987415|NCT00085202|453245505|FG000|Overall Study|Still on therapy|2|||
125987416|NCT00085202|453245506|FG001|Overall Study|Still on therapy|0|||
125987417|NCT00085202|453245505|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
125987418|NCT00085202|453245506|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
125987419|NCT00085202|453245505|FG000|Overall Study|Excessive toxicity|6|||
125987420|NCT00085202|453245506|FG001|Overall Study|Excessive toxicity|5|||
125987421|NCT00085202|453245505|FG000|Overall Study|Non-specified|3|||
125987422|NCT00085202|453245506|FG001|Overall Study|Non-specified|5|||
125987423|NCT00085202|453245505|FG000|Overall Study|Withdrawal by Subject|2|||
125987424|NCT00085202|453245506|FG001|Overall Study|Withdrawal by Subject|1|||
125987425|NCT00085202|453245505|FG000|Overall Study|Physician Decision|4|||
125987426|NCT00085202|453245506|FG001|Overall Study|Physician Decision|1|||
125987427|NCT00085202|453245505|FG000|Overall Study|Progressive disease|1|||
125987428|NCT00085202|453245506|FG001|Overall Study|Progressive disease|11|||
125987429|NCT03238300|453245510|FG000|Baseline (Before Intervention)|Physician Decision|0|||
125987430|NCT03238300|453245511|FG001|Baseline (Before Intervention)|Physician Decision|1|||
125987431|NCT03238300|453245510|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
125987432|NCT03238300|453245511|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
125987433|NCT03238300|453245510|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
125987434|NCT03238300|453245511|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
125987435|NCT03238300|453245510|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
125987436|NCT03238300|453245511|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
125987437|NCT01435655|453245517|FG000|Overall Study|Death|2|||
125987438|NCT01435655|453245517|FG000|Overall Study|Other|1|||
125987439|NCT01436201|453245518|FG000|Overall Study|Adverse Event|2|||
125987440|NCT01436201|453245518|FG000|Overall Study|Withdrawal by Subject|1|||
125987441|NCT01436201|453245518|FG000|Overall Study|Protocol Violation|1|||
125987442|NCT00110890|453245520|FG000|Overall Study|Adverse Event|30|||
125987443|NCT00110890|453245521|FG001|Overall Study|Adverse Event|7|||
125987444|NCT00110890|453245520|FG000|Overall Study|Death|16|||
125987445|NCT00110890|453245521|FG001|Overall Study|Death|9|||
125987446|NCT00110890|453245520|FG000|Overall Study|Lost to Follow-up|3|||
125987447|NCT00110890|453245521|FG001|Overall Study|Lost to Follow-up|1|||
125987448|NCT00110890|453245520|FG000|Overall Study|Physician Decision|4|||
125987449|NCT00110890|453245521|FG001|Overall Study|Physician Decision|5|||
125987450|NCT00110890|453245520|FG000|Overall Study|Withdrawal by Subject|17|||
125987451|NCT00110890|453245521|FG001|Overall Study|Withdrawal by Subject|5|||
125987452|NCT00110890|453245520|FG000|Overall Study|Protocol Deviation|1|||
125987453|NCT00110890|453245521|FG001|Overall Study|Protocol Deviation|0|||
125987454|NCT00110890|453245520|FG000|Overall Study|Noncompliance|10|||
125987455|NCT00110890|453245521|FG001|Overall Study|Noncompliance|0|||
125987456|NCT00110890|453245520|FG000|Overall Study|Kidney Transplant|16|||
125987457|NCT00110890|453245521|FG001|Overall Study|Kidney Transplant|12|||
125987458|NCT00110890|453245520|FG000|Overall Study|Invest. Product Commercially Available|217|||
125987459|NCT00110890|453245521|FG001|Overall Study|Invest. Product Commercially Available|110|||
125987460|NCT00110890|453245520|FG000|Overall Study|Other|34|||
125987461|NCT00110890|453245521|FG001|Overall Study|Other|23|||
125987462|NCT00110890|453245520|FG000|Overall Study|Ineligibility determined|3|||
125987463|NCT00110890|453245521|FG001|Overall Study|Ineligibility determined|0|||
125987464|NCT00110890|453245520|FG000|Overall Study|Requirement for alternative therapy|0|||
125987465|NCT00110890|453245521|FG001|Overall Study|Requirement for alternative therapy|1|||
125987466|NCT00110890|453245520|FG000|Overall Study|Disease progression|0|||
125987467|NCT00110890|453245521|FG001|Overall Study|Disease progression|1|||
125987468|NCT00110890|453245520|FG000|Overall Study|Parathyroidectomy|0|||
125987469|NCT00110890|453245521|FG001|Overall Study|Parathyroidectomy|1|||
125987470|NCT00110890|453245520|FG000|Overall Study|Did not enter follow-up phase|10|||
126329902|NCT02028507|454501735|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
126329903|NCT02028507|454501736|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
125987471|NCT00110890|453245521|FG001|Overall Study|Did not enter follow-up phase|4|||
125987472|NCT01975220|453245522|FG000|Test Period 1|Not treated|0|||
125987473|NCT01975220|453245523|FG001|Test Period 1|Not treated|1|||
125987474|NCT01975220|453245524|FG002|Test Period 1|Not treated|0|||
125987475|NCT01975220|453245525|FG003|Test Period 1|Not treated|0|||
125987476|NCT01975220|453245526|FG004|Test Period 1|Not treated|0|||
125987477|NCT01975220|453245527|FG005|Test Period 1|Not treated|0|||
125987478|NCT02839343|453245528|FG000|Overall Study|Withdrawal by Subject|3|||
125987479|NCT02839343|453245529|FG001|Overall Study|Withdrawal by Subject|1|||
125987480|NCT02839343|453245528|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
125987481|NCT02839343|453245529|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
125987482|NCT02839343|453245528|FG000|Overall Study|Adverse Event|1|||
126329904|NCT02028507|454501737|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
126329905|NCT02028507|454501738|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
126329906|NCT02258659|454501739|FG000|Overall Study|Withdrawal by Subject|1|||
126329907|NCT00272844|454501740|FG000|Overall Study|Withdrawal by Subject|5|||
125987483|NCT02839343|453245529|FG001|Overall Study|Adverse Event|0|||
125987484|NCT01852058|453245530|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
125987485|NCT01852058|453245531|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987486|NCT01852058|453245532|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987487|NCT01852058|453245533|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987488|NCT01852058|453245534|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987489|NCT01852058|453245535|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987490|NCT01852058|453245536|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987491|NCT01852058|453245537|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987492|NCT01852058|453245538|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987493|NCT01852058|453245539|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987494|NCT01852058|453245540|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987495|NCT01852058|453245541|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125987496|NCT01852058|453245530|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987497|NCT01852058|453245531|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987498|NCT01852058|453245532|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987499|NCT01852058|453245533|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987500|NCT01852058|453245534|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
125987501|NCT01852058|453245535|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987502|NCT01852058|453245536|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987503|NCT01852058|453245537|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987504|NCT01852058|453245538|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987505|NCT01852058|453245539|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987506|NCT01852058|453245540|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987507|NCT01852058|453245541|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125987508|NCT01852058|453245530|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987509|NCT01852058|453245531|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987510|NCT01852058|453245532|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987511|NCT01852058|453245533|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987512|NCT01852058|453245534|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
125987513|NCT01852058|453245535|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
125987514|NCT01852058|453245536|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987515|NCT01852058|453245537|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987516|NCT01852058|453245538|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987517|NCT01852058|453245539|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987518|NCT01852058|453245540|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987519|NCT01852058|453245541|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125987520|NCT01852058|453245530|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987521|NCT01852058|453245531|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987522|NCT01852058|453245532|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987523|NCT01852058|453245533|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987524|NCT01852058|453245534|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
125987525|NCT01852058|453245535|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987526|NCT01852058|453245536|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987527|NCT01852058|453245537|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987528|NCT01852058|453245538|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987529|NCT01852058|453245539|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987530|NCT01852058|453245540|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987531|NCT01852058|453245541|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125987532|NCT01852058|453245530|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987533|NCT01852058|453245531|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987534|NCT01852058|453245532|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987535|NCT01852058|453245533|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987536|NCT01852058|453245534|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
125987537|NCT01852058|453245535|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
125987538|NCT01852058|453245536|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987539|NCT01852058|453245537|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987540|NCT01852058|453245538|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987541|NCT01852058|453245539|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987542|NCT01852058|453245540|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987543|NCT01852058|453245541|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125987544|NCT01852058|453245530|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987545|NCT01852058|453245531|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987546|NCT01852058|453245532|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987547|NCT01852058|453245533|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
126329908|NCT01502033|454501744|FG000|Overall Study|1 participant had scalp discomfort|1|||
126329909|NCT01502033|454501744|FG000|Overall Study|1 participant had worsening depression|1|||
126329910|NCT01502033|454501744|FG000|Overall Study|1 participant went back to school|1|||
126329911|NCT01808261|454501745|FG000|Overall Study|Physician Decision|0|||
125987548|NCT01852058|453245534|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987549|NCT01852058|453245535|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126329912|NCT01808261|454501746|FG001|Overall Study|Physician Decision|2|||
126329913|NCT01808261|454501745|FG000|Overall Study|Study Closed/Terminated|25|||
126329914|NCT01808261|454501746|FG001|Overall Study|Study Closed/Terminated|23|||
126329915|NCT01808261|454501745|FG000|Overall Study|Adverse event, non-fatal|2|||
126329916|NCT01808261|454501746|FG001|Overall Study|Adverse event, non-fatal|0|||
126329917|NCT01808261|454501745|FG000|Overall Study|Consent withdrawn by subject|6|||
126329918|NCT01808261|454501746|FG001|Overall Study|Consent withdrawn by subject|7|||
126329919|NCT01808261|454501745|FG000|Overall Study|Lost to Follow-up|3|||
126329920|NCT01808261|454501746|FG001|Overall Study|Lost to Follow-up|1|||
126329921|NCT02609984|454501751|FG000|Overall Study|Death|29|||
126329922|NCT02609984|454501752|FG001|Overall Study|Death|26|||
126329923|NCT02609984|454501751|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
126329924|NCT02609984|454501752|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
126329925|NCT02609984|454501751|FG000|Overall Study|Lost to Follow-up|1|||
126329926|NCT02609984|454501752|FG001|Overall Study|Lost to Follow-up|2|||
126329927|NCT02609984|454501751|FG000|Overall Study|Withdrawal by Subject|0|||
126329928|NCT02609984|454501752|FG001|Overall Study|Withdrawal by Subject|1|||
126329929|NCT02609984|454501751|FG000|Overall Study|Disease Progression|2|||
126329930|NCT02609984|454501752|FG001|Overall Study|Disease Progression|0|||
126329931|NCT02080364|454501753|FG000|Baseline Period|Protocol Violation|2|||
126329932|NCT02080364|454501754|FG001|Baseline Period|Protocol Violation|1|||
125987550|NCT01852058|453245536|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126329933|NCT02080364|454501755|FG002|Baseline Period|Protocol Violation|0|||
126329934|NCT02080364|454501756|FG003|Baseline Period|Protocol Violation|0|||
126329935|NCT02080364|454501753|FG000|Baseline Period|Other|0|||
126329936|NCT02080364|454501754|FG001|Baseline Period|Other|1|||
126329937|NCT02080364|454501755|FG002|Baseline Period|Other|1|||
125987551|NCT01852058|453245537|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987552|NCT01852058|453245538|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987553|NCT01852058|453245539|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987554|NCT01852058|453245540|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987555|NCT01852058|453245541|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125987556|NCT01852058|453245530|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987557|NCT01852058|453245531|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987558|NCT01852058|453245532|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987559|NCT01852058|453245533|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987560|NCT01852058|453245534|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
125987561|NCT01852058|453245535|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
125987562|NCT01852058|453245536|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987563|NCT01852058|453245537|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987564|NCT01852058|453245538|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987565|NCT01852058|453245539|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987566|NCT01852058|453245540|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987567|NCT01852058|453245541|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125987568|NCT01852058|453245530|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987569|NCT01852058|453245531|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987570|NCT01852058|453245532|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987571|NCT01852058|453245533|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987572|NCT01852058|453245534|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987573|NCT01852058|453245535|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987574|NCT01852058|453245536|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987575|NCT01852058|453245537|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
125987576|NCT01852058|453245538|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987577|NCT01852058|453245539|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126329938|NCT02080364|454501756|FG003|Baseline Period|Other|0|||
126329939|NCT02080364|454501753|FG000|Treatment Period|Adverse Event|10|||
126329940|NCT02080364|454501754|FG001|Treatment Period|Adverse Event|15|||
126329941|NCT02080364|454501755|FG002|Treatment Period|Adverse Event|11|||
126329942|NCT02080364|454501756|FG003|Treatment Period|Adverse Event|14|||
126329943|NCT02080364|454501753|FG000|Treatment Period|Lost to Follow-up|2|||
126329944|NCT02080364|454501754|FG001|Treatment Period|Lost to Follow-up|3|||
126329945|NCT02080364|454501755|FG002|Treatment Period|Lost to Follow-up|5|||
126329946|NCT02080364|454501756|FG003|Treatment Period|Lost to Follow-up|0|||
126329947|NCT02080364|454501753|FG000|Treatment Period|Protocol Violation|5|||
125987578|NCT01852058|453245540|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987579|NCT01852058|453245541|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125987580|NCT01852058|453245530|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987581|NCT01852058|453245531|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987582|NCT01852058|453245532|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987583|NCT01852058|453245533|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987584|NCT01852058|453245534|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987585|NCT01852058|453245535|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987586|NCT01852058|453245536|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987587|NCT01852058|453245537|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987588|NCT01852058|453245538|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
125987589|NCT01852058|453245539|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987590|NCT01852058|453245540|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987591|NCT01852058|453245541|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125987592|NCT01301274|453245545|FG000|Overall Study|Physician Decision|2|||
125987593|NCT01301274|453245546|FG001|Overall Study|Physician Decision|1|||
125987594|NCT00661661|453245547|FG000|Overall Study|Adverse Event|99|||
125987595|NCT00661661|453245548|FG001|Overall Study|Adverse Event|24|||
125987596|NCT00661661|453245547|FG000|Overall Study|Lack of Efficacy|3|||
125987597|NCT00661661|453245548|FG001|Overall Study|Lack of Efficacy|2|||
125987598|NCT00661661|453245547|FG000|Overall Study|Lost to Follow-up|0|||
125987599|NCT00661661|453245548|FG001|Overall Study|Lost to Follow-up|1|||
125987600|NCT00661661|453245547|FG000|Overall Study|Withdrawal by Subject|15|||
125987601|NCT00661661|453245548|FG001|Overall Study|Withdrawal by Subject|5|||
125987602|NCT00661661|453245547|FG000|Overall Study|Other|22|||
125987603|NCT00661661|453245548|FG001|Overall Study|Other|7|||
125987604|NCT00661661|453245547|FG000|Overall Study|Not assigned treatment|1|||
125987605|NCT00661661|453245548|FG001|Overall Study|Not assigned treatment|0|||
125987606|NCT01893827|453245549|FG000|Overall Study|Lost to Follow-up|19|||
125987607|NCT01893827|453245550|FG001|Overall Study|Lost to Follow-up|26|||
125987608|NCT04182880|453245553|FG000|Overall Study|Pregnancy|1|||
125987609|NCT04182880|453245554|FG001|Overall Study|Pregnancy|0|||
125987610|NCT03389477|453245555|FG000|Step 1|Withdrawal by Subject|1|||
125987611|NCT03389477|453245556|FG001|Step 1|Withdrawal by Subject|0|||
125987612|NCT03389477|453245555|FG000|Step 2|Withdrawal by Subject|1|||
125987613|NCT03389477|453245556|FG001|Step 2|Withdrawal by Subject|2|||
125987614|NCT03389477|453245555|FG000|Step 2|Disease progression|1|||
125987615|NCT03389477|453245556|FG001|Step 2|Disease progression|0|||
125987616|NCT03389477|453245555|FG000|Step 2|Death|0|||
125987617|NCT03389477|453245556|FG001|Step 2|Death|1|||
125987618|NCT03389477|453245555|FG000|Step 2|Poor performance status and nutrition|0|||
125987619|NCT03389477|453245556|FG001|Step 2|Poor performance status and nutrition|1|||
125987620|NCT03389477|453245555|FG000|Step 3|Withdrawal after 3 cycles|0|||
125987621|NCT03389477|453245556|FG001|Step 3|Withdrawal after 3 cycles|1|||
125987622|NCT03389477|453245555|FG000|Step 3|Still receiving active treatment|4|||
125987623|NCT03389477|453245556|FG001|Step 3|Still receiving active treatment|0|||
125987624|NCT03389477|453245555|FG000|Step 3|Progressive disease after 2 cycles|1|||
125987625|NCT03389477|453245556|FG001|Step 3|Progressive disease after 2 cycles|0|||
125987626|NCT03403426|453245561|FG000|Overall Study|Death|1|||
125987627|NCT03403426|453245561|FG000|Overall Study|Lost to Follow-up|2|||
125987628|NCT03520400|453245562|FG000|Overall Study|Physician Decision|15|||
125987629|NCT03520400|453245563|FG001|Overall Study|Physician Decision|7|||
125987630|NCT00445679|453245566|FG000|Overall Study|Adverse Event|22|||
125987631|NCT00445679|453245567|FG001|Overall Study|Adverse Event|12|||
125987632|NCT00445679|453245568|FG002|Overall Study|Adverse Event|30|||
125987633|NCT00445679|453245569|FG003|Overall Study|Adverse Event|19|||
125987634|NCT00445679|453245566|FG000|Overall Study|Failed to return|1|||
125987635|NCT00445679|453245567|FG001|Overall Study|Failed to return|3|||
125987636|NCT00445679|453245568|FG002|Overall Study|Failed to return|2|||
125987637|NCT00445679|453245569|FG003|Overall Study|Failed to return|2|||
125987638|NCT00445679|453245566|FG000|Overall Study|Physician Decision|0|||
125987639|NCT00445679|453245567|FG001|Overall Study|Physician Decision|0|||
125987640|NCT00445679|453245568|FG002|Overall Study|Physician Decision|1|||
125987641|NCT00445679|453245569|FG003|Overall Study|Physician Decision|0|||
125987642|NCT00445679|453245566|FG000|Overall Study|Lost to Follow-up|10|||
125987643|NCT00445679|453245567|FG001|Overall Study|Lost to Follow-up|6|||
125987644|NCT00445679|453245568|FG002|Overall Study|Lost to Follow-up|6|||
125987645|NCT00445679|453245569|FG003|Overall Study|Lost to Follow-up|5|||
125987646|NCT00445679|453245566|FG000|Overall Study|Compliance|3|||
125987647|NCT00445679|453245567|FG001|Overall Study|Compliance|2|||
125987648|NCT00445679|453245568|FG002|Overall Study|Compliance|1|||
125987649|NCT00445679|453245569|FG003|Overall Study|Compliance|2|||
125987650|NCT00445679|453245566|FG000|Overall Study|Withdrawal of Informed Consent|0|||
125987651|NCT00445679|453245567|FG001|Overall Study|Withdrawal of Informed Consent|0|||
125987652|NCT00445679|453245568|FG002|Overall Study|Withdrawal of Informed Consent|1|||
125987653|NCT00445679|453245569|FG003|Overall Study|Withdrawal of Informed Consent|0|||
125987654|NCT00445679|453245566|FG000|Overall Study|Protocol Violation|2|||
125987655|NCT00445679|453245567|FG001|Overall Study|Protocol Violation|3|||
125987656|NCT00445679|453245568|FG002|Overall Study|Protocol Violation|3|||
125987657|NCT00445679|453245569|FG003|Overall Study|Protocol Violation|1|||
125987658|NCT00445679|453245566|FG000|Overall Study|Withdrawal by Subject|8|||
125987659|NCT00445679|453245567|FG001|Overall Study|Withdrawal by Subject|14|||
125987660|NCT00445679|453245568|FG002|Overall Study|Withdrawal by Subject|20|||
125987661|NCT00445679|453245569|FG003|Overall Study|Withdrawal by Subject|18|||
125987662|NCT00445679|453245566|FG000|Overall Study|Lack of Efficacy|2|||
125987663|NCT00445679|453245567|FG001|Overall Study|Lack of Efficacy|6|||
125987664|NCT00445679|453245568|FG002|Overall Study|Lack of Efficacy|2|||
125987665|NCT00445679|453245569|FG003|Overall Study|Lack of Efficacy|0|||
125987666|NCT01353222|453245571|FG000|Overall Study|Death|30|||
125987667|NCT01353222|453245572|FG001|Overall Study|Death|30|||
125987668|NCT01353222|453245571|FG000|Overall Study|Withdrawal by Subject|8|||
125987669|NCT01353222|453245572|FG001|Overall Study|Withdrawal by Subject|5|||
125987670|NCT01353222|453245571|FG000|Overall Study|Study Terminated|31|||
125987671|NCT01353222|453245572|FG001|Overall Study|Study Terminated|37|||
125987672|NCT01353222|453245571|FG000|Overall Study|Site closed research department|1|||
125987673|NCT01353222|453245572|FG001|Overall Study|Site closed research department|0|||
125987674|NCT01654601|453245573|FG000|1st Administration|Withdrawal by Subject|2|||
125987675|NCT01654601|453245574|FG001|1st Administration|Withdrawal by Subject|0|||
125987676|NCT01654601|453245573|FG000|1st Administration|Protocol Violation|0|||
125987677|NCT01654601|453245574|FG001|1st Administration|Protocol Violation|2|||
125987678|NCT01654601|453245573|FG000|2nd Administration|Adverse Event|1|||
125987679|NCT01654601|453245574|FG001|2nd Administration|Adverse Event|0|||
125987680|NCT01654601|453245573|FG000|2nd Administration|Protocol Violation|0|||
125987681|NCT01654601|453245574|FG001|2nd Administration|Protocol Violation|1|||
125987682|NCT02636270|453245575|FG000|Overall Study|Adverse Event|1|||
125987683|NCT02636270|453245576|FG001|Overall Study|Adverse Event|0|||
125987684|NCT02636270|453245577|FG002|Overall Study|Adverse Event|0|||
125987685|NCT02636270|453245575|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
125987686|NCT02636270|453245576|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
125987687|NCT02636270|453245577|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
125987688|NCT01119898|453245578|FG000|Overall Study|Adverse Event|4|||
125987689|NCT01119898|453245579|FG001|Overall Study|Adverse Event|5|||
125987690|NCT01119898|453245578|FG000|Overall Study|Withdrawal by Subject|1|||
125987691|NCT01119898|453245579|FG001|Overall Study|Withdrawal by Subject|4|||
125987692|NCT01119898|453245578|FG000|Overall Study|Lack of Efficacy|0|||
125987693|NCT01119898|453245579|FG001|Overall Study|Lack of Efficacy|2|||
125987694|NCT01119898|453245578|FG000|Overall Study|Protocol Violation|1|||
125987695|NCT01119898|453245579|FG001|Overall Study|Protocol Violation|1|||
125987696|NCT01119898|453245578|FG000|Overall Study|Medical procedure|1|||
125987697|NCT01119898|453245579|FG001|Overall Study|Medical procedure|0|||
125987698|NCT01119898|453245578|FG000|Overall Study|Randomized in error did not participate|1|||
125987699|NCT01119898|453245579|FG001|Overall Study|Randomized in error did not participate|0|||
125987700|NCT01806584|453245580|FG000|Overall Study|Adverse Event|2|||
125987701|NCT01806584|453245581|FG001|Overall Study|Adverse Event|1|||
125987702|NCT01806584|453245580|FG000|Overall Study|Death|1|||
125987703|NCT01806584|453245581|FG001|Overall Study|Death|0|||
125987704|NCT01806584|453245580|FG000|Overall Study|Lost to Follow-up|0|||
125987705|NCT01806584|453245581|FG001|Overall Study|Lost to Follow-up|2|||
125987706|NCT01806584|453245580|FG000|Overall Study|Study terminated by sponsor|9|||
125987707|NCT01806584|453245581|FG001|Overall Study|Study terminated by sponsor|14|||
125987708|NCT01806584|453245580|FG000|Overall Study|Withdrawal by Subject|1|||
125987709|NCT01806584|453245581|FG001|Overall Study|Withdrawal by Subject|1|||
125987710|NCT01806584|453245580|FG000|Overall Study|Other unspecified|1|||
125987711|NCT01806584|453245581|FG001|Overall Study|Other unspecified|0|||
125987712|NCT04398537|453245582|FG000|Overall Study|Physician Decision|10|||
125987713|NCT04398537|453245583|FG001|Overall Study|Physician Decision|15|||
125987714|NCT02396537|453247250|FG000|Overall Study|Protocol Violation|0|||
125987715|NCT02396537|453247251|FG001|Overall Study|Protocol Violation|1|||
125987716|NCT02312856|453247252|FG000|Overall Study|Death|1|||
125987717|NCT02312856|453247252|FG000|Overall Study|Lost to Follow-up|3|||
125987718|NCT04415151|453247253|FG000|Overall Study|Death|1|||
125987719|NCT04415151|453247254|FG001|Overall Study|Death|1|||
125987720|NCT04415151|453247253|FG000|Overall Study|Withdrawal by Subject|1|||
125987721|NCT04415151|453247254|FG001|Overall Study|Withdrawal by Subject|0|||
125987722|NCT03505476|453247260|FG000|Overall Study|Physician Decision|18|||
125987723|NCT03505476|453247260|FG000|Overall Study|Device Malfunctioned|101|||
126209294|NCT05182840|454053175|FG002|Treatment Period|Change of residence|0|||
126209295|NCT05182840|454053176|FG003|Treatment Period|Change of residence|0|||
125987724|NCT03505476|453247260|FG000|Overall Study|Data Corrupt|6|||
125987725|NCT03505476|453247260|FG000|Overall Study|Device application insufficiant|3|||
125987726|NCT03075904|453247261|FG000|Overall Study|Physician Decision|3|||
125987727|NCT03075904|453247261|FG000|Overall Study|Need for Medication not Permitted|1|||
125987728|NCT00539643|453247262|FG000|Overall Study|Adverse Event|1|||
125987729|NCT00539643|453247263|FG001|Overall Study|Adverse Event|0|||
125987730|NCT00539643|453247262|FG000|Overall Study|Death|2|||
125987731|NCT00539643|453247263|FG001|Overall Study|Death|1|||
125987732|NCT00539643|453247262|FG000|Overall Study|Physician Decision|3|||
125987733|NCT00539643|453247263|FG001|Overall Study|Physician Decision|1|||
125987734|NCT00539643|453247262|FG000|Overall Study|Withdrawal by Subject|0|||
125987735|NCT00539643|453247263|FG001|Overall Study|Withdrawal by Subject|1|||
125987736|NCT01576367|453247266|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125987737|NCT01576367|453247266|FG000|Overall Study|Moved to commercial use after 6 months|1|||
125987738|NCT01453348|453247267|FG000|Overall Study|Death|0|||
125987739|NCT01453348|453247268|FG001|Overall Study|Death|0|||
125987740|NCT01453348|453247269|FG002|Overall Study|Death|1|||
125987741|NCT01453348|453247267|FG000|Overall Study|Withdrawal by Subject|0|||
125987742|NCT01453348|453247268|FG001|Overall Study|Withdrawal by Subject|1|||
125987743|NCT01453348|453247269|FG002|Overall Study|Withdrawal by Subject|0|||
125987744|NCT01453348|453247267|FG000|Overall Study|Protocol Violation|1|||
125987745|NCT01453348|453247268|FG001|Overall Study|Protocol Violation|0|||
125987746|NCT01453348|453247269|FG002|Overall Study|Protocol Violation|0|||
125987747|NCT04359771|453247271|FG000|Overall Study|Lack of Efficacy|2|||
125987748|NCT04359771|453247272|FG001|Overall Study|Lack of Efficacy|2|||
125987749|NCT00954733|453247273|FG000|Overall Study|blood gas machine did not work|1|||
125987750|NCT03592277|453247274|FG000|Overall Study|Withdrawal by Subject|6|||
125987751|NCT03592277|453247275|FG001|Overall Study|Withdrawal by Subject|8|||
125987752|NCT00622713|453247276|FG000|Overall Study|Adverse Event|35|||
125987753|NCT00622713|453247276|FG000|Overall Study|Administrative problems|4|||
125987754|NCT00622713|453247276|FG000|Overall Study|Withdrawal by Subject|11|||
125987755|NCT00622713|453247276|FG000|Overall Study|Lost to Follow-up|5|||
125987756|NCT00622713|453247276|FG000|Overall Study|Death|2|||
125987757|NCT00622713|453247276|FG000|Overall Study|Subject no longer required study drug|1|||
125987758|NCT00622713|453247276|FG000|Overall Study|Did not meet eligibility criteria|1|||
125987759|NCT01462162|453247277|FG000|Overall Study|Adverse Event|5|||
125987760|NCT01462162|453247277|FG000|Overall Study|Lack of Efficacy|4|||
125987761|NCT01462162|453247277|FG000|Overall Study|Abnormal laboratory parameters|1|||
125987762|NCT01462162|453247277|FG000|Overall Study|Other|2|||
125987763|NCT03485911|453247278|FG000|Part 1|Perceived lack of efficacy|1|||
125987764|NCT03485911|453247279|FG001|Part 1|Perceived lack of efficacy|1|||
125987765|NCT03485911|453247280|FG002|Part 1|Perceived lack of efficacy|2|||
125987766|NCT03485911|453247281|FG003|Part 1|Perceived lack of efficacy|0|||
125987767|NCT03485911|453247278|FG000|Part 1|Subject withdrew consent|0|||
125987768|NCT03485911|453247279|FG001|Part 1|Subject withdrew consent|1|||
125987769|NCT03485911|453247280|FG002|Part 1|Subject withdrew consent|0|||
125987770|NCT03485911|453247281|FG003|Part 1|Subject withdrew consent|1|||
125987771|NCT03485911|453247278|FG000|Part 1|Lab abnormalities/AEs|3|||
125987772|NCT03485911|453247279|FG001|Part 1|Lab abnormalities/AEs|1|||
125987773|NCT03485911|453247280|FG002|Part 1|Lab abnormalities/AEs|1|||
125987774|NCT03485911|453247281|FG003|Part 1|Lab abnormalities/AEs|0|||
125987775|NCT03485911|453247278|FG000|Part 1|Withdrew Consent prior to dosing|0|||
125987776|NCT03485911|453247279|FG001|Part 1|Withdrew Consent prior to dosing|0|||
125987777|NCT03485911|453247280|FG002|Part 1|Withdrew Consent prior to dosing|0|||
125987778|NCT03485911|453247281|FG003|Part 1|Withdrew Consent prior to dosing|1|||
125987779|NCT03485911|453247278|FG000|Part 1|Other NOS|0|||
125987780|NCT03485911|453247279|FG001|Part 1|Other NOS|0|||
125987781|NCT03485911|453247280|FG002|Part 1|Other NOS|0|||
125987782|NCT03485911|453247281|FG003|Part 1|Other NOS|1|||
125987783|NCT03485911|453247278|FG000|Part 2|Perceived lack of efficacy|5|||
125987784|NCT03485911|453247279|FG001|Part 2|Perceived lack of efficacy|3|||
125987785|NCT03485911|453247280|FG002|Part 2|Perceived lack of efficacy|0|||
125987786|NCT03485911|453247281|FG003|Part 2|Perceived lack of efficacy|2|||
125987787|NCT03485911|453247278|FG000|Part 2|Subject withdrew consent|1|||
125987788|NCT03485911|453247279|FG001|Part 2|Subject withdrew consent|0|||
125987789|NCT03485911|453247280|FG002|Part 2|Subject withdrew consent|2|||
125987790|NCT03485911|453247281|FG003|Part 2|Subject withdrew consent|1|||
125987791|NCT03485911|453247278|FG000|Part 2|Lab abnormalities/AEs|1|||
125987792|NCT03485911|453247279|FG001|Part 2|Lab abnormalities/AEs|2|||
125987793|NCT03485911|453247280|FG002|Part 2|Lab abnormalities/AEs|0|||
125987794|NCT03485911|453247281|FG003|Part 2|Lab abnormalities/AEs|0|||
125987795|NCT03485911|453247278|FG000|Part 2|Other NOS|0|||
125987796|NCT03485911|453247279|FG001|Part 2|Other NOS|1|||
125987797|NCT03485911|453247280|FG002|Part 2|Other NOS|0|||
125987798|NCT03485911|453247281|FG003|Part 2|Other NOS|0|||
125987799|NCT03485911|453247278|FG000|Part 2|Intercurrent illness/new medical condition|1|||
125987800|NCT03485911|453247279|FG001|Part 2|Intercurrent illness/new medical condition|0|||
125987801|NCT03485911|453247280|FG002|Part 2|Intercurrent illness/new medical condition|0|||
125987802|NCT03485911|453247281|FG003|Part 2|Intercurrent illness/new medical condition|0|||
125987803|NCT03485911|453247278|FG000|Part 2|Investigator judgement|1|||
125987804|NCT03485911|453247279|FG001|Part 2|Investigator judgement|0|||
125987805|NCT03485911|453247280|FG002|Part 2|Investigator judgement|0|||
125987806|NCT03485911|453247281|FG003|Part 2|Investigator judgement|0|||
125987807|NCT03485911|453247278|FG000|Part 3|Perceived lack of efficacy|2|||
125987808|NCT03485911|453247279|FG001|Part 3|Perceived lack of efficacy|2|||
125987809|NCT03485911|453247280|FG002|Part 3|Perceived lack of efficacy|2|||
125987810|NCT03485911|453247281|FG003|Part 3|Perceived lack of efficacy|0|||
125987811|NCT03485911|453247278|FG000|Part 3|Subject withdrew consent|1|||
125987812|NCT03485911|453247279|FG001|Part 3|Subject withdrew consent|4|||
125987813|NCT03485911|453247280|FG002|Part 3|Subject withdrew consent|0|||
125987814|NCT03485911|453247281|FG003|Part 3|Subject withdrew consent|1|||
125987815|NCT03485911|453247278|FG000|Part 3|Lab abnormalities/AEs|1|||
125987816|NCT03485911|453247279|FG001|Part 3|Lab abnormalities/AEs|1|||
125987817|NCT03485911|453247280|FG002|Part 3|Lab abnormalities/AEs|0|||
125987818|NCT03485911|453247281|FG003|Part 3|Lab abnormalities/AEs|2|||
125987819|NCT03485911|453247278|FG000|Part 3|Other NOS|1|||
125987820|NCT03485911|453247279|FG001|Part 3|Other NOS|1|||
125987821|NCT03485911|453247280|FG002|Part 3|Other NOS|0|||
125987822|NCT03485911|453247281|FG003|Part 3|Other NOS|0|||
125987823|NCT03485911|453247278|FG000|Part 3|Intercurrent illness/new medical condition|0|||
125987824|NCT03485911|453247279|FG001|Part 3|Intercurrent illness/new medical condition|1|||
125987825|NCT03485911|453247280|FG002|Part 3|Intercurrent illness/new medical condition|1|||
125987826|NCT03485911|453247281|FG003|Part 3|Intercurrent illness/new medical condition|0|||
125987827|NCT03485911|453247278|FG000|Part 3|Sponsor discontinuation|1|||
125987828|NCT03485911|453247279|FG001|Part 3|Sponsor discontinuation|0|||
125987829|NCT03485911|453247280|FG002|Part 3|Sponsor discontinuation|0|||
125987830|NCT03485911|453247281|FG003|Part 3|Sponsor discontinuation|0|||
125987831|NCT03485911|453247278|FG000|Part 3|Berotralstat provided by alternative means|13|||
125987832|NCT03485911|453247279|FG001|Part 3|Berotralstat provided by alternative means|13|||
125987833|NCT03485911|453247280|FG002|Part 3|Berotralstat provided by alternative means|7|||
125987834|NCT03485911|453247281|FG003|Part 3|Berotralstat provided by alternative means|7|||
125987835|NCT01215357|453247285|FG000|Overall Study|Withdrawal by Subject|3|||
125987836|NCT01215357|453247285|FG000|Overall Study|Protocol Violation|9|||
125987837|NCT00909480|453247286|FG000|Overall Study|Adverse Event|5|||
125987838|NCT00909480|453247287|FG001|Overall Study|Adverse Event|3|||
125987839|NCT00909480|453247286|FG000|Overall Study|Protocol Violation|6|||
125987840|NCT00909480|453247287|FG001|Overall Study|Protocol Violation|8|||
125987841|NCT00909480|453247286|FG000|Overall Study|Withdrawal criteria|9|||
125987842|NCT00909480|453247287|FG001|Overall Study|Withdrawal criteria|11|||
125987843|NCT00909480|453247286|FG000|Overall Study|Unclassified|18|||
125987844|NCT00909480|453247287|FG001|Overall Study|Unclassified|19|||
125987845|NCT03528174|453247288|FG000|Overall Study|Adverse Event|1|||
125987846|NCT03528174|453247288|FG000|Overall Study|sensors dislodged|1|||
125987847|NCT04146896|453247296|FG000|Overall Study|Adverse Event|5|||
125987848|NCT04146896|453247297|FG001|Overall Study|Adverse Event|8|||
125987849|NCT04146896|453247296|FG000|Overall Study|Lack of Efficacy|3|||
125987850|NCT04146896|453247297|FG001|Overall Study|Lack of Efficacy|2|||
125987851|NCT04146896|453247296|FG000|Overall Study|Lost to Follow-up|0|||
125987852|NCT04146896|453247297|FG001|Overall Study|Lost to Follow-up|1|||
125987853|NCT04146896|453247296|FG000|Overall Study|Non-compliance|5|||
125987854|NCT04146896|453247297|FG001|Overall Study|Non-compliance|4|||
125987855|NCT04146896|453247296|FG000|Overall Study|Withdrawal by Subject|3|||
125987856|NCT04146896|453247297|FG001|Overall Study|Withdrawal by Subject|5|||
125987857|NCT04146896|453247296|FG000|Overall Study|Randomized in error|1|||
125987858|NCT04146896|453247297|FG001|Overall Study|Randomized in error|2|||
125987859|NCT02118337|453247298|FG000|Overall Study|Other|1|||
125987860|NCT02118337|453247299|FG001|Overall Study|Other|0|||
125987861|NCT02118337|453247300|FG002|Overall Study|Other|0|||
125987862|NCT02118337|453247301|FG003|Overall Study|Other|0|||
125987863|NCT02118337|453247302|FG004|Overall Study|Other|2|||
125987864|NCT02118337|453247303|FG005|Overall Study|Other|3|||
125987865|NCT02118337|453247304|FG006|Overall Study|Other|1|||
125987866|NCT02118337|453247305|FG007|Overall Study|Other|28|||
125987867|NCT02118337|453247306|FG008|Overall Study|Other|15|||
125987868|NCT02118337|453247298|FG000|Overall Study|Lost to Follow-up|0|||
125987869|NCT02118337|453247299|FG001|Overall Study|Lost to Follow-up|0|||
125987870|NCT02118337|453247300|FG002|Overall Study|Lost to Follow-up|0|||
125987871|NCT02118337|453247301|FG003|Overall Study|Lost to Follow-up|0|||
125987872|NCT02118337|453247302|FG004|Overall Study|Lost to Follow-up|0|||
125987873|NCT02118337|453247303|FG005|Overall Study|Lost to Follow-up|0|||
125987874|NCT02118337|453247304|FG006|Overall Study|Lost to Follow-up|0|||
125987875|NCT02118337|453247305|FG007|Overall Study|Lost to Follow-up|1|||
125987876|NCT02118337|453247306|FG008|Overall Study|Lost to Follow-up|0|||
125987877|NCT02118337|453247298|FG000|Overall Study|Withdrawal by Subject|1|||
125987878|NCT02118337|453247299|FG001|Overall Study|Withdrawal by Subject|3|||
125987879|NCT02118337|453247300|FG002|Overall Study|Withdrawal by Subject|2|||
125987880|NCT02118337|453247301|FG003|Overall Study|Withdrawal by Subject|1|||
125987881|NCT02118337|453247302|FG004|Overall Study|Withdrawal by Subject|2|||
125987882|NCT02118337|453247303|FG005|Overall Study|Withdrawal by Subject|2|||
125987883|NCT02118337|453247304|FG006|Overall Study|Withdrawal by Subject|1|||
125987884|NCT02118337|453247305|FG007|Overall Study|Withdrawal by Subject|4|||
125987885|NCT02118337|453247306|FG008|Overall Study|Withdrawal by Subject|2|||
125987886|NCT02118337|453247298|FG000|Overall Study|Death|2|||
125987887|NCT02118337|453247299|FG001|Overall Study|Death|2|||
125987888|NCT02118337|453247300|FG002|Overall Study|Death|1|||
125987889|NCT02118337|453247301|FG003|Overall Study|Death|2|||
126329948|NCT02080364|454501754|FG001|Treatment Period|Protocol Violation|3|||
126329949|NCT02080364|454501755|FG002|Treatment Period|Protocol Violation|5|||
126329950|NCT02080364|454501756|FG003|Treatment Period|Protocol Violation|1|||
126329951|NCT02080364|454501753|FG000|Treatment Period|Withdrawal by Subject|16|||
126329952|NCT02080364|454501754|FG001|Treatment Period|Withdrawal by Subject|16|||
126329953|NCT02080364|454501755|FG002|Treatment Period|Withdrawal by Subject|15|||
126329954|NCT02080364|454501756|FG003|Treatment Period|Withdrawal by Subject|10|||
126329955|NCT02080364|454501753|FG000|Treatment Period|Study Terminated by Sponsor|0|||
126329956|NCT02080364|454501754|FG001|Treatment Period|Study Terminated by Sponsor|0|||
126329957|NCT02080364|454501755|FG002|Treatment Period|Study Terminated by Sponsor|180|||
126329958|NCT02080364|454501756|FG003|Treatment Period|Study Terminated by Sponsor|183|||
126329959|NCT02080364|454501753|FG000|Treatment Period|Other|14|||
126329960|NCT02080364|454501754|FG001|Treatment Period|Other|12|||
126329961|NCT02080364|454501755|FG002|Treatment Period|Other|21|||
126329962|NCT02080364|454501756|FG003|Treatment Period|Other|16|||
126329963|NCT02504320|454501757|FG000|Treatment Period 1|Positive Drug Screen|0|||
126329964|NCT02504320|454501758|FG001|Treatment Period 1|Positive Drug Screen|0|||
126329965|NCT02504320|454501759|FG002|Treatment Period 1|Positive Drug Screen|1|||
126329966|NCT02504320|454501760|FG003|Treatment Period 1|Positive Drug Screen|0|||
126329967|NCT02504320|454501757|FG000|Treatment Period 2|Positive Drug Screen|0|||
126329968|NCT02504320|454501758|FG001|Treatment Period 2|Positive Drug Screen|1|||
126329969|NCT02504320|454501759|FG002|Treatment Period 2|Positive Drug Screen|0|||
125987890|NCT02118337|453247302|FG004|Overall Study|Death|5|||
125987891|NCT02118337|453247303|FG005|Overall Study|Death|1|||
125987892|NCT02118337|453247304|FG006|Overall Study|Death|2|||
125987893|NCT02118337|453247305|FG007|Overall Study|Death|9|||
125987894|NCT02118337|453247306|FG008|Overall Study|Death|4|||
125987895|NCT00717314|453247312|FG000|Overall Study|Adverse Event|3|||
125987896|NCT00717314|453247313|FG001|Overall Study|Adverse Event|2|||
125987897|NCT00717314|453247312|FG000|Overall Study|Protocol Violation|1|||
125987898|NCT00717314|453247313|FG001|Overall Study|Protocol Violation|0|||
125987899|NCT00717314|453247312|FG000|Overall Study|Lost to Follow-up|1|||
125987900|NCT00717314|453247313|FG001|Overall Study|Lost to Follow-up|5|||
125987901|NCT00717314|453247312|FG000|Overall Study|Withdrawal by Subject|1|||
125987902|NCT00717314|453247313|FG001|Overall Study|Withdrawal by Subject|3|||
125987903|NCT00117156|453247315|FG000|Overall Study|Adverse Event|9|||
125987904|NCT00117156|453247315|FG000|Overall Study|Physician Decision|1|||
125987905|NCT00117156|453247315|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
125987906|NCT01919970|453247316|FG000|Overall Study|Withdrawal by Subject|3|||
125987907|NCT01919970|453247317|FG001|Overall Study|Withdrawal by Subject|0|||
125987908|NCT04043962|453247318|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
125987909|NCT04043962|453247318|FG000|Post-Treatment|Withdrawal by Subject|5|||
125987910|NCT04043962|453247318|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
125987911|NCT01126060|453247319|FG000|Overall Study|Protocol Violation|0|||
125987912|NCT01126060|453247320|FG001|Overall Study|Protocol Violation|2|||
125987913|NCT01521884|453247322|FG000|Overall Study|Non Responders|10|||
125987914|NCT01521884|453247322|FG000|Overall Study|Adverse Event|5|||
125987915|NCT01521884|453247322|FG000|Overall Study|Pregnancy|1|||
125987916|NCT01521884|453247322|FG000|Overall Study|Withdrawal by Subject|1|||
125987917|NCT01521884|453247322|FG000|Overall Study|Physician Decision|2|||
125987918|NCT01521884|453247322|FG000|Overall Study|Protocol Violation|3|||
125987919|NCT01521884|453247322|FG000|Overall Study|Participant non-eligible|1|||
125987920|NCT01521884|453247322|FG000|Overall Study|Lost to Follow-up|4|||
125987921|NCT00909428|453247325|FG000|Overall Study|Lost to Follow-up|13|||
125987922|NCT00909428|453247326|FG001|Overall Study|Lost to Follow-up|10|||
125987923|NCT00909428|453247327|FG002|Overall Study|Lost to Follow-up|9|||
125987924|NCT03021668|453247328|FG000|Overall Study|Physician Decision|0|||
125987925|NCT03021668|453247329|FG001|Overall Study|Physician Decision|1|||
125987926|NCT01122381|453247330|FG000|Overall Study|study terminated early|0|||
125987927|NCT01122381|453247331|FG001|Overall Study|study terminated early|1|||
125987928|NCT00736489|453247334|FG000|Period 1|Lost to Follow-up|1|||
125987929|NCT00736489|453247335|FG001|Period 1|Lost to Follow-up|0|||
125987930|NCT00736489|453247336|FG002|Period 1|Lost to Follow-up|0|||
125987931|NCT00736489|453247337|FG003|Period 1|Lost to Follow-up|0|||
125987932|NCT00736489|453247338|FG004|Period 1|Lost to Follow-up|0|||
126329970|NCT02504320|454501760|FG003|Treatment Period 2|Positive Drug Screen|0|||
126329971|NCT02504320|454501757|FG000|Treatment Period 3|Positive Drug Screen|0|||
126329972|NCT02504320|454501758|FG001|Treatment Period 3|Positive Drug Screen|0|||
125987933|NCT00736489|453247339|FG005|Period 1|Lost to Follow-up|0|||
125987934|NCT00736489|453247334|FG000|Period 1|Withdrawal by Subject|0|||
125987935|NCT00736489|453247335|FG001|Period 1|Withdrawal by Subject|0|||
125987936|NCT00736489|453247336|FG002|Period 1|Withdrawal by Subject|0|||
125987937|NCT00736489|453247337|FG003|Period 1|Withdrawal by Subject|0|||
125987938|NCT00736489|453247338|FG004|Period 1|Withdrawal by Subject|0|||
125987939|NCT00736489|453247339|FG005|Period 1|Withdrawal by Subject|1|||
125987940|NCT00116844|453247340|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
125987941|NCT00116844|453247341|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
126329973|NCT02504320|454501759|FG002|Treatment Period 3|Positive Drug Screen|0|||
125987942|NCT00116844|453247340|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
125987943|NCT00116844|453247341|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
125987944|NCT00116844|453247340|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
125987945|NCT00116844|453247341|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
125987946|NCT00116844|453247340|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
125987947|NCT00116844|453247341|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
125987948|NCT00116844|453247340|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
125987949|NCT00116844|453247341|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
125987950|NCT00116844|453247340|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
125987951|NCT00116844|453247341|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
125987952|NCT00116844|453247340|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
125987953|NCT00116844|453247341|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
125987954|NCT00116844|453247340|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
125987955|NCT00116844|453247341|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
125987956|NCT00116844|453247340|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
125987957|NCT00116844|453247341|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
125987958|NCT01933880|453247342|FG000|Overall Study|Withdrawal by Subject|5|||
125987959|NCT01933880|453247343|FG001|Overall Study|Withdrawal by Subject|0|||
125987960|NCT01933880|453247342|FG000|Overall Study|Lack of Efficacy|1|||
125987961|NCT01933880|453247343|FG001|Overall Study|Lack of Efficacy|0|||
125987962|NCT01933880|453247342|FG000|Overall Study|Concomitant medication Interference|0|||
125987963|NCT01933880|453247343|FG001|Overall Study|Concomitant medication Interference|1|||
125987964|NCT01933880|453247342|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
125987965|NCT01933880|453247343|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
125987966|NCT01933880|453247342|FG000|Overall Study|Other|4|||
125987967|NCT01933880|453247343|FG001|Overall Study|Other|0|||
125987968|NCT01933880|453247342|FG000|Overall Study|Protocol Violation|1|||
125987969|NCT01933880|453247343|FG001|Overall Study|Protocol Violation|0|||
125987970|NCT03474549|453247344|FG000|Overall Study|Death|31|||
125987971|NCT03474549|453247344|FG000|Overall Study|Lost to Follow-up|4|||
125987972|NCT03474549|453247344|FG000|Overall Study|Withdrawal by Subject|2|||
125987973|NCT00738101|453247348|FG000|Overall Study|Physician Decision|5|||
125987974|NCT00738101|453247348|FG000|Overall Study|Death|1|||
125987975|NCT00738101|453247348|FG000|Overall Study|Repeat enrollment|1|||
125987976|NCT03445065|453247355|FG000|Overall Study|Withdrawal by Subject|3|||
125987977|NCT03445065|453247356|FG001|Overall Study|Withdrawal by Subject|6|||
125987978|NCT03445065|453247357|FG002|Overall Study|Withdrawal by Subject|2|||
125987979|NCT03445065|453247358|FG003|Overall Study|Withdrawal by Subject|2|||
125987980|NCT03445065|453247355|FG000|Overall Study|Other|4|||
125987981|NCT03445065|453247356|FG001|Overall Study|Other|3|||
125987982|NCT03445065|453247357|FG002|Overall Study|Other|3|||
125987983|NCT03445065|453247358|FG003|Overall Study|Other|1|||
125987984|NCT03315130|453247359|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
125987985|NCT03315130|453247360|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
125987986|NCT03315130|453247361|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
125987987|NCT03315130|453247362|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
125987988|NCT03315130|453247359|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
125987989|NCT03315130|453247360|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
125987990|NCT03315130|453247361|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
125987991|NCT03315130|453247362|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
125987992|NCT03315130|453247359|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
125987993|NCT03315130|453247360|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
125987994|NCT03315130|453247361|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
125987995|NCT03315130|453247362|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
125987996|NCT03315130|453247359|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
125987997|NCT03315130|453247360|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
125987998|NCT03315130|453247361|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
125987999|NCT03315130|453247362|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
125988000|NCT03315130|453247359|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
125988001|NCT03315130|453247360|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
125988002|NCT03315130|453247361|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
126329974|NCT02504320|454501760|FG003|Treatment Period 3|Positive Drug Screen|1|||
126329975|NCT02504320|454501757|FG000|Treatment Period 3|Adverse Event|0|||
126329976|NCT02504320|454501758|FG001|Treatment Period 3|Adverse Event|0|||
125988003|NCT03315130|453247362|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
125988004|NCT03315130|453247359|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
125988005|NCT03315130|453247360|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
125988006|NCT03315130|453247361|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
125988007|NCT03315130|453247362|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
125988008|NCT03535337|453247371|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
125988009|NCT03535337|453247372|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
125988010|NCT03535337|453247373|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
125988011|NCT03535337|453247374|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
125988012|NCT03535337|453247375|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
125988013|NCT03535337|453247376|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
125988014|NCT03535337|453247377|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
125988015|NCT03535337|453247378|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
125988016|NCT03535337|453247379|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
125988017|NCT03535337|453247380|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
125988018|NCT02089230|453247381|FG000|Overall Study|Death|0|||
125988019|NCT02089230|453247382|FG001|Overall Study|Death|0|||
125988020|NCT02089230|453247383|FG002|Overall Study|Death|2|||
125988021|NCT02089230|453247381|FG000|Overall Study|Seeking Alternative Therapy|0|||
125988022|NCT02089230|453247382|FG001|Overall Study|Seeking Alternative Therapy|0|||
125988023|NCT02089230|453247383|FG002|Overall Study|Seeking Alternative Therapy|4|||
125988024|NCT02272725|453247384|FG000|Overall Study|equipment malfunction|2|||
125988025|NCT02272725|453247385|FG001|Overall Study|equipment malfunction|0|||
125988026|NCT00976703|453248994|FG000|Overall Study|Physician Decision|1|||
125988027|NCT00976703|453248995|FG001|Overall Study|Physician Decision|1|||
125988028|NCT00976703|453248994|FG000|Overall Study|ineligible for study|2|||
125988029|NCT00976703|453248995|FG001|Overall Study|ineligible for study|2|||
125988030|NCT02202434|453248996|FG000|Overall Study|Death|70|||
125988031|NCT02202434|453248997|FG001|Overall Study|Death|39|||
125988032|NCT02202434|453248998|FG002|Overall Study|Death|13|||
125988033|NCT02202434|453248999|FG003|Overall Study|Death|27|||
125988034|NCT02202434|453248996|FG000|Overall Study|Lost to Follow-up|1|||
125988035|NCT02202434|453248997|FG001|Overall Study|Lost to Follow-up|1|||
125988036|NCT02202434|453248998|FG002|Overall Study|Lost to Follow-up|1|||
125988037|NCT02202434|453248999|FG003|Overall Study|Lost to Follow-up|0|||
125988038|NCT02202434|453248996|FG000|Overall Study|Physician Decision|2|||
125988039|NCT02202434|453248997|FG001|Overall Study|Physician Decision|3|||
125988040|NCT02202434|453248998|FG002|Overall Study|Physician Decision|0|||
125988041|NCT02202434|453248999|FG003|Overall Study|Physician Decision|0|||
125988042|NCT02202434|453248996|FG000|Overall Study|Withdrawal by Subject|13|||
125988043|NCT02202434|453248997|FG001|Overall Study|Withdrawal by Subject|14|||
125988044|NCT02202434|453248998|FG002|Overall Study|Withdrawal by Subject|1|||
125988045|NCT02202434|453248999|FG003|Overall Study|Withdrawal by Subject|4|||
125988046|NCT02202434|453248996|FG000|Overall Study|Completed Study|1|||
125988047|NCT02202434|453248997|FG001|Overall Study|Completed Study|0|||
125988048|NCT02202434|453248998|FG002|Overall Study|Completed Study|0|||
125988049|NCT02202434|453248999|FG003|Overall Study|Completed Study|0|||
125988050|NCT02202434|453248996|FG000|Overall Study|Visit Missed|21|||
125988051|NCT02202434|453248997|FG001|Overall Study|Visit Missed|12|||
125988052|NCT02202434|453248998|FG002|Overall Study|Visit Missed|0|||
125988053|NCT02202434|453248999|FG003|Overall Study|Visit Missed|5|||
125988054|NCT02202434|453248996|FG000|Overall Study|Other|1|||
125988055|NCT02202434|453248997|FG001|Overall Study|Other|0|||
125988056|NCT02202434|453248998|FG002|Overall Study|Other|0|||
125988057|NCT02202434|453248999|FG003|Overall Study|Other|1|||
125988058|NCT03075501|453249000|FG000|Overall Study|Scheduling difficulties|15|||
125988059|NCT03075501|453249001|FG001|Overall Study|Scheduling difficulties|9|||
125988060|NCT01062763|453249005|FG000|Overall Study|Adverse Event|3|||
125988061|NCT01062763|453249006|FG001|Overall Study|Adverse Event|4|||
125988062|NCT02494921|453249007|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
125988063|NCT02494921|453249008|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
125988064|NCT02494921|453249009|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
125988065|NCT02494921|453249010|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
125988066|NCT02494921|453249011|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
125988067|NCT02494921|453249007|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
126329977|NCT02504320|454501759|FG002|Treatment Period 3|Adverse Event|1|||
126329978|NCT02504320|454501760|FG003|Treatment Period 3|Adverse Event|0|||
126329979|NCT01210222|454501761|FG000|Overall Study|Ineligible|2|||
126329980|NCT01210222|454501761|FG000|Overall Study|Never treated|1|||
126329981|NCT00941304|454501762|FG000|Overall Study|Lost to Follow-up|1|||
126329982|NCT00941304|454501763|FG001|Overall Study|Lost to Follow-up|0|||
126329983|NCT00941304|454501764|FG002|Overall Study|Lost to Follow-up|0|||
126329984|NCT00941304|454501765|FG003|Overall Study|Lost to Follow-up|0|||
126329985|NCT00941304|454501766|FG004|Overall Study|Lost to Follow-up|0|||
125988068|NCT02494921|453249008|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
125988069|NCT02494921|453249009|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
125988070|NCT02494921|453249010|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
125988071|NCT02494921|453249011|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
125988072|NCT02494921|453249007|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
125988073|NCT02494921|453249008|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
125988074|NCT02494921|453249009|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
125988075|NCT02494921|453249010|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
125988076|NCT02494921|453249011|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
125988077|NCT02714868|453249014|FG000|Overall Study|Withdrawal by Subject|3|||
126329986|NCT03293394|454501767|FG000|Follow-up (6 Months)|Adverse Event|4|||
126329987|NCT03293394|454501768|FG001|Follow-up (6 Months)|Adverse Event|2|||
126329988|NCT01408901|454501771|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
126329989|NCT01408901|454501772|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
126329990|NCT01408901|454501773|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
126329991|NCT01408901|454501774|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
126329992|NCT01408901|454501771|FG000|6-Week Follow-Up|Death|1|||
126329993|NCT01408901|454501772|FG001|6-Week Follow-Up|Death|0|||
126329994|NCT01408901|454501773|FG002|6-Week Follow-Up|Death|0|||
126329995|NCT01408901|454501774|FG003|6-Week Follow-Up|Death|0|||
126329996|NCT01408901|454501771|FG000|6-Week Follow-Up|Cancelled visit|0|||
126329997|NCT01408901|454501772|FG001|6-Week Follow-Up|Cancelled visit|1|||
125878505|NCT05138653|452851312|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878506|NCT05138653|452851313|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878507|NCT05138653|452851314|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878508|NCT05138653|452851315|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878509|NCT05138653|452851316|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878510|NCT05138653|452851317|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878511|NCT05138653|452851318|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878512|NCT05138653|452851319|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878513|NCT05138653|452851320|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878514|NCT05138653|452851321|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878515|NCT05138653|452851322|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878516|NCT05138653|452851323|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125878517|NCT05138653|452851324|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
125878518|NCT05138653|452851309|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878519|NCT05138653|452851310|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878520|NCT05138653|452851311|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878521|NCT05138653|452851312|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878522|NCT05138653|452851313|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878523|NCT05138653|452851314|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878524|NCT05138653|452851315|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878525|NCT05138653|452851316|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878526|NCT05138653|452851317|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878527|NCT05138653|452851318|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878528|NCT05138653|452851319|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878529|NCT05138653|452851320|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878530|NCT05138653|452851321|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878531|NCT05138653|452851322|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
125878532|NCT05138653|452851323|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878533|NCT05138653|452851324|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125878534|NCT04825574|452851325|FG000|Overall Study|Commercial treatment became available|1|||
125878535|NCT04825574|452851325|FG000|Overall Study|Disease progression|1|||
125878536|NCT04272242|452851326|FG000|Overall Study|Withdrawal by Subject|3|||
125878537|NCT04272242|452851326|FG000|Overall Study|Lost to Follow-up|1|||
125878538|NCT04272242|452851326|FG000|Overall Study|Adverse Event|1|||
125878539|NCT02702492|452851327|FG000|Overall Study|Disease progression|3|||
125878540|NCT02702492|452851328|FG001|Overall Study|Disease progression|3|||
125878541|NCT02702492|452851329|FG002|Overall Study|Disease progression|2|||
125878542|NCT02702492|452851330|FG003|Overall Study|Disease progression|4|||
125878543|NCT02702492|452851331|FG004|Overall Study|Disease progression|4|||
125878544|NCT02702492|452851332|FG005|Overall Study|Disease progression|1|||
125878545|NCT02702492|452851333|FG006|Overall Study|Disease progression|2|||
125878546|NCT02702492|452851334|FG007|Overall Study|Disease progression|8|||
125878547|NCT02702492|452851335|FG008|Overall Study|Disease progression|5|||
125878548|NCT02702492|452851336|FG009|Overall Study|Disease progression|1|||
125878549|NCT02702492|452851337|FG010|Overall Study|Disease progression|0|||
125878550|NCT02702492|452851338|FG011|Overall Study|Disease progression|3|||
125878551|NCT02702492|452851339|FG012|Overall Study|Disease progression|2|||
125878552|NCT02702492|452851327|FG000|Overall Study|Clinical progression|0|||
125878553|NCT02702492|452851328|FG001|Overall Study|Clinical progression|0|||
125878554|NCT02702492|452851329|FG002|Overall Study|Clinical progression|2|||
125878555|NCT02702492|452851330|FG003|Overall Study|Clinical progression|1|||
125878556|NCT02702492|452851331|FG004|Overall Study|Clinical progression|0|||
125878557|NCT02702492|452851332|FG005|Overall Study|Clinical progression|2|||
125878558|NCT02702492|452851333|FG006|Overall Study|Clinical progression|1|||
125878559|NCT02702492|452851334|FG007|Overall Study|Clinical progression|4|||
125878560|NCT02702492|452851335|FG008|Overall Study|Clinical progression|0|||
125878561|NCT02702492|452851336|FG009|Overall Study|Clinical progression|0|||
125878562|NCT02702492|452851337|FG010|Overall Study|Clinical progression|1|||
125878563|NCT02702492|452851338|FG011|Overall Study|Clinical progression|2|||
125878564|NCT02702492|452851339|FG012|Overall Study|Clinical progression|0|||
126329998|NCT01408901|454501773|FG002|6-Week Follow-Up|Cancelled visit|0|||
125988078|NCT02714868|453249015|FG001|Overall Study|Withdrawal by Subject|0|||
125988079|NCT02714868|453249014|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
125988080|NCT02714868|453249015|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
125988081|NCT02714868|453249014|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
125988082|NCT02714868|453249015|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
125988083|NCT00369681|453249016|FG000|Overall Study|Death|1|||
125988084|NCT02948959|453249021|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
125988085|NCT02948959|453249022|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
125988086|NCT02948959|453249021|FG000|52 Weeks Treatment Period|Adverse Event|2|||
125988087|NCT02948959|453249022|FG001|52 Weeks Treatment Period|Adverse Event|5|||
125988088|NCT02948959|453249021|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
125988089|NCT02948959|453249022|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
125988090|NCT02948959|453249021|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
125988091|NCT02948959|453249022|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
125988092|NCT02948959|453249021|FG000|52 Weeks Treatment Period|Randomized by error|0|||
125988093|NCT02948959|453249022|FG001|52 Weeks Treatment Period|Randomized by error|5|||
125988094|NCT02948959|453249021|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
125988095|NCT02948959|453249022|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
125988096|NCT02948959|453249021|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
125988097|NCT02948959|453249022|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
125988098|NCT02948959|453249021|FG000|52 Weeks Treatment Period|Change of residence location|0|||
125988099|NCT02948959|453249022|FG001|52 Weeks Treatment Period|Change of residence location|1|||
125988100|NCT02948959|453249021|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
125988101|NCT02948959|453249022|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
125988102|NCT02948959|453249021|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
125988103|NCT02948959|453249022|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
125988104|NCT02948959|453249021|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
125988105|NCT02948959|453249022|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
125988106|NCT02948959|453249021|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
125988107|NCT02948959|453249022|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
125988108|NCT02948959|453249021|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
125988109|NCT02948959|453249022|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
125988110|NCT02948959|453249021|FG000|12 Weeks Follow-up Period|Study site closure|1|||
125988111|NCT02948959|453249022|FG001|12 Weeks Follow-up Period|Study site closure|0|||
125988112|NCT02508532|453249027|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125988113|NCT02508532|453249028|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125988114|NCT02508532|453249029|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125988115|NCT02508532|453249030|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125988116|NCT02508532|453249031|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125988117|NCT02508532|453249032|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125988118|NCT02508532|453249033|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
125988119|NCT02508532|453249034|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125988120|NCT02508532|453249035|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125988121|NCT02508532|453249027|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
125988122|NCT02508532|453249028|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
125988123|NCT02508532|453249029|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
125988124|NCT02508532|453249030|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
125988125|NCT02508532|453249031|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
125988126|NCT02508532|453249032|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
125988127|NCT02508532|453249033|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
125988128|NCT02508532|453249034|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
125988129|NCT02508532|453249035|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
125988130|NCT02508532|453249027|FG000|Part 2 - Treatment|Disease Progression|0|||
125988131|NCT02508532|453249028|FG001|Part 2 - Treatment|Disease Progression|0|||
125988132|NCT02508532|453249029|FG002|Part 2 - Treatment|Disease Progression|0|||
125988133|NCT02508532|453249030|FG003|Part 2 - Treatment|Disease Progression|0|||
125988134|NCT02508532|453249031|FG004|Part 2 - Treatment|Disease Progression|0|||
125988135|NCT02508532|453249032|FG005|Part 2 - Treatment|Disease Progression|0|||
125988136|NCT02508532|453249033|FG006|Part 2 - Treatment|Disease Progression|0|||
125988137|NCT02508532|453249034|FG007|Part 2 - Treatment|Disease Progression|0|||
125988138|NCT02508532|453249035|FG008|Part 2 - Treatment|Disease Progression|118|||
125988139|NCT02508532|453249027|FG000|Part 2 - Treatment|Adverse Event|0|||
125988140|NCT02508532|453249028|FG001|Part 2 - Treatment|Adverse Event|0|||
125988141|NCT02508532|453249029|FG002|Part 2 - Treatment|Adverse Event|0|||
125988142|NCT02508532|453249030|FG003|Part 2 - Treatment|Adverse Event|0|||
125988143|NCT02508532|453249031|FG004|Part 2 - Treatment|Adverse Event|0|||
125988144|NCT02508532|453249032|FG005|Part 2 - Treatment|Adverse Event|0|||
125988145|NCT02508532|453249033|FG006|Part 2 - Treatment|Adverse Event|0|||
125988146|NCT02508532|453249034|FG007|Part 2 - Treatment|Adverse Event|0|||
125988147|NCT02508532|453249035|FG008|Part 2 - Treatment|Adverse Event|49|||
125988148|NCT02508532|453249027|FG000|Part 2 - Treatment|Physician Decision|0|||
125988149|NCT02508532|453249028|FG001|Part 2 - Treatment|Physician Decision|0|||
125988150|NCT02508532|453249029|FG002|Part 2 - Treatment|Physician Decision|0|||
125988151|NCT02508532|453249030|FG003|Part 2 - Treatment|Physician Decision|0|||
125988152|NCT02508532|453249031|FG004|Part 2 - Treatment|Physician Decision|0|||
125988153|NCT02508532|453249032|FG005|Part 2 - Treatment|Physician Decision|0|||
125988154|NCT02508532|453249033|FG006|Part 2 - Treatment|Physician Decision|0|||
125988155|NCT02508532|453249034|FG007|Part 2 - Treatment|Physician Decision|0|||
125988156|NCT02508532|453249035|FG008|Part 2 - Treatment|Physician Decision|12|||
125988157|NCT02508532|453249027|FG000|Part 2 - Treatment|Administrative|0|||
125988158|NCT02508532|453249028|FG001|Part 2 - Treatment|Administrative|0|||
125988159|NCT02508532|453249029|FG002|Part 2 - Treatment|Administrative|0|||
125988160|NCT02508532|453249030|FG003|Part 2 - Treatment|Administrative|0|||
125988161|NCT02508532|453249031|FG004|Part 2 - Treatment|Administrative|0|||
125988162|NCT02508532|453249032|FG005|Part 2 - Treatment|Administrative|0|||
125988163|NCT02508532|453249033|FG006|Part 2 - Treatment|Administrative|0|||
125988164|NCT02508532|453249034|FG007|Part 2 - Treatment|Administrative|0|||
125988165|NCT02508532|453249035|FG008|Part 2 - Treatment|Administrative|3|||
125988166|NCT02508532|453249027|FG000|Part 2 - Treatment|Sponsor Decision|0|||
125988167|NCT02508532|453249028|FG001|Part 2 - Treatment|Sponsor Decision|0|||
125988168|NCT02508532|453249029|FG002|Part 2 - Treatment|Sponsor Decision|0|||
125988169|NCT02508532|453249030|FG003|Part 2 - Treatment|Sponsor Decision|0|||
125988170|NCT02508532|453249031|FG004|Part 2 - Treatment|Sponsor Decision|0|||
125988171|NCT02508532|453249032|FG005|Part 2 - Treatment|Sponsor Decision|0|||
125988172|NCT02508532|453249033|FG006|Part 2 - Treatment|Sponsor Decision|0|||
125988173|NCT02508532|453249034|FG007|Part 2 - Treatment|Sponsor Decision|0|||
125988174|NCT02508532|453249035|FG008|Part 2 - Treatment|Sponsor Decision|28|||
125988175|NCT02508532|453249027|FG000|Part 2 - Treatment|Death|0|||
125988176|NCT02508532|453249028|FG001|Part 2 - Treatment|Death|0|||
125988177|NCT02508532|453249029|FG002|Part 2 - Treatment|Death|0|||
125988178|NCT02508532|453249030|FG003|Part 2 - Treatment|Death|0|||
125988179|NCT02508532|453249031|FG004|Part 2 - Treatment|Death|0|||
125988180|NCT02508532|453249032|FG005|Part 2 - Treatment|Death|0|||
125988181|NCT02508532|453249033|FG006|Part 2 - Treatment|Death|0|||
125988182|NCT02508532|453249034|FG007|Part 2 - Treatment|Death|0|||
125988183|NCT02508532|453249035|FG008|Part 2 - Treatment|Death|1|||
125988184|NCT02508532|453249027|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
125988185|NCT02508532|453249028|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
125988186|NCT02508532|453249029|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
125988187|NCT02508532|453249030|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
125988188|NCT02508532|453249031|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
125988189|NCT02508532|453249032|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
125988190|NCT02508532|453249033|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
125988191|NCT02508532|453249034|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
125988192|NCT02508532|453249035|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
125988193|NCT02508532|453249027|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
125988194|NCT02508532|453249028|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
125988195|NCT02508532|453249029|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
125988196|NCT02508532|453249030|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
125988197|NCT02508532|453249031|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
125988198|NCT02508532|453249032|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
125988199|NCT02508532|453249033|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
125988200|NCT02508532|453249034|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
125988201|NCT02508532|453249035|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
125988202|NCT02508532|453249027|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
125988203|NCT02508532|453249028|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
125988204|NCT02508532|453249029|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
125988205|NCT02508532|453249030|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
125988206|NCT02508532|453249031|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
125988207|NCT02508532|453249032|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
125988208|NCT02508532|453249033|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
125988209|NCT02508532|453249034|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
125988210|NCT02508532|453249035|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
125988211|NCT02508532|453249027|FG000|Part 1 and Part 2 End of Study|Death|0|||
125988212|NCT02508532|453249028|FG001|Part 1 and Part 2 End of Study|Death|4|||
125988213|NCT02508532|453249029|FG002|Part 1 and Part 2 End of Study|Death|2|||
125988214|NCT02508532|453249030|FG003|Part 1 and Part 2 End of Study|Death|4|||
125988215|NCT02508532|453249031|FG004|Part 1 and Part 2 End of Study|Death|3|||
125988216|NCT02508532|453249032|FG005|Part 1 and Part 2 End of Study|Death|0|||
125988217|NCT02508532|453249033|FG006|Part 1 and Part 2 End of Study|Death|0|||
125988218|NCT02508532|453249034|FG007|Part 1 and Part 2 End of Study|Death|1|||
125988219|NCT02508532|453249035|FG008|Part 1 and Part 2 End of Study|Death|111|||
126209296|NCT05182840|454053177|FG004|Treatment Period|Change of residence|0|||
125988220|NCT02508532|453249027|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
125878565|NCT02702492|452851327|FG000|Overall Study|Adverse Event|0|||
125878566|NCT02702492|452851328|FG001|Overall Study|Adverse Event|0|||
125878567|NCT02702492|452851329|FG002|Overall Study|Adverse Event|1|||
125878568|NCT02702492|452851330|FG003|Overall Study|Adverse Event|2|||
125878569|NCT02702492|452851331|FG004|Overall Study|Adverse Event|1|||
125878570|NCT02702492|452851332|FG005|Overall Study|Adverse Event|0|||
125878571|NCT02702492|452851333|FG006|Overall Study|Adverse Event|1|||
125878572|NCT02702492|452851334|FG007|Overall Study|Adverse Event|0|||
125878573|NCT02702492|452851335|FG008|Overall Study|Adverse Event|2|||
125988221|NCT02508532|453249028|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
125988222|NCT02508532|453249029|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
125988223|NCT02508532|453249030|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
126329999|NCT01408901|454501774|FG003|6-Week Follow-Up|Cancelled visit|2|||
126330000|NCT01408901|454501771|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
126330001|NCT01408901|454501772|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
126330002|NCT01408901|454501773|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
126330003|NCT01408901|454501774|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
126330004|NCT01408901|454501771|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
126330005|NCT01408901|454501772|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
126330006|NCT01408901|454501773|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
126330007|NCT01408901|454501774|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
126330008|NCT01408901|454501771|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
126330009|NCT01408901|454501772|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
126330010|NCT01408901|454501773|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
126330011|NCT01408901|454501774|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
126330012|NCT01408901|454501771|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
126330013|NCT01408901|454501772|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
126330014|NCT01408901|454501773|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
126330015|NCT01408901|454501774|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
126330016|NCT01408901|454501771|FG000|26-Week Follow-Up|Death|0|||
126330017|NCT01408901|454501772|FG001|26-Week Follow-Up|Death|1|||
126330018|NCT01408901|454501773|FG002|26-Week Follow-Up|Death|0|||
126330019|NCT01408901|454501774|FG003|26-Week Follow-Up|Death|0|||
125988224|NCT02508532|453249031|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125988225|NCT02508532|453249032|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125988226|NCT02508532|453249033|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125988227|NCT02508532|453249034|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125988228|NCT02508532|453249035|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
125988229|NCT02508532|453249027|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125988230|NCT02508532|453249028|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125988231|NCT02508532|453249029|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125988232|NCT02508532|453249030|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125988233|NCT02508532|453249031|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125988234|NCT02508532|453249032|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125988235|NCT02508532|453249033|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125988236|NCT02508532|453249034|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125988237|NCT02508532|453249035|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
125988238|NCT02508532|453249027|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
125988239|NCT02508532|453249028|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
125988240|NCT02508532|453249029|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
125988241|NCT02508532|453249030|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
125988242|NCT02508532|453249031|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
125988243|NCT02508532|453249032|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
125988244|NCT02508532|453249033|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
125988245|NCT02508532|453249034|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
125988246|NCT02508532|453249035|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
125988247|NCT02508532|453249027|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125988248|NCT02508532|453249028|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125988249|NCT02508532|453249029|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125988250|NCT02508532|453249030|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125988251|NCT02508532|453249031|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125988252|NCT02508532|453249032|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126330020|NCT02497404|454501775|FG000|Overall Study|Adverse Event|1|||
126330021|NCT04978337|454501776|FG000|Overall Study|Withdrawal by Subject|0|||
126330022|NCT04978337|454501777|FG001|Overall Study|Withdrawal by Subject|1|||
126330023|NCT01436227|454501783|FG000|Overall Study|Adverse Event|7|||
126330024|NCT01436227|454501783|FG000|Overall Study|Death|1|||
126330025|NCT01436227|454501783|FG000|Overall Study|Lack of Efficacy|1|||
125878574|NCT02702492|452851336|FG009|Overall Study|Adverse Event|0|||
125878575|NCT02702492|452851337|FG010|Overall Study|Adverse Event|0|||
125878576|NCT02702492|452851338|FG011|Overall Study|Adverse Event|0|||
125878577|NCT02702492|452851339|FG012|Overall Study|Adverse Event|1|||
125988253|NCT02508532|453249033|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125988254|NCT02508532|453249034|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125988255|NCT02508532|453249035|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
125988256|NCT02508532|453249027|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
125988257|NCT02508532|453249028|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
125988258|NCT02508532|453249029|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
125988259|NCT02508532|453249030|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
125988260|NCT02508532|453249031|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
125988261|NCT02508532|453249032|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
125988262|NCT02508532|453249033|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
125988263|NCT02508532|453249034|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
125988264|NCT02508532|453249035|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
125988265|NCT03097861|453249036|FG000|Overall Study|Adverse Event|3|||
125988266|NCT03097861|453249037|FG001|Overall Study|Adverse Event|8|||
125988267|NCT03097861|453249038|FG002|Overall Study|Adverse Event|4|||
125988268|NCT03097861|453249036|FG000|Overall Study|Investigator Decision|0|||
125988269|NCT03097861|453249037|FG001|Overall Study|Investigator Decision|1|||
125988270|NCT03097861|453249038|FG002|Overall Study|Investigator Decision|0|||
125988271|NCT03097861|453249036|FG000|Overall Study|Lost to Follow-up|0|||
125988272|NCT03097861|453249037|FG001|Overall Study|Lost to Follow-up|7|||
125988273|NCT03097861|453249038|FG002|Overall Study|Lost to Follow-up|1|||
125988274|NCT03097861|453249036|FG000|Overall Study|Withdrawal by Subject|1|||
125988275|NCT03097861|453249037|FG001|Overall Study|Withdrawal by Subject|5|||
125988276|NCT03097861|453249038|FG002|Overall Study|Withdrawal by Subject|3|||
125988277|NCT03097861|453249036|FG000|Overall Study|Reason not provided|3|||
125988278|NCT03097861|453249037|FG001|Overall Study|Reason not provided|1|||
125988279|NCT03097861|453249038|FG002|Overall Study|Reason not provided|1|||
125988280|NCT02281760|453249041|FG000|Overall Study|Withdrawal by Subject|1|||
125988281|NCT00154310|453249045|FG000|Overall Study|Adverse Event|19|||
125988282|NCT00154310|453249046|FG001|Overall Study|Adverse Event|9|||
125988283|NCT00154310|453249045|FG000|Overall Study|Lack of Efficacy|5|||
125988284|NCT00154310|453249046|FG001|Overall Study|Lack of Efficacy|4|||
125988285|NCT00154310|453249045|FG000|Overall Study|Protocol Violation|4|||
125988286|NCT00154310|453249046|FG001|Overall Study|Protocol Violation|2|||
125988287|NCT00154310|453249045|FG000|Overall Study|Withdrawal by Subject|9|||
125988288|NCT00154310|453249046|FG001|Overall Study|Withdrawal by Subject|3|||
125988289|NCT00154310|453249045|FG000|Overall Study|Lost to Follow-up|0|||
125988290|NCT00154310|453249046|FG001|Overall Study|Lost to Follow-up|8|||
125988291|NCT00154310|453249045|FG000|Overall Study|Administrative problems|0|||
125988292|NCT00154310|453249046|FG001|Overall Study|Administrative problems|1|||
125988293|NCT00154310|453249045|FG000|Overall Study|Death|0|||
125988294|NCT00154310|453249046|FG001|Overall Study|Death|1|||
125988295|NCT01346514|453249051|FG000|Overall Study|Lost to Follow-up|19|||
125988296|NCT01346514|453249052|FG001|Overall Study|Lost to Follow-up|30|||
125988297|NCT01346514|453249051|FG000|Overall Study|Withdrawal by Subject|7|||
125988298|NCT01346514|453249052|FG001|Overall Study|Withdrawal by Subject|3|||
125988299|NCT01346514|453249051|FG000|Overall Study|Death|3|||
125988300|NCT01346514|453249052|FG001|Overall Study|Death|4|||
125988301|NCT03002038|453249059|FG000|Overall Study|Adverse Event|3|||
125988302|NCT03002038|453249060|FG001|Overall Study|Adverse Event|1|||
125988303|NCT03002038|453249059|FG000|Overall Study|Withdrawal by Subject|8|||
125988304|NCT03002038|453249060|FG001|Overall Study|Withdrawal by Subject|4|||
125988305|NCT03002038|453249059|FG000|Overall Study|Immigration to another region|0|||
125988306|NCT03002038|453249060|FG001|Overall Study|Immigration to another region|2|||
125988307|NCT05266963|453249072|FG000|Drug Period A|Withdrawal by Subject|0|||
125988308|NCT05266963|453249073|FG001|Drug Period A|Withdrawal by Subject|1|||
125988309|NCT02712398|453249074|FG000|Overall Study|Withdrawal by Subject|6|||
125988310|NCT02712398|453249074|FG000|Overall Study|Lost to Follow-up|6|||
125988311|NCT02712398|453249074|FG000|Overall Study|Sponsor Decision|1|||
125988312|NCT02712398|453249074|FG000|Overall Study|Physician Decision|1|||
125988313|NCT02712398|453249074|FG000|Overall Study|Death|2|||
125988314|NCT02712398|453249074|FG000|Overall Study|Re-operation|21|||
125988315|NCT01719237|453249075|FG000|Overall Study|Physician Decision|0|||
125988316|NCT01719237|453249076|FG001|Overall Study|Physician Decision|1|||
125988317|NCT01725386|453249077|FG000|Overall Study|Death|84|||
125988318|NCT01725386|453249078|FG001|Overall Study|Death|40|||
125988319|NCT01725386|453249077|FG000|Overall Study|Lost to Follow-up|81|||
125988320|NCT01725386|453249078|FG001|Overall Study|Lost to Follow-up|6|||
125988321|NCT01725386|453249077|FG000|Overall Study|Withdrawal by Subject|10|||
125988322|NCT01725386|453249078|FG001|Overall Study|Withdrawal by Subject|0|||
125988323|NCT03812536|453249079|FG000|Overall Study|Protocol Violation|2|||
125988324|NCT03812536|453249080|FG001|Overall Study|Protocol Violation|0|||
125988325|NCT03812536|453249079|FG000|Overall Study|Withdrawal by Subject|1|||
125988326|NCT03812536|453249080|FG001|Overall Study|Withdrawal by Subject|1|||
125988327|NCT00152009|453249081|FG000|Overall Study|Adverse Event|9|||
125988328|NCT00152009|453249082|FG001|Overall Study|Adverse Event|13|||
125988329|NCT00152009|453249083|FG002|Overall Study|Adverse Event|20|||
125988330|NCT00152009|453249084|FG003|Overall Study|Adverse Event|1|||
125988331|NCT00152009|453249081|FG000|Overall Study|Protocol Violation|3|||
125988332|NCT00152009|453249082|FG001|Overall Study|Protocol Violation|0|||
125988333|NCT00152009|453249083|FG002|Overall Study|Protocol Violation|0|||
125988334|NCT00152009|453249084|FG003|Overall Study|Protocol Violation|1|||
125988335|NCT00152009|453249081|FG000|Overall Study|Withdrawal by Subject|2|||
125988336|NCT00152009|453249082|FG001|Overall Study|Withdrawal by Subject|3|||
125988337|NCT00152009|453249083|FG002|Overall Study|Withdrawal by Subject|4|||
125988338|NCT00152009|453249084|FG003|Overall Study|Withdrawal by Subject|9|||
125988339|NCT00152009|453249081|FG000|Overall Study|Lost to Follow-up|2|||
125988340|NCT00152009|453249082|FG001|Overall Study|Lost to Follow-up|4|||
125988341|NCT00152009|453249083|FG002|Overall Study|Lost to Follow-up|3|||
125988342|NCT00152009|453249084|FG003|Overall Study|Lost to Follow-up|3|||
125988343|NCT00152009|453249081|FG000|Overall Study|Lack of Efficacy|8|||
125988344|NCT00152009|453249082|FG001|Overall Study|Lack of Efficacy|6|||
125988345|NCT00152009|453249083|FG002|Overall Study|Lack of Efficacy|7|||
125988346|NCT00152009|453249084|FG003|Overall Study|Lack of Efficacy|15|||
125988347|NCT00152009|453249081|FG000|Overall Study|ECG abnormalities|2|||
125988348|NCT00152009|453249082|FG001|Overall Study|ECG abnormalities|2|||
125988349|NCT00152009|453249083|FG002|Overall Study|ECG abnormalities|2|||
125988350|NCT00152009|453249084|FG003|Overall Study|ECG abnormalities|1|||
125988351|NCT00152009|453249081|FG000|Overall Study|Sponsor's decision|3|||
125988352|NCT00152009|453249082|FG001|Overall Study|Sponsor's decision|3|||
125988353|NCT00152009|453249083|FG002|Overall Study|Sponsor's decision|1|||
125988354|NCT00152009|453249084|FG003|Overall Study|Sponsor's decision|3|||
125988355|NCT02914314|453249085|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
125988356|NCT02914314|453249086|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
125988357|NCT02914314|453249087|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
125988358|NCT02914314|453249088|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
125988359|NCT02914314|453249085|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
125988360|NCT02914314|453249086|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
125988361|NCT02914314|453249087|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
125988362|NCT02914314|453249088|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
125988363|NCT02914314|453249085|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
125988364|NCT02914314|453249086|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
125988365|NCT02914314|453249087|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
125988366|NCT02914314|453249088|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
125988367|NCT02914314|453249085|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
125988368|NCT02914314|453249086|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
125988369|NCT02914314|453249087|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
125988370|NCT02914314|453249088|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
125988371|NCT02914314|453249085|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
125988372|NCT02914314|453249086|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
125988373|NCT02914314|453249087|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
125988374|NCT02914314|453249088|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
125988375|NCT01306201|453249091|FG000|Overall Study|Arrhythmia|4|||
125988376|NCT01306201|453249091|FG000|Overall Study|Files could not be processed|3|||
125988377|NCT01306201|453249091|FG000|Overall Study|Files unreadable|3|||
125988378|NCT04702568|453249092|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
125988379|NCT04702568|453249093|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
125988380|NCT04702568|453249092|FG000|Overall Study|Pregnancy|1|||
125988381|NCT04702568|453249093|FG001|Overall Study|Pregnancy|0|||
125988382|NCT04702568|453249092|FG000|Overall Study|Bone marrow transplant|1|||
125988383|NCT04702568|453249093|FG001|Overall Study|Bone marrow transplant|0|||
125988384|NCT04702568|453249092|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
125988385|NCT04702568|453249093|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
125988386|NCT04702568|453249092|FG000|Overall Study|Withdrawal by Subject|0|||
125988387|NCT04702568|453249093|FG001|Overall Study|Withdrawal by Subject|2|||
125988388|NCT00393523|453249094|FG000|Overall Study|Lost to Follow-up|0|||
125988389|NCT00393523|453249095|FG001|Overall Study|Lost to Follow-up|0|||
125988390|NCT00393523|453249096|FG002|Overall Study|Lost to Follow-up|0|||
125988391|NCT00393523|453249097|FG003|Overall Study|Lost to Follow-up|2|||
125988392|NCT00393523|453249098|FG004|Overall Study|Lost to Follow-up|1|||
125988393|NCT00393523|453249094|FG000|Overall Study|Protocol Violation|6|||
125988394|NCT00393523|453249095|FG001|Overall Study|Protocol Violation|2|||
125988395|NCT00393523|453249096|FG002|Overall Study|Protocol Violation|0|||
125988396|NCT00393523|453249097|FG003|Overall Study|Protocol Violation|1|||
126330026|NCT01436227|454501783|FG000|Overall Study|Lost to Follow-up|3|||
125988397|NCT00393523|453249098|FG004|Overall Study|Protocol Violation|0|||
125988398|NCT00393523|453249094|FG000|Overall Study|Withdrawal by Subject|6|||
125988399|NCT00393523|453249095|FG001|Overall Study|Withdrawal by Subject|7|||
126330027|NCT01436227|454501783|FG000|Overall Study|Physician Decision|1|||
125988400|NCT00393523|453249096|FG002|Overall Study|Withdrawal by Subject|2|||
125988401|NCT00393523|453249097|FG003|Overall Study|Withdrawal by Subject|3|||
125988402|NCT00393523|453249098|FG004|Overall Study|Withdrawal by Subject|0|||
125988403|NCT00393523|453249094|FG000|Overall Study|Difficulties in specimen collection|0|||
125988404|NCT00393523|453249095|FG001|Overall Study|Difficulties in specimen collection|0|||
125988405|NCT00393523|453249096|FG002|Overall Study|Difficulties in specimen collection|1|||
125988406|NCT00393523|453249097|FG003|Overall Study|Difficulties in specimen collection|0|||
125988407|NCT00393523|453249098|FG004|Overall Study|Difficulties in specimen collection|0|||
125988408|NCT00393523|453249094|FG000|Overall Study|Vaccine supply issue|0|||
125988409|NCT00393523|453249095|FG001|Overall Study|Vaccine supply issue|0|||
125988410|NCT00393523|453249096|FG002|Overall Study|Vaccine supply issue|1|||
125988411|NCT00393523|453249097|FG003|Overall Study|Vaccine supply issue|0|||
125988412|NCT00393523|453249098|FG004|Overall Study|Vaccine supply issue|0|||
125988413|NCT04599101|453249107|FG000|Overall Study|Lost to Follow-up|5|||
125988414|NCT04599101|453249108|FG001|Overall Study|Lost to Follow-up|5|||
125988415|NCT00098254|453249109|FG000|Overall Study|Adverse Event|2|||
125988416|NCT00098254|453249109|FG000|Overall Study|Death|1|||
125988417|NCT01515189|453249111|FG000|Induction|Disease Progression|109|||
125988418|NCT01515189|453249112|FG001|Induction|Disease Progression|155|||
125988419|NCT01515189|453249111|FG000|Induction|Study drug toxicity|86|||
125988420|NCT01515189|453249112|FG001|Induction|Study drug toxicity|36|||
125988421|NCT01515189|453249111|FG000|Induction|Death|24|||
125988422|NCT01515189|453249112|FG001|Induction|Death|17|||
125988423|NCT01515189|453249111|FG000|Induction|Adverse Event|14|||
125988424|NCT01515189|453249112|FG001|Induction|Adverse Event|9|||
125988425|NCT01515189|453249111|FG000|Induction|Withdrawal by Subject|3|||
125988426|NCT01515189|453249112|FG001|Induction|Withdrawal by Subject|9|||
125988427|NCT01515189|453249111|FG000|Induction|No longer meets study criteria|0|||
125988428|NCT01515189|453249112|FG001|Induction|No longer meets study criteria|2|||
125988429|NCT01515189|453249111|FG000|Induction|Lost to Follow-up|1|||
125988430|NCT01515189|453249112|FG001|Induction|Lost to Follow-up|0|||
125988431|NCT01515189|453249111|FG000|Induction|Other|0|||
125988432|NCT01515189|453249112|FG001|Induction|Other|4|||
125988433|NCT01515189|453249111|FG000|First Re-Induction Phase|Disease progression|6|||
125988434|NCT01515189|453249112|FG001|First Re-Induction Phase|Disease progression|14|||
125988435|NCT01515189|453249111|FG000|First Re-Induction Phase|Study drug toxicity|5|||
125988436|NCT01515189|453249112|FG001|First Re-Induction Phase|Study drug toxicity|0|||
125988437|NCT01515189|453249111|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
125988438|NCT01515189|453249112|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
125988439|NCT01515189|453249111|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
125988440|NCT01515189|453249112|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
125988441|NCT01515189|453249111|FG000|First Re-Induction Phase|Other|1|||
125988442|NCT01515189|453249112|FG001|First Re-Induction Phase|Other|0|||
125988443|NCT01395823|453249116|FG000|Overall Study|Death|4|||
125988444|NCT01395823|453249117|FG001|Overall Study|Death|4|||
125988445|NCT01395823|453249116|FG000|Overall Study|Physician Decision|3|||
125988446|NCT01395823|453249117|FG001|Overall Study|Physician Decision|1|||
125988447|NCT01395823|453249116|FG000|Overall Study|Lost to Follow-up|1|||
125988448|NCT01395823|453249117|FG001|Overall Study|Lost to Follow-up|0|||
125988449|NCT01395823|453249116|FG000|Overall Study|Transplant|1|||
125988450|NCT01395823|453249117|FG001|Overall Study|Transplant|0|||
125988451|NCT01395823|453249116|FG000|Overall Study|GI symptoms|1|||
125988452|NCT01395823|453249117|FG001|Overall Study|GI symptoms|0|||
125988453|NCT01395823|453249116|FG000|Overall Study|Withdrawal by Subject|5|||
125988454|NCT01395823|453249117|FG001|Overall Study|Withdrawal by Subject|4|||
125988455|NCT05076149|453249118|FG000|Overall Study|Adverse Event|3|||
125988456|NCT05076149|453249119|FG001|Overall Study|Adverse Event|9|||
125988457|NCT05076149|453249118|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125988458|NCT05076149|453249119|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
125988459|NCT05076149|453249118|FG000|Overall Study|Lost to Follow-up|0|||
125988460|NCT05076149|453249119|FG001|Overall Study|Lost to Follow-up|1|||
125988461|NCT05076149|453249118|FG000|Overall Study|Commercial drug is available for participant|0|||
125988462|NCT05076149|453249119|FG001|Overall Study|Commercial drug is available for participant|1|||
125988463|NCT05076149|453249118|FG000|Overall Study|Other non compliance|1|||
125988464|NCT05076149|453249119|FG001|Overall Study|Other non compliance|1|||
125988465|NCT05076149|453249118|FG000|Overall Study|Physician Decision|0|||
125988466|NCT05076149|453249119|FG001|Overall Study|Physician Decision|1|||
125988467|NCT05076149|453249118|FG000|Overall Study|Other|5|||
125988468|NCT05076149|453249119|FG001|Overall Study|Other|4|||
125988469|NCT02087501|453249120|FG000|Overall Study|Death|7|||
125988470|NCT02087501|453249120|FG000|Overall Study|Open repair of aneurysm|1|||
125988471|NCT02087501|453249120|FG000|Overall Study|Lost to Follow-up|2|||
125988472|NCT00094328|453249121|FG000|Overall Study|Lost to Follow-up|1|||
125988473|NCT04631705|453249124|FG000|Overall Study|Withdrawal by Subject|0|||
125988474|NCT04631705|453249125|FG001|Overall Study|Withdrawal by Subject|0|||
125988475|NCT04631705|453249126|FG002|Overall Study|Withdrawal by Subject|0|||
125988476|NCT04631705|453249127|FG003|Overall Study|Withdrawal by Subject|0|||
125988477|NCT04631705|453249128|FG004|Overall Study|Withdrawal by Subject|0|||
125988478|NCT04631705|453249129|FG005|Overall Study|Withdrawal by Subject|0|||
125988479|NCT04631705|453249130|FG006|Overall Study|Withdrawal by Subject|1|||
125988480|NCT04631705|453249131|FG007|Overall Study|Withdrawal by Subject|0|||
125988481|NCT04631705|453249132|FG008|Overall Study|Withdrawal by Subject|0|||
125988482|NCT02130284|453249133|FG000|Overall Study|Withdrawal by Subject|3|||
125988483|NCT02130284|453249133|FG000|Overall Study|Subject Withdrew Consent|1|||
125988484|NCT02130284|453249133|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
125988485|NCT02130284|453249133|FG000|Overall Study|Subject was screened as backup for study|3|||
125988486|NCT02130284|453249133|FG000|Overall Study|Screen Failure|1|||
125988487|NCT01875185|453249134|FG000|Overall Study|study was terminated|52|||
125988488|NCT01875185|453249135|FG001|Overall Study|study was terminated|48|||
125988489|NCT04838613|453249136|FG000|Overall Study|Withdrawal by Subject|3|||
125988490|NCT04838613|453249137|FG001|Overall Study|Withdrawal by Subject|6|||
125988491|NCT04838613|453249136|FG000|Overall Study|Protocol Deviation|3|||
125988492|NCT04838613|453249137|FG001|Overall Study|Protocol Deviation|2|||
125988493|NCT04838613|453249136|FG000|Overall Study|Technical Problems|0|||
125988494|NCT04838613|453249137|FG001|Overall Study|Technical Problems|5|||
125988495|NCT04838613|453249136|FG000|Overall Study|Physician Decision|2|||
125988496|NCT04838613|453249137|FG001|Overall Study|Physician Decision|0|||
125988497|NCT01686581|453249138|FG000|Overall Study|Side-effects or Health Problems|15|||
125988498|NCT01686581|453249138|FG000|Overall Study|Lack of Efficacy|90|||
125988499|NCT01686581|453249138|FG000|Overall Study|Participant Concerned about Risks|6|||
125988500|NCT01686581|453249138|FG000|Overall Study|Thinks Injections Too Painful|8|||
125988501|NCT01686581|453249138|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
125988502|NCT01686581|453249138|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
125988503|NCT01686581|453249138|FG000|Overall Study|Thinks it is Inconvenient|17|||
125988504|NCT01686581|453249138|FG000|Overall Study|Other Miscellaneous Reasons|36|||
125988505|NCT01686581|453249138|FG000|Overall Study|Reason Missing|1|||
125988506|NCT02217280|453249139|FG000|Overall Study|Withdrawal by Subject|2|||
125988507|NCT02217280|453249139|FG000|Overall Study|Post-consent sceen fail|2|||
125988508|NCT02395133|453249140|FG000|Overall Study|Adverse Event|4|||
125988509|NCT02395133|453249141|FG001|Overall Study|Adverse Event|1|||
125988510|NCT02395133|453249142|FG002|Overall Study|Adverse Event|3|||
125988511|NCT02395133|453249143|FG003|Overall Study|Adverse Event|0|||
125988512|NCT02395133|453249140|FG000|Overall Study|Lack of Efficacy|1|||
125988513|NCT02395133|453249141|FG001|Overall Study|Lack of Efficacy|0|||
125988514|NCT02395133|453249142|FG002|Overall Study|Lack of Efficacy|1|||
125988515|NCT02395133|453249143|FG003|Overall Study|Lack of Efficacy|1|||
125988516|NCT02395133|453249140|FG000|Overall Study|Protocol Violation|1|||
125988517|NCT02395133|453249141|FG001|Overall Study|Protocol Violation|1|||
125988518|NCT02395133|453249142|FG002|Overall Study|Protocol Violation|0|||
125988519|NCT02395133|453249143|FG003|Overall Study|Protocol Violation|3|||
125988520|NCT02395133|453249140|FG000|Overall Study|Lost to Follow-up|0|||
125988521|NCT02395133|453249141|FG001|Overall Study|Lost to Follow-up|1|||
125988522|NCT02395133|453249142|FG002|Overall Study|Lost to Follow-up|1|||
125988523|NCT02395133|453249143|FG003|Overall Study|Lost to Follow-up|0|||
125988524|NCT02395133|453249140|FG000|Overall Study|Pregnancy|0|||
125988525|NCT02395133|453249141|FG001|Overall Study|Pregnancy|0|||
125988526|NCT02395133|453249142|FG002|Overall Study|Pregnancy|3|||
125988527|NCT02395133|453249143|FG003|Overall Study|Pregnancy|0|||
125988528|NCT02395133|453249140|FG000|Overall Study|Consent withdrawn with no reason given|1|||
125988529|NCT02395133|453249141|FG001|Overall Study|Consent withdrawn with no reason given|3|||
125988530|NCT02395133|453249142|FG002|Overall Study|Consent withdrawn with no reason given|0|||
125988531|NCT02395133|453249143|FG003|Overall Study|Consent withdrawn with no reason given|2|||
125988532|NCT02395133|453249140|FG000|Overall Study|Consent withdrawn with personal reason|0|||
125988533|NCT02395133|453249141|FG001|Overall Study|Consent withdrawn with personal reason|1|||
125988534|NCT02395133|453249142|FG002|Overall Study|Consent withdrawn with personal reason|0|||
125988535|NCT02395133|453249143|FG003|Overall Study|Consent withdrawn with personal reason|3|||
125988536|NCT02395133|453249140|FG000|Overall Study|Sponsor decision|2|||
125988537|NCT02395133|453249141|FG001|Overall Study|Sponsor decision|0|||
125988538|NCT02395133|453249142|FG002|Overall Study|Sponsor decision|0|||
125988539|NCT02395133|453249143|FG003|Overall Study|Sponsor decision|1|||
125988540|NCT02395133|453249140|FG000|Overall Study|Other than specified above|5|||
125988541|NCT02395133|453249141|FG001|Overall Study|Other than specified above|2|||
125988542|NCT02395133|453249142|FG002|Overall Study|Other than specified above|2|||
125988543|NCT02395133|453249143|FG003|Overall Study|Other than specified above|4|||
125988544|NCT00709059|453249144|FG000|Overall Study|Lost to Follow-up|34|||
125988545|NCT00709059|453249144|FG000|Overall Study|Withdrawal by Subject|19|||
125988546|NCT00709059|453249144|FG000|Overall Study|Physician Decision|7|||
125988547|NCT00709059|453249144|FG000|Overall Study|Disease complication|3|||
125988548|NCT00709059|453249144|FG000|Overall Study|Side effects|20|||
125988549|NCT00709059|453249144|FG000|Overall Study|Serious side effects|11|||
125988550|NCT01816763|453250757|FG000|Overall Study|The main reason for an incomplete survey|4|||
125988551|NCT01816763|453250758|FG001|Overall Study|The main reason for an incomplete survey|15|||
126330028|NCT01436227|454501783|FG000|Overall Study|Withdrawal by Subject|7|||
125988552|NCT01816763|453250759|FG002|Overall Study|The main reason for an incomplete survey|11|||
125988553|NCT00311155|453250762|FG000|Overall Study|Adverse Event|21|||
125988554|NCT00311155|453250762|FG000|Overall Study|Withdrawal by Subject|17|||
125988555|NCT00311155|453250762|FG000|Overall Study|Did not meet entry criteria|55|||
125988556|NCT00429494|453250764|FG000|Overall Study|Withdrawal by Subject|9|||
125988557|NCT00429494|453250764|FG000|Overall Study|Death|6|||
125988558|NCT02392611|453250769|FG000|Overall Study|Adverse Event|0|||
125988559|NCT02392611|453250770|FG001|Overall Study|Adverse Event|0|||
125988560|NCT02392611|453250771|FG002|Overall Study|Adverse Event|0|||
125988561|NCT02392611|453250772|FG003|Overall Study|Adverse Event|1|||
125988562|NCT02392611|453250773|FG004|Overall Study|Adverse Event|0|||
125988563|NCT02392611|453250774|FG005|Overall Study|Adverse Event|0|||
125988564|NCT02392611|453250775|FG006|Overall Study|Adverse Event|0|||
125988565|NCT02392611|453250776|FG007|Overall Study|Adverse Event|0|||
125988566|NCT02392611|453250777|FG008|Overall Study|Adverse Event|0|||
125988567|NCT02392611|453250769|FG000|Overall Study|Progressive disease|0|||
125988568|NCT02392611|453250770|FG001|Overall Study|Progressive disease|0|||
125988569|NCT02392611|453250771|FG002|Overall Study|Progressive disease|0|||
125988570|NCT02392611|453250772|FG003|Overall Study|Progressive disease|2|||
125988571|NCT02392611|453250773|FG004|Overall Study|Progressive disease|1|||
125988572|NCT02392611|453250774|FG005|Overall Study|Progressive disease|0|||
125988573|NCT02392611|453250775|FG006|Overall Study|Progressive disease|0|||
125988574|NCT02392611|453250776|FG007|Overall Study|Progressive disease|0|||
125988575|NCT02392611|453250777|FG008|Overall Study|Progressive disease|0|||
125988576|NCT02392611|453250769|FG000|Overall Study|Death|1|||
125988577|NCT02392611|453250770|FG001|Overall Study|Death|0|||
125988578|NCT02392611|453250771|FG002|Overall Study|Death|0|||
125988579|NCT02392611|453250772|FG003|Overall Study|Death|0|||
125988580|NCT02392611|453250773|FG004|Overall Study|Death|0|||
125988581|NCT02392611|453250774|FG005|Overall Study|Death|1|||
125988582|NCT02392611|453250775|FG006|Overall Study|Death|0|||
125988583|NCT02392611|453250776|FG007|Overall Study|Death|0|||
125988584|NCT02392611|453250777|FG008|Overall Study|Death|0|||
125988585|NCT02392611|453250769|FG000|Overall Study|Withdrawal by Subject|0|||
125988586|NCT02392611|453250770|FG001|Overall Study|Withdrawal by Subject|0|||
125988587|NCT02392611|453250771|FG002|Overall Study|Withdrawal by Subject|0|||
125988588|NCT02392611|453250772|FG003|Overall Study|Withdrawal by Subject|1|||
125988589|NCT02392611|453250773|FG004|Overall Study|Withdrawal by Subject|0|||
125988590|NCT02392611|453250774|FG005|Overall Study|Withdrawal by Subject|0|||
125988591|NCT02392611|453250775|FG006|Overall Study|Withdrawal by Subject|0|||
125988592|NCT02392611|453250776|FG007|Overall Study|Withdrawal by Subject|0|||
125988593|NCT02392611|453250777|FG008|Overall Study|Withdrawal by Subject|0|||
125988594|NCT02392611|453250769|FG000|Overall Study|Lost to Follow-up|0|||
125988595|NCT02392611|453250770|FG001|Overall Study|Lost to Follow-up|0|||
125988596|NCT02392611|453250771|FG002|Overall Study|Lost to Follow-up|0|||
125988597|NCT02392611|453250772|FG003|Overall Study|Lost to Follow-up|0|||
125988598|NCT02392611|453250773|FG004|Overall Study|Lost to Follow-up|0|||
125988599|NCT02392611|453250774|FG005|Overall Study|Lost to Follow-up|0|||
125988600|NCT02392611|453250775|FG006|Overall Study|Lost to Follow-up|1|||
125988601|NCT02392611|453250776|FG007|Overall Study|Lost to Follow-up|0|||
125988602|NCT02392611|453250777|FG008|Overall Study|Lost to Follow-up|0|||
125988603|NCT02392611|453250769|FG000|Overall Study|Enrolled, not treated|0|||
125988604|NCT02392611|453250770|FG001|Overall Study|Enrolled, not treated|0|||
125988605|NCT02392611|453250771|FG002|Overall Study|Enrolled, not treated|0|||
125988606|NCT02392611|453250772|FG003|Overall Study|Enrolled, not treated|2|||
125988607|NCT02392611|453250773|FG004|Overall Study|Enrolled, not treated|0|||
125988608|NCT02392611|453250774|FG005|Overall Study|Enrolled, not treated|0|||
125988609|NCT02392611|453250775|FG006|Overall Study|Enrolled, not treated|0|||
125988610|NCT02392611|453250776|FG007|Overall Study|Enrolled, not treated|0|||
125988611|NCT02392611|453250777|FG008|Overall Study|Enrolled, not treated|0|||
125988612|NCT03585296|453250793|FG000|Overall Study|Adverse Event|1|||
125988613|NCT03585296|453250793|FG000|Overall Study|Lost to Follow-up|2|||
125988614|NCT03585296|453250793|FG000|Overall Study|Withdrawal by Subject|2|||
125988615|NCT00462670|453250797|FG000|Overall Study|Adverse Event|3|||
125988616|NCT00462670|453250798|FG001|Overall Study|Adverse Event|5|||
125988617|NCT00462670|453250797|FG000|Overall Study|Lack of Efficacy|1|||
125988618|NCT00462670|453250798|FG001|Overall Study|Lack of Efficacy|0|||
125988619|NCT00462670|453250797|FG000|Overall Study|Protocol Violation|1|||
125988620|NCT00462670|453250798|FG001|Overall Study|Protocol Violation|0|||
125988621|NCT00462670|453250797|FG000|Overall Study|Resolution of signs and symptoms|0|||
125988622|NCT00462670|453250798|FG001|Overall Study|Resolution of signs and symptoms|2|||
125988623|NCT02110732|453250799|FG000|Overall Study|Physician Decision|5|||
125988624|NCT02110732|453250800|FG001|Overall Study|Physician Decision|2|||
125988625|NCT02110732|453250799|FG000|Overall Study|Lost to Follow-up|1|||
125988626|NCT02110732|453250800|FG001|Overall Study|Lost to Follow-up|1|||
125988627|NCT00633932|453250801|FG000|Overall Study|Adverse Event|1|||
125988628|NCT00633932|453250802|FG001|Overall Study|Adverse Event|3|||
125988629|NCT00633932|453250803|FG002|Overall Study|Adverse Event|4|||
125988630|NCT00633932|453250801|FG000|Overall Study|Withdrawal by Subject|3|||
125988631|NCT00633932|453250802|FG001|Overall Study|Withdrawal by Subject|9|||
125988632|NCT00633932|453250803|FG002|Overall Study|Withdrawal by Subject|1|||
125988633|NCT00633932|453250801|FG000|Overall Study|Lost to Follow-up|1|||
125988634|NCT00633932|453250802|FG001|Overall Study|Lost to Follow-up|0|||
125988635|NCT00633932|453250803|FG002|Overall Study|Lost to Follow-up|2|||
125988636|NCT00633932|453250801|FG000|Overall Study|Protocol Violation|5|||
125988637|NCT00633932|453250802|FG001|Overall Study|Protocol Violation|2|||
125988638|NCT00633932|453250803|FG002|Overall Study|Protocol Violation|3|||
125988639|NCT00633932|453250801|FG000|Overall Study|Physician Decision|0|||
125988640|NCT00633932|453250802|FG001|Overall Study|Physician Decision|0|||
125988641|NCT00633932|453250803|FG002|Overall Study|Physician Decision|1|||
125988642|NCT00633932|453250801|FG000|Overall Study|Doctor's judgement|1|||
125988643|NCT00633932|453250802|FG001|Overall Study|Doctor's judgement|0|||
125988644|NCT00633932|453250803|FG002|Overall Study|Doctor's judgement|0|||
125988645|NCT00633932|453250801|FG000|Overall Study|Moved Away|1|||
125988646|NCT00633932|453250802|FG001|Overall Study|Moved Away|0|||
125988647|NCT00633932|453250803|FG002|Overall Study|Moved Away|0|||
125988648|NCT00482274|453250804|FG000|Overall Study|Adverse Event|1|||
125988649|NCT04836858|453250805|FG000|Overall Study|Adverse Event|0|||
125988650|NCT04836858|453250806|FG001|Overall Study|Adverse Event|0|||
125988651|NCT04836858|453250807|FG002|Overall Study|Adverse Event|0|||
125988652|NCT04836858|453250808|FG003|Overall Study|Adverse Event|1|||
125988653|NCT04836858|453250805|FG000|Overall Study|Lost to Follow-up|1|||
125988654|NCT04836858|453250806|FG001|Overall Study|Lost to Follow-up|0|||
125988655|NCT04836858|453250807|FG002|Overall Study|Lost to Follow-up|0|||
125988656|NCT04836858|453250808|FG003|Overall Study|Lost to Follow-up|0|||
125988657|NCT04836858|453250805|FG000|Overall Study|Subject/Guardian decision|3|||
125988658|NCT04836858|453250806|FG001|Overall Study|Subject/Guardian decision|0|||
125988659|NCT04836858|453250807|FG002|Overall Study|Subject/Guardian decision|0|||
125988660|NCT04836858|453250808|FG003|Overall Study|Subject/Guardian decision|1|||
125988661|NCT04836858|453250805|FG000|Overall Study|Randomized but not treated|4|||
125988662|NCT04836858|453250806|FG001|Overall Study|Randomized but not treated|0|||
125988663|NCT04836858|453250807|FG002|Overall Study|Randomized but not treated|0|||
125988664|NCT04836858|453250808|FG003|Overall Study|Randomized but not treated|0|||
125988665|NCT00597714|453250809|FG000|Overall Study|Death|56|||
125988666|NCT00597714|453250810|FG001|Overall Study|Death|46|||
125988667|NCT00597714|453250811|FG002|Overall Study|Death|0|||
125988668|NCT00597714|453250809|FG000|Overall Study|Recipient death|0|||
125988669|NCT00597714|453250810|FG001|Overall Study|Recipient death|0|||
125988670|NCT00597714|453250811|FG002|Overall Study|Recipient death|10|||
125988671|NCT01350141|453250812|FG000|Overall Study|Lost to Follow-up|1|||
125988672|NCT01350141|453250813|FG001|Overall Study|Lost to Follow-up|0|||
125988673|NCT01350141|453250814|FG002|Overall Study|Lost to Follow-up|1|||
125988674|NCT01350141|453250812|FG000|Overall Study|Withdrawal by Subject|1|||
125988675|NCT01350141|453250813|FG001|Overall Study|Withdrawal by Subject|0|||
125988676|NCT01350141|453250814|FG002|Overall Study|Withdrawal by Subject|0|||
125988677|NCT01350141|453250812|FG000|Overall Study|Randomized but not treated|1|||
125988678|NCT01350141|453250813|FG001|Overall Study|Randomized but not treated|0|||
125988679|NCT01350141|453250814|FG002|Overall Study|Randomized but not treated|0|||
125988680|NCT00519896|453250815|FG000|Overall Study|Protocol Violation|1|||
125988681|NCT00519896|453250815|FG000|Overall Study|Adverse Event|1|||
125988682|NCT00810082|453250816|FG000|Overall Study|Lost to Follow-up|0|||
125988683|NCT00810082|453250817|FG001|Overall Study|Lost to Follow-up|4|||
125988684|NCT01588990|453250818|FG000|Phase A|Withdrawal by Subject|5|||
125988685|NCT01588990|453250818|FG000|Phase A|Physician Decision|11|||
125988686|NCT01588990|453250818|FG000|Phase A|Other|14|||
125988687|NCT01588990|453250818|FG000|Phase A|Lost to Follow-up|1|||
125988688|NCT01588990|453250818|FG000|Phase A|Death|5|||
125988689|NCT01588990|453250818|FG000|Phase A|Adverse Event|28|||
125988690|NCT01588990|453250818|FG000|Phase A|Still on therapy at end of study|6|||
125988691|NCT01588990|453250818|FG000|Phase B|Adverse Event|2|||
125988692|NCT01588990|453250818|FG000|Phase B|Still on therapy at end of study|5|||
125988693|NCT01588990|453250818|FG000|Phase B|Withdrawal by Subject|3|||
125988694|NCT01588990|453250818|FG000|Phase B|Physician Decision|4|||
125988695|NCT01588990|453250818|FG000|Phase B|Other|2|||
125988696|NCT02367716|453250823|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
125988697|NCT01834222|453250830|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
125988698|NCT04251065|453250831|FG000|Overall Study|Death|2|||
125988699|NCT04251065|453250831|FG000|Overall Study|Lack of Efficacy|3|||
125988700|NCT04251065|453250831|FG000|Overall Study|Death|1|||
125988701|NCT01054573|453250832|FG000|Overall Study|Adverse Event|1|||
125988702|NCT01054573|453250833|FG001|Overall Study|Adverse Event|0|||
125988703|NCT01054573|453250834|FG002|Overall Study|Adverse Event|1|||
125988704|NCT01054573|453250835|FG003|Overall Study|Adverse Event|1|||
125988705|NCT01054573|453250832|FG000|Overall Study|Lost to Follow-up|0|||
125988706|NCT01054573|453250833|FG001|Overall Study|Lost to Follow-up|2|||
126209297|NCT05182840|454053178|FG005|Treatment Period|Change of residence|1|||
125988707|NCT01054573|453250834|FG002|Overall Study|Lost to Follow-up|0|||
125988708|NCT01054573|453250835|FG003|Overall Study|Lost to Follow-up|0|||
125988709|NCT01054573|453250832|FG000|Overall Study|Withdrawal by Subject|0|||
125988710|NCT01054573|453250833|FG001|Overall Study|Withdrawal by Subject|2|||
125988711|NCT01054573|453250834|FG002|Overall Study|Withdrawal by Subject|2|||
125988712|NCT01054573|453250835|FG003|Overall Study|Withdrawal by Subject|1|||
125988713|NCT00979602|453250836|FG000|Overall Study|Serious Adverse Event|5|||
125988714|NCT00979602|453250837|FG001|Overall Study|Serious Adverse Event|3|||
125988715|NCT00979602|453250836|FG000|Overall Study|Protocol Violation|3|||
125988716|NCT00979602|453250837|FG001|Overall Study|Protocol Violation|0|||
125988717|NCT00979602|453250836|FG000|Overall Study|Withdrawal by Subject|31|||
125988718|NCT00979602|453250837|FG001|Overall Study|Withdrawal by Subject|25|||
125988719|NCT00979602|453250836|FG000|Overall Study|Lost to Follow-up|100|||
125988720|NCT00979602|453250837|FG001|Overall Study|Lost to Follow-up|96|||
125988721|NCT00979602|453250836|FG000|Overall Study|Migrated/moved from study area|3|||
125988722|NCT00979602|453250837|FG001|Overall Study|Migrated/moved from study area|6|||
125988723|NCT00979602|453250836|FG000|Overall Study|Others|3|||
125988724|NCT00979602|453250837|FG001|Overall Study|Others|3|||
125988725|NCT04091360|453250838|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125988726|NCT04091360|453250839|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125988727|NCT04091360|453250840|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125988728|NCT04091360|453250841|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125988729|NCT04091360|453250842|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125988730|NCT04091360|453250843|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125988731|NCT04091360|453250844|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125988732|NCT04091360|453250845|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125988733|NCT04091360|453250846|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
125988734|NCT04091360|453250847|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
125988735|NCT04091360|453250838|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125988736|NCT04091360|453250839|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125988737|NCT04091360|453250840|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125988738|NCT04091360|453250841|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125988739|NCT04091360|453250842|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125988740|NCT04091360|453250843|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125988741|NCT04091360|453250844|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
125988742|NCT04091360|453250845|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
125988743|NCT04091360|453250846|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125988744|NCT04091360|453250847|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125988745|NCT04091360|453250838|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125988746|NCT04091360|453250839|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125988747|NCT04091360|453250840|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125988748|NCT04091360|453250841|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125988749|NCT04091360|453250842|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125988750|NCT04091360|453250843|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125988751|NCT04091360|453250844|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
125988752|NCT04091360|453250845|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125988753|NCT04091360|453250846|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125988754|NCT04091360|453250847|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
125988755|NCT04772053|453250848|FG000|Overall Study|Physician Decision|2|||
125988756|NCT04772053|453250848|FG000|Overall Study|Withdrawal by Subject|3|||
125988757|NCT04772053|453250848|FG000|Overall Study|Study Terminated by Sponsor|1|||
125988758|NCT03787680|453250852|FG000|Overall Study|Physician Decision|2|||
125988759|NCT03787680|453250853|FG001|Overall Study|Physician Decision|3|||
125988760|NCT03787680|453250852|FG000|Overall Study|Adverse Event|7|||
125988761|NCT03787680|453250853|FG001|Overall Study|Adverse Event|3|||
125988762|NCT03787680|453250852|FG000|Overall Study|Withdrawal by Subject|2|||
125988763|NCT03787680|453250853|FG001|Overall Study|Withdrawal by Subject|1|||
125988764|NCT00594217|453250854|FG000|Overall Study|Withdrawal by Subject|1|||
125988765|NCT00594217|453250855|FG001|Overall Study|Withdrawal by Subject|3|||
125988766|NCT00943306|453250856|FG000|Overall Study|Physician Decision|1|||
125988767|NCT00943306|453250856|FG000|Overall Study|Death|1|||
125988768|NCT00943306|453250856|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
125988769|NCT01036022|453250857|FG000|Overall Study|Adverse Event|1|||
125988770|NCT01036022|453250858|FG001|Overall Study|Adverse Event|3|||
125988771|NCT01036022|453250859|FG002|Overall Study|Adverse Event|2|||
125988772|NCT01036022|453250860|FG003|Overall Study|Adverse Event|1|||
125988773|NCT01036022|453250861|FG004|Overall Study|Adverse Event|0|||
125988774|NCT01036022|453250862|FG005|Overall Study|Adverse Event|2|||
125988775|NCT01036022|453250857|FG000|Overall Study|Lack of Efficacy|1|||
125988776|NCT01036022|453250858|FG001|Overall Study|Lack of Efficacy|1|||
125988777|NCT01036022|453250859|FG002|Overall Study|Lack of Efficacy|1|||
125988778|NCT01036022|453250860|FG003|Overall Study|Lack of Efficacy|0|||
125988779|NCT01036022|453250861|FG004|Overall Study|Lack of Efficacy|1|||
125988780|NCT01036022|453250862|FG005|Overall Study|Lack of Efficacy|1|||
125988781|NCT01036022|453250857|FG000|Overall Study|Physician Decision|0|||
125988782|NCT01036022|453250858|FG001|Overall Study|Physician Decision|0|||
125988783|NCT01036022|453250859|FG002|Overall Study|Physician Decision|1|||
125988784|NCT01036022|453250860|FG003|Overall Study|Physician Decision|0|||
125988785|NCT01036022|453250861|FG004|Overall Study|Physician Decision|0|||
125988786|NCT01036022|453250862|FG005|Overall Study|Physician Decision|0|||
125988787|NCT01036022|453250857|FG000|Overall Study|Withdrawal by Subject|0|||
125988788|NCT01036022|453250858|FG001|Overall Study|Withdrawal by Subject|0|||
125988789|NCT01036022|453250859|FG002|Overall Study|Withdrawal by Subject|0|||
125988790|NCT01036022|453250860|FG003|Overall Study|Withdrawal by Subject|1|||
125988791|NCT01036022|453250861|FG004|Overall Study|Withdrawal by Subject|2|||
125988792|NCT01036022|453250862|FG005|Overall Study|Withdrawal by Subject|0|||
125988793|NCT00576732|453250863|FG000|DOUBLE BLIND|Adverse Event|0|||
125988794|NCT00576732|453250864|FG001|DOUBLE BLIND|Adverse Event|0|||
125988795|NCT00576732|453250865|FG002|DOUBLE BLIND|Adverse Event|1|||
125988796|NCT00576732|453250866|FG003|DOUBLE BLIND|Adverse Event|0|||
125988797|NCT00576732|453250867|FG004|DOUBLE BLIND|Adverse Event|0|||
125988798|NCT00576732|453250868|FG005|DOUBLE BLIND|Adverse Event|0|||
125988799|NCT00576732|453250863|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
125988800|NCT00576732|453250864|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
125988801|NCT00576732|453250865|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
125988802|NCT00576732|453250866|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
125988803|NCT00576732|453250867|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
125988804|NCT00576732|453250868|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
125988805|NCT00576732|453250863|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
125988806|NCT00576732|453250864|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
125988807|NCT00576732|453250865|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
125988808|NCT00576732|453250866|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
125988809|NCT00576732|453250867|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
125988810|NCT00576732|453250868|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
125988811|NCT00576732|453250863|FG000|DOUBLE BLIND|OTHER|0|||
125988812|NCT00576732|453250864|FG001|DOUBLE BLIND|OTHER|2|||
125988813|NCT00576732|453250865|FG002|DOUBLE BLIND|OTHER|1|||
125988814|NCT00576732|453250866|FG003|DOUBLE BLIND|OTHER|0|||
125988815|NCT00576732|453250867|FG004|DOUBLE BLIND|OTHER|0|||
125988816|NCT00576732|453250868|FG005|DOUBLE BLIND|OTHER|0|||
125988817|NCT00576732|453250863|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
125988818|NCT00576732|453250864|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
125988819|NCT00576732|453250865|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
125988820|NCT00576732|453250866|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
125988821|NCT00576732|453250867|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
125988822|NCT00576732|453250868|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
125988823|NCT00576732|453250863|FG000|DOUBLE BLIND|Protocol Violation|1|||
125988824|NCT00576732|453250864|FG001|DOUBLE BLIND|Protocol Violation|0|||
125988825|NCT00576732|453250865|FG002|DOUBLE BLIND|Protocol Violation|0|||
125988826|NCT00576732|453250866|FG003|DOUBLE BLIND|Protocol Violation|0|||
125988827|NCT00576732|453250867|FG004|DOUBLE BLIND|Protocol Violation|0|||
125988828|NCT00576732|453250868|FG005|DOUBLE BLIND|Protocol Violation|0|||
125988829|NCT00576732|453250863|FG000|OPEN LABEL|Adverse Event|0|||
125988830|NCT00576732|453250864|FG001|OPEN LABEL|Adverse Event|0|||
125988831|NCT00576732|453250865|FG002|OPEN LABEL|Adverse Event|0|||
125988832|NCT00576732|453250866|FG003|OPEN LABEL|Adverse Event|4|||
125988833|NCT00576732|453250867|FG004|OPEN LABEL|Adverse Event|0|||
125988834|NCT00576732|453250868|FG005|OPEN LABEL|Adverse Event|1|||
125988835|NCT00576732|453250863|FG000|OPEN LABEL|Lost to Follow-up|0|||
125988836|NCT00576732|453250864|FG001|OPEN LABEL|Lost to Follow-up|0|||
125988837|NCT00576732|453250865|FG002|OPEN LABEL|Lost to Follow-up|0|||
125988838|NCT00576732|453250866|FG003|OPEN LABEL|Lost to Follow-up|2|||
125988839|NCT00576732|453250867|FG004|OPEN LABEL|Lost to Follow-up|1|||
125988840|NCT00576732|453250868|FG005|OPEN LABEL|Lost to Follow-up|1|||
125988841|NCT00576732|453250863|FG000|OPEN LABEL|Withdrawal by Subject|0|||
125988842|NCT00576732|453250864|FG001|OPEN LABEL|Withdrawal by Subject|0|||
125988843|NCT00576732|453250865|FG002|OPEN LABEL|Withdrawal by Subject|0|||
125988844|NCT00576732|453250866|FG003|OPEN LABEL|Withdrawal by Subject|1|||
125988845|NCT00576732|453250867|FG004|OPEN LABEL|Withdrawal by Subject|0|||
125988846|NCT00576732|453250868|FG005|OPEN LABEL|Withdrawal by Subject|1|||
125988847|NCT00576732|453250863|FG000|OPEN LABEL|OTHER|0|||
125988848|NCT00576732|453250864|FG001|OPEN LABEL|OTHER|0|||
125988849|NCT00576732|453250865|FG002|OPEN LABEL|OTHER|0|||
125988850|NCT00576732|453250866|FG003|OPEN LABEL|OTHER|0|||
125988851|NCT00576732|453250867|FG004|OPEN LABEL|OTHER|0|||
125988852|NCT00576732|453250868|FG005|OPEN LABEL|OTHER|2|||
125988853|NCT00576732|453250863|FG000|OPEN LABEL|Lack of Efficacy|0|||
125988854|NCT00576732|453250864|FG001|OPEN LABEL|Lack of Efficacy|0|||
125988855|NCT00576732|453250865|FG002|OPEN LABEL|Lack of Efficacy|0|||
125988856|NCT00576732|453250866|FG003|OPEN LABEL|Lack of Efficacy|2|||
125988857|NCT00576732|453250867|FG004|OPEN LABEL|Lack of Efficacy|2|||
125988858|NCT00576732|453250868|FG005|OPEN LABEL|Lack of Efficacy|3|||
125988859|NCT00576732|453250863|FG000|OPEN LABEL|Protocol Violation|0|||
125988860|NCT00576732|453250864|FG001|OPEN LABEL|Protocol Violation|0|||
125988861|NCT00576732|453250865|FG002|OPEN LABEL|Protocol Violation|0|||
125988862|NCT00576732|453250866|FG003|OPEN LABEL|Protocol Violation|2|||
125988863|NCT00576732|453250867|FG004|OPEN LABEL|Protocol Violation|1|||
125988864|NCT00576732|453250868|FG005|OPEN LABEL|Protocol Violation|0|||
125988865|NCT02213328|453250871|FG000|Overall Study|Withdrawal by Subject|10|||
125988866|NCT02213328|453250871|FG000|Overall Study|Physician Decision|2|||
125988867|NCT02213328|453250871|FG000|Overall Study|Lost to Follow-up|16|||
125988868|NCT02487095|453250874|FG000|Dose Expansion|Unable to scan/restage participant|0|||
125988869|NCT02487095|453250875|FG001|Dose Expansion|Unable to scan/restage participant|0|||
125988870|NCT02487095|453250876|FG002|Dose Expansion|Unable to scan/restage participant|0|||
125988871|NCT02487095|453250877|FG003|Dose Expansion|Unable to scan/restage participant|0|||
125988872|NCT02487095|453250878|FG004|Dose Expansion|Unable to scan/restage participant|1|||
125988873|NCT01807650|453250879|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
125988874|NCT01807650|453250879|FG000|Overall Study|Adverse Event|5|||
125988875|NCT01807650|453250879|FG000|Overall Study|Other|2|||
125988876|NCT00962247|453250882|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
125988877|NCT00962247|453250882|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
125988878|NCT02234063|453250883|FG000|Overall Study|Lost to Follow-up|235|||
125988879|NCT02234063|453250884|FG001|Overall Study|Lost to Follow-up|42|||
125988880|NCT02234063|453250883|FG000|Overall Study|Withdrawal by Subject|20|||
125988881|NCT02234063|453250884|FG001|Overall Study|Withdrawal by Subject|1|||
125988882|NCT02946918|453250885|FG000|Overall Study|Patient unblinded himself|1|||
125988883|NCT02946918|453250886|FG001|Overall Study|Patient unblinded himself|0|||
125988884|NCT02946918|453250885|FG000|Overall Study|Physician Decision|0|||
125988885|NCT02946918|453250886|FG001|Overall Study|Physician Decision|2|||
125988886|NCT02946918|453250885|FG000|Overall Study|Ran out of study medication|0|||
125988887|NCT02946918|453250886|FG001|Overall Study|Ran out of study medication|1|||
125988888|NCT01125722|453250887|FG000|Overall Study|Withdrawal by Subject|2|||
125988889|NCT01125722|453250888|FG001|Overall Study|Withdrawal by Subject|1|||
125988890|NCT01125722|453250887|FG000|Overall Study|Lost to Follow-up|1|||
125988891|NCT01125722|453250888|FG001|Overall Study|Lost to Follow-up|0|||
125988892|NCT00069784|453250889|FG000|Overall Study|Adverse Event|105|||
125988893|NCT00069784|453250890|FG001|Overall Study|Adverse Event|0|||
125988894|NCT00069784|453250889|FG000|Overall Study|Withdrawal by Subject|1090|||
125988895|NCT00069784|453250890|FG001|Overall Study|Withdrawal by Subject|0|||
125988896|NCT00069784|453250889|FG000|Overall Study|Other|17|||
125988897|NCT00069784|453250890|FG001|Overall Study|Other|0|||
125988898|NCT01786330|453250897|FG000|Overall Study|Withdrawal by Subject|0|||
125988899|NCT01786330|453250898|FG001|Overall Study|Withdrawal by Subject|1|||
125988900|NCT01786330|453250897|FG000|Overall Study|Lost to Follow-up|0|||
125988901|NCT01786330|453250898|FG001|Overall Study|Lost to Follow-up|1|||
125988902|NCT01786330|453250897|FG000|Overall Study|Excluded intraoperatively|0|||
125988903|NCT01786330|453250898|FG001|Overall Study|Excluded intraoperatively|1|||
125988904|NCT01786330|453250897|FG000|Overall Study|Protocol Violation|1|||
125988905|NCT01786330|453250898|FG001|Overall Study|Protocol Violation|0|||
125988906|NCT02969525|453250901|FG000|Double-Blind Period|Adverse Event|0|||
125988907|NCT02969525|453250902|FG001|Double-Blind Period|Adverse Event|0|||
125988908|NCT02969525|453250903|FG002|Double-Blind Period|Adverse Event|1|||
125988909|NCT02969525|453250904|FG003|Double-Blind Period|Adverse Event|1|||
125988910|NCT02969525|453250905|FG004|Double-Blind Period|Adverse Event|0|||
125988911|NCT02969525|453250906|FG005|Double-Blind Period|Adverse Event|0|||
125988912|NCT02969525|453250907|FG006|Double-Blind Period|Adverse Event|0|||
125988913|NCT02969525|453250908|FG007|Double-Blind Period|Adverse Event|0|||
125988914|NCT02969525|453250909|FG008|Double-Blind Period|Adverse Event|0|||
125988915|NCT02969525|453250910|FG009|Double-Blind Period|Adverse Event|0|||
125988916|NCT02969525|453250911|FG010|Double-Blind Period|Adverse Event|0|||
125988917|NCT02969525|453250912|FG011|Double-Blind Period|Adverse Event|0|||
125988918|NCT02969525|453250901|FG000|Double-Blind Period|LOW EGFR|0|||
125988919|NCT02969525|453250902|FG001|Double-Blind Period|LOW EGFR|0|||
125988920|NCT02969525|453250903|FG002|Double-Blind Period|LOW EGFR|0|||
125988921|NCT02969525|453250904|FG003|Double-Blind Period|LOW EGFR|1|||
125988922|NCT02969525|453250905|FG004|Double-Blind Period|LOW EGFR|0|||
125988923|NCT02969525|453250906|FG005|Double-Blind Period|LOW EGFR|0|||
125988924|NCT02969525|453250907|FG006|Double-Blind Period|LOW EGFR|0|||
125988925|NCT02969525|453250908|FG007|Double-Blind Period|LOW EGFR|0|||
125988926|NCT02969525|453250909|FG008|Double-Blind Period|LOW EGFR|0|||
125988927|NCT02969525|453250910|FG009|Double-Blind Period|LOW EGFR|0|||
125988928|NCT02969525|453250911|FG010|Double-Blind Period|LOW EGFR|0|||
125988929|NCT02969525|453250912|FG011|Double-Blind Period|LOW EGFR|0|||
125988930|NCT02969525|453250901|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
125988931|NCT02969525|453250902|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988932|NCT02969525|453250903|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988933|NCT02969525|453250904|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
125988934|NCT02969525|453250905|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988935|NCT02969525|453250906|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988936|NCT02969525|453250907|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988937|NCT02969525|453250908|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988938|NCT02969525|453250909|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988939|NCT02969525|453250910|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988940|NCT02969525|453250911|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988941|NCT02969525|453250912|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125988942|NCT02969525|453250901|FG000|Dose-Blind Period|Adverse Event|0|||
125988943|NCT02969525|453250902|FG001|Dose-Blind Period|Adverse Event|0|||
125988944|NCT02969525|453250903|FG002|Dose-Blind Period|Adverse Event|0|||
125988945|NCT02969525|453250904|FG003|Dose-Blind Period|Adverse Event|0|||
125988946|NCT02969525|453250905|FG004|Dose-Blind Period|Adverse Event|0|||
125988947|NCT02969525|453250906|FG005|Dose-Blind Period|Adverse Event|0|||
125988948|NCT02969525|453250907|FG006|Dose-Blind Period|Adverse Event|0|||
125988949|NCT02969525|453250908|FG007|Dose-Blind Period|Adverse Event|0|||
125988950|NCT02969525|453250909|FG008|Dose-Blind Period|Adverse Event|0|||
125988951|NCT02969525|453250910|FG009|Dose-Blind Period|Adverse Event|1|||
125988952|NCT02969525|453250911|FG010|Dose-Blind Period|Adverse Event|1|||
125988953|NCT02969525|453250912|FG011|Dose-Blind Period|Adverse Event|1|||
125988954|NCT02969525|453250901|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
125988955|NCT02969525|453250902|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
125988956|NCT02969525|453250903|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
125988957|NCT02969525|453250904|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
125988958|NCT02969525|453250905|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
125988959|NCT02969525|453250906|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
125988960|NCT02969525|453250907|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
125988961|NCT02969525|453250908|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
125988962|NCT02969525|453250909|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
125988963|NCT02969525|453250910|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
125988964|NCT02969525|453250911|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
125988965|NCT02969525|453250912|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
125988966|NCT02969525|453250901|FG000|Dose-Blind Period|Non-cooperating patient|0|||
125988967|NCT02969525|453250902|FG001|Dose-Blind Period|Non-cooperating patient|0|||
125988968|NCT02969525|453250903|FG002|Dose-Blind Period|Non-cooperating patient|0|||
125988969|NCT02969525|453250904|FG003|Dose-Blind Period|Non-cooperating patient|0|||
125988970|NCT02969525|453250905|FG004|Dose-Blind Period|Non-cooperating patient|0|||
125988971|NCT02969525|453250906|FG005|Dose-Blind Period|Non-cooperating patient|0|||
125988972|NCT02969525|453250907|FG006|Dose-Blind Period|Non-cooperating patient|0|||
125988973|NCT02969525|453250908|FG007|Dose-Blind Period|Non-cooperating patient|0|||
125988974|NCT02969525|453250909|FG008|Dose-Blind Period|Non-cooperating patient|0|||
125988975|NCT02969525|453250910|FG009|Dose-Blind Period|Non-cooperating patient|0|||
125988976|NCT02969525|453250911|FG010|Dose-Blind Period|Non-cooperating patient|0|||
125988977|NCT02969525|453250912|FG011|Dose-Blind Period|Non-cooperating patient|1|||
125988978|NCT02969525|453250901|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988979|NCT02969525|453250902|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988980|NCT02969525|453250903|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988981|NCT02969525|453250904|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988982|NCT02969525|453250905|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988983|NCT02969525|453250906|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988984|NCT02969525|453250907|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988985|NCT02969525|453250908|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988986|NCT02969525|453250909|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988987|NCT02969525|453250910|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988988|NCT02969525|453250911|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
125988989|NCT02969525|453250912|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125988990|NCT02172625|453250913|FG000|Overall Study|Adverse Event|0|||
125988991|NCT02172625|453250914|FG001|Overall Study|Adverse Event|1|||
125988992|NCT02172625|453250913|FG000|Overall Study|Pregnancy|0|||
125988993|NCT02172625|453250914|FG001|Overall Study|Pregnancy|1|||
125988994|NCT02172625|453250913|FG000|Overall Study|car accident|0|||
125988995|NCT02172625|453250914|FG001|Overall Study|car accident|1|||
125988996|NCT00524030|453250915|FG000|Overall Study|Lack of Efficacy|10|||
125988997|NCT00524030|453250916|FG001|Overall Study|Lack of Efficacy|24|||
125988998|NCT00524030|453250915|FG000|Overall Study|Lost to Follow-up|0|||
125988999|NCT00524030|453250916|FG001|Overall Study|Lost to Follow-up|2|||
125989000|NCT00524030|453250915|FG000|Overall Study|Withdrawal by Subject|3|||
125989001|NCT00524030|453250916|FG001|Overall Study|Withdrawal by Subject|8|||
125989002|NCT00524030|453250915|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
125989003|NCT00524030|453250916|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
125989004|NCT00524030|453250915|FG000|Overall Study|Protocol Violation|0|||
125989005|NCT00524030|453250916|FG001|Overall Study|Protocol Violation|1|||
126330029|NCT01436227|454501783|FG000|Overall Study|Disease progression, relapse|6|||
125989006|NCT00524030|453250915|FG000|Overall Study|Pregnancy|1|||
125989007|NCT00524030|453250916|FG001|Overall Study|Pregnancy|0|||
125989008|NCT00524030|453250915|FG000|Overall Study|Adverse Event|3|||
125989009|NCT00524030|453250916|FG001|Overall Study|Adverse Event|21|||
125989010|NCT00524030|453250915|FG000|Overall Study|Death|0|||
125989011|NCT00524030|453250916|FG001|Overall Study|Death|1|||
125989012|NCT05648357|453252072|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
125989013|NCT00255346|453252073|FG000|Overall Study|Adverse Event|1|||
125989014|NCT00255346|453252074|FG001|Overall Study|Adverse Event|0|||
125989015|NCT00255346|453252075|FG002|Overall Study|Adverse Event|0|||
125989016|NCT00255346|453252076|FG003|Overall Study|Adverse Event|0|||
125989017|NCT00255346|453252077|FG004|Overall Study|Adverse Event|0|||
125989018|NCT00409786|453252078|FG000|Overall Study|Withdrawal by Subject|3|||
125989019|NCT01641926|453252084|FG000|Overall Study|Adverse Event|5|||
125989020|NCT01641926|453252085|FG001|Overall Study|Adverse Event|2|||
125989021|NCT01641926|453252086|FG002|Overall Study|Adverse Event|3|||
125989022|NCT01641926|453252087|FG003|Overall Study|Adverse Event|1|||
125989023|NCT01641926|453252084|FG000|Overall Study|Lost to Follow-up|2|||
125989024|NCT01641926|453252085|FG001|Overall Study|Lost to Follow-up|2|||
125989025|NCT01641926|453252086|FG002|Overall Study|Lost to Follow-up|1|||
125989026|NCT01641926|453252087|FG003|Overall Study|Lost to Follow-up|0|||
125989027|NCT01641926|453252084|FG000|Overall Study|Physician Decision|6|||
125989028|NCT01641926|453252085|FG001|Overall Study|Physician Decision|5|||
125989029|NCT01641926|453252086|FG002|Overall Study|Physician Decision|0|||
125989030|NCT01641926|453252087|FG003|Overall Study|Physician Decision|1|||
125989031|NCT01641926|453252084|FG000|Overall Study|Protocol Violation|1|||
125989032|NCT01641926|453252085|FG001|Overall Study|Protocol Violation|0|||
125989033|NCT01641926|453252086|FG002|Overall Study|Protocol Violation|0|||
125989034|NCT01641926|453252087|FG003|Overall Study|Protocol Violation|1|||
125989035|NCT01641926|453252084|FG000|Overall Study|Withdrawal by Subject|13|||
125989036|NCT01641926|453252085|FG001|Overall Study|Withdrawal by Subject|5|||
125989037|NCT01641926|453252086|FG002|Overall Study|Withdrawal by Subject|6|||
125989038|NCT01641926|453252087|FG003|Overall Study|Withdrawal by Subject|1|||
125989039|NCT01641926|453252084|FG000|Overall Study|Not Treated|1|||
125989040|NCT01641926|453252085|FG001|Overall Study|Not Treated|1|||
125989041|NCT01641926|453252086|FG002|Overall Study|Not Treated|1|||
125989042|NCT01641926|453252087|FG003|Overall Study|Not Treated|0|||
125989043|NCT01111838|453252088|FG000|Overall Study|Patient Ineligible|2|||
125989044|NCT01111838|453252088|FG000|Overall Study|Not Treated|3|||
125989045|NCT01111838|453252088|FG000|Overall Study|Clinical deterioration|1|||
125989046|NCT01111838|453252088|FG000|Overall Study|Other Complicating Disease|1|||
125989047|NCT03303469|453252093|FG000|Overall Study|Lost to Follow-up|2|||
125989048|NCT02567825|453252096|FG000|Overall Study|No follow-up post-randomization|5|||
125989049|NCT02567825|453252097|FG001|Overall Study|No follow-up post-randomization|1|||
125989050|NCT02567825|453252096|FG000|Overall Study|Follow-up less than 23 months|16|||
125989051|NCT02567825|453252097|FG001|Overall Study|Follow-up less than 23 months|20|||
125989052|NCT04741802|453252099|FG000|Overall Study|Death|1|||
125989053|NCT04741802|453252099|FG000|Overall Study|Lost to Follow-up|11|||
125989054|NCT01785563|453252102|FG000|Overall Study|Physician Decision|10|||
125989055|NCT01785563|453252102|FG000|Overall Study|Withdrawal by Subject|1|||
125989056|NCT01785563|453252102|FG000|Overall Study|Protocol Violation|2|||
125989057|NCT01540565|453252103|FG000|Overall Study|Ineligible|2|||
125989058|NCT04399356|453252104|FG000|Overall Study|Lost to Follow-up|1|||
125989059|NCT04399356|453252105|FG001|Overall Study|Lost to Follow-up|1|||
125989060|NCT04399356|453252104|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
125989061|NCT04399356|453252105|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
125989062|NCT04399356|453252104|FG000|Overall Study|Withdrawal by Subject|1|||
125989063|NCT04399356|453252105|FG001|Overall Study|Withdrawal by Subject|0|||
125989064|NCT03447730|453252106|FG000|Overall Study|Adverse Event|0|||
125989065|NCT03447730|453252107|FG001|Overall Study|Adverse Event|2|||
125989066|NCT03447730|453252108|FG002|Overall Study|Adverse Event|0|||
125989067|NCT00423852|453252111|FG000|Overall Study|Removed pior to the high-dose portion|3|||
125989068|NCT00572624|453252112|FG000|Overall Study|Lost to Follow-up|10|||
125989069|NCT00572624|453252113|FG001|Overall Study|Lost to Follow-up|4|||
125989070|NCT00572624|453252112|FG000|Overall Study|Wanted to do a different diet program|1|||
125989071|NCT00572624|453252113|FG001|Overall Study|Wanted to do a different diet program|0|||
125989072|NCT00572624|453252112|FG000|Overall Study|Medication change|1|||
125989073|NCT00572624|453252113|FG001|Overall Study|Medication change|0|||
125989074|NCT00572624|453252112|FG000|Overall Study|Started a new job-- no time for study|1|||
125989075|NCT00572624|453252113|FG001|Overall Study|Started a new job-- no time for study|0|||
125989076|NCT00572624|453252112|FG000|Overall Study|Admitted to being a smoker|1|||
125989077|NCT00572624|453252113|FG001|Overall Study|Admitted to being a smoker|0|||
125989078|NCT00572624|453252112|FG000|Overall Study|Refused to do the stress test|1|||
125989079|NCT00572624|453252113|FG001|Overall Study|Refused to do the stress test|0|||
125989080|NCT00572624|453252112|FG000|Overall Study|Problem with vascular access|1|||
125989081|NCT00572624|453252113|FG001|Overall Study|Problem with vascular access|0|||
125989082|NCT00572624|453252112|FG000|Overall Study|Health issues unrelated to the study|1|||
125989083|NCT00572624|453252113|FG001|Overall Study|Health issues unrelated to the study|0|||
125989084|NCT03107377|453252115|FG000|Overall Study|Adverse Event|3|||
125989085|NCT03107377|453252116|FG001|Overall Study|Adverse Event|3|||
125989086|NCT03107377|453252115|FG000|Overall Study|Protocol Violation|9|||
125989087|NCT03107377|453252116|FG001|Overall Study|Protocol Violation|12|||
125989088|NCT03107377|453252115|FG000|Overall Study|Physician Decision|3|||
125989089|NCT03107377|453252116|FG001|Overall Study|Physician Decision|6|||
125989090|NCT03107377|453252115|FG000|Overall Study|Pregnancy|7|||
125989091|NCT03107377|453252116|FG001|Overall Study|Pregnancy|7|||
125989092|NCT03107377|453252115|FG000|Overall Study|Withdrawal by Subject|16|||
125989093|NCT03107377|453252116|FG001|Overall Study|Withdrawal by Subject|22|||
125989094|NCT03107377|453252115|FG000|Overall Study|Lost to Follow-up|37|||
125989095|NCT03107377|453252116|FG001|Overall Study|Lost to Follow-up|34|||
125989096|NCT03107377|453252115|FG000|Overall Study|Other reason not specified|16|||
125989097|NCT03107377|453252116|FG001|Overall Study|Other reason not specified|15|||
125989098|NCT00130793|453252117|FG000|Overall Study|Lost to Follow-up|1|||
125989099|NCT00130793|453252118|FG001|Overall Study|Lost to Follow-up|4|||
125989100|NCT00130793|453252117|FG000|Overall Study|Withdrew consent|2|||
125989101|NCT00130793|453252118|FG001|Overall Study|Withdrew consent|0|||
125989102|NCT00211237|453252119|FG000|Baseline|Withdrew|1|||
125989103|NCT00211237|453252120|FG001|Baseline|Withdrew|3|||
125989104|NCT00211237|453252121|FG002|Baseline|Withdrew|0|||
125989105|NCT00211237|453252119|FG000|Baseline|Refused random assignment|1|||
125989106|NCT00211237|453252120|FG001|Baseline|Refused random assignment|0|||
125989107|NCT00211237|453252121|FG002|Baseline|Refused random assignment|0|||
125989108|NCT00211237|453252119|FG000|1 Month|Death|2|||
125989109|NCT00211237|453252120|FG001|1 Month|Death|1|||
125989110|NCT00211237|453252121|FG002|1 Month|Death|0|||
125989111|NCT00211237|453252119|FG000|1 Month|Lost to Follow-up|0|||
125989112|NCT00211237|453252120|FG001|1 Month|Lost to Follow-up|2|||
125989113|NCT00211237|453252121|FG002|1 Month|Lost to Follow-up|0|||
125989114|NCT00211237|453252119|FG000|1 Month|Withdrew|0|||
125989115|NCT00211237|453252120|FG001|1 Month|Withdrew|4|||
125989116|NCT00211237|453252121|FG002|1 Month|Withdrew|0|||
125989117|NCT00211237|453252119|FG000|1 Month|Additional surgery needed|1|||
125989118|NCT00211237|453252120|FG001|1 Month|Additional surgery needed|0|||
125989119|NCT00211237|453252121|FG002|1 Month|Additional surgery needed|0|||
125989120|NCT00211237|453252119|FG000|1 Month|Non-medical problem|0|||
125989121|NCT00211237|453252120|FG001|1 Month|Non-medical problem|2|||
125989122|NCT00211237|453252121|FG002|1 Month|Non-medical problem|0|||
125989123|NCT00211237|453252119|FG000|3 Months|Death|7|||
125989124|NCT00211237|453252120|FG001|3 Months|Death|3|||
125989125|NCT00211237|453252121|FG002|3 Months|Death|0|||
125989126|NCT00211237|453252119|FG000|3 Months|Could not comply with protocol|1|||
125989127|NCT00211237|453252120|FG001|3 Months|Could not comply with protocol|0|||
125989128|NCT00211237|453252121|FG002|3 Months|Could not comply with protocol|0|||
125989129|NCT00211237|453252119|FG000|3 Months|Withdrew|0|||
125989130|NCT00211237|453252120|FG001|3 Months|Withdrew|1|||
125989131|NCT00211237|453252121|FG002|3 Months|Withdrew|0|||
125989132|NCT00211237|453252119|FG000|3 Months|Non-medical problem|0|||
125989133|NCT00211237|453252120|FG001|3 Months|Non-medical problem|0|||
125989134|NCT00211237|453252121|FG002|3 Months|Non-medical problem|1|||
125989135|NCT00211237|453252119|FG000|6 Months|Death|6|||
125989136|NCT00211237|453252120|FG001|6 Months|Death|0|||
125989137|NCT00211237|453252121|FG002|6 Months|Death|3|||
125989138|NCT00211237|453252119|FG000|6 Months|Lost to Follow-up|2|||
125989139|NCT00211237|453252120|FG001|6 Months|Lost to Follow-up|0|||
125989140|NCT00211237|453252121|FG002|6 Months|Lost to Follow-up|0|||
125989141|NCT00211237|453252119|FG000|6 Months|Could not comply with protocol|0|||
125989142|NCT00211237|453252120|FG001|6 Months|Could not comply with protocol|2|||
125989143|NCT00211237|453252121|FG002|6 Months|Could not comply with protocol|0|||
126330030|NCT04004260|454501786|FG000|Overall Study|Withdrawal by Subject|7|||
126330031|NCT04004260|454501787|FG001|Overall Study|Withdrawal by Subject|3|||
126330032|NCT04004260|454501786|FG000|Overall Study|Lost to Follow-up|22|||
126330033|NCT04004260|454501787|FG001|Overall Study|Lost to Follow-up|12|||
125989144|NCT00211237|453252119|FG000|12 Months|Death|8|||
125989145|NCT00211237|453252120|FG001|12 Months|Death|2|||
125989146|NCT00211237|453252121|FG002|12 Months|Death|3|||
125989147|NCT00211237|453252119|FG000|12 Months|Lost to Follow-up|1|||
125989148|NCT00211237|453252120|FG001|12 Months|Lost to Follow-up|0|||
125989149|NCT00211237|453252121|FG002|12 Months|Lost to Follow-up|1|||
125989150|NCT00211237|453252119|FG000|12 Months|Withdrew|0|||
125989151|NCT00211237|453252120|FG001|12 Months|Withdrew|0|||
125989152|NCT00211237|453252121|FG002|12 Months|Withdrew|1|||
125989153|NCT00211237|453252119|FG000|12 Months|unrelated medical problem|0|||
125989154|NCT00211237|453252120|FG001|12 Months|unrelated medical problem|0|||
125989155|NCT00211237|453252121|FG002|12 Months|unrelated medical problem|1|||
125989156|NCT00453102|453252124|FG000|Overall Study|Withdrawal by Subject|2|||
125989157|NCT02100722|453252125|FG000|Overall Study|Withdrawal pre-procedure|4|||
125989158|NCT02100722|453252126|FG001|Overall Study|Withdrawal pre-procedure|9|||
125989159|NCT02100722|453252125|FG000|Overall Study|Withdrawal post-procedure|0|||
125989160|NCT02100722|453252126|FG001|Overall Study|Withdrawal post-procedure|3|||
125989161|NCT02100722|453252125|FG000|Overall Study|Lost to Follow-up|2|||
125989162|NCT02100722|453252126|FG001|Overall Study|Lost to Follow-up|2|||
125989163|NCT02100722|453252125|FG000|Overall Study|Continuing on study|751|||
125989164|NCT02100722|453252126|FG001|Overall Study|Continuing on study|729|||
125989165|NCT02541383|453252128|FG000|Overall Study|Death|50|||
125989166|NCT02541383|453252129|FG001|Overall Study|Death|37|||
125989167|NCT02541383|453252130|FG002|Overall Study|Death|48|||
125989168|NCT02541383|453252131|FG003|Overall Study|Death|41|||
125989169|NCT02541383|453252132|FG004|Overall Study|Death|21|||
125989170|NCT02541383|453252133|FG005|Overall Study|Death|25|||
125989171|NCT02541383|453252128|FG000|Overall Study|Lost to Follow-up|5|||
125989172|NCT02541383|453252129|FG001|Overall Study|Lost to Follow-up|3|||
125989173|NCT02541383|453252130|FG002|Overall Study|Lost to Follow-up|1|||
126330034|NCT04004260|454501786|FG000|Overall Study|Did not engage in intervention|13|||
125989174|NCT02541383|453252131|FG003|Overall Study|Lost to Follow-up|1|||
125989175|NCT02541383|453252132|FG004|Overall Study|Lost to Follow-up|3|||
125989176|NCT02541383|453252133|FG005|Overall Study|Lost to Follow-up|0|||
125989177|NCT02541383|453252128|FG000|Overall Study|Consent withdrawn|5|||
125989178|NCT02541383|453252129|FG001|Overall Study|Consent withdrawn|6|||
125989179|NCT02541383|453252130|FG002|Overall Study|Consent withdrawn|1|||
125989180|NCT02541383|453252131|FG003|Overall Study|Consent withdrawn|1|||
125989181|NCT02541383|453252132|FG004|Overall Study|Consent withdrawn|0|||
125989182|NCT02541383|453252133|FG005|Overall Study|Consent withdrawn|0|||
125989183|NCT02541383|453252128|FG000|Overall Study|Sponsor's decision|1|||
125989184|NCT02541383|453252129|FG001|Overall Study|Sponsor's decision|1|||
125989185|NCT02541383|453252130|FG002|Overall Study|Sponsor's decision|0|||
125989186|NCT02541383|453252131|FG003|Overall Study|Sponsor's decision|0|||
125989187|NCT02541383|453252132|FG004|Overall Study|Sponsor's decision|0|||
125989188|NCT02541383|453252133|FG005|Overall Study|Sponsor's decision|0|||
125989189|NCT03500640|453252134|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
125989190|NCT03500640|453252135|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
125989191|NCT03500640|453252136|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
125989192|NCT03500640|453252134|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
125989193|NCT03500640|453252135|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
125989194|NCT03500640|453252136|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
125989195|NCT03500640|453252134|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
125989196|NCT03500640|453252135|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
125989197|NCT03500640|453252136|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
125989198|NCT03500640|453252134|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
125989199|NCT03500640|453252135|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
125989200|NCT03500640|453252136|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
125989201|NCT03500640|453252134|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
125989202|NCT03500640|453252135|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
125989203|NCT03500640|453252136|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
125989204|NCT03500640|453252134|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
125989205|NCT03500640|453252135|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
125989206|NCT03500640|453252136|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
125989207|NCT03500640|453252134|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
125989208|NCT03500640|453252135|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
125989209|NCT03500640|453252136|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
125989210|NCT03500640|453252134|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
125989211|NCT03500640|453252135|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
125989212|NCT03500640|453252136|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
125989213|NCT03500640|453252134|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
125989214|NCT03500640|453252135|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
125989215|NCT03500640|453252136|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
125989216|NCT03500640|453252134|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
125989217|NCT03500640|453252135|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
125989218|NCT03500640|453252136|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
125989219|NCT01650519|453252137|FG000|Overall Study|Withdrawal by Subject|1|||
125989220|NCT01650519|453252138|FG001|Overall Study|Withdrawal by Subject|0|||
125989221|NCT05458024|453252141|FG000|Overall Study|Withdrawal by Subject|1|||
125989222|NCT05458024|453252142|FG001|Overall Study|Withdrawal by Subject|1|||
125989223|NCT05229653|453252144|FG000|Overall Study|Lost to Follow-up|1|||
125989224|NCT05229653|453252145|FG001|Overall Study|Lost to Follow-up|0|||
125989225|NCT01845974|453252146|FG000|Overall Study|screen failure|1|||
125989226|NCT01845974|453252147|FG001|Overall Study|screen failure|0|||
125989227|NCT02667886|453252148|FG000|Dose Escalation (Part A)|Adverse Event|1|||
125989228|NCT02667886|453252149|FG001|Dose Escalation (Part A)|Adverse Event|3|||
125989229|NCT02667886|453252150|FG002|Dose Escalation (Part A)|Adverse Event|1|||
125989230|NCT02667886|453252151|FG003|Dose Escalation (Part A)|Adverse Event|0|||
125989231|NCT02667886|453252152|FG004|Dose Escalation (Part A)|Adverse Event|0|||
125989232|NCT02667886|453252148|FG000|Dose Escalation (Part A)|Disease Progression|1|||
125989233|NCT02667886|453252149|FG001|Dose Escalation (Part A)|Disease Progression|4|||
125989234|NCT02667886|453252150|FG002|Dose Escalation (Part A)|Disease Progression|3|||
125989235|NCT02667886|453252151|FG003|Dose Escalation (Part A)|Disease Progression|0|||
125989236|NCT02667886|453252152|FG004|Dose Escalation (Part A)|Disease Progression|0|||
125989237|NCT02667886|453252148|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
125989238|NCT02667886|453252149|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
125989239|NCT02667886|453252150|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
125989240|NCT02667886|453252151|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
125989241|NCT02667886|453252152|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
125989242|NCT02667886|453252148|FG000|Dose Expansion (Part B)|Adverse Event|0|||
126091065|NCT04187326|453626893|FG000|Overall Study|Computer error- task was only partially completed.|0|||
126330035|NCT04004260|454501787|FG001|Overall Study|Did not engage in intervention|17|||
125989243|NCT02667886|453252149|FG001|Dose Expansion (Part B)|Adverse Event|0|||
125989244|NCT02667886|453252150|FG002|Dose Expansion (Part B)|Adverse Event|0|||
125989245|NCT02667886|453252151|FG003|Dose Expansion (Part B)|Adverse Event|9|||
125989246|NCT02667886|453252152|FG004|Dose Expansion (Part B)|Adverse Event|0|||
125989247|NCT02667886|453252148|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
125989248|NCT02667886|453252149|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
125989249|NCT02667886|453252150|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
125989250|NCT02667886|453252151|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
125989251|NCT02667886|453252152|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
125989252|NCT02667886|453252148|FG000|Dose Expansion (Part B)|Disease Progression|0|||
125989253|NCT02667886|453252149|FG001|Dose Expansion (Part B)|Disease Progression|0|||
125989254|NCT02667886|453252150|FG002|Dose Expansion (Part B)|Disease Progression|0|||
125989255|NCT02667886|453252151|FG003|Dose Expansion (Part B)|Disease Progression|38|||
125989256|NCT02667886|453252152|FG004|Dose Expansion (Part B)|Disease Progression|0|||
125989257|NCT02667886|453252148|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
125989258|NCT02667886|453252149|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
125989259|NCT02667886|453252150|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
125989260|NCT02667886|453252151|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
125989261|NCT02667886|453252152|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
125989262|NCT02667886|453252148|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125989263|NCT02667886|453252149|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125989264|NCT02667886|453252150|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125989265|NCT02667886|453252151|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125989266|NCT02667886|453252152|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
125989267|NCT02667886|453252148|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
125989268|NCT02667886|453252149|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
125989269|NCT02667886|453252150|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
125989270|NCT02667886|453252151|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
125989271|NCT02667886|453252152|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
125989272|NCT05672680|453252153|FG000|Overall Study|Patient Did Not Complete the Form|5|||
125989273|NCT05672680|453252154|FG001|Overall Study|Patient Did Not Complete the Form|4|||
125989274|NCT05672680|453252153|FG000|Overall Study|Procedure Aborted|1|||
125989275|NCT05672680|453252154|FG001|Overall Study|Procedure Aborted|0|||
125989276|NCT03635489|453252155|FG000|Overall Study|Death|19|||
125989277|NCT03635489|453252156|FG001|Overall Study|Death|13|||
125989278|NCT03635489|453252155|FG000|Overall Study|Lost to Follow-up|1|||
125989279|NCT03635489|453252156|FG001|Overall Study|Lost to Follow-up|2|||
125989280|NCT03635489|453252155|FG000|Overall Study|Withdrawal by Subject|1|||
125989281|NCT03635489|453252156|FG001|Overall Study|Withdrawal by Subject|2|||
125989282|NCT03635489|453252155|FG000|Overall Study|Study Ended by Sponsor|28|||
125989283|NCT03635489|453252156|FG001|Overall Study|Study Ended by Sponsor|34|||
125989284|NCT05096208|453252161|FG000|Overall Study|Lost to Follow-up|3|||
125989285|NCT05096208|453252162|FG001|Overall Study|Lost to Follow-up|5|||
125989286|NCT05096208|453252163|FG002|Overall Study|Lost to Follow-up|5|||
125989287|NCT05096208|453252164|FG003|Overall Study|Lost to Follow-up|2|||
125989288|NCT05096208|453252161|FG000|Overall Study|Withdrawal by Subject|0|||
125989289|NCT05096208|453252162|FG001|Overall Study|Withdrawal by Subject|1|||
125989290|NCT05096208|453252163|FG002|Overall Study|Withdrawal by Subject|2|||
125989291|NCT05096208|453252164|FG003|Overall Study|Withdrawal by Subject|3|||
125989292|NCT05096208|453252161|FG000|Overall Study|No longer met eligibility criteria|1|||
125989293|NCT05096208|453252162|FG001|Overall Study|No longer met eligibility criteria|0|||
125989294|NCT05096208|453252163|FG002|Overall Study|No longer met eligibility criteria|0|||
125989295|NCT05096208|453252164|FG003|Overall Study|No longer met eligibility criteria|0|||
125989296|NCT05096208|453252161|FG000|Overall Study|Other|0|||
125989297|NCT05096208|453252162|FG001|Overall Study|Other|0|||
125989298|NCT05096208|453252163|FG002|Overall Study|Other|1|||
125989299|NCT05096208|453252164|FG003|Overall Study|Other|0|||
125989300|NCT01279343|453252172|FG000|Overall Study|Did not receive treatment|2|||
125989301|NCT01279343|453252173|FG001|Overall Study|Did not receive treatment|6|||
125989302|NCT04534114|453252174|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
125989303|NCT04534114|453252175|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
125989304|NCT04534114|453252176|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
125989305|NCT04534114|453252177|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
125989306|NCT04534114|453252174|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
125989307|NCT04534114|453252175|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
125989308|NCT04534114|453252176|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
125989309|NCT04534114|453252177|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
125989310|NCT04534114|453252174|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
125989311|NCT04534114|453252175|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
125989312|NCT04534114|453252176|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
125989313|NCT04534114|453252177|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
126330036|NCT01765569|454501792|FG000|Period B|Withdrawal by Subject|1|||
125989314|NCT04534114|453252174|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
125989315|NCT04534114|453252175|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
125989316|NCT04534114|453252176|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
125989317|NCT04534114|453252177|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
125989318|NCT04534114|453252174|FG000|Main Treatment Period|Physician Decision|0|||
125989319|NCT04534114|453252175|FG001|Main Treatment Period|Physician Decision|0|||
125989320|NCT04534114|453252176|FG002|Main Treatment Period|Physician Decision|0|||
125989321|NCT04534114|453252177|FG003|Main Treatment Period|Physician Decision|1|||
125989322|NCT04534114|453252174|FG000|Main Treatment Period|Death|1|||
125989323|NCT04534114|453252175|FG001|Main Treatment Period|Death|0|||
125989324|NCT04534114|453252176|FG002|Main Treatment Period|Death|0|||
125989325|NCT04534114|453252177|FG003|Main Treatment Period|Death|1|||
125989326|NCT04534114|453252174|FG000|Main Treatment Period|Other reason|1|||
125989327|NCT04534114|453252175|FG001|Main Treatment Period|Other reason|1|||
125989328|NCT04534114|453252176|FG002|Main Treatment Period|Other reason|0|||
125989329|NCT04534114|453252177|FG003|Main Treatment Period|Other reason|0|||
125989330|NCT04534114|453252174|FG000|Main Treatment Period|Participant decision|1|||
125989331|NCT04534114|453252175|FG001|Main Treatment Period|Participant decision|3|||
125989332|NCT04534114|453252176|FG002|Main Treatment Period|Participant decision|3|||
125989333|NCT04534114|453252177|FG003|Main Treatment Period|Participant decision|1|||
125989334|NCT04534114|453252174|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
125989335|NCT04534114|453252175|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
125989336|NCT04534114|453252176|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
125989337|NCT04534114|453252177|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
125989338|NCT04534114|453252174|FG000|Main Treatment Period|Adverse Event|4|||
125989339|NCT04534114|453252175|FG001|Main Treatment Period|Adverse Event|2|||
125989340|NCT04534114|453252176|FG002|Main Treatment Period|Adverse Event|1|||
125989341|NCT04534114|453252177|FG003|Main Treatment Period|Adverse Event|2|||
125989342|NCT04534114|453252174|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
125989343|NCT04534114|453252175|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
125989344|NCT04534114|453252176|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
125989345|NCT04534114|453252177|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
125989346|NCT04534114|453252174|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
125989347|NCT04534114|453252175|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
125989348|NCT04534114|453252176|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
125989349|NCT04534114|453252177|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
125989350|NCT04534114|453252174|FG000|Extension Treatment Period|Other reason|0|||
125989351|NCT04534114|453252175|FG001|Extension Treatment Period|Other reason|1|||
125989352|NCT04534114|453252176|FG002|Extension Treatment Period|Other reason|0|||
125989353|NCT04534114|453252177|FG003|Extension Treatment Period|Other reason|0|||
125989354|NCT04534114|453252174|FG000|Extension Treatment Period|Death|0|||
125989355|NCT04534114|453252175|FG001|Extension Treatment Period|Death|0|||
125989356|NCT04534114|453252176|FG002|Extension Treatment Period|Death|1|||
125989357|NCT04534114|453252177|FG003|Extension Treatment Period|Death|2|||
125989358|NCT04534114|453252174|FG000|Extension Treatment Period|Adverse Event|0|||
125989359|NCT04534114|453252175|FG001|Extension Treatment Period|Adverse Event|1|||
125989360|NCT04534114|453252176|FG002|Extension Treatment Period|Adverse Event|0|||
125989361|NCT04534114|453252177|FG003|Extension Treatment Period|Adverse Event|1|||
125989362|NCT04534114|453252174|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
125989363|NCT04534114|453252175|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
125989364|NCT04534114|453252176|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
125989365|NCT04534114|453252177|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
125989366|NCT02613221|453252183|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
125989367|NCT02613221|453252183|FG000|Overall Study|Adverse Event|2|||
125989368|NCT02613221|453252183|FG000|Overall Study|Voluntary Discontinuation|1|||
125989369|NCT02613221|453252183|FG000|Overall Study|Delayed Treatment|1|||
125989370|NCT02613221|453252183|FG000|Overall Study|Enrolled but Not Treated|1|||
125989371|NCT00399763|453252186|FG000|Overall Study|Lost to Follow-up|2|||
125989372|NCT00399763|453252187|FG001|Overall Study|Lost to Follow-up|3|||
125989373|NCT01657266|453252191|FG000|Overall Study|Lost to Follow-up|2|||
125989374|NCT01657266|453252192|FG001|Overall Study|Lost to Follow-up|2|||
125989375|NCT01657266|453252191|FG000|Overall Study|Adverse Event|2|||
125989376|NCT01657266|453252192|FG001|Overall Study|Adverse Event|3|||
125989377|NCT02944656|453252196|FG000|Overall Study|No longer eligible|3|||
125989378|NCT02944656|453252197|FG001|Overall Study|No longer eligible|0|||
125989379|NCT02944656|453252196|FG000|Overall Study|Lost to Follow-up|7|||
125989380|NCT02944656|453252197|FG001|Overall Study|Lost to Follow-up|10|||
125989381|NCT02243631|453254025|FG000|Overall Study|no synovial fluid on second aspirate|0|||
125989382|NCT02243631|453254026|FG001|Overall Study|no synovial fluid on second aspirate|1|||
126330037|NCT01765569|454501792|FG000|Period C|Death|1|||
126330038|NCT03414229|454501793|FG000|Overall Study|Adverse Event|1|||
125989383|NCT01785628|453254029|FG000|Overall Study|Lost to Follow-up|2|||
125989384|NCT01785628|453254030|FG001|Overall Study|Lost to Follow-up|3|||
125989385|NCT00840996|453254031|FG000|Overall Study|Withdrawal by Subject|1|||
125989386|NCT00840996|453254032|FG001|Overall Study|Withdrawal by Subject|0|||
125989387|NCT00957931|453254034|FG000|Overall Study|Death|4|||
125989388|NCT00857805|453254035|FG000|Overall Study|Withdrawal by Subject|1|||
125989389|NCT00857805|453254036|FG001|Overall Study|Withdrawal by Subject|1|||
125989390|NCT04867785|453254037|FG000|Overall Study|Adverse Event|1|||
125989391|NCT04867785|453254038|FG001|Overall Study|Adverse Event|0|||
125989392|NCT04867785|453254039|FG002|Overall Study|Adverse Event|1|||
125989393|NCT04867785|453254040|FG003|Overall Study|Adverse Event|0|||
125989394|NCT04867785|453254041|FG004|Overall Study|Adverse Event|0|||
125989395|NCT04867785|453254042|FG005|Overall Study|Adverse Event|0|||
125989396|NCT04867785|453254043|FG006|Overall Study|Adverse Event|0|||
125989397|NCT04867785|453254044|FG007|Overall Study|Adverse Event|2|||
125989398|NCT04867785|453254037|FG000|Overall Study|Lost to Follow-up|4|||
125989399|NCT04867785|453254038|FG001|Overall Study|Lost to Follow-up|4|||
125989400|NCT04867785|453254039|FG002|Overall Study|Lost to Follow-up|3|||
125989401|NCT04867785|453254040|FG003|Overall Study|Lost to Follow-up|2|||
125989402|NCT04867785|453254041|FG004|Overall Study|Lost to Follow-up|0|||
125989403|NCT04867785|453254042|FG005|Overall Study|Lost to Follow-up|1|||
125989404|NCT04867785|453254043|FG006|Overall Study|Lost to Follow-up|0|||
125989405|NCT04867785|453254044|FG007|Overall Study|Lost to Follow-up|1|||
125989406|NCT04867785|453254037|FG000|Overall Study|Withdrawal by Subject|6|||
125989407|NCT04867785|453254038|FG001|Overall Study|Withdrawal by Subject|2|||
125989408|NCT04867785|453254039|FG002|Overall Study|Withdrawal by Subject|2|||
125989409|NCT04867785|453254040|FG003|Overall Study|Withdrawal by Subject|1|||
125989410|NCT04867785|453254041|FG004|Overall Study|Withdrawal by Subject|2|||
125989411|NCT04867785|453254042|FG005|Overall Study|Withdrawal by Subject|0|||
125989412|NCT04867785|453254043|FG006|Overall Study|Withdrawal by Subject|2|||
125989413|NCT04867785|453254044|FG007|Overall Study|Withdrawal by Subject|5|||
125989414|NCT04867785|453254037|FG000|Overall Study|Physician Decision|0|||
125989415|NCT04867785|453254038|FG001|Overall Study|Physician Decision|0|||
125989416|NCT04867785|453254039|FG002|Overall Study|Physician Decision|0|||
125989417|NCT04867785|453254040|FG003|Overall Study|Physician Decision|0|||
125989418|NCT04867785|453254041|FG004|Overall Study|Physician Decision|0|||
125989419|NCT04867785|453254042|FG005|Overall Study|Physician Decision|0|||
125989420|NCT04867785|453254043|FG006|Overall Study|Physician Decision|0|||
125989421|NCT04867785|453254044|FG007|Overall Study|Physician Decision|1|||
125989422|NCT04867785|453254037|FG000|Overall Study|Inadvertent Enrollment|0|||
125989423|NCT04867785|453254038|FG001|Overall Study|Inadvertent Enrollment|0|||
125989424|NCT04867785|453254039|FG002|Overall Study|Inadvertent Enrollment|0|||
125989425|NCT04867785|453254040|FG003|Overall Study|Inadvertent Enrollment|1|||
125989426|NCT04867785|453254041|FG004|Overall Study|Inadvertent Enrollment|1|||
125989427|NCT04867785|453254042|FG005|Overall Study|Inadvertent Enrollment|0|||
125989428|NCT04867785|453254043|FG006|Overall Study|Inadvertent Enrollment|0|||
125989429|NCT04867785|453254044|FG007|Overall Study|Inadvertent Enrollment|1|||
125989430|NCT04867785|453254037|FG000|Overall Study|Eligibility Criteria Not Met|0|||
125989431|NCT04867785|453254038|FG001|Overall Study|Eligibility Criteria Not Met|0|||
125989432|NCT04867785|453254039|FG002|Overall Study|Eligibility Criteria Not Met|0|||
125989433|NCT04867785|453254040|FG003|Overall Study|Eligibility Criteria Not Met|0|||
125989434|NCT04867785|453254041|FG004|Overall Study|Eligibility Criteria Not Met|0|||
125989435|NCT04867785|453254042|FG005|Overall Study|Eligibility Criteria Not Met|0|||
125989436|NCT04867785|453254043|FG006|Overall Study|Eligibility Criteria Not Met|0|||
125989437|NCT04867785|453254044|FG007|Overall Study|Eligibility Criteria Not Met|1|||
125989438|NCT01289041|453254045|FG000|Overall Study|Adverse Event|24|||
125989439|NCT01289041|453254045|FG000|Overall Study|Physician Decision|1|||
125989440|NCT01289041|453254045|FG000|Overall Study|Progressive Disease|41|||
125989441|NCT01289041|453254045|FG000|Overall Study|Withdrawal by Subject|3|||
125989442|NCT01289041|453254045|FG000|Overall Study|Death|1|||
125989443|NCT02670538|453254051|FG000|Overall Study|Withdrawal of Consent|8|||
125989444|NCT02670538|453254052|FG001|Overall Study|Withdrawal of Consent|6|||
125989445|NCT02670538|453254053|FG002|Overall Study|Withdrawal of Consent|5|||
125989446|NCT02670538|453254051|FG000|Overall Study|Lost to Follow-up|8|||
125989447|NCT02670538|453254052|FG001|Overall Study|Lost to Follow-up|12|||
125989448|NCT02670538|453254053|FG002|Overall Study|Lost to Follow-up|7|||
125989449|NCT02670538|453254051|FG000|Overall Study|Adverse Event|5|||
125989450|NCT02670538|453254052|FG001|Overall Study|Adverse Event|5|||
125989451|NCT02670538|453254053|FG002|Overall Study|Adverse Event|11|||
125989452|NCT02670538|453254051|FG000|Overall Study|Lack of Efficacy|7|||
125989453|NCT02670538|453254052|FG001|Overall Study|Lack of Efficacy|1|||
125989454|NCT02670538|453254053|FG002|Overall Study|Lack of Efficacy|2|||
125989455|NCT02670538|453254051|FG000|Overall Study|Protocol Violation|3|||
125989456|NCT02670538|453254052|FG001|Overall Study|Protocol Violation|4|||
126330039|NCT03414229|454501794|FG001|Overall Study|Adverse Event|0|||
125989457|NCT02670538|453254053|FG002|Overall Study|Protocol Violation|1|||
125989458|NCT02670538|453254051|FG000|Overall Study|Noncompliance with Study Drug|1|||
125989459|NCT02670538|453254052|FG001|Overall Study|Noncompliance with Study Drug|3|||
125989460|NCT02670538|453254053|FG002|Overall Study|Noncompliance with Study Drug|2|||
125989461|NCT02670538|453254051|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125989462|NCT02670538|453254052|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125989463|NCT02670538|453254053|FG002|Overall Study|Other Miscellaneous Reasons|2|||
125989464|NCT00674323|453254054|FG000|Overall Study|Adverse Event|0|||
125989465|NCT00674323|453254055|FG001|Overall Study|Adverse Event|1|||
125989466|NCT00674323|453254056|FG002|Overall Study|Adverse Event|0|||
125989467|NCT00674323|453254054|FG000|Overall Study|Protocol Violation|1|||
125989468|NCT00674323|453254055|FG001|Overall Study|Protocol Violation|0|||
125989469|NCT00674323|453254056|FG002|Overall Study|Protocol Violation|0|||
125989470|NCT02045433|453254060|FG000|Overall Study|Withdrawal by Subject|1|||
125989471|NCT02440594|453254063|FG000|Overall Study|Lost to Follow-up|34|||
125989472|NCT02440594|453254064|FG001|Overall Study|Lost to Follow-up|33|||
125989473|NCT02440594|453254065|FG002|Overall Study|Lost to Follow-up|54|||
125989474|NCT02440594|453254066|FG003|Overall Study|Lost to Follow-up|47|||
125989475|NCT02440594|453254067|FG004|Overall Study|Lost to Follow-up|5|||
125989476|NCT02440594|453254068|FG005|Overall Study|Lost to Follow-up|4|||
125989477|NCT02440594|453254069|FG006|Overall Study|Lost to Follow-up|28|||
125989478|NCT02440594|453254070|FG007|Overall Study|Lost to Follow-up|48|||
125989479|NCT02440594|453254063|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
125989480|NCT02440594|453254064|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
125989481|NCT02440594|453254065|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
125989482|NCT02440594|453254066|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
125989483|NCT02440594|453254067|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
125989484|NCT02440594|453254068|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
125989485|NCT02440594|453254069|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
125989486|NCT02440594|453254070|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
125989487|NCT02440594|453254063|FG000|Overall Study|Withdrawal by Subject|81|||
125989488|NCT02440594|453254064|FG001|Overall Study|Withdrawal by Subject|67|||
125989489|NCT02440594|453254065|FG002|Overall Study|Withdrawal by Subject|59|||
125989490|NCT02440594|453254066|FG003|Overall Study|Withdrawal by Subject|38|||
125989491|NCT02440594|453254067|FG004|Overall Study|Withdrawal by Subject|2|||
125989492|NCT02440594|453254068|FG005|Overall Study|Withdrawal by Subject|2|||
125989493|NCT02440594|453254069|FG006|Overall Study|Withdrawal by Subject|7|||
125989494|NCT02440594|453254070|FG007|Overall Study|Withdrawal by Subject|7|||
125989495|NCT02440594|453254063|FG000|Overall Study|Administratively w/drawn|3|||
125989496|NCT02440594|453254064|FG001|Overall Study|Administratively w/drawn|2|||
125989497|NCT02440594|453254065|FG002|Overall Study|Administratively w/drawn|0|||
125989498|NCT02440594|453254066|FG003|Overall Study|Administratively w/drawn|0|||
125989499|NCT02440594|453254067|FG004|Overall Study|Administratively w/drawn|0|||
125989500|NCT02440594|453254068|FG005|Overall Study|Administratively w/drawn|0|||
125989501|NCT02440594|453254069|FG006|Overall Study|Administratively w/drawn|2|||
125989502|NCT02440594|453254070|FG007|Overall Study|Administratively w/drawn|1|||
125989503|NCT00584805|453254071|FG000|Overall Study|No longer at risk of exposure|39|||
125989504|NCT00584805|453254071|FG000|Overall Study|Relocation|36|||
125989505|NCT00584805|453254071|FG000|Overall Study|Withdrawal by Subject|18|||
125989506|NCT00584805|453254071|FG000|Overall Study|Non-compliance|1|||
125989507|NCT00584805|453254071|FG000|Overall Study|Lost to follow up|3|||
125989508|NCT00584805|453254071|FG000|Overall Study|Screen failures|2|||
125989509|NCT01993823|453254072|FG000|Overall Study|Requested by the patient|6|||
125989510|NCT01993823|453254073|FG001|Overall Study|Requested by the patient|11|||
125989511|NCT01993823|453254072|FG000|Overall Study|Protocol Violation|0|||
125989512|NCT01993823|453254073|FG001|Overall Study|Protocol Violation|1|||
125989513|NCT01993823|453254072|FG000|Overall Study|Lost to Follow-up|1|||
125989514|NCT01993823|453254073|FG001|Overall Study|Lost to Follow-up|4|||
125989515|NCT02341456|453254074|FG000|Overall Study|Disease progression|2|||
125989516|NCT02341456|453254075|FG001|Overall Study|Disease progression|3|||
126330040|NCT03414229|454501795|FG002|Overall Study|Adverse Event|2|||
126330041|NCT03414229|454501796|FG003|Overall Study|Adverse Event|1|||
126330042|NCT03414229|454501793|FG000|Overall Study|Lack of Efficacy|7|||
126330043|NCT03414229|454501794|FG001|Overall Study|Lack of Efficacy|4|||
126330044|NCT03414229|454501795|FG002|Overall Study|Lack of Efficacy|1|||
126330045|NCT03414229|454501796|FG003|Overall Study|Lack of Efficacy|9|||
126330046|NCT03414229|454501793|FG000|Overall Study|Change in therapy|1|||
126330047|NCT03414229|454501794|FG001|Overall Study|Change in therapy|0|||
126330048|NCT03414229|454501795|FG002|Overall Study|Change in therapy|0|||
125989517|NCT02341456|453254076|FG002|Overall Study|Disease progression|1|||
125989518|NCT02341456|453254074|FG000|Overall Study|Death|1|||
125989519|NCT02341456|453254075|FG001|Overall Study|Death|1|||
125989520|NCT02341456|453254076|FG002|Overall Study|Death|1|||
125989521|NCT02341456|453254074|FG000|Overall Study|Withdrawal by Subject|0|||
125989522|NCT02341456|453254075|FG001|Overall Study|Withdrawal by Subject|1|||
125989523|NCT02341456|453254076|FG002|Overall Study|Withdrawal by Subject|1|||
125989524|NCT02341456|453254074|FG000|Overall Study|Moved to local access programme.|0|||
125989525|NCT02341456|453254075|FG001|Overall Study|Moved to local access programme.|1|||
126330049|NCT03414229|454501796|FG003|Overall Study|Change in therapy|0|||
126330050|NCT03414229|454501793|FG000|Overall Study|Pregnancy|0|||
125989526|NCT02341456|453254076|FG002|Overall Study|Moved to local access programme.|1|||
125989527|NCT02341456|453254074|FG000|Overall Study|Physician Decision|1|||
125989528|NCT02341456|453254075|FG001|Overall Study|Physician Decision|0|||
125989529|NCT02341456|453254076|FG002|Overall Study|Physician Decision|0|||
125989530|NCT01077362|453254077|FG000|Overall Study|Lack of Efficacy|13|||
125989531|NCT01077362|453254078|FG001|Overall Study|Lack of Efficacy|8|||
125989532|NCT01077362|453254079|FG002|Overall Study|Lack of Efficacy|10|||
125989533|NCT01077362|453254077|FG000|Overall Study|Lost to Follow-up|1|||
125989534|NCT01077362|453254078|FG001|Overall Study|Lost to Follow-up|0|||
125989535|NCT01077362|453254079|FG002|Overall Study|Lost to Follow-up|3|||
125989536|NCT01077362|453254077|FG000|Overall Study|Adverse Event|12|||
125989537|NCT01077362|453254078|FG001|Overall Study|Adverse Event|7|||
125989538|NCT01077362|453254079|FG002|Overall Study|Adverse Event|4|||
125989539|NCT01077362|453254077|FG000|Overall Study|Withdrawal by Subject|5|||
125989540|NCT01077362|453254078|FG001|Overall Study|Withdrawal by Subject|3|||
125989541|NCT01077362|453254079|FG002|Overall Study|Withdrawal by Subject|5|||
125989542|NCT01077362|453254077|FG000|Overall Study|Other|0|||
125989543|NCT01077362|453254078|FG001|Overall Study|Other|1|||
125989544|NCT01077362|453254079|FG002|Overall Study|Other|2|||
125989545|NCT00301080|453254080|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
125989546|NCT00301080|453254081|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
125989547|NCT00301080|453254082|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
125989548|NCT00301080|453254083|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
125989549|NCT00301080|453254084|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
125989550|NCT01872910|453254085|FG000|Overall Study|Lost to Follow-up|2|||
125989551|NCT01872910|453254086|FG001|Overall Study|Lost to Follow-up|0|||
125989552|NCT01872910|453254087|FG002|Overall Study|Lost to Follow-up|2|||
125989553|NCT01872910|453254088|FG003|Overall Study|Lost to Follow-up|0|||
125989554|NCT01872910|453254089|FG004|Overall Study|Lost to Follow-up|0|||
125989555|NCT01872910|453254090|FG005|Overall Study|Lost to Follow-up|0|||
125989556|NCT03101241|453254091|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
125989557|NCT03101241|453254092|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
125989558|NCT03101241|453254091|FG000|Overall Study|Participant withdrew consent|3|||
125989559|NCT03101241|453254092|FG001|Overall Study|Participant withdrew consent|1|||
125989560|NCT03101241|453254091|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
125989561|NCT03101241|453254092|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
125989562|NCT03101241|453254091|FG000|Overall Study|Lost to Follow-up|2|||
125989563|NCT03101241|453254092|FG001|Overall Study|Lost to Follow-up|0|||
125989564|NCT03101241|453254091|FG000|Overall Study|Lack of Efficacy|0|||
125989565|NCT03101241|453254092|FG001|Overall Study|Lack of Efficacy|1|||
125989566|NCT03101241|453254091|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
125989567|NCT03101241|453254092|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
125989568|NCT01678820|453254093|FG000|Overall Study|Study Terminated by Sponsor|45|||
125989569|NCT01678820|453254094|FG001|Overall Study|Study Terminated by Sponsor|43|||
125989570|NCT01678820|453254095|FG002|Overall Study|Study Terminated by Sponsor|43|||
125989571|NCT01678820|453254093|FG000|Overall Study|Withdrawal by Subject|2|||
125989572|NCT01678820|453254094|FG001|Overall Study|Withdrawal by Subject|5|||
125989573|NCT01678820|453254095|FG002|Overall Study|Withdrawal by Subject|2|||
125989574|NCT01678820|453254093|FG000|Overall Study|Protocol Specified Criteria|2|||
125989575|NCT01678820|453254094|FG001|Overall Study|Protocol Specified Criteria|3|||
125989576|NCT01678820|453254095|FG002|Overall Study|Protocol Specified Criteria|1|||
125989577|NCT01678820|453254093|FG000|Overall Study|Adverse Event|2|||
125989578|NCT01678820|453254094|FG001|Overall Study|Adverse Event|2|||
125989579|NCT01678820|453254095|FG002|Overall Study|Adverse Event|2|||
125989580|NCT01678820|453254093|FG000|Overall Study|Lost to Follow-up|7|||
125989581|NCT01678820|453254094|FG001|Overall Study|Lost to Follow-up|2|||
125989582|NCT01678820|453254095|FG002|Overall Study|Lost to Follow-up|2|||
125989583|NCT01678820|453254093|FG000|Overall Study|Non-compliance with study drug|0|||
125989584|NCT01678820|453254094|FG001|Overall Study|Non-compliance with study drug|1|||
125989585|NCT01678820|453254095|FG002|Overall Study|Non-compliance with study drug|0|||
125989586|NCT01678820|453254093|FG000|Overall Study|Physician Decision|0|||
125989587|NCT01678820|453254094|FG001|Overall Study|Physician Decision|0|||
125989588|NCT01678820|453254095|FG002|Overall Study|Physician Decision|1|||
125989589|NCT01678820|453254093|FG000|Overall Study|Protocol Violation|4|||
125989590|NCT01678820|453254094|FG001|Overall Study|Protocol Violation|5|||
125989591|NCT01678820|453254095|FG002|Overall Study|Protocol Violation|4|||
125989592|NCT01678820|453254093|FG000|Overall Study|Not treated with double-blind study drug|0|||
125989593|NCT01678820|453254094|FG001|Overall Study|Not treated with double-blind study drug|2|||
125989594|NCT01678820|453254095|FG002|Overall Study|Not treated with double-blind study drug|2|||
125989595|NCT02306265|453254096|FG000|Overall Study|Withdrawal by Subject|1|||
125989596|NCT00980005|453254099|FG000|Overall Study|Withdrawal by Subject|6|||
125989597|NCT00980005|453254100|FG001|Overall Study|Withdrawal by Subject|17|||
125989598|NCT00980005|453254099|FG000|Overall Study|Lost to Follow-up|37|||
125989599|NCT00980005|453254100|FG001|Overall Study|Lost to Follow-up|43|||
125989600|NCT00980005|453254099|FG000|Overall Study|Other|4|||
126330051|NCT03414229|454501794|FG001|Overall Study|Pregnancy|0|||
126330052|NCT03414229|454501795|FG002|Overall Study|Pregnancy|1|||
126330053|NCT03414229|454501796|FG003|Overall Study|Pregnancy|0|||
126330054|NCT03414229|454501793|FG000|Overall Study|Withdrawal by Subject|0|||
126330055|NCT03414229|454501794|FG001|Overall Study|Withdrawal by Subject|1|||
126330056|NCT03414229|454501795|FG002|Overall Study|Withdrawal by Subject|1|||
126330057|NCT03414229|454501796|FG003|Overall Study|Withdrawal by Subject|0|||
126330058|NCT04533438|454501800|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
126330059|NCT04533438|454501801|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
126330060|NCT05568797|454501805|FG000|Overall Study|Adverse Event|0|||
126330061|NCT05568797|454501806|FG001|Overall Study|Adverse Event|8|||
126330062|NCT05568797|454501805|FG000|Overall Study|Lost to Follow-up|2|||
126330063|NCT05568797|454501806|FG001|Overall Study|Lost to Follow-up|3|||
126330064|NCT05568797|454501805|FG000|Overall Study|Withdrawal by Subject|1|||
125878578|NCT02702492|452851327|FG000|Overall Study|Other|0|||
125878579|NCT02702492|452851328|FG001|Overall Study|Other|0|||
125878580|NCT02702492|452851329|FG002|Overall Study|Other|0|||
125878581|NCT02702492|452851330|FG003|Overall Study|Other|0|||
125878582|NCT02702492|452851331|FG004|Overall Study|Other|0|||
125878583|NCT02702492|452851332|FG005|Overall Study|Other|0|||
125878584|NCT02702492|452851333|FG006|Overall Study|Other|0|||
125878585|NCT02702492|452851334|FG007|Overall Study|Other|0|||
125878586|NCT02702492|452851335|FG008|Overall Study|Other|0|||
125878587|NCT02702492|452851336|FG009|Overall Study|Other|0|||
125878588|NCT02702492|452851337|FG010|Overall Study|Other|0|||
125878589|NCT02702492|452851338|FG011|Overall Study|Other|0|||
125878590|NCT02702492|452851339|FG012|Overall Study|Other|1|||
125878591|NCT01824836|452851340|FG000|Overall Study|Adverse Event|48|||
125878592|NCT01824836|452851340|FG000|Overall Study|Withdrawal by Subject|63|||
125878593|NCT01824836|452851340|FG000|Overall Study|Other complicating disease|116|||
125878594|NCT01824836|452851340|FG000|Overall Study|Disease progression|5|||
125878595|NCT01824836|452851340|FG000|Overall Study|Alternative therapy|2|||
125878596|NCT01824836|452851340|FG000|Overall Study|Depression|1|||
125878597|NCT01824836|452851340|FG000|Overall Study|Non-compliance|3|||
125878598|NCT01824836|452851340|FG000|Overall Study|Patient regained ovarian function|3|||
125878599|NCT01824836|452851340|FG000|Overall Study|Lost to Follow-up|8|||
125878600|NCT01824836|452851340|FG000|Overall Study|Physician Decision|2|||
125878601|NCT01824836|452851340|FG000|Overall Study|Research office was closed|3|||
125878602|NCT01824836|452851340|FG000|Overall Study|Relocation|3|||
125878603|NCT01824836|452851340|FG000|Overall Study|Insurance-related issue|1|||
125878604|NCT01824836|452851340|FG000|Overall Study|Transportation issue|1|||
125878605|NCT01824836|452851340|FG000|Overall Study|Patient transferred care|1|||
125878606|NCT01824836|452851340|FG000|Overall Study|Unknown reasons|4|||
125878607|NCT01824836|452851340|FG000|Overall Study|Never started treatment|16|||
125878608|NCT00303069|452853363|FG000|Overall Study|Lost to Follow-up|1|||
125878609|NCT00303069|452853364|FG001|Overall Study|Lost to Follow-up|0|||
125878610|NCT00303069|452853365|FG002|Overall Study|Lost to Follow-up|0|||
125878611|NCT00303069|452853366|FG003|Overall Study|Lost to Follow-up|2|||
125878612|NCT00303069|452853363|FG000|Overall Study|subject moved|1|||
125878613|NCT00303069|452853364|FG001|Overall Study|subject moved|0|||
125878614|NCT00303069|452853365|FG002|Overall Study|subject moved|0|||
125878615|NCT00303069|452853366|FG003|Overall Study|subject moved|0|||
125878616|NCT00303069|452853363|FG000|Overall Study|Recruitment into Army Reserves|0|||
125878617|NCT00303069|452853364|FG001|Overall Study|Recruitment into Army Reserves|0|||
125878618|NCT00303069|452853365|FG002|Overall Study|Recruitment into Army Reserves|1|||
125878619|NCT00303069|452853366|FG003|Overall Study|Recruitment into Army Reserves|0|||
125878620|NCT00092417|452853367|FG000|Overall Study|Lost to Follow-up|2|||
125878621|NCT00092417|452853368|FG001|Overall Study|Lost to Follow-up|0|||
125878622|NCT00092417|452853367|FG000|Overall Study|Withdrawal by Subject|2|||
125878623|NCT00092417|452853368|FG001|Overall Study|Withdrawal by Subject|1|||
125878624|NCT00092417|452853367|FG000|Overall Study|Other|1|||
125878625|NCT00092417|452853368|FG001|Overall Study|Other|0|||
125878626|NCT00751296|452853370|FG000|Overall Study|Adverse Event|2|||
125878627|NCT01972217|452853371|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125878628|NCT01972217|452853372|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
125878629|NCT01972217|452853373|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125878630|NCT01972217|452853374|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125878631|NCT01972217|452853371|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
125878632|NCT01972217|452853372|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
125878633|NCT01972217|452853373|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
125878634|NCT01972217|452853374|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
125878635|NCT01972217|452853371|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125878636|NCT01972217|452853372|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
125878637|NCT01972217|452853373|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125878638|NCT01972217|452853374|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125878639|NCT01972217|452853371|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
125989601|NCT00980005|453254100|FG001|Overall Study|Other|3|||
125989602|NCT00692406|453254101|FG000|Overall Study|PI dropped, bad data|57|||
125989603|NCT02307513|453254102|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
125989604|NCT02307513|453254103|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
125989605|NCT02307513|453254102|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
125989606|NCT02307513|453254103|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
125989607|NCT02307513|453254102|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
125989608|NCT02307513|453254103|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
125989609|NCT02307513|453254102|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
125989610|NCT02307513|453254103|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
125989611|NCT02307513|453254102|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
125989612|NCT02307513|453254103|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
125989613|NCT02307513|453254102|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
125989614|NCT02307513|453254103|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
125989615|NCT02307513|453254102|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
125989616|NCT02307513|453254103|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
125989617|NCT02307513|453254102|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
125989618|NCT02307513|453254103|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
125989619|NCT02307513|453254102|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
125989620|NCT02307513|453254103|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
125989621|NCT02307513|453254102|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
125989622|NCT02307513|453254103|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
125989623|NCT02307513|453254102|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
125989624|NCT02307513|453254103|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
125989625|NCT02307513|453254102|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
125989626|NCT02307513|453254103|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
125989627|NCT02307513|453254102|FG000|Long-term Extension|Physician Decision|1|||
125989628|NCT02307513|453254103|FG001|Long-term Extension|Physician Decision|0|||
125989629|NCT00525265|453254106|FG000|Overall Study|Protocol Violation|1|||
125989630|NCT00525265|453254107|FG001|Overall Study|Protocol Violation|0|||
125989631|NCT00744263|453254108|FG000|Overall Study|Death|3006|||
125989632|NCT00744263|453254109|FG001|Overall Study|Death|3005|||
125989633|NCT00744263|453254108|FG000|Overall Study|Lost to Follow-up|2038|||
125989634|NCT00744263|453254109|FG001|Overall Study|Lost to Follow-up|2135|||
125989635|NCT00744263|453254108|FG000|Overall Study|Withdrawal by Subject|166|||
125989636|NCT00744263|453254109|FG001|Overall Study|Withdrawal by Subject|150|||
125989637|NCT00744263|453254108|FG000|Overall Study|Physician Decision|20|||
125989638|NCT00744263|453254109|FG001|Overall Study|Physician Decision|23|||
125989639|NCT00744263|453254108|FG000|Overall Study|Protocol Violation|3|||
125989640|NCT00744263|453254109|FG001|Overall Study|Protocol Violation|5|||
125989641|NCT00744263|453254108|FG000|Overall Study|Adverse Event|1|||
125989642|NCT00744263|453254109|FG001|Overall Study|Adverse Event|0|||
125989643|NCT00744263|453254108|FG000|Overall Study|Other|2|||
125989644|NCT00744263|453254109|FG001|Overall Study|Other|2|||
125989645|NCT01013792|453254114|FG000|Overall Study|Study suspended|2|||
125989646|NCT01013792|453254115|FG001|Overall Study|Study suspended|1|||
125989647|NCT01013792|453254114|FG000|Overall Study|Adverse Event|0|||
125989648|NCT01013792|453254115|FG001|Overall Study|Adverse Event|3|||
125989649|NCT01013792|453254114|FG000|Overall Study|Lost to Follow-up|0|||
125989650|NCT01013792|453254115|FG001|Overall Study|Lost to Follow-up|1|||
125989651|NCT05796518|453254127|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
125989652|NCT02690077|453254130|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
125989653|NCT02690077|453254131|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
125989654|NCT02690077|453254130|FG000|Overall Study|Withdrawal by Subject|0|||
125989655|NCT02690077|453254131|FG001|Overall Study|Withdrawal by Subject|5|||
125989656|NCT02690077|453254130|FG000|Overall Study|Excluded by IRB|0|||
125989657|NCT02690077|453254131|FG001|Overall Study|Excluded by IRB|2|||
125989658|NCT05408468|453254132|FG000|Overall Study|Lost to Follow-up|3|||
125989659|NCT05408468|453254133|FG001|Overall Study|Lost to Follow-up|1|||
125989660|NCT05408468|453254132|FG000|Overall Study|Physician Decision|1|||
125989661|NCT05408468|453254133|FG001|Overall Study|Physician Decision|0|||
125989662|NCT05408468|453254132|FG000|Overall Study|Overwhelmed by clinical situation|3|||
125989663|NCT05408468|453254133|FG001|Overall Study|Overwhelmed by clinical situation|0|||
125989664|NCT05408468|453254132|FG000|Overall Study|Personal illness precluding participation|1|||
125989665|NCT05408468|453254133|FG001|Overall Study|Personal illness precluding participation|0|||
125989666|NCT05408468|453254132|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
125989667|NCT05408468|453254133|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
125989668|NCT00747123|453254134|FG000|Overall Study|Investigator's request|0|||
125989669|NCT00747123|453254135|FG001|Overall Study|Investigator's request|0|||
125989670|NCT00747123|453254136|FG002|Overall Study|Investigator's request|1|||
126330065|NCT05568797|454501806|FG001|Overall Study|Withdrawal by Subject|10|||
125989671|NCT00747123|453254137|FG003|Overall Study|Investigator's request|0|||
125989672|NCT00747123|453254134|FG000|Overall Study|Withdrew consent|0|||
125989673|NCT00747123|453254135|FG001|Overall Study|Withdrew consent|1|||
125989674|NCT00747123|453254136|FG002|Overall Study|Withdrew consent|0|||
125989675|NCT00747123|453254137|FG003|Overall Study|Withdrew consent|0|||
125989676|NCT00747123|453254134|FG000|Overall Study|Adverse Event|0|||
125989677|NCT00747123|453254135|FG001|Overall Study|Adverse Event|1|||
125989678|NCT00747123|453254136|FG002|Overall Study|Adverse Event|0|||
125989679|NCT00747123|453254137|FG003|Overall Study|Adverse Event|1|||
125989680|NCT04186403|453254138|FG000|Overall Study|Adverse Event|1|||
125989681|NCT04186403|453254139|FG001|Overall Study|Adverse Event|8|||
125989682|NCT04186403|453254138|FG000|Overall Study|Lost to Follow-up|7|||
125989683|NCT04186403|453254139|FG001|Overall Study|Lost to Follow-up|3|||
125989684|NCT04186403|453254138|FG000|Overall Study|Physician Decision|1|||
125989685|NCT04186403|453254139|FG001|Overall Study|Physician Decision|0|||
125989686|NCT04186403|453254138|FG000|Overall Study|Withdrawal by Subject|7|||
125989687|NCT04186403|453254139|FG001|Overall Study|Withdrawal by Subject|8|||
125989688|NCT04186403|453254138|FG000|Overall Study|Other: Not Related to Covid-19|3|||
125989689|NCT04186403|453254139|FG001|Overall Study|Other: Not Related to Covid-19|0|||
125989690|NCT00405639|453254149|FG000|Overall Study|Withdrawal by Subject|1|||
125989691|NCT00405639|453254150|FG001|Overall Study|Withdrawal by Subject|0|||
125989692|NCT00405639|453254149|FG000|Overall Study|Adverse Event|1|||
126330066|NCT05568797|454501805|FG000|Overall Study|Other|2|||
125989693|NCT00405639|453254150|FG001|Overall Study|Adverse Event|0|||
125989694|NCT00405639|453254149|FG000|Overall Study|Seizure prior to receiving BNP|1|||
125989695|NCT00405639|453254150|FG001|Overall Study|Seizure prior to receiving BNP|0|||
125989696|NCT01483937|453254151|FG000|Overall Study|Withdrawal by Subject|4|||
125989697|NCT01483937|453254152|FG001|Overall Study|Withdrawal by Subject|3|||
125989698|NCT00265330|453254153|FG000|Overall Study|Adverse Event|41|||
125989699|NCT00265330|453254153|FG000|Overall Study|Lost to Follow-up|8|||
125989700|NCT00265330|453254153|FG000|Overall Study|Withdrawal by Subject|34|||
125989701|NCT00265330|453254153|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
125989702|NCT00265330|453254153|FG000|Overall Study|Lack of Efficacy|4|||
125989703|NCT00265330|453254153|FG000|Overall Study|Family Scheduling Conflicts|1|||
125989704|NCT00265330|453254153|FG000|Overall Study|Began Taking Formulary Geodon|1|||
125989705|NCT00265330|453254153|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
125989706|NCT00265330|453254153|FG000|Overall Study|Site Closed by Sponsor|1|||
125989707|NCT00265330|453254153|FG000|Overall Study|Principal Investigators Request|1|||
125989708|NCT00265330|453254153|FG000|Overall Study|Withdrew Consent|1|||
125989709|NCT00265330|453254153|FG000|Overall Study|Protocol Violation|1|||
125989710|NCT05778526|453254154|FG000|Overall Study|Lost to Follow-up|0|||
125989711|NCT05778526|453254155|FG001|Overall Study|Lost to Follow-up|1|||
125989712|NCT05778526|453254156|FG002|Overall Study|Lost to Follow-up|3|||
125989713|NCT05778526|453254154|FG000|Overall Study|Protocol Violation|0|||
125989714|NCT05778526|453254155|FG001|Overall Study|Protocol Violation|0|||
125989715|NCT05778526|453254156|FG002|Overall Study|Protocol Violation|8|||
125989716|NCT03108157|453254157|FG000|Overall Study|Protocol Violation|15|||
125989717|NCT03108157|453254158|FG001|Overall Study|Protocol Violation|4|||
125989718|NCT03287414|453254159|FG000|Treatment Epoch|Adverse Event|0|||
125989719|NCT03287414|453254160|FG001|Treatment Epoch|Adverse Event|1|||
125989720|NCT03287414|453254159|FG000|Treatment Epoch|Study terminated by sponsor|2|||
125989721|NCT03287414|453254160|FG001|Treatment Epoch|Study terminated by sponsor|2|||
125989722|NCT03287414|453254159|FG000|Treatment Epoch|Subject/Guardian decision|4|||
125989723|NCT03287414|453254160|FG001|Treatment Epoch|Subject/Guardian decision|0|||
125989724|NCT03287414|453254159|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
125989725|NCT03287414|453254160|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
125989726|NCT03287414|453254159|FG000|Treatment Epoch|Withdrawal by Subject|1|||
125989727|NCT03287414|453254160|FG001|Treatment Epoch|Withdrawal by Subject|0|||
125989728|NCT03287414|453254159|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
125989729|NCT03287414|453254160|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
125989730|NCT03287414|453254159|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
125989731|NCT03287414|453254160|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
125989732|NCT02759185|453254161|FG000|Stage 1|Adverse Event|0|||
125989733|NCT02759185|453254162|FG001|Stage 1|Adverse Event|1|||
125989734|NCT02759185|453254163|FG002|Stage 1|Adverse Event|3|||
125989735|NCT02759185|453254164|FG003|Stage 1|Adverse Event|0|||
125989736|NCT02759185|453254165|FG004|Stage 1|Adverse Event|0|||
125989737|NCT02759185|453254166|FG005|Stage 1|Adverse Event|0|||
125989738|NCT02759185|453254167|FG006|Stage 1|Adverse Event|0|||
125989739|NCT02759185|453254161|FG000|Stage 1|Withdrawal by Subject|1|||
125989740|NCT02759185|453254162|FG001|Stage 1|Withdrawal by Subject|0|||
125989741|NCT02759185|453254163|FG002|Stage 1|Withdrawal by Subject|0|||
125989742|NCT02759185|453254164|FG003|Stage 1|Withdrawal by Subject|0|||
125989743|NCT02759185|453254165|FG004|Stage 1|Withdrawal by Subject|0|||
125989744|NCT02759185|453254166|FG005|Stage 1|Withdrawal by Subject|0|||
125989745|NCT02759185|453254167|FG006|Stage 1|Withdrawal by Subject|0|||
125989746|NCT02759185|453254161|FG000|Stage 2|Adverse Event|0|||
125989747|NCT02759185|453254162|FG001|Stage 2|Adverse Event|0|||
125989748|NCT02759185|453254163|FG002|Stage 2|Adverse Event|0|||
125989749|NCT02759185|453254164|FG003|Stage 2|Adverse Event|0|||
125989750|NCT02759185|453254165|FG004|Stage 2|Adverse Event|1|||
125989751|NCT02759185|453254166|FG005|Stage 2|Adverse Event|2|||
125989752|NCT02759185|453254167|FG006|Stage 2|Adverse Event|0|||
125989753|NCT02759185|453254161|FG000|Stage 2|Withdrawal by Subject|0|||
125989754|NCT02759185|453254162|FG001|Stage 2|Withdrawal by Subject|0|||
125989755|NCT02759185|453254163|FG002|Stage 2|Withdrawal by Subject|0|||
125989756|NCT02759185|453254164|FG003|Stage 2|Withdrawal by Subject|0|||
125989757|NCT02759185|453254165|FG004|Stage 2|Withdrawal by Subject|1|||
125989758|NCT02759185|453254166|FG005|Stage 2|Withdrawal by Subject|1|||
125989759|NCT02759185|453254167|FG006|Stage 2|Withdrawal by Subject|1|||
125989760|NCT02668016|453254170|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
125989761|NCT02668016|453254170|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
125989762|NCT02668016|453254170|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
125989763|NCT02668016|453254170|FG000|Month 4|Withdrawal due to severe symptoms|1|||
125989764|NCT02668016|453254170|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
125989765|NCT02668016|453254170|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
125989766|NCT02668016|453254170|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
125989767|NCT02668016|453254170|FG000|Month 6|Withdrawal due to severe symptoms|2|||
125989768|NCT02668016|453254170|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
125989769|NCT02668016|453254170|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
125989770|NCT02668016|453254170|FG000|Month 8|Withdrawal due to severe symptoms|1|||
125989771|NCT02668016|453254170|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
125989772|NCT02668016|453254170|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
125989773|NCT02668016|453254170|FG000|Month 10|Withdrawal due to severe symptoms|1|||
125989774|NCT02668016|453254170|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
125989775|NCT05067933|453254182|FG000|Overall Study|Withdrawal by Subject|2|||
125989776|NCT05067933|453254183|FG001|Overall Study|Withdrawal by Subject|0|||
125989777|NCT05067933|453254184|FG002|Overall Study|Withdrawal by Subject|0|||
125989778|NCT05067933|453254185|FG003|Overall Study|Withdrawal by Subject|0|||
125989779|NCT05067933|453254186|FG004|Overall Study|Withdrawal by Subject|0|||
125989780|NCT05067933|453254187|FG005|Overall Study|Withdrawal by Subject|0|||
125989781|NCT05067933|453254182|FG000|Overall Study|Lost to Follow-up|1|||
125989782|NCT05067933|453254183|FG001|Overall Study|Lost to Follow-up|1|||
125989783|NCT05067933|453254184|FG002|Overall Study|Lost to Follow-up|1|||
125989784|NCT05067933|453254185|FG003|Overall Study|Lost to Follow-up|2|||
125989785|NCT05067933|453254186|FG004|Overall Study|Lost to Follow-up|1|||
125989786|NCT05067933|453254187|FG005|Overall Study|Lost to Follow-up|0|||
125989787|NCT05067933|453254182|FG000|Overall Study|Miscellaneous|1|||
125989788|NCT05067933|453254183|FG001|Overall Study|Miscellaneous|0|||
125989789|NCT05067933|453254184|FG002|Overall Study|Miscellaneous|0|||
125989790|NCT05067933|453254185|FG003|Overall Study|Miscellaneous|0|||
125989791|NCT05067933|453254186|FG004|Overall Study|Miscellaneous|0|||
125989792|NCT05067933|453254187|FG005|Overall Study|Miscellaneous|0|||
125989793|NCT05067933|453254182|FG000|Overall Study|Death|0|||
125989794|NCT05067933|453254183|FG001|Overall Study|Death|0|||
125989795|NCT05067933|453254184|FG002|Overall Study|Death|0|||
125989796|NCT05067933|453254185|FG003|Overall Study|Death|1|||
125989797|NCT05067933|453254186|FG004|Overall Study|Death|0|||
125989798|NCT05067933|453254187|FG005|Overall Study|Death|0|||
125989799|NCT01065350|453254193|FG000|Overall Study|Received incorrect drug allocation|0|||
125989800|NCT01065350|453254194|FG001|Overall Study|Received incorrect drug allocation|1|||
125989801|NCT02294474|453254202|FG000|Overall Study|Adverse Event|7|||
125989802|NCT02294474|453254203|FG001|Overall Study|Adverse Event|7|||
125989803|NCT02294474|453254202|FG000|Overall Study|Lack of Efficacy|2|||
125989804|NCT02294474|453254203|FG001|Overall Study|Lack of Efficacy|1|||
125989805|NCT02294474|453254202|FG000|Overall Study|Protocol Violation|4|||
125989806|NCT02294474|453254203|FG001|Overall Study|Protocol Violation|2|||
125989807|NCT02294474|453254202|FG000|Overall Study|Other than specified above|12|||
125989808|NCT02294474|453254203|FG001|Overall Study|Other than specified above|12|||
125989809|NCT05200936|453254204|FG000|Overall Study|Withdrawal by Subject|2|||
125989810|NCT05200936|453254205|FG001|Overall Study|Withdrawal by Subject|2|||
125989811|NCT05200936|453254204|FG000|Overall Study|Lost to Follow-up|2|||
125989812|NCT05200936|453254205|FG001|Overall Study|Lost to Follow-up|0|||
125989813|NCT05200936|453254204|FG000|Overall Study|Pregnancy|0|||
125989814|NCT05200936|453254205|FG001|Overall Study|Pregnancy|1|||
125989815|NCT03443713|453254206|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
125989816|NCT03443713|453254207|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
125989817|NCT03443713|453254208|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
125989818|NCT01672853|453254210|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
126330067|NCT05568797|454501806|FG001|Overall Study|Other|2|||
126330068|NCT00869128|454501808|FG000|Overall Study|lack of Compliance|6|||
126330069|NCT00869128|454501809|FG001|Overall Study|lack of Compliance|6|||
125989819|NCT01672853|453254211|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
126330070|NCT02998996|454501815|FG000|Overall Study|Lost to Follow-up|0|||
126330071|NCT02998996|454501816|FG001|Overall Study|Lost to Follow-up|0|||
126330072|NCT02998996|454501817|FG002|Overall Study|Lost to Follow-up|1|||
126330073|NCT02998996|454501818|FG003|Overall Study|Lost to Follow-up|0|||
126330074|NCT02998996|454501819|FG004|Overall Study|Lost to Follow-up|0|||
126330075|NCT02998996|454501820|FG005|Overall Study|Lost to Follow-up|0|||
125989820|NCT01672853|453254212|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
125989821|NCT01672853|453254210|FG000|Overall Study|Pregnancy|0|||
125989822|NCT01672853|453254211|FG001|Overall Study|Pregnancy|1|||
125989823|NCT01672853|453254212|FG002|Overall Study|Pregnancy|0|||
125989824|NCT01672853|453254210|FG000|Overall Study|Investigator's Discretion|1|||
125989825|NCT01672853|453254211|FG001|Overall Study|Investigator's Discretion|0|||
125989826|NCT01672853|453254212|FG002|Overall Study|Investigator's Discretion|0|||
125989827|NCT01672853|453254210|FG000|Overall Study|Withdrew Consent|5|||
125989828|NCT01672853|453254211|FG001|Overall Study|Withdrew Consent|5|||
125989829|NCT01672853|453254212|FG002|Overall Study|Withdrew Consent|5|||
125989830|NCT01672853|453254210|FG000|Overall Study|Adverse Event|4|||
125989831|NCT01672853|453254211|FG001|Overall Study|Adverse Event|6|||
125989832|NCT01672853|453254212|FG002|Overall Study|Adverse Event|8|||
125989833|NCT01672853|453254210|FG000|Overall Study|Lost to Follow-up|0|||
125989834|NCT01672853|453254211|FG001|Overall Study|Lost to Follow-up|1|||
125989835|NCT01672853|453254212|FG002|Overall Study|Lost to Follow-up|0|||
125989836|NCT01672853|453254210|FG000|Overall Study|Randomized but Never Treated|0|||
125989837|NCT01672853|453254211|FG001|Overall Study|Randomized but Never Treated|0|||
125989838|NCT01672853|453254212|FG002|Overall Study|Randomized but Never Treated|1|||
125989839|NCT00118898|453254214|FG000|Overall Study|Death|6|||
125989840|NCT00118898|453254215|FG001|Overall Study|Death|11|||
125989841|NCT00118898|453254216|FG002|Overall Study|Death|6|||
125989842|NCT00118898|453254217|FG003|Overall Study|Death|8|||
125989843|NCT00118898|453254214|FG000|Overall Study|Lost to Follow-up|26|||
125989844|NCT00118898|453254215|FG001|Overall Study|Lost to Follow-up|34|||
125989845|NCT00118898|453254216|FG002|Overall Study|Lost to Follow-up|33|||
125989846|NCT00118898|453254217|FG003|Overall Study|Lost to Follow-up|33|||
125989847|NCT00118898|453254214|FG000|Overall Study|Withdrawal by Subject|10|||
125989848|NCT00118898|453254215|FG001|Overall Study|Withdrawal by Subject|5|||
125989849|NCT00118898|453254216|FG002|Overall Study|Withdrawal by Subject|8|||
125989850|NCT00118898|453254217|FG003|Overall Study|Withdrawal by Subject|8|||
125989851|NCT00118898|453254214|FG000|Overall Study|Site Closure|33|||
125989852|NCT00118898|453254215|FG001|Overall Study|Site Closure|31|||
125989853|NCT00118898|453254216|FG002|Overall Study|Site Closure|28|||
125989854|NCT00118898|453254217|FG003|Overall Study|Site Closure|37|||
125989855|NCT00118898|453254214|FG000|Overall Study|Severe debilitation|1|||
125989856|NCT00118898|453254215|FG001|Overall Study|Severe debilitation|4|||
125989857|NCT00118898|453254216|FG002|Overall Study|Severe debilitation|6|||
125989858|NCT00118898|453254217|FG003|Overall Study|Severe debilitation|4|||
125989859|NCT00118898|453254214|FG000|Overall Study|Not compliant with requirements|11|||
125989860|NCT00118898|453254215|FG001|Overall Study|Not compliant with requirements|13|||
125989861|NCT00118898|453254216|FG002|Overall Study|Not compliant with requirements|11|||
125989862|NCT00118898|453254217|FG003|Overall Study|Not compliant with requirements|11|||
125989863|NCT00118898|453254214|FG000|Overall Study|Not able to get to clinic|34|||
125989864|NCT00118898|453254215|FG001|Overall Study|Not able to get to clinic|43|||
125989865|NCT00118898|453254216|FG002|Overall Study|Not able to get to clinic|31|||
125989866|NCT00118898|453254217|FG003|Overall Study|Not able to get to clinic|40|||
125989867|NCT05879198|453254220|FG000|Overall Study|Lost to Follow-up|1|||
125989868|NCT01693692|453254221|FG000|Overall Study|Withdrawal by Subject|12|||
125989869|NCT01693692|453254222|FG001|Overall Study|Withdrawal by Subject|10|||
125989870|NCT01693692|453254223|FG002|Overall Study|Withdrawal by Subject|11|||
125989871|NCT01693692|453254221|FG000|Overall Study|Adverse Event|7|||
125989872|NCT01693692|453254222|FG001|Overall Study|Adverse Event|14|||
125989873|NCT01693692|453254223|FG002|Overall Study|Adverse Event|9|||
125989874|NCT01693692|453254221|FG000|Overall Study|Physician Decision|0|||
125989875|NCT01693692|453254222|FG001|Overall Study|Physician Decision|0|||
126330076|NCT02998996|454501815|FG000|Overall Study|Pregnancy|0|||
125989876|NCT01693692|453254223|FG002|Overall Study|Physician Decision|1|||
126330077|NCT02998996|454501816|FG001|Overall Study|Pregnancy|1|||
125989877|NCT01693692|453254221|FG000|Overall Study|Protocol Violation|5|||
125989878|NCT01693692|453254222|FG001|Overall Study|Protocol Violation|4|||
125989879|NCT01693692|453254223|FG002|Overall Study|Protocol Violation|6|||
125989880|NCT01693692|453254221|FG000|Overall Study|Lost to Follow-up|2|||
125989881|NCT01693692|453254222|FG001|Overall Study|Lost to Follow-up|2|||
125989882|NCT01693692|453254223|FG002|Overall Study|Lost to Follow-up|3|||
125989883|NCT01693692|453254221|FG000|Overall Study|Other|4|||
125989884|NCT01693692|453254222|FG001|Overall Study|Other|4|||
125989885|NCT01693692|453254223|FG002|Overall Study|Other|6|||
126330078|NCT02998996|454501817|FG002|Overall Study|Pregnancy|0|||
125989886|NCT00663117|453255339|FG000|Overall Study|Lack of Efficacy|1|||
125989887|NCT00663117|453255340|FG001|Overall Study|Lack of Efficacy|0|||
126330079|NCT02998996|454501818|FG003|Overall Study|Pregnancy|0|||
126330080|NCT02998996|454501819|FG004|Overall Study|Pregnancy|0|||
126330081|NCT02998996|454501820|FG005|Overall Study|Pregnancy|0|||
126330082|NCT02998996|454501815|FG000|Overall Study|Family reasons|0|||
126330083|NCT02998996|454501816|FG001|Overall Study|Family reasons|0|||
126330084|NCT02998996|454501817|FG002|Overall Study|Family reasons|0|||
126330085|NCT02998996|454501818|FG003|Overall Study|Family reasons|0|||
126330086|NCT02998996|454501819|FG004|Overall Study|Family reasons|1|||
126330087|NCT02998996|454501820|FG005|Overall Study|Family reasons|0|||
126330088|NCT01118663|454501822|FG000|Overall Study|Adverse Event|2|||
126330089|NCT01118663|454501823|FG001|Overall Study|Adverse Event|1|||
126330090|NCT01118663|454501822|FG000|Overall Study|Withdrawal by Subject|0|||
126330091|NCT01118663|454501823|FG001|Overall Study|Withdrawal by Subject|1|||
126330092|NCT03046953|454501824|FG000|Overall Study|Relapse/progressive disease|21|||
126330093|NCT03046953|454501824|FG000|Overall Study|Death|2|||
126330094|NCT03046953|454501824|FG000|Overall Study|Withdrawal by Subject|3|||
126330095|NCT04039204|454501825|FG000|Overall Study|Withdrawal by Subject|0|||
126330096|NCT04039204|454501826|FG001|Overall Study|Withdrawal by Subject|2|||
126330097|NCT01189461|454501827|FG000|Overall Study|Lack of Efficacy|13|||
126330098|NCT01189461|454501827|FG000|Overall Study|Lost to Follow-up|1|||
126330099|NCT01189461|454501827|FG000|Overall Study|Withdrawal by Subject|6|||
126330100|NCT01189461|454501827|FG000|Overall Study|Protocol Violation|1|||
126330101|NCT01189461|454501827|FG000|Overall Study|Adverse Event|2|||
126330102|NCT01189461|454501827|FG000|Overall Study|Did not meet entrance criteria|3|||
126330103|NCT01189461|454501827|FG000|Overall Study|Other|8|||
126330104|NCT02716584|454501828|FG000|Overall Study|Lost to Follow-up|8|||
126330105|NCT02716584|454501829|FG001|Overall Study|Lost to Follow-up|5|||
126330106|NCT05279131|454501831|FG000|Overall Study|Lost to Follow-up|1|||
126330107|NCT05279131|454501831|FG000|Overall Study|Death|1|||
126330108|NCT05279131|454501831|FG000|Overall Study|Physician Decision|1|||
126330109|NCT04530838|454503240|FG000|Overall Study|Other|2|||
126330110|NCT04530838|454503241|FG001|Overall Study|Other|1|||
126330111|NCT04530838|454503242|FG002|Overall Study|Other|0|||
126330112|NCT04530838|454503240|FG000|Overall Study|Physician Decision|0|||
126330113|NCT04530838|454503241|FG001|Overall Study|Physician Decision|0|||
126330114|NCT04530838|454503242|FG002|Overall Study|Physician Decision|1|||
126330115|NCT04530838|454503240|FG000|Overall Study|Death|0|||
126330116|NCT04530838|454503241|FG001|Overall Study|Death|0|||
126330117|NCT04530838|454503242|FG002|Overall Study|Death|1|||
126330118|NCT04530838|454503240|FG000|Overall Study|Adverse Event|0|||
126330119|NCT04530838|454503241|FG001|Overall Study|Adverse Event|1|||
126330120|NCT04530838|454503242|FG002|Overall Study|Adverse Event|0|||
126330121|NCT04530838|454503240|FG000|Overall Study|No longer meets eligibility criteria|1|||
126330122|NCT04530838|454503241|FG001|Overall Study|No longer meets eligibility criteria|0|||
126330123|NCT04530838|454503242|FG002|Overall Study|No longer meets eligibility criteria|2|||
126330124|NCT04530838|454503240|FG000|Overall Study|Withdrawal by parent/guardian|5|||
126330125|NCT04530838|454503241|FG001|Overall Study|Withdrawal by parent/guardian|2|||
126330126|NCT04530838|454503242|FG002|Overall Study|Withdrawal by parent/guardian|2|||
126330127|NCT00803712|454503243|FG000|Overall Study|Noncompliance|3|||
126330128|NCT00803712|454503244|FG001|Overall Study|Noncompliance|0|||
126330129|NCT00803712|454503243|FG000|Overall Study|Adverse Event|5|||
126330130|NCT00803712|454503244|FG001|Overall Study|Adverse Event|0|||
126330131|NCT00803712|454503243|FG000|Overall Study|Death|8|||
126330132|NCT00803712|454503244|FG001|Overall Study|Death|7|||
126330133|NCT00803712|454503243|FG000|Overall Study|Lost to Follow-up|3|||
126330134|NCT00803712|454503244|FG001|Overall Study|Lost to Follow-up|1|||
126330135|NCT00803712|454503243|FG000|Overall Study|Withdrawal by Subject|2|||
126330136|NCT00803712|454503244|FG001|Overall Study|Withdrawal by Subject|4|||
126330137|NCT00803712|454503243|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
126330138|NCT00803712|454503244|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
126330139|NCT00803712|454503243|FG000|Overall Study|Protocol criteria (other)|0|||
126330140|NCT00803712|454503244|FG001|Overall Study|Protocol criteria (other)|2|||
126330141|NCT00803712|454503243|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
126330142|NCT00803712|454503244|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
126330143|NCT00803712|454503243|FG000|Overall Study|Administrative decision|2|||
126330144|NCT00803712|454503244|FG001|Overall Study|Administrative decision|3|||
126330145|NCT00803712|454503243|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
126330146|NCT00803712|454503244|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
126330147|NCT02100839|454503255|FG000|Multiple Ascending Dose|Adverse Event|2|||
126330148|NCT02100839|454503256|FG001|Multiple Ascending Dose|Adverse Event|0|||
126330149|NCT02100839|454503255|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
126330150|NCT02100839|454503256|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
126330151|NCT00669318|454503259|FG000|Overall Study|Withdrawal by Subject|2|||
126330152|NCT01073163|454503260|FG000|Overall Study|Adverse Event|1|||
126330153|NCT01073163|454503260|FG000|Overall Study|Disease Progression|1|||
126330154|NCT01073163|454503260|FG000|Overall Study|Early termination|1|||
126330155|NCT03272347|454503261|FG000|Overall Study|Death|0|||
126330156|NCT03272347|454503262|FG001|Overall Study|Death|0|||
126330157|NCT03272347|454503263|FG002|Overall Study|Death|0|||
126330158|NCT03272347|454503264|FG003|Overall Study|Death|1|||
125989888|NCT01992549|453255346|FG000|Overall Study|Lost to Follow-up|2|||
125989889|NCT01992549|453255346|FG000|Overall Study|Serious Adverse Event|1|||
125989890|NCT01992549|453255346|FG000|Overall Study|Product Switch to Extend Half Life|1|||
125989891|NCT01590771|453255347|FG000|Overall Study|Other Protocol Specified Criteria|5|||
125989892|NCT01590771|453255348|FG001|Overall Study|Other Protocol Specified Criteria|14|||
125989893|NCT01590771|453255347|FG000|Overall Study|Withdrawal by Subject|8|||
125989894|NCT01590771|453255348|FG001|Overall Study|Withdrawal by Subject|15|||
125989895|NCT01590771|453255347|FG000|Overall Study|Protocol Violation|1|||
125989896|NCT01590771|453255348|FG001|Overall Study|Protocol Violation|2|||
125989897|NCT01590771|453255347|FG000|Overall Study|Lost to Follow-up|1|||
125989898|NCT01590771|453255348|FG001|Overall Study|Lost to Follow-up|1|||
125989899|NCT01590771|453255347|FG000|Overall Study|Lack of Efficacy|1|||
125989900|NCT01590771|453255348|FG001|Overall Study|Lack of Efficacy|0|||
125989901|NCT01590771|453255347|FG000|Overall Study|Adverse Event|3|||
125989902|NCT01590771|453255348|FG001|Overall Study|Adverse Event|7|||
125989903|NCT04022889|453255354|FG000|Stage 1: Period 1|Adverse Event|1|||
125989904|NCT04022889|453255355|FG001|Stage 1: Period 1|Adverse Event|0|||
125989905|NCT04022889|453255356|FG002|Stage 1: Period 1|Adverse Event|0|||
125989906|NCT04022889|453255354|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
125989907|NCT04022889|453255355|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
125989908|NCT04022889|453255356|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
125989909|NCT04022889|453255354|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
125989910|NCT04022889|453255355|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
125989911|NCT04022889|453255356|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
125989912|NCT04022889|453255354|FG000|Stage 2|Screen Failure|0|||
125989913|NCT04022889|453255355|FG001|Stage 2|Screen Failure|0|||
125989914|NCT04022889|453255356|FG002|Stage 2|Screen Failure|3|||
125989915|NCT04022889|453255354|FG000|Stage 2|Ineligible for apheresis donation|0|||
125989916|NCT04022889|453255355|FG001|Stage 2|Ineligible for apheresis donation|0|||
125989917|NCT04022889|453255356|FG002|Stage 2|Ineligible for apheresis donation|2|||
125989918|NCT04022889|453255354|FG000|Stage 2|Adverse Event|0|||
125989919|NCT04022889|453255355|FG001|Stage 2|Adverse Event|0|||
125989920|NCT04022889|453255356|FG002|Stage 2|Adverse Event|2|||
125989921|NCT04022889|453255354|FG000|Stage 2|Protocol Violation|0|||
125989922|NCT04022889|453255355|FG001|Stage 2|Protocol Violation|0|||
125989923|NCT04022889|453255356|FG002|Stage 2|Protocol Violation|1|||
125989924|NCT04022889|453255354|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
125989925|NCT04022889|453255355|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
125989926|NCT04022889|453255356|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
125989927|NCT01900054|453255357|FG000|Overall Study|Physician Decision|1|||
125989928|NCT01900054|453255357|FG000|Overall Study|Withdrawal by Subject|1|||
125989929|NCT03285295|453255360|FG000|Alinity s HBsAg|Protocol Violation|11|||
125989930|NCT03285295|453255361|FG001|Alinity s HBsAg|Protocol Violation|0|||
125989931|NCT03285295|453255362|FG002|Alinity s HBsAg|Protocol Violation|0|||
125989932|NCT03285295|453255363|FG003|Alinity s HBsAg|Protocol Violation|0|||
125989933|NCT03285295|453255364|FG004|Alinity s HBsAg|Protocol Violation|0|||
125989934|NCT03285295|453255360|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
125989935|NCT03285295|453255361|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
125989936|NCT03285295|453255362|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
125989937|NCT03285295|453255363|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
125989938|NCT03285295|453255364|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
125989939|NCT03285295|453255360|FG000|Alinity s HBsAg|No Results Generated|74|||
125989940|NCT03285295|453255361|FG001|Alinity s HBsAg|No Results Generated|6|||
125989941|NCT03285295|453255362|FG002|Alinity s HBsAg|No Results Generated|0|||
125989942|NCT03285295|453255363|FG003|Alinity s HBsAg|No Results Generated|0|||
125989943|NCT03285295|453255364|FG004|Alinity s HBsAg|No Results Generated|0|||
125989944|NCT03285295|453255360|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
125989945|NCT03285295|453255361|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
125989946|NCT03285295|453255362|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
125989947|NCT03285295|453255363|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
125989948|NCT03285295|453255364|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
125989949|NCT03285295|453255360|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
125989950|NCT03285295|453255361|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125989951|NCT03285295|453255362|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125989952|NCT03285295|453255363|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125989953|NCT03285295|453255364|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125989954|NCT03285295|453255360|FG000|Alinity s HTLV I/II|No Results Generated|70|||
125989955|NCT03285295|453255361|FG001|Alinity s HTLV I/II|No Results Generated|0|||
125989956|NCT03285295|453255362|FG002|Alinity s HTLV I/II|No Results Generated|0|||
125989957|NCT03285295|453255363|FG003|Alinity s HTLV I/II|No Results Generated|0|||
125989958|NCT03285295|453255364|FG004|Alinity s HTLV I/II|No Results Generated|0|||
125989959|NCT03285295|453255360|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
126330159|NCT03272347|454503261|FG000|Overall Study|Lost to Follow-up|1|||
125989960|NCT03285295|453255361|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125989961|NCT03285295|453255362|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
126330160|NCT03272347|454503262|FG001|Overall Study|Lost to Follow-up|3|||
126330161|NCT03272347|454503263|FG002|Overall Study|Lost to Follow-up|5|||
126330162|NCT03272347|454503264|FG003|Overall Study|Lost to Follow-up|1|||
126330163|NCT03272347|454503261|FG000|Overall Study|Physician Decision|4|||
126330164|NCT03272347|454503262|FG001|Overall Study|Physician Decision|2|||
126330165|NCT03272347|454503263|FG002|Overall Study|Physician Decision|5|||
126330166|NCT03272347|454503264|FG003|Overall Study|Physician Decision|4|||
126330167|NCT03272347|454503261|FG000|Overall Study|Screen Failure|1|||
126330168|NCT03272347|454503262|FG001|Overall Study|Screen Failure|0|||
126330169|NCT03272347|454503263|FG002|Overall Study|Screen Failure|0|||
126330170|NCT03272347|454503264|FG003|Overall Study|Screen Failure|0|||
126330171|NCT03272347|454503261|FG000|Overall Study|Withdrawal by Subject|5|||
125989962|NCT03285295|453255363|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125989963|NCT03285295|453255364|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125989964|NCT03285295|453255360|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
125989965|NCT03285295|453255361|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
125989966|NCT03285295|453255362|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
125989967|NCT03285295|453255363|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
125989968|NCT03285295|453255364|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
125989969|NCT03285295|453255360|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
125989970|NCT03285295|453255361|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125989971|NCT03285295|453255362|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125989972|NCT03285295|453255363|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125989973|NCT03285295|453255364|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125989974|NCT03285295|453255360|FG000|Alinity s Anti-HCV|No Results Generated|71|||
125989975|NCT03285295|453255361|FG001|Alinity s Anti-HCV|No Results Generated|0|||
125989976|NCT03285295|453255362|FG002|Alinity s Anti-HCV|No Results Generated|0|||
125989977|NCT03285295|453255363|FG003|Alinity s Anti-HCV|No Results Generated|0|||
125989978|NCT03285295|453255364|FG004|Alinity s Anti-HCV|No Results Generated|0|||
125989979|NCT03285295|453255360|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
125989980|NCT03285295|453255361|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
125989981|NCT03285295|453255362|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
125989982|NCT03285295|453255363|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
125989983|NCT03285295|453255364|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
125989984|NCT03285295|453255360|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
125989985|NCT03285295|453255361|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125989986|NCT03285295|453255362|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125989987|NCT03285295|453255363|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125989988|NCT03285295|453255364|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125989989|NCT03285295|453255360|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
125989990|NCT03285295|453255361|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
125989991|NCT03285295|453255362|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
125989992|NCT03285295|453255363|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
125989993|NCT03285295|453255364|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
125989994|NCT03285295|453255360|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
125989995|NCT03285295|453255361|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
125989996|NCT03285295|453255362|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
125989997|NCT03285295|453255363|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
125989998|NCT03285295|453255364|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
125989999|NCT03285295|453255360|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
125990000|NCT03285295|453255361|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125990001|NCT03285295|453255362|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125990002|NCT03285295|453255363|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125990003|NCT03285295|453255364|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125990004|NCT03285295|453255360|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
125990005|NCT03285295|453255361|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
125990006|NCT03285295|453255362|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
125990007|NCT03285295|453255363|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
125990008|NCT03285295|453255364|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
126330172|NCT03272347|454503262|FG001|Overall Study|Withdrawal by Subject|1|||
126330173|NCT03272347|454503263|FG002|Overall Study|Withdrawal by Subject|2|||
126330174|NCT03272347|454503264|FG003|Overall Study|Withdrawal by Subject|1|||
125990009|NCT03285295|453255360|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
125990010|NCT03285295|453255361|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
125990011|NCT03285295|453255362|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
125990012|NCT03285295|453255363|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
125990013|NCT03285295|453255364|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
125990014|NCT03285295|453255360|FG000|Alinity s Anti-HBc|No Results Generated|70|||
126330175|NCT00703677|454503265|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
126330176|NCT00940888|454503266|FG000|Overall Study|Unsuccessful Implant|4|||
126330177|NCT00940888|454503266|FG000|Overall Study|Death|461|||
126330178|NCT00940888|454503266|FG000|Overall Study|Withdrawn - Non-Death|364|||
126330179|NCT00940888|454503266|FG000|Overall Study|Lost to Follow-up|6|||
125990015|NCT03285295|453255361|FG001|Alinity s Anti-HBc|No Results Generated|0|||
125990016|NCT03285295|453255362|FG002|Alinity s Anti-HBc|No Results Generated|0|||
126330180|NCT04441788|454503269|FG000|Overall Study|Voluntary Withdrawl|0|||
126330181|NCT04441788|454503270|FG001|Overall Study|Voluntary Withdrawl|1|||
126330182|NCT04441788|454503271|FG002|Overall Study|Voluntary Withdrawl|0|||
126330183|NCT04441788|454503269|FG000|Overall Study|Ineligibility|1|||
126330184|NCT04441788|454503270|FG001|Overall Study|Ineligibility|0|||
126330185|NCT04441788|454503271|FG002|Overall Study|Ineligibility|0|||
126330186|NCT04441788|454503269|FG000|Overall Study|Adverse Event|0|||
126330187|NCT04441788|454503270|FG001|Overall Study|Adverse Event|0|||
126330188|NCT04441788|454503271|FG002|Overall Study|Adverse Event|4|||
126330189|NCT04441788|454503269|FG000|Overall Study|Study Terminated by Sponsor|16|||
126330190|NCT04441788|454503270|FG001|Overall Study|Study Terminated by Sponsor|16|||
126330191|NCT04441788|454503271|FG002|Overall Study|Study Terminated by Sponsor|12|||
126330192|NCT03859648|454503278|FG000|Overall Study|Lost to Follow-up|1|||
126330193|NCT03859648|454503278|FG000|Overall Study|Adverse Event|1|||
126330194|NCT01677182|454503279|FG000|Overall Study|Adverse Event|2|||
125990017|NCT03285295|453255363|FG003|Alinity s Anti-HBc|No Results Generated|0|||
125990018|NCT03285295|453255364|FG004|Alinity s Anti-HBc|No Results Generated|0|||
125990019|NCT03285295|453255360|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
125990020|NCT03285295|453255361|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
125990021|NCT03285295|453255362|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
125990022|NCT03285295|453255363|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
125990023|NCT03285295|453255364|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
125990024|NCT03285295|453255360|FG000|Alinity s Chagas|Protocol Violation|76|||
125990025|NCT03285295|453255361|FG001|Alinity s Chagas|Protocol Violation|0|||
125990026|NCT03285295|453255362|FG002|Alinity s Chagas|Protocol Violation|0|||
125990027|NCT03285295|453255363|FG003|Alinity s Chagas|Protocol Violation|0|||
125990028|NCT03285295|453255364|FG004|Alinity s Chagas|Protocol Violation|0|||
125990029|NCT03285295|453255360|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
125990030|NCT03285295|453255361|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
125990031|NCT03285295|453255362|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
125990032|NCT03285295|453255363|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
125990033|NCT03285295|453255364|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
125990034|NCT03285295|453255360|FG000|Alinity s Chagas|No Results Generated|105|||
125990035|NCT03285295|453255361|FG001|Alinity s Chagas|No Results Generated|0|||
125990036|NCT03285295|453255362|FG002|Alinity s Chagas|No Results Generated|0|||
125990037|NCT03285295|453255363|FG003|Alinity s Chagas|No Results Generated|0|||
125990038|NCT03285295|453255364|FG004|Alinity s Chagas|No Results Generated|0|||
125990039|NCT03285295|453255360|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
125990040|NCT03285295|453255361|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
125990041|NCT03285295|453255362|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
125990042|NCT03285295|453255363|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
125990043|NCT03285295|453255364|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
125990044|NCT02746575|453255365|FG000|Overall Study|Surgery cancelled or time chaned|13|||
125990045|NCT02746575|453255365|FG000|Overall Study|Received epidural|10|||
125990046|NCT02746575|453255365|FG000|Overall Study|Withdrawal by Subject|3|||
125990047|NCT02746575|453255365|FG000|Overall Study|Bradycardia/hypotension|9|||
125990048|NCT02746575|453255365|FG000|Overall Study|Study paused|8|||
125990049|NCT02746575|453255365|FG000|Overall Study|put on beta-blocker|3|||
125990050|NCT02746575|453255365|FG000|Overall Study|type of surgery|1|||
125990051|NCT02746575|453255365|FG000|Overall Study|typ of surgery|1|||
125990052|NCT02746575|453255365|FG000|Overall Study|PI unavailable|1|||
125990053|NCT02746575|453255365|FG000|Overall Study|Unknown history of CVA|1|||
125990054|NCT03239873|453255368|FG000|Overall Study|Lost to Follow-up|15|||
125990055|NCT03239873|453255369|FG001|Overall Study|Lost to Follow-up|16|||
125990056|NCT03239873|453255368|FG000|Overall Study|Physician Decision|1|||
125990057|NCT03239873|453255369|FG001|Overall Study|Physician Decision|0|||
125990058|NCT03239873|453255368|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
125990059|NCT03239873|453255369|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
125990060|NCT03239873|453255368|FG000|Overall Study|Withdrawal by Subject|2|||
125990061|NCT03239873|453255369|FG001|Overall Study|Withdrawal by Subject|0|||
125990062|NCT03239873|453255368|FG000|Overall Study|Contraindication to study medication|1|||
125990063|NCT03239873|453255369|FG001|Overall Study|Contraindication to study medication|0|||
125990064|NCT03239873|453255368|FG000|Overall Study|Protocol Violation|1|||
125990065|NCT03239873|453255369|FG001|Overall Study|Protocol Violation|0|||
125990066|NCT00605319|453255374|FG000|Overall Study|Adverse Event|6|||
125990067|NCT01250119|453255375|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
125990068|NCT01250119|453255376|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
125990069|NCT01250119|453255375|FG000|Diagnostic Phase|Participants Not Tested|44|||
125990070|NCT01250119|453255376|FG001|Diagnostic Phase|Participants Not Tested|0|||
125990071|NCT01250119|453255375|FG000|Treatment Phase|Progressive Disease|0|||
125990072|NCT01250119|453255376|FG001|Treatment Phase|Progressive Disease|32|||
126330195|NCT01677182|454503280|FG001|Overall Study|Adverse Event|1|||
126330196|NCT01677182|454503281|FG002|Overall Study|Adverse Event|8|||
125990073|NCT01250119|453255375|FG000|Treatment Phase|Death|0|||
125990074|NCT01250119|453255376|FG001|Treatment Phase|Death|2|||
125990075|NCT01250119|453255375|FG000|Treatment Phase|Withdrawal by Subject|0|||
125990076|NCT01250119|453255376|FG001|Treatment Phase|Withdrawal by Subject|1|||
125990077|NCT01250119|453255375|FG000|Treatment Phase|Adverse Event|0|||
125990078|NCT01250119|453255376|FG001|Treatment Phase|Adverse Event|2|||
125990079|NCT01250119|453255375|FG000|Treatment Phase|Unknown reason|0|||
125990080|NCT01250119|453255376|FG001|Treatment Phase|Unknown reason|4|||
125990081|NCT02887989|453255380|FG000|Overall Study|Withdrawal by Subject|8|||
125990082|NCT02887989|453255381|FG001|Overall Study|Withdrawal by Subject|11|||
125990083|NCT02887989|453255380|FG000|Overall Study|Death|1|||
125990084|NCT02887989|453255381|FG001|Overall Study|Death|0|||
125990085|NCT01112514|453255385|FG000|Overall Study|Lost to Follow-up|1|||
125990086|NCT02176421|453255386|FG000|Overall Study|Lost to Follow-up|4|||
125990087|NCT02176421|453255386|FG000|Overall Study|Adverse Event|1|||
125990088|NCT02145078|453255389|FG000|Overall Study|Death|1|||
125990089|NCT02145078|453255389|FG000|Overall Study|Reason not given|3|||
125990090|NCT03066622|453255393|FG000|Overall Study|Lost to Follow-up|24|||
125990091|NCT03066622|453255394|FG001|Overall Study|Lost to Follow-up|25|||
125990092|NCT03066622|453255393|FG000|Overall Study|Withdrawal by Subject|2|||
125990093|NCT03066622|453255394|FG001|Overall Study|Withdrawal by Subject|1|||
125990094|NCT00641719|453255395|FG000|Overall Study|Lack of Efficacy|1|||
125990095|NCT00641719|453255396|FG001|Overall Study|Lack of Efficacy|2|||
125990096|NCT00641719|453255395|FG000|Overall Study|Adverse Event|24|||
125990097|NCT00641719|453255396|FG001|Overall Study|Adverse Event|29|||
125990098|NCT00641719|453255395|FG000|Overall Study|Withdrawal by Subject|4|||
125990099|NCT00641719|453255396|FG001|Overall Study|Withdrawal by Subject|4|||
125990100|NCT00641719|453255395|FG000|Overall Study|Reason Not Specified|1|||
125990101|NCT00641719|453255396|FG001|Overall Study|Reason Not Specified|2|||
125990102|NCT03469349|453255401|FG000|Overall Study|Withdrawal by Subject|1|||
125990103|NCT03469349|453255402|FG001|Overall Study|Withdrawal by Subject|3|||
125990104|NCT03469349|453255401|FG000|Overall Study|Progressive Disease|0|||
125990105|NCT03469349|453255402|FG001|Overall Study|Progressive Disease|1|||
125990106|NCT03469349|453255401|FG000|Overall Study|Lost to Follow-up|2|||
125990107|NCT03469349|453255402|FG001|Overall Study|Lost to Follow-up|2|||
125990108|NCT03469349|453255401|FG000|Overall Study|Adverse Event|2|||
125990109|NCT03469349|453255402|FG001|Overall Study|Adverse Event|4|||
125990110|NCT04488003|453255408|FG000|Assessed for Eligibility|Screen Failure|24|||
125990111|NCT04488003|453255409|FG001|Assessed for Eligibility|Screen Failure|0|||
125990112|NCT04488003|453255410|FG002|Assessed for Eligibility|Screen Failure|0|||
125990113|NCT04488003|453255408|FG000|Assessed for Eligibility|Adverse Event|1|||
125990114|NCT04488003|453255409|FG001|Assessed for Eligibility|Adverse Event|0|||
125990115|NCT04488003|453255410|FG002|Assessed for Eligibility|Adverse Event|0|||
125990116|NCT04488003|453255408|FG000|Assessed for Eligibility|Death|1|||
125990117|NCT04488003|453255409|FG001|Assessed for Eligibility|Death|0|||
125990118|NCT04488003|453255410|FG002|Assessed for Eligibility|Death|0|||
125990119|NCT04488003|453255408|FG000|Assessed for Eligibility|Physician Decision|1|||
125990120|NCT04488003|453255409|FG001|Assessed for Eligibility|Physician Decision|0|||
125990121|NCT04488003|453255410|FG002|Assessed for Eligibility|Physician Decision|0|||
125990122|NCT04488003|453255408|FG000|Allocated to Treatment|Progressive Disease|51|||
125990123|NCT04488003|453255409|FG001|Allocated to Treatment|Progressive Disease|0|||
125990124|NCT04488003|453255410|FG002|Allocated to Treatment|Progressive Disease|0|||
125990125|NCT04488003|453255408|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
125990126|NCT04488003|453255409|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
125990127|NCT04488003|453255410|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
126330197|NCT01677182|454503279|FG000|Overall Study|Protocol Violation|5|||
126330198|NCT01677182|454503280|FG001|Overall Study|Protocol Violation|1|||
126330199|NCT01677182|454503281|FG002|Overall Study|Protocol Violation|4|||
126330200|NCT01677182|454503279|FG000|Overall Study|Lost to Follow-up|4|||
126330201|NCT01677182|454503280|FG001|Overall Study|Lost to Follow-up|0|||
126330202|NCT01677182|454503281|FG002|Overall Study|Lost to Follow-up|3|||
126330203|NCT01677182|454503279|FG000|Overall Study|Withdrawal by Subject|7|||
126330204|NCT01677182|454503280|FG001|Overall Study|Withdrawal by Subject|12|||
125990128|NCT04488003|453255408|FG000|Allocated to Treatment|Adverse Event|6|||
125990129|NCT04488003|453255409|FG001|Allocated to Treatment|Adverse Event|0|||
125990130|NCT04488003|453255410|FG002|Allocated to Treatment|Adverse Event|0|||
125990131|NCT04488003|453255408|FG000|Allocated to Treatment|Other|5|||
125990132|NCT04488003|453255409|FG001|Allocated to Treatment|Other|0|||
125990133|NCT04488003|453255410|FG002|Allocated to Treatment|Other|0|||
125990134|NCT04488003|453255408|FG000|Allocated to Treatment|Physician Decision|4|||
125990135|NCT04488003|453255409|FG001|Allocated to Treatment|Physician Decision|0|||
125990136|NCT04488003|453255410|FG002|Allocated to Treatment|Physician Decision|0|||
125990137|NCT04488003|453255408|FG000|Allocated to Treatment|Death|4|||
125990138|NCT04488003|453255409|FG001|Allocated to Treatment|Death|0|||
125990139|NCT04488003|453255410|FG002|Allocated to Treatment|Death|0|||
125990140|NCT01350505|453255415|FG000|Overall Study|Lost to Follow-up|4|||
126330205|NCT01677182|454503281|FG002|Overall Study|Withdrawal by Subject|10|||
126330206|NCT01677182|454503279|FG000|Overall Study|Study termination|12|||
125990141|NCT02357810|453255416|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
125990142|NCT02357810|453255416|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
125990143|NCT02357810|453255416|FG000|Reached 12 Weeks Response|Adverse Event|5|||
125990144|NCT02357810|453255416|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
125990145|NCT02357810|453255416|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
125990146|NCT02357810|453255416|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
125990147|NCT02357810|453255416|FG000|Reached 12 Weeks Response|Death|1|||
125990148|NCT02357810|453255416|FG000|Reached 12 Weeks Response|Physician Decision|1|||
125990149|NCT02357810|453255416|FG000|Reached 12 Weeks Response|Other|1|||
125990150|NCT02357810|453255416|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
125990151|NCT02357810|453255416|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
125990152|NCT02357810|453255416|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
125990153|NCT02357810|453255416|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
125990154|NCT02357810|453255416|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
125990155|NCT02357810|453255416|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
125990156|NCT04145037|453255417|FG000|Overall Study|Study terminated|2|||
125990157|NCT04145037|453255418|FG001|Overall Study|Study terminated|0|||
125990158|NCT04145037|453255417|FG000|Overall Study|Withdrawal by Subject|1|||
125990159|NCT04145037|453255418|FG001|Overall Study|Withdrawal by Subject|0|||
125990160|NCT04145037|453255417|FG000|Overall Study|Lost to Follow-up|1|||
125990161|NCT04145037|453255418|FG001|Overall Study|Lost to Follow-up|0|||
125990162|NCT05952297|453255421|FG000|Overall Study|Withdrawal by Subject|1|||
125990163|NCT05952297|453255422|FG001|Overall Study|Withdrawal by Subject|0|||
125990164|NCT00612534|453255426|FG000|Overall Study|Adverse Event|0|||
125990165|NCT00612534|453255427|FG001|Overall Study|Adverse Event|4|||
125990166|NCT00612534|453255428|FG002|Overall Study|Adverse Event|2|||
125990167|NCT00612534|453255429|FG003|Overall Study|Adverse Event|1|||
125990168|NCT00612534|453255426|FG000|Overall Study|Lack of Efficacy|13|||
125990169|NCT00612534|453255427|FG001|Overall Study|Lack of Efficacy|12|||
125990170|NCT00612534|453255428|FG002|Overall Study|Lack of Efficacy|5|||
125990171|NCT00612534|453255429|FG003|Overall Study|Lack of Efficacy|16|||
125990172|NCT00612534|453255426|FG000|Overall Study|Other Reason|0|||
125990173|NCT00612534|453255427|FG001|Overall Study|Other Reason|1|||
125990174|NCT00612534|453255428|FG002|Overall Study|Other Reason|0|||
125990175|NCT00612534|453255429|FG003|Overall Study|Other Reason|0|||
125990176|NCT02223754|453255430|FG000|Period 1|Adverse Event|1|||
125990177|NCT02223754|453255431|FG001|Period 1|Adverse Event|0|||
125990178|NCT02223754|453255430|FG000|Period 1|Lost to Follow-up|0|||
125990179|NCT02223754|453255431|FG001|Period 1|Lost to Follow-up|1|||
125990180|NCT02223754|453255430|FG000|Period 1|Protocol Violation|2|||
125990181|NCT02223754|453255431|FG001|Period 1|Protocol Violation|4|||
125990182|NCT02223754|453255430|FG000|Period 1|Withdrawal by Subject|0|||
125990183|NCT02223754|453255431|FG001|Period 1|Withdrawal by Subject|4|||
125990184|NCT02223754|453255430|FG000|Period 1|Test Article No Longer Available|1|||
125990185|NCT02223754|453255431|FG001|Period 1|Test Article No Longer Available|5|||
125990186|NCT02223754|453255430|FG000|Period 1|Unsatisfactory Visual Response|0|||
125990187|NCT02223754|453255431|FG001|Period 1|Unsatisfactory Visual Response|1|||
125990188|NCT02223754|453255430|FG000|Period 2|Adverse Event|0|||
125990189|NCT02223754|453255431|FG001|Period 2|Adverse Event|1|||
126330207|NCT01677182|454503280|FG001|Overall Study|Study termination|9|||
125990190|NCT02223754|453255430|FG000|Period 2|Protocol Violation|1|||
125990191|NCT02223754|453255431|FG001|Period 2|Protocol Violation|0|||
125990192|NCT02223754|453255430|FG000|Period 2|Lens Discomfort|1|||
125990193|NCT02223754|453255431|FG001|Period 2|Lens Discomfort|1|||
125990194|NCT02223754|453255430|FG000|Period 2|Lost to Follow-up|1|||
125990195|NCT02223754|453255431|FG001|Period 2|Lost to Follow-up|0|||
125990196|NCT02223754|453255430|FG000|Period 2|Test Article No Longer Available|0|||
125990197|NCT02223754|453255431|FG001|Period 2|Test Article No Longer Available|1|||
125990198|NCT01008475|453255432|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
125990199|NCT01008475|453255433|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
125990200|NCT01008475|453255434|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
125990201|NCT01008475|453255435|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
125990202|NCT01008475|453255436|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
125990203|NCT01008475|453255437|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
125990204|NCT01008475|453255438|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
125990205|NCT03556358|453255439|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
125990206|NCT03556358|453255440|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
126330208|NCT01677182|454503281|FG002|Overall Study|Study termination|11|||
125990207|NCT03556358|453255439|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
125990208|NCT03556358|453255440|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
125990209|NCT03556358|453255439|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
125990210|NCT03556358|453255440|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
126330209|NCT01677182|454503279|FG000|Overall Study|Lack of Efficacy|3|||
126330210|NCT01677182|454503280|FG001|Overall Study|Lack of Efficacy|0|||
126330211|NCT01677182|454503281|FG002|Overall Study|Lack of Efficacy|1|||
126330212|NCT01677182|454503279|FG000|Overall Study|Other reasons|1|||
125990211|NCT03556358|453255439|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
125990212|NCT03556358|453255440|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
125990213|NCT03556358|453255439|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
125990214|NCT03556358|453255440|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
125990215|NCT03556358|453255439|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
125990216|NCT03556358|453255440|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
125990217|NCT03556358|453255439|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
125990218|NCT03556358|453255440|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
125990219|NCT02917941|453255444|FG000|Treatment Period|Adverse Event|11|||
125990220|NCT02917941|453255444|FG000|Treatment Period|Progressive Disease|11|||
125990221|NCT02917941|453255444|FG000|Treatment Period|Reason not Specified|2|||
125990222|NCT02917941|453255444|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
125990223|NCT02917941|453255444|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
125990224|NCT01351025|453255445|FG000|Week 0 - 20|Lost to Follow-up|2|||
125990225|NCT01351025|453255446|FG001|Week 0 - 20|Lost to Follow-up|1|||
125990226|NCT01351025|453255445|FG000|Week 0 - 20|Withdrawal by Subject|1|||
125990227|NCT01351025|453255446|FG001|Week 0 - 20|Withdrawal by Subject|0|||
125990228|NCT01351025|453255445|FG000|Week 24 - 44|Lost to Follow-up|0|||
125990229|NCT01351025|453255446|FG001|Week 24 - 44|Lost to Follow-up|2|||
125990230|NCT01351025|453255445|FG000|Week 24 - 44|Site closed|0|||
125990231|NCT01351025|453255446|FG001|Week 24 - 44|Site closed|1|||
125990232|NCT01351025|453255445|FG000|Week 24 - 44|unable to get to clinic|1|||
125990233|NCT01351025|453255446|FG001|Week 24 - 44|unable to get to clinic|1|||
125990234|NCT00510458|453255463|FG000|Overall Study|5 year not evaluable/missed|21|||
125990235|NCT00510458|453255463|FG000|Overall Study|Death|1|||
125990236|NCT00510458|453255463|FG000|Overall Study|Terminated|14|||
125990237|NCT00510458|453255463|FG000|Overall Study|Lost to Follow-up|6|||
125990238|NCT00510458|453255463|FG000|Overall Study|Withdrawal by Subject|3|||
125990239|NCT00510458|453255463|FG000|Overall Study|Revision|2|||
125990240|NCT01861522|453255464|FG000|Overall Study|Adverse Event|1|||
125990241|NCT01861522|453255465|FG001|Overall Study|Adverse Event|0|||
125990242|NCT01861522|453255464|FG000|Overall Study|Withdrawal by Subject|2|||
125990243|NCT01861522|453255465|FG001|Overall Study|Withdrawal by Subject|0|||
125990244|NCT02716038|453255466|FG000|Overall Study|Not evaluable|1|||
125990245|NCT02716038|453255466|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
125990246|NCT02716038|453255466|FG000|Overall Study|Unresectable|3|||
125990247|NCT03573908|453255467|FG000|Treatment Period|Adverse Event|4|||
126330213|NCT01677182|454503280|FG001|Overall Study|Other reasons|5|||
126330214|NCT01677182|454503281|FG002|Overall Study|Other reasons|2|||
126330215|NCT00762762|454503286|FG000|Overall Study|Did not return for appointments|6|||
126330216|NCT00762762|454503287|FG001|Overall Study|Did not return for appointments|8|||
126330217|NCT02489448|454503288|FG000|Overall Study|Death|3|||
126330218|NCT02489448|454503288|FG000|Overall Study|Withdrawal by Subject|2|||
126330219|NCT00391872|454503290|FG000|Overall Study|Protocol Violation|7|||
126330220|NCT00391872|454503291|FG001|Overall Study|Protocol Violation|2|||
126330221|NCT00391872|454503290|FG000|Overall Study|Withdrawal by Subject|296|||
126330222|NCT00391872|454503291|FG001|Overall Study|Withdrawal by Subject|249|||
126330223|NCT00391872|454503290|FG000|Overall Study|Reason unknown|2|||
126330224|NCT00391872|454503291|FG001|Overall Study|Reason unknown|4|||
126330225|NCT00391872|454503290|FG000|Overall Study|Lost to Follow-up|2|||
126330226|NCT00391872|454503291|FG001|Overall Study|Lost to Follow-up|0|||
126330227|NCT00215644|454503293|FG000|Overall Study|Disease Progression|28|||
126330228|NCT00215644|454503294|FG001|Overall Study|Disease Progression|10|||
126330229|NCT00215644|454503293|FG000|Overall Study|Adverse Event|2|||
126330230|NCT00215644|454503294|FG001|Overall Study|Adverse Event|9|||
126330231|NCT00215644|454503293|FG000|Overall Study|Death|1|||
126330232|NCT00215644|454503294|FG001|Overall Study|Death|2|||
126330233|NCT00215644|454503293|FG000|Overall Study|Withdrawal by Subject|1|||
126330234|NCT00215644|454503294|FG001|Overall Study|Withdrawal by Subject|0|||
126330235|NCT00215644|454503293|FG000|Overall Study|Other|3|||
126330236|NCT00215644|454503294|FG001|Overall Study|Other|15|||
126330237|NCT00215644|454503293|FG000|Overall Study|Randomized but Not Treated|1|||
125990248|NCT03573908|453255468|FG001|Treatment Period|Adverse Event|9|||
125990249|NCT03573908|453255469|FG002|Treatment Period|Adverse Event|0|||
125990250|NCT03573908|453255470|FG003|Treatment Period|Adverse Event|0|||
125990251|NCT03573908|453255471|FG004|Treatment Period|Adverse Event|0|||
126330238|NCT00215644|454503294|FG001|Overall Study|Randomized but Not Treated|0|||
126330239|NCT02861664|454503297|FG000|Overall Study|Withdrawal of Consent|0|||
126330240|NCT02861664|454503298|FG001|Overall Study|Withdrawal of Consent|1|||
126330241|NCT01239394|454503299|FG000|Overall Study|Adverse Event|1|||
126330242|NCT00905632|454503301|FG000|Overall Study|Adverse Event|0|||
126330243|NCT00905632|454503302|FG001|Overall Study|Adverse Event|0|||
126330244|NCT00905632|454503303|FG002|Overall Study|Adverse Event|0|||
126330245|NCT00905632|454503304|FG003|Overall Study|Adverse Event|0|||
125990252|NCT03573908|453255467|FG000|Treatment Period|Protocol Violation|1|||
125990253|NCT03573908|453255468|FG001|Treatment Period|Protocol Violation|0|||
125990254|NCT03573908|453255469|FG002|Treatment Period|Protocol Violation|0|||
125990255|NCT03573908|453255470|FG003|Treatment Period|Protocol Violation|0|||
125990256|NCT03573908|453255471|FG004|Treatment Period|Protocol Violation|0|||
125990257|NCT03573908|453255467|FG000|Treatment Period|Withdrawal by Subject|7|||
125990258|NCT03573908|453255468|FG001|Treatment Period|Withdrawal by Subject|5|||
125990259|NCT03573908|453255469|FG002|Treatment Period|Withdrawal by Subject|0|||
125990260|NCT03573908|453255470|FG003|Treatment Period|Withdrawal by Subject|0|||
125990261|NCT03573908|453255471|FG004|Treatment Period|Withdrawal by Subject|0|||
126330246|NCT00905632|454503305|FG004|Overall Study|Adverse Event|0|||
126330247|NCT00905632|454503306|FG005|Overall Study|Adverse Event|1|||
126330248|NCT00905632|454503307|FG006|Overall Study|Adverse Event|4|||
126330249|NCT01307891|454503309|FG000|Overall Study|Progressive Disease|3|||
126330250|NCT01307891|454503310|FG001|Overall Study|Progressive Disease|1|||
126330251|NCT02937740|454503311|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
126330252|NCT02937740|454503312|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
126330253|NCT02937740|454503311|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
126330254|NCT02937740|454503312|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
126330255|NCT02937740|454503311|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
126330256|NCT02937740|454503312|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
126330257|NCT02937740|454503311|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
126330258|NCT02937740|454503312|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
126330259|NCT02937740|454503311|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
126330260|NCT02937740|454503312|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
126330261|NCT02937740|454503311|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
126330262|NCT02937740|454503312|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
126330263|NCT00305227|454503317|FG000|Overall Study|Lost to Follow-up|7|||
126330264|NCT00305227|454503318|FG001|Overall Study|Lost to Follow-up|6|||
126330265|NCT04085601|454503319|FG000|Overall Study|Lost to Follow-up|1|||
126330266|NCT04085601|454503320|FG001|Overall Study|Lost to Follow-up|0|||
126330267|NCT04085601|454503319|FG000|Overall Study|Death|1|||
126330268|NCT04085601|454503320|FG001|Overall Study|Death|1|||
126330269|NCT03492437|454503321|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126330270|NCT03492437|454503322|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126330271|NCT04534517|454503324|FG000|Overall Study|Adverse Event|1|||
126330272|NCT04534517|454503324|FG000|Overall Study|Withdrawal by Subject|1|||
126330273|NCT04534517|454503324|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
126330274|NCT04534517|454503324|FG000|Overall Study|COVID-19 Related|1|||
126330275|NCT03872843|454503325|FG000|Overall Study|Lost to Follow-up|5|||
126330276|NCT03872843|454503326|FG001|Overall Study|Lost to Follow-up|7|||
126330277|NCT00823264|454503327|FG000|Overall Study|Protocol Violation|2|||
126330278|NCT00823264|454503328|FG001|Overall Study|Protocol Violation|0|||
126330279|NCT05133323|454503329|FG000|Overall Study|Lack of Efficacy|0|||
126330280|NCT05133323|454503330|FG001|Overall Study|Lack of Efficacy|0|||
126330281|NCT05133323|454503331|FG002|Overall Study|Lack of Efficacy|1|||
126330282|NCT05133323|454503329|FG000|Overall Study|Withdrawal by Subject|2|||
126330283|NCT05133323|454503330|FG001|Overall Study|Withdrawal by Subject|1|||
126330284|NCT05133323|454503331|FG002|Overall Study|Withdrawal by Subject|0|||
126330285|NCT00113295|454503332|FG000|Overall Study|Adverse Event|4|||
126330286|NCT00113295|454503333|FG001|Overall Study|Adverse Event|1|||
126330287|NCT00113295|454503332|FG000|Overall Study|Unrelated Medical Illness|1|||
126330288|NCT00113295|454503333|FG001|Overall Study|Unrelated Medical Illness|0|||
126330289|NCT01714544|454503334|FG000|Overall Study|Lost to Follow-up|1|||
126330290|NCT01714544|454503334|FG000|Overall Study|Physician Decision|1|||
126330291|NCT01714544|454503334|FG000|Overall Study|Withdrawal by Subject|1|||
126330292|NCT00577772|454503343|FG000|Overall Study|Lost to Follow-up|0|||
126330293|NCT00577772|454503344|FG001|Overall Study|Lost to Follow-up|1|||
126330294|NCT00572455|454503345|FG000|Stage I (14 Days)|Adverse Event|0|||
126330295|NCT00572455|454503346|FG001|Stage I (14 Days)|Adverse Event|0|||
126330296|NCT00572455|454503347|FG002|Stage I (14 Days)|Adverse Event|0|||
126330297|NCT00572455|454503348|FG003|Stage I (14 Days)|Adverse Event|0|||
126330298|NCT00572455|454503349|FG004|Stage I (14 Days)|Adverse Event|0|||
126330299|NCT00572455|454503350|FG005|Stage I (14 Days)|Adverse Event|3|||
126330300|NCT00572455|454503351|FG006|Stage I (14 Days)|Adverse Event|0|||
126330301|NCT00572455|454503352|FG007|Stage I (14 Days)|Adverse Event|0|||
126330302|NCT00572455|454503353|FG008|Stage I (14 Days)|Adverse Event|0|||
126330303|NCT00572455|454503354|FG009|Stage I (14 Days)|Adverse Event|0|||
126330304|NCT00572455|454503355|FG010|Stage I (14 Days)|Adverse Event|0|||
126330305|NCT00572455|454503356|FG011|Stage I (14 Days)|Adverse Event|0|||
125990262|NCT03573908|453255467|FG000|Treatment Period|Lost to Follow-up|7|||
126330306|NCT00572455|454503357|FG012|Stage I (14 Days)|Adverse Event|0|||
126330307|NCT00572455|454503358|FG013|Stage I (14 Days)|Adverse Event|0|||
126330308|NCT00572455|454503345|FG000|Stage I (14 Days)|Other|0|||
126330309|NCT00572455|454503346|FG001|Stage I (14 Days)|Other|0|||
126330310|NCT00572455|454503347|FG002|Stage I (14 Days)|Other|0|||
126330311|NCT00572455|454503348|FG003|Stage I (14 Days)|Other|0|||
126330312|NCT00572455|454503349|FG004|Stage I (14 Days)|Other|1|||
126330313|NCT00572455|454503350|FG005|Stage I (14 Days)|Other|0|||
126330314|NCT00572455|454503351|FG006|Stage I (14 Days)|Other|0|||
126330315|NCT00572455|454503352|FG007|Stage I (14 Days)|Other|0|||
126330316|NCT00572455|454503353|FG008|Stage I (14 Days)|Other|0|||
126330317|NCT00572455|454503354|FG009|Stage I (14 Days)|Other|0|||
126330318|NCT00572455|454503355|FG010|Stage I (14 Days)|Other|0|||
126330319|NCT00572455|454503356|FG011|Stage I (14 Days)|Other|0|||
125990263|NCT03573908|453255468|FG001|Treatment Period|Lost to Follow-up|6|||
125990264|NCT03573908|453255469|FG002|Treatment Period|Lost to Follow-up|0|||
125990265|NCT03573908|453255470|FG003|Treatment Period|Lost to Follow-up|0|||
125990266|NCT03573908|453255471|FG004|Treatment Period|Lost to Follow-up|0|||
125990267|NCT03573908|453255467|FG000|Treatment Period|Pregnancy|1|||
126330320|NCT00572455|454503357|FG012|Stage I (14 Days)|Other|0|||
126330321|NCT00572455|454503358|FG013|Stage I (14 Days)|Other|0|||
126330322|NCT00572455|454503345|FG000|Stage II (28 Days)|Adverse Event|0|||
126330323|NCT00572455|454503346|FG001|Stage II (28 Days)|Adverse Event|0|||
126330324|NCT00572455|454503347|FG002|Stage II (28 Days)|Adverse Event|0|||
126330325|NCT00572455|454503348|FG003|Stage II (28 Days)|Adverse Event|0|||
126330326|NCT00572455|454503349|FG004|Stage II (28 Days)|Adverse Event|0|||
126330327|NCT00572455|454503350|FG005|Stage II (28 Days)|Adverse Event|0|||
126330328|NCT00572455|454503351|FG006|Stage II (28 Days)|Adverse Event|0|||
126330329|NCT00572455|454503352|FG007|Stage II (28 Days)|Adverse Event|0|||
125990268|NCT03573908|453255468|FG001|Treatment Period|Pregnancy|0|||
125990269|NCT03573908|453255469|FG002|Treatment Period|Pregnancy|0|||
125990270|NCT03573908|453255470|FG003|Treatment Period|Pregnancy|0|||
126330330|NCT00572455|454503353|FG008|Stage II (28 Days)|Adverse Event|1|||
126330331|NCT00572455|454503354|FG009|Stage II (28 Days)|Adverse Event|3|||
126330332|NCT00572455|454503355|FG010|Stage II (28 Days)|Adverse Event|3|||
125990271|NCT03573908|453255471|FG004|Treatment Period|Pregnancy|0|||
125990272|NCT03573908|453255467|FG000|Treatment Period|Other, Not Specified|4|||
125990273|NCT03573908|453255468|FG001|Treatment Period|Other, Not Specified|6|||
125990274|NCT03573908|453255469|FG002|Treatment Period|Other, Not Specified|0|||
125990275|NCT03573908|453255470|FG003|Treatment Period|Other, Not Specified|0|||
125990276|NCT03573908|453255471|FG004|Treatment Period|Other, Not Specified|0|||
125990277|NCT03573908|453255467|FG000|Randomized Withdrawal Period|Adverse Event|0|||
125990278|NCT03573908|453255468|FG001|Randomized Withdrawal Period|Adverse Event|0|||
125990279|NCT03573908|453255469|FG002|Randomized Withdrawal Period|Adverse Event|3|||
125990280|NCT03573908|453255470|FG003|Randomized Withdrawal Period|Adverse Event|0|||
125990281|NCT03573908|453255471|FG004|Randomized Withdrawal Period|Adverse Event|0|||
125990282|NCT03573908|453255467|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125990283|NCT03573908|453255468|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125990284|NCT03573908|453255469|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125990285|NCT03573908|453255470|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125990286|NCT03573908|453255471|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
125990287|NCT03573908|453255467|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
125990288|NCT03573908|453255468|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
125990289|NCT03573908|453255469|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
125990290|NCT03573908|453255470|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
125990291|NCT03573908|453255471|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
125990292|NCT03573908|453255467|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
125990293|NCT03573908|453255468|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
125990294|NCT03573908|453255469|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
125990295|NCT03573908|453255470|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
125990296|NCT03573908|453255471|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
125990297|NCT04006925|453255472|FG000|Overall Study|Side effects|2|||
125990298|NCT04006925|453255473|FG001|Overall Study|Side effects|0|||
125990299|NCT02669095|453255478|FG000|Overall Study|Adverse Event|1|||
125990300|NCT02669095|453255479|FG001|Overall Study|Adverse Event|0|||
125990301|NCT02669095|453255478|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125990302|NCT02669095|453255479|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125990303|NCT02669095|453255478|FG000|Overall Study|Torn Lens|0|||
125990304|NCT02669095|453255479|FG001|Overall Study|Torn Lens|1|||
125990305|NCT02669095|453255478|FG000|Overall Study|Visit 5 assessments not completed|0|||
125990306|NCT02669095|453255479|FG001|Overall Study|Visit 5 assessments not completed|1|||
126330333|NCT00572455|454503356|FG011|Stage II (28 Days)|Adverse Event|4|||
126330334|NCT00572455|454503357|FG012|Stage II (28 Days)|Adverse Event|5|||
126330335|NCT00572455|454503358|FG013|Stage II (28 Days)|Adverse Event|1|||
126330336|NCT00572455|454503345|FG000|Stage II (28 Days)|Death|0|||
126330337|NCT00572455|454503346|FG001|Stage II (28 Days)|Death|0|||
126330338|NCT00572455|454503347|FG002|Stage II (28 Days)|Death|0|||
126330339|NCT00572455|454503348|FG003|Stage II (28 Days)|Death|0|||
125990307|NCT02769065|453257262|FG000|Overall Study|Voluntary Withdrawal|1|||
125990308|NCT02769065|453257263|FG001|Overall Study|Voluntary Withdrawal|0|||
126330340|NCT00572455|454503349|FG004|Stage II (28 Days)|Death|0|||
126330341|NCT00572455|454503350|FG005|Stage II (28 Days)|Death|0|||
126330342|NCT00572455|454503351|FG006|Stage II (28 Days)|Death|0|||
126330343|NCT00572455|454503352|FG007|Stage II (28 Days)|Death|0|||
125990309|NCT02769065|453257264|FG002|Overall Study|Voluntary Withdrawal|0|||
125990310|NCT02769065|453257265|FG003|Overall Study|Voluntary Withdrawal|0|||
125990311|NCT02769065|453257266|FG004|Overall Study|Voluntary Withdrawal|0|||
125990312|NCT02769065|453257267|FG005|Overall Study|Voluntary Withdrawal|0|||
125990313|NCT02769065|453257268|FG006|Overall Study|Voluntary Withdrawal|0|||
125990314|NCT02769065|453257269|FG007|Overall Study|Voluntary Withdrawal|0|||
125990315|NCT02769065|453257270|FG008|Overall Study|Voluntary Withdrawal|0|||
125990316|NCT02769065|453257271|FG009|Overall Study|Voluntary Withdrawal|0|||
125990317|NCT02769065|453257272|FG010|Overall Study|Voluntary Withdrawal|0|||
125990318|NCT02769065|453257273|FG011|Overall Study|Voluntary Withdrawal|0|||
125990319|NCT02769065|453257274|FG012|Overall Study|Voluntary Withdrawal|0|||
125990320|NCT02769065|453257275|FG013|Overall Study|Voluntary Withdrawal|0|||
125990321|NCT02769065|453257276|FG014|Overall Study|Voluntary Withdrawal|0|||
125990322|NCT02769065|453257277|FG015|Overall Study|Voluntary Withdrawal|0|||
125990323|NCT02769065|453257278|FG016|Overall Study|Voluntary Withdrawal|0|||
125990324|NCT02769065|453257279|FG017|Overall Study|Voluntary Withdrawal|0|||
125990325|NCT02769065|453257280|FG018|Overall Study|Voluntary Withdrawal|0|||
125990326|NCT02769065|453257281|FG019|Overall Study|Voluntary Withdrawal|0|||
125990327|NCT02769065|453257282|FG020|Overall Study|Voluntary Withdrawal|0|||
125990328|NCT02769065|453257283|FG021|Overall Study|Voluntary Withdrawal|0|||
125990329|NCT02769065|453257284|FG022|Overall Study|Voluntary Withdrawal|0|||
125990330|NCT02769065|453257285|FG023|Overall Study|Voluntary Withdrawal|0|||
125990331|NCT02769065|453257286|FG024|Overall Study|Voluntary Withdrawal|0|||
125990332|NCT02769065|453257287|FG025|Overall Study|Voluntary Withdrawal|0|||
125990333|NCT02769065|453257288|FG026|Overall Study|Voluntary Withdrawal|0|||
125990334|NCT02769065|453257289|FG027|Overall Study|Voluntary Withdrawal|0|||
125990335|NCT02769065|453257290|FG028|Overall Study|Voluntary Withdrawal|0|||
125990336|NCT02769065|453257291|FG029|Overall Study|Voluntary Withdrawal|0|||
125990337|NCT02769065|453257262|FG000|Overall Study|Reason Not Specified|0|||
125990338|NCT02769065|453257263|FG001|Overall Study|Reason Not Specified|0|||
125990339|NCT02769065|453257264|FG002|Overall Study|Reason Not Specified|0|||
125990340|NCT02769065|453257265|FG003|Overall Study|Reason Not Specified|0|||
125990341|NCT02769065|453257266|FG004|Overall Study|Reason Not Specified|0|||
125990342|NCT02769065|453257267|FG005|Overall Study|Reason Not Specified|0|||
125990343|NCT02769065|453257268|FG006|Overall Study|Reason Not Specified|1|||
125990344|NCT02769065|453257269|FG007|Overall Study|Reason Not Specified|0|||
125990345|NCT02769065|453257270|FG008|Overall Study|Reason Not Specified|0|||
125990346|NCT02769065|453257271|FG009|Overall Study|Reason Not Specified|0|||
125990347|NCT02769065|453257272|FG010|Overall Study|Reason Not Specified|0|||
125990348|NCT02769065|453257273|FG011|Overall Study|Reason Not Specified|0|||
125990349|NCT02769065|453257274|FG012|Overall Study|Reason Not Specified|0|||
125990350|NCT02769065|453257275|FG013|Overall Study|Reason Not Specified|0|||
125990351|NCT02769065|453257276|FG014|Overall Study|Reason Not Specified|0|||
125990352|NCT02769065|453257277|FG015|Overall Study|Reason Not Specified|0|||
125990353|NCT02769065|453257278|FG016|Overall Study|Reason Not Specified|0|||
125990354|NCT02769065|453257279|FG017|Overall Study|Reason Not Specified|0|||
125990355|NCT02769065|453257280|FG018|Overall Study|Reason Not Specified|0|||
125990356|NCT02769065|453257281|FG019|Overall Study|Reason Not Specified|0|||
125990357|NCT02769065|453257282|FG020|Overall Study|Reason Not Specified|0|||
125990358|NCT02769065|453257283|FG021|Overall Study|Reason Not Specified|0|||
125990359|NCT02769065|453257284|FG022|Overall Study|Reason Not Specified|0|||
125990360|NCT02769065|453257285|FG023|Overall Study|Reason Not Specified|0|||
125990361|NCT02769065|453257286|FG024|Overall Study|Reason Not Specified|0|||
125990362|NCT02769065|453257287|FG025|Overall Study|Reason Not Specified|0|||
125990363|NCT02769065|453257288|FG026|Overall Study|Reason Not Specified|0|||
125990364|NCT02769065|453257289|FG027|Overall Study|Reason Not Specified|0|||
125990365|NCT02769065|453257290|FG028|Overall Study|Reason Not Specified|0|||
125990366|NCT02769065|453257291|FG029|Overall Study|Reason Not Specified|0|||
125990367|NCT02769065|453257262|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990368|NCT02769065|453257263|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990369|NCT02769065|453257264|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990370|NCT02769065|453257265|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990371|NCT02769065|453257266|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990372|NCT02769065|453257267|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990373|NCT02769065|453257268|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990374|NCT02769065|453257269|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990375|NCT02769065|453257270|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990376|NCT02769065|453257271|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990377|NCT02769065|453257272|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
125990378|NCT02769065|453257273|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990379|NCT02769065|453257274|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990380|NCT02769065|453257275|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990381|NCT02769065|453257276|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990382|NCT02769065|453257277|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990383|NCT02769065|453257278|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990384|NCT02769065|453257279|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990385|NCT02769065|453257280|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990386|NCT02769065|453257281|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990387|NCT02769065|453257282|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990388|NCT02769065|453257283|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990389|NCT02769065|453257284|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990390|NCT02769065|453257285|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990391|NCT02769065|453257286|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990392|NCT02769065|453257287|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990393|NCT02769065|453257288|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990394|NCT02769065|453257289|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990395|NCT02769065|453257290|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990396|NCT02769065|453257291|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
125990397|NCT02764775|453257294|FG000|Overall Study|Death|1|||
125990398|NCT02764775|453257294|FG000|Overall Study|Lost to Follow-up|2|||
125990399|NCT02764775|453257294|FG000|Overall Study|Withdrawal by Subject|3|||
126330344|NCT00572455|454503353|FG008|Stage II (28 Days)|Death|1|||
126330345|NCT00572455|454503354|FG009|Stage II (28 Days)|Death|0|||
126330346|NCT00572455|454503355|FG010|Stage II (28 Days)|Death|0|||
126330347|NCT00572455|454503356|FG011|Stage II (28 Days)|Death|0|||
126330348|NCT00572455|454503357|FG012|Stage II (28 Days)|Death|0|||
126330349|NCT00572455|454503358|FG013|Stage II (28 Days)|Death|0|||
126330350|NCT00572455|454503345|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
126330351|NCT00572455|454503346|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
125990400|NCT00767104|453257297|FG000|Overall Study|Lost to Follow-up|1|||
125990401|NCT00767104|453257298|FG001|Overall Study|Lost to Follow-up|2|||
125990402|NCT01186328|453257306|FG000|Overall Study|Death|1|||
125990403|NCT01186328|453257307|FG001|Overall Study|Death|0|||
125990404|NCT01186328|453257308|FG002|Overall Study|Death|0|||
125990405|NCT03015116|453257311|FG000|Overall Study|Lost to Follow-up|3|||
125990406|NCT03015116|453257312|FG001|Overall Study|Lost to Follow-up|0|||
125990407|NCT03015116|453257313|FG002|Overall Study|Lost to Follow-up|2|||
125990408|NCT03015116|453257311|FG000|Overall Study|Withdrawal by Subject|3|||
125990409|NCT03015116|453257312|FG001|Overall Study|Withdrawal by Subject|1|||
125990410|NCT03015116|453257313|FG002|Overall Study|Withdrawal by Subject|0|||
125990411|NCT03015116|453257311|FG000|Overall Study|Subject has New Medical Status|1|||
125990412|NCT03015116|453257312|FG001|Overall Study|Subject has New Medical Status|0|||
125990413|NCT03015116|453257313|FG002|Overall Study|Subject has New Medical Status|0|||
125990414|NCT03015116|453257311|FG000|Overall Study|Physician Decision|0|||
125990415|NCT03015116|453257312|FG001|Overall Study|Physician Decision|1|||
125990416|NCT03015116|453257313|FG002|Overall Study|Physician Decision|0|||
125990417|NCT02200939|453257318|FG000|Overall Study|Participant withdrew consent|0|||
125990418|NCT02200939|453257319|FG001|Overall Study|Participant withdrew consent|1|||
125990419|NCT02200939|453257318|FG000|Overall Study|Lost to Follow-up|2|||
125990420|NCT02200939|453257319|FG001|Overall Study|Lost to Follow-up|9|||
125990421|NCT02200939|453257318|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
125990422|NCT02200939|453257319|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
125990423|NCT02762981|453257320|FG000|Overall Study|Adverse Event|2|||
125990424|NCT02762981|453257321|FG001|Overall Study|Adverse Event|3|||
125990425|NCT02762981|453257322|FG002|Overall Study|Adverse Event|1|||
125990426|NCT02762981|453257323|FG003|Overall Study|Adverse Event|1|||
125990427|NCT02762981|453257324|FG004|Overall Study|Adverse Event|3|||
125990428|NCT02762981|453257320|FG000|Overall Study|Physician Decision|0|||
125990429|NCT02762981|453257321|FG001|Overall Study|Physician Decision|1|||
125990430|NCT02762981|453257322|FG002|Overall Study|Physician Decision|0|||
125990431|NCT02762981|453257323|FG003|Overall Study|Physician Decision|0|||
125990432|NCT02762981|453257324|FG004|Overall Study|Physician Decision|1|||
125990433|NCT02762981|453257320|FG000|Overall Study|Disease progression|11|||
125990434|NCT02762981|453257321|FG001|Overall Study|Disease progression|23|||
125990435|NCT02762981|453257322|FG002|Overall Study|Disease progression|4|||
125990436|NCT02762981|453257323|FG003|Overall Study|Disease progression|10|||
126330352|NCT00572455|454503347|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
126330353|NCT00572455|454503348|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
125990437|NCT02762981|453257324|FG004|Overall Study|Disease progression|1|||
125990438|NCT02762981|453257320|FG000|Overall Study|Enrolled not treated|1|||
125990439|NCT02762981|453257321|FG001|Overall Study|Enrolled not treated|5|||
125990440|NCT02762981|453257322|FG002|Overall Study|Enrolled not treated|0|||
125990441|NCT02762981|453257323|FG003|Overall Study|Enrolled not treated|2|||
125990442|NCT02762981|453257324|FG004|Overall Study|Enrolled not treated|0|||
125990443|NCT02762981|453257320|FG000|Overall Study|Other|2|||
125990444|NCT02762981|453257321|FG001|Overall Study|Other|3|||
125990445|NCT02762981|453257322|FG002|Overall Study|Other|1|||
125990446|NCT02762981|453257323|FG003|Overall Study|Other|0|||
125990447|NCT02762981|453257324|FG004|Overall Study|Other|0|||
125990448|NCT02762981|453257320|FG000|Overall Study|Missing|1|||
126330354|NCT00572455|454503349|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
125990449|NCT02762981|453257321|FG001|Overall Study|Missing|0|||
125990450|NCT02762981|453257322|FG002|Overall Study|Missing|0|||
125990451|NCT02762981|453257323|FG003|Overall Study|Missing|0|||
125990452|NCT02762981|453257324|FG004|Overall Study|Missing|0|||
125990453|NCT02762981|453257320|FG000|Overall Study|Withdrawal by Subject|0|||
125990454|NCT02762981|453257321|FG001|Overall Study|Withdrawal by Subject|5|||
125990455|NCT02762981|453257322|FG002|Overall Study|Withdrawal by Subject|1|||
125990456|NCT02762981|453257323|FG003|Overall Study|Withdrawal by Subject|3|||
125990457|NCT02762981|453257324|FG004|Overall Study|Withdrawal by Subject|0|||
125990458|NCT00976482|453257327|FG000|Overall Study|Death|208|||
125990459|NCT00976482|453257327|FG000|Overall Study|Withdrawal by Subject|45|||
125990460|NCT00976482|453257327|FG000|Overall Study|Center terminated|1|||
125990461|NCT00976482|453257327|FG000|Overall Study|Protocol Violation|5|||
125990462|NCT00720902|453257328|FG000|Overall Study|Withdrawal by Subject|1|||
125990463|NCT00720902|453257329|FG001|Overall Study|Withdrawal by Subject|0|||
125990464|NCT00720902|453257328|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
125990465|NCT00720902|453257329|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
125990466|NCT02254408|453257333|FG000|Overall Study|Randomized But Not Treated|1|||
126330355|NCT00572455|454503350|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
126330356|NCT00572455|454503351|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
126330357|NCT00572455|454503352|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
126330358|NCT00572455|454503353|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
126330359|NCT00572455|454503354|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
126330360|NCT00572455|454503355|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
126330361|NCT00572455|454503356|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
126330362|NCT00572455|454503357|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
126330363|NCT00572455|454503358|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
126330364|NCT00572455|454503345|FG000|Stage II (28 Days)|Other|0|||
126330365|NCT00572455|454503346|FG001|Stage II (28 Days)|Other|0|||
126330366|NCT00572455|454503347|FG002|Stage II (28 Days)|Other|0|||
126330367|NCT00572455|454503348|FG003|Stage II (28 Days)|Other|0|||
126330368|NCT00572455|454503349|FG004|Stage II (28 Days)|Other|0|||
126330369|NCT00572455|454503350|FG005|Stage II (28 Days)|Other|0|||
126330370|NCT00572455|454503351|FG006|Stage II (28 Days)|Other|0|||
126330371|NCT00572455|454503352|FG007|Stage II (28 Days)|Other|0|||
126330372|NCT00572455|454503353|FG008|Stage II (28 Days)|Other|1|||
126330373|NCT00572455|454503354|FG009|Stage II (28 Days)|Other|0|||
126330374|NCT00572455|454503355|FG010|Stage II (28 Days)|Other|0|||
126330375|NCT00572455|454503356|FG011|Stage II (28 Days)|Other|0|||
126330376|NCT00572455|454503357|FG012|Stage II (28 Days)|Other|0|||
126330377|NCT00572455|454503358|FG013|Stage II (28 Days)|Other|0|||
126330378|NCT00572455|454503345|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
126330379|NCT00572455|454503346|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
126330380|NCT00572455|454503347|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
126330381|NCT00572455|454503348|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
126330382|NCT00572455|454503349|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
126330383|NCT00572455|454503350|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
126330384|NCT00572455|454503351|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
126330385|NCT00572455|454503352|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
126330386|NCT00572455|454503353|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
126330387|NCT00572455|454503354|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
126330388|NCT00572455|454503355|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
126330389|NCT00572455|454503356|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
126330390|NCT00572455|454503357|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
126330391|NCT00572455|454503358|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
126330392|NCT02824224|454503359|FG000|Overall Study|Discontinued, IUS expulsion|0|||
126330393|NCT02824224|454503360|FG001|Overall Study|Discontinued, IUS expulsion|1|||
126330394|NCT02824224|454503359|FG000|Overall Study|Did not show up for allocation visit|2|||
126330395|NCT02824224|454503360|FG001|Overall Study|Did not show up for allocation visit|0|||
126330396|NCT04152083|454503363|FG000|Overall Study|Lost to Follow-up|2|||
126330397|NCT04152083|454503364|FG001|Overall Study|Lost to Follow-up|1|||
126330398|NCT04152083|454503363|FG000|Overall Study|Adverse Event|1|||
126330399|NCT04152083|454503364|FG001|Overall Study|Adverse Event|0|||
126330400|NCT04152083|454503363|FG000|Overall Study|Randomized but not treated|3|||
125990467|NCT02254408|453257334|FG001|Overall Study|Randomized But Not Treated|3|||
125990468|NCT02254408|453257333|FG000|Overall Study|Adverse Event|1|||
126330401|NCT04152083|454503364|FG001|Overall Study|Randomized but not treated|2|||
126330402|NCT00856999|454503365|FG000|Overall Study|Withdrawal by Subject|5|||
126330403|NCT02465437|454503370|FG000|Overall Study|Physician Decision|0|||
126330404|NCT02465437|454503371|FG001|Overall Study|Physician Decision|0|||
125990469|NCT02254408|453257334|FG001|Overall Study|Adverse Event|0|||
125990470|NCT02254408|453257333|FG000|Overall Study|Death|2|||
125990471|NCT02254408|453257334|FG001|Overall Study|Death|3|||
126330405|NCT02465437|454503372|FG002|Overall Study|Physician Decision|1|||
126330406|NCT02465437|454503373|FG003|Overall Study|Physician Decision|0|||
126330407|NCT02465437|454503370|FG000|Overall Study|Withdrawal by Subject|1|||
126330408|NCT02465437|454503371|FG001|Overall Study|Withdrawal by Subject|0|||
125990472|NCT02254408|453257333|FG000|Overall Study|Investigator's Discretion|0|||
125990473|NCT02254408|453257334|FG001|Overall Study|Investigator's Discretion|1|||
125990474|NCT02254408|453257333|FG000|Overall Study|Withdrawal by Subject|3|||
125990475|NCT02254408|453257334|FG001|Overall Study|Withdrawal by Subject|3|||
125990476|NCT02254408|453257333|FG000|Overall Study|Lost to Follow-up|1|||
125990477|NCT02254408|453257334|FG001|Overall Study|Lost to Follow-up|0|||
125990478|NCT02914184|453257335|FG000|Overall Study|Lost to Follow-up|7|||
125990479|NCT02914184|453257336|FG001|Overall Study|Lost to Follow-up|10|||
125990480|NCT02914184|453257337|FG002|Overall Study|Lost to Follow-up|8|||
125990481|NCT02914184|453257338|FG003|Overall Study|Lost to Follow-up|7|||
125990482|NCT02914184|453257335|FG000|Overall Study|Withdrawal by Subject|4|||
125990483|NCT02914184|453257336|FG001|Overall Study|Withdrawal by Subject|2|||
125990484|NCT02914184|453257337|FG002|Overall Study|Withdrawal by Subject|7|||
125990485|NCT02914184|453257338|FG003|Overall Study|Withdrawal by Subject|3|||
125990486|NCT02914184|453257335|FG000|Overall Study|Other|1|||
125990487|NCT02914184|453257336|FG001|Overall Study|Other|0|||
125990488|NCT02914184|453257337|FG002|Overall Study|Other|0|||
125990489|NCT02914184|453257338|FG003|Overall Study|Other|0|||
125990490|NCT02914184|453257335|FG000|Overall Study|Migrated/moved from the study area|2|||
125990491|NCT02914184|453257336|FG001|Overall Study|Migrated/moved from the study area|1|||
125990492|NCT02914184|453257337|FG002|Overall Study|Migrated/moved from the study area|2|||
125990493|NCT02914184|453257338|FG003|Overall Study|Migrated/moved from the study area|1|||
125990494|NCT00798174|453257339|FG000|Overall Study|inability to implant azygos coil|3|||
125990495|NCT00798174|453257340|FG001|Overall Study|inability to implant azygos coil|3|||
125990496|NCT00798174|453257339|FG000|Overall Study|Inability to sedate for DFT testing|1|||
125990497|NCT00798174|453257340|FG001|Overall Study|Inability to sedate for DFT testing|0|||
125990498|NCT03980184|453257345|FG000|Overall Study|Dropped out before treatment|2|||
125990499|NCT03980184|453257346|FG001|Overall Study|Dropped out before treatment|2|||
125990500|NCT03980184|453257345|FG000|Overall Study|Lost to Follow-up|11|||
125990501|NCT03980184|453257346|FG001|Overall Study|Lost to Follow-up|13|||
125990502|NCT01460160|453257347|FG000|Treatment Phase|Lack of Efficacy|3|||
125990503|NCT01460160|453257347|FG000|Treatment Phase|Study Drug Toxicity|2|||
125990504|NCT01460160|453257347|FG000|Treatment Phase|Adverse Event|8|||
125990505|NCT01460160|453257347|FG000|Treatment Phase|Withdrawal by Subject|4|||
125990506|NCT01460160|453257347|FG000|Treatment Phase|Death|2|||
125990507|NCT01460160|453257347|FG000|Treatment Phase|Other reasons|9|||
125990508|NCT01460160|453257347|FG000|Follow-up Phase|Withdrawal by Subject|4|||
125990509|NCT01460160|453257347|FG000|Follow-up Phase|Death|14|||
125990510|NCT01460160|453257347|FG000|Follow-up Phase|Lost to Follow-up|7|||
125990511|NCT01460160|453257347|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
125990512|NCT01460160|453257347|FG000|Follow-up Phase|Other and not reported reasons|5|||
125990513|NCT01737996|453257350|FG000|Overall Study|Adverse Event|0|||
125990514|NCT01737996|453257351|FG001|Overall Study|Adverse Event|1|||
125990515|NCT01737996|453257352|FG002|Overall Study|Adverse Event|1|||
125990516|NCT01737996|453257350|FG000|Overall Study|Withdrawal by Subject|0|||
125990517|NCT01737996|453257351|FG001|Overall Study|Withdrawal by Subject|0|||
125990518|NCT01737996|453257352|FG002|Overall Study|Withdrawal by Subject|1|||
125990519|NCT00452413|453257353|FG000|Overall Study|Progressive Disease|4|||
125990520|NCT00452413|453257354|FG001|Overall Study|Progressive Disease|11|||
125990521|NCT00452413|453257355|FG002|Overall Study|Progressive Disease|30|||
125990522|NCT00452413|453257353|FG000|Overall Study|Withdrawal by Subject|0|||
125990523|NCT00452413|453257354|FG001|Overall Study|Withdrawal by Subject|1|||
125990524|NCT00452413|453257355|FG002|Overall Study|Withdrawal by Subject|4|||
125990525|NCT00452413|453257353|FG000|Overall Study|Adverse Event|0|||
125990526|NCT00452413|453257354|FG001|Overall Study|Adverse Event|0|||
125990527|NCT00452413|453257355|FG002|Overall Study|Adverse Event|5|||
125990528|NCT00452413|453257353|FG000|Overall Study|Physician Decision|0|||
125990529|NCT00452413|453257354|FG001|Overall Study|Physician Decision|0|||
125990530|NCT00452413|453257355|FG002|Overall Study|Physician Decision|4|||
125990531|NCT00452413|453257353|FG000|Overall Study|Death due to study disease|0|||
125990532|NCT00452413|453257354|FG001|Overall Study|Death due to study disease|0|||
125990533|NCT00452413|453257355|FG002|Overall Study|Death due to study disease|2|||
125990534|NCT00452413|453257353|FG000|Overall Study|Death due to adverse event (AE)|0|||
125990535|NCT00452413|453257354|FG001|Overall Study|Death due to adverse event (AE)|0|||
126330409|NCT02465437|454503372|FG002|Overall Study|Withdrawal by Subject|0|||
126330410|NCT02465437|454503373|FG003|Overall Study|Withdrawal by Subject|1|||
126330411|NCT02465437|454503370|FG000|Overall Study|Adverse Event|0|||
125990536|NCT00452413|453257355|FG002|Overall Study|Death due to adverse event (AE)|1|||
125990537|NCT00452413|453257353|FG000|Overall Study|On treatment|0|||
125990538|NCT00452413|453257354|FG001|Overall Study|On treatment|0|||
125990539|NCT00452413|453257355|FG002|Overall Study|On treatment|3|||
125990540|NCT00114634|453257356|FG000|Overall Study|failure to return forms|3|||
125990541|NCT01539863|453257357|FG000|Overall Study|Lost to Follow-up|5|||
125990542|NCT01539863|453257358|FG001|Overall Study|Lost to Follow-up|4|||
125990543|NCT00007475|453257359|FG000|Overall Study|Withdrawal by Subject|1|||
125990544|NCT00007475|453257360|FG001|Overall Study|Withdrawal by Subject|0|||
125990545|NCT00007475|453257361|FG002|Overall Study|Withdrawal by Subject|0|||
125990546|NCT00007475|453257362|FG003|Overall Study|Withdrawal by Subject|0|||
125990547|NCT00007475|453257359|FG000|Overall Study|Adverse Event|3|||
125990548|NCT00007475|453257360|FG001|Overall Study|Adverse Event|0|||
125990549|NCT00007475|453257361|FG002|Overall Study|Adverse Event|0|||
125990550|NCT00007475|453257362|FG003|Overall Study|Adverse Event|0|||
125990551|NCT01512745|453257363|FG000|Overall Study|Adverse Event|22|||
125990552|NCT01512745|453257364|FG001|Overall Study|Adverse Event|3|||
125990553|NCT01512745|453257363|FG000|Overall Study|Death|9|||
125990554|NCT01512745|453257364|FG001|Overall Study|Death|13|||
125990555|NCT01512745|453257363|FG000|Overall Study|Withdrawal by Subject|2|||
125990556|NCT01512745|453257364|FG001|Overall Study|Withdrawal by Subject|2|||
125990557|NCT01512745|453257363|FG000|Overall Study|Lost to Follow-up|4|||
125990558|NCT01512745|453257364|FG001|Overall Study|Lost to Follow-up|0|||
125990559|NCT01512745|453257363|FG000|Overall Study|Lack of Efficacy|2|||
125990560|NCT01512745|453257364|FG001|Overall Study|Lack of Efficacy|2|||
125990561|NCT01512745|453257363|FG000|Overall Study|Protocol Violation|1|||
125990562|NCT01512745|453257364|FG001|Overall Study|Protocol Violation|0|||
125990563|NCT03151395|453257365|FG000|Overall Study|Adverse Event|2|||
125990564|NCT03151395|453257365|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
125990565|NCT03151395|453257365|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
125990566|NCT03151395|453257365|FG000|Overall Study|Unspecified reason|4|||
125990567|NCT02597933|453257366|FG000|Overall Study|Withdrawal by Subject|7|||
125990568|NCT02597933|453257367|FG001|Overall Study|Withdrawal by Subject|5|||
125990569|NCT02597933|453257366|FG000|Overall Study|Protocol Violation|2|||
125990570|NCT02597933|453257367|FG001|Overall Study|Protocol Violation|2|||
125990571|NCT02597933|453257366|FG000|Overall Study|Adverse Event|20|||
125990572|NCT02597933|453257367|FG001|Overall Study|Adverse Event|28|||
125990573|NCT02597933|453257366|FG000|Overall Study|Not treated|2|||
125990574|NCT02597933|453257367|FG001|Overall Study|Not treated|2|||
125990575|NCT02597933|453257366|FG000|Overall Study|Other than stated above|7|||
125990576|NCT02597933|453257367|FG001|Overall Study|Other than stated above|14|||
125990577|NCT01107743|453257370|FG000|Overall Study|Protocol Violation|46|||
125990578|NCT00308737|453257371|FG000|Overall Study|Adverse Event|104|||
125990579|NCT00308737|453257372|FG001|Overall Study|Adverse Event|9|||
125990580|NCT00308737|453257373|FG002|Overall Study|Adverse Event|0|||
125990581|NCT00308737|453257371|FG000|Overall Study|Death|4|||
125990582|NCT00308737|453257372|FG001|Overall Study|Death|3|||
125990583|NCT00308737|453257373|FG002|Overall Study|Death|0|||
125990584|NCT00308737|453257371|FG000|Overall Study|Lost to Follow-up|56|||
125990585|NCT00308737|453257372|FG001|Overall Study|Lost to Follow-up|80|||
125990586|NCT00308737|453257373|FG002|Overall Study|Lost to Follow-up|5|||
125990587|NCT00308737|453257371|FG000|Overall Study|Physician Decision|15|||
125990588|NCT00308737|453257372|FG001|Overall Study|Physician Decision|2|||
125990589|NCT00308737|453257373|FG002|Overall Study|Physician Decision|1|||
125990590|NCT00308737|453257371|FG000|Overall Study|Protocol Violation|34|||
125990591|NCT00308737|453257372|FG001|Overall Study|Protocol Violation|9|||
125990592|NCT00308737|453257373|FG002|Overall Study|Protocol Violation|5|||
125990593|NCT00308737|453257371|FG000|Overall Study|Withdrawal by Subject|218|||
125990594|NCT00308737|453257372|FG001|Overall Study|Withdrawal by Subject|166|||
125990595|NCT00308737|453257373|FG002|Overall Study|Withdrawal by Subject|18|||
125990596|NCT00308737|453257371|FG000|Overall Study|Various|32|||
125990597|NCT00308737|453257372|FG001|Overall Study|Various|20|||
125990598|NCT00308737|453257373|FG002|Overall Study|Various|8|||
125990599|NCT01225822|453257385|FG000|Overall Study|Adverse Event|13|||
125990600|NCT01225822|453257386|FG001|Overall Study|Adverse Event|31|||
125990601|NCT01225822|453257387|FG002|Overall Study|Adverse Event|18|||
125990602|NCT01225822|453257388|FG003|Overall Study|Adverse Event|23|||
125990603|NCT01225822|453257389|FG004|Overall Study|Adverse Event|14|||
125990604|NCT01225822|453257385|FG000|Overall Study|Protocol Violation|6|||
125990605|NCT01225822|453257386|FG001|Overall Study|Protocol Violation|8|||
125990606|NCT01225822|453257387|FG002|Overall Study|Protocol Violation|6|||
125990607|NCT01225822|453257388|FG003|Overall Study|Protocol Violation|7|||
125990608|NCT01225822|453257389|FG004|Overall Study|Protocol Violation|4|||
126330412|NCT02465437|454503371|FG001|Overall Study|Adverse Event|1|||
125990609|NCT01225822|453257385|FG000|Overall Study|Lost to Follow-up|0|||
125990610|NCT01225822|453257386|FG001|Overall Study|Lost to Follow-up|0|||
125990611|NCT01225822|453257387|FG002|Overall Study|Lost to Follow-up|0|||
125990612|NCT01225822|453257388|FG003|Overall Study|Lost to Follow-up|1|||
125990613|NCT01225822|453257389|FG004|Overall Study|Lost to Follow-up|0|||
125990614|NCT01225822|453257385|FG000|Overall Study|Withdrawal by Subject|6|||
125990615|NCT01225822|453257386|FG001|Overall Study|Withdrawal by Subject|7|||
125990616|NCT01225822|453257387|FG002|Overall Study|Withdrawal by Subject|7|||
125990617|NCT01225822|453257388|FG003|Overall Study|Withdrawal by Subject|11|||
125990618|NCT01225822|453257389|FG004|Overall Study|Withdrawal by Subject|6|||
125990619|NCT01225822|453257385|FG000|Overall Study|Other|13|||
125990620|NCT01225822|453257386|FG001|Overall Study|Other|10|||
125990621|NCT01225822|453257387|FG002|Overall Study|Other|7|||
125990622|NCT01225822|453257388|FG003|Overall Study|Other|10|||
125990623|NCT01225822|453257389|FG004|Overall Study|Other|7|||
125990624|NCT04078035|453257390|FG000|Session 2|Lost to Follow-up|3|||
125990625|NCT04078035|453257391|FG001|Session 2|Lost to Follow-up|1|||
125990626|NCT04078035|453257390|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
125990627|NCT04078035|453257391|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
125990628|NCT05644353|453257392|FG000|Overall Study|Physician Decision|1|||
125990629|NCT05644353|453257393|FG001|Overall Study|Physician Decision|0|||
125990630|NCT05644353|453257394|FG002|Overall Study|Physician Decision|0|||
125990631|NCT05644353|453257395|FG003|Overall Study|Physician Decision|0|||
125990632|NCT05644353|453257396|FG004|Overall Study|Physician Decision|0|||
125990633|NCT05644353|453257397|FG005|Overall Study|Physician Decision|0|||
125990634|NCT05644353|453257392|FG000|Overall Study|Protocol Violation|1|||
125990635|NCT05644353|453257393|FG001|Overall Study|Protocol Violation|0|||
125990636|NCT05644353|453257394|FG002|Overall Study|Protocol Violation|0|||
125990637|NCT05644353|453257395|FG003|Overall Study|Protocol Violation|0|||
125990638|NCT05644353|453257396|FG004|Overall Study|Protocol Violation|0|||
125990639|NCT05644353|453257397|FG005|Overall Study|Protocol Violation|0|||
125990640|NCT05644353|453257392|FG000|Overall Study|Withdrawal by Subject|0|||
125990641|NCT05644353|453257393|FG001|Overall Study|Withdrawal by Subject|2|||
125990642|NCT05644353|453257394|FG002|Overall Study|Withdrawal by Subject|0|||
125990643|NCT05644353|453257395|FG003|Overall Study|Withdrawal by Subject|0|||
125990644|NCT05644353|453257396|FG004|Overall Study|Withdrawal by Subject|1|||
125990645|NCT05644353|453257397|FG005|Overall Study|Withdrawal by Subject|0|||
125990646|NCT05644353|453257392|FG000|Overall Study|Lost to Follow-up|0|||
125990647|NCT05644353|453257393|FG001|Overall Study|Lost to Follow-up|0|||
125990648|NCT05644353|453257394|FG002|Overall Study|Lost to Follow-up|1|||
125990649|NCT05644353|453257395|FG003|Overall Study|Lost to Follow-up|0|||
125990650|NCT05644353|453257396|FG004|Overall Study|Lost to Follow-up|0|||
125990651|NCT05644353|453257397|FG005|Overall Study|Lost to Follow-up|0|||
125990652|NCT01407354|453257398|FG000|First Intervention|Withdrawal by Subject|0|||
125990653|NCT01407354|453257399|FG001|First Intervention|Withdrawal by Subject|2|||
125990654|NCT01407354|453257398|FG000|First Intervention|Adverse Event|1|||
125990655|NCT01407354|453257399|FG001|First Intervention|Adverse Event|0|||
125990656|NCT01407354|453257398|FG000|First Intervention|Physician Decision|1|||
125990657|NCT01407354|453257399|FG001|First Intervention|Physician Decision|0|||
125990658|NCT02204579|453257400|FG000|Overall Study|Screen failures|2|||
125990659|NCT02778399|453257401|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
125990660|NCT02778399|453257402|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
125990661|NCT02778399|453257403|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
125990662|NCT02778399|453257404|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
125990663|NCT02778399|453257405|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
125990664|NCT02778399|453257406|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
125990665|NCT02778399|453257401|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
125990666|NCT02778399|453257402|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
125990667|NCT02778399|453257403|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
125990668|NCT02778399|453257404|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
126330413|NCT02465437|454503372|FG002|Overall Study|Adverse Event|0|||
126330414|NCT02465437|454503373|FG003|Overall Study|Adverse Event|0|||
126330415|NCT00003483|454503374|FG000|Overall Study|Not evaluable|1|||
126330416|NCT02401035|454503375|FG000|Overall Study|Withdrawal by Subject|1|||
126330417|NCT02401035|454503376|FG001|Overall Study|Withdrawal by Subject|0|||
126330418|NCT00656175|454503377|FG000|Overall Study|Adverse Event|1|||
126330419|NCT00656175|454503378|FG001|Overall Study|Adverse Event|0|||
126330420|NCT00656175|454503377|FG000|Overall Study|Transportation issues|0|||
126330421|NCT00656175|454503378|FG001|Overall Study|Transportation issues|1|||
126330422|NCT01066871|454503389|FG000|Overall Study|Lost to Follow-up|0|||
126330423|NCT01066871|454503390|FG001|Overall Study|Lost to Follow-up|2|||
126330424|NCT01066871|454503391|FG002|Overall Study|Lost to Follow-up|2|||
126330425|NCT01066871|454503392|FG003|Overall Study|Lost to Follow-up|0|||
126330426|NCT01066871|454503389|FG000|Overall Study|Protocol Violation|1|||
126330427|NCT01066871|454503390|FG001|Overall Study|Protocol Violation|0|||
126330428|NCT01066871|454503391|FG002|Overall Study|Protocol Violation|3|||
126330429|NCT01066871|454503392|FG003|Overall Study|Protocol Violation|2|||
126330430|NCT01066871|454503389|FG000|Overall Study|Lack of Efficacy|0|||
126330431|NCT01066871|454503390|FG001|Overall Study|Lack of Efficacy|0|||
126330432|NCT01066871|454503391|FG002|Overall Study|Lack of Efficacy|0|||
126330433|NCT01066871|454503392|FG003|Overall Study|Lack of Efficacy|1|||
125990669|NCT02778399|453257405|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
125990670|NCT02778399|453257406|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
126330434|NCT01066871|454503389|FG000|Overall Study|Withdrawal by Subject|3|||
126330435|NCT01066871|454503390|FG001|Overall Study|Withdrawal by Subject|1|||
126330436|NCT01066871|454503391|FG002|Overall Study|Withdrawal by Subject|0|||
125990671|NCT02778399|453257401|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
125990672|NCT02778399|453257402|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
125990673|NCT02778399|453257403|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
125990674|NCT02778399|453257404|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
126330437|NCT01066871|454503392|FG003|Overall Study|Withdrawal by Subject|0|||
126330438|NCT01066871|454503389|FG000|Overall Study|Other|0|||
125990675|NCT02778399|453257405|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
125990676|NCT02778399|453257406|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
125990677|NCT02778399|453257401|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
125990678|NCT02778399|453257402|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
125990679|NCT02778399|453257403|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
125990680|NCT02778399|453257404|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
125990681|NCT02778399|453257405|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
125990682|NCT02778399|453257406|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
125990683|NCT02778399|453257401|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
125990684|NCT02778399|453257402|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
125990685|NCT02778399|453257403|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
125990686|NCT02778399|453257404|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
125990687|NCT02778399|453257405|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
125990688|NCT02778399|453257406|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
125990689|NCT02778399|453257401|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
125990690|NCT02778399|453257402|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
125990691|NCT02778399|453257403|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
125990692|NCT02778399|453257404|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
125990693|NCT02778399|453257405|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
125990694|NCT02778399|453257406|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
125990695|NCT02778399|453257401|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
125990696|NCT02778399|453257402|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
125990697|NCT02778399|453257403|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
125990698|NCT02778399|453257404|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
125990699|NCT02778399|453257405|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
125990700|NCT02778399|453257406|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
125990701|NCT02778399|453257401|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125990702|NCT02778399|453257402|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
125990703|NCT02778399|453257403|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125990704|NCT02778399|453257404|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125990705|NCT02778399|453257405|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125990706|NCT02778399|453257406|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125990707|NCT02778399|453257401|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
125990708|NCT02778399|453257402|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
125990709|NCT02778399|453257403|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
125990710|NCT02778399|453257404|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
125990711|NCT02778399|453257405|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
125990712|NCT02778399|453257406|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
125990713|NCT02778399|453257401|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
125990714|NCT02778399|453257402|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
125990715|NCT02778399|453257403|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
125990716|NCT02778399|453257404|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
125990717|NCT02778399|453257405|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
125990718|NCT02778399|453257406|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
125990719|NCT02778399|453257401|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
125990720|NCT02778399|453257402|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
125990721|NCT02778399|453257403|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
125990722|NCT02778399|453257404|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
125990723|NCT02778399|453257405|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
125990724|NCT02778399|453257406|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
125990725|NCT03916744|453257407|FG000|Overall Study|Withdrawal by Subject|0|||
125990726|NCT03916744|453257408|FG001|Overall Study|Withdrawal by Subject|1|||
125990727|NCT03916744|453257409|FG002|Overall Study|Withdrawal by Subject|2|||
125990728|NCT03757234|453257410|FG000|Overall Study|Adverse Event|0|||
125990729|NCT03757234|453257411|FG001|Overall Study|Adverse Event|0|||
125990730|NCT03757234|453257412|FG002|Overall Study|Adverse Event|0|||
125990731|NCT03757234|453257413|FG003|Overall Study|Adverse Event|0|||
125990732|NCT03757234|453257414|FG004|Overall Study|Adverse Event|1|||
125990733|NCT03757234|453257410|FG000|Overall Study|Lost to Follow-up|1|||
125990734|NCT03757234|453257411|FG001|Overall Study|Lost to Follow-up|0|||
126209298|NCT05182840|454053179|FG006|Treatment Period|Change of residence|0|||
126209299|NCT05182840|454053180|FG007|Treatment Period|Change of residence|0|||
126330439|NCT01066871|454503390|FG001|Overall Study|Other|2|||
125990735|NCT03757234|453257412|FG002|Overall Study|Lost to Follow-up|0|||
125990736|NCT03757234|453257413|FG003|Overall Study|Lost to Follow-up|0|||
125990737|NCT03757234|453257414|FG004|Overall Study|Lost to Follow-up|1|||
125990738|NCT03757234|453257410|FG000|Overall Study|Withdrawal by Subject|1|||
125990739|NCT03757234|453257411|FG001|Overall Study|Withdrawal by Subject|1|||
125990740|NCT03757234|453257412|FG002|Overall Study|Withdrawal by Subject|0|||
125990741|NCT03757234|453257413|FG003|Overall Study|Withdrawal by Subject|1|||
125990742|NCT03757234|453257414|FG004|Overall Study|Withdrawal by Subject|2|||
125990743|NCT03757234|453257410|FG000|Overall Study|Other|1|||
125990744|NCT03757234|453257411|FG001|Overall Study|Other|1|||
125990745|NCT03757234|453257412|FG002|Overall Study|Other|0|||
125990746|NCT03757234|453257413|FG003|Overall Study|Other|0|||
125990747|NCT03757234|453257414|FG004|Overall Study|Other|0|||
125990748|NCT01555164|453257416|FG000|Overall Study|Adverse Event|5|||
125990749|NCT01555164|453257417|FG001|Overall Study|Adverse Event|7|||
125990750|NCT01555164|453257416|FG000|Overall Study|Hyperglycemia|0|||
125990751|NCT01555164|453257417|FG001|Overall Study|Hyperglycemia|1|||
125990752|NCT01555164|453257416|FG000|Overall Study|Investigator's Discretion|2|||
125990753|NCT01555164|453257417|FG001|Overall Study|Investigator's Discretion|2|||
125990754|NCT01555164|453257416|FG000|Overall Study|Lost to Follow-up|4|||
125990755|NCT01555164|453257417|FG001|Overall Study|Lost to Follow-up|3|||
125990756|NCT01555164|453257416|FG000|Overall Study|Protocol Violation|9|||
125990757|NCT01555164|453257417|FG001|Overall Study|Protocol Violation|5|||
125990758|NCT01555164|453257416|FG000|Overall Study|Subject Non-compliance|14|||
125990759|NCT01555164|453257417|FG001|Overall Study|Subject Non-compliance|6|||
125990760|NCT01555164|453257416|FG000|Overall Study|Subject Withdrew Consent|6|||
125990761|NCT01555164|453257417|FG001|Overall Study|Subject Withdrew Consent|11|||
125990762|NCT00926003|453257418|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
125990763|NCT00926003|453257419|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
125990764|NCT00926003|453257420|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
125990765|NCT00926003|453257418|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
125990766|NCT00926003|453257419|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
125990767|NCT00926003|453257420|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
125990768|NCT01396317|453257423|FG000|Overall Study|Adverse Event|1|||
125990769|NCT01396317|453257424|FG001|Overall Study|Adverse Event|0|||
125990770|NCT01709305|453257427|FG000|Phase 1|Clinical Adverse Event|80|||
125990771|NCT01709305|453257428|FG001|Phase 1|Clinical Adverse Event|0|||
125990772|NCT01709305|453257429|FG002|Phase 1|Clinical Adverse Event|0|||
125990773|NCT01709305|453257430|FG003|Phase 1|Clinical Adverse Event|0|||
125990774|NCT01709305|453257431|FG004|Phase 1|Clinical Adverse Event|0|||
125990775|NCT01709305|453257427|FG000|Phase 1|Death|2|||
125990776|NCT01709305|453257428|FG001|Phase 1|Death|0|||
125990777|NCT01709305|453257429|FG002|Phase 1|Death|0|||
125990778|NCT01709305|453257430|FG003|Phase 1|Death|0|||
125990779|NCT01709305|453257431|FG004|Phase 1|Death|0|||
125990780|NCT01709305|453257427|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
125990781|NCT01709305|453257428|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
125990782|NCT01709305|453257429|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
125990783|NCT01709305|453257430|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
125990784|NCT01709305|453257431|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
125990785|NCT01709305|453257427|FG000|Phase 1|Laboratory Adverse Event|16|||
125990786|NCT01709305|453257428|FG001|Phase 1|Laboratory Adverse Event|0|||
125990787|NCT01709305|453257429|FG002|Phase 1|Laboratory Adverse Event|0|||
125990788|NCT01709305|453257430|FG003|Phase 1|Laboratory Adverse Event|0|||
125990789|NCT01709305|453257431|FG004|Phase 1|Laboratory Adverse Event|0|||
125990790|NCT01709305|453257427|FG000|Phase 1|Lost to Follow-up|147|||
125990791|NCT01709305|453257428|FG001|Phase 1|Lost to Follow-up|0|||
125990792|NCT01709305|453257429|FG002|Phase 1|Lost to Follow-up|0|||
125990793|NCT01709305|453257430|FG003|Phase 1|Lost to Follow-up|0|||
125990794|NCT01709305|453257431|FG004|Phase 1|Lost to Follow-up|0|||
125990795|NCT01709305|453257427|FG000|Phase 1|Travel, moving, etc.|30|||
125990796|NCT01709305|453257428|FG001|Phase 1|Travel, moving, etc.|0|||
125990797|NCT01709305|453257429|FG002|Phase 1|Travel, moving, etc.|0|||
125990798|NCT01709305|453257430|FG003|Phase 1|Travel, moving, etc.|0|||
125990799|NCT01709305|453257431|FG004|Phase 1|Travel, moving, etc.|0|||
125990800|NCT01709305|453257427|FG000|Phase 1|Physician Decision|13|||
125990801|NCT01709305|453257428|FG001|Phase 1|Physician Decision|0|||
125990802|NCT01709305|453257429|FG002|Phase 1|Physician Decision|0|||
125990803|NCT01709305|453257430|FG003|Phase 1|Physician Decision|0|||
125990804|NCT01709305|453257431|FG004|Phase 1|Physician Decision|0|||
125990805|NCT01709305|453257427|FG000|Phase 1|Protocol Violation|118|||
125990806|NCT01709305|453257428|FG001|Phase 1|Protocol Violation|0|||
125990807|NCT01709305|453257429|FG002|Phase 1|Protocol Violation|0|||
125990808|NCT01709305|453257430|FG003|Phase 1|Protocol Violation|0|||
125990809|NCT01709305|453257431|FG004|Phase 1|Protocol Violation|0|||
125990810|NCT01709305|453257427|FG000|Phase 1|Withdrawal by Subject|218|||
125990811|NCT01709305|453257428|FG001|Phase 1|Withdrawal by Subject|0|||
125990812|NCT01709305|453257429|FG002|Phase 1|Withdrawal by Subject|0|||
125990813|NCT01709305|453257430|FG003|Phase 1|Withdrawal by Subject|0|||
125990814|NCT01709305|453257431|FG004|Phase 1|Withdrawal by Subject|0|||
125990815|NCT01709305|453257427|FG000|Phase 2|Clinical Adverse Event|0|||
125990816|NCT01709305|453257428|FG001|Phase 2|Clinical Adverse Event|10|||
125990817|NCT01709305|453257429|FG002|Phase 2|Clinical Adverse Event|10|||
125990818|NCT01709305|453257430|FG003|Phase 2|Clinical Adverse Event|6|||
125990819|NCT01709305|453257431|FG004|Phase 2|Clinical Adverse Event|11|||
125990820|NCT01709305|453257427|FG000|Phase 2|Death|0|||
125990821|NCT01709305|453257428|FG001|Phase 2|Death|0|||
125990822|NCT01709305|453257429|FG002|Phase 2|Death|1|||
125990823|NCT01709305|453257430|FG003|Phase 2|Death|0|||
125990824|NCT01709305|453257431|FG004|Phase 2|Death|0|||
125990825|NCT01709305|453257427|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125990826|NCT01709305|453257428|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125990827|NCT01709305|453257429|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125990828|NCT01709305|453257430|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125990829|NCT01709305|453257431|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
125990830|NCT01709305|453257427|FG000|Phase 2|Laboratory Adverse Event|0|||
125990831|NCT01709305|453257428|FG001|Phase 2|Laboratory Adverse Event|1|||
125990832|NCT01709305|453257429|FG002|Phase 2|Laboratory Adverse Event|0|||
125990833|NCT01709305|453257430|FG003|Phase 2|Laboratory Adverse Event|1|||
125990834|NCT01709305|453257431|FG004|Phase 2|Laboratory Adverse Event|1|||
125990835|NCT01709305|453257427|FG000|Phase 2|Lost to Follow-up|0|||
125990836|NCT01709305|453257428|FG001|Phase 2|Lost to Follow-up|10|||
125990837|NCT01709305|453257429|FG002|Phase 2|Lost to Follow-up|6|||
125990838|NCT01709305|453257430|FG003|Phase 2|Lost to Follow-up|9|||
125990839|NCT01709305|453257431|FG004|Phase 2|Lost to Follow-up|5|||
125990840|NCT01709305|453257427|FG000|Phase 2|Travel, moving, etc.|0|||
125990841|NCT01709305|453257428|FG001|Phase 2|Travel, moving, etc.|2|||
125990842|NCT01709305|453257429|FG002|Phase 2|Travel, moving, etc.|3|||
125990843|NCT01709305|453257430|FG003|Phase 2|Travel, moving, etc.|3|||
125990844|NCT01709305|453257431|FG004|Phase 2|Travel, moving, etc.|5|||
125990845|NCT01709305|453257427|FG000|Phase 2|Physician Decision|0|||
125990846|NCT01709305|453257428|FG001|Phase 2|Physician Decision|2|||
125990847|NCT01709305|453257429|FG002|Phase 2|Physician Decision|0|||
125990848|NCT01709305|453257430|FG003|Phase 2|Physician Decision|1|||
125990849|NCT01709305|453257431|FG004|Phase 2|Physician Decision|2|||
125990850|NCT01709305|453257427|FG000|Phase 2|Protocol Violation|0|||
125990851|NCT01709305|453257428|FG001|Phase 2|Protocol Violation|19|||
125990852|NCT01709305|453257429|FG002|Phase 2|Protocol Violation|19|||
125990853|NCT01709305|453257430|FG003|Phase 2|Protocol Violation|13|||
125990854|NCT01709305|453257431|FG004|Phase 2|Protocol Violation|9|||
125990855|NCT01709305|453257427|FG000|Phase 2|Withdrawal by Subject|0|||
125990856|NCT01709305|453257428|FG001|Phase 2|Withdrawal by Subject|8|||
125990857|NCT01709305|453257429|FG002|Phase 2|Withdrawal by Subject|6|||
125990858|NCT01709305|453257430|FG003|Phase 2|Withdrawal by Subject|15|||
125990859|NCT01709305|453257431|FG004|Phase 2|Withdrawal by Subject|12|||
125990860|NCT00171873|453257436|FG000|Overall Study|Withdrawal by Subject|4|||
125990861|NCT00171873|453257437|FG001|Overall Study|Withdrawal by Subject|2|||
125990862|NCT00171873|453257436|FG000|Overall Study|Adverse Event|5|||
125990863|NCT00171873|453257437|FG001|Overall Study|Adverse Event|0|||
125990864|NCT00171873|453257436|FG000|Overall Study|Switched to Octreotide|0|||
125990865|NCT00171873|453257437|FG001|Overall Study|Switched to Octreotide|1|||
125990866|NCT00539279|453257438|FG000|Treatment|Withdrawal by Subject|10|||
125990867|NCT00539279|453257439|FG001|Treatment|Withdrawal by Subject|8|||
125990868|NCT00539279|453257438|FG000|Treatment|Death|1|||
125990869|NCT00539279|453257439|FG001|Treatment|Death|0|||
125990870|NCT00539279|453257438|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
125990871|NCT00539279|453257439|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
125990872|NCT00539279|453257438|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
125990873|NCT00539279|453257439|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
125990874|NCT01338012|453257444|FG000|Overall Study|Death|4|||
125990875|NCT01338012|453257444|FG000|Overall Study|Study terminated|4|||
125990876|NCT02073097|453257445|FG000|Overall Study|Adverse Event|0|||
125990877|NCT02073097|453257446|FG001|Overall Study|Adverse Event|0|||
125990878|NCT02073097|453257447|FG002|Overall Study|Adverse Event|0|||
125990879|NCT02073097|453257448|FG003|Overall Study|Adverse Event|0|||
125990880|NCT02073097|453257449|FG004|Overall Study|Adverse Event|0|||
125990881|NCT02073097|453257450|FG005|Overall Study|Adverse Event|0|||
125990882|NCT02073097|453257451|FG006|Overall Study|Adverse Event|0|||
125990883|NCT02073097|453257452|FG007|Overall Study|Adverse Event|2|||
125990884|NCT02073097|453257445|FG000|Overall Study|Withdrawal by Subject|0|||
125990885|NCT02073097|453257446|FG001|Overall Study|Withdrawal by Subject|0|||
125990886|NCT02073097|453257447|FG002|Overall Study|Withdrawal by Subject|0|||
125990887|NCT02073097|453257448|FG003|Overall Study|Withdrawal by Subject|0|||
125990888|NCT02073097|453257449|FG004|Overall Study|Withdrawal by Subject|0|||
125990889|NCT02073097|453257450|FG005|Overall Study|Withdrawal by Subject|0|||
125990890|NCT02073097|453257451|FG006|Overall Study|Withdrawal by Subject|0|||
125990891|NCT02073097|453257452|FG007|Overall Study|Withdrawal by Subject|2|||
125990892|NCT02073097|453257445|FG000|Overall Study|Death|0|||
125990893|NCT02073097|453257446|FG001|Overall Study|Death|0|||
125990894|NCT02073097|453257447|FG002|Overall Study|Death|0|||
125990895|NCT02073097|453257448|FG003|Overall Study|Death|0|||
125990896|NCT02073097|453257449|FG004|Overall Study|Death|0|||
125990897|NCT02073097|453257450|FG005|Overall Study|Death|0|||
125990898|NCT02073097|453257451|FG006|Overall Study|Death|0|||
125990899|NCT02073097|453257452|FG007|Overall Study|Death|1|||
125990900|NCT02073097|453257445|FG000|Overall Study|Physician Decision|0|||
125990901|NCT02073097|453257446|FG001|Overall Study|Physician Decision|0|||
125990902|NCT02073097|453257447|FG002|Overall Study|Physician Decision|0|||
125990903|NCT02073097|453257448|FG003|Overall Study|Physician Decision|0|||
125990904|NCT02073097|453257449|FG004|Overall Study|Physician Decision|0|||
125990905|NCT02073097|453257450|FG005|Overall Study|Physician Decision|0|||
125990906|NCT02073097|453257451|FG006|Overall Study|Physician Decision|0|||
125990907|NCT02073097|453257452|FG007|Overall Study|Physician Decision|1|||
125990908|NCT02936037|453259173|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
125990909|NCT02936037|453259174|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
125990910|NCT02936037|453259173|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
125990911|NCT02936037|453259174|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
125990912|NCT02936037|453259173|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
125990913|NCT02936037|453259174|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
125990914|NCT02936037|453259173|FG000|Double-Blind Treatment Period|Death|0|||
125990915|NCT02936037|453259174|FG001|Double-Blind Treatment Period|Death|1|||
125990916|NCT02936037|453259173|FG000|Double-Blind Treatment Period|Adverse Event|11|||
125990917|NCT02936037|453259174|FG001|Double-Blind Treatment Period|Adverse Event|11|||
125990918|NCT02936037|453259173|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
125990919|NCT02936037|453259174|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
125990920|NCT02936037|453259173|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125990921|NCT02936037|453259174|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125990922|NCT02936037|453259173|FG000|Open Label Extension|Adverse Event|0|||
125990923|NCT02936037|453259174|FG001|Open Label Extension|Adverse Event|3|||
125990924|NCT02936037|453259173|FG000|Open Label Extension|Other|0|||
125990925|NCT02936037|453259174|FG001|Open Label Extension|Other|3|||
125990926|NCT02936037|453259173|FG000|Open Label Extension|Withdrawal by Subject|0|||
125990927|NCT02936037|453259174|FG001|Open Label Extension|Withdrawal by Subject|4|||
125990928|NCT01382940|453259175|FG000|Overall Study|Adverse Event|19|||
125990929|NCT01382940|453259175|FG000|Overall Study|Lost to Follow-up|4|||
125990930|NCT01382940|453259175|FG000|Overall Study|Physician Decision|7|||
125990931|NCT01382940|453259175|FG000|Overall Study|Withdrawal by Subject|23|||
125990932|NCT01382940|453259175|FG000|Overall Study|Protocol Violation|20|||
125990933|NCT00244374|453259176|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
125990934|NCT00244374|453259177|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
125990935|NCT00244374|453259178|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
125990936|NCT00244374|453259179|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
125990937|NCT00244374|453259180|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
125990938|NCT00244374|453259176|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
125990939|NCT00244374|453259177|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
125990940|NCT00244374|453259178|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
125990941|NCT00244374|453259179|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
125990942|NCT00244374|453259180|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
125990943|NCT00244374|453259176|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
125990944|NCT00244374|453259177|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
125990945|NCT00244374|453259178|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
125990946|NCT00244374|453259179|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
125990947|NCT00244374|453259180|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
125990948|NCT00244374|453259176|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
125990949|NCT00244374|453259177|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
125990950|NCT00244374|453259178|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
125990951|NCT00244374|453259179|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
125990952|NCT00244374|453259180|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
125990953|NCT00244374|453259176|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
125990954|NCT00244374|453259177|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
125990955|NCT00244374|453259178|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
125990956|NCT00244374|453259179|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
125990957|NCT00244374|453259180|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
125990958|NCT00244374|453259176|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
125990959|NCT00244374|453259177|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
125990960|NCT00244374|453259178|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
125990961|NCT00244374|453259179|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
125990962|NCT00244374|453259180|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
125990963|NCT00244374|453259176|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
125990964|NCT00244374|453259177|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
125990965|NCT00244374|453259178|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
125990966|NCT00244374|453259179|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
125990967|NCT00244374|453259180|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
125990968|NCT00244374|453259176|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
125990969|NCT00244374|453259177|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
125990970|NCT00244374|453259178|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
125990971|NCT00244374|453259179|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
125990972|NCT00244374|453259180|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
125990973|NCT00244374|453259176|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
125990974|NCT00244374|453259177|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
125990975|NCT00244374|453259178|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
125990976|NCT00244374|453259179|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
125990977|NCT00244374|453259180|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
125990978|NCT01486758|453259183|FG000|Overall Study|Lost to Follow-up|0|||
125990979|NCT01486758|453259184|FG001|Overall Study|Lost to Follow-up|1|||
125990980|NCT01478113|453259194|FG000|Overall Study|Withdrawal by Subject|0|||
125990981|NCT01478113|453259195|FG001|Overall Study|Withdrawal by Subject|1|||
125990982|NCT01478113|453259194|FG000|Overall Study|Physician Decision|1|||
125990983|NCT01478113|453259195|FG001|Overall Study|Physician Decision|0|||
125990984|NCT03093428|453259199|FG000|Overall Study|Not eligible for treatment|2|||
125990985|NCT03093428|453259200|FG001|Overall Study|Not eligible for treatment|1|||
125990986|NCT03093428|453259199|FG000|Overall Study|Progression|14|||
125990987|NCT03093428|453259200|FG001|Overall Study|Progression|4|||
125990988|NCT03093428|453259199|FG000|Overall Study|Death|1|||
125990989|NCT03093428|453259200|FG001|Overall Study|Death|0|||
125990990|NCT03093428|453259199|FG000|Overall Study|Adverse Event|1|||
125990991|NCT03093428|453259200|FG001|Overall Study|Adverse Event|0|||
125990992|NCT03093428|453259199|FG000|Overall Study|Withdrawal by Subject|1|||
125990993|NCT03093428|453259200|FG001|Overall Study|Withdrawal by Subject|1|||
125990994|NCT01642602|453259202|FG000|Overall Study|Adverse Event|2|||
125990995|NCT01118455|453259203|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
125990996|NCT01118455|453259204|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
125990997|NCT03327402|453259205|FG000|Overall Study|Withdrawal by Subject|1|||
125990998|NCT03327402|453259205|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
125990999|NCT03810313|453259206|FG000|Overall Study|Study terminated by sponsor|164|||
125991000|NCT03810313|453259207|FG001|Overall Study|Study terminated by sponsor|159|||
125991001|NCT03810313|453259206|FG000|Overall Study|Subject decision|10|||
125991002|NCT03810313|453259207|FG001|Overall Study|Subject decision|11|||
125991003|NCT03810313|453259206|FG000|Overall Study|Lost to Follow-up|3|||
125991004|NCT03810313|453259207|FG001|Overall Study|Lost to Follow-up|3|||
125991005|NCT03810313|453259206|FG000|Overall Study|Adverse Event|2|||
125991006|NCT03810313|453259207|FG001|Overall Study|Adverse Event|1|||
125991007|NCT03810313|453259206|FG000|Overall Study|Death|2|||
125991008|NCT03810313|453259207|FG001|Overall Study|Death|1|||
125991009|NCT03810313|453259206|FG000|Overall Study|Physician Decision|0|||
125991010|NCT03810313|453259207|FG001|Overall Study|Physician Decision|1|||
125991011|NCT00422799|453259210|FG000|Overall Study|Withdrawal by Subject|6|||
125991012|NCT00422799|453259210|FG000|Overall Study|Adverse Event|7|||
125991013|NCT03029780|453259212|FG000|Overall Study|Disease Progression|20|||
125991014|NCT03029780|453259213|FG001|Overall Study|Disease Progression|22|||
125991015|NCT03029780|453259212|FG000|Overall Study|Study Drug Toxicity|15|||
125991016|NCT03029780|453259213|FG001|Overall Study|Study Drug Toxicity|11|||
125991017|NCT03029780|453259212|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
125991018|NCT03029780|453259213|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125991019|NCT03029780|453259212|FG000|Overall Study|Participant request to discontinue study treatment|4|||
125991020|NCT03029780|453259213|FG001|Overall Study|Participant request to discontinue study treatment|1|||
125991021|NCT03029780|453259212|FG000|Overall Study|Maximum clinical benefit|1|||
125991022|NCT03029780|453259213|FG001|Overall Study|Maximum clinical benefit|0|||
125991023|NCT03029780|453259212|FG000|Overall Study|Participant no longer meets study criteria|0|||
125991024|NCT03029780|453259213|FG001|Overall Study|Participant no longer meets study criteria|1|||
125991025|NCT03029780|453259212|FG000|Overall Study|Other reasons|6|||
125991026|NCT03029780|453259213|FG001|Overall Study|Other reasons|6|||
125991027|NCT03029780|453259212|FG000|Overall Study|Not reported|1|||
125991028|NCT03029780|453259213|FG001|Overall Study|Not reported|1|||
125991029|NCT03029780|453259212|FG000|Overall Study|Death|2|||
125991030|NCT03029780|453259213|FG001|Overall Study|Death|6|||
125991031|NCT01616771|453259214|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
125991032|NCT00100932|453259215|FG000|Overall Study|Adverse Event|11|||
125991033|NCT00100932|453259216|FG001|Overall Study|Adverse Event|2|||
125991034|NCT00100932|453259215|FG000|Overall Study|Withdrawal by Subject|6|||
125991035|NCT00100932|453259216|FG001|Overall Study|Withdrawal by Subject|0|||
125991036|NCT00100932|453259215|FG000|Overall Study|Progressive Disease|44|||
125991037|NCT00100932|453259216|FG001|Overall Study|Progressive Disease|18|||
125991038|NCT00100932|453259215|FG000|Overall Study|Physician Decision|7|||
125991039|NCT00100932|453259216|FG001|Overall Study|Physician Decision|5|||
125991040|NCT00100932|453259215|FG000|Overall Study|Other|5|||
125991041|NCT00100932|453259216|FG001|Overall Study|Other|2|||
125991042|NCT00744328|453259217|FG000|Overall Study|Lost to Follow-up|2|||
125991043|NCT00744328|453259218|FG001|Overall Study|Lost to Follow-up|5|||
125991044|NCT00744328|453259219|FG002|Overall Study|Lost to Follow-up|3|||
125991045|NCT00744328|453259217|FG000|Overall Study|Withdrawal by Subject|5|||
125991046|NCT00744328|453259218|FG001|Overall Study|Withdrawal by Subject|3|||
125991047|NCT00744328|453259219|FG002|Overall Study|Withdrawal by Subject|4|||
125991048|NCT00744328|453259217|FG000|Overall Study|Found ineligible after randomization|0|||
125991049|NCT00744328|453259218|FG001|Overall Study|Found ineligible after randomization|0|||
125991050|NCT00744328|453259219|FG002|Overall Study|Found ineligible after randomization|1|||
125991051|NCT02387216|453259222|FG000|Overall Study|Progressive disease|2|||
125991052|NCT02387216|453259223|FG001|Overall Study|Progressive disease|0|||
125991053|NCT02387216|453259222|FG000|Overall Study|Withdrawal by Subject|3|||
125991054|NCT02387216|453259223|FG001|Overall Study|Withdrawal by Subject|5|||
125991055|NCT02387216|453259222|FG000|Overall Study|Physician Decision|2|||
125991056|NCT02387216|453259223|FG001|Overall Study|Physician Decision|0|||
125991057|NCT02387216|453259222|FG000|Overall Study|Sponsor Decision|28|||
125991058|NCT02387216|453259223|FG001|Overall Study|Sponsor Decision|12|||
125991059|NCT02387216|453259222|FG000|Overall Study|Death|60|||
125991060|NCT02387216|453259223|FG001|Overall Study|Death|23|||
125991061|NCT02387216|453259222|FG000|Overall Study|Other|5|||
125991062|NCT02387216|453259223|FG001|Overall Study|Other|4|||
125991063|NCT02387216|453259222|FG000|Overall Study|Lost to Follow-up|0|||
125991064|NCT02387216|453259223|FG001|Overall Study|Lost to Follow-up|3|||
125991065|NCT04498247|453259224|FG000|Overall Study|Lost to Follow-up|0|||
125991066|NCT04498247|453259225|FG001|Overall Study|Lost to Follow-up|0|||
125991067|NCT04498247|453259226|FG002|Overall Study|Lost to Follow-up|0|||
125991068|NCT04498247|453259227|FG003|Overall Study|Lost to Follow-up|1|||
125991069|NCT04498247|453259228|FG004|Overall Study|Lost to Follow-up|0|||
125991070|NCT04498247|453259229|FG005|Overall Study|Lost to Follow-up|0|||
125991071|NCT04498247|453259230|FG006|Overall Study|Lost to Follow-up|0|||
125991072|NCT04498247|453259231|FG007|Overall Study|Lost to Follow-up|0|||
125991073|NCT04498247|453259224|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
125991074|NCT04498247|453259225|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
125991075|NCT04498247|453259226|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
125991076|NCT04498247|453259227|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
125991077|NCT04498247|453259228|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
125991078|NCT04498247|453259229|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
125991079|NCT04498247|453259230|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
125991080|NCT04498247|453259231|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
125991081|NCT04498247|453259224|FG000|Overall Study|Withdrawal by Subject|0|||
125991082|NCT04498247|453259225|FG001|Overall Study|Withdrawal by Subject|8|||
125991083|NCT04498247|453259226|FG002|Overall Study|Withdrawal by Subject|0|||
125991084|NCT04498247|453259227|FG003|Overall Study|Withdrawal by Subject|7|||
125991085|NCT04498247|453259228|FG004|Overall Study|Withdrawal by Subject|0|||
125991086|NCT04498247|453259229|FG005|Overall Study|Withdrawal by Subject|0|||
125991087|NCT04498247|453259230|FG006|Overall Study|Withdrawal by Subject|1|||
125991088|NCT04498247|453259231|FG007|Overall Study|Withdrawal by Subject|0|||
125991089|NCT04498247|453259224|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125991090|NCT04498247|453259225|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
125991091|NCT04498247|453259226|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125991092|NCT04498247|453259227|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
125991093|NCT04498247|453259228|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125991094|NCT04498247|453259229|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125991095|NCT04498247|453259230|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
125991096|NCT04498247|453259231|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125991097|NCT04041440|453259232|FG000|Overall Study|Withdrawal by Subject|0|||
125991098|NCT04041440|453259233|FG001|Overall Study|Withdrawal by Subject|1|||
125991099|NCT04041440|453259232|FG000|Overall Study|Lost to Follow-up|0|||
125991100|NCT04041440|453259233|FG001|Overall Study|Lost to Follow-up|1|||
125991101|NCT01381874|453259234|FG000|Overall Study|Lost to Follow-up|1|||
125991102|NCT01381874|453259235|FG001|Overall Study|Lost to Follow-up|1|||
125991103|NCT01381874|453259236|FG002|Overall Study|Lost to Follow-up|0|||
125991104|NCT01381874|453259234|FG000|Overall Study|Withdrawal by Subject|9|||
126091066|NCT04187326|453626894|FG001|Overall Study|Computer error- task was only partially completed.|1|||
126209300|NCT05182840|454053181|FG008|Treatment Period|Change of residence|0|||
125991105|NCT01381874|453259235|FG001|Overall Study|Withdrawal by Subject|10|||
125991106|NCT01381874|453259236|FG002|Overall Study|Withdrawal by Subject|9|||
125991107|NCT01381874|453259234|FG000|Overall Study|Other|67|||
125991108|NCT01381874|453259235|FG001|Overall Study|Other|52|||
125991109|NCT01381874|453259236|FG002|Overall Study|Other|67|||
125991110|NCT02247804|453259237|FG000|Treatment Period 1|Adverse Event|9|||
125991111|NCT02247804|453259238|FG001|Treatment Period 1|Adverse Event|2|||
125991112|NCT02247804|453259239|FG002|Treatment Period 1|Adverse Event|0|||
125991113|NCT02247804|453259237|FG000|Treatment Period 1|Lack of Efficacy|0|||
125991114|NCT02247804|453259238|FG001|Treatment Period 1|Lack of Efficacy|0|||
125991115|NCT02247804|453259239|FG002|Treatment Period 1|Lack of Efficacy|2|||
125991116|NCT02247804|453259237|FG000|Treatment Period 1|Lost to Follow-up|1|||
125991117|NCT02247804|453259238|FG001|Treatment Period 1|Lost to Follow-up|0|||
125991118|NCT02247804|453259239|FG002|Treatment Period 1|Lost to Follow-up|2|||
125991119|NCT02247804|453259237|FG000|Treatment Period 1|Personal Reasons|7|||
125991120|NCT02247804|453259238|FG001|Treatment Period 1|Personal Reasons|1|||
125991121|NCT02247804|453259239|FG002|Treatment Period 1|Personal Reasons|2|||
125991122|NCT02247804|453259237|FG000|Treatment Period 1|Protocol Deviation|0|||
125991123|NCT02247804|453259238|FG001|Treatment Period 1|Protocol Deviation|0|||
125991124|NCT02247804|453259239|FG002|Treatment Period 1|Protocol Deviation|1|||
125991125|NCT02247804|453259237|FG000|Treatment Period 1|Randomized but not Treated|5|||
125991126|NCT02247804|453259238|FG001|Treatment Period 1|Randomized but not Treated|1|||
125991127|NCT02247804|453259239|FG002|Treatment Period 1|Randomized but not Treated|1|||
125991128|NCT02247804|453259237|FG000|Treatment Period 2|Adverse Event|6|||
125991129|NCT02247804|453259238|FG001|Treatment Period 2|Adverse Event|3|||
125991130|NCT02247804|453259239|FG002|Treatment Period 2|Adverse Event|3|||
125991131|NCT02247804|453259237|FG000|Treatment Period 2|Lack of Efficacy|0|||
125991132|NCT02247804|453259238|FG001|Treatment Period 2|Lack of Efficacy|0|||
125991133|NCT02247804|453259239|FG002|Treatment Period 2|Lack of Efficacy|1|||
125991134|NCT02247804|453259237|FG000|Treatment Period 2|Lost to Follow-up|0|||
125991135|NCT02247804|453259238|FG001|Treatment Period 2|Lost to Follow-up|1|||
125991136|NCT02247804|453259239|FG002|Treatment Period 2|Lost to Follow-up|1|||
125991137|NCT02247804|453259237|FG000|Treatment Period 2|Personal Reasons|2|||
125991138|NCT02247804|453259238|FG001|Treatment Period 2|Personal Reasons|1|||
125991139|NCT02247804|453259239|FG002|Treatment Period 2|Personal Reasons|1|||
125991140|NCT02247804|453259237|FG000|Treatment Period 2|Reason not Specified|0|||
125991141|NCT02247804|453259238|FG001|Treatment Period 2|Reason not Specified|0|||
125991142|NCT02247804|453259239|FG002|Treatment Period 2|Reason not Specified|2|||
125991143|NCT02247804|453259237|FG000|Treatment Period 3|Adverse Event|4|||
125991144|NCT02247804|453259238|FG001|Treatment Period 3|Adverse Event|3|||
125991145|NCT02247804|453259239|FG002|Treatment Period 3|Adverse Event|3|||
125991146|NCT02247804|453259237|FG000|Treatment Period 3|Lack of Efficacy|0|||
125991147|NCT02247804|453259238|FG001|Treatment Period 3|Lack of Efficacy|1|||
125991148|NCT02247804|453259239|FG002|Treatment Period 3|Lack of Efficacy|0|||
125991149|NCT02247804|453259237|FG000|Treatment Period 3|Lost to Follow-up|1|||
125991150|NCT02247804|453259238|FG001|Treatment Period 3|Lost to Follow-up|2|||
125991151|NCT02247804|453259239|FG002|Treatment Period 3|Lost to Follow-up|2|||
125991152|NCT02247804|453259237|FG000|Treatment Period 3|Personal Reasons|4|||
125991153|NCT02247804|453259238|FG001|Treatment Period 3|Personal Reasons|3|||
125991154|NCT02247804|453259239|FG002|Treatment Period 3|Personal Reasons|2|||
125991155|NCT02247804|453259237|FG000|Treatment Period 3|Reason not Specified|2|||
125991156|NCT02247804|453259238|FG001|Treatment Period 3|Reason not Specified|1|||
125991157|NCT02247804|453259239|FG002|Treatment Period 3|Reason not Specified|3|||
125991158|NCT02917265|453259243|FG000|Overall Study|Physician Decision|1|||
125991159|NCT02917265|453259244|FG001|Overall Study|Physician Decision|0|||
125991160|NCT02917265|453259243|FG000|Overall Study|Withdrawal by Subject|1|||
125991161|NCT02917265|453259244|FG001|Overall Study|Withdrawal by Subject|0|||
125991162|NCT01248962|453259246|FG000|Overall Study|Withdrawal by Subject|1|||
125991163|NCT01248962|453259247|FG001|Overall Study|Withdrawal by Subject|1|||
125991164|NCT01248962|453259246|FG000|Overall Study|Adverse Event|2|||
125991165|NCT01248962|453259247|FG001|Overall Study|Adverse Event|1|||
125991166|NCT01248962|453259246|FG000|Overall Study|Complete Response after 4 Cycles|1|||
125991167|NCT01248962|453259247|FG001|Overall Study|Complete Response after 4 Cycles|0|||
125991168|NCT01248962|453259246|FG000|Overall Study|Complete Response after 3 Cycles|0|||
125991169|NCT01248962|453259247|FG001|Overall Study|Complete Response after 3 Cycles|1|||
125991170|NCT01248962|453259246|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
125991171|NCT01248962|453259247|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
125991172|NCT03119610|453259248|FG000|Overall Study|Adverse Event|1|||
125991173|NCT03119610|453259249|FG001|Overall Study|Adverse Event|0|||
125991174|NCT03119610|453259248|FG000|Overall Study|Lost to Follow-up|0|||
125991175|NCT03119610|453259249|FG001|Overall Study|Lost to Follow-up|1|||
125991176|NCT03283696|453259250|FG000|Overall Study|Physician Decision|5|||
125991177|NCT03283696|453259251|FG001|Overall Study|Physician Decision|6|||
126330440|NCT01066871|454503391|FG002|Overall Study|Other|1|||
125991178|NCT03283696|453259250|FG000|Overall Study|Withdrawal by Subject|2|||
125991179|NCT03283696|453259251|FG001|Overall Study|Withdrawal by Subject|0|||
125991180|NCT00557622|453259255|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
125991181|NCT00557622|453259256|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
125991182|NCT00557622|453259255|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
125991183|NCT00557622|453259256|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
125991184|NCT00557622|453259255|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
125991185|NCT00557622|453259256|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
125991186|NCT02765490|453259259|FG000|Overall Study|Lost to Follow-up|1|||
125991187|NCT02765490|453259260|FG001|Overall Study|Lost to Follow-up|1|||
125991188|NCT02765490|453259259|FG000|Overall Study|Other|0|||
126330441|NCT01066871|454503392|FG003|Overall Study|Other|2|||
125991189|NCT02765490|453259260|FG001|Overall Study|Other|1|||
125991190|NCT02765490|453259259|FG000|Overall Study|Death|0|||
125991191|NCT02765490|453259260|FG001|Overall Study|Death|1|||
125991192|NCT01468922|453259261|FG000|Overall Study|Screening failure|0|||
125991193|NCT01468922|453259262|FG001|Overall Study|Screening failure|0|||
125991194|NCT01468922|453259263|FG002|Overall Study|Screening failure|0|||
125991195|NCT01468922|453259264|FG003|Overall Study|Screening failure|0|||
125991196|NCT01468922|453259265|FG004|Overall Study|Screening failure|0|||
125991197|NCT01468922|453259266|FG005|Overall Study|Screening failure|0|||
125991198|NCT01468922|453259267|FG006|Overall Study|Screening failure|0|||
125991199|NCT01468922|453259268|FG007|Overall Study|Screening failure|0|||
125991200|NCT01468922|453259269|FG008|Overall Study|Screening failure|1|||
125991201|NCT01468922|453259261|FG000|Overall Study|Per patient choice|1|||
125991202|NCT01468922|453259262|FG001|Overall Study|Per patient choice|0|||
125991203|NCT01468922|453259263|FG002|Overall Study|Per patient choice|0|||
125991204|NCT01468922|453259264|FG003|Overall Study|Per patient choice|0|||
125991205|NCT01468922|453259265|FG004|Overall Study|Per patient choice|0|||
125991206|NCT01468922|453259266|FG005|Overall Study|Per patient choice|0|||
125991207|NCT01468922|453259267|FG006|Overall Study|Per patient choice|0|||
125991208|NCT01468922|453259268|FG007|Overall Study|Per patient choice|0|||
125991209|NCT01468922|453259269|FG008|Overall Study|Per patient choice|0|||
125991210|NCT01468922|453259261|FG000|Overall Study|Switched to alternative treatment|1|||
125991211|NCT01468922|453259262|FG001|Overall Study|Switched to alternative treatment|0|||
125991212|NCT01468922|453259263|FG002|Overall Study|Switched to alternative treatment|0|||
125991213|NCT01468922|453259264|FG003|Overall Study|Switched to alternative treatment|0|||
125991214|NCT01468922|453259265|FG004|Overall Study|Switched to alternative treatment|1|||
125991215|NCT01468922|453259266|FG005|Overall Study|Switched to alternative treatment|0|||
125991216|NCT01468922|453259267|FG006|Overall Study|Switched to alternative treatment|0|||
125991217|NCT01468922|453259268|FG007|Overall Study|Switched to alternative treatment|0|||
125991218|NCT01468922|453259269|FG008|Overall Study|Switched to alternative treatment|0|||
125991219|NCT01468922|453259261|FG000|Overall Study|Enrolled on new protocol|0|||
125991220|NCT01468922|453259262|FG001|Overall Study|Enrolled on new protocol|0|||
125991221|NCT01468922|453259263|FG002|Overall Study|Enrolled on new protocol|0|||
125991222|NCT01468922|453259264|FG003|Overall Study|Enrolled on new protocol|0|||
125991223|NCT01468922|453259265|FG004|Overall Study|Enrolled on new protocol|1|||
125991224|NCT01468922|453259266|FG005|Overall Study|Enrolled on new protocol|0|||
125991225|NCT01468922|453259267|FG006|Overall Study|Enrolled on new protocol|0|||
125991226|NCT01468922|453259268|FG007|Overall Study|Enrolled on new protocol|0|||
125991227|NCT01468922|453259269|FG008|Overall Study|Enrolled on new protocol|0|||
125991228|NCT01468922|453259261|FG000|Overall Study|Adverse Event|0|||
125991229|NCT01468922|453259262|FG001|Overall Study|Adverse Event|0|||
125991230|NCT01468922|453259263|FG002|Overall Study|Adverse Event|0|||
125991231|NCT01468922|453259264|FG003|Overall Study|Adverse Event|0|||
125991232|NCT01468922|453259265|FG004|Overall Study|Adverse Event|0|||
125991233|NCT01468922|453259266|FG005|Overall Study|Adverse Event|0|||
125991234|NCT01468922|453259267|FG006|Overall Study|Adverse Event|0|||
125991235|NCT01468922|453259268|FG007|Overall Study|Adverse Event|1|||
125991236|NCT01468922|453259269|FG008|Overall Study|Adverse Event|0|||
125991237|NCT01468922|453259261|FG000|Overall Study|Infection of blood|0|||
125991238|NCT01468922|453259262|FG001|Overall Study|Infection of blood|0|||
125991239|NCT01468922|453259263|FG002|Overall Study|Infection of blood|0|||
125991240|NCT01468922|453259264|FG003|Overall Study|Infection of blood|0|||
125991241|NCT01468922|453259265|FG004|Overall Study|Infection of blood|0|||
125991242|NCT01468922|453259266|FG005|Overall Study|Infection of blood|0|||
125991243|NCT01468922|453259267|FG006|Overall Study|Infection of blood|0|||
125991244|NCT01468922|453259268|FG007|Overall Study|Infection of blood|1|||
125991245|NCT01468922|453259269|FG008|Overall Study|Infection of blood|0|||
125991246|NCT01468922|453259261|FG000|Overall Study|Patient choice - surgery|0|||
125991247|NCT01468922|453259262|FG001|Overall Study|Patient choice - surgery|0|||
125991248|NCT01468922|453259263|FG002|Overall Study|Patient choice - surgery|0|||
125991249|NCT01468922|453259264|FG003|Overall Study|Patient choice - surgery|0|||
125991250|NCT01468922|453259265|FG004|Overall Study|Patient choice - surgery|0|||
125991251|NCT01468922|453259266|FG005|Overall Study|Patient choice - surgery|0|||
125991252|NCT01468922|453259267|FG006|Overall Study|Patient choice - surgery|0|||
125991253|NCT01468922|453259268|FG007|Overall Study|Patient choice - surgery|1|||
125991254|NCT01468922|453259269|FG008|Overall Study|Patient choice - surgery|0|||
125991255|NCT01468922|453259261|FG000|Overall Study|Refused further treatment|0|||
125991256|NCT01468922|453259262|FG001|Overall Study|Refused further treatment|0|||
125991257|NCT01468922|453259263|FG002|Overall Study|Refused further treatment|0|||
125991258|NCT01468922|453259264|FG003|Overall Study|Refused further treatment|0|||
125991259|NCT01468922|453259265|FG004|Overall Study|Refused further treatment|0|||
125991260|NCT01468922|453259266|FG005|Overall Study|Refused further treatment|0|||
125991261|NCT01468922|453259267|FG006|Overall Study|Refused further treatment|0|||
125991262|NCT01468922|453259268|FG007|Overall Study|Refused further treatment|1|||
125991263|NCT01468922|453259269|FG008|Overall Study|Refused further treatment|0|||
125991264|NCT02563522|453259277|FG000|Overall Study|Adverse Event|2|||
125991265|NCT02563522|453259278|FG001|Overall Study|Adverse Event|3|||
125991266|NCT02563522|453259277|FG000|Overall Study|Lost to Follow-up|1|||
125991267|NCT02563522|453259278|FG001|Overall Study|Lost to Follow-up|0|||
125991268|NCT02563522|453259277|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
125991269|NCT02563522|453259278|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
125991270|NCT00675506|453259280|FG000|Overall Study|Lost to Follow-up|1|||
125991271|NCT00675506|453259281|FG001|Overall Study|Lost to Follow-up|5|||
125991272|NCT00675506|453259280|FG000|Overall Study|Lost interest|3|||
125991273|NCT00675506|453259281|FG001|Overall Study|Lost interest|5|||
125991274|NCT00675506|453259280|FG000|Overall Study|Elevated fasting glucose|2|||
125991275|NCT00675506|453259281|FG001|Overall Study|Elevated fasting glucose|1|||
125991276|NCT00675506|453259280|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
125991277|NCT00675506|453259281|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
125991278|NCT00675506|453259280|FG000|Overall Study|Elevated IGF-1|2|||
125991279|NCT00675506|453259281|FG001|Overall Study|Elevated IGF-1|0|||
125991280|NCT00675506|453259280|FG000|Overall Study|Hypersensitivity Reaction|1|||
125991281|NCT00675506|453259281|FG001|Overall Study|Hypersensitivity Reaction|0|||
125991282|NCT00675506|453259280|FG000|Overall Study|Disclosed history of cancer|1|||
125991283|NCT00675506|453259281|FG001|Overall Study|Disclosed history of cancer|0|||
125991284|NCT00675506|453259280|FG000|Overall Study|Declined participation|1|||
125991285|NCT00675506|453259281|FG001|Overall Study|Declined participation|0|||
125991286|NCT00675506|453259280|FG000|Overall Study|Schedule conflict|0|||
125991287|NCT00675506|453259281|FG001|Overall Study|Schedule conflict|1|||
125991288|NCT00936221|453259282|FG000|Overall Study|Withdrawal by Subject|1|||
125991289|NCT00936221|453259283|FG001|Overall Study|Withdrawal by Subject|1|||
125991290|NCT03820323|453259284|FG000|Overall Study|Lost to Follow-up|2|||
125991291|NCT03820323|453259285|FG001|Overall Study|Lost to Follow-up|1|||
125991292|NCT03820323|453259284|FG000|Overall Study|Missed 12-month visit|22|||
125991293|NCT03820323|453259285|FG001|Overall Study|Missed 12-month visit|14|||
125991294|NCT03820323|453259284|FG000|Overall Study|Death|2|||
125991295|NCT03820323|453259285|FG001|Overall Study|Death|1|||
125991296|NCT03820323|453259284|FG000|Overall Study|Transferred out|13|||
125991297|NCT03820323|453259285|FG001|Overall Study|Transferred out|11|||
125991298|NCT03820323|453259284|FG000|Overall Study|Terminated|0|||
125991299|NCT03820323|453259285|FG001|Overall Study|Terminated|3|||
125991300|NCT03820323|453259284|FG000|Overall Study|Withdrawal by Subject|1|||
125991301|NCT03820323|453259285|FG001|Overall Study|Withdrawal by Subject|6|||
125991302|NCT00879996|453259286|FG000|Overall Study|Lost to Follow-up|7|||
125991303|NCT00879996|453259287|FG001|Overall Study|Lost to Follow-up|6|||
125991304|NCT00879996|453259286|FG000|Overall Study|non-compliance|6|||
125991305|NCT00879996|453259287|FG001|Overall Study|non-compliance|4|||
125991306|NCT00879996|453259286|FG000|Overall Study|Physician Decision|1|||
125991307|NCT00879996|453259287|FG001|Overall Study|Physician Decision|2|||
125991308|NCT00879996|453259286|FG000|Overall Study|psychiatric problem|0|||
125991309|NCT00879996|453259287|FG001|Overall Study|psychiatric problem|1|||
125991310|NCT00879996|453259286|FG000|Overall Study|put on parole|1|||
125991311|NCT00879996|453259287|FG001|Overall Study|put on parole|0|||
125991312|NCT01617005|453259289|FG000|Overall Study|Pregnancy|1|||
125991313|NCT01617005|453259289|FG000|Overall Study|Lack of motivation for treatment|1|||
125991314|NCT02954458|453259295|FG000|Overall Study|Adverse Event|0|||
125991315|NCT02954458|453259296|FG001|Overall Study|Adverse Event|0|||
125991316|NCT02954458|453259297|FG002|Overall Study|Adverse Event|0|||
125991317|NCT02954458|453259298|FG003|Overall Study|Adverse Event|1|||
125991318|NCT02954458|453259295|FG000|Overall Study|Withdrawal by Subject|0|||
125991319|NCT02954458|453259296|FG001|Overall Study|Withdrawal by Subject|0|||
125991320|NCT02954458|453259297|FG002|Overall Study|Withdrawal by Subject|0|||
125991321|NCT02954458|453259298|FG003|Overall Study|Withdrawal by Subject|1|||
125991322|NCT02954458|453259295|FG000|Overall Study|Physician Decision|0|||
125991323|NCT02954458|453259296|FG001|Overall Study|Physician Decision|0|||
125991324|NCT02954458|453259297|FG002|Overall Study|Physician Decision|1|||
125991325|NCT02954458|453259298|FG003|Overall Study|Physician Decision|1|||
125991326|NCT02954458|453259295|FG000|Overall Study|Lost to Follow-up|1|||
125991327|NCT02954458|453259296|FG001|Overall Study|Lost to Follow-up|0|||
125991328|NCT02954458|453259297|FG002|Overall Study|Lost to Follow-up|0|||
125991329|NCT02954458|453259298|FG003|Overall Study|Lost to Follow-up|1|||
125991330|NCT02954458|453259295|FG000|Overall Study|Death|0|||
125991331|NCT02954458|453259296|FG001|Overall Study|Death|0|||
126330442|NCT04162795|454503393|FG000|Overall Study|Other|16|||
125991332|NCT02954458|453259297|FG002|Overall Study|Death|0|||
125991333|NCT02954458|453259298|FG003|Overall Study|Death|1|||
125991334|NCT02954458|453259295|FG000|Overall Study|Other|0|||
125991335|NCT02954458|453259296|FG001|Overall Study|Other|0|||
125991336|NCT02954458|453259297|FG002|Overall Study|Other|0|||
125991337|NCT02954458|453259298|FG003|Overall Study|Other|7|||
125991338|NCT00882921|453259300|FG000|Overall Study|Death|2|||
125991339|NCT00882921|453259300|FG000|Overall Study|Other|3|||
125991340|NCT00882921|453259300|FG000|Overall Study|Lost to Follow-up|2|||
125991341|NCT00882921|453259300|FG000|Overall Study|Termination By Investigator|3|||
125991342|NCT00882921|453259300|FG000|Overall Study|Withdrawal Of Consent|1|||
125991343|NCT02460263|453259301|FG000|Transition Period|Withdrawal by Subject|1|||
125991344|NCT02460263|453259301|FG000|Transition Period|Death|1|||
125991345|NCT03176238|453259302|FG000|Overall Study|Unacceptable AEs|15|||
125991346|NCT03176238|453259303|FG001|Overall Study|Unacceptable AEs|8|||
125991347|NCT03176238|453259302|FG000|Overall Study|Abnormal lab value(s)|2|||
125991348|NCT03176238|453259303|FG001|Overall Study|Abnormal lab value(s)|0|||
125991349|NCT03176238|453259302|FG000|Overall Study|Inter-current illness|0|||
125991350|NCT03176238|453259303|FG001|Overall Study|Inter-current illness|1|||
125991351|NCT03176238|453259302|FG000|Overall Study|Consent withdrawal|14|||
125991352|NCT03176238|453259303|FG001|Overall Study|Consent withdrawal|2|||
125991353|NCT03176238|453259302|FG000|Overall Study|Lost to Follow-up|3|||
125991354|NCT03176238|453259303|FG001|Overall Study|Lost to Follow-up|0|||
125991355|NCT03176238|453259302|FG000|Overall Study|Administrative problems|1|||
125991356|NCT03176238|453259303|FG001|Overall Study|Administrative problems|0|||
125991357|NCT03176238|453259302|FG000|Overall Study|Death|3|||
125991358|NCT03176238|453259303|FG001|Overall Study|Death|0|||
125991359|NCT03176238|453259302|FG000|Overall Study|Disease Progression|133|||
125991360|NCT03176238|453259303|FG001|Overall Study|Disease Progression|22|||
125991361|NCT03176238|453259302|FG000|Overall Study|Tx duration completed per EAP|0|||
125991362|NCT03176238|453259303|FG001|Overall Study|Tx duration completed per EAP|1|||
125991363|NCT03176238|453259302|FG000|Overall Study|Patient is switched to commercial drug|16|||
125991364|NCT03176238|453259303|FG001|Overall Study|Patient is switched to commercial drug|1|||
125991365|NCT03176238|453259302|FG000|Overall Study|Protocol Violation|1|||
125991366|NCT03176238|453259303|FG001|Overall Study|Protocol Violation|0|||
125991367|NCT03176238|453259302|FG000|Overall Study|Changes in the patient's condition|2|||
125991368|NCT03176238|453259303|FG001|Overall Study|Changes in the patient's condition|1|||
125991369|NCT03176238|453259302|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
125991370|NCT03176238|453259303|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
125991371|NCT02569710|453259305|FG000|Overall Study|Adverse Event|1|||
125991372|NCT02569710|453259306|FG001|Overall Study|Adverse Event|0|||
125991373|NCT02569710|453259307|FG002|Overall Study|Adverse Event|0|||
125991374|NCT02569710|453259308|FG003|Overall Study|Adverse Event|0|||
125991375|NCT02569710|453259309|FG004|Overall Study|Adverse Event|0|||
125991376|NCT02569710|453259310|FG005|Overall Study|Adverse Event|0|||
125991377|NCT02569710|453259311|FG006|Overall Study|Adverse Event|0|||
125991378|NCT02569710|453259312|FG007|Overall Study|Adverse Event|0|||
125991379|NCT02569710|453259313|FG008|Overall Study|Adverse Event|0|||
125991380|NCT02569710|453259314|FG009|Overall Study|Adverse Event|0|||
125991381|NCT02569710|453259305|FG000|Overall Study|Lost to Follow-up|0|||
125991382|NCT02569710|453259306|FG001|Overall Study|Lost to Follow-up|0|||
125991383|NCT02569710|453259307|FG002|Overall Study|Lost to Follow-up|0|||
125991384|NCT02569710|453259308|FG003|Overall Study|Lost to Follow-up|0|||
125991385|NCT02569710|453259309|FG004|Overall Study|Lost to Follow-up|0|||
125991386|NCT02569710|453259310|FG005|Overall Study|Lost to Follow-up|0|||
125991387|NCT02569710|453259311|FG006|Overall Study|Lost to Follow-up|1|||
125991388|NCT02569710|453259312|FG007|Overall Study|Lost to Follow-up|0|||
125991389|NCT02569710|453259313|FG008|Overall Study|Lost to Follow-up|1|||
125991390|NCT02569710|453259314|FG009|Overall Study|Lost to Follow-up|0|||
125991391|NCT02569710|453259305|FG000|Overall Study|Virologic failure|0|||
125991392|NCT02569710|453259306|FG001|Overall Study|Virologic failure|0|||
125991393|NCT02569710|453259307|FG002|Overall Study|Virologic failure|0|||
125991394|NCT02569710|453259308|FG003|Overall Study|Virologic failure|0|||
125991395|NCT02569710|453259309|FG004|Overall Study|Virologic failure|1|||
125991396|NCT02569710|453259310|FG005|Overall Study|Virologic failure|0|||
125991397|NCT02569710|453259311|FG006|Overall Study|Virologic failure|1|||
125991398|NCT02569710|453259312|FG007|Overall Study|Virologic failure|0|||
125991399|NCT02569710|453259313|FG008|Overall Study|Virologic failure|0|||
125991400|NCT02569710|453259314|FG009|Overall Study|Virologic failure|0|||
125991401|NCT02569710|453259305|FG000|Overall Study|Withdrawal by Subject|0|||
125991402|NCT02569710|453259306|FG001|Overall Study|Withdrawal by Subject|0|||
125991403|NCT02569710|453259307|FG002|Overall Study|Withdrawal by Subject|0|||
125991404|NCT02569710|453259308|FG003|Overall Study|Withdrawal by Subject|0|||
125991405|NCT02569710|453259309|FG004|Overall Study|Withdrawal by Subject|0|||
125991406|NCT02569710|453259310|FG005|Overall Study|Withdrawal by Subject|1|||
125991407|NCT02569710|453259311|FG006|Overall Study|Withdrawal by Subject|0|||
125991408|NCT02569710|453259312|FG007|Overall Study|Withdrawal by Subject|0|||
125991409|NCT02569710|453259313|FG008|Overall Study|Withdrawal by Subject|0|||
125991410|NCT02569710|453259314|FG009|Overall Study|Withdrawal by Subject|0|||
125991411|NCT04152343|453259315|FG000|Overall Study|Transplanted|5|||
125991412|NCT04152343|453259315|FG000|Overall Study|Death|20|||
125991413|NCT04152343|453259315|FG000|Overall Study|Lost to Follow-up|3|||
125991414|NCT00550550|453259316|FG000|Overall Study|Adverse Event|13|||
125991415|NCT00550550|453259317|FG001|Overall Study|Adverse Event|5|||
125991416|NCT00550550|453259316|FG000|Overall Study|Treatment Failure|0|||
125991417|NCT00550550|453259317|FG001|Overall Study|Treatment Failure|1|||
125991418|NCT00550550|453259316|FG000|Overall Study|Lost to Follow-up|4|||
125991419|NCT00550550|453259317|FG001|Overall Study|Lost to Follow-up|0|||
125991420|NCT00550550|453259316|FG000|Overall Study|Withdrawal by Subject|10|||
125991421|NCT00550550|453259317|FG001|Overall Study|Withdrawal by Subject|8|||
125991422|NCT00550550|453259316|FG000|Overall Study|Protocol Violation|5|||
125991423|NCT00550550|453259317|FG001|Overall Study|Protocol Violation|14|||
125991424|NCT00550550|453259316|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
125991425|NCT00550550|453259317|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
125991426|NCT00550550|453259316|FG000|Overall Study|Randomized But Not Treated|1|||
125991427|NCT00550550|453259317|FG001|Overall Study|Randomized But Not Treated|0|||
125991428|NCT02714205|453259331|FG000|Overall Study|Cannot tolerate medication|1|||
125991429|NCT02714205|453259332|FG001|Overall Study|Cannot tolerate medication|0|||
125991430|NCT02714205|453259331|FG000|Overall Study|Adverse Event|2|||
125991431|NCT02714205|453259332|FG001|Overall Study|Adverse Event|0|||
125991432|NCT02714205|453259331|FG000|Overall Study|Too busy|1|||
125991433|NCT02714205|453259332|FG001|Overall Study|Too busy|0|||
125991434|NCT02714205|453259331|FG000|Overall Study|Incomplete outcome data|0|||
125991435|NCT02714205|453259332|FG001|Overall Study|Incomplete outcome data|1|||
125991436|NCT00381641|453259333|FG000|Overall Study|Withdrawal by Subject|0|||
125991437|NCT00381641|453259334|FG001|Overall Study|Withdrawal by Subject|2|||
125991438|NCT01598298|453259335|FG000|Overall Study|Not eligible|5|||
125991439|NCT01598298|453259336|FG001|Overall Study|Not eligible|5|||
125991440|NCT01598298|453259335|FG000|Overall Study|Adverse Event|21|||
125991441|NCT01598298|453259336|FG001|Overall Study|Adverse Event|19|||
125991442|NCT01598298|453259335|FG000|Overall Study|Progression/relapse|0|||
125991443|NCT01598298|453259336|FG001|Overall Study|Progression/relapse|2|||
125991444|NCT01598298|453259335|FG000|Overall Study|Withdrawal by Subject|10|||
125991445|NCT01598298|453259336|FG001|Overall Study|Withdrawal by Subject|15|||
125991446|NCT01598298|453259335|FG000|Overall Study|Other reason (not protocol specified)|4|||
125991447|NCT01598298|453259336|FG001|Overall Study|Other reason (not protocol specified)|0|||
125991448|NCT04287868|453259337|FG000|Overall Study|Screening fail|1|||
125991449|NCT04287868|453259338|FG001|Overall Study|Screening fail|0|||
125991450|NCT03813147|453259339|FG000|Overall Study|Lack of Efficacy|4|||
125991451|NCT03813147|453259340|FG001|Overall Study|Lack of Efficacy|4|||
125991452|NCT03813147|453259339|FG000|Overall Study|Physician Decision|2|||
125991453|NCT03813147|453259340|FG001|Overall Study|Physician Decision|1|||
125991454|NCT04567693|453261058|FG000|Overall Study|Death|0|||
125991455|NCT04567693|453261059|FG001|Overall Study|Death|0|||
125991456|NCT04567693|453261060|FG002|Overall Study|Death|2|||
125991457|NCT04567693|453261058|FG000|Overall Study|Lost to Follow-up|1|||
125991458|NCT04567693|453261059|FG001|Overall Study|Lost to Follow-up|0|||
125991459|NCT04567693|453261060|FG002|Overall Study|Lost to Follow-up|2|||
125991460|NCT04567693|453261058|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
125991461|NCT04567693|453261059|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
125991462|NCT04567693|453261060|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
125991463|NCT03462706|453261061|FG000|Overall Study|Polyp was pedunculated|1|||
126330443|NCT04162795|454503393|FG000|Overall Study|Screen failures|10|||
126330444|NCT05259163|454505063|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
126330445|NCT05259163|454505064|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
126330446|NCT00103285|454505067|FG000|Induction|Adverse Event|14|||
126330447|NCT00103285|454505068|FG001|Induction|Adverse Event|0|||
126330448|NCT00103285|454505069|FG002|Induction|Adverse Event|0|||
126330449|NCT00103285|454505070|FG003|Induction|Adverse Event|0|||
126330450|NCT00103285|454505071|FG004|Induction|Adverse Event|0|||
126330451|NCT00103285|454505072|FG005|Induction|Adverse Event|0|||
126330452|NCT00103285|454505073|FG006|Induction|Adverse Event|0|||
126330453|NCT00103285|454505074|FG007|Induction|Adverse Event|0|||
126330454|NCT00103285|454505067|FG000|Induction|Death|24|||
126330455|NCT00103285|454505068|FG001|Induction|Death|0|||
126330456|NCT00103285|454505069|FG002|Induction|Death|0|||
126330457|NCT00103285|454505070|FG003|Induction|Death|0|||
126330458|NCT00103285|454505071|FG004|Induction|Death|0|||
126330459|NCT00103285|454505072|FG005|Induction|Death|0|||
126330460|NCT00103285|454505073|FG006|Induction|Death|0|||
126330461|NCT00103285|454505074|FG007|Induction|Death|0|||
126330462|NCT00103285|454505067|FG000|Induction|Physician Decision|103|||
126330463|NCT00103285|454505068|FG001|Induction|Physician Decision|0|||
126330464|NCT00103285|454505069|FG002|Induction|Physician Decision|0|||
126330465|NCT00103285|454505070|FG003|Induction|Physician Decision|0|||
126330466|NCT00103285|454505071|FG004|Induction|Physician Decision|0|||
126330467|NCT00103285|454505072|FG005|Induction|Physician Decision|0|||
126330468|NCT00103285|454505073|FG006|Induction|Physician Decision|0|||
125991464|NCT03462706|453261062|FG001|Overall Study|Polyp was pedunculated|0|||
126330469|NCT00103285|454505074|FG007|Induction|Physician Decision|0|||
126330470|NCT00103285|454505067|FG000|Induction|Withdrawal by Subject|1|||
125991465|NCT03462706|453261063|FG002|Overall Study|Polyp was pedunculated|1|||
125991466|NCT03462706|453261064|FG003|Overall Study|Polyp was pedunculated|0|||
125991467|NCT03462706|453261061|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
125991468|NCT03462706|453261062|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
126330471|NCT00103285|454505068|FG001|Induction|Withdrawal by Subject|0|||
126330472|NCT00103285|454505069|FG002|Induction|Withdrawal by Subject|0|||
126330473|NCT00103285|454505070|FG003|Induction|Withdrawal by Subject|0|||
126330474|NCT00103285|454505071|FG004|Induction|Withdrawal by Subject|0|||
125991469|NCT03462706|453261063|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
125991470|NCT03462706|453261064|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
125991471|NCT04105972|453261065|FG000|Overall Study|Adverse Event|2|||
125991472|NCT04105972|453261066|FG001|Overall Study|Adverse Event|1|||
125991473|NCT01161472|453261067|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
125991474|NCT01161472|453261068|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
125991475|NCT01161472|453261069|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
125991476|NCT01161472|453261070|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
125991477|NCT00067990|453261080|FG000|Overall Study|Death|5|||
125991478|NCT00067990|453261081|FG001|Overall Study|Death|7|||
125991479|NCT00067990|453261080|FG000|Overall Study|ESRD, Non IF/TA|1|||
125991480|NCT00067990|453261081|FG001|Overall Study|ESRD, Non IF/TA|3|||
125991481|NCT00067990|453261080|FG000|Overall Study|Withdrawal by Subject|4|||
125991482|NCT00067990|453261081|FG001|Overall Study|Withdrawal by Subject|12|||
125991483|NCT02291432|453261089|FG000|Overall Study|Withdrawal by Subject|2|||
125991484|NCT03377790|453261090|FG000|Overall Study|Withdrawal by Subject|1|||
125991485|NCT03377790|453261091|FG001|Overall Study|Withdrawal by Subject|0|||
125991486|NCT03377790|453261090|FG000|Overall Study|Adverse Event|1|||
125991487|NCT03377790|453261091|FG001|Overall Study|Adverse Event|0|||
125991488|NCT03377790|453261090|FG000|Overall Study|Lost to Follow-up|0|||
125991489|NCT03377790|453261091|FG001|Overall Study|Lost to Follow-up|2|||
125991490|NCT03377790|453261090|FG000|Overall Study|Randomized but not treated|1|||
125991491|NCT03377790|453261091|FG001|Overall Study|Randomized but not treated|0|||
125991492|NCT03377790|453261090|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
125991493|NCT03377790|453261091|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
125991494|NCT02632786|453261095|FG000|Overall Study|Adverse Event|2|||
125991495|NCT02632786|453261096|FG001|Overall Study|Adverse Event|1|||
125991496|NCT02632786|453261095|FG000|Overall Study|Death|3|||
125991497|NCT02632786|453261096|FG001|Overall Study|Death|2|||
125991498|NCT02632786|453261095|FG000|Overall Study|Physician Decision|5|||
125991499|NCT02632786|453261096|FG001|Overall Study|Physician Decision|4|||
125991500|NCT02632786|453261095|FG000|Overall Study|Withdrawal by Subject|1|||
125991501|NCT02632786|453261096|FG001|Overall Study|Withdrawal by Subject|0|||
125991502|NCT01454830|453261100|FG000|Overall Study|Withdrawal by Subject|4|||
125991503|NCT01454830|453261101|FG001|Overall Study|Withdrawal by Subject|4|||
125991504|NCT01454830|453261100|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
125991505|NCT01454830|453261101|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
125991506|NCT01454830|453261100|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
125991507|NCT01454830|453261101|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
125991508|NCT01454830|453261100|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
125991509|NCT01454830|453261101|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
125991510|NCT01454830|453261100|FG000|Overall Study|Withdrawal - no polysomnography|3|||
125991511|NCT01454830|453261101|FG001|Overall Study|Withdrawal - no polysomnography|2|||
125991512|NCT00152763|453261102|FG000|Overall Study|Death|4|||
125991513|NCT00152763|453261103|FG001|Overall Study|Death|1|||
125991514|NCT00152763|453261104|FG002|Overall Study|Death|2|||
125991515|NCT00152763|453261105|FG003|Overall Study|Death|1|||
125991516|NCT00152763|453261102|FG000|Overall Study|Lost to Follow-up|6|||
125991517|NCT00152763|453261103|FG001|Overall Study|Lost to Follow-up|4|||
125991518|NCT00152763|453261104|FG002|Overall Study|Lost to Follow-up|2|||
125991519|NCT00152763|453261105|FG003|Overall Study|Lost to Follow-up|13|||
125991520|NCT00569803|453261106|FG000|Overall Study|Lost to Follow-up|1|||
125991521|NCT00569803|453261107|FG001|Overall Study|Lost to Follow-up|0|||
125991522|NCT00569803|453261108|FG002|Overall Study|Lost to Follow-up|0|||
125991523|NCT00569803|453261109|FG003|Overall Study|Lost to Follow-up|0|||
125991524|NCT00569803|453261110|FG004|Overall Study|Lost to Follow-up|0|||
125991525|NCT00569803|453261111|FG005|Overall Study|Lost to Follow-up|0|||
125991526|NCT00569803|453261112|FG006|Overall Study|Lost to Follow-up|0|||
125991527|NCT00569803|453261113|FG007|Overall Study|Lost to Follow-up|0|||
125991528|NCT00569803|453261106|FG000|Overall Study|injection syringe leaked during dosing|0|||
125991529|NCT00569803|453261107|FG001|Overall Study|injection syringe leaked during dosing|0|||
125991530|NCT00569803|453261108|FG002|Overall Study|injection syringe leaked during dosing|0|||
125991531|NCT00569803|453261109|FG003|Overall Study|injection syringe leaked during dosing|1|||
125991532|NCT00569803|453261110|FG004|Overall Study|injection syringe leaked during dosing|0|||
125991533|NCT00569803|453261111|FG005|Overall Study|injection syringe leaked during dosing|0|||
125991534|NCT00569803|453261112|FG006|Overall Study|injection syringe leaked during dosing|0|||
125991535|NCT00569803|453261113|FG007|Overall Study|injection syringe leaked during dosing|0|||
125991536|NCT00569803|453261106|FG000|Overall Study|Withdrawal by Subject|0|||
125991537|NCT00569803|453261107|FG001|Overall Study|Withdrawal by Subject|0|||
125991538|NCT00569803|453261108|FG002|Overall Study|Withdrawal by Subject|0|||
125991539|NCT00569803|453261109|FG003|Overall Study|Withdrawal by Subject|0|||
125991540|NCT00569803|453261110|FG004|Overall Study|Withdrawal by Subject|0|||
125991541|NCT00569803|453261111|FG005|Overall Study|Withdrawal by Subject|0|||
125991542|NCT00569803|453261112|FG006|Overall Study|Withdrawal by Subject|0|||
125991543|NCT00569803|453261113|FG007|Overall Study|Withdrawal by Subject|1|||
125991544|NCT01235975|453261116|FG000|Overall Study|Serious Adverse Event|0|||
125991545|NCT01235975|453261117|FG001|Overall Study|Serious Adverse Event|1|||
125991546|NCT01235975|453261116|FG000|Overall Study|Withdrawal by Subject|8|||
125991547|NCT01235975|453261117|FG001|Overall Study|Withdrawal by Subject|2|||
125991548|NCT01235975|453261116|FG000|Overall Study|Migrated/moved from study area|2|||
125991549|NCT01235975|453261117|FG001|Overall Study|Migrated/moved from study area|1|||
125991550|NCT01235975|453261116|FG000|Overall Study|Lost to Follow-up|7|||
125991551|NCT01235975|453261117|FG001|Overall Study|Lost to Follow-up|3|||
125991552|NCT00791921|453261118|FG000|Overall Study|Protocol planed|24|||
125991553|NCT00791921|453261119|FG001|Overall Study|Protocol planed|88|||
125991554|NCT00791921|453261118|FG000|Overall Study|Withdrawal by Subject|1|||
125991555|NCT00791921|453261119|FG001|Overall Study|Withdrawal by Subject|2|||
125991556|NCT00791921|453261118|FG000|Overall Study|Adverse Event|8|||
125991557|NCT00791921|453261119|FG001|Overall Study|Adverse Event|2|||
125991558|NCT00791921|453261118|FG000|Overall Study|Lack of Efficacy|0|||
125991559|NCT00791921|453261119|FG001|Overall Study|Lack of Efficacy|2|||
125991560|NCT00791921|453261118|FG000|Overall Study|Lack of study drug administration|1|||
125991561|NCT00791921|453261119|FG001|Overall Study|Lack of study drug administration|1|||
125991562|NCT00791921|453261118|FG000|Overall Study|Reason other than those above|0|||
125991563|NCT00791921|453261119|FG001|Overall Study|Reason other than those above|1|||
125991564|NCT01965158|453261121|FG000|Overall Study|Adverse Event|14|||
125991565|NCT01965158|453261122|FG001|Overall Study|Adverse Event|5|||
125991566|NCT01965158|453261121|FG000|Overall Study|Withdrawal by Subject|16|||
125991567|NCT01965158|453261122|FG001|Overall Study|Withdrawal by Subject|24|||
125991568|NCT01965158|453261121|FG000|Overall Study|Lost to Follow-up|7|||
125991569|NCT01965158|453261122|FG001|Overall Study|Lost to Follow-up|5|||
125991570|NCT01965158|453261121|FG000|Overall Study|Protocol Violation|1|||
125991571|NCT01965158|453261122|FG001|Overall Study|Protocol Violation|1|||
125991572|NCT01965158|453261121|FG000|Overall Study|Other - Miscellaneous|3|||
125991573|NCT01965158|453261122|FG001|Overall Study|Other - Miscellaneous|0|||
125991574|NCT00474175|453261123|FG000|Overall Study|Lack of Efficacy|0|||
125991575|NCT00474175|453261124|FG001|Overall Study|Lack of Efficacy|0|||
125991576|NCT00474175|453261125|FG002|Overall Study|Lack of Efficacy|1|||
125991577|NCT00474175|453261123|FG000|Overall Study|Withdrawal by Subject|0|||
125991578|NCT00474175|453261124|FG001|Overall Study|Withdrawal by Subject|1|||
125991579|NCT00474175|453261125|FG002|Overall Study|Withdrawal by Subject|1|||
125991580|NCT00474175|453261123|FG000|Overall Study|Ineligible|1|||
125991581|NCT00474175|453261124|FG001|Overall Study|Ineligible|3|||
125991582|NCT00474175|453261125|FG002|Overall Study|Ineligible|1|||
125991583|NCT00474175|453261123|FG000|Overall Study|Protocol Violation|0|||
125991584|NCT00474175|453261124|FG001|Overall Study|Protocol Violation|2|||
125991585|NCT00474175|453261125|FG002|Overall Study|Protocol Violation|1|||
125991586|NCT00474175|453261123|FG000|Overall Study|Administrative|0|||
125991587|NCT00474175|453261124|FG001|Overall Study|Administrative|1|||
125991588|NCT00474175|453261125|FG002|Overall Study|Administrative|0|||
125991589|NCT01619787|453261128|FG000|Overall Study|Lost to Follow-up|5|||
125991590|NCT01130883|453261129|FG000|Overall Study|Patient Noncompliance|6|||
125991591|NCT01130883|453261129|FG000|Overall Study|Reason Unknown|1|||
125991592|NCT01130883|453261129|FG000|Overall Study|Adverse Event|3|||
125991593|NCT03560258|453261132|FG000|Overall Study|Lost to Follow-up|3|||
125991594|NCT03560258|453261133|FG001|Overall Study|Lost to Follow-up|0|||
125991595|NCT03560258|453261134|FG002|Overall Study|Lost to Follow-up|0|||
125991596|NCT03560258|453261132|FG000|Overall Study|Protocol Violation|0|||
125991597|NCT03560258|453261133|FG001|Overall Study|Protocol Violation|1|||
125991598|NCT03560258|453261134|FG002|Overall Study|Protocol Violation|0|||
125991599|NCT03560258|453261132|FG000|Overall Study|Withdrawal by Subject|0|||
125991600|NCT03560258|453261133|FG001|Overall Study|Withdrawal by Subject|0|||
125991601|NCT03560258|453261134|FG002|Overall Study|Withdrawal by Subject|1|||
125991602|NCT02091739|453261142|FG000|MP: 16 Weeks|Adverse Event|1|||
125991603|NCT02091739|453261143|FG001|MP: 16 Weeks|Adverse Event|1|||
125991604|NCT02091739|453261144|FG002|MP: 16 Weeks|Adverse Event|1|||
125991605|NCT02091739|453261145|FG003|MP: 16 Weeks|Adverse Event|0|||
125991606|NCT02091739|453261146|FG004|MP: 16 Weeks|Adverse Event|0|||
125991607|NCT02091739|453261142|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
125991608|NCT02091739|453261143|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
126091067|NCT01607476|453626895|FG000|Overall Study|Withdrawal by Subject|1|||
125991609|NCT02091739|453261144|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
125991610|NCT02091739|453261145|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
125991611|NCT02091739|453261146|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
125991612|NCT02091739|453261142|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
125991613|NCT02091739|453261143|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
125991614|NCT02091739|453261144|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
125991615|NCT02091739|453261145|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
125991616|NCT02091739|453261146|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
125991617|NCT02091739|453261142|FG000|EP: 48 Weeks|Other|0|||
125991618|NCT02091739|453261143|FG001|EP: 48 Weeks|Other|0|||
125991619|NCT02091739|453261144|FG002|EP: 48 Weeks|Other|0|||
125991620|NCT02091739|453261145|FG003|EP: 48 Weeks|Other|1|||
125991621|NCT02091739|453261146|FG004|EP: 48 Weeks|Other|0|||
125991622|NCT02091739|453261142|FG000|EP: 48 Weeks|Death|0|||
125991623|NCT02091739|453261143|FG001|EP: 48 Weeks|Death|0|||
125991624|NCT02091739|453261144|FG002|EP: 48 Weeks|Death|0|||
125991625|NCT02091739|453261145|FG003|EP: 48 Weeks|Death|3|||
125991626|NCT02091739|453261146|FG004|EP: 48 Weeks|Death|2|||
125991627|NCT02091739|453261142|FG000|EP: 48 Weeks|Adverse Event|0|||
125991628|NCT02091739|453261143|FG001|EP: 48 Weeks|Adverse Event|0|||
125991629|NCT02091739|453261144|FG002|EP: 48 Weeks|Adverse Event|0|||
125991630|NCT02091739|453261145|FG003|EP: 48 Weeks|Adverse Event|2|||
125991631|NCT02091739|453261146|FG004|EP: 48 Weeks|Adverse Event|6|||
125991632|NCT02091739|453261142|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
125991633|NCT02091739|453261143|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
125991634|NCT02091739|453261144|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
125991635|NCT02091739|453261145|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
125991636|NCT02091739|453261146|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
125991637|NCT00192023|453261147|FG000|Period III - Double-Blind|Adverse Event|3|||
125991638|NCT00192023|453261148|FG001|Period III - Double-Blind|Adverse Event|0|||
125991639|NCT00192023|453261147|FG000|Period III - Double-Blind|Physician Decision|2|||
125991640|NCT00192023|453261148|FG001|Period III - Double-Blind|Physician Decision|0|||
125991641|NCT00192023|453261147|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
125991642|NCT00192023|453261148|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
125991643|NCT00192023|453261147|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
125991644|NCT00192023|453261148|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
125991645|NCT00192023|453261147|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
125991646|NCT00192023|453261148|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
125991647|NCT00192023|453261147|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
125991648|NCT00192023|453261148|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
125991649|NCT00192023|453261147|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
125991650|NCT00192023|453261148|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
125991651|NCT00192023|453261147|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
125991652|NCT00192023|453261148|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
125991653|NCT00192023|453261147|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
125991654|NCT00192023|453261148|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
125991655|NCT00192023|453261147|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
125991656|NCT00192023|453261148|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
125991657|NCT02086162|453261149|FG000|Overall Study|Withdrawal by Subject|4|||
125991658|NCT02086162|453261150|FG001|Overall Study|Withdrawal by Subject|4|||
125991659|NCT02086162|453261149|FG000|Overall Study|moved|1|||
125991660|NCT02086162|453261150|FG001|Overall Study|moved|1|||
125991661|NCT02086162|453261149|FG000|Overall Study|Lost to Follow-up|4|||
125991662|NCT02086162|453261150|FG001|Overall Study|Lost to Follow-up|2|||
125991663|NCT02086162|453261149|FG000|Overall Study|Death|1|||
125991664|NCT02086162|453261150|FG001|Overall Study|Death|0|||
125991665|NCT01027364|453261151|FG000|Overall Study|Adverse Event|1|||
125991666|NCT01027364|453261152|FG001|Overall Study|Adverse Event|0|||
125991667|NCT01027364|453261153|FG002|Overall Study|Adverse Event|1|||
125991668|NCT01027364|453261154|FG003|Overall Study|Adverse Event|0|||
125991669|NCT01027364|453261151|FG000|Overall Study|Lost to Follow-up|1|||
125991670|NCT01027364|453261152|FG001|Overall Study|Lost to Follow-up|0|||
125991671|NCT01027364|453261153|FG002|Overall Study|Lost to Follow-up|0|||
125991672|NCT01027364|453261154|FG003|Overall Study|Lost to Follow-up|0|||
125991673|NCT01027364|453261151|FG000|Overall Study|Protocol Violation|1|||
125991674|NCT01027364|453261152|FG001|Overall Study|Protocol Violation|0|||
125991675|NCT01027364|453261153|FG002|Overall Study|Protocol Violation|0|||
125991676|NCT01027364|453261154|FG003|Overall Study|Protocol Violation|1|||
125991677|NCT01027364|453261151|FG000|Overall Study|Withdrawal by Subject|1|||
125991678|NCT01027364|453261152|FG001|Overall Study|Withdrawal by Subject|2|||
125991679|NCT01027364|453261153|FG002|Overall Study|Withdrawal by Subject|0|||
125991680|NCT01027364|453261154|FG003|Overall Study|Withdrawal by Subject|0|||
125991681|NCT00245856|453261158|FG000|Period Two|Withdrawal by Subject|0|||
125991682|NCT00245856|453261159|FG001|Period Two|Withdrawal by Subject|1|||
125991683|NCT01003184|453261160|FG000|Overall Study|Adverse Event|12|||
125991684|NCT01003184|453261161|FG001|Overall Study|Adverse Event|5|||
125991685|NCT01003184|453261160|FG000|Overall Study|Lost to Follow-up|1|||
126330475|NCT00103285|454505072|FG005|Induction|Withdrawal by Subject|0|||
125991686|NCT01003184|453261161|FG001|Overall Study|Lost to Follow-up|0|||
125991687|NCT01003184|453261160|FG000|Overall Study|Loss of glucose control|1|||
125991688|NCT01003184|453261161|FG001|Overall Study|Loss of glucose control|1|||
125991689|NCT01003184|453261160|FG000|Overall Study|Protocol Violation|3|||
125991690|NCT01003184|453261161|FG001|Overall Study|Protocol Violation|0|||
125991691|NCT01003184|453261160|FG000|Overall Study|Withdrawal by Subject|1|||
125991692|NCT01003184|453261161|FG001|Overall Study|Withdrawal by Subject|6|||
125991693|NCT01003184|453261160|FG000|Overall Study|Physician Decision|1|||
125991694|NCT01003184|453261161|FG001|Overall Study|Physician Decision|0|||
125991695|NCT03662997|453261162|FG000|Overall Study|Adverse Event|0|||
125991696|NCT03662997|453261163|FG001|Overall Study|Adverse Event|2|||
125991697|NCT03662997|453261164|FG002|Overall Study|Adverse Event|0|||
125991698|NCT03662997|453261165|FG003|Overall Study|Adverse Event|0|||
125991699|NCT01719224|453261166|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
125991700|NCT01719224|453261167|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
125991701|NCT02912468|453261172|FG000|Overall Study|Adverse Event|3|||
125991702|NCT02912468|453261173|FG001|Overall Study|Adverse Event|2|||
125991703|NCT02912468|453261172|FG000|Overall Study|Withdrawal by Subject|6|||
125991704|NCT02912468|453261173|FG001|Overall Study|Withdrawal by Subject|2|||
125991705|NCT02912468|453261172|FG000|Overall Study|Randomized and not treated|0|||
125991706|NCT02912468|453261173|FG001|Overall Study|Randomized and not treated|1|||
125991707|NCT03853317|453261174|FG000|Overall Study|Progressive Disease|5|||
125991708|NCT03853317|453261174|FG000|Overall Study|Adverse Event|1|||
125991709|NCT03853317|453261174|FG000|Overall Study|Death|1|||
125991710|NCT03853317|453261174|FG000|Overall Study|other event|2|||
125991711|NCT01320735|453261175|FG000|Overall Study|Adverse Event|3|||
125991712|NCT01320735|453261175|FG000|Overall Study|Withdrawal by Subject|3|||
125991713|NCT01320735|453261175|FG000|Overall Study|Lost to Follow-up|13|||
125991714|NCT01320735|453261175|FG000|Overall Study|Administrative Reason|6|||
125991715|NCT01320735|453261175|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
125991716|NCT01320735|453261175|FG000|Overall Study|Protocol Violation|1|||
125991717|NCT01320735|453261175|FG000|Overall Study|Other|1|||
125991718|NCT01320735|453261175|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
125991719|NCT01320735|453261175|FG000|Overall Study|Investigator Unable to be Contacted|17|||
125991720|NCT00406419|453261178|FG000|Overall Study|Death|3|||
125991721|NCT00406419|453261179|FG001|Overall Study|Death|1|||
125991722|NCT00406419|453261180|FG002|Overall Study|Death|4|||
125991723|NCT00406419|453261178|FG000|Overall Study|Protocol Violation|6|||
125991724|NCT00406419|453261179|FG001|Overall Study|Protocol Violation|2|||
125991725|NCT00406419|453261180|FG002|Overall Study|Protocol Violation|5|||
125991726|NCT00406419|453261178|FG000|Overall Study|Study Terminated by Sponsor|260|||
125991727|NCT00406419|453261179|FG001|Overall Study|Study Terminated by Sponsor|288|||
125991728|NCT00406419|453261180|FG002|Overall Study|Study Terminated by Sponsor|282|||
125991729|NCT00406419|453261178|FG000|Overall Study|Withdrawal by Subject|17|||
125991730|NCT00406419|453261179|FG001|Overall Study|Withdrawal by Subject|24|||
125991731|NCT00406419|453261180|FG002|Overall Study|Withdrawal by Subject|26|||
125991732|NCT00406419|453261178|FG000|Overall Study|Lack of Efficacy|12|||
125991733|NCT00406419|453261179|FG001|Overall Study|Lack of Efficacy|1|||
125991734|NCT00406419|453261180|FG002|Overall Study|Lack of Efficacy|6|||
125991735|NCT00406419|453261178|FG000|Overall Study|Non-Compliance with Study Drug|5|||
125991736|NCT00406419|453261179|FG001|Overall Study|Non-Compliance with Study Drug|6|||
125991737|NCT00406419|453261180|FG002|Overall Study|Non-Compliance with Study Drug|3|||
125991738|NCT00406419|453261178|FG000|Overall Study|Adverse Event|10|||
125991739|NCT00406419|453261179|FG001|Overall Study|Adverse Event|12|||
125991740|NCT00406419|453261180|FG002|Overall Study|Adverse Event|16|||
125991741|NCT00406419|453261178|FG000|Overall Study|Lost to Follow-up|11|||
125991742|NCT00406419|453261179|FG001|Overall Study|Lost to Follow-up|10|||
125991743|NCT00406419|453261180|FG002|Overall Study|Lost to Follow-up|5|||
125991744|NCT01290822|453261181|FG000|Overall Study|Withdrawal by Subject|1|||
125991745|NCT01290822|453261181|FG000|Overall Study|Physician Decision|10|||
125991746|NCT00089895|453261184|FG000|Overall Study|Consent Withdrawn|11|||
125991747|NCT00089895|453261185|FG001|Overall Study|Consent Withdrawn|14|||
125991748|NCT00089895|453261184|FG000|Overall Study|Technical reason|7|||
125991749|NCT00089895|453261185|FG001|Overall Study|Technical reason|2|||
125991750|NCT00089895|453261184|FG000|Overall Study|Surgery|0|||
125991751|NCT00089895|453261185|FG001|Overall Study|Surgery|1|||
125991752|NCT00089895|453261184|FG000|Overall Study|Bleeding|0|||
125991753|NCT00089895|453261185|FG001|Overall Study|Bleeding|2|||
125991754|NCT00089895|453261184|FG000|Overall Study|Physician Decision|3|||
125991755|NCT00089895|453261185|FG001|Overall Study|Physician Decision|7|||
125991756|NCT00089895|453261184|FG000|Overall Study|Exclusion criteria met|6|||
125991757|NCT00089895|453261185|FG001|Overall Study|Exclusion criteria met|6|||
125991758|NCT00089895|453261184|FG000|Overall Study|Not otherwise specified|4|||
125991759|NCT00089895|453261185|FG001|Overall Study|Not otherwise specified|8|||
125991760|NCT00089895|453261184|FG000|Overall Study|Missing|4|||
125991761|NCT00089895|453261185|FG001|Overall Study|Missing|2|||
125991762|NCT01535274|453261186|FG000|Overall Study|Determined to be ineligible|0|||
125991763|NCT01535274|453261187|FG001|Overall Study|Determined to be ineligible|1|||
125991764|NCT01535274|453261186|FG000|Overall Study|Misallocated to propofol intervention|0|||
125991765|NCT01535274|453261187|FG001|Overall Study|Misallocated to propofol intervention|1|||
125991766|NCT03679767|453261188|FG000|Overall Study|Death|16|||
125991767|NCT03679767|453261189|FG001|Overall Study|Death|11|||
125991768|NCT03679767|453261190|FG002|Overall Study|Death|17|||
125991769|NCT03679767|453261191|FG003|Overall Study|Death|10|||
125991770|NCT03679767|453261188|FG000|Overall Study|Lost to Follow-up|1|||
125991771|NCT03679767|453261189|FG001|Overall Study|Lost to Follow-up|1|||
125991772|NCT03679767|453261190|FG002|Overall Study|Lost to Follow-up|1|||
125991773|NCT03679767|453261191|FG003|Overall Study|Lost to Follow-up|1|||
125991774|NCT03679767|453261188|FG000|Overall Study|Withdrawal by Subject|0|||
125991775|NCT03679767|453261189|FG001|Overall Study|Withdrawal by Subject|0|||
126330476|NCT00103285|454505073|FG006|Induction|Withdrawal by Subject|0|||
125991776|NCT03679767|453261190|FG002|Overall Study|Withdrawal by Subject|0|||
125991777|NCT03679767|453261191|FG003|Overall Study|Withdrawal by Subject|1|||
125991778|NCT03679767|453261188|FG000|Overall Study|Follow-up Completed|18|||
125991779|NCT03679767|453261189|FG001|Overall Study|Follow-up Completed|11|||
125991780|NCT03679767|453261190|FG002|Overall Study|Follow-up Completed|11|||
125991781|NCT03679767|453261191|FG003|Overall Study|Follow-up Completed|20|||
125991782|NCT03679767|453261188|FG000|Overall Study|Entered Hospice Care|0|||
125991783|NCT03679767|453261189|FG001|Overall Study|Entered Hospice Care|0|||
125991784|NCT03679767|453261190|FG002|Overall Study|Entered Hospice Care|0|||
125991785|NCT03679767|453261191|FG003|Overall Study|Entered Hospice Care|1|||
125991786|NCT03679767|453261188|FG000|Overall Study|Progressive Disease|0|||
125991787|NCT03679767|453261189|FG001|Overall Study|Progressive Disease|0|||
125991788|NCT03679767|453261190|FG002|Overall Study|Progressive Disease|0|||
125991789|NCT03679767|453261191|FG003|Overall Study|Progressive Disease|1|||
125991790|NCT01396395|453261196|FG000|Overall Study|Withdrawal by Subject|10|||
125991791|NCT01396395|453261197|FG001|Overall Study|Withdrawal by Subject|12|||
125991792|NCT01396395|453261196|FG000|Overall Study|Protocol Violation|3|||
125991793|NCT01396395|453261197|FG001|Overall Study|Protocol Violation|1|||
125991794|NCT01396395|453261196|FG000|Overall Study|Adverse Event|10|||
125991795|NCT01396395|453261197|FG001|Overall Study|Adverse Event|2|||
125991796|NCT01396395|453261196|FG000|Overall Study|Lost to Follow-up|17|||
125991797|NCT01396395|453261197|FG001|Overall Study|Lost to Follow-up|11|||
125991798|NCT01396395|453261196|FG000|Overall Study|Other|0|||
125991799|NCT01396395|453261197|FG001|Overall Study|Other|1|||
125991800|NCT02009696|453261202|FG000|Overall Study|Withdrawal by Subject|2|||
125991801|NCT05490329|453261204|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
125991802|NCT05490329|453261205|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
125991803|NCT05490329|453261204|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
125991804|NCT05490329|453261205|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
125991805|NCT05490329|453261204|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
125991806|NCT05490329|453261205|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
125991807|NCT00447954|453261206|FG000|Overall Study|Adverse Event|0|||
125991808|NCT00447954|453261207|FG001|Overall Study|Adverse Event|2|||
125991809|NCT00447954|453261208|FG002|Overall Study|Adverse Event|0|||
125991810|NCT00447954|453261206|FG000|Overall Study|Withdrawal by Subject|0|||
125991811|NCT00447954|453261207|FG001|Overall Study|Withdrawal by Subject|1|||
125991812|NCT00447954|453261208|FG002|Overall Study|Withdrawal by Subject|1|||
125991813|NCT00447954|453261206|FG000|Overall Study|Lost to Follow-up|0|||
125991814|NCT00447954|453261207|FG001|Overall Study|Lost to Follow-up|1|||
125991815|NCT00447954|453261208|FG002|Overall Study|Lost to Follow-up|0|||
125991816|NCT00447954|453261206|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
125991817|NCT00447954|453261207|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
125991818|NCT00447954|453261208|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
125991819|NCT00856661|453261209|FG000|Overall Study|Death|15|||
125991820|NCT00856661|453261210|FG001|Overall Study|Death|18|||
125991821|NCT00856661|453261209|FG000|Overall Study|Protocol Violation|2|||
125991822|NCT00856661|453261210|FG001|Overall Study|Protocol Violation|1|||
125991823|NCT00856661|453261209|FG000|Overall Study|Withdrawal by Subject|1|||
125991824|NCT00856661|453261210|FG001|Overall Study|Withdrawal by Subject|2|||
125991825|NCT00856661|453261209|FG000|Overall Study|Lost to Follow-up|1|||
125991826|NCT00856661|453261210|FG001|Overall Study|Lost to Follow-up|3|||
125991827|NCT00856661|453261209|FG000|Overall Study|Physician Judgement|8|||
125991828|NCT00856661|453261210|FG001|Overall Study|Physician Judgement|5|||
125991829|NCT02120664|453261211|FG000|Overall Study|Withdrawal by Subject|0|||
125991830|NCT02120664|453261212|FG001|Overall Study|Withdrawal by Subject|0|||
125991831|NCT02120664|453261213|FG002|Overall Study|Withdrawal by Subject|0|||
125991832|NCT02120664|453261214|FG003|Overall Study|Withdrawal by Subject|1|||
125991833|NCT02120664|453261215|FG004|Overall Study|Withdrawal by Subject|0|||
125991834|NCT04524598|453261218|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
125991835|NCT04524598|453261219|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
125991836|NCT04524598|453261220|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
125991837|NCT04524598|453261221|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
125991838|NCT04524598|453261222|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
125991839|NCT04524598|453261218|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
125991840|NCT04524598|453261219|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
125991841|NCT04524598|453261220|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991842|NCT04524598|453261221|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991843|NCT04524598|453261222|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991844|NCT04524598|453261218|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
125991845|NCT04524598|453261219|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
125991846|NCT04524598|453261220|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
125991847|NCT04524598|453261221|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
125991848|NCT04524598|453261222|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
125991849|NCT04524598|453261218|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
125991850|NCT04524598|453261219|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
125991851|NCT04524598|453261220|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
125991852|NCT04524598|453261221|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
125991853|NCT04524598|453261222|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
125991854|NCT04524598|453261218|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991855|NCT04524598|453261219|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991856|NCT04524598|453261220|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
125991857|NCT04524598|453261221|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
125991858|NCT04524598|453261222|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991859|NCT04524598|453261218|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
125991860|NCT04524598|453261219|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
125991861|NCT04524598|453261220|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
125991862|NCT04524598|453261221|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
125991863|NCT04524598|453261222|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
125991864|NCT04524598|453261218|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991865|NCT04524598|453261219|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991866|NCT04524598|453261220|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991867|NCT04524598|453261221|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
125991868|NCT04524598|453261222|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
125991869|NCT04395183|453261223|FG000|Overall Study|Withdrawal by Subject|1|||
125991870|NCT04395183|453261224|FG001|Overall Study|Withdrawal by Subject|0|||
125991871|NCT04395183|453261225|FG002|Overall Study|Withdrawal by Subject|2|||
125991872|NCT04395183|453261226|FG003|Overall Study|Withdrawal by Subject|2|||
125991873|NCT01164228|453261227|FG000|Overall Study|Progression|24|||
125991874|NCT01164228|453261228|FG001|Overall Study|Progression|25|||
125991875|NCT01164228|453261227|FG000|Overall Study|Adverse Event|13|||
125991876|NCT01164228|453261228|FG001|Overall Study|Adverse Event|7|||
125991877|NCT01164228|453261227|FG000|Overall Study|Death|1|||
125991878|NCT01164228|453261228|FG001|Overall Study|Death|1|||
125991879|NCT01164228|453261227|FG000|Overall Study|Withdrawal by Subject|2|||
125991880|NCT01164228|453261228|FG001|Overall Study|Withdrawal by Subject|0|||
125991881|NCT01164228|453261227|FG000|Overall Study|Physician Decision|1|||
125991882|NCT01164228|453261228|FG001|Overall Study|Physician Decision|2|||
125991883|NCT01164228|453261227|FG000|Overall Study|Symptomatic deterioration|1|||
125991884|NCT01164228|453261228|FG001|Overall Study|Symptomatic deterioration|0|||
125991885|NCT01164228|453261227|FG000|Overall Study|Never started treatment|1|||
125991886|NCT01164228|453261228|FG001|Overall Study|Never started treatment|3|||
125991887|NCT01164228|453261227|FG000|Overall Study|Ineligible|1|||
125991888|NCT01164228|453261228|FG001|Overall Study|Ineligible|0|||
125991889|NCT02090634|453261229|FG000|Overall Study|Lost to Follow-up|0|||
125991890|NCT02090634|453261230|FG001|Overall Study|Lost to Follow-up|1|||
125991891|NCT02090634|453261229|FG000|Overall Study|Death|0|||
125991892|NCT02090634|453261230|FG001|Overall Study|Death|1|||
125991893|NCT02090634|453261229|FG000|Overall Study|Protocol Violation|3|||
125991894|NCT02090634|453261230|FG001|Overall Study|Protocol Violation|1|||
125991895|NCT02090634|453261229|FG000|Overall Study|Adverse Event|2|||
125991896|NCT02090634|453261230|FG001|Overall Study|Adverse Event|0|||
125991897|NCT01965938|453261231|FG000|Overall Study|Withdrawal by Subject|1|||
125991898|NCT01965938|453261232|FG001|Overall Study|Withdrawal by Subject|0|||
125991899|NCT00553202|453262807|FG000|Overall Study|Death|16|||
125991900|NCT00553202|453262807|FG000|Overall Study|Lost to Follow-up|1|||
125991901|NCT00553202|453262807|FG000|Overall Study|Physician Decision|28|||
125991902|NCT00553202|453262807|FG000|Overall Study|Withdrawal by Subject|1|||
125991903|NCT00553202|453262807|FG000|Overall Study|No donor identified|16|||
125991904|NCT00553202|453262807|FG000|Overall Study|Fails to meet organ function|6|||
125991905|NCT04651114|453262808|FG000|Overall Study|Withdrawal by Subject|8|||
125991906|NCT00474929|453262813|FG000|Overall Study|Withdrawal by Subject|0|||
125991907|NCT00474929|453262814|FG001|Overall Study|Withdrawal by Subject|1|||
125991908|NCT00474929|453262815|FG002|Overall Study|Withdrawal by Subject|0|||
125991909|NCT00474929|453262816|FG003|Overall Study|Withdrawal by Subject|0|||
125991910|NCT00474929|453262817|FG004|Overall Study|Withdrawal by Subject|0|||
125991911|NCT00474929|453262813|FG000|Overall Study|Unrelated medical condition|0|||
125991912|NCT00474929|453262814|FG001|Overall Study|Unrelated medical condition|0|||
125991913|NCT00474929|453262815|FG002|Overall Study|Unrelated medical condition|1|||
125991914|NCT00474929|453262816|FG003|Overall Study|Unrelated medical condition|0|||
125991915|NCT00474929|453262817|FG004|Overall Study|Unrelated medical condition|0|||
125991916|NCT00474929|453262813|FG000|Overall Study|Physician Decision|0|||
125991917|NCT00474929|453262814|FG001|Overall Study|Physician Decision|0|||
125991918|NCT00474929|453262815|FG002|Overall Study|Physician Decision|1|||
125991919|NCT00474929|453262816|FG003|Overall Study|Physician Decision|2|||
125991920|NCT00474929|453262817|FG004|Overall Study|Physician Decision|0|||
125991921|NCT02593305|453262818|FG000|Post 1|Comparison only group. No intervention.|0|||
125991922|NCT02593305|453262819|FG001|Post 1|Comparison only group. No intervention.|0|||
125991923|NCT02593305|453262820|FG002|Post 1|Comparison only group. No intervention.|10|||
125991924|NCT00768430|453262838|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
125991925|NCT00768430|453262839|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
125991926|NCT00041756|453262840|FG000|Overall Study|Adverse Event|4|||
125991927|NCT00041756|453262841|FG001|Overall Study|Adverse Event|10|||
125991928|NCT00041756|453262842|FG002|Overall Study|Adverse Event|6|||
125991929|NCT00041756|453262843|FG003|Overall Study|Adverse Event|11|||
125991930|NCT00041756|453262844|FG004|Overall Study|Adverse Event|34|||
125991931|NCT00041756|453262840|FG000|Overall Study|Protocol Violation|1|||
125991932|NCT00041756|453262841|FG001|Overall Study|Protocol Violation|1|||
125991933|NCT00041756|453262842|FG002|Overall Study|Protocol Violation|2|||
125991934|NCT00041756|453262843|FG003|Overall Study|Protocol Violation|2|||
125991935|NCT00041756|453262844|FG004|Overall Study|Protocol Violation|1|||
125991936|NCT00041756|453262840|FG000|Overall Study|Withdrawal by Subject|3|||
125991937|NCT00041756|453262841|FG001|Overall Study|Withdrawal by Subject|3|||
125991938|NCT00041756|453262842|FG002|Overall Study|Withdrawal by Subject|4|||
125991939|NCT00041756|453262843|FG003|Overall Study|Withdrawal by Subject|2|||
125991940|NCT00041756|453262844|FG004|Overall Study|Withdrawal by Subject|3|||
125991941|NCT00041756|453262840|FG000|Overall Study|Lost to Follow-up|0|||
125991942|NCT00041756|453262841|FG001|Overall Study|Lost to Follow-up|1|||
125991943|NCT00041756|453262842|FG002|Overall Study|Lost to Follow-up|0|||
125991944|NCT00041756|453262843|FG003|Overall Study|Lost to Follow-up|1|||
125991945|NCT00041756|453262844|FG004|Overall Study|Lost to Follow-up|0|||
125991946|NCT00041756|453262840|FG000|Overall Study|Unable to meet protocol criteria|0|||
125991947|NCT00041756|453262841|FG001|Overall Study|Unable to meet protocol criteria|0|||
125991948|NCT00041756|453262842|FG002|Overall Study|Unable to meet protocol criteria|1|||
125991949|NCT00041756|453262843|FG003|Overall Study|Unable to meet protocol criteria|0|||
125991950|NCT00041756|453262844|FG004|Overall Study|Unable to meet protocol criteria|1|||
125991951|NCT00041756|453262840|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
125991952|NCT00041756|453262841|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
125991953|NCT00041756|453262842|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
125991954|NCT00041756|453262843|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
125991955|NCT00041756|453262844|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
125991956|NCT00603265|453262845|FG000|Overall Study|Adverse Event|2|||
125991957|NCT00603265|453262846|FG001|Overall Study|Adverse Event|11|||
125991958|NCT00603265|453262847|FG002|Overall Study|Adverse Event|1|||
125991959|NCT00603265|453262845|FG000|Overall Study|Withdrawal by Subject|1|||
125991960|NCT00603265|453262846|FG001|Overall Study|Withdrawal by Subject|2|||
125991961|NCT00603265|453262847|FG002|Overall Study|Withdrawal by Subject|1|||
125991962|NCT00603265|453262845|FG000|Overall Study|Lack of Efficacy|3|||
125991963|NCT00603265|453262846|FG001|Overall Study|Lack of Efficacy|0|||
125991964|NCT00603265|453262847|FG002|Overall Study|Lack of Efficacy|3|||
125991965|NCT00603265|453262845|FG000|Overall Study|Lost to Follow-up|0|||
125991966|NCT00603265|453262846|FG001|Overall Study|Lost to Follow-up|1|||
125991967|NCT00603265|453262847|FG002|Overall Study|Lost to Follow-up|0|||
125991968|NCT00603265|453262845|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
125991969|NCT00603265|453262846|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
125991970|NCT00603265|453262847|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
125991971|NCT00603265|453262845|FG000|Overall Study|Participant Left Country, No Responses|0|||
125991972|NCT00603265|453262846|FG001|Overall Study|Participant Left Country, No Responses|1|||
125991973|NCT00603265|453262847|FG002|Overall Study|Participant Left Country, No Responses|0|||
125991974|NCT00603265|453262845|FG000|Overall Study|Protocol Violation|1|||
125991975|NCT00603265|453262846|FG001|Overall Study|Protocol Violation|0|||
126330477|NCT00103285|454505074|FG007|Induction|Withdrawal by Subject|0|||
126330478|NCT00103285|454505067|FG000|Induction|Ineligible|43|||
126330479|NCT00103285|454505068|FG001|Induction|Ineligible|0|||
126330480|NCT00103285|454505069|FG002|Induction|Ineligible|0|||
126330481|NCT00103285|454505070|FG003|Induction|Ineligible|0|||
126330482|NCT00103285|454505071|FG004|Induction|Ineligible|0|||
126330483|NCT00103285|454505072|FG005|Induction|Ineligible|0|||
126330484|NCT00103285|454505073|FG006|Induction|Ineligible|0|||
126330485|NCT00103285|454505074|FG007|Induction|Ineligible|0|||
126330486|NCT00103285|454505067|FG000|Induction|Refusal|906|||
126330487|NCT00103285|454505068|FG001|Induction|Refusal|0|||
126330488|NCT00103285|454505069|FG002|Induction|Refusal|0|||
125991976|NCT00603265|453262847|FG002|Overall Study|Protocol Violation|0|||
125991977|NCT02002884|453262848|FG000|Main Period (MP)|Other|0|||
125991978|NCT02002884|453262849|FG001|Main Period (MP)|Other|3|||
125991979|NCT02002884|453262850|FG002|Main Period (MP)|Other|3|||
126330489|NCT00103285|454505070|FG003|Induction|Refusal|0|||
125991980|NCT02002884|453262851|FG003|Main Period (MP)|Other|0|||
125991981|NCT02002884|453262848|FG000|Main Period (MP)|Adverse Event|0|||
125991982|NCT02002884|453262849|FG001|Main Period (MP)|Adverse Event|1|||
125991983|NCT02002884|453262850|FG002|Main Period (MP)|Adverse Event|1|||
125991984|NCT02002884|453262851|FG003|Main Period (MP)|Adverse Event|0|||
126330490|NCT00103285|454505071|FG004|Induction|Refusal|0|||
126330491|NCT00103285|454505072|FG005|Induction|Refusal|0|||
125878640|NCT01972217|452853372|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
126330492|NCT00103285|454505073|FG006|Induction|Refusal|0|||
125991985|NCT02002884|453262848|FG000|Main Period (MP)|Withdrawal by Subject|6|||
125991986|NCT02002884|453262849|FG001|Main Period (MP)|Withdrawal by Subject|2|||
125991987|NCT02002884|453262850|FG002|Main Period (MP)|Withdrawal by Subject|2|||
125991988|NCT02002884|453262851|FG003|Main Period (MP)|Withdrawal by Subject|0|||
125991989|NCT02002884|453262848|FG000|Main Period (MP)|Lost to Follow-up|0|||
125991990|NCT02002884|453262849|FG001|Main Period (MP)|Lost to Follow-up|0|||
125991991|NCT02002884|453262850|FG002|Main Period (MP)|Lost to Follow-up|2|||
125991992|NCT02002884|453262851|FG003|Main Period (MP)|Lost to Follow-up|0|||
125991993|NCT02002884|453262848|FG000|Open-Label Extension Period (OLEX)|Other|0|||
125991994|NCT02002884|453262849|FG001|Open-Label Extension Period (OLEX)|Other|0|||
125991995|NCT02002884|453262850|FG002|Open-Label Extension Period (OLEX)|Other|0|||
125991996|NCT02002884|453262851|FG003|Open-Label Extension Period (OLEX)|Other|24|||
125991997|NCT02002884|453262848|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
125991998|NCT02002884|453262849|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
125991999|NCT02002884|453262850|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
125992000|NCT02002884|453262851|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
125992001|NCT02002884|453262848|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
125992002|NCT02002884|453262849|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
125992003|NCT02002884|453262850|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
125992004|NCT02002884|453262851|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
125992005|NCT02002884|453262848|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
125992006|NCT02002884|453262849|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
125992007|NCT02002884|453262850|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
125992008|NCT02002884|453262851|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
125992009|NCT02002884|453262848|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
125992010|NCT02002884|453262849|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
125992011|NCT02002884|453262850|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
125992012|NCT02002884|453262851|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
125992013|NCT02966002|453262852|FG000|Overall Study|Withdrawal by Subject|2|||
125992014|NCT02966002|453262852|FG000|Overall Study|Adverse Event|1|||
125992015|NCT02966002|453262852|FG000|Overall Study|Lost to Follow-up|1|||
125992016|NCT01928225|453262853|FG000|Overall Study|Pregnancy|1|||
125992017|NCT01928225|453262854|FG001|Overall Study|Pregnancy|0|||
125992018|NCT01928225|453262853|FG000|Overall Study|basaloid cervical cancer|1|||
125992019|NCT01928225|453262854|FG001|Overall Study|basaloid cervical cancer|0|||
125992020|NCT01928225|453262853|FG000|Overall Study|Lost to Follow-up|1|||
125992021|NCT01928225|453262854|FG001|Overall Study|Lost to Follow-up|3|||
125992022|NCT03321006|453262857|FG000|Overall Study|Death|1|||
125992023|NCT03321006|453262858|FG001|Overall Study|Death|0|||
125992024|NCT03321006|453262857|FG000|Overall Study|Lack of Efficacy|1|||
125992025|NCT03321006|453262858|FG001|Overall Study|Lack of Efficacy|0|||
125992026|NCT00365378|453262859|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
125992027|NCT00365378|453262860|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
125992028|NCT00365378|453262861|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125992029|NCT00365378|453262859|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
125992030|NCT00365378|453262860|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
125992031|NCT00365378|453262861|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
125992032|NCT00365378|453262859|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
125992033|NCT00365378|453262860|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
125992034|NCT00365378|453262861|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
125992035|NCT00365378|453262859|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
125992036|NCT00365378|453262860|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
125992037|NCT00365378|453262861|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
125992038|NCT00365378|453262859|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
125992039|NCT00365378|453262860|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
125992040|NCT00365378|453262861|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
125992041|NCT00365378|453262859|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
125992042|NCT00365378|453262860|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
125992043|NCT00365378|453262861|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
125992044|NCT00365378|453262859|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
125992045|NCT00365378|453262860|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
125992046|NCT00365378|453262861|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
125992047|NCT00365378|453262859|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
125992048|NCT00365378|453262860|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
125992049|NCT00365378|453262861|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
125992050|NCT00365378|453262859|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
125992051|NCT00365378|453262860|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
125992052|NCT00365378|453262861|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
125992053|NCT00365378|453262859|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
125992054|NCT00365378|453262860|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
126330493|NCT00103285|454505074|FG007|Induction|Refusal|0|||
125992055|NCT00365378|453262861|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
125992056|NCT00365378|453262859|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
125992057|NCT00365378|453262860|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
125992058|NCT00365378|453262861|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
125992059|NCT00365378|453262859|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
125992060|NCT00365378|453262860|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
125992061|NCT00365378|453262861|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
125992062|NCT00365378|453262859|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
125992063|NCT00365378|453262860|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
125992064|NCT00365378|453262861|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
125992065|NCT00365378|453262859|FG000|Extension|Adverse Event|0|||
125992066|NCT00365378|453262860|FG001|Extension|Adverse Event|0|||
125992067|NCT00365378|453262861|FG002|Extension|Adverse Event|1|||
125992068|NCT00365378|453262859|FG000|Extension|Moved|0|||
125992069|NCT00365378|453262860|FG001|Extension|Moved|0|||
125992070|NCT00365378|453262861|FG002|Extension|Moved|8|||
125992071|NCT00365378|453262859|FG000|Extension|Lost to Follow-up|0|||
125992072|NCT00365378|453262860|FG001|Extension|Lost to Follow-up|0|||
125992073|NCT00365378|453262861|FG002|Extension|Lost to Follow-up|57|||
125992074|NCT00365378|453262859|FG000|Extension|Protocol Violation|0|||
125992075|NCT00365378|453262860|FG001|Extension|Protocol Violation|0|||
125992076|NCT00365378|453262861|FG002|Extension|Protocol Violation|2|||
125992077|NCT00365378|453262859|FG000|Extension|Withdrawal by Subject|0|||
125992078|NCT00365378|453262860|FG001|Extension|Withdrawal by Subject|0|||
125992079|NCT00365378|453262861|FG002|Extension|Withdrawal by Subject|98|||
126330494|NCT00103285|454505067|FG000|Induction|Other|258|||
126330495|NCT00103285|454505068|FG001|Induction|Other|0|||
126330496|NCT00103285|454505069|FG002|Induction|Other|0|||
126330497|NCT00103285|454505070|FG003|Induction|Other|0|||
126330498|NCT00103285|454505071|FG004|Induction|Other|0|||
126330499|NCT00103285|454505072|FG005|Induction|Other|0|||
126330500|NCT00103285|454505073|FG006|Induction|Other|0|||
126330501|NCT00103285|454505074|FG007|Induction|Other|0|||
126330502|NCT00103285|454505067|FG000|Response Assignment|Adverse Event|0|||
126330503|NCT00103285|454505068|FG001|Response Assignment|Adverse Event|8|||
126330504|NCT00103285|454505069|FG002|Response Assignment|Adverse Event|3|||
126330505|NCT00103285|454505070|FG003|Response Assignment|Adverse Event|2|||
125992080|NCT00365378|453262859|FG000|Extension|Other|0|||
125992081|NCT00365378|453262860|FG001|Extension|Other|0|||
125992082|NCT00365378|453262861|FG002|Extension|Other|31|||
125992083|NCT04161807|453262864|FG000|Overall Study|Withdrawal by Subject|2|||
125992084|NCT04161807|453262864|FG000|Overall Study|Performed only 1 treatment|2|||
125992085|NCT02006121|453262865|FG000|Double Blind Phase|Adverse Event|6|||
126330506|NCT00103285|454505071|FG004|Response Assignment|Adverse Event|3|||
125992086|NCT02006121|453262866|FG001|Double Blind Phase|Adverse Event|0|||
125992087|NCT02006121|453262865|FG000|Double Blind Phase|Lack of Efficacy|1|||
125992088|NCT02006121|453262866|FG001|Double Blind Phase|Lack of Efficacy|16|||
125992089|NCT02006121|453262865|FG000|Double Blind Phase|Withdrawal by Subject|3|||
125992090|NCT02006121|453262866|FG001|Double Blind Phase|Withdrawal by Subject|4|||
125992091|NCT02006121|453262865|FG000|Double Blind Phase|Non-compliance with study drug|1|||
125992092|NCT02006121|453262866|FG001|Double Blind Phase|Non-compliance with study drug|3|||
125992093|NCT02006121|453262865|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
125992094|NCT02006121|453262866|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
125992095|NCT02006121|453262865|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
125992096|NCT02006121|453262866|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
125992097|NCT02006121|453262865|FG000|Open Label Phase|Adverse Event|15|||
125992098|NCT02006121|453262866|FG001|Open Label Phase|Adverse Event|0|||
125992099|NCT02006121|453262865|FG000|Open Label Phase|Lack of Efficacy|2|||
125992100|NCT02006121|453262866|FG001|Open Label Phase|Lack of Efficacy|0|||
126330507|NCT00103285|454505072|FG005|Response Assignment|Adverse Event|1|||
126330508|NCT00103285|454505073|FG006|Response Assignment|Adverse Event|1|||
125992101|NCT02006121|453262865|FG000|Open Label Phase|Protocol Violation|2|||
125992102|NCT02006121|453262866|FG001|Open Label Phase|Protocol Violation|0|||
125992103|NCT02006121|453262865|FG000|Open Label Phase|Withdrawal by Subject|3|||
125992104|NCT02006121|453262866|FG001|Open Label Phase|Withdrawal by Subject|0|||
125992105|NCT02006121|453262865|FG000|Open Label Phase|Non-compliance with study drug|3|||
125992106|NCT02006121|453262866|FG001|Open Label Phase|Non-compliance with study drug|0|||
125992107|NCT04789577|453262869|FG000|Overall Study|Withdrawal by Subject|1|||
125992108|NCT04789577|453262870|FG001|Overall Study|Withdrawal by Subject|1|||
125992109|NCT04789577|453262871|FG002|Overall Study|Withdrawal by Subject|1|||
125992110|NCT04789577|453262872|FG003|Overall Study|Withdrawal by Subject|3|||
125992111|NCT04789577|453262873|FG004|Overall Study|Withdrawal by Subject|1|||
126330509|NCT00103285|454505074|FG007|Response Assignment|Adverse Event|2|||
126330510|NCT00103285|454505067|FG000|Response Assignment|Death|0|||
126330511|NCT00103285|454505068|FG001|Response Assignment|Death|5|||
125878641|NCT01972217|452853373|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
125878642|NCT01972217|452853374|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
125878643|NCT01972217|452853371|FG000|Part B Double-blind, Randomised Period|Death|0|||
125878644|NCT01972217|452853372|FG001|Part B Double-blind, Randomised Period|Death|0|||
125878645|NCT01972217|452853373|FG002|Part B Double-blind, Randomised Period|Death|43|||
125992112|NCT04789577|453262874|FG005|Overall Study|Withdrawal by Subject|7|||
125992113|NCT04789577|453262875|FG006|Overall Study|Withdrawal by Subject|1|||
125992114|NCT04789577|453262869|FG000|Overall Study|Lost to Follow-up|7|||
125992115|NCT04789577|453262870|FG001|Overall Study|Lost to Follow-up|12|||
125992116|NCT04789577|453262871|FG002|Overall Study|Lost to Follow-up|7|||
125992117|NCT04789577|453262872|FG003|Overall Study|Lost to Follow-up|10|||
125992118|NCT04789577|453262873|FG004|Overall Study|Lost to Follow-up|8|||
126330512|NCT00103285|454505069|FG002|Response Assignment|Death|2|||
125992119|NCT04789577|453262874|FG005|Overall Study|Lost to Follow-up|6|||
125992120|NCT04789577|453262875|FG006|Overall Study|Lost to Follow-up|10|||
125992121|NCT04789577|453262869|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
125992122|NCT04789577|453262870|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
125992123|NCT04789577|453262871|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
125992124|NCT04789577|453262872|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
125992125|NCT04789577|453262873|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
125992126|NCT04789577|453262874|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
125992127|NCT04789577|453262875|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
125992128|NCT04789577|453262869|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
125992129|NCT04789577|453262870|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
125992130|NCT04789577|453262871|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
125992131|NCT04789577|453262872|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
125992132|NCT04789577|453262873|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
125992133|NCT04789577|453262874|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
125992134|NCT04789577|453262875|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
125992135|NCT02693834|453262884|FG000|Baseline Measurement|Withdrawal by Subject|1|||
125992136|NCT02693834|453262885|FG001|Baseline Measurement|Withdrawal by Subject|0|||
125992137|NCT02693834|453262884|FG000|Baseline Measurement|Adverse Event|1|||
125992138|NCT02693834|453262885|FG001|Baseline Measurement|Adverse Event|0|||
125992139|NCT02693834|453262884|FG000|Week 2 Practice|Adverse Event|0|||
125992140|NCT02693834|453262885|FG001|Week 2 Practice|Adverse Event|1|||
125992141|NCT04848662|453262888|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
125992142|NCT04848662|453262889|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
125992143|NCT03000673|453262890|FG000|Overall Study|Withdrawal by Subject|1|||
125992144|NCT03000673|453262891|FG001|Overall Study|Withdrawal by Subject|0|||
125992145|NCT03000673|453262892|FG002|Overall Study|Withdrawal by Subject|0|||
125992146|NCT03000673|453262893|FG003|Overall Study|Withdrawal by Subject|0|||
125992147|NCT01121484|453262894|FG000|Overall Study|Adverse Event|12|||
125992148|NCT01121484|453262895|FG001|Overall Study|Adverse Event|5|||
125992149|NCT01121484|453262894|FG000|Overall Study|Lack of Efficacy|3|||
125992150|NCT01121484|453262895|FG001|Overall Study|Lack of Efficacy|11|||
125992151|NCT01121484|453262894|FG000|Overall Study|Lost to Follow-up|5|||
125992152|NCT01121484|453262895|FG001|Overall Study|Lost to Follow-up|9|||
125992153|NCT01121484|453262894|FG000|Overall Study|Physician Decision|0|||
125992154|NCT01121484|453262895|FG001|Overall Study|Physician Decision|3|||
125992155|NCT01121484|453262894|FG000|Overall Study|Protocol Violation|1|||
125992156|NCT01121484|453262895|FG001|Overall Study|Protocol Violation|0|||
125992157|NCT01121484|453262894|FG000|Overall Study|Withdrawal by Subject|8|||
125992158|NCT01121484|453262895|FG001|Overall Study|Withdrawal by Subject|7|||
125992159|NCT01121484|453262894|FG000|Overall Study|Discontinuation of study by sponsor|0|||
125992160|NCT01121484|453262895|FG001|Overall Study|Discontinuation of study by sponsor|1|||
126330513|NCT00103285|454505070|FG003|Response Assignment|Death|2|||
126330514|NCT00103285|454505071|FG004|Response Assignment|Death|3|||
126330515|NCT00103285|454505072|FG005|Response Assignment|Death|1|||
126330516|NCT00103285|454505073|FG006|Response Assignment|Death|0|||
126330517|NCT00103285|454505074|FG007|Response Assignment|Death|8|||
126330518|NCT00103285|454505067|FG000|Response Assignment|Lost to Follow-up|0|||
126330519|NCT00103285|454505068|FG001|Response Assignment|Lost to Follow-up|9|||
126330520|NCT00103285|454505069|FG002|Response Assignment|Lost to Follow-up|5|||
126330521|NCT00103285|454505070|FG003|Response Assignment|Lost to Follow-up|5|||
126330522|NCT00103285|454505071|FG004|Response Assignment|Lost to Follow-up|1|||
126330523|NCT00103285|454505072|FG005|Response Assignment|Lost to Follow-up|2|||
125992161|NCT01121484|453262894|FG000|Overall Study|Other|3|||
125992162|NCT01121484|453262895|FG001|Overall Study|Other|3|||
125992163|NCT01121484|453262894|FG000|Overall Study|Randomized, not treated|1|||
125992164|NCT01121484|453262895|FG001|Overall Study|Randomized, not treated|4|||
126330524|NCT00103285|454505073|FG006|Response Assignment|Lost to Follow-up|2|||
126330525|NCT00103285|454505074|FG007|Response Assignment|Lost to Follow-up|5|||
125992165|NCT00562978|453262896|FG000|Overall Study|Patient had imaging dose only|1|||
125992166|NCT00562978|453262897|FG001|Overall Study|Patient had imaging dose only|11|||
125992167|NCT00779584|453262905|FG000|Overall Study|Protocol Violation|0|||
126330526|NCT00103285|454505067|FG000|Response Assignment|Physician Decision|0|||
126330527|NCT00103285|454505068|FG001|Response Assignment|Physician Decision|13|||
126330528|NCT00103285|454505069|FG002|Response Assignment|Physician Decision|14|||
125992168|NCT00779584|453262906|FG001|Overall Study|Protocol Violation|0|||
125992169|NCT00779584|453262907|FG002|Overall Study|Protocol Violation|0|||
125992170|NCT00779584|453262908|FG003|Overall Study|Protocol Violation|0|||
125992171|NCT00779584|453262909|FG004|Overall Study|Protocol Violation|0|||
125992172|NCT00779584|453262910|FG005|Overall Study|Protocol Violation|1|||
125992173|NCT00779584|453262911|FG006|Overall Study|Protocol Violation|0|||
125992174|NCT00779584|453262912|FG007|Overall Study|Protocol Violation|0|||
125992175|NCT00779584|453262913|FG008|Overall Study|Protocol Violation|0|||
125992176|NCT00779584|453262905|FG000|Overall Study|Withdrawal by Subject|1|||
125992177|NCT00779584|453262906|FG001|Overall Study|Withdrawal by Subject|1|||
125992178|NCT00779584|453262907|FG002|Overall Study|Withdrawal by Subject|2|||
125992179|NCT00779584|453262908|FG003|Overall Study|Withdrawal by Subject|0|||
125992180|NCT00779584|453262909|FG004|Overall Study|Withdrawal by Subject|0|||
125992181|NCT00779584|453262910|FG005|Overall Study|Withdrawal by Subject|2|||
125992182|NCT00779584|453262911|FG006|Overall Study|Withdrawal by Subject|1|||
125992183|NCT00779584|453262912|FG007|Overall Study|Withdrawal by Subject|0|||
125992184|NCT00779584|453262913|FG008|Overall Study|Withdrawal by Subject|0|||
125992185|NCT00779584|453262905|FG000|Overall Study|Lost to Follow-up|0|||
125992186|NCT00779584|453262906|FG001|Overall Study|Lost to Follow-up|0|||
125992187|NCT00779584|453262907|FG002|Overall Study|Lost to Follow-up|0|||
125992188|NCT00779584|453262908|FG003|Overall Study|Lost to Follow-up|0|||
125992189|NCT00779584|453262909|FG004|Overall Study|Lost to Follow-up|1|||
125992190|NCT00779584|453262910|FG005|Overall Study|Lost to Follow-up|0|||
125992191|NCT00779584|453262911|FG006|Overall Study|Lost to Follow-up|0|||
125992192|NCT00779584|453262912|FG007|Overall Study|Lost to Follow-up|0|||
125992193|NCT00779584|453262913|FG008|Overall Study|Lost to Follow-up|0|||
125992194|NCT00779584|453262905|FG000|Overall Study|Progression of Disease|0|||
125992195|NCT00779584|453262906|FG001|Overall Study|Progression of Disease|1|||
125992196|NCT00779584|453262907|FG002|Overall Study|Progression of Disease|2|||
125992197|NCT00779584|453262908|FG003|Overall Study|Progression of Disease|6|||
125992198|NCT00779584|453262909|FG004|Overall Study|Progression of Disease|5|||
125992199|NCT00779584|453262910|FG005|Overall Study|Progression of Disease|1|||
125992200|NCT00779584|453262911|FG006|Overall Study|Progression of Disease|4|||
125992201|NCT00779584|453262912|FG007|Overall Study|Progression of Disease|2|||
125992202|NCT00779584|453262913|FG008|Overall Study|Progression of Disease|1|||
125992203|NCT00779584|453262905|FG000|Overall Study|Adverse Event|1|||
125992204|NCT00779584|453262906|FG001|Overall Study|Adverse Event|0|||
125992205|NCT00779584|453262907|FG002|Overall Study|Adverse Event|2|||
125992206|NCT00779584|453262908|FG003|Overall Study|Adverse Event|0|||
125992207|NCT00779584|453262909|FG004|Overall Study|Adverse Event|0|||
125992208|NCT00779584|453262910|FG005|Overall Study|Adverse Event|0|||
125992209|NCT00779584|453262911|FG006|Overall Study|Adverse Event|2|||
125992210|NCT00779584|453262912|FG007|Overall Study|Adverse Event|1|||
125992211|NCT00779584|453262913|FG008|Overall Study|Adverse Event|1|||
125992212|NCT00779584|453262905|FG000|Overall Study|Symptomatic Deterioration|1|||
125992213|NCT00779584|453262906|FG001|Overall Study|Symptomatic Deterioration|1|||
125992214|NCT00779584|453262907|FG002|Overall Study|Symptomatic Deterioration|1|||
125992215|NCT00779584|453262908|FG003|Overall Study|Symptomatic Deterioration|0|||
125992216|NCT00779584|453262909|FG004|Overall Study|Symptomatic Deterioration|0|||
125992217|NCT00779584|453262910|FG005|Overall Study|Symptomatic Deterioration|1|||
125992218|NCT00779584|453262911|FG006|Overall Study|Symptomatic Deterioration|1|||
125992219|NCT00779584|453262912|FG007|Overall Study|Symptomatic Deterioration|0|||
125992220|NCT00779584|453262913|FG008|Overall Study|Symptomatic Deterioration|0|||
125992221|NCT00779584|453262905|FG000|Overall Study|Ongoing in Study|0|||
125992222|NCT00779584|453262906|FG001|Overall Study|Ongoing in Study|0|||
125992223|NCT00779584|453262907|FG002|Overall Study|Ongoing in Study|0|||
125992224|NCT00779584|453262908|FG003|Overall Study|Ongoing in Study|0|||
125992225|NCT00779584|453262909|FG004|Overall Study|Ongoing in Study|1|||
125992226|NCT00779584|453262910|FG005|Overall Study|Ongoing in Study|1|||
125992227|NCT00779584|453262911|FG006|Overall Study|Ongoing in Study|0|||
125992228|NCT00779584|453262912|FG007|Overall Study|Ongoing in Study|0|||
125992229|NCT00779584|453262913|FG008|Overall Study|Ongoing in Study|0|||
125992230|NCT02878213|453262918|FG000|Overall Study|Withdrawal by Subject|2|||
125992231|NCT02878213|453262918|FG000|Overall Study|Adverse Event|1|||
125992232|NCT01913639|453262919|FG000|Overall Study|Not Eligible|3|||
125992233|NCT02302066|453262920|FG000|Overall Study|Adverse Event|1|||
125992234|NCT02302066|453262921|FG001|Overall Study|Adverse Event|1|||
125992235|NCT02302066|453262922|FG002|Overall Study|Adverse Event|3|||
125992236|NCT02302066|453262923|FG003|Overall Study|Adverse Event|0|||
125992237|NCT02302066|453262920|FG000|Overall Study|Lost to Follow-up|4|||
125992238|NCT02302066|453262921|FG001|Overall Study|Lost to Follow-up|5|||
125992239|NCT02302066|453262922|FG002|Overall Study|Lost to Follow-up|24|||
125992240|NCT02302066|453262923|FG003|Overall Study|Lost to Follow-up|7|||
125992241|NCT02302066|453262920|FG000|Overall Study|Withdrawal by Subject|25|||
125992242|NCT02302066|453262921|FG001|Overall Study|Withdrawal by Subject|58|||
125992243|NCT02302066|453262922|FG002|Overall Study|Withdrawal by Subject|124|||
125992244|NCT02302066|453262923|FG003|Overall Study|Withdrawal by Subject|33|||
125992245|NCT02302066|453262920|FG000|Overall Study|Pregnancy|2|||
125992246|NCT02302066|453262921|FG001|Overall Study|Pregnancy|10|||
125992247|NCT02302066|453262922|FG002|Overall Study|Pregnancy|12|||
125992248|NCT02302066|453262923|FG003|Overall Study|Pregnancy|0|||
125992249|NCT02302066|453262920|FG000|Overall Study|Reason Not Specified|1|||
125992250|NCT02302066|453262921|FG001|Overall Study|Reason Not Specified|1|||
125992251|NCT02302066|453262922|FG002|Overall Study|Reason Not Specified|9|||
125992252|NCT02302066|453262923|FG003|Overall Study|Reason Not Specified|1|||
125992253|NCT02301156|453262924|FG000|Overall Study|Adverse Event|13|||
125992254|NCT02301156|453262925|FG001|Overall Study|Adverse Event|14|||
125992255|NCT02301156|453262924|FG000|Overall Study|Death|1|||
125992256|NCT02301156|453262925|FG001|Overall Study|Death|5|||
125992257|NCT02301156|453262924|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
125992258|NCT02301156|453262925|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
125992259|NCT02301156|453262924|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
125992260|NCT02301156|453262925|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
125992261|NCT02301156|453262924|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
125992262|NCT02301156|453262925|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
125992263|NCT02301156|453262924|FG000|Overall Study|Reason not Specified|6|||
125992264|NCT02301156|453262925|FG001|Overall Study|Reason not Specified|3|||
125992265|NCT00105586|453262926|FG000|Overall Study|Adverse Event|4|||
125992266|NCT00105586|453262927|FG001|Overall Study|Adverse Event|3|||
125992267|NCT00105586|453262926|FG000|Overall Study|Physician Decision|13|||
125992268|NCT00105586|453262927|FG001|Overall Study|Physician Decision|13|||
125992269|NCT02306122|453262928|FG000|Initial Physician Randomization|Physician Decision|0|||
125992270|NCT02306122|453262929|FG001|Initial Physician Randomization|Physician Decision|0|||
125992271|NCT02306122|453262930|FG002|Initial Physician Randomization|Physician Decision|0|||
125992272|NCT02306122|453262931|FG003|Initial Physician Randomization|Physician Decision|0|||
125992273|NCT02306122|453262932|FG004|Initial Physician Randomization|Physician Decision|0|||
125992274|NCT02306122|453262933|FG005|Initial Physician Randomization|Physician Decision|0|||
125992275|NCT02306122|453262934|FG006|Initial Physician Randomization|Physician Decision|0|||
125992276|NCT02306122|453262935|FG007|Initial Physician Randomization|Physician Decision|0|||
125992277|NCT02306122|453262936|FG008|Initial Physician Randomization|Physician Decision|1|||
125992278|NCT02306122|453262937|FG009|Initial Physician Randomization|Physician Decision|0|||
125992279|NCT02306122|453262938|FG010|Initial Physician Randomization|Physician Decision|0|||
125992280|NCT03734991|453262941|FG000|Overall Study|Adverse Event|4|||
125992281|NCT03734991|453262942|FG001|Overall Study|Adverse Event|0|||
125992282|NCT03734991|453262941|FG000|Overall Study|Lost to Follow-up|4|||
125992283|NCT03734991|453262942|FG001|Overall Study|Lost to Follow-up|0|||
125992284|NCT03734991|453262941|FG000|Overall Study|Physician Decision|0|||
125992285|NCT03734991|453262942|FG001|Overall Study|Physician Decision|1|||
125992286|NCT03734991|453262941|FG000|Overall Study|Pregnancy|1|||
125992287|NCT03734991|453262942|FG001|Overall Study|Pregnancy|0|||
125992288|NCT03734991|453262941|FG000|Overall Study|Withdrawal by Subject|6|||
125992289|NCT03734991|453262942|FG001|Overall Study|Withdrawal by Subject|3|||
125992290|NCT03734991|453262941|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
125992291|NCT03734991|453262942|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
125992292|NCT03734991|453262941|FG000|Overall Study|Other|2|||
125992293|NCT03734991|453262942|FG001|Overall Study|Other|2|||
125992294|NCT02638623|453262943|FG000|Overall Study|Surgery timing|5|||
125992295|NCT02638623|453262944|FG001|Overall Study|Surgery timing|6|||
125992296|NCT02638623|453262943|FG000|Overall Study|Not given intervention|2|||
125992297|NCT02638623|453262944|FG001|Overall Study|Not given intervention|0|||
125992298|NCT00886639|453262945|FG000|Overall Study|acute exacerbation|14|||
125992299|NCT00886639|453262945|FG000|Overall Study|non-compliance|2|||
125992300|NCT03203694|453262946|FG000|Overall Study|Withdrawal by Subject|2|||
125992301|NCT03203694|453262947|FG001|Overall Study|Withdrawal by Subject|0|||
125992302|NCT03203694|453262948|FG002|Overall Study|Withdrawal by Subject|0|||
125992303|NCT03203694|453262949|FG003|Overall Study|Withdrawal by Subject|0|||
125992304|NCT03203694|453262950|FG004|Overall Study|Withdrawal by Subject|0|||
125992305|NCT03203694|453262951|FG005|Overall Study|Withdrawal by Subject|0|||
125992306|NCT01103960|453262952|FG000|Overall Study|Adverse Event|2|||
125992307|NCT01103960|453262953|FG001|Overall Study|Adverse Event|1|||
125992308|NCT01103960|453262952|FG000|Overall Study|Withdrawal by Subject|2|||
125992309|NCT01103960|453262953|FG001|Overall Study|Withdrawal by Subject|1|||
125992310|NCT01103960|453262952|FG000|Overall Study|Other|1|||
125992311|NCT01103960|453262953|FG001|Overall Study|Other|0|||
125992312|NCT02875834|453262956|FG000|Open-label Phase|Withdrawal by Subject|3|||
125992313|NCT02875834|453262957|FG001|Open-label Phase|Withdrawal by Subject|0|||
125992314|NCT02875834|453262958|FG002|Open-label Phase|Withdrawal by Subject|0|||
125992315|NCT02875834|453262959|FG003|Open-label Phase|Withdrawal by Subject|0|||
125992316|NCT02875834|453262956|FG000|Open-label Phase|(Not collected)|4|||
125992317|NCT02875834|453262957|FG001|Open-label Phase|(Not collected)|0|||
125992318|NCT02875834|453262958|FG002|Open-label Phase|(Not collected)|0|||
125992319|NCT02875834|453262959|FG003|Open-label Phase|(Not collected)|0|||
125992320|NCT02875834|453262956|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
125992321|NCT02875834|453262957|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
125992322|NCT02875834|453262958|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
125992323|NCT02875834|453262959|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
125992324|NCT02875834|453262956|FG000|Randomized Treatment Phase|Protocol Violation|0|||
125992325|NCT02875834|453262957|FG001|Randomized Treatment Phase|Protocol Violation|2|||
125992326|NCT02875834|453262958|FG002|Randomized Treatment Phase|Protocol Violation|0|||
125992327|NCT02875834|453262959|FG003|Randomized Treatment Phase|Protocol Violation|0|||
125992328|NCT02875834|453262956|FG000|Randomized Treatment Phase|(Not collected)|0|||
125992329|NCT02875834|453262957|FG001|Randomized Treatment Phase|(Not collected)|9|||
125992330|NCT02875834|453262958|FG002|Randomized Treatment Phase|(Not collected)|10|||
125992331|NCT02875834|453262959|FG003|Randomized Treatment Phase|(Not collected)|9|||
125992332|NCT01032044|453262960|FG000|Overall Study|Protocol Violation|14|||
125992333|NCT01032044|453262961|FG001|Overall Study|Protocol Violation|8|||
125992334|NCT01032044|453262960|FG000|Overall Study|Adverse Event|0|||
125992335|NCT01032044|453262961|FG001|Overall Study|Adverse Event|1|||
125992336|NCT01032044|453262960|FG000|Overall Study|Lost to Follow-up|11|||
125992337|NCT01032044|453262961|FG001|Overall Study|Lost to Follow-up|11|||
125992338|NCT03311230|453262964|FG000|Overall Study|Withdrawal by Subject|1|||
125992339|NCT03311230|453262965|FG001|Overall Study|Withdrawal by Subject|4|||
125992340|NCT03311230|453262966|FG002|Overall Study|Withdrawal by Subject|2|||
125992341|NCT03311230|453262967|FG003|Overall Study|Withdrawal by Subject|7|||
125992342|NCT03311230|453262964|FG000|Overall Study|Unrelated injury|0|||
125992343|NCT03311230|453262965|FG001|Overall Study|Unrelated injury|1|||
125992344|NCT03311230|453262966|FG002|Overall Study|Unrelated injury|0|||
125992345|NCT03311230|453262967|FG003|Overall Study|Unrelated injury|0|||
125992346|NCT03342053|453262968|FG000|Overall Study|Adverse Event|2|||
125992347|NCT03342053|453262969|FG001|Overall Study|Adverse Event|0|||
125992348|NCT03342053|453262968|FG000|Overall Study|Withdrawal by Subject|0|||
125992349|NCT03342053|453262969|FG001|Overall Study|Withdrawal by Subject|1|||
125992350|NCT01302938|453262970|FG000|Overall Study|Withdrawal by Subject|1|||
125992351|NCT01302938|453262971|FG001|Overall Study|Withdrawal by Subject|0|||
125992352|NCT01302938|453262970|FG000|Overall Study|Adverse Event|1|||
125992353|NCT01302938|453262971|FG001|Overall Study|Adverse Event|0|||
125992354|NCT01233609|453262972|FG000|Overall Study|Death|1|||
125992355|NCT01233609|453262973|FG001|Overall Study|Death|0|||
125992356|NCT01233609|453262972|FG000|Overall Study|Lost to Follow-up|3|||
125992357|NCT01233609|453262973|FG001|Overall Study|Lost to Follow-up|1|||
125992358|NCT01233609|453262972|FG000|Overall Study|Adverse Event|2|||
125992359|NCT01233609|453262973|FG001|Overall Study|Adverse Event|1|||
125992360|NCT01233609|453262972|FG000|Overall Study|Withdrawal by Subject|3|||
125992361|NCT01233609|453262973|FG001|Overall Study|Withdrawal by Subject|0|||
125992362|NCT02961374|453262974|FG000|Overall Study|Adverse Event|4|||
125992363|NCT00735644|453262975|FG000|Overall Study|Did not receive study vaccine|0|||
125992364|NCT00735644|453262976|FG001|Overall Study|Did not receive study vaccine|1|||
125992365|NCT00735644|453262977|FG002|Overall Study|Did not receive study vaccine|0|||
125992366|NCT00735644|453262978|FG003|Overall Study|Did not receive study vaccine|0|||
125992367|NCT00735644|453262979|FG004|Overall Study|Did not receive study vaccine|0|||
125992368|NCT00735644|453262975|FG000|Overall Study|Withdrawal by Subject|0|||
125992369|NCT00735644|453262976|FG001|Overall Study|Withdrawal by Subject|1|||
125992370|NCT00735644|453262977|FG002|Overall Study|Withdrawal by Subject|1|||
125992371|NCT00735644|453262978|FG003|Overall Study|Withdrawal by Subject|1|||
125992372|NCT00735644|453262979|FG004|Overall Study|Withdrawal by Subject|0|||
125992373|NCT01518946|453262986|FG000|Open-label Phase|Other|4|||
125992374|NCT01518946|453262987|FG001|Open-label Phase|Other|0|||
125992375|NCT01518946|453262988|FG002|Open-label Phase|Other|0|||
125992376|NCT01518946|453262986|FG000|Randomized Phase (First Intervention)|Other|0|||
125992377|NCT01518946|453262987|FG001|Randomized Phase (First Intervention)|Other|1|||
125992378|NCT01518946|453262988|FG002|Randomized Phase (First Intervention)|Other|0|||
125992379|NCT00384059|453262989|FG000|Infant Series|Not consented|2|||
125992380|NCT00384059|453262990|FG001|Infant Series|Not consented|6|||
125992381|NCT00384059|453262989|FG000|Infant Series|Withdrawal by Subject|2|||
125992382|NCT00384059|453262990|FG001|Infant Series|Withdrawal by Subject|2|||
125992383|NCT00384059|453262989|FG000|Infant Series|Adverse Event|1|||
125992384|NCT00384059|453262990|FG001|Infant Series|Adverse Event|2|||
125992385|NCT00384059|453262989|FG000|Infant Series|Protocol Violation|1|||
125992386|NCT00384059|453262990|FG001|Infant Series|Protocol Violation|2|||
125992387|NCT00384059|453262989|FG000|Infant Series|Lost to Follow-up|0|||
125992388|NCT00384059|453262990|FG001|Infant Series|Lost to Follow-up|1|||
125992389|NCT00384059|453262989|FG000|After Infant Series|Protocol Violation|2|||
125992390|NCT00384059|453262990|FG001|After Infant Series|Protocol Violation|3|||
125992391|NCT00384059|453262989|FG000|After Infant Series|Withdrawal by Subject|2|||
125992392|NCT00384059|453262990|FG001|After Infant Series|Withdrawal by Subject|2|||
125992393|NCT00384059|453262989|FG000|After Infant Series|Failed to Return|0|||
125992394|NCT00384059|453262990|FG001|After Infant Series|Failed to Return|2|||
125992395|NCT00384059|453262989|FG000|After Infant Series|Adverse Event|0|||
125992396|NCT00384059|453262990|FG001|After Infant Series|Adverse Event|1|||
125992397|NCT00384059|453262989|FG000|After Infant Series|Physician Decision|0|||
125992398|NCT00384059|453262990|FG001|After Infant Series|Physician Decision|1|||
125992399|NCT00384059|453262989|FG000|After Infant Series|Lost to Follow-up|0|||
125992400|NCT00384059|453262990|FG001|After Infant Series|Lost to Follow-up|1|||
125992401|NCT00384059|453262989|FG000|Toddler Dose|Lost to Follow-up|1|||
125992402|NCT00384059|453262990|FG001|Toddler Dose|Lost to Follow-up|1|||
125992403|NCT00384059|453262989|FG000|Toddler Dose|Failed to return|0|||
125992404|NCT00384059|453262990|FG001|Toddler Dose|Failed to return|1|||
125992405|NCT00649389|453265048|FG000|Overall Study|Adverse Event|22|||
125992406|NCT00649389|453265049|FG001|Overall Study|Adverse Event|46|||
125992407|NCT00649389|453265050|FG002|Overall Study|Adverse Event|38|||
125992408|NCT00649389|453265051|FG003|Overall Study|Adverse Event|48|||
125992409|NCT00649389|453265048|FG000|Overall Study|Lost to Follow-up|15|||
125992410|NCT00649389|453265049|FG001|Overall Study|Lost to Follow-up|17|||
125992411|NCT00649389|453265050|FG002|Overall Study|Lost to Follow-up|21|||
125992412|NCT00649389|453265051|FG003|Overall Study|Lost to Follow-up|26|||
125992413|NCT00649389|453265048|FG000|Overall Study|Protocol Violation|11|||
125992414|NCT00649389|453265049|FG001|Overall Study|Protocol Violation|13|||
125992415|NCT00649389|453265050|FG002|Overall Study|Protocol Violation|9|||
125992416|NCT00649389|453265051|FG003|Overall Study|Protocol Violation|8|||
125992417|NCT00649389|453265048|FG000|Overall Study|Withdrawal by Subject|20|||
125992418|NCT00649389|453265049|FG001|Overall Study|Withdrawal by Subject|21|||
125992419|NCT00649389|453265050|FG002|Overall Study|Withdrawal by Subject|19|||
125992420|NCT00649389|453265051|FG003|Overall Study|Withdrawal by Subject|23|||
125992421|NCT00649389|453265048|FG000|Overall Study|Other|3|||
125992422|NCT00649389|453265049|FG001|Overall Study|Other|9|||
125992423|NCT00649389|453265050|FG002|Overall Study|Other|1|||
125992424|NCT00649389|453265051|FG003|Overall Study|Other|6|||
125992425|NCT01806740|453265052|FG000|Overall Study|Withdrawal by Subject|4|||
125992426|NCT01806740|453265052|FG000|Overall Study|Physician Decision|1|||
125992427|NCT01806740|453265052|FG000|Overall Study|Patient's refusal of treatment|1|||
125992428|NCT04666922|453265053|FG000|Overall Study|Withdrawal by Subject|1|||
125992429|NCT04666922|453265054|FG001|Overall Study|Withdrawal by Subject|0|||
125992430|NCT04666922|453265055|FG002|Overall Study|Withdrawal by Subject|0|||
125992431|NCT04666922|453265056|FG003|Overall Study|Withdrawal by Subject|0|||
125992432|NCT04666922|453265057|FG004|Overall Study|Withdrawal by Subject|0|||
125992433|NCT04666922|453265058|FG005|Overall Study|Withdrawal by Subject|0|||
125992434|NCT04666922|453265059|FG006|Overall Study|Withdrawal by Subject|0|||
125992435|NCT03722264|453265060|FG000|Overall Study|Physician Decision|3|||
125992436|NCT02959671|453265061|FG000|Overall Study|Adverse Event|2|||
125992437|NCT02959671|453265061|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
125992438|NCT01923896|453265064|FG000|Overall Study|Adverse Event|1|||
125992439|NCT01923896|453265065|FG001|Overall Study|Adverse Event|0|||
125992440|NCT00592319|453265068|FG000|Overall Study|Lost to Follow-up|0|||
125992441|NCT00592319|453265069|FG001|Overall Study|Lost to Follow-up|3|||
125992442|NCT00235443|453265072|FG000|Overall Study|Adverse Event|4|||
125992443|NCT00235443|453265073|FG001|Overall Study|Adverse Event|12|||
125992444|NCT00235443|453265074|FG002|Overall Study|Adverse Event|17|||
125992445|NCT00235443|453265075|FG003|Overall Study|Adverse Event|44|||
125992446|NCT00235443|453265076|FG004|Overall Study|Adverse Event|10|||
125992447|NCT00235443|453265077|FG005|Overall Study|Adverse Event|15|||
125992448|NCT00235443|453265072|FG000|Overall Study|Lack of Efficacy|0|||
125992449|NCT00235443|453265073|FG001|Overall Study|Lack of Efficacy|1|||
125992450|NCT00235443|453265074|FG002|Overall Study|Lack of Efficacy|5|||
125992451|NCT00235443|453265075|FG003|Overall Study|Lack of Efficacy|12|||
125992452|NCT00235443|453265076|FG004|Overall Study|Lack of Efficacy|2|||
125992453|NCT00235443|453265077|FG005|Overall Study|Lack of Efficacy|9|||
125992454|NCT00235443|453265072|FG000|Overall Study|Withdrawal by Subject|3|||
125992455|NCT00235443|453265073|FG001|Overall Study|Withdrawal by Subject|9|||
125992456|NCT00235443|453265074|FG002|Overall Study|Withdrawal by Subject|25|||
125992457|NCT00235443|453265075|FG003|Overall Study|Withdrawal by Subject|24|||
125992458|NCT00235443|453265076|FG004|Overall Study|Withdrawal by Subject|10|||
125992459|NCT00235443|453265077|FG005|Overall Study|Withdrawal by Subject|12|||
125992460|NCT00235443|453265072|FG000|Overall Study|Lost to Follow-up|0|||
125992461|NCT00235443|453265073|FG001|Overall Study|Lost to Follow-up|8|||
125992462|NCT00235443|453265074|FG002|Overall Study|Lost to Follow-up|6|||
125992463|NCT00235443|453265075|FG003|Overall Study|Lost to Follow-up|6|||
125992464|NCT00235443|453265076|FG004|Overall Study|Lost to Follow-up|4|||
125992465|NCT00235443|453265077|FG005|Overall Study|Lost to Follow-up|3|||
125992466|NCT00235443|453265072|FG000|Overall Study|Unsatisfactory compliance|0|||
125992467|NCT00235443|453265073|FG001|Overall Study|Unsatisfactory compliance|2|||
125992468|NCT00235443|453265074|FG002|Overall Study|Unsatisfactory compliance|3|||
125992469|NCT00235443|453265075|FG003|Overall Study|Unsatisfactory compliance|4|||
125992470|NCT00235443|453265076|FG004|Overall Study|Unsatisfactory compliance|1|||
125992471|NCT00235443|453265077|FG005|Overall Study|Unsatisfactory compliance|0|||
125992472|NCT00235443|453265072|FG000|Overall Study|Other reasons for premature termination|1|||
125992473|NCT00235443|453265073|FG001|Overall Study|Other reasons for premature termination|6|||
125992474|NCT00235443|453265074|FG002|Overall Study|Other reasons for premature termination|6|||
125992475|NCT00235443|453265075|FG003|Overall Study|Other reasons for premature termination|7|||
125992476|NCT00235443|453265076|FG004|Overall Study|Other reasons for premature termination|3|||
125992477|NCT00235443|453265077|FG005|Overall Study|Other reasons for premature termination|6|||
125992478|NCT03661996|453265083|FG000|Overall Study|Adverse Event|0|||
125992479|NCT03661996|453265084|FG001|Overall Study|Adverse Event|0|||
125992480|NCT03661996|453265085|FG002|Overall Study|Adverse Event|1|||
125992481|NCT03661996|453265086|FG003|Overall Study|Adverse Event|1|||
125992482|NCT03661996|453265087|FG004|Overall Study|Adverse Event|0|||
125992483|NCT03661996|453265083|FG000|Overall Study|Lost to Follow-up|5|||
125992484|NCT03661996|453265084|FG001|Overall Study|Lost to Follow-up|1|||
125992485|NCT03661996|453265085|FG002|Overall Study|Lost to Follow-up|2|||
125992486|NCT03661996|453265086|FG003|Overall Study|Lost to Follow-up|2|||
125992487|NCT03661996|453265087|FG004|Overall Study|Lost to Follow-up|6|||
125992488|NCT03661996|453265083|FG000|Overall Study|Physician Decision|1|||
125992489|NCT03661996|453265084|FG001|Overall Study|Physician Decision|1|||
125992490|NCT03661996|453265085|FG002|Overall Study|Physician Decision|1|||
125992491|NCT03661996|453265086|FG003|Overall Study|Physician Decision|2|||
125992492|NCT03661996|453265087|FG004|Overall Study|Physician Decision|0|||
125992493|NCT03661996|453265083|FG000|Overall Study|Protocol Violation|0|||
125992494|NCT03661996|453265084|FG001|Overall Study|Protocol Violation|0|||
125992495|NCT03661996|453265085|FG002|Overall Study|Protocol Violation|0|||
125992496|NCT03661996|453265086|FG003|Overall Study|Protocol Violation|0|||
125992497|NCT03661996|453265087|FG004|Overall Study|Protocol Violation|1|||
125992498|NCT03661996|453265083|FG000|Overall Study|Withdrawal by Subject|3|||
125992499|NCT03661996|453265084|FG001|Overall Study|Withdrawal by Subject|5|||
125992500|NCT03661996|453265085|FG002|Overall Study|Withdrawal by Subject|1|||
125992501|NCT03661996|453265086|FG003|Overall Study|Withdrawal by Subject|7|||
125992502|NCT03661996|453265087|FG004|Overall Study|Withdrawal by Subject|7|||
125992503|NCT03661996|453265083|FG000|Overall Study|Sponsors Decision|2|||
125992504|NCT03661996|453265084|FG001|Overall Study|Sponsors Decision|0|||
125992505|NCT03661996|453265085|FG002|Overall Study|Sponsors Decision|0|||
125992506|NCT03661996|453265086|FG003|Overall Study|Sponsors Decision|0|||
125992507|NCT03661996|453265087|FG004|Overall Study|Sponsors Decision|0|||
125992508|NCT03661996|453265083|FG000|Overall Study|Other|1|||
125992509|NCT03661996|453265084|FG001|Overall Study|Other|1|||
125992510|NCT03661996|453265085|FG002|Overall Study|Other|1|||
125992511|NCT03661996|453265086|FG003|Overall Study|Other|1|||
125992512|NCT03661996|453265087|FG004|Overall Study|Other|0|||
125992513|NCT03321513|453265088|FG000|Overall Study|Death|11|||
125992514|NCT03321513|453265089|FG001|Overall Study|Death|5|||
125992515|NCT03321513|453265088|FG000|Overall Study|Withdrawal by Subject|5|||
125992516|NCT03321513|453265089|FG001|Overall Study|Withdrawal by Subject|10|||
125992517|NCT03321513|453265088|FG000|Overall Study|Lost to Follow-up|10|||
125992518|NCT03321513|453265089|FG001|Overall Study|Lost to Follow-up|11|||
125992519|NCT03029247|453265090|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
125992520|NCT03029247|453265091|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
125992521|NCT03029247|453265090|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
125992522|NCT03029247|453265091|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
125992523|NCT03029247|453265090|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
125992524|NCT03029247|453265091|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
125992525|NCT03029247|453265090|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
125992526|NCT03029247|453265091|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
125992527|NCT00068380|453265094|FG000|Overall Study|Withdrawal by Subject|3|||
125992528|NCT00068380|453265094|FG000|Overall Study|Adverse Event|2|||
125992529|NCT01976364|453265095|FG000|Main Study (36 Months)|Adverse Event|63|||
125992530|NCT01976364|453265096|FG001|Main Study (36 Months)|Adverse Event|0|||
125992531|NCT01976364|453265097|FG002|Main Study (36 Months)|Adverse Event|0|||
125992532|NCT01976364|453265095|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
125992533|NCT01976364|453265096|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
125992534|NCT01976364|453265097|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
125992535|NCT01976364|453265095|FG000|Main Study (36 Months)|Other|13|||
125992536|NCT01976364|453265096|FG001|Main Study (36 Months)|Other|0|||
125992537|NCT01976364|453265097|FG002|Main Study (36 Months)|Other|0|||
125992538|NCT01976364|453265095|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
125992539|NCT01976364|453265096|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
125992540|NCT01976364|453265097|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
125992541|NCT01976364|453265095|FG000|Main Study (36 Months)|Medication error|1|||
125992542|NCT01976364|453265096|FG001|Main Study (36 Months)|Medication error|0|||
125992543|NCT01976364|453265097|FG002|Main Study (36 Months)|Medication error|0|||
125992544|NCT01976364|453265095|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
125992545|NCT01976364|453265096|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
125992546|NCT01976364|453265097|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
125992547|NCT01976364|453265095|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
125992548|NCT01976364|453265096|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
125992549|NCT01976364|453265097|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
125992550|NCT01976364|453265095|FG000|Main Study (36 Months)|Protocol Violation|13|||
125992551|NCT01976364|453265096|FG001|Main Study (36 Months)|Protocol Violation|0|||
125992552|NCT01976364|453265097|FG002|Main Study (36 Months)|Protocol Violation|0|||
125992553|NCT01976364|453265095|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
125992554|NCT01976364|453265096|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
125992555|NCT01976364|453265097|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
125992556|NCT01976364|453265095|FG000|Main Study (36 Months)|Death|5|||
125992557|NCT01976364|453265096|FG001|Main Study (36 Months)|Death|0|||
125992558|NCT01976364|453265097|FG002|Main Study (36 Months)|Death|0|||
125992559|NCT01976364|453265095|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
125992560|NCT01976364|453265096|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
125992561|NCT01976364|453265097|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
125992562|NCT01976364|453265095|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
125992563|NCT01976364|453265096|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
125992564|NCT01976364|453265097|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
125992565|NCT01976364|453265095|FG000|Sub-study (12 Months)|Protocol Violation|0|||
125992566|NCT01976364|453265096|FG001|Sub-study (12 Months)|Protocol Violation|1|||
125992567|NCT01976364|453265097|FG002|Sub-study (12 Months)|Protocol Violation|1|||
125992568|NCT01976364|453265095|FG000|Sub-study (12 Months)|Adverse Event|0|||
125992569|NCT01976364|453265096|FG001|Sub-study (12 Months)|Adverse Event|4|||
125992570|NCT01976364|453265097|FG002|Sub-study (12 Months)|Adverse Event|3|||
125992571|NCT02757521|453265098|FG000|Overall Study|Adverse Event|1|||
125992572|NCT02757521|453265099|FG001|Overall Study|Adverse Event|0|||
125992573|NCT01190215|453265100|FG000|Up to Month 6|Lost to Follow-up|2|||
125992574|NCT01190215|453265101|FG001|Up to Month 6|Lost to Follow-up|0|||
125992575|NCT00003511|453265103|FG000|Overall Study|Not evaluable|4|||
125992576|NCT05340751|453265111|FG000|Overall Study|Physician Decision|3|||
125992577|NCT04399551|453265112|FG000|Overall Study|Adverse Event|15|||
125992578|NCT04399551|453265112|FG000|Overall Study|Withdrawal by Subject|6|||
125992579|NCT04399551|453265112|FG000|Overall Study|Physician Decision|3|||
125992580|NCT04399551|453265112|FG000|Overall Study|Lost to Follow-up|2|||
125992581|NCT04399551|453265112|FG000|Overall Study|Protocol Deviation|2|||
125992582|NCT02961881|453265125|FG000|Overall Study|Adverse Event|1|||
125992583|NCT02961881|453265126|FG001|Overall Study|Adverse Event|2|||
125992584|NCT02961881|453265127|FG002|Overall Study|Adverse Event|2|||
125992585|NCT02961881|453265128|FG003|Overall Study|Adverse Event|0|||
125992586|NCT02961881|453265129|FG004|Overall Study|Adverse Event|1|||
125992587|NCT02961881|453265125|FG000|Overall Study|Participant request|0|||
125992588|NCT02961881|453265126|FG001|Overall Study|Participant request|2|||
125992589|NCT02961881|453265127|FG002|Overall Study|Participant request|0|||
125992590|NCT02961881|453265128|FG003|Overall Study|Participant request|0|||
125992591|NCT02961881|453265129|FG004|Overall Study|Participant request|0|||
125992592|NCT02961881|453265125|FG000|Overall Study|Disease progression|1|||
125992593|NCT02961881|453265126|FG001|Overall Study|Disease progression|0|||
125992594|NCT02961881|453265127|FG002|Overall Study|Disease progression|1|||
125992595|NCT02961881|453265128|FG003|Overall Study|Disease progression|0|||
125992596|NCT02961881|453265129|FG004|Overall Study|Disease progression|0|||
125992597|NCT01973491|453265130|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
125992598|NCT01973491|453265130|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
125992599|NCT01973491|453265130|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
125992600|NCT03154359|453265133|FG000|Overall Study|Adverse Event|1|||
125992601|NCT03154359|453265133|FG000|Overall Study|Lack of Efficacy|2|||
125992602|NCT03154359|453265133|FG000|Overall Study|Lost to Follow-up|3|||
125992603|NCT03154359|453265133|FG000|Overall Study|Physician Decision|3|||
125992604|NCT03154359|453265133|FG000|Overall Study|Protocol Violation|4|||
125992605|NCT03154359|453265133|FG000|Overall Study|Withdrawal by Subject|5|||
125992606|NCT03154359|453265133|FG000|Overall Study|Disruption of study due to COVID-19|4|||
125992607|NCT04250337|453265134|FG000|Overall Study|Adverse Event|0|||
125992608|NCT04250337|453265135|FG001|Overall Study|Adverse Event|3|||
125992609|NCT04250337|453265134|FG000|Overall Study|Lack of Efficacy|1|||
126330529|NCT00103285|454505070|FG003|Response Assignment|Physician Decision|9|||
126330530|NCT00103285|454505071|FG004|Response Assignment|Physician Decision|13|||
126330531|NCT00103285|454505072|FG005|Response Assignment|Physician Decision|7|||
126330532|NCT00103285|454505073|FG006|Response Assignment|Physician Decision|4|||
126330533|NCT00103285|454505074|FG007|Response Assignment|Physician Decision|35|||
126330534|NCT00103285|454505067|FG000|Response Assignment|Protocol Violation|0|||
126330535|NCT00103285|454505068|FG001|Response Assignment|Protocol Violation|2|||
126330536|NCT00103285|454505069|FG002|Response Assignment|Protocol Violation|0|||
126330537|NCT00103285|454505070|FG003|Response Assignment|Protocol Violation|0|||
126330538|NCT00103285|454505071|FG004|Response Assignment|Protocol Violation|0|||
126330539|NCT00103285|454505072|FG005|Response Assignment|Protocol Violation|0|||
125992610|NCT04250337|453265135|FG001|Overall Study|Lack of Efficacy|3|||
126330540|NCT00103285|454505073|FG006|Response Assignment|Protocol Violation|0|||
125992611|NCT04250337|453265134|FG000|Overall Study|Physician Decision|1|||
125992612|NCT04250337|453265135|FG001|Overall Study|Physician Decision|0|||
125992613|NCT04250337|453265134|FG000|Overall Study|Protocol Deviation|2|||
125992614|NCT04250337|453265135|FG001|Overall Study|Protocol Deviation|2|||
125992615|NCT04250337|453265134|FG000|Overall Study|Withdrawal by Subject|4|||
125992616|NCT04250337|453265135|FG001|Overall Study|Withdrawal by Subject|3|||
125992617|NCT00152971|453265147|FG000|Overall Study|Adverse Event|12|||
125992618|NCT00152971|453265148|FG001|Overall Study|Adverse Event|10|||
125992619|NCT00152971|453265149|FG002|Overall Study|Adverse Event|9|||
125992620|NCT00152971|453265147|FG000|Overall Study|Protocol Violation|10|||
125992621|NCT00152971|453265148|FG001|Overall Study|Protocol Violation|11|||
125992622|NCT00152971|453265149|FG002|Overall Study|Protocol Violation|8|||
125992623|NCT00152971|453265147|FG000|Overall Study|Lost to Follow-up|17|||
125992624|NCT00152971|453265148|FG001|Overall Study|Lost to Follow-up|14|||
125992625|NCT00152971|453265149|FG002|Overall Study|Lost to Follow-up|13|||
125992626|NCT00152971|453265147|FG000|Overall Study|Withdrawal by Subject|9|||
125992627|NCT00152971|453265148|FG001|Overall Study|Withdrawal by Subject|8|||
125992628|NCT00152971|453265149|FG002|Overall Study|Withdrawal by Subject|14|||
125992629|NCT00152971|453265147|FG000|Overall Study|Other|3|||
125992630|NCT00152971|453265148|FG001|Overall Study|Other|5|||
125992631|NCT00152971|453265149|FG002|Overall Study|Other|5|||
125992632|NCT00152971|453265147|FG000|Treatment|Adverse Event|49|||
125992633|NCT00152971|453265148|FG001|Treatment|Adverse Event|40|||
125992634|NCT00152971|453265149|FG002|Treatment|Adverse Event|54|||
125992635|NCT00152971|453265147|FG000|Treatment|Protocol Violation|8|||
125992636|NCT00152971|453265148|FG001|Treatment|Protocol Violation|6|||
125992637|NCT00152971|453265149|FG002|Treatment|Protocol Violation|10|||
125992638|NCT00152971|453265147|FG000|Treatment|Lost to Follow-up|1|||
125992639|NCT00152971|453265148|FG001|Treatment|Lost to Follow-up|2|||
125992640|NCT00152971|453265149|FG002|Treatment|Lost to Follow-up|1|||
125992641|NCT00152971|453265147|FG000|Treatment|Withdrawal by Subject|4|||
125992642|NCT00152971|453265148|FG001|Treatment|Withdrawal by Subject|4|||
125992643|NCT00152971|453265149|FG002|Treatment|Withdrawal by Subject|5|||
125992644|NCT00152971|453265147|FG000|Treatment|Other|9|||
125992645|NCT00152971|453265148|FG001|Treatment|Other|11|||
125992646|NCT00152971|453265149|FG002|Treatment|Other|10|||
125992647|NCT00366301|453265150|FG000|Overall Study|Lost to Follow-up|4|||
125992648|NCT00366301|453265151|FG001|Overall Study|Lost to Follow-up|4|||
125992649|NCT00366301|453265152|FG002|Overall Study|Lost to Follow-up|3|||
125992650|NCT00366301|453265153|FG003|Overall Study|Lost to Follow-up|7|||
125992651|NCT00366301|453265150|FG000|Overall Study|Withdrawal by Subject|4|||
125992652|NCT00366301|453265151|FG001|Overall Study|Withdrawal by Subject|2|||
125992653|NCT00366301|453265152|FG002|Overall Study|Withdrawal by Subject|1|||
125992654|NCT00366301|453265153|FG003|Overall Study|Withdrawal by Subject|1|||
125992655|NCT01348776|453265156|FG000|Overall Study|Lost to Follow-up|3|||
125992656|NCT01463293|453265157|FG000|Overall Study|Lost to Follow-up|1|||
125992657|NCT01463293|453265158|FG001|Overall Study|Lost to Follow-up|4|||
125992658|NCT01463293|453265159|FG002|Overall Study|Lost to Follow-up|5|||
125992659|NCT01463293|453265157|FG000|Overall Study|Adverse Event|1|||
125992660|NCT01463293|453265158|FG001|Overall Study|Adverse Event|2|||
125992661|NCT01463293|453265159|FG002|Overall Study|Adverse Event|0|||
125992662|NCT01463293|453265157|FG000|Overall Study|Withdrawal by Subject|4|||
125992663|NCT01463293|453265158|FG001|Overall Study|Withdrawal by Subject|10|||
125992664|NCT01463293|453265159|FG002|Overall Study|Withdrawal by Subject|5|||
125992665|NCT01463293|453265157|FG000|Overall Study|Other|0|||
125992666|NCT01463293|453265158|FG001|Overall Study|Other|0|||
125992667|NCT01463293|453265159|FG002|Overall Study|Other|2|||
125992668|NCT02494206|453265183|FG000|Overall Study|Adverse Event|1|||
125992669|NCT02494206|453265183|FG000|Overall Study|Disease Progression|1|||
125992670|NCT04276090|453265184|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
125992671|NCT04276090|453265185|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
125992672|NCT01799720|453265186|FG000|Overall Study|Withdrawal by Subject|3|||
125992673|NCT01799720|453265187|FG001|Overall Study|Withdrawal by Subject|0|||
125992674|NCT01799720|453265188|FG002|Overall Study|Withdrawal by Subject|0|||
125992675|NCT01799720|453265186|FG000|Overall Study|Protocol Violation|0|||
125992676|NCT01799720|453265187|FG001|Overall Study|Protocol Violation|1|||
125992677|NCT01799720|453265188|FG002|Overall Study|Protocol Violation|0|||
125992678|NCT01799720|453265186|FG000|Overall Study|Pregnancy|0|||
125992679|NCT01799720|453265187|FG001|Overall Study|Pregnancy|0|||
126330541|NCT00103285|454505074|FG007|Response Assignment|Protocol Violation|0|||
126330542|NCT00103285|454505067|FG000|Response Assignment|Withdrawal by Subject|0|||
126330543|NCT00103285|454505068|FG001|Response Assignment|Withdrawal by Subject|4|||
126330544|NCT00103285|454505069|FG002|Response Assignment|Withdrawal by Subject|1|||
126330545|NCT00103285|454505070|FG003|Response Assignment|Withdrawal by Subject|1|||
126330546|NCT00103285|454505071|FG004|Response Assignment|Withdrawal by Subject|2|||
125992680|NCT01799720|453265188|FG002|Overall Study|Pregnancy|1|||
125992681|NCT04986982|453265189|FG000|Overall Study|Withdrawal by Subject|3|||
125992682|NCT04986982|453265190|FG001|Overall Study|Withdrawal by Subject|1|||
125992683|NCT04986982|453265189|FG000|Overall Study|Lack of Efficacy|0|||
125992684|NCT04986982|453265190|FG001|Overall Study|Lack of Efficacy|2|||
125992685|NCT04986982|453265189|FG000|Overall Study|Ineligibility|3|||
125992686|NCT04986982|453265190|FG001|Overall Study|Ineligibility|0|||
125992687|NCT04986982|453265189|FG000|Overall Study|Adverse Event|4|||
125992688|NCT04986982|453265190|FG001|Overall Study|Adverse Event|4|||
125992689|NCT04986982|453265189|FG000|Overall Study|Lost to Follow-up|0|||
125992690|NCT04986982|453265190|FG001|Overall Study|Lost to Follow-up|1|||
125992691|NCT04986982|453265189|FG000|Overall Study|Sponsor's discretion|1|||
125992692|NCT04986982|453265190|FG001|Overall Study|Sponsor's discretion|0|||
125992693|NCT01155661|453265191|FG000|Overall Study|Adverse Event|101|||
125992694|NCT01155661|453265191|FG000|Overall Study|Death|1|||
125992695|NCT01155661|453265191|FG000|Overall Study|Lack of Efficacy|32|||
125992696|NCT01155661|453265191|FG000|Overall Study|Lost to Follow-up|22|||
125992697|NCT01155661|453265191|FG000|Overall Study|Physician Decision|3|||
125992698|NCT01155661|453265191|FG000|Overall Study|Protocol Violation|35|||
125992699|NCT01155661|453265191|FG000|Overall Study|Withdrawal by Subject|73|||
125992700|NCT01155661|453265191|FG000|Overall Study|Sponsor Decision|13|||
125992701|NCT01370005|453265192|FG000|Overall Study|Not treated|1|||
125992702|NCT01370005|453265193|FG001|Overall Study|Not treated|0|||
125992703|NCT01370005|453265194|FG002|Overall Study|Not treated|0|||
125992704|NCT01370005|453265192|FG000|Overall Study|Adverse Event|5|||
125992705|NCT01370005|453265193|FG001|Overall Study|Adverse Event|5|||
125992706|NCT01370005|453265194|FG002|Overall Study|Adverse Event|6|||
125992707|NCT01370005|453265192|FG000|Overall Study|Lack of Efficacy|1|||
125992708|NCT01370005|453265193|FG001|Overall Study|Lack of Efficacy|0|||
125992709|NCT01370005|453265194|FG002|Overall Study|Lack of Efficacy|0|||
125992710|NCT01370005|453265192|FG000|Overall Study|Non compliant with protocol|0|||
125992711|NCT01370005|453265193|FG001|Overall Study|Non compliant with protocol|1|||
125992712|NCT01370005|453265194|FG002|Overall Study|Non compliant with protocol|2|||
125992713|NCT01370005|453265192|FG000|Overall Study|Lost to Follow-up|1|||
125992714|NCT01370005|453265193|FG001|Overall Study|Lost to Follow-up|1|||
125992715|NCT01370005|453265194|FG002|Overall Study|Lost to Follow-up|1|||
125992716|NCT01370005|453265192|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
125992717|NCT01370005|453265193|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
125992718|NCT01370005|453265194|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
125992719|NCT01370005|453265192|FG000|Overall Study|Other reason not defined above|3|||
125992720|NCT01370005|453265193|FG001|Overall Study|Other reason not defined above|0|||
125992721|NCT01370005|453265194|FG002|Overall Study|Other reason not defined above|2|||
125992722|NCT01871558|453265204|FG000|Overall Study|Other reason|0|||
125992723|NCT01871558|453265205|FG001|Overall Study|Other reason|1|||
125992724|NCT01871558|453265204|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
125992725|NCT01871558|453265205|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
125992726|NCT01871558|453265204|FG000|Overall Study|Withdrawal by Subject|2|||
125992727|NCT01871558|453265205|FG001|Overall Study|Withdrawal by Subject|0|||
125992728|NCT02401308|453265206|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
125992729|NCT02401308|453265207|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
125992730|NCT02736968|453265208|FG000|Overall Study|Lost to Follow-up|0|||
125992731|NCT02736968|453265209|FG001|Overall Study|Lost to Follow-up|0|||
125992732|NCT02736968|453265210|FG002|Overall Study|Lost to Follow-up|0|||
125992733|NCT02736968|453265211|FG003|Overall Study|Lost to Follow-up|0|||
125992734|NCT02736968|453265212|FG004|Overall Study|Lost to Follow-up|0|||
125992735|NCT02736968|453265213|FG005|Overall Study|Lost to Follow-up|0|||
125992736|NCT02736968|453265214|FG006|Overall Study|Lost to Follow-up|5|||
125992737|NCT02736968|453265215|FG007|Overall Study|Lost to Follow-up|2|||
125992738|NCT02736968|453265208|FG000|Overall Study|COVID-19 Pandemic|0|||
125992739|NCT02736968|453265209|FG001|Overall Study|COVID-19 Pandemic|0|||
125992740|NCT02736968|453265210|FG002|Overall Study|COVID-19 Pandemic|0|||
125992741|NCT02736968|453265211|FG003|Overall Study|COVID-19 Pandemic|0|||
125992742|NCT02736968|453265212|FG004|Overall Study|COVID-19 Pandemic|0|||
125992743|NCT02736968|453265213|FG005|Overall Study|COVID-19 Pandemic|0|||
125992744|NCT02736968|453265214|FG006|Overall Study|COVID-19 Pandemic|2|||
125992745|NCT02736968|453265215|FG007|Overall Study|COVID-19 Pandemic|0|||
125992746|NCT02736968|453265208|FG000|Overall Study|Withdrawal by Subject|0|||
125992747|NCT02736968|453265209|FG001|Overall Study|Withdrawal by Subject|0|||
125992748|NCT02736968|453265210|FG002|Overall Study|Withdrawal by Subject|0|||
125992749|NCT02736968|453265211|FG003|Overall Study|Withdrawal by Subject|0|||
125992750|NCT02736968|453265212|FG004|Overall Study|Withdrawal by Subject|0|||
125992751|NCT02736968|453265213|FG005|Overall Study|Withdrawal by Subject|0|||
125992752|NCT02736968|453265214|FG006|Overall Study|Withdrawal by Subject|1|||
125992753|NCT02736968|453265215|FG007|Overall Study|Withdrawal by Subject|0|||
125992754|NCT00147225|453265216|FG000|Overall Study|Withdrawal by Subject|1|||
125992755|NCT00147225|453265217|FG001|Overall Study|Withdrawal by Subject|0|||
125992756|NCT00147225|453265218|FG002|Overall Study|Withdrawal by Subject|1|||
125992757|NCT00147225|453265219|FG003|Overall Study|Withdrawal by Subject|0|||
125992758|NCT00147225|453265220|FG004|Overall Study|Withdrawal by Subject|0|||
125992759|NCT00147225|453265221|FG005|Overall Study|Withdrawal by Subject|1|||
125992760|NCT00147225|453265216|FG000|Overall Study|Adverse Event|0|||
125992761|NCT00147225|453265217|FG001|Overall Study|Adverse Event|0|||
125992762|NCT00147225|453265218|FG002|Overall Study|Adverse Event|1|||
125992763|NCT00147225|453265219|FG003|Overall Study|Adverse Event|1|||
125992764|NCT00147225|453265220|FG004|Overall Study|Adverse Event|0|||
125992765|NCT00147225|453265221|FG005|Overall Study|Adverse Event|0|||
125992766|NCT00147225|453265216|FG000|Overall Study|Screen Failure|0|||
125992767|NCT00147225|453265217|FG001|Overall Study|Screen Failure|0|||
126330547|NCT00103285|454505072|FG005|Response Assignment|Withdrawal by Subject|2|||
125992768|NCT00147225|453265218|FG002|Overall Study|Screen Failure|0|||
125992769|NCT00147225|453265219|FG003|Overall Study|Screen Failure|0|||
125992770|NCT00147225|453265220|FG004|Overall Study|Screen Failure|1|||
125992771|NCT00147225|453265221|FG005|Overall Study|Screen Failure|0|||
125992772|NCT00147225|453265216|FG000|Overall Study|Chemotherapy Changed|0|||
125992773|NCT00147225|453265217|FG001|Overall Study|Chemotherapy Changed|0|||
125992774|NCT00147225|453265218|FG002|Overall Study|Chemotherapy Changed|0|||
125992775|NCT00147225|453265219|FG003|Overall Study|Chemotherapy Changed|0|||
125992776|NCT00147225|453265220|FG004|Overall Study|Chemotherapy Changed|0|||
125992777|NCT00147225|453265221|FG005|Overall Study|Chemotherapy Changed|1|||
125992778|NCT02998021|453265222|FG000|Overall Study|Withdrawal by Subject|3|||
125992779|NCT02998021|453265223|FG001|Overall Study|Withdrawal by Subject|1|||
125992780|NCT02998021|453265222|FG000|Overall Study|unsafe home|0|||
125992781|NCT02998021|453265223|FG001|Overall Study|unsafe home|1|||
126330548|NCT00103285|454505073|FG006|Response Assignment|Withdrawal by Subject|0|||
125992782|NCT02041923|453265226|FG000|Overall Study|Lost to Follow-up|26|||
125992783|NCT02041923|453265227|FG001|Overall Study|Lost to Follow-up|30|||
125992784|NCT01734434|453265228|FG000|Overall Study|Death Infant|3|||
125992785|NCT01734434|453265229|FG001|Overall Study|Death Infant|1|||
125992786|NCT01734434|453265230|FG002|Overall Study|Death Infant|17|||
125992787|NCT01734434|453265231|FG003|Overall Study|Death Infant|5|||
126330549|NCT00103285|454505074|FG007|Response Assignment|Withdrawal by Subject|2|||
126330550|NCT00103285|454505067|FG000|Response Assignment|Ineligible|0|||
126330551|NCT00103285|454505068|FG001|Response Assignment|Ineligible|8|||
126330552|NCT00103285|454505069|FG002|Response Assignment|Ineligible|6|||
126330553|NCT00103285|454505070|FG003|Response Assignment|Ineligible|2|||
126330554|NCT00103285|454505071|FG004|Response Assignment|Ineligible|0|||
126330555|NCT00103285|454505072|FG005|Response Assignment|Ineligible|3|||
126330556|NCT00103285|454505073|FG006|Response Assignment|Ineligible|1|||
126330557|NCT00103285|454505074|FG007|Response Assignment|Ineligible|5|||
126330558|NCT00103285|454505067|FG000|Response Assignment|Refusal|0|||
126330559|NCT00103285|454505068|FG001|Response Assignment|Refusal|53|||
126330560|NCT00103285|454505069|FG002|Response Assignment|Refusal|5|||
126330561|NCT00103285|454505070|FG003|Response Assignment|Refusal|3|||
126330562|NCT00103285|454505071|FG004|Response Assignment|Refusal|25|||
126330563|NCT00103285|454505072|FG005|Response Assignment|Refusal|15|||
126330564|NCT00103285|454505073|FG006|Response Assignment|Refusal|30|||
126330565|NCT00103285|454505074|FG007|Response Assignment|Refusal|10|||
126330566|NCT00103285|454505067|FG000|Response Assignment|Other|0|||
126330567|NCT00103285|454505068|FG001|Response Assignment|Other|30|||
126330568|NCT00103285|454505069|FG002|Response Assignment|Other|48|||
126330569|NCT00103285|454505070|FG003|Response Assignment|Other|38|||
126330570|NCT00103285|454505071|FG004|Response Assignment|Other|37|||
126330571|NCT00103285|454505072|FG005|Response Assignment|Other|17|||
126330572|NCT00103285|454505073|FG006|Response Assignment|Other|11|||
126330573|NCT00103285|454505074|FG007|Response Assignment|Other|53|||
126330574|NCT01381926|454505078|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
126330575|NCT01381926|454505079|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
126330576|NCT01381926|454505078|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
126330577|NCT01381926|454505079|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
126330578|NCT02624947|454505080|FG000|Maternal Participants|Adverse Event|5|||
126330579|NCT02624947|454505081|FG001|Maternal Participants|Adverse Event|0|||
126330580|NCT02624947|454505080|FG000|Maternal Participants|Investigator Decision|5|||
126330581|NCT02624947|454505081|FG001|Maternal Participants|Investigator Decision|3|||
126330582|NCT02624947|454505080|FG000|Maternal Participants|Lost to Follow-up|54|||
126330583|NCT02624947|454505081|FG001|Maternal Participants|Lost to Follow-up|24|||
126330584|NCT02624947|454505080|FG000|Maternal Participants|Non Compliance|8|||
126330585|NCT02624947|454505081|FG001|Maternal Participants|Non Compliance|5|||
126330586|NCT02624947|454505080|FG000|Maternal Participants|Sponsor Request|1|||
126330587|NCT02624947|454505081|FG001|Maternal Participants|Sponsor Request|1|||
126330588|NCT02624947|454505080|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
126330589|NCT02624947|454505081|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
126330590|NCT02624947|454505080|FG000|Maternal Participants|Miscellaneous|23|||
126330591|NCT02624947|454505081|FG001|Maternal Participants|Miscellaneous|15|||
126330592|NCT02624947|454505080|FG000|Infant Participants|Adverse Event|18|||
126330593|NCT02624947|454505081|FG001|Infant Participants|Adverse Event|11|||
126330594|NCT02624947|454505080|FG000|Infant Participants|Investigator Decision|5|||
126330595|NCT02624947|454505081|FG001|Infant Participants|Investigator Decision|4|||
126330596|NCT02624947|454505080|FG000|Infant Participants|Lost to Follow-up|93|||
126330597|NCT02624947|454505081|FG001|Infant Participants|Lost to Follow-up|58|||
126330598|NCT02624947|454505080|FG000|Infant Participants|Non Compliance|17|||
126330599|NCT02624947|454505081|FG001|Infant Participants|Non Compliance|7|||
126330600|NCT02624947|454505080|FG000|Infant Participants|Sponsor Request|0|||
126330601|NCT02624947|454505081|FG001|Infant Participants|Sponsor Request|1|||
125992788|NCT01734434|453265228|FG000|Overall Study|Lost to Follow-up|2|||
125992789|NCT01734434|453265229|FG001|Overall Study|Lost to Follow-up|9|||
125992790|NCT01734434|453265230|FG002|Overall Study|Lost to Follow-up|67|||
126330602|NCT02624947|454505080|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
126330603|NCT02624947|454505081|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
126330604|NCT02624947|454505080|FG000|Infant Participants|Miscellaneous|50|||
126330605|NCT02624947|454505081|FG001|Infant Participants|Miscellaneous|26|||
126330606|NCT01971567|454505090|FG000|Overall Study|Withdrawal by Subject|3|||
126330607|NCT01971567|454505091|FG001|Overall Study|Withdrawal by Subject|2|||
126330608|NCT01971567|454505090|FG000|Overall Study|Lost to Follow-up|1|||
126330609|NCT01971567|454505091|FG001|Overall Study|Lost to Follow-up|0|||
126330610|NCT01409915|454505092|FG000|Overall Study|Adverse Event|0|||
126330611|NCT01409915|454505093|FG001|Overall Study|Adverse Event|2|||
126330612|NCT01409915|454505092|FG000|Overall Study|Withdrawal by Subject|0|||
126330613|NCT01409915|454505093|FG001|Overall Study|Withdrawal by Subject|1|||
126330614|NCT01409915|454505092|FG000|Overall Study|Protocol Violation|1|||
125992791|NCT01734434|453265231|FG003|Overall Study|Lost to Follow-up|11|||
125992792|NCT01734434|453265228|FG000|Overall Study|No Live Birth|1|||
125992793|NCT01734434|453265229|FG001|Overall Study|No Live Birth|2|||
125992794|NCT01734434|453265230|FG002|Overall Study|No Live Birth|32|||
125992795|NCT01734434|453265231|FG003|Overall Study|No Live Birth|6|||
125992796|NCT01734434|453265228|FG000|Overall Study|Withdrawal by Subject|4|||
125992797|NCT01734434|453265229|FG001|Overall Study|Withdrawal by Subject|0|||
125992798|NCT01734434|453265230|FG002|Overall Study|Withdrawal by Subject|8|||
125992799|NCT01734434|453265231|FG003|Overall Study|Withdrawal by Subject|1|||
125992800|NCT01734434|453265228|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
125992801|NCT01734434|453265229|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
125992802|NCT01734434|453265230|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
125992803|NCT01734434|453265231|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
125992804|NCT01734434|453265228|FG000|Overall Study|Subject Not Reachable|0|||
125992805|NCT01734434|453265229|FG001|Overall Study|Subject Not Reachable|0|||
125992806|NCT01734434|453265230|FG002|Overall Study|Subject Not Reachable|1|||
125992807|NCT01734434|453265231|FG003|Overall Study|Subject Not Reachable|0|||
125992808|NCT01734434|453265228|FG000|Overall Study|Treatment Defaulter|0|||
125992809|NCT01734434|453265229|FG001|Overall Study|Treatment Defaulter|0|||
125992810|NCT01734434|453265230|FG002|Overall Study|Treatment Defaulter|1|||
125992811|NCT01734434|453265231|FG003|Overall Study|Treatment Defaulter|0|||
125992812|NCT01734434|453265228|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
125992813|NCT01734434|453265229|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
125992814|NCT01734434|453265230|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
125992815|NCT01734434|453265231|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
125992816|NCT01734434|453265228|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
125992817|NCT01734434|453265229|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
125992818|NCT01734434|453265230|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
125992819|NCT01734434|453265231|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
125992820|NCT02049710|453265232|FG000|Overall Study|Lost to Follow-up|319|||
125992821|NCT02049710|453265233|FG001|Overall Study|Lost to Follow-up|324|||
125992822|NCT00874432|453265237|FG000|Overall Study|Withdrawal by Subject|1|||
125992823|NCT00874432|453265238|FG001|Overall Study|Withdrawal by Subject|0|||
125992824|NCT00874432|453265239|FG002|Overall Study|Withdrawal by Subject|0|||
125992825|NCT00874432|453265240|FG003|Overall Study|Withdrawal by Subject|0|||
125992826|NCT00874432|453265237|FG000|Overall Study|Physician Decision|1|||
125992827|NCT00874432|453265238|FG001|Overall Study|Physician Decision|0|||
125992828|NCT00874432|453265239|FG002|Overall Study|Physician Decision|0|||
125992829|NCT00874432|453265240|FG003|Overall Study|Physician Decision|0|||
125992830|NCT00874432|453265237|FG000|Overall Study|Other|1|||
125992831|NCT00874432|453265238|FG001|Overall Study|Other|2|||
125992832|NCT00874432|453265239|FG002|Overall Study|Other|8|||
125992833|NCT00874432|453265240|FG003|Overall Study|Other|3|||
125992834|NCT03713021|453265241|FG000|Overall Study|Did not have CT sim scan available|6|||
125992835|NCT03713021|453265241|FG000|Overall Study|Not eligible|4|||
125992836|NCT03713021|453265241|FG000|Overall Study|Issues with TraceIT markers|5|||
125992837|NCT03391960|453265247|FG000|Overall Study|Protocol Violation|0|||
126330615|NCT01409915|454505093|FG001|Overall Study|Protocol Violation|0|||
126330616|NCT04826484|454505094|FG000|Overall Study|Lost to Follow-up|2|||
126330617|NCT04826484|454505095|FG001|Overall Study|Lost to Follow-up|0|||
126330618|NCT02250300|454505097|FG000|Expansion Phase|Death|6|||
126330619|NCT02250300|454505098|FG001|Expansion Phase|Death|7|||
126330620|NCT02250300|454505099|FG002|Expansion Phase|Death|0|||
126330621|NCT02250300|454505100|FG003|Expansion Phase|Death|0|||
126330622|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
126330623|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
126330624|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
125992838|NCT03391960|453265248|FG001|Overall Study|Protocol Violation|0|||
125992839|NCT01167179|453266731|FG000|Overall Study|disease recurrence|4|||
125992840|NCT01167179|453266732|FG001|Overall Study|disease recurrence|4|||
125992841|NCT01167179|453266731|FG000|Overall Study|Death|4|||
125992842|NCT01167179|453266732|FG001|Overall Study|Death|10|||
125992843|NCT01167179|453266731|FG000|Overall Study|Withdrawal by Subject|1|||
125992844|NCT01167179|453266732|FG001|Overall Study|Withdrawal by Subject|2|||
125992845|NCT01167179|453266731|FG000|Overall Study|diverse|6|||
125992846|NCT01167179|453266732|FG001|Overall Study|diverse|5|||
125992847|NCT01158378|453266733|FG000|Overall Study|Death|4|||
125992848|NCT01158378|453266734|FG001|Overall Study|Death|5|||
125992849|NCT01158378|453266733|FG000|Overall Study|Lost to Follow-up|2|||
125992850|NCT01158378|453266734|FG001|Overall Study|Lost to Follow-up|4|||
125992851|NCT01158378|453266733|FG000|Overall Study|Withdrawal by Subject|4|||
125992852|NCT01158378|453266734|FG001|Overall Study|Withdrawal by Subject|0|||
125992853|NCT03017235|453266735|FG000|Overall Study|Withdrawal by Subject|4|||
125992854|NCT03017235|453266736|FG001|Overall Study|Withdrawal by Subject|3|||
125992855|NCT03017235|453266735|FG000|Overall Study|Lost to Follow-up|2|||
125992856|NCT03017235|453266736|FG001|Overall Study|Lost to Follow-up|7|||
125992857|NCT03017235|453266735|FG000|Overall Study|Adverse Event|0|||
125992858|NCT03017235|453266736|FG001|Overall Study|Adverse Event|1|||
125992859|NCT03017235|453266735|FG000|Overall Study|Protocol Violation|2|||
125992860|NCT03017235|453266736|FG001|Overall Study|Protocol Violation|1|||
125992861|NCT03017235|453266735|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
125992862|NCT03017235|453266736|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
125992863|NCT02593539|453266740|FG000|Overall Study|Adverse Event|1|||
125992864|NCT01282476|453266741|FG000|Overall Study|Death|11|||
125992865|NCT00437125|453266742|FG000|Overall Study|Adverse Event|12|||
125992866|NCT00437125|453266742|FG000|Overall Study|Death|1|||
125992867|NCT00437125|453266742|FG000|Overall Study|Clinical Relapse|1|||
125992868|NCT00437125|453266742|FG000|Overall Study|Lack of Efficacy|1|||
125992869|NCT00437125|453266742|FG000|Overall Study|Lost to Follow-up|1|||
125992870|NCT00437125|453266742|FG000|Overall Study|Withdrawal by Subject|13|||
125992871|NCT00437125|453266742|FG000|Overall Study|Withdrawal by Caregiver|2|||
125992872|NCT00437125|453266742|FG000|Overall Study|Physician Decision|1|||
125992873|NCT02248961|453266745|FG000|Overall Study|Adverse Event|1|||
125992874|NCT02248961|453266746|FG001|Overall Study|Adverse Event|0|||
125992875|NCT02248961|453266745|FG000|Overall Study|Withdrawal by Subject|1|||
125992876|NCT02248961|453266746|FG001|Overall Study|Withdrawal by Subject|2|||
125992877|NCT02248961|453266745|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
125992878|NCT02248961|453266746|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
125992879|NCT03518658|453266749|FG000|Overall Study|Other|51|||
125992880|NCT03518658|453266750|FG001|Overall Study|Other|0|||
125992881|NCT00453310|453266755|FG000|Overall Study|Progression of Disease|10|||
125992882|NCT01267825|453266756|FG000|Overall Study|study terminated. no data collected.|1|||
125992883|NCT01267825|453266757|FG001|Overall Study|study terminated. no data collected.|0|||
125992884|NCT02105636|453266766|FG000|Pre-Treatment|Disease Progression|1|||
125992885|NCT02105636|453266767|FG001|Pre-Treatment|Disease Progression|0|||
125992886|NCT02105636|453266766|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
125992887|NCT02105636|453266767|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
125992888|NCT02105636|453266766|FG000|Pre-Treatment|Participant withdrew consent|0|||
125992889|NCT02105636|453266767|FG001|Pre-Treatment|Participant withdrew consent|6|||
125992890|NCT02105636|453266766|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125992891|NCT02105636|453266767|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
125992892|NCT02105636|453266766|FG000|Treatment|Study Drug Toxicity|14|||
125992893|NCT02105636|453266767|FG001|Treatment|Study Drug Toxicity|10|||
125992894|NCT02105636|453266766|FG000|Treatment|Adverse event unrelated to study drug|19|||
125992895|NCT02105636|453266767|FG001|Treatment|Adverse event unrelated to study drug|3|||
125992896|NCT02105636|453266766|FG000|Treatment|Participant request to discontinue study treatment|8|||
125992897|NCT02105636|453266767|FG001|Treatment|Participant request to discontinue study treatment|6|||
125992898|NCT02105636|453266766|FG000|Treatment|Participant withdrew consent|5|||
125992899|NCT02105636|453266767|FG001|Treatment|Participant withdrew consent|1|||
125992900|NCT02105636|453266766|FG000|Treatment|Lost to Follow-up|1|||
125992901|NCT02105636|453266767|FG001|Treatment|Lost to Follow-up|0|||
125992902|NCT02105636|453266766|FG000|Treatment|Maximum Clinical Benefit|1|||
125992903|NCT02105636|453266767|FG001|Treatment|Maximum Clinical Benefit|3|||
125992904|NCT02105636|453266766|FG000|Treatment|Poor/Non-compliance|0|||
125992905|NCT02105636|453266767|FG001|Treatment|Poor/Non-compliance|1|||
125992906|NCT02105636|453266766|FG000|Treatment|Participant no longer meets study criteria|1|||
125992907|NCT02105636|453266767|FG001|Treatment|Participant no longer meets study criteria|0|||
125992908|NCT02105636|453266766|FG000|Treatment|Other reasons|1|||
125992909|NCT02105636|453266767|FG001|Treatment|Other reasons|0|||
125992910|NCT02105636|453266766|FG000|Treatment|Disease Progression|185|||
125992911|NCT02105636|453266767|FG001|Treatment|Disease Progression|87|||
125992912|NCT00871351|453266768|FG000|Overall Study|Withdrawal by Subject|1|||
125992913|NCT00871351|453266769|FG001|Overall Study|Withdrawal by Subject|0|||
125992914|NCT00871351|453266770|FG002|Overall Study|Withdrawal by Subject|0|||
125992915|NCT00871351|453266768|FG000|Overall Study|Adverse Event|3|||
125992916|NCT00871351|453266769|FG001|Overall Study|Adverse Event|1|||
125992917|NCT00871351|453266770|FG002|Overall Study|Adverse Event|0|||
125992918|NCT02791490|453266772|FG000|Overall Study|Lost to Follow-up|1|||
125992919|NCT02791490|453266773|FG001|Overall Study|Lost to Follow-up|2|||
126330625|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
126330626|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
126330627|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
126330628|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
126330629|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
126330630|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
125992920|NCT02791490|453266772|FG000|Overall Study|Withdrawal by Subject|2|||
125992921|NCT02791490|453266773|FG001|Overall Study|Withdrawal by Subject|6|||
125992922|NCT01984424|453266774|FG000|Overall Study|Withdrawal by Subject|3|||
125992923|NCT01984424|453266775|FG001|Overall Study|Withdrawal by Subject|5|||
125992924|NCT01984424|453266774|FG000|Overall Study|Sponsor Decision|0|||
125992925|NCT01984424|453266775|FG001|Overall Study|Sponsor Decision|1|||
125992926|NCT01984424|453266774|FG000|Overall Study|Lost to Follow-up|0|||
125992927|NCT01984424|453266775|FG001|Overall Study|Lost to Follow-up|1|||
125992928|NCT00077636|453266777|FG000|Overall Study|Refused Treatment|9|||
125992929|NCT00077636|453266778|FG001|Overall Study|Refused Treatment|31|||
125992930|NCT00077636|453266777|FG000|Overall Study|Admin|3|||
125992931|NCT00077636|453266778|FG001|Overall Study|Admin|3|||
125992932|NCT00077636|453266777|FG000|Overall Study|Withdrawal by Subject|2|||
126330631|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
126330632|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
126330633|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
126330634|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
126330635|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
125992933|NCT00077636|453266778|FG001|Overall Study|Withdrawal by Subject|2|||
125992934|NCT00077636|453266777|FG000|Overall Study|Adverse Event|17|||
125992935|NCT00077636|453266778|FG001|Overall Study|Adverse Event|34|||
125992936|NCT00077636|453266777|FG000|Overall Study|Protocol Violation|0|||
125992937|NCT00077636|453266778|FG001|Overall Study|Protocol Violation|2|||
125992938|NCT00077636|453266777|FG000|Overall Study|Lost to Follow-up|10|||
125992939|NCT00077636|453266778|FG001|Overall Study|Lost to Follow-up|18|||
125992940|NCT00077636|453266777|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
125992941|NCT00077636|453266778|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
125992942|NCT02032173|453266779|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
125992943|NCT01993017|453266782|FG000|Overall Study|Death|23|||
125992944|NCT01993017|453266783|FG001|Overall Study|Death|26|||
125992945|NCT01993017|453266784|FG002|Overall Study|Death|18|||
125992946|NCT01993017|453266782|FG000|Overall Study|Could not be contacted|43|||
125992947|NCT01993017|453266783|FG001|Overall Study|Could not be contacted|42|||
125992948|NCT01993017|453266784|FG002|Overall Study|Could not be contacted|38|||
125992949|NCT01993017|453266782|FG000|Overall Study|Dropped out|19|||
125992950|NCT01993017|453266783|FG001|Overall Study|Dropped out|6|||
125992951|NCT01993017|453266784|FG002|Overall Study|Dropped out|11|||
125992952|NCT01993017|453266782|FG000|Overall Study|Other reasons|17|||
125992953|NCT01993017|453266783|FG001|Overall Study|Other reasons|11|||
125992954|NCT01993017|453266784|FG002|Overall Study|Other reasons|7|||
125992955|NCT01993017|453266782|FG000|Overall Study|Ineligible after randomization|4|||
125992956|NCT01993017|453266783|FG001|Overall Study|Ineligible after randomization|5|||
125992957|NCT01993017|453266784|FG002|Overall Study|Ineligible after randomization|5|||
125992958|NCT00917267|453266786|FG000|Overall Study|Adverse Event|15|||
125992959|NCT00917267|453266787|FG001|Overall Study|Adverse Event|36|||
125992960|NCT00917267|453266786|FG000|Overall Study|Physician Decision|2|||
125992961|NCT00917267|453266787|FG001|Overall Study|Physician Decision|4|||
125992962|NCT00917267|453266786|FG000|Overall Study|Protocol Violation|9|||
125992963|NCT00917267|453266787|FG001|Overall Study|Protocol Violation|18|||
125992964|NCT00917267|453266786|FG000|Overall Study|Withdrawal by Subject|5|||
125992965|NCT00917267|453266787|FG001|Overall Study|Withdrawal by Subject|12|||
125992966|NCT00917267|453266786|FG000|Overall Study|Lost to follow up|0|||
125992967|NCT00917267|453266787|FG001|Overall Study|Lost to follow up|2|||
125992968|NCT00917267|453266786|FG000|Overall Study|Entry Criteria Not Met|1|||
125992969|NCT00917267|453266787|FG001|Overall Study|Entry Criteria Not Met|0|||
125992970|NCT00917267|453266786|FG000|Overall Study|Sponsor Decision|5|||
125992971|NCT00917267|453266787|FG001|Overall Study|Sponsor Decision|5|||
125992972|NCT00917267|453266786|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
125992973|NCT00917267|453266787|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
125992974|NCT02960763|453266788|FG000|Step 1|Withdrawal by Subject|10|||
125992975|NCT02960763|453266789|FG001|Step 1|Withdrawal by Subject|8|||
125992976|NCT02960763|453266790|FG002|Step 1|Withdrawal by Subject|13|||
125992977|NCT02960763|453266791|FG003|Step 1|Withdrawal by Subject|0|||
125992978|NCT02960763|453266792|FG004|Step 1|Withdrawal by Subject|0|||
125992979|NCT02960763|453266788|FG000|Step 1|Lost to Follow-up|7|||
125992980|NCT02960763|453266789|FG001|Step 1|Lost to Follow-up|9|||
125992981|NCT02960763|453266790|FG002|Step 1|Lost to Follow-up|12|||
125992982|NCT02960763|453266791|FG003|Step 1|Lost to Follow-up|0|||
125992983|NCT02960763|453266792|FG004|Step 1|Lost to Follow-up|0|||
125992984|NCT02960763|453266788|FG000|Step 1|Death|1|||
125992985|NCT02960763|453266789|FG001|Step 1|Death|1|||
125992986|NCT02960763|453266790|FG002|Step 1|Death|1|||
125992987|NCT02960763|453266791|FG003|Step 1|Death|0|||
125992988|NCT02960763|453266792|FG004|Step 1|Death|0|||
125992989|NCT02960763|453266788|FG000|Step 1|Investigator discretion|1|||
125992990|NCT02960763|453266789|FG001|Step 1|Investigator discretion|0|||
125992991|NCT02960763|453266790|FG002|Step 1|Investigator discretion|1|||
125992992|NCT02960763|453266791|FG003|Step 1|Investigator discretion|0|||
125992993|NCT02960763|453266792|FG004|Step 1|Investigator discretion|0|||
125992994|NCT02960763|453266788|FG000|Step 1|Other|0|||
125992995|NCT02960763|453266789|FG001|Step 1|Other|0|||
125992996|NCT02960763|453266790|FG002|Step 1|Other|1|||
125992997|NCT02960763|453266791|FG003|Step 1|Other|0|||
125992998|NCT02960763|453266792|FG004|Step 1|Other|0|||
125992999|NCT02960763|453266788|FG000|Step 2|Withdrawal by Subject|0|||
125993000|NCT02960763|453266789|FG001|Step 2|Withdrawal by Subject|0|||
125993001|NCT02960763|453266790|FG002|Step 2|Withdrawal by Subject|0|||
125993002|NCT02960763|453266791|FG003|Step 2|Withdrawal by Subject|7|||
125993003|NCT02960763|453266792|FG004|Step 2|Withdrawal by Subject|3|||
125993004|NCT02960763|453266788|FG000|Step 2|Lost to Follow-up|0|||
125993005|NCT02960763|453266789|FG001|Step 2|Lost to Follow-up|0|||
125993006|NCT02960763|453266790|FG002|Step 2|Lost to Follow-up|0|||
125993007|NCT02960763|453266791|FG003|Step 2|Lost to Follow-up|4|||
125993008|NCT02960763|453266792|FG004|Step 2|Lost to Follow-up|1|||
125993009|NCT02960763|453266788|FG000|Step 2|Investigator discretion|0|||
125993010|NCT02960763|453266789|FG001|Step 2|Investigator discretion|0|||
125993011|NCT02960763|453266790|FG002|Step 2|Investigator discretion|0|||
126330636|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
126330637|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
126330638|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
125993012|NCT02960763|453266791|FG003|Step 2|Investigator discretion|0|||
125993013|NCT02960763|453266792|FG004|Step 2|Investigator discretion|1|||
125993014|NCT00312858|453266796|FG000|Overall Study|Adverse Event|0|||
125993015|NCT00312858|453266797|FG001|Overall Study|Adverse Event|1|||
125993016|NCT00312858|453266796|FG000|Overall Study|Lost to Follow-up|25|||
125993017|NCT00312858|453266797|FG001|Overall Study|Lost to Follow-up|42|||
125993018|NCT00312858|453266796|FG000|Overall Study|Protocol Violation|3|||
125993019|NCT00312858|453266797|FG001|Overall Study|Protocol Violation|8|||
125993020|NCT00312858|453266796|FG000|Overall Study|Withdraw by Participant|20|||
125993021|NCT00312858|453266797|FG001|Overall Study|Withdraw by Participant|20|||
125993022|NCT00312858|453266796|FG000|Overall Study|Participant Moved|11|||
125993023|NCT00312858|453266797|FG001|Overall Study|Participant Moved|10|||
125993024|NCT00312858|453266796|FG000|Overall Study|Other|9|||
125993025|NCT00312858|453266797|FG001|Overall Study|Other|12|||
125993026|NCT02318719|453266798|FG000|Double-blind Phase|Adverse Event|7|||
125993027|NCT02318719|453266799|FG001|Double-blind Phase|Adverse Event|6|||
125993028|NCT02318719|453266800|FG002|Double-blind Phase|Adverse Event|12|||
125993029|NCT02318719|453266801|FG003|Double-blind Phase|Adverse Event|4|||
125993030|NCT02318719|453266802|FG004|Double-blind Phase|Adverse Event|0|||
125993031|NCT02318719|453266798|FG000|Double-blind Phase|Lack of Efficacy|5|||
125993032|NCT02318719|453266799|FG001|Double-blind Phase|Lack of Efficacy|0|||
125993033|NCT02318719|453266800|FG002|Double-blind Phase|Lack of Efficacy|1|||
125993034|NCT02318719|453266801|FG003|Double-blind Phase|Lack of Efficacy|1|||
125993035|NCT02318719|453266802|FG004|Double-blind Phase|Lack of Efficacy|0|||
125993036|NCT02318719|453266798|FG000|Double-blind Phase|Protocol Violation|0|||
125993037|NCT02318719|453266799|FG001|Double-blind Phase|Protocol Violation|1|||
125993038|NCT02318719|453266800|FG002|Double-blind Phase|Protocol Violation|3|||
125993039|NCT02318719|453266801|FG003|Double-blind Phase|Protocol Violation|0|||
125993040|NCT02318719|453266802|FG004|Double-blind Phase|Protocol Violation|0|||
125993041|NCT02318719|453266798|FG000|Double-blind Phase|Withdrawal by Subject|25|||
125993042|NCT02318719|453266799|FG001|Double-blind Phase|Withdrawal by Subject|7|||
125993043|NCT02318719|453266800|FG002|Double-blind Phase|Withdrawal by Subject|9|||
125993044|NCT02318719|453266801|FG003|Double-blind Phase|Withdrawal by Subject|10|||
125993045|NCT02318719|453266802|FG004|Double-blind Phase|Withdrawal by Subject|0|||
126330639|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
126330640|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Other|1|||
126330641|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Other|0|||
126330642|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Other|1|||
126330643|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
125993046|NCT02318719|453266798|FG000|Double-blind Phase|Other|1|||
125993047|NCT02318719|453266799|FG001|Double-blind Phase|Other|2|||
125993048|NCT02318719|453266800|FG002|Double-blind Phase|Other|0|||
125993049|NCT02318719|453266801|FG003|Double-blind Phase|Other|0|||
125993050|NCT02318719|453266802|FG004|Double-blind Phase|Other|0|||
125993051|NCT02318719|453266798|FG000|Open-label Extension Phase|Adverse Event|0|||
125993052|NCT02318719|453266799|FG001|Open-label Extension Phase|Adverse Event|0|||
125993053|NCT02318719|453266800|FG002|Open-label Extension Phase|Adverse Event|0|||
125993054|NCT02318719|453266801|FG003|Open-label Extension Phase|Adverse Event|0|||
125993055|NCT02318719|453266802|FG004|Open-label Extension Phase|Adverse Event|15|||
125993056|NCT02318719|453266798|FG000|Open-label Extension Phase|Death|0|||
125993057|NCT02318719|453266799|FG001|Open-label Extension Phase|Death|0|||
126330644|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
125993058|NCT02318719|453266800|FG002|Open-label Extension Phase|Death|0|||
125993059|NCT02318719|453266801|FG003|Open-label Extension Phase|Death|0|||
125993060|NCT02318719|453266802|FG004|Open-label Extension Phase|Death|1|||
125993061|NCT02318719|453266798|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
125993062|NCT02318719|453266799|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
125993063|NCT02318719|453266800|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
125993064|NCT02318719|453266801|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
125993065|NCT02318719|453266802|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
125993066|NCT02318719|453266798|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
125993067|NCT02318719|453266799|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
125993068|NCT02318719|453266800|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
125993069|NCT02318719|453266801|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
125993070|NCT02318719|453266802|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
125993071|NCT02318719|453266798|FG000|Open-label Extension Phase|Other|0|||
125993072|NCT02318719|453266799|FG001|Open-label Extension Phase|Other|0|||
125993073|NCT02318719|453266800|FG002|Open-label Extension Phase|Other|0|||
125993074|NCT02318719|453266801|FG003|Open-label Extension Phase|Other|0|||
125993075|NCT02318719|453266802|FG004|Open-label Extension Phase|Other|7|||
125993076|NCT01868035|453266803|FG000|Overall Study|Lost to Follow-up|3|||
125993077|NCT01868035|453266803|FG000|Overall Study|Withdrawal by Subject|1|||
125993078|NCT01868035|453266803|FG000|Overall Study|Progressive Disease|2|||
125993079|NCT01868035|453266803|FG000|Overall Study|Non-compliance|1|||
125993080|NCT00432835|453266804|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
125993081|NCT00432835|453266805|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
125993082|NCT00802659|453266806|FG000|Overall Study|Physician Decision|0|||
125993083|NCT00802659|453266807|FG001|Overall Study|Physician Decision|1|||
125993084|NCT00802659|453266808|FG002|Overall Study|Physician Decision|0|||
125993085|NCT00802659|453266809|FG003|Overall Study|Physician Decision|0|||
125993086|NCT00423293|453266810|FG000|Overall Study|Ineligible / No protocol treatment|11|||
125993087|NCT01912222|453266813|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
125993088|NCT01912222|453266814|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
125993089|NCT01912222|453266815|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
125993090|NCT01912222|453266813|FG000|Part B: Treatment Period|Progressive disease|10|||
125993091|NCT01912222|453266814|FG001|Part B: Treatment Period|Progressive disease|12|||
125993092|NCT01912222|453266815|FG002|Part B: Treatment Period|Progressive disease|15|||
125993093|NCT01912222|453266813|FG000|Part B: Treatment Period|Adverse Event|1|||
125993094|NCT01912222|453266814|FG001|Part B: Treatment Period|Adverse Event|2|||
125993095|NCT01912222|453266815|FG002|Part B: Treatment Period|Adverse Event|3|||
125993096|NCT01912222|453266813|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
125993097|NCT01912222|453266814|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
125993098|NCT01912222|453266815|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
125993099|NCT01014975|453266816|FG000|Overall Study|Withdrawal by Subject|1|||
125993100|NCT01014975|453266817|FG001|Overall Study|Withdrawal by Subject|0|||
125993101|NCT01014975|453266818|FG002|Overall Study|Withdrawal by Subject|1|||
125993102|NCT01014975|453266816|FG000|Overall Study|Death|3|||
125993103|NCT01014975|453266817|FG001|Overall Study|Death|3|||
125993104|NCT01014975|453266818|FG002|Overall Study|Death|4|||
125993105|NCT01014975|453266816|FG000|Overall Study|Lost to Follow-up|0|||
125993106|NCT01014975|453266817|FG001|Overall Study|Lost to Follow-up|0|||
125993107|NCT01014975|453266818|FG002|Overall Study|Lost to Follow-up|1|||
125993108|NCT01336634|453266821|FG000|Overall Study|Study closed/terminated|5|||
125993109|NCT01336634|453266822|FG001|Overall Study|Study closed/terminated|6|||
125993110|NCT01336634|453266823|FG002|Overall Study|Study closed/terminated|6|||
125993111|NCT01336634|453266821|FG000|Overall Study|Lost to Follow-up|2|||
125993112|NCT01336634|453266822|FG001|Overall Study|Lost to Follow-up|1|||
125993113|NCT01336634|453266823|FG002|Overall Study|Lost to Follow-up|1|||
125993114|NCT01336634|453266821|FG000|Overall Study|Physician Decision|1|||
125993115|NCT01336634|453266822|FG001|Overall Study|Physician Decision|1|||
125993116|NCT01336634|453266823|FG002|Overall Study|Physician Decision|0|||
125993117|NCT01336634|453266821|FG000|Overall Study|Withdrawal by Subject|6|||
125993118|NCT01336634|453266822|FG001|Overall Study|Withdrawal by Subject|0|||
125993119|NCT01336634|453266823|FG002|Overall Study|Withdrawal by Subject|2|||
125993120|NCT01863043|453266824|FG000|Overall Study|Death|6|||
125993121|NCT01863043|453266825|FG001|Overall Study|Death|1|||
125993122|NCT01863043|453266824|FG000|Overall Study|Withdrawal by Subject|0|||
125993123|NCT01863043|453266825|FG001|Overall Study|Withdrawal by Subject|2|||
125993124|NCT01863043|453266824|FG000|Overall Study|Adverse Event|7|||
125993125|NCT01863043|453266825|FG001|Overall Study|Adverse Event|8|||
125993126|NCT01863043|453266824|FG000|Overall Study|exclusion criteria found after enrollment|0|||
125993127|NCT01863043|453266825|FG001|Overall Study|exclusion criteria found after enrollment|1|||
125993128|NCT01912781|453266826|FG000|Overall Study|Withdrawal by Subject|2|||
125993129|NCT01912781|453266827|FG001|Overall Study|Withdrawal by Subject|0|||
125993130|NCT00854295|453266828|FG000|Overall Study|Death|7|||
125993131|NCT00854295|453266829|FG001|Overall Study|Death|0|||
125993132|NCT00854295|453266830|FG002|Overall Study|Death|1|||
125993133|NCT00854295|453266831|FG003|Overall Study|Death|1|||
126330645|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
126330646|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
126330647|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
126330648|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
126330649|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
126330650|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
126330651|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
126330652|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
126330653|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
126330654|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
126330655|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
125993134|NCT00854295|453266828|FG000|Overall Study|Adverse Event|6|||
125993135|NCT00854295|453266829|FG001|Overall Study|Adverse Event|1|||
125993136|NCT00854295|453266830|FG002|Overall Study|Adverse Event|1|||
125993137|NCT00854295|453266831|FG003|Overall Study|Adverse Event|3|||
125993138|NCT00854295|453266828|FG000|Overall Study|Lost to Follow-up|18|||
125993139|NCT00854295|453266829|FG001|Overall Study|Lost to Follow-up|5|||
125993140|NCT00854295|453266830|FG002|Overall Study|Lost to Follow-up|21|||
125993141|NCT00854295|453266831|FG003|Overall Study|Lost to Follow-up|21|||
125993142|NCT00854295|453266828|FG000|Overall Study|Physician Decision|10|||
125993143|NCT00854295|453266829|FG001|Overall Study|Physician Decision|0|||
125993144|NCT00854295|453266830|FG002|Overall Study|Physician Decision|0|||
125993145|NCT00854295|453266831|FG003|Overall Study|Physician Decision|0|||
125993146|NCT05033743|453266837|FG000|Overall Study|Lost to Follow-up|1|||
125993147|NCT05033743|453266837|FG000|Overall Study|Protocol Violation|2|||
125993148|NCT05033743|453266837|FG000|Overall Study|Withdrawal by Subject|1|||
125993149|NCT04537897|453266838|FG000|Overall Study|Other than listed|0|||
125993150|NCT04537897|453266839|FG001|Overall Study|Other than listed|0|||
125993151|NCT04537897|453266840|FG002|Overall Study|Other than listed|0|||
125993152|NCT04537897|453266841|FG003|Overall Study|Other than listed|0|||
125993153|NCT04537897|453266842|FG004|Overall Study|Other than listed|0|||
125993154|NCT04537897|453266843|FG005|Overall Study|Other than listed|0|||
125993155|NCT04537897|453266844|FG006|Overall Study|Other than listed|1|||
125993156|NCT04537897|453266845|FG007|Overall Study|Other than listed|0|||
125993157|NCT04537897|453266846|FG008|Overall Study|Other than listed|0|||
125993158|NCT04537897|453266838|FG000|Overall Study|Adverse Event|0|||
125993159|NCT04537897|453266839|FG001|Overall Study|Adverse Event|0|||
125993160|NCT04537897|453266840|FG002|Overall Study|Adverse Event|0|||
126330656|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
126330657|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
126330658|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
126330659|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
126330660|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
126330661|NCT00758498|454505104|FG000|Overall Study|Adverse Event|2|||
126330662|NCT00758498|454505105|FG001|Overall Study|Adverse Event|2|||
126330663|NCT00758498|454505106|FG002|Overall Study|Adverse Event|3|||
126330664|NCT00758498|454505104|FG000|Overall Study|Subject legally detained out of state|1|||
126330665|NCT00758498|454505105|FG001|Overall Study|Subject legally detained out of state|0|||
126330666|NCT00758498|454505106|FG002|Overall Study|Subject legally detained out of state|0|||
126330667|NCT00758498|454505104|FG000|Overall Study|Withdrawal by Subject|0|||
126330668|NCT00758498|454505105|FG001|Overall Study|Withdrawal by Subject|0|||
126330669|NCT00758498|454505106|FG002|Overall Study|Withdrawal by Subject|1|||
126330670|NCT00758498|454505104|FG000|Overall Study|Noncompliance to study procedures|0|||
126330671|NCT00758498|454505105|FG001|Overall Study|Noncompliance to study procedures|0|||
126330672|NCT00758498|454505106|FG002|Overall Study|Noncompliance to study procedures|1|||
126330673|NCT01516736|454505112|FG000|Overall Study|Withdrawal by Subject|10|||
126330674|NCT01516736|454505113|FG001|Overall Study|Withdrawal by Subject|4|||
126330675|NCT01516736|454505112|FG000|Overall Study|Adverse Event|4|||
126330676|NCT01516736|454505113|FG001|Overall Study|Adverse Event|5|||
126330677|NCT01516736|454505112|FG000|Overall Study|Death|3|||
126330678|NCT01516736|454505113|FG001|Overall Study|Death|1|||
126330679|NCT01516736|454505112|FG000|Overall Study|Physician Decision|2|||
125993161|NCT04537897|453266841|FG003|Overall Study|Adverse Event|1|||
125993162|NCT04537897|453266842|FG004|Overall Study|Adverse Event|0|||
125993163|NCT04537897|453266843|FG005|Overall Study|Adverse Event|0|||
126330680|NCT01516736|454505113|FG001|Overall Study|Physician Decision|1|||
126330681|NCT01516736|454505112|FG000|Overall Study|Lack of Efficacy|1|||
126330682|NCT01516736|454505113|FG001|Overall Study|Lack of Efficacy|0|||
126330683|NCT01516736|454505112|FG000|Overall Study|Protocol Violation|0|||
126330684|NCT01516736|454505113|FG001|Overall Study|Protocol Violation|1|||
126330685|NCT01516736|454505112|FG000|Overall Study|Other (not specified)|0|||
126330686|NCT01516736|454505113|FG001|Overall Study|Other (not specified)|1|||
126330687|NCT01697800|454505114|FG000|Overall Study|Death|0|||
125993164|NCT04537897|453266844|FG006|Overall Study|Adverse Event|0|||
125993165|NCT04537897|453266845|FG007|Overall Study|Adverse Event|0|||
125993166|NCT04537897|453266846|FG008|Overall Study|Adverse Event|0|||
125993167|NCT04537897|453266838|FG000|Overall Study|Withdrawal by Subject|0|||
125993168|NCT04537897|453266839|FG001|Overall Study|Withdrawal by Subject|1|||
125993169|NCT04537897|453266840|FG002|Overall Study|Withdrawal by Subject|0|||
125993170|NCT04537897|453266841|FG003|Overall Study|Withdrawal by Subject|0|||
125993171|NCT04537897|453266842|FG004|Overall Study|Withdrawal by Subject|0|||
125993172|NCT04537897|453266843|FG005|Overall Study|Withdrawal by Subject|0|||
125993173|NCT04537897|453266844|FG006|Overall Study|Withdrawal by Subject|0|||
125993174|NCT04537897|453266845|FG007|Overall Study|Withdrawal by Subject|0|||
125993175|NCT04537897|453266846|FG008|Overall Study|Withdrawal by Subject|0|||
125993176|NCT00197028|453266850|FG000|Overall Study|Adverse Event|2|||
125993177|NCT00197028|453266851|FG001|Overall Study|Adverse Event|2|||
125993178|NCT00197028|453266850|FG000|Overall Study|Protocol Violation|2|||
125993179|NCT00197028|453266851|FG001|Overall Study|Protocol Violation|1|||
125993180|NCT00197028|453266850|FG000|Overall Study|Withdrawal by Subject|8|||
125993181|NCT00197028|453266851|FG001|Overall Study|Withdrawal by Subject|12|||
125993182|NCT00197028|453266850|FG000|Overall Study|Lost to Follow-up|1|||
125993183|NCT00197028|453266851|FG001|Overall Study|Lost to Follow-up|0|||
125993184|NCT00197028|453266850|FG000|Overall Study|Other|3|||
125993185|NCT00197028|453266851|FG001|Overall Study|Other|6|||
125993186|NCT00885352|453266856|FG000|Overall Study|Adverse Event|2|||
125993187|NCT00885352|453266857|FG001|Overall Study|Adverse Event|3|||
125993188|NCT00885352|453266856|FG000|Overall Study|Lost to Follow-up|2|||
125993189|NCT00885352|453266857|FG001|Overall Study|Lost to Follow-up|2|||
125993190|NCT00885352|453266856|FG000|Overall Study|Physician Decision|0|||
125993191|NCT00885352|453266857|FG001|Overall Study|Physician Decision|3|||
125993192|NCT00885352|453266856|FG000|Overall Study|Protocol Violation|0|||
125993193|NCT00885352|453266857|FG001|Overall Study|Protocol Violation|2|||
125993194|NCT00885352|453266856|FG000|Overall Study|Withdrawal by Subject|1|||
125993195|NCT00885352|453266857|FG001|Overall Study|Withdrawal by Subject|5|||
125993196|NCT00885352|453266856|FG000|Overall Study|Contradiction to study medication|0|||
125993197|NCT00885352|453266857|FG001|Overall Study|Contradiction to study medication|2|||
125993198|NCT00885352|453266856|FG000|Overall Study|Excluded medication|2|||
125993199|NCT00885352|453266857|FG001|Overall Study|Excluded medication|2|||
125993200|NCT00885352|453266856|FG000|Overall Study|Lab abnormalities|1|||
125993201|NCT00885352|453266857|FG001|Overall Study|Lab abnormalities|1|||
125993202|NCT00669903|453266860|FG000|Overall Study|Adverse Event|0|||
125993203|NCT00669903|453266861|FG001|Overall Study|Adverse Event|1|||
125993204|NCT00669903|453266862|FG002|Overall Study|Adverse Event|3|||
125993205|NCT00669903|453266863|FG003|Overall Study|Adverse Event|1|||
125993206|NCT00669903|453266860|FG000|Overall Study|Withdrawal by Subject|0|||
125993207|NCT00669903|453266861|FG001|Overall Study|Withdrawal by Subject|2|||
125993208|NCT00669903|453266862|FG002|Overall Study|Withdrawal by Subject|2|||
125993209|NCT00669903|453266863|FG003|Overall Study|Withdrawal by Subject|2|||
125993210|NCT00669903|453266860|FG000|Overall Study|Lost to Follow-up|1|||
125993211|NCT00669903|453266861|FG001|Overall Study|Lost to Follow-up|1|||
125993212|NCT00669903|453266862|FG002|Overall Study|Lost to Follow-up|0|||
125993213|NCT00669903|453266863|FG003|Overall Study|Lost to Follow-up|1|||
125993214|NCT00669903|453266860|FG000|Overall Study|Protocol Violation|0|||
125993215|NCT00669903|453266861|FG001|Overall Study|Protocol Violation|1|||
125993216|NCT00669903|453266862|FG002|Overall Study|Protocol Violation|0|||
125993217|NCT00669903|453266863|FG003|Overall Study|Protocol Violation|0|||
125993218|NCT01827254|453266866|FG000|Overall Study|Death|10|||
125993219|NCT01827254|453266866|FG000|Overall Study|Case report form not completed|4|||
125993220|NCT01827254|453266866|FG000|Overall Study|Invalidated centre|3|||
125993221|NCT01827254|453266866|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
125993222|NCT01827254|453266866|FG000|Overall Study|Did not complete re-challenge|1|||
125993223|NCT01827254|453266866|FG000|Overall Study|Disease progression|36|||
125993224|NCT01827254|453266866|FG000|Overall Study|Intolerance to treatment|4|||
125993225|NCT01923389|453266867|FG000|Overall Study|Protocol Violation|1|||
125993226|NCT01923389|453266868|FG001|Overall Study|Protocol Violation|0|||
125993227|NCT03292146|453266869|FG000|Baseline to 12 Months|Relocation|1|||
125993228|NCT03292146|453266870|FG001|Baseline to 12 Months|Relocation|0|||
125993229|NCT03292146|453266869|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
125993230|NCT03292146|453266870|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
125993231|NCT03292146|453266869|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
125993232|NCT03292146|453266870|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
125993233|NCT03292146|453266869|FG000|12 Months to 24 Months|Planning pregnancy|2|||
125993234|NCT03292146|453266870|FG001|12 Months to 24 Months|Planning pregnancy|2|||
125993235|NCT03292146|453266869|FG000|12 Months to 24 Months|Personal reasons|1|||
125993236|NCT03292146|453266870|FG001|12 Months to 24 Months|Personal reasons|0|||
125993237|NCT03292146|453266869|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
125993238|NCT03292146|453266870|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
125993239|NCT00545363|453266873|FG000|Overall Study|Adverse Event|6|||
125993240|NCT00545363|453266874|FG001|Overall Study|Adverse Event|7|||
125993241|NCT00545363|453266873|FG000|Overall Study|Withdrawal by Subject|6|||
125993242|NCT00545363|453266874|FG001|Overall Study|Withdrawal by Subject|5|||
125993243|NCT00545363|453266873|FG000|Overall Study|Non-compliance|3|||
125993244|NCT00545363|453266874|FG001|Overall Study|Non-compliance|1|||
125993245|NCT00545363|453266873|FG000|Overall Study|Did not meet entry criteria|1|||
125993246|NCT00545363|453266874|FG001|Overall Study|Did not meet entry criteria|1|||
125993247|NCT00545363|453266873|FG000|Overall Study|Lost to Follow-up|2|||
125993248|NCT00545363|453266874|FG001|Overall Study|Lost to Follow-up|0|||
125993249|NCT00545363|453266873|FG000|Overall Study|Other|1|||
125993250|NCT00545363|453266874|FG001|Overall Study|Other|1|||
125993251|NCT03125941|453266877|FG000|Overall Study|did not receive intervention|1|||
125993252|NCT03125941|453266878|FG001|Overall Study|did not receive intervention|2|||
125993253|NCT00582491|453266879|FG000|Overall Study|Withdrawal by Subject|1|||
125993254|NCT00582491|453266880|FG001|Overall Study|Withdrawal by Subject|0|||
125993255|NCT04192630|453266881|FG000|Overall Study|Discontinued before surgery|2|||
125993256|NCT04192630|453266882|FG001|Overall Study|Discontinued before surgery|0|||
125993257|NCT04192630|453266881|FG000|Overall Study|Discontinued after surgery|5|||
125993258|NCT04192630|453266882|FG001|Overall Study|Discontinued after surgery|3|||
125993259|NCT01425632|453266883|FG000|Overall Study|Adverse Event|0|||
125993260|NCT01425632|453266884|FG001|Overall Study|Adverse Event|1|||
125993261|NCT01425632|453266885|FG002|Overall Study|Adverse Event|1|||
125993262|NCT01425632|453266883|FG000|Overall Study|Physician Decision|1|||
125993263|NCT01425632|453266884|FG001|Overall Study|Physician Decision|0|||
125993264|NCT01425632|453266885|FG002|Overall Study|Physician Decision|0|||
125993265|NCT01425632|453266883|FG000|Overall Study|Protocol Violation|0|||
125993266|NCT01425632|453266884|FG001|Overall Study|Protocol Violation|0|||
125993267|NCT01425632|453266885|FG002|Overall Study|Protocol Violation|2|||
125993268|NCT01425632|453266883|FG000|Overall Study|Withdrawal by Subject|0|||
125993269|NCT01425632|453266884|FG001|Overall Study|Withdrawal by Subject|0|||
125993270|NCT01425632|453266885|FG002|Overall Study|Withdrawal by Subject|1|||
125993271|NCT01208415|453266888|FG000|Overall Study|Death|1|||
125993272|NCT01208415|453266888|FG000|Overall Study|Lost to Follow-up|2|||
125993273|NCT01208415|453266888|FG000|Overall Study|Withdrawal by Subject|3|||
125993274|NCT01208415|453266888|FG000|Overall Study|Device not placed|1|||
125993275|NCT01208415|453266888|FG000|Overall Study|Still be eligible for follow-up|33|||
125993276|NCT01115491|453266889|FG000|Overall Study|Death|22|||
125993277|NCT01115491|453266889|FG000|Overall Study|Adverse Event|3|||
125993278|NCT01115491|453266889|FG000|Overall Study|Lost to Follow-up|3|||
125993279|NCT01115491|453266889|FG000|Overall Study|Withdrawal by Subject|1|||
125993280|NCT01115491|453266889|FG000|Overall Study|Physician Decision|1|||
125993281|NCT04297241|453266890|FG000|Overall Study|Withdrawal by Subject|1|||
125993282|NCT04297241|453266890|FG000|Overall Study|Adverse Event|1|||
125993283|NCT04297241|453266890|FG000|Overall Study|Physician Decision|3|||
125993284|NCT01003639|453266891|FG000|Overall Study|Lost to Follow-up|6|||
125993285|NCT01003639|453266892|FG001|Overall Study|Lost to Follow-up|9|||
125993286|NCT01003639|453266891|FG000|Overall Study|Withdrawal by Subject|9|||
125993287|NCT01003639|453266892|FG001|Overall Study|Withdrawal by Subject|5|||
125993288|NCT01003639|453266891|FG000|Overall Study|Lack of Efficacy|1|||
125993289|NCT01003639|453266892|FG001|Overall Study|Lack of Efficacy|6|||
125993290|NCT01003639|453266891|FG000|Overall Study|Adverse Event|0|||
125993291|NCT01003639|453266892|FG001|Overall Study|Adverse Event|1|||
125993292|NCT01003639|453266891|FG000|Overall Study|Protocol Violation|0|||
125993293|NCT01003639|453266892|FG001|Overall Study|Protocol Violation|1|||
125993294|NCT01003639|453266891|FG000|Overall Study|Physician Decision|1|||
125993295|NCT01003639|453266892|FG001|Overall Study|Physician Decision|0|||
125993296|NCT00386308|453268461|FG000|Overall Study|Adverse Event|3|||
125993297|NCT00386308|453268462|FG001|Overall Study|Adverse Event|3|||
125993298|NCT00386308|453268461|FG000|Overall Study|Protocol Violation|2|||
125993299|NCT00386308|453268462|FG001|Overall Study|Protocol Violation|5|||
125993300|NCT00386308|453268461|FG000|Overall Study|Lack of Efficacy|0|||
125993301|NCT00386308|453268462|FG001|Overall Study|Lack of Efficacy|2|||
125993302|NCT00386308|453268461|FG000|Overall Study|Lost to Follow-up|10|||
125993303|NCT00386308|453268462|FG001|Overall Study|Lost to Follow-up|6|||
125993304|NCT00386308|453268461|FG000|Overall Study|Withdrawal by Subject|6|||
125993305|NCT00386308|453268462|FG001|Overall Study|Withdrawal by Subject|2|||
125993306|NCT00386308|453268461|FG000|Overall Study|Other Event|8|||
125993307|NCT00386308|453268462|FG001|Overall Study|Other Event|1|||
125993308|NCT02906683|453268463|FG000|Overall Study|Adverse Event|0|||
125993309|NCT02906683|453268464|FG001|Overall Study|Adverse Event|1|||
125993310|NCT02906683|453268465|FG002|Overall Study|Adverse Event|0|||
125993311|NCT02906683|453268463|FG000|Overall Study|Physician Decision|0|||
125993312|NCT02906683|453268464|FG001|Overall Study|Physician Decision|1|||
125993313|NCT02906683|453268465|FG002|Overall Study|Physician Decision|1|||
125993314|NCT02906683|453268463|FG000|Overall Study|Withdrawal by Subject|0|||
125993315|NCT02906683|453268464|FG001|Overall Study|Withdrawal by Subject|2|||
125993316|NCT02906683|453268465|FG002|Overall Study|Withdrawal by Subject|1|||
125993317|NCT02906683|453268463|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
125993318|NCT02906683|453268464|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
125993319|NCT02906683|453268465|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
125993320|NCT02906683|453268463|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
126330688|NCT01697800|454505115|FG001|Overall Study|Death|1|||
125993321|NCT02906683|453268464|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
125993322|NCT02906683|453268465|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
125993323|NCT02781506|453268466|FG000|Overall Study|Adverse Event|5|||
125993324|NCT01340482|453268467|FG000|Overall Study|Adverse Event|2|||
125993325|NCT01340482|453268468|FG001|Overall Study|Adverse Event|0|||
125993326|NCT01340482|453268469|FG002|Overall Study|Adverse Event|0|||
125993327|NCT00744237|453268470|FG000|Overall Study|Lack of Efficacy|1|||
125993328|NCT00744237|453268471|FG001|Overall Study|Lack of Efficacy|1|||
125993329|NCT00744237|453268472|FG002|Overall Study|Lack of Efficacy|0|||
125993330|NCT00744237|453268470|FG000|Overall Study|Withdrawal by Subject|9|||
125993331|NCT00744237|453268471|FG001|Overall Study|Withdrawal by Subject|5|||
125993332|NCT00744237|453268472|FG002|Overall Study|Withdrawal by Subject|3|||
125993333|NCT00744237|453268470|FG000|Overall Study|Lost to Follow-up|1|||
125993334|NCT00744237|453268471|FG001|Overall Study|Lost to Follow-up|1|||
125993335|NCT00744237|453268472|FG002|Overall Study|Lost to Follow-up|1|||
125993336|NCT00744237|453268470|FG000|Overall Study|Protocol Violation|3|||
125993337|NCT00744237|453268471|FG001|Overall Study|Protocol Violation|4|||
125993338|NCT00744237|453268472|FG002|Overall Study|Protocol Violation|3|||
125993339|NCT00744237|453268470|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
125993340|NCT00744237|453268471|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
125993341|NCT00744237|453268472|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
125993342|NCT00744237|453268470|FG000|Overall Study|Dosing Error|1|||
125993343|NCT00744237|453268471|FG001|Overall Study|Dosing Error|0|||
125993344|NCT00744237|453268472|FG002|Overall Study|Dosing Error|1|||
125993345|NCT00744237|453268470|FG000|Overall Study|Study Drug Error|1|||
125993346|NCT00744237|453268471|FG001|Overall Study|Study Drug Error|0|||
125993347|NCT00744237|453268472|FG002|Overall Study|Study Drug Error|0|||
125993348|NCT00744237|453268470|FG000|Overall Study|Prohibited Concomitant Medication|0|||
125993349|NCT00744237|453268471|FG001|Overall Study|Prohibited Concomitant Medication|0|||
125993350|NCT00744237|453268472|FG002|Overall Study|Prohibited Concomitant Medication|1|||
125993351|NCT00744237|453268470|FG000|Overall Study|Poor Compliance|0|||
125993352|NCT00744237|453268471|FG001|Overall Study|Poor Compliance|2|||
125993353|NCT00744237|453268472|FG002|Overall Study|Poor Compliance|0|||
125993354|NCT00744237|453268470|FG000|Overall Study|Administrative. Site Closed|1|||
125993355|NCT00744237|453268471|FG001|Overall Study|Administrative. Site Closed|1|||
125993356|NCT00744237|453268472|FG002|Overall Study|Administrative. Site Closed|1|||
125993357|NCT00744237|453268470|FG000|Overall Study|Adverse Event|9|||
125993358|NCT00744237|453268471|FG001|Overall Study|Adverse Event|13|||
125993359|NCT00744237|453268472|FG002|Overall Study|Adverse Event|5|||
125993360|NCT02802319|453268473|FG000|Overall Study|Physician Decision|2|||
125993361|NCT02802319|453268474|FG001|Overall Study|Physician Decision|1|||
125993362|NCT02802319|453268473|FG000|Overall Study|Lost to Follow-up|0|||
125993363|NCT02802319|453268474|FG001|Overall Study|Lost to Follow-up|4|||
125993364|NCT03545113|453268475|FG000|Overall Study|Surgery Cancelled|1|||
125993365|NCT03545113|453268476|FG001|Overall Study|Surgery Cancelled|0|||
125993366|NCT03545113|453268475|FG000|Overall Study|Death|1|||
125993367|NCT03545113|453268476|FG001|Overall Study|Death|0|||
125993368|NCT03545113|453268475|FG000|Overall Study|Adverse Event|2|||
125993369|NCT03545113|453268476|FG001|Overall Study|Adverse Event|0|||
125993370|NCT03545113|453268475|FG000|Overall Study|Received different surgery|1|||
125993371|NCT03545113|453268476|FG001|Overall Study|Received different surgery|0|||
125993372|NCT00999661|453268479|FG000|Overall Study|Lost to Follow-up|59|||
125993373|NCT00999661|453268479|FG000|Overall Study|Adverse Event|1|||
125993374|NCT00999661|453268479|FG000|Overall Study|Withdrawal by Subject|1|||
125993375|NCT00999661|453268479|FG000|Overall Study|Not meeting eligibility criteria|9|||
125993376|NCT03638635|453268481|FG000|Initial Hospitalization|Study terminated prematurely|0|||
125993377|NCT03638635|453268482|FG001|Initial Hospitalization|Study terminated prematurely|1|||
125993378|NCT03638635|453268481|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
125993379|NCT03638635|453268482|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
125993380|NCT03638635|453268481|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
125993381|NCT03638635|453268482|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
126330689|NCT00954122|454505116|FG000|Overall Study|Withdrawal by Subject|5|||
126330690|NCT00954122|454505116|FG000|Overall Study|Adverse Event|1|||
126330691|NCT00954122|454505116|FG000|Overall Study|Safety Reason|1|||
126330692|NCT03365934|454505123|FG000|Overall Study|Adverse Event|1|||
125993382|NCT00313911|453268486|FG000|Overall Study|Serious adverse event|6|||
125993383|NCT00313911|453268487|FG001|Overall Study|Serious adverse event|1|||
125993384|NCT00313911|453268486|FG000|Overall Study|Adverse Event|2|||
125993385|NCT00313911|453268487|FG001|Overall Study|Adverse Event|3|||
126330693|NCT03365934|454505123|FG000|Overall Study|Withdrawal by Subject|1|||
125993386|NCT00313911|453268486|FG000|Overall Study|Protocol Violation|19|||
125993387|NCT00313911|453268487|FG001|Overall Study|Protocol Violation|10|||
125993388|NCT00313911|453268486|FG000|Overall Study|Lost to Follow-up|27|||
125993389|NCT00313911|453268487|FG001|Overall Study|Lost to Follow-up|14|||
125993390|NCT00313911|453268486|FG000|Overall Study|Withdrawal by Subject|39|||
125993391|NCT00313911|453268487|FG001|Overall Study|Withdrawal by Subject|12|||
125993392|NCT00313911|453268486|FG000|Overall Study|Did not meet age criteria|1|||
125993393|NCT00313911|453268487|FG001|Overall Study|Did not meet age criteria|1|||
125993394|NCT02406261|453268495|FG000|Period 1|Lost to Follow-up|2|||
125993395|NCT02406261|453268496|FG001|Period 1|Lost to Follow-up|0|||
125993396|NCT02406261|453268495|FG000|Period 1|Adverse Event|1|||
125993397|NCT02406261|453268496|FG001|Period 1|Adverse Event|0|||
125993398|NCT02406261|453268495|FG000|Period 2|Physician Decision|0|||
125993399|NCT02406261|453268496|FG001|Period 2|Physician Decision|1|||
125993400|NCT02406261|453268495|FG000|Period 2|Protocol Violation|0|||
125993401|NCT02406261|453268496|FG001|Period 2|Protocol Violation|1|||
125993402|NCT02406261|453268495|FG000|Period 2|Withdrawal by Subject|0|||
125993403|NCT02406261|453268496|FG001|Period 2|Withdrawal by Subject|1|||
125993404|NCT02222896|453268497|FG000|Abdomen|Did not qualify|34|||
125993405|NCT02222896|453268498|FG001|Abdomen|Did not qualify|10|||
125993406|NCT02222896|453268499|FG002|Abdomen|Did not qualify|32|||
126330694|NCT04194489|454505124|FG000|Overall Study|Withdrawal by Subject|5|||
126330695|NCT04194489|454505124|FG000|Overall Study|Lost to Follow-up|48|||
126330696|NCT00522548|454505131|FG000|Overall Study|Adverse Event|2|||
126330697|NCT00522548|454505132|FG001|Overall Study|Adverse Event|2|||
126330698|NCT00522548|454505131|FG000|Overall Study|Withdrawal by Subject|0|||
126330699|NCT00522548|454505132|FG001|Overall Study|Withdrawal by Subject|2|||
126330700|NCT02121795|454505133|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
126330701|NCT02121795|454505134|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
126330702|NCT02121795|454505133|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
126330703|NCT02121795|454505134|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
126330704|NCT02121795|454505133|FG000|Double-Blind Phase|Lost to Follow-up|7|||
126330705|NCT02121795|454505134|FG001|Double-Blind Phase|Lost to Follow-up|4|||
126330706|NCT02121795|454505133|FG000|Double-Blind Phase|Physician Decision|2|||
126330707|NCT02121795|454505134|FG001|Double-Blind Phase|Physician Decision|5|||
126330708|NCT02121795|454505133|FG000|Double-Blind Phase|Adverse Event|5|||
126330709|NCT02121795|454505134|FG001|Double-Blind Phase|Adverse Event|0|||
126330710|NCT02121795|454505133|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
126330711|NCT02121795|454505134|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
126330712|NCT02121795|454505133|FG000|Double-Blind Phase|Protocol Violation|0|||
126330713|NCT02121795|454505134|FG001|Double-Blind Phase|Protocol Violation|3|||
126330714|NCT02121795|454505133|FG000|Double-Blind Phase|Death|1|||
126330715|NCT02121795|454505134|FG001|Double-Blind Phase|Death|1|||
126330716|NCT02121795|454505133|FG000|Open-Label Phase|Physician Decision|8|||
126330717|NCT02121795|454505134|FG001|Open-Label Phase|Physician Decision|8|||
126330718|NCT02121795|454505133|FG000|Open-Label Phase|Withdrawal by Subject|3|||
126330719|NCT02121795|454505134|FG001|Open-Label Phase|Withdrawal by Subject|2|||
126330720|NCT02121795|454505133|FG000|Open-Label Phase|Lost to Follow-up|1|||
126330721|NCT02121795|454505134|FG001|Open-Label Phase|Lost to Follow-up|0|||
126330722|NCT00666211|454505135|FG000|Overall Study|Withdrawal by Subject|10|||
126330723|NCT00666211|454505136|FG001|Overall Study|Withdrawal by Subject|13|||
126330724|NCT00666211|454505135|FG000|Overall Study|went off medication, no more pain|1|||
126330725|NCT00666211|454505136|FG001|Overall Study|went off medication, no more pain|0|||
126330726|NCT00666211|454505135|FG000|Overall Study|patient non-compliant|6|||
126330727|NCT00666211|454505136|FG001|Overall Study|patient non-compliant|6|||
126330728|NCT00666211|454505135|FG000|Overall Study|disease progression|1|||
126330729|NCT00666211|454505136|FG001|Overall Study|disease progression|8|||
126330730|NCT00666211|454505135|FG000|Overall Study|Lost to Follow-up|2|||
126330731|NCT00666211|454505136|FG001|Overall Study|Lost to Follow-up|0|||
126330732|NCT00666211|454505135|FG000|Overall Study|toxicity|0|||
126330733|NCT00666211|454505136|FG001|Overall Study|toxicity|2|||
126330734|NCT00666211|454505135|FG000|Overall Study|hospital admission|0|||
126330735|NCT00666211|454505136|FG001|Overall Study|hospital admission|5|||
126330736|NCT00666211|454505135|FG000|Overall Study|Death|0|||
126330737|NCT00666211|454505136|FG001|Overall Study|Death|2|||
126330738|NCT00666211|454505135|FG000|Overall Study|off tx for other complicating disease|0|||
126330739|NCT00666211|454505136|FG001|Overall Study|off tx for other complicating disease|1|||
126330740|NCT00666211|454505135|FG000|Overall Study|Physician Decision|0|||
126330741|NCT00666211|454505136|FG001|Overall Study|Physician Decision|1|||
126330742|NCT02609386|454505141|FG000|Overall Study|Withdrawal by Subject|6|||
126330743|NCT02609386|454505142|FG001|Overall Study|Withdrawal by Subject|1|||
126330744|NCT02609386|454505141|FG000|Overall Study|Lost to Follow-up|3|||
125993407|NCT02222896|453268497|FG000|Groin|Did not qualify|43|||
126330745|NCT02609386|454505142|FG001|Overall Study|Lost to Follow-up|5|||
126330746|NCT02609386|454505141|FG000|Overall Study|Death|19|||
125993408|NCT02222896|453268498|FG001|Groin|Did not qualify|9|||
125993409|NCT02222896|453268499|FG002|Groin|Did not qualify|40|||
126330747|NCT02609386|454505142|FG001|Overall Study|Death|9|||
126330748|NCT02609386|454505141|FG000|Overall Study|Physician Decision|0|||
126330749|NCT02609386|454505142|FG001|Overall Study|Physician Decision|2|||
125993410|NCT01865617|453268506|FG000|Overall Study|Death|27|||
126330750|NCT02299388|454505145|FG000|Overall Study|Withdrawal by Subject|0|||
125993411|NCT01865617|453268507|FG001|Overall Study|Death|3|||
125993412|NCT01865617|453268508|FG002|Overall Study|Death|1|||
125993413|NCT01865617|453268509|FG003|Overall Study|Death|1|||
125993414|NCT01865617|453268510|FG004|Overall Study|Death|5|||
125993415|NCT01865617|453268511|FG005|Overall Study|Death|1|||
125993416|NCT01865617|453268512|FG006|Overall Study|Death|11|||
125993417|NCT01865617|453268513|FG007|Overall Study|Death|1|||
125993418|NCT01865617|453268514|FG008|Overall Study|Death|11|||
125993419|NCT01865617|453268515|FG009|Overall Study|Death|3|||
125993420|NCT01865617|453268516|FG010|Overall Study|Death|32|||
125993421|NCT01865617|453268517|FG011|Overall Study|Death|6|||
125993422|NCT01865617|453268518|FG012|Overall Study|Death|13|||
125993423|NCT01865617|453268506|FG000|Overall Study|Lost to Follow-up|2|||
125993424|NCT01865617|453268507|FG001|Overall Study|Lost to Follow-up|0|||
125993425|NCT01865617|453268508|FG002|Overall Study|Lost to Follow-up|0|||
125993426|NCT01865617|453268509|FG003|Overall Study|Lost to Follow-up|0|||
125993427|NCT01865617|453268510|FG004|Overall Study|Lost to Follow-up|0|||
125993428|NCT01865617|453268511|FG005|Overall Study|Lost to Follow-up|0|||
125993429|NCT01865617|453268512|FG006|Overall Study|Lost to Follow-up|0|||
125993430|NCT01865617|453268513|FG007|Overall Study|Lost to Follow-up|0|||
125993431|NCT01865617|453268514|FG008|Overall Study|Lost to Follow-up|0|||
125993432|NCT01865617|453268515|FG009|Overall Study|Lost to Follow-up|0|||
125993433|NCT01865617|453268516|FG010|Overall Study|Lost to Follow-up|0|||
125993434|NCT01865617|453268517|FG011|Overall Study|Lost to Follow-up|0|||
125993435|NCT01865617|453268518|FG012|Overall Study|Lost to Follow-up|0|||
125993436|NCT01865617|453268506|FG000|Overall Study|Withdrawal by Subject|1|||
125993437|NCT01865617|453268507|FG001|Overall Study|Withdrawal by Subject|0|||
125993438|NCT01865617|453268508|FG002|Overall Study|Withdrawal by Subject|0|||
125993439|NCT01865617|453268509|FG003|Overall Study|Withdrawal by Subject|0|||
125993440|NCT01865617|453268510|FG004|Overall Study|Withdrawal by Subject|0|||
125993441|NCT01865617|453268511|FG005|Overall Study|Withdrawal by Subject|0|||
125993442|NCT01865617|453268512|FG006|Overall Study|Withdrawal by Subject|0|||
125993443|NCT01865617|453268513|FG007|Overall Study|Withdrawal by Subject|0|||
125993444|NCT01865617|453268514|FG008|Overall Study|Withdrawal by Subject|0|||
125993445|NCT01865617|453268515|FG009|Overall Study|Withdrawal by Subject|0|||
125993446|NCT01865617|453268516|FG010|Overall Study|Withdrawal by Subject|0|||
125993447|NCT01865617|453268517|FG011|Overall Study|Withdrawal by Subject|0|||
125993448|NCT01865617|453268518|FG012|Overall Study|Withdrawal by Subject|0|||
125993449|NCT01865617|453268506|FG000|Overall Study|Patient proceeded to new therapy|0|||
125993450|NCT01865617|453268507|FG001|Overall Study|Patient proceeded to new therapy|0|||
125993451|NCT01865617|453268508|FG002|Overall Study|Patient proceeded to new therapy|0|||
125993452|NCT01865617|453268509|FG003|Overall Study|Patient proceeded to new therapy|0|||
125993453|NCT01865617|453268510|FG004|Overall Study|Patient proceeded to new therapy|2|||
125993454|NCT01865617|453268511|FG005|Overall Study|Patient proceeded to new therapy|0|||
125993455|NCT01865617|453268512|FG006|Overall Study|Patient proceeded to new therapy|0|||
125993456|NCT01865617|453268513|FG007|Overall Study|Patient proceeded to new therapy|0|||
125993457|NCT01865617|453268514|FG008|Overall Study|Patient proceeded to new therapy|0|||
125993458|NCT01865617|453268515|FG009|Overall Study|Patient proceeded to new therapy|0|||
125993459|NCT01865617|453268516|FG010|Overall Study|Patient proceeded to new therapy|0|||
125993460|NCT01865617|453268517|FG011|Overall Study|Patient proceeded to new therapy|0|||
125993461|NCT01865617|453268518|FG012|Overall Study|Patient proceeded to new therapy|0|||
125993462|NCT01865617|453268506|FG000|Overall Study|Other|0|||
125993463|NCT01865617|453268507|FG001|Overall Study|Other|0|||
125993464|NCT01865617|453268508|FG002|Overall Study|Other|0|||
125993465|NCT01865617|453268509|FG003|Overall Study|Other|0|||
125993466|NCT01865617|453268510|FG004|Overall Study|Other|0|||
125993467|NCT01865617|453268511|FG005|Overall Study|Other|0|||
125993468|NCT01865617|453268512|FG006|Overall Study|Other|1|||
125993469|NCT01865617|453268513|FG007|Overall Study|Other|0|||
125993470|NCT01865617|453268514|FG008|Overall Study|Other|0|||
125993471|NCT01865617|453268515|FG009|Overall Study|Other|0|||
125993472|NCT01865617|453268516|FG010|Overall Study|Other|0|||
125993473|NCT01865617|453268517|FG011|Overall Study|Other|0|||
125993474|NCT01865617|453268518|FG012|Overall Study|Other|0|||
125993475|NCT02226172|453268519|FG000|Overall Study|Participant refused further follow-up|4|||
125993476|NCT02226172|453268519|FG000|Overall Study|Other|5|||
125993477|NCT02226172|453268519|FG000|Overall Study|Death|1|||
125993478|NCT02226172|453268519|FG000|Overall Study|Study terminated by sponsor|1|||
125993479|NCT02226172|453268519|FG000|Overall Study|Adverse Event|6|||
125993480|NCT00258440|453268525|FG000|Overall Study|Withdrawal by Subject|0|||
125993481|NCT00258440|453268526|FG001|Overall Study|Withdrawal by Subject|0|||
125993482|NCT00258440|453268527|FG002|Overall Study|Withdrawal by Subject|1|||
125993483|NCT00737061|453268528|FG000|Waiting Period|Lost to Follow-up|6|||
125993484|NCT00737061|453268528|FG000|Waiting Period|Withdrawal by Subject|1|||
125993485|NCT00737061|453268528|FG000|Waiting Period|Bilateral placement failure|34|||
125993486|NCT00737061|453268528|FG000|Waiting Period|Deemed patent following HSG|26|||
125993487|NCT00737061|453268528|FG000|Waiting Period|Alternative contraception failure|3|||
125993488|NCT00737061|453268528|FG000|Waiting Period|Elected surgical tubal ligation|5|||
125993489|NCT00737061|453268528|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
125993490|NCT00737061|453268528|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
125993491|NCT00737061|453268528|FG000|1 Year Wearing Period|Discontinued reilance|3|||
125993492|NCT00737061|453268528|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
125993493|NCT00439179|453268530|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
125993494|NCT00439179|453268531|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
125993495|NCT00439179|453268532|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
125993496|NCT00439179|453268533|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
125993497|NCT01844115|453268537|FG000|Overall Study|Adverse Event|4|||
125993498|NCT01844115|453268538|FG001|Overall Study|Adverse Event|22|||
125993499|NCT01844115|453268537|FG000|Overall Study|Lack of Efficacy|1|||
126330751|NCT02299388|454505146|FG001|Overall Study|Withdrawal by Subject|1|||
126330752|NCT03334188|454505150|FG000|Overall Study|Withdrawal by Subject|0|||
125993500|NCT01844115|453268538|FG001|Overall Study|Lack of Efficacy|4|||
125993501|NCT01844115|453268537|FG000|Overall Study|Protocol Violation|12|||
125993502|NCT01844115|453268538|FG001|Overall Study|Protocol Violation|10|||
125993503|NCT01844115|453268537|FG000|Overall Study|Withdrawal by Subject|11|||
125993504|NCT01844115|453268538|FG001|Overall Study|Withdrawal by Subject|11|||
125993505|NCT01844115|453268537|FG000|Overall Study|Lost to Follow-up|11|||
125993506|NCT01844115|453268538|FG001|Overall Study|Lost to Follow-up|10|||
125993507|NCT01844115|453268537|FG000|Overall Study|Pregnancy|0|||
125993508|NCT01844115|453268538|FG001|Overall Study|Pregnancy|1|||
125993509|NCT00758160|453268539|FG000|Overall Study|No Longer Requires Study Medication|4|||
125993510|NCT00758160|453268539|FG000|Overall Study|Administration Problems|3|||
125993511|NCT00758160|453268539|FG000|Overall Study|Adverse Event|15|||
125993512|NCT00758160|453268539|FG000|Overall Study|Lack of Efficacy|10|||
125993513|NCT00758160|453268539|FG000|Overall Study|Lost to Follow-up|14|||
125993514|NCT00758160|453268539|FG000|Overall Study|Protocol Violation|12|||
125993515|NCT00758160|453268539|FG000|Overall Study|Withdrawal by Subject|8|||
125993516|NCT01613027|453268540|FG000|Overall Study|Lost to Follow-up|5|||
125993517|NCT01613027|453268540|FG000|Overall Study|Switched Physician|1|||
125993518|NCT01613027|453268540|FG000|Overall Study|Lack of Efficacy|1|||
125993519|NCT01613027|453268540|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
125993520|NCT00993317|453268541|FG000|Overall Study|Adverse Event|2|||
125993521|NCT00993317|453268542|FG001|Overall Study|Adverse Event|4|||
125993522|NCT00993317|453268541|FG000|Overall Study|Lack of Efficacy|18|||
125993523|NCT00993317|453268542|FG001|Overall Study|Lack of Efficacy|18|||
125993524|NCT00993317|453268541|FG000|Overall Study|Withdrawal by Subject|0|||
125993525|NCT00993317|453268542|FG001|Overall Study|Withdrawal by Subject|2|||
125993526|NCT00993317|453268541|FG000|Overall Study|Investigator's opinion|0|||
125993527|NCT00993317|453268542|FG001|Overall Study|Investigator's opinion|1|||
125993528|NCT00993317|453268541|FG000|Overall Study|Early study termination at the site|1|||
125993529|NCT00993317|453268542|FG001|Overall Study|Early study termination at the site|0|||
125993530|NCT02153359|453268543|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
125993531|NCT02153359|453268544|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
125993532|NCT04422639|453268545|FG000|Overall Study|Death|1|||
125993533|NCT04422639|453268546|FG001|Overall Study|Death|0|||
125993534|NCT04422639|453268545|FG000|Overall Study|study closed prior to completion of FU visits|0|||
125993535|NCT04422639|453268546|FG001|Overall Study|study closed prior to completion of FU visits|2|||
125993536|NCT01964521|453268547|FG000|Overall Study|Lost to Follow-up|4|||
125993537|NCT01372605|453268548|FG000|Overall Study|Death|1|||
125993538|NCT01372605|453268549|FG001|Overall Study|Death|2|||
125993539|NCT01372605|453268548|FG000|Overall Study|Lost to Follow-up|2|||
125993540|NCT01372605|453268549|FG001|Overall Study|Lost to Follow-up|1|||
125993541|NCT01372605|453268548|FG000|Overall Study|Withdrawal by Subject|4|||
125993542|NCT01372605|453268549|FG001|Overall Study|Withdrawal by Subject|7|||
125993543|NCT01372605|453268548|FG000|Overall Study|Moved|3|||
126330753|NCT03334188|454505151|FG001|Overall Study|Withdrawal by Subject|1|||
126330754|NCT03334188|454505150|FG000|Overall Study|Death|1|||
126330755|NCT03334188|454505151|FG001|Overall Study|Death|0|||
126330756|NCT03334188|454505150|FG000|Overall Study|Never had qualifying clinic visit|7|||
126330757|NCT03334188|454505151|FG001|Overall Study|Never had qualifying clinic visit|7|||
126330758|NCT03373760|454505154|FG000|Overall Study|Adverse Event|8|||
126330759|NCT03373760|454505154|FG000|Overall Study|Disease Progression|46|||
126330760|NCT03373760|454505154|FG000|Overall Study|Death|4|||
126330761|NCT01093586|454505155|FG000|Overall Study|Failed to engraft|3|||
126330762|NCT03442088|454505156|FG000|Overall Study|Adverse Event|1|||
126330763|NCT03442088|454505156|FG000|Overall Study|Lack of Efficacy|2|||
126330764|NCT03442088|454505156|FG000|Overall Study|Lost to Follow-up|2|||
126330765|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
126330766|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
126330767|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
125993544|NCT01372605|453268549|FG001|Overall Study|Moved|0|||
125993545|NCT01372605|453268548|FG000|Overall Study|Changed medical home|2|||
125993546|NCT01372605|453268549|FG001|Overall Study|Changed medical home|0|||
125993547|NCT01108510|453268550|FG000|Overall Study|Randomized but Not Treated|5|||
125993548|NCT01108510|453268551|FG001|Overall Study|Randomized but Not Treated|1|||
125993549|NCT01108510|453268550|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
125993550|NCT01108510|453268551|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
125993551|NCT01108510|453268550|FG000|Overall Study|Adverse Event|26|||
125993552|NCT01108510|453268551|FG001|Overall Study|Adverse Event|19|||
125993553|NCT01108510|453268550|FG000|Overall Study|Lost to Follow-up|20|||
125993554|NCT01108510|453268551|FG001|Overall Study|Lost to Follow-up|17|||
125993555|NCT01108510|453268550|FG000|Overall Study|Withdrew Consent|21|||
125993556|NCT01108510|453268551|FG001|Overall Study|Withdrew Consent|15|||
125993557|NCT01108510|453268550|FG000|Overall Study|Investigator's Discretion|12|||
125993558|NCT01108510|453268551|FG001|Overall Study|Investigator's Discretion|10|||
125993559|NCT01108510|453268550|FG000|Overall Study|Participant Noncompliance|5|||
125993560|NCT01108510|453268551|FG001|Overall Study|Participant Noncompliance|7|||
125993561|NCT01108510|453268550|FG000|Overall Study|Lack of Efficacy|3|||
125993562|NCT01108510|453268551|FG001|Overall Study|Lack of Efficacy|0|||
125993563|NCT01108510|453268550|FG000|Overall Study|Pregnancy|0|||
125993564|NCT01108510|453268551|FG001|Overall Study|Pregnancy|3|||
125993565|NCT01108510|453268550|FG000|Overall Study|Death|1|||
125993566|NCT01108510|453268551|FG001|Overall Study|Death|1|||
125993567|NCT02796963|453268552|FG000|Overall Study|Lost to Follow-up|89|||
125993568|NCT02796963|453268553|FG001|Overall Study|Lost to Follow-up|76|||
125993569|NCT02796963|453268554|FG002|Overall Study|Lost to Follow-up|69|||
125993570|NCT02796963|453268555|FG003|Overall Study|Lost to Follow-up|72|||
125993571|NCT00951509|453268556|FG000|Overall Study|Withdrawal by Subject|2|||
125993572|NCT04362137|453268557|FG000|Overall Study|Death|9|||
125993573|NCT04362137|453268558|FG001|Overall Study|Death|3|||
125993574|NCT04362137|453268557|FG000|Overall Study|Patient decision|6|||
125993575|NCT04362137|453268558|FG001|Overall Study|Patient decision|3|||
125993576|NCT04362137|453268557|FG000|Overall Study|Adverse Event|1|||
125993577|NCT04362137|453268558|FG001|Overall Study|Adverse Event|0|||
125993578|NCT04362137|453268557|FG000|Overall Study|Lost to Follow-up|1|||
125993579|NCT04362137|453268558|FG001|Overall Study|Lost to Follow-up|0|||
125993580|NCT04362137|453268557|FG000|Overall Study|Protocol deviation|1|||
125993581|NCT04362137|453268558|FG001|Overall Study|Protocol deviation|0|||
125993582|NCT01076088|453268559|FG000|Overall Study|Adverse Event|1|||
125993583|NCT01076088|453268560|FG001|Overall Study|Adverse Event|6|||
125993584|NCT01076088|453268561|FG002|Overall Study|Adverse Event|3|||
125993585|NCT01076088|453268562|FG003|Overall Study|Adverse Event|2|||
125993586|NCT01076088|453268563|FG004|Overall Study|Adverse Event|3|||
126330768|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
126330769|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
126330770|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
126330771|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
126330772|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
126330773|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
126330774|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
126330775|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
126330776|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
126330777|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
126330778|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
126330779|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Death|1|||
126330780|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Death|0|||
126330781|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
126330782|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
126330783|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
126330784|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
126330785|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
126330786|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
126330787|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
126330788|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
126330789|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
126330790|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
126330791|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
126330792|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
126330793|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
126330794|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
126330795|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
126330796|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
126330797|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
125993587|NCT01076088|453268564|FG005|Overall Study|Adverse Event|3|||
125993588|NCT01076088|453268559|FG000|Overall Study|Lost to Follow-up|1|||
125993589|NCT01076088|453268560|FG001|Overall Study|Lost to Follow-up|1|||
125993590|NCT01076088|453268561|FG002|Overall Study|Lost to Follow-up|0|||
125993591|NCT01076088|453268562|FG003|Overall Study|Lost to Follow-up|1|||
125993592|NCT01076088|453268563|FG004|Overall Study|Lost to Follow-up|1|||
125993593|NCT01076088|453268564|FG005|Overall Study|Lost to Follow-up|2|||
125993594|NCT01076088|453268559|FG000|Overall Study|Non-compliance with study drug|0|||
125993595|NCT01076088|453268560|FG001|Overall Study|Non-compliance with study drug|0|||
126330798|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
126330799|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Death|0|||
126330800|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Death|0|||
126330801|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
125993596|NCT01076088|453268561|FG002|Overall Study|Non-compliance with study drug|0|||
125993597|NCT01076088|453268562|FG003|Overall Study|Non-compliance with study drug|1|||
125993598|NCT01076088|453268563|FG004|Overall Study|Non-compliance with study drug|0|||
125993599|NCT01076088|453268564|FG005|Overall Study|Non-compliance with study drug|0|||
125993600|NCT01076088|453268559|FG000|Overall Study|Physician Decision|1|||
125993601|NCT01076088|453268560|FG001|Overall Study|Physician Decision|3|||
125993602|NCT01076088|453268561|FG002|Overall Study|Physician Decision|0|||
125993603|NCT01076088|453268562|FG003|Overall Study|Physician Decision|1|||
125993604|NCT01076088|453268563|FG004|Overall Study|Physician Decision|1|||
125993605|NCT01076088|453268564|FG005|Overall Study|Physician Decision|0|||
125993606|NCT01076088|453268559|FG000|Overall Study|Withdrawal by Subject|8|||
125993607|NCT01076088|453268560|FG001|Overall Study|Withdrawal by Subject|8|||
125993608|NCT01076088|453268561|FG002|Overall Study|Withdrawal by Subject|14|||
125993609|NCT01076088|453268562|FG003|Overall Study|Withdrawal by Subject|10|||
125993610|NCT01076088|453268563|FG004|Overall Study|Withdrawal by Subject|11|||
125993611|NCT01076088|453268564|FG005|Overall Study|Withdrawal by Subject|17|||
125993612|NCT01076088|453268559|FG000|Overall Study|Other protocol specified criteria|0|||
125993613|NCT01076088|453268560|FG001|Overall Study|Other protocol specified criteria|0|||
125993614|NCT01076088|453268561|FG002|Overall Study|Other protocol specified criteria|0|||
125993615|NCT01076088|453268562|FG003|Overall Study|Other protocol specified criteria|0|||
125993616|NCT01076088|453268563|FG004|Overall Study|Other protocol specified criteria|0|||
125993617|NCT01076088|453268564|FG005|Overall Study|Other protocol specified criteria|1|||
125993618|NCT03306043|453268568|FG000|Overall Study|Adverse Event|1|||
125993619|NCT03306043|453268568|FG000|Overall Study|Lost to Follow-up|1|||
125993620|NCT03306043|453268568|FG000|Overall Study|Withdrawal by Subject|2|||
125993621|NCT00785538|453268569|FG000|Treatment Period|Adverse Event|1|||
125993622|NCT00785538|453268570|FG001|Treatment Period|Adverse Event|2|||
125993623|NCT00785538|453268571|FG002|Treatment Period|Adverse Event|2|||
125993624|NCT00785538|453268572|FG003|Treatment Period|Adverse Event|0|||
125993625|NCT00785538|453268569|FG000|Treatment Period|Withdrawal by Subject|0|||
125993626|NCT00785538|453268570|FG001|Treatment Period|Withdrawal by Subject|0|||
125993627|NCT00785538|453268571|FG002|Treatment Period|Withdrawal by Subject|0|||
125993628|NCT00785538|453268572|FG003|Treatment Period|Withdrawal by Subject|1|||
125993629|NCT01234649|453268573|FG000|Overall Study|Withdrawal by Subject|32|||
125993630|NCT01234649|453268574|FG001|Overall Study|Withdrawal by Subject|26|||
125993631|NCT01234649|453268573|FG000|Overall Study|Pregnancy|6|||
125993632|NCT01234649|453268574|FG001|Overall Study|Pregnancy|6|||
125993633|NCT01234649|453268573|FG000|Overall Study|intolerant to side effects|4|||
125993634|NCT01234649|453268574|FG001|Overall Study|intolerant to side effects|3|||
125993635|NCT01234649|453268573|FG000|Overall Study|Allergic reaction|1|||
125993636|NCT01234649|453268574|FG001|Overall Study|Allergic reaction|0|||
125993637|NCT01234649|453268573|FG000|Overall Study|Lack of Efficacy|0|||
125993638|NCT01234649|453268574|FG001|Overall Study|Lack of Efficacy|3|||
125993639|NCT00318149|453268577|FG000|Overall Study|Adverse Event|0|||
125993640|NCT00318149|453268578|FG001|Overall Study|Adverse Event|0|||
125993641|NCT00318149|453268579|FG002|Overall Study|Adverse Event|0|||
125993642|NCT00318149|453268580|FG003|Overall Study|Adverse Event|0|||
125993643|NCT00318149|453268581|FG004|Overall Study|Adverse Event|0|||
125993644|NCT00318149|453268582|FG005|Overall Study|Adverse Event|2|||
125993645|NCT00785707|453268589|FG000|Overall Study|Lost to Follow-up|7|||
125993646|NCT02262260|453268590|FG000|Overall Study|Adverse Event|4|||
125993647|NCT02262260|453268591|FG001|Overall Study|Adverse Event|1|||
125993648|NCT02262260|453268590|FG000|Overall Study|Withdrawal of consent|4|||
125993649|NCT02262260|453268591|FG001|Overall Study|Withdrawal of consent|2|||
126330802|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
126330803|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
126330804|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
126330805|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
126330806|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
126330807|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
126330808|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
126330809|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
125993650|NCT02262260|453268590|FG000|Overall Study|Lost to Follow-up|1|||
125993651|NCT02262260|453268591|FG001|Overall Study|Lost to Follow-up|2|||
125993652|NCT02262260|453268590|FG000|Overall Study|Protocol deviation|2|||
125993653|NCT02262260|453268591|FG001|Overall Study|Protocol deviation|5|||
125993654|NCT01794117|453268593|FG000|Overall Study|Adverse Event|1|||
125993655|NCT01794117|453268594|FG001|Overall Study|Adverse Event|0|||
125993656|NCT01794117|453268595|FG002|Overall Study|Adverse Event|0|||
125993657|NCT01794117|453268596|FG003|Overall Study|Adverse Event|0|||
125993658|NCT01794117|453268593|FG000|Overall Study|Participant noncompliance|0|||
125993659|NCT01794117|453268594|FG001|Overall Study|Participant noncompliance|1|||
125993660|NCT01794117|453268595|FG002|Overall Study|Participant noncompliance|0|||
125993661|NCT01794117|453268596|FG003|Overall Study|Participant noncompliance|0|||
125993662|NCT01794117|453268593|FG000|Overall Study|Refused further treatment|0|||
125993663|NCT01794117|453268594|FG001|Overall Study|Refused further treatment|2|||
125993664|NCT01794117|453268595|FG002|Overall Study|Refused further treatment|0|||
125993665|NCT01794117|453268596|FG003|Overall Study|Refused further treatment|0|||
125993666|NCT02322814|453268597|FG000|Overall Study|Death|7|||
125993667|NCT02322814|453268598|FG001|Overall Study|Death|29|||
125993668|NCT02322814|453268599|FG002|Overall Study|Death|32|||
125993669|NCT02322814|453268600|FG003|Overall Study|Death|23|||
125993670|NCT02322814|453268601|FG004|Overall Study|Death|14|||
125993671|NCT02322814|453268597|FG000|Overall Study|Lost to Follow-up|1|||
125993672|NCT02322814|453268598|FG001|Overall Study|Lost to Follow-up|3|||
125993673|NCT02322814|453268599|FG002|Overall Study|Lost to Follow-up|3|||
125993674|NCT02322814|453268600|FG003|Overall Study|Lost to Follow-up|1|||
125993675|NCT02322814|453268601|FG004|Overall Study|Lost to Follow-up|0|||
125993676|NCT02322814|453268597|FG000|Overall Study|Various Reasons|2|||
125993677|NCT02322814|453268598|FG001|Overall Study|Various Reasons|0|||
125993678|NCT02322814|453268599|FG002|Overall Study|Various Reasons|1|||
125993679|NCT02322814|453268600|FG003|Overall Study|Various Reasons|1|||
125993680|NCT02322814|453268601|FG004|Overall Study|Various Reasons|0|||
125993681|NCT02322814|453268597|FG000|Overall Study|Progressive Disease|0|||
125993682|NCT02322814|453268598|FG001|Overall Study|Progressive Disease|0|||
125993683|NCT02322814|453268599|FG002|Overall Study|Progressive Disease|0|||
125993684|NCT02322814|453268600|FG003|Overall Study|Progressive Disease|1|||
125993685|NCT02322814|453268601|FG004|Overall Study|Progressive Disease|1|||
125993686|NCT02322814|453268597|FG000|Overall Study|Protocol Violation|1|||
125993687|NCT02322814|453268598|FG001|Overall Study|Protocol Violation|0|||
125993688|NCT02322814|453268599|FG002|Overall Study|Protocol Violation|0|||
125993689|NCT02322814|453268600|FG003|Overall Study|Protocol Violation|0|||
125993690|NCT02322814|453268601|FG004|Overall Study|Protocol Violation|0|||
125993691|NCT02322814|453268597|FG000|Overall Study|Study Terminated by Sponsor|0|||
125993692|NCT02322814|453268598|FG001|Overall Study|Study Terminated by Sponsor|7|||
125993693|NCT02322814|453268599|FG002|Overall Study|Study Terminated by Sponsor|9|||
125993694|NCT02322814|453268600|FG003|Overall Study|Study Terminated by Sponsor|5|||
125993695|NCT02322814|453268601|FG004|Overall Study|Study Terminated by Sponsor|13|||
125993696|NCT02322814|453268597|FG000|Overall Study|Withdrawal by Subject|5|||
125993697|NCT02322814|453268598|FG001|Overall Study|Withdrawal by Subject|4|||
125993698|NCT02322814|453268599|FG002|Overall Study|Withdrawal by Subject|2|||
125993699|NCT02322814|453268600|FG003|Overall Study|Withdrawal by Subject|1|||
125993700|NCT02322814|453268601|FG004|Overall Study|Withdrawal by Subject|3|||
125993701|NCT00118092|453268602|FG000|Overall Study|Withdrawal by Subject|1|||
126330810|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
126330811|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
126330812|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
126330813|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
126330814|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
126330815|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
126330816|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
126330817|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
126330818|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
126330819|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
126330820|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
126330821|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
126330822|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
126330823|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
126330824|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
126330825|NCT00357877|454505159|FG000|Overall Study|Death|2|||
126330826|NCT00357877|454505160|FG001|Overall Study|Death|1|||
126330827|NCT00357877|454505159|FG000|Overall Study|Lost to Follow-up|20|||
126330828|NCT00357877|454505160|FG001|Overall Study|Lost to Follow-up|23|||
126330829|NCT00357877|454505159|FG000|Overall Study|Withdrawal by Subject|3|||
126330830|NCT00357877|454505160|FG001|Overall Study|Withdrawal by Subject|3|||
126330831|NCT00357877|454505159|FG000|Overall Study|Administrative withdrawal|1|||
125993702|NCT00118092|453268602|FG000|Overall Study|Protocol Violation|1|||
125993703|NCT00591864|453268603|FG000|Overall Study|Incomplete Imaging|5|||
125993704|NCT02459093|453268604|FG000|Overall Study|Protocol Violation|6|||
125993705|NCT02459093|453268605|FG001|Overall Study|Protocol Violation|11|||
125993706|NCT02459093|453268604|FG000|Overall Study|Lost to Follow-up|6|||
125993707|NCT02459093|453268605|FG001|Overall Study|Lost to Follow-up|7|||
125993708|NCT01567865|453268611|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
125993709|NCT01567865|453268612|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
125993710|NCT01567865|453268613|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
126330832|NCT00357877|454505160|FG001|Overall Study|Administrative withdrawal|1|||
125993711|NCT01567865|453268614|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
125993712|NCT01567865|453268611|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
125993713|NCT01567865|453268612|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
125993714|NCT01567865|453268613|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
125993715|NCT01567865|453268614|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
125993716|NCT00309608|453268623|FG000|Overall Study|Adverse Event|1|||
125993717|NCT00309608|453268624|FG001|Overall Study|Adverse Event|5|||
125993718|NCT00309608|453268625|FG002|Overall Study|Adverse Event|3|||
125993719|NCT00309608|453268626|FG003|Overall Study|Adverse Event|2|||
125993720|NCT00309608|453268627|FG004|Overall Study|Adverse Event|3|||
125993721|NCT00309608|453268623|FG000|Overall Study|Protocol Violation|2|||
125993722|NCT00309608|453268624|FG001|Overall Study|Protocol Violation|0|||
125993723|NCT00309608|453268625|FG002|Overall Study|Protocol Violation|0|||
125993724|NCT00309608|453268626|FG003|Overall Study|Protocol Violation|0|||
125993725|NCT00309608|453268627|FG004|Overall Study|Protocol Violation|0|||
125993726|NCT00309608|453268623|FG000|Overall Study|Lost to Follow-up|0|||
125993727|NCT00309608|453268624|FG001|Overall Study|Lost to Follow-up|0|||
126330833|NCT00357877|454505159|FG000|Overall Study|Other|0|||
126330834|NCT00357877|454505160|FG001|Overall Study|Other|2|||
126330835|NCT04668209|454505161|FG000|Overall Study|Withdrawal by Subject|2|||
126330836|NCT04668209|454505162|FG001|Overall Study|Withdrawal by Subject|2|||
126330837|NCT04668209|454505161|FG000|Overall Study|Lost to Follow-up|3|||
126330838|NCT04668209|454505162|FG001|Overall Study|Lost to Follow-up|4|||
126330839|NCT04668209|454505161|FG000|Overall Study|Subject Expired|2|||
126330840|NCT04668209|454505162|FG001|Overall Study|Subject Expired|0|||
126330841|NCT04668209|454505161|FG000|Overall Study|Withdrawn from study|0|||
126330842|NCT04668209|454505162|FG001|Overall Study|Withdrawn from study|1|||
126330843|NCT04668209|454505161|FG000|Overall Study|Adverse Event|0|||
125993728|NCT00309608|453268625|FG002|Overall Study|Lost to Follow-up|2|||
125993729|NCT00309608|453268626|FG003|Overall Study|Lost to Follow-up|0|||
125993730|NCT00309608|453268627|FG004|Overall Study|Lost to Follow-up|1|||
125993731|NCT00309608|453268623|FG000|Overall Study|Withdrawal by Subject|1|||
125993732|NCT00309608|453268624|FG001|Overall Study|Withdrawal by Subject|4|||
125993733|NCT00309608|453268625|FG002|Overall Study|Withdrawal by Subject|2|||
125993734|NCT00309608|453268626|FG003|Overall Study|Withdrawal by Subject|0|||
125993735|NCT00309608|453268627|FG004|Overall Study|Withdrawal by Subject|0|||
125993736|NCT00309608|453268623|FG000|Overall Study|Other incl. Lack of efficacy|10|||
125993737|NCT00309608|453268624|FG001|Overall Study|Other incl. Lack of efficacy|4|||
125993738|NCT00309608|453268625|FG002|Overall Study|Other incl. Lack of efficacy|3|||
125993739|NCT00309608|453268626|FG003|Overall Study|Other incl. Lack of efficacy|4|||
125993740|NCT00309608|453268627|FG004|Overall Study|Other incl. Lack of efficacy|0|||
125993741|NCT00621296|453268628|FG000|Overall Study|Adverse Event|2|||
125993742|NCT00621296|453268628|FG000|Overall Study|Lack of Efficacy|1|||
125993743|NCT00621296|453268628|FG000|Overall Study|Physician Decision|7|||
125993744|NCT00621296|453268628|FG000|Overall Study|Unmatch Criteria|1|||
125993745|NCT00621296|453268628|FG000|Overall Study|Stopping Criteria|3|||
125993746|NCT04921969|453268629|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125993747|NCT04921969|453268630|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
125993748|NCT04921969|453268631|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
125993749|NCT04921969|453268632|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125993750|NCT04921969|453268633|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125993751|NCT04921969|453268634|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125993752|NCT04921969|453268635|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125993753|NCT04921969|453268629|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
125993754|NCT04921969|453268630|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125993755|NCT04921969|453268631|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125993756|NCT04921969|453268632|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125993757|NCT04921969|453268633|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125993758|NCT04921969|453268634|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125993759|NCT04921969|453268635|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125993760|NCT04921969|453268629|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
126330844|NCT04668209|454505162|FG001|Overall Study|Adverse Event|1|||
126330845|NCT01869777|454505169|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
125993761|NCT04921969|453268630|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
126330846|NCT00613366|454505172|FG000|Overall Study|Withdrawal by Subject|3|||
126330847|NCT00613366|454505173|FG001|Overall Study|Withdrawal by Subject|2|||
125993762|NCT04921969|453268631|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
125993763|NCT04921969|453268632|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125993764|NCT04921969|453268633|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125993765|NCT04921969|453268634|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125993766|NCT04921969|453268635|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125993767|NCT04921969|453268629|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125993768|NCT04921969|453268630|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
125993769|NCT04921969|453268631|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
126330848|NCT00766597|454505174|FG000|Overall Study|Unexpected closure of study|4|||
125993770|NCT04921969|453268632|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125993771|NCT04921969|453268633|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125993772|NCT04921969|453268634|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125993773|NCT04921969|453268635|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125993774|NCT04921969|453268629|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125993775|NCT04921969|453268630|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125993776|NCT04921969|453268631|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
125993777|NCT04921969|453268632|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125993778|NCT04921969|453268633|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125993779|NCT04921969|453268634|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125993780|NCT04921969|453268635|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125993781|NCT04921969|453268629|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
125993782|NCT04921969|453268630|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
125993783|NCT04921969|453268631|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
125993784|NCT04921969|453268632|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125993785|NCT04921969|453268633|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125993786|NCT04921969|453268634|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125993787|NCT04921969|453268635|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125993788|NCT04921969|453268629|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
125993789|NCT04921969|453268630|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
125993790|NCT04921969|453268631|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125993791|NCT04921969|453268632|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125993792|NCT04921969|453268633|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125993793|NCT04921969|453268634|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125993794|NCT04921969|453268635|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125993795|NCT04921969|453268629|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125993796|NCT04921969|453268630|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125993797|NCT04921969|453268631|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125993798|NCT04921969|453268632|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125993799|NCT04921969|453268633|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125993800|NCT04921969|453268634|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125993801|NCT04921969|453268635|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
125993802|NCT04921969|453268629|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125993803|NCT04921969|453268630|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125993804|NCT04921969|453268631|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125993805|NCT04921969|453268632|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
125993806|NCT04921969|453268633|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125993807|NCT04921969|453268634|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
125993808|NCT04921969|453268635|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
125993809|NCT04921969|453268629|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125993810|NCT04921969|453268630|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125993811|NCT04921969|453268631|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125993812|NCT04921969|453268632|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
125993813|NCT04921969|453268633|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
125993814|NCT04921969|453268634|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
125993815|NCT04921969|453268635|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
125993816|NCT04921969|453268629|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
125993817|NCT04921969|453268630|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
125993818|NCT04921969|453268631|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
125993819|NCT04921969|453268632|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
125993820|NCT04921969|453268633|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
125993821|NCT04921969|453268634|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
125993822|NCT04921969|453268635|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
125993823|NCT04921969|453268629|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125993824|NCT04921969|453268630|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125993825|NCT04921969|453268631|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125993826|NCT04921969|453268632|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
125993827|NCT04921969|453268633|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
125993828|NCT04921969|453268634|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
125993829|NCT04921969|453268635|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
125993830|NCT04921969|453268629|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
125993831|NCT04921969|453268630|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
125993832|NCT04921969|453268631|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
125993833|NCT04921969|453268632|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
125993834|NCT04921969|453268633|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
125993835|NCT04921969|453268634|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
125993836|NCT04921969|453268635|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
125993837|NCT04921969|453268629|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125993838|NCT04921969|453268630|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125993839|NCT04921969|453268631|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125993840|NCT04921969|453268632|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
125993841|NCT04921969|453268633|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125993842|NCT04921969|453268634|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125993843|NCT04921969|453268635|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
125993844|NCT04921969|453268629|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125993845|NCT04921969|453268630|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125993846|NCT04921969|453268631|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125993847|NCT04921969|453268632|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125993848|NCT04921969|453268633|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125993849|NCT04921969|453268634|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
125993850|NCT04921969|453268635|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
125993851|NCT01683994|453270665|FG000|Overall Study|Withdrawal by Subject|1|||
125993852|NCT01683994|453270666|FG001|Overall Study|Withdrawal by Subject|0|||
125993853|NCT01683994|453270667|FG002|Overall Study|Withdrawal by Subject|0|||
125993854|NCT01683994|453270668|FG003|Overall Study|Withdrawal by Subject|1|||
125993855|NCT01683994|453270669|FG004|Overall Study|Withdrawal by Subject|0|||
125993856|NCT01683994|453270665|FG000|Overall Study|Intercurrent illness|0|||
125993857|NCT01683994|453270666|FG001|Overall Study|Intercurrent illness|0|||
125993858|NCT01683994|453270667|FG002|Overall Study|Intercurrent illness|0|||
125993859|NCT01683994|453270668|FG003|Overall Study|Intercurrent illness|2|||
125993860|NCT01683994|453270669|FG004|Overall Study|Intercurrent illness|1|||
125993861|NCT01533714|453270673|FG000|Overall Study|Adverse Event|0|||
125993862|NCT01533714|453270674|FG001|Overall Study|Adverse Event|1|||
125993863|NCT01533714|453270675|FG002|Overall Study|Adverse Event|2|||
125993864|NCT01533714|453270676|FG003|Overall Study|Adverse Event|2|||
125993865|NCT01533714|453270677|FG004|Overall Study|Adverse Event|2|||
125993866|NCT01533714|453270678|FG005|Overall Study|Adverse Event|1|||
125993867|NCT01533714|453270673|FG000|Overall Study|Lack of Efficacy|0|||
125993868|NCT01533714|453270674|FG001|Overall Study|Lack of Efficacy|0|||
125993869|NCT01533714|453270675|FG002|Overall Study|Lack of Efficacy|0|||
125993870|NCT01533714|453270676|FG003|Overall Study|Lack of Efficacy|0|||
125993871|NCT01533714|453270677|FG004|Overall Study|Lack of Efficacy|0|||
125993872|NCT01533714|453270678|FG005|Overall Study|Lack of Efficacy|1|||
125993873|NCT01533714|453270673|FG000|Overall Study|Withdrawal by Subject|0|||
125993874|NCT01533714|453270674|FG001|Overall Study|Withdrawal by Subject|1|||
125993875|NCT01533714|453270675|FG002|Overall Study|Withdrawal by Subject|0|||
125993876|NCT01533714|453270676|FG003|Overall Study|Withdrawal by Subject|1|||
125993877|NCT01533714|453270677|FG004|Overall Study|Withdrawal by Subject|1|||
125993878|NCT01533714|453270678|FG005|Overall Study|Withdrawal by Subject|0|||
125993879|NCT01533714|453270673|FG000|Overall Study|Exclusion criteria|0|||
125993880|NCT01533714|453270674|FG001|Overall Study|Exclusion criteria|1|||
125993881|NCT01533714|453270675|FG002|Overall Study|Exclusion criteria|0|||
125993882|NCT01533714|453270676|FG003|Overall Study|Exclusion criteria|0|||
125993883|NCT01533714|453270677|FG004|Overall Study|Exclusion criteria|0|||
125993884|NCT01533714|453270678|FG005|Overall Study|Exclusion criteria|0|||
125993885|NCT01533714|453270673|FG000|Overall Study|Positive for purified protein derivative|0|||
125993886|NCT01533714|453270674|FG001|Overall Study|Positive for purified protein derivative|0|||
125993887|NCT01533714|453270675|FG002|Overall Study|Positive for purified protein derivative|1|||
125993888|NCT01533714|453270676|FG003|Overall Study|Positive for purified protein derivative|0|||
125993889|NCT01533714|453270677|FG004|Overall Study|Positive for purified protein derivative|1|||
125993890|NCT01533714|453270678|FG005|Overall Study|Positive for purified protein derivative|0|||
125993891|NCT01533714|453270673|FG000|Overall Study|Withdrawal criteria|0|||
125993892|NCT01533714|453270674|FG001|Overall Study|Withdrawal criteria|0|||
125993893|NCT01533714|453270675|FG002|Overall Study|Withdrawal criteria|1|||
125993894|NCT01533714|453270676|FG003|Overall Study|Withdrawal criteria|0|||
125993895|NCT01533714|453270677|FG004|Overall Study|Withdrawal criteria|3|||
125993896|NCT01533714|453270678|FG005|Overall Study|Withdrawal criteria|1|||
125993897|NCT01533714|453270673|FG000|Overall Study|Ineligibility reason|0|||
125993898|NCT01533714|453270674|FG001|Overall Study|Ineligibility reason|0|||
125993899|NCT01533714|453270675|FG002|Overall Study|Ineligibility reason|0|||
125993900|NCT01533714|453270676|FG003|Overall Study|Ineligibility reason|1|||
125993901|NCT01533714|453270677|FG004|Overall Study|Ineligibility reason|0|||
125993902|NCT01533714|453270678|FG005|Overall Study|Ineligibility reason|0|||
125993903|NCT00251927|453270679|FG000|Overall Study|Adverse Event|3|||
125993904|NCT00251927|453270680|FG001|Overall Study|Adverse Event|15|||
125993905|NCT00251927|453270679|FG000|Overall Study|Lack of Efficacy|22|||
125993906|NCT00251927|453270680|FG001|Overall Study|Lack of Efficacy|16|||
125993907|NCT00251927|453270679|FG000|Overall Study|Lost to Follow-up|22|||
125993908|NCT00251927|453270680|FG001|Overall Study|Lost to Follow-up|8|||
125993909|NCT00251927|453270679|FG000|Overall Study|Protocol Violation|1|||
125993910|NCT00251927|453270680|FG001|Overall Study|Protocol Violation|2|||
126330849|NCT00766597|454505174|FG000|Overall Study|Without CCR5-tropic virus|5|||
126330850|NCT01135524|454505178|FG000|Overall Study|Withdrawal by Subject|14|||
126330851|NCT01135524|454505178|FG000|Overall Study|Adverse Event|20|||
126330852|NCT01135524|454505178|FG000|Overall Study|Lost to Follow-up|3|||
126330853|NCT01135524|454505178|FG000|Overall Study|Administrative|151|||
126330854|NCT01135524|454505178|FG000|Overall Study|Lack of Efficacy|8|||
126330855|NCT03318003|454505179|FG000|Overall Study|Withdrawal by Subject|1|||
125993911|NCT00251927|453270679|FG000|Overall Study|Pregnancy|2|||
125993912|NCT00251927|453270680|FG001|Overall Study|Pregnancy|0|||
125993913|NCT00251927|453270679|FG000|Overall Study|Withdrawal by Subject|40|||
125993914|NCT00251927|453270680|FG001|Overall Study|Withdrawal by Subject|25|||
126330856|NCT03318003|454505180|FG001|Overall Study|Withdrawal by Subject|1|||
126330857|NCT03318003|454505179|FG000|Overall Study|fetal loss|0|||
126330858|NCT03318003|454505180|FG001|Overall Study|fetal loss|1|||
126330859|NCT02907463|454505182|FG000|Overall Study|Lost to Follow-up|17|||
126330860|NCT02907463|454505182|FG000|Overall Study|Death|10|||
126330861|NCT02907463|454505182|FG000|Overall Study|Withdrawal by Subject|4|||
126330862|NCT02907463|454505182|FG000|Overall Study|MIS Approach was not used|2|||
126330863|NCT02907463|454505182|FG000|Overall Study|Not Implanted with Study Device|2|||
126330864|NCT02907463|454505182|FG000|Overall Study|Device Explanted|1|||
126330865|NCT02907463|454505182|FG000|Overall Study|Missing Exit Form|1|||
126330866|NCT01716663|454505183|FG000|Overall Study|Withdrawn prior to procedure|4|||
126330867|NCT01716663|454505183|FG000|Overall Study|Treated with non-study catheter|2|||
126330868|NCT00511810|454505190|FG000|Overall Study|Lost to Follow-up|1|||
126330869|NCT00511810|454505191|FG001|Overall Study|Lost to Follow-up|2|||
126330870|NCT00511810|454505190|FG000|Overall Study|Lack of Efficacy|0|||
126330871|NCT00511810|454505191|FG001|Overall Study|Lack of Efficacy|2|||
126330872|NCT00511810|454505190|FG000|Overall Study|Refused second scn|0|||
126330873|NCT00511810|454505191|FG001|Overall Study|Refused second scn|1|||
126330874|NCT00452439|454506765|FG000|Overall Study|Lost to Follow-up|1|||
126330875|NCT00452439|454506766|FG001|Overall Study|Lost to Follow-up|1|||
126330876|NCT00452439|454506765|FG000|Overall Study|Refused Treatment|4|||
126330877|NCT00452439|454506766|FG001|Overall Study|Refused Treatment|3|||
126330878|NCT00452439|454506765|FG000|Overall Study|Death|3|||
126330879|NCT00452439|454506766|FG001|Overall Study|Death|1|||
126330880|NCT00452439|454506765|FG000|Overall Study|Bone Marrow Transplant|0|||
126330881|NCT00452439|454506766|FG001|Overall Study|Bone Marrow Transplant|1|||
126330882|NCT00452439|454506765|FG000|Overall Study|Too Ill to Continue|0|||
126330883|NCT00452439|454506766|FG001|Overall Study|Too Ill to Continue|1|||
126330884|NCT00452439|454506765|FG000|Overall Study|Failed to achieve complete response|2|||
126330885|NCT00452439|454506766|FG001|Overall Study|Failed to achieve complete response|0|||
126330886|NCT00452439|454506765|FG000|Overall Study|Relapse|3|||
125993915|NCT00251927|453270679|FG000|Overall Study|Study-specific discont. achieved|13|||
125993916|NCT00251927|453270680|FG001|Overall Study|Study-specific discont. achieved|2|||
125993917|NCT00251927|453270679|FG000|Overall Study|Study procedure non-compliance|5|||
125993918|NCT00251927|453270680|FG001|Overall Study|Study procedure non-compliance|6|||
125993919|NCT01258660|453270691|FG000|Overall Study|Adverse Event|2|||
125993920|NCT01258660|453270692|FG001|Overall Study|Adverse Event|4|||
125993921|NCT01258660|453270691|FG000|Overall Study|Withdrawal by Subject|3|||
125993922|NCT01258660|453270692|FG001|Overall Study|Withdrawal by Subject|0|||
125993923|NCT01258660|453270691|FG000|Overall Study|due to relocation|2|||
125993924|NCT01258660|453270692|FG001|Overall Study|due to relocation|0|||
125993925|NCT01258660|453270691|FG000|Overall Study|Protocol Violation|0|||
125993926|NCT01258660|453270692|FG001|Overall Study|Protocol Violation|1|||
125993927|NCT01258660|453270691|FG000|Overall Study|Invalid for primary analysis data set|4|||
125993928|NCT01258660|453270692|FG001|Overall Study|Invalid for primary analysis data set|6|||
125993929|NCT01193582|453270693|FG000|Vaccination Series|Withdrawal by Subject|11|||
125993930|NCT01193582|453270694|FG001|Vaccination Series|Withdrawal by Subject|13|||
125993931|NCT01193582|453270695|FG002|Vaccination Series|Withdrawal by Subject|8|||
125993932|NCT01193582|453270696|FG003|Vaccination Series|Withdrawal by Subject|3|||
125993933|NCT01193582|453270693|FG000|12 Month Follow-up|Death|0|||
125993934|NCT01193582|453270694|FG001|12 Month Follow-up|Death|0|||
125993935|NCT01193582|453270695|FG002|12 Month Follow-up|Death|1|||
126330887|NCT00452439|454506766|FG001|Overall Study|Relapse|0|||
126330888|NCT00452439|454506765|FG000|Overall Study|Fracture|1|||
126330889|NCT00452439|454506766|FG001|Overall Study|Fracture|0|||
126330890|NCT00994110|454506773|FG000|Overall Study|Withdrawal by Subject|9|||
126330891|NCT00994110|454506774|FG001|Overall Study|Withdrawal by Subject|9|||
126330892|NCT00994110|454506773|FG000|Overall Study|Not Treated|4|||
126330893|NCT00994110|454506774|FG001|Overall Study|Not Treated|8|||
126330894|NCT00994110|454506773|FG000|Overall Study|Adverse Event|1|||
125993936|NCT01193582|453270696|FG003|12 Month Follow-up|Death|0|||
125993937|NCT01193582|453270693|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
125993938|NCT01193582|453270694|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
125993939|NCT01193582|453270695|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
126330895|NCT00994110|454506774|FG001|Overall Study|Adverse Event|0|||
126330896|NCT00994110|454506773|FG000|Overall Study|Patient not resected|41|||
126330897|NCT00994110|454506774|FG001|Overall Study|Patient not resected|52|||
126330898|NCT00994110|454506773|FG000|Overall Study|Pt not eligible|10|||
125993940|NCT01193582|453270696|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
125993941|NCT03632434|453270709|FG000|Overall Study|Withdrawal by Subject|2|||
125993942|NCT01751113|453270710|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125993943|NCT01751113|453270711|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125993944|NCT01751113|453270712|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125993945|NCT01751113|453270713|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
125993946|NCT01751113|453270714|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
125993947|NCT01751113|453270715|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125993948|NCT01751113|453270710|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125993949|NCT01751113|453270711|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125993950|NCT01751113|453270712|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125993951|NCT01751113|453270713|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125993952|NCT01751113|453270714|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125993953|NCT01751113|453270715|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
125993954|NCT01775930|453270716|FG000|Overall Study|Futility stopping boundary met|1|||
125993955|NCT01551303|453270718|FG000|Overall Study|failed awareness check on vision test|4|||
125993956|NCT01551303|453270719|FG001|Overall Study|failed awareness check on vision test|7|||
125993957|NCT00363896|453270720|FG000|Overall Study|Withdrawal by Subject|29|||
125993958|NCT00363896|453270721|FG001|Overall Study|Withdrawal by Subject|16|||
125993959|NCT00363896|453270720|FG000|Overall Study|Adverse Event|24|||
125993960|NCT00363896|453270721|FG001|Overall Study|Adverse Event|13|||
125993961|NCT00363896|453270720|FG000|Overall Study|COPD exacerbation|13|||
125993962|NCT00363896|453270721|FG001|Overall Study|COPD exacerbation|7|||
125993963|NCT00363896|453270720|FG000|Overall Study|Lack of Efficacy|12|||
125993964|NCT00363896|453270721|FG001|Overall Study|Lack of Efficacy|8|||
125993965|NCT00363896|453270720|FG000|Overall Study|Protocol Violation|6|||
125993966|NCT00363896|453270721|FG001|Overall Study|Protocol Violation|1|||
125993967|NCT00363896|453270720|FG000|Overall Study|Lost to Follow-up|3|||
125993968|NCT00363896|453270721|FG001|Overall Study|Lost to Follow-up|0|||
125993969|NCT00363896|453270720|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
125993970|NCT00363896|453270721|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
125993971|NCT00363896|453270720|FG000|Overall Study|Other|1|||
125993972|NCT00363896|453270721|FG001|Overall Study|Other|2|||
125993973|NCT03044353|453270726|FG000|Overall Study|Adverse Event|0|||
125993974|NCT03044353|453270727|FG001|Overall Study|Adverse Event|1|||
125993975|NCT03044353|453270728|FG002|Overall Study|Adverse Event|0|||
125993976|NCT02141659|453270741|FG000|Overall Study|Major Protocol Deviation|0|||
125993977|NCT02141659|453270742|FG001|Overall Study|Major Protocol Deviation|1|||
125993978|NCT02141659|453270743|FG002|Overall Study|Major Protocol Deviation|0|||
125993979|NCT02141659|453270744|FG003|Overall Study|Major Protocol Deviation|0|||
125993980|NCT02141659|453270745|FG004|Overall Study|Major Protocol Deviation|0|||
125993981|NCT02141659|453270746|FG005|Overall Study|Major Protocol Deviation|0|||
125993982|NCT02141659|453270741|FG000|Overall Study|Lack of Efficacy|0|||
125993983|NCT02141659|453270742|FG001|Overall Study|Lack of Efficacy|0|||
125993984|NCT02141659|453270743|FG002|Overall Study|Lack of Efficacy|0|||
125993985|NCT02141659|453270744|FG003|Overall Study|Lack of Efficacy|0|||
125993986|NCT02141659|453270745|FG004|Overall Study|Lack of Efficacy|0|||
125993987|NCT02141659|453270746|FG005|Overall Study|Lack of Efficacy|1|||
125993988|NCT02141659|453270741|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
125993989|NCT02141659|453270742|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
125993990|NCT02141659|453270743|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
125993991|NCT02141659|453270744|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
125993992|NCT02141659|453270745|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
125993993|NCT02141659|453270746|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
125993994|NCT03856996|453270749|FG000|Overall Study|Withdrawal by Subject|1|||
125993995|NCT03856996|453270750|FG001|Overall Study|Withdrawal by Subject|0|||
125993996|NCT03856996|453270749|FG000|Overall Study|Lost to Follow-up|0|||
125993997|NCT03856996|453270750|FG001|Overall Study|Lost to Follow-up|1|||
125993998|NCT03856996|453270749|FG000|Overall Study|Adverse Event|1|||
125993999|NCT03856996|453270750|FG001|Overall Study|Adverse Event|1|||
125994000|NCT03856996|453270749|FG000|Overall Study|Other|1|||
125994001|NCT03856996|453270750|FG001|Overall Study|Other|0|||
125994002|NCT02340520|453270751|FG000|Overall Study|Lost to Follow-up|1|||
126330899|NCT00994110|454506774|FG001|Overall Study|Pt not eligible|5|||
125994003|NCT02340520|453270751|FG000|Overall Study|Patient did not take drug as specified|1|||
126330900|NCT02683239|454506775|FG000|Overall Study|Protocol Violation|35|||
125994004|NCT02340520|453270751|FG000|Overall Study|Withdrawal by Subject|1|||
125994005|NCT01464255|453270752|FG000|Overall Study|unresolve corneal staining|0|||
125994006|NCT01464255|453270753|FG001|Overall Study|unresolve corneal staining|1|||
125994007|NCT01231503|453270754|FG000|Overall Study|Adverse Event|0|||
125994008|NCT01231503|453270755|FG001|Overall Study|Adverse Event|0|||
125994009|NCT01231503|453270756|FG002|Overall Study|Adverse Event|0|||
125994010|NCT01231503|453270757|FG003|Overall Study|Adverse Event|0|||
125994011|NCT01231503|453270758|FG004|Overall Study|Adverse Event|0|||
125994012|NCT01231503|453270759|FG005|Overall Study|Adverse Event|1|||
125994013|NCT01231503|453270760|FG006|Overall Study|Adverse Event|0|||
125994014|NCT01231503|453270761|FG007|Overall Study|Adverse Event|0|||
125994015|NCT01231503|453270754|FG000|Overall Study|Adverse event, serious fatal|0|||
125994016|NCT01231503|453270755|FG001|Overall Study|Adverse event, serious fatal|0|||
125994017|NCT01231503|453270756|FG002|Overall Study|Adverse event, serious fatal|1|||
125994018|NCT01231503|453270757|FG003|Overall Study|Adverse event, serious fatal|1|||
125994019|NCT01231503|453270758|FG004|Overall Study|Adverse event, serious fatal|0|||
125994020|NCT01231503|453270759|FG005|Overall Study|Adverse event, serious fatal|1|||
125994021|NCT01231503|453270760|FG006|Overall Study|Adverse event, serious fatal|0|||
125994022|NCT01231503|453270761|FG007|Overall Study|Adverse event, serious fatal|0|||
125994023|NCT01231503|453270754|FG000|Overall Study|Withdrawal by Subject|6|||
125994024|NCT01231503|453270755|FG001|Overall Study|Withdrawal by Subject|3|||
125994025|NCT01231503|453270756|FG002|Overall Study|Withdrawal by Subject|3|||
125994026|NCT01231503|453270757|FG003|Overall Study|Withdrawal by Subject|1|||
125994027|NCT01231503|453270758|FG004|Overall Study|Withdrawal by Subject|3|||
125994028|NCT01231503|453270759|FG005|Overall Study|Withdrawal by Subject|5|||
125994029|NCT01231503|453270760|FG006|Overall Study|Withdrawal by Subject|1|||
125994030|NCT01231503|453270761|FG007|Overall Study|Withdrawal by Subject|2|||
125994031|NCT01231503|453270754|FG000|Overall Study|Lost to Follow-up|8|||
125994032|NCT01231503|453270755|FG001|Overall Study|Lost to Follow-up|10|||
125994033|NCT01231503|453270756|FG002|Overall Study|Lost to Follow-up|8|||
125994034|NCT01231503|453270757|FG003|Overall Study|Lost to Follow-up|5|||
125994035|NCT01231503|453270758|FG004|Overall Study|Lost to Follow-up|7|||
125994036|NCT01231503|453270759|FG005|Overall Study|Lost to Follow-up|9|||
125994037|NCT01231503|453270760|FG006|Overall Study|Lost to Follow-up|6|||
125994038|NCT01231503|453270761|FG007|Overall Study|Lost to Follow-up|6|||
125994039|NCT01231503|453270754|FG000|Overall Study|Protocol Violation|0|||
125994040|NCT01231503|453270755|FG001|Overall Study|Protocol Violation|0|||
125994041|NCT01231503|453270756|FG002|Overall Study|Protocol Violation|0|||
125994042|NCT01231503|453270757|FG003|Overall Study|Protocol Violation|1|||
125994043|NCT01231503|453270758|FG004|Overall Study|Protocol Violation|0|||
125994044|NCT01231503|453270759|FG005|Overall Study|Protocol Violation|0|||
125994045|NCT01231503|453270760|FG006|Overall Study|Protocol Violation|0|||
125994046|NCT01231503|453270761|FG007|Overall Study|Protocol Violation|0|||
125994047|NCT01586338|453270762|FG000|Overall Study|Adverse Event|3|||
125994048|NCT01586338|453270762|FG000|Overall Study|Lost to Follow-up|1|||
125994049|NCT01586338|453270762|FG000|Overall Study|Withdrawal by participant|3|||
125994050|NCT01586338|453270762|FG000|Overall Study|Other|1|||
125994051|NCT00284089|453270763|FG000|Multiple Dose Phase|Adverse Event|1|||
125994052|NCT00284089|453270764|FG001|Multiple Dose Phase|Adverse Event|0|||
125994053|NCT00284089|453270765|FG002|Multiple Dose Phase|Adverse Event|1|||
125994054|NCT00284089|453270766|FG003|Multiple Dose Phase|Adverse Event|1|||
125994055|NCT00284089|453270763|FG000|Multiple Dose Phase|Protocol Violation|0|||
125994056|NCT00284089|453270764|FG001|Multiple Dose Phase|Protocol Violation|0|||
125994057|NCT00284089|453270765|FG002|Multiple Dose Phase|Protocol Violation|1|||
125994058|NCT00284089|453270766|FG003|Multiple Dose Phase|Protocol Violation|0|||
125994059|NCT00284089|453270763|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
125994060|NCT00284089|453270764|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
125994061|NCT00284089|453270765|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
125994062|NCT00284089|453270766|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
125994063|NCT00284089|453270763|FG000|Multiple Dose Phase|Death|0|||
125994064|NCT00284089|453270764|FG001|Multiple Dose Phase|Death|0|||
125994065|NCT00284089|453270765|FG002|Multiple Dose Phase|Death|1|||
125994066|NCT00284089|453270766|FG003|Multiple Dose Phase|Death|1|||
125994067|NCT00284089|453270763|FG000|Extension Phase|Adverse Event|0|||
125994068|NCT00284089|453270764|FG001|Extension Phase|Adverse Event|0|||
125994069|NCT00284089|453270765|FG002|Extension Phase|Adverse Event|2|||
125994070|NCT00284089|453270766|FG003|Extension Phase|Adverse Event|2|||
125994071|NCT00284089|453270763|FG000|Extension Phase|condition no longer requires study drug|2|||
125994072|NCT00284089|453270764|FG001|Extension Phase|condition no longer requires study drug|0|||
125994073|NCT00284089|453270765|FG002|Extension Phase|condition no longer requires study drug|2|||
125994074|NCT00284089|453270766|FG003|Extension Phase|condition no longer requires study drug|7|||
125994075|NCT00284089|453270763|FG000|Extension Phase|Protocol Violation|0|||
125994076|NCT00284089|453270764|FG001|Extension Phase|Protocol Violation|0|||
125994077|NCT00284089|453270765|FG002|Extension Phase|Protocol Violation|1|||
125994078|NCT00284089|453270766|FG003|Extension Phase|Protocol Violation|0|||
125994079|NCT00284089|453270763|FG000|Extension Phase|Withdrawal by Subject|0|||
125994080|NCT00284089|453270764|FG001|Extension Phase|Withdrawal by Subject|0|||
125994081|NCT00284089|453270765|FG002|Extension Phase|Withdrawal by Subject|1|||
125994082|NCT00284089|453270766|FG003|Extension Phase|Withdrawal by Subject|3|||
125994083|NCT01146574|453270769|FG000|Overall Study|Death|0|||
125994084|NCT01146574|453270770|FG001|Overall Study|Death|1|||
125994085|NCT01146574|453270771|FG002|Overall Study|Death|1|||
125994086|NCT01146574|453270772|FG003|Overall Study|Death|0|||
125994087|NCT01146574|453270773|FG004|Overall Study|Death|0|||
125994088|NCT01146574|453270774|FG005|Overall Study|Death|0|||
125994089|NCT01146574|453270775|FG006|Overall Study|Death|0|||
125994090|NCT01146574|453270769|FG000|Overall Study|Other reasons|0|||
125994091|NCT01146574|453270770|FG001|Overall Study|Other reasons|0|||
125994092|NCT01146574|453270771|FG002|Overall Study|Other reasons|3|||
125994093|NCT01146574|453270772|FG003|Overall Study|Other reasons|0|||
125994094|NCT01146574|453270773|FG004|Overall Study|Other reasons|0|||
125994095|NCT01146574|453270774|FG005|Overall Study|Other reasons|0|||
125994096|NCT01146574|453270775|FG006|Overall Study|Other reasons|0|||
125994097|NCT01146574|453270769|FG000|Overall Study|Kidney transplant|0|||
125994098|NCT01146574|453270770|FG001|Overall Study|Kidney transplant|0|||
125994099|NCT01146574|453270771|FG002|Overall Study|Kidney transplant|1|||
125994100|NCT01146574|453270772|FG003|Overall Study|Kidney transplant|1|||
125994101|NCT01146574|453270773|FG004|Overall Study|Kidney transplant|0|||
125994102|NCT01146574|453270774|FG005|Overall Study|Kidney transplant|0|||
125994103|NCT01146574|453270775|FG006|Overall Study|Kidney transplant|0|||
125994104|NCT01146574|453270769|FG000|Overall Study|Withdrew consent|0|||
126330901|NCT02683239|454506776|FG001|Overall Study|Protocol Violation|23|||
126330902|NCT02683239|454506777|FG002|Overall Study|Protocol Violation|26|||
126330903|NCT02683239|454506778|FG003|Overall Study|Protocol Violation|4|||
126330904|NCT02683239|454506779|FG004|Overall Study|Protocol Violation|35|||
126330905|NCT02683239|454506780|FG005|Overall Study|Protocol Violation|4|||
126330906|NCT02683239|454506781|FG006|Overall Study|Protocol Violation|5|||
126330907|NCT02683239|454506775|FG000|Overall Study|Adverse Event|64|||
126330908|NCT02683239|454506776|FG001|Overall Study|Adverse Event|39|||
126330909|NCT02683239|454506777|FG002|Overall Study|Adverse Event|42|||
126330910|NCT02683239|454506778|FG003|Overall Study|Adverse Event|16|||
126330911|NCT02683239|454506779|FG004|Overall Study|Adverse Event|189|||
126330912|NCT02683239|454506780|FG005|Overall Study|Adverse Event|9|||
126330913|NCT02683239|454506781|FG006|Overall Study|Adverse Event|9|||
126330914|NCT02683239|454506775|FG000|Overall Study|Physician Decision|38|||
126330915|NCT02683239|454506776|FG001|Overall Study|Physician Decision|19|||
126330916|NCT02683239|454506777|FG002|Overall Study|Physician Decision|14|||
126330917|NCT02683239|454506778|FG003|Overall Study|Physician Decision|73|||
126330918|NCT02683239|454506779|FG004|Overall Study|Physician Decision|143|||
126330919|NCT02683239|454506780|FG005|Overall Study|Physician Decision|14|||
126330920|NCT02683239|454506781|FG006|Overall Study|Physician Decision|15|||
126330921|NCT02683239|454506775|FG000|Overall Study|Withdrawal by Subject|187|||
126330922|NCT02683239|454506776|FG001|Overall Study|Withdrawal by Subject|99|||
126330923|NCT02683239|454506777|FG002|Overall Study|Withdrawal by Subject|91|||
126330924|NCT02683239|454506778|FG003|Overall Study|Withdrawal by Subject|18|||
126330925|NCT02683239|454506779|FG004|Overall Study|Withdrawal by Subject|248|||
126330926|NCT02683239|454506780|FG005|Overall Study|Withdrawal by Subject|22|||
126330927|NCT02683239|454506781|FG006|Overall Study|Withdrawal by Subject|28|||
126330928|NCT02683239|454506775|FG000|Overall Study|Lost to Follow-up|77|||
126330929|NCT02683239|454506776|FG001|Overall Study|Lost to Follow-up|24|||
126330930|NCT02683239|454506777|FG002|Overall Study|Lost to Follow-up|25|||
126330931|NCT02683239|454506778|FG003|Overall Study|Lost to Follow-up|7|||
126330932|NCT02683239|454506779|FG004|Overall Study|Lost to Follow-up|88|||
126330933|NCT02683239|454506780|FG005|Overall Study|Lost to Follow-up|8|||
126330934|NCT02683239|454506781|FG006|Overall Study|Lost to Follow-up|11|||
126330935|NCT02683239|454506775|FG000|Overall Study|Death|9|||
126330936|NCT02683239|454506776|FG001|Overall Study|Death|5|||
126330937|NCT02683239|454506777|FG002|Overall Study|Death|8|||
126330938|NCT02683239|454506778|FG003|Overall Study|Death|0|||
126330939|NCT02683239|454506779|FG004|Overall Study|Death|12|||
126330940|NCT02683239|454506780|FG005|Overall Study|Death|1|||
126330941|NCT02683239|454506781|FG006|Overall Study|Death|0|||
126330942|NCT02683239|454506775|FG000|Overall Study|Lack of Efficacy|50|||
126330943|NCT02683239|454506776|FG001|Overall Study|Lack of Efficacy|23|||
126330944|NCT02683239|454506777|FG002|Overall Study|Lack of Efficacy|12|||
126330945|NCT02683239|454506778|FG003|Overall Study|Lack of Efficacy|2|||
126330946|NCT02683239|454506779|FG004|Overall Study|Lack of Efficacy|29|||
126330947|NCT02683239|454506780|FG005|Overall Study|Lack of Efficacy|2|||
126330948|NCT02683239|454506781|FG006|Overall Study|Lack of Efficacy|3|||
126330949|NCT02683239|454506775|FG000|Overall Study|Missing data|0|||
126330950|NCT02683239|454506776|FG001|Overall Study|Missing data|1|||
126330951|NCT02683239|454506777|FG002|Overall Study|Missing data|1|||
126330952|NCT02683239|454506778|FG003|Overall Study|Missing data|0|||
126330953|NCT02683239|454506779|FG004|Overall Study|Missing data|1|||
126330954|NCT02683239|454506780|FG005|Overall Study|Missing data|0|||
126330955|NCT02683239|454506781|FG006|Overall Study|Missing data|0|||
126330956|NCT04131712|454506782|FG000|Overall Study|COVID related|0|||
126330957|NCT04131712|454506783|FG001|Overall Study|COVID related|0|||
125994105|NCT01146574|453270770|FG001|Overall Study|Withdrew consent|0|||
125994106|NCT01146574|453270771|FG002|Overall Study|Withdrew consent|1|||
126330958|NCT04131712|454506784|FG002|Overall Study|COVID related|2|||
126330959|NCT04131712|454506785|FG003|Overall Study|COVID related|0|||
126330960|NCT04131712|454506782|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
126330961|NCT04131712|454506783|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
126330962|NCT04131712|454506784|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
126330963|NCT04131712|454506785|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
126330964|NCT00873730|454506786|FG000|Overall Study|Protocol Deviation|5|||
126330965|NCT00873730|454506787|FG001|Overall Study|Protocol Deviation|2|||
125994107|NCT01146574|453270772|FG003|Overall Study|Withdrew consent|1|||
125994108|NCT01146574|453270773|FG004|Overall Study|Withdrew consent|2|||
125994109|NCT01146574|453270774|FG005|Overall Study|Withdrew consent|1|||
125994110|NCT01146574|453270775|FG006|Overall Study|Withdrew consent|1|||
125994111|NCT03051659|453270776|FG000|Treatment Period|Withdrawal by Subject|0|||
125994112|NCT03051659|453270777|FG001|Treatment Period|Withdrawal by Subject|2|||
125994113|NCT03051659|453270776|FG000|Survival Follow-up|Lost to Follow-up|23|||
125994114|NCT03051659|453270777|FG001|Survival Follow-up|Lost to Follow-up|22|||
125994115|NCT00786474|453270778|FG000|Overall Study|Death|5|||
125994116|NCT00786474|453270779|FG001|Overall Study|Death|4|||
125994117|NCT00786474|453270778|FG000|Overall Study|Withdrawal by Subject|23|||
125994118|NCT00786474|453270779|FG001|Overall Study|Withdrawal by Subject|31|||
125994119|NCT00786474|453270778|FG000|Overall Study|Lost to Follow-up|3|||
125994120|NCT00786474|453270779|FG001|Overall Study|Lost to Follow-up|3|||
125994121|NCT00786474|453270778|FG000|Overall Study|Physician Decision|2|||
125994122|NCT00786474|453270779|FG001|Overall Study|Physician Decision|1|||
125994123|NCT00786474|453270778|FG000|Overall Study|Other|4|||
125994124|NCT00786474|453270779|FG001|Overall Study|Other|4|||
125994125|NCT03053492|453270780|FG000|Overall Study|Adverse Event|1|||
125994126|NCT03053492|453270781|FG001|Overall Study|Adverse Event|1|||
125994127|NCT03053492|453270780|FG000|Overall Study|Withdrawal by Subject|7|||
125994128|NCT03053492|453270781|FG001|Overall Study|Withdrawal by Subject|5|||
125994129|NCT01868074|453270782|FG000|Overall Study|Lost to Follow-up|3|||
125994130|NCT01868074|453270783|FG001|Overall Study|Lost to Follow-up|2|||
125994131|NCT01868074|453270782|FG000|Overall Study|Withdrawal by Subject|4|||
125994132|NCT01868074|453270783|FG001|Overall Study|Withdrawal by Subject|2|||
125994133|NCT01544491|453270784|FG000|Overall Study|Withdrawal by Subject|3|||
125994134|NCT01544491|453270785|FG001|Overall Study|Withdrawal by Subject|2|||
125994135|NCT01544491|453270784|FG000|Overall Study|Lost to Follow-up|0|||
125994136|NCT01544491|453270785|FG001|Overall Study|Lost to Follow-up|1|||
125994137|NCT01544491|453270784|FG000|Overall Study|administrative problems|2|||
125994138|NCT01544491|453270785|FG001|Overall Study|administrative problems|0|||
125994139|NCT00967018|453270786|FG000|Overall Study|Adverse Event|2|||
125994140|NCT00967018|453270786|FG000|Overall Study|Physician Decision|7|||
125994141|NCT00967018|453270786|FG000|Overall Study|Lost to Follow-up|2|||
125994142|NCT00967018|453270786|FG000|Overall Study|Withdrawal by Subject|1|||
125994143|NCT00967018|453270786|FG000|Overall Study|Miscellaneous Reasons|9|||
125994144|NCT04642469|453270791|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
125994145|NCT04642469|453270792|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
125994146|NCT04642469|453270791|FG000|Overall Study|Death|1|||
125994147|NCT04642469|453270792|FG001|Overall Study|Death|2|||
125994148|NCT04642469|453270791|FG000|Overall Study|Study/site closed following amendment 1|11|||
125994149|NCT04642469|453270792|FG001|Overall Study|Study/site closed following amendment 1|11|||
125994150|NCT04642469|453270791|FG000|Overall Study|Other|1|||
125994151|NCT04642469|453270792|FG001|Overall Study|Other|1|||
125994152|NCT04642469|453270791|FG000|Overall Study|Withdrawal by Subject|1|||
125994153|NCT04642469|453270792|FG001|Overall Study|Withdrawal by Subject|0|||
125994154|NCT00680056|453270795|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
125994155|NCT00680056|453270796|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
125994156|NCT00680056|453270795|FG000|Second Intervention|Protocol Violation|3|||
125994157|NCT00680056|453270796|FG001|Second Intervention|Protocol Violation|1|||
125994158|NCT02733042|453270797|FG000|Overall Study|Adverse Event|1|||
125994159|NCT02733042|453270798|FG001|Overall Study|Adverse Event|0|||
125994160|NCT02733042|453270799|FG002|Overall Study|Adverse Event|1|||
125994161|NCT02733042|453270800|FG003|Overall Study|Adverse Event|1|||
125994162|NCT02733042|453270801|FG004|Overall Study|Adverse Event|0|||
125994163|NCT02733042|453270802|FG005|Overall Study|Adverse Event|0|||
125994164|NCT02733042|453270803|FG006|Overall Study|Adverse Event|0|||
125994165|NCT02733042|453270804|FG007|Overall Study|Adverse Event|0|||
125994166|NCT02733042|453270805|FG008|Overall Study|Adverse Event|0|||
125994167|NCT02733042|453270806|FG009|Overall Study|Adverse Event|0|||
125994168|NCT02733042|453270807|FG010|Overall Study|Adverse Event|2|||
125994169|NCT02733042|453270808|FG011|Overall Study|Adverse Event|2|||
125994170|NCT02733042|453270809|FG012|Overall Study|Adverse Event|0|||
125994171|NCT02733042|453270810|FG013|Overall Study|Adverse Event|2|||
125994172|NCT02733042|453270811|FG014|Overall Study|Adverse Event|0|||
125994173|NCT02733042|453270812|FG015|Overall Study|Adverse Event|0|||
125994174|NCT02733042|453270813|FG016|Overall Study|Adverse Event|0|||
125994175|NCT02733042|453270814|FG017|Overall Study|Adverse Event|1|||
125994176|NCT02733042|453270815|FG018|Overall Study|Adverse Event|0|||
125994177|NCT02733042|453270797|FG000|Overall Study|Progressive Disease|2|||
125994178|NCT02733042|453270798|FG001|Overall Study|Progressive Disease|1|||
125994179|NCT02733042|453270799|FG002|Overall Study|Progressive Disease|3|||
126330966|NCT00873730|454506786|FG000|Overall Study|Adverse Event|0|||
125994180|NCT02733042|453270800|FG003|Overall Study|Progressive Disease|1|||
125994181|NCT02733042|453270801|FG004|Overall Study|Progressive Disease|2|||
125994182|NCT02733042|453270802|FG005|Overall Study|Progressive Disease|3|||
125994183|NCT02733042|453270803|FG006|Overall Study|Progressive Disease|0|||
125994184|NCT02733042|453270804|FG007|Overall Study|Progressive Disease|3|||
125994185|NCT02733042|453270805|FG008|Overall Study|Progressive Disease|3|||
125994186|NCT02733042|453270806|FG009|Overall Study|Progressive Disease|2|||
125994187|NCT02733042|453270807|FG010|Overall Study|Progressive Disease|2|||
125994188|NCT02733042|453270808|FG011|Overall Study|Progressive Disease|2|||
125994189|NCT02733042|453270809|FG012|Overall Study|Progressive Disease|8|||
125994190|NCT02733042|453270810|FG013|Overall Study|Progressive Disease|1|||
125994191|NCT02733042|453270811|FG014|Overall Study|Progressive Disease|4|||
125994192|NCT02733042|453270812|FG015|Overall Study|Progressive Disease|7|||
125994193|NCT02733042|453270813|FG016|Overall Study|Progressive Disease|2|||
125994194|NCT02733042|453270814|FG017|Overall Study|Progressive Disease|3|||
125994195|NCT02733042|453270815|FG018|Overall Study|Progressive Disease|4|||
125994196|NCT02733042|453270797|FG000|Overall Study|Withdrawal by Subject|0|||
125994197|NCT02733042|453270798|FG001|Overall Study|Withdrawal by Subject|1|||
125994198|NCT02733042|453270799|FG002|Overall Study|Withdrawal by Subject|2|||
125994199|NCT02733042|453270800|FG003|Overall Study|Withdrawal by Subject|1|||
125994200|NCT02733042|453270801|FG004|Overall Study|Withdrawal by Subject|1|||
125994201|NCT02733042|453270802|FG005|Overall Study|Withdrawal by Subject|0|||
125994202|NCT02733042|453270803|FG006|Overall Study|Withdrawal by Subject|0|||
125994203|NCT02733042|453270804|FG007|Overall Study|Withdrawal by Subject|0|||
125994204|NCT02733042|453270805|FG008|Overall Study|Withdrawal by Subject|1|||
125994205|NCT02733042|453270806|FG009|Overall Study|Withdrawal by Subject|1|||
125994206|NCT02733042|453270807|FG010|Overall Study|Withdrawal by Subject|0|||
125994207|NCT02733042|453270808|FG011|Overall Study|Withdrawal by Subject|2|||
125994208|NCT02733042|453270809|FG012|Overall Study|Withdrawal by Subject|1|||
125994209|NCT02733042|453270810|FG013|Overall Study|Withdrawal by Subject|1|||
125994210|NCT02733042|453270811|FG014|Overall Study|Withdrawal by Subject|0|||
125994211|NCT02733042|453270812|FG015|Overall Study|Withdrawal by Subject|0|||
125994212|NCT02733042|453270813|FG016|Overall Study|Withdrawal by Subject|0|||
125994213|NCT02733042|453270814|FG017|Overall Study|Withdrawal by Subject|0|||
125994214|NCT02733042|453270815|FG018|Overall Study|Withdrawal by Subject|0|||
125994215|NCT02733042|453270797|FG000|Overall Study|Other Reasons|0|||
125994216|NCT02733042|453270798|FG001|Overall Study|Other Reasons|0|||
125994217|NCT02733042|453270799|FG002|Overall Study|Other Reasons|1|||
125994218|NCT02733042|453270800|FG003|Overall Study|Other Reasons|0|||
125994219|NCT02733042|453270801|FG004|Overall Study|Other Reasons|0|||
125994220|NCT02733042|453270802|FG005|Overall Study|Other Reasons|0|||
125994221|NCT02733042|453270803|FG006|Overall Study|Other Reasons|0|||
125994222|NCT02733042|453270804|FG007|Overall Study|Other Reasons|0|||
125994223|NCT02733042|453270805|FG008|Overall Study|Other Reasons|0|||
125994224|NCT02733042|453270806|FG009|Overall Study|Other Reasons|1|||
125994225|NCT02733042|453270807|FG010|Overall Study|Other Reasons|1|||
125994226|NCT02733042|453270808|FG011|Overall Study|Other Reasons|0|||
125994227|NCT02733042|453270809|FG012|Overall Study|Other Reasons|0|||
125994228|NCT02733042|453270810|FG013|Overall Study|Other Reasons|0|||
125994229|NCT02733042|453270811|FG014|Overall Study|Other Reasons|0|||
125994230|NCT02733042|453270812|FG015|Overall Study|Other Reasons|1|||
125994231|NCT02733042|453270813|FG016|Overall Study|Other Reasons|0|||
125994232|NCT02733042|453270814|FG017|Overall Study|Other Reasons|1|||
125994233|NCT02733042|453270815|FG018|Overall Study|Other Reasons|0|||
125994234|NCT02733042|453270797|FG000|Overall Study|Death|0|||
125994235|NCT02733042|453270798|FG001|Overall Study|Death|0|||
125994236|NCT02733042|453270799|FG002|Overall Study|Death|0|||
125994237|NCT02733042|453270800|FG003|Overall Study|Death|0|||
125994238|NCT02733042|453270801|FG004|Overall Study|Death|0|||
125994239|NCT02733042|453270802|FG005|Overall Study|Death|0|||
125994240|NCT02733042|453270803|FG006|Overall Study|Death|1|||
125994241|NCT02733042|453270804|FG007|Overall Study|Death|0|||
125994242|NCT02733042|453270805|FG008|Overall Study|Death|1|||
125994243|NCT02733042|453270806|FG009|Overall Study|Death|0|||
125994244|NCT02733042|453270807|FG010|Overall Study|Death|1|||
125994245|NCT02733042|453270808|FG011|Overall Study|Death|0|||
125994246|NCT02733042|453270809|FG012|Overall Study|Death|0|||
125994247|NCT02733042|453270810|FG013|Overall Study|Death|0|||
125994248|NCT02733042|453270811|FG014|Overall Study|Death|1|||
125994249|NCT02733042|453270812|FG015|Overall Study|Death|2|||
125994250|NCT02733042|453270813|FG016|Overall Study|Death|0|||
125994251|NCT02733042|453270814|FG017|Overall Study|Death|0|||
125994252|NCT02733042|453270815|FG018|Overall Study|Death|0|||
125994253|NCT01821898|453270816|FG000|Overall Study|Withdrawal by Subject|2|||
125994254|NCT01821898|453270817|FG001|Overall Study|Withdrawal by Subject|1|||
125994255|NCT00337662|453270820|FG000|Study Period II|Lost to Follow-up|0|||
125994256|NCT00337662|453270821|FG001|Study Period II|Lost to Follow-up|0|||
125994257|NCT00337662|453270822|FG002|Study Period II|Lost to Follow-up|0|||
125994258|NCT00337662|453270823|FG003|Study Period II|Lost to Follow-up|35|||
125994259|NCT00337662|453270820|FG000|Study Period II|Withdrawal by Subject|0|||
125994260|NCT00337662|453270821|FG001|Study Period II|Withdrawal by Subject|0|||
125994261|NCT00337662|453270822|FG002|Study Period II|Withdrawal by Subject|0|||
125994262|NCT00337662|453270823|FG003|Study Period II|Withdrawal by Subject|20|||
125994263|NCT00337662|453270820|FG000|Study Period II|Adverse Event|0|||
125994264|NCT00337662|453270821|FG001|Study Period II|Adverse Event|0|||
125994265|NCT00337662|453270822|FG002|Study Period II|Adverse Event|0|||
125994266|NCT00337662|453270823|FG003|Study Period II|Adverse Event|16|||
125994267|NCT00337662|453270820|FG000|Study Period II|Physician Decision|0|||
125994268|NCT00337662|453270821|FG001|Study Period II|Physician Decision|0|||
125994269|NCT00337662|453270822|FG002|Study Period II|Physician Decision|0|||
125994270|NCT00337662|453270823|FG003|Study Period II|Physician Decision|13|||
125994271|NCT00337662|453270820|FG000|Study Period II|Entry Criteria Not Met|0|||
125994272|NCT00337662|453270821|FG001|Study Period II|Entry Criteria Not Met|0|||
125994273|NCT00337662|453270822|FG002|Study Period II|Entry Criteria Not Met|0|||
125994274|NCT00337662|453270823|FG003|Study Period II|Entry Criteria Not Met|6|||
125994275|NCT00337662|453270820|FG000|Study Period II|Protocol Violation|0|||
125994276|NCT00337662|453270821|FG001|Study Period II|Protocol Violation|0|||
125994277|NCT00337662|453270822|FG002|Study Period II|Protocol Violation|0|||
125994278|NCT00337662|453270823|FG003|Study Period II|Protocol Violation|6|||
125994279|NCT00337662|453270820|FG000|Study Period II|Lack of Efficacy|0|||
125994280|NCT00337662|453270821|FG001|Study Period II|Lack of Efficacy|0|||
125994281|NCT00337662|453270822|FG002|Study Period II|Lack of Efficacy|0|||
125994282|NCT00337662|453270823|FG003|Study Period II|Lack of Efficacy|7|||
125994283|NCT00337662|453270820|FG000|Study Period II|Sponsor Decision|0|||
125994284|NCT00337662|453270821|FG001|Study Period II|Sponsor Decision|0|||
125994285|NCT00337662|453270822|FG002|Study Period II|Sponsor Decision|0|||
125994286|NCT00337662|453270823|FG003|Study Period II|Sponsor Decision|2|||
125994287|NCT00337662|453270820|FG000|Study Period II|Parent/Caregiver Decision|0|||
125994288|NCT00337662|453270821|FG001|Study Period II|Parent/Caregiver Decision|0|||
125994289|NCT00337662|453270822|FG002|Study Period II|Parent/Caregiver Decision|0|||
125994290|NCT00337662|453270823|FG003|Study Period II|Parent/Caregiver Decision|1|||
125994291|NCT00337662|453270820|FG000|Study Period III|Lost to Follow-up|14|||
125994292|NCT00337662|453270821|FG001|Study Period III|Lost to Follow-up|16|||
125994293|NCT00337662|453270822|FG002|Study Period III|Lost to Follow-up|14|||
125994294|NCT00337662|453270823|FG003|Study Period III|Lost to Follow-up|0|||
125994295|NCT00337662|453270820|FG000|Study Period III|Withdrawal by Subject|18|||
125994296|NCT00337662|453270821|FG001|Study Period III|Withdrawal by Subject|14|||
125994297|NCT00337662|453270822|FG002|Study Period III|Withdrawal by Subject|12|||
125994298|NCT00337662|453270823|FG003|Study Period III|Withdrawal by Subject|0|||
125994299|NCT00337662|453270820|FG000|Study Period III|Adverse Event|9|||
125994300|NCT00337662|453270821|FG001|Study Period III|Adverse Event|10|||
125994301|NCT00337662|453270822|FG002|Study Period III|Adverse Event|8|||
125994302|NCT00337662|453270823|FG003|Study Period III|Adverse Event|0|||
125994303|NCT00337662|453270820|FG000|Study Period III|Protocol Violation|3|||
125994304|NCT00337662|453270821|FG001|Study Period III|Protocol Violation|8|||
125994305|NCT00337662|453270822|FG002|Study Period III|Protocol Violation|2|||
125994306|NCT00337662|453270823|FG003|Study Period III|Protocol Violation|0|||
125994307|NCT00337662|453270820|FG000|Study Period III|Physician Decision|6|||
125994308|NCT00337662|453270821|FG001|Study Period III|Physician Decision|5|||
125994309|NCT00337662|453270822|FG002|Study Period III|Physician Decision|0|||
125994310|NCT00337662|453270823|FG003|Study Period III|Physician Decision|0|||
125994311|NCT00337662|453270820|FG000|Study Period III|Entry Criteria Not Met|4|||
125994312|NCT00337662|453270821|FG001|Study Period III|Entry Criteria Not Met|1|||
125994313|NCT00337662|453270822|FG002|Study Period III|Entry Criteria Not Met|3|||
125994314|NCT00337662|453270823|FG003|Study Period III|Entry Criteria Not Met|0|||
125994315|NCT00337662|453270820|FG000|Study Period III|Lack of Efficacy|4|||
125994316|NCT00337662|453270821|FG001|Study Period III|Lack of Efficacy|4|||
125994317|NCT00337662|453270822|FG002|Study Period III|Lack of Efficacy|2|||
125994318|NCT00337662|453270823|FG003|Study Period III|Lack of Efficacy|0|||
125994319|NCT00337662|453270820|FG000|Study Period III|Parent/Caregiver Decision|0|||
125994320|NCT00337662|453270821|FG001|Study Period III|Parent/Caregiver Decision|0|||
125994321|NCT00337662|453270822|FG002|Study Period III|Parent/Caregiver Decision|2|||
125994322|NCT00337662|453270823|FG003|Study Period III|Parent/Caregiver Decision|0|||
125994323|NCT00337662|453270820|FG000|Study Period III|Sponsor Decision|1|||
125994324|NCT00337662|453270821|FG001|Study Period III|Sponsor Decision|0|||
125994325|NCT00337662|453270822|FG002|Study Period III|Sponsor Decision|1|||
125994326|NCT00337662|453270823|FG003|Study Period III|Sponsor Decision|0|||
125994327|NCT00337662|453270820|FG000|Study Period III|Clinical Relapse|1|||
125994328|NCT00337662|453270821|FG001|Study Period III|Clinical Relapse|0|||
125994329|NCT00337662|453270822|FG002|Study Period III|Clinical Relapse|0|||
125994330|NCT00337662|453270823|FG003|Study Period III|Clinical Relapse|0|||
125994331|NCT03691948|453270824|FG000|Overall Study|Lost to Follow-up|1|||
125994332|NCT03691948|453270825|FG001|Overall Study|Lost to Follow-up|3|||
125994333|NCT02344537|453270827|FG000|Overall Study|Protocol Violation|1|||
125994334|NCT02344537|453270828|FG001|Overall Study|Protocol Violation|1|||
125994335|NCT02344537|453270827|FG000|Overall Study|Subject started another treatment after wk 6|1|||
125878646|NCT01972217|452853374|FG003|Part B Double-blind, Randomised Period|Death|44|||
125994336|NCT02344537|453270828|FG001|Overall Study|Subject started another treatment after wk 6|0|||
125994337|NCT02344537|453270827|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
125994338|NCT02344537|453270828|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
125994339|NCT00960752|453270830|FG000|Overall Study|Adverse Event|0|||
125994340|NCT00960752|453270831|FG001|Overall Study|Adverse Event|0|||
125994341|NCT00960752|453270832|FG002|Overall Study|Adverse Event|1|||
125994342|NCT00960752|453270830|FG000|Overall Study|Progression|0|||
125994343|NCT00960752|453270831|FG001|Overall Study|Progression|0|||
125994344|NCT00960752|453270832|FG002|Overall Study|Progression|1|||
125994345|NCT02180438|453270838|FG000|Overall Study|Lost to Follow-up|1|||
125994346|NCT00180713|453270841|FG000|Overall Study|Withdrawal by Subject|2|||
125994347|NCT00180713|453270842|FG001|Overall Study|Withdrawal by Subject|0|||
125994348|NCT00180713|453270841|FG000|Overall Study|Adverse Event|3|||
125994349|NCT00180713|453270842|FG001|Overall Study|Adverse Event|3|||
125994350|NCT00514046|453270848|FG000|Overall Study|transferred to another protocol|2|||
125994351|NCT00514046|453270849|FG001|Overall Study|transferred to another protocol|1|||
125994352|NCT00514046|453270850|FG002|Overall Study|transferred to another protocol|3|||
125994353|NCT00514046|453270851|FG003|Overall Study|transferred to another protocol|0|||
125994354|NCT00514046|453270852|FG004|Overall Study|transferred to another protocol|1|||
125994355|NCT00514046|453270853|FG005|Overall Study|transferred to another protocol|0|||
125994356|NCT00514046|453270854|FG006|Overall Study|transferred to another protocol|0|||
125994357|NCT00514046|453270855|FG007|Overall Study|transferred to another protocol|0|||
125994358|NCT00514046|453270856|FG008|Overall Study|transferred to another protocol|0|||
125994359|NCT00514046|453270848|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
125994360|NCT00514046|453270849|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
125994361|NCT00514046|453270850|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
125994362|NCT00514046|453270851|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
125994363|NCT00514046|453270852|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
125994364|NCT00514046|453270853|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
125994365|NCT00514046|453270854|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
125994366|NCT00514046|453270855|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
125994367|NCT00514046|453270856|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
125994368|NCT00514046|453270848|FG000|Overall Study|Disease progression on study|0|||
125994369|NCT00514046|453270849|FG001|Overall Study|Disease progression on study|0|||
125994370|NCT00514046|453270850|FG002|Overall Study|Disease progression on study|2|||
125994371|NCT00514046|453270851|FG003|Overall Study|Disease progression on study|0|||
125994372|NCT00514046|453270852|FG004|Overall Study|Disease progression on study|0|||
125994373|NCT00514046|453270853|FG005|Overall Study|Disease progression on study|1|||
125994374|NCT00514046|453270854|FG006|Overall Study|Disease progression on study|0|||
125994375|NCT00514046|453270855|FG007|Overall Study|Disease progression on study|0|||
125994376|NCT00514046|453270856|FG008|Overall Study|Disease progression on study|0|||
125994377|NCT00655551|453270857|FG000|All Periods Combined|Adverse Event|0|||
125994378|NCT00655551|453270858|FG001|All Periods Combined|Adverse Event|3|||
125994379|NCT00655551|453270859|FG002|All Periods Combined|Adverse Event|4|||
125994380|NCT00655551|453270857|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
125994381|NCT00655551|453270858|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
125994382|NCT00655551|453270859|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
125994383|NCT00655551|453270857|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
125994384|NCT00655551|453270858|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
126330967|NCT00873730|454506787|FG001|Overall Study|Adverse Event|2|||
126330968|NCT00873730|454506786|FG000|Overall Study|Withdrawal by Subject|0|||
126330969|NCT00873730|454506787|FG001|Overall Study|Withdrawal by Subject|1|||
126330970|NCT00873730|454506786|FG000|Overall Study|Sponsor decision|1|||
126330971|NCT00873730|454506787|FG001|Overall Study|Sponsor decision|0|||
126330972|NCT00103662|454506788|FG000|Overall Study|Entered Rescue Procedure|0|||
126330973|NCT00103662|454506789|FG001|Overall Study|Entered Rescue Procedure|7|||
126330974|NCT00103662|454506788|FG000|Overall Study|Death|7|||
126330975|NCT00103662|454506789|FG001|Overall Study|Death|7|||
126330976|NCT00103662|454506788|FG000|Overall Study|Elective Withdrawal|5|||
126330977|NCT00103662|454506789|FG001|Overall Study|Elective Withdrawal|5|||
126330978|NCT00103662|454506788|FG000|Overall Study|Lost to Follow-up|0|||
126330979|NCT00103662|454506789|FG001|Overall Study|Lost to Follow-up|1|||
126330980|NCT00103662|454506788|FG000|Overall Study|Other|6|||
126330981|NCT00103662|454506789|FG001|Overall Study|Other|9|||
126330982|NCT00103662|454506788|FG000|Overall Study|Failed mobilization|0|||
126330983|NCT00103662|454506789|FG001|Overall Study|Failed mobilization|4|||
126330984|NCT00103662|454506788|FG000|Overall Study|Intercurrent illness|1|||
126330985|NCT00103662|454506789|FG001|Overall Study|Intercurrent illness|0|||
126330986|NCT00943397|454506790|FG000|Overall Study|Adverse Event|0|||
126330987|NCT00943397|454506791|FG001|Overall Study|Adverse Event|6|||
126330988|NCT00943397|454506790|FG000|Overall Study|Lost to Follow-up|0|||
125994385|NCT00655551|453270859|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
125994386|NCT00655551|453270857|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
125994387|NCT00655551|453270858|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
125994388|NCT00655551|453270859|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
125994389|NCT00876460|453270861|FG000|Combination Therapy Phase|Progressive disease|2|||
125994390|NCT00876460|453270862|FG001|Combination Therapy Phase|Progressive disease|3|||
125994391|NCT00876460|453270863|FG002|Combination Therapy Phase|Progressive disease|3|||
125994392|NCT00876460|453270864|FG003|Combination Therapy Phase|Progressive disease|3|||
125994393|NCT00876460|453270865|FG004|Combination Therapy Phase|Progressive disease|3|||
125994394|NCT00876460|453270866|FG005|Combination Therapy Phase|Progressive disease|1|||
125994395|NCT00876460|453270867|FG006|Combination Therapy Phase|Progressive disease|1|||
125994396|NCT00876460|453270868|FG007|Combination Therapy Phase|Progressive disease|1|||
125994397|NCT00876460|453270861|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
125994398|NCT00876460|453270862|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
125994399|NCT00876460|453270863|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
125994400|NCT00876460|453270864|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
125994401|NCT00876460|453270865|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
125994402|NCT00876460|453270866|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
125994403|NCT00876460|453270867|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
125994404|NCT00876460|453270868|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
125994405|NCT00876460|453270861|FG000|Combination Therapy Phase|Adverse Event|0|||
125994406|NCT00876460|453270862|FG001|Combination Therapy Phase|Adverse Event|2|||
125994407|NCT00876460|453270863|FG002|Combination Therapy Phase|Adverse Event|0|||
125994408|NCT00876460|453270864|FG003|Combination Therapy Phase|Adverse Event|2|||
125994409|NCT00876460|453270865|FG004|Combination Therapy Phase|Adverse Event|2|||
125994410|NCT00876460|453270866|FG005|Combination Therapy Phase|Adverse Event|0|||
125994411|NCT00876460|453270867|FG006|Combination Therapy Phase|Adverse Event|3|||
125994412|NCT00876460|453270868|FG007|Combination Therapy Phase|Adverse Event|2|||
125994413|NCT00876460|453270861|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
125994414|NCT00876460|453270862|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
125994415|NCT00876460|453270863|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
125994416|NCT00876460|453270864|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
125994417|NCT00876460|453270865|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
125994418|NCT00876460|453270866|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
125994419|NCT00876460|453270867|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
125994420|NCT00876460|453270868|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
125994421|NCT00876460|453270861|FG000|Combination Therapy Phase|Other reason not defined above|0|||
125994422|NCT00876460|453270862|FG001|Combination Therapy Phase|Other reason not defined above|0|||
125994423|NCT00876460|453270863|FG002|Combination Therapy Phase|Other reason not defined above|0|||
125994424|NCT00876460|453270864|FG003|Combination Therapy Phase|Other reason not defined above|0|||
125994425|NCT00876460|453270865|FG004|Combination Therapy Phase|Other reason not defined above|0|||
126330989|NCT00943397|454506791|FG001|Overall Study|Lost to Follow-up|4|||
126330990|NCT00943397|454506790|FG000|Overall Study|Protocol Violation|2|||
126330991|NCT00943397|454506791|FG001|Overall Study|Protocol Violation|5|||
126330992|NCT00943397|454506790|FG000|Overall Study|Withdrawal by Subject|1|||
126330993|NCT00943397|454506791|FG001|Overall Study|Withdrawal by Subject|1|||
126330994|NCT00943397|454506790|FG000|Overall Study|Site terminated and other|12|||
126330995|NCT00943397|454506791|FG001|Overall Study|Site terminated and other|56|||
126330996|NCT04878055|454506792|FG000|Overall Study|Patient transferred in another department|0|||
126330997|NCT04878055|454506793|FG001|Overall Study|Patient transferred in another department|2|||
126330998|NCT04878055|454506792|FG000|Overall Study|Physician Decision|1|||
126330999|NCT04878055|454506793|FG001|Overall Study|Physician Decision|1|||
126331000|NCT04878055|454506792|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
126331001|NCT04878055|454506793|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
126331002|NCT04878055|454506792|FG000|Overall Study|Adverse Event|12|||
126331003|NCT04878055|454506793|FG001|Overall Study|Adverse Event|7|||
126331004|NCT04878055|454506792|FG000|Overall Study|Other|5|||
126331005|NCT04878055|454506793|FG001|Overall Study|Other|0|||
126331006|NCT04878055|454506792|FG000|Overall Study|Withdrawal by Subject|7|||
126331007|NCT04878055|454506793|FG001|Overall Study|Withdrawal by Subject|3|||
126331008|NCT04878055|454506792|FG000|Overall Study|Lost to Follow-up|10|||
126331009|NCT04878055|454506793|FG001|Overall Study|Lost to Follow-up|1|||
126331010|NCT01968811|454506794|FG000|Overall Study|Protocol Violation|4|||
126331011|NCT01968811|454506794|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
126331012|NCT05225558|454506798|FG000|Overall Study|Withdrawal by Subject|4|||
126331013|NCT05225558|454506799|FG001|Overall Study|Withdrawal by Subject|3|||
126331014|NCT05225558|454506798|FG000|Overall Study|Adverse Event|1|||
126331015|NCT05225558|454506799|FG001|Overall Study|Adverse Event|0|||
125994426|NCT00876460|453270866|FG005|Combination Therapy Phase|Other reason not defined above|0|||
125994427|NCT00876460|453270867|FG006|Combination Therapy Phase|Other reason not defined above|1|||
126331016|NCT05225558|454506798|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
126331017|NCT05225558|454506799|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
126331018|NCT05225558|454506798|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
126331019|NCT05225558|454506799|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
126331020|NCT03006562|454506800|FG000|Overall Study|Lost to Follow-up|0|||
126331021|NCT03006562|454506801|FG001|Overall Study|Lost to Follow-up|1|||
125878647|NCT01972217|452853371|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125994428|NCT00876460|453270868|FG007|Combination Therapy Phase|Other reason not defined above|2|||
125994429|NCT00876460|453270861|FG000|Combination Therapy Phase|Not treated|0|||
125994430|NCT00876460|453270862|FG001|Combination Therapy Phase|Not treated|0|||
125994431|NCT00876460|453270863|FG002|Combination Therapy Phase|Not treated|0|||
125994432|NCT00876460|453270864|FG003|Combination Therapy Phase|Not treated|0|||
125994433|NCT00876460|453270865|FG004|Combination Therapy Phase|Not treated|0|||
125994434|NCT00876460|453270866|FG005|Combination Therapy Phase|Not treated|0|||
125994435|NCT00876460|453270867|FG006|Combination Therapy Phase|Not treated|1|||
125994436|NCT00876460|453270868|FG007|Combination Therapy Phase|Not treated|0|||
125994437|NCT00876460|453270861|FG000|Mono Therapy Phase|Progressive disease|0|||
125994438|NCT00876460|453270862|FG001|Mono Therapy Phase|Progressive disease|0|||
125994439|NCT00876460|453270863|FG002|Mono Therapy Phase|Progressive disease|0|||
125994440|NCT00876460|453270864|FG003|Mono Therapy Phase|Progressive disease|0|||
125994441|NCT00876460|453270865|FG004|Mono Therapy Phase|Progressive disease|2|||
125994442|NCT00876460|453270866|FG005|Mono Therapy Phase|Progressive disease|0|||
125994443|NCT00876460|453270867|FG006|Mono Therapy Phase|Progressive disease|1|||
125994444|NCT00876460|453270868|FG007|Mono Therapy Phase|Progressive disease|3|||
125994445|NCT00876460|453270861|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
125994446|NCT00876460|453270862|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
125994447|NCT00876460|453270863|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
125994448|NCT00876460|453270864|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
125994449|NCT00876460|453270865|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
125994450|NCT00876460|453270866|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
125994451|NCT00876460|453270867|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
125994452|NCT00876460|453270868|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
126331022|NCT02427841|454506803|FG000|Overall Study|Lack of Efficacy|5|||
126331023|NCT02427841|454506803|FG000|Overall Study|Physician Decision|2|||
126331024|NCT02427841|454506803|FG000|Overall Study|Withdrawal by Subject|1|||
126331025|NCT05417412|454506804|FG000|Overall Study|Lost to Follow-up|2|||
126331026|NCT02592447|454506807|FG000|Overall Study|Lost to Follow-up|1|||
126331027|NCT02592447|454506808|FG001|Overall Study|Lost to Follow-up|0|||
126331028|NCT02592447|454506807|FG000|Overall Study|Ineligible after randomization|1|||
126331029|NCT02592447|454506808|FG001|Overall Study|Ineligible after randomization|0|||
126331030|NCT02592447|454506807|FG000|Overall Study|Withdrawal by Subject|0|||
126331031|NCT02592447|454506808|FG001|Overall Study|Withdrawal by Subject|1|||
126331032|NCT01841970|454506809|FG000|Overall Study|Withdrawal by Subject|1|||
126331033|NCT01841970|454506809|FG000|Overall Study|Physician Decision|2|||
126331034|NCT01841970|454506809|FG000|Overall Study|Lost to Follow-up|8|||
126331035|NCT03478371|454506810|FG000|Overall Study|non-compliance|1|||
126331036|NCT03478371|454506810|FG000|Overall Study|Lost to Follow-up|4|||
126331037|NCT02849743|454506815|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
126331038|NCT02849743|454506816|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
126331039|NCT02849743|454506815|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
126331040|NCT02849743|454506816|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
126331041|NCT01048541|454506819|FG000|Overall Study|Withdrawal by Subject|1|||
126331042|NCT01048541|454506820|FG001|Overall Study|Withdrawal by Subject|0|||
126331043|NCT00627497|454506821|FG000|Overall Study|Lost to Follow-up|1|||
126331044|NCT00627497|454506822|FG001|Overall Study|Lost to Follow-up|1|||
126331045|NCT00627497|454506823|FG002|Overall Study|Lost to Follow-up|0|||
126331046|NCT00627497|454506824|FG003|Overall Study|Lost to Follow-up|0|||
126331047|NCT00922116|454506825|FG000|Overall Study|Adverse Event|4|||
126331048|NCT00922116|454506825|FG000|Overall Study|Death|1|||
126331049|NCT00922116|454506825|FG000|Overall Study|Lost to Follow-up|1|||
126331050|NCT00922116|454506825|FG000|Overall Study|Withdrawal by Subject|4|||
126331051|NCT00922116|454506825|FG000|Overall Study|Other|5|||
126331052|NCT04607135|454506826|FG000|Overall Study|Physician Decision|1|||
126331053|NCT04607135|454506826|FG000|Overall Study|Withdrawal by Subject|1|||
126331054|NCT04607135|454506826|FG000|Overall Study|Equipment not working|3|||
126331055|NCT00618826|454506827|FG000|Overall Study|Adverse Event|1|||
126331056|NCT01509664|454506829|FG000|Overall Study|Lost to Follow-up|15|||
126331057|NCT01509664|454506830|FG001|Overall Study|Lost to Follow-up|21|||
126331058|NCT00807885|454506835|FG000|Overall Study|Lost to Follow-up|0|||
126331059|NCT00807885|454506836|FG001|Overall Study|Lost to Follow-up|0|||
126331060|NCT00807885|454506837|FG002|Overall Study|Lost to Follow-up|0|||
126331061|NCT00807885|454506838|FG003|Overall Study|Lost to Follow-up|0|||
126331062|NCT00807885|454506839|FG004|Overall Study|Lost to Follow-up|0|||
126331063|NCT00807885|454506840|FG005|Overall Study|Lost to Follow-up|1|||
126331064|NCT00807885|454506841|FG006|Overall Study|Lost to Follow-up|0|||
126331065|NCT00807885|454506842|FG007|Overall Study|Lost to Follow-up|0|||
126331066|NCT00807885|454506843|FG008|Overall Study|Lost to Follow-up|0|||
125994453|NCT00876460|453270861|FG000|Mono Therapy Phase|Adverse Event|0|||
125994454|NCT00876460|453270862|FG001|Mono Therapy Phase|Adverse Event|0|||
126331067|NCT02364388|454506844|FG000|Overall Study|Protocol Violation|1|||
126331068|NCT02364388|454506844|FG000|Overall Study|Technical Failure|3|||
125994455|NCT00876460|453270863|FG002|Mono Therapy Phase|Adverse Event|0|||
126331069|NCT02364388|454506844|FG000|Overall Study|No OA/US data|2|||
126331070|NCT02364388|454506844|FG000|Overall Study|No Biopsy|2|||
126331071|NCT00327717|454506845|FG000|Overall Study|Adverse Event|6|||
126331072|NCT00327717|454506846|FG001|Overall Study|Adverse Event|6|||
126331073|NCT00327717|454506845|FG000|Overall Study|Lack of Efficacy|0|||
126331074|NCT00327717|454506846|FG001|Overall Study|Lack of Efficacy|1|||
126331075|NCT00327717|454506845|FG000|Overall Study|Withdrawal by Subject|3|||
126331076|NCT00327717|454506846|FG001|Overall Study|Withdrawal by Subject|7|||
125994456|NCT00876460|453270864|FG003|Mono Therapy Phase|Adverse Event|1|||
125994457|NCT00876460|453270865|FG004|Mono Therapy Phase|Adverse Event|0|||
125994458|NCT00876460|453270866|FG005|Mono Therapy Phase|Adverse Event|0|||
125994459|NCT00876460|453270867|FG006|Mono Therapy Phase|Adverse Event|0|||
125994460|NCT00876460|453270868|FG007|Mono Therapy Phase|Adverse Event|0|||
125994461|NCT01051063|453270869|FG000|Overall Study|Death|2|||
125994462|NCT01051063|453270870|FG001|Overall Study|Death|2|||
125994463|NCT01051063|453270869|FG000|Overall Study|Withdrawal by Subject|1|||
125994464|NCT01051063|453270870|FG001|Overall Study|Withdrawal by Subject|1|||
125994465|NCT01051063|453270869|FG000|Overall Study|Termination of the study|5|||
125994466|NCT01051063|453270870|FG001|Overall Study|Termination of the study|0|||
125994467|NCT01051063|453270869|FG000|Overall Study|Moved from the study site area|1|||
126331077|NCT00905424|454506847|FG000|Overall Study|Lost to Follow-up|3|||
126331078|NCT00905424|454506848|FG001|Overall Study|Lost to Follow-up|3|||
126331079|NCT00905424|454506847|FG000|Overall Study|Withdrawal by Subject|1|||
126331080|NCT00905424|454506848|FG001|Overall Study|Withdrawal by Subject|2|||
126331081|NCT00905424|454506847|FG000|Overall Study|Adverse Event|4|||
126331082|NCT00905424|454506848|FG001|Overall Study|Adverse Event|2|||
126331083|NCT00905424|454506847|FG000|Overall Study|Non-compliance with study medication|2|||
126331084|NCT00905424|454506848|FG001|Overall Study|Non-compliance with study medication|0|||
126331085|NCT00905424|454506847|FG000|Overall Study|Sponsor decision|1|||
126331086|NCT00905424|454506848|FG001|Overall Study|Sponsor decision|0|||
126331087|NCT00905424|454506847|FG000|Overall Study|Positive urine drug screen|0|||
126331088|NCT00905424|454506848|FG001|Overall Study|Positive urine drug screen|1|||
126331089|NCT00905424|454506847|FG000|Overall Study|Non-adherence to visit schedule|0|||
126331090|NCT00905424|454506848|FG001|Overall Study|Non-adherence to visit schedule|1|||
126331091|NCT00426764|454506849|FG000|Overall Study|Protocol Violation|1|||
126331092|NCT00426764|454506849|FG000|Overall Study|Withdrawal by Subject|4|||
126331093|NCT00426764|454506849|FG000|Overall Study|Physician Decision|6|||
126331094|NCT00426764|454506849|FG000|Overall Study|Compassionate Use|1|||
126331095|NCT00426764|454506849|FG000|Overall Study|Progressive Disease|83|||
126331096|NCT00426764|454506849|FG000|Overall Study|Adverse Event|24|||
126331097|NCT00426764|454506849|FG000|Overall Study|Other|1|||
126331098|NCT00426764|454506849|FG000|Overall Study|Death|1|||
126331099|NCT00426764|454506849|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
126331100|NCT01737879|454506850|FG000|Overall Study|Death|1|||
126331101|NCT01737879|454506850|FG000|Overall Study|Sponsor decision|40|||
126331102|NCT05285787|454506851|FG000|Overall Study|Withdrawal by Subject|1|||
126331103|NCT02360280|454506855|FG000|Overall Study|Withdrawal by Subject|2|||
126331104|NCT02360280|454506856|FG001|Overall Study|Withdrawal by Subject|0|||
126331105|NCT02360280|454506855|FG000|Overall Study|Adverse Event|0|||
126331106|NCT02360280|454506856|FG001|Overall Study|Adverse Event|1|||
126331107|NCT02360280|454506855|FG000|Overall Study|Lost to Follow-up|1|||
126331108|NCT02360280|454506856|FG001|Overall Study|Lost to Follow-up|0|||
126331109|NCT02472886|454506857|FG000|Overall Study|Lack of Efficacy|0|||
126331110|NCT02472886|454506858|FG001|Overall Study|Lack of Efficacy|2|||
126331111|NCT02472886|454506859|FG002|Overall Study|Lack of Efficacy|1|||
126331112|NCT00320788|454506860|FG000|Overall Study|Adverse Event|0|||
126331113|NCT00320788|454506861|FG001|Overall Study|Adverse Event|0|||
126331114|NCT00320788|454506862|FG002|Overall Study|Adverse Event|0|||
126331115|NCT00320788|454506863|FG003|Overall Study|Adverse Event|1|||
126331116|NCT00320788|454506864|FG004|Overall Study|Adverse Event|0|||
126331117|NCT00320788|454506860|FG000|Overall Study|Death|0|||
126331118|NCT00320788|454506861|FG001|Overall Study|Death|0|||
126331119|NCT00320788|454506862|FG002|Overall Study|Death|1|||
126331120|NCT00320788|454506863|FG003|Overall Study|Death|0|||
126331121|NCT00320788|454506864|FG004|Overall Study|Death|1|||
126331122|NCT00320788|454506860|FG000|Overall Study|Lost to Follow-up|0|||
126331123|NCT00320788|454506861|FG001|Overall Study|Lost to Follow-up|2|||
126331124|NCT00320788|454506862|FG002|Overall Study|Lost to Follow-up|1|||
126331125|NCT00320788|454506863|FG003|Overall Study|Lost to Follow-up|0|||
126331126|NCT00320788|454506864|FG004|Overall Study|Lost to Follow-up|0|||
126331127|NCT00320788|454506860|FG000|Overall Study|Decision by the Sponsor|1|||
126331128|NCT00320788|454506861|FG001|Overall Study|Decision by the Sponsor|1|||
126331129|NCT00320788|454506862|FG002|Overall Study|Decision by the Sponsor|0|||
126331130|NCT00320788|454506863|FG003|Overall Study|Decision by the Sponsor|0|||
126331131|NCT00320788|454506864|FG004|Overall Study|Decision by the Sponsor|1|||
126331132|NCT00320788|454506860|FG000|Overall Study|Other|1|||
125994468|NCT01051063|453270870|FG001|Overall Study|Moved from the study site area|0|||
126331133|NCT00320788|454506861|FG001|Overall Study|Other|2|||
126331134|NCT00320788|454506862|FG002|Overall Study|Other|1|||
126331135|NCT00320788|454506863|FG003|Overall Study|Other|1|||
125994469|NCT01051063|453270869|FG000|Overall Study|Other|1|||
126331136|NCT00320788|454506864|FG004|Overall Study|Other|1|||
126331137|NCT00320788|454506860|FG000|Overall Study|Physician Decision|1|||
126331138|NCT00320788|454506861|FG001|Overall Study|Physician Decision|1|||
126331139|NCT00320788|454506862|FG002|Overall Study|Physician Decision|0|||
125994470|NCT01051063|453270870|FG001|Overall Study|Other|0|||
125994471|NCT01051063|453270869|FG000|Overall Study|Lost to Follow-up|0|||
125994472|NCT01051063|453270870|FG001|Overall Study|Lost to Follow-up|1|||
125994473|NCT03857841|453270874|FG000|Overall Study|Death|1|||
125994474|NCT03857841|453270875|FG001|Overall Study|Death|0|||
125994475|NCT03857841|453270876|FG002|Overall Study|Death|0|||
125994476|NCT03857841|453270877|FG003|Overall Study|Death|0|||
125994477|NCT03857841|453270874|FG000|Overall Study|Study Terminated by Sponsor|1|||
125994478|NCT03857841|453270875|FG001|Overall Study|Study Terminated by Sponsor|0|||
125994479|NCT03857841|453270876|FG002|Overall Study|Study Terminated by Sponsor|0|||
125994480|NCT03857841|453270877|FG003|Overall Study|Study Terminated by Sponsor|0|||
125994481|NCT01091428|453272574|FG000|Phase 1|Progressive Disease|24|||
125994482|NCT01091428|453272575|FG001|Phase 1|Progressive Disease|8|||
125994483|NCT01091428|453272576|FG002|Phase 1|Progressive Disease|0|||
125994484|NCT01091428|453272577|FG003|Phase 1|Progressive Disease|0|||
125994485|NCT01091428|453272574|FG000|Phase 1|Symptomatic Deterioration|3|||
125994486|NCT01091428|453272575|FG001|Phase 1|Symptomatic Deterioration|2|||
125994487|NCT01091428|453272576|FG002|Phase 1|Symptomatic Deterioration|0|||
125994488|NCT01091428|453272577|FG003|Phase 1|Symptomatic Deterioration|0|||
125994489|NCT01091428|453272574|FG000|Phase 1|Adverse Event|2|||
125994490|NCT01091428|453272575|FG001|Phase 1|Adverse Event|0|||
125994491|NCT01091428|453272576|FG002|Phase 1|Adverse Event|0|||
125994492|NCT01091428|453272577|FG003|Phase 1|Adverse Event|0|||
125994493|NCT01091428|453272574|FG000|Phase 1|Withdrawal by Subject|7|||
125994494|NCT01091428|453272575|FG001|Phase 1|Withdrawal by Subject|0|||
125994495|NCT01091428|453272576|FG002|Phase 1|Withdrawal by Subject|0|||
125994496|NCT01091428|453272577|FG003|Phase 1|Withdrawal by Subject|0|||
125994497|NCT01091428|453272574|FG000|Phase 1|Reason not specified|0|||
125994498|NCT01091428|453272575|FG001|Phase 1|Reason not specified|1|||
125994499|NCT01091428|453272576|FG002|Phase 1|Reason not specified|0|||
125994500|NCT01091428|453272577|FG003|Phase 1|Reason not specified|0|||
125994501|NCT01091428|453272574|FG000|Phase 1|Single-Patient IND|2|||
125994502|NCT01091428|453272575|FG001|Phase 1|Single-Patient IND|0|||
125994503|NCT01091428|453272576|FG002|Phase 1|Single-Patient IND|0|||
125994504|NCT01091428|453272577|FG003|Phase 1|Single-Patient IND|0|||
125994505|NCT01091428|453272574|FG000|Phase 2|Progressive Disease|0|||
125994506|NCT01091428|453272575|FG001|Phase 2|Progressive Disease|0|||
125994507|NCT01091428|453272576|FG002|Phase 2|Progressive Disease|44|||
125994508|NCT01091428|453272577|FG003|Phase 2|Progressive Disease|46|||
125994509|NCT01091428|453272574|FG000|Phase 2|Symptomatic Deterioration|0|||
125994510|NCT01091428|453272575|FG001|Phase 2|Symptomatic Deterioration|0|||
125994511|NCT01091428|453272576|FG002|Phase 2|Symptomatic Deterioration|1|||
125994512|NCT01091428|453272577|FG003|Phase 2|Symptomatic Deterioration|6|||
125994513|NCT01091428|453272574|FG000|Phase 2|Adverse Event|0|||
125994514|NCT01091428|453272575|FG001|Phase 2|Adverse Event|0|||
125994515|NCT01091428|453272576|FG002|Phase 2|Adverse Event|12|||
125994516|NCT01091428|453272577|FG003|Phase 2|Adverse Event|5|||
125994517|NCT01091428|453272574|FG000|Phase 2|Withdrawal by Subject|0|||
125994518|NCT01091428|453272575|FG001|Phase 2|Withdrawal by Subject|0|||
125994519|NCT01091428|453272576|FG002|Phase 2|Withdrawal by Subject|9|||
125994520|NCT01091428|453272577|FG003|Phase 2|Withdrawal by Subject|8|||
125994521|NCT01091428|453272574|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
125994522|NCT01091428|453272575|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
125994523|NCT01091428|453272576|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
125994524|NCT01091428|453272577|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
125994525|NCT01091428|453272574|FG000|Phase 2|Reason not specified|0|||
125994526|NCT01091428|453272575|FG001|Phase 2|Reason not specified|0|||
125994527|NCT01091428|453272576|FG002|Phase 2|Reason not specified|4|||
125994528|NCT01091428|453272577|FG003|Phase 2|Reason not specified|3|||
125994529|NCT01091428|453272574|FG000|Phase 2|Physician Decision|0|||
125994530|NCT01091428|453272575|FG001|Phase 2|Physician Decision|0|||
125994531|NCT01091428|453272576|FG002|Phase 2|Physician Decision|2|||
125994532|NCT01091428|453272577|FG003|Phase 2|Physician Decision|0|||
125994533|NCT02531295|453272578|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
125994534|NCT02531295|453272579|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
125994535|NCT02531295|453272580|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
125878648|NCT01972217|452853372|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125994536|NCT02531295|453272581|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
125994537|NCT02531295|453272582|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
125994538|NCT02531295|453272583|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
125994539|NCT04424290|453272585|FG000|Overall Study|Not treated|0|||
125994540|NCT04424290|453272586|FG001|Overall Study|Not treated|0|||
125994541|NCT04424290|453272587|FG002|Overall Study|Not treated|1|||
125994542|NCT04424290|453272588|FG003|Overall Study|Not treated|0|||
125994543|NCT04424290|453272589|FG004|Overall Study|Not treated|1|||
125994544|NCT04424290|453272585|FG000|Overall Study|Adverse Event|0|||
125994545|NCT04424290|453272586|FG001|Overall Study|Adverse Event|0|||
125994546|NCT04424290|453272587|FG002|Overall Study|Adverse Event|0|||
125994547|NCT04424290|453272588|FG003|Overall Study|Adverse Event|2|||
125994548|NCT04424290|453272589|FG004|Overall Study|Adverse Event|0|||
125994549|NCT04424290|453272585|FG000|Overall Study|Withdrawal by Subject|0|||
125994550|NCT04424290|453272586|FG001|Overall Study|Withdrawal by Subject|0|||
125994551|NCT04424290|453272587|FG002|Overall Study|Withdrawal by Subject|0|||
125994552|NCT04424290|453272588|FG003|Overall Study|Withdrawal by Subject|0|||
125994553|NCT04424290|453272589|FG004|Overall Study|Withdrawal by Subject|1|||
125994554|NCT04424290|453272585|FG000|Overall Study|Other than listed|0|||
125994555|NCT04424290|453272586|FG001|Overall Study|Other than listed|0|||
125994556|NCT04424290|453272587|FG002|Overall Study|Other than listed|0|||
125994557|NCT04424290|453272588|FG003|Overall Study|Other than listed|1|||
125994558|NCT04424290|453272589|FG004|Overall Study|Other than listed|0|||
125994559|NCT04249336|453272592|FG000|Overall Study|Lost to Follow-up|3|||
125994560|NCT04249336|453272593|FG001|Overall Study|Lost to Follow-up|3|||
125994561|NCT04249336|453272594|FG002|Overall Study|Lost to Follow-up|3|||
125994562|NCT04249336|453272595|FG003|Overall Study|Lost to Follow-up|3|||
125994563|NCT01242176|453272596|FG000|Washout Period of 7 Days|Adverse Event|0|||
125994564|NCT01242176|453272597|FG001|Washout Period of 7 Days|Adverse Event|2|||
125994565|NCT01242176|453272596|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
125994566|NCT01242176|453272597|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
125994567|NCT03390036|453272598|FG000|Overall Study|Lost to Follow-up|1|||
125994568|NCT03390036|453272599|FG001|Overall Study|Lost to Follow-up|0|||
125994569|NCT03390036|453272600|FG002|Overall Study|Lost to Follow-up|0|||
125994570|NCT03390036|453272598|FG000|Overall Study|Lack of Efficacy|1|||
125994571|NCT03390036|453272599|FG001|Overall Study|Lack of Efficacy|0|||
125994572|NCT03390036|453272600|FG002|Overall Study|Lack of Efficacy|0|||
125994573|NCT00358215|453272601|FG000|Overall Study|Ineligibility determined|4|||
125994574|NCT00358215|453272602|FG001|Overall Study|Ineligibility determined|3|||
125994575|NCT00358215|453272601|FG000|Overall Study|Adverse Event|83|||
125994576|NCT00358215|453272602|FG001|Overall Study|Adverse Event|65|||
125994577|NCT00358215|453272601|FG000|Overall Study|Withdrawal by Subject|111|||
125994578|NCT00358215|453272602|FG001|Overall Study|Withdrawal by Subject|102|||
125994579|NCT00358215|453272601|FG000|Overall Study|Participant request|65|||
125994580|NCT00358215|453272602|FG001|Overall Study|Participant request|64|||
125994581|NCT00358215|453272601|FG000|Overall Study|Physician Decision|47|||
125994582|NCT00358215|453272602|FG001|Overall Study|Physician Decision|39|||
125994583|NCT00358215|453272601|FG000|Overall Study|Lost to Follow-up|16|||
125994584|NCT00358215|453272602|FG001|Overall Study|Lost to Follow-up|22|||
125994585|NCT00358215|453272601|FG000|Overall Study|Death|265|||
125994586|NCT00358215|453272602|FG001|Overall Study|Death|281|||
125994587|NCT00358215|453272601|FG000|Overall Study|Protocol Violation|64|||
125994588|NCT00358215|453272602|FG001|Overall Study|Protocol Violation|59|||
125994589|NCT00358215|453272601|FG000|Overall Study|Pregnancy|1|||
125994590|NCT00358215|453272602|FG001|Overall Study|Pregnancy|0|||
125994591|NCT00358215|453272601|FG000|Overall Study|Other|21|||
125994592|NCT00358215|453272602|FG001|Overall Study|Other|14|||
125994593|NCT00358215|453272601|FG000|Overall Study|Did not receive investigational product|2|||
125994594|NCT00358215|453272602|FG001|Overall Study|Did not receive investigational product|3|||
125994595|NCT04329104|453272609|FG000|Efficacy Study|Withdrawal by Subject|0|||
125994596|NCT04329104|453272610|FG001|Efficacy Study|Withdrawal by Subject|0|||
125994597|NCT04329104|453272611|FG002|Efficacy Study|Withdrawal by Subject|0|||
125994598|NCT04329104|453272612|FG003|Efficacy Study|Withdrawal by Subject|5|||
125994599|NCT04329104|453272613|FG004|Efficacy Study|Withdrawal by Subject|6|||
125994600|NCT04329104|453272614|FG005|Efficacy Study|Withdrawal by Subject|8|||
125994601|NCT03884231|453272615|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
125994602|NCT03884231|453272615|FG000|Overall Study|Subject Withdrew Consent|1|||
125994603|NCT03884231|453272615|FG000|Overall Study|MRI Scan Not Performed|1|||
125994604|NCT01853254|453272616|FG000|Overall Study|Abnormal Laboratory Test|1|||
125994605|NCT01853254|453272616|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
125994606|NCT01853254|453272616|FG000|Overall Study|Death|1|||
125994607|NCT01853254|453272616|FG000|Overall Study|Failure to Return|43|||
125994608|NCT01853254|453272616|FG000|Overall Study|Insufficient Therapeutic Response|22|||
125994609|NCT01853254|453272616|FG000|Overall Study|Refusal of Treatment|1|||
125994610|NCT01853254|453272616|FG000|Overall Study|Other Protocol Violation|1|||
125994611|NCT01853254|453272616|FG000|Overall Study|Withdrawal of Consent|16|||
125994612|NCT01853254|453272616|FG000|Overall Study|Administrative/Other|16|||
125994613|NCT01017120|453272627|FG000|Overall Study|Adverse Event|9|||
125994614|NCT01017120|453272628|FG001|Overall Study|Adverse Event|0|||
125994615|NCT01017120|453272627|FG000|Overall Study|Lost to Follow-up|13|||
125994616|NCT01017120|453272628|FG001|Overall Study|Lost to Follow-up|11|||
125994617|NCT01017120|453272627|FG000|Overall Study|Lack of Efficacy|1|||
125994618|NCT01017120|453272628|FG001|Overall Study|Lack of Efficacy|0|||
125994619|NCT01017120|453272627|FG000|Overall Study|Withdrawal by Subject|39|||
125994620|NCT01017120|453272628|FG001|Overall Study|Withdrawal by Subject|21|||
125994621|NCT01017120|453272627|FG000|Overall Study|Pregnancy|1|||
125994622|NCT01017120|453272628|FG001|Overall Study|Pregnancy|1|||
125994623|NCT01017120|453272627|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
125994624|NCT01017120|453272628|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
125994625|NCT01017120|453272627|FG000|Overall Study|Relocated Out of Town|0|||
125994626|NCT01017120|453272628|FG001|Overall Study|Relocated Out of Town|2|||
125994627|NCT01017120|453272627|FG000|Overall Study|Protocol Violation|1|||
125994628|NCT01017120|453272628|FG001|Overall Study|Protocol Violation|0|||
125994629|NCT01017120|453272627|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
125994630|NCT01017120|453272628|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
125994631|NCT01087723|453272630|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
125994632|NCT01087723|453272631|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
125994633|NCT01087723|453272630|FG000|Overall Study|Withdrawal by Subject|10|||
125994634|NCT01087723|453272631|FG001|Overall Study|Withdrawal by Subject|13|||
125994635|NCT01087723|453272630|FG000|Overall Study|Physician Decision|2|||
125994636|NCT01087723|453272631|FG001|Overall Study|Physician Decision|0|||
125994637|NCT01087723|453272630|FG000|Overall Study|Lost to Follow-up|1|||
125994638|NCT01087723|453272631|FG001|Overall Study|Lost to Follow-up|4|||
125994639|NCT01087723|453272630|FG000|Overall Study|Reason Not Specified|1|||
125994640|NCT01087723|453272631|FG001|Overall Study|Reason Not Specified|2|||
125994641|NCT00289770|453272636|FG000|Year 15|Withdrawal by Subject|1|||
125994642|NCT00806624|453272637|FG000|Overall Study|Adverse Event|2|||
125994643|NCT00806624|453272638|FG001|Overall Study|Adverse Event|8|||
125994644|NCT00806624|453272639|FG002|Overall Study|Adverse Event|0|||
125994645|NCT00806624|453272637|FG000|Overall Study|Death|0|||
125994646|NCT00806624|453272638|FG001|Overall Study|Death|1|||
125994647|NCT00806624|453272639|FG002|Overall Study|Death|1|||
125994648|NCT00806624|453272637|FG000|Overall Study|Lost to Follow-up|1|||
125994649|NCT00806624|453272638|FG001|Overall Study|Lost to Follow-up|0|||
125994650|NCT00806624|453272639|FG002|Overall Study|Lost to Follow-up|1|||
125994651|NCT00806624|453272637|FG000|Overall Study|Withdrawal by Subject|6|||
125994652|NCT00806624|453272638|FG001|Overall Study|Withdrawal by Subject|3|||
125994653|NCT00806624|453272639|FG002|Overall Study|Withdrawal by Subject|3|||
125994654|NCT00806624|453272637|FG000|Overall Study|discontinued before start of treatment|0|||
125994655|NCT00806624|453272638|FG001|Overall Study|discontinued before start of treatment|0|||
125994656|NCT00806624|453272639|FG002|Overall Study|discontinued before start of treatment|1|||
125994657|NCT01702428|453272641|FG000|Overall Study|Adverse Event|2|||
125994658|NCT01702428|453272642|FG001|Overall Study|Adverse Event|0|||
125994659|NCT01702428|453272643|FG002|Overall Study|Adverse Event|0|||
125994660|NCT01702428|453272644|FG003|Overall Study|Adverse Event|0|||
125994661|NCT01702428|453272641|FG000|Overall Study|Lost to Follow-up|33|||
125994662|NCT01702428|453272642|FG001|Overall Study|Lost to Follow-up|41|||
125994663|NCT01702428|453272643|FG002|Overall Study|Lost to Follow-up|37|||
125994664|NCT01702428|453272644|FG003|Overall Study|Lost to Follow-up|44|||
125994665|NCT01702428|453272641|FG000|Overall Study|Parents cannot assist to site|1|||
125994666|NCT01702428|453272642|FG001|Overall Study|Parents cannot assist to site|0|||
125994667|NCT01702428|453272643|FG002|Overall Study|Parents cannot assist to site|1|||
125994668|NCT01702428|453272644|FG003|Overall Study|Parents cannot assist to site|0|||
125994669|NCT01702428|453272641|FG000|Overall Study|Lost Coverage|0|||
125994670|NCT01702428|453272642|FG001|Overall Study|Lost Coverage|0|||
125994671|NCT01702428|453272643|FG002|Overall Study|Lost Coverage|0|||
125994672|NCT01702428|453272644|FG003|Overall Study|Lost Coverage|1|||
125994673|NCT01702428|453272641|FG000|Overall Study|Lost Health Plan|3|||
125994674|NCT01702428|453272642|FG001|Overall Study|Lost Health Plan|5|||
125994675|NCT01702428|453272643|FG002|Overall Study|Lost Health Plan|0|||
125994676|NCT01702428|453272644|FG003|Overall Study|Lost Health Plan|2|||
125994677|NCT01702428|453272641|FG000|Overall Study|Mother transferred care|0|||
125994678|NCT01702428|453272642|FG001|Overall Study|Mother transferred care|1|||
126331140|NCT00320788|454506863|FG003|Overall Study|Physician Decision|0|||
126331141|NCT00320788|454506864|FG004|Overall Study|Physician Decision|0|||
126331142|NCT00320788|454506860|FG000|Overall Study|Protocol Violation|0|||
126331143|NCT00320788|454506861|FG001|Overall Study|Protocol Violation|0|||
126331144|NCT00320788|454506862|FG002|Overall Study|Protocol Violation|0|||
126331145|NCT00320788|454506863|FG003|Overall Study|Protocol Violation|0|||
126331146|NCT00320788|454506864|FG004|Overall Study|Protocol Violation|1|||
126331147|NCT00320788|454506860|FG000|Overall Study|Withdrawal by Subject|3|||
126331148|NCT00320788|454506861|FG001|Overall Study|Withdrawal by Subject|0|||
125994679|NCT01702428|453272643|FG002|Overall Study|Mother transferred care|0|||
125994680|NCT01702428|453272644|FG003|Overall Study|Mother transferred care|0|||
125994681|NCT01702428|453272641|FG000|Overall Study|Parents too busy|1|||
125994682|NCT01702428|453272642|FG001|Overall Study|Parents too busy|0|||
125994683|NCT01702428|453272643|FG002|Overall Study|Parents too busy|0|||
125994684|NCT01702428|453272644|FG003|Overall Study|Parents too busy|0|||
125994685|NCT01702428|453272641|FG000|Overall Study|Protocol Violation|3|||
125994686|NCT01702428|453272642|FG001|Overall Study|Protocol Violation|0|||
125994687|NCT01702428|453272643|FG002|Overall Study|Protocol Violation|1|||
125994688|NCT01702428|453272644|FG003|Overall Study|Protocol Violation|0|||
126331149|NCT00320788|454506862|FG002|Overall Study|Withdrawal by Subject|0|||
126331150|NCT00320788|454506863|FG003|Overall Study|Withdrawal by Subject|3|||
125994689|NCT01702428|453272641|FG000|Overall Study|Withdrawal by Subject|21|||
125994690|NCT01702428|453272642|FG001|Overall Study|Withdrawal by Subject|23|||
125994691|NCT01702428|453272643|FG002|Overall Study|Withdrawal by Subject|14|||
125994692|NCT01702428|453272644|FG003|Overall Study|Withdrawal by Subject|10|||
125994693|NCT00154063|453272647|FG000|Overall Study|Adverse Event|4|||
125994694|NCT00154063|453272648|FG001|Overall Study|Adverse Event|8|||
125994695|NCT00154063|453272647|FG000|Overall Study|Protocol Violation|1|||
125994696|NCT00154063|453272648|FG001|Overall Study|Protocol Violation|1|||
126331151|NCT00320788|454506864|FG004|Overall Study|Withdrawal by Subject|1|||
126331152|NCT00627926|454506865|FG000|Overall Study|Adverse Event|26|||
126331153|NCT00627926|454506866|FG001|Overall Study|Adverse Event|37|||
126331154|NCT00627926|454506867|FG002|Overall Study|Adverse Event|36|||
126331155|NCT00627926|454506865|FG000|Overall Study|Death|1|||
125994697|NCT00154063|453272647|FG000|Overall Study|Investigator or Sponsor Request|0|||
125994698|NCT00154063|453272648|FG001|Overall Study|Investigator or Sponsor Request|1|||
125994699|NCT00154063|453272647|FG000|Overall Study|Withdrawal by Subject|4|||
125994700|NCT00154063|453272648|FG001|Overall Study|Withdrawal by Subject|9|||
126331156|NCT00627926|454506866|FG001|Overall Study|Death|0|||
126331157|NCT00627926|454506867|FG002|Overall Study|Death|0|||
126331158|NCT00627926|454506865|FG000|Overall Study|Lost to Follow-up|4|||
125994701|NCT00154063|453272647|FG000|Overall Study|Other|3|||
125994702|NCT00154063|453272648|FG001|Overall Study|Other|3|||
125994703|NCT02091869|453272649|FG000|Overall Study|Withdrawal by Subject|0|||
125994704|NCT02091869|453272650|FG001|Overall Study|Withdrawal by Subject|3|||
125994705|NCT01804673|453272651|FG000|Overall Study|Adverse Event|4|||
125994706|NCT01804673|453272651|FG000|Overall Study|Withdrawal by Subject|1|||
125994707|NCT01804673|453272651|FG000|Overall Study|Lack of Efficacy|9|||
125994708|NCT01804673|453272651|FG000|Overall Study|Change to Oral Therapy|37|||
125994709|NCT01804673|453272651|FG000|Overall Study|No Further Therapy Required|84|||
125994710|NCT01804673|453272651|FG000|Overall Study|Use of Prohibited Medication|1|||
125994711|NCT01804673|453272651|FG000|Overall Study|Other|4|||
125994712|NCT01987596|453272663|FG000|Overall Study|Physician Decision|1|||
125994713|NCT01987596|453272664|FG001|Overall Study|Physician Decision|0|||
125994714|NCT01987596|453272663|FG000|Overall Study|Progressive Disease; missing all period|0|||
125994715|NCT01987596|453272664|FG001|Overall Study|Progressive Disease; missing all period|1|||
125994716|NCT00451217|453272666|FG000|Overall Study|Lost to Follow-up|0|||
125994717|NCT00451217|453272667|FG001|Overall Study|Lost to Follow-up|1|||
125994718|NCT00451217|453272668|FG002|Overall Study|Lost to Follow-up|1|||
125994719|NCT00451217|453272669|FG003|Overall Study|Lost to Follow-up|1|||
125994720|NCT00451217|453272666|FG000|Overall Study|Withdrawal by Subject|1|||
125994721|NCT00451217|453272667|FG001|Overall Study|Withdrawal by Subject|0|||
125994722|NCT00451217|453272668|FG002|Overall Study|Withdrawal by Subject|0|||
125994723|NCT00451217|453272669|FG003|Overall Study|Withdrawal by Subject|0|||
125994724|NCT00451217|453272666|FG000|Overall Study|Not Treated|1|||
125994725|NCT00451217|453272667|FG001|Overall Study|Not Treated|1|||
125994726|NCT00451217|453272668|FG002|Overall Study|Not Treated|3|||
125994727|NCT00451217|453272669|FG003|Overall Study|Not Treated|4|||
125994728|NCT00358150|453272670|FG000|Overall Study|Adverse Event|3|||
125994729|NCT00358150|453272670|FG000|Overall Study|Withdrawal by Subject|1|||
125994730|NCT00358150|453272670|FG000|Overall Study|Undefined|3|||
125994731|NCT04668989|453272674|FG000|First Intervention|Covid-19 related self-isolation|0|||
125994732|NCT04668989|453272675|FG001|First Intervention|Covid-19 related self-isolation|1|||
125994733|NCT04668989|453272674|FG000|Second Intervention|Adverse Event|0|||
125994734|NCT04668989|453272675|FG001|Second Intervention|Adverse Event|1|||
125994735|NCT01622348|453272677|FG000|Overall Study|Withdrawal by Subject|1|||
125994736|NCT01622348|453272678|FG001|Overall Study|Withdrawal by Subject|0|||
125994737|NCT01622348|453272679|FG002|Overall Study|Withdrawal by Subject|1|||
125994738|NCT00179010|453272680|FG000|Overall Study|Muscle probe defective|1|||
125994739|NCT00179010|453272681|FG001|Overall Study|Muscle probe defective|1|||
125994740|NCT00179010|453272680|FG000|Overall Study|Failure to place arterial line|0|||
125994741|NCT00179010|453272681|FG001|Overall Study|Failure to place arterial line|1|||
125994742|NCT01592695|453272690|FG000|Overall Study|Lost to Follow-up|8|||
125994743|NCT01592695|453272691|FG001|Overall Study|Lost to Follow-up|4|||
125994744|NCT00467142|453272698|FG000|Overall Study|Withdrawal by Subject|1|||
125994745|NCT00467142|453272698|FG000|Overall Study|Adverse Event|1|||
125994746|NCT00467142|453272698|FG000|Overall Study|Protocol Violation|1|||
125994747|NCT01763788|453272704|FG000|Overall Study|Lost to Follow-up|0|||
125994748|NCT01763788|453272705|FG001|Overall Study|Lost to Follow-up|0|||
125994749|NCT01763788|453272706|FG002|Overall Study|Lost to Follow-up|1|||
126331159|NCT00627926|454506866|FG001|Overall Study|Lost to Follow-up|3|||
125994750|NCT01763788|453272707|FG003|Overall Study|Lost to Follow-up|0|||
125994751|NCT03893825|453272708|FG000|Overall Study|Death|2|||
125994752|NCT03893825|453272709|FG001|Overall Study|Death|1|||
125994753|NCT03893825|453272708|FG000|Overall Study|Adverse Event|0|||
125994754|NCT03893825|453272709|FG001|Overall Study|Adverse Event|2|||
126331160|NCT00627926|454506867|FG002|Overall Study|Lost to Follow-up|4|||
125994755|NCT03893825|453272708|FG000|Overall Study|Withdrawal by Subject|19|||
125994756|NCT03893825|453272709|FG001|Overall Study|Withdrawal by Subject|21|||
125994757|NCT03893825|453272708|FG000|Overall Study|Protocol deviation|1|||
125994758|NCT03893825|453272709|FG001|Overall Study|Protocol deviation|0|||
125994759|NCT03893825|453272708|FG000|Overall Study|Lost to Follow-up|10|||
125994760|NCT03893825|453272709|FG001|Overall Study|Lost to Follow-up|10|||
125994761|NCT03893825|453272708|FG000|Overall Study|Other than specified|7|||
125994762|NCT03893825|453272709|FG001|Overall Study|Other than specified|6|||
125994763|NCT02771210|453272710|FG000|Period 1|Adverse Event|5|||
125994764|NCT02771210|453272711|FG001|Period 1|Adverse Event|3|||
125994765|NCT02771210|453272710|FG000|Period 1|Lack of Efficacy|3|||
125994766|NCT02771210|453272711|FG001|Period 1|Lack of Efficacy|6|||
125994767|NCT02771210|453272710|FG000|Period 1|Lost to Follow-up|2|||
125994768|NCT02771210|453272711|FG001|Period 1|Lost to Follow-up|0|||
125994769|NCT02771210|453272710|FG000|Period 1|Physician Decision|0|||
125994770|NCT02771210|453272711|FG001|Period 1|Physician Decision|1|||
125994771|NCT02771210|453272710|FG000|Period 1|Withdrawal by Subject|0|||
125994772|NCT02771210|453272711|FG001|Period 1|Withdrawal by Subject|3|||
125994773|NCT02771210|453272710|FG000|Period 1|Withdrawal of informed consent|1|||
125994774|NCT02771210|453272711|FG001|Period 1|Withdrawal of informed consent|5|||
125994775|NCT02771210|453272710|FG000|Period 2|Adverse Event|1|||
125994776|NCT02771210|453272711|FG001|Period 2|Adverse Event|0|||
125994777|NCT02771210|453272710|FG000|Period 2|Lack of Efficacy|0|||
125994778|NCT02771210|453272711|FG001|Period 2|Lack of Efficacy|1|||
125994779|NCT02771210|453272710|FG000|Period 2|Withdrawal by Subject|1|||
125994780|NCT02771210|453272711|FG001|Period 2|Withdrawal by Subject|0|||
125994781|NCT02771210|453272710|FG000|Period 2|Withdrawal of informed consent|0|||
125994782|NCT02771210|453272711|FG001|Period 2|Withdrawal of informed consent|2|||
125994783|NCT04397523|453272712|FG000|Overall Study|Lost to Follow-up|3|||
125994784|NCT04397523|453272712|FG000|Overall Study|Transfer from/to other hospital|8|||
125994785|NCT01275196|453272713|FG000|Overall Study|Adverse Event|3|||
125994786|NCT01275196|453272714|FG001|Overall Study|Adverse Event|5|||
125994787|NCT01275196|453272713|FG000|Overall Study|Withdrawal by Subject|4|||
125994788|NCT01275196|453272714|FG001|Overall Study|Withdrawal by Subject|5|||
125994789|NCT01275196|453272713|FG000|Overall Study|Lost to Follow-up|1|||
125994790|NCT01275196|453272714|FG001|Overall Study|Lost to Follow-up|0|||
125994791|NCT01275196|453272713|FG000|Overall Study|Disease Progression|6|||
125994792|NCT01275196|453272714|FG001|Overall Study|Disease Progression|5|||
125994793|NCT01275196|453272713|FG000|Overall Study|Protocol Violation|1|||
125994794|NCT01275196|453272714|FG001|Overall Study|Protocol Violation|0|||
125994795|NCT01275196|453272713|FG000|Overall Study|Suboptimal response/treatment failure|5|||
125994796|NCT01275196|453272714|FG001|Overall Study|Suboptimal response/treatment failure|6|||
125994797|NCT00684762|453272716|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
125994798|NCT00684762|453272717|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
125994799|NCT02572817|453272718|FG000|Overall Study|Death|6|||
125994800|NCT02572817|453272719|FG001|Overall Study|Death|3|||
125994801|NCT02572817|453272718|FG000|Overall Study|Lost to Follow-up|3|||
125994802|NCT02572817|453272719|FG001|Overall Study|Lost to Follow-up|3|||
125994803|NCT02441946|453272721|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
125994804|NCT02441946|453272722|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
125994805|NCT02441946|453272723|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
125994806|NCT02441946|453272721|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
125994807|NCT02441946|453272722|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
125994808|NCT02441946|453272723|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
125994809|NCT02441946|453272721|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125994810|NCT02441946|453272722|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
125994811|NCT02441946|453272723|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125994812|NCT02441946|453272721|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
125994813|NCT02441946|453272722|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
125994814|NCT02441946|453272723|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
125994815|NCT02441946|453272721|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
125994816|NCT02441946|453272722|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
125994817|NCT02441946|453272723|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
125994818|NCT02441946|453272721|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
125994819|NCT02441946|453272722|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
125994820|NCT02441946|453272723|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
125994821|NCT02441946|453272721|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
125994822|NCT02441946|453272722|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
125994823|NCT02441946|453272723|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
125994824|NCT02441946|453272721|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
126331161|NCT00627926|454506865|FG000|Overall Study|Withdrawal by Subject|2|||
126331162|NCT00627926|454506866|FG001|Overall Study|Withdrawal by Subject|1|||
126331163|NCT00627926|454506867|FG002|Overall Study|Withdrawal by Subject|0|||
126331164|NCT00627926|454506865|FG000|Overall Study|Lack of Efficacy|118|||
125994825|NCT02441946|453272722|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
125994826|NCT02441946|453272723|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
125994827|NCT02441946|453272721|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
126331165|NCT00627926|454506866|FG001|Overall Study|Lack of Efficacy|40|||
125994828|NCT02441946|453272722|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
125994829|NCT02441946|453272723|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
125994830|NCT02441946|453272721|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
126331166|NCT00627926|454506867|FG002|Overall Study|Lack of Efficacy|38|||
126331167|NCT00627926|454506865|FG000|Overall Study|Noncompliance/unspecified|8|||
125994831|NCT02441946|453272722|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
125994832|NCT02441946|453272723|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
125994833|NCT02441946|453272721|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
125994834|NCT02441946|453272722|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125994835|NCT02441946|453272723|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125994836|NCT02111213|453272724|FG000|Overall Study|Withdrawal by Subject|3|||
125994837|NCT02111213|453272725|FG001|Overall Study|Withdrawal by Subject|2|||
125994838|NCT02111213|453272724|FG000|Overall Study|Lost to Follow-up|3|||
125994839|NCT02111213|453272725|FG001|Overall Study|Lost to Follow-up|4|||
125994840|NCT00119262|453272726|FG000|Overall Study|Lack of Efficacy|0|||
125994841|NCT00119262|453272727|FG001|Overall Study|Lack of Efficacy|3|||
125994842|NCT00119262|453272726|FG000|Overall Study|Withdrawal by Subject|12|||
125994843|NCT00119262|453272727|FG001|Overall Study|Withdrawal by Subject|11|||
125994844|NCT00119262|453272726|FG000|Overall Study|Adverse Event|33|||
125994845|NCT00119262|453272727|FG001|Overall Study|Adverse Event|35|||
125994846|NCT00119262|453272726|FG000|Overall Study|other disease|0|||
125994847|NCT00119262|453272727|FG001|Overall Study|other disease|2|||
125994848|NCT00119262|453272726|FG000|Overall Study|ineligble|1|||
125994849|NCT00119262|453272727|FG001|Overall Study|ineligble|2|||
125994850|NCT00119262|453272726|FG000|Overall Study|others|0|||
125994851|NCT00119262|453272727|FG001|Overall Study|others|5|||
125994852|NCT00734214|453272728|FG000|Overall Study|Withdrawal by Subject|3|||
125994853|NCT00734214|453272729|FG001|Overall Study|Withdrawal by Subject|4|||
125994854|NCT00734214|453272728|FG000|Overall Study|MD withdrawal|1|||
125994855|NCT00734214|453272729|FG001|Overall Study|MD withdrawal|0|||
125994856|NCT00924469|453272736|FG000|Overall Study|Adverse Event|2|||
125994857|NCT00924469|453272737|FG001|Overall Study|Adverse Event|0|||
125994858|NCT00924469|453272736|FG000|Overall Study|Withdrawal by Subject|0|||
125994859|NCT00924469|453272737|FG001|Overall Study|Withdrawal by Subject|1|||
125994860|NCT00924469|453272736|FG000|Overall Study|Lost to Follow-up|0|||
125994861|NCT00924469|453272737|FG001|Overall Study|Lost to Follow-up|1|||
125994862|NCT00630058|453272738|FG000|Overall Study|Adverse Event|1|||
125994863|NCT00630058|453272739|FG001|Overall Study|Adverse Event|1|||
125994864|NCT00630058|453272738|FG000|Overall Study|Withdrawal by Subject|0|||
125994865|NCT00630058|453272739|FG001|Overall Study|Withdrawal by Subject|1|||
125994866|NCT00630058|453272738|FG000|Overall Study|stopping criteria|3|||
125994867|NCT00630058|453272739|FG001|Overall Study|stopping criteria|2|||
125994868|NCT01651936|453272740|FG000|Base Study|Adverse Event|3|||
125994869|NCT01651936|453272741|FG001|Base Study|Adverse Event|0|||
125994870|NCT01651936|453272742|FG002|Base Study|Adverse Event|0|||
125994871|NCT01651936|453272740|FG000|Base Study|Withdrawal by Subject|1|||
125994872|NCT01651936|453272741|FG001|Base Study|Withdrawal by Subject|1|||
125994873|NCT01651936|453272742|FG002|Base Study|Withdrawal by Subject|0|||
125994874|NCT01651936|453272740|FG000|Base Study|Early Escape|2|||
125994875|NCT01651936|453272741|FG001|Base Study|Early Escape|8|||
125994876|NCT01651936|453272742|FG002|Base Study|Early Escape|0|||
125994877|NCT01651936|453272740|FG000|Base Study|Study terminated by sponsor|21|||
125994878|NCT01651936|453272741|FG001|Base Study|Study terminated by sponsor|16|||
125994879|NCT01651936|453272742|FG002|Base Study|Study terminated by sponsor|0|||
125994880|NCT01651936|453272740|FG000|Extension Study|Lack of Efficacy|0|||
125994881|NCT01651936|453272741|FG001|Extension Study|Lack of Efficacy|0|||
125994882|NCT01651936|453272742|FG002|Extension Study|Lack of Efficacy|1|||
125994883|NCT01651936|453272740|FG000|Extension Study|Study terminated by sponsor|0|||
125994884|NCT01651936|453272741|FG001|Extension Study|Study terminated by sponsor|0|||
125994885|NCT01651936|453272742|FG002|Extension Study|Study terminated by sponsor|13|||
125994886|NCT03918239|453274680|FG000|Overall Study|Lost to Follow-up|3|||
125994887|NCT03918239|453274681|FG001|Overall Study|Lost to Follow-up|1|||
125994888|NCT03918239|453274680|FG000|Overall Study|Pregnancy|0|||
125994889|NCT03918239|453274681|FG001|Overall Study|Pregnancy|2|||
125994890|NCT03918239|453274680|FG000|Overall Study|Withdrawal by Subject|3|||
125994891|NCT03918239|453274681|FG001|Overall Study|Withdrawal by Subject|3|||
125994892|NCT03918239|453274680|FG000|Overall Study|positive urine drug screening results|4|||
125994893|NCT03918239|453274681|FG001|Overall Study|positive urine drug screening results|1|||
125994894|NCT02761629|453274718|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
125994895|NCT02761629|453274719|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
125994896|NCT02761629|453274718|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125994897|NCT02761629|453274719|FG001|Overall Study|Insufficient Therapeutic Response|7|||
125994898|NCT02761629|453274718|FG000|Overall Study|Failure to Return|2|||
125994899|NCT02761629|453274719|FG001|Overall Study|Failure to Return|4|||
125994900|NCT02761629|453274718|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
125994901|NCT02761629|453274719|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
125994902|NCT02761629|453274718|FG000|Overall Study|Protocol Violation|2|||
125994903|NCT02761629|453274719|FG001|Overall Study|Protocol Violation|2|||
125994904|NCT02761629|453274718|FG000|Overall Study|Withdrawal by Subject|0|||
125994905|NCT02761629|453274719|FG001|Overall Study|Withdrawal by Subject|3|||
125994906|NCT02761629|453274718|FG000|Overall Study|Other|0|||
125994907|NCT02761629|453274719|FG001|Overall Study|Other|2|||
125994908|NCT02761629|453274718|FG000|Overall Study|Lost to Follow-up|4|||
126331168|NCT00627926|454506866|FG001|Overall Study|Noncompliance/unspecified|23|||
126331169|NCT00627926|454506867|FG002|Overall Study|Noncompliance/unspecified|17|||
126331170|NCT02797678|454506890|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
126331171|NCT02797678|454506891|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125994909|NCT02761629|453274719|FG001|Overall Study|Lost to Follow-up|1|||
125994910|NCT02761629|453274718|FG000|Overall Study|Randomized But Not Treated|8|||
125994911|NCT02761629|453274719|FG001|Overall Study|Randomized But Not Treated|4|||
125994912|NCT02001974|453274722|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
125994913|NCT02001974|453274723|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
125994914|NCT02001974|453274724|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
125994915|NCT02001974|453274722|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
125994916|NCT02001974|453274723|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
125994917|NCT02001974|453274724|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
125994918|NCT02001974|453274722|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
125994919|NCT02001974|453274723|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
125994920|NCT02001974|453274724|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
125994921|NCT02001974|453274722|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
125994922|NCT02001974|453274723|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
125994923|NCT02001974|453274724|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
125994924|NCT04827134|453274725|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
125994925|NCT04827134|453274726|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
125994926|NCT04827134|453274727|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
125994927|NCT04827134|453274728|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
125994928|NCT04844918|453274729|FG000|Overall Study|Adverse Event|7|||
125994929|NCT04844918|453274730|FG001|Overall Study|Adverse Event|8|||
125994930|NCT04844918|453274731|FG002|Overall Study|Adverse Event|5|||
125994931|NCT04844918|453274729|FG000|Overall Study|Physician Decision|0|||
125994932|NCT04844918|453274730|FG001|Overall Study|Physician Decision|1|||
125994933|NCT04844918|453274731|FG002|Overall Study|Physician Decision|0|||
125994934|NCT04844918|453274729|FG000|Overall Study|Withdrawal by Subject|6|||
125994935|NCT04844918|453274730|FG001|Overall Study|Withdrawal by Subject|3|||
125994936|NCT04844918|453274731|FG002|Overall Study|Withdrawal by Subject|3|||
125994937|NCT04844918|453274729|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
125994938|NCT04844918|453274730|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
125994939|NCT04844918|453274731|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
125994940|NCT02743793|453274736|FG000|Overall Study|Death|1|||
125994941|NCT02743793|453274737|FG001|Overall Study|Death|1|||
125994942|NCT02743793|453274736|FG000|Overall Study|Withdrawal by Subject|0|||
125994943|NCT02743793|453274737|FG001|Overall Study|Withdrawal by Subject|1|||
125994944|NCT02743793|453274736|FG000|Overall Study|Screen Failure|4|||
125994945|NCT02743793|453274737|FG001|Overall Study|Screen Failure|0|||
125994946|NCT02743793|453274736|FG000|Overall Study|No Primary Care Physician|0|||
125994947|NCT02743793|453274737|FG001|Overall Study|No Primary Care Physician|1|||
125994948|NCT02743793|453274736|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
125994949|NCT02743793|453274737|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
125994950|NCT02743793|453274736|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
125994951|NCT02743793|453274737|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
125994952|NCT01461993|453274743|FG000|Overall Study|Withdrawal by Subject|60|||
125994953|NCT01461993|453274744|FG001|Overall Study|Withdrawal by Subject|53|||
125994954|NCT01461993|453274745|FG002|Overall Study|Withdrawal by Subject|16|||
125994955|NCT01461993|453274743|FG000|Overall Study|Lost to Follow-up|44|||
125994956|NCT01461993|453274744|FG001|Overall Study|Lost to Follow-up|48|||
125994957|NCT01461993|453274745|FG002|Overall Study|Lost to Follow-up|22|||
125994958|NCT01461993|453274743|FG000|Overall Study|Protocol Violation|10|||
125994959|NCT01461993|453274744|FG001|Overall Study|Protocol Violation|9|||
125994960|NCT01461993|453274745|FG002|Overall Study|Protocol Violation|7|||
125994961|NCT01461993|453274743|FG000|Overall Study|Adverse Event|9|||
125994962|NCT01461993|453274744|FG001|Overall Study|Adverse Event|11|||
125994963|NCT01461993|453274745|FG002|Overall Study|Adverse Event|3|||
126331172|NCT02797678|454506892|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125994964|NCT01461993|453274743|FG000|Overall Study|No longer met eligibility criteria|13|||
125994965|NCT01461993|453274744|FG001|Overall Study|No longer met eligibility criteria|18|||
125994966|NCT01461993|453274745|FG002|Overall Study|No longer met eligibility criteria|10|||
126331173|NCT02797678|454506893|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125994967|NCT01461993|453274743|FG000|Overall Study|Did not meet entrance criteria|2|||
125994968|NCT01461993|453274744|FG001|Overall Study|Did not meet entrance criteria|3|||
125994969|NCT01461993|453274745|FG002|Overall Study|Did not meet entrance criteria|0|||
125994970|NCT01461993|453274743|FG000|Overall Study|Other|13|||
125994971|NCT01461993|453274744|FG001|Overall Study|Other|15|||
126331174|NCT02797678|454506890|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
125994972|NCT01461993|453274745|FG002|Overall Study|Other|6|||
125994973|NCT00219141|453274747|FG000|Overall Study|Adverse Event|4|||
125994974|NCT00219141|453274748|FG001|Overall Study|Adverse Event|10|||
125994975|NCT00219141|453274749|FG002|Overall Study|Adverse Event|5|||
125994976|NCT00219141|453274747|FG000|Overall Study|Lack of Efficacy|3|||
125994977|NCT00219141|453274748|FG001|Overall Study|Lack of Efficacy|2|||
125994978|NCT00219141|453274749|FG002|Overall Study|Lack of Efficacy|0|||
125994979|NCT00219141|453274747|FG000|Overall Study|Administrative problems|0|||
125994980|NCT00219141|453274748|FG001|Overall Study|Administrative problems|1|||
125994981|NCT00219141|453274749|FG002|Overall Study|Administrative problems|0|||
125994982|NCT00219141|453274747|FG000|Overall Study|Lost to Follow-up|2|||
125994983|NCT00219141|453274748|FG001|Overall Study|Lost to Follow-up|4|||
125994984|NCT00219141|453274749|FG002|Overall Study|Lost to Follow-up|1|||
125994985|NCT00219141|453274747|FG000|Overall Study|Protocol Violation|3|||
125994986|NCT00219141|453274748|FG001|Overall Study|Protocol Violation|1|||
125994987|NCT00219141|453274749|FG002|Overall Study|Protocol Violation|1|||
125994988|NCT00219141|453274747|FG000|Overall Study|Withdrawal by Subject|1|||
125994989|NCT00219141|453274748|FG001|Overall Study|Withdrawal by Subject|3|||
125994990|NCT00219141|453274749|FG002|Overall Study|Withdrawal by Subject|5|||
125994991|NCT00219141|453274747|FG000|Overall Study|Condition no longer requires study drug|1|||
125994992|NCT00219141|453274748|FG001|Overall Study|Condition no longer requires study drug|0|||
125994993|NCT00219141|453274749|FG002|Overall Study|Condition no longer requires study drug|0|||
125994994|NCT01088529|453274750|FG000|Overall Study|Did not receive study treatment|0|||
125994995|NCT01088529|453274751|FG001|Overall Study|Did not receive study treatment|1|||
125994996|NCT02838628|453274753|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
125994997|NCT02838628|453274754|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
125994998|NCT02838628|453274753|FG000|Recurrence Follow-up Period|Adverse Event|1|||
125994999|NCT02838628|453274754|FG001|Recurrence Follow-up Period|Adverse Event|0|||
125995000|NCT02838628|453274753|FG000|Recurrence Follow-up Period|Non-compliance|0|||
125995001|NCT02838628|453274754|FG001|Recurrence Follow-up Period|Non-compliance|1|||
125995002|NCT02838628|453274753|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
125995003|NCT02838628|453274754|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
125995004|NCT02838628|453274753|FG000|Recurrence Follow-up Period|Other un-specified|1|||
125995005|NCT02838628|453274754|FG001|Recurrence Follow-up Period|Other un-specified|1|||
125995006|NCT02066532|453274757|FG000|Phase II|Withdrawal by Subject|1|||
125995007|NCT02066532|453274758|FG001|Phase II|Withdrawal by Subject|0|||
125995008|NCT02066532|453274759|FG002|Phase II|Withdrawal by Subject|0|||
125995009|NCT02066532|453274760|FG003|Phase II|Withdrawal by Subject|0|||
125995010|NCT03560245|453274761|FG000|Overall Study|Withdrawal by Subject|3|||
125995011|NCT03560245|453274762|FG001|Overall Study|Withdrawal by Subject|2|||
125995012|NCT03560245|453274761|FG000|Overall Study|Adverse Event|1|||
125995013|NCT03560245|453274762|FG001|Overall Study|Adverse Event|1|||
125995014|NCT03560245|453274761|FG000|Overall Study|Protocol Violation|1|||
125995015|NCT03560245|453274762|FG001|Overall Study|Protocol Violation|0|||
125995016|NCT03560245|453274761|FG000|Overall Study|Death|0|||
125995017|NCT03560245|453274762|FG001|Overall Study|Death|1|||
125995018|NCT03560245|453274761|FG000|Overall Study|Lost to Follow-up|0|||
125995019|NCT03560245|453274762|FG001|Overall Study|Lost to Follow-up|1|||
125995020|NCT03560245|453274761|FG000|Overall Study|Physician Decision|0|||
125995021|NCT03560245|453274762|FG001|Overall Study|Physician Decision|1|||
125995022|NCT03560245|453274761|FG000|Overall Study|Other|0|||
125995023|NCT03560245|453274762|FG001|Overall Study|Other|1|||
125995024|NCT01265823|453274763|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
125995025|NCT01265823|453274763|FG000|Overall Study|Failure to Return|4|||
125995026|NCT01265823|453274763|FG000|Overall Study|Protocol Violation|1|||
125995027|NCT01265823|453274763|FG000|Overall Study|Participant Request|1|||
125995028|NCT01263106|453274764|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
125995029|NCT01263106|453274765|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
125995030|NCT01018563|453274776|FG000|Overall Study|Termination of the study by Sponsor|2|||
125995031|NCT01018563|453274777|FG001|Overall Study|Termination of the study by Sponsor|1|||
125995032|NCT02611830|453274780|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
125995033|NCT02611830|453274781|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
125995034|NCT02611830|453274782|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
125995035|NCT02611830|453274783|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
125995036|NCT02611830|453274780|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
125995037|NCT02611830|453274781|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
125995038|NCT02611830|453274782|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
125995039|NCT02611830|453274783|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
125995040|NCT02611830|453274780|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
125995041|NCT02611830|453274781|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
125995042|NCT02611830|453274782|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
125995043|NCT02611830|453274783|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
125995044|NCT02611830|453274780|FG000|OL Induction Phase|Lack of Efficacy|9|||
125995045|NCT02611830|453274781|FG001|OL Induction Phase|Lack of Efficacy|0|||
125995046|NCT02611830|453274782|FG002|OL Induction Phase|Lack of Efficacy|0|||
125995047|NCT02611830|453274783|FG003|OL Induction Phase|Lack of Efficacy|0|||
125995048|NCT02611830|453274780|FG000|OL Induction Phase|Reason not specified|3|||
125995049|NCT02611830|453274781|FG001|OL Induction Phase|Reason not specified|0|||
125995050|NCT02611830|453274782|FG002|OL Induction Phase|Reason not specified|0|||
125995051|NCT02611830|453274783|FG003|OL Induction Phase|Reason not specified|0|||
125995052|NCT02611830|453274780|FG000|Maintenance Phase|Lack of Efficacy|0|||
125995053|NCT02611830|453274781|FG001|Maintenance Phase|Lack of Efficacy|29|||
125995054|NCT02611830|453274782|FG002|Maintenance Phase|Lack of Efficacy|18|||
125995055|NCT02611830|453274783|FG003|Maintenance Phase|Lack of Efficacy|6|||
125995056|NCT02611830|453274780|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125995057|NCT02611830|453274781|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
125995058|NCT02611830|453274782|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
125995059|NCT02611830|453274783|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
125995060|NCT02611830|453274780|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
125995061|NCT02611830|453274781|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
125995062|NCT02611830|453274782|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
125995063|NCT02611830|453274783|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
125995064|NCT02611830|453274780|FG000|Maintenance Phase|Lost to Follow-up|0|||
125995065|NCT02611830|453274781|FG001|Maintenance Phase|Lost to Follow-up|0|||
125995066|NCT02611830|453274782|FG002|Maintenance Phase|Lost to Follow-up|0|||
125995067|NCT02611830|453274783|FG003|Maintenance Phase|Lost to Follow-up|1|||
125995068|NCT02611830|453274780|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
125995069|NCT02611830|453274781|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
125995070|NCT02611830|453274782|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
125995071|NCT02611830|453274783|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
125995072|NCT02611830|453274780|FG000|Maintenance Phase|Pregnancy|0|||
125995073|NCT02611830|453274781|FG001|Maintenance Phase|Pregnancy|0|||
125995074|NCT02611830|453274782|FG002|Maintenance Phase|Pregnancy|1|||
125995075|NCT02611830|453274783|FG003|Maintenance Phase|Pregnancy|0|||
125995076|NCT02611830|453274780|FG000|Maintenance Phase|Reason not specified|0|||
125995077|NCT02611830|453274781|FG001|Maintenance Phase|Reason not specified|1|||
125995078|NCT02611830|453274782|FG002|Maintenance Phase|Reason not specified|4|||
125995079|NCT02611830|453274783|FG003|Maintenance Phase|Reason not specified|0|||
125995080|NCT00903786|453274787|FG000|Overall Study|Physician Decision|6|||
125995081|NCT00903786|453274787|FG000|Overall Study|Lack of Efficacy|5|||
125995082|NCT00903786|453274787|FG000|Overall Study|Reason other than lack of efficacy|4|||
125995083|NCT02058290|453274790|FG000|Overall Study|Protocol Violation|2|||
125995084|NCT02058290|453274791|FG001|Overall Study|Protocol Violation|1|||
125995085|NCT02058290|453274790|FG000|Overall Study|Physician Decision|1|||
125995086|NCT02058290|453274791|FG001|Overall Study|Physician Decision|0|||
125995087|NCT02058290|453274790|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
125995088|NCT02058290|453274791|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
125995089|NCT02058290|453274790|FG000|Overall Study|Withdrawal by Subject|0|||
125995090|NCT02058290|453274791|FG001|Overall Study|Withdrawal by Subject|1|||
125995091|NCT03012061|453274798|FG000|Overall Study|Withdrawal by Subject|1|||
125995092|NCT03012061|453274799|FG001|Overall Study|Withdrawal by Subject|5|||
125995093|NCT03012061|453274800|FG002|Overall Study|Withdrawal by Subject|4|||
125995094|NCT03012061|453274798|FG000|Overall Study|Investigator Site Closed|1|||
125995095|NCT03012061|453274799|FG001|Overall Study|Investigator Site Closed|2|||
126091068|NCT01607476|453626896|FG001|Overall Study|Withdrawal by Subject|0|||
126091069|NCT01607476|453626897|FG002|Overall Study|Withdrawal by Subject|1|||
126091070|NCT01607476|453626895|FG000|Overall Study|Lost to Follow-up|0|||
126091071|NCT01607476|453626896|FG001|Overall Study|Lost to Follow-up|0|||
126091072|NCT01607476|453626897|FG002|Overall Study|Lost to Follow-up|2|||
126091073|NCT04958200|453626904|FG000|Overall Study|Withdrawal by Subject|0|||
126091074|NCT04958200|453626905|FG001|Overall Study|Withdrawal by Subject|2|||
126091075|NCT04958200|453626904|FG000|Overall Study|Lost to Follow-up|3|||
126091076|NCT04958200|453626905|FG001|Overall Study|Lost to Follow-up|2|||
126091077|NCT02145468|453626906|FG000|Overall Study|Withdrawal by Subject|5|||
126091078|NCT02145468|453626907|FG001|Overall Study|Withdrawal by Subject|8|||
126331175|NCT02797678|454506891|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
126331176|NCT02797678|454506892|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
126331177|NCT02797678|454506893|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
126331178|NCT02797678|454506890|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
125995096|NCT03012061|453274800|FG002|Overall Study|Investigator Site Closed|0|||
125995097|NCT03012061|453274798|FG000|Overall Study|Lost to Follow-up|2|||
125995098|NCT03012061|453274799|FG001|Overall Study|Lost to Follow-up|1|||
125995099|NCT03012061|453274800|FG002|Overall Study|Lost to Follow-up|0|||
125995100|NCT03012061|453274798|FG000|Overall Study|Study closed/ Terminated|0|||
125995101|NCT03012061|453274799|FG001|Overall Study|Study closed/ Terminated|0|||
125995102|NCT03012061|453274800|FG002|Overall Study|Study closed/ Terminated|1|||
125995103|NCT03012061|453274798|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
125995104|NCT03012061|453274799|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
125995105|NCT03012061|453274800|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
125995106|NCT03012061|453274798|FG000|Overall Study|Protocol Violation|0|||
125995107|NCT03012061|453274799|FG001|Overall Study|Protocol Violation|0|||
125995108|NCT03012061|453274800|FG002|Overall Study|Protocol Violation|2|||
125995109|NCT03012061|453274798|FG000|Overall Study|Lack of Efficacy|0|||
125995110|NCT03012061|453274799|FG001|Overall Study|Lack of Efficacy|1|||
125995111|NCT03012061|453274800|FG002|Overall Study|Lack of Efficacy|0|||
125995112|NCT03012061|453274798|FG000|Overall Study|Adverse Event|2|||
125995113|NCT03012061|453274799|FG001|Overall Study|Adverse Event|0|||
125995114|NCT03012061|453274800|FG002|Overall Study|Adverse Event|0|||
125995115|NCT02696902|453274801|FG000|Overall Study|Lost to Follow-up|0|||
125995116|NCT02696902|453274802|FG001|Overall Study|Lost to Follow-up|1|||
125995117|NCT02696902|453274803|FG002|Overall Study|Lost to Follow-up|1|||
125995118|NCT02696902|453274801|FG000|Overall Study|Withdrawal by Subject|0|||
125995119|NCT02696902|453274802|FG001|Overall Study|Withdrawal by Subject|0|||
125995120|NCT02696902|453274803|FG002|Overall Study|Withdrawal by Subject|1|||
125995121|NCT02696902|453274801|FG000|Overall Study|Death|19|||
125995122|NCT02696902|453274802|FG001|Overall Study|Death|3|||
125995123|NCT02696902|453274803|FG002|Overall Study|Death|24|||
125995124|NCT02696902|453274801|FG000|Overall Study|Participant not fit post-randomization|0|||
125995125|NCT02696902|453274802|FG001|Overall Study|Participant not fit post-randomization|0|||
125995126|NCT02696902|453274803|FG002|Overall Study|Participant not fit post-randomization|1|||
125995127|NCT02696902|453274801|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
125995128|NCT02696902|453274802|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
125995129|NCT02696902|453274803|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
125995130|NCT02696902|453274801|FG000|Overall Study|Principal investigator's decision|1|||
125995131|NCT02696902|453274802|FG001|Overall Study|Principal investigator's decision|0|||
125995132|NCT02696902|453274803|FG002|Overall Study|Principal investigator's decision|0|||
125995133|NCT02696902|453274801|FG000|Overall Study|Sponsor's decision|1|||
125995134|NCT02696902|453274802|FG001|Overall Study|Sponsor's decision|0|||
125995135|NCT02696902|453274803|FG002|Overall Study|Sponsor's decision|0|||
125995136|NCT02696902|453274801|FG000|Overall Study|Transferred to other hospital|1|||
125995137|NCT02696902|453274802|FG001|Overall Study|Transferred to other hospital|0|||
125995138|NCT02696902|453274803|FG002|Overall Study|Transferred to other hospital|0|||
125995139|NCT05822921|453274806|FG000|Overall Study|Lost to Follow-up|1|||
125995140|NCT05822921|453274807|FG001|Overall Study|Lost to Follow-up|1|||
125995141|NCT00544544|453274808|FG000|Overall Study|Withdrawal by Subject|1|||
125995142|NCT00544544|453274808|FG000|Overall Study|Adverse Event|1|||
125995143|NCT00544544|453274808|FG000|Overall Study|Lost to Follow-up|1|||
125995144|NCT03406702|453274809|FG000|Overall Study|Missed Day 27 Dosing|1|||
125995145|NCT01857622|453274813|FG000|Overall Study|Adverse Event|5|||
125995146|NCT01857622|453274814|FG001|Overall Study|Adverse Event|0|||
125995147|NCT01857622|453274815|FG002|Overall Study|Adverse Event|2|||
125995148|NCT01857622|453274813|FG000|Overall Study|Physician Decision|1|||
125995149|NCT01857622|453274814|FG001|Overall Study|Physician Decision|0|||
125995150|NCT01857622|453274815|FG002|Overall Study|Physician Decision|0|||
125995151|NCT01857622|453274813|FG000|Overall Study|Protocol Violation|4|||
125995152|NCT01857622|453274814|FG001|Overall Study|Protocol Violation|1|||
125995153|NCT01857622|453274815|FG002|Overall Study|Protocol Violation|0|||
125995154|NCT01857622|453274813|FG000|Overall Study|Withdrawal by Subject|1|||
125995155|NCT01857622|453274814|FG001|Overall Study|Withdrawal by Subject|0|||
125995156|NCT01857622|453274815|FG002|Overall Study|Withdrawal by Subject|0|||
125995157|NCT01291225|453274816|FG000|Overall Study|Lost to Follow-up|85|||
125995158|NCT01291225|453274817|FG001|Overall Study|Lost to Follow-up|39|||
125995159|NCT01267253|453274818|FG000|Overall Study|Ineligible - required test not done|1|||
125995160|NCT01267253|453274818|FG000|Overall Study|Inevaluable-never received study treatme|2|||
125995161|NCT04318093|453274821|FG000|Overall Study|Adverse Event|2|||
125995162|NCT04318093|453274822|FG001|Overall Study|Adverse Event|2|||
125995163|NCT04318093|453274821|FG000|Overall Study|Participant withdrew consent|1|||
125995164|NCT04318093|453274822|FG001|Overall Study|Participant withdrew consent|0|||
125995165|NCT04318093|453274821|FG000|Overall Study|Other reasons|0|||
125995166|NCT04318093|453274822|FG001|Overall Study|Other reasons|1|||
125995167|NCT02855164|453274823|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125995168|NCT02855164|453274824|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125995169|NCT02855164|453274825|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
125995170|NCT02855164|453274826|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
125995171|NCT02855164|453274827|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
125995172|NCT02855164|453274828|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125995173|NCT02855164|453274829|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125995174|NCT02855164|453274830|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125995175|NCT02855164|453274823|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
125995176|NCT02855164|453274824|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
125995177|NCT02855164|453274825|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
125995178|NCT02855164|453274826|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
125995179|NCT02855164|453274827|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
125995180|NCT02855164|453274828|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
125995181|NCT02855164|453274829|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
126091079|NCT00623805|453626908|FG000|Overall Study|Adverse Event|9|||
125995182|NCT02855164|453274830|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
126331179|NCT02797678|454506891|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
126331180|NCT02797678|454506892|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
126331181|NCT02797678|454506893|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
126331182|NCT03360019|454506895|FG000|Overall Study|Withdrawal by Subject|2|||
126331183|NCT03360019|454506896|FG001|Overall Study|Withdrawal by Subject|0|||
126331184|NCT03360019|454506897|FG002|Overall Study|Withdrawal by Subject|0|||
126331185|NCT03360019|454506895|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
126331186|NCT03360019|454506896|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
126331187|NCT03360019|454506897|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
126331188|NCT01462110|454506898|FG000|Overall Study|Adverse Event|1|||
126331189|NCT01462110|454506899|FG001|Overall Study|Adverse Event|0|||
126331190|NCT02149264|454506905|FG000|Overall Study|Withdrawal by Subject|9|||
126331191|NCT02149264|454506905|FG000|Overall Study|Adverse Event|7|||
126331192|NCT02149264|454506905|FG000|Overall Study|Physician Decision|3|||
126331193|NCT02149264|454506905|FG000|Overall Study|Protocol Violation|1|||
126331194|NCT03283930|454506906|FG000|Overall Study|Scheduling conflict|8|||
126331195|NCT03283930|454506907|FG001|Overall Study|Scheduling conflict|10|||
126331196|NCT03283930|454506906|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
126331197|NCT03283930|454506907|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
126331198|NCT03283930|454506906|FG000|Overall Study|Technical software issue|2|||
126331199|NCT03283930|454506907|FG001|Overall Study|Technical software issue|2|||
126331200|NCT00805129|454506908|FG000|Overall Study|Not treated|1|||
126331201|NCT02499120|454506909|FG000|Overall Study|Death|52|||
126331202|NCT02499120|454506910|FG001|Overall Study|Death|43|||
126331203|NCT02499120|454506909|FG000|Overall Study|Lost to Follow-up|1|||
126331204|NCT02499120|454506910|FG001|Overall Study|Lost to Follow-up|2|||
126331205|NCT02499120|454506909|FG000|Overall Study|Participant refused further follow-up|1|||
126331206|NCT02499120|454506910|FG001|Overall Study|Participant refused further follow-up|0|||
126331207|NCT02499120|454506909|FG000|Overall Study|Withdrawal by Subject|2|||
126331208|NCT02499120|454506910|FG001|Overall Study|Withdrawal by Subject|5|||
126331209|NCT02499120|454506909|FG000|Overall Study|Other|9|||
126331210|NCT02499120|454506910|FG001|Overall Study|Other|10|||
126331211|NCT00964028|454506915|FG000|Overall Study|Withdrawal by Subject|0|||
126331212|NCT00964028|454506916|FG001|Overall Study|Withdrawal by Subject|1|||
126331213|NCT02385110|454506917|FG000|Overall Study|Early Death|1|||
126331214|NCT02385110|454506918|FG001|Overall Study|Early Death|0|||
126331215|NCT03472521|454506919|FG000|Overall Study|Lost to Follow-up|3|||
126331216|NCT03472521|454506920|FG001|Overall Study|Lost to Follow-up|2|||
126331217|NCT03472521|454506919|FG000|Overall Study|Discontinued intervention|3|||
126331218|NCT03472521|454506920|FG001|Overall Study|Discontinued intervention|1|||
126331219|NCT00534638|454506923|FG000|Overall Study|Withdrawal by Subject|3|||
126331220|NCT00534638|454506924|FG001|Overall Study|Withdrawal by Subject|4|||
126331221|NCT00534638|454506923|FG000|Overall Study|Migrated/moved from study area|13|||
126331222|NCT00534638|454506924|FG001|Overall Study|Migrated/moved from study area|11|||
126331223|NCT00534638|454506923|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
126331224|NCT00534638|454506924|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
126331225|NCT00534638|454506923|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
126331226|NCT00534638|454506924|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
126331227|NCT00534638|454506923|FG000|Overall Study|Other|1685|||
126331228|NCT00534638|454506924|FG001|Overall Study|Other|902|||
126331229|NCT01931397|454506931|FG000|Overall Study|Physician Decision|2|||
126331230|NCT01931397|454506931|FG000|Overall Study|Withdrawal by Subject|8|||
126331231|NCT01931397|454506931|FG000|Overall Study|moved out of state|1|||
126331232|NCT00520039|454506932|FG000|Overall Study|Exclusion criteria met at first visit|7|||
126331233|NCT00520039|454506933|FG001|Overall Study|Exclusion criteria met at first visit|5|||
126331234|NCT05176717|454506934|FG000|Overall Study|Sponsor Decision|1|||
126331235|NCT05176717|454506935|FG001|Overall Study|Sponsor Decision|2|||
126331236|NCT05176717|454506936|FG002|Overall Study|Sponsor Decision|2|||
126331237|NCT00765817|454506937|FG000|Overall Study|Adverse Event|13|||
126331238|NCT00765817|454506938|FG001|Overall Study|Adverse Event|1|||
126331239|NCT00765817|454506937|FG000|Overall Study|Death|0|||
126331240|NCT00765817|454506938|FG001|Overall Study|Death|1|||
126331241|NCT00765817|454506937|FG000|Overall Study|Entry criteria not met|2|||
126331242|NCT00765817|454506938|FG001|Overall Study|Entry criteria not met|2|||
126331243|NCT00765817|454506937|FG000|Overall Study|Loss of glucose control|0|||
126331244|NCT00765817|454506938|FG001|Overall Study|Loss of glucose control|2|||
126331245|NCT00765817|454506937|FG000|Overall Study|Lost to Follow-up|1|||
126331246|NCT00765817|454506938|FG001|Overall Study|Lost to Follow-up|3|||
126331247|NCT00765817|454506937|FG000|Overall Study|Physician Decision|2|||
126331248|NCT00765817|454506938|FG001|Overall Study|Physician Decision|1|||
126331249|NCT00765817|454506937|FG000|Overall Study|Protocol Violation|1|||
126331250|NCT00765817|454506938|FG001|Overall Study|Protocol Violation|1|||
126331251|NCT00765817|454506937|FG000|Overall Study|Subject decision|7|||
125995183|NCT02855164|453274823|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
125995184|NCT02855164|453274824|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
125995185|NCT02855164|453274825|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
125995186|NCT02855164|453274826|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
125995187|NCT02855164|453274827|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
125995188|NCT02855164|453274828|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
125995189|NCT02855164|453274829|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
125995190|NCT02855164|453274830|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
125995191|NCT02855164|453274823|FG000|Part C (Randomized Set)|Adverse Event|0|||
125995192|NCT02855164|453274824|FG001|Part C (Randomized Set)|Adverse Event|0|||
125995193|NCT02855164|453274825|FG002|Part C (Randomized Set)|Adverse Event|0|||
125995194|NCT02855164|453274826|FG003|Part C (Randomized Set)|Adverse Event|0|||
125995195|NCT02855164|453274827|FG004|Part C (Randomized Set)|Adverse Event|0|||
125995196|NCT02855164|453274828|FG005|Part C (Randomized Set)|Adverse Event|5|||
125995197|NCT02855164|453274829|FG006|Part C (Randomized Set)|Adverse Event|9|||
126331252|NCT00765817|454506938|FG001|Overall Study|Subject decision|11|||
126331253|NCT02308228|454506939|FG000|Overall Study|Adverse Event|3|||
125995198|NCT02855164|453274830|FG007|Part C (Randomized Set)|Adverse Event|2|||
125995199|NCT02855164|453274823|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
125995200|NCT02855164|453274824|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
125995201|NCT02855164|453274825|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
125995202|NCT02855164|453274826|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
125995203|NCT02855164|453274827|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
125995204|NCT02855164|453274828|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
126331254|NCT02308228|454506940|FG001|Overall Study|Adverse Event|4|||
126331255|NCT02308228|454506939|FG000|Overall Study|Withdrawal by Subject|5|||
125995205|NCT02855164|453274829|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
125995206|NCT02855164|453274830|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
125995207|NCT02855164|453274823|FG000|Part C (Randomized Set)|Physician Decision|0|||
126331256|NCT02308228|454506940|FG001|Overall Study|Withdrawal by Subject|3|||
126331257|NCT03999749|454506943|FG000|Overall Study|Toxicity|16|||
126331258|NCT03999749|454506943|FG000|Overall Study|Withdrawal by Subject|3|||
126331259|NCT03999749|454506943|FG000|Overall Study|Disease progression|26|||
126331260|NCT03999749|454506943|FG000|Overall Study|Physician Decision|4|||
126331261|NCT03999749|454506943|FG000|Overall Study|Death|5|||
126331262|NCT03999749|454506943|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
126331263|NCT05219968|454506944|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
126331264|NCT05219968|454506945|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
126331265|NCT05219968|454506946|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
126331266|NCT05219968|454506947|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
126331267|NCT05219968|454506948|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
126331268|NCT05219968|454506944|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
126331269|NCT05219968|454506945|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
126331270|NCT05219968|454506946|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
126331271|NCT05219968|454506947|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
126331272|NCT05219968|454506948|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
126331273|NCT05219968|454506944|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
126331274|NCT05219968|454506945|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
126331275|NCT05219968|454506946|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
126331276|NCT05219968|454506947|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
126331277|NCT05219968|454506948|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
126331278|NCT05219968|454506944|FG000|Week 24 Treatment Period|Adverse Event|3|||
126331279|NCT05219968|454506945|FG001|Week 24 Treatment Period|Adverse Event|0|||
126331280|NCT05219968|454506946|FG002|Week 24 Treatment Period|Adverse Event|0|||
126331281|NCT05219968|454506947|FG003|Week 24 Treatment Period|Adverse Event|0|||
126331282|NCT05219968|454506948|FG004|Week 24 Treatment Period|Adverse Event|0|||
126331283|NCT05219968|454506944|FG000|Week 24 Treatment Period|Physician Decision|0|||
126331284|NCT05219968|454506945|FG001|Week 24 Treatment Period|Physician Decision|1|||
126331285|NCT05219968|454506946|FG002|Week 24 Treatment Period|Physician Decision|0|||
126331286|NCT05219968|454506947|FG003|Week 24 Treatment Period|Physician Decision|0|||
126331287|NCT05219968|454506948|FG004|Week 24 Treatment Period|Physician Decision|0|||
126331288|NCT05219968|454506944|FG000|Week 24 Treatment Period|Other, not specified|3|||
126331289|NCT05219968|454506945|FG001|Week 24 Treatment Period|Other, not specified|0|||
126331290|NCT05219968|454506946|FG002|Week 24 Treatment Period|Other, not specified|0|||
125995208|NCT02855164|453274824|FG001|Part C (Randomized Set)|Physician Decision|0|||
125995209|NCT02855164|453274825|FG002|Part C (Randomized Set)|Physician Decision|0|||
125995210|NCT02855164|453274826|FG003|Part C (Randomized Set)|Physician Decision|0|||
125995211|NCT02855164|453274827|FG004|Part C (Randomized Set)|Physician Decision|0|||
125995212|NCT02855164|453274828|FG005|Part C (Randomized Set)|Physician Decision|1|||
125995213|NCT02855164|453274829|FG006|Part C (Randomized Set)|Physician Decision|0|||
125995214|NCT02855164|453274830|FG007|Part C (Randomized Set)|Physician Decision|1|||
125995215|NCT02855164|453274823|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
125995216|NCT02855164|453274824|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
125995217|NCT02855164|453274825|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
125995218|NCT02855164|453274826|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
125995219|NCT02855164|453274827|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
125995220|NCT02855164|453274828|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
125995221|NCT02855164|453274829|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
125995222|NCT02855164|453274830|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
125995223|NCT00383240|453274831|FG000|Overall Study|Adverse Event|4|||
125995224|NCT00383240|453274832|FG001|Overall Study|Adverse Event|6|||
125995225|NCT00383240|453274833|FG002|Overall Study|Adverse Event|9|||
125995226|NCT00383240|453274834|FG003|Overall Study|Adverse Event|7|||
125995227|NCT00383240|453274831|FG000|Overall Study|Treatment Failure|8|||
125995228|NCT00383240|453274832|FG001|Overall Study|Treatment Failure|13|||
125995229|NCT00383240|453274833|FG002|Overall Study|Treatment Failure|47|||
125995230|NCT00383240|453274834|FG003|Overall Study|Treatment Failure|46|||
125995231|NCT00383240|453274831|FG000|Overall Study|Lost to Follow-up|3|||
125995232|NCT00383240|453274832|FG001|Overall Study|Lost to Follow-up|0|||
125995233|NCT00383240|453274833|FG002|Overall Study|Lost to Follow-up|0|||
125995234|NCT00383240|453274834|FG003|Overall Study|Lost to Follow-up|2|||
125995235|NCT00383240|453274831|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
125995236|NCT00383240|453274832|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
125995237|NCT00383240|453274833|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
125995238|NCT00383240|453274834|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
125995239|NCT00383240|453274831|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
125995240|NCT00383240|453274832|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
125995241|NCT00383240|453274833|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
125995242|NCT00383240|453274834|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
125995243|NCT00383240|453274831|FG000|Overall Study|Protocol Violation|4|||
125995244|NCT00383240|453274832|FG001|Overall Study|Protocol Violation|5|||
125995245|NCT00383240|453274833|FG002|Overall Study|Protocol Violation|9|||
125995246|NCT00383240|453274834|FG003|Overall Study|Protocol Violation|6|||
125995247|NCT00383240|453274831|FG000|Overall Study|Did not meet protocol eligibility|9|||
125995248|NCT00383240|453274832|FG001|Overall Study|Did not meet protocol eligibility|4|||
125995249|NCT00383240|453274833|FG002|Overall Study|Did not meet protocol eligibility|9|||
125995250|NCT00383240|453274834|FG003|Overall Study|Did not meet protocol eligibility|3|||
125995251|NCT00383240|453274831|FG000|Overall Study|Administrative|1|||
125995252|NCT00383240|453274832|FG001|Overall Study|Administrative|1|||
125995253|NCT00383240|453274833|FG002|Overall Study|Administrative|0|||
125995254|NCT00383240|453274834|FG003|Overall Study|Administrative|0|||
125995255|NCT00127413|453274839|FG000|Overall Study|Lost to Follow-up|6|||
125995256|NCT00127413|453274840|FG001|Overall Study|Lost to Follow-up|4|||
125995257|NCT00127413|453274841|FG002|Overall Study|Lost to Follow-up|8|||
125995258|NCT00127413|453274842|FG003|Overall Study|Lost to Follow-up|2|||
125995259|NCT00547911|453274845|FG000|Overall Study|Adverse Event|0|||
125995260|NCT00547911|453274846|FG001|Overall Study|Adverse Event|0|||
125995261|NCT00547911|453274847|FG002|Overall Study|Adverse Event|0|||
125995262|NCT00547911|453274848|FG003|Overall Study|Adverse Event|1|||
125995263|NCT00547911|453274849|FG004|Overall Study|Adverse Event|0|||
125995264|NCT00547911|453274850|FG005|Overall Study|Adverse Event|0|||
125995265|NCT01644474|453274852|FG000|Overall Study|Poor compliance to protocol|1|||
125995266|NCT01644474|453274853|FG001|Overall Study|Poor compliance to protocol|0|||
125995267|NCT01644474|453274852|FG000|Overall Study|Consent withdrawn by participant|0|||
125995268|NCT01644474|453274853|FG001|Overall Study|Consent withdrawn by participant|1|||
125995269|NCT01644474|453274852|FG000|Overall Study|Participant moved|0|||
125995270|NCT01644474|453274853|FG001|Overall Study|Participant moved|1|||
125995271|NCT01644474|453274852|FG000|Overall Study|Adverse Event|4|||
125995272|NCT01644474|453274853|FG001|Overall Study|Adverse Event|5|||
125995273|NCT01644474|453274852|FG000|Overall Study|Site scheduling error|1|||
125995274|NCT01644474|453274853|FG001|Overall Study|Site scheduling error|1|||
125995275|NCT01644474|453274852|FG000|Overall Study|Protocol Violation|1|||
125995276|NCT01644474|453274853|FG001|Overall Study|Protocol Violation|0|||
125995277|NCT02023879|453274854|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
125995278|NCT02023879|453274855|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
125995279|NCT02023879|453274856|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
125995280|NCT02023879|453274854|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
125995281|NCT02023879|453274855|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
125995282|NCT02023879|453274856|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
125995283|NCT02023879|453274854|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
125995284|NCT02023879|453274855|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
125995285|NCT02023879|453274856|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
125995286|NCT02023879|453274854|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
125995287|NCT02023879|453274855|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
125995288|NCT02023879|453274856|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
125995289|NCT02023879|453274854|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
125995290|NCT02023879|453274855|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
125995291|NCT02023879|453274856|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
125995292|NCT02023879|453274854|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
125995293|NCT02023879|453274855|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
125995294|NCT02023879|453274856|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
125995295|NCT02023879|453274854|FG000|Extension Open Label Treatment|Adverse Event|1|||
125995296|NCT02023879|453274855|FG001|Extension Open Label Treatment|Adverse Event|7|||
125995297|NCT02023879|453274856|FG002|Extension Open Label Treatment|Adverse Event|3|||
125995298|NCT02023879|453274854|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
125995299|NCT02023879|453274855|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
125995300|NCT02023879|453274856|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
125995301|NCT02023879|453274854|FG000|Extension Open Label Treatment|Participant moved|1|||
125995302|NCT02023879|453274855|FG001|Extension Open Label Treatment|Participant moved|2|||
125995303|NCT02023879|453274856|FG002|Extension Open Label Treatment|Participant moved|0|||
125995304|NCT02023879|453274854|FG000|Extension Open Label Treatment|Other than specified above|2|||
125995305|NCT02023879|453274855|FG001|Extension Open Label Treatment|Other than specified above|7|||
125995306|NCT02023879|453274856|FG002|Extension Open Label Treatment|Other than specified above|2|||
125995307|NCT02044458|453274860|FG000|Overall Study|Protocol Violation|3|||
125995308|NCT02044458|453274861|FG001|Overall Study|Protocol Violation|8|||
125995309|NCT03363659|453274862|FG000|Overall Study|Adverse Event|1|||
125995310|NCT03363659|453274862|FG000|Overall Study|Screen fail|1|||
125995311|NCT03363659|453274862|FG000|Overall Study|Withdrawal by Subject|1|||
125995312|NCT03872388|453274863|FG000|Overall Study|Disease Progression|0|||
125995313|NCT03872388|453274864|FG001|Overall Study|Disease Progression|0|||
125995314|NCT03872388|453274865|FG002|Overall Study|Disease Progression|0|||
125995315|NCT03872388|453274866|FG003|Overall Study|Disease Progression|0|||
125995316|NCT03872388|453274867|FG004|Overall Study|Disease Progression|0|||
125995317|NCT03872388|453274868|FG005|Overall Study|Disease Progression|0|||
125995318|NCT03872388|453274869|FG006|Overall Study|Disease Progression|1|||
125995319|NCT03872388|453274870|FG007|Overall Study|Disease Progression|1|||
125995320|NCT02601937|453274871|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
125995321|NCT02601937|453274872|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
125995322|NCT02601937|453274873|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
125995323|NCT02601937|453274874|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
125995324|NCT02601937|453274875|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
125995325|NCT02601937|453274876|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
125995326|NCT02601937|453274877|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
125995327|NCT02601937|453274878|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
126331291|NCT05219968|454506947|FG003|Week 24 Treatment Period|Other, not specified|0|||
126331292|NCT05219968|454506948|FG004|Week 24 Treatment Period|Other, not specified|0|||
126331293|NCT05219968|454506944|FG000|Safety Extension Period|Treatment administration failure|0|||
126331294|NCT05219968|454506945|FG001|Safety Extension Period|Treatment administration failure|0|||
126331295|NCT05219968|454506946|FG002|Safety Extension Period|Treatment administration failure|0|||
126331296|NCT05219968|454506947|FG003|Safety Extension Period|Treatment administration failure|1|||
126331297|NCT05219968|454506948|FG004|Safety Extension Period|Treatment administration failure|4|||
126331298|NCT05219968|454506944|FG000|Safety Extension Period|Bilateral dislodgement|0|||
126331299|NCT05219968|454506945|FG001|Safety Extension Period|Bilateral dislodgement|0|||
126331300|NCT05219968|454506946|FG002|Safety Extension Period|Bilateral dislodgement|4|||
126331301|NCT05219968|454506947|FG003|Safety Extension Period|Bilateral dislodgement|0|||
126331302|NCT05219968|454506948|FG004|Safety Extension Period|Bilateral dislodgement|1|||
126331303|NCT05219968|454506944|FG000|Safety Extension Period|Withdrawal by Subject|0|||
126331304|NCT05219968|454506945|FG001|Safety Extension Period|Withdrawal by Subject|0|||
126331305|NCT05219968|454506946|FG002|Safety Extension Period|Withdrawal by Subject|2|||
126331306|NCT05219968|454506947|FG003|Safety Extension Period|Withdrawal by Subject|0|||
126331307|NCT05219968|454506948|FG004|Safety Extension Period|Withdrawal by Subject|4|||
126331308|NCT05219968|454506944|FG000|Safety Extension Period|Adverse Event|0|||
126331309|NCT05219968|454506945|FG001|Safety Extension Period|Adverse Event|0|||
126331310|NCT05219968|454506946|FG002|Safety Extension Period|Adverse Event|2|||
126331311|NCT05219968|454506947|FG003|Safety Extension Period|Adverse Event|1|||
126331312|NCT05219968|454506948|FG004|Safety Extension Period|Adverse Event|1|||
126331313|NCT05219968|454506944|FG000|Safety Extension Period|Lost to Follow-up|0|||
126331314|NCT05219968|454506945|FG001|Safety Extension Period|Lost to Follow-up|0|||
126331315|NCT05219968|454506946|FG002|Safety Extension Period|Lost to Follow-up|0|||
126331316|NCT05219968|454506947|FG003|Safety Extension Period|Lost to Follow-up|1|||
126331317|NCT05219968|454506948|FG004|Safety Extension Period|Lost to Follow-up|0|||
126331318|NCT04587336|454506949|FG000|Overall Study|Lost to Follow-up|1|||
126331319|NCT04587336|454506950|FG001|Overall Study|Lost to Follow-up|0|||
125995328|NCT02601937|453274879|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
126091080|NCT00623805|453626909|FG001|Overall Study|Adverse Event|6|||
126331320|NCT03512353|454508816|FG000|Overall Study|Sponsor Decision|3|||
125995329|NCT02601937|453274880|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
125995330|NCT02601937|453274881|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
125995331|NCT02601937|453274871|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
125995332|NCT02601937|453274872|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995333|NCT02601937|453274873|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995334|NCT02601937|453274874|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995335|NCT02601937|453274875|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995336|NCT02601937|453274876|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995337|NCT02601937|453274877|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
125995338|NCT02601937|453274878|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995339|NCT02601937|453274879|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995340|NCT02601937|453274880|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995341|NCT02601937|453274881|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125995342|NCT02601937|453274871|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995343|NCT02601937|453274872|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995344|NCT02601937|453274873|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
125995345|NCT02601937|453274874|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995346|NCT02601937|453274875|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995347|NCT02601937|453274876|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995348|NCT02601937|453274877|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995349|NCT02601937|453274878|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995350|NCT02601937|453274879|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995351|NCT02601937|453274880|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995352|NCT02601937|453274881|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125995353|NCT02601937|453274871|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
125995354|NCT02601937|453274872|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
125995355|NCT02601937|453274873|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
125995356|NCT02601937|453274874|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
125995357|NCT02601937|453274875|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
125995358|NCT02601937|453274876|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
125995359|NCT02601937|453274877|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
125995360|NCT02601937|453274878|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
125995361|NCT02601937|453274879|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
125995362|NCT02601937|453274880|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
125995363|NCT02601937|453274881|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
125995364|NCT02601937|453274871|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995365|NCT02601937|453274872|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995366|NCT02601937|453274873|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995367|NCT02601937|453274874|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995368|NCT02601937|453274875|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995369|NCT02601937|453274876|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995370|NCT02601937|453274877|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995371|NCT02601937|453274878|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995372|NCT02601937|453274879|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995373|NCT02601937|453274880|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
125995374|NCT02601937|453274881|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125995375|NCT02601937|453274871|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126331321|NCT03512353|454508816|FG000|Overall Study|Death|1|||
126331322|NCT01845597|454508817|FG000|Overall Study|Death|8|||
126331323|NCT01845597|454508817|FG000|Overall Study|Lost to Follow-up|22|||
126331324|NCT02581488|454508820|FG000|Overall Study|Adverse Event|6|||
126331325|NCT02581488|454508821|FG001|Overall Study|Adverse Event|7|||
126331326|NCT02581488|454508820|FG000|Overall Study|Lost to Follow-up|1|||
126331327|NCT02581488|454508821|FG001|Overall Study|Lost to Follow-up|0|||
126331328|NCT02581488|454508820|FG000|Overall Study|Withdrawal by Subject|1|||
126331329|NCT02581488|454508821|FG001|Overall Study|Withdrawal by Subject|0|||
126331330|NCT02581488|454508820|FG000|Overall Study|Non-Compliance|1|||
126331331|NCT02581488|454508821|FG001|Overall Study|Non-Compliance|0|||
126331332|NCT02581488|454508820|FG000|Overall Study|Protocol Violation|0|||
126331333|NCT02581488|454508821|FG001|Overall Study|Protocol Violation|4|||
126331334|NCT01877668|454508822|FG000|Overall Study|Death|0|||
126331335|NCT01877668|454508823|FG001|Overall Study|Death|0|||
126331336|NCT01877668|454508824|FG002|Overall Study|Death|0|||
125995376|NCT02601937|453274872|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126091081|NCT00623805|453626908|FG000|Overall Study|Death|2|||
126091082|NCT00623805|453626909|FG001|Overall Study|Death|0|||
126331337|NCT01877668|454508825|FG003|Overall Study|Death|1|||
126331338|NCT01877668|454508826|FG004|Overall Study|Death|0|||
125995377|NCT02601937|453274873|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125995378|NCT02601937|453274874|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125995379|NCT02601937|453274875|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125995380|NCT02601937|453274876|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125995381|NCT02601937|453274877|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125995382|NCT02601937|453274878|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
125995383|NCT02601937|453274879|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125995384|NCT02601937|453274880|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125995385|NCT02601937|453274881|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125995386|NCT02601937|453274871|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995387|NCT02601937|453274872|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995388|NCT02601937|453274873|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995389|NCT02601937|453274874|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995390|NCT02601937|453274875|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995391|NCT02601937|453274876|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995392|NCT02601937|453274877|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995393|NCT02601937|453274878|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995394|NCT02601937|453274879|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125995395|NCT02601937|453274880|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
125995396|NCT02601937|453274881|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
125995397|NCT02601937|453274871|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125995398|NCT02601937|453274872|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125995399|NCT02601937|453274873|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125995400|NCT02601937|453274874|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125995401|NCT02601937|453274875|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125995402|NCT02601937|453274876|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125995403|NCT02601937|453274877|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125995404|NCT02601937|453274878|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
125995405|NCT02601937|453274879|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
126331339|NCT01877668|454508822|FG000|Overall Study|No longer met study criteria|1|||
126331340|NCT01877668|454508823|FG001|Overall Study|No longer met study criteria|0|||
126331341|NCT01877668|454508824|FG002|Overall Study|No longer met study criteria|1|||
126331342|NCT01877668|454508825|FG003|Overall Study|No longer met study criteria|0|||
126331343|NCT01877668|454508826|FG004|Overall Study|No longer met study criteria|0|||
125995406|NCT02601937|453274880|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
125995407|NCT02601937|453274881|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
126331344|NCT01877668|454508822|FG000|Overall Study|Insufficient clinical response|0|||
126331345|NCT01877668|454508823|FG001|Overall Study|Insufficient clinical response|1|||
126331346|NCT01877668|454508824|FG002|Overall Study|Insufficient clinical response|2|||
126331347|NCT01877668|454508825|FG003|Overall Study|Insufficient clinical response|2|||
126331348|NCT01877668|454508826|FG004|Overall Study|Insufficient clinical response|0|||
126331349|NCT01877668|454508822|FG000|Overall Study|Lost to Follow-up|0|||
126331350|NCT01877668|454508823|FG001|Overall Study|Lost to Follow-up|2|||
126331351|NCT01877668|454508824|FG002|Overall Study|Lost to Follow-up|1|||
126331352|NCT01877668|454508825|FG003|Overall Study|Lost to Follow-up|0|||
126331353|NCT01877668|454508826|FG004|Overall Study|Lost to Follow-up|0|||
126331354|NCT01877668|454508822|FG000|Overall Study|Withdrawal by Subject|2|||
126331355|NCT01877668|454508823|FG001|Overall Study|Withdrawal by Subject|0|||
126331356|NCT01877668|454508824|FG002|Overall Study|Withdrawal by Subject|3|||
126331357|NCT01877668|454508825|FG003|Overall Study|Withdrawal by Subject|2|||
126331358|NCT01877668|454508826|FG004|Overall Study|Withdrawal by Subject|2|||
126331359|NCT01877668|454508822|FG000|Overall Study|Other|1|||
126331360|NCT01877668|454508823|FG001|Overall Study|Other|1|||
126331361|NCT01877668|454508824|FG002|Overall Study|Other|1|||
126331362|NCT01877668|454508825|FG003|Overall Study|Other|1|||
126331363|NCT01877668|454508826|FG004|Overall Study|Other|3|||
126331364|NCT01877668|454508822|FG000|Overall Study|Protocol Violation|1|||
126331365|NCT01877668|454508823|FG001|Overall Study|Protocol Violation|1|||
126331366|NCT01877668|454508824|FG002|Overall Study|Protocol Violation|0|||
126331367|NCT01877668|454508825|FG003|Overall Study|Protocol Violation|0|||
126331368|NCT01877668|454508826|FG004|Overall Study|Protocol Violation|3|||
126331369|NCT01877668|454508822|FG000|Overall Study|Adverse event related to study drug|2|||
126331370|NCT01877668|454508823|FG001|Overall Study|Adverse event related to study drug|2|||
126331371|NCT01877668|454508824|FG002|Overall Study|Adverse event related to study drug|2|||
126331372|NCT01877668|454508825|FG003|Overall Study|Adverse event related to study drug|2|||
126331373|NCT01877668|454508826|FG004|Overall Study|Adverse event related to study drug|1|||
126331374|NCT01877668|454508822|FG000|Overall Study|Adverse event unrelated to study drug|4|||
126331375|NCT01877668|454508823|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125995408|NCT02601937|453274871|FG000|Period 2: Dose Expansion Cohort|Other|0|||
125995409|NCT02601937|453274872|FG001|Period 2: Dose Expansion Cohort|Other|0|||
125995410|NCT02601937|453274873|FG002|Period 2: Dose Expansion Cohort|Other|0|||
125995411|NCT02601937|453274874|FG003|Period 2: Dose Expansion Cohort|Other|0|||
125995412|NCT02601937|453274875|FG004|Period 2: Dose Expansion Cohort|Other|0|||
125995413|NCT02601937|453274876|FG005|Period 2: Dose Expansion Cohort|Other|0|||
125995414|NCT02601937|453274877|FG006|Period 2: Dose Expansion Cohort|Other|0|||
125995415|NCT02601937|453274878|FG007|Period 2: Dose Expansion Cohort|Other|0|||
125995416|NCT02601937|453274879|FG008|Period 2: Dose Expansion Cohort|Other|2|||
125995417|NCT02601937|453274880|FG009|Period 2: Dose Expansion Cohort|Other|2|||
125995418|NCT02601937|453274881|FG010|Period 2: Dose Expansion Cohort|Other|0|||
125995419|NCT02601937|453274871|FG000|Period 2: Dose Expansion Cohort|Death|0|||
125995420|NCT02601937|453274872|FG001|Period 2: Dose Expansion Cohort|Death|0|||
125995421|NCT02601937|453274873|FG002|Period 2: Dose Expansion Cohort|Death|0|||
125995422|NCT02601937|453274874|FG003|Period 2: Dose Expansion Cohort|Death|0|||
125995423|NCT02601937|453274875|FG004|Period 2: Dose Expansion Cohort|Death|0|||
125995424|NCT02601937|453274876|FG005|Period 2: Dose Expansion Cohort|Death|0|||
125995425|NCT02601937|453274877|FG006|Period 2: Dose Expansion Cohort|Death|0|||
125995426|NCT02601937|453274878|FG007|Period 2: Dose Expansion Cohort|Death|0|||
125995427|NCT02601937|453274879|FG008|Period 2: Dose Expansion Cohort|Death|1|||
125995428|NCT02601937|453274880|FG009|Period 2: Dose Expansion Cohort|Death|0|||
125995429|NCT02601937|453274881|FG010|Period 2: Dose Expansion Cohort|Death|0|||
125995430|NCT02924389|453274882|FG000|Overall Study|Lost to Follow-up|1|||
125995431|NCT02924389|453274883|FG001|Overall Study|Lost to Follow-up|0|||
125995432|NCT02924389|453274882|FG000|Overall Study|Physician Decision|2|||
125995433|NCT02924389|453274883|FG001|Overall Study|Physician Decision|0|||
125995434|NCT02924389|453274882|FG000|Overall Study|Withdrawal by Subject|3|||
125995435|NCT02924389|453274883|FG001|Overall Study|Withdrawal by Subject|0|||
125995436|NCT02924389|453274882|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
125995437|NCT02924389|453274883|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
125995438|NCT02930122|453276995|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
125995439|NCT02930122|453276996|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
125995440|NCT00593554|453276998|FG000|Overall Study|Death|1|||
125995441|NCT00593554|453276999|FG001|Overall Study|Death|2|||
125995442|NCT00593554|453276998|FG000|Overall Study|Physician Decision|0|||
125995443|NCT00593554|453276999|FG001|Overall Study|Physician Decision|1|||
125995444|NCT00593554|453276998|FG000|Overall Study|Withdrawal by Subject|1|||
125995445|NCT00593554|453276999|FG001|Overall Study|Withdrawal by Subject|0|||
125995446|NCT00593554|453276998|FG000|Overall Study|Disease Progression|1|||
125995447|NCT00593554|453276999|FG001|Overall Study|Disease Progression|2|||
125995448|NCT01024959|453277000|FG000|Overall Study|ineligible|12|||
125995449|NCT01024959|453277000|FG000|Overall Study|results not evaluable|12|||
125995450|NCT01024959|453277000|FG000|Overall Study|missing results required for analysis|17|||
125995451|NCT00636792|453277001|FG000|Overall Study|Adverse Event|16|||
125995452|NCT00636792|453277001|FG000|Overall Study|Physician Decision|7|||
125995453|NCT00636792|453277001|FG000|Overall Study|Progressive Disease|4|||
125995454|NCT00636792|453277001|FG000|Overall Study|Withdrawal by Subject|3|||
125995455|NCT00636792|453277001|FG000|Overall Study|Other|3|||
125995456|NCT00709592|453277002|FG000|Overall Study|Unable to proceed to transplant|0|||
125995457|NCT00709592|453277003|FG001|Overall Study|Unable to proceed to transplant|1|||
125995458|NCT01129336|453277004|FG000|Overall Study|Protocol Violation|1|||
125995459|NCT01129336|453277005|FG001|Overall Study|Protocol Violation|0|||
125995460|NCT01129336|453277004|FG000|Overall Study|Disease Progression|1|||
125995461|NCT01129336|453277005|FG001|Overall Study|Disease Progression|4|||
125995462|NCT01129336|453277004|FG000|Overall Study|Lost to Follow-up|1|||
125995463|NCT01129336|453277005|FG001|Overall Study|Lost to Follow-up|0|||
125995464|NCT01129336|453277004|FG000|Overall Study|Withdrawal by Subject|7|||
125995465|NCT01129336|453277005|FG001|Overall Study|Withdrawal by Subject|4|||
125995466|NCT01129336|453277004|FG000|Overall Study|Adverse Event|0|||
125995467|NCT01129336|453277005|FG001|Overall Study|Adverse Event|1|||
125995468|NCT01129336|453277004|FG000|Overall Study|Missing Study Completion Status|2|||
125995469|NCT01129336|453277005|FG001|Overall Study|Missing Study Completion Status|3|||
125995470|NCT01129336|453277004|FG000|Overall Study|Death|0|||
125995471|NCT01129336|453277005|FG001|Overall Study|Death|4|||
125995472|NCT00919893|453277006|FG000|Overall Study|Protocol Violation|19|||
125995473|NCT00919893|453277007|FG001|Overall Study|Protocol Violation|9|||
125995474|NCT01375959|453277008|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
125995475|NCT01375959|453277009|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
125995476|NCT01375959|453277008|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
125995477|NCT01375959|453277009|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
125995478|NCT01375959|453277008|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125995479|NCT01375959|453277009|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
125995480|NCT00178256|453277010|FG000|Overall Study|Adverse Event|2|||
125995481|NCT00178256|453277011|FG001|Overall Study|Adverse Event|0|||
125995482|NCT00178256|453277012|FG002|Overall Study|Adverse Event|0|||
125995483|NCT00178256|453277013|FG003|Overall Study|Adverse Event|0|||
125995484|NCT00178256|453277010|FG000|Overall Study|Death|0|||
125995485|NCT00178256|453277011|FG001|Overall Study|Death|1|||
125995486|NCT00178256|453277012|FG002|Overall Study|Death|0|||
125995487|NCT00178256|453277013|FG003|Overall Study|Death|1|||
125995488|NCT00178256|453277010|FG000|Overall Study|Cancer progression|2|||
125995489|NCT00178256|453277011|FG001|Overall Study|Cancer progression|0|||
125995490|NCT00178256|453277012|FG002|Overall Study|Cancer progression|0|||
125995491|NCT00178256|453277013|FG003|Overall Study|Cancer progression|1|||
125995492|NCT02086552|453277014|FG000|Overall Study|Withdrawal by Subject|1|||
125995493|NCT00708305|453277015|FG000|Period 1|Protocol Violation|1|||
125995494|NCT00708305|453277016|FG001|Period 1|Protocol Violation|0|||
125995495|NCT00708305|453277017|FG002|Period 1|Protocol Violation|1|||
125995496|NCT00708305|453277018|FG003|Period 1|Protocol Violation|0|||
125995497|NCT00708305|453277015|FG000|Period 1|Other Reason|0|||
125995498|NCT00708305|453277016|FG001|Period 1|Other Reason|0|||
125995499|NCT00708305|453277017|FG002|Period 1|Other Reason|0|||
125995500|NCT00708305|453277018|FG003|Period 1|Other Reason|2|||
125995501|NCT00708305|453277015|FG000|Period 2|Lost to Follow-up|0|||
125995502|NCT00708305|453277016|FG001|Period 2|Lost to Follow-up|1|||
125995503|NCT00708305|453277017|FG002|Period 2|Lost to Follow-up|0|||
125995504|NCT00708305|453277018|FG003|Period 2|Lost to Follow-up|0|||
125995505|NCT00708305|453277015|FG000|Period 2|Protocol Violation|0|||
125995506|NCT00708305|453277016|FG001|Period 2|Protocol Violation|1|||
125995507|NCT00708305|453277017|FG002|Period 2|Protocol Violation|0|||
125995508|NCT00708305|453277018|FG003|Period 2|Protocol Violation|0|||
125995509|NCT00708305|453277015|FG000|Period 2|Other Reason|1|||
125995510|NCT00708305|453277016|FG001|Period 2|Other Reason|0|||
125995511|NCT00708305|453277017|FG002|Period 2|Other Reason|0|||
125995512|NCT00708305|453277018|FG003|Period 2|Other Reason|1|||
125995513|NCT00708305|453277015|FG000|Period 3|Protocol Violation|0|||
125995514|NCT00708305|453277016|FG001|Period 3|Protocol Violation|2|||
125995515|NCT00708305|453277017|FG002|Period 3|Protocol Violation|0|||
125995516|NCT00708305|453277018|FG003|Period 3|Protocol Violation|0|||
125995517|NCT00708305|453277015|FG000|Period 3|Other Reason|1|||
125995518|NCT00708305|453277016|FG001|Period 3|Other Reason|0|||
125995519|NCT00708305|453277017|FG002|Period 3|Other Reason|0|||
125995520|NCT00708305|453277018|FG003|Period 3|Other Reason|0|||
125995521|NCT02823964|453277019|FG000|Overall Study|Adverse Event|2|||
125995522|NCT02823964|453277019|FG000|Overall Study|Physician Decision|1|||
125995523|NCT02823964|453277019|FG000|Overall Study|Lack of Efficacy|1|||
125995524|NCT02823964|453277019|FG000|Overall Study|Withdrawal by Subject|1|||
125995525|NCT04012814|453277021|FG000|Overall Study|Lost to Follow-up|4|||
125995526|NCT04012814|453277021|FG000|Overall Study|Withdrawal by Subject|2|||
125995527|NCT04012814|453277021|FG000|Overall Study|Protocol Violation|1|||
125995528|NCT04012814|453277021|FG000|Overall Study|Adverse Event|1|||
125995529|NCT00390455|453277022|FG000|Overall Study|Adverse Event|17|||
125995530|NCT00390455|453277023|FG001|Overall Study|Adverse Event|3|||
125995531|NCT00390455|453277022|FG000|Overall Study|Withdrawal by Subject|8|||
125995532|NCT00390455|453277023|FG001|Overall Study|Withdrawal by Subject|8|||
125995533|NCT00390455|453277022|FG000|Overall Study|Alternate Treatment|0|||
125995534|NCT00390455|453277023|FG001|Overall Study|Alternate Treatment|1|||
125995535|NCT00390455|453277022|FG000|Overall Study|Other Medical Reasons|7|||
125995536|NCT00390455|453277023|FG001|Overall Study|Other Medical Reasons|11|||
125995537|NCT00794820|453277027|FG000|Overall Study|Adverse Event|11|||
125995538|NCT00794820|453277027|FG000|Overall Study|Secondary Malignancies|2|||
125995539|NCT00794820|453277027|FG000|Overall Study|Resistant Disease|2|||
125995540|NCT00794820|453277027|FG000|Overall Study|Ineligible/Screen Failure|1|||
125995541|NCT04076020|453277028|FG000|Overall Study|Death|4|||
125995542|NCT04076020|453277029|FG001|Overall Study|Death|6|||
125995543|NCT04076020|453277028|FG000|Overall Study|Withdrawal by Subject|12|||
125995544|NCT04076020|453277029|FG001|Overall Study|Withdrawal by Subject|8|||
125995545|NCT02310126|453277031|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
125995546|NCT02310126|453277032|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
125995547|NCT02310126|453277031|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
125995548|NCT02310126|453277032|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
126331376|NCT01877668|454508824|FG002|Overall Study|Adverse event unrelated to study drug|2|||
125995549|NCT03537261|453277042|FG000|Overall Study|Lost to Follow-up|4|||
125995550|NCT03537261|453277043|FG001|Overall Study|Lost to Follow-up|5|||
125995551|NCT03537261|453277042|FG000|Overall Study|Withdrawal by Subject|4|||
125995552|NCT03537261|453277043|FG001|Overall Study|Withdrawal by Subject|6|||
125995553|NCT03537261|453277042|FG000|Overall Study|Did not return study questionnaires|0|||
125995554|NCT03537261|453277043|FG001|Overall Study|Did not return study questionnaires|1|||
125995555|NCT03237013|453277044|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
125995556|NCT03237013|453277045|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
125995557|NCT03237013|453277046|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
125995558|NCT00502996|453277049|FG000|Overall Study|Lost to Follow-up|9|||
125995559|NCT00502996|453277049|FG000|Overall Study|Protocol Violation|2|||
125995560|NCT00502996|453277049|FG000|Overall Study|Treatment failure|25|||
125995561|NCT00502996|453277049|FG000|Overall Study|Withdrawal Informed Consent|6|||
125995562|NCT00502996|453277049|FG000|Overall Study|Adverse Event|2|||
125995563|NCT01729728|453277050|FG000|Overall Study|Adverse Event|0|||
125995564|NCT01729728|453277051|FG001|Overall Study|Adverse Event|6|||
125995565|NCT01729728|453277052|FG002|Overall Study|Adverse Event|0|||
125995566|NCT01729728|453277050|FG000|Overall Study|Protocol Violation|1|||
125995567|NCT01729728|453277051|FG001|Overall Study|Protocol Violation|0|||
125995568|NCT01729728|453277052|FG002|Overall Study|Protocol Violation|1|||
125995569|NCT02500979|453277053|FG000|Period 1|Hyperglycemia|1|||
125995570|NCT02500979|453277054|FG001|Period 1|Hyperglycemia|0|||
125995571|NCT02500979|453277053|FG000|Period 1|Severe non-compliance to protocol|0|||
125995572|NCT02500979|453277054|FG001|Period 1|Severe non-compliance to protocol|1|||
125995573|NCT02500979|453277053|FG000|Period 1|Adverse Event|1|||
125995574|NCT02500979|453277054|FG001|Period 1|Adverse Event|0|||
125995575|NCT02500979|453277053|FG000|Period 1|Subject decision|2|||
125995576|NCT02500979|453277054|FG001|Period 1|Subject decision|0|||
125995577|NCT02500979|453277053|FG000|Period 2|Change in risk|1|||
125995578|NCT02500979|453277054|FG001|Period 2|Change in risk|0|||
125995579|NCT00672958|453277055|FG000|Overall Study|Adverse Event|11|||
125995580|NCT00672958|453277056|FG001|Overall Study|Adverse Event|9|||
125995581|NCT00672958|453277055|FG000|Overall Study|Lack of Efficacy|6|||
125995582|NCT00672958|453277056|FG001|Overall Study|Lack of Efficacy|11|||
125995583|NCT00672958|453277055|FG000|Overall Study|Non-compliance with study drug|2|||
125995584|NCT00672958|453277056|FG001|Overall Study|Non-compliance with study drug|3|||
125995585|NCT00672958|453277055|FG000|Overall Study|Protocol deviations|11|||
125995586|NCT00672958|453277056|FG001|Overall Study|Protocol deviations|5|||
125995587|NCT00672958|453277055|FG000|Overall Study|Voluntary withdrawal|12|||
125995588|NCT00672958|453277056|FG001|Overall Study|Voluntary withdrawal|8|||
125995589|NCT00672958|453277055|FG000|Overall Study|Lost to Follow-up|22|||
125995590|NCT00672958|453277056|FG001|Overall Study|Lost to Follow-up|17|||
125995591|NCT00672958|453277055|FG000|Overall Study|Reason not specified|0|||
125995592|NCT00672958|453277056|FG001|Overall Study|Reason not specified|3|||
125995593|NCT01380990|453277057|FG000|Overall Study|Treatment Failure|1|||
125995594|NCT01380990|453277058|FG001|Overall Study|Treatment Failure|0|||
125995595|NCT01380990|453277057|FG000|Overall Study|Death|0|||
125995596|NCT01380990|453277058|FG001|Overall Study|Death|1|||
125995597|NCT02374593|453277059|FG000|Overall Study|non-compliant|2|||
125995598|NCT02374593|453277060|FG001|Overall Study|non-compliant|0|||
125995599|NCT04267614|453277062|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
125995600|NCT04267614|453277062|FG000|Overall Study|Lost to Follow-up|115|||
125995601|NCT00210119|453277063|FG000|Overall Study|Protocol Violation|1|||
125995602|NCT00210119|453277063|FG000|Overall Study|Withdrawal by Subject|1|||
125995603|NCT01830881|453277064|FG000|Overall Study|Changed decision to have an abortion|0|||
125995604|NCT01830881|453277065|FG001|Overall Study|Changed decision to have an abortion|1|||
125995605|NCT00988351|453277066|FG000|Overall Study|Withdrawal by Subject|8|||
125995606|NCT00988351|453277067|FG001|Overall Study|Withdrawal by Subject|0|||
125995607|NCT00988351|453277066|FG000|Overall Study|Lost to Follow-up|6|||
125995608|NCT00988351|453277067|FG001|Overall Study|Lost to Follow-up|9|||
125995609|NCT00988351|453277066|FG000|Overall Study|not using CPAP|5|||
125995610|NCT00988351|453277067|FG001|Overall Study|not using CPAP|3|||
125995611|NCT02038764|453277068|FG000|Overall Study|Adverse Event|0|||
125995612|NCT02038764|453277069|FG001|Overall Study|Adverse Event|0|||
126331377|NCT01877668|454508825|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126331378|NCT01877668|454508826|FG004|Overall Study|Adverse event unrelated to study drug|1|||
126331379|NCT01302418|454508827|FG000|Overall Study|Protocol Violation|9|||
126331380|NCT01302418|454508827|FG000|Overall Study|Non-evaluable|9|||
126331381|NCT00377637|454508829|FG000|Induction Phase|Adverse Event|12|||
126331382|NCT00377637|454508830|FG001|Induction Phase|Adverse Event|21|||
126331383|NCT00377637|454508831|FG002|Induction Phase|Adverse Event|0|||
126331384|NCT00377637|454508832|FG003|Induction Phase|Adverse Event|0|||
125995613|NCT02038764|453277070|FG002|Overall Study|Adverse Event|1|||
125995614|NCT02038764|453277071|FG003|Overall Study|Adverse Event|0|||
125995615|NCT02038764|453277072|FG004|Overall Study|Adverse Event|0|||
125995616|NCT02038764|453277068|FG000|Overall Study|Lost to Follow-up|0|||
125995617|NCT02038764|453277069|FG001|Overall Study|Lost to Follow-up|1|||
125995618|NCT02038764|453277070|FG002|Overall Study|Lost to Follow-up|0|||
125995619|NCT02038764|453277071|FG003|Overall Study|Lost to Follow-up|0|||
125995620|NCT02038764|453277072|FG004|Overall Study|Lost to Follow-up|0|||
125995621|NCT02038764|453277068|FG000|Overall Study|Withdrawal by Subject|0|||
125995622|NCT02038764|453277069|FG001|Overall Study|Withdrawal by Subject|0|||
125995623|NCT02038764|453277070|FG002|Overall Study|Withdrawal by Subject|0|||
125995624|NCT02038764|453277071|FG003|Overall Study|Withdrawal by Subject|0|||
125995625|NCT02038764|453277072|FG004|Overall Study|Withdrawal by Subject|1|||
125995626|NCT02038764|453277068|FG000|Overall Study|Other|1|||
125995627|NCT02038764|453277069|FG001|Overall Study|Other|0|||
125995628|NCT02038764|453277070|FG002|Overall Study|Other|1|||
125995629|NCT02038764|453277071|FG003|Overall Study|Other|0|||
125995630|NCT02038764|453277072|FG004|Overall Study|Other|0|||
125995631|NCT01927731|453277088|FG000|Overall Study|Graft Failure|1|||
125995632|NCT01927731|453277089|FG001|Overall Study|Graft Failure|2|||
125995633|NCT01927731|453277088|FG000|Overall Study|Physician Decision|2|||
125995634|NCT01927731|453277089|FG001|Overall Study|Physician Decision|3|||
125995635|NCT01927731|453277088|FG000|Overall Study|Withdrawal by Subject|0|||
125995636|NCT01927731|453277089|FG001|Overall Study|Withdrawal by Subject|2|||
125995637|NCT01927731|453277088|FG000|Overall Study|Death|0|||
125995638|NCT01927731|453277089|FG001|Overall Study|Death|3|||
125995639|NCT01388530|453277090|FG000|Overall Study|Lost to Follow-up|5|||
125995640|NCT00305864|453277093|FG000|Overall Study|Ineligible / No protocol treatment|0|||
125995641|NCT00305864|453277094|FG001|Overall Study|Ineligible / No protocol treatment|1|||
125995642|NCT00305864|453277095|FG002|Overall Study|Ineligible / No protocol treatment|1|||
125995643|NCT00305864|453277096|FG003|Overall Study|Ineligible / No protocol treatment|13|||
125995644|NCT02836613|453277099|FG000|Overall Study|Accidental drowning|1|||
125995645|NCT02836613|453277100|FG001|Overall Study|Accidental drowning|0|||
125995646|NCT02836613|453277099|FG000|Overall Study|Lost to Follow-up|0|||
125995647|NCT02836613|453277100|FG001|Overall Study|Lost to Follow-up|1|||
125995648|NCT02836613|453277099|FG000|Overall Study|Withdrawal by Subject|0|||
125995649|NCT02836613|453277100|FG001|Overall Study|Withdrawal by Subject|2|||
125995650|NCT03881059|453277101|FG000|Treatment Period - Part A|Adverse Event|1|||
125995651|NCT03881059|453277102|FG001|Treatment Period - Part A|Adverse Event|3|||
125995652|NCT03881059|453277103|FG002|Treatment Period - Part A|Adverse Event|4|||
125995653|NCT03881059|453277101|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
125995654|NCT03881059|453277102|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
125995655|NCT03881059|453277103|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
125995656|NCT03881059|453277101|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
125995657|NCT03881059|453277102|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
125995658|NCT03881059|453277103|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
125995659|NCT03881059|453277101|FG000|Treatment Period - Part A|Other reasons|2|||
125995660|NCT03881059|453277102|FG001|Treatment Period - Part A|Other reasons|1|||
125995661|NCT03881059|453277103|FG002|Treatment Period - Part A|Other reasons|0|||
125995662|NCT03881059|453277101|FG000|Treatment Period - Part B|Adverse Event|0|||
125995663|NCT03881059|453277102|FG001|Treatment Period - Part B|Adverse Event|0|||
125995664|NCT03881059|453277103|FG002|Treatment Period - Part B|Adverse Event|3|||
125995665|NCT03881059|453277101|FG000|Treatment Period - Part B|Death|0|||
125995666|NCT03881059|453277102|FG001|Treatment Period - Part B|Death|1|||
125995667|NCT03881059|453277103|FG002|Treatment Period - Part B|Death|1|||
125995668|NCT03881059|453277101|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
125995669|NCT03881059|453277102|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
125995670|NCT03881059|453277103|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
125995671|NCT03881059|453277101|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
125995672|NCT03881059|453277102|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
125995673|NCT03881059|453277103|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
125995674|NCT03881059|453277101|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
125995675|NCT03881059|453277102|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
125995676|NCT03881059|453277103|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
125995677|NCT03881059|453277101|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
125995678|NCT03881059|453277102|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
125995679|NCT03881059|453277103|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
125995680|NCT03881059|453277101|FG000|Treatment Period - Part B|Other reasons|4|||
125995681|NCT03881059|453277102|FG001|Treatment Period - Part B|Other reasons|3|||
125995682|NCT03881059|453277103|FG002|Treatment Period - Part B|Other reasons|3|||
125995683|NCT05284019|453277104|FG000|Overall Study|Study terminated|2|||
125995684|NCT05284019|453277105|FG001|Overall Study|Study terminated|2|||
125995685|NCT05284019|453277106|FG002|Overall Study|Study terminated|2|||
125995686|NCT05284019|453277107|FG003|Overall Study|Study terminated|5|||
125995687|NCT05284019|453277108|FG004|Overall Study|Study terminated|15|||
125995688|NCT05284019|453277104|FG000|Overall Study|Withdrawal by Subject|0|||
125995689|NCT05284019|453277105|FG001|Overall Study|Withdrawal by Subject|0|||
125995690|NCT05284019|453277106|FG002|Overall Study|Withdrawal by Subject|0|||
125995691|NCT05284019|453277107|FG003|Overall Study|Withdrawal by Subject|1|||
125995692|NCT05284019|453277108|FG004|Overall Study|Withdrawal by Subject|1|||
125995693|NCT05284019|453277104|FG000|Overall Study|Lost to Follow-up|1|||
125995694|NCT05284019|453277105|FG001|Overall Study|Lost to Follow-up|0|||
125995695|NCT05284019|453277106|FG002|Overall Study|Lost to Follow-up|0|||
125995696|NCT05284019|453277107|FG003|Overall Study|Lost to Follow-up|2|||
125995697|NCT05284019|453277108|FG004|Overall Study|Lost to Follow-up|1|||
125995698|NCT02065570|453277109|FG000|Induction Study|Adverse Event|5|||
125995699|NCT02065570|453277110|FG001|Induction Study|Adverse Event|12|||
125995700|NCT02065570|453277111|FG002|Induction Study|Adverse Event|0|||
125995701|NCT02065570|453277112|FG003|Induction Study|Adverse Event|0|||
125995702|NCT02065570|453277109|FG000|Induction Study|Withdrawal by Subject|2|||
125995703|NCT02065570|453277110|FG001|Induction Study|Withdrawal by Subject|3|||
125995704|NCT02065570|453277111|FG002|Induction Study|Withdrawal by Subject|0|||
125995705|NCT02065570|453277112|FG003|Induction Study|Withdrawal by Subject|0|||
125995706|NCT02065570|453277109|FG000|Induction Study|Lost to Follow-up|1|||
125995707|NCT02065570|453277110|FG001|Induction Study|Lost to Follow-up|1|||
125995708|NCT02065570|453277111|FG002|Induction Study|Lost to Follow-up|0|||
125995709|NCT02065570|453277112|FG003|Induction Study|Lost to Follow-up|0|||
125995710|NCT02065570|453277109|FG000|Induction Study|Other, Not Specified|6|||
125995711|NCT02065570|453277110|FG001|Induction Study|Other, Not Specified|5|||
125995712|NCT02065570|453277111|FG002|Induction Study|Other, Not Specified|0|||
125995713|NCT02065570|453277112|FG003|Induction Study|Other, Not Specified|0|||
125995714|NCT02065570|453277109|FG000|Maintenance Study|Adverse Event|0|||
125995715|NCT02065570|453277110|FG001|Maintenance Study|Adverse Event|0|||
125995716|NCT02065570|453277111|FG002|Maintenance Study|Adverse Event|8|||
125995717|NCT02065570|453277112|FG003|Maintenance Study|Adverse Event|8|||
125995718|NCT02065570|453277109|FG000|Maintenance Study|Withdrawal by Subject|0|||
125995719|NCT02065570|453277110|FG001|Maintenance Study|Withdrawal by Subject|0|||
125995720|NCT02065570|453277111|FG002|Maintenance Study|Withdrawal by Subject|1|||
125995721|NCT02065570|453277112|FG003|Maintenance Study|Withdrawal by Subject|4|||
125995722|NCT02065570|453277109|FG000|Maintenance Study|Lost to Follow-up|0|||
125995723|NCT02065570|453277110|FG001|Maintenance Study|Lost to Follow-up|0|||
125995724|NCT02065570|453277111|FG002|Maintenance Study|Lost to Follow-up|2|||
125995725|NCT02065570|453277112|FG003|Maintenance Study|Lost to Follow-up|2|||
125995726|NCT02065570|453277109|FG000|Maintenance Study|Other, Not Specified|0|||
125995727|NCT02065570|453277110|FG001|Maintenance Study|Other, Not Specified|0|||
125995728|NCT02065570|453277111|FG002|Maintenance Study|Other, Not Specified|11|||
125995729|NCT02065570|453277112|FG003|Maintenance Study|Other, Not Specified|5|||
125995730|NCT00287469|453277113|FG000|Overall Study|serious adverse event|1|||
125995731|NCT00287469|453277114|FG001|Overall Study|serious adverse event|6|||
125995732|NCT00287469|453277113|FG000|Overall Study|Adverse Event|1|||
125995733|NCT00287469|453277114|FG001|Overall Study|Adverse Event|1|||
125995734|NCT00287469|453277113|FG000|Overall Study|moved from area|144|||
125995735|NCT00287469|453277114|FG001|Overall Study|moved from area|138|||
125995736|NCT00287469|453277113|FG000|Overall Study|Lost to Follow-up|74|||
125995737|NCT00287469|453277114|FG001|Overall Study|Lost to Follow-up|69|||
125995738|NCT01266993|453277117|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
125995739|NCT01266993|453277118|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
125995740|NCT01266993|453277117|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
125995741|NCT01266993|453277118|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
125995742|NCT02293837|453277119|FG000|Overall Study|Lost to Follow-up|0|||
125995743|NCT02293837|453277120|FG001|Overall Study|Lost to Follow-up|2|||
125995744|NCT02293837|453277121|FG002|Overall Study|Lost to Follow-up|1|||
125995745|NCT02293837|453277122|FG003|Overall Study|Lost to Follow-up|0|||
125995746|NCT02293837|453277119|FG000|Overall Study|Withdrawal by Subject|2|||
125995747|NCT02293837|453277120|FG001|Overall Study|Withdrawal by Subject|1|||
125995748|NCT02293837|453277121|FG002|Overall Study|Withdrawal by Subject|2|||
125995749|NCT02293837|453277122|FG003|Overall Study|Withdrawal by Subject|1|||
125995750|NCT02293837|453277119|FG000|Overall Study|COVID-19 Related|1|||
125995751|NCT02293837|453277120|FG001|Overall Study|COVID-19 Related|1|||
125995752|NCT02293837|453277121|FG002|Overall Study|COVID-19 Related|0|||
125995753|NCT02293837|453277122|FG003|Overall Study|COVID-19 Related|0|||
125995754|NCT02293837|453277119|FG000|Overall Study|Participant ill and could not be infused|0|||
125995755|NCT02293837|453277120|FG001|Overall Study|Participant ill and could not be infused|0|||
125995756|NCT02293837|453277121|FG002|Overall Study|Participant ill and could not be infused|1|||
125995757|NCT02293837|453277122|FG003|Overall Study|Participant ill and could not be infused|0|||
125995758|NCT04779242|453277123|FG000|Overall Study|Adverse Event|1|||
125995759|NCT04779242|453277124|FG001|Overall Study|Adverse Event|1|||
125995760|NCT04779242|453277123|FG000|Overall Study|Lost to Follow-up|2|||
125995761|NCT04779242|453277124|FG001|Overall Study|Lost to Follow-up|4|||
125995762|NCT04779242|453277123|FG000|Overall Study|Withdrawal by Subject|7|||
125995763|NCT04779242|453277124|FG001|Overall Study|Withdrawal by Subject|9|||
125995764|NCT04779242|453277123|FG000|Overall Study|Death|6|||
125995765|NCT04779242|453277124|FG001|Overall Study|Death|6|||
125995766|NCT04779242|453277123|FG000|Overall Study|COVID-19 related reasons|2|||
125995767|NCT04779242|453277124|FG001|Overall Study|COVID-19 related reasons|1|||
125995768|NCT04779242|453277123|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
125995769|NCT04779242|453277124|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
125995770|NCT04779242|453277123|FG000|Overall Study|Martial Law in Ukraine|2|||
125995771|NCT04779242|453277124|FG001|Overall Study|Martial Law in Ukraine|3|||
125995772|NCT03285113|453277127|FG000|Overall Study|Unable to implant leads|2|||
125995773|NCT00849680|453277130|FG000|Overall Study|Adverse Event|0|||
125995774|NCT00849680|453277131|FG001|Overall Study|Adverse Event|0|||
125995775|NCT00849680|453277132|FG002|Overall Study|Adverse Event|0|||
125995776|NCT00849680|453277133|FG003|Overall Study|Adverse Event|0|||
125995777|NCT00849680|453277134|FG004|Overall Study|Adverse Event|0|||
125995778|NCT00849680|453277135|FG005|Overall Study|Adverse Event|0|||
125995779|NCT00849680|453277136|FG006|Overall Study|Adverse Event|2|||
125995780|NCT00849680|453277137|FG007|Overall Study|Adverse Event|0|||
125995781|NCT00849680|453277130|FG000|Overall Study|Lost to Follow-up|7|||
125995782|NCT00849680|453277131|FG001|Overall Study|Lost to Follow-up|3|||
125995783|NCT00849680|453277132|FG002|Overall Study|Lost to Follow-up|12|||
125995784|NCT00849680|453277133|FG003|Overall Study|Lost to Follow-up|11|||
125995785|NCT00849680|453277134|FG004|Overall Study|Lost to Follow-up|8|||
125995786|NCT00849680|453277135|FG005|Overall Study|Lost to Follow-up|11|||
125995787|NCT00849680|453277136|FG006|Overall Study|Lost to Follow-up|12|||
125995788|NCT00849680|453277137|FG007|Overall Study|Lost to Follow-up|5|||
125995789|NCT00849680|453277130|FG000|Overall Study|Subject moved|1|||
125995790|NCT00849680|453277131|FG001|Overall Study|Subject moved|0|||
125995791|NCT00849680|453277132|FG002|Overall Study|Subject moved|3|||
125995792|NCT00849680|453277133|FG003|Overall Study|Subject moved|1|||
125995793|NCT00849680|453277134|FG004|Overall Study|Subject moved|0|||
125995794|NCT00849680|453277135|FG005|Overall Study|Subject moved|2|||
125995795|NCT00849680|453277136|FG006|Overall Study|Subject moved|2|||
125995796|NCT00849680|453277137|FG007|Overall Study|Subject moved|2|||
125995797|NCT00849680|453277130|FG000|Overall Study|Withdrawal by Subject|2|||
125995798|NCT00849680|453277131|FG001|Overall Study|Withdrawal by Subject|0|||
125995799|NCT00849680|453277132|FG002|Overall Study|Withdrawal by Subject|0|||
125995800|NCT00849680|453277133|FG003|Overall Study|Withdrawal by Subject|2|||
125995801|NCT00849680|453277134|FG004|Overall Study|Withdrawal by Subject|2|||
125995802|NCT00849680|453277135|FG005|Overall Study|Withdrawal by Subject|2|||
125995803|NCT00849680|453277136|FG006|Overall Study|Withdrawal by Subject|1|||
125995804|NCT00849680|453277137|FG007|Overall Study|Withdrawal by Subject|1|||
125995805|NCT00849680|453277130|FG000|Overall Study|Subject unable to comply with protocol|1|||
125995806|NCT00849680|453277131|FG001|Overall Study|Subject unable to comply with protocol|0|||
125995807|NCT00849680|453277132|FG002|Overall Study|Subject unable to comply with protocol|0|||
125995808|NCT00849680|453277133|FG003|Overall Study|Subject unable to comply with protocol|0|||
125995809|NCT00849680|453277134|FG004|Overall Study|Subject unable to comply with protocol|0|||
125995810|NCT00849680|453277135|FG005|Overall Study|Subject unable to comply with protocol|0|||
125995811|NCT00849680|453277136|FG006|Overall Study|Subject unable to comply with protocol|0|||
125995812|NCT00849680|453277137|FG007|Overall Study|Subject unable to comply with protocol|0|||
125995813|NCT02942004|453277138|FG000|Overall Study|Withdrawal by Subject|0|||
125995814|NCT02942004|453277139|FG001|Overall Study|Withdrawal by Subject|2|||
125995815|NCT02942004|453277140|FG002|Overall Study|Withdrawal by Subject|3|||
125995816|NCT02942004|453277138|FG000|Overall Study|Lost to Follow-up|1|||
125995817|NCT02942004|453277139|FG001|Overall Study|Lost to Follow-up|1|||
125995818|NCT02942004|453277140|FG002|Overall Study|Lost to Follow-up|2|||
125995819|NCT02942004|453277138|FG000|Overall Study|Randomized but not dosed|3|||
125995820|NCT02942004|453277139|FG001|Overall Study|Randomized but not dosed|9|||
125995821|NCT02942004|453277140|FG002|Overall Study|Randomized but not dosed|4|||
125995822|NCT03382600|453277141|FG000|Overall Study|Adverse Event|3|||
125995823|NCT03382600|453277142|FG001|Overall Study|Adverse Event|3|||
125995824|NCT03382600|453277141|FG000|Overall Study|Clinical Disease Progression|2|||
125995825|NCT03382600|453277142|FG001|Overall Study|Clinical Disease Progression|4|||
125995826|NCT03382600|453277141|FG000|Overall Study|Radiological Progression|40|||
125995827|NCT03382600|453277142|FG001|Overall Study|Radiological Progression|31|||
125995828|NCT03382600|453277141|FG000|Overall Study|Withdrawal by Subject|0|||
125995829|NCT03382600|453277142|FG001|Overall Study|Withdrawal by Subject|1|||
125995830|NCT03382600|453277141|FG000|Overall Study|Other|9|||
125995831|NCT03382600|453277142|FG001|Overall Study|Other|7|||
125995832|NCT01448044|453277143|FG000|Treatment Period|Adverse Event|4|||
125995833|NCT01448044|453277144|FG001|Treatment Period|Adverse Event|3|||
125995834|NCT01448044|453277143|FG000|Treatment Period|Lack of Efficacy|5|||
125995835|NCT01448044|453277144|FG001|Treatment Period|Lack of Efficacy|12|||
125995836|NCT01448044|453277143|FG000|Treatment Period|Subject requested discontinue study drug|1|||
125995837|NCT01448044|453277144|FG001|Treatment Period|Subject requested discontinue study drug|0|||
125995838|NCT01448044|453277143|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
125995839|NCT01448044|453277144|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
125995840|NCT01448044|453277143|FG000|Treatment Period|Participant does not meet study criteria|1|||
125995841|NCT01448044|453277144|FG001|Treatment Period|Participant does not meet study criteria|0|||
125995842|NCT01448044|453277143|FG000|Treatment Period|Lost to Follow-up|2|||
125995843|NCT01448044|453277144|FG001|Treatment Period|Lost to Follow-up|1|||
125995844|NCT01448044|453277143|FG000|Treatment Period|Other reason|2|||
125995845|NCT01448044|453277144|FG001|Treatment Period|Other reason|0|||
125995846|NCT01448044|453277143|FG000|Follow Up Period|Withdrawal by Subject|1|||
125995847|NCT01448044|453277144|FG001|Follow Up Period|Withdrawal by Subject|1|||
125995848|NCT01448044|453277143|FG000|Follow Up Period|Lost to Follow-up|6|||
125995849|NCT01448044|453277144|FG001|Follow Up Period|Lost to Follow-up|2|||
125995850|NCT01448044|453277143|FG000|Follow Up Period|Other|5|||
125995851|NCT01448044|453277144|FG001|Follow Up Period|Other|11|||
125995852|NCT01000376|453277147|FG000|Cycle 1 Day 1|Adverse Event|1|||
125995853|NCT01000376|453277148|FG001|Cycle 1 Day 1|Adverse Event|0|||
125995854|NCT01000376|453277147|FG000|Cycle 1 Day 1|Progressive Disease|1|||
125995855|NCT01000376|453277148|FG001|Cycle 1 Day 1|Progressive Disease|0|||
125995856|NCT00507026|453277149|FG000|Overall Study|Lack of Efficacy|6|||
125995857|NCT00507026|453277150|FG001|Overall Study|Lack of Efficacy|4|||
125995858|NCT00507026|453277151|FG002|Overall Study|Lack of Efficacy|21|||
125995859|NCT00507026|453277149|FG000|Overall Study|Withdrawal by Subject|2|||
125995860|NCT00507026|453277150|FG001|Overall Study|Withdrawal by Subject|0|||
125995861|NCT00507026|453277151|FG002|Overall Study|Withdrawal by Subject|0|||
125995862|NCT00507026|453277149|FG000|Overall Study|Investigator Decision|1|||
125995863|NCT00507026|453277150|FG001|Overall Study|Investigator Decision|0|||
125995864|NCT00507026|453277151|FG002|Overall Study|Investigator Decision|0|||
125995865|NCT00507026|453277149|FG000|Overall Study|Adverse Event|2|||
125995866|NCT00507026|453277150|FG001|Overall Study|Adverse Event|0|||
125995867|NCT00507026|453277151|FG002|Overall Study|Adverse Event|0|||
125995868|NCT00507026|453277149|FG000|Overall Study|Protocol Violation|1|||
125995869|NCT00507026|453277150|FG001|Overall Study|Protocol Violation|0|||
125995870|NCT00507026|453277151|FG002|Overall Study|Protocol Violation|0|||
125995871|NCT00507026|453277149|FG000|Overall Study|Other|1|||
125995872|NCT00507026|453277150|FG001|Overall Study|Other|0|||
125995873|NCT00507026|453277151|FG002|Overall Study|Other|0|||
125995874|NCT00896454|453277152|FG000|Overall Study|Death|10|||
125995875|NCT00896454|453277152|FG000|Overall Study|Adverse Event|8|||
125995876|NCT00896454|453277152|FG000|Overall Study|Disease Progression|5|||
125995877|NCT00896454|453277152|FG000|Overall Study|Other|4|||
125995878|NCT00896454|453277152|FG000|Overall Study|Requirement for alternative therapy|3|||
125995879|NCT00896454|453277152|FG000|Overall Study|Ongoing in study|2|||
125995880|NCT00896454|453277152|FG000|Overall Study|Withdrawal by Subject|1|||
125995881|NCT03688711|453277155|FG000|Overall Study|Withdrawal by Subject|0|||
125995882|NCT03688711|453277156|FG001|Overall Study|Withdrawal by Subject|1|||
125995883|NCT05033080|453277163|FG000|Overall Study|Adverse Event|4|||
125995884|NCT05033080|453277164|FG001|Overall Study|Adverse Event|4|||
125995885|NCT05033080|453277163|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
125995886|NCT05033080|453277164|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
125995887|NCT05033080|453277163|FG000|Overall Study|Lost to Follow-up|1|||
125995888|NCT05033080|453277164|FG001|Overall Study|Lost to Follow-up|0|||
125995889|NCT05033080|453277163|FG000|Overall Study|Other non-compliance|0|||
125995890|NCT05033080|453277164|FG001|Overall Study|Other non-compliance|1|||
125995891|NCT05033080|453277163|FG000|Overall Study|Physician Decision|0|||
125995892|NCT05033080|453277164|FG001|Overall Study|Physician Decision|1|||
125995893|NCT05033080|453277163|FG000|Overall Study|Other|1|||
125995894|NCT05033080|453277164|FG001|Overall Study|Other|1|||
125995895|NCT01680458|453277176|FG000|Overall Study|Protocol Violation|3|||
125995896|NCT01040780|453279662|FG000|Overall Study|Protocol Violation|1|||
125995897|NCT01040780|453279663|FG001|Overall Study|Protocol Violation|3|||
125995898|NCT00802737|453279664|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
125995899|NCT00802737|453279665|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
125995900|NCT00802737|453279666|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
125995901|NCT00802737|453279664|FG000|Overall Study|Death|6|||
125995902|NCT00802737|453279665|FG001|Overall Study|Death|5|||
125995903|NCT00802737|453279666|FG002|Overall Study|Death|1|||
125995904|NCT00802737|453279664|FG000|Overall Study|Adverse Event|1|||
125995905|NCT00802737|453279665|FG001|Overall Study|Adverse Event|0|||
125995906|NCT00802737|453279666|FG002|Overall Study|Adverse Event|0|||
125995907|NCT00802737|453279664|FG000|Overall Study|Received Prohibited Therapy|1|||
125995908|NCT00802737|453279665|FG001|Overall Study|Received Prohibited Therapy|0|||
125995909|NCT00802737|453279666|FG002|Overall Study|Received Prohibited Therapy|0|||
125995910|NCT00802737|453279664|FG000|Overall Study|Ongoing CLL-Treatment|0|||
125995911|NCT00802737|453279665|FG001|Overall Study|Ongoing CLL-Treatment|1|||
125995912|NCT00802737|453279666|FG002|Overall Study|Ongoing CLL-Treatment|0|||
125995913|NCT00802737|453279664|FG000|Overall Study|Participant too Unwell|0|||
125995914|NCT00802737|453279665|FG001|Overall Study|Participant too Unwell|2|||
125995915|NCT00802737|453279666|FG002|Overall Study|Participant too Unwell|0|||
125995916|NCT03864926|453279674|FG000|Overall Study|Death|0|||
125995917|NCT03864926|453279675|FG001|Overall Study|Death|2|||
125995918|NCT00445601|453279676|FG000|Overall Study|Withdrawal by Subject|11|||
125995919|NCT00445601|453279677|FG001|Overall Study|Withdrawal by Subject|11|||
125995920|NCT00445601|453279676|FG000|Overall Study|TURBT Complication|12|||
125995921|NCT00445601|453279677|FG001|Overall Study|TURBT Complication|8|||
125995922|NCT00445601|453279676|FG000|Overall Study|Incorrect Disease Status|6|||
125995923|NCT00445601|453279677|FG001|Overall Study|Incorrect Disease Status|6|||
125995924|NCT00445601|453279676|FG000|Overall Study|Drug Delivery Issue|2|||
125995925|NCT00445601|453279677|FG001|Overall Study|Drug Delivery Issue|2|||
125995926|NCT00445601|453279676|FG000|Overall Study|Adverse Event|2|||
125995927|NCT00445601|453279677|FG001|Overall Study|Adverse Event|0|||
125995928|NCT00445601|453279676|FG000|Overall Study|Death prior to TURBT|0|||
125995929|NCT00445601|453279677|FG001|Overall Study|Death prior to TURBT|1|||
125995930|NCT01625910|453279684|FG000|Overall Study|Lost to Follow-up|3|||
126331385|NCT00377637|454508829|FG000|Induction Phase|Deterioration/serum creatinine|2|||
125995931|NCT01625910|453279685|FG001|Overall Study|Lost to Follow-up|4|||
125995932|NCT02391038|453279686|FG000|Overall Study|Progressive disease|3|||
125995933|NCT02391038|453279687|FG001|Overall Study|Progressive disease|3|||
125995934|NCT02391038|453279688|FG002|Overall Study|Progressive disease|6|||
125995935|NCT02959138|453279689|FG000|Overall Study|Enrolled but Never Treated|0|||
125995936|NCT02959138|453279690|FG001|Overall Study|Enrolled but Never Treated|1|||
125995937|NCT02959138|453279691|FG002|Overall Study|Enrolled but Never Treated|0|||
125995938|NCT04213989|453279692|FG000|Overall Study|Withdrawal by Subject|3|||
125995939|NCT04213989|453279693|FG001|Overall Study|Withdrawal by Subject|2|||
125995940|NCT04213989|453279692|FG000|Overall Study|Physician Decision|1|||
125995941|NCT04213989|453279693|FG001|Overall Study|Physician Decision|0|||
125995942|NCT04213989|453279692|FG000|Overall Study|Lost to Follow-up|0|||
125995943|NCT04213989|453279693|FG001|Overall Study|Lost to Follow-up|4|||
125995944|NCT01681368|453279696|FG000|Overall Study|Refused further treatment|1|||
125995945|NCT01681368|453279696|FG000|Overall Study|Refused further follow up|1|||
125995946|NCT01189890|453279697|FG000|Overall Study|Adverse Event|3|||
125995947|NCT01189890|453279698|FG001|Overall Study|Adverse Event|4|||
125995948|NCT01189890|453279697|FG000|Overall Study|Lack of Efficacy|7|||
125995949|NCT01189890|453279698|FG001|Overall Study|Lack of Efficacy|2|||
125995950|NCT01189890|453279697|FG000|Overall Study|Lost to Follow-up|1|||
125995951|NCT01189890|453279698|FG001|Overall Study|Lost to Follow-up|7|||
125995952|NCT01189890|453279697|FG000|Overall Study|Protocol Violation|1|||
125995953|NCT01189890|453279698|FG001|Overall Study|Protocol Violation|5|||
125995954|NCT01189890|453279697|FG000|Overall Study|Withdrawal by Subject|15|||
125995955|NCT01189890|453279698|FG001|Overall Study|Withdrawal by Subject|11|||
125995956|NCT01189890|453279697|FG000|Overall Study|Non Compliance|0|||
125995957|NCT01189890|453279698|FG001|Overall Study|Non Compliance|1|||
125995958|NCT01189890|453279697|FG000|Overall Study|Physician Decision|5|||
125995959|NCT01189890|453279698|FG001|Overall Study|Physician Decision|4|||
125995960|NCT01189890|453279697|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
125995961|NCT01189890|453279698|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
125995962|NCT01807221|453279701|FG000|Overall Study|Progressive disease|1|||
125995963|NCT01807221|453279702|FG001|Overall Study|Progressive disease|0|||
125995964|NCT01807221|453279703|FG002|Overall Study|Progressive disease|1|||
125995965|NCT01807221|453279704|FG003|Overall Study|Progressive disease|0|||
125995966|NCT01807221|453279705|FG004|Overall Study|Progressive disease|0|||
125995967|NCT01807221|453279706|FG005|Overall Study|Progressive disease|0|||
125995968|NCT01807221|453279701|FG000|Overall Study|Death|7|||
125995969|NCT01807221|453279702|FG001|Overall Study|Death|9|||
125995970|NCT01807221|453279703|FG002|Overall Study|Death|4|||
125995971|NCT01807221|453279704|FG003|Overall Study|Death|2|||
125995972|NCT01807221|453279705|FG004|Overall Study|Death|1|||
125995973|NCT01807221|453279706|FG005|Overall Study|Death|6|||
125995974|NCT01807221|453279701|FG000|Overall Study|Physician Decision|2|||
125995975|NCT01807221|453279702|FG001|Overall Study|Physician Decision|1|||
125995976|NCT01807221|453279703|FG002|Overall Study|Physician Decision|0|||
125995977|NCT01807221|453279704|FG003|Overall Study|Physician Decision|0|||
126331386|NCT00377637|454508830|FG001|Induction Phase|Deterioration/serum creatinine|0|||
126331387|NCT00377637|454508831|FG002|Induction Phase|Deterioration/serum creatinine|0|||
126331388|NCT00377637|454508832|FG003|Induction Phase|Deterioration/serum creatinine|0|||
126331389|NCT00377637|454508829|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
126331390|NCT00377637|454508830|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
126331391|NCT00377637|454508831|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
126331392|NCT00377637|454508832|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
126331393|NCT00377637|454508829|FG000|Induction Phase|Lost to Follow-up|2|||
125995978|NCT01807221|453279705|FG004|Overall Study|Physician Decision|0|||
125995979|NCT01807221|453279706|FG005|Overall Study|Physician Decision|0|||
125995980|NCT01807221|453279701|FG000|Overall Study|Adverse Event|33|||
125995981|NCT01807221|453279702|FG001|Overall Study|Adverse Event|22|||
125995982|NCT01807221|453279703|FG002|Overall Study|Adverse Event|26|||
125995983|NCT01807221|453279704|FG003|Overall Study|Adverse Event|25|||
125995984|NCT01807221|453279705|FG004|Overall Study|Adverse Event|18|||
125995985|NCT01807221|453279706|FG005|Overall Study|Adverse Event|21|||
125995986|NCT01807221|453279701|FG000|Overall Study|Protocol Violation|0|||
125995987|NCT01807221|453279702|FG001|Overall Study|Protocol Violation|2|||
125995988|NCT01807221|453279703|FG002|Overall Study|Protocol Violation|1|||
125995989|NCT01807221|453279704|FG003|Overall Study|Protocol Violation|2|||
125995990|NCT01807221|453279705|FG004|Overall Study|Protocol Violation|0|||
125995991|NCT01807221|453279706|FG005|Overall Study|Protocol Violation|1|||
125995992|NCT01807221|453279701|FG000|Overall Study|Non-compliance|1|||
125995993|NCT01807221|453279702|FG001|Overall Study|Non-compliance|2|||
125995994|NCT01807221|453279703|FG002|Overall Study|Non-compliance|0|||
125995995|NCT01807221|453279704|FG003|Overall Study|Non-compliance|1|||
125995996|NCT01807221|453279705|FG004|Overall Study|Non-compliance|0|||
125995997|NCT01807221|453279706|FG005|Overall Study|Non-compliance|0|||
125995998|NCT01807221|453279701|FG000|Overall Study|Logistical difficulties|0|||
125995999|NCT01807221|453279702|FG001|Overall Study|Logistical difficulties|1|||
125996000|NCT01807221|453279703|FG002|Overall Study|Logistical difficulties|0|||
125996001|NCT01807221|453279704|FG003|Overall Study|Logistical difficulties|0|||
125996002|NCT01807221|453279705|FG004|Overall Study|Logistical difficulties|1|||
125996003|NCT01807221|453279706|FG005|Overall Study|Logistical difficulties|0|||
125996004|NCT01807221|453279701|FG000|Overall Study|Withdrawal by Subject|33|||
125996005|NCT01807221|453279702|FG001|Overall Study|Withdrawal by Subject|15|||
125996006|NCT01807221|453279703|FG002|Overall Study|Withdrawal by Subject|8|||
125996007|NCT01807221|453279704|FG003|Overall Study|Withdrawal by Subject|14|||
125996008|NCT01807221|453279705|FG004|Overall Study|Withdrawal by Subject|16|||
125996009|NCT01807221|453279706|FG005|Overall Study|Withdrawal by Subject|13|||
125996010|NCT01807221|453279701|FG000|Overall Study|Sponsor decision|2|||
125996011|NCT01807221|453279702|FG001|Overall Study|Sponsor decision|0|||
125996012|NCT01807221|453279703|FG002|Overall Study|Sponsor decision|1|||
125996013|NCT01807221|453279704|FG003|Overall Study|Sponsor decision|1|||
125996014|NCT01807221|453279705|FG004|Overall Study|Sponsor decision|0|||
125996015|NCT01807221|453279706|FG005|Overall Study|Sponsor decision|0|||
125996016|NCT01807221|453279701|FG000|Overall Study|Lost to Follow-up|1|||
125996017|NCT01807221|453279702|FG001|Overall Study|Lost to Follow-up|0|||
125996018|NCT01807221|453279703|FG002|Overall Study|Lost to Follow-up|2|||
125996019|NCT01807221|453279704|FG003|Overall Study|Lost to Follow-up|1|||
125996020|NCT01807221|453279705|FG004|Overall Study|Lost to Follow-up|0|||
125996021|NCT01807221|453279706|FG005|Overall Study|Lost to Follow-up|0|||
125996022|NCT02609659|453279707|FG000|Overall Study|Adverse Event|1|||
125996023|NCT02609659|453279707|FG000|Overall Study|Lost to Follow-up|6|||
125996024|NCT02609659|453279707|FG000|Overall Study|Other|1|||
125996025|NCT01155388|453279708|FG000|Overall Study|Adverse Event|1|||
125996026|NCT01155388|453279709|FG001|Overall Study|Adverse Event|0|||
125996027|NCT01004250|453279710|FG000|Induction Therapy Period|Adverse Event|10|||
125996028|NCT01004250|453279710|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
125996029|NCT01004250|453279710|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
125996030|NCT01004250|453279710|FG000|Induction Therapy Period|Physician Decision|2|||
125996031|NCT01004250|453279710|FG000|Maintenance Therapy Period|Adverse Event|15|||
125996032|NCT01004250|453279710|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
125996033|NCT01004250|453279710|FG000|Maintenance Therapy Period|Protocol Violation|1|||
125996034|NCT01004250|453279710|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
125996035|NCT01004250|453279710|FG000|Maintenance Therapy Period|Physician Decision|4|||
125996036|NCT01004250|453279710|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
125996037|NCT03943589|453279711|FG000|Overall Study|Death|1|||
125996038|NCT03943589|453279711|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
125996039|NCT00900627|453279712|FG000|Overall Study|Condition under investigation worsened|4|||
125996040|NCT00900627|453279713|FG001|Overall Study|Condition under investigation worsened|0|||
125996041|NCT00900627|453279714|FG002|Overall Study|Condition under investigation worsened|5|||
125996042|NCT00900627|453279715|FG003|Overall Study|Condition under investigation worsened|3|||
125996043|NCT00900627|453279716|FG004|Overall Study|Condition under investigation worsened|0|||
125996044|NCT00900627|453279717|FG005|Overall Study|Condition under investigation worsened|0|||
125996045|NCT00900627|453279712|FG000|Overall Study|Withdrawal by Subject|1|||
125996046|NCT00900627|453279713|FG001|Overall Study|Withdrawal by Subject|0|||
125996047|NCT00900627|453279714|FG002|Overall Study|Withdrawal by Subject|1|||
125996048|NCT00900627|453279715|FG003|Overall Study|Withdrawal by Subject|0|||
125996049|NCT00900627|453279716|FG004|Overall Study|Withdrawal by Subject|1|||
125996050|NCT00900627|453279717|FG005|Overall Study|Withdrawal by Subject|2|||
125996051|NCT00900627|453279712|FG000|Overall Study|Adverse Event|1|||
125996052|NCT00900627|453279713|FG001|Overall Study|Adverse Event|2|||
125996053|NCT00900627|453279714|FG002|Overall Study|Adverse Event|0|||
125996054|NCT00900627|453279715|FG003|Overall Study|Adverse Event|3|||
125996055|NCT00900627|453279716|FG004|Overall Study|Adverse Event|0|||
125996056|NCT00900627|453279717|FG005|Overall Study|Adverse Event|0|||
125996057|NCT00900627|453279712|FG000|Overall Study|Death|0|||
125996058|NCT00900627|453279713|FG001|Overall Study|Death|0|||
125996059|NCT00900627|453279714|FG002|Overall Study|Death|0|||
125996060|NCT00900627|453279715|FG003|Overall Study|Death|0|||
125996061|NCT00900627|453279716|FG004|Overall Study|Death|28|||
125996062|NCT00900627|453279717|FG005|Overall Study|Death|24|||
125996063|NCT00373295|453279718|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125996064|NCT00373295|453279719|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
125996065|NCT00373295|453279720|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125996066|NCT00373295|453279721|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125996067|NCT00373295|453279722|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
125996068|NCT00373295|453279723|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125996069|NCT00830947|453279724|FG000|Overall Study|Lost to Follow-up|4|||
125996070|NCT00830947|453279725|FG001|Overall Study|Lost to Follow-up|4|||
125996071|NCT00962585|453279732|FG000|Overall Study|Adverse Event|0|||
125996072|NCT00962585|453279733|FG001|Overall Study|Adverse Event|2|||
125996073|NCT00962585|453279734|FG002|Overall Study|Adverse Event|1|||
125996074|NCT00962585|453279735|FG003|Overall Study|Adverse Event|0|||
125996075|NCT00962585|453279732|FG000|Overall Study|Lost to Follow-up|3|||
125996076|NCT00962585|453279733|FG001|Overall Study|Lost to Follow-up|0|||
125996077|NCT00962585|453279734|FG002|Overall Study|Lost to Follow-up|1|||
126331394|NCT00377637|454508830|FG001|Induction Phase|Lost to Follow-up|1|||
125996078|NCT00962585|453279735|FG003|Overall Study|Lost to Follow-up|0|||
125996079|NCT00962585|453279732|FG000|Overall Study|Protocol Violation|0|||
125996080|NCT00962585|453279733|FG001|Overall Study|Protocol Violation|0|||
125996081|NCT00962585|453279734|FG002|Overall Study|Protocol Violation|1|||
125996082|NCT00962585|453279735|FG003|Overall Study|Protocol Violation|0|||
125996083|NCT00962585|453279732|FG000|Overall Study|Withdrawal by Subject|1|||
125996084|NCT00962585|453279733|FG001|Overall Study|Withdrawal by Subject|0|||
125996085|NCT00962585|453279734|FG002|Overall Study|Withdrawal by Subject|0|||
125996086|NCT00962585|453279735|FG003|Overall Study|Withdrawal by Subject|0|||
125996087|NCT00962585|453279732|FG000|Overall Study|Withdrew Consent|2|||
125996088|NCT00962585|453279733|FG001|Overall Study|Withdrew Consent|0|||
125996089|NCT00962585|453279734|FG002|Overall Study|Withdrew Consent|0|||
125996090|NCT00962585|453279735|FG003|Overall Study|Withdrew Consent|0|||
125996091|NCT02254421|453279738|FG000|Overall Study|Randomized but Not Treated|1|||
125996092|NCT02254421|453279739|FG001|Overall Study|Randomized but Not Treated|0|||
125996093|NCT02254421|453279738|FG000|Overall Study|Death|0|||
125996094|NCT02254421|453279739|FG001|Overall Study|Death|2|||
125996095|NCT02254421|453279738|FG000|Overall Study|Withdrew Consent|1|||
125996096|NCT02254421|453279739|FG001|Overall Study|Withdrew Consent|1|||
125996097|NCT00594906|453279742|FG000|Overall Study|Physician Decision|1|||
125996098|NCT00594906|453279743|FG001|Overall Study|Physician Decision|0|||
125996099|NCT00594906|453279742|FG000|Overall Study|Physician Decision|0|||
125996100|NCT00594906|453279743|FG001|Overall Study|Physician Decision|1|||
125996101|NCT00594906|453279742|FG000|Overall Study|Death|0|||
125996102|NCT00594906|453279743|FG001|Overall Study|Death|1|||
125996103|NCT00839917|453279745|FG000|Overall Study|Lost to Follow-up|1|||
125996104|NCT00839917|453279746|FG001|Overall Study|Lost to Follow-up|0|||
125996105|NCT00839917|453279745|FG000|Overall Study|Did not receive vaccine|0|||
125996106|NCT00839917|453279746|FG001|Overall Study|Did not receive vaccine|1|||
125996107|NCT00867490|453279747|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
125996108|NCT00867490|453279747|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
125996109|NCT00867490|453279747|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
125996110|NCT00867490|453279747|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
125996111|NCT00867490|453279747|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
125996112|NCT01950273|453279748|FG000|Overall Study|Protocol Violation|1|||
125996113|NCT01950273|453279749|FG001|Overall Study|Protocol Violation|0|||
125996114|NCT01950273|453279748|FG000|Overall Study|Withdrawal by Subject|2|||
125996115|NCT01950273|453279749|FG001|Overall Study|Withdrawal by Subject|0|||
125996116|NCT01950273|453279748|FG000|Overall Study|Other not defined above|1|||
125996117|NCT01950273|453279749|FG001|Overall Study|Other not defined above|0|||
125996118|NCT01254565|453279750|FG000|Overall Study|Non-compliance to Study Procedures|0|||
125996119|NCT01254565|453279751|FG001|Overall Study|Non-compliance to Study Procedures|0|||
125996120|NCT01254565|453279752|FG002|Overall Study|Non-compliance to Study Procedures|0|||
125996121|NCT01254565|453279753|FG003|Overall Study|Non-compliance to Study Procedures|0|||
125996122|NCT01254565|453279754|FG004|Overall Study|Non-compliance to Study Procedures|1|||
125996123|NCT01254565|453279755|FG005|Overall Study|Non-compliance to Study Procedures|0|||
125996124|NCT01254565|453279750|FG000|Overall Study|Did not Receive Treatment|1|||
125996125|NCT01254565|453279751|FG001|Overall Study|Did not Receive Treatment|1|||
125996126|NCT01254565|453279752|FG002|Overall Study|Did not Receive Treatment|0|||
125996127|NCT01254565|453279753|FG003|Overall Study|Did not Receive Treatment|0|||
125996128|NCT01254565|453279754|FG004|Overall Study|Did not Receive Treatment|3|||
125996129|NCT01254565|453279755|FG005|Overall Study|Did not Receive Treatment|4|||
125996130|NCT01254565|453279750|FG000|Overall Study|Other|0|||
125996131|NCT01254565|453279751|FG001|Overall Study|Other|0|||
125996132|NCT01254565|453279752|FG002|Overall Study|Other|0|||
125996133|NCT01254565|453279753|FG003|Overall Study|Other|1|||
125996134|NCT01254565|453279754|FG004|Overall Study|Other|0|||
125996135|NCT01254565|453279755|FG005|Overall Study|Other|0|||
125996136|NCT00472186|453279756|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
125996137|NCT00472186|453279757|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
125996138|NCT03354637|453279762|FG000|Double-blind Period|Protocol Violation|2|||
125996139|NCT03354637|453279763|FG001|Double-blind Period|Protocol Violation|0|||
125996140|NCT03354637|453279764|FG002|Double-blind Period|Protocol Violation|0|||
125996141|NCT03354637|453279762|FG000|Double-blind Period|Adverse Event|1|||
125996142|NCT03354637|453279763|FG001|Double-blind Period|Adverse Event|2|||
126331395|NCT00377637|454508831|FG002|Induction Phase|Lost to Follow-up|0|||
126331396|NCT00377637|454508832|FG003|Induction Phase|Lost to Follow-up|0|||
126331397|NCT00377637|454508829|FG000|Induction Phase|Death|1|||
126331398|NCT00377637|454508830|FG001|Induction Phase|Death|3|||
126331399|NCT00377637|454508831|FG002|Induction Phase|Death|0|||
125996143|NCT03354637|453279764|FG002|Double-blind Period|Adverse Event|0|||
125996144|NCT03354637|453279762|FG000|Double-blind Period|Lost to Follow-up|3|||
125996145|NCT03354637|453279763|FG001|Double-blind Period|Lost to Follow-up|4|||
125996146|NCT03354637|453279764|FG002|Double-blind Period|Lost to Follow-up|3|||
125996147|NCT03354637|453279762|FG000|Double-blind Period|Withdrawal by Subject|10|||
125996148|NCT03354637|453279763|FG001|Double-blind Period|Withdrawal by Subject|6|||
125996149|NCT03354637|453279764|FG002|Double-blind Period|Withdrawal by Subject|4|||
125996150|NCT03354637|453279762|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
125996151|NCT03354637|453279763|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
125996152|NCT03354637|453279764|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
125996153|NCT03354637|453279762|FG000|Open Label Extension|Adverse Event|0|||
125996154|NCT03354637|453279763|FG001|Open Label Extension|Adverse Event|0|||
125996155|NCT03354637|453279764|FG002|Open Label Extension|Adverse Event|1|||
126331400|NCT00377637|454508832|FG003|Induction Phase|Death|0|||
126331401|NCT00377637|454508829|FG000|Induction Phase|Withdrawal by Subject|5|||
126331402|NCT00377637|454508830|FG001|Induction Phase|Withdrawal by Subject|6|||
126331403|NCT00377637|454508831|FG002|Induction Phase|Withdrawal by Subject|0|||
126331404|NCT00377637|454508832|FG003|Induction Phase|Withdrawal by Subject|0|||
126331405|NCT00377637|454508829|FG000|Induction Phase|Physician Decision|3|||
126331406|NCT00377637|454508830|FG001|Induction Phase|Physician Decision|1|||
126331407|NCT00377637|454508831|FG002|Induction Phase|Physician Decision|0|||
126331408|NCT00377637|454508832|FG003|Induction Phase|Physician Decision|0|||
126331409|NCT00377637|454508829|FG000|Induction Phase|Sponsor decision|1|||
126331410|NCT00377637|454508830|FG001|Induction Phase|Sponsor decision|2|||
126331411|NCT00377637|454508831|FG002|Induction Phase|Sponsor decision|0|||
126331412|NCT00377637|454508832|FG003|Induction Phase|Sponsor decision|0|||
126331413|NCT00377637|454508829|FG000|Induction Phase|Non-Compliance|1|||
126331414|NCT00377637|454508830|FG001|Induction Phase|Non-Compliance|0|||
126331415|NCT00377637|454508831|FG002|Induction Phase|Non-Compliance|0|||
126331416|NCT00377637|454508832|FG003|Induction Phase|Non-Compliance|0|||
125996156|NCT03354637|453279762|FG000|Open Label Extension|Lost to Follow-up|0|||
125996157|NCT03354637|453279763|FG001|Open Label Extension|Lost to Follow-up|0|||
125996158|NCT03354637|453279764|FG002|Open Label Extension|Lost to Follow-up|2|||
125996159|NCT03354637|453279762|FG000|Open Label Extension|Withdrawal by Subject|0|||
125996160|NCT03354637|453279763|FG001|Open Label Extension|Withdrawal by Subject|0|||
125996161|NCT03354637|453279764|FG002|Open Label Extension|Withdrawal by Subject|5|||
125996162|NCT03354637|453279762|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
125996163|NCT03354637|453279763|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
125996164|NCT03354637|453279764|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
125996165|NCT03354637|453279762|FG000|Open Label Extension|Subject Noncompliance|0|||
125996166|NCT03354637|453279763|FG001|Open Label Extension|Subject Noncompliance|0|||
125996167|NCT03354637|453279764|FG002|Open Label Extension|Subject Noncompliance|1|||
125996168|NCT03354637|453279762|FG000|Open Label Extension|Lack of Efficacy|0|||
125996169|NCT03354637|453279763|FG001|Open Label Extension|Lack of Efficacy|0|||
125996170|NCT03354637|453279764|FG002|Open Label Extension|Lack of Efficacy|1|||
125996171|NCT03354637|453279762|FG000|Open Label Extension|Physician Decision|0|||
125996172|NCT03354637|453279763|FG001|Open Label Extension|Physician Decision|0|||
125996173|NCT03354637|453279764|FG002|Open Label Extension|Physician Decision|1|||
125996174|NCT02726399|453279765|FG000|Overall Study|Participant Non-Compliance|1|||
125996175|NCT02726399|453279765|FG000|Overall Study|Adverse Event|2|||
125996176|NCT02726399|453279765|FG000|Overall Study|Progression of disease|4|||
125996177|NCT04430335|453279766|FG000|Overall Study|Withdrawal by Subject|1|||
125996178|NCT02564055|453279767|FG000|Overall Study|Adverse Event|1|||
125996179|NCT02564055|453279768|FG001|Overall Study|Adverse Event|0|||
125996180|NCT02564055|453279769|FG002|Overall Study|Adverse Event|4|||
125996181|NCT02564055|453279770|FG003|Overall Study|Adverse Event|1|||
125996182|NCT02564055|453279771|FG004|Overall Study|Adverse Event|4|||
125996183|NCT02564055|453279772|FG005|Overall Study|Adverse Event|1|||
125996184|NCT02564055|453279767|FG000|Overall Study|Protocol Violation|1|||
125996185|NCT02564055|453279768|FG001|Overall Study|Protocol Violation|0|||
125996186|NCT02564055|453279769|FG002|Overall Study|Protocol Violation|0|||
125996187|NCT02564055|453279770|FG003|Overall Study|Protocol Violation|0|||
125996188|NCT02564055|453279771|FG004|Overall Study|Protocol Violation|0|||
125996189|NCT02564055|453279772|FG005|Overall Study|Protocol Violation|0|||
125996190|NCT02564055|453279767|FG000|Overall Study|Reached stopping criteria|0|||
125996191|NCT02564055|453279768|FG001|Overall Study|Reached stopping criteria|0|||
125996192|NCT02564055|453279769|FG002|Overall Study|Reached stopping criteria|0|||
125996193|NCT02564055|453279770|FG003|Overall Study|Reached stopping criteria|0|||
125996194|NCT02564055|453279771|FG004|Overall Study|Reached stopping criteria|0|||
125996195|NCT02564055|453279772|FG005|Overall Study|Reached stopping criteria|1|||
125996196|NCT02564055|453279767|FG000|Overall Study|Lost to Follow-up|0|||
125996197|NCT02564055|453279768|FG001|Overall Study|Lost to Follow-up|1|||
125996198|NCT02564055|453279769|FG002|Overall Study|Lost to Follow-up|4|||
125996199|NCT02564055|453279770|FG003|Overall Study|Lost to Follow-up|2|||
125996200|NCT02564055|453279771|FG004|Overall Study|Lost to Follow-up|1|||
125996201|NCT02564055|453279772|FG005|Overall Study|Lost to Follow-up|0|||
125996202|NCT02564055|453279767|FG000|Overall Study|Physician Decision|0|||
125996203|NCT02564055|453279768|FG001|Overall Study|Physician Decision|0|||
125996204|NCT02564055|453279769|FG002|Overall Study|Physician Decision|1|||
125996205|NCT02564055|453279770|FG003|Overall Study|Physician Decision|0|||
126331417|NCT00377637|454508829|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
126331418|NCT00377637|454508830|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
125996206|NCT02564055|453279771|FG004|Overall Study|Physician Decision|0|||
125996207|NCT02564055|453279772|FG005|Overall Study|Physician Decision|0|||
125996208|NCT02564055|453279767|FG000|Overall Study|Withdrawal by Subject|4|||
125996209|NCT02564055|453279768|FG001|Overall Study|Withdrawal by Subject|4|||
125996210|NCT02564055|453279769|FG002|Overall Study|Withdrawal by Subject|3|||
125996211|NCT02564055|453279770|FG003|Overall Study|Withdrawal by Subject|3|||
125996212|NCT02564055|453279771|FG004|Overall Study|Withdrawal by Subject|10|||
125996213|NCT02564055|453279772|FG005|Overall Study|Withdrawal by Subject|10|||
125996214|NCT04747275|453279773|FG000|Overall Study|Study terminated|0|||
125996215|NCT04747275|453279774|FG001|Overall Study|Study terminated|1|||
125996216|NCT00531011|453279778|FG000|Overall Study|Withdrawal by Subject|2|||
125996217|NCT00531011|453279779|FG001|Overall Study|Withdrawal by Subject|4|||
125996218|NCT00531011|453279778|FG000|Overall Study|Death|1|||
125996219|NCT00531011|453279779|FG001|Overall Study|Death|0|||
125996220|NCT00531011|453279778|FG000|Overall Study|Lost to Follow-up|1|||
125996221|NCT00531011|453279779|FG001|Overall Study|Lost to Follow-up|0|||
125996222|NCT00531011|453279778|FG000|Overall Study|Physician Decision|0|||
125996223|NCT00531011|453279779|FG001|Overall Study|Physician Decision|3|||
125996224|NCT03268590|453279780|FG000|Overall Study|Previously unknown exclusion criteria|1|||
125996225|NCT02139982|453279783|FG000|Overall Study|Lack of Efficacy|0|||
125996226|NCT02139982|453279784|FG001|Overall Study|Lack of Efficacy|1|||
125996227|NCT02139982|453279785|FG002|Overall Study|Lack of Efficacy|0|||
125996228|NCT02139982|453279786|FG003|Overall Study|Lack of Efficacy|1|||
125996229|NCT02139982|453279787|FG004|Overall Study|Lack of Efficacy|0|||
125996230|NCT02139982|453279788|FG005|Overall Study|Lack of Efficacy|0|||
125996231|NCT02139982|453279789|FG006|Overall Study|Lack of Efficacy|0|||
125996232|NCT02139982|453279790|FG007|Overall Study|Lack of Efficacy|0|||
125996233|NCT02139982|453279791|FG008|Overall Study|Lack of Efficacy|0|||
125996234|NCT02139982|453279792|FG009|Overall Study|Lack of Efficacy|0|||
125996235|NCT04254679|453279825|FG000|Overall Study|Protocol Violation|1|||
125996236|NCT04254679|453279826|FG001|Overall Study|Protocol Violation|1|||
125996237|NCT04254679|453279825|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
125996238|NCT04254679|453279826|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
125996239|NCT02206152|453279831|FG000|Pre-Randomization|Withdrawal by Subject|2|||
125996240|NCT00478608|453279832|FG000|Overall Study|Adverse Event|1|||
125996241|NCT00478608|453279832|FG000|Overall Study|Serious Adverse Event|14|||
125996242|NCT00478608|453279832|FG000|Overall Study|Withdrawal by Subject|2|||
125996243|NCT00478608|453279832|FG000|Overall Study|Protocol Violation|3|||
125996244|NCT02080520|453279833|FG000|Overall Study|Self-reported symptoms|5|||
125996245|NCT02080520|453279834|FG001|Overall Study|Self-reported symptoms|6|||
125996246|NCT02080520|453279833|FG000|Overall Study|Unable to contact|2|||
125996247|NCT02080520|453279834|FG001|Overall Study|Unable to contact|1|||
125996248|NCT02080520|453279833|FG000|Overall Study|Initiated aspirin|2|||
125996249|NCT02080520|453279834|FG001|Overall Study|Initiated aspirin|0|||
125996250|NCT02080520|453279833|FG000|Overall Study|Atrial fibrillation|1|||
125996251|NCT02080520|453279834|FG001|Overall Study|Atrial fibrillation|1|||
125996252|NCT02080520|453279833|FG000|Overall Study|Cancer|1|||
125996253|NCT02080520|453279834|FG001|Overall Study|Cancer|2|||
125996254|NCT02080520|453279833|FG000|Overall Study|Not interested in study|1|||
125996255|NCT02080520|453279834|FG001|Overall Study|Not interested in study|3|||
125996256|NCT02080520|453279833|FG000|Overall Study|Too busy|1|||
125996257|NCT02080520|453279834|FG001|Overall Study|Too busy|1|||
125996258|NCT02080520|453279833|FG000|Overall Study|Work-related injury|1|||
125996259|NCT02080520|453279834|FG001|Overall Study|Work-related injury|0|||
125996260|NCT02080520|453279833|FG000|Overall Study|Personal reasons|0|||
125996261|NCT02080520|453279834|FG001|Overall Study|Personal reasons|3|||
125996262|NCT01394250|453279842|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
125996263|NCT01394250|453279843|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
125996264|NCT01394250|453279842|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
125996265|NCT01394250|453279843|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
125996266|NCT00432679|453279844|FG000|Overall Study|Adverse Event|2|||
125996267|NCT00432679|453279845|FG001|Overall Study|Adverse Event|1|||
125996268|NCT00432679|453279844|FG000|Overall Study|Withdrawal by Subject|3|||
125996269|NCT00432679|453279845|FG001|Overall Study|Withdrawal by Subject|2|||
125996270|NCT01177813|453279851|FG000|Overall Study|Adverse Event|8|||
125996271|NCT01177813|453279852|FG001|Overall Study|Adverse Event|2|||
125996272|NCT01177813|453279853|FG002|Overall Study|Adverse Event|4|||
126331419|NCT00377637|454508831|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
125996273|NCT01177813|453279854|FG003|Overall Study|Adverse Event|6|||
125996274|NCT01177813|453279855|FG004|Overall Study|Adverse Event|3|||
125996275|NCT01177813|453279851|FG000|Overall Study|Lack of Efficacy|1|||
125996276|NCT01177813|453279852|FG001|Overall Study|Lack of Efficacy|0|||
125996277|NCT01177813|453279853|FG002|Overall Study|Lack of Efficacy|0|||
125996278|NCT01177813|453279854|FG003|Overall Study|Lack of Efficacy|0|||
125996279|NCT01177813|453279855|FG004|Overall Study|Lack of Efficacy|0|||
125996280|NCT01177813|453279851|FG000|Overall Study|Protocol Violation|3|||
125996281|NCT01177813|453279852|FG001|Overall Study|Protocol Violation|2|||
125996282|NCT01177813|453279853|FG002|Overall Study|Protocol Violation|2|||
125996283|NCT01177813|453279854|FG003|Overall Study|Protocol Violation|0|||
125996284|NCT01177813|453279855|FG004|Overall Study|Protocol Violation|1|||
125996285|NCT01177813|453279851|FG000|Overall Study|Lost to Follow-up|12|||
125996286|NCT01177813|453279852|FG001|Overall Study|Lost to Follow-up|5|||
125996287|NCT01177813|453279853|FG002|Overall Study|Lost to Follow-up|6|||
125996288|NCT01177813|453279854|FG003|Overall Study|Lost to Follow-up|3|||
125996289|NCT01177813|453279855|FG004|Overall Study|Lost to Follow-up|0|||
125996290|NCT01177813|453279851|FG000|Overall Study|Withdrawal by Subject|12|||
125996291|NCT01177813|453279852|FG001|Overall Study|Withdrawal by Subject|7|||
125996292|NCT01177813|453279853|FG002|Overall Study|Withdrawal by Subject|6|||
125996293|NCT01177813|453279854|FG003|Overall Study|Withdrawal by Subject|5|||
125996294|NCT01177813|453279855|FG004|Overall Study|Withdrawal by Subject|3|||
125996295|NCT01177813|453279851|FG000|Overall Study|Other reason not defined above|5|||
125996296|NCT01177813|453279852|FG001|Overall Study|Other reason not defined above|2|||
125996297|NCT01177813|453279853|FG002|Overall Study|Other reason not defined above|2|||
125996298|NCT01177813|453279854|FG003|Overall Study|Other reason not defined above|3|||
125996299|NCT01177813|453279855|FG004|Overall Study|Other reason not defined above|2|||
125996300|NCT00109928|453279858|FG000|Overall Study|Adverse Event|2|||
125996301|NCT00109928|453279858|FG000|Overall Study|Progression|6|||
125996302|NCT00109928|453279858|FG000|Overall Study|Death|2|||
125996303|NCT00109928|453279858|FG000|Overall Study|not protocol specified|2|||
125996304|NCT00109928|453279858|FG000|Overall Study|not eligible|1|||
125996305|NCT01196104|453279859|FG000|Overall Study|Lost to Follow-up|1|||
125996306|NCT01196104|453279860|FG001|Overall Study|Lost to Follow-up|0|||
125996307|NCT01196104|453279859|FG000|Overall Study|Physician Decision|0|||
125996308|NCT01196104|453279860|FG001|Overall Study|Physician Decision|1|||
125996309|NCT01196104|453279859|FG000|Overall Study|Withdrawal by Subject|3|||
125996310|NCT01196104|453279860|FG001|Overall Study|Withdrawal by Subject|3|||
126331420|NCT00377637|454508832|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
126331421|NCT00377637|454508829|FG000|Maintenance Phase|Adverse Event|0|||
126331422|NCT00377637|454508830|FG001|Maintenance Phase|Adverse Event|0|||
126331423|NCT00377637|454508831|FG002|Maintenance Phase|Adverse Event|29|||
126331424|NCT00377637|454508832|FG003|Maintenance Phase|Adverse Event|43|||
126331425|NCT00377637|454508829|FG000|Maintenance Phase|Physician Decision|0|||
126331426|NCT00377637|454508830|FG001|Maintenance Phase|Physician Decision|0|||
126331427|NCT00377637|454508831|FG002|Maintenance Phase|Physician Decision|5|||
126331428|NCT00377637|454508832|FG003|Maintenance Phase|Physician Decision|4|||
126331429|NCT00377637|454508829|FG000|Maintenance Phase|Lost to Follow-up|0|||
126331430|NCT00377637|454508830|FG001|Maintenance Phase|Lost to Follow-up|0|||
126331431|NCT00377637|454508831|FG002|Maintenance Phase|Lost to Follow-up|3|||
126331432|NCT00377637|454508832|FG003|Maintenance Phase|Lost to Follow-up|1|||
126331433|NCT00377637|454508829|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126331434|NCT00377637|454508830|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126331435|NCT00377637|454508831|FG002|Maintenance Phase|Withdrawal by Subject|3|||
126331436|NCT00377637|454508832|FG003|Maintenance Phase|Withdrawal by Subject|3|||
126331437|NCT00377637|454508829|FG000|Maintenance Phase|Sponsor decision|0|||
126331438|NCT00377637|454508830|FG001|Maintenance Phase|Sponsor decision|0|||
126331439|NCT00377637|454508831|FG002|Maintenance Phase|Sponsor decision|2|||
126331440|NCT00377637|454508832|FG003|Maintenance Phase|Sponsor decision|3|||
126331441|NCT00377637|454508829|FG000|Maintenance Phase|Non-compliance|0|||
126331442|NCT00377637|454508830|FG001|Maintenance Phase|Non-compliance|0|||
126331443|NCT00377637|454508831|FG002|Maintenance Phase|Non-compliance|1|||
126331444|NCT00377637|454508832|FG003|Maintenance Phase|Non-compliance|1|||
126331445|NCT00377637|454508829|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
126331446|NCT00377637|454508830|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
126331447|NCT00377637|454508831|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
126331448|NCT00377637|454508832|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
126331449|NCT00377637|454508829|FG000|Maintenance Phase|Death|0|||
126331450|NCT00377637|454508830|FG001|Maintenance Phase|Death|0|||
126331451|NCT00377637|454508831|FG002|Maintenance Phase|Death|0|||
126331452|NCT00377637|454508832|FG003|Maintenance Phase|Death|1|||
126331453|NCT04147247|454508834|FG000|Overall Study|Progressive disease|3|||
126331454|NCT04147247|454508835|FG001|Overall Study|Progressive disease|3|||
126331455|NCT04147247|454508836|FG002|Overall Study|Progressive disease|4|||
126331456|NCT04147247|454508837|FG003|Overall Study|Progressive disease|4|||
126331457|NCT04147247|454508838|FG004|Overall Study|Progressive disease|3|||
126331458|NCT04147247|454508834|FG000|Overall Study|Physician Decision|0|||
126331459|NCT04147247|454508835|FG001|Overall Study|Physician Decision|1|||
126331460|NCT04147247|454508836|FG002|Overall Study|Physician Decision|0|||
126331461|NCT04147247|454508837|FG003|Overall Study|Physician Decision|0|||
126331462|NCT04147247|454508838|FG004|Overall Study|Physician Decision|0|||
126331463|NCT04147247|454508834|FG000|Overall Study|Clinical Disease Progression|0|||
126331464|NCT04147247|454508835|FG001|Overall Study|Clinical Disease Progression|0|||
126331465|NCT04147247|454508836|FG002|Overall Study|Clinical Disease Progression|0|||
126331466|NCT04147247|454508837|FG003|Overall Study|Clinical Disease Progression|0|||
125996311|NCT01196104|453279859|FG000|Overall Study|Various|0|||
125996312|NCT01196104|453279860|FG001|Overall Study|Various|1|||
125996313|NCT00610675|453279861|FG000|Overall Study|Untreated|4|||
125996314|NCT00610675|453279861|FG000|Overall Study|Adverse Event|67|||
125996315|NCT00610675|453279861|FG000|Overall Study|Insufficient Effect|31|||
125996316|NCT00610675|453279861|FG000|Overall Study|Withdrawal by Subject|28|||
125996317|NCT00610675|453279861|FG000|Overall Study|Reasons unrelated to trial|27|||
125996318|NCT00610675|453279861|FG000|Overall Study|Lack of Compliance|7|||
126331467|NCT04147247|454508838|FG004|Overall Study|Clinical Disease Progression|1|||
126331468|NCT04147247|454508834|FG000|Overall Study|Adverse Event|0|||
126331469|NCT04147247|454508835|FG001|Overall Study|Adverse Event|0|||
126331470|NCT04147247|454508836|FG002|Overall Study|Adverse Event|1|||
126331471|NCT04147247|454508837|FG003|Overall Study|Adverse Event|0|||
126331472|NCT04147247|454508838|FG004|Overall Study|Adverse Event|1|||
126331473|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
126331474|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125996319|NCT00610675|453279861|FG000|Overall Study|Lost to Follow-up|31|||
125996320|NCT00610675|453279861|FG000|Overall Study|Other reason (not specified)|25|||
126331475|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
126331476|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
126331477|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
126331478|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
126331479|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
126331480|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
126331481|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125996321|NCT01316692|453279864|FG000|Overall Study|Adverse Event|5|||
125996322|NCT01316692|453279864|FG000|Overall Study|Disease Progression|7|||
125996323|NCT00983619|453279865|FG000|Overall Study|Lost to Follow-up|0|||
125996324|NCT00983619|453279866|FG001|Overall Study|Lost to Follow-up|1|||
125996325|NCT00983619|453279867|FG002|Overall Study|Lost to Follow-up|0|||
125996326|NCT00983619|453279868|FG003|Overall Study|Lost to Follow-up|0|||
125996327|NCT00983619|453279869|FG004|Overall Study|Lost to Follow-up|0|||
125996328|NCT00983619|453279870|FG005|Overall Study|Lost to Follow-up|2|||
125996329|NCT00983619|453279871|FG006|Overall Study|Lost to Follow-up|0|||
125996330|NCT00983619|453279872|FG007|Overall Study|Lost to Follow-up|0|||
125996331|NCT00983619|453279873|FG008|Overall Study|Lost to Follow-up|0|||
125996332|NCT00983619|453279874|FG009|Overall Study|Lost to Follow-up|0|||
125996333|NCT00983619|453279875|FG010|Overall Study|Lost to Follow-up|0|||
125996334|NCT00983619|453279876|FG011|Overall Study|Lost to Follow-up|2|||
125996335|NCT00983619|453279865|FG000|Overall Study|Withdrawal by Subject|2|||
125996336|NCT00983619|453279866|FG001|Overall Study|Withdrawal by Subject|1|||
125996337|NCT00983619|453279867|FG002|Overall Study|Withdrawal by Subject|1|||
125996338|NCT00983619|453279868|FG003|Overall Study|Withdrawal by Subject|3|||
125996339|NCT00983619|453279869|FG004|Overall Study|Withdrawal by Subject|1|||
125996340|NCT00983619|453279870|FG005|Overall Study|Withdrawal by Subject|23|||
125996341|NCT00983619|453279871|FG006|Overall Study|Withdrawal by Subject|0|||
125996342|NCT00983619|453279872|FG007|Overall Study|Withdrawal by Subject|0|||
125996343|NCT00983619|453279873|FG008|Overall Study|Withdrawal by Subject|0|||
125996344|NCT00983619|453279874|FG009|Overall Study|Withdrawal by Subject|0|||
125996345|NCT00983619|453279875|FG010|Overall Study|Withdrawal by Subject|1|||
125996346|NCT00983619|453279876|FG011|Overall Study|Withdrawal by Subject|1|||
125996347|NCT00983619|453279865|FG000|Overall Study|Death|0|||
125996348|NCT00983619|453279866|FG001|Overall Study|Death|2|||
125996349|NCT00983619|453279867|FG002|Overall Study|Death|2|||
125996350|NCT00983619|453279868|FG003|Overall Study|Death|1|||
125996351|NCT00983619|453279869|FG004|Overall Study|Death|2|||
125996352|NCT00983619|453279870|FG005|Overall Study|Death|30|||
125996353|NCT00983619|453279871|FG006|Overall Study|Death|1|||
125996354|NCT00983619|453279872|FG007|Overall Study|Death|0|||
125996355|NCT00983619|453279873|FG008|Overall Study|Death|1|||
125996356|NCT00983619|453279874|FG009|Overall Study|Death|2|||
125996357|NCT00983619|453279875|FG010|Overall Study|Death|9|||
125996358|NCT00983619|453279876|FG011|Overall Study|Death|8|||
125996359|NCT00983619|453279865|FG000|Overall Study|Other|1|||
125996360|NCT00983619|453279866|FG001|Overall Study|Other|0|||
125996361|NCT00983619|453279867|FG002|Overall Study|Other|0|||
125996362|NCT00983619|453279868|FG003|Overall Study|Other|1|||
125996363|NCT00983619|453279869|FG004|Overall Study|Other|0|||
125996364|NCT00983619|453279870|FG005|Overall Study|Other|12|||
125996365|NCT00983619|453279871|FG006|Overall Study|Other|2|||
125996366|NCT00983619|453279872|FG007|Overall Study|Other|2|||
125996367|NCT00983619|453279873|FG008|Overall Study|Other|0|||
126331482|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
126331483|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
126331484|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125996368|NCT00983619|453279874|FG009|Overall Study|Other|1|||
125996369|NCT00983619|453279875|FG010|Overall Study|Other|1|||
125996370|NCT00983619|453279876|FG011|Overall Study|Other|0|||
125996371|NCT03772314|453279883|FG000|Overall Study|Adverse Event|7|||
125996372|NCT03772314|453279884|FG001|Overall Study|Adverse Event|2|||
125996373|NCT01536145|453279885|FG000|Overall Study|Progressive disease|3|||
125996374|NCT01536145|453279886|FG001|Overall Study|Progressive disease|4|||
125996375|NCT01536145|453279887|FG002|Overall Study|Progressive disease|1|||
125996376|NCT01536145|453279888|FG003|Overall Study|Progressive disease|2|||
125996377|NCT01536145|453279889|FG004|Overall Study|Progressive disease|1|||
125996378|NCT01536145|453279890|FG005|Overall Study|Progressive disease|2|||
125996379|NCT01536145|453279891|FG006|Overall Study|Progressive disease|1|||
125996380|NCT01536145|453279892|FG007|Overall Study|Progressive disease|2|||
125996381|NCT01536145|453279893|FG008|Overall Study|Progressive disease|1|||
125996382|NCT01536145|453279894|FG009|Overall Study|Progressive disease|3|||
125996383|NCT01536145|453279895|FG010|Overall Study|Progressive disease|3|||
125996384|NCT01536145|453279885|FG000|Overall Study|Withdrawal by Subject|0|||
125996385|NCT01536145|453279886|FG001|Overall Study|Withdrawal by Subject|0|||
125996386|NCT01536145|453279887|FG002|Overall Study|Withdrawal by Subject|1|||
125996387|NCT01536145|453279888|FG003|Overall Study|Withdrawal by Subject|0|||
125996388|NCT01536145|453279889|FG004|Overall Study|Withdrawal by Subject|0|||
125996389|NCT01536145|453279890|FG005|Overall Study|Withdrawal by Subject|1|||
125996390|NCT01536145|453279891|FG006|Overall Study|Withdrawal by Subject|0|||
125996391|NCT01536145|453279892|FG007|Overall Study|Withdrawal by Subject|0|||
125996392|NCT01536145|453279893|FG008|Overall Study|Withdrawal by Subject|2|||
125996393|NCT01536145|453279894|FG009|Overall Study|Withdrawal by Subject|0|||
125996394|NCT01536145|453279895|FG010|Overall Study|Withdrawal by Subject|2|||
125996395|NCT01536145|453279885|FG000|Overall Study|Other|0|||
125996396|NCT01536145|453279886|FG001|Overall Study|Other|0|||
125996397|NCT01536145|453279887|FG002|Overall Study|Other|0|||
125996398|NCT01536145|453279888|FG003|Overall Study|Other|0|||
125996399|NCT01536145|453279889|FG004|Overall Study|Other|1|||
125996400|NCT01536145|453279890|FG005|Overall Study|Other|0|||
125996401|NCT01536145|453279891|FG006|Overall Study|Other|0|||
125996402|NCT01536145|453279892|FG007|Overall Study|Other|0|||
125996403|NCT01536145|453279893|FG008|Overall Study|Other|0|||
125996404|NCT01536145|453279894|FG009|Overall Study|Other|3|||
125996405|NCT01536145|453279895|FG010|Overall Study|Other|2|||
125996406|NCT01536145|453279885|FG000|Overall Study|Death|0|||
125996407|NCT01536145|453279886|FG001|Overall Study|Death|0|||
125996408|NCT01536145|453279887|FG002|Overall Study|Death|0|||
125996409|NCT01536145|453279888|FG003|Overall Study|Death|0|||
125996410|NCT01536145|453279889|FG004|Overall Study|Death|0|||
125996411|NCT01536145|453279890|FG005|Overall Study|Death|0|||
125996412|NCT01536145|453279891|FG006|Overall Study|Death|1|||
125996413|NCT01536145|453279892|FG007|Overall Study|Death|0|||
125996414|NCT01536145|453279893|FG008|Overall Study|Death|0|||
125996415|NCT01536145|453279894|FG009|Overall Study|Death|0|||
125996416|NCT01536145|453279895|FG010|Overall Study|Death|0|||
125996417|NCT01536145|453279885|FG000|Overall Study|Adverse Event|0|||
125996418|NCT01536145|453279886|FG001|Overall Study|Adverse Event|0|||
125996419|NCT01536145|453279887|FG002|Overall Study|Adverse Event|0|||
125996420|NCT01536145|453279888|FG003|Overall Study|Adverse Event|0|||
125996421|NCT01536145|453279889|FG004|Overall Study|Adverse Event|0|||
125996422|NCT01536145|453279890|FG005|Overall Study|Adverse Event|0|||
125996423|NCT01536145|453279891|FG006|Overall Study|Adverse Event|0|||
125996424|NCT01536145|453279892|FG007|Overall Study|Adverse Event|2|||
125996425|NCT01536145|453279893|FG008|Overall Study|Adverse Event|0|||
125996426|NCT01536145|453279894|FG009|Overall Study|Adverse Event|0|||
125996427|NCT01536145|453279895|FG010|Overall Study|Adverse Event|3|||
125996428|NCT01284140|453279900|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
125996429|NCT01284140|453279901|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
125996430|NCT01284140|453279900|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
125996431|NCT01284140|453279901|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
125996432|NCT00579982|453279902|FG000|Overall Study|Adverse Event|4|||
125996433|NCT00579982|453279902|FG000|Overall Study|Protocol Violation|4|||
125996434|NCT00088205|453279903|FG000|Overall Study|Adverse Event|4|||
125996435|NCT00088205|453279903|FG000|Overall Study|Progressive Disease|51|||
125996436|NCT00088205|453279903|FG000|Overall Study|Physician Decision|1|||
125996437|NCT00088205|453279903|FG000|Overall Study|Death Due to Study Disease|4|||
125996438|NCT03192215|453279904|FG000|Overall Study|Death|28|||
125996439|NCT03192215|453279905|FG001|Overall Study|Death|23|||
125996440|NCT03192215|453279904|FG000|Overall Study|Lost to Follow-up|10|||
125996441|NCT03192215|453279905|FG001|Overall Study|Lost to Follow-up|15|||
125996442|NCT03192215|453279904|FG000|Overall Study|Withdrawal by Subject|49|||
125996443|NCT03192215|453279905|FG001|Overall Study|Withdrawal by Subject|48|||
125996444|NCT03192215|453279904|FG000|Overall Study|Other as reported in analysis|4|||
125996445|NCT03192215|453279905|FG001|Overall Study|Other as reported in analysis|1|||
125996446|NCT05199233|453279908|FG000|Overall Study|Lack of Efficacy|1|||
125996447|NCT01818141|453281903|FG000|Overall Study|Withdrawal by Subject|2|||
125996448|NCT01818141|453281904|FG001|Overall Study|Withdrawal by Subject|0|||
125996449|NCT01818141|453281903|FG000|Overall Study|No baseline C.diff colonies|1|||
125996450|NCT01818141|453281904|FG001|Overall Study|No baseline C.diff colonies|1|||
125996451|NCT01818141|453281903|FG000|Overall Study|Lost to Follow-up|0|||
125996452|NCT01818141|453281904|FG001|Overall Study|Lost to Follow-up|2|||
125996453|NCT00619476|453281905|FG000|Overall Study|Adverse Event|12|||
125996454|NCT00619476|453281906|FG001|Overall Study|Adverse Event|6|||
125996455|NCT00619476|453281907|FG002|Overall Study|Adverse Event|12|||
125996456|NCT00619476|453281908|FG003|Overall Study|Adverse Event|16|||
125996457|NCT00619476|453281905|FG000|Overall Study|Lack of Efficacy|6|||
125996458|NCT00619476|453281906|FG001|Overall Study|Lack of Efficacy|1|||
125996459|NCT00619476|453281907|FG002|Overall Study|Lack of Efficacy|1|||
125996460|NCT00619476|453281908|FG003|Overall Study|Lack of Efficacy|4|||
125996461|NCT00619476|453281905|FG000|Overall Study|Protocol Violation|5|||
125996462|NCT00619476|453281906|FG001|Overall Study|Protocol Violation|4|||
125996463|NCT00619476|453281907|FG002|Overall Study|Protocol Violation|4|||
125996464|NCT00619476|453281908|FG003|Overall Study|Protocol Violation|9|||
125996465|NCT00619476|453281905|FG000|Overall Study|Lost to Follow-up|1|||
125996466|NCT00619476|453281906|FG001|Overall Study|Lost to Follow-up|2|||
125996467|NCT00619476|453281907|FG002|Overall Study|Lost to Follow-up|0|||
125996468|NCT00619476|453281908|FG003|Overall Study|Lost to Follow-up|1|||
125996469|NCT00619476|453281905|FG000|Overall Study|Investigator Discretion|2|||
125996470|NCT00619476|453281906|FG001|Overall Study|Investigator Discretion|2|||
125996471|NCT00619476|453281907|FG002|Overall Study|Investigator Discretion|2|||
125996472|NCT00619476|453281908|FG003|Overall Study|Investigator Discretion|0|||
125996473|NCT00619476|453281905|FG000|Overall Study|Withdrawal by Subject|5|||
125996474|NCT00619476|453281906|FG001|Overall Study|Withdrawal by Subject|7|||
125996475|NCT00619476|453281907|FG002|Overall Study|Withdrawal by Subject|5|||
125996476|NCT00619476|453281908|FG003|Overall Study|Withdrawal by Subject|4|||
125996477|NCT01811563|453281911|FG000|Overall Study|Lost to Follow-up|5|||
125996478|NCT01811563|453281912|FG001|Overall Study|Lost to Follow-up|2|||
125996479|NCT01811563|453281911|FG000|Overall Study|Incorrect Randomization procedure|0|||
125996480|NCT01811563|453281912|FG001|Overall Study|Incorrect Randomization procedure|1|||
125996481|NCT02291289|453281913|FG000|Induction Treatment|Withdrawal by Subject|0|||
125996482|NCT02291289|453281914|FG001|Induction Treatment|Withdrawal by Subject|0|||
125996483|NCT02291289|453281915|FG002|Induction Treatment|Withdrawal by Subject|0|||
125996484|NCT02291289|453281916|FG003|Induction Treatment|Withdrawal by Subject|24|||
125996485|NCT02291289|453281917|FG004|Induction Treatment|Withdrawal by Subject|0|||
125996486|NCT02291289|453281918|FG005|Induction Treatment|Withdrawal by Subject|0|||
125996487|NCT02291289|453281919|FG006|Induction Treatment|Withdrawal by Subject|0|||
125996488|NCT02291289|453281920|FG007|Induction Treatment|Withdrawal by Subject|0|||
125996489|NCT02291289|453281921|FG008|Induction Treatment|Withdrawal by Subject|0|||
125996490|NCT02291289|453281922|FG009|Induction Treatment|Withdrawal by Subject|18|||
125996491|NCT02291289|453281923|FG010|Induction Treatment|Withdrawal by Subject|0|||
125996492|NCT02291289|453281924|FG011|Induction Treatment|Withdrawal by Subject|0|||
125996493|NCT02291289|453281925|FG012|Induction Treatment|Withdrawal by Subject|0|||
125996494|NCT02291289|453281913|FG000|Induction Treatment|Adverse Event|0|||
125996495|NCT02291289|453281914|FG001|Induction Treatment|Adverse Event|0|||
125996496|NCT02291289|453281915|FG002|Induction Treatment|Adverse Event|0|||
125996497|NCT02291289|453281916|FG003|Induction Treatment|Adverse Event|3|||
125996498|NCT02291289|453281917|FG004|Induction Treatment|Adverse Event|0|||
125996499|NCT02291289|453281918|FG005|Induction Treatment|Adverse Event|0|||
125996500|NCT02291289|453281919|FG006|Induction Treatment|Adverse Event|0|||
125996501|NCT02291289|453281920|FG007|Induction Treatment|Adverse Event|0|||
125996502|NCT02291289|453281921|FG008|Induction Treatment|Adverse Event|0|||
125996503|NCT02291289|453281922|FG009|Induction Treatment|Adverse Event|1|||
125996504|NCT02291289|453281923|FG010|Induction Treatment|Adverse Event|0|||
125996505|NCT02291289|453281924|FG011|Induction Treatment|Adverse Event|0|||
125996506|NCT02291289|453281925|FG012|Induction Treatment|Adverse Event|0|||
125996507|NCT02291289|453281913|FG000|Induction Treatment|Death|25|||
125996508|NCT02291289|453281914|FG001|Induction Treatment|Death|0|||
125996509|NCT02291289|453281915|FG002|Induction Treatment|Death|0|||
125996510|NCT02291289|453281916|FG003|Induction Treatment|Death|111|||
125996511|NCT02291289|453281917|FG004|Induction Treatment|Death|0|||
125996512|NCT02291289|453281918|FG005|Induction Treatment|Death|0|||
125996513|NCT02291289|453281919|FG006|Induction Treatment|Death|1|||
125996514|NCT02291289|453281920|FG007|Induction Treatment|Death|0|||
125996515|NCT02291289|453281921|FG008|Induction Treatment|Death|0|||
125996516|NCT02291289|453281922|FG009|Induction Treatment|Death|82|||
125996517|NCT02291289|453281923|FG010|Induction Treatment|Death|0|||
125996518|NCT02291289|453281924|FG011|Induction Treatment|Death|0|||
125996519|NCT02291289|453281925|FG012|Induction Treatment|Death|0|||
125996520|NCT02291289|453281913|FG000|Induction Treatment|Lost to Follow-up|1|||
125996521|NCT02291289|453281914|FG001|Induction Treatment|Lost to Follow-up|0|||
125996522|NCT02291289|453281915|FG002|Induction Treatment|Lost to Follow-up|0|||
125996523|NCT02291289|453281916|FG003|Induction Treatment|Lost to Follow-up|12|||
125996524|NCT02291289|453281917|FG004|Induction Treatment|Lost to Follow-up|0|||
125996525|NCT02291289|453281918|FG005|Induction Treatment|Lost to Follow-up|0|||
125996526|NCT02291289|453281919|FG006|Induction Treatment|Lost to Follow-up|0|||
125996527|NCT02291289|453281920|FG007|Induction Treatment|Lost to Follow-up|0|||
125996528|NCT02291289|453281921|FG008|Induction Treatment|Lost to Follow-up|0|||
125996529|NCT02291289|453281922|FG009|Induction Treatment|Lost to Follow-up|9|||
125996530|NCT02291289|453281923|FG010|Induction Treatment|Lost to Follow-up|0|||
125996531|NCT02291289|453281924|FG011|Induction Treatment|Lost to Follow-up|0|||
125996532|NCT02291289|453281925|FG012|Induction Treatment|Lost to Follow-up|0|||
125996533|NCT02291289|453281913|FG000|Induction Treatment|Non-Compliance|0|||
125996534|NCT02291289|453281914|FG001|Induction Treatment|Non-Compliance|0|||
125996535|NCT02291289|453281915|FG002|Induction Treatment|Non-Compliance|0|||
125996536|NCT02291289|453281916|FG003|Induction Treatment|Non-Compliance|1|||
125996537|NCT02291289|453281917|FG004|Induction Treatment|Non-Compliance|0|||
125996538|NCT02291289|453281918|FG005|Induction Treatment|Non-Compliance|0|||
125996539|NCT02291289|453281919|FG006|Induction Treatment|Non-Compliance|0|||
126331485|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
126331486|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
126331487|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
126331488|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
126331489|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
126331490|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
126331491|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
126331492|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
126331493|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
126331494|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
126331495|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
126331496|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
126331497|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
126331498|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
125996540|NCT02291289|453281920|FG007|Induction Treatment|Non-Compliance|0|||
125996541|NCT02291289|453281921|FG008|Induction Treatment|Non-Compliance|0|||
125996542|NCT02291289|453281922|FG009|Induction Treatment|Non-Compliance|1|||
125996543|NCT02291289|453281923|FG010|Induction Treatment|Non-Compliance|0|||
125996544|NCT02291289|453281924|FG011|Induction Treatment|Non-Compliance|0|||
125996545|NCT02291289|453281925|FG012|Induction Treatment|Non-Compliance|0|||
125996546|NCT02291289|453281913|FG000|Induction Treatment|Reason Not Specified|0|||
125996547|NCT02291289|453281914|FG001|Induction Treatment|Reason Not Specified|0|||
126331499|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
126331500|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
126331501|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
126331502|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
126331503|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
126331504|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
126331505|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
126331506|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125996548|NCT02291289|453281915|FG002|Induction Treatment|Reason Not Specified|0|||
125996549|NCT02291289|453281916|FG003|Induction Treatment|Reason Not Specified|4|||
125996550|NCT02291289|453281917|FG004|Induction Treatment|Reason Not Specified|0|||
125996551|NCT02291289|453281918|FG005|Induction Treatment|Reason Not Specified|0|||
125996552|NCT02291289|453281919|FG006|Induction Treatment|Reason Not Specified|0|||
125996553|NCT02291289|453281920|FG007|Induction Treatment|Reason Not Specified|0|||
125996554|NCT02291289|453281921|FG008|Induction Treatment|Reason Not Specified|0|||
125996555|NCT02291289|453281922|FG009|Induction Treatment|Reason Not Specified|7|||
125996556|NCT02291289|453281923|FG010|Induction Treatment|Reason Not Specified|0|||
125996557|NCT02291289|453281924|FG011|Induction Treatment|Reason Not Specified|0|||
125996558|NCT02291289|453281925|FG012|Induction Treatment|Reason Not Specified|0|||
125996559|NCT02291289|453281913|FG000|Induction Treatment|Physician Decision|0|||
125996560|NCT02291289|453281914|FG001|Induction Treatment|Physician Decision|0|||
125996561|NCT02291289|453281915|FG002|Induction Treatment|Physician Decision|0|||
125996562|NCT02291289|453281916|FG003|Induction Treatment|Physician Decision|3|||
125996563|NCT02291289|453281917|FG004|Induction Treatment|Physician Decision|0|||
125996564|NCT02291289|453281918|FG005|Induction Treatment|Physician Decision|0|||
125996565|NCT02291289|453281919|FG006|Induction Treatment|Physician Decision|0|||
125996566|NCT02291289|453281920|FG007|Induction Treatment|Physician Decision|0|||
125996567|NCT02291289|453281921|FG008|Induction Treatment|Physician Decision|0|||
125996568|NCT02291289|453281922|FG009|Induction Treatment|Physician Decision|1|||
125996569|NCT02291289|453281923|FG010|Induction Treatment|Physician Decision|0|||
125996570|NCT02291289|453281924|FG011|Induction Treatment|Physician Decision|0|||
125996571|NCT02291289|453281925|FG012|Induction Treatment|Physician Decision|0|||
125996572|NCT02291289|453281913|FG000|Induction Treatment|Protocol Violation|0|||
125996573|NCT02291289|453281914|FG001|Induction Treatment|Protocol Violation|0|||
125996574|NCT02291289|453281915|FG002|Induction Treatment|Protocol Violation|0|||
125996575|NCT02291289|453281916|FG003|Induction Treatment|Protocol Violation|3|||
125996576|NCT02291289|453281917|FG004|Induction Treatment|Protocol Violation|0|||
125996577|NCT02291289|453281918|FG005|Induction Treatment|Protocol Violation|0|||
125996578|NCT02291289|453281919|FG006|Induction Treatment|Protocol Violation|0|||
125996579|NCT02291289|453281920|FG007|Induction Treatment|Protocol Violation|0|||
125996580|NCT02291289|453281921|FG008|Induction Treatment|Protocol Violation|0|||
125996581|NCT02291289|453281922|FG009|Induction Treatment|Protocol Violation|2|||
125996582|NCT02291289|453281923|FG010|Induction Treatment|Protocol Violation|0|||
125996583|NCT02291289|453281924|FG011|Induction Treatment|Protocol Violation|0|||
125996584|NCT02291289|453281925|FG012|Induction Treatment|Protocol Violation|0|||
125996585|NCT02291289|453281913|FG000|Induction Treatment|Missing|4|||
125996586|NCT02291289|453281914|FG001|Induction Treatment|Missing|0|||
125996587|NCT02291289|453281915|FG002|Induction Treatment|Missing|0|||
126091083|NCT00623805|453626908|FG000|Overall Study|Lack of Efficacy|3|||
126331507|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125996588|NCT02291289|453281916|FG003|Induction Treatment|Missing|14|||
125996589|NCT02291289|453281917|FG004|Induction Treatment|Missing|0|||
125996590|NCT02291289|453281918|FG005|Induction Treatment|Missing|0|||
125996591|NCT02291289|453281919|FG006|Induction Treatment|Missing|0|||
125996592|NCT02291289|453281920|FG007|Induction Treatment|Missing|0|||
125996593|NCT02291289|453281921|FG008|Induction Treatment|Missing|0|||
125996594|NCT02291289|453281922|FG009|Induction Treatment|Missing|54|||
125996595|NCT02291289|453281923|FG010|Induction Treatment|Missing|0|||
125996596|NCT02291289|453281924|FG011|Induction Treatment|Missing|0|||
125996597|NCT02291289|453281925|FG012|Induction Treatment|Missing|0|||
125996598|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996599|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996600|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996601|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996602|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
125996603|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
125996604|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996605|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996606|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996607|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996608|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
125996609|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
125996610|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125996611|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Death|0|||
125996612|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Death|29|||
125996613|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Death|16|||
125996614|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Death|0|||
125996615|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Death|188|||
125996616|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Death|107|||
125996617|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Death|0|||
125996618|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Death|1|||
125996619|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Death|1|||
125996620|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Death|0|||
125996621|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Death|46|||
125996622|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Death|19|||
125996623|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Death|0|||
125996624|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Adverse Event|0|||
125996625|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Adverse Event|0|||
125996626|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Adverse Event|0|||
125996627|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Adverse Event|0|||
125996628|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Adverse Event|1|||
125996629|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Adverse Event|1|||
125996630|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Adverse Event|0|||
125996631|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Adverse Event|0|||
125996632|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Adverse Event|0|||
125996633|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Adverse Event|0|||
125996634|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Adverse Event|0|||
125996635|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Adverse Event|0|||
125996636|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Adverse Event|0|||
125996637|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
125996638|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
125996639|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
125996640|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
125996641|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
125996642|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
125996643|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
125996644|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
125996645|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
125996646|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
125996647|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
125996648|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
125996649|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
125996650|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
125996651|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
125996652|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
125996653|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
125996654|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
125996655|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
125996656|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
125996657|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
125996658|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
125996659|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
125996660|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
125996661|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
125996662|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
125996663|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Physician Decision|0|||
125996664|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Physician Decision|2|||
125996665|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Physician Decision|0|||
125996666|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Physician Decision|0|||
125996667|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Physician Decision|3|||
125996668|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Physician Decision|0|||
125996669|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Physician Decision|0|||
125996670|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Physician Decision|0|||
125996671|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Physician Decision|0|||
125996672|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Physician Decision|0|||
125996673|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Physician Decision|1|||
125996674|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Physician Decision|3|||
125996675|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Physician Decision|0|||
125996676|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Not Treated|0|||
125996677|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Not Treated|0|||
125996678|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Not Treated|2|||
125996679|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Not Treated|0|||
125996680|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Not Treated|0|||
125996681|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Not Treated|0|||
125996682|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Not Treated|0|||
125996683|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Not Treated|0|||
125996684|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Not Treated|0|||
125996685|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Not Treated|0|||
125996686|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Not Treated|0|||
125996687|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Not Treated|0|||
125996688|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Not Treated|0|||
125996689|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996690|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
125996691|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996692|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996693|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996694|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996695|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996696|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996697|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996698|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996699|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996700|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996701|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125996702|NCT02291289|453281913|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
125996703|NCT02291289|453281914|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
125996704|NCT02291289|453281915|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
125996705|NCT02291289|453281916|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
125996706|NCT02291289|453281917|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
125996707|NCT02291289|453281918|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
125996708|NCT02291289|453281919|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
125996709|NCT02291289|453281920|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
125996710|NCT02291289|453281921|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
125996711|NCT02291289|453281922|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
125996712|NCT02291289|453281923|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
125996713|NCT02291289|453281924|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
125996714|NCT02291289|453281925|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
125996715|NCT02291289|453281913|FG000|Early Disease Progression|Death|0|||
125996716|NCT02291289|453281914|FG001|Early Disease Progression|Death|0|||
125996717|NCT02291289|453281915|FG002|Early Disease Progression|Death|0|||
125996718|NCT02291289|453281916|FG003|Early Disease Progression|Death|0|||
125996719|NCT02291289|453281917|FG004|Early Disease Progression|Death|0|||
125996720|NCT02291289|453281918|FG005|Early Disease Progression|Death|0|||
125996721|NCT02291289|453281919|FG006|Early Disease Progression|Death|0|||
125996722|NCT02291289|453281920|FG007|Early Disease Progression|Death|0|||
125996723|NCT02291289|453281921|FG008|Early Disease Progression|Death|0|||
125996724|NCT02291289|453281922|FG009|Early Disease Progression|Death|0|||
125996725|NCT02291289|453281923|FG010|Early Disease Progression|Death|0|||
125996726|NCT02291289|453281924|FG011|Early Disease Progression|Death|0|||
125996727|NCT02291289|453281925|FG012|Early Disease Progression|Death|10|||
125996728|NCT02291289|453281913|FG000|Early Disease Progression|Lost to Follow-up|0|||
125996729|NCT02291289|453281914|FG001|Early Disease Progression|Lost to Follow-up|0|||
125996730|NCT02291289|453281915|FG002|Early Disease Progression|Lost to Follow-up|0|||
125996731|NCT02291289|453281916|FG003|Early Disease Progression|Lost to Follow-up|0|||
125996732|NCT02291289|453281917|FG004|Early Disease Progression|Lost to Follow-up|0|||
125996733|NCT02291289|453281918|FG005|Early Disease Progression|Lost to Follow-up|0|||
126331508|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126331509|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126331510|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126331511|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
126331512|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126331513|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126331514|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126331515|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
126331516|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126331517|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126331518|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
126331519|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
126331520|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
126331521|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
126331522|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
126331523|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
126331524|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
126331525|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125996734|NCT02291289|453281919|FG006|Early Disease Progression|Lost to Follow-up|0|||
126331526|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
126331527|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
126331528|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
126331529|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
126331530|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
126331531|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
126331532|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
126331533|NCT00368108|454508844|FG000|Overall Study|Adverse Event|38|||
126331534|NCT00368108|454508845|FG001|Overall Study|Adverse Event|26|||
126331535|NCT00368108|454508846|FG002|Overall Study|Adverse Event|44|||
126331536|NCT00368108|454508844|FG000|Overall Study|Abnormal Laboratory Value|0|||
126331537|NCT00368108|454508845|FG001|Overall Study|Abnormal Laboratory Value|0|||
126331538|NCT00368108|454508846|FG002|Overall Study|Abnormal Laboratory Value|3|||
126331539|NCT00368108|454508844|FG000|Overall Study|Protocol Violation|5|||
126331540|NCT00368108|454508845|FG001|Overall Study|Protocol Violation|9|||
126331541|NCT00368108|454508846|FG002|Overall Study|Protocol Violation|9|||
126331542|NCT00368108|454508844|FG000|Overall Study|Withdrawal by Subject|9|||
126331543|NCT00368108|454508845|FG001|Overall Study|Withdrawal by Subject|3|||
126331544|NCT00368108|454508846|FG002|Overall Study|Withdrawal by Subject|5|||
126331545|NCT00368108|454508844|FG000|Overall Study|Lack of Efficacy|7|||
126331546|NCT00368108|454508845|FG001|Overall Study|Lack of Efficacy|8|||
126331547|NCT00368108|454508846|FG002|Overall Study|Lack of Efficacy|5|||
126331548|NCT00368108|454508844|FG000|Overall Study|Physician Decision|2|||
126331549|NCT00368108|454508845|FG001|Overall Study|Physician Decision|0|||
126331550|NCT00368108|454508846|FG002|Overall Study|Physician Decision|1|||
126331551|NCT00368108|454508844|FG000|Overall Study|Other|3|||
126331552|NCT00368108|454508845|FG001|Overall Study|Other|7|||
125996735|NCT02291289|453281920|FG007|Early Disease Progression|Lost to Follow-up|0|||
125996736|NCT02291289|453281921|FG008|Early Disease Progression|Lost to Follow-up|0|||
125996737|NCT02291289|453281922|FG009|Early Disease Progression|Lost to Follow-up|0|||
125996738|NCT02291289|453281923|FG010|Early Disease Progression|Lost to Follow-up|0|||
125996739|NCT02291289|453281924|FG011|Early Disease Progression|Lost to Follow-up|0|||
125996740|NCT02291289|453281925|FG012|Early Disease Progression|Lost to Follow-up|1|||
125996741|NCT01668147|453281926|FG000|Overall Study|Withdrawal by Subject|6|||
125996742|NCT01089556|453281933|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
125996743|NCT01089556|453281934|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
125996744|NCT01089556|453281935|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
125996745|NCT01089556|453281936|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
125996746|NCT01089556|453281937|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
125996747|NCT01089556|453281938|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
125996748|NCT01089556|453281933|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
125996749|NCT01089556|453281934|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
125996750|NCT01089556|453281935|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
125996751|NCT01089556|453281936|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
125996752|NCT01089556|453281937|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
125996753|NCT01089556|453281938|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
126091084|NCT00623805|453626909|FG001|Overall Study|Lack of Efficacy|7|||
126331553|NCT00368108|454508846|FG002|Overall Study|Other|1|||
126331554|NCT02532374|454508862|FG000|Overall Study|Withdrawal by Subject|1|||
126331555|NCT02532374|454508862|FG000|Overall Study|Physician Decision|1|||
126331556|NCT02254772|454508865|FG000|Overall Study|Ineligible|1|||
125996754|NCT01089556|453281933|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
125996755|NCT01089556|453281934|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
125996756|NCT01089556|453281935|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
125996757|NCT01089556|453281936|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
125996758|NCT01089556|453281937|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
125996759|NCT01089556|453281938|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
125996760|NCT01089556|453281933|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
126331557|NCT02254772|454508865|FG000|Overall Study|Withdrawal by Subject|1|||
125996761|NCT01089556|453281934|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
125996762|NCT01089556|453281935|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125996763|NCT01089556|453281936|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125996764|NCT01089556|453281937|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125996765|NCT01089556|453281938|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125996766|NCT01089556|453281933|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
125996767|NCT01089556|453281934|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
125996768|NCT01089556|453281935|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
125996769|NCT01089556|453281936|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
125996770|NCT01089556|453281937|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
125996771|NCT01089556|453281938|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
125996772|NCT01089556|453281933|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
125996773|NCT01089556|453281934|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
125996774|NCT01089556|453281935|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
125996775|NCT01089556|453281936|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
125996776|NCT01089556|453281937|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
125996777|NCT01089556|453281938|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
125996778|NCT01089556|453281933|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
125996779|NCT01089556|453281934|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
125996780|NCT01089556|453281935|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
125996781|NCT01089556|453281936|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
125996782|NCT01089556|453281937|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
125996783|NCT01089556|453281938|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
125996784|NCT01089556|453281933|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
125996785|NCT01089556|453281934|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
125996786|NCT01089556|453281935|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
125996787|NCT01089556|453281936|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
125996788|NCT01089556|453281937|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
125996789|NCT01089556|453281938|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
126331558|NCT03904420|454508866|FG000|Overall Study|Study terminated|2|||
126331559|NCT03904420|454508867|FG001|Overall Study|Study terminated|2|||
126331560|NCT01089127|454508868|FG000|Overall Study|Adverse Event|5|||
126331561|NCT01089127|454508869|FG001|Overall Study|Adverse Event|1|||
126331562|NCT01089127|454508870|FG002|Overall Study|Adverse Event|1|||
126331563|NCT01089127|454508871|FG003|Overall Study|Adverse Event|0|||
126331564|NCT01089127|454508872|FG004|Overall Study|Adverse Event|0|||
126331565|NCT01089127|454508873|FG005|Overall Study|Adverse Event|1|||
126331566|NCT01089127|454508868|FG000|Overall Study|Subject withdrew consent|0|||
126331567|NCT01089127|454508869|FG001|Overall Study|Subject withdrew consent|1|||
126331568|NCT01089127|454508870|FG002|Overall Study|Subject withdrew consent|1|||
126331569|NCT01089127|454508871|FG003|Overall Study|Subject withdrew consent|1|||
126331570|NCT01089127|454508872|FG004|Overall Study|Subject withdrew consent|0|||
126331571|NCT01089127|454508873|FG005|Overall Study|Subject withdrew consent|2|||
126331572|NCT01089127|454508868|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126331573|NCT01089127|454508869|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126331574|NCT01089127|454508870|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126331575|NCT01089127|454508871|FG003|Overall Study|Abnormal test procedure result(s)|0|||
126331576|NCT01089127|454508872|FG004|Overall Study|Abnormal test procedure result(s)|0|||
126331577|NCT01089127|454508873|FG005|Overall Study|Abnormal test procedure result(s)|0|||
126331578|NCT01089127|454508868|FG000|Overall Study|Lost to Follow-up|1|||
126331579|NCT01089127|454508869|FG001|Overall Study|Lost to Follow-up|1|||
126331580|NCT01089127|454508870|FG002|Overall Study|Lost to Follow-up|0|||
126331581|NCT01089127|454508871|FG003|Overall Study|Lost to Follow-up|0|||
126331582|NCT01089127|454508872|FG004|Overall Study|Lost to Follow-up|1|||
126331583|NCT01089127|454508873|FG005|Overall Study|Lost to Follow-up|0|||
126331584|NCT01089127|454508868|FG000|Overall Study|Protocol deviation|0|||
126331585|NCT01089127|454508869|FG001|Overall Study|Protocol deviation|1|||
126331586|NCT01089127|454508870|FG002|Overall Study|Protocol deviation|0|||
126331587|NCT01089127|454508871|FG003|Overall Study|Protocol deviation|0|||
126331588|NCT01089127|454508872|FG004|Overall Study|Protocol deviation|1|||
126331589|NCT01089127|454508873|FG005|Overall Study|Protocol deviation|0|||
126331590|NCT00716456|454508874|FG000|Overall Study|Adverse Event|0|||
126331591|NCT00716456|454508875|FG001|Overall Study|Adverse Event|2|||
126091085|NCT00623805|453626908|FG000|Overall Study|Lost to Follow-up|2|||
126331592|NCT00716456|454508876|FG002|Overall Study|Adverse Event|0|||
125996790|NCT01089556|453281933|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
125996791|NCT01089556|453281934|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
125996792|NCT01089556|453281935|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
125996793|NCT01089556|453281936|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
125996794|NCT01089556|453281937|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
125996795|NCT01089556|453281938|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
125996796|NCT01089556|453281933|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
125996797|NCT01089556|453281934|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
125996798|NCT01089556|453281935|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
125996799|NCT01089556|453281936|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
125996800|NCT01089556|453281937|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
125996801|NCT01089556|453281938|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
125996802|NCT01089556|453281933|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
125996803|NCT01089556|453281934|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
125996804|NCT01089556|453281935|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
125996805|NCT01089556|453281936|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
125996806|NCT01089556|453281937|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
125996807|NCT01089556|453281938|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
125996808|NCT01089556|453281933|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125996809|NCT01089556|453281934|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125996810|NCT01089556|453281935|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
125996811|NCT01089556|453281936|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125996812|NCT01089556|453281937|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125996813|NCT01089556|453281938|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125996814|NCT01089556|453281933|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
125996815|NCT01089556|453281934|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
125996816|NCT01089556|453281935|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
125996817|NCT01089556|453281936|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
125996818|NCT01089556|453281937|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
125996819|NCT01089556|453281938|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
125996820|NCT01089556|453281933|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
125996821|NCT01089556|453281934|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
125996822|NCT01089556|453281935|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
125996823|NCT01089556|453281936|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
125996824|NCT01089556|453281937|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
125996825|NCT01089556|453281938|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
125996826|NCT01089556|453281933|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
125996827|NCT01089556|453281934|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
125996828|NCT01089556|453281935|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
125996829|NCT01089556|453281936|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
125996830|NCT01089556|453281937|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
125996831|NCT01089556|453281938|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
125996832|NCT02443103|453281940|FG000|Overall Study|Adverse Event|2|||
125996833|NCT02443103|453281940|FG000|Overall Study|Noncompliance|1|||
125996834|NCT01630590|453281941|FG000|Overall Study|Adverse Event|9|||
125996835|NCT01630590|453281941|FG000|Overall Study|Lack of Efficacy|37|||
125996836|NCT01630590|453281941|FG000|Overall Study|Withdrawal by Subject|4|||
125996837|NCT01630590|453281941|FG000|Overall Study|2nd primary tumor|2|||
125996838|NCT01630590|453281941|FG000|Overall Study|Automobile accident|1|||
125996839|NCT01630590|453281941|FG000|Overall Study|Maximum benefit|4|||
125996840|NCT02366936|453281942|FG000|Overall Study|Withdrawal by Subject|2|||
125996841|NCT02366936|453281942|FG000|Overall Study|Lost to Follow-up|4|||
125996842|NCT02366936|453281942|FG000|Overall Study|Physician Decision|2|||
125996843|NCT01313923|453281945|FG000|Overall Study|Physician Decision|3|||
125996844|NCT03358329|453281946|FG000|Overall Study|Lost to Follow-up|2|||
125996845|NCT03358329|453281946|FG000|Overall Study|Withdrawal by Subject|2|||
125996846|NCT02471404|453281947|FG000|Overall Study|Adverse Event|7|||
125996847|NCT02471404|453281948|FG001|Overall Study|Adverse Event|1|||
125996848|NCT02471404|453281949|FG002|Overall Study|Adverse Event|2|||
125996849|NCT02471404|453281947|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
125996850|NCT02471404|453281948|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
125996851|NCT02471404|453281949|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
125996852|NCT02471404|453281947|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
125996853|NCT02471404|453281948|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125996854|NCT02471404|453281949|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
125996855|NCT02471404|453281947|FG000|Overall Study|Lost to Follow-up|1|||
125996856|NCT02471404|453281948|FG001|Overall Study|Lost to Follow-up|1|||
125996857|NCT02471404|453281949|FG002|Overall Study|Lost to Follow-up|3|||
125996858|NCT02471404|453281947|FG000|Overall Study|Protocol Violation|1|||
125996859|NCT02471404|453281948|FG001|Overall Study|Protocol Violation|0|||
125996860|NCT02471404|453281949|FG002|Overall Study|Protocol Violation|0|||
125996861|NCT02471404|453281947|FG000|Overall Study|Withdrawal by Subject|8|||
125996862|NCT02471404|453281948|FG001|Overall Study|Withdrawal by Subject|4|||
125996863|NCT02471404|453281949|FG002|Overall Study|Withdrawal by Subject|5|||
125996864|NCT02471404|453281947|FG000|Overall Study|Other reasons not specified|10|||
125996865|NCT02471404|453281948|FG001|Overall Study|Other reasons not specified|7|||
125996866|NCT02471404|453281949|FG002|Overall Study|Other reasons not specified|12|||
125996867|NCT02982720|453281950|FG000|Overall Study|Adverse Event|3|||
125996868|NCT02982720|453281950|FG000|Overall Study|Death|1|||
125996869|NCT00065468|453281955|FG000|Overall Study|Death|172|||
125996870|NCT00065468|453281956|FG001|Overall Study|Death|169|||
125996871|NCT00065468|453281957|FG002|Overall Study|Death|171|||
125996872|NCT00065468|453281955|FG000|Overall Study|Withdrawal by Subject|3|||
125996873|NCT00065468|453281956|FG001|Overall Study|Withdrawal by Subject|4|||
125996874|NCT00065468|453281957|FG002|Overall Study|Withdrawal by Subject|5|||
125996875|NCT00065468|453281955|FG000|Overall Study|Lost to Follow-up|5|||
125996876|NCT00065468|453281956|FG001|Overall Study|Lost to Follow-up|3|||
125996877|NCT00065468|453281957|FG002|Overall Study|Lost to Follow-up|2|||
125996878|NCT00065468|453281955|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
125996879|NCT00065468|453281956|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
125996880|NCT00065468|453281957|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
125996881|NCT00065468|453281955|FG000|Overall Study|Disease progression|0|||
125996882|NCT00065468|453281956|FG001|Overall Study|Disease progression|0|||
125996883|NCT00065468|453281957|FG002|Overall Study|Disease progression|1|||
125996884|NCT00065468|453281955|FG000|Overall Study|Other|14|||
125996885|NCT00065468|453281956|FG001|Overall Study|Other|24|||
125996886|NCT00065468|453281957|FG002|Overall Study|Other|18|||
125996887|NCT01225835|453281958|FG000|Overall Study|Completed protocol|2|||
125996888|NCT01225835|453281959|FG001|Overall Study|Completed protocol|1|||
125996889|NCT01225835|453281958|FG000|Overall Study|Did not meet hCG criterion|2|||
125996890|NCT01225835|453281959|FG001|Overall Study|Did not meet hCG criterion|0|||
125996891|NCT01225835|453281958|FG000|Overall Study|Adverse Event|2|||
125996892|NCT01225835|453281959|FG001|Overall Study|Adverse Event|1|||
125996893|NCT01225835|453281958|FG000|Overall Study|Other|1|||
125996894|NCT01225835|453281959|FG001|Overall Study|Other|1|||
125996895|NCT02589392|453281960|FG000|Overall Study|Adverse Event|1|||
125996896|NCT02589392|453281961|FG001|Overall Study|Adverse Event|1|||
125996897|NCT02589392|453281960|FG000|Overall Study|Withdrawal by Subject|1|||
125996898|NCT02589392|453281961|FG001|Overall Study|Withdrawal by Subject|2|||
125996899|NCT02589392|453281960|FG000|Overall Study|Protocol Violation|1|||
125996900|NCT02589392|453281961|FG001|Overall Study|Protocol Violation|1|||
125996901|NCT02589392|453281960|FG000|Overall Study|Lost to Follow-up|2|||
125996902|NCT02589392|453281961|FG001|Overall Study|Lost to Follow-up|2|||
125996903|NCT02589392|453281960|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
125996904|NCT02589392|453281961|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
125996905|NCT02207374|453281968|FG000|Overall Study|Withdrawal by Subject|5|||
125996906|NCT02207374|453281969|FG001|Overall Study|Withdrawal by Subject|9|||
125996907|NCT02207374|453281970|FG002|Overall Study|Withdrawal by Subject|4|||
125996908|NCT02207374|453281968|FG000|Overall Study|Death|1|||
125996909|NCT02207374|453281969|FG001|Overall Study|Death|0|||
125996910|NCT02207374|453281970|FG002|Overall Study|Death|1|||
125996911|NCT02207374|453281968|FG000|Overall Study|Missing follow-up information|0|||
125996912|NCT02207374|453281969|FG001|Overall Study|Missing follow-up information|1|||
125996913|NCT02207374|453281970|FG002|Overall Study|Missing follow-up information|1|||
125996914|NCT02087150|453281971|FG000|Overall Study|Death|0|||
125996915|NCT02087150|453281972|FG001|Overall Study|Death|1|||
125996916|NCT02087150|453281973|FG002|Overall Study|Death|0|||
125996917|NCT02087150|453281971|FG000|Overall Study|Lost to Follow-up|6|||
125996918|NCT02087150|453281972|FG001|Overall Study|Lost to Follow-up|13|||
125996919|NCT02087150|453281973|FG002|Overall Study|Lost to Follow-up|7|||
126331593|NCT00447772|454508877|FG000|Overall Study|Lack of Efficacy|3|||
126331594|NCT00447772|454508877|FG000|Overall Study|Insufficient compliance|6|||
126331595|NCT00447772|454508877|FG000|Overall Study|Discontinuation of drug therapy|1|||
126331596|NCT00447772|454508877|FG000|Overall Study|Lost to Follow-up|9|||
126331597|NCT00447772|454508877|FG000|Overall Study|Withdrawal by Subject|1|||
126331598|NCT00447772|454508877|FG000|Overall Study|Unable to attend all study visits|2|||
125996920|NCT02087150|453281971|FG000|Overall Study|Withdrawal by Subject|2|||
125996921|NCT02087150|453281972|FG001|Overall Study|Withdrawal by Subject|5|||
126331599|NCT00447772|454508877|FG000|Overall Study|Adverse Event|1|||
126331600|NCT00447772|454508877|FG000|Overall Study|Patient relocated|1|||
126331601|NCT00447772|454508877|FG000|Overall Study|Incomplete documentation at visit 1|1|||
126331602|NCT00447772|454508877|FG000|Overall Study|Chemotherapy for lung cancer|1|||
125996922|NCT02087150|453281973|FG002|Overall Study|Withdrawal by Subject|3|||
125996923|NCT02087150|453281971|FG000|Overall Study|Physician Decision|0|||
125996924|NCT02087150|453281972|FG001|Overall Study|Physician Decision|1|||
125996925|NCT02087150|453281973|FG002|Overall Study|Physician Decision|0|||
125996926|NCT02087150|453281971|FG000|Overall Study|Procedure not done|1|||
125996927|NCT02087150|453281972|FG001|Overall Study|Procedure not done|13|||
125996928|NCT02087150|453281973|FG002|Overall Study|Procedure not done|0|||
125996929|NCT02087150|453281971|FG000|Overall Study|F/U not completed w/in study window|0|||
126331603|NCT00447772|454508877|FG000|Overall Study|Premature re-injection required|1|||
126331604|NCT00875563|454508878|FG000|Overall Study|Death|4|||
125996930|NCT02087150|453281972|FG001|Overall Study|F/U not completed w/in study window|0|||
125996931|NCT02087150|453281973|FG002|Overall Study|F/U not completed w/in study window|1|||
125996932|NCT02087150|453281971|FG000|Overall Study|Other|1|||
125996933|NCT02087150|453281972|FG001|Overall Study|Other|0|||
125996934|NCT02087150|453281973|FG002|Overall Study|Other|0|||
125996935|NCT02087150|453281971|FG000|Overall Study|Pt moved out of town|0|||
125996936|NCT02087150|453281972|FG001|Overall Study|Pt moved out of town|1|||
125996937|NCT02087150|453281973|FG002|Overall Study|Pt moved out of town|0|||
125996938|NCT02372058|453281975|FG000|Overall Study|Withdrawal by Subject|3|||
125996939|NCT00972179|453281977|FG000|Overall Study|Noncompliance|1|||
125996940|NCT00972179|453281978|FG001|Overall Study|Noncompliance|0|||
125996941|NCT00972179|453281979|FG002|Overall Study|Noncompliance|0|||
125996942|NCT00972179|453281980|FG003|Overall Study|Noncompliance|0|||
125996943|NCT00972179|453281981|FG004|Overall Study|Noncompliance|1|||
125996944|NCT00972179|453281982|FG005|Overall Study|Noncompliance|0|||
125996945|NCT00972179|453281983|FG006|Overall Study|Noncompliance|1|||
125996946|NCT00972179|453281977|FG000|Overall Study|Withdrawal by Subject|0|||
125996947|NCT00972179|453281978|FG001|Overall Study|Withdrawal by Subject|3|||
125996948|NCT00972179|453281979|FG002|Overall Study|Withdrawal by Subject|0|||
125996949|NCT00972179|453281980|FG003|Overall Study|Withdrawal by Subject|1|||
125996950|NCT00972179|453281981|FG004|Overall Study|Withdrawal by Subject|0|||
125996951|NCT00972179|453281982|FG005|Overall Study|Withdrawal by Subject|0|||
125996952|NCT00972179|453281983|FG006|Overall Study|Withdrawal by Subject|2|||
125996953|NCT00972179|453281977|FG000|Overall Study|Administrative Decision|0|||
126331605|NCT00875563|454508878|FG000|Overall Study|Withdrawal by Subject|7|||
126331606|NCT00875563|454508878|FG000|Overall Study|No long-term (3-5 year) consent|6|||
126331607|NCT00875563|454508878|FG000|Overall Study|Still be eligible for follow-up|7|||
126331608|NCT02896569|454508881|FG000|Overall Study|Lost to Follow-up|2|||
126331609|NCT02896569|454508882|FG001|Overall Study|Lost to Follow-up|1|||
126331610|NCT02896569|454508881|FG000|Overall Study|Physician Decision|1|||
126331611|NCT02896569|454508882|FG001|Overall Study|Physician Decision|3|||
126331612|NCT02896569|454508881|FG000|Overall Study|Adverse Event|0|||
126331613|NCT02896569|454508882|FG001|Overall Study|Adverse Event|1|||
126331614|NCT02896569|454508881|FG000|Overall Study|Withdrawal by Subject|1|||
126331615|NCT02896569|454508882|FG001|Overall Study|Withdrawal by Subject|0|||
126331616|NCT03257436|454508883|FG000|Overall Study|Withdrawal by Subject|76|||
126331617|NCT03257436|454508883|FG000|Overall Study|Death|19|||
126331618|NCT03874013|454508890|FG000|Overall Study|Adverse Event|0|||
126331619|NCT03874013|454508891|FG001|Overall Study|Adverse Event|1|||
126331620|NCT06060496|454508893|FG000|Overall Study|Withdrawal by Subject|2|||
126331621|NCT06060496|454508893|FG000|Overall Study|Lost to Follow-up|2|||
126331622|NCT03990051|454508894|FG000|Masked Period|Lost to Follow-up|1|||
126331623|NCT03990051|454508895|FG001|Masked Period|Lost to Follow-up|0|||
126331624|NCT03990051|454508894|FG000|Long Term Period|Death|1|||
126331625|NCT03990051|454508895|FG001|Long Term Period|Death|1|||
126331626|NCT03990051|454508894|FG000|Long Term Period|Lost to Follow-up|7|||
126331627|NCT03990051|454508895|FG001|Long Term Period|Lost to Follow-up|2|||
126331628|NCT01411852|454508896|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
126331629|NCT01411852|454508897|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
126331630|NCT01411852|454508896|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
126331631|NCT01411852|454508897|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
126331632|NCT01411852|454508896|FG000|Prehospital Intervention Phase|Found to be under age|0|||
126331633|NCT01411852|454508897|FG001|Prehospital Intervention Phase|Found to be under age|1|||
126331634|NCT01411852|454508896|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
126331635|NCT01411852|454508897|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
126331636|NCT01411852|454508896|FG000|Hospital Intervention Phase|Severe head injury|5|||
126331637|NCT01411852|454508897|FG001|Hospital Intervention Phase|Severe head injury|4|||
126331638|NCT01411852|454508896|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
125996954|NCT00972179|453281978|FG001|Overall Study|Administrative Decision|0|||
125996955|NCT00972179|453281979|FG002|Overall Study|Administrative Decision|0|||
125996956|NCT00972179|453281980|FG003|Overall Study|Administrative Decision|0|||
125996957|NCT00972179|453281981|FG004|Overall Study|Administrative Decision|1|||
125996958|NCT00972179|453281982|FG005|Overall Study|Administrative Decision|0|||
125996959|NCT00972179|453281983|FG006|Overall Study|Administrative Decision|0|||
126331639|NCT01411852|454508897|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
126331640|NCT01411852|454508896|FG000|Hospital Intervention Phase|Miscommunication error|1|||
126331641|NCT01411852|454508897|FG001|Hospital Intervention Phase|Miscommunication error|2|||
126331642|NCT01411852|454508896|FG000|Hospital Intervention Phase|CPR administered|3|||
126331643|NCT01411852|454508897|FG001|Hospital Intervention Phase|CPR administered|1|||
126331644|NCT01411852|454508896|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
126331645|NCT01411852|454508897|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
125996960|NCT00972179|453281977|FG000|Overall Study|Lost to Follow-up|0|||
126331646|NCT01411852|454508896|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
126331647|NCT01411852|454508897|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
126331648|NCT01411852|454508896|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
126331649|NCT01411852|454508897|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
126331650|NCT01411852|454508896|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
126331651|NCT01411852|454508897|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
125996961|NCT00972179|453281978|FG001|Overall Study|Lost to Follow-up|0|||
125996962|NCT00972179|453281979|FG002|Overall Study|Lost to Follow-up|1|||
125996963|NCT00972179|453281980|FG003|Overall Study|Lost to Follow-up|0|||
125996964|NCT00972179|453281981|FG004|Overall Study|Lost to Follow-up|0|||
125996965|NCT00972179|453281982|FG005|Overall Study|Lost to Follow-up|3|||
125996966|NCT00972179|453281983|FG006|Overall Study|Lost to Follow-up|1|||
125996967|NCT02061761|453281984|FG000|Overall Study|Disease progression|2|||
125996968|NCT02061761|453281985|FG001|Overall Study|Disease progression|8|||
125996969|NCT02061761|453281986|FG002|Overall Study|Disease progression|4|||
125996970|NCT02061761|453281987|FG003|Overall Study|Disease progression|5|||
125996971|NCT02061761|453281988|FG004|Overall Study|Disease progression|9|||
125996972|NCT02061761|453281989|FG005|Overall Study|Disease progression|3|||
125996973|NCT02061761|453281990|FG006|Overall Study|Disease progression|1|||
125996974|NCT02061761|453281991|FG007|Overall Study|Disease progression|2|||
125996975|NCT02061761|453281992|FG008|Overall Study|Disease progression|28|||
125996976|NCT02061761|453281984|FG000|Overall Study|Study Drug toxicity|0|||
125996977|NCT02061761|453281985|FG001|Overall Study|Study Drug toxicity|0|||
125996978|NCT02061761|453281986|FG002|Overall Study|Study Drug toxicity|0|||
125996979|NCT02061761|453281987|FG003|Overall Study|Study Drug toxicity|0|||
125996980|NCT02061761|453281988|FG004|Overall Study|Study Drug toxicity|0|||
125996981|NCT02061761|453281989|FG005|Overall Study|Study Drug toxicity|1|||
125996982|NCT02061761|453281990|FG006|Overall Study|Study Drug toxicity|0|||
125996983|NCT02061761|453281991|FG007|Overall Study|Study Drug toxicity|2|||
125996984|NCT02061761|453281992|FG008|Overall Study|Study Drug toxicity|6|||
125996985|NCT02061761|453281984|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
125996986|NCT02061761|453281985|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
125996987|NCT02061761|453281986|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
125996988|NCT02061761|453281987|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
125996989|NCT02061761|453281988|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
125996990|NCT02061761|453281989|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
125996991|NCT02061761|453281990|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
125996992|NCT02061761|453281991|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
125996993|NCT02061761|453281992|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
125996994|NCT02061761|453281984|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125996995|NCT02061761|453281985|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125996996|NCT02061761|453281986|FG002|Overall Study|Participant request to discontinue study treatment|2|||
125996997|NCT02061761|453281987|FG003|Overall Study|Participant request to discontinue study treatment|2|||
125996998|NCT02061761|453281988|FG004|Overall Study|Participant request to discontinue study treatment|0|||
125996999|NCT02061761|453281989|FG005|Overall Study|Participant request to discontinue study treatment|1|||
125997000|NCT02061761|453281990|FG006|Overall Study|Participant request to discontinue study treatment|0|||
125997001|NCT02061761|453281991|FG007|Overall Study|Participant request to discontinue study treatment|0|||
125997002|NCT02061761|453281992|FG008|Overall Study|Participant request to discontinue study treatment|2|||
125997003|NCT02061761|453281984|FG000|Overall Study|Withdrawal by Subject|0|||
125997004|NCT02061761|453281985|FG001|Overall Study|Withdrawal by Subject|0|||
125997005|NCT02061761|453281986|FG002|Overall Study|Withdrawal by Subject|0|||
125997006|NCT02061761|453281987|FG003|Overall Study|Withdrawal by Subject|0|||
125997007|NCT02061761|453281988|FG004|Overall Study|Withdrawal by Subject|0|||
125997008|NCT02061761|453281989|FG005|Overall Study|Withdrawal by Subject|0|||
125997009|NCT02061761|453281990|FG006|Overall Study|Withdrawal by Subject|0|||
125997010|NCT02061761|453281991|FG007|Overall Study|Withdrawal by Subject|0|||
125997011|NCT02061761|453281992|FG008|Overall Study|Withdrawal by Subject|2|||
125997012|NCT02061761|453281984|FG000|Overall Study|Maximum clinical benefit|0|||
125997013|NCT02061761|453281985|FG001|Overall Study|Maximum clinical benefit|0|||
125997014|NCT02061761|453281986|FG002|Overall Study|Maximum clinical benefit|0|||
125997015|NCT02061761|453281987|FG003|Overall Study|Maximum clinical benefit|1|||
125997016|NCT02061761|453281988|FG004|Overall Study|Maximum clinical benefit|0|||
125997017|NCT02061761|453281989|FG005|Overall Study|Maximum clinical benefit|0|||
125997018|NCT02061761|453281990|FG006|Overall Study|Maximum clinical benefit|0|||
125997019|NCT02061761|453281991|FG007|Overall Study|Maximum clinical benefit|0|||
125997020|NCT02061761|453281992|FG008|Overall Study|Maximum clinical benefit|6|||
125997021|NCT02061761|453281984|FG000|Overall Study|Participant no longer meets study criteria|0|||
125997022|NCT02061761|453281985|FG001|Overall Study|Participant no longer meets study criteria|0|||
125997023|NCT02061761|453281986|FG002|Overall Study|Participant no longer meets study criteria|0|||
125997024|NCT02061761|453281987|FG003|Overall Study|Participant no longer meets study criteria|0|||
125997025|NCT02061761|453281988|FG004|Overall Study|Participant no longer meets study criteria|0|||
125997026|NCT02061761|453281989|FG005|Overall Study|Participant no longer meets study criteria|0|||
126331652|NCT01411852|454508896|FG000|Hospital Intervention Phase|Other ineligible|2|||
126331653|NCT01411852|454508897|FG001|Hospital Intervention Phase|Other ineligible|2|||
126331654|NCT01411852|454508896|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
126331655|NCT01411852|454508897|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
126331656|NCT01411852|454508896|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
126331657|NCT01411852|454508897|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
126331658|NCT01411852|454508896|FG000|Hospital Intervention Phase|Vascular access failed|1|||
126331659|NCT01411852|454508897|FG001|Hospital Intervention Phase|Vascular access failed|0|||
126331660|NCT03126786|454508902|FG000|Overall Study|Adverse Event|3|||
126331661|NCT03126786|454508903|FG001|Overall Study|Adverse Event|0|||
126331662|NCT03126786|454508902|FG000|Overall Study|Lost to Follow-up|0|||
126331663|NCT03126786|454508903|FG001|Overall Study|Lost to Follow-up|1|||
126331664|NCT03126786|454508902|FG000|Overall Study|Withdrawal by Subject|3|||
126331665|NCT03126786|454508903|FG001|Overall Study|Withdrawal by Subject|1|||
126331666|NCT00991289|454508904|FG000|Overall Study|Adverse Event|1|||
126331667|NCT00991289|454508904|FG000|Overall Study|Physician Decision|2|||
126331668|NCT00991289|454508904|FG000|Overall Study|Withdrawal by Subject|3|||
126331669|NCT00991289|454508904|FG000|Overall Study|Lost to Follow-up|4|||
126331670|NCT00991289|454508904|FG000|Overall Study|Protocol Violation|2|||
126331671|NCT00379899|454508905|FG000|Overall Study|Adverse Event|7|||
126331672|NCT00379899|454508906|FG001|Overall Study|Adverse Event|3|||
126331673|NCT00379899|454508905|FG000|Overall Study|Death|10|||
125997027|NCT02061761|453281990|FG006|Overall Study|Participant no longer meets study criteria|0|||
125997028|NCT02061761|453281991|FG007|Overall Study|Participant no longer meets study criteria|0|||
125997029|NCT02061761|453281992|FG008|Overall Study|Participant no longer meets study criteria|1|||
125997030|NCT02061761|453281984|FG000|Overall Study|Other reasons|0|||
126331674|NCT00379899|454508906|FG001|Overall Study|Death|10|||
126331675|NCT00379899|454508905|FG000|Overall Study|Lost to Follow-up|2|||
126331676|NCT00379899|454508906|FG001|Overall Study|Lost to Follow-up|4|||
126331677|NCT00379899|454508905|FG000|Overall Study|Physician Decision|3|||
126331678|NCT00379899|454508906|FG001|Overall Study|Physician Decision|4|||
126331679|NCT00379899|454508905|FG000|Overall Study|Withdrawal by Subject|5|||
126331680|NCT00379899|454508906|FG001|Overall Study|Withdrawal by Subject|5|||
126331681|NCT00379899|454508905|FG000|Overall Study|Ineligibility determined|0|||
126331682|NCT00379899|454508906|FG001|Overall Study|Ineligibility determined|1|||
126331683|NCT00379899|454508905|FG000|Overall Study|Noncompliance|1|||
126331684|NCT00379899|454508906|FG001|Overall Study|Noncompliance|1|||
126331685|NCT00379899|454508905|FG000|Overall Study|Parathyroidectomy|0|||
126331686|NCT00379899|454508906|FG001|Overall Study|Parathyroidectomy|2|||
126331687|NCT00379899|454508905|FG000|Overall Study|Renal transplantation|5|||
126331688|NCT00379899|454508906|FG001|Overall Study|Renal transplantation|4|||
126331689|NCT00379899|454508905|FG000|Overall Study|Coronary artery bypass graft|1|||
126331690|NCT00379899|454508906|FG001|Overall Study|Coronary artery bypass graft|1|||
126331691|NCT00379899|454508905|FG000|Overall Study|Other protocol-specified criteria|3|||
126331692|NCT00379899|454508906|FG001|Overall Study|Other protocol-specified criteria|4|||
126331693|NCT00379899|454508905|FG000|Overall Study|Other|3|||
126331694|NCT00379899|454508906|FG001|Overall Study|Other|1|||
126331695|NCT05225389|454508909|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
126331696|NCT03804268|454508910|FG000|Overall Study|Adverse Event|2|||
126331697|NCT03804268|454508911|FG001|Overall Study|Adverse Event|2|||
126331698|NCT03804268|454508910|FG000|Overall Study|Withdrawal by Subject|2|||
126331699|NCT03804268|454508911|FG001|Overall Study|Withdrawal by Subject|0|||
126331700|NCT03804268|454508910|FG000|Overall Study|Lost to Follow-up|1|||
126331701|NCT03804268|454508911|FG001|Overall Study|Lost to Follow-up|0|||
126331702|NCT03804268|454508910|FG000|Overall Study|Physician Decision|2|||
126331703|NCT03804268|454508911|FG001|Overall Study|Physician Decision|0|||
126331704|NCT02716779|454508912|FG000|Monotherapy|Adverse Event|0|||
126331705|NCT02716779|454508913|FG001|Monotherapy|Adverse Event|1|||
126331706|NCT02716779|454508914|FG002|Monotherapy|Adverse Event|1|||
126331707|NCT02716779|454508912|FG000|Combination Therapy|Adverse Event|0|||
126331708|NCT02716779|454508913|FG001|Combination Therapy|Adverse Event|2|||
126331709|NCT02716779|454508914|FG002|Combination Therapy|Adverse Event|1|||
126331710|NCT01843803|454508917|FG000|Overall Study|not a Veteran, did not see provider|1|||
126331711|NCT01843803|454508918|FG001|Overall Study|not a Veteran, did not see provider|3|||
126331712|NCT03311841|454508919|FG000|14-day Wash-out|Adverse Event|0|||
126331713|NCT03311841|454508920|FG001|14-day Wash-out|Adverse Event|1|||
126331714|NCT03311841|454508921|FG002|14-day Wash-out|Adverse Event|0|||
126331715|NCT03311841|454508922|FG003|14-day Wash-out|Adverse Event|0|||
125997031|NCT02061761|453281985|FG001|Overall Study|Other reasons|0|||
126331716|NCT03311841|454508923|FG004|14-day Wash-out|Adverse Event|0|||
126331717|NCT03311841|454508919|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
126331718|NCT03311841|454508920|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
126331719|NCT03311841|454508921|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
126331720|NCT03311841|454508922|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
126331721|NCT03311841|454508923|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
126331722|NCT01051817|454508931|FG000|Overall Study|Adverse Event|0|||
125997032|NCT02061761|453281986|FG002|Overall Study|Other reasons|0|||
125997033|NCT02061761|453281987|FG003|Overall Study|Other reasons|0|||
125997034|NCT02061761|453281988|FG004|Overall Study|Other reasons|2|||
125997035|NCT02061761|453281989|FG005|Overall Study|Other reasons|0|||
125997036|NCT02061761|453281990|FG006|Overall Study|Other reasons|0|||
125997037|NCT02061761|453281991|FG007|Overall Study|Other reasons|0|||
125997038|NCT02061761|453281992|FG008|Overall Study|Other reasons|6|||
125997039|NCT02500316|453281999|FG000|Overall Study|Adverse Event|3|||
126331723|NCT01051817|454508932|FG001|Overall Study|Adverse Event|2|||
126331724|NCT01051817|454508931|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
126331725|NCT01051817|454508932|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
125997040|NCT02500316|453281999|FG000|Overall Study|Lost to Follow-up|2|||
125997041|NCT02500316|453281999|FG000|Overall Study|Protocol Violation|1|||
125997042|NCT02500316|453281999|FG000|Overall Study|Withdrawal by Subject|15|||
125997043|NCT02500316|453281999|FG000|Overall Study|Final height achieved|5|||
125997044|NCT02500316|453281999|FG000|Overall Study|Due to war activity|1|||
125997045|NCT01406717|453282000|FG000|Overall Study|Subject non-compliance|4|||
125997046|NCT01406717|453282001|FG001|Overall Study|Subject non-compliance|3|||
125997047|NCT01406717|453282000|FG000|Overall Study|Protocol Violation|5|||
125997048|NCT01406717|453282001|FG001|Overall Study|Protocol Violation|1|||
125997049|NCT01406717|453282000|FG000|Overall Study|Lost to Follow-up|14|||
125997050|NCT01406717|453282001|FG001|Overall Study|Lost to Follow-up|8|||
125997051|NCT01406717|453282000|FG000|Overall Study|Withdrawal by Subject|19|||
125997052|NCT01406717|453282001|FG001|Overall Study|Withdrawal by Subject|15|||
125997053|NCT01406717|453282000|FG000|Overall Study|Adverse Event|1|||
125997054|NCT01406717|453282001|FG001|Overall Study|Adverse Event|2|||
125997055|NCT01406717|453282000|FG000|Overall Study|Lack of Efficacy|0|||
125997056|NCT01406717|453282001|FG001|Overall Study|Lack of Efficacy|1|||
126331726|NCT01051817|454508931|FG000|Overall Study|Withdrawal by Subject|3|||
126331727|NCT01051817|454508932|FG001|Overall Study|Withdrawal by Subject|5|||
126331728|NCT01051817|454508931|FG000|Overall Study|Protocol Violation|0|||
126331729|NCT01051817|454508932|FG001|Overall Study|Protocol Violation|1|||
126331730|NCT01026948|454508933|FG000|Overall Study|Physician Decision|8|||
126331731|NCT00753675|454508938|FG000|Overall Study|other reason|11|||
126331732|NCT00753675|454508939|FG001|Overall Study|other reason|12|||
126331733|NCT00753675|454508940|FG002|Overall Study|other reason|13|||
126331734|NCT00753675|454508938|FG000|Overall Study|Death|1|||
126331735|NCT00753675|454508939|FG001|Overall Study|Death|2|||
126331736|NCT00753675|454508940|FG002|Overall Study|Death|4|||
126331737|NCT00753675|454508938|FG000|Overall Study|Adverse Event|11|||
126331738|NCT00753675|454508939|FG001|Overall Study|Adverse Event|9|||
126331739|NCT00753675|454508940|FG002|Overall Study|Adverse Event|4|||
126331740|NCT00753675|454508938|FG000|Overall Study|Objective progression of disease|35|||
126331741|NCT00753675|454508939|FG001|Overall Study|Objective progression of disease|35|||
126331742|NCT00753675|454508940|FG002|Overall Study|Objective progression of disease|35|||
126331743|NCT00753675|454508938|FG000|Overall Study|Withdrawal by Subject|0|||
126331744|NCT00753675|454508939|FG001|Overall Study|Withdrawal by Subject|1|||
126331745|NCT00753675|454508940|FG002|Overall Study|Withdrawal by Subject|0|||
126331746|NCT00753675|454508938|FG000|Overall Study|Lost to Follow-up|1|||
126331747|NCT00753675|454508939|FG001|Overall Study|Lost to Follow-up|0|||
126331748|NCT00753675|454508940|FG002|Overall Study|Lost to Follow-up|0|||
126331749|NCT02686164|454508941|FG000|Overall Study|Adverse Event|1|||
126331750|NCT02686164|454508941|FG000|Overall Study|Withdrawal of consent|1|||
126331751|NCT02686164|454508941|FG000|Overall Study|Clinical progression|1|||
126331752|NCT02824627|454508944|FG000|Overall Study|Adverse Event|1|||
126331753|NCT02824627|454508945|FG001|Overall Study|Adverse Event|2|||
126331754|NCT02824627|454508944|FG000|Overall Study|Lost to Follow-up|2|||
126331755|NCT02824627|454508945|FG001|Overall Study|Lost to Follow-up|1|||
126331756|NCT00672633|454508946|FG000|Overall Study|Withdrawal by Subject|0|||
126331757|NCT00672633|454508947|FG001|Overall Study|Withdrawal by Subject|1|||
126331758|NCT00571662|454508959|FG000|Overall Study|Withdrawal by Subject|2|||
126331759|NCT00571662|454508959|FG000|Overall Study|psychiatric instability|1|||
126331760|NCT00571662|454508959|FG000|Overall Study|Adverse Event|5|||
126331761|NCT01839916|454508960|FG000|Overall Study|Death|9|||
125997057|NCT01406717|453282000|FG000|Overall Study|Non-completion of visit activity|0|||
126331762|NCT01839916|454508960|FG000|Overall Study|Physician Decision|17|||
126331763|NCT01839916|454508960|FG000|Overall Study|Relapse|12|||
126331764|NCT01839916|454508960|FG000|Overall Study|GVHD|2|||
126331765|NCT01839916|454508960|FG000|Overall Study|Graft Failure|1|||
126331766|NCT04235504|454508965|FG000|Study Phase|Withdrawal by Subject|5|||
126331767|NCT04235504|454508966|FG001|Study Phase|Withdrawal by Subject|2|||
126331768|NCT04235504|454508967|FG002|Study Phase|Withdrawal by Subject|0|||
126331769|NCT04235504|454508968|FG003|Study Phase|Withdrawal by Subject|0|||
126331770|NCT04235504|454508965|FG000|Continuation Phase|Withdrawal by Subject|0|||
125997058|NCT01406717|453282001|FG001|Overall Study|Non-completion of visit activity|1|||
125997059|NCT03257995|453282002|FG000|Overall Study|Adverse Event|0|||
125997060|NCT03257995|453282003|FG001|Overall Study|Adverse Event|1|||
125997061|NCT03257995|453282004|FG002|Overall Study|Adverse Event|0|||
125997062|NCT03257995|453282005|FG003|Overall Study|Adverse Event|0|||
126331771|NCT04235504|454508966|FG001|Continuation Phase|Withdrawal by Subject|4|||
126331772|NCT04235504|454508967|FG002|Continuation Phase|Withdrawal by Subject|0|||
126331773|NCT04235504|454508968|FG003|Continuation Phase|Withdrawal by Subject|0|||
126331774|NCT04235504|454508965|FG000|Continuation Phase|Adverse Event|0|||
126331775|NCT04235504|454508966|FG001|Continuation Phase|Adverse Event|1|||
126331776|NCT04235504|454508967|FG002|Continuation Phase|Adverse Event|0|||
126331777|NCT04235504|454508968|FG003|Continuation Phase|Adverse Event|0|||
126331778|NCT04235504|454508965|FG000|Continuation Phase|Physician Decision|1|||
126331779|NCT04235504|454508966|FG001|Continuation Phase|Physician Decision|2|||
126331780|NCT04235504|454508967|FG002|Continuation Phase|Physician Decision|1|||
126331781|NCT04235504|454508968|FG003|Continuation Phase|Physician Decision|0|||
126331782|NCT00181883|454508976|FG000|Overall Study|Lack of Efficacy|2|||
126331783|NCT00181883|454508976|FG000|Overall Study|Treatment Limiting AEs|3|||
126331784|NCT00181883|454508976|FG000|Overall Study|Withdrawal by Subject|4|||
126331785|NCT00181883|454508976|FG000|Overall Study|Lost to Follow-up|1|||
126331786|NCT02106351|454508977|FG000|Treatment Cycle 1|Adverse Event|2|||
126331787|NCT02106351|454508978|FG001|Treatment Cycle 1|Adverse Event|0|||
126331788|NCT02106351|454508979|FG002|Treatment Cycle 1|Adverse Event|0|||
126331789|NCT02106351|454508977|FG000|Treatment Cycle 1|Consent withdrawn|1|||
126331790|NCT02106351|454508978|FG001|Treatment Cycle 1|Consent withdrawn|0|||
126331791|NCT02106351|454508979|FG002|Treatment Cycle 1|Consent withdrawn|2|||
126331792|NCT02106351|454508977|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
126331793|NCT02106351|454508978|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
126331794|NCT02106351|454508979|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
126331795|NCT02106351|454508977|FG000|Treatment Cycle 1|Other|0|||
126331796|NCT02106351|454508978|FG001|Treatment Cycle 1|Other|3|||
126331797|NCT02106351|454508979|FG002|Treatment Cycle 1|Other|1|||
126331798|NCT02106351|454508977|FG000|Treatment Cycle 1|Randomised but not treated|1|||
126331799|NCT02106351|454508978|FG001|Treatment Cycle 1|Randomised but not treated|0|||
126331800|NCT02106351|454508979|FG002|Treatment Cycle 1|Randomised but not treated|1|||
126331801|NCT02106351|454508977|FG000|Treatment Cycle 2|Adverse Event|0|||
126331802|NCT02106351|454508978|FG001|Treatment Cycle 2|Adverse Event|2|||
126331803|NCT02106351|454508979|FG002|Treatment Cycle 2|Adverse Event|0|||
126331804|NCT02106351|454508977|FG000|Treatment Cycle 2|Consent withdrawn|0|||
126331805|NCT02106351|454508978|FG001|Treatment Cycle 2|Consent withdrawn|1|||
126331806|NCT02106351|454508979|FG002|Treatment Cycle 2|Consent withdrawn|1|||
126331807|NCT02106351|454508977|FG000|Treatment Cycle 2|Other|0|||
126331808|NCT02106351|454508978|FG001|Treatment Cycle 2|Other|2|||
126331809|NCT02106351|454508979|FG002|Treatment Cycle 2|Other|2|||
126331810|NCT02106351|454508977|FG000|Treatment Cycle 3|Adverse Event|0|||
126331811|NCT02106351|454508978|FG001|Treatment Cycle 3|Adverse Event|1|||
126331812|NCT02106351|454508979|FG002|Treatment Cycle 3|Adverse Event|0|||
126331813|NCT02106351|454508977|FG000|Treatment Cycle 3|Consent withdrawn|0|||
126331814|NCT02106351|454508978|FG001|Treatment Cycle 3|Consent withdrawn|0|||
126331815|NCT02106351|454508979|FG002|Treatment Cycle 3|Consent withdrawn|2|||
126331816|NCT02106351|454508977|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
126331817|NCT02106351|454508978|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
126331818|NCT02106351|454508979|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
126331819|NCT02106351|454508977|FG000|Treatment Cycle 3|Other|0|||
126331820|NCT02106351|454508978|FG001|Treatment Cycle 3|Other|2|||
126331821|NCT02106351|454508979|FG002|Treatment Cycle 3|Other|3|||
126331822|NCT02106351|454508977|FG000|Treatment Cycle 4|Consent withdrawn|0|||
126331823|NCT02106351|454508978|FG001|Treatment Cycle 4|Consent withdrawn|0|||
126331824|NCT02106351|454508979|FG002|Treatment Cycle 4|Consent withdrawn|2|||
126331825|NCT02106351|454508977|FG000|Treatment Cycle 4|Other|0|||
126331826|NCT02106351|454508978|FG001|Treatment Cycle 4|Other|1|||
125997063|NCT03257995|453282006|FG004|Overall Study|Adverse Event|0|||
125997064|NCT03257995|453282007|FG005|Overall Study|Adverse Event|0|||
125997065|NCT03257995|453282002|FG000|Overall Study|Protocol deviation|0|||
125997066|NCT03257995|453282003|FG001|Overall Study|Protocol deviation|0|||
125997067|NCT03257995|453282004|FG002|Overall Study|Protocol deviation|0|||
125997068|NCT03257995|453282005|FG003|Overall Study|Protocol deviation|0|||
126331827|NCT02106351|454508979|FG002|Treatment Cycle 4|Other|0|||
126331828|NCT00101868|454508980|FG000|Overall Study|Death|10|||
126331829|NCT00101868|454508981|FG001|Overall Study|Death|10|||
126331830|NCT00101868|454508980|FG000|Overall Study|Withdrawal by Subject|8|||
125997069|NCT03257995|453282006|FG004|Overall Study|Protocol deviation|0|||
126331831|NCT00101868|454508981|FG001|Overall Study|Withdrawal by Subject|9|||
126331832|NCT00101868|454508980|FG000|Overall Study|Protocol Violation|3|||
126331833|NCT00101868|454508981|FG001|Overall Study|Protocol Violation|0|||
126331834|NCT00101868|454508980|FG000|Overall Study|Lost to Follow-up|8|||
126331835|NCT00101868|454508981|FG001|Overall Study|Lost to Follow-up|13|||
126331836|NCT00069823|454508982|FG000|Overall Study|Did not have follow-up diary cards|6|||
126331837|NCT00069823|454508983|FG001|Overall Study|Did not have follow-up diary cards|3|||
126331838|NCT02329327|454508986|FG000|Overall Study|Death|78|||
126331839|NCT02329327|454508987|FG001|Overall Study|Death|0|||
126331840|NCT02329327|454508986|FG000|Overall Study|Withdrawal by Subject|3|||
125997070|NCT03257995|453282007|FG005|Overall Study|Protocol deviation|2|||
126331841|NCT02329327|454508987|FG001|Overall Study|Withdrawal by Subject|0|||
125997071|NCT01556763|453282012|FG000|Overall Study|Withdrawal by Subject|0|||
125997072|NCT01556763|453282013|FG001|Overall Study|Withdrawal by Subject|1|||
125997073|NCT01556763|453282014|FG002|Overall Study|Withdrawal by Subject|0|||
125997074|NCT02258464|453282015|FG000|Overall Study|Progressive disease (PD)|9|||
125997075|NCT02258464|453282016|FG001|Overall Study|Progressive disease (PD)|17|||
125997076|NCT02258464|453282015|FG000|Overall Study|Study drug never administered|1|||
125997077|NCT02258464|453282016|FG001|Overall Study|Study drug never administered|1|||
125997078|NCT02258464|453282015|FG000|Overall Study|AE not related to clinical PD|1|||
125997079|NCT02258464|453282016|FG001|Overall Study|AE not related to clinical PD|3|||
125997080|NCT02258464|453282015|FG000|Overall Study|Withdrawal by Subject|5|||
125997081|NCT02258464|453282016|FG001|Overall Study|Withdrawal by Subject|4|||
125997082|NCT02258464|453282015|FG000|Overall Study|AE related to clinical PD|1|||
125997083|NCT02258464|453282016|FG001|Overall Study|AE related to clinical PD|0|||
125997084|NCT02337478|453282017|FG000|Overall Study|Lack of Efficacy|5|||
125997085|NCT04170296|453282018|FG000|Overall Study|Adverse Event|1|||
125997086|NCT04170296|453282019|FG001|Overall Study|Adverse Event|0|||
125997087|NCT04170296|453282018|FG000|Overall Study|Withdrawal by Subject|3|||
125997088|NCT04170296|453282019|FG001|Overall Study|Withdrawal by Subject|2|||
125997089|NCT04170296|453282018|FG000|Overall Study|Lost to Follow-up|4|||
125997090|NCT04170296|453282019|FG001|Overall Study|Lost to Follow-up|2|||
125997091|NCT00932646|453282020|FG000|Overall Study|Adverse Event|2|||
125997092|NCT00932646|453282021|FG001|Overall Study|Adverse Event|1|||
125997093|NCT00932646|453282022|FG002|Overall Study|Adverse Event|1|||
125997094|NCT00932646|453282023|FG003|Overall Study|Adverse Event|1|||
125997095|NCT00932646|453282020|FG000|Overall Study|Lost to Follow-up|2|||
125997096|NCT00932646|453282021|FG001|Overall Study|Lost to Follow-up|1|||
125997097|NCT00932646|453282022|FG002|Overall Study|Lost to Follow-up|0|||
125997098|NCT00932646|453282023|FG003|Overall Study|Lost to Follow-up|0|||
125997099|NCT00932646|453282020|FG000|Overall Study|Withdrawal by Subject|1|||
125997100|NCT00932646|453282021|FG001|Overall Study|Withdrawal by Subject|1|||
125997101|NCT00932646|453282022|FG002|Overall Study|Withdrawal by Subject|3|||
125997102|NCT00932646|453282023|FG003|Overall Study|Withdrawal by Subject|0|||
125997103|NCT00653263|453282024|FG000|Overall Study|Withdrawal by Subject|1|||
125997104|NCT00653263|453282024|FG000|Overall Study|Physician Decision|1|||
125997105|NCT02285595|453282029|FG000|Overall Study|Lost to Follow-up|14|||
125997106|NCT02285595|453282029|FG000|Overall Study|Withdrawal by Subject|1|||
125997107|NCT00195715|453282030|FG000|Overall Study|Adverse Event|122|||
125997108|NCT00195715|453282030|FG000|Overall Study|Withdrawal by Subject|58|||
125997109|NCT00195715|453282030|FG000|Overall Study|Lost to Follow-up|27|||
125997110|NCT00195715|453282030|FG000|Overall Study|Protocol Violation|13|||
125997111|NCT00195715|453282030|FG000|Overall Study|Lack of Efficacy|93|||
125997112|NCT00195715|453282030|FG000|Overall Study|Pregnancy|14|||
125997113|NCT00195715|453282030|FG000|Overall Study|Investigative site closure|8|||
125997114|NCT00195715|453282030|FG000|Overall Study|Subject moved/relocated|7|||
125997115|NCT00195715|453282030|FG000|Overall Study|Subject non-compliance|6|||
125997116|NCT00195715|453282030|FG000|Overall Study|Subject started commercial Humira|5|||
125997117|NCT00195715|453282030|FG000|Overall Study|Subject choice|3|||
125997118|NCT00195715|453282030|FG000|Overall Study|Loss of response/no improvement|3|||
125997119|NCT00195715|453282030|FG000|Overall Study|Sponsor stopped study|1|||
125997120|NCT00195715|453282030|FG000|Overall Study|Administrative reasons|2|||
125997121|NCT00195715|453282030|FG000|Overall Study|Investigator's decision|2|||
125997122|NCT00195715|453282030|FG000|Overall Study|Subject wants to get pregnant|4|||
125997123|NCT00195715|453282030|FG000|Overall Study|Use of prohibited medication|2|||
125997124|NCT00195715|453282030|FG000|Overall Study|Planned surgery|2|||
125997125|NCT00195715|453282030|FG000|Overall Study|Increased infection rate|1|||
125997126|NCT00195715|453282030|FG000|Overall Study|Ineligible|1|||
125997127|NCT00195715|453282030|FG000|Overall Study|Colonic stricture|1|||
125997128|NCT00195715|453282030|FG000|Overall Study|Sponsor discontinued trial|1|||
125997129|NCT00195715|453282030|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
125997130|NCT00845871|453282034|FG000|Assessment Period|Adverse Event|2|||
125997131|NCT00845871|453282034|FG000|Assessment Period|Abnormal laboratory values|1|||
125997132|NCT00845871|453282034|FG000|Assessment Period|Abnormal test procedure results|1|||
125997133|NCT00845871|453282034|FG000|Assessment Period|Patient withdrew consent|3|||
125997134|NCT00064025|453282043|FG000|Overall Study|Ineligible|4|||
125997135|NCT00064025|453282043|FG000|Overall Study|Inevaluable|3|||
125997136|NCT02468934|453282044|FG000|Overall Study|Withdrawal by Subject|4|||
125997137|NCT02468934|453282044|FG000|Overall Study|Screen Failure|3|||
125997138|NCT01370603|453282047|FG000|Period 1|Adverse Event|5|||
125997139|NCT01370603|453282048|FG001|Period 1|Adverse Event|3|||
125997140|NCT01370603|453282047|FG000|Period 1|Lost to Follow-up|2|||
125997141|NCT01370603|453282048|FG001|Period 1|Lost to Follow-up|0|||
125997142|NCT01370603|453282047|FG000|Period 1|Protocol Violation|2|||
125997143|NCT01370603|453282048|FG001|Period 1|Protocol Violation|2|||
125997144|NCT01370603|453282047|FG000|Period 1|Withdrawal by Subject|5|||
125997145|NCT01370603|453282048|FG001|Period 1|Withdrawal by Subject|5|||
125997146|NCT01370603|453282047|FG000|Crossover Washout|Adverse Event|2|||
125997147|NCT01370603|453282048|FG001|Crossover Washout|Adverse Event|1|||
126091086|NCT00623805|453626909|FG001|Overall Study|Lost to Follow-up|2|||
126331842|NCT02329327|454508986|FG000|Overall Study|Lost to Follow-up|4|||
126331843|NCT02329327|454508987|FG001|Overall Study|Lost to Follow-up|0|||
126331844|NCT03560869|454508988|FG000|Overall Study|Withdrawal by Subject|3|||
126331845|NCT03560869|454508989|FG001|Overall Study|Withdrawal by Subject|4|||
125997148|NCT01370603|453282047|FG000|Crossover Washout|Lost to Follow-up|2|||
125997149|NCT01370603|453282048|FG001|Crossover Washout|Lost to Follow-up|0|||
125997150|NCT01370603|453282047|FG000|Crossover Washout|Protocol Violation|1|||
125997151|NCT01370603|453282048|FG001|Crossover Washout|Protocol Violation|0|||
125997152|NCT01370603|453282047|FG000|Crossover Washout|Withdrawal by Subject|4|||
125997153|NCT01370603|453282048|FG001|Crossover Washout|Withdrawal by Subject|1|||
125997154|NCT01370603|453282047|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
125997155|NCT01370603|453282048|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
125997156|NCT01370603|453282047|FG000|Period 2|Adverse Event|1|||
125997157|NCT01370603|453282048|FG001|Period 2|Adverse Event|4|||
125997158|NCT01370603|453282047|FG000|Period 2|Lost to Follow-up|1|||
125997159|NCT01370603|453282048|FG001|Period 2|Lost to Follow-up|0|||
125997160|NCT01370603|453282047|FG000|Period 2|Withdrawal by Subject|1|||
125997161|NCT01370603|453282048|FG001|Period 2|Withdrawal by Subject|0|||
125997162|NCT02218489|453282055|FG000|Overall Study|Withdrawal by Subject|4|||
125997163|NCT02218489|453282056|FG001|Overall Study|Withdrawal by Subject|3|||
125997164|NCT02218489|453282055|FG000|Overall Study|Lost to Follow-up|1|||
125997165|NCT02218489|453282056|FG001|Overall Study|Lost to Follow-up|0|||
125997166|NCT02404493|453282057|FG000|Overall Study|Adverse Event|1|||
125997167|NCT02404493|453282058|FG001|Overall Study|Adverse Event|1|||
125997168|NCT04039503|453282059|FG000|Overall Study|Adverse Event|3|||
125997169|NCT04039503|453282060|FG001|Overall Study|Adverse Event|0|||
125997170|NCT04039503|453282061|FG002|Overall Study|Adverse Event|2|||
125997171|NCT04039503|453282062|FG003|Overall Study|Adverse Event|0|||
125997172|NCT04039503|453282059|FG000|Overall Study|Lost to Follow-up|0|||
125997173|NCT04039503|453282060|FG001|Overall Study|Lost to Follow-up|0|||
125997174|NCT04039503|453282061|FG002|Overall Study|Lost to Follow-up|1|||
125997175|NCT04039503|453282062|FG003|Overall Study|Lost to Follow-up|0|||
125997176|NCT04039503|453282059|FG000|Overall Study|Protocol Violation|0|||
125997177|NCT04039503|453282060|FG001|Overall Study|Protocol Violation|1|||
125997178|NCT04039503|453282061|FG002|Overall Study|Protocol Violation|2|||
125997179|NCT04039503|453282062|FG003|Overall Study|Protocol Violation|1|||
125997180|NCT04039503|453282059|FG000|Overall Study|Withdrawal by Subject|4|||
125997181|NCT04039503|453282060|FG001|Overall Study|Withdrawal by Subject|3|||
125997182|NCT04039503|453282061|FG002|Overall Study|Withdrawal by Subject|5|||
125997183|NCT04039503|453282062|FG003|Overall Study|Withdrawal by Subject|2|||
125997184|NCT01163747|453282064|FG000|Overall Study|Adverse Event|0|||
125997185|NCT01163747|453282065|FG001|Overall Study|Adverse Event|5|||
125997186|NCT01163747|453282064|FG000|Overall Study|Insufficient Therapeutic Response|0|||
125997187|NCT01163747|453282065|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125997188|NCT01163747|453282064|FG000|Overall Study|Protocol Violation|0|||
125997189|NCT01163747|453282065|FG001|Overall Study|Protocol Violation|1|||
125997190|NCT01163747|453282064|FG000|Overall Study|Refused Treatment|6|||
125997191|NCT01163747|453282065|FG001|Overall Study|Refused Treatment|4|||
125997192|NCT03681639|453283842|FG000|Overall Study|Death|4|||
125997193|NCT03681639|453283842|FG000|Overall Study|Lost to Follow-up|2|||
125997194|NCT03681639|453283842|FG000|Overall Study|Withdrawal by Subject|1|||
125997195|NCT03681639|453283842|FG000|Overall Study|Adverse Event|2|||
125997196|NCT00654940|453283843|FG000|Period 1|Adverse Event|0|||
125997197|NCT00654940|453283844|FG001|Period 1|Adverse Event|1|||
125997198|NCT00654940|453283843|FG000|Period 1|Intolerable Pain Level|1|||
125997199|NCT00654940|453283844|FG001|Period 1|Intolerable Pain Level|0|||
125997200|NCT04714216|453283845|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
125997201|NCT04714216|453283845|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
125997202|NCT00581113|453283846|FG000|Overall Study|Withdrawal by Subject|0|||
125997203|NCT00581113|453283847|FG001|Overall Study|Withdrawal by Subject|1|||
125997204|NCT03204695|453283849|FG000|Overall Study|Death|1|||
125997205|NCT03204695|453283849|FG000|Overall Study|Participant was treated with another device|1|||
125997206|NCT03204695|453283849|FG000|Overall Study|Physician Decision|2|||
125997207|NCT04834362|453283850|FG000|Overall Study|Death|1|||
125997208|NCT04834362|453283851|FG001|Overall Study|Death|2|||
125997209|NCT01349829|453283854|FG000|Overall Study|Lost to Follow-up|4|||
125997210|NCT01349829|453283855|FG001|Overall Study|Lost to Follow-up|8|||
125997211|NCT01349829|453283854|FG000|Overall Study|Consent withdrawal|3|||
125997212|NCT01349829|453283855|FG001|Overall Study|Consent withdrawal|8|||
125997213|NCT01349829|453283854|FG000|Overall Study|Migrated/moved|2|||
125997214|NCT01349829|453283855|FG001|Overall Study|Migrated/moved|7|||
125997215|NCT03095599|453283856|FG000|Overall Study|Withdrawal by Subject|1|||
126331846|NCT03560869|454508988|FG000|Overall Study|Screening failure|4|||
125997216|NCT03095599|453283857|FG001|Overall Study|Withdrawal by Subject|0|||
125997217|NCT03095599|453283856|FG000|Overall Study|Lost to Follow-up|1|||
125997218|NCT03095599|453283857|FG001|Overall Study|Lost to Follow-up|0|||
125997219|NCT03095599|453283856|FG000|Overall Study|Withdrawal prior to vaccination|1|||
125997220|NCT03095599|453283857|FG001|Overall Study|Withdrawal prior to vaccination|0|||
125997221|NCT00742885|453283859|FG000|Overall Study|Lost to Follow-up|1|||
125997222|NCT00742885|453283860|FG001|Overall Study|Lost to Follow-up|0|||
125997223|NCT04781647|453283861|FG000|Overall Study|Study terminated by Sponsor|11|||
125997224|NCT04781647|453283862|FG001|Overall Study|Study terminated by Sponsor|9|||
125997225|NCT04781647|453283863|FG002|Overall Study|Study terminated by Sponsor|9|||
125997226|NCT04781647|453283861|FG000|Overall Study|Withdrawal by Subject|1|||
125997227|NCT04781647|453283862|FG001|Overall Study|Withdrawal by Subject|2|||
125997228|NCT04781647|453283863|FG002|Overall Study|Withdrawal by Subject|0|||
125997229|NCT04781647|453283861|FG000|Overall Study|Adverse Event|0|||
125997230|NCT04781647|453283862|FG001|Overall Study|Adverse Event|1|||
125997231|NCT04781647|453283863|FG002|Overall Study|Adverse Event|1|||
125997232|NCT04781647|453283861|FG000|Overall Study|Protocol Violation|1|||
125997233|NCT04781647|453283862|FG001|Overall Study|Protocol Violation|0|||
125997234|NCT04781647|453283863|FG002|Overall Study|Protocol Violation|0|||
125997235|NCT04781647|453283861|FG000|Overall Study|Pregnancy|0|||
125997236|NCT04781647|453283862|FG001|Overall Study|Pregnancy|0|||
125997237|NCT04781647|453283863|FG002|Overall Study|Pregnancy|1|||
125997238|NCT04781647|453283861|FG000|Overall Study|Virology rebounded|1|||
125997239|NCT04781647|453283862|FG001|Overall Study|Virology rebounded|0|||
125997240|NCT04781647|453283863|FG002|Overall Study|Virology rebounded|0|||
125997241|NCT01755689|453283864|FG000|Overall Study|Withdrawal by Subject|1|||
125997242|NCT01755689|453283865|FG001|Overall Study|Withdrawal by Subject|3|||
125997243|NCT01755689|453283866|FG002|Overall Study|Withdrawal by Subject|2|||
125997244|NCT01755689|453283867|FG003|Overall Study|Withdrawal by Subject|1|||
125997245|NCT01755689|453283868|FG004|Overall Study|Withdrawal by Subject|1|||
125997246|NCT01755689|453283864|FG000|Overall Study|Migrated/moved from study area|0|||
125997247|NCT01755689|453283865|FG001|Overall Study|Migrated/moved from study area|1|||
125997248|NCT01755689|453283866|FG002|Overall Study|Migrated/moved from study area|1|||
125997249|NCT01755689|453283867|FG003|Overall Study|Migrated/moved from study area|1|||
125997250|NCT01755689|453283868|FG004|Overall Study|Migrated/moved from study area|1|||
125997251|NCT01755689|453283864|FG000|Overall Study|Lost to Follow-up|1|||
125997252|NCT01755689|453283865|FG001|Overall Study|Lost to Follow-up|0|||
125997253|NCT01755689|453283866|FG002|Overall Study|Lost to Follow-up|1|||
125997254|NCT01755689|453283867|FG003|Overall Study|Lost to Follow-up|0|||
125997255|NCT01755689|453283868|FG004|Overall Study|Lost to Follow-up|2|||
125997256|NCT01755689|453283864|FG000|Overall Study|Pregnancy|1|||
125997257|NCT01755689|453283865|FG001|Overall Study|Pregnancy|1|||
125997258|NCT01755689|453283866|FG002|Overall Study|Pregnancy|2|||
125997259|NCT01755689|453283867|FG003|Overall Study|Pregnancy|4|||
125997260|NCT01755689|453283868|FG004|Overall Study|Pregnancy|2|||
125997261|NCT01327547|453283869|FG000|Overall Study|Adverse Event|4|||
125997262|NCT01327547|453283870|FG001|Overall Study|Adverse Event|1|||
125997263|NCT01327547|453283869|FG000|Overall Study|Death|1|||
125997264|NCT01327547|453283870|FG001|Overall Study|Death|2|||
125997265|NCT01327547|453283869|FG000|Overall Study|Lost to Follow-up|6|||
125997266|NCT01327547|453283870|FG001|Overall Study|Lost to Follow-up|6|||
125997267|NCT01327547|453283869|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
125997268|NCT01327547|453283870|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
125997269|NCT01327547|453283869|FG000|Overall Study|Withdrawal by Subject|3|||
125997270|NCT01327547|453283870|FG001|Overall Study|Withdrawal by Subject|7|||
125997271|NCT01327547|453283869|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
125997272|NCT01327547|453283870|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
125997273|NCT01327547|453283869|FG000|Overall Study|Protocol Violation|1|||
125997274|NCT01327547|453283870|FG001|Overall Study|Protocol Violation|0|||
125997275|NCT01327547|453283869|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
125997276|NCT01327547|453283870|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
125997277|NCT01327547|453283869|FG000|Overall Study|Required prohibited medication|2|||
125997278|NCT01327547|453283870|FG001|Overall Study|Required prohibited medication|0|||
125997279|NCT01327547|453283869|FG000|Overall Study|Non-compliance with study procedures|1|||
125997280|NCT01327547|453283870|FG001|Overall Study|Non-compliance with study procedures|0|||
125997281|NCT01327547|453283869|FG000|Overall Study|By investigator in subject's interest|0|||
126331847|NCT03560869|454508989|FG001|Overall Study|Screening failure|4|||
126331848|NCT03560869|454508988|FG000|Overall Study|Withdrawal by PI|0|||
126331849|NCT03560869|454508989|FG001|Overall Study|Withdrawal by PI|1|||
126331850|NCT01801111|454508990|FG000|Overall Study|Adverse Event|12|||
125997282|NCT01327547|453283870|FG001|Overall Study|By investigator in subject's interest|1|||
125997283|NCT00329719|453283871|FG000|Overall Study|Lost to Follow-up|0|||
125997284|NCT00329719|453283872|FG001|Overall Study|Lost to Follow-up|0|||
125997285|NCT00329719|453283873|FG002|Overall Study|Lost to Follow-up|0|||
125997286|NCT00329719|453283874|FG003|Overall Study|Lost to Follow-up|1|||
125997287|NCT01995357|453283877|FG000|Period 5|Lack of Efficacy|1|||
126331851|NCT01801111|454508990|FG000|Overall Study|Death|8|||
126331852|NCT01801111|454508990|FG000|Overall Study|Physician Decision|5|||
125997288|NCT01995357|453283878|FG001|Period 5|Lack of Efficacy|0|||
125997289|NCT01995357|453283879|FG002|Period 5|Lack of Efficacy|0|||
125997290|NCT01995357|453283880|FG003|Period 5|Lack of Efficacy|0|||
125997291|NCT01995357|453283881|FG004|Period 5|Lack of Efficacy|0|||
125997292|NCT01995357|453283882|FG005|Period 5|Lack of Efficacy|0|||
125997293|NCT01995357|453283877|FG000|Period 5|Adverse Event|1|||
126331853|NCT01801111|454508990|FG000|Overall Study|Other|1|||
126331854|NCT01801111|454508990|FG000|Overall Study|Withdrawal by Subject|4|||
126331855|NCT01801111|454508990|FG000|Overall Study|Study Terminated by Sponsor|27|||
126331856|NCT01801111|454508990|FG000|Overall Study|Progressive Disease|81|||
126331857|NCT01210482|454508991|FG000|Overall Study|Protocol Violation|1|||
126331858|NCT01210482|454508991|FG000|Overall Study|Case Report Forms were not collected|18|||
126331859|NCT01210482|454508991|FG000|Overall Study|Duplicated|2|||
126331860|NCT01210482|454508991|FG000|Overall Study|No Drug Administration|28|||
126331861|NCT01223937|454508992|FG000|Overall Study|Withdrawal by Subject|3|||
126331862|NCT01223937|454508993|FG001|Overall Study|Withdrawal by Subject|2|||
126331863|NCT01223937|454508992|FG000|Overall Study|Lost to Follow-up|1|||
126331864|NCT01223937|454508993|FG001|Overall Study|Lost to Follow-up|4|||
126331865|NCT01223937|454508992|FG000|Overall Study|Adverse Event|1|||
126331866|NCT01223937|454508993|FG001|Overall Study|Adverse Event|4|||
126331867|NCT01223937|454508992|FG000|Overall Study|Protocol Violation|8|||
126331868|NCT01223937|454508993|FG001|Overall Study|Protocol Violation|7|||
126331869|NCT01223937|454508992|FG000|Overall Study|Other|4|||
126331870|NCT01223937|454508993|FG001|Overall Study|Other|1|||
126331871|NCT03284853|454508995|FG000|Overall Study|Adverse Event|40|||
126331872|NCT03284853|454508996|FG001|Overall Study|Adverse Event|4|||
126331873|NCT03284853|454508995|FG000|Overall Study|Withdrawal by Subject|5|||
126331874|NCT03284853|454508996|FG001|Overall Study|Withdrawal by Subject|1|||
126331875|NCT03284853|454508995|FG000|Overall Study|Lost to Follow-up|1|||
126331876|NCT03284853|454508996|FG001|Overall Study|Lost to Follow-up|0|||
126331877|NCT03284853|454508995|FG000|Overall Study|Lack of Efficacy|1|||
126331878|NCT03284853|454508996|FG001|Overall Study|Lack of Efficacy|0|||
126331879|NCT03284853|454508995|FG000|Overall Study|Disallowed Concurrent Medication|1|||
126331880|NCT03284853|454508996|FG001|Overall Study|Disallowed Concurrent Medication|1|||
126331881|NCT03284853|454508995|FG000|Overall Study|Protocol Violation|3|||
126331882|NCT03284853|454508996|FG001|Overall Study|Protocol Violation|3|||
126331883|NCT03284853|454508995|FG000|Overall Study|Death|0|||
126331884|NCT03284853|454508996|FG001|Overall Study|Death|1|||
126331885|NCT03284853|454508995|FG000|Overall Study|Other - Reason not reported in CSR|4|||
126331886|NCT03284853|454508996|FG001|Overall Study|Other - Reason not reported in CSR|3|||
126331887|NCT00255164|454508998|FG000|Overall Study|Adverse Event|10|||
126331888|NCT00255164|454508999|FG001|Overall Study|Adverse Event|6|||
126331889|NCT00255164|454509000|FG002|Overall Study|Adverse Event|9|||
126331890|NCT00255164|454508998|FG000|Overall Study|Lost to Follow-up|4|||
126331891|NCT00255164|454508999|FG001|Overall Study|Lost to Follow-up|3|||
126331892|NCT00255164|454509000|FG002|Overall Study|Lost to Follow-up|4|||
126331893|NCT00255164|454508998|FG000|Overall Study|Withdrawal by Subject|18|||
126331894|NCT00255164|454508999|FG001|Overall Study|Withdrawal by Subject|17|||
126331895|NCT00255164|454509000|FG002|Overall Study|Withdrawal by Subject|8|||
126331896|NCT00255164|454508998|FG000|Overall Study|Noncompliance|0|||
126331897|NCT00255164|454508999|FG001|Overall Study|Noncompliance|1|||
126331898|NCT00255164|454509000|FG002|Overall Study|Noncompliance|2|||
126331899|NCT00255164|454508998|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
126331900|NCT00255164|454508999|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
125997294|NCT01995357|453283878|FG001|Period 5|Adverse Event|0|||
125997295|NCT01995357|453283879|FG002|Period 5|Adverse Event|1|||
125997296|NCT01995357|453283880|FG003|Period 5|Adverse Event|0|||
125997297|NCT01995357|453283881|FG004|Period 5|Adverse Event|0|||
125997298|NCT01995357|453283882|FG005|Period 5|Adverse Event|0|||
125997299|NCT02462083|453283883|FG000|Overall Study|Sponsor request|39|||
125997300|NCT02462083|453283883|FG000|Overall Study|Withdrawal by Subject|87|||
125997301|NCT02462083|453283883|FG000|Overall Study|Lost to Follow-up|41|||
125997302|NCT02462083|453283883|FG000|Overall Study|Lack of Efficacy|151|||
125997303|NCT02462083|453283883|FG000|Overall Study|Pregnancy|1|||
125997304|NCT02462083|453283883|FG000|Overall Study|Protocol Violation|6|||
125997305|NCT02462083|453283883|FG000|Overall Study|Adverse Event|33|||
125997306|NCT02462083|453283883|FG000|Overall Study|Worsening condition|16|||
125997307|NCT02462083|453283883|FG000|Overall Study|Other than specified|45|||
125997308|NCT01642186|453283886|FG000|Overall Study|Death|0|||
125997309|NCT01642186|453283887|FG001|Overall Study|Death|2|||
125997310|NCT01642186|453283888|FG002|Overall Study|Death|2|||
126331901|NCT00255164|454509000|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
126331902|NCT00255164|454508998|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
126331903|NCT00255164|454508999|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
126331904|NCT00255164|454509000|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
126331905|NCT00255164|454508998|FG000|Overall Study|Possible Barrett's Esophagus|1|||
126331906|NCT00255164|454508999|FG001|Overall Study|Possible Barrett's Esophagus|3|||
126331907|NCT00255164|454509000|FG002|Overall Study|Possible Barrett's Esophagus|8|||
125997311|NCT01642186|453283886|FG000|Overall Study|Lost to Follow-up|0|||
126331908|NCT00255164|454508998|FG000|Overall Study|Esophageal Stricture|0|||
125997312|NCT01642186|453283887|FG001|Overall Study|Lost to Follow-up|0|||
125997313|NCT01642186|453283888|FG002|Overall Study|Lost to Follow-up|1|||
125997314|NCT00590980|453283889|FG000|Overall Study|Did not meet all inclusion criteria|10|||
126331909|NCT00255164|454508999|FG001|Overall Study|Esophageal Stricture|0|||
126331910|NCT00255164|454509000|FG002|Overall Study|Esophageal Stricture|1|||
125997315|NCT00506285|453283890|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
125997316|NCT00506285|453283891|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
125997317|NCT00506285|453283890|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
125997318|NCT00506285|453283891|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
125997319|NCT00506285|453283890|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
125997320|NCT00506285|453283891|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
125997321|NCT00506285|453283890|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
125997322|NCT00506285|453283891|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
125997323|NCT00506285|453283890|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
125997324|NCT00506285|453283891|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
125997325|NCT01238575|453283892|FG000|Overall Study|Lack of Efficacy|2|||
125997326|NCT01238575|453283893|FG001|Overall Study|Lack of Efficacy|4|||
125997327|NCT01238575|453283892|FG000|Overall Study|Adverse Event|2|||
125997328|NCT01238575|453283893|FG001|Overall Study|Adverse Event|0|||
125997329|NCT00262743|453283895|FG000|Overall Study|Adverse Event|0|||
125997330|NCT00262743|453283896|FG001|Overall Study|Adverse Event|9|||
125997331|NCT00262743|453283895|FG000|Overall Study|Disease progression|0|||
125997332|NCT00262743|453283896|FG001|Overall Study|Disease progression|3|||
125997333|NCT01591460|453283917|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
125997334|NCT01591460|453283917|FG000|Overall Study|Futility Rule (Week 12)|7|||
125997335|NCT01591460|453283917|FG000|Overall Study|Futility Rule (Week 24)|3|||
125997336|NCT01591460|453283917|FG000|Overall Study|Rebound or Breakthrough|3|||
125997337|NCT01591460|453283917|FG000|Overall Study|Treatment Discontinued by Error|1|||
125997338|NCT01591460|453283917|FG000|Overall Study|Lost to Follow-up|1|||
125997339|NCT01591460|453283917|FG000|Overall Study|Noncompliance|1|||
125997340|NCT01591460|453283917|FG000|Overall Study|Participant Refusal|3|||
125997341|NCT01591460|453283917|FG000|Overall Study|Withdrawal by Subject|1|||
125997342|NCT01591460|453283917|FG000|Overall Study|Protocol Violation|1|||
125997343|NCT03230864|453283918|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
125997344|NCT03230864|453283919|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
125997345|NCT03230864|453283920|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
125997346|NCT03230864|453283921|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
125997347|NCT03230864|453283918|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125997348|NCT03230864|453283919|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
125997349|NCT03230864|453283920|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126331911|NCT00255164|454508998|FG000|Overall Study|Therapeutic Failure|11|||
126331912|NCT00255164|454508999|FG001|Overall Study|Therapeutic Failure|2|||
126331913|NCT00255164|454509000|FG002|Overall Study|Therapeutic Failure|3|||
126331914|NCT00130689|454510825|FG000|Overall Study|Progressive Disease|29|||
126331915|NCT00130689|454510825|FG000|Overall Study|Death|1|||
126331916|NCT00130689|454510825|FG000|Overall Study|Clinical Deterioration|4|||
126331917|NCT00130689|454510825|FG000|Overall Study|Withdrawal by Subject|3|||
126331918|NCT00130689|454510825|FG000|Overall Study|Ineligible|6|||
126331919|NCT01254656|454510826|FG000|Overall Study|Discontinued due to termination of study|40|||
126331920|NCT01254656|454510827|FG001|Overall Study|Discontinued due to termination of study|39|||
126331921|NCT01254656|454510828|FG002|Overall Study|Discontinued due to termination of study|13|||
126331922|NCT01254656|454510826|FG000|Overall Study|Lack of Efficacy|3|||
126331923|NCT01254656|454510827|FG001|Overall Study|Lack of Efficacy|0|||
126331924|NCT01254656|454510828|FG002|Overall Study|Lack of Efficacy|0|||
126331925|NCT01254656|454510826|FG000|Overall Study|Lost to Follow-up|1|||
126331926|NCT01254656|454510827|FG001|Overall Study|Lost to Follow-up|0|||
126331927|NCT01254656|454510828|FG002|Overall Study|Lost to Follow-up|2|||
126331928|NCT01254656|454510826|FG000|Overall Study|Withdrawal by Subject|2|||
126331929|NCT01254656|454510827|FG001|Overall Study|Withdrawal by Subject|2|||
126331930|NCT01254656|454510828|FG002|Overall Study|Withdrawal by Subject|1|||
126331931|NCT01254656|454510826|FG000|Overall Study|Pregnancy|0|||
126331932|NCT01254656|454510827|FG001|Overall Study|Pregnancy|0|||
126331933|NCT01254656|454510828|FG002|Overall Study|Pregnancy|2|||
126331934|NCT01254656|454510826|FG000|Overall Study|Adverse Event|1|||
126331935|NCT01254656|454510827|FG001|Overall Study|Adverse Event|1|||
126331936|NCT01254656|454510828|FG002|Overall Study|Adverse Event|0|||
126331937|NCT01254656|454510826|FG000|Overall Study|Death|0|||
126331938|NCT01254656|454510827|FG001|Overall Study|Death|1|||
126331939|NCT01254656|454510828|FG002|Overall Study|Death|0|||
126331940|NCT03286218|454510838|FG000|Qualification Phase Period 1|Adverse Event|1|||
126331941|NCT03286218|454510839|FG001|Qualification Phase Period 1|Adverse Event|0|||
126331942|NCT03286218|454510840|FG002|Qualification Phase Period 1|Adverse Event|0|||
126331943|NCT03286218|454510841|FG003|Qualification Phase Period 1|Adverse Event|0|||
126331944|NCT03286218|454510842|FG004|Qualification Phase Period 1|Adverse Event|0|||
126331945|NCT03286218|454510843|FG005|Qualification Phase Period 1|Adverse Event|0|||
126331946|NCT03286218|454510844|FG006|Qualification Phase Period 1|Adverse Event|0|||
125997350|NCT03230864|453283921|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125997351|NCT03230864|453283918|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
125997352|NCT03230864|453283919|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
126331947|NCT03286218|454510845|FG007|Qualification Phase Period 1|Adverse Event|0|||
125997353|NCT03230864|453283920|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125997354|NCT03230864|453283921|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125997355|NCT03230864|453283918|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
125997356|NCT03230864|453283919|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
126331948|NCT03286218|454510846|FG008|Qualification Phase Period 1|Adverse Event|0|||
126331949|NCT03286218|454510847|FG009|Qualification Phase Period 1|Adverse Event|0|||
126331950|NCT03286218|454510848|FG010|Qualification Phase Period 1|Adverse Event|0|||
126331951|NCT03286218|454510849|FG011|Qualification Phase Period 1|Adverse Event|0|||
126331952|NCT03286218|454510838|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331953|NCT03286218|454510839|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
126331954|NCT03286218|454510840|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331955|NCT03286218|454510841|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331956|NCT03286218|454510842|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331957|NCT03286218|454510843|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331958|NCT03286218|454510844|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331959|NCT03286218|454510845|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331960|NCT03286218|454510846|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331961|NCT03286218|454510847|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331962|NCT03286218|454510848|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331963|NCT03286218|454510849|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331964|NCT03286218|454510838|FG000|Qualification Phase Period 2|Adverse Event|0|||
126331965|NCT03286218|454510839|FG001|Qualification Phase Period 2|Adverse Event|1|||
126331966|NCT03286218|454510840|FG002|Qualification Phase Period 2|Adverse Event|0|||
126331967|NCT03286218|454510841|FG003|Qualification Phase Period 2|Adverse Event|0|||
126331968|NCT03286218|454510842|FG004|Qualification Phase Period 2|Adverse Event|0|||
126331969|NCT03286218|454510843|FG005|Qualification Phase Period 2|Adverse Event|0|||
126331970|NCT03286218|454510844|FG006|Qualification Phase Period 2|Adverse Event|0|||
126331971|NCT03286218|454510845|FG007|Qualification Phase Period 2|Adverse Event|0|||
126331972|NCT03286218|454510846|FG008|Qualification Phase Period 2|Adverse Event|0|||
126331973|NCT03286218|454510847|FG009|Qualification Phase Period 2|Adverse Event|0|||
125997357|NCT03230864|453283920|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125997358|NCT03230864|453283921|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125997359|NCT03230864|453283918|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
125997360|NCT03230864|453283919|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
125997361|NCT03230864|453283920|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
125997362|NCT03230864|453283921|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
125997363|NCT03230864|453283918|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
125997364|NCT03230864|453283919|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
125997365|NCT03230864|453283920|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
125997366|NCT03230864|453283921|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
125997367|NCT03230864|453283918|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
125997368|NCT03230864|453283919|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
125997369|NCT03230864|453283920|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
125997370|NCT03230864|453283921|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
125997371|NCT03230864|453283918|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
125997372|NCT03230864|453283919|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
125997373|NCT03230864|453283920|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
125997374|NCT03230864|453283921|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
125997375|NCT03230864|453283918|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125997376|NCT03230864|453283919|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125997377|NCT03230864|453283920|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
125997378|NCT03230864|453283921|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
125997379|NCT03230864|453283918|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
125997380|NCT03230864|453283919|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
125997381|NCT03230864|453283920|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
125997382|NCT03230864|453283921|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
125997383|NCT01744496|453283928|FG000|Titration Period|Adverse Event|2|||
125997384|NCT01744496|453283929|FG001|Titration Period|Adverse Event|1|||
125997385|NCT01744496|453283928|FG000|Titration Period|Personal reasons|0|||
125997386|NCT01744496|453283929|FG001|Titration Period|Personal reasons|1|||
125997387|NCT01744496|453283928|FG000|Maintenance Period|Adverse Event|1|||
125997388|NCT01744496|453283929|FG001|Maintenance Period|Adverse Event|3|||
126331974|NCT03286218|454510848|FG010|Qualification Phase Period 2|Adverse Event|0|||
126331975|NCT03286218|454510849|FG011|Qualification Phase Period 2|Adverse Event|0|||
126331976|NCT03286218|454510838|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
126331977|NCT03286218|454510839|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
125997389|NCT01744496|453283928|FG000|Maintenance Period|Protocol Violation|1|||
125997390|NCT01744496|453283929|FG001|Maintenance Period|Protocol Violation|0|||
125997391|NCT01744496|453283928|FG000|Maintenance Period|Withdrawal by Subject|1|||
125997392|NCT01744496|453283929|FG001|Maintenance Period|Withdrawal by Subject|1|||
125997393|NCT01744496|453283928|FG000|Maintenance Period|Subject left town|1|||
125997394|NCT01744496|453283929|FG001|Maintenance Period|Subject left town|0|||
125997395|NCT01567163|453283930|FG000|Overall Study|Progressive Disease|2|||
125997396|NCT01567163|453283930|FG000|Overall Study|Lost to Follow-up|2|||
125997397|NCT04716881|453283938|FG000|Overall Study|Adverse Event|1|||
125997398|NCT04716881|453283938|FG000|Overall Study|Lost to Follow-up|1|||
125997399|NCT01558674|453283939|FG000|Part 1|Study Terminated by Sponsor|10|||
126331978|NCT03286218|454510840|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331979|NCT03286218|454510841|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331980|NCT03286218|454510842|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331981|NCT03286218|454510843|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331982|NCT03286218|454510844|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331983|NCT03286218|454510845|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331984|NCT03286218|454510846|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331985|NCT03286218|454510847|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331986|NCT03286218|454510848|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331987|NCT03286218|454510849|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331988|NCT03286218|454510838|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
126331989|NCT03286218|454510839|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
126331990|NCT03286218|454510840|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
126331991|NCT03286218|454510841|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
126331992|NCT03286218|454510842|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
126331993|NCT03286218|454510843|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
126331994|NCT03286218|454510844|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
126331995|NCT03286218|454510845|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
126331996|NCT03286218|454510846|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
125997400|NCT01558674|453283940|FG001|Part 1|Study Terminated by Sponsor|0|||
125997401|NCT01558674|453283939|FG000|Part 1|Withdrawal by Subject|1|||
125997402|NCT01558674|453283940|FG001|Part 1|Withdrawal by Subject|0|||
125997403|NCT04147260|453283941|FG000|Overall Study|Adverse Event|1|||
125997404|NCT04147260|453283942|FG001|Overall Study|Adverse Event|0|||
125997405|NCT04147260|453283943|FG002|Overall Study|Adverse Event|1|||
125997406|NCT04147260|453283944|FG003|Overall Study|Adverse Event|2|||
125997407|NCT04147260|453283945|FG004|Overall Study|Adverse Event|0|||
125997408|NCT04147260|453283941|FG000|Overall Study|Withdrawal by Subject|0|||
125997409|NCT04147260|453283942|FG001|Overall Study|Withdrawal by Subject|0|||
125997410|NCT04147260|453283943|FG002|Overall Study|Withdrawal by Subject|1|||
125997411|NCT04147260|453283944|FG003|Overall Study|Withdrawal by Subject|1|||
125997412|NCT04147260|453283945|FG004|Overall Study|Withdrawal by Subject|0|||
125997413|NCT01555021|453283946|FG000|Overall Study|Lost to Follow-up|1|||
125997414|NCT01555021|453283947|FG001|Overall Study|Lost to Follow-up|2|||
125997415|NCT00750893|453283952|FG000|Overall Study|Adverse Event|5|||
125997416|NCT00750893|453283952|FG000|Overall Study|Withdrawal by Subject|10|||
125997417|NCT00750893|453283952|FG000|Overall Study|Lost to Follow-up|510|||
125997418|NCT00750893|453283952|FG000|Overall Study|Other|17|||
125997419|NCT01734850|453283953|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
125997420|NCT01734850|453283954|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
125997421|NCT01734850|453283955|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
125997422|NCT01734850|453283953|FG000|Overall Study|Not infused due to manufacturing failure|0|||
125997423|NCT01734850|453283954|FG001|Overall Study|Not infused due to manufacturing failure|0|||
125997424|NCT01734850|453283955|FG002|Overall Study|Not infused due to manufacturing failure|1|||
125997425|NCT02204293|453283959|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
125997426|NCT02204293|453283960|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
125997427|NCT02204293|453283961|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
125997428|NCT02204293|453283962|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
126331997|NCT03286218|454510847|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
126331998|NCT03286218|454510848|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
126331999|NCT03286218|454510849|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
126332000|NCT03286218|454510838|FG000|Qualification Phase Period 2|Protocol Violation|2|||
126332001|NCT03286218|454510839|FG001|Qualification Phase Period 2|Protocol Violation|0|||
125997429|NCT02204293|453283963|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
125997430|NCT02204293|453283964|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
125997431|NCT02204293|453283959|FG000|Core Study Part I|Adverse Event|1|||
125997432|NCT02204293|453283960|FG001|Core Study Part I|Adverse Event|0|||
125997433|NCT02204293|453283961|FG002|Core Study Part I|Adverse Event|0|||
125997434|NCT02204293|453283962|FG003|Core Study Part I|Adverse Event|0|||
125997435|NCT02204293|453283963|FG004|Core Study Part I|Adverse Event|0|||
126332002|NCT03286218|454510840|FG002|Qualification Phase Period 2|Protocol Violation|0|||
126332003|NCT03286218|454510841|FG003|Qualification Phase Period 2|Protocol Violation|0|||
126332004|NCT03286218|454510842|FG004|Qualification Phase Period 2|Protocol Violation|0|||
126332005|NCT03286218|454510843|FG005|Qualification Phase Period 2|Protocol Violation|0|||
126332006|NCT03286218|454510844|FG006|Qualification Phase Period 2|Protocol Violation|0|||
126332007|NCT03286218|454510845|FG007|Qualification Phase Period 2|Protocol Violation|0|||
125997436|NCT02204293|453283964|FG005|Core Study Part I|Adverse Event|0|||
125997437|NCT02204293|453283959|FG000|Core Study Part I|Physician Decision|0|||
126332008|NCT03286218|454510846|FG008|Qualification Phase Period 2|Protocol Violation|0|||
126332009|NCT03286218|454510847|FG009|Qualification Phase Period 2|Protocol Violation|0|||
126332010|NCT03286218|454510848|FG010|Qualification Phase Period 2|Protocol Violation|0|||
126332011|NCT03286218|454510849|FG011|Qualification Phase Period 2|Protocol Violation|0|||
126332012|NCT03286218|454510838|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
125997438|NCT02204293|453283960|FG001|Core Study Part I|Physician Decision|3|||
125997439|NCT02204293|453283961|FG002|Core Study Part I|Physician Decision|0|||
125997440|NCT02204293|453283962|FG003|Core Study Part I|Physician Decision|0|||
125997441|NCT02204293|453283963|FG004|Core Study Part I|Physician Decision|0|||
125997442|NCT02204293|453283964|FG005|Core Study Part I|Physician Decision|0|||
125997443|NCT02204293|453283959|FG000|LTE Phase|Study Suspended|0|||
125997444|NCT02204293|453283960|FG001|LTE Phase|Study Suspended|0|||
125997445|NCT02204293|453283961|FG002|LTE Phase|Study Suspended|0|||
125997446|NCT02204293|453283962|FG003|LTE Phase|Study Suspended|0|||
125997447|NCT02204293|453283963|FG004|LTE Phase|Study Suspended|0|||
125997448|NCT02204293|453283964|FG005|LTE Phase|Study Suspended|7|||
125997449|NCT02420327|453283965|FG000|Overall Study|Adverse Event|7|||
125997450|NCT02420327|453283965|FG000|Overall Study|Pregnancy|1|||
125997451|NCT02420327|453283965|FG000|Overall Study|Withdrawal by Subject|6|||
125997452|NCT02420327|453283965|FG000|Overall Study|Lost to Follow-up|1|||
125997453|NCT02420327|453283965|FG000|Overall Study|Protocol Violation|1|||
125997454|NCT02019602|453283967|FG000|Screening Period|Ineligibility|4|||
125997455|NCT02019602|453283968|FG001|Screening Period|Ineligibility|0|||
125997456|NCT02019602|453283967|FG000|Screening Period|Adverse Event|1|||
125997457|NCT02019602|453283968|FG001|Screening Period|Adverse Event|0|||
125997458|NCT00322374|453283969|FG000|Starting Dose|Physician Decision|2|||
125997459|NCT00322374|453283970|FG001|Starting Dose|Physician Decision|0|||
125997460|NCT00322374|453283971|FG002|Starting Dose|Physician Decision|0|||
125997461|NCT00322374|453283972|FG003|Starting Dose|Physician Decision|0|||
125997462|NCT00322374|453283969|FG000|Starting Dose|Study Drug Toxicity|4|||
125997463|NCT00322374|453283970|FG001|Starting Dose|Study Drug Toxicity|0|||
125997464|NCT00322374|453283971|FG002|Starting Dose|Study Drug Toxicity|0|||
125997465|NCT00322374|453283972|FG003|Starting Dose|Study Drug Toxicity|0|||
125997466|NCT00322374|453283969|FG000|First Escalation|Documented Disease Progression|0|||
125997467|NCT00322374|453283970|FG001|First Escalation|Documented Disease Progression|6|||
125997468|NCT00322374|453283971|FG002|First Escalation|Documented Disease Progression|0|||
125997469|NCT00322374|453283972|FG003|First Escalation|Documented Disease Progression|0|||
125997470|NCT00322374|453283969|FG000|First Escalation|Physician Decision|0|||
125997471|NCT00322374|453283970|FG001|First Escalation|Physician Decision|12|||
125997472|NCT00322374|453283971|FG002|First Escalation|Physician Decision|0|||
125997473|NCT00322374|453283972|FG003|First Escalation|Physician Decision|0|||
125997474|NCT00322374|453283969|FG000|First Escalation|Study Drug Toxicity|0|||
126332013|NCT03286218|454510839|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
126332014|NCT03286218|454510840|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332015|NCT03286218|454510841|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332016|NCT03286218|454510842|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332017|NCT03286218|454510843|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332018|NCT03286218|454510844|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332019|NCT03286218|454510845|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332020|NCT03286218|454510846|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332021|NCT03286218|454510847|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332022|NCT03286218|454510848|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332023|NCT03286218|454510849|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332024|NCT03286218|454510838|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332025|NCT03286218|454510839|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
125997475|NCT00322374|453283970|FG001|First Escalation|Study Drug Toxicity|11|||
125997476|NCT00322374|453283971|FG002|First Escalation|Study Drug Toxicity|0|||
125997477|NCT00322374|453283972|FG003|First Escalation|Study Drug Toxicity|0|||
125997478|NCT00322374|453283969|FG000|First Escalation|Participant Request|0|||
125997479|NCT00322374|453283970|FG001|First Escalation|Participant Request|1|||
125997480|NCT00322374|453283971|FG002|First Escalation|Participant Request|0|||
125997481|NCT00322374|453283972|FG003|First Escalation|Participant Request|0|||
125997482|NCT00322374|453283969|FG000|Second Escalation|Physician Decision|0|||
125997483|NCT00322374|453283970|FG001|Second Escalation|Physician Decision|0|||
125997484|NCT00322374|453283971|FG002|Second Escalation|Physician Decision|5|||
125997485|NCT00322374|453283972|FG003|Second Escalation|Physician Decision|0|||
125997486|NCT00322374|453283969|FG000|Second Escalation|Study Drug Toxicity|0|||
125997487|NCT00322374|453283970|FG001|Second Escalation|Study Drug Toxicity|0|||
125997488|NCT00322374|453283971|FG002|Second Escalation|Study Drug Toxicity|1|||
125997489|NCT00322374|453283972|FG003|Second Escalation|Study Drug Toxicity|0|||
125997490|NCT02584855|453283977|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
125997491|NCT02584855|453283978|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125997492|NCT02584855|453283979|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125997493|NCT02584855|453283980|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
125997494|NCT02584855|453283981|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
125997495|NCT02584855|453283982|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
125997496|NCT02584855|453283977|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
125997497|NCT02584855|453283978|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
125997498|NCT02584855|453283979|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
125997499|NCT02584855|453283980|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
125997500|NCT02584855|453283981|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
125997501|NCT02584855|453283982|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
125997502|NCT02584855|453283977|FG000|Open-Label Treatment Period|Adverse Event|14|||
125997503|NCT02584855|453283978|FG001|Open-Label Treatment Period|Adverse Event|0|||
125997504|NCT02584855|453283979|FG002|Open-Label Treatment Period|Adverse Event|0|||
125997505|NCT02584855|453283980|FG003|Open-Label Treatment Period|Adverse Event|0|||
125997506|NCT02584855|453283981|FG004|Open-Label Treatment Period|Adverse Event|0|||
125997507|NCT02584855|453283982|FG005|Open-Label Treatment Period|Adverse Event|0|||
125997508|NCT02584855|453283977|FG000|Open-Label Treatment Period|Death|2|||
125997509|NCT02584855|453283978|FG001|Open-Label Treatment Period|Death|0|||
125997510|NCT02584855|453283979|FG002|Open-Label Treatment Period|Death|0|||
125997511|NCT02584855|453283980|FG003|Open-Label Treatment Period|Death|0|||
125997512|NCT02584855|453283981|FG004|Open-Label Treatment Period|Death|0|||
125997513|NCT02584855|453283982|FG005|Open-Label Treatment Period|Death|0|||
125997514|NCT02584855|453283977|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
125997515|NCT02584855|453283978|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
125997516|NCT02584855|453283979|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
125997517|NCT02584855|453283980|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
125997518|NCT02584855|453283981|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
125997519|NCT02584855|453283982|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
125997520|NCT02584855|453283977|FG000|Open-Label Treatment Period|Protocol Violation|1|||
125997521|NCT02584855|453283978|FG001|Open-Label Treatment Period|Protocol Violation|0|||
125997522|NCT02584855|453283979|FG002|Open-Label Treatment Period|Protocol Violation|0|||
125997523|NCT02584855|453283980|FG003|Open-Label Treatment Period|Protocol Violation|0|||
125997524|NCT02584855|453283981|FG004|Open-Label Treatment Period|Protocol Violation|0|||
125997525|NCT02584855|453283982|FG005|Open-Label Treatment Period|Protocol Violation|0|||
125997526|NCT02584855|453283977|FG000|Open-Label Treatment Period|No PI Available|2|||
125997527|NCT02584855|453283978|FG001|Open-Label Treatment Period|No PI Available|0|||
125997528|NCT02584855|453283979|FG002|Open-Label Treatment Period|No PI Available|0|||
125997529|NCT02584855|453283980|FG003|Open-Label Treatment Period|No PI Available|0|||
125997530|NCT02584855|453283981|FG004|Open-Label Treatment Period|No PI Available|0|||
125997531|NCT02584855|453283982|FG005|Open-Label Treatment Period|No PI Available|0|||
125997532|NCT02584855|453283977|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
125997533|NCT02584855|453283978|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
125997534|NCT02584855|453283979|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
125997535|NCT02584855|453283980|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
125997536|NCT02584855|453283981|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
125997537|NCT02584855|453283982|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
125997538|NCT02584855|453283977|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125997539|NCT02584855|453283978|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125997540|NCT02584855|453283979|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
125997541|NCT02584855|453283980|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125997542|NCT02584855|453283981|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125997543|NCT02584855|453283982|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125997544|NCT02584855|453283977|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
125997545|NCT02584855|453283978|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
125997546|NCT02584855|453283979|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
125997547|NCT02584855|453283980|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
125997548|NCT02584855|453283981|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
125997549|NCT02584855|453283982|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
125997550|NCT02584855|453283977|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125997551|NCT02584855|453283978|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
125997552|NCT02584855|453283979|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125997553|NCT02584855|453283980|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125997554|NCT02584855|453283981|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125997555|NCT02584855|453283982|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125997556|NCT02584855|453283977|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
126332026|NCT03286218|454510840|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
126332027|NCT03286218|454510841|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
126332028|NCT03286218|454510842|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332029|NCT03286218|454510843|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
126332030|NCT03286218|454510844|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
125997557|NCT02584855|453283978|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
125997558|NCT02584855|453283979|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125997559|NCT02584855|453283980|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125997560|NCT02584855|453283981|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125997561|NCT02584855|453283982|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125997562|NCT02584855|453283977|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125997563|NCT02584855|453283978|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125997564|NCT02584855|453283979|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125997565|NCT02584855|453283980|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125997566|NCT02584855|453283981|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
125997567|NCT02584855|453283982|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125997568|NCT02584855|453283977|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
125997569|NCT02584855|453283978|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
125997570|NCT02584855|453283979|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
125997571|NCT02584855|453283980|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
125997572|NCT02584855|453283981|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
125997573|NCT02584855|453283982|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
125997574|NCT02138747|453283983|FG000|Treatment Period 1|Adverse Event|10|||
125997575|NCT02138747|453283984|FG001|Treatment Period 1|Adverse Event|14|||
125997576|NCT02138747|453283985|FG002|Treatment Period 1|Adverse Event|2|||
125997577|NCT02138747|453283986|FG003|Treatment Period 1|Adverse Event|1|||
125997578|NCT02138747|453283983|FG000|Treatment Period 1|Lost to Follow-up|0|||
125997579|NCT02138747|453283984|FG001|Treatment Period 1|Lost to Follow-up|1|||
125997580|NCT02138747|453283985|FG002|Treatment Period 1|Lost to Follow-up|1|||
125997581|NCT02138747|453283986|FG003|Treatment Period 1|Lost to Follow-up|0|||
125997582|NCT02138747|453283983|FG000|Treatment Period 1|Protocol Violation|0|||
125997583|NCT02138747|453283984|FG001|Treatment Period 1|Protocol Violation|2|||
125997584|NCT02138747|453283985|FG002|Treatment Period 1|Protocol Violation|0|||
125997585|NCT02138747|453283986|FG003|Treatment Period 1|Protocol Violation|0|||
125997586|NCT02138747|453283983|FG000|Treatment Period 1|Withdrawal by Subject|8|||
125997587|NCT02138747|453283984|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125997588|NCT02138747|453283985|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125997589|NCT02138747|453283986|FG003|Treatment Period 1|Withdrawal by Subject|3|||
125997590|NCT02138747|453283983|FG000|Treatment Period 1|Other - Miscellaneous|2|||
125997591|NCT02138747|453283984|FG001|Treatment Period 1|Other - Miscellaneous|4|||
125997592|NCT02138747|453283985|FG002|Treatment Period 1|Other - Miscellaneous|0|||
125997593|NCT02138747|453283986|FG003|Treatment Period 1|Other - Miscellaneous|0|||
125997594|NCT02138747|453283983|FG000|Treatment Period 2|Adverse Event|6|||
125997595|NCT02138747|453283984|FG001|Treatment Period 2|Adverse Event|3|||
125997596|NCT02138747|453283985|FG002|Treatment Period 2|Adverse Event|1|||
125997597|NCT02138747|453283986|FG003|Treatment Period 2|Adverse Event|1|||
125997598|NCT02138747|453283983|FG000|Treatment Period 2|Lost to Follow-up|2|||
125997599|NCT02138747|453283984|FG001|Treatment Period 2|Lost to Follow-up|0|||
125997600|NCT02138747|453283985|FG002|Treatment Period 2|Lost to Follow-up|0|||
125997601|NCT02138747|453283986|FG003|Treatment Period 2|Lost to Follow-up|0|||
125997602|NCT02138747|453283983|FG000|Treatment Period 2|Protocol Violation|1|||
125997603|NCT02138747|453283984|FG001|Treatment Period 2|Protocol Violation|0|||
125997604|NCT02138747|453283985|FG002|Treatment Period 2|Protocol Violation|0|||
125997605|NCT02138747|453283986|FG003|Treatment Period 2|Protocol Violation|0|||
125997606|NCT02138747|453283983|FG000|Treatment Period 2|Withdrawal by Subject|5|||
125997607|NCT02138747|453283984|FG001|Treatment Period 2|Withdrawal by Subject|4|||
125997608|NCT02138747|453283985|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125997609|NCT02138747|453283986|FG003|Treatment Period 2|Withdrawal by Subject|2|||
125997610|NCT02138747|453283983|FG000|Treatment Period 2|Other - Miscellaneous|3|||
125997611|NCT02138747|453283984|FG001|Treatment Period 2|Other - Miscellaneous|0|||
125997612|NCT02138747|453283985|FG002|Treatment Period 2|Other - Miscellaneous|0|||
125997613|NCT02138747|453283986|FG003|Treatment Period 2|Other - Miscellaneous|0|||
125997614|NCT00776100|453283992|FG000|Overall Study|Disease Progression|1|||
125997615|NCT00776100|453283993|FG001|Overall Study|Disease Progression|0|||
125997616|NCT03567993|453283996|FG000|Overall Study|Lost to Follow-up|4|||
125997617|NCT03567993|453283997|FG001|Overall Study|Lost to Follow-up|2|||
125997618|NCT03567993|453283996|FG000|Overall Study|Death|1|||
125997619|NCT03567993|453283997|FG001|Overall Study|Death|1|||
125997620|NCT03567993|453283996|FG000|Overall Study|Withdrawal by Subject|1|||
125997621|NCT03567993|453283997|FG001|Overall Study|Withdrawal by Subject|0|||
125997622|NCT00641186|453284000|FG000|Overall Study|Adverse Event|3|||
125997623|NCT05221749|453284001|FG000|Overall Study|Lost to Follow-up|2|||
125997624|NCT05221749|453284002|FG001|Overall Study|Lost to Follow-up|3|||
125997625|NCT02388074|453284003|FG000|Overall Study|Lost in Transit|2|||
125997626|NCT02388074|453284003|FG000|Overall Study|Sample Not Returned|1|||
125997627|NCT00003458|453284006|FG000|Overall Study|Not evaluable|4|||
125997628|NCT02133924|453284007|FG000|Overall Study|Death|38|||
125997629|NCT02133924|453284007|FG000|Overall Study|Physician Decision|1|||
125997630|NCT02133924|453284007|FG000|Overall Study|Withdrawal by Subject|3|||
125997631|NCT01254890|453284008|FG000|Overall Study|Ineligible|0|||
125997632|NCT01254890|453284009|FG001|Overall Study|Ineligible|3|||
125997633|NCT01254890|453284008|FG000|Overall Study|Withdrawal by Subject|1|||
125997634|NCT01254890|453284009|FG001|Overall Study|Withdrawal by Subject|2|||
125997635|NCT01254890|453284008|FG000|Overall Study|Disease Progression|0|||
125997636|NCT01254890|453284009|FG001|Overall Study|Disease Progression|5|||
125997637|NCT04157686|453284014|FG000|Overall Study|Adverse Event|1|||
125997638|NCT04157686|453284015|FG001|Overall Study|Adverse Event|0|||
125997639|NCT04157686|453284016|FG002|Overall Study|Adverse Event|1|||
125997640|NCT04157686|453284017|FG003|Overall Study|Adverse Event|0|||
125997641|NCT04157686|453284018|FG004|Overall Study|Adverse Event|1|||
125997642|NCT04157686|453284019|FG005|Overall Study|Adverse Event|0|||
125997643|NCT04157686|453284020|FG006|Overall Study|Adverse Event|0|||
125997644|NCT04157686|453284021|FG007|Overall Study|Adverse Event|0|||
125997645|NCT04157686|453284014|FG000|Overall Study|Pregnancy|0|||
125997646|NCT04157686|453284015|FG001|Overall Study|Pregnancy|1|||
125997647|NCT04157686|453284016|FG002|Overall Study|Pregnancy|3|||
125997648|NCT04157686|453284017|FG003|Overall Study|Pregnancy|0|||
125997649|NCT04157686|453284018|FG004|Overall Study|Pregnancy|0|||
125997650|NCT04157686|453284019|FG005|Overall Study|Pregnancy|0|||
125997651|NCT04157686|453284020|FG006|Overall Study|Pregnancy|3|||
125997652|NCT04157686|453284021|FG007|Overall Study|Pregnancy|0|||
125997653|NCT04157686|453284014|FG000|Overall Study|Lost to Follow-up|1|||
125997654|NCT04157686|453284015|FG001|Overall Study|Lost to Follow-up|2|||
125997655|NCT04157686|453284016|FG002|Overall Study|Lost to Follow-up|8|||
125997656|NCT04157686|453284017|FG003|Overall Study|Lost to Follow-up|6|||
125997657|NCT04157686|453284018|FG004|Overall Study|Lost to Follow-up|6|||
125997658|NCT04157686|453284019|FG005|Overall Study|Lost to Follow-up|3|||
125997659|NCT04157686|453284020|FG006|Overall Study|Lost to Follow-up|7|||
125997660|NCT04157686|453284021|FG007|Overall Study|Lost to Follow-up|9|||
125997661|NCT04157686|453284014|FG000|Overall Study|Lack of Efficacy|0|||
125997662|NCT04157686|453284015|FG001|Overall Study|Lack of Efficacy|0|||
125997663|NCT04157686|453284016|FG002|Overall Study|Lack of Efficacy|0|||
125997664|NCT04157686|453284017|FG003|Overall Study|Lack of Efficacy|0|||
125997665|NCT04157686|453284018|FG004|Overall Study|Lack of Efficacy|0|||
125997666|NCT04157686|453284019|FG005|Overall Study|Lack of Efficacy|2|||
125997667|NCT04157686|453284020|FG006|Overall Study|Lack of Efficacy|0|||
125997668|NCT04157686|453284021|FG007|Overall Study|Lack of Efficacy|1|||
125997669|NCT04157686|453284014|FG000|Overall Study|Withdrawal by Subject|10|||
125997670|NCT04157686|453284015|FG001|Overall Study|Withdrawal by Subject|10|||
125997671|NCT04157686|453284016|FG002|Overall Study|Withdrawal by Subject|12|||
125997672|NCT04157686|453284017|FG003|Overall Study|Withdrawal by Subject|20|||
125997673|NCT04157686|453284018|FG004|Overall Study|Withdrawal by Subject|12|||
125997674|NCT04157686|453284019|FG005|Overall Study|Withdrawal by Subject|11|||
125997675|NCT04157686|453284020|FG006|Overall Study|Withdrawal by Subject|18|||
125997676|NCT04157686|453284021|FG007|Overall Study|Withdrawal by Subject|24|||
125997677|NCT04157686|453284014|FG000|Overall Study|Physician Decision|0|||
125997678|NCT04157686|453284015|FG001|Overall Study|Physician Decision|0|||
125997679|NCT04157686|453284016|FG002|Overall Study|Physician Decision|1|||
125997680|NCT04157686|453284017|FG003|Overall Study|Physician Decision|0|||
125997681|NCT04157686|453284018|FG004|Overall Study|Physician Decision|1|||
125997682|NCT04157686|453284019|FG005|Overall Study|Physician Decision|0|||
125997683|NCT04157686|453284020|FG006|Overall Study|Physician Decision|3|||
125997684|NCT04157686|453284021|FG007|Overall Study|Physician Decision|0|||
125997685|NCT04157686|453284014|FG000|Overall Study|Death|0|||
125997686|NCT04157686|453284015|FG001|Overall Study|Death|0|||
125997687|NCT04157686|453284016|FG002|Overall Study|Death|0|||
125997688|NCT04157686|453284017|FG003|Overall Study|Death|2|||
125997689|NCT04157686|453284018|FG004|Overall Study|Death|0|||
125997690|NCT04157686|453284019|FG005|Overall Study|Death|0|||
125997691|NCT04157686|453284020|FG006|Overall Study|Death|0|||
125997692|NCT04157686|453284021|FG007|Overall Study|Death|0|||
125997693|NCT04157686|453284014|FG000|Overall Study|Protocol Violation|0|||
125997694|NCT04157686|453284015|FG001|Overall Study|Protocol Violation|0|||
125997695|NCT04157686|453284016|FG002|Overall Study|Protocol Violation|0|||
125997696|NCT04157686|453284017|FG003|Overall Study|Protocol Violation|0|||
125997697|NCT04157686|453284018|FG004|Overall Study|Protocol Violation|1|||
125997698|NCT04157686|453284019|FG005|Overall Study|Protocol Violation|0|||
125997699|NCT04157686|453284020|FG006|Overall Study|Protocol Violation|0|||
125997700|NCT04157686|453284021|FG007|Overall Study|Protocol Violation|0|||
125997701|NCT04157686|453284014|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
125997702|NCT04157686|453284015|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
125997703|NCT04157686|453284016|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
125997704|NCT04157686|453284017|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
125997705|NCT04157686|453284018|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
126332031|NCT03286218|454510845|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332032|NCT03286218|454510846|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332033|NCT03286218|454510847|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332034|NCT03286218|454510848|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332035|NCT03286218|454510849|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
126332036|NCT03286218|454510838|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332037|NCT03286218|454510839|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332038|NCT03286218|454510840|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332039|NCT03286218|454510841|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332040|NCT03286218|454510842|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332041|NCT03286218|454510843|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
125997706|NCT04157686|453284019|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
125997707|NCT04157686|453284020|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
125997708|NCT04157686|453284021|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
125997709|NCT01216293|453284022|FG000|Main Study|Adverse Event|1|||
125997710|NCT01216293|453284023|FG001|Main Study|Adverse Event|4|||
125997711|NCT01216293|453284024|FG002|Main Study|Adverse Event|2|||
125997712|NCT01216293|453284022|FG000|Main Study|Major Protocol Deviation|1|||
125997713|NCT01216293|453284023|FG001|Main Study|Major Protocol Deviation|0|||
125997714|NCT01216293|453284024|FG002|Main Study|Major Protocol Deviation|1|||
125997715|NCT01216293|453284022|FG000|Main Study|Lost to Follow-up|3|||
125997716|NCT01216293|453284023|FG001|Main Study|Lost to Follow-up|1|||
125997717|NCT01216293|453284024|FG002|Main Study|Lost to Follow-up|0|||
125997718|NCT01216293|453284022|FG000|Main Study|Voluntary Withdrawal|2|||
125997719|NCT01216293|453284023|FG001|Main Study|Voluntary Withdrawal|2|||
125997720|NCT01216293|453284024|FG002|Main Study|Voluntary Withdrawal|2|||
125997721|NCT01216293|453284022|FG000|Main Study|Other Reason Not Specified|0|||
125997722|NCT01216293|453284023|FG001|Main Study|Other Reason Not Specified|1|||
125997723|NCT01216293|453284024|FG002|Main Study|Other Reason Not Specified|1|||
125997724|NCT01216293|453284022|FG000|Main Study|Randomized, Not Treated|1|||
125997725|NCT01216293|453284023|FG001|Main Study|Randomized, Not Treated|0|||
125997726|NCT01216293|453284024|FG002|Main Study|Randomized, Not Treated|0|||
125997727|NCT01216293|453284022|FG000|Calcium Absorption Substudy|Adverse Event|0|||
125997728|NCT01216293|453284023|FG001|Calcium Absorption Substudy|Adverse Event|2|||
125997729|NCT01216293|453284024|FG002|Calcium Absorption Substudy|Adverse Event|0|||
125997730|NCT01216293|453284022|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
125997731|NCT01216293|453284023|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
125997732|NCT01216293|453284024|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
125997733|NCT01216293|453284022|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
125997734|NCT01216293|453284023|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
125997735|NCT01216293|453284024|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
125997736|NCT01671748|453284025|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
125997737|NCT01671748|453284026|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
125997738|NCT01671748|453284025|FG000|4 Week run-in Phase|Adverse Event|1|||
125997739|NCT01671748|453284026|FG001|4 Week run-in Phase|Adverse Event|0|||
125997740|NCT01671748|453284025|FG000|4 Week run-in Phase|Not eligible|9|||
125997741|NCT01671748|453284026|FG001|4 Week run-in Phase|Not eligible|0|||
125997742|NCT02555371|453285309|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
125997743|NCT02555371|453285310|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
125997744|NCT02555371|453285311|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
125997745|NCT02555371|453285312|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
125997746|NCT02555371|453285313|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
125997747|NCT02555371|453285309|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
125997748|NCT02555371|453285310|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125997749|NCT02555371|453285311|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125997750|NCT02555371|453285312|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125997751|NCT02555371|453285313|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125997752|NCT02555371|453285309|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
125997753|NCT02555371|453285310|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
125997754|NCT02555371|453285311|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
125997755|NCT02555371|453285312|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
125997756|NCT02555371|453285313|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
125997757|NCT02555371|453285309|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
125997758|NCT02555371|453285310|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
125997759|NCT02555371|453285311|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
125997760|NCT02555371|453285312|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
125997761|NCT02555371|453285313|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
125997762|NCT02555371|453285309|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
125997763|NCT02555371|453285310|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
125997764|NCT02555371|453285311|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
125997765|NCT02555371|453285312|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
126332042|NCT03286218|454510844|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332043|NCT03286218|454510845|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332044|NCT03286218|454510846|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332045|NCT03286218|454510847|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332046|NCT03286218|454510848|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332047|NCT03286218|454510849|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
126332048|NCT01348139|454510850|FG000|Period 1|Adverse Event|1|||
126332049|NCT01348139|454510851|FG001|Period 1|Adverse Event|0|||
126332050|NCT01348139|454510852|FG002|Period 1|Adverse Event|0|||
126332051|NCT01348139|454510853|FG003|Period 1|Adverse Event|0|||
126332052|NCT01348139|454510854|FG004|Period 1|Adverse Event|0|||
126332053|NCT01348139|454510855|FG005|Period 1|Adverse Event|0|||
126332054|NCT02762084|454510858|FG000|Overall Study|Withdrawal by Subject|1|||
126332055|NCT02762084|454510859|FG001|Overall Study|Withdrawal by Subject|0|||
126332056|NCT02762084|454510860|FG002|Overall Study|Withdrawal by Subject|0|||
126332057|NCT02762084|454510858|FG000|Overall Study|Adverse Event|0|||
126332058|NCT02762084|454510859|FG001|Overall Study|Adverse Event|0|||
126332059|NCT02762084|454510860|FG002|Overall Study|Adverse Event|1|||
126332060|NCT01001910|454510863|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
126332061|NCT03200548|454510864|FG000|Overall Study|Withdrawal by Subject|5|||
126332062|NCT03200548|454510865|FG001|Overall Study|Withdrawal by Subject|11|||
126332063|NCT03200548|454510866|FG002|Overall Study|Withdrawal by Subject|7|||
126332064|NCT03200548|454510867|FG003|Overall Study|Withdrawal by Subject|6|||
126332065|NCT01619852|454510872|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
126332066|NCT01619852|454510873|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
126332067|NCT01619852|454510872|FG000|3 Month Follow up|Lost to Follow-up|31|||
126332068|NCT01619852|454510873|FG001|3 Month Follow up|Lost to Follow-up|34|||
126332069|NCT00970489|454510876|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
126332070|NCT00970489|454510877|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
126332071|NCT02168491|454510880|FG000|Overall Study|Withdrawal by Subject|1|||
126332072|NCT01096160|454510881|FG000|Overall Study|Adverse Event|0|||
126332073|NCT01096160|454510882|FG001|Overall Study|Adverse Event|0|||
126332074|NCT01096160|454510883|FG002|Overall Study|Adverse Event|1|||
126332075|NCT01096160|454510884|FG003|Overall Study|Adverse Event|0|||
126332076|NCT01096160|454510885|FG004|Overall Study|Adverse Event|0|||
126332077|NCT01096160|454510886|FG005|Overall Study|Adverse Event|0|||
126332078|NCT01096160|454510887|FG006|Overall Study|Adverse Event|0|||
126332079|NCT01096160|454510888|FG007|Overall Study|Adverse Event|0|||
126332080|NCT01096160|454510889|FG008|Overall Study|Adverse Event|0|||
126332081|NCT01096160|454510890|FG009|Overall Study|Adverse Event|1|||
126332082|NCT01096160|454510881|FG000|Overall Study|Met stopping criteria per protocol|0|||
126332083|NCT01096160|454510882|FG001|Overall Study|Met stopping criteria per protocol|0|||
126332084|NCT01096160|454510883|FG002|Overall Study|Met stopping criteria per protocol|0|||
126332085|NCT01096160|454510884|FG003|Overall Study|Met stopping criteria per protocol|0|||
126332086|NCT01096160|454510885|FG004|Overall Study|Met stopping criteria per protocol|1|||
126332087|NCT01096160|454510886|FG005|Overall Study|Met stopping criteria per protocol|0|||
125997766|NCT02555371|453285313|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
125997767|NCT02555371|453285309|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
126332088|NCT01096160|454510887|FG006|Overall Study|Met stopping criteria per protocol|2|||
126332089|NCT01096160|454510888|FG007|Overall Study|Met stopping criteria per protocol|0|||
126332090|NCT01096160|454510889|FG008|Overall Study|Met stopping criteria per protocol|2|||
126332091|NCT01096160|454510890|FG009|Overall Study|Met stopping criteria per protocol|0|||
126332092|NCT01610037|454510891|FG000|All Patients|Adverse Event|27|||
125997768|NCT02555371|453285310|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
125997769|NCT02555371|453285311|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
125997770|NCT02555371|453285312|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
125997771|NCT02555371|453285313|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
125997772|NCT02555371|453285309|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
125997773|NCT02555371|453285310|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
125997774|NCT02555371|453285311|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
125997775|NCT02555371|453285312|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
125997776|NCT02555371|453285313|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
125997777|NCT02555371|453285309|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125997778|NCT02555371|453285310|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
125997779|NCT02555371|453285311|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125997780|NCT02555371|453285312|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125997781|NCT02555371|453285313|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
126332093|NCT01610037|454510892|FG001|All Patients|Adverse Event|22|||
126332094|NCT01610037|454510893|FG002|All Patients|Adverse Event|26|||
126332095|NCT01610037|454510891|FG000|All Patients|Withdrawal by Subject|12|||
126332096|NCT01610037|454510892|FG001|All Patients|Withdrawal by Subject|10|||
126332097|NCT01610037|454510893|FG002|All Patients|Withdrawal by Subject|20|||
126332098|NCT01610037|454510891|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
125997782|NCT02555371|453285309|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
125997783|NCT02555371|453285310|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
125997784|NCT02555371|453285311|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
125997785|NCT02555371|453285312|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
125997786|NCT02555371|453285313|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
125997787|NCT02555371|453285309|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125997788|NCT02555371|453285310|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125997789|NCT02555371|453285311|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125997790|NCT02555371|453285312|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
125997791|NCT02555371|453285313|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125997792|NCT02555371|453285309|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125997793|NCT02555371|453285310|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125997794|NCT02555371|453285311|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125997795|NCT02555371|453285312|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
125997796|NCT02555371|453285313|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125997797|NCT02555371|453285309|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
125997798|NCT02555371|453285310|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
125997799|NCT02555371|453285311|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
125997800|NCT02555371|453285312|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
125997801|NCT02555371|453285313|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
125997802|NCT02555371|453285309|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125997803|NCT02555371|453285310|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125997804|NCT02555371|453285311|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125997805|NCT02555371|453285312|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125997806|NCT02555371|453285313|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
125997807|NCT02555371|453285309|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125997808|NCT02555371|453285310|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125997809|NCT02555371|453285311|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125997810|NCT02555371|453285312|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
125997811|NCT02555371|453285313|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125997812|NCT00513019|453285314|FG000|Overall Study|Adverse Event|1|||
125997813|NCT00513019|453285315|FG001|Overall Study|Adverse Event|0|||
125997814|NCT00513019|453285314|FG000|Overall Study|Withdrawal by Subject|4|||
125997815|NCT00513019|453285315|FG001|Overall Study|Withdrawal by Subject|5|||
125997816|NCT01500226|453285318|FG000|Overall Study|Adverse Event|31|||
125997817|NCT01500226|453285319|FG001|Overall Study|Adverse Event|38|||
125997818|NCT01500226|453285318|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
125997819|NCT01500226|453285319|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
125997820|NCT01500226|453285318|FG000|Overall Study|Withdrawal by Subject|93|||
125997821|NCT01500226|453285319|FG001|Overall Study|Withdrawal by Subject|96|||
125997822|NCT01500226|453285318|FG000|Overall Study|Death|12|||
125997823|NCT01500226|453285319|FG001|Overall Study|Death|4|||
125997824|NCT01500226|453285318|FG000|Overall Study|Disease Progression|16|||
125997825|NCT01500226|453285319|FG001|Overall Study|Disease Progression|14|||
125997826|NCT01500226|453285318|FG000|Overall Study|Protocol Violation|53|||
125997827|NCT01500226|453285319|FG001|Overall Study|Protocol Violation|39|||
125997828|NCT01500226|453285318|FG000|Overall Study|Physician Decision|17|||
125997829|NCT01500226|453285319|FG001|Overall Study|Physician Decision|15|||
125997830|NCT01500226|453285318|FG000|Overall Study|Lack of Efficacy|14|||
125997831|NCT01500226|453285319|FG001|Overall Study|Lack of Efficacy|30|||
125997832|NCT01500226|453285318|FG000|Overall Study|Lost to Follow-up|9|||
125997833|NCT01500226|453285319|FG001|Overall Study|Lost to Follow-up|5|||
125997834|NCT01500226|453285318|FG000|Overall Study|Other Reasons|19|||
125997835|NCT01500226|453285319|FG001|Overall Study|Other Reasons|16|||
125997836|NCT02955277|453285320|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
125997837|NCT02955277|453285321|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
125997838|NCT02955277|453285320|FG000|Post to Follow-up|Lost to Follow-up|8|||
125997839|NCT02955277|453285321|FG001|Post to Follow-up|Lost to Follow-up|11|||
125997840|NCT01809210|453285334|FG000|Overall Study|Withdrawal by Subject|0|||
125997841|NCT01809210|453285335|FG001|Overall Study|Withdrawal by Subject|0|||
125997842|NCT01809210|453285336|FG002|Overall Study|Withdrawal by Subject|1|||
125997843|NCT01809210|453285337|FG003|Overall Study|Withdrawal by Subject|1|||
125997844|NCT01809210|453285338|FG004|Overall Study|Withdrawal by Subject|1|||
125997845|NCT01809210|453285339|FG005|Overall Study|Withdrawal by Subject|0|||
125997846|NCT01809210|453285340|FG006|Overall Study|Withdrawal by Subject|4|||
125997847|NCT01809210|453285334|FG000|Overall Study|Death|1|||
125997848|NCT01809210|453285335|FG001|Overall Study|Death|1|||
125997849|NCT01809210|453285336|FG002|Overall Study|Death|2|||
125997850|NCT01809210|453285337|FG003|Overall Study|Death|0|||
125997851|NCT01809210|453285338|FG004|Overall Study|Death|1|||
125997852|NCT01809210|453285339|FG005|Overall Study|Death|3|||
125997853|NCT01809210|453285340|FG006|Overall Study|Death|1|||
126332099|NCT01610037|454510892|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
126332100|NCT01610037|454510893|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
126332101|NCT01610037|454510891|FG000|All Patients|Death|4|||
126332102|NCT01610037|454510892|FG001|All Patients|Death|2|||
126332103|NCT01610037|454510893|FG002|All Patients|Death|1|||
126332104|NCT01610037|454510891|FG000|All Patients|Protocol deviation|4|||
126332105|NCT01610037|454510892|FG001|All Patients|Protocol deviation|3|||
126332106|NCT01610037|454510893|FG002|All Patients|Protocol deviation|3|||
126332107|NCT01610037|454510891|FG000|All Patients|Abnormal laboratory value|1|||
126332108|NCT01610037|454510892|FG001|All Patients|Abnormal laboratory value|1|||
126332109|NCT01610037|454510893|FG002|All Patients|Abnormal laboratory value|0|||
126332110|NCT01610037|454510891|FG000|All Patients|Administrative problems|1|||
126332111|NCT01610037|454510892|FG001|All Patients|Administrative problems|4|||
126332112|NCT01610037|454510893|FG002|All Patients|Administrative problems|4|||
126332113|NCT01610037|454510891|FG000|All Patients|Lost to Follow-up|1|||
126332114|NCT01610037|454510892|FG001|All Patients|Lost to Follow-up|0|||
126332115|NCT01610037|454510893|FG002|All Patients|Lost to Follow-up|0|||
126332116|NCT01610037|454510891|FG000|All Patients|Abnormal test procedure result(s)|0|||
126332117|NCT01610037|454510892|FG001|All Patients|Abnormal test procedure result(s)|1|||
126332118|NCT01610037|454510893|FG002|All Patients|Abnormal test procedure result(s)|3|||
126332119|NCT01610037|454510891|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
126332120|NCT01610037|454510892|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
126332121|NCT01610037|454510893|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
126332122|NCT01610037|454510891|FG000|Treatment and Follow up Period|Death|10|||
126332123|NCT01610037|454510892|FG001|Treatment and Follow up Period|Death|5|||
126332124|NCT01610037|454510893|FG002|Treatment and Follow up Period|Death|4|||
126332125|NCT01610037|454510891|FG000|Treatment and Follow up Period|Administrative problems|1|||
126332126|NCT01610037|454510892|FG001|Treatment and Follow up Period|Administrative problems|3|||
126332127|NCT01610037|454510893|FG002|Treatment and Follow up Period|Administrative problems|2|||
126332128|NCT01610037|454510891|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
126332129|NCT01610037|454510892|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
126332130|NCT01610037|454510893|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
126332131|NCT00705757|454510895|FG000|Overall Study|Lack of Efficacy|5|||
126332132|NCT00705757|454510896|FG001|Overall Study|Lack of Efficacy|1|||
126332133|NCT00705757|454510897|FG002|Overall Study|Lack of Efficacy|3|||
126332134|NCT00705757|454510895|FG000|Overall Study|Lost to Follow-up|7|||
126332135|NCT00705757|454510896|FG001|Overall Study|Lost to Follow-up|6|||
126332136|NCT00705757|454510897|FG002|Overall Study|Lost to Follow-up|6|||
126332137|NCT00705757|454510895|FG000|Overall Study|Withdrawal by Subject|1|||
126332138|NCT00705757|454510896|FG001|Overall Study|Withdrawal by Subject|1|||
126332139|NCT00705757|454510897|FG002|Overall Study|Withdrawal by Subject|2|||
126332140|NCT03193047|454510898|FG000|Overall Study|Physician Decision|1|||
126332141|NCT03193047|454510899|FG001|Overall Study|Physician Decision|0|||
126332142|NCT03193047|454510898|FG000|Overall Study|Participant Left State|1|||
126332143|NCT03193047|454510899|FG001|Overall Study|Participant Left State|0|||
126332144|NCT03743025|454510900|FG000|Overall Study|Surgery was cancelled|2|||
126332145|NCT03743025|454510901|FG001|Overall Study|Surgery was cancelled|1|||
126332146|NCT02420119|454510902|FG000|Overall Study|insufficient laboratory data|5|||
126332147|NCT00149396|454510903|FG000|Overall Study|Death|15|||
126332148|NCT00149396|454510903|FG000|Overall Study|Withdrawal by Subject|1|||
126332149|NCT00149396|454510903|FG000|Overall Study|Subject noncompliance|2|||
126332150|NCT00149396|454510903|FG000|Overall Study|other treatment|5|||
126332151|NCT00186485|454510906|FG000|Overall Study|Lost to Follow-up|3|||
126332152|NCT00227539|454510909|FG000|Overall Study|Protocol Violation|1|||
126332153|NCT01922258|454510910|FG000|Overall Study|Lost to Follow-up|1|||
126332154|NCT01922258|454510911|FG001|Overall Study|Lost to Follow-up|1|||
126332155|NCT01922258|454510910|FG000|Overall Study|Adverse Event|9|||
126332156|NCT01922258|454510911|FG001|Overall Study|Adverse Event|2|||
126332157|NCT01922258|454510910|FG000|Overall Study|Met Withdrawal Criteria|0|||
126332158|NCT01922258|454510911|FG001|Overall Study|Met Withdrawal Criteria|4|||
126332159|NCT01922258|454510910|FG000|Overall Study|Withdrawn by the Investigator|1|||
126332160|NCT01922258|454510911|FG001|Overall Study|Withdrawn by the Investigator|4|||
126332161|NCT01922258|454510910|FG000|Overall Study|Withdrawal by participant|5|||
126332162|NCT01922258|454510911|FG001|Overall Study|Withdrawal by participant|5|||
126332163|NCT00673257|454510912|FG000|Overall Study|Withdrawal by Subject|4|||
126332164|NCT00673257|454510912|FG000|Overall Study|Unable to obtain specimen|1|||
126332165|NCT04552132|454510913|FG000|Overall Study|Lost to Follow-up|4|||
126332166|NCT04552132|454510914|FG001|Overall Study|Lost to Follow-up|3|||
126332167|NCT04552132|454510913|FG000|Overall Study|Protocol Violation|1|||
126332168|NCT04552132|454510914|FG001|Overall Study|Protocol Violation|0|||
126332169|NCT02256839|454510915|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
126332170|NCT02256839|454510916|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
126332171|NCT01951417|454510931|FG000|Overall Study|Withdrawal by Subject|1|||
126332172|NCT01951417|454510931|FG000|Overall Study|Protocol Violation|2|||
126332173|NCT01951417|454510931|FG000|Overall Study|Lost to Follow-up|6|||
126332174|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
125997854|NCT00504348|453285341|FG000|Overall Study|Adverse Event|3|||
125997855|NCT00504348|453285341|FG000|Overall Study|Lack of Efficacy|4|||
125997856|NCT00504348|453285341|FG000|Overall Study|Physician Decision|1|||
125997857|NCT03699124|453285342|FG000|Overall Study|Adverse Event|6|||
125997858|NCT03699124|453285343|FG001|Overall Study|Adverse Event|5|||
125997859|NCT03699124|453285344|FG002|Overall Study|Adverse Event|2|||
125997860|NCT03699124|453285342|FG000|Overall Study|Death|0|||
125997861|NCT03699124|453285343|FG001|Overall Study|Death|2|||
125997862|NCT03699124|453285344|FG002|Overall Study|Death|0|||
125997863|NCT03699124|453285342|FG000|Overall Study|Lost to Follow-up|20|||
125997864|NCT03699124|453285343|FG001|Overall Study|Lost to Follow-up|16|||
126332175|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
126332176|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Adverse Event|57|||
126332177|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Adverse Event|49|||
126332178|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
126332179|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
126332180|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Site closure|3|||
126332181|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Site closure|2|||
126332182|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
126332183|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
126332184|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Physician Decision|48|||
126332185|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Physician Decision|38|||
126332186|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
126332187|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
126332188|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
126332189|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
126332190|NCT01705977|454510938|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
126332191|NCT01705977|454510939|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
126332192|NCT01705977|454510938|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
126332193|NCT01705977|454510939|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
126332194|NCT01705977|454510938|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
126332195|NCT01705977|454510939|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
126332196|NCT01705977|454510938|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
126332197|NCT01705977|454510939|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
126332198|NCT00096538|454510941|FG000|Overall Study|Withdrawal by Subject|1|||
126332199|NCT01938846|454510942|FG000|Overall Study|Progressive disease|26|||
126332200|NCT01938846|454510943|FG001|Overall Study|Progressive disease|18|||
126332201|NCT01938846|454510944|FG002|Overall Study|Progressive disease|16|||
126332202|NCT01938846|454510942|FG000|Overall Study|Adverse Event|8|||
126332203|NCT01938846|454510943|FG001|Overall Study|Adverse Event|4|||
126332204|NCT01938846|454510944|FG002|Overall Study|Adverse Event|3|||
126332205|NCT01938846|454510942|FG000|Overall Study|Withdrawal by Subject|2|||
126332206|NCT01938846|454510943|FG001|Overall Study|Withdrawal by Subject|2|||
126332207|NCT01938846|454510944|FG002|Overall Study|Withdrawal by Subject|1|||
126332208|NCT01938846|454510942|FG000|Overall Study|Other than listed|5|||
126332209|NCT01938846|454510943|FG001|Overall Study|Other than listed|1|||
126332210|NCT01938846|454510944|FG002|Overall Study|Other than listed|4|||
126332211|NCT02324361|454510945|FG000|Overall Study|Lost to Follow-up|5|||
126332212|NCT02324361|454510946|FG001|Overall Study|Lost to Follow-up|2|||
126332213|NCT00808067|454510949|FG000|Overall Study|Major/minor bleed|30|||
126332214|NCT00808067|454510950|FG001|Overall Study|Major/minor bleed|44|||
126332215|NCT00808067|454510949|FG000|Overall Study|Outcome event - other|33|||
126332216|NCT00808067|454510950|FG001|Overall Study|Outcome event - other|25|||
126332217|NCT00808067|454510949|FG000|Overall Study|Adverse Event|111|||
126332218|NCT00808067|454510950|FG001|Overall Study|Adverse Event|121|||
126332219|NCT00808067|454510949|FG000|Overall Study|Hospitalization (not including surgery)|18|||
126332220|NCT00808067|454510950|FG001|Overall Study|Hospitalization (not including surgery)|17|||
126332221|NCT00808067|454510949|FG000|Overall Study|Hospitalization due to surgery|37|||
126332222|NCT00808067|454510950|FG001|Overall Study|Hospitalization due to surgery|40|||
126332223|NCT00808067|454510949|FG000|Overall Study|Reduced creatinine clearance|53|||
126332224|NCT00808067|454510950|FG001|Overall Study|Reduced creatinine clearance|55|||
126332225|NCT00808067|454510949|FG000|Overall Study|Elevated LFT results|7|||
126332226|NCT00808067|454510950|FG001|Overall Study|Elevated LFT results|3|||
125997865|NCT03699124|453285344|FG002|Overall Study|Lost to Follow-up|15|||
125997866|NCT03699124|453285342|FG000|Overall Study|Protocol Violation|1|||
125997867|NCT03699124|453285343|FG001|Overall Study|Protocol Violation|0|||
126332227|NCT00808067|454510949|FG000|Overall Study|Patient refused to take study medication|65|||
126332228|NCT00808067|454510950|FG001|Overall Study|Patient refused to take study medication|76|||
126332229|NCT00808067|454510949|FG000|Overall Study|Missing|1|||
126332230|NCT00808067|454510950|FG001|Overall Study|Missing|0|||
126332231|NCT00808067|454510949|FG000|Overall Study|Death|1|||
126332232|NCT00808067|454510950|FG001|Overall Study|Death|1|||
126332233|NCT00808067|454510949|FG000|Overall Study|Procedure|6|||
126332234|NCT00808067|454510950|FG001|Overall Study|Procedure|7|||
126332235|NCT00808067|454510949|FG000|Overall Study|Withdrawal by Subject|21|||
126332236|NCT00808067|454510950|FG001|Overall Study|Withdrawal by Subject|25|||
126332237|NCT00808067|454510949|FG000|Overall Study|Site closed|4|||
126332238|NCT00808067|454510950|FG001|Overall Study|Site closed|3|||
126332239|NCT00808067|454510949|FG000|Overall Study|Physician Decision|47|||
126332240|NCT00808067|454510950|FG001|Overall Study|Physician Decision|38|||
126332241|NCT00808067|454510949|FG000|Overall Study|Protocol Violation|3|||
126332242|NCT00808067|454510950|FG001|Overall Study|Protocol Violation|11|||
126332243|NCT00808067|454510949|FG000|Overall Study|Patient elected|7|||
126332244|NCT00808067|454510950|FG001|Overall Study|Patient elected|9|||
126332245|NCT00808067|454510949|FG000|Overall Study|Site closed for cause|19|||
126332246|NCT00808067|454510950|FG001|Overall Study|Site closed for cause|19|||
126332247|NCT00808067|454510949|FG000|Overall Study|Other reason not defined above|5|||
126332248|NCT00808067|454510950|FG001|Overall Study|Other reason not defined above|5|||
126332249|NCT00808067|454510949|FG000|Overall Study|Excluded from analysis|13|||
126332250|NCT00808067|454510950|FG001|Overall Study|Excluded from analysis|19|||
126332251|NCT02058589|454510952|FG000|Overall Study|Serious Adverse Event|1|||
126332252|NCT02058589|454510953|FG001|Overall Study|Serious Adverse Event|1|||
126332253|NCT02058589|454510952|FG000|Overall Study|Non-Serious Adverse Event|1|||
126332254|NCT02058589|454510953|FG001|Overall Study|Non-Serious Adverse Event|0|||
126332255|NCT02058589|454510952|FG000|Overall Study|Withdrawal by Subject|0|||
126332256|NCT02058589|454510953|FG001|Overall Study|Withdrawal by Subject|1|||
126332257|NCT02143024|454510955|FG000|Overall Study|Lost to Follow-up|1|||
126332258|NCT02143024|454510956|FG001|Overall Study|Lost to Follow-up|1|||
126332259|NCT02143024|454510955|FG000|Overall Study|Withdrawal by Subject|1|||
126332260|NCT02143024|454510956|FG001|Overall Study|Withdrawal by Subject|0|||
126332261|NCT02532283|454510957|FG000|Overall Study|Adverse Event|0|||
126332262|NCT02532283|454510958|FG001|Overall Study|Adverse Event|1|||
126332263|NCT02532283|454510957|FG000|Overall Study|Death|1|||
126332264|NCT02532283|454510958|FG001|Overall Study|Death|0|||
126332265|NCT02532283|454510957|FG000|Overall Study|Lost to Follow-up|0|||
126332266|NCT02532283|454510958|FG001|Overall Study|Lost to Follow-up|1|||
126332267|NCT02532283|454510957|FG000|Overall Study|Withdrawal by Subject|8|||
126332268|NCT02532283|454510958|FG001|Overall Study|Withdrawal by Subject|3|||
126332269|NCT01945944|454510959|FG000|Overall Study|Adverse Event|0|||
126332270|NCT01945944|454510960|FG001|Overall Study|Adverse Event|2|||
126332271|NCT01945944|454510959|FG000|Overall Study|Physician Decision|1|||
126332272|NCT01945944|454510960|FG001|Overall Study|Physician Decision|0|||
126332273|NCT01945944|454510959|FG000|Overall Study|Withdrawal by Subject|0|||
126332274|NCT01945944|454510960|FG001|Overall Study|Withdrawal by Subject|1|||
126332275|NCT00490971|454510968|FG000|Acute/Continuation|Adverse Event|62|||
126332276|NCT00490971|454510969|FG001|Acute/Continuation|Adverse Event|13|||
126332277|NCT00490971|454510970|FG002|Acute/Continuation|Adverse Event|0|||
126332278|NCT00490971|454510971|FG003|Acute/Continuation|Adverse Event|0|||
126332279|NCT00490971|454510972|FG004|Acute/Continuation|Adverse Event|0|||
126332280|NCT00490971|454510968|FG000|Acute/Continuation|Death|2|||
126332281|NCT00490971|454510969|FG001|Acute/Continuation|Death|0|||
126332282|NCT00490971|454510970|FG002|Acute/Continuation|Death|0|||
126332283|NCT00490971|454510971|FG003|Acute/Continuation|Death|0|||
126332284|NCT00490971|454510972|FG004|Acute/Continuation|Death|0|||
126332285|NCT00490971|454510968|FG000|Acute/Continuation|Lack of Efficacy|106|||
126332286|NCT00490971|454510969|FG001|Acute/Continuation|Lack of Efficacy|12|||
126332287|NCT00490971|454510970|FG002|Acute/Continuation|Lack of Efficacy|0|||
126332288|NCT00490971|454510971|FG003|Acute/Continuation|Lack of Efficacy|0|||
126332289|NCT00490971|454510972|FG004|Acute/Continuation|Lack of Efficacy|0|||
126332290|NCT00490971|454510968|FG000|Acute/Continuation|Lost to Follow-up|23|||
126332291|NCT00490971|454510969|FG001|Acute/Continuation|Lost to Follow-up|7|||
126332292|NCT00490971|454510970|FG002|Acute/Continuation|Lost to Follow-up|0|||
126332293|NCT00490971|454510971|FG003|Acute/Continuation|Lost to Follow-up|0|||
126332294|NCT00490971|454510972|FG004|Acute/Continuation|Lost to Follow-up|0|||
126332295|NCT00490971|454510968|FG000|Acute/Continuation|Protocol Violation|10|||
126332296|NCT00490971|454510969|FG001|Acute/Continuation|Protocol Violation|2|||
126332297|NCT00490971|454510970|FG002|Acute/Continuation|Protocol Violation|0|||
126332298|NCT00490971|454510971|FG003|Acute/Continuation|Protocol Violation|0|||
126332299|NCT00490971|454510972|FG004|Acute/Continuation|Protocol Violation|0|||
126332300|NCT00490971|454510968|FG000|Acute/Continuation|Withdrawal by Subject|92|||
126332301|NCT00490971|454510969|FG001|Acute/Continuation|Withdrawal by Subject|24|||
126332302|NCT00490971|454510970|FG002|Acute/Continuation|Withdrawal by Subject|0|||
126332303|NCT00490971|454510971|FG003|Acute/Continuation|Withdrawal by Subject|0|||
126332304|NCT00490971|454510972|FG004|Acute/Continuation|Withdrawal by Subject|0|||
126332305|NCT00490971|454510968|FG000|Acute/Continuation|Other|11|||
126332306|NCT00490971|454510969|FG001|Acute/Continuation|Other|4|||
126332307|NCT00490971|454510970|FG002|Acute/Continuation|Other|0|||
126332308|NCT00490971|454510971|FG003|Acute/Continuation|Other|0|||
126332309|NCT00490971|454510972|FG004|Acute/Continuation|Other|0|||
126332310|NCT00490971|454510968|FG000|Maintenance|Adverse Event|0|||
126332311|NCT00490971|454510969|FG001|Maintenance|Adverse Event|0|||
126332312|NCT00490971|454510970|FG002|Maintenance|Adverse Event|4|||
126332313|NCT00490971|454510971|FG003|Maintenance|Adverse Event|5|||
126332314|NCT00490971|454510972|FG004|Maintenance|Adverse Event|7|||
126332315|NCT00490971|454510968|FG000|Maintenance|Death|0|||
126332316|NCT00490971|454510969|FG001|Maintenance|Death|0|||
126332317|NCT00490971|454510970|FG002|Maintenance|Death|0|||
126332318|NCT00490971|454510971|FG003|Maintenance|Death|2|||
126332319|NCT00490971|454510972|FG004|Maintenance|Death|0|||
126332320|NCT00490971|454510968|FG000|Maintenance|Lost to Follow-up|0|||
126332321|NCT00490971|454510969|FG001|Maintenance|Lost to Follow-up|0|||
126332322|NCT00490971|454510970|FG002|Maintenance|Lost to Follow-up|5|||
126332323|NCT00490971|454510971|FG003|Maintenance|Lost to Follow-up|8|||
126332324|NCT00490971|454510972|FG004|Maintenance|Lost to Follow-up|10|||
126332325|NCT00490971|454510968|FG000|Maintenance|Pregnancy|0|||
126332326|NCT00490971|454510969|FG001|Maintenance|Pregnancy|0|||
126332327|NCT00490971|454510970|FG002|Maintenance|Pregnancy|1|||
126332328|NCT00490971|454510971|FG003|Maintenance|Pregnancy|0|||
126332329|NCT00490971|454510972|FG004|Maintenance|Pregnancy|0|||
126332330|NCT00490971|454510968|FG000|Maintenance|Protocol Violation|0|||
126332331|NCT00490971|454510969|FG001|Maintenance|Protocol Violation|0|||
126332332|NCT00490971|454510970|FG002|Maintenance|Protocol Violation|4|||
126332333|NCT00490971|454510971|FG003|Maintenance|Protocol Violation|1|||
126332334|NCT00490971|454510972|FG004|Maintenance|Protocol Violation|1|||
126332335|NCT00490971|454510968|FG000|Maintenance|Withdrawal by Subject|0|||
126332336|NCT00490971|454510969|FG001|Maintenance|Withdrawal by Subject|0|||
126332337|NCT00490971|454510970|FG002|Maintenance|Withdrawal by Subject|26|||
126332338|NCT00490971|454510971|FG003|Maintenance|Withdrawal by Subject|28|||
126332339|NCT00490971|454510972|FG004|Maintenance|Withdrawal by Subject|18|||
126332340|NCT00490971|454510968|FG000|Maintenance|Other|0|||
126332341|NCT00490971|454510969|FG001|Maintenance|Other|0|||
126332342|NCT00490971|454510970|FG002|Maintenance|Other|11|||
126332343|NCT00490971|454510971|FG003|Maintenance|Other|9|||
126332344|NCT00490971|454510972|FG004|Maintenance|Other|3|||
126332345|NCT04376515|454510976|FG000|Overall Study|Found to have been vaccinated before study start|6|||
126332346|NCT04376515|454510977|FG001|Overall Study|Found to have been vaccinated before study start|6|||
126332347|NCT01683604|454510979|FG000|Overall Study|Adverse Event|2|||
126332348|NCT01683604|454510979|FG000|Overall Study|Lack of Efficacy|1|||
126332349|NCT01683604|454510979|FG000|Overall Study|Other|2|||
126332350|NCT03430856|454510983|FG000|Overall Study|Adverse Event|0|||
126332351|NCT03430856|454510984|FG001|Overall Study|Adverse Event|1|||
126332352|NCT03430856|454510985|FG002|Overall Study|Adverse Event|0|||
126332353|NCT03430856|454510983|FG000|Overall Study|Rescue criteria|1|||
126332354|NCT03430856|454510984|FG001|Overall Study|Rescue criteria|1|||
126332355|NCT03430856|454510985|FG002|Overall Study|Rescue criteria|0|||
126332356|NCT03430856|454510983|FG000|Overall Study|Voluntary withdrawal of consent|1|||
126332357|NCT03430856|454510984|FG001|Overall Study|Voluntary withdrawal of consent|1|||
126332358|NCT03430856|454510985|FG002|Overall Study|Voluntary withdrawal of consent|1|||
126332359|NCT01949142|454510990|FG000|Overall Study|Withdrawal of consent|1|||
126332360|NCT01949142|454510991|FG001|Overall Study|Withdrawal of consent|0|||
126332361|NCT01949142|454510990|FG000|Overall Study|Lost to Follow-up|1|||
126332362|NCT01949142|454510991|FG001|Overall Study|Lost to Follow-up|1|||
126332363|NCT01949142|454510990|FG000|Overall Study|Parent changed their mind|1|||
126332364|NCT01949142|454510991|FG001|Overall Study|Parent changed their mind|0|||
126332365|NCT04771013|454513121|FG000|Overall Study|Withdrawal by Subject|2|||
126332366|NCT04771013|454513122|FG001|Overall Study|Withdrawal by Subject|0|||
126332367|NCT04771013|454513121|FG000|Overall Study|Death|0|||
126332368|NCT04771013|454513122|FG001|Overall Study|Death|5|||
126332369|NCT04771013|454513121|FG000|Overall Study|Referred to another hospital before day 20|0|||
126332370|NCT04771013|454513122|FG001|Overall Study|Referred to another hospital before day 20|1|||
126332371|NCT00493012|454513123|FG000|Overall Study|Lost to Follow-up|18|||
126332372|NCT00493012|454513124|FG001|Overall Study|Lost to Follow-up|17|||
126332373|NCT01519817|454513126|FG000|Overall Study|Withdrawal by Subject|1|||
126332374|NCT01519817|454513127|FG001|Overall Study|Withdrawal by Subject|0|||
126332375|NCT01519817|454513128|FG002|Overall Study|Withdrawal by Subject|0|||
126332376|NCT01519817|454513129|FG003|Overall Study|Withdrawal by Subject|0|||
126332377|NCT01519817|454513126|FG000|Overall Study|Off study due to infection|0|||
126332378|NCT01519817|454513127|FG001|Overall Study|Off study due to infection|0|||
126332379|NCT01519817|454513128|FG002|Overall Study|Off study due to infection|0|||
126332380|NCT01519817|454513129|FG003|Overall Study|Off study due to infection|1|||
126332381|NCT03234036|454513133|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
126332382|NCT03234036|454513134|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
126332383|NCT03234036|454513135|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
126332384|NCT03234036|454513136|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
126332385|NCT02999789|454513139|FG000|Overall Study|Withdrawal by Subject|0|||
126332386|NCT02999789|454513140|FG001|Overall Study|Withdrawal by Subject|1|||
126332387|NCT02999789|454513139|FG000|Overall Study|Became ineligible|1|||
125878649|NCT01972217|452853373|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
126332388|NCT02999789|454513140|FG001|Overall Study|Became ineligible|2|||
126332389|NCT04547140|454513143|FG000|Overall Study|Adverse Event|0|||
126332390|NCT04547140|454513144|FG001|Overall Study|Adverse Event|1|||
126332391|NCT04547140|454513143|FG000|Overall Study|Withdrawal by Subject|0|||
126332392|NCT04547140|454513144|FG001|Overall Study|Withdrawal by Subject|1|||
126332393|NCT04547140|454513143|FG000|Overall Study|Lost to Follow-up|3|||
126332394|NCT04547140|454513144|FG001|Overall Study|Lost to Follow-up|1|||
126332395|NCT04547140|454513143|FG000|Overall Study|Death|2|||
126332396|NCT04547140|454513144|FG001|Overall Study|Death|1|||
126332397|NCT04547140|454513143|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
126332398|NCT04547140|454513144|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
126332399|NCT04547140|454513143|FG000|Overall Study|Pregnancy|1|||
126332400|NCT04547140|454513144|FG001|Overall Study|Pregnancy|0|||
126332401|NCT04547140|454513143|FG000|Overall Study|Reason Not Specified|4|||
126332402|NCT04547140|454513144|FG001|Overall Study|Reason Not Specified|1|||
126332403|NCT04613739|454513145|FG000|Overall Study|Lost to Follow-up|6|||
126332404|NCT04613739|454513146|FG001|Overall Study|Lost to Follow-up|9|||
126332405|NCT04613739|454513145|FG000|Overall Study|potentially duplicative/fraudulent|1|||
126332406|NCT04613739|454513146|FG001|Overall Study|potentially duplicative/fraudulent|3|||
126332407|NCT00003537|454513147|FG000|Overall Study|Not evalauable|1|||
126332408|NCT00737100|454513158|FG000|Overall Study|Adverse Event|6|||
126332409|NCT00737100|454513159|FG001|Overall Study|Adverse Event|5|||
126332410|NCT00737100|454513160|FG002|Overall Study|Adverse Event|3|||
126332411|NCT00737100|454513158|FG000|Overall Study|Lost to Follow-up|0|||
126332412|NCT00737100|454513159|FG001|Overall Study|Lost to Follow-up|1|||
126332413|NCT00737100|454513160|FG002|Overall Study|Lost to Follow-up|0|||
126332414|NCT00737100|454513158|FG000|Overall Study|Withdrawal by Subject|0|||
126332415|NCT00737100|454513159|FG001|Overall Study|Withdrawal by Subject|0|||
126332416|NCT00737100|454513160|FG002|Overall Study|Withdrawal by Subject|3|||
126332417|NCT00737100|454513158|FG000|Overall Study|Reason discontinued not explained above|1|||
126332418|NCT00737100|454513159|FG001|Overall Study|Reason discontinued not explained above|1|||
126332419|NCT00737100|454513160|FG002|Overall Study|Reason discontinued not explained above|1|||
126332420|NCT01265394|454513163|FG000|Overall Study|Subjects withdrawn|37|||
126332421|NCT00735943|454513164|FG000|Overall Study|Lost to Follow-up|1|||
126332422|NCT00735943|454513164|FG000|Overall Study|Adverse Event|1|||
126332423|NCT01719380|454513169|FG000|Overall Study|Adverse Event|0|||
126332424|NCT01719380|454513170|FG001|Overall Study|Adverse Event|0|||
126332425|NCT01719380|454513171|FG002|Overall Study|Adverse Event|1|||
126332426|NCT01719380|454513172|FG003|Overall Study|Adverse Event|2|||
126332427|NCT01719380|454513173|FG004|Overall Study|Adverse Event|0|||
126332428|NCT01719380|454513174|FG005|Overall Study|Adverse Event|1|||
126332429|NCT01719380|454513175|FG006|Overall Study|Adverse Event|0|||
126332430|NCT01719380|454513176|FG007|Overall Study|Adverse Event|1|||
126332431|NCT01719380|454513177|FG008|Overall Study|Adverse Event|4|||
126332432|NCT01719380|454513178|FG009|Overall Study|Adverse Event|3|||
126332433|NCT01719380|454513169|FG000|Overall Study|Death|0|||
126332434|NCT01719380|454513170|FG001|Overall Study|Death|1|||
126332435|NCT01719380|454513171|FG002|Overall Study|Death|0|||
126332436|NCT01719380|454513172|FG003|Overall Study|Death|0|||
126332437|NCT01719380|454513173|FG004|Overall Study|Death|0|||
126332438|NCT01719380|454513174|FG005|Overall Study|Death|0|||
126332439|NCT01719380|454513175|FG006|Overall Study|Death|0|||
126332440|NCT01719380|454513176|FG007|Overall Study|Death|0|||
126332441|NCT01719380|454513177|FG008|Overall Study|Death|3|||
126332442|NCT01719380|454513178|FG009|Overall Study|Death|3|||
126332443|NCT01719380|454513169|FG000|Overall Study|Participant/Guardian Decision|0|||
126332444|NCT01719380|454513170|FG001|Overall Study|Participant/Guardian Decision|0|||
126332445|NCT01719380|454513171|FG002|Overall Study|Participant/Guardian Decision|1|||
126332446|NCT01719380|454513172|FG003|Overall Study|Participant/Guardian Decision|0|||
126332447|NCT01719380|454513173|FG004|Overall Study|Participant/Guardian Decision|0|||
126332448|NCT01719380|454513174|FG005|Overall Study|Participant/Guardian Decision|0|||
126332449|NCT01719380|454513175|FG006|Overall Study|Participant/Guardian Decision|0|||
126332450|NCT01719380|454513176|FG007|Overall Study|Participant/Guardian Decision|0|||
126332451|NCT01719380|454513177|FG008|Overall Study|Participant/Guardian Decision|2|||
126332452|NCT01719380|454513178|FG009|Overall Study|Participant/Guardian Decision|2|||
126332453|NCT01719380|454513169|FG000|Overall Study|Physician Decision|0|||
126332454|NCT01719380|454513170|FG001|Overall Study|Physician Decision|0|||
126332455|NCT01719380|454513171|FG002|Overall Study|Physician Decision|2|||
126332456|NCT01719380|454513172|FG003|Overall Study|Physician Decision|0|||
126332457|NCT01719380|454513173|FG004|Overall Study|Physician Decision|0|||
126332458|NCT01719380|454513174|FG005|Overall Study|Physician Decision|0|||
126332459|NCT01719380|454513175|FG006|Overall Study|Physician Decision|0|||
126332460|NCT01719380|454513176|FG007|Overall Study|Physician Decision|0|||
126332461|NCT01719380|454513177|FG008|Overall Study|Physician Decision|1|||
126332462|NCT01719380|454513178|FG009|Overall Study|Physician Decision|1|||
126332463|NCT01719380|454513169|FG000|Overall Study|Lack of Efficacy|2|||
126332464|NCT01719380|454513170|FG001|Overall Study|Lack of Efficacy|6|||
126332465|NCT01719380|454513171|FG002|Overall Study|Lack of Efficacy|5|||
126332466|NCT01719380|454513172|FG003|Overall Study|Lack of Efficacy|6|||
126332467|NCT01719380|454513173|FG004|Overall Study|Lack of Efficacy|3|||
126332468|NCT01719380|454513174|FG005|Overall Study|Lack of Efficacy|7|||
126332469|NCT01719380|454513175|FG006|Overall Study|Lack of Efficacy|10|||
126332470|NCT01719380|454513176|FG007|Overall Study|Lack of Efficacy|6|||
126332471|NCT01719380|454513177|FG008|Overall Study|Lack of Efficacy|39|||
126332472|NCT01719380|454513178|FG009|Overall Study|Lack of Efficacy|42|||
125997868|NCT03699124|453285344|FG002|Overall Study|Protocol Violation|0|||
125997869|NCT03699124|453285342|FG000|Overall Study|Withdrawal by Subject|13|||
125997870|NCT03699124|453285343|FG001|Overall Study|Withdrawal by Subject|14|||
125997871|NCT03699124|453285344|FG002|Overall Study|Withdrawal by Subject|13|||
126332473|NCT01719380|454513169|FG000|Overall Study|Progressive Disease|0|||
126332474|NCT01719380|454513170|FG001|Overall Study|Progressive Disease|0|||
126332475|NCT01719380|454513171|FG002|Overall Study|Progressive Disease|0|||
126332476|NCT01719380|454513172|FG003|Overall Study|Progressive Disease|0|||
126332477|NCT01719380|454513173|FG004|Overall Study|Progressive Disease|0|||
126332478|NCT01719380|454513174|FG005|Overall Study|Progressive Disease|0|||
126332479|NCT01719380|454513175|FG006|Overall Study|Progressive Disease|0|||
126332480|NCT01719380|454513176|FG007|Overall Study|Progressive Disease|0|||
126332481|NCT01719380|454513177|FG008|Overall Study|Progressive Disease|1|||
126332482|NCT01719380|454513178|FG009|Overall Study|Progressive Disease|0|||
126332483|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
126332484|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
126332485|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
126332486|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Death|0|||
126332487|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Death|1|||
126332488|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Death|0|||
126332489|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
126332490|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
126332491|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
126332492|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
126332493|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
126332494|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
126332495|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126332496|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126332497|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126332498|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Other|4|||
126332499|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Other|7|||
126332500|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Other|2|||
126332501|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
126332502|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126332503|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
126332504|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Death|0|||
126332505|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Death|1|||
126332506|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Death|0|||
126332507|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
126332508|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126332509|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126332510|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
126332511|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126332512|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126332513|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126332514|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126332515|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126332516|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
126332517|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
126332518|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
126332519|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126332520|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126332521|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126332522|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Other|5|||
126332523|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Other|2|||
126332524|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Other|1|||
126332525|NCT00249873|454513182|FG000|Overall Study|Not treated|7|||
126332526|NCT00249873|454513183|FG001|Overall Study|Not treated|8|||
126332527|NCT00249873|454513182|FG000|Overall Study|Significant thrombocytopenia|9|||
126332528|NCT00249873|454513183|FG001|Overall Study|Significant thrombocytopenia|8|||
126332529|NCT00249873|454513182|FG000|Overall Study|Severe allergic reaction|8|||
126332530|NCT00249873|454513183|FG001|Overall Study|Severe allergic reaction|1|||
126332531|NCT00249873|454513182|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
126332532|NCT00249873|454513183|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
126332533|NCT00249873|454513182|FG000|Overall Study|Other Serious Adverse Event|86|||
126332534|NCT00249873|454513183|FG001|Overall Study|Other Serious Adverse Event|97|||
126332535|NCT00249873|454513182|FG000|Overall Study|Qualifying condition not present|20|||
126332536|NCT00249873|454513183|FG001|Overall Study|Qualifying condition not present|23|||
126332537|NCT00249873|454513182|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
126332538|NCT00249873|454513183|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
126332539|NCT00249873|454513182|FG000|Overall Study|Withdrawal by Subject|504|||
126332540|NCT00249873|454513183|FG001|Overall Study|Withdrawal by Subject|466|||
126332541|NCT00249873|454513182|FG000|Overall Study|Lost to Follow-up|4|||
126332542|NCT00249873|454513183|FG001|Overall Study|Lost to Follow-up|7|||
126332543|NCT00249873|454513182|FG000|Overall Study|Minor bleeding|99|||
126332544|NCT00249873|454513183|FG001|Overall Study|Minor bleeding|37|||
126332545|NCT00249873|454513182|FG000|Overall Study|Non-compliance|41|||
126332546|NCT00249873|454513183|FG001|Overall Study|Non-compliance|46|||
126332547|NCT00249873|454513182|FG000|Overall Study|Other non serious Adverse Event|112|||
126332548|NCT00249873|454513183|FG001|Overall Study|Other non serious Adverse Event|108|||
126332549|NCT00249873|454513182|FG000|Overall Study|Other contraindicated medication|1|||
126332550|NCT00249873|454513183|FG001|Overall Study|Other contraindicated medication|0|||
126332551|NCT00249873|454513182|FG000|Overall Study|Patient not wish to continue after May08|3|||
126332552|NCT00249873|454513183|FG001|Overall Study|Patient not wish to continue after May08|4|||
126332553|NCT00249873|454513182|FG000|Overall Study|Physician withdrew consent|59|||
126332554|NCT00249873|454513183|FG001|Overall Study|Physician withdrew consent|60|||
126332555|NCT00249873|454513182|FG000|Overall Study|Open label clopidogrel required|31|||
126332556|NCT00249873|454513183|FG001|Overall Study|Open label clopidogrel required|42|||
126332557|NCT00249873|454513182|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
126332558|NCT00249873|454513183|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
126332559|NCT00249873|454513182|FG000|Overall Study|Oral anticoagulant required|159|||
126332560|NCT00249873|454513183|FG001|Overall Study|Oral anticoagulant required|157|||
126332561|NCT00249873|454513182|FG000|Overall Study|Study drug intolerance|5|||
126332562|NCT00249873|454513183|FG001|Overall Study|Study drug intolerance|0|||
126332563|NCT00249873|454513182|FG000|Overall Study|Surgery/ procedure|9|||
126332564|NCT00249873|454513183|FG001|Overall Study|Surgery/ procedure|9|||
126332565|NCT00249873|454513182|FG000|Overall Study|Event related to cardiac condition|12|||
126332566|NCT00249873|454513183|FG001|Overall Study|Event related to cardiac condition|21|||
126332567|NCT00249873|454513182|FG000|Overall Study|Thromboembolic/outcome event|82|||
125997872|NCT03699124|453285342|FG000|Overall Study|Other reasons|5|||
126332568|NCT00249873|454513183|FG001|Overall Study|Thromboembolic/outcome event|122|||
125997873|NCT03699124|453285343|FG001|Overall Study|Other reasons|3|||
125997874|NCT03699124|453285344|FG002|Overall Study|Other reasons|10|||
125997875|NCT01118962|453285345|FG000|Overall Study|Adverse Event|2|||
125997876|NCT01118962|453285345|FG000|Overall Study|Lack of Efficacy|1|||
125997877|NCT01118962|453285345|FG000|Overall Study|Protocol Violation|1|||
125997878|NCT01118962|453285345|FG000|Overall Study|Withdrawal by Subject|4|||
125997879|NCT01118962|453285345|FG000|Overall Study|Pregnancy|1|||
125997880|NCT01118962|453285345|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
126332569|NCT03131167|454513184|FG000|Overall Study|Other (Unspecified)|0|||
126332570|NCT03131167|454513185|FG001|Overall Study|Other (Unspecified)|0|||
126332571|NCT03131167|454513186|FG002|Overall Study|Other (Unspecified)|0|||
126332572|NCT03131167|454513187|FG003|Overall Study|Other (Unspecified)|0|||
126332573|NCT03131167|454513188|FG004|Overall Study|Other (Unspecified)|0|||
126332574|NCT03131167|454513189|FG005|Overall Study|Other (Unspecified)|1|||
126332575|NCT03131167|454513190|FG006|Overall Study|Other (Unspecified)|0|||
126332576|NCT03131167|454513191|FG007|Overall Study|Other (Unspecified)|0|||
126332577|NCT03131167|454513192|FG008|Overall Study|Other (Unspecified)|0|||
126332578|NCT03131167|454513193|FG009|Overall Study|Other (Unspecified)|0|||
126332579|NCT03131167|454513194|FG010|Overall Study|Other (Unspecified)|0|||
126332580|NCT03131167|454513195|FG011|Overall Study|Other (Unspecified)|0|||
126332581|NCT03131167|454513196|FG012|Overall Study|Other (Unspecified)|0|||
126332582|NCT00165503|454513197|FG000|Overall Study|Death|1|||
126332583|NCT00165503|454513197|FG000|Overall Study|Lost to Follow-up|12|||
126332584|NCT00165503|454513197|FG000|Overall Study|Unresectable|3|||
126332585|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Death|20|||
126332586|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Death|26|||
126332587|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
126332588|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
126332589|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
126332590|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
126332591|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
126332592|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
126332593|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
126332594|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
126332595|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
126332596|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
126332597|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
125997881|NCT01023308|453285348|FG000|Overall Study|Abnormal test proceedure results|3|||
125997882|NCT01023308|453285349|FG001|Overall Study|Abnormal test proceedure results|8|||
125997883|NCT01023308|453285348|FG000|Overall Study|Administrative problems|2|||
126091087|NCT00623805|453626908|FG000|Overall Study|Protocol Violation|1|||
126091088|NCT00623805|453626909|FG001|Overall Study|Protocol Violation|1|||
126332598|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
126332599|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
126332600|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
126332601|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Other|107|||
126332602|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Other|107|||
126332603|NCT00643201|454513198|FG000|Completed Study Follow Up|Death|28|||
126332604|NCT00643201|454513199|FG001|Completed Study Follow Up|Death|34|||
126332605|NCT00643201|454513198|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
126332606|NCT00643201|454513199|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
126332607|NCT00643201|454513198|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
126332608|NCT00643201|454513199|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
126332609|NCT00643201|454513198|FG000|Completed Study Follow Up|non-specified|1|||
126332610|NCT00643201|454513199|FG001|Completed Study Follow Up|non-specified|0|||
126332611|NCT02346708|454513200|FG000|Overall Study|Adverse Event|2|||
126332612|NCT02346708|454513201|FG001|Overall Study|Adverse Event|0|||
126332613|NCT02346708|454513200|FG000|Overall Study|Protocol Violation|0|||
126332614|NCT02346708|454513201|FG001|Overall Study|Protocol Violation|1|||
126332615|NCT02976519|454513202|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332616|NCT02976519|454513203|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
126332617|NCT02976519|454513204|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332618|NCT02976519|454513205|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332619|NCT02976519|454513206|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332620|NCT02976519|454513207|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332621|NCT02976519|454513208|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332622|NCT02976519|454513202|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332623|NCT02976519|454513203|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332624|NCT02976519|454513204|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332625|NCT02976519|454513205|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
126332626|NCT02976519|454513206|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332627|NCT02976519|454513207|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332628|NCT02976519|454513208|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332629|NCT02976519|454513202|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332630|NCT02976519|454513203|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332631|NCT02976519|454513204|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332632|NCT02976519|454513205|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332633|NCT02976519|454513206|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332634|NCT02976519|454513207|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332635|NCT02976519|454513208|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
126332636|NCT02976519|454513202|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332637|NCT02976519|454513203|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332638|NCT02976519|454513204|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332639|NCT02976519|454513205|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332640|NCT02976519|454513206|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332641|NCT02976519|454513207|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332642|NCT02976519|454513208|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
126332643|NCT02976519|454513202|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126332644|NCT02976519|454513203|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126332645|NCT02976519|454513204|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125997884|NCT01023308|453285349|FG001|Overall Study|Administrative problems|1|||
125997885|NCT01023308|453285348|FG000|Overall Study|Adverse Event|130|||
125997886|NCT01023308|453285349|FG001|Overall Study|Adverse Event|66|||
125997887|NCT01023308|453285348|FG000|Overall Study|Death|21|||
125997888|NCT01023308|453285349|FG001|Overall Study|Death|17|||
125997889|NCT01023308|453285348|FG000|Overall Study|Disease progression|82|||
125997890|NCT01023308|453285349|FG001|Overall Study|Disease progression|153|||
125997891|NCT01023308|453285348|FG000|Overall Study|New Cancer therapy|4|||
125997892|NCT01023308|453285349|FG001|Overall Study|New Cancer therapy|7|||
125997893|NCT01023308|453285348|FG000|Overall Study|Protocol Violation|3|||
125997894|NCT01023308|453285349|FG001|Overall Study|Protocol Violation|4|||
125997895|NCT01023308|453285348|FG000|Overall Study|Untreated|5|||
125997896|NCT01023308|453285349|FG001|Overall Study|Untreated|5|||
125997897|NCT01023308|453285348|FG000|Overall Study|Lost to Follow-up|1|||
125997898|NCT01023308|453285349|FG001|Overall Study|Lost to Follow-up|0|||
125997899|NCT01023308|453285348|FG000|Overall Study|Withdrawal by Subject|34|||
125997900|NCT01023308|453285349|FG001|Overall Study|Withdrawal by Subject|18|||
126091089|NCT00623805|453626908|FG000|Overall Study|Reason not Specified|3|||
126332646|NCT02976519|454513205|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125997901|NCT00551213|453285350|FG000|Overall Study|Adverse Event|6|||
125997902|NCT00551213|453285351|FG001|Overall Study|Adverse Event|3|||
125997903|NCT00551213|453285350|FG000|Overall Study|Progressive Disease|41|||
125997904|NCT00551213|453285351|FG001|Overall Study|Progressive Disease|12|||
125997905|NCT00551213|453285350|FG000|Overall Study|Withdrawal by Subject|2|||
125997906|NCT00551213|453285351|FG001|Overall Study|Withdrawal by Subject|0|||
125997907|NCT00551213|453285350|FG000|Overall Study|Not Treated|1|||
125997908|NCT00551213|453285351|FG001|Overall Study|Not Treated|2|||
125997909|NCT01383993|453285352|FG000|Overall Study|Adverse Event|1|||
125997910|NCT01383993|453285353|FG001|Overall Study|Adverse Event|1|||
125997911|NCT01383993|453285354|FG002|Overall Study|Adverse Event|0|||
125997912|NCT01383993|453285352|FG000|Overall Study|Withdrawal by Subject|0|||
125997913|NCT01383993|453285353|FG001|Overall Study|Withdrawal by Subject|0|||
125997914|NCT01383993|453285354|FG002|Overall Study|Withdrawal by Subject|1|||
125997915|NCT01383993|453285352|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
125997916|NCT01383993|453285353|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
125997917|NCT01383993|453285354|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
125997918|NCT02561455|453285357|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
125997919|NCT02561455|453285358|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
126332647|NCT02976519|454513206|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126332648|NCT02976519|454513207|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126332649|NCT02976519|454513208|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
126332650|NCT01781962|454513211|FG000|Overall Study|Other Miscellaneous Reasons|5|||
126332651|NCT00928434|454513212|FG000|Overall Study|Adverse Event|14|||
126332652|NCT00928434|454513213|FG001|Overall Study|Adverse Event|5|||
126332653|NCT00928434|454513214|FG002|Overall Study|Adverse Event|18|||
126332654|NCT00928434|454513212|FG000|Overall Study|Protocol Violation|5|||
126332655|NCT00928434|454513213|FG001|Overall Study|Protocol Violation|0|||
126332656|NCT00928434|454513214|FG002|Overall Study|Protocol Violation|8|||
126332657|NCT00928434|454513212|FG000|Overall Study|Physician Decision|2|||
126332658|NCT00928434|454513213|FG001|Overall Study|Physician Decision|0|||
126332659|NCT00928434|454513214|FG002|Overall Study|Physician Decision|3|||
126332660|NCT00928434|454513212|FG000|Overall Study|Lost to Follow-up|1|||
126332661|NCT00928434|454513213|FG001|Overall Study|Lost to Follow-up|0|||
126332662|NCT00928434|454513214|FG002|Overall Study|Lost to Follow-up|3|||
126332663|NCT00928434|454513212|FG000|Overall Study|Withdrawal by Subject|5|||
126332664|NCT00928434|454513213|FG001|Overall Study|Withdrawal by Subject|3|||
126332665|NCT00928434|454513214|FG002|Overall Study|Withdrawal by Subject|2|||
126332666|NCT00928434|454513212|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
126332667|NCT00928434|454513213|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
126332668|NCT00928434|454513214|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
126332669|NCT00928434|454513212|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
126332670|NCT00928434|454513213|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
126332671|NCT00928434|454513214|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
126332672|NCT00928434|454513212|FG000|Overall Study|Other (not meeting above criteria)|5|||
126332673|NCT00928434|454513213|FG001|Overall Study|Other (not meeting above criteria)|1|||
126332674|NCT00928434|454513214|FG002|Overall Study|Other (not meeting above criteria)|2|||
126332675|NCT01278342|454513217|FG000|Overall Study|Physician Decision|0|||
126332676|NCT01278342|454513218|FG001|Overall Study|Physician Decision|1|||
126332677|NCT01278342|454513219|FG002|Overall Study|Physician Decision|0|||
126332678|NCT01278342|454513217|FG000|Overall Study|Lost to Follow-up|1|||
126332679|NCT01278342|454513218|FG001|Overall Study|Lost to Follow-up|0|||
126332680|NCT01278342|454513219|FG002|Overall Study|Lost to Follow-up|0|||
126332681|NCT01278342|454513217|FG000|Overall Study|Administrative problems|2|||
126332682|NCT01278342|454513218|FG001|Overall Study|Administrative problems|0|||
126332683|NCT01278342|454513219|FG002|Overall Study|Administrative problems|0|||
126332684|NCT01278342|454513217|FG000|Overall Study|Other|1|||
126332685|NCT01278342|454513218|FG001|Overall Study|Other|0|||
125997920|NCT02561455|453285359|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
125997921|NCT02561455|453285360|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
125997922|NCT02561455|453285357|FG000|Overall Study|Withdrawal by Subject|1|||
125997923|NCT02561455|453285358|FG001|Overall Study|Withdrawal by Subject|0|||
125997924|NCT02561455|453285359|FG002|Overall Study|Withdrawal by Subject|1|||
125997925|NCT02561455|453285360|FG003|Overall Study|Withdrawal by Subject|0|||
125997926|NCT02561455|453285357|FG000|Overall Study|Disease Progression|0|||
125997927|NCT02561455|453285358|FG001|Overall Study|Disease Progression|1|||
125997928|NCT02561455|453285359|FG002|Overall Study|Disease Progression|0|||
125997929|NCT02561455|453285360|FG003|Overall Study|Disease Progression|0|||
126332686|NCT01278342|454513219|FG002|Overall Study|Other|0|||
126332687|NCT00313846|454513225|FG000|Overall Study|Withdrawal by Subject|2|||
126332688|NCT00313846|454513226|FG001|Overall Study|Withdrawal by Subject|0|||
126332689|NCT00313846|454513225|FG000|Overall Study|Adverse Event|1|||
126332690|NCT00313846|454513226|FG001|Overall Study|Adverse Event|8|||
125997930|NCT03249376|453285369|FG000|Overall Study|Adverse Event|11|||
126332691|NCT00313846|454513225|FG000|Overall Study|Administrative|2|||
126332692|NCT00313846|454513226|FG001|Overall Study|Administrative|3|||
126332693|NCT01462630|454513228|FG000|Overall Study|Did not initiate therapy|3|||
126332694|NCT01462630|454513228|FG000|Overall Study|Death|1|||
126332695|NCT01462630|454513228|FG000|Overall Study|Protocol Violation|2|||
126332696|NCT01462630|454513228|FG000|Overall Study|Adverse Event|1|||
126332697|NCT01765296|454513229|FG000|Overall Study|Protocol Violation|0|||
126332698|NCT01765296|454513230|FG001|Overall Study|Protocol Violation|5|||
126332699|NCT01765296|454513231|FG002|Overall Study|Protocol Violation|4|||
126332700|NCT01765296|454513229|FG000|Overall Study|Withdrawal by Subject|4|||
126332701|NCT01765296|454513230|FG001|Overall Study|Withdrawal by Subject|2|||
126332702|NCT01765296|454513231|FG002|Overall Study|Withdrawal by Subject|2|||
126332703|NCT01765296|454513229|FG000|Overall Study|Adverse Event|1|||
126332704|NCT01765296|454513230|FG001|Overall Study|Adverse Event|13|||
126332705|NCT01765296|454513231|FG002|Overall Study|Adverse Event|5|||
126332706|NCT01765296|454513229|FG000|Overall Study|Lack of Efficacy|0|||
126332707|NCT01765296|454513230|FG001|Overall Study|Lack of Efficacy|0|||
126332708|NCT01765296|454513231|FG002|Overall Study|Lack of Efficacy|2|||
126332709|NCT03933449|454513232|FG000|Overall Study|Adverse Event|6|||
126332710|NCT03933449|454513233|FG001|Overall Study|Adverse Event|4|||
126332711|NCT03933449|454513232|FG000|Overall Study|Death|55|||
126332712|NCT03933449|454513233|FG001|Overall Study|Death|57|||
126332713|NCT03933449|454513232|FG000|Overall Study|Sponsor Decision|1|||
126332714|NCT03933449|454513233|FG001|Overall Study|Sponsor Decision|0|||
126332715|NCT02659943|454513234|FG000|Overall Study|Switched to alternative treatment|1|||
126332716|NCT02659943|454513235|FG001|Overall Study|Switched to alternative treatment|1|||
126332717|NCT02659943|454513236|FG002|Overall Study|Switched to alternative treatment|0|||
126332718|NCT02659943|454513237|FG003|Overall Study|Switched to alternative treatment|2|||
126332719|NCT02659943|454513238|FG004|Overall Study|Switched to alternative treatment|1|||
126332720|NCT02659943|454513239|FG005|Overall Study|Switched to alternative treatment|0|||
126332721|NCT02659943|454513240|FG006|Overall Study|Switched to alternative treatment|1|||
126332722|NCT02659943|454513234|FG000|Overall Study|Disease progression on study|0|||
126332723|NCT02659943|454513235|FG001|Overall Study|Disease progression on study|1|||
126332724|NCT02659943|454513236|FG002|Overall Study|Disease progression on study|1|||
126332725|NCT02659943|454513237|FG003|Overall Study|Disease progression on study|1|||
126332726|NCT02659943|454513238|FG004|Overall Study|Disease progression on study|1|||
126332727|NCT02659943|454513239|FG005|Overall Study|Disease progression on study|4|||
126332728|NCT02659943|454513240|FG006|Overall Study|Disease progression on study|0|||
126332729|NCT02659943|454513234|FG000|Overall Study|Patient's condition per principal investigator|0|||
126332730|NCT02659943|454513235|FG001|Overall Study|Patient's condition per principal investigator|0|||
126332731|NCT02659943|454513236|FG002|Overall Study|Patient's condition per principal investigator|0|||
126332732|NCT02659943|454513237|FG003|Overall Study|Patient's condition per principal investigator|0|||
126332733|NCT02659943|454513238|FG004|Overall Study|Patient's condition per principal investigator|0|||
126332734|NCT02659943|454513239|FG005|Overall Study|Patient's condition per principal investigator|1|||
126332735|NCT02659943|454513240|FG006|Overall Study|Patient's condition per principal investigator|0|||
126332736|NCT02659943|454513234|FG000|Overall Study|Ineligible|0|||
126332737|NCT02659943|454513235|FG001|Overall Study|Ineligible|0|||
126332738|NCT02659943|454513236|FG002|Overall Study|Ineligible|0|||
126332739|NCT02659943|454513237|FG003|Overall Study|Ineligible|0|||
126332740|NCT02659943|454513238|FG004|Overall Study|Ineligible|0|||
126332741|NCT02659943|454513239|FG005|Overall Study|Ineligible|0|||
126332742|NCT02659943|454513240|FG006|Overall Study|Ineligible|1|||
126332743|NCT02659943|454513234|FG000|Overall Study|No longer meets eligibility|0|||
126332744|NCT02659943|454513235|FG001|Overall Study|No longer meets eligibility|0|||
126332745|NCT02659943|454513236|FG002|Overall Study|No longer meets eligibility|0|||
126332746|NCT02659943|454513237|FG003|Overall Study|No longer meets eligibility|0|||
126332747|NCT02659943|454513238|FG004|Overall Study|No longer meets eligibility|0|||
126332748|NCT02659943|454513239|FG005|Overall Study|No longer meets eligibility|0|||
126332749|NCT02659943|454513240|FG006|Overall Study|No longer meets eligibility|1|||
126332750|NCT02659943|454513234|FG000|Overall Study|No treatment, per protocol|0|||
126332751|NCT02659943|454513235|FG001|Overall Study|No treatment, per protocol|0|||
126332752|NCT02659943|454513236|FG002|Overall Study|No treatment, per protocol|0|||
126332753|NCT02659943|454513237|FG003|Overall Study|No treatment, per protocol|0|||
126332754|NCT02659943|454513238|FG004|Overall Study|No treatment, per protocol|0|||
126332755|NCT02659943|454513239|FG005|Overall Study|No treatment, per protocol|0|||
126332756|NCT02659943|454513240|FG006|Overall Study|No treatment, per protocol|3|||
126332757|NCT01576575|454513241|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
125997931|NCT03249376|453285370|FG001|Overall Study|Adverse Event|5|||
125997932|NCT03249376|453285369|FG000|Overall Study|Lack of Efficacy|2|||
125997933|NCT03249376|453285370|FG001|Overall Study|Lack of Efficacy|4|||
126332758|NCT01576575|454513241|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
125997934|NCT03249376|453285369|FG000|Overall Study|Protocol Violation|3|||
126332759|NCT01576575|454513241|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
126332760|NCT01723072|454513242|FG000|Overall Study|Withdrawal by Subject|7|||
126332761|NCT01723072|454513243|FG001|Overall Study|Withdrawal by Subject|13|||
126332762|NCT01723072|454513242|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
126332763|NCT01723072|454513243|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
126332764|NCT01723072|454513242|FG000|Overall Study|Other|4|||
126332765|NCT01723072|454513243|FG001|Overall Study|Other|3|||
126332766|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
125997935|NCT03249376|453285370|FG001|Overall Study|Protocol Violation|2|||
125997936|NCT03249376|453285369|FG000|Overall Study|Physician Decision|0|||
125997937|NCT03249376|453285370|FG001|Overall Study|Physician Decision|2|||
125997938|NCT03249376|453285369|FG000|Overall Study|Withdrawal by Subject|3|||
125997939|NCT03249376|453285370|FG001|Overall Study|Withdrawal by Subject|9|||
125997940|NCT03249376|453285369|FG000|Overall Study|LTFU|2|||
125997941|NCT03249376|453285370|FG001|Overall Study|LTFU|1|||
125997942|NCT00627042|453285371|FG000|Overall Study|Withdrawal by Subject|2|||
125997943|NCT01154036|453285372|FG000|Phase I|Physician Decision|0|||
125997944|NCT01154036|453285373|FG001|Phase I|Physician Decision|1|||
125997945|NCT01154036|453285374|FG002|Phase I|Physician Decision|0|||
125997946|NCT01154036|453285375|FG003|Phase I|Physician Decision|0|||
125997947|NCT01154036|453285376|FG004|Phase I|Physician Decision|0|||
125997948|NCT01154036|453285377|FG005|Phase I|Physician Decision|0|||
125997949|NCT01154036|453285378|FG006|Phase I|Physician Decision|0|||
125997950|NCT01154036|453285379|FG007|Phase I|Physician Decision|0|||
125997951|NCT01154036|453285372|FG000|Phase I|Lost to Follow-up|0|||
125997952|NCT01154036|453285373|FG001|Phase I|Lost to Follow-up|3|||
125997953|NCT01154036|453285374|FG002|Phase I|Lost to Follow-up|6|||
125997954|NCT01154036|453285375|FG003|Phase I|Lost to Follow-up|0|||
125997955|NCT01154036|453285376|FG004|Phase I|Lost to Follow-up|0|||
125997956|NCT01154036|453285377|FG005|Phase I|Lost to Follow-up|0|||
125997957|NCT01154036|453285378|FG006|Phase I|Lost to Follow-up|0|||
125997958|NCT01154036|453285379|FG007|Phase I|Lost to Follow-up|0|||
125997959|NCT01154036|453285372|FG000|Phase I|Protocol Violation|0|||
125997960|NCT01154036|453285373|FG001|Phase I|Protocol Violation|3|||
125997961|NCT01154036|453285374|FG002|Phase I|Protocol Violation|9|||
125997962|NCT01154036|453285375|FG003|Phase I|Protocol Violation|0|||
125997963|NCT01154036|453285376|FG004|Phase I|Protocol Violation|0|||
125997964|NCT01154036|453285377|FG005|Phase I|Protocol Violation|0|||
125997965|NCT01154036|453285378|FG006|Phase I|Protocol Violation|0|||
125997966|NCT01154036|453285379|FG007|Phase I|Protocol Violation|0|||
125997967|NCT01154036|453285372|FG000|Phase I|Withdrawal by Subject|2|||
125997968|NCT01154036|453285373|FG001|Phase I|Withdrawal by Subject|10|||
125997969|NCT01154036|453285374|FG002|Phase I|Withdrawal by Subject|29|||
125997970|NCT01154036|453285375|FG003|Phase I|Withdrawal by Subject|0|||
125997971|NCT01154036|453285376|FG004|Phase I|Withdrawal by Subject|0|||
125997972|NCT01154036|453285377|FG005|Phase I|Withdrawal by Subject|0|||
125997973|NCT01154036|453285378|FG006|Phase I|Withdrawal by Subject|0|||
125997974|NCT01154036|453285379|FG007|Phase I|Withdrawal by Subject|0|||
125997975|NCT01154036|453285372|FG000|Phase I|Adverse Event|1|||
125997976|NCT01154036|453285373|FG001|Phase I|Adverse Event|11|||
125997977|NCT01154036|453285374|FG002|Phase I|Adverse Event|12|||
125997978|NCT01154036|453285375|FG003|Phase I|Adverse Event|0|||
125997979|NCT01154036|453285376|FG004|Phase I|Adverse Event|0|||
125997980|NCT01154036|453285377|FG005|Phase I|Adverse Event|0|||
125997981|NCT01154036|453285378|FG006|Phase I|Adverse Event|0|||
125997982|NCT01154036|453285379|FG007|Phase I|Adverse Event|0|||
125997983|NCT01154036|453285372|FG000|Phase II|Adverse Event|0|||
125997984|NCT01154036|453285373|FG001|Phase II|Adverse Event|0|||
125997985|NCT01154036|453285374|FG002|Phase II|Adverse Event|0|||
125997986|NCT01154036|453285375|FG003|Phase II|Adverse Event|0|||
126332767|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332768|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
126332769|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
126332770|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332771|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332772|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332773|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332774|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332775|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332776|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125997987|NCT01154036|453285376|FG004|Phase II|Adverse Event|1|||
125997988|NCT01154036|453285377|FG005|Phase II|Adverse Event|1|||
125997989|NCT01154036|453285378|FG006|Phase II|Adverse Event|1|||
125997990|NCT01154036|453285379|FG007|Phase II|Adverse Event|1|||
125997991|NCT01154036|453285372|FG000|Phase II|Physician Decision|0|||
125997992|NCT01154036|453285373|FG001|Phase II|Physician Decision|0|||
125997993|NCT01154036|453285374|FG002|Phase II|Physician Decision|0|||
125997994|NCT01154036|453285375|FG003|Phase II|Physician Decision|0|||
125997995|NCT01154036|453285376|FG004|Phase II|Physician Decision|0|||
125997996|NCT01154036|453285377|FG005|Phase II|Physician Decision|0|||
125997997|NCT01154036|453285378|FG006|Phase II|Physician Decision|1|||
125997998|NCT01154036|453285379|FG007|Phase II|Physician Decision|0|||
125997999|NCT01154036|453285372|FG000|Phase II|Lost to Follow-up|0|||
125998000|NCT01154036|453285373|FG001|Phase II|Lost to Follow-up|0|||
125998001|NCT01154036|453285374|FG002|Phase II|Lost to Follow-up|0|||
125998002|NCT01154036|453285375|FG003|Phase II|Lost to Follow-up|1|||
125998003|NCT01154036|453285376|FG004|Phase II|Lost to Follow-up|2|||
125998004|NCT01154036|453285377|FG005|Phase II|Lost to Follow-up|0|||
125998005|NCT01154036|453285378|FG006|Phase II|Lost to Follow-up|2|||
126332777|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332778|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332779|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332780|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332781|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332782|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332783|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332784|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332785|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
126332786|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
126332787|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
126332788|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
126332789|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332790|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332791|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332792|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332793|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332794|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332795|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332796|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332797|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332798|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332799|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332800|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332801|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332802|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332803|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332804|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332805|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
126332806|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
126332807|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332808|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332809|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332810|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332811|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332812|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332813|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332814|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332815|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332816|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332817|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332818|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332819|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332820|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332821|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332822|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332823|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
126332824|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332825|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332826|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332827|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332828|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332829|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332830|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332831|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332832|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332833|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332834|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332835|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332836|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332837|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332838|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332839|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332840|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332841|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332842|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332843|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
126332844|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332845|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332846|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332847|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332848|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332849|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332850|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332851|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332852|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332853|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332854|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332855|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332856|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332857|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332858|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332859|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332860|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332861|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332862|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332863|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332864|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332865|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332866|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
126332867|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332868|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
126332869|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332870|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332871|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332872|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332873|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
126332874|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332875|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332876|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332877|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
126332878|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332879|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332880|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
126332881|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
126332882|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
126332883|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
126332884|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
126332885|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
125998006|NCT01154036|453285379|FG007|Phase II|Lost to Follow-up|1|||
125998007|NCT01154036|453285372|FG000|Phase II|Protocol Violation|0|||
125998008|NCT01154036|453285373|FG001|Phase II|Protocol Violation|0|||
125998009|NCT01154036|453285374|FG002|Phase II|Protocol Violation|0|||
125998010|NCT01154036|453285375|FG003|Phase II|Protocol Violation|0|||
125998011|NCT01154036|453285376|FG004|Phase II|Protocol Violation|1|||
125998012|NCT01154036|453285377|FG005|Phase II|Protocol Violation|2|||
125998013|NCT01154036|453285378|FG006|Phase II|Protocol Violation|0|||
125998014|NCT01154036|453285379|FG007|Phase II|Protocol Violation|0|||
125998015|NCT01154036|453285372|FG000|Phase II|Withdrawal by Subject|0|||
125998016|NCT01154036|453285373|FG001|Phase II|Withdrawal by Subject|0|||
125998017|NCT01154036|453285374|FG002|Phase II|Withdrawal by Subject|0|||
125998018|NCT01154036|453285375|FG003|Phase II|Withdrawal by Subject|0|||
125998019|NCT01154036|453285376|FG004|Phase II|Withdrawal by Subject|4|||
125998020|NCT01154036|453285377|FG005|Phase II|Withdrawal by Subject|2|||
125998021|NCT01154036|453285378|FG006|Phase II|Withdrawal by Subject|5|||
125998022|NCT01154036|453285379|FG007|Phase II|Withdrawal by Subject|4|||
125998023|NCT01349907|453285380|FG000|Overall Study|Adverse Event|37|||
125998024|NCT01349907|453285381|FG001|Overall Study|Adverse Event|11|||
125998025|NCT01349907|453285380|FG000|Overall Study|Treatment failure|13|||
125998026|NCT01349907|453285381|FG001|Overall Study|Treatment failure|4|||
125998027|NCT01349907|453285380|FG000|Overall Study|Lost to Follow-up|25|||
125998028|NCT01349907|453285381|FG001|Overall Study|Lost to Follow-up|6|||
126332886|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
126332887|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
126332888|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
126332889|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
126332890|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
126332891|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
126332892|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
126332893|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
126332894|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
126332895|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
126332896|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
126332897|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
126332898|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
126332899|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332900|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332901|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332902|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332903|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
126332904|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
126332905|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
126332906|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332907|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332908|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332909|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332910|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332911|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
126332912|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
126332913|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
126332914|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
126332915|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332916|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332917|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
126332918|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332919|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332920|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332921|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125998029|NCT01349907|453285380|FG000|Overall Study|Withdrawal by Subject|30|||
125998030|NCT01349907|453285381|FG001|Overall Study|Withdrawal by Subject|8|||
125998031|NCT01349907|453285380|FG000|Overall Study|Protocol Violation|33|||
125998032|NCT01349907|453285381|FG001|Overall Study|Protocol Violation|13|||
125998033|NCT01349907|453285380|FG000|Overall Study|Administrative|1|||
125998034|NCT01349907|453285381|FG001|Overall Study|Administrative|1|||
125998035|NCT03583541|453285389|FG000|Overall Study|Lost to Follow-up|31|||
125998036|NCT03583541|453285390|FG001|Overall Study|Lost to Follow-up|65|||
125998037|NCT04102540|453285391|FG000|Overall Study|Withdrawn by PI|2|||
125998038|NCT04102540|453285391|FG000|Overall Study|Lost to Follow-up|6|||
125998039|NCT03405662|453285393|FG000|Overall Study|COVID-19 restriction|1|||
125998040|NCT03405662|453285394|FG001|Overall Study|COVID-19 restriction|0|||
125998041|NCT03405662|453285393|FG000|Overall Study|unblinding|0|||
125998042|NCT03405662|453285394|FG001|Overall Study|unblinding|1|||
125998043|NCT03405662|453285393|FG000|Overall Study|placement in memory care facility|0|||
125998044|NCT03405662|453285394|FG001|Overall Study|placement in memory care facility|2|||
125998045|NCT01686932|453285400|FG000|Period 1|Adverse Event|1|||
125998046|NCT01686932|453285401|FG001|Period 1|Adverse Event|1|||
125998047|NCT01364727|453285402|FG000|Overall Study|Not Eligible|2|||
125998048|NCT01009047|453285403|FG000|Overall Study|Adverse Event|5|||
125998049|NCT01009047|453285404|FG001|Overall Study|Adverse Event|0|||
125998050|NCT01009047|453285403|FG000|Overall Study|Lost to Follow-up|0|||
125998051|NCT01009047|453285404|FG001|Overall Study|Lost to Follow-up|2|||
125998052|NCT01009047|453285403|FG000|Overall Study|Lack of Efficacy|4|||
125998053|NCT01009047|453285404|FG001|Overall Study|Lack of Efficacy|11|||
125998054|NCT01009047|453285403|FG000|Overall Study|Withdrawal by consent|16|||
125998055|NCT01009047|453285404|FG001|Overall Study|Withdrawal by consent|11|||
126332922|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332923|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332924|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332925|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
126332926|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125998056|NCT01009047|453285403|FG000|Overall Study|Other|3|||
125998057|NCT01009047|453285404|FG001|Overall Study|Other|2|||
125998058|NCT03875911|453285409|FG000|Overall Study|Lost to Follow-up|3|||
125998059|NCT03875911|453285410|FG001|Overall Study|Lost to Follow-up|6|||
126332927|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332928|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332929|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
126332930|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
126332931|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332932|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
126332933|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332934|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332935|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
126332936|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332937|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
126332938|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
126332939|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
126332940|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
126332941|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
126332942|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
126332943|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
126332944|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
126332945|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
126332946|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
126332947|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
126332948|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
126332949|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
126332950|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
126332951|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
126332952|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
125998060|NCT03875911|453285411|FG002|Overall Study|Lost to Follow-up|2|||
125998061|NCT03875911|453285409|FG000|Overall Study|Surgery cancelled|1|||
125998062|NCT03875911|453285410|FG001|Overall Study|Surgery cancelled|0|||
125998063|NCT03875911|453285411|FG002|Overall Study|Surgery cancelled|1|||
125998064|NCT03875911|453285409|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
125998065|NCT03875911|453285410|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
125998066|NCT03875911|453285411|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
125998067|NCT03824938|453285412|FG000|Overall Study|Withdrawal by Subject|2|||
125998068|NCT03824938|453285413|FG001|Overall Study|Withdrawal by Subject|1|||
125998069|NCT03824938|453285414|FG002|Overall Study|Withdrawal by Subject|0|||
125998070|NCT03824938|453285415|FG003|Overall Study|Withdrawal by Subject|2|||
126332953|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
126332954|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
126332955|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
125998071|NCT03824938|453285416|FG004|Overall Study|Withdrawal by Subject|0|||
126332956|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125998072|NCT03824938|453285417|FG005|Overall Study|Withdrawal by Subject|1|||
125998073|NCT03824938|453285412|FG000|Overall Study|Lost to Follow-up|0|||
125998074|NCT03824938|453285413|FG001|Overall Study|Lost to Follow-up|1|||
125998075|NCT03824938|453285414|FG002|Overall Study|Lost to Follow-up|0|||
125998076|NCT03824938|453285415|FG003|Overall Study|Lost to Follow-up|0|||
125998077|NCT03824938|453285416|FG004|Overall Study|Lost to Follow-up|1|||
125998078|NCT03824938|453285417|FG005|Overall Study|Lost to Follow-up|0|||
125998079|NCT01990300|453285418|FG000|Overall Study|Case Report Forms Uncollected|89|||
125998080|NCT01990300|453285418|FG000|Overall Study|Protocol Deviation|53|||
125998081|NCT00393094|453285421|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
125998082|NCT00393094|453285421|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
125998083|NCT03653416|453285422|FG000|Overall Study|Protocol Violation|6|||
125998084|NCT03653416|453285423|FG001|Overall Study|Protocol Violation|1|||
125998085|NCT02788006|453285424|FG000|Overall Study|Patient not treated|1|||
125998086|NCT03050398|453285425|FG000|Overall Study|Study terminated by sponsor|8|||
125998087|NCT00598481|453285426|FG000|Treatment|Physician Decision|1|||
125998088|NCT03523871|453285427|FG000|Overall Study|Death|1|||
125998089|NCT01994720|453285428|FG000|Overall Study|Withdrawal by Subject|46|||
126332957|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332958|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332959|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125998090|NCT01994720|453285429|FG001|Overall Study|Withdrawal by Subject|56|||
125998091|NCT01991197|453285430|FG000|Overall Study|Lost to Follow-up|1|||
125998092|NCT01991197|453285431|FG001|Overall Study|Lost to Follow-up|1|||
125998093|NCT01991197|453285430|FG000|Overall Study|Physician Decision|0|||
125998094|NCT01991197|453285431|FG001|Overall Study|Physician Decision|2|||
125998095|NCT01991197|453285430|FG000|Overall Study|Withdrawal by Subject|2|||
126332960|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125998096|NCT01991197|453285431|FG001|Overall Study|Withdrawal by Subject|0|||
125998097|NCT04285229|453285435|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126332961|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332962|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
126332963|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332964|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332965|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332966|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332967|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332968|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332969|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332970|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332971|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332972|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332973|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332974|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
126332975|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
126332976|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
126332977|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
126332978|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
126332979|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
126332980|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
126332981|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
126332982|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
126332983|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
126332984|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
126332985|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
126332986|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
126332987|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
126332988|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
126332989|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
126332990|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
126332991|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
126332992|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
126332993|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
126332994|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126332995|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126332996|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126332997|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126332998|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
126332999|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126333000|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
126333001|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
126333002|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126333003|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
126333004|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
126333005|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
126333006|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125998098|NCT04285229|453285436|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125998099|NCT04285229|453285437|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125998100|NCT04285229|453285438|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125998101|NCT04285229|453285439|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125998102|NCT04285229|453285440|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125998103|NCT04285229|453285435|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
125998104|NCT04285229|453285436|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
125998105|NCT04285229|453285437|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
125998106|NCT04285229|453285438|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
125998107|NCT04285229|453285439|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
125998108|NCT04285229|453285440|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
125998109|NCT04285229|453285435|FG000|Extended Treatment Period|Adverse Event|0|||
125998110|NCT04285229|453285436|FG001|Extended Treatment Period|Adverse Event|0|||
125998111|NCT04285229|453285437|FG002|Extended Treatment Period|Adverse Event|0|||
126333007|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
126333008|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
126333009|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126333010|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
126333011|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
126333012|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126333013|NCT04556760|454513263|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333014|NCT04556760|454513264|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
126333015|NCT04556760|454513265|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333016|NCT04556760|454513266|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333017|NCT04556760|454513267|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333018|NCT04556760|454513268|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333019|NCT04556760|454513263|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333020|NCT04556760|454513264|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333021|NCT04556760|454513265|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333022|NCT04556760|454513266|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
126333023|NCT04556760|454513267|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333024|NCT04556760|454513268|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333025|NCT02221648|454513275|FG000|Overall Study|Withdrawal by Subject|3|||
126333026|NCT02221648|454513276|FG001|Overall Study|Withdrawal by Subject|3|||
126333027|NCT03489343|454513280|FG000|Overall Study|Documented progressive disease|1|||
126333028|NCT03489343|454513281|FG001|Overall Study|Documented progressive disease|0|||
126333029|NCT03489343|454513282|FG002|Overall Study|Documented progressive disease|3|||
126333030|NCT03489343|454513283|FG003|Overall Study|Documented progressive disease|1|||
126333031|NCT03489343|454513284|FG004|Overall Study|Documented progressive disease|3|||
126333032|NCT03489343|454513285|FG005|Overall Study|Documented progressive disease|5|||
126333033|NCT03489343|454513286|FG006|Overall Study|Documented progressive disease|4|||
126333034|NCT03489343|454513280|FG000|Overall Study|Adverse Event|0|||
126333035|NCT03489343|454513281|FG001|Overall Study|Adverse Event|1|||
126333036|NCT03489343|454513282|FG002|Overall Study|Adverse Event|0|||
126333037|NCT03489343|454513283|FG003|Overall Study|Adverse Event|0|||
126333038|NCT03489343|454513284|FG004|Overall Study|Adverse Event|0|||
126333039|NCT03489343|454513285|FG005|Overall Study|Adverse Event|1|||
126333040|NCT03489343|454513286|FG006|Overall Study|Adverse Event|0|||
126333041|NCT03489343|454513280|FG000|Overall Study|Withdrawal by Subject|0|||
126333042|NCT03489343|454513281|FG001|Overall Study|Withdrawal by Subject|0|||
126333043|NCT03489343|454513282|FG002|Overall Study|Withdrawal by Subject|0|||
126333044|NCT03489343|454513283|FG003|Overall Study|Withdrawal by Subject|1|||
126333045|NCT03489343|454513284|FG004|Overall Study|Withdrawal by Subject|0|||
126333046|NCT03489343|454513285|FG005|Overall Study|Withdrawal by Subject|1|||
126333047|NCT03489343|454513286|FG006|Overall Study|Withdrawal by Subject|1|||
126333048|NCT03489343|454513280|FG000|Overall Study|Clinical progression|0|||
126333049|NCT03489343|454513281|FG001|Overall Study|Clinical progression|0|||
126333050|NCT03489343|454513282|FG002|Overall Study|Clinical progression|0|||
126333051|NCT03489343|454513283|FG003|Overall Study|Clinical progression|1|||
126333052|NCT03489343|454513284|FG004|Overall Study|Clinical progression|0|||
126333053|NCT03489343|454513285|FG005|Overall Study|Clinical progression|0|||
126333054|NCT03489343|454513286|FG006|Overall Study|Clinical progression|1|||
126333055|NCT00565604|454513290|FG000|Overall Study|Failure to treat|2|||
126333056|NCT00565604|454513290|FG000|Overall Study|Lost to Follow-up|2|||
126333057|NCT05027815|454513291|FG000|Overall Study|Death|2|||
126333058|NCT05027815|454513292|FG001|Overall Study|Death|1|||
126333059|NCT01395810|454513295|FG000|Overall Study|Adverse Event|0|||
126333060|NCT01395810|454513296|FG001|Overall Study|Adverse Event|1|||
126333061|NCT01395810|454513297|FG002|Overall Study|Adverse Event|0|||
126333062|NCT01395810|454513298|FG003|Overall Study|Adverse Event|0|||
126333063|NCT01395810|454513295|FG000|Overall Study|Lack of Efficacy|0|||
126333064|NCT01395810|454513296|FG001|Overall Study|Lack of Efficacy|1|||
126333065|NCT01395810|454513297|FG002|Overall Study|Lack of Efficacy|0|||
126333066|NCT01395810|454513298|FG003|Overall Study|Lack of Efficacy|0|||
126333067|NCT01395810|454513295|FG000|Overall Study|Withdrawal criteria|0|||
126333068|NCT01395810|454513296|FG001|Overall Study|Withdrawal criteria|2|||
126333069|NCT01395810|454513297|FG002|Overall Study|Withdrawal criteria|0|||
126333070|NCT01395810|454513298|FG003|Overall Study|Withdrawal criteria|0|||
126333071|NCT01395810|454513295|FG000|Overall Study|Unclassified|2|||
126333072|NCT01395810|454513296|FG001|Overall Study|Unclassified|0|||
126333073|NCT01395810|454513297|FG002|Overall Study|Unclassified|0|||
126333074|NCT01395810|454513298|FG003|Overall Study|Unclassified|0|||
126333075|NCT03677869|454513302|FG000|Overall Study|Withdrawal by Subject|1|||
126333076|NCT04265261|454513304|FG000|Overall Study|Adverse Event|2|||
126333077|NCT04265261|454513305|FG001|Overall Study|Adverse Event|0|||
126333078|NCT04265261|454513306|FG002|Overall Study|Adverse Event|0|||
126333079|NCT04265261|454513304|FG000|Overall Study|Death|1|||
126333080|NCT04265261|454513305|FG001|Overall Study|Death|0|||
126333081|NCT04265261|454513306|FG002|Overall Study|Death|0|||
125998112|NCT04285229|453285438|FG003|Extended Treatment Period|Adverse Event|1|||
126333082|NCT04265261|454513304|FG000|Overall Study|Lost to Follow-up|4|||
126333083|NCT04265261|454513305|FG001|Overall Study|Lost to Follow-up|1|||
126333084|NCT04265261|454513306|FG002|Overall Study|Lost to Follow-up|3|||
126333085|NCT04265261|454513304|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126333086|NCT04265261|454513305|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126333087|NCT04265261|454513306|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126333088|NCT04265261|454513304|FG000|Overall Study|Physician Decision|0|||
126333089|NCT04265261|454513305|FG001|Overall Study|Physician Decision|0|||
126333090|NCT04265261|454513306|FG002|Overall Study|Physician Decision|1|||
126333091|NCT04265261|454513304|FG000|Overall Study|Protocol Deviation|0|||
126333092|NCT04265261|454513305|FG001|Overall Study|Protocol Deviation|2|||
126333093|NCT04265261|454513306|FG002|Overall Study|Protocol Deviation|0|||
126333094|NCT04265261|454513304|FG000|Overall Study|Withdrawal by Subject|2|||
126333095|NCT04265261|454513305|FG001|Overall Study|Withdrawal by Subject|1|||
126333096|NCT04265261|454513306|FG002|Overall Study|Withdrawal by Subject|4|||
126333097|NCT03877224|454513307|FG000|Overall Study|Death|3|||
126333098|NCT03877224|454513308|FG001|Overall Study|Death|2|||
126333099|NCT03877224|454513307|FG000|Overall Study|Withdrawal by Subject|1|||
125998113|NCT04285229|453285439|FG004|Extended Treatment Period|Adverse Event|0|||
125998114|NCT04285229|453285440|FG005|Extended Treatment Period|Adverse Event|0|||
125998115|NCT04285229|453285435|FG000|Extended Treatment Period|Physician Decision|0|||
126333100|NCT03877224|454513308|FG001|Overall Study|Withdrawal by Subject|6|||
126333101|NCT03877224|454513307|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
126333102|NCT03877224|454513308|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
126333103|NCT01212094|454515011|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
126333104|NCT01212094|454515012|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
126333105|NCT01212094|454515013|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
126333106|NCT01212094|454515011|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
126333107|NCT01212094|454515012|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
126333108|NCT01212094|454515013|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
126333109|NCT01212094|454515011|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
126333110|NCT01212094|454515012|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
126333111|NCT01212094|454515013|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
126333112|NCT01212094|454515011|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
126333113|NCT01212094|454515012|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
126333114|NCT01212094|454515013|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
126333115|NCT01212094|454515011|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
126333116|NCT01212094|454515012|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
126333117|NCT01212094|454515013|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
126333118|NCT01212094|454515011|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
126333119|NCT01212094|454515012|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
126333120|NCT01212094|454515013|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
126333121|NCT02019550|454515015|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
126333122|NCT02019550|454515016|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
126333123|NCT00823134|454515018|FG000|Overall Study|Invalid measurement|1|||
126333124|NCT02291029|454515019|FG000|Overall Study|Withdrawal by Subject|0|||
126333125|NCT02291029|454515020|FG001|Overall Study|Withdrawal by Subject|0|||
126333126|NCT02291029|454515021|FG002|Overall Study|Withdrawal by Subject|1|||
126333127|NCT02291029|454515022|FG003|Overall Study|Withdrawal by Subject|0|||
126333128|NCT02291029|454515023|FG004|Overall Study|Withdrawal by Subject|0|||
126333129|NCT02291029|454515024|FG005|Overall Study|Withdrawal by Subject|0|||
126333130|NCT02291029|454515019|FG000|Overall Study|Adverse Event|0|||
126333131|NCT02291029|454515020|FG001|Overall Study|Adverse Event|1|||
126333132|NCT02291029|454515021|FG002|Overall Study|Adverse Event|0|||
126333133|NCT02291029|454515022|FG003|Overall Study|Adverse Event|0|||
126333134|NCT02291029|454515023|FG004|Overall Study|Adverse Event|0|||
126333135|NCT02291029|454515024|FG005|Overall Study|Adverse Event|0|||
126333136|NCT02922153|454515028|FG000|Overall Study|Death|8|||
126333137|NCT02922153|454515029|FG001|Overall Study|Death|1|||
126333138|NCT02922153|454515028|FG000|Overall Study|Lost to Follow-up|1|||
126333139|NCT02922153|454515029|FG001|Overall Study|Lost to Follow-up|0|||
126333140|NCT02922153|454515028|FG000|Overall Study|Physician Decision|1|||
126333141|NCT02922153|454515029|FG001|Overall Study|Physician Decision|1|||
125998116|NCT04285229|453285436|FG001|Extended Treatment Period|Physician Decision|0|||
126333142|NCT02692586|454515032|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
126333143|NCT02692586|454515032|FG000|Overall Study|Received adjunctive thrombolytics|2|||
126333144|NCT01051557|454515034|FG000|Overall Study|Physician Decision|1|||
126333145|NCT01051557|454515035|FG001|Overall Study|Physician Decision|0|||
126333146|NCT01051557|454515036|FG002|Overall Study|Physician Decision|0|||
126333147|NCT01051557|454515037|FG003|Overall Study|Physician Decision|0|||
126333148|NCT01051557|454515038|FG004|Overall Study|Physician Decision|0|||
125998117|NCT04285229|453285437|FG002|Extended Treatment Period|Physician Decision|1|||
125998118|NCT04285229|453285438|FG003|Extended Treatment Period|Physician Decision|0|||
125998119|NCT04285229|453285439|FG004|Extended Treatment Period|Physician Decision|0|||
125998120|NCT04285229|453285440|FG005|Extended Treatment Period|Physician Decision|0|||
125998121|NCT04285229|453285435|FG000|Follow-up Period|Adverse Event|0|||
125998122|NCT04285229|453285436|FG001|Follow-up Period|Adverse Event|0|||
125998123|NCT04285229|453285437|FG002|Follow-up Period|Adverse Event|0|||
125998124|NCT04285229|453285438|FG003|Follow-up Period|Adverse Event|0|||
125998125|NCT04285229|453285439|FG004|Follow-up Period|Adverse Event|1|||
125998126|NCT04285229|453285440|FG005|Follow-up Period|Adverse Event|4|||
125998127|NCT04285229|453285435|FG000|Follow-up Period|Withdrawal by Subject|0|||
125998128|NCT04285229|453285436|FG001|Follow-up Period|Withdrawal by Subject|0|||
125998129|NCT04285229|453285437|FG002|Follow-up Period|Withdrawal by Subject|0|||
125998130|NCT04285229|453285438|FG003|Follow-up Period|Withdrawal by Subject|0|||
125998131|NCT04285229|453285439|FG004|Follow-up Period|Withdrawal by Subject|0|||
125998132|NCT04285229|453285440|FG005|Follow-up Period|Withdrawal by Subject|5|||
125998133|NCT04285229|453285435|FG000|Follow-up Period|Covid-19|0|||
125998134|NCT04285229|453285436|FG001|Follow-up Period|Covid-19|0|||
125998135|NCT04285229|453285437|FG002|Follow-up Period|Covid-19|0|||
125998136|NCT04285229|453285438|FG003|Follow-up Period|Covid-19|0|||
125998137|NCT04285229|453285439|FG004|Follow-up Period|Covid-19|0|||
125998138|NCT04285229|453285440|FG005|Follow-up Period|Covid-19|2|||
125998139|NCT04285229|453285435|FG000|Follow-up Period|Physician Decision|0|||
125998140|NCT04285229|453285436|FG001|Follow-up Period|Physician Decision|0|||
125998141|NCT04285229|453285437|FG002|Follow-up Period|Physician Decision|0|||
125998142|NCT04285229|453285438|FG003|Follow-up Period|Physician Decision|0|||
125998143|NCT04285229|453285439|FG004|Follow-up Period|Physician Decision|0|||
125998144|NCT04285229|453285440|FG005|Follow-up Period|Physician Decision|1|||
125998145|NCT02397460|453285441|FG000|Treatment Period 2|Adverse Event|0|||
125998146|NCT02397460|453285442|FG001|Treatment Period 2|Adverse Event|0|||
125998147|NCT02397460|453285443|FG002|Treatment Period 2|Adverse Event|0|||
126333149|NCT01051557|454515039|FG005|Overall Study|Physician Decision|0|||
126333150|NCT01051557|454515040|FG006|Overall Study|Physician Decision|0|||
126333151|NCT01051557|454515034|FG000|Overall Study|disease progression|3|||
126333152|NCT01051557|454515035|FG001|Overall Study|disease progression|3|||
126333153|NCT01051557|454515036|FG002|Overall Study|disease progression|5|||
126333154|NCT01051557|454515037|FG003|Overall Study|disease progression|2|||
126333155|NCT01051557|454515038|FG004|Overall Study|disease progression|4|||
126333156|NCT01051557|454515039|FG005|Overall Study|disease progression|3|||
126333157|NCT01051557|454515040|FG006|Overall Study|disease progression|1|||
126333158|NCT01051557|454515034|FG000|Overall Study|Withdrawal by Subject|0|||
126333159|NCT01051557|454515035|FG001|Overall Study|Withdrawal by Subject|0|||
126333160|NCT01051557|454515036|FG002|Overall Study|Withdrawal by Subject|1|||
126333161|NCT01051557|454515037|FG003|Overall Study|Withdrawal by Subject|0|||
126333162|NCT01051557|454515038|FG004|Overall Study|Withdrawal by Subject|2|||
126333163|NCT01051557|454515039|FG005|Overall Study|Withdrawal by Subject|0|||
126333164|NCT01051557|454515040|FG006|Overall Study|Withdrawal by Subject|1|||
126333165|NCT01051557|454515034|FG000|Overall Study|Adverse Event|0|||
126333166|NCT01051557|454515035|FG001|Overall Study|Adverse Event|0|||
126333167|NCT01051557|454515036|FG002|Overall Study|Adverse Event|0|||
126333168|NCT01051557|454515037|FG003|Overall Study|Adverse Event|1|||
126333169|NCT01051557|454515038|FG004|Overall Study|Adverse Event|1|||
126333170|NCT01051557|454515039|FG005|Overall Study|Adverse Event|3|||
126333171|NCT01051557|454515040|FG006|Overall Study|Adverse Event|4|||
126333172|NCT04110314|454515041|FG000|Overall Study|Did not meet inclusion criteria|35255|||
126333173|NCT04110314|454515042|FG001|Overall Study|Did not meet inclusion criteria|35104|||
126333174|NCT04110314|454515043|FG002|Overall Study|Did not meet inclusion criteria|35636|||
126333175|NCT04110314|454515044|FG003|Overall Study|Did not meet inclusion criteria|35135|||
126333176|NCT04110314|454515045|FG004|Overall Study|Did not meet inclusion criteria|35247|||
126333177|NCT04110314|454515046|FG005|Overall Study|Did not meet inclusion criteria|35727|||
126333178|NCT01178125|454515055|FG000|Overall Study|Lost to Follow-up|397|||
126333179|NCT01178125|454515055|FG000|Overall Study|Adverse Event|244|||
126333180|NCT01178125|454515055|FG000|Overall Study|Withdrawal by Subject|209|||
126333181|NCT01178125|454515055|FG000|Overall Study|Noncompliance|184|||
125998148|NCT02397460|453285444|FG003|Treatment Period 2|Adverse Event|0|||
125998149|NCT02397460|453285445|FG004|Treatment Period 2|Adverse Event|0|||
125998150|NCT02397460|453285446|FG005|Treatment Period 2|Adverse Event|0|||
125998151|NCT02397460|453285447|FG006|Treatment Period 2|Adverse Event|0|||
125998152|NCT02397460|453285448|FG007|Treatment Period 2|Adverse Event|1|||
125998153|NCT02397460|453285441|FG000|Treatment Period 4|Adverse Event|0|||
125998154|NCT02397460|453285442|FG001|Treatment Period 4|Adverse Event|1|||
125998155|NCT02397460|453285443|FG002|Treatment Period 4|Adverse Event|0|||
126333182|NCT01178125|454515055|FG000|Overall Study|Pregnancy|55|||
126333183|NCT01178125|454515055|FG000|Overall Study|Other Reason|39|||
126333184|NCT01178125|454515055|FG000|Overall Study|Sponsor Decision|28|||
126333185|NCT01178125|454515055|FG000|Overall Study|Protocol Violation|17|||
126333186|NCT01178125|454515055|FG000|Overall Study|Investigator Decision|5|||
126333187|NCT02948829|454515056|FG000|Overall Study|Lost to Follow-up|2|||
126333188|NCT02948829|454515056|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
125998156|NCT02397460|453285444|FG003|Treatment Period 4|Adverse Event|0|||
125998157|NCT02397460|453285445|FG004|Treatment Period 4|Adverse Event|0|||
125998158|NCT02397460|453285446|FG005|Treatment Period 4|Adverse Event|0|||
125998159|NCT02397460|453285447|FG006|Treatment Period 4|Adverse Event|0|||
125998160|NCT02397460|453285448|FG007|Treatment Period 4|Adverse Event|0|||
125998161|NCT02397460|453285441|FG000|Treatment Period 4|Physician Decision|0|||
125998162|NCT02397460|453285442|FG001|Treatment Period 4|Physician Decision|0|||
125998163|NCT02397460|453285443|FG002|Treatment Period 4|Physician Decision|0|||
125998164|NCT02397460|453285444|FG003|Treatment Period 4|Physician Decision|0|||
125998165|NCT02397460|453285445|FG004|Treatment Period 4|Physician Decision|1|||
126333189|NCT02948829|454515056|FG000|Overall Study|Pregnancy|1|||
126333190|NCT02948829|454515056|FG000|Overall Study|Other: Reason not Specified|8|||
126333191|NCT01004978|454515057|FG000|Overall Study|Disease progression|31|||
126333192|NCT01004978|454515058|FG001|Overall Study|Disease progression|48|||
126333193|NCT01004978|454515057|FG000|Overall Study|Adverse Event|42|||
126333194|NCT01004978|454515058|FG001|Overall Study|Adverse Event|22|||
125998166|NCT02397460|453285446|FG005|Treatment Period 4|Physician Decision|0|||
125998167|NCT02397460|453285447|FG006|Treatment Period 4|Physician Decision|0|||
125998168|NCT02397460|453285448|FG007|Treatment Period 4|Physician Decision|0|||
125998169|NCT04793464|453285449|FG000|Overall Study|Lost to Follow-up|458|||
125998170|NCT04793464|453285450|FG001|Overall Study|Lost to Follow-up|168|||
125998171|NCT04793464|453285451|FG002|Overall Study|Lost to Follow-up|5|||
125998172|NCT04793464|453285449|FG000|Overall Study|Withdrawal by Subject|43|||
125998173|NCT04793464|453285450|FG001|Overall Study|Withdrawal by Subject|15|||
125998174|NCT04793464|453285451|FG002|Overall Study|Withdrawal by Subject|0|||
125998175|NCT02169830|453286996|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
125998176|NCT02169830|453286997|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
125998177|NCT02169830|453286998|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
125998178|NCT02169830|453286996|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
125998179|NCT02169830|453286997|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
125998180|NCT02169830|453286998|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
125998181|NCT02169830|453286996|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
125998182|NCT02169830|453286997|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
125998183|NCT02169830|453286998|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
125998184|NCT02169830|453286996|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
125998185|NCT02169830|453286997|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
125998186|NCT02169830|453286998|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
125998187|NCT02169830|453286996|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
125998188|NCT02169830|453286997|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
125998189|NCT02169830|453286998|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
125998190|NCT03615482|453286999|FG000|Overall Study|Death|1|||
125998191|NCT03615482|453287000|FG001|Overall Study|Death|0|||
125998192|NCT03615482|453286999|FG000|Overall Study|Lost to Follow-up|7|||
125998193|NCT03615482|453287000|FG001|Overall Study|Lost to Follow-up|7|||
125998194|NCT03615482|453286999|FG000|Overall Study|Physician Decision|2|||
125998195|NCT03615482|453287000|FG001|Overall Study|Physician Decision|3|||
125998196|NCT03615482|453286999|FG000|Overall Study|Withdrawal by Subject|7|||
125998197|NCT03615482|453287000|FG001|Overall Study|Withdrawal by Subject|7|||
125998198|NCT02018861|453287003|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125998199|NCT02018861|453287004|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
125998200|NCT02018861|453287005|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
125998201|NCT02018861|453287006|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
125998202|NCT02018861|453287007|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
125998203|NCT02018861|453287008|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
125998204|NCT02018861|453287009|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125998205|NCT02018861|453287010|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125998206|NCT02018861|453287011|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125998207|NCT02018861|453287012|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125998208|NCT02018861|453287003|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125998209|NCT02018861|453287004|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125998210|NCT02018861|453287005|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125998211|NCT02018861|453287006|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
125998212|NCT02018861|453287007|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
125998213|NCT02018861|453287008|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125998214|NCT02018861|453287009|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125998215|NCT02018861|453287010|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125998216|NCT02018861|453287011|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125998217|NCT02018861|453287012|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125998218|NCT02018861|453287003|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
126333195|NCT01004978|454515057|FG000|Overall Study|Death|3|||
126333196|NCT01004978|454515058|FG001|Overall Study|Death|2|||
126333197|NCT01004978|454515057|FG000|Overall Study|Withdrawal by Subject|16|||
126333198|NCT01004978|454515058|FG001|Overall Study|Withdrawal by Subject|16|||
126333199|NCT01004978|454515057|FG000|Overall Study|Alternative therapy|4|||
126333200|NCT01004978|454515058|FG001|Overall Study|Alternative therapy|8|||
126333201|NCT01004978|454515057|FG000|Overall Study|Physician Decision|6|||
126333202|NCT01004978|454515058|FG001|Overall Study|Physician Decision|3|||
126333203|NCT01004978|454515057|FG000|Overall Study|Other complicating disease|2|||
126333204|NCT01004978|454515058|FG001|Overall Study|Other complicating disease|2|||
126333205|NCT01004978|454515057|FG000|Overall Study|Protocol Violation|2|||
126333206|NCT01004978|454515058|FG001|Overall Study|Protocol Violation|3|||
126333207|NCT01004978|454515057|FG000|Overall Study|Non-compliance|3|||
126333208|NCT01004978|454515058|FG001|Overall Study|Non-compliance|2|||
126333209|NCT01004978|454515057|FG000|Overall Study|Ineligible|1|||
126333210|NCT01004978|454515058|FG001|Overall Study|Ineligible|0|||
126333211|NCT01004978|454515057|FG000|Overall Study|Unblinded|0|||
126333212|NCT01004978|454515058|FG001|Overall Study|Unblinded|1|||
126333213|NCT01004978|454515057|FG000|Overall Study|Performance status worsening|0|||
126333214|NCT01004978|454515058|FG001|Overall Study|Performance status worsening|1|||
126333215|NCT01004978|454515057|FG000|Overall Study|Never started treatment|8|||
125998219|NCT02018861|453287004|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
125998220|NCT02018861|453287005|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
125998221|NCT02018861|453287006|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
126333216|NCT01004978|454515058|FG001|Overall Study|Never started treatment|9|||
126333217|NCT00369915|454515059|FG000|Overall Study|expected side effects|2|||
126333218|NCT00369915|454515060|FG001|Overall Study|expected side effects|1|||
126333219|NCT00369915|454515059|FG000|Overall Study|Withdrawal by Subject|4|||
126333220|NCT00369915|454515060|FG001|Overall Study|Withdrawal by Subject|1|||
126333221|NCT00369915|454515059|FG000|Overall Study|W/drawl by investigators|0|||
126333222|NCT00369915|454515060|FG001|Overall Study|W/drawl by investigators|1|||
126333223|NCT01711983|454515061|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
126333224|NCT01711983|454515061|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
126333225|NCT01711983|454515061|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
126333226|NCT01711983|454515061|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
126333227|NCT01447407|454515062|FG000|Overall Study|Withdrawal by Subject|2|||
126333228|NCT01447407|454515063|FG001|Overall Study|Withdrawal by Subject|0|||
126333229|NCT01447407|454515064|FG002|Overall Study|Withdrawal by Subject|0|||
126333230|NCT01447407|454515065|FG003|Overall Study|Withdrawal by Subject|1|||
126333231|NCT01447407|454515062|FG000|Overall Study|Physician Decision|0|||
126333232|NCT01447407|454515063|FG001|Overall Study|Physician Decision|0|||
126333233|NCT01447407|454515064|FG002|Overall Study|Physician Decision|1|||
126333234|NCT01447407|454515065|FG003|Overall Study|Physician Decision|1|||
126333235|NCT00268983|454515066|FG000|Overall Study|Death|3|||
126333236|NCT00268983|454515067|FG001|Overall Study|Death|0|||
126333237|NCT00321906|454515074|FG000|Overall Study|Adverse Event|36|||
126333238|NCT00321906|454515075|FG001|Overall Study|Adverse Event|44|||
126333239|NCT00321906|454515074|FG000|Overall Study|Death|9|||
126333240|NCT00321906|454515075|FG001|Overall Study|Death|6|||
126333241|NCT00321906|454515074|FG000|Overall Study|Lost to Follow-up|1|||
126333242|NCT00321906|454515075|FG001|Overall Study|Lost to Follow-up|2|||
126333243|NCT00321906|454515074|FG000|Overall Study|Withdrawal by Subject|0|||
126333244|NCT00321906|454515075|FG001|Overall Study|Withdrawal by Subject|4|||
126333245|NCT01272908|454515076|FG000|Initial Treatment Period|Adverse Event|1|||
126333246|NCT01272908|454515076|FG000|Initial Treatment Period|Lack of Efficacy|5|||
126333247|NCT01272908|454515076|FG000|Initial Treatment Period|Protocol Violation|1|||
126333248|NCT01272908|454515076|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
126333249|NCT01272908|454515076|FG000|Re-Treatment Period|Adverse Event|2|||
126333250|NCT01272908|454515076|FG000|Re-Treatment Period|Lack of Efficacy|3|||
126333251|NCT01272908|454515076|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
126333252|NCT01158261|454515077|FG000|Overall Study|Lost to Follow-up|9|||
126333253|NCT01158261|454515077|FG000|Overall Study|Death|7|||
126333254|NCT01158261|454515077|FG000|Overall Study|Withdrawal by Subject|1|||
126333255|NCT03143101|454515078|FG000|Overall Study|Withdrawal by Subject|0|||
126333256|NCT03143101|454515079|FG001|Overall Study|Withdrawal by Subject|1|||
126333257|NCT03143101|454515080|FG002|Overall Study|Withdrawal by Subject|0|||
126333258|NCT03143101|454515078|FG000|Overall Study|Lost to Follow-up|2|||
126333259|NCT03143101|454515079|FG001|Overall Study|Lost to Follow-up|2|||
125998222|NCT02018861|453287007|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
126333260|NCT03143101|454515080|FG002|Overall Study|Lost to Follow-up|0|||
126333261|NCT01630135|454515082|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
126333262|NCT01630135|454515083|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
126333263|NCT03243305|454515086|FG000|Overall Study|Lost to Follow-up|250|||
126333264|NCT03243305|454515086|FG000|Overall Study|Withdrawal by Subject|170|||
126333265|NCT03243305|454515086|FG000|Overall Study|Pregnancy|104|||
126333266|NCT03243305|454515086|FG000|Overall Study|Non-Compliance with Study Drug|38|||
126333267|NCT03243305|454515086|FG000|Overall Study|Adverse Event|23|||
126333268|NCT03243305|454515086|FG000|Overall Study|No sexually active|26|||
126333269|NCT03243305|454515086|FG000|Overall Study|Physician Decision|22|||
125998223|NCT02018861|453287008|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
125998224|NCT02018861|453287009|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125998225|NCT02018861|453287010|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125998226|NCT02018861|453287011|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125998227|NCT02018861|453287012|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125998228|NCT02018861|453287003|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
125998229|NCT02018861|453287004|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125998230|NCT02018861|453287005|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
126209301|NCT05182840|454053182|FG009|Treatment Period|Change of residence|0|||
126209302|NCT05182840|454053173|FG000|Treatment Period|Adverse Event|0|||
126209303|NCT05182840|454053174|FG001|Treatment Period|Adverse Event|0|||
126209304|NCT05182840|454053175|FG002|Treatment Period|Adverse Event|4|||
126209305|NCT05182840|454053176|FG003|Treatment Period|Adverse Event|16|||
126209306|NCT05182840|454053177|FG004|Treatment Period|Adverse Event|12|||
126209307|NCT05182840|454053178|FG005|Treatment Period|Adverse Event|6|||
126209308|NCT05182840|454053179|FG006|Treatment Period|Adverse Event|4|||
126209309|NCT05182840|454053180|FG007|Treatment Period|Adverse Event|8|||
126209310|NCT05182840|454053181|FG008|Treatment Period|Adverse Event|16|||
126209311|NCT05182840|454053182|FG009|Treatment Period|Adverse Event|5|||
126209312|NCT05182840|454053173|FG000|Treatment Period|Not treated with study drug|0|||
126209313|NCT05182840|454053174|FG001|Treatment Period|Not treated with study drug|0|||
126209314|NCT05182840|454053175|FG002|Treatment Period|Not treated with study drug|0|||
126209315|NCT05182840|454053176|FG003|Treatment Period|Not treated with study drug|1|||
126209316|NCT05182840|454053177|FG004|Treatment Period|Not treated with study drug|0|||
126209317|NCT05182840|454053178|FG005|Treatment Period|Not treated with study drug|0|||
126209318|NCT05182840|454053179|FG006|Treatment Period|Not treated with study drug|1|||
126209319|NCT05182840|454053180|FG007|Treatment Period|Not treated with study drug|1|||
126209320|NCT05182840|454053181|FG008|Treatment Period|Not treated with study drug|0|||
126209321|NCT05182840|454053182|FG009|Treatment Period|Not treated with study drug|0|||
126209322|NCT02161380|454053183|FG000|Overall Study|Lost to Follow-up|0|||
126209323|NCT02161380|454053184|FG001|Overall Study|Lost to Follow-up|1|||
126209324|NCT02161380|454053185|FG002|Overall Study|Lost to Follow-up|0|||
126209325|NCT02161380|454053186|FG003|Overall Study|Lost to Follow-up|0|||
126209326|NCT02268214|454053193|FG000|Overall Study|Subject no longer meets study criteria|0|||
126209327|NCT02268214|454053194|FG001|Overall Study|Subject no longer meets study criteria|2|||
126209328|NCT02268214|454053195|FG002|Overall Study|Subject no longer meets study criteria|0|||
126209329|NCT02268214|454053193|FG000|Overall Study|Pregnancy|2|||
126209330|NCT02268214|454053194|FG001|Overall Study|Pregnancy|2|||
126209331|NCT02268214|454053195|FG002|Overall Study|Pregnancy|1|||
126209332|NCT02268214|454053193|FG000|Overall Study|Lost to Follow-up|3|||
126209333|NCT02268214|454053194|FG001|Overall Study|Lost to Follow-up|3|||
126209334|NCT02268214|454053195|FG002|Overall Study|Lost to Follow-up|4|||
126209335|NCT02268214|454053193|FG000|Overall Study|Lack of Efficacy|1|||
126209336|NCT02268214|454053194|FG001|Overall Study|Lack of Efficacy|0|||
126209337|NCT02268214|454053195|FG002|Overall Study|Lack of Efficacy|2|||
126209338|NCT02268214|454053193|FG000|Overall Study|Adverse Event|11|||
126209339|NCT02268214|454053194|FG001|Overall Study|Adverse Event|14|||
126209340|NCT02268214|454053195|FG002|Overall Study|Adverse Event|9|||
126209341|NCT02268214|454053193|FG000|Overall Study|Withdrawal by Subject|4|||
126209342|NCT02268214|454053194|FG001|Overall Study|Withdrawal by Subject|5|||
126209343|NCT02268214|454053195|FG002|Overall Study|Withdrawal by Subject|10|||
126209344|NCT02268214|454053193|FG000|Overall Study|Subject request to discontinue treatment|10|||
126209345|NCT02268214|454053194|FG001|Overall Study|Subject request to discontinue treatment|8|||
126209346|NCT02268214|454053195|FG002|Overall Study|Subject request to discontinue treatment|6|||
126209347|NCT02268214|454053193|FG000|Overall Study|Poor/non-compliance|2|||
126209348|NCT02268214|454053194|FG001|Overall Study|Poor/non-compliance|1|||
126209349|NCT02268214|454053195|FG002|Overall Study|Poor/non-compliance|2|||
126209350|NCT02268214|454053193|FG000|Overall Study|Other reasons|7|||
126209351|NCT02268214|454053194|FG001|Overall Study|Other reasons|3|||
126209352|NCT02268214|454053195|FG002|Overall Study|Other reasons|3|||
126209353|NCT02268214|454053193|FG000|Overall Study|Not entering long-term period|2|||
126209354|NCT02268214|454053194|FG001|Overall Study|Not entering long-term period|3|||
126209355|NCT02268214|454053195|FG002|Overall Study|Not entering long-term period|5|||
126209356|NCT04342390|454053196|FG000|Overall Study|Lost to Follow-up|3|||
126209357|NCT04342390|454053197|FG001|Overall Study|Lost to Follow-up|0|||
126209358|NCT01083121|454053207|FG000|Overall Study|Use of Humira outside the approved label|81|||
126209359|NCT01958619|454053212|FG000|Overall Study|Protocol Violation|2|||
126209360|NCT01958619|454053213|FG001|Overall Study|Protocol Violation|0|||
126209361|NCT01958619|454053214|FG002|Overall Study|Protocol Violation|1|||
126209362|NCT01958619|454053215|FG003|Overall Study|Protocol Violation|0|||
126209363|NCT05403502|454053217|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
126209364|NCT05403502|454053217|FG000|Humalog Lead-In Period|Physician Decision|2|||
126209365|NCT05403502|454053217|FG000|Humalog Lead-In Period|Protocol Violation|1|||
126209366|NCT05403502|454053217|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
126333270|NCT03243305|454515086|FG000|Overall Study|Protocol Violation|22|||
125998231|NCT02018861|453287006|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
125998232|NCT02018861|453287007|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
125998233|NCT02018861|453287008|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125998234|NCT02018861|453287009|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125998235|NCT02018861|453287010|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125998236|NCT02018861|453287011|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125998237|NCT02018861|453287012|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125998238|NCT02018861|453287003|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125998239|NCT02018861|453287004|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125998240|NCT02018861|453287005|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
125998241|NCT02018861|453287006|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
125998242|NCT02018861|453287007|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125998243|NCT02018861|453287008|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125998244|NCT02018861|453287009|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125998245|NCT02018861|453287010|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125998246|NCT02018861|453287011|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125998247|NCT02018861|453287012|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125998248|NCT02018861|453287003|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125998249|NCT02018861|453287004|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125998250|NCT02018861|453287005|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125998251|NCT02018861|453287006|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125998252|NCT02018861|453287007|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
125998253|NCT02018861|453287008|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125998254|NCT02018861|453287009|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125998255|NCT02018861|453287010|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125998256|NCT02018861|453287011|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126333271|NCT03243305|454515086|FG000|Overall Study|Study method no longer primary method|12|||
126333272|NCT03243305|454515086|FG000|Overall Study|Study Terminated by Sponsor|1|||
126333273|NCT03243305|454515086|FG000|Overall Study|Early terminations|267|||
126333274|NCT01166750|454515088|FG000|Overall Study|Lost to Follow-up|1|||
126333275|NCT01166750|454515089|FG001|Overall Study|Lost to Follow-up|0|||
126333276|NCT01585246|454515090|FG000|Overall Study|Lost to Follow-up|0|||
126333277|NCT01585246|454515091|FG001|Overall Study|Lost to Follow-up|0|||
126333278|NCT01585246|454515092|FG002|Overall Study|Lost to Follow-up|2|||
126333279|NCT01585246|454515093|FG003|Overall Study|Lost to Follow-up|1|||
126333280|NCT01585246|454515094|FG004|Overall Study|Lost to Follow-up|0|||
126333281|NCT01585246|454515090|FG000|Overall Study|Protocol Violation|0|||
126333282|NCT01585246|454515091|FG001|Overall Study|Protocol Violation|0|||
126333283|NCT01585246|454515092|FG002|Overall Study|Protocol Violation|0|||
126333284|NCT01585246|454515093|FG003|Overall Study|Protocol Violation|0|||
126333285|NCT01585246|454515094|FG004|Overall Study|Protocol Violation|1|||
126333286|NCT01585246|454515090|FG000|Overall Study|Withdrawal by Subject|0|||
126333287|NCT01585246|454515091|FG001|Overall Study|Withdrawal by Subject|0|||
126333288|NCT01585246|454515092|FG002|Overall Study|Withdrawal by Subject|1|||
126333289|NCT01585246|454515093|FG003|Overall Study|Withdrawal by Subject|2|||
126333290|NCT01585246|454515094|FG004|Overall Study|Withdrawal by Subject|1|||
126333291|NCT01585246|454515090|FG000|Overall Study|Other|0|||
126333292|NCT01585246|454515091|FG001|Overall Study|Other|1|||
126333293|NCT01585246|454515092|FG002|Overall Study|Other|1|||
126333294|NCT01585246|454515093|FG003|Overall Study|Other|1|||
126333295|NCT01585246|454515094|FG004|Overall Study|Other|0|||
126333296|NCT04396626|454515095|FG000|Overall Study|Premature termination of study|975|||
126333297|NCT02111174|454515098|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
126333298|NCT02111174|454515099|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
126333299|NCT02111174|454515098|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
126333300|NCT02111174|454515099|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
126333301|NCT02111174|454515098|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
126333302|NCT02111174|454515099|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
126333303|NCT02111174|454515098|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
126333304|NCT02111174|454515099|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
126333305|NCT00838097|454515102|FG000|Overall Study|Ineligibility determined|6|||
126333306|NCT00838097|454515102|FG000|Overall Study|Adverse Event|2|||
126333307|NCT00838097|454515102|FG000|Overall Study|Withdrawal by Subject|3|||
126333308|NCT00838097|454515102|FG000|Overall Study|Requirement for alternative therapy|2|||
126333309|NCT00838097|454515102|FG000|Overall Study|Physician Decision|4|||
126333310|NCT00838097|454515102|FG000|Overall Study|Lost to Follow-up|11|||
126333311|NCT00838097|454515102|FG000|Overall Study|Death|6|||
126333312|NCT00838097|454515102|FG000|Overall Study|Protocol-specified criteria|142|||
126333313|NCT00871234|454515103|FG000|Overall Study|Adverse Event|2|||
126333314|NCT00871234|454515103|FG000|Overall Study|Lost to Follow-up|3|||
126333315|NCT03380377|454515106|FG000|Overall Study|Physician Decision|1|||
126333316|NCT03380377|454515106|FG000|Overall Study|Withdrawal by Subject|1|||
126333317|NCT02600923|454515109|FG000|Overall Study|Death|10|||
126333318|NCT02600923|454515109|FG000|Overall Study|Adverse Event|3|||
126333319|NCT02600923|454515109|FG000|Overall Study|Global deterioration of health status|2|||
126333320|NCT02600923|454515109|FG000|Overall Study|Insufficient clinical response|6|||
126333321|NCT02600923|454515109|FG000|Overall Study|Lost to Follow-up|1|||
126333322|NCT02600923|454515109|FG000|Overall Study|Withdrawal by Subject|5|||
126333323|NCT02600923|454515109|FG000|Overall Study|Objective progression or relapse|50|||
126333324|NCT02600923|454515109|FG000|Overall Study|Study terminated by Sponsor|53|||
126333325|NCT02600923|454515109|FG000|Overall Study|Not treated|1|||
126333326|NCT00792909|454515110|FG000|Overall Study|Withdrawal by Subject|0|||
126333327|NCT00792909|454515111|FG001|Overall Study|Withdrawal by Subject|1|||
126333328|NCT00792909|454515112|FG002|Overall Study|Withdrawal by Subject|0|||
126333329|NCT00128661|454515115|FG000|Overall Study|Adverse Event|14|||
126333330|NCT00128661|454515116|FG001|Overall Study|Adverse Event|11|||
126333331|NCT00128661|454515115|FG000|Overall Study|Lost to Follow-up|10|||
126333332|NCT00128661|454515116|FG001|Overall Study|Lost to Follow-up|7|||
126333333|NCT00128661|454515115|FG000|Overall Study|Withdrawal by Subject|243|||
126333334|NCT00128661|454515116|FG001|Overall Study|Withdrawal by Subject|232|||
126333335|NCT00128661|454515115|FG000|Overall Study|Other|7|||
126333336|NCT00128661|454515116|FG001|Overall Study|Other|8|||
126333337|NCT01261390|454515118|FG000|Overall Study|Significant Concurrent Illness|1|||
126333338|NCT01261390|454515119|FG001|Overall Study|Significant Concurrent Illness|0|||
126333339|NCT01261390|454515120|FG002|Overall Study|Significant Concurrent Illness|1|||
126333340|NCT01261390|454515121|FG003|Overall Study|Significant Concurrent Illness|0|||
126333341|NCT01261390|454515118|FG000|Overall Study|Dissatisfaction with Treatment|2|||
126333342|NCT01261390|454515119|FG001|Overall Study|Dissatisfaction with Treatment|1|||
126333343|NCT01261390|454515120|FG002|Overall Study|Dissatisfaction with Treatment|1|||
126333344|NCT01261390|454515121|FG003|Overall Study|Dissatisfaction with Treatment|2|||
126333345|NCT01261390|454515118|FG000|Overall Study|Relocation|0|||
126333346|NCT01261390|454515119|FG001|Overall Study|Relocation|1|||
126333347|NCT01261390|454515120|FG002|Overall Study|Relocation|0|||
126333348|NCT01261390|454515121|FG003|Overall Study|Relocation|0|||
126333349|NCT01261390|454515118|FG000|Overall Study|Loss of Interest in the Study|3|||
126333350|NCT01261390|454515119|FG001|Overall Study|Loss of Interest in the Study|1|||
126333351|NCT01261390|454515120|FG002|Overall Study|Loss of Interest in the Study|0|||
126333352|NCT01261390|454515121|FG003|Overall Study|Loss of Interest in the Study|0|||
126333353|NCT01261390|454515118|FG000|Overall Study|Lost to Follow-up|1|||
126333354|NCT01261390|454515119|FG001|Overall Study|Lost to Follow-up|6|||
126333355|NCT01261390|454515120|FG002|Overall Study|Lost to Follow-up|5|||
126333356|NCT01261390|454515121|FG003|Overall Study|Lost to Follow-up|6|||
126333357|NCT00977613|454515126|FG000|Overall Study|Lost to Follow-up|16|||
126333358|NCT01497067|454515127|FG000|Overall Study|Lost to Follow-up|56|||
126333359|NCT01497067|454515127|FG000|Overall Study|Adverse Event|3|||
126333360|NCT01497067|454515127|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
126333361|NCT01497067|454515127|FG000|Overall Study|Other|13|||
126333362|NCT01598610|454515130|FG000|Overall Study|Adverse Event|1|||
126333363|NCT04346199|454515131|FG000|Overall Study|Death|8|||
126333364|NCT04346199|454515132|FG001|Overall Study|Death|9|||
125998257|NCT02018861|453287012|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125998258|NCT02018861|453287003|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125998259|NCT02018861|453287004|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125998260|NCT02018861|453287005|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125998261|NCT02018861|453287006|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
126333365|NCT04346199|454515131|FG000|Overall Study|Lost to Follow-up|0|||
126333366|NCT04346199|454515132|FG001|Overall Study|Lost to Follow-up|1|||
126333367|NCT04346199|454515131|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
126333368|NCT04346199|454515132|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
126333369|NCT04346199|454515131|FG000|Overall Study|Withdrawal by Subject|5|||
126333370|NCT04346199|454515132|FG001|Overall Study|Withdrawal by Subject|1|||
126333371|NCT03066830|454515133|FG000|Overall Study|At the Participant's own Request|16|||
126333372|NCT03066830|454515134|FG001|Overall Study|At the Participant's own Request|17|||
126333373|NCT03066830|454515133|FG000|Overall Study|Other|3|||
126333374|NCT03066830|454515134|FG001|Overall Study|Other|0|||
126333375|NCT03066830|454515133|FG000|Overall Study|Poor Compliance to Protocol|1|||
126333376|NCT03066830|454515134|FG001|Overall Study|Poor Compliance to Protocol|0|||
126333377|NCT03066830|454515133|FG000|Overall Study|Adverse Event|2|||
126333378|NCT03066830|454515134|FG001|Overall Study|Adverse Event|2|||
126333379|NCT03066830|454515133|FG000|Overall Study|Lost to Follow-up|11|||
125998262|NCT02018861|453287007|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
126333380|NCT03066830|454515134|FG001|Overall Study|Lost to Follow-up|3|||
126333381|NCT02989402|454515135|FG000|Overall Study|Adverse event, or serious adverse event|4|||
126333382|NCT02989402|454515135|FG000|Overall Study|Death|2|||
126333383|NCT02989402|454515135|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
126333384|NCT02989402|454515135|FG000|Overall Study|Lost to Follow-up|8|||
126333385|NCT02989402|454515135|FG000|Overall Study|Patient no longer on monotherapy|1|||
126333386|NCT02989402|454515135|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
126333387|NCT02989402|454515135|FG000|Overall Study|Withdrawal by Subject|7|||
126333388|NCT02989402|454515135|FG000|Overall Study|Other|2|||
126333389|NCT02039778|454515136|FG000|Overall Study|Death|2|||
126333390|NCT02039778|454515136|FG000|Overall Study|Withdrawal by Subject|1|||
126333391|NCT02039778|454515136|FG000|Overall Study|Never started the protocol treatment|1|||
126333392|NCT04001803|454515144|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
126333393|NCT04001803|454515144|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
126333394|NCT04001803|454515144|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
126333395|NCT04001803|454515144|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
126333396|NCT04001803|454515144|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
126333397|NCT04001803|454515144|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
126333398|NCT04001803|454515144|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
126333399|NCT04001803|454515144|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
126333400|NCT04001803|454515144|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
126333401|NCT04001803|454515144|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
126333402|NCT05404711|454515145|FG000|Completed Study Visit|Withdrawal by Subject|1|||
126333403|NCT05404711|454515145|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
126333404|NCT05404711|454515145|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
126333405|NCT05404711|454515145|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
126333406|NCT05404711|454515145|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
126333407|NCT05404711|454515145|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
126333408|NCT02346877|454515148|FG000|Overall Study|Adverse Event|1|||
126333409|NCT02346877|454515149|FG001|Overall Study|Adverse Event|0|||
126333410|NCT02346877|454515148|FG000|Overall Study|Administrative Decision|1|||
126333411|NCT02346877|454515149|FG001|Overall Study|Administrative Decision|0|||
126333412|NCT02346877|454515148|FG000|Overall Study|Sponsor Decision|12|||
126333413|NCT02346877|454515149|FG001|Overall Study|Sponsor Decision|0|||
126333414|NCT02346877|454515148|FG000|Overall Study|Missing|5|||
126333415|NCT02346877|454515149|FG001|Overall Study|Missing|0|||
126333416|NCT00447902|454515150|FG000|Overall Study|Adverse Event|0|||
126333417|NCT00447902|454515151|FG001|Overall Study|Adverse Event|3|||
126333418|NCT00447902|454515150|FG000|Overall Study|Protocol Violation|1|||
126333419|NCT00447902|454515151|FG001|Overall Study|Protocol Violation|0|||
126333420|NCT00447902|454515150|FG000|Overall Study|Withdrawal by Subject|0|||
126333421|NCT00447902|454515151|FG001|Overall Study|Withdrawal by Subject|1|||
126333422|NCT00447902|454515150|FG000|Overall Study|included patients who discontinued|1|||
126333423|NCT00447902|454515151|FG001|Overall Study|included patients who discontinued|1|||
126333424|NCT00447902|454515150|FG000|Overall Study|Lack of Efficacy|2|||
126333425|NCT00447902|454515151|FG001|Overall Study|Lack of Efficacy|1|||
126333426|NCT04754542|454515152|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
126333427|NCT04754542|454515153|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
126333428|NCT00419757|454516875|FG000|Overall Study|Adverse Event|1|||
126333429|NCT00419757|454516876|FG001|Overall Study|Adverse Event|4|||
126333430|NCT00419757|454516875|FG000|Overall Study|Lost to Follow-up|1|||
126333431|NCT00419757|454516876|FG001|Overall Study|Lost to Follow-up|4|||
126333432|NCT00419757|454516875|FG000|Overall Study|Withdrawal by Subject|7|||
126333433|NCT00419757|454516876|FG001|Overall Study|Withdrawal by Subject|1|||
126333434|NCT00419757|454516875|FG000|Overall Study|Protocol Violation|2|||
126333435|NCT00419757|454516876|FG001|Overall Study|Protocol Violation|3|||
126333436|NCT00419757|454516875|FG000|Overall Study|Study specific discontinuation criteria|4|||
126333437|NCT00419757|454516876|FG001|Overall Study|Study specific discontinuation criteria|8|||
126333438|NCT00419757|454516875|FG000|Overall Study|Multiple reasons|3|||
126333439|NCT00419757|454516876|FG001|Overall Study|Multiple reasons|1|||
125998263|NCT02018861|453287008|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
125998264|NCT02018861|453287009|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125998265|NCT02018861|453287010|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125998266|NCT02018861|453287011|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125998267|NCT02018861|453287012|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125998268|NCT02018861|453287003|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125998269|NCT02018861|453287004|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125998270|NCT02018861|453287005|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126333440|NCT00327340|454516877|FG000|Overall Study|Withdrawal by Subject|1|||
126333441|NCT00327340|454516878|FG001|Overall Study|Withdrawal by Subject|5|||
126333442|NCT00327340|454516877|FG000|Overall Study|Physician Decision|1|||
126333443|NCT00327340|454516878|FG001|Overall Study|Physician Decision|1|||
125998271|NCT02018861|453287006|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
125998272|NCT02018861|453287007|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
126333444|NCT00327340|454516877|FG000|Overall Study|Disease Progression|10|||
126333445|NCT00327340|454516878|FG001|Overall Study|Disease Progression|19|||
126333446|NCT00327340|454516877|FG000|Overall Study|Symptomatic Disease|0|||
126333447|NCT00327340|454516878|FG001|Overall Study|Symptomatic Disease|2|||
126333448|NCT00327340|454516877|FG000|Overall Study|Adverse Event|3|||
126333449|NCT00327340|454516878|FG001|Overall Study|Adverse Event|3|||
126333450|NCT03316586|454516883|FG000|Overall Study|Adverse Event|2|||
126333451|NCT03316586|454516883|FG000|Overall Study|Physician Decision|3|||
126333452|NCT03316586|454516883|FG000|Overall Study|Lack of Efficacy|10|||
126333453|NCT03316586|454516883|FG000|Overall Study|still on treatment|1|||
126333454|NCT03316586|454516883|FG000|Overall Study|Patient needed radiation therapy|1|||
126333455|NCT03316586|454516883|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
126333456|NCT01396083|454516884|FG000|Overall Study|Adverse Event|2|||
126333457|NCT01396083|454516885|FG001|Overall Study|Adverse Event|28|||
126333458|NCT01396083|454516884|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125998273|NCT02018861|453287008|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125998274|NCT02018861|453287009|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125998275|NCT02018861|453287010|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126333459|NCT01396083|454516885|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
126333460|NCT01396083|454516884|FG000|Overall Study|Consent withdrawn|4|||
126333461|NCT01396083|454516885|FG001|Overall Study|Consent withdrawn|5|||
126333462|NCT01396083|454516884|FG000|Overall Study|Protocol deviation(s)|0|||
126333463|NCT01396083|454516885|FG001|Overall Study|Protocol deviation(s)|1|||
126333464|NCT01396083|454516884|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126333465|NCT01396083|454516885|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126333466|NCT01396083|454516884|FG000|Overall Study|Administrative problems|1|||
126333467|NCT01396083|454516885|FG001|Overall Study|Administrative problems|0|||
126333468|NCT01396083|454516884|FG000|Overall Study|Lost to Follow-up|1|||
126333469|NCT01396083|454516885|FG001|Overall Study|Lost to Follow-up|0|||
126333470|NCT02806713|454516886|FG000|Overall Study|Urethral injury during procedure|1|||
125998276|NCT02018861|453287011|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125998277|NCT02018861|453287012|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125998278|NCT02018861|453287003|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125998279|NCT02018861|453287004|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125998280|NCT02018861|453287005|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125998281|NCT02018861|453287006|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125998282|NCT02018861|453287007|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125998283|NCT02018861|453287008|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125998284|NCT02018861|453287009|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
125998285|NCT02018861|453287010|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
125998286|NCT02018861|453287011|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125998287|NCT02018861|453287012|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125998288|NCT02018861|453287003|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125998289|NCT02018861|453287004|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125998290|NCT02018861|453287005|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125998291|NCT02018861|453287006|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125998292|NCT02018861|453287007|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125998293|NCT02018861|453287008|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125998294|NCT02018861|453287009|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
125998295|NCT02018861|453287010|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
125998296|NCT02018861|453287011|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125998297|NCT02018861|453287012|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125998298|NCT02018861|453287003|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125998299|NCT02018861|453287004|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125998300|NCT02018861|453287005|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125998301|NCT02018861|453287006|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126333471|NCT02806713|454516887|FG001|Overall Study|Urethral injury during procedure|0|||
126333472|NCT02806713|454516886|FG000|Overall Study|cancelled surgery|1|||
126333473|NCT02806713|454516887|FG001|Overall Study|cancelled surgery|2|||
126333474|NCT00735709|454516888|FG000|Overall Study|Adverse Event|2|||
126333475|NCT00735709|454516889|FG001|Overall Study|Adverse Event|3|||
126333476|NCT00735709|454516890|FG002|Overall Study|Adverse Event|1|||
126333477|NCT00735709|454516891|FG003|Overall Study|Adverse Event|5|||
126333478|NCT00735709|454516888|FG000|Overall Study|Lack of Efficacy|8|||
126333479|NCT00735709|454516889|FG001|Overall Study|Lack of Efficacy|4|||
125998302|NCT02018861|453287007|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126333480|NCT00735709|454516890|FG002|Overall Study|Lack of Efficacy|2|||
126333481|NCT00735709|454516891|FG003|Overall Study|Lack of Efficacy|3|||
126333482|NCT00735709|454516888|FG000|Overall Study|Noncompliance|0|||
126333483|NCT00735709|454516889|FG001|Overall Study|Noncompliance|0|||
126333484|NCT00735709|454516890|FG002|Overall Study|Noncompliance|1|||
125998303|NCT02018861|453287008|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125998304|NCT02018861|453287009|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125998305|NCT02018861|453287010|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125998306|NCT02018861|453287011|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
125998307|NCT02018861|453287012|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125998308|NCT02018861|453287003|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998309|NCT02018861|453287004|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998310|NCT02018861|453287005|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998311|NCT02018861|453287006|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998312|NCT02018861|453287007|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998313|NCT02018861|453287008|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998314|NCT02018861|453287009|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998315|NCT02018861|453287010|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998316|NCT02018861|453287011|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
125998317|NCT02018861|453287012|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125998318|NCT02018861|453287003|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125998319|NCT02018861|453287004|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125998320|NCT02018861|453287005|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125998321|NCT02018861|453287006|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125998322|NCT02018861|453287007|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126333485|NCT00735709|454516891|FG003|Overall Study|Noncompliance|0|||
126333486|NCT00735709|454516888|FG000|Overall Study|Protocol deviations|1|||
126333487|NCT00735709|454516889|FG001|Overall Study|Protocol deviations|2|||
126333488|NCT00735709|454516890|FG002|Overall Study|Protocol deviations|1|||
126333489|NCT00735709|454516891|FG003|Overall Study|Protocol deviations|1|||
126333490|NCT00735709|454516888|FG000|Overall Study|Voluntary Withdrawal|1|||
126333491|NCT00735709|454516889|FG001|Overall Study|Voluntary Withdrawal|3|||
126333492|NCT00735709|454516890|FG002|Overall Study|Voluntary Withdrawal|5|||
126333493|NCT00735709|454516891|FG003|Overall Study|Voluntary Withdrawal|7|||
126333494|NCT00735709|454516888|FG000|Overall Study|Lost to Follow-up|0|||
126333495|NCT00735709|454516889|FG001|Overall Study|Lost to Follow-up|1|||
126333496|NCT00735709|454516890|FG002|Overall Study|Lost to Follow-up|1|||
126333497|NCT00735709|454516891|FG003|Overall Study|Lost to Follow-up|1|||
126333498|NCT00735709|454516888|FG000|Overall Study|Excluded medication|1|||
126333499|NCT00735709|454516889|FG001|Overall Study|Excluded medication|0|||
126333500|NCT00735709|454516890|FG002|Overall Study|Excluded medication|0|||
126333501|NCT00735709|454516891|FG003|Overall Study|Excluded medication|1|||
126333502|NCT01165307|454516893|FG000|Overall Study|Lost to Follow-up|11|||
126333503|NCT01165307|454516894|FG001|Overall Study|Lost to Follow-up|3|||
126333504|NCT01165307|454516893|FG000|Overall Study|Withdrawal by Subject|2|||
126333505|NCT01165307|454516894|FG001|Overall Study|Withdrawal by Subject|0|||
126333506|NCT01165307|454516893|FG000|Overall Study|Subject not available for contact|1|||
126333507|NCT01165307|454516894|FG001|Overall Study|Subject not available for contact|0|||
126333508|NCT00521365|454516898|FG000|Overall Study|Adverse Event|3|||
126333509|NCT00521365|454516898|FG000|Overall Study|Lost to Follow-up|6|||
126333510|NCT00521365|454516898|FG000|Overall Study|Protocol deviation|2|||
126333511|NCT00521365|454516898|FG000|Overall Study|Drug compliance|3|||
126333512|NCT00521365|454516898|FG000|Overall Study|Usage of not allowed drugs|6|||
126333513|NCT03627832|454516899|FG000|Overall Study|Withdrawal by Subject|10|||
126333514|NCT03627832|454516900|FG001|Overall Study|Withdrawal by Subject|1|||
126333515|NCT03150082|454516901|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
126333516|NCT03150082|454516902|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
126333517|NCT01718483|454516903|FG000|Overall Study|Withdrawal by Subject|14|||
126333518|NCT01718483|454516904|FG001|Overall Study|Withdrawal by Subject|12|||
126333519|NCT01718483|454516903|FG000|Overall Study|Adverse Event|5|||
126333520|NCT01718483|454516904|FG001|Overall Study|Adverse Event|12|||
126333521|NCT01718483|454516903|FG000|Overall Study|Lost to Follow-up|8|||
126333522|NCT01718483|454516904|FG001|Overall Study|Lost to Follow-up|3|||
126333523|NCT01718483|454516903|FG000|Overall Study|Protocol Violation|4|||
126333524|NCT01718483|454516904|FG001|Overall Study|Protocol Violation|2|||
126333525|NCT01718483|454516903|FG000|Overall Study|Other|1|||
126333526|NCT01718483|454516904|FG001|Overall Study|Other|4|||
126333527|NCT01718483|454516903|FG000|Overall Study|Pregnancy|1|||
126333528|NCT01718483|454516904|FG001|Overall Study|Pregnancy|1|||
126333529|NCT01718483|454516903|FG000|Overall Study|Lack of Efficacy|1|||
126333530|NCT01718483|454516904|FG001|Overall Study|Lack of Efficacy|0|||
126333531|NCT00536510|454516907|FG000|Overall Study|Adverse Event|27|||
126333532|NCT00536510|454516908|FG001|Overall Study|Adverse Event|4|||
126333533|NCT00536510|454516907|FG000|Overall Study|Lost to Follow-up|11|||
126333534|NCT00536510|454516908|FG001|Overall Study|Lost to Follow-up|8|||
126333535|NCT00536510|454516907|FG000|Overall Study|Protocol Violation|4|||
126333536|NCT00536510|454516908|FG001|Overall Study|Protocol Violation|5|||
126333537|NCT00536510|454516907|FG000|Overall Study|Withdrawal by Subject|16|||
126333538|NCT00536510|454516908|FG001|Overall Study|Withdrawal by Subject|9|||
126333539|NCT00536510|454516907|FG000|Overall Study|Flushing with Product|20|||
126333540|NCT00536510|454516908|FG001|Overall Study|Flushing with Product|0|||
126333541|NCT00536510|454516907|FG000|Overall Study|Laboratory Adverse Event|2|||
126333542|NCT00536510|454516908|FG001|Overall Study|Laboratory Adverse Event|1|||
126333543|NCT00536510|454516907|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
126333544|NCT00536510|454516908|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
126333545|NCT00809445|454516909|FG000|1 Month Follow-up|Lost contact|1|||
126333546|NCT00809445|454516910|FG001|1 Month Follow-up|Lost contact|2|||
126333547|NCT00809445|454516911|FG002|1 Month Follow-up|Lost contact|1|||
126333548|NCT00809445|454516909|FG000|1 Month Follow-up|Withdrew consent|1|||
126333549|NCT00809445|454516910|FG001|1 Month Follow-up|Withdrew consent|1|||
126333550|NCT00809445|454516911|FG002|1 Month Follow-up|Withdrew consent|1|||
126333551|NCT00809445|454516909|FG000|1 Month Follow-up|Death|0|||
126333552|NCT00809445|454516910|FG001|1 Month Follow-up|Death|1|||
126333553|NCT00809445|454516911|FG002|1 Month Follow-up|Death|1|||
126333554|NCT00809445|454516909|FG000|1 Month Follow-up|Incarcerated|0|||
126333555|NCT00809445|454516910|FG001|1 Month Follow-up|Incarcerated|0|||
126333556|NCT00809445|454516911|FG002|1 Month Follow-up|Incarcerated|1|||
126333557|NCT00809445|454516909|FG000|6 Month Follow-up|Lost contact|16|||
126333558|NCT00809445|454516910|FG001|6 Month Follow-up|Lost contact|14|||
126333559|NCT00809445|454516911|FG002|6 Month Follow-up|Lost contact|14|||
126333560|NCT00809445|454516909|FG000|6 Month Follow-up|Death|2|||
126333561|NCT00809445|454516910|FG001|6 Month Follow-up|Death|1|||
126333562|NCT00809445|454516911|FG002|6 Month Follow-up|Death|1|||
126333563|NCT00809445|454516909|FG000|6 Month Follow-up|Incarcerated|6|||
126333564|NCT00809445|454516910|FG001|6 Month Follow-up|Incarcerated|8|||
126333565|NCT00809445|454516911|FG002|6 Month Follow-up|Incarcerated|8|||
126333566|NCT00809445|454516909|FG000|6 Month Follow-up|Withdrew consent|0|||
126333567|NCT00809445|454516910|FG001|6 Month Follow-up|Withdrew consent|0|||
126333568|NCT00809445|454516911|FG002|6 Month Follow-up|Withdrew consent|1|||
126333569|NCT00676403|454516912|FG000|Overall Study|Adverse Event|1|||
126333570|NCT00676403|454516913|FG001|Overall Study|Adverse Event|2|||
126333571|NCT00676403|454516914|FG002|Overall Study|Adverse Event|0|||
126333572|NCT00676403|454516915|FG003|Overall Study|Adverse Event|5|||
126333573|NCT00676403|454516916|FG004|Overall Study|Adverse Event|1|||
126333574|NCT00676403|454516917|FG005|Overall Study|Adverse Event|2|||
126333575|NCT00676403|454516912|FG000|Overall Study|Lost to Follow-up|0|||
126333576|NCT00676403|454516913|FG001|Overall Study|Lost to Follow-up|0|||
126333577|NCT00676403|454516914|FG002|Overall Study|Lost to Follow-up|0|||
126333578|NCT00676403|454516915|FG003|Overall Study|Lost to Follow-up|0|||
126333579|NCT00676403|454516916|FG004|Overall Study|Lost to Follow-up|0|||
126333580|NCT00676403|454516917|FG005|Overall Study|Lost to Follow-up|1|||
126333581|NCT00676403|454516912|FG000|Overall Study|Reason Unspecified|1|||
126333582|NCT00676403|454516913|FG001|Overall Study|Reason Unspecified|0|||
126333583|NCT00676403|454516914|FG002|Overall Study|Reason Unspecified|1|||
126333584|NCT00676403|454516915|FG003|Overall Study|Reason Unspecified|0|||
126333585|NCT00676403|454516916|FG004|Overall Study|Reason Unspecified|0|||
126333586|NCT00676403|454516917|FG005|Overall Study|Reason Unspecified|1|||
126333587|NCT00676403|454516912|FG000|Overall Study|Withdrawal by Subject|0|||
126333588|NCT00676403|454516913|FG001|Overall Study|Withdrawal by Subject|0|||
126333589|NCT00676403|454516914|FG002|Overall Study|Withdrawal by Subject|0|||
126333590|NCT00676403|454516915|FG003|Overall Study|Withdrawal by Subject|0|||
126333591|NCT00676403|454516916|FG004|Overall Study|Withdrawal by Subject|0|||
126333592|NCT00676403|454516917|FG005|Overall Study|Withdrawal by Subject|1|||
126333593|NCT02048722|454516918|FG000|2 Cycles of Treatment|Adverse Event|2|||
126333594|NCT02048722|454516918|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
126333595|NCT02048722|454516918|FG000|2 Cycles of Treatment|Progressive Disease|2|||
126333596|NCT02048722|454516918|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
126333597|NCT02048722|454516918|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
126333598|NCT02048722|454516918|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
126333599|NCT04073303|454516919|FG000|Overall Study|Adverse Event|0|||
125998323|NCT02018861|453287008|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125998324|NCT02018861|453287009|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126333600|NCT04073303|454516920|FG001|Overall Study|Adverse Event|2|||
126333601|NCT04073303|454516919|FG000|Overall Study|Withdrawal by Subject|16|||
126333602|NCT04073303|454516920|FG001|Overall Study|Withdrawal by Subject|36|||
126333603|NCT04073303|454516919|FG000|Overall Study|Lost to Follow-up|6|||
125998325|NCT02018861|453287010|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126333604|NCT04073303|454516920|FG001|Overall Study|Lost to Follow-up|1|||
126333605|NCT04073303|454516919|FG000|Overall Study|Protocol Deviation|0|||
126333606|NCT04073303|454516920|FG001|Overall Study|Protocol Deviation|4|||
126333607|NCT04073303|454516919|FG000|Overall Study|Other|1|||
126333608|NCT04073303|454516920|FG001|Overall Study|Other|1|||
126333609|NCT02899065|454516923|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
126333610|NCT02899065|454516924|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
126333611|NCT02899065|454516923|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
126333612|NCT02899065|454516924|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
126333613|NCT02899065|454516923|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
126333614|NCT02899065|454516924|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
126333615|NCT05227118|454516927|FG000|Overall Study|Adverse Event|0|||
125998326|NCT02018861|453287011|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
126333616|NCT05227118|454516928|FG001|Overall Study|Adverse Event|0|||
126333617|NCT05227118|454516929|FG002|Overall Study|Adverse Event|1|||
126333618|NCT05227118|454516930|FG003|Overall Study|Adverse Event|0|||
126333619|NCT05227118|454516927|FG000|Overall Study|Withdrawal by Subject|0|||
126333620|NCT05227118|454516928|FG001|Overall Study|Withdrawal by Subject|0|||
126333621|NCT05227118|454516929|FG002|Overall Study|Withdrawal by Subject|2|||
126333622|NCT05227118|454516930|FG003|Overall Study|Withdrawal by Subject|0|||
126333623|NCT02689804|454516931|FG000|Overall Study|Withdrawal by Subject|2|||
126333624|NCT02689804|454516932|FG001|Overall Study|Withdrawal by Subject|0|||
126333625|NCT02417753|454516933|FG000|Overall Study|Death|1|||
126333626|NCT03113968|454516936|FG000|Overall Study|Withdrawal by Subject|31|||
126333627|NCT03113968|454516937|FG001|Overall Study|Withdrawal by Subject|4|||
126333628|NCT04805671|454516938|FG000|Overall Study|Death|2|||
126333629|NCT04805671|454516939|FG001|Overall Study|Death|7|||
126333630|NCT04805671|454516938|FG000|Overall Study|Lost to Follow-up|1|||
126333631|NCT04805671|454516939|FG001|Overall Study|Lost to Follow-up|0|||
126333632|NCT04805671|454516938|FG000|Overall Study|Withdrawal by Subject|9|||
126333633|NCT04805671|454516939|FG001|Overall Study|Withdrawal by Subject|7|||
126333634|NCT04805671|454516938|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
126333635|NCT04805671|454516939|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
126333636|NCT01657162|454516946|FG000|Overall Study|Adverse Event|26|||
126333637|NCT01657162|454516947|FG001|Overall Study|Adverse Event|36|||
126333638|NCT01657162|454516946|FG000|Overall Study|Withdrawal by Subject|13|||
126333639|NCT01657162|454516947|FG001|Overall Study|Withdrawal by Subject|13|||
126333640|NCT01657162|454516946|FG000|Overall Study|Continuing Significant Deterioration|9|||
126333641|NCT01657162|454516947|FG001|Overall Study|Continuing Significant Deterioration|3|||
126333642|NCT01657162|454516946|FG000|Overall Study|Refusal of Treatment|4|||
126333643|NCT01657162|454516947|FG001|Overall Study|Refusal of Treatment|6|||
126333644|NCT01657162|454516946|FG000|Overall Study|Lost to Follow-up|3|||
126333645|NCT01657162|454516947|FG001|Overall Study|Lost to Follow-up|4|||
126333646|NCT01657162|454516946|FG000|Overall Study|Death|2|||
126333647|NCT01657162|454516947|FG001|Overall Study|Death|3|||
126333648|NCT01657162|454516946|FG000|Overall Study|Inability to Complete Study Procedures|1|||
126333649|NCT01657162|454516947|FG001|Overall Study|Inability to Complete Study Procedures|7|||
126333650|NCT01657162|454516946|FG000|Overall Study|Protocol Violation|1|||
126333651|NCT01657162|454516947|FG001|Overall Study|Protocol Violation|0|||
126333652|NCT01657162|454516946|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
126333653|NCT01657162|454516947|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
126333654|NCT01657162|454516946|FG000|Overall Study|Other than Specified|0|||
126333655|NCT01657162|454516947|FG001|Overall Study|Other than Specified|2|||
126333656|NCT00901342|454516948|FG000|Overall Study|Adverse Event|1|||
126333657|NCT00901342|454516948|FG000|Overall Study|Death|4|||
126333658|NCT00901342|454516948|FG000|Overall Study|Disease progression|1|||
126333659|NCT00901342|454516948|FG000|Overall Study|Withdrawal by Subject|9|||
126333660|NCT02782741|454516950|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
126333661|NCT02782741|454516951|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
126333662|NCT02782741|454516952|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
126333663|NCT02782741|454516950|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
126333664|NCT02782741|454516951|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
126333665|NCT02782741|454516952|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
126333666|NCT02782741|454516950|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
126333667|NCT02782741|454516951|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
126333668|NCT02782741|454516952|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
126333669|NCT02782741|454516950|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
126333670|NCT02782741|454516951|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
126333671|NCT02782741|454516952|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
126333672|NCT02782741|454516950|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
126333673|NCT02782741|454516951|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
126333674|NCT02782741|454516952|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
126333675|NCT04058028|454516953|FG000|Overall Study|Withdrawal of Consent from Study|12|||
126333676|NCT04058028|454516954|FG001|Overall Study|Withdrawal of Consent from Study|8|||
125998327|NCT02018861|453287012|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126333677|NCT04058028|454516955|FG002|Overall Study|Withdrawal of Consent from Study|6|||
126333678|NCT04058028|454516956|FG003|Overall Study|Withdrawal of Consent from Study|7|||
126333679|NCT04058028|454516953|FG000|Overall Study|Decision by Sponsor|13|||
126333680|NCT04058028|454516954|FG001|Overall Study|Decision by Sponsor|4|||
126333681|NCT04058028|454516955|FG002|Overall Study|Decision by Sponsor|1|||
126333682|NCT04058028|454516956|FG003|Overall Study|Decision by Sponsor|35|||
126333683|NCT04058028|454516953|FG000|Overall Study|Lost to Follow-up|1|||
126333684|NCT04058028|454516954|FG001|Overall Study|Lost to Follow-up|1|||
126333685|NCT04058028|454516955|FG002|Overall Study|Lost to Follow-up|1|||
126333686|NCT04058028|454516956|FG003|Overall Study|Lost to Follow-up|0|||
126333687|NCT04058028|454516953|FG000|Overall Study|Death|0|||
126333688|NCT04058028|454516954|FG001|Overall Study|Death|1|||
126333689|NCT04058028|454516955|FG002|Overall Study|Death|0|||
126333690|NCT04058028|454516956|FG003|Overall Study|Death|0|||
126333691|NCT00485069|454516957|FG000|Overall Study|Adverse Event|10|||
126333692|NCT00485069|454516958|FG001|Overall Study|Adverse Event|4|||
126333693|NCT00485069|454516957|FG000|Overall Study|Lack of Efficacy|2|||
126333694|NCT00485069|454516958|FG001|Overall Study|Lack of Efficacy|1|||
126333695|NCT00485069|454516957|FG000|Overall Study|Protocol Violation|0|||
126333696|NCT00485069|454516958|FG001|Overall Study|Protocol Violation|1|||
126333697|NCT00485069|454516957|FG000|Overall Study|Withdrawal by Subject|6|||
126333698|NCT00485069|454516958|FG001|Overall Study|Withdrawal by Subject|6|||
126333699|NCT00992017|454516970|FG000|Overall Study|Lost to Follow-up|2|||
126333700|NCT00992017|454516970|FG000|Overall Study|Withdrawal by Subject|2|||
126333701|NCT00992017|454516970|FG000|Overall Study|Unable to get to clinic|5|||
126333702|NCT00992017|454516970|FG000|Overall Study|Not adhere to study requirements|1|||
126333703|NCT01691378|454516981|FG000|Overall Study|Withdrawal by Subject|2|||
126333704|NCT01691378|454516982|FG001|Overall Study|Withdrawal by Subject|0|||
126333705|NCT01691378|454516981|FG000|Overall Study|Lost to Follow-up|5|||
126333706|NCT01691378|454516982|FG001|Overall Study|Lost to Follow-up|2|||
126333707|NCT01827592|454516983|FG000|Overall Study|Adverse Event|11|||
126333708|NCT01827592|454516984|FG001|Overall Study|Adverse Event|9|||
126333709|NCT01827592|454516985|FG002|Overall Study|Adverse Event|2|||
126333710|NCT01827592|454516983|FG000|Overall Study|Physician Decision|0|||
126333711|NCT01827592|454516984|FG001|Overall Study|Physician Decision|2|||
126333712|NCT01827592|454516985|FG002|Overall Study|Physician Decision|1|||
126333713|NCT01827592|454516983|FG000|Overall Study|Protocol Violation|2|||
126333714|NCT01827592|454516984|FG001|Overall Study|Protocol Violation|1|||
126333715|NCT01827592|454516985|FG002|Overall Study|Protocol Violation|0|||
126333716|NCT01827592|454516983|FG000|Overall Study|Lost to Follow-up|1|||
126333717|NCT01827592|454516984|FG001|Overall Study|Lost to Follow-up|2|||
126333718|NCT01827592|454516985|FG002|Overall Study|Lost to Follow-up|2|||
126333719|NCT01827592|454516983|FG000|Overall Study|Withdrawal by Subject|12|||
126333720|NCT01827592|454516984|FG001|Overall Study|Withdrawal by Subject|11|||
126333721|NCT01827592|454516985|FG002|Overall Study|Withdrawal by Subject|11|||
126333722|NCT01827592|454516983|FG000|Overall Study|Patient's substantial non-compliance|1|||
126333723|NCT01827592|454516984|FG001|Overall Study|Patient's substantial non-compliance|1|||
126333724|NCT01827592|454516985|FG002|Overall Study|Patient's substantial non-compliance|6|||
126333725|NCT01827592|454516983|FG000|Overall Study|Trial terminated by Sponsor|47|||
126333726|NCT01827592|454516984|FG001|Overall Study|Trial terminated by Sponsor|53|||
126333727|NCT01827592|454516985|FG002|Overall Study|Trial terminated by Sponsor|51|||
126333728|NCT01827592|454516983|FG000|Overall Study|Others|0|||
126333729|NCT01827592|454516984|FG001|Overall Study|Others|1|||
126333730|NCT01827592|454516985|FG002|Overall Study|Others|3|||
126333731|NCT02155985|454516986|FG000|Overall Study|Withdrawal by Subject|0|||
126333732|NCT02155985|454516987|FG001|Overall Study|Withdrawal by Subject|0|||
126333733|NCT02155985|454516988|FG002|Overall Study|Withdrawal by Subject|1|||
126333734|NCT02155985|454516986|FG000|Overall Study|Lost to Follow-up|1|||
126333735|NCT02155985|454516987|FG001|Overall Study|Lost to Follow-up|0|||
126333736|NCT02155985|454516988|FG002|Overall Study|Lost to Follow-up|0|||
126333737|NCT02998151|454516991|FG000|Overall Study|Withdrawal by Subject|3|||
126333738|NCT02998151|454516991|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
126333739|NCT02998151|454516991|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
126333740|NCT02573259|454516992|FG000|Overall Study|Death|1|||
126333741|NCT02573259|454516993|FG001|Overall Study|Death|6|||
126333742|NCT02573259|454516994|FG002|Overall Study|Death|5|||
126333743|NCT02573259|454516995|FG003|Overall Study|Death|6|||
125998328|NCT01474512|453287016|FG000|Induction Period|Adverse Event|6|||
125998329|NCT01474512|453287017|FG001|Induction Period|Adverse Event|10|||
125998330|NCT01474512|453287018|FG002|Induction Period|Adverse Event|10|||
126333744|NCT02573259|454516996|FG004|Overall Study|Death|9|||
126333745|NCT02573259|454516997|FG005|Overall Study|Death|32|||
126333746|NCT02573259|454516998|FG006|Overall Study|Death|21|||
126333747|NCT02573259|454516992|FG000|Overall Study|Lost to Follow-up|0|||
126333748|NCT02573259|454516993|FG001|Overall Study|Lost to Follow-up|0|||
126333749|NCT02573259|454516994|FG002|Overall Study|Lost to Follow-up|0|||
126333750|NCT02573259|454516995|FG003|Overall Study|Lost to Follow-up|0|||
126333751|NCT02573259|454516996|FG004|Overall Study|Lost to Follow-up|0|||
126333752|NCT02573259|454516997|FG005|Overall Study|Lost to Follow-up|2|||
126333753|NCT02573259|454516998|FG006|Overall Study|Lost to Follow-up|1|||
125998331|NCT01474512|453287019|FG003|Induction Period|Adverse Event|0|||
126333754|NCT02573259|454516992|FG000|Overall Study|Participant refused further follow-up|0|||
126333755|NCT02573259|454516993|FG001|Overall Study|Participant refused further follow-up|2|||
126333756|NCT02573259|454516994|FG002|Overall Study|Participant refused further follow-up|1|||
126333757|NCT02573259|454516995|FG003|Overall Study|Participant refused further follow-up|0|||
126333758|NCT02573259|454516996|FG004|Overall Study|Participant refused further follow-up|3|||
125998332|NCT01474512|453287020|FG004|Induction Period|Adverse Event|0|||
125998333|NCT01474512|453287021|FG005|Induction Period|Adverse Event|0|||
125998334|NCT01474512|453287022|FG006|Induction Period|Adverse Event|0|||
125998335|NCT01474512|453287023|FG007|Induction Period|Adverse Event|0|||
125998336|NCT01474512|453287024|FG008|Induction Period|Adverse Event|0|||
125998337|NCT01474512|453287025|FG009|Induction Period|Adverse Event|0|||
125998338|NCT01474512|453287026|FG010|Induction Period|Adverse Event|0|||
125998339|NCT01474512|453287027|FG011|Induction Period|Adverse Event|0|||
125998340|NCT01474512|453287028|FG012|Induction Period|Adverse Event|0|||
125998341|NCT01474512|453287029|FG013|Induction Period|Adverse Event|0|||
126333759|NCT02573259|454516997|FG005|Overall Study|Participant refused further follow-up|20|||
126333760|NCT02573259|454516998|FG006|Overall Study|Participant refused further follow-up|7|||
126333761|NCT02573259|454516992|FG000|Overall Study|Other|0|||
126333762|NCT02573259|454516993|FG001|Overall Study|Other|0|||
126333763|NCT02573259|454516994|FG002|Overall Study|Other|0|||
126333764|NCT02573259|454516995|FG003|Overall Study|Other|0|||
126333765|NCT02573259|454516996|FG004|Overall Study|Other|1|||
126333766|NCT02573259|454516997|FG005|Overall Study|Other|4|||
126333767|NCT02573259|454516998|FG006|Overall Study|Other|5|||
126333768|NCT00751140|454516999|FG000|Overall Study|benign angioma excluded from analysis|1|||
126333769|NCT02493517|454517005|FG000|Overall Study|Protocol Violation|1|||
126333770|NCT02493517|454517006|FG001|Overall Study|Protocol Violation|2|||
126333771|NCT02493517|454517005|FG000|Overall Study|Withdrawal by Subject|1|||
126333772|NCT02493517|454517006|FG001|Overall Study|Withdrawal by Subject|2|||
126333773|NCT02493517|454517005|FG000|Overall Study|Adverse Event|0|||
126333774|NCT02493517|454517006|FG001|Overall Study|Adverse Event|2|||
126333775|NCT02493517|454517005|FG000|Overall Study|Missed study visit|0|||
126333776|NCT02493517|454517006|FG001|Overall Study|Missed study visit|1|||
126333777|NCT03718429|454517008|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
126333778|NCT03718429|454517009|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
126333779|NCT03718429|454517010|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
126333780|NCT03718429|454517011|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
126333781|NCT04632225|454517013|FG000|Overall Study|Withdrawal by Subject|2|||
126333782|NCT04632225|454517014|FG001|Overall Study|Withdrawal by Subject|2|||
126333783|NCT00325819|454517015|FG000|Overall Study|Study product lost in mail|2|||
126333784|NCT00325819|454517016|FG001|Overall Study|Study product lost in mail|1|||
126333785|NCT00325819|454517015|FG000|Overall Study|Did not take a dose of study product|4|||
126333786|NCT00325819|454517016|FG001|Overall Study|Did not take a dose of study product|9|||
126333787|NCT00325819|454517015|FG000|Overall Study|Lost to Follow-up|3|||
126333788|NCT00325819|454517016|FG001|Overall Study|Lost to Follow-up|3|||
126333789|NCT01817075|454517017|FG000|Overall Study|Adverse Event|7|||
126333790|NCT01817075|454517018|FG001|Overall Study|Adverse Event|5|||
126333791|NCT01817075|454517017|FG000|Overall Study|Physician Decision|9|||
126333792|NCT01817075|454517018|FG001|Overall Study|Physician Decision|12|||
126333793|NCT01817075|454517017|FG000|Overall Study|Withdrawal by Subject|31|||
126333794|NCT01817075|454517018|FG001|Overall Study|Withdrawal by Subject|15|||
126333795|NCT01817075|454517017|FG000|Overall Study|Received Sorafenib after enrollment|0|||
126333796|NCT01817075|454517018|FG001|Overall Study|Received Sorafenib after enrollment|1|||
126333797|NCT01817075|454517017|FG000|Overall Study|Ineligible|0|||
126333798|NCT01817075|454517018|FG001|Overall Study|Ineligible|2|||
126333799|NCT05212168|454517019|FG000|Overall Study|Lost to Follow-up|0|||
126333800|NCT05212168|454517020|FG001|Overall Study|Lost to Follow-up|3|||
126333801|NCT05212168|454517019|FG000|Overall Study|Study terminated by sponsor|30|||
126333802|NCT05212168|454517020|FG001|Overall Study|Study terminated by sponsor|27|||
126333803|NCT05212168|454517019|FG000|Overall Study|Other|4|||
126333804|NCT05212168|454517020|FG001|Overall Study|Other|7|||
126333805|NCT03811821|454517021|FG000|Overall Study|Adverse Event|1|||
126333806|NCT03811821|454517022|FG001|Overall Study|Adverse Event|1|||
126333807|NCT03811821|454517021|FG000|Overall Study|Withdrawal by Subject|5|||
126333808|NCT03811821|454517022|FG001|Overall Study|Withdrawal by Subject|4|||
126333809|NCT03811821|454517021|FG000|Overall Study|Lost to Follow-up|2|||
126333810|NCT03811821|454517022|FG001|Overall Study|Lost to Follow-up|2|||
126333811|NCT03811821|454517021|FG000|Overall Study|Contraindication for treatment|0|||
126333812|NCT03811821|454517022|FG001|Overall Study|Contraindication for treatment|1|||
126333813|NCT03811821|454517021|FG000|Overall Study|Tolerability|0|||
126333814|NCT03811821|454517022|FG001|Overall Study|Tolerability|3|||
126333815|NCT03811821|454517021|FG000|Overall Study|Comorbidities|0|||
126333816|NCT03811821|454517022|FG001|Overall Study|Comorbidities|2|||
126333817|NCT04888494|454517025|FG000|Overall Study|Lost to Follow-up|2|||
125998342|NCT01474512|453287030|FG014|Induction Period|Adverse Event|0|||
125998343|NCT01474512|453287031|FG015|Induction Period|Adverse Event|0|||
125998344|NCT01474512|453287032|FG016|Induction Period|Adverse Event|0|||
126333818|NCT04888494|454517026|FG001|Overall Study|Lost to Follow-up|3|||
126333819|NCT04888494|454517025|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
126333820|NCT04888494|454517026|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
126333821|NCT02317991|454518521|FG000|Overall Study|Adverse Event|12|||
126333822|NCT02317991|454518521|FG000|Overall Study|Death|4|||
126333823|NCT02317991|454518521|FG000|Overall Study|Withdrawal by Subject|8|||
126333824|NCT02317991|454518521|FG000|Overall Study|Progressive Disease|41|||
126333825|NCT01325350|454518522|FG000|Overall Study|Adverse Event|3|||
126333826|NCT01325350|454518523|FG001|Overall Study|Adverse Event|3|||
126333827|NCT01325350|454518524|FG002|Overall Study|Adverse Event|3|||
126333828|NCT01325350|454518525|FG003|Overall Study|Adverse Event|1|||
126333829|NCT01325350|454518526|FG004|Overall Study|Adverse Event|2|||
125998345|NCT01474512|453287033|FG017|Induction Period|Adverse Event|0|||
125998346|NCT01474512|453287016|FG000|Induction Period|Lack of Efficacy|7|||
125998347|NCT01474512|453287017|FG001|Induction Period|Lack of Efficacy|1|||
125998348|NCT01474512|453287018|FG002|Induction Period|Lack of Efficacy|0|||
125998349|NCT01474512|453287019|FG003|Induction Period|Lack of Efficacy|0|||
125998350|NCT01474512|453287020|FG004|Induction Period|Lack of Efficacy|0|||
125998351|NCT01474512|453287021|FG005|Induction Period|Lack of Efficacy|0|||
125998352|NCT01474512|453287022|FG006|Induction Period|Lack of Efficacy|0|||
125998353|NCT01474512|453287023|FG007|Induction Period|Lack of Efficacy|0|||
125998354|NCT01474512|453287024|FG008|Induction Period|Lack of Efficacy|0|||
125998355|NCT01474512|453287025|FG009|Induction Period|Lack of Efficacy|0|||
125998356|NCT01474512|453287026|FG010|Induction Period|Lack of Efficacy|0|||
125998357|NCT01474512|453287027|FG011|Induction Period|Lack of Efficacy|0|||
125998358|NCT01474512|453287028|FG012|Induction Period|Lack of Efficacy|0|||
125998359|NCT01474512|453287029|FG013|Induction Period|Lack of Efficacy|0|||
125998360|NCT01474512|453287030|FG014|Induction Period|Lack of Efficacy|0|||
125998361|NCT01474512|453287031|FG015|Induction Period|Lack of Efficacy|0|||
125998362|NCT01474512|453287032|FG016|Induction Period|Lack of Efficacy|0|||
125998363|NCT01474512|453287033|FG017|Induction Period|Lack of Efficacy|0|||
125998364|NCT01474512|453287016|FG000|Induction Period|Withdrawal by Subject|6|||
125998365|NCT01474512|453287017|FG001|Induction Period|Withdrawal by Subject|6|||
125998366|NCT01474512|453287018|FG002|Induction Period|Withdrawal by Subject|5|||
125998367|NCT01474512|453287019|FG003|Induction Period|Withdrawal by Subject|0|||
125998368|NCT01474512|453287020|FG004|Induction Period|Withdrawal by Subject|0|||
125998369|NCT01474512|453287021|FG005|Induction Period|Withdrawal by Subject|0|||
125998370|NCT01474512|453287022|FG006|Induction Period|Withdrawal by Subject|0|||
125998371|NCT01474512|453287023|FG007|Induction Period|Withdrawal by Subject|0|||
125998372|NCT01474512|453287024|FG008|Induction Period|Withdrawal by Subject|0|||
125998373|NCT01474512|453287025|FG009|Induction Period|Withdrawal by Subject|0|||
125998374|NCT01474512|453287026|FG010|Induction Period|Withdrawal by Subject|0|||
125998375|NCT01474512|453287027|FG011|Induction Period|Withdrawal by Subject|0|||
125998376|NCT01474512|453287028|FG012|Induction Period|Withdrawal by Subject|0|||
125998377|NCT01474512|453287029|FG013|Induction Period|Withdrawal by Subject|0|||
125998378|NCT01474512|453287030|FG014|Induction Period|Withdrawal by Subject|0|||
125998379|NCT01474512|453287031|FG015|Induction Period|Withdrawal by Subject|0|||
125998380|NCT01474512|453287032|FG016|Induction Period|Withdrawal by Subject|0|||
125998381|NCT01474512|453287033|FG017|Induction Period|Withdrawal by Subject|0|||
125998382|NCT01474512|453287016|FG000|Induction Period|Protocol Violation|3|||
125998383|NCT01474512|453287017|FG001|Induction Period|Protocol Violation|6|||
125998384|NCT01474512|453287018|FG002|Induction Period|Protocol Violation|0|||
125998385|NCT01474512|453287019|FG003|Induction Period|Protocol Violation|0|||
125998386|NCT01474512|453287020|FG004|Induction Period|Protocol Violation|0|||
125998387|NCT01474512|453287021|FG005|Induction Period|Protocol Violation|0|||
125998388|NCT01474512|453287022|FG006|Induction Period|Protocol Violation|0|||
125998389|NCT01474512|453287023|FG007|Induction Period|Protocol Violation|0|||
125998390|NCT01474512|453287024|FG008|Induction Period|Protocol Violation|0|||
125998391|NCT01474512|453287025|FG009|Induction Period|Protocol Violation|0|||
125998392|NCT01474512|453287026|FG010|Induction Period|Protocol Violation|0|||
125998393|NCT01474512|453287027|FG011|Induction Period|Protocol Violation|0|||
125998394|NCT01474512|453287028|FG012|Induction Period|Protocol Violation|0|||
125998395|NCT01474512|453287029|FG013|Induction Period|Protocol Violation|0|||
125998396|NCT01474512|453287030|FG014|Induction Period|Protocol Violation|0|||
125998397|NCT01474512|453287031|FG015|Induction Period|Protocol Violation|0|||
125998398|NCT01474512|453287032|FG016|Induction Period|Protocol Violation|0|||
125998399|NCT01474512|453287033|FG017|Induction Period|Protocol Violation|0|||
125998400|NCT01474512|453287016|FG000|Induction Period|Sponsor Decision|1|||
125998401|NCT01474512|453287017|FG001|Induction Period|Sponsor Decision|1|||
125998402|NCT01474512|453287018|FG002|Induction Period|Sponsor Decision|1|||
125998403|NCT01474512|453287019|FG003|Induction Period|Sponsor Decision|0|||
125998404|NCT01474512|453287020|FG004|Induction Period|Sponsor Decision|0|||
125878650|NCT01972217|452853374|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125998405|NCT01474512|453287021|FG005|Induction Period|Sponsor Decision|0|||
125998406|NCT01474512|453287022|FG006|Induction Period|Sponsor Decision|0|||
125998407|NCT01474512|453287023|FG007|Induction Period|Sponsor Decision|0|||
125998408|NCT01474512|453287024|FG008|Induction Period|Sponsor Decision|0|||
125998409|NCT01474512|453287025|FG009|Induction Period|Sponsor Decision|0|||
125998410|NCT01474512|453287026|FG010|Induction Period|Sponsor Decision|0|||
125998411|NCT01474512|453287027|FG011|Induction Period|Sponsor Decision|0|||
126333830|NCT01325350|454518522|FG000|Overall Study|Pregnancy|0|||
125998412|NCT01474512|453287028|FG012|Induction Period|Sponsor Decision|0|||
125998413|NCT01474512|453287029|FG013|Induction Period|Sponsor Decision|0|||
125998414|NCT01474512|453287030|FG014|Induction Period|Sponsor Decision|0|||
125998415|NCT01474512|453287031|FG015|Induction Period|Sponsor Decision|0|||
125998416|NCT01474512|453287032|FG016|Induction Period|Sponsor Decision|0|||
125998417|NCT01474512|453287033|FG017|Induction Period|Sponsor Decision|0|||
125998418|NCT01474512|453287016|FG000|Induction Period|Lost to Follow-up|1|||
125998419|NCT01474512|453287017|FG001|Induction Period|Lost to Follow-up|0|||
125998420|NCT01474512|453287018|FG002|Induction Period|Lost to Follow-up|2|||
125998421|NCT01474512|453287019|FG003|Induction Period|Lost to Follow-up|0|||
125998422|NCT01474512|453287020|FG004|Induction Period|Lost to Follow-up|0|||
125998423|NCT01474512|453287021|FG005|Induction Period|Lost to Follow-up|0|||
125998424|NCT01474512|453287022|FG006|Induction Period|Lost to Follow-up|0|||
125998425|NCT01474512|453287023|FG007|Induction Period|Lost to Follow-up|0|||
125998426|NCT01474512|453287024|FG008|Induction Period|Lost to Follow-up|0|||
125998427|NCT01474512|453287025|FG009|Induction Period|Lost to Follow-up|0|||
125998428|NCT01474512|453287026|FG010|Induction Period|Lost to Follow-up|0|||
125998429|NCT01474512|453287027|FG011|Induction Period|Lost to Follow-up|0|||
125998430|NCT01474512|453287028|FG012|Induction Period|Lost to Follow-up|0|||
125998431|NCT01474512|453287029|FG013|Induction Period|Lost to Follow-up|0|||
125998432|NCT01474512|453287030|FG014|Induction Period|Lost to Follow-up|0|||
125998433|NCT01474512|453287031|FG015|Induction Period|Lost to Follow-up|0|||
125998434|NCT01474512|453287032|FG016|Induction Period|Lost to Follow-up|0|||
126091090|NCT00623805|453626909|FG001|Overall Study|Reason not Specified|6|||
126091091|NCT04655027|453626913|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
126091092|NCT04655027|453626914|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
126091093|NCT03519997|453626917|FG000|Overall Study|Adverse Event|4|||
126091094|NCT03519997|453626917|FG000|Overall Study|Withdrawal by Subject|2|||
126091095|NCT03519997|453626917|FG000|Overall Study|Protocol Violation|1|||
126333831|NCT01325350|454518523|FG001|Overall Study|Pregnancy|0|||
125998435|NCT01474512|453287033|FG017|Induction Period|Lost to Follow-up|0|||
125998436|NCT01474512|453287016|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998437|NCT01474512|453287017|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998438|NCT01474512|453287018|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998439|NCT01474512|453287019|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
125998440|NCT01474512|453287020|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
125998441|NCT01474512|453287021|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
125998442|NCT01474512|453287022|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
125998443|NCT01474512|453287023|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998444|NCT01474512|453287024|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998445|NCT01474512|453287025|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998446|NCT01474512|453287026|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998447|NCT01474512|453287027|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998448|NCT01474512|453287028|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126333832|NCT01325350|454518524|FG002|Overall Study|Pregnancy|1|||
126333833|NCT01325350|454518525|FG003|Overall Study|Pregnancy|0|||
126333834|NCT01325350|454518526|FG004|Overall Study|Pregnancy|1|||
126333835|NCT01325350|454518522|FG000|Overall Study|Lost to Follow-up|1|||
126333836|NCT01325350|454518523|FG001|Overall Study|Lost to Follow-up|0|||
126333837|NCT01325350|454518524|FG002|Overall Study|Lost to Follow-up|5|||
126333838|NCT01325350|454518525|FG003|Overall Study|Lost to Follow-up|1|||
126333839|NCT01325350|454518526|FG004|Overall Study|Lost to Follow-up|5|||
126333840|NCT01325350|454518522|FG000|Overall Study|Personal Reasons|2|||
126333841|NCT01325350|454518523|FG001|Overall Study|Personal Reasons|1|||
126333842|NCT01325350|454518524|FG002|Overall Study|Personal Reasons|6|||
126333843|NCT01325350|454518525|FG003|Overall Study|Personal Reasons|5|||
126333844|NCT01325350|454518526|FG004|Overall Study|Personal Reasons|3|||
126333845|NCT01325350|454518522|FG000|Overall Study|Protocol Violation|0|||
126333846|NCT01325350|454518523|FG001|Overall Study|Protocol Violation|0|||
126333847|NCT01325350|454518524|FG002|Overall Study|Protocol Violation|0|||
126333848|NCT01325350|454518525|FG003|Overall Study|Protocol Violation|1|||
126333849|NCT01325350|454518526|FG004|Overall Study|Protocol Violation|0|||
126333850|NCT01325350|454518522|FG000|Overall Study|Withdrawal by Subject|0|||
126333851|NCT01325350|454518523|FG001|Overall Study|Withdrawal by Subject|0|||
125998449|NCT01474512|453287029|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998450|NCT01474512|453287030|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998451|NCT01474512|453287031|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998452|NCT01474512|453287032|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998453|NCT01474512|453287033|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125998454|NCT01474512|453287016|FG000|Maintenance Period|Adverse Event|0|||
125998455|NCT01474512|453287017|FG001|Maintenance Period|Adverse Event|0|||
126333852|NCT01325350|454518524|FG002|Overall Study|Withdrawal by Subject|1|||
126333853|NCT01325350|454518525|FG003|Overall Study|Withdrawal by Subject|1|||
126333854|NCT01325350|454518526|FG004|Overall Study|Withdrawal by Subject|0|||
125998456|NCT01474512|453287018|FG002|Maintenance Period|Adverse Event|0|||
126333855|NCT01325350|454518522|FG000|Overall Study|Did Not Receive Treatment|0|||
126333856|NCT01325350|454518523|FG001|Overall Study|Did Not Receive Treatment|1|||
126333857|NCT01325350|454518524|FG002|Overall Study|Did Not Receive Treatment|1|||
125998457|NCT01474512|453287019|FG003|Maintenance Period|Adverse Event|4|||
125998458|NCT01474512|453287020|FG004|Maintenance Period|Adverse Event|2|||
125998459|NCT01474512|453287021|FG005|Maintenance Period|Adverse Event|7|||
126209367|NCT05403502|454053217|FG000|Lyumjev Treatment Period|Physician Decision|2|||
126209368|NCT01054443|454053218|FG000|Overall Study|Withdrawal by Subject|0|||
126209369|NCT01054443|454053219|FG001|Overall Study|Withdrawal by Subject|0|||
126209370|NCT01054443|454053220|FG002|Overall Study|Withdrawal by Subject|0|||
126209371|NCT01054443|454053221|FG003|Overall Study|Withdrawal by Subject|1|||
126209372|NCT00985114|454053222|FG000|Overall Study|Adverse Event|1|||
126209373|NCT00985114|454053223|FG001|Overall Study|Adverse Event|0|||
126209374|NCT00985114|454053222|FG000|Overall Study|Withdrawal by Subject|0|||
126209375|NCT00985114|454053223|FG001|Overall Study|Withdrawal by Subject|2|||
126209376|NCT01119118|454053224|FG000|Overall Study|Adverse Event|1|||
126209377|NCT01003691|454053226|FG000|Overall Study|Adverse Event|0|||
126209378|NCT01003691|454053227|FG001|Overall Study|Adverse Event|0|||
126209379|NCT01003691|454053228|FG002|Overall Study|Adverse Event|0|||
126209380|NCT01003691|454053229|FG003|Overall Study|Adverse Event|1|||
126209381|NCT00167414|454053230|FG000|Overall Study|Death|10|||
126209382|NCT01593761|454053233|FG000|Overall Study|Lost to Follow-up|1|||
126209383|NCT01593761|454053233|FG000|Overall Study|culture negative for MRSA at baseline|5|||
126209384|NCT01593761|454053233|FG000|Overall Study|positive for hepatitis C virus|1|||
126209385|NCT01593761|454053233|FG000|Overall Study|secondary cellulitis|1|||
126209386|NCT01302366|454055378|FG000|Overall Study|patient choice or noncompliance|5|||
126209387|NCT00509223|454055379|FG000|Overall Study|Lost to Follow-up|1|||
126209388|NCT00509223|454055380|FG001|Overall Study|Lost to Follow-up|1|||
126209389|NCT00509223|454055379|FG000|Overall Study|Adverse Event|1|||
126209390|NCT00509223|454055380|FG001|Overall Study|Adverse Event|1|||
126209391|NCT00509223|454055379|FG000|Overall Study|Withdrawal by Subject|25|||
126209392|NCT00509223|454055380|FG001|Overall Study|Withdrawal by Subject|6|||
126209393|NCT00509223|454055379|FG000|Overall Study|Including: subject change of address|5|||
126209394|NCT00509223|454055380|FG001|Overall Study|Including: subject change of address|2|||
126209395|NCT00509223|454055379|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
126209396|NCT00509223|454055380|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
126209397|NCT00467051|454055381|FG000|Overall Study|Adverse Event|2|||
126209398|NCT00934661|454055382|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
126209399|NCT00934661|454055383|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
126209400|NCT00122954|454055386|FG000|Overall Study|Withdrawal by Subject|2|||
126209401|NCT00122954|454055387|FG001|Overall Study|Withdrawal by Subject|2|||
126209402|NCT00122954|454055386|FG000|Overall Study|Protocol Violation|0|||
126209403|NCT00122954|454055387|FG001|Overall Study|Protocol Violation|1|||
126209404|NCT05279807|454055391|FG000|Overall Study|Withdrawal by Subject|1|||
126209405|NCT05279807|454055392|FG001|Overall Study|Withdrawal by Subject|0|||
126209406|NCT05279807|454055391|FG000|Overall Study|Adverse Event|0|||
126209407|NCT05279807|454055392|FG001|Overall Study|Adverse Event|1|||
126209408|NCT05279807|454055391|FG000|Overall Study|Laboratory Abnormal Results|1|||
126209409|NCT05279807|454055392|FG001|Overall Study|Laboratory Abnormal Results|0|||
126209410|NCT03110107|454055393|FG000|Treatment Period|Disease Progression|3|||
126209411|NCT03110107|454055394|FG001|Treatment Period|Disease Progression|9|||
126209412|NCT03110107|454055395|FG002|Treatment Period|Disease Progression|8|||
126209413|NCT03110107|454055396|FG003|Treatment Period|Disease Progression|11|||
126209414|NCT03110107|454055397|FG004|Treatment Period|Disease Progression|8|||
126209415|NCT03110107|454055398|FG005|Treatment Period|Disease Progression|4|||
126209416|NCT03110107|454055399|FG006|Treatment Period|Disease Progression|6|||
126209417|NCT03110107|454055400|FG007|Treatment Period|Disease Progression|7|||
126209418|NCT03110107|454055401|FG008|Treatment Period|Disease Progression|2|||
126209419|NCT03110107|454055402|FG009|Treatment Period|Disease Progression|10|||
126209420|NCT03110107|454055403|FG010|Treatment Period|Disease Progression|5|||
126209421|NCT03110107|454055404|FG011|Treatment Period|Disease Progression|2|||
126209422|NCT03110107|454055405|FG012|Treatment Period|Disease Progression|0|||
126209423|NCT03110107|454055406|FG013|Treatment Period|Disease Progression|5|||
126209424|NCT03110107|454055407|FG014|Treatment Period|Disease Progression|14|||
126209425|NCT03110107|454055408|FG015|Treatment Period|Disease Progression|14|||
126209426|NCT03110107|454055409|FG016|Treatment Period|Disease Progression|4|||
126209427|NCT03110107|454055410|FG017|Treatment Period|Disease Progression|3|||
126209428|NCT03110107|454055411|FG018|Treatment Period|Disease Progression|16|||
126209429|NCT03110107|454055412|FG019|Treatment Period|Disease Progression|14|||
126209430|NCT03110107|454055413|FG020|Treatment Period|Disease Progression|12|||
126209431|NCT03110107|454055414|FG021|Treatment Period|Disease Progression|16|||
126209432|NCT03110107|454055415|FG022|Treatment Period|Disease Progression|18|||
126209433|NCT03110107|454055416|FG023|Treatment Period|Disease Progression|13|||
126209434|NCT03110107|454055417|FG024|Treatment Period|Disease Progression|16|||
126209435|NCT03110107|454055418|FG025|Treatment Period|Disease Progression|31|||
126209436|NCT03110107|454055393|FG000|Treatment Period|Study drug toxicity|1|||
126209437|NCT03110107|454055394|FG001|Treatment Period|Study drug toxicity|0|||
126209438|NCT03110107|454055395|FG002|Treatment Period|Study drug toxicity|1|||
126209439|NCT03110107|454055396|FG003|Treatment Period|Study drug toxicity|2|||
126209440|NCT03110107|454055397|FG004|Treatment Period|Study drug toxicity|0|||
126333858|NCT01325350|454518525|FG003|Overall Study|Did Not Receive Treatment|0|||
126333859|NCT01325350|454518526|FG004|Overall Study|Did Not Receive Treatment|1|||
126333860|NCT01716806|454518527|FG000|Overall Study|Patient withdrawal of consent|4|||
126333861|NCT01716806|454518528|FG001|Overall Study|Patient withdrawal of consent|2|||
126333862|NCT01716806|454518529|FG002|Overall Study|Patient withdrawal of consent|4|||
126333863|NCT01716806|454518530|FG003|Overall Study|Patient withdrawal of consent|3|||
126333864|NCT01716806|454518531|FG004|Overall Study|Patient withdrawal of consent|2|||
126333865|NCT01716806|454518532|FG005|Overall Study|Patient withdrawal of consent|0|||
126333866|NCT01716806|454518527|FG000|Overall Study|Lost to Follow-up|3|||
126333867|NCT01716806|454518528|FG001|Overall Study|Lost to Follow-up|3|||
126333868|NCT01716806|454518529|FG002|Overall Study|Lost to Follow-up|0|||
126333869|NCT01716806|454518530|FG003|Overall Study|Lost to Follow-up|2|||
126333870|NCT01716806|454518531|FG004|Overall Study|Lost to Follow-up|1|||
126333871|NCT01716806|454518532|FG005|Overall Study|Lost to Follow-up|0|||
126333872|NCT01716806|454518527|FG000|Overall Study|Death|13|||
126333873|NCT01716806|454518528|FG001|Overall Study|Death|9|||
126333874|NCT01716806|454518529|FG002|Overall Study|Death|12|||
126333875|NCT01716806|454518530|FG003|Overall Study|Death|4|||
126333876|NCT01716806|454518531|FG004|Overall Study|Death|10|||
126333877|NCT01716806|454518532|FG005|Overall Study|Death|5|||
126333878|NCT01716806|454518527|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
126333879|NCT01716806|454518528|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
126333880|NCT01716806|454518529|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
126333881|NCT01716806|454518530|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
126333882|NCT01716806|454518531|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
126333883|NCT01716806|454518532|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
126333884|NCT01716806|454518527|FG000|Overall Study|PI decision|0|||
126333885|NCT01716806|454518528|FG001|Overall Study|PI decision|0|||
126333886|NCT01716806|454518529|FG002|Overall Study|PI decision|0|||
126333887|NCT01716806|454518530|FG003|Overall Study|PI decision|0|||
126333888|NCT01716806|454518531|FG004|Overall Study|PI decision|1|||
126333889|NCT01716806|454518532|FG005|Overall Study|PI decision|0|||
126333890|NCT01716806|454518527|FG000|Overall Study|Change in performance status|1|||
126333891|NCT01716806|454518528|FG001|Overall Study|Change in performance status|0|||
126333892|NCT01716806|454518529|FG002|Overall Study|Change in performance status|0|||
126333893|NCT01716806|454518530|FG003|Overall Study|Change in performance status|0|||
126333894|NCT01716806|454518531|FG004|Overall Study|Change in performance status|0|||
126333895|NCT01716806|454518532|FG005|Overall Study|Change in performance status|0|||
126333896|NCT01716806|454518527|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333897|NCT01716806|454518528|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333898|NCT01716806|454518529|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
126333899|NCT01716806|454518530|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333900|NCT01716806|454518531|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333901|NCT01716806|454518532|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333902|NCT01716806|454518527|FG000|Overall Study|Sponsor direction|7|||
126333903|NCT01716806|454518528|FG001|Overall Study|Sponsor direction|8|||
126333904|NCT01716806|454518529|FG002|Overall Study|Sponsor direction|5|||
126333905|NCT01716806|454518530|FG003|Overall Study|Sponsor direction|12|||
126333906|NCT01716806|454518531|FG004|Overall Study|Sponsor direction|16|||
126333907|NCT01716806|454518532|FG005|Overall Study|Sponsor direction|1|||
126333908|NCT00956839|454518533|FG000|Overall Study|Lost to Follow-up|3|||
126333909|NCT00956839|454518534|FG001|Overall Study|Lost to Follow-up|0|||
126333910|NCT00956839|454518535|FG002|Overall Study|Lost to Follow-up|3|||
126333911|NCT03506438|454518536|FG000|Overall Study|Lost to Follow-up|8|||
126333912|NCT03506438|454518537|FG001|Overall Study|Lost to Follow-up|7|||
126333913|NCT03506438|454518538|FG002|Overall Study|Lost to Follow-up|8|||
126333914|NCT03506438|454518539|FG003|Overall Study|Lost to Follow-up|7|||
126333915|NCT03506438|454518540|FG004|Overall Study|Lost to Follow-up|0|||
126333916|NCT03506438|454518541|FG005|Overall Study|Lost to Follow-up|0|||
126333917|NCT03527277|454518542|FG000|Overall Study|Withdrawal by Subject|5|||
126333918|NCT03527277|454518543|FG001|Overall Study|Withdrawal by Subject|0|||
126333919|NCT03527277|454518542|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
126333920|NCT03527277|454518543|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
125998460|NCT01474512|453287022|FG006|Maintenance Period|Adverse Event|0|||
126333921|NCT03527277|454518542|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
126333922|NCT03527277|454518543|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
125998461|NCT01474512|453287023|FG007|Maintenance Period|Adverse Event|19|||
125998462|NCT01474512|453287024|FG008|Maintenance Period|Adverse Event|1|||
126333923|NCT01128296|454518544|FG000|Overall Study|Physician Decision|0|||
126333924|NCT01128296|454518545|FG001|Overall Study|Physician Decision|0|||
126333925|NCT01128296|454518546|FG002|Overall Study|Physician Decision|0|||
125998463|NCT01474512|453287025|FG009|Maintenance Period|Adverse Event|3|||
126333926|NCT01128296|454518547|FG003|Overall Study|Physician Decision|0|||
126333927|NCT01128296|454518548|FG004|Overall Study|Physician Decision|0|||
126333928|NCT01128296|454518549|FG005|Overall Study|Physician Decision|3|||
126333929|NCT01128296|454518544|FG000|Overall Study|Withdrawal by Subject|0|||
126333930|NCT01128296|454518545|FG001|Overall Study|Withdrawal by Subject|0|||
126333931|NCT01128296|454518546|FG002|Overall Study|Withdrawal by Subject|0|||
126333932|NCT01128296|454518547|FG003|Overall Study|Withdrawal by Subject|0|||
126333933|NCT01128296|454518548|FG004|Overall Study|Withdrawal by Subject|0|||
126333934|NCT01128296|454518549|FG005|Overall Study|Withdrawal by Subject|2|||
126333935|NCT04155463|454518550|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
126333936|NCT04155463|454518551|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
126333937|NCT01914393|454518556|FG000|Overall Study|Protocol Violation|11|||
126333938|NCT01914393|454518557|FG001|Overall Study|Protocol Violation|3|||
126333939|NCT01914393|454518558|FG002|Overall Study|Protocol Violation|19|||
126333940|NCT01914393|454518556|FG000|Overall Study|Lack of Efficacy|11|||
126333941|NCT01914393|454518557|FG001|Overall Study|Lack of Efficacy|16|||
126333942|NCT01914393|454518558|FG002|Overall Study|Lack of Efficacy|5|||
126333943|NCT01914393|454518556|FG000|Overall Study|no reason given|14|||
126333944|NCT01914393|454518557|FG001|Overall Study|no reason given|8|||
126333945|NCT01914393|454518558|FG002|Overall Study|no reason given|16|||
126333946|NCT01914393|454518556|FG000|Overall Study|Adverse Event|29|||
126333947|NCT01914393|454518557|FG001|Overall Study|Adverse Event|18|||
126333948|NCT01914393|454518558|FG002|Overall Study|Adverse Event|31|||
126333949|NCT01914393|454518556|FG000|Overall Study|Withdrawal by Subject|38|||
126333950|NCT01914393|454518557|FG001|Overall Study|Withdrawal by Subject|20|||
126333951|NCT01914393|454518558|FG002|Overall Study|Withdrawal by Subject|47|||
126333952|NCT01914393|454518556|FG000|Overall Study|Lost to Follow-up|12|||
126333953|NCT01914393|454518557|FG001|Overall Study|Lost to Follow-up|6|||
126333954|NCT01914393|454518558|FG002|Overall Study|Lost to Follow-up|19|||
126333955|NCT01914393|454518556|FG000|Overall Study|subject never dosed|0|||
126333956|NCT01914393|454518557|FG001|Overall Study|subject never dosed|0|||
126333957|NCT01914393|454518558|FG002|Overall Study|subject never dosed|1|||
126333958|NCT01831427|454518559|FG000|Overall Study|Adverse Event|0|||
126333959|NCT01831427|454518560|FG001|Overall Study|Adverse Event|1|||
126333960|NCT01831427|454518561|FG002|Overall Study|Adverse Event|0|||
126333961|NCT01831427|454518562|FG003|Overall Study|Adverse Event|0|||
126333962|NCT01831427|454518563|FG004|Overall Study|Adverse Event|0|||
126333963|NCT01831427|454518564|FG005|Overall Study|Adverse Event|1|||
126333964|NCT01831427|454518565|FG006|Overall Study|Adverse Event|0|||
126333965|NCT01831427|454518566|FG007|Overall Study|Adverse Event|1|||
126333966|NCT01831427|454518567|FG008|Overall Study|Adverse Event|0|||
126333967|NCT01831427|454518568|FG009|Overall Study|Adverse Event|0|||
126333968|NCT01831427|454518569|FG010|Overall Study|Adverse Event|2|||
126333969|NCT01831427|454518559|FG000|Overall Study|Investigator's Discretion|0|||
126333970|NCT01831427|454518560|FG001|Overall Study|Investigator's Discretion|0|||
126333971|NCT01831427|454518561|FG002|Overall Study|Investigator's Discretion|0|||
126333972|NCT01831427|454518562|FG003|Overall Study|Investigator's Discretion|1|||
126333973|NCT01831427|454518563|FG004|Overall Study|Investigator's Discretion|0|||
126333974|NCT01831427|454518564|FG005|Overall Study|Investigator's Discretion|0|||
126333975|NCT01831427|454518565|FG006|Overall Study|Investigator's Discretion|0|||
126333976|NCT01831427|454518566|FG007|Overall Study|Investigator's Discretion|0|||
126333977|NCT01831427|454518567|FG008|Overall Study|Investigator's Discretion|0|||
126333978|NCT01831427|454518568|FG009|Overall Study|Investigator's Discretion|0|||
126333979|NCT01831427|454518569|FG010|Overall Study|Investigator's Discretion|0|||
125998464|NCT01474512|453287026|FG010|Maintenance Period|Adverse Event|0|||
125998465|NCT01474512|453287027|FG011|Maintenance Period|Adverse Event|0|||
125998466|NCT01474512|453287028|FG012|Maintenance Period|Adverse Event|0|||
125998467|NCT01474512|453287029|FG013|Maintenance Period|Adverse Event|0|||
125998468|NCT01474512|453287030|FG014|Maintenance Period|Adverse Event|0|||
125998469|NCT01474512|453287031|FG015|Maintenance Period|Adverse Event|0|||
126333980|NCT01831427|454518559|FG000|Overall Study|Withdrew Consent|0|||
126333981|NCT01831427|454518560|FG001|Overall Study|Withdrew Consent|0|||
126333982|NCT01831427|454518561|FG002|Overall Study|Withdrew Consent|0|||
126333983|NCT01831427|454518562|FG003|Overall Study|Withdrew Consent|0|||
126333984|NCT01831427|454518563|FG004|Overall Study|Withdrew Consent|0|||
126333985|NCT01831427|454518564|FG005|Overall Study|Withdrew Consent|0|||
126333986|NCT01831427|454518565|FG006|Overall Study|Withdrew Consent|2|||
126333987|NCT01831427|454518566|FG007|Overall Study|Withdrew Consent|0|||
126333988|NCT01831427|454518567|FG008|Overall Study|Withdrew Consent|0|||
126333989|NCT01831427|454518568|FG009|Overall Study|Withdrew Consent|1|||
126333990|NCT01831427|454518569|FG010|Overall Study|Withdrew Consent|1|||
126333991|NCT02169505|454518570|FG000|Overall Study|Withdrawal by Subject|1|||
126333992|NCT05137717|454518571|FG000|Overall Study|Death|2|||
126333993|NCT05137717|454518571|FG000|Overall Study|Withdrawal by Subject|6|||
126333994|NCT02035553|454518572|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
126333995|NCT02035553|454518573|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
125998470|NCT01474512|453287032|FG016|Maintenance Period|Adverse Event|0|||
125998471|NCT01474512|453287033|FG017|Maintenance Period|Adverse Event|0|||
125998472|NCT01474512|453287016|FG000|Maintenance Period|Withdrawal by Subject|0|||
125998473|NCT01474512|453287017|FG001|Maintenance Period|Withdrawal by Subject|0|||
125998474|NCT01474512|453287018|FG002|Maintenance Period|Withdrawal by Subject|0|||
125998475|NCT01474512|453287019|FG003|Maintenance Period|Withdrawal by Subject|6|||
125998476|NCT01474512|453287020|FG004|Maintenance Period|Withdrawal by Subject|2|||
125998477|NCT01474512|453287021|FG005|Maintenance Period|Withdrawal by Subject|3|||
125998478|NCT01474512|453287022|FG006|Maintenance Period|Withdrawal by Subject|1|||
125998479|NCT01474512|453287023|FG007|Maintenance Period|Withdrawal by Subject|6|||
125998480|NCT01474512|453287024|FG008|Maintenance Period|Withdrawal by Subject|3|||
125998481|NCT01474512|453287025|FG009|Maintenance Period|Withdrawal by Subject|1|||
125998482|NCT01474512|453287026|FG010|Maintenance Period|Withdrawal by Subject|0|||
125998483|NCT01474512|453287027|FG011|Maintenance Period|Withdrawal by Subject|0|||
126333996|NCT02035553|454518572|FG000|Overall Study|Adverse Event|10|||
126333997|NCT02035553|454518573|FG001|Overall Study|Adverse Event|6|||
125998484|NCT01474512|453287028|FG012|Maintenance Period|Withdrawal by Subject|0|||
125998485|NCT01474512|453287029|FG013|Maintenance Period|Withdrawal by Subject|0|||
125998486|NCT01474512|453287030|FG014|Maintenance Period|Withdrawal by Subject|0|||
125998487|NCT01474512|453287031|FG015|Maintenance Period|Withdrawal by Subject|0|||
125998488|NCT01474512|453287032|FG016|Maintenance Period|Withdrawal by Subject|0|||
125998489|NCT01474512|453287033|FG017|Maintenance Period|Withdrawal by Subject|0|||
125998490|NCT01474512|453287016|FG000|Maintenance Period|Lost to Follow-up|0|||
125998491|NCT01474512|453287017|FG001|Maintenance Period|Lost to Follow-up|0|||
125998492|NCT01474512|453287018|FG002|Maintenance Period|Lost to Follow-up|0|||
125998493|NCT01474512|453287019|FG003|Maintenance Period|Lost to Follow-up|3|||
125998494|NCT01474512|453287020|FG004|Maintenance Period|Lost to Follow-up|3|||
125998495|NCT01474512|453287021|FG005|Maintenance Period|Lost to Follow-up|0|||
125998496|NCT01474512|453287022|FG006|Maintenance Period|Lost to Follow-up|0|||
125998497|NCT01474512|453287023|FG007|Maintenance Period|Lost to Follow-up|2|||
125998498|NCT01474512|453287024|FG008|Maintenance Period|Lost to Follow-up|1|||
125998499|NCT01474512|453287025|FG009|Maintenance Period|Lost to Follow-up|1|||
125998500|NCT01474512|453287026|FG010|Maintenance Period|Lost to Follow-up|0|||
125998501|NCT01474512|453287027|FG011|Maintenance Period|Lost to Follow-up|0|||
125998502|NCT01474512|453287028|FG012|Maintenance Period|Lost to Follow-up|0|||
125998503|NCT01474512|453287029|FG013|Maintenance Period|Lost to Follow-up|0|||
125998504|NCT01474512|453287030|FG014|Maintenance Period|Lost to Follow-up|0|||
125998505|NCT01474512|453287031|FG015|Maintenance Period|Lost to Follow-up|0|||
125998506|NCT01474512|453287032|FG016|Maintenance Period|Lost to Follow-up|0|||
125998507|NCT01474512|453287033|FG017|Maintenance Period|Lost to Follow-up|0|||
125998508|NCT01474512|453287016|FG000|Maintenance Period|Death|0|||
125998509|NCT01474512|453287017|FG001|Maintenance Period|Death|0|||
125998510|NCT01474512|453287018|FG002|Maintenance Period|Death|0|||
125998511|NCT01474512|453287019|FG003|Maintenance Period|Death|0|||
125998512|NCT01474512|453287020|FG004|Maintenance Period|Death|0|||
125998513|NCT01474512|453287021|FG005|Maintenance Period|Death|2|||
125998514|NCT01474512|453287022|FG006|Maintenance Period|Death|0|||
125998515|NCT01474512|453287023|FG007|Maintenance Period|Death|0|||
125998516|NCT01474512|453287024|FG008|Maintenance Period|Death|0|||
125998517|NCT01474512|453287025|FG009|Maintenance Period|Death|0|||
125998518|NCT01474512|453287026|FG010|Maintenance Period|Death|0|||
125998519|NCT01474512|453287027|FG011|Maintenance Period|Death|0|||
126333998|NCT02035553|454518572|FG000|Overall Study|Physician Decision|3|||
126333999|NCT02035553|454518573|FG001|Overall Study|Physician Decision|2|||
126334000|NCT02035553|454518572|FG000|Overall Study|Lack of Efficacy|1|||
126334001|NCT02035553|454518573|FG001|Overall Study|Lack of Efficacy|1|||
126334002|NCT02035553|454518572|FG000|Overall Study|Withdrawal by Subject|4|||
126334003|NCT02035553|454518573|FG001|Overall Study|Withdrawal by Subject|7|||
125998520|NCT01474512|453287028|FG012|Maintenance Period|Death|0|||
125998521|NCT01474512|453287029|FG013|Maintenance Period|Death|0|||
125998522|NCT01474512|453287030|FG014|Maintenance Period|Death|0|||
125998523|NCT01474512|453287031|FG015|Maintenance Period|Death|0|||
125998524|NCT01474512|453287032|FG016|Maintenance Period|Death|0|||
125998525|NCT01474512|453287033|FG017|Maintenance Period|Death|0|||
125998526|NCT01474512|453287016|FG000|Maintenance Period|Physician Decision|0|||
125998527|NCT01474512|453287017|FG001|Maintenance Period|Physician Decision|0|||
125998528|NCT01474512|453287018|FG002|Maintenance Period|Physician Decision|0|||
125998529|NCT01474512|453287019|FG003|Maintenance Period|Physician Decision|0|||
125998530|NCT01474512|453287020|FG004|Maintenance Period|Physician Decision|0|||
125998531|NCT01474512|453287021|FG005|Maintenance Period|Physician Decision|1|||
125998532|NCT01474512|453287022|FG006|Maintenance Period|Physician Decision|0|||
125998533|NCT01474512|453287023|FG007|Maintenance Period|Physician Decision|2|||
125998534|NCT01474512|453287024|FG008|Maintenance Period|Physician Decision|0|||
126334004|NCT02035553|454518572|FG000|Overall Study|Non-compliance with Study Drug|0|||
126334005|NCT02035553|454518573|FG001|Overall Study|Non-compliance with Study Drug|1|||
125998535|NCT01474512|453287025|FG009|Maintenance Period|Physician Decision|0|||
125998536|NCT01474512|453287026|FG010|Maintenance Period|Physician Decision|0|||
125998537|NCT01474512|453287027|FG011|Maintenance Period|Physician Decision|0|||
125998538|NCT01474512|453287028|FG012|Maintenance Period|Physician Decision|0|||
125998539|NCT01474512|453287029|FG013|Maintenance Period|Physician Decision|0|||
126334006|NCT02035553|454518572|FG000|Overall Study|Lost to Follow-up|0|||
126334007|NCT02035553|454518573|FG001|Overall Study|Lost to Follow-up|1|||
126334008|NCT02035553|454518572|FG000|Overall Study|Other Reason|0|||
126334009|NCT02035553|454518573|FG001|Overall Study|Other Reason|4|||
126334010|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334011|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
126334012|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
126334013|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334014|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334015|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334016|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334017|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334018|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334019|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334020|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334021|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334022|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334023|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334024|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334025|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
126334026|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
126334027|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334028|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334029|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334030|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334031|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334032|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334033|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334034|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334035|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334036|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334037|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334038|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334039|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334040|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
126334041|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
126334042|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
126334043|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334044|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334045|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334046|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334047|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334048|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334049|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334050|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334051|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334052|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334053|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334054|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334055|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334056|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334057|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
126334058|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334059|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334060|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334061|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334062|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334063|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334064|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334065|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334066|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334067|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334068|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334069|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334070|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334071|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334072|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
126334073|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334074|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334075|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334076|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334077|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125998540|NCT01474512|453287030|FG014|Maintenance Period|Physician Decision|0|||
125998541|NCT01474512|453287031|FG015|Maintenance Period|Physician Decision|0|||
125998542|NCT01474512|453287032|FG016|Maintenance Period|Physician Decision|0|||
125998543|NCT01474512|453287033|FG017|Maintenance Period|Physician Decision|0|||
125998544|NCT01474512|453287016|FG000|Maintenance Period|Clinical Relapse|0|||
125998545|NCT01474512|453287017|FG001|Maintenance Period|Clinical Relapse|0|||
125998546|NCT01474512|453287018|FG002|Maintenance Period|Clinical Relapse|0|||
125998547|NCT01474512|453287019|FG003|Maintenance Period|Clinical Relapse|1|||
125998548|NCT01474512|453287020|FG004|Maintenance Period|Clinical Relapse|0|||
125998549|NCT01474512|453287021|FG005|Maintenance Period|Clinical Relapse|0|||
125998550|NCT01474512|453287022|FG006|Maintenance Period|Clinical Relapse|0|||
125998551|NCT01474512|453287023|FG007|Maintenance Period|Clinical Relapse|0|||
125998552|NCT01474512|453287024|FG008|Maintenance Period|Clinical Relapse|0|||
125998553|NCT01474512|453287025|FG009|Maintenance Period|Clinical Relapse|0|||
125998554|NCT01474512|453287026|FG010|Maintenance Period|Clinical Relapse|0|||
125998555|NCT01474512|453287027|FG011|Maintenance Period|Clinical Relapse|0|||
125998556|NCT01474512|453287028|FG012|Maintenance Period|Clinical Relapse|0|||
125998557|NCT01474512|453287029|FG013|Maintenance Period|Clinical Relapse|0|||
125998558|NCT01474512|453287030|FG014|Maintenance Period|Clinical Relapse|0|||
125998559|NCT01474512|453287031|FG015|Maintenance Period|Clinical Relapse|0|||
125998560|NCT01474512|453287032|FG016|Maintenance Period|Clinical Relapse|0|||
125998561|NCT01474512|453287033|FG017|Maintenance Period|Clinical Relapse|0|||
125998562|NCT01474512|453287016|FG000|Maintenance Period|Lack of Efficacy|0|||
125998563|NCT01474512|453287017|FG001|Maintenance Period|Lack of Efficacy|0|||
125998564|NCT01474512|453287018|FG002|Maintenance Period|Lack of Efficacy|0|||
125998565|NCT01474512|453287019|FG003|Maintenance Period|Lack of Efficacy|1|||
125998566|NCT01474512|453287020|FG004|Maintenance Period|Lack of Efficacy|0|||
125998567|NCT01474512|453287021|FG005|Maintenance Period|Lack of Efficacy|0|||
125998568|NCT01474512|453287022|FG006|Maintenance Period|Lack of Efficacy|0|||
125998569|NCT01474512|453287023|FG007|Maintenance Period|Lack of Efficacy|11|||
125998570|NCT01474512|453287024|FG008|Maintenance Period|Lack of Efficacy|11|||
125998571|NCT01474512|453287025|FG009|Maintenance Period|Lack of Efficacy|12|||
125998572|NCT01474512|453287026|FG010|Maintenance Period|Lack of Efficacy|0|||
125998573|NCT01474512|453287027|FG011|Maintenance Period|Lack of Efficacy|0|||
125998574|NCT01474512|453287028|FG012|Maintenance Period|Lack of Efficacy|0|||
125998575|NCT01474512|453287029|FG013|Maintenance Period|Lack of Efficacy|0|||
126334078|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125998576|NCT01474512|453287030|FG014|Maintenance Period|Lack of Efficacy|0|||
125998577|NCT01474512|453287031|FG015|Maintenance Period|Lack of Efficacy|0|||
125998578|NCT01474512|453287032|FG016|Maintenance Period|Lack of Efficacy|0|||
125998579|NCT01474512|453287033|FG017|Maintenance Period|Lack of Efficacy|0|||
125998580|NCT01474512|453287016|FG000|Maintenance Period|Protocol Violation|0|||
125998581|NCT01474512|453287017|FG001|Maintenance Period|Protocol Violation|0|||
125998582|NCT01474512|453287018|FG002|Maintenance Period|Protocol Violation|0|||
125998583|NCT01474512|453287019|FG003|Maintenance Period|Protocol Violation|1|||
125998584|NCT01474512|453287020|FG004|Maintenance Period|Protocol Violation|0|||
125998585|NCT01474512|453287021|FG005|Maintenance Period|Protocol Violation|0|||
125998586|NCT01474512|453287022|FG006|Maintenance Period|Protocol Violation|0|||
125998587|NCT01474512|453287023|FG007|Maintenance Period|Protocol Violation|1|||
125998588|NCT01474512|453287024|FG008|Maintenance Period|Protocol Violation|0|||
125998589|NCT01474512|453287025|FG009|Maintenance Period|Protocol Violation|1|||
125998590|NCT01474512|453287026|FG010|Maintenance Period|Protocol Violation|0|||
125998591|NCT01474512|453287027|FG011|Maintenance Period|Protocol Violation|0|||
126334079|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125998592|NCT01474512|453287028|FG012|Maintenance Period|Protocol Violation|0|||
125998593|NCT01474512|453287029|FG013|Maintenance Period|Protocol Violation|0|||
125998594|NCT01474512|453287030|FG014|Maintenance Period|Protocol Violation|0|||
125998595|NCT01474512|453287031|FG015|Maintenance Period|Protocol Violation|0|||
125998596|NCT01474512|453287032|FG016|Maintenance Period|Protocol Violation|0|||
125998597|NCT01474512|453287033|FG017|Maintenance Period|Protocol Violation|0|||
125998598|NCT01474512|453287016|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
125998599|NCT01474512|453287017|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
125998600|NCT01474512|453287018|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
125998601|NCT01474512|453287019|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
125998602|NCT01474512|453287020|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
125998603|NCT01474512|453287021|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
125998604|NCT01474512|453287022|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
125998605|NCT01474512|453287023|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
125998606|NCT01474512|453287024|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
125998607|NCT01474512|453287025|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
125998608|NCT01474512|453287026|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
125998609|NCT01474512|453287027|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
125998610|NCT01474512|453287028|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
125998611|NCT01474512|453287029|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
126334080|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334081|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334082|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334083|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334084|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334085|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334086|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334087|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
126334088|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334089|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334090|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334091|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334092|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334093|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334094|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334095|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334096|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334097|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334098|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334099|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334100|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334101|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334102|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
126334103|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334104|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334105|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334106|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334107|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334108|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334109|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334110|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334111|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334112|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334113|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334114|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334115|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334116|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334117|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334118|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334119|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
126334120|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
126334121|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
126334122|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
126334123|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
126334124|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334125|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334126|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334127|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334128|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334129|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125998612|NCT01474512|453287030|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
126091096|NCT03820947|453626918|FG000|Overall Study|Physician Decision|0|||
126334130|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334131|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334132|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334133|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334134|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334135|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
126334136|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
126334137|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334138|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
126334139|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
126334140|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334141|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334142|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334143|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334144|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334145|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334146|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334147|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334148|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334149|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334150|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
126334151|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334152|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
126334153|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334154|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334155|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334156|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334157|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334158|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334159|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334160|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334161|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334162|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334163|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126334164|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334165|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
126334166|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126334167|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126334168|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334169|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126334170|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334171|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334172|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334173|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334174|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334175|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334176|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334177|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334178|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334179|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334180|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334181|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334182|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
126334183|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334184|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334185|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334186|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334187|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334188|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334189|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334190|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334191|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334192|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125998613|NCT01474512|453287031|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
125998614|NCT01474512|453287032|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
125998615|NCT01474512|453287033|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
125998616|NCT01474512|453287016|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
125998617|NCT01474512|453287017|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
125998618|NCT01474512|453287018|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
125998619|NCT01474512|453287019|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
125998620|NCT01474512|453287020|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
125998621|NCT01474512|453287021|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
125998622|NCT01474512|453287022|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
125998623|NCT01474512|453287023|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
125998624|NCT01474512|453287024|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
125998625|NCT01474512|453287025|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
125998626|NCT01474512|453287026|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
125998627|NCT01474512|453287027|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
125998628|NCT01474512|453287028|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
125998629|NCT01474512|453287029|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
125998630|NCT01474512|453287030|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
125998631|NCT01474512|453287031|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
125998632|NCT01474512|453287032|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
125998633|NCT01474512|453287033|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
125998634|NCT01474512|453287016|FG000|Long-Term Extension Period|Adverse Event|0|||
125998635|NCT01474512|453287017|FG001|Long-Term Extension Period|Adverse Event|0|||
125998636|NCT01474512|453287018|FG002|Long-Term Extension Period|Adverse Event|0|||
125998637|NCT01474512|453287019|FG003|Long-Term Extension Period|Adverse Event|0|||
125998638|NCT01474512|453287020|FG004|Long-Term Extension Period|Adverse Event|0|||
125998639|NCT01474512|453287021|FG005|Long-Term Extension Period|Adverse Event|0|||
125998640|NCT01474512|453287022|FG006|Long-Term Extension Period|Adverse Event|0|||
125998641|NCT01474512|453287023|FG007|Long-Term Extension Period|Adverse Event|0|||
125998642|NCT01474512|453287024|FG008|Long-Term Extension Period|Adverse Event|0|||
125998643|NCT01474512|453287025|FG009|Long-Term Extension Period|Adverse Event|0|||
125998644|NCT01474512|453287026|FG010|Long-Term Extension Period|Adverse Event|0|||
125998645|NCT01474512|453287027|FG011|Long-Term Extension Period|Adverse Event|1|||
125998646|NCT01474512|453287028|FG012|Long-Term Extension Period|Adverse Event|57|||
125998647|NCT01474512|453287029|FG013|Long-Term Extension Period|Adverse Event|58|||
125998648|NCT01474512|453287030|FG014|Long-Term Extension Period|Adverse Event|0|||
125998649|NCT01474512|453287031|FG015|Long-Term Extension Period|Adverse Event|0|||
125998650|NCT01474512|453287032|FG016|Long-Term Extension Period|Adverse Event|0|||
125998651|NCT01474512|453287033|FG017|Long-Term Extension Period|Adverse Event|0|||
125998652|NCT01474512|453287016|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
125998653|NCT01474512|453287017|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
125998654|NCT01474512|453287018|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
125998655|NCT01474512|453287019|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
125998656|NCT01474512|453287020|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
125998657|NCT01474512|453287021|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
125998658|NCT01474512|453287022|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
125998659|NCT01474512|453287023|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
125998660|NCT01474512|453287024|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
125998661|NCT01474512|453287025|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
125998662|NCT01474512|453287026|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
125998663|NCT01474512|453287027|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
125998664|NCT01474512|453287028|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
125998665|NCT01474512|453287029|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
125998666|NCT01474512|453287030|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
125998667|NCT01474512|453287031|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
125998668|NCT01474512|453287032|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
125998669|NCT01474512|453287033|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
125998670|NCT01474512|453287016|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
125998671|NCT01474512|453287017|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
125998672|NCT01474512|453287018|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
125998673|NCT01474512|453287019|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
125998674|NCT01474512|453287020|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
125998675|NCT01474512|453287021|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
125998676|NCT01474512|453287022|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
125998677|NCT01474512|453287023|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
125998678|NCT01474512|453287024|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
125998679|NCT01474512|453287025|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
125998680|NCT01474512|453287026|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
125998681|NCT01474512|453287027|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
125998682|NCT01474512|453287028|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
125878651|NCT01972217|452853371|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
126334193|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334194|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334195|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334196|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
126334197|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334198|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334199|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334200|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334201|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334202|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334203|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334204|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334205|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334206|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334207|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334208|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334209|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334210|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334211|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334212|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334213|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
126334214|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334215|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334216|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334217|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334218|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334219|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334220|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334221|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334222|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334223|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334224|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334225|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
126334226|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
126334227|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
126334228|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
126334229|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334230|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334231|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334232|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334233|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334234|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334235|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334236|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334237|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334238|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334239|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334240|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
126334241|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334242|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334243|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334244|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334245|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334246|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334247|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334248|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334249|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334250|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125998683|NCT01474512|453287029|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
125998684|NCT01474512|453287030|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
126209441|NCT03110107|454055398|FG005|Treatment Period|Study drug toxicity|3|||
126209442|NCT03110107|454055399|FG006|Treatment Period|Study drug toxicity|1|||
125998685|NCT01474512|453287031|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
125998686|NCT01474512|453287032|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
125998687|NCT01474512|453287033|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
125998688|NCT01474512|453287016|FG000|Long-Term Extension Period|Physician Decision|0|||
125998689|NCT01474512|453287017|FG001|Long-Term Extension Period|Physician Decision|0|||
125998690|NCT01474512|453287018|FG002|Long-Term Extension Period|Physician Decision|0|||
125998691|NCT01474512|453287019|FG003|Long-Term Extension Period|Physician Decision|0|||
125998692|NCT01474512|453287020|FG004|Long-Term Extension Period|Physician Decision|0|||
125998693|NCT01474512|453287021|FG005|Long-Term Extension Period|Physician Decision|0|||
125998694|NCT01474512|453287022|FG006|Long-Term Extension Period|Physician Decision|0|||
125998695|NCT01474512|453287023|FG007|Long-Term Extension Period|Physician Decision|0|||
125998696|NCT01474512|453287024|FG008|Long-Term Extension Period|Physician Decision|0|||
125998697|NCT01474512|453287025|FG009|Long-Term Extension Period|Physician Decision|0|||
125998698|NCT01474512|453287026|FG010|Long-Term Extension Period|Physician Decision|0|||
125998699|NCT01474512|453287027|FG011|Long-Term Extension Period|Physician Decision|0|||
125998700|NCT01474512|453287028|FG012|Long-Term Extension Period|Physician Decision|21|||
125998701|NCT01474512|453287029|FG013|Long-Term Extension Period|Physician Decision|21|||
125998702|NCT01474512|453287030|FG014|Long-Term Extension Period|Physician Decision|0|||
125998703|NCT01474512|453287031|FG015|Long-Term Extension Period|Physician Decision|0|||
125998704|NCT01474512|453287032|FG016|Long-Term Extension Period|Physician Decision|0|||
125998705|NCT01474512|453287033|FG017|Long-Term Extension Period|Physician Decision|0|||
125998706|NCT01474512|453287016|FG000|Long-Term Extension Period|Clinical Relapse|0|||
125998707|NCT01474512|453287017|FG001|Long-Term Extension Period|Clinical Relapse|0|||
125998708|NCT01474512|453287018|FG002|Long-Term Extension Period|Clinical Relapse|0|||
125998709|NCT01474512|453287019|FG003|Long-Term Extension Period|Clinical Relapse|0|||
125998710|NCT01474512|453287020|FG004|Long-Term Extension Period|Clinical Relapse|0|||
125998711|NCT01474512|453287021|FG005|Long-Term Extension Period|Clinical Relapse|0|||
125998712|NCT01474512|453287022|FG006|Long-Term Extension Period|Clinical Relapse|0|||
125998713|NCT01474512|453287023|FG007|Long-Term Extension Period|Clinical Relapse|0|||
125998714|NCT01474512|453287024|FG008|Long-Term Extension Period|Clinical Relapse|0|||
125998715|NCT01474512|453287025|FG009|Long-Term Extension Period|Clinical Relapse|0|||
125998716|NCT01474512|453287026|FG010|Long-Term Extension Period|Clinical Relapse|0|||
125998717|NCT01474512|453287027|FG011|Long-Term Extension Period|Clinical Relapse|0|||
125998718|NCT01474512|453287028|FG012|Long-Term Extension Period|Clinical Relapse|9|||
125998719|NCT01474512|453287029|FG013|Long-Term Extension Period|Clinical Relapse|9|||
125998720|NCT01474512|453287030|FG014|Long-Term Extension Period|Clinical Relapse|0|||
125998721|NCT01474512|453287031|FG015|Long-Term Extension Period|Clinical Relapse|0|||
125998722|NCT01474512|453287032|FG016|Long-Term Extension Period|Clinical Relapse|0|||
125998723|NCT01474512|453287033|FG017|Long-Term Extension Period|Clinical Relapse|0|||
125998724|NCT01474512|453287016|FG000|Long-Term Extension Period|Death|0|||
125998725|NCT01474512|453287017|FG001|Long-Term Extension Period|Death|0|||
125998726|NCT01474512|453287018|FG002|Long-Term Extension Period|Death|0|||
125998727|NCT01474512|453287019|FG003|Long-Term Extension Period|Death|0|||
125998728|NCT01474512|453287020|FG004|Long-Term Extension Period|Death|0|||
125998729|NCT01474512|453287021|FG005|Long-Term Extension Period|Death|0|||
125998730|NCT01474512|453287022|FG006|Long-Term Extension Period|Death|0|||
125998731|NCT01474512|453287023|FG007|Long-Term Extension Period|Death|0|||
125998732|NCT01474512|453287024|FG008|Long-Term Extension Period|Death|0|||
125998733|NCT01474512|453287025|FG009|Long-Term Extension Period|Death|0|||
125998734|NCT01474512|453287026|FG010|Long-Term Extension Period|Death|0|||
125998735|NCT01474512|453287027|FG011|Long-Term Extension Period|Death|0|||
125998736|NCT01474512|453287028|FG012|Long-Term Extension Period|Death|9|||
125998737|NCT01474512|453287029|FG013|Long-Term Extension Period|Death|9|||
125998738|NCT01474512|453287030|FG014|Long-Term Extension Period|Death|0|||
125998739|NCT01474512|453287031|FG015|Long-Term Extension Period|Death|0|||
125998740|NCT01474512|453287032|FG016|Long-Term Extension Period|Death|0|||
125998741|NCT01474512|453287033|FG017|Long-Term Extension Period|Death|0|||
125998742|NCT01474512|453287016|FG000|Long-Term Extension Period|Sponsor Decision|0|||
125998743|NCT01474512|453287017|FG001|Long-Term Extension Period|Sponsor Decision|0|||
125998744|NCT01474512|453287018|FG002|Long-Term Extension Period|Sponsor Decision|0|||
125998745|NCT01474512|453287019|FG003|Long-Term Extension Period|Sponsor Decision|0|||
125998746|NCT01474512|453287020|FG004|Long-Term Extension Period|Sponsor Decision|0|||
125998747|NCT01474512|453287021|FG005|Long-Term Extension Period|Sponsor Decision|0|||
125998748|NCT01474512|453287022|FG006|Long-Term Extension Period|Sponsor Decision|0|||
125998749|NCT01474512|453287023|FG007|Long-Term Extension Period|Sponsor Decision|0|||
125998750|NCT01474512|453287024|FG008|Long-Term Extension Period|Sponsor Decision|0|||
125998751|NCT01474512|453287025|FG009|Long-Term Extension Period|Sponsor Decision|0|||
125998752|NCT01474512|453287026|FG010|Long-Term Extension Period|Sponsor Decision|0|||
125998753|NCT01474512|453287027|FG011|Long-Term Extension Period|Sponsor Decision|0|||
125998754|NCT01474512|453287028|FG012|Long-Term Extension Period|Sponsor Decision|6|||
125998755|NCT01474512|453287029|FG013|Long-Term Extension Period|Sponsor Decision|6|||
126334251|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334252|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334253|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334254|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334255|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334256|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
126334257|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334258|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334259|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334260|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334261|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334262|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334263|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334264|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334265|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
126334266|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
126334267|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
126334268|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
126334269|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
126334270|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
126334271|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
126334272|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
126334273|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
126334274|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
126334275|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
126334276|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
126334277|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
126334278|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
126334279|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
126334280|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334281|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334282|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334283|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334284|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334285|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334286|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334287|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334288|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334289|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334290|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
126334291|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
126334292|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
126334293|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334294|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
126334295|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334296|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334297|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334298|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334299|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334300|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334301|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125998756|NCT01474512|453287030|FG014|Long-Term Extension Period|Sponsor Decision|0|||
125998757|NCT01474512|453287031|FG015|Long-Term Extension Period|Sponsor Decision|0|||
126334302|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334303|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125998758|NCT01474512|453287032|FG016|Long-Term Extension Period|Sponsor Decision|0|||
125998759|NCT01474512|453287033|FG017|Long-Term Extension Period|Sponsor Decision|0|||
125998760|NCT01474512|453287016|FG000|Long-Term Extension Period|Protocol Violation|0|||
125998761|NCT01474512|453287017|FG001|Long-Term Extension Period|Protocol Violation|0|||
125998762|NCT01474512|453287018|FG002|Long-Term Extension Period|Protocol Violation|0|||
125998763|NCT01474512|453287019|FG003|Long-Term Extension Period|Protocol Violation|0|||
125998764|NCT01474512|453287020|FG004|Long-Term Extension Period|Protocol Violation|0|||
125998765|NCT01474512|453287021|FG005|Long-Term Extension Period|Protocol Violation|0|||
125998766|NCT01474512|453287022|FG006|Long-Term Extension Period|Protocol Violation|0|||
125998767|NCT01474512|453287023|FG007|Long-Term Extension Period|Protocol Violation|0|||
125998768|NCT01474512|453287024|FG008|Long-Term Extension Period|Protocol Violation|0|||
125998769|NCT01474512|453287025|FG009|Long-Term Extension Period|Protocol Violation|0|||
125998770|NCT01474512|453287026|FG010|Long-Term Extension Period|Protocol Violation|0|||
125998771|NCT01474512|453287027|FG011|Long-Term Extension Period|Protocol Violation|0|||
125998772|NCT01474512|453287028|FG012|Long-Term Extension Period|Protocol Violation|5|||
125998773|NCT01474512|453287029|FG013|Long-Term Extension Period|Protocol Violation|5|||
125998774|NCT01474512|453287030|FG014|Long-Term Extension Period|Protocol Violation|0|||
125998775|NCT01474512|453287031|FG015|Long-Term Extension Period|Protocol Violation|0|||
125998776|NCT01474512|453287032|FG016|Long-Term Extension Period|Protocol Violation|0|||
125998777|NCT01474512|453287033|FG017|Long-Term Extension Period|Protocol Violation|0|||
125998778|NCT01474512|453287016|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998779|NCT01474512|453287017|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998780|NCT01474512|453287018|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998781|NCT01474512|453287019|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998782|NCT01474512|453287020|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998783|NCT01474512|453287021|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126334304|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334305|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126334306|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334307|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126334308|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334309|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334310|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334311|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334312|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334313|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125998784|NCT01474512|453287022|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998785|NCT01474512|453287023|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998786|NCT01474512|453287024|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998787|NCT01474512|453287025|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998788|NCT01474512|453287026|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998789|NCT01474512|453287027|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998790|NCT01474512|453287028|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
125998791|NCT01474512|453287029|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
125998792|NCT01474512|453287030|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998793|NCT01474512|453287031|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998794|NCT01474512|453287032|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998795|NCT01474512|453287033|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125998796|NCT01474512|453287016|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998797|NCT01474512|453287017|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998798|NCT01474512|453287018|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998799|NCT01474512|453287019|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998800|NCT01474512|453287020|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998801|NCT01474512|453287021|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998802|NCT01474512|453287022|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998803|NCT01474512|453287023|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998804|NCT01474512|453287024|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998805|NCT01474512|453287025|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998806|NCT01474512|453287026|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998807|NCT01474512|453287027|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
125998808|NCT01474512|453287028|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998809|NCT01474512|453287029|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998810|NCT01474512|453287030|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998811|NCT01474512|453287031|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998812|NCT01474512|453287032|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998813|NCT01474512|453287033|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125998814|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
125998815|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
125998816|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
125998817|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
125998818|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
125998819|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
125998820|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
125998821|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
125998822|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
125998823|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
125998824|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
125998825|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
126334314|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334315|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334316|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334317|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125998826|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
126334318|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334319|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334320|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334321|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
126334322|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334323|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334324|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334325|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334326|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334327|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334328|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334329|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334330|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334331|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334332|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334333|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334334|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334335|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
126334336|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334337|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
126334338|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334339|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
126334340|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334341|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334342|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334343|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334344|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334345|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334346|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334347|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334348|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334349|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334350|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334351|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
126334352|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334353|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334354|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
126334355|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334356|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334357|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334358|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334359|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334360|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334361|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334362|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334363|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334364|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334365|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334366|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
126334367|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
126334368|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334369|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
126334370|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334371|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334372|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125998827|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
125998828|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
125998829|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
125998830|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
125998831|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
125998832|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998833|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998834|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998835|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998836|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998837|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998838|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998839|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998840|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998841|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998842|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998843|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998844|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998845|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125998846|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
125998847|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
126334373|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125998848|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
125998849|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
125998850|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998851|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998852|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998853|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998854|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998855|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998856|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998857|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998858|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998859|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998860|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126334374|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334375|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334376|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125998861|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998862|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126334377|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334378|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334379|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334380|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334381|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
126334382|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334383|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334384|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334385|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334386|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334387|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334388|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334389|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334390|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334391|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334392|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334393|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334394|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334395|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334396|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334397|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
126334398|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334399|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125998863|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125998864|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
125998865|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
125998866|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
125998867|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
125998868|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998869|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998870|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998871|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126091097|NCT03820947|453626919|FG001|Overall Study|Physician Decision|1|||
126334400|NCT03713684|454518589|FG000|Overall Study|Adverse Event|1|||
126334401|NCT03713684|454518590|FG001|Overall Study|Adverse Event|3|||
126334402|NCT03713684|454518591|FG002|Overall Study|Adverse Event|1|||
126334403|NCT03713684|454518592|FG003|Overall Study|Adverse Event|0|||
126334404|NCT03713684|454518589|FG000|Overall Study|Poor compliance to protocol|2|||
126334405|NCT03713684|454518590|FG001|Overall Study|Poor compliance to protocol|1|||
126334406|NCT03713684|454518591|FG002|Overall Study|Poor compliance to protocol|0|||
126334407|NCT03713684|454518592|FG003|Overall Study|Poor compliance to protocol|1|||
126334408|NCT03713684|454518589|FG000|Overall Study|Withdrawal by Subject|14|||
126334409|NCT03713684|454518590|FG001|Overall Study|Withdrawal by Subject|6|||
126334410|NCT03713684|454518591|FG002|Overall Study|Withdrawal by Subject|14|||
126334411|NCT03713684|454518592|FG003|Overall Study|Withdrawal by Subject|16|||
126334412|NCT03713684|454518589|FG000|Overall Study|Other than specified|69|||
126334413|NCT03713684|454518590|FG001|Overall Study|Other than specified|77|||
126334414|NCT03713684|454518591|FG002|Overall Study|Other than specified|73|||
126334415|NCT03713684|454518592|FG003|Overall Study|Other than specified|70|||
126334416|NCT02185417|454518593|FG000|Overall Study|Death|448|||
126334417|NCT02185417|454518594|FG001|Overall Study|Death|446|||
126334418|NCT02185417|454518595|FG002|Overall Study|Death|0|||
126334419|NCT02185417|454518593|FG000|Overall Study|Withdrawal by Subject|7|||
126334420|NCT02185417|454518594|FG001|Overall Study|Withdrawal by Subject|12|||
126334421|NCT02185417|454518595|FG002|Overall Study|Withdrawal by Subject|0|||
126334422|NCT02595502|454518596|FG000|Period 1|Adverse Event|0|||
126334423|NCT02595502|454518597|FG001|Period 1|Adverse Event|1|||
126334424|NCT02595502|454518596|FG000|Period 1|Withdrawal by Subject|1|||
126334425|NCT02595502|454518597|FG001|Period 1|Withdrawal by Subject|0|||
126334426|NCT02595502|454518596|FG000|Period 1|Lost to Follow-up|0|||
126334427|NCT02595502|454518597|FG001|Period 1|Lost to Follow-up|1|||
126334428|NCT02595502|454518596|FG000|Period 2|Adverse Event|1|||
126334429|NCT02595502|454518597|FG001|Period 2|Adverse Event|1|||
126334430|NCT02595502|454518596|FG000|Period 2|Received incorrect lens at Period 1|0|||
126334431|NCT02595502|454518597|FG001|Period 2|Received incorrect lens at Period 1|1|||
126334432|NCT02595502|454518596|FG000|Period 3|Protocol Violation|0|||
126334433|NCT02595502|454518597|FG001|Period 3|Protocol Violation|1|||
126334434|NCT02595502|454518596|FG000|Period 3|Lost to Follow-up|1|||
126334435|NCT02595502|454518597|FG001|Period 3|Lost to Follow-up|0|||
126334436|NCT02595502|454518596|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
126334437|NCT02595502|454518597|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
126334438|NCT05556148|454518598|FG000|Overall Study|Early Termination|29|||
126334439|NCT05556148|454518598|FG000|Overall Study|Baseline Tasks Expired|4|||
126334440|NCT05556148|454518598|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
126334441|NCT05556148|454518598|FG000|Overall Study|No Longer Wished to Participate|1|||
126334442|NCT05556148|454518598|FG000|Overall Study|Bacterial Conjunctivitis|1|||
126334443|NCT00458003|454518604|FG000|Overall Study|Non protocol spinal anesthesia|1|||
126334444|NCT00458003|454518605|FG001|Overall Study|Non protocol spinal anesthesia|1|||
126334445|NCT00468585|454518608|FG000|Overall Study|Patient not treated|1|||
126334446|NCT00468585|454518609|FG001|Overall Study|Patient not treated|0|||
126334447|NCT00468585|454518610|FG002|Overall Study|Patient not treated|1|||
126334448|NCT00468585|454518611|FG003|Overall Study|Patient not treated|0|||
126334449|NCT00468585|454518608|FG000|Overall Study|Patient found to be ineligible|0|||
126334450|NCT00468585|454518609|FG001|Overall Study|Patient found to be ineligible|0|||
126334451|NCT00468585|454518610|FG002|Overall Study|Patient found to be ineligible|1|||
126334452|NCT00468585|454518611|FG003|Overall Study|Patient found to be ineligible|0|||
126334453|NCT00468585|454518608|FG000|Overall Study|Adverse Event|0|||
126334454|NCT00468585|454518609|FG001|Overall Study|Adverse Event|0|||
126334455|NCT00468585|454518610|FG002|Overall Study|Adverse Event|1|||
126334456|NCT00468585|454518611|FG003|Overall Study|Adverse Event|0|||
126334457|NCT00468585|454518608|FG000|Overall Study|Withdrawal by Subject|0|||
126334458|NCT00468585|454518609|FG001|Overall Study|Withdrawal by Subject|0|||
126334459|NCT00468585|454518610|FG002|Overall Study|Withdrawal by Subject|2|||
126334460|NCT00468585|454518611|FG003|Overall Study|Withdrawal by Subject|1|||
126334461|NCT02154139|454518612|FG000|Overall Study|Injection not administered|2|||
126334462|NCT02154139|454518612|FG000|Overall Study|Other|2|||
126334463|NCT02154139|454518612|FG000|Overall Study|Investigator transferred|3|||
126334464|NCT01529606|454518616|FG000|Overall Study|Lost to Follow-up|21|||
126334465|NCT01529606|454518617|FG001|Overall Study|Lost to Follow-up|18|||
126334466|NCT01746862|454518618|FG000|Overall Study|Withdrawal by Subject|1|||
126334467|NCT01746862|454518619|FG001|Overall Study|Withdrawal by Subject|1|||
126334468|NCT01746862|454518618|FG000|Overall Study|Protocol Violation|1|||
126334469|NCT01746862|454518619|FG001|Overall Study|Protocol Violation|0|||
126334470|NCT01746862|454518618|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
126334471|NCT01746862|454518619|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
126334472|NCT01746862|454518618|FG000|Overall Study|Entered puberty during the study|1|||
126334473|NCT01746862|454518619|FG001|Overall Study|Entered puberty during the study|0|||
126334474|NCT04742673|454518620|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
126334475|NCT04742673|454518621|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
126334476|NCT01900444|454518622|FG000|Overall Study|Protocol Violation|2|||
126334477|NCT01900444|454518622|FG000|Overall Study|Lost to Follow-up|1|||
125998872|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126334478|NCT01825200|454518626|FG000|Overall Study|Lost to Follow-up|5|||
125998873|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998874|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998875|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998876|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998877|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126334479|NCT01825200|454518627|FG001|Overall Study|Lost to Follow-up|6|||
126334480|NCT01825200|454518626|FG000|Overall Study|Withdrawal by Subject|0|||
126334481|NCT01825200|454518627|FG001|Overall Study|Withdrawal by Subject|1|||
125998878|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998879|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998880|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998881|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126334482|NCT06058390|454518631|FG000|Overall Study|Lost to Follow-up|0|||
126334483|NCT06058390|454518632|FG001|Overall Study|Lost to Follow-up|0|||
126334484|NCT06058390|454518633|FG002|Overall Study|Lost to Follow-up|2|||
126334485|NCT06058390|454518634|FG003|Overall Study|Lost to Follow-up|1|||
126334486|NCT06058390|454518631|FG000|Overall Study|Physician Decision|0|||
126334487|NCT06058390|454518632|FG001|Overall Study|Physician Decision|0|||
126334488|NCT06058390|454518633|FG002|Overall Study|Physician Decision|0|||
126334489|NCT06058390|454518634|FG003|Overall Study|Physician Decision|1|||
126334490|NCT06058390|454518631|FG000|Overall Study|Participants did not receive any study intervention|0|||
126334491|NCT06058390|454518632|FG001|Overall Study|Participants did not receive any study intervention|0|||
126334492|NCT06058390|454518633|FG002|Overall Study|Participants did not receive any study intervention|0|||
126334493|NCT06058390|454518634|FG003|Overall Study|Participants did not receive any study intervention|1|||
126334494|NCT03361306|454518635|FG000|Overall Study|Death|6|||
126334495|NCT02131064|454518637|FG000|Overall Study|Death|5|||
126334496|NCT02131064|454518638|FG001|Overall Study|Death|6|||
126334497|NCT02131064|454518637|FG000|Overall Study|Lost to Follow-up|4|||
126334498|NCT02131064|454518638|FG001|Overall Study|Lost to Follow-up|8|||
126334499|NCT02131064|454518637|FG000|Overall Study|Withdrawal by Subject|14|||
126334500|NCT02131064|454518638|FG001|Overall Study|Withdrawal by Subject|18|||
126334501|NCT02131064|454518637|FG000|Overall Study|Other|2|||
126334502|NCT02131064|454518638|FG001|Overall Study|Other|2|||
126334503|NCT00810069|454518641|FG000|Lead-in Period I|Adverse Event|43|||
126334504|NCT00810069|454518642|FG001|Lead-in Period I|Adverse Event|0|||
126334505|NCT00810069|454518643|FG002|Lead-in Period I|Adverse Event|0|||
126334506|NCT00810069|454518641|FG000|Lead-in Period I|Lack of Efficacy|1|||
126334507|NCT00810069|454518642|FG001|Lead-in Period I|Lack of Efficacy|0|||
126334508|NCT00810069|454518643|FG002|Lead-in Period I|Lack of Efficacy|0|||
126334509|NCT00810069|454518641|FG000|Lead-in Period I|Lost to Follow-up|19|||
126334510|NCT00810069|454518642|FG001|Lead-in Period I|Lost to Follow-up|0|||
126334511|NCT00810069|454518643|FG002|Lead-in Period I|Lost to Follow-up|0|||
126334512|NCT00810069|454518641|FG000|Lead-in Period I|Physician Decision|1|||
126334513|NCT00810069|454518642|FG001|Lead-in Period I|Physician Decision|0|||
126334514|NCT00810069|454518643|FG002|Lead-in Period I|Physician Decision|0|||
126334515|NCT00810069|454518641|FG000|Lead-in Period I|Protocol Violation|1|||
126334516|NCT00810069|454518642|FG001|Lead-in Period I|Protocol Violation|0|||
126334517|NCT00810069|454518643|FG002|Lead-in Period I|Protocol Violation|0|||
126334518|NCT00810069|454518641|FG000|Lead-in Period I|Withdrawal by Subject|46|||
126334519|NCT00810069|454518642|FG001|Lead-in Period I|Withdrawal by Subject|0|||
126334520|NCT00810069|454518643|FG002|Lead-in Period I|Withdrawal by Subject|0|||
126334521|NCT00810069|454518641|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
126334522|NCT00810069|454518642|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
126334523|NCT00810069|454518643|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
126334524|NCT00810069|454518641|FG000|Lead-in Period I|Randomization criteria not met|158|||
126334525|NCT00810069|454518642|FG001|Lead-in Period I|Randomization criteria not met|0|||
126334526|NCT00810069|454518643|FG002|Lead-in Period I|Randomization criteria not met|0|||
126334527|NCT00810069|454518641|FG000|Double-Blind Period II|Adverse Event|0|||
126334528|NCT00810069|454518642|FG001|Double-Blind Period II|Adverse Event|9|||
126334529|NCT00810069|454518643|FG002|Double-Blind Period II|Adverse Event|8|||
126334530|NCT00810069|454518641|FG000|Double-Blind Period II|Lack of Efficacy|0|||
126334531|NCT00810069|454518642|FG001|Double-Blind Period II|Lack of Efficacy|7|||
126334532|NCT00810069|454518643|FG002|Double-Blind Period II|Lack of Efficacy|12|||
125998882|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998883|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125998884|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
126334533|NCT00810069|454518641|FG000|Double-Blind Period II|Lost to Follow-up|0|||
126334534|NCT00810069|454518642|FG001|Double-Blind Period II|Lost to Follow-up|9|||
126334535|NCT00810069|454518643|FG002|Double-Blind Period II|Lost to Follow-up|9|||
126334536|NCT00810069|454518641|FG000|Double-Blind Period II|Physician Decision|0|||
126334537|NCT00810069|454518642|FG001|Double-Blind Period II|Physician Decision|0|||
126334538|NCT00810069|454518643|FG002|Double-Blind Period II|Physician Decision|1|||
126334539|NCT00810069|454518641|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
126334540|NCT00810069|454518642|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
126334541|NCT00810069|454518643|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
126334542|NCT00810069|454518641|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
126334543|NCT00810069|454518642|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
126334544|NCT00810069|454518643|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
126334545|NCT00810069|454518641|FG000|Double-Blind Period II|Clinical relapse|0|||
126334546|NCT00810069|454518642|FG001|Double-Blind Period II|Clinical relapse|3|||
126334547|NCT00810069|454518643|FG002|Double-Blind Period II|Clinical relapse|0|||
126334548|NCT00810069|454518641|FG000|Double-Blind Period II|Protocol Violation|0|||
126334549|NCT00810069|454518642|FG001|Double-Blind Period II|Protocol Violation|7|||
126334550|NCT00810069|454518643|FG002|Double-Blind Period II|Protocol Violation|6|||
126334551|NCT00971867|454518647|FG000|Overall Study|Adverse Event|4|||
126334552|NCT00971867|454518647|FG000|Overall Study|Participant Withdrew Consent|1|||
126334553|NCT00971867|454518647|FG000|Overall Study|Disease Progression|6|||
126334554|NCT04767373|454518648|FG000|Overall Study|Death|6|||
126334555|NCT04767373|454518649|FG001|Overall Study|Death|3|||
126334556|NCT04767373|454518648|FG000|Overall Study|Lost to Follow-up|67|||
126334557|NCT04767373|454518649|FG001|Overall Study|Lost to Follow-up|35|||
126334558|NCT04767373|454518648|FG000|Overall Study|Physician Decision|15|||
126334559|NCT04767373|454518649|FG001|Overall Study|Physician Decision|4|||
126334560|NCT04767373|454518648|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126334561|NCT04767373|454518649|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126334562|NCT04767373|454518648|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
126334563|NCT04767373|454518649|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
126334564|NCT04767373|454518648|FG000|Overall Study|Other|1|||
126334565|NCT04767373|454518649|FG001|Overall Study|Other|2|||
126334566|NCT02983045|454518651|FG000|Overall Study|Withdrawal by Subject|0|||
126334567|NCT02983045|454518652|FG001|Overall Study|Withdrawal by Subject|1|||
126334568|NCT02983045|454518653|FG002|Overall Study|Withdrawal by Subject|0|||
126334569|NCT02983045|454518654|FG003|Overall Study|Withdrawal by Subject|5|||
126334570|NCT02983045|454518655|FG004|Overall Study|Withdrawal by Subject|0|||
126334571|NCT02983045|454518656|FG005|Overall Study|Withdrawal by Subject|72|||
126334572|NCT02983045|454518657|FG006|Overall Study|Withdrawal by Subject|0|||
126334573|NCT02983045|454518658|FG007|Overall Study|Withdrawal by Subject|0|||
126334574|NCT02983045|454518659|FG008|Overall Study|Withdrawal by Subject|0|||
126334575|NCT02983045|454518660|FG009|Overall Study|Withdrawal by Subject|2|||
126334576|NCT02983045|454518651|FG000|Overall Study|Lost to Follow-up|0|||
126334577|NCT02983045|454518652|FG001|Overall Study|Lost to Follow-up|0|||
126334578|NCT02983045|454518653|FG002|Overall Study|Lost to Follow-up|0|||
126334579|NCT02983045|454518654|FG003|Overall Study|Lost to Follow-up|0|||
126334580|NCT02983045|454518655|FG004|Overall Study|Lost to Follow-up|0|||
126334581|NCT02983045|454518656|FG005|Overall Study|Lost to Follow-up|10|||
126334582|NCT02983045|454518657|FG006|Overall Study|Lost to Follow-up|0|||
126334583|NCT02983045|454518658|FG007|Overall Study|Lost to Follow-up|0|||
126334584|NCT02983045|454518659|FG008|Overall Study|Lost to Follow-up|0|||
126334585|NCT02983045|454518660|FG009|Overall Study|Lost to Follow-up|0|||
126334586|NCT00593918|454518661|FG000|Overall Study|Withdrawal by Subject|5|||
126334587|NCT00593918|454518662|FG001|Overall Study|Withdrawal by Subject|24|||
126334588|NCT02658669|454518663|FG000|Overall Study|Lost to Follow-up|7|||
126334589|NCT02658669|454518664|FG001|Overall Study|Lost to Follow-up|5|||
126334590|NCT03727841|454518665|FG000|Overall Study|Physician Decision|3|||
126334591|NCT03727841|454518666|FG001|Overall Study|Physician Decision|1|||
126334592|NCT01601496|454518667|FG000|Overall Study|Physician Decision|1|||
126334593|NCT01601496|454518667|FG000|Overall Study|Withdrawal by Subject|1|||
126334594|NCT01601496|454518667|FG000|Overall Study|Lost to Follow-up|6|||
126334595|NCT01601496|454518667|FG000|Overall Study|Death|4|||
126334596|NCT01601496|454518667|FG000|Overall Study|Other: patient refusal to continue|3|||
126334597|NCT03421379|454518675|FG000|Period 1|Withdrawal by Subject|0|||
126334598|NCT03421379|454518676|FG001|Period 1|Withdrawal by Subject|1|||
126334599|NCT03421379|454518675|FG000|Period 1|Physician Decision|1|||
126334600|NCT03421379|454518676|FG001|Period 1|Physician Decision|1|||
126334601|NCT03421379|454518675|FG000|Period 1|Did not receive treatment|1|||
126334602|NCT03421379|454518676|FG001|Period 1|Did not receive treatment|2|||
126334603|NCT04157088|454518677|FG000|Overall Study|Study terminated by sponsor|23|||
126334604|NCT04157088|454518677|FG000|Overall Study|Withdrawal by Subject|4|||
126334605|NCT04157088|454518677|FG000|Overall Study|Lost to Follow-up|2|||
126334606|NCT04157088|454518677|FG000|Overall Study|Death|1|||
126334607|NCT02421419|454518678|FG000|Overall Study|Physician Decision|0|||
126334608|NCT02421419|454518679|FG001|Overall Study|Physician Decision|0|||
126334609|NCT02421419|454518680|FG002|Overall Study|Physician Decision|1|||
126334610|NCT00196105|454518686|FG000|Overall Study|Lost to Follow-up|4|||
126334611|NCT00196105|454518687|FG001|Overall Study|Lost to Follow-up|5|||
126334612|NCT00196105|454518688|FG002|Overall Study|Lost to Follow-up|7|||
126334613|NCT04863872|454518689|FG000|Overall Study|Withdrawal by Subject|4|||
126334614|NCT04863872|454518690|FG001|Overall Study|Withdrawal by Subject|15|||
126334615|NCT04863872|454518689|FG000|Overall Study|Death|5|||
126334616|NCT04863872|454518690|FG001|Overall Study|Death|2|||
126334617|NCT04863872|454518689|FG000|Overall Study|Lost to Follow-up|2|||
126334618|NCT04863872|454518690|FG001|Overall Study|Lost to Follow-up|1|||
126334619|NCT03771963|454518691|FG000|Overall Study|Lost to Follow-up|22|||
126334620|NCT03771963|454518691|FG000|Overall Study|Withdrawal of Consent|10|||
126334621|NCT03014206|454518692|FG000|Overall Study|Registration Violation|12|||
125998885|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
125998886|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
125998887|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
125998888|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
125998889|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
125998890|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
125998891|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
125998892|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
125998893|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
125998894|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
125998895|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
125998896|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
125998897|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
125998898|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
125998899|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
125998900|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
125998901|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
125998902|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
125998903|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
125998904|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998905|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998906|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998907|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998908|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998909|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998910|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998911|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998912|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998913|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998914|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998915|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998916|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998917|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998918|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998919|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
125998920|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
125998921|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
125998922|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
125998923|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
125998924|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
125998925|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
125998926|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
125998927|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
125998928|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
125998929|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
125998930|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
125998931|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
125998932|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
125998933|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
125998934|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
125998935|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
125998936|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
125998937|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
125998938|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
125998939|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
125998940|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998941|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998942|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998943|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
126334622|NCT02864407|454518694|FG000|Overall Study|Protocol Violation|3|||
125998944|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998945|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998946|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998947|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998948|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998949|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
126334623|NCT02864407|454518694|FG000|Overall Study|Lost to Follow-up|115|||
125998950|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998951|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
126334624|NCT02864407|454518694|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
126334625|NCT02864407|454518694|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
126334626|NCT02864407|454518694|FG000|Overall Study|Consent prior to the contract date|1|||
126334627|NCT05502302|454518696|FG000|Overall Study|Lost to Follow-up|6|||
126334628|NCT05502302|454518696|FG000|Overall Study|Death|2|||
126334629|NCT02849080|454518697|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
126334630|NCT02849080|454518698|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
126334631|NCT02849080|454518699|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
126334632|NCT02849080|454518700|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
126334633|NCT02849080|454518697|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
126334634|NCT02849080|454518698|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
126334635|NCT02849080|454518699|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
126334636|NCT02849080|454518700|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
126334637|NCT02849080|454518697|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
126334638|NCT02849080|454518698|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
126334639|NCT02849080|454518699|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
126334640|NCT02849080|454518700|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
126334641|NCT02849080|454518697|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
126334642|NCT02849080|454518698|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
126334643|NCT02849080|454518699|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
126334644|NCT02849080|454518700|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
126334645|NCT02849080|454518697|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
126334646|NCT02849080|454518698|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
126334647|NCT02849080|454518699|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
126334648|NCT02849080|454518700|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
126334649|NCT02849080|454518697|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
126334650|NCT02849080|454518698|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
126334651|NCT02849080|454518699|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
126334652|NCT02849080|454518700|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
126334653|NCT01819727|454518701|FG000|Overall Study|Adverse Event|8|||
126334654|NCT01819727|454518702|FG001|Overall Study|Adverse Event|9|||
126334655|NCT01819727|454518701|FG000|Overall Study|Death|1|||
126334656|NCT01819727|454518702|FG001|Overall Study|Death|0|||
126334657|NCT01819727|454518701|FG000|Overall Study|Lost to Follow-up|1|||
126334658|NCT01819727|454518702|FG001|Overall Study|Lost to Follow-up|1|||
126334659|NCT01819727|454518701|FG000|Overall Study|Physician Decision|3|||
126334660|NCT01819727|454518702|FG001|Overall Study|Physician Decision|2|||
126334661|NCT01819727|454518701|FG000|Overall Study|Pregnancy|1|||
126334662|NCT01819727|454518702|FG001|Overall Study|Pregnancy|0|||
126334663|NCT01819727|454518701|FG000|Overall Study|Protocol Violation|0|||
126334664|NCT01819727|454518702|FG001|Overall Study|Protocol Violation|2|||
126334665|NCT01819727|454518701|FG000|Overall Study|Study Terminated by Sponsor|0|||
126334666|NCT01819727|454518702|FG001|Overall Study|Study Terminated by Sponsor|1|||
126334667|NCT01819727|454518701|FG000|Overall Study|Withdrawal by Subject|6|||
126334668|NCT01819727|454518702|FG001|Overall Study|Withdrawal by Subject|11|||
126334669|NCT01819727|454518701|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
126334670|NCT01819727|454518702|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
126334671|NCT01819727|454518701|FG000|Overall Study|Quit due to lack of health benifits|0|||
126334672|NCT01819727|454518702|FG001|Overall Study|Quit due to lack of health benifits|1|||
126334673|NCT00611806|454520452|FG000|Overall Study|Withdrawal by Subject|8|||
126334674|NCT00611806|454520453|FG001|Overall Study|Withdrawal by Subject|2|||
126334675|NCT00611806|454520452|FG000|Overall Study|Adverse Event|2|||
126334676|NCT00611806|454520453|FG001|Overall Study|Adverse Event|1|||
126334677|NCT00611806|454520452|FG000|Overall Study|Lost to Follow-up|6|||
126334678|NCT00611806|454520453|FG001|Overall Study|Lost to Follow-up|0|||
126334679|NCT01921517|454520454|FG000|Overall Study|Lost to Follow-up|5|||
126334680|NCT01921517|454520455|FG001|Overall Study|Lost to Follow-up|0|||
126334681|NCT01921517|454520454|FG000|Overall Study|Newly diagnosed health concern|2|||
126334682|NCT01921517|454520455|FG001|Overall Study|Newly diagnosed health concern|0|||
126334683|NCT01921517|454520454|FG000|Overall Study|Physician Decision|0|||
125998952|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998953|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998954|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
126334684|NCT01921517|454520455|FG001|Overall Study|Physician Decision|2|||
126334685|NCT01921517|454520454|FG000|Overall Study|Withdrawal by Subject|7|||
126334686|NCT01921517|454520455|FG001|Overall Study|Withdrawal by Subject|3|||
126334687|NCT01921517|454520454|FG000|Overall Study|Subject missed final imaging|1|||
126334688|NCT01921517|454520455|FG001|Overall Study|Subject missed final imaging|4|||
126334689|NCT00643760|454520456|FG000|Overall Study|Adverse Event|11|||
126334690|NCT00643760|454520457|FG001|Overall Study|Adverse Event|5|||
126334691|NCT00643760|454520458|FG002|Overall Study|Adverse Event|12|||
126334692|NCT00643760|454520459|FG003|Overall Study|Adverse Event|21|||
126334693|NCT00643760|454520460|FG004|Overall Study|Adverse Event|6|||
125998955|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998956|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
125998957|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
125998958|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126334694|NCT00643760|454520456|FG000|Overall Study|Lack of Efficacy|3|||
126334695|NCT00643760|454520457|FG001|Overall Study|Lack of Efficacy|1|||
126334696|NCT00643760|454520458|FG002|Overall Study|Lack of Efficacy|0|||
126334697|NCT00643760|454520459|FG003|Overall Study|Lack of Efficacy|4|||
126334698|NCT00643760|454520460|FG004|Overall Study|Lack of Efficacy|3|||
126334699|NCT00643760|454520456|FG000|Overall Study|Protocol Violation|7|||
126334700|NCT00643760|454520457|FG001|Overall Study|Protocol Violation|6|||
126334701|NCT00643760|454520458|FG002|Overall Study|Protocol Violation|4|||
126334702|NCT00643760|454520459|FG003|Overall Study|Protocol Violation|4|||
126334703|NCT00643760|454520460|FG004|Overall Study|Protocol Violation|6|||
126334704|NCT00643760|454520456|FG000|Overall Study|Lost to Follow-up|6|||
126334705|NCT00643760|454520457|FG001|Overall Study|Lost to Follow-up|2|||
126334706|NCT00643760|454520458|FG002|Overall Study|Lost to Follow-up|1|||
126334707|NCT00643760|454520459|FG003|Overall Study|Lost to Follow-up|3|||
126334708|NCT00643760|454520460|FG004|Overall Study|Lost to Follow-up|3|||
126334709|NCT00643760|454520456|FG000|Overall Study|Investigator Discretion|0|||
126334710|NCT00643760|454520457|FG001|Overall Study|Investigator Discretion|0|||
126334711|NCT00643760|454520458|FG002|Overall Study|Investigator Discretion|0|||
126334712|NCT00643760|454520459|FG003|Overall Study|Investigator Discretion|2|||
126334713|NCT00643760|454520460|FG004|Overall Study|Investigator Discretion|0|||
126334714|NCT00643760|454520456|FG000|Overall Study|Withdrawal by Subject|3|||
126334715|NCT00643760|454520457|FG001|Overall Study|Withdrawal by Subject|1|||
126334716|NCT00643760|454520458|FG002|Overall Study|Withdrawal by Subject|2|||
126334717|NCT00643760|454520459|FG003|Overall Study|Withdrawal by Subject|4|||
126334718|NCT00643760|454520460|FG004|Overall Study|Withdrawal by Subject|1|||
126334719|NCT03934216|454520461|FG000|Overall Study|Other Reasons|5|||
126334720|NCT03934216|454520462|FG001|Overall Study|Other Reasons|5|||
126334721|NCT03934216|454520461|FG000|Overall Study|Adverse Event|22|||
126334722|NCT03934216|454520462|FG001|Overall Study|Adverse Event|11|||
126334723|NCT03934216|454520461|FG000|Overall Study|Lack of Efficacy|8|||
126334724|NCT03934216|454520462|FG001|Overall Study|Lack of Efficacy|7|||
126334725|NCT03934216|454520461|FG000|Overall Study|Lost to Follow-up|2|||
126334726|NCT03934216|454520462|FG001|Overall Study|Lost to Follow-up|0|||
126334727|NCT03934216|454520461|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126334728|NCT03934216|454520462|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126334729|NCT03934216|454520461|FG000|Overall Study|Pregnancy|1|||
126334730|NCT03934216|454520462|FG001|Overall Study|Pregnancy|0|||
126334731|NCT03934216|454520461|FG000|Overall Study|Withdrawal by Subject|18|||
126334732|NCT03934216|454520462|FG001|Overall Study|Withdrawal by Subject|6|||
126334733|NCT03934216|454520461|FG000|Overall Study|Randomized but not treated|1|||
126334734|NCT03934216|454520462|FG001|Overall Study|Randomized but not treated|1|||
126334735|NCT01063855|454520463|FG000|Overall Study|Adverse Event|4|||
126334736|NCT01063855|454520464|FG001|Overall Study|Adverse Event|4|||
126334737|NCT01063855|454520463|FG000|Overall Study|Death|0|||
126334738|NCT01063855|454520464|FG001|Overall Study|Death|1|||
126334739|NCT01063855|454520463|FG000|Overall Study|Lost to Follow-up|8|||
126334740|NCT01063855|454520464|FG001|Overall Study|Lost to Follow-up|4|||
126334741|NCT01063855|454520463|FG000|Overall Study|Pregnancy|1|||
126334742|NCT01063855|454520464|FG001|Overall Study|Pregnancy|0|||
126334743|NCT01063855|454520463|FG000|Overall Study|Lack of Efficacy|0|||
126334744|NCT01063855|454520464|FG001|Overall Study|Lack of Efficacy|1|||
126334745|NCT01063855|454520463|FG000|Overall Study|Withdrawal by Subject|11|||
126334746|NCT01063855|454520464|FG001|Overall Study|Withdrawal by Subject|8|||
126334747|NCT01063855|454520463|FG000|Overall Study|Reason not specified|13|||
126334748|NCT01063855|454520464|FG001|Overall Study|Reason not specified|11|||
125998959|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998960|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998961|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126334749|NCT02163395|454520467|FG000|Overall Study|Withdrawal by Subject|1|||
126334750|NCT02163395|454520467|FG000|Overall Study|Lost to Follow-up|3|||
126334751|NCT02163395|454520467|FG000|Overall Study|Adverse Event|1|||
126334752|NCT00048035|454520490|FG000|Core Period|Early Withdrawals|4|||
125998962|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126334753|NCT00048035|454520491|FG001|Core Period|Early Withdrawals|2|||
126334754|NCT00048035|454520492|FG002|Core Period|Early Withdrawals|1|||
126334755|NCT00048035|454520493|FG003|Core Period|Early Withdrawals|1|||
126334756|NCT00048035|454520494|FG004|Core Period|Early Withdrawals|1|||
126334757|NCT00048035|454520495|FG005|Core Period|Early Withdrawals|1|||
126334758|NCT00048035|454520496|FG006|Core Period|Early Withdrawals|0|||
126334759|NCT00048035|454520497|FG007|Core Period|Early Withdrawals|0|||
126334760|NCT00048035|454520490|FG000|Extension Year 1|Early Withdrawals|0|||
126334761|NCT00048035|454520491|FG001|Extension Year 1|Early Withdrawals|0|||
126334762|NCT00048035|454520492|FG002|Extension Year 1|Early Withdrawals|0|||
126334763|NCT00048035|454520493|FG003|Extension Year 1|Early Withdrawals|0|||
126334764|NCT00048035|454520494|FG004|Extension Year 1|Early Withdrawals|0|||
126334765|NCT00048035|454520495|FG005|Extension Year 1|Early Withdrawals|0|||
126334766|NCT00048035|454520496|FG006|Extension Year 1|Early Withdrawals|11|||
126334767|NCT00048035|454520497|FG007|Extension Year 1|Early Withdrawals|11|||
126334768|NCT00048035|454520490|FG000|Extension Year 2|Early Withdrawals|0|||
126334769|NCT00048035|454520491|FG001|Extension Year 2|Early Withdrawals|0|||
126334770|NCT00048035|454520492|FG002|Extension Year 2|Early Withdrawals|0|||
126334771|NCT00048035|454520493|FG003|Extension Year 2|Early Withdrawals|0|||
126334772|NCT00048035|454520494|FG004|Extension Year 2|Early Withdrawals|0|||
126334773|NCT00048035|454520495|FG005|Extension Year 2|Early Withdrawals|0|||
126334774|NCT00048035|454520496|FG006|Extension Year 2|Early Withdrawals|3|||
126334775|NCT00048035|454520497|FG007|Extension Year 2|Early Withdrawals|3|||
126334776|NCT02619617|454520498|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
126334777|NCT02619617|454520499|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
126334778|NCT02619617|454520498|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
126334779|NCT02619617|454520499|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
126334780|NCT02735980|454520500|FG000|Overall Study|Adverse Event|0|||
126334781|NCT02735980|454520501|FG001|Overall Study|Adverse Event|4|||
126334782|NCT02735980|454520502|FG002|Overall Study|Adverse Event|1|||
125998963|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126334783|NCT02735980|454520500|FG000|Overall Study|Death|5|||
126334784|NCT02735980|454520501|FG001|Overall Study|Death|4|||
126334785|NCT02735980|454520502|FG002|Overall Study|Death|0|||
126334786|NCT02735980|454520500|FG000|Overall Study|Physician Decision|3|||
126334787|NCT02735980|454520501|FG001|Overall Study|Physician Decision|1|||
126334788|NCT02735980|454520502|FG002|Overall Study|Physician Decision|0|||
126334789|NCT02735980|454520500|FG000|Overall Study|Screen failure|1|||
126334790|NCT02735980|454520501|FG001|Overall Study|Screen failure|0|||
126334791|NCT02735980|454520502|FG002|Overall Study|Screen failure|0|||
126334792|NCT02735980|454520500|FG000|Overall Study|Withdrawal by Subject|1|||
126334793|NCT02735980|454520501|FG001|Overall Study|Withdrawal by Subject|2|||
126334794|NCT02735980|454520502|FG002|Overall Study|Withdrawal by Subject|0|||
126334795|NCT00509899|454520503|FG000|Overall Study|Progressive disease|1|||
126334796|NCT00509899|454520504|FG001|Overall Study|Progressive disease|3|||
126334797|NCT00509899|454520505|FG002|Overall Study|Progressive disease|5|||
126334798|NCT00509899|454520506|FG003|Overall Study|Progressive disease|1|||
126334799|NCT00509899|454520507|FG004|Overall Study|Progressive disease|0|||
126334800|NCT00509899|454520508|FG005|Overall Study|Progressive disease|1|||
126334801|NCT00509899|454520509|FG006|Overall Study|Progressive disease|0|||
126334802|NCT00509899|454520510|FG007|Overall Study|Progressive disease|0|||
126334803|NCT00509899|454520503|FG000|Overall Study|Unacceptable Toxicity|1|||
126334804|NCT00509899|454520504|FG001|Overall Study|Unacceptable Toxicity|0|||
126334805|NCT00509899|454520505|FG002|Overall Study|Unacceptable Toxicity|0|||
126334806|NCT00509899|454520506|FG003|Overall Study|Unacceptable Toxicity|2|||
126334807|NCT00509899|454520507|FG004|Overall Study|Unacceptable Toxicity|0|||
126334808|NCT00509899|454520508|FG005|Overall Study|Unacceptable Toxicity|0|||
126334809|NCT00509899|454520509|FG006|Overall Study|Unacceptable Toxicity|0|||
126334810|NCT00509899|454520510|FG007|Overall Study|Unacceptable Toxicity|0|||
126334811|NCT00509899|454520503|FG000|Overall Study|Withdrawal by Subject|6|||
126334812|NCT00509899|454520504|FG001|Overall Study|Withdrawal by Subject|2|||
126334813|NCT00509899|454520505|FG002|Overall Study|Withdrawal by Subject|3|||
126334814|NCT00509899|454520506|FG003|Overall Study|Withdrawal by Subject|0|||
126334815|NCT00509899|454520507|FG004|Overall Study|Withdrawal by Subject|3|||
126334816|NCT00509899|454520508|FG005|Overall Study|Withdrawal by Subject|2|||
126334817|NCT00509899|454520509|FG006|Overall Study|Withdrawal by Subject|0|||
126334818|NCT00509899|454520510|FG007|Overall Study|Withdrawal by Subject|0|||
126334819|NCT00509899|454520503|FG000|Overall Study|Physician Decision|4|||
125998964|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998965|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998966|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998967|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998968|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998969|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126334820|NCT00509899|454520504|FG001|Overall Study|Physician Decision|2|||
126334821|NCT00509899|454520505|FG002|Overall Study|Physician Decision|7|||
126334822|NCT00509899|454520506|FG003|Overall Study|Physician Decision|0|||
126334823|NCT00509899|454520507|FG004|Overall Study|Physician Decision|1|||
126334824|NCT00509899|454520508|FG005|Overall Study|Physician Decision|4|||
125998970|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126334825|NCT00509899|454520509|FG006|Overall Study|Physician Decision|0|||
126334826|NCT00509899|454520510|FG007|Overall Study|Physician Decision|0|||
126334827|NCT00509899|454520503|FG000|Overall Study|Intercurrent Illness|1|||
126334828|NCT00509899|454520504|FG001|Overall Study|Intercurrent Illness|0|||
126334829|NCT00509899|454520505|FG002|Overall Study|Intercurrent Illness|0|||
126334830|NCT00509899|454520506|FG003|Overall Study|Intercurrent Illness|1|||
126334831|NCT00509899|454520507|FG004|Overall Study|Intercurrent Illness|0|||
125998971|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998972|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
125998973|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998974|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125998975|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
125998976|NCT01474512|453287016|FG000|Post-Treatment Follow-Up|Death|0|||
125998977|NCT01474512|453287017|FG001|Post-Treatment Follow-Up|Death|0|||
125998978|NCT01474512|453287018|FG002|Post-Treatment Follow-Up|Death|0|||
125998979|NCT01474512|453287019|FG003|Post-Treatment Follow-Up|Death|0|||
126334832|NCT00509899|454520508|FG005|Overall Study|Intercurrent Illness|1|||
126334833|NCT00509899|454520509|FG006|Overall Study|Intercurrent Illness|0|||
126334834|NCT00509899|454520510|FG007|Overall Study|Intercurrent Illness|0|||
126334835|NCT00509899|454520503|FG000|Overall Study|Death|2|||
126334836|NCT00509899|454520504|FG001|Overall Study|Death|2|||
126334837|NCT00509899|454520505|FG002|Overall Study|Death|3|||
126334838|NCT00509899|454520506|FG003|Overall Study|Death|0|||
126334839|NCT00509899|454520507|FG004|Overall Study|Death|1|||
126334840|NCT00509899|454520508|FG005|Overall Study|Death|1|||
126334841|NCT00509899|454520509|FG006|Overall Study|Death|1|||
126334842|NCT00509899|454520510|FG007|Overall Study|Death|1|||
126334843|NCT00509899|454520503|FG000|Overall Study|Lack of Efficacy|1|||
126334844|NCT00509899|454520504|FG001|Overall Study|Lack of Efficacy|0|||
126334845|NCT00509899|454520505|FG002|Overall Study|Lack of Efficacy|2|||
126334846|NCT00509899|454520506|FG003|Overall Study|Lack of Efficacy|0|||
126334847|NCT00509899|454520507|FG004|Overall Study|Lack of Efficacy|0|||
126334848|NCT00509899|454520508|FG005|Overall Study|Lack of Efficacy|1|||
126334849|NCT00509899|454520509|FG006|Overall Study|Lack of Efficacy|0|||
126334850|NCT00509899|454520510|FG007|Overall Study|Lack of Efficacy|0|||
126334851|NCT01854697|454520511|FG000|Overall Study|Adverse Event|1|||
126334852|NCT01854697|454520512|FG001|Overall Study|Adverse Event|0|||
126334853|NCT01854697|454520513|FG002|Overall Study|Adverse Event|0|||
126334854|NCT01854697|454520514|FG003|Overall Study|Adverse Event|0|||
126334855|NCT01854697|454520515|FG004|Overall Study|Adverse Event|1|||
126334856|NCT01854697|454520511|FG000|Overall Study|Lost to Follow-up|4|||
126334857|NCT01854697|454520512|FG001|Overall Study|Lost to Follow-up|1|||
126334858|NCT01854697|454520513|FG002|Overall Study|Lost to Follow-up|1|||
126334859|NCT01854697|454520514|FG003|Overall Study|Lost to Follow-up|2|||
126334860|NCT01854697|454520515|FG004|Overall Study|Lost to Follow-up|0|||
126334861|NCT01854697|454520511|FG000|Overall Study|To enter another AbbVie study|1|||
126334862|NCT01854697|454520512|FG001|Overall Study|To enter another AbbVie study|0|||
126334863|NCT01854697|454520513|FG002|Overall Study|To enter another AbbVie study|0|||
126334864|NCT01854697|454520514|FG003|Overall Study|To enter another AbbVie study|0|||
126334865|NCT01854697|454520515|FG004|Overall Study|To enter another AbbVie study|1|||
126334866|NCT01854697|454520511|FG000|Overall Study|Withdrew Consent|0|||
126334867|NCT01854697|454520512|FG001|Overall Study|Withdrew Consent|1|||
126334868|NCT01854697|454520513|FG002|Overall Study|Withdrew Consent|0|||
126334869|NCT01854697|454520514|FG003|Overall Study|Withdrew Consent|1|||
126334870|NCT01854697|454520515|FG004|Overall Study|Withdrew Consent|0|||
126334871|NCT01854697|454520511|FG000|Overall Study|Other|0|||
126334872|NCT01854697|454520512|FG001|Overall Study|Other|1|||
126334873|NCT01854697|454520513|FG002|Overall Study|Other|1|||
126334874|NCT01854697|454520514|FG003|Overall Study|Other|0|||
126334875|NCT01854697|454520515|FG004|Overall Study|Other|0|||
126334876|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
126334877|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
126334878|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Death|561|||
126334879|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Death|298|||
126334880|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
126334881|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
126334882|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
126334883|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
126334884|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Other|1|||
126334885|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Other|0|||
126334886|NCT00974311|454520516|FG000|OLE Phase (up to 77 Months)|Death|14|||
126334887|NCT00974311|454520517|FG001|OLE Phase (up to 77 Months)|Death|21|||
126334888|NCT00974311|454520516|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
126334889|NCT00974311|454520517|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
126334890|NCT00974311|454520516|FG000|OLE Phase (up to 77 Months)|Other|15|||
126334891|NCT00974311|454520517|FG001|OLE Phase (up to 77 Months)|Other|2|||
126334892|NCT00974311|454520516|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
126334893|NCT00974311|454520517|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
126334894|NCT02087774|454520520|FG000|Overall Study|Were absent day of data collection|8|||
126334895|NCT02087774|454520521|FG001|Overall Study|Were absent day of data collection|20|||
126334896|NCT02157519|454520528|FG000|Overall Study|Death|3|||
126334897|NCT02157519|454520529|FG001|Overall Study|Death|1|||
126334898|NCT02157519|454520528|FG000|Overall Study|Withdrawal by Subject|7|||
126334899|NCT02157519|454520529|FG001|Overall Study|Withdrawal by Subject|0|||
126334900|NCT02157519|454520528|FG000|Overall Study|Lost to Follow-up|1|||
126334901|NCT02157519|454520529|FG001|Overall Study|Lost to Follow-up|0|||
126334902|NCT01656395|454520530|FG000|Overall Study|Adverse Event|1|||
126334903|NCT01656395|454520531|FG001|Overall Study|Adverse Event|14|||
126334904|NCT01656395|454520532|FG002|Overall Study|Adverse Event|5|||
126334905|NCT01656395|454520533|FG003|Overall Study|Adverse Event|4|||
126334906|NCT01656395|454520534|FG004|Overall Study|Adverse Event|5|||
126334907|NCT01656395|454520535|FG005|Overall Study|Adverse Event|7|||
126334908|NCT01656395|454520536|FG006|Overall Study|Adverse Event|0|||
126334909|NCT01656395|454520537|FG007|Overall Study|Adverse Event|0|||
126334910|NCT01656395|454520530|FG000|Overall Study|Lack of Efficacy|1|||
126334911|NCT01656395|454520531|FG001|Overall Study|Lack of Efficacy|8|||
126334912|NCT01656395|454520532|FG002|Overall Study|Lack of Efficacy|6|||
126334913|NCT01656395|454520533|FG003|Overall Study|Lack of Efficacy|1|||
126334914|NCT01656395|454520534|FG004|Overall Study|Lack of Efficacy|1|||
126334915|NCT01656395|454520535|FG005|Overall Study|Lack of Efficacy|6|||
126334916|NCT01656395|454520536|FG006|Overall Study|Lack of Efficacy|0|||
126334917|NCT01656395|454520537|FG007|Overall Study|Lack of Efficacy|0|||
126334918|NCT01656395|454520530|FG000|Overall Study|Lost to Follow-up|1|||
126334919|NCT01656395|454520531|FG001|Overall Study|Lost to Follow-up|0|||
126334920|NCT01656395|454520532|FG002|Overall Study|Lost to Follow-up|0|||
126334921|NCT01656395|454520533|FG003|Overall Study|Lost to Follow-up|0|||
126334922|NCT01656395|454520534|FG004|Overall Study|Lost to Follow-up|0|||
126334923|NCT01656395|454520535|FG005|Overall Study|Lost to Follow-up|0|||
126334924|NCT01656395|454520536|FG006|Overall Study|Lost to Follow-up|0|||
126334925|NCT01656395|454520537|FG007|Overall Study|Lost to Follow-up|0|||
126334926|NCT01656395|454520530|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126334927|NCT01656395|454520531|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126334928|NCT01656395|454520532|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126334929|NCT01656395|454520533|FG003|Overall Study|Non-Compliance with Study Drug|0|||
126334930|NCT01656395|454520534|FG004|Overall Study|Non-Compliance with Study Drug|1|||
126334931|NCT01656395|454520535|FG005|Overall Study|Non-Compliance with Study Drug|1|||
126334932|NCT01656395|454520536|FG006|Overall Study|Non-Compliance with Study Drug|0|||
126334933|NCT01656395|454520537|FG007|Overall Study|Non-Compliance with Study Drug|0|||
125998980|NCT01474512|453287020|FG004|Post-Treatment Follow-Up|Death|0|||
125998981|NCT01474512|453287021|FG005|Post-Treatment Follow-Up|Death|0|||
125998982|NCT01474512|453287022|FG006|Post-Treatment Follow-Up|Death|0|||
125998983|NCT01474512|453287023|FG007|Post-Treatment Follow-Up|Death|0|||
125998984|NCT01474512|453287024|FG008|Post-Treatment Follow-Up|Death|0|||
125998985|NCT01474512|453287025|FG009|Post-Treatment Follow-Up|Death|0|||
125998986|NCT01474512|453287026|FG010|Post-Treatment Follow-Up|Death|0|||
125998987|NCT01474512|453287027|FG011|Post-Treatment Follow-Up|Death|0|||
125998988|NCT01474512|453287028|FG012|Post-Treatment Follow-Up|Death|0|||
125998989|NCT01474512|453287029|FG013|Post-Treatment Follow-Up|Death|0|||
125998990|NCT01474512|453287030|FG014|Post-Treatment Follow-Up|Death|0|||
125998991|NCT01474512|453287031|FG015|Post-Treatment Follow-Up|Death|0|||
125998992|NCT01474512|453287032|FG016|Post-Treatment Follow-Up|Death|1|||
125998993|NCT01474512|453287033|FG017|Post-Treatment Follow-Up|Death|0|||
125998994|NCT01890967|453287036|FG000|Overall Study|Adverse Event|3|||
125998995|NCT01890967|453287037|FG001|Overall Study|Adverse Event|3|||
125998996|NCT01890967|453287038|FG002|Overall Study|Adverse Event|3|||
125998997|NCT01890967|453287039|FG003|Overall Study|Adverse Event|2|||
125998998|NCT01890967|453287040|FG004|Overall Study|Adverse Event|1|||
125998999|NCT01890967|453287041|FG005|Overall Study|Adverse Event|7|||
125999000|NCT01890967|453287036|FG000|Overall Study|Death|1|||
125999001|NCT01890967|453287037|FG001|Overall Study|Death|0|||
125999002|NCT01890967|453287038|FG002|Overall Study|Death|0|||
125999003|NCT01890967|453287039|FG003|Overall Study|Death|0|||
125999004|NCT01890967|453287040|FG004|Overall Study|Death|0|||
125999005|NCT01890967|453287041|FG005|Overall Study|Death|0|||
125999006|NCT01890967|453287036|FG000|Overall Study|Lost to Follow-up|1|||
125999007|NCT01890967|453287037|FG001|Overall Study|Lost to Follow-up|1|||
125999008|NCT01890967|453287038|FG002|Overall Study|Lost to Follow-up|1|||
125999009|NCT01890967|453287039|FG003|Overall Study|Lost to Follow-up|1|||
125999010|NCT01890967|453287040|FG004|Overall Study|Lost to Follow-up|0|||
125999011|NCT01890967|453287041|FG005|Overall Study|Lost to Follow-up|1|||
125999012|NCT01890967|453287036|FG000|Overall Study|Protocol Violation|0|||
125999013|NCT01890967|453287037|FG001|Overall Study|Protocol Violation|3|||
125999014|NCT01890967|453287038|FG002|Overall Study|Protocol Violation|3|||
125999015|NCT01890967|453287039|FG003|Overall Study|Protocol Violation|2|||
125999016|NCT01890967|453287040|FG004|Overall Study|Protocol Violation|4|||
125999017|NCT01890967|453287041|FG005|Overall Study|Protocol Violation|1|||
125999018|NCT01890967|453287036|FG000|Overall Study|Sponsor Decision|2|||
125999019|NCT01890967|453287037|FG001|Overall Study|Sponsor Decision|0|||
125999020|NCT01890967|453287038|FG002|Overall Study|Sponsor Decision|1|||
126334934|NCT01656395|454520530|FG000|Overall Study|Other|0|||
126334935|NCT01656395|454520531|FG001|Overall Study|Other|0|||
126334936|NCT01656395|454520532|FG002|Overall Study|Other|1|||
125999021|NCT01890967|453287039|FG003|Overall Study|Sponsor Decision|3|||
125999022|NCT01890967|453287040|FG004|Overall Study|Sponsor Decision|2|||
125999023|NCT01890967|453287041|FG005|Overall Study|Sponsor Decision|3|||
126334937|NCT01656395|454520533|FG003|Overall Study|Other|0|||
125999024|NCT01890967|453287036|FG000|Overall Study|Withdrawal by Subject|3|||
126334938|NCT01656395|454520534|FG004|Overall Study|Other|0|||
126334939|NCT01656395|454520535|FG005|Overall Study|Other|1|||
126334940|NCT01656395|454520536|FG006|Overall Study|Other|0|||
126334941|NCT01656395|454520537|FG007|Overall Study|Other|0|||
126334942|NCT01656395|454520530|FG000|Overall Study|Physician Decision|2|||
126334943|NCT01656395|454520531|FG001|Overall Study|Physician Decision|3|||
126334944|NCT01656395|454520532|FG002|Overall Study|Physician Decision|3|||
126334945|NCT01656395|454520533|FG003|Overall Study|Physician Decision|2|||
126334946|NCT01656395|454520534|FG004|Overall Study|Physician Decision|3|||
126334947|NCT01656395|454520535|FG005|Overall Study|Physician Decision|3|||
126334948|NCT01656395|454520536|FG006|Overall Study|Physician Decision|0|||
126334949|NCT01656395|454520537|FG007|Overall Study|Physician Decision|0|||
126334950|NCT01656395|454520530|FG000|Overall Study|Pregnancy|0|||
126334951|NCT01656395|454520531|FG001|Overall Study|Pregnancy|0|||
126334952|NCT01656395|454520532|FG002|Overall Study|Pregnancy|1|||
126334953|NCT01656395|454520533|FG003|Overall Study|Pregnancy|0|||
126334954|NCT01656395|454520534|FG004|Overall Study|Pregnancy|0|||
126334955|NCT01656395|454520535|FG005|Overall Study|Pregnancy|0|||
126334956|NCT01656395|454520536|FG006|Overall Study|Pregnancy|0|||
126334957|NCT01656395|454520537|FG007|Overall Study|Pregnancy|0|||
126334958|NCT01656395|454520530|FG000|Overall Study|Progressive Disease|0|||
126334959|NCT01656395|454520531|FG001|Overall Study|Progressive Disease|0|||
126334960|NCT01656395|454520532|FG002|Overall Study|Progressive Disease|0|||
126334961|NCT01656395|454520533|FG003|Overall Study|Progressive Disease|0|||
125999025|NCT01890967|453287037|FG001|Overall Study|Withdrawal by Subject|4|||
125999026|NCT01890967|453287038|FG002|Overall Study|Withdrawal by Subject|2|||
125999027|NCT01890967|453287039|FG003|Overall Study|Withdrawal by Subject|3|||
125999028|NCT01890967|453287040|FG004|Overall Study|Withdrawal by Subject|3|||
125999029|NCT01890967|453287041|FG005|Overall Study|Withdrawal by Subject|1|||
125999030|NCT03685708|453287045|FG000|Overall Study|Withdrawal by Subject|0|||
125999031|NCT03685708|453287046|FG001|Overall Study|Withdrawal by Subject|0|||
125999032|NCT03685708|453287047|FG002|Overall Study|Withdrawal by Subject|1|||
125999033|NCT03685708|453287045|FG000|Overall Study|Screen Fail|0|||
125999034|NCT03685708|453287046|FG001|Overall Study|Screen Fail|1|||
125999035|NCT03685708|453287047|FG002|Overall Study|Screen Fail|1|||
125999036|NCT03685708|453287045|FG000|Overall Study|COVID 19 Pandemic|1|||
125999037|NCT03685708|453287046|FG001|Overall Study|COVID 19 Pandemic|1|||
125999038|NCT03685708|453287047|FG002|Overall Study|COVID 19 Pandemic|6|||
125999039|NCT03685708|453287045|FG000|Overall Study|Disease Progression|0|||
125999040|NCT03685708|453287046|FG001|Overall Study|Disease Progression|0|||
125999041|NCT03685708|453287047|FG002|Overall Study|Disease Progression|1|||
125999042|NCT01058863|453287051|FG000|Overall Study|Lost to Follow-up|1|||
125999043|NCT01058863|453287051|FG000|Overall Study|Withdrawal by Subject|1|||
125999044|NCT01058863|453287051|FG000|Overall Study|Sponsor requested withdrawal|1|||
125999045|NCT01058863|453287051|FG000|Overall Study|Randomized in error|1|||
125999046|NCT00681187|453287052|FG000|Overall Study|Withdrawal by Subject|1|||
125999047|NCT00681187|453287053|FG001|Overall Study|Withdrawal by Subject|0|||
125999048|NCT00681187|453287052|FG000|Overall Study|Death|0|||
125999049|NCT00681187|453287053|FG001|Overall Study|Death|1|||
125999050|NCT00681187|453287052|FG000|Overall Study|Adverse Event|0|||
125999051|NCT00681187|453287053|FG001|Overall Study|Adverse Event|1|||
125999052|NCT04230980|453287054|FG000|Overall Study|Lost to Follow-up|1|||
125999053|NCT04230980|453287055|FG001|Overall Study|Lost to Follow-up|2|||
125999054|NCT04230980|453287054|FG000|Overall Study|Adverse Event|0|||
125999055|NCT04230980|453287055|FG001|Overall Study|Adverse Event|1|||
125999056|NCT02213055|453287059|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
125999057|NCT02213055|453287060|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
125999058|NCT02213055|453287059|FG000|Overall Study|Protocol was not Followed during Study|1|||
125999059|NCT02213055|453287060|FG001|Overall Study|Protocol was not Followed during Study|0|||
125999060|NCT02213055|453287059|FG000|Overall Study|Documentation Issue at Enrollment|1|||
125999061|NCT02213055|453287060|FG001|Overall Study|Documentation Issue at Enrollment|0|||
125999062|NCT02213055|453287059|FG000|Overall Study|Documentation Issue during Study|10|||
125999063|NCT02213055|453287060|FG001|Overall Study|Documentation Issue during Study|0|||
125999064|NCT02213055|453287059|FG000|Overall Study|Did not have Live Lice|8|||
125999065|NCT02213055|453287060|FG001|Overall Study|Did not have Live Lice|0|||
125999066|NCT02213055|453287059|FG000|Overall Study|Had another Treatment during the Study|3|||
125999067|NCT02213055|453287060|FG001|Overall Study|Had another Treatment during the Study|0|||
126334962|NCT01656395|454520534|FG004|Overall Study|Progressive Disease|0|||
126334963|NCT01656395|454520535|FG005|Overall Study|Progressive Disease|1|||
126334964|NCT01656395|454520536|FG006|Overall Study|Progressive Disease|0|||
125999068|NCT02213055|453287059|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
125999069|NCT02213055|453287060|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
125999070|NCT02213055|453287059|FG000|Overall Study|Did not Return to School|5|||
125999071|NCT02213055|453287060|FG001|Overall Study|Did not Return to School|0|||
126334965|NCT01656395|454520537|FG007|Overall Study|Progressive Disease|0|||
126334966|NCT01656395|454520530|FG000|Overall Study|Protocol Violation|6|||
126334967|NCT01656395|454520531|FG001|Overall Study|Protocol Violation|6|||
126334968|NCT01656395|454520532|FG002|Overall Study|Protocol Violation|9|||
126334969|NCT01656395|454520533|FG003|Overall Study|Protocol Violation|2|||
126334970|NCT01656395|454520534|FG004|Overall Study|Protocol Violation|4|||
126334971|NCT01656395|454520535|FG005|Overall Study|Protocol Violation|10|||
126334972|NCT01656395|454520536|FG006|Overall Study|Protocol Violation|0|||
126334973|NCT01656395|454520537|FG007|Overall Study|Protocol Violation|0|||
126334974|NCT01656395|454520530|FG000|Overall Study|Screen Failure|2|||
126334975|NCT01656395|454520531|FG001|Overall Study|Screen Failure|1|||
126334976|NCT01656395|454520532|FG002|Overall Study|Screen Failure|7|||
126334977|NCT01656395|454520533|FG003|Overall Study|Screen Failure|1|||
126334978|NCT01656395|454520534|FG004|Overall Study|Screen Failure|0|||
126334979|NCT01656395|454520535|FG005|Overall Study|Screen Failure|8|||
126334980|NCT01656395|454520536|FG006|Overall Study|Screen Failure|0|||
126334981|NCT01656395|454520537|FG007|Overall Study|Screen Failure|0|||
126334982|NCT01656395|454520530|FG000|Overall Study|Withdrawal by Subject|3|||
126334983|NCT01656395|454520531|FG001|Overall Study|Withdrawal by Subject|1|||
126334984|NCT01656395|454520532|FG002|Overall Study|Withdrawal by Subject|4|||
126334985|NCT01656395|454520533|FG003|Overall Study|Withdrawal by Subject|2|||
126334986|NCT01656395|454520534|FG004|Overall Study|Withdrawal by Subject|0|||
126334987|NCT01656395|454520535|FG005|Overall Study|Withdrawal by Subject|3|||
126334988|NCT01656395|454520536|FG006|Overall Study|Withdrawal by Subject|0|||
126334989|NCT01656395|454520537|FG007|Overall Study|Withdrawal by Subject|0|||
126334990|NCT03075267|454520538|FG000|Overall Study|Protocol Violation|1|||
126334991|NCT03075267|454520539|FG001|Overall Study|Protocol Violation|0|||
126334992|NCT03075267|454520540|FG002|Overall Study|Protocol Violation|0|||
126334993|NCT00661089|454520544|FG000|Overall Study|1 subject withdrawal|0|||
126334994|NCT00661089|454520545|FG001|Overall Study|1 subject withdrawal|1|||
126334995|NCT00661089|454520544|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
126334996|NCT00661089|454520545|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
126334997|NCT00274742|454520546|FG000|Overall Study|Adverse Event|0|||
126334998|NCT00274742|454520547|FG001|Overall Study|Adverse Event|4|||
126334999|NCT00274742|454520548|FG002|Overall Study|Adverse Event|1|||
126335000|NCT00274742|454520549|FG003|Overall Study|Adverse Event|4|||
126335001|NCT00274742|454520550|FG004|Overall Study|Adverse Event|12|||
126335002|NCT00274742|454520551|FG005|Overall Study|Adverse Event|3|||
126335003|NCT00274742|454520546|FG000|Overall Study|Lost to Follow-up|0|||
126335004|NCT00274742|454520547|FG001|Overall Study|Lost to Follow-up|0|||
126335005|NCT00274742|454520548|FG002|Overall Study|Lost to Follow-up|0|||
126335006|NCT00274742|454520549|FG003|Overall Study|Lost to Follow-up|0|||
126335007|NCT00274742|454520550|FG004|Overall Study|Lost to Follow-up|1|||
126335008|NCT00274742|454520551|FG005|Overall Study|Lost to Follow-up|0|||
126335009|NCT00274742|454520546|FG000|Overall Study|End of Study|0|||
126335010|NCT00274742|454520547|FG001|Overall Study|End of Study|0|||
126335011|NCT00274742|454520548|FG002|Overall Study|End of Study|0|||
126335012|NCT00274742|454520549|FG003|Overall Study|End of Study|1|||
126335013|NCT00274742|454520550|FG004|Overall Study|End of Study|0|||
126335014|NCT00274742|454520551|FG005|Overall Study|End of Study|0|||
126335015|NCT00274742|454520546|FG000|Overall Study|Disease Progression|0|||
126335016|NCT00274742|454520547|FG001|Overall Study|Disease Progression|1|||
126335017|NCT00274742|454520548|FG002|Overall Study|Disease Progression|1|||
126335018|NCT00274742|454520549|FG003|Overall Study|Disease Progression|0|||
126335019|NCT00274742|454520550|FG004|Overall Study|Disease Progression|1|||
126335020|NCT00274742|454520551|FG005|Overall Study|Disease Progression|0|||
126335021|NCT00274742|454520546|FG000|Overall Study|Other|0|||
126335022|NCT00274742|454520547|FG001|Overall Study|Other|3|||
126335023|NCT00274742|454520548|FG002|Overall Study|Other|0|||
126335024|NCT00274742|454520549|FG003|Overall Study|Other|0|||
126335025|NCT00274742|454520550|FG004|Overall Study|Other|2|||
126335026|NCT00274742|454520551|FG005|Overall Study|Other|0|||
126335027|NCT00072384|454520560|FG000|Overall Study|Physician Decision|1|||
126335028|NCT00072384|454520560|FG000|Overall Study|Ineligible|8|||
126335029|NCT00490035|454520561|FG000|Overall Study|AE, non-serious non-fatal|3|||
126335030|NCT00490035|454520562|FG001|Overall Study|AE, non-serious non-fatal|4|||
126335031|NCT00490035|454520563|FG002|Overall Study|AE, non-serious non-fatal|4|||
125999072|NCT00231894|453287061|FG000|Overall Study|Withdrawal by Subject|1|||
125999073|NCT00231894|453287062|FG001|Overall Study|Withdrawal by Subject|1|||
126335032|NCT00490035|454520564|FG003|Overall Study|AE, non-serious non-fatal|5|||
126335033|NCT00490035|454520561|FG000|Overall Study|Lost to Follow-up|2|||
126335034|NCT00490035|454520562|FG001|Overall Study|Lost to Follow-up|0|||
125999074|NCT02025205|453287063|FG000|Overall Study|Withdrawal by Subject|1|||
126335035|NCT00490035|454520563|FG002|Overall Study|Lost to Follow-up|1|||
126335036|NCT00490035|454520564|FG003|Overall Study|Lost to Follow-up|0|||
126335037|NCT00490035|454520561|FG000|Overall Study|Withdrawal by Subject|2|||
126335038|NCT00490035|454520562|FG001|Overall Study|Withdrawal by Subject|1|||
126335039|NCT00490035|454520563|FG002|Overall Study|Withdrawal by Subject|1|||
126335040|NCT00490035|454520564|FG003|Overall Study|Withdrawal by Subject|0|||
126335041|NCT00490035|454520561|FG000|Overall Study|Other reason|0|||
126335042|NCT00490035|454520562|FG001|Overall Study|Other reason|1|||
126335043|NCT00490035|454520563|FG002|Overall Study|Other reason|3|||
126335044|NCT00490035|454520564|FG003|Overall Study|Other reason|1|||
126335045|NCT00490035|454520561|FG000|Overall Study|AE, serious fatal|1|||
126335046|NCT00490035|454520562|FG001|Overall Study|AE, serious fatal|0|||
126335047|NCT00490035|454520563|FG002|Overall Study|AE, serious fatal|0|||
126335048|NCT00490035|454520564|FG003|Overall Study|AE, serious fatal|0|||
126335049|NCT00490035|454520561|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
126335050|NCT00490035|454520562|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
126335051|NCT00490035|454520563|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
126335052|NCT00490035|454520564|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
126335053|NCT00490035|454520561|FG000|Overall Study|AE of unknown type|0|||
126335054|NCT00490035|454520562|FG001|Overall Study|AE of unknown type|0|||
126335055|NCT00490035|454520563|FG002|Overall Study|AE of unknown type|2|||
126335056|NCT00490035|454520564|FG003|Overall Study|AE of unknown type|0|||
126335057|NCT05209880|454520567|FG000|1-Month Follow-up|Spoke with Doctor|5|||
126335058|NCT05209880|454520568|FG001|1-Month Follow-up|Spoke with Doctor|5|||
126335059|NCT05209880|454520567|FG000|1-Month Follow-up|Lost to Follow-up|7|||
126335060|NCT05209880|454520568|FG001|1-Month Follow-up|Lost to Follow-up|9|||
126335061|NCT05209880|454520567|FG000|1-Month Follow-up|Discontinued|0|||
126335062|NCT05209880|454520568|FG001|1-Month Follow-up|Discontinued|1|||
126335063|NCT05209880|454520567|FG000|3-Month Follow-up|Spoke with Doctor|17|||
126335064|NCT05209880|454520568|FG001|3-Month Follow-up|Spoke with Doctor|7|||
126335065|NCT05209880|454520567|FG000|3-Month Follow-up|Lost to Follow-up|8|||
126335066|NCT05209880|454520568|FG001|3-Month Follow-up|Lost to Follow-up|10|||
126335067|NCT05209880|454520567|FG000|3-Month Follow-up|Discontinued|1|||
126335068|NCT05209880|454520568|FG001|3-Month Follow-up|Discontinued|3|||
126335069|NCT05209880|454520567|FG000|6-Month Follow-up|Spoke with Doctor|25|||
126335070|NCT05209880|454520568|FG001|6-Month Follow-up|Spoke with Doctor|14|||
126335071|NCT05209880|454520567|FG000|6-Month Follow-up|Lost to Follow-up|9|||
126335072|NCT05209880|454520568|FG001|6-Month Follow-up|Lost to Follow-up|14|||
126335073|NCT05209880|454520567|FG000|6-Month Follow-up|Discontinued|1|||
126335074|NCT05209880|454520568|FG001|6-Month Follow-up|Discontinued|3|||
126335075|NCT04144322|454520571|FG000|Overall Study|Lack of Efficacy|2|||
126335076|NCT04144322|454520572|FG001|Overall Study|Lack of Efficacy|2|||
126335077|NCT04817332|454520573|FG000|Overall Study|Lost to Follow-up|3|||
126335078|NCT04817332|454520574|FG001|Overall Study|Lost to Follow-up|3|||
126335079|NCT04817332|454520573|FG000|Overall Study|Protocol Violation|2|||
126335080|NCT04817332|454520574|FG001|Overall Study|Protocol Violation|0|||
126335081|NCT04795466|454520580|FG000|Overall Study|Adverse Event|3|||
126335082|NCT04795466|454520581|FG001|Overall Study|Adverse Event|1|||
126335083|NCT04795466|454520580|FG000|Overall Study|Physician Decision|1|||
126335084|NCT04795466|454520581|FG001|Overall Study|Physician Decision|0|||
126335085|NCT04795466|454520580|FG000|Overall Study|Withdrawal by Subject|2|||
126335086|NCT04795466|454520581|FG001|Overall Study|Withdrawal by Subject|1|||
126335087|NCT05635045|454520582|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
126335088|NCT05635045|454520583|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
126335089|NCT05635045|454520584|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
126335090|NCT05635045|454520585|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
126335091|NCT04577794|454520591|FG000|Overall Study|Adverse Event|1|||
126335092|NCT04577794|454520592|FG001|Overall Study|Adverse Event|1|||
126335093|NCT01628848|454520593|FG000|Overall Study|Adverse Event|9|||
126335094|NCT01628848|454520594|FG001|Overall Study|Adverse Event|7|||
126335095|NCT01628848|454520593|FG000|Overall Study|Lack of Efficacy|0|||
126335096|NCT01628848|454520594|FG001|Overall Study|Lack of Efficacy|4|||
126335097|NCT01628848|454520593|FG000|Overall Study|Withdrawal by Subject|0|||
126335098|NCT01628848|454520594|FG001|Overall Study|Withdrawal by Subject|2|||
126335099|NCT01628848|454520593|FG000|Overall Study|Physician Decision|3|||
126335100|NCT01628848|454520594|FG001|Overall Study|Physician Decision|1|||
126335101|NCT00003471|454520595|FG000|Overall Study|Not evaluable|4|||
125999075|NCT02025205|453287064|FG001|Overall Study|Withdrawal by Subject|1|||
125999076|NCT02025205|453287063|FG000|Overall Study|Protocol Violation|2|||
125999077|NCT02025205|453287064|FG001|Overall Study|Protocol Violation|1|||
126335102|NCT02104895|454520596|FG000|Overall Study|Withdrawal by Subject|0|||
126335103|NCT02104895|454520597|FG001|Overall Study|Withdrawal by Subject|14|||
126335104|NCT01107925|454520599|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
126335105|NCT01107925|454520600|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
126335106|NCT01107925|454520601|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
126335107|NCT01107925|454520602|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
126335108|NCT01107925|454520603|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
126335109|NCT01107925|454520604|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
126335110|NCT01107925|454520599|FG000|Period 2|Withdrawal by Subject|0|||
126335111|NCT01107925|454520600|FG001|Period 2|Withdrawal by Subject|1|||
126335112|NCT01107925|454520601|FG002|Period 2|Withdrawal by Subject|0|||
126335113|NCT01107925|454520602|FG003|Period 2|Withdrawal by Subject|0|||
125999078|NCT02025205|453287063|FG000|Overall Study|Death|0|||
126335114|NCT01107925|454520603|FG004|Period 2|Withdrawal by Subject|0|||
126335115|NCT01107925|454520604|FG005|Period 2|Withdrawal by Subject|1|||
126335116|NCT03311945|454520605|FG000|Overall Study|Adverse Event|2|||
126335117|NCT03311945|454520605|FG000|Overall Study|Lack of Efficacy|1|||
126335118|NCT04877990|454520606|FG000|Treatment|Other reasons|3|||
126335119|NCT04877990|454520607|FG001|Treatment|Other reasons|1|||
126335120|NCT04877990|454520606|FG000|Treatment|Administrative reasons by sponsor|17|||
126335121|NCT04877990|454520607|FG001|Treatment|Administrative reasons by sponsor|33|||
126335122|NCT04877990|454520606|FG000|Treatment|Withdrawal by Subject|2|||
126335123|NCT04877990|454520607|FG001|Treatment|Withdrawal by Subject|6|||
126335124|NCT04877990|454520606|FG000|Treatment|Adverse Event|2|||
126335125|NCT04877990|454520607|FG001|Treatment|Adverse Event|1|||
126335126|NCT03839394|454520608|FG000|Overall Study|Lost to Follow-up|6|||
126335127|NCT03839394|454520609|FG001|Overall Study|Lost to Follow-up|8|||
126335128|NCT03839394|454520608|FG000|Overall Study|Withdrawal by Subject|0|||
126335129|NCT03839394|454520609|FG001|Overall Study|Withdrawal by Subject|2|||
126335130|NCT01619878|454520610|FG000|6 Week Follow-up Phase|Adverse Event|1|||
126335131|NCT01619878|454520610|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
125999079|NCT02025205|453287064|FG001|Overall Study|Death|1|||
125999080|NCT01767129|453287065|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
125999081|NCT01767129|453287066|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
125999082|NCT03389893|453287067|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
125999083|NCT03389893|453287068|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
125999084|NCT03389893|453287069|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
125999085|NCT03389893|453287070|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
125999086|NCT03389893|453287067|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
125999087|NCT03389893|453287068|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
125999088|NCT03389893|453287069|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
125999089|NCT03389893|453287070|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
125999090|NCT03389893|453287067|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
125999091|NCT03389893|453287068|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
125999092|NCT03389893|453287069|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
125999093|NCT03389893|453287070|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
125999094|NCT03389893|453287067|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
125999095|NCT03389893|453287068|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
126335132|NCT01619878|454520610|FG000|Follow-up at 12 Months of Age|Death|2|||
125999096|NCT03389893|453287069|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
125999097|NCT03389893|453287070|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
125999098|NCT01024751|453287074|FG000|Enrolled Participants|Ineligible at baseline|3|||
125999099|NCT01024751|453287075|FG001|Enrolled Participants|Ineligible at baseline|4|||
125999100|NCT01024751|453287074|FG000|Eligible Participants|Withdrawal by Subject|0|||
125999101|NCT01024751|453287075|FG001|Eligible Participants|Withdrawal by Subject|1|||
125999102|NCT01024751|453287074|FG000|Eligible Participants|Lost to Follow-up|0|||
125999103|NCT01024751|453287075|FG001|Eligible Participants|Lost to Follow-up|1|||
125999104|NCT01024751|453287074|FG000|Eligible Participants|Ineligible|0|||
125999105|NCT01024751|453287075|FG001|Eligible Participants|Ineligible|1|||
125999106|NCT01232556|453287076|FG000|Overall Study|Withdrawal by Subject|21|||
125999107|NCT01232556|453287077|FG001|Overall Study|Withdrawal by Subject|17|||
125999108|NCT01232556|453287076|FG000|Overall Study|Death|97|||
126335133|NCT02895295|454520613|FG000|Overall Study|Survey Non-response|71|||
126335134|NCT02895295|454520614|FG001|Overall Study|Survey Non-response|94|||
126335135|NCT02895295|454520615|FG002|Overall Study|Survey Non-response|92|||
126335136|NCT01367249|454520616|FG000|Overall Study|Withdrawal by Subject|6|||
126335137|NCT01367249|454520617|FG001|Overall Study|Withdrawal by Subject|6|||
126335138|NCT01367249|454520616|FG000|Overall Study|Other|3|||
126335139|NCT01367249|454520617|FG001|Overall Study|Other|10|||
126335140|NCT04821830|454520620|FG000|Overall Study|Withdrawal by Subject|1|||
126335141|NCT04821830|454520621|FG001|Overall Study|Withdrawal by Subject|0|||
126335142|NCT00960804|454520627|FG000|Overall Study|Adverse Event|1|||
126335143|NCT00960804|454520628|FG001|Overall Study|Adverse Event|0|||
126335144|NCT00960804|454520629|FG002|Overall Study|Adverse Event|0|||
126335145|NCT00960804|454520627|FG000|Overall Study|Withdrawal by Subject|1|||
126335146|NCT00960804|454520628|FG001|Overall Study|Withdrawal by Subject|0|||
126335147|NCT00960804|454520629|FG002|Overall Study|Withdrawal by Subject|0|||
125999109|NCT01232556|453287077|FG001|Overall Study|Death|97|||
125999110|NCT01232556|453287076|FG000|Overall Study|Lost to Follow-up|0|||
126335148|NCT00960804|454520627|FG000|Overall Study|Study terminated by the sponsor|5|||
126335149|NCT00960804|454520628|FG001|Overall Study|Study terminated by the sponsor|4|||
125999111|NCT01232556|453287077|FG001|Overall Study|Lost to Follow-up|2|||
126335150|NCT00960804|454520629|FG002|Overall Study|Study terminated by the sponsor|10|||
126335151|NCT00490919|454520630|FG000|Open-label Run-in Period|Adverse Event|239|||
126335152|NCT00490919|454520631|FG001|Open-label Run-in Period|Adverse Event|0|||
126335153|NCT00490919|454520632|FG002|Open-label Run-in Period|Adverse Event|0|||
126335154|NCT00490919|454520630|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
126335155|NCT00490919|454520631|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
126335156|NCT00490919|454520632|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
125999112|NCT01232556|453287076|FG000|Overall Study|Terminated by Sponsor|35|||
125999113|NCT01232556|453287077|FG001|Overall Study|Terminated by Sponsor|51|||
125999114|NCT01232556|453287076|FG000|Overall Study|Other|6|||
125999115|NCT01232556|453287077|FG001|Overall Study|Other|4|||
125999116|NCT02448719|453287078|FG000|Overall Study|Withdrawal by Subject|0|||
125999117|NCT02448719|453287079|FG001|Overall Study|Withdrawal by Subject|0|||
125999118|NCT02448719|453287080|FG002|Overall Study|Withdrawal by Subject|0|||
125999119|NCT02448719|453287081|FG003|Overall Study|Withdrawal by Subject|0|||
125999120|NCT02448719|453287082|FG004|Overall Study|Withdrawal by Subject|1|||
125999121|NCT02448719|453287083|FG005|Overall Study|Withdrawal by Subject|0|||
125999122|NCT02448719|453287084|FG006|Overall Study|Withdrawal by Subject|0|||
125999123|NCT02448719|453287085|FG007|Overall Study|Withdrawal by Subject|0|||
125999124|NCT02448719|453287086|FG008|Overall Study|Withdrawal by Subject|0|||
125999125|NCT02448719|453287087|FG009|Overall Study|Withdrawal by Subject|0|||
125999126|NCT02448719|453287088|FG010|Overall Study|Withdrawal by Subject|0|||
125999127|NCT01473420|453287090|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
125999128|NCT01473420|453287091|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
125999129|NCT01473420|453287090|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
125999130|NCT01473420|453287091|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
125999131|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
125999132|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
125999133|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
125999134|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
125999135|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
125999136|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
125999137|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
125999138|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
125999139|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
125999140|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
125999141|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
125999142|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
125999143|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
125999144|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
125999145|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
125999146|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
125999147|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
125999148|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
125999149|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
125999150|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
125999151|NCT01473420|453287090|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
125999152|NCT01473420|453287091|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
125999153|NCT00388362|453287098|FG000|Enrolled|Ineligible|1|||
125999154|NCT00388362|453287098|FG000|Enrolled|Adverse Event|9|||
125999155|NCT00388362|453287098|FG000|Enrolled|Death|1|||
125999156|NCT00388362|453287098|FG000|Enrolled|Loss insurance|1|||
125999157|NCT00388362|453287098|FG000|Enrolled|Withdrawal by Subject|1|||
125999158|NCT00388362|453287098|FG000|Remained on Study Median of 514 Days|Death|2|||
125999159|NCT01141660|453287099|FG000|Overall Study|Physician Decision|0|||
125999160|NCT01141660|453287100|FG001|Overall Study|Physician Decision|12|||
125999161|NCT00209027|453287101|FG000|Overall Study|study terminated|10|||
125999162|NCT00209027|453287102|FG001|Overall Study|study terminated|0|||
125999163|NCT01932996|453287103|FG000|Overall Study|Protocol Violation|2|||
125999164|NCT01932996|453287104|FG001|Overall Study|Protocol Violation|0|||
125999165|NCT01848834|453287105|FG000|Overall Study|Adverse Event|3|||
125999166|NCT01848834|453287106|FG001|Overall Study|Adverse Event|11|||
125999167|NCT01848834|453287107|FG002|Overall Study|Adverse Event|3|||
126335157|NCT00490919|454520630|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
126335158|NCT00490919|454520631|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
126335159|NCT00490919|454520632|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
126335160|NCT00490919|454520630|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
126335161|NCT00490919|454520631|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
126335162|NCT00490919|454520632|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
126335163|NCT00490919|454520630|FG000|Open-label Run-in Period|Administrative|40|||
126335164|NCT00490919|454520631|FG001|Open-label Run-in Period|Administrative|0|||
126335165|NCT00490919|454520632|FG002|Open-label Run-in Period|Administrative|0|||
126335166|NCT00490919|454520630|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
125999168|NCT01848834|453287108|FG003|Overall Study|Adverse Event|5|||
126335167|NCT00490919|454520631|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
125999169|NCT01848834|453287109|FG004|Overall Study|Adverse Event|9|||
125999170|NCT01848834|453287105|FG000|Overall Study|Death|2|||
125999171|NCT01848834|453287106|FG001|Overall Study|Death|11|||
125999172|NCT01848834|453287107|FG002|Overall Study|Death|1|||
125999173|NCT01848834|453287108|FG003|Overall Study|Death|8|||
125999174|NCT01848834|453287109|FG004|Overall Study|Death|27|||
125999175|NCT01848834|453287105|FG000|Overall Study|Excluded Medication|5|||
126335168|NCT00490919|454520632|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
125999176|NCT01848834|453287106|FG001|Overall Study|Excluded Medication|4|||
125999177|NCT01848834|453287107|FG002|Overall Study|Excluded Medication|3|||
125999178|NCT01848834|453287108|FG003|Overall Study|Excluded Medication|6|||
125999179|NCT01848834|453287109|FG004|Overall Study|Excluded Medication|6|||
125999180|NCT01848834|453287105|FG000|Overall Study|Lost to Follow-up|5|||
125999181|NCT01848834|453287106|FG001|Overall Study|Lost to Follow-up|5|||
125999182|NCT01848834|453287107|FG002|Overall Study|Lost to Follow-up|3|||
125999183|NCT01848834|453287108|FG003|Overall Study|Lost to Follow-up|0|||
125999184|NCT01848834|453287109|FG004|Overall Study|Lost to Follow-up|3|||
125999185|NCT01848834|453287105|FG000|Overall Study|Physician Decision|1|||
125999186|NCT01848834|453287106|FG001|Overall Study|Physician Decision|3|||
125999187|NCT01848834|453287107|FG002|Overall Study|Physician Decision|4|||
125999188|NCT01848834|453287108|FG003|Overall Study|Physician Decision|0|||
125999189|NCT01848834|453287109|FG004|Overall Study|Physician Decision|11|||
125999190|NCT01848834|453287105|FG000|Overall Study|Protocol Violation|0|||
125999191|NCT01848834|453287106|FG001|Overall Study|Protocol Violation|0|||
125999192|NCT01848834|453287107|FG002|Overall Study|Protocol Violation|0|||
125999193|NCT01848834|453287108|FG003|Overall Study|Protocol Violation|0|||
125999194|NCT01848834|453287109|FG004|Overall Study|Protocol Violation|1|||
125999195|NCT01848834|453287105|FG000|Overall Study|Sponsor Decision|1|||
126335169|NCT00490919|454520630|FG000|Double-blind Phase|Adverse Event|0|||
126335170|NCT00490919|454520631|FG001|Double-blind Phase|Adverse Event|40|||
126335171|NCT00490919|454520632|FG002|Double-blind Phase|Adverse Event|20|||
126335172|NCT00490919|454520630|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126335173|NCT00490919|454520631|FG001|Double-blind Phase|Withdrawal by Subject|10|||
126335174|NCT00490919|454520632|FG002|Double-blind Phase|Withdrawal by Subject|11|||
126335175|NCT00490919|454520630|FG000|Double-blind Phase|Lost to Follow-up|0|||
126335176|NCT00490919|454520631|FG001|Double-blind Phase|Lost to Follow-up|8|||
126335177|NCT00490919|454520632|FG002|Double-blind Phase|Lost to Follow-up|11|||
126335178|NCT00490919|454520630|FG000|Double-blind Phase|Lack of Efficacy|0|||
126335179|NCT00490919|454520631|FG001|Double-blind Phase|Lack of Efficacy|22|||
126335180|NCT00490919|454520632|FG002|Double-blind Phase|Lack of Efficacy|36|||
126335181|NCT00490919|454520630|FG000|Double-blind Phase|Administrative|0|||
126335182|NCT00490919|454520631|FG001|Double-blind Phase|Administrative|6|||
126335183|NCT00490919|454520632|FG002|Double-blind Phase|Administrative|6|||
126335184|NCT02358031|454522356|FG000|Overall Study|Death|253|||
126335185|NCT02358031|454522357|FG001|Overall Study|Death|237|||
126335186|NCT02358031|454522358|FG002|Overall Study|Death|266|||
126335187|NCT02358031|454522356|FG000|Overall Study|Lost to Follow-up|1|||
126335188|NCT02358031|454522357|FG001|Overall Study|Lost to Follow-up|1|||
126335189|NCT02358031|454522358|FG002|Overall Study|Lost to Follow-up|0|||
126335190|NCT02358031|454522356|FG000|Overall Study|Withdrawal by Subject|19|||
126335191|NCT02358031|454522357|FG001|Overall Study|Withdrawal by Subject|14|||
126335192|NCT02358031|454522358|FG002|Overall Study|Withdrawal by Subject|18|||
126335193|NCT02358031|454522356|FG000|Overall Study|Sponsor Decision|26|||
126335194|NCT02358031|454522357|FG001|Overall Study|Sponsor Decision|28|||
126335195|NCT02358031|454522358|FG002|Overall Study|Sponsor Decision|16|||
126335196|NCT05664581|454522359|FG000|Overall Study|Withdrawal by Subject|2|||
126335197|NCT03101150|454522360|FG000|Overall Study|Lost to Follow-up|2|||
126335198|NCT03101150|454522361|FG001|Overall Study|Lost to Follow-up|4|||
126335199|NCT03101150|454522360|FG000|Overall Study|Miscarriage|3|||
126335200|NCT03101150|454522361|FG001|Overall Study|Miscarriage|6|||
126335201|NCT03163446|454522364|FG000|Overall Study|Unable to return for Day 180 visit|2|||
126335202|NCT03163446|454522365|FG001|Overall Study|Unable to return for Day 180 visit|0|||
126335203|NCT03163446|454522364|FG000|Overall Study|Withdrawal by Subject|2|||
126335204|NCT03163446|454522365|FG001|Overall Study|Withdrawal by Subject|6|||
126335205|NCT03163446|454522364|FG000|Overall Study|Death|16|||
126335206|NCT03163446|454522365|FG001|Overall Study|Death|5|||
126335207|NCT03163446|454522364|FG000|Overall Study|Lost to Follow-up|6|||
126335208|NCT03163446|454522365|FG001|Overall Study|Lost to Follow-up|5|||
126335209|NCT03163446|454522364|FG000|Overall Study|Physician Decision|1|||
126335210|NCT03163446|454522365|FG001|Overall Study|Physician Decision|1|||
126335211|NCT03163446|454522364|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
126335212|NCT03163446|454522365|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
126335213|NCT01317641|454522366|FG000|Overall Study|Not treated|0|||
126335214|NCT01317641|454522367|FG001|Overall Study|Not treated|0|||
126335215|NCT01317641|454522368|FG002|Overall Study|Not treated|0|||
126335216|NCT01317641|454522369|FG003|Overall Study|Not treated|0|||
126335217|NCT01317641|454522370|FG004|Overall Study|Not treated|0|||
126335218|NCT01317641|454522371|FG005|Overall Study|Not treated|0|||
126335219|NCT01317641|454522372|FG006|Overall Study|Not treated|0|||
126335220|NCT01317641|454522373|FG007|Overall Study|Not treated|1|||
125999196|NCT01848834|453287106|FG001|Overall Study|Sponsor Decision|1|||
125999197|NCT01848834|453287107|FG002|Overall Study|Sponsor Decision|0|||
125999198|NCT01848834|453287108|FG003|Overall Study|Sponsor Decision|1|||
125999199|NCT01848834|453287109|FG004|Overall Study|Sponsor Decision|1|||
125999200|NCT01848834|453287105|FG000|Overall Study|Withdrawal by Subject|2|||
126335221|NCT01317641|454522374|FG008|Overall Study|Not treated|1|||
126335222|NCT01317641|454522366|FG000|Overall Study|Adverse Event|0|||
126335223|NCT01317641|454522367|FG001|Overall Study|Adverse Event|1|||
126335224|NCT01317641|454522368|FG002|Overall Study|Adverse Event|0|||
125999201|NCT01848834|453287106|FG001|Overall Study|Withdrawal by Subject|13|||
125999202|NCT01848834|453287107|FG002|Overall Study|Withdrawal by Subject|10|||
125999203|NCT01848834|453287108|FG003|Overall Study|Withdrawal by Subject|6|||
125999204|NCT01848834|453287109|FG004|Overall Study|Withdrawal by Subject|36|||
125999205|NCT02040090|453287112|FG000|Overall Study|Adverse Event|2|||
125999206|NCT02040090|453287113|FG001|Overall Study|Adverse Event|0|||
125999207|NCT02040090|453287112|FG000|Overall Study|Physician Decision|1|||
125999208|NCT02040090|453287113|FG001|Overall Study|Physician Decision|0|||
126335225|NCT01317641|454522369|FG003|Overall Study|Adverse Event|1|||
126335226|NCT01317641|454522370|FG004|Overall Study|Adverse Event|0|||
126335227|NCT01317641|454522371|FG005|Overall Study|Adverse Event|0|||
126335228|NCT01317641|454522372|FG006|Overall Study|Adverse Event|2|||
126335229|NCT01317641|454522373|FG007|Overall Study|Adverse Event|1|||
126335230|NCT01317641|454522374|FG008|Overall Study|Adverse Event|0|||
126335231|NCT01317641|454522366|FG000|Overall Study|Protocol Violation|1|||
126335232|NCT01317641|454522367|FG001|Overall Study|Protocol Violation|0|||
126335233|NCT01317641|454522368|FG002|Overall Study|Protocol Violation|0|||
126335234|NCT01317641|454522369|FG003|Overall Study|Protocol Violation|0|||
126335235|NCT01317641|454522370|FG004|Overall Study|Protocol Violation|0|||
126335236|NCT01317641|454522371|FG005|Overall Study|Protocol Violation|0|||
126335237|NCT01317641|454522372|FG006|Overall Study|Protocol Violation|0|||
126335238|NCT01317641|454522373|FG007|Overall Study|Protocol Violation|0|||
126335239|NCT01317641|454522374|FG008|Overall Study|Protocol Violation|0|||
126335240|NCT01317641|454522366|FG000|Overall Study|Disease progression|0|||
126335241|NCT01317641|454522367|FG001|Overall Study|Disease progression|0|||
126335242|NCT01317641|454522368|FG002|Overall Study|Disease progression|0|||
126335243|NCT01317641|454522369|FG003|Overall Study|Disease progression|0|||
126335244|NCT01317641|454522370|FG004|Overall Study|Disease progression|0|||
126335245|NCT01317641|454522371|FG005|Overall Study|Disease progression|0|||
126335246|NCT01317641|454522372|FG006|Overall Study|Disease progression|0|||
126335247|NCT01317641|454522373|FG007|Overall Study|Disease progression|3|||
126335248|NCT01317641|454522374|FG008|Overall Study|Disease progression|4|||
126335249|NCT01317641|454522366|FG000|Overall Study|Withdrawal by Subject|0|||
126335250|NCT01317641|454522367|FG001|Overall Study|Withdrawal by Subject|0|||
126335251|NCT01317641|454522368|FG002|Overall Study|Withdrawal by Subject|0|||
126335252|NCT01317641|454522369|FG003|Overall Study|Withdrawal by Subject|0|||
126335253|NCT01317641|454522370|FG004|Overall Study|Withdrawal by Subject|0|||
126335254|NCT01317641|454522371|FG005|Overall Study|Withdrawal by Subject|0|||
126335255|NCT01317641|454522372|FG006|Overall Study|Withdrawal by Subject|1|||
126335256|NCT01317641|454522373|FG007|Overall Study|Withdrawal by Subject|0|||
126335257|NCT01317641|454522374|FG008|Overall Study|Withdrawal by Subject|0|||
126335258|NCT01228591|454522375|FG000|Baseline|Lack of Efficacy|1|||
126335259|NCT01228591|454522376|FG001|Baseline|Lack of Efficacy|2|||
126335260|NCT02787304|454522377|FG000|Overall Study|Adverse Event|9|||
126335261|NCT02787304|454522378|FG001|Overall Study|Adverse Event|3|||
126335262|NCT02787304|454522379|FG002|Overall Study|Adverse Event|8|||
126335263|NCT02787304|454522380|FG003|Overall Study|Adverse Event|1|||
126335264|NCT02787304|454522377|FG000|Overall Study|Withdrawal by Subject|1|||
126335265|NCT02787304|454522378|FG001|Overall Study|Withdrawal by Subject|4|||
126335266|NCT02787304|454522379|FG002|Overall Study|Withdrawal by Subject|0|||
126335267|NCT02787304|454522380|FG003|Overall Study|Withdrawal by Subject|0|||
126335268|NCT02787304|454522377|FG000|Overall Study|Lost to Follow-up|1|||
126335269|NCT02787304|454522378|FG001|Overall Study|Lost to Follow-up|0|||
126335270|NCT02787304|454522379|FG002|Overall Study|Lost to Follow-up|0|||
126335271|NCT02787304|454522380|FG003|Overall Study|Lost to Follow-up|1|||
126335272|NCT02787304|454522377|FG000|Overall Study|Noncompliance with study drug|0|||
126335273|NCT02787304|454522378|FG001|Overall Study|Noncompliance with study drug|0|||
126335274|NCT02787304|454522379|FG002|Overall Study|Noncompliance with study drug|1|||
125999209|NCT02040090|453287112|FG000|Overall Study|Withdrawal by Subject|0|||
125999210|NCT02040090|453287113|FG001|Overall Study|Withdrawal by Subject|1|||
126335275|NCT02787304|454522380|FG003|Overall Study|Noncompliance with study drug|0|||
126335276|NCT02787304|454522377|FG000|Overall Study|Physician Decision|0|||
126335277|NCT02787304|454522378|FG001|Overall Study|Physician Decision|0|||
126335278|NCT02787304|454522379|FG002|Overall Study|Physician Decision|1|||
126335279|NCT02787304|454522380|FG003|Overall Study|Physician Decision|0|||
126335280|NCT02787304|454522377|FG000|Overall Study|Study terminated by sponsor|25|||
126335281|NCT02787304|454522378|FG001|Overall Study|Study terminated by sponsor|31|||
126335282|NCT02787304|454522379|FG002|Overall Study|Study terminated by sponsor|31|||
126335283|NCT02787304|454522380|FG003|Overall Study|Study terminated by sponsor|32|||
126335284|NCT03110354|454522386|FG000|Overall Study|Death|1|||
126335285|NCT03110354|454522387|FG001|Overall Study|Death|0|||
125999211|NCT02040090|453287112|FG000|Overall Study|Lost to Follow-up|0|||
125999212|NCT02040090|453287113|FG001|Overall Study|Lost to Follow-up|1|||
126091098|NCT03820947|453626920|FG002|Overall Study|Physician Decision|1|||
126335286|NCT03110354|454522388|FG002|Overall Study|Death|0|||
126335287|NCT03110354|454522389|FG003|Overall Study|Death|1|||
126335288|NCT03110354|454522390|FG004|Overall Study|Death|0|||
126335289|NCT03110354|454522386|FG000|Overall Study|Start of new therapy|0|||
126335290|NCT03110354|454522387|FG001|Overall Study|Start of new therapy|0|||
126335291|NCT03110354|454522388|FG002|Overall Study|Start of new therapy|0|||
126335292|NCT03110354|454522389|FG003|Overall Study|Start of new therapy|0|||
126335293|NCT03110354|454522390|FG004|Overall Study|Start of new therapy|1|||
126335294|NCT03110354|454522386|FG000|Overall Study|Failure to achieve response|2|||
126335295|NCT03110354|454522387|FG001|Overall Study|Failure to achieve response|3|||
126335296|NCT03110354|454522388|FG002|Overall Study|Failure to achieve response|0|||
126335297|NCT03110354|454522389|FG003|Overall Study|Failure to achieve response|2|||
125999213|NCT03259373|453287120|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
125999214|NCT03259373|453287121|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
125999215|NCT03259373|453287120|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
125999216|NCT03259373|453287121|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
125999217|NCT03259373|453287120|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
125999218|NCT03259373|453287121|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
125999219|NCT03259373|453287120|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
125999220|NCT03259373|453287121|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
125999221|NCT03259373|453287120|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
125999222|NCT03259373|453287121|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
125999223|NCT03259373|453287120|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
125999224|NCT03259373|453287121|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
125999225|NCT04894903|453287122|FG000|Overall Study|Death|1|||
125999226|NCT04894903|453287123|FG001|Overall Study|Death|0|||
125999227|NCT04894903|453287122|FG000|Overall Study|Pregnancy|1|||
125999228|NCT04894903|453287123|FG001|Overall Study|Pregnancy|0|||
125999229|NCT04894903|453287122|FG000|Overall Study|Withdrawal by Subject|1|||
125999230|NCT04894903|453287123|FG001|Overall Study|Withdrawal by Subject|1|||
125999231|NCT04894903|453287122|FG000|Overall Study|moved or exited health system|1|||
125999232|NCT04894903|453287123|FG001|Overall Study|moved or exited health system|3|||
125999233|NCT01368211|453287126|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
125999234|NCT01368211|453287127|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
125999235|NCT01987830|453287128|FG000|Overall Study|Never received baseline scan|1|||
125999236|NCT03990363|453287129|FG000|Overall Study|Withdrawal by Subject|10|||
125999237|NCT03990363|453287130|FG001|Overall Study|Withdrawal by Subject|9|||
125999238|NCT03990363|453287131|FG002|Overall Study|Withdrawal by Subject|18|||
125999239|NCT03990363|453287132|FG003|Overall Study|Withdrawal by Subject|11|||
125999240|NCT03990363|453287133|FG004|Overall Study|Withdrawal by Subject|9|||
125999241|NCT03990363|453287129|FG000|Overall Study|Physician Decision|1|||
125999242|NCT03990363|453287130|FG001|Overall Study|Physician Decision|0|||
125999243|NCT03990363|453287131|FG002|Overall Study|Physician Decision|0|||
125999244|NCT03990363|453287132|FG003|Overall Study|Physician Decision|0|||
125999245|NCT03990363|453287133|FG004|Overall Study|Physician Decision|0|||
125999246|NCT03990363|453287129|FG000|Overall Study|Adverse Event|1|||
125999247|NCT03990363|453287130|FG001|Overall Study|Adverse Event|3|||
125999248|NCT03990363|453287131|FG002|Overall Study|Adverse Event|2|||
125999249|NCT03990363|453287132|FG003|Overall Study|Adverse Event|2|||
125999250|NCT03990363|453287133|FG004|Overall Study|Adverse Event|0|||
125999251|NCT03990363|453287129|FG000|Overall Study|Death|14|||
125999252|NCT03990363|453287130|FG001|Overall Study|Death|8|||
125999253|NCT03990363|453287131|FG002|Overall Study|Death|14|||
125999254|NCT03990363|453287132|FG003|Overall Study|Death|10|||
125999255|NCT03990363|453287133|FG004|Overall Study|Death|11|||
125999256|NCT03990363|453287129|FG000|Overall Study|Failure to meet randomization criteria|0|||
125999257|NCT03990363|453287130|FG001|Overall Study|Failure to meet randomization criteria|1|||
125999258|NCT03990363|453287131|FG002|Overall Study|Failure to meet randomization criteria|1|||
125999259|NCT03990363|453287132|FG003|Overall Study|Failure to meet randomization criteria|0|||
126091099|NCT03820947|453626921|FG003|Overall Study|Physician Decision|0|||
126335298|NCT03110354|454522390|FG004|Overall Study|Failure to achieve response|1|||
126335299|NCT03110354|454522386|FG000|Overall Study|Progressive disease|1|||
126335300|NCT03110354|454522387|FG001|Overall Study|Progressive disease|1|||
126335301|NCT03110354|454522388|FG002|Overall Study|Progressive disease|3|||
126335302|NCT03110354|454522389|FG003|Overall Study|Progressive disease|4|||
126335303|NCT03110354|454522390|FG004|Overall Study|Progressive disease|2|||
126335304|NCT03110354|454522386|FG000|Overall Study|Adverse Event|0|||
126335305|NCT03110354|454522387|FG001|Overall Study|Adverse Event|0|||
126335306|NCT03110354|454522388|FG002|Overall Study|Adverse Event|0|||
126335307|NCT03110354|454522389|FG003|Overall Study|Adverse Event|2|||
126335308|NCT03110354|454522390|FG004|Overall Study|Adverse Event|2|||
126335309|NCT03110354|454522386|FG000|Overall Study|Other|0|||
126335310|NCT03110354|454522387|FG001|Overall Study|Other|0|||
126335311|NCT03110354|454522388|FG002|Overall Study|Other|0|||
126335312|NCT03110354|454522389|FG003|Overall Study|Other|1|||
126335313|NCT03110354|454522390|FG004|Overall Study|Other|1|||
125999260|NCT03990363|453287133|FG004|Overall Study|Failure to meet randomization criteria|0|||
125999261|NCT03990363|453287129|FG000|Overall Study|Lost to Follow-up|0|||
125999262|NCT03990363|453287130|FG001|Overall Study|Lost to Follow-up|0|||
125999263|NCT03990363|453287131|FG002|Overall Study|Lost to Follow-up|0|||
125999264|NCT03990363|453287132|FG003|Overall Study|Lost to Follow-up|1|||
125999265|NCT03990363|453287133|FG004|Overall Study|Lost to Follow-up|2|||
125999266|NCT03990363|453287129|FG000|Overall Study|Non-compliance with study drug|2|||
125999267|NCT03990363|453287130|FG001|Overall Study|Non-compliance with study drug|1|||
125999268|NCT03990363|453287131|FG002|Overall Study|Non-compliance with study drug|2|||
125999269|NCT03990363|453287132|FG003|Overall Study|Non-compliance with study drug|0|||
125999270|NCT03990363|453287133|FG004|Overall Study|Non-compliance with study drug|0|||
125999271|NCT03990363|453287129|FG000|Overall Study|Study terminated by sponsor|0|||
125999272|NCT03990363|453287130|FG001|Overall Study|Study terminated by sponsor|1|||
125999273|NCT03990363|453287131|FG002|Overall Study|Study terminated by sponsor|0|||
125999274|NCT03990363|453287132|FG003|Overall Study|Study terminated by sponsor|0|||
125999275|NCT03990363|453287133|FG004|Overall Study|Study terminated by sponsor|0|||
125999276|NCT03990363|453287129|FG000|Overall Study|Site terminated by sponsor|2|||
125999277|NCT03990363|453287130|FG001|Overall Study|Site terminated by sponsor|1|||
125999278|NCT03990363|453287131|FG002|Overall Study|Site terminated by sponsor|2|||
125999279|NCT03990363|453287132|FG003|Overall Study|Site terminated by sponsor|0|||
125999280|NCT03990363|453287133|FG004|Overall Study|Site terminated by sponsor|2|||
125999281|NCT03990363|453287129|FG000|Overall Study|Not categorized|5|||
125999282|NCT03990363|453287130|FG001|Overall Study|Not categorized|5|||
125999283|NCT03990363|453287131|FG002|Overall Study|Not categorized|3|||
125999284|NCT03990363|453287132|FG003|Overall Study|Not categorized|2|||
125999285|NCT03990363|453287133|FG004|Overall Study|Not categorized|2|||
125999286|NCT01349660|453287137|FG000|Overall Study|Still Receiving Study Treatment|0|||
125999287|NCT01349660|453287138|FG001|Overall Study|Still Receiving Study Treatment|0|||
125999288|NCT01349660|453287139|FG002|Overall Study|Still Receiving Study Treatment|1|||
125999289|NCT01349660|453287137|FG000|Overall Study|Disease Progression|2|||
125999290|NCT01349660|453287138|FG001|Overall Study|Disease Progression|4|||
125999291|NCT01349660|453287139|FG002|Overall Study|Disease Progression|50|||
125999292|NCT01349660|453287137|FG000|Overall Study|Adverse Event|1|||
125999293|NCT01349660|453287138|FG001|Overall Study|Adverse Event|1|||
125999294|NCT01349660|453287139|FG002|Overall Study|Adverse Event|12|||
125999295|NCT01349660|453287137|FG000|Overall Study|Withdrawal by Subject|2|||
125999296|NCT01349660|453287138|FG001|Overall Study|Withdrawal by Subject|0|||
125999297|NCT01349660|453287139|FG002|Overall Study|Withdrawal by Subject|9|||
125999298|NCT01349660|453287137|FG000|Overall Study|Death|1|||
125999299|NCT01349660|453287138|FG001|Overall Study|Death|1|||
125999300|NCT01349660|453287139|FG002|Overall Study|Death|0|||
125999301|NCT01349660|453287137|FG000|Overall Study|Non-Permitted Interventions|0|||
125999302|NCT01349660|453287138|FG001|Overall Study|Non-Permitted Interventions|0|||
125999303|NCT01349660|453287139|FG002|Overall Study|Non-Permitted Interventions|2|||
125999304|NCT01349660|453287137|FG000|Overall Study|Study Compliance|0|||
125999305|NCT01349660|453287138|FG001|Overall Study|Study Compliance|0|||
125999306|NCT01349660|453287139|FG002|Overall Study|Study Compliance|1|||
125999307|NCT01349660|453287137|FG000|Overall Study|Declining Performance Status|0|||
125999308|NCT01349660|453287138|FG001|Overall Study|Declining Performance Status|0|||
125999309|NCT01349660|453287139|FG002|Overall Study|Declining Performance Status|1|||
125999310|NCT05764239|453287140|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
125999311|NCT05764239|453287140|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
125999312|NCT05764239|453287140|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
125999313|NCT05764239|453287140|FG000|DEP (Part 1)|Adverse Event|1|||
125999314|NCT05764239|453287140|FG000|DEP (Part 1)|Lost to Follow-up|1|||
125999315|NCT05764239|453287140|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
125999316|NCT05764239|453287140|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
125999317|NCT05764239|453287140|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
125999318|NCT05764239|453287140|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
125999319|NCT00057811|453287141|FG000|Overall Study|Lack of Efficacy|1|||
125999320|NCT00057811|453287142|FG001|Overall Study|Lack of Efficacy|4|||
125999321|NCT00057811|453287141|FG000|Overall Study|Physician Decision|1|||
125999322|NCT00057811|453287142|FG001|Overall Study|Physician Decision|0|||
125999323|NCT00057811|453287141|FG000|Overall Study|Withdrawal by Subject|3|||
125999324|NCT00057811|453287142|FG001|Overall Study|Withdrawal by Subject|4|||
125999325|NCT00057811|453287141|FG000|Overall Study|Ineligible|4|||
125999326|NCT00057811|453287142|FG001|Overall Study|Ineligible|2|||
125999327|NCT00057811|453287141|FG000|Overall Study|Inevaluable|1|||
125999328|NCT00057811|453287142|FG001|Overall Study|Inevaluable|2|||
125999329|NCT00663962|453287143|FG000|Overall Study|somnolence|1|||
125999330|NCT00663962|453287144|FG001|Overall Study|somnolence|0|||
125999331|NCT00519636|453287145|FG000|Treatment Period 1|Adverse Event|1|||
125999332|NCT00519636|453287146|FG001|Treatment Period 1|Adverse Event|0|||
125999333|NCT00519636|453287147|FG002|Treatment Period 1|Adverse Event|1|||
125999334|NCT00519636|453287148|FG003|Treatment Period 1|Adverse Event|0|||
125999335|NCT00519636|453287145|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
125999336|NCT00519636|453287146|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
126335314|NCT00379834|454522391|FG000|Overall Study|Time constraints|2|||
126335315|NCT01298700|454522393|FG000|Overall Study|Adverse Event|50|||
126335316|NCT01298700|454522394|FG001|Overall Study|Adverse Event|51|||
126335317|NCT01298700|454522393|FG000|Overall Study|Lack of Efficacy|9|||
126335318|NCT01298700|454522394|FG001|Overall Study|Lack of Efficacy|14|||
126335319|NCT01298700|454522393|FG000|Overall Study|Lost to Follow-up|5|||
126335320|NCT01298700|454522394|FG001|Overall Study|Lost to Follow-up|2|||
126335321|NCT01298700|454522393|FG000|Overall Study|Withdrawal by Subject|12|||
126335322|NCT01298700|454522394|FG001|Overall Study|Withdrawal by Subject|9|||
126335323|NCT01298700|454522393|FG000|Overall Study|Protocol Violation|6|||
126335324|NCT01298700|454522394|FG001|Overall Study|Protocol Violation|4|||
126335325|NCT01298700|454522393|FG000|Overall Study|Other Miscellaneous Reasons|16|||
126335326|NCT01298700|454522394|FG001|Overall Study|Other Miscellaneous Reasons|15|||
126335327|NCT01298700|454522393|FG000|Overall Study|Did not Receive Study Drug|3|||
126335328|NCT01298700|454522394|FG001|Overall Study|Did not Receive Study Drug|5|||
126335329|NCT01001429|454522397|FG000|Overall Study|surgery cancelled|0|||
126335330|NCT01001429|454522398|FG001|Overall Study|surgery cancelled|1|||
126335331|NCT01053741|454522405|FG000|2nd Study Intervention|Physician Decision|0|||
126335332|NCT01053741|454522406|FG001|2nd Study Intervention|Physician Decision|1|||
126335333|NCT02063672|454522407|FG000|Overall Study|Ongoing Follow-up|27|||
126335334|NCT02063672|454522408|FG001|Overall Study|Ongoing Follow-up|14|||
126335335|NCT02063672|454522407|FG000|Overall Study|Death|5|||
126335336|NCT02063672|454522408|FG001|Overall Study|Death|3|||
126335337|NCT02063672|454522407|FG000|Overall Study|Lost to Follow-up|1|||
126335338|NCT02063672|454522408|FG001|Overall Study|Lost to Follow-up|3|||
126335339|NCT02063672|454522407|FG000|Overall Study|Withdrawal by Subject|2|||
126335340|NCT02063672|454522408|FG001|Overall Study|Withdrawal by Subject|2|||
126335341|NCT00619827|454522410|FG000|Overall Study|Adverse Event|1|||
126335342|NCT00619827|454522411|FG001|Overall Study|Adverse Event|2|||
126335343|NCT00619827|454522410|FG000|Overall Study|Withdrawal by Subject|2|||
126335344|NCT00619827|454522411|FG001|Overall Study|Withdrawal by Subject|2|||
126335345|NCT00104052|454522412|FG000|Overall Study|Adverse Event|1|||
126335346|NCT00104052|454522412|FG000|Overall Study|Lack of Efficacy|26|||
126335347|NCT00104052|454522412|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
126335348|NCT02498678|454522413|FG000|Overall Study|interference from the surgical team|0|||
126335349|NCT02498678|454522414|FG001|Overall Study|interference from the surgical team|2|||
126335350|NCT00239720|454522420|FG000|Overall Study|Adverse Event|1|||
126335351|NCT00239720|454522421|FG001|Overall Study|Adverse Event|0|||
126335352|NCT00239720|454522420|FG000|Overall Study|Lost to Follow-up|0|||
126335353|NCT00239720|454522421|FG001|Overall Study|Lost to Follow-up|1|||
126335354|NCT01484951|454522423|FG000|Overall Study|Adverse Event|3|||
126335355|NCT01484951|454522423|FG000|Overall Study|Personal Reasons|1|||
126335356|NCT01484951|454522423|FG000|Overall Study|Non-Compliance|1|||
126335357|NCT00917124|454522428|FG000|Overall Study|Protocol Violation|4|||
126335358|NCT00917124|454522429|FG001|Overall Study|Protocol Violation|6|||
126335359|NCT00115778|454522430|FG000|Overall Study|Withdrawal by Subject|0|||
126335360|NCT00115778|454522431|FG001|Overall Study|Withdrawal by Subject|1|||
126335361|NCT00528424|454522434|FG000|Overall Study|Lost to Follow-up|13|||
126335362|NCT00528424|454522434|FG000|Overall Study|Withdrew consent|2|||
126335363|NCT00528424|454522434|FG000|Overall Study|Administrative reason|2|||
126335364|NCT00528424|454522434|FG000|Overall Study|Other|12|||
126335365|NCT02515630|454522435|FG000|Overall Study|Withdrawal by Subject|5|||
126335366|NCT02515630|454522435|FG000|Overall Study|Adverse Event|4|||
126335367|NCT02515630|454522435|FG000|Overall Study|Physician Decision|4|||
126335368|NCT02515630|454522435|FG000|Overall Study|Death|2|||
126335369|NCT02515630|454522435|FG000|Overall Study|Disease Progression|1|||
126335370|NCT00483652|454522436|FG000|Double-blind Treatment Period|Protocol Violation|2|||
126335371|NCT00483652|454522437|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126335372|NCT00483652|454522436|FG000|Double-blind Treatment Period|Adverse Event|3|||
126335373|NCT00483652|454522437|FG001|Double-blind Treatment Period|Adverse Event|4|||
126335374|NCT00483652|454522436|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
125999337|NCT00519636|453287147|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
125999338|NCT00519636|453287148|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
126335375|NCT00483652|454522437|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
126335376|NCT00483652|454522436|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
126335377|NCT00483652|454522437|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
126335378|NCT00473655|454522444|FG000|Overall Study|Lost to Follow-up|9|||
126335379|NCT00473655|454522445|FG001|Overall Study|Lost to Follow-up|5|||
126335380|NCT00473655|454522446|FG002|Overall Study|Lost to Follow-up|8|||
126335381|NCT05081388|454522447|FG000|Overall Study|Adverse Event|1|||
126335382|NCT05081388|454522448|FG001|Overall Study|Adverse Event|0|||
126335383|NCT05081388|454522449|FG002|Overall Study|Adverse Event|0|||
126335384|NCT05081388|454522450|FG003|Overall Study|Adverse Event|0|||
126335385|NCT05081388|454522451|FG004|Overall Study|Adverse Event|0|||
126335386|NCT05081388|454522447|FG000|Overall Study|Lost to Follow-up|0|||
126335387|NCT05081388|454522448|FG001|Overall Study|Lost to Follow-up|1|||
126335388|NCT05081388|454522449|FG002|Overall Study|Lost to Follow-up|0|||
126335389|NCT05081388|454522450|FG003|Overall Study|Lost to Follow-up|0|||
126335390|NCT05081388|454522451|FG004|Overall Study|Lost to Follow-up|0|||
126335391|NCT05081388|454522447|FG000|Overall Study|Subject decision|0|||
126335392|NCT05081388|454522448|FG001|Overall Study|Subject decision|0|||
126335393|NCT05081388|454522449|FG002|Overall Study|Subject decision|0|||
126335394|NCT05081388|454522450|FG003|Overall Study|Subject decision|1|||
126335395|NCT05081388|454522451|FG004|Overall Study|Subject decision|0|||
126335396|NCT04176939|454522452|FG000|Overall Study|Withdrawal by Subject|5|||
126335397|NCT04176939|454522452|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
126335398|NCT04176939|454522452|FG000|Overall Study|Lost to Follow-up|2|||
126335399|NCT04176939|454522452|FG000|Overall Study|Unspecified reason|4|||
126335400|NCT04176939|454522452|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
126335401|NCT02219685|454522455|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
126335402|NCT02219685|454522456|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
126335403|NCT02219685|454522455|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
126335404|NCT02219685|454522456|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
126335405|NCT02869789|454522457|FG000|Overall Study|Disease progression|184|||
126335406|NCT02869789|454522458|FG001|Overall Study|Disease progression|109|||
126335407|NCT02869789|454522459|FG002|Overall Study|Disease progression|260|||
126335408|NCT02869789|454522460|FG003|Overall Study|Disease progression|19|||
126335409|NCT02869789|454522457|FG000|Overall Study|Study drug toxicity|90|||
126335410|NCT02869789|454522458|FG001|Overall Study|Study drug toxicity|32|||
126335411|NCT02869789|454522459|FG002|Overall Study|Study drug toxicity|55|||
126335412|NCT02869789|454522460|FG003|Overall Study|Study drug toxicity|14|||
126335413|NCT02869789|454522457|FG000|Overall Study|Death|7|||
126335414|NCT02869789|454522458|FG001|Overall Study|Death|3|||
126335415|NCT02869789|454522459|FG002|Overall Study|Death|5|||
126335416|NCT02869789|454522460|FG003|Overall Study|Death|1|||
126335417|NCT02869789|454522457|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
126335418|NCT02869789|454522458|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
126335419|NCT02869789|454522459|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
126335420|NCT02869789|454522460|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
126335421|NCT02869789|454522457|FG000|Overall Study|Participant request to discontinue study treatment|10|||
126335422|NCT02869789|454522458|FG001|Overall Study|Participant request to discontinue study treatment|5|||
126335423|NCT02869789|454522459|FG002|Overall Study|Participant request to discontinue study treatment|5|||
126335424|NCT02869789|454522460|FG003|Overall Study|Participant request to discontinue study treatment|3|||
126335425|NCT02869789|454522457|FG000|Overall Study|Withdrawal by Subject|5|||
126335426|NCT02869789|454522458|FG001|Overall Study|Withdrawal by Subject|2|||
126335427|NCT02869789|454522459|FG002|Overall Study|Withdrawal by Subject|7|||
126335428|NCT02869789|454522460|FG003|Overall Study|Withdrawal by Subject|2|||
126335429|NCT02869789|454522457|FG000|Overall Study|Lost to Follow-up|0|||
126335430|NCT02869789|454522458|FG001|Overall Study|Lost to Follow-up|0|||
126335431|NCT02869789|454522459|FG002|Overall Study|Lost to Follow-up|2|||
126335432|NCT02869789|454522460|FG003|Overall Study|Lost to Follow-up|0|||
126335433|NCT02869789|454522457|FG000|Overall Study|Maximum clinical benefit|5|||
126335434|NCT02869789|454522458|FG001|Overall Study|Maximum clinical benefit|2|||
126335435|NCT02869789|454522459|FG002|Overall Study|Maximum clinical benefit|1|||
126335436|NCT02869789|454522460|FG003|Overall Study|Maximum clinical benefit|0|||
126335437|NCT02869789|454522457|FG000|Overall Study|Poor/Non-compliance|0|||
126335438|NCT02869789|454522458|FG001|Overall Study|Poor/Non-compliance|2|||
126335439|NCT02869789|454522459|FG002|Overall Study|Poor/Non-compliance|1|||
126335440|NCT02869789|454522460|FG003|Overall Study|Poor/Non-compliance|0|||
126335441|NCT02869789|454522457|FG000|Overall Study|Participant no longer meets study criteria|0|||
126335442|NCT02869789|454522458|FG001|Overall Study|Participant no longer meets study criteria|1|||
126335443|NCT02869789|454522459|FG002|Overall Study|Participant no longer meets study criteria|1|||
126335444|NCT02869789|454522460|FG003|Overall Study|Participant no longer meets study criteria|0|||
126335445|NCT02869789|454522457|FG000|Overall Study|Administrative reason by sponsor|0|||
126335446|NCT02869789|454522458|FG001|Overall Study|Administrative reason by sponsor|0|||
126335447|NCT02869789|454522459|FG002|Overall Study|Administrative reason by sponsor|1|||
126335448|NCT02869789|454522460|FG003|Overall Study|Administrative reason by sponsor|0|||
126335449|NCT02869789|454522457|FG000|Overall Study|Other reasons|4|||
126335450|NCT02869789|454522458|FG001|Overall Study|Other reasons|8|||
126335451|NCT02869789|454522459|FG002|Overall Study|Other reasons|6|||
125999339|NCT00519636|453287145|FG000|Washout Period|Adverse Event|2|||
126335452|NCT02869789|454522460|FG003|Overall Study|Other reasons|0|||
126335453|NCT01566604|454522463|FG000|Overall Study|Patient's inability to use the device|1|||
126335454|NCT01566604|454522464|FG001|Overall Study|Patient's inability to use the device|0|||
126335455|NCT01566604|454522463|FG000|Overall Study|Administrative problems|1|||
126335456|NCT01566604|454522464|FG001|Overall Study|Administrative problems|0|||
126335457|NCT01566604|454522463|FG000|Overall Study|Lack of Efficacy|1|||
126335458|NCT01566604|454522464|FG001|Overall Study|Lack of Efficacy|2|||
126335459|NCT01566604|454522463|FG000|Overall Study|Protocol deviation|2|||
126335460|NCT01566604|454522464|FG001|Overall Study|Protocol deviation|0|||
126335461|NCT01566604|454522463|FG000|Overall Study|Abnormal laboratory value|2|||
126335462|NCT01566604|454522464|FG001|Overall Study|Abnormal laboratory value|0|||
125999340|NCT00519636|453287146|FG001|Washout Period|Adverse Event|1|||
125999341|NCT00519636|453287147|FG002|Washout Period|Adverse Event|1|||
125999342|NCT00519636|453287148|FG003|Washout Period|Adverse Event|0|||
125999343|NCT00519636|453287145|FG000|Washout Period|Lost to Follow-up|1|||
125999344|NCT00519636|453287146|FG001|Washout Period|Lost to Follow-up|0|||
125999345|NCT00519636|453287147|FG002|Washout Period|Lost to Follow-up|0|||
125999346|NCT00519636|453287148|FG003|Washout Period|Lost to Follow-up|0|||
125999347|NCT00519636|453287145|FG000|Washout Period|Protocol Violation|0|||
125999348|NCT00519636|453287146|FG001|Washout Period|Protocol Violation|0|||
125999349|NCT00519636|453287147|FG002|Washout Period|Protocol Violation|1|||
125999350|NCT00519636|453287148|FG003|Washout Period|Protocol Violation|2|||
125999351|NCT00519636|453287145|FG000|Washout Period|Withdrawal by Subject|1|||
125999352|NCT00519636|453287146|FG001|Washout Period|Withdrawal by Subject|0|||
125999353|NCT00519636|453287147|FG002|Washout Period|Withdrawal by Subject|1|||
125999354|NCT00519636|453287148|FG003|Washout Period|Withdrawal by Subject|0|||
125999355|NCT00519636|453287145|FG000|Washout Period|Failed to meet continuation criteria|14|||
126335463|NCT01566604|454522463|FG000|Overall Study|Death|4|||
126335464|NCT01566604|454522464|FG001|Overall Study|Death|1|||
126335465|NCT01566604|454522463|FG000|Overall Study|Adverse Event|4|||
126335466|NCT01566604|454522464|FG001|Overall Study|Adverse Event|2|||
126335467|NCT01566604|454522463|FG000|Overall Study|Withdrawal by Subject|9|||
126335468|NCT01566604|454522464|FG001|Overall Study|Withdrawal by Subject|6|||
126335469|NCT03225170|454522465|FG000|Overall Study|Lost to Follow-up|4|||
125999356|NCT00519636|453287146|FG001|Washout Period|Failed to meet continuation criteria|11|||
125999357|NCT00519636|453287147|FG002|Washout Period|Failed to meet continuation criteria|9|||
125999358|NCT00519636|453287148|FG003|Washout Period|Failed to meet continuation criteria|3|||
126335470|NCT03225170|454522466|FG001|Overall Study|Lost to Follow-up|4|||
126335471|NCT03225170|454522467|FG002|Overall Study|Lost to Follow-up|0|||
126335472|NCT03225170|454522465|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
126335473|NCT03225170|454522466|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
126335474|NCT03225170|454522467|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
126335475|NCT00385918|454522486|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
126335476|NCT00385918|454522487|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
126335477|NCT00385918|454522488|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
126335478|NCT00385918|454522486|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
126335479|NCT00385918|454522487|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
126335480|NCT00385918|454522488|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
126335481|NCT00385918|454522486|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
126335482|NCT00385918|454522487|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
126335483|NCT00385918|454522488|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
126335484|NCT00385918|454522486|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
126335485|NCT00385918|454522487|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
126335486|NCT00385918|454522488|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
126335487|NCT00385918|454522486|FG000|Intervention Phase After Randomization|Physician Decision|1|||
126335488|NCT00385918|454522487|FG001|Intervention Phase After Randomization|Physician Decision|0|||
126335489|NCT00385918|454522488|FG002|Intervention Phase After Randomization|Physician Decision|0|||
126335490|NCT00385918|454522486|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
126335491|NCT00385918|454522487|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
126335492|NCT00385918|454522488|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
126335493|NCT01676701|454522489|FG000|Overall Study|Protocol Violation|1|||
126335494|NCT01676701|454522490|FG001|Overall Study|Protocol Violation|0|||
126335495|NCT01676701|454522489|FG000|Overall Study|Sponsor Decision|3|||
126335496|NCT01676701|454522490|FG001|Overall Study|Sponsor Decision|4|||
126335497|NCT02227784|454522495|FG000|Double-Blind Phase|Adverse Event|3|||
126335498|NCT02227784|454522496|FG001|Double-Blind Phase|Adverse Event|2|||
126335499|NCT02227784|454522497|FG002|Double-Blind Phase|Adverse Event|1|||
126335500|NCT02227784|454522498|FG003|Double-Blind Phase|Adverse Event|3|||
126335501|NCT02227784|454522499|FG004|Double-Blind Phase|Adverse Event|0|||
126335502|NCT02227784|454522495|FG000|Double-Blind Phase|Physician Decision|1|||
126335503|NCT02227784|454522496|FG001|Double-Blind Phase|Physician Decision|0|||
126335504|NCT02227784|454522497|FG002|Double-Blind Phase|Physician Decision|0|||
126335505|NCT02227784|454522498|FG003|Double-Blind Phase|Physician Decision|1|||
126335506|NCT02227784|454522499|FG004|Double-Blind Phase|Physician Decision|0|||
126335507|NCT02227784|454522495|FG000|Double-Blind Phase|Protocol Violation|0|||
126335508|NCT02227784|454522496|FG001|Double-Blind Phase|Protocol Violation|0|||
126335509|NCT02227784|454522497|FG002|Double-Blind Phase|Protocol Violation|1|||
125999359|NCT00519636|453287145|FG000|Washout Period|Out of pollen area > 48 hours|1|||
125999360|NCT00519636|453287146|FG001|Washout Period|Out of pollen area > 48 hours|0|||
125999361|NCT00519636|453287147|FG002|Washout Period|Out of pollen area > 48 hours|0|||
126335510|NCT02227784|454522498|FG003|Double-Blind Phase|Protocol Violation|1|||
126335511|NCT02227784|454522499|FG004|Double-Blind Phase|Protocol Violation|0|||
126335512|NCT02227784|454522495|FG000|Double-Blind Phase|Sponsor Decision|34|||
126335513|NCT02227784|454522496|FG001|Double-Blind Phase|Sponsor Decision|15|||
126335514|NCT02227784|454522497|FG002|Double-Blind Phase|Sponsor Decision|14|||
126335515|NCT02227784|454522498|FG003|Double-Blind Phase|Sponsor Decision|32|||
126335516|NCT02227784|454522499|FG004|Double-Blind Phase|Sponsor Decision|0|||
126335517|NCT02227784|454522495|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
126335518|NCT02227784|454522496|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
126335519|NCT02227784|454522497|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
126335520|NCT02227784|454522498|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
126335521|NCT02227784|454522499|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
126335522|NCT02227784|454522495|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
126335523|NCT02227784|454522496|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
126335524|NCT02227784|454522497|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
126335525|NCT02227784|454522498|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
126335526|NCT02227784|454522499|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
126335527|NCT02227784|454522495|FG000|Open-Label Extension Phase (OLE)|Death|0|||
126335528|NCT02227784|454522496|FG001|Open-Label Extension Phase (OLE)|Death|0|||
126335529|NCT02227784|454522497|FG002|Open-Label Extension Phase (OLE)|Death|0|||
126335530|NCT02227784|454522498|FG003|Open-Label Extension Phase (OLE)|Death|0|||
126335531|NCT02227784|454522499|FG004|Open-Label Extension Phase (OLE)|Death|1|||
126335532|NCT02227784|454522495|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125999362|NCT00519636|453287148|FG003|Washout Period|Out of pollen area > 48 hours|0|||
125999363|NCT00519636|453287145|FG000|Washout Period|Participating in study at another site|1|||
125999364|NCT00519636|453287146|FG001|Washout Period|Participating in study at another site|0|||
125999365|NCT00519636|453287147|FG002|Washout Period|Participating in study at another site|0|||
125999366|NCT00519636|453287148|FG003|Washout Period|Participating in study at another site|0|||
125999367|NCT00519636|453287145|FG000|Washout Period|Non-compliant|0|||
125999368|NCT00519636|453287146|FG001|Washout Period|Non-compliant|1|||
125999369|NCT00519636|453287147|FG002|Washout Period|Non-compliant|0|||
125999370|NCT00519636|453287148|FG003|Washout Period|Non-compliant|0|||
125999371|NCT00519636|453287145|FG000|Washout Period|Per doctors request|0|||
125999372|NCT00519636|453287146|FG001|Washout Period|Per doctors request|1|||
125999373|NCT00519636|453287147|FG002|Washout Period|Per doctors request|0|||
125999374|NCT00519636|453287148|FG003|Washout Period|Per doctors request|0|||
125999375|NCT00519636|453287145|FG000|Washout Period|Subject randomized in error|0|||
125999376|NCT00519636|453287146|FG001|Washout Period|Subject randomized in error|0|||
125999377|NCT00519636|453287147|FG002|Washout Period|Subject randomized in error|1|||
125999378|NCT00519636|453287148|FG003|Washout Period|Subject randomized in error|0|||
125999379|NCT00519636|453287145|FG000|Washout Period|Prohibited medications|0|||
125999380|NCT00519636|453287146|FG001|Washout Period|Prohibited medications|0|||
125999381|NCT00519636|453287147|FG002|Washout Period|Prohibited medications|1|||
125999382|NCT00519636|453287148|FG003|Washout Period|Prohibited medications|0|||
125999383|NCT00519636|453287145|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
125999384|NCT00519636|453287146|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
125999385|NCT00519636|453287147|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
125999386|NCT00519636|453287148|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
125999387|NCT00519636|453287145|FG000|Treatment Period 2|Subject randomized in error|0|||
125999388|NCT00519636|453287146|FG001|Treatment Period 2|Subject randomized in error|1|||
125999389|NCT00519636|453287147|FG002|Treatment Period 2|Subject randomized in error|0|||
125999390|NCT00519636|453287148|FG003|Treatment Period 2|Subject randomized in error|0|||
125999391|NCT00519636|453287145|FG000|Treatment Period 2|Per doctors request|0|||
125999392|NCT00519636|453287146|FG001|Treatment Period 2|Per doctors request|0|||
125999393|NCT00519636|453287147|FG002|Treatment Period 2|Per doctors request|1|||
125999394|NCT00519636|453287148|FG003|Treatment Period 2|Per doctors request|0|||
125999395|NCT00519636|453287145|FG000|Treatment Period 2|Subject misrandomized|0|||
125999396|NCT00519636|453287146|FG001|Treatment Period 2|Subject misrandomized|0|||
125999397|NCT00519636|453287147|FG002|Treatment Period 2|Subject misrandomized|0|||
125999398|NCT00519636|453287148|FG003|Treatment Period 2|Subject misrandomized|1|||
125999399|NCT00519636|453287145|FG000|Post Study Period|Subject randomized in error|0|||
125999400|NCT00519636|453287146|FG001|Post Study Period|Subject randomized in error|0|||
125999401|NCT00519636|453287147|FG002|Post Study Period|Subject randomized in error|0|||
125999402|NCT00519636|453287148|FG003|Post Study Period|Subject randomized in error|1|||
126335533|NCT02227784|454522496|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
126335534|NCT02227784|454522497|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
126335535|NCT02227784|454522498|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125999403|NCT02846558|453287149|FG000|Overall Study|Adverse Event|1|||
125999404|NCT02846558|453287150|FG001|Overall Study|Adverse Event|0|||
125999405|NCT02846558|453287151|FG002|Overall Study|Adverse Event|0|||
125999406|NCT02846558|453287152|FG003|Overall Study|Adverse Event|0|||
125999407|NCT02846558|453287149|FG000|Overall Study|Withdrawal by Subject|5|||
126335536|NCT02227784|454522499|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
126335537|NCT02227784|454522495|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
126335538|NCT02227784|454522496|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
126335539|NCT02227784|454522497|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
126335540|NCT02227784|454522498|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
126335541|NCT02227784|454522499|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
126335542|NCT02155699|454522500|FG000|Overall Study|Withdrawal by Subject|0|||
126335543|NCT02155699|454522501|FG001|Overall Study|Withdrawal by Subject|3|||
126335544|NCT02155699|454522502|FG002|Overall Study|Withdrawal by Subject|6|||
126335545|NCT02155699|454522503|FG003|Overall Study|Withdrawal by Subject|1|||
126335546|NCT02155699|454522500|FG000|Overall Study|Lost to Follow-up|0|||
126335547|NCT02155699|454522501|FG001|Overall Study|Lost to Follow-up|0|||
126335548|NCT02155699|454522502|FG002|Overall Study|Lost to Follow-up|0|||
126335549|NCT02155699|454522503|FG003|Overall Study|Lost to Follow-up|3|||
126335550|NCT02155699|454522500|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
126335551|NCT02155699|454522501|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
126335552|NCT02155699|454522502|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
126335553|NCT02155699|454522503|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
126335554|NCT00715559|454524728|FG000|Overall Study|medication not tolerated - nausea|1|||
126335555|NCT02699996|454524729|FG000|Overall Study|Withdrawal by Subject|5|||
126335556|NCT02699996|454524730|FG001|Overall Study|Withdrawal by Subject|2|||
126335557|NCT01095835|454524733|FG000|Overall Study|Adverse Event|8|||
126335558|NCT01095835|454524734|FG001|Overall Study|Adverse Event|6|||
126335559|NCT01095835|454524735|FG002|Overall Study|Adverse Event|6|||
126335560|NCT01095835|454524733|FG000|Overall Study|Lack of Efficacy|0|||
126335561|NCT01095835|454524734|FG001|Overall Study|Lack of Efficacy|1|||
126335562|NCT01095835|454524735|FG002|Overall Study|Lack of Efficacy|0|||
126335563|NCT01095835|454524733|FG000|Overall Study|Physician Decision|0|||
126335564|NCT01095835|454524734|FG001|Overall Study|Physician Decision|0|||
126335565|NCT01095835|454524735|FG002|Overall Study|Physician Decision|1|||
126335566|NCT01095835|454524733|FG000|Overall Study|Withdrawal by Subject|1|||
126335567|NCT01095835|454524734|FG001|Overall Study|Withdrawal by Subject|3|||
126335568|NCT01095835|454524735|FG002|Overall Study|Withdrawal by Subject|0|||
126335569|NCT01095835|454524733|FG000|Overall Study|Non study compliance|0|||
126335570|NCT01095835|454524734|FG001|Overall Study|Non study compliance|0|||
126335571|NCT01095835|454524735|FG002|Overall Study|Non study compliance|1|||
126335572|NCT01095835|454524733|FG000|Overall Study|Protocol Violation|1|||
126335573|NCT01095835|454524734|FG001|Overall Study|Protocol Violation|2|||
126335574|NCT01095835|454524735|FG002|Overall Study|Protocol Violation|0|||
126335575|NCT01051921|454524736|FG000|Overall Study|Physician Decision|9|||
126335576|NCT01051921|454524736|FG000|Overall Study|Adverse Event|8|||
126335577|NCT01051921|454524736|FG000|Overall Study|Withdrawal by Subject|7|||
126335578|NCT01051921|454524736|FG000|Overall Study|Lost to Follow-up|4|||
126335579|NCT01051921|454524736|FG000|Overall Study|virological failure|1|||
126335580|NCT01051921|454524736|FG000|Overall Study|patient moved|1|||
126335581|NCT00116688|454524741|FG000|Overall Study|Protocol deviation|1|||
126335582|NCT00116688|454524742|FG001|Overall Study|Protocol deviation|0|||
126335583|NCT00116688|454524741|FG000|Overall Study|Noncompliance|3|||
126335584|NCT00116688|454524742|FG001|Overall Study|Noncompliance|1|||
126335585|NCT00116688|454524741|FG000|Overall Study|Adverse Event|11|||
125999408|NCT02846558|453287150|FG001|Overall Study|Withdrawal by Subject|4|||
125999409|NCT02846558|453287151|FG002|Overall Study|Withdrawal by Subject|2|||
125999410|NCT02846558|453287152|FG003|Overall Study|Withdrawal by Subject|2|||
125999411|NCT02846558|453287149|FG000|Overall Study|Lost to Follow-up|2|||
125999412|NCT02846558|453287150|FG001|Overall Study|Lost to Follow-up|0|||
125999413|NCT02846558|453287151|FG002|Overall Study|Lost to Follow-up|0|||
125999414|NCT02846558|453287152|FG003|Overall Study|Lost to Follow-up|0|||
125999415|NCT00810641|453287153|FG000|Overall Study|Withdrawal by Subject|0|||
125999416|NCT00810641|453287154|FG001|Overall Study|Withdrawal by Subject|1|||
125999417|NCT00810641|453287155|FG002|Overall Study|Withdrawal by Subject|2|||
125999418|NCT02684903|453287164|FG000|Overall Study|COVID-19 shutdown of lab|4|||
125999419|NCT02684903|453287165|FG001|Overall Study|COVID-19 shutdown of lab|6|||
125999420|NCT02684903|453287164|FG000|Overall Study|Lost to Follow-up|31|||
125999421|NCT02684903|453287165|FG001|Overall Study|Lost to Follow-up|41|||
125999422|NCT00904150|453287166|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
125999423|NCT00904150|453287167|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
125999424|NCT00904150|453287166|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
125999425|NCT00904150|453287167|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
126335586|NCT00116688|454524742|FG001|Overall Study|Adverse Event|0|||
126335587|NCT00116688|454524741|FG000|Overall Study|Withdrawal by Subject|26|||
126335588|NCT00116688|454524742|FG001|Overall Study|Withdrawal by Subject|2|||
126335589|NCT00116688|454524741|FG000|Overall Study|Requirement for alternative therapy|11|||
125999426|NCT01475786|453287168|FG000|Overall Study|Adverse Event|0|||
126335590|NCT00116688|454524742|FG001|Overall Study|Requirement for alternative therapy|1|||
125999427|NCT01475786|453287169|FG001|Overall Study|Adverse Event|1|||
126335591|NCT00116688|454524741|FG000|Overall Study|Physician Decision|7|||
126335592|NCT00116688|454524742|FG001|Overall Study|Physician Decision|0|||
126335593|NCT00116688|454524741|FG000|Overall Study|Lost to Follow-up|3|||
126335594|NCT00116688|454524742|FG001|Overall Study|Lost to Follow-up|0|||
126335595|NCT00116688|454524741|FG000|Overall Study|Death|15|||
126335596|NCT00116688|454524742|FG001|Overall Study|Death|0|||
126335597|NCT00116688|454524741|FG000|Overall Study|Protocol-specified criteria|3|||
126335598|NCT00116688|454524742|FG001|Overall Study|Protocol-specified criteria|0|||
126335599|NCT00116688|454524741|FG000|Overall Study|Pregnancy|1|||
126335600|NCT00116688|454524742|FG001|Overall Study|Pregnancy|0|||
126335601|NCT00116688|454524741|FG000|Overall Study|Other|11|||
126335602|NCT00116688|454524742|FG001|Overall Study|Other|0|||
126335603|NCT01775670|454524747|FG000|Overall Study|Lost to Follow-up|1|||
126335604|NCT01775670|454524748|FG001|Overall Study|Lost to Follow-up|1|||
126335605|NCT04006145|454524749|FG000|Overall Study|Lost to Follow-up|0|||
126335606|NCT04006145|454524750|FG001|Overall Study|Lost to Follow-up|1|||
126335607|NCT04006145|454524749|FG000|Overall Study|Other|1|||
126335608|NCT04006145|454524750|FG001|Overall Study|Other|2|||
126335609|NCT00010257|454524753|FG000|Overall Study|Withdrawal by Subject|1|||
126335610|NCT00010257|454524754|FG001|Overall Study|Withdrawal by Subject|0|||
126335611|NCT01249417|454524760|FG000|Randomised Population|Study treatment not received|0|||
126335612|NCT01249417|454524761|FG001|Randomised Population|Study treatment not received|0|||
126335613|NCT01249417|454524762|FG002|Randomised Population|Study treatment not received|2|||
125999428|NCT01475786|453287170|FG002|Overall Study|Adverse Event|0|||
125999429|NCT01475786|453287168|FG000|Overall Study|Lost to Follow-up|1|||
125999430|NCT01475786|453287169|FG001|Overall Study|Lost to Follow-up|2|||
125999431|NCT01475786|453287170|FG002|Overall Study|Lost to Follow-up|1|||
125999432|NCT01475786|453287168|FG000|Overall Study|Withdrawal by Subject|0|||
125999433|NCT01475786|453287169|FG001|Overall Study|Withdrawal by Subject|1|||
125999434|NCT01475786|453287170|FG002|Overall Study|Withdrawal by Subject|1|||
125999435|NCT01475786|453287168|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
125999436|NCT01475786|453287169|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
125999437|NCT01475786|453287170|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
125999438|NCT04129580|453288963|FG000|Overall Study|Lost to Follow-up|14|||
125999439|NCT04129580|453288964|FG001|Overall Study|Lost to Follow-up|25|||
125999440|NCT04212169|453288967|FG000|Overall Study|Adverse Event|0|||
125999441|NCT04212169|453288968|FG001|Overall Study|Adverse Event|0|||
125999442|NCT04212169|453288969|FG002|Overall Study|Adverse Event|0|||
125999443|NCT04212169|453288970|FG003|Overall Study|Adverse Event|2|||
125999444|NCT04212169|453288967|FG000|Overall Study|Lost to Follow-up|1|||
126335614|NCT01249417|454524760|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
126335615|NCT01249417|454524761|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
126335616|NCT01249417|454524762|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
126335617|NCT01249417|454524760|FG000|Treatment Phase - ITT Population|Other|0|||
126335618|NCT01249417|454524761|FG001|Treatment Phase - ITT Population|Other|0|||
126335619|NCT01249417|454524762|FG002|Treatment Phase - ITT Population|Other|1|||
126335620|NCT01249417|454524760|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
126335621|NCT01249417|454524761|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
126335622|NCT01249417|454524762|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
126335623|NCT01249417|454524760|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
126335624|NCT01249417|454524761|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
126335625|NCT01249417|454524762|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
126335626|NCT01249417|454524760|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
126335627|NCT01249417|454524761|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
126335628|NCT01249417|454524762|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
126335629|NCT00126594|454524764|FG000|Overall Study|Ineligible|2|||
126335630|NCT00126594|454524765|FG001|Overall Study|Ineligible|0|||
126335631|NCT00126594|454524764|FG000|Overall Study|Withdrawal by Subject|0|||
126335632|NCT00126594|454524765|FG001|Overall Study|Withdrawal by Subject|4|||
126335633|NCT00126594|454524764|FG000|Overall Study|Physician Decision|1|||
126335634|NCT00126594|454524765|FG001|Overall Study|Physician Decision|3|||
126335635|NCT00126594|454524764|FG000|Overall Study|Adverse Event|7|||
126335636|NCT00126594|454524765|FG001|Overall Study|Adverse Event|5|||
126335637|NCT00126594|454524764|FG000|Overall Study|Non-compliance|0|||
126335638|NCT00126594|454524765|FG001|Overall Study|Non-compliance|1|||
126335639|NCT00126594|454524764|FG000|Overall Study|Disease Progression|29|||
126335640|NCT00126594|454524765|FG001|Overall Study|Disease Progression|24|||
125999445|NCT04212169|453288968|FG001|Overall Study|Lost to Follow-up|0|||
125999446|NCT04212169|453288969|FG002|Overall Study|Lost to Follow-up|0|||
126335641|NCT03769649|454524766|FG000|Overall Study|Lost to Follow-up|4|||
126335642|NCT01290718|454524769|FG000|Overall Study|Early termination of the study|4|||
126335643|NCT00243919|454524770|FG000|Overall Study|Death|3|||
126335644|NCT00243919|454524771|FG001|Overall Study|Death|4|||
126335645|NCT00243919|454524772|FG002|Overall Study|Death|6|||
126335646|NCT00243919|454524770|FG000|Overall Study|Withdrawal by Subject|6|||
126335647|NCT00243919|454524771|FG001|Overall Study|Withdrawal by Subject|6|||
126335648|NCT00243919|454524772|FG002|Overall Study|Withdrawal by Subject|2|||
126335649|NCT00243919|454524770|FG000|Overall Study|Lost to Follow-up|6|||
125999447|NCT04212169|453288970|FG003|Overall Study|Lost to Follow-up|2|||
126335650|NCT00243919|454524771|FG001|Overall Study|Lost to Follow-up|7|||
126335651|NCT00243919|454524772|FG002|Overall Study|Lost to Follow-up|3|||
126335652|NCT00243919|454524770|FG000|Overall Study|Administrative Error|1|||
126335653|NCT00243919|454524771|FG001|Overall Study|Administrative Error|0|||
126335654|NCT00243919|454524772|FG002|Overall Study|Administrative Error|0|||
126335655|NCT00243919|454524770|FG000|Overall Study|Physician Decision|1|||
126335656|NCT00243919|454524771|FG001|Overall Study|Physician Decision|1|||
126335657|NCT00243919|454524772|FG002|Overall Study|Physician Decision|0|||
126335658|NCT02059239|454524775|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
126335659|NCT02059239|454524776|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
126335660|NCT02059239|454524775|FG000|Overall Study|Physician Decision|1|||
126335661|NCT02059239|454524776|FG001|Overall Study|Physician Decision|0|||
126335662|NCT01268267|454524777|FG000|Overall Study|Protocol Violation|1|||
126335663|NCT04919317|454524782|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
126335664|NCT04919317|454524783|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
126335665|NCT04919317|454524782|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
126335666|NCT04919317|454524783|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
126335667|NCT00230048|454524784|FG000|Overall Study|Lost to Follow-up|13|||
126335668|NCT00230048|454524785|FG001|Overall Study|Lost to Follow-up|18|||
126335669|NCT00731822|454524794|FG000|Overall Study|Adverse Event|2|||
126335670|NCT00731822|454524795|FG001|Overall Study|Adverse Event|1|||
126335671|NCT00731822|454524794|FG000|Overall Study|Protocol Violation|1|||
126335672|NCT00731822|454524795|FG001|Overall Study|Protocol Violation|0|||
126335673|NCT00731822|454524794|FG000|Overall Study|Lost to Follow-up|1|||
126335674|NCT00731822|454524795|FG001|Overall Study|Lost to Follow-up|0|||
126335675|NCT02127658|454524797|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
126335676|NCT02127658|454524798|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
126335677|NCT02127658|454524797|FG000|Overall Study|Withdrawal by Subject|0|||
126335678|NCT02127658|454524798|FG001|Overall Study|Withdrawal by Subject|2|||
126335679|NCT02127658|454524797|FG000|Overall Study|Physician Decision|0|||
126335680|NCT02127658|454524798|FG001|Overall Study|Physician Decision|1|||
126335681|NCT01443858|454524799|FG000|Overall Study|Withdrawal by Subject|9|||
126335682|NCT01443858|454524800|FG001|Overall Study|Withdrawal by Subject|8|||
126335683|NCT01443858|454524801|FG002|Overall Study|Withdrawal by Subject|5|||
126335684|NCT01443858|454524799|FG000|Overall Study|Lack of Efficacy|1|||
126335685|NCT01443858|454524800|FG001|Overall Study|Lack of Efficacy|0|||
126335686|NCT01443858|454524801|FG002|Overall Study|Lack of Efficacy|0|||
126335687|NCT01443858|454524799|FG000|Overall Study|Lost to Follow-up|5|||
126335688|NCT01443858|454524800|FG001|Overall Study|Lost to Follow-up|5|||
126335689|NCT01443858|454524801|FG002|Overall Study|Lost to Follow-up|2|||
126335690|NCT03589807|454524802|FG000|Overall Study|Lost to Follow-up|0|||
126335691|NCT03589807|454524803|FG001|Overall Study|Lost to Follow-up|2|||
125999448|NCT04212169|453288967|FG000|Overall Study|Withdrawal by Subject|10|||
125999449|NCT04212169|453288968|FG001|Overall Study|Withdrawal by Subject|2|||
125999450|NCT04212169|453288969|FG002|Overall Study|Withdrawal by Subject|5|||
125999451|NCT04212169|453288970|FG003|Overall Study|Withdrawal by Subject|7|||
125999452|NCT04212169|453288967|FG000|Overall Study|Other reason, unspecified|3|||
125999453|NCT04212169|453288968|FG001|Overall Study|Other reason, unspecified|1|||
125999454|NCT04212169|453288969|FG002|Overall Study|Other reason, unspecified|0|||
125999455|NCT04212169|453288970|FG003|Overall Study|Other reason, unspecified|2|||
125999456|NCT02718417|453288972|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
125999457|NCT02718417|453288973|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
125999458|NCT02718417|453288974|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
125999459|NCT02718417|453288972|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
125999460|NCT02718417|453288973|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
125999461|NCT02718417|453288974|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
125999462|NCT02718417|453288972|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
125999463|NCT02718417|453288973|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
125999464|NCT02718417|453288974|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
125999465|NCT02718417|453288972|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
125999466|NCT02718417|453288973|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
125999467|NCT02718417|453288974|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
125999468|NCT02718417|453288972|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
125999469|NCT02718417|453288973|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
126335692|NCT03589807|454524804|FG002|Overall Study|Lost to Follow-up|2|||
126091100|NCT03820947|453626922|FG004|Overall Study|Physician Decision|3|||
126335693|NCT03589807|454524805|FG003|Overall Study|Lost to Follow-up|3|||
126335694|NCT03589807|454524806|FG004|Overall Study|Lost to Follow-up|1|||
126335695|NCT03589807|454524807|FG005|Overall Study|Lost to Follow-up|1|||
126335696|NCT03589807|454524802|FG000|Overall Study|Withdrawal by Subject|0|||
126335697|NCT03589807|454524803|FG001|Overall Study|Withdrawal by Subject|5|||
126335698|NCT03589807|454524804|FG002|Overall Study|Withdrawal by Subject|0|||
126335699|NCT03589807|454524805|FG003|Overall Study|Withdrawal by Subject|0|||
126335700|NCT03589807|454524806|FG004|Overall Study|Withdrawal by Subject|0|||
125999470|NCT02718417|453288974|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
125999471|NCT02718417|453288972|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
125999472|NCT02718417|453288973|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
126335701|NCT03589807|454524807|FG005|Overall Study|Withdrawal by Subject|0|||
126335702|NCT03589807|454524802|FG000|Overall Study|Protocol Violation|0|||
126335703|NCT03589807|454524803|FG001|Overall Study|Protocol Violation|0|||
126335704|NCT03589807|454524804|FG002|Overall Study|Protocol Violation|0|||
126335705|NCT03589807|454524805|FG003|Overall Study|Protocol Violation|1|||
126335706|NCT03589807|454524806|FG004|Overall Study|Protocol Violation|0|||
126335707|NCT03589807|454524807|FG005|Overall Study|Protocol Violation|0|||
126335708|NCT03589807|454524802|FG000|Overall Study|Enrolled but treatment not administered|0|||
126335709|NCT03589807|454524803|FG001|Overall Study|Enrolled but treatment not administered|0|||
126335710|NCT03589807|454524804|FG002|Overall Study|Enrolled but treatment not administered|0|||
126335711|NCT03589807|454524805|FG003|Overall Study|Enrolled but treatment not administered|0|||
126335712|NCT03589807|454524806|FG004|Overall Study|Enrolled but treatment not administered|1|||
126335713|NCT03589807|454524807|FG005|Overall Study|Enrolled but treatment not administered|0|||
126335714|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
126335715|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
126335716|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
126335717|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
126335718|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
126335719|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
126335720|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
126335721|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
125999473|NCT02718417|453288974|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
125999474|NCT02718417|453288972|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
125999475|NCT02718417|453288973|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
125999476|NCT02718417|453288974|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
125999477|NCT02718417|453288972|FG000|Chemotherapy Phase (CP)|Other|2|||
125999478|NCT02718417|453288973|FG001|Chemotherapy Phase (CP)|Other|0|||
125999479|NCT02718417|453288974|FG002|Chemotherapy Phase (CP)|Other|1|||
125999480|NCT02718417|453288972|FG000|Maintenance Phase (MP)|Adverse Event|21|||
125999481|NCT02718417|453288973|FG001|Maintenance Phase (MP)|Adverse Event|26|||
125999482|NCT02718417|453288974|FG002|Maintenance Phase (MP)|Adverse Event|0|||
125999483|NCT02718417|453288972|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
125999484|NCT02718417|453288973|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
125999485|NCT02718417|453288974|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
125999486|NCT02718417|453288972|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
125999487|NCT02718417|453288973|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
125999488|NCT02718417|453288974|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
125999489|NCT02718417|453288972|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
125999490|NCT02718417|453288973|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
125999491|NCT02718417|453288974|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
125999492|NCT02718417|453288972|FG000|Maintenance Phase (MP)|Physician's decision|6|||
125999493|NCT02718417|453288973|FG001|Maintenance Phase (MP)|Physician's decision|7|||
125999494|NCT02718417|453288974|FG002|Maintenance Phase (MP)|Physician's decision|0|||
125999495|NCT02718417|453288972|FG000|Maintenance Phase (MP)|Progressive disease|100|||
125999496|NCT02718417|453288973|FG001|Maintenance Phase (MP)|Progressive disease|88|||
125999497|NCT02718417|453288974|FG002|Maintenance Phase (MP)|Progressive disease|0|||
125999498|NCT02718417|453288972|FG000|Maintenance Phase (MP)|Other|2|||
125999499|NCT02718417|453288973|FG001|Maintenance Phase (MP)|Other|1|||
125999500|NCT02718417|453288974|FG002|Maintenance Phase (MP)|Other|0|||
125999501|NCT02718417|453288972|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
125999502|NCT02718417|453288973|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
125999503|NCT02718417|453288974|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
125999504|NCT02718417|453288972|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
125999505|NCT02718417|453288973|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
125999506|NCT02718417|453288974|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
125999507|NCT02718417|453288972|FG000|Observation Phase (OP)|Adverse Event|0|||
125999508|NCT02718417|453288973|FG001|Observation Phase (OP)|Adverse Event|0|||
125999509|NCT02718417|453288974|FG002|Observation Phase (OP)|Adverse Event|1|||
125999510|NCT02718417|453288972|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
125999511|NCT02718417|453288973|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
125999512|NCT02718417|453288974|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
125999513|NCT02718417|453288972|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
125999514|NCT02718417|453288973|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
126335722|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
126335723|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
126335724|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
126335725|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
125999515|NCT02718417|453288974|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
125999516|NCT02718417|453288972|FG000|Observation Phase (OP)|Physician Decision|0|||
125999517|NCT02718417|453288973|FG001|Observation Phase (OP)|Physician Decision|0|||
125999518|NCT02718417|453288974|FG002|Observation Phase (OP)|Physician Decision|9|||
125999519|NCT02718417|453288972|FG000|Observation Phase (OP)|Progressive disease|0|||
125999520|NCT02718417|453288973|FG001|Observation Phase (OP)|Progressive disease|0|||
125999521|NCT02718417|453288974|FG002|Observation Phase (OP)|Progressive disease|92|||
125999522|NCT02718417|453288972|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
125999523|NCT02718417|453288973|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
125999524|NCT02718417|453288974|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
125999525|NCT02718417|453288972|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
125999526|NCT02718417|453288973|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
125999527|NCT02718417|453288974|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
125999528|NCT02718417|453288972|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
125999529|NCT02718417|453288973|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
125999530|NCT02718417|453288974|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
125999531|NCT02718417|453288972|FG000|Observation Phase (OP)|Other|0|||
125999532|NCT02718417|453288973|FG001|Observation Phase (OP)|Other|0|||
125999533|NCT02718417|453288974|FG002|Observation Phase (OP)|Other|7|||
126335726|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
126335727|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335728|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335729|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335730|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335731|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335732|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
126335733|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335734|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335735|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335736|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335737|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335738|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
126335739|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335740|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335741|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335742|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335743|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335744|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Other|119|||
126335745|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Other|0|||
126335746|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Other|0|||
126335747|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Other|0|||
126335748|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Other|0|||
126335749|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Other|0|||
126335750|NCT01435759|454524809|FG000|Double-blind Phase|Adverse Event|7|||
126335751|NCT01435759|454524810|FG001|Double-blind Phase|Adverse Event|0|||
126335752|NCT01435759|454524811|FG002|Double-blind Phase|Adverse Event|1|||
126335753|NCT01435759|454524812|FG003|Double-blind Phase|Adverse Event|1|||
126335754|NCT01435759|454524813|FG004|Double-blind Phase|Adverse Event|1|||
126335755|NCT01435759|454524814|FG005|Double-blind Phase|Adverse Event|3|||
126335756|NCT01435759|454524809|FG000|Double-blind Phase|Protocol Violation|2|||
126335757|NCT01435759|454524810|FG001|Double-blind Phase|Protocol Violation|0|||
126335758|NCT01435759|454524811|FG002|Double-blind Phase|Protocol Violation|1|||
126335759|NCT01435759|454524812|FG003|Double-blind Phase|Protocol Violation|2|||
126335760|NCT01435759|454524813|FG004|Double-blind Phase|Protocol Violation|0|||
126335761|NCT01435759|454524814|FG005|Double-blind Phase|Protocol Violation|1|||
126335762|NCT01435759|454524809|FG000|Double-blind Phase|Withdrawal by Subject|17|||
126335763|NCT01435759|454524810|FG001|Double-blind Phase|Withdrawal by Subject|4|||
126335764|NCT01435759|454524811|FG002|Double-blind Phase|Withdrawal by Subject|3|||
126335765|NCT01435759|454524812|FG003|Double-blind Phase|Withdrawal by Subject|4|||
126335766|NCT01435759|454524813|FG004|Double-blind Phase|Withdrawal by Subject|2|||
126335767|NCT01435759|454524814|FG005|Double-blind Phase|Withdrawal by Subject|2|||
126335768|NCT01435759|454524809|FG000|Double-blind Phase|Lost to Follow-up|31|||
126335769|NCT01435759|454524810|FG001|Double-blind Phase|Lost to Follow-up|1|||
126335770|NCT01435759|454524811|FG002|Double-blind Phase|Lost to Follow-up|2|||
126335771|NCT01435759|454524812|FG003|Double-blind Phase|Lost to Follow-up|0|||
126335772|NCT01435759|454524813|FG004|Double-blind Phase|Lost to Follow-up|3|||
126335773|NCT01435759|454524814|FG005|Double-blind Phase|Lost to Follow-up|3|||
126335774|NCT01435759|454524809|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
126335775|NCT01435759|454524810|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125999534|NCT02718417|453288972|FG000|Follow-up Phase|Adverse Event|3|||
126335776|NCT01435759|454524811|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335777|NCT01435759|454524812|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335778|NCT01435759|454524813|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
126335779|NCT01435759|454524814|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335780|NCT01435759|454524809|FG000|Double-blind Phase|Other|8|||
126335781|NCT01435759|454524810|FG001|Double-blind Phase|Other|2|||
126335782|NCT01435759|454524811|FG002|Double-blind Phase|Other|0|||
126335783|NCT01435759|454524812|FG003|Double-blind Phase|Other|2|||
126335784|NCT01435759|454524813|FG004|Double-blind Phase|Other|0|||
126335785|NCT01435759|454524814|FG005|Double-blind Phase|Other|0|||
126335786|NCT02849587|454524817|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
126335787|NCT02849587|454524818|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
126335788|NCT02849587|454524819|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
126335789|NCT02849587|454524817|FG000|Overall Study|Withdrawal by Subject|0|||
126335790|NCT02849587|454524818|FG001|Overall Study|Withdrawal by Subject|1|||
126335791|NCT02849587|454524819|FG002|Overall Study|Withdrawal by Subject|0|||
126335792|NCT00549549|454524833|FG000|Overall Study|Adverse Event|5|||
126335793|NCT00549549|454524834|FG001|Overall Study|Adverse Event|3|||
126335794|NCT00549549|454524835|FG002|Overall Study|Adverse Event|1|||
126335795|NCT00549549|454524836|FG003|Overall Study|Adverse Event|9|||
126335796|NCT00549549|454524833|FG000|Overall Study|Lack of Efficacy|9|||
126335797|NCT00549549|454524834|FG001|Overall Study|Lack of Efficacy|6|||
126335798|NCT00549549|454524835|FG002|Overall Study|Lack of Efficacy|4|||
126335799|NCT00549549|454524836|FG003|Overall Study|Lack of Efficacy|2|||
126335800|NCT00549549|454524833|FG000|Overall Study|Lost to Follow-up|1|||
126335801|NCT00549549|454524834|FG001|Overall Study|Lost to Follow-up|0|||
126335802|NCT00549549|454524835|FG002|Overall Study|Lost to Follow-up|1|||
125999535|NCT02718417|453288973|FG001|Follow-up Phase|Adverse Event|1|||
125999536|NCT02718417|453288974|FG002|Follow-up Phase|Adverse Event|1|||
125999537|NCT02718417|453288972|FG000|Follow-up Phase|Other|4|||
125999538|NCT02718417|453288973|FG001|Follow-up Phase|Other|6|||
125999539|NCT02718417|453288974|FG002|Follow-up Phase|Other|4|||
125999540|NCT02718417|453288972|FG000|Follow-up Phase|Withdrawal by Subject|19|||
125999541|NCT02718417|453288973|FG001|Follow-up Phase|Withdrawal by Subject|17|||
125999542|NCT02718417|453288974|FG002|Follow-up Phase|Withdrawal by Subject|5|||
125999543|NCT02718417|453288972|FG000|Follow-up Phase|Study terminated by sponsor|100|||
125999544|NCT02718417|453288973|FG001|Follow-up Phase|Study terminated by sponsor|138|||
125999545|NCT02718417|453288974|FG002|Follow-up Phase|Study terminated by sponsor|6|||
125999546|NCT02718417|453288972|FG000|Follow-up Phase|Lost to Follow-up|2|||
125999547|NCT02718417|453288973|FG001|Follow-up Phase|Lost to Follow-up|3|||
125999548|NCT02718417|453288974|FG002|Follow-up Phase|Lost to Follow-up|0|||
125999549|NCT02718417|453288972|FG000|Follow-up Phase|Death leading to discontinuation|7|||
125999550|NCT02718417|453288973|FG001|Follow-up Phase|Death leading to discontinuation|7|||
125999551|NCT02718417|453288974|FG002|Follow-up Phase|Death leading to discontinuation|3|||
125999552|NCT02718417|453288972|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
125999553|NCT02718417|453288973|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
125999554|NCT02718417|453288974|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
125999555|NCT02718417|453288972|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
125999556|NCT02718417|453288973|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
125999557|NCT02718417|453288974|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
125999558|NCT02718417|453288972|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
125999559|NCT02718417|453288973|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
125999560|NCT02718417|453288974|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
125999561|NCT02718417|453288972|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
125999562|NCT02718417|453288973|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
125999563|NCT02718417|453288974|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
125999564|NCT02718417|453288972|FG000|Long-term Follow-up Phase|Other|0|||
125999565|NCT02718417|453288973|FG001|Long-term Follow-up Phase|Other|2|||
125999566|NCT02718417|453288974|FG002|Long-term Follow-up Phase|Other|0|||
125999567|NCT04006366|453288975|FG000|Overall Study|Withdrawal by Subject|1|||
125999568|NCT01440049|453288979|FG000|Overall Study|Adverse Event|5|||
125999569|NCT02268552|453288980|FG000|Part 1|Death|1|||
125999570|NCT02268552|453288981|FG001|Part 1|Death|1|||
125999571|NCT02268552|453288982|FG002|Part 1|Death|1|||
125999572|NCT02268552|453288983|FG003|Part 1|Death|2|||
125999573|NCT02268552|453288984|FG004|Part 1|Death|0|||
126335803|NCT00549549|454524836|FG003|Overall Study|Lost to Follow-up|2|||
125999574|NCT02268552|453288985|FG005|Part 1|Death|0|||
125999575|NCT02268552|453288986|FG006|Part 1|Death|0|||
125999576|NCT02268552|453288980|FG000|Part 1|Subject/guardian decision|0|||
125999577|NCT02268552|453288981|FG001|Part 1|Subject/guardian decision|0|||
125999578|NCT02268552|453288982|FG002|Part 1|Subject/guardian decision|0|||
125999579|NCT02268552|453288983|FG003|Part 1|Subject/guardian decision|1|||
125999580|NCT02268552|453288984|FG004|Part 1|Subject/guardian decision|0|||
126335804|NCT00549549|454524833|FG000|Overall Study|Withdrawal by Subject|0|||
126335805|NCT00549549|454524834|FG001|Overall Study|Withdrawal by Subject|4|||
126335806|NCT00549549|454524835|FG002|Overall Study|Withdrawal by Subject|1|||
126335807|NCT00549549|454524836|FG003|Overall Study|Withdrawal by Subject|0|||
126335808|NCT00549549|454524833|FG000|Overall Study|Other|9|||
126335809|NCT00549549|454524834|FG001|Overall Study|Other|9|||
126335810|NCT00549549|454524835|FG002|Overall Study|Other|9|||
126335811|NCT00549549|454524836|FG003|Overall Study|Other|11|||
126335812|NCT00549549|454524833|FG000|Overall Study|Randomized but not treated|0|||
126335813|NCT00549549|454524834|FG001|Overall Study|Randomized but not treated|0|||
126335814|NCT00549549|454524835|FG002|Overall Study|Randomized but not treated|1|||
126335815|NCT00549549|454524836|FG003|Overall Study|Randomized but not treated|1|||
126335816|NCT00102596|454524840|FG000|Part A|Screen failures|6|||
126335817|NCT00102596|454524841|FG001|Part A|Screen failures|0|||
126335818|NCT00102596|454524840|FG000|Part A|Adverse Event|1|||
126335819|NCT00102596|454524841|FG001|Part A|Adverse Event|0|||
126335820|NCT02688933|454524846|FG000|Overall Study|Adverse Event|3|||
126335821|NCT02688933|454524847|FG001|Overall Study|Adverse Event|1|||
126335822|NCT02688933|454524846|FG000|Overall Study|Lack of Efficacy|2|||
126335823|NCT02688933|454524847|FG001|Overall Study|Lack of Efficacy|2|||
126335824|NCT02688933|454524846|FG000|Overall Study|Poor compliance to protocol|7|||
126335825|NCT02688933|454524847|FG001|Overall Study|Poor compliance to protocol|4|||
126335826|NCT02688933|454524846|FG000|Overall Study|Hypoglycemia|2|||
126335827|NCT02688933|454524847|FG001|Overall Study|Hypoglycemia|0|||
126335828|NCT02688933|454524846|FG000|Overall Study|Other than Specified|14|||
126335829|NCT02688933|454524847|FG001|Overall Study|Other than Specified|25|||
126335830|NCT02688933|454524846|FG000|Overall Study|Lost to Follow-up|1|||
126335831|NCT02688933|454524847|FG001|Overall Study|Lost to Follow-up|5|||
126335832|NCT00248651|454524848|FG000|Overall Study|Withdrawal by Subject|28|||
126335833|NCT00248651|454524849|FG001|Overall Study|Withdrawal by Subject|40|||
126335834|NCT00248651|454524850|FG002|Overall Study|Withdrawal by Subject|32|||
126335835|NCT01275144|454524851|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
126335836|NCT01275144|454524852|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
126335837|NCT00828113|454524853|FG000|Overall Study|Withdrawal by Subject|27|||
126335838|NCT00828113|454524854|FG001|Overall Study|Withdrawal by Subject|26|||
126335839|NCT00828113|454524853|FG000|Overall Study|Lost to Follow-up|3|||
126335840|NCT00828113|454524854|FG001|Overall Study|Lost to Follow-up|5|||
126335841|NCT01365130|454524855|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
126335842|NCT05547386|454524858|FG000|Overall Study|Withdrawal by Subject|7|||
126335843|NCT04622969|454524859|FG000|Overall Study|Withdrawal by Subject|2|||
126335844|NCT04622969|454524860|FG001|Overall Study|Withdrawal by Subject|3|||
126335845|NCT05607576|454524861|FG000|Overall Study|immediate sensor error|2|||
126335846|NCT05607576|454524861|FG000|Overall Study|Physician Decision|2|||
126335847|NCT04467515|454524862|FG000|Overall Study|Lost to Follow-up|1|||
126335848|NCT04467515|454524863|FG001|Overall Study|Lost to Follow-up|0|||
126335849|NCT04467515|454524864|FG002|Overall Study|Lost to Follow-up|0|||
126335850|NCT04467515|454524862|FG000|Overall Study|Withdrawal by Subject|1|||
126335851|NCT04467515|454524863|FG001|Overall Study|Withdrawal by Subject|0|||
126335852|NCT04467515|454524864|FG002|Overall Study|Withdrawal by Subject|1|||
126335853|NCT04467515|454524862|FG000|Overall Study|Progressive Disease|0|||
126335854|NCT04467515|454524863|FG001|Overall Study|Progressive Disease|1|||
126335855|NCT04467515|454524864|FG002|Overall Study|Progressive Disease|3|||
126335856|NCT04467515|454524862|FG000|Overall Study|Death|0|||
126335857|NCT04467515|454524863|FG001|Overall Study|Death|1|||
126335858|NCT04467515|454524864|FG002|Overall Study|Death|0|||
126335859|NCT03834506|454524867|FG000|Overall Study|Death|336|||
126335860|NCT03834506|454524868|FG001|Overall Study|Death|326|||
126335861|NCT03834506|454524867|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126335862|NCT03834506|454524868|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126335863|NCT03834506|454524867|FG000|Overall Study|Withdrawal by Subject|10|||
126335864|NCT03834506|454524868|FG001|Overall Study|Withdrawal by Subject|8|||
126335865|NCT03834506|454524867|FG000|Overall Study|Sponsor decision|165|||
126335866|NCT03834506|454524868|FG001|Overall Study|Sponsor decision|178|||
126335867|NCT03834506|454524867|FG000|Overall Study|Physician Decision|3|||
126335868|NCT03834506|454524868|FG001|Overall Study|Physician Decision|1|||
126335869|NCT03834506|454524867|FG000|Overall Study|Lost to Follow-up|0|||
126335870|NCT03834506|454524868|FG001|Overall Study|Lost to Follow-up|1|||
126335871|NCT05067972|454524869|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
126335872|NCT05067972|454524870|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
126335873|NCT05067972|454524871|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
126335874|NCT05067972|454524872|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
126335875|NCT05067972|454524873|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
126335876|NCT05067972|454524874|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
126335877|NCT05067972|454524875|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
126335878|NCT05067972|454524869|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
126335879|NCT05067972|454524870|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
126335880|NCT05067972|454524871|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
126335881|NCT05067972|454524872|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
126335882|NCT05067972|454524873|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
126335883|NCT05067972|454524874|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
126335884|NCT05067972|454524875|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
126335885|NCT05067972|454524869|FG000|Part 1: Treatment|Progressive Disease|3|||
126335886|NCT05067972|454524870|FG001|Part 1: Treatment|Progressive Disease|3|||
126335887|NCT05067972|454524871|FG002|Part 1: Treatment|Progressive Disease|4|||
126335888|NCT05067972|454524872|FG003|Part 1: Treatment|Progressive Disease|2|||
126335889|NCT05067972|454524873|FG004|Part 1: Treatment|Progressive Disease|3|||
126335890|NCT05067972|454524874|FG005|Part 1: Treatment|Progressive Disease|0|||
126335891|NCT05067972|454524875|FG006|Part 1: Treatment|Progressive Disease|2|||
126335892|NCT05067972|454524869|FG000|Part 1: Treatment|Physician Decision|0|||
126335893|NCT05067972|454524870|FG001|Part 1: Treatment|Physician Decision|0|||
126335894|NCT05067972|454524871|FG002|Part 1: Treatment|Physician Decision|0|||
126335895|NCT05067972|454524872|FG003|Part 1: Treatment|Physician Decision|1|||
126335896|NCT05067972|454524873|FG004|Part 1: Treatment|Physician Decision|0|||
126335897|NCT05067972|454524874|FG005|Part 1: Treatment|Physician Decision|0|||
125999581|NCT02268552|453288985|FG005|Part 1|Subject/guardian decision|0|||
125999582|NCT02268552|453288986|FG006|Part 1|Subject/guardian decision|0|||
126335898|NCT05067972|454524875|FG006|Part 1: Treatment|Physician Decision|0|||
126335899|NCT05067972|454524869|FG000|Part 1: Treatment|Death|0|||
126335900|NCT05067972|454524870|FG001|Part 1: Treatment|Death|0|||
126335901|NCT05067972|454524871|FG002|Part 1: Treatment|Death|0|||
126335902|NCT05067972|454524872|FG003|Part 1: Treatment|Death|2|||
126335903|NCT05067972|454524873|FG004|Part 1: Treatment|Death|0|||
126335904|NCT05067972|454524874|FG005|Part 1: Treatment|Death|0|||
126335905|NCT05067972|454524875|FG006|Part 1: Treatment|Death|0|||
126335906|NCT05067972|454524869|FG000|Part 1: Treatment|Adverse Event|0|||
126335907|NCT05067972|454524870|FG001|Part 1: Treatment|Adverse Event|0|||
126335908|NCT05067972|454524871|FG002|Part 1: Treatment|Adverse Event|0|||
126335909|NCT05067972|454524872|FG003|Part 1: Treatment|Adverse Event|0|||
126335910|NCT05067972|454524873|FG004|Part 1: Treatment|Adverse Event|0|||
126335911|NCT05067972|454524874|FG005|Part 1: Treatment|Adverse Event|2|||
126335912|NCT05067972|454524875|FG006|Part 1: Treatment|Adverse Event|1|||
126335913|NCT05067972|454524869|FG000|Part 1: Follow-up|Adverse Event|0|||
126335914|NCT05067972|454524870|FG001|Part 1: Follow-up|Adverse Event|0|||
126335915|NCT05067972|454524871|FG002|Part 1: Follow-up|Adverse Event|0|||
126335916|NCT05067972|454524872|FG003|Part 1: Follow-up|Adverse Event|0|||
126335917|NCT05067972|454524873|FG004|Part 1: Follow-up|Adverse Event|0|||
126335918|NCT05067972|454524874|FG005|Part 1: Follow-up|Adverse Event|1|||
126335919|NCT05067972|454524875|FG006|Part 1: Follow-up|Adverse Event|0|||
126335920|NCT05067972|454524869|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
126335921|NCT05067972|454524870|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
125999583|NCT02268552|453288980|FG000|Part 2|Death|0|||
125999584|NCT02268552|453288981|FG001|Part 2|Death|0|||
125999585|NCT02268552|453288982|FG002|Part 2|Death|0|||
125999586|NCT02268552|453288983|FG003|Part 2|Death|0|||
125999587|NCT02268552|453288984|FG004|Part 2|Death|0|||
125999588|NCT02268552|453288985|FG005|Part 2|Death|0|||
125999589|NCT02268552|453288986|FG006|Part 2|Death|2|||
125999590|NCT02268552|453288980|FG000|Part 2|Subject/guardian decision|0|||
125999591|NCT02268552|453288981|FG001|Part 2|Subject/guardian decision|0|||
125999592|NCT02268552|453288982|FG002|Part 2|Subject/guardian decision|0|||
125999593|NCT02268552|453288983|FG003|Part 2|Subject/guardian decision|0|||
125999594|NCT02268552|453288984|FG004|Part 2|Subject/guardian decision|0|||
125999595|NCT02268552|453288985|FG005|Part 2|Subject/guardian decision|0|||
125999596|NCT02268552|453288986|FG006|Part 2|Subject/guardian decision|1|||
125999597|NCT02268552|453288980|FG000|Part 3 Extension|Death|0|||
125999598|NCT02268552|453288981|FG001|Part 3 Extension|Death|1|||
125999599|NCT02268552|453288982|FG002|Part 3 Extension|Death|1|||
125999600|NCT02268552|453288983|FG003|Part 3 Extension|Death|1|||
125999601|NCT02268552|453288984|FG004|Part 3 Extension|Death|1|||
125999602|NCT02268552|453288985|FG005|Part 3 Extension|Death|1|||
125999603|NCT02268552|453288986|FG006|Part 3 Extension|Death|0|||
125999604|NCT02268552|453288980|FG000|Part 3 Extension|Early termination of trial|1|||
125999605|NCT02268552|453288981|FG001|Part 3 Extension|Early termination of trial|0|||
126335922|NCT05067972|454524871|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
126335923|NCT05067972|454524872|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
126335924|NCT05067972|454524873|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
126335925|NCT05067972|454524874|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
126335926|NCT05067972|454524875|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
126335927|NCT05067972|454524869|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335928|NCT05067972|454524870|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335929|NCT05067972|454524871|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335930|NCT05067972|454524872|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125999606|NCT02268552|453288982|FG002|Part 3 Extension|Early termination of trial|0|||
125999607|NCT02268552|453288983|FG003|Part 3 Extension|Early termination of trial|0|||
125999608|NCT02268552|453288984|FG004|Part 3 Extension|Early termination of trial|2|||
125999609|NCT02268552|453288985|FG005|Part 3 Extension|Early termination of trial|9|||
125999610|NCT02268552|453288986|FG006|Part 3 Extension|Early termination of trial|11|||
126335931|NCT05067972|454524873|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335932|NCT05067972|454524874|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
126335933|NCT05067972|454524875|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335934|NCT05067972|454524869|FG000|Part 1: Follow-up|Physician Decision|0|||
126335935|NCT05067972|454524870|FG001|Part 1: Follow-up|Physician Decision|0|||
126335936|NCT05067972|454524871|FG002|Part 1: Follow-up|Physician Decision|0|||
126335937|NCT05067972|454524872|FG003|Part 1: Follow-up|Physician Decision|1|||
126335938|NCT05067972|454524873|FG004|Part 1: Follow-up|Physician Decision|0|||
126335939|NCT05067972|454524874|FG005|Part 1: Follow-up|Physician Decision|0|||
126335940|NCT05067972|454524875|FG006|Part 1: Follow-up|Physician Decision|0|||
126335941|NCT05067972|454524869|FG000|Part 1: Follow-up|Death|1|||
126335942|NCT05067972|454524870|FG001|Part 1: Follow-up|Death|2|||
126335943|NCT05067972|454524871|FG002|Part 1: Follow-up|Death|1|||
126335944|NCT05067972|454524872|FG003|Part 1: Follow-up|Death|0|||
126335945|NCT05067972|454524873|FG004|Part 1: Follow-up|Death|1|||
126335946|NCT05067972|454524874|FG005|Part 1: Follow-up|Death|0|||
126335947|NCT05067972|454524875|FG006|Part 1: Follow-up|Death|1|||
126335948|NCT04391842|454524876|FG000|Overall Study|Withdrawal by Subject|2|||
126335949|NCT00810199|454524877|FG000|Overall Study|Adverse Event|24|||
126335950|NCT00810199|454524878|FG001|Overall Study|Adverse Event|26|||
126335951|NCT00810199|454524877|FG000|Overall Study|Death|4|||
126335952|NCT00810199|454524878|FG001|Overall Study|Death|6|||
126335953|NCT00810199|454524877|FG000|Overall Study|Withdrew consent|9|||
126335954|NCT00810199|454524878|FG001|Overall Study|Withdrew consent|12|||
126335955|NCT00810199|454524877|FG000|Overall Study|Insufficient therapeutic response|5|||
126335956|NCT00810199|454524878|FG001|Overall Study|Insufficient therapeutic response|14|||
126335957|NCT00810199|454524877|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
126335958|NCT00810199|454524878|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
126335959|NCT00810199|454524877|FG000|Overall Study|Administrative/Other|5|||
126335960|NCT00810199|454524878|FG001|Overall Study|Administrative/Other|6|||
126335961|NCT00810199|454524877|FG000|Overall Study|Protocol Violation|2|||
126335962|NCT00810199|454524878|FG001|Overall Study|Protocol Violation|6|||
126335963|NCT00810199|454524877|FG000|Overall Study|Failure to return|1|||
126335964|NCT00810199|454524878|FG001|Overall Study|Failure to return|4|||
126335965|NCT00810199|454524877|FG000|Overall Study|Did not receive study drug|2|||
126335966|NCT00810199|454524878|FG001|Overall Study|Did not receive study drug|1|||
126335967|NCT01091246|454524879|FG000|Overall Study|Lost to Follow-up|23|||
126335968|NCT01091246|454524880|FG001|Overall Study|Lost to Follow-up|11|||
126335969|NCT01091246|454524881|FG002|Overall Study|Lost to Follow-up|7|||
126335970|NCT01091246|454524879|FG000|Overall Study|Adverse Event|1|||
126335971|NCT01091246|454524880|FG001|Overall Study|Adverse Event|0|||
126335972|NCT01091246|454524881|FG002|Overall Study|Adverse Event|1|||
126335973|NCT01091246|454524879|FG000|Overall Study|Withdrawal by Subject|9|||
126335974|NCT01091246|454524880|FG001|Overall Study|Withdrawal by Subject|5|||
126335975|NCT01091246|454524881|FG002|Overall Study|Withdrawal by Subject|4|||
126335976|NCT01091246|454524879|FG000|Overall Study|Subject not dosed|2|||
126335977|NCT01091246|454524880|FG001|Overall Study|Subject not dosed|0|||
126335978|NCT01091246|454524881|FG002|Overall Study|Subject not dosed|1|||
126335979|NCT02287038|454524882|FG000|Overall Study|Stopped attending appointments|3|||
126335980|NCT02287038|454524883|FG001|Overall Study|Stopped attending appointments|2|||
126335981|NCT02287038|454524882|FG000|Overall Study|Anxiety after starting medication|0|||
126335982|NCT02287038|454524883|FG001|Overall Study|Anxiety after starting medication|1|||
126335983|NCT02287038|454524882|FG000|Overall Study|Nausea after starting medication|1|||
126335984|NCT02287038|454524883|FG001|Overall Study|Nausea after starting medication|0|||
126335985|NCT02287038|454524882|FG000|Overall Study|Abnormal ECG after starting medication|1|||
126335986|NCT02287038|454524883|FG001|Overall Study|Abnormal ECG after starting medication|0|||
126335987|NCT01676012|454524889|FG000|Overall Study|Adverse Event|2|||
126335988|NCT01676012|454524889|FG000|Overall Study|incomplete set of videos|1|||
126335989|NCT02667301|454524904|FG000|Overall Study|Adverse Event|1|||
126335990|NCT02667301|454524904|FG000|Overall Study|Lack of Efficacy|1|||
126335991|NCT02283658|454524905|FG000|Overall Study|Withdrawal by Subject|1|||
126335992|NCT03528551|454524907|FG000|Overall Study|Lost to Follow-up|0|||
126335993|NCT03528551|454524908|FG001|Overall Study|Lost to Follow-up|1|||
126335994|NCT03528551|454524909|FG002|Overall Study|Lost to Follow-up|0|||
126335995|NCT03528551|454524907|FG000|Overall Study|Transferred to other arm/group|2|||
126335996|NCT03528551|454524908|FG001|Overall Study|Transferred to other arm/group|3|||
126335997|NCT03528551|454524909|FG002|Overall Study|Transferred to other arm/group|0|||
126335998|NCT03528551|454524907|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126335999|NCT03528551|454524908|FG001|Overall Study|Withdrawal by parent/guardian|5|||
126336000|NCT03528551|454524909|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126336001|NCT03528551|454524907|FG000|Overall Study|Protocol Violation|0|||
126336002|NCT03528551|454524908|FG001|Overall Study|Protocol Violation|3|||
126336003|NCT03528551|454524909|FG002|Overall Study|Protocol Violation|0|||
126336004|NCT03528551|454524907|FG000|Overall Study|Withdrawal by Subject|0|||
126336005|NCT03528551|454524908|FG001|Overall Study|Withdrawal by Subject|7|||
126336006|NCT03528551|454524909|FG002|Overall Study|Withdrawal by Subject|0|||
126336007|NCT00846586|454524910|FG000|Overall Study|Adverse Event|20|||
126336008|NCT00846586|454524911|FG001|Overall Study|Adverse Event|10|||
126336009|NCT00846586|454524910|FG000|Overall Study|Subject withdrew consent|8|||
126336010|NCT00846586|454524911|FG001|Overall Study|Subject withdrew consent|10|||
126336011|NCT00846586|454524910|FG000|Overall Study|Administrative problems|5|||
126336012|NCT00846586|454524911|FG001|Overall Study|Administrative problems|4|||
126336013|NCT00846586|454524910|FG000|Overall Study|Death|2|||
126336014|NCT00846586|454524911|FG001|Overall Study|Death|0|||
126336015|NCT00846586|454524910|FG000|Overall Study|Protocol deviation|2|||
126336016|NCT00846586|454524911|FG001|Overall Study|Protocol deviation|6|||
126336017|NCT00846586|454524910|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126336018|NCT00846586|454524911|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126336019|NCT00846586|454524910|FG000|Overall Study|Lost to Follow-up|1|||
126336020|NCT00846586|454524911|FG001|Overall Study|Lost to Follow-up|4|||
126336021|NCT00846586|454524910|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126336022|NCT00846586|454524911|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126336023|NCT00689338|454524912|FG000|Overall Study|Death|65|||
126336024|NCT00689338|454524912|FG000|Overall Study|Adverse Event|13|||
126336025|NCT00689338|454524912|FG000|Overall Study|Insufficient Clinical Response|1|||
126336026|NCT00689338|454524912|FG000|Overall Study|Lack of Efficacy|6|||
126336027|NCT00689338|454524912|FG000|Overall Study|Other|8|||
126336028|NCT00689338|454524912|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
126336029|NCT00689338|454524912|FG000|Overall Study|Lost to Follow-up|5|||
125999611|NCT02268552|453288980|FG000|Part 3 Extension|Subject/guardian decision|0|||
125999612|NCT02268552|453288981|FG001|Part 3 Extension|Subject/guardian decision|0|||
126336030|NCT00689338|454524912|FG000|Overall Study|Withdrawal by Subject|3|||
126336031|NCT00689338|454524912|FG000|Overall Study|Protocol Violation|15|||
126336032|NCT00735007|454524913|FG000|Overall Study|Adverse Event|4|||
126336033|NCT00735007|454524913|FG000|Overall Study|Protocol Violation|1|||
126336034|NCT01061606|454524914|FG000|Overall Study|Adverse Event|1|||
126336035|NCT01061606|454524914|FG000|Overall Study|Death|1|||
126336036|NCT01061606|454524914|FG000|Overall Study|Disease Progression|4|||
126336037|NCT01061606|454524914|FG000|Overall Study|alternative therapy|2|||
126336038|NCT01789047|454524915|FG000|Overall Study|Adverse Event|3|||
126336039|NCT01789047|454524916|FG001|Overall Study|Adverse Event|2|||
126336040|NCT01789047|454524915|FG000|Overall Study|Withdrawal by Subject|1|||
126336041|NCT01789047|454524916|FG001|Overall Study|Withdrawal by Subject|2|||
126336042|NCT00715403|454524917|FG000|Overall Study|Progressive disease|0|||
126336043|NCT00715403|454524918|FG001|Overall Study|Progressive disease|1|||
126336044|NCT00715403|454524919|FG002|Overall Study|Progressive disease|3|||
126336045|NCT00715403|454524920|FG003|Overall Study|Progressive disease|9|||
126336046|NCT00715403|454524921|FG004|Overall Study|Progressive disease|5|||
125999613|NCT02268552|453288982|FG002|Part 3 Extension|Subject/guardian decision|0|||
125999614|NCT02268552|453288983|FG003|Part 3 Extension|Subject/guardian decision|0|||
125999615|NCT02268552|453288984|FG004|Part 3 Extension|Subject/guardian decision|0|||
125999616|NCT02268552|453288985|FG005|Part 3 Extension|Subject/guardian decision|0|||
125999617|NCT02268552|453288986|FG006|Part 3 Extension|Subject/guardian decision|1|||
125999618|NCT00997243|453288987|FG000|Overall Study|Early termination of study by sponsor|7|||
125999619|NCT03415022|453288992|FG000|Overall Study|Withdrawal by Subject|1|||
125999620|NCT03415022|453288993|FG001|Overall Study|Withdrawal by Subject|2|||
125999621|NCT03415022|453288992|FG000|Overall Study|COVID-19 Suspension|2|||
125999622|NCT03415022|453288993|FG001|Overall Study|COVID-19 Suspension|3|||
125999623|NCT03415022|453288992|FG000|Overall Study|Lost to Follow-up|2|||
125999624|NCT03415022|453288993|FG001|Overall Study|Lost to Follow-up|0|||
125999625|NCT04466618|453288994|FG000|Overall Study|Withdrawal by Subject|0|||
125999626|NCT04466618|453288995|FG001|Overall Study|Withdrawal by Subject|1|||
125999627|NCT00280293|453289001|FG000|Overall Study|Protocol Violation|3|||
125999628|NCT00280293|453289002|FG001|Overall Study|Protocol Violation|0|||
126336047|NCT00715403|454524922|FG005|Overall Study|Progressive disease|14|||
126336048|NCT00715403|454524923|FG006|Overall Study|Progressive disease|1|||
126336049|NCT00715403|454524917|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336050|NCT00715403|454524918|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336051|NCT00715403|454524919|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336052|NCT00715403|454524920|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336053|NCT00715403|454524921|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336054|NCT00715403|454524922|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
126336055|NCT00715403|454524923|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336056|NCT00715403|454524917|FG000|Overall Study|Other Adverse Event than DLT|1|||
126336057|NCT00715403|454524918|FG001|Overall Study|Other Adverse Event than DLT|0|||
126336058|NCT00715403|454524919|FG002|Overall Study|Other Adverse Event than DLT|0|||
126336059|NCT00715403|454524920|FG003|Overall Study|Other Adverse Event than DLT|0|||
126336060|NCT00715403|454524921|FG004|Overall Study|Other Adverse Event than DLT|0|||
126336061|NCT00715403|454524922|FG005|Overall Study|Other Adverse Event than DLT|2|||
125999629|NCT00280293|453289001|FG000|Overall Study|Physician Decision|5|||
125999630|NCT00280293|453289002|FG001|Overall Study|Physician Decision|4|||
125999631|NCT00280293|453289001|FG000|Overall Study|Lost to Follow-up|14|||
125999632|NCT00280293|453289002|FG001|Overall Study|Lost to Follow-up|12|||
125999633|NCT00280293|453289001|FG000|Overall Study|Withdrawal by Subject|3|||
126336062|NCT00715403|454524923|FG006|Overall Study|Other Adverse Event than DLT|0|||
125999634|NCT00280293|453289002|FG001|Overall Study|Withdrawal by Subject|5|||
125999635|NCT00280293|453289001|FG000|Overall Study|Incarceration/Legal Reasons|1|||
125999636|NCT00280293|453289002|FG001|Overall Study|Incarceration/Legal Reasons|1|||
125999637|NCT00280293|453289001|FG000|Overall Study|Adverse Event|0|||
125999638|NCT00280293|453289002|FG001|Overall Study|Adverse Event|1|||
125999639|NCT01458249|453289007|FG000|Overall Study|Not treated|1|||
125999640|NCT01458249|453289007|FG000|Overall Study|Adverse Event|4|||
125999641|NCT01458249|453289007|FG000|Overall Study|Other|2|||
125999642|NCT01458249|453289007|FG000|Overall Study|Ongoing|1|||
125999643|NCT02056119|453289010|FG000|Overall Study|Death|1|||
125999644|NCT02056119|453289011|FG001|Overall Study|Death|2|||
125999645|NCT02056119|453289010|FG000|Overall Study|Intubated for less than 24 hrs|2|||
125999646|NCT02056119|453289011|FG001|Overall Study|Intubated for less than 24 hrs|7|||
125999647|NCT02056119|453289010|FG000|Overall Study|No aerosol treatments were given.|3|||
125999648|NCT02056119|453289011|FG001|Overall Study|No aerosol treatments were given.|2|||
125999649|NCT02056119|453289010|FG000|Overall Study|Received Metaneb treatment|0|||
125999650|NCT02056119|453289011|FG001|Overall Study|Received Metaneb treatment|2|||
125999651|NCT02056119|453289010|FG000|Overall Study|Protocol Violation|4|||
125999652|NCT02056119|453289011|FG001|Overall Study|Protocol Violation|7|||
125999653|NCT01348854|453289012|FG000|Overall Study|Lost to Follow-up|2|||
125999654|NCT01348854|453289013|FG001|Overall Study|Lost to Follow-up|1|||
125999655|NCT01348854|453289012|FG000|Overall Study|Withdrawal by Subject|1|||
125999656|NCT01348854|453289013|FG001|Overall Study|Withdrawal by Subject|0|||
125999657|NCT03220737|453289014|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
125999658|NCT03220737|453289015|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
125999659|NCT03220737|453289016|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
125999660|NCT03220737|453289017|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
125999661|NCT03220737|453289018|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
125999662|NCT03220737|453289019|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
125999663|NCT03220737|453289020|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
125999664|NCT03220737|453289014|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
125999665|NCT03220737|453289015|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
125999666|NCT03220737|453289016|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
125999667|NCT03220737|453289017|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
125999668|NCT03220737|453289018|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
125999669|NCT03220737|453289019|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
125999670|NCT03220737|453289020|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
125999671|NCT03220737|453289014|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
126336063|NCT00715403|454524917|FG000|Overall Study|Protocol Violation|0|||
126336064|NCT00715403|454524918|FG001|Overall Study|Protocol Violation|0|||
126336065|NCT00715403|454524919|FG002|Overall Study|Protocol Violation|0|||
126336066|NCT00715403|454524920|FG003|Overall Study|Protocol Violation|0|||
126336067|NCT00715403|454524921|FG004|Overall Study|Protocol Violation|0|||
126336068|NCT00715403|454524922|FG005|Overall Study|Protocol Violation|1|||
126336069|NCT00715403|454524923|FG006|Overall Study|Protocol Violation|0|||
126336070|NCT00715403|454524917|FG000|Overall Study|Other reason not defined above|0|||
126336071|NCT00715403|454524918|FG001|Overall Study|Other reason not defined above|0|||
126336072|NCT00715403|454524919|FG002|Overall Study|Other reason not defined above|1|||
126336073|NCT00715403|454524920|FG003|Overall Study|Other reason not defined above|0|||
126336074|NCT00715403|454524921|FG004|Overall Study|Other reason not defined above|1|||
126336075|NCT00715403|454524922|FG005|Overall Study|Other reason not defined above|1|||
126336076|NCT00715403|454524923|FG006|Overall Study|Other reason not defined above|0|||
126336077|NCT03644017|454524924|FG000|Overall Study|Access Abandonment|5|||
126336078|NCT03644017|454524924|FG000|Overall Study|Kidney Transplant|2|||
126336079|NCT02700048|454524925|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
126336080|NCT02700048|454524926|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
126336081|NCT02175225|454524929|FG000|Overall Study|Withdrawal by Subject|1|||
126336082|NCT02175225|454524930|FG001|Overall Study|Withdrawal by Subject|2|||
126336083|NCT02175225|454524929|FG000|Overall Study|Lost to Follow-up|6|||
126336084|NCT02175225|454524930|FG001|Overall Study|Lost to Follow-up|7|||
126336085|NCT02175225|454524929|FG000|Overall Study|Study drug not administered|1|||
126336086|NCT02175225|454524930|FG001|Overall Study|Study drug not administered|2|||
126336087|NCT02340000|454524931|FG000|Time Period 1|Withdrawal by Subject|6|||
126336088|NCT02340000|454524932|FG001|Time Period 1|Withdrawal by Subject|8|||
126336089|NCT02340000|454524931|FG000|Time Period 1|Lost to Follow-up|6|||
126336090|NCT02340000|454524932|FG001|Time Period 1|Lost to Follow-up|7|||
125999672|NCT03220737|453289015|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
125999673|NCT03220737|453289016|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
125999674|NCT03220737|453289017|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
126336091|NCT02340000|454524931|FG000|Time Period 2|Withdrawal by Subject|9|||
126336092|NCT02340000|454524932|FG001|Time Period 2|Withdrawal by Subject|7|||
126336093|NCT02340000|454524931|FG000|Time Period 2|Lost to Follow-up|10|||
125999675|NCT03220737|453289018|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
125999676|NCT03220737|453289019|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
126336094|NCT02340000|454524932|FG001|Time Period 2|Lost to Follow-up|8|||
126336095|NCT01883895|454524933|FG000|Overall Study|Lost to Follow-up|2|||
126336096|NCT02481050|454526800|FG000|Overall Study|Adverse Event|1|||
126336097|NCT02481050|454526800|FG000|Overall Study|Disease Progression|47|||
126336098|NCT02481050|454526800|FG000|Overall Study|Withdrawal by Subject|7|||
126336099|NCT02481050|454526800|FG000|Overall Study|Other|3|||
126336100|NCT01386606|454526801|FG000|Overall Study|Adverse Event|0|||
126336101|NCT01386606|454526802|FG001|Overall Study|Adverse Event|1|||
126336102|NCT01386606|454526803|FG002|Overall Study|Adverse Event|0|||
126336103|NCT01386606|454526804|FG003|Overall Study|Adverse Event|0|||
126336104|NCT01386606|454526801|FG000|Overall Study|Withdrawal by Subject|0|||
125999677|NCT03220737|453289020|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
125999678|NCT03220737|453289014|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125999679|NCT03220737|453289015|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125999680|NCT03220737|453289016|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
125999681|NCT03220737|453289017|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
126336105|NCT01386606|454526802|FG001|Overall Study|Withdrawal by Subject|1|||
126336106|NCT01386606|454526803|FG002|Overall Study|Withdrawal by Subject|1|||
126336107|NCT01386606|454526804|FG003|Overall Study|Withdrawal by Subject|0|||
126336108|NCT01386606|454526801|FG000|Overall Study|Protocol Violation|1|||
126336109|NCT01386606|454526802|FG001|Overall Study|Protocol Violation|0|||
126336110|NCT01386606|454526803|FG002|Overall Study|Protocol Violation|1|||
126336111|NCT01386606|454526804|FG003|Overall Study|Protocol Violation|1|||
126336112|NCT01386606|454526801|FG000|Overall Study|Lost to Follow-up|2|||
126336113|NCT01386606|454526802|FG001|Overall Study|Lost to Follow-up|0|||
126336114|NCT01386606|454526803|FG002|Overall Study|Lost to Follow-up|0|||
126336115|NCT01386606|454526804|FG003|Overall Study|Lost to Follow-up|0|||
126336116|NCT01386606|454526801|FG000|Overall Study|Subject incarcerated|0|||
126336117|NCT01386606|454526802|FG001|Overall Study|Subject incarcerated|1|||
126336118|NCT01386606|454526803|FG002|Overall Study|Subject incarcerated|0|||
126336119|NCT01386606|454526804|FG003|Overall Study|Subject incarcerated|0|||
126336120|NCT01386606|454526801|FG000|Overall Study|Unable to draw PK|1|||
126336121|NCT01386606|454526802|FG001|Overall Study|Unable to draw PK|0|||
126336122|NCT01386606|454526803|FG002|Overall Study|Unable to draw PK|0|||
125999682|NCT03220737|453289018|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125999683|NCT03220737|453289019|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125999684|NCT03220737|453289020|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125999685|NCT03220737|453289014|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125999686|NCT03220737|453289015|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125999687|NCT03220737|453289016|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125999688|NCT03220737|453289017|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125999689|NCT03220737|453289018|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
125999690|NCT03220737|453289019|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125999691|NCT03220737|453289020|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125999692|NCT03220737|453289014|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
125999693|NCT03220737|453289015|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125999694|NCT03220737|453289016|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125999695|NCT03220737|453289017|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125999696|NCT03220737|453289018|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125999697|NCT03220737|453289019|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125999698|NCT03220737|453289020|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125999699|NCT03220737|453289014|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
125999700|NCT03220737|453289015|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125999701|NCT03220737|453289016|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125999702|NCT03220737|453289017|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
126336123|NCT01386606|454526804|FG003|Overall Study|Unable to draw PK|0|||
126336124|NCT01386606|454526801|FG000|Overall Study|T levels too high|0|||
126336125|NCT01386606|454526802|FG001|Overall Study|T levels too high|1|||
126336126|NCT01386606|454526803|FG002|Overall Study|T levels too high|1|||
126336127|NCT01386606|454526804|FG003|Overall Study|T levels too high|0|||
126336128|NCT01022203|454526811|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
126336129|NCT01022203|454526812|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
126336130|NCT01022203|454526811|FG000|Post Treatment Assessment|Physician Decision|2|||
125999703|NCT03220737|453289018|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
126336131|NCT01022203|454526812|FG001|Post Treatment Assessment|Physician Decision|0|||
126336132|NCT01022203|454526811|FG000|Post Treatment Assessment|Adverse Event|0|||
126336133|NCT01022203|454526812|FG001|Post Treatment Assessment|Adverse Event|2|||
126336134|NCT01022203|454526811|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
126336135|NCT01022203|454526812|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
126336136|NCT01094288|454526814|FG000|Overall Study|Adverse Event|0|||
126336137|NCT01094288|454526815|FG001|Overall Study|Adverse Event|3|||
126336138|NCT01094288|454526816|FG002|Overall Study|Adverse Event|1|||
126336139|NCT01094288|454526817|FG003|Overall Study|Adverse Event|1|||
126336140|NCT01094288|454526818|FG004|Overall Study|Adverse Event|0|||
126336141|NCT01094288|454526819|FG005|Overall Study|Adverse Event|0|||
126336142|NCT01094288|454526820|FG006|Overall Study|Adverse Event|0|||
126336143|NCT01094288|454526821|FG007|Overall Study|Adverse Event|0|||
126336144|NCT01094288|454526814|FG000|Overall Study|Withdrawal by Subject|0|||
126336145|NCT01094288|454526815|FG001|Overall Study|Withdrawal by Subject|1|||
126336146|NCT01094288|454526816|FG002|Overall Study|Withdrawal by Subject|2|||
126336147|NCT01094288|454526817|FG003|Overall Study|Withdrawal by Subject|0|||
126336148|NCT01094288|454526818|FG004|Overall Study|Withdrawal by Subject|0|||
126336149|NCT01094288|454526819|FG005|Overall Study|Withdrawal by Subject|0|||
126336150|NCT01094288|454526820|FG006|Overall Study|Withdrawal by Subject|0|||
126336151|NCT01094288|454526821|FG007|Overall Study|Withdrawal by Subject|2|||
126336152|NCT01094288|454526814|FG000|Overall Study|Initiation of Alternative Therapy|0|||
126336153|NCT01094288|454526815|FG001|Overall Study|Initiation of Alternative Therapy|0|||
126336154|NCT01094288|454526816|FG002|Overall Study|Initiation of Alternative Therapy|1|||
126336155|NCT01094288|454526817|FG003|Overall Study|Initiation of Alternative Therapy|0|||
126336156|NCT01094288|454526818|FG004|Overall Study|Initiation of Alternative Therapy|0|||
126336157|NCT01094288|454526819|FG005|Overall Study|Initiation of Alternative Therapy|0|||
126336158|NCT01094288|454526820|FG006|Overall Study|Initiation of Alternative Therapy|0|||
126336159|NCT01094288|454526821|FG007|Overall Study|Initiation of Alternative Therapy|0|||
126336160|NCT01094288|454526814|FG000|Overall Study|Reason not Specified|2|||
126336161|NCT01094288|454526815|FG001|Overall Study|Reason not Specified|3|||
126336162|NCT01094288|454526816|FG002|Overall Study|Reason not Specified|0|||
126336163|NCT01094288|454526817|FG003|Overall Study|Reason not Specified|1|||
126336164|NCT01094288|454526818|FG004|Overall Study|Reason not Specified|0|||
126336165|NCT01094288|454526819|FG005|Overall Study|Reason not Specified|0|||
126336166|NCT01094288|454526820|FG006|Overall Study|Reason not Specified|0|||
126336167|NCT01094288|454526821|FG007|Overall Study|Reason not Specified|0|||
126336168|NCT01094288|454526814|FG000|Overall Study|Ongoing Participants|0|||
126336169|NCT01094288|454526815|FG001|Overall Study|Ongoing Participants|3|||
126336170|NCT01094288|454526816|FG002|Overall Study|Ongoing Participants|0|||
126336171|NCT01094288|454526817|FG003|Overall Study|Ongoing Participants|0|||
126336172|NCT01094288|454526818|FG004|Overall Study|Ongoing Participants|0|||
126336173|NCT01094288|454526819|FG005|Overall Study|Ongoing Participants|0|||
126336174|NCT01094288|454526820|FG006|Overall Study|Ongoing Participants|0|||
126336175|NCT01094288|454526821|FG007|Overall Study|Ongoing Participants|0|||
126336176|NCT02611882|454526822|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
126336177|NCT02611882|454526823|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
126336178|NCT02611882|454526824|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
126336179|NCT01317940|454526825|FG000|Overall Study|Death|1|||
126336180|NCT01317940|454526826|FG001|Overall Study|Death|0|||
126336181|NCT01317940|454526827|FG002|Overall Study|Death|1|||
126336182|NCT01317940|454526828|FG003|Overall Study|Death|0|||
126336183|NCT01317940|454526829|FG004|Overall Study|Death|0|||
126336184|NCT01317940|454526830|FG005|Overall Study|Death|0|||
126336185|NCT01317940|454526825|FG000|Overall Study|Lost to Follow-up|0|||
126336186|NCT01317940|454526826|FG001|Overall Study|Lost to Follow-up|0|||
126336187|NCT01317940|454526827|FG002|Overall Study|Lost to Follow-up|1|||
126336188|NCT01317940|454526828|FG003|Overall Study|Lost to Follow-up|1|||
126336189|NCT01317940|454526829|FG004|Overall Study|Lost to Follow-up|1|||
126336190|NCT01317940|454526830|FG005|Overall Study|Lost to Follow-up|0|||
126336191|NCT01317940|454526825|FG000|Overall Study|Change in therapy plan|0|||
126336192|NCT01317940|454526826|FG001|Overall Study|Change in therapy plan|0|||
126336193|NCT01317940|454526827|FG002|Overall Study|Change in therapy plan|3|||
126336194|NCT01317940|454526828|FG003|Overall Study|Change in therapy plan|0|||
126336195|NCT01317940|454526829|FG004|Overall Study|Change in therapy plan|0|||
125999704|NCT03220737|453289019|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125999705|NCT03220737|453289020|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125999706|NCT03220737|453289014|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
125999707|NCT03220737|453289015|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125999708|NCT03220737|453289016|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125999709|NCT03220737|453289017|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125999710|NCT03220737|453289018|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125999711|NCT03220737|453289019|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125999712|NCT03220737|453289020|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125999713|NCT01720797|453289021|FG000|Overall Study|Withdrawal by Subject|3|||
125999714|NCT01720797|453289022|FG001|Overall Study|Withdrawal by Subject|0|||
125999715|NCT04011384|453289030|FG000|Overall Study|Withdrawal by Subject|2|||
125999716|NCT04011384|453289031|FG001|Overall Study|Withdrawal by Subject|0|||
126336196|NCT01317940|454526830|FG005|Overall Study|Change in therapy plan|0|||
126336197|NCT04152200|454526832|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
126336198|NCT04152200|454526833|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
125999717|NCT00594932|453289032|FG000|First 3 Months|Withdrawal by Subject|1|||
125999718|NCT00594932|453289033|FG001|First 3 Months|Withdrawal by Subject|3|||
125999719|NCT00594932|453289032|FG000|Final 3 Months|Withdrawal by Subject|4|||
125999720|NCT00594932|453289033|FG001|Final 3 Months|Withdrawal by Subject|3|||
125999721|NCT01094171|453289034|FG000|Overall Study|Lost to Follow-up|2|||
125999722|NCT01094171|453289034|FG000|Overall Study|Informed consent withdrawal|4|||
125999723|NCT01094171|453289034|FG000|Overall Study|Migration from the study area|3|||
125999724|NCT01094171|453289034|FG000|Overall Study|Other|1|||
125999725|NCT01676220|453289035|FG000|Overall Study|Randomized But Not Treated|4|||
125999726|NCT01676220|453289036|FG001|Overall Study|Randomized But Not Treated|1|||
125999727|NCT01676220|453289035|FG000|Overall Study|Adverse Event|10|||
125999728|NCT01676220|453289036|FG001|Overall Study|Adverse Event|8|||
125999729|NCT01676220|453289035|FG000|Overall Study|Lack of Efficacy|2|||
125999730|NCT01676220|453289036|FG001|Overall Study|Lack of Efficacy|5|||
125999731|NCT01676220|453289035|FG000|Overall Study|Protocol Violation|11|||
125999732|NCT01676220|453289036|FG001|Overall Study|Protocol Violation|12|||
125999733|NCT01676220|453289035|FG000|Overall Study|Received Rescue Therapy|14|||
125999734|NCT01676220|453289036|FG001|Overall Study|Received Rescue Therapy|22|||
125999735|NCT01676220|453289035|FG000|Overall Study|Personal Reason|34|||
125999736|NCT01676220|453289036|FG001|Overall Study|Personal Reason|45|||
125999737|NCT01676220|453289035|FG000|Overall Study|Lost to Follow-up|11|||
126336199|NCT04980014|454526834|FG000|Overall Study|Participants who are Duplicated|1|||
126336200|NCT04980014|454526834|FG000|Overall Study|Follow-up Failure|13|||
126336201|NCT04980014|454526834|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
126336202|NCT04980014|454526834|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
126336203|NCT04980014|454526834|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
126336204|NCT00593814|454526835|FG000|Overall Study|Death|7|||
126336205|NCT00593814|454526836|FG001|Overall Study|Death|0|||
126336206|NCT00593814|454526835|FG000|Overall Study|Withdrawal by Subject|7|||
126336207|NCT00593814|454526836|FG001|Overall Study|Withdrawal by Subject|0|||
126336208|NCT00593814|454526835|FG000|Overall Study|Lost to Follow-up|7|||
126336209|NCT00593814|454526836|FG001|Overall Study|Lost to Follow-up|0|||
126336210|NCT00593814|454526835|FG000|Overall Study|Physician Decision|3|||
126336211|NCT00593814|454526836|FG001|Overall Study|Physician Decision|0|||
126336212|NCT04069715|454526837|FG000|Overall Study|Lost to Follow-up|1|||
126336213|NCT04069715|454526838|FG001|Overall Study|Lost to Follow-up|1|||
126336214|NCT04069715|454526837|FG000|Overall Study|Physician Decision|1|||
126336215|NCT04069715|454526838|FG001|Overall Study|Physician Decision|1|||
126336216|NCT04069715|454526837|FG000|Overall Study|Withdrawal by Subject|3|||
126336217|NCT04069715|454526838|FG001|Overall Study|Withdrawal by Subject|3|||
126336218|NCT02723188|454526839|FG000|Overall Study|Withdrawal by Subject|1|||
126336219|NCT02723188|454526840|FG001|Overall Study|Withdrawal by Subject|0|||
126336220|NCT02723188|454526841|FG002|Overall Study|Withdrawal by Subject|0|||
126336221|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
126336222|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
126336223|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
126336224|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
126336225|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
126336226|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
126336227|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
126336228|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
126336229|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
126336230|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
126336231|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
126336232|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
126336233|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
126336234|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
126336235|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
126336236|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
126336237|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
126336238|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
126336239|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
126336240|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
125999738|NCT01676220|453289036|FG001|Overall Study|Lost to Follow-up|18|||
125999739|NCT01676220|453289035|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
125999740|NCT01676220|453289036|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
125999741|NCT01676220|453289035|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
125999742|NCT01676220|453289036|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
125999743|NCT01676220|453289035|FG000|Overall Study|Perceived Lack of Efficacy|3|||
126336241|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
126336242|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
126336243|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
126336244|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
126336245|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
126336246|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
126336247|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
126336248|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
126336249|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
126336250|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
126336251|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
126336252|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
126336253|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
126336254|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
126336255|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
126336256|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
126336257|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
126336258|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
126336259|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
126336260|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
126336261|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
126336262|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
126336263|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
126336264|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
126336265|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
126336266|NCT03652818|454526854|FG000|Overall Study|Adverse Event|1|||
126336267|NCT03652818|454526855|FG001|Overall Study|Adverse Event|0|||
126336268|NCT03652818|454526856|FG002|Overall Study|Adverse Event|0|||
126336269|NCT03652818|454526857|FG003|Overall Study|Adverse Event|0|||
126336270|NCT03652818|454526858|FG004|Overall Study|Adverse Event|0|||
126336271|NCT03652818|454526854|FG000|Overall Study|Physician Decision|1|||
126336272|NCT03652818|454526855|FG001|Overall Study|Physician Decision|0|||
126336273|NCT03652818|454526856|FG002|Overall Study|Physician Decision|0|||
126336274|NCT03652818|454526857|FG003|Overall Study|Physician Decision|0|||
126336275|NCT03652818|454526858|FG004|Overall Study|Physician Decision|0|||
126336276|NCT03652818|454526854|FG000|Overall Study|Lost to Follow-up|0|||
126336277|NCT03652818|454526855|FG001|Overall Study|Lost to Follow-up|1|||
126336278|NCT03652818|454526856|FG002|Overall Study|Lost to Follow-up|2|||
126336279|NCT03652818|454526857|FG003|Overall Study|Lost to Follow-up|1|||
126336280|NCT03652818|454526858|FG004|Overall Study|Lost to Follow-up|1|||
126336281|NCT01241279|454526859|FG000|Overall Study|Lost to Follow-up|0|||
126336282|NCT01241279|454526860|FG001|Overall Study|Lost to Follow-up|1|||
126336283|NCT00301834|454526863|FG000|Overall Study|Death|1|||
126336284|NCT01811732|454526864|FG000|Overall Study|Lost to Follow-up|24|||
126336285|NCT01811732|454526865|FG001|Overall Study|Lost to Follow-up|30|||
126336286|NCT01811732|454526864|FG000|Overall Study|Withdrawal by Subject|16|||
126336287|NCT01811732|454526865|FG001|Overall Study|Withdrawal by Subject|10|||
126336288|NCT01811732|454526864|FG000|Overall Study|Adverse Event|3|||
126336289|NCT01811732|454526865|FG001|Overall Study|Adverse Event|9|||
126336290|NCT01811732|454526864|FG000|Overall Study|Lack of Efficacy|3|||
126336291|NCT01811732|454526865|FG001|Overall Study|Lack of Efficacy|1|||
126336292|NCT01811732|454526864|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
126336293|NCT01811732|454526865|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
126336294|NCT01811732|454526864|FG000|Overall Study|Physician Decision|2|||
126336295|NCT01811732|454526865|FG001|Overall Study|Physician Decision|0|||
126336296|NCT01811732|454526864|FG000|Overall Study|Death|1|||
126336297|NCT01811732|454526865|FG001|Overall Study|Death|1|||
126336298|NCT01811732|454526864|FG000|Overall Study|Insufficient venous access|0|||
126336299|NCT01811732|454526865|FG001|Overall Study|Insufficient venous access|1|||
126336300|NCT01811732|454526864|FG000|Overall Study|Protocol Violation|0|||
126336301|NCT01811732|454526865|FG001|Overall Study|Protocol Violation|1|||
126336302|NCT01811732|454526864|FG000|Overall Study|Subject incarcerated|1|||
126336303|NCT01811732|454526865|FG001|Overall Study|Subject incarcerated|2|||
126336304|NCT01811732|454526864|FG000|Overall Study|Admitted to another facility|1|||
126336305|NCT01811732|454526865|FG001|Overall Study|Admitted to another facility|0|||
126336306|NCT01811732|454526864|FG000|Overall Study|Correct study drug not available on site|1|||
126336307|NCT01811732|454526865|FG001|Overall Study|Correct study drug not available on site|0|||
126336308|NCT01607593|454526866|FG000|Overall Study|Adverse Event|15|||
126336309|NCT01607593|454526866|FG000|Overall Study|Lack of Efficacy|16|||
126336310|NCT01607593|454526866|FG000|Overall Study|Lost to Follow-up|25|||
126336311|NCT01607593|454526866|FG000|Overall Study|Continuation|33|||
126336312|NCT01607593|454526866|FG000|Overall Study|Other|4|||
126336313|NCT01867008|454526867|FG000|Overall Study|Withdrawal by Subject|1|||
126336314|NCT01534273|454526868|FG000|Period 1|Physician Decision|0|||
126336315|NCT01534273|454526869|FG001|Period 1|Physician Decision|0|||
126336316|NCT01534273|454526870|FG002|Period 1|Physician Decision|0|||
126336317|NCT01534273|454526871|FG003|Period 1|Physician Decision|1|||
126336318|NCT01534273|454526872|FG004|Period 1|Physician Decision|0|||
126336319|NCT01534273|454526873|FG005|Period 1|Physician Decision|0|||
125999744|NCT01676220|453289036|FG001|Overall Study|Perceived Lack of Efficacy|1|||
125999745|NCT01676220|453289035|FG000|Overall Study|Non Serious Hypoglycemia|2|||
125999746|NCT01676220|453289036|FG001|Overall Study|Non Serious Hypoglycemia|0|||
125999747|NCT01676220|453289035|FG000|Overall Study|No More Need of Insulin|1|||
125999748|NCT01676220|453289036|FG001|Overall Study|No More Need of Insulin|0|||
125999749|NCT04496167|453289037|FG000|Overall Study|Adverse Event|6|||
126336320|NCT01534273|454526874|FG006|Period 1|Physician Decision|0|||
126336321|NCT03586050|454526875|FG000|Overall Study|Death|3|||
126336322|NCT03586050|454526875|FG000|Overall Study|Withdrawal by Subject|2|||
126336323|NCT01211145|454526876|FG000|Overall Study|Reason not specified|3|||
126336324|NCT01211145|454526877|FG001|Overall Study|Reason not specified|2|||
126336325|NCT01211145|454526878|FG002|Overall Study|Reason not specified|2|||
126336326|NCT01211145|454526879|FG003|Overall Study|Reason not specified|1|||
126336327|NCT01211145|454526876|FG000|Overall Study|Lost to Follow-up|3|||
126336328|NCT01211145|454526877|FG001|Overall Study|Lost to Follow-up|2|||
126336329|NCT01211145|454526878|FG002|Overall Study|Lost to Follow-up|1|||
126336330|NCT01211145|454526879|FG003|Overall Study|Lost to Follow-up|2|||
126336331|NCT01211145|454526876|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126336332|NCT01211145|454526877|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126336333|NCT01211145|454526878|FG002|Overall Study|Study-specific withdrawal criteria|0|||
126336334|NCT01211145|454526879|FG003|Overall Study|Study-specific withdrawal criteria|0|||
126336335|NCT01211145|454526876|FG000|Overall Study|Severe noncompliance to protocol|1|||
126336336|NCT01211145|454526877|FG001|Overall Study|Severe noncompliance to protocol|0|||
126336337|NCT01211145|454526878|FG002|Overall Study|Severe noncompliance to protocol|0|||
126336338|NCT01211145|454526879|FG003|Overall Study|Severe noncompliance to protocol|0|||
126336339|NCT01211145|454526876|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
126336340|NCT01211145|454526877|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
126336341|NCT01211145|454526878|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
126336342|NCT01211145|454526879|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
126336343|NCT01211145|454526876|FG000|Overall Study|Patient decision|2|||
126336344|NCT01211145|454526877|FG001|Overall Study|Patient decision|1|||
126336345|NCT01211145|454526878|FG002|Overall Study|Patient decision|0|||
126336346|NCT01211145|454526879|FG003|Overall Study|Patient decision|2|||
126336347|NCT00570401|454526880|FG000|Overall Study|Adverse Event|2|||
126336348|NCT04202497|454526881|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
126336349|NCT04202497|454526882|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
126336350|NCT04202497|454526883|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
126336351|NCT04202497|454526884|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
126336352|NCT02115607|454526885|FG000|Overall Study|Withdrawal by Subject|1|||
126336353|NCT00069264|454526886|FG000|Overall Study|Adverse Event|3|||
126336354|NCT00069264|454526886|FG000|Overall Study|Progressive Disease|23|||
126336355|NCT00069264|454526886|FG000|Overall Study|Withdrawal by Subject|3|||
126336356|NCT00069264|454526886|FG000|Overall Study|Discon Therapy|3|||
126336357|NCT05616013|454526887|FG000|Overall Study|Adverse Event|6|||
126336358|NCT05616013|454526888|FG001|Overall Study|Adverse Event|12|||
126336359|NCT05616013|454526889|FG002|Overall Study|Adverse Event|8|||
126336360|NCT05616013|454526890|FG003|Overall Study|Adverse Event|4|||
126336361|NCT05616013|454526891|FG004|Overall Study|Adverse Event|6|||
126336362|NCT05616013|454526892|FG005|Overall Study|Adverse Event|8|||
126336363|NCT05616013|454526893|FG006|Overall Study|Adverse Event|3|||
126336364|NCT05616013|454526894|FG007|Overall Study|Adverse Event|6|||
126336365|NCT05616013|454526895|FG008|Overall Study|Adverse Event|1|||
126336366|NCT05616013|454526887|FG000|Overall Study|Lost to Follow-up|5|||
126336367|NCT05616013|454526888|FG001|Overall Study|Lost to Follow-up|4|||
126336368|NCT05616013|454526889|FG002|Overall Study|Lost to Follow-up|3|||
126336369|NCT05616013|454526890|FG003|Overall Study|Lost to Follow-up|2|||
126336370|NCT05616013|454526891|FG004|Overall Study|Lost to Follow-up|0|||
126336371|NCT05616013|454526892|FG005|Overall Study|Lost to Follow-up|5|||
126336372|NCT05616013|454526893|FG006|Overall Study|Lost to Follow-up|2|||
126336373|NCT05616013|454526894|FG007|Overall Study|Lost to Follow-up|1|||
126336374|NCT05616013|454526895|FG008|Overall Study|Lost to Follow-up|2|||
126336375|NCT05616013|454526887|FG000|Overall Study|Non-compliance with study requirements|2|||
126336376|NCT05616013|454526888|FG001|Overall Study|Non-compliance with study requirements|2|||
126336377|NCT05616013|454526889|FG002|Overall Study|Non-compliance with study requirements|2|||
126336378|NCT05616013|454526890|FG003|Overall Study|Non-compliance with study requirements|3|||
126336379|NCT05616013|454526891|FG004|Overall Study|Non-compliance with study requirements|0|||
126336380|NCT05616013|454526892|FG005|Overall Study|Non-compliance with study requirements|2|||
126336381|NCT05616013|454526893|FG006|Overall Study|Non-compliance with study requirements|1|||
126336382|NCT05616013|454526894|FG007|Overall Study|Non-compliance with study requirements|1|||
126336383|NCT05616013|454526895|FG008|Overall Study|Non-compliance with study requirements|4|||
126336384|NCT05616013|454526887|FG000|Overall Study|Withdrawal by Subject|11|||
126336385|NCT05616013|454526888|FG001|Overall Study|Withdrawal by Subject|9|||
126336386|NCT05616013|454526889|FG002|Overall Study|Withdrawal by Subject|8|||
125999750|NCT04496167|453289038|FG001|Overall Study|Adverse Event|2|||
126336387|NCT05616013|454526890|FG003|Overall Study|Withdrawal by Subject|6|||
126336388|NCT05616013|454526891|FG004|Overall Study|Withdrawal by Subject|3|||
126336389|NCT05616013|454526892|FG005|Overall Study|Withdrawal by Subject|4|||
126336390|NCT05616013|454526893|FG006|Overall Study|Withdrawal by Subject|6|||
126336391|NCT05616013|454526894|FG007|Overall Study|Withdrawal by Subject|5|||
126336392|NCT05616013|454526895|FG008|Overall Study|Withdrawal by Subject|4|||
126336393|NCT05616013|454526887|FG000|Overall Study|Physician Decision|0|||
126336394|NCT05616013|454526888|FG001|Overall Study|Physician Decision|0|||
126336395|NCT05616013|454526889|FG002|Overall Study|Physician Decision|1|||
126336396|NCT05616013|454526890|FG003|Overall Study|Physician Decision|0|||
126336397|NCT05616013|454526891|FG004|Overall Study|Physician Decision|0|||
126336398|NCT05616013|454526892|FG005|Overall Study|Physician Decision|1|||
126336399|NCT05616013|454526893|FG006|Overall Study|Physician Decision|3|||
126336400|NCT05616013|454526894|FG007|Overall Study|Physician Decision|0|||
126336401|NCT05616013|454526895|FG008|Overall Study|Physician Decision|0|||
126336402|NCT05616013|454526887|FG000|Overall Study|Protocol Violation|0|||
126336403|NCT05616013|454526888|FG001|Overall Study|Protocol Violation|0|||
126336404|NCT05616013|454526889|FG002|Overall Study|Protocol Violation|0|||
126336405|NCT05616013|454526890|FG003|Overall Study|Protocol Violation|0|||
126336406|NCT05616013|454526891|FG004|Overall Study|Protocol Violation|0|||
126336407|NCT05616013|454526892|FG005|Overall Study|Protocol Violation|0|||
126336408|NCT05616013|454526893|FG006|Overall Study|Protocol Violation|1|||
126336409|NCT05616013|454526894|FG007|Overall Study|Protocol Violation|0|||
126336410|NCT05616013|454526895|FG008|Overall Study|Protocol Violation|2|||
126336411|NCT05616013|454526887|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
126336412|NCT05616013|454526888|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336413|NCT05616013|454526889|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336414|NCT05616013|454526890|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336415|NCT05616013|454526891|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336416|NCT05616013|454526892|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336417|NCT05616013|454526893|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336418|NCT05616013|454526894|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336419|NCT05616013|454526895|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336420|NCT05616013|454526887|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
126336421|NCT05616013|454526888|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336422|NCT05616013|454526889|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336423|NCT05616013|454526890|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336424|NCT05616013|454526891|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336425|NCT05616013|454526892|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336426|NCT05616013|454526893|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336427|NCT05616013|454526894|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336428|NCT05616013|454526895|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336429|NCT05616013|454526887|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
126336430|NCT05616013|454526888|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336431|NCT05616013|454526889|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336432|NCT05616013|454526890|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336433|NCT05616013|454526891|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336434|NCT05616013|454526892|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336435|NCT05616013|454526893|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336436|NCT05616013|454526894|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336437|NCT05616013|454526895|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125999751|NCT04496167|453289037|FG000|Overall Study|Withdrawal by Subject|7|||
125999752|NCT04496167|453289038|FG001|Overall Study|Withdrawal by Subject|6|||
126336438|NCT05616013|454526887|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336439|NCT05616013|454526888|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
126336440|NCT05616013|454526889|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125999753|NCT04496167|453289037|FG000|Overall Study|Lost to Follow-up|3|||
125999754|NCT04496167|453289038|FG001|Overall Study|Lost to Follow-up|5|||
125999755|NCT04496167|453289037|FG000|Overall Study|Not Treated|1|||
125999756|NCT04496167|453289038|FG001|Overall Study|Not Treated|2|||
125999757|NCT04496167|453289037|FG000|Overall Study|Other Than Specified|1|||
126336441|NCT05616013|454526890|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336442|NCT05616013|454526891|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125999758|NCT04496167|453289038|FG001|Overall Study|Other Than Specified|1|||
126336443|NCT05616013|454526892|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336444|NCT05616013|454526893|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336445|NCT05616013|454526894|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125999759|NCT02269943|453289039|FG000|Treatment Period|Death|0|||
126336446|NCT05616013|454526895|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336447|NCT05616013|454526887|FG000|Overall Study|Participant Decision, Time Constraints|0|||
126336448|NCT05616013|454526888|FG001|Overall Study|Participant Decision, Time Constraints|1|||
126336449|NCT05616013|454526889|FG002|Overall Study|Participant Decision, Time Constraints|0|||
126336450|NCT05616013|454526890|FG003|Overall Study|Participant Decision, Time Constraints|0|||
126336451|NCT05616013|454526891|FG004|Overall Study|Participant Decision, Time Constraints|0|||
126336452|NCT05616013|454526892|FG005|Overall Study|Participant Decision, Time Constraints|0|||
126336453|NCT05616013|454526893|FG006|Overall Study|Participant Decision, Time Constraints|0|||
126336454|NCT05616013|454526894|FG007|Overall Study|Participant Decision, Time Constraints|0|||
126336455|NCT05616013|454526895|FG008|Overall Study|Participant Decision, Time Constraints|0|||
126336456|NCT05616013|454526887|FG000|Overall Study|Prohibited Concomitant Medication|0|||
126336457|NCT05616013|454526888|FG001|Overall Study|Prohibited Concomitant Medication|0|||
126336458|NCT05616013|454526889|FG002|Overall Study|Prohibited Concomitant Medication|1|||
126336459|NCT05616013|454526890|FG003|Overall Study|Prohibited Concomitant Medication|0|||
126336460|NCT05616013|454526891|FG004|Overall Study|Prohibited Concomitant Medication|0|||
126336461|NCT05616013|454526892|FG005|Overall Study|Prohibited Concomitant Medication|0|||
126336462|NCT05616013|454526893|FG006|Overall Study|Prohibited Concomitant Medication|0|||
126336463|NCT05616013|454526894|FG007|Overall Study|Prohibited Concomitant Medication|0|||
126336464|NCT05616013|454526895|FG008|Overall Study|Prohibited Concomitant Medication|0|||
126336465|NCT05616013|454526887|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336466|NCT05616013|454526888|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336467|NCT05616013|454526889|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
126336468|NCT05616013|454526890|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336469|NCT05616013|454526891|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336470|NCT05616013|454526892|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336471|NCT05616013|454526893|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336472|NCT05616013|454526894|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336473|NCT05616013|454526895|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336474|NCT05616013|454526887|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336475|NCT05616013|454526888|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336476|NCT05616013|454526889|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336477|NCT05616013|454526890|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
126336478|NCT05616013|454526891|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336479|NCT05616013|454526892|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336480|NCT05616013|454526893|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336481|NCT05616013|454526894|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336482|NCT05616013|454526895|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336483|NCT05616013|454526887|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336484|NCT05616013|454526888|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336485|NCT05616013|454526889|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336486|NCT05616013|454526890|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336487|NCT05616013|454526891|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336488|NCT05616013|454526892|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336489|NCT05616013|454526893|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
126336490|NCT05616013|454526894|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336491|NCT05616013|454526895|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336492|NCT05616013|454526887|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336493|NCT05616013|454526888|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336494|NCT05616013|454526889|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336495|NCT05616013|454526890|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336496|NCT05616013|454526891|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336497|NCT05616013|454526892|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336498|NCT05616013|454526893|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336499|NCT05616013|454526894|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336500|NCT05616013|454526895|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
126336501|NCT05616013|454526887|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336502|NCT05616013|454526888|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336503|NCT05616013|454526889|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336504|NCT05616013|454526890|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
125999760|NCT02269943|453289040|FG001|Treatment Period|Death|1|||
125999761|NCT02269943|453289039|FG000|Treatment Period|Adverse Event|1|||
125999762|NCT02269943|453289040|FG001|Treatment Period|Adverse Event|10|||
125999763|NCT02269943|453289039|FG000|Treatment Period|Progressive Disease|5|||
125999764|NCT02269943|453289040|FG001|Treatment Period|Progressive Disease|17|||
125999765|NCT02269943|453289039|FG000|Treatment Period|Symptomatic Deterioration|0|||
125999766|NCT02269943|453289040|FG001|Treatment Period|Symptomatic Deterioration|2|||
125999767|NCT02269943|453289039|FG000|Follow-Up Survival Period|Death|3|||
125999768|NCT02269943|453289040|FG001|Follow-Up Survival Period|Death|16|||
125999769|NCT02269943|453289039|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
125999770|NCT02269943|453289040|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
125999771|NCT02269943|453289039|FG000|Follow-Up Survival Period|Alive|2|||
125999772|NCT02269943|453289040|FG001|Follow-Up Survival Period|Alive|8|||
125999773|NCT03541642|453289041|FG000|Overall Study|Withdrawal by Subject|1|||
125999774|NCT03541642|453289042|FG001|Overall Study|Withdrawal by Subject|2|||
125999775|NCT03541642|453289041|FG000|Overall Study|Lost to Follow-up|16|||
125999776|NCT03541642|453289042|FG001|Overall Study|Lost to Follow-up|12|||
125999777|NCT03541642|453289041|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
125999778|NCT03541642|453289042|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
126336505|NCT05616013|454526891|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336506|NCT05616013|454526892|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336507|NCT05616013|454526893|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336508|NCT05616013|454526894|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336509|NCT05616013|454526895|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
126336510|NCT05116202|454526896|FG000|Overall Study|Study Terminated by Sponsor|21|||
126336511|NCT05116202|454526897|FG001|Overall Study|Study Terminated by Sponsor|38|||
126336512|NCT05116202|454526898|FG002|Overall Study|Study Terminated by Sponsor|17|||
126336513|NCT05116202|454526899|FG003|Overall Study|Study Terminated by Sponsor|18|||
126336514|NCT05116202|454526900|FG004|Overall Study|Study Terminated by Sponsor|0|||
126336515|NCT05116202|454526896|FG000|Overall Study|Withdrawal by Subject|0|||
126336516|NCT05116202|454526897|FG001|Overall Study|Withdrawal by Subject|1|||
126336517|NCT05116202|454526898|FG002|Overall Study|Withdrawal by Subject|1|||
126336518|NCT05116202|454526899|FG003|Overall Study|Withdrawal by Subject|1|||
126336519|NCT05116202|454526900|FG004|Overall Study|Withdrawal by Subject|1|||
126336520|NCT05116202|454526896|FG000|Overall Study|Lost to Follow-up|0|||
126336521|NCT05116202|454526897|FG001|Overall Study|Lost to Follow-up|0|||
126336522|NCT05116202|454526898|FG002|Overall Study|Lost to Follow-up|0|||
126336523|NCT05116202|454526899|FG003|Overall Study|Lost to Follow-up|0|||
126336524|NCT05116202|454526900|FG004|Overall Study|Lost to Follow-up|2|||
126336525|NCT05116202|454526896|FG000|Overall Study|Death|1|||
126336526|NCT05116202|454526897|FG001|Overall Study|Death|1|||
126336527|NCT05116202|454526898|FG002|Overall Study|Death|2|||
126336528|NCT05116202|454526899|FG003|Overall Study|Death|1|||
126336529|NCT05116202|454526900|FG004|Overall Study|Death|5|||
126336530|NCT02668640|454526913|FG000|Overall Study|Lost to Follow-up|13|||
126336531|NCT02668640|454526913|FG000|Overall Study|Other, not specified|1|||
126336532|NCT03669588|454526914|FG000|Overall Study|Adverse Event|1|||
126336533|NCT03669588|454526915|FG001|Overall Study|Adverse Event|0|||
126336534|NCT03669588|454526914|FG000|Overall Study|Physician Decision|0|||
126336535|NCT03669588|454526915|FG001|Overall Study|Physician Decision|1|||
126336536|NCT03669588|454526914|FG000|Overall Study|Protocol Violation|1|||
126336537|NCT03669588|454526915|FG001|Overall Study|Protocol Violation|0|||
126336538|NCT03669588|454526914|FG000|Overall Study|Sponsor Decision|1|||
126336539|NCT03669588|454526915|FG001|Overall Study|Sponsor Decision|1|||
126336540|NCT03669588|454526914|FG000|Overall Study|Withdrawal by Subject|1|||
126336541|NCT03669588|454526915|FG001|Overall Study|Withdrawal by Subject|4|||
126336542|NCT03669588|454526914|FG000|Overall Study|Rescue Therapy Needed|0|||
126336543|NCT03669588|454526915|FG001|Overall Study|Rescue Therapy Needed|1|||
126336544|NCT00369343|454526917|FG000|Double-blind Phase|Adverse Event|19|||
126336545|NCT00369343|454526918|FG001|Double-blind Phase|Adverse Event|4|||
126336546|NCT00369343|454526917|FG000|Double-blind Phase|Failed to return|2|||
126336547|NCT00369343|454526918|FG001|Double-blind Phase|Failed to return|0|||
126336548|NCT00369343|454526917|FG000|Double-blind Phase|Lost to Follow-up|9|||
125999779|NCT01083160|453289047|FG000|Overall Study|Adverse Event|1|||
125999780|NCT01951092|453289050|FG000|Overall Study|Lost to Follow-up|10|||
126336549|NCT00369343|454526918|FG001|Double-blind Phase|Lost to Follow-up|2|||
126336550|NCT00369343|454526917|FG000|Double-blind Phase|Protocol Violation|2|||
126336551|NCT00369343|454526918|FG001|Double-blind Phase|Protocol Violation|0|||
126336552|NCT00369343|454526917|FG000|Double-blind Phase|Withdrawal by Subject|8|||
126336553|NCT00369343|454526918|FG001|Double-blind Phase|Withdrawal by Subject|6|||
126336554|NCT00369343|454526917|FG000|Double-blind Phase|Lack of Efficacy|0|||
126336555|NCT00369343|454526918|FG001|Double-blind Phase|Lack of Efficacy|4|||
126336556|NCT00369343|454526917|FG000|Double-blind Phase|Protocol deviation|4|||
126336557|NCT00369343|454526918|FG001|Double-blind Phase|Protocol deviation|0|||
126336558|NCT00369343|454526917|FG000|Open-label Phase|Adverse Event|19|||
126336559|NCT00369343|454526918|FG001|Open-label Phase|Adverse Event|7|||
126336560|NCT00369343|454526917|FG000|Open-label Phase|Failed to return|4|||
126336561|NCT00369343|454526918|FG001|Open-label Phase|Failed to return|0|||
126336562|NCT00369343|454526917|FG000|Open-label Phase|Physician Decision|2|||
126336563|NCT00369343|454526918|FG001|Open-label Phase|Physician Decision|0|||
126336564|NCT00369343|454526917|FG000|Open-label Phase|Lost to Follow-up|5|||
126336565|NCT00369343|454526918|FG001|Open-label Phase|Lost to Follow-up|3|||
126336566|NCT00369343|454526917|FG000|Open-label Phase|inadvertently reported study completers|3|||
126336567|NCT00369343|454526918|FG001|Open-label Phase|inadvertently reported study completers|2|||
126336568|NCT00369343|454526917|FG000|Open-label Phase|Protocol Violation|1|||
126336569|NCT00369343|454526918|FG001|Open-label Phase|Protocol Violation|3|||
126336570|NCT00369343|454526917|FG000|Open-label Phase|Withdrawal by Subject|15|||
126336571|NCT00369343|454526918|FG001|Open-label Phase|Withdrawal by Subject|6|||
126336572|NCT00369343|454526917|FG000|Open-label Phase|Lack of Efficacy|4|||
126336573|NCT00369343|454526918|FG001|Open-label Phase|Lack of Efficacy|3|||
126336574|NCT00369343|454526917|FG000|Open-label Phase|Lack of continuance tolerability|3|||
126336575|NCT00369343|454526918|FG001|Open-label Phase|Lack of continuance tolerability|4|||
126336576|NCT00369343|454526917|FG000|Open-label Phase|did not take study drug|1|||
126336577|NCT00369343|454526918|FG001|Open-label Phase|did not take study drug|2|||
126336578|NCT01100502|454526919|FG000|Overall Study|Withdrawal by Subject|18|||
126336579|NCT01100502|454526920|FG001|Overall Study|Withdrawal by Subject|25|||
126336580|NCT01100502|454526919|FG000|Overall Study|Lost to Follow-up|13|||
126336581|NCT01100502|454526920|FG001|Overall Study|Lost to Follow-up|28|||
126336582|NCT01100502|454526919|FG000|Overall Study|Site request to end participation in study|0|||
126336583|NCT01100502|454526920|FG001|Overall Study|Site request to end participation in study|1|||
126336584|NCT01100502|454526919|FG000|Overall Study|Death|45|||
126336585|NCT01100502|454526920|FG001|Overall Study|Death|40|||
126336586|NCT02322749|454526921|FG000|Period 2|Adverse Event|0|||
126336587|NCT02322749|454526922|FG001|Period 2|Adverse Event|0|||
126336588|NCT02322749|454526923|FG002|Period 2|Adverse Event|0|||
126336589|NCT02322749|454526924|FG003|Period 2|Adverse Event|1|||
126336590|NCT02322749|454526925|FG004|Period 2|Adverse Event|0|||
126336591|NCT02322749|454526926|FG005|Period 2|Adverse Event|0|||
126336592|NCT02322749|454526921|FG000|Period 2|Withdrawal by Subject|0|||
126336593|NCT02322749|454526922|FG001|Period 2|Withdrawal by Subject|0|||
126336594|NCT02322749|454526923|FG002|Period 2|Withdrawal by Subject|0|||
126336595|NCT02322749|454526924|FG003|Period 2|Withdrawal by Subject|1|||
126336596|NCT02322749|454526925|FG004|Period 2|Withdrawal by Subject|0|||
126336597|NCT02322749|454526926|FG005|Period 2|Withdrawal by Subject|0|||
126336598|NCT02322749|454526921|FG000|Period 3|Withdrawal by Subject|0|||
126336599|NCT02322749|454526922|FG001|Period 3|Withdrawal by Subject|0|||
126336600|NCT02322749|454526923|FG002|Period 3|Withdrawal by Subject|1|||
126336601|NCT02322749|454526924|FG003|Period 3|Withdrawal by Subject|0|||
126336602|NCT02322749|454526925|FG004|Period 3|Withdrawal by Subject|0|||
125999781|NCT01951092|453289050|FG000|Overall Study|Incarceration|1|||
125999782|NCT01951092|453289050|FG000|Overall Study|Transfer of Care|1|||
125999783|NCT00918749|453289051|FG000|Overall Study|Adverse Event|1|||
125999784|NCT00918749|453289052|FG001|Overall Study|Adverse Event|0|||
125999785|NCT00918749|453289053|FG002|Overall Study|Adverse Event|1|||
125999786|NCT00918749|453289051|FG000|Overall Study|Lost to Follow-up|0|||
125999787|NCT00918749|453289052|FG001|Overall Study|Lost to Follow-up|0|||
125999788|NCT00918749|453289053|FG002|Overall Study|Lost to Follow-up|1|||
125999789|NCT00918749|453289051|FG000|Overall Study|Withdrawal by Subject|5|||
125999790|NCT00918749|453289052|FG001|Overall Study|Withdrawal by Subject|3|||
125999791|NCT00918749|453289053|FG002|Overall Study|Withdrawal by Subject|5|||
125999792|NCT00918749|453289051|FG000|Overall Study|No Study Medication Taken|1|||
125999793|NCT00918749|453289052|FG001|Overall Study|No Study Medication Taken|0|||
125999794|NCT00918749|453289053|FG002|Overall Study|No Study Medication Taken|0|||
125999795|NCT01712789|453289054|FG000|Overall Study|Lack of Efficacy|2|||
125999796|NCT01712789|453289054|FG000|Overall Study|Lost to Follow-up|1|||
125999797|NCT01712789|453289054|FG000|Overall Study|Progressive Disease|504|||
125999798|NCT01712789|453289054|FG000|Overall Study|Death|57|||
125999799|NCT01712789|453289054|FG000|Overall Study|Adverse Event|52|||
125999800|NCT01712789|453289054|FG000|Overall Study|Miscellaneous|31|||
125999801|NCT01712789|453289054|FG000|Overall Study|Withdrawal by Subject|21|||
125999802|NCT01712789|453289054|FG000|Overall Study|Transition to Commercial Treatment|8|||
126336603|NCT02322749|454526926|FG005|Period 3|Withdrawal by Subject|0|||
126336604|NCT00073918|454526931|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
126336605|NCT00073918|454526931|FG000|Overall Study|Rapid disease progression|2|||
126336606|NCT00073918|454526931|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
126336607|NCT01190813|454526932|FG000|Overall Study|Lost to Follow-up|1|||
125999803|NCT01712789|453289054|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
125999804|NCT00873093|453289055|FG000|Overall Study|Adverse Event|0|||
125999805|NCT00873093|453289056|FG001|Overall Study|Adverse Event|2|||
125999806|NCT00873093|453289057|FG002|Overall Study|Adverse Event|0|||
126336608|NCT01190813|454526933|FG001|Overall Study|Lost to Follow-up|2|||
126336609|NCT01190813|454526932|FG000|Overall Study|Withdrawal by Subject|2|||
126336610|NCT01190813|454526933|FG001|Overall Study|Withdrawal by Subject|1|||
126336611|NCT01190813|454526932|FG000|Overall Study|Refused study treatment after randomized|1|||
126336612|NCT01190813|454526933|FG001|Overall Study|Refused study treatment after randomized|0|||
126336613|NCT01190813|454526932|FG000|Overall Study|Adverse Event|0|||
126336614|NCT01190813|454526933|FG001|Overall Study|Adverse Event|1|||
126336615|NCT05158140|454526940|FG000|Overall Study|Death|0|||
126336616|NCT05158140|454526941|FG001|Overall Study|Death|0|||
126336617|NCT05158140|454526942|FG002|Overall Study|Death|0|||
126336618|NCT05158140|454526943|FG003|Overall Study|Death|1|||
126336619|NCT05158140|454526940|FG000|Overall Study|Lost to Follow-up|3|||
126336620|NCT05158140|454526941|FG001|Overall Study|Lost to Follow-up|6|||
126336621|NCT05158140|454526942|FG002|Overall Study|Lost to Follow-up|4|||
126336622|NCT05158140|454526943|FG003|Overall Study|Lost to Follow-up|3|||
126336623|NCT05158140|454526940|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126336624|NCT05158140|454526941|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126336625|NCT05158140|454526942|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
126336626|NCT05158140|454526943|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126336627|NCT05158140|454526940|FG000|Overall Study|Withdrawal by Subject|3|||
126336628|NCT05158140|454526941|FG001|Overall Study|Withdrawal by Subject|7|||
126336629|NCT05158140|454526942|FG002|Overall Study|Withdrawal by Subject|3|||
126336630|NCT05158140|454526943|FG003|Overall Study|Withdrawal by Subject|7|||
126336631|NCT04414787|454526948|FG000|Overall Study|Patient Death|18|||
126336632|NCT04414787|454526949|FG001|Overall Study|Patient Death|18|||
126336633|NCT04414787|454526950|FG002|Overall Study|Patient Death|15|||
126336634|NCT04414787|454526951|FG003|Overall Study|Patient Death|15|||
126336635|NCT04414787|454526948|FG000|Overall Study|Patient Hospitalization|1|||
126336636|NCT04414787|454526949|FG001|Overall Study|Patient Hospitalization|1|||
126336637|NCT04414787|454526950|FG002|Overall Study|Patient Hospitalization|2|||
126336638|NCT04414787|454526951|FG003|Overall Study|Patient Hospitalization|2|||
126336639|NCT04414787|454526948|FG000|Overall Study|Lost to Follow-up|7|||
126336640|NCT04414787|454526949|FG001|Overall Study|Lost to Follow-up|7|||
126336641|NCT04414787|454526950|FG002|Overall Study|Lost to Follow-up|5|||
126336642|NCT04414787|454526951|FG003|Overall Study|Lost to Follow-up|5|||
126336643|NCT04414787|454526948|FG000|Overall Study|Residence in post-acute care facility|3|||
126336644|NCT04414787|454526949|FG001|Overall Study|Residence in post-acute care facility|3|||
126336645|NCT04414787|454526950|FG002|Overall Study|Residence in post-acute care facility|5|||
126336646|NCT04414787|454526951|FG003|Overall Study|Residence in post-acute care facility|5|||
126336647|NCT00807365|454526952|FG000|Overall Study|Study Terminated|5|||
126336648|NCT00919633|454526953|FG000|Overall Study|Adverse Event|1|||
126336649|NCT00919633|454526954|FG001|Overall Study|Adverse Event|9|||
126336650|NCT00919633|454526955|FG002|Overall Study|Adverse Event|12|||
126336651|NCT00919633|454526956|FG003|Overall Study|Adverse Event|10|||
126336652|NCT00919633|454526953|FG000|Overall Study|Death|0|||
126336653|NCT00919633|454526954|FG001|Overall Study|Death|0|||
126336654|NCT00919633|454526955|FG002|Overall Study|Death|2|||
126336655|NCT00919633|454526956|FG003|Overall Study|Death|0|||
126336656|NCT00919633|454526953|FG000|Overall Study|Lack of Efficacy|17|||
126336657|NCT00919633|454526954|FG001|Overall Study|Lack of Efficacy|3|||
126336658|NCT00919633|454526955|FG002|Overall Study|Lack of Efficacy|2|||
126336659|NCT00919633|454526956|FG003|Overall Study|Lack of Efficacy|3|||
126336660|NCT00919633|454526953|FG000|Overall Study|Withdrawal by Subject|1|||
126336661|NCT00919633|454526954|FG001|Overall Study|Withdrawal by Subject|2|||
126336662|NCT00919633|454526955|FG002|Overall Study|Withdrawal by Subject|4|||
126336663|NCT00919633|454526956|FG003|Overall Study|Withdrawal by Subject|3|||
126336664|NCT00919633|454526953|FG000|Overall Study|Lost to Follow-up|3|||
126336665|NCT00919633|454526954|FG001|Overall Study|Lost to Follow-up|1|||
126336666|NCT00919633|454526955|FG002|Overall Study|Lost to Follow-up|0|||
126336667|NCT00919633|454526956|FG003|Overall Study|Lost to Follow-up|2|||
126336668|NCT00919633|454526953|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
126336669|NCT00919633|454526954|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
126336670|NCT00919633|454526955|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
126336671|NCT00919633|454526956|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
126336672|NCT00919633|454526953|FG000|Overall Study|Protocol Violation|0|||
126336673|NCT00919633|454526954|FG001|Overall Study|Protocol Violation|0|||
126336674|NCT00919633|454526955|FG002|Overall Study|Protocol Violation|0|||
126336675|NCT00919633|454526956|FG003|Overall Study|Protocol Violation|1|||
126336676|NCT00919633|454526953|FG000|Overall Study|Physician Decision|0|||
126336677|NCT00919633|454526954|FG001|Overall Study|Physician Decision|0|||
126336678|NCT00919633|454526955|FG002|Overall Study|Physician Decision|0|||
126336679|NCT00919633|454526956|FG003|Overall Study|Physician Decision|1|||
126336680|NCT00919633|454526953|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
126336681|NCT00919633|454526954|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
126336682|NCT00919633|454526955|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
126336683|NCT00919633|454526956|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
126336684|NCT00919633|454526953|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
126336685|NCT00919633|454526954|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
126336686|NCT00919633|454526955|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
126336687|NCT00919633|454526956|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
125999807|NCT00873093|453289058|FG003|Overall Study|Adverse Event|0|||
125999808|NCT00873093|453289059|FG004|Overall Study|Adverse Event|0|||
125999809|NCT00873093|453289055|FG000|Overall Study|Death|0|||
125999810|NCT00873093|453289056|FG001|Overall Study|Death|3|||
125999811|NCT00873093|453289057|FG002|Overall Study|Death|2|||
125999812|NCT00873093|453289058|FG003|Overall Study|Death|0|||
125999813|NCT00873093|453289059|FG004|Overall Study|Death|0|||
125999814|NCT00873093|453289055|FG000|Overall Study|Physician Decision|0|||
125999815|NCT00873093|453289056|FG001|Overall Study|Physician Decision|17|||
125999816|NCT00873093|453289057|FG002|Overall Study|Physician Decision|10|||
125999817|NCT00873093|453289058|FG003|Overall Study|Physician Decision|10|||
125999818|NCT00873093|453289059|FG004|Overall Study|Physician Decision|2|||
125999819|NCT00873093|453289055|FG000|Overall Study|Withdrawal by Subject|1|||
125999820|NCT00873093|453289056|FG001|Overall Study|Withdrawal by Subject|4|||
125999821|NCT00873093|453289057|FG002|Overall Study|Withdrawal by Subject|4|||
125999822|NCT00873093|453289058|FG003|Overall Study|Withdrawal by Subject|0|||
125999823|NCT00873093|453289059|FG004|Overall Study|Withdrawal by Subject|0|||
125999824|NCT00873093|453289055|FG000|Overall Study|Ineligible|0|||
125999825|NCT00873093|453289056|FG001|Overall Study|Ineligible|1|||
125999826|NCT00873093|453289057|FG002|Overall Study|Ineligible|0|||
125999827|NCT00873093|453289058|FG003|Overall Study|Ineligible|1|||
125999828|NCT00873093|453289059|FG004|Overall Study|Ineligible|0|||
125999829|NCT01708187|453289060|FG000|Overall Study|Lost to Follow-up|0|||
126336688|NCT01526785|454526957|FG000|Overall Study|Study Terminated by Sponsor|8|||
126336689|NCT01526785|454526957|FG000|Overall Study|Death|2|||
126336690|NCT01526785|454526957|FG000|Overall Study|Physician Decision|1|||
126336691|NCT01526785|454526957|FG000|Overall Study|Withdrawal by Subject|2|||
126336692|NCT01121263|454526960|FG000|Overall Study|Death|3|||
126336693|NCT01121263|454526961|FG001|Overall Study|Death|2|||
126336694|NCT01121263|454526960|FG000|Overall Study|Lost to Follow-up|22|||
126336695|NCT01121263|454526961|FG001|Overall Study|Lost to Follow-up|12|||
126336696|NCT01121263|454526960|FG000|Overall Study|Withdrawal by Subject|0|||
126336697|NCT01121263|454526961|FG001|Overall Study|Withdrawal by Subject|1|||
126336698|NCT02007720|454526962|FG000|Overall Study|Withdrawal by Subject|9|||
126336699|NCT02007720|454526963|FG001|Overall Study|Withdrawal by Subject|11|||
126336700|NCT02007720|454526962|FG000|Overall Study|study terminated by sponsor|58|||
126336701|NCT02007720|454526963|FG001|Overall Study|study terminated by sponsor|54|||
126336702|NCT02007720|454526962|FG000|Overall Study|technical problem|4|||
126336703|NCT02007720|454526963|FG001|Overall Study|technical problem|2|||
125999830|NCT01708187|453289061|FG001|Overall Study|Lost to Follow-up|1|||
125999831|NCT03055832|453289063|FG000|Week 2|Withdrawal by Subject|1|||
125999832|NCT03055832|453289064|FG001|Week 2|Withdrawal by Subject|0|||
125999833|NCT00136916|453289065|FG000|Overall Study|Never received study treatment|3|||
125999834|NCT00136916|453289066|FG001|Overall Study|Never received study treatment|5|||
125999835|NCT00136916|453289065|FG000|Overall Study|Death|1|||
125999836|NCT00136916|453289066|FG001|Overall Study|Death|3|||
125999837|NCT00136916|453289065|FG000|Overall Study|Adverse Event|27|||
125999838|NCT00136916|453289066|FG001|Overall Study|Adverse Event|8|||
125999839|NCT00136916|453289065|FG000|Overall Study|Laboratory abnormality|0|||
125999840|NCT00136916|453289066|FG001|Overall Study|Laboratory abnormality|1|||
125999841|NCT00136916|453289065|FG000|Overall Study|Lack of Efficacy|13|||
125999842|NCT00136916|453289066|FG001|Overall Study|Lack of Efficacy|3|||
125999843|NCT00136916|453289065|FG000|Overall Study|Lost to Follow-up|12|||
125999844|NCT00136916|453289066|FG001|Overall Study|Lost to Follow-up|14|||
125999845|NCT00136916|453289065|FG000|Overall Study|Withdrawal by Subject|44|||
125999846|NCT00136916|453289066|FG001|Overall Study|Withdrawal by Subject|46|||
125999847|NCT00136916|453289065|FG000|Overall Study|Other|22|||
125999848|NCT00136916|453289066|FG001|Overall Study|Other|24|||
125999849|NCT00136916|453289065|FG000|Overall Study|Discontinued in follow up period|3|||
125999850|NCT00136916|453289066|FG001|Overall Study|Discontinued in follow up period|0|||
126336704|NCT02007720|454526962|FG000|Overall Study|patient followd less than 165 days|11|||
126336705|NCT02007720|454526963|FG001|Overall Study|patient followd less than 165 days|5|||
125999851|NCT01152554|453289067|FG000|Overall Study|Withdrawal by Subject|73|||
125999852|NCT01152554|453289068|FG001|Overall Study|Withdrawal by Subject|28|||
125999853|NCT01152554|453289067|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
125999854|NCT01152554|453289068|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
125999855|NCT01152554|453289067|FG000|Overall Study|Adverse Event|67|||
125999856|NCT01152554|453289068|FG001|Overall Study|Adverse Event|14|||
125999857|NCT01152554|453289067|FG000|Overall Study|Severe non-compliance to protocol|36|||
125999858|NCT01152554|453289068|FG001|Overall Study|Severe non-compliance to protocol|14|||
125999859|NCT01152554|453289067|FG000|Overall Study|Condition under investigation worsened|5|||
125999860|NCT01152554|453289068|FG001|Overall Study|Condition under investigation worsened|2|||
125999861|NCT01152554|453289067|FG000|Overall Study|Lack of Efficacy|20|||
125999862|NCT01152554|453289068|FG001|Overall Study|Lack of Efficacy|3|||
126336706|NCT03810456|454526964|FG000|Treatment|Urgent Family Matters|3|||
126336707|NCT03810456|454526965|FG001|Treatment|Urgent Family Matters|0|||
126336708|NCT03810456|454526966|FG002|Treatment|Urgent Family Matters|0|||
126336709|NCT03810456|454526964|FG000|Treatment|Scheduling Conflicts|0|||
126336710|NCT03810456|454526965|FG001|Treatment|Scheduling Conflicts|11|||
125999863|NCT01152554|453289067|FG000|Overall Study|Study-specific withdrawal criteria|17|||
125999864|NCT01152554|453289068|FG001|Overall Study|Study-specific withdrawal criteria|8|||
125999865|NCT01152554|453289067|FG000|Overall Study|Lost to Follow-up|87|||
125999866|NCT01152554|453289068|FG001|Overall Study|Lost to Follow-up|32|||
125999867|NCT01152554|453289067|FG000|Overall Study|Other|28|||
125999868|NCT01152554|453289068|FG001|Overall Study|Other|8|||
125999869|NCT01152554|453289067|FG000|Overall Study|Death|1|||
125999870|NCT01152554|453289068|FG001|Overall Study|Death|1|||
125999871|NCT02117544|453289069|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
125999872|NCT02117544|453289070|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
125999873|NCT01439711|453289073|FG000|Overall Study|Ineligible|13|||
125999874|NCT01439711|453289073|FG000|Overall Study|Cancel|3|||
125999875|NCT01439711|453289073|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
125999876|NCT01439711|453289073|FG000|Overall Study|Adverse Event|5|||
125999877|NCT01439711|453289073|FG000|Overall Study|Withdrawal by Subject|3|||
125999878|NCT01439711|453289073|FG000|Overall Study|Progression During Active Tx|3|||
125999879|NCT01439711|453289073|FG000|Overall Study|Noncompliance|3|||
125999880|NCT01439711|453289073|FG000|Overall Study|No MRI|9|||
125999881|NCT04242875|453289074|FG000|Overall Study|Adverse Event|2|||
125999882|NCT01012973|453289075|FG000|Overall Study|Adverse Event|5|||
125999883|NCT01012973|453289076|FG001|Overall Study|Adverse Event|5|||
125999884|NCT01012973|453289075|FG000|Overall Study|Lack of Efficacy|0|||
125999885|NCT01012973|453289076|FG001|Overall Study|Lack of Efficacy|5|||
125999886|NCT01012973|453289075|FG000|Overall Study|Lost to Follow-up|1|||
125999887|NCT01012973|453289076|FG001|Overall Study|Lost to Follow-up|0|||
125999888|NCT01012973|453289075|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
125999889|NCT01012973|453289076|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
125999890|NCT01012973|453289075|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
125999891|NCT01012973|453289076|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
125999892|NCT01012973|453289075|FG000|Overall Study|Protocol Violation|5|||
125999893|NCT01012973|453289076|FG001|Overall Study|Protocol Violation|2|||
125999894|NCT01012973|453289075|FG000|Overall Study|Withdrawal by Subject|4|||
125999895|NCT01012973|453289076|FG001|Overall Study|Withdrawal by Subject|6|||
125999896|NCT04172987|453289081|FG000|Lead In Period|Adverse Event|1|||
125999897|NCT04172987|453289081|FG000|Lead In Period|Protocol Violation|1|||
125999898|NCT04172987|453289081|FG000|Period 1|Physician Decision|1|||
125999899|NCT04172987|453289081|FG000|Period 2|Adverse Event|5|||
125999900|NCT04172987|453289081|FG000|Period 2|Dosing Termination by Sponsor|4|||
125999901|NCT04179461|453289082|FG000|Overall Study|Lost to Follow-up|4|||
125999902|NCT02806336|453289083|FG000|Overall Study|Physician Decision|1|||
125999903|NCT02806336|453289084|FG001|Overall Study|Physician Decision|0|||
125999904|NCT02806336|453289083|FG000|Overall Study|Withdrawal by Subject|2|||
125999905|NCT02806336|453289084|FG001|Overall Study|Withdrawal by Subject|4|||
125999906|NCT02806336|453289083|FG000|Overall Study|COVID-19 research shut down|3|||
125999907|NCT02806336|453289084|FG001|Overall Study|COVID-19 research shut down|4|||
125999908|NCT02806336|453289083|FG000|Overall Study|Lack of Efficacy|0|||
125999909|NCT02806336|453289084|FG001|Overall Study|Lack of Efficacy|1|||
125999910|NCT00895843|453289085|FG000|Overall Study|Protocol Violation|12|||
125999911|NCT00895843|453289086|FG001|Overall Study|Protocol Violation|12|||
125999912|NCT04963062|453289094|FG000|Overall Study|withdrew by the study team|4|||
125999913|NCT04963062|453289095|FG001|Overall Study|withdrew by the study team|2|||
125999914|NCT01857323|453289096|FG000|Overall Study|Adverse Event|1|||
125999915|NCT01857323|453289096|FG000|Overall Study|Withdrawal by Subject|3|||
125999916|NCT01857323|453289096|FG000|Overall Study|Non-compliance|1|||
125999917|NCT01857323|453289096|FG000|Overall Study|Protocol Violation|6|||
125999918|NCT01857323|453289096|FG000|Overall Study|Lost to Follow-up|1|||
125999919|NCT01857323|453289096|FG000|Overall Study|Other|4|||
125999920|NCT01857323|453289096|FG000|Overall Study|Did not complete 180 doses|48|||
125999921|NCT03873246|453289097|FG000|Overall Study|Adverse Event|1|||
125999922|NCT03873246|453289098|FG001|Overall Study|Adverse Event|3|||
125999923|NCT03873246|453289099|FG002|Overall Study|Adverse Event|3|||
125999924|NCT03873246|453289097|FG000|Overall Study|Lost to Follow-up|4|||
125999925|NCT03873246|453289098|FG001|Overall Study|Lost to Follow-up|4|||
125999926|NCT03873246|453289099|FG002|Overall Study|Lost to Follow-up|5|||
125999927|NCT03873246|453289097|FG000|Overall Study|Protocol Violation|0|||
125999928|NCT03873246|453289098|FG001|Overall Study|Protocol Violation|1|||
125999929|NCT03873246|453289099|FG002|Overall Study|Protocol Violation|0|||
125999930|NCT03873246|453289097|FG000|Overall Study|Withdrawal by Subject|0|||
125999931|NCT03873246|453289098|FG001|Overall Study|Withdrawal by Subject|4|||
125999932|NCT03873246|453289099|FG002|Overall Study|Withdrawal by Subject|1|||
125999933|NCT03658811|453289100|FG000|Overall Study|Lost to Follow-up|3|||
125999934|NCT00946647|453289104|FG000|Phase 1 Part|Adverse Event|2|||
125999935|NCT00946647|453289105|FG001|Phase 1 Part|Adverse Event|5|||
125999936|NCT00946647|453289106|FG002|Phase 1 Part|Adverse Event|3|||
125999937|NCT00946647|453289107|FG003|Phase 1 Part|Adverse Event|0|||
125999938|NCT00946647|453289108|FG004|Phase 1 Part|Adverse Event|0|||
125999939|NCT00946647|453289104|FG000|Phase 1 Part|Disease progression|3|||
125999940|NCT00946647|453289105|FG001|Phase 1 Part|Disease progression|6|||
125999941|NCT00946647|453289106|FG002|Phase 1 Part|Disease progression|1|||
125999942|NCT00946647|453289107|FG003|Phase 1 Part|Disease progression|0|||
125999943|NCT00946647|453289108|FG004|Phase 1 Part|Disease progression|0|||
125999944|NCT00946647|453289104|FG000|Phase 1 Part|Withdrawal by Subject|1|||
125999945|NCT00946647|453289105|FG001|Phase 1 Part|Withdrawal by Subject|4|||
125999946|NCT00946647|453289106|FG002|Phase 1 Part|Withdrawal by Subject|3|||
125999947|NCT00946647|453289107|FG003|Phase 1 Part|Withdrawal by Subject|0|||
125999948|NCT00946647|453289108|FG004|Phase 1 Part|Withdrawal by Subject|0|||
125999949|NCT00946647|453289104|FG000|Phase 1 Part|Abnormal values|0|||
125999950|NCT00946647|453289105|FG001|Phase 1 Part|Abnormal values|2|||
125999951|NCT00946647|453289106|FG002|Phase 1 Part|Abnormal values|0|||
125999952|NCT00946647|453289107|FG003|Phase 1 Part|Abnormal values|0|||
125999953|NCT00946647|453289108|FG004|Phase 1 Part|Abnormal values|0|||
125999954|NCT00946647|453289104|FG000|Phase 1 Part|Reason missing|0|||
125999955|NCT00946647|453289105|FG001|Phase 1 Part|Reason missing|1|||
125999956|NCT00946647|453289106|FG002|Phase 1 Part|Reason missing|0|||
125999957|NCT00946647|453289107|FG003|Phase 1 Part|Reason missing|0|||
125999958|NCT00946647|453289108|FG004|Phase 1 Part|Reason missing|0|||
125999959|NCT00946647|453289104|FG000|Phase ll Part|Untreated|0|||
125999960|NCT00946647|453289105|FG001|Phase ll Part|Untreated|0|||
125999961|NCT00946647|453289106|FG002|Phase ll Part|Untreated|0|||
125999962|NCT00946647|453289107|FG003|Phase ll Part|Untreated|0|||
125999963|NCT00946647|453289108|FG004|Phase ll Part|Untreated|2|||
125999964|NCT00946647|453289104|FG000|Phase ll Part|Adverse Event|0|||
125999965|NCT00946647|453289105|FG001|Phase ll Part|Adverse Event|0|||
125999966|NCT00946647|453289106|FG002|Phase ll Part|Adverse Event|0|||
125999967|NCT00946647|453289107|FG003|Phase ll Part|Adverse Event|10|||
125999968|NCT00946647|453289108|FG004|Phase ll Part|Adverse Event|6|||
125999969|NCT00946647|453289104|FG000|Phase ll Part|Withdrawal by Subject|0|||
125999970|NCT00946647|453289105|FG001|Phase ll Part|Withdrawal by Subject|0|||
125999971|NCT00946647|453289106|FG002|Phase ll Part|Withdrawal by Subject|0|||
125999972|NCT00946647|453289107|FG003|Phase ll Part|Withdrawal by Subject|8|||
125999973|NCT00946647|453289108|FG004|Phase ll Part|Withdrawal by Subject|6|||
125999974|NCT00946647|453289104|FG000|Phase ll Part|Administrative problems|0|||
125999975|NCT00946647|453289105|FG001|Phase ll Part|Administrative problems|0|||
125999976|NCT00946647|453289106|FG002|Phase ll Part|Administrative problems|0|||
125999977|NCT00946647|453289107|FG003|Phase ll Part|Administrative problems|3|||
125999978|NCT00946647|453289108|FG004|Phase ll Part|Administrative problems|8|||
125999979|NCT00946647|453289104|FG000|Phase ll Part|Death|0|||
125999980|NCT00946647|453289105|FG001|Phase ll Part|Death|0|||
125999981|NCT00946647|453289106|FG002|Phase ll Part|Death|0|||
125999982|NCT00946647|453289107|FG003|Phase ll Part|Death|7|||
125999983|NCT00946647|453289108|FG004|Phase ll Part|Death|4|||
125999984|NCT00946647|453289104|FG000|Phase ll Part|Disease progression|0|||
125999985|NCT00946647|453289105|FG001|Phase ll Part|Disease progression|0|||
125999986|NCT00946647|453289106|FG002|Phase ll Part|Disease progression|0|||
125999987|NCT00946647|453289107|FG003|Phase ll Part|Disease progression|6|||
125999988|NCT00946647|453289108|FG004|Phase ll Part|Disease progression|14|||
125999989|NCT00946647|453289104|FG000|Phase ll Part|Protocol Violation|0|||
125999990|NCT00946647|453289105|FG001|Phase ll Part|Protocol Violation|0|||
125999991|NCT00946647|453289106|FG002|Phase ll Part|Protocol Violation|0|||
125999992|NCT00946647|453289107|FG003|Phase ll Part|Protocol Violation|4|||
125999993|NCT00946647|453289108|FG004|Phase ll Part|Protocol Violation|2|||
125999994|NCT00946647|453289104|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
125999995|NCT00946647|453289105|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
125999996|NCT00946647|453289106|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
125999997|NCT00946647|453289107|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
125999998|NCT00946647|453289108|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
125999999|NCT00556374|453289111|FG000|Overall Study|Withdrawal by Subject|235|||
126336711|NCT03810456|454526966|FG002|Treatment|Scheduling Conflicts|0|||
126336712|NCT03810456|454526964|FG000|Treatment|No Longer Interested|0|||
126336713|NCT03810456|454526965|FG001|Treatment|No Longer Interested|12|||
126000000|NCT00556374|453289112|FG001|Overall Study|Withdrawal by Subject|205|||
126000001|NCT00556374|453289111|FG000|Overall Study|Death|158|||
126000002|NCT00556374|453289112|FG001|Overall Study|Death|127|||
126000003|NCT00556374|453289111|FG000|Overall Study|Lost to Follow-up|24|||
126000004|NCT00556374|453289112|FG001|Overall Study|Lost to Follow-up|17|||
126000005|NCT00556374|453289111|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
126000006|NCT00556374|453289112|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
126000007|NCT00322868|453290439|FG000|Overall Study|disease progression|1|||
126000008|NCT02176928|453290442|FG000|Overall Study|Lost to Follow-up|2|||
126000009|NCT02176928|453290443|FG001|Overall Study|Lost to Follow-up|4|||
126000010|NCT00224133|453290448|FG000|Overall Study|Adverse Event|93|||
126000011|NCT00224133|453290448|FG000|Overall Study|Protocol Violation|6|||
126000012|NCT00224133|453290448|FG000|Overall Study|Withdrawal by Subject|33|||
126000013|NCT00224133|453290448|FG000|Overall Study|Lack of Efficacy|58|||
126000014|NCT00224133|453290448|FG000|Overall Study|Lost to Follow-up|21|||
126000015|NCT00224133|453290448|FG000|Overall Study|Physician Decision|1|||
126000016|NCT00224133|453290448|FG000|Overall Study|Other|14|||
126336714|NCT03810456|454526966|FG002|Treatment|No Longer Interested|0|||
126000017|NCT00795132|453290454|FG000|Overall Study|Death|1|||
126000018|NCT00795132|453290454|FG000|Overall Study|Relapse|2|||
126000019|NCT02451930|453290455|FG000|Overall Study|Death|0|||
126000020|NCT02451930|453290456|FG001|Overall Study|Death|15|||
126000021|NCT02451930|453290455|FG000|Overall Study|Lost to Follow-up|0|||
126000022|NCT02451930|453290456|FG001|Overall Study|Lost to Follow-up|3|||
126000023|NCT02451930|453290455|FG000|Overall Study|Sponsor Decision|2|||
126336715|NCT03810456|454526964|FG000|Treatment|Transportation Issues|0|||
126336716|NCT03810456|454526965|FG001|Treatment|Transportation Issues|1|||
126336717|NCT03810456|454526966|FG002|Treatment|Transportation Issues|0|||
126336718|NCT03810456|454526964|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
126336719|NCT03810456|454526965|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
126336720|NCT03810456|454526966|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
126336721|NCT03810456|454526964|FG000|1 Month Follow-Up|Relocated to Different State|1|||
126000024|NCT02451930|453290456|FG001|Overall Study|Sponsor Decision|10|||
126000025|NCT02451930|453290455|FG000|Overall Study|Withdrawal by Subject|0|||
126000026|NCT02451930|453290456|FG001|Overall Study|Withdrawal by Subject|1|||
126000027|NCT02451930|453290455|FG000|Overall Study|Other|0|||
126000028|NCT02451930|453290456|FG001|Overall Study|Other|1|||
126000029|NCT03018106|453290457|FG000|Overall Study|Lost to Follow-up|0|||
126000030|NCT03018106|453290458|FG001|Overall Study|Lost to Follow-up|1|||
126000031|NCT03619174|453290459|FG000|Overall Study|Lost to Follow-up|3|||
126000032|NCT03619174|453290460|FG001|Overall Study|Lost to Follow-up|0|||
126000033|NCT03619174|453290459|FG000|Overall Study|Withdrawal by Subject|4|||
126000034|NCT03619174|453290460|FG001|Overall Study|Withdrawal by Subject|3|||
126000035|NCT03619174|453290459|FG000|Overall Study|Pregnancy|1|||
126000036|NCT03619174|453290460|FG001|Overall Study|Pregnancy|1|||
126000037|NCT03619174|453290459|FG000|Overall Study|Discomfort during treatment|1|||
126000038|NCT03619174|453290460|FG001|Overall Study|Discomfort during treatment|0|||
126000039|NCT03486899|453290461|FG000|Overall Study|Lost to Follow-up|4|||
126000040|NCT03486899|453290462|FG001|Overall Study|Lost to Follow-up|1|||
126000041|NCT03486899|453290463|FG002|Overall Study|Lost to Follow-up|4|||
126000042|NCT03486899|453290464|FG003|Overall Study|Lost to Follow-up|3|||
126000043|NCT03486899|453290461|FG000|Overall Study|Death|1|||
126000044|NCT03486899|453290462|FG001|Overall Study|Death|0|||
126000045|NCT03486899|453290463|FG002|Overall Study|Death|0|||
126000046|NCT03486899|453290464|FG003|Overall Study|Death|1|||
126000047|NCT03486899|453290461|FG000|Overall Study|Adverse Event|0|||
126000048|NCT03486899|453290462|FG001|Overall Study|Adverse Event|2|||
126000049|NCT03486899|453290463|FG002|Overall Study|Adverse Event|0|||
126000050|NCT03486899|453290464|FG003|Overall Study|Adverse Event|2|||
126000051|NCT03486899|453290461|FG000|Overall Study|Withdrawal by Subject|3|||
126000052|NCT03486899|453290462|FG001|Overall Study|Withdrawal by Subject|7|||
126000053|NCT03486899|453290463|FG002|Overall Study|Withdrawal by Subject|4|||
126000054|NCT03486899|453290464|FG003|Overall Study|Withdrawal by Subject|3|||
126000055|NCT03486899|453290461|FG000|Overall Study|Other Reasons|0|||
126000056|NCT03486899|453290462|FG001|Overall Study|Other Reasons|1|||
126000057|NCT03486899|453290463|FG002|Overall Study|Other Reasons|0|||
126336722|NCT03810456|454526965|FG001|1 Month Follow-Up|Relocated to Different State|0|||
126336723|NCT03810456|454526966|FG002|1 Month Follow-Up|Relocated to Different State|1|||
126336724|NCT03810456|454526964|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
126336725|NCT03810456|454526965|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
126336726|NCT03810456|454526966|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
126336727|NCT03810456|454526964|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
126336728|NCT03810456|454526965|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
126336729|NCT03810456|454526966|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
126336730|NCT03810456|454526964|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
126336731|NCT03810456|454526965|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
126000058|NCT03486899|453290464|FG003|Overall Study|Other Reasons|1|||
126000059|NCT01010217|453290465|FG000|Overall Study|Lost to Follow-up|4|||
126000060|NCT01010217|453290466|FG001|Overall Study|Lost to Follow-up|5|||
126000061|NCT01010217|453290467|FG002|Overall Study|Lost to Follow-up|1|||
126000062|NCT01010217|453290468|FG003|Overall Study|Lost to Follow-up|0|||
126000063|NCT01010217|453290469|FG004|Overall Study|Lost to Follow-up|0|||
126000064|NCT01010217|453290465|FG000|Overall Study|Withdrawal by Subject|1|||
126000065|NCT01010217|453290466|FG001|Overall Study|Withdrawal by Subject|0|||
126000066|NCT01010217|453290467|FG002|Overall Study|Withdrawal by Subject|0|||
126000067|NCT01010217|453290468|FG003|Overall Study|Withdrawal by Subject|0|||
126000068|NCT01010217|453290469|FG004|Overall Study|Withdrawal by Subject|0|||
126336732|NCT03810456|454526966|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
126336733|NCT03810456|454526964|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
126336734|NCT03810456|454526965|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
126336735|NCT03810456|454526966|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
126000069|NCT01010217|453290465|FG000|Overall Study|Physician Decision|0|||
126000070|NCT01010217|453290466|FG001|Overall Study|Physician Decision|0|||
126000071|NCT01010217|453290467|FG002|Overall Study|Physician Decision|0|||
126000072|NCT01010217|453290468|FG003|Overall Study|Physician Decision|6|||
126000073|NCT01010217|453290469|FG004|Overall Study|Physician Decision|3|||
126336736|NCT03810456|454526964|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
126000074|NCT01782326|453290471|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
126000075|NCT01782326|453290472|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
126000076|NCT01782326|453290471|FG000|Planned Treatment Epoch|Death|29|||
126000077|NCT01782326|453290472|FG001|Planned Treatment Epoch|Death|30|||
126336737|NCT03810456|454526965|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
126336738|NCT03810456|454526966|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
126000078|NCT01782326|453290471|FG000|Planned Treatment Epoch|Physician Decision|18|||
126000079|NCT01782326|453290472|FG001|Planned Treatment Epoch|Physician Decision|16|||
126000080|NCT01782326|453290471|FG000|Planned Treatment Epoch|Protocol deviation|2|||
126000081|NCT01782326|453290472|FG001|Planned Treatment Epoch|Protocol deviation|3|||
126336739|NCT04194814|454526971|FG000|Overall Study|Physician Decision|3|||
126336740|NCT04194814|454526972|FG001|Overall Study|Physician Decision|0|||
126336741|NCT04194814|454526971|FG000|Overall Study|Withdrawal by Subject|0|||
126000082|NCT01782326|453290471|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
126000083|NCT01782326|453290472|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
126000084|NCT01782326|453290471|FG000|Planned Treatment Epoch|Technical problems|0|||
126000085|NCT01782326|453290472|FG001|Planned Treatment Epoch|Technical problems|4|||
126000086|NCT01782326|453290471|FG000|Double-blind Treatment|Adverse Event|129|||
126000087|NCT01782326|453290472|FG001|Double-blind Treatment|Adverse Event|145|||
126000088|NCT01782326|453290471|FG000|Double-blind Treatment|Subject/guardian decision|111|||
126000089|NCT01782326|453290472|FG001|Double-blind Treatment|Subject/guardian decision|125|||
126000090|NCT01782326|453290471|FG000|Double-blind Treatment|Lack of Efficacy|17|||
126000091|NCT01782326|453290472|FG001|Double-blind Treatment|Lack of Efficacy|22|||
126000092|NCT01782326|453290471|FG000|Double-blind Treatment|Physician Decision|13|||
126000093|NCT01782326|453290472|FG001|Double-blind Treatment|Physician Decision|16|||
126000094|NCT01782326|453290471|FG000|Double-blind Treatment|Protocol deviation|8|||
126000095|NCT01782326|453290472|FG001|Double-blind Treatment|Protocol deviation|7|||
126000096|NCT01782326|453290471|FG000|Double-blind Treatment|Technical problems|0|||
126000097|NCT01782326|453290472|FG001|Double-blind Treatment|Technical problems|5|||
126000098|NCT00738530|453290485|FG000|Overall Study|Death|220|||
126000099|NCT00738530|453290486|FG001|Overall Study|Death|224|||
126000100|NCT00738530|453290485|FG000|Overall Study|Lost to Follow-up|8|||
126000101|NCT00738530|453290486|FG001|Overall Study|Lost to Follow-up|6|||
126000102|NCT00738530|453290485|FG000|Overall Study|Withdrawal by Subject|6|||
126000103|NCT00738530|453290486|FG001|Overall Study|Withdrawal by Subject|8|||
126000104|NCT01628510|453290487|FG000|Overall Study|Withdrawal by Subject|0|||
126000105|NCT01628510|453290488|FG001|Overall Study|Withdrawal by Subject|4|||
126000106|NCT01628510|453290487|FG000|Overall Study|Death|3|||
126000107|NCT01628510|453290488|FG001|Overall Study|Death|1|||
126000108|NCT01653847|453290489|FG000|Overall Study|Withdrawal by Subject|1|||
126000109|NCT01653847|453290490|FG001|Overall Study|Withdrawal by Subject|0|||
126000110|NCT04707391|453290491|FG000|Overall Study|Adverse Event|5|||
126000111|NCT04707391|453290492|FG001|Overall Study|Adverse Event|8|||
126000112|NCT04707391|453290491|FG000|Overall Study|Lost to Follow-up|44|||
126000113|NCT04707391|453290492|FG001|Overall Study|Lost to Follow-up|31|||
126000114|NCT04707391|453290491|FG000|Overall Study|Protocol Violation|1|||
126000115|NCT04707391|453290492|FG001|Overall Study|Protocol Violation|5|||
126000116|NCT04707391|453290491|FG000|Overall Study|Withdrawal by Subject|27|||
126000117|NCT04707391|453290492|FG001|Overall Study|Withdrawal by Subject|25|||
126000118|NCT04707391|453290491|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
126000119|NCT04707391|453290492|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
126000120|NCT04707391|453290491|FG000|Overall Study|Other|0|||
126000121|NCT04707391|453290492|FG001|Overall Study|Other|2|||
126000122|NCT03246672|453290493|FG000|Overall Study|Lost to Follow-up|2|||
126000123|NCT01347645|453290494|FG000|Overall Study|Death|1|||
126000124|NCT01347645|453290495|FG001|Overall Study|Death|5|||
126000125|NCT01347645|453290496|FG002|Overall Study|Death|2|||
126000126|NCT01347645|453290497|FG003|Overall Study|Death|7|||
126000127|NCT01347645|453290498|FG004|Overall Study|Death|7|||
126000128|NCT01347645|453290494|FG000|Overall Study|Lost to Follow-up|1|||
126000129|NCT01347645|453290495|FG001|Overall Study|Lost to Follow-up|1|||
126000130|NCT01347645|453290496|FG002|Overall Study|Lost to Follow-up|0|||
126000131|NCT01347645|453290497|FG003|Overall Study|Lost to Follow-up|1|||
126336742|NCT04194814|454526972|FG001|Overall Study|Withdrawal by Subject|2|||
126336743|NCT03246347|454528363|FG000|Overall Study|On Study|23|||
126336744|NCT00329108|454528364|FG000|Overall Study|Adverse Event|2|||
126000132|NCT01347645|453290498|FG004|Overall Study|Lost to Follow-up|1|||
126000133|NCT01347645|453290494|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
126000134|NCT01347645|453290495|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
126000135|NCT01347645|453290496|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
126000136|NCT01347645|453290497|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
126000137|NCT01347645|453290498|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
126000138|NCT01347645|453290494|FG000|Overall Study|Other|1|||
126000139|NCT01347645|453290495|FG001|Overall Study|Other|0|||
126000140|NCT01347645|453290496|FG002|Overall Study|Other|0|||
126000141|NCT01347645|453290497|FG003|Overall Study|Other|0|||
126000142|NCT01347645|453290498|FG004|Overall Study|Other|1|||
126000143|NCT01347645|453290494|FG000|Overall Study|Withdrawal by Subject|0|||
126000144|NCT01347645|453290495|FG001|Overall Study|Withdrawal by Subject|0|||
126000145|NCT01347645|453290496|FG002|Overall Study|Withdrawal by Subject|0|||
126000146|NCT01347645|453290497|FG003|Overall Study|Withdrawal by Subject|3|||
126000147|NCT01347645|453290498|FG004|Overall Study|Withdrawal by Subject|3|||
126000148|NCT01347645|453290494|FG000|Overall Study|Physician Decision|0|||
126000149|NCT01347645|453290495|FG001|Overall Study|Physician Decision|0|||
126000150|NCT01347645|453290496|FG002|Overall Study|Physician Decision|0|||
126000151|NCT01347645|453290497|FG003|Overall Study|Physician Decision|0|||
126000152|NCT01347645|453290498|FG004|Overall Study|Physician Decision|1|||
126000153|NCT01347645|453290494|FG000|Overall Study|Adverse Event|0|||
126000154|NCT01347645|453290495|FG001|Overall Study|Adverse Event|0|||
126000155|NCT01347645|453290496|FG002|Overall Study|Adverse Event|0|||
126000156|NCT01347645|453290497|FG003|Overall Study|Adverse Event|1|||
126000157|NCT01347645|453290498|FG004|Overall Study|Adverse Event|1|||
126000158|NCT01163149|453290500|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
126000159|NCT01163149|453290501|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126000160|NCT01163149|453290502|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
126000161|NCT01163149|453290500|FG000|Extension Treatment Period|Adverse Event|0|||
126000162|NCT01163149|453290501|FG001|Extension Treatment Period|Adverse Event|1|||
126000163|NCT01163149|453290502|FG002|Extension Treatment Period|Adverse Event|0|||
126000164|NCT01163149|453290500|FG000|Extension Treatment Period|Noncompliance|0|||
126000165|NCT01163149|453290501|FG001|Extension Treatment Period|Noncompliance|0|||
126000166|NCT01163149|453290502|FG002|Extension Treatment Period|Noncompliance|1|||
126000167|NCT01923428|453290511|FG000|Overall Study|Adverse Event|8|||
126000168|NCT01923428|453290512|FG001|Overall Study|Adverse Event|6|||
126000169|NCT01923428|453290513|FG002|Overall Study|Adverse Event|3|||
126000170|NCT01923428|453290514|FG003|Overall Study|Adverse Event|3|||
126000171|NCT01923428|453290511|FG000|Overall Study|Withdrawal by Subject|5|||
126000172|NCT01923428|453290512|FG001|Overall Study|Withdrawal by Subject|3|||
126000173|NCT01923428|453290513|FG002|Overall Study|Withdrawal by Subject|0|||
126000174|NCT01923428|453290514|FG003|Overall Study|Withdrawal by Subject|4|||
126000175|NCT01923428|453290511|FG000|Overall Study|Lost to Follow-up|2|||
126000176|NCT01923428|453290512|FG001|Overall Study|Lost to Follow-up|1|||
126000177|NCT01923428|453290513|FG002|Overall Study|Lost to Follow-up|5|||
126000178|NCT01923428|453290514|FG003|Overall Study|Lost to Follow-up|0|||
126000179|NCT01923428|453290511|FG000|Overall Study|Protocol Violation|3|||
126000180|NCT01923428|453290512|FG001|Overall Study|Protocol Violation|0|||
126000181|NCT01923428|453290513|FG002|Overall Study|Protocol Violation|2|||
126000182|NCT01923428|453290514|FG003|Overall Study|Protocol Violation|1|||
126000183|NCT01923428|453290511|FG000|Overall Study|Non Compliance to treatment|1|||
126000184|NCT01923428|453290512|FG001|Overall Study|Non Compliance to treatment|2|||
126000185|NCT01923428|453290513|FG002|Overall Study|Non Compliance to treatment|0|||
126000186|NCT01923428|453290514|FG003|Overall Study|Non Compliance to treatment|1|||
126000187|NCT01923428|453290511|FG000|Overall Study|Lack of Efficacy|0|||
126000188|NCT01923428|453290512|FG001|Overall Study|Lack of Efficacy|0|||
126000189|NCT01923428|453290513|FG002|Overall Study|Lack of Efficacy|1|||
126000190|NCT01923428|453290514|FG003|Overall Study|Lack of Efficacy|1|||
126000191|NCT02550873|453290515|FG000|Randomized Double Blind|Adverse Event|3|||
126000192|NCT02550873|453290516|FG001|Randomized Double Blind|Adverse Event|1|||
126000193|NCT02550873|453290517|FG002|Randomized Double Blind|Adverse Event|0|||
126000194|NCT02550873|453290515|FG000|Randomized Double Blind|Disease progression|1|||
126000195|NCT02550873|453290516|FG001|Randomized Double Blind|Disease progression|1|||
126000196|NCT02550873|453290517|FG002|Randomized Double Blind|Disease progression|0|||
126000197|NCT02550873|453290515|FG000|Open Label Extension|Study ongoing|0|||
126000198|NCT02550873|453290516|FG001|Open Label Extension|Study ongoing|0|||
126000199|NCT02550873|453290517|FG002|Open Label Extension|Study ongoing|111|||
126000200|NCT01822353|453290518|FG000|Overall Study|Adverse Event|1|||
126000201|NCT01822353|453290519|FG001|Overall Study|Adverse Event|3|||
126000202|NCT01822353|453290520|FG002|Overall Study|Adverse Event|1|||
126000203|NCT01822353|453290518|FG000|Overall Study|Pregnancy|0|||
126000204|NCT01822353|453290519|FG001|Overall Study|Pregnancy|1|||
126336745|NCT00329108|454528365|FG001|Overall Study|Adverse Event|2|||
126000205|NCT01822353|453290520|FG002|Overall Study|Pregnancy|0|||
126000206|NCT01822353|453290518|FG000|Overall Study|Withdrawal by Subject|3|||
126000207|NCT01822353|453290519|FG001|Overall Study|Withdrawal by Subject|1|||
126000208|NCT01822353|453290520|FG002|Overall Study|Withdrawal by Subject|0|||
126000209|NCT04320615|453290521|FG000|Overall Study|Withdrawal by Subject|4|||
126000210|NCT04320615|453290522|FG001|Overall Study|Withdrawal by Subject|10|||
126000211|NCT04320615|453290521|FG000|Overall Study|Physician Decision|2|||
126000212|NCT04320615|453290522|FG001|Overall Study|Physician Decision|0|||
126000213|NCT04320615|453290521|FG000|Overall Study|Other|2|||
126000214|NCT04320615|453290522|FG001|Overall Study|Other|0|||
126000215|NCT04320615|453290521|FG000|Overall Study|Lost to Follow-up|5|||
126000216|NCT04320615|453290522|FG001|Overall Study|Lost to Follow-up|23|||
126000217|NCT04320615|453290521|FG000|Overall Study|Death|35|||
126000218|NCT04320615|453290522|FG001|Overall Study|Death|71|||
126000219|NCT01449721|453290523|FG000|Overall Study|Physician Decision|0|||
126000220|NCT01449721|453290524|FG001|Overall Study|Physician Decision|1|||
126000221|NCT01449721|453290523|FG000|Overall Study|Physician Decision|0|||
126000222|NCT01449721|453290524|FG001|Overall Study|Physician Decision|1|||
126000223|NCT02107443|453290525|FG000|Overall Study|Death|42|||
126000224|NCT02107443|453290526|FG001|Overall Study|Death|30|||
126000225|NCT02107443|453290525|FG000|Overall Study|Study Protocol Violation|3|||
126000226|NCT02107443|453290526|FG001|Overall Study|Study Protocol Violation|1|||
126000227|NCT02107443|453290525|FG000|Overall Study|Registered but Not Eligible|0|||
126000228|NCT02107443|453290526|FG001|Overall Study|Registered but Not Eligible|1|||
126000229|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
126000230|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
126000231|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
126000232|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
126000233|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Changed Mind|2|||
126000234|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Changed Mind|0|||
126000235|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
126000236|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
126000237|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
126000238|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
126000239|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
126000240|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
126000241|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
126000242|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
126000243|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Other Medical|9|||
126000244|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Other Medical|5|||
126000245|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Disease Progression|4|||
126000246|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Disease Progression|2|||
126000247|NCT02107443|453290525|FG000|Overall Study|Withdrawal: Personal Issues|0|||
126000248|NCT02107443|453290526|FG001|Overall Study|Withdrawal: Personal Issues|3|||
126000249|NCT01513967|453290527|FG000|Overall Study|Pregnancy|0|||
126000250|NCT01513967|453290528|FG001|Overall Study|Pregnancy|0|||
126000251|NCT01513967|453290529|FG002|Overall Study|Pregnancy|0|||
126000252|NCT01513967|453290530|FG003|Overall Study|Pregnancy|0|||
126000253|NCT01513967|453290531|FG004|Overall Study|Pregnancy|0|||
126000254|NCT01513967|453290532|FG005|Overall Study|Pregnancy|0|||
126000255|NCT01513967|453290533|FG006|Overall Study|Pregnancy|1|||
126000256|NCT01513967|453290534|FG007|Overall Study|Pregnancy|0|||
126336746|NCT00329108|454528364|FG000|Overall Study|Lack of Efficacy|3|||
126336747|NCT00329108|454528365|FG001|Overall Study|Lack of Efficacy|3|||
126336748|NCT00329108|454528364|FG000|Overall Study|Withdrawal by Subject|0|||
126336749|NCT00329108|454528365|FG001|Overall Study|Withdrawal by Subject|2|||
126336750|NCT00329108|454528364|FG000|Overall Study|symptomatic deterioration|1|||
126336751|NCT00329108|454528365|FG001|Overall Study|symptomatic deterioration|1|||
126336752|NCT00329108|454528364|FG000|Overall Study|Subject no longer willing to participate|2|||
126336753|NCT00329108|454528365|FG001|Overall Study|Subject no longer willing to participate|2|||
126336754|NCT00329108|454528364|FG000|Overall Study|study terminated by sponsor|1|||
126336755|NCT00329108|454528365|FG001|Overall Study|study terminated by sponsor|0|||
126336756|NCT00329108|454528364|FG000|Overall Study|withdrew patient after SAE resolved|1|||
126336757|NCT00329108|454528365|FG001|Overall Study|withdrew patient after SAE resolved|0|||
126336758|NCT00329108|454528364|FG000|Overall Study|Protocol Violation|0|||
126336759|NCT00329108|454528365|FG001|Overall Study|Protocol Violation|2|||
126336760|NCT00903201|454528366|FG000|Overall Study|Adverse Event|1|||
126336761|NCT00903201|454528367|FG001|Overall Study|Adverse Event|4|||
126336762|NCT00903201|454528368|FG002|Overall Study|Adverse Event|0|||
126336763|NCT00903201|454528366|FG000|Overall Study|Protocol Violation|2|||
126336764|NCT00903201|454528367|FG001|Overall Study|Protocol Violation|1|||
126336765|NCT00903201|454528368|FG002|Overall Study|Protocol Violation|0|||
126336766|NCT00903201|454528366|FG000|Overall Study|Lost to Follow-up|0|||
126336767|NCT00903201|454528367|FG001|Overall Study|Lost to Follow-up|1|||
126000257|NCT01513967|453290527|FG000|Overall Study|missed a study visit|0|||
126000258|NCT01513967|453290528|FG001|Overall Study|missed a study visit|0|||
126336768|NCT00903201|454528368|FG002|Overall Study|Lost to Follow-up|0|||
126000259|NCT01513967|453290529|FG002|Overall Study|missed a study visit|0|||
126000260|NCT01513967|453290530|FG003|Overall Study|missed a study visit|0|||
126000261|NCT01513967|453290531|FG004|Overall Study|missed a study visit|0|||
126000262|NCT01513967|453290532|FG005|Overall Study|missed a study visit|0|||
126000263|NCT01513967|453290533|FG006|Overall Study|missed a study visit|1|||
126000264|NCT01513967|453290534|FG007|Overall Study|missed a study visit|0|||
126000265|NCT01513967|453290527|FG000|Overall Study|excluded due to positive drug screen|0|||
126336769|NCT00903201|454528366|FG000|Overall Study|Physician Decision|1|||
126000266|NCT01513967|453290528|FG001|Overall Study|excluded due to positive drug screen|0|||
126000267|NCT01513967|453290529|FG002|Overall Study|excluded due to positive drug screen|0|||
126336770|NCT00903201|454528367|FG001|Overall Study|Physician Decision|0|||
126000268|NCT01513967|453290530|FG003|Overall Study|excluded due to positive drug screen|0|||
126000269|NCT01513967|453290531|FG004|Overall Study|excluded due to positive drug screen|0|||
126000270|NCT01513967|453290532|FG005|Overall Study|excluded due to positive drug screen|0|||
126000271|NCT01513967|453290533|FG006|Overall Study|excluded due to positive drug screen|0|||
126000272|NCT01513967|453290534|FG007|Overall Study|excluded due to positive drug screen|2|||
126000273|NCT01513967|453290527|FG000|Overall Study|Physician Decision|0|||
126000274|NCT01513967|453290528|FG001|Overall Study|Physician Decision|0|||
126000275|NCT01513967|453290529|FG002|Overall Study|Physician Decision|0|||
126000276|NCT01513967|453290530|FG003|Overall Study|Physician Decision|0|||
126336771|NCT00903201|454528368|FG002|Overall Study|Physician Decision|1|||
126336772|NCT00903201|454528366|FG000|Overall Study|Withdrawal by Subject|1|||
126000277|NCT01513967|453290531|FG004|Overall Study|Physician Decision|0|||
126000278|NCT01513967|453290532|FG005|Overall Study|Physician Decision|1|||
126000279|NCT01513967|453290533|FG006|Overall Study|Physician Decision|0|||
126000280|NCT01513967|453290534|FG007|Overall Study|Physician Decision|0|||
126000281|NCT02906202|453290535|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
126000282|NCT01563978|453290539|FG000|Overall Study|Physician Decision|1|||
126000283|NCT01563978|453290540|FG001|Overall Study|Physician Decision|0|||
126000284|NCT01563978|453290539|FG000|Overall Study|Lost to Follow-up|1|||
126000285|NCT01563978|453290540|FG001|Overall Study|Lost to Follow-up|0|||
126000286|NCT01563978|453290539|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
126000287|NCT01563978|453290540|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
126000288|NCT01563978|453290539|FG000|Overall Study|Adverse Event|1|||
126000289|NCT01563978|453290540|FG001|Overall Study|Adverse Event|2|||
126000290|NCT00729690|453290541|FG000|Overall Study|IT Catheter Malfunction|0|||
126000291|NCT00729690|453290542|FG001|Overall Study|IT Catheter Malfunction|2|||
126000292|NCT00729690|453290543|FG002|Overall Study|IT Catheter Malfunction|2|||
126000293|NCT04562779|453290546|FG000|Overall Study|Lost to Follow-up|7|||
126000294|NCT04562779|453290547|FG001|Overall Study|Lost to Follow-up|5|||
126000295|NCT04562779|453290548|FG002|Overall Study|Lost to Follow-up|10|||
126000296|NCT04562779|453290546|FG000|Overall Study|Protocol Violation|2|||
126336773|NCT00903201|454528367|FG001|Overall Study|Withdrawal by Subject|0|||
126336774|NCT00903201|454528368|FG002|Overall Study|Withdrawal by Subject|1|||
126336775|NCT01389232|454528369|FG000|Overall Study|Had scaffold removed|15|||
126336776|NCT01389232|454528369|FG000|Overall Study|Personal reasons|2|||
126336777|NCT01389232|454528369|FG000|Overall Study|Adverse Event|1|||
126336778|NCT01389232|454528369|FG000|Overall Study|Death|1|||
126336779|NCT03205150|454528370|FG000|Overall Study|Protocol deviation|1|||
126336780|NCT03205150|454528371|FG001|Overall Study|Protocol deviation|3|||
126336781|NCT03205150|454528372|FG002|Overall Study|Protocol deviation|0|||
126336782|NCT03205150|454528370|FG000|Overall Study|Patient/guardian decision|0|||
126336783|NCT03205150|454528371|FG001|Overall Study|Patient/guardian decision|3|||
126336784|NCT03205150|454528372|FG002|Overall Study|Patient/guardian decision|0|||
126336785|NCT03205150|454528370|FG000|Overall Study|Adverse Event|1|||
126336786|NCT03205150|454528371|FG001|Overall Study|Adverse Event|1|||
126336787|NCT03205150|454528372|FG002|Overall Study|Adverse Event|1|||
126336788|NCT03205150|454528370|FG000|Overall Study|Lost to Follow-up|0|||
126336789|NCT03205150|454528371|FG001|Overall Study|Lost to Follow-up|0|||
126336790|NCT03205150|454528372|FG002|Overall Study|Lost to Follow-up|1|||
126336791|NCT00789321|454528377|FG000|Overall Study|Adverse Event|0|||
126336792|NCT00789321|454528378|FG001|Overall Study|Adverse Event|1|||
126336793|NCT01162343|454528379|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
126336794|NCT01162343|454528379|FG000|Overall Study|Refused psychiatrist assessment|12|||
126336795|NCT03964207|454528381|FG000|First Treatment|Withdrawal by Subject|1|||
126336796|NCT03964207|454528382|FG001|First Treatment|Withdrawal by Subject|2|||
126336797|NCT03964207|454528381|FG000|First Treatment|Protocol Violation|1|||
126336798|NCT03964207|454528382|FG001|First Treatment|Protocol Violation|0|||
126336799|NCT03964207|454528381|FG000|First Treatment|Lost to Follow-up|1|||
126336800|NCT03964207|454528382|FG001|First Treatment|Lost to Follow-up|0|||
126336801|NCT03964207|454528381|FG000|Second Treatment|Lost to Follow-up|0|||
126336802|NCT03964207|454528382|FG001|Second Treatment|Lost to Follow-up|1|||
126336803|NCT03964207|454528381|FG000|Second Treatment|Adverse Event|1|||
126336804|NCT03964207|454528382|FG001|Second Treatment|Adverse Event|2|||
126336805|NCT01930539|454528384|FG000|Overall Study|Withdrawal by Subject|2|||
126336806|NCT01930539|454528385|FG001|Overall Study|Withdrawal by Subject|2|||
126336807|NCT01405560|454528390|FG000|Overall Study|Physician Decision|1|||
126336808|NCT02119299|454528392|FG000|Overall Study|Withdrawal by Subject|7|||
126336809|NCT02119299|454528392|FG000|Overall Study|Lack of Efficacy|1|||
126336810|NCT02119299|454528392|FG000|Overall Study|Pregnancy|1|||
126000297|NCT04562779|453290547|FG001|Overall Study|Protocol Violation|2|||
126000298|NCT04562779|453290548|FG002|Overall Study|Protocol Violation|0|||
126000299|NCT00333138|453290549|FG000|Core Study (6 Months)|Adverse Event|4|||
126000300|NCT00333138|453290550|FG001|Core Study (6 Months)|Adverse Event|5|||
126000301|NCT00333138|453290551|FG002|Core Study (6 Months)|Adverse Event|8|||
126000302|NCT00333138|453290549|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
126336811|NCT00744939|454528393|FG000|Overall Study|Withdrawal by Subject|9|||
126336812|NCT00744939|454528393|FG000|Overall Study|Protocol Violation|13|||
126336813|NCT00744939|454528393|FG000|Overall Study|Death|24|||
126336814|NCT00744939|454528393|FG000|Overall Study|distance|4|||
126336815|NCT00744939|454528393|FG000|Overall Study|Lost to Follow-up|12|||
126336816|NCT00744939|454528393|FG000|Overall Study|Medical history exclusionary|1|||
126336817|NCT00744939|454528393|FG000|Overall Study|Did not receive Magnevist|7|||
126336818|NCT00744939|454528393|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
126336819|NCT00744939|454528393|FG000|Overall Study|coma|1|||
126336820|NCT00744939|454528393|FG000|Overall Study|incorrect race|1|||
126336821|NCT02452047|454528394|FG000|Overall Study|Adverse Event|0|||
126336822|NCT02452047|454528395|FG001|Overall Study|Adverse Event|1|||
126336823|NCT02452047|454528396|FG002|Overall Study|Adverse Event|1|||
126336824|NCT02452047|454528394|FG000|Overall Study|Death|1|||
126336825|NCT02452047|454528395|FG001|Overall Study|Death|3|||
126336826|NCT02452047|454528396|FG002|Overall Study|Death|1|||
126336827|NCT02452047|454528394|FG000|Overall Study|Physician Decision|1|||
126336828|NCT02452047|454528395|FG001|Overall Study|Physician Decision|0|||
126336829|NCT02452047|454528396|FG002|Overall Study|Physician Decision|0|||
126336830|NCT02452047|454528394|FG000|Overall Study|Lost to Follow-up|1|||
126336831|NCT02452047|454528395|FG001|Overall Study|Lost to Follow-up|1|||
126000303|NCT00333138|453290550|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
126336832|NCT02452047|454528396|FG002|Overall Study|Lost to Follow-up|0|||
126336833|NCT02452047|454528394|FG000|Overall Study|Withdrawal by Subject|1|||
126336834|NCT02452047|454528395|FG001|Overall Study|Withdrawal by Subject|0|||
126336835|NCT02452047|454528396|FG002|Overall Study|Withdrawal by Subject|0|||
126336836|NCT00288912|454528397|FG000|Overall Study|Developed exclusion criterion|4|||
126336837|NCT00288912|454528398|FG001|Overall Study|Developed exclusion criterion|6|||
126336838|NCT00288912|454528399|FG002|Overall Study|Developed exclusion criterion|7|||
126336839|NCT00288912|454528397|FG000|Overall Study|Lost to Follow-up|9|||
126336840|NCT00288912|454528398|FG001|Overall Study|Lost to Follow-up|6|||
126336841|NCT00288912|454528399|FG002|Overall Study|Lost to Follow-up|9|||
126336842|NCT00288912|454528397|FG000|Overall Study|Withdrawal by Subject|4|||
126336843|NCT00288912|454528398|FG001|Overall Study|Withdrawal by Subject|5|||
126336844|NCT00288912|454528399|FG002|Overall Study|Withdrawal by Subject|12|||
126336845|NCT02026141|454528403|FG000|Overall Study|Protocol Violation|0|||
126336846|NCT02026141|454528404|FG001|Overall Study|Protocol Violation|1|||
126336847|NCT01783743|454528409|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
126336848|NCT01783743|454528410|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
126336849|NCT01783743|454528409|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
126336850|NCT01783743|454528410|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
126336851|NCT01783743|454528409|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
126336852|NCT01783743|454528410|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
126336853|NCT02771275|454528411|FG000|Overall Study|Reoperation|3|||
126336854|NCT02771275|454528411|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
126336855|NCT00728494|454528424|FG000|Overall Study|Adverse Event|7|||
126336856|NCT00728494|454528425|FG001|Overall Study|Adverse Event|0|||
126336857|NCT00728494|454528424|FG000|Overall Study|Withdrawal by Subject|0|||
126336858|NCT00728494|454528425|FG001|Overall Study|Withdrawal by Subject|2|||
126336859|NCT00728494|454528424|FG000|Overall Study|Lack of Efficacy|2|||
126336860|NCT00728494|454528425|FG001|Overall Study|Lack of Efficacy|4|||
126336861|NCT00728494|454528424|FG000|Overall Study|No data available|0|||
126336862|NCT00728494|454528425|FG001|Overall Study|No data available|1|||
126336863|NCT03439137|454528426|FG000|Overall Study|Adverse Event|16|||
126336864|NCT03439137|454528427|FG001|Overall Study|Adverse Event|12|||
126000304|NCT00333138|453290551|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
126000305|NCT00333138|453290549|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
126000306|NCT00333138|453290550|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
126000307|NCT00333138|453290551|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
126000308|NCT00333138|453290549|FG000|Core Study (6 Months)|Protocol Violation|1|||
126000309|NCT00333138|453290550|FG001|Core Study (6 Months)|Protocol Violation|0|||
126000310|NCT00333138|453290551|FG002|Core Study (6 Months)|Protocol Violation|1|||
126000311|NCT00333138|453290549|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
126000312|NCT00333138|453290550|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
126000313|NCT00333138|453290551|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
126336865|NCT03439137|454528426|FG000|Overall Study|Physician Decision|0|||
126336866|NCT03439137|454528427|FG001|Overall Study|Physician Decision|5|||
126336867|NCT03439137|454528426|FG000|Overall Study|Withdrawal by Subject|14|||
126336868|NCT03439137|454528427|FG001|Overall Study|Withdrawal by Subject|4|||
126336869|NCT03439137|454528426|FG000|Overall Study|Conducting rescue therapy|2|||
126336870|NCT03439137|454528427|FG001|Overall Study|Conducting rescue therapy|1|||
126336871|NCT03439137|454528426|FG000|Overall Study|Difficult to control Hb|10|||
126336872|NCT03439137|454528427|FG001|Overall Study|Difficult to control Hb|2|||
126336873|NCT03439137|454528426|FG000|Overall Study|Initiation of a renal transplant|0|||
126336874|NCT03439137|454528427|FG001|Overall Study|Initiation of a renal transplant|2|||
126000314|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
126336875|NCT00748241|454528428|FG000|Overall Study|Implant failure|1|||
126000315|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
126000316|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
126000317|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
126000318|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
126000319|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
126000320|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
126336876|NCT00748241|454528428|FG000|Overall Study|Lost to Follow-up|5|||
126336877|NCT00748241|454528428|FG000|Overall Study|Death|2|||
126336878|NCT01240382|454528429|FG000|Overall Study|Adverse Event|2|||
126336879|NCT01240382|454528430|FG001|Overall Study|Adverse Event|1|||
126336880|NCT01240382|454528429|FG000|Overall Study|Lack of Efficacy|0|||
126336881|NCT01240382|454528430|FG001|Overall Study|Lack of Efficacy|2|||
126336882|NCT01240382|454528429|FG000|Overall Study|Fear of adverse events|0|||
126336883|NCT01240382|454528430|FG001|Overall Study|Fear of adverse events|1|||
126336884|NCT02456727|454528438|FG000|Overall Study|Lost to Follow-up|63|||
126336885|NCT02456727|454528439|FG001|Overall Study|Lost to Follow-up|65|||
126336886|NCT02456727|454528438|FG000|Overall Study|Death|2|||
126336887|NCT02456727|454528439|FG001|Overall Study|Death|1|||
126336888|NCT02456727|454528438|FG000|Overall Study|Withdrawal by Subject|1|||
126336889|NCT02456727|454528439|FG001|Overall Study|Withdrawal by Subject|10|||
126336890|NCT02456727|454528438|FG000|Overall Study|Never Initiated Treatment|43|||
126336891|NCT02456727|454528439|FG001|Overall Study|Never Initiated Treatment|30|||
126336892|NCT02643693|454528440|FG000|Overall Study|Physician Decision|0|||
126336893|NCT02643693|454528441|FG001|Overall Study|Physician Decision|1|||
126336894|NCT02643693|454528442|FG002|Overall Study|Physician Decision|0|||
126336895|NCT02643693|454528443|FG003|Overall Study|Physician Decision|0|||
126336896|NCT02643693|454528444|FG004|Overall Study|Physician Decision|0|||
126336897|NCT02643693|454528445|FG005|Overall Study|Physician Decision|0|||
126336898|NCT02643693|454528440|FG000|Overall Study|Withdrawal by Subject|0|||
126336899|NCT02643693|454528441|FG001|Overall Study|Withdrawal by Subject|1|||
126336900|NCT02643693|454528442|FG002|Overall Study|Withdrawal by Subject|0|||
126336901|NCT02643693|454528443|FG003|Overall Study|Withdrawal by Subject|0|||
126336902|NCT02643693|454528444|FG004|Overall Study|Withdrawal by Subject|0|||
126336903|NCT02643693|454528445|FG005|Overall Study|Withdrawal by Subject|0|||
126336904|NCT02643693|454528440|FG000|Overall Study|Protocol Adherence Issues|2|||
126336905|NCT02643693|454528441|FG001|Overall Study|Protocol Adherence Issues|0|||
126336906|NCT02643693|454528442|FG002|Overall Study|Protocol Adherence Issues|1|||
126336907|NCT02643693|454528443|FG003|Overall Study|Protocol Adherence Issues|0|||
126336908|NCT02643693|454528444|FG004|Overall Study|Protocol Adherence Issues|0|||
126336909|NCT02643693|454528445|FG005|Overall Study|Protocol Adherence Issues|1|||
126336910|NCT01408706|454528446|FG000|Overall Study|Physician Decision|1|||
126336911|NCT01408706|454528447|FG001|Overall Study|Physician Decision|0|||
126336912|NCT03669549|454528450|FG000|Overall Study|Adverse Event|4|||
126336913|NCT03669549|454528450|FG000|Overall Study|Withdrawal by Subject|1|||
126336914|NCT03669549|454528450|FG000|Overall Study|Study terminated by the Sponsor|1|||
126336915|NCT00698815|454528451|FG000|Overall Study|Death|1|||
126336916|NCT00698815|454528452|FG001|Overall Study|Death|2|||
126336917|NCT00698815|454528453|FG002|Overall Study|Death|4|||
126336918|NCT00698815|454528451|FG000|Overall Study|Withdrawal by Subject|6|||
126336919|NCT00698815|454528452|FG001|Overall Study|Withdrawal by Subject|3|||
126336920|NCT00698815|454528453|FG002|Overall Study|Withdrawal by Subject|2|||
126336921|NCT00698815|454528451|FG000|Overall Study|MD discretion|2|||
126336922|NCT00698815|454528452|FG001|Overall Study|MD discretion|7|||
126336923|NCT00698815|454528453|FG002|Overall Study|MD discretion|2|||
126336924|NCT00698815|454528451|FG000|Overall Study|Did not receive protocol treatment|1|||
126336925|NCT00698815|454528452|FG001|Overall Study|Did not receive protocol treatment|2|||
126336926|NCT00698815|454528453|FG002|Overall Study|Did not receive protocol treatment|2|||
126336927|NCT02974868|454528454|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
126336928|NCT02974868|454528455|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
126336929|NCT02974868|454528456|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
126000321|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
126000322|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
126336930|NCT02974868|454528457|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
126336931|NCT02974868|454528454|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
126336932|NCT02974868|454528455|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
126336933|NCT02974868|454528456|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
126336934|NCT02974868|454528457|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
126336935|NCT02974868|454528454|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
126336936|NCT02974868|454528455|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
126336937|NCT02974868|454528456|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
126336938|NCT02974868|454528457|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
126336939|NCT02974868|454528454|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
126336940|NCT02974868|454528455|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
126000323|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
126000324|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
126000325|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
126000326|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
126000327|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
126000328|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
126000329|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
126000330|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
126000331|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
126000332|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
126000333|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
126000334|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
126000335|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
126000336|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
126000337|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
126000338|NCT00333138|453290549|FG000|Extension Study (Month6 to End of Study)|Death|0|||
126000339|NCT00333138|453290550|FG001|Extension Study (Month6 to End of Study)|Death|1|||
126000340|NCT00333138|453290551|FG002|Extension Study (Month6 to End of Study)|Death|0|||
126000341|NCT05593211|453290552|FG000|Overall Study|Withdrawal by Subject|1|||
126000342|NCT03077620|453290556|FG000|Overall Study|Unable to place lumbar catheter|1|||
126000343|NCT03077620|453290557|FG001|Overall Study|Unable to place lumbar catheter|0|||
126000344|NCT03077620|453290558|FG002|Overall Study|Unable to place lumbar catheter|1|||
126000345|NCT03077620|453290559|FG003|Overall Study|Unable to place lumbar catheter|0|||
126000346|NCT03077620|453290556|FG000|Overall Study|Withdrawal by Subject|0|||
126000347|NCT03077620|453290557|FG001|Overall Study|Withdrawal by Subject|1|||
126000348|NCT03077620|453290558|FG002|Overall Study|Withdrawal by Subject|0|||
126000349|NCT03077620|453290559|FG003|Overall Study|Withdrawal by Subject|0|||
126000350|NCT03077620|453290556|FG000|Overall Study|Physician Decision|0|||
126336941|NCT02974868|454528456|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
126336942|NCT02974868|454528457|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
126336943|NCT00297648|454528460|FG000|Overall Study|Adverse Event|13|||
126336944|NCT00297648|454528460|FG000|Overall Study|Lack of Efficacy|18|||
126336945|NCT00297648|454528460|FG000|Overall Study|Lost to Follow-up|1|||
126336946|NCT00297648|454528460|FG000|Overall Study|Withdrawal by Subject|3|||
126336947|NCT00297648|454528460|FG000|Overall Study|Other: Incompliance|1|||
126336948|NCT03575702|454528461|FG000|Overall Study|Withdrawal by Subject|1|||
126336949|NCT03575702|454528462|FG001|Overall Study|Withdrawal by Subject|1|||
126336950|NCT03575702|454528461|FG000|Overall Study|Lost to Follow-up|1|||
126336951|NCT03575702|454528462|FG001|Overall Study|Lost to Follow-up|2|||
126336952|NCT03575702|454528461|FG000|Overall Study|Protocol Violation|0|||
126336953|NCT03575702|454528462|FG001|Overall Study|Protocol Violation|1|||
126336954|NCT03575702|454528461|FG000|Overall Study|Patient non compliance|4|||
126336955|NCT03575702|454528462|FG001|Overall Study|Patient non compliance|0|||
126336956|NCT03903172|454528463|FG000|Overall Study|screen fail|4|||
126336957|NCT03903172|454528464|FG001|Overall Study|screen fail|1|||
126336958|NCT01545388|454528465|FG000|Overall Study|Adverse Event|2|||
126336959|NCT01545388|454528466|FG001|Overall Study|Adverse Event|4|||
126336960|NCT01545388|454528467|FG002|Overall Study|Adverse Event|1|||
126336961|NCT01545388|454528465|FG000|Overall Study|Lack of Efficacy|3|||
126336962|NCT01545388|454528466|FG001|Overall Study|Lack of Efficacy|2|||
126336963|NCT01545388|454528467|FG002|Overall Study|Lack of Efficacy|5|||
126336964|NCT01545388|454528465|FG000|Overall Study|Participant moved or relocated|1|||
126336965|NCT01545388|454528466|FG001|Overall Study|Participant moved or relocated|0|||
126336966|NCT01545388|454528467|FG002|Overall Study|Participant moved or relocated|0|||
126336967|NCT01545388|454528465|FG000|Overall Study|Withdrawal by Subject|1|||
126336968|NCT01545388|454528466|FG001|Overall Study|Withdrawal by Subject|4|||
126336969|NCT01545388|454528467|FG002|Overall Study|Withdrawal by Subject|2|||
126336970|NCT01545388|454528465|FG000|Overall Study|Other|1|||
126336971|NCT01545388|454528466|FG001|Overall Study|Other|1|||
126336972|NCT01545388|454528467|FG002|Overall Study|Other|0|||
126336973|NCT01255163|454528468|FG000|Overall Study|Withdrawal by Subject|1|||
126336974|NCT01255163|454528469|FG001|Overall Study|Withdrawal by Subject|0|||
126336975|NCT01255163|454528468|FG000|Overall Study|Lost to Follow-up|2|||
126336976|NCT01255163|454528469|FG001|Overall Study|Lost to Follow-up|0|||
126336977|NCT01255163|454528468|FG000|Overall Study|Adverse Event|0|||
126000351|NCT03077620|453290557|FG001|Overall Study|Physician Decision|0|||
126000352|NCT03077620|453290558|FG002|Overall Study|Physician Decision|1|||
126000353|NCT03077620|453290559|FG003|Overall Study|Physician Decision|0|||
126000354|NCT03225846|453290560|FG000|Overall Study|Adverse Event|0|||
126336978|NCT01255163|454528469|FG001|Overall Study|Adverse Event|2|||
126336979|NCT01255163|454528468|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
126336980|NCT01255163|454528469|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
126336981|NCT02495389|454528470|FG000|Overall Study|Withdrawal by Subject|40|||
126336982|NCT01802385|454528474|FG000|Overall Study|Death|106|||
126336983|NCT01802385|454528475|FG001|Overall Study|Death|120|||
126336984|NCT03834493|454528476|FG000|Overall Study|Participants Ongoing|311|||
126336985|NCT03834493|454528477|FG001|Overall Study|Participants Ongoing|324|||
126336986|NCT03834493|454528476|FG000|Overall Study|Withdrawal by Subject|20|||
126336987|NCT03834493|454528477|FG001|Overall Study|Withdrawal by Subject|17|||
126336988|NCT03834493|454528476|FG000|Overall Study|Physician Decision|1|||
126336989|NCT03834493|454528477|FG001|Overall Study|Physician Decision|0|||
126336990|NCT03834493|454528476|FG000|Overall Study|Death|289|||
126000355|NCT03225846|453290561|FG001|Overall Study|Adverse Event|0|||
126000356|NCT03225846|453290562|FG002|Overall Study|Adverse Event|0|||
126000357|NCT03225846|453290563|FG003|Overall Study|Adverse Event|0|||
126000358|NCT03225846|453290564|FG004|Overall Study|Adverse Event|0|||
126000359|NCT03225846|453290565|FG005|Overall Study|Adverse Event|0|||
126000360|NCT03225846|453290566|FG006|Overall Study|Adverse Event|6|||
126000361|NCT03225846|453290560|FG000|Overall Study|Withdrawal by Subject|0|||
126000362|NCT03225846|453290561|FG001|Overall Study|Withdrawal by Subject|1|||
126000363|NCT03225846|453290562|FG002|Overall Study|Withdrawal by Subject|0|||
126000364|NCT03225846|453290563|FG003|Overall Study|Withdrawal by Subject|0|||
126000365|NCT03225846|453290564|FG004|Overall Study|Withdrawal by Subject|0|||
126000366|NCT03225846|453290565|FG005|Overall Study|Withdrawal by Subject|0|||
126000367|NCT03225846|453290566|FG006|Overall Study|Withdrawal by Subject|0|||
126000368|NCT03225846|453290560|FG000|Overall Study|Death|0|||
126000369|NCT03225846|453290561|FG001|Overall Study|Death|1|||
126000370|NCT03225846|453290562|FG002|Overall Study|Death|0|||
126000371|NCT03225846|453290563|FG003|Overall Study|Death|0|||
126000372|NCT03225846|453290564|FG004|Overall Study|Death|0|||
126209443|NCT03110107|454055400|FG007|Treatment Period|Study drug toxicity|1|||
126209444|NCT03110107|454055401|FG008|Treatment Period|Study drug toxicity|3|||
126209445|NCT03110107|454055402|FG009|Treatment Period|Study drug toxicity|2|||
126209446|NCT03110107|454055403|FG010|Treatment Period|Study drug toxicity|0|||
126209447|NCT03110107|454055404|FG011|Treatment Period|Study drug toxicity|2|||
126209448|NCT03110107|454055405|FG012|Treatment Period|Study drug toxicity|0|||
126209449|NCT03110107|454055406|FG013|Treatment Period|Study drug toxicity|0|||
126209450|NCT03110107|454055407|FG014|Treatment Period|Study drug toxicity|2|||
126209451|NCT03110107|454055408|FG015|Treatment Period|Study drug toxicity|3|||
126209452|NCT03110107|454055409|FG016|Treatment Period|Study drug toxicity|3|||
126209453|NCT03110107|454055410|FG017|Treatment Period|Study drug toxicity|3|||
126209454|NCT03110107|454055411|FG018|Treatment Period|Study drug toxicity|1|||
126209455|NCT03110107|454055412|FG019|Treatment Period|Study drug toxicity|2|||
126209456|NCT03110107|454055413|FG020|Treatment Period|Study drug toxicity|2|||
126209457|NCT03110107|454055414|FG021|Treatment Period|Study drug toxicity|0|||
126209458|NCT03110107|454055415|FG022|Treatment Period|Study drug toxicity|2|||
126209459|NCT03110107|454055416|FG023|Treatment Period|Study drug toxicity|6|||
126336991|NCT03834493|454528477|FG001|Overall Study|Death|282|||
126336992|NCT05559905|454528478|FG000|Overall Study|Withdrawal by Subject|1|||
126000373|NCT03225846|453290565|FG005|Overall Study|Death|0|||
126000374|NCT03225846|453290566|FG006|Overall Study|Death|0|||
126000375|NCT03225846|453290560|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
126000376|NCT03225846|453290561|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
126000377|NCT03225846|453290562|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
126000378|NCT03225846|453290563|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
126000379|NCT03225846|453290564|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
126000380|NCT03225846|453290565|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
126000381|NCT03225846|453290566|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
126000382|NCT03225846|453290560|FG000|Overall Study|Patient decision|0|||
126000383|NCT03225846|453290561|FG001|Overall Study|Patient decision|0|||
126000384|NCT03225846|453290562|FG002|Overall Study|Patient decision|0|||
126000385|NCT03225846|453290563|FG003|Overall Study|Patient decision|0|||
126000386|NCT03225846|453290564|FG004|Overall Study|Patient decision|0|||
126000387|NCT03225846|453290565|FG005|Overall Study|Patient decision|0|||
126000388|NCT03225846|453290566|FG006|Overall Study|Patient decision|1|||
126000389|NCT00238420|453290567|FG000|Overall Study|Protocol Violation|1|||
126000390|NCT00238420|453290568|FG001|Overall Study|Protocol Violation|1|||
126000391|NCT04140890|453290571|FG000|Overall Study|Withdrawal by Subject|0|||
126000392|NCT04140890|453290572|FG001|Overall Study|Withdrawal by Subject|1|||
126000393|NCT02102464|453290573|FG000|Randomized Study|Withdrawal by Subject|0|||
126000394|NCT02102464|453290574|FG001|Randomized Study|Withdrawal by Subject|1|||
126336993|NCT05559905|454528479|FG001|Overall Study|Withdrawal by Subject|0|||
126000395|NCT02102464|453290575|FG002|Randomized Study|Withdrawal by Subject|0|||
126000396|NCT03958630|453290576|FG000|Overall Study|Withdrawal by Subject|0|||
126000397|NCT03958630|453290577|FG001|Overall Study|Withdrawal by Subject|0|||
126000398|NCT03958630|453290578|FG002|Overall Study|Withdrawal by Subject|1|||
126000399|NCT03958630|453290576|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
126209460|NCT03110107|454055417|FG024|Treatment Period|Study drug toxicity|7|||
126209461|NCT03110107|454055418|FG025|Treatment Period|Study drug toxicity|6|||
126209462|NCT03110107|454055393|FG000|Treatment Period|Death|0|||
126336994|NCT05559905|454528480|FG002|Overall Study|Withdrawal by Subject|0|||
126336995|NCT05559905|454528478|FG000|Overall Study|Not Reported|1|||
126336996|NCT05559905|454528479|FG001|Overall Study|Not Reported|0|||
126336997|NCT05559905|454528480|FG002|Overall Study|Not Reported|0|||
126336998|NCT04003103|454528481|FG000|Overall Study|Death|1|||
126336999|NCT04003103|454528482|FG001|Overall Study|Death|0|||
126337000|NCT04003103|454528483|FG002|Overall Study|Death|0|||
126337001|NCT04003103|454528481|FG000|Overall Study|Lost to Follow-up|4|||
126337002|NCT04003103|454528482|FG001|Overall Study|Lost to Follow-up|3|||
126337003|NCT04003103|454528483|FG002|Overall Study|Lost to Follow-up|2|||
126337004|NCT04003103|454528481|FG000|Overall Study|Withdrawal by Subject|10|||
126337005|NCT04003103|454528482|FG001|Overall Study|Withdrawal by Subject|1|||
126337006|NCT04003103|454528483|FG002|Overall Study|Withdrawal by Subject|1|||
126337007|NCT04003103|454528481|FG000|Overall Study|Status not recorded|0|||
126337008|NCT04003103|454528482|FG001|Overall Study|Status not recorded|2|||
126337009|NCT04003103|454528483|FG002|Overall Study|Status not recorded|0|||
126337010|NCT03829462|454528488|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
126337011|NCT03829462|454528489|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
126337012|NCT03829462|454528488|FG000|Overall Study|No treatment due to progression disease|0|||
126337013|NCT03829462|454528489|FG001|Overall Study|No treatment due to progression disease|1|||
126337014|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
126337015|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
126337016|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
126337017|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Adverse Event|2|||
126337018|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Adverse Event|0|||
126337019|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Adverse Event|1|||
126337020|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
126337021|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
126337022|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
126337023|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
126337024|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
126337025|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
126000400|NCT03958630|453290577|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
126000401|NCT03958630|453290578|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
126000402|NCT00245011|453290581|FG000|Overall Study|Lack of Efficacy|1|||
126337026|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Other Reasons|2|||
126337027|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Other Reasons|0|||
126000403|NCT03040687|453290582|FG000|Overall Study|Withdrawal by Subject|1|||
126000404|NCT03040687|453290583|FG001|Overall Study|Withdrawal by Subject|0|||
126000405|NCT03040687|453290584|FG002|Overall Study|Withdrawal by Subject|0|||
126000406|NCT00107380|453292508|FG000|Overall Study|Adverse Event|7|||
126000407|NCT00107380|453292508|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
126000408|NCT00107380|453292508|FG000|Overall Study|Progression/relapse|4|||
126000409|NCT00107380|453292508|FG000|Overall Study|Death|3|||
126000410|NCT00107380|453292508|FG000|Overall Study|Other - not protocol specified|7|||
126000411|NCT00107380|453292508|FG000|Overall Study|Ineligible|2|||
126000412|NCT03673098|453292509|FG000|Overall Study|Lost to Follow-up|2|||
126000413|NCT03673098|453292510|FG001|Overall Study|Lost to Follow-up|3|||
126000414|NCT03673098|453292509|FG000|Overall Study|Withdrawal by Subject|6|||
126000415|NCT03673098|453292510|FG001|Overall Study|Withdrawal by Subject|1|||
126000416|NCT03673098|453292509|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
126000417|NCT03673098|453292510|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
126000418|NCT03531905|453292515|FG000|Overall Study|Withdrawal by Subject|3|||
126000419|NCT03531905|453292516|FG001|Overall Study|Withdrawal by Subject|3|||
126000420|NCT03531905|453292517|FG002|Overall Study|Withdrawal by Subject|2|||
126000421|NCT03531905|453292515|FG000|Overall Study|Lost to Follow-up|2|||
126000422|NCT03531905|453292516|FG001|Overall Study|Lost to Follow-up|2|||
126000423|NCT03531905|453292517|FG002|Overall Study|Lost to Follow-up|1|||
126000424|NCT03531905|453292515|FG000|Overall Study|Participant was out of town|1|||
126000425|NCT03531905|453292516|FG001|Overall Study|Participant was out of town|0|||
126000426|NCT03531905|453292517|FG002|Overall Study|Participant was out of town|0|||
126000427|NCT03531905|453292515|FG000|Overall Study|Could not speak with the participant|1|||
126000428|NCT03531905|453292516|FG001|Overall Study|Could not speak with the participant|0|||
126000429|NCT03531905|453292517|FG002|Overall Study|Could not speak with the participant|0|||
126000430|NCT01155726|453292518|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
126000431|NCT01155726|453292519|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
126000432|NCT01155726|453292520|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
126337028|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Other Reasons|0|||
126337029|NCT04613518|454528491|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
126337030|NCT04613518|454528492|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
126337031|NCT04613518|454528493|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
126337032|NCT04613518|454528491|FG000|Open-Label Treatment Period|Adverse Event|1|||
126000433|NCT01155726|453292521|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
126000434|NCT01536262|453292522|FG000|Overall Study|Adverse Event|6|||
126000435|NCT01536262|453292523|FG001|Overall Study|Adverse Event|1|||
126000436|NCT01536262|453292524|FG002|Overall Study|Adverse Event|2|||
126000437|NCT01536262|453292522|FG000|Overall Study|Withdrawal by Subject|1|||
126000438|NCT01536262|453292523|FG001|Overall Study|Withdrawal by Subject|1|||
126337033|NCT04613518|454528492|FG001|Open-Label Treatment Period|Adverse Event|0|||
126337034|NCT04613518|454528493|FG002|Open-Label Treatment Period|Adverse Event|3|||
126337035|NCT04613518|454528491|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
126337036|NCT04613518|454528492|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
126337037|NCT04613518|454528493|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
126337038|NCT04613518|454528491|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
126337039|NCT04613518|454528492|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
126337040|NCT04613518|454528493|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
126337041|NCT04613518|454528491|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
126337042|NCT04613518|454528492|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
126337043|NCT04613518|454528493|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
126337044|NCT04613518|454528491|FG000|Open-Label Treatment Period|Other reasons|1|||
126337045|NCT04613518|454528492|FG001|Open-Label Treatment Period|Other reasons|0|||
126337046|NCT04613518|454528493|FG002|Open-Label Treatment Period|Other reasons|0|||
126337047|NCT04113694|454530831|FG000|Overall Study|Adverse Event|2|||
126337048|NCT04113694|454530831|FG000|Overall Study|Lost to Follow-up|2|||
126337049|NCT04113694|454530831|FG000|Overall Study|Withdrawal by Subject|6|||
126337050|NCT04113694|454530831|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
126337051|NCT03638128|454530836|FG000|Overall Study|Withdrawal by Subject|1|||
126337052|NCT03638128|454530837|FG001|Overall Study|Withdrawal by Subject|7|||
126337053|NCT03638128|454530838|FG002|Overall Study|Withdrawal by Subject|6|||
126337054|NCT03638128|454530836|FG000|Overall Study|Sponsor Decision|15|||
126337055|NCT03638128|454530837|FG001|Overall Study|Sponsor Decision|12|||
126337056|NCT03638128|454530838|FG002|Overall Study|Sponsor Decision|19|||
126337057|NCT03638128|454530836|FG000|Overall Study|Lost to Follow-up|0|||
126337058|NCT03638128|454530837|FG001|Overall Study|Lost to Follow-up|0|||
126337059|NCT03638128|454530838|FG002|Overall Study|Lost to Follow-up|1|||
126337060|NCT01307787|454530840|FG000|Overall Study|Withdrawal by Subject|2|||
126337061|NCT01307787|454530841|FG001|Overall Study|Withdrawal by Subject|0|||
126337062|NCT01965327|454530847|FG000|Overall Study|Physician Decision|2|||
126337063|NCT02579629|454530865|FG000|Overall Study|Withdrawal by Subject|0|||
126337064|NCT02579629|454530866|FG001|Overall Study|Withdrawal by Subject|1|||
126337065|NCT02579629|454530867|FG002|Overall Study|Withdrawal by Subject|0|||
126337066|NCT02579629|454530865|FG000|Overall Study|Screen Failure|2|||
126337067|NCT02579629|454530866|FG001|Overall Study|Screen Failure|0|||
126337068|NCT02579629|454530867|FG002|Overall Study|Screen Failure|2|||
126337069|NCT00830219|454530868|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126337070|NCT00830219|454530869|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126337071|NCT01294423|454530870|FG000|Overall Study|Adverse Event|1|||
126337072|NCT01294423|454530871|FG001|Overall Study|Adverse Event|2|||
126337073|NCT01294423|454530872|FG002|Overall Study|Adverse Event|3|||
126337074|NCT01294423|454530870|FG000|Overall Study|Withdrawal by Subject|1|||
126337075|NCT01294423|454530871|FG001|Overall Study|Withdrawal by Subject|2|||
126337076|NCT01294423|454530872|FG002|Overall Study|Withdrawal by Subject|2|||
126337077|NCT01294423|454530870|FG000|Overall Study|subject no longer meets study criteria|2|||
126337078|NCT01294423|454530871|FG001|Overall Study|subject no longer meets study criteria|5|||
126337079|NCT01294423|454530872|FG002|Overall Study|subject no longer meets study criteria|2|||
126337080|NCT01294423|454530870|FG000|Overall Study|poor/non-compliance|1|||
126337081|NCT01294423|454530871|FG001|Overall Study|poor/non-compliance|0|||
126337082|NCT01294423|454530872|FG002|Overall Study|poor/non-compliance|1|||
126337083|NCT01145482|454530873|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
126337084|NCT01145482|454530874|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
126337085|NCT01699750|454530875|FG000|Overall Study|Withdrew Consent|0|||
126337086|NCT01699750|454530876|FG001|Overall Study|Withdrew Consent|1|||
126337087|NCT01699750|454530875|FG000|Overall Study|Other|0|||
126337088|NCT01699750|454530876|FG001|Overall Study|Other|2|||
126337089|NCT04635839|454530877|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
126337090|NCT04635839|454530878|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
126337091|NCT02737358|454530879|FG000|Overall Study|Withdrawal by Subject|7|||
126000439|NCT01536262|453292524|FG002|Overall Study|Withdrawal by Subject|0|||
126000440|NCT01536262|453292522|FG000|Overall Study|Other than stated above|1|||
126337092|NCT02737358|454530880|FG001|Overall Study|Withdrawal by Subject|12|||
126337093|NCT02737358|454530879|FG000|Overall Study|Lost to Follow-up|2|||
126337094|NCT02737358|454530880|FG001|Overall Study|Lost to Follow-up|3|||
126337095|NCT00896493|454530881|FG000|Overall Study|Early disease relapse|3|||
126337096|NCT02870868|454530882|FG000|Overall Study|Withdrawal by Subject|2|||
126337097|NCT02870868|454530883|FG001|Overall Study|Withdrawal by Subject|1|||
126337098|NCT01739335|454530884|FG000|Overall Study|Lost to Follow-up|7|||
126000441|NCT01536262|453292523|FG001|Overall Study|Other than stated above|0|||
126000442|NCT01536262|453292524|FG002|Overall Study|Other than stated above|0|||
126337099|NCT01739335|454530885|FG001|Overall Study|Lost to Follow-up|4|||
126000443|NCT01781611|453292528|FG000|Overall Study|Adverse Event|4|||
126000444|NCT01781611|453292529|FG001|Overall Study|Adverse Event|0|||
126000445|NCT03639675|453292530|FG000|Overall Study|Withdrawal by Subject|1|||
126000446|NCT02459587|453292531|FG000|3-Month Follow-up Assessment|Death|0|||
126000447|NCT02459587|453292532|FG001|3-Month Follow-up Assessment|Death|2|||
126000448|NCT02459587|453292531|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
126000449|NCT02459587|453292532|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
126000450|NCT02459587|453292531|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
126000451|NCT02459587|453292532|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
126000452|NCT02459587|453292531|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
126000453|NCT02459587|453292532|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
126000454|NCT02459587|453292531|FG000|6-month Follow-up Assessment|Death|2|||
126000455|NCT02459587|453292532|FG001|6-month Follow-up Assessment|Death|1|||
126000456|NCT02459587|453292531|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
126000457|NCT02459587|453292532|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
126000458|NCT02459587|453292531|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
126000459|NCT02459587|453292532|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
126000460|NCT02459587|453292531|FG000|12-month Follow-up Assessment|Death|2|||
126000461|NCT02459587|453292532|FG001|12-month Follow-up Assessment|Death|0|||
126000462|NCT02459587|453292531|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
126000463|NCT02459587|453292532|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
126000464|NCT02459587|453292531|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
126000465|NCT02459587|453292532|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
126000466|NCT02459587|453292531|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
126000467|NCT02459587|453292532|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
126000468|NCT02264574|453292533|FG000|Overall Study|Death|21|||
126000469|NCT02264574|453292534|FG001|Overall Study|Death|21|||
126000470|NCT02264574|453292533|FG000|Overall Study|Withdrawal by Subject|8|||
126000471|NCT02264574|453292534|FG001|Overall Study|Withdrawal by Subject|6|||
126000472|NCT02264574|453292533|FG000|Overall Study|Other, Not Specified|0|||
126000473|NCT02264574|453292534|FG001|Overall Study|Other, Not Specified|3|||
126000474|NCT01477749|453292536|FG000|Overall Study|Physician Decision|4|||
126000475|NCT02886728|453292540|FG000|Overall Study|Withdrew Consent|31|||
126000476|NCT02886728|453292541|FG001|Overall Study|Withdrew Consent|13|||
126000477|NCT02886728|453292542|FG002|Overall Study|Withdrew Consent|11|||
126000478|NCT02886728|453292543|FG003|Overall Study|Withdrew Consent|47|||
126000479|NCT02886728|453292540|FG000|Overall Study|Lost to Follow-up|12|||
126000480|NCT02886728|453292541|FG001|Overall Study|Lost to Follow-up|6|||
126000481|NCT02886728|453292542|FG002|Overall Study|Lost to Follow-up|13|||
126000482|NCT02886728|453292543|FG003|Overall Study|Lost to Follow-up|12|||
126000483|NCT02886728|453292540|FG000|Overall Study|Adverse Event|13|||
126000484|NCT02886728|453292541|FG001|Overall Study|Adverse Event|5|||
126000485|NCT02886728|453292542|FG002|Overall Study|Adverse Event|5|||
126000486|NCT02886728|453292543|FG003|Overall Study|Adverse Event|11|||
126000487|NCT02886728|453292540|FG000|Overall Study|Investigator's Discretion|11|||
126000488|NCT02886728|453292541|FG001|Overall Study|Investigator's Discretion|7|||
126000489|NCT02886728|453292542|FG002|Overall Study|Investigator's Discretion|5|||
126000490|NCT02886728|453292543|FG003|Overall Study|Investigator's Discretion|11|||
126000491|NCT02886728|453292540|FG000|Overall Study|Death|3|||
126000492|NCT02886728|453292541|FG001|Overall Study|Death|1|||
126000493|NCT02886728|453292542|FG002|Overall Study|Death|0|||
126337100|NCT01739335|454530884|FG000|Overall Study|Ineligible patient randomized|0|||
126337101|NCT01739335|454530885|FG001|Overall Study|Ineligible patient randomized|1|||
126337102|NCT01868646|454530888|FG000|Overall Study|Do not meet inclusion criteria|3|||
126337103|NCT01868646|454530889|FG001|Overall Study|Do not meet inclusion criteria|5|||
126337104|NCT03191799|454530892|FG000|Overall Study|Withdrawal by Subject|4|||
126337105|NCT03191799|454530892|FG000|Overall Study|Physician Decision|2|||
126000494|NCT02886728|453292543|FG003|Overall Study|Death|0|||
126000495|NCT02886728|453292540|FG000|Overall Study|Protocol Violation|0|||
126000496|NCT02886728|453292541|FG001|Overall Study|Protocol Violation|0|||
126000497|NCT02886728|453292542|FG002|Overall Study|Protocol Violation|0|||
126000498|NCT02886728|453292543|FG003|Overall Study|Protocol Violation|4|||
126000499|NCT02886728|453292540|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126000500|NCT02886728|453292541|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126000501|NCT02886728|453292542|FG002|Overall Study|Non-Compliance with Study Drug|1|||
126000502|NCT02886728|453292543|FG003|Overall Study|Non-Compliance with Study Drug|0|||
126000503|NCT02886728|453292540|FG000|Overall Study|Pregnancy|0|||
126000504|NCT02886728|453292541|FG001|Overall Study|Pregnancy|0|||
126337106|NCT03191799|454530892|FG000|Overall Study|Lost to Follow-up|1|||
126337107|NCT03191799|454530892|FG000|Overall Study|Death|2|||
126000505|NCT02886728|453292542|FG002|Overall Study|Pregnancy|1|||
126337108|NCT00853762|454530900|FG000|Overall Study|Premature Termination|16|||
126000506|NCT02886728|453292543|FG003|Overall Study|Pregnancy|0|||
126000507|NCT02886728|453292540|FG000|Overall Study|Randomized but Not Dosed|1|||
126000508|NCT02886728|453292541|FG001|Overall Study|Randomized but Not Dosed|0|||
126000509|NCT02886728|453292542|FG002|Overall Study|Randomized but Not Dosed|0|||
126000510|NCT02886728|453292543|FG003|Overall Study|Randomized but Not Dosed|2|||
126000511|NCT00884286|453292544|FG000|Overall Study|Progressive disease|21|||
126000512|NCT00884286|453292545|FG001|Overall Study|Progressive disease|28|||
126000513|NCT00884286|453292544|FG000|Overall Study|Toxicity|4|||
126000514|NCT00884286|453292545|FG001|Overall Study|Toxicity|1|||
126000515|NCT00884286|453292544|FG000|Overall Study|Death|2|||
126000516|NCT00884286|453292545|FG001|Overall Study|Death|2|||
126000517|NCT00884286|453292544|FG000|Overall Study|Physician Decision|1|||
126000518|NCT00884286|453292545|FG001|Overall Study|Physician Decision|0|||
126000519|NCT00884286|453292544|FG000|Overall Study|Septic shock|1|||
126000520|NCT00884286|453292545|FG001|Overall Study|Septic shock|0|||
126000521|NCT00884286|453292544|FG000|Overall Study|Thrombus in right auricle|1|||
126000522|NCT00884286|453292545|FG001|Overall Study|Thrombus in right auricle|0|||
126000523|NCT00884286|453292544|FG000|Overall Study|Not treated|2|||
126000524|NCT00884286|453292545|FG001|Overall Study|Not treated|1|||
126000525|NCT00884286|453292544|FG000|Overall Study|Comprised lung carcinoma|0|||
126000526|NCT00884286|453292545|FG001|Overall Study|Comprised lung carcinoma|1|||
126000527|NCT02724020|453292551|FG000|Overall Study|Death|16|||
126000528|NCT02724020|453292552|FG001|Overall Study|Death|18|||
126000529|NCT02724020|453292553|FG002|Overall Study|Death|19|||
126000530|NCT02724020|453292551|FG000|Overall Study|Lost to Follow-up|0|||
126000531|NCT02724020|453292552|FG001|Overall Study|Lost to Follow-up|3|||
126000532|NCT02724020|453292553|FG002|Overall Study|Lost to Follow-up|0|||
126000533|NCT02724020|453292551|FG000|Overall Study|Site Terminated by Sponsor|15|||
126000534|NCT02724020|453292552|FG001|Overall Study|Site Terminated by Sponsor|8|||
126337109|NCT00853762|454530901|FG001|Overall Study|Premature Termination|15|||
126337110|NCT00853762|454530902|FG002|Overall Study|Premature Termination|14|||
126000535|NCT02724020|453292553|FG002|Overall Study|Site Terminated by Sponsor|8|||
126000536|NCT02724020|453292551|FG000|Overall Study|Withdrawal by Subject|1|||
126000537|NCT02724020|453292552|FG001|Overall Study|Withdrawal by Subject|3|||
126000538|NCT02724020|453292553|FG002|Overall Study|Withdrawal by Subject|5|||
126000539|NCT00425503|453292554|FG000|Overall Study|Adverse Event|2|||
126000540|NCT00425503|453292554|FG000|Overall Study|Protocol Violation|1|||
126000541|NCT02118714|453292556|FG000|Overall Study|Lost to Follow-up|2|||
126000542|NCT02118714|453292556|FG000|Overall Study|Protocol Violation|1|||
126000543|NCT01310868|453292557|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
126000544|NCT02411591|453292558|FG000|Overall Study|Adverse Event|0|||
126000545|NCT02411591|453292559|FG001|Overall Study|Adverse Event|4|||
126000546|NCT02411591|453292560|FG002|Overall Study|Adverse Event|2|||
126000547|NCT02411591|453292558|FG000|Overall Study|Withdrawal by Subject|0|||
126000548|NCT02411591|453292559|FG001|Overall Study|Withdrawal by Subject|3|||
126000549|NCT02411591|453292560|FG002|Overall Study|Withdrawal by Subject|0|||
126000550|NCT02411591|453292558|FG000|Overall Study|Physician Decision|0|||
126000551|NCT02411591|453292559|FG001|Overall Study|Physician Decision|3|||
126000552|NCT02411591|453292560|FG002|Overall Study|Physician Decision|1|||
126000553|NCT02491892|453292561|FG000|Overall Study|Adverse Event|1|||
126000554|NCT02491892|453292562|FG001|Overall Study|Adverse Event|1|||
126000555|NCT02491892|453292561|FG000|Overall Study|Death|1|||
126000556|NCT02491892|453292562|FG001|Overall Study|Death|1|||
126000557|NCT02491892|453292561|FG000|Overall Study|Lack of Efficacy|37|||
126000558|NCT02491892|453292562|FG001|Overall Study|Lack of Efficacy|36|||
126000559|NCT02491892|453292561|FG000|Overall Study|Refused Treatment|1|||
126000560|NCT02491892|453292562|FG001|Overall Study|Refused Treatment|0|||
126000561|NCT02491892|453292561|FG000|Overall Study|Lost to Follow-up|1|||
126000562|NCT02491892|453292562|FG001|Overall Study|Lost to Follow-up|0|||
126000563|NCT04227340|453292563|FG000|Overall Study|Withdrawal by Subject|3|||
126000564|NCT01066156|453292564|FG000|Overall Study|ineligible|2|||
126000565|NCT01066156|453292564|FG000|Overall Study|Lost to Follow-up|7|||
126337111|NCT00853762|454530903|FG003|Overall Study|Premature Termination|21|||
126337112|NCT00853762|454530900|FG000|Overall Study|Protocol Violation|0|||
126337113|NCT00853762|454530901|FG001|Overall Study|Protocol Violation|0|||
126000566|NCT01066156|453292564|FG000|Overall Study|Withdrawal by Subject|1|||
126000567|NCT00661258|453292575|FG000|Overall Study|Death|1|||
126000568|NCT00661258|453292576|FG001|Overall Study|Death|0|||
126000569|NCT00661258|453292575|FG000|Overall Study|caught by police and in detox center|2|||
126000570|NCT00661258|453292576|FG001|Overall Study|caught by police and in detox center|1|||
126000571|NCT01628874|453292577|FG000|Overall Study|Physician Decision|1|||
126337114|NCT00853762|454530902|FG002|Overall Study|Protocol Violation|0|||
126000572|NCT01628874|453292578|FG001|Overall Study|Physician Decision|1|||
126337115|NCT00853762|454530903|FG003|Overall Study|Protocol Violation|1|||
126000573|NCT01628874|453292577|FG000|Overall Study|Age >4 months|4|||
126337116|NCT00853762|454530900|FG000|Overall Study|Withdrawal by Subject|0|||
126000574|NCT01628874|453292578|FG001|Overall Study|Age >4 months|2|||
126000575|NCT03285711|453292579|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
126000576|NCT03285711|453292580|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
126000577|NCT03285711|453292581|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
126337117|NCT00853762|454530901|FG001|Overall Study|Withdrawal by Subject|0|||
126337118|NCT00853762|454530902|FG002|Overall Study|Withdrawal by Subject|1|||
126337119|NCT00853762|454530903|FG003|Overall Study|Withdrawal by Subject|0|||
126337120|NCT00853762|454530900|FG000|Overall Study|Other|0|||
126337121|NCT00853762|454530901|FG001|Overall Study|Other|2|||
126337122|NCT00853762|454530902|FG002|Overall Study|Other|0|||
126337123|NCT00853762|454530903|FG003|Overall Study|Other|0|||
126337124|NCT00853762|454530900|FG000|Overall Study|Randomised but not Treated|0|||
126337125|NCT00853762|454530901|FG001|Overall Study|Randomised but not Treated|2|||
126337126|NCT00853762|454530902|FG002|Overall Study|Randomised but not Treated|2|||
126337127|NCT00853762|454530903|FG003|Overall Study|Randomised but not Treated|0|||
126337128|NCT02000921|454530905|FG000|Overall Study|Withdrawal by Subject|3|||
126337129|NCT02000921|454530906|FG001|Overall Study|Withdrawal by Subject|10|||
126337130|NCT02000921|454530907|FG002|Overall Study|Withdrawal by Subject|5|||
126337131|NCT02000921|454530905|FG000|Overall Study|Lost to Follow-up|2|||
126337132|NCT02000921|454530906|FG001|Overall Study|Lost to Follow-up|4|||
126337133|NCT02000921|454530907|FG002|Overall Study|Lost to Follow-up|5|||
126000578|NCT03285711|453292582|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
126000579|NCT03285711|453292579|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
126000580|NCT03285711|453292580|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
126000581|NCT03285711|453292581|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
126337134|NCT02000921|454530905|FG000|Overall Study|Physician Decision|0|||
126337135|NCT02000921|454530906|FG001|Overall Study|Physician Decision|2|||
126337136|NCT02000921|454530907|FG002|Overall Study|Physician Decision|0|||
126337137|NCT02051296|454530912|FG000|Overall Study|Lost to Follow-up|1|||
126337138|NCT02051296|454530913|FG001|Overall Study|Lost to Follow-up|2|||
126337139|NCT02051296|454530912|FG000|Overall Study|withdraw prior to treatment|7|||
126337140|NCT02051296|454530913|FG001|Overall Study|withdraw prior to treatment|7|||
126337141|NCT02631941|454530916|FG000|Overall Study|Physician Decision|0|||
126337142|NCT02631941|454530917|FG001|Overall Study|Physician Decision|1|||
126337143|NCT02631941|454530918|FG002|Overall Study|Physician Decision|0|||
126337144|NCT02631941|454530919|FG003|Overall Study|Physician Decision|0|||
126337145|NCT02631941|454530920|FG004|Overall Study|Physician Decision|0|||
126337146|NCT02631941|454530921|FG005|Overall Study|Physician Decision|0|||
126337147|NCT02631941|454530922|FG006|Overall Study|Physician Decision|0|||
126337148|NCT02631941|454530923|FG007|Overall Study|Physician Decision|0|||
126337149|NCT02631941|454530924|FG008|Overall Study|Physician Decision|0|||
126337150|NCT02631941|454530925|FG009|Overall Study|Physician Decision|0|||
126337151|NCT02631941|454530916|FG000|Overall Study|Adverse Event|0|||
126337152|NCT02631941|454530917|FG001|Overall Study|Adverse Event|1|||
126337153|NCT02631941|454530918|FG002|Overall Study|Adverse Event|0|||
126337154|NCT02631941|454530919|FG003|Overall Study|Adverse Event|0|||
126337155|NCT02631941|454530920|FG004|Overall Study|Adverse Event|0|||
126337156|NCT02631941|454530921|FG005|Overall Study|Adverse Event|0|||
126337157|NCT02631941|454530922|FG006|Overall Study|Adverse Event|0|||
126337158|NCT02631941|454530923|FG007|Overall Study|Adverse Event|0|||
126337159|NCT02631941|454530924|FG008|Overall Study|Adverse Event|0|||
126000582|NCT03285711|453292582|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
126000583|NCT03285711|453292579|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
126000584|NCT03285711|453292580|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
126000585|NCT03285711|453292581|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
126000586|NCT03285711|453292582|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
126000587|NCT03285711|453292579|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
126000588|NCT03285711|453292580|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
126000589|NCT03285711|453292581|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
126000590|NCT03285711|453292582|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
126000591|NCT02431533|453292583|FG000|Overall Study|Withdrawal by Subject|1|||
126000592|NCT02431533|453292584|FG001|Overall Study|Withdrawal by Subject|3|||
126000593|NCT02431533|453292583|FG000|Overall Study|Developed Exclusionary criteria|1|||
126000594|NCT02431533|453292584|FG001|Overall Study|Developed Exclusionary criteria|0|||
126000595|NCT00885495|453292589|FG000|Overall Study|Adverse Event|1|||
126000596|NCT00885495|453292590|FG001|Overall Study|Adverse Event|2|||
126000597|NCT00885495|453292589|FG000|Overall Study|Protocol Violation|0|||
126000598|NCT00885495|453292590|FG001|Overall Study|Protocol Violation|1|||
126000599|NCT00885495|453292589|FG000|Overall Study|Withdrawal by Subject|1|||
126000600|NCT00885495|453292590|FG001|Overall Study|Withdrawal by Subject|0|||
126000601|NCT01400893|453292591|FG000|Overall Study|Death|27|||
126337160|NCT02631941|454530925|FG009|Overall Study|Adverse Event|0|||
126337161|NCT02631941|454530916|FG000|Overall Study|Withdrawal by Subject|0|||
126337162|NCT02631941|454530917|FG001|Overall Study|Withdrawal by Subject|0|||
126337163|NCT02631941|454530918|FG002|Overall Study|Withdrawal by Subject|0|||
126337164|NCT02631941|454530919|FG003|Overall Study|Withdrawal by Subject|0|||
126337165|NCT02631941|454530920|FG004|Overall Study|Withdrawal by Subject|1|||
126337166|NCT02631941|454530921|FG005|Overall Study|Withdrawal by Subject|0|||
126337167|NCT02631941|454530922|FG006|Overall Study|Withdrawal by Subject|0|||
126337168|NCT02631941|454530923|FG007|Overall Study|Withdrawal by Subject|1|||
126337169|NCT02631941|454530924|FG008|Overall Study|Withdrawal by Subject|0|||
126000602|NCT01400893|453292592|FG001|Overall Study|Death|21|||
126000603|NCT01400893|453292591|FG000|Overall Study|Lost to Follow-up|0|||
126000604|NCT01400893|453292592|FG001|Overall Study|Lost to Follow-up|6|||
126000605|NCT02320721|453292602|FG000|Overall Study|Adverse Event|6|||
126000606|NCT02320721|453292603|FG001|Overall Study|Adverse Event|6|||
126000607|NCT02320721|453292602|FG000|Overall Study|Lack of Efficacy|2|||
126000608|NCT02320721|453292603|FG001|Overall Study|Lack of Efficacy|0|||
126000609|NCT02320721|453292602|FG000|Overall Study|Poor compliance to protocol|3|||
126000610|NCT02320721|453292603|FG001|Overall Study|Poor compliance to protocol|7|||
126000611|NCT02320721|453292602|FG000|Overall Study|Randomized but not treated|0|||
126000612|NCT02320721|453292603|FG001|Overall Study|Randomized but not treated|1|||
126000613|NCT02320721|453292602|FG000|Overall Study|Hypoglycemia|1|||
126000614|NCT02320721|453292603|FG001|Overall Study|Hypoglycemia|0|||
126000615|NCT02320721|453292602|FG000|Overall Study|Other than specified above|15|||
126000616|NCT02320721|453292603|FG001|Overall Study|Other than specified above|20|||
126000617|NCT04630756|453292604|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
126000618|NCT04630756|453292605|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
126000619|NCT04630756|453292606|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
126000620|NCT00847301|453292607|FG000|Overall Study|Adverse Event|35|||
126000621|NCT00847301|453292607|FG000|Overall Study|Switch to other anticoagulants|16|||
126000622|NCT00847301|453292607|FG000|Overall Study|Lost to Follow-up|1|||
126000623|NCT00847301|453292607|FG000|Overall Study|No prescription after hospital discharge|1|||
126000624|NCT00847301|453292607|FG000|Overall Study|Other reason not defined above|1|||
126337170|NCT02631941|454530925|FG009|Overall Study|Withdrawal by Subject|0|||
126337171|NCT02631941|454530916|FG000|Overall Study|Lost to Follow-up|0|||
126337172|NCT02631941|454530917|FG001|Overall Study|Lost to Follow-up|0|||
126337173|NCT02631941|454530918|FG002|Overall Study|Lost to Follow-up|0|||
126337174|NCT02631941|454530919|FG003|Overall Study|Lost to Follow-up|0|||
126337175|NCT02631941|454530920|FG004|Overall Study|Lost to Follow-up|0|||
126337176|NCT02631941|454530921|FG005|Overall Study|Lost to Follow-up|0|||
126337177|NCT02631941|454530922|FG006|Overall Study|Lost to Follow-up|0|||
126337178|NCT02631941|454530923|FG007|Overall Study|Lost to Follow-up|0|||
126337179|NCT02631941|454530924|FG008|Overall Study|Lost to Follow-up|1|||
126337180|NCT02631941|454530925|FG009|Overall Study|Lost to Follow-up|0|||
126337181|NCT02858401|454530927|FG000|Overall Study|Withdrew Consent|0|||
126337182|NCT02858401|454530928|FG001|Overall Study|Withdrew Consent|0|||
126337183|NCT02858401|454530929|FG002|Overall Study|Withdrew Consent|0|||
126337184|NCT02858401|454530930|FG003|Overall Study|Withdrew Consent|0|||
126337185|NCT02858401|454530931|FG004|Overall Study|Withdrew Consent|0|||
126337186|NCT02858401|454530932|FG005|Overall Study|Withdrew Consent|1|||
126337187|NCT02858401|454530933|FG006|Overall Study|Withdrew Consent|0|||
126337188|NCT02858401|454530927|FG000|Overall Study|Lost to Follow-up|0|||
126337189|NCT02858401|454530928|FG001|Overall Study|Lost to Follow-up|1|||
126337190|NCT02858401|454530929|FG002|Overall Study|Lost to Follow-up|0|||
126337191|NCT02858401|454530930|FG003|Overall Study|Lost to Follow-up|0|||
126337192|NCT02858401|454530931|FG004|Overall Study|Lost to Follow-up|0|||
126337193|NCT02858401|454530932|FG005|Overall Study|Lost to Follow-up|0|||
126337194|NCT02858401|454530933|FG006|Overall Study|Lost to Follow-up|0|||
126337195|NCT02513550|454530934|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
126337196|NCT02513550|454530935|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
126337197|NCT02513550|454530936|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
126337198|NCT02513550|454530937|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
126337199|NCT02513550|454530938|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
126337200|NCT02513550|454530939|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
126337201|NCT02513550|454530934|FG000|Double Blind Treatment Period|Adverse Event|5|||
126337202|NCT02513550|454530935|FG001|Double Blind Treatment Period|Adverse Event|13|||
126337203|NCT02513550|454530936|FG002|Double Blind Treatment Period|Adverse Event|17|||
126337204|NCT02513550|454530937|FG003|Double Blind Treatment Period|Adverse Event|0|||
126337205|NCT02513550|454530938|FG004|Double Blind Treatment Period|Adverse Event|1|||
126000625|NCT00996580|453292608|FG000|Overall Study|Adverse Event|466|||
126000626|NCT00996580|453292608|FG000|Overall Study|Lost to Follow-up|480|||
126000627|NCT00996580|453292608|FG000|Overall Study|Noncompliance with the protocol|137|||
126000628|NCT00996580|453292608|FG000|Overall Study|Physician Decision|5|||
126337206|NCT02513550|454530939|FG005|Double Blind Treatment Period|Adverse Event|0|||
126337207|NCT02513550|454530934|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
126337208|NCT02513550|454530935|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
126337209|NCT02513550|454530936|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
126337210|NCT02513550|454530937|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
126337211|NCT02513550|454530938|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
126337212|NCT02513550|454530939|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
126337213|NCT02513550|454530934|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
126337214|NCT02513550|454530935|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
126337215|NCT02513550|454530936|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
126000629|NCT00996580|453292608|FG000|Overall Study|Pregnancy|68|||
126000630|NCT00996580|453292608|FG000|Overall Study|Protocol Violation|16|||
126000631|NCT00996580|453292608|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
126000632|NCT00996580|453292608|FG000|Overall Study|Withdrawal by Subject|217|||
126000633|NCT00996580|453292608|FG000|Overall Study|Other|29|||
126000634|NCT04248465|453292609|FG000|Randomized-Controlled Period|Death|12|||
126000635|NCT04248465|453292610|FG001|Randomized-Controlled Period|Death|5|||
126000636|NCT04248465|453292609|FG000|Randomized-Controlled Period|Adverse Event|2|||
126000637|NCT04248465|453292610|FG001|Randomized-Controlled Period|Adverse Event|0|||
126000638|NCT04248465|453292609|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
126000639|NCT04248465|453292610|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
126000640|NCT04248465|453292609|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
126000641|NCT04248465|453292610|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
126000642|NCT04248465|453292609|FG000|Randomized-Controlled Period|Physician Decision|1|||
126000643|NCT04248465|453292610|FG001|Randomized-Controlled Period|Physician Decision|1|||
126000644|NCT04248465|453292609|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
126000645|NCT04248465|453292610|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
126000646|NCT04248465|453292609|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
126000647|NCT04248465|453292610|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
126000648|NCT04248465|453292609|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126000649|NCT04248465|453292610|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
126000650|NCT05708846|453292611|FG000|Overall Study|Death|5|||
126000651|NCT05708846|453292611|FG000|Overall Study|Withdrawal by Subject|20|||
126000652|NCT02036515|453292612|FG000|Overall Study|Adverse Event|1|||
126000653|NCT02036515|453292613|FG001|Overall Study|Adverse Event|1|||
126000654|NCT02036515|453292614|FG002|Overall Study|Adverse Event|2|||
126000655|NCT02036515|453292612|FG000|Overall Study|Lost to Follow-up|0|||
126000656|NCT02036515|453292613|FG001|Overall Study|Lost to Follow-up|2|||
126000657|NCT02036515|453292614|FG002|Overall Study|Lost to Follow-up|0|||
126000658|NCT02036515|453292612|FG000|Overall Study|Non-compliance with study drug|0|||
126000659|NCT02036515|453292613|FG001|Overall Study|Non-compliance with study drug|0|||
126000660|NCT02036515|453292614|FG002|Overall Study|Non-compliance with study drug|2|||
126000661|NCT02036515|453292612|FG000|Overall Study|Screen failure|0|||
126000662|NCT02036515|453292613|FG001|Overall Study|Screen failure|2|||
126000663|NCT02036515|453292614|FG002|Overall Study|Screen failure|0|||
126000664|NCT02036515|453292612|FG000|Overall Study|Withdrawal by Subject|4|||
126000665|NCT02036515|453292613|FG001|Overall Study|Withdrawal by Subject|7|||
126000666|NCT02036515|453292614|FG002|Overall Study|Withdrawal by Subject|9|||
126000667|NCT02036515|453292612|FG000|Overall Study|Hyperglycemia|0|||
126000668|NCT02036515|453292613|FG001|Overall Study|Hyperglycemia|0|||
126000669|NCT02036515|453292614|FG002|Overall Study|Hyperglycemia|1|||
126000670|NCT03621982|453292615|FG000|Overall Study|Withdrawal by Subject|1|||
126000671|NCT03621982|453292616|FG001|Overall Study|Withdrawal by Subject|0|||
126000672|NCT03621982|453292617|FG002|Overall Study|Withdrawal by Subject|0|||
126000673|NCT03621982|453292618|FG003|Overall Study|Withdrawal by Subject|1|||
126000674|NCT03621982|453292619|FG004|Overall Study|Withdrawal by Subject|0|||
126000675|NCT03621982|453292620|FG005|Overall Study|Withdrawal by Subject|1|||
126000676|NCT03621982|453292621|FG006|Overall Study|Withdrawal by Subject|1|||
126000677|NCT03621982|453292622|FG007|Overall Study|Withdrawal by Subject|0|||
126000678|NCT03621982|453292623|FG008|Overall Study|Withdrawal by Subject|1|||
126000679|NCT03621982|453292624|FG009|Overall Study|Withdrawal by Subject|0|||
126000680|NCT03621982|453292625|FG010|Overall Study|Withdrawal by Subject|2|||
126000681|NCT03621982|453292626|FG011|Overall Study|Withdrawal by Subject|1|||
126000682|NCT03621982|453292627|FG012|Overall Study|Withdrawal by Subject|2|||
126000683|NCT03621982|453292628|FG013|Overall Study|Withdrawal by Subject|2|||
126000684|NCT03621982|453292615|FG000|Overall Study|Investigator/Sponsor decision|0|||
126000685|NCT03621982|453292616|FG001|Overall Study|Investigator/Sponsor decision|0|||
126000686|NCT03621982|453292617|FG002|Overall Study|Investigator/Sponsor decision|0|||
126000687|NCT03621982|453292618|FG003|Overall Study|Investigator/Sponsor decision|0|||
126000688|NCT03621982|453292619|FG004|Overall Study|Investigator/Sponsor decision|0|||
126000689|NCT03621982|453292620|FG005|Overall Study|Investigator/Sponsor decision|0|||
126000690|NCT03621982|453292621|FG006|Overall Study|Investigator/Sponsor decision|0|||
126000691|NCT03621982|453292622|FG007|Overall Study|Investigator/Sponsor decision|0|||
126000692|NCT03621982|453292623|FG008|Overall Study|Investigator/Sponsor decision|0|||
126000693|NCT03621982|453292624|FG009|Overall Study|Investigator/Sponsor decision|0|||
126000694|NCT03621982|453292625|FG010|Overall Study|Investigator/Sponsor decision|0|||
126000695|NCT03621982|453292626|FG011|Overall Study|Investigator/Sponsor decision|4|||
126000696|NCT03621982|453292627|FG012|Overall Study|Investigator/Sponsor decision|0|||
126000697|NCT03621982|453292628|FG013|Overall Study|Investigator/Sponsor decision|2|||
126000698|NCT03621982|453292615|FG000|Overall Study|Death|2|||
126000699|NCT03621982|453292616|FG001|Overall Study|Death|4|||
126000700|NCT03621982|453292617|FG002|Overall Study|Death|4|||
126000701|NCT03621982|453292618|FG003|Overall Study|Death|3|||
126000702|NCT03621982|453292619|FG004|Overall Study|Death|8|||
126000703|NCT03621982|453292620|FG005|Overall Study|Death|4|||
126000704|NCT03621982|453292621|FG006|Overall Study|Death|6|||
126000705|NCT03621982|453292622|FG007|Overall Study|Death|3|||
126000706|NCT03621982|453292623|FG008|Overall Study|Death|0|||
126000707|NCT03621982|453292624|FG009|Overall Study|Death|3|||
126000708|NCT03621982|453292625|FG010|Overall Study|Death|8|||
126000709|NCT03621982|453292626|FG011|Overall Study|Death|4|||
126000710|NCT03621982|453292627|FG012|Overall Study|Death|2|||
126000711|NCT03621982|453292628|FG013|Overall Study|Death|2|||
126000712|NCT03621982|453292615|FG000|Overall Study|Lost to Follow-up|0|||
126000713|NCT03621982|453292616|FG001|Overall Study|Lost to Follow-up|0|||
126000714|NCT03621982|453292617|FG002|Overall Study|Lost to Follow-up|1|||
126000715|NCT03621982|453292618|FG003|Overall Study|Lost to Follow-up|0|||
126000716|NCT03621982|453292619|FG004|Overall Study|Lost to Follow-up|0|||
126000717|NCT03621982|453292620|FG005|Overall Study|Lost to Follow-up|0|||
126000718|NCT03621982|453292621|FG006|Overall Study|Lost to Follow-up|1|||
126000719|NCT03621982|453292622|FG007|Overall Study|Lost to Follow-up|0|||
126000720|NCT03621982|453292623|FG008|Overall Study|Lost to Follow-up|0|||
126000721|NCT03621982|453292624|FG009|Overall Study|Lost to Follow-up|1|||
126000722|NCT03621982|453292625|FG010|Overall Study|Lost to Follow-up|0|||
126000723|NCT03621982|453292626|FG011|Overall Study|Lost to Follow-up|0|||
126000724|NCT03621982|453292627|FG012|Overall Study|Lost to Follow-up|0|||
126000725|NCT03621982|453292628|FG013|Overall Study|Lost to Follow-up|0|||
126000726|NCT00442286|453292629|FG000|Overall Study|Death|2|||
126000727|NCT00442286|453292630|FG001|Overall Study|Death|2|||
126000728|NCT00442286|453292629|FG000|Overall Study|Lost to Follow-up|1|||
126000729|NCT00442286|453292630|FG001|Overall Study|Lost to Follow-up|0|||
126000730|NCT00442286|453292629|FG000|Overall Study|Withdrawal by Subject|2|||
126000731|NCT00442286|453292630|FG001|Overall Study|Withdrawal by Subject|0|||
126000732|NCT00442286|453292629|FG000|Overall Study|System explanted|1|||
126000733|NCT00442286|453292630|FG001|Overall Study|System explanted|0|||
126000734|NCT00442286|453292629|FG000|Overall Study|Patient Injury|1|||
126000735|NCT00442286|453292630|FG001|Overall Study|Patient Injury|0|||
126000736|NCT01544582|453292633|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
126000737|NCT01544582|453292634|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
126000738|NCT01544582|453292635|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
126000739|NCT01544582|453292636|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
126000740|NCT01544582|453292633|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
126000741|NCT01544582|453292634|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
126000742|NCT01544582|453292635|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
126000743|NCT01544582|453292636|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
126000744|NCT01544582|453292633|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
126000745|NCT01544582|453292634|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
126000746|NCT01544582|453292635|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
126000747|NCT01544582|453292636|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
126000748|NCT01544582|453292633|FG000|Analysis Population|Physician Decision|0|||
126000749|NCT01544582|453292634|FG001|Analysis Population|Physician Decision|13|||
126000750|NCT01544582|453292635|FG002|Analysis Population|Physician Decision|10|||
126000751|NCT01544582|453292636|FG003|Analysis Population|Physician Decision|9|||
126000752|NCT01544582|453292633|FG000|Analysis Population|Safety Reason|0|||
126000753|NCT01544582|453292634|FG001|Analysis Population|Safety Reason|33|||
126000754|NCT01544582|453292635|FG002|Analysis Population|Safety Reason|31|||
126000755|NCT01544582|453292636|FG003|Analysis Population|Safety Reason|8|||
126000756|NCT01544582|453292633|FG000|Analysis Population|Effectiveness Reason|0|||
126000757|NCT01544582|453292634|FG001|Analysis Population|Effectiveness Reason|48|||
126000758|NCT01544582|453292635|FG002|Analysis Population|Effectiveness Reason|29|||
126000759|NCT01544582|453292636|FG003|Analysis Population|Effectiveness Reason|12|||
126000760|NCT01544582|453292633|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
126000761|NCT01544582|453292634|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
126000762|NCT01544582|453292635|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
126000763|NCT01544582|453292636|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
126000764|NCT01544582|453292633|FG000|Analysis Population|Lost to Follow-up|0|||
126000765|NCT01544582|453292634|FG001|Analysis Population|Lost to Follow-up|6|||
126000766|NCT01544582|453292635|FG002|Analysis Population|Lost to Follow-up|6|||
126000767|NCT01544582|453292636|FG003|Analysis Population|Lost to Follow-up|5|||
126000768|NCT01544582|453292633|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
126000769|NCT01544582|453292634|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
126337216|NCT02513550|454530937|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
126000770|NCT01544582|453292635|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
126000771|NCT01544582|453292636|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
126000772|NCT01544582|453292633|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
126000773|NCT01544582|453292634|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
126000774|NCT01544582|453292635|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
126000775|NCT01544582|453292636|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
126000776|NCT01544582|453292633|FG000|Analysis Population|Intolerance|0|||
126000777|NCT01544582|453292634|FG001|Analysis Population|Intolerance|1|||
126000778|NCT01544582|453292635|FG002|Analysis Population|Intolerance|0|||
126337217|NCT02513550|454530938|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
126000779|NCT01544582|453292636|FG003|Analysis Population|Intolerance|0|||
126000780|NCT01544582|453292633|FG000|Analysis Population|Liver Transplantation|0|||
126000781|NCT01544582|453292634|FG001|Analysis Population|Liver Transplantation|0|||
126000782|NCT01544582|453292635|FG002|Analysis Population|Liver Transplantation|1|||
126000783|NCT01544582|453292636|FG003|Analysis Population|Liver Transplantation|0|||
126000784|NCT01544582|453292633|FG000|Analysis Population|No Social Insurance|0|||
126000785|NCT01544582|453292634|FG001|Analysis Population|No Social Insurance|0|||
126000786|NCT01544582|453292635|FG002|Analysis Population|No Social Insurance|1|||
126000787|NCT01544582|453292636|FG003|Analysis Population|No Social Insurance|0|||
126000788|NCT01544582|453292633|FG000|Analysis Population|Poor Adherence|0|||
126000789|NCT01544582|453292634|FG001|Analysis Population|Poor Adherence|0|||
126000790|NCT01544582|453292635|FG002|Analysis Population|Poor Adherence|1|||
126000791|NCT01544582|453292636|FG003|Analysis Population|Poor Adherence|0|||
126000792|NCT01544582|453292633|FG000|Analysis Population|Poor Participant Compliance|0|||
126000793|NCT01544582|453292634|FG001|Analysis Population|Poor Participant Compliance|1|||
126000794|NCT01544582|453292635|FG002|Analysis Population|Poor Participant Compliance|0|||
126000795|NCT01544582|453292636|FG003|Analysis Population|Poor Participant Compliance|0|||
126000796|NCT01544582|453292633|FG000|Analysis Population|Programmed Surgery|0|||
126000797|NCT01544582|453292634|FG001|Analysis Population|Programmed Surgery|1|||
126000798|NCT01544582|453292635|FG002|Analysis Population|Programmed Surgery|0|||
126000799|NCT01544582|453292636|FG003|Analysis Population|Programmed Surgery|0|||
126000800|NCT01544582|453292633|FG000|Analysis Population|Participant in Jail|0|||
126000801|NCT01544582|453292634|FG001|Analysis Population|Participant in Jail|0|||
126000802|NCT01544582|453292635|FG002|Analysis Population|Participant in Jail|1|||
126000803|NCT01544582|453292636|FG003|Analysis Population|Participant in Jail|0|||
126000804|NCT03428815|453292637|FG000|Overall Study|Lost to Follow-up|2|||
126000805|NCT03428815|453292638|FG001|Overall Study|Lost to Follow-up|2|||
126000806|NCT03428815|453292637|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
126000807|NCT03428815|453292638|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
126000808|NCT03428815|453292637|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
126000809|NCT03428815|453292638|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
126000810|NCT01700348|453292639|FG000|Overall Study|Withdrawal by Subject|22|||
126000811|NCT01700348|453292639|FG000|Overall Study|Lost to Follow-up|1|||
126000812|NCT01824472|453292642|FG000|Overall Study|Lost to Follow-up|0|||
126000813|NCT01824472|453292643|FG001|Overall Study|Lost to Follow-up|0|||
126000814|NCT01824472|453292644|FG002|Overall Study|Lost to Follow-up|1|||
126000815|NCT01824472|453292642|FG000|Overall Study|Withdrawal by Subject|1|||
126000816|NCT01824472|453292643|FG001|Overall Study|Withdrawal by Subject|5|||
126000817|NCT01824472|453292644|FG002|Overall Study|Withdrawal by Subject|3|||
126000818|NCT01824472|453292642|FG000|Overall Study|Ineligible post randomization&screening|0|||
126000819|NCT01824472|453292643|FG001|Overall Study|Ineligible post randomization&screening|2|||
126000820|NCT01824472|453292644|FG002|Overall Study|Ineligible post randomization&screening|0|||
126000821|NCT01815736|453292645|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
126337218|NCT02513550|454530939|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
126337219|NCT02513550|454530934|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126337220|NCT02513550|454530935|FG001|Double Blind Treatment Period|Protocol Violation|1|||
126337221|NCT02513550|454530936|FG002|Double Blind Treatment Period|Protocol Violation|4|||
126337222|NCT02513550|454530937|FG003|Double Blind Treatment Period|Protocol Violation|0|||
126337223|NCT02513550|454530938|FG004|Double Blind Treatment Period|Protocol Violation|0|||
126337224|NCT02513550|454530939|FG005|Double Blind Treatment Period|Protocol Violation|0|||
126337225|NCT02513550|454530934|FG000|Double Blind Treatment Period|Physician Decision|2|||
126337226|NCT02513550|454530935|FG001|Double Blind Treatment Period|Physician Decision|0|||
126337227|NCT02513550|454530936|FG002|Double Blind Treatment Period|Physician Decision|4|||
126337228|NCT02513550|454530937|FG003|Double Blind Treatment Period|Physician Decision|0|||
126337229|NCT02513550|454530938|FG004|Double Blind Treatment Period|Physician Decision|0|||
126337230|NCT02513550|454530939|FG005|Double Blind Treatment Period|Physician Decision|0|||
126337231|NCT02513550|454530934|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
126337232|NCT02513550|454530935|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
126337233|NCT02513550|454530936|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
126337234|NCT02513550|454530937|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
126337235|NCT02513550|454530938|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
126337236|NCT02513550|454530939|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
126337237|NCT02513550|454530934|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126337238|NCT02513550|454530935|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126000822|NCT01815736|453292646|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
126000823|NCT01815736|453292645|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
126000824|NCT01815736|453292646|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
126337239|NCT02513550|454530936|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
126337240|NCT02513550|454530937|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126337241|NCT02513550|454530938|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126000825|NCT01815736|453292645|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
126000826|NCT01815736|453292646|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
126000827|NCT01815736|453292645|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
126000828|NCT01815736|453292646|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
126000829|NCT01815736|453292645|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
126000830|NCT01815736|453292646|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
126000831|NCT01815736|453292645|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
126000832|NCT01815736|453292646|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
126000833|NCT01815736|453292645|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
126000834|NCT01815736|453292646|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
126000835|NCT01815736|453292645|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
126000836|NCT01815736|453292646|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
126000837|NCT01815736|453292645|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
126000838|NCT01815736|453292646|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
126000839|NCT01815736|453292645|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
126000840|NCT01815736|453292646|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
126000841|NCT01815736|453292645|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
126000842|NCT01815736|453292646|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
126000843|NCT01815736|453292645|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
126000844|NCT01815736|453292646|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
126000845|NCT01815736|453292645|FG000|Extension Treatment Phase- After Week 96|Death|1|||
126000846|NCT01815736|453292646|FG001|Extension Treatment Phase- After Week 96|Death|0|||
126000847|NCT03317379|453292652|FG000|Overall Study|Lost to Follow-up|0|||
126000848|NCT03317379|453292653|FG001|Overall Study|Lost to Follow-up|3|||
126000849|NCT03317379|453292654|FG002|Overall Study|Lost to Follow-up|2|||
126000850|NCT00550173|453292655|FG000|Overall Study|Death|45|||
126000851|NCT00550173|453292656|FG001|Overall Study|Death|38|||
126000852|NCT00550173|453292657|FG002|Overall Study|Death|50|||
126000853|NCT00550173|453292655|FG000|Overall Study|Physician Decision|1|||
126000854|NCT00550173|453292656|FG001|Overall Study|Physician Decision|2|||
126000855|NCT00550173|453292657|FG002|Overall Study|Physician Decision|2|||
126000856|NCT00550173|453292655|FG000|Overall Study|Withdrawal by Subject|9|||
126000857|NCT00550173|453292656|FG001|Overall Study|Withdrawal by Subject|12|||
126000858|NCT00550173|453292657|FG002|Overall Study|Withdrawal by Subject|17|||
126000859|NCT00550173|453292655|FG000|Overall Study|Sponsor Decision|13|||
126000860|NCT00550173|453292656|FG001|Overall Study|Sponsor Decision|7|||
126000861|NCT00550173|453292657|FG002|Overall Study|Sponsor Decision|1|||
126000862|NCT00550173|453292655|FG000|Overall Study|Lost to Follow-up|4|||
126000863|NCT00550173|453292656|FG001|Overall Study|Lost to Follow-up|4|||
126000864|NCT00550173|453292657|FG002|Overall Study|Lost to Follow-up|3|||
126000865|NCT01388543|453292664|FG000|Day 14|Adverse Event|1|||
126000866|NCT01388543|453292665|FG001|Day 14|Adverse Event|4|||
126000867|NCT01556243|453292666|FG000|Overall Study|Ineligible|34|||
126000868|NCT01556243|453292666|FG000|Overall Study|Converted to mastectomy|14|||
126000869|NCT01556243|453292666|FG000|Overall Study|Unable to achieve negative margins|2|||
126000870|NCT01556243|453292666|FG000|Overall Study|Withdrawal by Subject|16|||
126000871|NCT02325713|453292667|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000872|NCT02325713|453292668|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000873|NCT02325713|453292669|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126337242|NCT02513550|454530939|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126337243|NCT02513550|454530934|FG000|Double Blind Treatment Period|Due to personal business|2|||
126337244|NCT02513550|454530935|FG001|Double Blind Treatment Period|Due to personal business|0|||
126337245|NCT02513550|454530936|FG002|Double Blind Treatment Period|Due to personal business|1|||
126337246|NCT02513550|454530937|FG003|Double Blind Treatment Period|Due to personal business|0|||
126337247|NCT02513550|454530938|FG004|Double Blind Treatment Period|Due to personal business|0|||
126337248|NCT02513550|454530939|FG005|Double Blind Treatment Period|Due to personal business|0|||
126337249|NCT02513550|454530934|FG000|Double Blind Treatment Period|Death|1|||
126337250|NCT02513550|454530935|FG001|Double Blind Treatment Period|Death|0|||
126337251|NCT02513550|454530936|FG002|Double Blind Treatment Period|Death|2|||
126337252|NCT02513550|454530937|FG003|Double Blind Treatment Period|Death|0|||
126337253|NCT02513550|454530938|FG004|Double Blind Treatment Period|Death|0|||
126337254|NCT02513550|454530939|FG005|Double Blind Treatment Period|Death|0|||
126337255|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
126337256|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
126337257|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
126337258|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126000874|NCT02325713|453292670|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126337259|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126337260|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126337261|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
126337262|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
126337263|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
126337264|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
126337265|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
126337266|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
126337267|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
126337268|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
126337269|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
126337270|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126337271|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126337272|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126337273|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
126337274|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
126337275|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
126337276|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
126337277|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
126337278|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
126337279|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
126337280|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
126337281|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
126337282|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
126337283|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
126337284|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
126337285|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Death|0|||
126337286|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Death|0|||
126337287|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Death|1|||
126337288|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Death|0|||
126337289|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Death|0|||
126337290|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Death|0|||
126337291|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
126000875|NCT02325713|453292671|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000876|NCT02325713|453292672|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000877|NCT02325713|453292673|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000878|NCT02325713|453292674|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000879|NCT02325713|453292675|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000880|NCT02325713|453292676|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000881|NCT02325713|453292677|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
126000882|NCT02325713|453292678|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000883|NCT02325713|453292679|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000884|NCT02325713|453292680|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000885|NCT02325713|453292681|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000886|NCT02325713|453292682|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126000887|NCT02325713|453292667|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
126000888|NCT02325713|453292668|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000889|NCT02325713|453292669|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000890|NCT02325713|453292670|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126337292|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
126337293|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
126337294|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
126337295|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
126337296|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
126337297|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337298|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337299|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
126337300|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337301|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337302|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337303|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
126337304|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
126337305|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
126337306|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
126337307|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
126000891|NCT02325713|453292671|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126209463|NCT03110107|454055394|FG001|Treatment Period|Death|0|||
126337308|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
126337309|NCT00492297|454530943|FG000|Treatment|Death|2|||
126337310|NCT00492297|454530943|FG000|Treatment|Study terminated by sponsor|3|||
126000892|NCT02325713|453292672|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000893|NCT02325713|453292673|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000894|NCT02325713|453292674|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000895|NCT02325713|453292675|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000896|NCT02325713|453292676|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000897|NCT02325713|453292677|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000898|NCT02325713|453292678|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000899|NCT02325713|453292679|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000900|NCT02325713|453292680|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000901|NCT02325713|453292681|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000902|NCT02325713|453292682|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126000903|NCT02325713|453292667|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000904|NCT02325713|453292668|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000905|NCT02325713|453292669|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000906|NCT02325713|453292670|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000907|NCT02325713|453292671|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126209464|NCT03110107|454055395|FG002|Treatment Period|Death|0|||
126337311|NCT00492297|454530943|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
126337312|NCT00492297|454530943|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
126337313|NCT00492297|454530943|FG000|Survival Only Follow-up|Death|46|||
126337314|NCT00492297|454530943|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
126337315|NCT00492297|454530943|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
126337316|NCT00888654|454530946|FG000|Overall Study|Problems swallowing oral meds.|1|||
126337317|NCT00888654|454530946|FG000|Overall Study|Not enough oral meds before surgery|3|||
126337318|NCT00888654|454530946|FG000|Overall Study|Surgery aborted|2|||
126337319|NCT00888654|454530946|FG000|Overall Study|Withdrawal by Subject|1|||
126337320|NCT00888654|454530946|FG000|Overall Study|Inelig. due to contraindication of med|1|||
126337321|NCT00888654|454530946|FG000|Overall Study|Change in surg date|1|||
126337322|NCT00888654|454530946|FG000|Overall Study|Stopped meds due to headaches|1|||
126337323|NCT02204917|454530947|FG000|Overall Study|Protocol Violation|1|||
126337324|NCT01663402|454530950|FG000|Overall Study|Randomized but not treated|19|||
126337325|NCT01663402|454530951|FG001|Overall Study|Randomized but not treated|11|||
126337326|NCT01663402|454530950|FG000|Overall Study|Adverse Event|347|||
126337327|NCT01663402|454530951|FG001|Overall Study|Adverse Event|362|||
126337328|NCT01663402|454530950|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
126337329|NCT01663402|454530951|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
126337330|NCT01663402|454530950|FG000|Overall Study|Poor compliance to protocol|529|||
126337331|NCT01663402|454530951|FG001|Overall Study|Poor compliance to protocol|454|||
126337332|NCT01663402|454530950|FG000|Overall Study|Physician Decision|77|||
126337333|NCT01663402|454530951|FG001|Overall Study|Physician Decision|62|||
126337334|NCT01663402|454530950|FG000|Overall Study|Site terminated by sponsor|1|||
126337335|NCT01663402|454530951|FG001|Overall Study|Site terminated by sponsor|3|||
126337336|NCT01663402|454530950|FG000|Overall Study|Participant moved|139|||
126337337|NCT01663402|454530951|FG001|Overall Study|Participant moved|104|||
126337338|NCT01663402|454530950|FG000|Overall Study|Withdrawal by Subject|118|||
126337339|NCT01663402|454530951|FG001|Overall Study|Withdrawal by Subject|91|||
126337340|NCT01663402|454530950|FG000|Overall Study|Related to study drug administration|96|||
126337341|NCT01663402|454530951|FG001|Overall Study|Related to study drug administration|105|||
126337342|NCT01663402|454530950|FG000|Overall Study|Lost to Follow-up|17|||
126337343|NCT01663402|454530951|FG001|Overall Study|Lost to Follow-up|15|||
126337344|NCT01663402|454530950|FG000|Overall Study|Other than specified above|172|||
126337345|NCT01663402|454530951|FG001|Overall Study|Other than specified above|147|||
126337346|NCT01701245|454530957|FG000|Overall Study|Protocol Violation|1|||
126337347|NCT01701245|454530958|FG001|Overall Study|Protocol Violation|3|||
126337348|NCT01701245|454530957|FG000|Overall Study|Did not complete the open label period|11|||
126337349|NCT01701245|454530958|FG001|Overall Study|Did not complete the open label period|12|||
126337350|NCT02277028|454530959|FG000|Overall Study|Lost to Follow-up|1|||
126337351|NCT02277028|454530960|FG001|Overall Study|Lost to Follow-up|0|||
126337352|NCT02277028|454530959|FG000|Overall Study|Withdrawal by Subject|0|||
126337353|NCT02277028|454530960|FG001|Overall Study|Withdrawal by Subject|1|||
126337354|NCT05002972|454530961|FG000|Overall Study|Withdrawal by Subject|2|||
126337355|NCT05518539|454530965|FG000|Overall Study|Lost to Follow-up|6|||
126337356|NCT02053493|454530968|FG000|Overall Study|Withdrawal by Subject|1|||
126337357|NCT02053493|454530969|FG001|Overall Study|Withdrawal by Subject|1|||
126337358|NCT01619865|454530974|FG000|Overall Study|Adverse Event|1|||
126337359|NCT01619865|454530974|FG000|Overall Study|Death|2|||
126337360|NCT01619865|454530974|FG000|Overall Study|subject not able to comply|1|||
126337361|NCT01494818|454530975|FG000|Overall Study|Relocation|1|||
126337362|NCT01494818|454530976|FG001|Overall Study|Relocation|2|||
126337363|NCT01494818|454530975|FG000|Overall Study|Lost to Follow-up|1|||
126337364|NCT01494818|454530976|FG001|Overall Study|Lost to Follow-up|0|||
126337365|NCT00791999|454530977|FG000|Overall Study|Protocol planed withdrawal|14|||
126337366|NCT00791999|454530978|FG001|Overall Study|Protocol planed withdrawal|11|||
126000908|NCT02325713|453292672|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000909|NCT02325713|453292673|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000910|NCT02325713|453292674|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000911|NCT02325713|453292675|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000912|NCT02325713|453292676|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
126000913|NCT02325713|453292677|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000914|NCT02325713|453292678|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126337367|NCT00791999|454530979|FG002|Overall Study|Protocol planed withdrawal|11|||
126337368|NCT00791999|454530980|FG003|Overall Study|Protocol planed withdrawal|45|||
126337369|NCT00791999|454530977|FG000|Overall Study|Withdrawal by Subject|0|||
126000915|NCT02325713|453292679|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000916|NCT02325713|453292680|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000917|NCT02325713|453292681|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000918|NCT02325713|453292682|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126000919|NCT01213173|453292684|FG000|Overall Study|Protocol Violation|2|||
126000920|NCT01213173|453292685|FG001|Overall Study|Protocol Violation|0|||
126000921|NCT01213173|453292684|FG000|Overall Study|Adverse Event|4|||
126000922|NCT01213173|453292685|FG001|Overall Study|Adverse Event|8|||
126000923|NCT01213173|453292684|FG000|Overall Study|Withdrawal by Subject|5|||
126000924|NCT01213173|453292685|FG001|Overall Study|Withdrawal by Subject|5|||
126000925|NCT01213173|453292684|FG000|Overall Study|Incorrect Enrollment|1|||
126000926|NCT01213173|453292685|FG001|Overall Study|Incorrect Enrollment|3|||
126000927|NCT02353832|453292688|FG000|Overall Study|Ineligible after enrollment|1|||
126000928|NCT02353832|453292688|FG000|Overall Study|Lost to Follow-up|1|||
126000929|NCT04880161|453292689|FG000|Overall Study|Withdrawal by Subject|1|||
126000930|NCT04880161|453292690|FG001|Overall Study|Withdrawal by Subject|0|||
126000931|NCT04880161|453292689|FG000|Overall Study|Lack of Compliance|1|||
126000932|NCT04880161|453292690|FG001|Overall Study|Lack of Compliance|1|||
126000933|NCT04880161|453292689|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
126000934|NCT04880161|453292690|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
126000935|NCT04880161|453292689|FG000|Overall Study|Screen Failure|0|||
126000936|NCT04880161|453292690|FG001|Overall Study|Screen Failure|1|||
126000937|NCT01354106|453292691|FG000|Overall Study|Withdrawal by Subject|2|||
126000938|NCT00731042|453293972|FG000|Second Intervention|Did not meet inclusion criteria|0|||
126000939|NCT00731042|453293973|FG001|Second Intervention|Did not meet inclusion criteria|2|||
126000940|NCT02692235|453293974|FG000|Overall Study|Withdrawal by Subject|2|||
126000941|NCT02692235|453293975|FG001|Overall Study|Withdrawal by Subject|1|||
126000942|NCT02692235|453293974|FG000|Overall Study|Adverse Event|1|||
126000943|NCT02692235|453293975|FG001|Overall Study|Adverse Event|2|||
126000944|NCT00802841|453293976|FG000|Overall Study|Administrative problems|1|||
126000945|NCT00802841|453293977|FG001|Overall Study|Administrative problems|0|||
126000946|NCT00802841|453293976|FG000|Overall Study|Lost to Follow-up|2|||
126000947|NCT00802841|453293977|FG001|Overall Study|Lost to Follow-up|1|||
126000948|NCT00802841|453293976|FG000|Overall Study|Death|1|||
126000949|NCT00802841|453293977|FG001|Overall Study|Death|2|||
126000950|NCT00802841|453293976|FG000|Overall Study|Adverse Event|8|||
126000951|NCT00802841|453293977|FG001|Overall Study|Adverse Event|2|||
126000952|NCT00802841|453293976|FG000|Overall Study|Disease progression|7|||
126000953|NCT00802841|453293977|FG001|Overall Study|Disease progression|3|||
126000954|NCT00802841|453293976|FG000|Overall Study|Withdrawal by Subject|9|||
126000955|NCT00802841|453293977|FG001|Overall Study|Withdrawal by Subject|5|||
126000956|NCT00802841|453293976|FG000|Overall Study|Protocol deviation|2|||
126000957|NCT00802841|453293977|FG001|Overall Study|Protocol deviation|6|||
126000958|NCT00802841|453293976|FG000|Overall Study|Treatment duration completed|66|||
126000959|NCT00802841|453293977|FG001|Overall Study|Treatment duration completed|76|||
126000960|NCT02711995|453293980|FG000|Washout (90 Days)|Conflicting medication|1|||
126000961|NCT04990440|453293992|FG000|Overall Study|Sponsor's Decision|0|||
126000962|NCT04990440|453293993|FG001|Overall Study|Sponsor's Decision|0|||
126000963|NCT04990440|453293994|FG002|Overall Study|Sponsor's Decision|1|||
126337370|NCT00791999|454530978|FG001|Overall Study|Withdrawal by Subject|1|||
126337371|NCT00791999|454530979|FG002|Overall Study|Withdrawal by Subject|0|||
126337372|NCT00791999|454530980|FG003|Overall Study|Withdrawal by Subject|2|||
126337373|NCT00791999|454530977|FG000|Overall Study|Protocol Violation|3|||
126000964|NCT03712098|453293995|FG000|Overall Study|Lost to Follow-up|3|||
126337374|NCT00791999|454530978|FG001|Overall Study|Protocol Violation|0|||
126000965|NCT03712098|453293996|FG001|Overall Study|Lost to Follow-up|7|||
126000966|NCT03712098|453293995|FG000|Overall Study|Withdrawal by Subject|9|||
126000967|NCT03712098|453293996|FG001|Overall Study|Withdrawal by Subject|4|||
126000968|NCT03712098|453293995|FG000|Overall Study|Protocol Violation|2|||
126000969|NCT03712098|453293996|FG001|Overall Study|Protocol Violation|1|||
126000970|NCT00724061|453293999|FG000|Dose Escalation Phase|Adverse Event|2|||
126000971|NCT00724061|453293999|FG000|Dose Escalation Phase|Disease Progression|3|||
126000972|NCT02954575|453294002|FG000|Overall Study|Withdrawal by Subject|2|||
126000973|NCT02954575|453294002|FG000|Overall Study|Adverse Event|1|||
126209465|NCT03110107|454055396|FG003|Treatment Period|Death|0|||
126000974|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
126000975|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
126000976|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
126000977|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
126000978|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
126000979|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
126000980|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
126000981|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
126000982|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
126000983|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
126000984|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
126000985|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
126000986|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
126000987|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
126000988|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
126000989|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
126000990|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
126000991|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
126000992|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
126000993|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
126000994|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
126000995|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
126000996|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
126000997|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
126000998|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
126000999|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
126001000|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
126001001|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
126001002|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
126001003|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
126001004|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
126001005|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
126001006|NCT03890120|453294004|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
126001007|NCT03890120|453294005|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
126001008|NCT03890120|453294006|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
126001009|NCT03890120|453294007|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
126001010|NCT03890120|453294004|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
126001011|NCT03890120|453294005|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
126001012|NCT03890120|453294006|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
126001013|NCT03890120|453294007|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
126001014|NCT03890120|453294004|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
126001015|NCT03890120|453294005|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
126001016|NCT03890120|453294006|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
126001017|NCT03890120|453294007|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
126001018|NCT03890120|453294004|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
126001019|NCT03890120|453294005|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
126001020|NCT03890120|453294006|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
126001021|NCT03890120|453294007|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
126001022|NCT03890120|453294004|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
126001023|NCT03890120|453294005|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
126001024|NCT03890120|453294006|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
126001025|NCT03890120|453294007|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
126001026|NCT00479674|453294010|FG000|Overall Study|Adverse Event|18|||
126001027|NCT00479674|453294010|FG000|Overall Study|Withdrawal by Subject|6|||
126001028|NCT00479674|453294010|FG000|Overall Study|Physician Decision|14|||
126001029|NCT00479674|453294010|FG000|Overall Study|none provided|3|||
126001030|NCT02559817|453294011|FG000|Treatment Period|Adverse Event|1|||
126001031|NCT02559817|453294012|FG001|Treatment Period|Adverse Event|0|||
126001032|NCT02559817|453294013|FG002|Treatment Period|Adverse Event|1|||
126001033|NCT02559817|453294014|FG003|Treatment Period|Adverse Event|0|||
126001034|NCT02559817|453294015|FG004|Treatment Period|Adverse Event|0|||
126337375|NCT00791999|454530979|FG002|Overall Study|Protocol Violation|1|||
126337376|NCT00791999|454530980|FG003|Overall Study|Protocol Violation|0|||
126337377|NCT00791999|454530977|FG000|Overall Study|Adverse Event|3|||
126337378|NCT00791999|454530978|FG001|Overall Study|Adverse Event|3|||
126337379|NCT00791999|454530979|FG002|Overall Study|Adverse Event|7|||
126337380|NCT00791999|454530980|FG003|Overall Study|Adverse Event|3|||
126001035|NCT02559817|453294011|FG000|Treatment Period|Lack of Efficacy|0|||
126001036|NCT02559817|453294012|FG001|Treatment Period|Lack of Efficacy|1|||
126001037|NCT02559817|453294013|FG002|Treatment Period|Lack of Efficacy|0|||
126001038|NCT02559817|453294014|FG003|Treatment Period|Lack of Efficacy|0|||
126001039|NCT02559817|453294015|FG004|Treatment Period|Lack of Efficacy|0|||
126001040|NCT02559817|453294011|FG000|Treatment Period|Lost to Follow-up|0|||
126001041|NCT02559817|453294012|FG001|Treatment Period|Lost to Follow-up|1|||
126001042|NCT02559817|453294013|FG002|Treatment Period|Lost to Follow-up|0|||
126001043|NCT02559817|453294014|FG003|Treatment Period|Lost to Follow-up|1|||
126001044|NCT02559817|453294015|FG004|Treatment Period|Lost to Follow-up|0|||
126001045|NCT02559817|453294011|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
126001046|NCT02559817|453294012|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
126001047|NCT02559817|453294013|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
126001048|NCT02559817|453294014|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
126337381|NCT00791999|454530977|FG000|Overall Study|Lack of Efficacy|0|||
126001049|NCT02559817|453294015|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
126001050|NCT02559817|453294011|FG000|Treatment Period|Protocol Violation|0|||
126001051|NCT02559817|453294012|FG001|Treatment Period|Protocol Violation|0|||
126001052|NCT02559817|453294013|FG002|Treatment Period|Protocol Violation|0|||
126001053|NCT02559817|453294014|FG003|Treatment Period|Protocol Violation|1|||
126001054|NCT02559817|453294015|FG004|Treatment Period|Protocol Violation|0|||
126001055|NCT01925170|453294017|FG000|Overall Study|Unverified cancer status|53|||
126001056|NCT00577720|453294018|FG000|Overall Study|Adverse Event|2|||
126001057|NCT00577720|453294019|FG001|Overall Study|Adverse Event|1|||
126001058|NCT00577720|453294020|FG002|Overall Study|Adverse Event|0|||
126001059|NCT00577720|453294021|FG003|Overall Study|Adverse Event|4|||
126001060|NCT00577720|453294018|FG000|Overall Study|Lost to Follow-up|0|||
126001061|NCT00577720|453294019|FG001|Overall Study|Lost to Follow-up|0|||
126001062|NCT00577720|453294020|FG002|Overall Study|Lost to Follow-up|1|||
126001063|NCT00577720|453294021|FG003|Overall Study|Lost to Follow-up|0|||
126001064|NCT00577720|453294018|FG000|Overall Study|Protocol Violation|0|||
126001065|NCT00577720|453294019|FG001|Overall Study|Protocol Violation|0|||
126001066|NCT00577720|453294020|FG002|Overall Study|Protocol Violation|0|||
126001067|NCT00577720|453294021|FG003|Overall Study|Protocol Violation|1|||
126001068|NCT00577720|453294018|FG000|Overall Study|Withdrawal by Subject|2|||
126001069|NCT00577720|453294019|FG001|Overall Study|Withdrawal by Subject|0|||
126001070|NCT00577720|453294020|FG002|Overall Study|Withdrawal by Subject|0|||
126001071|NCT00577720|453294021|FG003|Overall Study|Withdrawal by Subject|2|||
126001072|NCT02839681|453294022|FG000|Overall Study|Death|2|||
126001073|NCT00772928|453294023|FG000|Overall Study|Lost to Follow-up|9|||
126001074|NCT00772928|453294024|FG001|Overall Study|Lost to Follow-up|6|||
126001075|NCT00772928|453294023|FG000|Overall Study|Protocol Violation|10|||
126001076|NCT00772928|453294024|FG001|Overall Study|Protocol Violation|12|||
126001077|NCT00772928|453294023|FG000|Overall Study|Withdrawal by Subject|25|||
126001078|NCT00772928|453294024|FG001|Overall Study|Withdrawal by Subject|22|||
126001079|NCT00772928|453294023|FG000|Overall Study|Did not receive vaccine|0|||
126001080|NCT00772928|453294024|FG001|Overall Study|Did not receive vaccine|1|||
126001081|NCT03100838|453294025|FG000|Overall Study|Adverse Event|1|||
126001082|NCT03100838|453294026|FG001|Overall Study|Adverse Event|0|||
126001083|NCT03100838|453294027|FG002|Overall Study|Adverse Event|0|||
126001084|NCT03100838|453294028|FG003|Overall Study|Adverse Event|0|||
126337382|NCT00791999|454530978|FG001|Overall Study|Lack of Efficacy|1|||
126001085|NCT03100838|453294025|FG000|Overall Study|Physician Decision|1|||
126001086|NCT03100838|453294026|FG001|Overall Study|Physician Decision|1|||
126001087|NCT03100838|453294027|FG002|Overall Study|Physician Decision|1|||
126001088|NCT03100838|453294028|FG003|Overall Study|Physician Decision|1|||
126001089|NCT03100838|453294025|FG000|Overall Study|Pregnancy|0|||
126001090|NCT03100838|453294026|FG001|Overall Study|Pregnancy|1|||
126001091|NCT03100838|453294027|FG002|Overall Study|Pregnancy|0|||
126001092|NCT03100838|453294028|FG003|Overall Study|Pregnancy|0|||
126001093|NCT03100838|453294025|FG000|Overall Study|Lost to Follow-up|0|||
126001094|NCT03100838|453294026|FG001|Overall Study|Lost to Follow-up|0|||
126337383|NCT00791999|454530979|FG002|Overall Study|Lack of Efficacy|0|||
126337384|NCT00791999|454530980|FG003|Overall Study|Lack of Efficacy|2|||
126001095|NCT03100838|453294027|FG002|Overall Study|Lost to Follow-up|1|||
126001096|NCT03100838|453294028|FG003|Overall Study|Lost to Follow-up|0|||
126001097|NCT02554513|453294030|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
126001098|NCT02554513|453294031|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
126001099|NCT00184028|453294034|FG000|Overall Study|Death|1|||
126001100|NCT00184028|453294034|FG000|Overall Study|Lack of Efficacy|4|||
126001101|NCT00184028|453294034|FG000|Overall Study|Adverse Event|2|||
126001102|NCT00184028|453294034|FG000|Overall Study|Withdrawal by Subject|1|||
126001103|NCT00184028|453294034|FG000|Overall Study|Non-compliance|2|||
126001104|NCT01354938|453294037|FG000|Overall Study|Lost to Follow-up|1|||
126001105|NCT02335268|453294038|FG000|Overall Study|Physician Decision|5|||
126001106|NCT02335268|453294039|FG001|Overall Study|Physician Decision|1|||
126001107|NCT02335268|453294038|FG000|Overall Study|Lack of Efficacy|2|||
126337385|NCT00791999|454530977|FG000|Overall Study|Reason other than those above|1|||
126001108|NCT02335268|453294039|FG001|Overall Study|Lack of Efficacy|1|||
126001109|NCT02335268|453294038|FG000|Overall Study|Adverse Event|5|||
126001110|NCT02335268|453294039|FG001|Overall Study|Adverse Event|2|||
126001111|NCT02335268|453294038|FG000|Overall Study|increase blasts|2|||
126001112|NCT02335268|453294039|FG001|Overall Study|increase blasts|0|||
126001113|NCT02335268|453294038|FG000|Overall Study|Withdrawal by Subject|3|||
126001114|NCT02335268|453294039|FG001|Overall Study|Withdrawal by Subject|2|||
126001115|NCT01192295|453294043|FG000|Overall Study|Adverse Event|3|||
126001116|NCT01192295|453294044|FG001|Overall Study|Adverse Event|7|||
126001117|NCT01192295|453294043|FG000|Overall Study|Withdrawal by Subject|3|||
126001118|NCT01192295|453294044|FG001|Overall Study|Withdrawal by Subject|4|||
126001119|NCT01192295|453294043|FG000|Overall Study|Lost to Follow-up|0|||
126001120|NCT01192295|453294044|FG001|Overall Study|Lost to Follow-up|1|||
126001121|NCT01192295|453294043|FG000|Overall Study|Lack of Efficacy|0|||
126001122|NCT01192295|453294044|FG001|Overall Study|Lack of Efficacy|5|||
126001123|NCT01192295|453294043|FG000|Overall Study|Administrative|4|||
126001124|NCT01192295|453294044|FG001|Overall Study|Administrative|6|||
126001125|NCT03785340|453294047|FG000|Overall Study|Lost to Follow-up|2|||
126001126|NCT03785340|453294048|FG001|Overall Study|Lost to Follow-up|0|||
126001127|NCT03785340|453294047|FG000|Overall Study|Adverse Event|1|||
126001128|NCT03785340|453294048|FG001|Overall Study|Adverse Event|0|||
126001129|NCT01670500|453294056|FG000|Overall Study|Withdrawal by Subject|1|||
126001130|NCT01670500|453294057|FG001|Overall Study|Withdrawal by Subject|0|||
126001131|NCT03473756|453294058|FG000|Overall Study|Withdrawal by Subject|1|||
126001132|NCT03473756|453294059|FG001|Overall Study|Withdrawal by Subject|4|||
126001133|NCT03473756|453294058|FG000|Overall Study|Adverse Event|6|||
126001134|NCT03473756|453294059|FG001|Overall Study|Adverse Event|7|||
126001135|NCT03473756|453294058|FG000|Overall Study|Lack of Efficacy|3|||
126001136|NCT03473756|453294059|FG001|Overall Study|Lack of Efficacy|10|||
126001137|NCT03473756|453294058|FG000|Overall Study|Physician Decision|0|||
126001138|NCT03473756|453294059|FG001|Overall Study|Physician Decision|2|||
126001139|NCT03473756|453294058|FG000|Overall Study|End of study treatment|0|||
126001140|NCT03473756|453294059|FG001|Overall Study|End of study treatment|2|||
126001141|NCT03473756|453294058|FG000|Overall Study|Lost to Follow-up|0|||
126001142|NCT03473756|453294059|FG001|Overall Study|Lost to Follow-up|1|||
126001143|NCT02148718|453294060|FG000|Overall Study|Protocol Violation|26|||
126001144|NCT02148718|453294060|FG000|Overall Study|Discontinued Study Prematurely|5|||
126001145|NCT00003509|453294061|FG000|Overall Study|Not evaluable|5|||
126001146|NCT00333788|453294062|FG000|Overall Study|Adverse Event|44|||
126001147|NCT00333788|453294062|FG000|Overall Study|Lack of Efficacy|80|||
126001148|NCT00333788|453294062|FG000|Overall Study|Lost to Follow-up|2|||
126001149|NCT00333788|453294062|FG000|Overall Study|Withdrawal by Subject|24|||
126001150|NCT00333788|453294062|FG000|Overall Study|Other: Non-compliance|2|||
126001151|NCT00333788|453294062|FG000|Overall Study|Other: Moved|2|||
126001152|NCT00333788|453294062|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
126001153|NCT00333788|453294062|FG000|Overall Study|Other: Investigator decision|1|||
126001154|NCT00333788|453294062|FG000|Overall Study|Other: Quality of life concern|1|||
126001155|NCT00333788|453294062|FG000|Overall Study|Other: Sponsor decision|1|||
126001156|NCT00333788|453294062|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
126001157|NCT00333788|453294062|FG000|Overall Study|Other: Medical monitor decision|1|||
126001158|NCT00333788|453294062|FG000|Overall Study|Other: Physician decision|1|||
126001159|NCT00333788|453294062|FG000|Overall Study|Other: Signed consent for another study|1|||
126001160|NCT04951479|453294063|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
126001161|NCT02711826|453294064|FG000|Overall Study|Physician Decision|0|||
126001162|NCT02711826|453294065|FG001|Overall Study|Physician Decision|0|||
126001163|NCT02711826|453294066|FG002|Overall Study|Physician Decision|0|||
126001164|NCT02711826|453294067|FG003|Overall Study|Physician Decision|1|||
126001165|NCT02711826|453294068|FG004|Overall Study|Physician Decision|0|||
126001166|NCT02711826|453294064|FG000|Overall Study|Withdrawal by Subject|0|||
126001167|NCT02711826|453294065|FG001|Overall Study|Withdrawal by Subject|1|||
126001168|NCT02711826|453294066|FG002|Overall Study|Withdrawal by Subject|0|||
126001169|NCT02711826|453294067|FG003|Overall Study|Withdrawal by Subject|4|||
126001170|NCT02711826|453294068|FG004|Overall Study|Withdrawal by Subject|0|||
126001171|NCT02711826|453294064|FG000|Overall Study|Failure to manufacture cellular product|0|||
126001172|NCT02711826|453294065|FG001|Overall Study|Failure to manufacture cellular product|0|||
126001173|NCT02711826|453294066|FG002|Overall Study|Failure to manufacture cellular product|5|||
126001174|NCT02711826|453294067|FG003|Overall Study|Failure to manufacture cellular product|0|||
126001175|NCT02711826|453294068|FG004|Overall Study|Failure to manufacture cellular product|0|||
126001176|NCT02711826|453294064|FG000|Overall Study|Infusion canceled for active infection|0|||
126001177|NCT02711826|453294065|FG001|Overall Study|Infusion canceled for active infection|1|||
126001178|NCT02711826|453294066|FG002|Overall Study|Infusion canceled for active infection|0|||
126001179|NCT02711826|453294067|FG003|Overall Study|Infusion canceled for active infection|0|||
126001180|NCT02711826|453294068|FG004|Overall Study|Infusion canceled for active infection|0|||
126001181|NCT02711826|453294064|FG000|Overall Study|Screen failures|0|||
126001182|NCT02711826|453294065|FG001|Overall Study|Screen failures|0|||
126001183|NCT02711826|453294066|FG002|Overall Study|Screen failures|0|||
126001184|NCT02711826|453294067|FG003|Overall Study|Screen failures|4|||
126001185|NCT02711826|453294068|FG004|Overall Study|Screen failures|0|||
126337386|NCT00791999|454530978|FG001|Overall Study|Reason other than those above|0|||
126337387|NCT00791999|454530979|FG002|Overall Study|Reason other than those above|1|||
126337388|NCT00791999|454530980|FG003|Overall Study|Reason other than those above|0|||
126337389|NCT01077323|454530981|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
126337390|NCT01077323|454530982|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
126337391|NCT01077323|454530983|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
126337392|NCT01077323|454530981|FG000|Overall Study|Dispensing of drug in baseline period|0|||
126337393|NCT01077323|454530982|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
126337394|NCT01077323|454530983|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
126337395|NCT01077323|454530981|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
126337396|NCT01077323|454530982|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
126001186|NCT01960790|453294069|FG000|Overall Study|Survey forms could not be recovered|3|||
126001187|NCT01960790|453294069|FG000|Overall Study|Treat with Humira outside survey period|3|||
126001188|NCT01960790|453294069|FG000|Overall Study|Transferred to another hospital|4|||
126001189|NCT01960790|453294069|FG000|Overall Study|Unevaluable for safety|1|||
126001190|NCT02169219|453294072|FG000|Overall Study|Lack of Efficacy|6|||
126001191|NCT02886936|453294079|FG000|Overall Study|Lost to Follow-up|4|||
126001192|NCT02886936|453294080|FG001|Overall Study|Lost to Follow-up|3|||
126001193|NCT02886936|453294081|FG002|Overall Study|Lost to Follow-up|0|||
126001194|NCT04131907|453294083|FG000|Overall Study|Adverse Event|2|||
126001195|NCT04131907|453294084|FG001|Overall Study|Adverse Event|0|||
126001196|NCT04131907|453294085|FG002|Overall Study|Adverse Event|0|||
126001197|NCT04131907|453294083|FG000|Overall Study|Physician Decision|4|||
126001198|NCT04131907|453294084|FG001|Overall Study|Physician Decision|22|||
126001199|NCT04131907|453294085|FG002|Overall Study|Physician Decision|0|||
126001200|NCT04131907|453294083|FG000|Overall Study|Withdrawal by Subject|2|||
126001201|NCT04131907|453294084|FG001|Overall Study|Withdrawal by Subject|0|||
126001202|NCT04131907|453294085|FG002|Overall Study|Withdrawal by Subject|1|||
126001203|NCT04131907|453294083|FG000|Overall Study|Treatment failure|2|||
126001204|NCT04131907|453294084|FG001|Overall Study|Treatment failure|0|||
126001205|NCT04131907|453294085|FG002|Overall Study|Treatment failure|1|||
126001206|NCT01778062|453294086|FG000|Overall Study|Adverse Event|1|||
126001207|NCT01778062|453294087|FG001|Overall Study|Adverse Event|3|||
126001208|NCT01778062|453294086|FG000|Overall Study|Consent Withdrawal|1|||
126001209|NCT01778062|453294087|FG001|Overall Study|Consent Withdrawal|5|||
126001210|NCT01778062|453294086|FG000|Overall Study|major protocol deviation|4|||
126001211|NCT01778062|453294087|FG001|Overall Study|major protocol deviation|3|||
126001212|NCT03387514|453294088|FG000|Overall Study|Withdrawal by Subject|2|||
126001213|NCT03387514|453294088|FG000|Overall Study|Physician Decision|1|||
126337397|NCT01077323|454530983|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
126337398|NCT01710020|454530984|FG000|Period 1|Protocol Violation|1|||
126337399|NCT00427908|454530985|FG000|Primary Phase|Lost to Follow-up|4|||
126001214|NCT03387514|453294088|FG000|Overall Study|Lost to Follow-up|2|||
126001215|NCT04445155|453294097|FG000|Overall Study|Lost to Follow-up|11|||
126001216|NCT04445155|453294098|FG001|Overall Study|Lost to Follow-up|2|||
126001217|NCT04445155|453294099|FG002|Overall Study|Lost to Follow-up|3|||
126001218|NCT04445155|453294100|FG003|Overall Study|Lost to Follow-up|0|||
126001219|NCT04445155|453294097|FG000|Overall Study|Withdrawal by Subject|8|||
126001220|NCT04445155|453294098|FG001|Overall Study|Withdrawal by Subject|0|||
126001221|NCT04445155|453294099|FG002|Overall Study|Withdrawal by Subject|0|||
126001222|NCT04445155|453294100|FG003|Overall Study|Withdrawal by Subject|0|||
126001223|NCT04445155|453294097|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
126001224|NCT04445155|453294098|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
126001225|NCT04445155|453294099|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
126337400|NCT00427908|454530986|FG001|Primary Phase|Lost to Follow-up|0|||
126337401|NCT00427908|454530987|FG002|Primary Phase|Lost to Follow-up|2|||
126337402|NCT00427908|454530988|FG003|Primary Phase|Lost to Follow-up|0|||
126001226|NCT04445155|453294100|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
126001227|NCT04445155|453294097|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
126001228|NCT04445155|453294098|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
126001229|NCT04445155|453294099|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
126001230|NCT04445155|453294100|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
126337403|NCT00427908|454530985|FG000|Primary Phase|Withdrawal by Subject|1|||
126001231|NCT00394095|453295708|FG000|Screening|Withdrawal by Subject|1|||
126001232|NCT00394095|453295709|FG001|Screening|Withdrawal by Subject|0|||
126001233|NCT00394095|453295708|FG000|Randomized|Withdrawal by Subject|5|||
126337404|NCT00427908|454530986|FG001|Primary Phase|Withdrawal by Subject|2|||
126001234|NCT00394095|453295709|FG001|Randomized|Withdrawal by Subject|1|||
126001235|NCT00394095|453295708|FG000|Randomized|Adverse Event|1|||
126337405|NCT00427908|454530987|FG002|Primary Phase|Withdrawal by Subject|1|||
126337406|NCT00427908|454530988|FG003|Primary Phase|Withdrawal by Subject|0|||
126001236|NCT00394095|453295709|FG001|Randomized|Adverse Event|1|||
126001237|NCT00394095|453295708|FG000|Randomized|Overdose|1|||
126001238|NCT00394095|453295709|FG001|Randomized|Overdose|0|||
126001239|NCT00394095|453295708|FG000|Randomized|Lost to Follow-up|1|||
126001240|NCT00394095|453295709|FG001|Randomized|Lost to Follow-up|2|||
126001241|NCT01268059|453295714|FG000|Overall Study|Lost to Follow-up|0|||
126001242|NCT01268059|453295715|FG001|Overall Study|Lost to Follow-up|1|||
126001243|NCT01268059|453295716|FG002|Overall Study|Lost to Follow-up|0|||
126001244|NCT01268059|453295717|FG003|Overall Study|Lost to Follow-up|0|||
126001245|NCT01268059|453295714|FG000|Overall Study|Withdrawal by Subject|7|||
126001246|NCT01268059|453295715|FG001|Overall Study|Withdrawal by Subject|4|||
126001247|NCT01268059|453295716|FG002|Overall Study|Withdrawal by Subject|0|||
126001248|NCT01268059|453295717|FG003|Overall Study|Withdrawal by Subject|0|||
126001249|NCT01268059|453295714|FG000|Overall Study|Death|20|||
126001250|NCT01268059|453295715|FG001|Overall Study|Death|30|||
126001251|NCT01268059|453295716|FG002|Overall Study|Death|3|||
126001252|NCT01268059|453295717|FG003|Overall Study|Death|5|||
126001253|NCT01268059|453295714|FG000|Overall Study|Progression of disease|1|||
126001254|NCT01268059|453295715|FG001|Overall Study|Progression of disease|0|||
126001255|NCT01268059|453295716|FG002|Overall Study|Progression of disease|0|||
126001256|NCT01268059|453295717|FG003|Overall Study|Progression of disease|0|||
126001257|NCT02819479|453295718|FG000|Overall Study|Adverse Event|2|||
126001258|NCT05310084|453295719|FG000|Overall Study|Withdrawal by Subject|2|||
126001259|NCT05310084|453295720|FG001|Overall Study|Withdrawal by Subject|3|||
126001260|NCT05310084|453295719|FG000|Overall Study|Participant availability|0|||
126001261|NCT05310084|453295720|FG001|Overall Study|Participant availability|4|||
126001262|NCT05310084|453295719|FG000|Overall Study|Lost to Follow-up|1|||
126001263|NCT05310084|453295720|FG001|Overall Study|Lost to Follow-up|1|||
126001264|NCT05310084|453295719|FG000|Overall Study|Adverse Event|1|||
126001265|NCT05310084|453295720|FG001|Overall Study|Adverse Event|1|||
126001266|NCT05310084|453295719|FG000|Overall Study|Randomized but not vaccinated|4|||
126001267|NCT05310084|453295720|FG001|Overall Study|Randomized but not vaccinated|2|||
126001268|NCT01646320|453295729|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
126001269|NCT01646320|453295730|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
126001270|NCT01646320|453295729|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
126001271|NCT01646320|453295730|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
126001272|NCT01646320|453295729|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
126001273|NCT01646320|453295730|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
126001274|NCT01646320|453295729|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
126001275|NCT01646320|453295730|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
126001276|NCT01646320|453295729|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
126001277|NCT01646320|453295730|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
126001278|NCT01646320|453295729|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
126001279|NCT01646320|453295730|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
126001280|NCT01646320|453295729|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
126001281|NCT01646320|453295730|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
126001282|NCT01646320|453295729|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
126001283|NCT01646320|453295730|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
126001284|NCT01646320|453295729|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
126001285|NCT01646320|453295730|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
126001286|NCT01646320|453295729|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
126001287|NCT01646320|453295730|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
126001288|NCT01646320|453295729|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
126001289|NCT01646320|453295730|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
126001290|NCT01489020|453295731|FG000|Overall Study|Withdrawal by Subject|1|||
126001291|NCT01489020|453295732|FG001|Overall Study|Withdrawal by Subject|0|||
126001292|NCT01489020|453295733|FG002|Overall Study|Withdrawal by Subject|0|||
126001293|NCT01489020|453295734|FG003|Overall Study|Withdrawal by Subject|0|||
126001294|NCT01489020|453295735|FG004|Overall Study|Withdrawal by Subject|0|||
126001295|NCT01489020|453295736|FG005|Overall Study|Withdrawal by Subject|0|||
126001296|NCT01489020|453295731|FG000|Overall Study|Adverse Event|0|||
126001297|NCT01489020|453295732|FG001|Overall Study|Adverse Event|0|||
126001298|NCT01489020|453295733|FG002|Overall Study|Adverse Event|3|||
126001299|NCT01489020|453295734|FG003|Overall Study|Adverse Event|0|||
126001300|NCT01489020|453295735|FG004|Overall Study|Adverse Event|3|||
126001301|NCT01489020|453295736|FG005|Overall Study|Adverse Event|0|||
126001302|NCT01489020|453295731|FG000|Overall Study|Concomitant disease|0|||
126001303|NCT01489020|453295732|FG001|Overall Study|Concomitant disease|0|||
126337407|NCT00427908|454530985|FG000|Primary Phase|Adverse Event|0|||
126001304|NCT01489020|453295733|FG002|Overall Study|Concomitant disease|0|||
126001305|NCT01489020|453295734|FG003|Overall Study|Concomitant disease|0|||
126001306|NCT01489020|453295735|FG004|Overall Study|Concomitant disease|3|||
126001307|NCT01489020|453295736|FG005|Overall Study|Concomitant disease|0|||
126337408|NCT00427908|454530986|FG001|Primary Phase|Adverse Event|1|||
126001308|NCT02424344|453295737|FG000|Overall Study|Lack of Efficacy|0|||
126001309|NCT02424344|453295738|FG001|Overall Study|Lack of Efficacy|1|||
126001310|NCT02424344|453295737|FG000|Overall Study|Withdrawal by Subject|2|||
126001311|NCT02424344|453295738|FG001|Overall Study|Withdrawal by Subject|1|||
126001312|NCT02424344|453295737|FG000|Overall Study|Lost to Follow-up|1|||
126001313|NCT02424344|453295738|FG001|Overall Study|Lost to Follow-up|0|||
126001314|NCT02424344|453295737|FG000|Overall Study|Adverse Event|4|||
126001315|NCT02424344|453295738|FG001|Overall Study|Adverse Event|8|||
126001316|NCT01174550|453295739|FG000|Overall Study|Death|75|||
126001317|NCT01174550|453295740|FG001|Overall Study|Death|74|||
126001318|NCT01174550|453295739|FG000|Overall Study|Lost to Follow-up|652|||
126001319|NCT01174550|453295740|FG001|Overall Study|Lost to Follow-up|510|||
126001320|NCT01174550|453295739|FG000|Overall Study|Withdrawal by Subject|543|||
126001321|NCT01174550|453295740|FG001|Overall Study|Withdrawal by Subject|289|||
126001322|NCT05257837|453295741|FG000|Overall Study|Excluded (did not find the guns)|4|||
126001323|NCT05257837|453295742|FG001|Overall Study|Excluded (did not find the guns)|2|||
126001324|NCT05257837|453295743|FG002|Overall Study|Excluded (did not find the guns)|4|||
126001325|NCT05257837|453295744|FG003|Overall Study|Excluded (did not find the guns)|0|||
126001326|NCT01625338|453295745|FG000|Overall Study|Enrolled but not Treated|0|||
126001327|NCT01625338|453295746|FG001|Overall Study|Enrolled but not Treated|0|||
126001328|NCT01625338|453295747|FG002|Overall Study|Enrolled but not Treated|1|||
126001329|NCT01625338|453295745|FG000|Overall Study|Efficacy Failure|27|||
126001330|NCT01625338|453295746|FG001|Overall Study|Efficacy Failure|39|||
126001331|NCT01625338|453295747|FG002|Overall Study|Efficacy Failure|31|||
126001332|NCT01625338|453295745|FG000|Overall Study|Lost to Follow-up|3|||
126001333|NCT01625338|453295746|FG001|Overall Study|Lost to Follow-up|3|||
126001334|NCT01625338|453295747|FG002|Overall Study|Lost to Follow-up|2|||
126001335|NCT01625338|453295745|FG000|Overall Study|Investigator Decision|0|||
126001336|NCT01625338|453295746|FG001|Overall Study|Investigator Decision|2|||
126001337|NCT01625338|453295747|FG002|Overall Study|Investigator Decision|1|||
126001338|NCT01625338|453295745|FG000|Overall Study|Subject Withdrew Consent|1|||
126001339|NCT01625338|453295746|FG001|Overall Study|Subject Withdrew Consent|0|||
126001340|NCT01625338|453295747|FG002|Overall Study|Subject Withdrew Consent|2|||
126001341|NCT01625338|453295745|FG000|Overall Study|Adverse Event|1|||
126001342|NCT01625338|453295746|FG001|Overall Study|Adverse Event|0|||
126001343|NCT01625338|453295747|FG002|Overall Study|Adverse Event|1|||
126001344|NCT01625338|453295745|FG000|Overall Study|Study Discontinued by Sponsor|0|||
126001345|NCT01625338|453295746|FG001|Overall Study|Study Discontinued by Sponsor|0|||
126001346|NCT01625338|453295747|FG002|Overall Study|Study Discontinued by Sponsor|1|||
126001347|NCT02485353|453295748|FG000|Overall Study|Death|1|||
126001348|NCT02485353|453295748|FG000|Overall Study|Disease Progression|1|||
126001349|NCT01021332|453295749|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
126001350|NCT01021332|453295749|FG000|Overall Study|Adverse Event|43|||
126001351|NCT01021332|453295749|FG000|Overall Study|Lack of Efficacy|19|||
126001352|NCT01021332|453295749|FG000|Overall Study|Withdrawal of Consent|23|||
126001353|NCT01021332|453295749|FG000|Overall Study|Lost to Follow-up|4|||
126001354|NCT01021332|453295749|FG000|Overall Study|Protocol Violation|9|||
126337409|NCT00427908|454530987|FG002|Primary Phase|Adverse Event|0|||
126337410|NCT00427908|454530988|FG003|Primary Phase|Adverse Event|0|||
126337411|NCT02984982|454530989|FG000|Overall Study|Adverse Event|2|||
126337412|NCT02984982|454530990|FG001|Overall Study|Adverse Event|5|||
126337413|NCT02984982|454530989|FG000|Overall Study|Poor Compliance to Protocol|4|||
126337414|NCT02984982|454530990|FG001|Overall Study|Poor Compliance to Protocol|4|||
126337415|NCT02984982|454530989|FG000|Overall Study|Withdrawal by Subject|2|||
126337416|NCT02984982|454530990|FG001|Overall Study|Withdrawal by Subject|0|||
126337417|NCT02984982|454530989|FG000|Overall Study|Randomized but not treated|0|||
126337418|NCT02984982|454530990|FG001|Overall Study|Randomized but not treated|1|||
126337419|NCT02153918|454530991|FG000|Overall Study|Refused further treatment|1|||
126337420|NCT02616783|454530992|FG000|Overall Study|Randomized but Not Treated|1|||
126337421|NCT02616783|454530993|FG001|Overall Study|Randomized but Not Treated|0|||
126337422|NCT02616783|454530992|FG000|Overall Study|Adverse Event|1|||
126337423|NCT02616783|454530993|FG001|Overall Study|Adverse Event|0|||
126337424|NCT02616783|454530992|FG000|Overall Study|Death|1|||
126337425|NCT02616783|454530993|FG001|Overall Study|Death|0|||
126337426|NCT02616783|454530992|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126337427|NCT02616783|454530993|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126337428|NCT02616783|454530992|FG000|Overall Study|Protocol Violation|1|||
126337429|NCT02616783|454530993|FG001|Overall Study|Protocol Violation|1|||
126001355|NCT01021332|453295749|FG000|Overall Study|Miscellaneous|3|||
126001356|NCT03487666|453295752|FG000|Overall Study|Disease progression|4|||
126001357|NCT03487666|453295753|FG001|Overall Study|Disease progression|2|||
126001358|NCT03487666|453295754|FG002|Overall Study|Disease progression|0|||
126001359|NCT03487666|453295752|FG000|Overall Study|Adverse Event|0|||
126337430|NCT02616783|454530992|FG000|Overall Study|Withdrew Consent|1|||
126337431|NCT02616783|454530993|FG001|Overall Study|Withdrew Consent|1|||
126337432|NCT04344301|454530994|FG000|Overall Study|Withdrawal by Subject|1|||
126001360|NCT03487666|453295753|FG001|Overall Study|Adverse Event|0|||
126337433|NCT04344301|454530995|FG001|Overall Study|Withdrawal by Subject|0|||
126337434|NCT04344301|454530994|FG000|Overall Study|Death|0|||
126337435|NCT04344301|454530995|FG001|Overall Study|Death|1|||
126337436|NCT01747499|454530996|FG000|Overall Study|Steroid refractory aGvHD|1|||
126337437|NCT01747499|454530997|FG001|Overall Study|Steroid refractory aGvHD|0|||
126337438|NCT01747499|454530998|FG002|Overall Study|Steroid refractory aGvHD|0|||
126337439|NCT01747499|454530999|FG003|Overall Study|Steroid refractory aGvHD|1|||
126337440|NCT01747499|454531000|FG004|Overall Study|Steroid refractory aGvHD|4|||
126337441|NCT01747499|454530996|FG000|Overall Study|Physician Decision|0|||
126337442|NCT01747499|454530997|FG001|Overall Study|Physician Decision|1|||
126337443|NCT01747499|454530998|FG002|Overall Study|Physician Decision|0|||
126337444|NCT01747499|454530999|FG003|Overall Study|Physician Decision|0|||
126337445|NCT01747499|454531000|FG004|Overall Study|Physician Decision|2|||
126337446|NCT01747499|454530996|FG000|Overall Study|Death|0|||
126337447|NCT01747499|454530997|FG001|Overall Study|Death|0|||
126337448|NCT01747499|454530998|FG002|Overall Study|Death|0|||
126337449|NCT01747499|454530999|FG003|Overall Study|Death|1|||
126337450|NCT01747499|454531000|FG004|Overall Study|Death|1|||
126337451|NCT01747499|454530996|FG000|Overall Study|Withdrawal by Subject|0|||
126337452|NCT01747499|454530997|FG001|Overall Study|Withdrawal by Subject|0|||
126001361|NCT03487666|453295754|FG002|Overall Study|Adverse Event|1|||
126001362|NCT05343455|453295757|FG000|Overall Study|Withdrawal by Subject|4|||
126001363|NCT05343455|453295758|FG001|Overall Study|Withdrawal by Subject|9|||
126001364|NCT05343455|453295759|FG002|Overall Study|Withdrawal by Subject|7|||
126001365|NCT05343455|453295757|FG000|Overall Study|Adverse Event|2|||
126001366|NCT05343455|453295758|FG001|Overall Study|Adverse Event|1|||
126001367|NCT05343455|453295759|FG002|Overall Study|Adverse Event|2|||
126001368|NCT05343455|453295757|FG000|Overall Study|Lost to Follow-up|1|||
126001369|NCT05343455|453295758|FG001|Overall Study|Lost to Follow-up|1|||
126001370|NCT05343455|453295759|FG002|Overall Study|Lost to Follow-up|3|||
126001371|NCT05343455|453295757|FG000|Overall Study|Pregnancy|1|||
126001372|NCT05343455|453295758|FG001|Overall Study|Pregnancy|0|||
126001373|NCT05343455|453295759|FG002|Overall Study|Pregnancy|0|||
126001374|NCT05343455|453295757|FG000|Overall Study|Physician Decision|0|||
126001375|NCT05343455|453295758|FG001|Overall Study|Physician Decision|0|||
126001376|NCT05343455|453295759|FG002|Overall Study|Physician Decision|1|||
126001377|NCT05343455|453295757|FG000|Overall Study|Protocol Violation|0|||
126001378|NCT05343455|453295758|FG001|Overall Study|Protocol Violation|1|||
126001379|NCT05343455|453295759|FG002|Overall Study|Protocol Violation|1|||
126001380|NCT02748512|453295764|FG000|Overall Study|Lost to Follow-up|1|||
126001381|NCT02748512|453295765|FG001|Overall Study|Lost to Follow-up|1|||
126001382|NCT00765362|453295767|FG000|Overall Study|Death|9|||
126001383|NCT00765362|453295767|FG000|Overall Study|Adverse Event|2|||
126001384|NCT00765362|453295767|FG000|Overall Study|Protocol Violation|18|||
126001385|NCT00765362|453295767|FG000|Overall Study|Withdrawal by Subject|13|||
126001386|NCT00765362|453295767|FG000|Overall Study|Lost to Follow-up|95|||
126001387|NCT03930186|453295768|FG000|Weeks 0 to 16|Adverse Event|6|||
126001388|NCT03930186|453295768|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
126001389|NCT03930186|453295768|FG000|Weeks 16 to 32|Adverse Event|1|||
126001390|NCT03930186|453295768|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
126001391|NCT00557505|453295771|FG000|Overall Study|Death|0|||
126001392|NCT00557505|453295772|FG001|Overall Study|Death|0|||
126001393|NCT00557505|453295773|FG002|Overall Study|Death|0|||
126001394|NCT00557505|453295774|FG003|Overall Study|Death|0|||
126001395|NCT00557505|453295775|FG004|Overall Study|Death|0|||
126001396|NCT00557505|453295776|FG005|Overall Study|Death|0|||
126001397|NCT00557505|453295777|FG006|Overall Study|Death|0|||
126001398|NCT00557505|453295778|FG007|Overall Study|Death|0|||
126001399|NCT00557505|453295779|FG008|Overall Study|Death|1|||
126001400|NCT00557505|453295771|FG000|Overall Study|Adverse Event|0|||
126001401|NCT00557505|453295772|FG001|Overall Study|Adverse Event|0|||
126001402|NCT00557505|453295773|FG002|Overall Study|Adverse Event|1|||
126001403|NCT00557505|453295774|FG003|Overall Study|Adverse Event|0|||
126001404|NCT00557505|453295775|FG004|Overall Study|Adverse Event|0|||
126001405|NCT00557505|453295776|FG005|Overall Study|Adverse Event|0|||
126001406|NCT00557505|453295777|FG006|Overall Study|Adverse Event|1|||
126001407|NCT00557505|453295778|FG007|Overall Study|Adverse Event|0|||
126001408|NCT00557505|453295779|FG008|Overall Study|Adverse Event|0|||
126001409|NCT00557505|453295771|FG000|Overall Study|Global deterioration of health|1|||
126001410|NCT00557505|453295772|FG001|Overall Study|Global deterioration of health|0|||
126001411|NCT00557505|453295773|FG002|Overall Study|Global deterioration of health|0|||
126001412|NCT00557505|453295774|FG003|Overall Study|Global deterioration of health|0|||
126001413|NCT00557505|453295775|FG004|Overall Study|Global deterioration of health|0|||
126001414|NCT00557505|453295776|FG005|Overall Study|Global deterioration of health|0|||
126337453|NCT01747499|454530998|FG002|Overall Study|Withdrawal by Subject|0|||
126337454|NCT01747499|454530999|FG003|Overall Study|Withdrawal by Subject|0|||
126001415|NCT00557505|453295777|FG006|Overall Study|Global deterioration of health|0|||
126001416|NCT00557505|453295778|FG007|Overall Study|Global deterioration of health|0|||
126337455|NCT01747499|454531000|FG004|Overall Study|Withdrawal by Subject|6|||
126337456|NCT01747499|454530996|FG000|Overall Study|Developed AML and death|0|||
126337457|NCT01747499|454530997|FG001|Overall Study|Developed AML and death|0|||
126001417|NCT00557505|453295779|FG008|Overall Study|Global deterioration of health|0|||
126001418|NCT00557505|453295771|FG000|Overall Study|Objective progression or relapse|2|||
126001419|NCT00557505|453295772|FG001|Overall Study|Objective progression or relapse|3|||
126001420|NCT00557505|453295773|FG002|Overall Study|Objective progression or relapse|3|||
126001421|NCT00557505|453295774|FG003|Overall Study|Objective progression or relapse|2|||
126001422|NCT00557505|453295775|FG004|Overall Study|Objective progression or relapse|2|||
126001423|NCT00557505|453295776|FG005|Overall Study|Objective progression or relapse|3|||
126001424|NCT00557505|453295777|FG006|Overall Study|Objective progression or relapse|2|||
126001425|NCT00557505|453295778|FG007|Overall Study|Objective progression or relapse|5|||
126001426|NCT00557505|453295779|FG008|Overall Study|Objective progression or relapse|15|||
126001427|NCT00557505|453295771|FG000|Overall Study|Withdrawal by Subject|0|||
126001428|NCT00557505|453295772|FG001|Overall Study|Withdrawal by Subject|0|||
126001429|NCT00557505|453295773|FG002|Overall Study|Withdrawal by Subject|0|||
126001430|NCT00557505|453295774|FG003|Overall Study|Withdrawal by Subject|1|||
126001431|NCT00557505|453295775|FG004|Overall Study|Withdrawal by Subject|0|||
126001432|NCT00557505|453295776|FG005|Overall Study|Withdrawal by Subject|0|||
126001433|NCT00557505|453295777|FG006|Overall Study|Withdrawal by Subject|0|||
126001434|NCT00557505|453295778|FG007|Overall Study|Withdrawal by Subject|0|||
126001435|NCT00557505|453295779|FG008|Overall Study|Withdrawal by Subject|1|||
126001436|NCT03019458|453295780|FG000|Overall Study|Death|0|||
126001437|NCT03019458|453295781|FG001|Overall Study|Death|1|||
126001438|NCT00031447|453295784|FG000|Overall Study|Lost to Follow-up|0|||
126001439|NCT00031447|453295785|FG001|Overall Study|Lost to Follow-up|1|||
126001440|NCT00031447|453295784|FG000|Overall Study|Non-compliant|1|||
126001441|NCT00031447|453295785|FG001|Overall Study|Non-compliant|1|||
126001442|NCT00031447|453295784|FG000|Overall Study|Re-activation of Disease|2|||
126001443|NCT00031447|453295785|FG001|Overall Study|Re-activation of Disease|1|||
126001444|NCT00031447|453295784|FG000|Overall Study|Disruption of blinded study drug supply|7|||
126001445|NCT00031447|453295785|FG001|Overall Study|Disruption of blinded study drug supply|4|||
126001446|NCT01636362|453295786|FG000|Overall Study|Physician Decision|6|||
126001447|NCT01636362|453295786|FG000|Overall Study|Subject healed, not returning|1|||
126001448|NCT01636362|453295786|FG000|Overall Study|Withdrawal by Subject|1|||
126001449|NCT01244763|453295787|FG000|Overall Study|Adverse Event|1|||
126001450|NCT01244763|453295788|FG001|Overall Study|Adverse Event|0|||
126001451|NCT01244763|453295789|FG002|Overall Study|Adverse Event|0|||
126001452|NCT01244763|453295790|FG003|Overall Study|Adverse Event|0|||
126001453|NCT01244763|453295791|FG004|Overall Study|Adverse Event|0|||
126001454|NCT01244763|453295792|FG005|Overall Study|Adverse Event|1|||
126001455|NCT01244763|453295787|FG000|Overall Study|Death|1|||
126001456|NCT01244763|453295788|FG001|Overall Study|Death|0|||
126001457|NCT01244763|453295789|FG002|Overall Study|Death|1|||
126001458|NCT01244763|453295790|FG003|Overall Study|Death|0|||
126001459|NCT01244763|453295791|FG004|Overall Study|Death|2|||
126001460|NCT01244763|453295792|FG005|Overall Study|Death|0|||
126001461|NCT01244763|453295787|FG000|Overall Study|Physician Decision|0|||
126001462|NCT01244763|453295788|FG001|Overall Study|Physician Decision|0|||
126001463|NCT01244763|453295789|FG002|Overall Study|Physician Decision|1|||
126001464|NCT01244763|453295790|FG003|Overall Study|Physician Decision|0|||
126001465|NCT01244763|453295791|FG004|Overall Study|Physician Decision|0|||
126001466|NCT01244763|453295792|FG005|Overall Study|Physician Decision|0|||
126001467|NCT01244763|453295787|FG000|Overall Study|Withdrawal by Subject|1|||
126001468|NCT01244763|453295788|FG001|Overall Study|Withdrawal by Subject|2|||
126001469|NCT01244763|453295789|FG002|Overall Study|Withdrawal by Subject|0|||
126001470|NCT01244763|453295790|FG003|Overall Study|Withdrawal by Subject|1|||
126001471|NCT01244763|453295791|FG004|Overall Study|Withdrawal by Subject|1|||
126001472|NCT01244763|453295792|FG005|Overall Study|Withdrawal by Subject|2|||
126001473|NCT01244763|453295787|FG000|Overall Study|Lost to Follow-up|0|||
126001474|NCT01244763|453295788|FG001|Overall Study|Lost to Follow-up|1|||
126001475|NCT01244763|453295789|FG002|Overall Study|Lost to Follow-up|0|||
126001476|NCT01244763|453295790|FG003|Overall Study|Lost to Follow-up|0|||
126337458|NCT01747499|454530998|FG002|Overall Study|Developed AML and death|0|||
126337459|NCT01747499|454530999|FG003|Overall Study|Developed AML and death|0|||
126337460|NCT01747499|454531000|FG004|Overall Study|Developed AML and death|1|||
126337461|NCT01747499|454530996|FG000|Overall Study|Determined not to be eligible|0|||
126337462|NCT01747499|454530997|FG001|Overall Study|Determined not to be eligible|0|||
126337463|NCT01747499|454530998|FG002|Overall Study|Determined not to be eligible|0|||
126001477|NCT01244763|453295791|FG004|Overall Study|Lost to Follow-up|0|||
126001478|NCT01244763|453295792|FG005|Overall Study|Lost to Follow-up|0|||
126001479|NCT01244763|453295787|FG000|Overall Study|Enrolled into the Extension Study|0|||
126001480|NCT01244763|453295788|FG001|Overall Study|Enrolled into the Extension Study|0|||
126001481|NCT01244763|453295789|FG002|Overall Study|Enrolled into the Extension Study|0|||
126001482|NCT01244763|453295790|FG003|Overall Study|Enrolled into the Extension Study|0|||
126001483|NCT01244763|453295791|FG004|Overall Study|Enrolled into the Extension Study|0|||
126001484|NCT01244763|453295792|FG005|Overall Study|Enrolled into the Extension Study|1|||
126001485|NCT01561079|453295796|FG000|Overall Study|Physician Decision|17|||
126001486|NCT01561079|453295796|FG000|Overall Study|Withdrawal by Subject|59|||
126001487|NCT01561079|453295796|FG000|Overall Study|Protocol Violation|2|||
126001488|NCT00688259|453295801|FG000|Overall Study|Lost to Follow-up|2|||
126001489|NCT00688259|453295802|FG001|Overall Study|Lost to Follow-up|4|||
126001490|NCT00688259|453295801|FG000|Overall Study|Physician Decision|1|||
126001491|NCT00688259|453295802|FG001|Overall Study|Physician Decision|0|||
126001492|NCT00688259|453295801|FG000|Overall Study|Withdrawal by Subject|2|||
126001493|NCT00688259|453295802|FG001|Overall Study|Withdrawal by Subject|0|||
126001494|NCT00688259|453295801|FG000|Overall Study|Declined Interview|2|||
126001495|NCT00688259|453295802|FG001|Overall Study|Declined Interview|3|||
126001496|NCT00688259|453295801|FG000|Overall Study|Hospitalized at Follow-up|0|||
126001497|NCT00688259|453295802|FG001|Overall Study|Hospitalized at Follow-up|1|||
126001498|NCT01734382|453295803|FG000|Part 1|Adverse Event|2|||
126001499|NCT01734382|453295804|FG001|Part 1|Adverse Event|0|||
126001500|NCT01734382|453295805|FG002|Part 1|Adverse Event|0|||
126001501|NCT01734382|453295803|FG000|Part 2|Adverse Event|0|||
126001502|NCT01734382|453295804|FG001|Part 2|Adverse Event|0|||
126001503|NCT01734382|453295805|FG002|Part 2|Adverse Event|1|||
126001504|NCT01734382|453295803|FG000|Part 2|Lack of Efficacy|0|||
126001505|NCT01734382|453295804|FG001|Part 2|Lack of Efficacy|1|||
126001506|NCT01734382|453295805|FG002|Part 2|Lack of Efficacy|1|||
126001507|NCT01734382|453295803|FG000|Part 2|Other|0|||
126001508|NCT01734382|453295804|FG001|Part 2|Other|0|||
126001509|NCT01734382|453295805|FG002|Part 2|Other|1|||
126001510|NCT01734382|453295803|FG000|Part 2|Physician Decision|0|||
126001511|NCT01734382|453295804|FG001|Part 2|Physician Decision|0|||
126001512|NCT01734382|453295805|FG002|Part 2|Physician Decision|3|||
126001513|NCT01734382|453295803|FG000|Part 2|Protocol Violation|0|||
126001514|NCT01734382|453295804|FG001|Part 2|Protocol Violation|1|||
126001515|NCT01734382|453295805|FG002|Part 2|Protocol Violation|0|||
126001516|NCT01734382|453295803|FG000|Part 2|Withdrawal by Subject|0|||
126001517|NCT01734382|453295804|FG001|Part 2|Withdrawal by Subject|0|||
126001518|NCT01734382|453295805|FG002|Part 2|Withdrawal by Subject|1|||
126001519|NCT00683449|453295806|FG000|Overall Study|Lost to Follow-up|0|||
126001520|NCT00683449|453295807|FG001|Overall Study|Lost to Follow-up|1|||
126001521|NCT00683449|453295808|FG002|Overall Study|Lost to Follow-up|0|||
126001522|NCT00683449|453295809|FG003|Overall Study|Lost to Follow-up|0|||
126001523|NCT00683449|453295810|FG004|Overall Study|Lost to Follow-up|0|||
126001524|NCT00146640|453295815|FG000|Overall Study|Adverse Event|12|||
126001525|NCT00146640|453295816|FG001|Overall Study|Adverse Event|10|||
126001526|NCT00146640|453295815|FG000|Overall Study|Medical Reasons|3|||
126001527|NCT00146640|453295816|FG001|Overall Study|Medical Reasons|0|||
126001528|NCT00146640|453295815|FG000|Overall Study|Non-Medical Reasons|8|||
126001529|NCT00146640|453295816|FG001|Overall Study|Non-Medical Reasons|4|||
126001530|NCT02059161|453295819|FG000|Overall Study|Pregnancy|0|||
126001531|NCT02059161|453295820|FG001|Overall Study|Pregnancy|2|||
126001532|NCT02059161|453295819|FG000|Overall Study|Adverse Event|2|||
126001533|NCT02059161|453295820|FG001|Overall Study|Adverse Event|6|||
126001534|NCT02059161|453295819|FG000|Overall Study|Lost to Follow-up|20|||
126001535|NCT02059161|453295820|FG001|Overall Study|Lost to Follow-up|12|||
126001536|NCT02059161|453295819|FG000|Overall Study|Physician Decision|4|||
126001537|NCT02059161|453295820|FG001|Overall Study|Physician Decision|4|||
126001538|NCT02059161|453295819|FG000|Overall Study|Protocol Violation|1|||
126001539|NCT02059161|453295820|FG001|Overall Study|Protocol Violation|1|||
126001540|NCT02059161|453295819|FG000|Overall Study|Withdrawal by Subject|16|||
126001541|NCT02059161|453295820|FG001|Overall Study|Withdrawal by Subject|13|||
126001542|NCT02059161|453295819|FG000|Overall Study|Randomized in error, no study drug|0|||
126001543|NCT02059161|453295820|FG001|Overall Study|Randomized in error, no study drug|1|||
126001544|NCT02059161|453295819|FG000|Overall Study|Non-compliance with study drug|6|||
126001545|NCT02059161|453295820|FG001|Overall Study|Non-compliance with study drug|2|||
126001546|NCT01237678|453295822|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
126001547|NCT01237678|453295823|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
126001548|NCT01237678|453295824|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
126001549|NCT01237678|453295822|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
126001550|NCT01237678|453295823|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
126001551|NCT01237678|453295824|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
126001552|NCT01237678|453295822|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
126001553|NCT01237678|453295823|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
126001554|NCT01237678|453295824|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
126001555|NCT01237678|453295822|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
126001556|NCT01237678|453295823|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
126001557|NCT01237678|453295824|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
126001558|NCT01237678|453295822|FG000|Phase II|Adverse Event|0|||
126001559|NCT01237678|453295823|FG001|Phase II|Adverse Event|39|||
126001560|NCT01237678|453295824|FG002|Phase II|Adverse Event|9|||
126001561|NCT01237678|453295822|FG000|Phase II|Death|0|||
126001562|NCT01237678|453295823|FG001|Phase II|Death|0|||
126001563|NCT01237678|453295824|FG002|Phase II|Death|2|||
126001564|NCT01237678|453295822|FG000|Phase II|Lack of Efficacy|0|||
126001565|NCT01237678|453295823|FG001|Phase II|Lack of Efficacy|25|||
126001566|NCT01237678|453295824|FG002|Phase II|Lack of Efficacy|3|||
126001567|NCT01237678|453295822|FG000|Phase II|Withdrawal by Subject|0|||
126001568|NCT01237678|453295823|FG001|Phase II|Withdrawal by Subject|1|||
126001569|NCT01237678|453295824|FG002|Phase II|Withdrawal by Subject|5|||
126001570|NCT01237678|453295822|FG000|Phase II|Completed Cycles 4-6|0|||
126001571|NCT01237678|453295823|FG001|Phase II|Completed Cycles 4-6|11|||
126001572|NCT01237678|453295824|FG002|Phase II|Completed Cycles 4-6|21|||
126001573|NCT01237678|453295822|FG000|Phase II|Sponsor Decision/Study Closed|0|||
126001574|NCT01237678|453295823|FG001|Phase II|Sponsor Decision/Study Closed|18|||
126001575|NCT01237678|453295824|FG002|Phase II|Sponsor Decision/Study Closed|7|||
126001576|NCT01237678|453295822|FG000|Phase II|Randomized but were not treated|0|||
126337464|NCT01747499|454530999|FG003|Overall Study|Determined not to be eligible|0|||
126337465|NCT01747499|454531000|FG004|Overall Study|Determined not to be eligible|1|||
126337466|NCT05214118|454531003|FG000|Overall Study|Lost to Follow-up|0|||
126337467|NCT05214118|454531004|FG001|Overall Study|Lost to Follow-up|2|||
126337468|NCT05214118|454531003|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
126337469|NCT05214118|454531004|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
126001577|NCT01237678|453295823|FG001|Phase II|Randomized but were not treated|4|||
126001578|NCT01237678|453295824|FG002|Phase II|Randomized but were not treated|3|||
126001579|NCT01723826|453295828|FG000|Overall Study|Adverse Event|4|||
126001580|NCT01723826|453295829|FG001|Overall Study|Adverse Event|1|||
126001581|NCT01723826|453295830|FG002|Overall Study|Adverse Event|4|||
126001582|NCT01723826|453295831|FG003|Overall Study|Adverse Event|5|||
126001583|NCT01723826|453295828|FG000|Overall Study|Death according to AE eCRF|2|||
126001584|NCT01723826|453295829|FG001|Overall Study|Death according to AE eCRF|3|||
126001585|NCT01723826|453295830|FG002|Overall Study|Death according to AE eCRF|3|||
126001586|NCT01723826|453295831|FG003|Overall Study|Death according to AE eCRF|7|||
126001587|NCT01723826|453295828|FG000|Overall Study|Lost to Follow-up|1|||
126001588|NCT01723826|453295829|FG001|Overall Study|Lost to Follow-up|3|||
126001589|NCT01723826|453295830|FG002|Overall Study|Lost to Follow-up|1|||
126001590|NCT01723826|453295831|FG003|Overall Study|Lost to Follow-up|1|||
126001591|NCT01723826|453295828|FG000|Overall Study|Non-compliance|0|||
126001592|NCT01723826|453295829|FG001|Overall Study|Non-compliance|1|||
126001593|NCT01723826|453295830|FG002|Overall Study|Non-compliance|3|||
126001594|NCT01723826|453295831|FG003|Overall Study|Non-compliance|3|||
126001595|NCT01723826|453295828|FG000|Overall Study|Non-compliance With Study Drug|0|||
126001596|NCT01723826|453295829|FG001|Overall Study|Non-compliance With Study Drug|1|||
126001597|NCT01723826|453295830|FG002|Overall Study|Non-compliance With Study Drug|0|||
126001598|NCT01723826|453295831|FG003|Overall Study|Non-compliance With Study Drug|0|||
126001599|NCT01723826|453295828|FG000|Overall Study|Other Reason|8|||
126001600|NCT01723826|453295829|FG001|Overall Study|Other Reason|6|||
126001601|NCT01723826|453295830|FG002|Overall Study|Other Reason|12|||
126001602|NCT01723826|453295831|FG003|Overall Study|Other Reason|14|||
126337470|NCT05214118|454531003|FG000|Overall Study|moved|1|||
126337471|NCT05214118|454531004|FG001|Overall Study|moved|0|||
126337472|NCT04010461|454531005|FG000|Overall Study|COVID based withdrawal|5|||
126337473|NCT04010461|454531005|FG000|Overall Study|Withdrawal by Subject|5|||
126337474|NCT04010461|454531005|FG000|Overall Study|Adverse Event|1|||
126337475|NCT04010461|454531005|FG000|Overall Study|No Motor Threshold obtainable|1|||
126337476|NCT04010461|454531005|FG000|Overall Study|Physician Decision|1|||
126337477|NCT03797898|454531006|FG000|Overall Study|Lost to Follow-up|60|||
126337478|NCT03797898|454531007|FG001|Overall Study|Lost to Follow-up|69|||
126337479|NCT03797898|454531006|FG000|Overall Study|Withdrawal by Subject|9|||
126337480|NCT03797898|454531007|FG001|Overall Study|Withdrawal by Subject|7|||
126337481|NCT03797898|454531006|FG000|Overall Study|Became ineligible|5|||
126337482|NCT03797898|454531007|FG001|Overall Study|Became ineligible|2|||
126337483|NCT00086190|454531008|FG000|Overall Study|Adverse Event|6|||
126337484|NCT00086190|454531009|FG001|Overall Study|Adverse Event|2|||
126337485|NCT00086190|454531010|FG002|Overall Study|Adverse Event|2|||
126337486|NCT00086190|454531008|FG000|Overall Study|Withdrawal by Subject|0|||
126337487|NCT00086190|454531009|FG001|Overall Study|Withdrawal by Subject|2|||
126337488|NCT00086190|454531010|FG002|Overall Study|Withdrawal by Subject|2|||
126337489|NCT00086190|454531008|FG000|Overall Study|Protocol Violation|1|||
126337490|NCT00086190|454531009|FG001|Overall Study|Protocol Violation|0|||
126337491|NCT00086190|454531010|FG002|Overall Study|Protocol Violation|0|||
126337492|NCT00086190|454531008|FG000|Overall Study|Moved|1|||
126337493|NCT00086190|454531009|FG001|Overall Study|Moved|0|||
126337494|NCT00086190|454531010|FG002|Overall Study|Moved|0|||
126001603|NCT01723826|453295828|FG000|Overall Study|Physician Decision|1|||
126001604|NCT01723826|453295829|FG001|Overall Study|Physician Decision|3|||
126337495|NCT00086190|454531008|FG000|Overall Study|Worsening depression|0|||
126337496|NCT00086190|454531009|FG001|Overall Study|Worsening depression|0|||
126337497|NCT00086190|454531010|FG002|Overall Study|Worsening depression|2|||
126337498|NCT03902613|454531011|FG000|Overall Study|Physician Decision|1|||
126337499|NCT02027025|454531015|FG000|Overall Study|Adverse Event|0|||
126001605|NCT01723826|453295830|FG002|Overall Study|Physician Decision|4|||
126001606|NCT01723826|453295831|FG003|Overall Study|Physician Decision|11|||
126001607|NCT01723826|453295828|FG000|Overall Study|Protocol Violation|1|||
126001608|NCT01723826|453295829|FG001|Overall Study|Protocol Violation|1|||
126001609|NCT01723826|453295830|FG002|Overall Study|Protocol Violation|3|||
126001610|NCT01723826|453295831|FG003|Overall Study|Protocol Violation|1|||
126001611|NCT01723826|453295828|FG000|Overall Study|Withdrawal by Subject|10|||
126001612|NCT01723826|453295829|FG001|Overall Study|Withdrawal by Subject|17|||
126001613|NCT01723826|453295830|FG002|Overall Study|Withdrawal by Subject|27|||
126001614|NCT01723826|453295831|FG003|Overall Study|Withdrawal by Subject|48|||
126001615|NCT03023332|453295832|FG000|Overall Study|Withdrawal by Subject|10|||
126001616|NCT03023332|453295833|FG001|Overall Study|Withdrawal by Subject|5|||
126001617|NCT03023332|453295834|FG002|Overall Study|Withdrawal by Subject|4|||
126001618|NCT03023332|453295835|FG003|Overall Study|Withdrawal by Subject|7|||
126001619|NCT03023332|453295832|FG000|Overall Study|Lost to Follow-up|13|||
126001620|NCT03023332|453295833|FG001|Overall Study|Lost to Follow-up|16|||
126001621|NCT03023332|453295834|FG002|Overall Study|Lost to Follow-up|8|||
126001622|NCT03023332|453295835|FG003|Overall Study|Lost to Follow-up|13|||
126001623|NCT03023332|453295832|FG000|Overall Study|Death|1|||
126001624|NCT03023332|453295833|FG001|Overall Study|Death|0|||
126001625|NCT03023332|453295834|FG002|Overall Study|Death|0|||
126001626|NCT03023332|453295835|FG003|Overall Study|Death|0|||
126001627|NCT01818700|453295836|FG000|Overall Study|Adverse Event|67|||
126001628|NCT01818700|453295836|FG000|Overall Study|Lack of Efficacy|2|||
126001629|NCT01818700|453295836|FG000|Overall Study|Lost to Follow-up|5|||
126001630|NCT01818700|453295836|FG000|Overall Study|Withdrawal by Subject|27|||
126001631|NCT01818700|453295836|FG000|Overall Study|Protocol Violation|2|||
126001632|NCT01818700|453295836|FG000|Overall Study|Other|1|||
126001633|NCT02408549|453295839|FG000|Overall Study|Adverse Event|15|||
126001634|NCT02408549|453295839|FG000|Overall Study|Death|4|||
126001635|NCT02408549|453295839|FG000|Overall Study|Lack of Efficacy|17|||
126001636|NCT02408549|453295839|FG000|Overall Study|Protocol Violation|4|||
126001637|NCT02408549|453295839|FG000|Overall Study|Lost to Follow-up|6|||
126001638|NCT02408549|453295839|FG000|Overall Study|Consent withdrawn|30|||
126001639|NCT02408549|453295839|FG000|Overall Study|Neurology research program closing at site|1|||
126001640|NCT02408549|453295839|FG000|Overall Study|Site closure|1|||
126001641|NCT02408549|453295839|FG000|Overall Study|Pregnancy|1|||
126001642|NCT02408549|453295839|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
126001643|NCT02408549|453295839|FG000|Overall Study|Subject moved to another place, far from site|1|||
126001644|NCT02408549|453295839|FG000|Overall Study|Study terminated at site|1|||
126001645|NCT01272011|453295840|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
126001646|NCT01272011|453295841|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
126001647|NCT01272011|453295842|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
126001648|NCT02013687|453295843|FG000|Overall Study|Lost to Follow-up|0|||
126001649|NCT02013687|453295844|FG001|Overall Study|Lost to Follow-up|0|||
126001650|NCT02013687|453295845|FG002|Overall Study|Lost to Follow-up|1|||
126001651|NCT02013687|453295846|FG003|Overall Study|Lost to Follow-up|0|||
126001652|NCT02013687|453295843|FG000|Overall Study|Protocol Violation|0|||
126001653|NCT02013687|453295844|FG001|Overall Study|Protocol Violation|0|||
126001654|NCT02013687|453295845|FG002|Overall Study|Protocol Violation|0|||
126001655|NCT02013687|453295846|FG003|Overall Study|Protocol Violation|1|||
126001656|NCT02013687|453295843|FG000|Overall Study|Withdrawal by Subject|0|||
126001657|NCT02013687|453295844|FG001|Overall Study|Withdrawal by Subject|0|||
126001658|NCT02013687|453295845|FG002|Overall Study|Withdrawal by Subject|0|||
126337500|NCT02027025|454531016|FG001|Overall Study|Adverse Event|1|||
126337501|NCT02027025|454531017|FG002|Overall Study|Adverse Event|1|||
126337502|NCT02027025|454531015|FG000|Overall Study|Protocol Violation|1|||
126337503|NCT02027025|454531016|FG001|Overall Study|Protocol Violation|0|||
126337504|NCT02027025|454531017|FG002|Overall Study|Protocol Violation|0|||
126337505|NCT02027025|454531015|FG000|Overall Study|Lost to Follow-up|0|||
126337506|NCT02027025|454531016|FG001|Overall Study|Lost to Follow-up|2|||
126337507|NCT02027025|454531017|FG002|Overall Study|Lost to Follow-up|0|||
126337508|NCT02027025|454531015|FG000|Overall Study|Withdrawal by Subject|0|||
126337509|NCT02027025|454531016|FG001|Overall Study|Withdrawal by Subject|1|||
126337510|NCT02027025|454531017|FG002|Overall Study|Withdrawal by Subject|0|||
126337511|NCT02027025|454531015|FG000|Overall Study|Sponsor's decision|0|||
126001659|NCT02013687|453295846|FG003|Overall Study|Withdrawal by Subject|1|||
126001660|NCT02013687|453295843|FG000|Overall Study|Missed visits due to patient travel|0|||
126001661|NCT02013687|453295844|FG001|Overall Study|Missed visits due to patient travel|0|||
126001662|NCT02013687|453295845|FG002|Overall Study|Missed visits due to patient travel|1|||
126001663|NCT02013687|453295846|FG003|Overall Study|Missed visits due to patient travel|0|||
126001664|NCT01627340|453295847|FG000|Overall Study|Adverse Event|1|||
126001665|NCT01627340|453295848|FG001|Overall Study|Adverse Event|0|||
126337512|NCT02027025|454531016|FG001|Overall Study|Sponsor's decision|1|||
126337513|NCT02027025|454531017|FG002|Overall Study|Sponsor's decision|0|||
126001666|NCT01627340|453295847|FG000|Overall Study|Lost to Follow-up|8|||
126001667|NCT01627340|453295848|FG001|Overall Study|Lost to Follow-up|4|||
126001668|NCT01627340|453295847|FG000|Overall Study|Pregnancy|1|||
126001669|NCT01627340|453295848|FG001|Overall Study|Pregnancy|0|||
126001670|NCT01627340|453295847|FG000|Overall Study|Withdrawal by Subject|2|||
126001671|NCT01627340|453295848|FG001|Overall Study|Withdrawal by Subject|0|||
126001672|NCT01657032|453295849|FG000|Overall Study|Lost to Follow-up|0|||
126001673|NCT01657032|453295850|FG001|Overall Study|Lost to Follow-up|7|||
126001674|NCT03633903|453295851|FG000|Overall Study|Withdrawal by Subject|1|||
126001675|NCT03633903|453295852|FG001|Overall Study|Withdrawal by Subject|2|||
126001676|NCT03633903|453295851|FG000|Overall Study|Lost to Follow-up|5|||
126001677|NCT03633903|453295852|FG001|Overall Study|Lost to Follow-up|5|||
126001678|NCT05968482|453295853|FG000|First Crossover Period|Withdrawal by Subject|0|||
126001679|NCT05968482|453295854|FG001|First Crossover Period|Withdrawal by Subject|0|||
126001680|NCT05968482|453295855|FG002|First Crossover Period|Withdrawal by Subject|1|||
126001681|NCT05968482|453295856|FG003|First Crossover Period|Withdrawal by Subject|0|||
126001682|NCT05968482|453295857|FG004|First Crossover Period|Withdrawal by Subject|0|||
126001683|NCT05968482|453295858|FG005|First Crossover Period|Withdrawal by Subject|0|||
126337514|NCT01939314|454531020|FG000|Overall Study|Withdrawal by Subject|3|||
126337515|NCT01939314|454531021|FG001|Overall Study|Withdrawal by Subject|1|||
126337516|NCT01939314|454531020|FG000|Overall Study|Protocol Violation|1|||
126337517|NCT01939314|454531021|FG001|Overall Study|Protocol Violation|0|||
126337518|NCT01939314|454531020|FG000|Overall Study|Pregnancy|0|||
126337519|NCT01939314|454531021|FG001|Overall Study|Pregnancy|1|||
126337520|NCT01939314|454531020|FG000|Overall Study|Lost to Follow-up|5|||
126337521|NCT01939314|454531021|FG001|Overall Study|Lost to Follow-up|6|||
126337522|NCT04350827|454531026|FG000|Overall Study|Lost to Follow-up|1|||
126337523|NCT04350827|454531027|FG001|Overall Study|Lost to Follow-up|2|||
126337524|NCT02357459|454532865|FG000|Overall Study|Adverse Event|0|||
126337525|NCT02357459|454532866|FG001|Overall Study|Adverse Event|1|||
126337526|NCT02357459|454532867|FG002|Overall Study|Adverse Event|1|||
126001684|NCT05968482|453295853|FG000|First Crossover Period|Adverse Event|0|||
126001685|NCT05968482|453295854|FG001|First Crossover Period|Adverse Event|0|||
126001686|NCT05968482|453295855|FG002|First Crossover Period|Adverse Event|0|||
126001687|NCT05968482|453295856|FG003|First Crossover Period|Adverse Event|0|||
126001688|NCT05968482|453295857|FG004|First Crossover Period|Adverse Event|0|||
126001689|NCT05968482|453295858|FG005|First Crossover Period|Adverse Event|1|||
126001690|NCT05968482|453295853|FG000|Second Crossover Period|Withdrawal by Subject|0|||
126001691|NCT05968482|453295854|FG001|Second Crossover Period|Withdrawal by Subject|0|||
126001692|NCT05968482|453295855|FG002|Second Crossover Period|Withdrawal by Subject|0|||
126001693|NCT05968482|453295856|FG003|Second Crossover Period|Withdrawal by Subject|0|||
126001694|NCT05968482|453295857|FG004|Second Crossover Period|Withdrawal by Subject|1|||
126001695|NCT05968482|453295858|FG005|Second Crossover Period|Withdrawal by Subject|0|||
126001696|NCT05968482|453295853|FG000|Third Crossover Period|Adverse Event|0|||
126001697|NCT05968482|453295854|FG001|Third Crossover Period|Adverse Event|0|||
126001698|NCT05968482|453295855|FG002|Third Crossover Period|Adverse Event|0|||
126001699|NCT05968482|453295856|FG003|Third Crossover Period|Adverse Event|0|||
126001700|NCT05968482|453295857|FG004|Third Crossover Period|Adverse Event|1|||
126001701|NCT05968482|453295858|FG005|Third Crossover Period|Adverse Event|0|||
126001702|NCT05968482|453295853|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
126001703|NCT05968482|453295854|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
126001704|NCT05968482|453295855|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
126001705|NCT05968482|453295856|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
126001706|NCT05968482|453295857|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
126001707|NCT05968482|453295858|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
126001708|NCT00761774|453295860|FG000|Overall Study|Adverse Event|17|||
126001709|NCT00761774|453295860|FG000|Overall Study|Lack of Efficacy|37|||
126001710|NCT00761774|453295860|FG000|Overall Study|Lost to Follow-up|2|||
126001711|NCT00761774|453295860|FG000|Overall Study|Withdrawal by Subject|9|||
126001712|NCT00761774|453295860|FG000|Overall Study|Non-compliance|4|||
126001713|NCT00761774|453295860|FG000|Overall Study|End of study|2|||
126001714|NCT00761774|453295860|FG000|Overall Study|Reclassification of seizures|1|||
126001715|NCT00761774|453295860|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
126001716|NCT00761774|453295860|FG000|Overall Study|Sponsor decision|1|||
126001717|NCT00761774|453295860|FG000|Overall Study|Investigator clinical judgement|1|||
126001718|NCT00761774|453295860|FG000|Overall Study|Patient moved out of study area|1|||
126337527|NCT02357459|454532865|FG000|Overall Study|Withdrawal by Subject|5|||
126337528|NCT02357459|454532866|FG001|Overall Study|Withdrawal by Subject|3|||
126337529|NCT02357459|454532867|FG002|Overall Study|Withdrawal by Subject|3|||
126001719|NCT00761774|453295860|FG000|Overall Study|Coordinator leaving site|1|||
126001720|NCT00761774|453295860|FG000|Overall Study|Subject IP non-compliance|1|||
126001721|NCT00761774|453295860|FG000|Overall Study|IP stopped by hospital physician|1|||
126001722|NCT01077024|453295863|FG000|Overall Study|Lost to Follow-up|20|||
126001723|NCT01077024|453295864|FG001|Overall Study|Lost to Follow-up|14|||
126001724|NCT01077024|453295863|FG000|Overall Study|Withdrawal by Subject|0|||
126001725|NCT01077024|453295864|FG001|Overall Study|Withdrawal by Subject|2|||
126001726|NCT01077024|453295863|FG000|Overall Study|Incarcerated|7|||
126337530|NCT02357459|454532865|FG000|Overall Study|Physician Decision|0|||
126337531|NCT02357459|454532866|FG001|Overall Study|Physician Decision|2|||
126337532|NCT02357459|454532867|FG002|Overall Study|Physician Decision|0|||
126337533|NCT02357459|454532865|FG000|Overall Study|Protocol Violation|1|||
126337534|NCT02357459|454532866|FG001|Overall Study|Protocol Violation|1|||
126337535|NCT02357459|454532867|FG002|Overall Study|Protocol Violation|0|||
126337536|NCT02357459|454532865|FG000|Overall Study|Lost to Follow-up|1|||
126001727|NCT01077024|453295864|FG001|Overall Study|Incarcerated|8|||
126001728|NCT01077024|453295863|FG000|Overall Study|Other|4|||
126001729|NCT01077024|453295864|FG001|Overall Study|Other|4|||
126001730|NCT01603121|453295865|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
126001731|NCT01603121|453295866|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
126001732|NCT02687919|453295869|FG000|Overall Study|Withdrawal by Subject|6|||
126001733|NCT02687919|453295870|FG001|Overall Study|Withdrawal by Subject|6|||
126001734|NCT02687919|453295869|FG000|Overall Study|Protocol Violation|2|||
126001735|NCT02687919|453295870|FG001|Overall Study|Protocol Violation|0|||
126001736|NCT01656759|453295871|FG000|Overall Study|Protocol Violation|2|||
126001737|NCT01656759|453295872|FG001|Overall Study|Protocol Violation|3|||
126001738|NCT02531438|453295873|FG000|Overall Study|Adverse Event|7|||
126001739|NCT02531438|453295874|FG001|Overall Study|Adverse Event|9|||
126001740|NCT02531438|453295873|FG000|Overall Study|Lost to Follow-up|0|||
126001741|NCT02531438|453295874|FG001|Overall Study|Lost to Follow-up|3|||
126001742|NCT02531438|453295873|FG000|Overall Study|Withdrawal by Subject|7|||
126001743|NCT02531438|453295874|FG001|Overall Study|Withdrawal by Subject|8|||
126001744|NCT02531438|453295873|FG000|Overall Study|Physician Decision|0|||
126001745|NCT02531438|453295874|FG001|Overall Study|Physician Decision|1|||
126001746|NCT02531438|453295873|FG000|Overall Study|Death|6|||
126001747|NCT02531438|453295874|FG001|Overall Study|Death|3|||
126001748|NCT02531438|453295873|FG000|Overall Study|Randomized, but Not Treated|4|||
126001749|NCT02531438|453295874|FG001|Overall Study|Randomized, but Not Treated|0|||
126001750|NCT02531438|453295873|FG000|Overall Study|Missed EOT/PTE Visit|5|||
126001751|NCT02531438|453295874|FG001|Overall Study|Missed EOT/PTE Visit|2|||
126001752|NCT02531438|453295873|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
126001753|NCT02531438|453295874|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
126001754|NCT00801242|453295876|FG000|Overall Study|Adverse Event|10|||
126001755|NCT00801242|453295876|FG000|Overall Study|Withdrawal by Subject|13|||
126001756|NCT00801242|453295876|FG000|Overall Study|Protocol Violation|5|||
126001757|NCT00801242|453295876|FG000|Overall Study|Physician Decision|3|||
126001758|NCT00801242|453295876|FG000|Overall Study|Lost to Follow-up|1|||
126001759|NCT00801242|453295876|FG000|Overall Study|Miscellaneous reasons|20|||
126001760|NCT00777803|453297219|FG000|Overall Study|Lost to Follow-up|12|||
126001761|NCT00777803|453297220|FG001|Overall Study|Lost to Follow-up|5|||
126001762|NCT00777803|453297219|FG000|Overall Study|Adverse Event|1|||
126001763|NCT00777803|453297220|FG001|Overall Study|Adverse Event|0|||
126001764|NCT00777803|453297219|FG000|Overall Study|Non-compliance|2|||
126001765|NCT00777803|453297220|FG001|Overall Study|Non-compliance|2|||
126001766|NCT01115998|453297221|FG000|Overall Study|Lost to Follow-up|6|||
126001767|NCT01115998|453297222|FG001|Overall Study|Lost to Follow-up|6|||
126001768|NCT03850444|453297223|FG000|Overall Study|Adverse Event|16|||
126001769|NCT03850444|453297224|FG001|Overall Study|Adverse Event|10|||
126001770|NCT03850444|453297223|FG000|Overall Study|Death|87|||
126001771|NCT03850444|453297224|FG001|Overall Study|Death|107|||
126001772|NCT03850444|453297223|FG000|Overall Study|Lost to Follow-up|1|||
126001773|NCT03850444|453297224|FG001|Overall Study|Lost to Follow-up|1|||
126001774|NCT03850444|453297223|FG000|Overall Study|Withdrawal by Subject|1|||
126001775|NCT03850444|453297224|FG001|Overall Study|Withdrawal by Subject|5|||
126001776|NCT03850444|453297223|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
126001777|NCT03850444|453297224|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
126001778|NCT04096365|453297225|FG000|Overall Study|Adverse Event|1|||
126001779|NCT01598987|453297227|FG000|Baseline to Month 12|Administrative problems|2|||
126001780|NCT01598987|453297227|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
126001781|NCT01598987|453297227|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
126001782|NCT01598987|453297227|FG000|Baseline to 24 Month|Administrative problems|2|||
126001783|NCT01598987|453297227|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
126001784|NCT02107274|453297228|FG000|Treatment vs. Placebo|Adverse Event|3|||
126001785|NCT02107274|453297229|FG001|Treatment vs. Placebo|Adverse Event|0|||
126001786|NCT02107274|453297228|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
126001787|NCT02107274|453297229|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
126001788|NCT02107274|453297228|FG000|Control Phase|Lost to Follow-up|1|||
126001789|NCT02107274|453297229|FG001|Control Phase|Lost to Follow-up|1|||
126001790|NCT02107274|453297228|FG000|Control Phase|Death|2|||
126001791|NCT02107274|453297229|FG001|Control Phase|Death|0|||
126001792|NCT02107274|453297228|FG000|Control Phase|Adverse Event|0|||
126337537|NCT02357459|454532866|FG001|Overall Study|Lost to Follow-up|3|||
126001793|NCT02107274|453297229|FG001|Control Phase|Adverse Event|1|||
126001794|NCT01036087|453297230|FG000|Overall Study|Adverse Event|2|||
126001795|NCT01036087|453297230|FG000|Overall Study|Lack of Efficacy|1|||
126001796|NCT05406791|453297231|FG000|Overall Study|Lost to Follow-up|13|||
126001797|NCT05406791|453297232|FG001|Overall Study|Lost to Follow-up|10|||
126001798|NCT00519779|453297234|FG000|Overall Study|Withdrawal by Subject|0|||
126337538|NCT02357459|454532867|FG002|Overall Study|Lost to Follow-up|0|||
126001799|NCT00519779|453297235|FG001|Overall Study|Withdrawal by Subject|1|||
126001800|NCT03330119|453297236|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
126001801|NCT03330119|453297237|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
126001802|NCT00664521|453297249|FG000|Overall Study|Adverse Event|4|||
126001803|NCT00664521|453297250|FG001|Overall Study|Adverse Event|1|||
126001804|NCT00664521|453297249|FG000|Overall Study|Lost to Follow-up|1|||
126001805|NCT00664521|453297250|FG001|Overall Study|Lost to Follow-up|0|||
126001806|NCT00664521|453297249|FG000|Overall Study|Other|1|||
126001807|NCT00664521|453297250|FG001|Overall Study|Other|0|||
126001808|NCT02459964|453297251|FG000|Overall Study|Withdrawal by Subject|0|||
126001809|NCT02459964|453297252|FG001|Overall Study|Withdrawal by Subject|0|||
126001810|NCT02459964|453297253|FG002|Overall Study|Withdrawal by Subject|1|||
126001811|NCT02459964|453297251|FG000|Overall Study|Abnormal EKG changes|0|||
126001812|NCT02459964|453297252|FG001|Overall Study|Abnormal EKG changes|0|||
126001813|NCT02459964|453297253|FG002|Overall Study|Abnormal EKG changes|1|||
126001814|NCT00367237|453297254|FG000|Overall Study|Adverse Event|7|||
126001815|NCT00367237|453297255|FG001|Overall Study|Adverse Event|2|||
126001816|NCT00367237|453297254|FG000|Overall Study|Lost to Follow-up|1|||
126001817|NCT00367237|453297255|FG001|Overall Study|Lost to Follow-up|0|||
126001818|NCT00367237|453297254|FG000|Overall Study|Withdrawal by Subject|0|||
126001819|NCT00367237|453297255|FG001|Overall Study|Withdrawal by Subject|4|||
126001820|NCT00367237|453297254|FG000|Overall Study|Protocol Violation|2|||
126001821|NCT00367237|453297255|FG001|Overall Study|Protocol Violation|5|||
126001822|NCT00550732|453297256|FG000|Overall Study|Death|4|||
126001823|NCT00550732|453297256|FG000|Overall Study|Withdrawal by Subject|2|||
126001824|NCT00550732|453297256|FG000|Overall Study|Physician Decision|2|||
126001825|NCT00550732|453297256|FG000|Overall Study|Lost to Follow-up|1|||
126001826|NCT00550732|453297256|FG000|Overall Study|Palliative care|1|||
126001827|NCT00550732|453297256|FG000|Overall Study|Adverse Event|1|||
126001828|NCT03302910|453297261|FG000|Overall Study|Protocol Violation|1|||
126001829|NCT03302910|453297262|FG001|Overall Study|Protocol Violation|0|||
126001830|NCT02800928|453297265|FG000|Overall Study|Withdrawal by Subject|1|||
126001831|NCT02800928|453297266|FG001|Overall Study|Withdrawal by Subject|1|||
126001832|NCT02800928|453297265|FG000|Overall Study|Protocol Violation|1|||
126001833|NCT02800928|453297266|FG001|Overall Study|Protocol Violation|1|||
126001834|NCT04004208|453297275|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126001835|NCT04004208|453297276|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126001836|NCT04004208|453297275|FG000|Overall Study|Death|3|||
126001837|NCT04004208|453297276|FG001|Overall Study|Death|0|||
126001838|NCT04004208|453297275|FG000|Overall Study|COVID-19 pandemic|1|||
126001839|NCT04004208|453297276|FG001|Overall Study|COVID-19 pandemic|0|||
126001840|NCT04004208|453297275|FG000|Overall Study|Physician Decision|1|||
126001841|NCT04004208|453297276|FG001|Overall Study|Physician Decision|0|||
126001842|NCT04004208|453297275|FG000|Overall Study|Adverse Event|1|||
126001843|NCT04004208|453297276|FG001|Overall Study|Adverse Event|1|||
126001844|NCT00953160|453297282|FG000|Overall Study|Lost to Follow-up|23|||
126001845|NCT00953160|453297282|FG000|Overall Study|Withdrawal by Subject|4|||
126001846|NCT00570661|453297289|FG000|Overall Study|Disease worsening|5|||
126001847|NCT00570661|453297289|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
126001848|NCT00570661|453297289|FG000|Overall Study|Adverse Event|1|||
126001849|NCT02400307|453297290|FG000|Overall Study|Enrolled and Never Dosed|1|||
126001850|NCT02400307|453297291|FG001|Overall Study|Enrolled and Never Dosed|0|||
126001851|NCT01052662|453297294|FG000|Overall Study|Lost to Follow-up|15|||
126001852|NCT01052662|453297295|FG001|Overall Study|Lost to Follow-up|13|||
126001853|NCT01052662|453297296|FG002|Overall Study|Lost to Follow-up|18|||
126001854|NCT01052662|453297294|FG000|Overall Study|Withdrawal by Subject|3|||
126001855|NCT01052662|453297295|FG001|Overall Study|Withdrawal by Subject|2|||
126001856|NCT01052662|453297296|FG002|Overall Study|Withdrawal by Subject|1|||
126001857|NCT01052662|453297294|FG000|Overall Study|Pharmacy issue|1|||
126001858|NCT01052662|453297295|FG001|Overall Study|Pharmacy issue|3|||
126001859|NCT01052662|453297296|FG002|Overall Study|Pharmacy issue|3|||
126001860|NCT01052662|453297294|FG000|Overall Study|Adverse Event|1|||
126001861|NCT01052662|453297295|FG001|Overall Study|Adverse Event|1|||
126001862|NCT01052662|453297296|FG002|Overall Study|Adverse Event|0|||
126001863|NCT01052662|453297294|FG000|Overall Study|Legal Problem|2|||
126337539|NCT02357459|454532865|FG000|Overall Study|Lack of Efficacy|7|||
126337540|NCT02357459|454532866|FG001|Overall Study|Lack of Efficacy|4|||
126337541|NCT02357459|454532867|FG002|Overall Study|Lack of Efficacy|4|||
126001864|NCT01052662|453297295|FG001|Overall Study|Legal Problem|0|||
126337542|NCT02357459|454532865|FG000|Overall Study|Patient Relocated|2|||
126337543|NCT02357459|454532866|FG001|Overall Study|Patient Relocated|0|||
126001865|NCT01052662|453297296|FG002|Overall Study|Legal Problem|0|||
126001866|NCT01052662|453297294|FG000|Overall Study|Administrative|0|||
126001867|NCT01052662|453297295|FG001|Overall Study|Administrative|3|||
126001868|NCT01052662|453297296|FG002|Overall Study|Administrative|0|||
126001869|NCT02015663|453297298|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
126001870|NCT02015663|453297299|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
126001871|NCT02015663|453297298|FG000|Overall Study|Withdrawal by Subject|1|||
126001872|NCT02015663|453297299|FG001|Overall Study|Withdrawal by Subject|0|||
126001873|NCT02015663|453297298|FG000|Overall Study|Protocol Violation|0|||
126001874|NCT02015663|453297299|FG001|Overall Study|Protocol Violation|1|||
126001875|NCT02015663|453297298|FG000|Overall Study|Adverse Event|3|||
126001876|NCT02015663|453297299|FG001|Overall Study|Adverse Event|0|||
126001877|NCT02015663|453297298|FG000|Overall Study|Administrative problems|10|||
126001878|NCT02015663|453297299|FG001|Overall Study|Administrative problems|11|||
126001879|NCT01113463|453297300|FG000|Overall Study|Physician Decision|5|||
126001880|NCT03293485|453297302|FG000|Overall Study|Death|1|||
126001881|NCT03293485|453297302|FG000|Overall Study|Screen Failure|2|||
126001882|NCT03293485|453297302|FG000|Overall Study|Withdrawal by Subject|2|||
126001883|NCT00087490|453297303|FG000|Overall Study|Death|6|||
126001884|NCT00087490|453297304|FG001|Overall Study|Death|4|||
126001885|NCT00087490|453297303|FG000|Overall Study|Adverse Event|3|||
126001886|NCT00087490|453297304|FG001|Overall Study|Adverse Event|8|||
126001887|NCT00087490|453297303|FG000|Overall Study|Lack of Efficacy|0|||
126001888|NCT00087490|453297304|FG001|Overall Study|Lack of Efficacy|2|||
126001889|NCT00087490|453297303|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
126001890|NCT00087490|453297304|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
126001891|NCT00087490|453297303|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
126001892|NCT00087490|453297304|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
126001893|NCT00087490|453297303|FG000|Overall Study|Randomized but not treated|7|||
126001894|NCT00087490|453297304|FG001|Overall Study|Randomized but not treated|18|||
126001895|NCT02034435|453297305|FG000|Overall Study|Withdrawal by Subject|1|||
126001896|NCT02034435|453297306|FG001|Overall Study|Withdrawal by Subject|0|||
126001897|NCT02034435|453297307|FG002|Overall Study|Withdrawal by Subject|0|||
126001898|NCT02034435|453297308|FG003|Overall Study|Withdrawal by Subject|0|||
126001899|NCT02034435|453297305|FG000|Overall Study|Illness|0|||
126001900|NCT02034435|453297306|FG001|Overall Study|Illness|2|||
126001901|NCT02034435|453297307|FG002|Overall Study|Illness|0|||
126001902|NCT02034435|453297308|FG003|Overall Study|Illness|0|||
126001903|NCT02034435|453297305|FG000|Overall Study|Inadequate IV access|1|||
126001904|NCT02034435|453297306|FG001|Overall Study|Inadequate IV access|0|||
126001905|NCT02034435|453297307|FG002|Overall Study|Inadequate IV access|0|||
126001906|NCT02034435|453297308|FG003|Overall Study|Inadequate IV access|1|||
126001907|NCT03379233|453297309|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
126001908|NCT03379233|453297310|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
126001909|NCT02300311|453297311|FG000|Overall Study|Other than the reason specified|1|||
126001910|NCT02300311|453297312|FG001|Overall Study|Other than the reason specified|0|||
126001911|NCT02300311|453297311|FG000|Overall Study|Refused to continue taking medication|18|||
126001912|NCT02300311|453297312|FG001|Overall Study|Refused to continue taking medication|0|||
126001913|NCT00419003|453297313|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
126001914|NCT00419003|453297314|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
126001915|NCT00419003|453297313|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
126001916|NCT00419003|453297314|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
126001917|NCT02015195|453297320|FG000|Overall Study|Adverse Event|0|||
126001918|NCT02015195|453297321|FG001|Overall Study|Adverse Event|0|||
126001919|NCT02015195|453297322|FG002|Overall Study|Adverse Event|0|||
126001920|NCT02015195|453297323|FG003|Overall Study|Adverse Event|1|||
126001921|NCT02015195|453297324|FG004|Overall Study|Adverse Event|0|||
126001922|NCT02015195|453297325|FG005|Overall Study|Adverse Event|0|||
126001923|NCT02015195|453297326|FG006|Overall Study|Adverse Event|0|||
126001924|NCT01318811|453297327|FG000|Overall Study|Physician Decision|1|||
126001925|NCT01318811|453297328|FG001|Overall Study|Physician Decision|1|||
126001926|NCT01318811|453297327|FG000|Overall Study|CRRT stopped for head CT|0|||
126001927|NCT01318811|453297328|FG001|Overall Study|CRRT stopped for head CT|1|||
126001928|NCT01318811|453297327|FG000|Overall Study|Death|0|||
126001929|NCT01318811|453297328|FG001|Overall Study|Death|1|||
126001930|NCT01318811|453297327|FG000|Overall Study|CRRT stopped for head MRI|0|||
126001931|NCT01318811|453297328|FG001|Overall Study|CRRT stopped for head MRI|1|||
126001932|NCT00811187|453297329|FG000|Overall Study|Unable to place device / procedure abort|3|||
126337544|NCT02357459|454532867|FG002|Overall Study|Patient Relocated|0|||
126001933|NCT00811187|453297330|FG001|Overall Study|Unable to place device / procedure abort|3|||
126001934|NCT00131911|453297331|FG000|Overall Study|Withdrawal by Subject|1|||
126001935|NCT00131911|453297332|FG001|Overall Study|Withdrawal by Subject|0|||
126001936|NCT00329303|453297333|FG000|Overall Study|Lack of Efficacy|1|||
126001937|NCT00329303|453297334|FG001|Overall Study|Lack of Efficacy|0|||
126001938|NCT00329303|453297333|FG000|Overall Study|Decision of the sponsor|0|||
126001939|NCT00329303|453297334|FG001|Overall Study|Decision of the sponsor|1|||
126001940|NCT00329303|453297333|FG000|Overall Study|Patient no longer available|1|||
126001941|NCT00329303|453297334|FG001|Overall Study|Patient no longer available|0|||
126001942|NCT00329303|453297333|FG000|Overall Study|Patient relocated|0|||
126001943|NCT00329303|453297334|FG001|Overall Study|Patient relocated|1|||
126001944|NCT00994279|453297339|FG000|Overall Study|Withdrawal by Subject|2|||
126001945|NCT00994279|453297340|FG001|Overall Study|Withdrawal by Subject|2|||
126001946|NCT00994279|453297339|FG000|Overall Study|Toxicity|1|||
126001947|NCT00994279|453297340|FG001|Overall Study|Toxicity|0|||
126001948|NCT00994279|453297339|FG000|Overall Study|Multiple reasons|1|||
126001949|NCT00994279|453297340|FG001|Overall Study|Multiple reasons|3|||
126001950|NCT01606189|453297341|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
126001951|NCT01606189|453297342|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
126001952|NCT01606189|453297343|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
126001953|NCT01606189|453297344|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
126001954|NCT01606189|453297345|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
126001955|NCT01606189|453297346|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
126001956|NCT01606189|453297341|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126001957|NCT01606189|453297342|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126001958|NCT01606189|453297343|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126001959|NCT01606189|453297344|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126001960|NCT01606189|453297345|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126001961|NCT01606189|453297346|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
126001962|NCT00162942|453297347|FG000|Overall Study|Adverse Event|10|||
126001963|NCT00162942|453297348|FG001|Overall Study|Adverse Event|6|||
126001964|NCT00162942|453297347|FG000|Overall Study|Death|1|||
126001965|NCT00162942|453297348|FG001|Overall Study|Death|0|||
126001966|NCT00162942|453297347|FG000|Overall Study|Withdrawal by Subject|3|||
126001967|NCT00162942|453297348|FG001|Overall Study|Withdrawal by Subject|6|||
126001968|NCT00162942|453297347|FG000|Overall Study|Physician Decision|1|||
126001969|NCT00162942|453297348|FG001|Overall Study|Physician Decision|0|||
126001970|NCT00162942|453297347|FG000|Overall Study|Enter Open-Label Study|76|||
126001971|NCT00162942|453297348|FG001|Overall Study|Enter Open-Label Study|35|||
126001972|NCT00162942|453297347|FG000|Overall Study|Alternate Therapy|6|||
126001973|NCT00162942|453297348|FG001|Overall Study|Alternate Therapy|2|||
126001974|NCT00162942|453297347|FG000|Overall Study|Lack of Efficacy|1|||
126001975|NCT00162942|453297348|FG001|Overall Study|Lack of Efficacy|0|||
126001976|NCT00162942|453297347|FG000|Overall Study|Flare During Active Treatment|7|||
126001977|NCT00162942|453297348|FG001|Overall Study|Flare During Active Treatment|3|||
126001978|NCT00162942|453297347|FG000|Overall Study|2 or more consecutive treatments missed|1|||
126001979|NCT00162942|453297348|FG001|Overall Study|2 or more consecutive treatments missed|0|||
126001980|NCT02162732|453297349|FG000|Overall Study|Biopsy not performed.|18|||
126001981|NCT00410384|453297350|FG000|Overall Study|Withdrawal by Subject|28|||
126001982|NCT00410384|453297351|FG001|Overall Study|Withdrawal by Subject|17|||
126001983|NCT00410384|453297352|FG002|Overall Study|Withdrawal by Subject|20|||
126001984|NCT00410384|453297350|FG000|Overall Study|Adverse Event|23|||
126001985|NCT00410384|453297351|FG001|Overall Study|Adverse Event|18|||
126001986|NCT00410384|453297352|FG002|Overall Study|Adverse Event|23|||
126001987|NCT00410384|453297350|FG000|Overall Study|Lack of Efficacy|20|||
126001988|NCT00410384|453297351|FG001|Overall Study|Lack of Efficacy|12|||
126001989|NCT00410384|453297352|FG002|Overall Study|Lack of Efficacy|17|||
126001990|NCT00410384|453297350|FG000|Overall Study|Lack of Compliance|2|||
126001991|NCT00410384|453297351|FG001|Overall Study|Lack of Compliance|2|||
126001992|NCT00410384|453297352|FG002|Overall Study|Lack of Compliance|2|||
126001993|NCT00410384|453297350|FG000|Overall Study|Lost to Follow-up|4|||
126001994|NCT00410384|453297351|FG001|Overall Study|Lost to Follow-up|6|||
126001995|NCT00410384|453297352|FG002|Overall Study|Lost to Follow-up|6|||
126001996|NCT00410384|453297350|FG000|Overall Study|Protocol Violation|6|||
126001997|NCT00410384|453297351|FG001|Overall Study|Protocol Violation|6|||
126001998|NCT00410384|453297352|FG002|Overall Study|Protocol Violation|6|||
126001999|NCT00410384|453297350|FG000|Overall Study|Physician Decision|3|||
126002000|NCT00410384|453297351|FG001|Overall Study|Physician Decision|3|||
126002001|NCT00410384|453297352|FG002|Overall Study|Physician Decision|4|||
126002002|NCT00410384|453297350|FG000|Overall Study|Other|3|||
126002003|NCT00410384|453297351|FG001|Overall Study|Other|8|||
126002004|NCT00410384|453297352|FG002|Overall Study|Other|4|||
126002005|NCT01167023|453297353|FG000|Overall Study|Lost to Follow-up|0|||
126002006|NCT01167023|453297354|FG001|Overall Study|Lost to Follow-up|1|||
126002007|NCT01167023|453297355|FG002|Overall Study|Lost to Follow-up|1|||
126002008|NCT01167023|453297353|FG000|Overall Study|Screen Failure|0|||
126002009|NCT01167023|453297354|FG001|Overall Study|Screen Failure|1|||
126002010|NCT01167023|453297355|FG002|Overall Study|Screen Failure|0|||
126002011|NCT01167023|453297353|FG000|Overall Study|Sponsor Decision|0|||
126002012|NCT01167023|453297354|FG001|Overall Study|Sponsor Decision|1|||
126002013|NCT01167023|453297355|FG002|Overall Study|Sponsor Decision|0|||
126337545|NCT02357459|454532865|FG000|Overall Study|Instruction from PCP|1|||
126337546|NCT02357459|454532866|FG001|Overall Study|Instruction from PCP|0|||
126337547|NCT02357459|454532867|FG002|Overall Study|Instruction from PCP|0|||
126002014|NCT01167023|453297353|FG000|Overall Study|Withdrawal by Subject|0|||
126002015|NCT01167023|453297354|FG001|Overall Study|Withdrawal by Subject|0|||
126002016|NCT01167023|453297355|FG002|Overall Study|Withdrawal by Subject|1|||
126002017|NCT01253200|453297358|FG000|Overall Study|Death|1|||
126002018|NCT01253200|453297359|FG001|Overall Study|Death|0|||
126002019|NCT01253200|453297360|FG002|Overall Study|Death|0|||
126002020|NCT01253200|453297361|FG003|Overall Study|Death|0|||
126002021|NCT01253200|453297362|FG004|Overall Study|Death|0|||
126002022|NCT01253200|453297358|FG000|Overall Study|Lost to Follow-up|1|||
126002023|NCT01253200|453297359|FG001|Overall Study|Lost to Follow-up|1|||
126002024|NCT01253200|453297360|FG002|Overall Study|Lost to Follow-up|0|||
126002025|NCT01253200|453297361|FG003|Overall Study|Lost to Follow-up|0|||
126002026|NCT01253200|453297362|FG004|Overall Study|Lost to Follow-up|0|||
126002027|NCT01253200|453297358|FG000|Overall Study|Withdrawal by Subject|2|||
126002028|NCT01253200|453297359|FG001|Overall Study|Withdrawal by Subject|0|||
126002029|NCT01253200|453297360|FG002|Overall Study|Withdrawal by Subject|0|||
126002030|NCT01253200|453297361|FG003|Overall Study|Withdrawal by Subject|0|||
126002031|NCT01253200|453297362|FG004|Overall Study|Withdrawal by Subject|0|||
126002032|NCT01253200|453297358|FG000|Overall Study|Protocol Violation|1|||
126002033|NCT01253200|453297359|FG001|Overall Study|Protocol Violation|4|||
126002034|NCT01253200|453297360|FG002|Overall Study|Protocol Violation|0|||
126002035|NCT01253200|453297361|FG003|Overall Study|Protocol Violation|0|||
126002036|NCT01253200|453297362|FG004|Overall Study|Protocol Violation|5|||
126002037|NCT01253200|453297358|FG000|Overall Study|intents|10|||
126337548|NCT02357459|454532865|FG000|Overall Study|Incarceration|0|||
126337549|NCT02357459|454532866|FG001|Overall Study|Incarceration|0|||
126337550|NCT02357459|454532867|FG002|Overall Study|Incarceration|1|||
126337551|NCT02357459|454532865|FG000|Overall Study|Pre-planned Knee surgery|0|||
126002038|NCT01253200|453297359|FG001|Overall Study|intents|10|||
126002039|NCT01253200|453297360|FG002|Overall Study|intents|1|||
126002040|NCT01253200|453297361|FG003|Overall Study|intents|3|||
126002041|NCT01253200|453297362|FG004|Overall Study|intents|0|||
126002042|NCT01253200|453297358|FG000|Overall Study|Attempts|6|||
126002043|NCT01253200|453297359|FG001|Overall Study|Attempts|4|||
126002044|NCT01253200|453297360|FG002|Overall Study|Attempts|1|||
126002045|NCT01253200|453297361|FG003|Overall Study|Attempts|2|||
126002046|NCT01253200|453297362|FG004|Overall Study|Attempts|0|||
126002047|NCT02049437|453297363|FG000|Period 1|Adverse Event|1|||
126002048|NCT02049437|453297364|FG001|Period 1|Adverse Event|1|||
126002049|NCT02049437|453297363|FG000|Period 1|Adverse Event|1|||
126002050|NCT02049437|453297364|FG001|Period 1|Adverse Event|0|||
126002051|NCT01700530|453297367|FG000|Overall Study|Withdrawal by Subject|0|||
126002052|NCT01700530|453297368|FG001|Overall Study|Withdrawal by Subject|3|||
126002053|NCT01700530|453297369|FG002|Overall Study|Withdrawal by Subject|1|||
126002054|NCT03289455|453297374|FG000|Overall Study|Death|1|||
126002055|NCT03289455|453297375|FG001|Overall Study|Death|0|||
126002056|NCT03289455|453297376|FG002|Overall Study|Death|0|||
126002057|NCT03289455|453297374|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
126002058|NCT03289455|453297375|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
126002059|NCT03289455|453297376|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
126002060|NCT03289455|453297374|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
126002061|NCT03289455|453297375|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
126002062|NCT03289455|453297376|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
126002063|NCT03289455|453297374|FG000|Overall Study|Progressive disease|3|||
126002064|NCT03289455|453297375|FG001|Overall Study|Progressive disease|4|||
126002065|NCT03289455|453297376|FG002|Overall Study|Progressive disease|5|||
126002066|NCT05567952|453299634|FG000|Overall Study|Lost to Follow-up|3|||
126002067|NCT05567952|453299635|FG001|Overall Study|Lost to Follow-up|2|||
126002068|NCT05567952|453299634|FG000|Overall Study|Withdrawal by Subject|6|||
126002069|NCT05567952|453299635|FG001|Overall Study|Withdrawal by Subject|3|||
126002070|NCT05567952|453299634|FG000|Overall Study|Other|3|||
126002071|NCT05567952|453299635|FG001|Overall Study|Other|1|||
126002072|NCT04213846|453299636|FG000|Overall Study|Withdrawal by Subject|7|||
126002073|NCT04213846|453299637|FG001|Overall Study|Withdrawal by Subject|6|||
126002074|NCT04213846|453299636|FG000|Overall Study|Lost to Follow-up|15|||
126002075|NCT04213846|453299637|FG001|Overall Study|Lost to Follow-up|21|||
126337552|NCT02357459|454532866|FG001|Overall Study|Pre-planned Knee surgery|0|||
126337553|NCT02357459|454532867|FG002|Overall Study|Pre-planned Knee surgery|2|||
126337554|NCT02357459|454532865|FG000|Overall Study|Job Commitments|0|||
126337555|NCT02357459|454532866|FG001|Overall Study|Job Commitments|0|||
126337556|NCT02357459|454532867|FG002|Overall Study|Job Commitments|1|||
126337557|NCT02188160|454532868|FG000|Overall Study|Adverse Event|1|||
126337558|NCT02188160|454532869|FG001|Overall Study|Adverse Event|0|||
126337559|NCT02188160|454532868|FG000|Overall Study|Use of an excluded medication|0|||
126002076|NCT04423393|453299638|FG000|Overall Study|Withdrawal by Subject|0|||
126002077|NCT04423393|453299639|FG001|Overall Study|Withdrawal by Subject|0|||
126002078|NCT04423393|453299640|FG002|Overall Study|Withdrawal by Subject|0|||
126002079|NCT04423393|453299641|FG003|Overall Study|Withdrawal by Subject|0|||
126002080|NCT04423393|453299642|FG004|Overall Study|Withdrawal by Subject|0|||
126002081|NCT04423393|453299643|FG005|Overall Study|Withdrawal by Subject|1|||
126002082|NCT04423393|453299644|FG006|Overall Study|Withdrawal by Subject|0|||
126337560|NCT02188160|454532869|FG001|Overall Study|Use of an excluded medication|1|||
126337561|NCT01655901|454532872|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
126002083|NCT04423393|453299645|FG007|Overall Study|Withdrawal by Subject|0|||
126002084|NCT04423393|453299646|FG008|Overall Study|Withdrawal by Subject|0|||
126002085|NCT04423393|453299647|FG009|Overall Study|Withdrawal by Subject|0|||
126002086|NCT04423393|453299648|FG010|Overall Study|Withdrawal by Subject|0|||
126002087|NCT04423393|453299649|FG011|Overall Study|Withdrawal by Subject|0|||
126002088|NCT04423393|453299650|FG012|Overall Study|Withdrawal by Subject|0|||
126002089|NCT04423393|453299651|FG013|Overall Study|Withdrawal by Subject|1|||
126002090|NCT04423393|453299652|FG014|Overall Study|Withdrawal by Subject|0|||
126002091|NCT04423393|453299653|FG015|Overall Study|Withdrawal by Subject|0|||
126002092|NCT04423393|453299654|FG016|Overall Study|Withdrawal by Subject|0|||
126002093|NCT04423393|453299655|FG017|Overall Study|Withdrawal by Subject|0|||
126002094|NCT04423393|453299638|FG000|Overall Study|Sponsor Decision|0|||
126002095|NCT04423393|453299639|FG001|Overall Study|Sponsor Decision|0|||
126002096|NCT04423393|453299640|FG002|Overall Study|Sponsor Decision|0|||
126002097|NCT04423393|453299641|FG003|Overall Study|Sponsor Decision|0|||
126002098|NCT04423393|453299642|FG004|Overall Study|Sponsor Decision|0|||
126002099|NCT04423393|453299643|FG005|Overall Study|Sponsor Decision|0|||
126002100|NCT04423393|453299644|FG006|Overall Study|Sponsor Decision|0|||
126002101|NCT04423393|453299645|FG007|Overall Study|Sponsor Decision|0|||
126002102|NCT04423393|453299646|FG008|Overall Study|Sponsor Decision|0|||
126002103|NCT04423393|453299647|FG009|Overall Study|Sponsor Decision|0|||
126002104|NCT04423393|453299648|FG010|Overall Study|Sponsor Decision|0|||
126002105|NCT04423393|453299649|FG011|Overall Study|Sponsor Decision|0|||
126002106|NCT04423393|453299650|FG012|Overall Study|Sponsor Decision|0|||
126002107|NCT04423393|453299651|FG013|Overall Study|Sponsor Decision|1|||
126002108|NCT04423393|453299652|FG014|Overall Study|Sponsor Decision|0|||
126002109|NCT04423393|453299653|FG015|Overall Study|Sponsor Decision|0|||
126002110|NCT04423393|453299654|FG016|Overall Study|Sponsor Decision|0|||
126002111|NCT04423393|453299655|FG017|Overall Study|Sponsor Decision|0|||
126002112|NCT00432159|453299664|FG000|Overall Study|Death|0|||
126002113|NCT00432159|453299665|FG001|Overall Study|Death|1|||
126002114|NCT00432159|453299666|FG002|Overall Study|Death|0|||
126002115|NCT00432159|453299667|FG003|Overall Study|Death|0|||
126002116|NCT00432159|453299668|FG004|Overall Study|Death|0|||
126002117|NCT00432159|453299664|FG000|Overall Study|Failure|9|||
126002118|NCT00432159|453299665|FG001|Overall Study|Failure|5|||
126002119|NCT00432159|453299666|FG002|Overall Study|Failure|3|||
126002120|NCT00432159|453299667|FG003|Overall Study|Failure|2|||
126002121|NCT00432159|453299668|FG004|Overall Study|Failure|3|||
126002122|NCT00432159|453299664|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
126002123|NCT00432159|453299665|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
126002124|NCT00432159|453299666|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
126002125|NCT00432159|453299667|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
126002126|NCT00432159|453299668|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
126002127|NCT01021878|453299675|FG000|Overall Study|Lost to Follow-up|4|||
126002128|NCT01021878|453299676|FG001|Overall Study|Lost to Follow-up|3|||
126002129|NCT01021878|453299675|FG000|Overall Study|Death|0|||
126002130|NCT01021878|453299676|FG001|Overall Study|Death|1|||
126002131|NCT01021878|453299675|FG000|Overall Study|Adverse Event|6|||
126002132|NCT01021878|453299676|FG001|Overall Study|Adverse Event|5|||
126002133|NCT01021878|453299675|FG000|Overall Study|Transplantation|6|||
126002134|NCT01021878|453299676|FG001|Overall Study|Transplantation|1|||
126002135|NCT05305040|453299680|FG000|Overall Study|Not Dosed|37|||
126002136|NCT05305040|453299681|FG001|Overall Study|Not Dosed|37|||
126002137|NCT05305040|453299680|FG000|Overall Study|Study Closure|34|||
126002138|NCT05305040|453299681|FG001|Overall Study|Study Closure|46|||
126002139|NCT05305040|453299680|FG000|Overall Study|Death|14|||
126002140|NCT05305040|453299681|FG001|Overall Study|Death|13|||
126002141|NCT05305040|453299680|FG000|Overall Study|Withdrawal by Subject|15|||
126002142|NCT05305040|453299681|FG001|Overall Study|Withdrawal by Subject|10|||
126002143|NCT05305040|453299680|FG000|Overall Study|Other|13|||
126002144|NCT05305040|453299681|FG001|Overall Study|Other|10|||
126002145|NCT05305040|453299680|FG000|Overall Study|Primary Malignancy Relapse|3|||
126002146|NCT05305040|453299681|FG001|Overall Study|Primary Malignancy Relapse|4|||
126002147|NCT05305040|453299680|FG000|Overall Study|Adverse Event|3|||
126002148|NCT05305040|453299681|FG001|Overall Study|Adverse Event|3|||
126002149|NCT05305040|453299680|FG000|Overall Study|Lost to Follow-up|2|||
126337562|NCT01655901|454532873|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
126337563|NCT01655901|454532874|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
126337564|NCT01655901|454532875|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
126002150|NCT05305040|453299681|FG001|Overall Study|Lost to Follow-up|1|||
126002151|NCT05305040|453299680|FG000|Overall Study|Graft versus host disease|2|||
126002152|NCT05305040|453299681|FG001|Overall Study|Graft versus host disease|0|||
126002153|NCT05305040|453299680|FG000|Overall Study|Investigator's Decision|1|||
126002154|NCT05305040|453299681|FG001|Overall Study|Investigator's Decision|1|||
126002155|NCT05305040|453299680|FG000|Overall Study|COVID-19 Reasons|1|||
126002156|NCT05305040|453299681|FG001|Overall Study|COVID-19 Reasons|0|||
126002157|NCT00465361|453299682|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
126002158|NCT01333943|453299686|FG000|Overall Study|Known neuropathy|1|||
126002159|NCT01333943|453299687|FG001|Overall Study|Known neuropathy|0|||
126002160|NCT01511536|453299696|FG000|Phase 1|Other|0|||
126002161|NCT01511536|453299697|FG001|Phase 1|Other|1|||
126002162|NCT01511536|453299698|FG002|Phase 1|Other|0|||
126337565|NCT01655901|454532876|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
126002163|NCT01511536|453299696|FG000|Phase 2|Other|0|||
126002164|NCT01511536|453299697|FG001|Phase 2|Other|0|||
126002165|NCT01511536|453299698|FG002|Phase 2|Other|9|||
126002166|NCT02297503|453299702|FG000|Overall Study|Withdrawal by Subject|1|||
126002167|NCT02297503|453299703|FG001|Overall Study|Withdrawal by Subject|1|||
126002168|NCT02297503|453299702|FG000|Overall Study|Protocol Violation|1|||
126002169|NCT02297503|453299703|FG001|Overall Study|Protocol Violation|0|||
126002170|NCT02297503|453299702|FG000|Overall Study|Pregnancy|0|||
126002171|NCT02297503|453299703|FG001|Overall Study|Pregnancy|1|||
126002172|NCT02297503|453299702|FG000|Overall Study|Lost to Follow-up|0|||
126002173|NCT02297503|453299703|FG001|Overall Study|Lost to Follow-up|1|||
126002174|NCT02297503|453299702|FG000|Overall Study|Medical reason|0|||
126002175|NCT02297503|453299703|FG001|Overall Study|Medical reason|1|||
126002176|NCT04337489|453299709|FG000|Overall Study|Withdrawal by Subject|1|||
126002177|NCT00972543|453299710|FG000|Overall Study|Adverse Event|1|||
126002178|NCT00972543|453299711|FG001|Overall Study|Adverse Event|0|||
126002179|NCT00972543|453299710|FG000|Overall Study|Early study termination by sponsor|4|||
126002180|NCT00972543|453299711|FG001|Overall Study|Early study termination by sponsor|1|||
126002181|NCT00965484|453299716|FG000|Overall Study|Protocol Violation|1|||
126002182|NCT00965484|453299716|FG000|Overall Study|Withdrawal by Subject|1|||
126002183|NCT01124617|453299717|FG000|Overall Study|Adverse Event|5|||
126002184|NCT01124617|453299718|FG001|Overall Study|Adverse Event|2|||
126002185|NCT01124617|453299717|FG000|Overall Study|Lack of Efficacy|2|||
126002186|NCT01124617|453299718|FG001|Overall Study|Lack of Efficacy|1|||
126002187|NCT01124617|453299717|FG000|Overall Study|Protocol Violation|1|||
126002188|NCT01124617|453299718|FG001|Overall Study|Protocol Violation|1|||
126002189|NCT01124617|453299717|FG000|Overall Study|Withdrawal by Subject|9|||
126002190|NCT01124617|453299718|FG001|Overall Study|Withdrawal by Subject|1|||
126002191|NCT01124617|453299717|FG000|Overall Study|Other|2|||
126002192|NCT01124617|453299718|FG001|Overall Study|Other|1|||
126002193|NCT00945477|453299719|FG000|Overall Study|Adverse Event|3|||
126002194|NCT00945477|453299719|FG000|Overall Study|Lack of Efficacy|2|||
126002195|NCT00945477|453299719|FG000|Overall Study|Withdrawal by Subject|1|||
126002196|NCT03582137|453299720|FG000|Overall Study|Adverse Event|1|||
126002197|NCT03582137|453299721|FG001|Overall Study|Adverse Event|0|||
126002198|NCT01982760|453299722|FG000|Overall Study|Physician Decision|1|||
126002199|NCT01982760|453299723|FG001|Overall Study|Physician Decision|0|||
126002200|NCT00859014|453299724|FG000|Overall Study|Death|4|||
126002201|NCT00859014|453299724|FG000|Overall Study|Lost to Follow-up|1|||
126002202|NCT00630539|453299725|FG000|Overall Study|Adverse Event|1|||
126002203|NCT00630539|453299726|FG001|Overall Study|Adverse Event|3|||
126002204|NCT00630539|453299727|FG002|Overall Study|Adverse Event|1|||
126002205|NCT00630539|453299728|FG003|Overall Study|Adverse Event|2|||
126002206|NCT00630539|453299725|FG000|Overall Study|Withdrawal by Subject|0|||
126002207|NCT00630539|453299726|FG001|Overall Study|Withdrawal by Subject|1|||
126002208|NCT00630539|453299727|FG002|Overall Study|Withdrawal by Subject|0|||
126002209|NCT00630539|453299728|FG003|Overall Study|Withdrawal by Subject|1|||
126002210|NCT04833855|453299735|FG000|Overall Study|Decision by sponsor|0|||
126002211|NCT04833855|453299736|FG001|Overall Study|Decision by sponsor|1|||
126002212|NCT04833855|453299737|FG002|Overall Study|Decision by sponsor|0|||
126002213|NCT04833855|453299738|FG003|Overall Study|Decision by sponsor|0|||
126002214|NCT04833855|453299735|FG000|Overall Study|Withdrawal by Subject|4|||
126002215|NCT04833855|453299736|FG001|Overall Study|Withdrawal by Subject|1|||
126002216|NCT04833855|453299737|FG002|Overall Study|Withdrawal by Subject|3|||
126002217|NCT04833855|453299738|FG003|Overall Study|Withdrawal by Subject|1|||
126002218|NCT04833855|453299735|FG000|Overall Study|Lost to Follow-up|1|||
126002219|NCT04833855|453299736|FG001|Overall Study|Lost to Follow-up|0|||
126002220|NCT04833855|453299737|FG002|Overall Study|Lost to Follow-up|2|||
126002221|NCT04833855|453299738|FG003|Overall Study|Lost to Follow-up|2|||
126002222|NCT04833855|453299735|FG000|Overall Study|Protocol specified criteria|0|||
126002223|NCT04833855|453299736|FG001|Overall Study|Protocol specified criteria|0|||
126002224|NCT04833855|453299737|FG002|Overall Study|Protocol specified criteria|2|||
126002225|NCT04833855|453299738|FG003|Overall Study|Protocol specified criteria|1|||
126002226|NCT03682536|453299740|FG000|Randomization|Withdrawal by Subject|0|||
126337566|NCT01655901|454532877|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
126337567|NCT00945243|454532880|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
126337568|NCT03256578|454532881|FG000|Overall Study|Excluded Post Randomization|66|||
126002227|NCT03682536|453299741|FG001|Randomization|Withdrawal by Subject|2|||
126337569|NCT03256578|454532882|FG001|Overall Study|Excluded Post Randomization|56|||
126337570|NCT02371616|454532883|FG000|Overall Study|Protocol Violation|2|||
126002228|NCT03682536|453299740|FG000|Treatment|Other Reasons|8|||
126002229|NCT03682536|453299741|FG001|Treatment|Other Reasons|7|||
126002230|NCT03682536|453299740|FG000|Treatment|Physician Decision|5|||
126002231|NCT03682536|453299741|FG001|Treatment|Physician Decision|5|||
126002232|NCT03682536|453299740|FG000|Treatment|Protocol Violation|1|||
126002233|NCT03682536|453299741|FG001|Treatment|Protocol Violation|0|||
126002234|NCT03682536|453299740|FG000|Treatment|Study Terminated by Sponsor|1|||
126002235|NCT03682536|453299741|FG001|Treatment|Study Terminated by Sponsor|2|||
126002236|NCT03682536|453299740|FG000|Treatment|Lost to Follow-up|0|||
126002237|NCT03682536|453299741|FG001|Treatment|Lost to Follow-up|1|||
126002238|NCT03682536|453299740|FG000|Treatment|Withdrawal by Subject|16|||
126002239|NCT03682536|453299741|FG001|Treatment|Withdrawal by Subject|18|||
126002240|NCT03682536|453299740|FG000|Treatment|Lack of Efficacy|41|||
126002241|NCT03682536|453299741|FG001|Treatment|Lack of Efficacy|68|||
126002242|NCT03682536|453299740|FG000|Treatment|Disease Progression|9|||
126002243|NCT03682536|453299741|FG001|Treatment|Disease Progression|7|||
126002244|NCT03682536|453299740|FG000|Treatment|Adverse Event|9|||
126002245|NCT03682536|453299741|FG001|Treatment|Adverse Event|5|||
126002246|NCT03682536|453299740|FG000|Treatment|Death|14|||
126002247|NCT03682536|453299741|FG001|Treatment|Death|13|||
126002248|NCT03008122|453299742|FG000|Overall Study|Physician Decision|3|||
126002249|NCT03008122|453299743|FG001|Overall Study|Physician Decision|2|||
126002250|NCT03008122|453299744|FG002|Overall Study|Physician Decision|0|||
126002251|NCT03008122|453299742|FG000|Overall Study|Withdrawal by Subject|1|||
126002252|NCT03008122|453299743|FG001|Overall Study|Withdrawal by Subject|3|||
126002253|NCT03008122|453299744|FG002|Overall Study|Withdrawal by Subject|0|||
126002254|NCT03008122|453299742|FG000|Overall Study|Lost to Follow-up|4|||
126002255|NCT03008122|453299743|FG001|Overall Study|Lost to Follow-up|8|||
126002256|NCT03008122|453299744|FG002|Overall Study|Lost to Follow-up|3|||
126002257|NCT03008122|453299742|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
126002258|NCT03008122|453299743|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126002259|NCT03008122|453299744|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
126002260|NCT03008122|453299742|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
126002261|NCT03008122|453299743|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
126002262|NCT03008122|453299744|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
126002263|NCT03008122|453299742|FG000|Overall Study|Death|0|||
126002264|NCT03008122|453299743|FG001|Overall Study|Death|0|||
126002265|NCT03008122|453299744|FG002|Overall Study|Death|1|||
126002266|NCT04529538|453299746|FG000|Overall Study|Lost to Follow-up|3|||
126002267|NCT04529538|453299747|FG001|Overall Study|Lost to Follow-up|2|||
126002268|NCT04529538|453299748|FG002|Overall Study|Lost to Follow-up|1|||
126002269|NCT04529538|453299749|FG003|Overall Study|Lost to Follow-up|0|||
126002270|NCT04529538|453299750|FG004|Overall Study|Lost to Follow-up|1|||
126337571|NCT02371616|454532884|FG001|Overall Study|Protocol Violation|1|||
126002271|NCT04529538|453299751|FG005|Overall Study|Lost to Follow-up|1|||
126002272|NCT04529538|453299752|FG006|Overall Study|Lost to Follow-up|2|||
126002273|NCT04529538|453299753|FG007|Overall Study|Lost to Follow-up|0|||
126002274|NCT04529538|453299746|FG000|Overall Study|Not eligible at enrollment|0|||
126002275|NCT04529538|453299747|FG001|Overall Study|Not eligible at enrollment|1|||
126002276|NCT04529538|453299748|FG002|Overall Study|Not eligible at enrollment|2|||
126002277|NCT04529538|453299749|FG003|Overall Study|Not eligible at enrollment|1|||
126002278|NCT04529538|453299750|FG004|Overall Study|Not eligible at enrollment|0|||
126002279|NCT04529538|453299751|FG005|Overall Study|Not eligible at enrollment|0|||
126002280|NCT04529538|453299752|FG006|Overall Study|Not eligible at enrollment|0|||
126002281|NCT04529538|453299753|FG007|Overall Study|Not eligible at enrollment|1|||
126002282|NCT04529538|453299746|FG000|Overall Study|Withdrawal by Subject|0|||
126002283|NCT04529538|453299747|FG001|Overall Study|Withdrawal by Subject|1|||
126337572|NCT02371616|454532883|FG000|Overall Study|Adverse Event|0|||
126337573|NCT02371616|454532884|FG001|Overall Study|Adverse Event|1|||
126337574|NCT02371616|454532883|FG000|Overall Study|Withdrawal of Consent|1|||
126337575|NCT02371616|454532884|FG001|Overall Study|Withdrawal of Consent|0|||
126337576|NCT02371616|454532883|FG000|Overall Study|Other (Not specified)|1|||
126337577|NCT02371616|454532884|FG001|Overall Study|Other (Not specified)|5|||
126337578|NCT02990000|454532885|FG000|Overall Study|Failed to provide data beyond baseline|36|||
126337579|NCT02990000|454532886|FG001|Overall Study|Failed to provide data beyond baseline|34|||
126337580|NCT00754741|454532887|FG000|Overall Study|Died or disenrolled|57|||
126337581|NCT00754741|454532888|FG001|Overall Study|Died or disenrolled|69|||
126337582|NCT00754741|454532889|FG002|Overall Study|Died or disenrolled|54|||
126337583|NCT00922636|454532890|FG000|Overall Study|Adverse Event|3|||
126337584|NCT00922636|454532891|FG001|Overall Study|Adverse Event|3|||
126337585|NCT00922636|454532892|FG002|Overall Study|Adverse Event|2|||
126337586|NCT00922636|454532893|FG003|Overall Study|Adverse Event|3|||
126337587|NCT00922636|454532894|FG004|Overall Study|Adverse Event|2|||
126337588|NCT00922636|454532890|FG000|Overall Study|Lack of Efficacy|1|||
126002284|NCT04529538|453299748|FG002|Overall Study|Withdrawal by Subject|1|||
126002285|NCT04529538|453299749|FG003|Overall Study|Withdrawal by Subject|2|||
126002286|NCT04529538|453299750|FG004|Overall Study|Withdrawal by Subject|0|||
126002287|NCT04529538|453299751|FG005|Overall Study|Withdrawal by Subject|2|||
126002288|NCT04529538|453299752|FG006|Overall Study|Withdrawal by Subject|3|||
126002289|NCT04529538|453299753|FG007|Overall Study|Withdrawal by Subject|0|||
126002290|NCT04529538|453299746|FG000|Overall Study|Other|0|||
126002291|NCT04529538|453299747|FG001|Overall Study|Other|1|||
126002292|NCT04529538|453299748|FG002|Overall Study|Other|0|||
126337589|NCT00922636|454532891|FG001|Overall Study|Lack of Efficacy|7|||
126337590|NCT00922636|454532892|FG002|Overall Study|Lack of Efficacy|3|||
126002293|NCT04529538|453299749|FG003|Overall Study|Other|0|||
126337591|NCT00922636|454532893|FG003|Overall Study|Lack of Efficacy|2|||
126002294|NCT04529538|453299750|FG004|Overall Study|Other|0|||
126002295|NCT04529538|453299751|FG005|Overall Study|Other|0|||
126002296|NCT04529538|453299752|FG006|Overall Study|Other|0|||
126002297|NCT04529538|453299753|FG007|Overall Study|Other|0|||
126002298|NCT04529538|453299746|FG000|Overall Study|Adverse Event|0|||
126002299|NCT04529538|453299747|FG001|Overall Study|Adverse Event|0|||
126002300|NCT04529538|453299748|FG002|Overall Study|Adverse Event|0|||
126002301|NCT04529538|453299749|FG003|Overall Study|Adverse Event|1|||
126002302|NCT04529538|453299750|FG004|Overall Study|Adverse Event|0|||
126002303|NCT04529538|453299751|FG005|Overall Study|Adverse Event|0|||
126002304|NCT04529538|453299752|FG006|Overall Study|Adverse Event|0|||
126002305|NCT04529538|453299753|FG007|Overall Study|Adverse Event|0|||
126002306|NCT04529538|453299746|FG000|Overall Study|Protocol Deviation|0|||
126337592|NCT00922636|454532894|FG004|Overall Study|Lack of Efficacy|4|||
126337593|NCT00922636|454532890|FG000|Overall Study|Sponsor Decision|0|||
126337594|NCT00922636|454532891|FG001|Overall Study|Sponsor Decision|0|||
126337595|NCT00922636|454532892|FG002|Overall Study|Sponsor Decision|2|||
126337596|NCT00922636|454532893|FG003|Overall Study|Sponsor Decision|0|||
126337597|NCT00922636|454532894|FG004|Overall Study|Sponsor Decision|0|||
126337598|NCT00922636|454532890|FG000|Overall Study|Withdrawal by Subject|0|||
126337599|NCT00922636|454532891|FG001|Overall Study|Withdrawal by Subject|0|||
126337600|NCT00922636|454532892|FG002|Overall Study|Withdrawal by Subject|5|||
126337601|NCT00922636|454532893|FG003|Overall Study|Withdrawal by Subject|2|||
126337602|NCT00922636|454532894|FG004|Overall Study|Withdrawal by Subject|4|||
126337603|NCT00922636|454532890|FG000|Overall Study|Protocol Violation|0|||
126337604|NCT00922636|454532891|FG001|Overall Study|Protocol Violation|0|||
126337605|NCT00922636|454532892|FG002|Overall Study|Protocol Violation|2|||
126337606|NCT00922636|454532893|FG003|Overall Study|Protocol Violation|2|||
126337607|NCT00922636|454532894|FG004|Overall Study|Protocol Violation|0|||
126337608|NCT00922636|454532890|FG000|Overall Study|Entry Criteria Not Met|0|||
126337609|NCT00922636|454532891|FG001|Overall Study|Entry Criteria Not Met|0|||
126337610|NCT00922636|454532892|FG002|Overall Study|Entry Criteria Not Met|1|||
126337611|NCT00922636|454532893|FG003|Overall Study|Entry Criteria Not Met|1|||
126337612|NCT00922636|454532894|FG004|Overall Study|Entry Criteria Not Met|0|||
126337613|NCT00922636|454532890|FG000|Overall Study|Parent/Caregiver Decision|2|||
126337614|NCT00922636|454532891|FG001|Overall Study|Parent/Caregiver Decision|4|||
126337615|NCT00922636|454532892|FG002|Overall Study|Parent/Caregiver Decision|3|||
126337616|NCT00922636|454532893|FG003|Overall Study|Parent/Caregiver Decision|5|||
126337617|NCT00922636|454532894|FG004|Overall Study|Parent/Caregiver Decision|2|||
126337618|NCT00922636|454532890|FG000|Overall Study|Lost to Follow-up|1|||
126337619|NCT00922636|454532891|FG001|Overall Study|Lost to Follow-up|2|||
126337620|NCT00922636|454532892|FG002|Overall Study|Lost to Follow-up|2|||
126337621|NCT00922636|454532893|FG003|Overall Study|Lost to Follow-up|2|||
126337622|NCT00922636|454532894|FG004|Overall Study|Lost to Follow-up|4|||
126337623|NCT04969289|454532895|FG000|Overall Study|Lost to Follow-up|13|||
126337624|NCT04969289|454532896|FG001|Overall Study|Lost to Follow-up|9|||
126337625|NCT00557466|454532897|FG000|Overall Study|Adverse Event|3|||
126337626|NCT00557466|454532898|FG001|Overall Study|Adverse Event|1|||
126337627|NCT00557466|454532899|FG002|Overall Study|Adverse Event|4|||
126337628|NCT00557466|454532900|FG003|Overall Study|Adverse Event|1|||
126337629|NCT00557466|454532901|FG004|Overall Study|Adverse Event|2|||
126337630|NCT00557466|454532902|FG005|Overall Study|Adverse Event|4|||
126337631|NCT00557466|454532897|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126337632|NCT00557466|454532898|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126337633|NCT00557466|454532899|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126337634|NCT00557466|454532900|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126337635|NCT00557466|454532901|FG004|Overall Study|Abnormal laboratory value(s)|0|||
126337636|NCT00557466|454532902|FG005|Overall Study|Abnormal laboratory value(s)|0|||
126337637|NCT00557466|454532897|FG000|Overall Study|Protocol deviation|0|||
126337638|NCT00557466|454532898|FG001|Overall Study|Protocol deviation|1|||
126337639|NCT00557466|454532899|FG002|Overall Study|Protocol deviation|0|||
126337640|NCT00557466|454532900|FG003|Overall Study|Protocol deviation|2|||
126337641|NCT00557466|454532901|FG004|Overall Study|Protocol deviation|0|||
126337642|NCT00557466|454532902|FG005|Overall Study|Protocol deviation|0|||
126337643|NCT00557466|454532897|FG000|Overall Study|Subject withdrew consent|0|||
126337644|NCT00557466|454532898|FG001|Overall Study|Subject withdrew consent|0|||
126337645|NCT00557466|454532899|FG002|Overall Study|Subject withdrew consent|0|||
126337646|NCT00557466|454532900|FG003|Overall Study|Subject withdrew consent|0|||
126337647|NCT00557466|454532901|FG004|Overall Study|Subject withdrew consent|1|||
126337648|NCT00557466|454532902|FG005|Overall Study|Subject withdrew consent|2|||
126337649|NCT00557466|454532897|FG000|Overall Study|Administrative problems|0|||
126337650|NCT00557466|454532898|FG001|Overall Study|Administrative problems|1|||
126002307|NCT04529538|453299747|FG001|Overall Study|Protocol Deviation|0|||
126002308|NCT04529538|453299748|FG002|Overall Study|Protocol Deviation|0|||
126337651|NCT00557466|454532899|FG002|Overall Study|Administrative problems|1|||
126337652|NCT00557466|454532900|FG003|Overall Study|Administrative problems|0|||
126337653|NCT00557466|454532901|FG004|Overall Study|Administrative problems|0|||
126337654|NCT00557466|454532902|FG005|Overall Study|Administrative problems|0|||
126002309|NCT04529538|453299749|FG003|Overall Study|Protocol Deviation|1|||
126002310|NCT04529538|453299750|FG004|Overall Study|Protocol Deviation|0|||
126002311|NCT04529538|453299751|FG005|Overall Study|Protocol Deviation|0|||
126002312|NCT04529538|453299752|FG006|Overall Study|Protocol Deviation|0|||
126002313|NCT04529538|453299753|FG007|Overall Study|Protocol Deviation|0|||
126002314|NCT04529538|453299746|FG000|Overall Study|Physician Decision|0|||
126002315|NCT04529538|453299747|FG001|Overall Study|Physician Decision|0|||
126002316|NCT04529538|453299748|FG002|Overall Study|Physician Decision|0|||
126002317|NCT04529538|453299749|FG003|Overall Study|Physician Decision|0|||
126002318|NCT04529538|453299750|FG004|Overall Study|Physician Decision|0|||
126002319|NCT04529538|453299751|FG005|Overall Study|Physician Decision|1|||
126002320|NCT04529538|453299752|FG006|Overall Study|Physician Decision|0|||
126002321|NCT04529538|453299753|FG007|Overall Study|Physician Decision|1|||
126002322|NCT02234310|453299761|FG000|Overall Study|Physician Decision|1|||
126002323|NCT02234310|453299761|FG000|Overall Study|Adverse Event|1|||
126002324|NCT02234310|453299761|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
126002325|NCT02234310|453299761|FG000|Overall Study|Withdrawal by Subject|2|||
126002326|NCT00235495|453299762|FG000|Overall Study|Death|52|||
126002327|NCT00235495|453299763|FG001|Overall Study|Death|42|||
126002328|NCT00235495|453299762|FG000|Overall Study|Withdrawal by Subject|5|||
126337655|NCT00557466|454532897|FG000|Overall Study|Abnormal test procedure results|0|||
126337656|NCT00557466|454532898|FG001|Overall Study|Abnormal test procedure results|0|||
126337657|NCT00557466|454532899|FG002|Overall Study|Abnormal test procedure results|1|||
126337658|NCT00557466|454532900|FG003|Overall Study|Abnormal test procedure results|0|||
126337659|NCT00557466|454532901|FG004|Overall Study|Abnormal test procedure results|0|||
126002329|NCT00235495|453299763|FG001|Overall Study|Withdrawal by Subject|3|||
126002330|NCT00235495|453299762|FG000|Overall Study|Lost to Follow-up|11|||
126002331|NCT00235495|453299763|FG001|Overall Study|Lost to Follow-up|13|||
126002332|NCT00235495|453299762|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
126002333|NCT00235495|453299763|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
126002334|NCT02192359|453299766|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
126002335|NCT02192359|453299767|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
126002336|NCT02192359|453299768|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
126002337|NCT02192359|453299769|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
126002338|NCT02192359|453299766|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
126002339|NCT02192359|453299767|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
126002340|NCT02192359|453299768|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
126002341|NCT02192359|453299769|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
126002342|NCT02192359|453299766|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
126002343|NCT02192359|453299767|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
126002344|NCT02192359|453299768|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
126002345|NCT02192359|453299769|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
126002346|NCT00114959|453299770|FG000|Overall Study|Lack of Efficacy|6|||
126002347|NCT00114959|453299770|FG000|Overall Study|Physician Decision|1|||
126002348|NCT00114959|453299770|FG000|Overall Study|Death|1|||
126337660|NCT00557466|454532902|FG005|Overall Study|Abnormal test procedure results|0|||
126337661|NCT00557466|454532897|FG000|Overall Study|Lost to Follow-up|0|||
126337662|NCT00557466|454532898|FG001|Overall Study|Lost to Follow-up|0|||
126002349|NCT04060680|453299774|FG000|Overall Study|Unsuccessful implant|17|||
126002350|NCT04060680|453299775|FG001|Overall Study|Unsuccessful implant|2|||
126337663|NCT00557466|454532899|FG002|Overall Study|Lost to Follow-up|0|||
126337664|NCT00557466|454532900|FG003|Overall Study|Lost to Follow-up|1|||
126337665|NCT00557466|454532901|FG004|Overall Study|Lost to Follow-up|0|||
126337666|NCT00557466|454532902|FG005|Overall Study|Lost to Follow-up|0|||
126337667|NCT01251952|454532905|FG000|Overall Study|Adverse Event|1|||
126337668|NCT03028142|454532906|FG000|Overall Study|Adverse Event|1|||
126337669|NCT03028142|454532907|FG001|Overall Study|Adverse Event|1|||
126337670|NCT03028142|454532908|FG002|Overall Study|Adverse Event|0|||
126337671|NCT03028142|454532909|FG003|Overall Study|Adverse Event|0|||
126337672|NCT03028142|454532910|FG004|Overall Study|Adverse Event|0|||
126337673|NCT03028142|454532911|FG005|Overall Study|Adverse Event|1|||
126337674|NCT03028142|454532906|FG000|Overall Study|Withdrawal by Subject|0|||
126337675|NCT03028142|454532907|FG001|Overall Study|Withdrawal by Subject|0|||
126337676|NCT03028142|454532908|FG002|Overall Study|Withdrawal by Subject|0|||
126337677|NCT03028142|454532909|FG003|Overall Study|Withdrawal by Subject|0|||
126002351|NCT04060680|453299774|FG000|Overall Study|Adverse Event|3|||
126002352|NCT04060680|453299775|FG001|Overall Study|Adverse Event|0|||
126002353|NCT04060680|453299774|FG000|Overall Study|Death|2|||
126002354|NCT04060680|453299775|FG001|Overall Study|Death|0|||
126337678|NCT03028142|454532910|FG004|Overall Study|Withdrawal by Subject|1|||
126337679|NCT03028142|454532911|FG005|Overall Study|Withdrawal by Subject|0|||
126337680|NCT02810418|454532912|FG000|Arm A Dose Escalation|Adverse Event|2|||
126002355|NCT04060680|453299774|FG000|Overall Study|Study product no longer in use|1|||
126002356|NCT04060680|453299775|FG001|Overall Study|Study product no longer in use|0|||
126002357|NCT04060680|453299774|FG000|Overall Study|Withdrawal by Subject|1|||
126002358|NCT04060680|453299775|FG001|Overall Study|Withdrawal by Subject|0|||
126002359|NCT02322775|453299776|FG000|Overall Study|Adverse Event|1|||
126002360|NCT02322775|453299777|FG001|Overall Study|Adverse Event|0|||
126002361|NCT02322775|453299776|FG000|Overall Study|Lost to Follow-up|0|||
126002362|NCT02322775|453299777|FG001|Overall Study|Lost to Follow-up|1|||
126002363|NCT02322775|453299776|FG000|Overall Study|Protocol Violation|1|||
126002364|NCT02322775|453299777|FG001|Overall Study|Protocol Violation|0|||
126002365|NCT02322775|453299776|FG000|Overall Study|Withdrawal by Subject|3|||
126002366|NCT02322775|453299777|FG001|Overall Study|Withdrawal by Subject|4|||
126002367|NCT02322775|453299776|FG000|Overall Study|Not willing to perform all FU visits|0|||
126002368|NCT02322775|453299777|FG001|Overall Study|Not willing to perform all FU visits|1|||
126002369|NCT02507219|453299788|FG000|Overall Study|Physician Decision|1|||
126002370|NCT02507219|453299789|FG001|Overall Study|Physician Decision|0|||
126002371|NCT02507219|453299790|FG002|Overall Study|Physician Decision|0|||
126002372|NCT02507219|453299791|FG003|Overall Study|Physician Decision|0|||
126002373|NCT02507219|453299792|FG004|Overall Study|Physician Decision|0|||
126002374|NCT02507219|453299793|FG005|Overall Study|Physician Decision|0|||
126002375|NCT02507219|453299788|FG000|Overall Study|Withdrawal by Subject|0|||
126002376|NCT02507219|453299789|FG001|Overall Study|Withdrawal by Subject|0|||
126002377|NCT02507219|453299790|FG002|Overall Study|Withdrawal by Subject|0|||
126002378|NCT02507219|453299791|FG003|Overall Study|Withdrawal by Subject|0|||
126002379|NCT02507219|453299792|FG004|Overall Study|Withdrawal by Subject|1|||
126002380|NCT02507219|453299793|FG005|Overall Study|Withdrawal by Subject|0|||
126002381|NCT01342887|453299800|FG000|Overall Study|Death|2|||
126002382|NCT00209274|453299801|FG000|Overall Study|Missed visit|3|||
126002383|NCT00209274|453299802|FG001|Overall Study|Missed visit|2|||
126002384|NCT00209274|453299801|FG000|Overall Study|Death|32|||
126002385|NCT00209274|453299802|FG001|Overall Study|Death|15|||
126002386|NCT00209274|453299801|FG000|Overall Study|Withdrawal by Subject|30|||
126002387|NCT00209274|453299802|FG001|Overall Study|Withdrawal by Subject|15|||
126002388|NCT00209274|453299801|FG000|Overall Study|Randomized not treated (RNT)|6|||
126002389|NCT00209274|453299802|FG001|Overall Study|Randomized not treated (RNT)|15|||
126002390|NCT02753530|453299803|FG000|Overall Study|Adverse Event|7|||
126002391|NCT02753530|453299804|FG001|Overall Study|Adverse Event|1|||
126002392|NCT02753530|453299803|FG000|Overall Study|Death|0|||
126002393|NCT02753530|453299804|FG001|Overall Study|Death|1|||
126002394|NCT02753530|453299803|FG000|Overall Study|Physician Decision|0|||
126002395|NCT02753530|453299804|FG001|Overall Study|Physician Decision|1|||
126002396|NCT02753530|453299803|FG000|Overall Study|Protocol Violation|1|||
126002397|NCT02753530|453299804|FG001|Overall Study|Protocol Violation|0|||
126002398|NCT02753530|453299803|FG000|Overall Study|Withdrawal by Subject|4|||
126002399|NCT02753530|453299804|FG001|Overall Study|Withdrawal by Subject|3|||
126002400|NCT01641861|453299805|FG000|Overall Study|Lost to Follow-up|21|||
126002401|NCT01641861|453299806|FG001|Overall Study|Lost to Follow-up|16|||
126002402|NCT01641861|453299805|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
126002403|NCT01641861|453299806|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
126002404|NCT01641861|453299805|FG000|Overall Study|Died due to drowning|0|||
126002405|NCT01641861|453299806|FG001|Overall Study|Died due to drowning|1|||
126002406|NCT01852162|453301657|FG000|Overall Study|Adverse Event|1|||
126002407|NCT01852162|453301658|FG001|Overall Study|Adverse Event|0|||
126002408|NCT01852162|453301657|FG000|Overall Study|Withdrawal by Subject|3|||
126002409|NCT01852162|453301658|FG001|Overall Study|Withdrawal by Subject|1|||
126002410|NCT00231179|453301663|FG000|Overall Study|Lost to Follow-up|21|||
126002411|NCT00231179|453301664|FG001|Overall Study|Lost to Follow-up|21|||
126002412|NCT00231179|453301663|FG000|Overall Study|Withdrawal by Subject|3|||
126002413|NCT00231179|453301664|FG001|Overall Study|Withdrawal by Subject|3|||
126002414|NCT02123966|453301665|FG000|Overall Study|Intercurrent Illness|1|||
126002415|NCT01460381|453301666|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
126002416|NCT01460381|453301667|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
126002417|NCT02652130|453301669|FG000|Overall Study|Death|1|||
126002418|NCT02028884|453301670|FG000|Double-blind Period|Adverse Event|5|||
126002419|NCT02028884|453301671|FG001|Double-blind Period|Adverse Event|3|||
126002420|NCT02028884|453301672|FG002|Double-blind Period|Adverse Event|0|||
126002421|NCT02028884|453301670|FG000|Double-blind Period|Eligibility Violation|1|||
126002422|NCT02028884|453301671|FG001|Double-blind Period|Eligibility Violation|0|||
126002423|NCT02028884|453301672|FG002|Double-blind Period|Eligibility Violation|0|||
126002424|NCT02028884|453301670|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
126002425|NCT02028884|453301671|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
126002426|NCT02028884|453301672|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
126002427|NCT02028884|453301670|FG000|Double-blind Period|Withdrawal by Subject|2|||
126002428|NCT02028884|453301671|FG001|Double-blind Period|Withdrawal by Subject|0|||
126002429|NCT02028884|453301672|FG002|Double-blind Period|Withdrawal by Subject|0|||
126002430|NCT02028884|453301670|FG000|Open-label Extension Period|Adverse Event|3|||
126002431|NCT02028884|453301671|FG001|Open-label Extension Period|Adverse Event|1|||
126002432|NCT02028884|453301672|FG002|Open-label Extension Period|Adverse Event|0|||
126002433|NCT02028884|453301670|FG000|Open-label Extension Period|Lack of Efficacy|3|||
126002434|NCT02028884|453301671|FG001|Open-label Extension Period|Lack of Efficacy|0|||
126002435|NCT02028884|453301672|FG002|Open-label Extension Period|Lack of Efficacy|0|||
126002436|NCT02028884|453301670|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
126002437|NCT02028884|453301671|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
126002438|NCT02028884|453301672|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
126002439|NCT02028884|453301670|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126002440|NCT02028884|453301671|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
126002441|NCT02028884|453301672|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
126002442|NCT02028884|453301670|FG000|Open-label Extension Period|Switched to another treatment option|3|||
126002443|NCT02028884|453301671|FG001|Open-label Extension Period|Switched to another treatment option|0|||
126002444|NCT02028884|453301672|FG002|Open-label Extension Period|Switched to another treatment option|0|||
126002445|NCT00354029|453301673|FG000|Overall Study|Protocol Violation|4|||
126002446|NCT00354029|453301674|FG001|Overall Study|Protocol Violation|2|||
126002447|NCT00723294|453301675|FG000|Overall Study|Lobular histology|2|||
126002448|NCT00723294|453301675|FG000|Overall Study|>25% intraductal component|1|||
126002449|NCT00723294|453301675|FG000|Overall Study|No MRI tumor enhancement|1|||
126337681|NCT02810418|454532913|FG001|Arm A Dose Escalation|Adverse Event|1|||
126337682|NCT02810418|454532914|FG002|Arm A Dose Escalation|Adverse Event|0|||
126337683|NCT02810418|454532915|FG003|Arm A Dose Escalation|Adverse Event|0|||
126002450|NCT00723294|453301675|FG000|Overall Study|1.0-Tesla MRI|1|||
126002451|NCT00723294|453301675|FG000|Overall Study|No cryoabalation|2|||
126002452|NCT00723294|453301675|FG000|Overall Study|Did not undergo surgery|1|||
126002453|NCT00723294|453301675|FG000|Overall Study|Treated prior to registration|1|||
126002454|NCT00723294|453301675|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
126002455|NCT00723294|453301675|FG000|Overall Study|Benign lesion|1|||
126002456|NCT00723294|453301675|FG000|Overall Study|Withdrawal by Subject|1|||
126002457|NCT00723294|453301675|FG000|Overall Study|No treatment due to probe failure|1|||
126002458|NCT00826280|453301676|FG000|Overall Study|Randomized but drug not received|1|||
126002459|NCT00826280|453301677|FG001|Overall Study|Randomized but drug not received|0|||
126002460|NCT00826280|453301678|FG002|Overall Study|Randomized but drug not received|1|||
126002461|NCT00826280|453301676|FG000|Overall Study|Adverse Event|1|||
126002462|NCT00826280|453301677|FG001|Overall Study|Adverse Event|3|||
126002463|NCT00826280|453301678|FG002|Overall Study|Adverse Event|0|||
126002464|NCT00826280|453301676|FG000|Overall Study|Lost to Follow-up|0|||
126002465|NCT00826280|453301677|FG001|Overall Study|Lost to Follow-up|1|||
126002466|NCT00826280|453301678|FG002|Overall Study|Lost to Follow-up|0|||
126002467|NCT00826280|453301676|FG000|Overall Study|Sponsor discontinued subject or study|1|||
126002468|NCT00826280|453301677|FG001|Overall Study|Sponsor discontinued subject or study|0|||
126002469|NCT00826280|453301678|FG002|Overall Study|Sponsor discontinued subject or study|0|||
126002470|NCT00826280|453301676|FG000|Overall Study|Reversible ischemic defect not present|43|||
126002471|NCT00826280|453301677|FG001|Overall Study|Reversible ischemic defect not present|40|||
126002472|NCT00826280|453301678|FG002|Overall Study|Reversible ischemic defect not present|44|||
126002473|NCT00826280|453301676|FG000|Overall Study|Interpretation Failure|1|||
126002474|NCT00826280|453301677|FG001|Overall Study|Interpretation Failure|0|||
126002475|NCT00826280|453301678|FG002|Overall Study|Interpretation Failure|0|||
126002476|NCT00826280|453301676|FG000|Overall Study|Machine Failure|1|||
126002477|NCT00826280|453301677|FG001|Overall Study|Machine Failure|1|||
126002478|NCT00826280|453301678|FG002|Overall Study|Machine Failure|0|||
126002479|NCT00826280|453301676|FG000|Overall Study|One or more non-interpretable scan|0|||
126002480|NCT00826280|453301677|FG001|Overall Study|One or more non-interpretable scan|1|||
126002481|NCT00826280|453301678|FG002|Overall Study|One or more non-interpretable scan|1|||
126002482|NCT03201757|453301679|FG000|Overall Study|Withdrawal by Subject|133|||
126002483|NCT03201757|453301679|FG000|Overall Study|Adverse Event|44|||
126002484|NCT03201757|453301679|FG000|Overall Study|Lost to Follow-up|37|||
126002485|NCT03201757|453301679|FG000|Overall Study|Pregnancy|2|||
126002486|NCT03201757|453301679|FG000|Overall Study|Lack of Efficacy|1|||
126002487|NCT03201757|453301679|FG000|Overall Study|Protocol Violation|20|||
126002488|NCT03201757|453301679|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
126002489|NCT03201757|453301679|FG000|Overall Study|Not Yet Determined|5|||
126002490|NCT03201757|453301679|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
126002491|NCT03201757|453301679|FG000|Overall Study|Other|20|||
126002492|NCT01254305|453301680|FG000|Overall Study|Adverse Event|6|||
126002493|NCT01254305|453301681|FG001|Overall Study|Adverse Event|3|||
126002494|NCT01254305|453301682|FG002|Overall Study|Adverse Event|2|||
126002495|NCT01254305|453301680|FG000|Overall Study|Lack of Efficacy|1|||
126002496|NCT01254305|453301681|FG001|Overall Study|Lack of Efficacy|0|||
126337684|NCT02810418|454532916|FG004|Arm A Dose Escalation|Adverse Event|0|||
126337685|NCT02810418|454532917|FG005|Arm A Dose Escalation|Adverse Event|0|||
126002497|NCT01254305|453301682|FG002|Overall Study|Lack of Efficacy|1|||
126002498|NCT01254305|453301680|FG000|Overall Study|Protocol Violation|1|||
126002499|NCT01254305|453301681|FG001|Overall Study|Protocol Violation|7|||
126337686|NCT02810418|454532918|FG006|Arm A Dose Escalation|Adverse Event|0|||
126337687|NCT02810418|454532912|FG000|Dose Expansion|Adverse Event|0|||
126337688|NCT02810418|454532913|FG001|Dose Expansion|Adverse Event|1|||
126337689|NCT02810418|454532914|FG002|Dose Expansion|Adverse Event|1|||
126337690|NCT02810418|454532915|FG003|Dose Expansion|Adverse Event|0|||
126337691|NCT02810418|454532916|FG004|Dose Expansion|Adverse Event|0|||
126337692|NCT02810418|454532917|FG005|Dose Expansion|Adverse Event|0|||
126337693|NCT02810418|454532918|FG006|Dose Expansion|Adverse Event|0|||
126337694|NCT02810418|454532912|FG000|Dose Expansion|Physician Decision|0|||
126337695|NCT02810418|454532913|FG001|Dose Expansion|Physician Decision|0|||
126337696|NCT02810418|454532914|FG002|Dose Expansion|Physician Decision|2|||
126337697|NCT02810418|454532915|FG003|Dose Expansion|Physician Decision|0|||
126337698|NCT02810418|454532916|FG004|Dose Expansion|Physician Decision|0|||
126337699|NCT02810418|454532917|FG005|Dose Expansion|Physician Decision|0|||
126337700|NCT02810418|454532918|FG006|Dose Expansion|Physician Decision|0|||
126337701|NCT02810418|454532912|FG000|Arm B Dose Escalation|Adverse Event|0|||
126337702|NCT02810418|454532913|FG001|Arm B Dose Escalation|Adverse Event|0|||
126337703|NCT02810418|454532914|FG002|Arm B Dose Escalation|Adverse Event|0|||
126337704|NCT02810418|454532915|FG003|Arm B Dose Escalation|Adverse Event|0|||
126002500|NCT01254305|453301682|FG002|Overall Study|Protocol Violation|3|||
126002501|NCT01254305|453301680|FG000|Overall Study|Withdrawal by Subject|4|||
126002502|NCT01254305|453301681|FG001|Overall Study|Withdrawal by Subject|2|||
126002503|NCT01254305|453301682|FG002|Overall Study|Withdrawal by Subject|4|||
126002504|NCT01254305|453301680|FG000|Overall Study|Lost to Follow-up|10|||
126002505|NCT01254305|453301681|FG001|Overall Study|Lost to Follow-up|6|||
126002506|NCT01254305|453301682|FG002|Overall Study|Lost to Follow-up|5|||
126002507|NCT01254305|453301680|FG000|Overall Study|Other Reasons|0|||
126002508|NCT01254305|453301681|FG001|Overall Study|Other Reasons|0|||
126002509|NCT01254305|453301682|FG002|Overall Study|Other Reasons|2|||
126002510|NCT02703532|453301683|FG000|Overall Study|Withdrawal by Subject|0|||
126002511|NCT02703532|453301684|FG001|Overall Study|Withdrawal by Subject|1|||
126002512|NCT02703532|453301685|FG002|Overall Study|Withdrawal by Subject|0|||
126002513|NCT02703532|453301686|FG003|Overall Study|Withdrawal by Subject|1|||
126002514|NCT02703532|453301683|FG000|Overall Study|Lost to Follow-up|2|||
126002515|NCT02703532|453301684|FG001|Overall Study|Lost to Follow-up|0|||
126002516|NCT02703532|453301685|FG002|Overall Study|Lost to Follow-up|2|||
126002517|NCT02703532|453301686|FG003|Overall Study|Lost to Follow-up|0|||
126002518|NCT02263885|453301687|FG000|Overall Study|Withdrawal by Subject|7|||
126002519|NCT02263885|453301687|FG000|Overall Study|Alternative Treatment|3|||
126002520|NCT02688621|453301688|FG000|Overall Study|Pregnancy|1|||
126002521|NCT02688621|453301689|FG001|Overall Study|Pregnancy|3|||
126002522|NCT02688621|453301688|FG000|Overall Study|Lost to Follow-up|38|||
126002523|NCT02688621|453301689|FG001|Overall Study|Lost to Follow-up|15|||
126002524|NCT02688621|453301688|FG000|Overall Study|Withdrawal by Subject|1|||
126002525|NCT02688621|453301689|FG001|Overall Study|Withdrawal by Subject|0|||
126002526|NCT03239210|453301690|FG000|Overall Study|Lost to Follow-up|2|||
126002527|NCT03239210|453301691|FG001|Overall Study|Lost to Follow-up|2|||
126002528|NCT03239210|453301690|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
126002529|NCT03239210|453301691|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
126002530|NCT03239210|453301690|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
126002531|NCT03239210|453301691|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
126002532|NCT01403987|453301693|FG000|Overall Study|Residents forgot their secret PIN|18|||
126002533|NCT01403987|453301694|FG001|Overall Study|Residents forgot their secret PIN|17|||
126002534|NCT01403987|453301695|FG002|Overall Study|Residents forgot their secret PIN|18|||
126002535|NCT00751790|453301696|FG000|Overall Study|Lost to Follow-up|1|||
126002536|NCT00751790|453301696|FG000|Overall Study|Death|3|||
126002537|NCT00751790|453301696|FG000|Overall Study|Withdrawal by Subject|1|||
126002538|NCT02179918|453301699|FG000|Overall Study|Death|0|||
126002539|NCT02179918|453301700|FG001|Overall Study|Death|0|||
126002540|NCT02179918|453301701|FG002|Overall Study|Death|0|||
126002541|NCT02179918|453301702|FG003|Overall Study|Death|1|||
126002542|NCT02179918|453301703|FG004|Overall Study|Death|0|||
126002543|NCT02179918|453301699|FG000|Overall Study|Lost to Follow-up|0|||
126002544|NCT02179918|453301700|FG001|Overall Study|Lost to Follow-up|0|||
126002545|NCT02179918|453301701|FG002|Overall Study|Lost to Follow-up|1|||
126337705|NCT02810418|454532916|FG004|Arm B Dose Escalation|Adverse Event|1|||
126337706|NCT02810418|454532917|FG005|Arm B Dose Escalation|Adverse Event|2|||
126002546|NCT02179918|453301702|FG003|Overall Study|Lost to Follow-up|0|||
126002547|NCT02179918|453301703|FG004|Overall Study|Lost to Follow-up|0|||
126002548|NCT02179918|453301699|FG000|Overall Study|Progressive Disease|4|||
126002549|NCT02179918|453301700|FG001|Overall Study|Progressive Disease|1|||
126002550|NCT02179918|453301701|FG002|Overall Study|Progressive Disease|1|||
126002551|NCT02179918|453301702|FG003|Overall Study|Progressive Disease|2|||
126002552|NCT02179918|453301703|FG004|Overall Study|Progressive Disease|6|||
126002553|NCT02179918|453301699|FG000|Overall Study|Other|0|||
126002554|NCT02179918|453301700|FG001|Overall Study|Other|1|||
126002555|NCT02179918|453301701|FG002|Overall Study|Other|0|||
126002556|NCT02179918|453301702|FG003|Overall Study|Other|0|||
126337707|NCT02810418|454532918|FG006|Arm B Dose Escalation|Adverse Event|0|||
126337708|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
126002557|NCT02179918|453301703|FG004|Overall Study|Other|1|||
126002558|NCT02179918|453301699|FG000|Overall Study|Subject refused further follow-up|0|||
126002559|NCT02179918|453301700|FG001|Overall Study|Subject refused further follow-up|1|||
126002560|NCT02179918|453301701|FG002|Overall Study|Subject refused further follow-up|0|||
126002561|NCT02179918|453301702|FG003|Overall Study|Subject refused further follow-up|0|||
126002562|NCT02179918|453301703|FG004|Overall Study|Subject refused further follow-up|1|||
126002563|NCT04537949|453301707|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
126002564|NCT04537949|453301708|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
126002565|NCT04537949|453301709|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
126002566|NCT04537949|453301710|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
126002567|NCT04537949|453301711|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
126002568|NCT04537949|453301712|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
126002569|NCT04537949|453301713|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
126002570|NCT04537949|453301714|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
126002571|NCT04537949|453301707|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
126002572|NCT04537949|453301708|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
126002573|NCT04537949|453301709|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
126002574|NCT04537949|453301710|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
126002575|NCT04537949|453301711|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
126002576|NCT04537949|453301712|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
126002577|NCT04537949|453301713|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
126002578|NCT04537949|453301714|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
126002579|NCT04537949|453301707|FG000|Follow-up Phase|Lost to Follow-up|0|||
126002580|NCT04537949|453301708|FG001|Follow-up Phase|Lost to Follow-up|3|||
126002581|NCT04537949|453301709|FG002|Follow-up Phase|Lost to Follow-up|0|||
126002582|NCT04537949|453301710|FG003|Follow-up Phase|Lost to Follow-up|0|||
126002583|NCT04537949|453301711|FG004|Follow-up Phase|Lost to Follow-up|0|||
126002584|NCT04537949|453301712|FG005|Follow-up Phase|Lost to Follow-up|0|||
126002585|NCT04537949|453301713|FG006|Follow-up Phase|Lost to Follow-up|0|||
126002586|NCT04537949|453301714|FG007|Follow-up Phase|Lost to Follow-up|0|||
126002587|NCT04537949|453301707|FG000|Follow-up Phase|personal reasons|0|||
126002588|NCT04537949|453301708|FG001|Follow-up Phase|personal reasons|0|||
126002589|NCT04537949|453301709|FG002|Follow-up Phase|personal reasons|0|||
126002590|NCT04537949|453301710|FG003|Follow-up Phase|personal reasons|1|||
126002591|NCT04537949|453301711|FG004|Follow-up Phase|personal reasons|1|||
126002592|NCT04537949|453301712|FG005|Follow-up Phase|personal reasons|0|||
126002593|NCT04537949|453301713|FG006|Follow-up Phase|personal reasons|0|||
126002594|NCT04537949|453301714|FG007|Follow-up Phase|personal reasons|0|||
126002595|NCT04537949|453301707|FG000|Follow-up Phase|Withdrawal by Subject|0|||
126002596|NCT04537949|453301708|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126002597|NCT04537949|453301709|FG002|Follow-up Phase|Withdrawal by Subject|0|||
126002598|NCT04537949|453301710|FG003|Follow-up Phase|Withdrawal by Subject|0|||
126002599|NCT04537949|453301711|FG004|Follow-up Phase|Withdrawal by Subject|1|||
126002600|NCT04537949|453301712|FG005|Follow-up Phase|Withdrawal by Subject|0|||
126002601|NCT04537949|453301713|FG006|Follow-up Phase|Withdrawal by Subject|0|||
126002602|NCT04537949|453301714|FG007|Follow-up Phase|Withdrawal by Subject|0|||
126002603|NCT00335153|453301716|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
126002604|NCT00335153|453301716|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
126002605|NCT00335153|453301716|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
126002606|NCT00335153|453301716|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
126002607|NCT00335153|453301716|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
126002608|NCT00335153|453301716|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
126002609|NCT00335153|453301716|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
126002610|NCT00335153|453301716|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
126002611|NCT00335153|453301716|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
126002612|NCT00335153|453301716|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
126002613|NCT02478359|453301719|FG000|Overall Study|Disenrolled from health plan|106|||
126002614|NCT02478359|453301720|FG001|Overall Study|Disenrolled from health plan|65|||
126002615|NCT00372528|453301721|FG000|Overall Study|Lack of Efficacy|1|||
126002616|NCT00372528|453301721|FG000|Overall Study|Adverse Event|1|||
126002617|NCT00372528|453301721|FG000|Overall Study|Study Terminated by Sponsor|18|||
126002618|NCT00372528|453301721|FG000|Overall Study|Other|1|||
126002619|NCT02412761|453301722|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126002620|NCT02412761|453301723|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126002621|NCT02412761|453301724|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126002622|NCT02412761|453301725|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126002623|NCT02412761|453301726|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126002624|NCT02412761|453301727|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126002625|NCT00562965|453301728|FG000|Overall Study|Withdrawal by Subject|0|||
126002626|NCT00562965|453301729|FG001|Overall Study|Withdrawal by Subject|1|||
126002627|NCT00562965|453301728|FG000|Overall Study|Death|2|||
126002628|NCT00562965|453301729|FG001|Overall Study|Death|4|||
126002629|NCT00562965|453301728|FG000|Overall Study|Lost to Follow-up|1|||
126002630|NCT00562965|453301729|FG001|Overall Study|Lost to Follow-up|0|||
126002631|NCT00562965|453301728|FG000|Overall Study|Other|0|||
126002632|NCT00562965|453301729|FG001|Overall Study|Other|1|||
126002633|NCT01657682|453301730|FG000|Overall Study|Lost to Follow-up|1|||
126002634|NCT01657682|453301731|FG001|Overall Study|Lost to Follow-up|0|||
126002635|NCT01657682|453301732|FG002|Overall Study|Lost to Follow-up|0|||
126002636|NCT01657682|453301730|FG000|Overall Study|Withdrawal by Subject|0|||
126002637|NCT01657682|453301731|FG001|Overall Study|Withdrawal by Subject|1|||
126002638|NCT01657682|453301732|FG002|Overall Study|Withdrawal by Subject|1|||
126002639|NCT01657682|453301730|FG000|Overall Study|Adverse Event|0|||
126002640|NCT01657682|453301731|FG001|Overall Study|Adverse Event|1|||
126002641|NCT01657682|453301732|FG002|Overall Study|Adverse Event|0|||
126002642|NCT01719861|453301736|FG000|Cycle 1|Death|4|||
126002643|NCT01719861|453301736|FG000|Cycle 2|Death|1|||
126002644|NCT00848211|453301737|FG000|Overall Study|Protocol Violation|0|||
126002645|NCT00848211|453301738|FG001|Overall Study|Protocol Violation|1|||
126002646|NCT00848211|453301739|FG002|Overall Study|Protocol Violation|1|||
126002647|NCT00848211|453301740|FG003|Overall Study|Protocol Violation|0|||
126002648|NCT00848211|453301737|FG000|Overall Study|Adverse Event|0|||
126002649|NCT00848211|453301738|FG001|Overall Study|Adverse Event|0|||
126002650|NCT00848211|453301739|FG002|Overall Study|Adverse Event|0|||
126002651|NCT00848211|453301740|FG003|Overall Study|Adverse Event|0|||
126002652|NCT00619151|453301741|FG000|Overall Study|Study terminated prior to followup|1|||
126002653|NCT00619151|453301742|FG001|Overall Study|Study terminated prior to followup|0|||
126002654|NCT02825043|453301743|FG000|Overall Study|Lost to Follow-up|4|||
126002655|NCT02303574|453301750|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002656|NCT02303574|453301751|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002657|NCT02303574|453301752|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
126002658|NCT02303574|453301753|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002659|NCT02303574|453301754|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002660|NCT02303574|453301755|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002661|NCT02303574|453301756|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002662|NCT02303574|453301757|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002663|NCT02303574|453301758|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002664|NCT02303574|453301759|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126002665|NCT02303574|453301750|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002666|NCT02303574|453301751|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002667|NCT02303574|453301752|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002668|NCT02303574|453301753|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002669|NCT02303574|453301754|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002670|NCT02303574|453301755|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002671|NCT02303574|453301756|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002672|NCT02303574|453301757|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
126002673|NCT02303574|453301758|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002674|NCT02303574|453301759|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126002675|NCT04796935|453301760|FG000|Overall Study|Withdrawal by Subject|0|||
126002676|NCT04796935|453301761|FG001|Overall Study|Withdrawal by Subject|1|||
126002677|NCT04796935|453301760|FG000|Overall Study|Physician Decision|0|||
126002678|NCT04796935|453301761|FG001|Overall Study|Physician Decision|1|||
126002679|NCT04796935|453301760|FG000|Overall Study|Device not available|1|||
126002680|NCT04796935|453301761|FG001|Overall Study|Device not available|0|||
126002681|NCT04796935|453301760|FG000|Overall Study|Trained provider not available|1|||
126002682|NCT04796935|453301761|FG001|Overall Study|Trained provider not available|0|||
126002683|NCT00783718|453301762|FG000|Induction Phase|Adverse Event|4|||
126002684|NCT00783718|453301763|FG001|Induction Phase|Adverse Event|0|||
126002685|NCT00783718|453301764|FG002|Induction Phase|Adverse Event|7|||
126002686|NCT00783718|453301765|FG003|Induction Phase|Adverse Event|0|||
126002687|NCT00783718|453301766|FG004|Induction Phase|Adverse Event|0|||
126002688|NCT00783718|453301767|FG005|Induction Phase|Adverse Event|0|||
126002689|NCT00783718|453301768|FG006|Induction Phase|Adverse Event|0|||
126002690|NCT00783718|453301762|FG000|Induction Phase|Protocol Violation|1|||
126002691|NCT00783718|453301763|FG001|Induction Phase|Protocol Violation|1|||
126002692|NCT00783718|453301764|FG002|Induction Phase|Protocol Violation|6|||
126002693|NCT00783718|453301765|FG003|Induction Phase|Protocol Violation|0|||
126002694|NCT00783718|453301766|FG004|Induction Phase|Protocol Violation|0|||
126002695|NCT00783718|453301767|FG005|Induction Phase|Protocol Violation|0|||
126002696|NCT00783718|453301768|FG006|Induction Phase|Protocol Violation|0|||
126002697|NCT00783718|453301762|FG000|Induction Phase|Lack of Efficacy|5|||
126002698|NCT00783718|453301763|FG001|Induction Phase|Lack of Efficacy|2|||
126002699|NCT00783718|453301764|FG002|Induction Phase|Lack of Efficacy|14|||
126002700|NCT00783718|453301765|FG003|Induction Phase|Lack of Efficacy|0|||
126002701|NCT00783718|453301766|FG004|Induction Phase|Lack of Efficacy|0|||
126002702|NCT00783718|453301767|FG005|Induction Phase|Lack of Efficacy|0|||
126002703|NCT00783718|453301768|FG006|Induction Phase|Lack of Efficacy|0|||
126002704|NCT00783718|453301762|FG000|Induction Phase|Withdrawal by Subject|3|||
126002705|NCT00783718|453301763|FG001|Induction Phase|Withdrawal by Subject|4|||
126002706|NCT00783718|453301764|FG002|Induction Phase|Withdrawal by Subject|8|||
126002707|NCT00783718|453301765|FG003|Induction Phase|Withdrawal by Subject|0|||
126002708|NCT00783718|453301766|FG004|Induction Phase|Withdrawal by Subject|0|||
126002709|NCT00783718|453301767|FG005|Induction Phase|Withdrawal by Subject|0|||
126002710|NCT00783718|453301768|FG006|Induction Phase|Withdrawal by Subject|0|||
126002711|NCT00783718|453301762|FG000|Induction Phase|Lost to Follow-up|1|||
126002712|NCT00783718|453301763|FG001|Induction Phase|Lost to Follow-up|0|||
126002713|NCT00783718|453301764|FG002|Induction Phase|Lost to Follow-up|1|||
126002714|NCT00783718|453301765|FG003|Induction Phase|Lost to Follow-up|0|||
126002715|NCT00783718|453301766|FG004|Induction Phase|Lost to Follow-up|0|||
126002716|NCT00783718|453301767|FG005|Induction Phase|Lost to Follow-up|0|||
126002717|NCT00783718|453301768|FG006|Induction Phase|Lost to Follow-up|0|||
126002718|NCT00783718|453301762|FG000|Maintenance Phase|Adverse Event|12|||
126002719|NCT00783718|453301763|FG001|Maintenance Phase|Adverse Event|0|||
126002720|NCT00783718|453301764|FG002|Maintenance Phase|Adverse Event|0|||
126002721|NCT00783718|453301765|FG003|Maintenance Phase|Adverse Event|15|||
126002722|NCT00783718|453301766|FG004|Maintenance Phase|Adverse Event|7|||
126002723|NCT00783718|453301767|FG005|Maintenance Phase|Adverse Event|6|||
126002724|NCT00783718|453301768|FG006|Maintenance Phase|Adverse Event|16|||
126002725|NCT00783718|453301762|FG000|Maintenance Phase|Protocol Violation|1|||
126002726|NCT00783718|453301763|FG001|Maintenance Phase|Protocol Violation|0|||
126002727|NCT00783718|453301764|FG002|Maintenance Phase|Protocol Violation|0|||
126002728|NCT00783718|453301765|FG003|Maintenance Phase|Protocol Violation|0|||
126002729|NCT00783718|453301766|FG004|Maintenance Phase|Protocol Violation|0|||
126002730|NCT00783718|453301767|FG005|Maintenance Phase|Protocol Violation|0|||
126002731|NCT00783718|453301768|FG006|Maintenance Phase|Protocol Violation|2|||
126002732|NCT00783718|453301762|FG000|Maintenance Phase|Lack of Efficacy|83|||
126002733|NCT00783718|453301763|FG001|Maintenance Phase|Lack of Efficacy|0|||
126002734|NCT00783718|453301764|FG002|Maintenance Phase|Lack of Efficacy|0|||
126002735|NCT00783718|453301765|FG003|Maintenance Phase|Lack of Efficacy|61|||
126002736|NCT00783718|453301766|FG004|Maintenance Phase|Lack of Efficacy|31|||
126002737|NCT00783718|453301767|FG005|Maintenance Phase|Lack of Efficacy|33|||
126002738|NCT00783718|453301768|FG006|Maintenance Phase|Lack of Efficacy|155|||
126002739|NCT00783718|453301762|FG000|Maintenance Phase|Withdrawal by Subject|6|||
126002740|NCT00783718|453301763|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126002741|NCT00783718|453301764|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126002742|NCT00783718|453301765|FG003|Maintenance Phase|Withdrawal by Subject|2|||
126002743|NCT00783718|453301766|FG004|Maintenance Phase|Withdrawal by Subject|5|||
126002744|NCT00783718|453301767|FG005|Maintenance Phase|Withdrawal by Subject|2|||
126002745|NCT00783718|453301768|FG006|Maintenance Phase|Withdrawal by Subject|20|||
126002746|NCT00783718|453301762|FG000|Maintenance Phase|Lost to Follow-up|3|||
126002747|NCT00783718|453301763|FG001|Maintenance Phase|Lost to Follow-up|0|||
126002748|NCT00783718|453301764|FG002|Maintenance Phase|Lost to Follow-up|0|||
126002749|NCT00783718|453301765|FG003|Maintenance Phase|Lost to Follow-up|0|||
126002750|NCT00783718|453301766|FG004|Maintenance Phase|Lost to Follow-up|2|||
126002751|NCT00783718|453301767|FG005|Maintenance Phase|Lost to Follow-up|0|||
126002752|NCT00783718|453301768|FG006|Maintenance Phase|Lost to Follow-up|2|||
126002753|NCT02338609|453301771|FG000|Overall Study|Physician Decision|1|||
126002754|NCT02338609|453301771|FG000|Overall Study|Death|1|||
126002755|NCT02223182|453301774|FG000|Double-Blind Period|Adverse Event|0|||
126002756|NCT02223182|453301775|FG001|Double-Blind Period|Adverse Event|2|||
126002757|NCT02223182|453301776|FG002|Double-Blind Period|Adverse Event|1|||
126002758|NCT02223182|453301777|FG003|Double-Blind Period|Adverse Event|0|||
126002759|NCT02223182|453301774|FG000|Double-Blind Period|Withdrawal by Subject|1|||
126002760|NCT02223182|453301775|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126002761|NCT02223182|453301776|FG002|Double-Blind Period|Withdrawal by Subject|1|||
126002762|NCT02223182|453301777|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126002763|NCT02223182|453301774|FG000|Double-Blind Period|Lost to Follow-up|0|||
126002764|NCT02223182|453301775|FG001|Double-Blind Period|Lost to Follow-up|1|||
126002765|NCT02223182|453301776|FG002|Double-Blind Period|Lost to Follow-up|0|||
126002766|NCT02223182|453301777|FG003|Double-Blind Period|Lost to Follow-up|0|||
126002767|NCT02223182|453301774|FG000|Double-Blind Period|Non Compliance|0|||
126002768|NCT02223182|453301775|FG001|Double-Blind Period|Non Compliance|0|||
126002769|NCT02223182|453301776|FG002|Double-Blind Period|Non Compliance|0|||
126002770|NCT02223182|453301777|FG003|Double-Blind Period|Non Compliance|1|||
126002771|NCT02223182|453301774|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
126002772|NCT02223182|453301775|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
126002773|NCT02223182|453301776|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
126002774|NCT02223182|453301777|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
126002775|NCT02223182|453301774|FG000|Open-Label 500 Period|Adverse Event|1|||
126002776|NCT02223182|453301775|FG001|Open-Label 500 Period|Adverse Event|0|||
126002777|NCT02223182|453301776|FG002|Open-Label 500 Period|Adverse Event|2|||
126002778|NCT02223182|453301777|FG003|Open-Label 500 Period|Adverse Event|1|||
126002779|NCT02223182|453301774|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
126002780|NCT02223182|453301775|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
126002781|NCT02223182|453301776|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
126002782|NCT02223182|453301777|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
126002783|NCT02223182|453301774|FG000|Open-Label 500 Period|Physician Decision|0|||
126002784|NCT02223182|453301775|FG001|Open-Label 500 Period|Physician Decision|0|||
126002785|NCT02223182|453301776|FG002|Open-Label 500 Period|Physician Decision|0|||
126002786|NCT02223182|453301777|FG003|Open-Label 500 Period|Physician Decision|1|||
126002787|NCT02223182|453301774|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
126002788|NCT02223182|453301775|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
126002789|NCT02223182|453301776|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
126002790|NCT02223182|453301777|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
126002791|NCT02223182|453301774|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
126002792|NCT02223182|453301775|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
126002793|NCT02223182|453301776|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
126002794|NCT02223182|453301777|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
126002795|NCT02223182|453301774|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
126002796|NCT02223182|453301775|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
126002797|NCT02223182|453301776|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
126002798|NCT02223182|453301777|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
126002799|NCT02223182|453301774|FG000|Open-Label 300 Period|Non Compliance|0|||
126002800|NCT02223182|453301775|FG001|Open-Label 300 Period|Non Compliance|2|||
126002801|NCT02223182|453301776|FG002|Open-Label 300 Period|Non Compliance|1|||
126002802|NCT02223182|453301777|FG003|Open-Label 300 Period|Non Compliance|0|||
126002803|NCT03714022|453301778|FG000|Overall Study|Adverse Event|1|||
126002804|NCT03714022|453301779|FG001|Overall Study|Adverse Event|0|||
126002805|NCT03714022|453301778|FG000|Overall Study|Consent withdrawal|0|||
126002806|NCT03714022|453301779|FG001|Overall Study|Consent withdrawal|1|||
126002807|NCT03714022|453301778|FG000|Overall Study|Lost to Follow-up|3|||
126002808|NCT03714022|453301779|FG001|Overall Study|Lost to Follow-up|2|||
126002809|NCT03251378|453301783|FG000|Overall Study|Death|3|||
126002810|NCT03251378|453301784|FG001|Overall Study|Death|2|||
126002811|NCT03251378|453301785|FG002|Overall Study|Death|3|||
126002812|NCT03251378|453301786|FG003|Overall Study|Death|30|||
126002813|NCT03251378|453301787|FG004|Overall Study|Death|24|||
126002814|NCT03251378|453301788|FG005|Overall Study|Death|12|||
126002815|NCT03251378|453301789|FG006|Overall Study|Death|12|||
126002816|NCT03251378|453301783|FG000|Overall Study|Lost to Follow-up|0|||
126002817|NCT03251378|453301784|FG001|Overall Study|Lost to Follow-up|0|||
126002818|NCT03251378|453301785|FG002|Overall Study|Lost to Follow-up|1|||
126002819|NCT03251378|453301786|FG003|Overall Study|Lost to Follow-up|3|||
126002820|NCT03251378|453301787|FG004|Overall Study|Lost to Follow-up|0|||
126002821|NCT03251378|453301788|FG005|Overall Study|Lost to Follow-up|0|||
126002822|NCT03251378|453301789|FG006|Overall Study|Lost to Follow-up|0|||
126002823|NCT03251378|453301783|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
126002824|NCT03251378|453301784|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
126002825|NCT03251378|453301785|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
126002826|NCT03251378|453301786|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
126002827|NCT03251378|453301787|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
126002828|NCT03251378|453301788|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
126002829|NCT03251378|453301789|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
126002830|NCT03251378|453301783|FG000|Overall Study|Progressive disease|2|||
126002831|NCT03251378|453301784|FG001|Overall Study|Progressive disease|0|||
126002832|NCT03251378|453301785|FG002|Overall Study|Progressive disease|0|||
126002833|NCT03251378|453301786|FG003|Overall Study|Progressive disease|1|||
126002834|NCT03251378|453301787|FG004|Overall Study|Progressive disease|0|||
126002835|NCT03251378|453301788|FG005|Overall Study|Progressive disease|0|||
126002836|NCT03251378|453301789|FG006|Overall Study|Progressive disease|0|||
126002837|NCT03251378|453301783|FG000|Overall Study|Physician Decision|0|||
126002838|NCT03251378|453301784|FG001|Overall Study|Physician Decision|2|||
126002839|NCT03251378|453301785|FG002|Overall Study|Physician Decision|0|||
126002840|NCT03251378|453301786|FG003|Overall Study|Physician Decision|0|||
126002841|NCT03251378|453301787|FG004|Overall Study|Physician Decision|0|||
126002842|NCT03251378|453301788|FG005|Overall Study|Physician Decision|0|||
126002843|NCT03251378|453301789|FG006|Overall Study|Physician Decision|0|||
126002844|NCT03251378|453301783|FG000|Overall Study|Other|2|||
126002845|NCT03251378|453301784|FG001|Overall Study|Other|3|||
126002846|NCT03251378|453301785|FG002|Overall Study|Other|2|||
126002847|NCT03251378|453301786|FG003|Overall Study|Other|0|||
126002848|NCT03251378|453301787|FG004|Overall Study|Other|1|||
126002849|NCT03251378|453301788|FG005|Overall Study|Other|1|||
126002850|NCT03251378|453301789|FG006|Overall Study|Other|1|||
126002851|NCT03251378|453301783|FG000|Overall Study|Other|0|||
126002852|NCT03251378|453301784|FG001|Overall Study|Other|0|||
126002853|NCT03251378|453301785|FG002|Overall Study|Other|0|||
126002854|NCT03251378|453301786|FG003|Overall Study|Other|4|||
126002855|NCT03251378|453301787|FG004|Overall Study|Other|13|||
126002856|NCT03251378|453301788|FG005|Overall Study|Other|0|||
126002857|NCT03251378|453301789|FG006|Overall Study|Other|0|||
126002858|NCT04739423|453301794|FG000|Overall Study|Protocol Violation|0|||
126002859|NCT04739423|453301795|FG001|Overall Study|Protocol Violation|1|||
126002860|NCT04739423|453301796|FG002|Overall Study|Protocol Violation|0|||
126002861|NCT04739423|453301797|FG003|Overall Study|Protocol Violation|0|||
126002862|NCT04739423|453301798|FG004|Overall Study|Protocol Violation|0|||
126002863|NCT04739423|453301799|FG005|Overall Study|Protocol Violation|0|||
126002864|NCT04739423|453301794|FG000|Overall Study|Adverse Event|0|||
126002865|NCT04739423|453301795|FG001|Overall Study|Adverse Event|0|||
126002866|NCT04739423|453301796|FG002|Overall Study|Adverse Event|1|||
126002867|NCT04739423|453301797|FG003|Overall Study|Adverse Event|0|||
126002868|NCT04739423|453301798|FG004|Overall Study|Adverse Event|1|||
126002869|NCT04739423|453301799|FG005|Overall Study|Adverse Event|0|||
126002870|NCT04739423|453301794|FG000|Overall Study|Withdrawal by Subject|0|||
126002871|NCT04739423|453301795|FG001|Overall Study|Withdrawal by Subject|0|||
126002872|NCT04739423|453301796|FG002|Overall Study|Withdrawal by Subject|0|||
126002873|NCT04739423|453301797|FG003|Overall Study|Withdrawal by Subject|0|||
126002874|NCT04739423|453301798|FG004|Overall Study|Withdrawal by Subject|0|||
126002875|NCT04739423|453301799|FG005|Overall Study|Withdrawal by Subject|1|||
126002876|NCT01007552|453301800|FG000|Overall Study|Withdrawal by Subject|1|||
126002877|NCT04482855|453301801|FG000|Overall Study|Lost to Follow-up|1|||
126002878|NCT04482855|453301802|FG001|Overall Study|Lost to Follow-up|0|||
126002879|NCT04482855|453301801|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
126002880|NCT04482855|453301802|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
126002881|NCT04482855|453301801|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
126002882|NCT04482855|453301802|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
126002883|NCT03212365|453301804|FG000|Overall Study|Discharged prior to Xa level|12|||
126002884|NCT03212365|453301805|FG001|Overall Study|Discharged prior to Xa level|8|||
126002885|NCT03212365|453301804|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
126002886|NCT03212365|453301805|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
126002887|NCT03212365|453301804|FG000|Overall Study|Refused study medication|3|||
126002888|NCT03212365|453301805|FG001|Overall Study|Refused study medication|0|||
126002889|NCT03212365|453301804|FG000|Overall Study|Initiated heparin infusion on floor|1|||
126002890|NCT03212365|453301805|FG001|Overall Study|Initiated heparin infusion on floor|1|||
126002891|NCT03212365|453301804|FG000|Overall Study|Unexpected return to OR|1|||
126002892|NCT03212365|453301805|FG001|Overall Study|Unexpected return to OR|1|||
126002893|NCT03212365|453301804|FG000|Overall Study|Medication distribution error|1|||
126002894|NCT03212365|453301805|FG001|Overall Study|Medication distribution error|0|||
126002895|NCT03212365|453301804|FG000|Overall Study|Required epidural placement|1|||
126002896|NCT03212365|453301805|FG001|Overall Study|Required epidural placement|0|||
126002897|NCT03212365|453301804|FG000|Overall Study|Withdrawal by Subject|0|||
126002898|NCT03212365|453301805|FG001|Overall Study|Withdrawal by Subject|1|||
126002899|NCT03212365|453301804|FG000|Overall Study|developed acute renal failure|0|||
126002900|NCT03212365|453301805|FG001|Overall Study|developed acute renal failure|1|||
126002901|NCT00429793|453301817|FG000|Overall Study|Improper pre-protocol treatment|3|||
126002902|NCT00429793|453301817|FG000|Overall Study|Required test not done|1|||
126002903|NCT00429793|453301817|FG000|Overall Study|Never treated|1|||
126002904|NCT00429793|453301817|FG000|Overall Study|Non-measurable|1|||
126002905|NCT00097370|453301818|FG000|Stage 1|Adverse Event|3|||
126002906|NCT00097370|453301818|FG000|Stage 1|Withdrawal by Subject|1|||
126002907|NCT00097370|453301818|FG000|Stage 1|Lack of Efficacy|2|||
126002908|NCT00097370|453301818|FG000|Stage 2|Adverse Event|5|||
126002909|NCT00097370|453301818|FG000|Stage 2|Withdrawal by Subject|1|||
126002910|NCT00097370|453301818|FG000|Stage 2|Lack of Efficacy|3|||
126002911|NCT00097370|453301818|FG000|Stage 2|Pregnancy|1|||
126002912|NCT00097370|453301818|FG000|Stage 2|Sponsor Terminated Study|2|||
126002913|NCT00097370|453301818|FG000|Stage 2|Lost to Follow-up|1|||
126002914|NCT00097370|453301818|FG000|Stage 3|Adverse Event|2|||
126002915|NCT00097370|453301818|FG000|Stage 3|Withdrawal by Subject|3|||
126002916|NCT00097370|453301818|FG000|Stage 3|Lack of Efficacy|1|||
126002917|NCT00097370|453301818|FG000|Stage 3|Sponsor Terminated Study|52|||
126002918|NCT00097370|453301818|FG000|Stage 3|Lost to Follow-up|1|||
126002919|NCT02419755|453301820|FG000|Overall Study|Death|1|||
126002920|NCT02419755|453301821|FG001|Overall Study|Death|3|||
126002921|NCT02419755|453301820|FG000|Overall Study|Relapse|0|||
126002922|NCT02419755|453301821|FG001|Overall Study|Relapse|1|||
126002923|NCT02419755|453301820|FG000|Overall Study|Ineligible|1|||
126002924|NCT02419755|453301821|FG001|Overall Study|Ineligible|0|||
126002925|NCT02419755|453301820|FG000|Overall Study|Withdrawal by Subject|1|||
126002926|NCT02419755|453301821|FG001|Overall Study|Withdrawal by Subject|0|||
126002927|NCT02337361|453301822|FG000|3-month Follow-up|Lost to Follow-up|19|||
126002928|NCT02337361|453301823|FG001|3-month Follow-up|Lost to Follow-up|14|||
126002929|NCT02337361|453301822|FG000|6-month Follow-up|Lost to Follow-up|2|||
126002930|NCT02337361|453301823|FG001|6-month Follow-up|Lost to Follow-up|4|||
126002931|NCT02427646|453301824|FG000|Overall Study|Lack of Efficacy|2|||
126002932|NCT02427646|453301825|FG001|Overall Study|Lack of Efficacy|3|||
126002933|NCT02427646|453301824|FG000|Overall Study|Physician Decision|1|||
126002934|NCT02427646|453301825|FG001|Overall Study|Physician Decision|4|||
126002935|NCT02427646|453301824|FG000|Overall Study|Protocol Violation|3|||
126002936|NCT02427646|453301825|FG001|Overall Study|Protocol Violation|3|||
126002937|NCT02427646|453301824|FG000|Overall Study|Bothersome hand weakness|2|||
126002938|NCT02427646|453301825|FG001|Overall Study|Bothersome hand weakness|4|||
126002939|NCT01101542|453301826|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
126002940|NCT01101542|453301826|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
126002941|NCT01101542|453301826|FG000|Year 4 Surveillance Period|Other|287|||
126002942|NCT01101542|453301826|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
126002943|NCT01101542|453301826|FG000|Year 5 Surveillance Period|Pregnancy|1|||
126002944|NCT01101542|453301826|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
126002945|NCT01101542|453301826|FG000|Year 6 Surveillance Period|Pregnancy|1|||
126002946|NCT01101542|453301826|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
126002947|NCT00901485|453301827|FG000|Overall Study|Lack of Efficacy|0|||
126002948|NCT00901485|453301828|FG001|Overall Study|Lack of Efficacy|2|||
126002949|NCT00901485|453301827|FG000|Overall Study|Withdrawal by Subject|1|||
126002950|NCT00901485|453301828|FG001|Overall Study|Withdrawal by Subject|2|||
126002951|NCT01929993|453303916|FG000|Overall Study|Protocol Violation|4|||
126002952|NCT01929993|453303917|FG001|Overall Study|Protocol Violation|6|||
126002953|NCT01929993|453303916|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
126002954|NCT01929993|453303917|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
126002955|NCT01256476|453303918|FG000|Overall Study|Adverse Event|2|||
126002956|NCT01256476|453303919|FG001|Overall Study|Adverse Event|1|||
126002957|NCT01256476|453303918|FG000|Overall Study|Withdrawal by Subject|2|||
126002958|NCT01256476|453303919|FG001|Overall Study|Withdrawal by Subject|1|||
126002959|NCT01256476|453303918|FG000|Overall Study|Lost to Follow-up|1|||
126002960|NCT01256476|453303919|FG001|Overall Study|Lost to Follow-up|2|||
126002961|NCT01256476|453303918|FG000|Overall Study|Persistent ALT or AST elevation|1|||
126002962|NCT01256476|453303919|FG001|Overall Study|Persistent ALT or AST elevation|0|||
126002963|NCT01256476|453303918|FG000|Overall Study|Physician Decision|0|||
126002964|NCT01256476|453303919|FG001|Overall Study|Physician Decision|1|||
126002965|NCT01256476|453303918|FG000|Overall Study|Subject non-compliance|0|||
126002966|NCT01256476|453303919|FG001|Overall Study|Subject non-compliance|1|||
126002967|NCT01256476|453303918|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
126002968|NCT01256476|453303919|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
126002969|NCT00163215|453303923|FG000|Overall Study|Lack of Efficacy|3|||
126002970|NCT00163215|453303923|FG000|Overall Study|Withdrawal by Subject|5|||
126002971|NCT00163215|453303923|FG000|Overall Study|Other|7|||
126002972|NCT04034238|453303924|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
126002973|NCT04034238|453303925|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126002974|NCT04034238|453303926|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126002975|NCT04034238|453303927|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126002976|NCT04034238|453303924|FG000|Dose Escalation Phase|Screen failures|0|||
126002977|NCT04034238|453303925|FG001|Dose Escalation Phase|Screen failures|0|||
126002978|NCT04034238|453303926|FG002|Dose Escalation Phase|Screen failures|0|||
126002979|NCT04034238|453303927|FG003|Dose Escalation Phase|Screen failures|2|||
126002980|NCT04034238|453303924|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
126002981|NCT04034238|453303925|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
126002982|NCT04034238|453303926|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
126002983|NCT04034238|453303927|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
126002984|NCT04034238|453303924|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
126002985|NCT04034238|453303925|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
126002986|NCT04034238|453303926|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
126002987|NCT04034238|453303927|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
126002988|NCT02892409|453303928|FG000|Overall Study|Adverse Event|1|||
126002989|NCT02892409|453303929|FG001|Overall Study|Adverse Event|0|||
126002990|NCT02892409|453303928|FG000|Overall Study|Withdrawal by Subject|2|||
126002991|NCT02892409|453303929|FG001|Overall Study|Withdrawal by Subject|1|||
126002992|NCT01345292|453303932|FG000|Overall Study|Withdrawal by Subject|2|||
126002993|NCT01345292|453303933|FG001|Overall Study|Withdrawal by Subject|0|||
126337709|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
126337710|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
126002994|NCT01345292|453303934|FG002|Overall Study|Withdrawal by Subject|1|||
126337711|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
126002995|NCT04822298|453303935|FG000|Overall Study|Death|3|||
126002996|NCT01033643|453303936|FG000|Overall Study|Withdrew Consent|0|||
126002997|NCT01033643|453303937|FG001|Overall Study|Withdrew Consent|3|||
126002998|NCT01033643|453303938|FG002|Overall Study|Withdrew Consent|0|||
126002999|NCT01033643|453303939|FG003|Overall Study|Withdrew Consent|0|||
126003000|NCT01033643|453303940|FG004|Overall Study|Withdrew Consent|0|||
126003001|NCT01033643|453303941|FG005|Overall Study|Withdrew Consent|1|||
126003002|NCT00852475|453303946|FG000|Overall Study|Lost to Follow-up|3|||
126003003|NCT00852475|453303947|FG001|Overall Study|Lost to Follow-up|4|||
126003004|NCT02373813|453303948|FG000|Run-In Period|Other, Not Specified|5|||
126003005|NCT02373813|453303949|FG001|Run-In Period|Other, Not Specified|0|||
126003006|NCT02373813|453303950|FG002|Run-In Period|Other, Not Specified|0|||
126003007|NCT02373813|453303951|FG003|Run-In Period|Other, Not Specified|0|||
126003008|NCT02373813|453303948|FG000|Run-In Period|Withdrawal by Subject|16|||
126003009|NCT02373813|453303949|FG001|Run-In Period|Withdrawal by Subject|0|||
126003010|NCT02373813|453303950|FG002|Run-In Period|Withdrawal by Subject|0|||
126003011|NCT02373813|453303951|FG003|Run-In Period|Withdrawal by Subject|0|||
126003012|NCT02373813|453303948|FG000|Run-In Period|Decision by Sponsor|11|||
126003013|NCT02373813|453303949|FG001|Run-In Period|Decision by Sponsor|0|||
126003014|NCT02373813|453303950|FG002|Run-In Period|Decision by Sponsor|0|||
126003015|NCT02373813|453303951|FG003|Run-In Period|Decision by Sponsor|0|||
126003016|NCT02373813|453303948|FG000|Run-In Period|Protocol Violation|75|||
126003017|NCT02373813|453303949|FG001|Run-In Period|Protocol Violation|0|||
126003018|NCT02373813|453303950|FG002|Run-In Period|Protocol Violation|0|||
126003019|NCT02373813|453303951|FG003|Run-In Period|Protocol Violation|0|||
126003020|NCT02373813|453303948|FG000|Run-In Period|Lost to Follow-up|2|||
126003021|NCT02373813|453303949|FG001|Run-In Period|Lost to Follow-up|0|||
126003022|NCT02373813|453303950|FG002|Run-In Period|Lost to Follow-up|0|||
126003023|NCT02373813|453303951|FG003|Run-In Period|Lost to Follow-up|0|||
126003024|NCT02373813|453303948|FG000|Run-In Period|Adverse Event|3|||
126003025|NCT02373813|453303949|FG001|Run-In Period|Adverse Event|0|||
126003026|NCT02373813|453303950|FG002|Run-In Period|Adverse Event|0|||
126003027|NCT02373813|453303951|FG003|Run-In Period|Adverse Event|0|||
126003028|NCT02373813|453303948|FG000|Run-In Period|Noncompliance|1|||
126003029|NCT02373813|453303949|FG001|Run-In Period|Noncompliance|0|||
126003030|NCT02373813|453303950|FG002|Run-In Period|Noncompliance|0|||
126003031|NCT02373813|453303951|FG003|Run-In Period|Noncompliance|0|||
126003032|NCT02373813|453303948|FG000|Run-In Period|Ineligibility Determined|3|||
126003033|NCT02373813|453303949|FG001|Run-In Period|Ineligibility Determined|0|||
126003034|NCT02373813|453303950|FG002|Run-In Period|Ineligibility Determined|0|||
126003035|NCT02373813|453303951|FG003|Run-In Period|Ineligibility Determined|0|||
126003036|NCT02373813|453303948|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
126003037|NCT02373813|453303949|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
126003038|NCT02373813|453303950|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
126003039|NCT02373813|453303951|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
126003040|NCT02373813|453303948|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126003041|NCT02373813|453303949|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
126003042|NCT02373813|453303950|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
126003043|NCT02373813|453303951|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
126003044|NCT02373813|453303948|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126003045|NCT02373813|453303949|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
126003046|NCT02373813|453303950|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
126337712|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
126337713|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
126337714|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
126337715|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
126337716|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
126337717|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
126337718|NCT01573000|454532919|FG000|Crossover Phase|Lack of Efficacy|0|||
126337719|NCT01573000|454532920|FG001|Crossover Phase|Lack of Efficacy|13|||
126337720|NCT01573000|454532919|FG000|Crossover Phase|Lost to Follow-up|0|||
126337721|NCT01573000|454532920|FG001|Crossover Phase|Lost to Follow-up|2|||
126337722|NCT01573000|454532919|FG000|Crossover Phase|Death|0|||
126337723|NCT01573000|454532920|FG001|Crossover Phase|Death|3|||
126337724|NCT01573000|454532919|FG000|Long-Term Follow-Up|Death|3|||
126337725|NCT01573000|454532920|FG001|Long-Term Follow-Up|Death|0|||
126337726|NCT01573000|454532919|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
126337727|NCT01573000|454532920|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
126337728|NCT03353792|454532921|FG000|Overall Study|Lost to Follow-up|1|||
126003047|NCT02373813|453303951|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
126003048|NCT02373813|453303948|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126003049|NCT02373813|453303949|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
126003050|NCT02373813|453303950|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
126003051|NCT02373813|453303951|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
126003052|NCT02403674|453303952|FG000|Base Study|Death|1|||
126003053|NCT02403674|453303953|FG001|Base Study|Death|4|||
126003054|NCT02403674|453303952|FG000|Base Study|Adverse Event|11|||
126003055|NCT02403674|453303953|FG001|Base Study|Adverse Event|26|||
126003056|NCT02403674|453303952|FG000|Base Study|Lack of Efficacy|31|||
126003057|NCT02403674|453303953|FG001|Base Study|Lack of Efficacy|23|||
126003058|NCT02403674|453303952|FG000|Base Study|Lost to Follow-up|6|||
126003059|NCT02403674|453303953|FG001|Base Study|Lost to Follow-up|8|||
126003060|NCT02403674|453303952|FG000|Base Study|Withdrawal by Subject|10|||
126337729|NCT03353792|454532922|FG001|Overall Study|Lost to Follow-up|0|||
126003061|NCT02403674|453303953|FG001|Base Study|Withdrawal by Subject|17|||
126003062|NCT02403674|453303952|FG000|Base Study|Physician Decision|2|||
126003063|NCT02403674|453303953|FG001|Base Study|Physician Decision|2|||
126003064|NCT02403674|453303952|FG000|Base Study|Pregnancy|2|||
126003065|NCT02403674|453303953|FG001|Base Study|Pregnancy|2|||
126003066|NCT02403674|453303952|FG000|Base Study|Protocol Violation|8|||
126003067|NCT02403674|453303953|FG001|Base Study|Protocol Violation|4|||
126003068|NCT02403674|453303952|FG000|Base Study|Non-Compliance with study drug|1|||
126003069|NCT02403674|453303953|FG001|Base Study|Non-Compliance with study drug|4|||
126003070|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
126003071|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
126003072|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
126003073|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
126003074|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
126003075|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
126003076|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
126003077|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
126003078|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
126003079|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
126003080|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
126003081|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
126003082|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Death|1|||
126003083|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Death|0|||
126003084|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
126003085|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
126003086|NCT02403674|453303952|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
126003087|NCT02403674|453303953|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
126003088|NCT02403674|453303952|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
126003089|NCT02403674|453303953|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
126003090|NCT02403674|453303952|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
126003091|NCT02403674|453303953|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
126003092|NCT02403674|453303952|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
126003093|NCT02403674|453303953|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
126003094|NCT02403674|453303952|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
126003095|NCT02403674|453303953|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
126003096|NCT02403674|453303952|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
126003097|NCT02403674|453303953|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
126003098|NCT02403674|453303952|FG000|Study Extension 2 (Open-Label)|Death|2|||
126003099|NCT02403674|453303953|FG001|Study Extension 2 (Open-Label)|Death|2|||
126003100|NCT02403674|453303952|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
126003101|NCT02403674|453303953|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
126003102|NCT02403674|453303952|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
126003103|NCT02403674|453303953|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
126003104|NCT02403674|453303952|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
126003105|NCT02403674|453303953|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
126003106|NCT02403674|453303952|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
126003107|NCT02403674|453303953|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
126003108|NCT02403674|453303952|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
126003109|NCT02403674|453303953|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
126003110|NCT02403674|453303952|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
126003111|NCT02403674|453303953|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
126003112|NCT02403674|453303952|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
126003113|NCT02403674|453303953|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
126003114|NCT03738241|453303958|FG000|Overall Study|Withdrawal by Subject|0|||
126003115|NCT03738241|453303959|FG001|Overall Study|Withdrawal by Subject|0|||
126003116|NCT03738241|453303960|FG002|Overall Study|Withdrawal by Subject|0|||
126003117|NCT03738241|453303961|FG003|Overall Study|Withdrawal by Subject|0|||
126003118|NCT03738241|453303962|FG004|Overall Study|Withdrawal by Subject|0|||
126003119|NCT03738241|453303963|FG005|Overall Study|Withdrawal by Subject|0|||
126003120|NCT03738241|453303964|FG006|Overall Study|Withdrawal by Subject|0|||
126003121|NCT03738241|453303965|FG007|Overall Study|Withdrawal by Subject|0|||
126003122|NCT03738241|453303966|FG008|Overall Study|Withdrawal by Subject|0|||
126003123|NCT03738241|453303967|FG009|Overall Study|Withdrawal by Subject|1|||
126003124|NCT03738241|453303958|FG000|Overall Study|Physician Decision|0|||
126003125|NCT03738241|453303959|FG001|Overall Study|Physician Decision|0|||
126003126|NCT03738241|453303960|FG002|Overall Study|Physician Decision|0|||
126003127|NCT03738241|453303961|FG003|Overall Study|Physician Decision|0|||
126003128|NCT03738241|453303962|FG004|Overall Study|Physician Decision|0|||
126003129|NCT03738241|453303963|FG005|Overall Study|Physician Decision|0|||
126003130|NCT03738241|453303964|FG006|Overall Study|Physician Decision|0|||
126003131|NCT03738241|453303965|FG007|Overall Study|Physician Decision|0|||
126003132|NCT03738241|453303966|FG008|Overall Study|Physician Decision|1|||
126003133|NCT03738241|453303967|FG009|Overall Study|Physician Decision|0|||
126003134|NCT03738241|453303958|FG000|Overall Study|Adverse Event|1|||
126003135|NCT03738241|453303959|FG001|Overall Study|Adverse Event|0|||
126003136|NCT03738241|453303960|FG002|Overall Study|Adverse Event|0|||
126003137|NCT03738241|453303961|FG003|Overall Study|Adverse Event|0|||
126003138|NCT03738241|453303962|FG004|Overall Study|Adverse Event|0|||
126003139|NCT03738241|453303963|FG005|Overall Study|Adverse Event|0|||
126003140|NCT03738241|453303964|FG006|Overall Study|Adverse Event|0|||
126003141|NCT03738241|453303965|FG007|Overall Study|Adverse Event|0|||
126003142|NCT03738241|453303966|FG008|Overall Study|Adverse Event|0|||
126003143|NCT03738241|453303967|FG009|Overall Study|Adverse Event|0|||
126003144|NCT02788656|453303968|FG000|Overall Study|Withdrawal by Subject|1|||
126003145|NCT02788656|453303969|FG001|Overall Study|Withdrawal by Subject|0|||
126003146|NCT03169361|453303970|FG000|Overall Study|Protocol Violation|32|||
126003147|NCT00088465|453303971|FG000|Overall Study|Withdrawal by Subject|290|||
126003148|NCT00088465|453303971|FG000|Overall Study|Adverse Event|77|||
126003149|NCT00088465|453303971|FG000|Overall Study|Lost to Follow-up|57|||
126003150|NCT00088465|453303971|FG000|Overall Study|Physician Decision|45|||
126003151|NCT00088465|453303971|FG000|Overall Study|Sponsor Decision|37|||
126003152|NCT00088465|453303971|FG000|Overall Study|Lack of Efficacy|27|||
126003153|NCT00088465|453303971|FG000|Overall Study|Protocol Violation|17|||
126003154|NCT00088465|453303971|FG000|Overall Study|Death|11|||
126003155|NCT00180674|453303975|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
126003156|NCT00180674|453303975|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
126003157|NCT03606460|453303976|FG000|Overall Study|Lost to Follow-up|1|||
126003158|NCT03606460|453303977|FG001|Overall Study|Lost to Follow-up|8|||
126003159|NCT04170023|453303978|FG000|LTE Period|Withdrawal by Subject|1|||
126003160|NCT04170023|453303979|FG001|LTE Period|Withdrawal by Subject|0|||
126003161|NCT04170023|453303980|FG002|LTE Period|Withdrawal by Subject|0|||
126003162|NCT04170023|453303978|FG000|LTE Period|Study Termination|11|||
126003163|NCT04170023|453303979|FG001|LTE Period|Study Termination|11|||
126003164|NCT04170023|453303980|FG002|LTE Period|Study Termination|5|||
126003165|NCT03836664|453303981|FG000|Overall Study|Didn't complete forms and lost drug|3|||
126003166|NCT03836664|453303982|FG001|Overall Study|Didn't complete forms and lost drug|3|||
126003167|NCT01427907|453303983|FG000|Overall Study|Withdrawal by Subject|3|||
126337730|NCT03353792|454532921|FG000|Overall Study|Participant Unable to Manage Device|1|||
126337731|NCT03353792|454532922|FG001|Overall Study|Participant Unable to Manage Device|0|||
126337732|NCT03342001|454532924|FG000|Overall Study|Adverse Event|1|||
126337733|NCT03342001|454532924|FG000|Overall Study|Lost to Follow-up|1|||
126337734|NCT04161391|454532928|FG000|Overall Study|Adverse Event|0|||
126337735|NCT04161391|454532929|FG001|Overall Study|Adverse Event|1|||
126337736|NCT04161391|454532930|FG002|Overall Study|Adverse Event|0|||
126337737|NCT04161391|454532931|FG003|Overall Study|Adverse Event|1|||
126003168|NCT01427907|453303984|FG001|Overall Study|Withdrawal by Subject|4|||
126003169|NCT04003974|453303986|FG000|Overall Study|Missing|1|||
126003170|NCT04003974|453303987|FG001|Overall Study|Missing|0|||
126003171|NCT04003974|453303986|FG000|Overall Study|Withdrawal by Subject|0|||
126003172|NCT04003974|453303987|FG001|Overall Study|Withdrawal by Subject|2|||
126003173|NCT04296942|453303988|FG000|Overall Study|Study closure by sponsor|1|||
126003174|NCT04296942|453303989|FG001|Overall Study|Study closure by sponsor|0|||
126003175|NCT04296942|453303990|FG002|Overall Study|Study closure by sponsor|0|||
126003176|NCT02240680|453303991|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
126003177|NCT02240680|453303992|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
126003178|NCT02240680|453303993|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
126003179|NCT02240680|453303994|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
126003180|NCT02240680|453303991|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
126003181|NCT02240680|453303992|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
126003182|NCT02240680|453303993|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
126003183|NCT02240680|453303994|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
126003184|NCT02240680|453303991|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
126003185|NCT02240680|453303992|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
126003186|NCT02240680|453303993|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
126003187|NCT02240680|453303994|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
126003188|NCT02240680|453303991|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
126003189|NCT02240680|453303992|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
126337738|NCT04161391|454532932|FG004|Overall Study|Adverse Event|0|||
126337739|NCT04161391|454532933|FG005|Overall Study|Adverse Event|0|||
126003190|NCT02240680|453303993|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
126003191|NCT02240680|453303994|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
126003192|NCT02240680|453303991|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
126003193|NCT02240680|453303992|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
126003194|NCT02240680|453303993|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
126003195|NCT02240680|453303994|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
126003196|NCT02240680|453303991|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
126337740|NCT04161391|454532934|FG006|Overall Study|Adverse Event|0|||
126209466|NCT03110107|454055397|FG004|Treatment Period|Death|0|||
126003197|NCT02240680|453303992|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
126003198|NCT02240680|453303993|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
126003199|NCT02240680|453303994|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
126003200|NCT02240680|453303991|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
126003201|NCT02240680|453303992|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
126003202|NCT02240680|453303993|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
126003203|NCT02240680|453303994|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
126003204|NCT02240680|453303991|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
126003205|NCT02240680|453303992|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
126003206|NCT02240680|453303993|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
126003207|NCT02240680|453303994|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
126003208|NCT03704298|453304000|FG000|Overall Study|Death|3|||
126003209|NCT03704298|453304001|FG001|Overall Study|Death|1|||
126003210|NCT03704298|453304002|FG002|Overall Study|Death|1|||
126003211|NCT03704298|453304003|FG003|Overall Study|Death|0|||
126003212|NCT03704298|453304000|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
126003213|NCT03704298|453304001|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
126003214|NCT03704298|453304002|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
126003215|NCT03704298|453304003|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
126003216|NCT03704298|453304000|FG000|Overall Study|Withdrawal by Subject|1|||
126003217|NCT03704298|453304001|FG001|Overall Study|Withdrawal by Subject|0|||
126003218|NCT03704298|453304002|FG002|Overall Study|Withdrawal by Subject|0|||
126003219|NCT03704298|453304003|FG003|Overall Study|Withdrawal by Subject|0|||
126003220|NCT03704298|453304000|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
126003221|NCT03704298|453304001|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
126003222|NCT03704298|453304002|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
126003223|NCT03704298|453304003|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
126003224|NCT01027871|453304004|FG000|Overall Study|Physician Decision|1|||
126003225|NCT01027871|453304005|FG001|Overall Study|Physician Decision|5|||
126003226|NCT01027871|453304006|FG002|Overall Study|Physician Decision|0|||
126003227|NCT01027871|453304004|FG000|Overall Study|Protocol Violation|0|||
126003228|NCT01027871|453304005|FG001|Overall Study|Protocol Violation|2|||
126003229|NCT01027871|453304006|FG002|Overall Study|Protocol Violation|2|||
126003230|NCT01027871|453304004|FG000|Overall Study|Withdrawal by Subject|1|||
126003231|NCT01027871|453304005|FG001|Overall Study|Withdrawal by Subject|2|||
126003232|NCT01027871|453304006|FG002|Overall Study|Withdrawal by Subject|2|||
126003233|NCT01027871|453304004|FG000|Overall Study|Adverse Event|0|||
126003234|NCT01027871|453304005|FG001|Overall Study|Adverse Event|2|||
126003235|NCT01027871|453304006|FG002|Overall Study|Adverse Event|2|||
126003236|NCT01027871|453304004|FG000|Overall Study|Sponsor Decision|0|||
126003237|NCT01027871|453304005|FG001|Overall Study|Sponsor Decision|2|||
126003238|NCT01027871|453304006|FG002|Overall Study|Sponsor Decision|0|||
126003239|NCT01027871|453304004|FG000|Overall Study|Discontinued Prior to Treatment|0|||
126003240|NCT01027871|453304005|FG001|Overall Study|Discontinued Prior to Treatment|0|||
126003241|NCT01027871|453304006|FG002|Overall Study|Discontinued Prior to Treatment|1|||
126003242|NCT01414166|453304007|FG000|Overall Study|Adverse Event|10|||
126003243|NCT01414166|453304008|FG001|Overall Study|Adverse Event|2|||
126003244|NCT01414166|453304007|FG000|Overall Study|Lost to Follow-up|4|||
126003245|NCT01414166|453304008|FG001|Overall Study|Lost to Follow-up|1|||
126003246|NCT01414166|453304007|FG000|Overall Study|Non-compliance with study drug|2|||
126003247|NCT01414166|453304008|FG001|Overall Study|Non-compliance with study drug|0|||
126003248|NCT01414166|453304007|FG000|Overall Study|Physician Decision|2|||
126003249|NCT01414166|453304008|FG001|Overall Study|Physician Decision|0|||
126003250|NCT01414166|453304007|FG000|Overall Study|Protocol Violation|2|||
126003251|NCT01414166|453304008|FG001|Overall Study|Protocol Violation|0|||
126003252|NCT01414166|453304007|FG000|Overall Study|Study terminated by Sponsor|68|||
126003253|NCT01414166|453304008|FG001|Overall Study|Study terminated by Sponsor|75|||
126003254|NCT01414166|453304007|FG000|Overall Study|Withdrawal by Subject|3|||
126003255|NCT01414166|453304008|FG001|Overall Study|Withdrawal by Subject|5|||
126003256|NCT03782727|453304009|FG000|Overall Study|Lost to Follow-up|32|||
126003257|NCT04159896|453304015|FG000|Overall Study|Lack of Efficacy|7|||
126003258|NCT04159896|453304015|FG000|Overall Study|Withdrawal by Subject|1|||
126003259|NCT04159896|453304015|FG000|Overall Study|Adverse Event|1|||
126003260|NCT04159896|453304015|FG000|Overall Study|A transient ischaemic attack|1|||
126003261|NCT02084082|453304016|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
126003262|NCT02084082|453304017|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
126003263|NCT02084082|453304018|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
126003264|NCT02084082|453304019|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
126003265|NCT02084082|453304016|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126003266|NCT02084082|453304017|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126003267|NCT02084082|453304018|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126003268|NCT02084082|453304019|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
126003269|NCT05705167|453304020|FG000|Overall Study|Randomised but not Treated|0|||
126003270|NCT05705167|453304021|FG001|Overall Study|Randomised but not Treated|2|||
126003271|NCT05705167|453304022|FG002|Overall Study|Randomised but not Treated|0|||
126337741|NCT04161391|454532935|FG007|Overall Study|Adverse Event|3|||
126337742|NCT04161391|454532936|FG008|Overall Study|Adverse Event|0|||
126003272|NCT05705167|453304023|FG003|Overall Study|Randomised but not Treated|7|||
126003273|NCT05705167|453304024|FG004|Overall Study|Randomised but not Treated|0|||
126003274|NCT05705167|453304025|FG005|Overall Study|Randomised but not Treated|0|||
126003275|NCT05705167|453304026|FG006|Overall Study|Randomised but not Treated|0|||
126003276|NCT05705167|453304020|FG000|Overall Study|Death|0|||
126003277|NCT05705167|453304021|FG001|Overall Study|Death|0|||
126003278|NCT05705167|453304022|FG002|Overall Study|Death|3|||
126003279|NCT05705167|453304023|FG003|Overall Study|Death|0|||
126003280|NCT05705167|453304024|FG004|Overall Study|Death|1|||
126003281|NCT05705167|453304025|FG005|Overall Study|Death|1|||
126003282|NCT05705167|453304026|FG006|Overall Study|Death|1|||
126003283|NCT05705167|453304020|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
126003284|NCT05705167|453304021|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
126003285|NCT05705167|453304022|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
126003286|NCT05705167|453304023|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
126003287|NCT05705167|453304024|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
126003288|NCT05705167|453304025|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
126003289|NCT05705167|453304026|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
126003290|NCT04736056|453304027|FG000|Overall Study|Death|0|||
126003291|NCT04736056|453304028|FG001|Overall Study|Death|0|||
126003292|NCT04736056|453304029|FG002|Overall Study|Death|0|||
126003293|NCT04736056|453304030|FG003|Overall Study|Death|1|||
126003294|NCT04736056|453304027|FG000|Overall Study|Lost to Follow-up|1|||
126003295|NCT04736056|453304028|FG001|Overall Study|Lost to Follow-up|0|||
126003296|NCT04736056|453304029|FG002|Overall Study|Lost to Follow-up|1|||
126003297|NCT04736056|453304030|FG003|Overall Study|Lost to Follow-up|1|||
126003298|NCT04736056|453304027|FG000|Overall Study|Withdrawal by Subject|2|||
126003299|NCT04736056|453304028|FG001|Overall Study|Withdrawal by Subject|0|||
126003300|NCT04736056|453304029|FG002|Overall Study|Withdrawal by Subject|0|||
126003301|NCT04736056|453304030|FG003|Overall Study|Withdrawal by Subject|0|||
126003302|NCT04736056|453304027|FG000|Overall Study|Physician Decision|1|||
126003303|NCT04736056|453304028|FG001|Overall Study|Physician Decision|0|||
126003304|NCT04736056|453304029|FG002|Overall Study|Physician Decision|1|||
126003305|NCT04736056|453304030|FG003|Overall Study|Physician Decision|0|||
126003306|NCT02099539|453304037|FG000|Overall Study|Progressive Disease|3|||
126003307|NCT02099539|453304038|FG001|Overall Study|Progressive Disease|2|||
126003308|NCT02099539|453304039|FG002|Overall Study|Progressive Disease|2|||
126003309|NCT02099539|453304040|FG003|Overall Study|Progressive Disease|1|||
126003310|NCT02099539|453304041|FG004|Overall Study|Progressive Disease|4|||
126003311|NCT02099539|453304042|FG005|Overall Study|Progressive Disease|2|||
126003312|NCT02099539|453304043|FG006|Overall Study|Progressive Disease|0|||
126003313|NCT02099539|453304037|FG000|Overall Study|Adverse Event|0|||
126003314|NCT02099539|453304038|FG001|Overall Study|Adverse Event|0|||
126003315|NCT02099539|453304039|FG002|Overall Study|Adverse Event|1|||
126003316|NCT02099539|453304040|FG003|Overall Study|Adverse Event|1|||
126003317|NCT02099539|453304041|FG004|Overall Study|Adverse Event|0|||
126003318|NCT02099539|453304042|FG005|Overall Study|Adverse Event|0|||
126003319|NCT02099539|453304043|FG006|Overall Study|Adverse Event|0|||
126003320|NCT02099539|453304037|FG000|Overall Study|Physician Decision|0|||
126003321|NCT02099539|453304038|FG001|Overall Study|Physician Decision|0|||
126003322|NCT02099539|453304039|FG002|Overall Study|Physician Decision|0|||
126003323|NCT02099539|453304040|FG003|Overall Study|Physician Decision|0|||
126003324|NCT02099539|453304041|FG004|Overall Study|Physician Decision|0|||
126003325|NCT02099539|453304042|FG005|Overall Study|Physician Decision|1|||
126003326|NCT02099539|453304043|FG006|Overall Study|Physician Decision|0|||
126003327|NCT02956967|453304045|FG000|Overall Study|Adverse Event|3|||
126003328|NCT02956967|453304045|FG000|Overall Study|Reason non-related to neutropenia|10|||
126337743|NCT04161391|454532928|FG000|Overall Study|Death|0|||
126003329|NCT02956967|453304045|FG000|Overall Study|Lost to Follow-up|5|||
126003330|NCT02956967|453304045|FG000|Overall Study|Missing|1|||
126003331|NCT02956967|453304045|FG000|Overall Study|Termination of Nivestim administration|29|||
126003332|NCT00819234|453304050|FG000|Overall Study|Withdrawal by Subject|8|||
126337744|NCT04161391|454532929|FG001|Overall Study|Death|0|||
126337745|NCT04161391|454532930|FG002|Overall Study|Death|0|||
126003333|NCT00819234|453304051|FG001|Overall Study|Withdrawal by Subject|13|||
126003334|NCT00819234|453304052|FG002|Overall Study|Withdrawal by Subject|6|||
126003335|NCT00819234|453304053|FG003|Overall Study|Withdrawal by Subject|3|||
126003336|NCT00819234|453304054|FG004|Overall Study|Withdrawal by Subject|0|||
126003337|NCT00819234|453304055|FG005|Overall Study|Withdrawal by Subject|4|||
126003338|NCT00819234|453304056|FG006|Overall Study|Withdrawal by Subject|4|||
126003339|NCT00819234|453304057|FG007|Overall Study|Withdrawal by Subject|8|||
126003340|NCT00819234|453304058|FG008|Overall Study|Withdrawal by Subject|5|||
126003341|NCT00819234|453304059|FG009|Overall Study|Withdrawal by Subject|3|||
126003342|NCT00819234|453304050|FG000|Overall Study|Adverse Event|0|||
126337746|NCT04161391|454532931|FG003|Overall Study|Death|0|||
126003343|NCT00819234|453304051|FG001|Overall Study|Adverse Event|0|||
126337747|NCT04161391|454532932|FG004|Overall Study|Death|0|||
126337748|NCT04161391|454532933|FG005|Overall Study|Death|0|||
126003344|NCT00819234|453304052|FG002|Overall Study|Adverse Event|1|||
126003345|NCT00819234|453304053|FG003|Overall Study|Adverse Event|0|||
126337749|NCT04161391|454532934|FG006|Overall Study|Death|0|||
126337750|NCT04161391|454532935|FG007|Overall Study|Death|1|||
126337751|NCT04161391|454532936|FG008|Overall Study|Death|0|||
126337752|NCT04161391|454532928|FG000|Overall Study|Physician Decision|0|||
126337753|NCT04161391|454532929|FG001|Overall Study|Physician Decision|0|||
126337754|NCT04161391|454532930|FG002|Overall Study|Physician Decision|1|||
126337755|NCT04161391|454532931|FG003|Overall Study|Physician Decision|2|||
126337756|NCT04161391|454532932|FG004|Overall Study|Physician Decision|0|||
126337757|NCT04161391|454532933|FG005|Overall Study|Physician Decision|0|||
126337758|NCT04161391|454532934|FG006|Overall Study|Physician Decision|2|||
126337759|NCT04161391|454532935|FG007|Overall Study|Physician Decision|0|||
126337760|NCT04161391|454532936|FG008|Overall Study|Physician Decision|0|||
126337761|NCT04161391|454532928|FG000|Overall Study|Progressive Disease|4|||
126337762|NCT04161391|454532929|FG001|Overall Study|Progressive Disease|3|||
126337763|NCT04161391|454532930|FG002|Overall Study|Progressive Disease|3|||
126337764|NCT04161391|454532931|FG003|Overall Study|Progressive Disease|5|||
126337765|NCT04161391|454532932|FG004|Overall Study|Progressive Disease|3|||
126003346|NCT00819234|453304054|FG004|Overall Study|Adverse Event|0|||
126003347|NCT00819234|453304055|FG005|Overall Study|Adverse Event|2|||
126003348|NCT00819234|453304056|FG006|Overall Study|Adverse Event|0|||
126003349|NCT00819234|453304057|FG007|Overall Study|Adverse Event|0|||
126003350|NCT00819234|453304058|FG008|Overall Study|Adverse Event|0|||
126003351|NCT00819234|453304059|FG009|Overall Study|Adverse Event|0|||
126003352|NCT00819234|453304050|FG000|Overall Study|Physician Decision|0|||
126003353|NCT00819234|453304051|FG001|Overall Study|Physician Decision|0|||
126003354|NCT00819234|453304052|FG002|Overall Study|Physician Decision|0|||
126003355|NCT00819234|453304053|FG003|Overall Study|Physician Decision|1|||
126003356|NCT00819234|453304054|FG004|Overall Study|Physician Decision|0|||
126003357|NCT00819234|453304055|FG005|Overall Study|Physician Decision|0|||
126003358|NCT00819234|453304056|FG006|Overall Study|Physician Decision|0|||
126003359|NCT00819234|453304057|FG007|Overall Study|Physician Decision|0|||
126003360|NCT00819234|453304058|FG008|Overall Study|Physician Decision|0|||
126003361|NCT00819234|453304059|FG009|Overall Study|Physician Decision|2|||
126003362|NCT00819234|453304050|FG000|Overall Study|Protocol Violation|0|||
126003363|NCT00819234|453304051|FG001|Overall Study|Protocol Violation|0|||
126003364|NCT00819234|453304052|FG002|Overall Study|Protocol Violation|1|||
126003365|NCT00819234|453304053|FG003|Overall Study|Protocol Violation|0|||
126003366|NCT00819234|453304054|FG004|Overall Study|Protocol Violation|0|||
126003367|NCT00819234|453304055|FG005|Overall Study|Protocol Violation|0|||
126003368|NCT00819234|453304056|FG006|Overall Study|Protocol Violation|0|||
126003369|NCT00819234|453304057|FG007|Overall Study|Protocol Violation|0|||
126003370|NCT00819234|453304058|FG008|Overall Study|Protocol Violation|0|||
126003371|NCT00819234|453304059|FG009|Overall Study|Protocol Violation|0|||
126003372|NCT00819234|453304050|FG000|Overall Study|Lost to Follow-up|2|||
126003373|NCT00819234|453304051|FG001|Overall Study|Lost to Follow-up|2|||
126003374|NCT00819234|453304052|FG002|Overall Study|Lost to Follow-up|0|||
126003375|NCT00819234|453304053|FG003|Overall Study|Lost to Follow-up|2|||
126003376|NCT00819234|453304054|FG004|Overall Study|Lost to Follow-up|1|||
126003377|NCT00819234|453304055|FG005|Overall Study|Lost to Follow-up|1|||
126003378|NCT00819234|453304056|FG006|Overall Study|Lost to Follow-up|1|||
126003379|NCT00819234|453304057|FG007|Overall Study|Lost to Follow-up|1|||
126003380|NCT00819234|453304058|FG008|Overall Study|Lost to Follow-up|1|||
126003381|NCT00819234|453304059|FG009|Overall Study|Lost to Follow-up|2|||
126003382|NCT01823341|453304060|FG000|Overall Study|Failed run-in|7|||
126003383|NCT01823341|453304060|FG000|Overall Study|Withdrawal by Subject|7|||
126003384|NCT01823341|453304060|FG000|Overall Study|Adverse Event|1|||
126003385|NCT05174065|453304061|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
126003386|NCT05174065|453304062|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
126337766|NCT04161391|454532933|FG005|Overall Study|Progressive Disease|3|||
126337767|NCT04161391|454532934|FG006|Overall Study|Progressive Disease|5|||
126003387|NCT05174065|453304063|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
126003388|NCT05174065|453304061|FG000|Placebo-controlled Period|Other|0|||
126003389|NCT05174065|453304062|FG001|Placebo-controlled Period|Other|1|||
126337768|NCT04161391|454532935|FG007|Overall Study|Progressive Disease|2|||
126337769|NCT04161391|454532936|FG008|Overall Study|Progressive Disease|2|||
126003390|NCT05174065|453304063|FG002|Placebo-controlled Period|Other|0|||
126003391|NCT05174065|453304061|FG000|Placebo-controlled Period|Adverse Event|1|||
126003392|NCT05174065|453304062|FG001|Placebo-controlled Period|Adverse Event|1|||
126003393|NCT05174065|453304063|FG002|Placebo-controlled Period|Adverse Event|0|||
126003394|NCT05174065|453304061|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
126003395|NCT05174065|453304062|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
126003396|NCT05174065|453304063|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
126003397|NCT05174065|453304061|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
126209467|NCT03110107|454055398|FG005|Treatment Period|Death|0|||
126337770|NCT02351934|454532937|FG000|Allocation|POD weight<pre-op weight|3|||
126337771|NCT02351934|454532938|FG001|Allocation|POD weight<pre-op weight|0|||
126337772|NCT02351934|454532937|FG000|Allocation|Hypotension preventing administration|2|||
126337773|NCT02351934|454532938|FG001|Allocation|Hypotension preventing administration|0|||
126337774|NCT02351934|454532937|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
126337775|NCT02351934|454532938|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
126337776|NCT02351934|454532937|FG000|Follow-Up|POD weight<pre-op weight|3|||
126337777|NCT02351934|454532938|FG001|Follow-Up|POD weight<pre-op weight|0|||
126337778|NCT02351934|454532937|FG000|Follow-Up|Acute Kidney Injury|1|||
126337779|NCT02351934|454532938|FG001|Follow-Up|Acute Kidney Injury|0|||
126337780|NCT02351934|454532937|FG000|Follow-Up|Early dismissal|3|||
126337781|NCT02351934|454532938|FG001|Follow-Up|Early dismissal|0|||
126337782|NCT02351934|454532937|FG000|Follow-Up|Hypotension|3|||
126337783|NCT02351934|454532938|FG001|Follow-Up|Hypotension|0|||
126337784|NCT02351934|454532937|FG000|Follow-Up|No documentation|2|||
126337785|NCT02351934|454532938|FG001|Follow-Up|No documentation|0|||
126337786|NCT02351934|454532937|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
126337787|NCT02351934|454532938|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
126337788|NCT02351934|454532937|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
126337789|NCT02351934|454532938|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
126337790|NCT00785356|454532945|FG000|Overall Study|Study prematurely terminated|8|||
126337791|NCT03238417|454532947|FG000|Overall|non-response|955|||
126337792|NCT03238417|454532948|FG001|Overall|non-response|1920|||
126337793|NCT03238417|454532947|FG000|Overall|partial completion|48|||
126337794|NCT03238417|454532948|FG001|Overall|partial completion|68|||
126337795|NCT03238417|454532947|FG000|Baseline|Partial completion|17|||
126337796|NCT03238417|454532948|FG001|Baseline|Partial completion|48|||
126337797|NCT03238417|454532947|FG000|Baseline|non-response|372|||
126337798|NCT03238417|454532948|FG001|Baseline|non-response|669|||
126337799|NCT03238417|454532947|FG000|12-month|non-response|296|||
126337800|NCT03238417|454532948|FG001|12-month|non-response|669|||
126003398|NCT05174065|453304062|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
126003399|NCT05174065|453304063|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
126003400|NCT05174065|453304061|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
126003401|NCT05174065|453304062|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
126003402|NCT05174065|453304063|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
126003403|NCT00924560|453304064|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
126003404|NCT00924560|453304065|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
126003405|NCT00924560|453304066|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
126003406|NCT00924560|453304064|FG000|Overall Study|Non Compliance with the Protocol|20|||
126003407|NCT00924560|453304065|FG001|Overall Study|Non Compliance with the Protocol|15|||
126003408|NCT00924560|453304066|FG002|Overall Study|Non Compliance with the Protocol|4|||
126003409|NCT00924560|453304064|FG000|Overall Study|Physician Decision|2|||
126003410|NCT00924560|453304065|FG001|Overall Study|Physician Decision|3|||
126003411|NCT00924560|453304066|FG002|Overall Study|Physician Decision|4|||
126003412|NCT00924560|453304064|FG000|Overall Study|Withdrawal by Subject|50|||
126003413|NCT00924560|453304065|FG001|Overall Study|Withdrawal by Subject|44|||
126003414|NCT00924560|453304066|FG002|Overall Study|Withdrawal by Subject|18|||
126003415|NCT00924560|453304064|FG000|Overall Study|Adverse Event|39|||
126003416|NCT00924560|453304065|FG001|Overall Study|Adverse Event|33|||
126003417|NCT00924560|453304066|FG002|Overall Study|Adverse Event|0|||
126003418|NCT00924560|453304064|FG000|Overall Study|Pregnancy|5|||
126003419|NCT00924560|453304065|FG001|Overall Study|Pregnancy|7|||
126003420|NCT00924560|453304066|FG002|Overall Study|Pregnancy|1|||
126003421|NCT00924560|453304064|FG000|Overall Study|Lost to Follow-up|78|||
126003422|NCT00924560|453304065|FG001|Overall Study|Lost to Follow-up|94|||
126003423|NCT00924560|453304066|FG002|Overall Study|Lost to Follow-up|45|||
126003424|NCT00924560|453304064|FG000|Overall Study|Miscellaneous Reasons|13|||
126003425|NCT00924560|453304065|FG001|Overall Study|Miscellaneous Reasons|10|||
126003426|NCT00924560|453304066|FG002|Overall Study|Miscellaneous Reasons|10|||
126003427|NCT03590743|453304068|FG000|Overall Study|Withdrawal by Subject|0|||
126003428|NCT03590743|453304069|FG001|Overall Study|Withdrawal by Subject|1|||
126003429|NCT02696226|453304070|FG000|Overall Study|Study terminated - lack of enrollment|1|||
126003430|NCT02696226|453304071|FG001|Overall Study|Study terminated - lack of enrollment|0|||
126003431|NCT02696226|453304072|FG002|Overall Study|Study terminated - lack of enrollment|2|||
126003432|NCT02696226|453304073|FG003|Overall Study|Study terminated - lack of enrollment|0|||
126003433|NCT02909101|453304081|FG000|Overall Study|Lost to Follow-up|1|||
126003434|NCT02909101|453304082|FG001|Overall Study|Lost to Follow-up|1|||
126337801|NCT03238417|454532947|FG000|12-month|partial completion|23|||
126003435|NCT00604786|453304083|FG000|Overall Study|Lost to Follow-up|2|||
126003436|NCT00604786|453304084|FG001|Overall Study|Lost to Follow-up|0|||
126337802|NCT03238417|454532948|FG001|12-month|partial completion|37|||
126337803|NCT03238417|454532947|FG000|24-month|non-response|287|||
126337804|NCT03238417|454532948|FG001|24-month|non-response|594|||
126337805|NCT03238417|454532947|FG000|24-month|partial completion|8|||
126337806|NCT03238417|454532948|FG001|24-month|partial completion|31|||
126337807|NCT01232790|454532949|FG000|Randomization|Withdrawal by Subject|2|||
126337808|NCT01232790|454532950|FG001|Randomization|Withdrawal by Subject|0|||
126337809|NCT01232790|454532949|FG000|Randomization|Protocol Violation|0|||
126337810|NCT01232790|454532950|FG001|Randomization|Protocol Violation|1|||
126337811|NCT01232790|454532949|FG000|Randomization|Physician Decision|0|||
126337812|NCT01232790|454532950|FG001|Randomization|Physician Decision|1|||
126337813|NCT01232790|454532949|FG000|Initial Assessment|Withdrawal by Subject|0|||
126337814|NCT01232790|454532950|FG001|Initial Assessment|Withdrawal by Subject|1|||
126337815|NCT01232790|454532949|FG000|First Crossover|Withdrawal by Subject|1|||
126337816|NCT01232790|454532950|FG001|First Crossover|Withdrawal by Subject|0|||
126337817|NCT01232790|454532949|FG000|Second Crossover|Withdrawal by Subject|1|||
126337818|NCT01232790|454532950|FG001|Second Crossover|Withdrawal by Subject|2|||
126337819|NCT00083915|454532951|FG000|Overall Study|Death|6|||
126337820|NCT00083915|454532952|FG001|Overall Study|Death|3|||
126337821|NCT00083915|454532951|FG000|Overall Study|Physician Decision|11|||
126337822|NCT00083915|454532952|FG001|Overall Study|Physician Decision|6|||
126337823|NCT00083915|454532951|FG000|Overall Study|Withdrawal by Subject|8|||
126337824|NCT00083915|454532952|FG001|Overall Study|Withdrawal by Subject|3|||
126337825|NCT00083915|454532951|FG000|Overall Study|disease progression|18|||
126337826|NCT00083915|454532952|FG001|Overall Study|disease progression|23|||
126337827|NCT00083915|454532951|FG000|Overall Study|Failure to collect|3|||
126337828|NCT00083915|454532952|FG001|Overall Study|Failure to collect|0|||
126337829|NCT00083915|454532951|FG000|Overall Study|No response|3|||
126337830|NCT00083915|454532952|FG001|Overall Study|No response|1|||
126337831|NCT00083915|454532951|FG000|Overall Study|Insurance issues|1|||
126337832|NCT00083915|454532952|FG001|Overall Study|Insurance issues|1|||
126337833|NCT01239797|454532953|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
126337834|NCT01239797|454532954|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
126337835|NCT01239797|454532953|FG000|Randomized Participants|Participant withdrew consent|1|||
126337836|NCT01239797|454532954|FG001|Randomized Participants|Participant withdrew consent|7|||
126337837|NCT01239797|454532953|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
126337838|NCT01239797|454532954|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
126337839|NCT01239797|454532953|FG000|Treated Participants|Disease progression|185|||
126337840|NCT01239797|454532954|FG001|Treated Participants|Disease progression|185|||
126337841|NCT01239797|454532953|FG000|Treated Participants|Study drug toxicity|39|||
126337842|NCT01239797|454532954|FG001|Treated Participants|Study drug toxicity|45|||
126337843|NCT01239797|454532953|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
126337844|NCT01239797|454532954|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
126337845|NCT01239797|454532953|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
126337846|NCT01239797|454532954|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
126337847|NCT01239797|454532953|FG000|Treated Participants|Administrative reason by sponsor|13|||
126337848|NCT01239797|454532954|FG001|Treated Participants|Administrative reason by sponsor|4|||
126337849|NCT01239797|454532953|FG000|Treated Participants|Other reasons|14|||
126337850|NCT01239797|454532954|FG001|Treated Participants|Other reasons|14|||
126337851|NCT01239797|454532953|FG000|Treated Participants|Participant withdrew consent|6|||
126337852|NCT01239797|454532954|FG001|Treated Participants|Participant withdrew consent|11|||
126337853|NCT01239797|454532953|FG000|Treated Participants|Death|1|||
126337854|NCT01239797|454532954|FG001|Treated Participants|Death|1|||
126337855|NCT01239797|454532953|FG000|Treated Participants|Participant no longer meets study criteria|1|||
126337856|NCT01239797|454532954|FG001|Treated Participants|Participant no longer meets study criteria|1|||
126337857|NCT01239797|454532953|FG000|Treated Participants|Poor/non-compliance|0|||
126003437|NCT01221181|453304085|FG000|Overall Study|Lost to Follow-up|1|||
126003438|NCT02698436|453304086|FG000|Overall Study|Adverse Event|1|||
126003439|NCT02698436|453304087|FG001|Overall Study|Adverse Event|0|||
126003440|NCT02698436|453304086|FG000|Overall Study|Withdrawal by Subject|3|||
126003441|NCT02698436|453304087|FG001|Overall Study|Withdrawal by Subject|3|||
126003442|NCT02698436|453304086|FG000|Overall Study|Lost to Follow-up|2|||
126003443|NCT02698436|453304087|FG001|Overall Study|Lost to Follow-up|4|||
126003444|NCT02698436|453304086|FG000|Overall Study|Non-compliance with study regimen|1|||
126003445|NCT02698436|453304087|FG001|Overall Study|Non-compliance with study regimen|0|||
126003446|NCT03073005|453304088|FG000|Overall Study|Death|6|||
126003447|NCT03073005|453304089|FG001|Overall Study|Death|0|||
126003448|NCT03073005|453304090|FG002|Overall Study|Death|7|||
126003449|NCT03073005|453304091|FG003|Overall Study|Death|0|||
126003450|NCT03073005|453304088|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
126003451|NCT03073005|453304089|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
126003452|NCT03073005|453304090|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
126003453|NCT03073005|453304091|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
126003454|NCT03073005|453304088|FG000|Overall Study|Lost to Follow-up|2|||
126003455|NCT03073005|453304089|FG001|Overall Study|Lost to Follow-up|2|||
126337858|NCT01239797|454532954|FG001|Treated Participants|Poor/non-compliance|1|||
126003456|NCT03073005|453304090|FG002|Overall Study|Lost to Follow-up|1|||
126003457|NCT03073005|453304091|FG003|Overall Study|Lost to Follow-up|2|||
126003458|NCT03073005|453304088|FG000|Overall Study|Withdrawal by Subject|0|||
126003459|NCT03073005|453304089|FG001|Overall Study|Withdrawal by Subject|4|||
126003460|NCT03073005|453304090|FG002|Overall Study|Withdrawal by Subject|4|||
126003461|NCT03073005|453304091|FG003|Overall Study|Withdrawal by Subject|4|||
126003462|NCT01290094|453304092|FG000|Overall Study|Withdrawal by Subject|1|||
126003463|NCT01290094|453304092|FG000|Overall Study|Lost to Follow-up|5|||
126337859|NCT01225549|454532957|FG000|Period 4 - Washout|Disallowed medication|0|||
126337860|NCT01225549|454532958|FG001|Period 4 - Washout|Disallowed medication|1|||
126337861|NCT01225549|454532959|FG002|Period 4 - Washout|Disallowed medication|0|||
126337862|NCT01225549|454532960|FG003|Period 4 - Washout|Disallowed medication|0|||
126337863|NCT01225549|454532961|FG004|Period 4 - Washout|Disallowed medication|0|||
126337864|NCT01225549|454532962|FG005|Period 4 - Washout|Disallowed medication|0|||
126337865|NCT01225549|454532963|FG006|Period 4 - Washout|Disallowed medication|0|||
126337866|NCT01225549|454532964|FG007|Period 4 - Washout|Disallowed medication|0|||
126337867|NCT01225549|454532965|FG008|Period 4 - Washout|Disallowed medication|0|||
126337868|NCT01225549|454532966|FG009|Period 4 - Washout|Disallowed medication|0|||
126337869|NCT01225549|454532957|FG000|Period 6 - Washout|Disallowed medication|0|||
126337870|NCT01225549|454532958|FG001|Period 6 - Washout|Disallowed medication|0|||
126337871|NCT01225549|454532959|FG002|Period 6 - Washout|Disallowed medication|0|||
126337872|NCT01225549|454532960|FG003|Period 6 - Washout|Disallowed medication|1|||
126337873|NCT01225549|454532961|FG004|Period 6 - Washout|Disallowed medication|0|||
126337874|NCT01225549|454532962|FG005|Period 6 - Washout|Disallowed medication|0|||
126337875|NCT01225549|454532963|FG006|Period 6 - Washout|Disallowed medication|0|||
126003464|NCT02268396|453305738|FG000|Overall Study|Adverse Event|3|||
126003465|NCT02268396|453305738|FG000|Overall Study|Administrative|2|||
126003466|NCT02268396|453305738|FG000|Overall Study|Withdrawal by Subject|1|||
126003467|NCT02268396|453305738|FG000|Overall Study|Lost to Follow-up|2|||
126003468|NCT02268396|453305738|FG000|Overall Study|Protocol-Specified Criteria|2|||
126003469|NCT02268396|453305738|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
126003470|NCT03660943|453305739|FG000|Overall Study|Adverse Event|5|||
126003471|NCT03660943|453305740|FG001|Overall Study|Adverse Event|3|||
126003472|NCT03660943|453305739|FG000|Overall Study|Death|0|||
126003473|NCT03660943|453305740|FG001|Overall Study|Death|2|||
126003474|NCT03660943|453305739|FG000|Overall Study|Lost to Follow-up|7|||
126337876|NCT01225549|454532964|FG007|Period 6 - Washout|Disallowed medication|0|||
126337877|NCT01225549|454532965|FG008|Period 6 - Washout|Disallowed medication|0|||
126337878|NCT01225549|454532966|FG009|Period 6 - Washout|Disallowed medication|0|||
126337879|NCT00891813|454532968|FG000|Overall Study|Adverse Event|3|||
126337880|NCT00891813|454532968|FG000|Overall Study|Withdrawal by Subject|1|||
126337881|NCT00891813|454532968|FG000|Overall Study|Patient Noncompliance|6|||
126337882|NCT00891813|454532968|FG000|Overall Study|Protocol Violation|2|||
126337883|NCT03722576|454532969|FG000|Overall Study|Withdrawal by Subject|3|||
126337884|NCT03722576|454532969|FG000|Overall Study|Adverse Event|2|||
126337885|NCT03722576|454532969|FG000|Overall Study|Physician Decision|1|||
126337886|NCT03722576|454532969|FG000|Overall Study|Lost to Follow-up|1|||
126337887|NCT00192114|454532972|FG000|Overall Study|Objective Tumor Progression|19|||
126337888|NCT00192114|454532972|FG000|Overall Study|Adverse Event|2|||
126337889|NCT00192114|454532972|FG000|Overall Study|Clinical Progression|2|||
126337890|NCT00192114|454532972|FG000|Overall Study|Death|1|||
126337891|NCT00749398|454532973|FG000|Overall Study|Lack of Efficacy|7|||
126337892|NCT00749398|454532973|FG000|Overall Study|Adverse Event|4|||
126337893|NCT00749398|454532973|FG000|Overall Study|Serious adverse event|11|||
126337894|NCT00749398|454532973|FG000|Overall Study|Withdrawal by Subject|17|||
126337895|NCT00749398|454532973|FG000|Overall Study|Lost to Follow-up|11|||
126337896|NCT00749398|454532973|FG000|Overall Study|Reason not specified|2|||
126337897|NCT00749398|454532973|FG000|Overall Study|Unknown reason|1|||
126337898|NCT02718911|454532976|FG000|Overall Study|Adverse Event|0|||
126337899|NCT02718911|454532977|FG001|Overall Study|Adverse Event|0|||
126337900|NCT02718911|454532978|FG002|Overall Study|Adverse Event|0|||
126337901|NCT02718911|454532979|FG003|Overall Study|Adverse Event|0|||
126337902|NCT02718911|454532980|FG004|Overall Study|Adverse Event|0|||
126337903|NCT02718911|454532981|FG005|Overall Study|Adverse Event|0|||
126337904|NCT02718911|454532982|FG006|Overall Study|Adverse Event|0|||
126337905|NCT02718911|454532983|FG007|Overall Study|Adverse Event|0|||
126337906|NCT02718911|454532984|FG008|Overall Study|Adverse Event|0|||
126337907|NCT02718911|454532985|FG009|Overall Study|Adverse Event|2|||
126337908|NCT02718911|454532976|FG000|Overall Study|Death|2|||
126337909|NCT02718911|454532977|FG001|Overall Study|Death|3|||
126337910|NCT02718911|454532978|FG002|Overall Study|Death|1|||
126337911|NCT02718911|454532979|FG003|Overall Study|Death|0|||
126337912|NCT02718911|454532980|FG004|Overall Study|Death|1|||
126337913|NCT02718911|454532981|FG005|Overall Study|Death|3|||
126337914|NCT02718911|454532982|FG006|Overall Study|Death|1|||
126337915|NCT02718911|454532983|FG007|Overall Study|Death|1|||
126337916|NCT02718911|454532984|FG008|Overall Study|Death|4|||
126003475|NCT03660943|453305740|FG001|Overall Study|Lost to Follow-up|3|||
126337917|NCT02718911|454532985|FG009|Overall Study|Death|3|||
126003476|NCT03660943|453305739|FG000|Overall Study|Protocol Violation|3|||
126003477|NCT03660943|453305740|FG001|Overall Study|Protocol Violation|5|||
126337918|NCT02718911|454532976|FG000|Overall Study|Lost to Follow-up|0|||
126337919|NCT02718911|454532977|FG001|Overall Study|Lost to Follow-up|0|||
126337920|NCT02718911|454532978|FG002|Overall Study|Lost to Follow-up|0|||
126337921|NCT02718911|454532979|FG003|Overall Study|Lost to Follow-up|0|||
126003478|NCT03660943|453305739|FG000|Overall Study|Withdrawal by Subject|8|||
126003479|NCT03660943|453305740|FG001|Overall Study|Withdrawal by Subject|15|||
126003480|NCT03660943|453305739|FG000|Overall Study|Lack of Efficacy|9|||
126003481|NCT03660943|453305740|FG001|Overall Study|Lack of Efficacy|12|||
126003482|NCT03660943|453305739|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
126003483|NCT03660943|453305740|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
126003484|NCT02491411|453305743|FG000|Overall Study|Physician Decision|4|||
126003485|NCT01939158|453305744|FG000|Overall Study|Adverse Event|1|||
126003486|NCT01939158|453305745|FG001|Overall Study|Adverse Event|0|||
126003487|NCT01939158|453305746|FG002|Overall Study|Adverse Event|0|||
126003488|NCT01939158|453305747|FG003|Overall Study|Adverse Event|0|||
126003489|NCT01939158|453305744|FG000|Overall Study|Withdrawal by Subject|22|||
126003490|NCT01939158|453305745|FG001|Overall Study|Withdrawal by Subject|25|||
126003491|NCT01939158|453305746|FG002|Overall Study|Withdrawal by Subject|15|||
126003492|NCT01939158|453305747|FG003|Overall Study|Withdrawal by Subject|17|||
126003493|NCT01939158|453305744|FG000|Overall Study|Migrated/moved from study area|5|||
126003494|NCT01939158|453305745|FG001|Overall Study|Migrated/moved from study area|7|||
126003495|NCT01939158|453305746|FG002|Overall Study|Migrated/moved from study area|3|||
126003496|NCT01939158|453305747|FG003|Overall Study|Migrated/moved from study area|6|||
126003497|NCT01939158|453305744|FG000|Overall Study|Lost to Follow-up|18|||
126003498|NCT01939158|453305745|FG001|Overall Study|Lost to Follow-up|17|||
126003499|NCT01939158|453305746|FG002|Overall Study|Lost to Follow-up|17|||
126003500|NCT01939158|453305747|FG003|Overall Study|Lost to Follow-up|17|||
126003501|NCT01939158|453305744|FG000|Overall Study|Death|0|||
126003502|NCT01939158|453305745|FG001|Overall Study|Death|0|||
126003503|NCT01939158|453305746|FG002|Overall Study|Death|1|||
126003504|NCT01939158|453305747|FG003|Overall Study|Death|1|||
126003505|NCT01939158|453305744|FG000|Overall Study|No longer meets eligibility criteria|0|||
126003506|NCT01939158|453305745|FG001|Overall Study|No longer meets eligibility criteria|0|||
126003507|NCT01939158|453305746|FG002|Overall Study|No longer meets eligibility criteria|1|||
126003508|NCT01939158|453305747|FG003|Overall Study|No longer meets eligibility criteria|0|||
126003509|NCT01939158|453305744|FG000|Overall Study|Other|1|||
126003510|NCT01939158|453305745|FG001|Overall Study|Other|3|||
126003511|NCT01939158|453305746|FG002|Overall Study|Other|4|||
126003512|NCT01939158|453305747|FG003|Overall Study|Other|3|||
126003513|NCT02065245|453305748|FG000|Infusion 1|Lost to Follow-up|0|||
126003514|NCT02065245|453305749|FG001|Infusion 1|Lost to Follow-up|0|||
126003515|NCT02065245|453305750|FG002|Infusion 1|Lost to Follow-up|0|||
126003516|NCT02065245|453305751|FG003|Infusion 1|Lost to Follow-up|0|||
126003517|NCT02065245|453305752|FG004|Infusion 1|Lost to Follow-up|0|||
126003518|NCT02065245|453305753|FG005|Infusion 1|Lost to Follow-up|0|||
126003519|NCT02065245|453305754|FG006|Infusion 1|Lost to Follow-up|1|||
126003520|NCT02065245|453305748|FG000|Infusion 1|Death|0|||
126003521|NCT02065245|453305749|FG001|Infusion 1|Death|0|||
126003522|NCT02065245|453305750|FG002|Infusion 1|Death|1|||
126003523|NCT02065245|453305751|FG003|Infusion 1|Death|0|||
126003524|NCT02065245|453305752|FG004|Infusion 1|Death|1|||
126003525|NCT02065245|453305753|FG005|Infusion 1|Death|0|||
126003526|NCT02065245|453305754|FG006|Infusion 1|Death|0|||
126003527|NCT02065245|453305748|FG000|Infusion 2|Death|0|||
126003528|NCT02065245|453305749|FG001|Infusion 2|Death|0|||
126003529|NCT02065245|453305750|FG002|Infusion 2|Death|0|||
126003530|NCT02065245|453305751|FG003|Infusion 2|Death|0|||
126003531|NCT02065245|453305752|FG004|Infusion 2|Death|0|||
126337922|NCT02718911|454532980|FG004|Overall Study|Lost to Follow-up|0|||
126337923|NCT02718911|454532981|FG005|Overall Study|Lost to Follow-up|0|||
126337924|NCT02718911|454532982|FG006|Overall Study|Lost to Follow-up|0|||
126337925|NCT02718911|454532983|FG007|Overall Study|Lost to Follow-up|0|||
126337926|NCT02718911|454532984|FG008|Overall Study|Lost to Follow-up|1|||
126337927|NCT02718911|454532985|FG009|Overall Study|Lost to Follow-up|0|||
126337928|NCT02718911|454532976|FG000|Overall Study|Physician Decision|2|||
126337929|NCT02718911|454532977|FG001|Overall Study|Physician Decision|0|||
126337930|NCT02718911|454532978|FG002|Overall Study|Physician Decision|1|||
126337931|NCT02718911|454532979|FG003|Overall Study|Physician Decision|1|||
126337932|NCT02718911|454532980|FG004|Overall Study|Physician Decision|0|||
126003532|NCT02065245|453305753|FG005|Infusion 2|Death|0|||
126003533|NCT02065245|453305754|FG006|Infusion 2|Death|1|||
126003534|NCT02065245|453305748|FG000|Infusion 3|Lost to Follow-up|1|||
126003535|NCT02065245|453305749|FG001|Infusion 3|Lost to Follow-up|1|||
126003536|NCT02065245|453305750|FG002|Infusion 3|Lost to Follow-up|0|||
126003537|NCT02065245|453305751|FG003|Infusion 3|Lost to Follow-up|0|||
126003538|NCT02065245|453305752|FG004|Infusion 3|Lost to Follow-up|0|||
126003539|NCT02065245|453305753|FG005|Infusion 3|Lost to Follow-up|0|||
126003540|NCT02065245|453305754|FG006|Infusion 3|Lost to Follow-up|0|||
126003541|NCT01304706|453305755|FG000|Overall Study|Adverse Event|2|||
126003542|NCT01304706|453305755|FG000|Overall Study|Lack of Efficacy|1|||
126003543|NCT01304706|453305755|FG000|Overall Study|Death|3|||
126003544|NCT01304706|453305755|FG000|Overall Study|Withdrawal by Subject|3|||
126003545|NCT01304706|453305755|FG000|Overall Study|Lost to Follow-up|7|||
126003546|NCT01304706|453305755|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
126337933|NCT02718911|454532981|FG005|Overall Study|Physician Decision|0|||
126003547|NCT01789203|453305762|FG000|Overall Study|Adverse Event|2|||
126003548|NCT01789203|453305763|FG001|Overall Study|Adverse Event|2|||
126003549|NCT01789203|453305762|FG000|Overall Study|Withdrawal by Subject|1|||
126003550|NCT01789203|453305763|FG001|Overall Study|Withdrawal by Subject|0|||
126003551|NCT01789203|453305762|FG000|Overall Study|Death|1|||
126003552|NCT01789203|453305763|FG001|Overall Study|Death|0|||
126003553|NCT01789203|453305762|FG000|Overall Study|Protocol Violation|2|||
126003554|NCT01789203|453305763|FG001|Overall Study|Protocol Violation|1|||
126003555|NCT01789203|453305762|FG000|Overall Study|Other|1|||
126003556|NCT01789203|453305763|FG001|Overall Study|Other|1|||
126003557|NCT01789203|453305762|FG000|Overall Study|patient non-adherent|2|||
126003558|NCT01789203|453305763|FG001|Overall Study|patient non-adherent|0|||
126003559|NCT00515086|453305766|FG000|Overall Study|Adverse Event|1|||
126003560|NCT00515086|453305767|FG001|Overall Study|Adverse Event|1|||
126003561|NCT00515086|453305768|FG002|Overall Study|Adverse Event|2|||
126003562|NCT00515086|453305769|FG003|Overall Study|Adverse Event|3|||
126003563|NCT00515086|453305766|FG000|Overall Study|Administrative|1|||
126003564|NCT00515086|453305767|FG001|Overall Study|Administrative|1|||
126003565|NCT00515086|453305768|FG002|Overall Study|Administrative|0|||
126003566|NCT00515086|453305769|FG003|Overall Study|Administrative|0|||
126003567|NCT00515086|453305766|FG000|Overall Study|Withdrawal by Subject|1|||
126003568|NCT00515086|453305767|FG001|Overall Study|Withdrawal by Subject|0|||
126003569|NCT00515086|453305768|FG002|Overall Study|Withdrawal by Subject|0|||
126003570|NCT00515086|453305769|FG003|Overall Study|Withdrawal by Subject|1|||
126003571|NCT00515086|453305766|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
126003572|NCT00515086|453305767|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126003573|NCT00515086|453305768|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
126003574|NCT00515086|453305769|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
126003575|NCT00515086|453305766|FG000|Overall Study|Lost to Follow-up|1|||
126003576|NCT00515086|453305767|FG001|Overall Study|Lost to Follow-up|0|||
126003577|NCT00515086|453305768|FG002|Overall Study|Lost to Follow-up|0|||
126003578|NCT00515086|453305769|FG003|Overall Study|Lost to Follow-up|0|||
126003579|NCT00515086|453305766|FG000|Overall Study|Study drug no longer required|0|||
126003580|NCT00515086|453305767|FG001|Overall Study|Study drug no longer required|1|||
126003581|NCT00515086|453305768|FG002|Overall Study|Study drug no longer required|0|||
126003582|NCT00515086|453305769|FG003|Overall Study|Study drug no longer required|0|||
126003583|NCT00515086|453305766|FG000|Overall Study|Death|2|||
126003584|NCT00515086|453305767|FG001|Overall Study|Death|0|||
126003585|NCT00515086|453305768|FG002|Overall Study|Death|0|||
126003586|NCT00515086|453305769|FG003|Overall Study|Death|0|||
126003587|NCT02271594|453305773|FG000|Overall Study|Study closed; recruiting failure|19|||
126003588|NCT02271594|453305774|FG001|Overall Study|Study closed; recruiting failure|12|||
126003589|NCT00495469|453305779|FG000|Overall Study|Adverse Event|0|||
126003590|NCT00495469|453305780|FG001|Overall Study|Adverse Event|1|||
126003591|NCT00495469|453305781|FG002|Overall Study|Adverse Event|3|||
126003592|NCT00495469|453305782|FG003|Overall Study|Adverse Event|0|||
126003593|NCT00495469|453305783|FG004|Overall Study|Adverse Event|1|||
126003594|NCT00495469|453305784|FG005|Overall Study|Adverse Event|1|||
126003595|NCT00495469|453305785|FG006|Overall Study|Adverse Event|1|||
126003596|NCT00495469|453305779|FG000|Overall Study|Lost to Follow-up|1|||
126003597|NCT00495469|453305780|FG001|Overall Study|Lost to Follow-up|1|||
126003598|NCT00495469|453305781|FG002|Overall Study|Lost to Follow-up|3|||
126003599|NCT00495469|453305782|FG003|Overall Study|Lost to Follow-up|1|||
126003600|NCT00495469|453305783|FG004|Overall Study|Lost to Follow-up|0|||
126337934|NCT02718911|454532982|FG006|Overall Study|Physician Decision|0|||
126003601|NCT00495469|453305784|FG005|Overall Study|Lost to Follow-up|0|||
126003602|NCT00495469|453305785|FG006|Overall Study|Lost to Follow-up|0|||
126003603|NCT00495469|453305779|FG000|Overall Study|Protocol Violation|0|||
126003604|NCT00495469|453305780|FG001|Overall Study|Protocol Violation|0|||
126003605|NCT00495469|453305781|FG002|Overall Study|Protocol Violation|0|||
126003606|NCT00495469|453305782|FG003|Overall Study|Protocol Violation|0|||
126337935|NCT02718911|454532983|FG007|Overall Study|Physician Decision|1|||
126337936|NCT02718911|454532984|FG008|Overall Study|Physician Decision|2|||
126337937|NCT02718911|454532985|FG009|Overall Study|Physician Decision|1|||
126337938|NCT02718911|454532976|FG000|Overall Study|Withdrawal by Subject|0|||
126003607|NCT00495469|453305783|FG004|Overall Study|Protocol Violation|1|||
126003608|NCT00495469|453305784|FG005|Overall Study|Protocol Violation|2|||
126003609|NCT00495469|453305785|FG006|Overall Study|Protocol Violation|0|||
126003610|NCT00495469|453305779|FG000|Overall Study|Withdrawal by Subject|5|||
126003611|NCT00495469|453305780|FG001|Overall Study|Withdrawal by Subject|3|||
126003612|NCT00495469|453305781|FG002|Overall Study|Withdrawal by Subject|1|||
126003613|NCT00495469|453305782|FG003|Overall Study|Withdrawal by Subject|3|||
126003614|NCT00495469|453305783|FG004|Overall Study|Withdrawal by Subject|3|||
126003615|NCT00495469|453305784|FG005|Overall Study|Withdrawal by Subject|2|||
126003616|NCT00495469|453305785|FG006|Overall Study|Withdrawal by Subject|3|||
126003617|NCT00495469|453305779|FG000|Overall Study|Lack of Efficacy|0|||
126003618|NCT00495469|453305780|FG001|Overall Study|Lack of Efficacy|0|||
126003619|NCT00495469|453305781|FG002|Overall Study|Lack of Efficacy|0|||
126003620|NCT00495469|453305782|FG003|Overall Study|Lack of Efficacy|0|||
126337939|NCT02718911|454532977|FG001|Overall Study|Withdrawal by Subject|0|||
126337940|NCT02718911|454532978|FG002|Overall Study|Withdrawal by Subject|0|||
126337941|NCT02718911|454532979|FG003|Overall Study|Withdrawal by Subject|0|||
126337942|NCT02718911|454532980|FG004|Overall Study|Withdrawal by Subject|1|||
126337943|NCT02718911|454532981|FG005|Overall Study|Withdrawal by Subject|0|||
126337944|NCT02718911|454532982|FG006|Overall Study|Withdrawal by Subject|0|||
126337945|NCT02718911|454532983|FG007|Overall Study|Withdrawal by Subject|0|||
126337946|NCT02718911|454532984|FG008|Overall Study|Withdrawal by Subject|1|||
126337947|NCT02718911|454532985|FG009|Overall Study|Withdrawal by Subject|4|||
126337948|NCT02718911|454532976|FG000|Overall Study|Reason Not Collected|0|||
126337949|NCT02718911|454532977|FG001|Overall Study|Reason Not Collected|0|||
126337950|NCT02718911|454532978|FG002|Overall Study|Reason Not Collected|1|||
126003621|NCT00495469|453305783|FG004|Overall Study|Lack of Efficacy|0|||
126003622|NCT00495469|453305784|FG005|Overall Study|Lack of Efficacy|0|||
126003623|NCT00495469|453305785|FG006|Overall Study|Lack of Efficacy|1|||
126003624|NCT00495469|453305779|FG000|Overall Study|Liver function test abnormality|0|||
126003625|NCT00495469|453305780|FG001|Overall Study|Liver function test abnormality|1|||
126003626|NCT00495469|453305781|FG002|Overall Study|Liver function test abnormality|0|||
126003627|NCT00495469|453305782|FG003|Overall Study|Liver function test abnormality|0|||
126003628|NCT00495469|453305783|FG004|Overall Study|Liver function test abnormality|0|||
126003629|NCT00495469|453305784|FG005|Overall Study|Liver function test abnormality|0|||
126003630|NCT00495469|453305785|FG006|Overall Study|Liver function test abnormality|0|||
126003631|NCT00495469|453305779|FG000|Overall Study|ST depression at randomisation in ECG|0|||
126003632|NCT00495469|453305780|FG001|Overall Study|ST depression at randomisation in ECG|1|||
126003633|NCT00495469|453305781|FG002|Overall Study|ST depression at randomisation in ECG|0|||
126003634|NCT00495469|453305782|FG003|Overall Study|ST depression at randomisation in ECG|0|||
126003635|NCT00495469|453305783|FG004|Overall Study|ST depression at randomisation in ECG|0|||
126003636|NCT00495469|453305784|FG005|Overall Study|ST depression at randomisation in ECG|0|||
126003637|NCT00495469|453305785|FG006|Overall Study|ST depression at randomisation in ECG|0|||
126003638|NCT00448864|453305788|FG000|Overall Study|Death|1|||
126003639|NCT00448864|453305789|FG001|Overall Study|Death|0|||
126003640|NCT00448864|453305790|FG002|Overall Study|Death|0|||
126003641|NCT00448864|453305788|FG000|Overall Study|Lost to Follow-up|3|||
126003642|NCT00448864|453305789|FG001|Overall Study|Lost to Follow-up|1|||
126003643|NCT00448864|453305790|FG002|Overall Study|Lost to Follow-up|0|||
126003644|NCT00448864|453305788|FG000|Overall Study|Physician Decision|1|||
126003645|NCT00448864|453305789|FG001|Overall Study|Physician Decision|0|||
126003646|NCT00448864|453305790|FG002|Overall Study|Physician Decision|1|||
126003647|NCT00448864|453305788|FG000|Overall Study|Withdrawal by Subject|0|||
126003648|NCT00448864|453305789|FG001|Overall Study|Withdrawal by Subject|2|||
126003649|NCT00448864|453305790|FG002|Overall Study|Withdrawal by Subject|0|||
126003650|NCT00448864|453305788|FG000|Overall Study|Protocol Violation|0|||
126003651|NCT00448864|453305789|FG001|Overall Study|Protocol Violation|2|||
126003652|NCT00448864|453305790|FG002|Overall Study|Protocol Violation|0|||
126003653|NCT01323660|453305793|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
126003654|NCT01323660|453305794|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
126003655|NCT01323660|453305795|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
126003656|NCT01323660|453305796|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
126003657|NCT01323660|453305797|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
126003658|NCT01323660|453305798|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
126003659|NCT01323660|453305793|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
126003660|NCT01323660|453305794|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
126003661|NCT01323660|453305795|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
126003662|NCT01323660|453305796|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
126003663|NCT01323660|453305797|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
126003664|NCT01323660|453305798|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
126003665|NCT01323660|453305793|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
126003666|NCT01323660|453305794|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
126003667|NCT01323660|453305795|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
126003668|NCT01323660|453305796|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
126337951|NCT02718911|454532979|FG003|Overall Study|Reason Not Collected|0|||
126003669|NCT01323660|453305797|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
126003670|NCT01323660|453305798|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
126003671|NCT01323660|453305793|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126003672|NCT01323660|453305794|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126003673|NCT01323660|453305795|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126003674|NCT01323660|453305796|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126337952|NCT02718911|454532980|FG004|Overall Study|Reason Not Collected|0|||
126003675|NCT01323660|453305797|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
126003676|NCT01323660|453305798|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126003677|NCT01323660|453305793|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126337953|NCT02718911|454532981|FG005|Overall Study|Reason Not Collected|0|||
126003678|NCT01323660|453305794|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126003679|NCT01323660|453305795|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126003680|NCT01323660|453305796|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126003681|NCT01323660|453305797|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126003682|NCT01323660|453305798|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126003683|NCT01323660|453305793|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
126003684|NCT01323660|453305794|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126003685|NCT01323660|453305795|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
126003686|NCT01323660|453305796|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
126003687|NCT01323660|453305797|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
126003688|NCT01323660|453305798|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126003689|NCT01323660|453305793|FG000|Washout Period (14 Days)|Adverse Event|0|||
126003690|NCT01323660|453305794|FG001|Washout Period (14 Days)|Adverse Event|0|||
126003691|NCT01323660|453305795|FG002|Washout Period (14 Days)|Adverse Event|0|||
126003692|NCT01323660|453305796|FG003|Washout Period (14 Days)|Adverse Event|0|||
126003693|NCT01323660|453305797|FG004|Washout Period (14 Days)|Adverse Event|1|||
126003694|NCT01323660|453305798|FG005|Washout Period (14 Days)|Adverse Event|0|||
126003695|NCT01323660|453305793|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
126003696|NCT01323660|453305794|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
126003697|NCT01323660|453305795|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
126003698|NCT01323660|453305796|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
126003699|NCT01323660|453305797|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
126003700|NCT01323660|453305798|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
126003701|NCT01323660|453305793|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126003702|NCT01323660|453305794|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126337954|NCT02718911|454532982|FG006|Overall Study|Reason Not Collected|2|||
126337955|NCT02718911|454532983|FG007|Overall Study|Reason Not Collected|1|||
126337956|NCT02718911|454532984|FG008|Overall Study|Reason Not Collected|4|||
126337957|NCT02718911|454532985|FG009|Overall Study|Reason Not Collected|9|||
126337958|NCT01172873|454532988|FG000|Overall Study|Withdrawal by Subject|3|||
126337959|NCT01172873|454532989|FG001|Overall Study|Withdrawal by Subject|2|||
126337960|NCT00983372|454532990|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
126337961|NCT00983372|454532990|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
126337962|NCT00983372|454532990|FG000|Diltiazem ER Alone|Adverse Event|1|||
126337963|NCT00617357|454532997|FG000|Overall Study|Lost to Follow-up|7|||
126337964|NCT00617357|454532997|FG000|Overall Study|Death|5|||
126337965|NCT00617357|454532997|FG000|Overall Study|insurance concerns|2|||
126337966|NCT00617357|454532997|FG000|Overall Study|Withdrawal by Subject|1|||
126337967|NCT00617357|454532997|FG000|Overall Study|Physician Decision|1|||
126337968|NCT01764841|454532998|FG000|Overall Study|Logistical Difficulties|0|||
126337969|NCT01764841|454532999|FG001|Overall Study|Logistical Difficulties|1|||
126337970|NCT01764841|454533000|FG002|Overall Study|Logistical Difficulties|0|||
126337971|NCT01764841|454533001|FG003|Overall Study|Logistical Difficulties|0|||
126337972|NCT01764841|454532998|FG000|Overall Study|Death|3|||
126337973|NCT01764841|454532999|FG001|Overall Study|Death|0|||
126337974|NCT01764841|454533000|FG002|Overall Study|Death|1|||
126337975|NCT01764841|454533001|FG003|Overall Study|Death|4|||
126337976|NCT01764841|454532998|FG000|Overall Study|No Follow Up|1|||
126337977|NCT01764841|454532999|FG001|Overall Study|No Follow Up|0|||
126337978|NCT01764841|454533000|FG002|Overall Study|No Follow Up|1|||
126337979|NCT01764841|454533001|FG003|Overall Study|No Follow Up|0|||
126337980|NCT01764841|454532998|FG000|Overall Study|Protocol Violation|0|||
126337981|NCT01764841|454532999|FG001|Overall Study|Protocol Violation|1|||
126337982|NCT01764841|454533000|FG002|Overall Study|Protocol Violation|0|||
126337983|NCT01764841|454533001|FG003|Overall Study|Protocol Violation|0|||
126337984|NCT01764841|454532998|FG000|Overall Study|Withdrawal by Subject|16|||
126337985|NCT01764841|454532999|FG001|Overall Study|Withdrawal by Subject|24|||
126337986|NCT01764841|454533000|FG002|Overall Study|Withdrawal by Subject|11|||
126337987|NCT01764841|454533001|FG003|Overall Study|Withdrawal by Subject|15|||
126337988|NCT01764841|454532998|FG000|Overall Study|Lost to Follow-up|3|||
126337989|NCT01764841|454532999|FG001|Overall Study|Lost to Follow-up|0|||
126337990|NCT01764841|454533000|FG002|Overall Study|Lost to Follow-up|1|||
126003703|NCT01323660|453305795|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126003704|NCT01323660|453305796|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126003705|NCT01323660|453305797|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126337991|NCT01764841|454533001|FG003|Overall Study|Lost to Follow-up|0|||
126003706|NCT01323660|453305798|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
126337992|NCT01103323|454533003|FG000|Without/Before Drug Switch|Adverse Event|50|||
126337993|NCT01103323|454533004|FG001|Without/Before Drug Switch|Adverse Event|7|||
126337994|NCT01103323|454533003|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
126337995|NCT01103323|454533004|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
126337996|NCT01103323|454533003|FG000|Without/Before Drug Switch|Protocol Violation|2|||
126003707|NCT01323660|453305793|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
126003708|NCT01323660|453305794|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126337997|NCT01103323|454533004|FG001|Without/Before Drug Switch|Protocol Violation|0|||
126003709|NCT01323660|453305795|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
126003710|NCT01323660|453305796|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
126003711|NCT01323660|453305797|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
126003712|NCT01323660|453305798|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
126003713|NCT01323660|453305793|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126003714|NCT01323660|453305794|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126003715|NCT01323660|453305795|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126003716|NCT01323660|453305796|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126003717|NCT01323660|453305797|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126003718|NCT01323660|453305798|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
126003719|NCT01323660|453305793|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
126003720|NCT01323660|453305794|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126003721|NCT01323660|453305795|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126003722|NCT01323660|453305796|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126003723|NCT01323660|453305797|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126003724|NCT01323660|453305798|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
126003725|NCT01323660|453305793|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126003726|NCT01323660|453305794|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126003727|NCT01323660|453305795|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126003728|NCT01323660|453305796|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126003729|NCT01323660|453305797|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
126003730|NCT01323660|453305798|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126003731|NCT04531540|453305801|FG000|Overall Study|Adverse Event|1|||
126003732|NCT04531540|453305801|FG000|Overall Study|Protocol Violation|3|||
126003733|NCT04531540|453305801|FG000|Overall Study|Withdrawal by Subject|4|||
126003734|NCT04531540|453305801|FG000|Overall Study|Found to be Ineligible|1|||
126003735|NCT01575860|453305802|FG000|Overall Study|Withdrawal by Subject|1|||
126003736|NCT01575860|453305802|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
126003737|NCT01106976|453305803|FG000|Overall Study|Lost to Follow-up|8|||
126003738|NCT00278564|453305805|FG000|Overall Study|Lack of Efficacy|4|||
126003739|NCT01094743|453305806|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
126003740|NCT02851511|453305807|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
126003741|NCT02851511|453305808|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
126003742|NCT02851511|453305809|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
126003743|NCT02851511|453305810|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
126003744|NCT02851511|453305807|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
126003745|NCT02851511|453305808|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
126003746|NCT02851511|453305809|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
126337998|NCT01103323|454533003|FG000|Without/Before Drug Switch|Physician Decision|2|||
126337999|NCT01103323|454533004|FG001|Without/Before Drug Switch|Physician Decision|0|||
126338000|NCT01103323|454533003|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
126338001|NCT01103323|454533004|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
126338002|NCT01103323|454533003|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
126338003|NCT01103323|454533004|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
126003747|NCT02851511|453305810|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
126003748|NCT02851511|453305807|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
126003749|NCT02851511|453305808|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
126003750|NCT02851511|453305809|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
126003751|NCT02851511|453305810|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
126003752|NCT02851511|453305807|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
126003753|NCT02851511|453305808|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
126003754|NCT02851511|453305809|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
126003755|NCT02851511|453305810|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
126003756|NCT02851511|453305807|FG000|Phase I|Physician Decision|0|||
126003757|NCT02851511|453305808|FG001|Phase I|Physician Decision|0|||
126003758|NCT02851511|453305809|FG002|Phase I|Physician Decision|0|||
126003759|NCT02851511|453305810|FG003|Phase I|Physician Decision|1|||
126003760|NCT02851511|453305807|FG000|Phase I|Withdrawal by Subject|2|||
126338004|NCT01103323|454533003|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
126338005|NCT01103323|454533004|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
126003761|NCT02851511|453305808|FG001|Phase I|Withdrawal by Subject|1|||
126003762|NCT02851511|453305809|FG002|Phase I|Withdrawal by Subject|0|||
126003763|NCT02851511|453305810|FG003|Phase I|Withdrawal by Subject|3|||
126003764|NCT02851511|453305807|FG000|Phase II|Physician Decision|18|||
126003765|NCT02851511|453305808|FG001|Phase II|Physician Decision|16|||
126003766|NCT02851511|453305809|FG002|Phase II|Physician Decision|0|||
126003767|NCT02851511|453305810|FG003|Phase II|Physician Decision|0|||
126003768|NCT02851511|453305807|FG000|Phase II|Withdrawal by Subject|18|||
126003769|NCT02851511|453305808|FG001|Phase II|Withdrawal by Subject|16|||
126003770|NCT02851511|453305809|FG002|Phase II|Withdrawal by Subject|0|||
126338006|NCT00732069|454533005|FG000|Washout After First Study Drug|Adverse Event|1|||
126338007|NCT00732069|454533006|FG001|Washout After First Study Drug|Adverse Event|0|||
126338008|NCT00732069|454533007|FG002|Washout After First Study Drug|Adverse Event|0|||
126003771|NCT02851511|453305810|FG003|Phase II|Withdrawal by Subject|0|||
126003772|NCT02851511|453305807|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
126003773|NCT02851511|453305808|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
126003774|NCT02851511|453305809|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
126003775|NCT02851511|453305810|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
126003776|NCT02851511|453305807|FG000|Phase II|Lost to Follow-up|0|||
126003777|NCT02851511|453305808|FG001|Phase II|Lost to Follow-up|1|||
126003778|NCT02851511|453305809|FG002|Phase II|Lost to Follow-up|0|||
126003779|NCT02851511|453305810|FG003|Phase II|Lost to Follow-up|0|||
126003780|NCT00051311|453305811|FG000|Overall Study|Starting new study|0|||
126003781|NCT00051311|453305812|FG001|Overall Study|Starting new study|1|||
126003782|NCT00051311|453305811|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
126003783|NCT00051311|453305812|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
126003784|NCT00051311|453305811|FG000|Overall Study|Death of recipient|8|||
126003785|NCT00051311|453305812|FG001|Overall Study|Death of recipient|8|||
126003786|NCT00051311|453305811|FG000|Overall Study|Recipient taken off study|4|||
126003787|NCT00051311|453305812|FG001|Overall Study|Recipient taken off study|4|||
126003788|NCT00372567|453305822|FG000|Phase 3 Study|Adverse Event|5|||
126003789|NCT00372567|453305823|FG001|Phase 3 Study|Adverse Event|1|||
126003790|NCT00372567|453305824|FG002|Phase 3 Study|Adverse Event|1|||
126003791|NCT00372567|453305822|FG000|Phase 3 Study|Death|1|||
126003792|NCT00372567|453305823|FG001|Phase 3 Study|Death|1|||
126003793|NCT00372567|453305824|FG002|Phase 3 Study|Death|0|||
126003794|NCT00372567|453305822|FG000|Phase 3 Study|Protocol Violation|0|||
126003795|NCT00372567|453305823|FG001|Phase 3 Study|Protocol Violation|0|||
126003796|NCT00372567|453305824|FG002|Phase 3 Study|Protocol Violation|1|||
126003797|NCT00372567|453305822|FG000|Phase 3 Study|Objective progression or relapse|10|||
126003798|NCT00372567|453305823|FG001|Phase 3 Study|Objective progression or relapse|13|||
126003799|NCT00372567|453305824|FG002|Phase 3 Study|Objective progression or relapse|4|||
126003800|NCT00372567|453305822|FG000|Phase 3 Study|Global deterioration of health status|0|||
126003801|NCT00372567|453305823|FG001|Phase 3 Study|Global deterioration of health status|1|||
126003802|NCT00372567|453305824|FG002|Phase 3 Study|Global deterioration of health status|0|||
126003803|NCT00372567|453305822|FG000|Phase 3 Study|Other|2|||
126003804|NCT00372567|453305823|FG001|Phase 3 Study|Other|2|||
126003805|NCT00372567|453305824|FG002|Phase 3 Study|Other|1|||
126003806|NCT00372567|453305822|FG000|Phase 3 Study|study terminated by sponsor|13|||
126003807|NCT00372567|453305823|FG001|Phase 3 Study|study terminated by sponsor|8|||
126003808|NCT00372567|453305824|FG002|Phase 3 Study|study terminated by sponsor|5|||
126003809|NCT00303303|453305826|FG000|Overall Study|Withdrawal by Subject|0|||
126003810|NCT00303303|453305827|FG001|Overall Study|Withdrawal by Subject|0|||
126003811|NCT00303303|453305828|FG002|Overall Study|Withdrawal by Subject|1|||
126003812|NCT00582790|453305831|FG000|Overall Study|Rapid progression of disease|1|||
126003813|NCT00480441|453305832|FG000|Screening|Not Eligible|37|||
126003814|NCT00480441|453305833|FG001|Screening|Not Eligible|0|||
126003815|NCT00480441|453305834|FG002|Screening|Not Eligible|0|||
126003816|NCT00480441|453305832|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
126003817|NCT00480441|453305833|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
126003818|NCT00480441|453305834|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
126003819|NCT00480441|453305832|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
126003820|NCT00480441|453305833|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
126003821|NCT00480441|453305834|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
126003822|NCT00480441|453305832|FG000|Baseline Functional MRI|physical contraindication|4|||
126003823|NCT00480441|453305833|FG001|Baseline Functional MRI|physical contraindication|0|||
126003824|NCT00480441|453305834|FG002|Baseline Functional MRI|physical contraindication|0|||
126003825|NCT00480441|453305832|FG000|Randomization|Lost to Follow-up|0|||
126003826|NCT00480441|453305833|FG001|Randomization|Lost to Follow-up|7|||
126003827|NCT00480441|453305834|FG002|Randomization|Lost to Follow-up|2|||
126003828|NCT01004263|453305846|FG000|Overall Study|Adverse Event|15|||
126003829|NCT01004263|453305846|FG000|Overall Study|Withdrawal by Subject|58|||
126003830|NCT01004263|453305846|FG000|Overall Study|Protocol Violation|10|||
126003831|NCT01004263|453305846|FG000|Overall Study|Lost to Follow-up|64|||
126003832|NCT01004263|453305846|FG000|Overall Study|Lack of Efficacy|13|||
126003833|NCT01004263|453305846|FG000|Overall Study|Pregnancy|2|||
126003834|NCT01004263|453305846|FG000|Overall Study|Physician Decision|15|||
126003835|NCT01004263|453305846|FG000|Overall Study|Lack of Qualifying Event|2|||
126003836|NCT00958009|453305848|FG000|Overall Study|Adverse Event|1|||
126003837|NCT00958009|453305848|FG000|Overall Study|Subject found device difficult to use|1|||
126003838|NCT00558753|453305849|FG000|Overall Study|Lost to Follow-up|5|||
126003839|NCT00558753|453305850|FG001|Overall Study|Lost to Follow-up|7|||
126003840|NCT00821236|453305851|FG000|Overall Study|Lost to Follow-up|3|||
126003841|NCT00578227|453305854|FG000|Overall Study|Lost to Follow-up|0|||
126003842|NCT00578227|453305855|FG001|Overall Study|Lost to Follow-up|1|||
126003843|NCT00578227|453305856|FG002|Overall Study|Lost to Follow-up|1|||
126003844|NCT00578227|453305854|FG000|Overall Study|Withdrawal by Subject|5|||
126003845|NCT00578227|453305855|FG001|Overall Study|Withdrawal by Subject|1|||
126003846|NCT00578227|453305856|FG002|Overall Study|Withdrawal by Subject|3|||
126003847|NCT04668144|453305857|FG000|Overall Study|Protocol Violation|0|||
126003848|NCT04668144|453305858|FG001|Overall Study|Protocol Violation|1|||
126003849|NCT04668144|453305859|FG002|Overall Study|Protocol Violation|2|||
126003850|NCT00577629|453305860|FG000|Treatment Period|Death|1|||
126003851|NCT00577629|453305860|FG000|Long Term Follow-Up|Death|15|||
126003852|NCT00577629|453305860|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
126003853|NCT00577629|453305860|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
126003854|NCT00577629|453305860|FG000|Long Term Follow-Up|Physician Decision|1|||
126003855|NCT01605136|453305863|FG000|Study Period|Withdrawal by Subject|2|||
126003856|NCT01605136|453305864|FG001|Study Period|Withdrawal by Subject|0|||
126003857|NCT01605136|453305863|FG000|Study Period|Physician Decision|1|||
126003858|NCT01605136|453305864|FG001|Study Period|Physician Decision|1|||
126003859|NCT01605136|453305863|FG000|Study Period|Lost to Follow-up|0|||
126003860|NCT01605136|453305864|FG001|Study Period|Lost to Follow-up|2|||
126003861|NCT01605136|453305863|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
126003862|NCT01605136|453305864|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
126003863|NCT01072929|453305865|FG000|Overall Study|Adverse Event|8|||
126003864|NCT01072929|453305866|FG001|Overall Study|Adverse Event|11|||
126003865|NCT01072929|453305867|FG002|Overall Study|Adverse Event|2|||
126003866|NCT01072929|453305865|FG000|Overall Study|Lack of Efficacy|7|||
126003867|NCT01072929|453305866|FG001|Overall Study|Lack of Efficacy|4|||
126003868|NCT01072929|453305867|FG002|Overall Study|Lack of Efficacy|0|||
126003869|NCT01072929|453305865|FG000|Overall Study|Withdrawal by Subject|7|||
126003870|NCT01072929|453305866|FG001|Overall Study|Withdrawal by Subject|15|||
126003871|NCT01072929|453305867|FG002|Overall Study|Withdrawal by Subject|3|||
126003872|NCT01072929|453305865|FG000|Overall Study|Protocol Violation|13|||
126003873|NCT01072929|453305866|FG001|Overall Study|Protocol Violation|11|||
126003874|NCT01072929|453305867|FG002|Overall Study|Protocol Violation|2|||
126003875|NCT01072929|453305865|FG000|Overall Study|Lost to Follow-up|8|||
126003876|NCT01072929|453305866|FG001|Overall Study|Lost to Follow-up|4|||
126003877|NCT01072929|453305867|FG002|Overall Study|Lost to Follow-up|1|||
126003878|NCT01072929|453305865|FG000|Overall Study|Noncompliance with study medication|0|||
126003879|NCT01072929|453305866|FG001|Overall Study|Noncompliance with study medication|3|||
126003880|NCT01072929|453305867|FG002|Overall Study|Noncompliance with study medication|0|||
126003881|NCT01072929|453305865|FG000|Overall Study|Noncompliance with study procedures|1|||
126003882|NCT01072929|453305866|FG001|Overall Study|Noncompliance with study procedures|0|||
126003883|NCT01072929|453305867|FG002|Overall Study|Noncompliance with study procedures|1|||
126003884|NCT01072929|453305865|FG000|Overall Study|Other|0|||
126003885|NCT01072929|453305866|FG001|Overall Study|Other|3|||
126003886|NCT01072929|453305867|FG002|Overall Study|Other|0|||
126003887|NCT02929108|453305870|FG000|Overall Study|Hospice patient death|100|||
126003888|NCT02929108|453305871|FG001|Overall Study|Hospice patient death|64|||
126003889|NCT02929108|453305872|FG002|Overall Study|Hospice patient death|28|||
126003890|NCT02929108|453305873|FG003|Overall Study|Hospice patient death|46|||
126003891|NCT02929108|453305874|FG004|Overall Study|Hospice patient death|55|||
126003892|NCT02929108|453305875|FG005|Overall Study|Hospice patient death|28|||
126003893|NCT02929108|453305876|FG006|Overall Study|Hospice patient death|78|||
126003894|NCT00052962|453305877|FG000|Overall Study|Not evaluable|0|||
126003895|NCT00052962|453305878|FG001|Overall Study|Not evaluable|2|||
126003896|NCT00052962|453305877|FG000|Overall Study|Not randomized/not evaluable|1|||
126003897|NCT00052962|453305878|FG001|Overall Study|Not randomized/not evaluable|0|||
126003898|NCT01723774|453305882|FG000|Neoadjuvant|Ki67 > 10%|4|||
126003899|NCT01723774|453305883|FG001|Neoadjuvant|Ki67 > 10%|0|||
126003900|NCT01723774|453305884|FG002|Neoadjuvant|Ki67 > 10%|10|||
126003901|NCT01723774|453305885|FG003|Neoadjuvant|Ki67 > 10%|0|||
126003902|NCT01723774|453305882|FG000|Neoadjuvant|Withdrawal by Subject|3|||
126003903|NCT01723774|453305883|FG001|Neoadjuvant|Withdrawal by Subject|1|||
126003904|NCT01723774|453305884|FG002|Neoadjuvant|Withdrawal by Subject|0|||
126003905|NCT01723774|453305885|FG003|Neoadjuvant|Withdrawal by Subject|0|||
126003906|NCT01723774|453305882|FG000|Neoadjuvant|Disease progression|0|||
126003907|NCT01723774|453305883|FG001|Neoadjuvant|Disease progression|1|||
126003908|NCT01723774|453305884|FG002|Neoadjuvant|Disease progression|1|||
126003909|NCT01723774|453305885|FG003|Neoadjuvant|Disease progression|0|||
126003910|NCT01723774|453305882|FG000|Neoadjuvant|Adverse Event|0|||
126003911|NCT01723774|453305883|FG001|Neoadjuvant|Adverse Event|1|||
126003912|NCT01723774|453305884|FG002|Neoadjuvant|Adverse Event|2|||
126003913|NCT01723774|453305885|FG003|Neoadjuvant|Adverse Event|0|||
126003914|NCT01723774|453305882|FG000|Neoadjuvant|High estradiol|0|||
126003915|NCT01723774|453305883|FG001|Neoadjuvant|High estradiol|1|||
126003916|NCT01723774|453305884|FG002|Neoadjuvant|High estradiol|0|||
126003917|NCT01723774|453305885|FG003|Neoadjuvant|High estradiol|0|||
126003918|NCT02487446|453305889|FG000|Period 1|Physician Decision|0|||
126003919|NCT02487446|453305890|FG001|Period 1|Physician Decision|1|||
126003920|NCT02487446|453305889|FG000|Period 1|Lack of Efficacy|1|||
126003921|NCT02487446|453305890|FG001|Period 1|Lack of Efficacy|0|||
126003922|NCT02487446|453305889|FG000|Period 1|Protocol deviation|3|||
126003923|NCT02487446|453305890|FG001|Period 1|Protocol deviation|2|||
126003924|NCT02487446|453305889|FG000|Period 1|Lost to Follow-up|2|||
126003925|NCT02487446|453305890|FG001|Period 1|Lost to Follow-up|0|||
126003926|NCT02487446|453305889|FG000|Period 1|Withdrawal by Subject|2|||
126003927|NCT02487446|453305890|FG001|Period 1|Withdrawal by Subject|0|||
126003928|NCT02487446|453305889|FG000|Period 1|Adverse Event|5|||
126003929|NCT02487446|453305890|FG001|Period 1|Adverse Event|5|||
126003930|NCT02487446|453305889|FG000|Washout|Lost to Follow-up|0|||
126003931|NCT02487446|453305890|FG001|Washout|Lost to Follow-up|2|||
126003932|NCT02487446|453305889|FG000|Washout|Withdrawal by Subject|1|||
126003933|NCT02487446|453305890|FG001|Washout|Withdrawal by Subject|4|||
126003934|NCT02487446|453305889|FG000|Washout|Adverse Event|2|||
126003935|NCT02487446|453305890|FG001|Washout|Adverse Event|2|||
126003936|NCT02487446|453305889|FG000|Period 2|Protocol deviation|0|||
126003937|NCT02487446|453305890|FG001|Period 2|Protocol deviation|1|||
126003938|NCT02487446|453305889|FG000|Period 2|Lost to Follow-up|1|||
126003939|NCT02487446|453305890|FG001|Period 2|Lost to Follow-up|1|||
126003940|NCT02487446|453305889|FG000|Period 2|Withdrawal by Subject|1|||
126003941|NCT02487446|453305890|FG001|Period 2|Withdrawal by Subject|1|||
126003942|NCT02487446|453305889|FG000|Period 2|Adverse Event|6|||
126003943|NCT02487446|453305890|FG001|Period 2|Adverse Event|2|||
126003944|NCT04438785|453305895|FG000|Overall Study|change of weight, give up intervention|2|||
126003945|NCT04438785|453305896|FG001|Overall Study|change of weight, give up intervention|10|||
126003946|NCT04011033|453305897|FG000|Overall Study|Physician Decision|2|||
126003947|NCT04011033|453305898|FG001|Overall Study|Physician Decision|3|||
126003948|NCT04011033|453305897|FG000|Overall Study|Withdrawal by Subject|1|||
126003949|NCT04011033|453305898|FG001|Overall Study|Withdrawal by Subject|0|||
126003950|NCT02027935|453305899|FG000|Overall Study|Death|1|||
126003951|NCT02027935|453305899|FG000|Overall Study|Lack of Efficacy|5|||
126003952|NCT02027935|453305899|FG000|Overall Study|Study Closure|1|||
126003953|NCT00689104|453305900|FG000|Overall Study|Eligibility criterion not met|5|||
126003954|NCT00689104|453305901|FG001|Overall Study|Eligibility criterion not met|8|||
126003955|NCT00689104|453305902|FG002|Overall Study|Eligibility criterion not met|0|||
126003956|NCT00689104|453305903|FG003|Overall Study|Eligibility criterion not met|4|||
126003957|NCT00689104|453305900|FG000|Overall Study|Adverse Event|13|||
126003958|NCT00689104|453305901|FG001|Overall Study|Adverse Event|25|||
126003959|NCT00689104|453305902|FG002|Overall Study|Adverse Event|16|||
126003960|NCT00689104|453305903|FG003|Overall Study|Adverse Event|24|||
126003961|NCT00689104|453305900|FG000|Overall Study|Lack of Efficacy|5|||
126003962|NCT00689104|453305901|FG001|Overall Study|Lack of Efficacy|6|||
126003963|NCT00689104|453305902|FG002|Overall Study|Lack of Efficacy|2|||
126003964|NCT00689104|453305903|FG003|Overall Study|Lack of Efficacy|3|||
126003965|NCT00689104|453305900|FG000|Overall Study|Withdrawal by Subject|12|||
126003966|NCT00689104|453305901|FG001|Overall Study|Withdrawal by Subject|11|||
126003967|NCT00689104|453305902|FG002|Overall Study|Withdrawal by Subject|18|||
126003968|NCT00689104|453305903|FG003|Overall Study|Withdrawal by Subject|11|||
126003969|NCT00689104|453305900|FG000|Overall Study|Lost to Follow-up|4|||
126003970|NCT00689104|453305901|FG001|Overall Study|Lost to Follow-up|3|||
126003971|NCT00689104|453305902|FG002|Overall Study|Lost to Follow-up|2|||
126003972|NCT00689104|453305903|FG003|Overall Study|Lost to Follow-up|5|||
126003973|NCT00689104|453305900|FG000|Overall Study|Protocol Violation|2|||
126003974|NCT00689104|453305901|FG001|Overall Study|Protocol Violation|3|||
126338009|NCT00732069|454533008|FG003|Washout After First Study Drug|Adverse Event|0|||
126003975|NCT00689104|453305902|FG002|Overall Study|Protocol Violation|5|||
126003976|NCT00689104|453305903|FG003|Overall Study|Protocol Violation|3|||
126003977|NCT00689104|453305900|FG000|Overall Study|Randomized but never received study drug|2|||
126003978|NCT00689104|453305901|FG001|Overall Study|Randomized but never received study drug|1|||
126003979|NCT00689104|453305902|FG002|Overall Study|Randomized but never received study drug|1|||
126003980|NCT00689104|453305903|FG003|Overall Study|Randomized but never received study drug|0|||
126003981|NCT00689104|453305900|FG000|Overall Study|Physician Decision|1|||
126003982|NCT00689104|453305901|FG001|Overall Study|Physician Decision|0|||
126003983|NCT00689104|453305902|FG002|Overall Study|Physician Decision|0|||
126003984|NCT00689104|453305903|FG003|Overall Study|Physician Decision|0|||
126338010|NCT00732069|454533009|FG004|Washout After First Study Drug|Adverse Event|0|||
126338011|NCT00732069|454533010|FG005|Washout After First Study Drug|Adverse Event|0|||
126338012|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Early discharge|5|||
126003985|NCT00689104|453305900|FG000|Overall Study|Non-compliance with study procedures|0|||
126003986|NCT00689104|453305901|FG001|Overall Study|Non-compliance with study procedures|0|||
126003987|NCT00689104|453305902|FG002|Overall Study|Non-compliance with study procedures|1|||
126003988|NCT00689104|453305903|FG003|Overall Study|Non-compliance with study procedures|0|||
126003989|NCT01394991|453305906|FG000|Overall Study|Adverse Event|0|||
126003990|NCT01394991|453305907|FG001|Overall Study|Adverse Event|4|||
126003991|NCT01394991|453305906|FG000|Overall Study|Lack of Efficacy|5|||
126003992|NCT01394991|453305907|FG001|Overall Study|Lack of Efficacy|7|||
126003993|NCT01394991|453305906|FG000|Overall Study|Lost to Follow-up|6|||
126003994|NCT01394991|453305907|FG001|Overall Study|Lost to Follow-up|8|||
126003995|NCT01394991|453305906|FG000|Overall Study|Physician Decision|1|||
126003996|NCT01394991|453305907|FG001|Overall Study|Physician Decision|3|||
126003997|NCT01394991|453305906|FG000|Overall Study|Protocol Violation|1|||
126003998|NCT01394991|453305907|FG001|Overall Study|Protocol Violation|1|||
126003999|NCT01394991|453305906|FG000|Overall Study|Withdrawal by Subject|20|||
126004000|NCT01394991|453305907|FG001|Overall Study|Withdrawal by Subject|17|||
126004001|NCT01394991|453305906|FG000|Overall Study|Chemotherapy Termination|10|||
126004002|NCT01394991|453305907|FG001|Overall Study|Chemotherapy Termination|15|||
126004003|NCT01394991|453305906|FG000|Overall Study|Disease Progression|7|||
126004004|NCT01394991|453305907|FG001|Overall Study|Disease Progression|7|||
126004005|NCT01394991|453305906|FG000|Overall Study|Prematurely Termination of Trial|9|||
126004006|NCT01394991|453305907|FG001|Overall Study|Prematurely Termination of Trial|10|||
126004007|NCT00725010|453305917|FG000|Overall Study|Toxicity|9|||
126004008|NCT00725010|453305917|FG000|Overall Study|Tumor Progression|7|||
126004009|NCT00725010|453305917|FG000|Overall Study|Withdrawal by Subject|2|||
126004010|NCT00725010|453305917|FG000|Overall Study|Death|1|||
126004011|NCT00725010|453305917|FG000|Overall Study|Lost to Follow-up|1|||
126004012|NCT00725010|453305917|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
126004013|NCT00725010|453305917|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
126004014|NCT00725010|453305917|FG000|Overall Study|No further documentation|1|||
126004015|NCT00725010|453305917|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
126004016|NCT04091672|453307756|FG000|Overall Study|Death|6|||
126004017|NCT04091672|453307757|FG001|Overall Study|Death|6|||
126004018|NCT04091672|453307756|FG000|Overall Study|Lost to Follow-up|7|||
126004019|NCT04091672|453307757|FG001|Overall Study|Lost to Follow-up|7|||
126004020|NCT04091672|453307756|FG000|Overall Study|Withdrawal by Subject|3|||
126004021|NCT04091672|453307757|FG001|Overall Study|Withdrawal by Subject|3|||
126004022|NCT04091672|453307756|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
126004023|NCT04091672|453307757|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
126004024|NCT05296629|453307758|FG000|Overall Study|Withdrawal by Subject|3|||
126004025|NCT05296629|453307759|FG001|Overall Study|Withdrawal by Subject|10|||
126004026|NCT05296629|453307760|FG002|Overall Study|Withdrawal by Subject|4|||
126004027|NCT05296629|453307758|FG000|Overall Study|Lost to Follow-up|2|||
126004028|NCT05296629|453307759|FG001|Overall Study|Lost to Follow-up|7|||
126004029|NCT05296629|453307760|FG002|Overall Study|Lost to Follow-up|1|||
126004030|NCT05296629|453307758|FG000|Overall Study|Adverse Event|0|||
126004031|NCT05296629|453307759|FG001|Overall Study|Adverse Event|4|||
126004032|NCT05296629|453307760|FG002|Overall Study|Adverse Event|2|||
126004033|NCT05296629|453307758|FG000|Overall Study|Protocol Violation|0|||
126004034|NCT05296629|453307759|FG001|Overall Study|Protocol Violation|2|||
126004035|NCT05296629|453307760|FG002|Overall Study|Protocol Violation|0|||
126004036|NCT02401529|453307763|FG000|Overall Study|Lost to Follow-up|2|||
126004037|NCT02401529|453307764|FG001|Overall Study|Lost to Follow-up|1|||
126004038|NCT02401529|453307763|FG000|Overall Study|Physician Decision|2|||
126004039|NCT02401529|453307764|FG001|Overall Study|Physician Decision|6|||
126004040|NCT02401529|453307763|FG000|Overall Study|Protocol Violation|5|||
126004041|NCT02401529|453307764|FG001|Overall Study|Protocol Violation|0|||
126004042|NCT01518257|453307767|FG000|Overall Study|Lost to Follow-up|1|||
126004043|NCT01518257|453307768|FG001|Overall Study|Lost to Follow-up|0|||
126004044|NCT01518257|453307767|FG000|Overall Study|Other Miscellaneous Reason|1|||
126004045|NCT01518257|453307768|FG001|Overall Study|Other Miscellaneous Reason|0|||
126004046|NCT00924664|453307769|FG000|Overall Study|Adverse Event|23|||
126004047|NCT00924664|453307770|FG001|Overall Study|Adverse Event|39|||
126004048|NCT00924664|453307769|FG000|Overall Study|Lack of Efficacy|10|||
126338013|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Early discharge|5|||
126338014|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
126338015|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
126004049|NCT00924664|453307770|FG001|Overall Study|Lack of Efficacy|15|||
126004050|NCT00924664|453307769|FG000|Overall Study|Lost to Follow-up|10|||
126338016|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
126338017|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
126004051|NCT00924664|453307770|FG001|Overall Study|Lost to Follow-up|12|||
126004052|NCT00924664|453307769|FG000|Overall Study|Withdrawal by Subject|47|||
126004053|NCT00924664|453307770|FG001|Overall Study|Withdrawal by Subject|71|||
126004054|NCT00924664|453307769|FG000|Overall Study|Protocol Violation|2|||
126004055|NCT00924664|453307770|FG001|Overall Study|Protocol Violation|5|||
126004056|NCT00924664|453307769|FG000|Overall Study|Pregnancy|1|||
126004057|NCT00924664|453307770|FG001|Overall Study|Pregnancy|1|||
126338018|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
126338019|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
126338020|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
126338021|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
126004058|NCT00924664|453307769|FG000|Overall Study|Death|0|||
126004059|NCT00924664|453307770|FG001|Overall Study|Death|2|||
126004060|NCT00924664|453307769|FG000|Overall Study|Study terminated by sponsor|199|||
126004061|NCT00924664|453307770|FG001|Overall Study|Study terminated by sponsor|330|||
126004062|NCT00924664|453307769|FG000|Overall Study|Other|29|||
126004063|NCT00924664|453307770|FG001|Overall Study|Other|52|||
126004064|NCT00924664|453307769|FG000|Overall Study|Randomized but not Treated|1|||
126004065|NCT00924664|453307770|FG001|Overall Study|Randomized but not Treated|0|||
126004066|NCT03158948|453307772|FG000|Overall Study|Death|1|||
126004067|NCT03158948|453307773|FG001|Overall Study|Death|1|||
126004068|NCT03158948|453307774|FG002|Overall Study|Death|3|||
126004069|NCT03158948|453307775|FG003|Overall Study|Death|2|||
126004070|NCT03158948|453307772|FG000|Overall Study|Physician Decision|0|||
126004071|NCT03158948|453307773|FG001|Overall Study|Physician Decision|0|||
126004072|NCT03158948|453307774|FG002|Overall Study|Physician Decision|0|||
126004073|NCT03158948|453307775|FG003|Overall Study|Physician Decision|1|||
126004074|NCT01876043|453307776|FG000|Overall Study|Death|1|||
126004075|NCT01876043|453307776|FG000|Overall Study|Withdrawal by Subject|1|||
126004076|NCT02206685|453307778|FG000|Overall Study|Surgery cancelled/changed|2|||
126004077|NCT02206685|453307779|FG001|Overall Study|Surgery cancelled/changed|3|||
126004078|NCT02206685|453307778|FG000|Overall Study|Withdrawal by Subject|1|||
126004079|NCT02206685|453307779|FG001|Overall Study|Withdrawal by Subject|2|||
126004080|NCT02206685|453307778|FG000|Overall Study|Protocol Violation|2|||
126004081|NCT02206685|453307779|FG001|Overall Study|Protocol Violation|2|||
126004082|NCT00079937|453307780|FG000|Overall Study|Adverse Event|2|||
126004083|NCT00079937|453307781|FG001|Overall Study|Adverse Event|1|||
126004084|NCT00079937|453307780|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126004085|NCT00079937|453307781|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126004086|NCT00079937|453307780|FG000|Overall Study|Subject no longer requires study drug|3|||
126004087|NCT00079937|453307781|FG001|Overall Study|Subject no longer requires study drug|0|||
126004088|NCT00079937|453307780|FG000|Overall Study|Protocol Violation|8|||
126004089|NCT00079937|453307781|FG001|Overall Study|Protocol Violation|6|||
126004090|NCT00079937|453307780|FG000|Overall Study|Withdrawal by Subject|21|||
126004091|NCT00079937|453307781|FG001|Overall Study|Withdrawal by Subject|7|||
126004092|NCT00079937|453307780|FG000|Overall Study|Lost to Follow-up|12|||
126004093|NCT00079937|453307781|FG001|Overall Study|Lost to Follow-up|5|||
126004094|NCT00079937|453307780|FG000|Overall Study|Administrative problems|22|||
126004095|NCT00079937|453307781|FG001|Overall Study|Administrative problems|11|||
126004096|NCT01616563|453307782|FG000|Overall Study|Lost to Follow-up|40|||
126004097|NCT00093795|453307786|FG000|Overall Study|No follow up data|20|||
126004098|NCT00093795|453307787|FG001|Overall Study|No follow up data|16|||
126004099|NCT00093795|453307788|FG002|Overall Study|No follow up data|17|||
126004100|NCT01195675|453307789|FG000|Overall Study|Adverse Event|1|||
126004101|NCT01195675|453307789|FG000|Overall Study|Withdrawal by Subject|2|||
126004102|NCT01106287|453307790|FG000|Overall Study|Adverse Event|1|||
126004103|NCT01106287|453307791|FG001|Overall Study|Adverse Event|0|||
126004104|NCT01106287|453307792|FG002|Overall Study|Adverse Event|0|||
126004105|NCT01106287|453307793|FG003|Overall Study|Adverse Event|0|||
126004106|NCT00072475|453307794|FG000|Overall Study|Adverse Event|44|||
126004107|NCT00072475|453307794|FG000|Overall Study|Death|3|||
126004108|NCT00072475|453307794|FG000|Overall Study|Withdrawal by Subject|46|||
126004109|NCT00072475|453307794|FG000|Overall Study|Patient/Investigator Decision|4|||
126004110|NCT04730947|453307795|FG000|Overall Study|Withdrawal by Subject|0|||
126004111|NCT04730947|453307796|FG001|Overall Study|Withdrawal by Subject|1|||
126004112|NCT00940017|453307797|FG000|Overall Study|did not meet entrance criteria|3|||
126004113|NCT00940017|453307797|FG000|Overall Study|Adverse Event|1|||
126004114|NCT01450943|453307800|FG000|Overall Study|Screen failure, loss to follow-up|2|||
126004115|NCT01450943|453307801|FG001|Overall Study|Screen failure, loss to follow-up|7|||
126004116|NCT01450943|453307802|FG002|Overall Study|Screen failure, loss to follow-up|6|||
126004117|NCT02949271|453307805|FG000|Overall Study|Lack of Efficacy|5|||
126004118|NCT02949271|453307806|FG001|Overall Study|Lack of Efficacy|4|||
126004119|NCT02949271|453307805|FG000|Overall Study|Lost to Follow-up|3|||
126004120|NCT02949271|453307806|FG001|Overall Study|Lost to Follow-up|6|||
126338022|NCT04460326|454533011|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
126338023|NCT04460326|454533012|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
126004121|NCT02949271|453307805|FG000|Overall Study|Physician Decision|5|||
126004122|NCT02949271|453307806|FG001|Overall Study|Physician Decision|5|||
126004123|NCT02949271|453307805|FG000|Overall Study|Protocol Violation|6|||
126338024|NCT00577317|454533013|FG000|Overall Study|Study Terminated|0|||
126338025|NCT00577317|454533014|FG001|Overall Study|Study Terminated|2|||
126338026|NCT03160716|454533015|FG000|Overall Study|Lost to Follow-up|1|||
126338027|NCT04794751|454533017|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
126004124|NCT02949271|453307806|FG001|Overall Study|Protocol Violation|3|||
126004125|NCT02949271|453307805|FG000|Overall Study|Withdrawal by Subject|1|||
126004126|NCT02949271|453307806|FG001|Overall Study|Withdrawal by Subject|0|||
126004127|NCT02949271|453307805|FG000|Overall Study|Delivered prior to intervention|7|||
126004128|NCT02949271|453307806|FG001|Overall Study|Delivered prior to intervention|9|||
126004129|NCT02949271|453307805|FG000|Overall Study|Outside the window for cervical dilation|2|||
126004130|NCT02949271|453307806|FG001|Overall Study|Outside the window for cervical dilation|3|||
126004131|NCT01684046|453307807|FG000|Period 1, First 30 Days|Adverse Event|0|||
126004132|NCT01684046|453307808|FG001|Period 1, First 30 Days|Adverse Event|2|||
126004133|NCT01097655|453307809|FG000|Overall Study|Withdrawal by Subject|1|||
126004134|NCT01097655|453307809|FG000|Overall Study|Subject Documented Twice|1|||
126004135|NCT01097655|453307809|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
126004136|NCT05458102|453307811|FG000|Overall Study|Withdrew consent|2|||
126004137|NCT05458102|453307812|FG001|Overall Study|Withdrew consent|0|||
126004138|NCT05458102|453307811|FG000|Overall Study|Adverse Event|1|||
126004139|NCT05458102|453307812|FG001|Overall Study|Adverse Event|0|||
126004140|NCT05458102|453307811|FG000|Overall Study|Enrolled but never treated|1|||
126004141|NCT05458102|453307812|FG001|Overall Study|Enrolled but never treated|0|||
126004142|NCT05458102|453307811|FG000|Overall Study|Protocol Violation|1|||
126004143|NCT05458102|453307812|FG001|Overall Study|Protocol Violation|0|||
126004144|NCT03303105|453307813|FG000|Overall Study|Adverse Event|0|||
126004145|NCT03303105|453307814|FG001|Overall Study|Adverse Event|2|||
126004146|NCT03303105|453307813|FG000|Overall Study|Lack of Efficacy|1|||
126004147|NCT03303105|453307814|FG001|Overall Study|Lack of Efficacy|0|||
126004148|NCT03303105|453307813|FG000|Overall Study|Protocol Violation|1|||
126004149|NCT03303105|453307814|FG001|Overall Study|Protocol Violation|0|||
126004150|NCT03303105|453307813|FG000|Overall Study|Withdrawal by Subject|0|||
126004151|NCT03303105|453307814|FG001|Overall Study|Withdrawal by Subject|2|||
126004152|NCT02790606|453307825|FG000|Overall Study|Death|27|||
126004153|NCT02790606|453307825|FG000|Overall Study|Lost to Follow-up|4|||
126004154|NCT02790606|453307825|FG000|Overall Study|Physician Decision|3|||
126004155|NCT02790606|453307825|FG000|Overall Study|Withdrawal by Subject|1|||
126004156|NCT02735915|453307826|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
126004157|NCT02735915|453307826|FG000|Overall Study|Withdrawal following SAE|2|||
126004158|NCT02735915|453307826|FG000|Overall Study|Withdrawal by Subject|1|||
126004159|NCT05328973|453307827|FG000|Overall Study|Withdrawal by Subject|0|||
126004160|NCT05328973|453307828|FG001|Overall Study|Withdrawal by Subject|1|||
126004161|NCT00946114|453307829|FG000|Overall Study|Death|5|||
126004162|NCT00946114|453307830|FG001|Overall Study|Death|2|||
126004163|NCT00946114|453307829|FG000|Overall Study|Other|1|||
126004164|NCT00946114|453307830|FG001|Overall Study|Other|0|||
126004165|NCT00946114|453307829|FG000|Overall Study|Withdrawal by Subject|2|||
126004166|NCT00946114|453307830|FG001|Overall Study|Withdrawal by Subject|0|||
126004167|NCT01764386|453307834|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
126004168|NCT01764386|453307835|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
126004169|NCT01764386|453307834|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
126004170|NCT01764386|453307835|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
126004171|NCT01764386|453307834|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
126004172|NCT01764386|453307835|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
126004173|NCT01764386|453307834|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
126004174|NCT01764386|453307835|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
126004175|NCT01764386|453307834|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
126004176|NCT01764386|453307835|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
126004177|NCT01764386|453307834|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
126004178|NCT01764386|453307835|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
126004179|NCT01764386|453307834|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
126004180|NCT01764386|453307835|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
126004181|NCT01764386|453307834|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
126004182|NCT01764386|453307835|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
126004183|NCT03929302|453307838|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
126004184|NCT03929302|453307839|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
126004185|NCT03929302|453307840|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
126004186|NCT03929302|453307838|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
126004187|NCT03929302|453307839|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
126004188|NCT03929302|453307840|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
126004189|NCT03929302|453307838|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
126004190|NCT03929302|453307839|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
126004191|NCT03929302|453307840|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
126004192|NCT04454567|453307842|FG000|Overall Study|Study Terminated by Sponsor|1|||
126004193|NCT04454567|453307843|FG001|Overall Study|Study Terminated by Sponsor|1|||
126004194|NCT01123161|453307846|FG000|Overall Study|Lost to Follow-up|1|||
126004195|NCT01123161|453307847|FG001|Overall Study|Lost to Follow-up|0|||
126004196|NCT01123161|453307846|FG000|Overall Study|Withdrawal by Subject|1|||
126004197|NCT01123161|453307847|FG001|Overall Study|Withdrawal by Subject|0|||
126004198|NCT02757885|453307848|FG000|Overall Study|Screen Failures|4|||
126004199|NCT01175707|453307849|FG000|Overall Study|Adverse Event|4|||
126004200|NCT01175707|453307850|FG001|Overall Study|Adverse Event|6|||
126004201|NCT00003377|453307853|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
126004202|NCT00003377|453307854|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
126004203|NCT00003377|453307855|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
126004204|NCT00003377|453307856|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
126004205|NCT00003377|453307857|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
126004206|NCT00003377|453307853|FG000|Period II|Ureteral stent complications|0|||
126004207|NCT00003377|453307854|FG001|Period II|Ureteral stent complications|0|||
126004208|NCT00003377|453307855|FG002|Period II|Ureteral stent complications|0|||
126004209|NCT00003377|453307856|FG003|Period II|Ureteral stent complications|0|||
126004210|NCT00003377|453307857|FG004|Period II|Ureteral stent complications|1|||
126004211|NCT05349084|453307860|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
126004212|NCT05124899|453307861|FG000|Overall Study|Lost to Follow-up|3|||
126004213|NCT00647348|453307869|FG000|Overall Study|Lost to Follow-up|3|||
126004214|NCT00647348|453307870|FG001|Overall Study|Lost to Follow-up|6|||
126004215|NCT01417000|453307871|FG000|Overall Study|Death|59|||
126004216|NCT01417000|453307872|FG001|Overall Study|Death|28|||
126004217|NCT01417000|453307871|FG000|Overall Study|Lost to Follow-up|1|||
126004218|NCT01417000|453307872|FG001|Overall Study|Lost to Follow-up|0|||
126004219|NCT01417000|453307871|FG000|Overall Study|Study Terminated by Sponsor|1|||
126004220|NCT01417000|453307872|FG001|Overall Study|Study Terminated by Sponsor|1|||
126004221|NCT02414828|453307873|FG000|Overall Study|Lost to Follow-up|0|||
126004222|NCT02414828|453307874|FG001|Overall Study|Lost to Follow-up|1|||
126004223|NCT02414828|453307875|FG002|Overall Study|Lost to Follow-up|1|||
126004224|NCT02414828|453307876|FG003|Overall Study|Lost to Follow-up|2|||
126004225|NCT04949399|453307877|FG000|Overall Study|Lost to Follow-up|11|||
126004226|NCT04949399|453307878|FG001|Overall Study|Lost to Follow-up|6|||
126004227|NCT04949399|453307877|FG000|Overall Study|Withdrawal by Subject|2|||
126004228|NCT04949399|453307878|FG001|Overall Study|Withdrawal by Subject|3|||
126004229|NCT00814489|453307904|FG000|Overall Study|Other|2|||
126004230|NCT00814489|453307905|FG001|Overall Study|Other|0|||
126004231|NCT00814489|453307906|FG002|Overall Study|Other|1|||
126004232|NCT01712685|453307907|FG000|Overall Study|pt declined to participate before trmt|1|||
126004233|NCT00662909|453307911|FG000|Overall Study|Adverse Event|17|||
126004234|NCT00662909|453307912|FG001|Overall Study|Adverse Event|18|||
126004235|NCT00662909|453307913|FG002|Overall Study|Adverse Event|19|||
126004236|NCT00662909|453307911|FG000|Overall Study|Lack of Efficacy|9|||
126004237|NCT00662909|453307912|FG001|Overall Study|Lack of Efficacy|1|||
126004238|NCT00662909|453307913|FG002|Overall Study|Lack of Efficacy|5|||
126004239|NCT00662909|453307911|FG000|Overall Study|Withdrawal by Subject|29|||
126004240|NCT00662909|453307912|FG001|Overall Study|Withdrawal by Subject|22|||
126004241|NCT00662909|453307913|FG002|Overall Study|Withdrawal by Subject|16|||
126004242|NCT00662909|453307911|FG000|Overall Study|Lost to Follow-up|2|||
126004243|NCT00662909|453307912|FG001|Overall Study|Lost to Follow-up|9|||
126004244|NCT00662909|453307913|FG002|Overall Study|Lost to Follow-up|3|||
126004245|NCT00662909|453307911|FG000|Overall Study|Protocol Violation|7|||
126004246|NCT00662909|453307912|FG001|Overall Study|Protocol Violation|4|||
126004247|NCT00662909|453307913|FG002|Overall Study|Protocol Violation|5|||
126004248|NCT00662909|453307911|FG000|Overall Study|Randomized- never received study drug|1|||
126004249|NCT00662909|453307912|FG001|Overall Study|Randomized- never received study drug|0|||
126004250|NCT00662909|453307913|FG002|Overall Study|Randomized- never received study drug|0|||
126004251|NCT00662909|453307911|FG000|Overall Study|Non-compliance with study procedures|3|||
126004252|NCT00662909|453307912|FG001|Overall Study|Non-compliance with study procedures|3|||
126004253|NCT00662909|453307913|FG002|Overall Study|Non-compliance with study procedures|2|||
126004254|NCT00662909|453307911|FG000|Overall Study|Physician Decision|1|||
126004255|NCT00662909|453307912|FG001|Overall Study|Physician Decision|1|||
126004256|NCT00662909|453307913|FG002|Overall Study|Physician Decision|2|||
126004257|NCT00662909|453307911|FG000|Overall Study|Eligibility criterion not met|0|||
126004258|NCT00662909|453307912|FG001|Overall Study|Eligibility criterion not met|1|||
126004259|NCT00662909|453307913|FG002|Overall Study|Eligibility criterion not met|1|||
126004260|NCT04610684|453309641|FG000|Study Treatment|Withdrawal by Subject|1|||
126004261|NCT04610684|453309641|FG000|Study Treatment|Disease Progression|2|||
126004262|NCT04610684|453309641|FG000|Follow up|Death|2|||
126004263|NCT04610684|453309641|FG000|Follow up|Withdrawal by Subject|1|||
126004264|NCT04978363|453309645|FG000|Overall Study|Other medical issues unrelated to the study|0|||
126004265|NCT04978363|453309646|FG001|Overall Study|Other medical issues unrelated to the study|0|||
126004266|NCT04978363|453309647|FG002|Overall Study|Other medical issues unrelated to the study|0|||
126004267|NCT04978363|453309648|FG003|Overall Study|Other medical issues unrelated to the study|0|||
126004268|NCT04978363|453309649|FG004|Overall Study|Other medical issues unrelated to the study|1|||
126004269|NCT04978363|453309650|FG005|Overall Study|Other medical issues unrelated to the study|0|||
126004270|NCT04978363|453309651|FG006|Overall Study|Other medical issues unrelated to the study|0|||
126004271|NCT04978363|453309652|FG007|Overall Study|Other medical issues unrelated to the study|0|||
126004272|NCT04978363|453309653|FG008|Overall Study|Other medical issues unrelated to the study|0|||
126004273|NCT04978363|453309654|FG009|Overall Study|Other medical issues unrelated to the study|0|||
126004274|NCT04978363|453309655|FG010|Overall Study|Other medical issues unrelated to the study|0|||
126004275|NCT04978363|453309645|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
126004276|NCT04978363|453309646|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
126004277|NCT04978363|453309647|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
126004278|NCT04978363|453309648|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
126004279|NCT04978363|453309649|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
126209468|NCT03110107|454055399|FG006|Treatment Period|Death|0|||
126004280|NCT04978363|453309650|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
126004281|NCT04978363|453309651|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
126004282|NCT04978363|453309652|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
126004283|NCT04978363|453309653|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
126004284|NCT04978363|453309654|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
126004285|NCT04978363|453309655|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
126338028|NCT04794751|454533018|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
126338029|NCT04794751|454533017|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
126338030|NCT04794751|454533018|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
126338031|NCT04794751|454533017|FG000|Period 1|Protocol Violation|0|||
126338032|NCT04794751|454533018|FG001|Period 1|Protocol Violation|2|||
126338033|NCT04794751|454533017|FG000|Period 1|Withdrawal by Subject|0|||
126004286|NCT04978363|453309645|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004287|NCT04978363|453309646|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
126004288|NCT04978363|453309647|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004289|NCT04978363|453309648|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004290|NCT04978363|453309649|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004291|NCT04978363|453309650|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004292|NCT04978363|453309651|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004293|NCT04978363|453309652|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004294|NCT04978363|453309653|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004295|NCT04978363|453309654|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004296|NCT04978363|453309655|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126004297|NCT01251614|453309656|FG000|Overall Study|Adverse Event|1|||
126004298|NCT01251614|453309657|FG001|Overall Study|Adverse Event|0|||
126004299|NCT01251614|453309658|FG002|Overall Study|Adverse Event|1|||
126004300|NCT01251614|453309656|FG000|Overall Study|Lack of Efficacy|1|||
126004301|NCT01251614|453309657|FG001|Overall Study|Lack of Efficacy|9|||
126004302|NCT01251614|453309658|FG002|Overall Study|Lack of Efficacy|4|||
126004303|NCT01251614|453309656|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
126004304|NCT01251614|453309657|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
126004305|NCT01251614|453309658|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
126004306|NCT01251614|453309656|FG000|Overall Study|Pregnancy|0|||
126004307|NCT01251614|453309657|FG001|Overall Study|Pregnancy|0|||
126004308|NCT01251614|453309658|FG002|Overall Study|Pregnancy|2|||
126004309|NCT01251614|453309656|FG000|Overall Study|Loss of Disease Control|0|||
126004310|NCT01251614|453309657|FG001|Overall Study|Loss of Disease Control|1|||
126004311|NCT01251614|453309658|FG002|Overall Study|Loss of Disease Control|0|||
126004312|NCT01251614|453309656|FG000|Overall Study|Withdrawal by Subject|0|||
126004313|NCT01251614|453309657|FG001|Overall Study|Withdrawal by Subject|2|||
126004314|NCT01251614|453309658|FG002|Overall Study|Withdrawal by Subject|1|||
126004315|NCT01251614|453309656|FG000|Overall Study|Lost to Follow-up|0|||
126004316|NCT01251614|453309657|FG001|Overall Study|Lost to Follow-up|1|||
126004317|NCT01251614|453309658|FG002|Overall Study|Lost to Follow-up|0|||
126004318|NCT02153788|453309659|FG000|Overall Study|Physician Decision|2|||
126004319|NCT02153788|453309660|FG001|Overall Study|Physician Decision|1|||
126004320|NCT04672460|453309661|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
126004321|NCT04672460|453309662|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
126004322|NCT04672460|453309661|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
126004323|NCT04672460|453309662|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
126004324|NCT04672460|453309661|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
126004325|NCT04672460|453309662|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
126004326|NCT04672460|453309661|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
126004327|NCT04672460|453309662|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
126004328|NCT04672460|453309661|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
126004329|NCT04672460|453309662|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
126004330|NCT04672460|453309661|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
126004331|NCT04672460|453309662|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
126004332|NCT04672460|453309661|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
126338034|NCT04794751|454533018|FG001|Period 1|Withdrawal by Subject|1|||
126004333|NCT04672460|453309662|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
126004334|NCT04672460|453309661|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
126004335|NCT04672460|453309662|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
126004336|NCT04672460|453309661|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
126004337|NCT04672460|453309662|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
126004338|NCT04672460|453309661|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
126004339|NCT04672460|453309662|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
126209469|NCT03110107|454055400|FG007|Treatment Period|Death|0|||
126004340|NCT04672460|453309661|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
126004341|NCT04672460|453309662|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
126004342|NCT04672460|453309661|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
126004343|NCT04672460|453309662|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
126004344|NCT04672460|453309661|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
126004345|NCT04672460|453309662|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
126004346|NCT04672460|453309661|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
126004347|NCT04672460|453309662|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
126004348|NCT04672460|453309661|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
126004349|NCT04672460|453309662|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
126004350|NCT04672460|453309661|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
126004351|NCT04672460|453309662|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
126004352|NCT04672460|453309661|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
126004353|NCT04672460|453309662|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
126004354|NCT00049517|453309665|FG000|Induction|Disease progression|0|||
126004355|NCT00049517|453309666|FG001|Induction|Disease progression|0|||
126004356|NCT00049517|453309667|FG002|Induction|Disease progression|0|||
126004357|NCT00049517|453309668|FG003|Induction|Disease progression|0|||
126004358|NCT00049517|453309669|FG004|Induction|Disease progression|18|||
126004359|NCT00049517|453309670|FG005|Induction|Disease progression|11|||
126004360|NCT00049517|453309665|FG000|Induction|Adverse Event|0|||
126004361|NCT00049517|453309666|FG001|Induction|Adverse Event|0|||
126004362|NCT00049517|453309667|FG002|Induction|Adverse Event|0|||
126004363|NCT00049517|453309668|FG003|Induction|Adverse Event|0|||
126004364|NCT00049517|453309669|FG004|Induction|Adverse Event|5|||
126004365|NCT00049517|453309670|FG005|Induction|Adverse Event|7|||
126004366|NCT00049517|453309665|FG000|Induction|Death|0|||
126004367|NCT00049517|453309666|FG001|Induction|Death|0|||
126004368|NCT00049517|453309667|FG002|Induction|Death|0|||
126004369|NCT00049517|453309668|FG003|Induction|Death|0|||
126004370|NCT00049517|453309669|FG004|Induction|Death|9|||
126004371|NCT00049517|453309670|FG005|Induction|Death|6|||
126004372|NCT00049517|453309665|FG000|Induction|Withdrawal by Subject|0|||
126004373|NCT00049517|453309666|FG001|Induction|Withdrawal by Subject|0|||
126004374|NCT00049517|453309667|FG002|Induction|Withdrawal by Subject|0|||
126004375|NCT00049517|453309668|FG003|Induction|Withdrawal by Subject|0|||
126004376|NCT00049517|453309669|FG004|Induction|Withdrawal by Subject|1|||
126004377|NCT00049517|453309670|FG005|Induction|Withdrawal by Subject|3|||
126004378|NCT00049517|453309665|FG000|Induction|Alternative therapy|0|||
126338035|NCT04794751|454533017|FG000|Period 2|Withdrawal by Subject|0|||
126338036|NCT04794751|454533018|FG001|Period 2|Withdrawal by Subject|1|||
126338037|NCT04794751|454533017|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
126338038|NCT04794751|454533018|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
126338039|NCT04794751|454533017|FG000|Period 2|Protocol Violation|1|||
126338040|NCT04794751|454533018|FG001|Period 2|Protocol Violation|0|||
126338041|NCT00875810|454533022|FG000|Overall Study|Withdrawal by Subject|1|||
126338042|NCT00875810|454533022|FG000|Overall Study|Physician Decision|3|||
126338043|NCT00875810|454533022|FG000|Overall Study|Lost to Follow-up|39|||
126338044|NCT00875810|454533022|FG000|Overall Study|Patient enroled but not implanted|2|||
126338045|NCT00875810|454533022|FG000|Overall Study|Device explanted|1|||
126338046|NCT00780975|454533025|FG000|Overall Study|Progressive disease|3|||
126338047|NCT00780975|454533025|FG000|Overall Study|Toxicity|5|||
126338048|NCT03044314|454533027|FG000|Overall Study|Physician Decision|2|||
126338049|NCT03044314|454533027|FG000|Overall Study|Withdrawal by Subject|1|||
126338050|NCT03044314|454533027|FG000|Overall Study|Connector tubing not available|1|||
126338051|NCT00969228|454533030|FG000|Overall Study|Adverse Event|1|||
126338052|NCT00969228|454533031|FG001|Overall Study|Adverse Event|0|||
126338053|NCT00969228|454533030|FG000|Overall Study|Withdrawal by Subject|4|||
126338054|NCT00969228|454533031|FG001|Overall Study|Withdrawal by Subject|0|||
126338055|NCT00969228|454533030|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
126338056|NCT00969228|454533031|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
126338057|NCT02563899|454533032|FG000|Overall Study|Protocol Violation|1|||
126338058|NCT02563899|454533033|FG001|Overall Study|Protocol Violation|0|||
126338059|NCT02563899|454533034|FG002|Overall Study|Protocol Violation|0|||
126338060|NCT02563899|454533035|FG003|Overall Study|Protocol Violation|0|||
126338061|NCT02563899|454533032|FG000|Overall Study|Withdrawal by Subject|0|||
126338062|NCT02563899|454533033|FG001|Overall Study|Withdrawal by Subject|0|||
126338063|NCT02563899|454533034|FG002|Overall Study|Withdrawal by Subject|1|||
126004379|NCT00049517|453309666|FG001|Induction|Alternative therapy|0|||
126004380|NCT00049517|453309667|FG002|Induction|Alternative therapy|0|||
126338064|NCT02563899|454533035|FG003|Overall Study|Withdrawal by Subject|0|||
126004381|NCT00049517|453309668|FG003|Induction|Alternative therapy|0|||
126004382|NCT00049517|453309669|FG004|Induction|Alternative therapy|2|||
126338065|NCT00794664|454533041|FG000|Treatment Period|Withdrawal by Subject|0|||
126338066|NCT00794664|454533042|FG001|Treatment Period|Withdrawal by Subject|2|||
126338067|NCT00794664|454533041|FG000|Treatment Period|Protocol non-compliance|0|||
126338068|NCT00794664|454533042|FG001|Treatment Period|Protocol non-compliance|1|||
126338069|NCT00794664|454533041|FG000|Treatment Period|Other|0|||
126338070|NCT00794664|454533042|FG001|Treatment Period|Other|1|||
126338071|NCT00794664|454533041|FG000|Treatment Period|Adverse Event|1|||
126338072|NCT00794664|454533042|FG001|Treatment Period|Adverse Event|8|||
126338073|NCT00794664|454533041|FG000|Follow-up Period|Other|1|||
126338074|NCT00794664|454533042|FG001|Follow-up Period|Other|2|||
126338075|NCT00794664|454533041|FG000|Follow-up Period|Withdrawal by Subject|0|||
126338076|NCT00794664|454533042|FG001|Follow-up Period|Withdrawal by Subject|2|||
126338077|NCT00794664|454533041|FG000|Follow-up Period|Protocol non-compliance|0|||
126338078|NCT00794664|454533042|FG001|Follow-up Period|Protocol non-compliance|1|||
126338079|NCT01305564|454533047|FG000|Overall Study|Death|21|||
126338080|NCT01305564|454533047|FG000|Overall Study|Lost to Follow-up|12|||
126338081|NCT01305564|454533047|FG000|Overall Study|Withdrawal by Subject|1|||
126338082|NCT01305564|454533047|FG000|Overall Study|Physician Decision|3|||
126338083|NCT02370511|454533048|FG000|Overall Study|Death|10|||
126338084|NCT02370511|454533049|FG001|Overall Study|Death|7|||
126338085|NCT02370511|454533050|FG002|Overall Study|Death|1|||
126338086|NCT02370511|454533048|FG000|Overall Study|Withdrawal by Subject|2|||
126338087|NCT02370511|454533049|FG001|Overall Study|Withdrawal by Subject|0|||
126338088|NCT02370511|454533050|FG002|Overall Study|Withdrawal by Subject|0|||
126338089|NCT02370511|454533048|FG000|Overall Study|Lost to Follow-up|0|||
126338090|NCT02370511|454533049|FG001|Overall Study|Lost to Follow-up|4|||
126338091|NCT02370511|454533050|FG002|Overall Study|Lost to Follow-up|0|||
126338092|NCT03882918|454533051|FG000|Overall Study|Study terminated by sponsor|98|||
126338093|NCT03882918|454533051|FG000|Overall Study|Protocol Violation|1|||
126338094|NCT03882918|454533051|FG000|Overall Study|Other|9|||
126338095|NCT03882918|454533051|FG000|Overall Study|Lack of Efficacy|14|||
126338096|NCT03882918|454533051|FG000|Overall Study|Adverse Event|13|||
126338097|NCT03882918|454533051|FG000|Overall Study|Withdrawal by Subject|5|||
126338098|NCT00916578|454534693|FG000|Overall Study|Physician Decision|2|||
126338099|NCT00916578|454534693|FG000|Overall Study|Withdrawal by Subject|3|||
126338100|NCT00916578|454534693|FG000|Overall Study|Insurance Denial|2|||
126338101|NCT00496769|454534696|FG000|Double Blind|>=1 reason assigned per patient|558|||
126338102|NCT00496769|454534697|FG001|Double Blind|>=1 reason assigned per patient|649|||
126338103|NCT00496769|454534698|FG002|Double Blind|>=1 reason assigned per patient|0|||
126338104|NCT00496769|454534696|FG000|Open Label|>=1 reason assigned per patient|0|||
126338105|NCT00496769|454534697|FG001|Open Label|>=1 reason assigned per patient|0|||
126338106|NCT00496769|454534698|FG002|Open Label|>=1 reason assigned per patient|1011|||
126338107|NCT02486692|454534699|FG000|Overall Study|did not login for randomization|4|||
126338108|NCT02486692|454534700|FG001|Overall Study|did not login for randomization|7|||
126338109|NCT02224625|454534703|FG000|Irritation|Adverse Event|6|||
126338110|NCT02224625|454534703|FG000|Sensitization|Adverse Event|55|||
126338111|NCT02812186|454534704|FG000|Period 1|Post randomization screen failure|5|||
126338112|NCT02812186|454534705|FG001|Period 1|Post randomization screen failure|9|||
126338113|NCT02812186|454534704|FG000|Period 1|nonevaluable data sets|6|||
126338114|NCT02812186|454534705|FG001|Period 1|nonevaluable data sets|6|||
126338115|NCT01433159|454534710|FG000|Overall Study|Adverse Event|1|||
126338116|NCT01433159|454534711|FG001|Overall Study|Adverse Event|0|||
126338117|NCT01433159|454534710|FG000|Overall Study|Physician Decision|1|||
126338118|NCT01433159|454534711|FG001|Overall Study|Physician Decision|0|||
126338119|NCT01433159|454534710|FG000|Overall Study|Protocol Violation|0|||
126338120|NCT01433159|454534711|FG001|Overall Study|Protocol Violation|1|||
126338121|NCT01100853|454534712|FG000|Overall Study|Lost to Follow-up|11|||
126338122|NCT01100853|454534713|FG001|Overall Study|Lost to Follow-up|6|||
126338123|NCT01100853|454534712|FG000|Overall Study|Received <4 study injections|10|||
126338124|NCT01100853|454534713|FG001|Overall Study|Received <4 study injections|13|||
126338125|NCT01100853|454534712|FG000|Overall Study|Withdrawal by Subject|6|||
126338126|NCT01100853|454534713|FG001|Overall Study|Withdrawal by Subject|4|||
126338127|NCT01190891|454534714|FG000|Overall Study|Protocol Violation|1|||
126338128|NCT01190891|454534715|FG001|Overall Study|Protocol Violation|0|||
126338129|NCT01190891|454534714|FG000|Overall Study|Withdrawal by Subject|5|||
126338130|NCT01190891|454534715|FG001|Overall Study|Withdrawal by Subject|0|||
126338131|NCT00266708|454534716|FG000|Overall Study|No renal function|1|||
126338132|NCT00266708|454534717|FG001|Overall Study|No renal function|1|||
126338133|NCT00266708|454534716|FG000|Overall Study|Refused biopsy|3|||
126338134|NCT00266708|454534717|FG001|Overall Study|Refused biopsy|6|||
126338135|NCT00266708|454534716|FG000|Overall Study|Asthma|0|||
126338136|NCT00266708|454534717|FG001|Overall Study|Asthma|2|||
126338137|NCT01926028|454534718|FG000|Overall Study|Lost to Follow-up|7|||
126338138|NCT01926028|454534719|FG001|Overall Study|Lost to Follow-up|6|||
126338139|NCT01926028|454534720|FG002|Overall Study|Lost to Follow-up|0|||
126338140|NCT01926028|454534718|FG000|Overall Study|Physician Decision|1|||
126338141|NCT01926028|454534719|FG001|Overall Study|Physician Decision|5|||
126338142|NCT01926028|454534720|FG002|Overall Study|Physician Decision|0|||
126338143|NCT01926028|454534718|FG000|Overall Study|Withdrawal by Subject|9|||
126338144|NCT01926028|454534719|FG001|Overall Study|Withdrawal by Subject|9|||
126338145|NCT01926028|454534720|FG002|Overall Study|Withdrawal by Subject|2|||
126338146|NCT01926028|454534718|FG000|Overall Study|Non compliance or other reasons|4|||
126338147|NCT01926028|454534719|FG001|Overall Study|Non compliance or other reasons|2|||
126338148|NCT01926028|454534720|FG002|Overall Study|Non compliance or other reasons|0|||
126338149|NCT01130272|454534721|FG000|Overall Study|Adverse Event|2|||
126338150|NCT01130272|454534722|FG001|Overall Study|Adverse Event|5|||
126338151|NCT01130272|454534723|FG002|Overall Study|Adverse Event|6|||
126338152|NCT01130272|454534724|FG003|Overall Study|Adverse Event|22|||
126338153|NCT01130272|454534725|FG004|Overall Study|Adverse Event|7|||
126338154|NCT01130272|454534721|FG000|Overall Study|IVRS-confirmed constipation|0|||
126338155|NCT01130272|454534722|FG001|Overall Study|IVRS-confirmed constipation|1|||
126338156|NCT01130272|454534723|FG002|Overall Study|IVRS-confirmed constipation|1|||
126338157|NCT01130272|454534724|FG003|Overall Study|IVRS-confirmed constipation|2|||
126338158|NCT01130272|454534725|FG004|Overall Study|IVRS-confirmed constipation|0|||
126338159|NCT01130272|454534721|FG000|Overall Study|Rescue medications due to diarrhea|3|||
126338160|NCT01130272|454534722|FG001|Overall Study|Rescue medications due to diarrhea|5|||
126338161|NCT01130272|454534723|FG002|Overall Study|Rescue medications due to diarrhea|8|||
126338162|NCT01130272|454534724|FG003|Overall Study|Rescue medications due to diarrhea|8|||
126338163|NCT01130272|454534725|FG004|Overall Study|Rescue medications due to diarrhea|6|||
126338164|NCT01130272|454534721|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
126338165|NCT01130272|454534722|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
126338166|NCT01130272|454534723|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
126338167|NCT01130272|454534724|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
126338168|NCT01130272|454534725|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
126338169|NCT01130272|454534721|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
126338170|NCT01130272|454534722|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
126338171|NCT01130272|454534723|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
126338172|NCT01130272|454534724|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
126338173|NCT01130272|454534725|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
126338174|NCT01130272|454534721|FG000|Overall Study|Protocol Violation|0|||
126338175|NCT01130272|454534722|FG001|Overall Study|Protocol Violation|0|||
126338176|NCT01130272|454534723|FG002|Overall Study|Protocol Violation|3|||
126338177|NCT01130272|454534724|FG003|Overall Study|Protocol Violation|5|||
126338178|NCT01130272|454534725|FG004|Overall Study|Protocol Violation|5|||
126338179|NCT01130272|454534721|FG000|Overall Study|Lost to Follow-up|4|||
126338180|NCT01130272|454534722|FG001|Overall Study|Lost to Follow-up|3|||
126338181|NCT01130272|454534723|FG002|Overall Study|Lost to Follow-up|4|||
126338182|NCT01130272|454534724|FG003|Overall Study|Lost to Follow-up|7|||
126338183|NCT01130272|454534725|FG004|Overall Study|Lost to Follow-up|6|||
126338184|NCT01130272|454534721|FG000|Overall Study|Withdrawal by Subject|4|||
126338185|NCT01130272|454534722|FG001|Overall Study|Withdrawal by Subject|11|||
126338186|NCT01130272|454534723|FG002|Overall Study|Withdrawal by Subject|10|||
126338187|NCT01130272|454534724|FG003|Overall Study|Withdrawal by Subject|9|||
126338188|NCT01130272|454534725|FG004|Overall Study|Withdrawal by Subject|8|||
126338189|NCT01130272|454534721|FG000|Overall Study|Physician Decision|1|||
126338190|NCT01130272|454534722|FG001|Overall Study|Physician Decision|1|||
126338191|NCT01130272|454534723|FG002|Overall Study|Physician Decision|0|||
126338192|NCT01130272|454534724|FG003|Overall Study|Physician Decision|1|||
126338193|NCT01130272|454534725|FG004|Overall Study|Physician Decision|2|||
126338194|NCT01130272|454534721|FG000|Overall Study|Sponsor decision|6|||
126338195|NCT01130272|454534722|FG001|Overall Study|Sponsor decision|15|||
126338196|NCT01130272|454534723|FG002|Overall Study|Sponsor decision|16|||
126338197|NCT01130272|454534724|FG003|Overall Study|Sponsor decision|13|||
126338198|NCT01130272|454534725|FG004|Overall Study|Sponsor decision|16|||
126338199|NCT01130272|454534721|FG000|Overall Study|Study arm discontinued|38|||
126338200|NCT01130272|454534722|FG001|Overall Study|Study arm discontinued|0|||
126338201|NCT01130272|454534723|FG002|Overall Study|Study arm discontinued|0|||
126338202|NCT01130272|454534724|FG003|Overall Study|Study arm discontinued|0|||
126338203|NCT01130272|454534725|FG004|Overall Study|Study arm discontinued|0|||
126338204|NCT01548404|454534726|FG000|Overall Study|Adverse Event|3|||
126338205|NCT01548404|454534727|FG001|Overall Study|Adverse Event|1|||
126338206|NCT01548404|454534726|FG000|Overall Study|Physician Decision|2|||
126338207|NCT01548404|454534727|FG001|Overall Study|Physician Decision|1|||
126338208|NCT01548404|454534726|FG000|Overall Study|Inadequate response to study treatment|23|||
126338209|NCT01548404|454534727|FG001|Overall Study|Inadequate response to study treatment|7|||
126338210|NCT01548404|454534726|FG000|Overall Study|Lost to Follow-up|2|||
126338211|NCT01548404|454534727|FG001|Overall Study|Lost to Follow-up|0|||
126338212|NCT01548404|454534726|FG000|Overall Study|Withdrawal by Subject|0|||
126338213|NCT01548404|454534727|FG001|Overall Study|Withdrawal by Subject|3|||
126338214|NCT01548404|454534726|FG000|Overall Study|Other than specified above|0|||
126338215|NCT01548404|454534727|FG001|Overall Study|Other than specified above|2|||
126338216|NCT00737048|454534728|FG000|Overall Study|Physician Decision|0|||
126338217|NCT00737048|454534729|FG001|Overall Study|Physician Decision|0|||
126338218|NCT00737048|454534730|FG002|Overall Study|Physician Decision|1|||
126338219|NCT00737048|454534728|FG000|Overall Study|Adverse Event|0|||
126338220|NCT00737048|454534729|FG001|Overall Study|Adverse Event|1|||
126338221|NCT00737048|454534730|FG002|Overall Study|Adverse Event|0|||
126338222|NCT00737048|454534728|FG000|Overall Study|Worsening of the symptoms|3|||
126338223|NCT00737048|454534729|FG001|Overall Study|Worsening of the symptoms|5|||
126338224|NCT00737048|454534730|FG002|Overall Study|Worsening of the symptoms|3|||
126338225|NCT00641056|454534731|FG000|Overall Study|Adverse Event|12|||
126338226|NCT00641056|454534732|FG001|Overall Study|Adverse Event|2|||
126338227|NCT00641056|454534731|FG000|Overall Study|Lost to Follow-up|2|||
126338228|NCT00641056|454534732|FG001|Overall Study|Lost to Follow-up|1|||
126338229|NCT00641056|454534731|FG000|Overall Study|Physician Decision|3|||
126338230|NCT00641056|454534732|FG001|Overall Study|Physician Decision|1|||
126338231|NCT00641056|454534731|FG000|Overall Study|Protocol Violation|2|||
126338232|NCT00641056|454534732|FG001|Overall Study|Protocol Violation|0|||
126338233|NCT00641056|454534731|FG000|Overall Study|Entry Criteria Not Met|3|||
126338234|NCT00641056|454534732|FG001|Overall Study|Entry Criteria Not Met|0|||
126338235|NCT00641056|454534731|FG000|Overall Study|Subject Decision|6|||
126338236|NCT00641056|454534732|FG001|Overall Study|Subject Decision|19|||
126338237|NCT00641056|454534731|FG000|Overall Study|Sponsor Decision|1|||
126338238|NCT00641056|454534732|FG001|Overall Study|Sponsor Decision|2|||
126338239|NCT04040439|454534734|FG000|Overall Study|Invalid registration|11|||
126338240|NCT04040439|454534734|FG000|Overall Study|No IC* on publication of study results|2|||
126338241|NCT01309386|454534735|FG000|Overall Study|Other|2|||
126338242|NCT01309386|454534736|FG001|Overall Study|Other|0|||
126338243|NCT01309386|454534735|FG000|Overall Study|Withdrawal by Subject|2|||
126338244|NCT01309386|454534736|FG001|Overall Study|Withdrawal by Subject|0|||
126338245|NCT01309386|454534735|FG000|Overall Study|Progressive disease|9|||
126338246|NCT01309386|454534736|FG001|Overall Study|Progressive disease|11|||
126338247|NCT01309386|454534735|FG000|Overall Study|Physician Decision|1|||
126338248|NCT01309386|454534736|FG001|Overall Study|Physician Decision|1|||
126338249|NCT01309386|454534735|FG000|Overall Study|Lack of Efficacy|3|||
126338250|NCT01309386|454534736|FG001|Overall Study|Lack of Efficacy|1|||
126338251|NCT01309386|454534735|FG000|Overall Study|Adverse Event|5|||
126338252|NCT01309386|454534736|FG001|Overall Study|Adverse Event|8|||
126338253|NCT02062437|454534737|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
126338254|NCT02062437|454534737|FG000|Overall Study|Patient not available for the 2y visit|18|||
126338255|NCT02062437|454534737|FG000|Overall Study|Death|2|||
126338256|NCT02062437|454534737|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
126338257|NCT01674725|454534738|FG000|Overall Study|Adverse Event|1|||
126338258|NCT01674725|454534739|FG001|Overall Study|Adverse Event|0|||
126338259|NCT01674725|454534738|FG000|Overall Study|Did not receive study drug|1|||
126338260|NCT01674725|454534739|FG001|Overall Study|Did not receive study drug|0|||
126338261|NCT01674725|454534738|FG000|Overall Study|Withdrawal by Subject|1|||
126338262|NCT01674725|454534739|FG001|Overall Study|Withdrawal by Subject|0|||
126338263|NCT01674725|454534738|FG000|Overall Study|Lost to Follow-up|0|||
126338264|NCT01674725|454534739|FG001|Overall Study|Lost to Follow-up|1|||
126338265|NCT02900352|454534740|FG000|Overall Study|Lost to Follow-up|28|||
126338266|NCT02900352|454534741|FG001|Overall Study|Lost to Follow-up|17|||
126338267|NCT03074695|454534742|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
126338268|NCT03074695|454534743|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
126338269|NCT03074695|454534742|FG000|Overall Study|Research staff not available|1|||
126338270|NCT03074695|454534743|FG001|Overall Study|Research staff not available|2|||
126338271|NCT03074695|454534742|FG000|Overall Study|Did not receive neuraxial block|2|||
126338272|NCT03074695|454534743|FG001|Overall Study|Did not receive neuraxial block|2|||
126338273|NCT01774981|454534744|FG000|Overall Study|Adverse Event|0|||
126338274|NCT01774981|454534745|FG001|Overall Study|Adverse Event|0|||
126338275|NCT01774981|454534746|FG002|Overall Study|Adverse Event|0|||
126338276|NCT01774981|454534747|FG003|Overall Study|Adverse Event|0|||
126338277|NCT01774981|454534748|FG004|Overall Study|Adverse Event|0|||
126338278|NCT01774981|454534749|FG005|Overall Study|Adverse Event|1|||
126338279|NCT01774981|454534750|FG006|Overall Study|Adverse Event|0|||
126338280|NCT01774981|454534751|FG007|Overall Study|Adverse Event|0|||
126338281|NCT01774981|454534744|FG000|Overall Study|Withdrawal by Subject|0|||
126338282|NCT01774981|454534745|FG001|Overall Study|Withdrawal by Subject|0|||
126338283|NCT01774981|454534746|FG002|Overall Study|Withdrawal by Subject|0|||
126338284|NCT01774981|454534747|FG003|Overall Study|Withdrawal by Subject|0|||
126338285|NCT01774981|454534748|FG004|Overall Study|Withdrawal by Subject|0|||
126338286|NCT01774981|454534749|FG005|Overall Study|Withdrawal by Subject|0|||
126338287|NCT01774981|454534750|FG006|Overall Study|Withdrawal by Subject|0|||
126338288|NCT01774981|454534751|FG007|Overall Study|Withdrawal by Subject|1|||
126338289|NCT01774981|454534744|FG000|Overall Study|Death|0|||
126338290|NCT01774981|454534745|FG001|Overall Study|Death|0|||
126338291|NCT01774981|454534746|FG002|Overall Study|Death|0|||
126338292|NCT01774981|454534747|FG003|Overall Study|Death|0|||
126338293|NCT01774981|454534748|FG004|Overall Study|Death|1|||
126338294|NCT01774981|454534749|FG005|Overall Study|Death|0|||
126338295|NCT01774981|454534750|FG006|Overall Study|Death|0|||
126338296|NCT01774981|454534751|FG007|Overall Study|Death|0|||
126338297|NCT00960193|454534752|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
126338298|NCT01324102|454534753|FG000|Overall Study|illness|1|||
126338299|NCT01324102|454534754|FG001|Overall Study|illness|6|||
126338300|NCT00386334|454534759|FG000|Double Blind Period|Adverse Event|9|||
126338301|NCT00386334|454534760|FG001|Double Blind Period|Adverse Event|14|||
126338302|NCT00386334|454534759|FG000|Double Blind Period|Protocol Violation|1|||
126338303|NCT00386334|454534760|FG001|Double Blind Period|Protocol Violation|1|||
126338304|NCT00386334|454534759|FG000|Double Blind Period|Withdrawal by Subject|9|||
126338305|NCT00386334|454534760|FG001|Double Blind Period|Withdrawal by Subject|13|||
126338306|NCT00386334|454534759|FG000|Double Blind Period|Lack of Efficacy|20|||
126338307|NCT00386334|454534760|FG001|Double Blind Period|Lack of Efficacy|11|||
126338308|NCT00386334|454534759|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
126338309|NCT00386334|454534760|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
126338310|NCT00386334|454534759|FG000|Double Blind Period|Other|3|||
126338311|NCT00386334|454534760|FG001|Double Blind Period|Other|3|||
126338312|NCT00386334|454534759|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
126338313|NCT00386334|454534760|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
126338314|NCT00902577|454534761|FG000|Overall Study|Withdrawal by Subject|6|||
126338315|NCT00902577|454534761|FG000|Overall Study|FMISO production failure|2|||
126338316|NCT00106002|454534762|FG000|Overall Study|Did not take any study drug|1|||
126338317|NCT00106002|454534762|FG000|Overall Study|Ineligible after Registration|1|||
126338318|NCT01245101|454534765|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
126338319|NCT01245101|454534766|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
126338320|NCT01245101|454534765|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
126338321|NCT01245101|454534766|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
126338322|NCT01245101|454534765|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
126338323|NCT01245101|454534766|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
126338324|NCT04456686|454534769|FG000|Overall Study|Adverse Event|2|||
126338325|NCT04456686|454534770|FG001|Overall Study|Adverse Event|1|||
126338326|NCT04456686|454534769|FG000|Overall Study|Lack of Efficacy|3|||
126338327|NCT04456686|454534770|FG001|Overall Study|Lack of Efficacy|1|||
126338328|NCT04456686|454534769|FG000|Overall Study|Withdrew consent|3|||
126338329|NCT04456686|454534770|FG001|Overall Study|Withdrew consent|1|||
126338330|NCT04456686|454534769|FG000|Overall Study|Physician Decision|2|||
126338331|NCT04456686|454534770|FG001|Overall Study|Physician Decision|2|||
126338332|NCT04456686|454534769|FG000|Overall Study|Withdrawal by Subject|5|||
126338333|NCT04456686|454534770|FG001|Overall Study|Withdrawal by Subject|1|||
126338334|NCT04456686|454534769|FG000|Overall Study|Protocol Violation|0|||
126338335|NCT04456686|454534770|FG001|Overall Study|Protocol Violation|1|||
126338336|NCT00473083|454534775|FG000|Overall Study|Adverse Event|1|||
126338337|NCT00473083|454534776|FG001|Overall Study|Adverse Event|0|||
126338338|NCT00473083|454534777|FG002|Overall Study|Adverse Event|0|||
126338339|NCT02915835|454534778|FG000|Overall Study|Physician Decision|1|||
126338340|NCT02915835|454534779|FG001|Overall Study|Physician Decision|0|||
126338341|NCT02915835|454534778|FG000|Overall Study|Withdrawal by Subject|0|||
126338342|NCT02915835|454534779|FG001|Overall Study|Withdrawal by Subject|1|||
126338343|NCT00113607|454534780|FG000|Overall Study|Adverse Event|40|||
126338344|NCT00113607|454534781|FG001|Overall Study|Adverse Event|71|||
126338345|NCT00113607|454534780|FG000|Overall Study|Death|8|||
126338346|NCT00113607|454534781|FG001|Overall Study|Death|8|||
126338347|NCT00113607|454534780|FG000|Overall Study|Withdrawal by Subject|50|||
126338348|NCT00113607|454534781|FG001|Overall Study|Withdrawal by Subject|58|||
126338349|NCT00113607|454534780|FG000|Overall Study|Lost to Follow-up|0|||
126338350|NCT00113607|454534781|FG001|Overall Study|Lost to Follow-up|2|||
126338351|NCT00113607|454534780|FG000|Overall Study|Disease Progression|180|||
126338352|NCT00113607|454534781|FG001|Overall Study|Disease Progression|142|||
126338353|NCT00113607|454534780|FG000|Overall Study|Complete Response (Confirmed)|14|||
126338354|NCT00113607|454534781|FG001|Overall Study|Complete Response (Confirmed)|24|||
126338355|NCT00113607|454534780|FG000|Overall Study|Other|43|||
126338356|NCT00113607|454534781|FG001|Overall Study|Other|32|||
126338357|NCT01222104|454534782|FG000|Overall Study|Lost to Follow-up|37|||
126338358|NCT01222104|454534782|FG000|Overall Study|Death|10|||
126338359|NCT01418339|454534783|FG000|Overall Study|Adverse Event|5|||
126338360|NCT01418339|454534784|FG001|Overall Study|Adverse Event|2|||
126338361|NCT01418339|454534783|FG000|Overall Study|Subject Withdrew Consent|1|||
126338362|NCT01418339|454534784|FG001|Overall Study|Subject Withdrew Consent|2|||
126338363|NCT01418339|454534783|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
126338364|NCT01418339|454534784|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
126338365|NCT03885908|454534785|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
126338366|NCT03885908|454534786|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
126338367|NCT03885908|454534785|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
126338368|NCT03885908|454534786|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
126338369|NCT03885908|454534785|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
126338370|NCT03885908|454534786|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
126338371|NCT03885908|454534785|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
126338372|NCT03885908|454534786|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
126004383|NCT00049517|453309670|FG005|Induction|Alternative therapy|2|||
126338373|NCT00909844|454534787|FG000|Overall Study|Adverse Event|1|||
126338374|NCT00909844|454534787|FG000|Overall Study|Withdrawal by Subject|1|||
126338375|NCT00909844|454534787|FG000|Overall Study|Lost to Follow-up|2|||
126338376|NCT00706004|454534788|FG000|Overall Study|Did not meet eligibility criteria|2|||
126338377|NCT01064479|454534789|FG000|Overall Study|Death|10|||
126338378|NCT01064479|454534790|FG001|Overall Study|Death|11|||
126338379|NCT01064479|454534789|FG000|Overall Study|Withdrawal by Subject|2|||
126338380|NCT01064479|454534790|FG001|Overall Study|Withdrawal by Subject|2|||
126338381|NCT01064479|454534789|FG000|Overall Study|Disease progression|1|||
126338382|NCT01064479|454534790|FG001|Overall Study|Disease progression|1|||
126338383|NCT01064479|454534789|FG000|Overall Study|Toxicity|1|||
126338384|NCT01064479|454534790|FG001|Overall Study|Toxicity|1|||
126338385|NCT01064479|454534789|FG000|Overall Study|Other|1|||
126338386|NCT01064479|454534790|FG001|Overall Study|Other|2|||
126338387|NCT03093181|454534793|FG000|Overall Study|Withdrawal by Subject|2|||
126338388|NCT03093181|454534794|FG001|Overall Study|Withdrawal by Subject|1|||
126338389|NCT03093181|454534795|FG002|Overall Study|Withdrawal by Subject|2|||
126338390|NCT03093181|454534793|FG000|Overall Study|Other (Not specified)|1|||
126338391|NCT03093181|454534794|FG001|Overall Study|Other (Not specified)|0|||
126338392|NCT03093181|454534795|FG002|Overall Study|Other (Not specified)|0|||
126338393|NCT03093181|454534793|FG000|Overall Study|Adverse Event|0|||
126338394|NCT03093181|454534794|FG001|Overall Study|Adverse Event|1|||
126338395|NCT03093181|454534795|FG002|Overall Study|Adverse Event|0|||
126338396|NCT03093181|454534793|FG000|Overall Study|Other (Protocol violation)|0|||
126338397|NCT03093181|454534794|FG001|Overall Study|Other (Protocol violation)|0|||
126338398|NCT03093181|454534795|FG002|Overall Study|Other (Protocol violation)|1|||
126338399|NCT04210986|454534796|FG000|Overall Study|Lost to Follow-up|5|||
126338400|NCT04210986|454534797|FG001|Overall Study|Lost to Follow-up|2|||
126338401|NCT04210986|454534796|FG000|Overall Study|Withdrawal by Subject|3|||
126338402|NCT04210986|454534797|FG001|Overall Study|Withdrawal by Subject|1|||
126338403|NCT04210986|454534796|FG000|Overall Study|Protocol Violation|1|||
126338404|NCT04210986|454534797|FG001|Overall Study|Protocol Violation|1|||
126338405|NCT04210986|454534796|FG000|Overall Study|Physician Decision|0|||
126338406|NCT04210986|454534797|FG001|Overall Study|Physician Decision|1|||
126338407|NCT02378662|454534798|FG000|Overall Study|Early Discontinuation|2|||
126338408|NCT02378662|454534799|FG001|Overall Study|Early Discontinuation|0|||
126338409|NCT01159574|454534800|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
126338410|NCT01159574|454534800|FG000|Treatment Phase|Adverse Event|3|||
126338411|NCT01159574|454534800|FG000|Treatment Phase|Death|6|||
126338412|NCT01159574|454534800|FG000|Treatment Phase|Physician Decision|2|||
126338413|NCT01159574|454534800|FG000|Treatment Phase|Withdrawal by Subject|7|||
126338414|NCT01159574|454534800|FG000|Treatment Phase|still on treatment|2|||
126338415|NCT01159574|454534800|FG000|Follow Up Phase|Lost to Follow-up|2|||
126338416|NCT01159574|454534800|FG000|Follow Up Phase|still being followed for overall surviva|18|||
126338417|NCT02666222|454534802|FG000|Overall Study|Death|2|||
126338418|NCT01474486|454534804|FG000|Overall Study|Death|2|||
126338419|NCT01474486|454534804|FG000|Overall Study|Withdrawal by Subject|4|||
126338420|NCT01474486|454534804|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
126338421|NCT03504917|454534805|FG000|Blinded Treatment Period|Protocol Violation|1|||
126338422|NCT03504917|454534806|FG001|Blinded Treatment Period|Protocol Violation|0|||
126338423|NCT03504917|454534805|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
126338424|NCT03504917|454534806|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
126338425|NCT03504917|454534805|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
126338426|NCT03504917|454534806|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
126338427|NCT03504917|454534805|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
126338428|NCT03504917|454534806|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
126338429|NCT03504917|454534805|FG000|Blinded Treatment Period|Adverse Event|4|||
126338430|NCT03504917|454534806|FG001|Blinded Treatment Period|Adverse Event|4|||
126338431|NCT03504917|454534805|FG000|Blinded Treatment Period|Physician Decision|1|||
126338432|NCT03504917|454534806|FG001|Blinded Treatment Period|Physician Decision|0|||
126338433|NCT03504917|454534805|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
126338434|NCT03504917|454534806|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
126338435|NCT03504917|454534805|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
126338436|NCT03504917|454534806|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
126338437|NCT03504917|454534805|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
126338438|NCT03504917|454534806|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
126338439|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
126338440|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
126338441|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
126338442|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
126338443|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
126338444|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
126338445|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
126338446|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
126338447|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
126338448|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
126338449|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
126338450|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
126338451|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
126338452|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
126338453|NCT04219189|454534807|FG000|Overall Study|Withdrawal by Subject|1|||
126338454|NCT04219189|454534808|FG001|Overall Study|Withdrawal by Subject|2|||
126338455|NCT04219189|454534807|FG000|Overall Study|Protocol Violation|0|||
126338456|NCT04219189|454534808|FG001|Overall Study|Protocol Violation|1|||
126338457|NCT04219189|454534807|FG000|Overall Study|Lost to Follow-up|0|||
126338458|NCT04219189|454534808|FG001|Overall Study|Lost to Follow-up|1|||
126338459|NCT04219189|454534807|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
126338460|NCT04219189|454534808|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
126338461|NCT03101020|454534809|FG000|Overall Study|Lack of time to participate|1|||
126338462|NCT03101020|454534810|FG001|Overall Study|Lack of time to participate|0|||
126338463|NCT03101020|454534809|FG000|Overall Study|Ran over by a car|0|||
126338464|NCT03101020|454534810|FG001|Overall Study|Ran over by a car|1|||
126338465|NCT03101020|454534809|FG000|Overall Study|Withdrawal by Subject|0|||
126338466|NCT03101020|454534810|FG001|Overall Study|Withdrawal by Subject|2|||
126338467|NCT04233879|454534811|FG000|Overall Study|Death|2|||
126338468|NCT04233879|454534812|FG001|Overall Study|Death|0|||
126338469|NCT04233879|454534811|FG000|Overall Study|Lost to Follow-up|3|||
126338470|NCT04233879|454534812|FG001|Overall Study|Lost to Follow-up|8|||
126338471|NCT04233879|454534811|FG000|Overall Study|Physician Decision|4|||
126338472|NCT04233879|454534812|FG001|Overall Study|Physician Decision|4|||
126338473|NCT04233879|454534811|FG000|Overall Study|Withdrawal by Subject|7|||
126338474|NCT04233879|454534812|FG001|Overall Study|Withdrawal by Subject|10|||
126338475|NCT04233879|454534811|FG000|Overall Study|Other|281|||
126338476|NCT04233879|454534812|FG001|Overall Study|Other|279|||
126338477|NCT03585270|454534815|FG000|Overall Study|Withdrawal by Subject|2|||
126338478|NCT03585270|454534816|FG001|Overall Study|Withdrawal by Subject|6|||
126338479|NCT03585270|454534815|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
126338480|NCT03585270|454534816|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
126338481|NCT03585270|454534815|FG000|Overall Study|Adverse Event|5|||
126338482|NCT03585270|454534816|FG001|Overall Study|Adverse Event|2|||
126338483|NCT03585270|454534815|FG000|Overall Study|Lost to Follow-up|1|||
126338484|NCT03585270|454534816|FG001|Overall Study|Lost to Follow-up|4|||
126338485|NCT03585270|454534815|FG000|Overall Study|Death|5|||
126338486|NCT03585270|454534816|FG001|Overall Study|Death|3|||
126338487|NCT03585270|454534815|FG000|Overall Study|Other reasons|2|||
126338488|NCT03585270|454534816|FG001|Overall Study|Other reasons|2|||
126338489|NCT03292016|454534817|FG000|Second Washout|Adverse Event|0|||
126338490|NCT03292016|454534818|FG001|Second Washout|Adverse Event|1|||
126338491|NCT03292016|454534819|FG002|Second Washout|Adverse Event|0|||
126338492|NCT03292016|454534820|FG003|Second Washout|Adverse Event|0|||
126338493|NCT03292016|454534821|FG004|Second Washout|Adverse Event|0|||
126338494|NCT03292016|454534822|FG005|Second Washout|Adverse Event|0|||
126338495|NCT01791985|454534827|FG000|Overall Study|Adverse Event|7|||
126338496|NCT01791985|454534827|FG000|Overall Study|Withdrawal by Subject|1|||
126338497|NCT00372424|454534828|FG000|Overall Study|Adverse Event|2|||
126338498|NCT00372424|454534828|FG000|Overall Study|Withdrawal by Subject|1|||
126338499|NCT00372424|454534828|FG000|Overall Study|Death|1|||
126338500|NCT00372424|454534828|FG000|Overall Study|Objective Progression or Relapse|14|||
126338501|NCT00372424|454534828|FG000|Overall Study|Other|7|||
126338502|NCT00372424|454534828|FG000|Overall Study|Enrolled, Not Treated|1|||
126338503|NCT00072410|454534829|FG000|Overall Study|Progressive disease|0|||
126338504|NCT00072410|454534830|FG001|Overall Study|Progressive disease|3|||
126338505|NCT02314728|454534836|FG000|Overall Study|Protocol Violation|1|||
126338506|NCT02314728|454534837|FG001|Overall Study|Protocol Violation|0|||
126338507|NCT02314728|454534836|FG000|Overall Study|Lost to Follow-up|0|||
126338508|NCT02314728|454534837|FG001|Overall Study|Lost to Follow-up|1|||
126338509|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
126338510|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338511|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338512|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338513|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338514|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338515|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338516|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
126338517|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338518|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338519|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338520|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338521|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338522|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338523|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338524|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
126338525|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338526|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338527|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338528|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338529|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338530|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338531|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338532|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
126338533|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338534|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338535|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338536|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338537|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338538|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338539|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
126338540|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338541|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338542|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338543|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338544|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338545|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338546|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
126338547|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338548|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338549|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338550|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338551|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338552|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338553|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338554|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
126338555|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338556|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338557|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338558|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338559|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338560|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338561|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
126338562|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338563|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338564|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338565|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338566|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338567|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338568|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338569|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
126338570|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338571|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338572|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338573|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338574|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338575|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338576|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
126338577|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338578|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338579|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338580|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338581|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338582|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338583|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
126338584|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338585|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338586|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338587|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338588|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338589|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338590|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
126338591|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338592|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338593|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338594|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338595|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338596|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338597|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338598|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
126338599|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338600|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338601|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338602|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338603|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338604|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338605|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
126338606|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338607|NCT01791595|454534838|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338608|NCT01791595|454534839|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338609|NCT01791595|454534840|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338610|NCT01791595|454534841|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338611|NCT01791595|454534842|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338612|NCT01791595|454534843|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338613|NCT01791595|454534844|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
126338614|NCT01791595|454534838|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338615|NCT01791595|454534839|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338616|NCT01791595|454534840|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338617|NCT01791595|454534841|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338618|NCT01791595|454534842|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338619|NCT01791595|454534843|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338620|NCT01791595|454534844|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
126338621|NCT01791595|454534838|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338622|NCT01791595|454534839|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338623|NCT01791595|454534840|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338624|NCT01791595|454534841|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338625|NCT01791595|454534842|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338626|NCT01791595|454534843|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338627|NCT01791595|454534844|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
126338628|NCT01791595|454534838|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338629|NCT01791595|454534839|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338630|NCT01791595|454534840|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338631|NCT01791595|454534841|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338632|NCT01791595|454534842|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338633|NCT01791595|454534843|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338634|NCT01791595|454534844|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
126338635|NCT03118934|454534845|FG000|Overall Study|Adverse Event|0|||
126338636|NCT03118934|454534846|FG001|Overall Study|Adverse Event|0|||
126338637|NCT03118934|454534847|FG002|Overall Study|Adverse Event|0|||
126338638|NCT03118934|454534848|FG003|Overall Study|Adverse Event|0|||
126338639|NCT03118934|454534849|FG004|Overall Study|Adverse Event|0|||
126338640|NCT03118934|454534850|FG005|Overall Study|Adverse Event|1|||
126338641|NCT03118934|454534845|FG000|Overall Study|Physician Decision|0|||
126338642|NCT03118934|454534846|FG001|Overall Study|Physician Decision|0|||
126338643|NCT03118934|454534847|FG002|Overall Study|Physician Decision|0|||
126338644|NCT03118934|454534848|FG003|Overall Study|Physician Decision|0|||
126338645|NCT03118934|454534849|FG004|Overall Study|Physician Decision|0|||
126338646|NCT03118934|454534850|FG005|Overall Study|Physician Decision|1|||
126338647|NCT03118934|454534845|FG000|Overall Study|Discontinued prior to exposure|0|||
126338648|NCT03118934|454534846|FG001|Overall Study|Discontinued prior to exposure|1|||
126338649|NCT03118934|454534847|FG002|Overall Study|Discontinued prior to exposure|1|||
126338650|NCT03118934|454534848|FG003|Overall Study|Discontinued prior to exposure|1|||
126338651|NCT03118934|454534849|FG004|Overall Study|Discontinued prior to exposure|2|||
126338652|NCT03118934|454534850|FG005|Overall Study|Discontinued prior to exposure|0|||
126338653|NCT01419314|454534855|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
126338654|NCT01419314|454534856|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
126338655|NCT01419314|454534855|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
126338656|NCT01419314|454534856|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
126338657|NCT01419314|454534855|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
126338658|NCT01419314|454534856|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
126338659|NCT01814007|454534861|FG000|Overall Study|Withdrawal by Subject|1|||
126338660|NCT02100124|454534863|FG000|Overall Study|Lost to Follow-up|5|||
126338661|NCT02100124|454534864|FG001|Overall Study|Lost to Follow-up|11|||
126338662|NCT02100124|454534865|FG002|Overall Study|Lost to Follow-up|3|||
126338663|NCT02100124|454534863|FG000|Overall Study|Withdrawal by Subject|1|||
126338664|NCT02100124|454534864|FG001|Overall Study|Withdrawal by Subject|0|||
126338665|NCT02100124|454534865|FG002|Overall Study|Withdrawal by Subject|0|||
126338666|NCT01548599|454536277|FG000|Overall Study|Lost to Follow-up|0|||
126338667|NCT01548599|454536278|FG001|Overall Study|Lost to Follow-up|1|||
126338668|NCT01548599|454536277|FG000|Overall Study|Withdrawal by Subject|4|||
126338669|NCT01548599|454536278|FG001|Overall Study|Withdrawal by Subject|0|||
126338670|NCT01548599|454536277|FG000|Overall Study|Death|2|||
126338671|NCT01548599|454536278|FG001|Overall Study|Death|1|||
126338672|NCT05630196|454536279|FG000|Overall Study|Adverse Event|2|||
126338673|NCT05630196|454536280|FG001|Overall Study|Adverse Event|1|||
126338674|NCT05630196|454536279|FG000|Overall Study|Lost to Follow-up|1|||
126338675|NCT05630196|454536280|FG001|Overall Study|Lost to Follow-up|1|||
126338676|NCT05630196|454536279|FG000|Overall Study|Protocol Violation|2|||
126338677|NCT05630196|454536280|FG001|Overall Study|Protocol Violation|3|||
126338678|NCT05630196|454536279|FG000|Overall Study|Physician Decision|1|||
126338679|NCT05630196|454536280|FG001|Overall Study|Physician Decision|0|||
126338680|NCT05630196|454536279|FG000|Overall Study|Withdrawal by Subject|3|||
126338681|NCT05630196|454536280|FG001|Overall Study|Withdrawal by Subject|4|||
126338682|NCT00352118|454536282|FG000|Overall Study|Physician Decision|4|||
126338683|NCT02308046|454536283|FG000|Overall Study|Negative yeast culture at Baseline|32|||
126338684|NCT02308046|454536284|FG001|Overall Study|Negative yeast culture at Baseline|33|||
126338685|NCT02308046|454536283|FG000|Overall Study|Positive for STD at Baseline|1|||
126338686|NCT02308046|454536284|FG001|Overall Study|Positive for STD at Baseline|2|||
126338687|NCT02308046|454536283|FG000|Overall Study|Lost to Follow-up|1|||
126338688|NCT02308046|454536284|FG001|Overall Study|Lost to Follow-up|3|||
126338689|NCT01587885|454536285|FG000|Treatment Period 1|Failure to Return|0|||
126338690|NCT01587885|454536286|FG001|Treatment Period 1|Failure to Return|1|||
126338691|NCT01587885|454536285|FG000|Treatment Period 1|Protocol Violation|0|||
126338692|NCT01587885|454536286|FG001|Treatment Period 1|Protocol Violation|2|||
126338693|NCT00752089|454536291|FG000|Overall Study|Adverse Event|1|||
126338694|NCT00752089|454536291|FG000|Overall Study|Protocol Deviation|2|||
126338695|NCT00752089|454536291|FG000|Overall Study|Could not attend visit 9|1|||
126338696|NCT00752089|454536291|FG000|Overall Study|Not capable of wearing partial denture|1|||
126338697|NCT00752089|454536291|FG000|Overall Study|Cannot continue the study|1|||
126338698|NCT00001566|454536292|FG000|Overall Study|patients' choice to discontinue protocol|3|||
126338699|NCT00001566|454536292|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
126338700|NCT00001566|454536292|FG000|Overall Study|Death|13|||
126338701|NCT00001566|454536292|FG000|Overall Study|Lost to Follow-up|1|||
126338702|NCT00001566|454536292|FG000|Overall Study|unable to complete initial apheresis|1|||
126338703|NCT02914834|454536293|FG000|Overall Study|Study halted due to COVID|1|||
126338704|NCT02914834|454536294|FG001|Overall Study|Study halted due to COVID|1|||
126338705|NCT02914834|454536293|FG000|Overall Study|1 subject withdrew|0|||
126338706|NCT02914834|454536294|FG001|Overall Study|1 subject withdrew|1|||
126338707|NCT00975416|454536297|FG000|Overall Study|early discharge from tx|3|||
126338708|NCT00975416|454536298|FG001|Overall Study|early discharge from tx|5|||
126338709|NCT01249131|454536303|FG000|Washout Period of 10 Days|Adverse Event|0|||
126338710|NCT01249131|454536304|FG001|Washout Period of 10 Days|Adverse Event|0|||
126338711|NCT01249131|454536305|FG002|Washout Period of 10 Days|Adverse Event|0|||
126338712|NCT01249131|454536306|FG003|Washout Period of 10 Days|Adverse Event|0|||
126338713|NCT01249131|454536307|FG004|Washout Period of 10 Days|Adverse Event|1|||
126338714|NCT01249131|454536308|FG005|Washout Period of 10 Days|Adverse Event|0|||
126338715|NCT03555149|454536313|FG000|Overall Study|Death|18|||
126338716|NCT03555149|454536314|FG001|Overall Study|Death|15|||
126338717|NCT03555149|454536315|FG002|Overall Study|Death|15|||
126338718|NCT03555149|454536316|FG003|Overall Study|Death|4|||
126338719|NCT03555149|454536317|FG004|Overall Study|Death|4|||
126338720|NCT03555149|454536318|FG005|Overall Study|Death|11|||
126338721|NCT03555149|454536319|FG006|Overall Study|Death|12|||
126338722|NCT03555149|454536320|FG007|Overall Study|Death|1|||
126338723|NCT03555149|454536313|FG000|Overall Study|Lost to Follow-up|1|||
126338724|NCT03555149|454536314|FG001|Overall Study|Lost to Follow-up|0|||
126338725|NCT03555149|454536315|FG002|Overall Study|Lost to Follow-up|0|||
126338726|NCT03555149|454536316|FG003|Overall Study|Lost to Follow-up|0|||
126338727|NCT03555149|454536317|FG004|Overall Study|Lost to Follow-up|0|||
126338728|NCT03555149|454536318|FG005|Overall Study|Lost to Follow-up|1|||
126338729|NCT03555149|454536319|FG006|Overall Study|Lost to Follow-up|0|||
126338730|NCT03555149|454536320|FG007|Overall Study|Lost to Follow-up|0|||
126338731|NCT03555149|454536313|FG000|Overall Study|Physician Decision|1|||
126338732|NCT03555149|454536314|FG001|Overall Study|Physician Decision|0|||
126338733|NCT03555149|454536315|FG002|Overall Study|Physician Decision|0|||
126338734|NCT03555149|454536316|FG003|Overall Study|Physician Decision|0|||
126338735|NCT03555149|454536317|FG004|Overall Study|Physician Decision|0|||
126338736|NCT03555149|454536318|FG005|Overall Study|Physician Decision|0|||
126338737|NCT03555149|454536319|FG006|Overall Study|Physician Decision|0|||
126338738|NCT03555149|454536320|FG007|Overall Study|Physician Decision|0|||
126338739|NCT03555149|454536313|FG000|Overall Study|Study Terminated By Sponsor|1|||
126338740|NCT03555149|454536314|FG001|Overall Study|Study Terminated By Sponsor|0|||
126338741|NCT03555149|454536315|FG002|Overall Study|Study Terminated By Sponsor|0|||
126338742|NCT03555149|454536316|FG003|Overall Study|Study Terminated By Sponsor|0|||
126338743|NCT03555149|454536317|FG004|Overall Study|Study Terminated By Sponsor|0|||
126338744|NCT03555149|454536318|FG005|Overall Study|Study Terminated By Sponsor|2|||
126338745|NCT03555149|454536319|FG006|Overall Study|Study Terminated By Sponsor|3|||
126338746|NCT03555149|454536320|FG007|Overall Study|Study Terminated By Sponsor|1|||
126338747|NCT03555149|454536313|FG000|Overall Study|Withdrawal by Subject|3|||
126338748|NCT03555149|454536314|FG001|Overall Study|Withdrawal by Subject|0|||
126338749|NCT03555149|454536315|FG002|Overall Study|Withdrawal by Subject|0|||
126338750|NCT03555149|454536316|FG003|Overall Study|Withdrawal by Subject|2|||
126423996|NCT02222558|454849254|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
126423997|NCT02222558|454849255|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
126423998|NCT02222558|454849256|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
126423999|NCT02222558|454849257|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
126424000|NCT02222558|454849258|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
126424001|NCT02222558|454849259|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
126424002|NCT02222558|454849254|FG000|Period 3|Withdrawal by Subject|0|||
126424003|NCT02222558|454849255|FG001|Period 3|Withdrawal by Subject|0|||
126424004|NCT02222558|454849256|FG002|Period 3|Withdrawal by Subject|0|||
126424005|NCT02222558|454849257|FG003|Period 3|Withdrawal by Subject|0|||
126424006|NCT02222558|454849258|FG004|Period 3|Withdrawal by Subject|0|||
126424007|NCT02222558|454849259|FG005|Period 3|Withdrawal by Subject|1|||
126424008|NCT03400852|454849260|FG000|Blinded Treatment Period|Physician Decision|0|||
126424009|NCT03400852|454849261|FG001|Blinded Treatment Period|Physician Decision|1|||
126424010|NCT03400852|454849262|FG002|Blinded Treatment Period|Physician Decision|0|||
126424011|NCT03400852|454849260|FG000|Blinded Treatment Period|Adverse Event|1|||
126424012|NCT03400852|454849261|FG001|Blinded Treatment Period|Adverse Event|1|||
126424013|NCT03400852|454849262|FG002|Blinded Treatment Period|Adverse Event|0|||
126424014|NCT03400852|454849260|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
126424015|NCT03400852|454849261|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
126424016|NCT03400852|454849262|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
126424017|NCT03400852|454849260|FG000|Open Label Period|Physician Decision|0|||
126424018|NCT03400852|454849261|FG001|Open Label Period|Physician Decision|0|||
126424019|NCT03400852|454849262|FG002|Open Label Period|Physician Decision|1|||
126424020|NCT03400852|454849260|FG000|Open Label Period|Study terminated by sponsor|0|||
126424021|NCT03400852|454849261|FG001|Open Label Period|Study terminated by sponsor|0|||
126338751|NCT03555149|454536317|FG004|Overall Study|Withdrawal by Subject|0|||
126338752|NCT03555149|454536318|FG005|Overall Study|Withdrawal by Subject|1|||
126338753|NCT03555149|454536319|FG006|Overall Study|Withdrawal by Subject|0|||
126338754|NCT03555149|454536320|FG007|Overall Study|Withdrawal by Subject|0|||
126338755|NCT03863353|454536324|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
126338756|NCT03863353|454536325|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
126338757|NCT05817669|454536326|FG000|Overall Study|Prohibited medication used|1|||
126338758|NCT05817669|454536327|FG001|Overall Study|Prohibited medication used|2|||
126338759|NCT05817669|454536326|FG000|Overall Study|Adverse Event|1|||
126338760|NCT05817669|454536327|FG001|Overall Study|Adverse Event|0|||
126338761|NCT05817669|454536326|FG000|Overall Study|Withdrawal by Subject|1|||
126338762|NCT05817669|454536327|FG001|Overall Study|Withdrawal by Subject|2|||
126424022|NCT03400852|454849262|FG002|Open Label Period|Study terminated by sponsor|21|||
126338763|NCT03810183|454536328|FG000|Overall Study|Study terminated by Sponsor|2|||
126338764|NCT03810183|454536329|FG001|Overall Study|Study terminated by Sponsor|1|||
126338765|NCT00323063|454536331|FG000|Overall Study|Adverse Event|1|||
126338766|NCT00323063|454536332|FG001|Overall Study|Adverse Event|0|||
126338767|NCT00323063|454536331|FG000|Overall Study|brain mets discovered prior to treatment|1|||
126338768|NCT00323063|454536332|FG001|Overall Study|brain mets discovered prior to treatment|0|||
126338769|NCT03786380|454536333|FG000|Overall Study|Adverse Event|1|||
126338770|NCT03786380|454536334|FG001|Overall Study|Adverse Event|0|||
126338771|NCT03786380|454536335|FG002|Overall Study|Adverse Event|0|||
126338772|NCT03786380|454536336|FG003|Overall Study|Adverse Event|3|||
126338773|NCT03786380|454536337|FG004|Overall Study|Adverse Event|1|||
126338774|NCT03786380|454536333|FG000|Overall Study|Lack of Efficacy|0|||
126338775|NCT03786380|454536334|FG001|Overall Study|Lack of Efficacy|0|||
126338776|NCT03786380|454536335|FG002|Overall Study|Lack of Efficacy|0|||
126338777|NCT03786380|454536336|FG003|Overall Study|Lack of Efficacy|0|||
126338778|NCT03786380|454536337|FG004|Overall Study|Lack of Efficacy|1|||
126338779|NCT03786380|454536333|FG000|Overall Study|Withdrawal by Subject|1|||
126338780|NCT03786380|454536334|FG001|Overall Study|Withdrawal by Subject|2|||
126338781|NCT03786380|454536335|FG002|Overall Study|Withdrawal by Subject|2|||
126338782|NCT03786380|454536336|FG003|Overall Study|Withdrawal by Subject|1|||
126338783|NCT03786380|454536337|FG004|Overall Study|Withdrawal by Subject|2|||
126338784|NCT03786380|454536333|FG000|Overall Study|Lost to Follow-up|3|||
126338785|NCT03786380|454536334|FG001|Overall Study|Lost to Follow-up|0|||
126338786|NCT03786380|454536335|FG002|Overall Study|Lost to Follow-up|1|||
126338787|NCT03786380|454536336|FG003|Overall Study|Lost to Follow-up|2|||
126338788|NCT03786380|454536337|FG004|Overall Study|Lost to Follow-up|0|||
126338789|NCT03786380|454536333|FG000|Overall Study|Physician Decision|0|||
126338790|NCT03786380|454536334|FG001|Overall Study|Physician Decision|0|||
126338791|NCT03786380|454536335|FG002|Overall Study|Physician Decision|1|||
126338792|NCT03786380|454536336|FG003|Overall Study|Physician Decision|0|||
126338793|NCT03786380|454536337|FG004|Overall Study|Physician Decision|0|||
126338794|NCT03786380|454536333|FG000|Overall Study|Study Terminated by the Sponsor|30|||
126338795|NCT03786380|454536334|FG001|Overall Study|Study Terminated by the Sponsor|20|||
126338796|NCT03786380|454536335|FG002|Overall Study|Study Terminated by the Sponsor|50|||
126338797|NCT03786380|454536336|FG003|Overall Study|Study Terminated by the Sponsor|57|||
126338798|NCT03786380|454536337|FG004|Overall Study|Study Terminated by the Sponsor|23|||
126338799|NCT03786380|454536333|FG000|Overall Study|Reason Not Specified|0|||
126338800|NCT03786380|454536334|FG001|Overall Study|Reason Not Specified|0|||
126338801|NCT03786380|454536335|FG002|Overall Study|Reason Not Specified|0|||
126338802|NCT03786380|454536336|FG003|Overall Study|Reason Not Specified|0|||
126338803|NCT03786380|454536337|FG004|Overall Study|Reason Not Specified|1|||
126338804|NCT01664091|454536338|FG000|Overall Study|Death|1|||
126338805|NCT01664091|454536338|FG000|Overall Study|Disease Progression|2|||
126338806|NCT01664091|454536338|FG000|Overall Study|Lost to Follow-up|2|||
126338807|NCT01664091|454536338|FG000|Overall Study|Withdrawal by Subject|1|||
126338808|NCT01038687|454536339|FG000|Overall Study|Adverse Event|0|||
126338809|NCT01038687|454536340|FG001|Overall Study|Adverse Event|2|||
126338810|NCT01038687|454536341|FG002|Overall Study|Adverse Event|1|||
126338811|NCT01076543|454536343|FG000|Overall Study|Withdrawal by Subject|2|||
126338812|NCT01076543|454536344|FG001|Overall Study|Withdrawal by Subject|0|||
126338813|NCT01076543|454536345|FG002|Overall Study|Withdrawal by Subject|0|||
126338814|NCT01076543|454536346|FG003|Overall Study|Withdrawal by Subject|0|||
126338815|NCT01076543|454536347|FG004|Overall Study|Withdrawal by Subject|0|||
126338816|NCT01076543|454536348|FG005|Overall Study|Withdrawal by Subject|0|||
126338817|NCT00338741|454536349|FG000|Overall Study|Lost to Follow-up|2|||
126338818|NCT00338741|454536350|FG001|Overall Study|Lost to Follow-up|0|||
126338819|NCT05222880|454536351|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
126338820|NCT05222880|454536351|FG000|Overall Study|Withdrew Consent during Study|1|||
126338821|NCT05222880|454536351|FG000|Overall Study|COVID-19 Related|1|||
126338822|NCT02895347|454536365|FG000|Overall Study|Withdrawal by Subject|3|||
126338823|NCT02895347|454536366|FG001|Overall Study|Withdrawal by Subject|1|||
126338824|NCT01673178|454536367|FG000|Overall Study|Lost to Follow-up|0|||
126338825|NCT01673178|454536368|FG001|Overall Study|Lost to Follow-up|1|||
126338826|NCT01673178|454536369|FG002|Overall Study|Lost to Follow-up|0|||
126338827|NCT01673178|454536370|FG003|Overall Study|Lost to Follow-up|0|||
126338828|NCT01673178|454536371|FG004|Overall Study|Lost to Follow-up|0|||
126338829|NCT01673178|454536367|FG000|Overall Study|Withdrawal by Subject|0|||
126338830|NCT01673178|454536368|FG001|Overall Study|Withdrawal by Subject|0|||
126338831|NCT01673178|454536369|FG002|Overall Study|Withdrawal by Subject|1|||
126338832|NCT01673178|454536370|FG003|Overall Study|Withdrawal by Subject|4|||
126338833|NCT01673178|454536371|FG004|Overall Study|Withdrawal by Subject|2|||
126338834|NCT01673178|454536367|FG000|Overall Study|Protocol Violation|1|||
126338835|NCT01673178|454536368|FG001|Overall Study|Protocol Violation|1|||
126338836|NCT01673178|454536369|FG002|Overall Study|Protocol Violation|0|||
126424023|NCT00936702|454849263|FG000|Overall Study|Disease progression|34|||
126424024|NCT00936702|454849263|FG000|Overall Study|Adverse Event|8|||
126424025|NCT00936702|454849263|FG000|Overall Study|Withdrawal by Subject|2|||
126424026|NCT00936702|454849263|FG000|Overall Study|Alternative Treatment|1|||
126424027|NCT00936702|454849263|FG000|Overall Study|Other|1|||
126424028|NCT02532465|454849264|FG000|Overall Study|Protocol Violation|1|||
126424029|NCT02532465|454849265|FG001|Overall Study|Protocol Violation|0|||
126424030|NCT02532465|454849264|FG000|Overall Study|Lack of Efficacy|0|||
126424031|NCT02532465|454849265|FG001|Overall Study|Lack of Efficacy|1|||
126338837|NCT01673178|454536370|FG003|Overall Study|Protocol Violation|1|||
126338838|NCT01673178|454536371|FG004|Overall Study|Protocol Violation|0|||
126338839|NCT01673178|454536367|FG000|Overall Study|Adverse Event|1|||
126338840|NCT01673178|454536368|FG001|Overall Study|Adverse Event|0|||
126338841|NCT01673178|454536369|FG002|Overall Study|Adverse Event|0|||
126338842|NCT01673178|454536370|FG003|Overall Study|Adverse Event|2|||
126424032|NCT00622505|454849271|FG000|Overall Study|Adverse Event|9|||
126424033|NCT00622505|454849272|FG001|Overall Study|Adverse Event|7|||
126424034|NCT00622505|454849271|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
126424035|NCT00622505|454849272|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
126424036|NCT00622505|454849271|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
126424037|NCT00622505|454849272|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126424038|NCT00622505|454849271|FG000|Overall Study|Withdrawal by Subject|12|||
126424039|NCT00622505|454849272|FG001|Overall Study|Withdrawal by Subject|5|||
126424040|NCT00622505|454849271|FG000|Overall Study|Administrative Problems|2|||
126424041|NCT00622505|454849272|FG001|Overall Study|Administrative Problems|4|||
126424042|NCT00622505|454849271|FG000|Overall Study|Death|2|||
126424043|NCT00622505|454849272|FG001|Overall Study|Death|2|||
126424044|NCT01544920|454849273|FG000|Overall Study|Adverse Event|0|||
126424045|NCT01544920|454849274|FG001|Overall Study|Adverse Event|3|||
126424046|NCT01544920|454849273|FG000|Overall Study|Death|0|||
126424047|NCT01544920|454849274|FG001|Overall Study|Death|1|||
126424048|NCT01544920|454849273|FG000|Overall Study|Lost to Follow-up|11|||
126424049|NCT01544920|454849274|FG001|Overall Study|Lost to Follow-up|12|||
126424050|NCT01544920|454849273|FG000|Overall Study|Protocol Violation|0|||
126424051|NCT01544920|454849274|FG001|Overall Study|Protocol Violation|2|||
126424052|NCT01544920|454849273|FG000|Overall Study|Physician Decision|4|||
126424053|NCT01544920|454849274|FG001|Overall Study|Physician Decision|1|||
126424054|NCT01544920|454849273|FG000|Overall Study|Withdrawal by Subject|4|||
126338843|NCT01673178|454536371|FG004|Overall Study|Adverse Event|0|||
126338844|NCT01673178|454536367|FG000|Overall Study|Other|1|||
126338845|NCT01673178|454536368|FG001|Overall Study|Other|0|||
126338846|NCT01673178|454536369|FG002|Overall Study|Other|2|||
126338847|NCT01673178|454536370|FG003|Overall Study|Other|1|||
126338848|NCT01673178|454536371|FG004|Overall Study|Other|0|||
126338849|NCT03177148|454536372|FG000|Overall Study|Lost to Follow-up|50|||
126338850|NCT03177148|454536373|FG001|Overall Study|Lost to Follow-up|1|||
126338851|NCT03177148|454536372|FG000|Overall Study|Death|1|||
126338852|NCT03177148|454536373|FG001|Overall Study|Death|0|||
126338853|NCT00887484|454536385|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
126338854|NCT00887484|454536385|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
126338855|NCT00887484|454536385|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
126338856|NCT01204671|454536386|FG000|Overall Study|Adverse Event|4|||
126338857|NCT01204671|454536387|FG001|Overall Study|Adverse Event|3|||
126338858|NCT01204671|454536388|FG002|Overall Study|Adverse Event|3|||
126338859|NCT01204671|454536389|FG003|Overall Study|Adverse Event|3|||
126338860|NCT01204671|454536390|FG004|Overall Study|Adverse Event|1|||
126338861|NCT01204671|454536386|FG000|Overall Study|Withdrawal by Subject|2|||
126338862|NCT01204671|454536387|FG001|Overall Study|Withdrawal by Subject|3|||
126338863|NCT01204671|454536388|FG002|Overall Study|Withdrawal by Subject|4|||
126338864|NCT01204671|454536389|FG003|Overall Study|Withdrawal by Subject|5|||
126338865|NCT01204671|454536390|FG004|Overall Study|Withdrawal by Subject|3|||
126338866|NCT01204671|454536386|FG000|Overall Study|Lost to Follow-up|7|||
126338867|NCT01204671|454536387|FG001|Overall Study|Lost to Follow-up|8|||
126338868|NCT01204671|454536388|FG002|Overall Study|Lost to Follow-up|6|||
126338869|NCT01204671|454536389|FG003|Overall Study|Lost to Follow-up|4|||
126338870|NCT01204671|454536390|FG004|Overall Study|Lost to Follow-up|0|||
126338871|NCT01204671|454536386|FG000|Overall Study|Unknown Completion Status|1|||
126338872|NCT01204671|454536387|FG001|Overall Study|Unknown Completion Status|1|||
126338873|NCT01204671|454536388|FG002|Overall Study|Unknown Completion Status|0|||
126338874|NCT01204671|454536389|FG003|Overall Study|Unknown Completion Status|0|||
126338875|NCT01204671|454536390|FG004|Overall Study|Unknown Completion Status|0|||
126338876|NCT01204671|454536386|FG000|Overall Study|Physician Decision|0|||
126338877|NCT01204671|454536387|FG001|Overall Study|Physician Decision|0|||
126338878|NCT01204671|454536388|FG002|Overall Study|Physician Decision|0|||
126338879|NCT01204671|454536389|FG003|Overall Study|Physician Decision|1|||
126338880|NCT01204671|454536390|FG004|Overall Study|Physician Decision|0|||
126338881|NCT01316224|454536391|FG000|Overall Study|Protocol Violation|3|||
126338882|NCT01316224|454536391|FG000|Overall Study|Adverse Event|3|||
126338883|NCT01316224|454536391|FG000|Overall Study|Lack of Efficacy|1|||
126338884|NCT01316224|454536391|FG000|Overall Study|Withdrawal by Subject|1|||
126338885|NCT01316224|454536391|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
126338886|NCT01316224|454536391|FG000|Overall Study|Other|1|||
126338887|NCT03106077|454536392|FG000|Overall Study|Screen Failure|94|||
126338888|NCT03106077|454536393|FG001|Overall Study|Screen Failure|0|||
126338889|NCT00606307|454536396|FG000|Overall Study|Adverse Event|2|||
126338890|NCT00606307|454536396|FG000|Overall Study|Withdrawal by Subject|2|||
126338891|NCT00606307|454536396|FG000|Overall Study|Disease progression|6|||
126338892|NCT00606307|454536396|FG000|Overall Study|QTc prolongation|1|||
126338893|NCT01274533|454536397|FG000|Overall Study|Withdrawal by Subject|1|||
126338894|NCT01274533|454536397|FG000|Overall Study|Non-compliance|1|||
126338895|NCT01274533|454536397|FG000|Overall Study|Disease progression|2|||
126338896|NCT02008526|454536406|FG000|Overall Study|Death|0|||
126338897|NCT02008526|454536407|FG001|Overall Study|Death|2|||
126338898|NCT02008526|454536408|FG002|Overall Study|Death|1|||
126338899|NCT02008526|454536406|FG000|Overall Study|Withdrawal by Subject|3|||
126424055|NCT01544920|454849274|FG001|Overall Study|Withdrawal by Subject|4|||
126338900|NCT02008526|454536407|FG001|Overall Study|Withdrawal by Subject|3|||
126338901|NCT02008526|454536408|FG002|Overall Study|Withdrawal by Subject|2|||
126338902|NCT02008526|454536406|FG000|Overall Study|Lost to Follow-up|5|||
126338903|NCT02008526|454536407|FG001|Overall Study|Lost to Follow-up|9|||
126338904|NCT02008526|454536408|FG002|Overall Study|Lost to Follow-up|6|||
126338905|NCT01118052|454536409|FG000|Overall Study|Never treated|2|||
126338906|NCT02949947|454536410|FG000|Overall Study|Non Compliance|0|||
126338907|NCT02949947|454536411|FG001|Overall Study|Non Compliance|1|||
126338908|NCT02949947|454536410|FG000|Overall Study|Insurance change|1|||
126338909|NCT02949947|454536411|FG001|Overall Study|Insurance change|0|||
126338910|NCT00492726|454536413|FG000|Overall Study|Adverse Event|10|||
126338911|NCT00492726|454536414|FG001|Overall Study|Adverse Event|6|||
126338912|NCT00492726|454536413|FG000|Overall Study|Death|7|||
126338913|NCT00492726|454536414|FG001|Overall Study|Death|2|||
126338914|NCT00492726|454536413|FG000|Overall Study|Lack of Efficacy|0|||
126338915|NCT00492726|454536414|FG001|Overall Study|Lack of Efficacy|2|||
126338916|NCT00492726|454536413|FG000|Overall Study|Lost to Follow-up|27|||
126338917|NCT00492726|454536414|FG001|Overall Study|Lost to Follow-up|19|||
126338918|NCT00492726|454536413|FG000|Overall Study|Physician Decision|0|||
126338919|NCT00492726|454536414|FG001|Overall Study|Physician Decision|1|||
126338920|NCT00492726|454536413|FG000|Overall Study|Withdrawal by Subject|6|||
126338921|NCT00492726|454536414|FG001|Overall Study|Withdrawal by Subject|3|||
126338922|NCT00492726|454536413|FG000|Overall Study|Non compliant with study medication|0|||
126338923|NCT00492726|454536414|FG001|Overall Study|Non compliant with study medication|3|||
126338924|NCT04386902|454536415|FG000|Overall Study|Withdrawal by Subject|5|||
126338925|NCT04386902|454536415|FG000|Overall Study|Technical problems in the recording|5|||
126338926|NCT00828711|454536416|FG000|Overall Study|Lost to Follow-up|1|||
126338927|NCT00828711|454536417|FG001|Overall Study|Lost to Follow-up|0|||
126338928|NCT00828711|454536418|FG002|Overall Study|Lost to Follow-up|0|||
126338929|NCT02230891|454536419|FG000|Baseline|Did not meet inclusion|0|||
126338930|NCT02230891|454536420|FG001|Baseline|Did not meet inclusion|1|||
126338931|NCT02230891|454536421|FG002|Baseline|Did not meet inclusion|1|||
126338932|NCT02230891|454536419|FG000|2 Week|Withdrawal by Subject|2|||
126338933|NCT02230891|454536420|FG001|2 Week|Withdrawal by Subject|2|||
126338934|NCT02230891|454536421|FG002|2 Week|Withdrawal by Subject|0|||
126338935|NCT02230891|454536419|FG000|2 Week|Consent withdrawn|1|||
126338936|NCT02230891|454536420|FG001|2 Week|Consent withdrawn|0|||
126338937|NCT02230891|454536421|FG002|2 Week|Consent withdrawn|0|||
126338938|NCT02230891|454536419|FG000|6 Month|Withdrawal by Subject|1|||
126338939|NCT02230891|454536420|FG001|6 Month|Withdrawal by Subject|1|||
126338940|NCT02230891|454536421|FG002|6 Month|Withdrawal by Subject|1|||
126338941|NCT02230891|454536419|FG000|6 Month|Physician Decision|0|||
126338942|NCT02230891|454536420|FG001|6 Month|Physician Decision|2|||
126338943|NCT02230891|454536421|FG002|6 Month|Physician Decision|0|||
126338944|NCT02230891|454536419|FG000|12 Month|Death|1|||
126338945|NCT02230891|454536420|FG001|12 Month|Death|0|||
126338946|NCT02230891|454536421|FG002|12 Month|Death|0|||
126338947|NCT02230891|454536419|FG000|12 Month|Lost to Follow-up|0|||
126338948|NCT02230891|454536420|FG001|12 Month|Lost to Follow-up|1|||
126338949|NCT02230891|454536421|FG002|12 Month|Lost to Follow-up|0|||
126338950|NCT02230891|454536419|FG000|12 Month|Withdrawal by Subject|0|||
126338951|NCT02230891|454536420|FG001|12 Month|Withdrawal by Subject|2|||
126338952|NCT02230891|454536421|FG002|12 Month|Withdrawal by Subject|0|||
126338953|NCT02230891|454536419|FG000|18 Month End of Study|Death|0|||
126338954|NCT02230891|454536420|FG001|18 Month End of Study|Death|0|||
126338955|NCT02230891|454536421|FG002|18 Month End of Study|Death|1|||
126338956|NCT02230891|454536419|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
126338957|NCT02230891|454536420|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
126338958|NCT02230891|454536421|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
126338959|NCT02404545|454536422|FG000|Overall Study|Sponsor Termination|6|||
126338960|NCT02404545|454536423|FG001|Overall Study|Sponsor Termination|6|||
126338961|NCT02033759|454536425|FG000|Overall Study|Withdrawal by Subject|2|||
126338962|NCT02033759|454536426|FG001|Overall Study|Withdrawal by Subject|1|||
126338963|NCT02033759|454536425|FG000|Overall Study|Protocol Violation|1|||
126338964|NCT02033759|454536426|FG001|Overall Study|Protocol Violation|1|||
126338965|NCT01419535|454536436|FG000|Overall Study|could not maintain iv line|1|||
126338966|NCT01419535|454536437|FG001|Overall Study|could not maintain iv line|1|||
126338967|NCT01419535|454536436|FG000|Overall Study|Withdrawal by Subject|0|||
126338968|NCT01419535|454536437|FG001|Overall Study|Withdrawal by Subject|1|||
126338969|NCT01712516|454538398|FG000|Overall Study|Technical problems|0|||
126338970|NCT01712516|454538399|FG001|Overall Study|Technical problems|0|||
126338971|NCT01712516|454538400|FG002|Overall Study|Technical problems|0|||
126338972|NCT01712516|454538401|FG003|Overall Study|Technical problems|2|||
126338973|NCT01712516|454538398|FG000|Overall Study|Lost to Follow-up|0|||
126338974|NCT01712516|454538399|FG001|Overall Study|Lost to Follow-up|0|||
126338975|NCT01712516|454538400|FG002|Overall Study|Lost to Follow-up|2|||
126338976|NCT01712516|454538401|FG003|Overall Study|Lost to Follow-up|1|||
126338977|NCT01712516|454538398|FG000|Overall Study|Death|0|||
126338978|NCT01712516|454538399|FG001|Overall Study|Death|1|||
126338979|NCT01712516|454538400|FG002|Overall Study|Death|0|||
126338980|NCT01712516|454538401|FG003|Overall Study|Death|0|||
126338981|NCT01712516|454538398|FG000|Overall Study|Protocol deviation|1|||
126338982|NCT01712516|454538399|FG001|Overall Study|Protocol deviation|0|||
126338983|NCT01712516|454538400|FG002|Overall Study|Protocol deviation|1|||
126338984|NCT01712516|454538401|FG003|Overall Study|Protocol deviation|0|||
126338985|NCT01712516|454538398|FG000|Overall Study|Physician Decision|2|||
126338986|NCT01712516|454538399|FG001|Overall Study|Physician Decision|0|||
126424056|NCT00466440|454849275|FG000|Overall Study|Adverse Event|0|||
126424057|NCT00466440|454849276|FG001|Overall Study|Adverse Event|3|||
126424058|NCT00466440|454849277|FG002|Overall Study|Adverse Event|1|||
126424059|NCT00466440|454849275|FG000|Overall Study|Death|1|||
126338987|NCT01712516|454538400|FG002|Overall Study|Physician Decision|0|||
126338988|NCT01712516|454538401|FG003|Overall Study|Physician Decision|1|||
126338989|NCT01712516|454538398|FG000|Overall Study|Withdrawal by Subject|3|||
126338990|NCT01712516|454538399|FG001|Overall Study|Withdrawal by Subject|9|||
126338991|NCT01712516|454538400|FG002|Overall Study|Withdrawal by Subject|3|||
126338992|NCT01712516|454538401|FG003|Overall Study|Withdrawal by Subject|9|||
126338993|NCT01181167|454538405|FG000|Overall Study|Adverse Event|11|||
126338994|NCT01181167|454538406|FG001|Overall Study|Adverse Event|21|||
126338995|NCT01181167|454538405|FG000|Overall Study|Lost to Follow-up|1|||
126338996|NCT01181167|454538406|FG001|Overall Study|Lost to Follow-up|0|||
126338997|NCT01181167|454538405|FG000|Overall Study|Physician Decision|2|||
126338998|NCT01181167|454538406|FG001|Overall Study|Physician Decision|3|||
126338999|NCT01181167|454538405|FG000|Overall Study|Protocol Violation|3|||
126339000|NCT01181167|454538406|FG001|Overall Study|Protocol Violation|0|||
126339001|NCT01181167|454538405|FG000|Overall Study|Withdrawal by Subject|6|||
126339002|NCT01181167|454538406|FG001|Overall Study|Withdrawal by Subject|8|||
126339003|NCT00161213|454538407|FG000|Overall Study|Withdrawal by Subject|1|||
126339004|NCT00161213|454538407|FG000|Overall Study|Evaluable for toxicity but not response|1|||
126339005|NCT03103503|454538408|FG000|Overall Study|Death|64|||
126339006|NCT03103503|454538408|FG000|Overall Study|Physician Decision|57|||
126339007|NCT03103503|454538408|FG000|Overall Study|Withdrawal by Subject|10|||
126339008|NCT03103503|454538408|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
126339009|NCT03103503|454538408|FG000|Overall Study|Lost to Follow-up|3|||
126339010|NCT03103503|454538408|FG000|Overall Study|Study Closure|757|||
126339011|NCT01384877|454538409|FG000|Treatment 2|Lost to Follow-up|2|||
126339012|NCT01384877|454538410|FG001|Treatment 2|Lost to Follow-up|2|||
126339013|NCT03630393|454538411|FG000|Overall Study|Death|1|||
126339014|NCT03630393|454538412|FG001|Overall Study|Death|0|||
126339015|NCT00408499|454538413|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
126339016|NCT00408499|454538414|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
126339017|NCT00408499|454538415|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
126339018|NCT00408499|454538416|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
126339019|NCT00408499|454538417|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
126339020|NCT00408499|454538413|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
126339021|NCT00408499|454538414|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
126339022|NCT00408499|454538415|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
126339023|NCT00408499|454538416|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
126339024|NCT00408499|454538417|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
126339025|NCT00408499|454538413|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
126339026|NCT00408499|454538414|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
126339027|NCT00408499|454538415|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
126339028|NCT00408499|454538416|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
126339029|NCT00408499|454538417|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
126339030|NCT00408499|454538413|FG000|Phase II- MTD Expansion|Adverse Event|0|||
126339031|NCT00408499|454538414|FG001|Phase II- MTD Expansion|Adverse Event|0|||
126339032|NCT00408499|454538415|FG002|Phase II- MTD Expansion|Adverse Event|0|||
126339033|NCT00408499|454538416|FG003|Phase II- MTD Expansion|Adverse Event|0|||
126339034|NCT00408499|454538417|FG004|Phase II- MTD Expansion|Adverse Event|9|||
126339035|NCT00408499|454538413|FG000|Phase II- MTD Expansion|Death|0|||
126339036|NCT00408499|454538414|FG001|Phase II- MTD Expansion|Death|0|||
126339037|NCT00408499|454538415|FG002|Phase II- MTD Expansion|Death|0|||
126339038|NCT00408499|454538416|FG003|Phase II- MTD Expansion|Death|0|||
126424060|NCT00466440|454849276|FG001|Overall Study|Death|1|||
126424061|NCT00466440|454849277|FG002|Overall Study|Death|0|||
126424062|NCT00466440|454849275|FG000|Overall Study|Progressive disease|13|||
126339039|NCT00408499|454538417|FG004|Phase II- MTD Expansion|Death|2|||
126339040|NCT00408499|454538413|FG000|Phase II- MTD Expansion|Physician Decision|0|||
126424063|NCT00466440|454849276|FG001|Overall Study|Progressive disease|5|||
126424064|NCT00466440|454849277|FG002|Overall Study|Progressive disease|4|||
126424065|NCT00466440|454849275|FG000|Overall Study|Lost to Follow-up|0|||
126424066|NCT00466440|454849276|FG001|Overall Study|Lost to Follow-up|1|||
126424067|NCT00466440|454849277|FG002|Overall Study|Lost to Follow-up|0|||
126424068|NCT00466440|454849275|FG000|Overall Study|Physician Decision|0|||
126424069|NCT00466440|454849276|FG001|Overall Study|Physician Decision|1|||
126424070|NCT00466440|454849277|FG002|Overall Study|Physician Decision|2|||
126339041|NCT00408499|454538414|FG001|Phase II- MTD Expansion|Physician Decision|0|||
126424071|NCT00466440|454849275|FG000|Overall Study|Protocol entry criteria not met|0|||
126339042|NCT00408499|454538415|FG002|Phase II- MTD Expansion|Physician Decision|0|||
126339043|NCT00408499|454538416|FG003|Phase II- MTD Expansion|Physician Decision|0|||
126339044|NCT00408499|454538417|FG004|Phase II- MTD Expansion|Physician Decision|1|||
126339045|NCT00408499|454538413|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
126339046|NCT00408499|454538414|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
126339047|NCT00408499|454538415|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
126339048|NCT00408499|454538416|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
126339049|NCT00408499|454538417|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
126339050|NCT00408499|454538413|FG000|Phase II- MTD Expansion|treatment delay|0|||
126339051|NCT00408499|454538414|FG001|Phase II- MTD Expansion|treatment delay|0|||
126339052|NCT00408499|454538415|FG002|Phase II- MTD Expansion|treatment delay|0|||
126339053|NCT00408499|454538416|FG003|Phase II- MTD Expansion|treatment delay|0|||
126339054|NCT00408499|454538417|FG004|Phase II- MTD Expansion|treatment delay|3|||
126339055|NCT00997334|454538419|FG000|Overall Study|still on therapy|12|||
126339056|NCT00997334|454538419|FG000|Overall Study|Adverse Event|3|||
126339057|NCT00997334|454538419|FG000|Overall Study|Patient non-compliance|1|||
126339058|NCT00997334|454538419|FG000|Overall Study|Withdrawal by Subject|3|||
126339059|NCT00997334|454538419|FG000|Overall Study|Death|2|||
126339060|NCT00997334|454538419|FG000|Overall Study|Urgent Palliative Care|2|||
126339061|NCT00997334|454538419|FG000|Overall Study|No lesion amenable|1|||
126339062|NCT00997334|454538419|FG000|Overall Study|Ineligible|1|||
126424072|NCT00466440|454849276|FG001|Overall Study|Protocol entry criteria not met|0|||
126424073|NCT00466440|454849277|FG002|Overall Study|Protocol entry criteria not met|4|||
126424074|NCT00466440|454849275|FG000|Overall Study|Withdrawal by Subject|0|||
126424075|NCT00466440|454849276|FG001|Overall Study|Withdrawal by Subject|1|||
126339063|NCT01586195|454538420|FG000|Overall Study|Death|11|||
126339064|NCT01586195|454538420|FG000|Overall Study|Withdrawal of Consent|5|||
126339065|NCT01586195|454538420|FG000|Overall Study|Started new anti-melanoma therapy|1|||
126339066|NCT01586195|454538420|FG000|Overall Study|Reason not specified|9|||
126339067|NCT02683109|454538424|FG000|Overall Study|Adverse Event|1|||
126339068|NCT02683109|454538425|FG001|Overall Study|Adverse Event|0|||
126339069|NCT00183430|454538426|FG000|Overall Study|Adverse Event|1|||
126339070|NCT00183430|454538427|FG001|Overall Study|Adverse Event|0|||
126339071|NCT00183430|454538426|FG000|Overall Study|Lost to Follow-up|3|||
126339072|NCT00183430|454538427|FG001|Overall Study|Lost to Follow-up|0|||
126339073|NCT00183430|454538426|FG000|Overall Study|did not meet inclusion criteria|1|||
126339074|NCT00183430|454538427|FG001|Overall Study|did not meet inclusion criteria|0|||
126339075|NCT00183430|454538426|FG000|Overall Study|Withdrawal by Subject|1|||
126339076|NCT00183430|454538427|FG001|Overall Study|Withdrawal by Subject|0|||
126339077|NCT00883181|454538430|FG000|Overall Study|Hematological Adverse Event|26|||
126339078|NCT00883181|454538430|FG000|Overall Study|Non-hematological Adverse Event|55|||
126339079|NCT00883181|454538430|FG000|Overall Study|Disease Progression|94|||
126339080|NCT00883181|454538430|FG000|Overall Study|Administrative Reason|24|||
126339081|NCT00883181|454538430|FG000|Overall Study|Withdrawal by Subject|4|||
126339082|NCT00883181|454538430|FG000|Overall Study|Death|31|||
126339083|NCT00883181|454538430|FG000|Overall Study|Other|38|||
126339084|NCT00883181|454538430|FG000|Overall Study|Protocol Deviation|3|||
126339085|NCT00883181|454538430|FG000|Overall Study|Noncompliance|3|||
126339086|NCT00426270|454538435|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
126339087|NCT00426270|454538435|FG000|Overall Study|Adverse Event|5|||
126339088|NCT00958074|454538436|FG000|Overall Study|Withdrawal by Subject|0|||
126339089|NCT00958074|454538437|FG001|Overall Study|Withdrawal by Subject|1|||
126339090|NCT03102762|454538438|FG000|Overall Study|Lost to Follow-up|1|||
126339091|NCT03102762|454538439|FG001|Overall Study|Lost to Follow-up|0|||
126339092|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
126339093|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
126339094|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
126339095|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
126339096|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
126339097|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
126339098|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
126339099|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
126339100|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
126339101|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
126339102|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
126339103|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
126339104|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
126339105|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
126339106|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
126339107|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
126339108|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
126209470|NCT03110107|454055401|FG008|Treatment Period|Death|0|||
126339109|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
126339110|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
126339111|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
126339112|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
126339113|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
126339114|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
126339115|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
126339116|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
126339117|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
126339118|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
126339119|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
126339120|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
126339121|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
126339122|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
126339123|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
126339124|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
126339125|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
126339126|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
126339127|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
126339128|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
126339129|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
126339130|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
126339131|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
126339132|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
126339133|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
126339134|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
126339135|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
126339136|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
126339137|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
126339138|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
126339139|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
126339140|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
126339141|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
126339142|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
126339143|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
126339144|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
126339145|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
126339146|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
126339147|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
126339148|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
126339149|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
126339150|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
126339151|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
126339152|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
126339153|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
126339154|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
126424076|NCT00466440|454849277|FG002|Overall Study|Withdrawal by Subject|0|||
126424077|NCT00466440|454849275|FG000|Overall Study|Sponsor decision|0|||
126424078|NCT00466440|454849276|FG001|Overall Study|Sponsor decision|0|||
126424079|NCT00466440|454849277|FG002|Overall Study|Sponsor decision|1|||
126424080|NCT00965081|454849282|FG000|Overall Study|Adverse Event|14|||
126424081|NCT00965081|454849283|FG001|Overall Study|Adverse Event|9|||
126424082|NCT00965081|454849282|FG000|Overall Study|Lack of Efficacy|2|||
126424083|NCT00965081|454849283|FG001|Overall Study|Lack of Efficacy|5|||
126424084|NCT00965081|454849282|FG000|Overall Study|Lost to Follow-up|4|||
126424085|NCT00965081|454849283|FG001|Overall Study|Lost to Follow-up|5|||
126424086|NCT00965081|454849282|FG000|Overall Study|Physician Decision|2|||
126424087|NCT00965081|454849283|FG001|Overall Study|Physician Decision|0|||
126424088|NCT00965081|454849282|FG000|Overall Study|Protocol Violation|2|||
126424089|NCT00965081|454849283|FG001|Overall Study|Protocol Violation|5|||
126424090|NCT00965081|454849282|FG000|Overall Study|Sponsor Decision|1|||
126424091|NCT00965081|454849283|FG001|Overall Study|Sponsor Decision|0|||
126424092|NCT00965081|454849282|FG000|Overall Study|Withdrawal by Subject|4|||
126424093|NCT00965081|454849283|FG001|Overall Study|Withdrawal by Subject|7|||
126424094|NCT00965081|454849282|FG000|Overall Study|Switched to Rescue Arm|5|||
126424095|NCT00965081|454849283|FG001|Overall Study|Switched to Rescue Arm|12|||
126424096|NCT02159066|454849288|FG000|Part I|Adverse Event|7|||
126424097|NCT02159066|454849289|FG001|Part I|Adverse Event|5|||
126424098|NCT02159066|454849290|FG002|Part I|Adverse Event|0|||
126424099|NCT02159066|454849291|FG003|Part I|Adverse Event|0|||
126424100|NCT02159066|454849292|FG004|Part I|Adverse Event|0|||
126424101|NCT02159066|454849293|FG005|Part I|Adverse Event|0|||
126424102|NCT02159066|454849288|FG000|Part I|Death|11|||
126424103|NCT02159066|454849289|FG001|Part I|Death|9|||
126424104|NCT02159066|454849290|FG002|Part I|Death|0|||
126424105|NCT02159066|454849291|FG003|Part I|Death|0|||
126424106|NCT02159066|454849292|FG004|Part I|Death|0|||
126424107|NCT02159066|454849293|FG005|Part I|Death|0|||
126424108|NCT02159066|454849288|FG000|Part I|Progressive Disease|37|||
126424109|NCT02159066|454849289|FG001|Part I|Progressive Disease|46|||
126424110|NCT02159066|454849290|FG002|Part I|Progressive Disease|0|||
126424111|NCT02159066|454849291|FG003|Part I|Progressive Disease|0|||
126424112|NCT02159066|454849292|FG004|Part I|Progressive Disease|0|||
126424113|NCT02159066|454849293|FG005|Part I|Progressive Disease|0|||
126424114|NCT02159066|454849288|FG000|Part I|New Therapy for Study Indication|5|||
126424115|NCT02159066|454849289|FG001|Part I|New Therapy for Study Indication|4|||
126424116|NCT02159066|454849290|FG002|Part I|New Therapy for Study Indication|0|||
126424117|NCT02159066|454849291|FG003|Part I|New Therapy for Study Indication|0|||
126424118|NCT02159066|454849292|FG004|Part I|New Therapy for Study Indication|0|||
126424119|NCT02159066|454849293|FG005|Part I|New Therapy for Study Indication|0|||
126424120|NCT02159066|454849288|FG000|Part I|Termination of participants from the study|3|||
126424121|NCT02159066|454849289|FG001|Part I|Termination of participants from the study|3|||
126424122|NCT02159066|454849290|FG002|Part I|Termination of participants from the study|0|||
126424123|NCT02159066|454849291|FG003|Part I|Termination of participants from the study|0|||
126424124|NCT02159066|454849292|FG004|Part I|Termination of participants from the study|0|||
126424125|NCT02159066|454849293|FG005|Part I|Termination of participants from the study|0|||
126424126|NCT02159066|454849288|FG000|Part I|Physician Decision|2|||
126424127|NCT02159066|454849289|FG001|Part I|Physician Decision|9|||
126424128|NCT02159066|454849290|FG002|Part I|Physician Decision|0|||
126424129|NCT02159066|454849291|FG003|Part I|Physician Decision|0|||
126424130|NCT02159066|454849292|FG004|Part I|Physician Decision|0|||
126424131|NCT02159066|454849293|FG005|Part I|Physician Decision|0|||
126424132|NCT02159066|454849288|FG000|Part I|Participant/Guardian Decision|9|||
126424133|NCT02159066|454849289|FG001|Part I|Participant/Guardian Decision|3|||
126424134|NCT02159066|454849290|FG002|Part I|Participant/Guardian Decision|0|||
126424135|NCT02159066|454849291|FG003|Part I|Participant/Guardian Decision|0|||
126424136|NCT02159066|454849292|FG004|Part I|Participant/Guardian Decision|0|||
126424137|NCT02159066|454849293|FG005|Part I|Participant/Guardian Decision|0|||
126424138|NCT02159066|454849288|FG000|Part I|Missing Data|1|||
126424139|NCT02159066|454849289|FG001|Part I|Missing Data|0|||
126424140|NCT02159066|454849290|FG002|Part I|Missing Data|0|||
126424141|NCT02159066|454849291|FG003|Part I|Missing Data|0|||
126424142|NCT02159066|454849292|FG004|Part I|Missing Data|0|||
126424143|NCT02159066|454849293|FG005|Part I|Missing Data|0|||
126424144|NCT02159066|454849288|FG000|Part II|Adverse Event|0|||
126424145|NCT02159066|454849289|FG001|Part II|Adverse Event|0|||
126424146|NCT02159066|454849290|FG002|Part II|Adverse Event|1|||
126424147|NCT02159066|454849291|FG003|Part II|Adverse Event|0|||
126424148|NCT02159066|454849292|FG004|Part II|Adverse Event|1|||
126424149|NCT02159066|454849293|FG005|Part II|Adverse Event|1|||
126424150|NCT02159066|454849288|FG000|Part II|Death|0|||
126424151|NCT02159066|454849289|FG001|Part II|Death|0|||
126424152|NCT02159066|454849290|FG002|Part II|Death|1|||
126424153|NCT02159066|454849291|FG003|Part II|Death|0|||
126424154|NCT02159066|454849292|FG004|Part II|Death|2|||
126424155|NCT02159066|454849293|FG005|Part II|Death|1|||
126424156|NCT02159066|454849288|FG000|Part II|Progressive Disease|0|||
126424157|NCT02159066|454849289|FG001|Part II|Progressive Disease|0|||
126424158|NCT02159066|454849290|FG002|Part II|Progressive Disease|35|||
126424159|NCT02159066|454849291|FG003|Part II|Progressive Disease|1|||
126424160|NCT02159066|454849292|FG004|Part II|Progressive Disease|7|||
126424161|NCT02159066|454849293|FG005|Part II|Progressive Disease|4|||
126424162|NCT02159066|454849288|FG000|Part II|New Therapy for Study Indication|0|||
126424163|NCT02159066|454849289|FG001|Part II|New Therapy for Study Indication|0|||
126424164|NCT02159066|454849290|FG002|Part II|New Therapy for Study Indication|0|||
126424165|NCT02159066|454849291|FG003|Part II|New Therapy for Study Indication|0|||
126424166|NCT02159066|454849292|FG004|Part II|New Therapy for Study Indication|1|||
126424167|NCT02159066|454849293|FG005|Part II|New Therapy for Study Indication|0|||
126424168|NCT02159066|454849288|FG000|Part II|Physician Decision|0|||
126424169|NCT02159066|454849289|FG001|Part II|Physician Decision|0|||
126424170|NCT02159066|454849290|FG002|Part II|Physician Decision|1|||
126424171|NCT02159066|454849291|FG003|Part II|Physician Decision|0|||
126424172|NCT02159066|454849292|FG004|Part II|Physician Decision|0|||
126424173|NCT02159066|454849293|FG005|Part II|Physician Decision|0|||
126424174|NCT02159066|454849288|FG000|Part II|Participant/Guardian Decision|0|||
126424175|NCT02159066|454849289|FG001|Part II|Participant/Guardian Decision|0|||
126424176|NCT02159066|454849290|FG002|Part II|Participant/Guardian Decision|0|||
126424177|NCT02159066|454849291|FG003|Part II|Participant/Guardian Decision|0|||
126424178|NCT02159066|454849292|FG004|Part II|Participant/Guardian Decision|2|||
126339155|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
126424179|NCT02159066|454849293|FG005|Part II|Participant/Guardian Decision|0|||
126424180|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
126424181|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
126424182|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
126424183|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424184|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424185|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424186|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424187|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424188|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424189|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424190|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424191|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424192|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
126424193|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424194|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424195|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424196|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
126424197|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424198|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424199|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
126424200|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
126424201|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
126424202|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
126424203|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424204|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
126424205|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424206|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424207|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
126424208|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424209|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
126424210|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
126424211|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
126424212|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
126424213|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
126424214|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
126424215|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
126424216|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
126424217|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
126424218|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
126424219|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
126424220|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
126424221|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
126424222|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
126424223|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
126424224|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
126424225|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
126424226|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424227|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424228|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
126424229|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424230|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424231|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424232|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424233|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424234|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424235|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
126424236|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424237|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424238|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424239|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126339156|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
126339157|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
126339158|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
126339159|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
126339160|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
126339161|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
126209471|NCT03110107|454055402|FG009|Treatment Period|Death|0|||
126339162|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
126339163|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
126339164|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
126339165|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
126339166|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
126339167|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
126339168|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
126339169|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
126339170|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
126339171|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
126339172|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
126339173|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
126339174|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
126339175|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
126339176|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
126339177|NCT00551369|454538445|FG000|Overall Study|Protocol Violation|5|||
126339178|NCT00551369|454538445|FG000|Overall Study|Withdrawal by Subject|1|||
126339179|NCT00551369|454538445|FG000|Overall Study|Not treated per protocol and re|1|||
126339180|NCT00719901|454538446|FG000|Overall Study|Adverse Event|5|||
126339181|NCT00719901|454538446|FG000|Overall Study|Withdrawal by Subject|1|||
126339182|NCT00719901|454538446|FG000|Overall Study|Alternate Treatment|1|||
126339183|NCT00719901|454538446|FG000|Overall Study|Disease Progression|3|||
126339184|NCT00719901|454538446|FG000|Overall Study|Availability of Study Drug|1|||
126424240|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424241|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424242|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424243|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424244|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424245|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126004384|NCT00049517|453309665|FG000|Induction|Other complicating disease|0|||
126004385|NCT00049517|453309666|FG001|Induction|Other complicating disease|0|||
126004386|NCT00049517|453309667|FG002|Induction|Other complicating disease|0|||
126004387|NCT00049517|453309668|FG003|Induction|Other complicating disease|0|||
126004388|NCT00049517|453309669|FG004|Induction|Other complicating disease|3|||
126004389|NCT00049517|453309670|FG005|Induction|Other complicating disease|0|||
126004390|NCT00049517|453309665|FG000|Induction|Reasons not reported|0|||
126004391|NCT00049517|453309666|FG001|Induction|Reasons not reported|0|||
126004392|NCT00049517|453309667|FG002|Induction|Reasons not reported|0|||
126004393|NCT00049517|453309668|FG003|Induction|Reasons not reported|0|||
126004394|NCT00049517|453309669|FG004|Induction|Reasons not reported|22|||
126004395|NCT00049517|453309670|FG005|Induction|Reasons not reported|25|||
126004396|NCT00049517|453309665|FG000|Conditioning/Transplant|Disease progression|14|||
126004397|NCT00049517|453309666|FG001|Conditioning/Transplant|Disease progression|6|||
126004398|NCT00049517|453309667|FG002|Conditioning/Transplant|Disease progression|10|||
126004399|NCT00049517|453309668|FG003|Conditioning/Transplant|Disease progression|6|||
126004400|NCT00049517|453309669|FG004|Conditioning/Transplant|Disease progression|0|||
126004401|NCT00049517|453309670|FG005|Conditioning/Transplant|Disease progression|0|||
126004402|NCT00049517|453309665|FG000|Conditioning/Transplant|Adverse Event|2|||
126004403|NCT00049517|453309666|FG001|Conditioning/Transplant|Adverse Event|1|||
126004404|NCT00049517|453309667|FG002|Conditioning/Transplant|Adverse Event|4|||
126004405|NCT00049517|453309668|FG003|Conditioning/Transplant|Adverse Event|8|||
126004406|NCT00049517|453309669|FG004|Conditioning/Transplant|Adverse Event|0|||
126004407|NCT00049517|453309670|FG005|Conditioning/Transplant|Adverse Event|0|||
126004408|NCT00049517|453309665|FG000|Conditioning/Transplant|Death|1|||
126004409|NCT00049517|453309666|FG001|Conditioning/Transplant|Death|0|||
126004410|NCT00049517|453309667|FG002|Conditioning/Transplant|Death|0|||
126004411|NCT00049517|453309668|FG003|Conditioning/Transplant|Death|2|||
126004412|NCT00049517|453309669|FG004|Conditioning/Transplant|Death|0|||
126004413|NCT00049517|453309670|FG005|Conditioning/Transplant|Death|0|||
126004414|NCT00049517|453309665|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
126004415|NCT00049517|453309666|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
126004416|NCT00049517|453309667|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
126004417|NCT00049517|453309668|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
126004418|NCT00049517|453309669|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
126004419|NCT00049517|453309670|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
126004420|NCT00049517|453309665|FG000|Conditioning/Transplant|Alternative therapy|4|||
126004421|NCT00049517|453309666|FG001|Conditioning/Transplant|Alternative therapy|4|||
126004422|NCT00049517|453309667|FG002|Conditioning/Transplant|Alternative therapy|2|||
126004423|NCT00049517|453309668|FG003|Conditioning/Transplant|Alternative therapy|1|||
126004424|NCT00049517|453309669|FG004|Conditioning/Transplant|Alternative therapy|1|||
126209472|NCT03110107|454055403|FG010|Treatment Period|Death|0|||
126004425|NCT00049517|453309670|FG005|Conditioning/Transplant|Alternative therapy|0|||
126004426|NCT00049517|453309665|FG000|Conditioning/Transplant|Other complicating disease|2|||
126004427|NCT00049517|453309666|FG001|Conditioning/Transplant|Other complicating disease|0|||
126004428|NCT00049517|453309667|FG002|Conditioning/Transplant|Other complicating disease|0|||
126004429|NCT00049517|453309668|FG003|Conditioning/Transplant|Other complicating disease|4|||
126004430|NCT00049517|453309669|FG004|Conditioning/Transplant|Other complicating disease|0|||
126004431|NCT00049517|453309670|FG005|Conditioning/Transplant|Other complicating disease|1|||
126004432|NCT00049517|453309665|FG000|Conditioning/Transplant|Reasons not reported|25|||
126004433|NCT00049517|453309666|FG001|Conditioning/Transplant|Reasons not reported|31|||
126004434|NCT00049517|453309667|FG002|Conditioning/Transplant|Reasons not reported|18|||
126004435|NCT00049517|453309668|FG003|Conditioning/Transplant|Reasons not reported|15|||
126004436|NCT00049517|453309669|FG004|Conditioning/Transplant|Reasons not reported|5|||
126004437|NCT00049517|453309670|FG005|Conditioning/Transplant|Reasons not reported|5|||
126004438|NCT02256969|453309672|FG000|Overall Study|Screenfailed or withdrew|2|||
126004439|NCT02256969|453309673|FG001|Overall Study|Screenfailed or withdrew|1|||
126004440|NCT02256969|453309674|FG002|Overall Study|Screenfailed or withdrew|1|||
126004441|NCT02347943|453309675|FG000|Overall Study|Study was cancelled|140|||
126004442|NCT02347943|453309676|FG001|Overall Study|Study was cancelled|67|||
126004443|NCT02347943|453309677|FG002|Overall Study|Study was cancelled|45|||
126004444|NCT03566680|453309681|FG000|Overall Study|Pregnancy|1|||
126004445|NCT03566680|453309681|FG000|Overall Study|Lost to Follow-up|13|||
126004446|NCT03566680|453309681|FG000|Overall Study|Withdrawal by Subject|3|||
126004447|NCT02374957|453309688|FG000|Overall Study|Patient did not complete forms correctly|1|||
126004448|NCT02374957|453309689|FG001|Overall Study|Patient did not complete forms correctly|0|||
126004449|NCT00748969|453309690|FG000|Overall Study|Withdrawal by Subject|1|||
126004450|NCT00748969|453309691|FG001|Overall Study|Withdrawal by Subject|0|||
126004451|NCT00748969|453309690|FG000|Overall Study|Withdrawal by Subject|0|||
126004452|NCT00748969|453309691|FG001|Overall Study|Withdrawal by Subject|1|||
126004453|NCT02334306|453309692|FG000|Double-blind Period|Adverse Event|0|||
126004454|NCT02334306|453309693|FG001|Double-blind Period|Adverse Event|1|||
126004455|NCT02334306|453309692|FG000|Double-blind Period|Withdrawal by Subject|1|||
126004456|NCT02334306|453309693|FG001|Double-blind Period|Withdrawal by Subject|1|||
126004457|NCT01687270|453309694|FG000|Overall Study|Lack of Efficacy|11|||
126004458|NCT01687270|453309694|FG000|Overall Study|Lost to Follow-up|1|||
126004459|NCT00465985|453309695|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
126004460|NCT00465985|453309696|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
126004461|NCT00465985|453309695|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
126004462|NCT00465985|453309696|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
126004463|NCT00465985|453309695|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
126004464|NCT00465985|453309696|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
126004465|NCT00465985|453309695|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
126004466|NCT00465985|453309696|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
126004467|NCT03532178|453309697|FG000|First Period|Withdrawal by Subject|1|||
126004468|NCT03532178|453309698|FG001|First Period|Withdrawal by Subject|3|||
126004469|NCT03532178|453309697|FG000|First Period|technical issues in data collection Technical issues|0|||
126004470|NCT03532178|453309698|FG001|First Period|technical issues in data collection Technical issues|1|||
126004471|NCT03532178|453309697|FG000|Second Period|Withdrawal by Subject|1|||
126004472|NCT03532178|453309698|FG001|Second Period|Withdrawal by Subject|1|||
126004473|NCT03532178|453309697|FG000|Second Period|Technical issues|0|||
126004474|NCT03532178|453309698|FG001|Second Period|Technical issues|1|||
126004475|NCT03302156|453309699|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
126004476|NCT03302156|453309700|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
126004477|NCT03302156|453309701|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
126004478|NCT02390557|453309702|FG000|Wave 2|Survey non-respondent|72|||
126004479|NCT02390557|453309703|FG001|Wave 2|Survey non-respondent|41|||
126004480|NCT02390557|453309704|FG002|Wave 2|Survey non-respondent|23|||
126004481|NCT03278028|453309708|FG000|Overall Study|Lost to Follow-up|1|||
126004482|NCT03278028|453309709|FG001|Overall Study|Lost to Follow-up|0|||
126004483|NCT03278028|453309708|FG000|Overall Study|Withdrawal by Subject|3|||
126004484|NCT03278028|453309709|FG001|Overall Study|Withdrawal by Subject|1|||
126004485|NCT03278028|453309708|FG000|Overall Study|Pregnancy|0|||
126004486|NCT03278028|453309709|FG001|Overall Study|Pregnancy|1|||
126004487|NCT01360840|453309710|FG000|Overall Study|Ongoing at data cut-off|10|||
126004488|NCT01360840|453309711|FG001|Overall Study|Ongoing at data cut-off|10|||
126004489|NCT01360840|453309712|FG002|Overall Study|Ongoing at data cut-off|9|||
126004490|NCT00463151|453309714|FG000|Overall Study|Adverse Event|0|||
126004491|NCT00463151|453309715|FG001|Overall Study|Adverse Event|0|||
126004492|NCT00463151|453309716|FG002|Overall Study|Adverse Event|1|||
126004493|NCT00463151|453309717|FG003|Overall Study|Adverse Event|0|||
126004494|NCT00463151|453309714|FG000|Overall Study|Lack of Efficacy|2|||
126004495|NCT00463151|453309715|FG001|Overall Study|Lack of Efficacy|5|||
126004496|NCT00463151|453309716|FG002|Overall Study|Lack of Efficacy|2|||
126004497|NCT00463151|453309717|FG003|Overall Study|Lack of Efficacy|5|||
126004498|NCT00463151|453309714|FG000|Overall Study|Protocol Violation|0|||
126004499|NCT00463151|453309715|FG001|Overall Study|Protocol Violation|0|||
126004500|NCT00463151|453309716|FG002|Overall Study|Protocol Violation|0|||
126004501|NCT00463151|453309717|FG003|Overall Study|Protocol Violation|1|||
126004502|NCT00463151|453309714|FG000|Overall Study|Withdrawal by Subject|0|||
126004503|NCT00463151|453309715|FG001|Overall Study|Withdrawal by Subject|0|||
126004504|NCT00463151|453309716|FG002|Overall Study|Withdrawal by Subject|0|||
126004505|NCT00463151|453309717|FG003|Overall Study|Withdrawal by Subject|1|||
126004506|NCT00293462|453309718|FG000|Overall Study|Withdrawal by Subject|4|||
126004507|NCT00293462|453309719|FG001|Overall Study|Withdrawal by Subject|3|||
126004508|NCT00293462|453309720|FG002|Overall Study|Withdrawal by Subject|8|||
126004509|NCT00293462|453309718|FG000|Overall Study|Death|1|||
126004510|NCT00293462|453309719|FG001|Overall Study|Death|0|||
126004511|NCT00293462|453309720|FG002|Overall Study|Death|0|||
126004512|NCT00293462|453309718|FG000|Overall Study|Lost to Follow-up|0|||
126004513|NCT00293462|453309719|FG001|Overall Study|Lost to Follow-up|1|||
126004514|NCT00293462|453309720|FG002|Overall Study|Lost to Follow-up|0|||
126004515|NCT00293462|453309718|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
126004516|NCT00293462|453309719|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
126004517|NCT00293462|453309720|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
126004518|NCT00293462|453309718|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
126004519|NCT00293462|453309719|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
126004520|NCT00293462|453309720|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
126004521|NCT00293462|453309718|FG000|Overall Study|Refuse Radiation Treatment|1|||
126004522|NCT00293462|453309719|FG001|Overall Study|Refuse Radiation Treatment|0|||
126004523|NCT00293462|453309720|FG002|Overall Study|Refuse Radiation Treatment|0|||
126004524|NCT00293462|453309718|FG000|Overall Study|No Show|0|||
126004525|NCT00293462|453309719|FG001|Overall Study|No Show|0|||
126004526|NCT00293462|453309720|FG002|Overall Study|No Show|1|||
126004527|NCT00293462|453309718|FG000|Overall Study|Went back to his home country|0|||
126004528|NCT00293462|453309719|FG001|Overall Study|Went back to his home country|0|||
126004529|NCT00293462|453309720|FG002|Overall Study|Went back to his home country|1|||
126004530|NCT00293462|453309718|FG000|Overall Study|Blood clot after chemotherapy|0|||
126004531|NCT00293462|453309719|FG001|Overall Study|Blood clot after chemotherapy|0|||
126004532|NCT00293462|453309720|FG002|Overall Study|Blood clot after chemotherapy|1|||
126004533|NCT00293462|453309718|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
126004534|NCT00293462|453309719|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
126004535|NCT00293462|453309720|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
126004536|NCT00293462|453309718|FG000|Overall Study|Possible Tracheostomy leakage|0|||
126004537|NCT00293462|453309719|FG001|Overall Study|Possible Tracheostomy leakage|1|||
126004538|NCT00293462|453309720|FG002|Overall Study|Possible Tracheostomy leakage|0|||
126004539|NCT00293462|453309718|FG000|Overall Study|Low radiation dose in oral cavity|0|||
126004540|NCT00293462|453309719|FG001|Overall Study|Low radiation dose in oral cavity|1|||
126004541|NCT00293462|453309720|FG002|Overall Study|Low radiation dose in oral cavity|0|||
126004542|NCT00293462|453309718|FG000|Overall Study|Physician Decision|0|||
126004543|NCT00293462|453309719|FG001|Overall Study|Physician Decision|1|||
126004544|NCT00293462|453309720|FG002|Overall Study|Physician Decision|0|||
126004545|NCT00688688|453309721|FG000|Overall Study|Eligibility criterion not met|7|||
126004546|NCT00688688|453309722|FG001|Overall Study|Eligibility criterion not met|7|||
126004547|NCT00688688|453309723|FG002|Overall Study|Eligibility criterion not met|10|||
126004548|NCT00688688|453309721|FG000|Overall Study|Adverse Event|52|||
126004549|NCT00688688|453309722|FG001|Overall Study|Adverse Event|51|||
126004550|NCT00688688|453309723|FG002|Overall Study|Adverse Event|50|||
126004551|NCT00688688|453309721|FG000|Overall Study|Lack of Efficacy|34|||
126339185|NCT01122173|454538447|FG000|Overall Study|Lost to Follow-up|3|||
126339186|NCT01122173|454538447|FG000|Overall Study|Withdrawal by Subject|3|||
126339187|NCT01122173|454538447|FG000|Overall Study|Left study for other reasons|3|||
126339188|NCT01184872|454538448|FG000|Overall Study|Adverse Event|3|||
126339189|NCT01184872|454538449|FG001|Overall Study|Adverse Event|4|||
126339190|NCT01184872|454538448|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126339191|NCT01184872|454538449|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126339192|NCT01184872|454538448|FG000|Overall Study|Withdrawal by Subject|2|||
126339193|NCT01184872|454538449|FG001|Overall Study|Withdrawal by Subject|0|||
126339194|NCT01184872|454538448|FG000|Overall Study|Lost to Follow-up|0|||
126339195|NCT01184872|454538449|FG001|Overall Study|Lost to Follow-up|1|||
126339196|NCT01184872|454538448|FG000|Overall Study|Administrative problems|1|||
126004552|NCT00688688|453309722|FG001|Overall Study|Lack of Efficacy|25|||
126004553|NCT00688688|453309723|FG002|Overall Study|Lack of Efficacy|45|||
126004554|NCT00688688|453309721|FG000|Overall Study|Withdrawal by Subject|66|||
126004555|NCT00688688|453309722|FG001|Overall Study|Withdrawal by Subject|75|||
126004556|NCT00688688|453309723|FG002|Overall Study|Withdrawal by Subject|65|||
126004557|NCT00688688|453309721|FG000|Overall Study|Lost to Follow-up|14|||
126339197|NCT01184872|454538449|FG001|Overall Study|Administrative problems|1|||
126004558|NCT00688688|453309722|FG001|Overall Study|Lost to Follow-up|7|||
126339198|NCT01184872|454538448|FG000|Overall Study|Protocol deviation|1|||
126004559|NCT00688688|453309723|FG002|Overall Study|Lost to Follow-up|7|||
126004560|NCT00688688|453309721|FG000|Overall Study|Protocol Violation|6|||
126004561|NCT00688688|453309722|FG001|Overall Study|Protocol Violation|9|||
126004562|NCT00688688|453309723|FG002|Overall Study|Protocol Violation|11|||
126004563|NCT00688688|453309721|FG000|Overall Study|Randomized but never received study drug|1|||
126004564|NCT00688688|453309722|FG001|Overall Study|Randomized but never received study drug|0|||
126004565|NCT00688688|453309723|FG002|Overall Study|Randomized but never received study drug|0|||
126004566|NCT00688688|453309721|FG000|Overall Study|Non-compliance with study procedures|5|||
126004567|NCT00688688|453309722|FG001|Overall Study|Non-compliance with study procedures|3|||
126004568|NCT00688688|453309723|FG002|Overall Study|Non-compliance with study procedures|4|||
126004569|NCT00688688|453309721|FG000|Overall Study|Taking exclusionary medications|1|||
126004570|NCT00688688|453309722|FG001|Overall Study|Taking exclusionary medications|0|||
126004571|NCT00688688|453309723|FG002|Overall Study|Taking exclusionary medications|0|||
126004572|NCT00688688|453309721|FG000|Overall Study|Site closure|0|||
126004573|NCT00688688|453309722|FG001|Overall Study|Site closure|1|||
126004574|NCT00688688|453309723|FG002|Overall Study|Site closure|0|||
126004575|NCT00688688|453309721|FG000|Overall Study|Violation of exclusion criterion|0|||
126004576|NCT00688688|453309722|FG001|Overall Study|Violation of exclusion criterion|1|||
126004577|NCT00688688|453309723|FG002|Overall Study|Violation of exclusion criterion|0|||
126339199|NCT01184872|454538449|FG001|Overall Study|Protocol deviation|0|||
126339200|NCT03426345|454538450|FG000|Overall Study|Adverse Event|4|||
126004578|NCT03283553|453309726|FG000|Patient Participant Flow|Death|5|||
126004579|NCT03283553|453309727|FG001|Patient Participant Flow|Death|10|||
126004580|NCT03283553|453309726|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
126004581|NCT03283553|453309727|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
126004582|NCT03283553|453309726|FG000|Patient Participant Flow|Lost to Follow-up|1|||
126004583|NCT03283553|453309727|FG001|Patient Participant Flow|Lost to Follow-up|1|||
126004584|NCT03283553|453309726|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
126004585|NCT03283553|453309727|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
126004586|NCT03283553|453309726|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
126004587|NCT03283553|453309727|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
126004588|NCT03283553|453309726|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
126004589|NCT03283553|453309727|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
126004590|NCT03686683|453309728|FG000|Overall Study|Withdrawal by Subject|52|||
126004591|NCT03686683|453309729|FG001|Overall Study|Withdrawal by Subject|32|||
126004592|NCT03686683|453309728|FG000|Overall Study|Lost to Follow-up|23|||
126004593|NCT03686683|453309729|FG001|Overall Study|Lost to Follow-up|19|||
126004594|NCT03686683|453309728|FG000|Overall Study|Adverse Event|1|||
126004595|NCT03686683|453309729|FG001|Overall Study|Adverse Event|0|||
126004596|NCT03686683|453309728|FG000|Overall Study|Death|10|||
126004597|NCT03686683|453309729|FG001|Overall Study|Death|5|||
126004598|NCT03686683|453309728|FG000|Overall Study|Progressive Disease|1|||
126004599|NCT03686683|453309729|FG001|Overall Study|Progressive Disease|1|||
126004600|NCT03686683|453309728|FG000|Overall Study|Noncompliance|1|||
126004601|NCT03686683|453309729|FG001|Overall Study|Noncompliance|0|||
126004602|NCT03686683|453309728|FG000|Overall Study|Physician Decision|1|||
126004603|NCT03686683|453309729|FG001|Overall Study|Physician Decision|1|||
126004604|NCT03686683|453309728|FG000|Overall Study|Screen fail post-randomization|1|||
126004605|NCT03686683|453309729|FG001|Overall Study|Screen fail post-randomization|0|||
126004606|NCT03686683|453309728|FG000|Overall Study|Protocol Violation|3|||
126004607|NCT03686683|453309729|FG001|Overall Study|Protocol Violation|0|||
126004608|NCT03686683|453309728|FG000|Overall Study|No data available|1|||
126004609|NCT03686683|453309729|FG001|Overall Study|No data available|0|||
126339201|NCT03426345|454538451|FG001|Overall Study|Adverse Event|4|||
126339202|NCT03426345|454538450|FG000|Overall Study|Lack of Efficacy|1|||
126339203|NCT03426345|454538451|FG001|Overall Study|Lack of Efficacy|0|||
126339204|NCT03426345|454538450|FG000|Overall Study|Withdrawal by Subject|5|||
126339205|NCT03426345|454538451|FG001|Overall Study|Withdrawal by Subject|6|||
126339206|NCT03426345|454538450|FG000|Overall Study|Lost to Follow-up|3|||
126339207|NCT03426345|454538451|FG001|Overall Study|Lost to Follow-up|1|||
126339208|NCT03426345|454538450|FG000|Overall Study|Protocol Deviation|3|||
126339209|NCT03426345|454538451|FG001|Overall Study|Protocol Deviation|4|||
126339210|NCT03426345|454538450|FG000|Overall Study|Reason Not Specified|1|||
126339211|NCT03426345|454538451|FG001|Overall Study|Reason Not Specified|2|||
126004610|NCT03255941|453309730|FG000|Overall Study|Not eligible or refused injection|37|||
126004611|NCT03255941|453309731|FG001|Overall Study|Not eligible or refused injection|44|||
126004612|NCT03255941|453309732|FG002|Overall Study|Not eligible or refused injection|5|||
126339212|NCT03426345|454538450|FG000|Overall Study|Missing Completion Status|1|||
126339213|NCT03426345|454538451|FG001|Overall Study|Missing Completion Status|0|||
126339214|NCT00116142|454538452|FG000|Overall Study|Adverse Event|8|||
126339215|NCT00116142|454538453|FG001|Overall Study|Adverse Event|7|||
126004613|NCT03255941|453309733|FG003|Overall Study|Not eligible or refused injection|6|||
126004614|NCT03255941|453309730|FG000|Overall Study|Did not complete exit interview|1|||
126004615|NCT03255941|453309731|FG001|Overall Study|Did not complete exit interview|2|||
126004616|NCT03255941|453309732|FG002|Overall Study|Did not complete exit interview|0|||
126424246|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424247|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424248|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424249|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424250|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424251|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424252|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424253|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424254|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424255|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424256|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424257|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424258|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
126424259|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424260|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424261|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424262|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424263|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126004617|NCT03255941|453309733|FG003|Overall Study|Did not complete exit interview|0|||
126004618|NCT00372060|453309734|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
126004619|NCT00372060|453309735|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
126004620|NCT00372060|453309734|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
126004621|NCT00372060|453309735|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
126004622|NCT00372060|453309734|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
126004623|NCT00372060|453309735|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
126004624|NCT00372060|453309734|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
126004625|NCT00372060|453309735|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
126004626|NCT00372060|453309734|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
126004627|NCT00372060|453309735|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
126004628|NCT00372060|453309734|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
126004629|NCT00372060|453309735|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
126004630|NCT01579578|453309736|FG000|Overall Study|Death|4|||
126004631|NCT01579578|453309737|FG001|Overall Study|Death|1|||
126004632|NCT01579578|453309736|FG000|Overall Study|Lost to Follow-up|1|||
126004633|NCT01579578|453309737|FG001|Overall Study|Lost to Follow-up|1|||
126004634|NCT01579578|453309736|FG000|Overall Study|Withdrawal by Subject|2|||
126004635|NCT01579578|453309737|FG001|Overall Study|Withdrawal by Subject|1|||
126004636|NCT01579578|453309736|FG000|Overall Study|Eligibility criteria|3|||
126004637|NCT01579578|453309737|FG001|Overall Study|Eligibility criteria|9|||
126004638|NCT01579578|453309736|FG000|Overall Study|Ongoing|3|||
126004639|NCT01579578|453309737|FG001|Overall Study|Ongoing|0|||
126004640|NCT00797225|453309739|FG000|Weeks 1 to 12|Adverse Event|0|||
126004641|NCT00797225|453309740|FG001|Weeks 1 to 12|Adverse Event|0|||
126004642|NCT00797225|453309741|FG002|Weeks 1 to 12|Adverse Event|1|||
126004643|NCT00797225|453309742|FG003|Weeks 1 to 12|Adverse Event|0|||
126004644|NCT00797225|453309743|FG004|Weeks 1 to 12|Adverse Event|0|||
126004645|NCT00797225|453309744|FG005|Weeks 1 to 12|Adverse Event|0|||
126004646|NCT00797225|453309745|FG006|Weeks 1 to 12|Adverse Event|0|||
126004647|NCT00797225|453309746|FG007|Weeks 1 to 12|Adverse Event|0|||
126004648|NCT00797225|453309739|FG000|Weeks 1 to 12|Non-compliance|0|||
126004649|NCT00797225|453309740|FG001|Weeks 1 to 12|Non-compliance|1|||
126004650|NCT00797225|453309741|FG002|Weeks 1 to 12|Non-compliance|0|||
126004651|NCT00797225|453309742|FG003|Weeks 1 to 12|Non-compliance|0|||
126004652|NCT00797225|453309743|FG004|Weeks 1 to 12|Non-compliance|0|||
126004653|NCT00797225|453309744|FG005|Weeks 1 to 12|Non-compliance|0|||
126004654|NCT00797225|453309745|FG006|Weeks 1 to 12|Non-compliance|0|||
126004655|NCT00797225|453309746|FG007|Weeks 1 to 12|Non-compliance|0|||
126004656|NCT00797225|453309739|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
126004657|NCT00797225|453309740|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
126004658|NCT00797225|453309741|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
126004659|NCT00797225|453309742|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
126004660|NCT00797225|453309743|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
126004661|NCT00797225|453309744|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
126004662|NCT00797225|453309745|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
126004663|NCT00797225|453309746|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
126004664|NCT00797225|453309739|FG000|Weeks 1 to 12|Sponsor Decision|1|||
126004665|NCT00797225|453309740|FG001|Weeks 1 to 12|Sponsor Decision|0|||
126004666|NCT00797225|453309741|FG002|Weeks 1 to 12|Sponsor Decision|0|||
126004667|NCT00797225|453309742|FG003|Weeks 1 to 12|Sponsor Decision|0|||
126004668|NCT00797225|453309743|FG004|Weeks 1 to 12|Sponsor Decision|0|||
126004669|NCT00797225|453309744|FG005|Weeks 1 to 12|Sponsor Decision|0|||
126004670|NCT00797225|453309745|FG006|Weeks 1 to 12|Sponsor Decision|0|||
126004671|NCT00797225|453309746|FG007|Weeks 1 to 12|Sponsor Decision|0|||
126424264|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126004672|NCT00797225|453309739|FG000|Weeks 13 to 24|Non-compliance|0|||
126004673|NCT00797225|453309740|FG001|Weeks 13 to 24|Non-compliance|2|||
126004674|NCT00797225|453309741|FG002|Weeks 13 to 24|Non-compliance|0|||
126004675|NCT00797225|453309742|FG003|Weeks 13 to 24|Non-compliance|0|||
126004676|NCT00797225|453309743|FG004|Weeks 13 to 24|Non-compliance|0|||
126004677|NCT00797225|453309744|FG005|Weeks 13 to 24|Non-compliance|0|||
126004678|NCT00797225|453309745|FG006|Weeks 13 to 24|Non-compliance|0|||
126004679|NCT00797225|453309746|FG007|Weeks 13 to 24|Non-compliance|0|||
126339216|NCT00116142|454538452|FG000|Overall Study|Protocol Violation|2|||
126339217|NCT00116142|454538453|FG001|Overall Study|Protocol Violation|1|||
126339218|NCT00116142|454538452|FG000|Overall Study|Withdrawal by Subject|5|||
126339219|NCT00116142|454538453|FG001|Overall Study|Withdrawal by Subject|5|||
126339220|NCT00116142|454538452|FG000|Overall Study|Physician Decision|3|||
126339221|NCT00116142|454538453|FG001|Overall Study|Physician Decision|1|||
126339222|NCT00116142|454538452|FG000|Overall Study|Delayed Radiation Therapy|1|||
126339223|NCT00116142|454538453|FG001|Overall Study|Delayed Radiation Therapy|0|||
126339224|NCT00116142|454538452|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
126339225|NCT00116142|454538453|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
126339226|NCT00116142|454538452|FG000|Overall Study|Patient stopped due to depression|0|||
126339227|NCT00116142|454538453|FG001|Overall Study|Patient stopped due to depression|1|||
126339228|NCT00116142|454538452|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
126339229|NCT00116142|454538453|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
126339230|NCT00116142|454538452|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
126339231|NCT00116142|454538453|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
126339232|NCT00116142|454538452|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
126339233|NCT00116142|454538453|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
126339234|NCT00644059|454538454|FG000|Overall Study|Lost to Follow-up|37|||
126339235|NCT00644059|454538455|FG001|Overall Study|Lost to Follow-up|34|||
126339236|NCT00644059|454538456|FG002|Overall Study|Lost to Follow-up|16|||
126339237|NCT00644059|454538454|FG000|Overall Study|Withdrawal by Subject|52|||
126339238|NCT00644059|454538455|FG001|Overall Study|Withdrawal by Subject|60|||
126339239|NCT00644059|454538456|FG002|Overall Study|Withdrawal by Subject|30|||
126339240|NCT00644059|454538454|FG000|Overall Study|Adverse Event|8|||
126339241|NCT00644059|454538455|FG001|Overall Study|Adverse Event|5|||
126339242|NCT00644059|454538456|FG002|Overall Study|Adverse Event|1|||
126339243|NCT00644059|454538454|FG000|Overall Study|Inappropriate Enrollment|1|||
126339244|NCT00644059|454538455|FG001|Overall Study|Inappropriate Enrollment|3|||
126339245|NCT00644059|454538456|FG002|Overall Study|Inappropriate Enrollment|0|||
126339246|NCT00644059|454538454|FG000|Overall Study|Protocol Deviation/violation|20|||
126339247|NCT00644059|454538455|FG001|Overall Study|Protocol Deviation/violation|19|||
126339248|NCT00644059|454538456|FG002|Overall Study|Protocol Deviation/violation|15|||
126339249|NCT00644059|454538454|FG000|Overall Study|Unable to classify|6|||
126339250|NCT00644059|454538455|FG001|Overall Study|Unable to classify|2|||
126339251|NCT00644059|454538456|FG002|Overall Study|Unable to classify|3|||
126339252|NCT02133508|454538457|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
126339253|NCT02133508|454538457|FG000|Overall Study|Death|12|||
126339254|NCT02133508|454538457|FG000|Overall Study|Lost to Follow-up|2|||
126339255|NCT02497469|454538464|FG000|Overall Study|Randomized but not Treated|0|||
126339256|NCT02497469|454538465|FG001|Overall Study|Randomized but not Treated|2|||
126339257|NCT02497469|454538464|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
126339258|NCT02497469|454538465|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
126339259|NCT02497469|454538464|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
126339260|NCT02497469|454538465|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
126339261|NCT02497469|454538464|FG000|Overall Study|Significant Protocol Deviation|4|||
126339262|NCT02497469|454538465|FG001|Overall Study|Significant Protocol Deviation|5|||
126339263|NCT02497469|454538464|FG000|Overall Study|Lost to Follow-up|14|||
126339264|NCT02497469|454538465|FG001|Overall Study|Lost to Follow-up|4|||
126339265|NCT02497469|454538464|FG000|Overall Study|Voluntary Withdrawal|39|||
126339266|NCT02497469|454538465|FG001|Overall Study|Voluntary Withdrawal|41|||
126339267|NCT02497469|454538464|FG000|Overall Study|Pregnancy|1|||
126339268|NCT02497469|454538465|FG001|Overall Study|Pregnancy|1|||
126339269|NCT02497469|454538464|FG000|Overall Study|Lack of Efficacy|86|||
126339270|NCT02497469|454538465|FG001|Overall Study|Lack of Efficacy|40|||
126339271|NCT02497469|454538464|FG000|Overall Study|Reason not Specified|6|||
126339272|NCT02497469|454538465|FG001|Overall Study|Reason not Specified|6|||
126339273|NCT04076917|454538467|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
126339274|NCT04076917|454538467|FG000|Overall Study|Study closure|13|||
126339275|NCT04076917|454538467|FG000|Overall Study|Physician Decision|3|||
126339276|NCT04076917|454538467|FG000|Overall Study|Death|1|||
126004680|NCT00797225|453309739|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
126339277|NCT04076917|454538467|FG000|Overall Study|Lost to Follow-up|1|||
126339278|NCT04076917|454538467|FG000|Overall Study|Withdrawal by Subject|1|||
126339279|NCT04076917|454538467|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
126424265|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
126424266|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424267|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424268|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424269|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424270|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424271|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424272|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126004681|NCT00797225|453309740|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
126004682|NCT00797225|453309741|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
126004683|NCT00797225|453309742|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
126004684|NCT00797225|453309743|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
126004685|NCT00797225|453309744|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
126004686|NCT00797225|453309745|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
126004687|NCT00797225|453309746|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
126004688|NCT00797225|453309739|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
126004689|NCT00797225|453309740|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
126004690|NCT00797225|453309741|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
126004691|NCT00797225|453309742|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
126004692|NCT00797225|453309743|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
126004693|NCT00797225|453309744|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
126004694|NCT00797225|453309745|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
126004695|NCT00797225|453309746|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
126004696|NCT00797225|453309739|FG000|Weeks 13 to 24|Adverse Event|0|||
126004697|NCT00797225|453309740|FG001|Weeks 13 to 24|Adverse Event|1|||
126004698|NCT00797225|453309741|FG002|Weeks 13 to 24|Adverse Event|0|||
126004699|NCT00797225|453309742|FG003|Weeks 13 to 24|Adverse Event|0|||
126004700|NCT00797225|453309743|FG004|Weeks 13 to 24|Adverse Event|0|||
126004701|NCT00797225|453309744|FG005|Weeks 13 to 24|Adverse Event|0|||
126004702|NCT00797225|453309745|FG006|Weeks 13 to 24|Adverse Event|1|||
126004703|NCT00797225|453309746|FG007|Weeks 13 to 24|Adverse Event|0|||
126004704|NCT00797225|453309739|FG000|Weeks 13 to 24|Sponsor Decision|0|||
126004705|NCT00797225|453309740|FG001|Weeks 13 to 24|Sponsor Decision|0|||
126004706|NCT00797225|453309741|FG002|Weeks 13 to 24|Sponsor Decision|0|||
126004707|NCT00797225|453309742|FG003|Weeks 13 to 24|Sponsor Decision|0|||
126004708|NCT00797225|453309743|FG004|Weeks 13 to 24|Sponsor Decision|0|||
126004709|NCT00797225|453309744|FG005|Weeks 13 to 24|Sponsor Decision|0|||
126004710|NCT00797225|453309745|FG006|Weeks 13 to 24|Sponsor Decision|1|||
126004711|NCT00797225|453309746|FG007|Weeks 13 to 24|Sponsor Decision|0|||
126004712|NCT02954055|453309747|FG000|Overall Study|Did not initiate therapy|6|||
126004713|NCT02954055|453309748|FG001|Overall Study|Did not initiate therapy|1|||
126004714|NCT01352507|453309751|FG000|Treatment Period 1|Adverse Event|3|||
126004715|NCT01352507|453309752|FG001|Treatment Period 1|Adverse Event|0|||
126004716|NCT01352507|453309751|FG000|Treatment Period 1|Lost to Follow-up|3|||
126004717|NCT01352507|453309752|FG001|Treatment Period 1|Lost to Follow-up|4|||
126004718|NCT01352507|453309751|FG000|Treatment Period 1|Withdrawal by Subject|7|||
126004719|NCT01352507|453309752|FG001|Treatment Period 1|Withdrawal by Subject|5|||
126004720|NCT01352507|453309751|FG000|Treatment Period 1|Physician Decision|1|||
126004721|NCT01352507|453309752|FG001|Treatment Period 1|Physician Decision|0|||
126004722|NCT01352507|453309751|FG000|Washout Period|Withdrawal by Subject|0|||
126004723|NCT01352507|453309752|FG001|Washout Period|Withdrawal by Subject|1|||
126004724|NCT01352507|453309751|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
126004725|NCT01352507|453309752|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
126004726|NCT01352507|453309751|FG000|Treatment Period 2|Withdrawal by Subject|4|||
126004727|NCT01352507|453309752|FG001|Treatment Period 2|Withdrawal by Subject|3|||
126004728|NCT01352507|453309751|FG000|Treatment Period 2|Lack of Efficacy|1|||
126004729|NCT01352507|453309752|FG001|Treatment Period 2|Lack of Efficacy|0|||
126004730|NCT01511250|453309753|FG000|Overall Study|Withdrawal of Consent|1|||
126004731|NCT01511250|453309754|FG001|Overall Study|Withdrawal of Consent|0|||
126004732|NCT01511250|453309755|FG002|Overall Study|Withdrawal of Consent|0|||
126004733|NCT01511250|453309756|FG003|Overall Study|Withdrawal of Consent|0|||
126004734|NCT01511250|453309757|FG004|Overall Study|Withdrawal of Consent|0|||
126004735|NCT01511250|453309758|FG005|Overall Study|Withdrawal of Consent|0|||
126004736|NCT01511250|453309759|FG006|Overall Study|Withdrawal of Consent|0|||
126004737|NCT01511250|453309760|FG007|Overall Study|Withdrawal of Consent|1|||
126004738|NCT01511250|453309761|FG008|Overall Study|Withdrawal of Consent|1|||
126004739|NCT01511250|453309762|FG009|Overall Study|Withdrawal of Consent|0|||
126004740|NCT01511250|453309753|FG000|Overall Study|Sponsor/Investigator Decision|1|||
126004741|NCT01511250|453309754|FG001|Overall Study|Sponsor/Investigator Decision|0|||
126004742|NCT01511250|453309755|FG002|Overall Study|Sponsor/Investigator Decision|0|||
126004743|NCT01511250|453309756|FG003|Overall Study|Sponsor/Investigator Decision|0|||
126004744|NCT01511250|453309757|FG004|Overall Study|Sponsor/Investigator Decision|0|||
126004745|NCT01511250|453309758|FG005|Overall Study|Sponsor/Investigator Decision|0|||
126004746|NCT01511250|453309759|FG006|Overall Study|Sponsor/Investigator Decision|0|||
126004747|NCT01511250|453309760|FG007|Overall Study|Sponsor/Investigator Decision|0|||
126004748|NCT01511250|453309761|FG008|Overall Study|Sponsor/Investigator Decision|0|||
126004749|NCT01511250|453309762|FG009|Overall Study|Sponsor/Investigator Decision|0|||
126004750|NCT01511250|453309753|FG000|Overall Study|Lost to Follow-up|7|||
126004751|NCT01511250|453309754|FG001|Overall Study|Lost to Follow-up|3|||
126004752|NCT01511250|453309755|FG002|Overall Study|Lost to Follow-up|3|||
126004753|NCT01511250|453309756|FG003|Overall Study|Lost to Follow-up|3|||
126004754|NCT01511250|453309757|FG004|Overall Study|Lost to Follow-up|0|||
126004755|NCT01511250|453309758|FG005|Overall Study|Lost to Follow-up|0|||
126004756|NCT01511250|453309759|FG006|Overall Study|Lost to Follow-up|2|||
126004757|NCT01511250|453309760|FG007|Overall Study|Lost to Follow-up|3|||
126004758|NCT01511250|453309761|FG008|Overall Study|Lost to Follow-up|13|||
126004759|NCT01511250|453309762|FG009|Overall Study|Lost to Follow-up|5|||
126004760|NCT01511250|453309753|FG000|Overall Study|Protocol Violation|0|||
126004761|NCT01511250|453309754|FG001|Overall Study|Protocol Violation|2|||
126004762|NCT01511250|453309755|FG002|Overall Study|Protocol Violation|1|||
126004763|NCT01511250|453309756|FG003|Overall Study|Protocol Violation|0|||
126004764|NCT01511250|453309757|FG004|Overall Study|Protocol Violation|0|||
126004765|NCT01511250|453309758|FG005|Overall Study|Protocol Violation|0|||
126004766|NCT01511250|453309759|FG006|Overall Study|Protocol Violation|0|||
126004767|NCT01511250|453309760|FG007|Overall Study|Protocol Violation|0|||
126004768|NCT01511250|453309761|FG008|Overall Study|Protocol Violation|0|||
126004769|NCT01511250|453309762|FG009|Overall Study|Protocol Violation|0|||
126004770|NCT05489224|453309763|FG000|Treatment Period I|Withdrawal by Subject|6|||
126004771|NCT05489224|453309764|FG001|Treatment Period I|Withdrawal by Subject|5|||
126004772|NCT05489224|453309765|FG002|Treatment Period I|Withdrawal by Subject|0|||
126004773|NCT05489224|453309763|FG000|Treatment Period I|Adverse Event|3|||
126004774|NCT05489224|453309764|FG001|Treatment Period I|Adverse Event|11|||
126004775|NCT05489224|453309765|FG002|Treatment Period I|Adverse Event|0|||
126004776|NCT05489224|453309763|FG000|Treatment Period I|Lost to Follow-up|0|||
126004777|NCT05489224|453309764|FG001|Treatment Period I|Lost to Follow-up|1|||
126004778|NCT05489224|453309765|FG002|Treatment Period I|Lost to Follow-up|0|||
126004779|NCT05489224|453309763|FG000|Treatment Period I|Physician Decision|0|||
126004780|NCT05489224|453309764|FG001|Treatment Period I|Physician Decision|1|||
126004781|NCT05489224|453309765|FG002|Treatment Period I|Physician Decision|0|||
126004782|NCT05489224|453309763|FG000|Treatment Period II up to Week 32|Ongoing|222|||
126004783|NCT05489224|453309764|FG001|Treatment Period II up to Week 32|Ongoing|107|||
126004784|NCT05489224|453309765|FG002|Treatment Period II up to Week 32|Ongoing|107|||
126004785|NCT05489224|453309763|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
126004786|NCT05489224|453309764|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
126004787|NCT05489224|453309765|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
126004788|NCT05489224|453309763|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
126004789|NCT05489224|453309764|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
126004790|NCT05489224|453309765|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
126004791|NCT00832780|453309770|FG000|Overall Study|Death|16|||
126004792|NCT00832780|453309770|FG000|Overall Study|Lost to Follow-up|4|||
126004793|NCT00832780|453309770|FG000|Overall Study|no reason given|2|||
126004794|NCT00832780|453309770|FG000|Overall Study|other complicating condition|2|||
126004795|NCT00832780|453309770|FG000|Overall Study|Physician Decision|1|||
126004796|NCT04319094|453309775|FG000|Baseline|Lost to Follow-up|4|||
126004797|NCT04319094|453309776|FG001|Baseline|Lost to Follow-up|5|||
126004798|NCT04319094|453309775|FG000|Baseline|Protocol Violation|0|||
126004799|NCT04319094|453309776|FG001|Baseline|Protocol Violation|3|||
126004800|NCT04319094|453309775|FG000|Baseline|Withdrawal by Subject|2|||
126004801|NCT04319094|453309776|FG001|Baseline|Withdrawal by Subject|1|||
126004802|NCT04319094|453309775|FG000|Post-Intervention|Death|0|||
126004803|NCT04319094|453309776|FG001|Post-Intervention|Death|1|||
126004804|NCT04319094|453309775|FG000|Post-Intervention|Lost to Follow-up|4|||
126004805|NCT04319094|453309776|FG001|Post-Intervention|Lost to Follow-up|4|||
126004806|NCT04319094|453309775|FG000|Post-Intervention|Withdrawal by Subject|8|||
126004807|NCT04319094|453309776|FG001|Post-Intervention|Withdrawal by Subject|5|||
126004808|NCT04319094|453309775|FG000|Post-Intervention|Incomplete Data Collection|1|||
126004809|NCT04319094|453309776|FG001|Post-Intervention|Incomplete Data Collection|3|||
126004810|NCT04319094|453309775|FG000|3-month|Death|1|||
126339280|NCT01774591|454538470|FG000|Overall Study|Physician Decision|1|||
126339281|NCT01774591|454538471|FG001|Overall Study|Physician Decision|1|||
126339282|NCT01774591|454538470|FG000|Overall Study|Withdrawal by Subject|0|||
126339283|NCT01774591|454538471|FG001|Overall Study|Withdrawal by Subject|1|||
126339284|NCT01774591|454538470|FG000|Overall Study|Adverse Event|0|||
126004811|NCT04319094|453309776|FG001|3-month|Death|0|||
126004812|NCT04319094|453309775|FG000|3-month|Lost to Follow-up|2|||
126004813|NCT04319094|453309776|FG001|3-month|Lost to Follow-up|2|||
126004814|NCT04319094|453309775|FG000|3-month|Withdrawal by Subject|0|||
126004815|NCT04319094|453309776|FG001|3-month|Withdrawal by Subject|3|||
126004816|NCT04319094|453309775|FG000|3-month|Incomplete data collection|9|||
126004817|NCT04319094|453309776|FG001|3-month|Incomplete data collection|7|||
126004818|NCT04319094|453309775|FG000|6-month|Lost to Follow-up|1|||
126004819|NCT04319094|453309776|FG001|6-month|Lost to Follow-up|1|||
126004820|NCT04319094|453309775|FG000|6-month|Withdrawal by Subject|0|||
126004821|NCT04319094|453309776|FG001|6-month|Withdrawal by Subject|3|||
126004822|NCT04319094|453309775|FG000|6-month|Incomplete data collection|14|||
126004823|NCT04319094|453309776|FG001|6-month|Incomplete data collection|9|||
126004824|NCT04319094|453309775|FG000|9-month|Lost to Follow-up|8|||
126004825|NCT04319094|453309776|FG001|9-month|Lost to Follow-up|4|||
126004826|NCT04319094|453309775|FG000|9-month|Withdrawal by Subject|0|||
126004827|NCT04319094|453309776|FG001|9-month|Withdrawal by Subject|1|||
126004828|NCT04319094|453309775|FG000|9-month|Incomplete data collection|8|||
126004829|NCT04319094|453309776|FG001|9-month|Incomplete data collection|5|||
126004830|NCT04319094|453309775|FG000|12-month|Lost to Follow-up|11|||
126004831|NCT04319094|453309776|FG001|12-month|Lost to Follow-up|8|||
126004832|NCT04956692|453309777|FG000|Overall Study|Death|115|||
126004833|NCT04956692|453309778|FG001|Overall Study|Death|47|||
126004834|NCT04956692|453309777|FG000|Overall Study|Lost to Follow-up|0|||
126004835|NCT04956692|453309778|FG001|Overall Study|Lost to Follow-up|1|||
126004836|NCT04956692|453309777|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126004837|NCT04956692|453309778|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126004838|NCT04956692|453309777|FG000|Overall Study|Withdrawal by Subject|5|||
126004839|NCT04956692|453309778|FG001|Overall Study|Withdrawal by Subject|2|||
126004840|NCT04956692|453309777|FG000|Overall Study|Ongoing in Study|236|||
126004841|NCT04956692|453309778|FG001|Overall Study|Ongoing in Study|123|||
126004842|NCT01822821|453309782|FG000|Overall Study|Eligible surgery cancelled|1|||
126004843|NCT01822821|453309783|FG001|Overall Study|Eligible surgery cancelled|1|||
126004844|NCT01822821|453309782|FG000|Overall Study|Other reasons|1|||
126004845|NCT01822821|453309783|FG001|Overall Study|Other reasons|0|||
126004846|NCT05780047|453309784|FG000|Overall Study|Did not submit baseline urine test kit|226|||
126339285|NCT01774591|454538471|FG001|Overall Study|Adverse Event|2|||
126339286|NCT01787552|454538472|FG000|Overall Study|Withdrawal by Subject|2|||
126339287|NCT01787552|454538473|FG001|Overall Study|Withdrawal by Subject|0|||
126339288|NCT01787552|454538474|FG002|Overall Study|Withdrawal by Subject|0|||
126339289|NCT01787552|454538475|FG003|Overall Study|Withdrawal by Subject|4|||
126339290|NCT01787552|454538472|FG000|Overall Study|Physician Decision|2|||
126339291|NCT01787552|454538473|FG001|Overall Study|Physician Decision|2|||
126339292|NCT01787552|454538474|FG002|Overall Study|Physician Decision|1|||
126339293|NCT01787552|454538475|FG003|Overall Study|Physician Decision|2|||
126339294|NCT01787552|454538472|FG000|Overall Study|Death|0|||
126339295|NCT01787552|454538473|FG001|Overall Study|Death|0|||
126339296|NCT01787552|454538474|FG002|Overall Study|Death|0|||
126339297|NCT01787552|454538475|FG003|Overall Study|Death|1|||
126339298|NCT01787552|454538472|FG000|Overall Study|Adverse Event|2|||
126339299|NCT01787552|454538473|FG001|Overall Study|Adverse Event|5|||
126339300|NCT01787552|454538474|FG002|Overall Study|Adverse Event|2|||
126339301|NCT01787552|454538475|FG003|Overall Study|Adverse Event|16|||
126339302|NCT01787552|454538472|FG000|Overall Study|Study terminated by Sponsor|0|||
126339303|NCT01787552|454538473|FG001|Overall Study|Study terminated by Sponsor|0|||
126339304|NCT01787552|454538474|FG002|Overall Study|Study terminated by Sponsor|1|||
126339305|NCT01787552|454538475|FG003|Overall Study|Study terminated by Sponsor|3|||
126339306|NCT01787552|454538472|FG000|Overall Study|Progressive Disease|2|||
126339307|NCT01787552|454538473|FG001|Overall Study|Progressive Disease|2|||
126339308|NCT01787552|454538474|FG002|Overall Study|Progressive Disease|1|||
126339309|NCT01787552|454538475|FG003|Overall Study|Progressive Disease|1|||
126339310|NCT03055936|454538481|FG000|Overall Study|Adverse Event|0|||
126339311|NCT03055936|454538482|FG001|Overall Study|Adverse Event|1|||
126339312|NCT03055936|454538483|FG002|Overall Study|Adverse Event|1|||
126339313|NCT03055936|454538484|FG003|Overall Study|Adverse Event|1|||
126339314|NCT03055936|454538481|FG000|Overall Study|Personal reason|2|||
126339315|NCT03055936|454538482|FG001|Overall Study|Personal reason|0|||
126339316|NCT03055936|454538483|FG002|Overall Study|Personal reason|1|||
126339317|NCT03055936|454538484|FG003|Overall Study|Personal reason|0|||
126339318|NCT03167242|454538485|FG000|Overall Study|Patient/Guardian Decision|0|||
126339319|NCT03167242|454538486|FG001|Overall Study|Patient/Guardian Decision|1|||
126339320|NCT03167242|454538487|FG002|Overall Study|Patient/Guardian Decision|2|||
126339321|NCT03167242|454538488|FG003|Overall Study|Patient/Guardian Decision|1|||
126339322|NCT03167242|454538489|FG004|Overall Study|Patient/Guardian Decision|1|||
126339323|NCT03167242|454538490|FG005|Overall Study|Patient/Guardian Decision|1|||
126339324|NCT03167242|454538491|FG006|Overall Study|Patient/Guardian Decision|0|||
126339325|NCT03167242|454538492|FG007|Overall Study|Patient/Guardian Decision|0|||
126004847|NCT05780047|453309784|FG000|Overall Study|Lost to Follow-up|34|||
126004848|NCT05780047|453309784|FG000|Overall Study|Did not submit second urine test kit|124|||
126004849|NCT04873817|453309787|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
126004850|NCT04873817|453309787|FG000|Overall Study|Lost to Follow-up|4|||
126004851|NCT04873817|453309787|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
126339326|NCT03167242|454538493|FG008|Overall Study|Patient/Guardian Decision|0|||
126339327|NCT03167242|454538494|FG009|Overall Study|Patient/Guardian Decision|0|||
126339328|NCT03167242|454538495|FG010|Overall Study|Patient/Guardian Decision|1|||
126339329|NCT03167242|454538496|FG011|Overall Study|Patient/Guardian Decision|0|||
126339330|NCT03167242|454538485|FG000|Overall Study|Lost to Follow-up|0|||
126339331|NCT03167242|454538486|FG001|Overall Study|Lost to Follow-up|0|||
126004852|NCT04873817|453309787|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
126004853|NCT04873817|453309787|FG000|Overall Study|Other Reasons|3|||
126004854|NCT00665561|453309788|FG000|Overall Study|Death recorded on subject summary pages|75|||
126004855|NCT00665561|453309789|FG001|Overall Study|Death recorded on subject summary pages|75|||
126004856|NCT00665561|453309788|FG000|Overall Study|Does not meet entrance criteria|19|||
126004857|NCT00665561|453309789|FG001|Overall Study|Does not meet entrance criteria|21|||
126004858|NCT00665561|453309788|FG000|Overall Study|Lost to Follow-up|203|||
126004859|NCT00665561|453309789|FG001|Overall Study|Lost to Follow-up|264|||
126004860|NCT00665561|453309788|FG000|Overall Study|Withdrawal by Subject|74|||
126004861|NCT00665561|453309789|FG001|Overall Study|Withdrawal by Subject|65|||
126004862|NCT00665561|453309788|FG000|Overall Study|Other|123|||
126004863|NCT00665561|453309789|FG001|Overall Study|Other|108|||
126004864|NCT00665561|453309788|FG000|Overall Study|Site closed|8|||
126004865|NCT00665561|453309789|FG001|Overall Study|Site closed|0|||
126004866|NCT00665561|453309788|FG000|Overall Study|Withdrawn due to pregnancy|0|||
126004867|NCT00665561|453309789|FG001|Overall Study|Withdrawn due to pregnancy|1|||
126004868|NCT00062868|453309792|FG000|Dose Level 1|Death|2|||
126004869|NCT00062868|453309793|FG001|Dose Level 1|Death|0|||
126004870|NCT00062868|453309794|FG002|Dose Level 1|Death|0|||
126004871|NCT00062868|453309795|FG003|Dose Level 1|Death|2|||
126004872|NCT00062868|453309796|FG004|Dose Level 1|Death|0|||
126004873|NCT00062868|453309797|FG005|Dose Level 1|Death|0|||
126004874|NCT00062868|453309798|FG006|Dose Level 1|Death|3|||
126004875|NCT00062868|453309799|FG007|Dose Level 1|Death|0|||
126004876|NCT00062868|453309800|FG008|Dose Level 1|Death|0|||
126004877|NCT00062868|453309801|FG009|Dose Level 1|Death|0|||
126004878|NCT00062868|453309802|FG010|Dose Level 1|Death|0|||
126004879|NCT00062868|453309803|FG011|Dose Level 1|Death|0|||
126004880|NCT00062868|453309804|FG012|Dose Level 1|Death|0|||
126004881|NCT00062868|453309805|FG013|Dose Level 1|Death|0|||
126004882|NCT00062868|453309806|FG014|Dose Level 1|Death|0|||
126004883|NCT00062868|453309807|FG015|Dose Level 1|Death|0|||
126004884|NCT00062868|453309808|FG016|Dose Level 1|Death|0|||
126004885|NCT00062868|453309809|FG017|Dose Level 1|Death|0|||
126004886|NCT00062868|453309810|FG018|Dose Level 1|Death|7|||
126004887|NCT00062868|453309811|FG019|Dose Level 1|Death|0|||
126004888|NCT00062868|453309812|FG020|Dose Level 1|Death|1|||
126004889|NCT00062868|453309792|FG000|Dose Level 1|Lost to Follow-up|0|||
126004890|NCT00062868|453309793|FG001|Dose Level 1|Lost to Follow-up|0|||
126004891|NCT00062868|453309794|FG002|Dose Level 1|Lost to Follow-up|0|||
126004892|NCT00062868|453309795|FG003|Dose Level 1|Lost to Follow-up|0|||
126004893|NCT00062868|453309796|FG004|Dose Level 1|Lost to Follow-up|0|||
126004894|NCT00062868|453309797|FG005|Dose Level 1|Lost to Follow-up|0|||
126004895|NCT00062868|453309798|FG006|Dose Level 1|Lost to Follow-up|0|||
126004896|NCT00062868|453309799|FG007|Dose Level 1|Lost to Follow-up|0|||
126004897|NCT00062868|453309800|FG008|Dose Level 1|Lost to Follow-up|0|||
126004898|NCT00062868|453309801|FG009|Dose Level 1|Lost to Follow-up|0|||
126004899|NCT00062868|453309802|FG010|Dose Level 1|Lost to Follow-up|0|||
126004900|NCT00062868|453309803|FG011|Dose Level 1|Lost to Follow-up|0|||
126004901|NCT00062868|453309804|FG012|Dose Level 1|Lost to Follow-up|1|||
126004902|NCT00062868|453309805|FG013|Dose Level 1|Lost to Follow-up|0|||
126004903|NCT00062868|453309806|FG014|Dose Level 1|Lost to Follow-up|0|||
126004904|NCT00062868|453309807|FG015|Dose Level 1|Lost to Follow-up|0|||
126004905|NCT00062868|453309808|FG016|Dose Level 1|Lost to Follow-up|0|||
126004906|NCT00062868|453309809|FG017|Dose Level 1|Lost to Follow-up|0|||
126004907|NCT00062868|453309810|FG018|Dose Level 1|Lost to Follow-up|2|||
126339332|NCT03167242|454538487|FG002|Overall Study|Lost to Follow-up|1|||
126004908|NCT00062868|453309811|FG019|Dose Level 1|Lost to Follow-up|0|||
126004909|NCT00062868|453309812|FG020|Dose Level 1|Lost to Follow-up|1|||
126004910|NCT00062868|453309792|FG000|Dose Level 2|Death|0|||
126339333|NCT03167242|454538488|FG003|Overall Study|Lost to Follow-up|0|||
126339334|NCT03167242|454538489|FG004|Overall Study|Lost to Follow-up|0|||
126339335|NCT03167242|454538490|FG005|Overall Study|Lost to Follow-up|1|||
126339336|NCT03167242|454538491|FG006|Overall Study|Lost to Follow-up|2|||
126339337|NCT03167242|454538492|FG007|Overall Study|Lost to Follow-up|1|||
126339338|NCT03167242|454538493|FG008|Overall Study|Lost to Follow-up|0|||
126004911|NCT00062868|453309793|FG001|Dose Level 2|Death|3|||
126004912|NCT00062868|453309794|FG002|Dose Level 2|Death|0|||
126339339|NCT03167242|454538494|FG009|Overall Study|Lost to Follow-up|0|||
126004913|NCT00062868|453309795|FG003|Dose Level 2|Death|0|||
126004914|NCT00062868|453309796|FG004|Dose Level 2|Death|2|||
126004915|NCT00062868|453309797|FG005|Dose Level 2|Death|0|||
126004916|NCT00062868|453309798|FG006|Dose Level 2|Death|0|||
126339340|NCT03167242|454538495|FG010|Overall Study|Lost to Follow-up|1|||
126004917|NCT00062868|453309799|FG007|Dose Level 2|Death|0|||
126004918|NCT00062868|453309800|FG008|Dose Level 2|Death|0|||
126004919|NCT00062868|453309801|FG009|Dose Level 2|Death|0|||
126004920|NCT00062868|453309802|FG010|Dose Level 2|Death|1|||
126004921|NCT00062868|453309803|FG011|Dose Level 2|Death|0|||
126004922|NCT00062868|453309804|FG012|Dose Level 2|Death|0|||
126004923|NCT00062868|453309805|FG013|Dose Level 2|Death|0|||
126004924|NCT00062868|453309806|FG014|Dose Level 2|Death|0|||
126339341|NCT03167242|454538496|FG011|Overall Study|Lost to Follow-up|1|||
126424273|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424274|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424275|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424276|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424277|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424278|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424279|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424280|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424281|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
126424282|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
126424283|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126004925|NCT00062868|453309807|FG015|Dose Level 2|Death|0|||
126004926|NCT00062868|453309808|FG016|Dose Level 2|Death|2|||
126004927|NCT00062868|453309809|FG017|Dose Level 2|Death|0|||
126004928|NCT00062868|453309810|FG018|Dose Level 2|Death|0|||
126004929|NCT00062868|453309811|FG019|Dose Level 2|Death|0|||
126004930|NCT00062868|453309812|FG020|Dose Level 2|Death|0|||
126004931|NCT00062868|453309792|FG000|Dose Level 2|Lost to Follow-up|0|||
126004932|NCT00062868|453309793|FG001|Dose Level 2|Lost to Follow-up|0|||
126004933|NCT00062868|453309794|FG002|Dose Level 2|Lost to Follow-up|0|||
126004934|NCT00062868|453309795|FG003|Dose Level 2|Lost to Follow-up|0|||
126004935|NCT00062868|453309796|FG004|Dose Level 2|Lost to Follow-up|0|||
126004936|NCT00062868|453309797|FG005|Dose Level 2|Lost to Follow-up|0|||
126004937|NCT00062868|453309798|FG006|Dose Level 2|Lost to Follow-up|0|||
126004938|NCT00062868|453309799|FG007|Dose Level 2|Lost to Follow-up|0|||
126004939|NCT00062868|453309800|FG008|Dose Level 2|Lost to Follow-up|0|||
126004940|NCT00062868|453309801|FG009|Dose Level 2|Lost to Follow-up|0|||
126004941|NCT00062868|453309802|FG010|Dose Level 2|Lost to Follow-up|0|||
126004942|NCT00062868|453309803|FG011|Dose Level 2|Lost to Follow-up|0|||
126004943|NCT00062868|453309804|FG012|Dose Level 2|Lost to Follow-up|0|||
126004944|NCT00062868|453309805|FG013|Dose Level 2|Lost to Follow-up|1|||
126004945|NCT00062868|453309806|FG014|Dose Level 2|Lost to Follow-up|0|||
126004946|NCT00062868|453309807|FG015|Dose Level 2|Lost to Follow-up|0|||
126004947|NCT00062868|453309808|FG016|Dose Level 2|Lost to Follow-up|1|||
126004948|NCT00062868|453309809|FG017|Dose Level 2|Lost to Follow-up|0|||
126004949|NCT00062868|453309810|FG018|Dose Level 2|Lost to Follow-up|0|||
126004950|NCT00062868|453309811|FG019|Dose Level 2|Lost to Follow-up|0|||
126004951|NCT00062868|453309812|FG020|Dose Level 2|Lost to Follow-up|0|||
126004952|NCT00062868|453309792|FG000|Dose Level 3|Death|0|||
126004953|NCT00062868|453309793|FG001|Dose Level 3|Death|0|||
126004954|NCT00062868|453309794|FG002|Dose Level 3|Death|0|||
126004955|NCT00062868|453309795|FG003|Dose Level 3|Death|0|||
126004956|NCT00062868|453309796|FG004|Dose Level 3|Death|0|||
126004957|NCT00062868|453309797|FG005|Dose Level 3|Death|0|||
126004958|NCT00062868|453309798|FG006|Dose Level 3|Death|0|||
126004959|NCT00062868|453309799|FG007|Dose Level 3|Death|0|||
126004960|NCT00062868|453309800|FG008|Dose Level 3|Death|0|||
126004961|NCT00062868|453309801|FG009|Dose Level 3|Death|0|||
126004962|NCT00062868|453309802|FG010|Dose Level 3|Death|0|||
126004963|NCT00062868|453309803|FG011|Dose Level 3|Death|1|||
126004964|NCT00062868|453309804|FG012|Dose Level 3|Death|0|||
126004965|NCT00062868|453309805|FG013|Dose Level 3|Death|0|||
126004966|NCT00062868|453309806|FG014|Dose Level 3|Death|0|||
126004967|NCT00062868|453309807|FG015|Dose Level 3|Death|0|||
126004968|NCT00062868|453309808|FG016|Dose Level 3|Death|0|||
126004969|NCT00062868|453309809|FG017|Dose Level 3|Death|1|||
126004970|NCT00062868|453309810|FG018|Dose Level 3|Death|0|||
126004971|NCT00062868|453309811|FG019|Dose Level 3|Death|0|||
126004972|NCT00062868|453309812|FG020|Dose Level 3|Death|0|||
126004973|NCT00062868|453309792|FG000|Dose Level 3|Lost to Follow-up|0|||
126004974|NCT00062868|453309793|FG001|Dose Level 3|Lost to Follow-up|0|||
126004975|NCT00062868|453309794|FG002|Dose Level 3|Lost to Follow-up|0|||
126004976|NCT00062868|453309795|FG003|Dose Level 3|Lost to Follow-up|0|||
126004977|NCT00062868|453309796|FG004|Dose Level 3|Lost to Follow-up|0|||
126004978|NCT00062868|453309797|FG005|Dose Level 3|Lost to Follow-up|0|||
126004979|NCT00062868|453309798|FG006|Dose Level 3|Lost to Follow-up|0|||
126004980|NCT00062868|453309799|FG007|Dose Level 3|Lost to Follow-up|0|||
126004981|NCT00062868|453309800|FG008|Dose Level 3|Lost to Follow-up|0|||
126004982|NCT00062868|453309801|FG009|Dose Level 3|Lost to Follow-up|0|||
126004983|NCT00062868|453309802|FG010|Dose Level 3|Lost to Follow-up|0|||
126004984|NCT00062868|453309803|FG011|Dose Level 3|Lost to Follow-up|0|||
126004985|NCT00062868|453309804|FG012|Dose Level 3|Lost to Follow-up|0|||
126004986|NCT00062868|453309805|FG013|Dose Level 3|Lost to Follow-up|0|||
126004987|NCT00062868|453309806|FG014|Dose Level 3|Lost to Follow-up|1|||
126004988|NCT00062868|453309807|FG015|Dose Level 3|Lost to Follow-up|0|||
126004989|NCT00062868|453309808|FG016|Dose Level 3|Lost to Follow-up|0|||
126004990|NCT00062868|453309809|FG017|Dose Level 3|Lost to Follow-up|0|||
126004991|NCT00062868|453309810|FG018|Dose Level 3|Lost to Follow-up|0|||
126004992|NCT00062868|453309811|FG019|Dose Level 3|Lost to Follow-up|0|||
126004993|NCT00062868|453309812|FG020|Dose Level 3|Lost to Follow-up|0|||
126424284|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
126424285|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
126424286|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
126004994|NCT00062868|453309792|FG000|Dose Level 3|Withdrew|0|||
126004995|NCT00062868|453309793|FG001|Dose Level 3|Withdrew|0|||
126004996|NCT00062868|453309794|FG002|Dose Level 3|Withdrew|2|||
126004997|NCT00062868|453309795|FG003|Dose Level 3|Withdrew|0|||
126004998|NCT00062868|453309796|FG004|Dose Level 3|Withdrew|0|||
126004999|NCT00062868|453309797|FG005|Dose Level 3|Withdrew|0|||
126005000|NCT00062868|453309798|FG006|Dose Level 3|Withdrew|0|||
126005001|NCT00062868|453309799|FG007|Dose Level 3|Withdrew|0|||
126005002|NCT00062868|453309800|FG008|Dose Level 3|Withdrew|0|||
126005003|NCT00062868|453309801|FG009|Dose Level 3|Withdrew|0|||
126005004|NCT00062868|453309802|FG010|Dose Level 3|Withdrew|0|||
126005005|NCT00062868|453309803|FG011|Dose Level 3|Withdrew|0|||
126005006|NCT00062868|453309804|FG012|Dose Level 3|Withdrew|0|||
126005007|NCT00062868|453309805|FG013|Dose Level 3|Withdrew|0|||
126005008|NCT00062868|453309806|FG014|Dose Level 3|Withdrew|0|||
126005009|NCT00062868|453309807|FG015|Dose Level 3|Withdrew|0|||
126005010|NCT00062868|453309808|FG016|Dose Level 3|Withdrew|0|||
126005011|NCT00062868|453309809|FG017|Dose Level 3|Withdrew|0|||
126005012|NCT00062868|453309810|FG018|Dose Level 3|Withdrew|0|||
126005013|NCT00062868|453309811|FG019|Dose Level 3|Withdrew|0|||
126005014|NCT00062868|453309812|FG020|Dose Level 3|Withdrew|0|||
126005015|NCT01734811|453309813|FG000|Overall Study|Lost to Follow-up|2|||
126005016|NCT01734811|453309814|FG001|Overall Study|Lost to Follow-up|3|||
126005017|NCT01734811|453309813|FG000|Overall Study|Withdrawal by Subject|2|||
126005018|NCT01734811|453309814|FG001|Overall Study|Withdrawal by Subject|0|||
126005019|NCT01866917|453309822|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
126005020|NCT01866917|453309823|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
126005021|NCT01515319|453309824|FG000|Overall Study|Withdrawal by Subject|0|||
126005022|NCT01515319|453309825|FG001|Overall Study|Withdrawal by Subject|0|||
126005023|NCT01515319|453309826|FG002|Overall Study|Withdrawal by Subject|0|||
126005024|NCT01515319|453309827|FG003|Overall Study|Withdrawal by Subject|0|||
126005025|NCT01515319|453309828|FG004|Overall Study|Withdrawal by Subject|0|||
126005026|NCT01515319|453309829|FG005|Overall Study|Withdrawal by Subject|0|||
126005027|NCT01515319|453309830|FG006|Overall Study|Withdrawal by Subject|1|||
126005028|NCT01515319|453309831|FG007|Overall Study|Withdrawal by Subject|0|||
126005029|NCT01515319|453309832|FG008|Overall Study|Withdrawal by Subject|0|||
126005030|NCT01515319|453309833|FG009|Overall Study|Withdrawal by Subject|0|||
126005031|NCT01515319|453309824|FG000|Overall Study|Adverse Event|0|||
126005032|NCT01515319|453309825|FG001|Overall Study|Adverse Event|0|||
126005033|NCT01515319|453309826|FG002|Overall Study|Adverse Event|0|||
126005034|NCT01515319|453309827|FG003|Overall Study|Adverse Event|0|||
126005035|NCT01515319|453309828|FG004|Overall Study|Adverse Event|0|||
126005036|NCT01515319|453309829|FG005|Overall Study|Adverse Event|0|||
126005037|NCT01515319|453309830|FG006|Overall Study|Adverse Event|0|||
126005038|NCT01515319|453309831|FG007|Overall Study|Adverse Event|0|||
126005039|NCT01515319|453309832|FG008|Overall Study|Adverse Event|3|||
126005040|NCT01515319|453309833|FG009|Overall Study|Adverse Event|0|||
126005041|NCT01515319|453309824|FG000|Overall Study|Protocol Violation|0|||
126005042|NCT01515319|453309825|FG001|Overall Study|Protocol Violation|0|||
126005043|NCT01515319|453309826|FG002|Overall Study|Protocol Violation|0|||
126005044|NCT01515319|453309827|FG003|Overall Study|Protocol Violation|0|||
126005045|NCT01515319|453309828|FG004|Overall Study|Protocol Violation|0|||
126005046|NCT01515319|453309829|FG005|Overall Study|Protocol Violation|0|||
126005047|NCT01515319|453309830|FG006|Overall Study|Protocol Violation|0|||
126005048|NCT01515319|453309831|FG007|Overall Study|Protocol Violation|0|||
126005049|NCT01515319|453309832|FG008|Overall Study|Protocol Violation|2|||
126005050|NCT01515319|453309833|FG009|Overall Study|Protocol Violation|0|||
126424287|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
126005051|NCT01959880|453309834|FG000|Overall Study|Withdrawal by Subject|11|||
126005052|NCT01959880|453309835|FG001|Overall Study|Withdrawal by Subject|13|||
126005053|NCT01959880|453309836|FG002|Overall Study|Withdrawal by Subject|8|||
126005054|NCT01959880|453309837|FG003|Overall Study|Withdrawal by Subject|7|||
126005055|NCT01959880|453309834|FG000|Overall Study|Death|1|||
126005056|NCT01959880|453309835|FG001|Overall Study|Death|10|||
126005057|NCT01959880|453309836|FG002|Overall Study|Death|1|||
126424288|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
126005058|NCT01959880|453309837|FG003|Overall Study|Death|2|||
126005059|NCT01959880|453309834|FG000|Overall Study|Lost to Follow-up|95|||
126424289|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
126005060|NCT01959880|453309835|FG001|Overall Study|Lost to Follow-up|18|||
126005061|NCT01959880|453309836|FG002|Overall Study|Lost to Follow-up|15|||
126005062|NCT01959880|453309837|FG003|Overall Study|Lost to Follow-up|8|||
126005063|NCT01959880|453309834|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
126424290|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
126005064|NCT01959880|453309835|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
126005065|NCT01959880|453309836|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
126005066|NCT01959880|453309837|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
126005067|NCT01959880|453309834|FG000|Overall Study|Study completed early-FDA approved|1003|||
126005068|NCT01959880|453309835|FG001|Overall Study|Study completed early-FDA approved|311|||
126005069|NCT01959880|453309836|FG002|Overall Study|Study completed early-FDA approved|179|||
126005070|NCT01959880|453309837|FG003|Overall Study|Study completed early-FDA approved|152|||
126005071|NCT01919619|453309838|FG000|Overall Study|Physician Decision|1|||
126005072|NCT01919619|453309839|FG001|Overall Study|Physician Decision|1|||
126005073|NCT03253653|453309840|FG000|Overall Study|Withdrawal by Subject|4|||
126005074|NCT03253653|453309841|FG001|Overall Study|Withdrawal by Subject|1|||
126005075|NCT03253653|453309840|FG000|Overall Study|Protocol Violation|0|||
126005076|NCT03253653|453309841|FG001|Overall Study|Protocol Violation|5|||
126005077|NCT00498186|453311050|FG000|Overall Study|Protocol Violation|10|||
126005078|NCT00498186|453311050|FG000|Overall Study|Lack of Efficacy|31|||
126005079|NCT00498186|453311050|FG000|Overall Study|Adverse Event|89|||
126005080|NCT00498186|453311050|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
126005081|NCT00498186|453311050|FG000|Overall Study|Withdrawal by Subject|18|||
126005082|NCT00498186|453311050|FG000|Overall Study|Lost to Follow-up|3|||
126005083|NCT00498186|453311050|FG000|Overall Study|Other|10|||
126005084|NCT01390857|453311051|FG000|Overall Study|Protocol Violation|2|||
126005085|NCT01390857|453311051|FG000|Overall Study|Lost to Follow-up|1|||
126005086|NCT01390857|453311051|FG000|Overall Study|No Visit after the First Visit|7|||
126005087|NCT00691028|453311059|FG000|Open-label Period|Adverse Event|0|||
126005088|NCT00691028|453311060|FG001|Open-label Period|Adverse Event|0|||
126005089|NCT00691028|453311061|FG002|Open-label Period|Adverse Event|0|||
126005090|NCT00691028|453311062|FG003|Open-label Period|Adverse Event|16|||
126005091|NCT00691028|453311059|FG000|Open-label Period|Withdrawal by Subject|0|||
126005092|NCT00691028|453311060|FG001|Open-label Period|Withdrawal by Subject|0|||
126005093|NCT00691028|453311061|FG002|Open-label Period|Withdrawal by Subject|0|||
126005094|NCT00691028|453311062|FG003|Open-label Period|Withdrawal by Subject|3|||
126005095|NCT00691028|453311059|FG000|Open-label Period|not come to a hospital|0|||
126005096|NCT00691028|453311060|FG001|Open-label Period|not come to a hospital|0|||
126005097|NCT00691028|453311061|FG002|Open-label Period|not come to a hospital|0|||
126005098|NCT00691028|453311062|FG003|Open-label Period|not come to a hospital|1|||
126005099|NCT00691028|453311059|FG000|Double-blind Period|Adverse Event|8|||
126339342|NCT03167242|454538485|FG000|Overall Study|Reason not provided|0|||
126005100|NCT00691028|453311060|FG001|Double-blind Period|Adverse Event|9|||
126005101|NCT00691028|453311061|FG002|Double-blind Period|Adverse Event|6|||
126005102|NCT00691028|453311062|FG003|Double-blind Period|Adverse Event|0|||
126005103|NCT00691028|453311059|FG000|Double-blind Period|Lack of Efficacy|4|||
126005104|NCT00691028|453311060|FG001|Double-blind Period|Lack of Efficacy|3|||
126005105|NCT00691028|453311061|FG002|Double-blind Period|Lack of Efficacy|2|||
126005106|NCT00691028|453311062|FG003|Double-blind Period|Lack of Efficacy|0|||
126005107|NCT00691028|453311059|FG000|Double-blind Period|Withdrawal by Subject|1|||
126005108|NCT00691028|453311060|FG001|Double-blind Period|Withdrawal by Subject|0|||
126005109|NCT00691028|453311061|FG002|Double-blind Period|Withdrawal by Subject|1|||
126005110|NCT00691028|453311062|FG003|Double-blind Period|Withdrawal by Subject|0|||
126005111|NCT00691028|453311059|FG000|Double-blind Period|not come to a hospital.|0|||
126005112|NCT00691028|453311060|FG001|Double-blind Period|not come to a hospital.|1|||
126005113|NCT00691028|453311061|FG002|Double-blind Period|not come to a hospital.|0|||
126005114|NCT00691028|453311062|FG003|Double-blind Period|not come to a hospital.|0|||
126005115|NCT03255018|453311064|FG000|Overall Study|Death on study|0|||
126005116|NCT03255018|453311065|FG001|Overall Study|Death on study|5|||
126005117|NCT03255018|453311064|FG000|Overall Study|Withdrawal by Subject|0|||
126005118|NCT03255018|453311065|FG001|Overall Study|Withdrawal by Subject|2|||
126005119|NCT01528709|453311066|FG000|Overall Study|Death|2|||
126005120|NCT01528709|453311067|FG001|Overall Study|Death|0|||
126005121|NCT01528709|453311066|FG000|Overall Study|Withdrawal by Subject|10|||
126005122|NCT01528709|453311067|FG001|Overall Study|Withdrawal by Subject|15|||
126005123|NCT01528709|453311066|FG000|Overall Study|allergy|1|||
126005124|NCT01528709|453311067|FG001|Overall Study|allergy|0|||
126005125|NCT01813422|453311078|FG000|Overall Study|Withdrawal by Subject|14|||
126005126|NCT01813422|453311079|FG001|Overall Study|Withdrawal by Subject|8|||
126005127|NCT01813422|453311078|FG000|Overall Study|Death|2|||
126005128|NCT01813422|453311079|FG001|Overall Study|Death|3|||
126005129|NCT01813422|453311078|FG000|Overall Study|Sponsor Decision|2|||
126005130|NCT01813422|453311079|FG001|Overall Study|Sponsor Decision|1|||
126005131|NCT01813422|453311078|FG000|Overall Study|Lost to Follow-up|2|||
126005132|NCT01813422|453311079|FG001|Overall Study|Lost to Follow-up|4|||
126005133|NCT01653743|453311080|FG000|Overall Study|Withdrawal by Subject|1|||
126005134|NCT01653743|453311081|FG001|Overall Study|Withdrawal by Subject|0|||
126339343|NCT03167242|454538486|FG001|Overall Study|Reason not provided|0|||
126339344|NCT03167242|454538487|FG002|Overall Study|Reason not provided|0|||
126339345|NCT03167242|454538488|FG003|Overall Study|Reason not provided|0|||
126005135|NCT01653743|453311080|FG000|Overall Study|Investigator discretion|3|||
126005136|NCT01653743|453311081|FG001|Overall Study|Investigator discretion|0|||
126005137|NCT04889118|453311082|FG000|Overall Study|Death|33|||
126005138|NCT04889118|453311083|FG001|Overall Study|Death|37|||
126005139|NCT04889118|453311082|FG000|Overall Study|Ongoing in Study|31|||
126339346|NCT03167242|454538489|FG004|Overall Study|Reason not provided|0|||
126005140|NCT04889118|453311083|FG001|Overall Study|Ongoing in Study|30|||
126005141|NCT02397889|453311088|FG000|Overall Study|Physician Decision|1|||
126005142|NCT02397889|453311089|FG001|Overall Study|Physician Decision|0|||
126005143|NCT01928940|453311097|FG000|Overall Study|Adverse Event|0|||
126005144|NCT01928940|453311098|FG001|Overall Study|Adverse Event|1|||
126005145|NCT02096003|453311101|FG000|Overall Study|Protocol Violation|0|||
126005146|NCT02096003|453311102|FG001|Overall Study|Protocol Violation|2|||
126005147|NCT02096003|453311101|FG000|Overall Study|additional surgery|2|||
126005148|NCT02096003|453311102|FG001|Overall Study|additional surgery|1|||
126005149|NCT00916006|453311108|FG000|Overall Study|Adverse Event|1|||
126005150|NCT00916006|453311109|FG001|Overall Study|Adverse Event|1|||
126005151|NCT00916006|453311108|FG000|Overall Study|Withdrawal by Subject|2|||
126005152|NCT00916006|453311109|FG001|Overall Study|Withdrawal by Subject|5|||
126005153|NCT00916006|453311108|FG000|Overall Study|Protocol Violation|0|||
126005154|NCT00916006|453311109|FG001|Overall Study|Protocol Violation|1|||
126005155|NCT05487703|453311110|FG000|Overall Study|Other|19|||
126005156|NCT05487703|453311110|FG000|Overall Study|Participant not well|5|||
126005157|NCT05487703|453311110|FG000|Overall Study|Insurance Reasons|6|||
126005158|NCT05487703|453311110|FG000|Overall Study|Physician Decision|19|||
126005159|NCT05487703|453311110|FG000|Overall Study|Lack of Efficacy|60|||
126005160|NCT04824131|453311111|FG000|CAB LA Oral Phase|Adverse Event|1|||
126005161|NCT04824131|453311111|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
126005162|NCT04824131|453311111|FG000|Step 3|Withdrawal by Subject|2|||
126005163|NCT04887285|453311112|FG000|Overall Study|Lost to Follow-up|0|||
126005164|NCT04887285|453311113|FG001|Overall Study|Lost to Follow-up|2|||
126005165|NCT04887285|453311114|FG002|Overall Study|Lost to Follow-up|3|||
126005166|NCT04640571|453311115|FG000|Overall Study|Withdrawal by Subject|0|||
126005167|NCT04640571|453311116|FG001|Overall Study|Withdrawal by Subject|0|||
126005168|NCT04640571|453311117|FG002|Overall Study|Withdrawal by Subject|0|||
126005169|NCT04640571|453311118|FG003|Overall Study|Withdrawal by Subject|0|||
126005170|NCT04640571|453311119|FG004|Overall Study|Withdrawal by Subject|0|||
126005171|NCT04640571|453311120|FG005|Overall Study|Withdrawal by Subject|2|||
126005172|NCT01767909|453311121|FG000|Overall Study|Withdrawal by Subject|4|||
126005173|NCT01767909|453311122|FG001|Overall Study|Withdrawal by Subject|7|||
126005174|NCT01767909|453311121|FG000|Overall Study|Adverse Event|3|||
126005175|NCT01767909|453311122|FG001|Overall Study|Adverse Event|1|||
126005176|NCT01767909|453311121|FG000|Overall Study|Withdrawal by Study Partner|3|||
126005177|NCT01767909|453311122|FG001|Overall Study|Withdrawal by Study Partner|1|||
126005178|NCT01767909|453311121|FG000|Overall Study|Non-Compliance|2|||
126005179|NCT01767909|453311122|FG001|Overall Study|Non-Compliance|0|||
126005180|NCT01767909|453311121|FG000|Overall Study|Perceived Lack of Efficacy|1|||
126005181|NCT01767909|453311122|FG001|Overall Study|Perceived Lack of Efficacy|0|||
126005182|NCT01767909|453311121|FG000|Overall Study|Investigator Recommendation|0|||
126005183|NCT01767909|453311122|FG001|Overall Study|Investigator Recommendation|1|||
126005184|NCT01767909|453311121|FG000|Overall Study|Lost to Follow-up|0|||
126005185|NCT01767909|453311122|FG001|Overall Study|Lost to Follow-up|1|||
126005186|NCT01767909|453311121|FG000|Overall Study|LP uncessessful|0|||
126005187|NCT01767909|453311122|FG001|Overall Study|LP uncessessful|1|||
126005188|NCT04939428|453311123|FG000|Overall Study|Death|0|||
126005189|NCT04939428|453311124|FG001|Overall Study|Death|1|||
126005190|NCT04939428|453311125|FG002|Overall Study|Death|0|||
126005191|NCT04939428|453311123|FG000|Overall Study|Lost to Follow-up|0|||
126005192|NCT04939428|453311124|FG001|Overall Study|Lost to Follow-up|5|||
126005193|NCT04939428|453311125|FG002|Overall Study|Lost to Follow-up|0|||
126005194|NCT04939428|453311123|FG000|Overall Study|Physician Decision|1|||
126005195|NCT04939428|453311124|FG001|Overall Study|Physician Decision|0|||
126005196|NCT04939428|453311125|FG002|Overall Study|Physician Decision|0|||
126005197|NCT04939428|453311123|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126005198|NCT04939428|453311124|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126005199|NCT04939428|453311125|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126005200|NCT04939428|453311123|FG000|Overall Study|Withdrawal by Subject|10|||
126005201|NCT04939428|453311124|FG001|Overall Study|Withdrawal by Subject|11|||
126005202|NCT04939428|453311125|FG002|Overall Study|Withdrawal by Subject|0|||
126005203|NCT04939428|453311123|FG000|Overall Study|Unkown|6|||
126005204|NCT04939428|453311124|FG001|Overall Study|Unkown|3|||
126005205|NCT04939428|453311125|FG002|Overall Study|Unkown|0|||
126005206|NCT04939428|453311123|FG000|Overall Study|Discotinued per protocol|0|||
126339347|NCT03167242|454538490|FG005|Overall Study|Reason not provided|0|||
126005207|NCT04939428|453311124|FG001|Overall Study|Discotinued per protocol|0|||
126005208|NCT04939428|453311125|FG002|Overall Study|Discotinued per protocol|902|||
126005209|NCT04863898|453311127|FG000|Overall Study|Away from study clinic during intervention training period|2|||
126005210|NCT04863898|453311127|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
126005211|NCT04863898|453311127|FG000|Overall Study|Lost to Follow-up|3|||
126005212|NCT04863898|453311127|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
126005213|NCT04863898|453311127|FG000|Overall Study|No longer employed at clinic|3|||
126005214|NCT00770211|453311128|FG000|Overall Study|Lost to Follow-up|1|||
126005215|NCT00770211|453311129|FG001|Overall Study|Lost to Follow-up|0|||
126424291|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
126424292|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
126424293|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
126424294|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
126424295|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
126424296|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
126424297|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
126424298|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
126424299|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
126424300|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126005216|NCT00770211|453311128|FG000|Overall Study|Withdrawal by Subject|0|||
126005217|NCT00770211|453311129|FG001|Overall Study|Withdrawal by Subject|2|||
126005218|NCT00764868|453311132|FG000|Overall Study|Adverse Event|18|||
126005219|NCT00764868|453311132|FG000|Overall Study|Withdrawal by Subject|31|||
126005220|NCT00764868|453311132|FG000|Overall Study|Non-compliance|16|||
126005221|NCT00764868|453311132|FG000|Overall Study|Lost to Follow-up|25|||
126005222|NCT00764868|453311132|FG000|Overall Study|Lack of Efficacy|5|||
126005223|NCT00764868|453311132|FG000|Overall Study|Subject moved|7|||
126005224|NCT00764868|453311132|FG000|Overall Study|Pregnancy|3|||
126005225|NCT00764868|453311132|FG000|Overall Study|Prohibited medication|1|||
126005226|NCT00764868|453311132|FG000|Overall Study|Out of town|1|||
126005227|NCT00764868|453311132|FG000|Overall Study|Misuse and compliance of study drug|1|||
126005228|NCT00764868|453311132|FG000|Overall Study|Subject sent to boarding school|1|||
126005229|NCT00764868|453311132|FG000|Overall Study|Met an exclusion criteria|1|||
126005230|NCT00764868|453311132|FG000|Overall Study|Positive drug screen|2|||
126005231|NCT00764868|453311132|FG000|Overall Study|Sponsor requested withdrawal|1|||
126005232|NCT03005288|453311135|FG000|Overall Study|Withdrawal by Subject|7|||
126005233|NCT03005288|453311136|FG001|Overall Study|Withdrawal by Subject|5|||
126005234|NCT03005288|453311135|FG000|Overall Study|Lost to Follow-up|0|||
126005235|NCT03005288|453311136|FG001|Overall Study|Lost to Follow-up|1|||
126005236|NCT03005288|453311135|FG000|Overall Study|Adverse Event|5|||
126005237|NCT03005288|453311136|FG001|Overall Study|Adverse Event|0|||
126005238|NCT03005288|453311135|FG000|Overall Study|Protocol deviation|0|||
126005239|NCT03005288|453311136|FG001|Overall Study|Protocol deviation|1|||
126005240|NCT03005288|453311135|FG000|Overall Study|Physician Decision|0|||
126005241|NCT03005288|453311136|FG001|Overall Study|Physician Decision|1|||
126005242|NCT03824236|453311139|FG000|Overall Study|Lost to Follow-up|0|||
126005243|NCT03824236|453311140|FG001|Overall Study|Lost to Follow-up|0|||
126005244|NCT03824236|453311141|FG002|Overall Study|Lost to Follow-up|1|||
126005245|NCT00701311|453311142|FG000|Overall Study|Lack of Efficacy|3|||
126005246|NCT00701311|453311142|FG000|Overall Study|Adverse Event|3|||
126005247|NCT00701311|453311142|FG000|Overall Study|Withdrawal by Subject|2|||
126005248|NCT00670540|453311145|FG000|Overall Study|ineligible|17|||
126005249|NCT00670540|453311145|FG000|Overall Study|not living in France|348|||
126005250|NCT00670540|453311145|FG000|Overall Study|refused to participate|189|||
126005251|NCT00670540|453311145|FG000|Overall Study|controls randomised for no follow up|2770|||
126005252|NCT00670540|453311145|FG000|Overall Study|missing information inclusion criteria|1|||
126005253|NCT01140347|453311146|FG000|Overall Study|Lost to Follow-up|5|||
126005254|NCT01140347|453311147|FG001|Overall Study|Lost to Follow-up|6|||
126005255|NCT01140347|453311146|FG000|Overall Study|Withdrawal by Subject|13|||
126005256|NCT01140347|453311147|FG001|Overall Study|Withdrawal by Subject|8|||
126005257|NCT00828919|453311148|FG000|Overall Study|Death|0|||
126005258|NCT00828919|453311149|FG001|Overall Study|Death|1|||
126005259|NCT00828919|453311150|FG002|Overall Study|Death|2|||
126005260|NCT00828919|453311151|FG003|Overall Study|Death|0|||
126005261|NCT00828919|453311152|FG004|Overall Study|Death|0|||
126005262|NCT00828919|453311148|FG000|Overall Study|Adverse Event|2|||
126005263|NCT00828919|453311149|FG001|Overall Study|Adverse Event|2|||
126005264|NCT00828919|453311150|FG002|Overall Study|Adverse Event|2|||
126005265|NCT00828919|453311151|FG003|Overall Study|Adverse Event|1|||
126005266|NCT00828919|453311152|FG004|Overall Study|Adverse Event|3|||
126005267|NCT00828919|453311148|FG000|Overall Study|Objective progression or relapse|4|||
126005268|NCT00828919|453311149|FG001|Overall Study|Objective progression or relapse|4|||
126005269|NCT00828919|453311150|FG002|Overall Study|Objective progression or relapse|11|||
126005270|NCT00828919|453311151|FG003|Overall Study|Objective progression or relapse|0|||
126005271|NCT00828919|453311152|FG004|Overall Study|Objective progression or relapse|5|||
126005272|NCT00828919|453311148|FG000|Overall Study|No longer willing to participate in study|0|||
126424301|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424302|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126005273|NCT00828919|453311149|FG001|Overall Study|No longer willing to participate in study|0|||
126005274|NCT00828919|453311150|FG002|Overall Study|No longer willing to participate in study|2|||
126005275|NCT00828919|453311151|FG003|Overall Study|No longer willing to participate in study|0|||
126005276|NCT00828919|453311152|FG004|Overall Study|No longer willing to participate in study|0|||
126005277|NCT00828919|453311148|FG000|Overall Study|Insufficient Clinical Response|0|||
126005278|NCT00828919|453311149|FG001|Overall Study|Insufficient Clinical Response|1|||
126005279|NCT00828919|453311150|FG002|Overall Study|Insufficient Clinical Response|2|||
126005280|NCT00828919|453311151|FG003|Overall Study|Insufficient Clinical Response|0|||
126005281|NCT00828919|453311152|FG004|Overall Study|Insufficient Clinical Response|0|||
126005282|NCT00828919|453311148|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
126005283|NCT00828919|453311149|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
126005284|NCT00828919|453311150|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
126005285|NCT00828919|453311151|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
126005286|NCT00828919|453311152|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
126005287|NCT00828919|453311148|FG000|Overall Study|Other|1|||
126005288|NCT00828919|453311149|FG001|Overall Study|Other|0|||
126005289|NCT00828919|453311150|FG002|Overall Study|Other|1|||
126005290|NCT00828919|453311151|FG003|Overall Study|Other|1|||
126339348|NCT03167242|454538491|FG006|Overall Study|Reason not provided|0|||
126339349|NCT03167242|454538492|FG007|Overall Study|Reason not provided|0|||
126339350|NCT03167242|454538493|FG008|Overall Study|Reason not provided|1|||
126339351|NCT03167242|454538494|FG009|Overall Study|Reason not provided|0|||
126339352|NCT03167242|454538495|FG010|Overall Study|Reason not provided|0|||
126339353|NCT03167242|454538496|FG011|Overall Study|Reason not provided|0|||
126339354|NCT00726609|454538499|FG000|Overall Study|Adverse Event|10|||
126339355|NCT00726609|454538499|FG000|Overall Study|Withdrawal by Subject|2|||
126339356|NCT00726609|454538499|FG000|Overall Study|Lack of Efficacy|25|||
126339357|NCT00726609|454538499|FG000|Overall Study|Other|16|||
126339358|NCT00726609|454538499|FG000|Overall Study|Missing|42|||
126339359|NCT00726609|454538499|FG000|Overall Study|Other|3|||
126339360|NCT02144701|454538505|FG000|Overall Study|development of relapse, GVHD or death|9|||
126339361|NCT02144701|454538506|FG001|Overall Study|development of relapse, GVHD or death|3|||
126339362|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339363|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
126339364|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339365|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
126339366|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339367|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
126339368|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|Refused|0|||
126339369|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|Refused|0|||
126339370|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|Refused|0|||
126339371|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|Refused|0|||
126339372|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|Refused|1|||
126339373|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|Refused|0|||
126339374|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339375|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
126339376|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339377|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339378|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339379|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339380|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|Death|0|||
126339381|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|Death|0|||
126339382|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|Death|0|||
126339383|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|Death|0|||
126339384|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|Death|1|||
126339385|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|Death|0|||
126339386|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339387|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339388|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339389|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339390|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339391|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
126339392|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339393|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339394|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
126339395|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339396|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126005291|NCT00828919|453311152|FG004|Overall Study|Other|0|||
126005292|NCT00828919|453311148|FG000|Overall Study|Lost to Follow-up|0|||
126005293|NCT00828919|453311149|FG001|Overall Study|Lost to Follow-up|1|||
126005294|NCT00828919|453311150|FG002|Overall Study|Lost to Follow-up|0|||
126005295|NCT00828919|453311151|FG003|Overall Study|Lost to Follow-up|0|||
126339397|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339398|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
126339399|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
126339400|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
126339401|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
126339402|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
126339403|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
126339404|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
126339405|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339406|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339407|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339408|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339409|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339410|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|Death|1|||
126339411|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|Death|0|||
126339412|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|Death|1|||
126339413|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|Death|1|||
126339414|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|Death|1|||
126339415|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|Death|0|||
126339416|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339417|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339418|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339419|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339420|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339421|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
126339422|NCT03327324|454538508|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
126339423|NCT03327324|454538509|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339424|NCT03327324|454538510|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339425|NCT03327324|454538511|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339426|NCT03327324|454538512|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339427|NCT03327324|454538513|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339428|NCT03327324|454538508|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
126339429|NCT03327324|454538509|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
126339430|NCT03327324|454538510|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
126339431|NCT03327324|454538511|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
126339432|NCT03327324|454538512|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
126339433|NCT03327324|454538513|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
126339434|NCT03327324|454538508|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
126339435|NCT03327324|454538509|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
126339436|NCT03327324|454538510|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
126339437|NCT03327324|454538511|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
126339438|NCT03327324|454538512|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
126339439|NCT03327324|454538513|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
126339440|NCT03327324|454538508|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339441|NCT03327324|454538509|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339442|NCT03327324|454538510|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339443|NCT03327324|454538511|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
126339444|NCT03327324|454538512|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
126339445|NCT03327324|454538513|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339446|NCT03327324|454538508|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
126339447|NCT03327324|454538509|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126339448|NCT03327324|454538510|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126005296|NCT00828919|453311152|FG004|Overall Study|Lost to Follow-up|0|||
126005297|NCT01449929|453311154|FG000|Randomization Phase 96 Week|Adverse Event|5|||
126424303|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424304|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
126424305|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
126424306|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
126424307|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
126424308|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424309|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
126424310|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424311|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424312|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
126424313|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424314|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
126424315|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424316|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424317|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424318|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
126424319|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424320|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424321|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424322|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424323|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424324|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424325|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424326|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424327|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424328|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424329|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424330|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424331|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424332|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424333|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424334|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424335|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424336|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424337|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424338|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424339|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424340|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424341|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424342|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424343|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424344|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424345|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424346|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424347|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424348|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
126424349|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424350|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424351|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424352|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126005298|NCT01449929|453311155|FG001|Randomization Phase 96 Week|Adverse Event|13|||
126005299|NCT01449929|453311156|FG002|Randomization Phase 96 Week|Adverse Event|0|||
126005300|NCT01449929|453311154|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
126005301|NCT01449929|453311155|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
126005302|NCT01449929|453311156|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
126005303|NCT01449929|453311154|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
126005304|NCT01449929|453311155|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
126005305|NCT01449929|453311156|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
126005306|NCT01449929|453311154|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
126005307|NCT01449929|453311155|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
126005308|NCT01449929|453311156|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
126005309|NCT01449929|453311154|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
126005310|NCT01449929|453311155|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
126005311|NCT01449929|453311156|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
126005312|NCT01449929|453311154|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
126005313|NCT01449929|453311155|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
126005314|NCT01449929|453311156|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
126005315|NCT01449929|453311154|FG000|Randomization Phase 96 Week|Physician Decision|2|||
126005316|NCT01449929|453311155|FG001|Randomization Phase 96 Week|Physician Decision|3|||
126005317|NCT01449929|453311156|FG002|Randomization Phase 96 Week|Physician Decision|0|||
126339449|NCT03327324|454538511|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126339450|NCT03327324|454538512|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126339451|NCT03327324|454538513|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126339452|NCT03327324|454538508|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
126339453|NCT03327324|454538509|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339454|NCT03327324|454538510|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339455|NCT03327324|454538511|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339456|NCT03327324|454538512|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339457|NCT03327324|454538513|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339458|NCT01614470|454538516|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
126339459|NCT01614470|454538517|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126339460|NCT01614470|454538518|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126339461|NCT01614470|454538516|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
126339462|NCT01614470|454538517|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
126339463|NCT01614470|454538518|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
126339464|NCT03217591|454538519|FG000|Overall Study|Adverse Event|1|||
126339465|NCT03217591|454538520|FG001|Overall Study|Adverse Event|2|||
126339466|NCT03217591|454538521|FG002|Overall Study|Adverse Event|6|||
126339467|NCT03217591|454538519|FG000|Overall Study|Withdrawal by Subject|0|||
126339468|NCT03217591|454538520|FG001|Overall Study|Withdrawal by Subject|1|||
126339469|NCT03217591|454538521|FG002|Overall Study|Withdrawal by Subject|3|||
126339470|NCT03217591|454538519|FG000|Overall Study|Lost to Follow-up|1|||
126339471|NCT03217591|454538520|FG001|Overall Study|Lost to Follow-up|0|||
126339472|NCT03217591|454538521|FG002|Overall Study|Lost to Follow-up|0|||
126339473|NCT03217591|454538519|FG000|Overall Study|Protocol Violation|1|||
126339474|NCT03217591|454538520|FG001|Overall Study|Protocol Violation|0|||
126339475|NCT03217591|454538521|FG002|Overall Study|Protocol Violation|1|||
126339476|NCT00249834|454538522|FG000|Overall Study|Ovarian stimulation failed|1|||
126339477|NCT00249834|454538523|FG001|Overall Study|Ovarian stimulation failed|0|||
126339478|NCT00249834|454538524|FG002|Overall Study|Ovarian stimulation failed|0|||
126339479|NCT00249834|454538525|FG003|Overall Study|Ovarian stimulation failed|0|||
126339480|NCT00249834|454538526|FG004|Overall Study|Ovarian stimulation failed|0|||
126339481|NCT00249834|454538527|FG005|Overall Study|Ovarian stimulation failed|0|||
126339482|NCT00249834|454538528|FG006|Overall Study|Ovarian stimulation failed|0|||
126339483|NCT00249834|454538529|FG007|Overall Study|Ovarian stimulation failed|0|||
126339484|NCT00249834|454538522|FG000|Overall Study|Failure of down-regulation|0|||
126339485|NCT00249834|454538523|FG001|Overall Study|Failure of down-regulation|0|||
126339486|NCT00249834|454538524|FG002|Overall Study|Failure of down-regulation|0|||
126339487|NCT00249834|454538525|FG003|Overall Study|Failure of down-regulation|0|||
126339488|NCT00249834|454538526|FG004|Overall Study|Failure of down-regulation|0|||
126339489|NCT00249834|454538527|FG005|Overall Study|Failure of down-regulation|0|||
126339490|NCT00249834|454538528|FG006|Overall Study|Failure of down-regulation|1|||
126339491|NCT00249834|454538529|FG007|Overall Study|Failure of down-regulation|0|||
126339492|NCT00249834|454538522|FG000|Overall Study|Protocol Violation|0|||
126339493|NCT00249834|454538523|FG001|Overall Study|Protocol Violation|19|||
126339494|NCT00249834|454538524|FG002|Overall Study|Protocol Violation|14|||
126339495|NCT00249834|454538525|FG003|Overall Study|Protocol Violation|8|||
126339496|NCT00249834|454538526|FG004|Overall Study|Protocol Violation|5|||
126339497|NCT00249834|454538527|FG005|Overall Study|Protocol Violation|2|||
126339498|NCT00249834|454538528|FG006|Overall Study|Protocol Violation|0|||
126339499|NCT00249834|454538529|FG007|Overall Study|Protocol Violation|0|||
126339500|NCT00269152|454538531|FG000|Overall Study|Adverse Event|9|||
126339501|NCT00269152|454538532|FG001|Overall Study|Adverse Event|3|||
126339502|NCT00269152|454538531|FG000|Overall Study|Withdrawal by Subject|7|||
126339503|NCT00269152|454538532|FG001|Overall Study|Withdrawal by Subject|3|||
126339504|NCT00269152|454538531|FG000|Overall Study|Physician Decision|2|||
126339505|NCT00269152|454538532|FG001|Overall Study|Physician Decision|3|||
126339506|NCT00269152|454538531|FG000|Overall Study|Protocol Violation|0|||
126339507|NCT00269152|454538532|FG001|Overall Study|Protocol Violation|1|||
126339508|NCT04249427|454538533|FG000|Overall Study|Adverse Event|3|||
126339509|NCT04249427|454538534|FG001|Overall Study|Adverse Event|1|||
126339510|NCT04249427|454538533|FG000|Overall Study|Lack of Efficacy|0|||
126339511|NCT04249427|454538534|FG001|Overall Study|Lack of Efficacy|1|||
126339512|NCT04249427|454538533|FG000|Overall Study|Withdrawal by Subject|1|||
126339513|NCT04249427|454538534|FG001|Overall Study|Withdrawal by Subject|2|||
126339514|NCT02557399|454538535|FG000|Overall Study|Adverse Event|6|||
126339515|NCT02557399|454538536|FG001|Overall Study|Adverse Event|5|||
126339516|NCT02557399|454538535|FG000|Overall Study|Protocol Violation|0|||
126339517|NCT02557399|454538536|FG001|Overall Study|Protocol Violation|1|||
126005318|NCT01449929|453311154|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
126005319|NCT01449929|453311155|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
126005320|NCT01449929|453311156|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
126005321|NCT01449929|453311154|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
126005322|NCT01449929|453311155|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
126005323|NCT01449929|453311156|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
126005324|NCT01449929|453311154|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
126005325|NCT01449929|453311155|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
126005326|NCT01449929|453311156|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
126005327|NCT01449929|453311154|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
126005328|NCT01449929|453311155|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
126005329|NCT01449929|453311156|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
126005330|NCT01871285|453311157|FG000|First Intervention (1 Day)|Adverse Event|1|||
126005331|NCT01871285|453311158|FG001|First Intervention (1 Day)|Adverse Event|0|||
126005332|NCT01871285|453311159|FG002|First Intervention (1 Day)|Adverse Event|0|||
126005333|NCT01871285|453311160|FG003|First Intervention (1 Day)|Adverse Event|0|||
126005334|NCT01871285|453311157|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
126005335|NCT01871285|453311158|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
126005336|NCT01871285|453311159|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
126005337|NCT01871285|453311160|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
126005338|NCT02501811|453311162|FG000|Overall Study|Death|1|||
126005339|NCT02501811|453311163|FG001|Overall Study|Death|3|||
126005340|NCT02501811|453311164|FG002|Overall Study|Death|2|||
126339518|NCT02557399|454538535|FG000|Overall Study|Protocol-defined stopping criteria|0|||
126339519|NCT02557399|454538536|FG001|Overall Study|Protocol-defined stopping criteria|1|||
126339520|NCT02557399|454538535|FG000|Overall Study|Withdrawal by Subject|1|||
126339521|NCT02557399|454538536|FG001|Overall Study|Withdrawal by Subject|1|||
126339522|NCT02848664|454538537|FG000|Overall Study|Withdrawal by Subject|2|||
126339523|NCT02848664|454538537|FG000|Overall Study|Adverse Event|1|||
126339524|NCT02848664|454538537|FG000|Overall Study|no assistance for device training|1|||
126339525|NCT00402727|454538538|FG000|Overall Study|Adverse Event|10|||
126339526|NCT00402727|454538539|FG001|Overall Study|Adverse Event|6|||
126339527|NCT00402727|454538538|FG000|Overall Study|Death|1|||
126339528|NCT00402727|454538539|FG001|Overall Study|Death|0|||
126339529|NCT00402727|454538538|FG000|Overall Study|Lack of Efficacy|1|||
126339530|NCT00402727|454538539|FG001|Overall Study|Lack of Efficacy|3|||
126339531|NCT00402727|454538538|FG000|Overall Study|Lost to Follow-up|24|||
126339532|NCT00402727|454538539|FG001|Overall Study|Lost to Follow-up|11|||
126339533|NCT00402727|454538538|FG000|Overall Study|Physician Decision|1|||
126339534|NCT00402727|454538539|FG001|Overall Study|Physician Decision|1|||
126339535|NCT00402727|454538538|FG000|Overall Study|Protocol Violation|0|||
126339536|NCT00402727|454538539|FG001|Overall Study|Protocol Violation|4|||
126339537|NCT00402727|454538538|FG000|Overall Study|Withdrawal by Subject|3|||
126339538|NCT00402727|454538539|FG001|Overall Study|Withdrawal by Subject|7|||
126339539|NCT00402727|454538538|FG000|Overall Study|supply problems|2|||
126339540|NCT00402727|454538539|FG001|Overall Study|supply problems|1|||
126339541|NCT00402727|454538538|FG000|Overall Study|non-compliance|0|||
126339542|NCT00402727|454538539|FG001|Overall Study|non-compliance|1|||
126339543|NCT03188055|454538540|FG000|Overall Study|Unavailable for training|0|||
126339544|NCT03188055|454538541|FG001|Overall Study|Unavailable for training|0|||
126339545|NCT03188055|454538542|FG002|Overall Study|Unavailable for training|19|||
126339546|NCT03188055|454538543|FG003|Overall Study|Unavailable for training|0|||
126339547|NCT03188055|454538544|FG004|Overall Study|Unavailable for training|0|||
126339548|NCT03188055|454538545|FG005|Overall Study|Unavailable for training|0|||
126339549|NCT03188055|454538540|FG000|Overall Study|Lost to Follow-up|0|||
126339550|NCT03188055|454538541|FG001|Overall Study|Lost to Follow-up|18|||
126339551|NCT03188055|454538542|FG002|Overall Study|Lost to Follow-up|0|||
126339552|NCT03188055|454538543|FG003|Overall Study|Lost to Follow-up|11|||
126339553|NCT03188055|454538544|FG004|Overall Study|Lost to Follow-up|0|||
126339554|NCT03188055|454538545|FG005|Overall Study|Lost to Follow-up|0|||
126339555|NCT03188055|454538540|FG000|Overall Study|Withdrawal by Subject|0|||
126339556|NCT03188055|454538541|FG001|Overall Study|Withdrawal by Subject|1|||
126339557|NCT03188055|454538542|FG002|Overall Study|Withdrawal by Subject|0|||
126339558|NCT03188055|454538543|FG003|Overall Study|Withdrawal by Subject|1|||
126339559|NCT03188055|454538544|FG004|Overall Study|Withdrawal by Subject|0|||
126339560|NCT03188055|454538545|FG005|Overall Study|Withdrawal by Subject|0|||
126339561|NCT01405898|454538546|FG000|Overall Study|Withdrawal by Subject|2|||
126339562|NCT01405898|454538547|FG001|Overall Study|Withdrawal by Subject|2|||
126339563|NCT00264147|454538550|FG000|Treatment I Period|Adverse Event|3|||
126339564|NCT00264147|454538551|FG001|Treatment I Period|Adverse Event|6|||
126005341|NCT02501811|453311165|FG003|Overall Study|Death|3|||
126005342|NCT02501811|453311162|FG000|Overall Study|Withdrawal by Subject|3|||
126339565|NCT00264147|454538552|FG002|Treatment I Period|Adverse Event|3|||
126339566|NCT00264147|454538553|FG003|Treatment I Period|Adverse Event|5|||
126339567|NCT00264147|454538554|FG004|Treatment I Period|Adverse Event|7|||
126339568|NCT00264147|454538555|FG005|Treatment I Period|Adverse Event|0|||
126005343|NCT02501811|453311163|FG001|Overall Study|Withdrawal by Subject|3|||
126005344|NCT02501811|453311164|FG002|Overall Study|Withdrawal by Subject|2|||
126005345|NCT02501811|453311165|FG003|Overall Study|Withdrawal by Subject|3|||
126005346|NCT02501811|453311162|FG000|Overall Study|Lost to Follow-up|0|||
126005347|NCT02501811|453311163|FG001|Overall Study|Lost to Follow-up|0|||
126005348|NCT02501811|453311164|FG002|Overall Study|Lost to Follow-up|2|||
126005349|NCT02501811|453311165|FG003|Overall Study|Lost to Follow-up|1|||
126005350|NCT00256308|453312793|FG000|Overall Study|Death|2|||
126005351|NCT01211665|453312799|FG000|Overall Study|Withdrawal by Subject|1|||
126005352|NCT01211665|453312800|FG001|Overall Study|Withdrawal by Subject|0|||
126005353|NCT01211665|453312799|FG000|Overall Study|Death|1|||
126005354|NCT01211665|453312800|FG001|Overall Study|Death|0|||
126005355|NCT00886613|453312803|FG000|Overall Study|Protocol deviation (Part B)|1|||
126005356|NCT00886613|453312804|FG001|Overall Study|Protocol deviation (Part B)|0|||
126005357|NCT00886613|453312805|FG002|Overall Study|Protocol deviation (Part B)|0|||
126005358|NCT00886613|453312803|FG000|Overall Study|Lost to follow-up (Part B)|1|||
126005359|NCT00886613|453312804|FG001|Overall Study|Lost to follow-up (Part B)|0|||
126005360|NCT00886613|453312805|FG002|Overall Study|Lost to follow-up (Part B)|1|||
126005361|NCT00886613|453312803|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
126005362|NCT00886613|453312804|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
126005363|NCT00886613|453312805|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
126005364|NCT04541186|453312808|FG000|Main Study|Adverse Event|0|||
126005365|NCT04541186|453312809|FG001|Main Study|Adverse Event|0|||
126005366|NCT04541186|453312810|FG002|Main Study|Adverse Event|4|||
126005367|NCT04541186|453312811|FG003|Main Study|Adverse Event|0|||
126005368|NCT04541186|453312812|FG004|Main Study|Adverse Event|0|||
126005369|NCT04541186|453312808|FG000|Main Study|Investigator Decision|0|||
126005370|NCT04541186|453312809|FG001|Main Study|Investigator Decision|0|||
126005371|NCT04541186|453312810|FG002|Main Study|Investigator Decision|1|||
126005372|NCT04541186|453312811|FG003|Main Study|Investigator Decision|1|||
126005373|NCT04541186|453312812|FG004|Main Study|Investigator Decision|0|||
126005374|NCT04541186|453312808|FG000|Main Study|Withdrawal by Subject|1|||
126005375|NCT04541186|453312809|FG001|Main Study|Withdrawal by Subject|1|||
126005376|NCT04541186|453312810|FG002|Main Study|Withdrawal by Subject|0|||
126005377|NCT04541186|453312811|FG003|Main Study|Withdrawal by Subject|0|||
126005378|NCT04541186|453312812|FG004|Main Study|Withdrawal by Subject|0|||
126005379|NCT04541186|453312808|FG000|Main Study|COVID-19-related Dose Interruption|0|||
126005380|NCT04541186|453312809|FG001|Main Study|COVID-19-related Dose Interruption|0|||
126005381|NCT04541186|453312810|FG002|Main Study|COVID-19-related Dose Interruption|0|||
126005382|NCT04541186|453312811|FG003|Main Study|COVID-19-related Dose Interruption|0|||
126005383|NCT04541186|453312812|FG004|Main Study|COVID-19-related Dose Interruption|1|||
126005384|NCT04541186|453312808|FG000|Main Study|Randomized in Error Not Treated|0|||
126005385|NCT04541186|453312809|FG001|Main Study|Randomized in Error Not Treated|0|||
126005386|NCT04541186|453312810|FG002|Main Study|Randomized in Error Not Treated|1|||
126005387|NCT04541186|453312811|FG003|Main Study|Randomized in Error Not Treated|0|||
126005388|NCT04541186|453312812|FG004|Main Study|Randomized in Error Not Treated|0|||
126005389|NCT04541186|453312808|FG000|Fibrate Expansion Study|Other than Specified|0|||
126339569|NCT00264147|454538550|FG000|Treatment I Period|Laboratory Adverse Event|0|||
126339570|NCT00264147|454538551|FG001|Treatment I Period|Laboratory Adverse Event|0|||
126339571|NCT00264147|454538552|FG002|Treatment I Period|Laboratory Adverse Event|0|||
126339572|NCT00264147|454538553|FG003|Treatment I Period|Laboratory Adverse Event|1|||
126339573|NCT00264147|454538554|FG004|Treatment I Period|Laboratory Adverse Event|0|||
126339574|NCT00264147|454538555|FG005|Treatment I Period|Laboratory Adverse Event|0|||
126339575|NCT00264147|454538550|FG000|Treatment I Period|Lack of Efficacy|6|||
126339576|NCT00264147|454538551|FG001|Treatment I Period|Lack of Efficacy|2|||
126339577|NCT00264147|454538552|FG002|Treatment I Period|Lack of Efficacy|8|||
126339578|NCT00264147|454538553|FG003|Treatment I Period|Lack of Efficacy|0|||
126339579|NCT00264147|454538554|FG004|Treatment I Period|Lack of Efficacy|1|||
126339580|NCT00264147|454538555|FG005|Treatment I Period|Lack of Efficacy|0|||
126339581|NCT00264147|454538550|FG000|Treatment I Period|Lost to Follow-up|1|||
126339582|NCT00264147|454538551|FG001|Treatment I Period|Lost to Follow-up|0|||
126339583|NCT00264147|454538552|FG002|Treatment I Period|Lost to Follow-up|0|||
126339584|NCT00264147|454538553|FG003|Treatment I Period|Lost to Follow-up|1|||
126339585|NCT00264147|454538554|FG004|Treatment I Period|Lost to Follow-up|1|||
126005390|NCT04541186|453312809|FG001|Fibrate Expansion Study|Other than Specified|0|||
126005391|NCT04541186|453312810|FG002|Fibrate Expansion Study|Other than Specified|0|||
126005392|NCT04541186|453312811|FG003|Fibrate Expansion Study|Other than Specified|0|||
126005393|NCT04541186|453312812|FG004|Fibrate Expansion Study|Other than Specified|1|||
126005394|NCT03085017|453312813|FG000|Overall Study|Death|0|||
126005395|NCT03085017|453312814|FG001|Overall Study|Death|3|||
126339586|NCT00264147|454538555|FG005|Treatment I Period|Lost to Follow-up|0|||
126339587|NCT00264147|454538550|FG000|Treatment I Period|Protocol Violation|2|||
126005396|NCT00058058|453312822|FG000|Overall Study|Withdrawal by Subject|4|||
126005397|NCT00058058|453312822|FG000|Overall Study|Ineligible|20|||
126005398|NCT00058058|453312822|FG000|Overall Study|Claustrophobic|5|||
126005399|NCT00058058|453312822|FG000|Overall Study|technical issues|6|||
126005400|NCT00058058|453312822|FG000|Overall Study|Poor positioning, illness,pain|3|||
126005401|NCT03681691|453312828|FG000|Overall Study|COVID|1|||
126005402|NCT03681691|453312829|FG001|Overall Study|COVID|0|||
126005403|NCT03681691|453312828|FG000|Overall Study|prolonged bleeding|1|||
126005404|NCT03681691|453312829|FG001|Overall Study|prolonged bleeding|0|||
126005405|NCT03681691|453312828|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
126005406|NCT03681691|453312829|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
126005407|NCT03432533|453312830|FG000|Overall Study|Lost to Follow-up|1|||
126005408|NCT03432533|453312831|FG001|Overall Study|Lost to Follow-up|2|||
126005409|NCT03432533|453312830|FG000|Overall Study|Withdrawal by Subject|14|||
126005410|NCT03432533|453312831|FG001|Overall Study|Withdrawal by Subject|9|||
126005411|NCT01582243|453312836|FG000|Overall Study|Withdrawal by Subject|1|||
126005412|NCT01582243|453312836|FG000|Overall Study|Adverse Event|1|||
126005413|NCT01582243|453312836|FG000|Overall Study|Lost to Follow-up|1|||
126005414|NCT01119703|453312841|FG000|Overall Study|Adverse Event|0|||
126005415|NCT01119703|453312842|FG001|Overall Study|Adverse Event|1|||
126005416|NCT03178201|453312843|FG000|Overall Study|Off study|5|||
126005417|NCT01763047|453312844|FG000|Period 1|Test Article Not Available|4|||
126005418|NCT01763047|453312845|FG001|Period 1|Test Article Not Available|1|||
126005419|NCT01763047|453312844|FG000|Period 1|Protocol Violation|4|||
126005420|NCT01763047|453312845|FG001|Period 1|Protocol Violation|4|||
126005421|NCT01763047|453312844|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
126005422|NCT01763047|453312845|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
126005423|NCT01763047|453312844|FG000|Period 1|Adverse Event|0|||
126005424|NCT01763047|453312845|FG001|Period 1|Adverse Event|1|||
126005425|NCT01763047|453312844|FG000|Period 1|Unsatisfactory Visual Response|0|||
126005426|NCT01763047|453312845|FG001|Period 1|Unsatisfactory Visual Response|3|||
126005427|NCT01763047|453312844|FG000|Period 1|Lens Power Not Available|0|||
126005428|NCT01763047|453312845|FG001|Period 1|Lens Power Not Available|1|||
126005429|NCT01763047|453312844|FG000|Period 1|Study Site office Closed|0|||
126005430|NCT01763047|453312845|FG001|Period 1|Study Site office Closed|1|||
126005431|NCT01763047|453312844|FG000|Period 2|Lens Discomfort|1|||
126005432|NCT01763047|453312845|FG001|Period 2|Lens Discomfort|0|||
126005433|NCT01763047|453312844|FG000|Period 2|No longer meets Eligibility Criteria|1|||
126005434|NCT01763047|453312845|FG001|Period 2|No longer meets Eligibility Criteria|0|||
126005435|NCT01763047|453312844|FG000|Period 2|Study Site office Closed|1|||
126005436|NCT01763047|453312845|FG001|Period 2|Study Site office Closed|1|||
126005437|NCT01763047|453312844|FG000|Period 2|Unsatisfactory Visual Response|1|||
126005438|NCT01763047|453312845|FG001|Period 2|Unsatisfactory Visual Response|1|||
126005439|NCT01763047|453312844|FG000|Period 2|Protocol Violation|0|||
126339588|NCT00264147|454538551|FG001|Treatment I Period|Protocol Violation|2|||
126339589|NCT00264147|454538552|FG002|Treatment I Period|Protocol Violation|0|||
126339590|NCT00264147|454538553|FG003|Treatment I Period|Protocol Violation|0|||
126339591|NCT00264147|454538554|FG004|Treatment I Period|Protocol Violation|0|||
126339592|NCT00264147|454538555|FG005|Treatment I Period|Protocol Violation|0|||
126339593|NCT00264147|454538550|FG000|Treatment I Period|Withdrawal by Subject|2|||
126339594|NCT00264147|454538551|FG001|Treatment I Period|Withdrawal by Subject|0|||
126339595|NCT00264147|454538552|FG002|Treatment I Period|Withdrawal by Subject|0|||
126339596|NCT00264147|454538553|FG003|Treatment I Period|Withdrawal by Subject|2|||
126339597|NCT00264147|454538554|FG004|Treatment I Period|Withdrawal by Subject|2|||
126339598|NCT00264147|454538555|FG005|Treatment I Period|Withdrawal by Subject|0|||
126339599|NCT00264147|454538550|FG000|Treatment I Period|Patient out of town for an extended time|0|||
126339600|NCT00264147|454538551|FG001|Treatment I Period|Patient out of town for an extended time|1|||
126339601|NCT00264147|454538552|FG002|Treatment I Period|Patient out of town for an extended time|0|||
126339602|NCT00264147|454538553|FG003|Treatment I Period|Patient out of town for an extended time|0|||
126339603|NCT00264147|454538554|FG004|Treatment I Period|Patient out of town for an extended time|0|||
126339604|NCT00264147|454538555|FG005|Treatment I Period|Patient out of town for an extended time|0|||
126339605|NCT00264147|454538550|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126005440|NCT01763047|453312845|FG001|Period 2|Protocol Violation|2|||
126005441|NCT01763047|453312844|FG000|Period 2|Unsatisfactory lens Fitting|0|||
126005442|NCT01763047|453312845|FG001|Period 2|Unsatisfactory lens Fitting|1|||
126005443|NCT03124108|453312849|FG000|Overall Study|Adverse Event|0|||
126005444|NCT03124108|453312850|FG001|Overall Study|Adverse Event|1|||
126005445|NCT03124108|453312851|FG002|Overall Study|Adverse Event|0|||
126005446|NCT05650333|453312852|FG000|Treatment Period (7 Days)|Adverse Event|1|||
126005447|NCT02616263|453312853|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
126005448|NCT02616263|453312854|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
126005449|NCT02616263|453312853|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
126005450|NCT02616263|453312854|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
126339606|NCT00264147|454538551|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126005451|NCT02616263|453312853|FG000|6 Month to 1.5 Year|Death|1|||
126005452|NCT02616263|453312854|FG001|6 Month to 1.5 Year|Death|0|||
126005453|NCT02616263|453312853|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
126005454|NCT02616263|453312854|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
126005455|NCT02616263|453312853|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
126005456|NCT02616263|453312854|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
126005457|NCT02616263|453312853|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
126005458|NCT02616263|453312854|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
126005459|NCT03686384|453312855|FG000|Overall Study|Lack of Efficacy|4|||
126005460|NCT03686384|453312856|FG001|Overall Study|Lack of Efficacy|13|||
126005461|NCT03686384|453312855|FG000|Overall Study|Lost to Follow-up|3|||
126005462|NCT03686384|453312856|FG001|Overall Study|Lost to Follow-up|0|||
126005463|NCT03686384|453312855|FG000|Overall Study|Physician Decision|0|||
126005464|NCT03686384|453312856|FG001|Overall Study|Physician Decision|1|||
126005465|NCT03686384|453312855|FG000|Overall Study|Took prohibited medication|0|||
126005466|NCT03686384|453312856|FG001|Overall Study|Took prohibited medication|1|||
126005467|NCT02820051|453312859|FG000|Overall Study|Lost to Follow-up|7|||
126005468|NCT02820051|453312860|FG001|Overall Study|Lost to Follow-up|4|||
126005469|NCT01222247|453312861|FG000|Overall Study|Lost to Follow-up|2|||
126005470|NCT01222247|453312862|FG001|Overall Study|Lost to Follow-up|2|||
126005471|NCT04639947|453312864|FG000|Overall Study|Screen fail|1|||
126005472|NCT02696785|453312869|FG000|Blinded Treatment Period|Adverse Event|0|||
126005473|NCT02696785|453312870|FG001|Blinded Treatment Period|Adverse Event|1|||
126005474|NCT02696785|453312871|FG002|Blinded Treatment Period|Adverse Event|3|||
126005475|NCT02696785|453312872|FG003|Blinded Treatment Period|Adverse Event|0|||
126005476|NCT02696785|453312869|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
126005477|NCT02696785|453312870|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
126005478|NCT02696785|453312871|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
126005479|NCT02696785|453312872|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
126005480|NCT02696785|453312869|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
126005481|NCT02696785|453312870|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
126005482|NCT02696785|453312871|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
126005483|NCT02696785|453312872|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
126005484|NCT02696785|453312869|FG000|Blinded Treatment Period|Screen Failure|1|||
126005485|NCT02696785|453312870|FG001|Blinded Treatment Period|Screen Failure|0|||
126005486|NCT02696785|453312871|FG002|Blinded Treatment Period|Screen Failure|0|||
126005487|NCT02696785|453312872|FG003|Blinded Treatment Period|Screen Failure|0|||
126005488|NCT02696785|453312869|FG000|Washout Period|Withdrawal by Subject|0|||
126005489|NCT02696785|453312870|FG001|Washout Period|Withdrawal by Subject|1|||
126005490|NCT02696785|453312871|FG002|Washout Period|Withdrawal by Subject|0|||
126005491|NCT02696785|453312872|FG003|Washout Period|Withdrawal by Subject|0|||
126005492|NCT02696785|453312869|FG000|Washout Period|Lack of Efficacy|0|||
126339607|NCT00264147|454538552|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
126339608|NCT00264147|454538553|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126339609|NCT00264147|454538554|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126339610|NCT00264147|454538555|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126339611|NCT00264147|454538550|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
126339612|NCT00264147|454538551|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
126339613|NCT00264147|454538552|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
126339614|NCT00264147|454538553|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
126339615|NCT00264147|454538554|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
126339616|NCT00264147|454538555|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
126339617|NCT00264147|454538550|FG000|Treatment II Period|Adverse Event|0|||
126339618|NCT00264147|454538551|FG001|Treatment II Period|Adverse Event|0|||
126339619|NCT00264147|454538552|FG002|Treatment II Period|Adverse Event|0|||
126339620|NCT00264147|454538553|FG003|Treatment II Period|Adverse Event|0|||
126339621|NCT00264147|454538554|FG004|Treatment II Period|Adverse Event|9|||
126339622|NCT00264147|454538555|FG005|Treatment II Period|Adverse Event|9|||
126339623|NCT00264147|454538550|FG000|Treatment II Period|Laboratory Adverse Event|0|||
126339624|NCT00264147|454538551|FG001|Treatment II Period|Laboratory Adverse Event|0|||
126339625|NCT00264147|454538552|FG002|Treatment II Period|Laboratory Adverse Event|0|||
126339626|NCT00264147|454538553|FG003|Treatment II Period|Laboratory Adverse Event|0|||
126339627|NCT00264147|454538554|FG004|Treatment II Period|Laboratory Adverse Event|0|||
126339628|NCT00264147|454538555|FG005|Treatment II Period|Laboratory Adverse Event|1|||
126339629|NCT00264147|454538550|FG000|Treatment II Period|Lack of Efficacy|0|||
126339630|NCT00264147|454538551|FG001|Treatment II Period|Lack of Efficacy|0|||
126339631|NCT00264147|454538552|FG002|Treatment II Period|Lack of Efficacy|0|||
126339632|NCT00264147|454538553|FG003|Treatment II Period|Lack of Efficacy|0|||
126339633|NCT00264147|454538554|FG004|Treatment II Period|Lack of Efficacy|20|||
126339634|NCT00264147|454538555|FG005|Treatment II Period|Lack of Efficacy|19|||
126339635|NCT00264147|454538550|FG000|Treatment II Period|Lost to Follow-up|0|||
126339636|NCT00264147|454538551|FG001|Treatment II Period|Lost to Follow-up|0|||
126339637|NCT00264147|454538552|FG002|Treatment II Period|Lost to Follow-up|0|||
126005493|NCT02696785|453312870|FG001|Washout Period|Lack of Efficacy|1|||
126005494|NCT02696785|453312871|FG002|Washout Period|Lack of Efficacy|0|||
126005495|NCT02696785|453312872|FG003|Washout Period|Lack of Efficacy|0|||
126005496|NCT02696785|453312869|FG000|Extended Treatment Period|Adverse Event|2|||
126209473|NCT03110107|454055404|FG011|Treatment Period|Death|0|||
126005497|NCT02696785|453312870|FG001|Extended Treatment Period|Adverse Event|3|||
126005498|NCT02696785|453312871|FG002|Extended Treatment Period|Adverse Event|2|||
126005499|NCT02696785|453312872|FG003|Extended Treatment Period|Adverse Event|1|||
126005500|NCT02696785|453312869|FG000|Extended Treatment Period|Lack of Efficacy|0|||
126005501|NCT02696785|453312870|FG001|Extended Treatment Period|Lack of Efficacy|1|||
126005502|NCT02696785|453312871|FG002|Extended Treatment Period|Lack of Efficacy|0|||
126005503|NCT02696785|453312872|FG003|Extended Treatment Period|Lack of Efficacy|0|||
126005504|NCT02696785|453312869|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
126005505|NCT02696785|453312870|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
126005506|NCT02696785|453312871|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
126005507|NCT02696785|453312872|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
126005508|NCT02696785|453312869|FG000|Follow-up Period|Adverse Event|0|||
126005509|NCT02696785|453312870|FG001|Follow-up Period|Adverse Event|0|||
126424353|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424354|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424355|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
126424356|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424357|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424358|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424359|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424360|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424361|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424362|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424363|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424364|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424365|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424366|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424367|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424368|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424369|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424370|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424371|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424372|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
126424373|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424374|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424375|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424376|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424377|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424378|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424379|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424380|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424381|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424382|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126005510|NCT02696785|453312871|FG002|Follow-up Period|Adverse Event|8|||
126339638|NCT00264147|454538553|FG003|Treatment II Period|Lost to Follow-up|0|||
126339639|NCT00264147|454538554|FG004|Treatment II Period|Lost to Follow-up|1|||
126339640|NCT00264147|454538555|FG005|Treatment II Period|Lost to Follow-up|1|||
126339641|NCT00264147|454538550|FG000|Treatment II Period|Withdrawal by Subject|0|||
126339642|NCT00264147|454538551|FG001|Treatment II Period|Withdrawal by Subject|0|||
126339643|NCT00264147|454538552|FG002|Treatment II Period|Withdrawal by Subject|0|||
126339644|NCT00264147|454538553|FG003|Treatment II Period|Withdrawal by Subject|0|||
126339645|NCT00264147|454538554|FG004|Treatment II Period|Withdrawal by Subject|3|||
126339646|NCT00264147|454538555|FG005|Treatment II Period|Withdrawal by Subject|2|||
126339647|NCT00264147|454538550|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339648|NCT00264147|454538551|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339649|NCT00264147|454538552|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339650|NCT00264147|454538553|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339651|NCT00264147|454538554|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339652|NCT00264147|454538555|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
126339653|NCT03234465|454538556|FG000|Overall Study|Adverse Event|4|||
126339654|NCT03234465|454538557|FG001|Overall Study|Adverse Event|2|||
126339655|NCT03234465|454538556|FG000|Overall Study|Death|0|||
126339656|NCT03234465|454538557|FG001|Overall Study|Death|1|||
126339657|NCT03234465|454538556|FG000|Overall Study|Lost to Follow-up|1|||
126424383|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424384|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126339658|NCT03234465|454538557|FG001|Overall Study|Lost to Follow-up|1|||
126005511|NCT02696785|453312872|FG003|Follow-up Period|Adverse Event|2|||
126339659|NCT03234465|454538556|FG000|Overall Study|Withdrawal by Subject|12|||
126339660|NCT03234465|454538557|FG001|Overall Study|Withdrawal by Subject|27|||
126339661|NCT03234465|454538556|FG000|Overall Study|Symptomatic deterioration|0|||
126339662|NCT03234465|454538557|FG001|Overall Study|Symptomatic deterioration|1|||
126339663|NCT03234465|454538556|FG000|Overall Study|Non-compliance|2|||
126339664|NCT03234465|454538557|FG001|Overall Study|Non-compliance|0|||
126339665|NCT03234465|454538556|FG000|Overall Study|Other|14|||
126339666|NCT03234465|454538557|FG001|Overall Study|Other|8|||
126339667|NCT00449163|454538558|FG000|Overall Study|Physician Decision|3|||
126339668|NCT02247466|454538559|FG000|Overall Study|Procedure changed to open surgery|0|||
126339669|NCT02247466|454538560|FG001|Overall Study|Procedure changed to open surgery|3|||
126339670|NCT01618968|454538561|FG000|Overall Study|Adverse Event|1|||
126339671|NCT01618968|454538562|FG001|Overall Study|Adverse Event|0|||
126339672|NCT01618968|454538563|FG002|Overall Study|Adverse Event|0|||
126339673|NCT01618968|454538564|FG003|Overall Study|Adverse Event|0|||
126339674|NCT01618968|454538561|FG000|Overall Study|Death|0|||
126339675|NCT01618968|454538562|FG001|Overall Study|Death|0|||
126339676|NCT01618968|454538563|FG002|Overall Study|Death|0|||
126339677|NCT01618968|454538564|FG003|Overall Study|Death|1|||
126339678|NCT00721799|454538565|FG000|Overall Study|Withdrawal by Subject|7|||
126339679|NCT00721799|454538565|FG000|Overall Study|withdraw by subject after scan 1|1|||
126339680|NCT04356937|454538568|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
126339681|NCT04356937|454538569|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
126339682|NCT03141359|454538570|FG000|Overall Study|Death|32|||
126339683|NCT03141359|454538570|FG000|Overall Study|Still On Study (in follow up)|29|||
126339684|NCT01081626|454538571|FG000|Overall Study|Dosing error|1|||
126339685|NCT01081626|454538572|FG001|Overall Study|Dosing error|1|||
126339686|NCT01081626|454538571|FG000|Overall Study|Missing Estradiol|25|||
126339687|NCT01081626|454538572|FG001|Overall Study|Missing Estradiol|28|||
126339688|NCT01081626|454538571|FG000|Overall Study|Low antral follicle count|1|||
126339689|NCT01081626|454538572|FG001|Overall Study|Low antral follicle count|0|||
126339690|NCT01081626|454538571|FG000|Overall Study|Overstimulation|0|||
126339691|NCT01081626|454538572|FG001|Overall Study|Overstimulation|1|||
126339692|NCT01081626|454538571|FG000|Overall Study|Lost to Follow-up|0|||
126339693|NCT01081626|454538572|FG001|Overall Study|Lost to Follow-up|1|||
126339694|NCT01081626|454538571|FG000|Overall Study|Other|33|||
126339695|NCT01081626|454538572|FG001|Overall Study|Other|30|||
126339696|NCT04158219|454538573|FG000|Overall Study|Lost to Follow-up|1|||
126339697|NCT05965752|454538574|FG000|Overall Study|Adverse Event|0|||
126339698|NCT05965752|454538575|FG001|Overall Study|Adverse Event|1|||
126339699|NCT05965752|454538576|FG002|Overall Study|Adverse Event|0|||
126339700|NCT05965752|454538577|FG003|Overall Study|Adverse Event|1|||
126339701|NCT05965752|454538578|FG004|Overall Study|Adverse Event|3|||
126339702|NCT05965752|454538574|FG000|Overall Study|Lost to Follow-up|2|||
126339703|NCT05965752|454538575|FG001|Overall Study|Lost to Follow-up|0|||
126339704|NCT05965752|454538576|FG002|Overall Study|Lost to Follow-up|1|||
126339705|NCT05965752|454538577|FG003|Overall Study|Lost to Follow-up|1|||
126339706|NCT05965752|454538578|FG004|Overall Study|Lost to Follow-up|1|||
126339707|NCT05965752|454538574|FG000|Overall Study|Withdrawal by Subject|2|||
126339708|NCT05965752|454538575|FG001|Overall Study|Withdrawal by Subject|2|||
126339709|NCT05965752|454538576|FG002|Overall Study|Withdrawal by Subject|1|||
126339710|NCT05965752|454538577|FG003|Overall Study|Withdrawal by Subject|5|||
126339711|NCT05965752|454538578|FG004|Overall Study|Withdrawal by Subject|0|||
126339712|NCT05965752|454538574|FG000|Overall Study|Disease Relapse|1|||
126339713|NCT05965752|454538575|FG001|Overall Study|Disease Relapse|0|||
126339714|NCT05965752|454538576|FG002|Overall Study|Disease Relapse|1|||
126339715|NCT05965752|454538577|FG003|Overall Study|Disease Relapse|0|||
126339716|NCT05965752|454538578|FG004|Overall Study|Disease Relapse|0|||
126339717|NCT05965752|454538574|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
126339718|NCT05965752|454538575|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
126339719|NCT05965752|454538576|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
126339720|NCT05965752|454538577|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
126339721|NCT05965752|454538578|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
126339722|NCT05965752|454538574|FG000|Overall Study|Unable to Return for Study Visits|0|||
126339723|NCT05965752|454538575|FG001|Overall Study|Unable to Return for Study Visits|1|||
126339724|NCT05965752|454538576|FG002|Overall Study|Unable to Return for Study Visits|0|||
126339725|NCT05965752|454538577|FG003|Overall Study|Unable to Return for Study Visits|3|||
126339726|NCT05965752|454538578|FG004|Overall Study|Unable to Return for Study Visits|1|||
126339727|NCT05965752|454538574|FG000|Overall Study|Early Termination|0|||
126339728|NCT05965752|454538575|FG001|Overall Study|Early Termination|0|||
126339729|NCT05965752|454538576|FG002|Overall Study|Early Termination|1|||
126424385|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126339730|NCT05965752|454538577|FG003|Overall Study|Early Termination|0|||
126339731|NCT05965752|454538578|FG004|Overall Study|Early Termination|0|||
126339732|NCT05965752|454538574|FG000|Overall Study|Reported Unwanted Symptoms|0|||
126339733|NCT05965752|454538575|FG001|Overall Study|Reported Unwanted Symptoms|0|||
126339734|NCT05965752|454538576|FG002|Overall Study|Reported Unwanted Symptoms|0|||
126339735|NCT05965752|454538577|FG003|Overall Study|Reported Unwanted Symptoms|0|||
126339736|NCT05965752|454538578|FG004|Overall Study|Reported Unwanted Symptoms|1|||
126339737|NCT05965752|454538574|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
126339738|NCT05965752|454538575|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
126339739|NCT05965752|454538576|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
126339740|NCT05965752|454538577|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
126339741|NCT05965752|454538578|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
126339742|NCT02074514|454538579|FG000|Overall Study|Lack of Efficacy|3|||
126339743|NCT02074514|454538580|FG001|Overall Study|Lack of Efficacy|2|||
126339744|NCT02074514|454538579|FG000|Overall Study|Lost to Follow-up|0|||
126339745|NCT02074514|454538580|FG001|Overall Study|Lost to Follow-up|1|||
126339746|NCT02074514|454538579|FG000|Overall Study|Withdrew Consent|0|||
126339747|NCT02074514|454538580|FG001|Overall Study|Withdrew Consent|1|||
126369331|NCT01153516|454648203|FG000|Overall Study|Both subjects refused surgery|2|||
126369332|NCT01153516|454648204|FG001|Overall Study|Both subjects refused surgery|0|||
126369333|NCT03502200|454648207|FG000|Overall Study|Adverse Event|1|||
126369334|NCT03502200|454648208|FG001|Overall Study|Adverse Event|0|||
126369335|NCT03502200|454648207|FG000|Overall Study|Lost to Follow-up|36|||
126369336|NCT03502200|454648208|FG001|Overall Study|Lost to Follow-up|38|||
126369337|NCT03502200|454648207|FG000|Overall Study|Study Team Decision|1|||
126369338|NCT03502200|454648208|FG001|Overall Study|Study Team Decision|1|||
126369339|NCT03502200|454648207|FG000|Overall Study|Withdrawal by Subject|5|||
126369340|NCT03502200|454648208|FG001|Overall Study|Withdrawal by Subject|7|||
126369341|NCT03502200|454648207|FG000|Overall Study|Death|0|||
126369342|NCT03502200|454648208|FG001|Overall Study|Death|2|||
126369343|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Adverse Event|3|||
126369344|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Adverse Event|0|||
126369345|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Adverse Event|0|||
126369346|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
126369347|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
126369348|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
126369349|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
126369350|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
126369351|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
126369352|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
126369353|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
126369354|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
126369355|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
126369356|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
126369357|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
126369358|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
126369359|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
126369360|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
126369361|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126369362|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126369363|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Adverse Event|14|||
126369364|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
126369365|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
126369366|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
126369367|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126369368|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
126369369|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
126369370|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
126369371|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
126369372|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
126369373|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
126369374|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
126424386|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424387|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
126424388|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424389|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
126424390|NCT00474955|454849309|FG000|Overall Study|Adverse Event|2|||
126424391|NCT00474955|454849309|FG000|Overall Study|Drug unavailability|1|||
126424392|NCT00474955|454849309|FG000|Overall Study|Personal reasons|5|||
126424393|NCT01135134|454849310|FG000|Overall Study|Adverse Event|1|||
126424394|NCT01135134|454849311|FG001|Overall Study|Adverse Event|1|||
126424395|NCT01135134|454849310|FG000|Overall Study|Did not meet protocol eligibility|1|||
126424396|NCT01135134|454849311|FG001|Overall Study|Did not meet protocol eligibility|0|||
126424397|NCT00256724|454849322|FG000|Overall Study|Physician Decision|2|||
126424398|NCT00256724|454849323|FG001|Overall Study|Physician Decision|5|||
126424399|NCT00256724|454849322|FG000|Overall Study|Protocol Violation|3|||
126424400|NCT00256724|454849323|FG001|Overall Study|Protocol Violation|3|||
126424401|NCT01217463|454849324|FG000|Overall Study|Adverse Event|8|||
126424402|NCT01217463|454849325|FG001|Overall Study|Adverse Event|5|||
126424403|NCT01217463|454849324|FG000|Overall Study|Physician Decision|0|||
126424404|NCT01217463|454849325|FG001|Overall Study|Physician Decision|1|||
126424405|NCT01217463|454849324|FG000|Overall Study|Withdrawal by Subject|3|||
126424406|NCT01217463|454849325|FG001|Overall Study|Withdrawal by Subject|0|||
126424407|NCT01217463|454849324|FG000|Overall Study|Surgery on the Target Limb|0|||
126424408|NCT01217463|454849325|FG001|Overall Study|Surgery on the Target Limb|1|||
126424409|NCT01217463|454849324|FG000|Overall Study|Patient Non-compliant|1|||
126424410|NCT01217463|454849325|FG001|Overall Study|Patient Non-compliant|0|||
126424411|NCT01217463|454849324|FG000|Overall Study|Other|1|||
126424412|NCT01217463|454849325|FG001|Overall Study|Other|1|||
126424413|NCT01569841|454849334|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
126424414|NCT01569841|454849335|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
126424415|NCT01859923|454849336|FG000|Overall Study|Adverse Event|0|||
126424416|NCT01859923|454849337|FG001|Overall Study|Adverse Event|0|||
126424417|NCT01859923|454849338|FG002|Overall Study|Adverse Event|1|||
126424418|NCT01859923|454849339|FG003|Overall Study|Adverse Event|1|||
126424419|NCT03634085|454849343|FG000|Overall Study|Adverse Event|1|||
126424420|NCT03634085|454849344|FG001|Overall Study|Adverse Event|0|||
126424421|NCT03634085|454849343|FG000|Overall Study|Withdrawal by Subject|0|||
126424422|NCT03634085|454849344|FG001|Overall Study|Withdrawal by Subject|2|||
126424423|NCT01517750|454851272|FG000|Overall Study|Lost to Follow-up|1|||
126424424|NCT01517750|454851273|FG001|Overall Study|Lost to Follow-up|2|||
126424425|NCT01517750|454851274|FG002|Overall Study|Lost to Follow-up|4|||
126424426|NCT01517750|454851275|FG003|Overall Study|Lost to Follow-up|1|||
126424427|NCT00248495|454851276|FG000|Overall Study|Withdrawal by Subject|1|||
126424428|NCT03812380|454851277|FG000|Overall Study|Protocol Violation|3|||
126424429|NCT03812380|454851278|FG001|Overall Study|Protocol Violation|3|||
126424430|NCT03812380|454851277|FG000|Overall Study|Withdrawal by Subject|5|||
126424431|NCT03812380|454851278|FG001|Overall Study|Withdrawal by Subject|4|||
126424432|NCT03812380|454851277|FG000|Overall Study|Early termination of study|14|||
126424433|NCT03812380|454851278|FG001|Overall Study|Early termination of study|14|||
126424434|NCT01285401|454851279|FG000|Overall Study|Prematurely withdrawn from the study|17|||
126424435|NCT01285401|454851280|FG001|Overall Study|Prematurely withdrawn from the study|29|||
126424436|NCT02366312|454851290|FG000|Overall Study|Lost to Follow-up|0|||
126424437|NCT02366312|454851291|FG001|Overall Study|Lost to Follow-up|1|||
126424438|NCT00354679|454851292|FG000|Overall Study|Patient Not Treated|1|||
126424439|NCT03719131|454851293|FG000|Overall Study|Death|1|||
126424440|NCT03719131|454851294|FG001|Overall Study|Death|2|||
126424441|NCT03294590|454851295|FG000|Overall Study|Lost to Follow-up|105|||
126424442|NCT03294590|454851296|FG001|Overall Study|Lost to Follow-up|107|||
126424443|NCT02420093|454851299|FG000|Overall Study|Withdrawal by Subject|1|||
126424444|NCT02420093|454851300|FG001|Overall Study|Withdrawal by Subject|1|||
126424445|NCT03244917|454851302|FG000|Overall Study|Lost to Follow-up|2|||
126424446|NCT03244917|454851303|FG001|Overall Study|Lost to Follow-up|2|||
126005512|NCT02696785|453312869|FG000|Follow-up Period|Lost to Follow-up|0|||
126005513|NCT02696785|453312870|FG001|Follow-up Period|Lost to Follow-up|0|||
126005514|NCT02696785|453312871|FG002|Follow-up Period|Lost to Follow-up|0|||
126005515|NCT02696785|453312872|FG003|Follow-up Period|Lost to Follow-up|1|||
126424447|NCT01272232|454851304|FG000|Weeks 0-56|Adverse Event|39|||
126005516|NCT02696785|453312869|FG000|Follow-up Period|Lack of Efficacy|0|||
126005517|NCT02696785|453312870|FG001|Follow-up Period|Lack of Efficacy|0|||
126005518|NCT02696785|453312871|FG002|Follow-up Period|Lack of Efficacy|0|||
126005519|NCT02696785|453312872|FG003|Follow-up Period|Lack of Efficacy|1|||
126005520|NCT02696785|453312869|FG000|Follow-up Period|Withdrawal by Subject|1|||
126005521|NCT02696785|453312870|FG001|Follow-up Period|Withdrawal by Subject|0|||
126005522|NCT02696785|453312871|FG002|Follow-up Period|Withdrawal by Subject|5|||
126005523|NCT02696785|453312872|FG003|Follow-up Period|Withdrawal by Subject|4|||
126005524|NCT00614744|453312874|FG000|Overall Study|Lost to Follow-up|5|||
126005525|NCT00614744|453312875|FG001|Overall Study|Lost to Follow-up|4|||
126005526|NCT00614744|453312874|FG000|Overall Study|Incomplete for Behavior Issues|0|||
126005527|NCT00614744|453312875|FG001|Overall Study|Incomplete for Behavior Issues|2|||
126005528|NCT00877851|453312876|FG000|Overall Study|Lost to Follow-up|5|||
126424448|NCT01272232|454851305|FG001|Weeks 0-56|Adverse Event|18|||
126424449|NCT01272232|454851306|FG002|Weeks 0-56|Adverse Event|7|||
126424450|NCT01272232|454851304|FG000|Weeks 0-56|Lack of Efficacy|0|||
126424451|NCT01272232|454851305|FG001|Weeks 0-56|Lack of Efficacy|0|||
126005529|NCT00877851|453312877|FG001|Overall Study|Lost to Follow-up|5|||
126005530|NCT00877851|453312876|FG000|Overall Study|computer problem|3|||
126005531|NCT00877851|453312877|FG001|Overall Study|computer problem|0|||
126005532|NCT00877851|453312876|FG000|Overall Study|no longer interested in participating|1|||
126424452|NCT01272232|454851306|FG002|Weeks 0-56|Lack of Efficacy|3|||
126424453|NCT01272232|454851304|FG000|Weeks 0-56|Protocol Violation|12|||
126424454|NCT01272232|454851305|FG001|Weeks 0-56|Protocol Violation|8|||
126424455|NCT01272232|454851306|FG002|Weeks 0-56|Protocol Violation|13|||
126424456|NCT01272232|454851304|FG000|Weeks 0-56|Withdrawal criteria|32|||
126424457|NCT01272232|454851305|FG001|Weeks 0-56|Withdrawal criteria|14|||
126424458|NCT01272232|454851306|FG002|Weeks 0-56|Withdrawal criteria|37|||
126424459|NCT01272232|454851304|FG000|Weeks 0-56|Unclassified|16|||
126005533|NCT00877851|453312877|FG001|Overall Study|no longer interested in participating|0|||
126005534|NCT03424239|453312885|FG000|Overall Study|Withdrawal by Subject|2|||
126005535|NCT02042443|453312886|FG000|Overall Study|Adverse Event|2|||
126005536|NCT02042443|453312887|FG001|Overall Study|Adverse Event|1|||
126005537|NCT02042443|453312886|FG000|Overall Study|Withdrawal by Subject|0|||
126005538|NCT02042443|453312887|FG001|Overall Study|Withdrawal by Subject|1|||
126005539|NCT02042443|453312886|FG000|Overall Study|Progression|21|||
126005540|NCT02042443|453312887|FG001|Overall Study|Progression|17|||
126005541|NCT02042443|453312886|FG000|Overall Study|not protocol specified|1|||
126005542|NCT02042443|453312887|FG001|Overall Study|not protocol specified|1|||
126005543|NCT02042443|453312886|FG000|Overall Study|Not eligible/not analyzable|3|||
126005544|NCT02042443|453312887|FG001|Overall Study|Not eligible/not analyzable|6|||
126005545|NCT02320253|453312888|FG000|Overall Study|Withdrawal by Subject|3|||
126005546|NCT02320253|453312889|FG001|Overall Study|Withdrawal by Subject|0|||
126005547|NCT02320253|453312890|FG002|Overall Study|Withdrawal by Subject|0|||
126005548|NCT02320253|453312888|FG000|Overall Study|Lost to Follow-up|2|||
126005549|NCT02320253|453312889|FG001|Overall Study|Lost to Follow-up|2|||
126005550|NCT02320253|453312890|FG002|Overall Study|Lost to Follow-up|1|||
126005551|NCT02320253|453312888|FG000|Overall Study|Death|1|||
126005552|NCT02320253|453312889|FG001|Overall Study|Death|0|||
126424460|NCT01272232|454851305|FG001|Weeks 0-56|Unclassified|7|||
126339748|NCT00870727|454540617|FG000|Overall Study|Lost to Follow-up|0|||
126339749|NCT00870727|454540618|FG001|Overall Study|Lost to Follow-up|1|||
126339750|NCT00870727|454540617|FG000|Overall Study|Lack of Efficacy|1|||
126339751|NCT00870727|454540618|FG001|Overall Study|Lack of Efficacy|3|||
126339752|NCT00870727|454540617|FG000|Overall Study|Adverse Event|0|||
126339753|NCT00870727|454540618|FG001|Overall Study|Adverse Event|1|||
126339754|NCT00720278|454540619|FG000|Overall Study|Adverse Event|5|||
126339755|NCT00720278|454540620|FG001|Overall Study|Adverse Event|3|||
126339756|NCT00720278|454540621|FG002|Overall Study|Adverse Event|4|||
126339757|NCT00720278|454540619|FG000|Overall Study|Withdrawal by Subject|0|||
126339758|NCT00720278|454540620|FG001|Overall Study|Withdrawal by Subject|1|||
126339759|NCT00720278|454540621|FG002|Overall Study|Withdrawal by Subject|0|||
126339760|NCT00720278|454540619|FG000|Overall Study|Lost to Follow-up|0|||
126339761|NCT00720278|454540620|FG001|Overall Study|Lost to Follow-up|0|||
126339762|NCT00720278|454540621|FG002|Overall Study|Lost to Follow-up|1|||
126339763|NCT00720278|454540619|FG000|Overall Study|Non-compliance|1|||
126339764|NCT00720278|454540620|FG001|Overall Study|Non-compliance|0|||
126339765|NCT00720278|454540621|FG002|Overall Study|Non-compliance|0|||
126339766|NCT00720278|454540619|FG000|Overall Study|eligibility criteria violation|1|||
126339767|NCT00720278|454540620|FG001|Overall Study|eligibility criteria violation|0|||
126339768|NCT00720278|454540621|FG002|Overall Study|eligibility criteria violation|1|||
126339769|NCT03312738|454540624|FG000|Overall Study|Progressive disease|58|||
126339770|NCT03312738|454540625|FG001|Overall Study|Progressive disease|67|||
126339771|NCT03312738|454540624|FG000|Overall Study|Patient/guardian decision|13|||
126339772|NCT03312738|454540625|FG001|Overall Study|Patient/guardian decision|5|||
126339773|NCT03312738|454540624|FG000|Overall Study|Adverse Event|5|||
126339774|NCT03312738|454540625|FG001|Overall Study|Adverse Event|3|||
126339775|NCT03312738|454540624|FG000|Overall Study|Protocol deviation|2|||
126339776|NCT03312738|454540625|FG001|Overall Study|Protocol deviation|0|||
126339777|NCT03312738|454540624|FG000|Overall Study|Technical problems|0|||
126339778|NCT03312738|454540625|FG001|Overall Study|Technical problems|1|||
126339779|NCT03312738|454540624|FG000|Overall Study|Physician Decision|2|||
126339780|NCT03312738|454540625|FG001|Overall Study|Physician Decision|3|||
126339781|NCT02466399|454540632|FG000|Overall Study|Adverse Event|1|||
126339782|NCT02466399|454540633|FG001|Overall Study|Adverse Event|0|||
126339783|NCT02466399|454540632|FG000|Overall Study|Early exit due to family emergency|1|||
126339784|NCT02466399|454540633|FG001|Overall Study|Early exit due to family emergency|0|||
126339785|NCT03408899|454540634|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
126339786|NCT00606008|454540635|FG000|Overall Study|Adverse Event|1|||
126339787|NCT00606008|454540635|FG000|Overall Study|Withdrawal by Subject|4|||
126339788|NCT01863771|454540636|FG000|Induction Phase|Adverse Event|9|||
126339789|NCT01863771|454540637|FG001|Induction Phase|Adverse Event|0|||
126339790|NCT01863771|454540638|FG002|Induction Phase|Adverse Event|0|||
126339791|NCT01863771|454540639|FG003|Induction Phase|Adverse Event|0|||
126339792|NCT01863771|454540636|FG000|Induction Phase|Lack of Efficacy|10|||
126339793|NCT01863771|454540637|FG001|Induction Phase|Lack of Efficacy|0|||
126339794|NCT01863771|454540638|FG002|Induction Phase|Lack of Efficacy|0|||
126424461|NCT01272232|454851306|FG002|Weeks 0-56|Unclassified|12|||
126005553|NCT02320253|453312890|FG002|Overall Study|Death|1|||
126005554|NCT04794179|453312891|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
126339795|NCT01863771|454540639|FG003|Induction Phase|Lack of Efficacy|0|||
126339796|NCT01863771|454540636|FG000|Induction Phase|Withdrawal by Subject|2|||
126339797|NCT01863771|454540637|FG001|Induction Phase|Withdrawal by Subject|0|||
126005555|NCT04794179|453312892|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
126339798|NCT01863771|454540638|FG002|Induction Phase|Withdrawal by Subject|0|||
126339799|NCT01863771|454540639|FG003|Induction Phase|Withdrawal by Subject|0|||
126424462|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
126005556|NCT00768066|453312893|FG000|Overall Study|Did not receive study product injection.|3|||
126005557|NCT00768066|453312894|FG001|Overall Study|Did not receive study product injection.|3|||
126005558|NCT00768066|453312895|FG002|Overall Study|Did not receive study product injection.|0|||
126005559|NCT04831775|453312896|FG000|Overall Study|Lost to Follow-up|11|||
126005560|NCT04831775|453312897|FG001|Overall Study|Lost to Follow-up|13|||
126339800|NCT01863771|454540636|FG000|Maintenance Phase|Adverse Event|0|||
126339801|NCT01863771|454540637|FG001|Maintenance Phase|Adverse Event|0|||
126339802|NCT01863771|454540638|FG002|Maintenance Phase|Adverse Event|1|||
126339803|NCT01863771|454540639|FG003|Maintenance Phase|Adverse Event|1|||
126339804|NCT01863771|454540636|FG000|Maintenance Phase|Lack of Efficacy|0|||
126339805|NCT01863771|454540637|FG001|Maintenance Phase|Lack of Efficacy|3|||
126339806|NCT01863771|454540638|FG002|Maintenance Phase|Lack of Efficacy|7|||
126339807|NCT01863771|454540639|FG003|Maintenance Phase|Lack of Efficacy|38|||
126339808|NCT01863771|454540636|FG000|Maintenance Phase|Physician Decision|0|||
126339809|NCT01863771|454540637|FG001|Maintenance Phase|Physician Decision|0|||
126339810|NCT01863771|454540638|FG002|Maintenance Phase|Physician Decision|2|||
126339811|NCT01863771|454540639|FG003|Maintenance Phase|Physician Decision|1|||
126339812|NCT01863771|454540636|FG000|Maintenance Phase|Pregnancy|0|||
126339813|NCT01863771|454540637|FG001|Maintenance Phase|Pregnancy|1|||
126339814|NCT01863771|454540638|FG002|Maintenance Phase|Pregnancy|0|||
126339815|NCT01863771|454540639|FG003|Maintenance Phase|Pregnancy|0|||
126339816|NCT01863771|454540636|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126339817|NCT01863771|454540637|FG001|Maintenance Phase|Withdrawal by Subject|1|||
126339818|NCT01863771|454540638|FG002|Maintenance Phase|Withdrawal by Subject|2|||
126339819|NCT01863771|454540639|FG003|Maintenance Phase|Withdrawal by Subject|3|||
126339820|NCT02014272|454540640|FG000|Intervention Period 1|Withdrawal by Subject|1|||
126339821|NCT02014272|454540641|FG001|Intervention Period 1|Withdrawal by Subject|0|||
126339822|NCT02014272|454540640|FG000|Intervention Period 1|Adverse Event|0|||
126339823|NCT02014272|454540641|FG001|Intervention Period 1|Adverse Event|1|||
126339824|NCT01218308|454540642|FG000|Overall Study|Adverse Event|1|||
126339825|NCT01218308|454540643|FG001|Overall Study|Adverse Event|2|||
126339826|NCT01218308|454540642|FG000|Overall Study|Protocol Violation|0|||
126339827|NCT01218308|454540643|FG001|Overall Study|Protocol Violation|2|||
126339828|NCT01218308|454540642|FG000|Overall Study|Withdrawal by Subject|61|||
126339829|NCT01218308|454540643|FG001|Overall Study|Withdrawal by Subject|64|||
126339830|NCT01218308|454540642|FG000|Overall Study|Lost to Follow-up|27|||
126339831|NCT01218308|454540643|FG001|Overall Study|Lost to Follow-up|31|||
126339832|NCT01218308|454540642|FG000|Overall Study|Other|14|||
126339833|NCT01218308|454540643|FG001|Overall Study|Other|21|||
126339834|NCT00547339|454540644|FG000|Overall Study|Physician Decision|0|||
126339835|NCT00547339|454540645|FG001|Overall Study|Physician Decision|0|||
126339836|NCT00547339|454540646|FG002|Overall Study|Physician Decision|1|||
126339837|NCT00547339|454540647|FG003|Overall Study|Physician Decision|0|||
126339838|NCT01248455|454540648|FG000|Overall Study|switched to alternate treatment|1|||
126339839|NCT01117870|454540649|FG000|Overall Study|Inability to place needle|1|||
126339840|NCT01117870|454540650|FG001|Overall Study|Inability to place needle|0|||
126339841|NCT01450813|454540651|FG000|Overall Study|Physician Decision|1|||
126339842|NCT01450813|454540652|FG001|Overall Study|Physician Decision|1|||
126339843|NCT01450813|454540653|FG002|Overall Study|Physician Decision|0|||
126339844|NCT01450813|454540654|FG003|Overall Study|Physician Decision|3|||
126339845|NCT01483118|454540657|FG000|Overall Study|Lost to Follow-up|12|||
126339846|NCT01483118|454540658|FG001|Overall Study|Lost to Follow-up|16|||
126339847|NCT03322293|454540664|FG000|Overall Study|Lost to Follow-up|0|||
126339848|NCT03322293|454540665|FG001|Overall Study|Lost to Follow-up|0|||
126339849|NCT03322293|454540666|FG002|Overall Study|Lost to Follow-up|1|||
126339850|NCT01178294|454540667|FG000|Overall Study|Adverse Event|4|||
126339851|NCT01178294|454540667|FG000|Overall Study|Lost to Follow-up|2|||
126339852|NCT01178294|454540667|FG000|Overall Study|Lack of Efficacy|1|||
126339853|NCT01178294|454540667|FG000|Overall Study|Death|1|||
126339854|NCT01178294|454540667|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
126339855|NCT01178294|454540667|FG000|Overall Study|Subject status is terminal|1|||
126339856|NCT01178294|454540667|FG000|Overall Study|Completion status could not be verified|1|||
126339857|NCT03435055|454540668|FG000|Screening|Physician Decision|2|||
126339858|NCT03435055|454540668|FG000|Received Intervention|Did not complete nitrous administration|3|||
126339859|NCT02089347|454540669|FG000|Overall Study|Protocol Violation|1|||
126339860|NCT02089347|454540670|FG001|Overall Study|Protocol Violation|0|||
126339861|NCT02783066|454540671|FG000|Overall Study|Withdrawal by Subject|13|||
126339862|NCT03712280|454540673|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
126339863|NCT03712280|454540674|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
126339864|NCT03712280|454540675|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
126339865|NCT03712280|454540676|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
126339866|NCT03712280|454540673|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
126339867|NCT03712280|454540674|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
126339868|NCT03712280|454540675|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
126339869|NCT03712280|454540676|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
126005561|NCT05550337|453312900|FG000|Overall Study|Lack of Efficacy|0|||
126424463|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
126424464|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
126424465|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
126424466|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
126424467|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
126424468|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
126424469|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
126424470|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
126424471|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
126424472|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
126424473|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
126424474|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
126424475|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
126424476|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
126424477|NCT00255190|454851310|FG000|Overall Study|Adverse Event|17|||
126424478|NCT00255190|454851311|FG001|Overall Study|Adverse Event|36|||
126424479|NCT00255190|454851310|FG000|Overall Study|Protocol Violation|2|||
126424480|NCT00255190|454851311|FG001|Overall Study|Protocol Violation|2|||
126005562|NCT05550337|453312901|FG001|Overall Study|Lack of Efficacy|0|||
126005563|NCT05550337|453312902|FG002|Overall Study|Lack of Efficacy|1|||
126005564|NCT05550337|453312900|FG000|Overall Study|Adverse Event|1|||
126339870|NCT03712280|454540673|FG000|Overall Study|Adverse Event|0|||
126339871|NCT03712280|454540674|FG001|Overall Study|Adverse Event|0|||
126339872|NCT03712280|454540675|FG002|Overall Study|Adverse Event|1|||
126339873|NCT03712280|454540676|FG003|Overall Study|Adverse Event|0|||
126339874|NCT05379920|454540677|FG000|Overall Study|Lost to Follow-up|0|||
126339875|NCT05379920|454540678|FG001|Overall Study|Lost to Follow-up|5|||
126339876|NCT05379920|454540679|FG002|Overall Study|Lost to Follow-up|0|||
126339877|NCT05379920|454540680|FG003|Overall Study|Lost to Follow-up|0|||
126339878|NCT03176771|454540683|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
126339879|NCT03176771|454540684|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
126339880|NCT03176771|454540685|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
126339881|NCT03176771|454540686|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
126339882|NCT03176771|454540687|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
126339883|NCT03176771|454540683|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
126339884|NCT03176771|454540684|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
126339885|NCT03176771|454540685|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
126339886|NCT03176771|454540686|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
126339887|NCT03176771|454540687|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
126339888|NCT03176771|454540683|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
126339889|NCT03176771|454540684|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
126339890|NCT03176771|454540685|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
126339891|NCT03176771|454540686|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
126339892|NCT03176771|454540687|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
126339893|NCT03176771|454540683|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
126339894|NCT03176771|454540684|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
126339895|NCT03176771|454540685|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
126339896|NCT03176771|454540686|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
126339897|NCT03176771|454540687|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
126339898|NCT03176771|454540683|FG000|Double-Blind Extension Period|Adverse Event|0|||
126339899|NCT03176771|454540684|FG001|Double-Blind Extension Period|Adverse Event|0|||
126339900|NCT03176771|454540685|FG002|Double-Blind Extension Period|Adverse Event|0|||
126339901|NCT03176771|454540686|FG003|Double-Blind Extension Period|Adverse Event|15|||
126339902|NCT03176771|454540687|FG004|Double-Blind Extension Period|Adverse Event|18|||
126339903|NCT03176771|454540683|FG000|Double-Blind Extension Period|Death|0|||
126339904|NCT03176771|454540684|FG001|Double-Blind Extension Period|Death|0|||
126339905|NCT03176771|454540685|FG002|Double-Blind Extension Period|Death|0|||
126339906|NCT03176771|454540686|FG003|Double-Blind Extension Period|Death|3|||
126339907|NCT03176771|454540687|FG004|Double-Blind Extension Period|Death|4|||
126339908|NCT03176771|454540683|FG000|Double-Blind Extension Period|Physician Decision|0|||
126339909|NCT03176771|454540684|FG001|Double-Blind Extension Period|Physician Decision|0|||
126339910|NCT03176771|454540685|FG002|Double-Blind Extension Period|Physician Decision|0|||
126339911|NCT03176771|454540686|FG003|Double-Blind Extension Period|Physician Decision|3|||
126339912|NCT03176771|454540687|FG004|Double-Blind Extension Period|Physician Decision|1|||
126424481|NCT00255190|454851310|FG000|Overall Study|Lost to Follow-up|10|||
126339913|NCT03176771|454540683|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
126339914|NCT03176771|454540684|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
126424482|NCT00255190|454851311|FG001|Overall Study|Lost to Follow-up|27|||
126424483|NCT00255190|454851310|FG000|Overall Study|Withdrew Consent|17|||
126424484|NCT00255190|454851311|FG001|Overall Study|Withdrew Consent|48|||
126424485|NCT00255190|454851310|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
126424486|NCT00255190|454851311|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
126424487|NCT00255190|454851310|FG000|Overall Study|Erosive esophagitis not healed|0|||
126424488|NCT00255190|454851311|FG001|Overall Study|Erosive esophagitis not healed|20|||
126424489|NCT00255190|454851310|FG000|Overall Study|Various|4|||
126424490|NCT00255190|454851311|FG001|Overall Study|Various|23|||
126424491|NCT00628030|454851312|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
126424492|NCT00628030|454851313|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
126424493|NCT00628030|454851312|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
126424494|NCT00628030|454851313|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
126424495|NCT00628030|454851312|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
126424496|NCT00628030|454851313|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
126424497|NCT03367858|454851315|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
126424498|NCT03367858|454851316|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
126424499|NCT03367858|454851315|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
126424500|NCT03367858|454851316|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
126424501|NCT03367858|454851315|FG000|3 Month Follow Up|Lost to Follow-up|8|||
126424502|NCT03367858|454851316|FG001|3 Month Follow Up|Lost to Follow-up|3|||
126424503|NCT03367858|454851315|FG000|3 Month Follow Up|Moved out of study area|2|||
126424504|NCT03367858|454851316|FG001|3 Month Follow Up|Moved out of study area|6|||
126424505|NCT03367858|454851315|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
126424506|NCT03367858|454851316|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
126424507|NCT03367858|454851315|FG000|3 Month Follow Up|MRI contraindication|2|||
126424508|NCT03367858|454851316|FG001|3 Month Follow Up|MRI contraindication|1|||
126424509|NCT03367858|454851315|FG000|3 Month Follow Up|Incarcerated|0|||
126424510|NCT03367858|454851316|FG001|3 Month Follow Up|Incarcerated|1|||
126424511|NCT03367858|454851315|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
126424512|NCT03367858|454851316|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
126424513|NCT03367858|454851315|FG000|6 Month Follow Up|Lost to Follow-up|5|||
126424514|NCT03367858|454851316|FG001|6 Month Follow Up|Lost to Follow-up|2|||
126424515|NCT03367858|454851315|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
126424516|NCT03367858|454851316|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
126424517|NCT03367858|454851315|FG000|12 Month Follow Up|Lost to Follow-up|3|||
126424518|NCT03367858|454851316|FG001|12 Month Follow Up|Lost to Follow-up|3|||
126424519|NCT03367858|454851315|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
126424520|NCT03367858|454851316|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
126424521|NCT03827655|454851317|FG000|Overall Study|Death|0|||
126424522|NCT03827655|454851318|FG001|Overall Study|Death|0|||
126424523|NCT03827655|454851319|FG002|Overall Study|Death|0|||
126424524|NCT03827655|454851320|FG003|Overall Study|Death|0|||
126424525|NCT03827655|454851321|FG004|Overall Study|Death|1|||
126424526|NCT03827655|454851317|FG000|Overall Study|Protocol Deviation|1|||
126424527|NCT03827655|454851318|FG001|Overall Study|Protocol Deviation|0|||
126424528|NCT03827655|454851319|FG002|Overall Study|Protocol Deviation|1|||
126424529|NCT03827655|454851320|FG003|Overall Study|Protocol Deviation|1|||
126424530|NCT03827655|454851321|FG004|Overall Study|Protocol Deviation|0|||
126424531|NCT03827655|454851317|FG000|Overall Study|Withdrawal by Subject|3|||
126424532|NCT03827655|454851318|FG001|Overall Study|Withdrawal by Subject|2|||
126424533|NCT03827655|454851319|FG002|Overall Study|Withdrawal by Subject|2|||
126424534|NCT03827655|454851320|FG003|Overall Study|Withdrawal by Subject|0|||
126424535|NCT03827655|454851321|FG004|Overall Study|Withdrawal by Subject|1|||
126424536|NCT03827655|454851317|FG000|Overall Study|Reason not Specified|3|||
126424537|NCT03827655|454851318|FG001|Overall Study|Reason not Specified|1|||
126424538|NCT03827655|454851319|FG002|Overall Study|Reason not Specified|1|||
126424539|NCT03827655|454851320|FG003|Overall Study|Reason not Specified|1|||
126424540|NCT03827655|454851321|FG004|Overall Study|Reason not Specified|1|||
126424541|NCT01721161|454851323|FG000|Overall Study|Adverse Event|2|||
126424542|NCT01721161|454851324|FG001|Overall Study|Adverse Event|3|||
126424543|NCT01721161|454851323|FG000|Overall Study|Lost to Follow-up|1|||
126424544|NCT01721161|454851324|FG001|Overall Study|Lost to Follow-up|2|||
126424545|NCT01721161|454851323|FG000|Overall Study|Withdrawal by Subject|1|||
126424546|NCT01721161|454851324|FG001|Overall Study|Withdrawal by Subject|1|||
126424547|NCT01721161|454851323|FG000|Overall Study|Other|0|||
126005565|NCT05550337|453312901|FG001|Overall Study|Adverse Event|5|||
126424548|NCT01721161|454851324|FG001|Overall Study|Other|1|||
126424549|NCT01216202|454851325|FG000|Overall Study|Withdrawal by Subject|8|||
126424550|NCT01216202|454851326|FG001|Overall Study|Withdrawal by Subject|0|||
126424551|NCT01216202|454851325|FG000|Overall Study|Death|0|||
126424552|NCT01216202|454851326|FG001|Overall Study|Death|2|||
126424553|NCT01216202|454851325|FG000|Overall Study|Lost to Follow-up|14|||
126005566|NCT05550337|453312902|FG002|Overall Study|Adverse Event|0|||
126424554|NCT01216202|454851326|FG001|Overall Study|Lost to Follow-up|0|||
126424555|NCT01091675|454851331|FG000|Overall Study|Adverse Event|7|||
126424556|NCT01091675|454851331|FG000|Overall Study|Lack of Efficacy|27|||
126424557|NCT02888106|454851338|FG000|Overall Study|Withdrawal by Subject|1|||
126005567|NCT05550337|453312900|FG000|Overall Study|Withdrawal by Subject|8|||
126005568|NCT05550337|453312901|FG001|Overall Study|Withdrawal by Subject|14|||
126339915|NCT03176771|454540685|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
126339916|NCT03176771|454540686|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
126339917|NCT03176771|454540687|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
126339918|NCT02732639|454540688|FG000|Overall Study|Lost to Follow-up|1|||
126339919|NCT02662569|454540690|FG000|Overall Study|Withdrawal by Subject|6|||
126339920|NCT02662569|454540691|FG001|Overall Study|Withdrawal by Subject|1|||
126339921|NCT02662569|454540692|FG002|Overall Study|Withdrawal by Subject|6|||
126339922|NCT02662569|454540693|FG003|Overall Study|Withdrawal by Subject|4|||
126339923|NCT02662569|454540690|FG000|Overall Study|Lost to Follow-up|1|||
126339924|NCT02662569|454540691|FG001|Overall Study|Lost to Follow-up|0|||
126339925|NCT02662569|454540692|FG002|Overall Study|Lost to Follow-up|0|||
126339926|NCT02662569|454540693|FG003|Overall Study|Lost to Follow-up|0|||
126339927|NCT00630916|454540697|FG000|Overall Study|Death|110|||
126339928|NCT00630916|454540697|FG000|Overall Study|Explant|8|||
126339929|NCT00630916|454540697|FG000|Overall Study|Lost to Follow-up|5|||
126339930|NCT00630916|454540697|FG000|Overall Study|Withdrawal by Subject|30|||
126339931|NCT00630916|454540697|FG000|Overall Study|Protocol Violation|7|||
126339932|NCT00630916|454540697|FG000|Overall Study|Physician Decision|47|||
126339933|NCT00630916|454540697|FG000|Overall Study|Lack of Efficacy|3|||
126339934|NCT01299584|454540704|FG000|Overall Study|Protocol Violation|9|||
126339935|NCT04079790|454540705|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
126339936|NCT04079790|454540706|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
126339937|NCT04079790|454540707|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
126339938|NCT04079790|454540708|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
126339939|NCT04079790|454540705|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
126339940|NCT04079790|454540706|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
126339941|NCT04079790|454540707|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
126339942|NCT04079790|454540708|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
126339943|NCT04079790|454540705|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
126339944|NCT04079790|454540706|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
126339945|NCT04079790|454540707|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
126339946|NCT04079790|454540708|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
126339947|NCT00390689|454540709|FG000|Overall Study|Adverse Event|2|||
126339948|NCT00390689|454540710|FG001|Overall Study|Adverse Event|5|||
126339949|NCT00390689|454540711|FG002|Overall Study|Adverse Event|2|||
126339950|NCT00390689|454540709|FG000|Overall Study|Lack of Efficacy|0|||
126339951|NCT00390689|454540710|FG001|Overall Study|Lack of Efficacy|0|||
126339952|NCT00390689|454540711|FG002|Overall Study|Lack of Efficacy|1|||
126339953|NCT00390689|454540709|FG000|Overall Study|Protocol Violation|1|||
126339954|NCT00390689|454540710|FG001|Overall Study|Protocol Violation|0|||
126339955|NCT00390689|454540711|FG002|Overall Study|Protocol Violation|0|||
126339956|NCT00390689|454540709|FG000|Overall Study|Investigator's judgement|2|||
126339957|NCT00390689|454540710|FG001|Overall Study|Investigator's judgement|0|||
126339958|NCT00390689|454540711|FG002|Overall Study|Investigator's judgement|0|||
126339959|NCT01253161|454540712|FG000|Overall Study|Adverse Event|1|||
126339960|NCT01924533|454540714|FG000|Overall Study|Death|181|||
126339961|NCT01924533|454540715|FG001|Overall Study|Death|200|||
126339962|NCT01924533|454540714|FG000|Overall Study|Lost to Follow-up|0|||
126339963|NCT01924533|454540715|FG001|Overall Study|Lost to Follow-up|1|||
126339964|NCT01924533|454540714|FG000|Overall Study|Withdrawal by Subject|7|||
126339965|NCT01924533|454540715|FG001|Overall Study|Withdrawal by Subject|3|||
126339966|NCT01924533|454540714|FG000|Overall Study|Other Eligibility criteria|1|||
126339967|NCT01924533|454540715|FG001|Overall Study|Other Eligibility criteria|1|||
126339968|NCT02747927|454540716|FG000|Overall Study|Adverse Event|5|||
126339969|NCT02747927|454540717|FG001|Overall Study|Adverse Event|14|||
126339970|NCT02747927|454540716|FG000|Overall Study|Lost to Follow-up|22|||
126339971|NCT02747927|454540717|FG001|Overall Study|Lost to Follow-up|43|||
126339972|NCT02747927|454540716|FG000|Overall Study|Pregnancy|34|||
126339973|NCT02747927|454540717|FG001|Overall Study|Pregnancy|66|||
126339974|NCT02747927|454540716|FG000|Overall Study|Protocol Violation|2|||
126339975|NCT02747927|454540717|FG001|Overall Study|Protocol Violation|4|||
126339976|NCT02747927|454540716|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
126339977|NCT02747927|454540717|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
126339978|NCT02747927|454540716|FG000|Overall Study|Reason not Specified|11|||
126339979|NCT02747927|454540717|FG001|Overall Study|Reason not Specified|27|||
126339980|NCT05412134|454540718|FG000|Overall Study|Lost to Follow-up|2|||
126339981|NCT05412134|454540719|FG001|Overall Study|Lost to Follow-up|0|||
126339982|NCT04275336|454540721|FG000|Overall Study|First venipuncture failed|4|||
126339983|NCT04275336|454540722|FG001|Overall Study|First venipuncture failed|6|||
126339984|NCT04275336|454540723|FG002|Overall Study|First venipuncture failed|5|||
126339985|NCT04275336|454540721|FG000|Overall Study|Unscheduled venipuncture|9|||
126339986|NCT04275336|454540722|FG001|Overall Study|Unscheduled venipuncture|13|||
126339987|NCT04275336|454540723|FG002|Overall Study|Unscheduled venipuncture|7|||
126424558|NCT02888106|454851339|FG001|Overall Study|Withdrawal by Subject|2|||
126424559|NCT02888106|454851340|FG002|Overall Study|Withdrawal by Subject|0|||
126424560|NCT02888106|454851341|FG003|Overall Study|Withdrawal by Subject|1|||
126424561|NCT02888106|454851342|FG004|Overall Study|Withdrawal by Subject|0|||
126005569|NCT05550337|453312902|FG002|Overall Study|Withdrawal by Subject|10|||
126005570|NCT05550337|453312900|FG000|Overall Study|Pregnancy|0|||
126005571|NCT05550337|453312901|FG001|Overall Study|Pregnancy|0|||
126005572|NCT05550337|453312902|FG002|Overall Study|Pregnancy|1|||
126005573|NCT05550337|453312900|FG000|Overall Study|Protocol Violation|1|||
126005574|NCT05550337|453312901|FG001|Overall Study|Protocol Violation|3|||
126005575|NCT05550337|453312902|FG002|Overall Study|Protocol Violation|4|||
126005576|NCT05550337|453312900|FG000|Overall Study|Physician Decision|2|||
126005577|NCT05550337|453312901|FG001|Overall Study|Physician Decision|1|||
126005578|NCT05550337|453312902|FG002|Overall Study|Physician Decision|1|||
126339988|NCT04275336|454540721|FG000|Overall Study|Failed specimen of saliva|4|||
126339989|NCT04275336|454540722|FG001|Overall Study|Failed specimen of saliva|3|||
126339990|NCT04275336|454540723|FG002|Overall Study|Failed specimen of saliva|4|||
126339991|NCT00423046|454540730|FG000|Overall Study|Other|340|||
126339992|NCT00423046|454540731|FG001|Overall Study|Other|345|||
126339993|NCT01909804|454540732|FG000|Overall Study|Randomized but Never Treated|0|||
126339994|NCT01909804|454540733|FG001|Overall Study|Randomized but Never Treated|0|||
126339995|NCT01909804|454540734|FG002|Overall Study|Randomized but Never Treated|0|||
126339996|NCT01909804|454540735|FG003|Overall Study|Randomized but Never Treated|0|||
126339997|NCT01909804|454540736|FG004|Overall Study|Randomized but Never Treated|0|||
126339998|NCT01909804|454540737|FG005|Overall Study|Randomized but Never Treated|0|||
126339999|NCT01909804|454540738|FG006|Overall Study|Randomized but Never Treated|1|||
126340000|NCT01909804|454540739|FG007|Overall Study|Randomized but Never Treated|0|||
126340001|NCT01909804|454540740|FG008|Overall Study|Randomized but Never Treated|0|||
126340002|NCT01909804|454540741|FG009|Overall Study|Randomized but Never Treated|0|||
126340003|NCT01909804|454540742|FG010|Overall Study|Randomized but Never Treated|0|||
126340004|NCT01909804|454540743|FG011|Overall Study|Randomized but Never Treated|1|||
126340005|NCT01909804|454540732|FG000|Overall Study|Death|0|||
126340006|NCT01909804|454540733|FG001|Overall Study|Death|0|||
126340007|NCT01909804|454540734|FG002|Overall Study|Death|0|||
126340008|NCT01909804|454540735|FG003|Overall Study|Death|0|||
126340009|NCT01909804|454540736|FG004|Overall Study|Death|0|||
126340010|NCT01909804|454540737|FG005|Overall Study|Death|0|||
126340011|NCT01909804|454540738|FG006|Overall Study|Death|0|||
126340012|NCT01909804|454540739|FG007|Overall Study|Death|0|||
126340013|NCT01909804|454540740|FG008|Overall Study|Death|0|||
126340014|NCT01909804|454540741|FG009|Overall Study|Death|0|||
126340015|NCT01909804|454540742|FG010|Overall Study|Death|1|||
126340016|NCT01909804|454540743|FG011|Overall Study|Death|0|||
126340017|NCT01909804|454540732|FG000|Overall Study|Lack of Efficacy|4|||
126340018|NCT01909804|454540733|FG001|Overall Study|Lack of Efficacy|1|||
126340019|NCT01909804|454540734|FG002|Overall Study|Lack of Efficacy|0|||
126340020|NCT01909804|454540735|FG003|Overall Study|Lack of Efficacy|0|||
126340021|NCT01909804|454540736|FG004|Overall Study|Lack of Efficacy|7|||
126340022|NCT01909804|454540737|FG005|Overall Study|Lack of Efficacy|3|||
126340023|NCT01909804|454540738|FG006|Overall Study|Lack of Efficacy|1|||
126340024|NCT01909804|454540739|FG007|Overall Study|Lack of Efficacy|1|||
126340025|NCT01909804|454540740|FG008|Overall Study|Lack of Efficacy|0|||
126340026|NCT01909804|454540741|FG009|Overall Study|Lack of Efficacy|1|||
126340027|NCT01909804|454540742|FG010|Overall Study|Lack of Efficacy|0|||
126340028|NCT01909804|454540743|FG011|Overall Study|Lack of Efficacy|1|||
126340029|NCT01909804|454540732|FG000|Overall Study|Withdrew Consent|0|||
126340030|NCT01909804|454540733|FG001|Overall Study|Withdrew Consent|0|||
126340031|NCT01909804|454540734|FG002|Overall Study|Withdrew Consent|0|||
126340032|NCT01909804|454540735|FG003|Overall Study|Withdrew Consent|0|||
126340033|NCT01909804|454540736|FG004|Overall Study|Withdrew Consent|1|||
126340034|NCT01909804|454540737|FG005|Overall Study|Withdrew Consent|1|||
126340035|NCT01909804|454540738|FG006|Overall Study|Withdrew Consent|0|||
126340036|NCT01909804|454540739|FG007|Overall Study|Withdrew Consent|0|||
126340037|NCT01909804|454540740|FG008|Overall Study|Withdrew Consent|0|||
126424562|NCT02888106|454851343|FG005|Overall Study|Withdrawal by Subject|0|||
126005579|NCT05550337|453312900|FG000|Overall Study|Lost to Follow-up|16|||
126005580|NCT05550337|453312901|FG001|Overall Study|Lost to Follow-up|11|||
126340038|NCT01909804|454540741|FG009|Overall Study|Withdrew Consent|0|||
126340039|NCT01909804|454540742|FG010|Overall Study|Withdrew Consent|0|||
126424563|NCT02888106|454851338|FG000|Overall Study|Lost to Follow-up|1|||
126005581|NCT05550337|453312902|FG002|Overall Study|Lost to Follow-up|11|||
126340040|NCT01909804|454540743|FG011|Overall Study|Withdrew Consent|0|||
126340041|NCT01909804|454540732|FG000|Overall Study|Protocol Violation|0|||
126340042|NCT01909804|454540733|FG001|Overall Study|Protocol Violation|0|||
126005582|NCT03115346|453312903|FG000|Overall Study|Did not have AAA surgery|28|||
126209474|NCT03110107|454055405|FG012|Treatment Period|Death|1|||
126340043|NCT01909804|454540734|FG002|Overall Study|Protocol Violation|0|||
126340044|NCT01909804|454540735|FG003|Overall Study|Protocol Violation|0|||
126340045|NCT01909804|454540736|FG004|Overall Study|Protocol Violation|0|||
126340046|NCT01909804|454540737|FG005|Overall Study|Protocol Violation|0|||
126424564|NCT02888106|454851339|FG001|Overall Study|Lost to Follow-up|0|||
126424565|NCT02888106|454851340|FG002|Overall Study|Lost to Follow-up|0|||
126424566|NCT02888106|454851341|FG003|Overall Study|Lost to Follow-up|1|||
126424567|NCT02888106|454851342|FG004|Overall Study|Lost to Follow-up|0|||
126424568|NCT02888106|454851343|FG005|Overall Study|Lost to Follow-up|1|||
126424569|NCT02888106|454851338|FG000|Overall Study|Adverse Event|2|||
126424570|NCT02888106|454851339|FG001|Overall Study|Adverse Event|0|||
126424571|NCT02888106|454851340|FG002|Overall Study|Adverse Event|0|||
126424572|NCT02888106|454851341|FG003|Overall Study|Adverse Event|0|||
126424573|NCT02888106|454851342|FG004|Overall Study|Adverse Event|0|||
126424574|NCT02888106|454851343|FG005|Overall Study|Adverse Event|0|||
126424575|NCT02888106|454851338|FG000|Overall Study|Withdrawal of consent|0|||
126424576|NCT02888106|454851339|FG001|Overall Study|Withdrawal of consent|0|||
126424577|NCT02888106|454851340|FG002|Overall Study|Withdrawal of consent|0|||
126424578|NCT02888106|454851341|FG003|Overall Study|Withdrawal of consent|0|||
126424579|NCT02888106|454851342|FG004|Overall Study|Withdrawal of consent|1|||
126424580|NCT02888106|454851343|FG005|Overall Study|Withdrawal of consent|0|||
126424581|NCT02888106|454851338|FG000|Overall Study|Pregnancy|1|||
126424582|NCT02888106|454851339|FG001|Overall Study|Pregnancy|0|||
126424583|NCT02888106|454851340|FG002|Overall Study|Pregnancy|0|||
126424584|NCT02888106|454851341|FG003|Overall Study|Pregnancy|0|||
126424585|NCT02888106|454851342|FG004|Overall Study|Pregnancy|0|||
126424586|NCT02888106|454851343|FG005|Overall Study|Pregnancy|0|||
126424587|NCT01894607|454851350|FG000|Overall Study|Ineligible|1|||
126424588|NCT03259555|454851369|FG000|Overall Study|Adverse Event|6|||
126424589|NCT03259555|454851370|FG001|Overall Study|Adverse Event|4|||
126424590|NCT03259555|454851369|FG000|Overall Study|Lack of Efficacy|6|||
126424591|NCT03259555|454851370|FG001|Overall Study|Lack of Efficacy|4|||
126424592|NCT03259555|454851369|FG000|Overall Study|Lost to Follow-up|0|||
126424593|NCT03259555|454851370|FG001|Overall Study|Lost to Follow-up|2|||
126424594|NCT03259555|454851369|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126424595|NCT03259555|454851370|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126424596|NCT03259555|454851369|FG000|Overall Study|Progressive Disease|0|||
126424597|NCT03259555|454851370|FG001|Overall Study|Progressive Disease|2|||
126424598|NCT03259555|454851369|FG000|Overall Study|Withdrawal by Subject|19|||
126424599|NCT03259555|454851370|FG001|Overall Study|Withdrawal by Subject|16|||
126424600|NCT03259555|454851369|FG000|Overall Study|Physician Decision|1|||
126424601|NCT03259555|454851370|FG001|Overall Study|Physician Decision|2|||
126424602|NCT03259555|454851369|FG000|Overall Study|Other|1|||
126424603|NCT03259555|454851370|FG001|Overall Study|Other|0|||
126424604|NCT04393493|454851371|FG000|First 4 Days of Intervention|Early improvement|5|||
126424605|NCT04393493|454851372|FG001|First 4 Days of Intervention|Early improvement|7|||
126424606|NCT01125800|454851373|FG000|Phase I|Protocol Violation|0|||
126424607|NCT01125800|454851374|FG001|Phase I|Protocol Violation|3|||
126424608|NCT01125800|454851375|FG002|Phase I|Protocol Violation|1|||
126424609|NCT01125800|454851376|FG003|Phase I|Protocol Violation|1|||
126424610|NCT01125800|454851377|FG004|Phase I|Protocol Violation|0|||
126424611|NCT01125800|454851373|FG000|Phase I|Adverse Event|2|||
126424612|NCT01125800|454851374|FG001|Phase I|Adverse Event|2|||
126424613|NCT01125800|454851375|FG002|Phase I|Adverse Event|1|||
126424614|NCT01125800|454851376|FG003|Phase I|Adverse Event|7|||
126424615|NCT01125800|454851377|FG004|Phase I|Adverse Event|0|||
126424616|NCT01125800|454851373|FG000|Phase I|Administrative problems|1|||
126424617|NCT01125800|454851374|FG001|Phase I|Administrative problems|0|||
126424618|NCT01125800|454851375|FG002|Phase I|Administrative problems|0|||
126424619|NCT01125800|454851376|FG003|Phase I|Administrative problems|0|||
126424620|NCT01125800|454851377|FG004|Phase I|Administrative problems|0|||
126424621|NCT01125800|454851373|FG000|Phase I|Withdrawal by Subject|0|||
126424622|NCT01125800|454851374|FG001|Phase I|Withdrawal by Subject|0|||
126424623|NCT01125800|454851375|FG002|Phase I|Withdrawal by Subject|1|||
126424624|NCT01125800|454851376|FG003|Phase I|Withdrawal by Subject|0|||
126424625|NCT01125800|454851377|FG004|Phase I|Withdrawal by Subject|0|||
126424626|NCT01125800|454851373|FG000|Phase I|Disease progression|5|||
126424627|NCT01125800|454851374|FG001|Phase I|Disease progression|4|||
126424628|NCT01125800|454851375|FG002|Phase I|Disease progression|1|||
126424629|NCT01125800|454851376|FG003|Phase I|Disease progression|3|||
126424630|NCT01125800|454851377|FG004|Phase I|Disease progression|0|||
126209475|NCT03110107|454055406|FG013|Treatment Period|Death|0|||
126209476|NCT03110107|454055407|FG014|Treatment Period|Death|0|||
126209477|NCT03110107|454055408|FG015|Treatment Period|Death|0|||
126209478|NCT03110107|454055409|FG016|Treatment Period|Death|0|||
126209479|NCT03110107|454055410|FG017|Treatment Period|Death|0|||
126424631|NCT01125800|454851373|FG000|Phase II|Protocol Violation|0|||
126424632|NCT01125800|454851374|FG001|Phase II|Protocol Violation|0|||
126424633|NCT01125800|454851375|FG002|Phase II|Protocol Violation|0|||
126424634|NCT01125800|454851376|FG003|Phase II|Protocol Violation|0|||
126424635|NCT01125800|454851377|FG004|Phase II|Protocol Violation|1|||
126424636|NCT01125800|454851373|FG000|Phase II|Adverse Event|0|||
126424637|NCT01125800|454851374|FG001|Phase II|Adverse Event|0|||
126424638|NCT01125800|454851375|FG002|Phase II|Adverse Event|0|||
126424639|NCT01125800|454851376|FG003|Phase II|Adverse Event|0|||
126424640|NCT01125800|454851377|FG004|Phase II|Adverse Event|2|||
126209480|NCT03110107|454055411|FG018|Treatment Period|Death|0|||
126209481|NCT03110107|454055412|FG019|Treatment Period|Death|0|||
126209482|NCT03110107|454055413|FG020|Treatment Period|Death|0|||
126340047|NCT01909804|454540738|FG006|Overall Study|Protocol Violation|0|||
126424641|NCT01125800|454851373|FG000|Phase II|Disease progression|0|||
126424642|NCT01125800|454851374|FG001|Phase II|Disease progression|0|||
126424643|NCT01125800|454851375|FG002|Phase II|Disease progression|0|||
126424644|NCT01125800|454851376|FG003|Phase II|Disease progression|1|||
126424645|NCT01125800|454851377|FG004|Phase II|Disease progression|8|||
126424646|NCT04332107|454851384|FG000|Day 3|Lost to Follow-up|23|||
126424647|NCT04332107|454851385|FG001|Day 3|Lost to Follow-up|14|||
126424648|NCT04332107|454851384|FG000|Day 3|Missing outcome data|3|||
126424649|NCT04332107|454851385|FG001|Day 3|Missing outcome data|6|||
126424650|NCT04332107|454851384|FG000|Day 14|Lost to Follow-up|13|||
126424651|NCT04332107|454851385|FG001|Day 14|Lost to Follow-up|4|||
126424652|NCT04332107|454851384|FG000|Day 14|Missing outcome data|4|||
126424653|NCT04332107|454851385|FG001|Day 14|Missing outcome data|4|||
126424654|NCT04332107|454851384|FG000|Day 21|Lost to Follow-up|10|||
126424655|NCT04332107|454851385|FG001|Day 21|Lost to Follow-up|2|||
126424656|NCT03370718|454851390|FG000|Overall Study|Withdrawal by Subject|1|||
126424657|NCT01670721|454851393|FG000|Overall Study|Participant's decision|15|||
126424658|NCT01670721|454851393|FG000|Overall Study|Other than specified above|38|||
126424659|NCT03863509|454851396|FG000|Overall Study|COVID-19 shutdown period|0|||
126424660|NCT03863509|454851397|FG001|Overall Study|COVID-19 shutdown period|4|||
126424661|NCT03863509|454851398|FG002|Overall Study|COVID-19 shutdown period|0|||
126424662|NCT03863509|454851396|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
126424663|NCT03863509|454851397|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
126424664|NCT03863509|454851398|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
126424665|NCT03863509|454851396|FG000|Overall Study|Lost to Follow-up|8|||
126424666|NCT03863509|454851397|FG001|Overall Study|Lost to Follow-up|0|||
126424667|NCT03863509|454851398|FG002|Overall Study|Lost to Follow-up|2|||
126424668|NCT03863509|454851396|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
126424669|NCT03863509|454851397|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
126424670|NCT03863509|454851398|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
126424671|NCT03863509|454851396|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
126424672|NCT03863509|454851397|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
126424673|NCT03863509|454851398|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
126424674|NCT04970654|454851399|FG000|Overall Study|Withdrawal by parents/guardian|1|||
126424675|NCT04970654|454851400|FG001|Overall Study|Withdrawal by parents/guardian|2|||
126424676|NCT04970654|454851399|FG000|Overall Study|Unclassified|2|||
126424677|NCT04970654|454851400|FG001|Overall Study|Unclassified|1|||
126424678|NCT04970654|454851399|FG000|Overall Study|Lost to Follow-up|1|||
126424679|NCT04970654|454851400|FG001|Overall Study|Lost to Follow-up|0|||
126424680|NCT01572480|454851403|FG000|Participants Enrolled|Withdrawal by Subject|1|||
126424681|NCT01572480|454851403|FG000|Drug Administration|Discontinued drug/Off Study|1|||
126424682|NCT01572480|454851403|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
126424683|NCT01572480|454851403|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
126424684|NCT06172348|454851404|FG000|Treatment Period 2|Adverse Event|0|||
126424685|NCT06172348|454851405|FG001|Treatment Period 2|Adverse Event|0|||
126424686|NCT06172348|454851406|FG002|Treatment Period 2|Adverse Event|1|||
126424687|NCT06172348|454851407|FG003|Treatment Period 2|Adverse Event|0|||
126424688|NCT06172348|454851408|FG004|Treatment Period 2|Adverse Event|0|||
126424689|NCT06172348|454851409|FG005|Treatment Period 2|Adverse Event|0|||
126424690|NCT00191334|454851410|FG000|Overall Study|Adverse Event|4|||
126424691|NCT00191334|454851410|FG000|Overall Study|Disease Progression or Relapse|8|||
126340048|NCT01909804|454540739|FG007|Overall Study|Protocol Violation|0|||
126340049|NCT01909804|454540740|FG008|Overall Study|Protocol Violation|0|||
126340050|NCT01909804|454540741|FG009|Overall Study|Protocol Violation|0|||
126340051|NCT01909804|454540742|FG010|Overall Study|Protocol Violation|0|||
126340052|NCT01909804|454540743|FG011|Overall Study|Protocol Violation|1|||
126340053|NCT00830128|454540745|FG000|Overall Study|Adverse Event|5|||
126340054|NCT00830128|454540745|FG000|Overall Study|Lack of Efficacy|7|||
126340055|NCT00830128|454540745|FG000|Overall Study|Protocol Violation|1|||
126340056|NCT00830128|454540745|FG000|Overall Study|Withdrawal by Subject|2|||
126340057|NCT00830128|454540745|FG000|Overall Study|Family obligation|1|||
126340058|NCT00830128|454540745|FG000|Overall Study|Relocation|1|||
126424692|NCT00191334|454851410|FG000|Overall Study|Physician Decision|1|||
126424693|NCT00191334|454851410|FG000|Overall Study|Withdrawal by Subject|4|||
126424694|NCT05579977|454851418|FG000|Treatment Phase|Other|0|||
126424695|NCT05579977|454851419|FG001|Treatment Phase|Other|0|||
126209483|NCT03110107|454055414|FG021|Treatment Period|Death|0|||
126424696|NCT05579977|454851420|FG002|Treatment Phase|Other|0|||
126424697|NCT05579977|454851421|FG003|Treatment Phase|Other|2|||
126424698|NCT05579977|454851422|FG004|Treatment Phase|Other|1|||
126424699|NCT05579977|454851423|FG005|Treatment Phase|Other|2|||
126424700|NCT05579977|454851424|FG006|Treatment Phase|Other|1|||
126424701|NCT05579977|454851425|FG007|Treatment Phase|Other|2|||
126424702|NCT05579977|454851426|FG008|Treatment Phase|Other|2|||
126424703|NCT05579977|454851427|FG009|Treatment Phase|Other|1|||
126424704|NCT05579977|454851428|FG010|Treatment Phase|Other|0|||
126424705|NCT05579977|454851429|FG011|Treatment Phase|Other|0|||
126424706|NCT05579977|454851430|FG012|Treatment Phase|Other|3|||
126424707|NCT05579977|454851418|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
126424708|NCT05579977|454851419|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
126424709|NCT05579977|454851420|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
126424710|NCT05579977|454851421|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
126424711|NCT05579977|454851422|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
126424712|NCT05579977|454851423|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
126424713|NCT05579977|454851424|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
126424714|NCT05579977|454851425|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
126424715|NCT05579977|454851426|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
126424716|NCT05579977|454851427|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
126424717|NCT05579977|454851428|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
126424718|NCT05579977|454851429|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
126424719|NCT05579977|454851430|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
126424720|NCT05579977|454851418|FG000|Treatment Phase|Withdrawal by Subject|2|||
126424721|NCT05579977|454851419|FG001|Treatment Phase|Withdrawal by Subject|0|||
126424722|NCT05579977|454851420|FG002|Treatment Phase|Withdrawal by Subject|0|||
126424723|NCT05579977|454851421|FG003|Treatment Phase|Withdrawal by Subject|1|||
126424724|NCT05579977|454851422|FG004|Treatment Phase|Withdrawal by Subject|2|||
126424725|NCT05579977|454851423|FG005|Treatment Phase|Withdrawal by Subject|0|||
126424726|NCT05579977|454851424|FG006|Treatment Phase|Withdrawal by Subject|1|||
126005583|NCT03115346|453312904|FG001|Overall Study|Did not have AAA surgery|15|||
126005584|NCT03115346|453312903|FG000|Overall Study|Death|3|||
126424727|NCT05579977|454851425|FG007|Treatment Phase|Withdrawal by Subject|8|||
126424728|NCT05579977|454851426|FG008|Treatment Phase|Withdrawal by Subject|3|||
126424729|NCT05579977|454851427|FG009|Treatment Phase|Withdrawal by Subject|3|||
126424730|NCT05579977|454851428|FG010|Treatment Phase|Withdrawal by Subject|5|||
126424731|NCT05579977|454851429|FG011|Treatment Phase|Withdrawal by Subject|1|||
126424732|NCT05579977|454851430|FG012|Treatment Phase|Withdrawal by Subject|3|||
126424733|NCT05579977|454851418|FG000|Treatment Phase|Study terminated by sponsor|70|||
126424734|NCT05579977|454851419|FG001|Treatment Phase|Study terminated by sponsor|70|||
126424735|NCT05579977|454851420|FG002|Treatment Phase|Study terminated by sponsor|61|||
126424736|NCT05579977|454851421|FG003|Treatment Phase|Study terminated by sponsor|59|||
126424737|NCT05579977|454851422|FG004|Treatment Phase|Study terminated by sponsor|63|||
126424738|NCT05579977|454851423|FG005|Treatment Phase|Study terminated by sponsor|53|||
126424739|NCT05579977|454851424|FG006|Treatment Phase|Study terminated by sponsor|66|||
126424740|NCT05579977|454851425|FG007|Treatment Phase|Study terminated by sponsor|48|||
126424741|NCT05579977|454851426|FG008|Treatment Phase|Study terminated by sponsor|47|||
126424742|NCT05579977|454851427|FG009|Treatment Phase|Study terminated by sponsor|37|||
126424743|NCT05579977|454851428|FG010|Treatment Phase|Study terminated by sponsor|44|||
126424744|NCT05579977|454851429|FG011|Treatment Phase|Study terminated by sponsor|36|||
126424745|NCT05579977|454851430|FG012|Treatment Phase|Study terminated by sponsor|32|||
126424746|NCT05579977|454851418|FG000|Treatment Phase|Pregnancy|0|||
126424747|NCT05579977|454851419|FG001|Treatment Phase|Pregnancy|0|||
126424748|NCT05579977|454851420|FG002|Treatment Phase|Pregnancy|0|||
126424749|NCT05579977|454851421|FG003|Treatment Phase|Pregnancy|0|||
126424750|NCT05579977|454851422|FG004|Treatment Phase|Pregnancy|0|||
126424751|NCT05579977|454851423|FG005|Treatment Phase|Pregnancy|0|||
126424752|NCT05579977|454851424|FG006|Treatment Phase|Pregnancy|0|||
126424753|NCT05579977|454851425|FG007|Treatment Phase|Pregnancy|0|||
126424754|NCT05579977|454851426|FG008|Treatment Phase|Pregnancy|0|||
126424755|NCT05579977|454851427|FG009|Treatment Phase|Pregnancy|1|||
126424756|NCT05579977|454851428|FG010|Treatment Phase|Pregnancy|0|||
126424757|NCT05579977|454851429|FG011|Treatment Phase|Pregnancy|0|||
126424758|NCT05579977|454851430|FG012|Treatment Phase|Pregnancy|0|||
126005585|NCT03115346|453312904|FG001|Overall Study|Death|1|||
126005586|NCT03115346|453312903|FG000|Overall Study|Withdrawal by Subject|0|||
126005587|NCT03115346|453312904|FG001|Overall Study|Withdrawal by Subject|3|||
126005588|NCT03115346|453312903|FG000|Overall Study|Lost to Follow-up|0|||
126005589|NCT03115346|453312904|FG001|Overall Study|Lost to Follow-up|3|||
126424759|NCT05579977|454851418|FG000|Treatment Phase|Physician Decision|0|||
126424760|NCT05579977|454851419|FG001|Treatment Phase|Physician Decision|0|||
126424761|NCT05579977|454851420|FG002|Treatment Phase|Physician Decision|0|||
126424762|NCT05579977|454851421|FG003|Treatment Phase|Physician Decision|0|||
126424763|NCT05579977|454851422|FG004|Treatment Phase|Physician Decision|0|||
126424764|NCT05579977|454851423|FG005|Treatment Phase|Physician Decision|0|||
126424765|NCT05579977|454851424|FG006|Treatment Phase|Physician Decision|0|||
126005590|NCT01737268|453312905|FG000|Overall Study|Adverse Event|6|||
126005591|NCT01737268|453312905|FG000|Overall Study|Worsening of Target Disease|2|||
126424766|NCT05579977|454851425|FG007|Treatment Phase|Physician Decision|0|||
126424767|NCT05579977|454851426|FG008|Treatment Phase|Physician Decision|0|||
126424768|NCT05579977|454851427|FG009|Treatment Phase|Physician Decision|0|||
126424769|NCT05579977|454851428|FG010|Treatment Phase|Physician Decision|0|||
126424770|NCT05579977|454851429|FG011|Treatment Phase|Physician Decision|1|||
126424771|NCT05579977|454851430|FG012|Treatment Phase|Physician Decision|0|||
126424772|NCT05579977|454851418|FG000|Treatment Phase|Lost to Follow-up|0|||
126424773|NCT05579977|454851419|FG001|Treatment Phase|Lost to Follow-up|0|||
126424774|NCT05579977|454851420|FG002|Treatment Phase|Lost to Follow-up|0|||
126424775|NCT05579977|454851421|FG003|Treatment Phase|Lost to Follow-up|1|||
126424776|NCT05579977|454851422|FG004|Treatment Phase|Lost to Follow-up|1|||
126424777|NCT05579977|454851423|FG005|Treatment Phase|Lost to Follow-up|1|||
126424778|NCT05579977|454851424|FG006|Treatment Phase|Lost to Follow-up|0|||
126424779|NCT05579977|454851425|FG007|Treatment Phase|Lost to Follow-up|1|||
126424780|NCT05579977|454851426|FG008|Treatment Phase|Lost to Follow-up|2|||
126424781|NCT05579977|454851427|FG009|Treatment Phase|Lost to Follow-up|2|||
126424782|NCT05579977|454851428|FG010|Treatment Phase|Lost to Follow-up|1|||
126424783|NCT05579977|454851429|FG011|Treatment Phase|Lost to Follow-up|4|||
126424784|NCT05579977|454851430|FG012|Treatment Phase|Lost to Follow-up|3|||
126424785|NCT05579977|454851418|FG000|Treatment Phase|Death|1|||
126424786|NCT05579977|454851419|FG001|Treatment Phase|Death|0|||
126424787|NCT05579977|454851420|FG002|Treatment Phase|Death|0|||
126424788|NCT05579977|454851421|FG003|Treatment Phase|Death|0|||
126424789|NCT05579977|454851422|FG004|Treatment Phase|Death|0|||
126424790|NCT05579977|454851423|FG005|Treatment Phase|Death|0|||
126424791|NCT05579977|454851424|FG006|Treatment Phase|Death|0|||
126424792|NCT05579977|454851425|FG007|Treatment Phase|Death|0|||
126424793|NCT05579977|454851426|FG008|Treatment Phase|Death|0|||
126424794|NCT05579977|454851427|FG009|Treatment Phase|Death|0|||
126424795|NCT05579977|454851428|FG010|Treatment Phase|Death|0|||
126424796|NCT05579977|454851429|FG011|Treatment Phase|Death|0|||
126424797|NCT05579977|454851430|FG012|Treatment Phase|Death|0|||
126424798|NCT05579977|454851418|FG000|Treatment Phase|Adverse Event|0|||
126424799|NCT05579977|454851419|FG001|Treatment Phase|Adverse Event|3|||
126424800|NCT05579977|454851420|FG002|Treatment Phase|Adverse Event|11|||
126424801|NCT05579977|454851421|FG003|Treatment Phase|Adverse Event|10|||
126424802|NCT05579977|454851422|FG004|Treatment Phase|Adverse Event|5|||
126424803|NCT05579977|454851423|FG005|Treatment Phase|Adverse Event|17|||
126424804|NCT05579977|454851424|FG006|Treatment Phase|Adverse Event|5|||
126424805|NCT05579977|454851425|FG007|Treatment Phase|Adverse Event|5|||
126424806|NCT05579977|454851426|FG008|Treatment Phase|Adverse Event|12|||
126424807|NCT05579977|454851427|FG009|Treatment Phase|Adverse Event|20|||
126424808|NCT05579977|454851428|FG010|Treatment Phase|Adverse Event|15|||
126424809|NCT05579977|454851429|FG011|Treatment Phase|Adverse Event|24|||
126424810|NCT05579977|454851430|FG012|Treatment Phase|Adverse Event|23|||
126424811|NCT05579977|454851418|FG000|Treatment Phase|Randomized not treated|0|||
126424812|NCT05579977|454851419|FG001|Treatment Phase|Randomized not treated|0|||
126424813|NCT05579977|454851420|FG002|Treatment Phase|Randomized not treated|0|||
126424814|NCT05579977|454851421|FG003|Treatment Phase|Randomized not treated|0|||
126424815|NCT05579977|454851422|FG004|Treatment Phase|Randomized not treated|1|||
126424816|NCT05579977|454851423|FG005|Treatment Phase|Randomized not treated|0|||
126424817|NCT05579977|454851424|FG006|Treatment Phase|Randomized not treated|0|||
126424818|NCT05579977|454851425|FG007|Treatment Phase|Randomized not treated|0|||
126424819|NCT05579977|454851426|FG008|Treatment Phase|Randomized not treated|0|||
126424820|NCT05579977|454851427|FG009|Treatment Phase|Randomized not treated|0|||
126424821|NCT05579977|454851428|FG010|Treatment Phase|Randomized not treated|0|||
126424822|NCT05579977|454851429|FG011|Treatment Phase|Randomized not treated|0|||
126424823|NCT05579977|454851430|FG012|Treatment Phase|Randomized not treated|0|||
126424824|NCT05579977|454851418|FG000|Follow up|Death|1|||
126005592|NCT01737268|453312905|FG000|Overall Study|In consideration of the patient's safety|1|||
126005593|NCT01458275|453312906|FG000|Overall Study|Adverse Event|3|||
126005594|NCT01458275|453312907|FG001|Overall Study|Adverse Event|4|||
126005595|NCT01458275|453312908|FG002|Overall Study|Adverse Event|1|||
126005596|NCT01458275|453312906|FG000|Overall Study|Lost to Follow-up|3|||
126005597|NCT01458275|453312907|FG001|Overall Study|Lost to Follow-up|2|||
126005598|NCT01458275|453312908|FG002|Overall Study|Lost to Follow-up|5|||
126005599|NCT01458275|453312906|FG000|Overall Study|Protocol Violation|5|||
126005600|NCT01458275|453312907|FG001|Overall Study|Protocol Violation|5|||
126424825|NCT05579977|454851419|FG001|Follow up|Death|0|||
126424826|NCT05579977|454851420|FG002|Follow up|Death|0|||
126424827|NCT05579977|454851421|FG003|Follow up|Death|0|||
126424828|NCT05579977|454851422|FG004|Follow up|Death|0|||
126424829|NCT05579977|454851423|FG005|Follow up|Death|0|||
126424830|NCT05579977|454851424|FG006|Follow up|Death|0|||
126424831|NCT05579977|454851425|FG007|Follow up|Death|0|||
126424832|NCT05579977|454851426|FG008|Follow up|Death|0|||
126424833|NCT05579977|454851427|FG009|Follow up|Death|0|||
126424834|NCT05579977|454851428|FG010|Follow up|Death|0|||
126424835|NCT05579977|454851429|FG011|Follow up|Death|0|||
126424836|NCT05579977|454851430|FG012|Follow up|Death|0|||
126424837|NCT05579977|454851418|FG000|Follow up|Lost to Follow-up|0|||
126424838|NCT05579977|454851419|FG001|Follow up|Lost to Follow-up|0|||
126424839|NCT05579977|454851420|FG002|Follow up|Lost to Follow-up|0|||
126005601|NCT01458275|453312908|FG002|Overall Study|Protocol Violation|2|||
126340059|NCT00830128|454540745|FG000|Overall Study|Work obligation|1|||
126340060|NCT00830128|454540745|FG000|Overall Study|Operating a vehicle|1|||
126340061|NCT05401565|454540746|FG000|Overall Study|Lost to Follow-up|1|||
126340062|NCT05401565|454540747|FG001|Overall Study|Lost to Follow-up|0|||
126340063|NCT05401565|454540746|FG000|Overall Study|Adverse Event|2|||
126340064|NCT05401565|454540747|FG001|Overall Study|Adverse Event|0|||
126340065|NCT01218802|454540756|FG000|Overall Study|Lost to Follow-up|5|||
126340066|NCT01218802|454540757|FG001|Overall Study|Lost to Follow-up|6|||
126340067|NCT01218802|454540756|FG000|Overall Study|Withdrawal by Subject|3|||
126340068|NCT01218802|454540757|FG001|Overall Study|Withdrawal by Subject|10|||
126340069|NCT01218802|454540756|FG000|Overall Study|Adverse Event|0|||
126340070|NCT01218802|454540757|FG001|Overall Study|Adverse Event|2|||
126340071|NCT01218802|454540756|FG000|Overall Study|Incarcerated|2|||
126340072|NCT01218802|454540757|FG001|Overall Study|Incarcerated|0|||
126340073|NCT03080935|454540758|FG000|Overall Study|Death|34|||
126340074|NCT03080935|454540759|FG001|Overall Study|Death|50|||
126340075|NCT03080935|454540758|FG000|Overall Study|Lost to Follow-up|5|||
126340076|NCT03080935|454540759|FG001|Overall Study|Lost to Follow-up|4|||
126340077|NCT03080935|454540758|FG000|Overall Study|Withdrawal by Subject|11|||
126340078|NCT03080935|454540759|FG001|Overall Study|Withdrawal by Subject|15|||
126340079|NCT02175121|454540760|FG000|Overall Study|Lack of Efficacy|1|||
126340080|NCT02175121|454540761|FG001|Overall Study|Lack of Efficacy|0|||
126340081|NCT02175121|454540762|FG002|Overall Study|Lack of Efficacy|0|||
126340082|NCT02175121|454540763|FG003|Overall Study|Lack of Efficacy|0|||
126340083|NCT02175121|454540764|FG004|Overall Study|Lack of Efficacy|0|||
126340084|NCT02175121|454540760|FG000|Overall Study|Lost to Follow-up|0|||
126340085|NCT02175121|454540761|FG001|Overall Study|Lost to Follow-up|1|||
126340086|NCT02175121|454540762|FG002|Overall Study|Lost to Follow-up|0|||
126340087|NCT02175121|454540763|FG003|Overall Study|Lost to Follow-up|1|||
126340088|NCT02175121|454540764|FG004|Overall Study|Lost to Follow-up|0|||
126340089|NCT02175121|454540760|FG000|Overall Study|Personal emergency|0|||
126340090|NCT02175121|454540761|FG001|Overall Study|Personal emergency|0|||
126340091|NCT02175121|454540762|FG002|Overall Study|Personal emergency|0|||
126340092|NCT02175121|454540763|FG003|Overall Study|Personal emergency|0|||
126340093|NCT02175121|454540764|FG004|Overall Study|Personal emergency|1|||
126340094|NCT02175121|454540760|FG000|Overall Study|Schedule conflict|0|||
126340095|NCT02175121|454540761|FG001|Overall Study|Schedule conflict|0|||
126340096|NCT02175121|454540762|FG002|Overall Study|Schedule conflict|1|||
126340097|NCT02175121|454540763|FG003|Overall Study|Schedule conflict|0|||
126340098|NCT02175121|454540764|FG004|Overall Study|Schedule conflict|0|||
126340099|NCT02175121|454540760|FG000|Overall Study|Time issues|0|||
126340100|NCT02175121|454540761|FG001|Overall Study|Time issues|0|||
126340101|NCT02175121|454540762|FG002|Overall Study|Time issues|1|||
126340102|NCT02175121|454540763|FG003|Overall Study|Time issues|0|||
126340103|NCT02175121|454540764|FG004|Overall Study|Time issues|0|||
126340104|NCT03329885|454540765|FG000|Overall Study|Sponsor discontinued the study early|0|||
126340105|NCT03329885|454540766|FG001|Overall Study|Sponsor discontinued the study early|0|||
126340106|NCT03329885|454540767|FG002|Overall Study|Sponsor discontinued the study early|0|||
126340107|NCT03329885|454540768|FG003|Overall Study|Sponsor discontinued the study early|0|||
126340108|NCT03329885|454540769|FG004|Overall Study|Sponsor discontinued the study early|0|||
126340109|NCT03329885|454540770|FG005|Overall Study|Sponsor discontinued the study early|0|||
126340110|NCT03329885|454540771|FG006|Overall Study|Sponsor discontinued the study early|1|||
126340111|NCT03329885|454540772|FG007|Overall Study|Sponsor discontinued the study early|1|||
126340112|NCT03329885|454540773|FG008|Overall Study|Sponsor discontinued the study early|0|||
126340113|NCT03886272|454540780|FG000|Period 1|Withdrawal by Subject|0|||
126340114|NCT03886272|454540781|FG001|Period 1|Withdrawal by Subject|0|||
126340115|NCT03886272|454540782|FG002|Period 1|Withdrawal by Subject|0|||
126340116|NCT03886272|454540783|FG003|Period 1|Withdrawal by Subject|0|||
126340117|NCT03886272|454540784|FG004|Period 1|Withdrawal by Subject|0|||
126340118|NCT03886272|454540785|FG005|Period 1|Withdrawal by Subject|1|||
126340119|NCT03886272|454540786|FG006|Period 1|Withdrawal by Subject|0|||
126340120|NCT00931632|454540787|FG000|Overall Study|Withdrawal by Subject|2|||
126340121|NCT00931632|454540788|FG001|Overall Study|Withdrawal by Subject|3|||
126340122|NCT00931632|454540787|FG000|Overall Study|Adverse Event|19|||
126340123|NCT00931632|454540788|FG001|Overall Study|Adverse Event|15|||
126005602|NCT01458275|453312906|FG000|Overall Study|Withdrawal by Subject|3|||
126340124|NCT03372798|454540791|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
126340125|NCT03372798|454540792|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
126424840|NCT05579977|454851421|FG003|Follow up|Lost to Follow-up|1|||
126424841|NCT05579977|454851422|FG004|Follow up|Lost to Follow-up|1|||
126340126|NCT03372798|454540791|FG000|Overall Study|Failure of imaging probe|0|||
126209484|NCT03110107|454055415|FG022|Treatment Period|Death|0|||
126340127|NCT03372798|454540792|FG001|Overall Study|Failure of imaging probe|1|||
126340128|NCT01687218|454540793|FG000|Overall Study|Withdrawal by Subject|2|||
126340129|NCT01687218|454540794|FG001|Overall Study|Withdrawal by Subject|3|||
126340130|NCT01687218|454540795|FG002|Overall Study|Withdrawal by Subject|0|||
126340131|NCT01687218|454540796|FG003|Overall Study|Withdrawal by Subject|1|||
126424842|NCT05579977|454851423|FG005|Follow up|Lost to Follow-up|2|||
126424843|NCT05579977|454851424|FG006|Follow up|Lost to Follow-up|1|||
126424844|NCT05579977|454851425|FG007|Follow up|Lost to Follow-up|1|||
126424845|NCT05579977|454851426|FG008|Follow up|Lost to Follow-up|3|||
126424846|NCT05579977|454851427|FG009|Follow up|Lost to Follow-up|2|||
126424847|NCT05579977|454851428|FG010|Follow up|Lost to Follow-up|2|||
126424848|NCT05579977|454851429|FG011|Follow up|Lost to Follow-up|4|||
126424849|NCT05579977|454851430|FG012|Follow up|Lost to Follow-up|4|||
126424850|NCT05579977|454851418|FG000|Follow up|Withdrawal by Subject|2|||
126424851|NCT05579977|454851419|FG001|Follow up|Withdrawal by Subject|0|||
126424852|NCT05579977|454851420|FG002|Follow up|Withdrawal by Subject|0|||
126424853|NCT05579977|454851421|FG003|Follow up|Withdrawal by Subject|0|||
126424854|NCT05579977|454851422|FG004|Follow up|Withdrawal by Subject|1|||
126424855|NCT05579977|454851423|FG005|Follow up|Withdrawal by Subject|0|||
126424856|NCT05579977|454851424|FG006|Follow up|Withdrawal by Subject|1|||
126424857|NCT05579977|454851425|FG007|Follow up|Withdrawal by Subject|4|||
126424858|NCT05579977|454851426|FG008|Follow up|Withdrawal by Subject|2|||
126424859|NCT05579977|454851427|FG009|Follow up|Withdrawal by Subject|3|||
126424860|NCT05579977|454851428|FG010|Follow up|Withdrawal by Subject|3|||
126424861|NCT05579977|454851429|FG011|Follow up|Withdrawal by Subject|1|||
126424862|NCT05579977|454851430|FG012|Follow up|Withdrawal by Subject|3|||
126424863|NCT00350844|454851431|FG000|Overall Study|Lost to Follow-up|1|||
126424864|NCT01420926|454851432|FG000|Overall Study|Adverse Event|6|||
126424865|NCT01420926|454851433|FG001|Overall Study|Adverse Event|4|||
126424866|NCT01420926|454851432|FG000|Overall Study|Death|18|||
126424867|NCT01420926|454851433|FG001|Overall Study|Death|17|||
126424868|NCT01420926|454851432|FG000|Overall Study|Withdrawal by Subject|11|||
126424869|NCT01420926|454851433|FG001|Overall Study|Withdrawal by Subject|17|||
126424870|NCT01420926|454851432|FG000|Overall Study|Non-protocol treatment|17|||
126424871|NCT01420926|454851433|FG001|Overall Study|Non-protocol treatment|20|||
126424872|NCT01420926|454851432|FG000|Overall Study|Physician Decision|8|||
126424873|NCT01420926|454851433|FG001|Overall Study|Physician Decision|5|||
126424874|NCT02775916|454851436|FG000|Overall Study|Adverse Event|1|||
126424875|NCT02775916|454851437|FG001|Overall Study|Adverse Event|0|||
126424876|NCT02775916|454851436|FG000|Overall Study|Subject/Guardian Decision|2|||
126424877|NCT02775916|454851437|FG001|Overall Study|Subject/Guardian Decision|0|||
126424878|NCT01232868|454853750|FG000|Overall Study|Lost to Follow-up|2|||
126424879|NCT01232868|454853751|FG001|Overall Study|Lost to Follow-up|4|||
126424880|NCT02539797|454853752|FG000|Overall Study|Lost to Follow-up|0|||
126424881|NCT02539797|454853753|FG001|Overall Study|Lost to Follow-up|1|||
126424882|NCT02539797|454853754|FG002|Overall Study|Lost to Follow-up|0|||
126424883|NCT04002960|454853756|FG000|Overall Study|Withdrawn prior to Completion|2|||
126424884|NCT00865345|454853759|FG000|Overall Study|Withdrawal by Subject|2|||
126424885|NCT00383786|454853760|FG000|Overall Study|Protocol Violation|2|||
126424886|NCT00383786|454853761|FG001|Overall Study|Protocol Violation|6|||
126424887|NCT00383786|454853760|FG000|Overall Study|Withdrawal by Subject|2|||
126424888|NCT00383786|454853761|FG001|Overall Study|Withdrawal by Subject|5|||
126424889|NCT00383786|454853760|FG000|Overall Study|Physician Decision|0|||
126424890|NCT00383786|454853761|FG001|Overall Study|Physician Decision|1|||
126424891|NCT02723773|454853764|FG000|Overall Study|Adverse Event|934|||
126424892|NCT02723773|454853765|FG001|Overall Study|Adverse Event|3|||
126424893|NCT02723773|454853766|FG002|Overall Study|Adverse Event|1|||
126424894|NCT02723773|454853767|FG003|Overall Study|Adverse Event|9|||
126424895|NCT02723773|454853764|FG000|Overall Study|Protocol Violation|1|||
126424896|NCT02723773|454853765|FG001|Overall Study|Protocol Violation|0|||
126424897|NCT02723773|454853766|FG002|Overall Study|Protocol Violation|0|||
126424898|NCT02723773|454853767|FG003|Overall Study|Protocol Violation|0|||
126424899|NCT02723773|454853764|FG000|Overall Study|Withdrawal by Subject|360|||
126424900|NCT02723773|454853765|FG001|Overall Study|Withdrawal by Subject|5|||
126424901|NCT02723773|454853766|FG002|Overall Study|Withdrawal by Subject|6|||
126424902|NCT02723773|454853767|FG003|Overall Study|Withdrawal by Subject|10|||
126424903|NCT02723773|454853764|FG000|Overall Study|Migrated/moved from study area|37|||
126424904|NCT02723773|454853765|FG001|Overall Study|Migrated/moved from study area|0|||
126424905|NCT02723773|454853766|FG002|Overall Study|Migrated/moved from study area|0|||
126424906|NCT02723773|454853767|FG003|Overall Study|Migrated/moved from study area|1|||
126424907|NCT02723773|454853764|FG000|Overall Study|Lost to Follow-up|198|||
126424908|NCT02723773|454853765|FG001|Overall Study|Lost to Follow-up|0|||
126424909|NCT02723773|454853766|FG002|Overall Study|Lost to Follow-up|0|||
126424910|NCT02723773|454853767|FG003|Overall Study|Lost to Follow-up|0|||
126424911|NCT02723773|454853764|FG000|Overall Study|Other|189|||
126424912|NCT02723773|454853765|FG001|Overall Study|Other|1|||
126005603|NCT01458275|453312907|FG001|Overall Study|Withdrawal by Subject|2|||
126424913|NCT02723773|454853766|FG002|Overall Study|Other|2|||
126424914|NCT02723773|454853767|FG003|Overall Study|Other|2|||
126424915|NCT03629886|454853768|FG000|Overall Study|Migrated / moved from the study area|0|||
126424916|NCT03629886|454853769|FG001|Overall Study|Migrated / moved from the study area|55|||
126424917|NCT03629886|454853768|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
126424918|NCT03629886|454853769|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
126424919|NCT03629886|454853768|FG000|Overall Study|Study vaccine not administrated|0|||
126005604|NCT01458275|453312908|FG002|Overall Study|Withdrawal by Subject|1|||
126005605|NCT03697460|453312909|FG000|Overall Study|Withdrawal by Subject|3|||
126005606|NCT03499600|453312916|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
126005607|NCT03499600|453312917|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
126005608|NCT00445692|453312918|FG000|Overall Study|Adverse Event|11|||
126005609|NCT00445692|453312918|FG000|Overall Study|Lack of Efficacy|5|||
126005610|NCT01137292|453312919|FG000|Overall Study|Death|30|||
126005611|NCT01137292|453312919|FG000|Overall Study|Adverse Event|3|||
126005612|NCT01137292|453312919|FG000|Overall Study|Lack of Efficacy|13|||
126005613|NCT01137292|453312919|FG000|Overall Study|Lost to Follow-up|1|||
126005614|NCT01137292|453312919|FG000|Overall Study|Other|7|||
126005615|NCT03425539|453312920|FG000|Overall Study|Randomized but not treated|0|||
126005616|NCT03425539|453312921|FG001|Overall Study|Randomized but not treated|1|||
126340132|NCT01687218|454540797|FG004|Overall Study|Withdrawal by Subject|1|||
126340133|NCT01687218|454540798|FG005|Overall Study|Withdrawal by Subject|0|||
126340134|NCT01687218|454540793|FG000|Overall Study|Relocated, no follow-up planned|1|||
126340135|NCT01687218|454540794|FG001|Overall Study|Relocated, no follow-up planned|0|||
126340136|NCT01687218|454540795|FG002|Overall Study|Relocated, no follow-up planned|1|||
126340137|NCT01687218|454540796|FG003|Overall Study|Relocated, no follow-up planned|1|||
126340138|NCT01687218|454540797|FG004|Overall Study|Relocated, no follow-up planned|0|||
126340139|NCT01687218|454540798|FG005|Overall Study|Relocated, no follow-up planned|0|||
126340140|NCT03139552|454540804|FG000|Overall Study|unable to attend tasting due to schedule|3|||
126340141|NCT03368807|454540813|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
126340142|NCT03368807|454540813|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
126340143|NCT03368807|454540813|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
126340144|NCT03368807|454540813|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
126340145|NCT01973218|454540814|FG000|Overall Study|Adverse Event|1|||
126340146|NCT01973218|454540815|FG001|Overall Study|Adverse Event|0|||
126340147|NCT01973218|454540814|FG000|Overall Study|Withdrawal by Subject|1|||
126340148|NCT01973218|454540815|FG001|Overall Study|Withdrawal by Subject|0|||
126340149|NCT03533751|454540816|FG000|Overall Study|Withdrawal by Subject|12|||
126340150|NCT03533751|454540817|FG001|Overall Study|Withdrawal by Subject|6|||
126340151|NCT03533751|454540818|FG002|Overall Study|Withdrawal by Subject|11|||
126340152|NCT03533751|454540819|FG003|Overall Study|Withdrawal by Subject|9|||
126340153|NCT03533751|454540820|FG004|Overall Study|Withdrawal by Subject|10|||
126340154|NCT03533751|454540816|FG000|Overall Study|Adverse Event|4|||
126340155|NCT03533751|454540817|FG001|Overall Study|Adverse Event|7|||
126340156|NCT03533751|454540818|FG002|Overall Study|Adverse Event|2|||
126340157|NCT03533751|454540819|FG003|Overall Study|Adverse Event|4|||
126340158|NCT03533751|454540820|FG004|Overall Study|Adverse Event|5|||
126340159|NCT03533751|454540816|FG000|Overall Study|Physician Decision|0|||
126340160|NCT03533751|454540817|FG001|Overall Study|Physician Decision|2|||
126340161|NCT03533751|454540818|FG002|Overall Study|Physician Decision|1|||
126340162|NCT03533751|454540819|FG003|Overall Study|Physician Decision|2|||
126340163|NCT03533751|454540820|FG004|Overall Study|Physician Decision|1|||
126340164|NCT03533751|454540816|FG000|Overall Study|Sponsor Decision|0|||
126340165|NCT03533751|454540817|FG001|Overall Study|Sponsor Decision|0|||
126340166|NCT03533751|454540818|FG002|Overall Study|Sponsor Decision|1|||
126340167|NCT03533751|454540819|FG003|Overall Study|Sponsor Decision|1|||
126340168|NCT03533751|454540820|FG004|Overall Study|Sponsor Decision|0|||
126340169|NCT03533751|454540816|FG000|Overall Study|Lost to Follow-up|3|||
126340170|NCT03533751|454540817|FG001|Overall Study|Lost to Follow-up|7|||
126340171|NCT03533751|454540818|FG002|Overall Study|Lost to Follow-up|6|||
126340172|NCT03533751|454540819|FG003|Overall Study|Lost to Follow-up|4|||
126340173|NCT03533751|454540820|FG004|Overall Study|Lost to Follow-up|3|||
126340174|NCT03533751|454540816|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
126340175|NCT03533751|454540817|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
126340176|NCT03533751|454540818|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
126340177|NCT03533751|454540819|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
126340178|NCT03533751|454540820|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
126340179|NCT03533751|454540816|FG000|Overall Study|Other|0|||
126340180|NCT03533751|454540817|FG001|Overall Study|Other|2|||
126340181|NCT03533751|454540818|FG002|Overall Study|Other|1|||
126340182|NCT03533751|454540819|FG003|Overall Study|Other|0|||
126424920|NCT03629886|454853769|FG001|Overall Study|Study vaccine not administrated|3|||
126424921|NCT03629886|454853768|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
126005617|NCT03425539|453312920|FG000|Overall Study|Adverse Event|2|||
126005618|NCT03425539|453312921|FG001|Overall Study|Adverse Event|2|||
126340183|NCT03533751|454540820|FG004|Overall Study|Other|3|||
126340184|NCT05117060|454540821|FG000|Overall Study|Adverse Event|3|||
126340185|NCT05117060|454540822|FG001|Overall Study|Adverse Event|5|||
126340186|NCT05117060|454540823|FG002|Overall Study|Adverse Event|6|||
126340187|NCT05117060|454540824|FG003|Overall Study|Adverse Event|1|||
126340188|NCT05117060|454540821|FG000|Overall Study|Lost to Follow-up|0|||
126340189|NCT05117060|454540822|FG001|Overall Study|Lost to Follow-up|0|||
126340190|NCT05117060|454540823|FG002|Overall Study|Lost to Follow-up|0|||
126424922|NCT03629886|454853769|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
126424923|NCT03629886|454853768|FG000|Overall Study|Refused vaccination step of the study|0|||
126424924|NCT03629886|454853769|FG001|Overall Study|Refused vaccination step of the study|44|||
126424925|NCT00404651|454853770|FG000|Overall Study|Serious Adverse Event|0|||
126424926|NCT00404651|454853771|FG001|Overall Study|Serious Adverse Event|0|||
126424927|NCT00404651|454853772|FG002|Overall Study|Serious Adverse Event|2|||
126424928|NCT00404651|454853773|FG003|Overall Study|Serious Adverse Event|0|||
126424929|NCT00404651|454853770|FG000|Overall Study|Protocol Violation|10|||
126424930|NCT00404651|454853771|FG001|Overall Study|Protocol Violation|5|||
126424931|NCT00404651|454853772|FG002|Overall Study|Protocol Violation|14|||
126424932|NCT00404651|454853773|FG003|Overall Study|Protocol Violation|5|||
126424933|NCT00404651|454853770|FG000|Overall Study|Lost to Follow-up|15|||
126424934|NCT00404651|454853771|FG001|Overall Study|Lost to Follow-up|11|||
126424935|NCT00404651|454853772|FG002|Overall Study|Lost to Follow-up|13|||
126424936|NCT00404651|454853773|FG003|Overall Study|Lost to Follow-up|10|||
126424937|NCT00404651|454853770|FG000|Overall Study|Withdrawal by Subject|14|||
126424938|NCT00404651|454853771|FG001|Overall Study|Withdrawal by Subject|12|||
126424939|NCT00404651|454853772|FG002|Overall Study|Withdrawal by Subject|16|||
126424940|NCT00404651|454853773|FG003|Overall Study|Withdrawal by Subject|6|||
126424941|NCT01702844|454853788|FG000|Overall Study|Adverse Event|9|||
126424942|NCT01702844|454853788|FG000|Overall Study|Death|1|||
126424943|NCT01702844|454853788|FG000|Overall Study|Withdrawal by Subject|3|||
126424944|NCT01702844|454853788|FG000|Overall Study|Physician Decision|6|||
126424945|NCT02123134|454853789|FG000|Overall Study|Withdrawal of consent|3|||
126424946|NCT02123134|454853790|FG001|Overall Study|Withdrawal of consent|2|||
126424947|NCT02123134|454853789|FG000|Overall Study|Administrative decision|0|||
126424948|NCT02123134|454853790|FG001|Overall Study|Administrative decision|1|||
126424949|NCT03431441|454853791|FG000|Overall Study|Withdrawal by Subject|2|||
126424950|NCT03431441|454853791|FG000|Overall Study|Adverse Event|2|||
126424951|NCT03431441|454853791|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
126424952|NCT00346216|454853792|FG000|Overall Study|Other|181|||
126424953|NCT00346216|454853793|FG001|Overall Study|Other|231|||
126424954|NCT00346216|454853794|FG002|Overall Study|Other|205|||
126424955|NCT00346216|454853792|FG000|Overall Study|No longer willing to participate|600|||
126424956|NCT00346216|454853793|FG001|Overall Study|No longer willing to participate|606|||
126424957|NCT00346216|454853794|FG002|Overall Study|No longer willing to participate|585|||
126424958|NCT00346216|454853792|FG000|Overall Study|Withdrawal by Subject|661|||
126424959|NCT00346216|454853793|FG001|Overall Study|Withdrawal by Subject|692|||
126424960|NCT00346216|454853794|FG002|Overall Study|Withdrawal by Subject|651|||
126424961|NCT00346216|454853792|FG000|Overall Study|Lost to Follow-up|611|||
126424962|NCT00346216|454853793|FG001|Overall Study|Lost to Follow-up|588|||
126424963|NCT00346216|454853794|FG002|Overall Study|Lost to Follow-up|542|||
126424964|NCT00346216|454853792|FG000|Overall Study|Physician Decision|80|||
126424965|NCT00346216|454853793|FG001|Overall Study|Physician Decision|76|||
126424966|NCT00346216|454853794|FG002|Overall Study|Physician Decision|59|||
126424967|NCT00346216|454853792|FG000|Overall Study|Does not meet entrance criteria|13|||
126424968|NCT00346216|454853793|FG001|Overall Study|Does not meet entrance criteria|10|||
126424969|NCT00346216|454853794|FG002|Overall Study|Does not meet entrance criteria|8|||
126424970|NCT00346216|454853792|FG000|Overall Study|Death|189|||
126424971|NCT00346216|454853793|FG001|Overall Study|Death|192|||
126424972|NCT00346216|454853794|FG002|Overall Study|Death|228|||
126424973|NCT00346216|454853792|FG000|Overall Study|Study terminated by sponsor|11|||
126424974|NCT00346216|454853793|FG001|Overall Study|Study terminated by sponsor|4|||
126424975|NCT00346216|454853794|FG002|Overall Study|Study terminated by sponsor|8|||
126424976|NCT00346216|454853792|FG000|Overall Study|Missing Subject Summary Status|62|||
126424977|NCT00346216|454853793|FG001|Overall Study|Missing Subject Summary Status|61|||
126424978|NCT00346216|454853794|FG002|Overall Study|Missing Subject Summary Status|62|||
126424979|NCT02648204|454853805|FG000|Overall Study|Withdrawal by Subject|12|||
126424980|NCT02648204|454853806|FG001|Overall Study|Withdrawal by Subject|8|||
126424981|NCT02648204|454853807|FG002|Overall Study|Withdrawal by Subject|2|||
126424982|NCT02648204|454853808|FG003|Overall Study|Withdrawal by Subject|6|||
126424983|NCT02648204|454853805|FG000|Overall Study|Lost to Follow-up|5|||
126424984|NCT02648204|454853806|FG001|Overall Study|Lost to Follow-up|8|||
126424985|NCT02648204|454853807|FG002|Overall Study|Lost to Follow-up|4|||
126424986|NCT02648204|454853808|FG003|Overall Study|Lost to Follow-up|6|||
126005619|NCT03425539|453312920|FG000|Overall Study|Withdrawal by Subject|3|||
126424987|NCT02648204|454853805|FG000|Overall Study|Missing follow-up information|4|||
126424988|NCT02648204|454853806|FG001|Overall Study|Missing follow-up information|4|||
126424989|NCT02648204|454853807|FG002|Overall Study|Missing follow-up information|4|||
126424990|NCT02648204|454853808|FG003|Overall Study|Missing follow-up information|2|||
126424991|NCT02648204|454853805|FG000|Overall Study|Death|1|||
126424992|NCT02648204|454853806|FG001|Overall Study|Death|1|||
126424993|NCT02648204|454853807|FG002|Overall Study|Death|2|||
126424994|NCT02648204|454853808|FG003|Overall Study|Death|2|||
126424995|NCT02648204|454853805|FG000|Overall Study|Adverse Event|0|||
126424996|NCT02648204|454853806|FG001|Overall Study|Adverse Event|0|||
126424997|NCT02648204|454853807|FG002|Overall Study|Adverse Event|1|||
126005620|NCT03425539|453312921|FG001|Overall Study|Withdrawal by Subject|0|||
126005621|NCT03425539|453312920|FG000|Overall Study|Lost to Follow-up|0|||
126005622|NCT03425539|453312921|FG001|Overall Study|Lost to Follow-up|1|||
126005623|NCT02014558|453312922|FG000|Overall Study|Never Received Study Drug|0|||
126005624|NCT02014558|453312923|FG001|Overall Study|Never Received Study Drug|0|||
126005625|NCT02014558|453312924|FG002|Overall Study|Never Received Study Drug|0|||
126005626|NCT02014558|453312925|FG003|Overall Study|Never Received Study Drug|0|||
126005627|NCT02014558|453312926|FG004|Overall Study|Never Received Study Drug|1|||
126005628|NCT02014558|453312927|FG005|Overall Study|Never Received Study Drug|0|||
126005629|NCT02014558|453312928|FG006|Overall Study|Never Received Study Drug|1|||
126005630|NCT02014558|453312929|FG007|Overall Study|Never Received Study Drug|0|||
126005631|NCT02014558|453312930|FG008|Overall Study|Never Received Study Drug|2|||
126005632|NCT02014558|453312931|FG009|Overall Study|Never Received Study Drug|0|||
126340191|NCT05117060|454540824|FG003|Overall Study|Lost to Follow-up|1|||
126340192|NCT05117060|454540821|FG000|Overall Study|Lack of Efficacy|4|||
126340193|NCT05117060|454540822|FG001|Overall Study|Lack of Efficacy|5|||
126340194|NCT05117060|454540823|FG002|Overall Study|Lack of Efficacy|2|||
126340195|NCT05117060|454540824|FG003|Overall Study|Lack of Efficacy|6|||
126340196|NCT05117060|454540821|FG000|Overall Study|Withdrawal by Subject|8|||
126340197|NCT05117060|454540822|FG001|Overall Study|Withdrawal by Subject|5|||
126340198|NCT05117060|454540823|FG002|Overall Study|Withdrawal by Subject|5|||
126340199|NCT05117060|454540824|FG003|Overall Study|Withdrawal by Subject|6|||
126340200|NCT05117060|454540821|FG000|Overall Study|Other|2|||
126340201|NCT05117060|454540822|FG001|Overall Study|Other|1|||
126340202|NCT05117060|454540823|FG002|Overall Study|Other|3|||
126340203|NCT05117060|454540824|FG003|Overall Study|Other|1|||
126340204|NCT00368251|454542189|FG000|Overall Study|SAE, non-fatal|1|||
126340205|NCT00368251|454542190|FG001|Overall Study|SAE, non-fatal|0|||
126340206|NCT00368251|454542191|FG002|Overall Study|SAE, non-fatal|0|||
126340207|NCT00368251|454542189|FG000|Overall Study|AE, non-serious non-fatal|0|||
126340208|NCT00368251|454542190|FG001|Overall Study|AE, non-serious non-fatal|0|||
126340209|NCT00368251|454542191|FG002|Overall Study|AE, non-serious non-fatal|1|||
126340210|NCT00607893|454542193|FG000|Overall Study|Lost to Follow-up|4|||
126340211|NCT00607893|454542194|FG001|Overall Study|Lost to Follow-up|0|||
126340212|NCT00607893|454542193|FG000|Overall Study|withdrew due to loss of interest|0|||
126340213|NCT00607893|454542194|FG001|Overall Study|withdrew due to loss of interest|1|||
126340214|NCT00607893|454542193|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
126340215|NCT00607893|454542194|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
126340216|NCT00607893|454542193|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
126340217|NCT00607893|454542194|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
126340218|NCT00607893|454542193|FG000|Overall Study|Declined to be treated|1|||
126340219|NCT00607893|454542194|FG001|Overall Study|Declined to be treated|0|||
126340220|NCT00607893|454542193|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
126340221|NCT00607893|454542194|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
126340222|NCT02669849|454542195|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126340223|NCT02669849|454542196|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126340224|NCT02669849|454542197|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
126340225|NCT02669849|454542195|FG000|Overall Study|Lost to Follow-up|1|||
126340226|NCT02669849|454542196|FG001|Overall Study|Lost to Follow-up|0|||
126340227|NCT02669849|454542197|FG002|Overall Study|Lost to Follow-up|3|||
126340228|NCT02669849|454542195|FG000|Overall Study|Death|1|||
126340229|NCT02669849|454542196|FG001|Overall Study|Death|1|||
126340230|NCT02669849|454542197|FG002|Overall Study|Death|2|||
126340231|NCT02669849|454542195|FG000|Overall Study|Study terminated by sponsor|16|||
126340232|NCT02669849|454542196|FG001|Overall Study|Study terminated by sponsor|1|||
126340233|NCT02669849|454542197|FG002|Overall Study|Study terminated by sponsor|14|||
126340234|NCT02669849|454542195|FG000|Overall Study|Other|0|||
126340235|NCT02669849|454542196|FG001|Overall Study|Other|0|||
126340236|NCT02669849|454542197|FG002|Overall Study|Other|2|||
126340237|NCT04745351|454542200|FG000|Overall Study|Death|51|||
126340238|NCT04745351|454542201|FG001|Overall Study|Death|25|||
126005633|NCT02014558|453312932|FG010|Overall Study|Never Received Study Drug|2|||
126005634|NCT02014558|453312933|FG011|Overall Study|Never Received Study Drug|2|||
126005635|NCT02014558|453312934|FG012|Overall Study|Never Received Study Drug|0|||
126005636|NCT02014558|453312922|FG000|Overall Study|Adverse Event|0|||
126005637|NCT02014558|453312923|FG001|Overall Study|Adverse Event|0|||
126340239|NCT04745351|454542200|FG000|Overall Study|Lost to Follow-up|9|||
126340240|NCT04745351|454542201|FG001|Overall Study|Lost to Follow-up|3|||
126340241|NCT04745351|454542200|FG000|Overall Study|Randomized but Never Treated|3|||
126340242|NCT04745351|454542201|FG001|Overall Study|Randomized but Never Treated|3|||
126340243|NCT04745351|454542200|FG000|Overall Study|Adverse Event|4|||
126340244|NCT04745351|454542201|FG001|Overall Study|Adverse Event|0|||
126340245|NCT04745351|454542200|FG000|Overall Study|Withdrew Consent|1|||
126340246|NCT04745351|454542201|FG001|Overall Study|Withdrew Consent|2|||
126005638|NCT02014558|453312924|FG002|Overall Study|Adverse Event|0|||
126340247|NCT04745351|454542200|FG000|Overall Study|Investigator's Discretion|2|||
126340248|NCT04745351|454542201|FG001|Overall Study|Investigator's Discretion|0|||
126005639|NCT02014558|453312925|FG003|Overall Study|Adverse Event|0|||
126005640|NCT02014558|453312926|FG004|Overall Study|Adverse Event|1|||
126005641|NCT02014558|453312927|FG005|Overall Study|Adverse Event|0|||
126005642|NCT02014558|453312928|FG006|Overall Study|Adverse Event|0|||
126005643|NCT02014558|453312929|FG007|Overall Study|Adverse Event|0|||
126005644|NCT02014558|453312930|FG008|Overall Study|Adverse Event|2|||
126005645|NCT02014558|453312931|FG009|Overall Study|Adverse Event|2|||
126005646|NCT02014558|453312932|FG010|Overall Study|Adverse Event|5|||
126005647|NCT02014558|453312933|FG011|Overall Study|Adverse Event|21|||
126005648|NCT02014558|453312934|FG012|Overall Study|Adverse Event|3|||
126005649|NCT02014558|453312922|FG000|Overall Study|Death|1|||
126005650|NCT02014558|453312923|FG001|Overall Study|Death|0|||
126005651|NCT02014558|453312924|FG002|Overall Study|Death|0|||
126005652|NCT02014558|453312925|FG003|Overall Study|Death|0|||
126005653|NCT02014558|453312926|FG004|Overall Study|Death|0|||
126005654|NCT02014558|453312927|FG005|Overall Study|Death|0|||
126005655|NCT02014558|453312928|FG006|Overall Study|Death|1|||
126005656|NCT02014558|453312929|FG007|Overall Study|Death|1|||
126005657|NCT02014558|453312930|FG008|Overall Study|Death|2|||
126005658|NCT02014558|453312931|FG009|Overall Study|Death|5|||
126005659|NCT02014558|453312932|FG010|Overall Study|Death|5|||
126424998|NCT02648204|454853808|FG003|Overall Study|Adverse Event|0|||
126424999|NCT01220167|454853809|FG000|Period 3|Urine positive for substance abuse|0|||
126425000|NCT01220167|454853810|FG001|Period 3|Urine positive for substance abuse|1|||
126425001|NCT01220167|454853811|FG002|Period 3|Urine positive for substance abuse|0|||
126425002|NCT05789745|454853817|FG000|Overall Study|Withdrawal by Subject|0|||
126425003|NCT05789745|454853818|FG001|Overall Study|Withdrawal by Subject|0|||
126425004|NCT05789745|454853819|FG002|Overall Study|Withdrawal by Subject|0|||
126425005|NCT05789745|454853820|FG003|Overall Study|Withdrawal by Subject|0|||
126425006|NCT05789745|454853821|FG004|Overall Study|Withdrawal by Subject|1|||
126005660|NCT02014558|453312933|FG011|Overall Study|Death|19|||
126005661|NCT02014558|453312934|FG012|Overall Study|Death|2|||
126005662|NCT02014558|453312922|FG000|Overall Study|Lack of Efficacy|1|||
126005663|NCT02014558|453312923|FG001|Overall Study|Lack of Efficacy|2|||
126005664|NCT02014558|453312924|FG002|Overall Study|Lack of Efficacy|1|||
126005665|NCT02014558|453312925|FG003|Overall Study|Lack of Efficacy|1|||
126425007|NCT00619515|454853822|FG000|Overall Study|Study Termination by IRB|73|||
126425008|NCT04862065|454853828|FG000|Screening|Protocol Violation|54|||
126425009|NCT04862065|454853829|FG001|Screening|Protocol Violation|0|||
126425010|NCT04862065|454853830|FG002|Screening|Protocol Violation|0|||
126425011|NCT04862065|454853828|FG000|Screening|Insufficient Sample|1|||
126425012|NCT04862065|454853829|FG001|Screening|Insufficient Sample|0|||
126425013|NCT04862065|454853830|FG002|Screening|Insufficient Sample|0|||
126425014|NCT04862065|454853828|FG000|Follow-Up|Lost to Follow-up|3|||
126425015|NCT04862065|454853829|FG001|Follow-Up|Lost to Follow-up|0|||
126425016|NCT04862065|454853830|FG002|Follow-Up|Lost to Follow-up|0|||
126425017|NCT02634333|454853831|FG000|Overall Study|Completed out of Window|3|||
126425018|NCT02634333|454853832|FG001|Overall Study|Completed out of Window|2|||
126425019|NCT02634333|454853831|FG000|Overall Study|Missed Visit|5|||
126425020|NCT02634333|454853832|FG001|Overall Study|Missed Visit|2|||
126425021|NCT02634333|454853831|FG000|Overall Study|Lost to Follow-up|12|||
126425022|NCT02634333|454853832|FG001|Overall Study|Lost to Follow-up|7|||
126425023|NCT02634333|454853831|FG000|Overall Study|Withdrawal by Subject|9|||
126425024|NCT02634333|454853832|FG001|Overall Study|Withdrawal by Subject|13|||
126425025|NCT02634333|454853831|FG000|Overall Study|Death|11|||
126425026|NCT02634333|454853832|FG001|Overall Study|Death|8|||
126425027|NCT03001557|454853835|FG000|Core Phase|Randomized but not treated|0|||
126425028|NCT03001557|454853836|FG001|Core Phase|Randomized but not treated|0|||
126425029|NCT03001557|454853837|FG002|Core Phase|Randomized but not treated|1|||
126425030|NCT03001557|454853838|FG003|Core Phase|Randomized but not treated|0|||
126425031|NCT03001557|454853839|FG004|Core Phase|Randomized but not treated|0|||
126425032|NCT03001557|454853840|FG005|Core Phase|Randomized but not treated|0|||
126425033|NCT03001557|454853841|FG006|Core Phase|Randomized but not treated|0|||
126425034|NCT03001557|454853842|FG007|Core Phase|Randomized but not treated|0|||
126005666|NCT02014558|453312926|FG004|Overall Study|Lack of Efficacy|0|||
126005667|NCT02014558|453312927|FG005|Overall Study|Lack of Efficacy|0|||
126425035|NCT03001557|454853835|FG000|Extension Phase|Adverse Event|0|||
126425036|NCT03001557|454853836|FG001|Extension Phase|Adverse Event|0|||
126005668|NCT02014558|453312928|FG006|Overall Study|Lack of Efficacy|1|||
126425037|NCT03001557|454853837|FG002|Extension Phase|Adverse Event|0|||
126425038|NCT03001557|454853838|FG003|Extension Phase|Adverse Event|0|||
126425039|NCT03001557|454853839|FG004|Extension Phase|Adverse Event|0|||
126005669|NCT02014558|453312929|FG007|Overall Study|Lack of Efficacy|3|||
126005670|NCT02014558|453312930|FG008|Overall Study|Lack of Efficacy|3|||
126425040|NCT03001557|454853840|FG005|Extension Phase|Adverse Event|2|||
126425041|NCT03001557|454853841|FG006|Extension Phase|Adverse Event|0|||
126005671|NCT02014558|453312931|FG009|Overall Study|Lack of Efficacy|3|||
126005672|NCT02014558|453312932|FG010|Overall Study|Lack of Efficacy|16|||
126005673|NCT02014558|453312933|FG011|Overall Study|Lack of Efficacy|8|||
126005674|NCT02014558|453312934|FG012|Overall Study|Lack of Efficacy|5|||
126005675|NCT02014558|453312922|FG000|Overall Study|Lost to Follow-up|0|||
126005676|NCT02014558|453312923|FG001|Overall Study|Lost to Follow-up|0|||
126005677|NCT02014558|453312924|FG002|Overall Study|Lost to Follow-up|0|||
126005678|NCT02014558|453312925|FG003|Overall Study|Lost to Follow-up|0|||
126005679|NCT02014558|453312926|FG004|Overall Study|Lost to Follow-up|0|||
126005680|NCT02014558|453312927|FG005|Overall Study|Lost to Follow-up|0|||
126005681|NCT02014558|453312928|FG006|Overall Study|Lost to Follow-up|0|||
126005682|NCT02014558|453312929|FG007|Overall Study|Lost to Follow-up|0|||
126005683|NCT02014558|453312930|FG008|Overall Study|Lost to Follow-up|0|||
126005684|NCT02014558|453312931|FG009|Overall Study|Lost to Follow-up|0|||
126005685|NCT02014558|453312932|FG010|Overall Study|Lost to Follow-up|1|||
126005686|NCT02014558|453312933|FG011|Overall Study|Lost to Follow-up|0|||
126005687|NCT02014558|453312934|FG012|Overall Study|Lost to Follow-up|0|||
126005688|NCT02014558|453312922|FG000|Overall Study|Progressive Disease|1|||
126340249|NCT04745351|454542200|FG000|Overall Study|Protocol Violation|1|||
126340250|NCT04745351|454542201|FG001|Overall Study|Protocol Violation|0|||
126340251|NCT03499795|454542207|FG000|Overall Study|Adverse Event|1|||
126340252|NCT03499795|454542207|FG000|Overall Study|Lost to Follow-up|1|||
126340253|NCT03636256|454542210|FG000|Overall Study|Lost to Follow-up|3|||
126340254|NCT03636256|454542211|FG001|Overall Study|Lost to Follow-up|0|||
126340255|NCT03636256|454542212|FG002|Overall Study|Lost to Follow-up|2|||
126340256|NCT03636256|454542213|FG003|Overall Study|Lost to Follow-up|1|||
126340257|NCT03636256|454542214|FG004|Overall Study|Lost to Follow-up|0|||
126340258|NCT03636256|454542215|FG005|Overall Study|Lost to Follow-up|4|||
126340259|NCT03636256|454542216|FG006|Overall Study|Lost to Follow-up|2|||
126340260|NCT03636256|454542217|FG007|Overall Study|Lost to Follow-up|0|||
126340261|NCT03636256|454542218|FG008|Overall Study|Lost to Follow-up|4|||
126340262|NCT03636256|454542210|FG000|Overall Study|Withdrawal by Subject|0|||
126340263|NCT03636256|454542211|FG001|Overall Study|Withdrawal by Subject|0|||
126340264|NCT03636256|454542212|FG002|Overall Study|Withdrawal by Subject|0|||
126340265|NCT03636256|454542213|FG003|Overall Study|Withdrawal by Subject|0|||
126340266|NCT03636256|454542214|FG004|Overall Study|Withdrawal by Subject|0|||
126340267|NCT03636256|454542215|FG005|Overall Study|Withdrawal by Subject|0|||
126340268|NCT03636256|454542216|FG006|Overall Study|Withdrawal by Subject|0|||
126340269|NCT03636256|454542217|FG007|Overall Study|Withdrawal by Subject|0|||
126340270|NCT03636256|454542218|FG008|Overall Study|Withdrawal by Subject|1|||
126340271|NCT01516216|454542221|FG000|Overall Study|Adverse Event|2|||
126340272|NCT01516216|454542222|FG001|Overall Study|Adverse Event|4|||
126340273|NCT01516216|454542221|FG000|Overall Study|Disease Progression|38|||
126340274|NCT01516216|454542222|FG001|Overall Study|Disease Progression|34|||
126340275|NCT01516216|454542221|FG000|Overall Study|Withdrawal by Subject|9|||
126340276|NCT01516216|454542222|FG001|Overall Study|Withdrawal by Subject|11|||
126340277|NCT01516216|454542221|FG000|Overall Study|Potentially Curative Resection|6|||
126340278|NCT01516216|454542222|FG001|Overall Study|Potentially Curative Resection|12|||
126340279|NCT01516216|454542221|FG000|Overall Study|Nonadherence|2|||
126340280|NCT01516216|454542222|FG001|Overall Study|Nonadherence|3|||
126340281|NCT01516216|454542221|FG000|Overall Study|Physician Decision|6|||
126340282|NCT01516216|454542222|FG001|Overall Study|Physician Decision|3|||
126340283|NCT01516216|454542221|FG000|Overall Study|Prolonged Treatment Delay|5|||
126340284|NCT01516216|454542222|FG001|Overall Study|Prolonged Treatment Delay|1|||
126340285|NCT01516216|454542221|FG000|Overall Study|Intercurrent Illness|1|||
126340286|NCT01516216|454542222|FG001|Overall Study|Intercurrent Illness|0|||
126340287|NCT01516216|454542221|FG000|Overall Study|Death|1|||
126340288|NCT01516216|454542222|FG001|Overall Study|Death|1|||
126340289|NCT01603602|454542225|FG000|Overall Study|Adverse Event|1|||
126340290|NCT01603602|454542226|FG001|Overall Study|Adverse Event|0|||
126340291|NCT01603602|454542227|FG002|Overall Study|Adverse Event|0|||
126340292|NCT01603602|454542225|FG000|Overall Study|Personal Reasons|1|||
126340293|NCT01603602|454542226|FG001|Overall Study|Personal Reasons|0|||
126340294|NCT01603602|454542227|FG002|Overall Study|Personal Reasons|1|||
126340295|NCT04748718|454542231|FG000|Overall Study|Lost to Follow-up|50|||
126340296|NCT01065818|454542232|FG000|Overall Study|Withdrawal by Subject|1|||
126340297|NCT01065818|454542232|FG000|Overall Study|Not a candidate for surgery|1|||
126340298|NCT01935089|454542233|FG000|Overall Study|Adverse Event|2|||
126340299|NCT01935089|454542233|FG000|Overall Study|Withdrawal by Subject|1|||
126005689|NCT02014558|453312923|FG001|Overall Study|Progressive Disease|0|||
126340300|NCT02337491|454542237|FG000|Overall Study|Death|1|||
126340301|NCT02337491|454542238|FG001|Overall Study|Death|1|||
126340302|NCT02337491|454542237|FG000|Overall Study|Adverse Event|0|||
126340303|NCT02337491|454542238|FG001|Overall Study|Adverse Event|1|||
126340304|NCT02337491|454542237|FG000|Overall Study|Withdrawal by Subject|3|||
126340305|NCT02337491|454542238|FG001|Overall Study|Withdrawal by Subject|0|||
126340306|NCT02337491|454542237|FG000|Overall Study|Progressive Disease|44|||
126340307|NCT02337491|454542238|FG001|Overall Study|Progressive Disease|28|||
126340308|NCT02337491|454542237|FG000|Overall Study|On Treatment|2|||
126340309|NCT02337491|454542238|FG001|Overall Study|On Treatment|0|||
126340310|NCT00723229|454542239|FG000|First Intervention|Lost to Follow-up|7|||
126340311|NCT00723229|454542240|FG001|First Intervention|Lost to Follow-up|3|||
126340312|NCT01079780|454542244|FG000|Overall Study|Disease progression|43|||
126005690|NCT02014558|453312924|FG002|Overall Study|Progressive Disease|1|||
126005691|NCT02014558|453312925|FG003|Overall Study|Progressive Disease|1|||
126005692|NCT02014558|453312926|FG004|Overall Study|Progressive Disease|1|||
126005693|NCT02014558|453312927|FG005|Overall Study|Progressive Disease|2|||
126005694|NCT02014558|453312928|FG006|Overall Study|Progressive Disease|1|||
126005695|NCT02014558|453312929|FG007|Overall Study|Progressive Disease|6|||
126005696|NCT02014558|453312930|FG008|Overall Study|Progressive Disease|5|||
126005697|NCT02014558|453312931|FG009|Overall Study|Progressive Disease|6|||
126005698|NCT02014558|453312932|FG010|Overall Study|Progressive Disease|22|||
126005699|NCT02014558|453312933|FG011|Overall Study|Progressive Disease|31|||
126005700|NCT02014558|453312934|FG012|Overall Study|Progressive Disease|6|||
126005701|NCT02014558|453312922|FG000|Overall Study|Withdrawal by Subject|0|||
126005702|NCT02014558|453312923|FG001|Overall Study|Withdrawal by Subject|0|||
126005703|NCT02014558|453312924|FG002|Overall Study|Withdrawal by Subject|0|||
126005704|NCT02014558|453312925|FG003|Overall Study|Withdrawal by Subject|0|||
126005705|NCT02014558|453312926|FG004|Overall Study|Withdrawal by Subject|1|||
126005706|NCT02014558|453312927|FG005|Overall Study|Withdrawal by Subject|0|||
126005707|NCT02014558|453312928|FG006|Overall Study|Withdrawal by Subject|0|||
126005708|NCT02014558|453312929|FG007|Overall Study|Withdrawal by Subject|0|||
126005709|NCT02014558|453312930|FG008|Overall Study|Withdrawal by Subject|0|||
126005710|NCT02014558|453312931|FG009|Overall Study|Withdrawal by Subject|2|||
126005711|NCT02014558|453312932|FG010|Overall Study|Withdrawal by Subject|6|||
126005712|NCT02014558|453312933|FG011|Overall Study|Withdrawal by Subject|10|||
126005713|NCT02014558|453312934|FG012|Overall Study|Withdrawal by Subject|0|||
126005714|NCT02014558|453312922|FG000|Overall Study|Miscellaneous|2|||
126005715|NCT02014558|453312923|FG001|Overall Study|Miscellaneous|1|||
126005716|NCT02014558|453312924|FG002|Overall Study|Miscellaneous|1|||
126005717|NCT02014558|453312925|FG003|Overall Study|Miscellaneous|1|||
126005718|NCT02014558|453312926|FG004|Overall Study|Miscellaneous|0|||
126005719|NCT02014558|453312927|FG005|Overall Study|Miscellaneous|1|||
126425042|NCT03001557|454853842|FG007|Extension Phase|Adverse Event|0|||
126425043|NCT03001557|454853835|FG000|Extension Phase|Withdrawal by Subject|0|||
126425044|NCT03001557|454853836|FG001|Extension Phase|Withdrawal by Subject|0|||
126425045|NCT03001557|454853837|FG002|Extension Phase|Withdrawal by Subject|0|||
126425046|NCT03001557|454853838|FG003|Extension Phase|Withdrawal by Subject|0|||
126425047|NCT03001557|454853839|FG004|Extension Phase|Withdrawal by Subject|0|||
126425048|NCT03001557|454853840|FG005|Extension Phase|Withdrawal by Subject|1|||
126425049|NCT03001557|454853841|FG006|Extension Phase|Withdrawal by Subject|5|||
126425050|NCT03001557|454853842|FG007|Extension Phase|Withdrawal by Subject|2|||
126425051|NCT03001557|454853835|FG000|Extension Phase|Lost to Follow-up|0|||
126425052|NCT03001557|454853836|FG001|Extension Phase|Lost to Follow-up|0|||
126425053|NCT03001557|454853837|FG002|Extension Phase|Lost to Follow-up|0|||
126425054|NCT03001557|454853838|FG003|Extension Phase|Lost to Follow-up|0|||
126425055|NCT03001557|454853839|FG004|Extension Phase|Lost to Follow-up|0|||
126425056|NCT03001557|454853840|FG005|Extension Phase|Lost to Follow-up|0|||
126425057|NCT03001557|454853841|FG006|Extension Phase|Lost to Follow-up|2|||
126425058|NCT03001557|454853842|FG007|Extension Phase|Lost to Follow-up|1|||
126425059|NCT03001557|454853835|FG000|Extension Phase|Administrative Reason|0|||
126425060|NCT03001557|454853836|FG001|Extension Phase|Administrative Reason|0|||
126425061|NCT03001557|454853837|FG002|Extension Phase|Administrative Reason|0|||
126425062|NCT03001557|454853838|FG003|Extension Phase|Administrative Reason|0|||
126425063|NCT03001557|454853839|FG004|Extension Phase|Administrative Reason|0|||
126425064|NCT03001557|454853840|FG005|Extension Phase|Administrative Reason|1|||
126425065|NCT03001557|454853841|FG006|Extension Phase|Administrative Reason|3|||
126425066|NCT03001557|454853842|FG007|Extension Phase|Administrative Reason|3|||
126425067|NCT03001557|454853835|FG000|Extension Phase|Loss of caregiver|0|||
126425068|NCT03001557|454853836|FG001|Extension Phase|Loss of caregiver|0|||
126425069|NCT03001557|454853837|FG002|Extension Phase|Loss of caregiver|0|||
126425070|NCT03001557|454853838|FG003|Extension Phase|Loss of caregiver|0|||
126425071|NCT03001557|454853839|FG004|Extension Phase|Loss of caregiver|0|||
126005720|NCT02014558|453312928|FG006|Overall Study|Miscellaneous|0|||
126005721|NCT02014558|453312929|FG007|Overall Study|Miscellaneous|1|||
126005722|NCT02014558|453312930|FG008|Overall Study|Miscellaneous|1|||
126005723|NCT02014558|453312931|FG009|Overall Study|Miscellaneous|3|||
126005724|NCT02014558|453312932|FG010|Overall Study|Miscellaneous|12|||
126005725|NCT02014558|453312933|FG011|Overall Study|Miscellaneous|11|||
126425072|NCT03001557|454853840|FG005|Extension Phase|Loss of caregiver|0|||
126425073|NCT03001557|454853841|FG006|Extension Phase|Loss of caregiver|1|||
126425074|NCT03001557|454853842|FG007|Extension Phase|Loss of caregiver|0|||
126425075|NCT03001557|454853835|FG000|Extension Phase|Others|0|||
126425076|NCT03001557|454853836|FG001|Extension Phase|Others|0|||
126425077|NCT03001557|454853837|FG002|Extension Phase|Others|0|||
126005726|NCT02014558|453312934|FG012|Overall Study|Miscellaneous|1|||
126209485|NCT03110107|454055416|FG023|Treatment Period|Death|0|||
126209486|NCT03110107|454055417|FG024|Treatment Period|Death|0|||
126005727|NCT04580407|453312935|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
126209487|NCT03110107|454055418|FG025|Treatment Period|Death|0|||
126425078|NCT03001557|454853838|FG003|Extension Phase|Others|0|||
126425079|NCT03001557|454853839|FG004|Extension Phase|Others|0|||
126005728|NCT05567159|453312940|FG000|Overall Study|Adverse Event|4|||
126425080|NCT03001557|454853840|FG005|Extension Phase|Others|1|||
126425081|NCT03001557|454853841|FG006|Extension Phase|Others|3|||
126425082|NCT03001557|454853842|FG007|Extension Phase|Others|0|||
126425083|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
126425084|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
126425085|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Death|1|||
126425086|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Death|2|||
126425087|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
126425088|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
126425089|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
126425090|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
126425091|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
126425092|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
126425093|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
126425094|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
126425095|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
126425096|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
126425097|NCT01794000|454853843|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
126425098|NCT01794000|454853844|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
126425099|NCT01960140|454853846|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
126425100|NCT01156480|454853847|FG000|Overall Study|change in diagnosis|0|||
126425101|NCT01156480|454853848|FG001|Overall Study|change in diagnosis|1|||
126425102|NCT05470387|454853849|FG000|Overall Study|Protocol Violation|0|||
126425103|NCT05470387|454853850|FG001|Overall Study|Protocol Violation|3|||
126425104|NCT01255423|454853851|FG000|Overall Study|Abnormal Laboratory value|3|||
126425105|NCT01255423|454853852|FG001|Overall Study|Abnormal Laboratory value|2|||
126425106|NCT01255423|454853851|FG000|Overall Study|Use of prohibited medications|0|||
126425107|NCT01255423|454853852|FG001|Overall Study|Use of prohibited medications|1|||
126425108|NCT00657046|454853853|FG000|Overall Study|Adverse Event|1|||
126425109|NCT00657046|454853854|FG001|Overall Study|Adverse Event|1|||
126425110|NCT00657046|454853855|FG002|Overall Study|Adverse Event|0|||
126425111|NCT00657046|454853853|FG000|Overall Study|Protocol Violation|2|||
126425112|NCT00657046|454853854|FG001|Overall Study|Protocol Violation|2|||
126425113|NCT00657046|454853855|FG002|Overall Study|Protocol Violation|0|||
126425114|NCT00657046|454853853|FG000|Overall Study|Withdrawal by Subject|1|||
126425115|NCT00657046|454853854|FG001|Overall Study|Withdrawal by Subject|0|||
126425116|NCT00657046|454853855|FG002|Overall Study|Withdrawal by Subject|0|||
126425117|NCT00657046|454853853|FG000|Overall Study|Death|0|||
126425118|NCT00657046|454853854|FG001|Overall Study|Death|0|||
126425119|NCT00657046|454853855|FG002|Overall Study|Death|1|||
126425120|NCT00657046|454853853|FG000|Overall Study|Surgery|0|||
126425121|NCT00657046|454853854|FG001|Overall Study|Surgery|0|||
126425122|NCT00657046|454853855|FG002|Overall Study|Surgery|1|||
126425123|NCT01176058|454853856|FG000|Overall Study|Adverse Event|1|||
126425124|NCT01176058|454853857|FG001|Overall Study|Adverse Event|0|||
126425125|NCT01176058|454853856|FG000|Overall Study|Insufficient clinical response|2|||
126425126|NCT01176058|454853857|FG001|Overall Study|Insufficient clinical response|2|||
126425127|NCT01176058|454853856|FG000|Overall Study|Insufficient mycological response|0|||
126425128|NCT01176058|454853857|FG001|Overall Study|Insufficient mycological response|1|||
126425129|NCT01176058|454853856|FG000|Overall Study|Withdrawal by Subject|1|||
126425130|NCT01176058|454853857|FG001|Overall Study|Withdrawal by Subject|0|||
126425131|NCT03480152|454853863|FG000|Phase I|Signed consent. Died before treatment.|1|||
126425132|NCT03480152|454853864|FG001|Phase I|Signed consent. Died before treatment.|0|||
126425133|NCT03480152|454853865|FG002|Phase I|Signed consent. Died before treatment.|0|||
126005729|NCT05567159|453312940|FG000|Overall Study|Physician Decision|3|||
126005730|NCT05567159|453312940|FG000|Overall Study|Protocol deviation|1|||
126005731|NCT00359619|453314699|FG000|Overall Study|Adverse Event|0|||
126005732|NCT00359619|453314700|FG001|Overall Study|Adverse Event|0|||
126005733|NCT00359619|453314701|FG002|Overall Study|Adverse Event|1|||
126005734|NCT00359619|453314702|FG003|Overall Study|Adverse Event|0|||
126005735|NCT00359619|453314703|FG004|Overall Study|Adverse Event|0|||
126005736|NCT00359619|453314704|FG005|Overall Study|Adverse Event|0|||
126005737|NCT00359619|453314705|FG006|Overall Study|Adverse Event|1|||
126005738|NCT00359619|453314699|FG000|Overall Study|Withdrawal by Subject|3|||
126425134|NCT04276233|454853866|FG000|Overall Study|Adverse Event|1|||
126425135|NCT04276233|454853866|FG000|Overall Study|Lost to Follow-up|3|||
126425136|NCT04276233|454853866|FG000|Overall Study|Physician Decision|4|||
126425137|NCT04276233|454853866|FG000|Overall Study|Withdrawal by Subject|2|||
126425138|NCT01946139|454853867|FG000|Overall Study|Withdrawal by Subject|8|||
126425139|NCT01946139|454853867|FG000|Overall Study|ineligible|8|||
126425140|NCT01946139|454853867|FG000|Overall Study|Specimens not available|4|||
126425141|NCT02525471|454853874|FG000|Overall Study|Screen Failure|6|||
126425142|NCT02525471|454853874|FG000|Overall Study|Withdrawal by Subject|4|||
126425143|NCT02525471|454853874|FG000|Overall Study|Death|1|||
126005739|NCT00359619|453314700|FG001|Overall Study|Withdrawal by Subject|1|||
126005740|NCT00359619|453314701|FG002|Overall Study|Withdrawal by Subject|4|||
126005741|NCT00359619|453314702|FG003|Overall Study|Withdrawal by Subject|2|||
126005742|NCT00359619|453314703|FG004|Overall Study|Withdrawal by Subject|2|||
126005743|NCT00359619|453314704|FG005|Overall Study|Withdrawal by Subject|0|||
126005744|NCT00359619|453314705|FG006|Overall Study|Withdrawal by Subject|3|||
126005745|NCT00359619|453314699|FG000|Overall Study|Other|1|||
126005746|NCT00359619|453314700|FG001|Overall Study|Other|0|||
126005747|NCT00359619|453314701|FG002|Overall Study|Other|0|||
126005748|NCT00359619|453314702|FG003|Overall Study|Other|0|||
126005749|NCT00359619|453314703|FG004|Overall Study|Other|0|||
126005750|NCT00359619|453314704|FG005|Overall Study|Other|0|||
126005751|NCT00359619|453314705|FG006|Overall Study|Other|0|||
126005752|NCT00359619|453314699|FG000|Overall Study|Lost to Follow-up|4|||
126005753|NCT00359619|453314700|FG001|Overall Study|Lost to Follow-up|4|||
126005754|NCT00359619|453314701|FG002|Overall Study|Lost to Follow-up|2|||
126005755|NCT00359619|453314702|FG003|Overall Study|Lost to Follow-up|1|||
126005756|NCT00359619|453314703|FG004|Overall Study|Lost to Follow-up|1|||
126425144|NCT03275740|454853875|FG000|Overall Study|Adverse Event|0|||
126425145|NCT03275740|454853876|FG001|Overall Study|Adverse Event|0|||
126425146|NCT03275740|454853877|FG002|Overall Study|Adverse Event|0|||
126425147|NCT03275740|454853878|FG003|Overall Study|Adverse Event|0|||
126425148|NCT03275740|454853879|FG004|Overall Study|Adverse Event|1|||
126425149|NCT03275740|454853880|FG005|Overall Study|Adverse Event|0|||
126425150|NCT03275740|454853881|FG006|Overall Study|Adverse Event|0|||
126425151|NCT03275740|454853882|FG007|Overall Study|Adverse Event|0|||
126425152|NCT03275740|454853883|FG008|Overall Study|Adverse Event|0|||
126425153|NCT03275740|454853884|FG009|Overall Study|Adverse Event|0|||
126425154|NCT03275740|454853885|FG010|Overall Study|Adverse Event|0|||
126425155|NCT03275740|454853886|FG011|Overall Study|Adverse Event|0|||
126425156|NCT03275740|454853875|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425157|NCT03275740|454853876|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425158|NCT03275740|454853877|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425159|NCT03275740|454853878|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425160|NCT03275740|454853879|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425161|NCT03275740|454853880|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
126425162|NCT03275740|454853881|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425163|NCT03275740|454853882|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425164|NCT03275740|454853883|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425165|NCT03275740|454853884|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425166|NCT03275740|454853885|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425167|NCT03275740|454853886|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425168|NCT03275740|454853875|FG000|Overall Study|Withdrawal by Subject|0|||
126425169|NCT03275740|454853876|FG001|Overall Study|Withdrawal by Subject|0|||
126425170|NCT03275740|454853877|FG002|Overall Study|Withdrawal by Subject|0|||
126425171|NCT03275740|454853878|FG003|Overall Study|Withdrawal by Subject|0|||
126425172|NCT03275740|454853879|FG004|Overall Study|Withdrawal by Subject|0|||
126425173|NCT03275740|454853880|FG005|Overall Study|Withdrawal by Subject|0|||
126425174|NCT03275740|454853881|FG006|Overall Study|Withdrawal by Subject|0|||
126425175|NCT03275740|454853882|FG007|Overall Study|Withdrawal by Subject|0|||
126425176|NCT03275740|454853883|FG008|Overall Study|Withdrawal by Subject|1|||
126425177|NCT03275740|454853884|FG009|Overall Study|Withdrawal by Subject|1|||
126425178|NCT03275740|454853885|FG010|Overall Study|Withdrawal by Subject|0|||
126425179|NCT03275740|454853886|FG011|Overall Study|Withdrawal by Subject|0|||
126425180|NCT00890825|454853887|FG000|Overall Study|Withdrawal by Subject|1|||
126425181|NCT00890825|454853888|FG001|Overall Study|Withdrawal by Subject|0|||
126425182|NCT00890825|454853887|FG000|Overall Study|Alive at data cut off (DCO)|13|||
126425183|NCT00890825|454853888|FG001|Overall Study|Alive at data cut off (DCO)|14|||
126425184|NCT02336607|454853890|FG000|Overall Study|Physician Decision|1|||
126425185|NCT02336607|454853891|FG001|Overall Study|Physician Decision|4|||
126425186|NCT02336607|454853892|FG002|Overall Study|Physician Decision|3|||
126425187|NCT02336607|454853893|FG003|Overall Study|Physician Decision|15|||
126425188|NCT02336607|454853890|FG000|Overall Study|Lack of Efficacy|1|||
126005757|NCT00359619|453314704|FG005|Overall Study|Lost to Follow-up|5|||
126005758|NCT00359619|453314705|FG006|Overall Study|Lost to Follow-up|0|||
126005759|NCT01419717|453314706|FG000|Overall Study|Protocol-specified Criteria|62|||
126425189|NCT02336607|454853891|FG001|Overall Study|Lack of Efficacy|0|||
126425190|NCT02336607|454853892|FG002|Overall Study|Lack of Efficacy|0|||
126425191|NCT02336607|454853893|FG003|Overall Study|Lack of Efficacy|2|||
126425192|NCT02336607|454853890|FG000|Overall Study|Lost to Follow-up|2|||
126425193|NCT02336607|454853891|FG001|Overall Study|Lost to Follow-up|1|||
126425194|NCT02336607|454853892|FG002|Overall Study|Lost to Follow-up|0|||
126425195|NCT02336607|454853893|FG003|Overall Study|Lost to Follow-up|21|||
126005760|NCT01419717|453314706|FG000|Overall Study|Adverse Event|19|||
126005761|NCT01419717|453314706|FG000|Overall Study|Death|17|||
126005762|NCT01419717|453314706|FG000|Overall Study|Withdrawal by Subject|10|||
126005763|NCT01419717|453314706|FG000|Overall Study|Disease Progression|9|||
126005764|NCT01419717|453314706|FG000|Overall Study|Other|4|||
126005765|NCT01419717|453314706|FG000|Overall Study|Lost to Follow-up|2|||
126005766|NCT01419717|453314706|FG000|Overall Study|Administrative Decision|1|||
126005767|NCT01419717|453314706|FG000|Overall Study|Noncompliance|1|||
126005768|NCT02857283|453314707|FG000|First Exposure|Withdrawal by Subject|1|||
126005769|NCT02857283|453314708|FG001|First Exposure|Withdrawal by Subject|0|||
126005770|NCT05074498|453314711|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126005771|NCT05074498|453314712|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126005772|NCT05074498|453314713|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126005773|NCT05074498|453314714|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
126005774|NCT05074498|453314715|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126005775|NCT05074498|453314716|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126005776|NCT05074498|453314711|FG000|Part 1 (Upto Day 104)|Other|1|||
126005777|NCT05074498|453314712|FG001|Part 1 (Upto Day 104)|Other|0|||
126005778|NCT05074498|453314713|FG002|Part 1 (Upto Day 104)|Other|0|||
126005779|NCT05074498|453314714|FG003|Part 1 (Upto Day 104)|Other|0|||
126005780|NCT05074498|453314715|FG004|Part 1 (Upto Day 104)|Other|0|||
126005781|NCT05074498|453314716|FG005|Part 1 (Upto Day 104)|Other|0|||
126005782|NCT05074498|453314711|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126005783|NCT05074498|453314712|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126425196|NCT02336607|454853890|FG000|Overall Study|Protocol Violation|0|||
126425197|NCT02336607|454853891|FG001|Overall Study|Protocol Violation|1|||
126425198|NCT02336607|454853892|FG002|Overall Study|Protocol Violation|1|||
126425199|NCT02336607|454853893|FG003|Overall Study|Protocol Violation|3|||
126425200|NCT02336607|454853890|FG000|Overall Study|Adverse Event|0|||
126425201|NCT02336607|454853891|FG001|Overall Study|Adverse Event|2|||
126425202|NCT02336607|454853892|FG002|Overall Study|Adverse Event|2|||
126425203|NCT02336607|454853893|FG003|Overall Study|Adverse Event|26|||
126425204|NCT02336607|454853890|FG000|Overall Study|Withdrawal by Subject|0|||
126425205|NCT02336607|454853891|FG001|Overall Study|Withdrawal by Subject|2|||
126425206|NCT02336607|454853892|FG002|Overall Study|Withdrawal by Subject|0|||
126425207|NCT02336607|454853893|FG003|Overall Study|Withdrawal by Subject|20|||
126425208|NCT02552966|454853896|FG000|Overall Study|Lost to Follow-up|2|||
126425209|NCT02552966|454853896|FG000|Overall Study|Withdrawal by Subject|3|||
126425210|NCT00614380|454853900|FG000|Overall Study|Adverse Event|14|||
126425211|NCT00614380|454853901|FG001|Overall Study|Adverse Event|4|||
126425212|NCT00614380|454853902|FG002|Overall Study|Adverse Event|0|||
126425213|NCT00614380|454853903|FG003|Overall Study|Adverse Event|0|||
126425214|NCT00614380|454853900|FG000|Overall Study|Lost to Follow-up|6|||
126425215|NCT00614380|454853901|FG001|Overall Study|Lost to Follow-up|1|||
126425216|NCT00614380|454853902|FG002|Overall Study|Lost to Follow-up|0|||
126425217|NCT00614380|454853903|FG003|Overall Study|Lost to Follow-up|0|||
126425218|NCT00614380|454853900|FG000|Overall Study|Non compliant with the protocol|12|||
126425219|NCT00614380|454853901|FG001|Overall Study|Non compliant with the protocol|2|||
126425220|NCT00614380|454853902|FG002|Overall Study|Non compliant with the protocol|1|||
126425221|NCT00614380|454853903|FG003|Overall Study|Non compliant with the protocol|2|||
126425222|NCT00614380|454853900|FG000|Overall Study|Consent withdrawn|3|||
126425223|NCT00614380|454853901|FG001|Overall Study|Consent withdrawn|1|||
126425224|NCT00614380|454853902|FG002|Overall Study|Consent withdrawn|0|||
126425225|NCT00614380|454853903|FG003|Overall Study|Consent withdrawn|0|||
126425226|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425227|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425228|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425229|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
126425230|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126005784|NCT05074498|453314713|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126005785|NCT05074498|453314714|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126005786|NCT05074498|453314715|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
126005787|NCT05074498|453314716|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126005788|NCT05074498|453314711|FG000|Part 2 (Upto Day 104)|Death|0|||
126005789|NCT05074498|453314712|FG001|Part 2 (Upto Day 104)|Death|0|||
126005790|NCT05074498|453314713|FG002|Part 2 (Upto Day 104)|Death|0|||
126005791|NCT05074498|453314714|FG003|Part 2 (Upto Day 104)|Death|0|||
126005792|NCT05074498|453314715|FG004|Part 2 (Upto Day 104)|Death|1|||
126005793|NCT05074498|453314716|FG005|Part 2 (Upto Day 104)|Death|0|||
126005794|NCT05074498|453314711|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
126005795|NCT05074498|453314712|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
126005796|NCT05074498|453314713|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
126005797|NCT05074498|453314714|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
126209488|NCT03110107|454055393|FG000|Treatment Period|Adverse Event|0|||
126425231|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425232|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126005798|NCT05074498|453314715|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
126005799|NCT05074498|453314716|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
126005800|NCT05074498|453314711|FG000|Part 2 (Upto Day 104)|Other|0|||
126005801|NCT05074498|453314712|FG001|Part 2 (Upto Day 104)|Other|0|||
126209489|NCT03110107|454055394|FG001|Treatment Period|Adverse Event|0|||
126005802|NCT05074498|453314713|FG002|Part 2 (Upto Day 104)|Other|0|||
126005803|NCT05074498|453314714|FG003|Part 2 (Upto Day 104)|Other|0|||
126005804|NCT05074498|453314715|FG004|Part 2 (Upto Day 104)|Other|1|||
126005805|NCT05074498|453314716|FG005|Part 2 (Upto Day 104)|Other|0|||
126005806|NCT01240356|453314717|FG000|Overall Study|Withdrawal by Subject|2|||
126005807|NCT01240356|453314718|FG001|Overall Study|Withdrawal by Subject|0|||
126005808|NCT01240356|453314717|FG000|Overall Study|MRI contraindication|1|||
126005809|NCT01240356|453314718|FG001|Overall Study|MRI contraindication|0|||
126005810|NCT03613129|453314720|FG000|Pre-treatment Assessment|Protocol Violation|2|||
126005811|NCT03613129|453314721|FG001|Pre-treatment Assessment|Protocol Violation|0|||
126005812|NCT03613129|453314722|FG002|Pre-treatment Assessment|Protocol Violation|0|||
126005813|NCT03613129|453314723|FG003|Pre-treatment Assessment|Protocol Violation|0|||
126005814|NCT03613129|453314724|FG004|Pre-treatment Assessment|Protocol Violation|0|||
126005815|NCT03613129|453314720|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
126005816|NCT03613129|453314721|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
126005817|NCT03613129|453314722|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
126005818|NCT03613129|453314723|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
126005819|NCT03613129|453314724|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
126005820|NCT02950545|453314729|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126005821|NCT02950545|453314730|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126005822|NCT02950545|453314731|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126005823|NCT02950545|453314732|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126005824|NCT02950545|453314733|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126005825|NCT02950545|453314734|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
126005826|NCT02950545|453314729|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
126005827|NCT02950545|453314730|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
126005828|NCT02950545|453314731|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
126005829|NCT02950545|453314732|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
126005830|NCT02950545|453314733|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
126005831|NCT02950545|453314734|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
126005832|NCT02950545|453314729|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126005833|NCT02950545|453314730|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126005834|NCT02950545|453314731|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126005835|NCT02950545|453314732|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126005836|NCT02950545|453314733|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
126005837|NCT02950545|453314734|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126005838|NCT02950545|453314729|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
126005839|NCT02950545|453314730|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126005840|NCT02950545|453314731|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126005841|NCT02950545|453314732|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126005842|NCT02950545|453314733|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126005843|NCT02950545|453314734|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126005844|NCT02950545|453314729|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126005845|NCT02950545|453314730|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126005846|NCT02950545|453314731|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126005847|NCT02950545|453314732|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126005848|NCT02950545|453314733|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126005849|NCT02950545|453314734|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
126005850|NCT01770860|453314735|FG000|Overall Study|Withdrawal by Subject|4|||
126005851|NCT01770860|453314735|FG000|Overall Study|Lost to Follow-up|1|||
126005852|NCT01770860|453314735|FG000|Overall Study|Administrative decision made by the PI|1|||
126005853|NCT03398356|453314738|FG000|Before Treatment|Lost to Follow-up|1|||
126005854|NCT03398356|453314739|FG001|Before Treatment|Lost to Follow-up|2|||
126005855|NCT03398356|453314740|FG002|Before Treatment|Lost to Follow-up|0|||
126005856|NCT03398356|453314738|FG000|Before Treatment|drug intolerance|2|||
126005857|NCT03398356|453314739|FG001|Before Treatment|drug intolerance|1|||
126005858|NCT03398356|453314740|FG002|Before Treatment|drug intolerance|0|||
126005859|NCT03398356|453314738|FG000|Before Treatment|Withdrawal by Subject|0|||
126005860|NCT03398356|453314739|FG001|Before Treatment|Withdrawal by Subject|5|||
126005861|NCT03398356|453314740|FG002|Before Treatment|Withdrawal by Subject|0|||
126005862|NCT03398356|453314738|FG000|Before Treatment|Physician Decision|0|||
126005863|NCT03398356|453314739|FG001|Before Treatment|Physician Decision|0|||
126005864|NCT03398356|453314740|FG002|Before Treatment|Physician Decision|11|||
126005865|NCT03398356|453314738|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
126005866|NCT03398356|453314739|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
126005867|NCT03398356|453314740|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
126005868|NCT01648283|453314743|FG000|Overall Study|Withdrawal by Subject|14|||
126005869|NCT00601640|453314749|FG000|Overall Study|Withdrawal by Subject|3|||
126005870|NCT00601640|453314750|FG001|Overall Study|Withdrawal by Subject|0|||
126005871|NCT00601640|453314751|FG002|Overall Study|Withdrawal by Subject|7|||
126005872|NCT00601640|453314749|FG000|Overall Study|Death|1|||
126005873|NCT00601640|453314750|FG001|Overall Study|Death|0|||
126005874|NCT00601640|453314751|FG002|Overall Study|Death|0|||
126005875|NCT00601640|453314749|FG000|Overall Study|Adverse Event|0|||
126340313|NCT01079780|454542245|FG001|Overall Study|Disease progression|7|||
126340314|NCT01079780|454542246|FG002|Overall Study|Disease progression|31|||
126340315|NCT01079780|454542244|FG000|Overall Study|Adverse Event|13|||
126340316|NCT01079780|454542245|FG001|Overall Study|Adverse Event|5|||
126340317|NCT01079780|454542246|FG002|Overall Study|Adverse Event|7|||
126340318|NCT01079780|454542244|FG000|Overall Study|Death|2|||
126340319|NCT01079780|454542245|FG001|Overall Study|Death|0|||
126340320|NCT01079780|454542246|FG002|Overall Study|Death|2|||
126340321|NCT01079780|454542244|FG000|Overall Study|Withdrawal by Subject|6|||
126340322|NCT01079780|454542245|FG001|Overall Study|Withdrawal by Subject|4|||
126340323|NCT01079780|454542246|FG002|Overall Study|Withdrawal by Subject|4|||
126340324|NCT01079780|454542244|FG000|Overall Study|Alternative therapy|2|||
126340325|NCT01079780|454542245|FG001|Overall Study|Alternative therapy|0|||
126340326|NCT01079780|454542246|FG002|Overall Study|Alternative therapy|2|||
126340327|NCT01079780|454542244|FG000|Overall Study|Physician Decision|1|||
126340328|NCT01079780|454542245|FG001|Overall Study|Physician Decision|0|||
126340329|NCT01079780|454542246|FG002|Overall Study|Physician Decision|1|||
126340330|NCT01079780|454542244|FG000|Overall Study|Error made in lesion measurement|1|||
126340331|NCT01079780|454542245|FG001|Overall Study|Error made in lesion measurement|0|||
126340332|NCT01079780|454542246|FG002|Overall Study|Error made in lesion measurement|0|||
126340333|NCT01079780|454542244|FG000|Overall Study|Patient had surgery|1|||
126340334|NCT01079780|454542245|FG001|Overall Study|Patient had surgery|0|||
126340335|NCT01079780|454542246|FG002|Overall Study|Patient had surgery|0|||
126340336|NCT01079780|454542244|FG000|Overall Study|Treatment cycle delay|0|||
126340337|NCT01079780|454542245|FG001|Overall Study|Treatment cycle delay|0|||
126340338|NCT01079780|454542246|FG002|Overall Study|Treatment cycle delay|1|||
126340339|NCT01079780|454542244|FG000|Overall Study|Never started treatment|1|||
126340340|NCT01079780|454542245|FG001|Overall Study|Never started treatment|0|||
126340341|NCT01079780|454542246|FG002|Overall Study|Never started treatment|2|||
126340342|NCT03530293|454542254|FG000|Pre-randomization|Adverse Event|12|||
126340343|NCT03530293|454542255|FG001|Pre-randomization|Adverse Event|0|||
126340344|NCT03530293|454542256|FG002|Pre-randomization|Adverse Event|0|||
126340345|NCT03530293|454542254|FG000|Pre-randomization|Protocol Violation|2|||
126340346|NCT03530293|454542255|FG001|Pre-randomization|Protocol Violation|0|||
126340347|NCT03530293|454542256|FG002|Pre-randomization|Protocol Violation|0|||
126340348|NCT03530293|454542254|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
126340349|NCT03530293|454542255|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
126340350|NCT03530293|454542256|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
126340351|NCT03530293|454542254|FG000|Pre-randomization|Withdrawal by Subject|5|||
126340352|NCT03530293|454542255|FG001|Pre-randomization|Withdrawal by Subject|0|||
126340353|NCT03530293|454542256|FG002|Pre-randomization|Withdrawal by Subject|0|||
126340354|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
126340355|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
126340356|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
126340357|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
126340358|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
126340359|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
126340360|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
126340361|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
126340362|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
126340363|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
126340364|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
126340365|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
126340366|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
126340367|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
126340368|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
126340369|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
126340370|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
126340371|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
126340372|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
126340373|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
126340374|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
126340375|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
126340376|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
126340377|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
126340378|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
126425233|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126005876|NCT00601640|453314750|FG001|Overall Study|Adverse Event|4|||
126340379|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
126340380|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
126425234|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425235|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425236|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
126425237|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
126425238|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425239|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
126425240|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
126425241|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
126425242|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425243|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425244|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425245|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425246|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
126425247|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
126425248|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
126425249|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
126425250|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
126425251|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
126425252|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
126425253|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
126425254|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
126425255|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
126425256|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
126425257|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425258|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
126425259|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
126005877|NCT00601640|453314751|FG002|Overall Study|Adverse Event|2|||
126005878|NCT00601640|453314749|FG000|Overall Study|intercurrent illness|1|||
126425260|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
126425261|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
126425262|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425263|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425264|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425265|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425266|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
126425267|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425268|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
126425269|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425270|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
126425271|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425272|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425273|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425274|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425275|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425276|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
126425277|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425278|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425279|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425280|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
126425281|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
126425282|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126005879|NCT00601640|453314750|FG001|Overall Study|intercurrent illness|0|||
126005880|NCT00601640|453314751|FG002|Overall Study|intercurrent illness|0|||
126005881|NCT00601640|453314749|FG000|Overall Study|change in eligibility status|0|||
126005882|NCT00601640|453314750|FG001|Overall Study|change in eligibility status|1|||
126005883|NCT00601640|453314751|FG002|Overall Study|change in eligibility status|1|||
126005884|NCT00530777|453314752|FG000|Overall Study|Lost to Follow-up|0|||
126005885|NCT00530777|453314753|FG001|Overall Study|Lost to Follow-up|1|||
126425283|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425284|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425285|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425286|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425287|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425288|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
126005886|NCT00530777|453314752|FG000|Overall Study|Death|1|||
126005887|NCT00530777|453314753|FG001|Overall Study|Death|2|||
126005888|NCT00530777|453314752|FG000|Overall Study|Physician Decision|1|||
126005889|NCT00530777|453314753|FG001|Overall Study|Physician Decision|0|||
126005890|NCT00530777|453314752|FG000|Overall Study|Withdrawal by Subject|0|||
126005891|NCT00530777|453314753|FG001|Overall Study|Withdrawal by Subject|1|||
126005892|NCT00530777|453314752|FG000|Overall Study|Unable to adhere to visit schedule|5|||
126005893|NCT00530777|453314753|FG001|Overall Study|Unable to adhere to visit schedule|1|||
126340381|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
126340382|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
126340383|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
126340384|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
126340385|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
126340386|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
126340387|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
126340388|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
126340389|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
126340390|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
126340391|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
126340392|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
126340393|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
126340394|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
126340395|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
126340396|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
126340397|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
126340398|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
126340399|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
126340400|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
126340401|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
126340402|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
126340403|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
126340404|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
126340405|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
126340406|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
126340407|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
126340408|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
126340409|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
126340410|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
126340411|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
126340412|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
126340413|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
126340414|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
126340415|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
126340416|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
126340417|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
126340418|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
126340419|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
126340420|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
126340421|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
126340422|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
126340423|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
126340424|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
126340425|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
126340426|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
126340427|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
126340428|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
126340429|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
126340430|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
126340431|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
126340432|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
126340433|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
126340434|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
126340435|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
126340436|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
126340437|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
126340438|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
126340439|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
126005894|NCT03382821|453314760|FG000|Overall Study|Did not receive allocated intervention.|0|||
126005895|NCT03382821|453314761|FG001|Overall Study|Did not receive allocated intervention.|3|||
126425289|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425290|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425291|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425292|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425293|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425294|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425295|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425296|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425297|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425298|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425299|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425300|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425301|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425302|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
126425303|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425304|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425305|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425306|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425307|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425308|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425309|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425310|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425311|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425312|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
126425313|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425314|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
126425315|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
126425316|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425317|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425318|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425319|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425320|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425321|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425322|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
126425323|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
126425324|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
126425325|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
126425326|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425327|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425328|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425329|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425330|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425331|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425332|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
126425333|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425334|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
126425335|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
126425336|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425337|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425338|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425339|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425340|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425341|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425342|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
126425343|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425344|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
126425345|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425346|NCT01188772|454853922|FG000|Overall Study|Randomized but Not Treated|0|||
126425347|NCT01188772|454853923|FG001|Overall Study|Randomized but Not Treated|1|||
126425348|NCT01188772|454853924|FG002|Overall Study|Randomized but Not Treated|0|||
126425349|NCT01188772|454853925|FG003|Overall Study|Randomized but Not Treated|0|||
126005896|NCT00282438|453314763|FG000|Overall Study|Lack of Efficacy|1|||
126005897|NCT00282438|453314764|FG001|Overall Study|Lack of Efficacy|0|||
126005898|NCT00282438|453314763|FG000|Overall Study|Death|0|||
126005899|NCT00282438|453314764|FG001|Overall Study|Death|1|||
126005900|NCT01674569|453314765|FG000|Overall Study|Adverse Event|0|||
126005901|NCT01674569|453314766|FG001|Overall Study|Adverse Event|2|||
126005902|NCT01674569|453314767|FG002|Overall Study|Adverse Event|0|||
126340440|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
126340441|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
126340442|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
126340443|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
126340444|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
126340445|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
126340446|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
126340447|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
126340448|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
126340449|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
126340450|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
126340451|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
126340452|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
126340453|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
126340454|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
126340455|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
126340456|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
126340457|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
126340458|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
126340459|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
126340460|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
126340461|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
126340462|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
126340463|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
126340464|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
126340465|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
126340466|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
126340467|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
126340468|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
126340469|NCT02530385|454542262|FG000|Overall Study|Withdrawal by Subject|0|||
126340470|NCT02530385|454542263|FG001|Overall Study|Withdrawal by Subject|1|||
126340471|NCT01569022|454542265|FG000|First Intervention|Lost to Follow-up|2|||
126340472|NCT01569022|454542266|FG001|First Intervention|Lost to Follow-up|1|||
126340473|NCT01569022|454542265|FG000|Second Intervention|Lost to Follow-up|2|||
126340474|NCT01569022|454542266|FG001|Second Intervention|Lost to Follow-up|2|||
126340475|NCT00433836|454542271|FG000|Overall Study|Adverse Event|7|||
126340476|NCT00433836|454542272|FG001|Overall Study|Adverse Event|0|||
126340477|NCT00433836|454542271|FG000|Overall Study|Lost to Follow-up|3|||
126340478|NCT00433836|454542272|FG001|Overall Study|Lost to Follow-up|0|||
126340479|NCT00433836|454542271|FG000|Overall Study|Withdrawal by Subject|2|||
126340480|NCT00433836|454542272|FG001|Overall Study|Withdrawal by Subject|1|||
126340481|NCT00433836|454542271|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126340482|NCT00433836|454542272|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126340483|NCT00433836|454542271|FG000|Overall Study|Protocol Violation|0|||
126340484|NCT00433836|454542272|FG001|Overall Study|Protocol Violation|2|||
126340485|NCT00433836|454542271|FG000|Overall Study|Condition no longer requires study drug|0|||
126340486|NCT00433836|454542272|FG001|Overall Study|Condition no longer requires study drug|1|||
126340487|NCT00433836|454542271|FG000|Overall Study|Abnormal laboratory values|0|||
126340488|NCT00433836|454542272|FG001|Overall Study|Abnormal laboratory values|1|||
126340489|NCT02446691|454542273|FG000|Overall Study|Withdrawal by Subject|2|||
126340490|NCT02446691|454542273|FG000|Overall Study|Lost to Follow-up|8|||
126340491|NCT02446691|454542273|FG000|Overall Study|Protocol Violation|1|||
126340492|NCT00472420|454542274|FG000|Induction Treatment Period|Physician Decision|9|||
126340493|NCT00472420|454542274|FG000|Induction Treatment Period|Adverse Event|3|||
126340494|NCT00472420|454542274|FG000|Induction Treatment Period|Non-compliance|1|||
126340495|NCT00472420|454542274|FG000|Induction Treatment Period|Death|3|||
126340496|NCT00472420|454542274|FG000|Follow-up Period|Death|5|||
126340497|NCT00472420|454542274|FG000|Follow-up Period|Physician Decision|9|||
126340498|NCT00472420|454542274|FG000|Follow-up Period|Lost to Follow-up|2|||
126340499|NCT00472420|454542274|FG000|Follow-up Period|Protocol Violation|1|||
126340500|NCT02674516|454542277|FG000|Overall Study|Lost to Follow-up|3|||
126340501|NCT02674516|454542278|FG001|Overall Study|Lost to Follow-up|0|||
126340502|NCT02674516|454542277|FG000|Overall Study|Protocol Violation|0|||
126005903|NCT01674569|453314768|FG003|Overall Study|Adverse Event|1|||
126425350|NCT01188772|454853922|FG000|Overall Study|Adverse Event|0|||
126425351|NCT01188772|454853923|FG001|Overall Study|Adverse Event|1|||
126425352|NCT01188772|454853924|FG002|Overall Study|Adverse Event|2|||
126425353|NCT01188772|454853925|FG003|Overall Study|Adverse Event|0|||
126425354|NCT01188772|454853922|FG000|Overall Study|Lost to Follow-up|4|||
126425355|NCT01188772|454853923|FG001|Overall Study|Lost to Follow-up|1|||
126425356|NCT01188772|454853924|FG002|Overall Study|Lost to Follow-up|1|||
126425357|NCT01188772|454853925|FG003|Overall Study|Lost to Follow-up|1|||
126425358|NCT01188772|454853922|FG000|Overall Study|Non-responder|0|||
126425359|NCT01188772|454853923|FG001|Overall Study|Non-responder|0|||
126425360|NCT01188772|454853924|FG002|Overall Study|Non-responder|3|||
126425361|NCT01188772|454853925|FG003|Overall Study|Non-responder|0|||
126425362|NCT01188772|454853922|FG000|Overall Study|Physician Decision|0|||
126425363|NCT01188772|454853923|FG001|Overall Study|Physician Decision|0|||
126425364|NCT01188772|454853924|FG002|Overall Study|Physician Decision|1|||
126425365|NCT01188772|454853925|FG003|Overall Study|Physician Decision|0|||
126425366|NCT01188772|454853922|FG000|Overall Study|Terminated by Sponsor|0|||
126425367|NCT01188772|454853923|FG001|Overall Study|Terminated by Sponsor|0|||
126425368|NCT01188772|454853924|FG002|Overall Study|Terminated by Sponsor|1|||
126425369|NCT01188772|454853925|FG003|Overall Study|Terminated by Sponsor|0|||
126425370|NCT01188772|454853922|FG000|Overall Study|Treatment Failure|0|||
126425371|NCT01188772|454853923|FG001|Overall Study|Treatment Failure|0|||
126425372|NCT01188772|454853924|FG002|Overall Study|Treatment Failure|1|||
126425373|NCT01188772|454853925|FG003|Overall Study|Treatment Failure|0|||
126425374|NCT01188772|454853922|FG000|Overall Study|Virologic Failure|1|||
126005904|NCT01674569|453314769|FG004|Overall Study|Adverse Event|2|||
126005905|NCT01674569|453314770|FG005|Overall Study|Adverse Event|2|||
126005906|NCT01674569|453314765|FG000|Overall Study|Protocol Violation|0|||
126005907|NCT01674569|453314766|FG001|Overall Study|Protocol Violation|1|||
126005908|NCT01674569|453314767|FG002|Overall Study|Protocol Violation|1|||
126340503|NCT02674516|454542278|FG001|Overall Study|Protocol Violation|4|||
126340504|NCT02674516|454542277|FG000|Overall Study|Knowledge of study hypothesis|1|||
126340505|NCT02674516|454542278|FG001|Overall Study|Knowledge of study hypothesis|0|||
126340506|NCT01026493|454542279|FG000|Overall Study|Protocol Violation|0|||
126340507|NCT01026493|454542280|FG001|Overall Study|Protocol Violation|1|||
126340508|NCT01026493|454542281|FG002|Overall Study|Protocol Violation|0|||
126340509|NCT01026493|454542282|FG003|Overall Study|Protocol Violation|0|||
126340510|NCT01026493|454542283|FG004|Overall Study|Protocol Violation|2|||
126340511|NCT01026493|454542284|FG005|Overall Study|Protocol Violation|3|||
126340512|NCT01026493|454542285|FG006|Overall Study|Protocol Violation|4|||
126340513|NCT01026493|454542286|FG007|Overall Study|Protocol Violation|1|||
126340514|NCT02295644|454542289|FG000|Overall Study|Did not meet inclusion criterion|0|||
126340515|NCT02295644|454542290|FG001|Overall Study|Did not meet inclusion criterion|0|||
126340516|NCT02295644|454542291|FG002|Overall Study|Did not meet inclusion criterion|1|||
126340517|NCT02295644|454542292|FG003|Overall Study|Did not meet inclusion criterion|2|||
126340518|NCT00324155|454542293|FG000|Enrolled and Randomized|No longer met study criteria|3|||
126340519|NCT00324155|454542294|FG001|Enrolled and Randomized|No longer met study criteria|0|||
126340520|NCT00324155|454542293|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
126340521|NCT00324155|454542294|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
126340522|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
126340523|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
126340524|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
126340525|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
126340526|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Death|8|||
126340527|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Death|15|||
126340528|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
126340529|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
126340530|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
126340531|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
126340532|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
126340533|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
126340534|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
126340535|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
126340536|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
126340537|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
126340538|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
126425375|NCT01188772|454853923|FG001|Overall Study|Virologic Failure|0|||
126425376|NCT01188772|454853924|FG002|Overall Study|Virologic Failure|0|||
126005909|NCT01674569|453314768|FG003|Overall Study|Protocol Violation|0|||
126005910|NCT01674569|453314769|FG004|Overall Study|Protocol Violation|0|||
126340539|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
126425377|NCT01188772|454853925|FG003|Overall Study|Virologic Failure|0|||
126425378|NCT01188772|454853922|FG000|Overall Study|Withdrawal by Subject|0|||
126425379|NCT01188772|454853923|FG001|Overall Study|Withdrawal by Subject|0|||
126425380|NCT01188772|454853924|FG002|Overall Study|Withdrawal by Subject|2|||
126425381|NCT01188772|454853925|FG003|Overall Study|Withdrawal by Subject|0|||
126425382|NCT02910466|454853926|FG000|Overall Study|Adverse Event|1|||
126425383|NCT02910466|454853926|FG000|Overall Study|Withdrawal by Subject|3|||
126425384|NCT02910466|454853926|FG000|Overall Study|Lost to Follow-up|5|||
126425385|NCT02910466|454853926|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
126425386|NCT02910466|454853926|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
126425387|NCT01808196|454853933|FG000|Overall Study|Lost to Follow-up|1|||
126425388|NCT00479713|454853934|FG000|Overall Study|Adverse Event|8|||
126425389|NCT00479713|454853935|FG001|Overall Study|Adverse Event|6|||
126425390|NCT00479713|454853934|FG000|Overall Study|Death|1|||
126425391|NCT00479713|454853935|FG001|Overall Study|Death|0|||
126425392|NCT00479713|454853934|FG000|Overall Study|Lost to Follow-up|0|||
126425393|NCT00479713|454853935|FG001|Overall Study|Lost to Follow-up|1|||
126425394|NCT00479713|454853934|FG000|Overall Study|Protocol Violation|0|||
126005911|NCT01674569|453314770|FG005|Overall Study|Protocol Violation|0|||
126005912|NCT01674569|453314765|FG000|Overall Study|Withdrawal by Subject|0|||
126340540|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
126340541|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
126340542|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
126340543|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
126340544|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
126340545|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
126340546|NCT00324155|454542293|FG000|Follow-up Phase|On-going participants still on drug|11|||
126340547|NCT00324155|454542294|FG001|Follow-up Phase|On-going participants still on drug|6|||
126340548|NCT03307174|454542295|FG000|Overall Study|Unplanned ICU Administrion|5|||
126340549|NCT03307174|454542296|FG001|Overall Study|Unplanned ICU Administrion|3|||
126340550|NCT03307174|454542295|FG000|Overall Study|Aborted Surgery|1|||
126340551|NCT03307174|454542296|FG001|Overall Study|Aborted Surgery|2|||
126340552|NCT03307174|454542295|FG000|Overall Study|Hypotension|6|||
126340553|NCT03307174|454542296|FG001|Overall Study|Hypotension|0|||
126340554|NCT03307174|454542295|FG000|Overall Study|Nonfunctional epidural|1|||
126340555|NCT03307174|454542296|FG001|Overall Study|Nonfunctional epidural|1|||
126340556|NCT03307174|454542295|FG000|Overall Study|Planned epidural removal|1|||
126340557|NCT03307174|454542296|FG001|Overall Study|Planned epidural removal|0|||
126340558|NCT03307174|454542295|FG000|Overall Study|Intrathecal catheter placement|0|||
126340559|NCT03307174|454542296|FG001|Overall Study|Intrathecal catheter placement|1|||
126340560|NCT00846053|454542297|FG000|Overall Study|Physician Decision|3|||
126340561|NCT00846053|454542298|FG001|Overall Study|Physician Decision|0|||
126340562|NCT00111761|454542299|FG000|Part 1|Physician Decision|0|||
126340563|NCT00111761|454542300|FG001|Part 1|Physician Decision|1|||
126340564|NCT00111761|454542299|FG000|Part 1|Death|0|||
126340565|NCT00111761|454542300|FG001|Part 1|Death|2|||
126340566|NCT00111761|454542299|FG000|Part 1|Other|0|||
126340567|NCT00111761|454542300|FG001|Part 1|Other|1|||
126340568|NCT00111761|454542299|FG000|Part 1|Withdrawal by Subject|0|||
126340569|NCT00111761|454542300|FG001|Part 1|Withdrawal by Subject|1|||
126340570|NCT00111761|454542299|FG000|Part 2|Adverse Event|1|||
126340571|NCT00111761|454542300|FG001|Part 2|Adverse Event|0|||
126340572|NCT00111761|454542299|FG000|Part 2|Physician Decision|1|||
126340573|NCT00111761|454542300|FG001|Part 2|Physician Decision|0|||
126340574|NCT00111761|454542299|FG000|Part 2|Death|1|||
126340575|NCT00111761|454542300|FG001|Part 2|Death|0|||
126340576|NCT00111761|454542299|FG000|Part 2|Disease progression|3|||
126340577|NCT00111761|454542300|FG001|Part 2|Disease progression|0|||
126340578|NCT00111761|454542299|FG000|Part 2|Protocol-specified criteria|1|||
126340579|NCT00111761|454542300|FG001|Part 2|Protocol-specified criteria|0|||
126340580|NCT00111761|454542299|FG000|Part 2|Other|1|||
126005913|NCT01674569|453314766|FG001|Overall Study|Withdrawal by Subject|0|||
126005914|NCT01674569|453314767|FG002|Overall Study|Withdrawal by Subject|1|||
126005915|NCT01674569|453314768|FG003|Overall Study|Withdrawal by Subject|0|||
126005916|NCT01674569|453314769|FG004|Overall Study|Withdrawal by Subject|0|||
126005917|NCT01674569|453314770|FG005|Overall Study|Withdrawal by Subject|0|||
126005918|NCT02095158|453314782|FG000|Overall Study|Adverse Event|14|||
126005919|NCT02095158|453314782|FG000|Overall Study|Lack of Efficacy|3|||
126005920|NCT02095158|453314782|FG000|Overall Study|Pregnancy|1|||
126340581|NCT00111761|454542300|FG001|Part 2|Other|0|||
126340582|NCT00746551|454542301|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
126425395|NCT00479713|454853935|FG001|Overall Study|Protocol Violation|1|||
126425396|NCT00479713|454853934|FG000|Overall Study|Withdrawal by Subject|4|||
126340583|NCT00746551|454542302|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
126340584|NCT00746551|454542301|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
126340585|NCT00746551|454542302|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
126340586|NCT00746551|454542301|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
126340587|NCT00746551|454542302|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
126340588|NCT00843492|454542306|FG000|Overall Study|Adverse Event|0|||
126340589|NCT00843492|454542307|FG001|Overall Study|Adverse Event|3|||
126425397|NCT00479713|454853935|FG001|Overall Study|Withdrawal by Subject|1|||
126425398|NCT00141102|454853936|FG000|Overall Study|Adverse Event|233|||
126425399|NCT00141102|454853937|FG001|Overall Study|Adverse Event|305|||
126425400|NCT00141102|454853936|FG000|Overall Study|Laboratory Abnormality|9|||
126425401|NCT00141102|454853937|FG001|Overall Study|Laboratory Abnormality|33|||
126425402|NCT00141102|454853936|FG000|Overall Study|Lack of Efficacy|21|||
126425403|NCT00141102|454853937|FG001|Overall Study|Lack of Efficacy|26|||
126425404|NCT00141102|454853936|FG000|Overall Study|Lost to Follow-up|29|||
126425405|NCT00141102|454853937|FG001|Overall Study|Lost to Follow-up|32|||
126425406|NCT00141102|454853936|FG000|Overall Study|Other|87|||
126425407|NCT00141102|454853937|FG001|Overall Study|Other|76|||
126425408|NCT00141102|454853936|FG000|Overall Study|Withdrawal by Subject|112|||
126425409|NCT00141102|454853937|FG001|Overall Study|Withdrawal by Subject|142|||
126425410|NCT00141102|454853936|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
126425411|NCT00141102|454853937|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
126425412|NCT00141102|454853936|FG000|Overall Study|Death|2|||
126425413|NCT00141102|454853937|FG001|Overall Study|Death|2|||
126005921|NCT02095158|453314782|FG000|Overall Study|Lost to Follow-up|20|||
126005922|NCT02095158|453314782|FG000|Overall Study|Personal Reasons|35|||
126005923|NCT02095158|453314782|FG000|Overall Study|Protocol Violation|1|||
126005924|NCT02095158|453314782|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126005925|NCT01008748|453314783|FG000|Overall Study|Lost to Follow-up|80|||
126005926|NCT01008748|453314783|FG000|Overall Study|Other|1|||
126005927|NCT02775435|453314784|FG000|Overall Study|Adverse Event|32|||
126005928|NCT02775435|453314785|FG001|Overall Study|Adverse Event|27|||
126005929|NCT02775435|453314784|FG000|Overall Study|Lost to Follow-up|2|||
126005930|NCT02775435|453314785|FG001|Overall Study|Lost to Follow-up|2|||
126005931|NCT02775435|453314784|FG000|Overall Study|Sponsor decision|44|||
126005932|NCT02775435|453314785|FG001|Overall Study|Sponsor decision|19|||
126005933|NCT02775435|453314784|FG000|Overall Study|Withdrawal by Subject|4|||
126005934|NCT02775435|453314785|FG001|Overall Study|Withdrawal by Subject|9|||
126005935|NCT02775435|453314784|FG000|Overall Study|Death|196|||
126005936|NCT02775435|453314785|FG001|Overall Study|Death|224|||
126005937|NCT02282527|453314786|FG000|Overall Study|Lost to Follow-up|0|||
126005938|NCT02282527|453314787|FG001|Overall Study|Lost to Follow-up|1|||
126005939|NCT02282527|453314786|FG000|Overall Study|Lack of home health aid|1|||
126005940|NCT02282527|453314787|FG001|Overall Study|Lack of home health aid|0|||
126005941|NCT00941031|453314788|FG000|Induction Period|Lack of Efficacy|2|||
126005942|NCT00941031|453314789|FG001|Induction Period|Lack of Efficacy|1|||
126005943|NCT00941031|453314790|FG002|Induction Period|Lack of Efficacy|0|||
126005944|NCT00941031|453314791|FG003|Induction Period|Lack of Efficacy|5|||
126005945|NCT00941031|453314792|FG004|Induction Period|Lack of Efficacy|0|||
126005946|NCT00941031|453314793|FG005|Induction Period|Lack of Efficacy|0|||
126005947|NCT00941031|453314794|FG006|Induction Period|Lack of Efficacy|0|||
126005948|NCT00941031|453314788|FG000|Induction Period|Withdrawal by Subject|1|||
126005949|NCT00941031|453314789|FG001|Induction Period|Withdrawal by Subject|2|||
126005950|NCT00941031|453314790|FG002|Induction Period|Withdrawal by Subject|2|||
126005951|NCT00941031|453314791|FG003|Induction Period|Withdrawal by Subject|2|||
126005952|NCT00941031|453314792|FG004|Induction Period|Withdrawal by Subject|0|||
126005953|NCT00941031|453314793|FG005|Induction Period|Withdrawal by Subject|0|||
126005954|NCT00941031|453314794|FG006|Induction Period|Withdrawal by Subject|0|||
126005955|NCT00941031|453314788|FG000|Induction Period|Adminstative Problems|1|||
126005956|NCT00941031|453314789|FG001|Induction Period|Adminstative Problems|1|||
126005957|NCT00941031|453314790|FG002|Induction Period|Adminstative Problems|1|||
126005958|NCT00941031|453314791|FG003|Induction Period|Adminstative Problems|0|||
126005959|NCT00941031|453314792|FG004|Induction Period|Adminstative Problems|0|||
126005960|NCT00941031|453314793|FG005|Induction Period|Adminstative Problems|0|||
126005961|NCT00941031|453314794|FG006|Induction Period|Adminstative Problems|0|||
126005962|NCT00941031|453314788|FG000|Induction Period|Adverse Event|1|||
126005963|NCT00941031|453314789|FG001|Induction Period|Adverse Event|0|||
126005964|NCT00941031|453314790|FG002|Induction Period|Adverse Event|3|||
126005965|NCT00941031|453314791|FG003|Induction Period|Adverse Event|2|||
126005966|NCT00941031|453314792|FG004|Induction Period|Adverse Event|0|||
126005967|NCT00941031|453314793|FG005|Induction Period|Adverse Event|0|||
126005968|NCT00941031|453314794|FG006|Induction Period|Adverse Event|0|||
126005969|NCT00941031|453314788|FG000|Maintenance Period|Withdrawal by Subject|0|||
126005970|NCT00941031|453314789|FG001|Maintenance Period|Withdrawal by Subject|0|||
126005971|NCT00941031|453314790|FG002|Maintenance Period|Withdrawal by Subject|0|||
126005972|NCT00941031|453314791|FG003|Maintenance Period|Withdrawal by Subject|0|||
126425414|NCT00866814|454853938|FG000|Overall Study|Lost to Follow-up|12|||
126425415|NCT00866814|454853938|FG000|Overall Study|Adverse Event|2|||
126425416|NCT00866814|454853938|FG000|Overall Study|Physician Decision|1|||
126425417|NCT00866814|454853938|FG000|Overall Study|Death|1|||
126425418|NCT00866814|454853938|FG000|Overall Study|No longer wished to participate|1|||
126425419|NCT00866814|454853938|FG000|Overall Study|Unable to meet follow-up requirements|2|||
126425420|NCT00866814|454853938|FG000|Overall Study|Moved to area without study site|1|||
126005973|NCT00941031|453314792|FG004|Maintenance Period|Withdrawal by Subject|6|||
126005974|NCT00941031|453314793|FG005|Maintenance Period|Withdrawal by Subject|2|||
126425421|NCT01063153|454853939|FG000|Overall Study|Found Ineligible During Screening|2|||
126425422|NCT01063153|454853940|FG001|Overall Study|Found Ineligible During Screening|0|||
126425423|NCT01063153|454853939|FG000|Overall Study|Lost to Follow-up|0|||
126425424|NCT01063153|454853940|FG001|Overall Study|Lost to Follow-up|7|||
126005975|NCT00941031|453314794|FG006|Maintenance Period|Withdrawal by Subject|13|||
126005976|NCT00941031|453314788|FG000|Maintenance Period|Administrative Problems|0|||
126005977|NCT00941031|453314789|FG001|Maintenance Period|Administrative Problems|0|||
126005978|NCT00941031|453314790|FG002|Maintenance Period|Administrative Problems|0|||
126005979|NCT00941031|453314791|FG003|Maintenance Period|Administrative Problems|0|||
126005980|NCT00941031|453314792|FG004|Maintenance Period|Administrative Problems|1|||
126005981|NCT00941031|453314793|FG005|Maintenance Period|Administrative Problems|0|||
126005982|NCT00941031|453314794|FG006|Maintenance Period|Administrative Problems|1|||
126005983|NCT00941031|453314788|FG000|Maintenance Period|Protocol Violation|0|||
126005984|NCT00941031|453314789|FG001|Maintenance Period|Protocol Violation|0|||
126005985|NCT00941031|453314790|FG002|Maintenance Period|Protocol Violation|0|||
126005986|NCT00941031|453314791|FG003|Maintenance Period|Protocol Violation|0|||
126005987|NCT00941031|453314792|FG004|Maintenance Period|Protocol Violation|0|||
126005988|NCT00941031|453314793|FG005|Maintenance Period|Protocol Violation|0|||
126005989|NCT00941031|453314794|FG006|Maintenance Period|Protocol Violation|1|||
126005990|NCT00941031|453314788|FG000|Maintenance Period|Adverse Event|0|||
126005991|NCT00941031|453314789|FG001|Maintenance Period|Adverse Event|0|||
126005992|NCT00941031|453314790|FG002|Maintenance Period|Adverse Event|0|||
126005993|NCT00941031|453314791|FG003|Maintenance Period|Adverse Event|0|||
126005994|NCT00941031|453314792|FG004|Maintenance Period|Adverse Event|0|||
126425425|NCT01063153|454853939|FG000|Overall Study|Withdrawal by Subject|0|||
126425426|NCT01063153|454853940|FG001|Overall Study|Withdrawal by Subject|1|||
126425427|NCT01063153|454853939|FG000|Overall Study|Physician Decision|0|||
126425428|NCT01063153|454853940|FG001|Overall Study|Physician Decision|4|||
126425429|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
126425430|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
126425431|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
126425432|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
126425433|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
126425434|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
126425435|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
126425436|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
126425437|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
126425438|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
126425439|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
126425440|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
126425441|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
126425442|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
126425443|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
126425444|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
126425445|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
126425446|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
126425447|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
126425448|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
126425449|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
126425450|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
126425451|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
126425452|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
126425453|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
126425454|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
126425455|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
126425456|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
126425457|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
126425458|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
126425459|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
126005995|NCT00941031|453314793|FG005|Maintenance Period|Adverse Event|2|||
126005996|NCT00941031|453314794|FG006|Maintenance Period|Adverse Event|8|||
126005997|NCT00941031|453314788|FG000|Maintenance Period|Lost to Follow-up|0|||
126005998|NCT00941031|453314789|FG001|Maintenance Period|Lost to Follow-up|0|||
126005999|NCT00941031|453314790|FG002|Maintenance Period|Lost to Follow-up|0|||
126006000|NCT00941031|453314791|FG003|Maintenance Period|Lost to Follow-up|0|||
126425460|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
126006001|NCT00941031|453314792|FG004|Maintenance Period|Lost to Follow-up|2|||
126006002|NCT00941031|453314793|FG005|Maintenance Period|Lost to Follow-up|2|||
126006003|NCT00941031|453314794|FG006|Maintenance Period|Lost to Follow-up|7|||
126006004|NCT00941031|453314788|FG000|Maintenance Period|Lack of Efficacy|0|||
126006005|NCT00941031|453314789|FG001|Maintenance Period|Lack of Efficacy|0|||
126006006|NCT00941031|453314790|FG002|Maintenance Period|Lack of Efficacy|0|||
126006007|NCT00941031|453314791|FG003|Maintenance Period|Lack of Efficacy|0|||
126006008|NCT00941031|453314792|FG004|Maintenance Period|Lack of Efficacy|0|||
126006009|NCT00941031|453314793|FG005|Maintenance Period|Lack of Efficacy|0|||
126006010|NCT00941031|453314794|FG006|Maintenance Period|Lack of Efficacy|13|||
126006011|NCT01872611|453314795|FG000|Overall Study|Adverse Event|3|||
126006012|NCT01872611|453314796|FG001|Overall Study|Adverse Event|1|||
126006013|NCT01872611|453314795|FG000|Overall Study|Adverse Event, prior to treatment|0|||
126006014|NCT01872611|453314796|FG001|Overall Study|Adverse Event, prior to treatment|1|||
126006015|NCT01872611|453314795|FG000|Overall Study|Death|0|||
126006016|NCT01872611|453314796|FG001|Overall Study|Death|1|||
126425461|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
126425462|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
126425463|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
126425464|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
126425465|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
126425466|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
126425467|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
126425468|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
126425469|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126425470|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126425471|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
126425472|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
126425473|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126425474|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126425475|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126425476|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
126425477|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126425478|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126425479|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126425480|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126425481|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
126425482|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
126425483|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126425484|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
126425485|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
126425486|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
126425487|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
126425488|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
126425489|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126425490|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126425491|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
126425492|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
126425493|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126425494|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126425495|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126425496|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
126425497|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
126425498|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126425499|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126425500|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126425501|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
126425502|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
126425503|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126425504|NCT02831764|454856123|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126425505|NCT02831764|454856124|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126425506|NCT02831764|454856125|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126425507|NCT02831764|454856126|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126425508|NCT02831764|454856127|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
126006017|NCT01872611|453314795|FG000|Overall Study|Death, prior to treatment|0|||
126006018|NCT01872611|453314796|FG001|Overall Study|Death, prior to treatment|1|||
126006019|NCT01872611|453314795|FG000|Overall Study|Lost to Follow-up|8|||
126006020|NCT01872611|453314796|FG001|Overall Study|Lost to Follow-up|1|||
126425509|NCT02831764|454856123|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126425510|NCT02831764|454856124|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126425511|NCT02831764|454856125|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126425512|NCT02831764|454856126|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126425513|NCT02831764|454856127|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
126425514|NCT02831764|454856123|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126425515|NCT02831764|454856124|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126425516|NCT02831764|454856125|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126425517|NCT02831764|454856126|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126425518|NCT02831764|454856127|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
126425519|NCT02831764|454856123|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126425520|NCT02831764|454856124|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126425521|NCT02831764|454856125|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126425522|NCT02831764|454856126|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126425523|NCT02831764|454856127|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
126425524|NCT04564846|454856128|FG000|Overall Study|Withdrawal by Subject|2|||
126425525|NCT04564846|454856129|FG001|Overall Study|Withdrawal by Subject|1|||
126425526|NCT04564846|454856128|FG000|Overall Study|Physician Decision|0|||
126425527|NCT04564846|454856129|FG001|Overall Study|Physician Decision|1|||
126425528|NCT04564846|454856128|FG000|Overall Study|Lost to Follow-up|0|||
126425529|NCT04564846|454856129|FG001|Overall Study|Lost to Follow-up|1|||
126425530|NCT04564846|454856128|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
126425531|NCT04564846|454856129|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
126425532|NCT04564846|454856128|FG000|Overall Study|Subject non-compliance|1|||
126425533|NCT04564846|454856129|FG001|Overall Study|Subject non-compliance|0|||
126425534|NCT02173769|454856130|FG000|Overall Study|Protocol Violation|4|||
126425535|NCT02735239|454856131|FG000|Overall Study|Adverse Event|0|||
126425536|NCT02735239|454856132|FG001|Overall Study|Adverse Event|0|||
126425537|NCT02735239|454856133|FG002|Overall Study|Adverse Event|4|||
126425538|NCT02735239|454856134|FG003|Overall Study|Adverse Event|0|||
126425539|NCT02735239|454856135|FG004|Overall Study|Adverse Event|0|||
126425540|NCT02735239|454856136|FG005|Overall Study|Adverse Event|0|||
126425541|NCT02735239|454856131|FG000|Overall Study|Death|1|||
126425542|NCT02735239|454856132|FG001|Overall Study|Death|1|||
126425543|NCT02735239|454856133|FG002|Overall Study|Death|0|||
126425544|NCT02735239|454856134|FG003|Overall Study|Death|0|||
126425545|NCT02735239|454856135|FG004|Overall Study|Death|0|||
126425546|NCT02735239|454856136|FG005|Overall Study|Death|0|||
126425547|NCT02735239|454856131|FG000|Overall Study|Physician Decision|0|||
126425548|NCT02735239|454856132|FG001|Overall Study|Physician Decision|0|||
126425549|NCT02735239|454856133|FG002|Overall Study|Physician Decision|1|||
126425550|NCT02735239|454856134|FG003|Overall Study|Physician Decision|0|||
126425551|NCT02735239|454856135|FG004|Overall Study|Physician Decision|0|||
126425552|NCT02735239|454856136|FG005|Overall Study|Physician Decision|0|||
126425553|NCT02735239|454856131|FG000|Overall Study|Progressive disease|3|||
126425554|NCT02735239|454856132|FG001|Overall Study|Progressive disease|1|||
126425555|NCT02735239|454856133|FG002|Overall Study|Progressive disease|3|||
126425556|NCT02735239|454856134|FG003|Overall Study|Progressive disease|0|||
126425557|NCT02735239|454856135|FG004|Overall Study|Progressive disease|0|||
126425558|NCT02735239|454856136|FG005|Overall Study|Progressive disease|2|||
126425559|NCT02735239|454856131|FG000|Overall Study|Withdrawal by Subject|0|||
126425560|NCT02735239|454856132|FG001|Overall Study|Withdrawal by Subject|1|||
126425561|NCT02735239|454856133|FG002|Overall Study|Withdrawal by Subject|0|||
126425562|NCT02735239|454856134|FG003|Overall Study|Withdrawal by Subject|0|||
126425563|NCT02735239|454856135|FG004|Overall Study|Withdrawal by Subject|0|||
126006021|NCT01872611|453314795|FG000|Overall Study|Physician Decision|1|||
126006022|NCT01872611|453314796|FG001|Overall Study|Physician Decision|0|||
126006023|NCT01872611|453314795|FG000|Overall Study|Withdrawal by Subject|6|||
126006024|NCT01872611|453314796|FG001|Overall Study|Withdrawal by Subject|1|||
126006025|NCT01872611|453314795|FG000|Overall Study|Reason not provided|6|||
126006026|NCT01872611|453314796|FG001|Overall Study|Reason not provided|6|||
126006027|NCT00631917|453314798|FG000|Overall Study|Adverse Event|34|||
126006028|NCT00631917|453314799|FG001|Overall Study|Adverse Event|45|||
126006029|NCT00631917|453314798|FG000|Overall Study|Abnormal laboratory value(s)|2|||
126006030|NCT00631917|453314799|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126006031|NCT00631917|453314798|FG000|Overall Study|Abnormal test procedure result(s)|3|||
126006032|NCT00631917|453314799|FG001|Overall Study|Abnormal test procedure result(s)|2|||
126425564|NCT02735239|454856136|FG005|Overall Study|Withdrawal by Subject|0|||
126425565|NCT00387881|454856142|FG000|Overall Study|Lost to Follow-up|23|||
126425566|NCT00387881|454856143|FG001|Overall Study|Lost to Follow-up|23|||
126425567|NCT00387881|454856142|FG000|Overall Study|Protocol Violation|2|||
126425568|NCT00387881|454856143|FG001|Overall Study|Protocol Violation|12|||
126006033|NCT00631917|453314798|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
126006034|NCT00631917|453314799|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
126006035|NCT00631917|453314798|FG000|Overall Study|No longer required study drug|0|||
126006036|NCT00631917|453314799|FG001|Overall Study|No longer required study drug|1|||
126006037|NCT00631917|453314798|FG000|Overall Study|Protocol deviation|6|||
126006038|NCT00631917|453314799|FG001|Overall Study|Protocol deviation|5|||
126006039|NCT00631917|453314798|FG000|Overall Study|Subject withdrew consent|25|||
126006040|NCT00631917|453314799|FG001|Overall Study|Subject withdrew consent|33|||
126006041|NCT00631917|453314798|FG000|Overall Study|Lost to Follow-up|7|||
126006042|NCT00631917|453314799|FG001|Overall Study|Lost to Follow-up|7|||
126006043|NCT00631917|453314798|FG000|Overall Study|Administrative problems|2|||
126006044|NCT00631917|453314799|FG001|Overall Study|Administrative problems|0|||
126340590|NCT00843492|454542306|FG000|Overall Study|Lost to Follow-up|4|||
126340591|NCT00843492|454542307|FG001|Overall Study|Lost to Follow-up|4|||
126340592|NCT00843492|454542306|FG000|Overall Study|Withdrawal by Subject|0|||
126340593|NCT00843492|454542307|FG001|Overall Study|Withdrawal by Subject|4|||
126340594|NCT00843492|454542306|FG000|Overall Study|Immobilization Stopped|1|||
126340595|NCT00843492|454542307|FG001|Overall Study|Immobilization Stopped|0|||
126340596|NCT00843492|454542306|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
126340597|NCT00843492|454542307|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
126340598|NCT00843492|454542306|FG000|Overall Study|Orthopedic Surgery|0|||
126340599|NCT00843492|454542307|FG001|Overall Study|Orthopedic Surgery|2|||
126340600|NCT00843492|454542306|FG000|Overall Study|Visit Not Performed|1|||
126340601|NCT00843492|454542307|FG001|Overall Study|Visit Not Performed|0|||
126340602|NCT00843492|454542306|FG000|Overall Study|Deep-vein Thrombosis|1|||
126340603|NCT00843492|454542307|FG001|Overall Study|Deep-vein Thrombosis|0|||
126340604|NCT01677741|454542309|FG000|Overall Study|Death|0|||
126340605|NCT01677741|454542310|FG001|Overall Study|Death|0|||
126340606|NCT01677741|454542311|FG002|Overall Study|Death|0|||
126340607|NCT01677741|454542312|FG003|Overall Study|Death|1|||
126340608|NCT01677741|454542313|FG004|Overall Study|Death|0|||
126340609|NCT01677741|454542314|FG005|Overall Study|Death|1|||
126340610|NCT01677741|454542315|FG006|Overall Study|Death|0|||
126340611|NCT01677741|454542316|FG007|Overall Study|Death|0|||
126340612|NCT01677741|454542309|FG000|Overall Study|Withdrawal by Subject|2|||
126340613|NCT01677741|454542310|FG001|Overall Study|Withdrawal by Subject|7|||
126340614|NCT01677741|454542311|FG002|Overall Study|Withdrawal by Subject|5|||
126340615|NCT01677741|454542312|FG003|Overall Study|Withdrawal by Subject|4|||
126340616|NCT01677741|454542313|FG004|Overall Study|Withdrawal by Subject|11|||
126340617|NCT01677741|454542314|FG005|Overall Study|Withdrawal by Subject|20|||
126340618|NCT01677741|454542315|FG006|Overall Study|Withdrawal by Subject|4|||
126340619|NCT01677741|454542316|FG007|Overall Study|Withdrawal by Subject|2|||
126340620|NCT01677741|454542309|FG000|Overall Study|Enrolled in a rollover study|0|||
126340621|NCT01677741|454542310|FG001|Overall Study|Enrolled in a rollover study|3|||
126340622|NCT01677741|454542311|FG002|Overall Study|Enrolled in a rollover study|2|||
126340623|NCT01677741|454542312|FG003|Overall Study|Enrolled in a rollover study|1|||
126340624|NCT01677741|454542313|FG004|Overall Study|Enrolled in a rollover study|6|||
126340625|NCT01677741|454542314|FG005|Overall Study|Enrolled in a rollover study|6|||
126340626|NCT01677741|454542315|FG006|Overall Study|Enrolled in a rollover study|7|||
126340627|NCT01677741|454542316|FG007|Overall Study|Enrolled in a rollover study|0|||
126340628|NCT01677741|454542309|FG000|Overall Study|Progressive disease|1|||
126340629|NCT01677741|454542310|FG001|Overall Study|Progressive disease|0|||
126340630|NCT01677741|454542311|FG002|Overall Study|Progressive disease|1|||
126340631|NCT01677741|454542312|FG003|Overall Study|Progressive disease|0|||
126340632|NCT01677741|454542313|FG004|Overall Study|Progressive disease|0|||
126340633|NCT01677741|454542314|FG005|Overall Study|Progressive disease|1|||
126340634|NCT01677741|454542315|FG006|Overall Study|Progressive disease|0|||
126340635|NCT01677741|454542316|FG007|Overall Study|Progressive disease|0|||
126340636|NCT00720499|454542317|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
126340637|NCT00720499|454542318|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
126340638|NCT00720499|454542317|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
126340639|NCT00720499|454542318|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
126340640|NCT00720499|454542317|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
126340641|NCT00720499|454542318|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
126340642|NCT01441973|454542326|FG000|Overall Study|Disease progression|8|||
126006045|NCT00631917|453314798|FG000|Overall Study|Death|1|||
126006046|NCT00631917|453314799|FG001|Overall Study|Death|0|||
126006047|NCT03537651|453314809|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
126340643|NCT01441973|454542327|FG001|Overall Study|Disease progression|6|||
126340644|NCT01441973|454542326|FG000|Overall Study|Adverse event unrelated to study drug|3|||
126340645|NCT01441973|454542327|FG001|Overall Study|Adverse event unrelated to study drug|2|||
126340646|NCT01441973|454542326|FG000|Overall Study|Participant request to discontinue|1|||
126340647|NCT01441973|454542327|FG001|Overall Study|Participant request to discontinue|1|||
126340648|NCT01441973|454542326|FG000|Overall Study|Poor compliance/noncompliance|0|||
126340649|NCT01441973|454542327|FG001|Overall Study|Poor compliance/noncompliance|1|||
126340650|NCT01441973|454542326|FG000|Overall Study|Administrative reason by sponsor|3|||
126340651|NCT01441973|454542327|FG001|Overall Study|Administrative reason by sponsor|5|||
126340652|NCT01441973|454542326|FG000|Overall Study|Participant withdrew consent|0|||
126006048|NCT03537651|453314809|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
126006049|NCT03537651|453314809|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
126006050|NCT03537651|453314809|FG000|Part A (Up to 96 Weeks)|Other|1|||
126006051|NCT03537651|453314809|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
126006052|NCT03537651|453314809|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
126006053|NCT03537651|453314809|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
126006054|NCT03537651|453314809|FG000|Part B (Up to 192 Weeks)|Other|1|||
126006055|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
126006056|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
126006057|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
126006058|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Death|3|||
126006059|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Death|0|||
126006060|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Death|0|||
126006061|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
126006062|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
126006063|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
126006064|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
126340653|NCT01441973|454542327|FG001|Overall Study|Participant withdrew consent|1|||
126340654|NCT04030598|454542328|FG000|Overall Study|Voluntary Withdrawal|0|||
126340655|NCT04030598|454542329|FG001|Overall Study|Voluntary Withdrawal|1|||
126340656|NCT04030598|454542330|FG002|Overall Study|Voluntary Withdrawal|0|||
126340657|NCT05079321|454542331|FG000|Overall Study|Withdrawal by Subject|2|||
126340658|NCT05079321|454542332|FG001|Overall Study|Withdrawal by Subject|2|||
126340659|NCT05079321|454542331|FG000|Overall Study|Lost to Follow-up|0|||
126340660|NCT05079321|454542332|FG001|Overall Study|Lost to Follow-up|1|||
126340661|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Other than specified|2|||
126340662|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Other than specified|4|||
126340663|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
126340664|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
126340665|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Pregnancy|0|||
126340666|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Pregnancy|2|||
126340667|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Physician Decision|1|||
126340668|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Physician Decision|1|||
126340669|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
126340670|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
126340671|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Adverse Event|2|||
126340672|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Adverse Event|1|||
126340673|NCT01324947|454542338|FG000|Overall Study|Adverse Event|7|||
126340674|NCT01324947|454542338|FG000|Overall Study|Death|10|||
126340675|NCT01324947|454542338|FG000|Overall Study|Other|3|||
126340676|NCT01324947|454542338|FG000|Overall Study|Progressive Disease|50|||
126340677|NCT01324947|454542338|FG000|Overall Study|Withdrawal by Subject|3|||
126340678|NCT01324947|454542338|FG000|Overall Study|1 discontinued before starting drug|1|||
126340679|NCT01274351|454542339|FG000|Overall Study|Lost to Follow-up|1|||
126340680|NCT01274351|454542339|FG000|Overall Study|patient not compliant with the protocol|1|||
126340681|NCT01274351|454542339|FG000|Overall Study|Pregnancy|1|||
126340682|NCT01274351|454542339|FG000|Overall Study|Death|2|||
126340683|NCT01274351|454542339|FG000|Overall Study|Withdrawal by Subject|3|||
126340684|NCT01274351|454542339|FG000|Overall Study|Adverse Event|8|||
126340685|NCT01274351|454542339|FG000|Overall Study|progression of disease|3|||
126340686|NCT01274351|454542339|FG000|Overall Study|hospitalization|1|||
126340687|NCT02873689|454544339|FG000|Overall Study|Lack of Efficacy|1|||
126340688|NCT02873689|454544340|FG001|Overall Study|Lack of Efficacy|0|||
126340689|NCT02873689|454544339|FG000|Overall Study|Withdrawal by Subject|2|||
126340690|NCT02873689|454544340|FG001|Overall Study|Withdrawal by Subject|2|||
126340691|NCT02873689|454544339|FG000|Overall Study|Protocol Violation|1|||
126340692|NCT02873689|454544340|FG001|Overall Study|Protocol Violation|0|||
126340693|NCT02873689|454544339|FG000|Overall Study|Adverse Event|2|||
126340694|NCT02873689|454544340|FG001|Overall Study|Adverse Event|2|||
126340695|NCT02873689|454544339|FG000|Overall Study|Randomized but not Treated|1|||
126340696|NCT02873689|454544340|FG001|Overall Study|Randomized but not Treated|1|||
126340697|NCT00350545|454544341|FG000|Overall Study|Withdrawal by Subject|2|||
126340698|NCT02997163|454544352|FG000|Overall Study|Adverse Event|1|||
126340699|NCT02997163|454544353|FG001|Overall Study|Adverse Event|0|||
126340700|NCT02997163|454544354|FG002|Overall Study|Adverse Event|0|||
126340701|NCT02997163|454544355|FG003|Overall Study|Adverse Event|1|||
126340702|NCT02337764|454544356|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
126340703|NCT02337764|454544356|FG000|Overall Study|Voluntary Withdrawal|12|||
126340704|NCT02337764|454544356|FG000|Overall Study|Lack of Efficacy|2|||
126340705|NCT01855958|454544376|FG000|Overall Study|Withdrawal by Subject|1|||
126340706|NCT01855958|454544377|FG001|Overall Study|Withdrawal by Subject|0|||
126340707|NCT00903968|454544378|FG000|Overall Study|Adverse Event|0|||
126340708|NCT00903968|454544379|FG001|Overall Study|Adverse Event|0|||
126340709|NCT00903968|454544380|FG002|Overall Study|Adverse Event|0|||
126425569|NCT00387881|454856142|FG000|Overall Study|Withdrawal by Subject|15|||
126425570|NCT00387881|454856143|FG001|Overall Study|Withdrawal by Subject|18|||
126425571|NCT00387881|454856142|FG000|Overall Study|Sponsor terminated Study|0|||
126425572|NCT00387881|454856143|FG001|Overall Study|Sponsor terminated Study|1|||
126425573|NCT00387881|454856142|FG000|Overall Study|Not eligible|6|||
126425574|NCT00387881|454856143|FG001|Overall Study|Not eligible|7|||
126425575|NCT00387881|454856142|FG000|Overall Study|No opportunity to treat headache|32|||
126425576|NCT00387881|454856143|FG001|Overall Study|No opportunity to treat headache|34|||
126425577|NCT00387881|454856142|FG000|Overall Study|Not otherwise specified|11|||
126425578|NCT00387881|454856143|FG001|Overall Study|Not otherwise specified|7|||
126425579|NCT02038153|454856144|FG000|Overall Study|Withdrawal by Subject|1|||
126425580|NCT03016312|454856145|FG000|Overall Study|discontinued before the treatment started|0|||
126425581|NCT03016312|454856146|FG001|Overall Study|discontinued before the treatment started|1|||
126425582|NCT03016312|454856145|FG000|Overall Study|Withdrawal by Subject|37|||
126425583|NCT03016312|454856146|FG001|Overall Study|Withdrawal by Subject|44|||
126425584|NCT03016312|454856145|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
126425585|NCT03016312|454856146|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
126425586|NCT03016312|454856145|FG000|Overall Study|Physician Decision|1|||
126425587|NCT03016312|454856146|FG001|Overall Study|Physician Decision|3|||
126425588|NCT03016312|454856145|FG000|Overall Study|Lost to Follow-up|12|||
126425589|NCT03016312|454856146|FG001|Overall Study|Lost to Follow-up|12|||
126425590|NCT03016312|454856145|FG000|Overall Study|Death|210|||
126425591|NCT03016312|454856146|FG001|Overall Study|Death|184|||
126425592|NCT03016312|454856145|FG000|Overall Study|loss to contact|1|||
126425593|NCT03016312|454856146|FG001|Overall Study|loss to contact|0|||
126425594|NCT03016312|454856145|FG000|Overall Study|started a new cancer therapy|1|||
126425595|NCT03016312|454856146|FG001|Overall Study|started a new cancer therapy|0|||
126425596|NCT01050634|454856147|FG000|Overall Study|Enrolled, but Not Treated|56|||
126425597|NCT01050634|454856147|FG000|Overall Study|Death|2|||
126425598|NCT01050634|454856147|FG000|Overall Study|Adverse Event|42|||
126425599|NCT01050634|454856147|FG000|Overall Study|Lost to Follow-up|2|||
126425600|NCT01050634|454856147|FG000|Overall Study|Other|21|||
126425601|NCT01050634|454856147|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
126425602|NCT00496015|454856148|FG000|Overall Study|Other|1|||
126425603|NCT00496015|454856149|FG001|Overall Study|Other|0|||
126425604|NCT00496015|454856150|FG002|Overall Study|Other|0|||
126425605|NCT00496015|454856151|FG003|Overall Study|Other|1|||
126425606|NCT00496015|454856152|FG004|Overall Study|Other|0|||
126425607|NCT00527735|454856153|FG000|Overall Study|Disease progression|47|||
126425608|NCT00527735|454856154|FG001|Overall Study|Disease progression|61|||
126425609|NCT00527735|454856155|FG002|Overall Study|Disease progression|53|||
126425610|NCT00527735|454856153|FG000|Overall Study|Death|23|||
126425611|NCT00527735|454856154|FG001|Overall Study|Death|13|||
126425612|NCT00527735|454856155|FG002|Overall Study|Death|15|||
126425613|NCT00527735|454856153|FG000|Overall Study|Completed treatment in treatment phase|14|||
126425614|NCT00527735|454856154|FG001|Overall Study|Completed treatment in treatment phase|13|||
126425615|NCT00527735|454856155|FG002|Overall Study|Completed treatment in treatment phase|18|||
126425616|NCT00527735|454856153|FG000|Overall Study|Adverse Event|10|||
126425617|NCT00527735|454856154|FG001|Overall Study|Adverse Event|6|||
126425618|NCT00527735|454856155|FG002|Overall Study|Adverse Event|7|||
126425619|NCT00527735|454856153|FG000|Overall Study|Not identified|5|||
126425620|NCT00527735|454856154|FG001|Overall Study|Not identified|5|||
126425621|NCT00527735|454856155|FG002|Overall Study|Not identified|5|||
126425622|NCT00527735|454856153|FG000|Overall Study|Withdrawal by Subject|5|||
126425623|NCT00527735|454856154|FG001|Overall Study|Withdrawal by Subject|4|||
126425624|NCT00527735|454856155|FG002|Overall Study|Withdrawal by Subject|3|||
126425625|NCT00527735|454856153|FG000|Overall Study|No longer met study criteria|2|||
126425626|NCT00527735|454856154|FG001|Overall Study|No longer met study criteria|2|||
126425627|NCT00527735|454856155|FG002|Overall Study|No longer met study criteria|1|||
126006065|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
126006066|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
126006067|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
126006068|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
126006069|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
126006070|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
126006071|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
126425628|NCT00527735|454856153|FG000|Overall Study|Lost to Follow-up|0|||
126425629|NCT00527735|454856154|FG001|Overall Study|Lost to Follow-up|0|||
126425630|NCT00527735|454856155|FG002|Overall Study|Lost to Follow-up|3|||
126425631|NCT00527735|454856153|FG000|Overall Study|Poor compliance or noncompliance|0|||
126425632|NCT00527735|454856154|FG001|Overall Study|Poor compliance or noncompliance|1|||
126425633|NCT00527735|454856155|FG002|Overall Study|Poor compliance or noncompliance|1|||
126425634|NCT00527735|454856153|FG000|Overall Study|Completed treatment during maintenance|2|||
126425635|NCT00527735|454856154|FG001|Overall Study|Completed treatment during maintenance|2|||
126425636|NCT00527735|454856155|FG002|Overall Study|Completed treatment during maintenance|1|||
126425637|NCT01535807|454856156|FG000|Overall Study|Withdrawal by Subject|1|||
126425638|NCT01535807|454856157|FG001|Overall Study|Withdrawal by Subject|1|||
126425639|NCT01535807|454856156|FG000|Overall Study|Data collection error|1|||
126425640|NCT01535807|454856157|FG001|Overall Study|Data collection error|1|||
126425641|NCT02730728|454856160|FG000|Overall Study|Withdrawal by Subject|0|||
126425642|NCT02730728|454856161|FG001|Overall Study|Withdrawal by Subject|1|||
126425643|NCT02730728|454856162|FG002|Overall Study|Withdrawal by Subject|0|||
126425644|NCT02730728|454856160|FG000|Overall Study|Lack of Efficacy|0|||
126425645|NCT02730728|454856161|FG001|Overall Study|Lack of Efficacy|1|||
126425646|NCT02730728|454856162|FG002|Overall Study|Lack of Efficacy|1|||
126425647|NCT01855412|454856163|FG000|Overall Study|Death|77|||
126425648|NCT01855412|454856164|FG001|Overall Study|Death|123|||
126425649|NCT01855412|454856165|FG002|Overall Study|Death|30|||
126425650|NCT01855412|454856163|FG000|Overall Study|Lost to Follow-up|28|||
126425651|NCT01855412|454856164|FG001|Overall Study|Lost to Follow-up|46|||
126425652|NCT01855412|454856165|FG002|Overall Study|Lost to Follow-up|15|||
126425653|NCT01855412|454856163|FG000|Overall Study|Withdrawal by Subject|77|||
126425654|NCT01855412|454856164|FG001|Overall Study|Withdrawal by Subject|123|||
126425655|NCT01855412|454856165|FG002|Overall Study|Withdrawal by Subject|24|||
126425656|NCT01855412|454856163|FG000|Overall Study|Physician Decision|25|||
126425657|NCT01855412|454856164|FG001|Overall Study|Physician Decision|31|||
126425658|NCT01855412|454856165|FG002|Overall Study|Physician Decision|3|||
126425659|NCT01855412|454856163|FG000|Overall Study|Site Closure|4|||
126425660|NCT01855412|454856164|FG001|Overall Study|Site Closure|18|||
126425661|NCT01855412|454856165|FG002|Overall Study|Site Closure|1|||
126425662|NCT01855412|454856163|FG000|Overall Study|Reason not Specified|1|||
126425663|NCT01855412|454856164|FG001|Overall Study|Reason not Specified|2|||
126425664|NCT01855412|454856165|FG002|Overall Study|Reason not Specified|3|||
126425665|NCT00764699|454856175|FG000|Overall Study|PI left and study terminated|3|||
126425666|NCT03985761|454856177|FG000|Overall Study|Withdrawal by Subject|2|||
126425667|NCT03985761|454856178|FG001|Overall Study|Withdrawal by Subject|3|||
126425668|NCT01755234|454856179|FG000|Overall Study|Lost to Follow-up|11|||
126425669|NCT01755234|454856180|FG001|Overall Study|Lost to Follow-up|6|||
126425670|NCT01755234|454856179|FG000|Overall Study|Change in surgical case|2|||
126425671|NCT01755234|454856180|FG001|Overall Study|Change in surgical case|1|||
126425672|NCT01755234|454856179|FG000|Overall Study|case cancelled|1|||
126425673|NCT01755234|454856180|FG001|Overall Study|case cancelled|0|||
126425674|NCT01755234|454856179|FG000|Overall Study|Withdrawal by Subject|0|||
126425675|NCT01755234|454856180|FG001|Overall Study|Withdrawal by Subject|1|||
126425676|NCT01755234|454856179|FG000|Overall Study|unblinded|1|||
126425677|NCT01755234|454856180|FG001|Overall Study|unblinded|0|||
126425678|NCT02322281|454856183|FG000|Overall Study|Progressive Disease|42|||
126425679|NCT02322281|454856184|FG001|Overall Study|Progressive Disease|14|||
126425680|NCT02322281|454856185|FG002|Overall Study|Progressive Disease|49|||
126425681|NCT02322281|454856183|FG000|Overall Study|Adverse Event|3|||
126425682|NCT02322281|454856184|FG001|Overall Study|Adverse Event|4|||
126425683|NCT02322281|454856185|FG002|Overall Study|Adverse Event|6|||
126425684|NCT02322281|454856183|FG000|Overall Study|Death|3|||
126425685|NCT02322281|454856184|FG001|Overall Study|Death|3|||
126425686|NCT02322281|454856185|FG002|Overall Study|Death|3|||
126425687|NCT02322281|454856183|FG000|Overall Study|Withdrawal by Subject|1|||
126425688|NCT02322281|454856184|FG001|Overall Study|Withdrawal by Subject|1|||
126425689|NCT02322281|454856185|FG002|Overall Study|Withdrawal by Subject|6|||
126425690|NCT02322281|454856183|FG000|Overall Study|Physician Decision|2|||
126425691|NCT02322281|454856184|FG001|Overall Study|Physician Decision|0|||
126425692|NCT02322281|454856185|FG002|Overall Study|Physician Decision|5|||
126425693|NCT02322281|454856183|FG000|Overall Study|Study Terminated by Sponsor|2|||
126425694|NCT02322281|454856184|FG001|Overall Study|Study Terminated by Sponsor|0|||
126425695|NCT02322281|454856185|FG002|Overall Study|Study Terminated by Sponsor|0|||
126425696|NCT02322281|454856183|FG000|Overall Study|Missing|0|||
126425697|NCT02322281|454856184|FG001|Overall Study|Missing|0|||
126425698|NCT02322281|454856185|FG002|Overall Study|Missing|1|||
126425699|NCT02322281|454856183|FG000|Overall Study|Miscellaneous|0|||
126425700|NCT02322281|454856184|FG001|Overall Study|Miscellaneous|0|||
126425701|NCT02322281|454856185|FG002|Overall Study|Miscellaneous|4|||
126425702|NCT04537793|454856187|FG000|Part B (24 Weeks)|Adverse Event|0|||
126425703|NCT04537793|454856188|FG001|Part B (24 Weeks)|Adverse Event|1|||
126425704|NCT01858363|454856190|FG000|Overall Study|Death|35|||
126425705|NCT01858363|454856191|FG001|Overall Study|Death|9|||
126425706|NCT01858363|454856190|FG000|Overall Study|Withdrawal by Subject|28|||
126425707|NCT01858363|454856191|FG001|Overall Study|Withdrawal by Subject|14|||
126425708|NCT01858363|454856190|FG000|Overall Study|Lost to Follow-up|13|||
126425709|NCT01858363|454856191|FG001|Overall Study|Lost to Follow-up|3|||
126425710|NCT00101686|454856196|FG000|Overall Study|Progressive Disease|37|||
126425711|NCT00101686|454856197|FG001|Overall Study|Progressive Disease|28|||
126425712|NCT00101686|454856198|FG002|Overall Study|Progressive Disease|37|||
126425713|NCT00101686|454856199|FG003|Overall Study|Progressive Disease|38|||
126425714|NCT00101686|454856200|FG004|Overall Study|Progressive Disease|28|||
126425715|NCT00101686|454856201|FG005|Overall Study|Progressive Disease|25|||
126425716|NCT00101686|454856202|FG006|Overall Study|Progressive Disease|5|||
126425717|NCT00101686|454856203|FG007|Overall Study|Progressive Disease|7|||
126425718|NCT00101686|454856204|FG008|Overall Study|Progressive Disease|10|||
126425719|NCT00101686|454856205|FG009|Overall Study|Progressive Disease|8|||
126425720|NCT00101686|454856196|FG000|Overall Study|initiation other anti-cancer treatment|4|||
126425721|NCT00101686|454856197|FG001|Overall Study|initiation other anti-cancer treatment|3|||
126425722|NCT00101686|454856198|FG002|Overall Study|initiation other anti-cancer treatment|4|||
126425723|NCT00101686|454856199|FG003|Overall Study|initiation other anti-cancer treatment|3|||
126425724|NCT00101686|454856200|FG004|Overall Study|initiation other anti-cancer treatment|1|||
126425725|NCT00101686|454856201|FG005|Overall Study|initiation other anti-cancer treatment|1|||
126425726|NCT00101686|454856202|FG006|Overall Study|initiation other anti-cancer treatment|2|||
126425727|NCT00101686|454856203|FG007|Overall Study|initiation other anti-cancer treatment|2|||
126425728|NCT00101686|454856204|FG008|Overall Study|initiation other anti-cancer treatment|3|||
126425729|NCT00101686|454856205|FG009|Overall Study|initiation other anti-cancer treatment|3|||
126425730|NCT00101686|454856196|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
126425731|NCT00101686|454856197|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
126425732|NCT00101686|454856198|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
126425733|NCT00101686|454856199|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
126425734|NCT00101686|454856200|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
126425735|NCT00101686|454856201|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
126425736|NCT00101686|454856202|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
126425737|NCT00101686|454856203|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
126425738|NCT00101686|454856204|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
126425739|NCT00101686|454856205|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
126425740|NCT00101686|454856196|FG000|Overall Study|unacceptable toxicity|3|||
126425741|NCT00101686|454856197|FG001|Overall Study|unacceptable toxicity|9|||
126425742|NCT00101686|454856198|FG002|Overall Study|unacceptable toxicity|10|||
126425743|NCT00101686|454856199|FG003|Overall Study|unacceptable toxicity|6|||
126425744|NCT00101686|454856200|FG004|Overall Study|unacceptable toxicity|16|||
126425745|NCT00101686|454856201|FG005|Overall Study|unacceptable toxicity|10|||
126425746|NCT00101686|454856202|FG006|Overall Study|unacceptable toxicity|4|||
126425747|NCT00101686|454856203|FG007|Overall Study|unacceptable toxicity|2|||
126425748|NCT00101686|454856204|FG008|Overall Study|unacceptable toxicity|1|||
126425749|NCT00101686|454856205|FG009|Overall Study|unacceptable toxicity|4|||
126425750|NCT00101686|454856196|FG000|Overall Study|Randomized but did not receive treament|1|||
126425751|NCT00101686|454856197|FG001|Overall Study|Randomized but did not receive treament|6|||
126425752|NCT00101686|454856198|FG002|Overall Study|Randomized but did not receive treament|2|||
126425753|NCT00101686|454856199|FG003|Overall Study|Randomized but did not receive treament|2|||
126425754|NCT00101686|454856200|FG004|Overall Study|Randomized but did not receive treament|2|||
126425755|NCT00101686|454856201|FG005|Overall Study|Randomized but did not receive treament|2|||
126425756|NCT00101686|454856202|FG006|Overall Study|Randomized but did not receive treament|0|||
126425757|NCT00101686|454856203|FG007|Overall Study|Randomized but did not receive treament|1|||
126425758|NCT00101686|454856204|FG008|Overall Study|Randomized but did not receive treament|0|||
126425759|NCT00101686|454856205|FG009|Overall Study|Randomized but did not receive treament|1|||
126425760|NCT00101686|454856196|FG000|Overall Study|intercurrent non-cancer related illness|0|||
126425761|NCT00101686|454856197|FG001|Overall Study|intercurrent non-cancer related illness|0|||
126425762|NCT00101686|454856198|FG002|Overall Study|intercurrent non-cancer related illness|2|||
126425763|NCT00101686|454856199|FG003|Overall Study|intercurrent non-cancer related illness|0|||
126425764|NCT00101686|454856200|FG004|Overall Study|intercurrent non-cancer related illness|1|||
126425765|NCT00101686|454856201|FG005|Overall Study|intercurrent non-cancer related illness|3|||
126425766|NCT00101686|454856202|FG006|Overall Study|intercurrent non-cancer related illness|1|||
126006072|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
126006073|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
126006074|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
126006075|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
126006076|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Other|1|||
126006077|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Other|0|||
126006078|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Other|0|||
126006079|NCT02403323|453314810|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
126006080|NCT02403323|453314811|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
126006081|NCT02403323|453314812|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
126006082|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
126006083|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
126425767|NCT00101686|454856203|FG007|Overall Study|intercurrent non-cancer related illness|0|||
126006084|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
126209490|NCT03110107|454055395|FG002|Treatment Period|Adverse Event|1|||
126425768|NCT00101686|454856204|FG008|Overall Study|intercurrent non-cancer related illness|1|||
126425769|NCT00101686|454856205|FG009|Overall Study|intercurrent non-cancer related illness|1|||
126425770|NCT00101686|454856196|FG000|Overall Study|Physician Decision|10|||
126006085|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
126006086|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
126006087|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
126006088|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
126006089|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
126006090|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
126006091|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
126006092|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
126006093|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
126006094|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
126340710|NCT00903968|454544381|FG003|Overall Study|Adverse Event|0|||
126340711|NCT00903968|454544382|FG004|Overall Study|Adverse Event|0|||
126340712|NCT00903968|454544383|FG005|Overall Study|Adverse Event|0|||
126340713|NCT00903968|454544384|FG006|Overall Study|Adverse Event|1|||
126340714|NCT00903968|454544385|FG007|Overall Study|Adverse Event|8|||
126340715|NCT00903968|454544378|FG000|Overall Study|DLT|0|||
126340716|NCT00903968|454544379|FG001|Overall Study|DLT|0|||
126340717|NCT00903968|454544380|FG002|Overall Study|DLT|0|||
126340718|NCT00903968|454544381|FG003|Overall Study|DLT|0|||
126340719|NCT00903968|454544382|FG004|Overall Study|DLT|0|||
126340720|NCT00903968|454544383|FG005|Overall Study|DLT|0|||
126340721|NCT00903968|454544384|FG006|Overall Study|DLT|2|||
126340722|NCT00903968|454544385|FG007|Overall Study|DLT|0|||
126340723|NCT00903968|454544378|FG000|Overall Study|Withdrawal by Subject|1|||
126340724|NCT00903968|454544379|FG001|Overall Study|Withdrawal by Subject|0|||
126340725|NCT00903968|454544380|FG002|Overall Study|Withdrawal by Subject|1|||
126340726|NCT00903968|454544381|FG003|Overall Study|Withdrawal by Subject|0|||
126340727|NCT00903968|454544382|FG004|Overall Study|Withdrawal by Subject|1|||
126340728|NCT00903968|454544383|FG005|Overall Study|Withdrawal by Subject|1|||
126340729|NCT00903968|454544384|FG006|Overall Study|Withdrawal by Subject|0|||
126340730|NCT00903968|454544385|FG007|Overall Study|Withdrawal by Subject|4|||
126340731|NCT00903968|454544378|FG000|Overall Study|Non-Compliance|0|||
126340732|NCT00903968|454544379|FG001|Overall Study|Non-Compliance|0|||
126340733|NCT00903968|454544380|FG002|Overall Study|Non-Compliance|0|||
126340734|NCT00903968|454544381|FG003|Overall Study|Non-Compliance|0|||
126340735|NCT00903968|454544382|FG004|Overall Study|Non-Compliance|0|||
126340736|NCT00903968|454544383|FG005|Overall Study|Non-Compliance|1|||
126340737|NCT00903968|454544384|FG006|Overall Study|Non-Compliance|0|||
126340738|NCT00903968|454544385|FG007|Overall Study|Non-Compliance|0|||
126340739|NCT00903968|454544378|FG000|Overall Study|Physician Decision|0|||
126340740|NCT00903968|454544379|FG001|Overall Study|Physician Decision|0|||
126340741|NCT00903968|454544380|FG002|Overall Study|Physician Decision|0|||
126340742|NCT00903968|454544381|FG003|Overall Study|Physician Decision|0|||
126340743|NCT00903968|454544382|FG004|Overall Study|Physician Decision|0|||
126340744|NCT00903968|454544383|FG005|Overall Study|Physician Decision|1|||
126340745|NCT00903968|454544384|FG006|Overall Study|Physician Decision|0|||
126340746|NCT00903968|454544385|FG007|Overall Study|Physician Decision|0|||
126340747|NCT00903968|454544378|FG000|Overall Study|Progressive Disease|2|||
126340748|NCT00903968|454544379|FG001|Overall Study|Progressive Disease|3|||
126340749|NCT00903968|454544380|FG002|Overall Study|Progressive Disease|2|||
126340750|NCT00903968|454544381|FG003|Overall Study|Progressive Disease|3|||
126340751|NCT00903968|454544382|FG004|Overall Study|Progressive Disease|3|||
126340752|NCT00903968|454544383|FG005|Overall Study|Progressive Disease|3|||
126340753|NCT00903968|454544384|FG006|Overall Study|Progressive Disease|0|||
126340754|NCT00903968|454544385|FG007|Overall Study|Progressive Disease|18|||
126340755|NCT00903968|454544378|FG000|Overall Study|Lack of Efficacy|0|||
126340756|NCT00903968|454544379|FG001|Overall Study|Lack of Efficacy|0|||
126340757|NCT00903968|454544380|FG002|Overall Study|Lack of Efficacy|0|||
126340758|NCT00903968|454544381|FG003|Overall Study|Lack of Efficacy|0|||
126340759|NCT00903968|454544382|FG004|Overall Study|Lack of Efficacy|0|||
126340760|NCT00903968|454544383|FG005|Overall Study|Lack of Efficacy|0|||
126340761|NCT00903968|454544384|FG006|Overall Study|Lack of Efficacy|0|||
126340762|NCT00903968|454544385|FG007|Overall Study|Lack of Efficacy|3|||
126340763|NCT00095979|454544386|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
126340764|NCT01663623|454544387|FG000|Overall Study|Adverse Event|3|||
126340765|NCT01663623|454544388|FG001|Overall Study|Adverse Event|7|||
126340766|NCT01663623|454544387|FG000|Overall Study|Lack of Efficacy|5|||
126340767|NCT01663623|454544388|FG001|Overall Study|Lack of Efficacy|6|||
126340768|NCT01663623|454544387|FG000|Overall Study|Protocol Violation|0|||
126340769|NCT01663623|454544388|FG001|Overall Study|Protocol Violation|1|||
126340770|NCT01663623|454544387|FG000|Overall Study|Other-Study closed/terminated|1|||
126340771|NCT01663623|454544388|FG001|Overall Study|Other-Study closed/terminated|1|||
126340772|NCT01663623|454544387|FG000|Overall Study|Physician Decision|1|||
126340773|NCT01663623|454544388|FG001|Overall Study|Physician Decision|4|||
126340774|NCT01663623|454544387|FG000|Overall Study|Withdrawal by Subject|2|||
126340775|NCT01663623|454544388|FG001|Overall Study|Withdrawal by Subject|1|||
126340776|NCT02251275|454544389|FG000|Overall Study|Adverse Event|23|||
126340777|NCT02251275|454544390|FG001|Overall Study|Adverse Event|60|||
126340778|NCT02251275|454544391|FG002|Overall Study|Adverse Event|28|||
126425771|NCT00101686|454856197|FG001|Overall Study|Physician Decision|13|||
126425772|NCT00101686|454856198|FG002|Overall Study|Physician Decision|6|||
126425773|NCT00101686|454856199|FG003|Overall Study|Physician Decision|7|||
126425774|NCT00101686|454856200|FG004|Overall Study|Physician Decision|8|||
126425775|NCT00101686|454856201|FG005|Overall Study|Physician Decision|9|||
126425776|NCT00101686|454856202|FG006|Overall Study|Physician Decision|5|||
126425777|NCT00101686|454856203|FG007|Overall Study|Physician Decision|5|||
126425778|NCT00101686|454856204|FG008|Overall Study|Physician Decision|1|||
126425779|NCT00101686|454856205|FG009|Overall Study|Physician Decision|1|||
126425780|NCT00101686|454856196|FG000|Overall Study|Other|1|||
126425781|NCT00101686|454856197|FG001|Overall Study|Other|4|||
126425782|NCT00101686|454856198|FG002|Overall Study|Other|1|||
126425783|NCT00101686|454856199|FG003|Overall Study|Other|6|||
126425784|NCT00101686|454856200|FG004|Overall Study|Other|2|||
126425785|NCT00101686|454856201|FG005|Overall Study|Other|12|||
126425786|NCT00101686|454856202|FG006|Overall Study|Other|1|||
126425787|NCT00101686|454856203|FG007|Overall Study|Other|5|||
126425788|NCT00101686|454856204|FG008|Overall Study|Other|3|||
126006095|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
126006096|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
126006097|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
126006098|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
126006099|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
126006100|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
126006101|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
126006102|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
126006103|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
126006104|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
126006105|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
126006106|NCT02403323|453314810|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
126006107|NCT02403323|453314811|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
126006108|NCT02403323|453314812|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
126006109|NCT03885596|453314813|FG000|Overall Study|Withdrawal by Subject|2|||
126425789|NCT00101686|454856205|FG009|Overall Study|Other|3|||
126425790|NCT00101686|454856196|FG000|Overall Study|Withdrawal by Subject|9|||
126425791|NCT00101686|454856197|FG001|Overall Study|Withdrawal by Subject|8|||
126425792|NCT00101686|454856198|FG002|Overall Study|Withdrawal by Subject|6|||
126425793|NCT00101686|454856199|FG003|Overall Study|Withdrawal by Subject|8|||
126425794|NCT00101686|454856200|FG004|Overall Study|Withdrawal by Subject|8|||
126425795|NCT00101686|454856201|FG005|Overall Study|Withdrawal by Subject|7|||
126425796|NCT00101686|454856202|FG006|Overall Study|Withdrawal by Subject|7|||
126425797|NCT00101686|454856203|FG007|Overall Study|Withdrawal by Subject|7|||
126425798|NCT00101686|454856204|FG008|Overall Study|Withdrawal by Subject|8|||
126425799|NCT00101686|454856205|FG009|Overall Study|Withdrawal by Subject|9|||
126425800|NCT00687401|454856206|FG000|Overall Study|Protocol Violation|7|||
126425801|NCT00687401|454856206|FG000|Overall Study|Adverse Event|6|||
126425802|NCT00687401|454856206|FG000|Overall Study|Lack of Efficacy|6|||
126425803|NCT00687401|454856206|FG000|Overall Study|Withdrawal by Subject|4|||
126425804|NCT00687401|454856206|FG000|Overall Study|Did not return for visit|3|||
126006110|NCT03885596|453314814|FG001|Overall Study|Withdrawal by Subject|1|||
126006111|NCT03885596|453314815|FG002|Overall Study|Withdrawal by Subject|0|||
126006112|NCT03885596|453314816|FG003|Overall Study|Withdrawal by Subject|0|||
126006113|NCT03852433|453314817|FG000|Overall Study|Withdrawal of consent|5|||
126006114|NCT03852433|453314818|FG001|Overall Study|Withdrawal of consent|8|||
126006115|NCT03852433|453314819|FG002|Overall Study|Withdrawal of consent|1|||
126006116|NCT03852433|453314820|FG003|Overall Study|Withdrawal of consent|1|||
126006117|NCT03852433|453314817|FG000|Overall Study|Adverse Event|1|||
126425805|NCT00687401|454856206|FG000|Overall Study|For reasons different from those above|4|||
126425806|NCT02920892|454856207|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
126006118|NCT03852433|453314818|FG001|Overall Study|Adverse Event|1|||
126006119|NCT03852433|453314819|FG002|Overall Study|Adverse Event|1|||
126006120|NCT03852433|453314820|FG003|Overall Study|Adverse Event|1|||
126006121|NCT03852433|453314817|FG000|Overall Study|Lost to Follow-up|0|||
126006122|NCT03852433|453314818|FG001|Overall Study|Lost to Follow-up|1|||
126425807|NCT02920892|454856208|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
126425808|NCT02920892|454856209|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
126006123|NCT03852433|453314819|FG002|Overall Study|Lost to Follow-up|0|||
126006124|NCT03852433|453314820|FG003|Overall Study|Lost to Follow-up|1|||
126006125|NCT03852433|453314817|FG000|Overall Study|Pregnancy|0|||
126425809|NCT02920892|454856207|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
126425810|NCT02920892|454856208|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
126425811|NCT02920892|454856209|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
126425812|NCT02920892|454856207|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
126425813|NCT02920892|454856208|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
126425814|NCT02920892|454856209|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
126006126|NCT03852433|453314818|FG001|Overall Study|Pregnancy|1|||
126006127|NCT03852433|453314819|FG002|Overall Study|Pregnancy|1|||
126006128|NCT03852433|453314820|FG003|Overall Study|Pregnancy|0|||
126006129|NCT03852433|453314817|FG000|Overall Study|Protocol Violation|0|||
126006130|NCT03852433|453314818|FG001|Overall Study|Protocol Violation|0|||
126006131|NCT03852433|453314819|FG002|Overall Study|Protocol Violation|1|||
126006132|NCT03852433|453314820|FG003|Overall Study|Protocol Violation|1|||
126006133|NCT03852433|453314817|FG000|Overall Study|Death|0|||
126006134|NCT03852433|453314818|FG001|Overall Study|Death|0|||
126006135|NCT03852433|453314819|FG002|Overall Study|Death|1|||
126006136|NCT03852433|453314820|FG003|Overall Study|Death|0|||
126006137|NCT03852433|453314817|FG000|Overall Study|Lack of Efficacy|0|||
126006138|NCT03852433|453314818|FG001|Overall Study|Lack of Efficacy|1|||
126006139|NCT03852433|453314819|FG002|Overall Study|Lack of Efficacy|0|||
126006140|NCT03852433|453314820|FG003|Overall Study|Lack of Efficacy|0|||
126006141|NCT03852433|453314817|FG000|Overall Study|Non-compliance with study drug|0|||
126006142|NCT03852433|453314818|FG001|Overall Study|Non-compliance with study drug|0|||
126006143|NCT03852433|453314819|FG002|Overall Study|Non-compliance with study drug|0|||
126006144|NCT03852433|453314820|FG003|Overall Study|Non-compliance with study drug|1|||
126006145|NCT03852433|453314817|FG000|Overall Study|Physician Decision|1|||
126006146|NCT03852433|453314818|FG001|Overall Study|Physician Decision|0|||
126006147|NCT03852433|453314819|FG002|Overall Study|Physician Decision|0|||
126006148|NCT03852433|453314820|FG003|Overall Study|Physician Decision|0|||
126006149|NCT03852433|453314817|FG000|Overall Study|Randomized but never treated|1|||
126425815|NCT02920892|454856207|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
126425816|NCT02920892|454856208|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
126425817|NCT02920892|454856209|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
126425818|NCT02920892|454856207|FG000|Placebo-Controlled Period|Physician Decision|0|||
126425819|NCT02920892|454856208|FG001|Placebo-Controlled Period|Physician Decision|0|||
126006150|NCT03852433|453314818|FG001|Overall Study|Randomized but never treated|0|||
126006151|NCT03852433|453314819|FG002|Overall Study|Randomized but never treated|0|||
126006152|NCT03852433|453314820|FG003|Overall Study|Randomized but never treated|0|||
126425820|NCT02920892|454856209|FG002|Placebo-Controlled Period|Physician Decision|1|||
126425821|NCT02920892|454856207|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
126425822|NCT02920892|454856208|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
126425823|NCT02920892|454856209|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
126425824|NCT02920892|454856207|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126425825|NCT02920892|454856208|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
126425826|NCT02920892|454856209|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
126425827|NCT02920892|454856207|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
126425828|NCT02920892|454856208|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
126425829|NCT02920892|454856209|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
126425830|NCT04486235|454856210|FG000|Overall Study|Pregnancy|1|||
126425831|NCT04486235|454856211|FG001|Overall Study|Pregnancy|0|||
126425832|NCT04486235|454856210|FG000|Overall Study|Lost to Follow-up|1|||
126425833|NCT04486235|454856211|FG001|Overall Study|Lost to Follow-up|0|||
126425834|NCT03935126|454856212|FG000|Overall Study|Study termination by sponsor|3|||
126425835|NCT03649217|454856213|FG000|Overall Study|subject had severe ataxia not initially found|1|||
126425836|NCT03649217|454856213|FG000|Overall Study|subject had cognitive issues not initially found|1|||
126425837|NCT01092728|454856214|FG000|Overall Study|Withdrawal by Subject|2|||
126425838|NCT01092728|454856215|FG001|Overall Study|Withdrawal by Subject|0|||
126425839|NCT01092728|454856214|FG000|Overall Study|Adverse Event|0|||
126425840|NCT01092728|454856215|FG001|Overall Study|Adverse Event|1|||
126425841|NCT01092728|454856214|FG000|Overall Study|Disease Progression|1|||
126425842|NCT01092728|454856215|FG001|Overall Study|Disease Progression|13|||
126425843|NCT01092728|454856214|FG000|Overall Study|Prohibited Concomitant Medications|1|||
126425844|NCT01092728|454856215|FG001|Overall Study|Prohibited Concomitant Medications|0|||
126425845|NCT02520726|454856216|FG000|Overall Study|Lost to Follow-up|3|||
126425846|NCT02520726|454856217|FG001|Overall Study|Lost to Follow-up|2|||
126006153|NCT01076335|453314821|FG000|Overall Study|Withdrawal by Subject|3|||
126006154|NCT01076335|453314821|FG000|Overall Study|Withdrawal without treatment|1|||
126006155|NCT02939183|453314824|FG000|Overall Study|Death|0|||
126006156|NCT02939183|453314825|FG001|Overall Study|Death|0|||
126006157|NCT02939183|453314826|FG002|Overall Study|Death|1|||
126006158|NCT02939183|453314827|FG003|Overall Study|Death|0|||
126425847|NCT00721396|454856218|FG000|Overall Study|Adverse Event|4|||
126425848|NCT00721396|454856219|FG001|Overall Study|Adverse Event|7|||
126425849|NCT00721396|454856220|FG002|Overall Study|Adverse Event|2|||
126425850|NCT00721396|454856221|FG003|Overall Study|Adverse Event|0|||
126425851|NCT00721396|454856218|FG000|Overall Study|Withdrawal by Subject|12|||
126425852|NCT00721396|454856219|FG001|Overall Study|Withdrawal by Subject|15|||
126006159|NCT02939183|453314828|FG004|Overall Study|Death|0|||
126006160|NCT02939183|453314829|FG005|Overall Study|Death|2|||
126006161|NCT02939183|453314830|FG006|Overall Study|Death|1|||
126006162|NCT02939183|453314831|FG007|Overall Study|Death|0|||
126006163|NCT02939183|453314832|FG008|Overall Study|Death|0|||
126006164|NCT02939183|453314824|FG000|Overall Study|Sponsor decision|0|||
126006165|NCT02939183|453314825|FG001|Overall Study|Sponsor decision|1|||
126006166|NCT02939183|453314826|FG002|Overall Study|Sponsor decision|0|||
126006167|NCT02939183|453314827|FG003|Overall Study|Sponsor decision|1|||
126006168|NCT02939183|453314828|FG004|Overall Study|Sponsor decision|2|||
126006169|NCT02939183|453314829|FG005|Overall Study|Sponsor decision|0|||
126006170|NCT02939183|453314830|FG006|Overall Study|Sponsor decision|3|||
126006171|NCT02939183|453314831|FG007|Overall Study|Sponsor decision|1|||
126006172|NCT02939183|453314832|FG008|Overall Study|Sponsor decision|4|||
126425853|NCT00721396|454856220|FG002|Overall Study|Withdrawal by Subject|3|||
126425854|NCT00721396|454856221|FG003|Overall Study|Withdrawal by Subject|7|||
126425855|NCT00721396|454856218|FG000|Overall Study|Lost to Follow-up|7|||
126425856|NCT00721396|454856219|FG001|Overall Study|Lost to Follow-up|9|||
126425857|NCT00721396|454856220|FG002|Overall Study|Lost to Follow-up|3|||
126425858|NCT00721396|454856221|FG003|Overall Study|Lost to Follow-up|3|||
126425859|NCT00721396|454856218|FG000|Overall Study|Protocol Violation|4|||
126425860|NCT00721396|454856219|FG001|Overall Study|Protocol Violation|3|||
126425861|NCT00721396|454856220|FG002|Overall Study|Protocol Violation|1|||
126425862|NCT00721396|454856221|FG003|Overall Study|Protocol Violation|0|||
126425863|NCT00721396|454856218|FG000|Overall Study|Inappropriate enrollment|0|||
126425864|NCT00721396|454856219|FG001|Overall Study|Inappropriate enrollment|2|||
126425865|NCT00721396|454856220|FG002|Overall Study|Inappropriate enrollment|0|||
126425866|NCT00721396|454856221|FG003|Overall Study|Inappropriate enrollment|0|||
126425867|NCT00721396|454856218|FG000|Overall Study|Administrative reason|3|||
126425868|NCT00721396|454856219|FG001|Overall Study|Administrative reason|0|||
126425869|NCT00721396|454856220|FG002|Overall Study|Administrative reason|1|||
126425870|NCT00721396|454856221|FG003|Overall Study|Administrative reason|0|||
126425871|NCT02021565|454856228|FG000|Baseline Through Intervention|Death|0|||
126425872|NCT02021565|454856229|FG001|Baseline Through Intervention|Death|1|||
126425873|NCT02021565|454856228|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
126425874|NCT02021565|454856229|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
126425875|NCT02021565|454856228|FG000|Baseline Through Intervention|Protocol Violation|0|||
126425876|NCT02021565|454856229|FG001|Baseline Through Intervention|Protocol Violation|7|||
126425877|NCT02021565|454856228|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
126425878|NCT02021565|454856229|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
126425879|NCT02021565|454856228|FG000|3-month Follow-up|Death|3|||
126425880|NCT02021565|454856229|FG001|3-month Follow-up|Death|0|||
126425881|NCT02021565|454856228|FG000|3-month Follow-up|Withdrawal by Subject|4|||
126425882|NCT02021565|454856229|FG001|3-month Follow-up|Withdrawal by Subject|0|||
126425883|NCT02021565|454856228|FG000|3-month Follow-up|Protocol Violation|3|||
126425884|NCT02021565|454856229|FG001|3-month Follow-up|Protocol Violation|2|||
126425885|NCT03318549|454856230|FG000|Overall Study|Withdrawal by Subject|5|||
126425886|NCT03318549|454856231|FG001|Overall Study|Withdrawal by Subject|19|||
126425887|NCT03318549|454856232|FG002|Overall Study|Withdrawal by Subject|2|||
126425888|NCT03318549|454856233|FG003|Overall Study|Withdrawal by Subject|0|||
126425889|NCT03318549|454856234|FG004|Overall Study|Withdrawal by Subject|0|||
126425890|NCT03318549|454856235|FG005|Overall Study|Withdrawal by Subject|0|||
126425891|NCT03318549|454856236|FG006|Overall Study|Withdrawal by Subject|0|||
126425892|NCT03318549|454856230|FG000|Overall Study|Physician Decision|0|||
126425893|NCT03318549|454856231|FG001|Overall Study|Physician Decision|4|||
126425894|NCT03318549|454856232|FG002|Overall Study|Physician Decision|1|||
126425895|NCT03318549|454856233|FG003|Overall Study|Physician Decision|0|||
126425896|NCT03318549|454856234|FG004|Overall Study|Physician Decision|0|||
126425897|NCT03318549|454856235|FG005|Overall Study|Physician Decision|0|||
126425898|NCT03318549|454856236|FG006|Overall Study|Physician Decision|0|||
126425899|NCT03318549|454856230|FG000|Overall Study|Lost to Follow-up|0|||
126425900|NCT03318549|454856231|FG001|Overall Study|Lost to Follow-up|3|||
126425901|NCT03318549|454856232|FG002|Overall Study|Lost to Follow-up|3|||
126425902|NCT03318549|454856233|FG003|Overall Study|Lost to Follow-up|0|||
126425903|NCT03318549|454856234|FG004|Overall Study|Lost to Follow-up|0|||
126425904|NCT03318549|454856235|FG005|Overall Study|Lost to Follow-up|0|||
126425905|NCT03318549|454856236|FG006|Overall Study|Lost to Follow-up|0|||
126425906|NCT00510835|454856239|FG000|Overall Study|Withdrawal by Subject|6|||
126425907|NCT00510835|454856240|FG001|Overall Study|Withdrawal by Subject|2|||
126006173|NCT02939183|453314824|FG000|Overall Study|Withdrawal by Subject|0|||
126006174|NCT02939183|453314825|FG001|Overall Study|Withdrawal by Subject|2|||
126006175|NCT02939183|453314826|FG002|Overall Study|Withdrawal by Subject|0|||
126006176|NCT02939183|453314827|FG003|Overall Study|Withdrawal by Subject|1|||
126425908|NCT00510835|454856241|FG002|Overall Study|Withdrawal by Subject|2|||
126425909|NCT00607087|454856245|FG000|Overall Study|Withdrawal by Subject|9|||
126425910|NCT00607087|454856246|FG001|Overall Study|Withdrawal by Subject|4|||
126425911|NCT00607087|454856247|FG002|Overall Study|Withdrawal by Subject|4|||
126425912|NCT00607087|454856245|FG000|Overall Study|Adverse Event|3|||
126425913|NCT00607087|454856246|FG001|Overall Study|Adverse Event|2|||
126425914|NCT00607087|454856247|FG002|Overall Study|Adverse Event|3|||
126425915|NCT00607087|454856245|FG000|Overall Study|Other reason|1|||
126006177|NCT02939183|453314828|FG004|Overall Study|Withdrawal by Subject|0|||
126006178|NCT02939183|453314829|FG005|Overall Study|Withdrawal by Subject|0|||
126425916|NCT00607087|454856246|FG001|Overall Study|Other reason|5|||
126425917|NCT00607087|454856247|FG002|Overall Study|Other reason|2|||
126006179|NCT02939183|453314830|FG006|Overall Study|Withdrawal by Subject|2|||
126006180|NCT02939183|453314831|FG007|Overall Study|Withdrawal by Subject|2|||
126006181|NCT02939183|453314832|FG008|Overall Study|Withdrawal by Subject|2|||
126006182|NCT02939183|453314824|FG000|Overall Study|Not treated due to adverse event|0|||
126425918|NCT00607087|454856245|FG000|Overall Study|Poor compliance to protocol|1|||
126425919|NCT00607087|454856246|FG001|Overall Study|Poor compliance to protocol|0|||
126425920|NCT00607087|454856247|FG002|Overall Study|Poor compliance to protocol|1|||
126006183|NCT02939183|453314825|FG001|Overall Study|Not treated due to adverse event|0|||
126006184|NCT02939183|453314826|FG002|Overall Study|Not treated due to adverse event|0|||
126006185|NCT02939183|453314827|FG003|Overall Study|Not treated due to adverse event|1|||
126006186|NCT02939183|453314828|FG004|Overall Study|Not treated due to adverse event|0|||
126006187|NCT02939183|453314829|FG005|Overall Study|Not treated due to adverse event|0|||
126006188|NCT02939183|453314830|FG006|Overall Study|Not treated due to adverse event|1|||
126006189|NCT02939183|453314831|FG007|Overall Study|Not treated due to adverse event|0|||
126006190|NCT02939183|453314832|FG008|Overall Study|Not treated due to adverse event|0|||
126006191|NCT00654238|453314837|FG000|Overall Study|Screen Failures|4|||
126006192|NCT01446003|453314838|FG000|Period 1|Protocol Violation|2|||
126006193|NCT01446003|453314839|FG001|Period 1|Protocol Violation|0|||
126006194|NCT01446003|453314838|FG000|Period 2|Adverse Event|1|||
126006195|NCT01446003|453314839|FG001|Period 2|Adverse Event|0|||
126425921|NCT00607087|454856245|FG000|Overall Study|Lost to Follow-up|1|||
126425922|NCT00607087|454856246|FG001|Overall Study|Lost to Follow-up|0|||
126425923|NCT00607087|454856247|FG002|Overall Study|Lost to Follow-up|0|||
126425924|NCT00607087|454856245|FG000|Period 1|Withdrawal by Subject|7|||
126425925|NCT00607087|454856246|FG001|Period 1|Withdrawal by Subject|2|||
126425926|NCT00607087|454856247|FG002|Period 1|Withdrawal by Subject|3|||
126425927|NCT00607087|454856245|FG000|Period 1|Adverse Event|3|||
126425928|NCT00607087|454856246|FG001|Period 1|Adverse Event|0|||
126425929|NCT00607087|454856247|FG002|Period 1|Adverse Event|0|||
126425930|NCT00607087|454856245|FG000|Period 1|Poor compliance to protocol|1|||
126425931|NCT00607087|454856246|FG001|Period 1|Poor compliance to protocol|0|||
126425932|NCT00607087|454856247|FG002|Period 1|Poor compliance to protocol|0|||
126425933|NCT00607087|454856245|FG000|Period 1|Lost to Follow-up|1|||
126425934|NCT00607087|454856246|FG001|Period 1|Lost to Follow-up|0|||
126425935|NCT00607087|454856247|FG002|Period 1|Lost to Follow-up|0|||
126425936|NCT00607087|454856245|FG000|Period 1|Other reason|0|||
126425937|NCT00607087|454856246|FG001|Period 1|Other reason|4|||
126425938|NCT00607087|454856247|FG002|Period 1|Other reason|2|||
126425939|NCT00607087|454856245|FG000|Period 2|Withdrawal by Subject|0|||
126425940|NCT00607087|454856246|FG001|Period 2|Withdrawal by Subject|1|||
126425941|NCT00607087|454856247|FG002|Period 2|Withdrawal by Subject|1|||
126425942|NCT00607087|454856245|FG000|Period 2|Other reason|1|||
126425943|NCT00607087|454856246|FG001|Period 2|Other reason|1|||
126425944|NCT00607087|454856247|FG002|Period 2|Other reason|0|||
126425945|NCT00607087|454856245|FG000|Period 2|Adverse Event|0|||
126425946|NCT00607087|454856246|FG001|Period 2|Adverse Event|1|||
126425947|NCT00607087|454856247|FG002|Period 2|Adverse Event|3|||
126425948|NCT00607087|454856245|FG000|Period 2|Poor compliance to protocol|0|||
126425949|NCT00607087|454856246|FG001|Period 2|Poor compliance to protocol|0|||
126425950|NCT00607087|454856247|FG002|Period 2|Poor compliance to protocol|1|||
126425951|NCT00607087|454856245|FG000|Period 3|Withdrawal by Subject|2|||
126425952|NCT00607087|454856246|FG001|Period 3|Withdrawal by Subject|1|||
126425953|NCT00607087|454856247|FG002|Period 3|Withdrawal by Subject|0|||
126425954|NCT00607087|454856245|FG000|Period 3|Adverse Event|0|||
126425955|NCT00607087|454856246|FG001|Period 3|Adverse Event|1|||
126425956|NCT00607087|454856247|FG002|Period 3|Adverse Event|0|||
126425957|NCT00650767|454856249|FG000|Overall Study|Adverse Event|0|||
126425958|NCT00650767|454856250|FG001|Overall Study|Adverse Event|3|||
126425959|NCT00650767|454856251|FG002|Overall Study|Adverse Event|10|||
126425960|NCT00650767|454856252|FG003|Overall Study|Adverse Event|8|||
126425961|NCT00650767|454856249|FG000|Overall Study|Death|1|||
126425962|NCT00650767|454856250|FG001|Overall Study|Death|0|||
126425963|NCT00650767|454856251|FG002|Overall Study|Death|0|||
126425964|NCT00650767|454856252|FG003|Overall Study|Death|0|||
126425965|NCT00650767|454856249|FG000|Overall Study|Withdrawal by Subject|2|||
126006196|NCT00318656|453314840|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
126006197|NCT00318656|453314841|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
126006198|NCT00318656|453314840|FG000|Overall Study|Did not receive any treatment|0|||
126006199|NCT00318656|453314841|FG001|Overall Study|Did not receive any treatment|1|||
126425966|NCT00650767|454856250|FG001|Overall Study|Withdrawal by Subject|4|||
126425967|NCT00650767|454856251|FG002|Overall Study|Withdrawal by Subject|3|||
126425968|NCT00650767|454856252|FG003|Overall Study|Withdrawal by Subject|3|||
126425969|NCT00650767|454856249|FG000|Overall Study|Lost to Follow-up|1|||
126425970|NCT00650767|454856250|FG001|Overall Study|Lost to Follow-up|1|||
126425971|NCT00650767|454856251|FG002|Overall Study|Lost to Follow-up|1|||
126425972|NCT00650767|454856252|FG003|Overall Study|Lost to Follow-up|0|||
126425973|NCT00650767|454856249|FG000|Overall Study|Other|1|||
126425974|NCT00650767|454856250|FG001|Overall Study|Other|1|||
126006200|NCT03905135|453314842|FG000|Dose Escalation|Adverse Event|1|||
126006201|NCT03905135|453314843|FG001|Dose Escalation|Adverse Event|1|||
126006202|NCT03905135|453314842|FG000|Dose Escalation|Progressive disease|3|||
126006203|NCT03905135|453314843|FG001|Dose Escalation|Progressive disease|1|||
126006204|NCT03905135|453314842|FG000|Dose Escalation|Intercurrent illness|1|||
126006205|NCT03905135|453314843|FG001|Dose Escalation|Intercurrent illness|0|||
126006206|NCT01740557|453314846|FG000|Overall Study|Ineligible|1|||
126006207|NCT01740557|453314846|FG000|Overall Study|Screen failure|1|||
126006208|NCT00490555|453314849|FG000|Overall Study|noncompliant with drug administration|0|||
126006209|NCT00490555|453314850|FG001|Overall Study|noncompliant with drug administration|0|||
126006210|NCT00490555|453314851|FG002|Overall Study|noncompliant with drug administration|2|||
126006211|NCT00490555|453314852|FG003|Overall Study|noncompliant with drug administration|0|||
126006212|NCT01268566|453314855|FG000|Overall Study|Lost to Follow-up|1|||
126006213|NCT01268566|453314855|FG000|Overall Study|Withdrawal by Subject|12|||
126006214|NCT01268566|453314855|FG000|Overall Study|Death|30|||
126006215|NCT01348087|453314863|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
126006216|NCT01348087|453314863|FG000|Overall Study|Administrative problems|79|||
126006217|NCT01348087|453314863|FG000|Overall Study|protocol deviation|1|||
126006218|NCT01348087|453314863|FG000|Overall Study|Lost to Follow-up|1|||
126006219|NCT01348087|453314863|FG000|Overall Study|Subject withdrew consent|7|||
126006220|NCT01348087|453314863|FG000|Overall Study|Adverse Event|25|||
126006221|NCT01007149|453314864|FG000|Overall Study|Administrative problems|0|||
126006222|NCT01007149|453314865|FG001|Overall Study|Administrative problems|1|||
126006223|NCT01913340|453314866|FG000|Overall Study|Death|2|||
126006224|NCT01913340|453314867|FG001|Overall Study|Death|5|||
126006225|NCT01913340|453314866|FG000|Overall Study|Lost to Follow-up|1|||
126006226|NCT01913340|453314867|FG001|Overall Study|Lost to Follow-up|1|||
126006227|NCT02784704|453314868|FG000|Overall Study|Adverse Event|4|||
126006228|NCT02784704|453314869|FG001|Overall Study|Adverse Event|2|||
126006229|NCT02784704|453314868|FG000|Overall Study|Lost to Follow-up|6|||
126006230|NCT02784704|453314869|FG001|Overall Study|Lost to Follow-up|4|||
126006231|NCT02784704|453314868|FG000|Overall Study|Withdrawal by Subject|1|||
126006232|NCT02784704|453314869|FG001|Overall Study|Withdrawal by Subject|3|||
126006233|NCT02784704|453314868|FG000|Overall Study|Subject Non Compliance|2|||
126006234|NCT02784704|453314869|FG001|Overall Study|Subject Non Compliance|0|||
126006235|NCT00603538|453314870|FG000|Overall Study|Adverse Event|0|||
126006236|NCT00603538|453314871|FG001|Overall Study|Adverse Event|4|||
126006237|NCT00603538|453314872|FG002|Overall Study|Adverse Event|2|||
126006238|NCT00603538|453314870|FG000|Overall Study|Objective progression or relapse|3|||
126006239|NCT00603538|453314871|FG001|Overall Study|Objective progression or relapse|0|||
126006240|NCT00603538|453314872|FG002|Overall Study|Objective progression or relapse|0|||
126006241|NCT05750745|453314874|FG000|Overall Study|Adverse Event|1|||
126006242|NCT05750745|453314875|FG001|Overall Study|Adverse Event|0|||
126006243|NCT05750745|453314876|FG002|Overall Study|Adverse Event|0|||
126006244|NCT05750745|453314874|FG000|Overall Study|Protocol Violation|1|||
126006245|NCT05750745|453314875|FG001|Overall Study|Protocol Violation|0|||
126006246|NCT05750745|453314876|FG002|Overall Study|Protocol Violation|0|||
126006247|NCT05750745|453314874|FG000|Overall Study|Withdrawal by Subject|0|||
126006248|NCT05750745|453314875|FG001|Overall Study|Withdrawal by Subject|1|||
126006249|NCT05750745|453314876|FG002|Overall Study|Withdrawal by Subject|0|||
126006250|NCT00783692|453314882|FG000|Induction Phase|Adverse Event|7|||
126006251|NCT00783692|453314883|FG001|Induction Phase|Adverse Event|9|||
126006252|NCT00783692|453314884|FG002|Induction Phase|Adverse Event|24|||
126006253|NCT00783692|453314885|FG003|Induction Phase|Adverse Event|0|||
126006254|NCT00783692|453314886|FG004|Induction Phase|Adverse Event|0|||
126006255|NCT00783692|453314887|FG005|Induction Phase|Adverse Event|0|||
126006256|NCT00783692|453314888|FG006|Induction Phase|Adverse Event|0|||
126006257|NCT00783692|453314882|FG000|Induction Phase|Protocol Violation|0|||
126006258|NCT00783692|453314883|FG001|Induction Phase|Protocol Violation|0|||
126340779|NCT02251275|454544392|FG003|Overall Study|Adverse Event|0|||
126340780|NCT02251275|454544393|FG004|Overall Study|Adverse Event|0|||
126340781|NCT02251275|454544389|FG000|Overall Study|Lost to Follow-up|5|||
126340782|NCT02251275|454544390|FG001|Overall Study|Lost to Follow-up|6|||
126006259|NCT00783692|453314884|FG002|Induction Phase|Protocol Violation|1|||
126006260|NCT00783692|453314885|FG003|Induction Phase|Protocol Violation|0|||
126006261|NCT00783692|453314886|FG004|Induction Phase|Protocol Violation|0|||
126006262|NCT00783692|453314887|FG005|Induction Phase|Protocol Violation|0|||
126006263|NCT00783692|453314888|FG006|Induction Phase|Protocol Violation|0|||
126006264|NCT00783692|453314882|FG000|Induction Phase|Lack of Efficacy|1|||
126340783|NCT02251275|454544391|FG002|Overall Study|Lost to Follow-up|4|||
126006265|NCT00783692|453314883|FG001|Induction Phase|Lack of Efficacy|3|||
126006266|NCT00783692|453314884|FG002|Induction Phase|Lack of Efficacy|28|||
126006267|NCT00783692|453314885|FG003|Induction Phase|Lack of Efficacy|0|||
126006268|NCT00783692|453314886|FG004|Induction Phase|Lack of Efficacy|0|||
126006269|NCT00783692|453314887|FG005|Induction Phase|Lack of Efficacy|0|||
126340784|NCT02251275|454544392|FG003|Overall Study|Lost to Follow-up|0|||
126006270|NCT00783692|453314888|FG006|Induction Phase|Lack of Efficacy|0|||
126006271|NCT00783692|453314882|FG000|Induction Phase|Withdrawal by Subject|3|||
126425975|NCT00650767|454856251|FG002|Overall Study|Other|0|||
126425976|NCT00650767|454856252|FG003|Overall Study|Other|0|||
126425977|NCT01774799|454856253|FG000|Overall Study|Lost to Follow-up|1|||
126425978|NCT01774799|454856254|FG001|Overall Study|Lost to Follow-up|1|||
126425979|NCT01774799|454856255|FG002|Overall Study|Lost to Follow-up|0|||
126425980|NCT01774799|454856256|FG003|Overall Study|Lost to Follow-up|0|||
126425981|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
126425982|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
126425983|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
126425984|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
126425985|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
126425986|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
126425987|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
126425988|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
126425989|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
126425990|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
126425991|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
126425992|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
126425993|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
126425994|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
126425995|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
126425996|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
126425997|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
126425998|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
126425999|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
126426000|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
126426001|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
126426002|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
126426003|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
126426004|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
126426005|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
126426006|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
126426007|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
126426008|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
126426009|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
126426010|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
126426011|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
126426012|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
126426013|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
126426014|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
126426015|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
126426016|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
126426017|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
126426018|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
126426019|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
126426020|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
126426021|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
126426022|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
126426023|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
126426024|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
126426025|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
126426026|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
126426027|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
126426028|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
126426029|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
126426030|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
126426031|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
126426032|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
126426033|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
126426034|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
126426035|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
126426036|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
126426037|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
126426038|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
126426039|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
126426040|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
126426041|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
126426042|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
126426043|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
126426044|NCT03064490|454856264|FG000|Overall Study|Physician Decision|5|||
126426045|NCT04158583|454856268|FG000|Overall Study|Withdrawal by Subject|1|||
126426046|NCT04158583|454856269|FG001|Overall Study|Withdrawal by Subject|1|||
126426047|NCT04158583|454856270|FG002|Overall Study|Withdrawal by Subject|0|||
126426048|NCT04158583|454856271|FG003|Overall Study|Withdrawal by Subject|0|||
126426049|NCT04158583|454856272|FG004|Overall Study|Withdrawal by Subject|1|||
126426050|NCT04158583|454856273|FG005|Overall Study|Withdrawal by Subject|0|||
126426051|NCT04158583|454856274|FG006|Overall Study|Withdrawal by Subject|0|||
126426052|NCT04158583|454856275|FG007|Overall Study|Withdrawal by Subject|0|||
126426053|NCT04158583|454856276|FG008|Overall Study|Withdrawal by Subject|2|||
126426054|NCT04158583|454856277|FG009|Overall Study|Withdrawal by Subject|0|||
126426055|NCT04158583|454856268|FG000|Overall Study|Study Terminated by Sponsor|0|||
126426056|NCT04158583|454856269|FG001|Overall Study|Study Terminated by Sponsor|0|||
126426057|NCT04158583|454856270|FG002|Overall Study|Study Terminated by Sponsor|0|||
126426058|NCT04158583|454856271|FG003|Overall Study|Study Terminated by Sponsor|1|||
126426059|NCT04158583|454856272|FG004|Overall Study|Study Terminated by Sponsor|0|||
126426060|NCT04158583|454856273|FG005|Overall Study|Study Terminated by Sponsor|0|||
126426061|NCT04158583|454856274|FG006|Overall Study|Study Terminated by Sponsor|0|||
126426062|NCT04158583|454856275|FG007|Overall Study|Study Terminated by Sponsor|0|||
126426063|NCT04158583|454856276|FG008|Overall Study|Study Terminated by Sponsor|0|||
126426064|NCT04158583|454856277|FG009|Overall Study|Study Terminated by Sponsor|0|||
126426065|NCT04158583|454856268|FG000|Overall Study|Progressive Disease|1|||
126426066|NCT04158583|454856269|FG001|Overall Study|Progressive Disease|0|||
126426067|NCT04158583|454856270|FG002|Overall Study|Progressive Disease|3|||
126426068|NCT04158583|454856271|FG003|Overall Study|Progressive Disease|5|||
126426069|NCT04158583|454856272|FG004|Overall Study|Progressive Disease|0|||
126426070|NCT04158583|454856273|FG005|Overall Study|Progressive Disease|1|||
126426071|NCT04158583|454856274|FG006|Overall Study|Progressive Disease|6|||
126426072|NCT04158583|454856275|FG007|Overall Study|Progressive Disease|2|||
126426073|NCT04158583|454856276|FG008|Overall Study|Progressive Disease|1|||
126426074|NCT04158583|454856277|FG009|Overall Study|Progressive Disease|2|||
126426075|NCT04158583|454856268|FG000|Overall Study|Lost to Follow-up|0|||
126426076|NCT04158583|454856269|FG001|Overall Study|Lost to Follow-up|0|||
126426077|NCT04158583|454856270|FG002|Overall Study|Lost to Follow-up|1|||
126426078|NCT04158583|454856271|FG003|Overall Study|Lost to Follow-up|1|||
126426079|NCT04158583|454856272|FG004|Overall Study|Lost to Follow-up|1|||
126426080|NCT04158583|454856273|FG005|Overall Study|Lost to Follow-up|0|||
126426081|NCT04158583|454856274|FG006|Overall Study|Lost to Follow-up|0|||
126426082|NCT04158583|454856275|FG007|Overall Study|Lost to Follow-up|0|||
126426083|NCT04158583|454856276|FG008|Overall Study|Lost to Follow-up|0|||
126426084|NCT04158583|454856277|FG009|Overall Study|Lost to Follow-up|0|||
126426085|NCT04158583|454856268|FG000|Overall Study|Due To Patient Status|0|||
126426086|NCT04158583|454856269|FG001|Overall Study|Due To Patient Status|0|||
126426087|NCT04158583|454856270|FG002|Overall Study|Due To Patient Status|0|||
126426088|NCT04158583|454856271|FG003|Overall Study|Due To Patient Status|0|||
126426089|NCT04158583|454856272|FG004|Overall Study|Due To Patient Status|0|||
126426090|NCT04158583|454856273|FG005|Overall Study|Due To Patient Status|0|||
126426091|NCT04158583|454856274|FG006|Overall Study|Due To Patient Status|0|||
126426092|NCT04158583|454856275|FG007|Overall Study|Due To Patient Status|0|||
126426093|NCT04158583|454856276|FG008|Overall Study|Due To Patient Status|1|||
126426094|NCT04158583|454856277|FG009|Overall Study|Due To Patient Status|0|||
126426095|NCT04158583|454856268|FG000|Overall Study|Death|3|||
126426096|NCT04158583|454856269|FG001|Overall Study|Death|4|||
126426097|NCT04158583|454856270|FG002|Overall Study|Death|2|||
126426098|NCT04158583|454856271|FG003|Overall Study|Death|2|||
126426099|NCT04158583|454856272|FG004|Overall Study|Death|4|||
126426100|NCT04158583|454856273|FG005|Overall Study|Death|3|||
126426101|NCT04158583|454856274|FG006|Overall Study|Death|5|||
126426102|NCT04158583|454856275|FG007|Overall Study|Death|2|||
126426103|NCT04158583|454856276|FG008|Overall Study|Death|0|||
126426104|NCT04158583|454856277|FG009|Overall Study|Death|1|||
126209491|NCT03110107|454055396|FG003|Treatment Period|Adverse Event|0|||
126426105|NCT04158583|454856268|FG000|Overall Study|Clinical Progression Disease|0|||
126426106|NCT04158583|454856269|FG001|Overall Study|Clinical Progression Disease|0|||
126426107|NCT04158583|454856270|FG002|Overall Study|Clinical Progression Disease|0|||
126426108|NCT04158583|454856271|FG003|Overall Study|Clinical Progression Disease|1|||
126426109|NCT04158583|454856272|FG004|Overall Study|Clinical Progression Disease|0|||
126426110|NCT04158583|454856273|FG005|Overall Study|Clinical Progression Disease|0|||
126426111|NCT04158583|454856274|FG006|Overall Study|Clinical Progression Disease|0|||
126426112|NCT04158583|454856275|FG007|Overall Study|Clinical Progression Disease|0|||
126426113|NCT04158583|454856276|FG008|Overall Study|Clinical Progression Disease|0|||
126426114|NCT04158583|454856277|FG009|Overall Study|Clinical Progression Disease|0|||
126426115|NCT04158583|454856268|FG000|Overall Study|Clinical Progression|0|||
126426116|NCT04158583|454856269|FG001|Overall Study|Clinical Progression|0|||
126426117|NCT04158583|454856270|FG002|Overall Study|Clinical Progression|0|||
126426118|NCT04158583|454856271|FG003|Overall Study|Clinical Progression|0|||
126340785|NCT02251275|454544393|FG004|Overall Study|Lost to Follow-up|0|||
126340786|NCT02251275|454544389|FG000|Overall Study|Physician Decision|19|||
126340787|NCT02251275|454544390|FG001|Overall Study|Physician Decision|30|||
126340788|NCT02251275|454544391|FG002|Overall Study|Physician Decision|26|||
126340789|NCT02251275|454544392|FG003|Overall Study|Physician Decision|0|||
126340790|NCT02251275|454544393|FG004|Overall Study|Physician Decision|1|||
126340791|NCT02251275|454544389|FG000|Overall Study|Protocol Deviation|0|||
126340792|NCT02251275|454544390|FG001|Overall Study|Protocol Deviation|0|||
126340793|NCT02251275|454544391|FG002|Overall Study|Protocol Deviation|1|||
126340794|NCT02251275|454544392|FG003|Overall Study|Protocol Deviation|0|||
126340795|NCT02251275|454544393|FG004|Overall Study|Protocol Deviation|0|||
126340796|NCT02251275|454544389|FG000|Overall Study|Withdrawal by Subject|25|||
126340797|NCT02251275|454544390|FG001|Overall Study|Withdrawal by Subject|51|||
126340798|NCT02251275|454544391|FG002|Overall Study|Withdrawal by Subject|35|||
126340799|NCT02251275|454544392|FG003|Overall Study|Withdrawal by Subject|1|||
126340800|NCT02251275|454544393|FG004|Overall Study|Withdrawal by Subject|0|||
126340801|NCT00856180|454544399|FG000|Overall Study|Adverse Event|4|||
126340802|NCT00856180|454544399|FG000|Overall Study|Progressive Disease|16|||
126340803|NCT02265510|454544400|FG000|Overall Study|Withdrawal by Subject|1|||
126340804|NCT02265510|454544401|FG001|Overall Study|Withdrawal by Subject|1|||
126340805|NCT02265510|454544402|FG002|Overall Study|Withdrawal by Subject|2|||
126340806|NCT02265510|454544403|FG003|Overall Study|Withdrawal by Subject|1|||
126340807|NCT02265510|454544404|FG004|Overall Study|Withdrawal by Subject|0|||
126340808|NCT02265510|454544405|FG005|Overall Study|Withdrawal by Subject|2|||
126340809|NCT02265510|454544406|FG006|Overall Study|Withdrawal by Subject|0|||
126340810|NCT02265510|454544407|FG007|Overall Study|Withdrawal by Subject|2|||
126340811|NCT02265510|454544408|FG008|Overall Study|Withdrawal by Subject|0|||
126340812|NCT02265510|454544409|FG009|Overall Study|Withdrawal by Subject|0|||
126340813|NCT02265510|454544410|FG010|Overall Study|Withdrawal by Subject|0|||
126340814|NCT02265510|454544411|FG011|Overall Study|Withdrawal by Subject|0|||
126340815|NCT02265510|454544412|FG012|Overall Study|Withdrawal by Subject|1|||
126340816|NCT02265510|454544413|FG013|Overall Study|Withdrawal by Subject|0|||
126340817|NCT02265510|454544400|FG000|Overall Study|Disease Progression|0|||
126340818|NCT02265510|454544401|FG001|Overall Study|Disease Progression|1|||
126340819|NCT02265510|454544402|FG002|Overall Study|Disease Progression|2|||
126340820|NCT02265510|454544403|FG003|Overall Study|Disease Progression|1|||
126340821|NCT02265510|454544404|FG004|Overall Study|Disease Progression|1|||
126340822|NCT02265510|454544405|FG005|Overall Study|Disease Progression|0|||
126340823|NCT02265510|454544406|FG006|Overall Study|Disease Progression|0|||
126340824|NCT02265510|454544407|FG007|Overall Study|Disease Progression|0|||
126340825|NCT02265510|454544408|FG008|Overall Study|Disease Progression|0|||
126340826|NCT02265510|454544409|FG009|Overall Study|Disease Progression|0|||
126340827|NCT02265510|454544410|FG010|Overall Study|Disease Progression|0|||
126340828|NCT02265510|454544411|FG011|Overall Study|Disease Progression|0|||
126340829|NCT02265510|454544412|FG012|Overall Study|Disease Progression|0|||
126340830|NCT02265510|454544413|FG013|Overall Study|Disease Progression|0|||
126340831|NCT02265510|454544400|FG000|Overall Study|Death|2|||
126340832|NCT02265510|454544401|FG001|Overall Study|Death|0|||
126340833|NCT02265510|454544402|FG002|Overall Study|Death|2|||
126340834|NCT02265510|454544403|FG003|Overall Study|Death|2|||
126340835|NCT02265510|454544404|FG004|Overall Study|Death|1|||
126340836|NCT02265510|454544405|FG005|Overall Study|Death|3|||
126340837|NCT02265510|454544406|FG006|Overall Study|Death|2|||
126340838|NCT02265510|454544407|FG007|Overall Study|Death|1|||
126340839|NCT02265510|454544408|FG008|Overall Study|Death|3|||
126340840|NCT02265510|454544409|FG009|Overall Study|Death|3|||
126340841|NCT02265510|454544410|FG010|Overall Study|Death|4|||
126340842|NCT02265510|454544411|FG011|Overall Study|Death|12|||
126340843|NCT02265510|454544412|FG012|Overall Study|Death|7|||
126340844|NCT02265510|454544413|FG013|Overall Study|Death|6|||
126340845|NCT02265510|454544400|FG000|Overall Study|Lost to Follow-up|0|||
126340846|NCT02265510|454544401|FG001|Overall Study|Lost to Follow-up|0|||
126340847|NCT02265510|454544402|FG002|Overall Study|Lost to Follow-up|0|||
126340848|NCT02265510|454544403|FG003|Overall Study|Lost to Follow-up|0|||
126340849|NCT02265510|454544404|FG004|Overall Study|Lost to Follow-up|1|||
126340850|NCT02265510|454544405|FG005|Overall Study|Lost to Follow-up|0|||
126340851|NCT02265510|454544406|FG006|Overall Study|Lost to Follow-up|0|||
126340852|NCT02265510|454544407|FG007|Overall Study|Lost to Follow-up|0|||
126426119|NCT04158583|454856272|FG004|Overall Study|Clinical Progression|1|||
126340853|NCT02265510|454544408|FG008|Overall Study|Lost to Follow-up|0|||
126340854|NCT02265510|454544409|FG009|Overall Study|Lost to Follow-up|2|||
126340855|NCT02265510|454544410|FG010|Overall Study|Lost to Follow-up|0|||
126340856|NCT02265510|454544411|FG011|Overall Study|Lost to Follow-up|0|||
126340857|NCT02265510|454544412|FG012|Overall Study|Lost to Follow-up|0|||
126340858|NCT02265510|454544413|FG013|Overall Study|Lost to Follow-up|2|||
126340859|NCT02265510|454544400|FG000|Overall Study|Other|0|||
126209492|NCT03110107|454055397|FG004|Treatment Period|Adverse Event|0|||
126340860|NCT02265510|454544401|FG001|Overall Study|Other|1|||
126340861|NCT02265510|454544402|FG002|Overall Study|Other|0|||
126340862|NCT02265510|454544403|FG003|Overall Study|Other|0|||
126340863|NCT02265510|454544404|FG004|Overall Study|Other|0|||
126426120|NCT04158583|454856273|FG005|Overall Study|Clinical Progression|0|||
126426121|NCT04158583|454856274|FG006|Overall Study|Clinical Progression|2|||
126426122|NCT04158583|454856275|FG007|Overall Study|Clinical Progression|0|||
126426123|NCT04158583|454856276|FG008|Overall Study|Clinical Progression|0|||
126426124|NCT04158583|454856277|FG009|Overall Study|Clinical Progression|0|||
126426125|NCT04158583|454856268|FG000|Overall Study|Clinical Deterioration|0|||
126426126|NCT04158583|454856269|FG001|Overall Study|Clinical Deterioration|0|||
126426127|NCT04158583|454856270|FG002|Overall Study|Clinical Deterioration|0|||
126426128|NCT04158583|454856271|FG003|Overall Study|Clinical Deterioration|1|||
126426129|NCT04158583|454856272|FG004|Overall Study|Clinical Deterioration|0|||
126426130|NCT04158583|454856273|FG005|Overall Study|Clinical Deterioration|0|||
126426131|NCT04158583|454856274|FG006|Overall Study|Clinical Deterioration|0|||
126426132|NCT04158583|454856275|FG007|Overall Study|Clinical Deterioration|0|||
126426133|NCT04158583|454856276|FG008|Overall Study|Clinical Deterioration|0|||
126426134|NCT04158583|454856277|FG009|Overall Study|Clinical Deterioration|1|||
126426135|NCT01871519|454856278|FG000|Overall Study|Death|26|||
126426136|NCT01871519|454856278|FG000|Overall Study|Lost to Follow-up|15|||
126426137|NCT01871519|454856278|FG000|Overall Study|Withdrawal by Subject|49|||
126426138|NCT00320515|454856279|FG000|Overall Study|Death|33|||
126426139|NCT00320515|454856279|FG000|Overall Study|Lost to Follow-up|6|||
126426140|NCT00320515|454856279|FG000|Overall Study|Physician Decision|2|||
126426141|NCT00320515|454856279|FG000|Overall Study|Withdrawal by Subject|8|||
126426142|NCT00794950|454856280|FG000|BCG Induction|Withdrawal by Subject|2|||
126426143|NCT00794950|454856280|FG000|BCG Induction|ineligible|3|||
126426144|NCT00794950|454856280|FG000|BCG Induction|noncompliant w. BCG|1|||
126426145|NCT00794950|454856280|FG000|BCG Induction|Adverse Event|1|||
126426146|NCT00794950|454856280|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
126426147|NCT00794950|454856280|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
126426148|NCT00794950|454856280|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
126426149|NCT00794950|454856280|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
126426150|NCT02485704|454856281|FG000|Overall Study|Lost to Follow-up|4|||
126426151|NCT02485704|454856282|FG001|Overall Study|Lost to Follow-up|5|||
126426152|NCT02485704|454856281|FG000|Overall Study|Withdrawal by Subject|0|||
126426153|NCT02485704|454856282|FG001|Overall Study|Withdrawal by Subject|3|||
126426154|NCT02485704|454856281|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
126426155|NCT02485704|454856282|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
126426156|NCT01777776|454856283|FG000|Overall Study|Adverse Event|2|||
126426157|NCT01777776|454856284|FG001|Overall Study|Adverse Event|4|||
126426158|NCT01777776|454856285|FG002|Overall Study|Adverse Event|0|||
126426159|NCT01777776|454856286|FG003|Overall Study|Adverse Event|0|||
126426160|NCT01777776|454856283|FG000|Overall Study|Disease Progression|4|||
126426161|NCT01777776|454856284|FG001|Overall Study|Disease Progression|8|||
126426162|NCT01777776|454856285|FG002|Overall Study|Disease Progression|6|||
126426163|NCT01777776|454856286|FG003|Overall Study|Disease Progression|3|||
126426164|NCT01777776|454856283|FG000|Overall Study|Withdrawal by Subject|0|||
126426165|NCT01777776|454856284|FG001|Overall Study|Withdrawal by Subject|0|||
126426166|NCT01777776|454856285|FG002|Overall Study|Withdrawal by Subject|0|||
126426167|NCT01777776|454856286|FG003|Overall Study|Withdrawal by Subject|1|||
126426168|NCT04481243|454857773|FG000|Overall Study|Withdrawal by Subject|4|||
126426169|NCT03737123|454857774|FG000|Study Treatment|Adverse Event|2|||
126426170|NCT03737123|454857775|FG001|Study Treatment|Adverse Event|0|||
126426171|NCT03737123|454857774|FG000|Study Treatment|Disease Progression|2|||
126426172|NCT03737123|454857775|FG001|Study Treatment|Disease Progression|0|||
126426173|NCT03737123|454857774|FG000|Study Treatment|Withdrawal by Subject|2|||
126426174|NCT03737123|454857775|FG001|Study Treatment|Withdrawal by Subject|0|||
126426175|NCT03737123|454857774|FG000|Follow up|Death|1|||
126426176|NCT03737123|454857775|FG001|Follow up|Death|0|||
126426177|NCT03737123|454857774|FG000|Follow up|Withdrawal by Subject|1|||
126426178|NCT03737123|454857775|FG001|Follow up|Withdrawal by Subject|0|||
126426179|NCT03737123|454857774|FG000|Follow up|Termination of study|4|||
126426180|NCT03737123|454857775|FG001|Follow up|Termination of study|0|||
126426181|NCT04388111|454857777|FG000|Overall Study|Lost to Follow-up|5|||
126426182|NCT04388111|454857778|FG001|Overall Study|Lost to Follow-up|3|||
126426183|NCT04388111|454857777|FG000|Overall Study|Adverse Event|1|||
126426184|NCT04388111|454857778|FG001|Overall Study|Adverse Event|1|||
126426185|NCT04388111|454857777|FG000|Overall Study|Protocol Violation|2|||
126426186|NCT04388111|454857778|FG001|Overall Study|Protocol Violation|4|||
126426187|NCT04388111|454857777|FG000|Overall Study|Withdrawal by Subject|1|||
126426188|NCT04388111|454857778|FG001|Overall Study|Withdrawal by Subject|0|||
126426189|NCT00928486|454857779|FG000|Overall Study|Adverse Event|2|||
126426190|NCT00928486|454857779|FG000|Overall Study|Disease Progression|7|||
126426191|NCT00928486|454857779|FG000|Overall Study|Withdrawal by Subject|1|||
126426192|NCT01342913|454857780|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
126426193|NCT01342913|454857781|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126426194|NCT01342913|454857782|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126426195|NCT01342913|454857780|FG000|2-week Run-in Period|Physician Decision|6|||
126426196|NCT01342913|454857781|FG001|2-week Run-in Period|Physician Decision|0|||
126426197|NCT01342913|454857782|FG002|2-week Run-in Period|Physician Decision|0|||
126426198|NCT01342913|454857780|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
126426199|NCT01342913|454857781|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126426200|NCT01342913|454857782|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126426201|NCT01342913|454857780|FG000|2-week Run-in Period|Adverse Event|2|||
126426202|NCT01342913|454857781|FG001|2-week Run-in Period|Adverse Event|0|||
126426203|NCT01342913|454857782|FG002|2-week Run-in Period|Adverse Event|0|||
126426204|NCT01342913|454857780|FG000|2-week Run-in Period|Protocol Violation|5|||
126426205|NCT01342913|454857781|FG001|2-week Run-in Period|Protocol Violation|0|||
126426206|NCT01342913|454857782|FG002|2-week Run-in Period|Protocol Violation|0|||
126426207|NCT01342913|454857780|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
126426208|NCT01342913|454857781|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
126426209|NCT01342913|454857782|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
126426210|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126426211|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Adverse Event|3|||
126426212|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Adverse Event|6|||
126426213|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126426214|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
126426215|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
126426216|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126426217|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
126426218|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
126426219|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126426220|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126426221|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
126426222|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Physician Decision|0|||
126426223|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Physician Decision|2|||
126426224|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Physician Decision|0|||
126426225|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126426226|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126426227|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126426228|NCT04024891|454857789|FG000|Overall Study|Pregnancy|0|||
126426229|NCT04024891|454857790|FG001|Overall Study|Pregnancy|1|||
126426230|NCT00453154|454857792|FG000|Double BIind Maintenance|Adverse Event|0|||
126426231|NCT00453154|454857793|FG001|Double BIind Maintenance|Adverse Event|0|||
126426232|NCT00453154|454857794|FG002|Double BIind Maintenance|Adverse Event|3|||
126426233|NCT00453154|454857795|FG003|Double BIind Maintenance|Adverse Event|12|||
126426234|NCT00453154|454857792|FG000|Double BIind Maintenance|Death|0|||
126426235|NCT00453154|454857793|FG001|Double BIind Maintenance|Death|0|||
126426236|NCT00453154|454857794|FG002|Double BIind Maintenance|Death|2|||
126426237|NCT00453154|454857795|FG003|Double BIind Maintenance|Death|1|||
126426238|NCT00453154|454857792|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
126426239|NCT00453154|454857793|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
126426240|NCT00453154|454857794|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
126426241|NCT00453154|454857795|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
126426242|NCT00453154|454857792|FG000|Double BIind Maintenance|Progression|0|||
126426243|NCT00453154|454857793|FG001|Double BIind Maintenance|Progression|0|||
126426244|NCT00453154|454857794|FG002|Double BIind Maintenance|Progression|29|||
126426245|NCT00453154|454857795|FG003|Double BIind Maintenance|Progression|26|||
126426246|NCT00453154|454857792|FG000|Double BIind Maintenance|Medical Issues|0|||
126426247|NCT00453154|454857793|FG001|Double BIind Maintenance|Medical Issues|0|||
126426248|NCT00453154|454857794|FG002|Double BIind Maintenance|Medical Issues|3|||
126426249|NCT00453154|454857795|FG003|Double BIind Maintenance|Medical Issues|1|||
126426250|NCT00453154|454857792|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
126426251|NCT00453154|454857793|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
126426252|NCT00453154|454857794|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
126426253|NCT00453154|454857795|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
126426254|NCT01790594|454857797|FG000|Overall Study|Death|1|||
126426255|NCT01790594|454857798|FG001|Overall Study|Death|0|||
126426256|NCT01790594|454857799|FG002|Overall Study|Death|0|||
126426257|NCT01790594|454857797|FG000|Overall Study|Physician Decision|2|||
126006272|NCT00783692|453314883|FG001|Induction Phase|Withdrawal by Subject|9|||
126006273|NCT00783692|453314884|FG002|Induction Phase|Withdrawal by Subject|16|||
126006274|NCT00783692|453314885|FG003|Induction Phase|Withdrawal by Subject|0|||
126006275|NCT00783692|453314886|FG004|Induction Phase|Withdrawal by Subject|0|||
126426258|NCT01790594|454857798|FG001|Overall Study|Physician Decision|1|||
126426259|NCT01790594|454857799|FG002|Overall Study|Physician Decision|0|||
126006276|NCT00783692|453314887|FG005|Induction Phase|Withdrawal by Subject|0|||
126426260|NCT01790594|454857797|FG000|Overall Study|Withdrawal by Subject|2|||
126426261|NCT01790594|454857798|FG001|Overall Study|Withdrawal by Subject|0|||
126426262|NCT01790594|454857799|FG002|Overall Study|Withdrawal by Subject|0|||
126006277|NCT00783692|453314888|FG006|Induction Phase|Withdrawal by Subject|0|||
126426263|NCT01790594|454857797|FG000|Overall Study|Transplant was not done|0|||
126426264|NCT01790594|454857798|FG001|Overall Study|Transplant was not done|0|||
126426265|NCT01790594|454857799|FG002|Overall Study|Transplant was not done|3|||
126426266|NCT01790594|454857797|FG000|Overall Study|Terminated prior to week 76|0|||
126426267|NCT01790594|454857798|FG001|Overall Study|Terminated prior to week 76|2|||
126426268|NCT01790594|454857799|FG002|Overall Study|Terminated prior to week 76|0|||
126426269|NCT03291067|454857801|FG000|Overall Study|Adverse Event|0|||
126426270|NCT03291067|454857802|FG001|Overall Study|Adverse Event|2|||
126426271|NCT03291067|454857803|FG002|Overall Study|Adverse Event|17|||
126426272|NCT03291067|454857804|FG003|Overall Study|Adverse Event|3|||
126426273|NCT03291067|454857801|FG000|Overall Study|Lost to Follow-up|2|||
126426274|NCT03291067|454857802|FG001|Overall Study|Lost to Follow-up|1|||
126426275|NCT03291067|454857803|FG002|Overall Study|Lost to Follow-up|0|||
126426276|NCT03291067|454857804|FG003|Overall Study|Lost to Follow-up|1|||
126426277|NCT03291067|454857801|FG000|Overall Study|Physician Decision|0|||
126426278|NCT03291067|454857802|FG001|Overall Study|Physician Decision|0|||
126426279|NCT03291067|454857803|FG002|Overall Study|Physician Decision|1|||
126426280|NCT03291067|454857804|FG003|Overall Study|Physician Decision|0|||
126426281|NCT03291067|454857801|FG000|Overall Study|Protocol Violation|5|||
126426282|NCT03291067|454857802|FG001|Overall Study|Protocol Violation|3|||
126426283|NCT03291067|454857803|FG002|Overall Study|Protocol Violation|4|||
126426284|NCT03291067|454857804|FG003|Overall Study|Protocol Violation|2|||
126426285|NCT03291067|454857801|FG000|Overall Study|Withdrawal by Subject|3|||
126426286|NCT03291067|454857802|FG001|Overall Study|Withdrawal by Subject|4|||
126426287|NCT03291067|454857803|FG002|Overall Study|Withdrawal by Subject|7|||
126426288|NCT03291067|454857804|FG003|Overall Study|Withdrawal by Subject|5|||
126426289|NCT03291067|454857801|FG000|Overall Study|Other|0|||
126426290|NCT03291067|454857802|FG001|Overall Study|Other|4|||
126426291|NCT03291067|454857803|FG002|Overall Study|Other|4|||
126426292|NCT03291067|454857804|FG003|Overall Study|Other|6|||
126426293|NCT02152631|454857805|FG000|Overall Study|Adverse Event|32|||
126426294|NCT02152631|454857806|FG001|Overall Study|Adverse Event|4|||
126426295|NCT02152631|454857805|FG000|Overall Study|Withdrawal by Subject|13|||
126426296|NCT02152631|454857806|FG001|Overall Study|Withdrawal by Subject|16|||
126426297|NCT02152631|454857805|FG000|Overall Study|Noncompliance with study drug|1|||
126426298|NCT02152631|454857806|FG001|Overall Study|Noncompliance with study drug|0|||
126426299|NCT02152631|454857805|FG000|Overall Study|Physician Decision|1|||
126426300|NCT02152631|454857806|FG001|Overall Study|Physician Decision|2|||
126426301|NCT02152631|454857805|FG000|Overall Study|Lost to Follow-up|0|||
126426302|NCT02152631|454857806|FG001|Overall Study|Lost to Follow-up|1|||
126426303|NCT02152631|454857805|FG000|Overall Study|On Treatment|19|||
126426304|NCT02152631|454857806|FG001|Overall Study|On Treatment|3|||
126426305|NCT05473026|454857807|FG000|Overall Study|Lost to Follow-up|5|||
126426306|NCT05473026|454857808|FG001|Overall Study|Lost to Follow-up|2|||
126426307|NCT03683173|454857819|FG000|Completed Follow-up|Unavailable|235|||
126426308|NCT03683173|454857820|FG001|Completed Follow-up|Unavailable|217|||
126426309|NCT03683173|454857819|FG000|Completed Follow-up|Refused|69|||
126426310|NCT03683173|454857820|FG001|Completed Follow-up|Refused|59|||
126426311|NCT03683173|454857819|FG000|Completed Follow-up|Disconnected phone|65|||
126426312|NCT03683173|454857820|FG001|Completed Follow-up|Disconnected phone|95|||
126426313|NCT03683173|454857819|FG000|Completed Follow-up|Health issue/deceased|10|||
126426314|NCT03683173|454857820|FG001|Completed Follow-up|Health issue/deceased|4|||
126426315|NCT03683173|454857819|FG000|Completed Follow-up|Moved away|8|||
126426316|NCT03683173|454857820|FG001|Completed Follow-up|Moved away|1|||
126426317|NCT02210000|454857821|FG000|Overall Study|Study Terminated|11|||
126426318|NCT02210000|454857822|FG001|Overall Study|Study Terminated|12|||
126426319|NCT02210000|454857821|FG000|Overall Study|Withdrawal by Subject|7|||
126426320|NCT02210000|454857822|FG001|Overall Study|Withdrawal by Subject|1|||
126426321|NCT02210000|454857821|FG000|Overall Study|Adverse Event|1|||
126426322|NCT02210000|454857822|FG001|Overall Study|Adverse Event|5|||
126426323|NCT02210000|454857821|FG000|Overall Study|Lost to Follow-up|0|||
126426324|NCT02210000|454857822|FG001|Overall Study|Lost to Follow-up|2|||
126426325|NCT02210000|454857821|FG000|Overall Study|Physician Decision|0|||
126426326|NCT02210000|454857822|FG001|Overall Study|Physician Decision|1|||
126426327|NCT01329263|454857825|FG000|Overall Study|Lost to Follow-up|4|||
126426328|NCT01329263|454857826|FG001|Overall Study|Lost to Follow-up|21|||
126426329|NCT01329263|454857825|FG000|Overall Study|Withdrawal by Subject|1|||
126426330|NCT01329263|454857826|FG001|Overall Study|Withdrawal by Subject|2|||
126426331|NCT01421017|454857828|FG000|Overall Study|Withdrawal by Subject|2|||
126426332|NCT01421017|454857829|FG001|Overall Study|Withdrawal by Subject|0|||
126426333|NCT01421017|454857830|FG002|Overall Study|Withdrawal by Subject|0|||
126426334|NCT01421017|454857828|FG000|Overall Study|POD|0|||
126426335|NCT01421017|454857829|FG001|Overall Study|POD|6|||
126426336|NCT01421017|454857830|FG002|Overall Study|POD|3|||
126426337|NCT00308139|454857831|FG000|Overall Study|Adverse Event|20|||
126426338|NCT00308139|454857832|FG001|Overall Study|Adverse Event|14|||
126426339|NCT00308139|454857831|FG000|Overall Study|Lost to Follow-up|13|||
126426340|NCT00308139|454857832|FG001|Overall Study|Lost to Follow-up|8|||
126426341|NCT00308139|454857831|FG000|Overall Study|Protocol Violation|3|||
126426342|NCT00308139|454857832|FG001|Overall Study|Protocol Violation|2|||
126426343|NCT00308139|454857831|FG000|Overall Study|Withdrawal of Consent|40|||
126426344|NCT00308139|454857832|FG001|Overall Study|Withdrawal of Consent|42|||
126426345|NCT00308139|454857831|FG000|Overall Study|Investigator Decision|11|||
126426346|NCT00308139|454857832|FG001|Overall Study|Investigator Decision|10|||
126426347|NCT00308139|454857831|FG000|Overall Study|Loss of Glucose Control|5|||
126426348|NCT00308139|454857832|FG001|Overall Study|Loss of Glucose Control|7|||
126426349|NCT00308139|454857831|FG000|Overall Study|Administrative|1|||
126426350|NCT00308139|454857832|FG001|Overall Study|Administrative|4|||
126426351|NCT00308139|454857831|FG000|Overall Study|Other|1|||
126006278|NCT00783692|453314882|FG000|Induction Phase|Lost to Follow-up|0|||
126006279|NCT00783692|453314883|FG001|Induction Phase|Lost to Follow-up|0|||
126006280|NCT00783692|453314884|FG002|Induction Phase|Lost to Follow-up|3|||
126006281|NCT00783692|453314885|FG003|Induction Phase|Lost to Follow-up|0|||
126006282|NCT00783692|453314886|FG004|Induction Phase|Lost to Follow-up|0|||
126006283|NCT00783692|453314887|FG005|Induction Phase|Lost to Follow-up|0|||
126006284|NCT00783692|453314888|FG006|Induction Phase|Lost to Follow-up|0|||
126006285|NCT00783692|453314882|FG000|Induction Phase|Other|0|||
126426352|NCT00308139|454857832|FG001|Overall Study|Other|0|||
126426353|NCT00833040|454857835|FG000|Overall Study|Adverse Event|0|||
126006286|NCT00783692|453314883|FG001|Induction Phase|Other|0|||
126006287|NCT00783692|453314884|FG002|Induction Phase|Other|2|||
126006288|NCT00783692|453314885|FG003|Induction Phase|Other|0|||
126006289|NCT00783692|453314886|FG004|Induction Phase|Other|0|||
126426354|NCT00833040|454857836|FG001|Overall Study|Adverse Event|0|||
126426355|NCT00833040|454857837|FG002|Overall Study|Adverse Event|0|||
126426356|NCT00833040|454857838|FG003|Overall Study|Adverse Event|0|||
126426357|NCT00833040|454857839|FG004|Overall Study|Adverse Event|0|||
126426358|NCT00833040|454857840|FG005|Overall Study|Adverse Event|1|||
126426359|NCT02313766|454857841|FG000|Overall Study|surgery cancelled|1|||
126426360|NCT02313766|454857842|FG001|Overall Study|surgery cancelled|0|||
126426361|NCT02313766|454857843|FG002|Overall Study|surgery cancelled|0|||
126426362|NCT02313766|454857841|FG000|Overall Study|Lost to Follow-up|0|||
126426363|NCT02313766|454857842|FG001|Overall Study|Lost to Follow-up|2|||
126426364|NCT02313766|454857843|FG002|Overall Study|Lost to Follow-up|0|||
126426365|NCT02313766|454857841|FG000|Overall Study|Adverse Event|0|||
126426366|NCT02313766|454857842|FG001|Overall Study|Adverse Event|1|||
126426367|NCT02313766|454857843|FG002|Overall Study|Adverse Event|0|||
126426368|NCT02193776|454857845|FG000|Overall Study|Consent withdrawn|1|||
126426369|NCT02193776|454857846|FG001|Overall Study|Consent withdrawn|0|||
126426370|NCT02193776|454857847|FG002|Overall Study|Consent withdrawn|0|||
126426371|NCT02193776|454857848|FG003|Overall Study|Consent withdrawn|0|||
126426372|NCT02193776|454857845|FG000|Overall Study|Failure to comply with protocol|0|||
126426373|NCT02193776|454857846|FG001|Overall Study|Failure to comply with protocol|1|||
126426374|NCT02193776|454857847|FG002|Overall Study|Failure to comply with protocol|0|||
126426375|NCT02193776|454857848|FG003|Overall Study|Failure to comply with protocol|0|||
126426376|NCT02193776|454857845|FG000|Overall Study|Investigator/Sponsor decision|1|||
126426377|NCT02193776|454857846|FG001|Overall Study|Investigator/Sponsor decision|1|||
126426378|NCT02193776|454857847|FG002|Overall Study|Investigator/Sponsor decision|0|||
126426379|NCT02193776|454857848|FG003|Overall Study|Investigator/Sponsor decision|0|||
126426380|NCT02193776|454857845|FG000|Overall Study|Death|1|||
126426381|NCT02193776|454857846|FG001|Overall Study|Death|0|||
126426382|NCT02193776|454857847|FG002|Overall Study|Death|0|||
126426383|NCT02193776|454857848|FG003|Overall Study|Death|0|||
126426384|NCT02193776|454857845|FG000|Overall Study|Adverse event/Specific toxicity|5|||
126426385|NCT02193776|454857846|FG001|Overall Study|Adverse event/Specific toxicity|5|||
126426386|NCT02193776|454857847|FG002|Overall Study|Adverse event/Specific toxicity|2|||
126426387|NCT02193776|454857848|FG003|Overall Study|Adverse event/Specific toxicity|2|||
126426388|NCT01458639|454857849|FG000|Overall Study|Physician Decision|4|||
126426389|NCT01458639|454857849|FG000|Overall Study|Equipment issue|1|||
126426390|NCT01458639|454857849|FG000|Overall Study|Inability to obtain subject blood sample|1|||
126006290|NCT00783692|453314887|FG005|Induction Phase|Other|0|||
126006291|NCT00783692|453314888|FG006|Induction Phase|Other|0|||
126006292|NCT00783692|453314882|FG000|Maintenance Phase|Adverse Event|7|||
126209493|NCT03110107|454055398|FG005|Treatment Period|Adverse Event|2|||
126426391|NCT01884077|454857850|FG000|Overall Study|screen fail|0|||
126426392|NCT01884077|454857851|FG001|Overall Study|screen fail|2|||
126426393|NCT01884077|454857850|FG000|Overall Study|canceled surgery|2|||
126426394|NCT01884077|454857851|FG001|Overall Study|canceled surgery|0|||
126426395|NCT01884077|454857850|FG000|Overall Study|Lost to Follow-up|0|||
126426396|NCT01884077|454857851|FG001|Overall Study|Lost to Follow-up|4|||
126426397|NCT01884077|454857850|FG000|Overall Study|study closed|6|||
126426398|NCT01884077|454857851|FG001|Overall Study|study closed|4|||
126426399|NCT00981149|454857852|FG000|Overall Study|Lost to Follow-up|1|||
126426400|NCT00981149|454857853|FG001|Overall Study|Lost to Follow-up|2|||
126426401|NCT00981149|454857852|FG000|Overall Study|Withdrawal by Subject|1|||
126426402|NCT00981149|454857853|FG001|Overall Study|Withdrawal by Subject|1|||
126426403|NCT02748863|454857854|FG000|Treatment Period 1|Adverse Event|0|||
126426404|NCT02748863|454857855|FG001|Treatment Period 1|Adverse Event|1|||
126426405|NCT02748863|454857856|FG002|Treatment Period 1|Adverse Event|0|||
126426406|NCT02748863|454857857|FG003|Treatment Period 1|Adverse Event|0|||
126426407|NCT02748863|454857858|FG004|Treatment Period 1|Adverse Event|0|||
126426408|NCT02748863|454857854|FG000|Treatment Period 1|Lack of Efficacy|0|||
126426409|NCT02748863|454857855|FG001|Treatment Period 1|Lack of Efficacy|0|||
126426410|NCT02748863|454857856|FG002|Treatment Period 1|Lack of Efficacy|1|||
126426411|NCT02748863|454857857|FG003|Treatment Period 1|Lack of Efficacy|0|||
126426412|NCT02748863|454857858|FG004|Treatment Period 1|Lack of Efficacy|0|||
126426413|NCT02748863|454857854|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126426414|NCT02748863|454857855|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126426415|NCT02748863|454857856|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126426416|NCT02748863|454857857|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126426417|NCT02748863|454857858|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126426418|NCT02748863|454857854|FG000|Treatment Period 2|Lost to Follow-up|2|||
126426419|NCT02748863|454857855|FG001|Treatment Period 2|Lost to Follow-up|0|||
126426420|NCT02748863|454857856|FG002|Treatment Period 2|Lost to Follow-up|0|||
126426421|NCT02748863|454857857|FG003|Treatment Period 2|Lost to Follow-up|0|||
126340864|NCT02265510|454544405|FG005|Overall Study|Other|0|||
126340865|NCT02265510|454544406|FG006|Overall Study|Other|0|||
126340866|NCT02265510|454544407|FG007|Overall Study|Other|0|||
126340867|NCT02265510|454544408|FG008|Overall Study|Other|0|||
126340868|NCT02265510|454544409|FG009|Overall Study|Other|0|||
126340869|NCT02265510|454544410|FG010|Overall Study|Other|0|||
126340870|NCT02265510|454544411|FG011|Overall Study|Other|0|||
126340871|NCT02265510|454544412|FG012|Overall Study|Other|0|||
126340872|NCT02265510|454544413|FG013|Overall Study|Other|0|||
126340873|NCT02265510|454544400|FG000|Overall Study|Study Terminated by Sponsor|0|||
126340874|NCT02265510|454544401|FG001|Overall Study|Study Terminated by Sponsor|0|||
126340875|NCT02265510|454544402|FG002|Overall Study|Study Terminated by Sponsor|0|||
126340876|NCT02265510|454544403|FG003|Overall Study|Study Terminated by Sponsor|0|||
126340877|NCT02265510|454544404|FG004|Overall Study|Study Terminated by Sponsor|0|||
126340878|NCT02265510|454544405|FG005|Overall Study|Study Terminated by Sponsor|1|||
126340879|NCT02265510|454544406|FG006|Overall Study|Study Terminated by Sponsor|1|||
126340880|NCT02265510|454544407|FG007|Overall Study|Study Terminated by Sponsor|1|||
126340881|NCT02265510|454544408|FG008|Overall Study|Study Terminated by Sponsor|1|||
126340882|NCT02265510|454544409|FG009|Overall Study|Study Terminated by Sponsor|2|||
126340883|NCT02265510|454544410|FG010|Overall Study|Study Terminated by Sponsor|1|||
126340884|NCT02265510|454544411|FG011|Overall Study|Study Terminated by Sponsor|4|||
126340885|NCT02265510|454544412|FG012|Overall Study|Study Terminated by Sponsor|1|||
126340886|NCT02265510|454544413|FG013|Overall Study|Study Terminated by Sponsor|2|||
126340887|NCT01004614|454544414|FG000|Washout|Withdrawal by Subject|0|||
126340888|NCT01004614|454544415|FG001|Washout|Withdrawal by Subject|1|||
126340889|NCT01004614|454544416|FG002|Washout|Withdrawal by Subject|0|||
126340890|NCT01004614|454544417|FG003|Washout|Withdrawal by Subject|0|||
126340891|NCT02111083|454544418|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
126340892|NCT02111083|454544419|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
126340893|NCT00686972|454544420|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
126340894|NCT00368550|454544421|FG000|Overall Study|Adverse Event|7|||
126340895|NCT00368550|454544422|FG001|Overall Study|Adverse Event|4|||
126340896|NCT00368550|454544421|FG000|Overall Study|Lack of Efficacy|4|||
126340897|NCT00368550|454544422|FG001|Overall Study|Lack of Efficacy|9|||
126340898|NCT00368550|454544421|FG000|Overall Study|Withdrawal by Subject|17|||
126340899|NCT00368550|454544422|FG001|Overall Study|Withdrawal by Subject|10|||
126340900|NCT00486044|454544423|FG000|Overall Study|Withdrawal by Subject|2|||
126340901|NCT00486044|454544424|FG001|Overall Study|Withdrawal by Subject|1|||
126340902|NCT00486044|454544423|FG000|Overall Study|Adverse Event|0|||
126340903|NCT00486044|454544424|FG001|Overall Study|Adverse Event|1|||
126340904|NCT00486044|454544423|FG000|Overall Study|Lost to Follow-up|0|||
126340905|NCT00486044|454544424|FG001|Overall Study|Lost to Follow-up|1|||
126340906|NCT01670292|454544429|FG000|Overall Study|Lost to Follow-up|14|||
126340907|NCT03154086|454544433|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340908|NCT03154086|454544434|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340909|NCT03154086|454544435|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340910|NCT03154086|454544436|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
126340911|NCT03154086|454544437|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340912|NCT03154086|454544438|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340913|NCT03154086|454544439|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340914|NCT03154086|454544440|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340915|NCT03154086|454544441|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340916|NCT03154086|454544442|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340917|NCT03154086|454544443|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340918|NCT03154086|454544444|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340919|NCT03154086|454544445|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340920|NCT03154086|454544446|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126426422|NCT02748863|454857858|FG004|Treatment Period 2|Lost to Follow-up|0|||
126426423|NCT02748863|454857854|FG000|Treatment Period 2|Adverse Event|3|||
126426424|NCT02748863|454857855|FG001|Treatment Period 2|Adverse Event|2|||
126426425|NCT02748863|454857856|FG002|Treatment Period 2|Adverse Event|0|||
126426426|NCT02748863|454857857|FG003|Treatment Period 2|Adverse Event|2|||
126426427|NCT02748863|454857858|FG004|Treatment Period 2|Adverse Event|0|||
126426428|NCT02748863|454857854|FG000|Treatment Period 2|Lack of Efficacy|0|||
126426429|NCT02748863|454857855|FG001|Treatment Period 2|Lack of Efficacy|1|||
126426430|NCT02748863|454857856|FG002|Treatment Period 2|Lack of Efficacy|0|||
126426431|NCT02748863|454857857|FG003|Treatment Period 2|Lack of Efficacy|0|||
126426432|NCT02748863|454857858|FG004|Treatment Period 2|Lack of Efficacy|0|||
126426433|NCT02748863|454857854|FG000|Treatment Period 2|Pregnancy|0|||
126426434|NCT02748863|454857855|FG001|Treatment Period 2|Pregnancy|0|||
126426435|NCT02748863|454857856|FG002|Treatment Period 2|Pregnancy|0|||
126426436|NCT02748863|454857857|FG003|Treatment Period 2|Pregnancy|0|||
126426437|NCT02748863|454857858|FG004|Treatment Period 2|Pregnancy|1|||
126426438|NCT00867165|454857859|FG000|Overall Study|Adverse Event|3|||
126426439|NCT00867165|454857860|FG001|Overall Study|Adverse Event|0|||
126426440|NCT00867165|454857859|FG000|Overall Study|Withdrawal by Subject|1|||
126426441|NCT00867165|454857860|FG001|Overall Study|Withdrawal by Subject|0|||
126426442|NCT01054456|454857861|FG000|Overall Study|Other|1|||
126426443|NCT02738008|454857862|FG000|Overall Study|Study Terminated by Sponsor|1|||
126426444|NCT02738008|454857863|FG001|Overall Study|Study Terminated by Sponsor|5|||
126426445|NCT02738008|454857864|FG002|Overall Study|Study Terminated by Sponsor|3|||
126426446|NCT02738008|454857862|FG000|Overall Study|Adverse Event|0|||
126426447|NCT02738008|454857863|FG001|Overall Study|Adverse Event|1|||
126426448|NCT02738008|454857864|FG002|Overall Study|Adverse Event|2|||
126426449|NCT03550378|454857867|FG000|Overall Study|Death|0|||
126426450|NCT03550378|454857868|FG001|Overall Study|Death|1|||
126426451|NCT00468299|454857869|FG000|Overall Study|Withdrawal by Subject|0|||
126426452|NCT00468299|454857870|FG001|Overall Study|Withdrawal by Subject|1|||
126426453|NCT03546621|454857871|FG000|Overall Study|Withdrawal by Subject|0|||
126426454|NCT03546621|454857872|FG001|Overall Study|Withdrawal by Subject|1|||
126426455|NCT03546621|454857873|FG002|Overall Study|Withdrawal by Subject|2|||
126426456|NCT03546621|454857874|FG003|Overall Study|Withdrawal by Subject|1|||
126426457|NCT03546621|454857871|FG000|Overall Study|Lost to Follow-up|0|||
126426458|NCT03546621|454857872|FG001|Overall Study|Lost to Follow-up|1|||
126426459|NCT03546621|454857873|FG002|Overall Study|Lost to Follow-up|0|||
126426460|NCT03546621|454857874|FG003|Overall Study|Lost to Follow-up|0|||
126426461|NCT03546621|454857871|FG000|Overall Study|Adverse Event|0|||
126426462|NCT03546621|454857872|FG001|Overall Study|Adverse Event|1|||
126426463|NCT03546621|454857873|FG002|Overall Study|Adverse Event|0|||
126426464|NCT03546621|454857874|FG003|Overall Study|Adverse Event|1|||
126426465|NCT03546621|454857871|FG000|Overall Study|Progressive disease|0|||
126426466|NCT03546621|454857872|FG001|Overall Study|Progressive disease|0|||
126426467|NCT03546621|454857873|FG002|Overall Study|Progressive disease|0|||
126426468|NCT03546621|454857874|FG003|Overall Study|Progressive disease|1|||
126426469|NCT00377520|454857879|FG000|Overall Study|Ineligible (Prior radiation)|1|||
126426470|NCT03040141|454857886|FG000|Overall Study|Death|1|||
126426471|NCT03040141|454857887|FG001|Overall Study|Death|2|||
126426472|NCT03040141|454857888|FG002|Overall Study|Death|3|||
126426473|NCT03040141|454857886|FG000|Overall Study|Withdrawal by Subject|3|||
126426474|NCT03040141|454857887|FG001|Overall Study|Withdrawal by Subject|1|||
126426475|NCT03040141|454857888|FG002|Overall Study|Withdrawal by Subject|1|||
126426476|NCT03040141|454857886|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
126426477|NCT03040141|454857887|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
126426478|NCT03040141|454857888|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
126426479|NCT03040141|454857886|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
126426480|NCT03040141|454857887|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
126426481|NCT03040141|454857888|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
126426482|NCT00462306|454857889|FG000|Overall Study|insufficient data|0|||
126426483|NCT00462306|454857890|FG001|Overall Study|insufficient data|13|||
126426484|NCT03515824|454857891|FG000|Overall Study|Death|3|||
126426485|NCT03515824|454857892|FG001|Overall Study|Death|2|||
126006293|NCT00783692|453314883|FG001|Maintenance Phase|Adverse Event|0|||
126006294|NCT00783692|453314884|FG002|Maintenance Phase|Adverse Event|0|||
126426486|NCT03515824|454857893|FG002|Overall Study|Death|6|||
126426487|NCT03515824|454857894|FG003|Overall Study|Death|0|||
126426488|NCT03515824|454857891|FG000|Overall Study|Lost to Follow-up|0|||
126426489|NCT03515824|454857892|FG001|Overall Study|Lost to Follow-up|1|||
126426490|NCT03515824|454857893|FG002|Overall Study|Lost to Follow-up|1|||
126426491|NCT03515824|454857894|FG003|Overall Study|Lost to Follow-up|0|||
126426492|NCT03515824|454857891|FG000|Overall Study|Study terminated by sponsor|0|||
126426493|NCT03515824|454857892|FG001|Overall Study|Study terminated by sponsor|1|||
126006295|NCT00783692|453314885|FG003|Maintenance Phase|Adverse Event|15|||
126006296|NCT00783692|453314886|FG004|Maintenance Phase|Adverse Event|12|||
126006297|NCT00783692|453314887|FG005|Maintenance Phase|Adverse Event|9|||
126006298|NCT00783692|453314888|FG006|Maintenance Phase|Adverse Event|38|||
126426494|NCT03515824|454857893|FG002|Overall Study|Study terminated by sponsor|6|||
126426495|NCT03515824|454857894|FG003|Overall Study|Study terminated by sponsor|0|||
126006299|NCT00783692|453314882|FG000|Maintenance Phase|Protocol Violation|0|||
126006300|NCT00783692|453314883|FG001|Maintenance Phase|Protocol Violation|0|||
126006301|NCT00783692|453314884|FG002|Maintenance Phase|Protocol Violation|0|||
126006302|NCT00783692|453314885|FG003|Maintenance Phase|Protocol Violation|1|||
126006303|NCT00783692|453314886|FG004|Maintenance Phase|Protocol Violation|2|||
126006304|NCT00783692|453314887|FG005|Maintenance Phase|Protocol Violation|3|||
126340921|NCT03154086|454544447|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340922|NCT03154086|454544433|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340923|NCT03154086|454544434|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
126340924|NCT03154086|454544435|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340925|NCT03154086|454544436|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340926|NCT03154086|454544437|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340927|NCT03154086|454544438|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340928|NCT03154086|454544439|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340929|NCT03154086|454544440|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340930|NCT03154086|454544441|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340931|NCT03154086|454544442|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340932|NCT03154086|454544443|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340933|NCT03154086|454544444|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340934|NCT03154086|454544445|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340935|NCT03154086|454544446|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340936|NCT03154086|454544447|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340937|NCT03154086|454544433|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340938|NCT03154086|454544434|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340939|NCT03154086|454544435|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
126340940|NCT03154086|454544436|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340941|NCT03154086|454544437|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340942|NCT03154086|454544438|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340943|NCT03154086|454544439|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340944|NCT03154086|454544440|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340945|NCT03154086|454544441|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340946|NCT03154086|454544442|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340947|NCT03154086|454544443|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340948|NCT03154086|454544444|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340949|NCT03154086|454544445|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340950|NCT03154086|454544446|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340951|NCT03154086|454544447|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340952|NCT03154086|454544433|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
126340953|NCT03154086|454544434|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340954|NCT03154086|454544435|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340955|NCT03154086|454544436|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340956|NCT03154086|454544437|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340957|NCT03154086|454544438|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340958|NCT03154086|454544439|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340959|NCT03154086|454544440|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340960|NCT03154086|454544441|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340961|NCT03154086|454544442|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340962|NCT03154086|454544443|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340963|NCT03154086|454544444|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340964|NCT03154086|454544445|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340965|NCT03154086|454544446|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340966|NCT03154086|454544447|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340967|NCT03154086|454544433|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340968|NCT03154086|454544434|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340969|NCT03154086|454544435|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340970|NCT03154086|454544436|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340971|NCT03154086|454544437|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340972|NCT03154086|454544438|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340973|NCT03154086|454544439|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340974|NCT03154086|454544440|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340975|NCT03154086|454544441|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
126340976|NCT03154086|454544442|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340977|NCT03154086|454544443|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340978|NCT03154086|454544444|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340979|NCT03154086|454544445|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126006305|NCT00783692|453314888|FG006|Maintenance Phase|Protocol Violation|4|||
126006306|NCT00783692|453314882|FG000|Maintenance Phase|Lack of Efficacy|79|||
126006307|NCT00783692|453314883|FG001|Maintenance Phase|Lack of Efficacy|0|||
126006308|NCT00783692|453314884|FG002|Maintenance Phase|Lack of Efficacy|0|||
126006309|NCT00783692|453314885|FG003|Maintenance Phase|Lack of Efficacy|64|||
126006310|NCT00783692|453314886|FG004|Maintenance Phase|Lack of Efficacy|58|||
126006311|NCT00783692|453314887|FG005|Maintenance Phase|Lack of Efficacy|48|||
126006312|NCT00783692|453314888|FG006|Maintenance Phase|Lack of Efficacy|177|||
126006313|NCT00783692|453314882|FG000|Maintenance Phase|Withdrawal by Subject|7|||
126006314|NCT00783692|453314883|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126006315|NCT00783692|453314884|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126006316|NCT00783692|453314885|FG003|Maintenance Phase|Withdrawal by Subject|7|||
126006317|NCT00783692|453314886|FG004|Maintenance Phase|Withdrawal by Subject|6|||
126006318|NCT00783692|453314887|FG005|Maintenance Phase|Withdrawal by Subject|9|||
126006319|NCT00783692|453314888|FG006|Maintenance Phase|Withdrawal by Subject|24|||
126006320|NCT00783692|453314882|FG000|Maintenance Phase|Lost to Follow-up|2|||
126006321|NCT00783692|453314883|FG001|Maintenance Phase|Lost to Follow-up|0|||
126006322|NCT00783692|453314884|FG002|Maintenance Phase|Lost to Follow-up|0|||
126006323|NCT00783692|453314885|FG003|Maintenance Phase|Lost to Follow-up|1|||
126006324|NCT00783692|453314886|FG004|Maintenance Phase|Lost to Follow-up|3|||
126006325|NCT00783692|453314887|FG005|Maintenance Phase|Lost to Follow-up|2|||
126006326|NCT00783692|453314888|FG006|Maintenance Phase|Lost to Follow-up|5|||
126006327|NCT00783692|453314882|FG000|Maintenance Phase|Other|0|||
126006328|NCT00783692|453314883|FG001|Maintenance Phase|Other|0|||
126006329|NCT00783692|453314884|FG002|Maintenance Phase|Other|0|||
126006330|NCT00783692|453314885|FG003|Maintenance Phase|Other|1|||
126006331|NCT00783692|453314886|FG004|Maintenance Phase|Other|0|||
126006332|NCT00783692|453314887|FG005|Maintenance Phase|Other|1|||
126006333|NCT00783692|453314888|FG006|Maintenance Phase|Other|1|||
126006334|NCT01190176|453314895|FG000|Overall Study|Withdrawal by Subject|1|||
126006335|NCT01190176|453314895|FG000|Overall Study|Lost to Follow-up|1|||
126046444|NCT00113360|453468223|FG000|Overall Study|Subject required surgery|1|||
126046445|NCT00113360|453468223|FG000|Overall Study|Did not meet eligibility criteria|3|||
126046446|NCT02467270|453468226|FG000|Overall Study|Participants Never Treated|0|||
126046447|NCT02467270|453468227|FG001|Overall Study|Participants Never Treated|1|||
126046448|NCT02467270|453468228|FG002|Overall Study|Participants Never Treated|0|||
126046449|NCT02467270|453468226|FG000|Overall Study|Ongoing|50|||
126046450|NCT02467270|453468227|FG001|Overall Study|Ongoing|41|||
126046451|NCT02467270|453468228|FG002|Overall Study|Ongoing|43|||
126340980|NCT03154086|454544446|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340981|NCT03154086|454544447|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340982|NCT03154086|454544433|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340983|NCT03154086|454544434|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340984|NCT03154086|454544435|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340985|NCT03154086|454544436|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340986|NCT03154086|454544437|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340987|NCT03154086|454544438|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340988|NCT03154086|454544439|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340989|NCT03154086|454544440|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
126340990|NCT03154086|454544441|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340991|NCT03154086|454544442|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340992|NCT03154086|454544443|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340993|NCT03154086|454544444|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340994|NCT03154086|454544445|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340995|NCT03154086|454544446|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340996|NCT03154086|454544447|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340997|NCT03154086|454544433|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
126340998|NCT03154086|454544434|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
126340999|NCT03154086|454544435|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
126341000|NCT03154086|454544436|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
126341001|NCT03154086|454544437|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
126341002|NCT03154086|454544438|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
126341003|NCT03154086|454544439|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
126341004|NCT03154086|454544440|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
126341005|NCT03154086|454544441|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
126341006|NCT03154086|454544442|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
126341007|NCT03154086|454544443|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
126341008|NCT03154086|454544444|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
126341009|NCT03154086|454544445|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
126341010|NCT03154086|454544446|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
126341011|NCT03154086|454544447|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
126341012|NCT01603277|454544448|FG000|Overall Study|Adverse Event|1|||
126341013|NCT01603277|454544449|FG001|Overall Study|Adverse Event|2|||
126046452|NCT02467270|453468226|FG000|Overall Study|Adverse Event|16|||
126006336|NCT01244984|453317053|FG000|Overall Study|Adverse Event|2|||
126006337|NCT01244984|453317054|FG001|Overall Study|Adverse Event|11|||
126426496|NCT03515824|454857891|FG000|Overall Study|Status not recorded|0|||
126006338|NCT01244984|453317055|FG002|Overall Study|Adverse Event|2|||
126006339|NCT01244984|453317053|FG000|Overall Study|Protocol Violation|1|||
126006340|NCT01244984|453317054|FG001|Overall Study|Protocol Violation|0|||
126006341|NCT01244984|453317055|FG002|Overall Study|Protocol Violation|0|||
126006342|NCT01244984|453317053|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
126006343|NCT01244984|453317054|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
126006344|NCT01244984|453317055|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
126006345|NCT01244984|453317053|FG000|Overall Study|Withdrawal by Subject|1|||
126006346|NCT01244984|453317054|FG001|Overall Study|Withdrawal by Subject|2|||
126006347|NCT01244984|453317055|FG002|Overall Study|Withdrawal by Subject|2|||
126006348|NCT00672256|453317060|FG000|Overall Study|PI dropped, bad data|44|||
126006349|NCT02072226|453317067|FG000|Overall Study|Lost to Follow-up|11|||
126006350|NCT02072226|453317068|FG001|Overall Study|Lost to Follow-up|7|||
126006351|NCT02072226|453317067|FG000|Overall Study|Patient Non-compliance|2|||
126006352|NCT02072226|453317068|FG001|Overall Study|Patient Non-compliance|3|||
126006353|NCT02072226|453317067|FG000|Overall Study|Death|1|||
126006354|NCT02072226|453317068|FG001|Overall Study|Death|0|||
126006355|NCT02072226|453317067|FG000|Overall Study|Patient Withdrawal of Consent|1|||
126006356|NCT02072226|453317068|FG001|Overall Study|Patient Withdrawal of Consent|0|||
126006357|NCT01124162|453317071|FG000|First Intervention|Adverse Event|2|||
126006358|NCT01124162|453317072|FG001|First Intervention|Adverse Event|0|||
126006359|NCT01124162|453317071|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126006360|NCT01124162|453317072|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126006361|NCT02680756|453317073|FG000|Overall Study|Adverse Event|10|||
126006362|NCT02680756|453317074|FG001|Overall Study|Adverse Event|2|||
126006363|NCT02680756|453317073|FG000|Overall Study|Lost to Follow-up|7|||
126006364|NCT02680756|453317074|FG001|Overall Study|Lost to Follow-up|6|||
126006365|NCT02680756|453317073|FG000|Overall Study|Withdrawal by Subject|5|||
126006366|NCT02680756|453317074|FG001|Overall Study|Withdrawal by Subject|5|||
126006367|NCT02680756|453317073|FG000|Overall Study|Physician Decision|4|||
126006368|NCT02680756|453317074|FG001|Overall Study|Physician Decision|1|||
126006369|NCT02680756|453317073|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
126426497|NCT03515824|454857892|FG001|Overall Study|Status not recorded|0|||
126426498|NCT03515824|454857893|FG002|Overall Study|Status not recorded|2|||
126426499|NCT03515824|454857894|FG003|Overall Study|Status not recorded|0|||
126426500|NCT01384734|454857896|FG000|Overall Study|Adverse Event|0|||
126006370|NCT02680756|453317074|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
126006371|NCT02680756|453317073|FG000|Overall Study|Blood transfusion for any reason|0|||
126426501|NCT01384734|454857897|FG001|Overall Study|Adverse Event|3|||
126426502|NCT01384734|454857898|FG002|Overall Study|Adverse Event|0|||
126426503|NCT01384734|454857899|FG003|Overall Study|Adverse Event|2|||
126426504|NCT01384734|454857900|FG004|Overall Study|Adverse Event|7|||
126426505|NCT01384734|454857896|FG000|Overall Study|Death|1|||
126426506|NCT01384734|454857897|FG001|Overall Study|Death|0|||
126426507|NCT01384734|454857898|FG002|Overall Study|Death|1|||
126426508|NCT01384734|454857899|FG003|Overall Study|Death|0|||
126426509|NCT01384734|454857900|FG004|Overall Study|Death|0|||
126426510|NCT01384734|454857896|FG000|Overall Study|Continuation criteria not met|0|||
126426511|NCT01384734|454857897|FG001|Overall Study|Continuation criteria not met|0|||
126426512|NCT01384734|454857898|FG002|Overall Study|Continuation criteria not met|1|||
126426513|NCT01384734|454857899|FG003|Overall Study|Continuation criteria not met|1|||
126426514|NCT01384734|454857900|FG004|Overall Study|Continuation criteria not met|0|||
126426515|NCT01384734|454857896|FG000|Overall Study|Lack of Efficacy|3|||
126426516|NCT01384734|454857897|FG001|Overall Study|Lack of Efficacy|7|||
126426517|NCT01384734|454857898|FG002|Overall Study|Lack of Efficacy|4|||
126426518|NCT01384734|454857899|FG003|Overall Study|Lack of Efficacy|4|||
126426519|NCT01384734|454857900|FG004|Overall Study|Lack of Efficacy|2|||
126426520|NCT01384734|454857896|FG000|Overall Study|Lost to Follow-up|5|||
126426521|NCT01384734|454857897|FG001|Overall Study|Lost to Follow-up|3|||
126426522|NCT01384734|454857898|FG002|Overall Study|Lost to Follow-up|3|||
126426523|NCT01384734|454857899|FG003|Overall Study|Lost to Follow-up|8|||
126426524|NCT01384734|454857900|FG004|Overall Study|Lost to Follow-up|5|||
126006372|NCT02680756|453317074|FG001|Overall Study|Blood transfusion for any reason|1|||
126006373|NCT02680756|453317073|FG000|Overall Study|Death|1|||
126006374|NCT02680756|453317074|FG001|Overall Study|Death|0|||
126006375|NCT02680756|453317073|FG000|Overall Study|Protocol Violation|1|||
126426525|NCT01384734|454857896|FG000|Overall Study|Non-compliance with study drug|1|||
126426526|NCT01384734|454857897|FG001|Overall Study|Non-compliance with study drug|2|||
126006376|NCT02680756|453317074|FG001|Overall Study|Protocol Violation|0|||
126006377|NCT02680756|453317073|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
126006378|NCT02680756|453317074|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
126426527|NCT01384734|454857898|FG002|Overall Study|Non-compliance with study drug|6|||
126426528|NCT01384734|454857899|FG003|Overall Study|Non-compliance with study drug|0|||
126426529|NCT01384734|454857900|FG004|Overall Study|Non-compliance with study drug|2|||
126426530|NCT01384734|454857896|FG000|Overall Study|Pregnancy|0|||
126006379|NCT02680756|453317073|FG000|Overall Study|None of above or not recorded|3|||
126006380|NCT02680756|453317074|FG001|Overall Study|None of above or not recorded|2|||
126006381|NCT00938340|453317075|FG000|Overall Study|Withdrawal by Subject|3|||
126006382|NCT00938340|453317075|FG000|Overall Study|Protocol Violation|1|||
126006383|NCT00938340|453317075|FG000|Overall Study|Adverse Event|1|||
126006384|NCT04353037|453317078|FG000|Overall Study|Lost to Follow-up|0|||
126006385|NCT04353037|453317079|FG001|Overall Study|Lost to Follow-up|1|||
126006386|NCT04353037|453317080|FG002|Overall Study|Lost to Follow-up|2|||
126006387|NCT04353037|453317081|FG003|Overall Study|Lost to Follow-up|3|||
126006388|NCT04353037|453317078|FG000|Overall Study|Withdrawal by Subject|0|||
126006389|NCT04353037|453317079|FG001|Overall Study|Withdrawal by Subject|2|||
126006390|NCT04353037|453317080|FG002|Overall Study|Withdrawal by Subject|3|||
126006391|NCT04353037|453317081|FG003|Overall Study|Withdrawal by Subject|5|||
126006392|NCT04353037|453317078|FG000|Overall Study|Adverse Event|0|||
126006393|NCT04353037|453317079|FG001|Overall Study|Adverse Event|0|||
126006394|NCT04353037|453317080|FG002|Overall Study|Adverse Event|2|||
126006395|NCT04353037|453317081|FG003|Overall Study|Adverse Event|0|||
126006396|NCT04353037|453317078|FG000|Overall Study|Exposure Change|0|||
126006397|NCT04353037|453317079|FG001|Overall Study|Exposure Change|0|||
126006398|NCT04353037|453317080|FG002|Overall Study|Exposure Change|0|||
126006399|NCT04353037|453317081|FG003|Overall Study|Exposure Change|2|||
126006400|NCT03635112|453317082|FG000|Overall Study|Adverse Event|5|||
126006401|NCT03635112|453317083|FG001|Overall Study|Adverse Event|9|||
126006402|NCT03635112|453317084|FG002|Overall Study|Adverse Event|14|||
126006403|NCT03635112|453317082|FG000|Overall Study|Lost to Follow-up|1|||
126006404|NCT03635112|453317083|FG001|Overall Study|Lost to Follow-up|0|||
126006405|NCT03635112|453317084|FG002|Overall Study|Lost to Follow-up|1|||
126006406|NCT03635112|453317082|FG000|Overall Study|Physician Decision|5|||
126006407|NCT03635112|453317083|FG001|Overall Study|Physician Decision|7|||
126006408|NCT03635112|453317084|FG002|Overall Study|Physician Decision|5|||
126006409|NCT03635112|453317082|FG000|Overall Study|Protocol Violation|0|||
126006410|NCT03635112|453317083|FG001|Overall Study|Protocol Violation|0|||
126006411|NCT03635112|453317084|FG002|Overall Study|Protocol Violation|1|||
126006412|NCT03635112|453317082|FG000|Overall Study|Study Terminated by Sponsor|11|||
126006413|NCT03635112|453317083|FG001|Overall Study|Study Terminated by Sponsor|17|||
126006414|NCT03635112|453317084|FG002|Overall Study|Study Terminated by Sponsor|21|||
126006415|NCT03635112|453317082|FG000|Overall Study|Withdrawal by Subject|4|||
126006416|NCT03635112|453317083|FG001|Overall Study|Withdrawal by Subject|9|||
126006417|NCT03635112|453317084|FG002|Overall Study|Withdrawal by Subject|7|||
126006418|NCT03635112|453317082|FG000|Overall Study|Miscellaneous|0|||
126006419|NCT03635112|453317083|FG001|Overall Study|Miscellaneous|0|||
126006420|NCT03635112|453317084|FG002|Overall Study|Miscellaneous|1|||
126006421|NCT03006341|453317086|FG000|Overall Study|Not linked in the EMR|25069|||
126006422|NCT03006341|453317087|FG001|Overall Study|Not linked in the EMR|67505|||
126006423|NCT03006341|453317088|FG002|Overall Study|Not linked in the EMR|30993|||
126006424|NCT03006341|453317089|FG003|Overall Study|Not linked in the EMR|10685|||
126006425|NCT03101592|453317090|FG000|Overall Study|participant files could not be located|111|||
126006426|NCT03101592|453317091|FG001|Overall Study|participant files could not be located|170|||
126006427|NCT03101592|453317092|FG002|Overall Study|participant files could not be located|118|||
126006428|NCT01941316|453317093|FG000|Overall Study|Adverse Event|0|||
126006429|NCT01941316|453317094|FG001|Overall Study|Adverse Event|1|||
126426531|NCT01384734|454857897|FG001|Overall Study|Pregnancy|1|||
126426532|NCT01384734|454857898|FG002|Overall Study|Pregnancy|0|||
126426533|NCT01384734|454857899|FG003|Overall Study|Pregnancy|0|||
126426534|NCT01384734|454857900|FG004|Overall Study|Pregnancy|1|||
126426535|NCT01384734|454857896|FG000|Overall Study|Sponsor terminated|0|||
126426536|NCT01384734|454857897|FG001|Overall Study|Sponsor terminated|0|||
126006430|NCT01941316|453317095|FG002|Overall Study|Adverse Event|0|||
126006431|NCT01941316|453317096|FG003|Overall Study|Adverse Event|7|||
126006432|NCT01941316|453317093|FG000|Overall Study|Progressive Disease|3|||
126006433|NCT01941316|453317094|FG001|Overall Study|Progressive Disease|6|||
126006434|NCT01941316|453317095|FG002|Overall Study|Progressive Disease|2|||
126006435|NCT01941316|453317096|FG003|Overall Study|Progressive Disease|29|||
126006436|NCT01941316|453317093|FG000|Overall Study|Withdrawal by Subject|0|||
126006437|NCT01941316|453317094|FG001|Overall Study|Withdrawal by Subject|2|||
126006438|NCT01941316|453317095|FG002|Overall Study|Withdrawal by Subject|1|||
126006439|NCT01941316|453317096|FG003|Overall Study|Withdrawal by Subject|8|||
126006440|NCT01941316|453317093|FG000|Overall Study|Death|0|||
126006441|NCT01941316|453317094|FG001|Overall Study|Death|0|||
126006442|NCT01941316|453317095|FG002|Overall Study|Death|0|||
126006443|NCT01941316|453317096|FG003|Overall Study|Death|3|||
126426537|NCT01384734|454857898|FG002|Overall Study|Sponsor terminated|0|||
126426538|NCT01384734|454857899|FG003|Overall Study|Sponsor terminated|0|||
126006444|NCT01941316|453317093|FG000|Overall Study|Physician Decision|0|||
126006445|NCT01941316|453317094|FG001|Overall Study|Physician Decision|0|||
126006446|NCT01941316|453317095|FG002|Overall Study|Physician Decision|0|||
126006447|NCT01941316|453317096|FG003|Overall Study|Physician Decision|3|||
126006448|NCT01941316|453317093|FG000|Overall Study|Protocol Violation|0|||
126006449|NCT01941316|453317094|FG001|Overall Study|Protocol Violation|0|||
126006450|NCT01941316|453317095|FG002|Overall Study|Protocol Violation|0|||
126006451|NCT01941316|453317096|FG003|Overall Study|Protocol Violation|3|||
126006452|NCT01941316|453317093|FG000|Overall Study|Intercurrent illness|0|||
126006453|NCT01941316|453317094|FG001|Overall Study|Intercurrent illness|0|||
126006454|NCT01941316|453317095|FG002|Overall Study|Intercurrent illness|0|||
126341014|NCT01603277|454544448|FG000|Overall Study|Physician Decision|0|||
126341015|NCT01603277|454544449|FG001|Overall Study|Physician Decision|1|||
126341016|NCT01603277|454544448|FG000|Overall Study|Protocol Violation|6|||
126341017|NCT01603277|454544449|FG001|Overall Study|Protocol Violation|10|||
126341018|NCT01603277|454544448|FG000|Overall Study|Withdrawal by Subject|5|||
126341019|NCT01603277|454544449|FG001|Overall Study|Withdrawal by Subject|4|||
126341020|NCT01603277|454544448|FG000|Overall Study|Non-Compliance|2|||
126341021|NCT01603277|454544449|FG001|Overall Study|Non-Compliance|1|||
126341022|NCT04494646|454544454|FG000|Overall Study|Adverse Event|0|||
126341023|NCT04494646|454544455|FG001|Overall Study|Adverse Event|1|||
126341024|NCT04494646|454544454|FG000|Overall Study|Withdrawal by Subject|0|||
126341025|NCT04494646|454544455|FG001|Overall Study|Withdrawal by Subject|1|||
126341026|NCT02785939|454544458|FG000|Overall Study|Progression|25|||
126341027|NCT02785939|454544459|FG001|Overall Study|Progression|8|||
126341028|NCT02785939|454544458|FG000|Overall Study|Adverse Event|3|||
126341029|NCT02785939|454544459|FG001|Overall Study|Adverse Event|1|||
126341030|NCT02785939|454544458|FG000|Overall Study|Death|1|||
126341031|NCT02785939|454544459|FG001|Overall Study|Death|0|||
126341032|NCT02785939|454544458|FG000|Overall Study|Refusal|1|||
126341033|NCT02785939|454544459|FG001|Overall Study|Refusal|0|||
126341034|NCT02785939|454544458|FG000|Overall Study|Deteriorating health|1|||
126341035|NCT02785939|454544459|FG001|Overall Study|Deteriorating health|0|||
126341036|NCT02785939|454544458|FG000|Overall Study|Not protocol specified|0|||
126341037|NCT02785939|454544459|FG001|Overall Study|Not protocol specified|1|||
126341038|NCT02391337|454544463|FG000|6 Months Follow-up|Death|5|||
126341039|NCT02391337|454544464|FG001|6 Months Follow-up|Death|4|||
126341040|NCT02391337|454544463|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
126341041|NCT02391337|454544464|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
126341042|NCT02391337|454544463|FG000|12 Months Follow-up|Death|2|||
126341043|NCT02391337|454544464|FG001|12 Months Follow-up|Death|0|||
126341044|NCT02391337|454544463|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
126341045|NCT02391337|454544464|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
126341046|NCT02391337|454544463|FG000|12 Months Follow-up|Lost to Follow-up|0|||
126341047|NCT02391337|454544464|FG001|12 Months Follow-up|Lost to Follow-up|2|||
126341048|NCT03122171|454544481|FG000|Overall Study|Withdrawal by Subject|1|||
126341049|NCT01326871|454544491|FG000|Overall Study|Major surgery|0|||
126341050|NCT01326871|454544492|FG001|Overall Study|Major surgery|1|||
126341051|NCT01326871|454544493|FG002|Overall Study|Major surgery|0|||
126341052|NCT01326871|454544491|FG000|Overall Study|SAE and death|0|||
126341053|NCT01326871|454544492|FG001|Overall Study|SAE and death|2|||
126341054|NCT01326871|454544493|FG002|Overall Study|SAE and death|0|||
126341055|NCT01326871|454544491|FG000|Overall Study|Physician decision and decreased performance status|0|||
126341056|NCT01326871|454544492|FG001|Overall Study|Physician decision and decreased performance status|1|||
126341057|NCT01326871|454544493|FG002|Overall Study|Physician decision and decreased performance status|0|||
126341058|NCT01326871|454544491|FG000|Overall Study|Disease progression|0|||
126341059|NCT01326871|454544492|FG001|Overall Study|Disease progression|11|||
126341060|NCT01326871|454544493|FG002|Overall Study|Disease progression|5|||
126341061|NCT01326871|454544491|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
126341062|NCT01326871|454544492|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
126341063|NCT01326871|454544493|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
126341064|NCT01326871|454544491|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
126341065|NCT01326871|454544492|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
126341066|NCT01326871|454544493|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
126341067|NCT01326871|454544491|FG000|Overall Study|Withdrawal by Subject|0|||
126341068|NCT01326871|454544492|FG001|Overall Study|Withdrawal by Subject|1|||
126341069|NCT01326871|454544493|FG002|Overall Study|Withdrawal by Subject|0|||
126341070|NCT01326871|454544491|FG000|Overall Study|DLT|0|||
126341071|NCT01326871|454544492|FG001|Overall Study|DLT|2|||
126341072|NCT01326871|454544493|FG002|Overall Study|DLT|0|||
126341073|NCT01326871|454544491|FG000|Overall Study|SAE, disease progression and subject decision|0|||
126341074|NCT01326871|454544492|FG001|Overall Study|SAE, disease progression and subject decision|1|||
126341075|NCT01326871|454544493|FG002|Overall Study|SAE, disease progression and subject decision|0|||
126209494|NCT03110107|454055399|FG006|Treatment Period|Adverse Event|0|||
126341076|NCT01326871|454544491|FG000|Overall Study|Death|0|||
126341077|NCT01326871|454544492|FG001|Overall Study|Death|1|||
126341078|NCT01326871|454544493|FG002|Overall Study|Death|0|||
126006455|NCT01941316|453317096|FG003|Overall Study|Intercurrent illness|1|||
126341079|NCT01326871|454544491|FG000|Overall Study|Other|0|||
126341080|NCT01326871|454544492|FG001|Overall Study|Other|3|||
126341081|NCT01326871|454544493|FG002|Overall Study|Other|0|||
126341082|NCT01326871|454544491|FG000|Overall Study|SAE and disease progression|0|||
126341083|NCT01326871|454544492|FG001|Overall Study|SAE and disease progression|0|||
126426539|NCT01384734|454857900|FG004|Overall Study|Sponsor terminated|1|||
126426540|NCT01384734|454857896|FG000|Overall Study|Withdrawal by Subject|5|||
126426541|NCT01384734|454857897|FG001|Overall Study|Withdrawal by Subject|5|||
126426542|NCT01384734|454857898|FG002|Overall Study|Withdrawal by Subject|6|||
126426543|NCT01384734|454857899|FG003|Overall Study|Withdrawal by Subject|7|||
126426544|NCT01384734|454857900|FG004|Overall Study|Withdrawal by Subject|9|||
126426545|NCT01384734|454857896|FG000|Overall Study|Investigator relocating|0|||
126426546|NCT01384734|454857897|FG001|Overall Study|Investigator relocating|2|||
126426547|NCT01384734|454857898|FG002|Overall Study|Investigator relocating|0|||
126426548|NCT01384734|454857899|FG003|Overall Study|Investigator relocating|3|||
126426549|NCT01384734|454857900|FG004|Overall Study|Investigator relocating|1|||
126426550|NCT01384734|454857896|FG000|Overall Study|Unable to come back for visit|1|||
126426551|NCT01384734|454857897|FG001|Overall Study|Unable to come back for visit|0|||
126426552|NCT01384734|454857898|FG002|Overall Study|Unable to come back for visit|1|||
126426553|NCT01384734|454857899|FG003|Overall Study|Unable to come back for visit|1|||
126426554|NCT01384734|454857900|FG004|Overall Study|Unable to come back for visit|0|||
126426555|NCT01384734|454857896|FG000|Overall Study|Prison|0|||
126426556|NCT01384734|454857897|FG001|Overall Study|Prison|0|||
126426557|NCT01384734|454857898|FG002|Overall Study|Prison|1|||
126426558|NCT01384734|454857899|FG003|Overall Study|Prison|0|||
126426559|NCT01384734|454857900|FG004|Overall Study|Prison|0|||
126426560|NCT01384734|454857896|FG000|Overall Study|As per Exclusion criteria|0|||
126426561|NCT01384734|454857897|FG001|Overall Study|As per Exclusion criteria|1|||
126426562|NCT01384734|454857898|FG002|Overall Study|As per Exclusion criteria|0|||
126426563|NCT01384734|454857899|FG003|Overall Study|As per Exclusion criteria|0|||
126426564|NCT01384734|454857900|FG004|Overall Study|As per Exclusion criteria|0|||
126426565|NCT01384734|454857896|FG000|Overall Study|Missed End of treatment visit|0|||
126426566|NCT01384734|454857897|FG001|Overall Study|Missed End of treatment visit|0|||
126426567|NCT01384734|454857898|FG002|Overall Study|Missed End of treatment visit|0|||
126426568|NCT01384734|454857899|FG003|Overall Study|Missed End of treatment visit|1|||
126426569|NCT01384734|454857900|FG004|Overall Study|Missed End of treatment visit|0|||
126426570|NCT01384734|454857896|FG000|Overall Study|Adhesion problem|0|||
126426571|NCT01384734|454857897|FG001|Overall Study|Adhesion problem|0|||
126426572|NCT01384734|454857898|FG002|Overall Study|Adhesion problem|0|||
126426573|NCT01384734|454857899|FG003|Overall Study|Adhesion problem|1|||
126426574|NCT01384734|454857900|FG004|Overall Study|Adhesion problem|0|||
126426575|NCT01384734|454857896|FG000|Overall Study|Early termination|0|||
126426576|NCT01384734|454857897|FG001|Overall Study|Early termination|0|||
126426577|NCT01384734|454857898|FG002|Overall Study|Early termination|0|||
126426578|NCT01384734|454857899|FG003|Overall Study|Early termination|0|||
126426579|NCT01384734|454857900|FG004|Overall Study|Early termination|1|||
126426580|NCT01384734|454857896|FG000|Overall Study|Physician Decision|1|||
126426581|NCT01384734|454857897|FG001|Overall Study|Physician Decision|0|||
126426582|NCT01384734|454857898|FG002|Overall Study|Physician Decision|0|||
126426583|NCT01384734|454857899|FG003|Overall Study|Physician Decision|0|||
126426584|NCT01384734|454857900|FG004|Overall Study|Physician Decision|0|||
126426585|NCT00154297|454857901|FG000|Overall Study|Death|5|||
126426586|NCT00154297|454857902|FG001|Overall Study|Death|2|||
126426587|NCT00154297|454857901|FG000|Overall Study|Withdrawal by Subject|0|||
126426588|NCT00154297|454857902|FG001|Overall Study|Withdrawal by Subject|5|||
126426589|NCT00154297|454857901|FG000|Overall Study|Lost to Follow-up|3|||
126426590|NCT00154297|454857902|FG001|Overall Study|Lost to Follow-up|0|||
126426591|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
126426592|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
126426593|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
126006456|NCT01941316|453317093|FG000|Overall Study|Other, not specified|0|||
126426594|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
126426595|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
126426596|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
126426597|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
126426598|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
126006457|NCT01941316|453317094|FG001|Overall Study|Other, not specified|0|||
126006458|NCT01941316|453317095|FG002|Overall Study|Other, not specified|0|||
126426599|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
126426600|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
126426601|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
126426602|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
126426603|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
126006459|NCT01941316|453317096|FG003|Overall Study|Other, not specified|1|||
126426604|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
126426605|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
126426606|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
126426607|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
126426608|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
126006460|NCT02138916|453317097|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
126426609|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
126426610|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
126426611|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
126426612|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
126426613|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
126426614|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
126426615|NCT00550407|454857904|FG000|26-Week Randomized Phase|Adverse Event|0|||
126426616|NCT00550407|454857905|FG001|26-Week Randomized Phase|Adverse Event|5|||
126426617|NCT00550407|454857906|FG002|26-Week Randomized Phase|Adverse Event|2|||
126426618|NCT00550407|454857904|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
126426619|NCT00550407|454857905|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
126426620|NCT00550407|454857906|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
126426621|NCT00550407|454857904|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
126426622|NCT00550407|454857905|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
126426623|NCT00550407|454857906|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
126426624|NCT00550407|454857904|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
126426625|NCT00550407|454857905|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
126426626|NCT00550407|454857906|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
126426627|NCT05051579|454857907|FG000|Overall Study|Withdrawal by Subject|3|||
126426628|NCT05051579|454857908|FG001|Overall Study|Withdrawal by Subject|5|||
126426629|NCT05051579|454857909|FG002|Overall Study|Withdrawal by Subject|2|||
126426630|NCT05051579|454857910|FG003|Overall Study|Withdrawal by Subject|1|||
126426631|NCT05051579|454857911|FG004|Overall Study|Withdrawal by Subject|4|||
126426632|NCT05051579|454857912|FG005|Overall Study|Withdrawal by Subject|0|||
126426633|NCT05051579|454857913|FG006|Overall Study|Withdrawal by Subject|4|||
126426634|NCT05051579|454857907|FG000|Overall Study|Lost to Follow-up|1|||
126426635|NCT05051579|454857908|FG001|Overall Study|Lost to Follow-up|0|||
126426636|NCT05051579|454857909|FG002|Overall Study|Lost to Follow-up|0|||
126426637|NCT05051579|454857910|FG003|Overall Study|Lost to Follow-up|0|||
126426638|NCT05051579|454857911|FG004|Overall Study|Lost to Follow-up|1|||
126426639|NCT05051579|454857912|FG005|Overall Study|Lost to Follow-up|0|||
126426640|NCT05051579|454857913|FG006|Overall Study|Lost to Follow-up|1|||
126426641|NCT05051579|454857907|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426642|NCT05051579|454857908|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426643|NCT05051579|454857909|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426644|NCT05051579|454857910|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426645|NCT05051579|454857911|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426646|NCT05051579|454857912|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426647|NCT05051579|454857913|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
126426648|NCT05051579|454857907|FG000|Overall Study|Adverse Event|2|||
126426649|NCT05051579|454857908|FG001|Overall Study|Adverse Event|1|||
126426650|NCT05051579|454857909|FG002|Overall Study|Adverse Event|0|||
126426651|NCT05051579|454857910|FG003|Overall Study|Adverse Event|4|||
126426652|NCT05051579|454857911|FG004|Overall Study|Adverse Event|1|||
126426653|NCT05051579|454857912|FG005|Overall Study|Adverse Event|2|||
126426654|NCT05051579|454857913|FG006|Overall Study|Adverse Event|0|||
126426655|NCT05051579|454857907|FG000|Overall Study|Inadvertent Enrollment|0|||
126426656|NCT05051579|454857908|FG001|Overall Study|Inadvertent Enrollment|0|||
126426657|NCT05051579|454857909|FG002|Overall Study|Inadvertent Enrollment|0|||
126426658|NCT05051579|454857910|FG003|Overall Study|Inadvertent Enrollment|0|||
126426659|NCT05051579|454857911|FG004|Overall Study|Inadvertent Enrollment|0|||
126426660|NCT05051579|454857912|FG005|Overall Study|Inadvertent Enrollment|0|||
126426661|NCT05051579|454857913|FG006|Overall Study|Inadvertent Enrollment|1|||
126426662|NCT05051579|454857907|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426663|NCT05051579|454857908|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
126426664|NCT05051579|454857909|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426665|NCT05051579|454857910|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426666|NCT05051579|454857911|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426667|NCT05051579|454857912|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426668|NCT05051579|454857913|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426669|NCT05051579|454857907|FG000|Overall Study|Sponsor Decision|0|||
126006461|NCT02138916|453317098|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
126006462|NCT02138916|453317099|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
126006463|NCT02138916|453317097|FG000|Overall Study|Death|14|||
126426670|NCT05051579|454857908|FG001|Overall Study|Sponsor Decision|0|||
126006464|NCT02138916|453317098|FG001|Overall Study|Death|11|||
126006465|NCT02138916|453317099|FG002|Overall Study|Death|12|||
126006466|NCT02138916|453317097|FG000|Overall Study|Withdrawal by Subject|27|||
126341084|NCT01326871|454544493|FG002|Overall Study|SAE and disease progression|1|||
126341085|NCT01326871|454544491|FG000|Overall Study|SAE and physician decision|0|||
126341086|NCT01326871|454544492|FG001|Overall Study|SAE and physician decision|0|||
126341087|NCT01326871|454544493|FG002|Overall Study|SAE and physician decision|1|||
126341088|NCT01326871|454544491|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
126341089|NCT01326871|454544492|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
126341090|NCT01326871|454544493|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
126341091|NCT01326871|454544491|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
126341092|NCT01326871|454544492|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
126341093|NCT01326871|454544493|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
126341094|NCT01326871|454544491|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
126341095|NCT01326871|454544492|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
126341096|NCT01326871|454544493|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
126341097|NCT01326871|454544491|FG000|Overall Study|Physician Decision|0|||
126341098|NCT01326871|454544492|FG001|Overall Study|Physician Decision|0|||
126341099|NCT01326871|454544493|FG002|Overall Study|Physician Decision|1|||
126341100|NCT01326871|454544491|FG000|Overall Study|SAE|0|||
126341101|NCT01326871|454544492|FG001|Overall Study|SAE|0|||
126341102|NCT01326871|454544493|FG002|Overall Study|SAE|1|||
126341103|NCT01326871|454544491|FG000|Overall Study|Disease progression and death|0|||
126341104|NCT01326871|454544492|FG001|Overall Study|Disease progression and death|0|||
126341105|NCT01326871|454544493|FG002|Overall Study|Disease progression and death|1|||
126341106|NCT01326871|454544491|FG000|Overall Study|Subject decision|0|||
126341107|NCT01326871|454544492|FG001|Overall Study|Subject decision|0|||
126341108|NCT01326871|454544493|FG002|Overall Study|Subject decision|1|||
126341109|NCT01200329|454544498|FG000|Overall Study|Lack of financial coverage|2|||
126341110|NCT01200329|454544498|FG000|Overall Study|Progressive disease|1|||
126341111|NCT03641508|454544501|FG000|First Injection|Lost to Follow-up|2|||
126341112|NCT03641508|454544502|FG001|First Injection|Lost to Follow-up|0|||
126341113|NCT03642990|454544503|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
126341114|NCT03642990|454544503|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
126341115|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
126341116|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
126341117|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
126341118|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
126341119|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
126341120|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
126341121|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
126341122|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126426671|NCT05051579|454857909|FG002|Overall Study|Sponsor Decision|0|||
126426672|NCT05051579|454857910|FG003|Overall Study|Sponsor Decision|0|||
126426673|NCT05051579|454857911|FG004|Overall Study|Sponsor Decision|1|||
126426674|NCT05051579|454857912|FG005|Overall Study|Sponsor Decision|0|||
126426675|NCT05051579|454857913|FG006|Overall Study|Sponsor Decision|0|||
126426676|NCT05051579|454857907|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426677|NCT05051579|454857908|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426678|NCT05051579|454857909|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426679|NCT05051579|454857910|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426680|NCT05051579|454857911|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
126341123|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126341124|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126341125|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
126341126|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
126341127|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
126341128|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
126341129|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
126341130|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
126341131|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
126341132|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
126341133|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
126341134|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
126341135|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
126341136|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
126341137|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
126046453|NCT02467270|453468227|FG001|Overall Study|Adverse Event|15|||
126426681|NCT05051579|454857912|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426682|NCT05051579|454857913|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426683|NCT00717249|454857914|FG000|Overall Study|Lens Discomfort|4|||
126426684|NCT00717249|454857915|FG001|Overall Study|Lens Discomfort|1|||
126426685|NCT00717249|454857914|FG000|Overall Study|Unsatisfactory visual Response|0|||
126426686|NCT00717249|454857915|FG001|Overall Study|Unsatisfactory visual Response|2|||
126426687|NCT00717249|454857914|FG000|Overall Study|Adverse Event|4|||
126426688|NCT00717249|454857915|FG001|Overall Study|Adverse Event|2|||
126426689|NCT00717249|454857914|FG000|Overall Study|Lost to Follow-up|2|||
126426690|NCT00717249|454857915|FG001|Overall Study|Lost to Follow-up|0|||
126426691|NCT00717249|454857914|FG000|Overall Study|Withdrawal by Subject|1|||
126426692|NCT00717249|454857915|FG001|Overall Study|Withdrawal by Subject|2|||
126426693|NCT00717249|454857914|FG000|Overall Study|Pregnancy|6|||
126426694|NCT00717249|454857915|FG001|Overall Study|Pregnancy|3|||
126426695|NCT00717249|454857914|FG000|Overall Study|Protocol Violation|0|||
126426696|NCT00717249|454857915|FG001|Overall Study|Protocol Violation|2|||
126426697|NCT00717249|454857914|FG000|Overall Study|Subject became Ineligible|1|||
126426698|NCT00717249|454857915|FG001|Overall Study|Subject became Ineligible|1|||
126426699|NCT00717249|454857914|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
126426700|NCT00717249|454857915|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
126426701|NCT00717249|454857914|FG000|Overall Study|Gastric Surgery|0|||
126426702|NCT00717249|454857915|FG001|Overall Study|Gastric Surgery|1|||
126426703|NCT00717249|454857914|FG000|Overall Study|Diagnosed with Diabetes|1|||
126426704|NCT00717249|454857915|FG001|Overall Study|Diagnosed with Diabetes|0|||
126426705|NCT00717249|454857914|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
126426706|NCT00717249|454857915|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
126426707|NCT00717249|454857914|FG000|Overall Study|Subject relocated|1|||
126426708|NCT00717249|454857915|FG001|Overall Study|Subject relocated|0|||
126426709|NCT00717249|454857914|FG000|Overall Study|Headaches|1|||
126426710|NCT00717249|454857915|FG001|Overall Study|Headaches|0|||
126426711|NCT00360412|454857916|FG000|Overall Study|Adverse Event|37|||
126426712|NCT00360412|454857917|FG001|Overall Study|Adverse Event|65|||
126426713|NCT00360412|454857916|FG000|Overall Study|Protocol Violation|2|||
126426714|NCT00360412|454857917|FG001|Overall Study|Protocol Violation|5|||
126426715|NCT00360412|454857916|FG000|Overall Study|Patient withdrew consent|27|||
126426716|NCT00360412|454857917|FG001|Overall Study|Patient withdrew consent|52|||
126426717|NCT00360412|454857916|FG000|Overall Study|Lack of therapeutic efficacy|46|||
126426718|NCT00360412|454857917|FG001|Overall Study|Lack of therapeutic efficacy|61|||
126426719|NCT00360412|454857916|FG000|Overall Study|Physician Decision|2|||
126426720|NCT00360412|454857917|FG001|Overall Study|Physician Decision|4|||
126426721|NCT00360412|454857916|FG000|Overall Study|Other|5|||
126426722|NCT00360412|454857917|FG001|Overall Study|Other|6|||
126426723|NCT00360412|454857916|FG000|Overall Study|Study termination by Sponsor|214|||
126426724|NCT00360412|454857917|FG001|Overall Study|Study termination by Sponsor|469|||
126426725|NCT00871871|454857918|FG000|Part I|Adverse Event|0|||
126426726|NCT00871871|454857919|FG001|Part I|Adverse Event|2|||
126426727|NCT00871871|454857920|FG002|Part I|Adverse Event|0|||
126426728|NCT00871871|454857921|FG003|Part I|Adverse Event|0|||
126426729|NCT00871871|454857918|FG000|Part I|Withdrawal by Subject|3|||
126426730|NCT00871871|454857919|FG001|Part I|Withdrawal by Subject|0|||
126426731|NCT00871871|454857920|FG002|Part I|Withdrawal by Subject|0|||
126426732|NCT00871871|454857921|FG003|Part I|Withdrawal by Subject|0|||
126426733|NCT00871871|454857918|FG000|Part I|Laboratory abnormality|0|||
126426734|NCT00871871|454857919|FG001|Part I|Laboratory abnormality|1|||
126426735|NCT00871871|454857920|FG002|Part I|Laboratory abnormality|0|||
126426736|NCT00871871|454857921|FG003|Part I|Laboratory abnormality|0|||
126426737|NCT00871871|454857918|FG000|Part II|Lack of Efficacy|0|||
126426738|NCT00871871|454857919|FG001|Part II|Lack of Efficacy|0|||
126426739|NCT00871871|454857920|FG002|Part II|Lack of Efficacy|1|||
126426740|NCT00871871|454857921|FG003|Part II|Lack of Efficacy|0|||
126426741|NCT00871871|454857918|FG000|Part II|Withdrawal by Subject|0|||
126426742|NCT00871871|454857919|FG001|Part II|Withdrawal by Subject|0|||
126426743|NCT00871871|454857920|FG002|Part II|Withdrawal by Subject|2|||
126426744|NCT00871871|454857921|FG003|Part II|Withdrawal by Subject|1|||
126426745|NCT00871871|454857918|FG000|Part II|Adverse Event|0|||
126426746|NCT00871871|454857919|FG001|Part II|Adverse Event|0|||
126426747|NCT00871871|454857920|FG002|Part II|Adverse Event|1|||
126426748|NCT00871871|454857921|FG003|Part II|Adverse Event|2|||
126426749|NCT00871871|454857918|FG000|Part II|Protocol Violation|0|||
126426750|NCT00871871|454857919|FG001|Part II|Protocol Violation|0|||
126426751|NCT00871871|454857920|FG002|Part II|Protocol Violation|0|||
126426752|NCT00871871|454857921|FG003|Part II|Protocol Violation|1|||
126426753|NCT00990106|454857925|FG000|Overall Study|"too busy to continue"|1|||
126426754|NCT00990106|454857926|FG001|Overall Study|"too busy to continue"|2|||
126426755|NCT00990106|454857925|FG000|Overall Study|Lost to Follow-up|1|||
126426756|NCT00990106|454857926|FG001|Overall Study|Lost to Follow-up|3|||
126426757|NCT00990106|454857925|FG000|Overall Study|Withdrawal by Subject|2|||
126426758|NCT00990106|454857926|FG001|Overall Study|Withdrawal by Subject|1|||
126006467|NCT02138916|453317098|FG001|Overall Study|Withdrawal by Subject|31|||
126006468|NCT02138916|453317099|FG002|Overall Study|Withdrawal by Subject|32|||
126006469|NCT02138916|453317097|FG000|Overall Study|Study specific withdrawal criteria|0|||
126006470|NCT02138916|453317098|FG001|Overall Study|Study specific withdrawal criteria|0|||
126341138|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
126341139|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
126341140|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
126341141|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
126341142|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
126341143|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
126341144|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
126341145|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
126341146|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
126341147|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
126341148|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
126341149|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
126341150|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
126341151|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
126341152|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
126341153|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
126341154|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
126341155|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
126341156|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
126341157|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
126341158|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
126341159|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
126341160|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
126341161|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
126341162|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
126341163|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
126341164|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
126341165|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
126341166|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
126341167|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
126341168|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
126341169|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
126341170|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
126341171|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
126341172|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
126341173|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
126341174|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
126341175|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
126341176|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
126341177|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
126341178|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
126341179|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
126341180|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
126341181|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
126341182|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
126341183|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
126341184|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
126341185|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
126341186|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
126341187|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
126341188|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
126341189|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
126341190|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
126341191|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
126341192|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
126341193|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
126006471|NCT02138916|453317099|FG002|Overall Study|Study specific withdrawal criteria|1|||
126006472|NCT02138916|453317097|FG000|Overall Study|incorrect enrolment|1|||
126006473|NCT02138916|453317098|FG001|Overall Study|incorrect enrolment|1|||
126006474|NCT02138916|453317099|FG002|Overall Study|incorrect enrolment|0|||
126006475|NCT02138916|453317097|FG000|Overall Study|Severe non-compliance|1|||
126006476|NCT02138916|453317098|FG001|Overall Study|Severe non-compliance|2|||
126006477|NCT02138916|453317099|FG002|Overall Study|Severe non-compliance|1|||
126006478|NCT02138916|453317097|FG000|Overall Study|Lost to Follow-up|4|||
126006479|NCT02138916|453317098|FG001|Overall Study|Lost to Follow-up|2|||
126006480|NCT02138916|453317099|FG002|Overall Study|Lost to Follow-up|3|||
126341194|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
126341195|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
126341196|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
126341197|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
126341198|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
126341199|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
126341200|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
126341201|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
126341202|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
126341203|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
126341204|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
126341205|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
126341206|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
126341207|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
126341208|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
126341209|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
126341210|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
126341211|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
126341212|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
126341213|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
126341214|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
126341215|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
126341216|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
126341217|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
126341218|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
126341219|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
126341220|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
126341221|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
126341222|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
126341223|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
126341224|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
126341225|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
126341226|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
126341227|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
126341228|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
126341229|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
126341230|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
126341231|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
126341232|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
126341233|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
126341234|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
126341235|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
126341236|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
126341237|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
126341238|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
126341239|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
126341240|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
126341241|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
126341242|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
126341243|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
126341244|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
126341245|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126341246|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126341247|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
126341248|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
126006481|NCT02138916|453317097|FG000|Overall Study|Adverse Event|4|||
126006482|NCT02138916|453317098|FG001|Overall Study|Adverse Event|4|||
126006483|NCT02138916|453317099|FG002|Overall Study|Adverse Event|3|||
126006484|NCT05096884|453317100|FG000|Overall Study|Excluded based on negative tilt table test|4|||
126006485|NCT01096056|453317101|FG000|Overall Study|Lost to Follow-up|0|||
126006486|NCT01096056|453317102|FG001|Overall Study|Lost to Follow-up|1|||
126006487|NCT03568162|453317106|FG000|Overall Study|Adverse Event|0|||
126006488|NCT03568162|453317107|FG001|Overall Study|Adverse Event|1|||
126006489|NCT03568162|453317108|FG002|Overall Study|Adverse Event|2|||
126006490|NCT03568162|453317109|FG003|Overall Study|Adverse Event|0|||
126006491|NCT03568162|453317110|FG004|Overall Study|Adverse Event|0|||
126006492|NCT03568162|453317111|FG005|Overall Study|Adverse Event|1|||
126006493|NCT03568162|453317106|FG000|Overall Study|Death|0|||
126006494|NCT03568162|453317107|FG001|Overall Study|Death|0|||
126006495|NCT03568162|453317108|FG002|Overall Study|Death|0|||
126006496|NCT03568162|453317109|FG003|Overall Study|Death|0|||
126006497|NCT03568162|453317110|FG004|Overall Study|Death|1|||
126006498|NCT03568162|453317111|FG005|Overall Study|Death|0|||
126006499|NCT03568162|453317106|FG000|Overall Study|Lost to Follow-up|3|||
126006500|NCT03568162|453317107|FG001|Overall Study|Lost to Follow-up|2|||
126006501|NCT03568162|453317108|FG002|Overall Study|Lost to Follow-up|4|||
126006502|NCT03568162|453317109|FG003|Overall Study|Lost to Follow-up|2|||
126006503|NCT03568162|453317110|FG004|Overall Study|Lost to Follow-up|3|||
126006504|NCT03568162|453317111|FG005|Overall Study|Lost to Follow-up|2|||
126006505|NCT03568162|453317106|FG000|Overall Study|Physician Decision|0|||
126006506|NCT03568162|453317107|FG001|Overall Study|Physician Decision|1|||
126006507|NCT03568162|453317108|FG002|Overall Study|Physician Decision|1|||
126006508|NCT03568162|453317109|FG003|Overall Study|Physician Decision|0|||
126006509|NCT03568162|453317110|FG004|Overall Study|Physician Decision|1|||
126006510|NCT03568162|453317111|FG005|Overall Study|Physician Decision|0|||
126006511|NCT03568162|453317106|FG000|Overall Study|Pregnancy|0|||
126006512|NCT03568162|453317107|FG001|Overall Study|Pregnancy|0|||
126006513|NCT03568162|453317108|FG002|Overall Study|Pregnancy|0|||
126006514|NCT03568162|453317109|FG003|Overall Study|Pregnancy|1|||
126006515|NCT03568162|453317110|FG004|Overall Study|Pregnancy|0|||
126006516|NCT03568162|453317111|FG005|Overall Study|Pregnancy|0|||
126006517|NCT03568162|453317106|FG000|Overall Study|Protocol Violation|1|||
126006518|NCT03568162|453317107|FG001|Overall Study|Protocol Violation|0|||
126006519|NCT03568162|453317108|FG002|Overall Study|Protocol Violation|1|||
126006520|NCT03568162|453317109|FG003|Overall Study|Protocol Violation|1|||
126006521|NCT03568162|453317110|FG004|Overall Study|Protocol Violation|1|||
126006522|NCT03568162|453317111|FG005|Overall Study|Protocol Violation|1|||
126006523|NCT03568162|453317106|FG000|Overall Study|Withdrawal by Subject|15|||
126006524|NCT03568162|453317107|FG001|Overall Study|Withdrawal by Subject|15|||
126341249|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
126341250|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
126341251|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
126341252|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
126006525|NCT03568162|453317108|FG002|Overall Study|Withdrawal by Subject|26|||
126006526|NCT03568162|453317109|FG003|Overall Study|Withdrawal by Subject|22|||
126006527|NCT03568162|453317110|FG004|Overall Study|Withdrawal by Subject|6|||
126006528|NCT03568162|453317111|FG005|Overall Study|Withdrawal by Subject|9|||
126006529|NCT03568162|453317106|FG000|Overall Study|Others|3|||
126006530|NCT03568162|453317107|FG001|Overall Study|Others|4|||
126341253|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
126341254|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
126341255|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
126341256|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
126341257|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
126341258|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
126341259|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
126341260|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
126341261|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
126341262|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
126341263|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
126341264|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
126006531|NCT03568162|453317108|FG002|Overall Study|Others|1|||
126006532|NCT03568162|453317109|FG003|Overall Study|Others|4|||
126006533|NCT03568162|453317110|FG004|Overall Study|Others|2|||
126006534|NCT03568162|453317111|FG005|Overall Study|Others|1|||
126006535|NCT03781804|453317112|FG000|Overall Study|Adverse Event|2|||
126006536|NCT03781804|453317113|FG001|Overall Study|Adverse Event|2|||
126006537|NCT03781804|453317114|FG002|Overall Study|Adverse Event|3|||
126006538|NCT03781804|453317112|FG000|Overall Study|Lost to Follow-up|1|||
126006539|NCT03781804|453317113|FG001|Overall Study|Lost to Follow-up|1|||
126006540|NCT03781804|453317114|FG002|Overall Study|Lost to Follow-up|2|||
126006541|NCT03781804|453317112|FG000|Overall Study|Lack of Efficacy|4|||
126006542|NCT03781804|453317113|FG001|Overall Study|Lack of Efficacy|2|||
126006543|NCT03781804|453317114|FG002|Overall Study|Lack of Efficacy|9|||
126006544|NCT03781804|453317112|FG000|Overall Study|Protocol Violation|0|||
126006545|NCT03781804|453317113|FG001|Overall Study|Protocol Violation|0|||
126006546|NCT03781804|453317114|FG002|Overall Study|Protocol Violation|1|||
126006547|NCT03781804|453317112|FG000|Overall Study|Withdrawal by Subject|0|||
126006548|NCT03781804|453317113|FG001|Overall Study|Withdrawal by Subject|1|||
126341265|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
126341266|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
126341267|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
126341268|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
126341269|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
126341270|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
126341271|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
126341272|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
126341273|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
126341274|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
126341275|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
126341276|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
126341277|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
126341278|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
126341279|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
126341280|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
126341281|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
126341282|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
126341283|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
126341284|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
126341285|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
126341286|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
126341287|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
126341288|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
126341289|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
126341290|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
126341291|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
126341292|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
126341293|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
126341294|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
126341295|NCT00855218|454544510|FG000|Overall Study|Adverse Event|43|||
126341296|NCT00855218|454544511|FG001|Overall Study|Adverse Event|27|||
126341297|NCT00855218|454544510|FG000|Overall Study|Withdrawal by Subject|10|||
126341298|NCT00855218|454544511|FG001|Overall Study|Withdrawal by Subject|6|||
126341299|NCT00855218|454544510|FG000|Overall Study|Physician Decision|18|||
126341300|NCT00855218|454544511|FG001|Overall Study|Physician Decision|11|||
126341301|NCT00855218|454544510|FG000|Overall Study|Lost to Follow-up|0|||
126341302|NCT00855218|454544511|FG001|Overall Study|Lost to Follow-up|1|||
126341303|NCT00855218|454544510|FG000|Overall Study|Protocol Violation|5|||
126341304|NCT00855218|454544511|FG001|Overall Study|Protocol Violation|9|||
126341305|NCT00855218|454544510|FG000|Overall Study|non-compliant with study drug|3|||
126341306|NCT00855218|454544511|FG001|Overall Study|non-compliant with study drug|1|||
126341307|NCT00855218|454544510|FG000|Overall Study|patient convenience|2|||
126341308|NCT00855218|454544511|FG001|Overall Study|patient convenience|0|||
126341309|NCT00855218|454544510|FG000|Overall Study|technical problems|2|||
126341310|NCT00855218|454544511|FG001|Overall Study|technical problems|1|||
126341311|NCT00855218|454544510|FG000|Overall Study|Still treated with study medication|0|||
126341312|NCT00855218|454544511|FG001|Overall Study|Still treated with study medication|1|||
126341313|NCT00855218|454544510|FG000|Overall Study|Untreatable disease progression|54|||
126341314|NCT00855218|454544511|FG001|Overall Study|Untreatable disease progression|67|||
126341315|NCT00855218|454544510|FG000|Overall Study|Second malignancy|0|||
126341316|NCT00855218|454544511|FG001|Overall Study|Second malignancy|1|||
126341317|NCT00855218|454544510|FG000|Overall Study|Progression measurement proven|7|||
126341318|NCT00855218|454544511|FG001|Overall Study|Progression measurement proven|15|||
126341319|NCT00855218|454544510|FG000|Overall Study|Clinical endpoint reached|10|||
126341320|NCT00855218|454544511|FG001|Overall Study|Clinical endpoint reached|13|||
126341321|NCT00764790|454544512|FG000|Overall Study|Protocol Violation|0|||
126341322|NCT00764790|454544513|FG001|Overall Study|Protocol Violation|0|||
126341323|NCT00764790|454544514|FG002|Overall Study|Protocol Violation|1|||
126341324|NCT00764790|454544512|FG000|Overall Study|Withdrawal by Subject|10|||
126341325|NCT00764790|454544513|FG001|Overall Study|Withdrawal by Subject|12|||
126341326|NCT00764790|454544514|FG002|Overall Study|Withdrawal by Subject|6|||
126341327|NCT00764790|454544512|FG000|Overall Study|Lost to Follow-up|28|||
126006549|NCT03781804|453317114|FG002|Overall Study|Withdrawal by Subject|1|||
126341328|NCT00764790|454544513|FG001|Overall Study|Lost to Follow-up|29|||
126341329|NCT00764790|454544514|FG002|Overall Study|Lost to Follow-up|23|||
126006550|NCT03781804|453317112|FG000|Overall Study|Reason not provided|2|||
126006551|NCT03781804|453317113|FG001|Overall Study|Reason not provided|2|||
126006552|NCT03781804|453317114|FG002|Overall Study|Reason not provided|0|||
126006553|NCT03717194|453317115|FG000|Overall Study|Withdrawal by Subject|2|||
126006554|NCT03717194|453317116|FG001|Overall Study|Withdrawal by Subject|4|||
126006555|NCT03717194|453317115|FG000|Overall Study|Adverse Event|1|||
126006556|NCT03717194|453317116|FG001|Overall Study|Adverse Event|1|||
126006557|NCT00337818|453317117|FG000|Overall Study|Lost to Follow-up|289|||
126006558|NCT00337818|453317118|FG001|Overall Study|Lost to Follow-up|91|||
126006559|NCT00337818|453317119|FG002|Overall Study|Lost to Follow-up|107|||
126006560|NCT04678830|453317120|FG000|Overall Study|Lack of Efficacy|2|||
126006561|NCT04678830|453317121|FG001|Overall Study|Lack of Efficacy|0|||
126006562|NCT04678830|453317120|FG000|Overall Study|Withdrawal by Subject|0|||
126341330|NCT03191552|454544515|FG000|Overall Study|Lost to Follow-up|1|||
126341331|NCT03191552|454544516|FG001|Overall Study|Lost to Follow-up|0|||
126426759|NCT00990106|454857925|FG000|Overall Study|opted for open label prazosin|1|||
126426760|NCT00990106|454857926|FG001|Overall Study|opted for open label prazosin|1|||
126426761|NCT00990106|454857925|FG000|Overall Study|relocation/deployment|4|||
126341332|NCT03191552|454544517|FG002|Overall Study|Lost to Follow-up|0|||
126341333|NCT03191552|454544515|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
126341334|NCT03191552|454544516|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
126341335|NCT03191552|454544517|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
126341336|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
126341337|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
126341338|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
126341339|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
126341340|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
126341341|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
126341342|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
126341343|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
126341344|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
126341345|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
126341346|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
126341347|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
126341348|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
126341349|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
126341350|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
126341351|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
126341352|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
126341353|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
126341354|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
126341355|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
126341356|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
126341357|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
126341358|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
126341359|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
126341360|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
126341361|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
126341362|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
126341363|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
126341364|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
126341365|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
126341366|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
126341367|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
126341368|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
126341369|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
126341370|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
126341371|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
126341372|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
126341373|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
126341374|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
126341375|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
126341376|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
126426762|NCT00990106|454857926|FG001|Overall Study|relocation/deployment|1|||
126006563|NCT04678830|453317121|FG001|Overall Study|Withdrawal by Subject|1|||
126006564|NCT03563053|453317124|FG000|Overall Study|Withdrawal by Subject|17|||
126006565|NCT03563053|453317124|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
126006566|NCT03563053|453317124|FG000|Overall Study|Adverse Event|3|||
126006567|NCT03563053|453317124|FG000|Overall Study|Physician Decision|1|||
126006568|NCT03563053|453317124|FG000|Overall Study|study terminated by sponsor|71|||
126006569|NCT01836458|453317125|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126006570|NCT01836458|453317126|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126006571|NCT01836458|453317127|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
126006572|NCT01836458|453317128|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
126006573|NCT02081391|453317129|FG000|12-hour Treatment|Withdrawal by Subject|3|||
126006574|NCT02081391|453317130|FG001|12-hour Treatment|Withdrawal by Subject|2|||
126006575|NCT02081391|453317131|FG002|12-hour Treatment|Withdrawal by Subject|0|||
126006576|NCT02081391|453317132|FG003|12-hour Treatment|Withdrawal by Subject|0|||
126006577|NCT02081391|453317129|FG000|12-hour Treatment|Physician Decision|4|||
126006578|NCT02081391|453317130|FG001|12-hour Treatment|Physician Decision|1|||
126006579|NCT02081391|453317131|FG002|12-hour Treatment|Physician Decision|0|||
126006580|NCT02081391|453317132|FG003|12-hour Treatment|Physician Decision|0|||
126006581|NCT02081391|453317129|FG000|12-hour Treatment|Lack of Efficacy|3|||
126426763|NCT00990106|454857925|FG000|Overall Study|started exclusionary medication|0|||
126426764|NCT00990106|454857926|FG001|Overall Study|started exclusionary medication|1|||
126426765|NCT00990106|454857925|FG000|Overall Study|planned major surgery|0|||
126426766|NCT00990106|454857926|FG001|Overall Study|planned major surgery|1|||
126426767|NCT00990106|454857925|FG000|Overall Study|scheduling conflicts|0|||
126426768|NCT00990106|454857926|FG001|Overall Study|scheduling conflicts|2|||
126426769|NCT00410956|454857928|FG000|Overall Study|Adverse Event|1|||
126426770|NCT00410956|454857928|FG000|Overall Study|Death|2|||
126426771|NCT00410956|454857928|FG000|Overall Study|Lack of Efficacy|10|||
126426772|NCT00410956|454857928|FG000|Overall Study|Physician Decision|6|||
126426773|NCT01650194|454857929|FG000|Overall Study|Progressive Disease (PD)|35|||
126426774|NCT01650194|454857929|FG000|Overall Study|Withdrawal by Subject|2|||
126426775|NCT01650194|454857929|FG000|Overall Study|Miscellaneous|10|||
126426776|NCT00880698|454857933|FG000|Overall Study|Death|0|||
126426777|NCT00880698|454857934|FG001|Overall Study|Death|0|||
126426778|NCT00880698|454857935|FG002|Overall Study|Death|1|||
126426779|NCT00880698|454857936|FG003|Overall Study|Death|2|||
126426780|NCT00880698|454857933|FG000|Overall Study|Lost to Follow-up|1|||
126426781|NCT00880698|454857934|FG001|Overall Study|Lost to Follow-up|3|||
126426782|NCT00880698|454857935|FG002|Overall Study|Lost to Follow-up|0|||
126426783|NCT00880698|454857936|FG003|Overall Study|Lost to Follow-up|1|||
126426784|NCT00851786|454857938|FG000|Overall Study|Withdrawal by Subject|0|||
126426785|NCT00851786|454857939|FG001|Overall Study|Withdrawal by Subject|1|||
126426786|NCT00851786|454857938|FG000|Overall Study|Protocol Violation|0|||
126426787|NCT00851786|454857939|FG001|Overall Study|Protocol Violation|1|||
126426788|NCT00851786|454857938|FG000|Overall Study|Lost to Follow-up|1|||
126426789|NCT00851786|454857939|FG001|Overall Study|Lost to Follow-up|0|||
126426790|NCT00851786|454857938|FG000|Overall Study|Incarceration|1|||
126426791|NCT00851786|454857939|FG001|Overall Study|Incarceration|0|||
126426792|NCT00851786|454857938|FG000|Overall Study|Site Closure|1|||
126426793|NCT00851786|454857939|FG001|Overall Study|Site Closure|0|||
126426794|NCT00851786|454857938|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
126006582|NCT02081391|453317130|FG001|12-hour Treatment|Lack of Efficacy|0|||
126006583|NCT02081391|453317131|FG002|12-hour Treatment|Lack of Efficacy|0|||
126006584|NCT02081391|453317132|FG003|12-hour Treatment|Lack of Efficacy|0|||
126006585|NCT02081391|453317129|FG000|12-hour Treatment|Adverse Event|4|||
126006586|NCT02081391|453317130|FG001|12-hour Treatment|Adverse Event|2|||
126006587|NCT02081391|453317131|FG002|12-hour Treatment|Adverse Event|0|||
126006588|NCT02081391|453317132|FG003|12-hour Treatment|Adverse Event|0|||
126006589|NCT02081391|453317129|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
126006590|NCT02081391|453317130|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
126006591|NCT02081391|453317131|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
126006592|NCT02081391|453317132|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
126006593|NCT02081391|453317129|FG000|12-hour Treatment|Further reasons|2|||
126006594|NCT02081391|453317130|FG001|12-hour Treatment|Further reasons|1|||
126006595|NCT02081391|453317131|FG002|12-hour Treatment|Further reasons|0|||
126006596|NCT02081391|453317132|FG003|12-hour Treatment|Further reasons|0|||
126006597|NCT02081391|453317129|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
126006598|NCT02081391|453317130|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
126341377|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
126341378|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
126341379|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
126341380|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
126341381|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
126341382|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
126341383|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
126341384|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
126426795|NCT00851786|454857939|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
126426796|NCT03858049|454860320|FG000|Overall Study|Adverse Event|16|||
126426797|NCT03858049|454860321|FG001|Overall Study|Adverse Event|9|||
126426798|NCT03858049|454860320|FG000|Overall Study|Other|1|||
126426799|NCT03858049|454860321|FG001|Overall Study|Other|1|||
126341385|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
126341386|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
126341387|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
126341388|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
126341389|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
126341390|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
126341391|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
126341392|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
126341393|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
126341394|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
126341395|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
126341396|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
126341397|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
126341398|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
126341399|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
126341400|NCT01265498|454544522|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
126341401|NCT01265498|454544523|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
126341402|NCT00921024|454544524|FG000|Overall Study|Lost to Follow-up|2|||
126341403|NCT00921024|454544525|FG001|Overall Study|Lost to Follow-up|0|||
126341404|NCT00921024|454544524|FG000|Overall Study|Received concomittant therapy|2|||
126341405|NCT00921024|454544525|FG001|Overall Study|Received concomittant therapy|0|||
126341406|NCT00921024|454544524|FG000|Overall Study|Withdrawal by Subject|0|||
126341407|NCT00921024|454544525|FG001|Overall Study|Withdrawal by Subject|3|||
126341408|NCT03225287|454544526|FG000|Overall Study|Adverse Event|0|||
126341409|NCT03225287|454544527|FG001|Overall Study|Adverse Event|0|||
126341410|NCT03225287|454544528|FG002|Overall Study|Adverse Event|1|||
126341411|NCT03225287|454544526|FG000|Overall Study|Protocol non-compliance|0|||
126341412|NCT03225287|454544527|FG001|Overall Study|Protocol non-compliance|0|||
126341413|NCT03225287|454544528|FG002|Overall Study|Protocol non-compliance|1|||
126341414|NCT03225287|454544526|FG000|Overall Study|Subject withdraws consent|3|||
126341415|NCT03225287|454544527|FG001|Overall Study|Subject withdraws consent|0|||
126341416|NCT03225287|454544528|FG002|Overall Study|Subject withdraws consent|0|||
126341417|NCT03225287|454544526|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
126341418|NCT03225287|454544527|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
126341419|NCT03225287|454544528|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
126341420|NCT03225287|454544526|FG000|Overall Study|Trial drug not effective|0|||
126341421|NCT03225287|454544527|FG001|Overall Study|Trial drug not effective|1|||
126341422|NCT03225287|454544528|FG002|Overall Study|Trial drug not effective|0|||
126341423|NCT03225287|454544526|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
126341424|NCT03225287|454544527|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
126341425|NCT03225287|454544528|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
126341426|NCT03225287|454544526|FG000|Overall Study|Stem cell transplantation|0|||
126341427|NCT03225287|454544527|FG001|Overall Study|Stem cell transplantation|1|||
126341428|NCT03225287|454544528|FG002|Overall Study|Stem cell transplantation|0|||
126341429|NCT01296412|454544530|FG000|Overall Study|Adverse Event|8|||
126341430|NCT01296412|454544531|FG001|Overall Study|Adverse Event|29|||
126341431|NCT01296412|454544530|FG000|Overall Study|Lack of Efficacy|1|||
126341432|NCT01296412|454544531|FG001|Overall Study|Lack of Efficacy|0|||
126341433|NCT01296412|454544530|FG000|Overall Study|Lost to Follow-up|10|||
126341434|NCT01296412|454544531|FG001|Overall Study|Lost to Follow-up|7|||
126341435|NCT01296412|454544530|FG000|Overall Study|Non-compliance with study drug|1|||
126341436|NCT01296412|454544531|FG001|Overall Study|Non-compliance with study drug|2|||
126341437|NCT01296412|454544530|FG000|Overall Study|Other reason not specified|20|||
126341438|NCT01296412|454544531|FG001|Overall Study|Other reason not specified|15|||
126341439|NCT01296412|454544530|FG000|Overall Study|Physician Decision|1|||
126341440|NCT01296412|454544531|FG001|Overall Study|Physician Decision|3|||
126341441|NCT01296412|454544530|FG000|Overall Study|Pregnancy|0|||
126341442|NCT01296412|454544531|FG001|Overall Study|Pregnancy|1|||
126341443|NCT01296412|454544530|FG000|Overall Study|Withdrawal by Subject|10|||
126341444|NCT01296412|454544531|FG001|Overall Study|Withdrawal by Subject|13|||
126341445|NCT02160626|454544532|FG000|Overall Study|Adverse Event|1|||
126341446|NCT02160626|454544533|FG001|Overall Study|Adverse Event|0|||
126341447|NCT02160626|454544534|FG002|Overall Study|Adverse Event|0|||
126341448|NCT02160626|454544532|FG000|Overall Study|Schedule not conducive to study visits|0|||
126341449|NCT02160626|454544533|FG001|Overall Study|Schedule not conducive to study visits|0|||
126341450|NCT02160626|454544534|FG002|Overall Study|Schedule not conducive to study visits|1|||
126341451|NCT02160626|454544532|FG000|Overall Study|Withdrawal by Subject|0|||
126341452|NCT02160626|454544533|FG001|Overall Study|Withdrawal by Subject|1|||
126341453|NCT02160626|454544534|FG002|Overall Study|Withdrawal by Subject|0|||
126341454|NCT04239924|454544535|FG000|Overall Study|Lost to Follow-up|2|||
126341455|NCT00296244|454546589|FG000|Overall Study|Underwent retransplant|0|||
126341456|NCT00296244|454546590|FG001|Overall Study|Underwent retransplant|1|||
126341457|NCT00427934|454546591|FG000|Overall Study|Adverse Event|1|||
126426800|NCT04617782|454860322|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
126426801|NCT04617782|454860322|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
126426802|NCT04617782|454860322|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
126426803|NCT04617782|454860322|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
126426804|NCT04617782|454860322|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
126426805|NCT04617782|454860322|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
126426806|NCT04233801|454860331|FG000|Overall Study|Other than listed|0|||
126426807|NCT04233801|454860332|FG001|Overall Study|Other than listed|0|||
126426808|NCT04233801|454860333|FG002|Overall Study|Other than listed|1|||
126426809|NCT04233801|454860331|FG000|Overall Study|Withdrawal by Subject|0|||
126426810|NCT04233801|454860332|FG001|Overall Study|Withdrawal by Subject|2|||
126426811|NCT04233801|454860333|FG002|Overall Study|Withdrawal by Subject|3|||
126426812|NCT01690052|454860338|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
126426813|NCT01690052|454860339|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
126426814|NCT02421172|454860340|FG000|Period 1|Adverse Event|1|||
126426815|NCT02421172|454860341|FG001|Period 1|Adverse Event|0|||
126426816|NCT02421172|454860342|FG002|Period 1|Adverse Event|0|||
126426817|NCT02421172|454860343|FG003|Period 1|Adverse Event|0|||
126426818|NCT02421172|454860344|FG004|Period 1|Adverse Event|0|||
126426819|NCT02421172|454860340|FG000|Period 1|Lost to Follow-up|3|||
126426820|NCT02421172|454860341|FG001|Period 1|Lost to Follow-up|1|||
126426821|NCT02421172|454860342|FG002|Period 1|Lost to Follow-up|0|||
126426822|NCT02421172|454860343|FG003|Period 1|Lost to Follow-up|0|||
126426823|NCT02421172|454860344|FG004|Period 1|Lost to Follow-up|0|||
126426824|NCT02421172|454860340|FG000|Period 1|Patient/guardian decision|0|||
126426825|NCT02421172|454860341|FG001|Period 1|Patient/guardian decision|1|||
126426826|NCT02421172|454860342|FG002|Period 1|Patient/guardian decision|0|||
126426827|NCT02421172|454860343|FG003|Period 1|Patient/guardian decision|0|||
126426828|NCT02421172|454860344|FG004|Period 1|Patient/guardian decision|0|||
126426829|NCT02421172|454860340|FG000|Period 2|Adverse Event|0|||
126426830|NCT02421172|454860341|FG001|Period 2|Adverse Event|0|||
126426831|NCT02421172|454860342|FG002|Period 2|Adverse Event|4|||
126426832|NCT02421172|454860343|FG003|Period 2|Adverse Event|0|||
126426833|NCT02421172|454860344|FG004|Period 2|Adverse Event|0|||
126426834|NCT02421172|454860340|FG000|Period 2|Lost to Follow-up|0|||
126426835|NCT02421172|454860341|FG001|Period 2|Lost to Follow-up|0|||
126426836|NCT02421172|454860342|FG002|Period 2|Lost to Follow-up|0|||
126426837|NCT02421172|454860343|FG003|Period 2|Lost to Follow-up|1|||
126426838|NCT02421172|454860344|FG004|Period 2|Lost to Follow-up|0|||
126426839|NCT02421172|454860340|FG000|Period 2|Patient/guardian decision|0|||
126426840|NCT02421172|454860341|FG001|Period 2|Patient/guardian decision|0|||
126426841|NCT02421172|454860342|FG002|Period 2|Patient/guardian decision|3|||
126426842|NCT02421172|454860343|FG003|Period 2|Patient/guardian decision|2|||
126426843|NCT02421172|454860344|FG004|Period 2|Patient/guardian decision|1|||
126426844|NCT00683878|454860345|FG000|Overall Study|Lack of Efficacy|3|||
126426845|NCT00683878|454860346|FG001|Overall Study|Lack of Efficacy|0|||
126426846|NCT00683878|454860347|FG002|Overall Study|Lack of Efficacy|1|||
126426847|NCT00683878|454860345|FG000|Overall Study|Adverse Event|4|||
126426848|NCT00683878|454860346|FG001|Overall Study|Adverse Event|3|||
126426849|NCT00683878|454860347|FG002|Overall Study|Adverse Event|3|||
126426850|NCT00683878|454860345|FG000|Overall Study|Withdrawal by Subject|9|||
126426851|NCT00683878|454860346|FG001|Overall Study|Withdrawal by Subject|8|||
126426852|NCT00683878|454860347|FG002|Overall Study|Withdrawal by Subject|6|||
126426853|NCT00683878|454860345|FG000|Overall Study|Death|0|||
126426854|NCT00683878|454860346|FG001|Overall Study|Death|1|||
126426855|NCT00683878|454860347|FG002|Overall Study|Death|0|||
126426856|NCT00683878|454860345|FG000|Overall Study|Lost to Follow-up|4|||
126426857|NCT00683878|454860346|FG001|Overall Study|Lost to Follow-up|2|||
126426858|NCT00683878|454860347|FG002|Overall Study|Lost to Follow-up|4|||
126426859|NCT00683878|454860345|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
126426860|NCT00683878|454860346|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
126426861|NCT00683878|454860347|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
126426862|NCT02869633|454860348|FG000|Overall Study|Death|2|||
126426863|NCT02869633|454860349|FG001|Overall Study|Death|1|||
126006599|NCT02081391|453317131|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
126006600|NCT02081391|453317132|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
126426864|NCT02869633|454860348|FG000|Overall Study|Patient refused follow-up|1|||
126426865|NCT02869633|454860349|FG001|Overall Study|Patient refused follow-up|0|||
126426866|NCT02869633|454860348|FG000|Overall Study|Provider discretion|1|||
126426867|NCT02869633|454860349|FG001|Overall Study|Provider discretion|0|||
126426868|NCT02869633|454860348|FG000|Overall Study|Investigator decision|1|||
126426869|NCT02869633|454860349|FG001|Overall Study|Investigator decision|0|||
126426870|NCT02869633|454860348|FG000|Overall Study|Lost to Follow-up|0|||
126426871|NCT02869633|454860349|FG001|Overall Study|Lost to Follow-up|1|||
126426872|NCT02869633|454860348|FG000|Overall Study|Not eligible|6|||
126426873|NCT02869633|454860349|FG001|Overall Study|Not eligible|1|||
126426874|NCT02869633|454860348|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
126426875|NCT02869633|454860349|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
126426876|NCT02869633|454860348|FG000|Overall Study|Withdrawal by Subject|0|||
126426877|NCT02869633|454860349|FG001|Overall Study|Withdrawal by Subject|1|||
126426878|NCT01474317|454860357|FG000|Overall Study|Adverse Event|1|||
126426879|NCT01474317|454860357|FG000|Overall Study|Subject ineligible for study|1|||
126426880|NCT01693029|454860360|FG000|Overall Study|Withdrawal by Subject|15|||
126426881|NCT01693029|454860361|FG001|Overall Study|Withdrawal by Subject|22|||
126426882|NCT01693029|454860360|FG000|Overall Study|Kidney transplantation|7|||
126426883|NCT01693029|454860361|FG001|Overall Study|Kidney transplantation|7|||
126426884|NCT01693029|454860360|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
126426885|NCT01693029|454860361|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
126426886|NCT01693029|454860360|FG000|Overall Study|Protocol Violation|6|||
126426887|NCT01693029|454860361|FG001|Overall Study|Protocol Violation|7|||
126426888|NCT01693029|454860360|FG000|Overall Study|Change in dialysis modality|2|||
126426889|NCT01693029|454860361|FG001|Overall Study|Change in dialysis modality|1|||
126426890|NCT01693029|454860360|FG000|Overall Study|Physician Decision|0|||
126426891|NCT01693029|454860361|FG001|Overall Study|Physician Decision|2|||
126426892|NCT01693029|454860360|FG000|Overall Study|Lost to Follow-up|0|||
126426893|NCT01693029|454860361|FG001|Overall Study|Lost to Follow-up|1|||
126426894|NCT01693029|454860360|FG000|Overall Study|Adverse Event|1|||
126426895|NCT01693029|454860361|FG001|Overall Study|Adverse Event|6|||
126426896|NCT01693029|454860360|FG000|Overall Study|Death|5|||
126426897|NCT01693029|454860361|FG001|Overall Study|Death|8|||
126426898|NCT01693029|454860360|FG000|Overall Study|Non-compliance|2|||
126426899|NCT01693029|454860361|FG001|Overall Study|Non-compliance|1|||
126426900|NCT02647281|454860362|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426901|NCT02647281|454860363|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426902|NCT02647281|454860364|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426903|NCT02647281|454860365|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426904|NCT02647281|454860366|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426905|NCT02647281|454860367|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426906|NCT02647281|454860368|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426907|NCT02647281|454860369|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426908|NCT02647281|454860370|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
126426909|NCT05801991|454860371|FG000|Overall Study|Lost to Follow-up|1|||
126426910|NCT05801991|454860372|FG001|Overall Study|Lost to Follow-up|0|||
126426911|NCT03489863|454860373|FG000|Overall Study|Withdrawal by Subject|0|||
126426912|NCT03489863|454860374|FG001|Overall Study|Withdrawal by Subject|1|||
126426913|NCT00962208|454860376|FG000|Overall Study|Could not achieve good vision|9|||
126426914|NCT00962208|454860377|FG001|Overall Study|Could not achieve good vision|0|||
126426915|NCT00962208|454860376|FG000|Overall Study|Contraindicated to continue study|5|||
126426916|NCT00962208|454860377|FG001|Overall Study|Contraindicated to continue study|1|||
126426917|NCT00962208|454860376|FG000|Overall Study|Lost to Follow-up|0|||
126426918|NCT00962208|454860377|FG001|Overall Study|Lost to Follow-up|9|||
126426919|NCT00791388|454860378|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
126426920|NCT00791388|454860379|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
126426921|NCT00791388|454860380|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
126426922|NCT00791388|454860381|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
126426923|NCT00791388|454860382|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
126006601|NCT02081391|453317129|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
126006602|NCT02081391|453317130|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
126006603|NCT02081391|453317131|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
126426924|NCT00791388|454860378|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
126426925|NCT00791388|454860379|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
126426926|NCT00791388|454860380|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
126426927|NCT00791388|454860381|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
126426928|NCT00791388|454860382|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
126426929|NCT00791388|454860378|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
126426930|NCT00791388|454860379|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
126426931|NCT00791388|454860380|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
126426932|NCT00791388|454860381|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
126426933|NCT00791388|454860382|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
126426934|NCT02995980|454860383|FG000|Overall Study|Lost to Follow-up|14|||
126006604|NCT02081391|453317132|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
126426935|NCT00657540|454860385|FG000|Overall Study|Lost to Follow-up|1|||
126426936|NCT00657540|454860386|FG001|Overall Study|Lost to Follow-up|4|||
126006605|NCT02081391|453317129|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
126426937|NCT01169103|454860388|FG000|Overall Study|Lost to Follow-up|3|||
126426938|NCT01169103|454860389|FG001|Overall Study|Lost to Follow-up|3|||
126006606|NCT02081391|453317130|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
126426939|NCT01169103|454860388|FG000|Overall Study|Withdrawal by Subject|3|||
126006607|NCT02081391|453317131|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
126426940|NCT01169103|454860389|FG001|Overall Study|Withdrawal by Subject|1|||
126426941|NCT03010527|454860390|FG000|Overall Study|Death|0|||
126006608|NCT02081391|453317132|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
126341458|NCT00427934|454546592|FG001|Overall Study|Adverse Event|0|||
126341459|NCT00427934|454546593|FG002|Overall Study|Adverse Event|5|||
126341460|NCT00427934|454546594|FG003|Overall Study|Adverse Event|4|||
126341461|NCT00427934|454546591|FG000|Overall Study|Lack of Efficacy|0|||
126341462|NCT00427934|454546592|FG001|Overall Study|Lack of Efficacy|0|||
126341463|NCT00427934|454546593|FG002|Overall Study|Lack of Efficacy|5|||
126341464|NCT00427934|454546594|FG003|Overall Study|Lack of Efficacy|2|||
126341465|NCT00427934|454546591|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
126341466|NCT00427934|454546592|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
126341467|NCT00427934|454546593|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
126341468|NCT00427934|454546594|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
126341469|NCT00427934|454546591|FG000|Overall Study|Other|0|||
126341470|NCT00427934|454546592|FG001|Overall Study|Other|0|||
126341471|NCT00427934|454546593|FG002|Overall Study|Other|11|||
126341472|NCT00427934|454546594|FG003|Overall Study|Other|5|||
126341473|NCT00427934|454546591|FG000|Overall Study|Withdrawal by Subject|0|||
126341474|NCT00427934|454546592|FG001|Overall Study|Withdrawal by Subject|0|||
126341475|NCT00427934|454546593|FG002|Overall Study|Withdrawal by Subject|1|||
126341476|NCT00427934|454546594|FG003|Overall Study|Withdrawal by Subject|3|||
126341477|NCT00499122|454546595|FG000|Overall Study|Withdrawal by Subject|2|||
126341478|NCT04539275|454546598|FG000|Overall Study|Death|2|||
126341479|NCT04539275|454546599|FG001|Overall Study|Death|4|||
126341480|NCT04539275|454546598|FG000|Overall Study|Lost to Follow-up|1|||
126341481|NCT04539275|454546599|FG001|Overall Study|Lost to Follow-up|1|||
126341482|NCT04539275|454546598|FG000|Overall Study|Withdrawal by Subject|3|||
126341483|NCT04539275|454546599|FG001|Overall Study|Withdrawal by Subject|0|||
126341484|NCT01373164|454546604|FG000|Overall Study|Lost to Follow-up|0|||
126341485|NCT01373164|454546605|FG001|Overall Study|Lost to Follow-up|0|||
126341486|NCT01373164|454546606|FG002|Overall Study|Lost to Follow-up|1|||
126341487|NCT01373164|454546607|FG003|Overall Study|Lost to Follow-up|2|||
126341488|NCT01373164|454546608|FG004|Overall Study|Lost to Follow-up|0|||
126341489|NCT01373164|454546604|FG000|Overall Study|Withdrawal by Subject|0|||
126341490|NCT01373164|454546605|FG001|Overall Study|Withdrawal by Subject|1|||
126341491|NCT01373164|454546606|FG002|Overall Study|Withdrawal by Subject|0|||
126341492|NCT01373164|454546607|FG003|Overall Study|Withdrawal by Subject|10|||
126341493|NCT01373164|454546608|FG004|Overall Study|Withdrawal by Subject|2|||
126341494|NCT01799941|454546609|FG000|Overall Study|Adverse Event|34|||
126341495|NCT01799941|454546609|FG000|Overall Study|Withdrawal by Subject|21|||
126341496|NCT01799941|454546609|FG000|Overall Study|Death|2|||
126341497|NCT01799941|454546609|FG000|Overall Study|Investigator Decision|4|||
126341498|NCT01799941|454546609|FG000|Overall Study|Lack of Efficacy|3|||
126341499|NCT01799941|454546609|FG000|Overall Study|Lost to Follow-up|17|||
126341500|NCT01799941|454546609|FG000|Overall Study|Other|15|||
126341501|NCT00420745|454546616|FG000|Overall Study|Adverse Event|2|||
126341502|NCT00420745|454546617|FG001|Overall Study|Adverse Event|2|||
126341503|NCT00420745|454546616|FG000|Overall Study|Lost to Follow-up|10|||
126341504|NCT00420745|454546617|FG001|Overall Study|Lost to Follow-up|2|||
126341505|NCT00420745|454546616|FG000|Overall Study|Protocol Violation|1|||
126341506|NCT00420745|454546617|FG001|Overall Study|Protocol Violation|0|||
126341507|NCT00420745|454546616|FG000|Overall Study|Physician Decision|1|||
126341508|NCT00420745|454546617|FG001|Overall Study|Physician Decision|1|||
126341509|NCT00420745|454546616|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
126341510|NCT00420745|454546617|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
126341511|NCT00420745|454546616|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
126341512|NCT00420745|454546617|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
126341513|NCT03736967|454546620|FG000|Overall Study|Withdrawal by Subject|26|||
126426942|NCT03010527|454860391|FG001|Overall Study|Death|0|||
126426943|NCT03010527|454860392|FG002|Overall Study|Death|1|||
126341514|NCT03736967|454546621|FG001|Overall Study|Withdrawal by Subject|25|||
126341515|NCT03736967|454546622|FG002|Overall Study|Withdrawal by Subject|23|||
126341516|NCT03736967|454546623|FG003|Overall Study|Withdrawal by Subject|26|||
126341517|NCT03736967|454546620|FG000|Overall Study|Lost to Follow-up|3|||
126341518|NCT03736967|454546621|FG001|Overall Study|Lost to Follow-up|2|||
126341519|NCT03736967|454546622|FG002|Overall Study|Lost to Follow-up|1|||
126341520|NCT03736967|454546623|FG003|Overall Study|Lost to Follow-up|1|||
126341521|NCT03736967|454546620|FG000|Overall Study|Physician Decision|1|||
126341522|NCT03736967|454546621|FG001|Overall Study|Physician Decision|0|||
126341523|NCT03736967|454546622|FG002|Overall Study|Physician Decision|0|||
126341524|NCT03736967|454546623|FG003|Overall Study|Physician Decision|1|||
126341525|NCT03736967|454546620|FG000|Overall Study|Adverse Event|0|||
126341526|NCT03736967|454546621|FG001|Overall Study|Adverse Event|1|||
126341527|NCT03736967|454546622|FG002|Overall Study|Adverse Event|0|||
126341528|NCT03736967|454546623|FG003|Overall Study|Adverse Event|1|||
126341529|NCT03736967|454546620|FG000|Overall Study|Death|0|||
126341530|NCT03736967|454546621|FG001|Overall Study|Death|0|||
126426944|NCT03010527|454860390|FG000|Overall Study|Adverse Event|0|||
126341531|NCT03736967|454546622|FG002|Overall Study|Death|0|||
126426945|NCT03010527|454860391|FG001|Overall Study|Adverse Event|4|||
126426946|NCT03010527|454860392|FG002|Overall Study|Adverse Event|2|||
126426947|NCT03010527|454860390|FG000|Overall Study|Protocol Violation|0|||
126426948|NCT03010527|454860391|FG001|Overall Study|Protocol Violation|1|||
126426949|NCT03010527|454860392|FG002|Overall Study|Protocol Violation|0|||
126426950|NCT03010527|454860390|FG000|Overall Study|Lost to Follow-up|0|||
126426951|NCT03010527|454860391|FG001|Overall Study|Lost to Follow-up|2|||
126426952|NCT03010527|454860392|FG002|Overall Study|Lost to Follow-up|1|||
126426953|NCT03010527|454860390|FG000|Overall Study|Withdrawal by Subject|0|||
126426954|NCT03010527|454860391|FG001|Overall Study|Withdrawal by Subject|3|||
126426955|NCT03010527|454860392|FG002|Overall Study|Withdrawal by Subject|4|||
126426956|NCT03010527|454860390|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
126426957|NCT03010527|454860391|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
126426958|NCT03010527|454860392|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
126426959|NCT03010527|454860390|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
126426960|NCT03010527|454860391|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
126426961|NCT03010527|454860392|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
126426962|NCT03010527|454860390|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
126426963|NCT03010527|454860391|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
126426964|NCT03010527|454860392|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
126426965|NCT02656017|454860393|FG000|Overall Study|Study burden|3|||
126426966|NCT02656017|454860394|FG001|Overall Study|Study burden|3|||
126426967|NCT02656017|454860393|FG000|Overall Study|Adverse Event|2|||
126426968|NCT02656017|454860394|FG001|Overall Study|Adverse Event|1|||
126426969|NCT02656017|454860393|FG000|Overall Study|Unable/unwilling to take study medication|2|||
126426970|NCT02656017|454860394|FG001|Overall Study|Unable/unwilling to take study medication|1|||
126426971|NCT02656017|454860393|FG000|Overall Study|Began Tolvaptan|1|||
126426972|NCT02656017|454860394|FG001|Overall Study|Began Tolvaptan|1|||
126006609|NCT02081391|453317129|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
126426973|NCT02656017|454860393|FG000|Overall Study|Withdrawal by Subject|1|||
126426974|NCT02656017|454860394|FG001|Overall Study|Withdrawal by Subject|0|||
126426975|NCT02792231|454860399|FG000|Overall Study|Patient/guardian decision|32|||
126426976|NCT02792231|454860400|FG001|Overall Study|Patient/guardian decision|42|||
126426977|NCT02792231|454860399|FG000|Overall Study|Adverse Event|15|||
126426978|NCT02792231|454860400|FG001|Overall Study|Adverse Event|11|||
126426979|NCT02792231|454860399|FG000|Overall Study|Physician Decision|14|||
126426980|NCT02792231|454860400|FG001|Overall Study|Physician Decision|12|||
126426981|NCT02792231|454860399|FG000|Overall Study|Lack of Efficacy|7|||
126426982|NCT02792231|454860400|FG001|Overall Study|Lack of Efficacy|9|||
126006610|NCT02081391|453317130|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
126006611|NCT02081391|453317131|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
126006612|NCT02081391|453317132|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
126006613|NCT02081391|453317129|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
126006614|NCT02081391|453317130|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
126006615|NCT02081391|453317131|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
126006616|NCT02081391|453317132|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
126426983|NCT02792231|454860399|FG000|Overall Study|Lost to Follow-up|9|||
126426984|NCT02792231|454860400|FG001|Overall Study|Lost to Follow-up|5|||
126006617|NCT02081391|453317129|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
126006618|NCT02081391|453317130|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
126006619|NCT02081391|453317131|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
126006620|NCT02081391|453317132|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
126006621|NCT02189863|453317133|FG000|First 2 Weeks|Motion Sickness|4|||
126426985|NCT02792231|454860399|FG000|Overall Study|Pregnancy|1|||
126426986|NCT02792231|454860400|FG001|Overall Study|Pregnancy|3|||
126426987|NCT02792231|454860399|FG000|Overall Study|Non-compliance with study treatment|2|||
126426988|NCT02792231|454860400|FG001|Overall Study|Non-compliance with study treatment|1|||
126426989|NCT02792231|454860399|FG000|Overall Study|Protocol deviation|2|||
126426990|NCT02792231|454860400|FG001|Overall Study|Protocol deviation|0|||
126426991|NCT02792231|454860399|FG000|Overall Study|Technical problems|0|||
126006622|NCT02189863|453317134|FG001|First 2 Weeks|Motion Sickness|2|||
126006623|NCT03369951|453317135|FG000|Overall Study|Withdrawal by Subject|3|||
126006624|NCT03369951|453317135|FG000|Overall Study|Death|1|||
126006625|NCT03369951|453317135|FG000|Overall Study|Lost to Follow-up|1|||
126426992|NCT02792231|454860400|FG001|Overall Study|Technical problems|1|||
126426993|NCT05196828|454860401|FG000|Overall Study|Withdrawal by Subject|2|||
126006626|NCT03369951|453317135|FG000|Overall Study|Protocol Violation|1|||
126426994|NCT05196828|454860402|FG001|Overall Study|Withdrawal by Subject|0|||
126426995|NCT05196828|454860401|FG000|Overall Study|Lost to Follow-up|0|||
126426996|NCT05196828|454860402|FG001|Overall Study|Lost to Follow-up|4|||
126426997|NCT05196828|454860401|FG000|Overall Study|Adverse Event|1|||
126426998|NCT05196828|454860402|FG001|Overall Study|Adverse Event|0|||
126426999|NCT02469623|454860403|FG000|Overall Study|Not consented for long-term follow-up|4|||
126427000|NCT02469623|454860403|FG000|Overall Study|Lost to Follow-up|4|||
126427001|NCT02469623|454860403|FG000|Overall Study|Withdrawal by Subject|2|||
126341532|NCT03736967|454546623|FG003|Overall Study|Death|1|||
126341533|NCT03736967|454546620|FG000|Overall Study|Randomized but never treated|1|||
126341534|NCT03736967|454546621|FG001|Overall Study|Randomized but never treated|0|||
126341535|NCT03736967|454546622|FG002|Overall Study|Randomized but never treated|0|||
126341536|NCT03736967|454546623|FG003|Overall Study|Randomized but never treated|0|||
126341537|NCT02419807|454546624|FG000|Overall Study|Withdrawal by Subject|4|||
126341538|NCT02419807|454546624|FG000|Overall Study|Physician Decision|1|||
126341539|NCT02419807|454546624|FG000|Overall Study|Protocol Violation|5|||
126341540|NCT01458587|454546625|FG000|Overall Study|Withdrawal by Subject|1|||
126341541|NCT01458587|454546626|FG001|Overall Study|Withdrawal by Subject|0|||
126341542|NCT02932943|454546628|FG000|Overall Study|Lost to Follow-up|0|||
126341543|NCT02932943|454546629|FG001|Overall Study|Lost to Follow-up|2|||
126341544|NCT02932943|454546628|FG000|Overall Study|Adverse Event|2|||
126341545|NCT02932943|454546629|FG001|Overall Study|Adverse Event|2|||
126341546|NCT02932943|454546628|FG000|Overall Study|Withdrawal by Subject|3|||
126341547|NCT02932943|454546629|FG001|Overall Study|Withdrawal by Subject|3|||
126341548|NCT01454284|454546630|FG000|Overall Study|Adverse Event|20|||
126341549|NCT01454284|454546631|FG001|Overall Study|Adverse Event|7|||
126341550|NCT01454284|454546630|FG000|Overall Study|Death|0|||
126341551|NCT01454284|454546631|FG001|Overall Study|Death|3|||
126341552|NCT01454284|454546630|FG000|Overall Study|Lost to Follow-up|13|||
126341553|NCT01454284|454546631|FG001|Overall Study|Lost to Follow-up|8|||
126341554|NCT01454284|454546630|FG000|Overall Study|Protocol Violation|9|||
126341555|NCT01454284|454546631|FG001|Overall Study|Protocol Violation|6|||
126341556|NCT01454284|454546630|FG000|Overall Study|Withdrawal by Subject|58|||
126341557|NCT01454284|454546631|FG001|Overall Study|Withdrawal by Subject|36|||
126341558|NCT01454284|454546630|FG000|Overall Study|Physician Decision|16|||
126341559|NCT01454284|454546631|FG001|Overall Study|Physician Decision|11|||
126341560|NCT01454284|454546630|FG000|Overall Study|Sponsor Decision|0|||
126341561|NCT01454284|454546631|FG001|Overall Study|Sponsor Decision|2|||
126341562|NCT03248037|454546634|FG000|Overall Study|Withdrawal by Subject|6|||
126341563|NCT03248037|454546635|FG001|Overall Study|Withdrawal by Subject|9|||
126341564|NCT03248037|454546634|FG000|Overall Study|Adverse Event|15|||
126341565|NCT03248037|454546635|FG001|Overall Study|Adverse Event|0|||
126341566|NCT04018066|454546636|FG000|Overall Study|participants started taking medications during the study period|3|||
126341567|NCT04018066|454546636|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
126341568|NCT01462942|454546645|FG000|Overall Study|Adverse Event|7|||
126341569|NCT01462942|454546646|FG001|Overall Study|Adverse Event|12|||
126341570|NCT01462942|454546647|FG002|Overall Study|Adverse Event|10|||
126341571|NCT01462942|454546648|FG003|Overall Study|Adverse Event|11|||
126341572|NCT01462942|454546649|FG004|Overall Study|Adverse Event|11|||
126341573|NCT01462942|454546645|FG000|Overall Study|Other, including COPD exacerbation|3|||
126341574|NCT01462942|454546646|FG001|Overall Study|Other, including COPD exacerbation|5|||
126341575|NCT01462942|454546647|FG002|Overall Study|Other, including COPD exacerbation|2|||
126341576|NCT01462942|454546648|FG003|Overall Study|Other, including COPD exacerbation|8|||
126341577|NCT01462942|454546649|FG004|Overall Study|Other, including COPD exacerbation|5|||
126341578|NCT01462942|454546645|FG000|Overall Study|Withdrawal by Subject|14|||
126341579|NCT01462942|454546646|FG001|Overall Study|Withdrawal by Subject|10|||
126341580|NCT01462942|454546647|FG002|Overall Study|Withdrawal by Subject|14|||
126341581|NCT01462942|454546648|FG003|Overall Study|Withdrawal by Subject|16|||
126341582|NCT01462942|454546649|FG004|Overall Study|Withdrawal by Subject|19|||
126341583|NCT01462942|454546645|FG000|Overall Study|Lack of Efficacy|6|||
126341584|NCT01462942|454546646|FG001|Overall Study|Lack of Efficacy|0|||
126341585|NCT01462942|454546647|FG002|Overall Study|Lack of Efficacy|4|||
126341586|NCT01462942|454546648|FG003|Overall Study|Lack of Efficacy|5|||
126341587|NCT01462942|454546649|FG004|Overall Study|Lack of Efficacy|3|||
126341588|NCT01462942|454546645|FG000|Overall Study|Lost to Follow-up|0|||
126341589|NCT01462942|454546646|FG001|Overall Study|Lost to Follow-up|1|||
126341590|NCT01462942|454546647|FG002|Overall Study|Lost to Follow-up|1|||
126341591|NCT01462942|454546648|FG003|Overall Study|Lost to Follow-up|1|||
126341592|NCT01462942|454546649|FG004|Overall Study|Lost to Follow-up|1|||
126341593|NCT01462942|454546645|FG000|Overall Study|Protocol Violation|4|||
126341594|NCT01462942|454546646|FG001|Overall Study|Protocol Violation|6|||
126341595|NCT01462942|454546647|FG002|Overall Study|Protocol Violation|9|||
126341596|NCT01462942|454546648|FG003|Overall Study|Protocol Violation|9|||
126341597|NCT01462942|454546649|FG004|Overall Study|Protocol Violation|6|||
126341598|NCT01027845|454546650|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
126341599|NCT01027845|454546651|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
126341600|NCT01027845|454546652|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
126341601|NCT01027845|454546653|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
126341602|NCT01027845|454546650|FG000|Primary Vaccination Phase|Adverse Event|1|||
126341603|NCT01027845|454546651|FG001|Primary Vaccination Phase|Adverse Event|0|||
126341604|NCT01027845|454546652|FG002|Primary Vaccination Phase|Adverse Event|0|||
126341605|NCT01027845|454546653|FG003|Primary Vaccination Phase|Adverse Event|0|||
126341606|NCT01027845|454546650|FG000|Primary Vaccination Phase|Protocol Violation|1|||
126341607|NCT01027845|454546651|FG001|Primary Vaccination Phase|Protocol Violation|0|||
126341608|NCT01027845|454546652|FG002|Primary Vaccination Phase|Protocol Violation|0|||
126006627|NCT02926937|453317136|FG000|Overall Study|Adverse Event|0|||
126006628|NCT02926937|453317137|FG001|Overall Study|Adverse Event|1|||
126006629|NCT02926937|453317138|FG002|Overall Study|Adverse Event|1|||
126006630|NCT02926937|453317136|FG000|Overall Study|Poor Compliance to Protocol|1|||
126006631|NCT02926937|453317137|FG001|Overall Study|Poor Compliance to Protocol|0|||
126006632|NCT02926937|453317138|FG002|Overall Study|Poor Compliance to Protocol|0|||
126006633|NCT02926937|453317136|FG000|Overall Study|Lost to Follow-up|4|||
126006634|NCT02926937|453317137|FG001|Overall Study|Lost to Follow-up|5|||
126006635|NCT02926937|453317138|FG002|Overall Study|Lost to Follow-up|0|||
126006636|NCT02926937|453317136|FG000|Overall Study|At the Participant's own Request|11|||
126006637|NCT02926937|453317137|FG001|Overall Study|At the Participant's own Request|5|||
126006638|NCT02926937|453317138|FG002|Overall Study|At the Participant's own Request|8|||
126006639|NCT02926937|453317136|FG000|Overall Study|Reason not Specified|3|||
126006640|NCT02926937|453317137|FG001|Overall Study|Reason not Specified|4|||
126006641|NCT02926937|453317138|FG002|Overall Study|Reason not Specified|2|||
126006642|NCT03677375|453317139|FG000|Overall Study|Incomplete procedure|8|||
126006643|NCT03677375|453317139|FG000|Overall Study|Adverse Event|3|||
126006644|NCT03677375|453317139|FG000|Overall Study|Physician Decision|1|||
126006645|NCT00630864|453317149|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
126006646|NCT00630864|453317149|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
126006647|NCT00124982|453317150|FG000|Short-term Period|Death|1|||
126006648|NCT00124982|453317151|FG001|Short-term Period|Death|1|||
126006649|NCT00124982|453317152|FG002|Short-term Period|Death|0|||
126006650|NCT00124982|453317150|FG000|Short-term Period|Adverse Event|17|||
126006651|NCT00124982|453317151|FG001|Short-term Period|Adverse Event|22|||
126006652|NCT00124982|453317152|FG002|Short-term Period|Adverse Event|0|||
126006653|NCT00124982|453317150|FG000|Short-term Period|Lack of Efficacy|32|||
126006654|NCT00124982|453317151|FG001|Short-term Period|Lack of Efficacy|73|||
126006655|NCT00124982|453317152|FG002|Short-term Period|Lack of Efficacy|0|||
126006656|NCT00124982|453317150|FG000|Short-term Period|Lost to Follow-up|8|||
126006657|NCT00124982|453317151|FG001|Short-term Period|Lost to Follow-up|5|||
126006658|NCT00124982|453317152|FG002|Short-term Period|Lost to Follow-up|0|||
126006659|NCT00124982|453317150|FG000|Short-term Period|Withdrawal of Consent|7|||
126006660|NCT00124982|453317151|FG001|Short-term Period|Withdrawal of Consent|9|||
126006661|NCT00124982|453317152|FG002|Short-term Period|Withdrawal of Consent|0|||
126006662|NCT00124982|453317150|FG000|Short-term Period|Poor/Non-compliance|3|||
126006663|NCT00124982|453317151|FG001|Short-term Period|Poor/Non-compliance|1|||
126006664|NCT00124982|453317152|FG002|Short-term Period|Poor/Non-compliance|0|||
126006665|NCT00124982|453317150|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
126006666|NCT00124982|453317151|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
126006667|NCT00124982|453317152|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
126006668|NCT00124982|453317150|FG000|Short-term Period|Participant Decision|1|||
126006669|NCT00124982|453317151|FG001|Short-term Period|Participant Decision|0|||
126006670|NCT00124982|453317152|FG002|Short-term Period|Participant Decision|0|||
126006671|NCT00124982|453317150|FG000|Short-term Period|Participant Chose Own Doctor|0|||
126006672|NCT00124982|453317151|FG001|Short-term Period|Participant Chose Own Doctor|1|||
126006673|NCT00124982|453317152|FG002|Short-term Period|Participant Chose Own Doctor|0|||
126006674|NCT00124982|453317150|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
126006675|NCT00124982|453317151|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
126006676|NCT00124982|453317152|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
126006677|NCT00124982|453317150|FG000|Short-term Period|Participant Had Lymphopenia|1|||
126006678|NCT00124982|453317151|FG001|Short-term Period|Participant Had Lymphopenia|0|||
126006679|NCT00124982|453317152|FG002|Short-term Period|Participant Had Lymphopenia|0|||
126006680|NCT00124982|453317150|FG000|Long-term Period|Death|0|||
126006681|NCT00124982|453317151|FG001|Long-term Period|Death|0|||
126006682|NCT00124982|453317152|FG002|Long-term Period|Death|1|||
126006683|NCT00124982|453317150|FG000|Long-term Period|Adverse Event|0|||
126006684|NCT00124982|453317151|FG001|Long-term Period|Adverse Event|0|||
126006685|NCT00124982|453317152|FG002|Long-term Period|Adverse Event|17|||
126006686|NCT00124982|453317150|FG000|Long-term Period|Lack of Efficacy|0|||
126006687|NCT00124982|453317151|FG001|Long-term Period|Lack of Efficacy|0|||
126006688|NCT00124982|453317152|FG002|Long-term Period|Lack of Efficacy|46|||
126341609|NCT01027845|454546653|FG003|Primary Vaccination Phase|Protocol Violation|0|||
126006689|NCT00124982|453317150|FG000|Long-term Period|Lost to Follow-up|0|||
126006690|NCT00124982|453317151|FG001|Long-term Period|Lost to Follow-up|0|||
126006691|NCT00124982|453317152|FG002|Long-term Period|Lost to Follow-up|4|||
126006692|NCT00124982|453317150|FG000|Long-term Period|Withdrawal by Subject|0|||
126006693|NCT00124982|453317151|FG001|Long-term Period|Withdrawal by Subject|0|||
126006694|NCT00124982|453317152|FG002|Long-term Period|Withdrawal by Subject|16|||
126006695|NCT00124982|453317150|FG000|Long-term Period|Pregnancy|0|||
126006696|NCT00124982|453317151|FG001|Long-term Period|Pregnancy|0|||
126006697|NCT00124982|453317152|FG002|Long-term Period|Pregnancy|1|||
126341610|NCT01027845|454546650|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
126006698|NCT00124982|453317150|FG000|Long-term Period|Poor/Non-compliance|0|||
126006699|NCT00124982|453317151|FG001|Long-term Period|Poor/Non-compliance|0|||
126341611|NCT01027845|454546651|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
126427002|NCT02469623|454860403|FG000|Overall Study|Death|3|||
126427003|NCT04073186|454860404|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
126006700|NCT00124982|453317152|FG002|Long-term Period|Poor/Non-compliance|2|||
126006701|NCT00124982|453317150|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
126006702|NCT00124982|453317151|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
126006703|NCT00124982|453317152|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
126006704|NCT00124982|453317150|FG000|Long-term Period|Neurologist Recommendation|0|||
126006705|NCT00124982|453317151|FG001|Long-term Period|Neurologist Recommendation|0|||
126006706|NCT00124982|453317152|FG002|Long-term Period|Neurologist Recommendation|1|||
126006707|NCT00430677|453317153|FG000|Short-term Period|Death|1|||
126006708|NCT00430677|453317154|FG001|Short-term Period|Death|1|||
126006709|NCT00430677|453317155|FG002|Short-term Period|Death|5|||
126006710|NCT00430677|453317153|FG000|Short-term Period|Adverse Event|15|||
126006711|NCT00430677|453317154|FG001|Short-term Period|Adverse Event|13|||
126006712|NCT00430677|453317155|FG002|Short-term Period|Adverse Event|9|||
126006713|NCT00430677|453317153|FG000|Short-term Period|Lack of Efficacy|5|||
126006714|NCT00430677|453317154|FG001|Short-term Period|Lack of Efficacy|6|||
126006715|NCT00430677|453317155|FG002|Short-term Period|Lack of Efficacy|4|||
126006716|NCT00430677|453317153|FG000|Short-term Period|Withdrawal by Subject|1|||
126006717|NCT00430677|453317154|FG001|Short-term Period|Withdrawal by Subject|1|||
126006718|NCT00430677|453317155|FG002|Short-term Period|Withdrawal by Subject|2|||
126006719|NCT00430677|453317153|FG000|Short-term Period|Participant no longer met study criteria|1|||
126006720|NCT00430677|453317154|FG001|Short-term Period|Participant no longer met study criteria|1|||
126006721|NCT00430677|453317155|FG002|Short-term Period|Participant no longer met study criteria|2|||
126006722|NCT00430677|453317153|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
126006723|NCT00430677|453317154|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
126006724|NCT00430677|453317155|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
126006725|NCT00430677|453317153|FG000|Short-term Period|Pregnancy|0|||
126006726|NCT00430677|453317154|FG001|Short-term Period|Pregnancy|2|||
126427004|NCT04073186|454860404|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
126427005|NCT04073186|454860404|FG000|First Wearing Cycle|Protocol Violation|1|||
126427006|NCT04073186|454860404|FG000|First Wearing Cycle|Lens Discomfort|2|||
126427007|NCT04073186|454860404|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
126427008|NCT04073186|454860404|FG000|Second Wearing Cycle|Adverse Event|1|||
126427009|NCT03309878|454860405|FG000|Overall Study|Adverse Event|1|||
126427010|NCT03309878|454860406|FG001|Overall Study|Adverse Event|0|||
126427011|NCT03309878|454860407|FG002|Overall Study|Adverse Event|0|||
126427012|NCT03309878|454860408|FG003|Overall Study|Adverse Event|0|||
126427013|NCT03309878|454860405|FG000|Overall Study|Did not maintain eligibility|2|||
126427014|NCT03309878|454860406|FG001|Overall Study|Did not maintain eligibility|1|||
126006727|NCT00430677|453317155|FG002|Short-term Period|Pregnancy|0|||
126006728|NCT00430677|453317153|FG000|Long-term Extension Period|Death|1|||
126006729|NCT00430677|453317154|FG001|Long-term Extension Period|Death|0|||
126006730|NCT00430677|453317155|FG002|Long-term Extension Period|Death|0|||
126006731|NCT00430677|453317153|FG000|Long-term Extension Period|Adverse Event|3|||
126006732|NCT00430677|453317154|FG001|Long-term Extension Period|Adverse Event|2|||
126006733|NCT00430677|453317155|FG002|Long-term Extension Period|Adverse Event|5|||
126006734|NCT00430677|453317153|FG000|Long-term Extension Period|Lack of Efficacy|5|||
126006735|NCT00430677|453317154|FG001|Long-term Extension Period|Lack of Efficacy|3|||
126006736|NCT00430677|453317155|FG002|Long-term Extension Period|Lack of Efficacy|8|||
126006737|NCT00430677|453317153|FG000|Long-term Extension Period|Lost to Follow-up|1|||
126006738|NCT00430677|453317154|FG001|Long-term Extension Period|Lost to Follow-up|1|||
126006739|NCT00430677|453317155|FG002|Long-term Extension Period|Lost to Follow-up|1|||
126006740|NCT00430677|453317153|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
126006741|NCT00430677|453317154|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
126006742|NCT00430677|453317155|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
126006743|NCT00430677|453317153|FG000|Long-term Extension Period|Pregnancy|1|||
126006744|NCT00430677|453317154|FG001|Long-term Extension Period|Pregnancy|1|||
126006745|NCT00430677|453317155|FG002|Long-term Extension Period|Pregnancy|0|||
126006746|NCT00430677|453317153|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
126006747|NCT00430677|453317154|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
126006748|NCT00430677|453317155|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
126006749|NCT00430677|453317153|FG000|Long-term Extension Period|Other|2|||
126006750|NCT00430677|453317154|FG001|Long-term Extension Period|Other|1|||
126006751|NCT00430677|453317155|FG002|Long-term Extension Period|Other|1|||
126006752|NCT00430677|453317153|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
126006753|NCT00430677|453317154|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
126006754|NCT00430677|453317155|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
126006755|NCT01555762|453317156|FG000|Overall Study|No information on Bevacizumab intake|11|||
126006756|NCT01555762|453317156|FG000|Overall Study|Missing start date of infusion|8|||
126006757|NCT01555762|453317156|FG000|Overall Study|75 years old or more ticked No|1|||
126006758|NCT01555762|453317156|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
126006759|NCT01555762|453317156|FG000|Overall Study|Death linked to progression of disease|165|||
126006760|NCT01555762|453317156|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
126006761|NCT01555762|453317156|FG000|Overall Study|Investigator's decision|10|||
126006762|NCT01555762|453317156|FG000|Overall Study|Participant not wishing to continue|5|||
126006763|NCT01555762|453317156|FG000|Overall Study|Missing data|1|||
126006764|NCT01555762|453317156|FG000|Overall Study|Death linked to an adverse event|14|||
126006765|NCT01333514|453317157|FG000|Overall Study|Withdrawal by Subject|1|||
126006766|NCT01333514|453317158|FG001|Overall Study|Withdrawal by Subject|0|||
126006767|NCT00836810|453317159|FG000|Overall Study|New diagnosis|1|||
126006768|NCT00836810|453317160|FG001|Overall Study|New diagnosis|0|||
126006769|NCT00389519|453317163|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
126006770|NCT00389519|453317164|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
126006771|NCT00389519|453317165|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
126006772|NCT00389519|453317166|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
126006773|NCT00389519|453317163|FG000|Placebo Run-In|Withdrawal by Subject|19|||
126006774|NCT00389519|453317164|FG001|Placebo Run-In|Withdrawal by Subject|0|||
126006775|NCT00389519|453317165|FG002|Placebo Run-In|Withdrawal by Subject|0|||
126006776|NCT00389519|453317166|FG003|Placebo Run-In|Withdrawal by Subject|0|||
126006777|NCT00389519|453317163|FG000|Placebo Run-In|Reason not specified|40|||
126006778|NCT00389519|453317164|FG001|Placebo Run-In|Reason not specified|0|||
126006779|NCT00389519|453317165|FG002|Placebo Run-In|Reason not specified|0|||
126006780|NCT00389519|453317166|FG003|Placebo Run-In|Reason not specified|0|||
126006781|NCT00389519|453317163|FG000|Randomized|Did not receive study drug|2|||
126006782|NCT00389519|453317164|FG001|Randomized|Did not receive study drug|0|||
126006783|NCT00389519|453317165|FG002|Randomized|Did not receive study drug|0|||
126006784|NCT00389519|453317166|FG003|Randomized|Did not receive study drug|0|||
126006785|NCT00389519|453317163|FG000|Treated|Adverse Event|1|||
126006786|NCT00389519|453317164|FG001|Treated|Adverse Event|0|||
126006787|NCT00389519|453317165|FG002|Treated|Adverse Event|0|||
126006788|NCT00389519|453317166|FG003|Treated|Adverse Event|2|||
126006789|NCT00389519|453317163|FG000|Treated|Reason not specified|1|||
126006790|NCT00389519|453317164|FG001|Treated|Reason not specified|1|||
126006791|NCT00389519|453317165|FG002|Treated|Reason not specified|0|||
126006792|NCT00389519|453317166|FG003|Treated|Reason not specified|2|||
126006793|NCT02040844|453317171|FG000|Overall Study|Adverse Event|0|||
126006794|NCT02040844|453317172|FG001|Overall Study|Adverse Event|0|||
126006795|NCT02040844|453317173|FG002|Overall Study|Adverse Event|1|||
126006796|NCT02040844|453317171|FG000|Overall Study|Withdrawal by Subject|16|||
126006797|NCT02040844|453317172|FG001|Overall Study|Withdrawal by Subject|22|||
126006798|NCT02040844|453317173|FG002|Overall Study|Withdrawal by Subject|25|||
126006799|NCT02040844|453317171|FG000|Overall Study|Lost to Follow-up|12|||
126006800|NCT02040844|453317172|FG001|Overall Study|Lost to Follow-up|9|||
126006801|NCT02040844|453317173|FG002|Overall Study|Lost to Follow-up|13|||
126006802|NCT02040844|453317171|FG000|Overall Study|Missing|13|||
126006803|NCT02040844|453317172|FG001|Overall Study|Missing|3|||
126006804|NCT02040844|453317173|FG002|Overall Study|Missing|2|||
126006805|NCT02040844|453317171|FG000|Overall Study|Non-specified|8|||
126006806|NCT02040844|453317172|FG001|Overall Study|Non-specified|2|||
126006807|NCT02040844|453317173|FG002|Overall Study|Non-specified|5|||
126006808|NCT02040844|453317171|FG000|Overall Study|Concomitant medication|1|||
126006809|NCT02040844|453317172|FG001|Overall Study|Concomitant medication|3|||
126006810|NCT02040844|453317173|FG002|Overall Study|Concomitant medication|1|||
126006811|NCT01560949|453317176|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
126006812|NCT01560949|453317176|FG000|Surgery Phase|Physician Decision|3|||
126006813|NCT02068885|453317181|FG000|Overall Study|Withdrew|3|||
126006814|NCT02068885|453317182|FG001|Overall Study|Withdrew|5|||
126006815|NCT02068885|453317183|FG002|Overall Study|Withdrew|8|||
126006816|NCT00681811|453317184|FG000|Overall Study|Adverse Event|1|||
126006817|NCT00681811|453317185|FG001|Overall Study|Adverse Event|1|||
126006818|NCT00681811|453317184|FG000|Overall Study|Withdrawal by Subject|2|||
126006819|NCT00681811|453317185|FG001|Overall Study|Withdrawal by Subject|2|||
126006820|NCT00681811|453317184|FG000|Overall Study|Non-compliance|0|||
126006821|NCT00681811|453317185|FG001|Overall Study|Non-compliance|1|||
126006822|NCT01562743|453317191|FG000|Overall Study|Adverse Event|29|||
126006823|NCT01562743|453317191|FG000|Overall Study|Lack of Efficacy|3|||
126006824|NCT01562743|453317191|FG000|Overall Study|Withdrawal by Subject|13|||
126006825|NCT01562743|453317191|FG000|Overall Study|Protocol Violation|1|||
126006826|NCT01562743|453317191|FG000|Overall Study|Discontinuation criteria|2|||
126006827|NCT01562743|453317191|FG000|Overall Study|Lost to Follow-up|2|||
126006828|NCT01562743|453317191|FG000|Overall Study|Physician Decision|2|||
126006829|NCT04155424|453317192|FG000|Overall Study|Other than specified|3|||
126006830|NCT04155424|453317192|FG000|Overall Study|Withdrawal by Subject|1|||
126006831|NCT04155424|453317192|FG000|Overall Study|Adverse Event|1|||
126006832|NCT03015740|453317193|FG000|Overall Study|Adverse Event|1|||
126006833|NCT03015740|453317194|FG001|Overall Study|Adverse Event|0|||
126006834|NCT03015740|453317195|FG002|Overall Study|Adverse Event|0|||
126006835|NCT03015740|453317193|FG000|Overall Study|Death|3|||
126006836|NCT03015740|453317194|FG001|Overall Study|Death|5|||
126006837|NCT03015740|453317195|FG002|Overall Study|Death|0|||
126006838|NCT03015740|453317193|FG000|Overall Study|Withdrawal by Subject|2|||
126006839|NCT03015740|453317194|FG001|Overall Study|Withdrawal by Subject|0|||
126006840|NCT03015740|453317195|FG002|Overall Study|Withdrawal by Subject|0|||
126006841|NCT04159506|453317196|FG000|Overall Study|Lost to Follow-up|2|||
126006842|NCT04159506|453317197|FG001|Overall Study|Lost to Follow-up|5|||
126006843|NCT02449044|453317198|FG000|Overall Study|Lost to Follow-up|2|||
126006844|NCT02449044|453317198|FG000|Overall Study|Withdrawal by Subject|13|||
126006845|NCT02449044|453317198|FG000|Overall Study|Adverse Event|30|||
126006846|NCT02449044|453317198|FG000|Overall Study|Met Withdrawal Criteria|7|||
126006847|NCT02449044|453317198|FG000|Overall Study|Physician Decision|9|||
126006848|NCT02449044|453317198|FG000|Overall Study|Sponsor Discontinued Trial|3|||
126006849|NCT02624778|453318584|FG000|Overall Study|Lost to Follow-up|0|||
126006850|NCT02624778|453318585|FG001|Overall Study|Lost to Follow-up|0|||
126006851|NCT02624778|453318586|FG002|Overall Study|Lost to Follow-up|1|||
126006852|NCT02624778|453318587|FG003|Overall Study|Lost to Follow-up|0|||
126006853|NCT02624778|453318588|FG004|Overall Study|Lost to Follow-up|0|||
126006854|NCT02624778|453318589|FG005|Overall Study|Lost to Follow-up|0|||
126006855|NCT02624778|453318590|FG006|Overall Study|Lost to Follow-up|0|||
126006856|NCT02624778|453318591|FG007|Overall Study|Lost to Follow-up|0|||
126006857|NCT02624778|453318592|FG008|Overall Study|Lost to Follow-up|0|||
126006858|NCT02624778|453318584|FG000|Overall Study|Withdrawal by Subject|0|||
126341612|NCT01027845|454546652|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
126341613|NCT01027845|454546653|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
126341614|NCT01027845|454546650|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
126341615|NCT01027845|454546651|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
126341616|NCT01027845|454546652|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
126341617|NCT01027845|454546653|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
126341618|NCT01027845|454546650|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
126341619|NCT01027845|454546651|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
126341620|NCT01027845|454546652|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
126341621|NCT01027845|454546653|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
126341622|NCT00087178|454546656|FG000|Overall Study|No follow up data|5|||
126341623|NCT00087178|454546657|FG001|Overall Study|No follow up data|15|||
126341624|NCT00087178|454546656|FG000|Overall Study|No clinical assessment|1|||
126341625|NCT00087178|454546657|FG001|Overall Study|No clinical assessment|2|||
126341626|NCT00087178|454546656|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
126341627|NCT00087178|454546657|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
126341628|NCT04465422|454546658|FG000|Overall Study|Lost to Follow-up|0|||
126341629|NCT04465422|454546659|FG001|Overall Study|Lost to Follow-up|2|||
126341630|NCT01692119|454546662|FG000|Overall Study|Protocol Violation|3|||
126341631|NCT01692119|454546663|FG001|Overall Study|Protocol Violation|1|||
126341632|NCT01692119|454546662|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
126341633|NCT01692119|454546663|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
126341634|NCT00997893|454546664|FG000|Overall Study|Adverse Event|1|||
126341635|NCT00997893|454546665|FG001|Overall Study|Adverse Event|0|||
126341636|NCT00997893|454546666|FG002|Overall Study|Adverse Event|0|||
126341637|NCT00997893|454546664|FG000|Overall Study|Unable to meet study timelines|1|||
126341638|NCT00997893|454546665|FG001|Overall Study|Unable to meet study timelines|0|||
126341639|NCT00997893|454546666|FG002|Overall Study|Unable to meet study timelines|0|||
126341640|NCT00997893|454546664|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
126341641|NCT00997893|454546665|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
126341642|NCT00997893|454546666|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
126341643|NCT03444584|454546667|FG000|Overall Study|Withdrawal by Subject|0|||
126341644|NCT03444584|454546668|FG001|Overall Study|Withdrawal by Subject|1|||
126341645|NCT03444584|454546667|FG000|Overall Study|Other|0|||
126341646|NCT03444584|454546668|FG001|Overall Study|Other|1|||
126341647|NCT01142336|454546669|FG000|Overall Study|Adverse Event|1|||
126341648|NCT01142336|454546670|FG001|Overall Study|Adverse Event|1|||
126341649|NCT01142336|454546669|FG000|Overall Study|Lost to Follow-up|0|||
126341650|NCT01142336|454546670|FG001|Overall Study|Lost to Follow-up|1|||
126341651|NCT01704261|454546671|FG000|Overall Study|Withdrawal by Subject|12|||
126341652|NCT01704261|454546672|FG001|Overall Study|Withdrawal by Subject|15|||
126341653|NCT01704261|454546671|FG000|Overall Study|Lost to Follow-up|1|||
126341654|NCT01704261|454546672|FG001|Overall Study|Lost to Follow-up|0|||
126341655|NCT02722967|454546673|FG000|Overall Study|Adverse Event|1|||
126341656|NCT02722967|454546674|FG001|Overall Study|Adverse Event|0|||
126341657|NCT02722967|454546675|FG002|Overall Study|Adverse Event|0|||
126341658|NCT02722967|454546673|FG000|Overall Study|Lost to Follow-up|0|||
126341659|NCT02722967|454546674|FG001|Overall Study|Lost to Follow-up|1|||
126341660|NCT02722967|454546675|FG002|Overall Study|Lost to Follow-up|0|||
126006859|NCT02624778|453318585|FG001|Overall Study|Withdrawal by Subject|1|||
126341661|NCT02722967|454546673|FG000|Overall Study|Non-compliance with patch wearing|2|||
126341662|NCT02722967|454546674|FG001|Overall Study|Non-compliance with patch wearing|1|||
126341663|NCT02722967|454546675|FG002|Overall Study|Non-compliance with patch wearing|1|||
126341664|NCT02722967|454546673|FG000|Overall Study|Withdrawal by Subject|1|||
126341665|NCT02722967|454546674|FG001|Overall Study|Withdrawal by Subject|0|||
126341666|NCT02722967|454546675|FG002|Overall Study|Withdrawal by Subject|1|||
126341667|NCT02722967|454546673|FG000|Overall Study|Physician Decision|1|||
126341668|NCT02722967|454546674|FG001|Overall Study|Physician Decision|0|||
126341669|NCT02722967|454546675|FG002|Overall Study|Physician Decision|0|||
126341670|NCT02722967|454546673|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
126341671|NCT02722967|454546674|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
126341672|NCT02722967|454546675|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
126341673|NCT00071981|454546678|FG000|Overall Study|Lack of Efficacy|37|||
126341674|NCT00071981|454546679|FG001|Overall Study|Lack of Efficacy|29|||
126341675|NCT00071981|454546680|FG002|Overall Study|Lack of Efficacy|30|||
126341676|NCT00071981|454546681|FG003|Overall Study|Lack of Efficacy|43|||
126341677|NCT00071981|454546678|FG000|Overall Study|Adverse Event|4|||
126341678|NCT00071981|454546679|FG001|Overall Study|Adverse Event|4|||
126341679|NCT00071981|454546680|FG002|Overall Study|Adverse Event|3|||
126341680|NCT00071981|454546681|FG003|Overall Study|Adverse Event|1|||
126341681|NCT00071981|454546678|FG000|Overall Study|Death|0|||
126341682|NCT00071981|454546679|FG001|Overall Study|Death|0|||
126341683|NCT00071981|454546680|FG002|Overall Study|Death|1|||
126341684|NCT00071981|454546681|FG003|Overall Study|Death|1|||
126341685|NCT00071981|454546678|FG000|Overall Study|Withdrawal by Subject|3|||
126341686|NCT00071981|454546679|FG001|Overall Study|Withdrawal by Subject|1|||
126341687|NCT00071981|454546680|FG002|Overall Study|Withdrawal by Subject|0|||
126341688|NCT00071981|454546681|FG003|Overall Study|Withdrawal by Subject|0|||
126341689|NCT00071981|454546678|FG000|Overall Study|No protocol therapy|2|||
126341690|NCT00071981|454546679|FG001|Overall Study|No protocol therapy|5|||
126341691|NCT00071981|454546680|FG002|Overall Study|No protocol therapy|1|||
126341692|NCT00071981|454546681|FG003|Overall Study|No protocol therapy|0|||
126341693|NCT00071981|454546678|FG000|Overall Study|others (not specified in the study)|0|||
126341694|NCT00071981|454546679|FG001|Overall Study|others (not specified in the study)|2|||
126341695|NCT00071981|454546680|FG002|Overall Study|others (not specified in the study)|2|||
126341696|NCT00071981|454546681|FG003|Overall Study|others (not specified in the study)|0|||
126341697|NCT00467519|454546682|FG000|Overall Study|Protocol Violation|8|||
126341698|NCT00467519|454546683|FG001|Overall Study|Protocol Violation|4|||
126341699|NCT00467519|454546682|FG000|Overall Study|Lost to Follow-up|2|||
126341700|NCT00467519|454546683|FG001|Overall Study|Lost to Follow-up|9|||
126341701|NCT00467519|454546682|FG000|Overall Study|Withdrawal by Subject|4|||
126341702|NCT00467519|454546683|FG001|Overall Study|Withdrawal by Subject|10|||
126341703|NCT01123655|454546686|FG000|Overall Study|Medication for RA had to be changed|1|||
126341704|NCT01123655|454546687|FG001|Overall Study|Medication for RA had to be changed|0|||
126341705|NCT01123655|454546688|FG002|Overall Study|Medication for RA had to be changed|0|||
126341706|NCT01123655|454546686|FG000|Overall Study|new illness|0|||
126341707|NCT01123655|454546687|FG001|Overall Study|new illness|1|||
126341708|NCT01123655|454546688|FG002|Overall Study|new illness|0|||
126341709|NCT01123655|454546686|FG000|Overall Study|began prohibitive drug|0|||
126341710|NCT01123655|454546687|FG001|Overall Study|began prohibitive drug|0|||
126341711|NCT01123655|454546688|FG002|Overall Study|began prohibitive drug|1|||
126341712|NCT00062166|454546689|FG000|Overall Study|Withdrawal by Subject|6|||
126341713|NCT00833755|454546690|FG000|Overall Study|Physician Decision|4|||
126341714|NCT00833755|454546691|FG001|Overall Study|Physician Decision|4|||
126341715|NCT00833755|454546692|FG002|Overall Study|Physician Decision|2|||
126341716|NCT00833755|454546693|FG003|Overall Study|Physician Decision|6|||
126341717|NCT00833755|454546690|FG000|Overall Study|Subject had scheduling issues|0|||
126341718|NCT00833755|454546691|FG001|Overall Study|Subject had scheduling issues|1|||
126341719|NCT00833755|454546692|FG002|Overall Study|Subject had scheduling issues|0|||
126341720|NCT00833755|454546693|FG003|Overall Study|Subject had scheduling issues|0|||
126341721|NCT01776554|454546697|FG000|Overall Study|Adverse Event|1|||
126341722|NCT01776554|454546698|FG001|Overall Study|Adverse Event|0|||
126341723|NCT01776554|454546697|FG000|Overall Study|Withdrawal by Subject|3|||
126341724|NCT01776554|454546698|FG001|Overall Study|Withdrawal by Subject|8|||
126341725|NCT01776554|454546697|FG000|Overall Study|Lost to Follow-up|6|||
126341726|NCT01776554|454546698|FG001|Overall Study|Lost to Follow-up|9|||
126341727|NCT01776554|454546697|FG000|Overall Study|Administrative Reason|2|||
126341728|NCT01776554|454546698|FG001|Overall Study|Administrative Reason|5|||
126341729|NCT01776554|454546697|FG000|Overall Study|Protocol Violation|1|||
126341730|NCT01776554|454546698|FG001|Overall Study|Protocol Violation|0|||
126341731|NCT01776554|454546697|FG000|Overall Study|Unclassified|4|||
126341732|NCT01776554|454546698|FG001|Overall Study|Unclassified|1|||
126341733|NCT00171249|454546699|FG000|Overall Study|Withdrawal by Subject|2|||
126341734|NCT00171249|454546700|FG001|Overall Study|Withdrawal by Subject|0|||
126341735|NCT00171249|454546701|FG002|Overall Study|Withdrawal by Subject|0|||
126341736|NCT00171249|454546702|FG003|Overall Study|Withdrawal by Subject|6|||
126341737|NCT00171249|454546703|FG004|Overall Study|Withdrawal by Subject|0|||
126341738|NCT00171249|454546704|FG005|Overall Study|Withdrawal by Subject|0|||
126341739|NCT00171249|454546705|FG006|Overall Study|Withdrawal by Subject|0|||
126341740|NCT00171249|454546699|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
126006860|NCT02624778|453318586|FG002|Overall Study|Withdrawal by Subject|0|||
126006861|NCT02624778|453318587|FG003|Overall Study|Withdrawal by Subject|0|||
126006862|NCT02624778|453318588|FG004|Overall Study|Withdrawal by Subject|0|||
126006863|NCT02624778|453318589|FG005|Overall Study|Withdrawal by Subject|1|||
126006864|NCT02624778|453318590|FG006|Overall Study|Withdrawal by Subject|1|||
126006865|NCT02624778|453318591|FG007|Overall Study|Withdrawal by Subject|1|||
126006866|NCT02624778|453318592|FG008|Overall Study|Withdrawal by Subject|1|||
126006867|NCT02624778|453318584|FG000|Overall Study|Adverse Event|0|||
126006868|NCT02624778|453318585|FG001|Overall Study|Adverse Event|0|||
126006869|NCT02624778|453318586|FG002|Overall Study|Adverse Event|0|||
126006870|NCT02624778|453318587|FG003|Overall Study|Adverse Event|0|||
126006871|NCT02624778|453318588|FG004|Overall Study|Adverse Event|0|||
126006872|NCT02624778|453318589|FG005|Overall Study|Adverse Event|0|||
126006873|NCT02624778|453318590|FG006|Overall Study|Adverse Event|0|||
126006874|NCT02624778|453318591|FG007|Overall Study|Adverse Event|0|||
126341741|NCT00171249|454546700|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126341742|NCT00171249|454546701|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
126341743|NCT00171249|454546702|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
126341744|NCT00171249|454546703|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126341745|NCT00171249|454546704|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
126341746|NCT00171249|454546705|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126341747|NCT00171249|454546699|FG000|Overall Study|Death|7|||
126341748|NCT00171249|454546700|FG001|Overall Study|Death|1|||
126341749|NCT00171249|454546701|FG002|Overall Study|Death|0|||
126341750|NCT00171249|454546702|FG003|Overall Study|Death|4|||
126341751|NCT00171249|454546703|FG004|Overall Study|Death|0|||
126341752|NCT00171249|454546704|FG005|Overall Study|Death|3|||
126341753|NCT00171249|454546705|FG006|Overall Study|Death|1|||
126341754|NCT00171249|454546699|FG000|Overall Study|Other|10|||
126341755|NCT00171249|454546700|FG001|Overall Study|Other|0|||
126341756|NCT00171249|454546701|FG002|Overall Study|Other|0|||
126341757|NCT00171249|454546702|FG003|Overall Study|Other|43|||
126341758|NCT00171249|454546703|FG004|Overall Study|Other|0|||
126341759|NCT00171249|454546704|FG005|Overall Study|Other|2|||
126341760|NCT00171249|454546705|FG006|Overall Study|Other|0|||
126341761|NCT00171249|454546699|FG000|Overall Study|No Longer Requires Study Drug|4|||
126341762|NCT00171249|454546700|FG001|Overall Study|No Longer Requires Study Drug|0|||
126341763|NCT00171249|454546701|FG002|Overall Study|No Longer Requires Study Drug|0|||
126341764|NCT00171249|454546702|FG003|Overall Study|No Longer Requires Study Drug|3|||
126341765|NCT00171249|454546703|FG004|Overall Study|No Longer Requires Study Drug|0|||
126341766|NCT00171249|454546704|FG005|Overall Study|No Longer Requires Study Drug|5|||
126341767|NCT00171249|454546705|FG006|Overall Study|No Longer Requires Study Drug|0|||
126341768|NCT00171249|454546699|FG000|Overall Study|Administrative Problems|1|||
126341769|NCT00171249|454546700|FG001|Overall Study|Administrative Problems|0|||
126341770|NCT00171249|454546701|FG002|Overall Study|Administrative Problems|0|||
126341771|NCT00171249|454546702|FG003|Overall Study|Administrative Problems|2|||
126341772|NCT00171249|454546703|FG004|Overall Study|Administrative Problems|0|||
126341773|NCT00171249|454546704|FG005|Overall Study|Administrative Problems|0|||
126341774|NCT00171249|454546705|FG006|Overall Study|Administrative Problems|0|||
126341775|NCT00171249|454546699|FG000|Overall Study|Adverse Event|3|||
126341776|NCT00171249|454546700|FG001|Overall Study|Adverse Event|1|||
126341777|NCT00171249|454546701|FG002|Overall Study|Adverse Event|0|||
126341778|NCT00171249|454546702|FG003|Overall Study|Adverse Event|15|||
126341779|NCT00171249|454546703|FG004|Overall Study|Adverse Event|0|||
126341780|NCT00171249|454546704|FG005|Overall Study|Adverse Event|2|||
126341781|NCT00171249|454546705|FG006|Overall Study|Adverse Event|0|||
126341782|NCT00171249|454546699|FG000|Overall Study|Lost to Follow-up|5|||
126341783|NCT00171249|454546700|FG001|Overall Study|Lost to Follow-up|0|||
126341784|NCT00171249|454546701|FG002|Overall Study|Lost to Follow-up|0|||
126341785|NCT00171249|454546702|FG003|Overall Study|Lost to Follow-up|9|||
126341786|NCT00171249|454546703|FG004|Overall Study|Lost to Follow-up|0|||
126341787|NCT00171249|454546704|FG005|Overall Study|Lost to Follow-up|0|||
126006875|NCT02624778|453318592|FG008|Overall Study|Adverse Event|2|||
126006876|NCT02624778|453318584|FG000|Overall Study|Death|0|||
126006877|NCT02624778|453318585|FG001|Overall Study|Death|0|||
126006878|NCT02624778|453318586|FG002|Overall Study|Death|0|||
126341788|NCT00171249|454546705|FG006|Overall Study|Lost to Follow-up|0|||
126341789|NCT02475369|454546706|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
126341790|NCT02475369|454546707|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
126341791|NCT03608826|454546711|FG000|Overall Study|Death|3|||
126341792|NCT03608826|454546711|FG000|Overall Study|Heart Transplant|3|||
126341793|NCT03608826|454546711|FG000|Overall Study|Physician Decision|4|||
126341794|NCT03087058|454546724|FG000|Overall Study|Withdrawal by Subject|2|||
126341795|NCT03087058|454546725|FG001|Overall Study|Withdrawal by Subject|0|||
126341796|NCT03087058|454546726|FG002|Overall Study|Withdrawal by Subject|0|||
126341797|NCT02577029|454546727|FG000|Overall Study|Adverse Event|1|||
126341798|NCT02577029|454546728|FG001|Overall Study|Adverse Event|0|||
126006879|NCT02624778|453318587|FG003|Overall Study|Death|0|||
126006880|NCT02624778|453318588|FG004|Overall Study|Death|0|||
126006881|NCT02624778|453318589|FG005|Overall Study|Death|0|||
126006882|NCT02624778|453318590|FG006|Overall Study|Death|1|||
126006883|NCT02624778|453318591|FG007|Overall Study|Death|0|||
126006884|NCT02624778|453318592|FG008|Overall Study|Death|0|||
126006885|NCT02624778|453318584|FG000|Overall Study|Physician Decision|0|||
126006886|NCT02624778|453318585|FG001|Overall Study|Physician Decision|0|||
126006887|NCT02624778|453318586|FG002|Overall Study|Physician Decision|0|||
126006888|NCT02624778|453318587|FG003|Overall Study|Physician Decision|0|||
126006889|NCT02624778|453318588|FG004|Overall Study|Physician Decision|0|||
126006890|NCT02624778|453318589|FG005|Overall Study|Physician Decision|0|||
126006891|NCT02624778|453318590|FG006|Overall Study|Physician Decision|0|||
126006892|NCT02624778|453318591|FG007|Overall Study|Physician Decision|3|||
126006893|NCT02624778|453318592|FG008|Overall Study|Physician Decision|3|||
126006894|NCT01537133|453318600|FG000|Overall Study|Withdrawal by Subject|2|||
126006895|NCT01537133|453318601|FG001|Overall Study|Withdrawal by Subject|0|||
126006896|NCT01537133|453318602|FG002|Overall Study|Withdrawal by Subject|0|||
126006897|NCT01537133|453318603|FG003|Overall Study|Withdrawal by Subject|0|||
126006898|NCT01537133|453318600|FG000|Overall Study|Lost to Follow-up|1|||
126006899|NCT01537133|453318601|FG001|Overall Study|Lost to Follow-up|0|||
126006900|NCT01537133|453318602|FG002|Overall Study|Lost to Follow-up|0|||
126006901|NCT01537133|453318603|FG003|Overall Study|Lost to Follow-up|0|||
126006902|NCT00587288|453318604|FG000|Overall Study|Adverse Event|0|||
126006903|NCT00587288|453318605|FG001|Overall Study|Adverse Event|1|||
126006904|NCT00587288|453318604|FG000|Overall Study|Lack of Efficacy|2|||
126006905|NCT00587288|453318605|FG001|Overall Study|Lack of Efficacy|8|||
126006906|NCT00587288|453318604|FG000|Overall Study|Protocol Violation|1|||
126006907|NCT00587288|453318605|FG001|Overall Study|Protocol Violation|0|||
126006908|NCT00531479|453318606|FG000|Overall Study|Death|68|||
126006909|NCT00531479|453318607|FG001|Overall Study|Death|71|||
126006910|NCT00531479|453318606|FG000|Overall Study|Lost to Follow-up|0|||
126006911|NCT00531479|453318607|FG001|Overall Study|Lost to Follow-up|2|||
126006912|NCT00531479|453318606|FG000|Overall Study|Other|0|||
126006913|NCT00531479|453318607|FG001|Overall Study|Other|1|||
126006914|NCT00531479|453318606|FG000|Overall Study|Withdrawal by Subject|6|||
126006915|NCT00531479|453318607|FG001|Overall Study|Withdrawal by Subject|6|||
126006916|NCT00531479|453318606|FG000|Overall Study|Did not receive treatment|2|||
126006917|NCT00531479|453318607|FG001|Overall Study|Did not receive treatment|3|||
126006918|NCT00409708|453318608|FG000|Treatment|Abnormal test procedure result(s)|1|||
126006919|NCT00409708|453318609|FG001|Treatment|Abnormal test procedure result(s)|0|||
126006920|NCT00409708|453318608|FG000|Treatment|Lack of Efficacy|0|||
126006921|NCT00409708|453318609|FG001|Treatment|Lack of Efficacy|1|||
126006922|NCT00409708|453318608|FG000|Treatment|Protocol Violation|6|||
126006923|NCT00409708|453318609|FG001|Treatment|Protocol Violation|2|||
126006924|NCT00409708|453318608|FG000|Treatment|Withdrawal by Subject|3|||
126006925|NCT00409708|453318609|FG001|Treatment|Withdrawal by Subject|8|||
126006926|NCT00409708|453318608|FG000|Treatment|Lost to Follow-up|0|||
126006927|NCT00409708|453318609|FG001|Treatment|Lost to Follow-up|6|||
126006928|NCT00409708|453318608|FG000|Treatment|Administrative problems|5|||
126006929|NCT00409708|453318609|FG001|Treatment|Administrative problems|0|||
126006930|NCT00409708|453318608|FG000|Washout|Lack of Efficacy|9|||
126006931|NCT00409708|453318609|FG001|Washout|Lack of Efficacy|1|||
126006932|NCT00409708|453318608|FG000|Washout|Protocol Violation|0|||
126006933|NCT00409708|453318609|FG001|Washout|Protocol Violation|1|||
126006934|NCT00409708|453318608|FG000|Washout|Withdrawal by Subject|11|||
126006935|NCT00409708|453318609|FG001|Washout|Withdrawal by Subject|5|||
126006936|NCT00409708|453318608|FG000|Washout|Lost to Follow-up|1|||
126341799|NCT02577029|454546729|FG002|Overall Study|Adverse Event|2|||
126341800|NCT02577029|454546730|FG003|Overall Study|Adverse Event|0|||
126341801|NCT02577029|454546731|FG004|Overall Study|Adverse Event|1|||
126341802|NCT02577029|454546732|FG005|Overall Study|Adverse Event|0|||
126341803|NCT02577029|454546733|FG006|Overall Study|Adverse Event|0|||
126341804|NCT02577029|454546734|FG007|Overall Study|Adverse Event|0|||
126341805|NCT02577029|454546727|FG000|Overall Study|Withdrawal by Subject|0|||
126006937|NCT00409708|453318609|FG001|Washout|Lost to Follow-up|3|||
126006938|NCT00868231|453318610|FG000|Treatment Period 1|Adverse Event|0|||
126006939|NCT00868231|453318611|FG001|Treatment Period 1|Adverse Event|0|||
126006940|NCT00868231|453318612|FG002|Treatment Period 1|Adverse Event|0|||
126006941|NCT00868231|453318613|FG003|Treatment Period 1|Adverse Event|0|||
126006942|NCT00868231|453318614|FG004|Treatment Period 1|Adverse Event|1|||
126006943|NCT00868231|453318615|FG005|Treatment Period 1|Adverse Event|0|||
126006944|NCT00868231|453318610|FG000|Treatment Period 2|Adverse Event|1|||
126006945|NCT00868231|453318611|FG001|Treatment Period 2|Adverse Event|0|||
126006946|NCT00868231|453318612|FG002|Treatment Period 2|Adverse Event|0|||
126006947|NCT00868231|453318613|FG003|Treatment Period 2|Adverse Event|0|||
126006948|NCT00868231|453318614|FG004|Treatment Period 2|Adverse Event|0|||
126006949|NCT00868231|453318615|FG005|Treatment Period 2|Adverse Event|0|||
126006950|NCT00868231|453318610|FG000|Treatment Period 3|Adverse Event|0|||
126006951|NCT00868231|453318611|FG001|Treatment Period 3|Adverse Event|0|||
126006952|NCT00868231|453318612|FG002|Treatment Period 3|Adverse Event|1|||
126006953|NCT00868231|453318613|FG003|Treatment Period 3|Adverse Event|0|||
126427015|NCT03309878|454860407|FG002|Overall Study|Did not maintain eligibility|0|||
126427016|NCT03309878|454860408|FG003|Overall Study|Did not maintain eligibility|0|||
126427017|NCT03309878|454860405|FG000|Overall Study|Withdrawal by Subject|0|||
126427018|NCT03309878|454860406|FG001|Overall Study|Withdrawal by Subject|1|||
126427019|NCT03309878|454860407|FG002|Overall Study|Withdrawal by Subject|0|||
126427020|NCT03309878|454860408|FG003|Overall Study|Withdrawal by Subject|0|||
126006954|NCT00868231|453318614|FG004|Treatment Period 3|Adverse Event|0|||
126006955|NCT00868231|453318615|FG005|Treatment Period 3|Adverse Event|0|||
126006956|NCT00926393|453318618|FG000|Overall Study|Withdrawal by Subject|1|||
126006957|NCT00926393|453318619|FG001|Overall Study|Withdrawal by Subject|2|||
126006958|NCT00926393|453318618|FG000|Overall Study|Adverse Event|1|||
126006959|NCT00926393|453318619|FG001|Overall Study|Adverse Event|1|||
126006960|NCT04577183|453318623|FG000|Overall Study|Death|1|||
126006961|NCT04577183|453318623|FG000|Overall Study|Withdrawal by Subject|3|||
126006962|NCT04577183|453318623|FG000|Overall Study|Early termination|2|||
126006963|NCT01168401|453318624|FG000|Overall Study|Lost to Follow-up|1|||
126006964|NCT01168401|453318625|FG001|Overall Study|Lost to Follow-up|1|||
126006965|NCT01168401|453318626|FG002|Overall Study|Lost to Follow-up|2|||
126006966|NCT01168401|453318627|FG003|Overall Study|Lost to Follow-up|1|||
126006967|NCT01168401|453318628|FG004|Overall Study|Lost to Follow-up|0|||
126006968|NCT01168401|453318629|FG005|Overall Study|Lost to Follow-up|0|||
126006969|NCT01168401|453318630|FG006|Overall Study|Lost to Follow-up|0|||
126006970|NCT01168401|453318631|FG007|Overall Study|Lost to Follow-up|0|||
126006971|NCT01168401|453318632|FG008|Overall Study|Lost to Follow-up|0|||
126006972|NCT01168401|453318633|FG009|Overall Study|Lost to Follow-up|0|||
126006973|NCT01168401|453318634|FG010|Overall Study|Lost to Follow-up|0|||
126006974|NCT01168401|453318624|FG000|Overall Study|Withdrawal by Subject|0|||
126006975|NCT01168401|453318625|FG001|Overall Study|Withdrawal by Subject|0|||
126006976|NCT01168401|453318626|FG002|Overall Study|Withdrawal by Subject|0|||
126006977|NCT01168401|453318627|FG003|Overall Study|Withdrawal by Subject|1|||
126006978|NCT01168401|453318628|FG004|Overall Study|Withdrawal by Subject|0|||
126006979|NCT01168401|453318629|FG005|Overall Study|Withdrawal by Subject|0|||
126006980|NCT01168401|453318630|FG006|Overall Study|Withdrawal by Subject|0|||
126006981|NCT01168401|453318631|FG007|Overall Study|Withdrawal by Subject|0|||
126006982|NCT01168401|453318632|FG008|Overall Study|Withdrawal by Subject|0|||
126006983|NCT01168401|453318633|FG009|Overall Study|Withdrawal by Subject|0|||
126006984|NCT01168401|453318634|FG010|Overall Study|Withdrawal by Subject|0|||
126006985|NCT01720043|453318640|FG000|Overall Study|Withdrawal by Subject|1|||
126006986|NCT01688973|453318641|FG000|Overall Study|Ineligible|2|||
126341806|NCT02577029|454546728|FG001|Overall Study|Withdrawal by Subject|0|||
126341807|NCT02577029|454546729|FG002|Overall Study|Withdrawal by Subject|0|||
126341808|NCT02577029|454546730|FG003|Overall Study|Withdrawal by Subject|0|||
126341809|NCT02577029|454546731|FG004|Overall Study|Withdrawal by Subject|0|||
126341810|NCT02577029|454546732|FG005|Overall Study|Withdrawal by Subject|1|||
126341811|NCT02577029|454546733|FG006|Overall Study|Withdrawal by Subject|0|||
126341812|NCT02577029|454546734|FG007|Overall Study|Withdrawal by Subject|0|||
126341813|NCT02577029|454546727|FG000|Overall Study|Sponsor Termination of the Study|9|||
126341814|NCT02577029|454546728|FG001|Overall Study|Sponsor Termination of the Study|2|||
126341815|NCT02577029|454546729|FG002|Overall Study|Sponsor Termination of the Study|5|||
126341816|NCT02577029|454546730|FG003|Overall Study|Sponsor Termination of the Study|12|||
126341817|NCT02577029|454546731|FG004|Overall Study|Sponsor Termination of the Study|10|||
126341818|NCT02577029|454546732|FG005|Overall Study|Sponsor Termination of the Study|12|||
126341819|NCT02577029|454546733|FG006|Overall Study|Sponsor Termination of the Study|12|||
126341820|NCT02577029|454546734|FG007|Overall Study|Sponsor Termination of the Study|12|||
126341821|NCT02078817|454546735|FG000|Overall Study|Withdrawal by Subject|1|||
126341822|NCT01420536|454546736|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
126341823|NCT01420536|454546737|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
126341824|NCT03054428|454546738|FG000|Overall Study|Physician Decision|0|||
126341825|NCT03054428|454546739|FG001|Overall Study|Physician Decision|1|||
126341826|NCT03054428|454546740|FG002|Overall Study|Physician Decision|1|||
126341827|NCT03054428|454546738|FG000|Overall Study|Lack of Efficacy|3|||
126341828|NCT03054428|454546739|FG001|Overall Study|Lack of Efficacy|1|||
126341829|NCT03054428|454546740|FG002|Overall Study|Lack of Efficacy|0|||
126341830|NCT03054428|454546738|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
126006987|NCT01688973|453318642|FG001|Overall Study|Ineligible|3|||
126006988|NCT01516892|453318647|FG000|Overall Study|Adverse Event|25|||
126341831|NCT03054428|454546739|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
126341832|NCT03054428|454546740|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
126427021|NCT01096316|454860409|FG000|Overall Study|Lost to Follow-up|15|||
126427022|NCT01096316|454860410|FG001|Overall Study|Lost to Follow-up|9|||
126006989|NCT01516892|453318647|FG000|Overall Study|Lack of Efficacy|35|||
126006990|NCT01516892|453318647|FG000|Overall Study|Pregnancy|5|||
126006991|NCT01516892|453318647|FG000|Overall Study|Lost to Follow-up|82|||
126006992|NCT01516892|453318647|FG000|Overall Study|Subject Withdrew Consent|92|||
126341833|NCT03054428|454546738|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
126341834|NCT03054428|454546739|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
126006993|NCT01516892|453318647|FG000|Overall Study|Protocol Violation|60|||
126006994|NCT01516892|453318647|FG000|Overall Study|Other Miscellaneous Reasons|43|||
126006995|NCT01516892|453318647|FG000|Overall Study|Missing|1|||
126006996|NCT02993471|453318648|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
126006997|NCT02993471|453318648|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
126006998|NCT04582877|453318651|FG000|Overall Study|Did not use device measurement|5|||
126006999|NCT04582877|453318651|FG000|Overall Study|No fractional flow reserve test results|2|||
126427023|NCT02763644|454860411|FG000|Overall Study|Patient/guardian decision|1|||
126427024|NCT02763644|454860412|FG001|Overall Study|Patient/guardian decision|0|||
126427025|NCT02763644|454860411|FG000|Overall Study|Death|1|||
126427026|NCT02763644|454860412|FG001|Overall Study|Death|1|||
126427027|NCT02763644|454860411|FG000|Overall Study|Adverse Event|1|||
126427028|NCT02763644|454860412|FG001|Overall Study|Adverse Event|1|||
126427029|NCT02836652|454860413|FG000|Overall Study|Death|3|||
126427030|NCT02836652|454860414|FG001|Overall Study|Death|3|||
126427031|NCT02836652|454860413|FG000|Overall Study|Transplant/Explant|3|||
126427032|NCT02836652|454860414|FG001|Overall Study|Transplant/Explant|4|||
126427033|NCT02836652|454860413|FG000|Overall Study|Withdrawn|9|||
126427034|NCT02836652|454860414|FG001|Overall Study|Withdrawn|9|||
126427035|NCT02836652|454860413|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
126427036|NCT02836652|454860414|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
126427037|NCT00473434|454860415|FG000|Overall Study|Physician Decision|3|||
126427038|NCT00473434|454860415|FG000|Overall Study|Withdrawal by Subject|9|||
126427039|NCT00473434|454860415|FG000|Overall Study|Compliance|3|||
126427040|NCT00473434|454860415|FG000|Overall Study|Lack of Efficacy|3|||
126427041|NCT00473434|454860415|FG000|Overall Study|Adverse Event|3|||
126427042|NCT00473434|454860415|FG000|Overall Study|Patient was selling medication to others|1|||
126427043|NCT00473434|454860415|FG000|Overall Study|Safety evaluation|1|||
126427044|NCT00473434|454860415|FG000|Overall Study|Reason not specified|6|||
126427045|NCT00473434|454860415|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
126427046|NCT00473434|454860415|FG000|Overall Study|Switching to trial medication|1|||
126427047|NCT00473434|454860415|FG000|Overall Study|No longer required|1|||
126427048|NCT02349633|454860416|FG000|Overall Study|Death|0|||
126427049|NCT02349633|454860417|FG001|Overall Study|Death|1|||
126427050|NCT02349633|454860418|FG002|Overall Study|Death|0|||
126427051|NCT02349633|454860419|FG003|Overall Study|Death|0|||
126427052|NCT02349633|454860420|FG004|Overall Study|Death|0|||
126427053|NCT02349633|454860421|FG005|Overall Study|Death|1|||
126427054|NCT02349633|454860422|FG006|Overall Study|Death|1|||
126427055|NCT02349633|454860423|FG007|Overall Study|Death|1|||
126007000|NCT04582877|453318651|FG000|Overall Study|Protocol Violation|1|||
126007001|NCT00003656|453318652|FG000|Overall Study|Adverse Event|0|||
126007002|NCT00003656|453318653|FG001|Overall Study|Adverse Event|1|||
126007003|NCT03055767|453318654|FG000|Open-Label Period|Lost to Follow-up|0|||
126007004|NCT03055767|453318655|FG001|Open-Label Period|Lost to Follow-up|0|||
126007005|NCT03055767|453318656|FG002|Open-Label Period|Lost to Follow-up|2|||
126007006|NCT03055767|453318657|FG003|Open-Label Period|Lost to Follow-up|0|||
126007007|NCT03055767|453318654|FG000|Open-Label Period|Withdrawal by Subject|0|||
126007008|NCT03055767|453318655|FG001|Open-Label Period|Withdrawal by Subject|0|||
126007009|NCT03055767|453318656|FG002|Open-Label Period|Withdrawal by Subject|0|||
126427056|NCT02349633|454860424|FG008|Overall Study|Death|0|||
126427057|NCT02349633|454860425|FG009|Overall Study|Death|1|||
126427058|NCT02349633|454860426|FG010|Overall Study|Death|0|||
126427059|NCT02349633|454860427|FG011|Overall Study|Death|0|||
126427060|NCT02349633|454860428|FG012|Overall Study|Death|0|||
126427061|NCT02349633|454860429|FG013|Overall Study|Death|0|||
126427062|NCT02349633|454860416|FG000|Overall Study|Withdrawal by Subject|0|||
126427063|NCT02349633|454860417|FG001|Overall Study|Withdrawal by Subject|0|||
126427064|NCT02349633|454860418|FG002|Overall Study|Withdrawal by Subject|0|||
126427065|NCT02349633|454860419|FG003|Overall Study|Withdrawal by Subject|1|||
126427066|NCT02349633|454860420|FG004|Overall Study|Withdrawal by Subject|0|||
126427067|NCT02349633|454860421|FG005|Overall Study|Withdrawal by Subject|0|||
126007010|NCT03055767|453318657|FG003|Open-Label Period|Withdrawal by Subject|1|||
126007011|NCT02974010|453318660|FG000|Overall Study|Lost to Follow-up|3|||
126427068|NCT02349633|454860422|FG006|Overall Study|Withdrawal by Subject|0|||
126427069|NCT02349633|454860423|FG007|Overall Study|Withdrawal by Subject|2|||
126007012|NCT02974010|453318661|FG001|Overall Study|Lost to Follow-up|1|||
126007013|NCT02974010|453318662|FG002|Overall Study|Lost to Follow-up|0|||
126427070|NCT02349633|454860424|FG008|Overall Study|Withdrawal by Subject|2|||
126007014|NCT02974010|453318663|FG003|Overall Study|Lost to Follow-up|0|||
126007015|NCT02974010|453318660|FG000|Overall Study|Withdrawal by Subject|2|||
126007016|NCT02974010|453318661|FG001|Overall Study|Withdrawal by Subject|1|||
126007017|NCT02974010|453318662|FG002|Overall Study|Withdrawal by Subject|0|||
126046454|NCT02467270|453468228|FG002|Overall Study|Adverse Event|14|||
126427071|NCT02349633|454860425|FG009|Overall Study|Withdrawal by Subject|1|||
126427072|NCT02349633|454860426|FG010|Overall Study|Withdrawal by Subject|0|||
126427073|NCT02349633|454860427|FG011|Overall Study|Withdrawal by Subject|0|||
126427074|NCT02349633|454860428|FG012|Overall Study|Withdrawal by Subject|0|||
126427075|NCT02349633|454860429|FG013|Overall Study|Withdrawal by Subject|0|||
126007018|NCT02974010|453318663|FG003|Overall Study|Withdrawal by Subject|0|||
126007019|NCT02974010|453318660|FG000|Overall Study|Adverse Event|0|||
126007020|NCT02974010|453318661|FG001|Overall Study|Adverse Event|1|||
126007021|NCT02974010|453318662|FG002|Overall Study|Adverse Event|0|||
126007022|NCT02974010|453318663|FG003|Overall Study|Adverse Event|0|||
126007023|NCT02974010|453318660|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
126007024|NCT02974010|453318661|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
126007025|NCT02974010|453318662|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
126007026|NCT02974010|453318663|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
126007027|NCT02974010|453318660|FG000|Overall Study|Lack of Efficacy|0|||
126007028|NCT02974010|453318661|FG001|Overall Study|Lack of Efficacy|0|||
126007029|NCT02974010|453318662|FG002|Overall Study|Lack of Efficacy|1|||
126007030|NCT02974010|453318663|FG003|Overall Study|Lack of Efficacy|0|||
126007031|NCT01670019|453318675|FG000|Overall Study|Adverse Event|3|||
126007032|NCT01670019|453318676|FG001|Overall Study|Adverse Event|0|||
126007033|NCT01670019|453318675|FG000|Overall Study|Withdrawal by Subject|6|||
126007034|NCT01670019|453318676|FG001|Overall Study|Withdrawal by Subject|0|||
126007035|NCT03601507|453318677|FG000|Overall Study|Adverse Event|1|||
126007036|NCT02107014|453318680|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
126007037|NCT03168438|453318682|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
126007038|NCT03168438|453318683|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
126341835|NCT03054428|454546740|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
126341836|NCT03054428|454546738|FG000|Overall Study|Transitioned to OLE study|76|||
126341837|NCT03054428|454546739|FG001|Overall Study|Transitioned to OLE study|76|||
126341838|NCT03054428|454546740|FG002|Overall Study|Transitioned to OLE study|73|||
126341839|NCT03054428|454546738|FG000|Overall Study|Withdrawal by Subject|3|||
126341840|NCT03054428|454546739|FG001|Overall Study|Withdrawal by Subject|2|||
126341841|NCT03054428|454546740|FG002|Overall Study|Withdrawal by Subject|3|||
126341842|NCT03054428|454546738|FG000|Overall Study|Lost to Follow-up|0|||
126341843|NCT03054428|454546739|FG001|Overall Study|Lost to Follow-up|0|||
126341844|NCT03054428|454546740|FG002|Overall Study|Lost to Follow-up|1|||
126341845|NCT01652690|454546742|FG000|Overall Study|Withdrawal by Subject|16|||
126341846|NCT01652690|454546743|FG001|Overall Study|Withdrawal by Subject|4|||
126341847|NCT01652690|454546742|FG000|Overall Study|Other|8|||
126341848|NCT01652690|454546743|FG001|Overall Study|Other|9|||
126341849|NCT01652690|454546742|FG000|Overall Study|Lost to Follow-up|6|||
126341850|NCT01652690|454546743|FG001|Overall Study|Lost to Follow-up|6|||
126341851|NCT01652690|454546742|FG000|Overall Study|Death|5|||
126341852|NCT01652690|454546743|FG001|Overall Study|Death|2|||
126341853|NCT00617279|454546744|FG000|Overall Study|Study terminated by Sponsor|10|||
126341854|NCT00617279|454546745|FG001|Overall Study|Study terminated by Sponsor|15|||
126341855|NCT00617279|454546744|FG000|Overall Study|Graft abandonment|2|||
126341856|NCT00617279|454546745|FG001|Overall Study|Graft abandonment|0|||
126341857|NCT00617279|454546744|FG000|Overall Study|Lost to Follow-up|1|||
126341858|NCT00617279|454546745|FG001|Overall Study|Lost to Follow-up|0|||
126341859|NCT00617279|454546744|FG000|Overall Study|Death|1|||
126341860|NCT00617279|454546745|FG001|Overall Study|Death|2|||
126341861|NCT03415178|454546752|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
126341862|NCT03415178|454546753|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
126341863|NCT03415178|454546752|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
126341864|NCT03415178|454546753|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
126341865|NCT01093846|454546755|FG000|Overall Study|Adverse Event|0|||
126341866|NCT01093846|454546756|FG001|Overall Study|Adverse Event|0|||
126341867|NCT01093846|454546757|FG002|Overall Study|Adverse Event|1|||
126341868|NCT01093846|454546755|FG000|Overall Study|Lack of Efficacy|0|||
126341869|NCT01093846|454546756|FG001|Overall Study|Lack of Efficacy|0|||
126341870|NCT01093846|454546757|FG002|Overall Study|Lack of Efficacy|4|||
126341871|NCT01093846|454546755|FG000|Overall Study|Condition no longer required study drug|1|||
126341872|NCT01093846|454546756|FG001|Overall Study|Condition no longer required study drug|1|||
126341873|NCT01093846|454546757|FG002|Overall Study|Condition no longer required study drug|1|||
126341874|NCT01093846|454546755|FG000|Overall Study|Administrative Problems|18|||
126341875|NCT01093846|454546756|FG001|Overall Study|Administrative Problems|17|||
126341876|NCT01093846|454546757|FG002|Overall Study|Administrative Problems|15|||
126341877|NCT01416571|454546758|FG000|Overall Study|Lost to Follow-up|2|||
126341878|NCT00753519|454548688|FG000|Overall Study|Withdrawal by Subject|0|||
126341879|NCT00753519|454548689|FG001|Overall Study|Withdrawal by Subject|2|||
126007039|NCT05015478|453318686|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
126341880|NCT00959751|454548690|FG000|Overall Study|Lost to Follow-up|2|||
126341881|NCT00959751|454548691|FG001|Overall Study|Lost to Follow-up|3|||
126341882|NCT00959751|454548690|FG000|Overall Study|Consent Withdrawn|0|||
126007040|NCT05015478|453318687|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
126007041|NCT05015478|453318688|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
126341883|NCT00959751|454548691|FG001|Overall Study|Consent Withdrawn|1|||
126341884|NCT00959751|454548690|FG000|Overall Study|Non-compliance to Study Procedures|0|||
126341885|NCT00959751|454548691|FG001|Overall Study|Non-compliance to Study Procedures|1|||
126007042|NCT05015478|453318689|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
126007043|NCT01649427|453318693|FG000|Overall Study|Adverse Event|1|||
126007044|NCT01649427|453318694|FG001|Overall Study|Adverse Event|1|||
126007045|NCT01649427|453318693|FG000|Overall Study|Withdrawal by Subject|8|||
126007046|NCT01649427|453318694|FG001|Overall Study|Withdrawal by Subject|7|||
126007047|NCT01649427|453318693|FG000|Overall Study|Lost to Follow-up|0|||
126007048|NCT01649427|453318694|FG001|Overall Study|Lost to Follow-up|1|||
126007049|NCT01649427|453318693|FG000|Overall Study|Graft loss|0|||
126007050|NCT01649427|453318694|FG001|Overall Study|Graft loss|1|||
126007051|NCT01649427|453318693|FG000|Overall Study|Surgical problems during nephrectomy|2|||
126007052|NCT01649427|453318694|FG001|Overall Study|Surgical problems during nephrectomy|2|||
126007053|NCT00117988|453318700|FG000|Overall Study|Death|3|||
126007054|NCT00117988|453318700|FG000|Overall Study|Adverse Event|1|||
126007055|NCT05196737|453318701|FG000|Non-intervention Week|Lost to Follow-up|2|||
126007056|NCT05196737|453318701|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
126007057|NCT04927975|453318702|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
126007058|NCT04927975|453318703|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
126007059|NCT04927975|453318704|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
126007060|NCT04927975|453318705|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
126007061|NCT04927975|453318706|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
126007062|NCT04927975|453318707|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
126007063|NCT04927975|453318702|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
126007064|NCT04927975|453318703|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
126007065|NCT04927975|453318704|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
126007066|NCT04927975|453318705|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
126007067|NCT04927975|453318706|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
126007068|NCT04927975|453318707|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
126007069|NCT04927975|453318702|FG000|Period 1 (Baseline-Week 24)|Death|0|||
126007070|NCT04927975|453318703|FG001|Period 1 (Baseline-Week 24)|Death|0|||
126007071|NCT04927975|453318704|FG002|Period 1 (Baseline-Week 24)|Death|0|||
126007072|NCT04927975|453318705|FG003|Period 1 (Baseline-Week 24)|Death|0|||
126007073|NCT04927975|453318706|FG004|Period 1 (Baseline-Week 24)|Death|0|||
126007074|NCT04927975|453318707|FG005|Period 1 (Baseline-Week 24)|Death|1|||
126007075|NCT04927975|453318702|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
126007076|NCT04927975|453318703|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
126007077|NCT04927975|453318704|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
126007078|NCT04927975|453318705|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
126007079|NCT04927975|453318706|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
126007080|NCT04927975|453318707|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
126007081|NCT04927975|453318702|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
126007082|NCT04927975|453318703|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
126007083|NCT04927975|453318704|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
126007084|NCT04927975|453318705|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
126007085|NCT04927975|453318706|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
126007086|NCT04927975|453318707|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
126007087|NCT01559090|453318710|FG000|Stage I|Withdrawal by Subject|2|||
126007088|NCT01559090|453318711|FG001|Stage I|Withdrawal by Subject|2|||
126007089|NCT01559090|453318712|FG002|Stage I|Withdrawal by Subject|3|||
126007090|NCT01559090|453318710|FG000|Stage II|Withdrawal by Subject|1|||
126007091|NCT01559090|453318711|FG001|Stage II|Withdrawal by Subject|0|||
126007092|NCT01559090|453318712|FG002|Stage II|Withdrawal by Subject|0|||
126007093|NCT00561574|453318713|FG000|Overall Study|Adverse Event|21|||
126007094|NCT00561574|453318714|FG001|Overall Study|Adverse Event|24|||
126007095|NCT00561574|453318713|FG000|Overall Study|Lack of Efficacy|11|||
126007096|NCT00561574|453318714|FG001|Overall Study|Lack of Efficacy|21|||
126007097|NCT00561574|453318713|FG000|Overall Study|Withdrawal by Subject|4|||
126007098|NCT00561574|453318714|FG001|Overall Study|Withdrawal by Subject|4|||
126007099|NCT00561574|453318713|FG000|Overall Study|Reason Unrelated to Trial|6|||
126007100|NCT00561574|453318714|FG001|Overall Study|Reason Unrelated to Trial|2|||
126007101|NCT00561574|453318713|FG000|Overall Study|Lost to Follow-up|1|||
126007102|NCT00561574|453318714|FG001|Overall Study|Lost to Follow-up|0|||
126007103|NCT00561574|453318713|FG000|Overall Study|Other|5|||
126007104|NCT00561574|453318714|FG001|Overall Study|Other|7|||
126007105|NCT03971357|453318715|FG000|Overall Study|Lack of Efficacy|0|||
126007106|NCT03971357|453318716|FG001|Overall Study|Lack of Efficacy|1|||
126007107|NCT03722446|453318720|FG000|Overall Study|Protocol Violation|15|||
126007108|NCT03722446|453318721|FG001|Overall Study|Protocol Violation|2|||
126007109|NCT03102242|453318724|FG000|Overall Study|Adverse Event|2|||
126007110|NCT00946192|453318725|FG000|Overall Study|Lost to Follow-up|6|||
126007111|NCT00946192|453318726|FG001|Overall Study|Lost to Follow-up|11|||
126007112|NCT00946192|453318727|FG002|Overall Study|Lost to Follow-up|9|||
126007113|NCT00946192|453318725|FG000|Overall Study|Withdrawal by Subject|10|||
126007114|NCT00946192|453318726|FG001|Overall Study|Withdrawal by Subject|7|||
126007115|NCT00946192|453318727|FG002|Overall Study|Withdrawal by Subject|3|||
126007116|NCT00946192|453318725|FG000|Overall Study|Did not start medication|2|||
126007117|NCT00946192|453318726|FG001|Overall Study|Did not start medication|0|||
126427076|NCT02349633|454860416|FG000|Overall Study|Withdrawal of informed consent|0|||
126427077|NCT02349633|454860417|FG001|Overall Study|Withdrawal of informed consent|0|||
126427078|NCT02349633|454860418|FG002|Overall Study|Withdrawal of informed consent|0|||
126427079|NCT02349633|454860419|FG003|Overall Study|Withdrawal of informed consent|1|||
126427080|NCT02349633|454860420|FG004|Overall Study|Withdrawal of informed consent|1|||
126427081|NCT02349633|454860421|FG005|Overall Study|Withdrawal of informed consent|0|||
126427082|NCT02349633|454860422|FG006|Overall Study|Withdrawal of informed consent|0|||
126427083|NCT02349633|454860423|FG007|Overall Study|Withdrawal of informed consent|3|||
126427084|NCT02349633|454860424|FG008|Overall Study|Withdrawal of informed consent|0|||
126427085|NCT02349633|454860425|FG009|Overall Study|Withdrawal of informed consent|0|||
126427086|NCT02349633|454860426|FG010|Overall Study|Withdrawal of informed consent|0|||
126427087|NCT02349633|454860427|FG011|Overall Study|Withdrawal of informed consent|0|||
126427088|NCT02349633|454860428|FG012|Overall Study|Withdrawal of informed consent|0|||
126427089|NCT02349633|454860429|FG013|Overall Study|Withdrawal of informed consent|0|||
126427090|NCT02349633|454860416|FG000|Overall Study|Transition to compassionate use|0|||
126427091|NCT02349633|454860417|FG001|Overall Study|Transition to compassionate use|0|||
126427092|NCT02349633|454860418|FG002|Overall Study|Transition to compassionate use|0|||
126427093|NCT02349633|454860419|FG003|Overall Study|Transition to compassionate use|0|||
126427094|NCT02349633|454860420|FG004|Overall Study|Transition to compassionate use|1|||
126007118|NCT00946192|453318727|FG002|Overall Study|Did not start medication|0|||
126341886|NCT00959751|454548690|FG000|Overall Study|No migraine headache without aura|7|||
126341887|NCT00959751|454548691|FG001|Overall Study|No migraine headache without aura|7|||
126341888|NCT00434252|454548692|FG000|Overall Study|Lack of Efficacy|50|||
126341889|NCT00434252|454548693|FG001|Overall Study|Lack of Efficacy|100|||
126341890|NCT00434252|454548692|FG000|Overall Study|Adverse Event|6|||
126341891|NCT00434252|454548693|FG001|Overall Study|Adverse Event|13|||
126341892|NCT00434252|454548692|FG000|Overall Study|Death|1|||
126341893|NCT00434252|454548693|FG001|Overall Study|Death|2|||
126341894|NCT00434252|454548692|FG000|Overall Study|Lost to Follow-up|0|||
126341895|NCT00434252|454548693|FG001|Overall Study|Lost to Follow-up|1|||
126341896|NCT00434252|454548692|FG000|Overall Study|Physician Decision|4|||
126341897|NCT00434252|454548693|FG001|Overall Study|Physician Decision|8|||
126341898|NCT00434252|454548692|FG000|Overall Study|Withdrawal by Subject|3|||
126341899|NCT00434252|454548693|FG001|Overall Study|Withdrawal by Subject|7|||
126341900|NCT02807259|454548694|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
126341901|NCT02807259|454548695|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
126341902|NCT02807259|454548694|FG000|Midline (3 Months)|migration, refusal, not available|30|||
126341903|NCT02807259|454548695|FG001|Midline (3 Months)|migration, refusal, not available|34|||
126341904|NCT02807259|454548694|FG000|Endline (3 Months)|migration, refusal, not available|35|||
126341905|NCT02807259|454548695|FG001|Endline (3 Months)|migration, refusal, not available|87|||
126341906|NCT03861039|454548696|FG000|Overall Study|Adverse Event|2|||
126341907|NCT03861039|454548697|FG001|Overall Study|Adverse Event|5|||
126341908|NCT03861039|454548698|FG002|Overall Study|Adverse Event|11|||
126341909|NCT03861039|454548696|FG000|Overall Study|Withdrawal by Subject|1|||
126341910|NCT03861039|454548697|FG001|Overall Study|Withdrawal by Subject|3|||
126341911|NCT03861039|454548698|FG002|Overall Study|Withdrawal by Subject|4|||
126341912|NCT01125930|454548706|FG000|Overall Study|Adverse Event|0|||
126341913|NCT01125930|454548707|FG001|Overall Study|Adverse Event|1|||
126341914|NCT01125930|454548706|FG000|Overall Study|Withdrawal by Subject|1|||
126341915|NCT01125930|454548707|FG001|Overall Study|Withdrawal by Subject|6|||
126341916|NCT01125930|454548706|FG000|Overall Study|Protocol Violation|0|||
126341917|NCT01125930|454548707|FG001|Overall Study|Protocol Violation|1|||
126341918|NCT01125930|454548706|FG000|Overall Study|Lost to Follow-up|0|||
126341919|NCT01125930|454548707|FG001|Overall Study|Lost to Follow-up|2|||
126341920|NCT01715831|454548708|FG000|Overall Study|Adverse Event|1|||
126341921|NCT00900562|454548709|FG000|Overall Study|Progressive disease|9|||
126341922|NCT00900562|454548710|FG001|Overall Study|Progressive disease|5|||
126341923|NCT00900562|454548709|FG000|Overall Study|Toxicity|1|||
126341924|NCT00900562|454548710|FG001|Overall Study|Toxicity|0|||
126341925|NCT00900562|454548709|FG000|Overall Study|Death|1|||
126341926|NCT00900562|454548710|FG001|Overall Study|Death|1|||
126341927|NCT00900562|454548709|FG000|Overall Study|Withdrawal by Subject|0|||
126341928|NCT00900562|454548710|FG001|Overall Study|Withdrawal by Subject|1|||
126341929|NCT00900562|454548709|FG000|Overall Study|Unrelated adverse event|1|||
126341930|NCT00900562|454548710|FG001|Overall Study|Unrelated adverse event|0|||
126341931|NCT03098979|454548711|FG000|Overall Study|Adverse Event|1|||
126341932|NCT03098979|454548712|FG001|Overall Study|Adverse Event|0|||
126341933|NCT03098979|454548713|FG002|Overall Study|Adverse Event|1|||
126427095|NCT02349633|454860421|FG005|Overall Study|Transition to compassionate use|0|||
126046455|NCT02467270|453468226|FG000|Overall Study|Progressive Disease|7|||
126427096|NCT02349633|454860422|FG006|Overall Study|Transition to compassionate use|0|||
126341934|NCT03098979|454548714|FG003|Overall Study|Adverse Event|4|||
126341935|NCT03098979|454548715|FG004|Overall Study|Adverse Event|6|||
126341936|NCT03098979|454548716|FG005|Overall Study|Adverse Event|1|||
126341937|NCT03098979|454548711|FG000|Overall Study|Withdrawal by Subject|2|||
126007119|NCT01080131|453318728|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
126007120|NCT01080131|453318729|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
126007121|NCT01080131|453318728|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
126007122|NCT01080131|453318729|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
126007123|NCT01080131|453318728|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
126007124|NCT01080131|453318729|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
126007125|NCT01080131|453318728|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
126007126|NCT01080131|453318729|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
126007127|NCT01080131|453318728|FG000|Core Study (0- 12 Weeks)|Death|1|||
126007128|NCT01080131|453318729|FG001|Core Study (0- 12 Weeks)|Death|0|||
126007129|NCT01080131|453318728|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
126007130|NCT01080131|453318729|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
126007131|NCT01080131|453318728|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
126007132|NCT01080131|453318729|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
126007133|NCT01080131|453318728|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
126007134|NCT01080131|453318729|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
126007135|NCT01080131|453318728|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
126007136|NCT01080131|453318729|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
126007137|NCT01080131|453318728|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
126007138|NCT01080131|453318729|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
126007139|NCT01080131|453318728|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
126007140|NCT01080131|453318729|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
126007141|NCT01080131|453318728|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
126007142|NCT01080131|453318729|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
126007143|NCT01080131|453318728|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
126007144|NCT01080131|453318729|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
126007145|NCT02501629|453321322|FG000|Overall Study|Death|0|||
126007146|NCT02501629|453321323|FG001|Overall Study|Death|1|||
126007147|NCT02501629|453321322|FG000|Overall Study|Withdrawn from study by sponsor|1|||
126007148|NCT02501629|453321323|FG001|Overall Study|Withdrawn from study by sponsor|0|||
126007149|NCT02501629|453321322|FG000|Overall Study|Early termination by sponsor|1|||
126007150|NCT02501629|453321323|FG001|Overall Study|Early termination by sponsor|0|||
126007151|NCT02501629|453321322|FG000|Overall Study|Withdrawal by Subject|3|||
126007152|NCT02501629|453321323|FG001|Overall Study|Withdrawal by Subject|5|||
126007153|NCT02501629|453321322|FG000|Overall Study|Subject did not return to site|0|||
126007154|NCT02501629|453321323|FG001|Overall Study|Subject did not return to site|1|||
126007155|NCT03120676|453321326|FG000|Overall Study|Not treated|1|||
126007156|NCT00530335|453321327|FG000|Overall Study|Adverse Event|3|||
126007157|NCT00530335|453321327|FG000|Overall Study|Protocol Violation|1|||
126007158|NCT00530335|453321327|FG000|Overall Study|Withdrawal by Subject|1|||
126007159|NCT00530335|453321327|FG000|Overall Study|Physician Decision|1|||
126007160|NCT02321540|453321328|FG000|Overall Study|Death|0|||
126007161|NCT02321540|453321329|FG001|Overall Study|Death|1|||
126007162|NCT02321540|453321328|FG000|Overall Study|Progression|3|||
126007163|NCT02321540|453321329|FG001|Overall Study|Progression|9|||
126007164|NCT01649791|453321330|FG000|Overall Study|Disease Progression|2|||
126007165|NCT01649791|453321330|FG000|Overall Study|Adverse Event|1|||
126007166|NCT00991276|453321334|FG000|First Intervention Period|Adverse Event|0|||
126007167|NCT00991276|453321335|FG001|First Intervention Period|Adverse Event|1|||
126007168|NCT00991276|453321336|FG002|First Intervention Period|Adverse Event|0|||
126007169|NCT00991276|453321337|FG003|First Intervention Period|Adverse Event|1|||
126007170|NCT00991276|453321338|FG004|First Intervention Period|Adverse Event|0|||
126007171|NCT00991276|453321339|FG005|First Intervention Period|Adverse Event|0|||
126007172|NCT00991276|453321334|FG000|First Intervention Period|Protocol Violation|0|||
126007173|NCT00991276|453321335|FG001|First Intervention Period|Protocol Violation|0|||
126007174|NCT00991276|453321336|FG002|First Intervention Period|Protocol Violation|0|||
126007175|NCT00991276|453321337|FG003|First Intervention Period|Protocol Violation|0|||
126007176|NCT00991276|453321338|FG004|First Intervention Period|Protocol Violation|2|||
126007177|NCT00991276|453321339|FG005|First Intervention Period|Protocol Violation|0|||
126007178|NCT00991276|453321334|FG000|First Intervention Period|Insufficient clinical response|0|||
126007179|NCT00991276|453321335|FG001|First Intervention Period|Insufficient clinical response|0|||
126007180|NCT00991276|453321336|FG002|First Intervention Period|Insufficient clinical response|0|||
126007181|NCT00991276|453321337|FG003|First Intervention Period|Insufficient clinical response|0|||
126007182|NCT00991276|453321338|FG004|First Intervention Period|Insufficient clinical response|1|||
126007183|NCT00991276|453321339|FG005|First Intervention Period|Insufficient clinical response|0|||
126007184|NCT00991276|453321334|FG000|First Intervention Period|Other|0|||
126007185|NCT00991276|453321335|FG001|First Intervention Period|Other|0|||
126007186|NCT00991276|453321336|FG002|First Intervention Period|Other|0|||
126007187|NCT00991276|453321337|FG003|First Intervention Period|Other|1|||
126007188|NCT00991276|453321338|FG004|First Intervention Period|Other|1|||
126007189|NCT00991276|453321339|FG005|First Intervention Period|Other|0|||
126007190|NCT00991276|453321334|FG000|First Intervention Period|Withdrawal by Subject|0|||
126007191|NCT00991276|453321335|FG001|First Intervention Period|Withdrawal by Subject|1|||
126007192|NCT00991276|453321336|FG002|First Intervention Period|Withdrawal by Subject|0|||
126007193|NCT00991276|453321337|FG003|First Intervention Period|Withdrawal by Subject|1|||
126007194|NCT00991276|453321338|FG004|First Intervention Period|Withdrawal by Subject|0|||
126007195|NCT00991276|453321339|FG005|First Intervention Period|Withdrawal by Subject|1|||
126007196|NCT00991276|453321334|FG000|First Intervention Period|Lost to Follow-up|0|||
126007197|NCT00991276|453321335|FG001|First Intervention Period|Lost to Follow-up|1|||
126007198|NCT00991276|453321336|FG002|First Intervention Period|Lost to Follow-up|0|||
126007199|NCT00991276|453321337|FG003|First Intervention Period|Lost to Follow-up|1|||
126007200|NCT00991276|453321338|FG004|First Intervention Period|Lost to Follow-up|0|||
126007201|NCT00991276|453321339|FG005|First Intervention Period|Lost to Follow-up|0|||
126007202|NCT00991276|453321334|FG000|Second Intervention Period|Adverse Event|0|||
126007203|NCT00991276|453321335|FG001|Second Intervention Period|Adverse Event|2|||
126007204|NCT00991276|453321336|FG002|Second Intervention Period|Adverse Event|0|||
126007205|NCT00991276|453321337|FG003|Second Intervention Period|Adverse Event|1|||
126007206|NCT00991276|453321338|FG004|Second Intervention Period|Adverse Event|1|||
126007207|NCT00991276|453321339|FG005|Second Intervention Period|Adverse Event|0|||
126007208|NCT00991276|453321334|FG000|Second Intervention Period|Protocol Violation|1|||
126007209|NCT00991276|453321335|FG001|Second Intervention Period|Protocol Violation|0|||
126007210|NCT00991276|453321336|FG002|Second Intervention Period|Protocol Violation|0|||
126007211|NCT00991276|453321337|FG003|Second Intervention Period|Protocol Violation|0|||
126427097|NCT02349633|454860423|FG007|Overall Study|Transition to compassionate use|3|||
126427098|NCT02349633|454860424|FG008|Overall Study|Transition to compassionate use|0|||
126427099|NCT02349633|454860425|FG009|Overall Study|Transition to compassionate use|1|||
126427100|NCT02349633|454860426|FG010|Overall Study|Transition to compassionate use|0|||
126427101|NCT02349633|454860427|FG011|Overall Study|Transition to compassionate use|0|||
126007212|NCT00991276|453321338|FG004|Second Intervention Period|Protocol Violation|0|||
126007213|NCT00991276|453321339|FG005|Second Intervention Period|Protocol Violation|0|||
126427102|NCT02349633|454860428|FG012|Overall Study|Transition to compassionate use|0|||
126427103|NCT02349633|454860429|FG013|Overall Study|Transition to compassionate use|0|||
126427104|NCT02349633|454860416|FG000|Overall Study|Early termination of survival follow-up|0|||
126427105|NCT02349633|454860417|FG001|Overall Study|Early termination of survival follow-up|0|||
126007214|NCT00991276|453321334|FG000|Second Intervention Period|Other|0|||
126427106|NCT02349633|454860418|FG002|Overall Study|Early termination of survival follow-up|0|||
126427107|NCT02349633|454860419|FG003|Overall Study|Early termination of survival follow-up|0|||
126427108|NCT02349633|454860420|FG004|Overall Study|Early termination of survival follow-up|0|||
126427109|NCT02349633|454860421|FG005|Overall Study|Early termination of survival follow-up|0|||
126427110|NCT02349633|454860422|FG006|Overall Study|Early termination of survival follow-up|0|||
126427111|NCT02349633|454860423|FG007|Overall Study|Early termination of survival follow-up|4|||
126427112|NCT02349633|454860424|FG008|Overall Study|Early termination of survival follow-up|0|||
126427113|NCT02349633|454860425|FG009|Overall Study|Early termination of survival follow-up|0|||
126427114|NCT02349633|454860426|FG010|Overall Study|Early termination of survival follow-up|0|||
126427115|NCT02349633|454860427|FG011|Overall Study|Early termination of survival follow-up|0|||
126427116|NCT02349633|454860428|FG012|Overall Study|Early termination of survival follow-up|0|||
126427117|NCT02349633|454860429|FG013|Overall Study|Early termination of survival follow-up|0|||
126427118|NCT02349633|454860416|FG000|Overall Study|Termination by sponsor|0|||
126007215|NCT00991276|453321335|FG001|Second Intervention Period|Other|0|||
126007216|NCT00991276|453321336|FG002|Second Intervention Period|Other|0|||
126007217|NCT00991276|453321337|FG003|Second Intervention Period|Other|1|||
126007218|NCT00991276|453321338|FG004|Second Intervention Period|Other|0|||
126007219|NCT00991276|453321339|FG005|Second Intervention Period|Other|1|||
126427119|NCT02349633|454860417|FG001|Overall Study|Termination by sponsor|0|||
126427120|NCT02349633|454860418|FG002|Overall Study|Termination by sponsor|0|||
126427121|NCT02349633|454860419|FG003|Overall Study|Termination by sponsor|0|||
126427122|NCT02349633|454860420|FG004|Overall Study|Termination by sponsor|0|||
126427123|NCT02349633|454860421|FG005|Overall Study|Termination by sponsor|0|||
126007220|NCT00991276|453321334|FG000|Third Intervention Period|Protocol Violation|1|||
126007221|NCT00991276|453321335|FG001|Third Intervention Period|Protocol Violation|0|||
126007222|NCT00991276|453321336|FG002|Third Intervention Period|Protocol Violation|0|||
126007223|NCT00991276|453321337|FG003|Third Intervention Period|Protocol Violation|0|||
126007224|NCT00991276|453321338|FG004|Third Intervention Period|Protocol Violation|0|||
126007225|NCT00991276|453321339|FG005|Third Intervention Period|Protocol Violation|0|||
126007226|NCT00991276|453321334|FG000|Third Intervention Period|Other|0|||
126007227|NCT00991276|453321335|FG001|Third Intervention Period|Other|0|||
126007228|NCT00991276|453321336|FG002|Third Intervention Period|Other|0|||
126007229|NCT00991276|453321337|FG003|Third Intervention Period|Other|0|||
126007230|NCT00991276|453321338|FG004|Third Intervention Period|Other|0|||
126007231|NCT00991276|453321339|FG005|Third Intervention Period|Other|1|||
126007232|NCT00991276|453321334|FG000|Third Intervention Period|Adverse Event|0|||
126427124|NCT02349633|454860422|FG006|Overall Study|Termination by sponsor|0|||
126427125|NCT02349633|454860423|FG007|Overall Study|Termination by sponsor|1|||
126427126|NCT02349633|454860424|FG008|Overall Study|Termination by sponsor|0|||
126007233|NCT00991276|453321335|FG001|Third Intervention Period|Adverse Event|0|||
126007234|NCT00991276|453321336|FG002|Third Intervention Period|Adverse Event|1|||
126007235|NCT00991276|453321337|FG003|Third Intervention Period|Adverse Event|0|||
126007236|NCT00991276|453321338|FG004|Third Intervention Period|Adverse Event|0|||
126007237|NCT00991276|453321339|FG005|Third Intervention Period|Adverse Event|0|||
126007238|NCT00991276|453321334|FG000|Third Intervention Period|Withdrawal by Subject|0|||
126007239|NCT00991276|453321335|FG001|Third Intervention Period|Withdrawal by Subject|0|||
126007240|NCT00991276|453321336|FG002|Third Intervention Period|Withdrawal by Subject|0|||
126007241|NCT00991276|453321337|FG003|Third Intervention Period|Withdrawal by Subject|1|||
126007242|NCT00991276|453321338|FG004|Third Intervention Period|Withdrawal by Subject|0|||
126007243|NCT00991276|453321339|FG005|Third Intervention Period|Withdrawal by Subject|0|||
126007244|NCT01268891|453321340|FG000|Overall Study|Adverse Event|3|||
126007245|NCT01268891|453321341|FG001|Overall Study|Adverse Event|7|||
126007246|NCT01268891|453321340|FG000|Overall Study|Lack of Efficacy|1|||
126007247|NCT01268891|453321341|FG001|Overall Study|Lack of Efficacy|0|||
126007248|NCT01268891|453321340|FG000|Overall Study|Withdrawal of Consent|3|||
126007249|NCT01268891|453321341|FG001|Overall Study|Withdrawal of Consent|1|||
126007250|NCT01268891|453321340|FG000|Overall Study|Administrative or other reason(s)|1|||
126007251|NCT01268891|453321341|FG001|Overall Study|Administrative or other reason(s)|0|||
126007252|NCT02534896|453321346|FG000|Overall Study|Adverse Event|2|||
126007253|NCT02534896|453321347|FG001|Overall Study|Adverse Event|1|||
126007254|NCT02534896|453321348|FG002|Overall Study|Adverse Event|1|||
126007255|NCT02534896|453321346|FG000|Overall Study|Insufficient therapeutic response|2|||
126007256|NCT02534896|453321347|FG001|Overall Study|Insufficient therapeutic response|0|||
126007257|NCT02534896|453321348|FG002|Overall Study|Insufficient therapeutic response|0|||
126007258|NCT00711646|453321349|FG000|Overall Study|Adverse Event|6|||
126007259|NCT00711646|453321350|FG001|Overall Study|Adverse Event|1|||
126427127|NCT02349633|454860425|FG009|Overall Study|Termination by sponsor|2|||
126427128|NCT02349633|454860426|FG010|Overall Study|Termination by sponsor|0|||
126427129|NCT02349633|454860427|FG011|Overall Study|Termination by sponsor|0|||
126427130|NCT02349633|454860428|FG012|Overall Study|Termination by sponsor|0|||
126427131|NCT02349633|454860429|FG013|Overall Study|Termination by sponsor|0|||
126427132|NCT02349633|454860416|FG000|Overall Study|Other|0|||
126427133|NCT02349633|454860417|FG001|Overall Study|Other|0|||
126427134|NCT02349633|454860418|FG002|Overall Study|Other|0|||
126427135|NCT02349633|454860419|FG003|Overall Study|Other|0|||
126427136|NCT02349633|454860420|FG004|Overall Study|Other|0|||
126427137|NCT02349633|454860421|FG005|Overall Study|Other|0|||
126427138|NCT02349633|454860422|FG006|Overall Study|Other|0|||
126427139|NCT02349633|454860423|FG007|Overall Study|Other|2|||
126427140|NCT02349633|454860424|FG008|Overall Study|Other|0|||
126427141|NCT02349633|454860425|FG009|Overall Study|Other|0|||
126427142|NCT02349633|454860426|FG010|Overall Study|Other|0|||
126427143|NCT02349633|454860427|FG011|Overall Study|Other|0|||
126427144|NCT02349633|454860428|FG012|Overall Study|Other|0|||
126427145|NCT02349633|454860429|FG013|Overall Study|Other|0|||
126427146|NCT01008943|454860432|FG000|Overall Study|Withdrawal by Subject|1|||
126427147|NCT00667628|454860435|FG000|Overall Study|Lost to Follow-up|1|||
126427148|NCT00667628|454860436|FG001|Overall Study|Lost to Follow-up|0|||
126427149|NCT00667628|454860435|FG000|Overall Study|Death|6|||
126427150|NCT00667628|454860436|FG001|Overall Study|Death|6|||
126427151|NCT00667628|454860435|FG000|Overall Study|Investigator Considers in Best Interest|1|||
126427152|NCT00667628|454860436|FG001|Overall Study|Investigator Considers in Best Interest|0|||
126427153|NCT00667628|454860435|FG000|Overall Study|Sponsor Terminated Study|17|||
126427154|NCT00667628|454860436|FG001|Overall Study|Sponsor Terminated Study|21|||
126427155|NCT04244253|454860437|FG000|Overall Study|Adverse Event|2|||
126427156|NCT04244253|454860438|FG001|Overall Study|Adverse Event|2|||
126427157|NCT04244253|454860439|FG002|Overall Study|Adverse Event|4|||
126427158|NCT04244253|454860437|FG000|Overall Study|Protocol Violation|1|||
126427159|NCT04244253|454860438|FG001|Overall Study|Protocol Violation|2|||
126427160|NCT04244253|454860439|FG002|Overall Study|Protocol Violation|1|||
126427161|NCT04244253|454860437|FG000|Overall Study|Withdrawal by Subject|0|||
126427162|NCT04244253|454860438|FG001|Overall Study|Withdrawal by Subject|1|||
126427163|NCT04244253|454860439|FG002|Overall Study|Withdrawal by Subject|6|||
126007260|NCT00711646|453321349|FG000|Overall Study|Withdrawal by Subject|4|||
126007261|NCT00711646|453321350|FG001|Overall Study|Withdrawal by Subject|0|||
126007262|NCT00711646|453321349|FG000|Overall Study|Protocol Violation|0|||
126007263|NCT00711646|453321350|FG001|Overall Study|Protocol Violation|1|||
126007264|NCT00711646|453321349|FG000|Overall Study|Lost to Follow-up|1|||
126007265|NCT00711646|453321350|FG001|Overall Study|Lost to Follow-up|0|||
126007266|NCT00711646|453321349|FG000|Overall Study|administrative decision|0|||
126007267|NCT00711646|453321350|FG001|Overall Study|administrative decision|1|||
126007268|NCT00711646|453321349|FG000|Overall Study|patient non-compliance|1|||
126427164|NCT04244253|454860437|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126427165|NCT04244253|454860438|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126427166|NCT04244253|454860439|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126007269|NCT00711646|453321350|FG001|Overall Study|patient non-compliance|0|||
126427167|NCT04663321|454860440|FG000|Overall Study|Study terminated by Sponsor|2|||
126341938|NCT03098979|454548712|FG001|Overall Study|Withdrawal by Subject|1|||
126341939|NCT03098979|454548713|FG002|Overall Study|Withdrawal by Subject|1|||
126341940|NCT03098979|454548714|FG003|Overall Study|Withdrawal by Subject|1|||
126341941|NCT03098979|454548715|FG004|Overall Study|Withdrawal by Subject|2|||
126341942|NCT03098979|454548716|FG005|Overall Study|Withdrawal by Subject|1|||
126341943|NCT03098979|454548711|FG000|Overall Study|Death|1|||
126341944|NCT03098979|454548712|FG001|Overall Study|Death|0|||
126341945|NCT03098979|454548713|FG002|Overall Study|Death|2|||
126341946|NCT03098979|454548714|FG003|Overall Study|Death|0|||
126341947|NCT03098979|454548715|FG004|Overall Study|Death|1|||
126341948|NCT03098979|454548716|FG005|Overall Study|Death|0|||
126341949|NCT03098979|454548711|FG000|Overall Study|Physician Decision|2|||
126341950|NCT03098979|454548712|FG001|Overall Study|Physician Decision|1|||
126341951|NCT03098979|454548713|FG002|Overall Study|Physician Decision|0|||
126341952|NCT03098979|454548714|FG003|Overall Study|Physician Decision|0|||
126341953|NCT03098979|454548715|FG004|Overall Study|Physician Decision|0|||
126341954|NCT03098979|454548716|FG005|Overall Study|Physician Decision|0|||
126341955|NCT03098979|454548711|FG000|Overall Study|Non-compliance|0|||
126341956|NCT03098979|454548712|FG001|Overall Study|Non-compliance|0|||
126341957|NCT03098979|454548713|FG002|Overall Study|Non-compliance|0|||
126341958|NCT03098979|454548714|FG003|Overall Study|Non-compliance|0|||
126341959|NCT03098979|454548715|FG004|Overall Study|Non-compliance|0|||
126341960|NCT03098979|454548716|FG005|Overall Study|Non-compliance|1|||
126341961|NCT03098979|454548711|FG000|Overall Study|Protocol Violation|0|||
126341962|NCT03098979|454548712|FG001|Overall Study|Protocol Violation|0|||
126341963|NCT03098979|454548713|FG002|Overall Study|Protocol Violation|0|||
126341964|NCT03098979|454548714|FG003|Overall Study|Protocol Violation|0|||
126341965|NCT03098979|454548715|FG004|Overall Study|Protocol Violation|0|||
126341966|NCT03098979|454548716|FG005|Overall Study|Protocol Violation|1|||
126341967|NCT02426684|454548717|FG000|Overall Study|Physician Decision|1|||
126341968|NCT02369653|454548718|FG000|Overall Study|Lost to Follow-up|0|||
126341969|NCT02369653|454548719|FG001|Overall Study|Lost to Follow-up|1|||
126341970|NCT02369653|454548718|FG000|Overall Study|Administrative reason by sponsor|0|||
126341971|NCT02369653|454548719|FG001|Overall Study|Administrative reason by sponsor|1|||
126341972|NCT02369653|454548718|FG000|Overall Study|Death|1|||
126341973|NCT02369653|454548719|FG001|Overall Study|Death|2|||
126341974|NCT02369653|454548718|FG000|Overall Study|Participant withdrew consent|13|||
126341975|NCT02369653|454548719|FG001|Overall Study|Participant withdrew consent|3|||
126341976|NCT03587636|454548720|FG000|Overall Study|Lost to Follow-up|2|||
126341977|NCT03587636|454548721|FG001|Overall Study|Lost to Follow-up|5|||
126341978|NCT01006629|454548722|FG000|Overall Study|Adverse Event|1|||
126341979|NCT01006629|454548722|FG000|Overall Study|Parent refused to continue participation|1|||
126341980|NCT01006629|454548722|FG000|Overall Study|Parent unable to perform site visit|4|||
126341981|NCT01118299|454548723|FG000|Overall Study|Death|7|||
126341982|NCT01118299|454548724|FG001|Overall Study|Death|5|||
126341983|NCT01118299|454548723|FG000|Overall Study|Withdrawal by Subject|8|||
126341984|NCT01118299|454548724|FG001|Overall Study|Withdrawal by Subject|8|||
126341985|NCT01118299|454548723|FG000|Overall Study|Lost to Follow-up|2|||
126341986|NCT01118299|454548724|FG001|Overall Study|Lost to Follow-up|1|||
126341987|NCT01118299|454548723|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
126007270|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
126007271|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
126007272|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
126007273|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
126007274|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Adverse Event|198|||
126007275|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Adverse Event|0|||
126007276|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Adverse Event|0|||
126007277|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Adverse Event|0|||
126007278|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Death|62|||
126007279|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Death|0|||
126007280|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Death|0|||
126007281|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Death|0|||
126007282|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
126007283|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
126007284|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
126007285|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
126341988|NCT01118299|454548724|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
126341989|NCT04459338|454548725|FG000|Overall Study|Loss of IV during study|1|||
126341990|NCT04459338|454548726|FG001|Overall Study|Loss of IV during study|0|||
126341991|NCT03157089|454548727|FG000|Overall Study|Treated only with pembrolizumab|1|||
126341992|NCT03157089|454548728|FG001|Overall Study|Treated only with pembrolizumab|0|||
126341993|NCT03157089|454548727|FG000|Overall Study|Adverse Event|5|||
126341994|NCT03157089|454548728|FG001|Overall Study|Adverse Event|4|||
126341995|NCT03157089|454548727|FG000|Overall Study|Progressive disease|6|||
126341996|NCT03157089|454548728|FG001|Overall Study|Progressive disease|8|||
126341997|NCT02665117|454548729|FG000|Overall Study|Physician Decision|1|||
126341998|NCT02665117|454548730|FG001|Overall Study|Physician Decision|0|||
126341999|NCT02300610|454548731|FG000|Overall Study|Withdrawal by Subject|1|||
126007286|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Complicating disease|13|||
126007287|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Complicating disease|0|||
126007288|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Complicating disease|0|||
126007289|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Complicating disease|0|||
126007290|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
126007291|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
126007292|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
126007293|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
126007294|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
126007295|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
126007296|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
126007297|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
126007298|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Non-compliance|4|||
126007299|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Non-compliance|0|||
126007300|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Non-compliance|0|||
126007301|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Non-compliance|0|||
126007302|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Pain|4|||
126007303|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Pain|0|||
126007304|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Pain|0|||
126007305|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Pain|0|||
126007306|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
126007307|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
126007308|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
126007309|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
126007310|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Hospice care|1|||
126007311|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Hospice care|0|||
126007312|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Hospice care|0|||
126007313|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Hospice care|0|||
126007314|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Physician Decision|1|||
126007315|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Physician Decision|0|||
126007316|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Physician Decision|0|||
126007317|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Physician Decision|0|||
126007318|NCT01107626|453321351|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
126007319|NCT01107626|453321352|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
126007320|NCT01107626|453321353|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
126007321|NCT01107626|453321354|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
126007322|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
126007323|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
126007324|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
126007325|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
126007326|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
126007327|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
126007328|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
126342000|NCT02300610|454548732|FG001|Overall Study|Withdrawal by Subject|0|||
126342001|NCT02300610|454548733|FG002|Overall Study|Withdrawal by Subject|1|||
126342002|NCT03743194|454548735|FG000|Overall Study|Protocol Violation|7|||
126342003|NCT03743194|454548736|FG001|Overall Study|Protocol Violation|7|||
126342004|NCT03743194|454548735|FG000|Overall Study|Physician Decision|0|||
126342005|NCT03743194|454548736|FG001|Overall Study|Physician Decision|2|||
126342006|NCT01829347|454548740|FG000|VTI-210|Death|5|||
126342007|NCT01829347|454548741|FG001|VTI-210|Death|3|||
126342008|NCT01829347|454548740|FG000|VTI-210|Withdrawal by Subject|1|||
126342009|NCT01829347|454548741|FG001|VTI-210|Withdrawal by Subject|0|||
126342010|NCT01829347|454548740|FG000|VTI-210E|Death|2|||
126342011|NCT01829347|454548741|FG001|VTI-210E|Death|1|||
126342012|NCT01829347|454548740|FG000|VTI-210E|Study terminated prematurely|1|||
126342013|NCT01829347|454548741|FG001|VTI-210E|Study terminated prematurely|5|||
126342014|NCT03817528|454548743|FG000|Overall Study|Withdrawal by Subject|1|||
126342015|NCT03817528|454548743|FG000|Overall Study|Adverse Event|2|||
126342016|NCT01259245|454548757|FG000|Overall Study|Withdrawal by Subject|27|||
126342017|NCT01259245|454548758|FG001|Overall Study|Withdrawal by Subject|24|||
126342018|NCT01259245|454548757|FG000|Overall Study|Death|1|||
126342019|NCT01259245|454548758|FG001|Overall Study|Death|2|||
126342020|NCT02152007|454548759|FG000|Overall Study|Withdrawal by Subject|1|||
126342021|NCT01302899|454548766|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
126342022|NCT01302899|454548767|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
126342023|NCT01302899|454548766|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
126342024|NCT01302899|454548767|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
126342025|NCT02834975|454548768|FG000|Overall Study|Physician Decision|2|||
126342026|NCT02834975|454548768|FG000|Overall Study|Adverse Event|1|||
126342027|NCT02834975|454548768|FG000|Overall Study|Withdrawal by Subject|1|||
126342028|NCT02834975|454548768|FG000|Overall Study|Lack of Efficacy|1|||
126342029|NCT03558516|454548770|FG000|Overall Study|Protocol Violation|2|||
126342030|NCT03558516|454548771|FG001|Overall Study|Protocol Violation|2|||
126007329|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
126007330|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Death|0|||
126007331|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Death|8|||
126007332|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Death|2|||
126007333|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Death|13|||
126007334|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
126007335|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
126007336|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
126007337|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
126007338|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
126007339|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
126007340|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
126007341|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
126007342|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
126007343|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
126007344|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
126007345|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
126007346|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
126007347|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
126007348|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
126007349|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
126007350|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
126007351|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
126007352|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
126007353|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
126007354|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
126007355|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
126007356|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
126007357|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
126007358|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
126007359|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
126007360|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
126007361|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
126007362|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
126007363|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
126007364|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
126007365|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
126007366|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
126007367|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
126007368|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
126007369|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
126007370|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
126007371|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
126007372|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
126007373|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
126007374|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Pain|0|||
126007375|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Pain|0|||
126007376|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Pain|0|||
126007377|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Pain|1|||
126007378|NCT01107626|453321351|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
126007379|NCT01107626|453321352|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
126007380|NCT01107626|453321353|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
126007381|NCT01107626|453321354|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
126007382|NCT04381494|453321355|FG000|Overall Study|Early termination of trial|19|||
126007383|NCT04381494|453321355|FG000|Overall Study|Investigator's discretion|1|||
126007384|NCT04381494|453321355|FG000|Overall Study|Withdrawal by Subject|9|||
126007385|NCT04381494|453321355|FG000|Overall Study|NSCLC disease progression|4|||
126007386|NCT04381494|453321355|FG000|Overall Study|Device-Related Adverse Event|2|||
126007387|NCT04310579|453321356|FG000|Overall Study|Adverse Event|0|||
126007388|NCT04310579|453321357|FG001|Overall Study|Adverse Event|0|||
126007389|NCT04310579|453321358|FG002|Overall Study|Adverse Event|0|||
126007390|NCT04310579|453321359|FG003|Overall Study|Adverse Event|0|||
126007391|NCT04310579|453321360|FG004|Overall Study|Adverse Event|0|||
126007392|NCT04310579|453321361|FG005|Overall Study|Adverse Event|0|||
126007393|NCT04310579|453321362|FG006|Overall Study|Adverse Event|2|||
126007394|NCT04310579|453321363|FG007|Overall Study|Adverse Event|0|||
126007395|NCT04310579|453321364|FG008|Overall Study|Adverse Event|1|||
126007396|NCT04310579|453321365|FG009|Overall Study|Adverse Event|1|||
126007397|NCT04310579|453321366|FG010|Overall Study|Adverse Event|0|||
126007398|NCT04310579|453321356|FG000|Overall Study|Withdrawal by Subject|0|||
126007399|NCT04310579|453321357|FG001|Overall Study|Withdrawal by Subject|0|||
126427168|NCT04663321|454860441|FG001|Overall Study|Study terminated by Sponsor|1|||
126427169|NCT04663321|454860442|FG002|Overall Study|Study terminated by Sponsor|2|||
126427170|NCT04663321|454860440|FG000|Overall Study|Withdrawal by Subject|10|||
126427171|NCT04663321|454860441|FG001|Overall Study|Withdrawal by Subject|3|||
126427172|NCT04663321|454860442|FG002|Overall Study|Withdrawal by Subject|2|||
126427173|NCT04663321|454860440|FG000|Overall Study|Not provided|0|||
126427174|NCT04663321|454860441|FG001|Overall Study|Not provided|0|||
126427175|NCT04663321|454860442|FG002|Overall Study|Not provided|1|||
126427176|NCT01453140|454860443|FG000|Overall Study|Adverse Event|3|||
126427177|NCT02611479|454860444|FG000|Baseline Enrollment|Exited study|13|||
126007400|NCT04310579|453321358|FG002|Overall Study|Withdrawal by Subject|0|||
126007401|NCT04310579|453321359|FG003|Overall Study|Withdrawal by Subject|0|||
126007402|NCT04310579|453321360|FG004|Overall Study|Withdrawal by Subject|0|||
126007403|NCT04310579|453321361|FG005|Overall Study|Withdrawal by Subject|1|||
126007404|NCT04310579|453321362|FG006|Overall Study|Withdrawal by Subject|0|||
126007405|NCT04310579|453321363|FG007|Overall Study|Withdrawal by Subject|0|||
126007406|NCT04310579|453321364|FG008|Overall Study|Withdrawal by Subject|0|||
126007407|NCT04310579|453321365|FG009|Overall Study|Withdrawal by Subject|0|||
126007408|NCT04310579|453321366|FG010|Overall Study|Withdrawal by Subject|0|||
126007409|NCT04310579|453321356|FG000|Overall Study|Positive COVID-19 test|0|||
126007410|NCT04310579|453321357|FG001|Overall Study|Positive COVID-19 test|0|||
126007411|NCT04310579|453321358|FG002|Overall Study|Positive COVID-19 test|0|||
126007412|NCT04310579|453321359|FG003|Overall Study|Positive COVID-19 test|0|||
126007413|NCT04310579|453321360|FG004|Overall Study|Positive COVID-19 test|0|||
126007414|NCT04310579|453321361|FG005|Overall Study|Positive COVID-19 test|0|||
126007415|NCT04310579|453321362|FG006|Overall Study|Positive COVID-19 test|0|||
126007416|NCT04310579|453321363|FG007|Overall Study|Positive COVID-19 test|0|||
126007417|NCT04310579|453321364|FG008|Overall Study|Positive COVID-19 test|0|||
126007418|NCT04310579|453321365|FG009|Overall Study|Positive COVID-19 test|0|||
126007419|NCT04310579|453321366|FG010|Overall Study|Positive COVID-19 test|1|||
126007420|NCT01149681|453321367|FG000|Overall Study|Withdrawal by Subject|7|||
126007421|NCT01149681|453321367|FG000|Overall Study|Progressive disease|1|||
126007422|NCT01149681|453321367|FG000|Overall Study|Physician Decision|2|||
126007423|NCT01149681|453321367|FG000|Overall Study|adverse events nonrelated study drug|2|||
126007424|NCT03710564|453321368|FG000|Overall Study|Study Terminated by Sponsor|104|||
126007425|NCT03710564|453321369|FG001|Overall Study|Study Terminated by Sponsor|55|||
126007426|NCT03710564|453321368|FG000|Overall Study|Withdrawal by Subject|57|||
126007427|NCT03710564|453321369|FG001|Overall Study|Withdrawal by Subject|25|||
126007428|NCT03710564|453321368|FG000|Overall Study|Death|10|||
126007429|NCT03710564|453321369|FG001|Overall Study|Death|4|||
126007430|NCT03710564|453321368|FG000|Overall Study|Lost to Follow-up|5|||
126007431|NCT03710564|453321369|FG001|Overall Study|Lost to Follow-up|4|||
126007432|NCT03710564|453321368|FG000|Overall Study|Protocol Violation|3|||
126007433|NCT03710564|453321369|FG001|Overall Study|Protocol Violation|2|||
126007434|NCT03710564|453321368|FG000|Overall Study|Adverse Event|3|||
126007435|NCT03710564|453321369|FG001|Overall Study|Adverse Event|0|||
126007436|NCT03710564|453321368|FG000|Overall Study|Physician Decision|2|||
126007437|NCT03710564|453321369|FG001|Overall Study|Physician Decision|3|||
126007438|NCT00930813|453321370|FG000|Overall Study|Death|4|||
126007439|NCT00930813|453321371|FG001|Overall Study|Death|5|||
126007440|NCT00930813|453321370|FG000|Overall Study|Withdrawal by Subject|2|||
126007441|NCT00930813|453321371|FG001|Overall Study|Withdrawal by Subject|5|||
126007442|NCT00930813|453321370|FG000|Overall Study|Lost to Follow-up|2|||
126007443|NCT00930813|453321371|FG001|Overall Study|Lost to Follow-up|4|||
126007444|NCT03999554|453321376|FG000|Overall Study|Lost to Follow-up|4|||
126007445|NCT03999554|453321377|FG001|Overall Study|Lost to Follow-up|5|||
126007446|NCT03999554|453321378|FG002|Overall Study|Lost to Follow-up|4|||
126007447|NCT03999554|453321379|FG003|Overall Study|Lost to Follow-up|5|||
126007448|NCT03999554|453321380|FG004|Overall Study|Lost to Follow-up|8|||
126007449|NCT03999554|453321376|FG000|Overall Study|Protocol Violation|0|||
126007450|NCT03999554|453321377|FG001|Overall Study|Protocol Violation|0|||
126007451|NCT03999554|453321378|FG002|Overall Study|Protocol Violation|5|||
126007452|NCT03999554|453321379|FG003|Overall Study|Protocol Violation|0|||
126007453|NCT03999554|453321380|FG004|Overall Study|Protocol Violation|0|||
126007454|NCT03999554|453321376|FG000|Overall Study|Pregnancy|0|||
126007455|NCT03999554|453321377|FG001|Overall Study|Pregnancy|0|||
126007456|NCT03999554|453321378|FG002|Overall Study|Pregnancy|1|||
126007457|NCT03999554|453321379|FG003|Overall Study|Pregnancy|0|||
126007458|NCT03999554|453321380|FG004|Overall Study|Pregnancy|0|||
126007459|NCT03999554|453321376|FG000|Overall Study|Withdrawal by Subject|2|||
126007460|NCT03999554|453321377|FG001|Overall Study|Withdrawal by Subject|2|||
126007461|NCT03999554|453321378|FG002|Overall Study|Withdrawal by Subject|2|||
126007462|NCT03999554|453321379|FG003|Overall Study|Withdrawal by Subject|1|||
126007463|NCT03999554|453321380|FG004|Overall Study|Withdrawal by Subject|1|||
126007464|NCT03999554|453321376|FG000|Overall Study|failure to comply with protocol requirements|0|||
126007465|NCT03999554|453321377|FG001|Overall Study|failure to comply with protocol requirements|0|||
126007466|NCT03999554|453321378|FG002|Overall Study|failure to comply with protocol requirements|0|||
126007467|NCT03999554|453321379|FG003|Overall Study|failure to comply with protocol requirements|1|||
126007468|NCT03999554|453321380|FG004|Overall Study|failure to comply with protocol requirements|0|||
126007469|NCT02759731|453321381|FG000|Overall Study|Did not complete treatment.|8|||
126007470|NCT00763282|453321384|FG000|Overall Study|Withdrawal by Subject|6|||
126007471|NCT00763282|453321385|FG001|Overall Study|Withdrawal by Subject|5|||
126427178|NCT02611479|454860444|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
126427179|NCT02611479|454860444|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
126427180|NCT02611479|454860444|FG000|Data Cleaning|No baseline function or pain metrics|2|||
126427181|NCT00743249|454860445|FG000|Overall Study|Adverse Event|0|||
126427182|NCT00743249|454860446|FG001|Overall Study|Adverse Event|4|||
126427183|NCT00743249|454860445|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
126427184|NCT00743249|454860446|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
126427185|NCT00743249|454860445|FG000|Overall Study|Unsuccessful insertion of stent|2|||
126427186|NCT00743249|454860446|FG001|Overall Study|Unsuccessful insertion of stent|1|||
126427187|NCT00423657|454860450|FG000|Overall Study|Withdrew consent|10|||
126427188|NCT00423657|454860451|FG001|Overall Study|Withdrew consent|8|||
126427189|NCT00423657|454860450|FG000|Overall Study|Non-compliance|0|||
126427190|NCT00423657|454860451|FG001|Overall Study|Non-compliance|1|||
126427191|NCT00423657|454860450|FG000|Overall Study|Other|15|||
126427192|NCT00423657|454860451|FG001|Overall Study|Other|16|||
126427193|NCT00423657|454860450|FG000|Overall Study|Request of sponsor/investigator|1|||
126427194|NCT00423657|454860451|FG001|Overall Study|Request of sponsor/investigator|0|||
126427195|NCT02422498|454860455|FG000|Overall Study|Inevaluable|4|||
126427196|NCT02653326|454860456|FG000|Overall Study|Lost to Follow-up|10|||
126427197|NCT02653326|454860457|FG001|Overall Study|Lost to Follow-up|7|||
126427198|NCT03206216|454860458|FG000|Overall Study|Withdrawal by Subject|0|||
126427199|NCT03206216|454860459|FG001|Overall Study|Withdrawal by Subject|1|||
126427200|NCT04621448|454860462|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
126427201|NCT04621448|454860463|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
126427202|NCT04621448|454860464|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
126427203|NCT04621448|454860465|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
126427204|NCT04621448|454860462|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
126427205|NCT04621448|454860463|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
126427206|NCT04621448|454860464|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
126427207|NCT04621448|454860465|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
126427208|NCT04621448|454860462|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
126427209|NCT04621448|454860463|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
126007472|NCT00763282|453321384|FG000|Overall Study|Death|4|||
126007473|NCT00763282|453321385|FG001|Overall Study|Death|3|||
126007474|NCT00763282|453321384|FG000|Overall Study|Lost to Follow-up|22|||
126342031|NCT03363906|454548772|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
126342032|NCT03363906|454548773|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
126342033|NCT03363906|454548772|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
126342034|NCT03363906|454548773|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
126342035|NCT03363906|454548772|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
126342036|NCT03363906|454548773|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
126342037|NCT03363906|454548772|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
126342038|NCT03363906|454548773|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
126342039|NCT00676143|454548774|FG000|Overall Study|Adverse Event|34|||
126342040|NCT00676143|454548775|FG001|Overall Study|Adverse Event|60|||
126342041|NCT00676143|454548774|FG000|Overall Study|Death|4|||
126342042|NCT00676143|454548775|FG001|Overall Study|Death|4|||
126342043|NCT00676143|454548774|FG000|Overall Study|Lack of Efficacy|0|||
126342044|NCT00676143|454548775|FG001|Overall Study|Lack of Efficacy|6|||
126342045|NCT00676143|454548774|FG000|Overall Study|Lost to Follow-up|0|||
126342046|NCT00676143|454548775|FG001|Overall Study|Lost to Follow-up|13|||
126342047|NCT00676143|454548774|FG000|Overall Study|Physician Decision|5|||
126342048|NCT00676143|454548775|FG001|Overall Study|Physician Decision|8|||
126342049|NCT00676143|454548774|FG000|Overall Study|Protocol Violation|4|||
126342050|NCT00676143|454548775|FG001|Overall Study|Protocol Violation|8|||
126342051|NCT00676143|454548774|FG000|Overall Study|Withdrawal by Subject|24|||
126342052|NCT00676143|454548775|FG001|Overall Study|Withdrawal by Subject|42|||
126342053|NCT00676143|454548774|FG000|Overall Study|Discontinuation of study by sponsor|65|||
126342054|NCT00676143|454548775|FG001|Overall Study|Discontinuation of study by sponsor|88|||
126342055|NCT00676143|454548774|FG000|Overall Study|Failed to return|2|||
126342056|NCT00676143|454548775|FG001|Overall Study|Failed to return|1|||
126342057|NCT00676143|454548774|FG000|Overall Study|Loss of caregiver|5|||
126342058|NCT00676143|454548775|FG001|Overall Study|Loss of caregiver|3|||
126342059|NCT00676143|454548774|FG000|Overall Study|Other|11|||
126342060|NCT00676143|454548775|FG001|Overall Study|Other|20|||
126342061|NCT00676143|454548774|FG000|Overall Study|Participant participation unknown|1|||
126342062|NCT00676143|454548775|FG001|Overall Study|Participant participation unknown|4|||
126427210|NCT04621448|454860464|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
126342063|NCT00676143|454548774|FG000|Overall Study|Vasogenic edema recurrence|1|||
126007475|NCT00763282|453321385|FG001|Overall Study|Lost to Follow-up|26|||
126007476|NCT00742274|453321386|FG000|Overall Study|Death|1|||
126007477|NCT00742274|453321387|FG001|Overall Study|Death|0|||
126007478|NCT00742274|453321386|FG000|Overall Study|Withdrawal by Subject|1|||
126007479|NCT00742274|453321387|FG001|Overall Study|Withdrawal by Subject|2|||
126007480|NCT00742274|453321386|FG000|Overall Study|Removed for medical reasons|1|||
126007481|NCT00742274|453321387|FG001|Overall Study|Removed for medical reasons|1|||
126007482|NCT00335556|453321390|FG000|Overall Study|Death|0|||
126007483|NCT00335556|453321391|FG001|Overall Study|Death|5|||
126007484|NCT00335556|453321392|FG002|Overall Study|Death|0|||
126007485|NCT00335556|453321393|FG003|Overall Study|Death|0|||
126007486|NCT00335556|453321394|FG004|Overall Study|Death|1|||
126007487|NCT00335556|453321395|FG005|Overall Study|Death|0|||
126007488|NCT00335556|453321390|FG000|Overall Study|Lack of Efficacy|0|||
126007489|NCT00335556|453321391|FG001|Overall Study|Lack of Efficacy|19|||
126007490|NCT00335556|453321392|FG002|Overall Study|Lack of Efficacy|3|||
126007491|NCT00335556|453321393|FG003|Overall Study|Lack of Efficacy|3|||
126007492|NCT00335556|453321394|FG004|Overall Study|Lack of Efficacy|0|||
126007493|NCT00335556|453321395|FG005|Overall Study|Lack of Efficacy|1|||
126007494|NCT00335556|453321390|FG000|Overall Study|Physician Decision|0|||
126007495|NCT00335556|453321391|FG001|Overall Study|Physician Decision|6|||
126007496|NCT00335556|453321392|FG002|Overall Study|Physician Decision|2|||
126007497|NCT00335556|453321393|FG003|Overall Study|Physician Decision|1|||
126007498|NCT00335556|453321394|FG004|Overall Study|Physician Decision|0|||
126007499|NCT00335556|453321395|FG005|Overall Study|Physician Decision|0|||
126007500|NCT00335556|453321390|FG000|Overall Study|Ineligible|2|||
126007501|NCT00335556|453321391|FG001|Overall Study|Ineligible|0|||
126007502|NCT00335556|453321392|FG002|Overall Study|Ineligible|0|||
126007503|NCT00335556|453321393|FG003|Overall Study|Ineligible|0|||
126007504|NCT00335556|453321394|FG004|Overall Study|Ineligible|0|||
126007505|NCT00335556|453321395|FG005|Overall Study|Ineligible|0|||
126007506|NCT00335556|453321390|FG000|Overall Study|Refusal of further protocol therapy|0|||
126007507|NCT00335556|453321391|FG001|Overall Study|Refusal of further protocol therapy|4|||
126007508|NCT00335556|453321392|FG002|Overall Study|Refusal of further protocol therapy|0|||
126007509|NCT00335556|453321393|FG003|Overall Study|Refusal of further protocol therapy|1|||
126007510|NCT00335556|453321394|FG004|Overall Study|Refusal of further protocol therapy|0|||
126007511|NCT00335556|453321395|FG005|Overall Study|Refusal of further protocol therapy|0|||
126007512|NCT02365298|453321396|FG000|Period 2|incorrect Rx dispensed|1|||
126007513|NCT02365298|453321397|FG001|Period 2|incorrect Rx dispensed|0|||
126007514|NCT02365298|453321396|FG000|Period 2|Discontinued at request of Sponsor|1|||
126007515|NCT02365298|453321397|FG001|Period 2|Discontinued at request of Sponsor|0|||
126007516|NCT02365298|453321396|FG000|Period 2|Test Article longer available|0|||
126007517|NCT02365298|453321397|FG001|Period 2|Test Article longer available|1|||
126007518|NCT02365298|453321396|FG000|Period 2|Protocol Violation|0|||
126007519|NCT02365298|453321397|FG001|Period 2|Protocol Violation|1|||
126007520|NCT01878890|453321398|FG000|Overall Study|Protocol Violation|0|||
126007521|NCT01878890|453321399|FG001|Overall Study|Protocol Violation|1|||
126007522|NCT01878890|453321400|FG002|Overall Study|Protocol Violation|0|||
126007523|NCT01878890|453321401|FG003|Overall Study|Protocol Violation|0|||
126007524|NCT00320489|453321402|FG000|Overall Study|Adverse Event|26|||
126007525|NCT00320489|453321403|FG001|Overall Study|Adverse Event|25|||
126007526|NCT00320489|453321402|FG000|Overall Study|Clinical Relapse|26|||
126007527|NCT00320489|453321403|FG001|Overall Study|Clinical Relapse|20|||
126007528|NCT00320489|453321402|FG000|Overall Study|Death|0|||
126007529|NCT00320489|453321403|FG001|Overall Study|Death|2|||
126007530|NCT00320489|453321402|FG000|Overall Study|Entry Criteria Exclusion|2|||
126007531|NCT00320489|453321403|FG001|Overall Study|Entry Criteria Exclusion|4|||
126007532|NCT00320489|453321402|FG000|Overall Study|Lack of Efficacy|16|||
126007533|NCT00320489|453321403|FG001|Overall Study|Lack of Efficacy|7|||
126007534|NCT00320489|453321402|FG000|Overall Study|Lost to Follow-up|21|||
126007535|NCT00320489|453321403|FG001|Overall Study|Lost to Follow-up|22|||
126007536|NCT00320489|453321402|FG000|Overall Study|Physician Decision|8|||
126007537|NCT00320489|453321403|FG001|Overall Study|Physician Decision|8|||
126007538|NCT00320489|453321402|FG000|Overall Study|Protocol Violation|4|||
126007539|NCT00320489|453321403|FG001|Overall Study|Protocol Violation|4|||
126007540|NCT00320489|453321402|FG000|Overall Study|Sponsor Decision|3|||
126007541|NCT00320489|453321403|FG001|Overall Study|Sponsor Decision|3|||
126007542|NCT00320489|453321402|FG000|Overall Study|Withdrawal by Subject|39|||
126007543|NCT00320489|453321403|FG001|Overall Study|Withdrawal by Subject|41|||
126007544|NCT03441984|453321404|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007545|NCT03441984|453321405|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007546|NCT03441984|453321406|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
126007547|NCT03441984|453321407|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007548|NCT03441984|453321408|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007549|NCT03441984|453321409|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007550|NCT03441984|453321410|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007551|NCT03441984|453321411|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007552|NCT03441984|453321412|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126046456|NCT02467270|453468227|FG001|Overall Study|Progressive Disease|7|||
126427211|NCT04621448|454860465|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
126427212|NCT04621448|454860462|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
126427213|NCT04621448|454860463|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
126427214|NCT04621448|454860464|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
126427215|NCT04621448|454860465|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
126427216|NCT04590014|454860468|FG000|Overall Study|Withdrawal by Subject|1|||
126427217|NCT04590014|454860469|FG001|Overall Study|Withdrawal by Subject|0|||
126427218|NCT01506271|454860470|FG000|Overall Study|Progressive disease|0|||
126427219|NCT01506271|454860471|FG001|Overall Study|Progressive disease|1|||
126427220|NCT01506271|454860472|FG002|Overall Study|Progressive disease|0|||
126427221|NCT01506271|454860470|FG000|Overall Study|Protocol Violation|3|||
126427222|NCT01506271|454860471|FG001|Overall Study|Protocol Violation|1|||
126342064|NCT00676143|454548775|FG001|Overall Study|Vasogenic edema recurrence|3|||
126342065|NCT00929669|454548777|FG000|Overall Study|elevated glucose levels|1|||
126342066|NCT02714153|454548778|FG000|Overall Study|Death|1|||
126342067|NCT02065557|454548782|FG000|Induction Period|Withdrawal by Subject|2|||
126342068|NCT02065557|454548783|FG001|Induction Period|Withdrawal by Subject|1|||
126342069|NCT02065557|454548784|FG002|Induction Period|Withdrawal by Subject|0|||
126342070|NCT02065557|454548785|FG003|Induction Period|Withdrawal by Subject|0|||
126342071|NCT02065557|454548786|FG004|Induction Period|Withdrawal by Subject|0|||
126342072|NCT02065557|454548787|FG005|Induction Period|Withdrawal by Subject|0|||
126342073|NCT02065557|454548782|FG000|Induction Period|Lack of Efficacy|2|||
126427223|NCT01506271|454860472|FG002|Overall Study|Protocol Violation|0|||
126427224|NCT01506271|454860470|FG000|Overall Study|Death|0|||
126427225|NCT01506271|454860471|FG001|Overall Study|Death|1|||
126427226|NCT01506271|454860472|FG002|Overall Study|Death|0|||
126427227|NCT01506271|454860470|FG000|Overall Study|Adverse Event|0|||
126427228|NCT01506271|454860471|FG001|Overall Study|Adverse Event|2|||
126427229|NCT01506271|454860472|FG002|Overall Study|Adverse Event|0|||
126427230|NCT01506271|454860470|FG000|Overall Study|Insufficient supply of study drug|1|||
126427231|NCT01506271|454860471|FG001|Overall Study|Insufficient supply of study drug|0|||
126427232|NCT01506271|454860472|FG002|Overall Study|Insufficient supply of study drug|0|||
126427233|NCT01506271|454860470|FG000|Overall Study|Withdrawal by Subject|0|||
126427234|NCT01506271|454860471|FG001|Overall Study|Withdrawal by Subject|1|||
126427235|NCT01506271|454860472|FG002|Overall Study|Withdrawal by Subject|1|||
126427236|NCT01506271|454860470|FG000|Overall Study|Lost to Follow-up|0|||
126427237|NCT01506271|454860471|FG001|Overall Study|Lost to Follow-up|1|||
126427238|NCT01506271|454860472|FG002|Overall Study|Lost to Follow-up|2|||
126427239|NCT01391663|454860473|FG000|Overall Study|Withdrawal by Subject|0|||
126427240|NCT01391663|454860474|FG001|Overall Study|Withdrawal by Subject|0|||
126007553|NCT03441984|453321413|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126342074|NCT02065557|454548783|FG001|Induction Period|Lack of Efficacy|1|||
126342075|NCT02065557|454548784|FG002|Induction Period|Lack of Efficacy|1|||
126342076|NCT02065557|454548785|FG003|Induction Period|Lack of Efficacy|0|||
126342077|NCT02065557|454548786|FG004|Induction Period|Lack of Efficacy|0|||
126342078|NCT02065557|454548787|FG005|Induction Period|Lack of Efficacy|0|||
126342079|NCT02065557|454548782|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
126342080|NCT02065557|454548783|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
126342081|NCT02065557|454548784|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
126342082|NCT02065557|454548785|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
126342083|NCT02065557|454548786|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
126342084|NCT02065557|454548787|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
126342085|NCT02065557|454548782|FG000|Induction Period|Non-Responder at Week 8|4|||
126342086|NCT02065557|454548783|FG001|Induction Period|Non-Responder at Week 8|4|||
126342087|NCT02065557|454548784|FG002|Induction Period|Non-Responder at Week 8|0|||
126342088|NCT02065557|454548785|FG003|Induction Period|Non-Responder at Week 8|0|||
126342089|NCT02065557|454548786|FG004|Induction Period|Non-Responder at Week 8|0|||
126342090|NCT02065557|454548787|FG005|Induction Period|Non-Responder at Week 8|0|||
126342091|NCT02065557|454548782|FG000|Induction Period|Adverse Event|1|||
126427241|NCT01391663|454860475|FG002|Overall Study|Withdrawal by Subject|1|||
126007554|NCT03441984|453321414|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007555|NCT03441984|453321415|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126007556|NCT04555044|453321418|FG000|Overall Study|Adverse Event|0|||
126007557|NCT04555044|453321419|FG001|Overall Study|Adverse Event|1|||
126007558|NCT04088188|453321422|FG000|Overall Study|Withdrawal by Subject|2|||
126007559|NCT04088188|453321423|FG001|Overall Study|Withdrawal by Subject|0|||
126342092|NCT02065557|454548783|FG001|Induction Period|Adverse Event|1|||
126342093|NCT02065557|454548784|FG002|Induction Period|Adverse Event|0|||
126342094|NCT02065557|454548785|FG003|Induction Period|Adverse Event|0|||
126342095|NCT02065557|454548786|FG004|Induction Period|Adverse Event|0|||
126342096|NCT02065557|454548787|FG005|Induction Period|Adverse Event|0|||
126427242|NCT01391663|454860476|FG003|Overall Study|Withdrawal by Subject|0|||
126427243|NCT00920855|454860477|FG000|Overall Study|Adverse Event|1|||
126427244|NCT00920855|454860478|FG001|Overall Study|Adverse Event|1|||
126427245|NCT00920855|454860479|FG002|Overall Study|Adverse Event|4|||
126427246|NCT00920855|454860477|FG000|Overall Study|Withdrawal by Subject|2|||
126342097|NCT02065557|454548782|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
126342098|NCT02065557|454548783|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
126342099|NCT02065557|454548784|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
126342100|NCT02065557|454548785|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
126342101|NCT02065557|454548786|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
126342102|NCT02065557|454548787|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
126342103|NCT02065557|454548782|FG000|Maintenance Period|Withdrawal by Subject|0|||
126342104|NCT02065557|454548783|FG001|Maintenance Period|Withdrawal by Subject|0|||
126342105|NCT02065557|454548784|FG002|Maintenance Period|Withdrawal by Subject|0|||
126342106|NCT02065557|454548785|FG003|Maintenance Period|Withdrawal by Subject|0|||
126342107|NCT02065557|454548786|FG004|Maintenance Period|Withdrawal by Subject|2|||
126342108|NCT02065557|454548787|FG005|Maintenance Period|Withdrawal by Subject|1|||
126342109|NCT02065557|454548782|FG000|Maintenance Period|Lack of Efficacy|0|||
126342110|NCT02065557|454548783|FG001|Maintenance Period|Lack of Efficacy|0|||
126342111|NCT02065557|454548784|FG002|Maintenance Period|Lack of Efficacy|0|||
126342112|NCT02065557|454548785|FG003|Maintenance Period|Lack of Efficacy|0|||
126342113|NCT02065557|454548786|FG004|Maintenance Period|Lack of Efficacy|5|||
126342114|NCT02065557|454548787|FG005|Maintenance Period|Lack of Efficacy|2|||
126342115|NCT02065557|454548782|FG000|Maintenance Period|Subject Non-Compliance|0|||
126342116|NCT02065557|454548783|FG001|Maintenance Period|Subject Non-Compliance|0|||
126342117|NCT02065557|454548784|FG002|Maintenance Period|Subject Non-Compliance|0|||
126007560|NCT04088188|453321422|FG000|Overall Study|Adverse Event|2|||
126007561|NCT04088188|453321423|FG001|Overall Study|Adverse Event|0|||
126007562|NCT00580801|453321426|FG000|Overall Study|Physician Decision|1|||
126007563|NCT00580801|453321427|FG001|Overall Study|Physician Decision|0|||
126007564|NCT00580801|453321428|FG002|Overall Study|Physician Decision|0|||
126007565|NCT00580801|453321426|FG000|Overall Study|Adverse Event|2|||
126007566|NCT00580801|453321427|FG001|Overall Study|Adverse Event|0|||
126007567|NCT00580801|453321428|FG002|Overall Study|Adverse Event|0|||
126007568|NCT00580801|453321426|FG000|Overall Study|Lost to Follow-up|2|||
126007569|NCT00580801|453321427|FG001|Overall Study|Lost to Follow-up|0|||
126007570|NCT00580801|453321428|FG002|Overall Study|Lost to Follow-up|0|||
126007571|NCT00580801|453321426|FG000|Overall Study|Reached a virologic endpoint|0|||
126007572|NCT00580801|453321427|FG001|Overall Study|Reached a virologic endpoint|1|||
126007573|NCT00580801|453321428|FG002|Overall Study|Reached a virologic endpoint|2|||
126007574|NCT00580801|453321426|FG000|Overall Study|Participant non-compliant|0|||
126007575|NCT00580801|453321427|FG001|Overall Study|Participant non-compliant|0|||
126007576|NCT00580801|453321428|FG002|Overall Study|Participant non-compliant|1|||
126007577|NCT00580801|453321426|FG000|Overall Study|Travel|1|||
126007578|NCT00580801|453321427|FG001|Overall Study|Travel|0|||
126007579|NCT00580801|453321428|FG002|Overall Study|Travel|0|||
126007580|NCT00502593|453321429|FG000|Overall Study|Withdrawn unspecified reason|1|||
126007581|NCT00502593|453321430|FG001|Overall Study|Withdrawn unspecified reason|1|||
126007582|NCT00502593|453321431|FG002|Overall Study|Withdrawn unspecified reason|3|||
126007583|NCT00502593|453321432|FG003|Overall Study|Withdrawn unspecified reason|1|||
126007584|NCT00502593|453321433|FG004|Overall Study|Withdrawn unspecified reason|2|||
126007585|NCT00502593|453321434|FG005|Overall Study|Withdrawn unspecified reason|0|||
126007586|NCT00502593|453321435|FG006|Overall Study|Withdrawn unspecified reason|2|||
126007587|NCT00502593|453321436|FG007|Overall Study|Withdrawn unspecified reason|0|||
126007588|NCT00502593|453321437|FG008|Overall Study|Withdrawn unspecified reason|0|||
126007589|NCT00502593|453321438|FG009|Overall Study|Withdrawn unspecified reason|0|||
126007590|NCT00502593|453321439|FG010|Overall Study|Withdrawn unspecified reason|0|||
126007591|NCT00502593|453321440|FG011|Overall Study|Withdrawn unspecified reason|0|||
126007592|NCT00502593|453321429|FG000|Overall Study|Withdrawal by Subject|0|||
126007593|NCT00502593|453321430|FG001|Overall Study|Withdrawal by Subject|0|||
126007594|NCT00502593|453321431|FG002|Overall Study|Withdrawal by Subject|6|||
126007595|NCT00502593|453321432|FG003|Overall Study|Withdrawal by Subject|2|||
126007596|NCT00502593|453321433|FG004|Overall Study|Withdrawal by Subject|2|||
126007597|NCT00502593|453321434|FG005|Overall Study|Withdrawal by Subject|0|||
126007598|NCT00502593|453321435|FG006|Overall Study|Withdrawal by Subject|3|||
126007599|NCT00502593|453321436|FG007|Overall Study|Withdrawal by Subject|0|||
126007600|NCT00502593|453321437|FG008|Overall Study|Withdrawal by Subject|3|||
126007601|NCT00502593|453321438|FG009|Overall Study|Withdrawal by Subject|0|||
126342118|NCT02065557|454548785|FG003|Maintenance Period|Subject Non-Compliance|0|||
126342119|NCT02065557|454548786|FG004|Maintenance Period|Subject Non-Compliance|0|||
126007602|NCT00502593|453321439|FG010|Overall Study|Withdrawal by Subject|1|||
126007603|NCT00502593|453321440|FG011|Overall Study|Withdrawal by Subject|0|||
126007604|NCT00502593|453321429|FG000|Overall Study|Lost to Follow-up|2|||
126007605|NCT00502593|453321430|FG001|Overall Study|Lost to Follow-up|1|||
126007606|NCT00502593|453321431|FG002|Overall Study|Lost to Follow-up|1|||
126209495|NCT03110107|454055400|FG007|Treatment Period|Adverse Event|2|||
126007607|NCT00502593|453321432|FG003|Overall Study|Lost to Follow-up|1|||
126007608|NCT00502593|453321433|FG004|Overall Study|Lost to Follow-up|0|||
126007609|NCT00502593|453321434|FG005|Overall Study|Lost to Follow-up|0|||
126209496|NCT03110107|454055401|FG008|Treatment Period|Adverse Event|0|||
126427247|NCT00920855|454860478|FG001|Overall Study|Withdrawal by Subject|1|||
126427248|NCT00920855|454860479|FG002|Overall Study|Withdrawal by Subject|6|||
126427249|NCT00920855|454860477|FG000|Overall Study|Disease progression|2|||
126427250|NCT00920855|454860478|FG001|Overall Study|Disease progression|1|||
126427251|NCT00920855|454860479|FG002|Overall Study|Disease progression|10|||
126427252|NCT00920855|454860477|FG000|Overall Study|Noncompliance to study medication|0|||
126427253|NCT00920855|454860478|FG001|Overall Study|Noncompliance to study medication|0|||
126427254|NCT00920855|454860479|FG002|Overall Study|Noncompliance to study medication|1|||
126427255|NCT00920855|454860477|FG000|Overall Study|Response plateau; started maintenance|0|||
126427256|NCT00920855|454860478|FG001|Overall Study|Response plateau; started maintenance|0|||
126427257|NCT00920855|454860479|FG002|Overall Study|Response plateau; started maintenance|1|||
126427258|NCT01290523|454860480|FG000|Overall Study|Death|3|||
126427259|NCT00539994|454860481|FG000|Overall Study|Lost to Follow-up|2|||
126427260|NCT00539994|454860482|FG001|Overall Study|Lost to Follow-up|1|||
126427261|NCT00539994|454860483|FG002|Overall Study|Lost to Follow-up|0|||
126427262|NCT00539994|454860481|FG000|Overall Study|Withdrawal by Subject|1|||
126427263|NCT00539994|454860482|FG001|Overall Study|Withdrawal by Subject|0|||
126427264|NCT00539994|454860483|FG002|Overall Study|Withdrawal by Subject|1|||
126427265|NCT00539994|454860481|FG000|Overall Study|Physician Decision|0|||
126427266|NCT00539994|454860482|FG001|Overall Study|Physician Decision|0|||
126427267|NCT00539994|454860483|FG002|Overall Study|Physician Decision|1|||
126427268|NCT03071263|454860484|FG000|Overall Study|Adverse Event|1|||
126427269|NCT03071263|454860485|FG001|Overall Study|Adverse Event|3|||
126427270|NCT03071263|454860484|FG000|Overall Study|Withdrawal by Subject|1|||
126427271|NCT03071263|454860485|FG001|Overall Study|Withdrawal by Subject|3|||
126427272|NCT03071263|454860484|FG000|Overall Study|Physician Decision|1|||
126427273|NCT03071263|454860485|FG001|Overall Study|Physician Decision|0|||
126427274|NCT03071263|454860484|FG000|Overall Study|Participant moved to another city|0|||
126427275|NCT03071263|454860485|FG001|Overall Study|Participant moved to another city|1|||
126427276|NCT03084796|454860486|FG000|Overall Study|Adverse Event|4|||
126427277|NCT03084796|454860487|FG001|Overall Study|Adverse Event|5|||
126427278|NCT03084796|454860488|FG002|Overall Study|Adverse Event|6|||
126427279|NCT03084796|454860489|FG003|Overall Study|Adverse Event|2|||
126427280|NCT03084796|454860490|FG004|Overall Study|Adverse Event|3|||
126427281|NCT03084796|454860491|FG005|Overall Study|Adverse Event|5|||
126427282|NCT03084796|454860486|FG000|Overall Study|Withdrawal by Subject|3|||
126427283|NCT03084796|454860487|FG001|Overall Study|Withdrawal by Subject|5|||
126427284|NCT03084796|454860488|FG002|Overall Study|Withdrawal by Subject|2|||
126427285|NCT03084796|454860489|FG003|Overall Study|Withdrawal by Subject|1|||
126427286|NCT03084796|454860490|FG004|Overall Study|Withdrawal by Subject|3|||
126427287|NCT03084796|454860491|FG005|Overall Study|Withdrawal by Subject|0|||
126427288|NCT03084796|454860486|FG000|Overall Study|Protocol Violation|0|||
126427289|NCT03084796|454860487|FG001|Overall Study|Protocol Violation|0|||
126007610|NCT00502593|453321435|FG006|Overall Study|Lost to Follow-up|0|||
126007611|NCT00502593|453321436|FG007|Overall Study|Lost to Follow-up|0|||
126007612|NCT00502593|453321437|FG008|Overall Study|Lost to Follow-up|3|||
126007613|NCT00502593|453321438|FG009|Overall Study|Lost to Follow-up|0|||
126007614|NCT00502593|453321439|FG010|Overall Study|Lost to Follow-up|1|||
126007615|NCT00502593|453321440|FG011|Overall Study|Lost to Follow-up|0|||
126007616|NCT01664104|453321441|FG000|Overall Study|Adverse Event|6|||
126007617|NCT01664104|453321441|FG000|Overall Study|Lack of Efficacy|2|||
126007618|NCT01664104|453321441|FG000|Overall Study|Withdrawal by Subject|1|||
126007619|NCT01664104|453321441|FG000|Overall Study|Lost to Follow-up|4|||
126007620|NCT01664104|453321441|FG000|Overall Study|Other|1|||
126007621|NCT01664104|453321441|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
126007622|NCT03761784|453321442|FG000|Overall Study|Adverse Event|4|||
126007623|NCT03761784|453321443|FG001|Overall Study|Adverse Event|0|||
126007624|NCT03761784|453321442|FG000|Overall Study|Lost to Follow-up|10|||
126007625|NCT03761784|453321443|FG001|Overall Study|Lost to Follow-up|7|||
126007626|NCT03761784|453321442|FG000|Overall Study|Pregnancy|1|||
126007627|NCT03761784|453321443|FG001|Overall Study|Pregnancy|0|||
126427290|NCT03084796|454860488|FG002|Overall Study|Protocol Violation|1|||
126427291|NCT03084796|454860489|FG003|Overall Study|Protocol Violation|0|||
126427292|NCT03084796|454860490|FG004|Overall Study|Protocol Violation|1|||
126007628|NCT03761784|453321442|FG000|Overall Study|Protocol Violation|2|||
126007629|NCT03761784|453321443|FG001|Overall Study|Protocol Violation|0|||
126007630|NCT03761784|453321442|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
126209497|NCT03110107|454055402|FG009|Treatment Period|Adverse Event|1|||
126427293|NCT03084796|454860491|FG005|Overall Study|Protocol Violation|1|||
126427294|NCT03084796|454860486|FG000|Overall Study|Lack of Efficacy|0|||
126427295|NCT03084796|454860487|FG001|Overall Study|Lack of Efficacy|0|||
126427296|NCT03084796|454860488|FG002|Overall Study|Lack of Efficacy|1|||
126427297|NCT03084796|454860489|FG003|Overall Study|Lack of Efficacy|0|||
126427298|NCT03084796|454860490|FG004|Overall Study|Lack of Efficacy|1|||
126427299|NCT03084796|454860491|FG005|Overall Study|Lack of Efficacy|0|||
126209498|NCT03110107|454055403|FG010|Treatment Period|Adverse Event|0|||
126427300|NCT03084796|454860486|FG000|Overall Study|Lost to Follow-up|0|||
126427301|NCT03084796|454860487|FG001|Overall Study|Lost to Follow-up|0|||
126427302|NCT03084796|454860488|FG002|Overall Study|Lost to Follow-up|1|||
126342120|NCT02065557|454548787|FG005|Maintenance Period|Subject Non-Compliance|1|||
126342121|NCT00250588|454548788|FG000|Overall Study|Withdrawal by Subject|3|||
126342122|NCT00250588|454548789|FG001|Overall Study|Withdrawal by Subject|6|||
126342123|NCT00250588|454548790|FG002|Overall Study|Withdrawal by Subject|0|||
126342124|NCT00250588|454548788|FG000|Overall Study|Lost to Follow-up|6|||
126342125|NCT00250588|454548789|FG001|Overall Study|Lost to Follow-up|13|||
126342126|NCT00250588|454548790|FG002|Overall Study|Lost to Follow-up|13|||
126342127|NCT00706797|454548791|FG000|Overall Study|Lack of Efficacy|3|||
126342128|NCT00706797|454548792|FG001|Overall Study|Lack of Efficacy|0|||
126342129|NCT00706797|454548791|FG000|Overall Study|Adverse Event|0|||
126342130|NCT00706797|454548792|FG001|Overall Study|Adverse Event|3|||
126007631|NCT03761784|453321443|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
126007632|NCT03761784|453321442|FG000|Overall Study|Withdrawal by Subject|9|||
126007633|NCT03761784|453321443|FG001|Overall Study|Withdrawal by Subject|4|||
126007634|NCT03761784|453321442|FG000|Overall Study|Physician Decision|1|||
126342131|NCT00706797|454548791|FG000|Overall Study|Withdrawal by Subject|8|||
126342132|NCT00706797|454548792|FG001|Overall Study|Withdrawal by Subject|1|||
126342133|NCT00706797|454548791|FG000|Overall Study|Death|1|||
126342134|NCT00706797|454548792|FG001|Overall Study|Death|0|||
126342135|NCT00706797|454548791|FG000|Overall Study|Discontinuation of study by sponsor|52|||
126342136|NCT00706797|454548792|FG001|Overall Study|Discontinuation of study by sponsor|63|||
126342137|NCT00706797|454548791|FG000|Overall Study|Protocol Violation|3|||
126342138|NCT00706797|454548792|FG001|Overall Study|Protocol Violation|2|||
126342139|NCT00706797|454548791|FG000|Overall Study|Lost to Follow-up|1|||
126342140|NCT00706797|454548792|FG001|Overall Study|Lost to Follow-up|2|||
126342141|NCT00706797|454548791|FG000|Overall Study|Other|1|||
126342142|NCT00706797|454548792|FG001|Overall Study|Other|0|||
126342143|NCT00485303|454548796|FG000|Overall Study|Adverse Event|5|||
126342144|NCT00485303|454548796|FG000|Overall Study|Progressive Disease|44|||
126342145|NCT00485303|454548796|FG000|Overall Study|Other|3|||
126342146|NCT00485303|454548796|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
126342147|NCT00485303|454548796|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
126342148|NCT02147626|454548798|FG000|Overall Study|Lost to Follow-up|4|||
126342149|NCT02147626|454548799|FG001|Overall Study|Lost to Follow-up|4|||
126342150|NCT02147626|454548798|FG000|Overall Study|Pregnancy|1|||
126342151|NCT02147626|454548799|FG001|Overall Study|Pregnancy|2|||
126342152|NCT02147626|454548798|FG000|Overall Study|Withdrawal by Subject|0|||
126342153|NCT02147626|454548799|FG001|Overall Study|Withdrawal by Subject|1|||
126342154|NCT00572832|454548801|FG000|Overall Study|Lost to Follow-up|0|||
126342155|NCT00572832|454548802|FG001|Overall Study|Lost to Follow-up|11|||
126342156|NCT00572832|454548801|FG000|Overall Study|Pregnancy|0|||
126342157|NCT00572832|454548802|FG001|Overall Study|Pregnancy|1|||
126342158|NCT03704064|454548807|FG000|Overall Study|Lost to Follow-up|8|||
126342159|NCT03704064|454548808|FG001|Overall Study|Lost to Follow-up|4|||
126342160|NCT03704064|454548807|FG000|Overall Study|Withdrawal by Subject|1|||
126342161|NCT03704064|454548808|FG001|Overall Study|Withdrawal by Subject|1|||
126342162|NCT03704064|454548807|FG000|Overall Study|No longer available for study visits|0|||
126342163|NCT03704064|454548808|FG001|Overall Study|No longer available for study visits|1|||
126342164|NCT03704064|454548807|FG000|Overall Study|Censoring event|1|||
126342165|NCT03704064|454548808|FG001|Overall Study|Censoring event|0|||
126007635|NCT03761784|453321443|FG001|Overall Study|Physician Decision|0|||
126007636|NCT03761784|453321442|FG000|Overall Study|Other Than Specified|1|||
126007637|NCT03761784|453321443|FG001|Overall Study|Other Than Specified|0|||
126007638|NCT00586339|453321444|FG000|Overall Study|Withdrawal by Subject|1|||
126007639|NCT00586339|453321445|FG001|Overall Study|Withdrawal by Subject|3|||
126007640|NCT00586339|453321446|FG002|Overall Study|Withdrawal by Subject|1|||
126007641|NCT00586339|453321444|FG000|Overall Study|Migrated/moved from study area|3|||
126007642|NCT00586339|453321445|FG001|Overall Study|Migrated/moved from study area|2|||
126342166|NCT00289276|454548811|FG000|Second Part of FAST Study (Expansion)|Death|0|||
126342167|NCT00289276|454548812|FG001|Second Part of FAST Study (Expansion)|Death|2|||
126342168|NCT00289276|454548811|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
126342169|NCT00289276|454548812|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
126342170|NCT02029417|454548813|FG000|Overall Study|Death|1|||
126342171|NCT02029417|454548813|FG000|Overall Study|Adverse Event|1|||
126342172|NCT02783911|454548814|FG000|Overall Study|Lost to Follow-up|3|||
126342173|NCT02783911|454548815|FG001|Overall Study|Lost to Follow-up|32|||
126342174|NCT01041859|454548818|FG000|Open-Label Titration|Adverse Event|69|||
126342175|NCT01041859|454548819|FG001|Open-Label Titration|Adverse Event|0|||
126342176|NCT01041859|454548820|FG002|Open-Label Titration|Adverse Event|0|||
126342177|NCT01041859|454548818|FG000|Open-Label Titration|Lack of Efficacy|3|||
126342178|NCT01041859|454548819|FG001|Open-Label Titration|Lack of Efficacy|0|||
126007643|NCT00586339|453321446|FG002|Overall Study|Migrated/moved from study area|4|||
126007644|NCT00586339|453321444|FG000|Overall Study|Lost to Follow-up|3|||
126342179|NCT01041859|454548820|FG002|Open-Label Titration|Lack of Efficacy|0|||
126007645|NCT00586339|453321445|FG001|Overall Study|Lost to Follow-up|2|||
126342180|NCT01041859|454548818|FG000|Open-Label Titration|Lost to Follow-up|1|||
126342181|NCT01041859|454548819|FG001|Open-Label Titration|Lost to Follow-up|0|||
126427303|NCT03084796|454860489|FG003|Overall Study|Lost to Follow-up|1|||
126427304|NCT03084796|454860490|FG004|Overall Study|Lost to Follow-up|3|||
126427305|NCT03084796|454860491|FG005|Overall Study|Lost to Follow-up|1|||
126427306|NCT03084796|454860486|FG000|Overall Study|Randomization error|0|||
126427307|NCT03084796|454860487|FG001|Overall Study|Randomization error|0|||
126427308|NCT03084796|454860488|FG002|Overall Study|Randomization error|1|||
126427309|NCT03084796|454860489|FG003|Overall Study|Randomization error|0|||
126427310|NCT03084796|454860490|FG004|Overall Study|Randomization error|0|||
126427311|NCT03084796|454860491|FG005|Overall Study|Randomization error|0|||
126427312|NCT05470985|454860492|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
126427313|NCT05470985|454860493|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
126427314|NCT05470985|454860492|FG000|Double Blind Treatment Period|Physician Decision|0|||
126427315|NCT05470985|454860493|FG001|Double Blind Treatment Period|Physician Decision|1|||
126427316|NCT05470985|454860492|FG000|Long Term Extension|Adverse Event|0|||
126427317|NCT05470985|454860493|FG001|Long Term Extension|Adverse Event|1|||
126427318|NCT05470985|454860492|FG000|Long Term Extension|Study terminated by sponsor|2|||
126427319|NCT05470985|454860493|FG001|Long Term Extension|Study terminated by sponsor|0|||
126427320|NCT01917747|454860494|FG000|Overall Study|Withdrawal by Subject|1|||
126427321|NCT01917747|454860495|FG001|Overall Study|Withdrawal by Subject|2|||
126427322|NCT01917747|454860494|FG000|Overall Study|Lost to Follow-up|18|||
126427323|NCT01917747|454860495|FG001|Overall Study|Lost to Follow-up|9|||
126427324|NCT02741245|454860496|FG000|Overall Study|Adverse Event|0|||
126427325|NCT02741245|454860497|FG001|Overall Study|Adverse Event|0|||
126427326|NCT02741245|454860498|FG002|Overall Study|Adverse Event|0|||
126427327|NCT02741245|454860499|FG003|Overall Study|Adverse Event|2|||
126427328|NCT02741245|454860500|FG004|Overall Study|Adverse Event|2|||
126427329|NCT02741245|454860496|FG000|Overall Study|Protocol Violation|0|||
126427330|NCT02741245|454860497|FG001|Overall Study|Protocol Violation|1|||
126427331|NCT02741245|454860498|FG002|Overall Study|Protocol Violation|0|||
126427332|NCT02741245|454860499|FG003|Overall Study|Protocol Violation|1|||
126427333|NCT02741245|454860500|FG004|Overall Study|Protocol Violation|0|||
126427334|NCT02741245|454860496|FG000|Overall Study|Withdrawal by Subject|0|||
126427335|NCT02741245|454860497|FG001|Overall Study|Withdrawal by Subject|0|||
126427336|NCT02741245|454860498|FG002|Overall Study|Withdrawal by Subject|0|||
126427337|NCT02741245|454860499|FG003|Overall Study|Withdrawal by Subject|1|||
126427338|NCT02741245|454860500|FG004|Overall Study|Withdrawal by Subject|0|||
126427339|NCT00152503|454860503|FG000|Overall Study|Adverse Event|4|||
126427340|NCT02922725|454860504|FG000|Overall Study|Withdrawal by Subject|1|||
126427341|NCT02922725|454860505|FG001|Overall Study|Withdrawal by Subject|0|||
126427342|NCT02922725|454860506|FG002|Overall Study|Withdrawal by Subject|0|||
126427343|NCT01300234|454860507|FG000|Overall Study|Adverse Event|1|||
126427344|NCT01300234|454860508|FG001|Overall Study|Adverse Event|1|||
126427345|NCT01300234|454860507|FG000|Overall Study|Protocol Violation|2|||
126427346|NCT01300234|454860508|FG001|Overall Study|Protocol Violation|3|||
126427347|NCT01300234|454860507|FG000|Overall Study|Withdrawal by Subject|5|||
126427348|NCT01300234|454860508|FG001|Overall Study|Withdrawal by Subject|9|||
126427349|NCT01300234|454860507|FG000|Overall Study|Lost to Follow-up|14|||
126427350|NCT01300234|454860508|FG001|Overall Study|Lost to Follow-up|12|||
126427351|NCT01300234|454860507|FG000|Overall Study|Pregnancy|2|||
126427352|NCT01300234|454860508|FG001|Overall Study|Pregnancy|1|||
126427353|NCT01300234|454860507|FG000|Overall Study|Participant reached stopping critera|2|||
126427354|NCT01300234|454860508|FG001|Overall Study|Participant reached stopping critera|0|||
126427355|NCT01300234|454860507|FG000|Overall Study|Participant stopped medication|1|||
126427356|NCT01300234|454860508|FG001|Overall Study|Participant stopped medication|1|||
126427357|NCT01300234|454860507|FG000|Overall Study|Participant refused return to hospital|1|||
126427358|NCT01300234|454860508|FG001|Overall Study|Participant refused return to hospital|0|||
126427359|NCT03253679|454860509|FG000|Overall Study|Screen Failure|1|||
126427360|NCT04816214|454860510|FG000|Overall Study|Progressive Disease|4|||
126427361|NCT04816214|454860511|FG001|Overall Study|Progressive Disease|0|||
126007646|NCT00586339|453321446|FG002|Overall Study|Lost to Follow-up|1|||
126007647|NCT00197236|453321451|FG000|Overall Study|Adverse Event|1|||
126007648|NCT00197236|453321452|FG001|Overall Study|Adverse Event|0|||
126007649|NCT00197236|453321453|FG002|Overall Study|Adverse Event|1|||
126007650|NCT00197236|453321451|FG000|Overall Study|Lost to Follow-up|5|||
126427362|NCT04816214|454860512|FG002|Overall Study|Progressive Disease|0|||
126427363|NCT04816214|454860510|FG000|Overall Study|Death|1|||
126427364|NCT04816214|454860511|FG001|Overall Study|Death|0|||
126427365|NCT04816214|454860512|FG002|Overall Study|Death|0|||
126427366|NCT04816214|454860510|FG000|Overall Study|Study Terminated by Sponsor|1|||
126427367|NCT04816214|454860511|FG001|Overall Study|Study Terminated by Sponsor|0|||
126427368|NCT04816214|454860512|FG002|Overall Study|Study Terminated by Sponsor|0|||
126427369|NCT00584415|454860513|FG000|Overall Study|Adverse Event|7|||
126427370|NCT01928927|454860514|FG000|Overall Study|Lost to Follow-up|1|||
126427371|NCT01928927|454860515|FG001|Overall Study|Lost to Follow-up|0|||
126427372|NCT01928927|454860514|FG000|Overall Study|Withdrawal by Subject|1|||
126427373|NCT01928927|454860515|FG001|Overall Study|Withdrawal by Subject|1|||
126427374|NCT04958785|454862178|FG000|Overall Study|Study Terminated by Sponsor|4|||
126427375|NCT04958785|454862179|FG001|Overall Study|Study Terminated by Sponsor|10|||
126427376|NCT04958785|454862180|FG002|Overall Study|Study Terminated by Sponsor|7|||
126427377|NCT04958785|454862181|FG003|Overall Study|Study Terminated by Sponsor|6|||
126427378|NCT04958785|454862182|FG004|Overall Study|Study Terminated by Sponsor|34|||
126427379|NCT04958785|454862178|FG000|Overall Study|Death|2|||
126427380|NCT04958785|454862179|FG001|Overall Study|Death|3|||
126427381|NCT04958785|454862180|FG002|Overall Study|Death|4|||
126427382|NCT04958785|454862181|FG003|Overall Study|Death|5|||
126427383|NCT04958785|454862182|FG004|Overall Study|Death|5|||
126427384|NCT04958785|454862178|FG000|Overall Study|Withdrew consent|2|||
126427385|NCT04958785|454862179|FG001|Overall Study|Withdrew consent|0|||
126427386|NCT04958785|454862180|FG002|Overall Study|Withdrew consent|3|||
126427387|NCT04958785|454862181|FG003|Overall Study|Withdrew consent|1|||
126427388|NCT04958785|454862182|FG004|Overall Study|Withdrew consent|0|||
126427389|NCT04958785|454862178|FG000|Overall Study|Investigator's discretion|0|||
126427390|NCT04958785|454862179|FG001|Overall Study|Investigator's discretion|1|||
126427391|NCT04958785|454862180|FG002|Overall Study|Investigator's discretion|0|||
126427392|NCT04958785|454862181|FG003|Overall Study|Investigator's discretion|1|||
126427393|NCT04958785|454862182|FG004|Overall Study|Investigator's discretion|2|||
126427394|NCT04958785|454862178|FG000|Overall Study|Adverse Event|0|||
126427395|NCT04958785|454862179|FG001|Overall Study|Adverse Event|0|||
126427396|NCT04958785|454862180|FG002|Overall Study|Adverse Event|0|||
126427397|NCT04958785|454862181|FG003|Overall Study|Adverse Event|0|||
126427398|NCT04958785|454862182|FG004|Overall Study|Adverse Event|1|||
126427399|NCT04958785|454862178|FG000|Overall Study|Lost to Follow-up|0|||
126427400|NCT04958785|454862179|FG001|Overall Study|Lost to Follow-up|0|||
126007651|NCT00197236|453321452|FG001|Overall Study|Lost to Follow-up|14|||
126007652|NCT00197236|453321453|FG002|Overall Study|Lost to Follow-up|6|||
126007653|NCT00197236|453321451|FG000|Overall Study|Protocol Violation|0|||
126007654|NCT00197236|453321452|FG001|Overall Study|Protocol Violation|0|||
126007655|NCT00197236|453321453|FG002|Overall Study|Protocol Violation|1|||
126007656|NCT00197236|453321451|FG000|Overall Study|Withdrawal by Subject|7|||
126007657|NCT00197236|453321452|FG001|Overall Study|Withdrawal by Subject|3|||
126007658|NCT00197236|453321453|FG002|Overall Study|Withdrawal by Subject|11|||
126007659|NCT00197236|453321451|FG000|Overall Study|Study drug/medication expiration|1|||
126007660|NCT00197236|453321452|FG001|Overall Study|Study drug/medication expiration|0|||
126007661|NCT00197236|453321453|FG002|Overall Study|Study drug/medication expiration|3|||
126007662|NCT00197236|453321451|FG000|Overall Study|Returned out of specified time window|0|||
126007663|NCT00197236|453321452|FG001|Overall Study|Returned out of specified time window|0|||
126007664|NCT00197236|453321453|FG002|Overall Study|Returned out of specified time window|1|||
126007665|NCT00746330|453321454|FG000|Period 1|Abnormal test procedure result|0|||
126007666|NCT00746330|453321455|FG001|Period 1|Abnormal test procedure result|0|||
126007667|NCT00746330|453321456|FG002|Period 1|Abnormal test procedure result|1|||
126007668|NCT00746330|453321457|FG003|Period 1|Abnormal test procedure result|0|||
126007669|NCT01981850|453321458|FG000|Main Phase Stage 1|Death|2|||
126007670|NCT01981850|453321459|FG001|Main Phase Stage 1|Death|0|||
126007671|NCT01981850|453321460|FG002|Main Phase Stage 1|Death|0|||
126007672|NCT01981850|453321461|FG003|Main Phase Stage 1|Death|0|||
126007673|NCT01981850|453321462|FG004|Main Phase Stage 1|Death|0|||
126007674|NCT01981850|453321463|FG005|Main Phase Stage 1|Death|0|||
126007675|NCT01981850|453321464|FG006|Main Phase Stage 1|Death|0|||
126007676|NCT01981850|453321465|FG007|Main Phase Stage 1|Death|0|||
126007677|NCT01981850|453321466|FG008|Main Phase Stage 1|Death|0|||
126007678|NCT01981850|453321467|FG009|Main Phase Stage 1|Death|0|||
126007679|NCT01981850|453321458|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
126007680|NCT01981850|453321459|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007681|NCT01981850|453321460|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007682|NCT01981850|453321461|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007683|NCT01981850|453321462|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007684|NCT01981850|453321463|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007685|NCT01981850|453321464|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007686|NCT01981850|453321465|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007687|NCT01981850|453321466|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007688|NCT01981850|453321467|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126007689|NCT01981850|453321458|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
126007690|NCT01981850|453321459|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
126007691|NCT01981850|453321460|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
126209499|NCT03110107|454055404|FG011|Treatment Period|Adverse Event|0|||
126209500|NCT03110107|454055405|FG012|Treatment Period|Adverse Event|0|||
126427401|NCT04958785|454862180|FG002|Overall Study|Lost to Follow-up|0|||
126427402|NCT04958785|454862181|FG003|Overall Study|Lost to Follow-up|0|||
126427403|NCT04958785|454862182|FG004|Overall Study|Lost to Follow-up|1|||
126427404|NCT02079740|454862183|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
126427405|NCT02079740|454862184|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
126427406|NCT02079740|454862185|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
126427407|NCT02079740|454862186|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
126427408|NCT02079740|454862187|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
126427409|NCT02079740|454862188|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
126427410|NCT02079740|454862189|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
126427411|NCT02079740|454862190|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
126427412|NCT02079740|454862191|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
126427413|NCT02079740|454862192|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
126427414|NCT02079740|454862193|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
126427415|NCT02079740|454862194|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
126427416|NCT02079740|454862195|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
126427417|NCT02079740|454862183|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
126427418|NCT02079740|454862184|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
126427419|NCT02079740|454862185|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
126427420|NCT02079740|454862186|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
126427421|NCT02079740|454862187|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
126427422|NCT02079740|454862188|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
126427423|NCT02079740|454862189|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
126427424|NCT02079740|454862190|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
126427425|NCT02079740|454862191|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
126427426|NCT02079740|454862192|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
126427427|NCT02079740|454862193|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
126427428|NCT02079740|454862194|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
126427429|NCT02079740|454862195|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
126427430|NCT02079740|454862183|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427431|NCT02079740|454862184|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427432|NCT02079740|454862185|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427433|NCT02079740|454862186|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427434|NCT02079740|454862187|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427435|NCT02079740|454862188|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427436|NCT02079740|454862189|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427437|NCT02079740|454862190|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
126427438|NCT02079740|454862191|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427439|NCT02079740|454862192|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427440|NCT02079740|454862193|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427441|NCT02079740|454862194|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427442|NCT02079740|454862195|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427443|NCT02079740|454862183|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427444|NCT02079740|454862184|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427445|NCT02079740|454862185|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427446|NCT02079740|454862186|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427447|NCT02079740|454862187|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427448|NCT02079740|454862188|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427449|NCT02079740|454862189|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427450|NCT02079740|454862190|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
126427451|NCT02079740|454862191|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427452|NCT02079740|454862192|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427453|NCT02079740|454862193|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427454|NCT02079740|454862194|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427455|NCT02079740|454862195|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427456|NCT02079740|454862183|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427457|NCT02079740|454862184|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427458|NCT02079740|454862185|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427459|NCT02079740|454862186|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126007692|NCT01981850|453321461|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
126427460|NCT02079740|454862187|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427461|NCT02079740|454862188|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427462|NCT02079740|454862189|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427463|NCT02079740|454862190|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427464|NCT02079740|454862191|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427465|NCT02079740|454862192|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
126007693|NCT01981850|453321462|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
126007694|NCT01981850|453321463|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
126007695|NCT01981850|453321464|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
126427466|NCT02079740|454862193|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427467|NCT02079740|454862194|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
126427468|NCT02079740|454862195|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
126427469|NCT00587561|454862196|FG000|Overall Study|Lost to Follow-up|6|||
126007696|NCT01981850|453321465|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
126427470|NCT00587561|454862197|FG001|Overall Study|Lost to Follow-up|4|||
126427471|NCT03493945|454862199|FG000|Phase I Dose Escalation|Ineligible|0|||
126427472|NCT03493945|454862200|FG001|Phase I Dose Escalation|Ineligible|0|||
126427473|NCT03493945|454862201|FG002|Phase I Dose Escalation|Ineligible|1|||
126427474|NCT03493945|454862202|FG003|Phase I Dose Escalation|Ineligible|0|||
126007697|NCT01981850|453321466|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
126007698|NCT01981850|453321467|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
126007699|NCT01981850|453321458|FG000|Main Phase Stage 1|Various reasons|0|||
126007700|NCT01981850|453321459|FG001|Main Phase Stage 1|Various reasons|0|||
126007701|NCT01981850|453321460|FG002|Main Phase Stage 1|Various reasons|2|||
126007702|NCT01981850|453321461|FG003|Main Phase Stage 1|Various reasons|0|||
126007703|NCT01981850|453321462|FG004|Main Phase Stage 1|Various reasons|0|||
126007704|NCT01981850|453321463|FG005|Main Phase Stage 1|Various reasons|0|||
126007705|NCT01981850|453321464|FG006|Main Phase Stage 1|Various reasons|0|||
126007706|NCT01981850|453321465|FG007|Main Phase Stage 1|Various reasons|0|||
126007707|NCT01981850|453321466|FG008|Main Phase Stage 1|Various reasons|0|||
126007708|NCT01981850|453321467|FG009|Main Phase Stage 1|Various reasons|0|||
126007709|NCT01981850|453321458|FG000|Main Phase Stage 2|Adverse Event|0|||
126007710|NCT01981850|453321459|FG001|Main Phase Stage 2|Adverse Event|0|||
126007711|NCT01981850|453321460|FG002|Main Phase Stage 2|Adverse Event|0|||
126007712|NCT01981850|453321461|FG003|Main Phase Stage 2|Adverse Event|0|||
126342182|NCT01041859|454548820|FG002|Open-Label Titration|Lost to Follow-up|0|||
126342183|NCT01041859|454548818|FG000|Open-Label Titration|Physician Decision|1|||
126342184|NCT01041859|454548819|FG001|Open-Label Titration|Physician Decision|0|||
126342185|NCT01041859|454548820|FG002|Open-Label Titration|Physician Decision|0|||
126342186|NCT01041859|454548818|FG000|Open-Label Titration|Protocol Violation|1|||
126342187|NCT01041859|454548819|FG001|Open-Label Titration|Protocol Violation|0|||
126342188|NCT01041859|454548820|FG002|Open-Label Titration|Protocol Violation|0|||
126342189|NCT01041859|454548818|FG000|Open-Label Titration|Other|7|||
126342190|NCT01041859|454548819|FG001|Open-Label Titration|Other|0|||
126342191|NCT01041859|454548820|FG002|Open-Label Titration|Other|0|||
126342192|NCT01041859|454548818|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
126342193|NCT01041859|454548819|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
126342194|NCT01041859|454548820|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
126342195|NCT01041859|454548818|FG000|Open-Label Titration|Withdrawal by Subject|11|||
126342196|NCT01041859|454548819|FG001|Open-Label Titration|Withdrawal by Subject|0|||
126342197|NCT01041859|454548820|FG002|Open-Label Titration|Withdrawal by Subject|0|||
126342198|NCT01041859|454548818|FG000|Double-Blind Maintenance|Adverse Event|0|||
126342199|NCT01041859|454548819|FG001|Double-Blind Maintenance|Adverse Event|23|||
126342200|NCT01041859|454548820|FG002|Double-Blind Maintenance|Adverse Event|13|||
126342201|NCT01041859|454548818|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
126342202|NCT01041859|454548819|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
126342203|NCT01041859|454548820|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
126342204|NCT01041859|454548818|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
126342205|NCT01041859|454548819|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
126342206|NCT01041859|454548820|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
126342207|NCT01041859|454548818|FG000|Double-Blind Maintenance|Physician Decision|0|||
126342208|NCT01041859|454548819|FG001|Double-Blind Maintenance|Physician Decision|2|||
126342209|NCT01041859|454548820|FG002|Double-Blind Maintenance|Physician Decision|1|||
126342210|NCT01041859|454548818|FG000|Double-Blind Maintenance|Protocol Violation|0|||
126342211|NCT01041859|454548819|FG001|Double-Blind Maintenance|Protocol Violation|1|||
126342212|NCT01041859|454548820|FG002|Double-Blind Maintenance|Protocol Violation|3|||
126342213|NCT01041859|454548818|FG000|Double-Blind Maintenance|Other|0|||
126342214|NCT01041859|454548819|FG001|Double-Blind Maintenance|Other|6|||
126342215|NCT01041859|454548820|FG002|Double-Blind Maintenance|Other|2|||
126342216|NCT01041859|454548818|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
126342217|NCT01041859|454548819|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
126342218|NCT01041859|454548820|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
126342219|NCT01041859|454548818|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
126342220|NCT01041859|454548819|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
126342221|NCT01041859|454548820|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
126342222|NCT02908347|454548826|FG000|Overall Study|Adverse Event|0|||
126342223|NCT02908347|454548827|FG001|Overall Study|Adverse Event|1|||
126342224|NCT02908347|454548826|FG000|Overall Study|Lost to Follow-up|1|||
126342225|NCT02908347|454548827|FG001|Overall Study|Lost to Follow-up|0|||
126342226|NCT00885118|454548828|FG000|Overall Study|Adverse Event|1|||
126342227|NCT00885118|454548829|FG001|Overall Study|Adverse Event|0|||
126342228|NCT00885118|454548830|FG002|Overall Study|Adverse Event|0|||
126342229|NCT00885118|454548831|FG003|Overall Study|Adverse Event|0|||
126342230|NCT00885118|454548832|FG004|Overall Study|Adverse Event|0|||
126342231|NCT00885118|454548828|FG000|Overall Study|Withdrawal by Subject|0|||
126342232|NCT00885118|454548829|FG001|Overall Study|Withdrawal by Subject|0|||
126342233|NCT00885118|454548830|FG002|Overall Study|Withdrawal by Subject|0|||
126342234|NCT00885118|454548831|FG003|Overall Study|Withdrawal by Subject|0|||
126342235|NCT00885118|454548832|FG004|Overall Study|Withdrawal by Subject|1|||
126342236|NCT00885118|454548828|FG000|Overall Study|Other reason not defined above|0|||
126007713|NCT01981850|453321462|FG004|Main Phase Stage 2|Adverse Event|6|||
126007714|NCT01981850|453321463|FG005|Main Phase Stage 2|Adverse Event|5|||
126007715|NCT01981850|453321464|FG006|Main Phase Stage 2|Adverse Event|7|||
126427475|NCT03493945|454862203|FG004|Phase I Dose Escalation|Ineligible|0|||
126427476|NCT03493945|454862204|FG005|Phase I Dose Escalation|Ineligible|0|||
126427477|NCT03493945|454862205|FG006|Phase I Dose Escalation|Ineligible|0|||
126427478|NCT03493945|454862199|FG000|Phase I Dose Escalation|New therapy|0|||
126427479|NCT03493945|454862200|FG001|Phase I Dose Escalation|New therapy|1|||
126427480|NCT03493945|454862201|FG002|Phase I Dose Escalation|New therapy|0|||
126427481|NCT03493945|454862202|FG003|Phase I Dose Escalation|New therapy|0|||
126427482|NCT03493945|454862203|FG004|Phase I Dose Escalation|New therapy|0|||
126427483|NCT03493945|454862204|FG005|Phase I Dose Escalation|New therapy|0|||
126007716|NCT01981850|453321465|FG007|Main Phase Stage 2|Adverse Event|0|||
126007717|NCT01981850|453321466|FG008|Main Phase Stage 2|Adverse Event|0|||
126007718|NCT01981850|453321467|FG009|Main Phase Stage 2|Adverse Event|0|||
126007719|NCT01981850|453321458|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126007720|NCT01981850|453321459|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126007721|NCT01981850|453321460|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126007722|NCT01981850|453321461|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126007723|NCT01981850|453321462|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
126007724|NCT01981850|453321463|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
126427484|NCT03493945|454862205|FG006|Phase I Dose Escalation|New therapy|0|||
126427485|NCT03493945|454862199|FG000|Phase II Dose Expansion|Refused further treatment|0|||
126427486|NCT03493945|454862200|FG001|Phase II Dose Expansion|Refused further treatment|0|||
126427487|NCT03493945|454862201|FG002|Phase II Dose Expansion|Refused further treatment|0|||
126427488|NCT03493945|454862202|FG003|Phase II Dose Expansion|Refused further treatment|0|||
126427489|NCT03493945|454862203|FG004|Phase II Dose Expansion|Refused further treatment|1|||
126427490|NCT03493945|454862204|FG005|Phase II Dose Expansion|Refused further treatment|1|||
126427491|NCT03493945|454862205|FG006|Phase II Dose Expansion|Refused further treatment|0|||
126007725|NCT01981850|453321464|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
126007726|NCT01981850|453321465|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126007727|NCT01981850|453321466|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126007728|NCT01981850|453321467|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126007729|NCT01981850|453321458|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
126007730|NCT01981850|453321459|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
126007731|NCT01981850|453321460|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
126007732|NCT01981850|453321461|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
126007733|NCT01981850|453321462|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
126007734|NCT01981850|453321463|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
126007735|NCT01981850|453321464|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
126007736|NCT01981850|453321465|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
126007737|NCT01981850|453321466|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
126007738|NCT01981850|453321467|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
126007739|NCT01981850|453321458|FG000|Main Phase Stage 2|Various reasons|0|||
126007740|NCT01981850|453321459|FG001|Main Phase Stage 2|Various reasons|0|||
126007741|NCT01981850|453321460|FG002|Main Phase Stage 2|Various reasons|0|||
126007742|NCT01981850|453321461|FG003|Main Phase Stage 2|Various reasons|0|||
126007743|NCT01981850|453321462|FG004|Main Phase Stage 2|Various reasons|2|||
126007744|NCT01981850|453321463|FG005|Main Phase Stage 2|Various reasons|0|||
126007745|NCT01981850|453321464|FG006|Main Phase Stage 2|Various reasons|1|||
126007746|NCT01981850|453321465|FG007|Main Phase Stage 2|Various reasons|0|||
126007747|NCT01981850|453321466|FG008|Main Phase Stage 2|Various reasons|0|||
126007748|NCT01981850|453321467|FG009|Main Phase Stage 2|Various reasons|0|||
126007749|NCT01981850|453321458|FG000|Main Phase Stage 2|Progressive Disease|0|||
126007750|NCT01981850|453321459|FG001|Main Phase Stage 2|Progressive Disease|0|||
126007751|NCT01981850|453321460|FG002|Main Phase Stage 2|Progressive Disease|0|||
126007752|NCT01981850|453321461|FG003|Main Phase Stage 2|Progressive Disease|0|||
126007753|NCT01981850|453321462|FG004|Main Phase Stage 2|Progressive Disease|0|||
126007754|NCT01981850|453321463|FG005|Main Phase Stage 2|Progressive Disease|6|||
126007755|NCT01981850|453321464|FG006|Main Phase Stage 2|Progressive Disease|6|||
126007756|NCT01981850|453321465|FG007|Main Phase Stage 2|Progressive Disease|0|||
126007757|NCT01981850|453321466|FG008|Main Phase Stage 2|Progressive Disease|0|||
126007758|NCT01981850|453321467|FG009|Main Phase Stage 2|Progressive Disease|0|||
126007759|NCT01981850|453321458|FG000|Open Label Extension (OLE)|Adverse Event|0|||
126007760|NCT01981850|453321459|FG001|Open Label Extension (OLE)|Adverse Event|0|||
126007761|NCT01981850|453321460|FG002|Open Label Extension (OLE)|Adverse Event|0|||
126007762|NCT01981850|453321461|FG003|Open Label Extension (OLE)|Adverse Event|0|||
126007763|NCT01981850|453321462|FG004|Open Label Extension (OLE)|Adverse Event|0|||
126007764|NCT01981850|453321463|FG005|Open Label Extension (OLE)|Adverse Event|0|||
126007765|NCT01981850|453321464|FG006|Open Label Extension (OLE)|Adverse Event|0|||
126007766|NCT01981850|453321465|FG007|Open Label Extension (OLE)|Adverse Event|2|||
126007767|NCT01981850|453321466|FG008|Open Label Extension (OLE)|Adverse Event|1|||
126046457|NCT02467270|453468228|FG002|Overall Study|Progressive Disease|4|||
126427492|NCT03493945|454862199|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427493|NCT03493945|454862200|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427494|NCT03493945|454862201|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427495|NCT03493945|454862202|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
126007768|NCT01981850|453321467|FG009|Open Label Extension (OLE)|Adverse Event|8|||
126007769|NCT01981850|453321458|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
126007770|NCT01981850|453321459|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
126007771|NCT01981850|453321460|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
126007772|NCT01981850|453321461|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
126007773|NCT01981850|453321462|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
126007774|NCT01981850|453321463|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
126007775|NCT01981850|453321464|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
126007776|NCT01981850|453321465|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
126007777|NCT01981850|453321466|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
126007778|NCT01981850|453321467|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
126007779|NCT01981850|453321458|FG000|Open Label Extension (OLE)|Various reasons|0|||
126007780|NCT01981850|453321459|FG001|Open Label Extension (OLE)|Various reasons|0|||
126007781|NCT01981850|453321460|FG002|Open Label Extension (OLE)|Various reasons|0|||
126007782|NCT01981850|453321461|FG003|Open Label Extension (OLE)|Various reasons|0|||
126007783|NCT01981850|453321462|FG004|Open Label Extension (OLE)|Various reasons|0|||
126007784|NCT01981850|453321463|FG005|Open Label Extension (OLE)|Various reasons|0|||
126007785|NCT01981850|453321464|FG006|Open Label Extension (OLE)|Various reasons|0|||
126007786|NCT01981850|453321465|FG007|Open Label Extension (OLE)|Various reasons|3|||
126007787|NCT01981850|453321466|FG008|Open Label Extension (OLE)|Various reasons|1|||
126007788|NCT01981850|453321467|FG009|Open Label Extension (OLE)|Various reasons|3|||
126007789|NCT01981850|453321458|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
126007790|NCT01981850|453321459|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
126007791|NCT01981850|453321460|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
126007792|NCT01981850|453321461|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
126007793|NCT01981850|453321462|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
126007794|NCT01981850|453321463|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
126007795|NCT01981850|453321464|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
126007796|NCT01981850|453321465|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
126007797|NCT01981850|453321466|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
126007798|NCT01981850|453321467|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
126007799|NCT01981850|453321458|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007800|NCT01981850|453321459|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007801|NCT01981850|453321460|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007802|NCT01981850|453321461|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007803|NCT01981850|453321462|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007804|NCT01981850|453321463|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007805|NCT01981850|453321464|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007806|NCT01981850|453321465|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007807|NCT01981850|453321466|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126007808|NCT01981850|453321467|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
126007809|NCT01981850|453321458|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007810|NCT01981850|453321459|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007811|NCT01981850|453321460|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007812|NCT01981850|453321461|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007813|NCT01981850|453321462|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007814|NCT01981850|453321463|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007815|NCT01981850|453321464|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007816|NCT01981850|453321465|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007817|NCT01981850|453321466|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
126007818|NCT01981850|453321467|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
126007819|NCT02524288|453321468|FG000|Overall Study|Adverse Event|115|||
126007820|NCT02524288|453321468|FG000|Overall Study|Lost to Follow-up|216|||
126007821|NCT02524288|453321468|FG000|Overall Study|Non-Compliance With Protocol|32|||
126007822|NCT02524288|453321468|FG000|Overall Study|Non-Compliance With Study Drug|14|||
126007823|NCT02524288|453321468|FG000|Overall Study|Pregnancy Wish|6|||
126007824|NCT02524288|453321468|FG000|Overall Study|Protocol Violation|6|||
126007825|NCT02524288|453321468|FG000|Overall Study|Screen Failure|2|||
126007826|NCT02524288|453321468|FG000|Overall Study|Site Discontinued Study Participation|1|||
126007827|NCT02524288|453321468|FG000|Overall Study|Study Terminated By Sponsor|1417|||
126007828|NCT02524288|453321468|FG000|Overall Study|Subject Moved|32|||
126007829|NCT02524288|453321468|FG000|Overall Study|Withdrawal by Subject|76|||
126007830|NCT02524288|453321468|FG000|Overall Study|Pregnancy|22|||
126007831|NCT02524288|453321468|FG000|Overall Study|Physician Decision|2|||
126007832|NCT00517933|453321469|FG000|Period 1|Death|2|||
126007833|NCT00517933|453321470|FG001|Period 1|Death|1|||
126342237|NCT00885118|454548829|FG001|Overall Study|Other reason not defined above|0|||
126342238|NCT00885118|454548830|FG002|Overall Study|Other reason not defined above|1|||
126342239|NCT00885118|454548831|FG003|Overall Study|Other reason not defined above|0|||
126007834|NCT00517933|453321469|FG000|Period 1|Adverse Event|4|||
126007835|NCT00517933|453321470|FG001|Period 1|Adverse Event|4|||
126342240|NCT00885118|454548832|FG004|Overall Study|Other reason not defined above|0|||
126007836|NCT00517933|453321469|FG000|Period 1|Lost to Follow-up|2|||
126007837|NCT00517933|453321470|FG001|Period 1|Lost to Follow-up|0|||
126007838|NCT00517933|453321469|FG000|Period 1|Underwent lung transplant|0|||
126007839|NCT00517933|453321470|FG001|Period 1|Underwent lung transplant|1|||
126007840|NCT00517933|453321469|FG000|Period 2|Death|2|||
126007841|NCT00517933|453321470|FG001|Period 2|Death|4|||
126007842|NCT00517933|453321469|FG000|Period 2|Adverse Event|2|||
126007843|NCT00517933|453321470|FG001|Period 2|Adverse Event|4|||
126007844|NCT00517933|453321469|FG000|Period 2|Physician Decision|1|||
126007845|NCT00517933|453321470|FG001|Period 2|Physician Decision|0|||
126007846|NCT00517933|453321469|FG000|Period 2|Withdrawal by Subject|1|||
126007847|NCT00517933|453321470|FG001|Period 2|Withdrawal by Subject|3|||
126007848|NCT00517933|453321469|FG000|Period 2|Underwent lung transplant|0|||
126007849|NCT00517933|453321470|FG001|Period 2|Underwent lung transplant|2|||
126007850|NCT01835899|453321472|FG000|Overall Study|Adverse Event|0|||
126007851|NCT01835899|453321473|FG001|Overall Study|Adverse Event|0|||
126007852|NCT01835899|453321474|FG002|Overall Study|Adverse Event|1|||
126007853|NCT01835899|453321472|FG000|Overall Study|Other than stated above|0|||
126007854|NCT01835899|453321473|FG001|Overall Study|Other than stated above|1|||
126007855|NCT01835899|453321474|FG002|Overall Study|Other than stated above|0|||
126007856|NCT04888585|453321478|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
126007857|NCT04888585|453321479|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
126007858|NCT04888585|453321480|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
126007859|NCT04888585|453321481|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
126007860|NCT04888585|453321482|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
126007861|NCT04888585|453321483|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126007862|NCT04888585|453321484|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126007863|NCT04888585|453321485|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126007864|NCT04888585|453321486|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126007865|NCT04888585|453321487|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126007866|NCT04888585|453321488|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126007867|NCT04888585|453321478|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126007868|NCT04888585|453321479|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
126007869|NCT04888585|453321480|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
126007870|NCT04888585|453321481|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
126007871|NCT04888585|453321482|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
126007872|NCT04888585|453321483|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126007873|NCT04888585|453321484|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126007874|NCT04888585|453321485|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126007875|NCT04888585|453321486|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126007876|NCT04888585|453321487|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126007877|NCT04888585|453321488|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126007878|NCT04888585|453321478|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007879|NCT04888585|453321479|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007880|NCT04888585|453321480|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
126007881|NCT04888585|453321481|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007882|NCT04888585|453321482|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
126007883|NCT04888585|453321483|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007884|NCT04888585|453321484|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007885|NCT04888585|453321485|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007886|NCT04888585|453321486|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007887|NCT04888585|453321487|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007888|NCT04888585|453321488|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126007889|NCT04888585|453321478|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007890|NCT04888585|453321479|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007891|NCT04888585|453321480|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007892|NCT04888585|453321481|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007893|NCT04888585|453321482|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007894|NCT04888585|453321483|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007895|NCT04888585|453321484|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007896|NCT04888585|453321485|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
126007897|NCT04888585|453321486|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007898|NCT04888585|453321487|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
126007899|NCT04888585|453321488|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
126007900|NCT04888585|453321478|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126007901|NCT04888585|453321479|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126007902|NCT04888585|453321480|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126007903|NCT04888585|453321481|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126007904|NCT04888585|453321482|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126007905|NCT04888585|453321483|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
126427496|NCT03493945|454862203|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427497|NCT03493945|454862204|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427498|NCT03493945|454862205|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427499|NCT04319198|454862218|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
126427500|NCT04319198|454862219|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
126427501|NCT04319198|454862220|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
126427502|NCT04319198|454862218|FG000|Overall Study|Death|0|||
126427503|NCT04319198|454862219|FG001|Overall Study|Death|3|||
126427504|NCT04319198|454862220|FG002|Overall Study|Death|3|||
126427505|NCT04319198|454862218|FG000|Overall Study|Reason Not Specified|0|||
126427506|NCT04319198|454862219|FG001|Overall Study|Reason Not Specified|2|||
126427507|NCT04319198|454862220|FG002|Overall Study|Reason Not Specified|4|||
126427508|NCT04319198|454862218|FG000|Overall Study|Withdrawal of Consent|0|||
126427509|NCT04319198|454862219|FG001|Overall Study|Withdrawal of Consent|0|||
126427510|NCT04319198|454862220|FG002|Overall Study|Withdrawal of Consent|5|||
126427511|NCT04319198|454862218|FG000|Overall Study|Site Terminated by Sponsor|0|||
126427512|NCT04319198|454862219|FG001|Overall Study|Site Terminated by Sponsor|1|||
126427513|NCT04319198|454862220|FG002|Overall Study|Site Terminated by Sponsor|0|||
126427514|NCT05472038|454862221|FG000|Overall Study|Adverse Event|0|||
126427515|NCT05472038|454862222|FG001|Overall Study|Adverse Event|0|||
126007906|NCT04888585|453321484|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
126007907|NCT04888585|453321485|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
126007908|NCT04888585|453321486|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
126007909|NCT04888585|453321487|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
126007910|NCT04888585|453321488|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
126427516|NCT05472038|454862223|FG002|Overall Study|Adverse Event|1|||
126427517|NCT05472038|454862224|FG003|Overall Study|Adverse Event|0|||
126427518|NCT05472038|454862225|FG004|Overall Study|Adverse Event|0|||
126427519|NCT05472038|454862226|FG005|Overall Study|Adverse Event|0|||
126007911|NCT04888585|453321478|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126007912|NCT04888585|453321479|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126007913|NCT04888585|453321480|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126007914|NCT04888585|453321481|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126007915|NCT04888585|453321482|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126007916|NCT04888585|453321483|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
126007917|NCT04888585|453321484|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
126007918|NCT04888585|453321485|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
126007919|NCT04888585|453321486|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
126007920|NCT04888585|453321487|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
126007921|NCT04888585|453321488|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
126007922|NCT04888585|453321478|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
126007923|NCT04888585|453321479|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
126007924|NCT04888585|453321480|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
126007925|NCT04888585|453321481|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
126007926|NCT04888585|453321482|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
126007927|NCT04888585|453321483|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
126007928|NCT04888585|453321484|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
126007929|NCT04888585|453321485|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
126007930|NCT04888585|453321486|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
126007931|NCT04888585|453321487|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
126007932|NCT04888585|453321488|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
126007933|NCT04888585|453321478|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126007934|NCT04888585|453321479|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126007935|NCT04888585|453321480|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126007936|NCT04888585|453321481|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126007937|NCT04888585|453321482|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126007938|NCT04888585|453321483|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126007939|NCT04888585|453321484|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
126007940|NCT04888585|453321485|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
126007941|NCT04888585|453321486|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
126007942|NCT04888585|453321487|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
126007943|NCT04888585|453321488|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126427520|NCT05472038|454862227|FG006|Overall Study|Adverse Event|0|||
126427521|NCT05472038|454862228|FG007|Overall Study|Adverse Event|0|||
126427522|NCT05472038|454862229|FG008|Overall Study|Adverse Event|0|||
126427523|NCT05472038|454862230|FG009|Overall Study|Adverse Event|0|||
126427524|NCT05472038|454862231|FG010|Overall Study|Adverse Event|0|||
126427525|NCT05472038|454862232|FG011|Overall Study|Adverse Event|0|||
126427526|NCT05472038|454862221|FG000|Overall Study|Death|0|||
126427527|NCT05472038|454862222|FG001|Overall Study|Death|0|||
126427528|NCT05472038|454862223|FG002|Overall Study|Death|0|||
126427529|NCT05472038|454862224|FG003|Overall Study|Death|0|||
126427530|NCT05472038|454862225|FG004|Overall Study|Death|0|||
126427531|NCT05472038|454862226|FG005|Overall Study|Death|1|||
126427532|NCT05472038|454862227|FG006|Overall Study|Death|0|||
126427533|NCT05472038|454862228|FG007|Overall Study|Death|0|||
126427534|NCT05472038|454862229|FG008|Overall Study|Death|0|||
126427535|NCT05472038|454862230|FG009|Overall Study|Death|0|||
126427536|NCT05472038|454862231|FG010|Overall Study|Death|0|||
126427537|NCT05472038|454862232|FG011|Overall Study|Death|0|||
126427538|NCT05472038|454862221|FG000|Overall Study|Lost to Follow-up|1|||
126427539|NCT05472038|454862222|FG001|Overall Study|Lost to Follow-up|3|||
126427540|NCT05472038|454862223|FG002|Overall Study|Lost to Follow-up|3|||
126427541|NCT05472038|454862224|FG003|Overall Study|Lost to Follow-up|9|||
126427542|NCT05472038|454862225|FG004|Overall Study|Lost to Follow-up|2|||
126427543|NCT05472038|454862226|FG005|Overall Study|Lost to Follow-up|2|||
126427544|NCT05472038|454862227|FG006|Overall Study|Lost to Follow-up|1|||
126427545|NCT05472038|454862228|FG007|Overall Study|Lost to Follow-up|0|||
126427546|NCT05472038|454862229|FG008|Overall Study|Lost to Follow-up|1|||
126427547|NCT05472038|454862230|FG009|Overall Study|Lost to Follow-up|0|||
126427548|NCT05472038|454862231|FG010|Overall Study|Lost to Follow-up|2|||
126427549|NCT05472038|454862232|FG011|Overall Study|Lost to Follow-up|1|||
126427550|NCT05472038|454862221|FG000|Overall Study|Physician Decision|0|||
126427551|NCT05472038|454862222|FG001|Overall Study|Physician Decision|0|||
126427552|NCT05472038|454862223|FG002|Overall Study|Physician Decision|0|||
126427553|NCT05472038|454862224|FG003|Overall Study|Physician Decision|0|||
126427554|NCT05472038|454862225|FG004|Overall Study|Physician Decision|1|||
126427555|NCT05472038|454862226|FG005|Overall Study|Physician Decision|0|||
126427556|NCT05472038|454862227|FG006|Overall Study|Physician Decision|0|||
126427557|NCT05472038|454862228|FG007|Overall Study|Physician Decision|0|||
126427558|NCT05472038|454862229|FG008|Overall Study|Physician Decision|0|||
126427559|NCT05472038|454862230|FG009|Overall Study|Physician Decision|0|||
126427560|NCT05472038|454862231|FG010|Overall Study|Physician Decision|0|||
126427561|NCT05472038|454862232|FG011|Overall Study|Physician Decision|0|||
126007944|NCT00819910|453321489|FG000|Overall Study|Adverse Event|0|||
126007945|NCT00819910|453321490|FG001|Overall Study|Adverse Event|0|||
126007946|NCT00819910|453321491|FG002|Overall Study|Adverse Event|2|||
126007947|NCT00819910|453321492|FG003|Overall Study|Adverse Event|1|||
126007948|NCT00819910|453321489|FG000|Overall Study|Withdrawal by Subject|1|||
126007949|NCT00819910|453321490|FG001|Overall Study|Withdrawal by Subject|1|||
126007950|NCT00819910|453321491|FG002|Overall Study|Withdrawal by Subject|1|||
126007951|NCT00819910|453321492|FG003|Overall Study|Withdrawal by Subject|0|||
126427562|NCT05472038|454862221|FG000|Overall Study|Withdrawal by Subject|1|||
126427563|NCT05472038|454862222|FG001|Overall Study|Withdrawal by Subject|3|||
126427564|NCT05472038|454862223|FG002|Overall Study|Withdrawal by Subject|1|||
126427565|NCT05472038|454862224|FG003|Overall Study|Withdrawal by Subject|6|||
126427566|NCT05472038|454862225|FG004|Overall Study|Withdrawal by Subject|1|||
126427567|NCT05472038|454862226|FG005|Overall Study|Withdrawal by Subject|3|||
126427568|NCT05472038|454862227|FG006|Overall Study|Withdrawal by Subject|0|||
126427569|NCT05472038|454862228|FG007|Overall Study|Withdrawal by Subject|2|||
126427570|NCT05472038|454862229|FG008|Overall Study|Withdrawal by Subject|3|||
126427571|NCT05472038|454862230|FG009|Overall Study|Withdrawal by Subject|1|||
126427572|NCT05472038|454862231|FG010|Overall Study|Withdrawal by Subject|2|||
126007952|NCT00819910|453321489|FG000|Overall Study|Lost to Follow-up|1|||
126007953|NCT00819910|453321490|FG001|Overall Study|Lost to Follow-up|0|||
126007954|NCT00819910|453321491|FG002|Overall Study|Lost to Follow-up|0|||
126007955|NCT00819910|453321492|FG003|Overall Study|Lost to Follow-up|0|||
126007956|NCT02908464|453321493|FG000|Overall Study|Withdrawal by Subject|2|||
126007957|NCT02908464|453321494|FG001|Overall Study|Withdrawal by Subject|1|||
126007958|NCT02908464|453321493|FG000|Overall Study|Found ineligible after randomization|0|||
126007959|NCT02908464|453321494|FG001|Overall Study|Found ineligible after randomization|2|||
126427573|NCT05472038|454862232|FG011|Overall Study|Withdrawal by Subject|2|||
126007960|NCT01311713|453321497|FG000|Overall Study|Death|0|||
126007961|NCT01311713|453321498|FG001|Overall Study|Death|0|||
126007962|NCT01311713|453321499|FG002|Overall Study|Death|1|||
126427574|NCT05472038|454862221|FG000|Overall Study|Protocol Violation|0|||
126427575|NCT05472038|454862222|FG001|Overall Study|Protocol Violation|0|||
126427576|NCT05472038|454862223|FG002|Overall Study|Protocol Violation|0|||
126427577|NCT05472038|454862224|FG003|Overall Study|Protocol Violation|0|||
126427578|NCT05472038|454862225|FG004|Overall Study|Protocol Violation|0|||
126427579|NCT05472038|454862226|FG005|Overall Study|Protocol Violation|0|||
126427580|NCT05472038|454862227|FG006|Overall Study|Protocol Violation|0|||
126427581|NCT05472038|454862228|FG007|Overall Study|Protocol Violation|1|||
126427582|NCT05472038|454862229|FG008|Overall Study|Protocol Violation|1|||
126427583|NCT05472038|454862230|FG009|Overall Study|Protocol Violation|1|||
126427584|NCT05472038|454862231|FG010|Overall Study|Protocol Violation|1|||
126427585|NCT05472038|454862232|FG011|Overall Study|Protocol Violation|1|||
126427586|NCT05472038|454862221|FG000|Overall Study|Not vaccinated|0|||
126427587|NCT05472038|454862222|FG001|Overall Study|Not vaccinated|0|||
126427588|NCT05472038|454862223|FG002|Overall Study|Not vaccinated|0|||
126427589|NCT05472038|454862224|FG003|Overall Study|Not vaccinated|1|||
126427590|NCT05472038|454862225|FG004|Overall Study|Not vaccinated|0|||
126427591|NCT05472038|454862226|FG005|Overall Study|Not vaccinated|0|||
126427592|NCT05472038|454862227|FG006|Overall Study|Not vaccinated|0|||
126427593|NCT05472038|454862228|FG007|Overall Study|Not vaccinated|0|||
126427594|NCT05472038|454862229|FG008|Overall Study|Not vaccinated|0|||
126427595|NCT05472038|454862230|FG009|Overall Study|Not vaccinated|0|||
126427596|NCT05472038|454862231|FG010|Overall Study|Not vaccinated|0|||
126427597|NCT05472038|454862232|FG011|Overall Study|Not vaccinated|0|||
126427598|NCT05369208|454862238|FG000|Core Phase|Prohibited Medication Required|2|||
126427599|NCT05369208|454862238|FG000|Core Phase|Adverse Event|1|||
126427600|NCT05369208|454862238|FG000|Core Phase|Lack of Efficacy|1|||
126427601|NCT03274687|454862239|FG000|Overall Study|Protocol Violation|1|||
126427602|NCT03274687|454862240|FG001|Overall Study|Protocol Violation|1|||
126427603|NCT04914897|454862241|FG000|Overall Study|Withdrawal by Subject|3|||
126427604|NCT04914897|454862242|FG001|Overall Study|Withdrawal by Subject|1|||
126427605|NCT04914897|454862243|FG002|Overall Study|Withdrawal by Subject|1|||
126427606|NCT04914897|454862244|FG003|Overall Study|Withdrawal by Subject|1|||
126427607|NCT04914897|454862241|FG000|Overall Study|Poor compliance to protocol|0|||
126427608|NCT04914897|454862242|FG001|Overall Study|Poor compliance to protocol|0|||
126427609|NCT04914897|454862243|FG002|Overall Study|Poor compliance to protocol|1|||
126427610|NCT04914897|454862244|FG003|Overall Study|Poor compliance to protocol|0|||
126427611|NCT04914897|454862241|FG000|Overall Study|Progressive disease|5|||
126427612|NCT04914897|454862242|FG001|Overall Study|Progressive disease|14|||
126427613|NCT04914897|454862243|FG002|Overall Study|Progressive disease|30|||
126427614|NCT04914897|454862244|FG003|Overall Study|Progressive disease|21|||
126427615|NCT04914897|454862241|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
126427616|NCT04914897|454862242|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
126427617|NCT04914897|454862243|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
126427618|NCT04914897|454862244|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
126427619|NCT04914897|454862241|FG000|Overall Study|Other|1|||
126427620|NCT04914897|454862242|FG001|Overall Study|Other|0|||
126427621|NCT04914897|454862243|FG002|Overall Study|Other|0|||
126427622|NCT04914897|454862244|FG003|Overall Study|Other|1|||
126427623|NCT02674152|454862245|FG000|Overall Study|Personal Reasons|1|||
126427624|NCT02674152|454862246|FG001|Overall Study|Personal Reasons|0|||
126427625|NCT02674152|454862247|FG002|Overall Study|Personal Reasons|0|||
126427626|NCT02674152|454862248|FG003|Overall Study|Personal Reasons|1|||
126427627|NCT02674152|454862249|FG004|Overall Study|Personal Reasons|1|||
126427628|NCT02674152|454862245|FG000|Overall Study|Other adverse event or clinical progression|0|||
126427629|NCT02674152|454862246|FG001|Overall Study|Other adverse event or clinical progression|1|||
126427630|NCT02674152|454862247|FG002|Overall Study|Other adverse event or clinical progression|0|||
126427631|NCT02674152|454862248|FG003|Overall Study|Other adverse event or clinical progression|3|||
126427632|NCT02674152|454862249|FG004|Overall Study|Other adverse event or clinical progression|0|||
126427633|NCT02674152|454862245|FG000|Overall Study|Dose-limiting toxicity|0|||
126427634|NCT02674152|454862246|FG001|Overall Study|Dose-limiting toxicity|0|||
126427635|NCT02674152|454862247|FG002|Overall Study|Dose-limiting toxicity|0|||
126427636|NCT02674152|454862248|FG003|Overall Study|Dose-limiting toxicity|0|||
126427637|NCT02674152|454862249|FG004|Overall Study|Dose-limiting toxicity|1|||
126427638|NCT02674152|454862245|FG000|Overall Study|Progressive Disease|2|||
126427639|NCT02674152|454862246|FG001|Overall Study|Progressive Disease|1|||
126427640|NCT02674152|454862247|FG002|Overall Study|Progressive Disease|1|||
126427641|NCT02674152|454862248|FG003|Overall Study|Progressive Disease|13|||
126427642|NCT02674152|454862249|FG004|Overall Study|Progressive Disease|2|||
126007963|NCT01311713|453321500|FG003|Overall Study|Death|1|||
126007964|NCT01311713|453321501|FG004|Overall Study|Death|0|||
126007965|NCT01311713|453321502|FG005|Overall Study|Death|1|||
126007966|NCT01311713|453321503|FG006|Overall Study|Death|0|||
126007967|NCT01311713|453321497|FG000|Overall Study|Adverse Event|0|||
126007968|NCT01311713|453321498|FG001|Overall Study|Adverse Event|1|||
126007969|NCT01311713|453321499|FG002|Overall Study|Adverse Event|0|||
126007970|NCT01311713|453321500|FG003|Overall Study|Adverse Event|2|||
126007971|NCT01311713|453321501|FG004|Overall Study|Adverse Event|0|||
126007972|NCT01311713|453321502|FG005|Overall Study|Adverse Event|0|||
126007973|NCT01311713|453321503|FG006|Overall Study|Adverse Event|2|||
126007974|NCT01311713|453321497|FG000|Overall Study|Withdrawal by Subject|0|||
126427643|NCT02674152|454862245|FG000|Overall Study|Adverse Event|0|||
126427644|NCT02674152|454862246|FG001|Overall Study|Adverse Event|0|||
126427645|NCT02674152|454862247|FG002|Overall Study|Adverse Event|1|||
126427646|NCT02674152|454862248|FG003|Overall Study|Adverse Event|0|||
126427647|NCT02674152|454862249|FG004|Overall Study|Adverse Event|1|||
126427648|NCT04734652|454862250|FG000|Overall Study|Withdrawal by Subject|2|||
126427649|NCT04734652|454862251|FG001|Overall Study|Withdrawal by Subject|0|||
126427650|NCT04734652|454862250|FG000|Overall Study|Death|0|||
126427651|NCT04734652|454862251|FG001|Overall Study|Death|1|||
126427652|NCT04934722|454862252|FG000|Overall Study|Death|4|||
126007975|NCT01311713|453321498|FG001|Overall Study|Withdrawal by Subject|1|||
126007976|NCT01311713|453321499|FG002|Overall Study|Withdrawal by Subject|1|||
126007977|NCT01311713|453321500|FG003|Overall Study|Withdrawal by Subject|0|||
126007978|NCT01311713|453321501|FG004|Overall Study|Withdrawal by Subject|0|||
126007979|NCT01311713|453321502|FG005|Overall Study|Withdrawal by Subject|1|||
126007980|NCT01311713|453321503|FG006|Overall Study|Withdrawal by Subject|2|||
126007981|NCT01311713|453321497|FG000|Overall Study|Disease progression|3|||
126007982|NCT01311713|453321498|FG001|Overall Study|Disease progression|4|||
126007983|NCT01311713|453321499|FG002|Overall Study|Disease progression|3|||
126007984|NCT01311713|453321500|FG003|Overall Study|Disease progression|2|||
126007985|NCT01311713|453321501|FG004|Overall Study|Disease progression|4|||
126007986|NCT01311713|453321502|FG005|Overall Study|Disease progression|4|||
126007987|NCT01311713|453321503|FG006|Overall Study|Disease progression|5|||
126007988|NCT01311713|453321497|FG000|Overall Study|Lost to Follow-up|0|||
126007989|NCT01311713|453321498|FG001|Overall Study|Lost to Follow-up|0|||
126007990|NCT01311713|453321499|FG002|Overall Study|Lost to Follow-up|1|||
126007991|NCT01311713|453321500|FG003|Overall Study|Lost to Follow-up|0|||
126007992|NCT01311713|453321501|FG004|Overall Study|Lost to Follow-up|0|||
126007993|NCT01311713|453321502|FG005|Overall Study|Lost to Follow-up|0|||
126007994|NCT01311713|453321503|FG006|Overall Study|Lost to Follow-up|0|||
126007995|NCT01311713|453321497|FG000|Overall Study|Stopped taking study medication|0|||
126007996|NCT01311713|453321498|FG001|Overall Study|Stopped taking study medication|0|||
126007997|NCT01311713|453321499|FG002|Overall Study|Stopped taking study medication|0|||
126007998|NCT01311713|453321500|FG003|Overall Study|Stopped taking study medication|1|||
126007999|NCT01311713|453321501|FG004|Overall Study|Stopped taking study medication|1|||
126008000|NCT01311713|453321502|FG005|Overall Study|Stopped taking study medication|0|||
126008001|NCT01311713|453321503|FG006|Overall Study|Stopped taking study medication|0|||
126008002|NCT01311713|453321497|FG000|Overall Study|Enrolled but not treated|0|||
126008003|NCT01311713|453321498|FG001|Overall Study|Enrolled but not treated|0|||
126008004|NCT01311713|453321499|FG002|Overall Study|Enrolled but not treated|1|||
126008005|NCT01311713|453321500|FG003|Overall Study|Enrolled but not treated|0|||
126008006|NCT01311713|453321501|FG004|Overall Study|Enrolled but not treated|0|||
126008007|NCT01311713|453321502|FG005|Overall Study|Enrolled but not treated|0|||
126008008|NCT01311713|453321503|FG006|Overall Study|Enrolled but not treated|0|||
126008009|NCT01311713|453321497|FG000|Overall Study|Other than specified|0|||
126008010|NCT01311713|453321498|FG001|Overall Study|Other than specified|1|||
126008011|NCT01311713|453321499|FG002|Overall Study|Other than specified|2|||
126008012|NCT01311713|453321500|FG003|Overall Study|Other than specified|0|||
126008013|NCT01311713|453321501|FG004|Overall Study|Other than specified|0|||
126008014|NCT01311713|453321502|FG005|Overall Study|Other than specified|0|||
126008015|NCT01311713|453321503|FG006|Overall Study|Other than specified|0|||
126008016|NCT05273801|453321504|FG000|Overall Study|Physician Decision|1|||
126008017|NCT00797862|453322914|FG000|Overall Study|Adverse Event|86|||
126008018|NCT00797862|453322915|FG001|Overall Study|Adverse Event|44|||
126008019|NCT00797862|453322916|FG002|Overall Study|Adverse Event|58|||
126008020|NCT00797862|453322914|FG000|Overall Study|Abnormal Test Procedure Result|0|||
126008021|NCT00797862|453322915|FG001|Overall Study|Abnormal Test Procedure Result|1|||
126008022|NCT00797862|453322916|FG002|Overall Study|Abnormal Test Procedure Result|1|||
126008023|NCT00797862|453322914|FG000|Overall Study|Lack of Efficacy|1|||
126008024|NCT00797862|453322915|FG001|Overall Study|Lack of Efficacy|7|||
126008025|NCT00797862|453322916|FG002|Overall Study|Lack of Efficacy|6|||
126008026|NCT00797862|453322914|FG000|Overall Study|No longer required study medication|1|||
126008027|NCT00797862|453322915|FG001|Overall Study|No longer required study medication|0|||
126008028|NCT00797862|453322916|FG002|Overall Study|No longer required study medication|0|||
126008029|NCT00797862|453322914|FG000|Overall Study|Withdrawal by Subject|14|||
126008030|NCT00797862|453322915|FG001|Overall Study|Withdrawal by Subject|7|||
126008031|NCT00797862|453322916|FG002|Overall Study|Withdrawal by Subject|7|||
126342241|NCT01884597|454548835|FG000|Overall Study|Adverse Event|0|||
126342242|NCT01884597|454548836|FG001|Overall Study|Adverse Event|0|||
126342243|NCT01884597|454548837|FG002|Overall Study|Adverse Event|1|||
126342244|NCT01884597|454548835|FG000|Overall Study|Lack of Efficacy|1|||
126342245|NCT01884597|454548836|FG001|Overall Study|Lack of Efficacy|0|||
126342246|NCT01884597|454548837|FG002|Overall Study|Lack of Efficacy|0|||
126342247|NCT01884597|454548835|FG000|Overall Study|Death|0|||
126342248|NCT01884597|454548836|FG001|Overall Study|Death|1|||
126008032|NCT00797862|453322914|FG000|Overall Study|Lost to Follow-up|11|||
126008033|NCT00797862|453322915|FG001|Overall Study|Lost to Follow-up|0|||
126008034|NCT00797862|453322916|FG002|Overall Study|Lost to Follow-up|5|||
126008035|NCT00797862|453322914|FG000|Overall Study|Administrative Problem|4|||
126008036|NCT00797862|453322915|FG001|Overall Study|Administrative Problem|0|||
126342249|NCT01884597|454548837|FG002|Overall Study|Death|0|||
126342250|NCT02097823|454548838|FG000|Overall Study|Withdrawal by Subject|1|||
126342251|NCT02097823|454548839|FG001|Overall Study|Withdrawal by Subject|1|||
126008037|NCT00797862|453322916|FG002|Overall Study|Administrative Problem|0|||
126008038|NCT00797862|453322914|FG000|Overall Study|Protocol Violation|4|||
126008039|NCT00797862|453322915|FG001|Overall Study|Protocol Violation|6|||
126342252|NCT03082729|454548840|FG000|Overall Study|Lost to Follow-up|7|||
126427653|NCT04934722|454862253|FG001|Overall Study|Death|3|||
126427654|NCT04934722|454862252|FG000|Overall Study|Participants Ongoing|88|||
126427655|NCT04934722|454862253|FG001|Overall Study|Participants Ongoing|91|||
126427656|NCT05265624|454862256|FG000|Overall Study|Lost to Follow-up|3|||
126427657|NCT05265624|454862257|FG001|Overall Study|Lost to Follow-up|0|||
126427658|NCT05265624|454862256|FG000|Overall Study|Withdrawal by Subject|1|||
126427659|NCT05265624|454862257|FG001|Overall Study|Withdrawal by Subject|0|||
126427660|NCT06039579|454862258|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427661|NCT06039579|454862259|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427662|NCT06039579|454862260|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427663|NCT06039579|454862261|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427664|NCT06039579|454862262|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427665|NCT06039579|454862263|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427666|NCT06039579|454862264|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427667|NCT06039579|454862265|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
126427668|NCT05927753|454862271|FG000|Overall Study|Withdrawal by Subject|0|||
126427669|NCT05927753|454862272|FG001|Overall Study|Withdrawal by Subject|2|||
126427670|NCT05927753|454862271|FG000|Overall Study|Physician Decision|0|||
126427671|NCT05927753|454862272|FG001|Overall Study|Physician Decision|1|||
126427672|NCT02356159|454862273|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427673|NCT02356159|454862274|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427674|NCT02356159|454862275|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427675|NCT02356159|454862276|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427676|NCT02356159|454862277|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427677|NCT02356159|454862278|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
126427678|NCT00861705|454862279|FG000|Overall Study|Never Began Treatment|7|||
126008040|NCT00797862|453322916|FG002|Overall Study|Protocol Violation|8|||
126008041|NCT00797862|453322914|FG000|Overall Study|Mis-randomized|3|||
126008042|NCT00797862|453322915|FG001|Overall Study|Mis-randomized|3|||
126342253|NCT03082729|454548840|FG000|Overall Study|Physician Decision|2|||
126342254|NCT03082729|454548840|FG000|Overall Study|Withdrawal by Subject|1|||
126342255|NCT03082729|454548840|FG000|Overall Study|Lack of Efficacy|9|||
126342256|NCT03082729|454548840|FG000|Overall Study|Adverse Event|4|||
126342257|NCT03082729|454548840|FG000|Overall Study|Protocol Violation|6|||
126342258|NCT03082729|454548840|FG000|Overall Study|Fear of study procedure|1|||
126342259|NCT03082729|454548840|FG000|Overall Study|Scheduling conflict|1|||
126342260|NCT02934178|454550431|FG000|Received Vaccination 2|Death|0|||
126342261|NCT02934178|454550432|FG001|Received Vaccination 2|Death|1|||
126342262|NCT02934178|454550431|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
126342263|NCT02934178|454550432|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
126342264|NCT01898078|454550435|FG000|Overall Study|Progressive Disease|1|||
126342265|NCT01898078|454550436|FG001|Overall Study|Progressive Disease|5|||
126342266|NCT01898078|454550435|FG000|Overall Study|Adverse Event|2|||
126342267|NCT01898078|454550436|FG001|Overall Study|Adverse Event|1|||
126342268|NCT01898078|454550435|FG000|Overall Study|Withdrawal by Subject|1|||
126342269|NCT01898078|454550436|FG001|Overall Study|Withdrawal by Subject|1|||
126342270|NCT01898078|454550435|FG000|Overall Study|Symptomatic Deterioration|2|||
126342271|NCT01898078|454550436|FG001|Overall Study|Symptomatic Deterioration|0|||
126342272|NCT01898078|454550435|FG000|Overall Study|Reason not Specified|0|||
126342273|NCT01898078|454550436|FG001|Overall Study|Reason not Specified|1|||
126342274|NCT01140906|454550438|FG000|Overall Study|Adverse Event|7|||
126342275|NCT01140906|454550439|FG001|Overall Study|Adverse Event|10|||
126342276|NCT01140906|454550440|FG002|Overall Study|Adverse Event|17|||
126342277|NCT01140906|454550441|FG003|Overall Study|Adverse Event|7|||
126342278|NCT01140906|454550438|FG000|Overall Study|Lack of Efficacy|6|||
126342279|NCT01140906|454550439|FG001|Overall Study|Lack of Efficacy|8|||
126342280|NCT01140906|454550440|FG002|Overall Study|Lack of Efficacy|2|||
126342281|NCT01140906|454550441|FG003|Overall Study|Lack of Efficacy|1|||
126342282|NCT01140906|454550438|FG000|Overall Study|Non-compliance|0|||
126342283|NCT01140906|454550439|FG001|Overall Study|Non-compliance|1|||
126342284|NCT01140906|454550440|FG002|Overall Study|Non-compliance|0|||
126342285|NCT01140906|454550441|FG003|Overall Study|Non-compliance|1|||
126342286|NCT01140906|454550438|FG000|Overall Study|Protocol Violation|5|||
126342287|NCT01140906|454550439|FG001|Overall Study|Protocol Violation|3|||
126342288|NCT01140906|454550440|FG002|Overall Study|Protocol Violation|2|||
126342289|NCT01140906|454550441|FG003|Overall Study|Protocol Violation|1|||
126342290|NCT01140906|454550438|FG000|Overall Study|Withdrawal of consent|6|||
126342291|NCT01140906|454550439|FG001|Overall Study|Withdrawal of consent|6|||
126342292|NCT01140906|454550440|FG002|Overall Study|Withdrawal of consent|2|||
126342293|NCT01140906|454550441|FG003|Overall Study|Withdrawal of consent|2|||
126342294|NCT01140906|454550438|FG000|Overall Study|Lost to Follow-up|1|||
126342295|NCT01140906|454550439|FG001|Overall Study|Lost to Follow-up|1|||
126342296|NCT01140906|454550440|FG002|Overall Study|Lost to Follow-up|0|||
126008043|NCT00797862|453322916|FG002|Overall Study|Mis-randomized|1|||
126008044|NCT01474538|453322926|FG000|Treatment Period 1|Death|1|||
126008045|NCT01474538|453322927|FG001|Treatment Period 1|Death|0|||
126008046|NCT01474538|453322926|FG000|Treatment Period 1|Physician Decision|1|||
126008047|NCT01474538|453322927|FG001|Treatment Period 1|Physician Decision|0|||
126008048|NCT01474538|453322926|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126008049|NCT01474538|453322927|FG001|Treatment Period 1|Withdrawal by Subject|3|||
126342297|NCT01140906|454550441|FG003|Overall Study|Lost to Follow-up|2|||
126342298|NCT01140906|454550438|FG000|Overall Study|Administrative or other reason|0|||
126342299|NCT01140906|454550439|FG001|Overall Study|Administrative or other reason|5|||
126342300|NCT01140906|454550440|FG002|Overall Study|Administrative or other reason|3|||
126342301|NCT01140906|454550441|FG003|Overall Study|Administrative or other reason|2|||
126342302|NCT00703534|454550442|FG000|Overall Study|Adverse Event|14|||
126342303|NCT00703534|454550443|FG001|Overall Study|Adverse Event|3|||
126342304|NCT00703534|454550442|FG000|Overall Study|Withdrawal by Subject|8|||
126342305|NCT00703534|454550443|FG001|Overall Study|Withdrawal by Subject|7|||
126342306|NCT00703534|454550442|FG000|Overall Study|Incorrect Enrollment|6|||
126342307|NCT00703534|454550443|FG001|Overall Study|Incorrect Enrollment|6|||
126342308|NCT00703534|454550442|FG000|Overall Study|Lost to Follow-up|1|||
126342309|NCT00703534|454550443|FG001|Overall Study|Lost to Follow-up|4|||
126342310|NCT00703534|454550442|FG000|Overall Study|Severe Non Compliance|1|||
126342311|NCT00703534|454550443|FG001|Overall Study|Severe Non Compliance|5|||
126342312|NCT02791269|454550444|FG000|Overall Study|Lost to Follow-up|0|||
126342313|NCT02791269|454550445|FG001|Overall Study|Lost to Follow-up|1|||
126342314|NCT01648764|454550446|FG000|Overall Study|Progressive Disease|0|||
126342315|NCT01648764|454550447|FG001|Overall Study|Progressive Disease|1|||
126342316|NCT01648764|454550448|FG002|Overall Study|Progressive Disease|0|||
126342317|NCT01648764|454550449|FG003|Overall Study|Progressive Disease|0|||
126342318|NCT01648764|454550450|FG004|Overall Study|Progressive Disease|0|||
126342319|NCT01648764|454550451|FG005|Overall Study|Progressive Disease|1|||
126342320|NCT01648764|454550452|FG006|Overall Study|Progressive Disease|1|||
126342321|NCT01648764|454550453|FG007|Overall Study|Progressive Disease|0|||
126342322|NCT01648764|454550454|FG008|Overall Study|Progressive Disease|0|||
126342323|NCT01648764|454550455|FG009|Overall Study|Progressive Disease|2|||
126342324|NCT01648764|454550456|FG010|Overall Study|Progressive Disease|0|||
126342325|NCT01648764|454550457|FG011|Overall Study|Progressive Disease|1|||
126342326|NCT01648764|454550458|FG012|Overall Study|Progressive Disease|2|||
126342327|NCT01648764|454550459|FG013|Overall Study|Progressive Disease|1|||
126342328|NCT01648764|454550446|FG000|Overall Study|Adverse Event|0|||
126342329|NCT01648764|454550447|FG001|Overall Study|Adverse Event|0|||
126342330|NCT01648764|454550448|FG002|Overall Study|Adverse Event|0|||
126342331|NCT01648764|454550449|FG003|Overall Study|Adverse Event|0|||
126342332|NCT01648764|454550450|FG004|Overall Study|Adverse Event|0|||
126342333|NCT01648764|454550451|FG005|Overall Study|Adverse Event|1|||
126342334|NCT01648764|454550452|FG006|Overall Study|Adverse Event|0|||
126342335|NCT01648764|454550453|FG007|Overall Study|Adverse Event|0|||
126342336|NCT01648764|454550454|FG008|Overall Study|Adverse Event|0|||
126342337|NCT01648764|454550455|FG009|Overall Study|Adverse Event|1|||
126342338|NCT01648764|454550456|FG010|Overall Study|Adverse Event|0|||
126342339|NCT01648764|454550457|FG011|Overall Study|Adverse Event|3|||
126342340|NCT01648764|454550458|FG012|Overall Study|Adverse Event|1|||
126342341|NCT01648764|454550459|FG013|Overall Study|Adverse Event|1|||
126342342|NCT01648764|454550446|FG000|Overall Study|Death|0|||
126342343|NCT01648764|454550447|FG001|Overall Study|Death|0|||
126342344|NCT01648764|454550448|FG002|Overall Study|Death|0|||
126342345|NCT01648764|454550449|FG003|Overall Study|Death|0|||
126342346|NCT01648764|454550450|FG004|Overall Study|Death|0|||
126342347|NCT01648764|454550451|FG005|Overall Study|Death|0|||
126342348|NCT01648764|454550452|FG006|Overall Study|Death|1|||
126342349|NCT01648764|454550453|FG007|Overall Study|Death|0|||
126342350|NCT01648764|454550454|FG008|Overall Study|Death|0|||
126342351|NCT01648764|454550455|FG009|Overall Study|Death|0|||
126342352|NCT01648764|454550456|FG010|Overall Study|Death|0|||
126342353|NCT01648764|454550457|FG011|Overall Study|Death|0|||
126342354|NCT01648764|454550458|FG012|Overall Study|Death|0|||
126342355|NCT01648764|454550459|FG013|Overall Study|Death|1|||
126342356|NCT01648764|454550446|FG000|Overall Study|Withdrawal by Subject|0|||
126342357|NCT01648764|454550447|FG001|Overall Study|Withdrawal by Subject|0|||
126342358|NCT01648764|454550448|FG002|Overall Study|Withdrawal by Subject|0|||
126342359|NCT01648764|454550449|FG003|Overall Study|Withdrawal by Subject|0|||
126342360|NCT01648764|454550450|FG004|Overall Study|Withdrawal by Subject|0|||
126342361|NCT01648764|454550451|FG005|Overall Study|Withdrawal by Subject|0|||
126342362|NCT01648764|454550452|FG006|Overall Study|Withdrawal by Subject|2|||
126342363|NCT01648764|454550453|FG007|Overall Study|Withdrawal by Subject|0|||
126342364|NCT01648764|454550454|FG008|Overall Study|Withdrawal by Subject|0|||
126342365|NCT01648764|454550455|FG009|Overall Study|Withdrawal by Subject|0|||
126342366|NCT01648764|454550456|FG010|Overall Study|Withdrawal by Subject|0|||
126342367|NCT01648764|454550457|FG011|Overall Study|Withdrawal by Subject|0|||
126342368|NCT01648764|454550458|FG012|Overall Study|Withdrawal by Subject|1|||
126342369|NCT01648764|454550459|FG013|Overall Study|Withdrawal by Subject|0|||
126342370|NCT01648764|454550446|FG000|Overall Study|Investigator Decision|0|||
126342371|NCT01648764|454550447|FG001|Overall Study|Investigator Decision|0|||
126008050|NCT01474538|453322926|FG000|Treatment Period 1|Protocol Violation|0|||
126008051|NCT01474538|453322927|FG001|Treatment Period 1|Protocol Violation|1|||
126008052|NCT01474538|453322926|FG000|Treatment Period 2|Death|1|||
126008053|NCT01474538|453322927|FG001|Treatment Period 2|Death|0|||
126008054|NCT01474538|453322926|FG000|Treatment Period 2|Adverse Event|1|||
126008055|NCT01474538|453322927|FG001|Treatment Period 2|Adverse Event|1|||
126008056|NCT01474538|453322926|FG000|Treatment Period 2|Withdrawal by Subject|2|||
126008057|NCT01474538|453322927|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126008058|NCT01474538|453322926|FG000|Treatment Period 2|Sponsor decision|1|||
126008059|NCT01474538|453322927|FG001|Treatment Period 2|Sponsor decision|0|||
126008060|NCT01474538|453322926|FG000|Treatment Period 2|Physician Decision|0|||
126008061|NCT01474538|453322927|FG001|Treatment Period 2|Physician Decision|1|||
126008062|NCT01474538|453322926|FG000|Treatment Period 2|Protocol Violation|1|||
126008063|NCT01474538|453322927|FG001|Treatment Period 2|Protocol Violation|0|||
126008064|NCT01456780|453322928|FG000|Overall Study|Lost to Follow-up|3|||
126008065|NCT01456780|453322929|FG001|Overall Study|Lost to Follow-up|3|||
126008066|NCT01456780|453322930|FG002|Overall Study|Lost to Follow-up|0|||
126008067|NCT00349908|453322933|FG000|Overall Study|Withdrawal by Subject|0|||
126008068|NCT00349908|453322934|FG001|Overall Study|Withdrawal by Subject|4|||
126008069|NCT04565249|453322935|FG000|Overall Study|Death|0|||
126008070|NCT04565249|453322936|FG001|Overall Study|Death|0|||
126008071|NCT04565249|453322937|FG002|Overall Study|Death|0|||
126008072|NCT04565249|453322938|FG003|Overall Study|Death|1|||
126008073|NCT02333630|453322939|FG000|Overall Study|Lost to Follow-up|5|||
126008074|NCT02333630|453322940|FG001|Overall Study|Lost to Follow-up|2|||
126008075|NCT05349864|453322941|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
126008076|NCT05349864|453322942|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
126008077|NCT00984282|453322943|FG000|Double Blind Treatment|Adverse Event|40|||
126008078|NCT00984282|453322944|FG001|Double Blind Treatment|Adverse Event|6|||
126008079|NCT00984282|453322943|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
126342372|NCT01648764|454550448|FG002|Overall Study|Investigator Decision|0|||
126342373|NCT01648764|454550449|FG003|Overall Study|Investigator Decision|0|||
126342374|NCT01648764|454550450|FG004|Overall Study|Investigator Decision|0|||
126342375|NCT01648764|454550451|FG005|Overall Study|Investigator Decision|0|||
126342376|NCT01648764|454550452|FG006|Overall Study|Investigator Decision|1|||
126342377|NCT01648764|454550453|FG007|Overall Study|Investigator Decision|0|||
126342378|NCT01648764|454550454|FG008|Overall Study|Investigator Decision|0|||
126342379|NCT01648764|454550455|FG009|Overall Study|Investigator Decision|0|||
126342380|NCT01648764|454550456|FG010|Overall Study|Investigator Decision|0|||
126342381|NCT01648764|454550457|FG011|Overall Study|Investigator Decision|1|||
126342382|NCT01648764|454550458|FG012|Overall Study|Investigator Decision|0|||
126342383|NCT01648764|454550459|FG013|Overall Study|Investigator Decision|0|||
126342384|NCT00715208|454550460|FG000|Overall Study|Withdrawal by Subject|1|||
126342385|NCT00715208|454550461|FG001|Overall Study|Withdrawal by Subject|1|||
126342386|NCT00715208|454550460|FG000|Overall Study|Adverse Event|0|||
126342387|NCT00715208|454550461|FG001|Overall Study|Adverse Event|6|||
126342388|NCT00715208|454550460|FG000|Overall Study|Lack of Efficacy|0|||
126342389|NCT00715208|454550461|FG001|Overall Study|Lack of Efficacy|2|||
126342390|NCT04889040|454550462|FG000|Overall Study|Withdrawal by Subject|3|||
126342391|NCT04889040|454550463|FG001|Overall Study|Withdrawal by Subject|3|||
126342392|NCT04889040|454550462|FG000|Overall Study|Lost to Follow-up|0|||
126342393|NCT04889040|454550463|FG001|Overall Study|Lost to Follow-up|1|||
126342394|NCT04889040|454550462|FG000|Overall Study|Adverse Event|2|||
126342395|NCT04889040|454550463|FG001|Overall Study|Adverse Event|1|||
126342396|NCT02058095|454550464|FG000|Overall Study|Adverse Event|1|||
126342397|NCT02058095|454550465|FG001|Overall Study|Adverse Event|0|||
126342398|NCT00316004|454550468|FG000|Overall Study|Subject was not given study fluid.|14|||
126342399|NCT00316004|454550469|FG001|Overall Study|Subject was not given study fluid.|14|||
126342400|NCT00316004|454550470|FG002|Overall Study|Subject was not given study fluid.|21|||
126342401|NCT00977197|454550473|FG000|Overall Study|Withdrawal by Subject|3|||
126342402|NCT00977197|454550474|FG001|Overall Study|Withdrawal by Subject|4|||
126342403|NCT00977197|454550473|FG000|Overall Study|Adverse Event|3|||
126342404|NCT00977197|454550474|FG001|Overall Study|Adverse Event|1|||
126342405|NCT00977197|454550473|FG000|Overall Study|Lack of Efficacy|1|||
126342406|NCT00977197|454550474|FG001|Overall Study|Lack of Efficacy|0|||
126342407|NCT00977197|454550473|FG000|Overall Study|Lost to Follow-up|1|||
126342408|NCT00977197|454550474|FG001|Overall Study|Lost to Follow-up|3|||
126342409|NCT00977197|454550473|FG000|Overall Study|Nonadherence|1|||
126342410|NCT00977197|454550474|FG001|Overall Study|Nonadherence|1|||
126342411|NCT00784875|454550475|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
126342412|NCT00784875|454550476|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
126342413|NCT00784875|454550477|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
126427679|NCT00861705|454862280|FG001|Overall Study|Never Began Treatment|3|||
126008080|NCT00984282|453322944|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
126008081|NCT00984282|453322943|FG000|Double Blind Treatment|Physician Decision|1|||
126008082|NCT00984282|453322944|FG001|Double Blind Treatment|Physician Decision|2|||
126046458|NCT02467270|453468226|FG000|Overall Study|Death|2|||
126427680|NCT00861705|454862281|FG002|Overall Study|Never Began Treatment|0|||
126427681|NCT00861705|454862282|FG003|Overall Study|Never Began Treatment|1|||
126427682|NCT06418152|454862284|FG000|Overall Study|Frequent DBS setting changes|1|||
126427683|NCT06418152|454862284|FG000|Overall Study|Withdrawal by Subject|2|||
126427684|NCT03653507|454862285|FG000|Overall Study|Miscellaneous|28|||
126427685|NCT03653507|454862286|FG001|Overall Study|Miscellaneous|19|||
126427686|NCT03653507|454862285|FG000|Overall Study|Withdrawal by Subject|37|||
126427687|NCT03653507|454862286|FG001|Overall Study|Withdrawal by Subject|22|||
126427688|NCT03653507|454862285|FG000|Overall Study|Protocol Deviation|2|||
126427689|NCT03653507|454862286|FG001|Overall Study|Protocol Deviation|1|||
126427690|NCT03653507|454862285|FG000|Overall Study|Progressive disease|117|||
126427691|NCT03653507|454862286|FG001|Overall Study|Progressive disease|168|||
126427692|NCT03653507|454862285|FG000|Overall Study|Lost to Follow-up|1|||
126427693|NCT03653507|454862286|FG001|Overall Study|Lost to Follow-up|1|||
126427694|NCT03653507|454862285|FG000|Overall Study|Death|25|||
126427695|NCT03653507|454862286|FG001|Overall Study|Death|22|||
126427696|NCT03653507|454862285|FG000|Overall Study|Adverse Event|35|||
126427697|NCT03653507|454862286|FG001|Overall Study|Adverse Event|14|||
126427698|NCT03360682|454862294|FG000|Overall Study|Adverse Event|3|||
126427699|NCT05381948|454862297|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
126427700|NCT05381948|454862298|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
126427701|NCT05381948|454862299|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
126427702|NCT05381948|454862297|FG000|Overall Study|Adverse Event: Non-ocular|0|||
126427703|NCT05381948|454862298|FG001|Overall Study|Adverse Event: Non-ocular|1|||
126427704|NCT05381948|454862299|FG002|Overall Study|Adverse Event: Non-ocular|0|||
126427705|NCT05381948|454862297|FG000|Overall Study|Lost to Follow-up|1|||
126427706|NCT05381948|454862298|FG001|Overall Study|Lost to Follow-up|0|||
126427707|NCT05381948|454862299|FG002|Overall Study|Lost to Follow-up|0|||
126427708|NCT05381948|454862297|FG000|Overall Study|Protocol Deviation|0|||
126427709|NCT05381948|454862298|FG001|Overall Study|Protocol Deviation|2|||
126427710|NCT05381948|454862299|FG002|Overall Study|Protocol Deviation|0|||
126427711|NCT05381948|454862297|FG000|Overall Study|Withdrawal by Subject|1|||
126008083|NCT00984282|453322943|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
126008084|NCT00984282|453322944|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
126008085|NCT00984282|453322943|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
126008086|NCT00984282|453322944|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
126008087|NCT00984282|453322943|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
126008088|NCT00984282|453322944|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
126008089|NCT00984282|453322943|FG000|Double Blind Treatment|Lost to Follow-up|3|||
126008090|NCT00984282|453322944|FG001|Double Blind Treatment|Lost to Follow-up|0|||
126008091|NCT00984282|453322943|FG000|Double Blind Treatment|Death|8|||
126008092|NCT00984282|453322944|FG001|Double Blind Treatment|Death|4|||
126008093|NCT00984282|453322943|FG000|Double Blind Treatment|Not treated|0|||
126008094|NCT00984282|453322944|FG001|Double Blind Treatment|Not treated|1|||
126008095|NCT00984282|453322943|FG000|Double Blind Treatment|Switched to commercial drug|6|||
126008096|NCT00984282|453322944|FG001|Double Blind Treatment|Switched to commercial drug|1|||
126008097|NCT00984282|453322943|FG000|Double Blind Treatment|protocol driven decision point|1|||
126008098|NCT00984282|453322944|FG001|Double Blind Treatment|protocol driven decision point|1|||
126008099|NCT00984282|453322943|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
126008100|NCT00984282|453322944|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
126008101|NCT00984282|453322943|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
126008102|NCT00984282|453322944|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
126008103|NCT00984282|453322943|FG000|Open-label Treatment|Adverse Event|20|||
126008104|NCT00984282|453322944|FG001|Open-label Treatment|Adverse Event|30|||
126008105|NCT00984282|453322943|FG000|Open-label Treatment|Withdrawal by Subject|6|||
126008106|NCT00984282|453322944|FG001|Open-label Treatment|Withdrawal by Subject|21|||
126008107|NCT00984282|453322943|FG000|Open-label Treatment|Death|7|||
126008108|NCT00984282|453322944|FG001|Open-label Treatment|Death|15|||
126008109|NCT00984282|453322943|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
126008110|NCT00984282|453322944|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
126008111|NCT00984282|453322943|FG000|Open-label Treatment|Lost to Follow-up|1|||
126008112|NCT00984282|453322944|FG001|Open-label Treatment|Lost to Follow-up|1|||
126008113|NCT00984282|453322943|FG000|Open-label Treatment|Patient convenience|1|||
126008114|NCT00984282|453322944|FG001|Open-label Treatment|Patient convenience|0|||
126008115|NCT00984282|453322943|FG000|Open-label Treatment|Non-compliant with study medication|1|||
126008116|NCT00984282|453322944|FG001|Open-label Treatment|Non-compliant with study medication|0|||
126008117|NCT00984282|453322943|FG000|Open-label Treatment|Target lesion removed|0|||
126427712|NCT05381948|454862298|FG001|Overall Study|Withdrawal by Subject|0|||
126427713|NCT05381948|454862299|FG002|Overall Study|Withdrawal by Subject|1|||
126427714|NCT05381948|454862297|FG000|Overall Study|Death|0|||
126427715|NCT05381948|454862298|FG001|Overall Study|Death|2|||
126427716|NCT05381948|454862299|FG002|Overall Study|Death|0|||
126427717|NCT05381948|454862297|FG000|Overall Study|Discontinued study without receiving study drug|0|||
126427718|NCT05381948|454862298|FG001|Overall Study|Discontinued study without receiving study drug|0|||
126008118|NCT00984282|453322944|FG001|Open-label Treatment|Target lesion removed|1|||
126008119|NCT00984282|453322943|FG000|Open-label Treatment|Protocol driven decision point|1|||
126008120|NCT00984282|453322944|FG001|Open-label Treatment|Protocol driven decision point|1|||
126008121|NCT00984282|453322943|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
126008122|NCT00984282|453322944|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
126008123|NCT00984282|453322943|FG000|Open-label Treatment|Switched to commercial drug|6|||
126008124|NCT00984282|453322944|FG001|Open-label Treatment|Switched to commercial drug|7|||
126008125|NCT00984282|453322943|FG000|Open-label Treatment|Physician Decision|1|||
126008126|NCT00984282|453322944|FG001|Open-label Treatment|Physician Decision|0|||
126008127|NCT00984282|453322943|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
126008128|NCT00984282|453322944|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
126008129|NCT00984282|453322943|FG000|Long Term Follow-up|Death|27|||
126008130|NCT00984282|453322944|FG001|Long Term Follow-up|Death|68|||
126008131|NCT00984282|453322943|FG000|Long Term Follow-up|Lost to Follow-up|3|||
126427719|NCT05381948|454862299|FG002|Overall Study|Discontinued study without receiving study drug|1|||
126427720|NCT04198428|454862300|FG000|Overall Study|Withdrawal by Subject|150|||
126427721|NCT04198428|454862301|FG001|Overall Study|Withdrawal by Subject|156|||
126008132|NCT00984282|453322944|FG001|Long Term Follow-up|Lost to Follow-up|6|||
126008133|NCT00984282|453322943|FG000|Long Term Follow-up|Protocol driven decision point|25|||
126008134|NCT00984282|453322944|FG001|Long Term Follow-up|Protocol driven decision point|26|||
126008135|NCT00984282|453322943|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
126008136|NCT00984282|453322944|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
126008137|NCT00984282|453322943|FG000|Long Term Follow-up|Switched to commercial drug|4|||
126008138|NCT00984282|453322944|FG001|Long Term Follow-up|Switched to commercial drug|2|||
126008139|NCT00984282|453322943|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
126008140|NCT00984282|453322944|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
126008141|NCT02223793|453322945|FG000|Overall Study|Lost to Follow-up|10|||
126008142|NCT02223793|453322946|FG001|Overall Study|Lost to Follow-up|1|||
126008143|NCT02223793|453322947|FG002|Overall Study|Lost to Follow-up|2|||
126008144|NCT02223793|453322945|FG000|Overall Study|Withdrawal by Subject|3|||
126008145|NCT02223793|453322946|FG001|Overall Study|Withdrawal by Subject|2|||
126008146|NCT02223793|453322947|FG002|Overall Study|Withdrawal by Subject|3|||
126008147|NCT02223793|453322945|FG000|Overall Study|Moved/studycenter unable to participate|4|||
126008148|NCT02223793|453322946|FG001|Overall Study|Moved/studycenter unable to participate|6|||
126008149|NCT02223793|453322947|FG002|Overall Study|Moved/studycenter unable to participate|8|||
126008150|NCT02359435|453322948|FG000|Overall Study|Lost to Follow-up|4|||
126008151|NCT02359435|453322949|FG001|Overall Study|Lost to Follow-up|4|||
126008152|NCT00315055|453322950|FG000|Overall Study|Protocol Violation|2|||
126008153|NCT00315055|453322951|FG001|Overall Study|Protocol Violation|4|||
126008154|NCT00315055|453322950|FG000|Overall Study|Lost to Follow-up|1|||
126008155|NCT00315055|453322951|FG001|Overall Study|Lost to Follow-up|1|||
126008156|NCT01289119|453322956|FG000|Overall Study|Adverse Event|2|||
126008157|NCT01289119|453322957|FG001|Overall Study|Adverse Event|1|||
126008158|NCT01289119|453322958|FG002|Overall Study|Adverse Event|0|||
126008159|NCT01289119|453322959|FG003|Overall Study|Adverse Event|2|||
126008160|NCT01289119|453322960|FG004|Overall Study|Adverse Event|1|||
126008161|NCT01289119|453322961|FG005|Overall Study|Adverse Event|0|||
126008162|NCT01289119|453322956|FG000|Overall Study|Major Protocol Deviation|2|||
126427722|NCT05104476|454862305|FG000|Overall Study|Randomized But Not Treated|1|||
126427723|NCT05104476|454862306|FG001|Overall Study|Randomized But Not Treated|2|||
126427724|NCT05104476|454862305|FG000|Overall Study|Adverse Event|2|||
126427725|NCT05104476|454862306|FG001|Overall Study|Adverse Event|2|||
126427726|NCT05104476|454862305|FG000|Overall Study|Withdrawal by Subject|3|||
126427727|NCT05104476|454862306|FG001|Overall Study|Withdrawal by Subject|3|||
126427728|NCT05104476|454862305|FG000|Overall Study|Other Than Specified|0|||
126427729|NCT05104476|454862306|FG001|Overall Study|Other Than Specified|3|||
126427730|NCT04649359|454862307|FG000|Overall Study|Withdrawal by Subject|7|||
126427731|NCT04649359|454862308|FG001|Overall Study|Withdrawal by Subject|7|||
126008163|NCT01289119|453322957|FG001|Overall Study|Major Protocol Deviation|1|||
126008164|NCT01289119|453322958|FG002|Overall Study|Major Protocol Deviation|3|||
126008165|NCT01289119|453322959|FG003|Overall Study|Major Protocol Deviation|0|||
126427732|NCT04649359|454862307|FG000|Overall Study|Death|41|||
126427733|NCT04649359|454862308|FG001|Overall Study|Death|26|||
126008166|NCT01289119|453322960|FG004|Overall Study|Major Protocol Deviation|2|||
126008167|NCT01289119|453322961|FG005|Overall Study|Major Protocol Deviation|1|||
126008168|NCT01289119|453322956|FG000|Overall Study|Lost to Follow-up|0|||
126008169|NCT01289119|453322957|FG001|Overall Study|Lost to Follow-up|3|||
126427734|NCT04649359|454862307|FG000|Overall Study|Ongoing in the study|75|||
126008170|NCT01289119|453322958|FG002|Overall Study|Lost to Follow-up|0|||
126008171|NCT01289119|453322959|FG003|Overall Study|Lost to Follow-up|0|||
126008172|NCT01289119|453322960|FG004|Overall Study|Lost to Follow-up|0|||
126008173|NCT01289119|453322961|FG005|Overall Study|Lost to Follow-up|1|||
126008174|NCT01289119|453322956|FG000|Overall Study|Withdrawal by Subject|4|||
126427735|NCT04649359|454862308|FG001|Overall Study|Ongoing in the study|31|||
126427736|NCT01701674|454862309|FG000|Overall Study|Unable to safely complete treatment|1|||
126427737|NCT05604170|454862310|FG000|Overall Study|Lack of Efficacy|5|||
126427738|NCT05604170|454862310|FG000|Overall Study|Adverse Event|6|||
126427739|NCT05604170|454862310|FG000|Overall Study|Physician Decision|6|||
126427740|NCT05604170|454862310|FG000|Overall Study|Lost to Follow-up|6|||
126427741|NCT05604170|454862310|FG000|Overall Study|Withdrawal by Subject|11|||
126427742|NCT05604170|454862310|FG000|Overall Study|Early study termination by sponsor|77|||
126427743|NCT05604170|454862310|FG000|Overall Study|Other|6|||
126427744|NCT04008030|454862311|FG000|Pre-Treatment|Withdrawal by Subject|0|||
126427745|NCT04008030|454862312|FG001|Pre-Treatment|Withdrawal by Subject|0|||
126427746|NCT04008030|454862313|FG002|Pre-Treatment|Withdrawal by Subject|9|||
126427747|NCT04008030|454862311|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
126427748|NCT04008030|454862312|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
126427749|NCT04008030|454862313|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
126427750|NCT04008030|454862311|FG000|Pre-Treatment|Other reasons|0|||
126427751|NCT04008030|454862312|FG001|Pre-Treatment|Other reasons|1|||
126427752|NCT04008030|454862313|FG002|Pre-Treatment|Other reasons|6|||
126427753|NCT04008030|454862311|FG000|Treatment|Withdrawal by Subject|1|||
126427754|NCT04008030|454862312|FG001|Treatment|Withdrawal by Subject|1|||
126427755|NCT04008030|454862313|FG002|Treatment|Withdrawal by Subject|1|||
126427756|NCT04008030|454862311|FG000|Treatment|Death|2|||
126427757|NCT04008030|454862312|FG001|Treatment|Death|4|||
126427758|NCT04008030|454862313|FG002|Treatment|Death|0|||
126427759|NCT04008030|454862311|FG000|Treatment|Pregnancy|0|||
126427760|NCT04008030|454862312|FG001|Treatment|Pregnancy|1|||
126427761|NCT04008030|454862313|FG002|Treatment|Pregnancy|0|||
126427762|NCT04008030|454862311|FG000|Treatment|Participant no longer meets study criteria|0|||
126427763|NCT04008030|454862312|FG001|Treatment|Participant no longer meets study criteria|1|||
126427764|NCT04008030|454862313|FG002|Treatment|Participant no longer meets study criteria|0|||
126427765|NCT04008030|454862311|FG000|Treatment|Other reasons|5|||
126427766|NCT04008030|454862312|FG001|Treatment|Other reasons|13|||
126427767|NCT04008030|454862313|FG002|Treatment|Other reasons|6|||
126427768|NCT04008030|454862311|FG000|Treatment|Disease Progression|137|||
126427769|NCT04008030|454862312|FG001|Treatment|Disease Progression|82|||
126427770|NCT04008030|454862313|FG002|Treatment|Disease Progression|85|||
126427771|NCT04008030|454862311|FG000|Treatment|Study drug toxicity|28|||
126427772|NCT04008030|454862312|FG001|Treatment|Study drug toxicity|48|||
126427773|NCT04008030|454862313|FG002|Treatment|Study drug toxicity|8|||
126427774|NCT04008030|454862311|FG000|Treatment|Adverse Event unrelated to study drug|28|||
126427775|NCT04008030|454862312|FG001|Treatment|Adverse Event unrelated to study drug|22|||
126427776|NCT04008030|454862313|FG002|Treatment|Adverse Event unrelated to study drug|6|||
126427777|NCT04008030|454862311|FG000|Treatment|Maximum Clinical Benefit|0|||
126427778|NCT04008030|454862312|FG001|Treatment|Maximum Clinical Benefit|1|||
126427779|NCT04008030|454862313|FG002|Treatment|Maximum Clinical Benefit|9|||
126427780|NCT04008030|454862311|FG000|Treatment|On-going treatment|13|||
126427781|NCT04008030|454862312|FG001|Treatment|On-going treatment|20|||
126427782|NCT04008030|454862313|FG002|Treatment|On-going treatment|0|||
126427783|NCT05767021|454862315|FG000|Overall Study|Adverse Event|2|||
126427784|NCT05767021|454862315|FG000|Overall Study|Protocol Deviation|1|||
126427785|NCT05767021|454862315|FG000|Overall Study|Withdrawal by Subject|1|||
126427786|NCT05767021|454862315|FG000|Overall Study|Physician Decision|1|||
126427787|NCT05767021|454862315|FG000|Overall Study|Lack of Efficacy|11|||
126427788|NCT05767021|454862315|FG000|Overall Study|Assigned Treatment by Mistake|1|||
126427789|NCT03032172|454862316|FG000|Treatment Period|Adverse Event|0|||
126427790|NCT03032172|454862317|FG001|Treatment Period|Adverse Event|1|||
126427791|NCT03032172|454862318|FG002|Treatment Period|Adverse Event|0|||
126427792|NCT03032172|454862319|FG003|Treatment Period|Adverse Event|0|||
126427793|NCT03032172|454862320|FG004|Treatment Period|Adverse Event|0|||
126427794|NCT03032172|454862321|FG005|Treatment Period|Adverse Event|0|||
126008175|NCT01289119|453322957|FG001|Overall Study|Withdrawal by Subject|2|||
126008176|NCT01289119|453322958|FG002|Overall Study|Withdrawal by Subject|4|||
126427795|NCT03032172|454862322|FG006|Treatment Period|Adverse Event|0|||
126427796|NCT03032172|454862323|FG007|Treatment Period|Adverse Event|0|||
126427797|NCT03032172|454862316|FG000|Treatment Period|Lack of Efficacy|0|||
126008177|NCT01289119|453322959|FG003|Overall Study|Withdrawal by Subject|3|||
126008178|NCT01289119|453322960|FG004|Overall Study|Withdrawal by Subject|1|||
126427798|NCT03032172|454862317|FG001|Treatment Period|Lack of Efficacy|1|||
126427799|NCT03032172|454862318|FG002|Treatment Period|Lack of Efficacy|0|||
126427800|NCT03032172|454862319|FG003|Treatment Period|Lack of Efficacy|0|||
126427801|NCT03032172|454862320|FG004|Treatment Period|Lack of Efficacy|0|||
126427802|NCT03032172|454862321|FG005|Treatment Period|Lack of Efficacy|0|||
126427803|NCT03032172|454862322|FG006|Treatment Period|Lack of Efficacy|0|||
126427804|NCT03032172|454862323|FG007|Treatment Period|Lack of Efficacy|0|||
126427805|NCT03032172|454862316|FG000|Treatment Period|Non-compliance With Study Drug|0|||
126427806|NCT03032172|454862317|FG001|Treatment Period|Non-compliance With Study Drug|1|||
126427807|NCT03032172|454862318|FG002|Treatment Period|Non-compliance With Study Drug|0|||
126427808|NCT03032172|454862319|FG003|Treatment Period|Non-compliance With Study Drug|0|||
126427809|NCT03032172|454862320|FG004|Treatment Period|Non-compliance With Study Drug|0|||
126008179|NCT01289119|453322961|FG005|Overall Study|Withdrawal by Subject|1|||
126427810|NCT03032172|454862321|FG005|Treatment Period|Non-compliance With Study Drug|0|||
126427811|NCT03032172|454862322|FG006|Treatment Period|Non-compliance With Study Drug|0|||
126427812|NCT03032172|454862323|FG007|Treatment Period|Non-compliance With Study Drug|0|||
126427813|NCT03032172|454862316|FG000|Treatment Period|Reason Not Specified|0|||
126427814|NCT03032172|454862317|FG001|Treatment Period|Reason Not Specified|4|||
126427815|NCT03032172|454862318|FG002|Treatment Period|Reason Not Specified|1|||
126427816|NCT03032172|454862319|FG003|Treatment Period|Reason Not Specified|0|||
126427817|NCT03032172|454862320|FG004|Treatment Period|Reason Not Specified|0|||
126427818|NCT03032172|454862321|FG005|Treatment Period|Reason Not Specified|0|||
126427819|NCT03032172|454862322|FG006|Treatment Period|Reason Not Specified|0|||
126427820|NCT03032172|454862323|FG007|Treatment Period|Reason Not Specified|0|||
126427821|NCT03032172|454862316|FG000|Treatment Period|Physician Decision|0|||
126427822|NCT03032172|454862317|FG001|Treatment Period|Physician Decision|2|||
126427823|NCT03032172|454862318|FG002|Treatment Period|Physician Decision|1|||
126427824|NCT03032172|454862319|FG003|Treatment Period|Physician Decision|0|||
126427825|NCT03032172|454862320|FG004|Treatment Period|Physician Decision|0|||
126427826|NCT03032172|454862321|FG005|Treatment Period|Physician Decision|0|||
126427827|NCT03032172|454862322|FG006|Treatment Period|Physician Decision|0|||
126427828|NCT03032172|454862323|FG007|Treatment Period|Physician Decision|0|||
126427829|NCT03032172|454862316|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126427830|NCT03032172|454862317|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
126427831|NCT03032172|454862318|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
126427832|NCT03032172|454862319|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
126427833|NCT03032172|454862320|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126427834|NCT03032172|454862321|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126427835|NCT03032172|454862322|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126427836|NCT03032172|454862323|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126427837|NCT03032172|454862316|FG000|Treatment Period|Withdrawal by Subject|2|||
126427838|NCT03032172|454862317|FG001|Treatment Period|Withdrawal by Subject|0|||
126427839|NCT03032172|454862318|FG002|Treatment Period|Withdrawal by Subject|3|||
126427840|NCT03032172|454862319|FG003|Treatment Period|Withdrawal by Subject|0|||
126427841|NCT03032172|454862320|FG004|Treatment Period|Withdrawal by Subject|0|||
126427842|NCT03032172|454862321|FG005|Treatment Period|Withdrawal by Subject|0|||
126427843|NCT03032172|454862322|FG006|Treatment Period|Withdrawal by Subject|0|||
126427844|NCT03032172|454862323|FG007|Treatment Period|Withdrawal by Subject|0|||
126427845|NCT03032172|454862316|FG000|Open-label Extension Period|Death|0|||
126427846|NCT03032172|454862317|FG001|Open-label Extension Period|Death|0|||
126427847|NCT03032172|454862318|FG002|Open-label Extension Period|Death|0|||
126427848|NCT03032172|454862319|FG003|Open-label Extension Period|Death|0|||
126427849|NCT03032172|454862320|FG004|Open-label Extension Period|Death|0|||
126427850|NCT03032172|454862321|FG005|Open-label Extension Period|Death|0|||
126427851|NCT03032172|454862322|FG006|Open-label Extension Period|Death|0|||
126427852|NCT03032172|454862323|FG007|Open-label Extension Period|Death|2|||
126427853|NCT03032172|454862316|FG000|Open-label Extension Period|Reason Not Specified|0|||
126427854|NCT03032172|454862317|FG001|Open-label Extension Period|Reason Not Specified|0|||
126427855|NCT03032172|454862318|FG002|Open-label Extension Period|Reason Not Specified|0|||
126427856|NCT03032172|454862319|FG003|Open-label Extension Period|Reason Not Specified|0|||
126427857|NCT03032172|454862320|FG004|Open-label Extension Period|Reason Not Specified|0|||
126427858|NCT03032172|454862321|FG005|Open-label Extension Period|Reason Not Specified|5|||
126427859|NCT03032172|454862322|FG006|Open-label Extension Period|Reason Not Specified|3|||
126427860|NCT03032172|454862323|FG007|Open-label Extension Period|Reason Not Specified|0|||
126427861|NCT03032172|454862316|FG000|Open-label Extension Period|Pregnancy|0|||
126427862|NCT03032172|454862317|FG001|Open-label Extension Period|Pregnancy|0|||
126427863|NCT03032172|454862318|FG002|Open-label Extension Period|Pregnancy|0|||
126427864|NCT03032172|454862319|FG003|Open-label Extension Period|Pregnancy|0|||
126427865|NCT03032172|454862320|FG004|Open-label Extension Period|Pregnancy|0|||
126427866|NCT03032172|454862321|FG005|Open-label Extension Period|Pregnancy|0|||
126427867|NCT03032172|454862322|FG006|Open-label Extension Period|Pregnancy|1|||
126427868|NCT03032172|454862323|FG007|Open-label Extension Period|Pregnancy|0|||
126427869|NCT03032172|454862316|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126427870|NCT03032172|454862317|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
126427871|NCT03032172|454862318|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
126427872|NCT03032172|454862319|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
126427873|NCT03032172|454862320|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
126427874|NCT03032172|454862321|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
126008180|NCT01289119|453322956|FG000|Overall Study|Pregnancy|0|||
126008181|NCT01289119|453322957|FG001|Overall Study|Pregnancy|1|||
126427875|NCT03032172|454862322|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
126008182|NCT01289119|453322958|FG002|Overall Study|Pregnancy|0|||
126427876|NCT03032172|454862323|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
126427877|NCT04751929|454862331|FG000|Overall Study|Withdrawal by Subject|2|||
126342414|NCT00784875|454550478|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
126342415|NCT00784875|454550475|FG000|Period A - Baseline|Adverse Event|0|||
126342416|NCT00784875|454550476|FG001|Period A - Baseline|Adverse Event|0|||
126342417|NCT00784875|454550477|FG002|Period A - Baseline|Adverse Event|0|||
126342418|NCT00784875|454550478|FG003|Period A - Baseline|Adverse Event|8|||
126342419|NCT00784875|454550475|FG000|Period A - Baseline|Protocol Violation|0|||
126342420|NCT00784875|454550476|FG001|Period A - Baseline|Protocol Violation|0|||
126342421|NCT00784875|454550477|FG002|Period A - Baseline|Protocol Violation|0|||
126342422|NCT00784875|454550478|FG003|Period A - Baseline|Protocol Violation|25|||
126342423|NCT00784875|454550475|FG000|Period A - Baseline|Withdrawal by Subject|0|||
126342424|NCT00784875|454550476|FG001|Period A - Baseline|Withdrawal by Subject|0|||
126342425|NCT00784875|454550477|FG002|Period A - Baseline|Withdrawal by Subject|0|||
126342426|NCT00784875|454550478|FG003|Period A - Baseline|Withdrawal by Subject|27|||
126342427|NCT00784875|454550475|FG000|Period A - Baseline|Physician Decision|0|||
126342428|NCT00784875|454550476|FG001|Period A - Baseline|Physician Decision|0|||
126342429|NCT00784875|454550477|FG002|Period A - Baseline|Physician Decision|0|||
126342430|NCT00784875|454550478|FG003|Period A - Baseline|Physician Decision|2|||
126342431|NCT00784875|454550475|FG000|Period A - Baseline|Sponsor Decision|0|||
126342432|NCT00784875|454550476|FG001|Period A - Baseline|Sponsor Decision|0|||
126342433|NCT00784875|454550477|FG002|Period A - Baseline|Sponsor Decision|0|||
126342434|NCT00784875|454550478|FG003|Period A - Baseline|Sponsor Decision|113|||
126342435|NCT00784875|454550475|FG000|Period A - Baseline|Lost to Follow-up|0|||
126342436|NCT00784875|454550476|FG001|Period A - Baseline|Lost to Follow-up|0|||
126342437|NCT00784875|454550477|FG002|Period A - Baseline|Lost to Follow-up|0|||
126342438|NCT00784875|454550478|FG003|Period A - Baseline|Lost to Follow-up|2|||
126342439|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
126342440|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
126342441|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
126342442|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
126342443|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
126342444|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
126342445|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
126342446|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
126342447|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
126342448|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
126342449|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
126342450|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
126342451|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
126342452|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
126342453|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
126342454|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
126342455|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
126342456|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
126342457|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
126342458|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
126342459|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
126342460|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
126342461|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
126342462|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
126342463|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
126342464|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
126342465|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
126342466|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
126342467|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
126342468|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
126342469|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
126342470|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
126342471|NCT00784875|454550475|FG000|Period C|Adverse Event|1|||
126342472|NCT00784875|454550476|FG001|Period C|Adverse Event|0|||
126342473|NCT00784875|454550477|FG002|Period C|Adverse Event|4|||
126342474|NCT00784875|454550478|FG003|Period C|Adverse Event|2|||
126342475|NCT00784875|454550475|FG000|Period C|Protocol Violation|0|||
126342476|NCT00784875|454550476|FG001|Period C|Protocol Violation|0|||
126342477|NCT00784875|454550477|FG002|Period C|Protocol Violation|1|||
126342478|NCT00784875|454550478|FG003|Period C|Protocol Violation|2|||
126342479|NCT00784875|454550475|FG000|Period C|Lack of Efficacy|0|||
126342480|NCT00784875|454550476|FG001|Period C|Lack of Efficacy|0|||
126342481|NCT00784875|454550477|FG002|Period C|Lack of Efficacy|1|||
126342482|NCT00784875|454550478|FG003|Period C|Lack of Efficacy|0|||
126342483|NCT00784875|454550475|FG000|Period C|Withdrawal by Subject|1|||
126427878|NCT04751929|454862332|FG001|Overall Study|Withdrawal by Subject|0|||
126342484|NCT00784875|454550476|FG001|Period C|Withdrawal by Subject|1|||
126342485|NCT00784875|454550477|FG002|Period C|Withdrawal by Subject|2|||
126342486|NCT00784875|454550478|FG003|Period C|Withdrawal by Subject|0|||
126427879|NCT04751929|454862333|FG002|Overall Study|Withdrawal by Subject|0|||
126427880|NCT04751929|454862334|FG003|Overall Study|Withdrawal by Subject|0|||
126427881|NCT04751929|454862331|FG000|Overall Study|Rising PSA|0|||
126427882|NCT04751929|454862332|FG001|Overall Study|Rising PSA|1|||
126427883|NCT04751929|454862333|FG002|Overall Study|Rising PSA|0|||
126427884|NCT04751929|454862334|FG003|Overall Study|Rising PSA|0|||
126427885|NCT04751929|454862331|FG000|Overall Study|Adverse Event|1|||
126427886|NCT04751929|454862332|FG001|Overall Study|Adverse Event|2|||
126427887|NCT04751929|454862333|FG002|Overall Study|Adverse Event|0|||
126427888|NCT04751929|454862334|FG003|Overall Study|Adverse Event|0|||
126427889|NCT04751929|454862331|FG000|Overall Study|Progressive Disease|3|||
126008183|NCT01289119|453322959|FG003|Overall Study|Pregnancy|0|||
126008184|NCT01289119|453322960|FG004|Overall Study|Pregnancy|0|||
126008185|NCT01289119|453322961|FG005|Overall Study|Pregnancy|0|||
126008186|NCT01289119|453322956|FG000|Overall Study|Lack of Efficacy|0|||
126008187|NCT01289119|453322957|FG001|Overall Study|Lack of Efficacy|1|||
126008188|NCT01289119|453322958|FG002|Overall Study|Lack of Efficacy|1|||
126008189|NCT01289119|453322959|FG003|Overall Study|Lack of Efficacy|1|||
126008190|NCT01289119|453322960|FG004|Overall Study|Lack of Efficacy|1|||
126008191|NCT01289119|453322961|FG005|Overall Study|Lack of Efficacy|1|||
126008192|NCT01289119|453322956|FG000|Overall Study|Other|1|||
126008193|NCT01289119|453322957|FG001|Overall Study|Other|0|||
126008194|NCT01289119|453322958|FG002|Overall Study|Other|1|||
126008195|NCT01289119|453322959|FG003|Overall Study|Other|0|||
126008196|NCT01289119|453322960|FG004|Overall Study|Other|0|||
126008197|NCT01289119|453322961|FG005|Overall Study|Other|0|||
126008198|NCT01704846|453322962|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126008199|NCT01704846|453322963|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126008200|NCT03467724|453322966|FG000|Overall Study|Lost to Follow-up|5|||
126008201|NCT03467724|453322966|FG000|Overall Study|Withdrawal by Subject|1|||
126008202|NCT03467724|453322966|FG000|Overall Study|Protocol Violation|1|||
126008203|NCT03467724|453322966|FG000|Overall Study|Adverse Event|1|||
126008204|NCT01908634|453322968|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
126008205|NCT01908634|453322968|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
126008206|NCT04176458|453322969|FG000|Overall Study|Covid 19|4|||
126008207|NCT01570751|453322970|FG000|Period A (16 Weeks)|Protocol Violation|1|||
126008208|NCT01570751|453322971|FG001|Period A (16 Weeks)|Protocol Violation|1|||
126008209|NCT01570751|453322970|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
126008210|NCT01570751|453322971|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
126008211|NCT01570751|453322970|FG000|Period A (16 Weeks)|Unclassified|2|||
126008212|NCT01570751|453322971|FG001|Period A (16 Weeks)|Unclassified|3|||
126008213|NCT01570751|453322970|FG000|Period B (16 Weeks)|Adverse Event|1|||
126008214|NCT01570751|453322971|FG001|Period B (16 Weeks)|Adverse Event|0|||
126008215|NCT01570751|453322970|FG000|Period B (16 Weeks)|Protocol Violation|0|||
126008216|NCT01570751|453322971|FG001|Period B (16 Weeks)|Protocol Violation|1|||
126342487|NCT00784875|454550475|FG000|Period C|Physician Decision|0|||
126342488|NCT00784875|454550476|FG001|Period C|Physician Decision|0|||
126342489|NCT00784875|454550477|FG002|Period C|Physician Decision|1|||
126342490|NCT00784875|454550478|FG003|Period C|Physician Decision|1|||
126091101|NCT03820947|453626918|FG000|Overall Study|Withdrawal by Subject|6|||
126091102|NCT03820947|453626919|FG001|Overall Study|Withdrawal by Subject|10|||
126091103|NCT03820947|453626920|FG002|Overall Study|Withdrawal by Subject|3|||
126091104|NCT03820947|453626921|FG003|Overall Study|Withdrawal by Subject|8|||
126342491|NCT00784875|454550475|FG000|Period C|Sponsor Decision|5|||
126342492|NCT00784875|454550476|FG001|Period C|Sponsor Decision|5|||
126342493|NCT00784875|454550477|FG002|Period C|Sponsor Decision|4|||
126342494|NCT00784875|454550478|FG003|Period C|Sponsor Decision|2|||
126342495|NCT00784875|454550475|FG000|Period D|Adverse Event|0|||
126342496|NCT00784875|454550476|FG001|Period D|Adverse Event|2|||
126342497|NCT00784875|454550477|FG002|Period D|Adverse Event|2|||
126342498|NCT00784875|454550478|FG003|Period D|Adverse Event|0|||
126008217|NCT05790408|453322972|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
126342499|NCT00784875|454550475|FG000|Period D|Protocol Violation|1|||
126342500|NCT00784875|454550476|FG001|Period D|Protocol Violation|0|||
126342501|NCT00784875|454550477|FG002|Period D|Protocol Violation|0|||
126342502|NCT00784875|454550478|FG003|Period D|Protocol Violation|0|||
126008218|NCT02145182|453322974|FG000|Overall Study|Adverse Event|4|||
126008219|NCT02145182|453322975|FG001|Overall Study|Adverse Event|1|||
126008220|NCT02145182|453322974|FG000|Overall Study|Death|7|||
126008221|NCT02145182|453322975|FG001|Overall Study|Death|7|||
126008222|NCT02145182|453322974|FG000|Overall Study|Lost to Follow-up|2|||
126008223|NCT02145182|453322975|FG001|Overall Study|Lost to Follow-up|2|||
126008224|NCT02145182|453322974|FG000|Overall Study|Pre-transplant Withdrawal|0|||
126008225|NCT02145182|453322975|FG001|Overall Study|Pre-transplant Withdrawal|2|||
126008226|NCT02145182|453322974|FG000|Overall Study|Withdrawal by Subject|5|||
126008227|NCT02145182|453322975|FG001|Overall Study|Withdrawal by Subject|4|||
126342503|NCT00784875|454550475|FG000|Period D|Withdrawal by Subject|2|||
126342504|NCT00784875|454550476|FG001|Period D|Withdrawal by Subject|0|||
126427890|NCT04751929|454862332|FG001|Overall Study|Progressive Disease|4|||
126427891|NCT04751929|454862333|FG002|Overall Study|Progressive Disease|4|||
126008228|NCT00588666|453322977|FG000|Overall Study|Adverse Event|4|||
126008229|NCT02274493|453322980|FG000|Overall Study|Withdrawal by Subject|1|||
126008230|NCT00558363|453322981|FG000|Overall Study|Physician Decision|18|||
126008231|NCT00558363|453322982|FG001|Overall Study|Physician Decision|4|||
126008232|NCT00558363|453322981|FG000|Overall Study|Withdrawal by Subject|11|||
126008233|NCT00558363|453322982|FG001|Overall Study|Withdrawal by Subject|4|||
126008234|NCT00558363|453322981|FG000|Overall Study|Adverse Event|5|||
126008235|NCT00558363|453322982|FG001|Overall Study|Adverse Event|5|||
126008236|NCT00558363|453322981|FG000|Overall Study|Lack of Efficacy|2|||
126008237|NCT00558363|453322982|FG001|Overall Study|Lack of Efficacy|2|||
126008238|NCT00558363|453322981|FG000|Overall Study|Protocol Violation|2|||
126008239|NCT00558363|453322982|FG001|Overall Study|Protocol Violation|1|||
126008240|NCT00558363|453322981|FG000|Overall Study|Lost to Follow-up|0|||
126342505|NCT00784875|454550477|FG002|Period D|Withdrawal by Subject|2|||
126342506|NCT00784875|454550478|FG003|Period D|Withdrawal by Subject|0|||
126342507|NCT00784875|454550475|FG000|Period D|Physician Decision|0|||
126342508|NCT00784875|454550476|FG001|Period D|Physician Decision|1|||
126342509|NCT00784875|454550477|FG002|Period D|Physician Decision|0|||
126342510|NCT00784875|454550478|FG003|Period D|Physician Decision|0|||
126342511|NCT00784875|454550475|FG000|Period D|Sponsor Decision|1|||
126342512|NCT00784875|454550476|FG001|Period D|Sponsor Decision|1|||
126342513|NCT00784875|454550477|FG002|Period D|Sponsor Decision|1|||
126342514|NCT00784875|454550478|FG003|Period D|Sponsor Decision|0|||
126342515|NCT00784875|454550475|FG000|Period D|Lost to Follow-up|1|||
126342516|NCT00784875|454550476|FG001|Period D|Lost to Follow-up|0|||
126342517|NCT00784875|454550477|FG002|Period D|Lost to Follow-up|1|||
126342518|NCT00784875|454550478|FG003|Period D|Lost to Follow-up|1|||
126342519|NCT02842866|454550479|FG000|Overall Study|Serious Adverse Event|0|||
126342520|NCT02842866|454550480|FG001|Overall Study|Serious Adverse Event|1|||
126342521|NCT02842866|454550479|FG000|Overall Study|Protocol Violation|4|||
126342522|NCT02842866|454550480|FG001|Overall Study|Protocol Violation|2|||
126342523|NCT02842866|454550479|FG000|Overall Study|Lost to Follow-up|2|||
126342524|NCT02842866|454550480|FG001|Overall Study|Lost to Follow-up|0|||
126342525|NCT02842866|454550479|FG000|Overall Study|Withdrawal by Subject|1|||
126342526|NCT02842866|454550480|FG001|Overall Study|Withdrawal by Subject|0|||
126342527|NCT02897349|454550485|FG000|Overall Study|Lost to Follow-up|2|||
126342528|NCT02897349|454550486|FG001|Overall Study|Lost to Follow-up|2|||
126342529|NCT02897349|454550485|FG000|Overall Study|Adverse Event|3|||
126342530|NCT02897349|454550486|FG001|Overall Study|Adverse Event|3|||
126342531|NCT02897349|454550485|FG000|Overall Study|Other than listed above|0|||
126342532|NCT02897349|454550486|FG001|Overall Study|Other than listed above|1|||
126342533|NCT01027949|454550492|FG000|Overall Study|Death|174|||
126342534|NCT01027949|454550492|FG000|Overall Study|Progressive Disease|163|||
126342535|NCT01027949|454550492|FG000|Overall Study|Adverse Event|172|||
126342536|NCT01027949|454550492|FG000|Overall Study|Withdrawal by Subject|113|||
126342537|NCT01027949|454550492|FG000|Overall Study|Lost to Follow-up|17|||
126342538|NCT01027949|454550492|FG000|Overall Study|Protocol Violation|13|||
126342539|NCT01027949|454550492|FG000|Overall Study|PI Decision|8|||
126342540|NCT01027949|454550492|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
126342541|NCT01027949|454550492|FG000|Overall Study|Non-compliance with Study Procedures|7|||
126342542|NCT01027949|454550492|FG000|Overall Study|Lung Transplant|5|||
126342543|NCT01027949|454550492|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
126342544|NCT01027949|454550492|FG000|Overall Study|Use of Excluded Medication|2|||
126342545|NCT01027949|454550492|FG000|Overall Study|Patient Self-discontinuation|1|||
126342546|NCT01027949|454550492|FG000|Overall Study|Pregnancy|1|||
126342547|NCT01027949|454550492|FG000|Overall Study|Surgery|1|||
126008241|NCT00558363|453322982|FG001|Overall Study|Lost to Follow-up|1|||
126008242|NCT00558363|453322981|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
126008243|NCT00558363|453322982|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
126008244|NCT00558363|453322981|FG000|Overall Study|Randomized in Error|1|||
126008245|NCT00558363|453322982|FG001|Overall Study|Randomized in Error|2|||
126342548|NCT00671749|454550495|FG000|Overall Study|Adverse Event|2|||
126342549|NCT00671749|454550495|FG000|Overall Study|Withdrawal by Subject|4|||
126342550|NCT00671749|454550495|FG000|Overall Study|Protocol Violation|1|||
126342551|NCT00671749|454550495|FG000|Overall Study|Lost to Follow-up|1|||
126342552|NCT02515227|454550496|FG000|Overall Study|Adverse Event|0|||
126342553|NCT02515227|454550497|FG001|Overall Study|Adverse Event|2|||
126342554|NCT02515227|454550496|FG000|Overall Study|Progressive disease|2|||
126342555|NCT02515227|454550497|FG001|Overall Study|Progressive disease|9|||
126342556|NCT03451071|454550498|FG000|First Vaccine|Withdrawal by Subject|1|||
126342557|NCT03451071|454550498|FG000|Second Vaccine|Lost to Follow-up|19|||
126342558|NCT03451071|454550498|FG000|Third Vaccine|Lost to Follow-up|22|||
126342559|NCT03451071|454550498|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
126008246|NCT00558363|453322981|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
126008247|NCT00558363|453322982|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
126008248|NCT03102710|453322983|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
126342560|NCT01901185|454550499|FG000|Overall Study|Withdrawal by Subject|2|||
126342561|NCT03502798|454550500|FG000|Overall Study|equipment failure|0|||
126342562|NCT03502798|454550501|FG001|Overall Study|equipment failure|7|||
126008249|NCT03102710|453322984|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
126008250|NCT03102710|453322985|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
126008251|NCT03102710|453322983|FG000|Overall Study|Technical issues during final MRI scan|0|||
126008252|NCT03102710|453322984|FG001|Overall Study|Technical issues during final MRI scan|1|||
126008253|NCT03102710|453322985|FG002|Overall Study|Technical issues during final MRI scan|0|||
126008254|NCT03102710|453322983|FG000|Overall Study|Nausea during MRI scan|0|||
126008255|NCT03102710|453322984|FG001|Overall Study|Nausea during MRI scan|1|||
126008256|NCT03102710|453322985|FG002|Overall Study|Nausea during MRI scan|0|||
126008257|NCT03102710|453322983|FG000|Overall Study|Subject unable to attend final session|0|||
126008258|NCT03102710|453322984|FG001|Overall Study|Subject unable to attend final session|1|||
126008259|NCT03102710|453322985|FG002|Overall Study|Subject unable to attend final session|0|||
126008260|NCT04012853|453322986|FG000|Overall Study|Withdrawal by Subject|1|||
126008261|NCT04012853|453322987|FG001|Overall Study|Withdrawal by Subject|1|||
126008262|NCT04012853|453322986|FG000|Overall Study|Protocol Violation|1|||
126008263|NCT04012853|453322987|FG001|Overall Study|Protocol Violation|0|||
126008264|NCT04012853|453322986|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
126008265|NCT04012853|453322987|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
126008266|NCT01101165|453322990|FG000|Period 1|Adverse Event|1|||
126008267|NCT01101165|453322991|FG001|Period 1|Adverse Event|2|||
126008268|NCT01101165|453322990|FG000|Period 1|Withdrawal by Subject|0|||
126008269|NCT01101165|453322991|FG001|Period 1|Withdrawal by Subject|2|||
126008270|NCT01101165|453322990|FG000|Period 1|Positive Drug Screen|0|||
126008271|NCT01101165|453322991|FG001|Period 1|Positive Drug Screen|1|||
126008272|NCT01101165|453322990|FG000|Period 1|Lost to Follow-up|1|||
126008273|NCT01101165|453322991|FG001|Period 1|Lost to Follow-up|0|||
126008274|NCT01101165|453322990|FG000|Period 2|Withdrawal by Subject|3|||
126008275|NCT01101165|453322991|FG001|Period 2|Withdrawal by Subject|1|||
126008276|NCT01101165|453322990|FG000|Period 2|Adverse Event|1|||
126008277|NCT01101165|453322991|FG001|Period 2|Adverse Event|0|||
126008278|NCT00015457|453322992|FG000|First Intervention|Adverse Event|0|||
126008279|NCT00015457|453322993|FG001|First Intervention|Adverse Event|2|||
126008280|NCT00015457|453322992|FG000|First Intervention|Lack of Efficacy|0|||
126008281|NCT00015457|453322993|FG001|First Intervention|Lack of Efficacy|1|||
126008282|NCT00015457|453322992|FG000|Second Intervention|Withdrawal by Subject|1|||
126008283|NCT00015457|453322993|FG001|Second Intervention|Withdrawal by Subject|0|||
126008284|NCT02219490|453322994|FG000|Overall Study|Adverse Event|24|||
126008285|NCT02219490|453322994|FG000|Overall Study|Withdrew consent|96|||
126008286|NCT02219490|453322994|FG000|Overall Study|Lost to Follow-up|126|||
126008287|NCT02219490|453322994|FG000|Overall Study|COVID-19 infection|2|||
126008288|NCT02219490|453322994|FG000|Overall Study|COVID-19 logistical restrictions|33|||
126008289|NCT02219490|453322994|FG000|Overall Study|Other, not specified|57|||
126008290|NCT03404843|453322998|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
126008291|NCT03404843|453322999|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
126008292|NCT00567164|453323000|FG000|Overall Study|Withdrawal by Subject|171|||
126008293|NCT00567164|453323001|FG001|Overall Study|Withdrawal by Subject|21|||
126008294|NCT00567164|453323002|FG002|Overall Study|Withdrawal by Subject|17|||
126008295|NCT00567164|453323000|FG000|Overall Study|Protocol Violation|23|||
126008296|NCT00567164|453323001|FG001|Overall Study|Protocol Violation|4|||
126008297|NCT00567164|453323002|FG002|Overall Study|Protocol Violation|2|||
126008298|NCT00567164|453323000|FG000|Overall Study|Adverse Event|92|||
126008299|NCT00567164|453323001|FG001|Overall Study|Adverse Event|13|||
126008300|NCT00567164|453323002|FG002|Overall Study|Adverse Event|9|||
126008301|NCT00567164|453323000|FG000|Overall Study|Death|0|||
126008302|NCT00567164|453323001|FG001|Overall Study|Death|0|||
126008303|NCT00567164|453323002|FG002|Overall Study|Death|1|||
126008304|NCT00567164|453323000|FG000|Overall Study|Lost to Follow-up|202|||
126008305|NCT00567164|453323001|FG001|Overall Study|Lost to Follow-up|23|||
126008306|NCT00567164|453323002|FG002|Overall Study|Lost to Follow-up|21|||
126008307|NCT00567164|453323000|FG000|Overall Study|Pregnancy|20|||
126008308|NCT00567164|453323001|FG001|Overall Study|Pregnancy|4|||
126008309|NCT00567164|453323002|FG002|Overall Study|Pregnancy|6|||
126008310|NCT00567164|453323000|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
126008311|NCT00567164|453323001|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
126209501|NCT03110107|454055406|FG013|Treatment Period|Adverse Event|0|||
126008312|NCT00567164|453323002|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
126008313|NCT00567164|453323000|FG000|Overall Study|Missing|1|||
126008314|NCT00567164|453323001|FG001|Overall Study|Missing|0|||
126008315|NCT00567164|453323002|FG002|Overall Study|Missing|0|||
126008316|NCT02430532|453323003|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
126008317|NCT02430532|453323004|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
126008318|NCT02430532|453323003|FG000|Overall Study|Consent Withdrawn|0|||
126008319|NCT02430532|453323004|FG001|Overall Study|Consent Withdrawn|2|||
126008320|NCT02430532|453323003|FG000|Overall Study|Adverse Event|0|||
126008321|NCT02430532|453323004|FG001|Overall Study|Adverse Event|1|||
126008322|NCT00121199|453323016|FG000|Overall Study|Adverse Event|11|||
126008323|NCT00121199|453323016|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126008324|NCT00121199|453323016|FG000|Overall Study|Progression/Relapse|1|||
126427892|NCT04751929|454862334|FG003|Overall Study|Progressive Disease|0|||
126427893|NCT04751929|454862331|FG000|Overall Study|Death|1|||
126427894|NCT04751929|454862332|FG001|Overall Study|Death|1|||
126427895|NCT04751929|454862333|FG002|Overall Study|Death|0|||
126427896|NCT04751929|454862334|FG003|Overall Study|Death|0|||
126427897|NCT04154943|454862336|FG000|Overall Study|Study Ongoing|68|||
126427898|NCT04154943|454862336|FG000|Overall Study|Lost to Follow-up|1|||
126427899|NCT04154943|454862336|FG000|Overall Study|Decision by the Investigator|1|||
126427900|NCT04154943|454862336|FG000|Overall Study|Death|5|||
126427901|NCT04154943|454862336|FG000|Overall Study|Withdrawal by Subject|4|||
126427902|NCT02869867|454862337|FG000|Overall Study|Protocol Violation|1|||
126427903|NCT02869867|454862338|FG001|Overall Study|Protocol Violation|0|||
126427904|NCT02869867|454862337|FG000|Overall Study|Lost to Follow-up|5|||
126427905|NCT02869867|454862338|FG001|Overall Study|Lost to Follow-up|5|||
126427906|NCT06284525|454862340|FG000|Overall Study|Withdrawal by Subject|1|||
126427907|NCT02069366|454862341|FG000|Overall Study|Lost to Follow-up|0|||
126427908|NCT02069366|454862342|FG001|Overall Study|Lost to Follow-up|0|||
126427909|NCT02069366|454862343|FG002|Overall Study|Lost to Follow-up|1|||
126427910|NCT02069366|454862344|FG003|Overall Study|Lost to Follow-up|0|||
126427911|NCT02069366|454862345|FG004|Overall Study|Lost to Follow-up|0|||
126427912|NCT02069366|454862346|FG005|Overall Study|Lost to Follow-up|2|||
126427913|NCT02069366|454862341|FG000|Overall Study|Protocol Violation|0|||
126427914|NCT02069366|454862342|FG001|Overall Study|Protocol Violation|0|||
126427915|NCT02069366|454862343|FG002|Overall Study|Protocol Violation|1|||
126427916|NCT02069366|454862344|FG003|Overall Study|Protocol Violation|0|||
126427917|NCT02069366|454862345|FG004|Overall Study|Protocol Violation|0|||
126427918|NCT02069366|454862346|FG005|Overall Study|Protocol Violation|0|||
126427919|NCT02069366|454862341|FG000|Overall Study|Withdrawal by Subject|1|||
126427920|NCT02069366|454862342|FG001|Overall Study|Withdrawal by Subject|0|||
126427921|NCT02069366|454862343|FG002|Overall Study|Withdrawal by Subject|1|||
126427922|NCT02069366|454862344|FG003|Overall Study|Withdrawal by Subject|2|||
126427923|NCT02069366|454862345|FG004|Overall Study|Withdrawal by Subject|0|||
126427924|NCT02069366|454862346|FG005|Overall Study|Withdrawal by Subject|0|||
126427925|NCT04516967|454862347|FG000|Core Phase|Adverse Event|2|||
126427926|NCT04516967|454862348|FG001|Core Phase|Adverse Event|1|||
126427927|NCT04516967|454862349|FG002|Core Phase|Adverse Event|0|||
126427928|NCT04516967|454862347|FG000|Core Phase|Physician Decision|1|||
126427929|NCT04516967|454862348|FG001|Core Phase|Physician Decision|1|||
126427930|NCT04516967|454862349|FG002|Core Phase|Physician Decision|0|||
126427931|NCT04516967|454862347|FG000|Core Phase|Lack of Efficacy|7|||
126427932|NCT04516967|454862348|FG001|Core Phase|Lack of Efficacy|18|||
126427933|NCT04516967|454862349|FG002|Core Phase|Lack of Efficacy|0|||
126427934|NCT03570749|454862350|FG000|Overall Study|Ongoing|26|||
126427935|NCT03570749|454862351|FG001|Overall Study|Ongoing|25|||
126427936|NCT03570749|454862352|FG002|Overall Study|Ongoing|25|||
126427937|NCT03570749|454862353|FG003|Overall Study|Ongoing|26|||
126427938|NCT03570749|454862354|FG004|Overall Study|Ongoing|140|||
126427939|NCT03570749|454862355|FG005|Overall Study|Ongoing|142|||
126427940|NCT03570749|454862356|FG006|Overall Study|Ongoing|220|||
126427941|NCT03570749|454862350|FG000|Overall Study|Adverse Event|0|||
126427942|NCT03570749|454862351|FG001|Overall Study|Adverse Event|0|||
126427943|NCT03570749|454862352|FG002|Overall Study|Adverse Event|0|||
126427944|NCT03570749|454862353|FG003|Overall Study|Adverse Event|0|||
126427945|NCT03570749|454862354|FG004|Overall Study|Adverse Event|2|||
126427946|NCT03570749|454862355|FG005|Overall Study|Adverse Event|3|||
126427947|NCT03570749|454862356|FG006|Overall Study|Adverse Event|6|||
126427948|NCT03570749|454862350|FG000|Overall Study|Lack of Efficacy|0|||
126427949|NCT03570749|454862351|FG001|Overall Study|Lack of Efficacy|0|||
126427950|NCT03570749|454862352|FG002|Overall Study|Lack of Efficacy|0|||
126427951|NCT03570749|454862353|FG003|Overall Study|Lack of Efficacy|0|||
126427952|NCT03570749|454862354|FG004|Overall Study|Lack of Efficacy|8|||
126427953|NCT03570749|454862355|FG005|Overall Study|Lack of Efficacy|2|||
126008325|NCT00121199|453323016|FG000|Overall Study|Death|3|||
126008326|NCT00121199|453323016|FG000|Overall Study|Other - Not Protocol Specified|3|||
126008327|NCT00121199|453323016|FG000|Overall Study|Ineligible|9|||
126008328|NCT04109118|453323019|FG000|Overall Study|Lost to Follow-up|3|||
126427954|NCT03570749|454862356|FG006|Overall Study|Lack of Efficacy|7|||
126427955|NCT03570749|454862350|FG000|Overall Study|Lost to Follow-up|0|||
126008329|NCT03235349|453323022|FG000|Overall Study|Adverse Event|1|||
126008330|NCT03235349|453323022|FG000|Overall Study|Other|1|||
126427956|NCT03570749|454862351|FG001|Overall Study|Lost to Follow-up|0|||
126427957|NCT03570749|454862352|FG002|Overall Study|Lost to Follow-up|0|||
126427958|NCT03570749|454862353|FG003|Overall Study|Lost to Follow-up|0|||
126046459|NCT02467270|453468227|FG001|Overall Study|Death|0|||
126427959|NCT03570749|454862354|FG004|Overall Study|Lost to Follow-up|5|||
126427960|NCT03570749|454862355|FG005|Overall Study|Lost to Follow-up|10|||
126427961|NCT03570749|454862356|FG006|Overall Study|Lost to Follow-up|10|||
126427962|NCT03570749|454862350|FG000|Overall Study|Pregnancy|0|||
126427963|NCT03570749|454862351|FG001|Overall Study|Pregnancy|0|||
126427964|NCT03570749|454862352|FG002|Overall Study|Pregnancy|0|||
126427965|NCT03570749|454862353|FG003|Overall Study|Pregnancy|0|||
126427966|NCT03570749|454862354|FG004|Overall Study|Pregnancy|0|||
126427967|NCT03570749|454862355|FG005|Overall Study|Pregnancy|1|||
126427968|NCT03570749|454862356|FG006|Overall Study|Pregnancy|1|||
126427969|NCT03570749|454862350|FG000|Overall Study|Screen Fail|0|||
126427970|NCT03570749|454862351|FG001|Overall Study|Screen Fail|0|||
126427971|NCT03570749|454862352|FG002|Overall Study|Screen Fail|0|||
126427972|NCT03570749|454862353|FG003|Overall Study|Screen Fail|0|||
126427973|NCT03570749|454862354|FG004|Overall Study|Screen Fail|0|||
126427974|NCT03570749|454862355|FG005|Overall Study|Screen Fail|0|||
126427975|NCT03570749|454862356|FG006|Overall Study|Screen Fail|1|||
126427976|NCT03570749|454862350|FG000|Overall Study|Withdrawal by Subject|2|||
126427977|NCT03570749|454862351|FG001|Overall Study|Withdrawal by Subject|3|||
126427978|NCT03570749|454862352|FG002|Overall Study|Withdrawal by Subject|2|||
126427979|NCT03570749|454862353|FG003|Overall Study|Withdrawal by Subject|1|||
126427980|NCT03570749|454862354|FG004|Overall Study|Withdrawal by Subject|17|||
126427981|NCT03570749|454862355|FG005|Overall Study|Withdrawal by Subject|12|||
126427982|NCT03570749|454862356|FG006|Overall Study|Withdrawal by Subject|15|||
126427983|NCT03570749|454862350|FG000|Overall Study|Other|0|||
126427984|NCT03570749|454862351|FG001|Overall Study|Other|0|||
126427985|NCT03570749|454862352|FG002|Overall Study|Other|0|||
126427986|NCT03570749|454862353|FG003|Overall Study|Other|0|||
126427987|NCT03570749|454862354|FG004|Overall Study|Other|17|||
126427988|NCT03570749|454862355|FG005|Overall Study|Other|14|||
126427989|NCT03570749|454862356|FG006|Overall Study|Other|21|||
126427990|NCT01239381|454862357|FG000|Overall Study|Protocol Violation|1|||
126427991|NCT01239381|454862357|FG000|Overall Study|Withdrawal by Subject|1|||
126427992|NCT06237049|454862358|FG000|Overall Study|Death|0|||
126427993|NCT06237049|454862359|FG001|Overall Study|Death|0|||
126427994|NCT06237049|454862360|FG002|Overall Study|Death|0|||
126008331|NCT01018511|453323024|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
126008332|NCT01018511|453323025|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
126008333|NCT01018511|453323026|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
126427995|NCT06237049|454862361|FG003|Overall Study|Death|1|||
126427996|NCT06237049|454862358|FG000|Overall Study|Lost to Follow-up|11|||
126427997|NCT06237049|454862359|FG001|Overall Study|Lost to Follow-up|5|||
126427998|NCT06237049|454862360|FG002|Overall Study|Lost to Follow-up|8|||
126427999|NCT06237049|454862361|FG003|Overall Study|Lost to Follow-up|8|||
126428000|NCT06237049|454862358|FG000|Overall Study|Protocol Violation|0|||
126428001|NCT06237049|454862359|FG001|Overall Study|Protocol Violation|1|||
126428002|NCT06237049|454862360|FG002|Overall Study|Protocol Violation|0|||
126428003|NCT06237049|454862361|FG003|Overall Study|Protocol Violation|1|||
126428004|NCT06237049|454862358|FG000|Overall Study|Withdrawal by Subject|4|||
126428005|NCT06237049|454862359|FG001|Overall Study|Withdrawal by Subject|2|||
126428006|NCT06237049|454862360|FG002|Overall Study|Withdrawal by Subject|1|||
126428007|NCT06237049|454862361|FG003|Overall Study|Withdrawal by Subject|0|||
126428008|NCT05407675|454863868|FG000|Overall Study|Withdrawal by Subject|0|||
126428009|NCT05407675|454863869|FG001|Overall Study|Withdrawal by Subject|2|||
126428010|NCT05407675|454863870|FG002|Overall Study|Withdrawal by Subject|3|||
126428011|NCT05407675|454863871|FG003|Overall Study|Withdrawal by Subject|5|||
126428012|NCT05407675|454863872|FG004|Overall Study|Withdrawal by Subject|0|||
126428013|NCT05407675|454863873|FG005|Overall Study|Withdrawal by Subject|2|||
126428014|NCT05407675|454863874|FG006|Overall Study|Withdrawal by Subject|0|||
126428015|NCT05407675|454863875|FG007|Overall Study|Withdrawal by Subject|0|||
126428016|NCT05407675|454863876|FG008|Overall Study|Withdrawal by Subject|2|||
126428017|NCT05407675|454863877|FG009|Overall Study|Withdrawal by Subject|0|||
126428018|NCT05407675|454863878|FG010|Overall Study|Withdrawal by Subject|1|||
126428019|NCT05407675|454863879|FG011|Overall Study|Withdrawal by Subject|0|||
126428020|NCT05407675|454863880|FG012|Overall Study|Withdrawal by Subject|0|||
126428021|NCT05407675|454863868|FG000|Overall Study|Site terminated by sponsor|0|||
126008334|NCT01018511|453323027|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
126008335|NCT01018511|453323024|FG000|Overall Study|Adverse Event|5|||
126008336|NCT01018511|453323025|FG001|Overall Study|Adverse Event|9|||
126428022|NCT05407675|454863869|FG001|Overall Study|Site terminated by sponsor|0|||
126008337|NCT01018511|453323026|FG002|Overall Study|Adverse Event|13|||
126008338|NCT01018511|453323027|FG003|Overall Study|Adverse Event|10|||
126008339|NCT01018511|453323024|FG000|Overall Study|Lack of Efficacy|4|||
126428023|NCT05407675|454863870|FG002|Overall Study|Site terminated by sponsor|1|||
126428024|NCT05407675|454863871|FG003|Overall Study|Site terminated by sponsor|0|||
126428025|NCT05407675|454863872|FG004|Overall Study|Site terminated by sponsor|2|||
126008340|NCT01018511|453323025|FG001|Overall Study|Lack of Efficacy|1|||
126008341|NCT01018511|453323026|FG002|Overall Study|Lack of Efficacy|1|||
126008342|NCT01018511|453323027|FG003|Overall Study|Lack of Efficacy|2|||
126428026|NCT05407675|454863873|FG005|Overall Study|Site terminated by sponsor|0|||
126428027|NCT05407675|454863874|FG006|Overall Study|Site terminated by sponsor|1|||
126428028|NCT05407675|454863875|FG007|Overall Study|Site terminated by sponsor|0|||
126428029|NCT05407675|454863876|FG008|Overall Study|Site terminated by sponsor|0|||
126428030|NCT05407675|454863877|FG009|Overall Study|Site terminated by sponsor|2|||
126428031|NCT05407675|454863878|FG010|Overall Study|Site terminated by sponsor|2|||
126428032|NCT05407675|454863879|FG011|Overall Study|Site terminated by sponsor|2|||
126428033|NCT05407675|454863880|FG012|Overall Study|Site terminated by sponsor|1|||
126008343|NCT01018511|453323024|FG000|Overall Study|Withdrawal by Subject|6|||
126008344|NCT01018511|453323025|FG001|Overall Study|Withdrawal by Subject|5|||
126008345|NCT01018511|453323026|FG002|Overall Study|Withdrawal by Subject|11|||
126008346|NCT01018511|453323027|FG003|Overall Study|Withdrawal by Subject|9|||
126008347|NCT01018511|453323024|FG000|Overall Study|Lost to Follow-up|0|||
126008348|NCT01018511|453323025|FG001|Overall Study|Lost to Follow-up|0|||
126008349|NCT01018511|453323026|FG002|Overall Study|Lost to Follow-up|1|||
126008350|NCT01018511|453323027|FG003|Overall Study|Lost to Follow-up|0|||
126008351|NCT01018511|453323024|FG000|Overall Study|Protocol Violation|5|||
126008352|NCT01018511|453323025|FG001|Overall Study|Protocol Violation|8|||
126008353|NCT01018511|453323026|FG002|Overall Study|Protocol Violation|7|||
126008354|NCT01018511|453323027|FG003|Overall Study|Protocol Violation|9|||
126008355|NCT01018511|453323024|FG000|Overall Study|Miscellaneous|0|||
126008356|NCT01018511|453323025|FG001|Overall Study|Miscellaneous|2|||
126008357|NCT01018511|453323026|FG002|Overall Study|Miscellaneous|0|||
126008358|NCT01018511|453323027|FG003|Overall Study|Miscellaneous|0|||
126008359|NCT04305912|453323028|FG000|First Intervention|COVID-19 Suspension|2|||
126008360|NCT04305912|453323029|FG001|First Intervention|COVID-19 Suspension|0|||
126008361|NCT04305912|453323028|FG000|First Intervention|Withdrawal by Subject|0|||
126008362|NCT04305912|453323029|FG001|First Intervention|Withdrawal by Subject|1|||
126008363|NCT04305912|453323028|FG000|Second Intervention|Adverse Event|0|||
126008364|NCT04305912|453323029|FG001|Second Intervention|Adverse Event|1|||
126008365|NCT04550039|453323030|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
126008366|NCT04550039|453323031|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
126008367|NCT04550039|453323030|FG000|Overall Study|patient self-withdrew from study|0|||
126008368|NCT04550039|453323031|FG001|Overall Study|patient self-withdrew from study|1|||
126008369|NCT03396913|453323032|FG000|Overall Study|Lost to Follow-up|0|||
126008370|NCT03396913|453323033|FG001|Overall Study|Lost to Follow-up|6|||
126008371|NCT00828945|453323034|FG000|Overall Study|Death|4|||
126008372|NCT00828945|453323034|FG000|Overall Study|Participant was missing|1|||
126008373|NCT00828945|453323034|FG000|Overall Study|Other|36|||
126008374|NCT02482233|453323035|FG000|Overall Study|Lost to Follow-up|1|||
126008375|NCT02482233|453323036|FG001|Overall Study|Lost to Follow-up|1|||
126428034|NCT05407675|454863868|FG000|Overall Study|Disease Progression|0|||
126428035|NCT05407675|454863869|FG001|Overall Study|Disease Progression|0|||
126428036|NCT05407675|454863870|FG002|Overall Study|Disease Progression|0|||
126428037|NCT05407675|454863871|FG003|Overall Study|Disease Progression|0|||
126428038|NCT05407675|454863872|FG004|Overall Study|Disease Progression|0|||
126428039|NCT05407675|454863873|FG005|Overall Study|Disease Progression|0|||
126428040|NCT05407675|454863874|FG006|Overall Study|Disease Progression|0|||
126428041|NCT05407675|454863875|FG007|Overall Study|Disease Progression|0|||
126428042|NCT05407675|454863876|FG008|Overall Study|Disease Progression|0|||
126428043|NCT05407675|454863877|FG009|Overall Study|Disease Progression|0|||
126428044|NCT05407675|454863878|FG010|Overall Study|Disease Progression|1|||
126428045|NCT05407675|454863879|FG011|Overall Study|Disease Progression|0|||
126428046|NCT05407675|454863880|FG012|Overall Study|Disease Progression|0|||
126428047|NCT05407675|454863868|FG000|Overall Study|Physician Decision|0|||
126428048|NCT05407675|454863869|FG001|Overall Study|Physician Decision|0|||
126428049|NCT05407675|454863870|FG002|Overall Study|Physician Decision|0|||
126428050|NCT05407675|454863871|FG003|Overall Study|Physician Decision|0|||
126428051|NCT05407675|454863872|FG004|Overall Study|Physician Decision|0|||
126428052|NCT05407675|454863873|FG005|Overall Study|Physician Decision|0|||
126428053|NCT05407675|454863874|FG006|Overall Study|Physician Decision|0|||
126428054|NCT05407675|454863875|FG007|Overall Study|Physician Decision|0|||
126428055|NCT05407675|454863876|FG008|Overall Study|Physician Decision|0|||
126428056|NCT05407675|454863877|FG009|Overall Study|Physician Decision|0|||
126428057|NCT05407675|454863878|FG010|Overall Study|Physician Decision|1|||
126428058|NCT05407675|454863879|FG011|Overall Study|Physician Decision|0|||
126428059|NCT05407675|454863880|FG012|Overall Study|Physician Decision|0|||
126428060|NCT05407675|454863868|FG000|Overall Study|Other reasons|0|||
126428061|NCT05407675|454863869|FG001|Overall Study|Other reasons|0|||
126428062|NCT05407675|454863870|FG002|Overall Study|Other reasons|0|||
126428063|NCT05407675|454863871|FG003|Overall Study|Other reasons|0|||
126428064|NCT05407675|454863872|FG004|Overall Study|Other reasons|0|||
126428065|NCT05407675|454863873|FG005|Overall Study|Other reasons|0|||
126428066|NCT05407675|454863874|FG006|Overall Study|Other reasons|0|||
126008376|NCT00871429|453323037|FG000|Overall Study|Lost to Follow-up|6|||
126008377|NCT00871429|453323037|FG000|Overall Study|Withdrawal by Subject|17|||
126008378|NCT00871429|453323037|FG000|Overall Study|Questionnaire not completed|1|||
126008379|NCT01772719|453323041|FG000|Overall Study|Withdrawal by Subject|3|||
126008380|NCT01772719|453323041|FG000|Overall Study|Adverse Event|2|||
126008381|NCT01772719|453323041|FG000|Overall Study|Protocol Violation|1|||
126008382|NCT01772719|453323041|FG000|Overall Study|Lost to Follow-up|1|||
126008383|NCT00299702|453323043|FG000|Overall Study|Death|1|||
126428067|NCT05407675|454863875|FG007|Overall Study|Other reasons|0|||
126428068|NCT05407675|454863876|FG008|Overall Study|Other reasons|1|||
126428069|NCT05407675|454863877|FG009|Overall Study|Other reasons|1|||
126428070|NCT05407675|454863878|FG010|Overall Study|Other reasons|1|||
126428071|NCT05407675|454863879|FG011|Overall Study|Other reasons|1|||
126428072|NCT05407675|454863880|FG012|Overall Study|Other reasons|0|||
126428073|NCT05407675|454863868|FG000|Overall Study|Death|3|||
126428074|NCT05407675|454863869|FG001|Overall Study|Death|4|||
126428075|NCT05407675|454863870|FG002|Overall Study|Death|3|||
126428076|NCT05407675|454863871|FG003|Overall Study|Death|6|||
126428077|NCT05407675|454863872|FG004|Overall Study|Death|0|||
126428078|NCT05407675|454863873|FG005|Overall Study|Death|2|||
126428079|NCT05407675|454863874|FG006|Overall Study|Death|4|||
126428080|NCT05407675|454863875|FG007|Overall Study|Death|2|||
126428081|NCT05407675|454863876|FG008|Overall Study|Death|2|||
126428082|NCT05407675|454863877|FG009|Overall Study|Death|4|||
126428083|NCT05407675|454863878|FG010|Overall Study|Death|2|||
126428084|NCT05407675|454863879|FG011|Overall Study|Death|1|||
126428085|NCT05407675|454863880|FG012|Overall Study|Death|0|||
126428086|NCT05407675|454863868|FG000|Overall Study|Adverse Event|0|||
126428087|NCT05407675|454863869|FG001|Overall Study|Adverse Event|0|||
126428088|NCT05407675|454863870|FG002|Overall Study|Adverse Event|0|||
126428089|NCT05407675|454863871|FG003|Overall Study|Adverse Event|0|||
126428090|NCT05407675|454863872|FG004|Overall Study|Adverse Event|1|||
126008384|NCT00299702|453323044|FG001|Overall Study|Death|0|||
126428091|NCT05407675|454863873|FG005|Overall Study|Adverse Event|0|||
126428092|NCT05407675|454863874|FG006|Overall Study|Adverse Event|0|||
126008385|NCT00299702|453323043|FG000|Overall Study|Adverse Event|0|||
126008386|NCT00299702|453323044|FG001|Overall Study|Adverse Event|4|||
126008387|NCT00299702|453323043|FG000|Overall Study|Lost to Follow-up|18|||
126008388|NCT00299702|453323044|FG001|Overall Study|Lost to Follow-up|10|||
126008389|NCT00299702|453323043|FG000|Overall Study|Withdrawal by Subject|25|||
126008390|NCT00299702|453323044|FG001|Overall Study|Withdrawal by Subject|23|||
126008391|NCT00299702|453323043|FG000|Overall Study|Pregnancy|0|||
126008392|NCT00299702|453323044|FG001|Overall Study|Pregnancy|1|||
126008393|NCT00299702|453323043|FG000|Overall Study|Insufficient Response|4|||
126008394|NCT00299702|453323044|FG001|Overall Study|Insufficient Response|3|||
126008395|NCT00299702|453323043|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
126008396|NCT00299702|453323044|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
126008397|NCT00751036|453323045|FG000|Overall Study|Disease Progression|28|||
126008398|NCT00751036|453323046|FG001|Overall Study|Disease Progression|29|||
126008399|NCT00751036|453323045|FG000|Overall Study|Adverse Event|6|||
126008400|NCT00751036|453323046|FG001|Overall Study|Adverse Event|4|||
126008401|NCT00751036|453323045|FG000|Overall Study|Administrative Problems|3|||
126008402|NCT00751036|453323046|FG001|Overall Study|Administrative Problems|4|||
126008403|NCT00751036|453323045|FG000|Overall Study|Withdrawal by Subject|5|||
126008404|NCT00751036|453323046|FG001|Overall Study|Withdrawal by Subject|2|||
126008405|NCT00751036|453323045|FG000|Overall Study|Death|3|||
126008406|NCT00751036|453323046|FG001|Overall Study|Death|3|||
126008407|NCT00751036|453323045|FG000|Overall Study|Lost to Follow-up|0|||
126008408|NCT00751036|453323046|FG001|Overall Study|Lost to Follow-up|1|||
126008409|NCT00751036|453323045|FG000|Overall Study|Protocol Violation|1|||
126008410|NCT00751036|453323046|FG001|Overall Study|Protocol Violation|0|||
126008411|NCT00751036|453323045|FG000|Overall Study|Missing end of Treatment Page|2|||
126008412|NCT00751036|453323046|FG001|Overall Study|Missing end of Treatment Page|3|||
126008413|NCT05460663|453323047|FG000|Overall Study|Withdrawal by Subject|2|||
126008414|NCT05460663|453323048|FG001|Overall Study|Withdrawal by Subject|5|||
126008415|NCT03820986|453323049|FG000|Overall Study|Death|177|||
126008416|NCT03820986|453323050|FG001|Overall Study|Death|156|||
126008417|NCT03820986|453323049|FG000|Overall Study|Lost to Follow-up|0|||
126008418|NCT03820986|453323050|FG001|Overall Study|Lost to Follow-up|1|||
126008419|NCT03820986|453323049|FG000|Overall Study|Withdrawal by Subject|8|||
126008420|NCT03820986|453323050|FG001|Overall Study|Withdrawal by Subject|3|||
126008421|NCT03820986|453323049|FG000|Overall Study|Ongoing|149|||
126008422|NCT03820986|453323050|FG001|Overall Study|Ongoing|180|||
126008423|NCT05025449|453324406|FG000|Overall Study|Withdrawal by Subject|1|||
126428093|NCT05407675|454863875|FG007|Overall Study|Adverse Event|0|||
126428094|NCT05407675|454863876|FG008|Overall Study|Adverse Event|0|||
126428095|NCT05407675|454863877|FG009|Overall Study|Adverse Event|0|||
126428096|NCT05407675|454863878|FG010|Overall Study|Adverse Event|0|||
126008424|NCT05025449|453324406|FG000|Overall Study|Patient emergently taken to operating room|1|||
126008425|NCT00613301|453324407|FG000|Overall Study|Adverse Event|49|||
126008426|NCT00613301|453324407|FG000|Overall Study|Lost to Follow-up|88|||
126008427|NCT00613301|453324407|FG000|Overall Study|Withdrawal by Subject|5|||
126008428|NCT00613301|453324407|FG000|Overall Study|Death|6|||
126008429|NCT00613301|453324407|FG000|Overall Study|Lack of Efficacy|13|||
126008430|NCT00613301|453324407|FG000|Overall Study|Physician Decision|2|||
126008431|NCT00613301|453324407|FG000|Overall Study|No data was collected|53|||
126008432|NCT00613301|453324407|FG000|Overall Study|Irregularly enrolled patients|12|||
126008433|NCT00569946|453324408|FG000|Overall Study|Adverse Event|16|||
126008434|NCT00569946|453324408|FG000|Overall Study|Objective Progression or Relapse|42|||
126428097|NCT05407675|454863879|FG011|Overall Study|Adverse Event|1|||
126428098|NCT05407675|454863880|FG012|Overall Study|Adverse Event|0|||
126428099|NCT05407675|454863868|FG000|Overall Study|Ongoing Treatment|0|||
126428100|NCT05407675|454863869|FG001|Overall Study|Ongoing Treatment|0|||
126428101|NCT05407675|454863870|FG002|Overall Study|Ongoing Treatment|0|||
126428102|NCT05407675|454863871|FG003|Overall Study|Ongoing Treatment|0|||
126428103|NCT05407675|454863872|FG004|Overall Study|Ongoing Treatment|0|||
126428104|NCT05407675|454863873|FG005|Overall Study|Ongoing Treatment|0|||
126008435|NCT00569946|453324408|FG000|Overall Study|Global Deterioration of Health Status|1|||
126008436|NCT00470626|453324411|FG000|Overall Study|Lost to Follow-up|10|||
126008437|NCT00470626|453324411|FG000|Overall Study|Withdrawal by Subject|7|||
126008438|NCT01729819|453324412|FG000|Overall Study|Adverse Event|2|||
126008439|NCT01729819|453324413|FG001|Overall Study|Adverse Event|4|||
126008440|NCT01729819|453324412|FG000|Overall Study|Lack of Efficacy|1|||
126008441|NCT01729819|453324413|FG001|Overall Study|Lack of Efficacy|0|||
126008442|NCT01729819|453324412|FG000|Overall Study|Lost to Follow-up|2|||
126428105|NCT05407675|454863874|FG006|Overall Study|Ongoing Treatment|0|||
126428106|NCT05407675|454863875|FG007|Overall Study|Ongoing Treatment|0|||
126428107|NCT05407675|454863876|FG008|Overall Study|Ongoing Treatment|1|||
126428108|NCT05407675|454863877|FG009|Overall Study|Ongoing Treatment|0|||
126428109|NCT05407675|454863878|FG010|Overall Study|Ongoing Treatment|0|||
126428110|NCT05407675|454863879|FG011|Overall Study|Ongoing Treatment|0|||
126428111|NCT05407675|454863880|FG012|Overall Study|Ongoing Treatment|0|||
126428112|NCT04191499|454863881|FG000|Overall Study|Adverse Event|1|||
126428113|NCT04191499|454863882|FG001|Overall Study|Adverse Event|0|||
126428114|NCT04191499|454863881|FG000|Overall Study|Death|42|||
126428115|NCT04191499|454863882|FG001|Overall Study|Death|55|||
126008443|NCT01729819|453324413|FG001|Overall Study|Lost to Follow-up|0|||
126008444|NCT01729819|453324412|FG000|Overall Study|Other reason|1|||
126008445|NCT01729819|453324413|FG001|Overall Study|Other reason|0|||
126008446|NCT01729819|453324412|FG000|Overall Study|Protocol Violation|0|||
126008447|NCT01729819|453324413|FG001|Overall Study|Protocol Violation|1|||
126008448|NCT01729819|453324412|FG000|Overall Study|Withdrawal by Subject|0|||
126008449|NCT01729819|453324413|FG001|Overall Study|Withdrawal by Subject|2|||
126008450|NCT03646669|453324414|FG000|Overall Study|Withdrawal by Subject|5|||
126008451|NCT03646669|453324415|FG001|Overall Study|Withdrawal by Subject|0|||
126008452|NCT03441360|453324423|FG000|Overall Study|Radiological disease progression|5|||
126008453|NCT03441360|453324424|FG001|Overall Study|Radiological disease progression|6|||
126008454|NCT03441360|453324425|FG002|Overall Study|Radiological disease progression|4|||
126008455|NCT03441360|453324423|FG000|Overall Study|Clinical disease progression|2|||
126428116|NCT04191499|454863881|FG000|Overall Study|Lost to Follow-up|4|||
126428117|NCT04191499|454863882|FG001|Overall Study|Lost to Follow-up|1|||
126428118|NCT04191499|454863881|FG000|Overall Study|Physician Decision|1|||
126428119|NCT04191499|454863882|FG001|Overall Study|Physician Decision|0|||
126428120|NCT04191499|454863881|FG000|Overall Study|Progressive Disease|1|||
126428121|NCT04191499|454863882|FG001|Overall Study|Progressive Disease|0|||
126428122|NCT04191499|454863881|FG000|Overall Study|Symptomatic Deterioration|1|||
126428123|NCT04191499|454863882|FG001|Overall Study|Symptomatic Deterioration|0|||
126428124|NCT04191499|454863881|FG000|Overall Study|Withdrawal by Subject|7|||
126428125|NCT04191499|454863882|FG001|Overall Study|Withdrawal by Subject|11|||
126428126|NCT04191499|454863881|FG000|Overall Study|Ongoing in the study|104|||
126428127|NCT04191499|454863882|FG001|Overall Study|Ongoing in the study|97|||
126428128|NCT01496313|454863883|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
126428129|NCT01496313|454863884|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
126428130|NCT01496313|454863885|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
126428131|NCT01496313|454863886|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
126428132|NCT01496313|454863887|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
126428133|NCT01496313|454863888|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
126428134|NCT01496313|454863883|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
126428135|NCT01496313|454863884|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
126428136|NCT01496313|454863885|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
126428137|NCT01496313|454863886|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
126428138|NCT01496313|454863887|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
126428139|NCT01496313|454863888|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
126428140|NCT01496313|454863883|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126428141|NCT01496313|454863884|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
126428142|NCT01496313|454863885|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126428143|NCT01496313|454863886|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126428144|NCT01496313|454863887|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126428145|NCT01496313|454863888|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126428146|NCT01496313|454863883|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
126008456|NCT03441360|453324424|FG001|Overall Study|Clinical disease progression|2|||
126008457|NCT03441360|453324425|FG002|Overall Study|Clinical disease progression|0|||
126428147|NCT01496313|454863884|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
126008458|NCT03441360|453324423|FG000|Overall Study|Adverse Event|1|||
126008459|NCT03441360|453324424|FG001|Overall Study|Adverse Event|0|||
126428148|NCT01496313|454863885|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
126428149|NCT01496313|454863886|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
126428150|NCT01496313|454863887|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
126428151|NCT01496313|454863888|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
126428152|NCT01496313|454863883|FG000|Randomized Period (up to 14 Months)|Other|1|||
126428153|NCT01496313|454863884|FG001|Randomized Period (up to 14 Months)|Other|2|||
126428154|NCT01496313|454863885|FG002|Randomized Period (up to 14 Months)|Other|0|||
126428155|NCT01496313|454863886|FG003|Randomized Period (up to 14 Months)|Other|0|||
126428156|NCT01496313|454863887|FG004|Randomized Period (up to 14 Months)|Other|0|||
126428157|NCT01496313|454863888|FG005|Randomized Period (up to 14 Months)|Other|0|||
126428158|NCT01496313|454863883|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126428159|NCT01496313|454863884|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126428160|NCT01496313|454863885|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126428161|NCT01496313|454863886|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126428162|NCT01496313|454863887|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126428163|NCT01496313|454863888|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
126428164|NCT01496313|454863883|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126428165|NCT01496313|454863884|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126428166|NCT01496313|454863885|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126428167|NCT01496313|454863886|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126428168|NCT01496313|454863887|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126428169|NCT01496313|454863888|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
126428170|NCT01496313|454863883|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
126428171|NCT01496313|454863884|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
126428172|NCT01496313|454863885|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
126428173|NCT01496313|454863886|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
126428174|NCT01496313|454863887|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
126428175|NCT01496313|454863888|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
126428176|NCT02469155|454863889|FG000|Overall Study|Adverse Event|6|||
126428177|NCT02469155|454863890|FG001|Overall Study|Adverse Event|0|||
126428178|NCT02469155|454863891|FG002|Overall Study|Adverse Event|1|||
126428179|NCT02469155|454863892|FG003|Overall Study|Adverse Event|10|||
126428180|NCT02469155|454863889|FG000|Overall Study|Lack of Efficacy|13|||
126428181|NCT02469155|454863890|FG001|Overall Study|Lack of Efficacy|10|||
126428182|NCT02469155|454863891|FG002|Overall Study|Lack of Efficacy|10|||
126428183|NCT02469155|454863892|FG003|Overall Study|Lack of Efficacy|8|||
126428184|NCT02469155|454863889|FG000|Overall Study|Death|0|||
126428185|NCT02469155|454863890|FG001|Overall Study|Death|0|||
126428186|NCT02469155|454863891|FG002|Overall Study|Death|0|||
126428187|NCT02469155|454863892|FG003|Overall Study|Death|1|||
126428188|NCT02469155|454863889|FG000|Overall Study|Lost to Follow-up|5|||
126428189|NCT02469155|454863890|FG001|Overall Study|Lost to Follow-up|2|||
126428190|NCT02469155|454863891|FG002|Overall Study|Lost to Follow-up|7|||
126428191|NCT02469155|454863892|FG003|Overall Study|Lost to Follow-up|2|||
126428192|NCT02469155|454863889|FG000|Overall Study|Physician Decision|0|||
126428193|NCT02469155|454863890|FG001|Overall Study|Physician Decision|0|||
126428194|NCT02469155|454863891|FG002|Overall Study|Physician Decision|1|||
126008460|NCT03441360|453324425|FG002|Overall Study|Adverse Event|1|||
126428195|NCT02469155|454863892|FG003|Overall Study|Physician Decision|0|||
126428196|NCT02469155|454863889|FG000|Overall Study|Withdrawal by Subject|34|||
126428197|NCT02469155|454863890|FG001|Overall Study|Withdrawal by Subject|30|||
126428198|NCT02469155|454863891|FG002|Overall Study|Withdrawal by Subject|20|||
126428199|NCT02469155|454863892|FG003|Overall Study|Withdrawal by Subject|37|||
126428200|NCT02469155|454863889|FG000|Overall Study|Other|3|||
126008461|NCT00269399|453324426|FG000|Overall Study|Lack of Efficacy|27|||
126008462|NCT00269399|453324427|FG001|Overall Study|Lack of Efficacy|10|||
126008463|NCT00269399|453324426|FG000|Overall Study|Adverse Event|10|||
126008464|NCT00269399|453324427|FG001|Overall Study|Adverse Event|4|||
126008465|NCT00269399|453324426|FG000|Overall Study|Withdrawal by Subject|2|||
126008466|NCT00269399|453324427|FG001|Overall Study|Withdrawal by Subject|5|||
126008467|NCT00269399|453324426|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
126008468|NCT00269399|453324427|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
126008469|NCT00269399|453324426|FG000|Overall Study|Other|0|||
126008470|NCT00269399|453324427|FG001|Overall Study|Other|4|||
126008471|NCT00269399|453324426|FG000|Overall Study|Development of exclusion criteria|0|||
126428201|NCT02469155|454863890|FG001|Overall Study|Other|3|||
126428202|NCT02469155|454863891|FG002|Overall Study|Other|2|||
126008472|NCT00269399|453324427|FG001|Overall Study|Development of exclusion criteria|1|||
126209502|NCT03110107|454055407|FG014|Treatment Period|Adverse Event|0|||
126428203|NCT02469155|454863892|FG003|Overall Study|Other|10|||
126428204|NCT02469155|454863889|FG000|Overall Study|Protocol Violation|0|||
126428205|NCT02469155|454863890|FG001|Overall Study|Protocol Violation|1|||
126209503|NCT03110107|454055408|FG015|Treatment Period|Adverse Event|2|||
126008473|NCT03396835|453324429|FG000|Overall Study|Withdrawn prior to completion|1|||
126008474|NCT03396835|453324429|FG000|Overall Study|Did not meet criteria for data analysis|1|||
126008475|NCT02049866|453324439|FG000|Overall Study|Withdrawal by Subject|1|||
126008476|NCT02955069|453324441|FG000|Overall Study|Adverse Event|7|||
126008477|NCT02955069|453324442|FG001|Overall Study|Adverse Event|2|||
126008478|NCT02955069|453324441|FG000|Overall Study|Death|7|||
126008479|NCT02955069|453324442|FG001|Overall Study|Death|3|||
126008480|NCT02955069|453324441|FG000|Overall Study|Physician Decision|10|||
126008481|NCT02955069|453324442|FG001|Overall Study|Physician Decision|2|||
126008482|NCT02955069|453324441|FG000|Overall Study|Progressive disease|64|||
126008483|NCT02955069|453324442|FG001|Overall Study|Progressive disease|13|||
126008484|NCT02955069|453324441|FG000|Overall Study|Study terminated by sponsor|4|||
126008485|NCT02955069|453324442|FG001|Overall Study|Study terminated by sponsor|0|||
126008486|NCT02955069|453324441|FG000|Overall Study|Subject/Guardian decision|3|||
126008487|NCT02955069|453324442|FG001|Overall Study|Subject/Guardian decision|1|||
126008488|NCT03721016|453324443|FG000|Overall Study|Adverse Event|0|||
126008489|NCT03721016|453324444|FG001|Overall Study|Adverse Event|1|||
126008490|NCT03721016|453324445|FG002|Overall Study|Adverse Event|1|||
126008491|NCT03721016|453324443|FG000|Overall Study|Withdrawal by Subject|8|||
126008492|NCT03721016|453324444|FG001|Overall Study|Withdrawal by Subject|16|||
126008493|NCT03721016|453324445|FG002|Overall Study|Withdrawal by Subject|13|||
126008494|NCT03721016|453324443|FG000|Overall Study|Lost to Follow-up|4|||
126008495|NCT03721016|453324444|FG001|Overall Study|Lost to Follow-up|6|||
126008496|NCT03721016|453324445|FG002|Overall Study|Lost to Follow-up|5|||
126008497|NCT03721016|453324443|FG000|Overall Study|Physician Decision|0|||
126008498|NCT03721016|453324444|FG001|Overall Study|Physician Decision|1|||
126008499|NCT03721016|453324445|FG002|Overall Study|Physician Decision|2|||
126008500|NCT03721016|453324443|FG000|Overall Study|Protocol Violation|0|||
126008501|NCT03721016|453324444|FG001|Overall Study|Protocol Violation|1|||
126008502|NCT03721016|453324445|FG002|Overall Study|Protocol Violation|0|||
126008503|NCT03721016|453324443|FG000|Overall Study|Site terminated by sponsor|3|||
126008504|NCT03721016|453324444|FG001|Overall Study|Site terminated by sponsor|7|||
126008505|NCT03721016|453324445|FG002|Overall Study|Site terminated by sponsor|6|||
126008506|NCT03721016|453324443|FG000|Overall Study|Subject exited early due to COVID-19|1|||
126008507|NCT03721016|453324444|FG001|Overall Study|Subject exited early due to COVID-19|0|||
126008508|NCT03721016|453324445|FG002|Overall Study|Subject exited early due to COVID-19|0|||
126008509|NCT04148937|453324447|FG000|Overall Study|Withdrawal by Subject|0|||
126008510|NCT04148937|453324448|FG001|Overall Study|Withdrawal by Subject|0|||
126008511|NCT04148937|453324449|FG002|Overall Study|Withdrawal by Subject|0|||
126008512|NCT04148937|453324450|FG003|Overall Study|Withdrawal by Subject|1|||
126008513|NCT04148937|453324451|FG004|Overall Study|Withdrawal by Subject|0|||
126008514|NCT04148937|453324452|FG005|Overall Study|Withdrawal by Subject|1|||
126008515|NCT04148937|453324453|FG006|Overall Study|Withdrawal by Subject|1|||
126008516|NCT04148937|453324454|FG007|Overall Study|Withdrawal by Subject|0|||
126008517|NCT04148937|453324447|FG000|Overall Study|Lost to Follow-up|0|||
126008518|NCT04148937|453324448|FG001|Overall Study|Lost to Follow-up|0|||
126008519|NCT04148937|453324449|FG002|Overall Study|Lost to Follow-up|1|||
126008520|NCT04148937|453324450|FG003|Overall Study|Lost to Follow-up|0|||
126008521|NCT04148937|453324451|FG004|Overall Study|Lost to Follow-up|0|||
126008522|NCT04148937|453324452|FG005|Overall Study|Lost to Follow-up|2|||
126008523|NCT04148937|453324453|FG006|Overall Study|Lost to Follow-up|0|||
126008524|NCT04148937|453324454|FG007|Overall Study|Lost to Follow-up|0|||
126008525|NCT02232178|453324457|FG000|Overall Study|Lost to Follow-up|0|||
126008526|NCT02232178|453324458|FG001|Overall Study|Lost to Follow-up|1|||
126008527|NCT02232178|453324459|FG002|Overall Study|Lost to Follow-up|0|||
126008528|NCT02232178|453324457|FG000|Overall Study|ineligibility|0|||
126008529|NCT02232178|453324458|FG001|Overall Study|ineligibility|0|||
126008530|NCT02232178|453324459|FG002|Overall Study|ineligibility|1|||
126008531|NCT02232178|453324457|FG000|Overall Study|surgical complication|1|||
126008532|NCT02232178|453324458|FG001|Overall Study|surgical complication|0|||
126008533|NCT02232178|453324459|FG002|Overall Study|surgical complication|0|||
126008534|NCT00817635|453324461|FG000|Overall Study|Adverse Event|1|||
126008535|NCT00817635|453324462|FG001|Overall Study|Adverse Event|0|||
126008536|NCT00817635|453324463|FG002|Overall Study|Adverse Event|0|||
126008537|NCT00817635|453324464|FG003|Overall Study|Adverse Event|1|||
126008538|NCT00817635|453324465|FG004|Overall Study|Adverse Event|1|||
126008539|NCT00817635|453324461|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
126008540|NCT00817635|453324462|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
126008541|NCT00817635|453324463|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
126008542|NCT00817635|453324464|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
126008543|NCT00817635|453324465|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
126008544|NCT00817635|453324461|FG000|Overall Study|Withdrawal by Subject|2|||
126008545|NCT00817635|453324462|FG001|Overall Study|Withdrawal by Subject|1|||
126008546|NCT00817635|453324463|FG002|Overall Study|Withdrawal by Subject|0|||
126008547|NCT00817635|453324464|FG003|Overall Study|Withdrawal by Subject|1|||
126008548|NCT00817635|453324465|FG004|Overall Study|Withdrawal by Subject|2|||
126008549|NCT00817635|453324461|FG000|Overall Study|Lost to Follow-up|0|||
126428206|NCT02469155|454863891|FG002|Overall Study|Protocol Violation|0|||
126428207|NCT02469155|454863892|FG003|Overall Study|Protocol Violation|1|||
126428208|NCT02062827|454863893|FG000|Overall Study|Death|1|||
126428209|NCT02062827|454863894|FG001|Overall Study|Death|0|||
126428210|NCT02062827|454863895|FG002|Overall Study|Death|0|||
126428211|NCT02062827|454863896|FG003|Overall Study|Death|0|||
126428212|NCT02062827|454863897|FG004|Overall Study|Death|0|||
126428213|NCT02062827|454863898|FG005|Overall Study|Death|0|||
126428214|NCT02062827|454863899|FG006|Overall Study|Death|0|||
126428215|NCT02062827|454863900|FG007|Overall Study|Death|0|||
126428216|NCT02062827|454863893|FG000|Overall Study|Withdrawal by Subject|3|||
126428217|NCT02062827|454863894|FG001|Overall Study|Withdrawal by Subject|1|||
126428218|NCT02062827|454863895|FG002|Overall Study|Withdrawal by Subject|1|||
126428219|NCT02062827|454863896|FG003|Overall Study|Withdrawal by Subject|2|||
126428220|NCT02062827|454863897|FG004|Overall Study|Withdrawal by Subject|6|||
126428221|NCT02062827|454863898|FG005|Overall Study|Withdrawal by Subject|0|||
126428222|NCT02062827|454863899|FG006|Overall Study|Withdrawal by Subject|5|||
126428223|NCT02062827|454863900|FG007|Overall Study|Withdrawal by Subject|0|||
126428224|NCT02062827|454863893|FG000|Overall Study|Screen Fail|0|||
126428225|NCT02062827|454863894|FG001|Overall Study|Screen Fail|0|||
126428226|NCT02062827|454863895|FG002|Overall Study|Screen Fail|0|||
126428227|NCT02062827|454863896|FG003|Overall Study|Screen Fail|0|||
126428228|NCT02062827|454863897|FG004|Overall Study|Screen Fail|0|||
126428229|NCT02062827|454863898|FG005|Overall Study|Screen Fail|0|||
126428230|NCT02062827|454863899|FG006|Overall Study|Screen Fail|0|||
126428231|NCT02062827|454863900|FG007|Overall Study|Screen Fail|8|||
126428232|NCT04908397|454863901|FG000|Overall Study|Withdrawal by Subject|2|||
126428233|NCT04264442|454863902|FG000|Overall Study|Lack of Efficacy|6|||
126428234|NCT04264442|454863902|FG000|Overall Study|Lost to Follow-up|2|||
126428235|NCT04264442|454863902|FG000|Overall Study|Sponsor Decision|23|||
126428236|NCT04264442|454863902|FG000|Overall Study|Withdrawal by Subject|11|||
126428237|NCT04264442|454863902|FG000|Overall Study|Study Termination|5|||
126428238|NCT00288353|454863903|FG000|Overall Study|Lack of Efficacy|2|||
126008550|NCT00817635|453324462|FG001|Overall Study|Lost to Follow-up|1|||
126008551|NCT00817635|453324463|FG002|Overall Study|Lost to Follow-up|0|||
126008552|NCT00817635|453324464|FG003|Overall Study|Lost to Follow-up|1|||
126008553|NCT00817635|453324465|FG004|Overall Study|Lost to Follow-up|0|||
126008554|NCT00817635|453324461|FG000|Overall Study|Administrative Problems|0|||
126008555|NCT00817635|453324462|FG001|Overall Study|Administrative Problems|0|||
126008556|NCT00817635|453324463|FG002|Overall Study|Administrative Problems|0|||
126008557|NCT00817635|453324464|FG003|Overall Study|Administrative Problems|0|||
126008558|NCT00817635|453324465|FG004|Overall Study|Administrative Problems|1|||
126008559|NCT00817635|453324461|FG000|Overall Study|Protocol Violation|5|||
126008560|NCT00817635|453324462|FG001|Overall Study|Protocol Violation|1|||
126008561|NCT00817635|453324463|FG002|Overall Study|Protocol Violation|3|||
126008562|NCT00817635|453324464|FG003|Overall Study|Protocol Violation|2|||
126008563|NCT00817635|453324465|FG004|Overall Study|Protocol Violation|3|||
126008564|NCT03107611|453324467|FG000|Overall Study|Adverse Event|1|||
126008565|NCT03107611|453324468|FG001|Overall Study|Adverse Event|0|||
126008566|NCT03107611|453324469|FG002|Overall Study|Adverse Event|2|||
126008567|NCT03107611|453324467|FG000|Overall Study|Lost to Follow-up|3|||
126008568|NCT03107611|453324468|FG001|Overall Study|Lost to Follow-up|3|||
126008569|NCT03107611|453324469|FG002|Overall Study|Lost to Follow-up|3|||
126008570|NCT03107611|453324467|FG000|Overall Study|Protocol Violation|0|||
126008571|NCT03107611|453324468|FG001|Overall Study|Protocol Violation|0|||
126008572|NCT03107611|453324469|FG002|Overall Study|Protocol Violation|1|||
126008573|NCT03107611|453324467|FG000|Overall Study|Withdrawal by Subject|1|||
126008574|NCT03107611|453324468|FG001|Overall Study|Withdrawal by Subject|0|||
126008575|NCT03107611|453324469|FG002|Overall Study|Withdrawal by Subject|1|||
126008576|NCT03107611|453324467|FG000|Overall Study|Worsening signs/symptoms|2|||
126008577|NCT03107611|453324468|FG001|Overall Study|Worsening signs/symptoms|1|||
126008578|NCT03107611|453324469|FG002|Overall Study|Worsening signs/symptoms|2|||
126008579|NCT01720446|453324472|FG000|Overall Study|Lost to Follow-up|12|||
126008580|NCT01720446|453324473|FG001|Overall Study|Lost to Follow-up|6|||
126008581|NCT01720446|453324474|FG002|Overall Study|Lost to Follow-up|16|||
126008582|NCT01720446|453324475|FG003|Overall Study|Lost to Follow-up|16|||
126008583|NCT01720446|453324472|FG000|Overall Study|Withdrawal by Subject|2|||
126428239|NCT00288353|454863904|FG001|Overall Study|Lack of Efficacy|2|||
126428240|NCT00288353|454863903|FG000|Overall Study|Withdrawal by Subject|5|||
126428241|NCT00288353|454863904|FG001|Overall Study|Withdrawal by Subject|5|||
126428242|NCT04604275|454863905|FG000|Washout-1 Week|Withdrawal by Subject|1|||
126428243|NCT04604275|454863906|FG001|Washout-1 Week|Withdrawal by Subject|0|||
126428244|NCT04519645|454863907|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
126428245|NCT04519645|454863908|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
126008584|NCT01720446|453324473|FG001|Overall Study|Withdrawal by Subject|5|||
126008585|NCT01720446|453324474|FG002|Overall Study|Withdrawal by Subject|4|||
126008586|NCT01720446|453324475|FG003|Overall Study|Withdrawal by Subject|4|||
126008587|NCT04464421|453324476|FG000|Overall Study|Lost to Follow-up|2|||
126008588|NCT04464421|453324477|FG001|Overall Study|Lost to Follow-up|2|||
126428246|NCT04519645|454863909|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
126428247|NCT04519645|454863907|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
126428248|NCT04519645|454863908|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
126428249|NCT04519645|454863909|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
126428250|NCT04519645|454863907|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
126428251|NCT04519645|454863908|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
126428252|NCT04519645|454863909|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
126428253|NCT04519645|454863907|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
126428254|NCT04519645|454863908|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
126428255|NCT04519645|454863909|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
126428256|NCT05615935|454863912|FG000|Overall Study|Lost to Follow-up|1|||
126428257|NCT05615935|454863913|FG001|Overall Study|Lost to Follow-up|1|||
126428258|NCT04985604|454863915|FG000|Overall Study|Death|4|||
126428259|NCT04985604|454863916|FG001|Overall Study|Death|6|||
126428260|NCT04985604|454863915|FG000|Overall Study|Withdrawal by Subject|0|||
126428261|NCT04985604|454863916|FG001|Overall Study|Withdrawal by Subject|1|||
126428262|NCT02282761|454863917|FG000|Overall Study|Death|0|||
126428263|NCT02282761|454863918|FG001|Overall Study|Death|0|||
126428264|NCT02282761|454863919|FG002|Overall Study|Death|1|||
126428265|NCT02282761|454863917|FG000|Overall Study|Adverse Event|6|||
126428266|NCT02282761|454863918|FG001|Overall Study|Adverse Event|2|||
126428267|NCT02282761|454863919|FG002|Overall Study|Adverse Event|0|||
126428268|NCT02282761|454863917|FG000|Overall Study|Lack of Efficacy|11|||
126428269|NCT02282761|454863918|FG001|Overall Study|Lack of Efficacy|6|||
126428270|NCT02282761|454863919|FG002|Overall Study|Lack of Efficacy|17|||
126428271|NCT02282761|454863917|FG000|Overall Study|Lost to Follow-up|2|||
126428272|NCT02282761|454863918|FG001|Overall Study|Lost to Follow-up|2|||
126428273|NCT02282761|454863919|FG002|Overall Study|Lost to Follow-up|1|||
126428274|NCT02282761|454863917|FG000|Overall Study|Physician Decision|0|||
126428275|NCT02282761|454863918|FG001|Overall Study|Physician Decision|0|||
126428276|NCT02282761|454863919|FG002|Overall Study|Physician Decision|2|||
126428277|NCT02282761|454863917|FG000|Overall Study|Withdrawal by Subject|8|||
126428278|NCT02282761|454863918|FG001|Overall Study|Withdrawal by Subject|10|||
126428279|NCT02282761|454863919|FG002|Overall Study|Withdrawal by Subject|16|||
126428280|NCT02282761|454863917|FG000|Overall Study|Other|3|||
126428281|NCT02282761|454863918|FG001|Overall Study|Other|2|||
126428282|NCT02282761|454863919|FG002|Overall Study|Other|1|||
126428283|NCT02838420|454863920|FG000|Overall Study|Ongoing in Study|113|||
126428284|NCT02838420|454863921|FG001|Overall Study|Ongoing in Study|45|||
126428285|NCT02838420|454863920|FG000|Overall Study|Lost to Follow-up|1|||
126428286|NCT02838420|454863921|FG001|Overall Study|Lost to Follow-up|0|||
126428287|NCT02838420|454863920|FG000|Overall Study|Withdrawal by Subject|3|||
126428288|NCT02838420|454863921|FG001|Overall Study|Withdrawal by Subject|4|||
126428289|NCT02838420|454863920|FG000|Overall Study|Death|8|||
126428290|NCT02838420|454863921|FG001|Overall Study|Death|13|||
126428291|NCT04501614|454863922|FG000|Overall Study|Study Terminated by Sponsor|6|||
126428292|NCT04501614|454863923|FG001|Overall Study|Study Terminated by Sponsor|3|||
126428293|NCT04501614|454863922|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
126428294|NCT04501614|454863923|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
126428295|NCT03742037|454863924|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126428296|NCT03742037|454863925|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
126428297|NCT03742037|454863926|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126428298|NCT03742037|454863927|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126428299|NCT03742037|454863928|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126428300|NCT03742037|454863929|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126428301|NCT03742037|454863930|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126428302|NCT03742037|454863924|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
126428303|NCT03742037|454863925|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
126428304|NCT03742037|454863926|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
126428305|NCT03742037|454863927|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
126428306|NCT03742037|454863928|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
126428307|NCT03742037|454863929|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
126428308|NCT03742037|454863930|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
126008589|NCT01020838|453324478|FG000|Overall Study|Death|90|||
126008590|NCT01020838|453324478|FG000|Overall Study|Adverse Event|1|||
126428309|NCT03742037|454863924|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
126428310|NCT03742037|454863925|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
126428311|NCT03742037|454863926|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
126428312|NCT03742037|454863927|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
126428313|NCT03742037|454863928|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
126428314|NCT03742037|454863929|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
126008591|NCT01020838|453324478|FG000|Overall Study|Withdrawal by Subject|9|||
126008592|NCT01020838|453324478|FG000|Overall Study|Lost to Follow-up|6|||
126008593|NCT01020838|453324478|FG000|Overall Study|Most common: Study ended by sponsor|77|||
126008594|NCT01167426|453324480|FG000|Overall Study|Lost to Follow-up|6|||
126008595|NCT01167426|453324480|FG000|Overall Study|Protocol Violation|1|||
126008596|NCT01167426|453324480|FG000|Overall Study|Withdrawal by Subject|2|||
126008597|NCT01167426|453324480|FG000|Overall Study|Sponsor Decision|1|||
126008598|NCT02317705|453324481|FG000|Overall Study|Withdrawal by Subject|3|||
126008599|NCT02317705|453324481|FG000|Overall Study|Physician Decision|1|||
126008600|NCT02317705|453324481|FG000|Overall Study|Drug not usable|1|||
126008601|NCT01599325|453324482|FG000|Primary Parent Phase|Adverse Event|5|||
126008602|NCT01599325|453324482|FG000|Primary Parent Phase|Disease Progression|7|||
126008603|NCT01599325|453324482|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
126008604|NCT01599325|453324482|FG000|Primary Parent Phase|Death|13|||
126008605|NCT01599325|453324482|FG000|Primary Parent Phase|Protocol Violation|1|||
126008606|NCT01599325|453324482|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
126008607|NCT01599325|453324482|FG000|Primary Parent Phase|Other|2|||
126008608|NCT01599325|453324482|FG000|Extension Phase|Study Closure|1|||
126008609|NCT01599325|453324482|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
126008610|NCT01599325|453324482|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
126008611|NCT01599325|453324482|FG000|Extension Phase|Disease Progression|1|||
126008612|NCT01599325|453324482|FG000|Extension Phase|Withdrawal by Subject|8|||
126008613|NCT03256344|453324483|FG000|Overall Study|Death|6|||
126008614|NCT03256344|453324484|FG001|Overall Study|Death|22|||
126008615|NCT03256344|453324483|FG000|Overall Study|Withdrawal by Subject|3|||
126008616|NCT03256344|453324484|FG001|Overall Study|Withdrawal by Subject|3|||
126008617|NCT03256344|453324483|FG000|Overall Study|Sponsor Decision|1|||
126008618|NCT03256344|453324484|FG001|Overall Study|Sponsor Decision|0|||
126008619|NCT00544440|453324486|FG000|Overall Study|Other|1|||
126008620|NCT00544440|453324486|FG000|Overall Study|Adverse Event|1|||
126008621|NCT00544440|453324486|FG000|Overall Study|Withdrawal by Subject|2|||
126008622|NCT00544440|453324486|FG000|Overall Study|Subject Non-compliance|1|||
126008623|NCT00544440|453324486|FG000|Overall Study|Progressive Disease|47|||
126008624|NCT00544440|453324486|FG000|Overall Study|Other|5|||
126008625|NCT03586167|453324487|FG000|Overall Study|Other|1|||
126008626|NCT03586167|453324488|FG001|Overall Study|Other|0|||
126008627|NCT00591838|453324489|FG000|Overall Study|Withdrawal by Subject|0|||
126008628|NCT00591838|453324490|FG001|Overall Study|Withdrawal by Subject|0|||
126008629|NCT00591838|453324491|FG002|Overall Study|Withdrawal by Subject|0|||
126008630|NCT00591838|453324492|FG003|Overall Study|Withdrawal by Subject|1|||
126008631|NCT00591838|453324493|FG004|Overall Study|Withdrawal by Subject|0|||
126008632|NCT02512042|453324494|FG000|Overall Study|Adverse Event|0|||
126008633|NCT02512042|453324495|FG001|Overall Study|Adverse Event|4|||
126008634|NCT02512042|453324494|FG000|Overall Study|Withdrawal by Subject|6|||
126008635|NCT02512042|453324495|FG001|Overall Study|Withdrawal by Subject|6|||
126008636|NCT02512042|453324494|FG000|Overall Study|Non-compliance with study drug|1|||
126008637|NCT02512042|453324495|FG001|Overall Study|Non-compliance with study drug|2|||
126008638|NCT02512042|453324494|FG000|Overall Study|Lost to Follow-up|5|||
126008639|NCT02512042|453324495|FG001|Overall Study|Lost to Follow-up|2|||
126008640|NCT02512042|453324494|FG000|Overall Study|Other|11|||
126428315|NCT03742037|454863930|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
126428316|NCT03742037|454863924|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126428317|NCT03742037|454863925|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
126428318|NCT03742037|454863926|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126008641|NCT02512042|453324495|FG001|Overall Study|Other|11|||
126008642|NCT04163458|453324498|FG000|Overall Study|Protocol Deviation|7|||
126008643|NCT04163458|453324499|FG001|Overall Study|Protocol Deviation|13|||
126008644|NCT04163458|453324498|FG000|Overall Study|Adverse Event|5|||
126008645|NCT04163458|453324499|FG001|Overall Study|Adverse Event|8|||
126008646|NCT04163458|453324498|FG000|Overall Study|Due to COVID-19 pandemic|4|||
126008647|NCT04163458|453324499|FG001|Overall Study|Due to COVID-19 pandemic|2|||
126008648|NCT04163458|453324498|FG000|Overall Study|Participant withdrew consent|2|||
126008649|NCT04163458|453324499|FG001|Overall Study|Participant withdrew consent|3|||
126008650|NCT04163458|453324498|FG000|Overall Study|Randomization failure|2|||
126008651|NCT04163458|453324499|FG001|Overall Study|Randomization failure|2|||
126008652|NCT04163458|453324498|FG000|Overall Study|Other|4|||
126008653|NCT04163458|453324499|FG001|Overall Study|Other|2|||
126008654|NCT01467700|453324502|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
126008655|NCT01467700|453324503|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
126008656|NCT01467700|453324504|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
126008657|NCT01467700|453324505|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
126209504|NCT03110107|454055409|FG016|Treatment Period|Adverse Event|0|||
126008658|NCT01467700|453324502|FG000|Overall Study|Major Protocol Deviation|3|||
126008659|NCT01467700|453324503|FG001|Overall Study|Major Protocol Deviation|3|||
126008660|NCT01467700|453324504|FG002|Overall Study|Major Protocol Deviation|2|||
126008661|NCT01467700|453324505|FG003|Overall Study|Major Protocol Deviation|3|||
126008662|NCT01467700|453324502|FG000|Overall Study|Lost to Follow-up|6|||
126008663|NCT01467700|453324503|FG001|Overall Study|Lost to Follow-up|5|||
126209505|NCT03110107|454055410|FG017|Treatment Period|Adverse Event|1|||
126342563|NCT00296335|454550502|FG000|Overall Study|Recurrence|3|||
126342564|NCT00296335|454550503|FG001|Overall Study|Recurrence|51|||
126342565|NCT00296335|454550502|FG000|Overall Study|Adverse Event|17|||
126342566|NCT00296335|454550503|FG001|Overall Study|Adverse Event|27|||
126342567|NCT00296335|454550502|FG000|Overall Study|Lost to Follow-up|7|||
126342568|NCT00296335|454550503|FG001|Overall Study|Lost to Follow-up|33|||
126342569|NCT00296335|454550502|FG000|Overall Study|Physician Decision|3|||
126342570|NCT00296335|454550503|FG001|Overall Study|Physician Decision|11|||
126342571|NCT01401322|454550504|FG000|Overall Study|Withdrawal by Subject|1|||
126342572|NCT01401322|454550504|FG000|Overall Study|Physician Decision|1|||
126342573|NCT02737722|454550505|FG000|Overall Study|Physician Decision|0|||
126342574|NCT02737722|454550506|FG001|Overall Study|Physician Decision|0|||
126342575|NCT02737722|454550507|FG002|Overall Study|Physician Decision|1|||
126342576|NCT02737722|454550508|FG003|Overall Study|Physician Decision|0|||
126342577|NCT00112957|454550523|FG000|Overall Study|Progressive disease|18|||
126342578|NCT00112957|454550523|FG000|Overall Study|Physician Decision|1|||
126342579|NCT02309359|454550526|FG000|Overall Study|Adverse Event|4|||
126342580|NCT02309359|454550527|FG001|Overall Study|Adverse Event|5|||
126342581|NCT02309359|454550528|FG002|Overall Study|Adverse Event|5|||
126342582|NCT02309359|454550529|FG003|Overall Study|Adverse Event|4|||
126342583|NCT02309359|454550530|FG004|Overall Study|Adverse Event|4|||
126342584|NCT02309359|454550526|FG000|Overall Study|Death|1|||
126342585|NCT02309359|454550527|FG001|Overall Study|Death|0|||
126342586|NCT02309359|454550528|FG002|Overall Study|Death|0|||
126342587|NCT02309359|454550529|FG003|Overall Study|Death|0|||
126342588|NCT02309359|454550530|FG004|Overall Study|Death|0|||
126342589|NCT02309359|454550526|FG000|Overall Study|Withdrawal by Subject|2|||
126342590|NCT02309359|454550527|FG001|Overall Study|Withdrawal by Subject|2|||
126342591|NCT02309359|454550528|FG002|Overall Study|Withdrawal by Subject|4|||
126342592|NCT02309359|454550529|FG003|Overall Study|Withdrawal by Subject|4|||
126342593|NCT02309359|454550530|FG004|Overall Study|Withdrawal by Subject|0|||
126342594|NCT02309359|454550526|FG000|Overall Study|Lack of Efficacy|3|||
126342595|NCT02309359|454550527|FG001|Overall Study|Lack of Efficacy|1|||
126342596|NCT02309359|454550528|FG002|Overall Study|Lack of Efficacy|0|||
126342597|NCT02309359|454550529|FG003|Overall Study|Lack of Efficacy|0|||
126342598|NCT02309359|454550530|FG004|Overall Study|Lack of Efficacy|3|||
126342599|NCT02309359|454550526|FG000|Overall Study|Lost to Follow-up|0|||
126342600|NCT02309359|454550527|FG001|Overall Study|Lost to Follow-up|0|||
126342601|NCT02309359|454550528|FG002|Overall Study|Lost to Follow-up|0|||
126342602|NCT02309359|454550529|FG003|Overall Study|Lost to Follow-up|1|||
126342603|NCT02309359|454550530|FG004|Overall Study|Lost to Follow-up|0|||
126342604|NCT02309359|454550526|FG000|Overall Study|Other|2|||
126342605|NCT02309359|454550527|FG001|Overall Study|Other|0|||
126342606|NCT02309359|454550528|FG002|Overall Study|Other|2|||
126342607|NCT02309359|454550529|FG003|Overall Study|Other|3|||
126342608|NCT02309359|454550530|FG004|Overall Study|Other|2|||
126342609|NCT00284856|454550531|FG000|Overall Study|Adverse Event|3|||
126342610|NCT00284856|454550532|FG001|Overall Study|Adverse Event|3|||
126342611|NCT00284856|454550533|FG002|Overall Study|Adverse Event|3|||
126342612|NCT00284856|454550531|FG000|Overall Study|Lack of Efficacy|2|||
126342613|NCT00284856|454550532|FG001|Overall Study|Lack of Efficacy|1|||
126342614|NCT00284856|454550533|FG002|Overall Study|Lack of Efficacy|8|||
126342615|NCT00284856|454550531|FG000|Overall Study|Lost to Follow-up|25|||
126342616|NCT00284856|454550532|FG001|Overall Study|Lost to Follow-up|21|||
126342617|NCT00284856|454550533|FG002|Overall Study|Lost to Follow-up|22|||
126342618|NCT00284856|454550531|FG000|Overall Study|Protocol Violation|5|||
126342619|NCT00284856|454550532|FG001|Overall Study|Protocol Violation|4|||
126342620|NCT00284856|454550533|FG002|Overall Study|Protocol Violation|5|||
126342621|NCT00284856|454550531|FG000|Overall Study|Withdrawal by Subject|12|||
126342622|NCT00284856|454550532|FG001|Overall Study|Withdrawal by Subject|16|||
126342623|NCT00284856|454550533|FG002|Overall Study|Withdrawal by Subject|18|||
126342624|NCT00284856|454550531|FG000|Overall Study|Other|4|||
126342625|NCT00284856|454550532|FG001|Overall Study|Other|5|||
126342626|NCT00284856|454550533|FG002|Overall Study|Other|4|||
126342627|NCT03451045|454550535|FG000|Overall Study|Lack of Efficacy|3|||
126342628|NCT03451045|454550536|FG001|Overall Study|Lack of Efficacy|2|||
126342629|NCT03451045|454550537|FG002|Overall Study|Lack of Efficacy|2|||
126342630|NCT03451045|454550535|FG000|Overall Study|Physician Decision|1|||
126342631|NCT03451045|454550536|FG001|Overall Study|Physician Decision|1|||
126342632|NCT03451045|454550537|FG002|Overall Study|Physician Decision|1|||
126342633|NCT03451045|454550535|FG000|Overall Study|Withdrawal by Subject|4|||
126342634|NCT03451045|454550536|FG001|Overall Study|Withdrawal by Subject|0|||
126342635|NCT03451045|454550537|FG002|Overall Study|Withdrawal by Subject|5|||
126342636|NCT03451045|454550535|FG000|Overall Study|Pregnancy|0|||
126342637|NCT03451045|454550536|FG001|Overall Study|Pregnancy|0|||
126342638|NCT03451045|454550537|FG002|Overall Study|Pregnancy|2|||
126342639|NCT03451045|454550535|FG000|Overall Study|Adverse Event|7|||
126342640|NCT03451045|454550536|FG001|Overall Study|Adverse Event|1|||
126342641|NCT03451045|454550537|FG002|Overall Study|Adverse Event|3|||
126342642|NCT03451045|454550535|FG000|Overall Study|Non-compliance with study|2|||
126342643|NCT03451045|454550536|FG001|Overall Study|Non-compliance with study|0|||
126428319|NCT03742037|454863927|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126428320|NCT03742037|454863928|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126428321|NCT03742037|454863929|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
126428322|NCT03742037|454863930|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126428323|NCT03742037|454863924|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
126428324|NCT03742037|454863925|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
126428325|NCT03742037|454863926|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
126428326|NCT03742037|454863927|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
126428327|NCT03742037|454863928|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
126428328|NCT03742037|454863929|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
126008664|NCT01467700|453324504|FG002|Overall Study|Lost to Follow-up|2|||
126008665|NCT01467700|453324505|FG003|Overall Study|Lost to Follow-up|3|||
126008666|NCT01467700|453324502|FG000|Overall Study|Voluntary Withdrawal|5|||
126008667|NCT01467700|453324503|FG001|Overall Study|Voluntary Withdrawal|7|||
126008668|NCT01467700|453324504|FG002|Overall Study|Voluntary Withdrawal|6|||
126428329|NCT03742037|454863930|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
126428330|NCT03742037|454863924|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126428331|NCT03742037|454863925|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126428332|NCT03742037|454863926|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126428333|NCT03742037|454863927|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126428334|NCT03742037|454863928|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126428335|NCT03742037|454863929|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
126428336|NCT03742037|454863930|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126428337|NCT03742037|454863924|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
126428338|NCT03742037|454863925|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
126428339|NCT03742037|454863926|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
126428340|NCT03742037|454863927|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
126428341|NCT03742037|454863928|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
126428342|NCT03742037|454863929|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
126428343|NCT03742037|454863930|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
126428344|NCT03742037|454863924|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126428345|NCT03742037|454863925|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126428346|NCT03742037|454863926|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126428347|NCT03742037|454863927|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126428348|NCT03742037|454863928|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126428349|NCT03742037|454863929|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126428350|NCT03742037|454863930|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
126428351|NCT03742037|454863924|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
126428352|NCT03742037|454863925|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
126428353|NCT03742037|454863926|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
126428354|NCT03742037|454863927|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
126008669|NCT01467700|453324505|FG003|Overall Study|Voluntary Withdrawal|2|||
126428355|NCT03742037|454863928|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
126428356|NCT03742037|454863929|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
126428357|NCT03742037|454863930|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
126428358|NCT03742037|454863924|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
126428359|NCT03742037|454863925|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
126428360|NCT03742037|454863926|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
126428361|NCT03742037|454863927|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
126008670|NCT01467700|453324502|FG000|Overall Study|Study Termination|6|||
126008671|NCT01467700|453324503|FG001|Overall Study|Study Termination|5|||
126008672|NCT01467700|453324504|FG002|Overall Study|Study Termination|10|||
126008673|NCT01467700|453324505|FG003|Overall Study|Study Termination|7|||
126342644|NCT03451045|454550537|FG002|Overall Study|Non-compliance with study|1|||
126342645|NCT03451045|454550535|FG000|Overall Study|any other reason|10|||
126342646|NCT03451045|454550536|FG001|Overall Study|any other reason|2|||
126342647|NCT03451045|454550537|FG002|Overall Study|any other reason|13|||
126342648|NCT00863707|454550538|FG000|Overall Study|Randomized, but drug not received|4|||
126428362|NCT03742037|454863928|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
126428363|NCT03742037|454863929|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
126008674|NCT01467700|453324502|FG000|Overall Study|Pregnancy|0|||
126008675|NCT01467700|453324503|FG001|Overall Study|Pregnancy|1|||
126342649|NCT00863707|454550539|FG001|Overall Study|Randomized, but drug not received|3|||
126342650|NCT04142242|454550540|FG000|Stage I|Non-compliance with the protocol|1|||
126342651|NCT04142242|454550541|FG001|Stage I|Non-compliance with the protocol|0|||
126342652|NCT04142242|454550542|FG002|Stage I|Non-compliance with the protocol|0|||
126008676|NCT01467700|453324504|FG002|Overall Study|Pregnancy|1|||
126008677|NCT01467700|453324505|FG003|Overall Study|Pregnancy|0|||
126008678|NCT01467700|453324502|FG000|Overall Study|Lack of Efficacy|2|||
126008679|NCT01467700|453324503|FG001|Overall Study|Lack of Efficacy|0|||
126008680|NCT01467700|453324504|FG002|Overall Study|Lack of Efficacy|2|||
126008681|NCT01467700|453324505|FG003|Overall Study|Lack of Efficacy|1|||
126008682|NCT01467700|453324502|FG000|Overall Study|Reason not Specified|1|||
126008683|NCT01467700|453324503|FG001|Overall Study|Reason not Specified|3|||
126008684|NCT01467700|453324504|FG002|Overall Study|Reason not Specified|2|||
126008685|NCT01467700|453324505|FG003|Overall Study|Reason not Specified|8|||
126008686|NCT05824351|453324511|FG000|Overall Study|Adverse Event|6|||
126008687|NCT03822351|453324516|FG000|Overall Study|Death|27|||
126008688|NCT03822351|453324517|FG001|Overall Study|Death|23|||
126008689|NCT03822351|453324518|FG002|Overall Study|Death|24|||
126008690|NCT03822351|453324516|FG000|Overall Study|Lost to Follow-up|6|||
126008691|NCT03822351|453324517|FG001|Overall Study|Lost to Follow-up|2|||
126008692|NCT03822351|453324518|FG002|Overall Study|Lost to Follow-up|1|||
126008693|NCT03822351|453324516|FG000|Overall Study|Withdrawal by Subject|10|||
126008694|NCT03822351|453324517|FG001|Overall Study|Withdrawal by Subject|4|||
126008695|NCT03822351|453324518|FG002|Overall Study|Withdrawal by Subject|6|||
126008696|NCT03822351|453324516|FG000|Overall Study|Progressive Disease|2|||
126008697|NCT03822351|453324517|FG001|Overall Study|Progressive Disease|1|||
126008698|NCT03822351|453324518|FG002|Overall Study|Progressive Disease|0|||
126008699|NCT03822351|453324516|FG000|Overall Study|Not Treated|1|||
126008700|NCT03822351|453324517|FG001|Overall Study|Not Treated|1|||
126008701|NCT03822351|453324518|FG002|Overall Study|Not Treated|1|||
126008702|NCT00813488|453324519|FG000|Titration Period 1|Adverse Event|6|||
126008703|NCT00813488|453324520|FG001|Titration Period 1|Adverse Event|1|||
126008704|NCT00813488|453324519|FG000|Titration Period 1|Lack of Efficacy|9|||
126008705|NCT00813488|453324520|FG001|Titration Period 1|Lack of Efficacy|7|||
126008706|NCT00813488|453324519|FG000|Titration Period 1|Withdrawal by Subject|2|||
126008707|NCT00813488|453324520|FG001|Titration Period 1|Withdrawal by Subject|2|||
126008708|NCT00813488|453324519|FG000|Titration Period 1|Protocol Violation|4|||
126008709|NCT00813488|453324520|FG001|Titration Period 1|Protocol Violation|3|||
126008710|NCT00813488|453324519|FG000|Titration Period 1|Non-compliance to study medication|4|||
126008711|NCT00813488|453324520|FG001|Titration Period 1|Non-compliance to study medication|1|||
126008712|NCT00813488|453324519|FG000|Titration Period 1|Non-compliance to study procedures|2|||
126008713|NCT00813488|453324520|FG001|Titration Period 1|Non-compliance to study procedures|2|||
126008714|NCT00813488|453324519|FG000|Titration Period 1|Technical Difficulties|0|||
126008715|NCT00813488|453324520|FG001|Titration Period 1|Technical Difficulties|1|||
126008716|NCT00813488|453324519|FG000|Titration Period 2|Adverse Event|2|||
126008717|NCT00813488|453324520|FG001|Titration Period 2|Adverse Event|3|||
126008718|NCT00813488|453324519|FG000|Titration Period 2|Lack of Efficacy|8|||
126008719|NCT00813488|453324520|FG001|Titration Period 2|Lack of Efficacy|4|||
126008720|NCT00813488|453324519|FG000|Titration Period 2|Protocol Violation|3|||
126008721|NCT00813488|453324520|FG001|Titration Period 2|Protocol Violation|2|||
126008722|NCT00813488|453324519|FG000|Titration Period 2|Lost to Follow-up|1|||
126428364|NCT03742037|454863930|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
126428365|NCT03742037|454863924|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126428366|NCT03742037|454863925|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
126428367|NCT03742037|454863926|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
126428368|NCT03742037|454863927|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126428369|NCT03742037|454863928|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126428370|NCT03742037|454863929|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126428371|NCT03742037|454863930|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126428372|NCT03742037|454863924|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
126428373|NCT03742037|454863925|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126428374|NCT03742037|454863926|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126428375|NCT03742037|454863927|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126428376|NCT03742037|454863928|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126428377|NCT03742037|454863929|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126008723|NCT00813488|453324520|FG001|Titration Period 2|Lost to Follow-up|0|||
126008724|NCT00813488|453324519|FG000|Titration Period 2|Non-compliance with study procedures|2|||
126008725|NCT00813488|453324520|FG001|Titration Period 2|Non-compliance with study procedures|1|||
126008726|NCT00813488|453324519|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
126008727|NCT00813488|453324520|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
126008728|NCT00813488|453324519|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
126008729|NCT00813488|453324520|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
126008730|NCT00813488|453324519|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
126008731|NCT00813488|453324520|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
126008732|NCT00813488|453324519|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
126008733|NCT00813488|453324520|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
126008734|NCT00813488|453324519|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
126428378|NCT03742037|454863930|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
126428379|NCT03742037|454863924|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
126428380|NCT03742037|454863925|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
126428381|NCT03742037|454863926|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
126428382|NCT03742037|454863927|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
126428383|NCT03742037|454863928|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
126428384|NCT03742037|454863929|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
126428385|NCT03742037|454863930|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
126428386|NCT03742037|454863924|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
126428387|NCT03742037|454863925|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
126428388|NCT03742037|454863926|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
126428389|NCT03742037|454863927|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
126428390|NCT03742037|454863928|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
126428391|NCT03742037|454863929|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
126428392|NCT03742037|454863930|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
126428393|NCT03742037|454863924|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126428394|NCT03742037|454863925|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126428395|NCT03742037|454863926|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
126428396|NCT03742037|454863927|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126428397|NCT03742037|454863928|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126428398|NCT03742037|454863929|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126428399|NCT03742037|454863930|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126008735|NCT00813488|453324520|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
126008736|NCT00813488|453324519|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
126008737|NCT00813488|453324520|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
126008738|NCT00813488|453324519|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
126008739|NCT00813488|453324520|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
126008740|NCT00813488|453324519|FG000|Double-blind Treatment Period 2|Other|1|||
126008741|NCT00813488|453324520|FG001|Double-blind Treatment Period 2|Other|0|||
126008742|NCT00813488|453324519|FG000|Open-label Extension|Adverse Event|1|||
126008743|NCT00813488|453324520|FG001|Open-label Extension|Adverse Event|2|||
126008744|NCT00813488|453324519|FG000|Open-label Extension|Lack of Efficacy|3|||
126008745|NCT00813488|453324520|FG001|Open-label Extension|Lack of Efficacy|0|||
126008746|NCT00813488|453324519|FG000|Open-label Extension|Withdrawal by Subject|0|||
126008747|NCT00813488|453324520|FG001|Open-label Extension|Withdrawal by Subject|2|||
126008748|NCT00813488|453324519|FG000|Open-label Extension|Protocol Violation|1|||
126428400|NCT04447755|454863931|FG000|Overall Study|Death|9|||
126428401|NCT04447755|454863932|FG001|Overall Study|Death|16|||
126428402|NCT04447755|454863933|FG002|Overall Study|Death|8|||
126428403|NCT04447755|454863934|FG003|Overall Study|Death|9|||
126428404|NCT04447755|454863935|FG004|Overall Study|Death|8|||
126428405|NCT04447755|454863936|FG005|Overall Study|Death|9|||
126428406|NCT04447755|454863937|FG006|Overall Study|Death|55|||
126428407|NCT04447755|454863931|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126428408|NCT04447755|454863932|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126428409|NCT04447755|454863933|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126428410|NCT04447755|454863934|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126428411|NCT04447755|454863935|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126428412|NCT04447755|454863936|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126428413|NCT04447755|454863937|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
126428414|NCT04447755|454863931|FG000|Overall Study|Sponsor Decision|0|||
126428415|NCT04447755|454863932|FG001|Overall Study|Sponsor Decision|0|||
126428416|NCT04447755|454863933|FG002|Overall Study|Sponsor Decision|0|||
126428417|NCT04447755|454863934|FG003|Overall Study|Sponsor Decision|0|||
126428418|NCT04447755|454863935|FG004|Overall Study|Sponsor Decision|1|||
126428419|NCT04447755|454863936|FG005|Overall Study|Sponsor Decision|0|||
126428420|NCT04447755|454863937|FG006|Overall Study|Sponsor Decision|10|||
126428421|NCT04447755|454863931|FG000|Overall Study|Lost to Follow-up|0|||
126428422|NCT04447755|454863932|FG001|Overall Study|Lost to Follow-up|0|||
126008749|NCT00813488|453324520|FG001|Open-label Extension|Protocol Violation|2|||
126008750|NCT00813488|453324519|FG000|Open-label Extension|Non-compliance study medication|4|||
126008751|NCT00813488|453324520|FG001|Open-label Extension|Non-compliance study medication|0|||
126008752|NCT00813488|453324519|FG000|Open-label Extension|Non-compliance study procedures|2|||
126046460|NCT02467270|453468228|FG002|Overall Study|Death|2|||
126428423|NCT04447755|454863933|FG002|Overall Study|Lost to Follow-up|0|||
126428424|NCT04447755|454863934|FG003|Overall Study|Lost to Follow-up|0|||
126428425|NCT04447755|454863935|FG004|Overall Study|Lost to Follow-up|0|||
126428426|NCT04447755|454863936|FG005|Overall Study|Lost to Follow-up|0|||
126428427|NCT04447755|454863937|FG006|Overall Study|Lost to Follow-up|1|||
126428428|NCT05263492|454863938|FG000|Overall Study|Adverse Event|1|||
126428429|NCT05263492|454863938|FG000|Overall Study|Disease progression during active treatment|3|||
126428430|NCT04879628|454863939|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
126428431|NCT04879628|454863940|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
126428432|NCT04879628|454863941|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
126428433|NCT04879628|454863942|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
126428434|NCT04879628|454863939|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
126428435|NCT04879628|454863940|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
126428436|NCT04879628|454863941|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
126428437|NCT04879628|454863942|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
126428438|NCT04879628|454863939|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
126428439|NCT04879628|454863940|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
126428440|NCT04879628|454863941|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
126428441|NCT04879628|454863942|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
126428442|NCT04879628|454863939|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
126428443|NCT04879628|454863940|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
126428444|NCT04879628|454863941|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
126428445|NCT04879628|454863942|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
126428446|NCT05446870|454863947|FG000|Overall Study|Death|6|||
126428447|NCT05446870|454863948|FG001|Overall Study|Death|5|||
126428448|NCT05446870|454863947|FG000|Overall Study|Lost to Follow-up|0|||
126428449|NCT05446870|454863948|FG001|Overall Study|Lost to Follow-up|1|||
126428450|NCT05446870|454863947|FG000|Overall Study|Physician Decision|52|||
126428451|NCT05446870|454863948|FG001|Overall Study|Physician Decision|53|||
126428452|NCT05446870|454863947|FG000|Overall Study|Withdrawal by Subject|3|||
126428453|NCT05446870|454863948|FG001|Overall Study|Withdrawal by Subject|3|||
126428454|NCT03345420|454863949|FG000|Overall Study|Withdrawal by Subject|1|||
126428455|NCT05216835|454863952|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
126428456|NCT05216835|454863953|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
126428457|NCT05216835|454863954|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
126428458|NCT05216835|454863955|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
126428459|NCT05216835|454863956|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
126428460|NCT05216835|454863957|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
126428461|NCT05216835|454863958|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
126428462|NCT05216835|454863959|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
126428463|NCT05216835|454863952|FG000|Overall Study|Death|0|||
126428464|NCT05216835|454863953|FG001|Overall Study|Death|0|||
126428465|NCT05216835|454863954|FG002|Overall Study|Death|0|||
126428466|NCT05216835|454863955|FG003|Overall Study|Death|1|||
126428467|NCT05216835|454863956|FG004|Overall Study|Death|1|||
126428468|NCT05216835|454863957|FG005|Overall Study|Death|1|||
126428469|NCT05216835|454863958|FG006|Overall Study|Death|1|||
126428470|NCT05216835|454863959|FG007|Overall Study|Death|1|||
126428471|NCT05216835|454863952|FG000|Overall Study|Physician Decision|0|||
126428472|NCT05216835|454863953|FG001|Overall Study|Physician Decision|0|||
126428473|NCT05216835|454863954|FG002|Overall Study|Physician Decision|0|||
126428474|NCT05216835|454863955|FG003|Overall Study|Physician Decision|0|||
126428475|NCT05216835|454863956|FG004|Overall Study|Physician Decision|0|||
126428476|NCT05216835|454863957|FG005|Overall Study|Physician Decision|1|||
126428477|NCT05216835|454863958|FG006|Overall Study|Physician Decision|1|||
126428478|NCT05216835|454863959|FG007|Overall Study|Physician Decision|0|||
126428479|NCT05216835|454863952|FG000|Overall Study|Study terminated by Sponsor|0|||
126428480|NCT05216835|454863953|FG001|Overall Study|Study terminated by Sponsor|0|||
126428481|NCT05216835|454863954|FG002|Overall Study|Study terminated by Sponsor|0|||
126428482|NCT05216835|454863955|FG003|Overall Study|Study terminated by Sponsor|0|||
126428483|NCT05216835|454863956|FG004|Overall Study|Study terminated by Sponsor|0|||
126008753|NCT00813488|453324520|FG001|Open-label Extension|Non-compliance study procedures|1|||
126008754|NCT00813488|453324519|FG000|Open-label Extension|Other|1|||
126428484|NCT05216835|454863957|FG005|Overall Study|Study terminated by Sponsor|0|||
126428485|NCT05216835|454863958|FG006|Overall Study|Study terminated by Sponsor|0|||
126428486|NCT05216835|454863959|FG007|Overall Study|Study terminated by Sponsor|1|||
126428487|NCT05216835|454863952|FG000|Overall Study|Withdrawal by Subject|1|||
126428488|NCT05216835|454863953|FG001|Overall Study|Withdrawal by Subject|0|||
126428489|NCT05216835|454863954|FG002|Overall Study|Withdrawal by Subject|1|||
126428490|NCT05216835|454863955|FG003|Overall Study|Withdrawal by Subject|0|||
126428491|NCT05216835|454863956|FG004|Overall Study|Withdrawal by Subject|1|||
126428492|NCT05216835|454863957|FG005|Overall Study|Withdrawal by Subject|0|||
126428493|NCT05216835|454863958|FG006|Overall Study|Withdrawal by Subject|0|||
126428494|NCT05216835|454863959|FG007|Overall Study|Withdrawal by Subject|1|||
126428495|NCT05216835|454863952|FG000|Overall Study|Other|0|||
126428496|NCT05216835|454863953|FG001|Overall Study|Other|1|||
126428497|NCT05216835|454863954|FG002|Overall Study|Other|0|||
126008755|NCT00813488|453324520|FG001|Open-label Extension|Other|0|||
126008756|NCT01729871|453324521|FG000|Overall Study|Adverse Event|7|||
126008757|NCT01729871|453324522|FG001|Overall Study|Adverse Event|7|||
126008758|NCT01729871|453324521|FG000|Overall Study|Death|0|||
126008759|NCT01729871|453324522|FG001|Overall Study|Death|1|||
126008760|NCT01729871|453324521|FG000|Overall Study|Lack of Efficacy|0|||
126008761|NCT01729871|453324522|FG001|Overall Study|Lack of Efficacy|1|||
126008762|NCT01729871|453324521|FG000|Overall Study|Physician Decision|0|||
126008763|NCT01729871|453324522|FG001|Overall Study|Physician Decision|2|||
126008764|NCT01729871|453324521|FG000|Overall Study|Protocol Violation|1|||
126008765|NCT01729871|453324522|FG001|Overall Study|Protocol Violation|0|||
126008766|NCT01729871|453324521|FG000|Overall Study|Withdrawal by Subject|0|||
126008767|NCT01729871|453324522|FG001|Overall Study|Withdrawal by Subject|3|||
126008768|NCT01729871|453324521|FG000|Overall Study|Other|4|||
126008769|NCT01729871|453324522|FG001|Overall Study|Other|9|||
126008770|NCT01143077|453324523|FG000|Overall Study|Lack of Efficacy|0|||
126008771|NCT01143077|453324524|FG001|Overall Study|Lack of Efficacy|2|||
126008772|NCT01143077|453324525|FG002|Overall Study|Lack of Efficacy|1|||
126008773|NCT01143077|453324523|FG000|Overall Study|Adverse Event|5|||
126008774|NCT01143077|453324524|FG001|Overall Study|Adverse Event|6|||
126008775|NCT01143077|453324525|FG002|Overall Study|Adverse Event|5|||
126008776|NCT01143077|453324523|FG000|Overall Study|Lost to Follow-up|2|||
126008777|NCT01143077|453324524|FG001|Overall Study|Lost to Follow-up|3|||
126008778|NCT01143077|453324525|FG002|Overall Study|Lost to Follow-up|4|||
126008779|NCT01143077|453324523|FG000|Overall Study|Protocol Violation|2|||
126008780|NCT01143077|453324524|FG001|Overall Study|Protocol Violation|0|||
126008781|NCT01143077|453324525|FG002|Overall Study|Protocol Violation|0|||
126008782|NCT01143077|453324523|FG000|Overall Study|Withdrawal by Subject|4|||
126008783|NCT01143077|453324524|FG001|Overall Study|Withdrawal by Subject|3|||
126008784|NCT01143077|453324525|FG002|Overall Study|Withdrawal by Subject|3|||
126008785|NCT01143077|453324523|FG000|Overall Study|Non-compliance with study drug|0|||
126008786|NCT01143077|453324524|FG001|Overall Study|Non-compliance with study drug|1|||
126008787|NCT01143077|453324525|FG002|Overall Study|Non-compliance with study drug|1|||
126008788|NCT01143077|453324523|FG000|Overall Study|Administrative|1|||
126008789|NCT01143077|453324524|FG001|Overall Study|Administrative|0|||
126008790|NCT01143077|453324525|FG002|Overall Study|Administrative|0|||
126008791|NCT01143077|453324523|FG000|Overall Study|Principal Investigator Decision|2|||
126008792|NCT01143077|453324524|FG001|Overall Study|Principal Investigator Decision|0|||
126008793|NCT01143077|453324525|FG002|Overall Study|Principal Investigator Decision|1|||
126008794|NCT05526911|453325987|FG000|Overall Study|Adverse Event|2|||
126008795|NCT00762463|453325989|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
126008796|NCT00762463|453325990|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
126008797|NCT00762463|453325991|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
126008798|NCT00762463|453325992|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
126008799|NCT00762463|453325989|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
126008800|NCT00762463|453325990|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
126008801|NCT00762463|453325991|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
126008802|NCT00762463|453325992|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
126008803|NCT00762463|453325989|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
126008804|NCT00762463|453325990|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
126008805|NCT00762463|453325991|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
126008806|NCT00762463|453325992|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
126008807|NCT00762463|453325989|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
126008808|NCT00762463|453325990|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
126008809|NCT00762463|453325991|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
126008810|NCT00762463|453325992|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
126008811|NCT00762463|453325989|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
126008812|NCT00762463|453325990|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
126008813|NCT00762463|453325991|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
126008814|NCT00762463|453325992|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
126008815|NCT00762463|453325989|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
126008816|NCT00762463|453325990|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
126008817|NCT00762463|453325991|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
126008818|NCT00762463|453325992|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
126008819|NCT00762463|453325989|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
126008820|NCT00762463|453325990|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
126008821|NCT00762463|453325991|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
126008822|NCT00762463|453325992|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
126008823|NCT00762463|453325989|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
126008824|NCT00762463|453325990|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
126428498|NCT05216835|454863955|FG003|Overall Study|Other|0|||
126428499|NCT05216835|454863956|FG004|Overall Study|Other|0|||
126428500|NCT05216835|454863957|FG005|Overall Study|Other|0|||
126428501|NCT05216835|454863958|FG006|Overall Study|Other|0|||
126428502|NCT05216835|454863959|FG007|Overall Study|Other|0|||
126428503|NCT05179603|454863960|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
126428504|NCT05179603|454863960|FG000|Overall Study|Withdrawal by Subject|1|||
126428505|NCT05179603|454863960|FG000|Overall Study|Progressive disease|4|||
126428506|NCT05179603|454863960|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
126428507|NCT02689505|454863961|FG000|Overall Study|Progressive disease|2|||
126428508|NCT02689505|454863962|FG001|Overall Study|Progressive disease|2|||
126428509|NCT02689505|454863963|FG002|Overall Study|Progressive disease|3|||
126428510|NCT02689505|454863964|FG003|Overall Study|Progressive disease|9|||
126428511|NCT02689505|454863965|FG004|Overall Study|Progressive disease|1|||
126428512|NCT02689505|454863961|FG000|Overall Study|Dose Limiting Toxicity|0|||
126428513|NCT02689505|454863962|FG001|Overall Study|Dose Limiting Toxicity|1|||
126428514|NCT02689505|454863963|FG002|Overall Study|Dose Limiting Toxicity|0|||
126428515|NCT02689505|454863964|FG003|Overall Study|Dose Limiting Toxicity|0|||
126428516|NCT02689505|454863965|FG004|Overall Study|Dose Limiting Toxicity|2|||
126428517|NCT02689505|454863961|FG000|Overall Study|Other AE or clinical progression|0|||
126428518|NCT02689505|454863962|FG001|Overall Study|Other AE or clinical progression|2|||
126428519|NCT02689505|454863963|FG002|Overall Study|Other AE or clinical progression|0|||
126428520|NCT02689505|454863964|FG003|Overall Study|Other AE or clinical progression|2|||
126428521|NCT02689505|454863965|FG004|Overall Study|Other AE or clinical progression|0|||
126428522|NCT04875195|454863971|FG000|Overall Study|Death|9|||
126008825|NCT00762463|453325991|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
126008826|NCT00762463|453325992|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
126008827|NCT01306331|453325993|FG000|Overall Study|Adverse Event|28|||
126008828|NCT01306331|453325994|FG001|Overall Study|Adverse Event|25|||
126428523|NCT04875195|454863972|FG001|Overall Study|Death|3|||
126428524|NCT04875195|454863971|FG000|Overall Study|Withdrawal by Subject|2|||
126428525|NCT04875195|454863972|FG001|Overall Study|Withdrawal by Subject|1|||
126008829|NCT01306331|453325993|FG000|Overall Study|Lost to Follow-up|321|||
126008830|NCT01306331|453325994|FG001|Overall Study|Lost to Follow-up|323|||
126008831|NCT01306331|453325993|FG000|Overall Study|Physician Decision|26|||
126008832|NCT01306331|453325994|FG001|Overall Study|Physician Decision|22|||
126008833|NCT01306331|453325993|FG000|Overall Study|Pregnancy|136|||
126008834|NCT01306331|453325994|FG001|Overall Study|Pregnancy|151|||
126008835|NCT01306331|453325993|FG000|Overall Study|Protocol Violation|154|||
126008836|NCT01306331|453325994|FG001|Overall Study|Protocol Violation|124|||
126008837|NCT01306331|453325993|FG000|Overall Study|Withdrawal by Subject|163|||
126008838|NCT01306331|453325994|FG001|Overall Study|Withdrawal by Subject|152|||
126008839|NCT01306331|453325993|FG000|Overall Study|Not sexually active|29|||
126008840|NCT01306331|453325994|FG001|Overall Study|Not sexually active|28|||
126008841|NCT01306331|453325993|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
126008842|NCT01306331|453325994|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
126008843|NCT01306331|453325993|FG000|Overall Study|Other|34|||
126008844|NCT01306331|453325994|FG001|Overall Study|Other|32|||
126008845|NCT04048135|453325997|FG000|Overall Study|Withdrawal by Subject|1|||
126008846|NCT04048135|453325998|FG001|Overall Study|Withdrawal by Subject|1|||
126008847|NCT04048135|453325999|FG002|Overall Study|Withdrawal by Subject|1|||
126008848|NCT04048135|453326000|FG003|Overall Study|Withdrawal by Subject|2|||
126428526|NCT04875195|454863971|FG000|Overall Study|Ongoing in study|49|||
126428527|NCT04875195|454863972|FG001|Overall Study|Ongoing in study|2|||
126428528|NCT05190120|454863973|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
126428529|NCT05190120|454863974|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
126428530|NCT05190120|454863975|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
126428531|NCT05190120|454863976|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
126428532|NCT05190120|454863973|FG000|Overall Study|Lost to Follow-up|5|||
126428533|NCT05190120|454863974|FG001|Overall Study|Lost to Follow-up|0|||
126428534|NCT05190120|454863975|FG002|Overall Study|Lost to Follow-up|2|||
126008849|NCT04048135|453326001|FG004|Overall Study|Withdrawal by Subject|0|||
126342653|NCT04142242|454550543|FG003|Stage I|Non-compliance with the protocol|0|||
126342654|NCT04142242|454550544|FG004|Stage I|Non-compliance with the protocol|0|||
126342655|NCT04142242|454550545|FG005|Stage I|Non-compliance with the protocol|1|||
126342656|NCT04142242|454550540|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126342657|NCT04142242|454550541|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
126342658|NCT04142242|454550542|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126342659|NCT04142242|454550543|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126428535|NCT05190120|454863976|FG003|Overall Study|Lost to Follow-up|3|||
126428536|NCT02446600|454863977|FG000|Overall Study|Never treated|20|||
126008850|NCT04048135|453326002|FG005|Overall Study|Withdrawal by Subject|0|||
126008851|NCT04048135|453326003|FG006|Overall Study|Withdrawal by Subject|1|||
126008852|NCT04048135|453326004|FG007|Overall Study|Withdrawal by Subject|1|||
126008853|NCT04048135|453325997|FG000|Overall Study|Adverse Event|0|||
126008854|NCT04048135|453325998|FG001|Overall Study|Adverse Event|0|||
126008855|NCT04048135|453325999|FG002|Overall Study|Adverse Event|0|||
126008856|NCT04048135|453326000|FG003|Overall Study|Adverse Event|1|||
126008857|NCT04048135|453326001|FG004|Overall Study|Adverse Event|1|||
126008858|NCT04048135|453326002|FG005|Overall Study|Adverse Event|0|||
126008859|NCT04048135|453326003|FG006|Overall Study|Adverse Event|0|||
126008860|NCT04048135|453326004|FG007|Overall Study|Adverse Event|0|||
126008861|NCT04048135|453325997|FG000|Overall Study|Protocol Violation|0|||
126008862|NCT04048135|453325998|FG001|Overall Study|Protocol Violation|0|||
126008863|NCT04048135|453325999|FG002|Overall Study|Protocol Violation|0|||
126008864|NCT04048135|453326000|FG003|Overall Study|Protocol Violation|0|||
126008865|NCT04048135|453326001|FG004|Overall Study|Protocol Violation|0|||
126008866|NCT04048135|453326002|FG005|Overall Study|Protocol Violation|1|||
126008867|NCT04048135|453326003|FG006|Overall Study|Protocol Violation|0|||
126008868|NCT04048135|453326004|FG007|Overall Study|Protocol Violation|0|||
126008869|NCT00172185|453326005|FG000|Overall Study|Adverse Event|0|||
126008870|NCT00172185|453326006|FG001|Overall Study|Adverse Event|1|||
126008871|NCT00172185|453326007|FG002|Overall Study|Adverse Event|3|||
126008872|NCT00172185|453326008|FG003|Overall Study|Adverse Event|4|||
126008873|NCT00172185|453326005|FG000|Overall Study|Physician Decision|0|||
126008874|NCT00172185|453326006|FG001|Overall Study|Physician Decision|0|||
126008875|NCT00172185|453326007|FG002|Overall Study|Physician Decision|1|||
126008876|NCT00172185|453326008|FG003|Overall Study|Physician Decision|0|||
126008877|NCT00172185|453326005|FG000|Overall Study|SPONSOR Decision|0|||
126008878|NCT00172185|453326006|FG001|Overall Study|SPONSOR Decision|1|||
126008879|NCT00172185|453326007|FG002|Overall Study|SPONSOR Decision|0|||
126008880|NCT00172185|453326008|FG003|Overall Study|SPONSOR Decision|0|||
126008881|NCT00172185|453326005|FG000|Overall Study|Withdrawal by Subject|0|||
126008882|NCT00172185|453326006|FG001|Overall Study|Withdrawal by Subject|0|||
126008883|NCT00172185|453326007|FG002|Overall Study|Withdrawal by Subject|1|||
126008884|NCT00172185|453326008|FG003|Overall Study|Withdrawal by Subject|0|||
126008885|NCT01677936|453326009|FG000|Overall Study|Lost to Follow-up|4|||
126008886|NCT01677936|453326010|FG001|Overall Study|Lost to Follow-up|1|||
126008887|NCT01677936|453326009|FG000|Overall Study|Protocol Violation|3|||
126008888|NCT01677936|453326010|FG001|Overall Study|Protocol Violation|0|||
126008889|NCT01677936|453326009|FG000|Overall Study|Adverse Event|1|||
126008890|NCT01677936|453326010|FG001|Overall Study|Adverse Event|0|||
126008891|NCT01677936|453326009|FG000|Overall Study|Lost to Follow-up|1|||
126008892|NCT01677936|453326010|FG001|Overall Study|Lost to Follow-up|0|||
126008893|NCT01677936|453326009|FG000|Overall Study|Protocol Violation|0|||
126008894|NCT01677936|453326010|FG001|Overall Study|Protocol Violation|4|||
126008895|NCT04358549|453326011|FG000|Overall Study|Adverse Event|0|||
126008896|NCT04358549|453326012|FG001|Overall Study|Adverse Event|1|||
126008897|NCT04358549|453326011|FG000|Overall Study|Death|1|||
126008898|NCT04358549|453326012|FG001|Overall Study|Death|0|||
126008899|NCT04358549|453326011|FG000|Overall Study|Lost to Follow-up|2|||
126008900|NCT04358549|453326012|FG001|Overall Study|Lost to Follow-up|1|||
126008901|NCT04358549|453326011|FG000|Overall Study|Withdrawal by Subject|6|||
126008902|NCT04358549|453326012|FG001|Overall Study|Withdrawal by Subject|6|||
126428537|NCT02446600|454863978|FG001|Overall Study|Never treated|2|||
126428538|NCT02446600|454863979|FG002|Overall Study|Never treated|6|||
126428539|NCT02446600|454863980|FG003|Overall Study|Never treated|0|||
126428540|NCT02446600|454863977|FG000|Overall Study|Withdrawal by Subject|19|||
126428541|NCT02446600|454863978|FG001|Overall Study|Withdrawal by Subject|5|||
126428542|NCT02446600|454863979|FG002|Overall Study|Withdrawal by Subject|17|||
126428543|NCT02446600|454863980|FG003|Overall Study|Withdrawal by Subject|0|||
126428544|NCT02446600|454863977|FG000|Overall Study|Ineligible|1|||
126008903|NCT04358549|453326011|FG000|Overall Study|Start remdesivir|1|||
126008904|NCT04358549|453326012|FG001|Overall Study|Start remdesivir|0|||
126008905|NCT04867902|453326013|FG000|Overall Study|Lost to Follow-up|1|||
126008906|NCT04867902|453326013|FG000|Overall Study|Withdrawal by Subject|2|||
126008907|NCT04867902|453326013|FG000|Overall Study|Protocol Violation|1|||
126008908|NCT05355116|453326014|FG000|Overall Study|Withdrawal by Subject|2|||
126008909|NCT02380742|453326019|FG000|Overall Study|Withdrawal by Subject|1|||
126008910|NCT02380742|453326020|FG001|Overall Study|Withdrawal by Subject|0|||
126008911|NCT00151996|453326021|FG000|Overall Study|Adverse Event|3|||
126008912|NCT00151996|453326022|FG001|Overall Study|Adverse Event|2|||
126008913|NCT00151996|453326021|FG000|Overall Study|Withdrawal by Subject|1|||
126008914|NCT00151996|453326022|FG001|Overall Study|Withdrawal by Subject|1|||
126008915|NCT00151996|453326021|FG000|Overall Study|Protocol Violation|1|||
126008916|NCT00151996|453326022|FG001|Overall Study|Protocol Violation|2|||
126008917|NCT00151996|453326021|FG000|Overall Study|Sponsor's decision|0|||
126008918|NCT00151996|453326022|FG001|Overall Study|Sponsor's decision|2|||
126008919|NCT01801930|453326025|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
126008920|NCT01801930|453326026|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
126428545|NCT02446600|454863978|FG001|Overall Study|Ineligible|4|||
126428546|NCT02446600|454863979|FG002|Overall Study|Ineligible|4|||
126008921|NCT01801930|453326027|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
126428547|NCT02446600|454863980|FG003|Overall Study|Ineligible|1|||
126428548|NCT02446600|454863977|FG000|Overall Study|Duplicate Enrollment|0|||
126428549|NCT02446600|454863978|FG001|Overall Study|Duplicate Enrollment|1|||
126428550|NCT02446600|454863979|FG002|Overall Study|Duplicate Enrollment|0|||
126428551|NCT02446600|454863980|FG003|Overall Study|Duplicate Enrollment|0|||
126428552|NCT04551053|454863981|FG000|Overall Study|Death|10|||
126428553|NCT04551053|454863982|FG001|Overall Study|Death|9|||
126428554|NCT04551053|454863981|FG000|Overall Study|Lost to Follow-up|0|||
126428555|NCT04551053|454863982|FG001|Overall Study|Lost to Follow-up|2|||
126428556|NCT04551053|454863981|FG000|Overall Study|Study Terminated by Sponsor|57|||
126428557|NCT04551053|454863982|FG001|Overall Study|Study Terminated by Sponsor|65|||
126428558|NCT04551053|454863981|FG000|Overall Study|Withdrawal by Subject|12|||
126428559|NCT04551053|454863982|FG001|Overall Study|Withdrawal by Subject|5|||
126428560|NCT04551053|454863981|FG000|Overall Study|Adverse Event|2|||
126428561|NCT04551053|454863982|FG001|Overall Study|Adverse Event|0|||
126428562|NCT04551053|454863981|FG000|Overall Study|Lack of Efficacy|2|||
126428563|NCT04551053|454863982|FG001|Overall Study|Lack of Efficacy|1|||
126428564|NCT04551053|454863981|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
126428565|NCT04551053|454863982|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
126428566|NCT04551053|454863981|FG000|Overall Study|Splenapendectomi|1|||
126428567|NCT04551053|454863982|FG001|Overall Study|Splenapendectomi|0|||
126428568|NCT04551053|454863981|FG000|Overall Study|Medical Decision|1|||
126428569|NCT04551053|454863982|FG001|Overall Study|Medical Decision|1|||
126428570|NCT04529941|454863983|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
126428571|NCT04529941|454863984|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
126428572|NCT04108858|454863985|FG000|Overall Study|Adverse Event|1|||
126428573|NCT01005745|454863986|FG000|Overall Study|No TIL growth|1|||
126428574|NCT01005745|454863986|FG000|Overall Study|Disease progressed during TIL growth|3|||
126428575|NCT01005745|454863986|FG000|Overall Study|Death prior to treatment|1|||
126428576|NCT01005745|454863986|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
126428577|NCT03069352|454863987|FG000|Overall Study|Ongoing|12|||
126428578|NCT03069352|454863988|FG001|Overall Study|Ongoing|40|||
126428579|NCT02621424|454863989|FG000|Overall Study|Withdrawal by Subject|1|||
126428580|NCT02621424|454863990|FG001|Overall Study|Withdrawal by Subject|2|||
126428581|NCT05646251|454863996|FG000|Overall Study|Physician Decision|1|||
126428582|NCT05646251|454863997|FG001|Overall Study|Physician Decision|0|||
126428583|NCT05646251|454863998|FG002|Overall Study|Physician Decision|2|||
126428584|NCT04016415|454863999|FG000|Overall Study|Adverse Event|2|||
126428585|NCT04016415|454864000|FG001|Overall Study|Adverse Event|1|||
126428586|NCT04016415|454863999|FG000|Overall Study|Lost to Follow-up|6|||
126428587|NCT04016415|454864000|FG001|Overall Study|Lost to Follow-up|2|||
126428588|NCT04016415|454863999|FG000|Overall Study|Physician Decision|5|||
126428589|NCT04016415|454864000|FG001|Overall Study|Physician Decision|1|||
126428590|NCT04016415|454863999|FG000|Overall Study|Pregnancy|0|||
126428591|NCT04016415|454864000|FG001|Overall Study|Pregnancy|1|||
126428592|NCT04016415|454863999|FG000|Overall Study|Withdrawal by Subject|24|||
126428593|NCT04016415|454864000|FG001|Overall Study|Withdrawal by Subject|27|||
126428594|NCT04016415|454863999|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
126428595|NCT04016415|454864000|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
126008922|NCT01801930|453326028|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
126008923|NCT01801930|453326025|FG000|Overall Study|DLT occurs|0|||
126008924|NCT01801930|453326026|FG001|Overall Study|DLT occurs|1|||
126008925|NCT01801930|453326027|FG002|Overall Study|DLT occurs|0|||
126008926|NCT01801930|453326028|FG003|Overall Study|DLT occurs|0|||
126008927|NCT03439124|453326029|FG000|Overall Study|Adverse Event|2|||
126008928|NCT03439124|453326030|FG001|Overall Study|Adverse Event|0|||
126008929|NCT03439124|453326029|FG000|Overall Study|Lost to Follow-up|1|||
126008930|NCT03439124|453326030|FG001|Overall Study|Lost to Follow-up|0|||
126008931|NCT03439124|453326029|FG000|Overall Study|Other reasons|1|||
126008932|NCT03439124|453326030|FG001|Overall Study|Other reasons|0|||
126008933|NCT02236559|453326031|FG000|Overall Study|Met Exclusion|3|||
126008934|NCT02236559|453326032|FG001|Overall Study|Met Exclusion|6|||
126008935|NCT02236559|453326031|FG000|Overall Study|Did not Meet Inclusion|3|||
126008936|NCT02236559|453326032|FG001|Overall Study|Did not Meet Inclusion|3|||
126008937|NCT02236559|453326031|FG000|Overall Study|Subject Did Not Consent|4|||
126008938|NCT02236559|453326032|FG001|Overall Study|Subject Did Not Consent|2|||
126008939|NCT02236559|453326031|FG000|Overall Study|Physician Decision|1|||
126428596|NCT05148234|454864001|FG000|Phase I|Ineligible|0|||
126428597|NCT05148234|454864002|FG001|Phase I|Ineligible|0|||
126428598|NCT05148234|454864003|FG002|Phase I|Ineligible|0|||
126428599|NCT05148234|454864004|FG003|Phase I|Ineligible|0|||
126428600|NCT05148234|454864005|FG004|Phase I|Ineligible|0|||
126008940|NCT02236559|453326032|FG001|Overall Study|Physician Decision|1|||
126008941|NCT02236559|453326031|FG000|Overall Study|Withdrawal by Subject|1|||
126008942|NCT02236559|453326032|FG001|Overall Study|Withdrawal by Subject|0|||
126008943|NCT01117480|453326033|FG000|Overall Study|Protocol Violation|8|||
126428601|NCT05148234|454864006|FG005|Phase I|Ineligible|0|||
126428602|NCT05148234|454864007|FG006|Phase I|Ineligible|0|||
126008944|NCT01117480|453326033|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
126008945|NCT00943605|453326034|FG000|Overall Study|Study termination|30|||
126008946|NCT00943605|453326035|FG001|Overall Study|Study termination|30|||
126008947|NCT01072357|453326040|FG000|Overall Study|Lost to Follow-up|0|||
126008948|NCT01072357|453326041|FG001|Overall Study|Lost to Follow-up|1|||
126008949|NCT01876511|453326042|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
126008950|NCT01876511|453326043|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
126008951|NCT01876511|453326044|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
126008952|NCT01876511|453326042|FG000|Overall Study|Death (unrelated)|3|||
126008953|NCT01876511|453326043|FG001|Overall Study|Death (unrelated)|0|||
126008954|NCT01876511|453326044|FG002|Overall Study|Death (unrelated)|2|||
126008955|NCT01876511|453326042|FG000|Overall Study|Drug-related Toxicity|5|||
126008956|NCT01876511|453326043|FG001|Overall Study|Drug-related Toxicity|1|||
126008957|NCT01876511|453326044|FG002|Overall Study|Drug-related Toxicity|6|||
126008958|NCT01876511|453326042|FG000|Overall Study|Patient Decision|3|||
126008959|NCT01876511|453326043|FG001|Overall Study|Patient Decision|0|||
126008960|NCT01876511|453326044|FG002|Overall Study|Patient Decision|6|||
126008961|NCT01876511|453326042|FG000|Overall Study|Physician Decision|1|||
126008962|NCT01876511|453326043|FG001|Overall Study|Physician Decision|0|||
126008963|NCT01876511|453326044|FG002|Overall Study|Physician Decision|1|||
126008964|NCT00891618|453326045|FG000|Overall Study|Withdrawal by Subject|1|||
126008965|NCT01048788|453326046|FG000|Overall Study|Adverse Event|5|||
126008966|NCT01048788|453326047|FG001|Overall Study|Adverse Event|1|||
126008967|NCT01048788|453326048|FG002|Overall Study|Adverse Event|1|||
126008968|NCT01048788|453326046|FG000|Overall Study|Lack of Efficacy|0|||
126008969|NCT01048788|453326047|FG001|Overall Study|Lack of Efficacy|0|||
126008970|NCT01048788|453326048|FG002|Overall Study|Lack of Efficacy|1|||
126008971|NCT01048788|453326046|FG000|Overall Study|Withdrawal by Subject|0|||
126008972|NCT01048788|453326047|FG001|Overall Study|Withdrawal by Subject|1|||
126008973|NCT01048788|453326048|FG002|Overall Study|Withdrawal by Subject|0|||
126008974|NCT00464672|453326051|FG000|Overall Study|withdrawal of consent|0|||
126008975|NCT00464672|453326052|FG001|Overall Study|withdrawal of consent|0|||
126008976|NCT00464672|453326053|FG002|Overall Study|withdrawal of consent|0|||
126008977|NCT00464672|453326054|FG003|Overall Study|withdrawal of consent|1|||
126008978|NCT00464672|453326055|FG004|Overall Study|withdrawal of consent|9|||
126008979|NCT00464672|453326056|FG005|Overall Study|withdrawal of consent|4|||
126008980|NCT00464672|453326051|FG000|Overall Study|Lost to Follow-up|25|||
126008981|NCT00464672|453326052|FG001|Overall Study|Lost to Follow-up|10|||
126008982|NCT00464672|453326053|FG002|Overall Study|Lost to Follow-up|0|||
126008983|NCT00464672|453326054|FG003|Overall Study|Lost to Follow-up|0|||
126008984|NCT00464672|453326055|FG004|Overall Study|Lost to Follow-up|1|||
126008985|NCT00464672|453326056|FG005|Overall Study|Lost to Follow-up|0|||
126008986|NCT00957229|453326058|FG000|Study Start|Adverse Event|0|||
126008987|NCT00957229|453326059|FG001|Study Start|Adverse Event|3|||
126008988|NCT00957229|453326058|FG000|Study Start|Disease Progression|1|||
126008989|NCT00957229|453326059|FG001|Study Start|Disease Progression|0|||
126008990|NCT00957229|453326058|FG000|Reallocated to or Continued Vismodegib|Death|1|||
126008991|NCT00957229|453326059|FG001|Reallocated to or Continued Vismodegib|Death|1|||
126008992|NCT00957229|453326058|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
126008993|NCT00957229|453326059|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
126008994|NCT00606580|453326060|FG000|Overall Study|Lost to Follow-up|1|||
126008995|NCT00606580|453326061|FG001|Overall Study|Lost to Follow-up|1|||
126008996|NCT00606580|453326062|FG002|Overall Study|Lost to Follow-up|4|||
126008997|NCT00606580|453326060|FG000|Overall Study|Clinical failures|1|||
126008998|NCT00606580|453326061|FG001|Overall Study|Clinical failures|0|||
126008999|NCT00606580|453326062|FG002|Overall Study|Clinical failures|12|||
126009000|NCT00606580|453326060|FG000|Overall Study|Withdrawal by investigator|0|||
126009001|NCT00606580|453326061|FG001|Overall Study|Withdrawal by investigator|1|||
126009002|NCT00606580|453326062|FG002|Overall Study|Withdrawal by investigator|6|||
126009003|NCT00606580|453326060|FG000|Overall Study|Withdrawal by Subject|0|||
126009004|NCT00606580|453326061|FG001|Overall Study|Withdrawal by Subject|1|||
126009005|NCT00606580|453326062|FG002|Overall Study|Withdrawal by Subject|0|||
126009006|NCT01250002|453326063|FG000|Overall Study|Change to open surgical procedure|4|||
126009007|NCT01250002|453326064|FG001|Overall Study|Change to open surgical procedure|3|||
126009008|NCT04511650|453326066|FG000|Overall Study|Lost to Follow-up|1|||
126009009|NCT04511650|453326067|FG001|Overall Study|Lost to Follow-up|0|||
126009010|NCT04511650|453326068|FG002|Overall Study|Lost to Follow-up|0|||
126009011|NCT04511650|453326066|FG000|Overall Study|Withdrawal by Subject|1|||
126009012|NCT04511650|453326067|FG001|Overall Study|Withdrawal by Subject|0|||
126009013|NCT04511650|453326068|FG002|Overall Study|Withdrawal by Subject|0|||
126009014|NCT04511650|453326066|FG000|Overall Study|reason not provided|0|||
126009015|NCT04511650|453326067|FG001|Overall Study|reason not provided|0|||
126009016|NCT04511650|453326068|FG002|Overall Study|reason not provided|1|||
126009017|NCT04511650|453326066|FG000|Overall Study|Death|1|||
126009018|NCT04511650|453326067|FG001|Overall Study|Death|1|||
126009019|NCT04511650|453326068|FG002|Overall Study|Death|1|||
126009020|NCT01253226|453326076|FG000|Overall Study|Adverse Event|0|||
126009021|NCT01253226|453326077|FG001|Overall Study|Adverse Event|0|||
126428603|NCT05148234|454864008|FG007|Phase I|Ineligible|1|||
126428604|NCT05148234|454864001|FG000|Phase I|Company closed the trial.|0|||
126428605|NCT05148234|454864002|FG001|Phase I|Company closed the trial.|1|||
126428606|NCT05148234|454864003|FG002|Phase I|Company closed the trial.|0|||
126428607|NCT05148234|454864004|FG003|Phase I|Company closed the trial.|0|||
126428608|NCT05148234|454864005|FG004|Phase I|Company closed the trial.|0|||
126428609|NCT05148234|454864006|FG005|Phase I|Company closed the trial.|0|||
126428610|NCT05148234|454864007|FG006|Phase I|Company closed the trial.|0|||
126428611|NCT05148234|454864008|FG007|Phase I|Company closed the trial.|0|||
126428612|NCT03061201|454864010|FG000|Overall Study|Participants Terminated at Month 36|0|||
126428613|NCT03061201|454864011|FG001|Overall Study|Participants Terminated at Month 36|1|||
126428614|NCT03061201|454864012|FG002|Overall Study|Participants Terminated at Month 36|0|||
126428615|NCT03061201|454864013|FG003|Overall Study|Participants Terminated at Month 36|1|||
126428616|NCT03061201|454864010|FG000|Overall Study|Lost to Follow-up|1|||
126428617|NCT03061201|454864011|FG001|Overall Study|Lost to Follow-up|0|||
126428618|NCT03061201|454864012|FG002|Overall Study|Lost to Follow-up|0|||
126428619|NCT03061201|454864013|FG003|Overall Study|Lost to Follow-up|0|||
126428620|NCT01499563|454864014|FG000|Overall Study|Withdrawal by Subject|10|||
126428621|NCT01499563|454864015|FG001|Overall Study|Withdrawal by Subject|11|||
126428622|NCT01499563|454864016|FG002|Overall Study|Withdrawal by Subject|7|||
126428623|NCT01499563|454864017|FG003|Overall Study|Withdrawal by Subject|8|||
126428624|NCT01499563|454864014|FG000|Overall Study|Physician Decision|2|||
126428625|NCT01499563|454864015|FG001|Overall Study|Physician Decision|1|||
126428626|NCT01499563|454864016|FG002|Overall Study|Physician Decision|3|||
126428627|NCT01499563|454864017|FG003|Overall Study|Physician Decision|0|||
126428628|NCT01499563|454864014|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
126428629|NCT01499563|454864015|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
126428630|NCT01499563|454864016|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
126428631|NCT01499563|454864017|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
126428632|NCT01499563|454864014|FG000|Overall Study|Adverse Event|2|||
126428633|NCT01499563|454864015|FG001|Overall Study|Adverse Event|0|||
126428634|NCT01499563|454864016|FG002|Overall Study|Adverse Event|1|||
126428635|NCT01499563|454864017|FG003|Overall Study|Adverse Event|3|||
126428636|NCT01499563|454864014|FG000|Overall Study|Lack of Efficacy|0|||
126428637|NCT01499563|454864015|FG001|Overall Study|Lack of Efficacy|1|||
126428638|NCT01499563|454864016|FG002|Overall Study|Lack of Efficacy|6|||
126428639|NCT01499563|454864017|FG003|Overall Study|Lack of Efficacy|3|||
126428640|NCT01499563|454864014|FG000|Overall Study|Other|8|||
126428641|NCT01499563|454864015|FG001|Overall Study|Other|6|||
126428642|NCT01499563|454864016|FG002|Overall Study|Other|6|||
126428643|NCT01499563|454864017|FG003|Overall Study|Other|4|||
126428644|NCT05615870|454864018|FG000|Overall Study|Lost to Follow-up|10|||
126428645|NCT05615870|454864019|FG001|Overall Study|Lost to Follow-up|13|||
126428646|NCT05615870|454864018|FG000|Overall Study|Physician Decision|2|||
126428647|NCT05615870|454864019|FG001|Overall Study|Physician Decision|0|||
126428648|NCT05615870|454864018|FG000|Overall Study|Withdrawal by Subject|0|||
126428649|NCT05615870|454864019|FG001|Overall Study|Withdrawal by Subject|2|||
126428650|NCT05615870|454864018|FG000|Overall Study|Protocol Violation|0|||
126428651|NCT05615870|454864019|FG001|Overall Study|Protocol Violation|3|||
126428652|NCT05615870|454864018|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
126428653|NCT05615870|454864019|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
126428654|NCT05615870|454864018|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
126428655|NCT05615870|454864019|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
126428656|NCT05615870|454864018|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
126428657|NCT05615870|454864019|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
126428658|NCT03062358|454864020|FG000|Overall Study|Death|269|||
126428659|NCT03062358|454864021|FG001|Overall Study|Death|145|||
126428660|NCT03062358|454864020|FG000|Overall Study|Withdrawal by Subject|2|||
126428661|NCT03062358|454864021|FG001|Overall Study|Withdrawal by Subject|1|||
126428662|NCT03062358|454864020|FG000|Overall Study|Sponsor Decision|29|||
126428663|NCT03062358|454864021|FG001|Overall Study|Sponsor Decision|7|||
126428664|NCT03861273|454864022|FG000|Screening Phase (3 Weeks)|Other|1|||
126428665|NCT03861273|454864022|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
126428666|NCT03861273|454864022|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
126428667|NCT03861273|454864022|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
126428668|NCT03861273|454864022|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
126428669|NCT03279692|454864023|FG000|Overall Study|Withdrawal by Subject|1|||
126428670|NCT04659603|454864024|FG000|Overall Study|Study terminated by sponsor|0|||
126428671|NCT04659603|454864025|FG001|Overall Study|Study terminated by sponsor|0|||
126428672|NCT04659603|454864026|FG002|Overall Study|Study terminated by sponsor|2|||
126428673|NCT04659603|454864024|FG000|Overall Study|Withdrawal by Subject|0|||
126428674|NCT04659603|454864025|FG001|Overall Study|Withdrawal by Subject|5|||
126428675|NCT04659603|454864026|FG002|Overall Study|Withdrawal by Subject|0|||
126428676|NCT04659603|454864024|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
126428677|NCT04659603|454864025|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
126009022|NCT01253226|453326078|FG002|Overall Study|Adverse Event|1|||
126009023|NCT01253226|453326079|FG003|Overall Study|Adverse Event|0|||
126009024|NCT01253226|453326080|FG004|Overall Study|Adverse Event|0|||
126009025|NCT01253226|453326076|FG000|Overall Study|Death|0|||
126009026|NCT01253226|453326077|FG001|Overall Study|Death|1|||
126009027|NCT01253226|453326078|FG002|Overall Study|Death|0|||
126009028|NCT01253226|453326079|FG003|Overall Study|Death|0|||
126009029|NCT01253226|453326080|FG004|Overall Study|Death|0|||
126009030|NCT01253226|453326076|FG000|Overall Study|Physician Decision|0|||
126009031|NCT01253226|453326077|FG001|Overall Study|Physician Decision|0|||
126009032|NCT01253226|453326078|FG002|Overall Study|Physician Decision|0|||
126009033|NCT01253226|453326079|FG003|Overall Study|Physician Decision|0|||
126009034|NCT01253226|453326080|FG004|Overall Study|Physician Decision|2|||
126009035|NCT01253226|453326076|FG000|Overall Study|Withdrawal by Subject|0|||
126009036|NCT01253226|453326077|FG001|Overall Study|Withdrawal by Subject|0|||
126009037|NCT01253226|453326078|FG002|Overall Study|Withdrawal by Subject|0|||
126009038|NCT01253226|453326079|FG003|Overall Study|Withdrawal by Subject|1|||
126009039|NCT01253226|453326080|FG004|Overall Study|Withdrawal by Subject|0|||
126009040|NCT00988637|453326081|FG000|Overall Study|Lost to Follow-up|2|||
126009041|NCT00988637|453326082|FG001|Overall Study|Lost to Follow-up|1|||
126009042|NCT00988637|453326081|FG000|Overall Study|Withdrawal by Subject|1|||
126009043|NCT00988637|453326082|FG001|Overall Study|Withdrawal by Subject|1|||
126009044|NCT00988637|453326081|FG000|Overall Study|non-compliance with study drug|0|||
126009045|NCT00988637|453326082|FG001|Overall Study|non-compliance with study drug|1|||
126009046|NCT03593070|453326083|FG000|Overall Study|administrative withdrawal|1|||
126009047|NCT03593070|453326084|FG001|Overall Study|administrative withdrawal|1|||
126009048|NCT01582945|453326085|FG000|Overall Study|Intolerable side-effects|1|||
126009049|NCT01582945|453326085|FG000|Overall Study|Scheduling conflicts|1|||
126009050|NCT03310983|453326086|FG000|Overall Study|Lost to Follow-up|15|||
126009051|NCT03310983|453326087|FG001|Overall Study|Lost to Follow-up|17|||
126009052|NCT04523181|453326090|FG000|Overall Study|Withdrawal by Subject|4|||
126009053|NCT04523181|453326091|FG001|Overall Study|Withdrawal by Subject|5|||
126009054|NCT04523181|453326090|FG000|Overall Study|Lost to Follow-up|2|||
126009055|NCT04523181|453326091|FG001|Overall Study|Lost to Follow-up|3|||
126009056|NCT04523181|453326090|FG000|Overall Study|Physician Decision|1|||
126009057|NCT04523181|453326091|FG001|Overall Study|Physician Decision|0|||
126009058|NCT04523181|453326090|FG000|Overall Study|Transferred to external facility.|1|||
126428678|NCT04659603|454864026|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
126428679|NCT03799341|454864027|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
126428680|NCT03799341|454864028|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
126428681|NCT03799341|454864029|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
126428682|NCT03799341|454864027|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
126428683|NCT03799341|454864028|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
126428684|NCT03799341|454864029|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
126428685|NCT03799341|454864027|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
126428686|NCT03799341|454864028|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
126428687|NCT03799341|454864029|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
126428688|NCT03799341|454864027|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
126428689|NCT03799341|454864028|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
126428690|NCT03799341|454864029|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
126428691|NCT03799341|454864027|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
126428692|NCT03799341|454864028|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
126428693|NCT03799341|454864029|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
126428694|NCT03799341|454864027|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
126428695|NCT03799341|454864028|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
126428696|NCT03799341|454864029|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
126009059|NCT04523181|453326091|FG001|Overall Study|Transferred to external facility.|1|||
126009060|NCT01656304|453326093|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
126009061|NCT04391309|453326094|FG000|Overall Study|Death|1|||
126009062|NCT04391309|453326095|FG001|Overall Study|Death|1|||
126009063|NCT04391309|453326094|FG000|Overall Study|Lost to Follow-up|3|||
126009064|NCT04391309|453326095|FG001|Overall Study|Lost to Follow-up|2|||
126009065|NCT04391309|453326094|FG000|Overall Study|Withdrawal by Subject|2|||
126009066|NCT04391309|453326095|FG001|Overall Study|Withdrawal by Subject|2|||
126009067|NCT01155869|453326101|FG000|Overall Study|Lost to Follow-up|3|||
126009068|NCT01155869|453326102|FG001|Overall Study|Lost to Follow-up|1|||
126009069|NCT00881335|453326103|FG000|Overall Study|Lost to Follow-up|3|||
126009070|NCT00881335|453326104|FG001|Overall Study|Lost to Follow-up|2|||
126009071|NCT00462943|453326105|FG000|Overall Study|Failure to achieve a response|5|||
126009072|NCT00462943|453326106|FG001|Overall Study|Failure to achieve a response|5|||
126009073|NCT00462943|453326107|FG002|Overall Study|Failure to achieve a response|1|||
126009074|NCT00462943|453326105|FG000|Overall Study|Adverse Event|6|||
126009075|NCT00462943|453326106|FG001|Overall Study|Adverse Event|4|||
126009076|NCT00462943|453326107|FG002|Overall Study|Adverse Event|1|||
126009077|NCT00462943|453326105|FG000|Overall Study|Protocol Violation|1|||
126428697|NCT05198843|454864030|FG000|Overall Study|Lack of Efficacy|1|||
126428698|NCT01231906|454864033|FG000|Overall Study|Lack of Efficacy|75|||
126428699|NCT01231906|454864034|FG001|Overall Study|Lack of Efficacy|68|||
126428700|NCT01231906|454864033|FG000|Overall Study|Lost to Follow-up|1|||
126428701|NCT01231906|454864034|FG001|Overall Study|Lost to Follow-up|0|||
126428702|NCT01231906|454864033|FG000|Overall Study|Physician Decision|34|||
126428703|NCT01231906|454864034|FG001|Overall Study|Physician Decision|24|||
126428704|NCT01231906|454864033|FG000|Overall Study|Withdrawal by Subject|0|||
126428705|NCT01231906|454864034|FG001|Overall Study|Withdrawal by Subject|4|||
126428706|NCT01231906|454864033|FG000|Overall Study|Ineligible|10|||
126428707|NCT01231906|454864034|FG001|Overall Study|Ineligible|3|||
126428708|NCT01231906|454864033|FG000|Overall Study|No treatment|1|||
126428709|NCT01231906|454864034|FG001|Overall Study|No treatment|2|||
126428710|NCT01116648|454864037|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
126428711|NCT01116648|454864038|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
126428712|NCT01116648|454864039|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
126428713|NCT01116648|454864040|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
126428714|NCT01116648|454864041|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
126428715|NCT01116648|454864042|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
126428716|NCT01116648|454864043|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
126428717|NCT01116648|454864044|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
126428718|NCT01116648|454864045|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
126428719|NCT01116648|454864046|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
126428720|NCT01116648|454864047|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
126428721|NCT01116648|454864048|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
126428722|NCT01116648|454864049|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
126428723|NCT01116648|454864050|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
126428724|NCT01116648|454864051|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
126428725|NCT04539938|454864052|FG000|Overall Study|Death|30|||
126428726|NCT04539938|454864052|FG000|Overall Study|Withdrawal by Subject|4|||
126428727|NCT03100149|454864666|FG000|Overall Study|Adverse Event|0|||
126428728|NCT03100149|454864667|FG001|Overall Study|Adverse Event|1|||
126428729|NCT03100149|454864668|FG002|Overall Study|Adverse Event|0|||
126428730|NCT03100149|454864666|FG000|Overall Study|Participant Moved out of Country|0|||
126428731|NCT03100149|454864667|FG001|Overall Study|Participant Moved out of Country|0|||
126428732|NCT03100149|454864668|FG002|Overall Study|Participant Moved out of Country|1|||
126428733|NCT03100149|454864666|FG000|Overall Study|Withdrawal by Subject|0|||
126428734|NCT03100149|454864667|FG001|Overall Study|Withdrawal by Subject|3|||
126428735|NCT03100149|454864668|FG002|Overall Study|Withdrawal by Subject|1|||
126428736|NCT02472795|454864674|FG000|Overall Study|Adverse Event|0|||
126428737|NCT02472795|454864675|FG001|Overall Study|Adverse Event|1|||
126428738|NCT02472795|454864676|FG002|Overall Study|Adverse Event|0|||
126428739|NCT02472795|454864677|FG003|Overall Study|Adverse Event|0|||
126428740|NCT02472795|454864678|FG004|Overall Study|Adverse Event|2|||
126428741|NCT02472795|454864674|FG000|Overall Study|Withdrawal by Subject|0|||
126428742|NCT02472795|454864675|FG001|Overall Study|Withdrawal by Subject|0|||
126428743|NCT02472795|454864676|FG002|Overall Study|Withdrawal by Subject|0|||
126428744|NCT02472795|454864677|FG003|Overall Study|Withdrawal by Subject|0|||
126428745|NCT02472795|454864678|FG004|Overall Study|Withdrawal by Subject|1|||
126428746|NCT01754597|454864680|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
126428747|NCT01754597|454864681|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
126428748|NCT01588236|454864682|FG000|Overall Study|Adverse Event|5|||
126428749|NCT01588236|454864683|FG001|Overall Study|Adverse Event|4|||
126428750|NCT01588236|454864684|FG002|Overall Study|Adverse Event|1|||
126428751|NCT01588236|454864682|FG000|Overall Study|Lost to Follow-up|8|||
126428752|NCT01588236|454864683|FG001|Overall Study|Lost to Follow-up|13|||
126428753|NCT01588236|454864684|FG002|Overall Study|Lost to Follow-up|6|||
126428754|NCT01588236|454864682|FG000|Overall Study|Physician Decision|1|||
126428755|NCT01588236|454864683|FG001|Overall Study|Physician Decision|2|||
126428756|NCT01588236|454864684|FG002|Overall Study|Physician Decision|0|||
126428757|NCT01588236|454864682|FG000|Overall Study|Protocol Violation|0|||
126428758|NCT01588236|454864683|FG001|Overall Study|Protocol Violation|1|||
126428759|NCT01588236|454864684|FG002|Overall Study|Protocol Violation|1|||
126428760|NCT01588236|454864682|FG000|Overall Study|Withdrawal by Subject|14|||
126428761|NCT01588236|454864683|FG001|Overall Study|Withdrawal by Subject|16|||
126428762|NCT01588236|454864684|FG002|Overall Study|Withdrawal by Subject|18|||
126428763|NCT01588236|454864682|FG000|Overall Study|Exclusion Criteria met during study|2|||
126428764|NCT01588236|454864683|FG001|Overall Study|Exclusion Criteria met during study|1|||
126428765|NCT01588236|454864684|FG002|Overall Study|Exclusion Criteria met during study|0|||
126428766|NCT01588236|454864682|FG000|Overall Study|sponsor decision|1|||
126428767|NCT01588236|454864683|FG001|Overall Study|sponsor decision|6|||
126428768|NCT01588236|454864684|FG002|Overall Study|sponsor decision|2|||
126428769|NCT02819141|454864685|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
126428770|NCT02819141|454864686|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
126428771|NCT04166513|454864687|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
126428772|NCT04166513|454864688|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
126428773|NCT04166513|454864689|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
126009078|NCT00462943|453326106|FG001|Overall Study|Protocol Violation|0|||
126009079|NCT00462943|453326107|FG002|Overall Study|Protocol Violation|0|||
126009080|NCT00462943|453326105|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
126009081|NCT00462943|453326106|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
126009082|NCT00462943|453326107|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
126009083|NCT00462943|453326105|FG000|Overall Study|Disease Progression|15|||
126009084|NCT00462943|453326106|FG001|Overall Study|Disease Progression|15|||
126009085|NCT00462943|453326107|FG002|Overall Study|Disease Progression|9|||
126009086|NCT00462943|453326105|FG000|Overall Study|Death|5|||
126009087|NCT00462943|453326106|FG001|Overall Study|Death|2|||
126009088|NCT00462943|453326107|FG002|Overall Study|Death|7|||
126009089|NCT00462943|453326105|FG000|Overall Study|Stem Cell Transplant|1|||
126009090|NCT00462943|453326106|FG001|Overall Study|Stem Cell Transplant|1|||
126009091|NCT00462943|453326107|FG002|Overall Study|Stem Cell Transplant|0|||
126009092|NCT00462943|453326105|FG000|Overall Study|Bone Marrow Transplant|1|||
126009093|NCT00462943|453326106|FG001|Overall Study|Bone Marrow Transplant|0|||
126009094|NCT00462943|453326107|FG002|Overall Study|Bone Marrow Transplant|0|||
126009095|NCT00462943|453326105|FG000|Overall Study|Required Lymphocyte Infusion|1|||
126009096|NCT00462943|453326106|FG001|Overall Study|Required Lymphocyte Infusion|0|||
126009097|NCT00462943|453326107|FG002|Overall Study|Required Lymphocyte Infusion|0|||
126009098|NCT00462943|453326105|FG000|Overall Study|Transplant - not specified|1|||
126009099|NCT00462943|453326106|FG001|Overall Study|Transplant - not specified|0|||
126009100|NCT00462943|453326107|FG002|Overall Study|Transplant - not specified|1|||
126009101|NCT00462943|453326105|FG000|Overall Study|Physician Decision|1|||
126009102|NCT00462943|453326106|FG001|Overall Study|Physician Decision|0|||
126009103|NCT00462943|453326107|FG002|Overall Study|Physician Decision|0|||
126009104|NCT00462943|453326105|FG000|Overall Study|Withdrawal by Subject|0|||
126009105|NCT00462943|453326106|FG001|Overall Study|Withdrawal by Subject|1|||
126009106|NCT00462943|453326107|FG002|Overall Study|Withdrawal by Subject|0|||
126009107|NCT00477412|453326114|FG000|Overall Study|Death|0|||
126009108|NCT00477412|453326115|FG001|Overall Study|Death|0|||
126009109|NCT00477412|453326116|FG002|Overall Study|Death|0|||
126009110|NCT00477412|453326117|FG003|Overall Study|Death|4|||
126342660|NCT04142242|454550544|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126342661|NCT04142242|454550545|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126342662|NCT04142242|454550540|FG000|Stage II|Non-compliance with the protocol|0|||
126342663|NCT04142242|454550541|FG001|Stage II|Non-compliance with the protocol|0|||
126342664|NCT04142242|454550542|FG002|Stage II|Non-compliance with the protocol|0|||
126342665|NCT04142242|454550543|FG003|Stage II|Non-compliance with the protocol|2|||
126342666|NCT04142242|454550544|FG004|Stage II|Non-compliance with the protocol|0|||
126342667|NCT04142242|454550545|FG005|Stage II|Non-compliance with the protocol|0|||
126342668|NCT04142242|454550540|FG000|Stage II|Lost to Follow-up|0|||
126342669|NCT04142242|454550541|FG001|Stage II|Lost to Follow-up|0|||
126342670|NCT04142242|454550542|FG002|Stage II|Lost to Follow-up|1|||
126342671|NCT04142242|454550543|FG003|Stage II|Lost to Follow-up|2|||
126342672|NCT04142242|454550544|FG004|Stage II|Lost to Follow-up|0|||
126342673|NCT04142242|454550545|FG005|Stage II|Lost to Follow-up|0|||
126342674|NCT04142242|454550540|FG000|Stage II|Withdrawal by Subject|0|||
126342675|NCT04142242|454550541|FG001|Stage II|Withdrawal by Subject|0|||
126342676|NCT04142242|454550542|FG002|Stage II|Withdrawal by Subject|5|||
126342677|NCT04142242|454550543|FG003|Stage II|Withdrawal by Subject|9|||
126342678|NCT04142242|454550544|FG004|Stage II|Withdrawal by Subject|0|||
126342679|NCT04142242|454550545|FG005|Stage II|Withdrawal by Subject|0|||
126342680|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
126342681|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
126342682|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
126342683|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
126342684|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
126342685|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
126342686|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
126342687|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
126342688|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
126342689|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
126342690|NCT05219162|454550550|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
126342691|NCT05219162|454550550|FG000|Overall Study|Withdrawal by Subject|23|||
126342692|NCT00666237|454550570|FG000|Overall Study|Death|5|||
126342693|NCT00666237|454550571|FG001|Overall Study|Death|5|||
126342694|NCT00666237|454550570|FG000|Overall Study|Lost to Follow-up|29|||
126342695|NCT00666237|454550571|FG001|Overall Study|Lost to Follow-up|25|||
126009111|NCT00477412|453326114|FG000|Overall Study|Lost to Follow-up|0|||
126009112|NCT00477412|453326115|FG001|Overall Study|Lost to Follow-up|0|||
126009113|NCT00477412|453326116|FG002|Overall Study|Lost to Follow-up|0|||
126009114|NCT00477412|453326117|FG003|Overall Study|Lost to Follow-up|1|||
126009115|NCT00477412|453326114|FG000|Overall Study|Withdrawal by Subject|0|||
126009116|NCT00477412|453326115|FG001|Overall Study|Withdrawal by Subject|0|||
126009117|NCT00477412|453326116|FG002|Overall Study|Withdrawal by Subject|0|||
126009118|NCT00477412|453326117|FG003|Overall Study|Withdrawal by Subject|2|||
126009119|NCT00477412|453326114|FG000|Overall Study|Second Malignancy|0|||
126009120|NCT00477412|453326115|FG001|Overall Study|Second Malignancy|0|||
126009121|NCT00477412|453326116|FG002|Overall Study|Second Malignancy|0|||
126428774|NCT04166513|454864690|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
126428775|NCT04166513|454864687|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
126009122|NCT00477412|453326117|FG003|Overall Study|Second Malignancy|1|||
126009123|NCT00477412|453326114|FG000|Overall Study|Adverse Event|1|||
126009124|NCT00477412|453326115|FG001|Overall Study|Adverse Event|0|||
126009125|NCT00477412|453326116|FG002|Overall Study|Adverse Event|1|||
126009126|NCT00477412|453326117|FG003|Overall Study|Adverse Event|0|||
126009127|NCT00708097|453326118|FG000|Period 1|Protocol Violation|0|||
126009128|NCT00708097|453326119|FG001|Period 1|Protocol Violation|1|||
126009129|NCT00708097|453326120|FG002|Period 1|Protocol Violation|0|||
126009130|NCT00708097|453326121|FG003|Period 1|Protocol Violation|2|||
126009131|NCT00708097|453326122|FG004|Period 1|Protocol Violation|0|||
126009132|NCT00708097|453326118|FG000|Period 1|Other Reason|0|||
126009133|NCT00708097|453326119|FG001|Period 1|Other Reason|0|||
126009134|NCT00708097|453326120|FG002|Period 1|Other Reason|0|||
126009135|NCT00708097|453326121|FG003|Period 1|Other Reason|0|||
126009136|NCT00708097|453326122|FG004|Period 1|Other Reason|1|||
126009137|NCT00708097|453326118|FG000|Period 2|Protocol Violation|0|||
126009138|NCT00708097|453326119|FG001|Period 2|Protocol Violation|1|||
126009139|NCT00708097|453326120|FG002|Period 2|Protocol Violation|1|||
126009140|NCT00708097|453326121|FG003|Period 2|Protocol Violation|1|||
126009141|NCT00708097|453326122|FG004|Period 2|Protocol Violation|0|||
126009142|NCT01244828|453326123|FG000|Overall Study|Adverse Event|37|||
126009143|NCT01244828|453326123|FG000|Overall Study|Withdrawal by Subject|31|||
126009144|NCT01244828|453326123|FG000|Overall Study|Lack of Efficacy|7|||
126009145|NCT01244828|453326123|FG000|Overall Study|Lost to Follow-up|2|||
126009146|NCT01244828|453326123|FG000|Overall Study|Other reason (not specified)|1|||
126009147|NCT01838200|453326124|FG000|Overall Study|Adverse Event|0|||
126009148|NCT01838200|453326125|FG001|Overall Study|Adverse Event|2|||
126009149|NCT01838200|453326124|FG000|Overall Study|Progressive disease|3|||
126009150|NCT01838200|453326125|FG001|Overall Study|Progressive disease|0|||
126009151|NCT03895034|453327697|FG000|Overall Study|Lost to Follow-up|2|||
126009152|NCT01118377|453327702|FG000|Overall Study|Did Not Receive Study Medication|1|||
126009153|NCT01118377|453327702|FG000|Overall Study|Death|38|||
126009154|NCT01118377|453327702|FG000|Overall Study|Failure to Return|3|||
126009155|NCT00739102|453327703|FG000|Overall Study|Death|5|||
126009156|NCT00739102|453327703|FG000|Overall Study|Withdrawal by Subject|10|||
126009157|NCT03179787|453327704|FG000|Overall Study|Lost to Follow-up|15|||
126009158|NCT03179787|453327704|FG000|Overall Study|Case report failures|2|||
126009159|NCT03179787|453327704|FG000|Overall Study|Treatment not administered|1|||
126009160|NCT00157014|453327705|FG000|Overall Study|Death|4|||
126009161|NCT00157014|453327706|FG001|Overall Study|Death|2|||
126009162|NCT00157014|453327707|FG002|Overall Study|Death|1|||
126009163|NCT00157014|453327708|FG003|Overall Study|Death|1|||
126009164|NCT00157014|453327705|FG000|Overall Study|Physician Decision|0|||
126009165|NCT00157014|453327706|FG001|Overall Study|Physician Decision|1|||
126009166|NCT00157014|453327707|FG002|Overall Study|Physician Decision|0|||
126009167|NCT00157014|453327708|FG003|Overall Study|Physician Decision|0|||
126009168|NCT00157014|453327705|FG000|Overall Study|Medications withdrawn on family request|0|||
126009169|NCT00157014|453327706|FG001|Overall Study|Medications withdrawn on family request|1|||
126009170|NCT00157014|453327707|FG002|Overall Study|Medications withdrawn on family request|0|||
126009171|NCT00157014|453327708|FG003|Overall Study|Medications withdrawn on family request|0|||
126009172|NCT00157014|453327705|FG000|Overall Study|Patient withdrawn by investigator|1|||
126009173|NCT00157014|453327706|FG001|Overall Study|Patient withdrawn by investigator|0|||
126009174|NCT00157014|453327707|FG002|Overall Study|Patient withdrawn by investigator|0|||
126009175|NCT00157014|453327708|FG003|Overall Study|Patient withdrawn by investigator|0|||
126009176|NCT00157014|453327705|FG000|Overall Study|Patient unable to return in nursing home|1|||
126009177|NCT00157014|453327706|FG001|Overall Study|Patient unable to return in nursing home|0|||
126009178|NCT00157014|453327707|FG002|Overall Study|Patient unable to return in nursing home|0|||
126009179|NCT00157014|453327708|FG003|Overall Study|Patient unable to return in nursing home|0|||
126009180|NCT00157014|453327705|FG000|Overall Study|Patient would not receive transplant|0|||
126009181|NCT00157014|453327706|FG001|Overall Study|Patient would not receive transplant|1|||
126009182|NCT00157014|453327707|FG002|Overall Study|Patient would not receive transplant|0|||
126009183|NCT00157014|453327708|FG003|Overall Study|Patient would not receive transplant|0|||
126009184|NCT00157014|453327705|FG000|Overall Study|Withdrawal by Subject|1|||
126009185|NCT00157014|453327706|FG001|Overall Study|Withdrawal by Subject|0|||
126009186|NCT00157014|453327707|FG002|Overall Study|Withdrawal by Subject|0|||
126009187|NCT00157014|453327708|FG003|Overall Study|Withdrawal by Subject|0|||
126009188|NCT03181958|453327709|FG000|Overall Study|Lost to Follow-up|17|||
126009189|NCT03181958|453327710|FG001|Overall Study|Lost to Follow-up|21|||
126009190|NCT03181958|453327711|FG002|Overall Study|Lost to Follow-up|15|||
126009191|NCT01257503|453327712|FG000|Overall Study|Lost to Follow-up|7|||
126009192|NCT01257503|453327713|FG001|Overall Study|Lost to Follow-up|10|||
126009193|NCT01257503|453327712|FG000|Overall Study|Over 5 years old at enrollment|0|||
126009194|NCT01257503|453327713|FG001|Overall Study|Over 5 years old at enrollment|1|||
126009195|NCT01257503|453327712|FG000|Overall Study|strep culture positive at enrollment|1|||
126009196|NCT01257503|453327713|FG001|Overall Study|strep culture positive at enrollment|0|||
126009197|NCT01090024|453327714|FG000|Period 1|Met exclusion criteria|0|||
126009198|NCT01090024|453327715|FG001|Period 1|Met exclusion criteria|0|||
126009199|NCT01090024|453327716|FG002|Period 1|Met exclusion criteria|0|||
126009200|NCT01090024|453327717|FG003|Period 1|Met exclusion criteria|0|||
126009201|NCT01090024|453327718|FG004|Period 1|Met exclusion criteria|0|||
126009202|NCT01090024|453327719|FG005|Period 1|Met exclusion criteria|0|||
126009203|NCT01090024|453327720|FG006|Period 1|Met exclusion criteria|0|||
126009204|NCT01090024|453327721|FG007|Period 1|Met exclusion criteria|0|||
126009205|NCT01090024|453327722|FG008|Period 1|Met exclusion criteria|0|||
126009206|NCT01090024|453327723|FG009|Period 1|Met exclusion criteria|0|||
126009207|NCT01090024|453327724|FG010|Period 1|Met exclusion criteria|0|||
126009208|NCT01090024|453327725|FG011|Period 1|Met exclusion criteria|0|||
126009209|NCT01090024|453327726|FG012|Period 1|Met exclusion criteria|0|||
126009210|NCT01090024|453327727|FG013|Period 1|Met exclusion criteria|0|||
126009211|NCT01090024|453327728|FG014|Period 1|Met exclusion criteria|1|||
126009212|NCT01090024|453327729|FG015|Period 1|Met exclusion criteria|0|||
126009213|NCT01090024|453327730|FG016|Period 1|Met exclusion criteria|0|||
126009214|NCT01090024|453327731|FG017|Period 1|Met exclusion criteria|0|||
126009215|NCT01090024|453327714|FG000|Period 1|Adverse Event|0|||
126009216|NCT01090024|453327715|FG001|Period 1|Adverse Event|0|||
126009217|NCT01090024|453327716|FG002|Period 1|Adverse Event|0|||
126009218|NCT01090024|453327717|FG003|Period 1|Adverse Event|0|||
126009219|NCT01090024|453327718|FG004|Period 1|Adverse Event|0|||
126009220|NCT01090024|453327719|FG005|Period 1|Adverse Event|0|||
126009221|NCT01090024|453327720|FG006|Period 1|Adverse Event|0|||
126009222|NCT01090024|453327721|FG007|Period 1|Adverse Event|0|||
126009223|NCT01090024|453327722|FG008|Period 1|Adverse Event|0|||
126009224|NCT01090024|453327723|FG009|Period 1|Adverse Event|1|||
126009225|NCT01090024|453327724|FG010|Period 1|Adverse Event|0|||
126009226|NCT01090024|453327725|FG011|Period 1|Adverse Event|1|||
126009227|NCT01090024|453327726|FG012|Period 1|Adverse Event|0|||
126009228|NCT01090024|453327727|FG013|Period 1|Adverse Event|0|||
126342696|NCT03321721|454550572|FG000|Overall Study|Lost to Follow-up|4|||
126342697|NCT03321721|454550573|FG001|Overall Study|Lost to Follow-up|8|||
126342698|NCT03321721|454550574|FG002|Overall Study|Lost to Follow-up|11|||
126342699|NCT03353220|454550575|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
126342700|NCT03353220|454550576|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
126342701|NCT01673386|454552003|FG000|Overall Study|Study terminated by sponsor|16|||
126342702|NCT01673386|454552004|FG001|Overall Study|Study terminated by sponsor|22|||
126342703|NCT01673386|454552003|FG000|Overall Study|Adverse Event|5|||
126342704|NCT01673386|454552004|FG001|Overall Study|Adverse Event|2|||
126342705|NCT01673386|454552003|FG000|Overall Study|Progressive disease|4|||
126342706|NCT01673386|454552004|FG001|Overall Study|Progressive disease|1|||
126342707|NCT01673386|454552003|FG000|Overall Study|Withdrawal by Subject|0|||
126342708|NCT01673386|454552004|FG001|Overall Study|Withdrawal by Subject|2|||
126342709|NCT01075048|454552005|FG000|Overall Study|Death|4|||
126342710|NCT01075048|454552006|FG001|Overall Study|Death|17|||
126342711|NCT01075048|454552007|FG002|Overall Study|Death|12|||
126342712|NCT01075048|454552005|FG000|Overall Study|Start of other or new therapy|4|||
126342713|NCT01075048|454552006|FG001|Overall Study|Start of other or new therapy|36|||
126342714|NCT01075048|454552007|FG002|Overall Study|Start of other or new therapy|46|||
126342715|NCT01075048|454552005|FG000|Overall Study|Withdrawal by Subject|1|||
126342716|NCT01075048|454552006|FG001|Overall Study|Withdrawal by Subject|6|||
126342717|NCT01075048|454552007|FG002|Overall Study|Withdrawal by Subject|3|||
126342718|NCT01075048|454552005|FG000|Overall Study|Lost to Follow-up|0|||
126342719|NCT01075048|454552006|FG001|Overall Study|Lost to Follow-up|1|||
126342720|NCT01075048|454552007|FG002|Overall Study|Lost to Follow-up|1|||
126342721|NCT01287936|454552011|FG000|Overall Study|Lost to Follow-up|0|||
126342722|NCT01287936|454552012|FG001|Overall Study|Lost to Follow-up|1|||
126342723|NCT01287936|454552013|FG002|Overall Study|Lost to Follow-up|1|||
126342724|NCT00336544|454552014|FG000|Overall Study|Lack of Efficacy|8|||
126342725|NCT00336544|454552015|FG001|Overall Study|Lack of Efficacy|5|||
126342726|NCT00336544|454552014|FG000|Overall Study|Adverse Event|4|||
126342727|NCT00336544|454552015|FG001|Overall Study|Adverse Event|9|||
126342728|NCT00336544|454552014|FG000|Overall Study|Withdrawal by Subject|4|||
126342729|NCT00336544|454552015|FG001|Overall Study|Withdrawal by Subject|3|||
126342730|NCT00336544|454552014|FG000|Overall Study|Other|3|||
126342731|NCT00336544|454552015|FG001|Overall Study|Other|5|||
126342732|NCT01649765|454552016|FG000|Overall Study|Adverse Event|5|||
126009229|NCT01090024|453327728|FG014|Period 1|Adverse Event|0|||
126009230|NCT01090024|453327729|FG015|Period 1|Adverse Event|0|||
126009231|NCT01090024|453327730|FG016|Period 1|Adverse Event|0|||
126009232|NCT01090024|453327731|FG017|Period 1|Adverse Event|1|||
126428776|NCT04166513|454864688|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
126428777|NCT04166513|454864689|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
126428778|NCT04166513|454864690|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
126428779|NCT04166513|454864687|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
126428780|NCT04166513|454864688|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
126428781|NCT04166513|454864689|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
126428782|NCT04166513|454864690|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
126428783|NCT04166513|454864687|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
126428784|NCT04166513|454864688|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
126428785|NCT04166513|454864689|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
126428786|NCT04166513|454864690|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
126428787|NCT04166513|454864687|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
126428788|NCT04166513|454864688|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
126428789|NCT04166513|454864689|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
126428790|NCT04166513|454864690|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
126428791|NCT04544410|454864692|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126428792|NCT04544410|454864693|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126428793|NCT04544410|454864692|FG000|Double-blind Treatment Period|Adverse Event|1|||
126428794|NCT04544410|454864693|FG001|Double-blind Treatment Period|Adverse Event|0|||
126428795|NCT04544410|454864692|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
126428796|NCT04544410|454864693|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126428797|NCT04544410|454864692|FG000|Double-blind Treatment Period|Protocol Violation|1|||
126428798|NCT04544410|454864693|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126428799|NCT04544410|454864692|FG000|Open-Label Treatment Period|Study Terminated|15|||
126428800|NCT04544410|454864693|FG001|Open-Label Treatment Period|Study Terminated|19|||
126009233|NCT01090024|453327714|FG000|Period 1|Withdrawal by Subject|0|||
126009234|NCT01090024|453327715|FG001|Period 1|Withdrawal by Subject|0|||
126009235|NCT01090024|453327716|FG002|Period 1|Withdrawal by Subject|0|||
126009236|NCT01090024|453327717|FG003|Period 1|Withdrawal by Subject|1|||
126009237|NCT01090024|453327718|FG004|Period 1|Withdrawal by Subject|0|||
126009238|NCT01090024|453327719|FG005|Period 1|Withdrawal by Subject|0|||
126009239|NCT01090024|453327720|FG006|Period 1|Withdrawal by Subject|0|||
126009240|NCT01090024|453327721|FG007|Period 1|Withdrawal by Subject|0|||
126009241|NCT01090024|453327722|FG008|Period 1|Withdrawal by Subject|0|||
126009242|NCT01090024|453327723|FG009|Period 1|Withdrawal by Subject|0|||
126009243|NCT01090024|453327724|FG010|Period 1|Withdrawal by Subject|0|||
126009244|NCT01090024|453327725|FG011|Period 1|Withdrawal by Subject|0|||
126009245|NCT01090024|453327726|FG012|Period 1|Withdrawal by Subject|0|||
126009246|NCT01090024|453327727|FG013|Period 1|Withdrawal by Subject|0|||
126009247|NCT01090024|453327728|FG014|Period 1|Withdrawal by Subject|0|||
126009248|NCT01090024|453327729|FG015|Period 1|Withdrawal by Subject|0|||
126009249|NCT01090024|453327730|FG016|Period 1|Withdrawal by Subject|0|||
126009250|NCT01090024|453327731|FG017|Period 1|Withdrawal by Subject|0|||
126009251|NCT01090024|453327714|FG000|Period 1|Lost to Follow-up|0|||
126009252|NCT01090024|453327715|FG001|Period 1|Lost to Follow-up|1|||
126009253|NCT01090024|453327716|FG002|Period 1|Lost to Follow-up|0|||
126009254|NCT01090024|453327717|FG003|Period 1|Lost to Follow-up|0|||
126009255|NCT01090024|453327718|FG004|Period 1|Lost to Follow-up|0|||
126009256|NCT01090024|453327719|FG005|Period 1|Lost to Follow-up|0|||
126009257|NCT01090024|453327720|FG006|Period 1|Lost to Follow-up|0|||
126009258|NCT01090024|453327721|FG007|Period 1|Lost to Follow-up|0|||
126009259|NCT01090024|453327722|FG008|Period 1|Lost to Follow-up|0|||
126009260|NCT01090024|453327723|FG009|Period 1|Lost to Follow-up|0|||
126009261|NCT01090024|453327724|FG010|Period 1|Lost to Follow-up|0|||
126009262|NCT01090024|453327725|FG011|Period 1|Lost to Follow-up|0|||
126009263|NCT01090024|453327726|FG012|Period 1|Lost to Follow-up|0|||
126009264|NCT01090024|453327727|FG013|Period 1|Lost to Follow-up|0|||
126009265|NCT01090024|453327728|FG014|Period 1|Lost to Follow-up|0|||
126009266|NCT01090024|453327729|FG015|Period 1|Lost to Follow-up|0|||
126009267|NCT01090024|453327730|FG016|Period 1|Lost to Follow-up|0|||
126009268|NCT01090024|453327731|FG017|Period 1|Lost to Follow-up|0|||
126009269|NCT01090024|453327714|FG000|Period 2|Lost to Follow-up|0|||
126009270|NCT01090024|453327715|FG001|Period 2|Lost to Follow-up|0|||
126009271|NCT01090024|453327716|FG002|Period 2|Lost to Follow-up|0|||
126009272|NCT01090024|453327717|FG003|Period 2|Lost to Follow-up|1|||
126009273|NCT01090024|453327718|FG004|Period 2|Lost to Follow-up|0|||
126009274|NCT01090024|453327719|FG005|Period 2|Lost to Follow-up|0|||
126009275|NCT01090024|453327720|FG006|Period 2|Lost to Follow-up|0|||
126009276|NCT01090024|453327721|FG007|Period 2|Lost to Follow-up|0|||
126009277|NCT01090024|453327722|FG008|Period 2|Lost to Follow-up|0|||
126009278|NCT01090024|453327723|FG009|Period 2|Lost to Follow-up|0|||
126009279|NCT01090024|453327724|FG010|Period 2|Lost to Follow-up|0|||
126009280|NCT01090024|453327725|FG011|Period 2|Lost to Follow-up|0|||
126009281|NCT01090024|453327726|FG012|Period 2|Lost to Follow-up|0|||
126009282|NCT01090024|453327727|FG013|Period 2|Lost to Follow-up|0|||
126009283|NCT01090024|453327728|FG014|Period 2|Lost to Follow-up|0|||
126009284|NCT01090024|453327729|FG015|Period 2|Lost to Follow-up|0|||
126009285|NCT01090024|453327730|FG016|Period 2|Lost to Follow-up|0|||
126009286|NCT01090024|453327731|FG017|Period 2|Lost to Follow-up|0|||
126009287|NCT01090024|453327714|FG000|Period 2|Adverse Event|1|||
126009288|NCT01090024|453327715|FG001|Period 2|Adverse Event|0|||
126009289|NCT01090024|453327716|FG002|Period 2|Adverse Event|0|||
126009290|NCT01090024|453327717|FG003|Period 2|Adverse Event|0|||
126009291|NCT01090024|453327718|FG004|Period 2|Adverse Event|0|||
126009292|NCT01090024|453327719|FG005|Period 2|Adverse Event|0|||
126009293|NCT01090024|453327720|FG006|Period 2|Adverse Event|0|||
126009294|NCT01090024|453327721|FG007|Period 2|Adverse Event|0|||
126009295|NCT01090024|453327722|FG008|Period 2|Adverse Event|0|||
126009296|NCT01090024|453327723|FG009|Period 2|Adverse Event|0|||
126009297|NCT01090024|453327724|FG010|Period 2|Adverse Event|0|||
126009298|NCT01090024|453327725|FG011|Period 2|Adverse Event|0|||
126009299|NCT01090024|453327726|FG012|Period 2|Adverse Event|0|||
126009300|NCT01090024|453327727|FG013|Period 2|Adverse Event|0|||
126009301|NCT01090024|453327728|FG014|Period 2|Adverse Event|0|||
126009302|NCT01090024|453327729|FG015|Period 2|Adverse Event|0|||
126009303|NCT01090024|453327730|FG016|Period 2|Adverse Event|0|||
126009304|NCT01090024|453327731|FG017|Period 2|Adverse Event|0|||
126009305|NCT01090024|453327714|FG000|Period 3|Withdrawal by Subject|0|||
126428801|NCT04544410|454864692|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
126428802|NCT04544410|454864693|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
126428803|NCT04544410|454864692|FG000|Open-Label Treatment Period|Adverse Event|0|||
126428804|NCT04544410|454864693|FG001|Open-Label Treatment Period|Adverse Event|1|||
126428805|NCT04544410|454864692|FG000|Open-Label Treatment Period|Physician Decision|1|||
126428806|NCT04544410|454864693|FG001|Open-Label Treatment Period|Physician Decision|0|||
126428807|NCT04544410|454864692|FG000|Open-Label Treatment Period|Other|0|||
126009306|NCT01090024|453327715|FG001|Period 3|Withdrawal by Subject|0|||
126009307|NCT01090024|453327716|FG002|Period 3|Withdrawal by Subject|0|||
126009308|NCT01090024|453327717|FG003|Period 3|Withdrawal by Subject|0|||
126428808|NCT04544410|454864693|FG001|Open-Label Treatment Period|Other|1|||
126428809|NCT04972162|454864699|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
126428810|NCT04972162|454864700|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
126428811|NCT03761173|454864701|FG000|Overall Study|Lost to Follow-up|93|||
126428812|NCT03761173|454864701|FG000|Overall Study|Withdrawal by Subject|74|||
126428813|NCT03761173|454864701|FG000|Overall Study|Death|45|||
126428814|NCT03761173|454864701|FG000|Overall Study|Withdrawal for Other Reasons|29|||
126428815|NCT03761173|454864701|FG000|Overall Study|Protocol Violation|1|||
126428816|NCT00336024|454864702|FG000|Overall Study|Death|2|||
126428817|NCT00336024|454864703|FG001|Overall Study|Death|1|||
126428818|NCT00336024|454864702|FG000|Overall Study|Physician Decision|4|||
126428819|NCT00336024|454864703|FG001|Overall Study|Physician Decision|1|||
126428820|NCT00336024|454864702|FG000|Overall Study|Protocol Violation|1|||
126428821|NCT00336024|454864703|FG001|Overall Study|Protocol Violation|0|||
126428822|NCT00336024|454864702|FG000|Overall Study|Withdrawal by Subject|1|||
126428823|NCT00336024|454864703|FG001|Overall Study|Withdrawal by Subject|2|||
126428824|NCT00336024|454864702|FG000|Overall Study|Failure to fulfill consolidation|1|||
126428825|NCT00336024|454864703|FG001|Overall Study|Failure to fulfill consolidation|1|||
126428826|NCT00336024|454864702|FG000|Overall Study|Progressive Disease|4|||
126428827|NCT00336024|454864703|FG001|Overall Study|Progressive Disease|7|||
126428828|NCT00336024|454864702|FG000|Overall Study|Ineligible|7|||
126428829|NCT00336024|454864703|FG001|Overall Study|Ineligible|7|||
126428830|NCT00597012|454864706|FG000|Overall Study|Death|1|||
126428831|NCT00597012|454864707|FG001|Overall Study|Death|1|||
126428832|NCT00597012|454864706|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
126428833|NCT00597012|454864707|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
126428834|NCT00597012|454864706|FG000|Overall Study|Withdrawal by Subject|7|||
126428835|NCT00597012|454864707|FG001|Overall Study|Withdrawal by Subject|4|||
126428836|NCT00597012|454864706|FG000|Overall Study|Ineligible|2|||
126428837|NCT00597012|454864707|FG001|Overall Study|Ineligible|0|||
126428838|NCT00597012|454864706|FG000|Overall Study|Lost to Follow-up|0|||
126428839|NCT00597012|454864707|FG001|Overall Study|Lost to Follow-up|2|||
126428840|NCT03556891|454864825|FG000|Initial Pivotal Study|Adverse Event|4|||
126428841|NCT03556891|454864825|FG000|Initial Pivotal Study|MRI Need|3|||
126428842|NCT03556891|454864825|FG000|Initial Pivotal Study|Device Failure|1|||
126428843|NCT03556891|454864825|FG000|Initial Pivotal Study|Death|1|||
126428844|NCT03556891|454864825|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
126009309|NCT01090024|453327718|FG004|Period 3|Withdrawal by Subject|0|||
126009310|NCT01090024|453327719|FG005|Period 3|Withdrawal by Subject|0|||
126009311|NCT01090024|453327720|FG006|Period 3|Withdrawal by Subject|0|||
126428845|NCT03556891|454864825|FG000|Initial Pivotal Study|Missing at random|1|||
126428846|NCT03556891|454864825|FG000|Initial Pivotal Study|Missing due to COVID|1|||
126428847|NCT03556891|454864825|FG000|Initial Pivotal Study|Protocol Violation|1|||
126009312|NCT01090024|453327721|FG007|Period 3|Withdrawal by Subject|0|||
126009313|NCT01090024|453327722|FG008|Period 3|Withdrawal by Subject|0|||
126009314|NCT01090024|453327723|FG009|Period 3|Withdrawal by Subject|0|||
126009315|NCT01090024|453327724|FG010|Period 3|Withdrawal by Subject|0|||
126009316|NCT01090024|453327725|FG011|Period 3|Withdrawal by Subject|0|||
126009317|NCT01090024|453327726|FG012|Period 3|Withdrawal by Subject|0|||
126009318|NCT01090024|453327727|FG013|Period 3|Withdrawal by Subject|0|||
126009319|NCT01090024|453327728|FG014|Period 3|Withdrawal by Subject|0|||
126009320|NCT01090024|453327729|FG015|Period 3|Withdrawal by Subject|1|||
126009321|NCT01090024|453327730|FG016|Period 3|Withdrawal by Subject|0|||
126009322|NCT01090024|453327731|FG017|Period 3|Withdrawal by Subject|0|||
126009323|NCT01090024|453327714|FG000|Period 3|Protocol Violation|0|||
126009324|NCT01090024|453327715|FG001|Period 3|Protocol Violation|0|||
126009325|NCT01090024|453327716|FG002|Period 3|Protocol Violation|0|||
126009326|NCT01090024|453327717|FG003|Period 3|Protocol Violation|0|||
126009327|NCT01090024|453327718|FG004|Period 3|Protocol Violation|0|||
126009328|NCT01090024|453327719|FG005|Period 3|Protocol Violation|0|||
126009329|NCT01090024|453327720|FG006|Period 3|Protocol Violation|0|||
126009330|NCT01090024|453327721|FG007|Period 3|Protocol Violation|0|||
126009331|NCT01090024|453327722|FG008|Period 3|Protocol Violation|1|||
126009332|NCT01090024|453327723|FG009|Period 3|Protocol Violation|0|||
126009333|NCT01090024|453327724|FG010|Period 3|Protocol Violation|0|||
126009334|NCT01090024|453327725|FG011|Period 3|Protocol Violation|0|||
126009335|NCT01090024|453327726|FG012|Period 3|Protocol Violation|0|||
126009336|NCT01090024|453327727|FG013|Period 3|Protocol Violation|0|||
126009337|NCT01090024|453327728|FG014|Period 3|Protocol Violation|0|||
126009338|NCT01090024|453327729|FG015|Period 3|Protocol Violation|0|||
126009339|NCT01090024|453327730|FG016|Period 3|Protocol Violation|0|||
126009340|NCT01090024|453327731|FG017|Period 3|Protocol Violation|0|||
126009341|NCT01090024|453327714|FG000|Period 3|Adverse Event|0|||
126009342|NCT01090024|453327715|FG001|Period 3|Adverse Event|0|||
126009343|NCT01090024|453327716|FG002|Period 3|Adverse Event|0|||
126009344|NCT01090024|453327717|FG003|Period 3|Adverse Event|0|||
126009345|NCT01090024|453327718|FG004|Period 3|Adverse Event|0|||
126009346|NCT01090024|453327719|FG005|Period 3|Adverse Event|1|||
126009347|NCT01090024|453327720|FG006|Period 3|Adverse Event|0|||
126009348|NCT01090024|453327721|FG007|Period 3|Adverse Event|0|||
126009349|NCT01090024|453327722|FG008|Period 3|Adverse Event|0|||
126009350|NCT01090024|453327723|FG009|Period 3|Adverse Event|0|||
126009351|NCT01090024|453327724|FG010|Period 3|Adverse Event|0|||
126009352|NCT01090024|453327725|FG011|Period 3|Adverse Event|0|||
126009353|NCT01090024|453327726|FG012|Period 3|Adverse Event|0|||
126009354|NCT01090024|453327727|FG013|Period 3|Adverse Event|0|||
126009355|NCT01090024|453327728|FG014|Period 3|Adverse Event|0|||
126009356|NCT01090024|453327729|FG015|Period 3|Adverse Event|0|||
126009357|NCT01090024|453327730|FG016|Period 3|Adverse Event|0|||
126009358|NCT01090024|453327731|FG017|Period 3|Adverse Event|0|||
126009359|NCT02131324|453327733|FG000|Overall Study|Withdrawal by Subject|1|||
126009360|NCT02131324|453327734|FG001|Overall Study|Withdrawal by Subject|2|||
126009361|NCT02131324|453327733|FG000|Overall Study|Lost to Follow-up|1|||
126009362|NCT02131324|453327734|FG001|Overall Study|Lost to Follow-up|1|||
126009363|NCT01693614|453327735|FG000|Overall Study|Adverse Event|7|||
126009364|NCT01693614|453327736|FG001|Overall Study|Adverse Event|11|||
126009365|NCT01693614|453327737|FG002|Overall Study|Adverse Event|5|||
126009366|NCT01693614|453327735|FG000|Overall Study|Disease progression|11|||
126009367|NCT01693614|453327736|FG001|Overall Study|Disease progression|8|||
126009368|NCT01693614|453327737|FG002|Overall Study|Disease progression|7|||
126009369|NCT01693614|453327735|FG000|Overall Study|Protocol Violation|5|||
126009370|NCT01693614|453327736|FG001|Overall Study|Protocol Violation|2|||
126009371|NCT01693614|453327737|FG002|Overall Study|Protocol Violation|1|||
126009372|NCT01693614|453327735|FG000|Overall Study|Death|1|||
126009373|NCT01693614|453327736|FG001|Overall Study|Death|0|||
126009374|NCT01693614|453327737|FG002|Overall Study|Death|0|||
126009375|NCT01693614|453327735|FG000|Overall Study|Physician Decision|1|||
126009376|NCT01693614|453327736|FG001|Overall Study|Physician Decision|1|||
126009377|NCT01693614|453327737|FG002|Overall Study|Physician Decision|4|||
126009378|NCT01693614|453327735|FG000|Overall Study|Withdrawal by subject/guardian|0|||
126009379|NCT01693614|453327736|FG001|Overall Study|Withdrawal by subject/guardian|0|||
126009380|NCT01693614|453327737|FG002|Overall Study|Withdrawal by subject/guardian|2|||
126009381|NCT01693614|453327735|FG000|Overall Study|Withdrawal by Subject|1|||
126009382|NCT01693614|453327736|FG001|Overall Study|Withdrawal by Subject|0|||
126009383|NCT01693614|453327737|FG002|Overall Study|Withdrawal by Subject|5|||
126009384|NCT00420316|453327738|FG000|Overall Study|Withdrawal by Subject|0|||
126009385|NCT00420316|453327739|FG001|Overall Study|Withdrawal by Subject|1|||
126009386|NCT00420316|453327738|FG000|Overall Study|Lost to Follow-up|12|||
126009387|NCT00420316|453327739|FG001|Overall Study|Lost to Follow-up|8|||
126009388|NCT01196988|453327740|FG000|Overall Study|Adverse Event|1|||
126009389|NCT01196988|453327741|FG001|Overall Study|Adverse Event|2|||
126009390|NCT01196988|453327742|FG002|Overall Study|Adverse Event|0|||
126009391|NCT01196988|453327743|FG003|Overall Study|Adverse Event|0|||
126009392|NCT01196988|453327740|FG000|Overall Study|Withdrawal by Subject|5|||
126009393|NCT01196988|453327741|FG001|Overall Study|Withdrawal by Subject|1|||
126009394|NCT01196988|453327742|FG002|Overall Study|Withdrawal by Subject|4|||
126009395|NCT01196988|453327743|FG003|Overall Study|Withdrawal by Subject|0|||
126009396|NCT01196988|453327740|FG000|Overall Study|Lost to Follow-up|16|||
126009397|NCT01196988|453327741|FG001|Overall Study|Lost to Follow-up|29|||
126009398|NCT01196988|453327742|FG002|Overall Study|Lost to Follow-up|21|||
126009399|NCT01196988|453327743|FG003|Overall Study|Lost to Follow-up|1|||
126009400|NCT01196988|453327740|FG000|Overall Study|Other|2|||
126009401|NCT01196988|453327741|FG001|Overall Study|Other|0|||
126009402|NCT01196988|453327742|FG002|Overall Study|Other|0|||
126009403|NCT01196988|453327743|FG003|Overall Study|Other|0|||
126009404|NCT05419557|453327744|FG000|Overall Study|Lost to Follow-up|11|||
126009405|NCT05419557|453327745|FG001|Overall Study|Lost to Follow-up|4|||
126009406|NCT00920686|453327747|FG000|Overall Study|Lost to Follow-up|2|||
126009407|NCT00920686|453327748|FG001|Overall Study|Lost to Follow-up|3|||
126009408|NCT00920686|453327749|FG002|Overall Study|Lost to Follow-up|1|||
126009409|NCT00920686|453327747|FG000|Overall Study|Study drug dosing criteria not met|17|||
126009410|NCT00920686|453327748|FG001|Overall Study|Study drug dosing criteria not met|19|||
126046461|NCT02467270|453468226|FG000|Overall Study|Lack of Efficacy|12|||
126009411|NCT00920686|453327749|FG002|Overall Study|Study drug dosing criteria not met|12|||
126009412|NCT00868192|453327750|FG000|Overall Study|Ineligible|4|||
126009413|NCT04304534|453327751|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
126009414|NCT04304534|453327752|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
126009415|NCT04304534|453327753|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
126009416|NCT04304534|453327754|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
126009417|NCT04304534|453327751|FG000|Overall Study|Non-Compliance with study drug|0|||
126009418|NCT04304534|453327752|FG001|Overall Study|Non-Compliance with study drug|1|||
126009419|NCT04304534|453327753|FG002|Overall Study|Non-Compliance with study drug|1|||
126009420|NCT04304534|453327754|FG003|Overall Study|Non-Compliance with study drug|1|||
126009421|NCT04304534|453327751|FG000|Overall Study|Lost to Follow-up|0|||
126009422|NCT04304534|453327752|FG001|Overall Study|Lost to Follow-up|1|||
126009423|NCT04304534|453327753|FG002|Overall Study|Lost to Follow-up|2|||
126009424|NCT04304534|453327754|FG003|Overall Study|Lost to Follow-up|3|||
126009425|NCT04304534|453327751|FG000|Overall Study|Unspecific|4|||
126009426|NCT04304534|453327752|FG001|Overall Study|Unspecific|2|||
126009427|NCT04304534|453327753|FG002|Overall Study|Unspecific|2|||
126009428|NCT04304534|453327754|FG003|Overall Study|Unspecific|2|||
126009429|NCT04304534|453327751|FG000|Overall Study|Technical Problems|2|||
126009430|NCT04304534|453327752|FG001|Overall Study|Technical Problems|2|||
126009431|NCT04304534|453327753|FG002|Overall Study|Technical Problems|3|||
126009432|NCT04304534|453327754|FG003|Overall Study|Technical Problems|4|||
126009433|NCT04304534|453327751|FG000|Overall Study|Death|7|||
126009434|NCT04304534|453327752|FG001|Overall Study|Death|2|||
126009435|NCT04304534|453327753|FG002|Overall Study|Death|4|||
126009436|NCT04304534|453327754|FG003|Overall Study|Death|3|||
126009437|NCT04304534|453327751|FG000|Overall Study|Withdrawal by Subject|7|||
126009438|NCT04304534|453327752|FG001|Overall Study|Withdrawal by Subject|2|||
126009439|NCT04304534|453327753|FG002|Overall Study|Withdrawal by Subject|7|||
126009440|NCT04304534|453327754|FG003|Overall Study|Withdrawal by Subject|4|||
126009441|NCT04304534|453327751|FG000|Overall Study|Physician Decision|4|||
126009442|NCT04304534|453327752|FG001|Overall Study|Physician Decision|9|||
126009443|NCT04304534|453327753|FG002|Overall Study|Physician Decision|9|||
126009444|NCT04304534|453327754|FG003|Overall Study|Physician Decision|5|||
126009445|NCT04304534|453327751|FG000|Overall Study|Subject Decision|34|||
126009446|NCT04304534|453327752|FG001|Overall Study|Subject Decision|25|||
126009447|NCT04304534|453327753|FG002|Overall Study|Subject Decision|25|||
126009448|NCT04304534|453327754|FG003|Overall Study|Subject Decision|26|||
126009449|NCT04304534|453327751|FG000|Overall Study|Adverse Event|35|||
126009450|NCT04304534|453327752|FG001|Overall Study|Adverse Event|40|||
126009451|NCT04304534|453327753|FG002|Overall Study|Adverse Event|39|||
126009452|NCT04304534|453327754|FG003|Overall Study|Adverse Event|44|||
126009453|NCT01313182|453327755|FG000|Overall Study|Protocol Violation|66|||
126009454|NCT01313182|453327756|FG001|Overall Study|Protocol Violation|92|||
126009455|NCT01695317|453327757|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
126342733|NCT01649765|454552017|FG001|Overall Study|Adverse Event|3|||
126342734|NCT01649765|454552016|FG000|Overall Study|Lack of Efficacy|1|||
126342735|NCT01649765|454552017|FG001|Overall Study|Lack of Efficacy|1|||
126342736|NCT01649765|454552016|FG000|Overall Study|Physician Decision|0|||
126342737|NCT01649765|454552017|FG001|Overall Study|Physician Decision|3|||
126342738|NCT01649765|454552016|FG000|Overall Study|Protocol Violation|1|||
126342739|NCT01649765|454552017|FG001|Overall Study|Protocol Violation|0|||
126342740|NCT01649765|454552016|FG000|Overall Study|Withdrawal by Subject|2|||
126342741|NCT01649765|454552017|FG001|Overall Study|Withdrawal by Subject|1|||
126342742|NCT01316614|454552018|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
126342743|NCT01316614|454552018|FG000|Overall Study|Cytology slides not available for review|4|||
126342744|NCT01316614|454552018|FG000|Overall Study|Cystic lesion|5|||
126342745|NCT01316614|454552018|FG000|Overall Study|Inadequate number of passes|2|||
126342746|NCT01316614|454552018|FG000|Overall Study|Medically unstable|1|||
126342747|NCT03427411|454552019|FG000|Overall Study|Screen failure - platelets too low|0|||
126342748|NCT03427411|454552020|FG001|Overall Study|Screen failure - platelets too low|1|||
126342749|NCT00076570|454552021|FG000|Overall Study|Drug intolerance|8|||
126342750|NCT00076570|454552022|FG001|Overall Study|Drug intolerance|8|||
126342751|NCT00998946|454552023|FG000|Overall Study|Lost to Follow-up|1|||
126342752|NCT00998946|454552023|FG000|Overall Study|Withdrawal by Subject|1|||
126342753|NCT00998946|454552023|FG000|Overall Study|Death|2|||
126342754|NCT00998946|454552023|FG000|Overall Study|Reason Unspecified|3|||
126342755|NCT00998946|454552023|FG000|Overall Study|Enrolled but not Dosed|2|||
126342756|NCT00701363|454552030|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
126342757|NCT00701363|454552031|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
126342758|NCT00701363|454552032|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
126342759|NCT00701363|454552033|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
126342760|NCT00701363|454552030|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
126342761|NCT00701363|454552031|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
126009456|NCT01695317|453327758|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
126009457|NCT01695317|453327757|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
126009458|NCT01695317|453327758|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
126009459|NCT04044664|453327777|FG000|Stage 1|Adverse Event|3|||
126009460|NCT04044664|453327778|FG001|Stage 1|Adverse Event|3|||
126009461|NCT04044664|453327779|FG002|Stage 1|Adverse Event|1|||
126009462|NCT04044664|453327777|FG000|Stage 1|Lost to Follow-up|3|||
126009463|NCT04044664|453327778|FG001|Stage 1|Lost to Follow-up|2|||
126009464|NCT04044664|453327779|FG002|Stage 1|Lost to Follow-up|2|||
126009465|NCT04044664|453327777|FG000|Stage 1|Withdrawal by Subject|9|||
126009466|NCT04044664|453327778|FG001|Stage 1|Withdrawal by Subject|1|||
126009467|NCT04044664|453327779|FG002|Stage 1|Withdrawal by Subject|0|||
126009468|NCT04044664|453327777|FG000|Stage 1|noncompliance, personal reason|2|||
126009469|NCT04044664|453327778|FG001|Stage 1|noncompliance, personal reason|0|||
126009470|NCT04044664|453327779|FG002|Stage 1|noncompliance, personal reason|0|||
126009471|NCT04044664|453327777|FG000|Stage 1|randomization error|0|||
126009472|NCT04044664|453327778|FG001|Stage 1|randomization error|1|||
126009473|NCT04044664|453327779|FG002|Stage 1|randomization error|0|||
126009474|NCT04044664|453327777|FG000|Stage 2|Adverse Event|2|||
126009475|NCT04044664|453327778|FG001|Stage 2|Adverse Event|0|||
126009476|NCT04044664|453327779|FG002|Stage 2|Adverse Event|0|||
126009477|NCT04044664|453327777|FG000|Stage 2|Lost to Follow-up|3|||
126009478|NCT04044664|453327778|FG001|Stage 2|Lost to Follow-up|2|||
126009479|NCT04044664|453327779|FG002|Stage 2|Lost to Follow-up|1|||
126009480|NCT04044664|453327777|FG000|Stage 2|Withdrawal by Subject|3|||
126009481|NCT04044664|453327778|FG001|Stage 2|Withdrawal by Subject|0|||
126009482|NCT04044664|453327779|FG002|Stage 2|Withdrawal by Subject|0|||
126009483|NCT04044664|453327777|FG000|Stage 2|protocol deviation|1|||
126009484|NCT04044664|453327778|FG001|Stage 2|protocol deviation|0|||
126009485|NCT04044664|453327779|FG002|Stage 2|protocol deviation|0|||
126009486|NCT00001575|453327780|FG000|Overall Study|Screening failures-Ph I portion|22|||
126009487|NCT00001575|453327780|FG000|Overall Study|Withdrawn/deaths|23|||
126009488|NCT03736785|453327782|FG000|Overall Study|Adverse Event|1|||
126009489|NCT03736785|453327783|FG001|Overall Study|Adverse Event|1|||
126009490|NCT03736785|453327784|FG002|Overall Study|Adverse Event|1|||
126009491|NCT03736785|453327782|FG000|Overall Study|Death|1|||
126009492|NCT03736785|453327783|FG001|Overall Study|Death|0|||
126009493|NCT03736785|453327784|FG002|Overall Study|Death|1|||
126009494|NCT03736785|453327782|FG000|Overall Study|Lost to Follow-up|0|||
126009495|NCT03736785|453327783|FG001|Overall Study|Lost to Follow-up|2|||
126009496|NCT03736785|453327784|FG002|Overall Study|Lost to Follow-up|3|||
126009497|NCT03736785|453327782|FG000|Overall Study|Non compliance with study drug|1|||
126009498|NCT03736785|453327783|FG001|Overall Study|Non compliance with study drug|1|||
126009499|NCT03736785|453327784|FG002|Overall Study|Non compliance with study drug|0|||
126009500|NCT03736785|453327782|FG000|Overall Study|Physician Decision|0|||
126009501|NCT03736785|453327783|FG001|Overall Study|Physician Decision|1|||
126009502|NCT03736785|453327784|FG002|Overall Study|Physician Decision|1|||
126009503|NCT03736785|453327782|FG000|Overall Study|Protocol Violation|1|||
126009504|NCT03736785|453327783|FG001|Overall Study|Protocol Violation|4|||
126009505|NCT03736785|453327784|FG002|Overall Study|Protocol Violation|3|||
126009506|NCT03736785|453327782|FG000|Overall Study|Sponsor Decision|1|||
126009507|NCT03736785|453327783|FG001|Overall Study|Sponsor Decision|0|||
126009508|NCT03736785|453327784|FG002|Overall Study|Sponsor Decision|0|||
126009509|NCT03736785|453327782|FG000|Overall Study|Unknown/Missing data|3|||
126009510|NCT03736785|453327783|FG001|Overall Study|Unknown/Missing data|2|||
126009511|NCT03736785|453327784|FG002|Overall Study|Unknown/Missing data|1|||
126009512|NCT03736785|453327782|FG000|Overall Study|Withdrawal by Subject|9|||
126009513|NCT03736785|453327783|FG001|Overall Study|Withdrawal by Subject|6|||
126009514|NCT03736785|453327784|FG002|Overall Study|Withdrawal by Subject|4|||
126009515|NCT01744691|453327793|FG000|Overall Study|Progressive Disease|18|||
126009516|NCT01744691|453327793|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
126009517|NCT01744691|453327793|FG000|Overall Study|Withdrawal of consent for treatment|3|||
126009518|NCT01744691|453327793|FG000|Overall Study|Physician Decision|4|||
126009519|NCT02701361|453327795|FG000|Overall Study|Lost to Follow-up|5|||
126009520|NCT02701361|453327796|FG001|Overall Study|Lost to Follow-up|2|||
126009521|NCT02701361|453327797|FG002|Overall Study|Lost to Follow-up|1|||
126009522|NCT02701361|453327795|FG000|Overall Study|Withdrawal by Subject|4|||
126009523|NCT02701361|453327796|FG001|Overall Study|Withdrawal by Subject|0|||
126009524|NCT02701361|453327797|FG002|Overall Study|Withdrawal by Subject|0|||
126009525|NCT02701361|453327795|FG000|Overall Study|timed out in rehab center|0|||
126009526|NCT02701361|453327796|FG001|Overall Study|timed out in rehab center|1|||
126009527|NCT02701361|453327797|FG002|Overall Study|timed out in rehab center|0|||
126009528|NCT02701361|453327795|FG000|Overall Study|incarceration|0|||
126009529|NCT02701361|453327796|FG001|Overall Study|incarceration|0|||
126009530|NCT02701361|453327797|FG002|Overall Study|incarceration|1|||
126009531|NCT04588480|453327798|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
126009532|NCT04588480|453327799|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
126009533|NCT04588480|453327800|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
126009534|NCT04588480|453327798|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
126009535|NCT04588480|453327799|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
126009536|NCT04588480|453327800|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
126009537|NCT01190150|453327805|FG000|First Treatment|Withdrawal by Subject|1|||
126009538|NCT01190150|453327806|FG001|First Treatment|Withdrawal by Subject|0|||
126009539|NCT01190150|453327805|FG000|Washout|Withdrawal by Subject|0|||
126009540|NCT01190150|453327806|FG001|Washout|Withdrawal by Subject|1|||
126009541|NCT01190150|453327805|FG000|Washout|Difficulty in adherence|0|||
126009542|NCT01190150|453327806|FG001|Washout|Difficulty in adherence|1|||
126009543|NCT00843193|453327809|FG000|Overall Study|Adverse Event|2|||
126009544|NCT00843193|453327810|FG001|Overall Study|Adverse Event|4|||
126009545|NCT00843193|453327809|FG000|Overall Study|Lack of Efficacy|1|||
126009546|NCT00843193|453327810|FG001|Overall Study|Lack of Efficacy|1|||
126009547|NCT00843193|453327809|FG000|Overall Study|Protocol Violation|1|||
126009548|NCT00843193|453327810|FG001|Overall Study|Protocol Violation|2|||
126009549|NCT00843193|453327809|FG000|Overall Study|Lost to Follow-up|1|||
126009550|NCT00843193|453327810|FG001|Overall Study|Lost to Follow-up|0|||
126009551|NCT00843193|453327809|FG000|Overall Study|Physician Decision|0|||
126009552|NCT00843193|453327810|FG001|Overall Study|Physician Decision|1|||
126009553|NCT00843193|453327809|FG000|Overall Study|Withdrawal by Subject|3|||
126009554|NCT00843193|453327810|FG001|Overall Study|Withdrawal by Subject|3|||
126009555|NCT02982213|453327811|FG000|Overall Study|Did not complete follow up questionnaire|5|||
126009556|NCT02982213|453327812|FG001|Overall Study|Did not complete follow up questionnaire|1|||
126009557|NCT01549652|453327813|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
126009558|NCT01549652|453327814|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
126009559|NCT01549652|453327815|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
126009560|NCT01549652|453327816|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
126009561|NCT01549652|453327813|FG000|Overall Study|Study Drug Titration Failure|5|||
126009562|NCT01549652|453327814|FG001|Overall Study|Study Drug Titration Failure|6|||
126009563|NCT01549652|453327815|FG002|Overall Study|Study Drug Titration Failure|0|||
126009564|NCT01549652|453327816|FG003|Overall Study|Study Drug Titration Failure|0|||
126009565|NCT01549652|453327813|FG000|Overall Study|Withdrawal Effect|0|||
126009566|NCT01549652|453327814|FG001|Overall Study|Withdrawal Effect|2|||
126009567|NCT01549652|453327815|FG002|Overall Study|Withdrawal Effect|0|||
126009568|NCT01549652|453327816|FG003|Overall Study|Withdrawal Effect|0|||
126342762|NCT00701363|454552032|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
126342763|NCT00701363|454552033|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
126342764|NCT00701363|454552030|FG000|Treatment Phase 1|Adverse Event|7|||
126342765|NCT00701363|454552031|FG001|Treatment Phase 1|Adverse Event|0|||
126342766|NCT00701363|454552032|FG002|Treatment Phase 1|Adverse Event|0|||
126342767|NCT00701363|454552033|FG003|Treatment Phase 1|Adverse Event|0|||
126342768|NCT00701363|454552030|FG000|Treatment Phase 1|Protocol Violation|1|||
126046462|NCT02467270|453468227|FG001|Overall Study|Lack of Efficacy|18|||
126342769|NCT00701363|454552031|FG001|Treatment Phase 1|Protocol Violation|0|||
126342770|NCT00701363|454552032|FG002|Treatment Phase 1|Protocol Violation|0|||
126009569|NCT01549652|453327813|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
126009570|NCT01549652|453327814|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
126342771|NCT00701363|454552033|FG003|Treatment Phase 1|Protocol Violation|0|||
126342772|NCT00701363|454552030|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
126342773|NCT00701363|454552031|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
126342774|NCT00701363|454552032|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
126342775|NCT00701363|454552033|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
126342776|NCT00701363|454552030|FG000|Treatment Phase 1|Lack of Efficacy|1|||
126342777|NCT00701363|454552031|FG001|Treatment Phase 1|Lack of Efficacy|0|||
126342778|NCT00701363|454552032|FG002|Treatment Phase 1|Lack of Efficacy|0|||
126342779|NCT00701363|454552033|FG003|Treatment Phase 1|Lack of Efficacy|0|||
126342780|NCT00701363|454552030|FG000|Treatment Phase 2|Adverse Event|0|||
126342781|NCT00701363|454552031|FG001|Treatment Phase 2|Adverse Event|0|||
126342782|NCT00701363|454552032|FG002|Treatment Phase 2|Adverse Event|1|||
126342783|NCT00701363|454552033|FG003|Treatment Phase 2|Adverse Event|0|||
126342784|NCT00701363|454552030|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
126342785|NCT00701363|454552031|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
126342786|NCT00701363|454552032|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
126342787|NCT00701363|454552033|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
126342788|NCT01192815|454552034|FG000|Overall Study|Withdrawal by Subject|1|||
126342789|NCT01192815|454552034|FG000|Overall Study|Lack of Efficacy|1|||
126342790|NCT01286129|454552038|FG000|Overall Study|Withdrawal by Subject|4|||
126342791|NCT01286129|454552039|FG001|Overall Study|Withdrawal by Subject|1|||
126342792|NCT01286129|454552038|FG000|Overall Study|Could not comply with study requirements|4|||
126342793|NCT01286129|454552039|FG001|Overall Study|Could not comply with study requirements|4|||
126342794|NCT00869960|454552040|FG000|Overall Study|Lost to Follow-up|2|||
126342795|NCT01394276|454552042|FG000|Overall Study|Related Adverse event (AEs)|15|||
126342796|NCT01394276|454552042|FG000|Overall Study|Not related AEs|9|||
126342797|NCT01394276|454552042|FG000|Overall Study|Remission of disease|2|||
126342798|NCT01394276|454552042|FG000|Overall Study|Insufficient therapeutic effect|17|||
126342799|NCT01394276|454552042|FG000|Overall Study|Insufficient compliance|9|||
126342800|NCT01394276|454552042|FG000|Overall Study|Lost to Follow-up|5|||
126342801|NCT01394276|454552042|FG000|Overall Study|Participant moved to another site|1|||
126342802|NCT01394276|454552042|FG000|Overall Study|Pregnancy|1|||
126342803|NCT01394276|454552042|FG000|Overall Study|unavailability of drug at the Hospital|2|||
126342804|NCT01394276|454552042|FG000|Overall Study|Symptoms of concurrent diseases|1|||
126342805|NCT00465179|454552043|FG000|Overall Study|Adverse Event|4|||
126342806|NCT00465179|454552043|FG000|Overall Study|Withdrawal by Subject|2|||
126342807|NCT00465179|454552043|FG000|Overall Study|Progression of Disease|47|||
126342808|NCT00262925|454552047|FG000|Overall Study|Lack of Efficacy|3|||
126342809|NCT00262925|454552047|FG000|Overall Study|Adverse Event|4|||
126342810|NCT00262925|454552047|FG000|Overall Study|Death|2|||
126342811|NCT00262925|454552047|FG000|Overall Study|alternative therapy|1|||
126342812|NCT00262925|454552047|FG000|Overall Study|Other|1|||
126342813|NCT04682301|454552049|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
126342814|NCT04682301|454552049|FG000|Overall Study|Death|2|||
126342815|NCT02187783|454552050|FG000|Overall Study|Adverse Event|8|||
126342816|NCT02187783|454552050|FG000|Overall Study|Death|3|||
126342817|NCT02187783|454552050|FG000|Overall Study|Progressive disease|80|||
126342818|NCT02187783|454552050|FG000|Overall Study|Protocol Violation|3|||
126342819|NCT02187783|454552050|FG000|Overall Study|Physician Decision|2|||
126342820|NCT02187783|454552050|FG000|Overall Study|Withdrawal by Subject|9|||
126342821|NCT02187783|454552050|FG000|Overall Study|Study terminated by sponsor|1|||
126342822|NCT00471497|454552051|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
126342823|NCT00471497|454552052|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
126342824|NCT00471497|454552053|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
126342825|NCT00471497|454552051|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
126342826|NCT00471497|454552052|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
126342827|NCT00471497|454552053|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
126342828|NCT00471497|454552051|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
126342829|NCT00471497|454552052|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
126342830|NCT00471497|454552053|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
126342831|NCT00471497|454552051|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
126009571|NCT01549652|453327815|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
126342832|NCT00471497|454552052|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
126342833|NCT00471497|454552053|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
126342834|NCT00471497|454552051|FG000|Core Treatment Phase|Lost to Follow-up|6|||
126342835|NCT00471497|454552052|FG001|Core Treatment Phase|Lost to Follow-up|6|||
126342836|NCT00471497|454552053|FG002|Core Treatment Phase|Lost to Follow-up|3|||
126342837|NCT00471497|454552051|FG000|Core Treatment Phase|Death|3|||
126009572|NCT01549652|453327816|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
126342838|NCT00471497|454552052|FG001|Core Treatment Phase|Death|9|||
126342839|NCT00471497|454552053|FG002|Core Treatment Phase|Death|3|||
126342840|NCT00471497|454552051|FG000|Core Treatment Phase|Disease Progression|10|||
126342841|NCT00471497|454552052|FG001|Core Treatment Phase|Disease Progression|2|||
126009573|NCT01549652|453327813|FG000|Overall Study|Problem with Infusion|1|||
126009574|NCT01549652|453327814|FG001|Overall Study|Problem with Infusion|0|||
126009575|NCT01549652|453327815|FG002|Overall Study|Problem with Infusion|0|||
126009576|NCT01549652|453327816|FG003|Overall Study|Problem with Infusion|0|||
126009577|NCT01549652|453327813|FG000|Overall Study|Titration Non-Compliance|1|||
126009578|NCT01549652|453327814|FG001|Overall Study|Titration Non-Compliance|3|||
126009579|NCT01549652|453327815|FG002|Overall Study|Titration Non-Compliance|4|||
126009580|NCT01549652|453327816|FG003|Overall Study|Titration Non-Compliance|5|||
126009581|NCT01549652|453327813|FG000|Overall Study|Titration Side Effects|0|||
126009582|NCT01549652|453327814|FG001|Overall Study|Titration Side Effects|0|||
126009583|NCT01549652|453327815|FG002|Overall Study|Titration Side Effects|6|||
126009584|NCT01549652|453327816|FG003|Overall Study|Titration Side Effects|3|||
126009585|NCT01549652|453327813|FG000|Overall Study|Withdrawal by Subject|0|||
126009586|NCT01549652|453327814|FG001|Overall Study|Withdrawal by Subject|0|||
126009587|NCT01549652|453327815|FG002|Overall Study|Withdrawal by Subject|5|||
126009588|NCT01549652|453327816|FG003|Overall Study|Withdrawal by Subject|3|||
126009589|NCT01972152|453327817|FG000|First Treatment Visit|Lost to Follow-up|0|||
126009590|NCT01972152|453327818|FG001|First Treatment Visit|Lost to Follow-up|1|||
126009591|NCT01972152|453327819|FG002|First Treatment Visit|Lost to Follow-up|0|||
126009592|NCT01972152|453327820|FG003|First Treatment Visit|Lost to Follow-up|0|||
126009593|NCT01972152|453327821|FG004|First Treatment Visit|Lost to Follow-up|0|||
126009594|NCT01972152|453327822|FG005|First Treatment Visit|Lost to Follow-up|0|||
126009595|NCT01972152|453327817|FG000|Second Treatment Visit|Protocol Violation|0|||
126009596|NCT01972152|453327818|FG001|Second Treatment Visit|Protocol Violation|1|||
126009597|NCT01972152|453327819|FG002|Second Treatment Visit|Protocol Violation|0|||
126009598|NCT01972152|453327820|FG003|Second Treatment Visit|Protocol Violation|0|||
126009599|NCT01972152|453327821|FG004|Second Treatment Visit|Protocol Violation|0|||
126009600|NCT01972152|453327822|FG005|Second Treatment Visit|Protocol Violation|0|||
126009601|NCT01194258|453327825|FG000|Titration Period|Withdrawal by Subject|6|||
126009602|NCT01194258|453327826|FG001|Titration Period|Withdrawal by Subject|0|||
126342842|NCT00471497|454552053|FG002|Core Treatment Phase|Disease Progression|4|||
126342843|NCT00471497|454552051|FG000|Core Treatment Phase|Protocol Violation|6|||
126342844|NCT00471497|454552052|FG001|Core Treatment Phase|Protocol Violation|15|||
126342845|NCT00471497|454552053|FG002|Core Treatment Phase|Protocol Violation|11|||
126342846|NCT00471497|454552051|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
126342847|NCT00471497|454552052|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
126342848|NCT00471497|454552053|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
126342849|NCT00471497|454552051|FG000|Core Treatment Phase|Administrative problems|14|||
126342850|NCT00471497|454552052|FG001|Core Treatment Phase|Administrative problems|14|||
126342851|NCT00471497|454552053|FG002|Core Treatment Phase|Administrative problems|12|||
126342852|NCT00471497|454552051|FG000|Core Treatment Phase|Adverse Event|43|||
126342853|NCT00471497|454552052|FG001|Core Treatment Phase|Adverse Event|53|||
126342854|NCT00471497|454552053|FG002|Core Treatment Phase|Adverse Event|89|||
126342855|NCT00471497|454552051|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
126342856|NCT00471497|454552052|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
126342857|NCT00471497|454552053|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
126342858|NCT00471497|454552051|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
126342859|NCT00471497|454552052|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
126342860|NCT00471497|454552053|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
126342861|NCT00471497|454552051|FG000|Extension Phase|Adverse Event|9|||
126342862|NCT00471497|454552052|FG001|Extension Phase|Adverse Event|5|||
126342863|NCT00471497|454552053|FG002|Extension Phase|Adverse Event|1|||
126342864|NCT00471497|454552051|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
126342865|NCT00471497|454552052|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
126342866|NCT00471497|454552053|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
126342867|NCT00471497|454552051|FG000|Extension Phase|Withdrawal by Subject|3|||
126342868|NCT00471497|454552052|FG001|Extension Phase|Withdrawal by Subject|1|||
126342869|NCT00471497|454552053|FG002|Extension Phase|Withdrawal by Subject|0|||
126342870|NCT00471497|454552051|FG000|Extension Phase|Lost to Follow-up|2|||
126342871|NCT00471497|454552052|FG001|Extension Phase|Lost to Follow-up|0|||
126342872|NCT00471497|454552053|FG002|Extension Phase|Lost to Follow-up|0|||
126342873|NCT00471497|454552051|FG000|Extension Phase|Death|1|||
126342874|NCT00471497|454552052|FG001|Extension Phase|Death|0|||
126342875|NCT00471497|454552053|FG002|Extension Phase|Death|0|||
126342876|NCT00471497|454552051|FG000|Extension Phase|Disease progression|2|||
126342877|NCT00471497|454552052|FG001|Extension Phase|Disease progression|0|||
126342878|NCT00471497|454552053|FG002|Extension Phase|Disease progression|0|||
126342879|NCT00471497|454552051|FG000|Extension Phase|Protocol Violation|2|||
126342880|NCT00471497|454552052|FG001|Extension Phase|Protocol Violation|2|||
126342881|NCT00471497|454552053|FG002|Extension Phase|Protocol Violation|0|||
126342882|NCT01654276|454552054|FG000|Overall Study|Lack of Efficacy|1|||
126342883|NCT01654276|454552054|FG000|Overall Study|Lost to Follow-up|4|||
126342884|NCT01654276|454552054|FG000|Overall Study|Withdrawal by Subject|1|||
126342885|NCT03344757|454552055|FG000|Overall Study|Withdrawal by Subject|18|||
126342886|NCT03344757|454552056|FG001|Overall Study|Withdrawal by Subject|16|||
126342887|NCT03344757|454552055|FG000|Overall Study|Lost to Follow-up|0|||
126342888|NCT03344757|454552056|FG001|Overall Study|Lost to Follow-up|2|||
126342889|NCT04609514|454552057|FG000|Overall Study|Lost to Follow-up|5|||
126342890|NCT04609514|454552058|FG001|Overall Study|Lost to Follow-up|4|||
126342891|NCT04609514|454552057|FG000|Overall Study|Withdrawal by PI|0|||
126342892|NCT04609514|454552058|FG001|Overall Study|Withdrawal by PI|2|||
126342893|NCT00909870|454552059|FG000|Overall Study|Adverse Event|13|||
126342894|NCT00909870|454552060|FG001|Overall Study|Adverse Event|7|||
126342895|NCT00909870|454552059|FG000|Overall Study|Protocol Violation|1|||
126342896|NCT00909870|454552060|FG001|Overall Study|Protocol Violation|2|||
126342897|NCT00909870|454552059|FG000|Overall Study|Withdrawal by Subject|5|||
126342898|NCT00909870|454552060|FG001|Overall Study|Withdrawal by Subject|8|||
126342899|NCT00909870|454552059|FG000|Overall Study|Lost to Follow-up|3|||
126342900|NCT00909870|454552060|FG001|Overall Study|Lost to Follow-up|3|||
126342901|NCT00909870|454552059|FG000|Overall Study|Physician Decision|0|||
126342902|NCT00909870|454552060|FG001|Overall Study|Physician Decision|2|||
126342903|NCT00909870|454552059|FG000|Overall Study|Other|1|||
126342904|NCT00909870|454552060|FG001|Overall Study|Other|5|||
126342905|NCT01316575|454552063|FG000|Overall Study|Withdrawal by Subject|2|||
126342906|NCT01316575|454552064|FG001|Overall Study|Withdrawal by Subject|0|||
126342907|NCT01316575|454552063|FG000|Overall Study|Required alternate treatment|0|||
126342908|NCT01316575|454552064|FG001|Overall Study|Required alternate treatment|1|||
126342909|NCT00402831|454552065|FG000|Overall Study|Lost to Follow-up|1|||
126342910|NCT00402831|454552066|FG001|Overall Study|Lost to Follow-up|2|||
126342911|NCT00402831|454552065|FG000|Overall Study|Non-compliance with protocol|0|||
126342912|NCT00402831|454552066|FG001|Overall Study|Non-compliance with protocol|1|||
126342913|NCT01114724|454552071|FG000|Overall Study|Death|8|||
126342914|NCT01114724|454552071|FG000|Overall Study|Lost to Follow-up|1|||
126342915|NCT01114724|454552071|FG000|Overall Study|Withdrawal by Subject|1|||
126342916|NCT02814526|454552072|FG000|Overall Study|Adverse Event|4|||
126342917|NCT02814526|454552073|FG001|Overall Study|Adverse Event|3|||
126009603|NCT01194258|453327827|FG002|Titration Period|Withdrawal by Subject|0|||
126009604|NCT01194258|453327828|FG003|Titration Period|Withdrawal by Subject|0|||
126009605|NCT01194258|453327829|FG004|Titration Period|Withdrawal by Subject|0|||
126009606|NCT01194258|453327825|FG000|Titration Period|Lost to Follow-up|2|||
126009607|NCT01194258|453327826|FG001|Titration Period|Lost to Follow-up|0|||
126009608|NCT01194258|453327827|FG002|Titration Period|Lost to Follow-up|0|||
126009609|NCT01194258|453327828|FG003|Titration Period|Lost to Follow-up|0|||
126009610|NCT01194258|453327829|FG004|Titration Period|Lost to Follow-up|0|||
126009611|NCT01194258|453327825|FG000|Titration Period|Titration failure|3|||
126009612|NCT01194258|453327826|FG001|Titration Period|Titration failure|0|||
126009613|NCT01194258|453327827|FG002|Titration Period|Titration failure|0|||
126009614|NCT01194258|453327828|FG003|Titration Period|Titration failure|0|||
126009615|NCT01194258|453327829|FG004|Titration Period|Titration failure|0|||
126009616|NCT01194258|453327825|FG000|Period 1 (12 Weeks)|Death|0|||
126009617|NCT01194258|453327826|FG001|Period 1 (12 Weeks)|Death|0|||
126009618|NCT01194258|453327827|FG002|Period 1 (12 Weeks)|Death|0|||
126009619|NCT01194258|453327828|FG003|Period 1 (12 Weeks)|Death|0|||
126009620|NCT01194258|453327829|FG004|Period 1 (12 Weeks)|Death|1|||
126009621|NCT01194258|453327825|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126342918|NCT02814526|454552072|FG000|Overall Study|Death|1|||
126342919|NCT02814526|454552073|FG001|Overall Study|Death|1|||
126342920|NCT02814526|454552072|FG000|Overall Study|Lost to Follow-up|3|||
126342921|NCT02814526|454552073|FG001|Overall Study|Lost to Follow-up|4|||
126342922|NCT02814526|454552072|FG000|Overall Study|non site physician decision|1|||
126342923|NCT02814526|454552073|FG001|Overall Study|non site physician decision|0|||
126342924|NCT02814526|454552072|FG000|Overall Study|participant noncompliance|1|||
126342925|NCT02814526|454552073|FG001|Overall Study|participant noncompliance|1|||
126342926|NCT02814526|454552072|FG000|Overall Study|Withdrawal by Subject|20|||
126342927|NCT02814526|454552073|FG001|Overall Study|Withdrawal by Subject|14|||
126342928|NCT02814526|454552072|FG000|Overall Study|safety risk|2|||
126342929|NCT02814526|454552073|FG001|Overall Study|safety risk|1|||
126342930|NCT02814526|454552072|FG000|Overall Study|early termination-study terminated|1|||
126342931|NCT02814526|454552073|FG001|Overall Study|early termination-study terminated|2|||
126342932|NCT02814526|454552072|FG000|Overall Study|Other|0|||
126342933|NCT02814526|454552073|FG001|Overall Study|Other|4|||
126342934|NCT03883386|454552074|FG000|First Assignment|Lost to Follow-up|1|||
126342935|NCT03883386|454552075|FG001|First Assignment|Lost to Follow-up|0|||
126342936|NCT03883386|454552074|FG000|First Assignment|Withdrawal by Subject|1|||
126342937|NCT03883386|454552075|FG001|First Assignment|Withdrawal by Subject|1|||
126342938|NCT00251758|454552076|FG000|Overall Study|Adverse Event|7|||
126342939|NCT00251758|454552077|FG001|Overall Study|Adverse Event|9|||
126342940|NCT00251758|454552078|FG002|Overall Study|Adverse Event|11|||
126342941|NCT00251758|454552076|FG000|Overall Study|Lost to Follow-up|4|||
126342942|NCT00251758|454552077|FG001|Overall Study|Lost to Follow-up|2|||
126342943|NCT00251758|454552078|FG002|Overall Study|Lost to Follow-up|5|||
126342944|NCT00251758|454552076|FG000|Overall Study|Withdrawal by Subject|13|||
126342945|NCT00251758|454552077|FG001|Overall Study|Withdrawal by Subject|7|||
126342946|NCT00251758|454552078|FG002|Overall Study|Withdrawal by Subject|3|||
126342947|NCT00251758|454552076|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
126342948|NCT00251758|454552077|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
126342949|NCT00251758|454552078|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
126342950|NCT00251758|454552076|FG000|Overall Study|Lack of Efficacy|3|||
126342951|NCT00251758|454552077|FG001|Overall Study|Lack of Efficacy|0|||
126342952|NCT00251758|454552078|FG002|Overall Study|Lack of Efficacy|0|||
126342953|NCT00251758|454552076|FG000|Overall Study|Noncompliant|0|||
126342954|NCT00251758|454552077|FG001|Overall Study|Noncompliant|2|||
126342955|NCT00251758|454552078|FG002|Overall Study|Noncompliant|2|||
126342956|NCT00251758|454552076|FG000|Overall Study|Pregnancy|0|||
126342957|NCT00251758|454552077|FG001|Overall Study|Pregnancy|1|||
126342958|NCT00251758|454552078|FG002|Overall Study|Pregnancy|0|||
126342959|NCT00251758|454552076|FG000|Overall Study|Per Subject Request|0|||
126342960|NCT00251758|454552077|FG001|Overall Study|Per Subject Request|0|||
126342961|NCT00251758|454552078|FG002|Overall Study|Per Subject Request|1|||
126342962|NCT00251758|454552076|FG000|Overall Study|Per Investigator Request|1|||
126342963|NCT00251758|454552077|FG001|Overall Study|Per Investigator Request|0|||
126342964|NCT00251758|454552078|FG002|Overall Study|Per Investigator Request|0|||
126342965|NCT01387269|454552079|FG000|Overall Study|Death|38|||
126342966|NCT01387269|454552080|FG001|Overall Study|Death|20|||
126342967|NCT01387269|454552079|FG000|Overall Study|Other|8|||
126342968|NCT01387269|454552080|FG001|Overall Study|Other|7|||
126009622|NCT01194258|453327826|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126342969|NCT01387269|454552079|FG000|Overall Study|Unrelated AE|12|||
126342970|NCT01387269|454552080|FG001|Overall Study|Unrelated AE|3|||
126342971|NCT01387269|454552079|FG000|Overall Study|Withdrawal by patient|32|||
126009623|NCT01194258|453327827|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126009624|NCT01194258|453327828|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126009625|NCT01194258|453327829|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
126342972|NCT01387269|454552080|FG001|Overall Study|Withdrawal by patient|10|||
126342973|NCT01387269|454552079|FG000|Overall Study|Study drug-related AE|1|||
126342974|NCT01387269|454552080|FG001|Overall Study|Study drug-related AE|0|||
126342975|NCT01387269|454552079|FG000|Overall Study|Lost to Follow-up|1|||
126342976|NCT01387269|454552080|FG001|Overall Study|Lost to Follow-up|0|||
126342977|NCT01981616|454552086|FG000|Overall Study|Adverse Event|0|||
126342978|NCT01981616|454552087|FG001|Overall Study|Adverse Event|1|||
126342979|NCT01981616|454552086|FG000|Overall Study|Protocol Violation|1|||
126342980|NCT01981616|454552087|FG001|Overall Study|Protocol Violation|0|||
126342981|NCT01020123|454552088|FG000|Main Period|Withdrawal by Subject|6|||
126009626|NCT01194258|453327825|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
126009627|NCT01194258|453327826|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
126009628|NCT01194258|453327827|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
126009629|NCT01194258|453327828|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
126009630|NCT01194258|453327829|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
126009631|NCT01194258|453327825|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126009632|NCT01194258|453327826|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126009633|NCT01194258|453327827|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126009634|NCT01194258|453327828|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126009635|NCT01194258|453327829|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126009636|NCT03523962|453327831|FG000|Closed Fractures|Death|86|||
126009637|NCT03523962|453327832|FG001|Closed Fractures|Death|71|||
126009638|NCT03523962|453327833|FG002|Closed Fractures|Death|0|||
126009639|NCT03523962|453327834|FG003|Closed Fractures|Death|0|||
126009640|NCT03523962|453327831|FG000|Closed Fractures|Lost to Follow-up|62|||
126009641|NCT03523962|453327832|FG001|Closed Fractures|Lost to Follow-up|36|||
126009642|NCT03523962|453327833|FG002|Closed Fractures|Lost to Follow-up|0|||
126009643|NCT03523962|453327834|FG003|Closed Fractures|Lost to Follow-up|0|||
126009644|NCT03523962|453327831|FG000|Closed Fractures|Withdrawal by Subject|19|||
126009645|NCT03523962|453327832|FG001|Closed Fractures|Withdrawal by Subject|29|||
126009646|NCT03523962|453327833|FG002|Closed Fractures|Withdrawal by Subject|0|||
126009647|NCT03523962|453327834|FG003|Closed Fractures|Withdrawal by Subject|0|||
126009648|NCT03523962|453327831|FG000|Closed Fractures|Incarceration|1|||
126009649|NCT03523962|453327832|FG001|Closed Fractures|Incarceration|4|||
126009650|NCT03523962|453327833|FG002|Closed Fractures|Incarceration|0|||
126009651|NCT03523962|453327834|FG003|Closed Fractures|Incarceration|0|||
126009652|NCT03523962|453327831|FG000|Open Fractures|Death|0|||
126009653|NCT03523962|453327832|FG001|Open Fractures|Death|0|||
126009654|NCT03523962|453327833|FG002|Open Fractures|Death|11|||
126009655|NCT03523962|453327834|FG003|Open Fractures|Death|6|||
126009656|NCT03523962|453327831|FG000|Open Fractures|Lost to Follow-up|0|||
126009657|NCT03523962|453327832|FG001|Open Fractures|Lost to Follow-up|0|||
126009658|NCT03523962|453327833|FG002|Open Fractures|Lost to Follow-up|15|||
126009659|NCT03523962|453327834|FG003|Open Fractures|Lost to Follow-up|8|||
126009660|NCT03523962|453327831|FG000|Open Fractures|Withdrawal by Subject|0|||
126009661|NCT03523962|453327832|FG001|Open Fractures|Withdrawal by Subject|0|||
126009662|NCT03523962|453327833|FG002|Open Fractures|Withdrawal by Subject|6|||
126009663|NCT03523962|453327834|FG003|Open Fractures|Withdrawal by Subject|2|||
126009664|NCT03523962|453327831|FG000|Open Fractures|Incarceration|0|||
126009665|NCT03523962|453327832|FG001|Open Fractures|Incarceration|0|||
126009666|NCT03523962|453327833|FG002|Open Fractures|Incarceration|1|||
126009667|NCT03523962|453327834|FG003|Open Fractures|Incarceration|0|||
126009668|NCT01081145|453327838|FG000|Open-Label Phase|Lack of Efficacy|56|||
126009669|NCT01081145|453327839|FG001|Open-Label Phase|Lack of Efficacy|0|||
126009670|NCT01081145|453327838|FG000|Open-Label Phase|Response criteria not met|46|||
126009671|NCT01081145|453327839|FG001|Open-Label Phase|Response criteria not met|0|||
126009672|NCT01081145|453327838|FG000|Open-Label Phase|Adverse Event|42|||
126009673|NCT01081145|453327839|FG001|Open-Label Phase|Adverse Event|0|||
126009674|NCT01081145|453327838|FG000|Open-Label Phase|Withdrawal by Subject|41|||
126009675|NCT01081145|453327839|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126009676|NCT01081145|453327838|FG000|Open-Label Phase|Other|12|||
126009677|NCT01081145|453327839|FG001|Open-Label Phase|Other|0|||
126009678|NCT01081145|453327838|FG000|Open-Label Phase|Lost to Follow-up|11|||
126009679|NCT01081145|453327839|FG001|Open-Label Phase|Lost to Follow-up|0|||
126009680|NCT01081145|453327838|FG000|Open-Label Phase|Protocol Violation|4|||
126009681|NCT01081145|453327839|FG001|Open-Label Phase|Protocol Violation|0|||
126009682|NCT01081145|453327838|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
126009683|NCT01081145|453327839|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
126009684|NCT01081145|453327838|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
126009685|NCT01081145|453327839|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
126009686|NCT01081145|453327838|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
126009687|NCT01081145|453327839|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
126009688|NCT01081145|453327838|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
126009689|NCT01081145|453327839|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
126009690|NCT01081145|453327838|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
126009691|NCT01081145|453327839|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
126009692|NCT01081145|453327838|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
126009693|NCT01081145|453327839|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
126009694|NCT01081145|453327838|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
126009695|NCT01081145|453327839|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
126009696|NCT03394027|453327842|FG000|Overall Study|Ineligible|3|||
126009697|NCT03394027|453327843|FG001|Overall Study|Ineligible|1|||
126009698|NCT03394027|453327844|FG002|Overall Study|Ineligible|3|||
126009699|NCT03394027|453327842|FG000|Overall Study|Participant declined to participate before treatment started|0|||
126009700|NCT03394027|453327843|FG001|Overall Study|Participant declined to participate before treatment started|0|||
126009701|NCT03394027|453327844|FG002|Overall Study|Participant declined to participate before treatment started|1|||
126009702|NCT02197234|453327847|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
126009703|NCT02197234|453327847|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
126009704|NCT02197234|453327847|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
126342982|NCT01020123|454552089|FG001|Main Period|Withdrawal by Subject|5|||
126342983|NCT01020123|454552090|FG002|Main Period|Withdrawal by Subject|3|||
126342984|NCT01020123|454552091|FG003|Main Period|Withdrawal by Subject|1|||
126342985|NCT01020123|454552092|FG004|Main Period|Withdrawal by Subject|6|||
126342986|NCT01020123|454552093|FG005|Main Period|Withdrawal by Subject|3|||
126342987|NCT01020123|454552094|FG006|Main Period|Withdrawal by Subject|2|||
126342988|NCT01020123|454552088|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
126342989|NCT01020123|454552089|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
126342990|NCT01020123|454552090|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
126342991|NCT01020123|454552091|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
126342992|NCT01020123|454552092|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
126342993|NCT01020123|454552093|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
126342994|NCT01020123|454552094|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
126342995|NCT01020123|454552088|FG000|Main Period|Adverse Event|5|||
126342996|NCT01020123|454552089|FG001|Main Period|Adverse Event|2|||
126342997|NCT01020123|454552090|FG002|Main Period|Adverse Event|2|||
126342998|NCT01020123|454552091|FG003|Main Period|Adverse Event|1|||
126342999|NCT01020123|454552092|FG004|Main Period|Adverse Event|1|||
126343000|NCT01020123|454552093|FG005|Main Period|Adverse Event|2|||
126343001|NCT01020123|454552094|FG006|Main Period|Adverse Event|1|||
126343002|NCT01020123|454552088|FG000|Main Period|Protocol Violation|4|||
126343003|NCT01020123|454552089|FG001|Main Period|Protocol Violation|4|||
126343004|NCT01020123|454552090|FG002|Main Period|Protocol Violation|2|||
126343005|NCT01020123|454552091|FG003|Main Period|Protocol Violation|5|||
126343006|NCT01020123|454552092|FG004|Main Period|Protocol Violation|2|||
126343007|NCT01020123|454552093|FG005|Main Period|Protocol Violation|3|||
126343008|NCT01020123|454552094|FG006|Main Period|Protocol Violation|2|||
126343009|NCT01020123|454552088|FG000|Main Period|Lost to Follow-up|0|||
126343010|NCT01020123|454552089|FG001|Main Period|Lost to Follow-up|2|||
126343011|NCT01020123|454552090|FG002|Main Period|Lost to Follow-up|0|||
126343012|NCT01020123|454552091|FG003|Main Period|Lost to Follow-up|0|||
126343013|NCT01020123|454552092|FG004|Main Period|Lost to Follow-up|0|||
126343014|NCT01020123|454552093|FG005|Main Period|Lost to Follow-up|0|||
126343015|NCT01020123|454552094|FG006|Main Period|Lost to Follow-up|0|||
126343016|NCT01020123|454552088|FG000|Main Period|Unclasified|2|||
126343017|NCT01020123|454552089|FG001|Main Period|Unclasified|0|||
126343018|NCT01020123|454552090|FG002|Main Period|Unclasified|1|||
126343019|NCT01020123|454552091|FG003|Main Period|Unclasified|0|||
126343020|NCT01020123|454552092|FG004|Main Period|Unclasified|1|||
126343021|NCT01020123|454552093|FG005|Main Period|Unclasified|3|||
126343022|NCT01020123|454552094|FG006|Main Period|Unclasified|6|||
126343023|NCT01020123|454552088|FG000|Extention Period|Withdrawal by Subject|2|||
126343024|NCT01020123|454552089|FG001|Extention Period|Withdrawal by Subject|1|||
126343025|NCT01020123|454552090|FG002|Extention Period|Withdrawal by Subject|1|||
126343026|NCT01020123|454552091|FG003|Extention Period|Withdrawal by Subject|0|||
126343027|NCT01020123|454552092|FG004|Extention Period|Withdrawal by Subject|0|||
126343028|NCT01020123|454552093|FG005|Extention Period|Withdrawal by Subject|0|||
126343029|NCT01020123|454552094|FG006|Extention Period|Withdrawal by Subject|0|||
126343030|NCT01020123|454552088|FG000|Extention Period|Adverse Event|0|||
126343031|NCT01020123|454552089|FG001|Extention Period|Adverse Event|0|||
126343032|NCT01020123|454552090|FG002|Extention Period|Adverse Event|0|||
126343033|NCT01020123|454552091|FG003|Extention Period|Adverse Event|1|||
126343034|NCT01020123|454552092|FG004|Extention Period|Adverse Event|0|||
126343035|NCT01020123|454552093|FG005|Extention Period|Adverse Event|0|||
126343036|NCT01020123|454552094|FG006|Extention Period|Adverse Event|0|||
126343037|NCT01020123|454552088|FG000|Extention Period|Protocol Violation|1|||
126343038|NCT01020123|454552089|FG001|Extention Period|Protocol Violation|1|||
126343039|NCT01020123|454552090|FG002|Extention Period|Protocol Violation|1|||
126009705|NCT02197234|453327847|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
126009706|NCT02197234|453327847|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
126009707|NCT02197234|453327847|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
126009708|NCT05826431|453327849|FG000|Overall Study|Withdrawal by Subject|1|||
126009709|NCT04771273|453327850|FG000|Dose Escalation Period|Not treated with trial medication|0|||
126009710|NCT04771273|453327851|FG001|Dose Escalation Period|Not treated with trial medication|1|||
126009711|NCT04771273|453327852|FG002|Dose Escalation Period|Not treated with trial medication|1|||
126009712|NCT04771273|453327853|FG003|Dose Escalation Period|Not treated with trial medication|0|||
126009713|NCT04771273|453327850|FG000|Dose Escalation Period|Other reasons than listed|2|||
126009714|NCT04771273|453327851|FG001|Dose Escalation Period|Other reasons than listed|0|||
126009715|NCT04771273|453327852|FG002|Dose Escalation Period|Other reasons than listed|2|||
126009716|NCT04771273|453327853|FG003|Dose Escalation Period|Other reasons than listed|1|||
126009717|NCT04771273|453327850|FG000|Dose Escalation Period|Protocol Violation|0|||
126009718|NCT04771273|453327851|FG001|Dose Escalation Period|Protocol Violation|0|||
126009719|NCT04771273|453327852|FG002|Dose Escalation Period|Protocol Violation|3|||
126009720|NCT04771273|453327853|FG003|Dose Escalation Period|Protocol Violation|1|||
126009721|NCT04771273|453327850|FG000|Dose Escalation Period|Burden of study procedures|1|||
126009722|NCT04771273|453327851|FG001|Dose Escalation Period|Burden of study procedures|0|||
126009723|NCT04771273|453327852|FG002|Dose Escalation Period|Burden of study procedures|0|||
126009724|NCT04771273|453327853|FG003|Dose Escalation Period|Burden of study procedures|0|||
126009725|NCT04771273|453327850|FG000|Dose Escalation Period|Change of residence|0|||
126009726|NCT04771273|453327851|FG001|Dose Escalation Period|Change of residence|0|||
126009727|NCT04771273|453327852|FG002|Dose Escalation Period|Change of residence|0|||
126009728|NCT04771273|453327853|FG003|Dose Escalation Period|Change of residence|1|||
126009729|NCT04771273|453327850|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
126009730|NCT04771273|453327851|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
126009731|NCT04771273|453327852|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
126009732|NCT04771273|453327853|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
126009733|NCT04771273|453327850|FG000|Dose Escalation Period|Adverse Event|8|||
126009734|NCT04771273|453327851|FG001|Dose Escalation Period|Adverse Event|9|||
126009735|NCT04771273|453327852|FG002|Dose Escalation Period|Adverse Event|12|||
126009736|NCT04771273|453327853|FG003|Dose Escalation Period|Adverse Event|2|||
126009737|NCT04771273|453327850|FG000|Maintenance Period|Other than listed|4|||
126009738|NCT04771273|453327851|FG001|Maintenance Period|Other than listed|2|||
126009739|NCT04771273|453327852|FG002|Maintenance Period|Other than listed|0|||
126009740|NCT04771273|453327853|FG003|Maintenance Period|Other than listed|3|||
126009741|NCT04771273|453327850|FG000|Maintenance Period|Burden of study procedures|1|||
126009742|NCT04771273|453327851|FG001|Maintenance Period|Burden of study procedures|0|||
126009743|NCT04771273|453327852|FG002|Maintenance Period|Burden of study procedures|0|||
126009744|NCT04771273|453327853|FG003|Maintenance Period|Burden of study procedures|0|||
126009745|NCT04771273|453327850|FG000|Maintenance Period|Change of residence|0|||
126009746|NCT04771273|453327851|FG001|Maintenance Period|Change of residence|1|||
126009747|NCT04771273|453327852|FG002|Maintenance Period|Change of residence|3|||
126009748|NCT04771273|453327853|FG003|Maintenance Period|Change of residence|0|||
126009749|NCT04771273|453327850|FG000|Maintenance Period|Perceived lack of efficacy|0|||
126009750|NCT04771273|453327851|FG001|Maintenance Period|Perceived lack of efficacy|0|||
126009751|NCT04771273|453327852|FG002|Maintenance Period|Perceived lack of efficacy|0|||
126009752|NCT04771273|453327853|FG003|Maintenance Period|Perceived lack of efficacy|1|||
126009753|NCT04771273|453327850|FG000|Maintenance Period|Adverse Event|4|||
126009754|NCT04771273|453327851|FG001|Maintenance Period|Adverse Event|5|||
126009755|NCT04771273|453327852|FG002|Maintenance Period|Adverse Event|5|||
126009756|NCT04771273|453327853|FG003|Maintenance Period|Adverse Event|0|||
126009757|NCT01543685|453327854|FG000|Overall Study|Lack of Efficacy|1|||
126009758|NCT01543685|453327855|FG001|Overall Study|Lack of Efficacy|2|||
126009759|NCT01543685|453327856|FG002|Overall Study|Lack of Efficacy|2|||
126009760|NCT01543685|453327857|FG003|Overall Study|Lack of Efficacy|0|||
126009761|NCT01543685|453327858|FG004|Overall Study|Lack of Efficacy|2|||
126009762|NCT01543685|453327854|FG000|Overall Study|Adverse Event|2|||
126343040|NCT01020123|454552091|FG003|Extention Period|Protocol Violation|0|||
126343041|NCT01020123|454552092|FG004|Extention Period|Protocol Violation|0|||
126343042|NCT01020123|454552093|FG005|Extention Period|Protocol Violation|0|||
126343043|NCT01020123|454552094|FG006|Extention Period|Protocol Violation|1|||
126343044|NCT01020123|454552088|FG000|Extention Period|Lost to Follow-up|0|||
126343045|NCT01020123|454552089|FG001|Extention Period|Lost to Follow-up|0|||
126343046|NCT01020123|454552090|FG002|Extention Period|Lost to Follow-up|0|||
126343047|NCT01020123|454552091|FG003|Extention Period|Lost to Follow-up|0|||
126343048|NCT01020123|454552092|FG004|Extention Period|Lost to Follow-up|0|||
126343049|NCT01020123|454552093|FG005|Extention Period|Lost to Follow-up|2|||
126343050|NCT01020123|454552094|FG006|Extention Period|Lost to Follow-up|0|||
126343051|NCT04711005|454552099|FG000|Overall Study|Withdrawal by Subject|0|||
126343052|NCT04711005|454552100|FG001|Overall Study|Withdrawal by Subject|0|||
126343053|NCT04711005|454552101|FG002|Overall Study|Withdrawal by Subject|0|||
126343054|NCT04711005|454552102|FG003|Overall Study|Withdrawal by Subject|0|||
126343055|NCT04711005|454552103|FG004|Overall Study|Withdrawal by Subject|0|||
126343056|NCT04711005|454552104|FG005|Overall Study|Withdrawal by Subject|0|||
126343057|NCT04711005|454552105|FG006|Overall Study|Withdrawal by Subject|0|||
126343058|NCT04711005|454552106|FG007|Overall Study|Withdrawal by Subject|1|||
126343059|NCT04711005|454552107|FG008|Overall Study|Withdrawal by Subject|0|||
126343060|NCT04711005|454552108|FG009|Overall Study|Withdrawal by Subject|0|||
126343061|NCT04711005|454552099|FG000|Overall Study|Physician Decision|0|||
126343062|NCT04711005|454552100|FG001|Overall Study|Physician Decision|0|||
126343063|NCT04711005|454552101|FG002|Overall Study|Physician Decision|0|||
126343064|NCT04711005|454552102|FG003|Overall Study|Physician Decision|0|||
126343065|NCT04711005|454552103|FG004|Overall Study|Physician Decision|0|||
126343066|NCT04711005|454552104|FG005|Overall Study|Physician Decision|0|||
126343067|NCT04711005|454552105|FG006|Overall Study|Physician Decision|0|||
126343068|NCT04711005|454552106|FG007|Overall Study|Physician Decision|2|||
126343069|NCT04711005|454552107|FG008|Overall Study|Physician Decision|1|||
126343070|NCT04711005|454552108|FG009|Overall Study|Physician Decision|0|||
126343071|NCT03824561|454552116|FG000|Overall Study|Protocol Violation|19|||
126343072|NCT03573297|454552118|FG000|Open Label Treatment Period|Adverse Event|67|||
126343073|NCT03573297|454552119|FG001|Open Label Treatment Period|Adverse Event|0|||
126343074|NCT03573297|454552120|FG002|Open Label Treatment Period|Adverse Event|0|||
126343075|NCT03573297|454552121|FG003|Open Label Treatment Period|Adverse Event|0|||
126343076|NCT03573297|454552118|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
126343077|NCT03573297|454552119|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
126343078|NCT03573297|454552120|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
126343079|NCT03573297|454552121|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
126343080|NCT03573297|454552118|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
126343081|NCT03573297|454552119|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
126343082|NCT03573297|454552120|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
126343083|NCT03573297|454552121|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
126343084|NCT03573297|454552118|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
126343085|NCT03573297|454552119|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
126343086|NCT03573297|454552120|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
126343087|NCT03573297|454552121|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
126343088|NCT03573297|454552118|FG000|Open Label Treatment Period|Pregnancy|1|||
126343089|NCT03573297|454552119|FG001|Open Label Treatment Period|Pregnancy|0|||
126343090|NCT03573297|454552120|FG002|Open Label Treatment Period|Pregnancy|0|||
126343091|NCT03573297|454552121|FG003|Open Label Treatment Period|Pregnancy|0|||
126343092|NCT03573297|454552118|FG000|Open Label Treatment Period|Protocol Violation|17|||
126343093|NCT03573297|454552119|FG001|Open Label Treatment Period|Protocol Violation|0|||
126009763|NCT01543685|453327855|FG001|Overall Study|Adverse Event|1|||
126009764|NCT01543685|453327856|FG002|Overall Study|Adverse Event|0|||
126009765|NCT01543685|453327857|FG003|Overall Study|Adverse Event|0|||
126343094|NCT03573297|454552120|FG002|Open Label Treatment Period|Protocol Violation|0|||
126009766|NCT01543685|453327858|FG004|Overall Study|Adverse Event|2|||
126009767|NCT04776213|453327859|FG000|Overall Study|Other|1|||
126009768|NCT04776213|453327859|FG000|Overall Study|Withdrawal by Subject|7|||
126009769|NCT04776213|453327859|FG000|Overall Study|Protocol Violation|1|||
126009770|NCT04776213|453327859|FG000|Overall Study|Lost to Follow-up|2|||
126009771|NCT02163915|453327860|FG000|Overall Study|Withdrawal by Subject|2|||
126009772|NCT02163915|453327861|FG001|Overall Study|Withdrawal by Subject|0|||
126009773|NCT02163915|453327862|FG002|Overall Study|Withdrawal by Subject|2|||
126009774|NCT02163915|453327863|FG003|Overall Study|Withdrawal by Subject|2|||
126343095|NCT03573297|454552121|FG003|Open Label Treatment Period|Protocol Violation|0|||
126343096|NCT03573297|454552118|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
126343097|NCT03573297|454552119|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
126343098|NCT03573297|454552120|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
126343099|NCT03573297|454552121|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
126343100|NCT03573297|454552118|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
126343101|NCT03573297|454552119|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
126343102|NCT03573297|454552120|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
126343103|NCT03573297|454552121|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
126343104|NCT03573297|454552118|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
126343105|NCT03573297|454552119|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
126343106|NCT03573297|454552120|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
126343107|NCT03573297|454552121|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
126343108|NCT03573297|454552118|FG000|Open Label Treatment Period|Other, Not Specified|7|||
126343109|NCT03573297|454552119|FG001|Open Label Treatment Period|Other, Not Specified|0|||
126343110|NCT03573297|454552120|FG002|Open Label Treatment Period|Other, Not Specified|0|||
126343111|NCT03573297|454552121|FG003|Open Label Treatment Period|Other, Not Specified|0|||
126343112|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
126343113|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
126343114|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
126343115|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
126343116|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126343117|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126343118|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Adverse Event|5|||
126343119|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Adverse Event|1|||
126343120|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126343121|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
126343122|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
126343123|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
126343124|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126343125|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
126343126|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
126343127|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
126343128|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126343129|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
126343130|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
126343131|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
126343132|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126343133|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
126343134|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
126343135|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
126343136|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
126343137|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
126343138|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
126343139|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
126343140|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
126343141|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
126343142|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
126343143|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
126343144|NCT01499810|454552122|FG000|Overall Study|Lost to Follow-up|10|||
126343145|NCT01499810|454552122|FG000|Overall Study|Protocol Violation|1|||
126343146|NCT01499810|454552122|FG000|Overall Study|Withdrawal by Subject|1|||
126343147|NCT06996301|454552123|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
126343148|NCT06996301|454552124|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
126343149|NCT06996301|454552123|FG000|Overall Study|Patients with discordant diagnostic results|107|||
126343150|NCT06996301|454552124|FG001|Overall Study|Patients with discordant diagnostic results|90|||
126343151|NCT06996301|454552123|FG000|Overall Study|Lost to Follow-up|31|||
126343152|NCT06996301|454552124|FG001|Overall Study|Lost to Follow-up|56|||
126343153|NCT06996301|454552123|FG000|Overall Study|Withdrawal by Subject|12|||
126343154|NCT06996301|454552124|FG001|Overall Study|Withdrawal by Subject|7|||
126343155|NCT02273167|454552128|FG000|Overall Study|Adverse Event|1|||
126343156|NCT02273167|454552129|FG001|Overall Study|Adverse Event|0|||
126009775|NCT02163915|453327864|FG004|Overall Study|Withdrawal by Subject|2|||
126009776|NCT02163915|453327860|FG000|Overall Study|Study termination|1|||
126009777|NCT02163915|453327861|FG001|Overall Study|Study termination|0|||
126009778|NCT02163915|453327862|FG002|Overall Study|Study termination|0|||
126009779|NCT02163915|453327863|FG003|Overall Study|Study termination|0|||
126009780|NCT02163915|453327864|FG004|Overall Study|Study termination|2|||
126009781|NCT02163915|453327860|FG000|Overall Study|Physician Decision|0|||
126009782|NCT02163915|453327861|FG001|Overall Study|Physician Decision|0|||
126009783|NCT02163915|453327862|FG002|Overall Study|Physician Decision|0|||
126009784|NCT02163915|453327863|FG003|Overall Study|Physician Decision|1|||
126009785|NCT02163915|453327864|FG004|Overall Study|Physician Decision|0|||
126009786|NCT02931396|453327865|FG000|Overall Study|Lost to Follow-up|3|||
126009787|NCT02931396|453327866|FG001|Overall Study|Lost to Follow-up|0|||
126009788|NCT02931396|453327865|FG000|Overall Study|Withdrawal by Subject|2|||
126009789|NCT02931396|453327866|FG001|Overall Study|Withdrawal by Subject|0|||
126009790|NCT02013037|453327870|FG000|Overall Study|Death|6|||
126009791|NCT02013037|453327870|FG000|Overall Study|Withdrawal by Subject|1|||
126009792|NCT02013037|453327870|FG000|Overall Study|Awaiting Transplantation|7|||
126009793|NCT02013037|453327870|FG000|Overall Study|Transplanted without DSA|2|||
126009794|NCT02465359|453327871|FG000|Overall Study|Lack of Efficacy|1|||
126009795|NCT02465359|453327871|FG000|Overall Study|Withdrawal by Subject|1|||
126009796|NCT02465359|453327871|FG000|Overall Study|Adverse Event|1|||
126009797|NCT01304147|453327872|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
126343157|NCT02273167|454552130|FG002|Overall Study|Adverse Event|0|||
126343158|NCT02273167|454552128|FG000|Overall Study|Protocol Violation|3|||
126343159|NCT02273167|454552129|FG001|Overall Study|Protocol Violation|1|||
126343160|NCT02273167|454552130|FG002|Overall Study|Protocol Violation|1|||
126343161|NCT02273167|454552128|FG000|Overall Study|Lost to Follow-up|0|||
126343162|NCT02273167|454552129|FG001|Overall Study|Lost to Follow-up|1|||
126343163|NCT02273167|454552130|FG002|Overall Study|Lost to Follow-up|1|||
126343164|NCT02273167|454552128|FG000|Overall Study|Withdrawal by Subject|10|||
126343165|NCT02273167|454552129|FG001|Overall Study|Withdrawal by Subject|12|||
126343166|NCT02273167|454552130|FG002|Overall Study|Withdrawal by Subject|11|||
126343167|NCT02273167|454552128|FG000|Overall Study|Various|10|||
126343168|NCT02273167|454552129|FG001|Overall Study|Various|9|||
126343169|NCT02273167|454552130|FG002|Overall Study|Various|8|||
126343170|NCT02781324|454552135|FG000|Overall Study|Withdrawal by Subject|1|||
126343171|NCT02781324|454552136|FG001|Overall Study|Withdrawal by Subject|0|||
126343172|NCT02781324|454552135|FG000|Overall Study|Physician Decision|1|||
126343173|NCT02781324|454552136|FG001|Overall Study|Physician Decision|2|||
126343174|NCT00834041|454552137|FG000|Overall Study|Withdrawal by Subject|1|||
126343175|NCT00834041|454552138|FG001|Overall Study|Withdrawal by Subject|0|||
126343176|NCT00834041|454552137|FG000|Overall Study|Lost to Follow-up|0|||
126343177|NCT00834041|454552138|FG001|Overall Study|Lost to Follow-up|1|||
126343178|NCT00661388|454552139|FG000|Overall Study|Adverse Event|14|||
126343179|NCT00661388|454552139|FG000|Overall Study|Protocol Violation|7|||
126343180|NCT00661388|454552139|FG000|Overall Study|Renal transplantation|1|||
126343181|NCT00661388|454552139|FG000|Overall Study|Dialysis initiation|1|||
126343182|NCT00661388|454552139|FG000|Overall Study|Administrative reasons|1|||
126343183|NCT03370172|454554023|FG000|Overall Study|Withdrawal by Subject|0|||
126343184|NCT03370172|454554024|FG001|Overall Study|Withdrawal by Subject|1|||
126343185|NCT01171534|454554031|FG000|Overall Study|Lost to Follow-up|0|||
126343186|NCT01171534|454554032|FG001|Overall Study|Lost to Follow-up|2|||
126343187|NCT01171534|454554031|FG000|Overall Study|screen failure|0|||
126343188|NCT01171534|454554032|FG001|Overall Study|screen failure|1|||
126343189|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
126343190|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
126343191|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
126343192|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
126343193|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
126343194|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
126343195|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
126343196|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
126343197|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
126343198|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
126343199|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
126343200|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
126343201|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
126343202|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
126343203|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
126343204|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
126343205|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
126343206|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
126343207|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
126009798|NCT01304147|453327873|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
126009799|NCT01091454|453329393|FG000|Overall Study|Ineligible|1|||
126343208|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
126343209|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
126343210|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
126343211|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
126343212|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
126343213|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
126343214|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
126009800|NCT03837028|453329396|FG000|Overall Study|Lost to Follow-up|4|||
126009801|NCT03837028|453329397|FG001|Overall Study|Lost to Follow-up|0|||
126009802|NCT03837028|453329398|FG002|Overall Study|Lost to Follow-up|2|||
126009803|NCT03837028|453329399|FG003|Overall Study|Lost to Follow-up|0|||
126009804|NCT03837028|453329396|FG000|Overall Study|Withdrawal by Subject|12|||
126009805|NCT03837028|453329397|FG001|Overall Study|Withdrawal by Subject|11|||
126009806|NCT03837028|453329398|FG002|Overall Study|Withdrawal by Subject|11|||
126009807|NCT03837028|453329399|FG003|Overall Study|Withdrawal by Subject|7|||
126009808|NCT00646451|453329400|FG000|Overall Study|Adverse Event|3|||
126009809|NCT00646451|453329401|FG001|Overall Study|Adverse Event|0|||
126009810|NCT00646451|453329400|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
126009811|NCT00646451|453329401|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
126009812|NCT03784963|453329402|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
126009813|NCT03784963|453329403|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
126009814|NCT03784963|453329404|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
126009815|NCT03784963|453329405|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
126009816|NCT01510912|453329406|FG000|Overall Study|Adverse Event|99|||
126009817|NCT01510912|453329406|FG000|Overall Study|Lack of Efficacy|12|||
126009818|NCT01510912|453329406|FG000|Overall Study|Non-compliance with trial drug|23|||
126009819|NCT01510912|453329406|FG000|Overall Study|Withdrawal by Subject|49|||
126009820|NCT01510912|453329406|FG000|Overall Study|Physician Decision|1|||
126009821|NCT01510912|453329406|FG000|Overall Study|Protocol Violation|27|||
126009822|NCT01510912|453329406|FG000|Overall Study|Lost to Follow-up|26|||
126009823|NCT01510912|453329406|FG000|Overall Study|Other, including joint replacement|5|||
126009824|NCT01362491|453329407|FG000|Overall Study|Ineligible|1|||
126009825|NCT01362491|453329408|FG001|Overall Study|Ineligible|0|||
126009826|NCT01362491|453329409|FG002|Overall Study|Ineligible|0|||
126009827|NCT02030028|453329410|FG000|Overall Study|Withdrawal by Subject|4|||
126009828|NCT02030028|453329410|FG000|Overall Study|lack of transportation|1|||
126009829|NCT00567879|453329413|FG000|Overall Study|Adverse Event|2|||
126009830|NCT00567879|453329414|FG001|Overall Study|Adverse Event|0|||
126009831|NCT00567879|453329415|FG002|Overall Study|Adverse Event|1|||
126009832|NCT00567879|453329416|FG003|Overall Study|Adverse Event|0|||
126009833|NCT00567879|453329417|FG004|Overall Study|Adverse Event|1|||
126009834|NCT00567879|453329418|FG005|Overall Study|Adverse Event|0|||
126009835|NCT00567879|453329413|FG000|Overall Study|Abnormal test procedure(s)|0|||
126009836|NCT00567879|453329414|FG001|Overall Study|Abnormal test procedure(s)|0|||
126009837|NCT00567879|453329415|FG002|Overall Study|Abnormal test procedure(s)|1|||
126009838|NCT00567879|453329416|FG003|Overall Study|Abnormal test procedure(s)|0|||
126009839|NCT00567879|453329417|FG004|Overall Study|Abnormal test procedure(s)|0|||
126009840|NCT00567879|453329418|FG005|Overall Study|Abnormal test procedure(s)|0|||
126009841|NCT00567879|453329413|FG000|Overall Study|Withdrawal by Subject|0|||
126009842|NCT00567879|453329414|FG001|Overall Study|Withdrawal by Subject|0|||
126009843|NCT00567879|453329415|FG002|Overall Study|Withdrawal by Subject|3|||
126009844|NCT00567879|453329416|FG003|Overall Study|Withdrawal by Subject|1|||
126009845|NCT00567879|453329417|FG004|Overall Study|Withdrawal by Subject|0|||
126009846|NCT00567879|453329418|FG005|Overall Study|Withdrawal by Subject|0|||
126009847|NCT00567879|453329413|FG000|Overall Study|New cancer therapy|0|||
126009848|NCT00567879|453329414|FG001|Overall Study|New cancer therapy|0|||
126009849|NCT00567879|453329415|FG002|Overall Study|New cancer therapy|1|||
126009850|NCT00567879|453329416|FG003|Overall Study|New cancer therapy|0|||
126009851|NCT00567879|453329417|FG004|Overall Study|New cancer therapy|0|||
126009852|NCT00567879|453329418|FG005|Overall Study|New cancer therapy|0|||
126009853|NCT00567879|453329413|FG000|Overall Study|Disease progression|5|||
126343215|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
126343216|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
126343217|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
126343218|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
126343219|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
126343220|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
126343221|NCT02711137|454554035|FG000|Overall Study|Death|1|||
126343222|NCT02711137|454554036|FG001|Overall Study|Death|4|||
126343223|NCT02711137|454554037|FG002|Overall Study|Death|5|||
126343224|NCT02711137|454554038|FG003|Overall Study|Death|5|||
126343225|NCT02711137|454554039|FG004|Overall Study|Death|3|||
126343226|NCT02711137|454554040|FG005|Overall Study|Death|1|||
126343227|NCT02711137|454554041|FG006|Overall Study|Death|61|||
126343228|NCT02711137|454554042|FG007|Overall Study|Death|3|||
126343229|NCT02711137|454554043|FG008|Overall Study|Death|0|||
126343230|NCT02711137|454554044|FG009|Overall Study|Death|1|||
126343231|NCT02711137|454554045|FG010|Overall Study|Death|1|||
126343232|NCT02711137|454554046|FG011|Overall Study|Death|1|||
126343233|NCT02711137|454554047|FG012|Overall Study|Death|0|||
126343234|NCT02711137|454554048|FG013|Overall Study|Death|0|||
126343235|NCT02711137|454554049|FG014|Overall Study|Death|0|||
126343236|NCT02711137|454554035|FG000|Overall Study|Study Terminated by Sponsor|0|||
126343237|NCT02711137|454554036|FG001|Overall Study|Study Terminated by Sponsor|0|||
126343238|NCT02711137|454554037|FG002|Overall Study|Study Terminated by Sponsor|1|||
126009854|NCT00567879|453329414|FG001|Overall Study|Disease progression|7|||
126009855|NCT00567879|453329415|FG002|Overall Study|Disease progression|15|||
126009856|NCT00567879|453329416|FG003|Overall Study|Disease progression|5|||
126009857|NCT00567879|453329417|FG004|Overall Study|Disease progression|11|||
126009858|NCT00567879|453329418|FG005|Overall Study|Disease progression|3|||
126009859|NCT00777556|453329419|FG000|Overall Study|Inappropriate self-selection|34|||
126009860|NCT00777556|453329419|FG000|Overall Study|Dispensed but did not use product|12|||
126343239|NCT02711137|454554038|FG003|Overall Study|Study Terminated by Sponsor|0|||
126343240|NCT02711137|454554039|FG004|Overall Study|Study Terminated by Sponsor|0|||
126343241|NCT02711137|454554040|FG005|Overall Study|Study Terminated by Sponsor|0|||
126343242|NCT02711137|454554041|FG006|Overall Study|Study Terminated by Sponsor|1|||
126009861|NCT00777556|453329419|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
126009862|NCT01249092|453329420|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
126009863|NCT01249092|453329420|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
126009864|NCT02930343|453329424|FG000|Overall Study|Lost to Follow-up|9|||
126009865|NCT02930343|453329425|FG001|Overall Study|Lost to Follow-up|7|||
126009866|NCT02987543|453329428|FG000|Overall Study|Ongoing study at data cut off|49|||
126009867|NCT02987543|453329429|FG001|Overall Study|Ongoing study at data cut off|21|||
126009868|NCT02987543|453329430|FG002|Overall Study|Ongoing study at data cut off|19|||
126009869|NCT02987543|453329431|FG003|Overall Study|Ongoing study at data cut off|12|||
126009870|NCT02987543|453329428|FG000|Overall Study|Death|88|||
126009871|NCT02987543|453329429|FG001|Overall Study|Death|54|||
126009872|NCT02987543|453329430|FG002|Overall Study|Death|67|||
126009873|NCT02987543|453329431|FG003|Overall Study|Death|28|||
126009874|NCT02987543|453329428|FG000|Overall Study|Lost to Follow-up|3|||
126009875|NCT02987543|453329429|FG001|Overall Study|Lost to Follow-up|0|||
126009876|NCT02987543|453329430|FG002|Overall Study|Lost to Follow-up|1|||
126009877|NCT02987543|453329431|FG003|Overall Study|Lost to Follow-up|0|||
126009878|NCT02987543|453329428|FG000|Overall Study|Screen failure|0|||
126009879|NCT02987543|453329429|FG001|Overall Study|Screen failure|0|||
126009880|NCT02987543|453329430|FG002|Overall Study|Screen failure|0|||
126009881|NCT02987543|453329431|FG003|Overall Study|Screen failure|1|||
126009882|NCT02987543|453329428|FG000|Overall Study|Withdrawal by Subject|21|||
126009883|NCT02987543|453329429|FG001|Overall Study|Withdrawal by Subject|7|||
126009884|NCT02987543|453329430|FG002|Overall Study|Withdrawal by Subject|7|||
126009885|NCT02987543|453329431|FG003|Overall Study|Withdrawal by Subject|6|||
126009886|NCT02987543|453329428|FG000|Overall Study|Study terminated by sponsor|1|||
126009887|NCT02987543|453329429|FG001|Overall Study|Study terminated by sponsor|0|||
126009888|NCT02987543|453329430|FG002|Overall Study|Study terminated by sponsor|0|||
126009889|NCT02987543|453329431|FG003|Overall Study|Study terminated by sponsor|0|||
126009890|NCT02987543|453329428|FG000|Overall Study|Investigator decision|0|||
126009891|NCT02987543|453329429|FG001|Overall Study|Investigator decision|1|||
126009892|NCT02987543|453329430|FG002|Overall Study|Investigator decision|0|||
126009893|NCT02987543|453329431|FG003|Overall Study|Investigator decision|0|||
126009894|NCT02987543|453329428|FG000|Overall Study|Disease progression|0|||
126009895|NCT02987543|453329429|FG001|Overall Study|Disease progression|0|||
126343243|NCT02711137|454554042|FG007|Overall Study|Study Terminated by Sponsor|0|||
126343244|NCT02711137|454554043|FG008|Overall Study|Study Terminated by Sponsor|0|||
126343245|NCT02711137|454554044|FG009|Overall Study|Study Terminated by Sponsor|0|||
126343246|NCT02711137|454554045|FG010|Overall Study|Study Terminated by Sponsor|0|||
126343247|NCT02711137|454554046|FG011|Overall Study|Study Terminated by Sponsor|0|||
126343248|NCT02711137|454554047|FG012|Overall Study|Study Terminated by Sponsor|0|||
126343249|NCT02711137|454554048|FG013|Overall Study|Study Terminated by Sponsor|0|||
126343250|NCT02711137|454554049|FG014|Overall Study|Study Terminated by Sponsor|0|||
126343251|NCT02711137|454554035|FG000|Overall Study|Physician Decision|1|||
126343252|NCT02711137|454554036|FG001|Overall Study|Physician Decision|0|||
126343253|NCT02711137|454554037|FG002|Overall Study|Physician Decision|2|||
126343254|NCT02711137|454554038|FG003|Overall Study|Physician Decision|1|||
126343255|NCT02711137|454554039|FG004|Overall Study|Physician Decision|1|||
126343256|NCT02711137|454554040|FG005|Overall Study|Physician Decision|0|||
126343257|NCT02711137|454554041|FG006|Overall Study|Physician Decision|12|||
126343258|NCT02711137|454554042|FG007|Overall Study|Physician Decision|2|||
126343259|NCT02711137|454554043|FG008|Overall Study|Physician Decision|1|||
126343260|NCT02711137|454554044|FG009|Overall Study|Physician Decision|1|||
126343261|NCT02711137|454554045|FG010|Overall Study|Physician Decision|3|||
126343262|NCT02711137|454554046|FG011|Overall Study|Physician Decision|2|||
126343263|NCT02711137|454554047|FG012|Overall Study|Physician Decision|1|||
126343264|NCT02711137|454554048|FG013|Overall Study|Physician Decision|1|||
126343265|NCT02711137|454554049|FG014|Overall Study|Physician Decision|2|||
126343266|NCT02711137|454554035|FG000|Overall Study|Other|0|||
126343267|NCT02711137|454554036|FG001|Overall Study|Other|1|||
126343268|NCT02711137|454554037|FG002|Overall Study|Other|0|||
126343269|NCT02711137|454554038|FG003|Overall Study|Other|0|||
126343270|NCT02711137|454554039|FG004|Overall Study|Other|0|||
126343271|NCT02711137|454554040|FG005|Overall Study|Other|0|||
126343272|NCT02711137|454554041|FG006|Overall Study|Other|3|||
126343273|NCT02711137|454554042|FG007|Overall Study|Other|0|||
126343274|NCT02711137|454554043|FG008|Overall Study|Other|0|||
126343275|NCT02711137|454554044|FG009|Overall Study|Other|0|||
126343276|NCT02711137|454554045|FG010|Overall Study|Other|0|||
126343277|NCT02711137|454554046|FG011|Overall Study|Other|0|||
126343278|NCT02711137|454554047|FG012|Overall Study|Other|0|||
126343279|NCT02711137|454554048|FG013|Overall Study|Other|0|||
126343280|NCT02711137|454554049|FG014|Overall Study|Other|1|||
126343281|NCT02711137|454554035|FG000|Overall Study|Withdrawal by Subject|1|||
126343282|NCT02711137|454554036|FG001|Overall Study|Withdrawal by Subject|0|||
126343283|NCT02711137|454554037|FG002|Overall Study|Withdrawal by Subject|0|||
126343284|NCT02711137|454554038|FG003|Overall Study|Withdrawal by Subject|1|||
126343285|NCT02711137|454554039|FG004|Overall Study|Withdrawal by Subject|1|||
126343286|NCT02711137|454554040|FG005|Overall Study|Withdrawal by Subject|0|||
126343287|NCT02711137|454554041|FG006|Overall Study|Withdrawal by Subject|7|||
126343288|NCT02711137|454554042|FG007|Overall Study|Withdrawal by Subject|0|||
126343289|NCT02711137|454554043|FG008|Overall Study|Withdrawal by Subject|0|||
126343290|NCT02711137|454554044|FG009|Overall Study|Withdrawal by Subject|0|||
126009896|NCT02987543|453329430|FG002|Overall Study|Disease progression|0|||
126009897|NCT02987543|453329431|FG003|Overall Study|Disease progression|1|||
126009898|NCT01977612|453329432|FG000|Overall Study|Lost to Follow-up|1|||
126343291|NCT02711137|454554045|FG010|Overall Study|Withdrawal by Subject|0|||
126343292|NCT02711137|454554046|FG011|Overall Study|Withdrawal by Subject|0|||
126343293|NCT02711137|454554047|FG012|Overall Study|Withdrawal by Subject|0|||
126343294|NCT02711137|454554048|FG013|Overall Study|Withdrawal by Subject|1|||
126343295|NCT02711137|454554049|FG014|Overall Study|Withdrawal by Subject|0|||
126343296|NCT02711137|454554035|FG000|Overall Study|Lost to Follow-up|1|||
126009899|NCT01977612|453329433|FG001|Overall Study|Lost to Follow-up|1|||
126009900|NCT01451814|453329434|FG000|Overall Study|Withdrawal by Subject|1|||
126009901|NCT01451814|453329435|FG001|Overall Study|Withdrawal by Subject|1|||
126343297|NCT02711137|454554036|FG001|Overall Study|Lost to Follow-up|0|||
126343298|NCT02711137|454554037|FG002|Overall Study|Lost to Follow-up|0|||
126343299|NCT02711137|454554038|FG003|Overall Study|Lost to Follow-up|0|||
126343300|NCT02711137|454554039|FG004|Overall Study|Lost to Follow-up|0|||
126343301|NCT02711137|454554040|FG005|Overall Study|Lost to Follow-up|0|||
126343302|NCT02711137|454554041|FG006|Overall Study|Lost to Follow-up|2|||
126343303|NCT02711137|454554042|FG007|Overall Study|Lost to Follow-up|0|||
126343304|NCT02711137|454554043|FG008|Overall Study|Lost to Follow-up|0|||
126343305|NCT02711137|454554044|FG009|Overall Study|Lost to Follow-up|0|||
126343306|NCT02711137|454554045|FG010|Overall Study|Lost to Follow-up|0|||
126343307|NCT02711137|454554046|FG011|Overall Study|Lost to Follow-up|0|||
126343308|NCT02711137|454554047|FG012|Overall Study|Lost to Follow-up|0|||
126343309|NCT02711137|454554048|FG013|Overall Study|Lost to Follow-up|0|||
126343310|NCT02711137|454554049|FG014|Overall Study|Lost to Follow-up|0|||
126343311|NCT03427892|454554050|FG000|Overall Study|Lost to Follow-up|2|||
126343312|NCT00548327|454554051|FG000|Overall Study|Adverse Event|0|||
126343313|NCT00548327|454554052|FG001|Overall Study|Adverse Event|1|||
126343314|NCT00274456|454554053|FG000|Overall Study|Still on treatment|2|||
126343315|NCT00274456|454554054|FG001|Overall Study|Still on treatment|3|||
126343316|NCT00274456|454554055|FG002|Overall Study|Still on treatment|5|||
126343317|NCT00274456|454554056|FG003|Overall Study|Still on treatment|1|||
126343318|NCT00274456|454554053|FG000|Overall Study|Unacceptable toxicity|10|||
126343319|NCT00274456|454554054|FG001|Overall Study|Unacceptable toxicity|5|||
126343320|NCT00274456|454554055|FG002|Overall Study|Unacceptable toxicity|12|||
126343321|NCT00274456|454554056|FG003|Overall Study|Unacceptable toxicity|16|||
126343322|NCT00274456|454554053|FG000|Overall Study|Adverse Event|0|||
126343323|NCT00274456|454554054|FG001|Overall Study|Adverse Event|1|||
126343324|NCT00274456|454554055|FG002|Overall Study|Adverse Event|2|||
126343325|NCT00274456|454554056|FG003|Overall Study|Adverse Event|2|||
126009902|NCT01451814|453329434|FG000|Overall Study|Lost to Follow-up|5|||
126009903|NCT01451814|453329435|FG001|Overall Study|Lost to Follow-up|4|||
126009904|NCT01280591|453329437|FG000|Overall Study|Withdrawal by Subject|0|||
126009905|NCT01280591|453329438|FG001|Overall Study|Withdrawal by Subject|0|||
126009906|NCT01280591|453329439|FG002|Overall Study|Withdrawal by Subject|0|||
126009907|NCT01280591|453329440|FG003|Overall Study|Withdrawal by Subject|2|||
126009908|NCT01280591|453329437|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
126009909|NCT01280591|453329438|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
126009910|NCT01280591|453329439|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
126009911|NCT01280591|453329440|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
126009912|NCT01883492|453329441|FG000|Overall Study|Lost to Follow-up|3|||
126009913|NCT01883492|453329442|FG001|Overall Study|Lost to Follow-up|4|||
126009914|NCT01883492|453329441|FG000|Overall Study|Surgery on contra-lateral hip|0|||
126009915|NCT01883492|453329442|FG001|Overall Study|Surgery on contra-lateral hip|1|||
126009916|NCT01883492|453329441|FG000|Overall Study|Poor X-ray quality|7|||
126009917|NCT01883492|453329442|FG001|Overall Study|Poor X-ray quality|4|||
126009918|NCT01883492|453329441|FG000|Overall Study|Withdrawal by Subject|1|||
126009919|NCT01883492|453329442|FG001|Overall Study|Withdrawal by Subject|0|||
126009920|NCT01883492|453329441|FG000|Overall Study|inappropriate implant used|1|||
126009921|NCT01883492|453329442|FG001|Overall Study|inappropriate implant used|1|||
126009922|NCT01883492|453329441|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
126009923|NCT01883492|453329442|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
126009924|NCT01259102|453329445|FG000|Overall Study|Adverse Event|1|||
126009925|NCT01259102|453329446|FG001|Overall Study|Adverse Event|0|||
126009926|NCT01259102|453329447|FG002|Overall Study|Adverse Event|1|||
126009927|NCT01259102|453329448|FG003|Overall Study|Adverse Event|1|||
126009928|NCT01259102|453329449|FG004|Overall Study|Adverse Event|0|||
126009929|NCT01259102|453329445|FG000|Overall Study|Other|0|||
126009930|NCT01259102|453329446|FG001|Overall Study|Other|0|||
126009931|NCT01259102|453329447|FG002|Overall Study|Other|1|||
126009932|NCT01259102|453329448|FG003|Overall Study|Other|1|||
126009933|NCT01259102|453329449|FG004|Overall Study|Other|1|||
126009934|NCT01956669|453329451|FG000|Overall Study|Disease Progression|12|||
126009935|NCT01956669|453329452|FG001|Overall Study|Disease Progression|7|||
126009936|NCT01956669|453329453|FG002|Overall Study|Disease Progression|7|||
126009937|NCT01956669|453329454|FG003|Overall Study|Disease Progression|8|||
126009938|NCT01956669|453329455|FG004|Overall Study|Disease Progression|4|||
126009939|NCT01956669|453329456|FG005|Overall Study|Disease Progression|3|||
126343326|NCT00274456|454554053|FG000|Overall Study|Physician Decision|7|||
126343327|NCT00274456|454554054|FG001|Overall Study|Physician Decision|5|||
126343328|NCT00274456|454554055|FG002|Overall Study|Physician Decision|6|||
126343329|NCT00274456|454554056|FG003|Overall Study|Physician Decision|13|||
126009940|NCT01956669|453329457|FG006|Overall Study|Disease Progression|5|||
126009941|NCT01956669|453329451|FG000|Overall Study|Adverse Event|0|||
126009942|NCT01956669|453329452|FG001|Overall Study|Adverse Event|2|||
126009943|NCT01956669|453329453|FG002|Overall Study|Adverse Event|2|||
126009944|NCT01956669|453329454|FG003|Overall Study|Adverse Event|1|||
126009945|NCT01956669|453329455|FG004|Overall Study|Adverse Event|0|||
126009946|NCT01956669|453329456|FG005|Overall Study|Adverse Event|0|||
126343330|NCT00274456|454554053|FG000|Overall Study|Lost to Follow-up|0|||
126343331|NCT00274456|454554054|FG001|Overall Study|Lost to Follow-up|0|||
126009947|NCT01956669|453329457|FG006|Overall Study|Adverse Event|0|||
126009948|NCT01956669|453329451|FG000|Overall Study|Physician Decision|0|||
126009949|NCT01956669|453329452|FG001|Overall Study|Physician Decision|2|||
126009950|NCT01956669|453329453|FG002|Overall Study|Physician Decision|0|||
126009951|NCT01956669|453329454|FG003|Overall Study|Physician Decision|0|||
126009952|NCT01956669|453329455|FG004|Overall Study|Physician Decision|0|||
126343332|NCT00274456|454554055|FG002|Overall Study|Lost to Follow-up|1|||
126343333|NCT00274456|454554056|FG003|Overall Study|Lost to Follow-up|0|||
126343334|NCT00274456|454554053|FG000|Overall Study|Withdrawal by Subject|18|||
126343335|NCT00274456|454554054|FG001|Overall Study|Withdrawal by Subject|13|||
126343336|NCT00274456|454554055|FG002|Overall Study|Withdrawal by Subject|9|||
126343337|NCT00274456|454554056|FG003|Overall Study|Withdrawal by Subject|13|||
126343338|NCT03255187|454554057|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
126343339|NCT03255187|454554058|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
126343340|NCT03255187|454554057|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
126343341|NCT03255187|454554058|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
126343342|NCT02034006|454554059|FG000|Overall Study|Withdrawal by Subject|7|||
126343343|NCT02034006|454554059|FG000|Overall Study|Lost to Follow-up|5|||
126343344|NCT02034006|454554059|FG000|Overall Study|Death|1|||
126343345|NCT02034006|454554059|FG000|Overall Study|Pregnancy|1|||
126343346|NCT00109343|454554060|FG000|Overall Study|Adverse Event|1|||
126343347|NCT00109343|454554061|FG001|Overall Study|Adverse Event|0|||
126343348|NCT00109343|454554062|FG002|Overall Study|Adverse Event|2|||
126343349|NCT00109343|454554060|FG000|Overall Study|Lack of Efficacy|1|||
126343350|NCT00109343|454554061|FG001|Overall Study|Lack of Efficacy|0|||
126343351|NCT00109343|454554062|FG002|Overall Study|Lack of Efficacy|0|||
126343352|NCT00109343|454554060|FG000|Overall Study|Lost to Follow-up|35|||
126343353|NCT00109343|454554061|FG001|Overall Study|Lost to Follow-up|20|||
126343354|NCT00109343|454554062|FG002|Overall Study|Lost to Follow-up|14|||
126343355|NCT00109343|454554060|FG000|Overall Study|Protocol Violation|1|||
126343356|NCT00109343|454554061|FG001|Overall Study|Protocol Violation|2|||
126343357|NCT00109343|454554062|FG002|Overall Study|Protocol Violation|2|||
126343358|NCT00109343|454554060|FG000|Overall Study|Withdrawal by Subject|15|||
126343359|NCT00109343|454554061|FG001|Overall Study|Withdrawal by Subject|11|||
126343360|NCT00109343|454554062|FG002|Overall Study|Withdrawal by Subject|10|||
126343361|NCT00109343|454554060|FG000|Overall Study|Subject Moved|6|||
126343362|NCT00109343|454554061|FG001|Overall Study|Subject Moved|2|||
126343363|NCT00109343|454554062|FG002|Overall Study|Subject Moved|1|||
126343364|NCT00109343|454554060|FG000|Overall Study|Other|5|||
126343365|NCT00109343|454554061|FG001|Overall Study|Other|2|||
126343366|NCT00109343|454554062|FG002|Overall Study|Other|1|||
126343367|NCT01799889|454554063|FG000|Overall Study|Adverse Event|4|||
126343368|NCT01799889|454554064|FG001|Overall Study|Adverse Event|4|||
126343369|NCT01799889|454554065|FG002|Overall Study|Adverse Event|5|||
126343370|NCT01799889|454554066|FG003|Overall Study|Adverse Event|1|||
126343371|NCT01799889|454554067|FG004|Overall Study|Adverse Event|11|||
126343372|NCT01799889|454554068|FG005|Overall Study|Adverse Event|1|||
126343373|NCT01799889|454554069|FG006|Overall Study|Adverse Event|5|||
126343374|NCT01799889|454554070|FG007|Overall Study|Adverse Event|2|||
126343375|NCT01799889|454554071|FG008|Overall Study|Adverse Event|3|||
126343376|NCT01799889|454554072|FG009|Overall Study|Adverse Event|1|||
126343377|NCT01799889|454554073|FG010|Overall Study|Adverse Event|1|||
126009953|NCT01956669|453329456|FG005|Overall Study|Physician Decision|1|||
126009954|NCT01956669|453329457|FG006|Overall Study|Physician Decision|0|||
126009955|NCT01956669|453329451|FG000|Overall Study|Withdrawal by Subject|0|||
126009956|NCT01956669|453329452|FG001|Overall Study|Withdrawal by Subject|0|||
126009957|NCT01956669|453329453|FG002|Overall Study|Withdrawal by Subject|1|||
126046463|NCT02467270|453468228|FG002|Overall Study|Lack of Efficacy|23|||
126343378|NCT01799889|454554074|FG011|Overall Study|Adverse Event|0|||
126343379|NCT01799889|454554063|FG000|Overall Study|Death|1|||
126343380|NCT01799889|454554064|FG001|Overall Study|Death|0|||
126343381|NCT01799889|454554065|FG002|Overall Study|Death|5|||
126343382|NCT01799889|454554066|FG003|Overall Study|Death|3|||
126343383|NCT01799889|454554067|FG004|Overall Study|Death|1|||
126343384|NCT01799889|454554068|FG005|Overall Study|Death|0|||
126009958|NCT01956669|453329454|FG003|Overall Study|Withdrawal by Subject|1|||
126009959|NCT01956669|453329455|FG004|Overall Study|Withdrawal by Subject|0|||
126009960|NCT01956669|453329456|FG005|Overall Study|Withdrawal by Subject|0|||
126009961|NCT01956669|453329457|FG006|Overall Study|Withdrawal by Subject|1|||
126009962|NCT01466881|453329458|FG000|Overall Study|Ineligible|5|||
126009963|NCT01466881|453329458|FG000|Overall Study|Adverse Event|6|||
126343385|NCT01799889|454554069|FG006|Overall Study|Death|0|||
126343386|NCT01799889|454554070|FG007|Overall Study|Death|0|||
126343387|NCT01799889|454554071|FG008|Overall Study|Death|1|||
126343388|NCT01799889|454554072|FG009|Overall Study|Death|0|||
126343389|NCT01799889|454554073|FG010|Overall Study|Death|1|||
126343390|NCT01799889|454554074|FG011|Overall Study|Death|0|||
126343391|NCT01799889|454554063|FG000|Overall Study|Lack of Efficacy|1|||
126343392|NCT01799889|454554064|FG001|Overall Study|Lack of Efficacy|1|||
126343393|NCT01799889|454554065|FG002|Overall Study|Lack of Efficacy|0|||
126343394|NCT01799889|454554066|FG003|Overall Study|Lack of Efficacy|1|||
126343395|NCT01799889|454554067|FG004|Overall Study|Lack of Efficacy|2|||
126343396|NCT01799889|454554068|FG005|Overall Study|Lack of Efficacy|2|||
126343397|NCT01799889|454554069|FG006|Overall Study|Lack of Efficacy|0|||
126343398|NCT01799889|454554070|FG007|Overall Study|Lack of Efficacy|0|||
126343399|NCT01799889|454554071|FG008|Overall Study|Lack of Efficacy|2|||
126343400|NCT01799889|454554072|FG009|Overall Study|Lack of Efficacy|0|||
126343401|NCT01799889|454554073|FG010|Overall Study|Lack of Efficacy|1|||
126343402|NCT01799889|454554074|FG011|Overall Study|Lack of Efficacy|0|||
126343403|NCT01799889|454554063|FG000|Overall Study|Lost to Follow-up|0|||
126343404|NCT01799889|454554064|FG001|Overall Study|Lost to Follow-up|1|||
126343405|NCT01799889|454554065|FG002|Overall Study|Lost to Follow-up|0|||
126343406|NCT01799889|454554066|FG003|Overall Study|Lost to Follow-up|0|||
126343407|NCT01799889|454554067|FG004|Overall Study|Lost to Follow-up|0|||
126343408|NCT01799889|454554068|FG005|Overall Study|Lost to Follow-up|0|||
126343409|NCT01799889|454554069|FG006|Overall Study|Lost to Follow-up|0|||
126343410|NCT01799889|454554070|FG007|Overall Study|Lost to Follow-up|0|||
126343411|NCT01799889|454554071|FG008|Overall Study|Lost to Follow-up|0|||
126343412|NCT01799889|454554072|FG009|Overall Study|Lost to Follow-up|0|||
126343413|NCT01799889|454554073|FG010|Overall Study|Lost to Follow-up|0|||
126343414|NCT01799889|454554074|FG011|Overall Study|Lost to Follow-up|0|||
126343415|NCT01799889|454554063|FG000|Overall Study|Physician Decision|3|||
126343416|NCT01799889|454554064|FG001|Overall Study|Physician Decision|2|||
126343417|NCT01799889|454554065|FG002|Overall Study|Physician Decision|4|||
126343418|NCT01799889|454554066|FG003|Overall Study|Physician Decision|4|||
126343419|NCT01799889|454554067|FG004|Overall Study|Physician Decision|5|||
126343420|NCT01799889|454554068|FG005|Overall Study|Physician Decision|5|||
126343421|NCT01799889|454554069|FG006|Overall Study|Physician Decision|5|||
126343422|NCT01799889|454554070|FG007|Overall Study|Physician Decision|2|||
126343423|NCT01799889|454554071|FG008|Overall Study|Physician Decision|6|||
126343424|NCT01799889|454554072|FG009|Overall Study|Physician Decision|0|||
126343425|NCT01799889|454554073|FG010|Overall Study|Physician Decision|0|||
126343426|NCT01799889|454554074|FG011|Overall Study|Physician Decision|1|||
126343427|NCT01799889|454554063|FG000|Overall Study|Progressive Disease|30|||
126343428|NCT01799889|454554064|FG001|Overall Study|Progressive Disease|26|||
126343429|NCT01799889|454554065|FG002|Overall Study|Progressive Disease|25|||
126343430|NCT01799889|454554066|FG003|Overall Study|Progressive Disease|30|||
126343431|NCT01799889|454554067|FG004|Overall Study|Progressive Disease|23|||
126343432|NCT01799889|454554068|FG005|Overall Study|Progressive Disease|9|||
126343433|NCT01799889|454554069|FG006|Overall Study|Progressive Disease|8|||
126343434|NCT01799889|454554070|FG007|Overall Study|Progressive Disease|13|||
126343435|NCT01799889|454554071|FG008|Overall Study|Progressive Disease|18|||
126343436|NCT01799889|454554072|FG009|Overall Study|Progressive Disease|5|||
126343437|NCT01799889|454554073|FG010|Overall Study|Progressive Disease|3|||
126343438|NCT01799889|454554074|FG011|Overall Study|Progressive Disease|1|||
126343439|NCT01799889|454554063|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
126343440|NCT01799889|454554064|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
126343441|NCT01799889|454554065|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
126343442|NCT01799889|454554066|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
126343443|NCT01799889|454554067|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
126343444|NCT01799889|454554068|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
126343445|NCT01799889|454554069|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
126343446|NCT01799889|454554070|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
126343447|NCT01799889|454554071|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
126343448|NCT01799889|454554072|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
126343449|NCT01799889|454554073|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
126343450|NCT01799889|454554074|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
126343451|NCT01799889|454554063|FG000|Overall Study|Study Terminated By Sponsor|1|||
126343452|NCT01799889|454554064|FG001|Overall Study|Study Terminated By Sponsor|0|||
126343453|NCT01799889|454554065|FG002|Overall Study|Study Terminated By Sponsor|0|||
126343454|NCT01799889|454554066|FG003|Overall Study|Study Terminated By Sponsor|0|||
126343455|NCT01799889|454554067|FG004|Overall Study|Study Terminated By Sponsor|2|||
126343456|NCT01799889|454554068|FG005|Overall Study|Study Terminated By Sponsor|1|||
126343457|NCT01799889|454554069|FG006|Overall Study|Study Terminated By Sponsor|0|||
126343458|NCT01799889|454554070|FG007|Overall Study|Study Terminated By Sponsor|2|||
126343459|NCT01799889|454554071|FG008|Overall Study|Study Terminated By Sponsor|1|||
126343460|NCT01799889|454554072|FG009|Overall Study|Study Terminated By Sponsor|1|||
126343461|NCT01799889|454554073|FG010|Overall Study|Study Terminated By Sponsor|0|||
126343462|NCT01799889|454554074|FG011|Overall Study|Study Terminated By Sponsor|0|||
126343463|NCT01799889|454554063|FG000|Overall Study|Withdrawal by Subject|1|||
126009964|NCT01466881|453329458|FG000|Overall Study|Progression/relapse|20|||
126009965|NCT01466881|453329458|FG000|Overall Study|Death|4|||
126009966|NCT01466881|453329458|FG000|Overall Study|Other reason not protocol specified|5|||
126009967|NCT02299635|453329459|FG000|Overall Study|Adverse Event|2|||
126009968|NCT02299635|453329459|FG000|Overall Study|Death|1|||
126009969|NCT02299635|453329459|FG000|Overall Study|Global deterioration of health status|1|||
126009970|NCT02299635|453329459|FG000|Overall Study|Objective progression or relapse|10|||
126009971|NCT02299635|453329459|FG000|Overall Study|Withdrawal by Subject|2|||
126009972|NCT02299635|453329459|FG000|Overall Study|Other|3|||
126009973|NCT00828672|453329460|FG000|Study Treatment|Lost to Follow-up|1|||
126009974|NCT00828672|453329461|FG001|Study Treatment|Lost to Follow-up|0|||
126009975|NCT00828672|453329460|FG000|Study Treatment|Adverse Event|0|||
126009976|NCT00828672|453329461|FG001|Study Treatment|Adverse Event|1|||
126009977|NCT00828672|453329460|FG000|Study Treatment|Complete response, no surgery|1|||
126009978|NCT00828672|453329461|FG001|Study Treatment|Complete response, no surgery|1|||
126009979|NCT00828672|453329460|FG000|Post-surgery (<30 Days)|No central review materials|0|||
126009980|NCT00828672|453329461|FG001|Post-surgery (<30 Days)|No central review materials|1|||
126009981|NCT00831792|453329468|FG000|Overall Study|Not Eligible|3|||
126009982|NCT00831792|453329468|FG000|Overall Study|Adverse Event|1|||
126343464|NCT01799889|454554064|FG001|Overall Study|Withdrawal by Subject|6|||
126343465|NCT01799889|454554065|FG002|Overall Study|Withdrawal by Subject|4|||
126343466|NCT01799889|454554066|FG003|Overall Study|Withdrawal by Subject|0|||
126343467|NCT01799889|454554067|FG004|Overall Study|Withdrawal by Subject|5|||
126343468|NCT01799889|454554068|FG005|Overall Study|Withdrawal by Subject|1|||
126343469|NCT01799889|454554069|FG006|Overall Study|Withdrawal by Subject|3|||
126343470|NCT01799889|454554070|FG007|Overall Study|Withdrawal by Subject|1|||
126343471|NCT01799889|454554071|FG008|Overall Study|Withdrawal by Subject|2|||
126343472|NCT01799889|454554072|FG009|Overall Study|Withdrawal by Subject|1|||
126343473|NCT01799889|454554073|FG010|Overall Study|Withdrawal by Subject|1|||
126343474|NCT01799889|454554074|FG011|Overall Study|Withdrawal by Subject|1|||
126343475|NCT01799889|454554063|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126343476|NCT01799889|454554064|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126343477|NCT01799889|454554065|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126343478|NCT01799889|454554066|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126343479|NCT01799889|454554067|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126343480|NCT01799889|454554068|FG005|Overall Study|Non-Compliance With Study Drug|1|||
126343481|NCT01799889|454554069|FG006|Overall Study|Non-Compliance With Study Drug|0|||
126343482|NCT01799889|454554070|FG007|Overall Study|Non-Compliance With Study Drug|0|||
126343483|NCT01799889|454554071|FG008|Overall Study|Non-Compliance With Study Drug|0|||
126343484|NCT01799889|454554072|FG009|Overall Study|Non-Compliance With Study Drug|0|||
126343485|NCT01799889|454554073|FG010|Overall Study|Non-Compliance With Study Drug|0|||
126343486|NCT01799889|454554074|FG011|Overall Study|Non-Compliance With Study Drug|0|||
126343487|NCT00750269|454554075|FG000|Overall Study|Protocol Violation|0|||
126343488|NCT00750269|454554076|FG001|Overall Study|Protocol Violation|1|||
126343489|NCT00750269|454554077|FG002|Overall Study|Protocol Violation|1|||
126343490|NCT00750269|454554078|FG003|Overall Study|Protocol Violation|2|||
126343491|NCT00750269|454554079|FG004|Overall Study|Protocol Violation|4|||
126343492|NCT00750269|454554075|FG000|Overall Study|Withdrawal by Subject|0|||
126343493|NCT00750269|454554076|FG001|Overall Study|Withdrawal by Subject|0|||
126343494|NCT00750269|454554077|FG002|Overall Study|Withdrawal by Subject|2|||
126343495|NCT00750269|454554078|FG003|Overall Study|Withdrawal by Subject|2|||
126343496|NCT00750269|454554079|FG004|Overall Study|Withdrawal by Subject|2|||
126343497|NCT00750269|454554075|FG000|Overall Study|Physician Decision|0|||
126343498|NCT00750269|454554076|FG001|Overall Study|Physician Decision|0|||
126343499|NCT00750269|454554077|FG002|Overall Study|Physician Decision|0|||
126343500|NCT00750269|454554078|FG003|Overall Study|Physician Decision|0|||
126343501|NCT00750269|454554079|FG004|Overall Study|Physician Decision|2|||
126343502|NCT00750269|454554075|FG000|Overall Study|Patient too large for positioning|0|||
126343503|NCT00750269|454554076|FG001|Overall Study|Patient too large for positioning|0|||
126343504|NCT00750269|454554077|FG002|Overall Study|Patient too large for positioning|1|||
126343505|NCT00750269|454554078|FG003|Overall Study|Patient too large for positioning|0|||
126343506|NCT00750269|454554079|FG004|Overall Study|Patient too large for positioning|0|||
126343507|NCT00750269|454554075|FG000|Overall Study|Site error|0|||
126343508|NCT00750269|454554076|FG001|Overall Study|Site error|0|||
126343509|NCT00750269|454554077|FG002|Overall Study|Site error|0|||
126343510|NCT00750269|454554078|FG003|Overall Study|Site error|1|||
126343511|NCT00750269|454554079|FG004|Overall Study|Site error|0|||
126343512|NCT00750269|454554075|FG000|Overall Study|SBRT plan could not be drawn|0|||
126343513|NCT00750269|454554076|FG001|Overall Study|SBRT plan could not be drawn|0|||
126343514|NCT00750269|454554077|FG002|Overall Study|SBRT plan could not be drawn|0|||
126343515|NCT00750269|454554078|FG003|Overall Study|SBRT plan could not be drawn|0|||
126343516|NCT00750269|454554079|FG004|Overall Study|SBRT plan could not be drawn|1|||
126343517|NCT00750269|454554075|FG000|Overall Study|Fiducials could not be placed|0|||
126343518|NCT00750269|454554076|FG001|Overall Study|Fiducials could not be placed|0|||
126343519|NCT00750269|454554077|FG002|Overall Study|Fiducials could not be placed|0|||
126343520|NCT00750269|454554078|FG003|Overall Study|Fiducials could not be placed|0|||
126009983|NCT00831792|453329468|FG000|Overall Study|Death|1|||
126343521|NCT00750269|454554079|FG004|Overall Study|Fiducials could not be placed|1|||
126343522|NCT03944616|454554080|FG000|Overall Study|Lost to Follow-up|0|||
126343523|NCT03944616|454554081|FG001|Overall Study|Lost to Follow-up|2|||
126343524|NCT01721798|454554082|FG000|Overall Study|Death|0|||
126343525|NCT01721798|454554083|FG001|Overall Study|Death|0|||
126343526|NCT01721798|454554084|FG002|Overall Study|Death|1|||
126343527|NCT01721798|454554085|FG003|Overall Study|Death|1|||
126009984|NCT00831792|453329468|FG000|Overall Study|Lack of Efficacy|1|||
126009985|NCT02469064|453329476|FG000|Overall Study|Request not to receive intervention.|1|||
126009986|NCT02469064|453329477|FG001|Overall Study|Request not to receive intervention.|3|||
126009987|NCT02155829|453329478|FG000|Overall Study|Adverse Event|1|||
126009988|NCT02155829|453329479|FG001|Overall Study|Adverse Event|0|||
126009989|NCT02155829|453329478|FG000|Overall Study|Withdrawal by Subject|3|||
126009990|NCT02155829|453329479|FG001|Overall Study|Withdrawal by Subject|3|||
126009991|NCT02155829|453329478|FG000|Overall Study|Protocol Violation|2|||
126009992|NCT02155829|453329479|FG001|Overall Study|Protocol Violation|0|||
126009993|NCT00678795|453329480|FG000|Overall Study|Adverse Event|7|||
126009994|NCT00678795|453329481|FG001|Overall Study|Adverse Event|3|||
126009995|NCT00678795|453329480|FG000|Overall Study|Withdrawal by Subject|3|||
126009996|NCT00678795|453329481|FG001|Overall Study|Withdrawal by Subject|0|||
126009997|NCT00678795|453329480|FG000|Overall Study|Protocol Violation|0|||
126009998|NCT00678795|453329481|FG001|Overall Study|Protocol Violation|1|||
126009999|NCT00678795|453329480|FG000|Overall Study|Lost to Follow-up|0|||
126010000|NCT00678795|453329481|FG001|Overall Study|Lost to Follow-up|1|||
126010001|NCT00678795|453329480|FG000|Overall Study|Lack of Efficacy|1|||
126010002|NCT00678795|453329481|FG001|Overall Study|Lack of Efficacy|1|||
126010003|NCT02750709|453329482|FG000|Treatment Period 1|Adverse Event|0|||
126010004|NCT02750709|453329483|FG001|Treatment Period 1|Adverse Event|0|||
126010005|NCT02750709|453329484|FG002|Treatment Period 1|Adverse Event|0|||
126010006|NCT02750709|453329485|FG003|Treatment Period 1|Adverse Event|0|||
126010007|NCT02750709|453329486|FG004|Treatment Period 1|Adverse Event|0|||
126010008|NCT02750709|453329487|FG005|Treatment Period 1|Adverse Event|1|||
126010009|NCT00404079|453329488|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
126010010|NCT00404079|453329489|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
126010011|NCT01120275|453329490|FG000|Overall Study|Adverse Event|3|||
126010012|NCT01120275|453329490|FG000|Overall Study|Progression|27|||
126010013|NCT01120275|453329490|FG000|Overall Study|Ineligible|3|||
126010014|NCT01120275|453329490|FG000|Overall Study|Withdrawal by Subject|1|||
126010015|NCT01120275|453329490|FG000|Overall Study|Refusal|1|||
126010016|NCT01120275|453329490|FG000|Overall Study|Not specific|1|||
126010017|NCT00290732|453329491|FG000|Overall Study|Inability to instill drug intraductally.|0|||
126010018|NCT00290732|453329492|FG001|Overall Study|Inability to instill drug intraductally.|1|||
126010019|NCT00290732|453329493|FG002|Overall Study|Inability to instill drug intraductally.|1|||
126010020|NCT00290732|453329494|FG003|Overall Study|Inability to instill drug intraductally.|0|||
126010021|NCT00290732|453329495|FG004|Overall Study|Inability to instill drug intraductally.|0|||
126010022|NCT02595398|453329496|FG000|Overall Study|Non-compliance|1|||
126010023|NCT02595398|453329497|FG001|Overall Study|Non-compliance|0|||
126010024|NCT02595398|453329496|FG000|Overall Study|Withdrawal by Subject|2|||
126010025|NCT02595398|453329497|FG001|Overall Study|Withdrawal by Subject|1|||
126010026|NCT02595398|453329496|FG000|Overall Study|Lost to Follow-up|1|||
126010027|NCT02595398|453329497|FG001|Overall Study|Lost to Follow-up|0|||
126010028|NCT00542386|453329498|FG000|Overall Study|Adverse Event|1|||
126010029|NCT00542386|453329499|FG001|Overall Study|Adverse Event|7|||
126010030|NCT00542386|453329500|FG002|Overall Study|Adverse Event|7|||
126010031|NCT00542386|453329501|FG003|Overall Study|Adverse Event|8|||
126010032|NCT00542386|453329502|FG004|Overall Study|Adverse Event|13|||
126010033|NCT00542386|453329503|FG005|Overall Study|Adverse Event|4|||
126010034|NCT00542386|453329498|FG000|Overall Study|Death|0|||
126010035|NCT00542386|453329499|FG001|Overall Study|Death|0|||
126010036|NCT00542386|453329500|FG002|Overall Study|Death|1|||
126010037|NCT00542386|453329501|FG003|Overall Study|Death|2|||
126010038|NCT00542386|453329502|FG004|Overall Study|Death|1|||
126010039|NCT00542386|453329503|FG005|Overall Study|Death|2|||
126010040|NCT00542386|453329498|FG000|Overall Study|Lack of Efficacy|32|||
126010041|NCT00542386|453329499|FG001|Overall Study|Lack of Efficacy|12|||
126010042|NCT00542386|453329500|FG002|Overall Study|Lack of Efficacy|10|||
126010043|NCT00542386|453329501|FG003|Overall Study|Lack of Efficacy|13|||
126010044|NCT00542386|453329502|FG004|Overall Study|Lack of Efficacy|7|||
126010045|NCT00542386|453329503|FG005|Overall Study|Lack of Efficacy|31|||
126010046|NCT00542386|453329498|FG000|Overall Study|Physician Decision|1|||
126010047|NCT00542386|453329499|FG001|Overall Study|Physician Decision|0|||
126010048|NCT00542386|453329500|FG002|Overall Study|Physician Decision|0|||
126010049|NCT00542386|453329501|FG003|Overall Study|Physician Decision|1|||
126010050|NCT00542386|453329502|FG004|Overall Study|Physician Decision|0|||
126010051|NCT00542386|453329503|FG005|Overall Study|Physician Decision|0|||
126010052|NCT00542386|453329498|FG000|Overall Study|Protocol Violation|0|||
126010053|NCT00542386|453329499|FG001|Overall Study|Protocol Violation|0|||
126010054|NCT00542386|453329500|FG002|Overall Study|Protocol Violation|1|||
126010055|NCT00542386|453329501|FG003|Overall Study|Protocol Violation|0|||
126010056|NCT00542386|453329502|FG004|Overall Study|Protocol Violation|0|||
126010057|NCT00542386|453329503|FG005|Overall Study|Protocol Violation|4|||
126010058|NCT00542386|453329498|FG000|Overall Study|Withdrawal by Subject|5|||
126010059|NCT00542386|453329499|FG001|Overall Study|Withdrawal by Subject|8|||
126010060|NCT00542386|453329500|FG002|Overall Study|Withdrawal by Subject|10|||
126010061|NCT00542386|453329501|FG003|Overall Study|Withdrawal by Subject|11|||
126010062|NCT00542386|453329502|FG004|Overall Study|Withdrawal by Subject|15|||
126010063|NCT00542386|453329503|FG005|Overall Study|Withdrawal by Subject|7|||
126010064|NCT00542386|453329498|FG000|Overall Study|Other Reasons|4|||
126343528|NCT01721798|454554082|FG000|Overall Study|Lost to Follow-up|2|||
126343529|NCT01721798|454554083|FG001|Overall Study|Lost to Follow-up|2|||
126343530|NCT01721798|454554084|FG002|Overall Study|Lost to Follow-up|9|||
126343531|NCT01721798|454554085|FG003|Overall Study|Lost to Follow-up|9|||
126343532|NCT01721798|454554082|FG000|Overall Study|Pregnancy|0|||
126343533|NCT01721798|454554083|FG001|Overall Study|Pregnancy|0|||
126343534|NCT01721798|454554084|FG002|Overall Study|Pregnancy|1|||
126343535|NCT01721798|454554085|FG003|Overall Study|Pregnancy|1|||
126343536|NCT01721798|454554082|FG000|Overall Study|Withdrawal by Subject|1|||
126343537|NCT01721798|454554083|FG001|Overall Study|Withdrawal by Subject|0|||
126343538|NCT01721798|454554084|FG002|Overall Study|Withdrawal by Subject|2|||
126343539|NCT01721798|454554085|FG003|Overall Study|Withdrawal by Subject|1|||
126343540|NCT01721798|454554082|FG000|Overall Study|Not eligible for 24 month visit|1|||
126343541|NCT01721798|454554083|FG001|Overall Study|Not eligible for 24 month visit|0|||
126343542|NCT01721798|454554084|FG002|Overall Study|Not eligible for 24 month visit|8|||
126343543|NCT01721798|454554085|FG003|Overall Study|Not eligible for 24 month visit|7|||
126343544|NCT01294046|454554086|FG000|Overall Study|Infection and surgical explant|1|||
126343545|NCT01294046|454554086|FG000|Overall Study|Eligibility criteria expanded|1|||
126343546|NCT01294046|454554086|FG000|Overall Study|Stimulation response inadqequate|1|||
126343547|NCT00577408|454554089|FG000|Overall Study|Stopped attending study visits|9|||
126343548|NCT00577408|454554090|FG001|Overall Study|Stopped attending study visits|11|||
126343549|NCT00577408|454554089|FG000|Overall Study|Continued opioid use|3|||
126343550|NCT00577408|454554090|FG001|Overall Study|Continued opioid use|2|||
126343551|NCT00577408|454554089|FG000|Overall Study|Non-compliance with study meds|0|||
126343552|NCT00577408|454554090|FG001|Overall Study|Non-compliance with study meds|3|||
126343553|NCT00577408|454554089|FG000|Overall Study|Refused Oral Naltrexone|0|||
126343554|NCT00577408|454554090|FG001|Overall Study|Refused Oral Naltrexone|1|||
126343555|NCT00577408|454554089|FG000|Overall Study|Moved out of state|0|||
126343556|NCT00577408|454554090|FG001|Overall Study|Moved out of state|1|||
126343557|NCT00577408|454554089|FG000|Overall Study|Scheduling Issues|0|||
126343558|NCT00577408|454554090|FG001|Overall Study|Scheduling Issues|3|||
126343559|NCT00577408|454554089|FG000|Overall Study|Death|0|||
126343560|NCT00577408|454554090|FG001|Overall Study|Death|1|||
126343561|NCT00577408|454554089|FG000|Overall Study|Psychiatric hospitalization|0|||
126343562|NCT00577408|454554090|FG001|Overall Study|Psychiatric hospitalization|1|||
126343563|NCT00656617|454554091|FG000|Overall Study|Adverse Event|1|||
126343564|NCT00656617|454554091|FG000|Overall Study|Death|2|||
126343565|NCT00656617|454554091|FG000|Overall Study|Insurance Issues|2|||
126343566|NCT00656617|454554091|FG000|Overall Study|Move to different clinical trial|2|||
126343567|NCT02349386|454554101|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
126343568|NCT02349386|454554102|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
126343569|NCT02349386|454554103|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
126343570|NCT02349386|454554104|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
126343571|NCT02349386|454554101|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
126343572|NCT02349386|454554102|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
126343573|NCT02349386|454554103|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
126343574|NCT02349386|454554104|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
126343575|NCT02349386|454554101|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
126343576|NCT02349386|454554102|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
126343577|NCT02349386|454554103|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
126343578|NCT02349386|454554104|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
126343579|NCT02349386|454554101|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
126343580|NCT02349386|454554102|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
126343581|NCT02349386|454554103|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
126343582|NCT02349386|454554104|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
126343583|NCT02349386|454554101|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
126343584|NCT02349386|454554102|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
126343585|NCT02349386|454554103|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
126343586|NCT02349386|454554104|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
126343587|NCT02349386|454554101|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
126343588|NCT02349386|454554102|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
126343589|NCT02349386|454554103|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
126343590|NCT02349386|454554104|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
126343591|NCT00091819|454554105|FG000|Overall Study|Adverse Event|1|||
126343592|NCT00091819|454554106|FG001|Overall Study|Adverse Event|1|||
126010065|NCT00542386|453329499|FG001|Overall Study|Other Reasons|1|||
126010066|NCT00542386|453329500|FG002|Overall Study|Other Reasons|4|||
126010067|NCT00542386|453329501|FG003|Overall Study|Other Reasons|3|||
126010068|NCT00542386|453329502|FG004|Overall Study|Other Reasons|4|||
126010069|NCT00542386|453329503|FG005|Overall Study|Other Reasons|2|||
126010070|NCT00197015|453329504|FG000|Overall Study|Adverse Event|3|||
126010071|NCT00197015|453329505|FG001|Overall Study|Adverse Event|0|||
126010072|NCT00197015|453329506|FG002|Overall Study|Adverse Event|1|||
126343593|NCT00091819|454554105|FG000|Overall Study|Death|4|||
126343594|NCT00091819|454554106|FG001|Overall Study|Death|5|||
126343595|NCT00091819|454554105|FG000|Overall Study|Lost to Follow-up|26|||
126343596|NCT00091819|454554106|FG001|Overall Study|Lost to Follow-up|23|||
126343597|NCT00091819|454554105|FG000|Overall Study|Withdrawal by Subject|5|||
126343598|NCT00091819|454554106|FG001|Overall Study|Withdrawal by Subject|8|||
126343599|NCT00091819|454554105|FG000|Overall Study|Protocol Violation|1|||
126343600|NCT00091819|454554106|FG001|Overall Study|Protocol Violation|2|||
126343601|NCT00091819|454554105|FG000|Overall Study|Other|2|||
126343602|NCT00091819|454554106|FG001|Overall Study|Other|3|||
126343603|NCT00091819|454554105|FG000|Overall Study|Never received study treatment|3|||
126343604|NCT00091819|454554106|FG001|Overall Study|Never received study treatment|4|||
126343605|NCT00961415|454554107|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
126343606|NCT00961415|454554108|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
126343607|NCT00961415|454554109|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
126343608|NCT00961415|454554107|FG000|Induction Treatment Phase|Death|77|||
126343609|NCT00961415|454554108|FG001|Induction Treatment Phase|Death|0|||
126343610|NCT00961415|454554109|FG002|Induction Treatment Phase|Death|0|||
126343611|NCT00961415|454554107|FG000|Induction Treatment Phase|Protocol Violation|1|||
126343612|NCT00961415|454554108|FG001|Induction Treatment Phase|Protocol Violation|0|||
126343613|NCT00961415|454554109|FG002|Induction Treatment Phase|Protocol Violation|0|||
126343614|NCT00961415|454554107|FG000|Induction Treatment Phase|Physician Decision|2|||
126343615|NCT00961415|454554108|FG001|Induction Treatment Phase|Physician Decision|0|||
126343616|NCT00961415|454554109|FG002|Induction Treatment Phase|Physician Decision|0|||
126343617|NCT00961415|454554107|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
126343618|NCT00961415|454554108|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
126343619|NCT00961415|454554109|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
126343620|NCT00961415|454554107|FG000|Induction Treatment Phase|Other Reason|5|||
126343621|NCT00961415|454554108|FG001|Induction Treatment Phase|Other Reason|0|||
126343622|NCT00961415|454554109|FG002|Induction Treatment Phase|Other Reason|0|||
126343623|NCT00961415|454554107|FG000|Maintenance Treatment Phase|Death|0|||
126343624|NCT00961415|454554108|FG001|Maintenance Treatment Phase|Death|42|||
126343625|NCT00961415|454554109|FG002|Maintenance Treatment Phase|Death|34|||
126343626|NCT00961415|454554107|FG000|Maintenance Treatment Phase|Investigators decision|0|||
126343627|NCT00961415|454554108|FG001|Maintenance Treatment Phase|Investigators decision|2|||
126343628|NCT00961415|454554109|FG002|Maintenance Treatment Phase|Investigators decision|0|||
126343629|NCT00961415|454554107|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126343630|NCT00961415|454554108|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
126343631|NCT00961415|454554109|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
126343632|NCT00961415|454554107|FG000|Maintenance Treatment Phase|Other reason|0|||
126343633|NCT00961415|454554108|FG001|Maintenance Treatment Phase|Other reason|1|||
126343634|NCT00961415|454554109|FG002|Maintenance Treatment Phase|Other reason|3|||
126343635|NCT04759131|454554113|FG000|Overall Study|Investigator's discretion|1|||
126343636|NCT04759131|454554114|FG001|Overall Study|Investigator's discretion|0|||
126343637|NCT04759131|454554113|FG000|Overall Study|Subject withdrawal|1|||
126343638|NCT04759131|454554114|FG001|Overall Study|Subject withdrawal|0|||
126343639|NCT05144945|454554115|FG000|Overall Study|Withdrawal by Subject|1|||
126010073|NCT00197015|453329504|FG000|Overall Study|Protocol Violation|0|||
126010074|NCT00197015|453329505|FG001|Overall Study|Protocol Violation|3|||
126010075|NCT00197015|453329506|FG002|Overall Study|Protocol Violation|3|||
126343640|NCT05144945|454554116|FG001|Overall Study|Withdrawal by Subject|0|||
126343641|NCT03692949|454554117|FG000|Overall Study|Lost to Follow-up|0|||
126343642|NCT03692949|454554118|FG001|Overall Study|Lost to Follow-up|0|||
126343643|NCT03692949|454554119|FG002|Overall Study|Lost to Follow-up|0|||
126343644|NCT03692949|454554120|FG003|Overall Study|Lost to Follow-up|0|||
126343645|NCT03692949|454554121|FG004|Overall Study|Lost to Follow-up|0|||
126010076|NCT00197015|453329504|FG000|Overall Study|Withdrawal by Subject|17|||
126010077|NCT00197015|453329505|FG001|Overall Study|Withdrawal by Subject|37|||
126010078|NCT00197015|453329506|FG002|Overall Study|Withdrawal by Subject|34|||
126010079|NCT00197015|453329504|FG000|Overall Study|Lost to Follow-up|28|||
126010080|NCT00197015|453329505|FG001|Overall Study|Lost to Follow-up|46|||
126010081|NCT00197015|453329506|FG002|Overall Study|Lost to Follow-up|37|||
126010082|NCT00197015|453329504|FG000|Overall Study|Other|2|||
126010083|NCT00197015|453329505|FG001|Overall Study|Other|3|||
126010084|NCT00197015|453329506|FG002|Overall Study|Other|2|||
126010085|NCT00880906|453329509|FG000|Overall Study|Lost to Follow-up|0|||
126010086|NCT00880906|453329510|FG001|Overall Study|Lost to Follow-up|1|||
126010087|NCT00880906|453329509|FG000|Overall Study|Did not meet criteria following patholog|12|||
126010088|NCT00880906|453329510|FG001|Overall Study|Did not meet criteria following patholog|6|||
126010089|NCT00559949|453329519|FG000|Overall Study|Progressive Disease during cycle 1|1|||
126010090|NCT00559949|453329519|FG000|Overall Study|Adverse Event|1|||
126010091|NCT00559949|453329519|FG000|Overall Study|Withdrawal by Subject|4|||
126010092|NCT00559949|453329519|FG000|Overall Study|No disease evaluation per protocol|1|||
126010093|NCT00414648|453329520|FG000|Overall Study|Adverse Event|5|||
126010094|NCT00414648|453329521|FG001|Overall Study|Adverse Event|5|||
126010095|NCT00414648|453329520|FG000|Overall Study|Death|0|||
126010096|NCT00414648|453329521|FG001|Overall Study|Death|1|||
126010097|NCT00414648|453329520|FG000|Overall Study|Lack of Efficacy|0|||
126010098|NCT00414648|453329521|FG001|Overall Study|Lack of Efficacy|2|||
126010099|NCT00414648|453329520|FG000|Overall Study|Withdrawal by Subject|0|||
126010100|NCT00414648|453329521|FG001|Overall Study|Withdrawal by Subject|1|||
126010101|NCT04173572|453329522|FG000|Overall Study|Withdrawal by Subject|1|||
126010102|NCT04173572|453329523|FG001|Overall Study|Withdrawal by Subject|5|||
126010103|NCT04173572|453329522|FG000|Overall Study|Lost to Follow-up|3|||
126010104|NCT04173572|453329523|FG001|Overall Study|Lost to Follow-up|1|||
126010105|NCT03098030|453329524|FG000|Overall Study|Death|10|||
126010106|NCT03098030|453329525|FG001|Overall Study|Death|156|||
126010107|NCT03098030|453329526|FG002|Overall Study|Death|156|||
126010108|NCT03098030|453329527|FG003|Overall Study|Death|82|||
126010109|NCT03098030|453329524|FG000|Overall Study|Withdrawal by Subject|0|||
126010110|NCT03098030|453329525|FG001|Overall Study|Withdrawal by Subject|7|||
126010111|NCT03098030|453329526|FG002|Overall Study|Withdrawal by Subject|8|||
126343646|NCT03692949|454554122|FG005|Overall Study|Lost to Follow-up|0|||
126343647|NCT03692949|454554123|FG006|Overall Study|Lost to Follow-up|0|||
126343648|NCT03692949|454554124|FG007|Overall Study|Lost to Follow-up|1|||
126343649|NCT02592824|454554126|FG000|Overall Study|Protocol Violation|5|||
126343650|NCT02592824|454554127|FG001|Overall Study|Protocol Violation|3|||
126343651|NCT02592824|454554126|FG000|Overall Study|Lost to Follow-up|2|||
126343652|NCT02592824|454554127|FG001|Overall Study|Lost to Follow-up|1|||
126343653|NCT03426878|454554128|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
126343654|NCT03426878|454554128|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
126343655|NCT03426878|454554128|FG000|Overall Study|Declined to receive results|3|||
126343656|NCT03426878|454554128|FG000|Overall Study|Received negative results by mailed letter|65|||
126343657|NCT03426878|454554128|FG000|Overall Study|Lost to Follow-up|177|||
126343658|NCT00560404|454554129|FG000|Overall Study|Adverse Event|2|||
126343659|NCT00560404|454554130|FG001|Overall Study|Adverse Event|3|||
126343660|NCT00560404|454554129|FG000|Overall Study|Death|3|||
126343661|NCT00560404|454554130|FG001|Overall Study|Death|3|||
126343662|NCT00560404|454554129|FG000|Overall Study|Protocol Violation|12|||
126343663|NCT00560404|454554130|FG001|Overall Study|Protocol Violation|7|||
126343664|NCT00560404|454554129|FG000|Overall Study|Administrative Reasons|1|||
126343665|NCT00560404|454554130|FG001|Overall Study|Administrative Reasons|1|||
126343666|NCT00560404|454554129|FG000|Overall Study|Withdrew Consent|4|||
126343667|NCT00560404|454554130|FG001|Overall Study|Withdrew Consent|0|||
126343668|NCT00560404|454554129|FG000|Overall Study|Failure to return|1|||
126343669|NCT00560404|454554130|FG001|Overall Study|Failure to return|2|||
126343670|NCT00560404|454554129|FG000|Overall Study|Other withdrawal reason|13|||
126343671|NCT00560404|454554130|FG001|Overall Study|Other withdrawal reason|5|||
126010112|NCT03098030|453329527|FG003|Overall Study|Withdrawal by Subject|2|||
126010113|NCT03098030|453329524|FG000|Overall Study|Lost to Follow-up|0|||
126010114|NCT03098030|453329525|FG001|Overall Study|Lost to Follow-up|0|||
126010115|NCT03098030|453329526|FG002|Overall Study|Lost to Follow-up|2|||
126010116|NCT03098030|453329527|FG003|Overall Study|Lost to Follow-up|1|||
126010117|NCT03643211|453329528|FG000|Overall Study|Contract violation/deficiency|12|||
126010118|NCT03643211|453329528|FG000|Overall Study|Invalid registration|3|||
126010119|NCT03643211|453329528|FG000|Overall Study|No treatment information|2|||
126010120|NCT03643211|453329528|FG000|Overall Study|No adverse event information - No revisit|4|||
126010121|NCT04858425|453329529|FG000|Overall Study|Adverse Event|2|||
126010122|NCT04858425|453329530|FG001|Overall Study|Adverse Event|2|||
126010123|NCT04858425|453329529|FG000|Overall Study|Withdrawal by Subject|3|||
126010124|NCT04858425|453329530|FG001|Overall Study|Withdrawal by Subject|1|||
126343672|NCT00392223|454554137|FG000|Overall Study|Adverse Event|5|||
126343673|NCT00392223|454554138|FG001|Overall Study|Adverse Event|4|||
126343674|NCT00392223|454554137|FG000|Overall Study|Lost to Follow-up|1|||
126010125|NCT04858425|453329529|FG000|Overall Study|Lost to Follow-up|4|||
126010126|NCT04858425|453329530|FG001|Overall Study|Lost to Follow-up|2|||
126010127|NCT04858425|453329529|FG000|Overall Study|Lost to Follow-up|1|||
126010128|NCT04858425|453329530|FG001|Overall Study|Lost to Follow-up|0|||
126010129|NCT03368001|453329532|FG000|Allocation|Lost to Pretest|16|||
126010130|NCT03368001|453329533|FG001|Allocation|Lost to Pretest|25|||
126010131|NCT03368001|453329532|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
126010132|NCT03368001|453329533|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
126010133|NCT03368001|453329532|FG000|Posttest|Lost to Posttest|7|||
126010134|NCT03368001|453329533|FG001|Posttest|Lost to Posttest|11|||
126343675|NCT00392223|454554138|FG001|Overall Study|Lost to Follow-up|4|||
126343676|NCT00392223|454554137|FG000|Overall Study|Protocol Violation|0|||
126343677|NCT00392223|454554138|FG001|Overall Study|Protocol Violation|3|||
126343678|NCT00392223|454554137|FG000|Overall Study|Withdrawal by Subject|3|||
126343679|NCT00392223|454554138|FG001|Overall Study|Withdrawal by Subject|2|||
126343680|NCT01991795|454554139|FG000|Overall Study|Lost to Follow-up|6|||
126343681|NCT01991795|454554140|FG001|Overall Study|Lost to Follow-up|4|||
126343682|NCT01991795|454554139|FG000|Overall Study|Withdrawal by Subject|117|||
126343683|NCT01991795|454554140|FG001|Overall Study|Withdrawal by Subject|94|||
126343684|NCT01991795|454554139|FG000|Overall Study|Site prematurely closed by sponsor|26|||
126343685|NCT01991795|454554140|FG001|Overall Study|Site prematurely closed by sponsor|25|||
126343686|NCT03104374|454554144|FG000|Period 1|Adverse Event|7|||
126343687|NCT03104374|454554145|FG001|Period 1|Adverse Event|7|||
126343688|NCT03104374|454554146|FG002|Period 1|Adverse Event|12|||
126343689|NCT03104374|454554147|FG003|Period 1|Adverse Event|14|||
126343690|NCT03104374|454554144|FG000|Period 1|Withdrawal by Subject|18|||
126343691|NCT03104374|454554145|FG001|Period 1|Withdrawal by Subject|9|||
126343692|NCT03104374|454554146|FG002|Period 1|Withdrawal by Subject|10|||
126343693|NCT03104374|454554147|FG003|Period 1|Withdrawal by Subject|17|||
126343694|NCT03104374|454554144|FG000|Period 1|Lost to Follow-up|4|||
126343695|NCT03104374|454554145|FG001|Period 1|Lost to Follow-up|4|||
126343696|NCT03104374|454554146|FG002|Period 1|Lost to Follow-up|6|||
126343697|NCT03104374|454554147|FG003|Period 1|Lost to Follow-up|8|||
126343698|NCT03104374|454554144|FG000|Period 1|Lack of Efficacy|6|||
126343699|NCT03104374|454554145|FG001|Period 1|Lack of Efficacy|7|||
126343700|NCT03104374|454554146|FG002|Period 1|Lack of Efficacy|12|||
126343701|NCT03104374|454554147|FG003|Period 1|Lack of Efficacy|6|||
126343702|NCT03104374|454554144|FG000|Period 1|Other|2|||
126343703|NCT03104374|454554145|FG001|Period 1|Other|2|||
126343704|NCT03104374|454554146|FG002|Period 1|Other|4|||
126343705|NCT03104374|454554147|FG003|Period 1|Other|7|||
126343706|NCT03104374|454554144|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
126343707|NCT03104374|454554145|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
126343708|NCT03104374|454554146|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
126343709|NCT03104374|454554147|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
126343710|NCT03104374|454554144|FG000|Period 2|Adverse Event|4|||
126343711|NCT03104374|454554145|FG001|Period 2|Adverse Event|7|||
126343712|NCT03104374|454554146|FG002|Period 2|Adverse Event|10|||
126343713|NCT03104374|454554147|FG003|Period 2|Adverse Event|10|||
126343714|NCT03104374|454554144|FG000|Period 2|Withdrawal by Subject|3|||
126343715|NCT03104374|454554145|FG001|Period 2|Withdrawal by Subject|7|||
126343716|NCT03104374|454554146|FG002|Period 2|Withdrawal by Subject|13|||
126343717|NCT03104374|454554147|FG003|Period 2|Withdrawal by Subject|16|||
126343718|NCT03104374|454554144|FG000|Period 2|Lost to Follow-up|2|||
126343719|NCT03104374|454554145|FG001|Period 2|Lost to Follow-up|2|||
126343720|NCT03104374|454554146|FG002|Period 2|Lost to Follow-up|3|||
126343721|NCT03104374|454554147|FG003|Period 2|Lost to Follow-up|5|||
126343722|NCT03104374|454554144|FG000|Period 2|Lack of Efficacy|2|||
126343723|NCT03104374|454554145|FG001|Period 2|Lack of Efficacy|4|||
126343724|NCT03104374|454554146|FG002|Period 2|Lack of Efficacy|7|||
126343725|NCT03104374|454554147|FG003|Period 2|Lack of Efficacy|4|||
126343726|NCT03104374|454554144|FG000|Period 2|COVID-19 Infection|0|||
126343727|NCT03104374|454554145|FG001|Period 2|COVID-19 Infection|0|||
126343728|NCT03104374|454554146|FG002|Period 2|COVID-19 Infection|1|||
126343729|NCT03104374|454554147|FG003|Period 2|COVID-19 Infection|0|||
126343730|NCT03104374|454554144|FG000|Period 2|Other|3|||
126343731|NCT03104374|454554145|FG001|Period 2|Other|2|||
126343732|NCT03104374|454554146|FG002|Period 2|Other|2|||
126343733|NCT03104374|454554147|FG003|Period 2|Other|4|||
126343734|NCT02121210|454554150|FG000|Overall Study|Adverse Event|5|||
126343735|NCT02121210|454554151|FG001|Overall Study|Adverse Event|7|||
126343736|NCT02121210|454554150|FG000|Overall Study|Lack of Efficacy|2|||
126343737|NCT02121210|454554151|FG001|Overall Study|Lack of Efficacy|0|||
126343738|NCT02121210|454554150|FG000|Overall Study|Other than specified above|0|||
126010135|NCT03368001|453329532|FG000|Posttest|Discontinued Intervention|6|||
126010136|NCT03368001|453329533|FG001|Posttest|Discontinued Intervention|19|||
126010137|NCT03368001|453329532|FG000|Follow-up|Lost to Follow-up|6|||
126343739|NCT02121210|454554151|FG001|Overall Study|Other than specified above|2|||
126343740|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
126010138|NCT03368001|453329533|FG001|Follow-up|Lost to Follow-up|3|||
126010139|NCT02824432|453329534|FG000|Overall Study|Major Protocol Deviation|1|||
126010140|NCT02824432|453329535|FG001|Overall Study|Major Protocol Deviation|0|||
126010141|NCT04436120|453329541|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126010142|NCT04436120|453329542|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126010143|NCT04436120|453329543|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126010144|NCT04436120|453329544|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
126010145|NCT04436120|453329545|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126010146|NCT04436120|453329546|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
126010147|NCT04436120|453329547|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126010148|NCT00604721|453329548|FG000|Overall Study|Physician Decision|1|||
126010149|NCT00604721|453329548|FG000|Overall Study|Withdrawal by Subject|1|||
126010150|NCT02317016|453329549|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
126010151|NCT02317016|453329549|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
126010152|NCT02317016|453329549|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
126010153|NCT02317016|453329549|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
126010154|NCT02317016|453329549|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
126010155|NCT02317016|453329549|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
126010156|NCT02317016|453329549|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
126010157|NCT00536380|453329550|FG000|Overall Study|Adverse Event|0|||
126010158|NCT00536380|453329551|FG001|Overall Study|Adverse Event|2|||
126010159|NCT00536380|453329552|FG002|Overall Study|Adverse Event|2|||
126343741|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
126343742|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343743|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343744|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343745|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343746|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343747|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343748|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343749|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343750|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
126343751|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
126343752|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343753|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343754|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343755|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343756|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343757|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343758|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343759|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343760|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
126343761|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343762|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343763|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343764|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343765|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343766|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343767|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343768|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343769|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343770|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
126343771|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
126343772|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343773|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343774|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343775|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343776|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343777|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343778|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343779|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343780|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
126010160|NCT00536380|453329550|FG000|Overall Study|Lost to Follow-up|0|||
126010161|NCT00536380|453329551|FG001|Overall Study|Lost to Follow-up|0|||
126343781|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
126343782|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343783|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343784|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343785|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343786|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343787|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343788|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343789|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343790|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
126343791|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
126343792|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343793|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343794|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343795|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343796|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343797|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343798|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343799|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343800|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
126343801|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
126343802|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343803|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126010162|NCT00536380|453329552|FG002|Overall Study|Lost to Follow-up|1|||
126010163|NCT00536380|453329550|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
126010164|NCT00536380|453329551|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
126010165|NCT00536380|453329552|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
126010166|NCT00536380|453329550|FG000|Overall Study|Withdrawal related to study drug|7|||
126010167|NCT00536380|453329551|FG001|Overall Study|Withdrawal related to study drug|5|||
126010168|NCT00536380|453329552|FG002|Overall Study|Withdrawal related to study drug|2|||
126010169|NCT00536380|453329550|FG000|Overall Study|Noncompliance with protocol|3|||
126010170|NCT00536380|453329551|FG001|Overall Study|Noncompliance with protocol|2|||
126010171|NCT00536380|453329552|FG002|Overall Study|Noncompliance with protocol|2|||
126010172|NCT00536380|453329550|FG000|Overall Study|Did not meet protocol eligibility|0|||
126010173|NCT00536380|453329551|FG001|Overall Study|Did not meet protocol eligibility|0|||
126010174|NCT00536380|453329552|FG002|Overall Study|Did not meet protocol eligibility|1|||
126010175|NCT00536380|453329550|FG000|Overall Study|Administrative|0|||
126010176|NCT00536380|453329551|FG001|Overall Study|Administrative|0|||
126010177|NCT00536380|453329552|FG002|Overall Study|Administrative|1|||
126010178|NCT02132702|453329556|FG000|Overall Study|Protocol Violation|2|||
126010179|NCT02132702|453329556|FG000|Overall Study|Adverse Event|3|||
126010180|NCT02132702|453329556|FG000|Overall Study|Withdrawal by Subject|3|||
126010181|NCT01278862|453329557|FG000|Overall Study|Lost to Follow-up|1|||
126010182|NCT01278862|453329558|FG001|Overall Study|Lost to Follow-up|1|||
126010183|NCT00603447|453329559|FG000|Overall Study|Adverse Event|0|||
126010184|NCT00603447|453329560|FG001|Overall Study|Adverse Event|1|||
126010185|NCT00603447|453329561|FG002|Overall Study|Adverse Event|1|||
126010186|NCT00603447|453329562|FG003|Overall Study|Adverse Event|2|||
126010187|NCT00603447|453329563|FG004|Overall Study|Adverse Event|1|||
126010188|NCT00603447|453329564|FG005|Overall Study|Adverse Event|2|||
126010189|NCT00603447|453329565|FG006|Overall Study|Adverse Event|10|||
126010190|NCT00603447|453329559|FG000|Overall Study|Other|0|||
126343804|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343805|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343806|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343807|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343808|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343809|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343810|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343811|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343812|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
126343813|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
126343814|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343815|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343816|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343817|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343818|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343819|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343820|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343821|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343822|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
126343823|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
126343824|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343825|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343826|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343827|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343828|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343829|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343830|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343831|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343832|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
126343833|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343834|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343835|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343836|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343837|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343838|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343839|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343840|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343841|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343842|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
126010191|NCT00603447|453329560|FG001|Overall Study|Other|0|||
126010192|NCT00603447|453329561|FG002|Overall Study|Other|1|||
126010193|NCT00603447|453329562|FG003|Overall Study|Other|0|||
126010194|NCT00603447|453329563|FG004|Overall Study|Other|3|||
126010195|NCT00603447|453329564|FG005|Overall Study|Other|0|||
126010196|NCT00603447|453329565|FG006|Overall Study|Other|13|||
126010197|NCT00603447|453329559|FG000|Overall Study|Withdrew Consent|0|||
126010198|NCT00603447|453329560|FG001|Overall Study|Withdrew Consent|2|||
126010199|NCT00603447|453329561|FG002|Overall Study|Withdrew Consent|0|||
126010200|NCT00603447|453329562|FG003|Overall Study|Withdrew Consent|0|||
126010201|NCT00603447|453329563|FG004|Overall Study|Withdrew Consent|1|||
126010202|NCT00603447|453329564|FG005|Overall Study|Withdrew Consent|0|||
126010203|NCT00603447|453329565|FG006|Overall Study|Withdrew Consent|1|||
126010204|NCT02952261|453329566|FG000|Overall Study|Withdrawal by Subject|4|||
126010205|NCT02952261|453329567|FG001|Overall Study|Withdrawal by Subject|5|||
126010206|NCT02952261|453329566|FG000|Overall Study|Protocol Violation|1|||
126010207|NCT02952261|453329567|FG001|Overall Study|Protocol Violation|0|||
126010208|NCT05233085|453329568|FG000|Overall Study|Adverse Event|1|||
126010209|NCT05233085|453329569|FG001|Overall Study|Adverse Event|0|||
126343843|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
126343844|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343845|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343846|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343847|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343848|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343849|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343850|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343851|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343852|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
126343853|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
126343854|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343855|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343856|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343857|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343858|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343859|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343860|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
126343861|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
126343862|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
126343863|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
126343864|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
126343865|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
126343866|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
126343867|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
126343868|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
126343869|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
126343870|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343871|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343872|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343873|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343874|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
126343875|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
126343876|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343877|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
126343878|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343879|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343880|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343881|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343882|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343883|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343884|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
126343885|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343886|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
126343887|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
126343888|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343889|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343890|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343891|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343892|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343893|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343894|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
126343895|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
126343896|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
126343897|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
126343898|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126010210|NCT05233085|453329570|FG002|Overall Study|Adverse Event|0|||
126010211|NCT05233085|453329571|FG003|Overall Study|Adverse Event|0|||
126010212|NCT00798265|453329572|FG000|Overall Study|Lost to Follow-up|1|||
126010213|NCT00798265|453329573|FG001|Overall Study|Lost to Follow-up|10|||
126010214|NCT00798265|453329572|FG000|Overall Study|Study closing|7|||
126010215|NCT00798265|453329573|FG001|Overall Study|Study closing|6|||
126010216|NCT00798265|453329572|FG000|Overall Study|Withdrawal by Subject|0|||
126010217|NCT00798265|453329573|FG001|Overall Study|Withdrawal by Subject|1|||
126010218|NCT00798265|453329572|FG000|Overall Study|Screen failure|0|||
126010219|NCT00798265|453329573|FG001|Overall Study|Screen failure|1|||
126010220|NCT02738840|453331275|FG000|Overall Study|MRI Scan not Performed|5|||
126010221|NCT02738840|453331275|FG000|Overall Study|Lost to Follow-up|1|||
126010222|NCT02738840|453331275|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
126010223|NCT02738840|453331275|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
126343899|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343900|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343901|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343902|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343903|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343904|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
126343905|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343906|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343907|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343908|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343909|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343910|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343911|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343912|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343913|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343914|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
126343915|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343916|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
126343917|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
126343918|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343919|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343920|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343921|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343922|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343923|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343924|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343925|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343926|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343927|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
126343928|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343929|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343930|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343931|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343932|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343933|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343934|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343935|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
126343936|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343937|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343938|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343939|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343940|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343941|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343942|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343943|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343944|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343945|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343946|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343947|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126010224|NCT01311648|453331278|FG000|Main Study|Protocol Violation|0|||
126010225|NCT01311648|453331279|FG001|Main Study|Protocol Violation|1|||
126010226|NCT01311648|453331278|FG000|Main Study|Adverse Event|0|||
126010227|NCT01311648|453331279|FG001|Main Study|Adverse Event|1|||
126010228|NCT01311648|453331278|FG000|Main Study|Inhibitor management|0|||
126010229|NCT01311648|453331279|FG001|Main Study|Inhibitor management|17|||
126010230|NCT01311648|453331278|FG000|Main Study|Withdrawal by Subject|0|||
126010231|NCT01311648|453331279|FG001|Main Study|Withdrawal by Subject|2|||
126010232|NCT01311648|453331278|FG000|Extension Study|Physician Decision|0|||
126010233|NCT01311648|453331279|FG001|Extension Study|Physician Decision|1|||
126010234|NCT01311648|453331278|FG000|Extension Study|ITI therapy with marketed product|0|||
126010235|NCT01311648|453331279|FG001|Extension Study|ITI therapy with marketed product|1|||
126010236|NCT01311648|453331278|FG000|Extension Study|Incorrect visit planning|0|||
126010237|NCT01311648|453331279|FG001|Extension Study|Incorrect visit planning|1|||
126010238|NCT01311648|453331278|FG000|Extension Study|Family's decision|0|||
126010239|NCT01311648|453331279|FG001|Extension Study|Family's decision|1|||
126010240|NCT01311648|453331278|FG000|Extension Study|Failure of ITI therapy|0|||
126010241|NCT01311648|453331279|FG001|Extension Study|Failure of ITI therapy|3|||
126343948|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
126343949|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
126343950|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343951|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343952|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343953|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343954|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343955|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343956|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343957|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343958|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
126343959|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
126343960|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343961|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343962|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343963|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343964|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343965|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343966|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343967|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343968|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
126343969|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
126343970|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343971|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343972|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343973|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343974|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343975|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343976|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343977|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343978|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
126343979|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
126343980|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343981|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343982|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343983|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343984|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343985|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343986|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343987|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343988|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
126343989|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
126010242|NCT01311648|453331278|FG000|Extension Study|Long travel|0|||
126010243|NCT01311648|453331279|FG001|Extension Study|Long travel|1|||
126209506|NCT03110107|454055411|FG018|Treatment Period|Adverse Event|2|||
126010244|NCT01311648|453331278|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
126343990|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343991|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343992|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343993|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343994|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343995|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343996|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343997|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343998|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
126343999|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126344000|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344001|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344002|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344003|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344004|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344005|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344006|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344007|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344008|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
126344009|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344010|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344011|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344012|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344013|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344014|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344015|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344016|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344017|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344018|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
126344019|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
126344020|NCT02792504|454554162|FG000|Overall Study|Lost to Follow-up|24|||
126344021|NCT02792504|454554162|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
126344022|NCT00848497|454554169|FG000|Overall Study|Screen failure|2|||
126344023|NCT00848497|454554170|FG001|Overall Study|Screen failure|0|||
126344024|NCT00848497|454554169|FG000|Overall Study|Withdrawal by Subject|0|||
126344025|NCT00848497|454554170|FG001|Overall Study|Withdrawal by Subject|1|||
126344026|NCT02966834|454554171|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344027|NCT02966834|454554172|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344028|NCT02966834|454554173|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344029|NCT02966834|454554174|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344030|NCT02966834|454554175|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
126344031|NCT02966834|454554176|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344032|NCT02966834|454554171|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
126344033|NCT02966834|454554172|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126344034|NCT02966834|454554173|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126010245|NCT01311648|453331279|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
126010246|NCT01311648|453331278|FG000|Extension Study|Withdrawal by Subject|0|||
126010247|NCT01311648|453331279|FG001|Extension Study|Withdrawal by Subject|1|||
126010248|NCT01311648|453331278|FG000|Extension Study|Inhibitor management|0|||
126010249|NCT01311648|453331279|FG001|Extension Study|Inhibitor management|2|||
126010250|NCT01645111|453331280|FG000|Overall Study|Did not require Clevidipine|15|||
126010251|NCT03712930|453331281|FG000|Overall Study|Death|7|||
126010252|NCT03712930|453331281|FG000|Overall Study|Physician Decision|1|||
126010253|NCT03712930|453331281|FG000|Overall Study|Study Terminated by Sponsor|3|||
126010254|NCT03712930|453331281|FG000|Overall Study|Progressive Disease|2|||
126010255|NCT03357341|453331284|FG000|Overall Study|Withdrawal by Subject|3|||
126010256|NCT03357341|453331285|FG001|Overall Study|Withdrawal by Subject|6|||
126010257|NCT03357341|453331284|FG000|Overall Study|Lost to Follow-up|4|||
126010258|NCT03357341|453331285|FG001|Overall Study|Lost to Follow-up|5|||
126010259|NCT03357341|453331284|FG000|Overall Study|Death|0|||
126010260|NCT03357341|453331285|FG001|Overall Study|Death|1|||
126010261|NCT01233050|453331288|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
126010262|NCT01233050|453331289|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
126010263|NCT01064817|453331291|FG000|Study Completion|Physician Decision|1|||
126010264|NCT01064817|453331292|FG001|Study Completion|Physician Decision|0|||
126010265|NCT01064817|453331291|FG000|Study Completion|Withdrawal by Subject|1|||
126010266|NCT01064817|453331292|FG001|Study Completion|Withdrawal by Subject|0|||
126010267|NCT04580303|453331296|FG000|Overall Study|Adverse Event|0|||
126010268|NCT04580303|453331297|FG001|Overall Study|Adverse Event|1|||
126010269|NCT04580303|453331298|FG002|Overall Study|Adverse Event|0|||
126344035|NCT02966834|454554174|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126344036|NCT02966834|454554175|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126344037|NCT02966834|454554176|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126344038|NCT02966834|454554171|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
126344039|NCT02966834|454554172|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
126344040|NCT02966834|454554173|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
126344041|NCT02966834|454554174|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
126344042|NCT02966834|454554175|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
126344043|NCT02966834|454554176|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
126010270|NCT04580303|453331299|FG003|Overall Study|Adverse Event|0|||
126010271|NCT04580303|453331296|FG000|Overall Study|Withdrawal by Subject|0|||
126010272|NCT04580303|453331297|FG001|Overall Study|Withdrawal by Subject|0|||
126010273|NCT04580303|453331298|FG002|Overall Study|Withdrawal by Subject|1|||
126010274|NCT04580303|453331299|FG003|Overall Study|Withdrawal by Subject|0|||
126010275|NCT00927823|453331303|FG000|Continuous Dosing Period|Death|0|||
126010276|NCT00927823|453331304|FG001|Continuous Dosing Period|Death|0|||
126010277|NCT00927823|453331305|FG002|Continuous Dosing Period|Death|6|||
126010278|NCT00927823|453331306|FG003|Continuous Dosing Period|Death|0|||
126010279|NCT00927823|453331303|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
126010280|NCT00927823|453331304|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
126010281|NCT00927823|453331305|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
126010282|NCT00927823|453331306|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
126010283|NCT00927823|453331303|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
126010284|NCT00927823|453331304|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
126010285|NCT00927823|453331305|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
126010286|NCT00927823|453331306|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
126010287|NCT00927823|453331303|FG000|Continuous Dosing Period|Other|1|||
126010288|NCT00927823|453331304|FG001|Continuous Dosing Period|Other|2|||
126344044|NCT02966834|454554171|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
126344045|NCT02966834|454554172|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
126344046|NCT02966834|454554173|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
126344047|NCT02966834|454554174|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
126344048|NCT02966834|454554175|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
126344049|NCT02966834|454554176|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
126344050|NCT02966834|454554171|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344051|NCT02966834|454554172|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344052|NCT02966834|454554173|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344053|NCT02966834|454554174|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
126344054|NCT02966834|454554175|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344055|NCT02966834|454554176|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344056|NCT02966834|454554171|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126344057|NCT02966834|454554172|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126344058|NCT02966834|454554173|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126010289|NCT00927823|453331305|FG002|Continuous Dosing Period|Other|9|||
126010290|NCT00927823|453331306|FG003|Continuous Dosing Period|Other|3|||
126010291|NCT01710514|453331311|FG000|Overall Study|Adverse Event|6|||
126010292|NCT01710514|453331312|FG001|Overall Study|Adverse Event|7|||
126344059|NCT02966834|454554174|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
126344060|NCT02966834|454554175|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126010293|NCT01710514|453331311|FG000|Overall Study|Withdrawal by Subject|1|||
126010294|NCT01710514|453331312|FG001|Overall Study|Withdrawal by Subject|0|||
126010295|NCT02846415|453331314|FG000|Overall Study|Lost to Follow-up|2|||
126010296|NCT02846415|453331315|FG001|Overall Study|Lost to Follow-up|0|||
126010297|NCT02846415|453331314|FG000|Overall Study|Withdrawal by Subject|1|||
126010298|NCT02846415|453331315|FG001|Overall Study|Withdrawal by Subject|1|||
126010299|NCT03383887|453331316|FG000|Overall Study|Lost to Follow-up|0|||
126010300|NCT03383887|453331317|FG001|Overall Study|Lost to Follow-up|1|||
126010301|NCT00246012|453331320|FG000|Overall Study|Adverse Event|0|||
126010302|NCT00246012|453331321|FG001|Overall Study|Adverse Event|0|||
126010303|NCT00246012|453331322|FG002|Overall Study|Adverse Event|0|||
126010304|NCT00246012|453331323|FG003|Overall Study|Adverse Event|0|||
126010305|NCT00246012|453331324|FG004|Overall Study|Adverse Event|0|||
126010306|NCT00246012|453331325|FG005|Overall Study|Adverse Event|1|||
126010307|NCT00246012|453331326|FG006|Overall Study|Adverse Event|0|||
126010308|NCT00246012|453331327|FG007|Overall Study|Adverse Event|0|||
126010309|NCT00246012|453331328|FG008|Overall Study|Adverse Event|2|||
126010310|NCT00246012|453331320|FG000|Overall Study|Withdrawal by Subject|0|||
126010311|NCT00246012|453331321|FG001|Overall Study|Withdrawal by Subject|0|||
126010312|NCT00246012|453331322|FG002|Overall Study|Withdrawal by Subject|0|||
126010313|NCT00246012|453331323|FG003|Overall Study|Withdrawal by Subject|0|||
126010314|NCT00246012|453331324|FG004|Overall Study|Withdrawal by Subject|0|||
126010315|NCT00246012|453331325|FG005|Overall Study|Withdrawal by Subject|1|||
126010316|NCT00246012|453331326|FG006|Overall Study|Withdrawal by Subject|0|||
126010317|NCT00246012|453331327|FG007|Overall Study|Withdrawal by Subject|0|||
126010318|NCT00246012|453331328|FG008|Overall Study|Withdrawal by Subject|0|||
126010319|NCT00246012|453331320|FG000|Overall Study|Disease progression|3|||
126010320|NCT00246012|453331321|FG001|Overall Study|Disease progression|1|||
126010321|NCT00246012|453331322|FG002|Overall Study|Disease progression|2|||
126010322|NCT00246012|453331323|FG003|Overall Study|Disease progression|3|||
126010323|NCT00246012|453331324|FG004|Overall Study|Disease progression|3|||
126010324|NCT00246012|453331325|FG005|Overall Study|Disease progression|25|||
126010325|NCT00246012|453331326|FG006|Overall Study|Disease progression|30|||
126010326|NCT00246012|453331327|FG007|Overall Study|Disease progression|27|||
126010327|NCT00246012|453331328|FG008|Overall Study|Disease progression|26|||
126010328|NCT00246012|453331320|FG000|Overall Study|Other|0|||
126010329|NCT00246012|453331321|FG001|Overall Study|Other|0|||
126010330|NCT00246012|453331322|FG002|Overall Study|Other|0|||
126010331|NCT00246012|453331323|FG003|Overall Study|Other|0|||
126010332|NCT00246012|453331324|FG004|Overall Study|Other|0|||
126010333|NCT00246012|453331325|FG005|Overall Study|Other|0|||
126010334|NCT00246012|453331326|FG006|Overall Study|Other|0|||
126010335|NCT00246012|453331327|FG007|Overall Study|Other|1|||
126010336|NCT00246012|453331328|FG008|Overall Study|Other|0|||
126010337|NCT00246012|453331320|FG000|Overall Study|Randomly assigned but not treated|0|||
126010338|NCT00246012|453331321|FG001|Overall Study|Randomly assigned but not treated|0|||
126010339|NCT00246012|453331322|FG002|Overall Study|Randomly assigned but not treated|0|||
126010340|NCT00246012|453331323|FG003|Overall Study|Randomly assigned but not treated|0|||
126010341|NCT00246012|453331324|FG004|Overall Study|Randomly assigned but not treated|0|||
126010342|NCT00246012|453331325|FG005|Overall Study|Randomly assigned but not treated|1|||
126010343|NCT00246012|453331326|FG006|Overall Study|Randomly assigned but not treated|1|||
126010344|NCT00246012|453331327|FG007|Overall Study|Randomly assigned but not treated|0|||
126010345|NCT00246012|453331328|FG008|Overall Study|Randomly assigned but not treated|0|||
126010346|NCT01242085|453331329|FG000|Overall Study|Withdrawal by Subject|4|||
126010347|NCT01242085|453331330|FG001|Overall Study|Withdrawal by Subject|2|||
126010348|NCT01242085|453331331|FG002|Overall Study|Withdrawal by Subject|0|||
126010349|NCT01242085|453331329|FG000|Overall Study|medically unable to have surgery|4|||
126010350|NCT01242085|453331330|FG001|Overall Study|medically unable to have surgery|5|||
126010351|NCT01242085|453331331|FG002|Overall Study|medically unable to have surgery|0|||
126010352|NCT01178762|453331332|FG000|Overall Study|Lost to Follow-up|15|||
126010353|NCT02322216|453331333|FG000|Overall Study|Adverse Event|1|||
126010354|NCT02322216|453331334|FG001|Overall Study|Adverse Event|0|||
126010355|NCT02322216|453331333|FG000|Overall Study|Withdrawal by Subject|1|||
126010356|NCT02322216|453331334|FG001|Overall Study|Withdrawal by Subject|4|||
126010357|NCT01651949|453331335|FG000|Overall Study|Unknown status|4|||
126010358|NCT01651949|453331336|FG001|Overall Study|Unknown status|4|||
126010359|NCT01651949|453331337|FG002|Overall Study|Unknown status|0|||
126010360|NCT01651949|453331335|FG000|Overall Study|Lost to Follow-up|30|||
126010361|NCT01651949|453331336|FG001|Overall Study|Lost to Follow-up|56|||
126010362|NCT01651949|453331337|FG002|Overall Study|Lost to Follow-up|20|||
126010363|NCT01651949|453331335|FG000|Overall Study|Protocol Violation|0|||
126010364|NCT01651949|453331336|FG001|Overall Study|Protocol Violation|2|||
126010365|NCT01651949|453331337|FG002|Overall Study|Protocol Violation|1|||
126010366|NCT01651949|453331335|FG000|Overall Study|Physician Decision|0|||
126010367|NCT01651949|453331336|FG001|Overall Study|Physician Decision|2|||
126010368|NCT01651949|453331337|FG002|Overall Study|Physician Decision|0|||
126010369|NCT01651949|453331335|FG000|Overall Study|Adverse Event|0|||
126010370|NCT01651949|453331336|FG001|Overall Study|Adverse Event|2|||
126010371|NCT01651949|453331337|FG002|Overall Study|Adverse Event|1|||
126010372|NCT01651949|453331335|FG000|Overall Study|Screen failure|2|||
126010373|NCT01651949|453331336|FG001|Overall Study|Screen failure|2|||
126010374|NCT01651949|453331337|FG002|Overall Study|Screen failure|0|||
126010375|NCT01651949|453331335|FG000|Overall Study|Withdrawal by Subject|17|||
126010376|NCT01651949|453331336|FG001|Overall Study|Withdrawal by Subject|18|||
126010377|NCT01651949|453331337|FG002|Overall Study|Withdrawal by Subject|9|||
126010378|NCT01806714|453331338|FG000|Overall Study|No functioning phone number|200|||
126010379|NCT01806714|453331339|FG001|Overall Study|No functioning phone number|170|||
126010380|NCT02596035|453331349|FG000|Overall Study|Disease Progression|64|||
126010381|NCT02596035|453331350|FG001|Overall Study|Disease Progression|32|||
126010382|NCT02596035|453331351|FG002|Overall Study|Disease Progression|1|||
126010383|NCT02596035|453331349|FG000|Overall Study|study drug toxicity|12|||
126010384|NCT02596035|453331350|FG001|Overall Study|study drug toxicity|3|||
126010385|NCT02596035|453331351|FG002|Overall Study|study drug toxicity|0|||
126010386|NCT02596035|453331349|FG000|Overall Study|AE unrelated to study drug|5|||
126010387|NCT02596035|453331350|FG001|Overall Study|AE unrelated to study drug|2|||
126010388|NCT02596035|453331351|FG002|Overall Study|AE unrelated to study drug|0|||
126010389|NCT02596035|453331349|FG000|Overall Study|participant request to discontinue study treatment|2|||
126010390|NCT02596035|453331350|FG001|Overall Study|participant request to discontinue study treatment|0|||
126010391|NCT02596035|453331351|FG002|Overall Study|participant request to discontinue study treatment|0|||
126010392|NCT02596035|453331349|FG000|Overall Study|participant withdrew consent|2|||
126010393|NCT02596035|453331350|FG001|Overall Study|participant withdrew consent|2|||
126010394|NCT02596035|453331351|FG002|Overall Study|participant withdrew consent|0|||
126010395|NCT02596035|453331349|FG000|Overall Study|Poor/Non Comlpiance|0|||
126010396|NCT02596035|453331350|FG001|Overall Study|Poor/Non Comlpiance|1|||
126010397|NCT02596035|453331351|FG002|Overall Study|Poor/Non Comlpiance|0|||
126010398|NCT02596035|453331349|FG000|Overall Study|participant no longer meets study criteria|1|||
126010399|NCT02596035|453331350|FG001|Overall Study|participant no longer meets study criteria|0|||
126010400|NCT02596035|453331351|FG002|Overall Study|participant no longer meets study criteria|0|||
126010401|NCT02596035|453331349|FG000|Overall Study|other reasons|11|||
126010402|NCT02596035|453331350|FG001|Overall Study|other reasons|4|||
126010403|NCT02596035|453331351|FG002|Overall Study|other reasons|0|||
126010404|NCT01235949|453331352|FG000|Primary Phase|Migrated/moved from study area|1|||
126010405|NCT01235949|453331353|FG001|Primary Phase|Migrated/moved from study area|1|||
126010406|NCT01235949|453331354|FG002|Primary Phase|Migrated/moved from study area|0|||
126010407|NCT01235949|453331355|FG003|Primary Phase|Migrated/moved from study area|0|||
126010408|NCT01235949|453331356|FG004|Primary Phase|Migrated/moved from study area|1|||
126344061|NCT02966834|454554176|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126344062|NCT00094445|454554178|FG000|Overall Study|Withdrawal by Subject|3|||
126344063|NCT00094445|454554178|FG000|Overall Study|Lost to Follow-up|1|||
126344064|NCT00094445|454554178|FG000|Overall Study|Progressive Disease|2|||
126344065|NCT00769561|454554179|FG000|Overall Study|Withdrawal by Subject|2|||
126344066|NCT00769561|454554180|FG001|Overall Study|Withdrawal by Subject|2|||
126010409|NCT01235949|453331357|FG005|Primary Phase|Migrated/moved from study area|2|||
126344067|NCT00769561|454554179|FG000|Overall Study|Lost to Follow-up|1|||
126344068|NCT00769561|454554180|FG001|Overall Study|Lost to Follow-up|3|||
126344069|NCT01773928|454554181|FG000|Overall Study|Adverse Event|0|||
126344070|NCT01773928|454554182|FG001|Overall Study|Adverse Event|0|||
126344071|NCT01773928|454554183|FG002|Overall Study|Adverse Event|0|||
126344072|NCT01773928|454554184|FG003|Overall Study|Adverse Event|0|||
126344073|NCT01773928|454554185|FG004|Overall Study|Adverse Event|0|||
126010410|NCT01235949|453331358|FG006|Primary Phase|Migrated/moved from study area|0|||
126010411|NCT01235949|453331359|FG007|Primary Phase|Migrated/moved from study area|0|||
126010412|NCT01235949|453331360|FG008|Primary Phase|Migrated/moved from study area|0|||
126344074|NCT01773928|454554186|FG005|Overall Study|Adverse Event|0|||
126010413|NCT01235949|453331361|FG009|Primary Phase|Migrated/moved from study area|0|||
126010414|NCT01235949|453331362|FG010|Primary Phase|Migrated/moved from study area|0|||
126010415|NCT01235949|453331363|FG011|Primary Phase|Migrated/moved from study area|0|||
126010416|NCT01235949|453331364|FG012|Primary Phase|Migrated/moved from study area|0|||
126010417|NCT01235949|453331365|FG013|Primary Phase|Migrated/moved from study area|0|||
126010418|NCT01235949|453331366|FG014|Primary Phase|Migrated/moved from study area|0|||
126010419|NCT01235949|453331367|FG015|Primary Phase|Migrated/moved from study area|0|||
126344075|NCT01773928|454554187|FG006|Overall Study|Adverse Event|0|||
126344076|NCT01773928|454554188|FG007|Overall Study|Adverse Event|1|||
126344077|NCT01773928|454554189|FG008|Overall Study|Adverse Event|0|||
126010420|NCT01235949|453331368|FG016|Primary Phase|Migrated/moved from study area|0|||
126010421|NCT01235949|453331369|FG017|Primary Phase|Migrated/moved from study area|0|||
126010422|NCT01235949|453331352|FG000|Primary Phase|Adverse Event|0|||
126010423|NCT01235949|453331353|FG001|Primary Phase|Adverse Event|0|||
126010424|NCT01235949|453331354|FG002|Primary Phase|Adverse Event|0|||
126010425|NCT01235949|453331355|FG003|Primary Phase|Adverse Event|1|||
126010426|NCT01235949|453331356|FG004|Primary Phase|Adverse Event|0|||
126010427|NCT01235949|453331357|FG005|Primary Phase|Adverse Event|0|||
126010428|NCT01235949|453331358|FG006|Primary Phase|Adverse Event|0|||
126010429|NCT01235949|453331359|FG007|Primary Phase|Adverse Event|0|||
126010430|NCT01235949|453331360|FG008|Primary Phase|Adverse Event|0|||
126010431|NCT01235949|453331361|FG009|Primary Phase|Adverse Event|0|||
126010432|NCT01235949|453331362|FG010|Primary Phase|Adverse Event|0|||
126010433|NCT01235949|453331363|FG011|Primary Phase|Adverse Event|0|||
126010434|NCT01235949|453331364|FG012|Primary Phase|Adverse Event|0|||
126010435|NCT01235949|453331365|FG013|Primary Phase|Adverse Event|0|||
126010436|NCT01235949|453331366|FG014|Primary Phase|Adverse Event|0|||
126010437|NCT01235949|453331367|FG015|Primary Phase|Adverse Event|0|||
126010438|NCT01235949|453331368|FG016|Primary Phase|Adverse Event|0|||
126010439|NCT01235949|453331369|FG017|Primary Phase|Adverse Event|0|||
126010440|NCT01235949|453331352|FG000|Primary Phase|Withdrawal by Subject|3|||
126010441|NCT01235949|453331353|FG001|Primary Phase|Withdrawal by Subject|2|||
126010442|NCT01235949|453331354|FG002|Primary Phase|Withdrawal by Subject|2|||
126010443|NCT01235949|453331355|FG003|Primary Phase|Withdrawal by Subject|0|||
126010444|NCT01235949|453331356|FG004|Primary Phase|Withdrawal by Subject|0|||
126010445|NCT01235949|453331357|FG005|Primary Phase|Withdrawal by Subject|3|||
126010446|NCT01235949|453331358|FG006|Primary Phase|Withdrawal by Subject|0|||
126010447|NCT01235949|453331359|FG007|Primary Phase|Withdrawal by Subject|0|||
126010448|NCT01235949|453331360|FG008|Primary Phase|Withdrawal by Subject|0|||
126010449|NCT01235949|453331361|FG009|Primary Phase|Withdrawal by Subject|0|||
126010450|NCT01235949|453331362|FG010|Primary Phase|Withdrawal by Subject|0|||
126010451|NCT01235949|453331363|FG011|Primary Phase|Withdrawal by Subject|0|||
126010452|NCT01235949|453331364|FG012|Primary Phase|Withdrawal by Subject|0|||
126010453|NCT01235949|453331365|FG013|Primary Phase|Withdrawal by Subject|0|||
126010454|NCT01235949|453331366|FG014|Primary Phase|Withdrawal by Subject|0|||
126010455|NCT01235949|453331367|FG015|Primary Phase|Withdrawal by Subject|0|||
126010456|NCT01235949|453331368|FG016|Primary Phase|Withdrawal by Subject|0|||
126010457|NCT01235949|453331369|FG017|Primary Phase|Withdrawal by Subject|0|||
126010458|NCT01235949|453331352|FG000|Primary Phase|Lost to Follow-up|0|||
126010459|NCT01235949|453331353|FG001|Primary Phase|Lost to Follow-up|0|||
126010460|NCT01235949|453331354|FG002|Primary Phase|Lost to Follow-up|1|||
126010461|NCT01235949|453331355|FG003|Primary Phase|Lost to Follow-up|1|||
126010462|NCT01235949|453331356|FG004|Primary Phase|Lost to Follow-up|0|||
126010463|NCT01235949|453331357|FG005|Primary Phase|Lost to Follow-up|2|||
126010464|NCT01235949|453331358|FG006|Primary Phase|Lost to Follow-up|0|||
126010465|NCT01235949|453331359|FG007|Primary Phase|Lost to Follow-up|0|||
126010466|NCT01235949|453331360|FG008|Primary Phase|Lost to Follow-up|0|||
126010467|NCT01235949|453331361|FG009|Primary Phase|Lost to Follow-up|0|||
126010468|NCT01235949|453331362|FG010|Primary Phase|Lost to Follow-up|0|||
126010469|NCT01235949|453331363|FG011|Primary Phase|Lost to Follow-up|0|||
126010470|NCT01235949|453331364|FG012|Primary Phase|Lost to Follow-up|0|||
126010471|NCT01235949|453331365|FG013|Primary Phase|Lost to Follow-up|0|||
126010472|NCT01235949|453331366|FG014|Primary Phase|Lost to Follow-up|0|||
126010473|NCT01235949|453331367|FG015|Primary Phase|Lost to Follow-up|0|||
126010474|NCT01235949|453331368|FG016|Primary Phase|Lost to Follow-up|0|||
126010475|NCT01235949|453331369|FG017|Primary Phase|Lost to Follow-up|0|||
126010476|NCT01235949|453331352|FG000|Booster Phase|Migrated/moved from study area|0|||
126010477|NCT01235949|453331353|FG001|Booster Phase|Migrated/moved from study area|0|||
126010478|NCT01235949|453331354|FG002|Booster Phase|Migrated/moved from study area|0|||
126010479|NCT01235949|453331355|FG003|Booster Phase|Migrated/moved from study area|0|||
126010480|NCT01235949|453331356|FG004|Booster Phase|Migrated/moved from study area|0|||
126010481|NCT01235949|453331357|FG005|Booster Phase|Migrated/moved from study area|0|||
126010482|NCT01235949|453331358|FG006|Booster Phase|Migrated/moved from study area|0|||
126010483|NCT01235949|453331359|FG007|Booster Phase|Migrated/moved from study area|0|||
126010484|NCT01235949|453331360|FG008|Booster Phase|Migrated/moved from study area|0|||
126010485|NCT01235949|453331361|FG009|Booster Phase|Migrated/moved from study area|0|||
126010486|NCT01235949|453331362|FG010|Booster Phase|Migrated/moved from study area|0|||
126010487|NCT01235949|453331363|FG011|Booster Phase|Migrated/moved from study area|1|||
126010488|NCT01235949|453331364|FG012|Booster Phase|Migrated/moved from study area|1|||
126010489|NCT01235949|453331365|FG013|Booster Phase|Migrated/moved from study area|0|||
126010490|NCT01235949|453331366|FG014|Booster Phase|Migrated/moved from study area|0|||
126010491|NCT01235949|453331367|FG015|Booster Phase|Migrated/moved from study area|0|||
126010492|NCT01235949|453331368|FG016|Booster Phase|Migrated/moved from study area|0|||
126010493|NCT01235949|453331369|FG017|Booster Phase|Migrated/moved from study area|1|||
126010494|NCT01235949|453331352|FG000|Booster Phase|Adverse Event|0|||
126010495|NCT01235949|453331353|FG001|Booster Phase|Adverse Event|0|||
126010496|NCT01235949|453331354|FG002|Booster Phase|Adverse Event|0|||
126010497|NCT01235949|453331355|FG003|Booster Phase|Adverse Event|0|||
126010498|NCT01235949|453331356|FG004|Booster Phase|Adverse Event|0|||
126010499|NCT01235949|453331357|FG005|Booster Phase|Adverse Event|0|||
126010500|NCT01235949|453331358|FG006|Booster Phase|Adverse Event|0|||
126010501|NCT01235949|453331359|FG007|Booster Phase|Adverse Event|0|||
126010502|NCT01235949|453331360|FG008|Booster Phase|Adverse Event|0|||
126010503|NCT01235949|453331361|FG009|Booster Phase|Adverse Event|0|||
126010504|NCT01235949|453331362|FG010|Booster Phase|Adverse Event|0|||
126010505|NCT01235949|453331363|FG011|Booster Phase|Adverse Event|0|||
126010506|NCT01235949|453331364|FG012|Booster Phase|Adverse Event|0|||
126010507|NCT01235949|453331365|FG013|Booster Phase|Adverse Event|0|||
126010508|NCT01235949|453331366|FG014|Booster Phase|Adverse Event|0|||
126010509|NCT01235949|453331367|FG015|Booster Phase|Adverse Event|1|||
126010510|NCT01235949|453331368|FG016|Booster Phase|Adverse Event|0|||
126010511|NCT01235949|453331369|FG017|Booster Phase|Adverse Event|0|||
126010512|NCT01235949|453331352|FG000|Booster Phase|Withdrawal by Subject|0|||
126010513|NCT01235949|453331353|FG001|Booster Phase|Withdrawal by Subject|0|||
126010514|NCT01235949|453331354|FG002|Booster Phase|Withdrawal by Subject|0|||
126010515|NCT01235949|453331355|FG003|Booster Phase|Withdrawal by Subject|0|||
126010516|NCT01235949|453331356|FG004|Booster Phase|Withdrawal by Subject|0|||
126010517|NCT01235949|453331357|FG005|Booster Phase|Withdrawal by Subject|0|||
126010518|NCT01235949|453331358|FG006|Booster Phase|Withdrawal by Subject|0|||
126010519|NCT01235949|453331359|FG007|Booster Phase|Withdrawal by Subject|1|||
126010520|NCT01235949|453331360|FG008|Booster Phase|Withdrawal by Subject|1|||
126010521|NCT01235949|453331361|FG009|Booster Phase|Withdrawal by Subject|0|||
126010522|NCT01235949|453331362|FG010|Booster Phase|Withdrawal by Subject|1|||
126010523|NCT01235949|453331363|FG011|Booster Phase|Withdrawal by Subject|1|||
126209507|NCT03110107|454055412|FG019|Treatment Period|Adverse Event|1|||
126010524|NCT01235949|453331364|FG012|Booster Phase|Withdrawal by Subject|2|||
126010525|NCT01235949|453331365|FG013|Booster Phase|Withdrawal by Subject|0|||
126010526|NCT01235949|453331366|FG014|Booster Phase|Withdrawal by Subject|2|||
126010527|NCT01235949|453331367|FG015|Booster Phase|Withdrawal by Subject|0|||
126010528|NCT01235949|453331368|FG016|Booster Phase|Withdrawal by Subject|0|||
126010529|NCT01235949|453331369|FG017|Booster Phase|Withdrawal by Subject|0|||
126010530|NCT01235949|453331352|FG000|Booster Phase|Lost to Follow-up|0|||
126010531|NCT01235949|453331353|FG001|Booster Phase|Lost to Follow-up|0|||
126010532|NCT01235949|453331354|FG002|Booster Phase|Lost to Follow-up|0|||
126010533|NCT01235949|453331355|FG003|Booster Phase|Lost to Follow-up|0|||
126010534|NCT01235949|453331356|FG004|Booster Phase|Lost to Follow-up|0|||
126010535|NCT01235949|453331357|FG005|Booster Phase|Lost to Follow-up|0|||
126010536|NCT01235949|453331358|FG006|Booster Phase|Lost to Follow-up|0|||
126010537|NCT01235949|453331359|FG007|Booster Phase|Lost to Follow-up|0|||
126010538|NCT01235949|453331360|FG008|Booster Phase|Lost to Follow-up|1|||
126010539|NCT01235949|453331361|FG009|Booster Phase|Lost to Follow-up|1|||
126010540|NCT01235949|453331362|FG010|Booster Phase|Lost to Follow-up|1|||
126010541|NCT01235949|453331363|FG011|Booster Phase|Lost to Follow-up|1|||
126010542|NCT01235949|453331364|FG012|Booster Phase|Lost to Follow-up|0|||
126010543|NCT01235949|453331365|FG013|Booster Phase|Lost to Follow-up|0|||
126010544|NCT01235949|453331366|FG014|Booster Phase|Lost to Follow-up|0|||
126010545|NCT01235949|453331367|FG015|Booster Phase|Lost to Follow-up|0|||
126010546|NCT01235949|453331368|FG016|Booster Phase|Lost to Follow-up|0|||
126010547|NCT01235949|453331369|FG017|Booster Phase|Lost to Follow-up|1|||
126010548|NCT00754936|453331370|FG000|Overall Study|Lost to Follow-up|3|||
126010549|NCT00754936|453331370|FG000|Overall Study|Physician Decision|1|||
126010550|NCT00754936|453331370|FG000|Overall Study|Withdrawal by Subject|2|||
126010551|NCT00754936|453331370|FG000|Overall Study|Side Effects|3|||
126010552|NCT00754936|453331370|FG000|Overall Study|Inter-current medical events|3|||
126010553|NCT03247543|453331376|FG000|Overall Study|Adverse Event|3|||
126010554|NCT03247543|453331377|FG001|Overall Study|Adverse Event|6|||
126010555|NCT03247543|453331378|FG002|Overall Study|Adverse Event|4|||
126010556|NCT03247543|453331376|FG000|Overall Study|Lost to Follow-up|10|||
126010557|NCT03247543|453331377|FG001|Overall Study|Lost to Follow-up|7|||
126010558|NCT03247543|453331378|FG002|Overall Study|Lost to Follow-up|8|||
126010559|NCT03247543|453331376|FG000|Overall Study|Consent withdrawn by caregiver|2|||
126010560|NCT03247543|453331377|FG001|Overall Study|Consent withdrawn by caregiver|2|||
126010561|NCT03247543|453331378|FG002|Overall Study|Consent withdrawn by caregiver|9|||
126010562|NCT03247543|453331376|FG000|Overall Study|Withdrawal by Subject|0|||
126010563|NCT03247543|453331377|FG001|Overall Study|Withdrawal by Subject|0|||
126010564|NCT03247543|453331378|FG002|Overall Study|Withdrawal by Subject|1|||
126010565|NCT03247543|453331376|FG000|Overall Study|Failure to Follow study procedures|1|||
126010566|NCT03247543|453331377|FG001|Overall Study|Failure to Follow study procedures|3|||
126010567|NCT03247543|453331378|FG002|Overall Study|Failure to Follow study procedures|1|||
126010568|NCT03247543|453331376|FG000|Overall Study|Lack of Efficacy|1|||
126010569|NCT03247543|453331377|FG001|Overall Study|Lack of Efficacy|0|||
126010570|NCT03247543|453331378|FG002|Overall Study|Lack of Efficacy|0|||
126010571|NCT03247543|453331376|FG000|Overall Study|Non-compliance with study visits|0|||
126010572|NCT03247543|453331377|FG001|Overall Study|Non-compliance with study visits|1|||
126010573|NCT03247543|453331378|FG002|Overall Study|Non-compliance with study visits|0|||
126010574|NCT02059980|453331381|FG000|Overall Study|Lost to Follow-up|2|||
126010575|NCT02059980|453331382|FG001|Overall Study|Lost to Follow-up|1|||
126010576|NCT01104415|453331383|FG000|Core Phase|Consent withdrawn by subjects|1|||
126010577|NCT01104415|453331384|FG001|Core Phase|Consent withdrawn by subjects|0|||
126010578|NCT01104415|453331383|FG000|Extension Period|Progressive disease|0|||
126010579|NCT01104415|453331384|FG001|Extension Period|Progressive disease|4|||
126010580|NCT01104415|453331383|FG000|Extension Period|Death|0|||
126010581|NCT01104415|453331384|FG001|Extension Period|Death|1|||
126010582|NCT01104415|453331383|FG000|Extension Period|Physician Decision|0|||
126010583|NCT01104415|453331384|FG001|Extension Period|Physician Decision|1|||
126010584|NCT01104415|453331383|FG000|Extension Period|Transition to Study LX1606.302|0|||
126010585|NCT01104415|453331384|FG001|Extension Period|Transition to Study LX1606.302|4|||
126010586|NCT01104415|453331383|FG000|Extension Period|Heart surgery/feeling miserable|0|||
126010587|NCT01104415|453331384|FG001|Extension Period|Heart surgery/feeling miserable|1|||
126010588|NCT02341625|453331389|FG000|Overall Study|Disease Progression|2|||
126010589|NCT02341625|453331390|FG001|Overall Study|Disease Progression|2|||
126010590|NCT02341625|453331391|FG002|Overall Study|Disease Progression|3|||
126010591|NCT02341625|453331392|FG003|Overall Study|Disease Progression|6|||
126010592|NCT02341625|453331393|FG004|Overall Study|Disease Progression|7|||
126010593|NCT02341625|453331394|FG005|Overall Study|Disease Progression|7|||
126010594|NCT02341625|453331395|FG006|Overall Study|Disease Progression|28|||
126010595|NCT02341625|453331396|FG007|Overall Study|Disease Progression|5|||
126010596|NCT02341625|453331397|FG008|Overall Study|Disease Progression|4|||
126010597|NCT02341625|453331398|FG009|Overall Study|Disease Progression|19|||
126010598|NCT02341625|453331389|FG000|Overall Study|Study Drug Toxicity|0|||
126010599|NCT02341625|453331390|FG001|Overall Study|Study Drug Toxicity|0|||
126010600|NCT02341625|453331391|FG002|Overall Study|Study Drug Toxicity|0|||
126010601|NCT02341625|453331392|FG003|Overall Study|Study Drug Toxicity|1|||
126010602|NCT02341625|453331393|FG004|Overall Study|Study Drug Toxicity|0|||
126010603|NCT02341625|453331394|FG005|Overall Study|Study Drug Toxicity|3|||
126010604|NCT02341625|453331395|FG006|Overall Study|Study Drug Toxicity|10|||
126010605|NCT02341625|453331396|FG007|Overall Study|Study Drug Toxicity|0|||
126010606|NCT02341625|453331397|FG008|Overall Study|Study Drug Toxicity|0|||
126010607|NCT02341625|453331398|FG009|Overall Study|Study Drug Toxicity|3|||
126010608|NCT02341625|453331389|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126010609|NCT02341625|453331390|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126010610|NCT02341625|453331391|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126010611|NCT02341625|453331392|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126010612|NCT02341625|453331393|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126010613|NCT02341625|453331394|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126010614|NCT02341625|453331395|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
126010615|NCT02341625|453331396|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
126010616|NCT02341625|453331397|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126010617|NCT02341625|453331398|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
126010618|NCT02341625|453331389|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126010619|NCT02341625|453331390|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126010620|NCT02341625|453331391|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126010621|NCT02341625|453331392|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126010622|NCT02341625|453331393|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126010623|NCT02341625|453331394|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126010624|NCT02341625|453331395|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
126010625|NCT02341625|453331396|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
126010626|NCT02341625|453331397|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126010627|NCT02341625|453331398|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126010628|NCT02341625|453331389|FG000|Overall Study|Participant Withdrew Consent|0|||
126010629|NCT02341625|453331390|FG001|Overall Study|Participant Withdrew Consent|0|||
126010630|NCT02341625|453331391|FG002|Overall Study|Participant Withdrew Consent|0|||
126010631|NCT02341625|453331392|FG003|Overall Study|Participant Withdrew Consent|1|||
126010632|NCT02341625|453331393|FG004|Overall Study|Participant Withdrew Consent|0|||
126010633|NCT02341625|453331394|FG005|Overall Study|Participant Withdrew Consent|0|||
126010634|NCT02341625|453331395|FG006|Overall Study|Participant Withdrew Consent|0|||
126010635|NCT02341625|453331396|FG007|Overall Study|Participant Withdrew Consent|0|||
126010636|NCT02341625|453331397|FG008|Overall Study|Participant Withdrew Consent|0|||
126010637|NCT02341625|453331398|FG009|Overall Study|Participant Withdrew Consent|0|||
126010638|NCT02341625|453331389|FG000|Overall Study|Completed Treatment as per Protocol|0|||
126344078|NCT01773928|454554181|FG000|Overall Study|Physician Decision|0|||
126344079|NCT01773928|454554182|FG001|Overall Study|Physician Decision|0|||
126344080|NCT01773928|454554183|FG002|Overall Study|Physician Decision|0|||
126344081|NCT01773928|454554184|FG003|Overall Study|Physician Decision|1|||
126344082|NCT01773928|454554185|FG004|Overall Study|Physician Decision|0|||
126344083|NCT01773928|454554186|FG005|Overall Study|Physician Decision|0|||
126344084|NCT01773928|454554187|FG006|Overall Study|Physician Decision|0|||
126344085|NCT01773928|454554188|FG007|Overall Study|Physician Decision|0|||
126344086|NCT01773928|454554189|FG008|Overall Study|Physician Decision|0|||
126344087|NCT01773928|454554181|FG000|Overall Study|Withdrawal by Subject|5|||
126010639|NCT02341625|453331390|FG001|Overall Study|Completed Treatment as per Protocol|0|||
126010640|NCT02341625|453331391|FG002|Overall Study|Completed Treatment as per Protocol|0|||
126091105|NCT03820947|453626922|FG004|Overall Study|Withdrawal by Subject|5|||
126010641|NCT02341625|453331392|FG003|Overall Study|Completed Treatment as per Protocol|0|||
126344088|NCT01773928|454554182|FG001|Overall Study|Withdrawal by Subject|4|||
126344089|NCT01773928|454554183|FG002|Overall Study|Withdrawal by Subject|4|||
126344090|NCT01773928|454554184|FG003|Overall Study|Withdrawal by Subject|4|||
126344091|NCT01773928|454554185|FG004|Overall Study|Withdrawal by Subject|7|||
126344092|NCT01773928|454554186|FG005|Overall Study|Withdrawal by Subject|1|||
126344093|NCT01773928|454554187|FG006|Overall Study|Withdrawal by Subject|0|||
126344094|NCT01773928|454554188|FG007|Overall Study|Withdrawal by Subject|0|||
126344095|NCT01773928|454554189|FG008|Overall Study|Withdrawal by Subject|1|||
126344096|NCT01773928|454554181|FG000|Overall Study|Lost to Follow-up|0|||
126344097|NCT01773928|454554182|FG001|Overall Study|Lost to Follow-up|0|||
126344098|NCT01773928|454554183|FG002|Overall Study|Lost to Follow-up|0|||
126344099|NCT01773928|454554184|FG003|Overall Study|Lost to Follow-up|0|||
126344100|NCT01773928|454554185|FG004|Overall Study|Lost to Follow-up|0|||
126344101|NCT01773928|454554186|FG005|Overall Study|Lost to Follow-up|1|||
126344102|NCT01773928|454554187|FG006|Overall Study|Lost to Follow-up|0|||
126344103|NCT01773928|454554188|FG007|Overall Study|Lost to Follow-up|0|||
126344104|NCT01773928|454554189|FG008|Overall Study|Lost to Follow-up|0|||
126344105|NCT01773928|454554181|FG000|Overall Study|Subject misrepresented age|0|||
126344106|NCT01773928|454554182|FG001|Overall Study|Subject misrepresented age|1|||
126344107|NCT01773928|454554183|FG002|Overall Study|Subject misrepresented age|0|||
126344108|NCT01773928|454554184|FG003|Overall Study|Subject misrepresented age|0|||
126010642|NCT02341625|453331393|FG004|Overall Study|Completed Treatment as per Protocol|0|||
126010643|NCT02341625|453331394|FG005|Overall Study|Completed Treatment as per Protocol|0|||
126010644|NCT02341625|453331395|FG006|Overall Study|Completed Treatment as per Protocol|0|||
126010645|NCT02341625|453331396|FG007|Overall Study|Completed Treatment as per Protocol|0|||
126010646|NCT02341625|453331397|FG008|Overall Study|Completed Treatment as per Protocol|0|||
126010647|NCT02341625|453331398|FG009|Overall Study|Completed Treatment as per Protocol|1|||
126010648|NCT02341625|453331389|FG000|Overall Study|Other Reasons|0|||
126010649|NCT02341625|453331390|FG001|Overall Study|Other Reasons|0|||
126010650|NCT02341625|453331391|FG002|Overall Study|Other Reasons|0|||
126010651|NCT02341625|453331392|FG003|Overall Study|Other Reasons|0|||
126010652|NCT02341625|453331393|FG004|Overall Study|Other Reasons|1|||
126010653|NCT02341625|453331394|FG005|Overall Study|Other Reasons|0|||
126010654|NCT02341625|453331395|FG006|Overall Study|Other Reasons|5|||
126010655|NCT02341625|453331396|FG007|Overall Study|Other Reasons|0|||
126010656|NCT02341625|453331397|FG008|Overall Study|Other Reasons|0|||
126344109|NCT01773928|454554185|FG004|Overall Study|Subject misrepresented age|0|||
126344110|NCT01773928|454554186|FG005|Overall Study|Subject misrepresented age|0|||
126344111|NCT01773928|454554187|FG006|Overall Study|Subject misrepresented age|0|||
126344112|NCT01773928|454554188|FG007|Overall Study|Subject misrepresented age|0|||
126344113|NCT01773928|454554189|FG008|Overall Study|Subject misrepresented age|0|||
126344114|NCT01773928|454554181|FG000|Overall Study|Subject met exclusion criteria|0|||
126344115|NCT01773928|454554182|FG001|Overall Study|Subject met exclusion criteria|0|||
126344116|NCT01773928|454554183|FG002|Overall Study|Subject met exclusion criteria|0|||
126344117|NCT01773928|454554184|FG003|Overall Study|Subject met exclusion criteria|0|||
126344118|NCT01773928|454554185|FG004|Overall Study|Subject met exclusion criteria|0|||
126344119|NCT01773928|454554186|FG005|Overall Study|Subject met exclusion criteria|0|||
126344120|NCT01773928|454554187|FG006|Overall Study|Subject met exclusion criteria|0|||
126344121|NCT01773928|454554188|FG007|Overall Study|Subject met exclusion criteria|0|||
126344122|NCT01773928|454554189|FG008|Overall Study|Subject met exclusion criteria|1|||
126344123|NCT01773928|454554181|FG000|Overall Study|Randomized, had to leave, never returned|0|||
126344124|NCT01773928|454554182|FG001|Overall Study|Randomized, had to leave, never returned|0|||
126344125|NCT01773928|454554183|FG002|Overall Study|Randomized, had to leave, never returned|0|||
126344126|NCT01773928|454554184|FG003|Overall Study|Randomized, had to leave, never returned|1|||
126344127|NCT01773928|454554185|FG004|Overall Study|Randomized, had to leave, never returned|0|||
126344128|NCT01773928|454554186|FG005|Overall Study|Randomized, had to leave, never returned|0|||
126344129|NCT01773928|454554187|FG006|Overall Study|Randomized, had to leave, never returned|0|||
126344130|NCT01773928|454554188|FG007|Overall Study|Randomized, had to leave, never returned|0|||
126344131|NCT01773928|454554189|FG008|Overall Study|Randomized, had to leave, never returned|0|||
126344132|NCT01773928|454554181|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
126344133|NCT01773928|454554182|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
126344134|NCT01773928|454554183|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
126344135|NCT01773928|454554184|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
126344136|NCT01773928|454554185|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
126344137|NCT01773928|454554186|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
126344138|NCT01773928|454554187|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
126344139|NCT01773928|454554188|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
126344140|NCT01773928|454554189|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
126344141|NCT03092752|454554190|FG000|Overall Study|Aged <40 years|14209|||
126344142|NCT03092752|454554190|FG000|Overall Study|At least one claim with T2DM|61299|||
126344143|NCT03092752|454554190|FG000|Overall Study|Having no claim of study drugs|29282|||
126344144|NCT03092752|454554190|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
126344145|NCT03092752|454554190|FG000|Overall Study|<6 month history|245900|||
126344146|NCT03729362|454555818|FG000|Overall Study|Withdrawal by Subject|2|||
126344147|NCT03729362|454555819|FG001|Overall Study|Withdrawal by Subject|0|||
126344148|NCT03729362|454555818|FG000|Overall Study|Physician Decision|1|||
126344149|NCT03729362|454555819|FG001|Overall Study|Physician Decision|0|||
126344150|NCT03729362|454555818|FG000|Overall Study|COVID-19 Pandemic|1|||
126344151|NCT03729362|454555819|FG001|Overall Study|COVID-19 Pandemic|0|||
126344152|NCT03729362|454555818|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
126344153|NCT03729362|454555819|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
126344154|NCT03729362|454555818|FG000|Overall Study|Adverse Event|0|||
126344155|NCT03729362|454555819|FG001|Overall Study|Adverse Event|1|||
126344156|NCT03729362|454555818|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
126344157|NCT03729362|454555819|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
126344158|NCT01113749|454555820|FG000|Overall Study|Lost to Follow-up|1|||
126344159|NCT01113749|454555821|FG001|Overall Study|Lost to Follow-up|2|||
126344160|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
126010657|NCT02341625|453331398|FG009|Overall Study|Other Reasons|2|||
126344161|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
126344162|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Death|1|||
126344163|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Death|3|||
126344164|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
126010658|NCT02341625|453331389|FG000|Overall Study|Not Reported|0|||
126010659|NCT02341625|453331390|FG001|Overall Study|Not Reported|0|||
126010660|NCT02341625|453331391|FG002|Overall Study|Not Reported|0|||
126010661|NCT02341625|453331392|FG003|Overall Study|Not Reported|0|||
126010662|NCT02341625|453331393|FG004|Overall Study|Not Reported|0|||
126010663|NCT02341625|453331394|FG005|Overall Study|Not Reported|0|||
126010664|NCT02341625|453331395|FG006|Overall Study|Not Reported|0|||
126010665|NCT02341625|453331396|FG007|Overall Study|Not Reported|0|||
126010666|NCT02341625|453331397|FG008|Overall Study|Not Reported|0|||
126010667|NCT02341625|453331398|FG009|Overall Study|Not Reported|3|||
126010668|NCT01839877|453331402|FG000|Overall Study|Protocol Violation|1|||
126010669|NCT01726023|453331403|FG000|Overall Study|Death|1|||
126010670|NCT01726023|453331404|FG001|Overall Study|Death|1|||
126010671|NCT01726023|453331403|FG000|Overall Study|Lost to Follow-up|5|||
126010672|NCT01726023|453331404|FG001|Overall Study|Lost to Follow-up|10|||
126010673|NCT01726023|453331403|FG000|Overall Study|Other Eligibility criteria|7|||
126010674|NCT01726023|453331404|FG001|Overall Study|Other Eligibility criteria|7|||
126010675|NCT01726023|453331403|FG000|Overall Study|Withdrawal by Subject|16|||
126010676|NCT01726023|453331404|FG001|Overall Study|Withdrawal by Subject|8|||
126010677|NCT04536077|453331407|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
126010678|NCT04536077|453331408|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
126010679|NCT04536077|453331407|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
126010680|NCT04536077|453331408|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
126010681|NCT05484726|453331409|FG000|Overall Study|Protocol Violation|3|||
126010682|NCT05484726|453331410|FG001|Overall Study|Protocol Violation|3|||
126010683|NCT05484726|453331409|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
126010684|NCT05484726|453331410|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
126010685|NCT05484726|453331409|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
126010686|NCT05484726|453331410|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
126010687|NCT05484726|453331409|FG000|Overall Study|continued need of mechanical ventilation|2|||
126010688|NCT05484726|453331410|FG001|Overall Study|continued need of mechanical ventilation|3|||
126010689|NCT05484726|453331409|FG000|Overall Study|Withdrawal by Subject|2|||
126010690|NCT05484726|453331410|FG001|Overall Study|Withdrawal by Subject|3|||
126010691|NCT05484726|453331409|FG000|Overall Study|IVH (G III & IV)|2|||
126010692|NCT05484726|453331410|FG001|Overall Study|IVH (G III & IV)|1|||
126010693|NCT05484726|453331409|FG000|Overall Study|NEC (stage II & III)|2|||
126010694|NCT05484726|453331410|FG001|Overall Study|NEC (stage II & III)|3|||
126010695|NCT00554801|453331411|FG000|Overall Study|left area before completion|5|||
126010696|NCT00554801|453331412|FG001|Overall Study|left area before completion|0|||
126010697|NCT00554801|453331411|FG000|Overall Study|Withdrawal by Subject|14|||
126010698|NCT00554801|453331412|FG001|Overall Study|Withdrawal by Subject|0|||
126010699|NCT02357784|453331413|FG000|Overall Study|Withdrawal by Subject|1|||
126010700|NCT02698241|453331419|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
126010701|NCT02698241|453331419|FG000|Overall Study|Screening not met|7|||
126010702|NCT02698241|453331419|FG000|Overall Study|Withdrawal by Subject|7|||
126010703|NCT02698241|453331419|FG000|Overall Study|Physician Decision|2|||
126010704|NCT02698241|453331419|FG000|Overall Study|Subject underwent system modification|2|||
126010705|NCT02698241|453331419|FG000|Overall Study|Lost to Follow-up|3|||
126010706|NCT02698241|453331419|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
126010707|NCT02698241|453331419|FG000|Overall Study|geographic and licensing issue|1|||
126010708|NCT02698241|453331419|FG000|Overall Study|Death|2|||
126010709|NCT01838551|453331423|FG000|Overall Study|Adverse Event|16|||
126010710|NCT01838551|453331423|FG000|Overall Study|Death|1|||
126344165|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
126344166|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
126344167|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
126344168|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
126344169|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
126344170|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
126344171|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
126344172|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
126344173|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
126344174|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
126344175|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
126344176|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
126344177|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
126344178|NCT00362232|454555822|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
126344179|NCT00362232|454555823|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
126344180|NCT00362232|454555822|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
126344181|NCT00362232|454555823|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
126010711|NCT01838551|453331423|FG000|Overall Study|Lack of Efficacy|10|||
126010712|NCT01838551|453331423|FG000|Overall Study|Physician Decision|4|||
126344182|NCT00362232|454555822|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
126010713|NCT01838551|453331423|FG000|Overall Study|Withdrawal by Subject|10|||
126010714|NCT01838551|453331423|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
126010715|NCT00906282|453331424|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
126010716|NCT00906282|453331424|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
126010717|NCT00906282|453331424|FG000|Preoperative Chemotherapy|Progressive disease|6|||
126010718|NCT00906282|453331424|FG000|Preoperative Chemotherapy|Toxicity|1|||
126010719|NCT02289560|453331425|FG000|Overall Study|Lost to Follow-up|6|||
126010720|NCT02289560|453331425|FG000|Overall Study|Alternative Treatment|4|||
126344183|NCT00362232|454555823|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
126344184|NCT00362232|454555822|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
126344185|NCT00362232|454555823|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
126344186|NCT00375752|454555827|FG000|Overall Study|Lack of Efficacy|4|||
126344187|NCT00375752|454555828|FG001|Overall Study|Lack of Efficacy|4|||
126344188|NCT00375752|454555827|FG000|Overall Study|Adverse Event|1|||
126344189|NCT00375752|454555828|FG001|Overall Study|Adverse Event|6|||
126344190|NCT00375752|454555827|FG000|Overall Study|Withdrawal by Subject|6|||
126344191|NCT00375752|454555828|FG001|Overall Study|Withdrawal by Subject|1|||
126344192|NCT00375752|454555827|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
126344193|NCT00375752|454555828|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
126344194|NCT00375752|454555827|FG000|Overall Study|Protocol Violation|0|||
126344195|NCT00375752|454555828|FG001|Overall Study|Protocol Violation|2|||
126344196|NCT00375752|454555827|FG000|Overall Study|Administrative Problems|0|||
126344197|NCT00375752|454555828|FG001|Overall Study|Administrative Problems|1|||
126344198|NCT00961064|454555834|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
126344199|NCT00961064|454555834|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
126344200|NCT00961064|454555834|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
126344201|NCT00961064|454555834|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
126344202|NCT00961064|454555834|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
126344203|NCT00961064|454555834|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
126344204|NCT00961064|454555834|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
126344205|NCT00961064|454555834|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
126344206|NCT00576758|454555835|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
126344207|NCT00576758|454555836|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
126344208|NCT00576758|454555835|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
126344209|NCT00576758|454555836|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
126344210|NCT00576758|454555835|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
126344211|NCT00576758|454555836|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
126344212|NCT00576758|454555835|FG000|Induction Treatment Period|Death|1|||
126344213|NCT00576758|454555836|FG001|Induction Treatment Period|Death|0|||
126344214|NCT00576758|454555835|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
126344215|NCT00576758|454555836|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
126344216|NCT00576758|454555835|FG000|Induction Treatment Period|Withdrew consent|1|||
126344217|NCT00576758|454555836|FG001|Induction Treatment Period|Withdrew consent|0|||
126344218|NCT00576758|454555835|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
126344219|NCT00576758|454555836|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
126344220|NCT00576758|454555835|FG000|Extension Treatment Period|Death|1|||
126344221|NCT00576758|454555836|FG001|Extension Treatment Period|Death|1|||
126344222|NCT00576758|454555835|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
126344223|NCT00576758|454555836|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
126344224|NCT00576758|454555835|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
126344225|NCT00576758|454555836|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
126344226|NCT00576758|454555835|FG000|Extension Treatment Period|Administrative/Other|3|||
126344227|NCT00576758|454555836|FG001|Extension Treatment Period|Administrative/Other|1|||
126344228|NCT00576758|454555835|FG000|Follow-up Period|Administrative/Other|6|||
126344229|NCT00576758|454555836|FG001|Follow-up Period|Administrative/Other|8|||
126344230|NCT00576758|454555835|FG000|Follow-up Period|Death|3|||
126344231|NCT00576758|454555836|FG001|Follow-up Period|Death|3|||
126344232|NCT00576758|454555835|FG000|Follow-up Period|Insufficient therapeutic response|16|||
126344233|NCT00576758|454555836|FG001|Follow-up Period|Insufficient therapeutic response|5|||
126344234|NCT00576758|454555835|FG000|Follow-up Period|Withdrew consent|2|||
126010721|NCT02289560|453331425|FG000|Overall Study|Inadequate Treatment|2|||
126010722|NCT02289560|453331425|FG000|Overall Study|Withdrawal by Subject|23|||
126010723|NCT02540213|453331426|FG000|Overall Study|Death/adverse event|18|||
126344235|NCT00576758|454555836|FG001|Follow-up Period|Withdrew consent|1|||
126344236|NCT00761319|454555837|FG000|Overall Study|Protocol Violation|21|||
126344237|NCT00761319|454555838|FG001|Overall Study|Protocol Violation|14|||
126344238|NCT00761319|454555837|FG000|Overall Study|Adverse Event|11|||
126344239|NCT00761319|454555838|FG001|Overall Study|Adverse Event|7|||
126010724|NCT02540213|453331426|FG000|Overall Study|Administrative reasons|3|||
126010725|NCT02540213|453331426|FG000|Overall Study|Kidney transplant|3|||
126010726|NCT02540213|453331426|FG000|Overall Study|Lack of Efficacy|6|||
126010727|NCT02540213|453331426|FG000|Overall Study|Consent withdrawn|7|||
126010728|NCT02540213|453331426|FG000|Overall Study|Enrolled but not treated|2|||
126010729|NCT01981356|453331429|FG000|Overall Study|Lost to Follow-up|4|||
126010730|NCT01981356|453331430|FG001|Overall Study|Lost to Follow-up|1|||
126010731|NCT01981356|453331429|FG000|Overall Study|Withdrawal by Subject|1|||
126010732|NCT01981356|453331430|FG001|Overall Study|Withdrawal by Subject|1|||
126010733|NCT01981356|453331429|FG000|Overall Study|Protocol Violation|2|||
126010734|NCT01981356|453331430|FG001|Overall Study|Protocol Violation|0|||
126010735|NCT00290706|453331433|FG000|Overall Study|Withdrawal by Subject|2|||
126010736|NCT00290706|453331434|FG001|Overall Study|Withdrawal by Subject|0|||
126010737|NCT00290706|453331435|FG002|Overall Study|Withdrawal by Subject|0|||
126010738|NCT00290706|453331436|FG003|Overall Study|Withdrawal by Subject|0|||
126010739|NCT00290706|453331433|FG000|Overall Study|Progressive Disease|3|||
126010740|NCT00290706|453331434|FG001|Overall Study|Progressive Disease|5|||
126010741|NCT00290706|453331435|FG002|Overall Study|Progressive Disease|4|||
126010742|NCT00290706|453331436|FG003|Overall Study|Progressive Disease|10|||
126010743|NCT00290706|453331433|FG000|Overall Study|Adverse Event|0|||
126010744|NCT00290706|453331434|FG001|Overall Study|Adverse Event|1|||
126010745|NCT00290706|453331435|FG002|Overall Study|Adverse Event|2|||
126010746|NCT00290706|453331436|FG003|Overall Study|Adverse Event|0|||
126010747|NCT00290706|453331433|FG000|Overall Study|Receive auto transplant or radiation|0|||
126010748|NCT00290706|453331434|FG001|Overall Study|Receive auto transplant or radiation|0|||
126010749|NCT00290706|453331435|FG002|Overall Study|Receive auto transplant or radiation|0|||
126010750|NCT00290706|453331436|FG003|Overall Study|Receive auto transplant or radiation|1|||
126010751|NCT00290706|453331433|FG000|Overall Study|Physician Decision|0|||
126010752|NCT00290706|453331434|FG001|Overall Study|Physician Decision|0|||
126010753|NCT00290706|453331435|FG002|Overall Study|Physician Decision|0|||
126010754|NCT00290706|453331436|FG003|Overall Study|Physician Decision|1|||
126344240|NCT00761319|454555837|FG000|Overall Study|Withdrawal by Subject|8|||
126344241|NCT00761319|454555838|FG001|Overall Study|Withdrawal by Subject|7|||
126344242|NCT00761319|454555837|FG000|Overall Study|Noncompliance|4|||
126344243|NCT00761319|454555838|FG001|Overall Study|Noncompliance|3|||
126344244|NCT00761319|454555837|FG000|Overall Study|Lost to Follow-up|1|||
126344245|NCT00761319|454555838|FG001|Overall Study|Lost to Follow-up|1|||
126344246|NCT00761319|454555837|FG000|Overall Study|Nonspecified|2|||
126344247|NCT00761319|454555838|FG001|Overall Study|Nonspecified|2|||
126344248|NCT00761319|454555837|FG000|Overall Study|Missing|1|||
126344249|NCT00761319|454555838|FG001|Overall Study|Missing|0|||
126344250|NCT01715298|454555839|FG000|Overall Study|Lost to Follow-up|0|||
126344251|NCT01715298|454555840|FG001|Overall Study|Lost to Follow-up|2|||
126344252|NCT01715298|454555839|FG000|Overall Study|Patient/guardian decision|7|||
126344253|NCT01715298|454555840|FG001|Overall Study|Patient/guardian decision|9|||
126344254|NCT01499511|454555841|FG000|Overall Study|Death|1|||
126344255|NCT01499511|454555842|FG001|Overall Study|Death|0|||
126344256|NCT00726453|454555844|FG000|Primary Enrollment Group|Death|18|||
126344257|NCT00726453|454555845|FG001|Primary Enrollment Group|Death|0|||
126344258|NCT00726453|454555844|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
126010755|NCT00605033|453331437|FG000|Overall Study|Adverse Event|2|||
126344259|NCT00726453|454555845|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
126344260|NCT00726453|454555844|FG000|38 mm Length Group|Death|0|||
126344261|NCT00726453|454555845|FG001|38 mm Length Group|Death|3|||
126344262|NCT01432951|454555846|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
126344263|NCT00853385|454555847|FG000|Overall Study|Death|0|||
126010756|NCT00605033|453331438|FG001|Overall Study|Adverse Event|2|||
126010757|NCT00605033|453331437|FG000|Overall Study|Lost to Follow-up|1|||
126010758|NCT00605033|453331438|FG001|Overall Study|Lost to Follow-up|1|||
126010759|NCT00605033|453331437|FG000|Overall Study|Withdrawal by Subject|3|||
126010760|NCT00605033|453331438|FG001|Overall Study|Withdrawal by Subject|4|||
126010761|NCT00605033|453331437|FG000|Overall Study|Protocol Violation|1|||
126010762|NCT00605033|453331438|FG001|Overall Study|Protocol Violation|1|||
126010763|NCT03395353|453331439|FG000|Overall Study|Adverse Event|20|||
126010764|NCT03395353|453331439|FG000|Overall Study|Protocol Violation|1|||
126010765|NCT03395353|453331439|FG000|Overall Study|Lack of Efficacy|3|||
126010766|NCT03395353|453331439|FG000|Overall Study|Withdrawal by Subject|24|||
126010767|NCT03395353|453331439|FG000|Overall Study|Discontinued visit|1|||
126010768|NCT03395353|453331439|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
126010769|NCT03395353|453331439|FG000|Overall Study|Physician Decision|4|||
126010770|NCT03395353|453331439|FG000|Overall Study|Early termination of overall study|33|||
126010771|NCT02486588|453331440|FG000|Overall Study|Randomized in error- ineligible|738|||
126010772|NCT02486588|453331441|FG001|Overall Study|Randomized in error- ineligible|750|||
126010773|NCT02486588|453331442|FG002|Overall Study|Randomized in error- ineligible|755|||
126010774|NCT02486588|453331443|FG003|Overall Study|Randomized in error- ineligible|738|||
126010775|NCT02486588|453331444|FG004|Overall Study|Randomized in error- ineligible|746|||
126010776|NCT02486588|453331445|FG005|Overall Study|Randomized in error- ineligible|746|||
126010777|NCT03354390|453331446|FG000|Level 1|Death|2|||
126010778|NCT03354390|453331447|FG001|Level 1|Death|0|||
126010779|NCT03354390|453331448|FG002|Level 1|Death|0|||
126010780|NCT03354390|453331449|FG003|Level 1|Death|0|||
126010781|NCT03354390|453331446|FG000|Level 1|Physician Decision|1|||
126010782|NCT03354390|453331447|FG001|Level 1|Physician Decision|0|||
126010783|NCT03354390|453331448|FG002|Level 1|Physician Decision|0|||
126010784|NCT03354390|453331449|FG003|Level 1|Physician Decision|0|||
126010785|NCT03354390|453331446|FG000|Level 2|Physician Decision|0|||
126010786|NCT03354390|453331447|FG001|Level 2|Physician Decision|2|||
126010787|NCT03354390|453331448|FG002|Level 2|Physician Decision|0|||
126010788|NCT03354390|453331449|FG003|Level 2|Physician Decision|0|||
126010789|NCT03354390|453331446|FG000|Level 2|Lack of Efficacy|0|||
126010790|NCT03354390|453331447|FG001|Level 2|Lack of Efficacy|1|||
126010791|NCT03354390|453331448|FG002|Level 2|Lack of Efficacy|0|||
126010792|NCT03354390|453331449|FG003|Level 2|Lack of Efficacy|0|||
126010793|NCT03354390|453331446|FG000|Level 2|Lost to Follow-up|0|||
126010794|NCT03354390|453331447|FG001|Level 2|Lost to Follow-up|1|||
126010795|NCT03354390|453331448|FG002|Level 2|Lost to Follow-up|0|||
126010796|NCT03354390|453331449|FG003|Level 2|Lost to Follow-up|0|||
126010797|NCT03354390|453331446|FG000|Level 3|Death|0|||
126010798|NCT03354390|453331447|FG001|Level 3|Death|0|||
126010799|NCT03354390|453331448|FG002|Level 3|Death|1|||
126010800|NCT03354390|453331449|FG003|Level 3|Death|0|||
126010801|NCT03354390|453331446|FG000|Level 3|Physician Decision|0|||
126010802|NCT03354390|453331447|FG001|Level 3|Physician Decision|0|||
126010803|NCT03354390|453331448|FG002|Level 3|Physician Decision|2|||
126010804|NCT03354390|453331449|FG003|Level 3|Physician Decision|0|||
126010805|NCT03354390|453331446|FG000|Level 4|Death|0|||
126010806|NCT03354390|453331447|FG001|Level 4|Death|0|||
126010807|NCT03354390|453331448|FG002|Level 4|Death|0|||
126344264|NCT00853385|454555848|FG001|Overall Study|Death|0|||
126344265|NCT00853385|454555849|FG002|Overall Study|Death|0|||
126344266|NCT00853385|454555850|FG003|Overall Study|Death|0|||
126344267|NCT00853385|454555851|FG004|Overall Study|Death|1|||
126344268|NCT00853385|454555847|FG000|Overall Study|Adverse Event|24|||
126344269|NCT00853385|454555848|FG001|Overall Study|Adverse Event|24|||
126344270|NCT00853385|454555849|FG002|Overall Study|Adverse Event|2|||
126344271|NCT00853385|454555850|FG003|Overall Study|Adverse Event|5|||
126344272|NCT00853385|454555851|FG004|Overall Study|Adverse Event|22|||
126344273|NCT00853385|454555847|FG000|Overall Study|Lack of Efficacy|6|||
126344274|NCT00853385|454555848|FG001|Overall Study|Lack of Efficacy|7|||
126344275|NCT00853385|454555849|FG002|Overall Study|Lack of Efficacy|3|||
126344276|NCT00853385|454555850|FG003|Overall Study|Lack of Efficacy|3|||
126344277|NCT00853385|454555851|FG004|Overall Study|Lack of Efficacy|6|||
126344278|NCT00853385|454555847|FG000|Overall Study|Lost to Follow-up|2|||
126344279|NCT00853385|454555848|FG001|Overall Study|Lost to Follow-up|1|||
126344280|NCT00853385|454555849|FG002|Overall Study|Lost to Follow-up|0|||
126344281|NCT00853385|454555850|FG003|Overall Study|Lost to Follow-up|0|||
126344282|NCT00853385|454555851|FG004|Overall Study|Lost to Follow-up|0|||
126344283|NCT00853385|454555847|FG000|Overall Study|Withdrawal by Subject|4|||
126344284|NCT00853385|454555848|FG001|Overall Study|Withdrawal by Subject|2|||
126344285|NCT00853385|454555849|FG002|Overall Study|Withdrawal by Subject|0|||
126344286|NCT00853385|454555850|FG003|Overall Study|Withdrawal by Subject|1|||
126344287|NCT00853385|454555851|FG004|Overall Study|Withdrawal by Subject|1|||
126344288|NCT00853385|454555847|FG000|Overall Study|Other|18|||
126344289|NCT00853385|454555848|FG001|Overall Study|Other|9|||
126344290|NCT00853385|454555849|FG002|Overall Study|Other|4|||
126344291|NCT00853385|454555850|FG003|Overall Study|Other|4|||
126344292|NCT00853385|454555851|FG004|Overall Study|Other|12|||
126344293|NCT00915525|454555854|FG000|Overall Study|Protocol Violation|9|||
126344294|NCT00915525|454555855|FG001|Overall Study|Protocol Violation|4|||
126344295|NCT00915525|454555854|FG000|Overall Study|Withdrawal by Subject|59|||
126344296|NCT00915525|454555855|FG001|Overall Study|Withdrawal by Subject|21|||
126344297|NCT00915525|454555854|FG000|Overall Study|Lost to Follow-up|27|||
126344298|NCT00915525|454555855|FG001|Overall Study|Lost to Follow-up|16|||
126344299|NCT00915525|454555854|FG000|Overall Study|Pregnancy|2|||
126344300|NCT00915525|454555855|FG001|Overall Study|Pregnancy|0|||
126344301|NCT00915525|454555854|FG000|Overall Study|Lack of Efficacy|15|||
126344302|NCT00915525|454555855|FG001|Overall Study|Lack of Efficacy|32|||
126344303|NCT00915525|454555854|FG000|Overall Study|Adverse Event|29|||
126344304|NCT00915525|454555855|FG001|Overall Study|Adverse Event|13|||
126344305|NCT00915525|454555854|FG000|Overall Study|Missing|12|||
126010808|NCT03354390|453331449|FG003|Level 4|Death|3|||
126344306|NCT00915525|454555855|FG001|Overall Study|Missing|1|||
126344307|NCT00915525|454555854|FG000|Overall Study|Other Reason|35|||
126344308|NCT00915525|454555855|FG001|Overall Study|Other Reason|12|||
126344309|NCT00915525|454555854|FG000|Overall Study|Site Closed|27|||
126344310|NCT00915525|454555855|FG001|Overall Study|Site Closed|9|||
126344311|NCT00915525|454555854|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
126344312|NCT00915525|454555855|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
126344313|NCT00915525|454555854|FG000|Overall Study|Study Burden|28|||
126344314|NCT00915525|454555855|FG001|Overall Study|Study Burden|12|||
126344315|NCT00915525|454555854|FG000|Overall Study|Non-Compliance|3|||
126010809|NCT02960659|453333357|FG000|Overall Study|Withdrawal by Subject|1|||
126010810|NCT02960659|453333358|FG001|Overall Study|Withdrawal by Subject|0|||
126010811|NCT02960659|453333357|FG000|Overall Study|Poor compliance|0|||
126344316|NCT00915525|454555855|FG001|Overall Study|Non-Compliance|1|||
126010812|NCT02960659|453333358|FG001|Overall Study|Poor compliance|1|||
126344317|NCT00915525|454555854|FG000|Overall Study|Patient Moved|15|||
126344318|NCT00915525|454555855|FG001|Overall Study|Patient Moved|9|||
126344319|NCT00941928|454555856|FG000|Overall Study|Withdrawal by Subject|1|||
126344320|NCT00941928|454555856|FG000|Overall Study|Disease Progression|1|||
126344321|NCT02765035|454555868|FG000|First Intervention (90 Days)|Adverse Event|1|||
126344322|NCT02765035|454555869|FG001|First Intervention (90 Days)|Adverse Event|1|||
126344323|NCT02765035|454555868|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
126344324|NCT02765035|454555869|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
126344325|NCT01712178|454555870|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
126344326|NCT01712178|454555871|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
126344327|NCT01712178|454555870|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
126344328|NCT01712178|454555871|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
126344329|NCT01712178|454555870|FG000|Overall Study|Lost to Follow-up|0|||
126344330|NCT01712178|454555871|FG001|Overall Study|Lost to Follow-up|1|||
126344331|NCT00984867|454555872|FG000|Overall Study|Adverse Event|3|||
126344332|NCT00984867|454555873|FG001|Overall Study|Adverse Event|7|||
126344333|NCT00984867|454555872|FG000|Overall Study|Death|1|||
126344334|NCT00984867|454555873|FG001|Overall Study|Death|0|||
126344335|NCT00984867|454555872|FG000|Overall Study|Withdrawal by Subject|13|||
126344336|NCT00984867|454555873|FG001|Overall Study|Withdrawal by Subject|4|||
126344337|NCT00984867|454555872|FG000|Overall Study|Lost to Follow-up|3|||
126344338|NCT00984867|454555873|FG001|Overall Study|Lost to Follow-up|4|||
126344339|NCT00984867|454555872|FG000|Overall Study|Poor/non-compliance|0|||
126344340|NCT00984867|454555873|FG001|Overall Study|Poor/non-compliance|1|||
126344341|NCT00984867|454555872|FG000|Overall Study|Subject no longer meets study criteria|1|||
126344342|NCT00984867|454555873|FG001|Overall Study|Subject no longer meets study criteria|1|||
126344343|NCT00984867|454555872|FG000|Overall Study|site closing|1|||
126344344|NCT00984867|454555873|FG001|Overall Study|site closing|0|||
126344345|NCT00984867|454555872|FG000|Overall Study|lack of efficacy and subject compliance|1|||
126344346|NCT00984867|454555873|FG001|Overall Study|lack of efficacy and subject compliance|0|||
126344347|NCT01200355|454555878|FG000|Overall Study|Death|7|||
126344348|NCT01200355|454555879|FG001|Overall Study|Death|2|||
126344349|NCT03834350|454555880|FG000|Overall Study|Withdrawal by Subject|1|||
126344350|NCT02765165|454555881|FG000|Treatment Period|Progressive disease|3|||
126344351|NCT02765165|454555882|FG001|Treatment Period|Progressive disease|2|||
126344352|NCT02765165|454555883|FG002|Treatment Period|Progressive disease|3|||
126344353|NCT02765165|454555884|FG003|Treatment Period|Progressive disease|3|||
126344354|NCT02765165|454555885|FG004|Treatment Period|Progressive disease|4|||
126344355|NCT02765165|454555886|FG005|Treatment Period|Progressive disease|2|||
126344356|NCT02765165|454555887|FG006|Treatment Period|Progressive disease|2|||
126344357|NCT02765165|454555881|FG000|Treatment Period|Physician Decision|0|||
126344358|NCT02765165|454555882|FG001|Treatment Period|Physician Decision|1|||
126344359|NCT02765165|454555883|FG002|Treatment Period|Physician Decision|0|||
126344360|NCT02765165|454555884|FG003|Treatment Period|Physician Decision|0|||
126344361|NCT02765165|454555885|FG004|Treatment Period|Physician Decision|0|||
126344362|NCT02765165|454555886|FG005|Treatment Period|Physician Decision|0|||
126344363|NCT02765165|454555887|FG006|Treatment Period|Physician Decision|0|||
126344364|NCT02765165|454555881|FG000|Treatment Period|Adverse Event|0|||
126344365|NCT02765165|454555882|FG001|Treatment Period|Adverse Event|1|||
126344366|NCT02765165|454555883|FG002|Treatment Period|Adverse Event|0|||
126344367|NCT02765165|454555884|FG003|Treatment Period|Adverse Event|0|||
126344368|NCT02765165|454555885|FG004|Treatment Period|Adverse Event|0|||
126344369|NCT02765165|454555886|FG005|Treatment Period|Adverse Event|0|||
126344370|NCT02765165|454555887|FG006|Treatment Period|Adverse Event|0|||
126344371|NCT02765165|454555881|FG000|Treatment Period|Withdrawal by Subject|0|||
126344372|NCT02765165|454555882|FG001|Treatment Period|Withdrawal by Subject|0|||
126344373|NCT02765165|454555883|FG002|Treatment Period|Withdrawal by Subject|0|||
126344374|NCT02765165|454555884|FG003|Treatment Period|Withdrawal by Subject|0|||
126344375|NCT02765165|454555885|FG004|Treatment Period|Withdrawal by Subject|2|||
126344376|NCT02765165|454555886|FG005|Treatment Period|Withdrawal by Subject|0|||
126344377|NCT02765165|454555887|FG006|Treatment Period|Withdrawal by Subject|0|||
126344378|NCT02765165|454555881|FG000|Treatment Period|Study terminated|0|||
126344379|NCT02765165|454555882|FG001|Treatment Period|Study terminated|0|||
126344380|NCT02765165|454555883|FG002|Treatment Period|Study terminated|0|||
126344381|NCT02765165|454555884|FG003|Treatment Period|Study terminated|0|||
126344382|NCT02765165|454555885|FG004|Treatment Period|Study terminated|0|||
126344383|NCT02765165|454555886|FG005|Treatment Period|Study terminated|1|||
126344384|NCT02765165|454555887|FG006|Treatment Period|Study terminated|2|||
126344385|NCT02765165|454555881|FG000|Post-treatment Follow-up|Death|1|||
126344386|NCT02765165|454555882|FG001|Post-treatment Follow-up|Death|2|||
126344387|NCT02765165|454555883|FG002|Post-treatment Follow-up|Death|1|||
126344388|NCT02765165|454555884|FG003|Post-treatment Follow-up|Death|1|||
126344389|NCT02765165|454555885|FG004|Post-treatment Follow-up|Death|1|||
126344390|NCT02765165|454555886|FG005|Post-treatment Follow-up|Death|1|||
126344391|NCT02765165|454555887|FG006|Post-treatment Follow-up|Death|0|||
126344392|NCT02765165|454555881|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
126344393|NCT02765165|454555882|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
126344394|NCT02765165|454555883|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
126344395|NCT02765165|454555884|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
126344396|NCT02765165|454555885|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
126344397|NCT02765165|454555886|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
126344398|NCT02765165|454555887|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
126344399|NCT02765165|454555881|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344400|NCT02765165|454555882|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344401|NCT02765165|454555883|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
126344402|NCT02765165|454555884|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344403|NCT02765165|454555885|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344404|NCT02765165|454555886|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344405|NCT02765165|454555887|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344406|NCT02765165|454555881|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344407|NCT02765165|454555882|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344408|NCT02765165|454555883|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
126344409|NCT02765165|454555884|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
126344410|NCT02765165|454555885|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344411|NCT02765165|454555886|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344412|NCT02765165|454555887|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344413|NCT02765165|454555881|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344414|NCT02765165|454555882|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
126344415|NCT02765165|454555883|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344416|NCT02765165|454555884|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344417|NCT02765165|454555885|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344418|NCT02765165|454555886|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344419|NCT02765165|454555887|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344420|NCT02765165|454555881|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
126344421|NCT02765165|454555882|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
126344422|NCT02765165|454555883|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
126344423|NCT02765165|454555884|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
126344424|NCT02765165|454555885|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
126344425|NCT02765165|454555886|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
126344426|NCT02765165|454555887|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
126344427|NCT01206764|454555888|FG000|Overall Study|Adverse Event|20|||
126344428|NCT01206764|454555888|FG000|Overall Study|Abnormal laboratory value|2|||
126344429|NCT01206764|454555888|FG000|Overall Study|Abnormal test procedure result|1|||
126344430|NCT01206764|454555888|FG000|Overall Study|Patient withdrew consent|5|||
126344431|NCT01206764|454555888|FG000|Overall Study|Lost to Follow-up|6|||
126344432|NCT01206764|454555888|FG000|Overall Study|Death|11|||
126344433|NCT01206764|454555888|FG000|Overall Study|New cancer therapy|2|||
126344434|NCT01206764|454555888|FG000|Overall Study|Disease progression|88|||
126344435|NCT01206764|454555888|FG000|Overall Study|Protocol deviation|3|||
126344436|NCT02567188|454555889|FG000|Overall Study|Death|10|||
126344437|NCT02567188|454555889|FG000|Overall Study|Terminated Mircera Treatment|9|||
126344438|NCT02567188|454555889|FG000|Overall Study|Lost to Follow-up|5|||
126344439|NCT02567188|454555889|FG000|Overall Study|Adverse Event|1|||
126344440|NCT02567188|454555889|FG000|Overall Study|Withdrawal by Subject|1|||
126344441|NCT02567188|454555889|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
126344442|NCT02567188|454555889|FG000|Overall Study|Moved and Changed Clinic|1|||
126344443|NCT02567188|454555889|FG000|Overall Study|Started Hemodialysis|2|||
126344444|NCT02567188|454555889|FG000|Overall Study|Protocol Violation|5|||
126344445|NCT00321763|454555891|FG000|Overall Study|Adverse Event|1|||
126344446|NCT00321763|454555892|FG001|Overall Study|Adverse Event|1|||
126344447|NCT00321763|454555893|FG002|Overall Study|Adverse Event|0|||
126344448|NCT00321763|454555894|FG003|Overall Study|Adverse Event|1|||
126344449|NCT00321763|454555891|FG000|Overall Study|Withdrawal by Subject|2|||
126344450|NCT00321763|454555892|FG001|Overall Study|Withdrawal by Subject|0|||
126344451|NCT00321763|454555893|FG002|Overall Study|Withdrawal by Subject|1|||
126344452|NCT00321763|454555894|FG003|Overall Study|Withdrawal by Subject|0|||
126344453|NCT00321763|454555891|FG000|Overall Study|Lost to Follow-up|3|||
126344454|NCT00321763|454555892|FG001|Overall Study|Lost to Follow-up|1|||
126344455|NCT00321763|454555893|FG002|Overall Study|Lost to Follow-up|5|||
126344456|NCT00321763|454555894|FG003|Overall Study|Lost to Follow-up|4|||
126344457|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
126344458|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
126344459|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
126344460|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
126344461|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
126344462|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
126010813|NCT01875250|453333360|FG000|Overall Study|Adverse Event|2|||
126010814|NCT01875250|453333361|FG001|Overall Study|Adverse Event|0|||
126010815|NCT04057196|453333364|FG000|Overall Study|Withdrawal by Subject|3|||
126010816|NCT04057196|453333364|FG000|Overall Study|Death|3|||
126010817|NCT03068468|453333365|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
126010818|NCT03068468|453333366|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
126010819|NCT03068468|453333367|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
126010820|NCT03068468|453333368|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
126344463|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
126344464|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
126344465|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
126344466|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
126344467|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
126344468|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
126344469|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
126344470|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
126344471|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
126344472|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
126344473|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
126344474|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
126344475|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
126344476|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
126344477|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
126344478|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
126344479|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
126344480|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
126344481|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
126344482|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
126344483|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
126344484|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
126344485|NCT00797563|454555898|FG000|Overall Study|Adverse Event|1|||
126344486|NCT00688597|454555899|FG000|Overall Study|Adverse Event|2|||
126344487|NCT00688597|454555900|FG001|Overall Study|Adverse Event|0|||
126344488|NCT00688597|454555901|FG002|Overall Study|Adverse Event|0|||
126344489|NCT00688597|454555899|FG000|Overall Study|Physician Decision|1|||
126344490|NCT00688597|454555900|FG001|Overall Study|Physician Decision|0|||
126344491|NCT00688597|454555901|FG002|Overall Study|Physician Decision|0|||
126344492|NCT05853120|454555904|FG000|Overall Study|Lost to Follow-up|4|||
126344493|NCT05853120|454555905|FG001|Overall Study|Lost to Follow-up|4|||
126344494|NCT05853120|454555904|FG000|Overall Study|Physician Decision|3|||
126344495|NCT05853120|454555905|FG001|Overall Study|Physician Decision|0|||
126344496|NCT05853120|454555904|FG000|Overall Study|Withdrawal by Subject|5|||
126344497|NCT05853120|454555905|FG001|Overall Study|Withdrawal by Subject|2|||
126344498|NCT00465517|454555910|FG000|Overall Study|Adverse Event|7|||
126344499|NCT00465517|454555911|FG001|Overall Study|Adverse Event|3|||
126344500|NCT00465517|454555910|FG000|Overall Study|Lost to Follow-up|1|||
126344501|NCT00465517|454555911|FG001|Overall Study|Lost to Follow-up|0|||
126344502|NCT00465517|454555910|FG000|Overall Study|Withdrawal by Subject|4|||
126344503|NCT00465517|454555911|FG001|Overall Study|Withdrawal by Subject|1|||
126344504|NCT05233761|454555918|FG000|Treatment Period A|Withdrawal by Subject|12|||
126344505|NCT05233761|454555919|FG001|Treatment Period A|Withdrawal by Subject|10|||
126344506|NCT05233761|454555918|FG000|Treatment Period A|Lost to Follow-up|6|||
126344507|NCT05233761|454555919|FG001|Treatment Period A|Lost to Follow-up|12|||
126344508|NCT05233761|454555918|FG000|Treatment Period A|Protocol Violation|8|||
126344509|NCT05233761|454555919|FG001|Treatment Period A|Protocol Violation|15|||
126344510|NCT01604785|454555920|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
126344511|NCT01604785|454555921|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
126344512|NCT05049122|454555924|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
126344513|NCT05049122|454555924|FG000|Overall Study|Participant moved|1|||
126344514|NCT05049122|454555924|FG000|Overall Study|At the direction of the doctor|1|||
126344515|NCT04798027|454555927|FG000|Overall Study|Protocol Violation|0|||
126344516|NCT04798027|454555928|FG001|Overall Study|Protocol Violation|0|||
126344517|NCT04798027|454555929|FG002|Overall Study|Protocol Violation|0|||
126344518|NCT04798027|454555930|FG003|Overall Study|Protocol Violation|0|||
126344519|NCT04798027|454555931|FG004|Overall Study|Protocol Violation|1|||
126344520|NCT04798027|454555932|FG005|Overall Study|Protocol Violation|0|||
126344521|NCT04798027|454555933|FG006|Overall Study|Protocol Violation|0|||
126344522|NCT04798027|454555934|FG007|Overall Study|Protocol Violation|1|||
126344523|NCT04798027|454555935|FG008|Overall Study|Protocol Violation|0|||
126344524|NCT04798027|454555927|FG000|Overall Study|Withdrawal by Subject|1|||
126344525|NCT04798027|454555928|FG001|Overall Study|Withdrawal by Subject|0|||
126010821|NCT03068468|453333365|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
126010822|NCT03068468|453333366|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
126010823|NCT03068468|453333367|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
126010824|NCT03068468|453333368|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
126010825|NCT03068468|453333365|FG000|Placebo-Controlled Period|Adverse Event|16|||
126010826|NCT03068468|453333366|FG001|Placebo-Controlled Period|Adverse Event|21|||
126010827|NCT03068468|453333367|FG002|Placebo-Controlled Period|Adverse Event|0|||
126010828|NCT03068468|453333368|FG003|Placebo-Controlled Period|Adverse Event|0|||
126010829|NCT03068468|453333365|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
126010830|NCT03068468|453333366|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
126010831|NCT03068468|453333367|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
126010832|NCT03068468|453333368|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
126010833|NCT03068468|453333365|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
126010834|NCT03068468|453333366|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
126010835|NCT03068468|453333367|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126010836|NCT03068468|453333368|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126010837|NCT03068468|453333365|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
126010838|NCT03068468|453333366|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
126010839|NCT03068468|453333367|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
126010840|NCT03068468|453333368|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
126010841|NCT03068468|453333365|FG000|Placebo-Controlled Period|Death|0|||
126010842|NCT03068468|453333366|FG001|Placebo-Controlled Period|Death|1|||
126010843|NCT03068468|453333367|FG002|Placebo-Controlled Period|Death|0|||
126010844|NCT03068468|453333368|FG003|Placebo-Controlled Period|Death|0|||
126010845|NCT03068468|453333365|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
126010846|NCT03068468|453333366|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
126010847|NCT03068468|453333367|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
126010848|NCT03068468|453333368|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
126010849|NCT03068468|453333365|FG000|Open-Label Extension Period|Adverse Event|0|||
126010850|NCT03068468|453333366|FG001|Open-Label Extension Period|Adverse Event|0|||
126010851|NCT03068468|453333367|FG002|Open-Label Extension Period|Adverse Event|13|||
126010852|NCT03068468|453333368|FG003|Open-Label Extension Period|Adverse Event|17|||
126010853|NCT03068468|453333365|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
126010854|NCT03068468|453333366|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
126010855|NCT03068468|453333367|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
126010856|NCT03068468|453333368|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
126010857|NCT03068468|453333365|FG000|Open-Label Extension Period|Death|0|||
126010858|NCT03068468|453333366|FG001|Open-Label Extension Period|Death|0|||
126010859|NCT03068468|453333367|FG002|Open-Label Extension Period|Death|0|||
126010860|NCT03068468|453333368|FG003|Open-Label Extension Period|Death|1|||
126010861|NCT03068468|453333365|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
126010862|NCT03068468|453333366|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
126010863|NCT03068468|453333367|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
126010864|NCT03068468|453333368|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
126344526|NCT04798027|454555929|FG002|Overall Study|Withdrawal by Subject|1|||
126344527|NCT04798027|454555930|FG003|Overall Study|Withdrawal by Subject|1|||
126344528|NCT04798027|454555931|FG004|Overall Study|Withdrawal by Subject|1|||
126344529|NCT04798027|454555932|FG005|Overall Study|Withdrawal by Subject|1|||
126344530|NCT04798027|454555933|FG006|Overall Study|Withdrawal by Subject|3|||
126344531|NCT04798027|454555934|FG007|Overall Study|Withdrawal by Subject|2|||
126344532|NCT04798027|454555935|FG008|Overall Study|Withdrawal by Subject|2|||
126344533|NCT04798027|454555927|FG000|Overall Study|Lost to Follow-up|1|||
126344534|NCT04798027|454555928|FG001|Overall Study|Lost to Follow-up|3|||
126344535|NCT04798027|454555929|FG002|Overall Study|Lost to Follow-up|0|||
126344536|NCT04798027|454555930|FG003|Overall Study|Lost to Follow-up|0|||
126344537|NCT04798027|454555931|FG004|Overall Study|Lost to Follow-up|0|||
126344538|NCT04798027|454555932|FG005|Overall Study|Lost to Follow-up|1|||
126344539|NCT04798027|454555933|FG006|Overall Study|Lost to Follow-up|0|||
126344540|NCT04798027|454555934|FG007|Overall Study|Lost to Follow-up|0|||
126344541|NCT04798027|454555935|FG008|Overall Study|Lost to Follow-up|1|||
126344542|NCT04798027|454555927|FG000|Overall Study|Withdrawal by Sponsor|8|||
126344543|NCT04798027|454555928|FG001|Overall Study|Withdrawal by Sponsor|22|||
126344544|NCT04798027|454555929|FG002|Overall Study|Withdrawal by Sponsor|9|||
126344545|NCT04798027|454555930|FG003|Overall Study|Withdrawal by Sponsor|26|||
126010865|NCT03068468|453333365|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
126010866|NCT03068468|453333366|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
126010867|NCT03068468|453333367|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
126344546|NCT04798027|454555931|FG004|Overall Study|Withdrawal by Sponsor|24|||
126344547|NCT04798027|454555932|FG005|Overall Study|Withdrawal by Sponsor|11|||
126344548|NCT04798027|454555933|FG006|Overall Study|Withdrawal by Sponsor|25|||
126344549|NCT04798027|454555934|FG007|Overall Study|Withdrawal by Sponsor|26|||
126344550|NCT04798027|454555935|FG008|Overall Study|Withdrawal by Sponsor|11|||
126344551|NCT04585893|454555936|FG000|Overall Study|Death|1|||
126010868|NCT03068468|453333368|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
126010869|NCT03068468|453333365|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
126010870|NCT03068468|453333366|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
126010871|NCT03068468|453333367|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
126010872|NCT03068468|453333368|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
126010873|NCT03068468|453333365|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
126010874|NCT03068468|453333366|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
126010875|NCT03068468|453333367|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
126010876|NCT03068468|453333368|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
126010877|NCT03068468|453333365|FG000|Open-Label Extension Period|Reason not Specified|0|||
126010878|NCT03068468|453333366|FG001|Open-Label Extension Period|Reason not Specified|0|||
126010879|NCT03068468|453333367|FG002|Open-Label Extension Period|Reason not Specified|1|||
126010880|NCT03068468|453333368|FG003|Open-Label Extension Period|Reason not Specified|4|||
126010881|NCT02466516|453333370|FG000|Overall Study|Adverse Event|1|||
126010882|NCT02466516|453333371|FG001|Overall Study|Adverse Event|1|||
126010883|NCT02466516|453333372|FG002|Overall Study|Adverse Event|0|||
126010884|NCT02466516|453333373|FG003|Overall Study|Adverse Event|0|||
126010885|NCT02466516|453333374|FG004|Overall Study|Adverse Event|0|||
126010886|NCT02466516|453333370|FG000|Overall Study|Withdrew Consent|1|||
126010887|NCT02466516|453333371|FG001|Overall Study|Withdrew Consent|0|||
126010888|NCT02466516|453333372|FG002|Overall Study|Withdrew Consent|0|||
126010889|NCT02466516|453333373|FG003|Overall Study|Withdrew Consent|0|||
126010890|NCT02466516|453333374|FG004|Overall Study|Withdrew Consent|0|||
126010891|NCT02466516|453333370|FG000|Overall Study|Lost to Follow-up|2|||
126010892|NCT02466516|453333371|FG001|Overall Study|Lost to Follow-up|0|||
126010893|NCT02466516|453333372|FG002|Overall Study|Lost to Follow-up|1|||
126010894|NCT02466516|453333373|FG003|Overall Study|Lost to Follow-up|0|||
126010895|NCT02466516|453333374|FG004|Overall Study|Lost to Follow-up|0|||
126010896|NCT01062126|453333376|FG000|Overall Study|Death|209|||
126010897|NCT01062126|453333376|FG000|Overall Study|All Withdrawals|324|||
126010898|NCT01331824|453333377|FG000|Overall Study|Adverse Event|2|||
126010899|NCT01331824|453333377|FG000|Overall Study|Death|1|||
126010900|NCT01331824|453333377|FG000|Overall Study|Disease Progression|9|||
126010901|NCT01331824|453333377|FG000|Overall Study|Withdrawal by Subject|1|||
126010902|NCT00486759|453333380|FG000|Treatment|Adverse event/intercurrent illness|86|||
126010903|NCT00486759|453333381|FG001|Treatment|Adverse event/intercurrent illness|39|||
126010904|NCT00486759|453333380|FG000|Treatment|Insufficient therapeutic response|37|||
126010905|NCT00486759|453333381|FG001|Treatment|Insufficient therapeutic response|39|||
126344552|NCT04585893|454555937|FG001|Overall Study|Death|0|||
126344553|NCT02100631|454557148|FG000|Overall Study|Withdrawal by Subject|1|||
126344554|NCT02100631|454557149|FG001|Overall Study|Withdrawal by Subject|0|||
126010906|NCT00486759|453333380|FG000|Treatment|Death|17|||
126010907|NCT00486759|453333381|FG001|Treatment|Death|10|||
126010908|NCT00486759|453333380|FG000|Treatment|Withdrew consent|15|||
126010909|NCT00486759|453333381|FG001|Treatment|Withdrew consent|12|||
126010910|NCT00486759|453333380|FG000|Treatment|Administrative/reason not specified|17|||
126010911|NCT00486759|453333381|FG001|Treatment|Administrative/reason not specified|21|||
126010912|NCT00486759|453333380|FG000|Treatment|Refused treatment|10|||
126010913|NCT00486759|453333381|FG001|Treatment|Refused treatment|7|||
126010914|NCT00486759|453333380|FG000|Treatment|Violation of selection criteria at entry|3|||
126010915|NCT00486759|453333381|FG001|Treatment|Violation of selection criteria at entry|3|||
126010916|NCT00486759|453333380|FG000|Treatment|Other protocol violation|1|||
126010917|NCT00486759|453333381|FG001|Treatment|Other protocol violation|5|||
126010918|NCT00486759|453333380|FG000|Treatment|Failure to return|1|||
126010919|NCT00486759|453333381|FG001|Treatment|Failure to return|1|||
126010920|NCT00486759|453333380|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
126010921|NCT00486759|453333381|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
126010922|NCT00486759|453333380|FG000|Safety Follow-up|Death|40|||
126010923|NCT00486759|453333381|FG001|Safety Follow-up|Death|29|||
126344555|NCT02100631|454557150|FG002|Overall Study|Withdrawal by Subject|0|||
126344556|NCT02100631|454557148|FG000|Overall Study|Lost to Follow-up|3|||
126344557|NCT02100631|454557149|FG001|Overall Study|Lost to Follow-up|4|||
126344558|NCT02100631|454557150|FG002|Overall Study|Lost to Follow-up|0|||
126344559|NCT02100631|454557148|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
126344560|NCT02100631|454557149|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
126344561|NCT02100631|454557150|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
126344562|NCT00300053|454557151|FG000|Overall Study|Patient/Caregiver Preference|2|||
126344563|NCT00300053|454557152|FG001|Overall Study|Patient/Caregiver Preference|2|||
126344564|NCT00300053|454557153|FG002|Overall Study|Patient/Caregiver Preference|3|||
126344565|NCT00300053|454557151|FG000|Overall Study|Death|0|||
126344566|NCT00300053|454557152|FG001|Overall Study|Death|0|||
126344567|NCT00300053|454557153|FG002|Overall Study|Death|3|||
126344568|NCT00300053|454557151|FG000|Overall Study|Lost to Follow-up|0|||
126344569|NCT00300053|454557152|FG001|Overall Study|Lost to Follow-up|1|||
126344570|NCT00300053|454557153|FG002|Overall Study|Lost to Follow-up|0|||
126344571|NCT02472405|454557154|FG000|Overall Study|Lost to Follow-up|9|||
126344572|NCT02472405|454557154|FG000|Overall Study|Adverse Event|1|||
126344573|NCT03261401|454557155|FG000|Overall Study|Withdrawal by Subject|0|||
126344574|NCT03261401|454557156|FG001|Overall Study|Withdrawal by Subject|0|||
126344575|NCT03261401|454557157|FG002|Overall Study|Withdrawal by Subject|0|||
126344576|NCT03261401|454557158|FG003|Overall Study|Withdrawal by Subject|0|||
126344577|NCT03261401|454557159|FG004|Overall Study|Withdrawal by Subject|0|||
126344578|NCT03261401|454557160|FG005|Overall Study|Withdrawal by Subject|1|||
126344579|NCT03261401|454557161|FG006|Overall Study|Withdrawal by Subject|0|||
126344580|NCT03261401|454557162|FG007|Overall Study|Withdrawal by Subject|0|||
126344581|NCT03261401|454557163|FG008|Overall Study|Withdrawal by Subject|0|||
126344582|NCT03261401|454557164|FG009|Overall Study|Withdrawal by Subject|0|||
126344583|NCT03261401|454557165|FG010|Overall Study|Withdrawal by Subject|0|||
126344584|NCT03261401|454557166|FG011|Overall Study|Withdrawal by Subject|0|||
126344585|NCT03261401|454557167|FG012|Overall Study|Withdrawal by Subject|0|||
126344586|NCT03261401|454557155|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
126344587|NCT03261401|454557156|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
126344588|NCT03261401|454557157|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
126344589|NCT03261401|454557158|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
126344590|NCT03261401|454557159|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
126344591|NCT03261401|454557160|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
126344592|NCT03261401|454557161|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
126344593|NCT03261401|454557162|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
126344594|NCT03261401|454557163|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
126344595|NCT03261401|454557164|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
126344596|NCT03261401|454557165|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
126344597|NCT03261401|454557166|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
126344598|NCT03261401|454557167|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
126010924|NCT00486759|453333380|FG000|Safety Follow-up|Withdrew consent|32|||
126010925|NCT00486759|453333381|FG001|Safety Follow-up|Withdrew consent|23|||
126010926|NCT00486759|453333380|FG000|Safety Follow-up|Failure to return|9|||
126010927|NCT00486759|453333381|FG001|Safety Follow-up|Failure to return|6|||
126344599|NCT01983930|454557173|FG000|Overall Study|Withdrawal by Subject|9|||
126344600|NCT01983930|454557174|FG001|Overall Study|Withdrawal by Subject|8|||
126344601|NCT01983930|454557173|FG000|Overall Study|Adverse Event|0|||
126344602|NCT01983930|454557174|FG001|Overall Study|Adverse Event|1|||
126344603|NCT03482024|454557179|FG000|Overall Study|Physician Decision|1|||
126344604|NCT03482024|454557180|FG001|Overall Study|Physician Decision|0|||
126344605|NCT03482024|454557181|FG002|Overall Study|Physician Decision|0|||
126344606|NCT03482024|454557182|FG003|Overall Study|Physician Decision|0|||
126344607|NCT03482024|454557183|FG004|Overall Study|Physician Decision|0|||
126344608|NCT00634504|454557184|FG000|Overall Study|Protocol Violation|1|||
126344609|NCT00634504|454557185|FG001|Overall Study|Protocol Violation|0|||
126344610|NCT05001620|454557188|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
126344611|NCT05001620|454557189|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
126344612|NCT00481676|454557190|FG000|Overall Study|Adverse Event|0|||
126344613|NCT00481676|454557191|FG001|Overall Study|Adverse Event|1|||
126344614|NCT00481676|454557190|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126344615|NCT00481676|454557191|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126344616|NCT00481676|454557190|FG000|Overall Study|Administrative problem|1|||
126344617|NCT00481676|454557191|FG001|Overall Study|Administrative problem|0|||
126344618|NCT03937778|454557192|FG000|Overall Study|Withdrawal by Subject|1|||
126344619|NCT03937778|454557192|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
126344620|NCT00819039|454557193|FG000|Overall Study|Physician Decision|1|||
126344621|NCT00819039|454557194|FG001|Overall Study|Physician Decision|0|||
126344622|NCT00819039|454557195|FG002|Overall Study|Physician Decision|1|||
126344623|NCT00819039|454557193|FG000|Overall Study|Protocol Violation|1|||
126344624|NCT00819039|454557194|FG001|Overall Study|Protocol Violation|0|||
126344625|NCT00819039|454557195|FG002|Overall Study|Protocol Violation|0|||
126344626|NCT01240694|454557196|FG000|Overall Study|Adverse Event|9|||
126344627|NCT01240694|454557196|FG000|Overall Study|Lack of Efficacy|6|||
126344628|NCT01240694|454557196|FG000|Overall Study|Withdrawal by Subject|6|||
126344629|NCT01240694|454557196|FG000|Overall Study|Protocol Violation|2|||
126344630|NCT01240694|454557196|FG000|Overall Study|Lost to Follow-up|2|||
126344631|NCT01240694|454557196|FG000|Overall Study|Other than specified|3|||
126010928|NCT00486759|453333380|FG000|Safety Follow-up|Administrative/not specified|8|||
126010929|NCT00486759|453333381|FG001|Safety Follow-up|Administrative/not specified|6|||
126344632|NCT01240694|454557196|FG000|Overall Study|Withdrawn due to early study termination|107|||
126344633|NCT01513590|454557197|FG000|Overall Study|Adverse Event|2|||
126344634|NCT01513590|454557198|FG001|Overall Study|Adverse Event|3|||
126344635|NCT01513590|454557197|FG000|Overall Study|Withdrawal Criteria|3|||
126010930|NCT00486759|453333380|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
126010931|NCT00486759|453333381|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
126010932|NCT00486759|453333380|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
126010933|NCT00486759|453333381|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
126010934|NCT00954707|453333382|FG000|Overall Study|Death|34|||
126010935|NCT00954707|453333382|FG000|Overall Study|Withdrawal by Subject|100|||
126010936|NCT00954707|453333382|FG000|Overall Study|Lost to Follow-up|33|||
126010937|NCT02001623|453333383|FG000|Overall Study|Disease Progression|2|||
126010938|NCT02001623|453333384|FG001|Overall Study|Disease Progression|2|||
126010939|NCT02001623|453333385|FG002|Overall Study|Disease Progression|3|||
126010940|NCT02001623|453333386|FG003|Overall Study|Disease Progression|2|||
126010941|NCT02001623|453333387|FG004|Overall Study|Disease Progression|3|||
126010942|NCT02001623|453333388|FG005|Overall Study|Disease Progression|2|||
126010943|NCT02001623|453333389|FG006|Overall Study|Disease Progression|3|||
126010944|NCT02001623|453333390|FG007|Overall Study|Disease Progression|3|||
126010945|NCT02001623|453333391|FG008|Overall Study|Disease Progression|7|||
126010946|NCT02001623|453333392|FG009|Overall Study|Disease Progression|40|||
126010947|NCT02001623|453333393|FG010|Overall Study|Disease Progression|5|||
126010948|NCT02001623|453333394|FG011|Overall Study|Disease Progression|9|||
126010949|NCT02001623|453333395|FG012|Overall Study|Disease Progression|9|||
126010950|NCT02001623|453333396|FG013|Overall Study|Disease Progression|20|||
126010951|NCT02001623|453333397|FG014|Overall Study|Disease Progression|9|||
126010952|NCT02001623|453333383|FG000|Overall Study|Physician Decision|0|||
126010953|NCT02001623|453333384|FG001|Overall Study|Physician Decision|0|||
126010954|NCT02001623|453333385|FG002|Overall Study|Physician Decision|0|||
126010955|NCT02001623|453333386|FG003|Overall Study|Physician Decision|0|||
126010956|NCT02001623|453333387|FG004|Overall Study|Physician Decision|0|||
126010957|NCT02001623|453333388|FG005|Overall Study|Physician Decision|0|||
126010958|NCT02001623|453333389|FG006|Overall Study|Physician Decision|0|||
126010959|NCT02001623|453333390|FG007|Overall Study|Physician Decision|0|||
126010960|NCT02001623|453333391|FG008|Overall Study|Physician Decision|3|||
126344636|NCT01513590|454557198|FG001|Overall Study|Withdrawal Criteria|0|||
126344637|NCT01513590|454557197|FG000|Overall Study|Unclassified|5|||
126344638|NCT01513590|454557198|FG001|Overall Study|Unclassified|10|||
126010961|NCT02001623|453333392|FG009|Overall Study|Physician Decision|2|||
126010962|NCT02001623|453333393|FG010|Overall Study|Physician Decision|3|||
126344639|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
126344640|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
126344641|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
126010963|NCT02001623|453333394|FG011|Overall Study|Physician Decision|3|||
126010964|NCT02001623|453333395|FG012|Overall Study|Physician Decision|1|||
126010965|NCT02001623|453333396|FG013|Overall Study|Physician Decision|2|||
126010966|NCT02001623|453333397|FG014|Overall Study|Physician Decision|1|||
126010967|NCT02001623|453333383|FG000|Overall Study|Death|0|||
126010968|NCT02001623|453333384|FG001|Overall Study|Death|1|||
126010969|NCT02001623|453333385|FG002|Overall Study|Death|0|||
126010970|NCT02001623|453333386|FG003|Overall Study|Death|0|||
126010971|NCT02001623|453333387|FG004|Overall Study|Death|0|||
126010972|NCT02001623|453333388|FG005|Overall Study|Death|0|||
126010973|NCT02001623|453333389|FG006|Overall Study|Death|0|||
126010974|NCT02001623|453333390|FG007|Overall Study|Death|0|||
126010975|NCT02001623|453333391|FG008|Overall Study|Death|0|||
126344642|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
126344643|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
126344644|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
126010976|NCT02001623|453333392|FG009|Overall Study|Death|0|||
126010977|NCT02001623|453333393|FG010|Overall Study|Death|0|||
126010978|NCT02001623|453333394|FG011|Overall Study|Death|0|||
126010979|NCT02001623|453333395|FG012|Overall Study|Death|0|||
126010980|NCT02001623|453333396|FG013|Overall Study|Death|0|||
126010981|NCT02001623|453333397|FG014|Overall Study|Death|0|||
126010982|NCT02001623|453333383|FG000|Overall Study|Adverse Event|0|||
126010983|NCT02001623|453333384|FG001|Overall Study|Adverse Event|0|||
126010984|NCT02001623|453333385|FG002|Overall Study|Adverse Event|0|||
126010985|NCT02001623|453333386|FG003|Overall Study|Adverse Event|0|||
126010986|NCT02001623|453333387|FG004|Overall Study|Adverse Event|0|||
126010987|NCT02001623|453333388|FG005|Overall Study|Adverse Event|1|||
126010988|NCT02001623|453333389|FG006|Overall Study|Adverse Event|0|||
126344645|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
126010989|NCT02001623|453333390|FG007|Overall Study|Adverse Event|3|||
126010990|NCT02001623|453333391|FG008|Overall Study|Adverse Event|4|||
126010991|NCT02001623|453333392|FG009|Overall Study|Adverse Event|6|||
126010992|NCT02001623|453333393|FG010|Overall Study|Adverse Event|4|||
126010993|NCT02001623|453333394|FG011|Overall Study|Adverse Event|0|||
126010994|NCT02001623|453333395|FG012|Overall Study|Adverse Event|3|||
126010995|NCT02001623|453333396|FG013|Overall Study|Adverse Event|5|||
126010996|NCT02001623|453333397|FG014|Overall Study|Adverse Event|6|||
126010997|NCT02001623|453333383|FG000|Overall Study|Other - Miscellaneous|0|||
126010998|NCT02001623|453333384|FG001|Overall Study|Other - Miscellaneous|0|||
126010999|NCT02001623|453333385|FG002|Overall Study|Other - Miscellaneous|0|||
126011000|NCT02001623|453333386|FG003|Overall Study|Other - Miscellaneous|0|||
126011001|NCT02001623|453333387|FG004|Overall Study|Other - Miscellaneous|0|||
126344646|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
126344647|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
126344648|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
126344649|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Death|3|||
126344650|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Death|1|||
126344651|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
126344652|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
126344653|NCT01056276|454557199|FG000|Maintenance Therapy|Toxicity|0|||
126344654|NCT01056276|454557200|FG001|Maintenance Therapy|Toxicity|2|||
126344655|NCT01056276|454557199|FG000|Maintenance Therapy|Progressive Disease|0|||
126344656|NCT01056276|454557200|FG001|Maintenance Therapy|Progressive Disease|9|||
126344657|NCT01056276|454557199|FG000|Maintenance Therapy|Physician Decision|0|||
126344658|NCT01056276|454557200|FG001|Maintenance Therapy|Physician Decision|1|||
126344659|NCT01056276|454557199|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
126344660|NCT01056276|454557200|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
126344661|NCT01056276|454557199|FG000|Maintenance Therapy|Intercurrent Illness|0|||
126011002|NCT02001623|453333388|FG005|Overall Study|Other - Miscellaneous|0|||
126011003|NCT02001623|453333389|FG006|Overall Study|Other - Miscellaneous|0|||
126011004|NCT02001623|453333390|FG007|Overall Study|Other - Miscellaneous|0|||
126344662|NCT01056276|454557200|FG001|Maintenance Therapy|Intercurrent Illness|1|||
126344663|NCT01056276|454557199|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
126344664|NCT01056276|454557200|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
126011005|NCT02001623|453333391|FG008|Overall Study|Other - Miscellaneous|0|||
126011006|NCT02001623|453333392|FG009|Overall Study|Other - Miscellaneous|1|||
126011007|NCT02001623|453333393|FG010|Overall Study|Other - Miscellaneous|0|||
126011008|NCT02001623|453333394|FG011|Overall Study|Other - Miscellaneous|0|||
126011009|NCT02001623|453333395|FG012|Overall Study|Other - Miscellaneous|0|||
126011010|NCT02001623|453333396|FG013|Overall Study|Other - Miscellaneous|1|||
126011011|NCT02001623|453333397|FG014|Overall Study|Other - Miscellaneous|0|||
126011012|NCT02001623|453333383|FG000|Overall Study|Withdrawal by Subject|1|||
126011013|NCT02001623|453333384|FG001|Overall Study|Withdrawal by Subject|0|||
126011014|NCT02001623|453333385|FG002|Overall Study|Withdrawal by Subject|0|||
126344665|NCT01881425|454557201|FG000|Overall Study|Death|5|||
126344666|NCT01881425|454557202|FG001|Overall Study|Death|1|||
126011015|NCT02001623|453333386|FG003|Overall Study|Withdrawal by Subject|0|||
126011016|NCT02001623|453333387|FG004|Overall Study|Withdrawal by Subject|0|||
126344667|NCT01881425|454557201|FG000|Overall Study|Withdrawal by Subject|8|||
126344668|NCT01881425|454557202|FG001|Overall Study|Withdrawal by Subject|3|||
126344669|NCT01881425|454557201|FG000|Overall Study|Physician Decision|2|||
126344670|NCT01881425|454557202|FG001|Overall Study|Physician Decision|1|||
126344671|NCT01881425|454557201|FG000|Overall Study|Adverse Event|3|||
126344672|NCT01881425|454557202|FG001|Overall Study|Adverse Event|0|||
126344673|NCT01881425|454557201|FG000|Overall Study|General Anesthesia panic attack|0|||
126344674|NCT01881425|454557202|FG001|Overall Study|General Anesthesia panic attack|1|||
126344675|NCT01881425|454557201|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
126344676|NCT01881425|454557202|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
126344677|NCT01881425|454557201|FG000|Overall Study|Lost to Follow-up|7|||
126344678|NCT01881425|454557202|FG001|Overall Study|Lost to Follow-up|2|||
126344679|NCT04424901|454557209|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
126344680|NCT04424901|454557210|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
126344681|NCT00147238|454557211|FG000|Overall Study|Inevaluable|8|||
126344682|NCT00297167|454557212|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
126344683|NCT00297167|454557213|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
126344684|NCT00297167|454557214|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
126344685|NCT00297167|454557212|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
126344686|NCT00297167|454557213|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
126344687|NCT00297167|454557214|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
126344688|NCT03185208|454557218|FG000|Overall Study|Did not start study medication|0|||
126344689|NCT03185208|454557219|FG001|Overall Study|Did not start study medication|3|||
126344690|NCT02410629|454557220|FG000|Overall Study|Family cannot commit to the study|2|||
126344691|NCT02410629|454557221|FG001|Overall Study|Family cannot commit to the study|1|||
126344692|NCT02410629|454557220|FG000|Overall Study|Subject returned to work|1|||
126344693|NCT02410629|454557221|FG001|Overall Study|Subject returned to work|0|||
126344694|NCT02410629|454557220|FG000|Overall Study|Subject moved back to home country|0|||
126344695|NCT02410629|454557221|FG001|Overall Study|Subject moved back to home country|1|||
126344696|NCT02410629|454557220|FG000|Overall Study|Subject underwent heart surgery|0|||
126344697|NCT02410629|454557221|FG001|Overall Study|Subject underwent heart surgery|1|||
126344698|NCT02701634|454557222|FG000|Overall Study|Adverse Event|2|||
126344699|NCT02701634|454557223|FG001|Overall Study|Adverse Event|3|||
126344700|NCT02701634|454557222|FG000|Overall Study|Death|1|||
126344701|NCT02701634|454557223|FG001|Overall Study|Death|0|||
126344702|NCT02701634|454557222|FG000|Overall Study|Investigator's Discretion|7|||
126344703|NCT02701634|454557223|FG001|Overall Study|Investigator's Discretion|4|||
126344704|NCT02701634|454557222|FG000|Overall Study|Study terminated by Sponsor|15|||
126344705|NCT02701634|454557223|FG001|Overall Study|Study terminated by Sponsor|17|||
126344706|NCT02701634|454557222|FG000|Overall Study|Withdrew Consent|6|||
126344707|NCT02701634|454557223|FG001|Overall Study|Withdrew Consent|7|||
126344708|NCT02701634|454557222|FG000|Overall Study|Randomized but not treated|1|||
126344709|NCT02701634|454557223|FG001|Overall Study|Randomized but not treated|0|||
126344710|NCT01186770|454557224|FG000|Overall Study|Ineligibility|0|||
126344711|NCT01186770|454557225|FG001|Overall Study|Ineligibility|0|||
126344712|NCT01186770|454557226|FG002|Overall Study|Ineligibility|2|||
126344713|NCT01186770|454557227|FG003|Overall Study|Ineligibility|0|||
126344714|NCT01186770|454557224|FG000|Overall Study|Protocol Violation|7|||
126344715|NCT01186770|454557225|FG001|Overall Study|Protocol Violation|9|||
126344716|NCT01186770|454557226|FG002|Overall Study|Protocol Violation|12|||
126344717|NCT01186770|454557227|FG003|Overall Study|Protocol Violation|14|||
126344718|NCT01186770|454557224|FG000|Overall Study|Adverse Event|2|||
126344719|NCT01186770|454557225|FG001|Overall Study|Adverse Event|9|||
126344720|NCT01186770|454557226|FG002|Overall Study|Adverse Event|7|||
126344721|NCT01186770|454557227|FG003|Overall Study|Adverse Event|9|||
126344722|NCT01186770|454557224|FG000|Overall Study|Withdrawal by Subject|15|||
126344723|NCT01186770|454557225|FG001|Overall Study|Withdrawal by Subject|13|||
126344724|NCT01186770|454557226|FG002|Overall Study|Withdrawal by Subject|11|||
126344725|NCT01186770|454557227|FG003|Overall Study|Withdrawal by Subject|17|||
126344726|NCT01186770|454557224|FG000|Overall Study|Lost to Follow-up|10|||
126344727|NCT01186770|454557225|FG001|Overall Study|Lost to Follow-up|6|||
126344728|NCT01186770|454557226|FG002|Overall Study|Lost to Follow-up|14|||
126344729|NCT01186770|454557227|FG003|Overall Study|Lost to Follow-up|9|||
126344730|NCT01186770|454557224|FG000|Overall Study|Insufficient response to treatment|7|||
126344731|NCT01186770|454557225|FG001|Overall Study|Insufficient response to treatment|8|||
126344732|NCT01186770|454557226|FG002|Overall Study|Insufficient response to treatment|5|||
126344733|NCT01186770|454557227|FG003|Overall Study|Insufficient response to treatment|7|||
126344734|NCT01186770|454557224|FG000|Overall Study|Other than specified|0|||
126344735|NCT01186770|454557225|FG001|Overall Study|Other than specified|1|||
126344736|NCT01186770|454557226|FG002|Overall Study|Other than specified|1|||
126344737|NCT01186770|454557227|FG003|Overall Study|Other than specified|2|||
126344738|NCT01033136|454557228|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
126344739|NCT01033136|454557229|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
126344740|NCT01572792|454557234|FG000|Lead-in Study|Lost to Follow-up|5|||
126011017|NCT02001623|453333388|FG005|Overall Study|Withdrawal by Subject|0|||
126011018|NCT02001623|453333389|FG006|Overall Study|Withdrawal by Subject|0|||
126011019|NCT02001623|453333390|FG007|Overall Study|Withdrawal by Subject|0|||
126011020|NCT02001623|453333391|FG008|Overall Study|Withdrawal by Subject|1|||
126011021|NCT02001623|453333392|FG009|Overall Study|Withdrawal by Subject|3|||
126011022|NCT02001623|453333393|FG010|Overall Study|Withdrawal by Subject|2|||
126011023|NCT02001623|453333394|FG011|Overall Study|Withdrawal by Subject|2|||
126011024|NCT02001623|453333395|FG012|Overall Study|Withdrawal by Subject|1|||
126011025|NCT02001623|453333396|FG013|Overall Study|Withdrawal by Subject|5|||
126011026|NCT02001623|453333397|FG014|Overall Study|Withdrawal by Subject|2|||
126011027|NCT02001623|453333383|FG000|Overall Study|Lost to Follow-up|0|||
126011028|NCT02001623|453333384|FG001|Overall Study|Lost to Follow-up|0|||
126011029|NCT02001623|453333385|FG002|Overall Study|Lost to Follow-up|0|||
126011030|NCT02001623|453333386|FG003|Overall Study|Lost to Follow-up|0|||
126011031|NCT02001623|453333387|FG004|Overall Study|Lost to Follow-up|0|||
126011032|NCT02001623|453333388|FG005|Overall Study|Lost to Follow-up|0|||
126011033|NCT02001623|453333389|FG006|Overall Study|Lost to Follow-up|0|||
126011034|NCT02001623|453333390|FG007|Overall Study|Lost to Follow-up|0|||
126011035|NCT02001623|453333391|FG008|Overall Study|Lost to Follow-up|0|||
126011036|NCT02001623|453333392|FG009|Overall Study|Lost to Follow-up|1|||
126011037|NCT02001623|453333393|FG010|Overall Study|Lost to Follow-up|0|||
126011038|NCT02001623|453333394|FG011|Overall Study|Lost to Follow-up|0|||
126011039|NCT02001623|453333395|FG012|Overall Study|Lost to Follow-up|0|||
126011040|NCT02001623|453333396|FG013|Overall Study|Lost to Follow-up|0|||
126011041|NCT02001623|453333397|FG014|Overall Study|Lost to Follow-up|0|||
126011042|NCT02001623|453333383|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
126011043|NCT02001623|453333384|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
126011044|NCT02001623|453333385|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
126011045|NCT02001623|453333386|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
126011046|NCT02001623|453333387|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
126011047|NCT02001623|453333388|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
126011048|NCT02001623|453333389|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
126011049|NCT02001623|453333390|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
126011050|NCT02001623|453333391|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
126011051|NCT02001623|453333392|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
126011052|NCT02001623|453333393|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
126011053|NCT02001623|453333394|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
126011054|NCT02001623|453333395|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
126011055|NCT02001623|453333396|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
126011056|NCT02001623|453333397|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
126011057|NCT02001623|453333383|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
126011058|NCT02001623|453333384|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
126011059|NCT02001623|453333385|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
126011060|NCT02001623|453333386|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
126011061|NCT02001623|453333387|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
126011062|NCT02001623|453333388|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
126011063|NCT02001623|453333389|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
126011064|NCT02001623|453333390|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
126011065|NCT02001623|453333391|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
126011066|NCT02001623|453333392|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
126011067|NCT02001623|453333393|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
126011068|NCT02001623|453333394|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
126011069|NCT02001623|453333395|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
126011070|NCT02001623|453333396|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
126011071|NCT02001623|453333397|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
126011072|NCT00309452|453333398|FG000|Overall Study|Withdrawal by Subject|3|||
126011073|NCT00309452|453333399|FG001|Overall Study|Withdrawal by Subject|0|||
126011074|NCT00686517|453333400|FG000|Treatment|Serious Adverse Event|1|||
126011075|NCT00686517|453333401|FG001|Treatment|Serious Adverse Event|2|||
126011076|NCT00686517|453333402|FG002|Treatment|Serious Adverse Event|1|||
126011077|NCT00686517|453333400|FG000|Treatment|Adverse Event|2|||
126011078|NCT00686517|453333401|FG001|Treatment|Adverse Event|0|||
126011079|NCT00686517|453333402|FG002|Treatment|Adverse Event|0|||
126011080|NCT00686517|453333400|FG000|Treatment|Poor Protocol Compliance|1|||
126011081|NCT00686517|453333401|FG001|Treatment|Poor Protocol Compliance|0|||
126011082|NCT00686517|453333402|FG002|Treatment|Poor Protocol Compliance|0|||
126011083|NCT00686517|453333400|FG000|Treatment|Protocol Violation|2|||
126011084|NCT00686517|453333401|FG001|Treatment|Protocol Violation|1|||
126011085|NCT00686517|453333402|FG002|Treatment|Protocol Violation|0|||
126011086|NCT02281318|453333403|FG000|Overall Study|Adverse Event|2|||
126011087|NCT02281318|453333404|FG001|Overall Study|Adverse Event|2|||
126011088|NCT02281318|453333403|FG000|Overall Study|Lack of Efficacy|2|||
126011089|NCT02281318|453333404|FG001|Overall Study|Lack of Efficacy|0|||
126011090|NCT02281318|453333403|FG000|Overall Study|Lost to Follow-up|2|||
126011091|NCT02281318|453333404|FG001|Overall Study|Lost to Follow-up|1|||
126011092|NCT02281318|453333403|FG000|Overall Study|Physician Decision|2|||
126011093|NCT02281318|453333404|FG001|Overall Study|Physician Decision|0|||
126011094|NCT02281318|453333403|FG000|Overall Study|Withdrawal by Subject|6|||
126011095|NCT02281318|453333404|FG001|Overall Study|Withdrawal by Subject|2|||
126011096|NCT01368406|453333407|FG000|Overall Study|Lost to Follow-up|8|||
126011097|NCT01368406|453333408|FG001|Overall Study|Lost to Follow-up|4|||
126011098|NCT01368406|453333407|FG000|Overall Study|Withdrawal by Subject|8|||
126011099|NCT01368406|453333408|FG001|Overall Study|Withdrawal by Subject|4|||
126011100|NCT01368406|453333407|FG000|Overall Study|relapse of the disease|3|||
126011101|NCT01368406|453333408|FG001|Overall Study|relapse of the disease|2|||
126011102|NCT01368406|453333407|FG000|Overall Study|started working|2|||
126011103|NCT01368406|453333408|FG001|Overall Study|started working|3|||
126011104|NCT03670602|453333410|FG000|Overall Study|Lost to Follow-up|1|||
126011105|NCT03670602|453333411|FG001|Overall Study|Lost to Follow-up|0|||
126011106|NCT03670602|453333410|FG000|Overall Study|Withdrawal by Subject|0|||
126011107|NCT03670602|453333411|FG001|Overall Study|Withdrawal by Subject|3|||
126011108|NCT01456936|453333412|FG000|Overall Study|Other reason|41|||
126011109|NCT01456936|453333413|FG001|Overall Study|Other reason|30|||
126011110|NCT01456936|453333414|FG002|Overall Study|Other reason|36|||
126011111|NCT01456936|453333415|FG003|Overall Study|Other reason|33|||
126011112|NCT01456936|453333412|FG000|Overall Study|No longer meets eligibility criteria|4|||
126011113|NCT01456936|453333413|FG001|Overall Study|No longer meets eligibility criteria|8|||
126011114|NCT01456936|453333414|FG002|Overall Study|No longer meets eligibility criteria|6|||
126011115|NCT01456936|453333415|FG003|Overall Study|No longer meets eligibility criteria|5|||
126011116|NCT01456936|453333412|FG000|Overall Study|Protocol Violation|4|||
126011117|NCT01456936|453333413|FG001|Overall Study|Protocol Violation|2|||
126011118|NCT01456936|453333414|FG002|Overall Study|Protocol Violation|5|||
126011119|NCT01456936|453333415|FG003|Overall Study|Protocol Violation|5|||
126011120|NCT01456936|453333412|FG000|Overall Study|Pregnancy|1|||
126011121|NCT01456936|453333413|FG001|Overall Study|Pregnancy|0|||
126011122|NCT01456936|453333414|FG002|Overall Study|Pregnancy|0|||
126011123|NCT01456936|453333415|FG003|Overall Study|Pregnancy|1|||
126011124|NCT01456936|453333412|FG000|Overall Study|Insufficient clinical response|4|||
126011125|NCT01456936|453333413|FG001|Overall Study|Insufficient clinical response|4|||
126011126|NCT01456936|453333414|FG002|Overall Study|Insufficient clinical response|14|||
126011127|NCT01456936|453333415|FG003|Overall Study|Insufficient clinical response|13|||
126011128|NCT01456936|453333412|FG000|Overall Study|No longer willing to participate|195|||
126011129|NCT01456936|453333413|FG001|Overall Study|No longer willing to participate|218|||
126011130|NCT01456936|453333414|FG002|Overall Study|No longer willing to participate|224|||
126011131|NCT01456936|453333415|FG003|Overall Study|No longer willing to participate|248|||
126011132|NCT01456936|453333412|FG000|Overall Study|Lost to Follow-up|135|||
126011133|NCT01456936|453333413|FG001|Overall Study|Lost to Follow-up|126|||
126011134|NCT01456936|453333414|FG002|Overall Study|Lost to Follow-up|144|||
126011135|NCT01456936|453333415|FG003|Overall Study|Lost to Follow-up|127|||
126011136|NCT01456936|453333412|FG000|Overall Study|Medication error|0|||
126011137|NCT01456936|453333413|FG001|Overall Study|Medication error|1|||
126011138|NCT01456936|453333414|FG002|Overall Study|Medication error|0|||
126011139|NCT01456936|453333415|FG003|Overall Study|Medication error|1|||
126011140|NCT01456936|453333412|FG000|Overall Study|Adverse event (study drug)|25|||
126011141|NCT01456936|453333413|FG001|Overall Study|Adverse event (study drug)|21|||
126011142|NCT01456936|453333414|FG002|Overall Study|Adverse event (study drug)|26|||
126011143|NCT01456936|453333415|FG003|Overall Study|Adverse event (study drug)|17|||
126011144|NCT01456936|453333412|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
126011145|NCT01456936|453333413|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
126011146|NCT01456936|453333414|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
126011147|NCT01456936|453333415|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
126011148|NCT01456936|453333412|FG000|Overall Study|Death|0|||
126011149|NCT01456936|453333413|FG001|Overall Study|Death|3|||
126011150|NCT01456936|453333414|FG002|Overall Study|Death|1|||
126011151|NCT01456936|453333415|FG003|Overall Study|Death|3|||
126011152|NCT01456936|453333412|FG000|Overall Study|Randomized but not treated|21|||
126011153|NCT01456936|453333413|FG001|Overall Study|Randomized but not treated|28|||
126011154|NCT01456936|453333414|FG002|Overall Study|Randomized but not treated|16|||
126011155|NCT01456936|453333415|FG003|Overall Study|Randomized but not treated|21|||
126011156|NCT00543725|453333416|FG000|Overall Study|Adverse Event|18|||
126011157|NCT00543725|453333417|FG001|Overall Study|Adverse Event|27|||
126011158|NCT00543725|453333416|FG000|Overall Study|Sponsor's Decision|0|||
126011159|NCT00543725|453333417|FG001|Overall Study|Sponsor's Decision|1|||
126011160|NCT00543725|453333416|FG000|Overall Study|Subject Non-Compliant|4|||
126011161|NCT00543725|453333417|FG001|Overall Study|Subject Non-Compliant|4|||
126011162|NCT00543725|453333416|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
126011163|NCT00543725|453333417|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
126011164|NCT00543725|453333416|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
126011165|NCT00543725|453333417|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
126344741|NCT01572792|454557235|FG001|Lead-in Study|Lost to Follow-up|9|||
126344742|NCT01572792|454557236|FG002|Lead-in Study|Lost to Follow-up|4|||
126344743|NCT01572792|454557237|FG003|Lead-in Study|Lost to Follow-up|2|||
126344744|NCT01572792|454557238|FG004|Lead-in Study|Lost to Follow-up|4|||
126344745|NCT01572792|454557234|FG000|Lead-in Study|Withdrawal by Subject|22|||
126344746|NCT01572792|454557235|FG001|Lead-in Study|Withdrawal by Subject|11|||
126344747|NCT01572792|454557236|FG002|Lead-in Study|Withdrawal by Subject|12|||
126344748|NCT01572792|454557237|FG003|Lead-in Study|Withdrawal by Subject|24|||
126344749|NCT01572792|454557238|FG004|Lead-in Study|Withdrawal by Subject|11|||
126344750|NCT01572792|454557234|FG000|Lead-in Study|Protocol Violation|19|||
126344751|NCT01572792|454557235|FG001|Lead-in Study|Protocol Violation|10|||
126344752|NCT01572792|454557236|FG002|Lead-in Study|Protocol Violation|12|||
126344753|NCT01572792|454557237|FG003|Lead-in Study|Protocol Violation|13|||
126344754|NCT01572792|454557238|FG004|Lead-in Study|Protocol Violation|21|||
126344755|NCT01572792|454557234|FG000|Lead-in Study|Lack of Efficacy|20|||
126344756|NCT01572792|454557235|FG001|Lead-in Study|Lack of Efficacy|5|||
126344757|NCT01572792|454557236|FG002|Lead-in Study|Lack of Efficacy|4|||
126344758|NCT01572792|454557237|FG003|Lead-in Study|Lack of Efficacy|8|||
126344759|NCT01572792|454557238|FG004|Lead-in Study|Lack of Efficacy|10|||
126344760|NCT01572792|454557234|FG000|Lead-in Study|Adverse Event|21|||
126344761|NCT01572792|454557235|FG001|Lead-in Study|Adverse Event|21|||
126344762|NCT01572792|454557236|FG002|Lead-in Study|Adverse Event|22|||
126344763|NCT01572792|454557237|FG003|Lead-in Study|Adverse Event|16|||
126344764|NCT01572792|454557238|FG004|Lead-in Study|Adverse Event|14|||
126344765|NCT01572792|454557234|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
126344766|NCT01572792|454557235|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
126344767|NCT01572792|454557236|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
126344768|NCT01572792|454557237|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
126344769|NCT01572792|454557238|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
126344770|NCT01572792|454557234|FG000|Extension Study|Lost to Follow-up|6|||
126344771|NCT01572792|454557235|FG001|Extension Study|Lost to Follow-up|2|||
126344772|NCT01572792|454557236|FG002|Extension Study|Lost to Follow-up|0|||
126344773|NCT01572792|454557237|FG003|Extension Study|Lost to Follow-up|3|||
126344774|NCT01572792|454557238|FG004|Extension Study|Lost to Follow-up|3|||
126344775|NCT01572792|454557234|FG000|Extension Study|Withdrawal by Subject|7|||
126344776|NCT01572792|454557235|FG001|Extension Study|Withdrawal by Subject|6|||
126344777|NCT01572792|454557236|FG002|Extension Study|Withdrawal by Subject|11|||
126011166|NCT00543725|453333416|FG000|Overall Study|Protocol Violation|0|||
126011167|NCT00543725|453333417|FG001|Overall Study|Protocol Violation|1|||
126011168|NCT00543725|453333416|FG000|Overall Study|Withdrawal by Subject|4|||
126011169|NCT00543725|453333417|FG001|Overall Study|Withdrawal by Subject|13|||
126011170|NCT00543725|453333416|FG000|Overall Study|Lost to Follow-up|15|||
126011171|NCT00543725|453333417|FG001|Overall Study|Lost to Follow-up|11|||
126011172|NCT00543725|453333416|FG000|Overall Study|Other|3|||
126011173|NCT00543725|453333417|FG001|Overall Study|Other|3|||
126011174|NCT00906698|453333418|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
126011175|NCT00906698|453333419|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
126011176|NCT00906698|453333420|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
126011177|NCT00906698|453333421|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
126011178|NCT00906698|453333422|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
126344778|NCT01572792|454557237|FG003|Extension Study|Withdrawal by Subject|8|||
126344779|NCT01572792|454557238|FG004|Extension Study|Withdrawal by Subject|14|||
126011179|NCT00906698|453333423|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
126011180|NCT00906698|453333418|FG000|Overall Study|Adverse Event|0|||
126011181|NCT00906698|453333419|FG001|Overall Study|Adverse Event|0|||
126011182|NCT00906698|453333420|FG002|Overall Study|Adverse Event|2|||
126011183|NCT00906698|453333421|FG003|Overall Study|Adverse Event|0|||
126011184|NCT00906698|453333422|FG004|Overall Study|Adverse Event|4|||
126011185|NCT00906698|453333423|FG005|Overall Study|Adverse Event|1|||
126011186|NCT00906698|453333418|FG000|Overall Study|Disease progression|3|||
126011187|NCT00906698|453333419|FG001|Overall Study|Disease progression|12|||
126011188|NCT00906698|453333420|FG002|Overall Study|Disease progression|4|||
126011189|NCT00906698|453333421|FG003|Overall Study|Disease progression|4|||
126011190|NCT00906698|453333422|FG004|Overall Study|Disease progression|12|||
126011191|NCT00906698|453333423|FG005|Overall Study|Disease progression|4|||
126011192|NCT00906698|453333418|FG000|Overall Study|Withdrawal by Subject|0|||
126011193|NCT00906698|453333419|FG001|Overall Study|Withdrawal by Subject|0|||
126011194|NCT00906698|453333420|FG002|Overall Study|Withdrawal by Subject|0|||
126011195|NCT00906698|453333421|FG003|Overall Study|Withdrawal by Subject|0|||
126011196|NCT00906698|453333422|FG004|Overall Study|Withdrawal by Subject|1|||
126011197|NCT00906698|453333423|FG005|Overall Study|Withdrawal by Subject|0|||
126011198|NCT00906698|453333418|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
126011199|NCT00906698|453333419|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
126011200|NCT00906698|453333420|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
126011201|NCT00906698|453333421|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
126011202|NCT00906698|453333422|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
126011203|NCT00906698|453333423|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
126011204|NCT03095508|453333424|FG000|Overall Study|Adverse Event|0|||
126011205|NCT03095508|453333425|FG001|Overall Study|Adverse Event|1|||
126011206|NCT03201809|453333426|FG000|Overall Study|Lost to Follow-up|2|||
126011207|NCT03201809|453333427|FG001|Overall Study|Lost to Follow-up|0|||
126011208|NCT00771849|453333438|FG000|Overall Study|Lost to Follow-up|1|||
126011209|NCT00771849|453333439|FG001|Overall Study|Lost to Follow-up|2|||
126011210|NCT00771849|453333438|FG000|Overall Study|Withdrawal by Subject|1|||
126011211|NCT00771849|453333439|FG001|Overall Study|Withdrawal by Subject|1|||
126011212|NCT00771849|453333438|FG000|Overall Study|Not vaccinated|0|||
126011213|NCT00771849|453333439|FG001|Overall Study|Not vaccinated|1|||
126011214|NCT02046616|453333444|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
126011215|NCT02046616|453333444|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
126011216|NCT02046616|453333444|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
126209508|NCT03110107|454055413|FG020|Treatment Period|Adverse Event|4|||
126011217|NCT02046616|453333444|FG000|24-Week Treatment Period|Physician Decision|3|||
126011218|NCT02046616|453333444|FG000|24-Week Treatment Period|Other|1|||
126011219|NCT02046616|453333444|FG000|8-Week FU Period|Lost to Follow-up|1|||
126011220|NCT01191788|453333445|FG000|Overall Study|Lost to Follow-up|21|||
126011221|NCT01191788|453333446|FG001|Overall Study|Lost to Follow-up|22|||
126011222|NCT01959412|453333448|FG000|Overall Study|Protocol deviation|1|||
126011223|NCT01959412|453333449|FG001|Overall Study|Protocol deviation|1|||
126011224|NCT01959412|453333450|FG002|Overall Study|Protocol deviation|0|||
126011225|NCT01959412|453333451|FG003|Overall Study|Protocol deviation|1|||
126011226|NCT01959412|453333452|FG004|Overall Study|Protocol deviation|3|||
126011227|NCT01959412|453333453|FG005|Overall Study|Protocol deviation|0|||
126011228|NCT01959412|453333448|FG000|Overall Study|Adverse Event|0|||
126011229|NCT01959412|453333449|FG001|Overall Study|Adverse Event|0|||
126011230|NCT01959412|453333450|FG002|Overall Study|Adverse Event|0|||
126011231|NCT01959412|453333451|FG003|Overall Study|Adverse Event|1|||
126011232|NCT01959412|453333452|FG004|Overall Study|Adverse Event|0|||
126011233|NCT01959412|453333453|FG005|Overall Study|Adverse Event|0|||
126011234|NCT00509769|453333454|FG000|Overall Study|Progressive disease|77|||
126011235|NCT00509769|453333454|FG000|Overall Study|Adverse Event|4|||
126011236|NCT00509769|453333454|FG000|Overall Study|Patient's decision|1|||
126011237|NCT00509769|453333454|FG000|Overall Study|Physician Decision|8|||
126209509|NCT03110107|454055414|FG021|Treatment Period|Adverse Event|2|||
126344780|NCT01572792|454557234|FG000|Extension Study|Protocol Violation|0|||
126344781|NCT01572792|454557235|FG001|Extension Study|Protocol Violation|4|||
126344782|NCT01572792|454557236|FG002|Extension Study|Protocol Violation|3|||
126344783|NCT01572792|454557237|FG003|Extension Study|Protocol Violation|4|||
126344784|NCT01572792|454557238|FG004|Extension Study|Protocol Violation|3|||
126344785|NCT01572792|454557234|FG000|Extension Study|Lack of Efficacy|2|||
126344786|NCT01572792|454557235|FG001|Extension Study|Lack of Efficacy|3|||
126344787|NCT01572792|454557236|FG002|Extension Study|Lack of Efficacy|3|||
126344788|NCT01572792|454557237|FG003|Extension Study|Lack of Efficacy|2|||
126344789|NCT01572792|454557238|FG004|Extension Study|Lack of Efficacy|2|||
126344790|NCT01572792|454557234|FG000|Extension Study|Adverse Event|7|||
126344791|NCT01572792|454557235|FG001|Extension Study|Adverse Event|6|||
126344792|NCT01572792|454557236|FG002|Extension Study|Adverse Event|5|||
126344793|NCT01572792|454557237|FG003|Extension Study|Adverse Event|6|||
126344794|NCT01572792|454557238|FG004|Extension Study|Adverse Event|4|||
126344795|NCT01572792|454557234|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
126344796|NCT01572792|454557235|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
126344797|NCT01572792|454557236|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
126344798|NCT01572792|454557237|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
126344799|NCT01572792|454557238|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
126344800|NCT03530696|454557239|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
126344801|NCT03530696|454557240|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
126344802|NCT02472353|454557241|FG000|Overall Study|Lost to Follow-up|1|||
126344803|NCT02472353|454557242|FG001|Overall Study|Lost to Follow-up|1|||
126344804|NCT02472353|454557241|FG000|Overall Study|Withdrawal by Subject|2|||
126344805|NCT02472353|454557242|FG001|Overall Study|Withdrawal by Subject|1|||
126011238|NCT00509769|453333454|FG000|Overall Study|Use of prohibited therapies during study|1|||
126011239|NCT04364269|453333459|FG000|Overall Study|Adverse Event|1|||
126011240|NCT04364269|453333460|FG001|Overall Study|Adverse Event|0|||
126344806|NCT02472353|454557241|FG000|Overall Study|Study Termination|1|||
126344807|NCT02472353|454557242|FG001|Overall Study|Study Termination|4|||
126344808|NCT02855268|454557247|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
126344809|NCT02855268|454557248|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
126344810|NCT02855268|454557247|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
126344811|NCT02855268|454557248|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
126344812|NCT02855268|454557247|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
126344813|NCT02855268|454557248|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
126344814|NCT02855268|454557247|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
126344815|NCT02855268|454557248|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
126344816|NCT02855268|454557247|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
126344817|NCT02855268|454557248|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
126344818|NCT02855268|454557247|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
126344819|NCT02855268|454557248|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
126344820|NCT00639509|454557251|FG000|Overall Study|Death|1|||
126344821|NCT05722015|454557252|FG000|Overall Study|Death|57|||
126344822|NCT05722015|454557253|FG001|Overall Study|Death|37|||
126344823|NCT05722015|454557252|FG000|Overall Study|Lost to Follow-up|1|||
126344824|NCT05722015|454557253|FG001|Overall Study|Lost to Follow-up|0|||
126344825|NCT05722015|454557252|FG000|Overall Study|Withdrawal by Subject|5|||
126344826|NCT05722015|454557253|FG001|Overall Study|Withdrawal by Subject|1|||
126344827|NCT05722015|454557252|FG000|Overall Study|Participants Ongoing|188|||
126344828|NCT05722015|454557253|FG001|Overall Study|Participants Ongoing|88|||
126344829|NCT04513366|454557254|FG000|Treatment Phase|Withdrawal by Subject|6|||
126344830|NCT04513366|454557255|FG001|Treatment Phase|Withdrawal by Subject|8|||
126344831|NCT04513366|454557256|FG002|Treatment Phase|Withdrawal by Subject|3|||
126344832|NCT04513366|454557254|FG000|Treatment Phase|Lost to Follow-up|1|||
126344833|NCT04513366|454557255|FG001|Treatment Phase|Lost to Follow-up|2|||
126344834|NCT04513366|454557256|FG002|Treatment Phase|Lost to Follow-up|5|||
126344835|NCT04513366|454557254|FG000|Treatment Phase|Other than Specified|1|||
126344836|NCT04513366|454557255|FG001|Treatment Phase|Other than Specified|0|||
126344837|NCT04513366|454557256|FG002|Treatment Phase|Other than Specified|2|||
126344838|NCT04513366|454557254|FG000|Treatment Phase|Physician Decision|2|||
126344839|NCT04513366|454557255|FG001|Treatment Phase|Physician Decision|0|||
126344840|NCT04513366|454557256|FG002|Treatment Phase|Physician Decision|0|||
126344841|NCT04513366|454557254|FG000|Treatment Phase|Adverse Event|0|||
126344842|NCT04513366|454557255|FG001|Treatment Phase|Adverse Event|1|||
126344843|NCT04513366|454557256|FG002|Treatment Phase|Adverse Event|1|||
126344844|NCT04513366|454557254|FG000|Extension Phase|Withdrawal by Subject|3|||
126344845|NCT04513366|454557255|FG001|Extension Phase|Withdrawal by Subject|1|||
126344846|NCT04513366|454557256|FG002|Extension Phase|Withdrawal by Subject|1|||
126344847|NCT04513366|454557254|FG000|Extension Phase|Other than Specified|4|||
126344848|NCT04513366|454557255|FG001|Extension Phase|Other than Specified|0|||
126344849|NCT04513366|454557256|FG002|Extension Phase|Other than Specified|1|||
126344850|NCT04513366|454557254|FG000|Extension Phase|Lost to Follow-up|1|||
126344851|NCT04513366|454557255|FG001|Extension Phase|Lost to Follow-up|1|||
126344852|NCT04513366|454557256|FG002|Extension Phase|Lost to Follow-up|1|||
126344853|NCT04513366|454557254|FG000|Extension Phase|Sponsor Decision|0|||
126344854|NCT04513366|454557255|FG001|Extension Phase|Sponsor Decision|1|||
126344855|NCT04513366|454557256|FG002|Extension Phase|Sponsor Decision|0|||
126344856|NCT04513366|454557254|FG000|Extension Phase|Death|0|||
126344857|NCT04513366|454557255|FG001|Extension Phase|Death|1|||
126344858|NCT04513366|454557256|FG002|Extension Phase|Death|0|||
126344859|NCT04513366|454557254|FG000|Extension Phase|Adverse Event|0|||
126344860|NCT04513366|454557255|FG001|Extension Phase|Adverse Event|0|||
126344861|NCT04513366|454557256|FG002|Extension Phase|Adverse Event|1|||
126344862|NCT04478266|454557260|FG000|Overall Study|Adverse Event|20|||
126344863|NCT04478266|454557261|FG001|Overall Study|Adverse Event|21|||
126344864|NCT04478266|454557260|FG000|Overall Study|Progressive disease|146|||
126344865|NCT04478266|454557261|FG001|Overall Study|Progressive disease|168|||
126344866|NCT04478266|454557260|FG000|Overall Study|Poor compliance to protocol|1|||
126344867|NCT04478266|454557261|FG001|Overall Study|Poor compliance to protocol|0|||
126344868|NCT04478266|454557260|FG000|Overall Study|Withdrawal by Subject|19|||
126344869|NCT04478266|454557261|FG001|Overall Study|Withdrawal by Subject|16|||
126344870|NCT04478266|454557260|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
126344871|NCT04478266|454557261|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
126344872|NCT04478266|454557260|FG000|Overall Study|Study terminated by sponsor|33|||
126344873|NCT04478266|454557261|FG001|Overall Study|Study terminated by sponsor|35|||
126344874|NCT04478266|454557260|FG000|Overall Study|Other: unspecified|5|||
126344875|NCT04478266|454557261|FG001|Overall Study|Other: unspecified|7|||
126344876|NCT04478266|454557260|FG000|Overall Study|Randomized but not treated|1|||
126344877|NCT04478266|454557261|FG001|Overall Study|Randomized but not treated|1|||
126344878|NCT04058717|454557262|FG000|Randomization Period|Lost to Follow-up|2|||
126344879|NCT04058717|454557263|FG001|Randomization Period|Lost to Follow-up|3|||
126011241|NCT04364269|453333461|FG002|Overall Study|Adverse Event|0|||
126011242|NCT04364269|453333459|FG000|Overall Study|Withdrawal by Subject|0|||
126011243|NCT04364269|453333460|FG001|Overall Study|Withdrawal by Subject|1|||
126344880|NCT04058717|454557264|FG002|Randomization Period|Lost to Follow-up|4|||
126344881|NCT04058717|454557265|FG003|Randomization Period|Lost to Follow-up|4|||
126344882|NCT04058717|454557262|FG000|Randomization Period|Withdrawal by Subject|1|||
126344883|NCT04058717|454557263|FG001|Randomization Period|Withdrawal by Subject|3|||
126344884|NCT04058717|454557264|FG002|Randomization Period|Withdrawal by Subject|3|||
126344885|NCT04058717|454557265|FG003|Randomization Period|Withdrawal by Subject|3|||
126344886|NCT04058717|454557262|FG000|Randomization Period|PI decision|0|||
126344887|NCT04058717|454557263|FG001|Randomization Period|PI decision|1|||
126344888|NCT04058717|454557264|FG002|Randomization Period|PI decision|0|||
126344889|NCT04058717|454557265|FG003|Randomization Period|PI decision|0|||
126344890|NCT00671788|454557266|FG000|Overall Study|Adverse Event|8|||
126344891|NCT00671788|454557266|FG000|Overall Study|Refused further treatment|3|||
126344892|NCT00671788|454557266|FG000|Overall Study|Ineligible|1|||
126344893|NCT00671788|454557266|FG000|Overall Study|MD Decision|1|||
126344894|NCT00671788|454557266|FG000|Overall Study|Other|1|||
126344895|NCT01832766|454557267|FG000|Washout|Lost to Follow-up|0|||
126344896|NCT01832766|454557268|FG001|Washout|Lost to Follow-up|1|||
126344897|NCT03074500|454557273|FG000|Overall Study|Lost to Follow-up|1|||
126344898|NCT03074500|454557274|FG001|Overall Study|Lost to Follow-up|0|||
126344899|NCT03074500|454557275|FG002|Overall Study|Lost to Follow-up|0|||
126344900|NCT03074500|454557273|FG000|Overall Study|Lack of Efficacy|0|||
126344901|NCT03074500|454557274|FG001|Overall Study|Lack of Efficacy|1|||
126344902|NCT03074500|454557275|FG002|Overall Study|Lack of Efficacy|0|||
126344903|NCT03074500|454557273|FG000|Overall Study|Adverse Event|0|||
126344904|NCT03074500|454557274|FG001|Overall Study|Adverse Event|0|||
126344905|NCT03074500|454557275|FG002|Overall Study|Adverse Event|1|||
126344906|NCT03608163|454557276|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
126344907|NCT03608163|454557277|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
126344908|NCT02194465|454558463|FG000|Overall Study|Adverse Event|6|||
126344909|NCT02194465|454558464|FG001|Overall Study|Adverse Event|1|||
126344910|NCT02194465|454558465|FG002|Overall Study|Adverse Event|4|||
126344911|NCT02194465|454558466|FG003|Overall Study|Adverse Event|4|||
126344912|NCT02194465|454558467|FG004|Overall Study|Adverse Event|4|||
126344913|NCT02194465|454558468|FG005|Overall Study|Adverse Event|2|||
126344914|NCT02194465|454558469|FG006|Overall Study|Adverse Event|0|||
126344915|NCT02194465|454558463|FG000|Overall Study|Lost to Follow-up|0|||
126344916|NCT02194465|454558464|FG001|Overall Study|Lost to Follow-up|0|||
126344917|NCT02194465|454558465|FG002|Overall Study|Lost to Follow-up|0|||
126344918|NCT02194465|454558466|FG003|Overall Study|Lost to Follow-up|1|||
126344919|NCT02194465|454558467|FG004|Overall Study|Lost to Follow-up|0|||
126344920|NCT02194465|454558468|FG005|Overall Study|Lost to Follow-up|1|||
126344921|NCT02194465|454558469|FG006|Overall Study|Lost to Follow-up|0|||
126344922|NCT02194465|454558463|FG000|Overall Study|Physician Decision|1|||
126344923|NCT02194465|454558464|FG001|Overall Study|Physician Decision|0|||
126344924|NCT02194465|454558465|FG002|Overall Study|Physician Decision|0|||
126344925|NCT02194465|454558466|FG003|Overall Study|Physician Decision|0|||
126344926|NCT02194465|454558467|FG004|Overall Study|Physician Decision|0|||
126344927|NCT02194465|454558468|FG005|Overall Study|Physician Decision|0|||
126344928|NCT02194465|454558469|FG006|Overall Study|Physician Decision|0|||
126344929|NCT02194465|454558463|FG000|Overall Study|Protocol Violation|1|||
126344930|NCT02194465|454558464|FG001|Overall Study|Protocol Violation|1|||
126344931|NCT02194465|454558465|FG002|Overall Study|Protocol Violation|2|||
126344932|NCT02194465|454558466|FG003|Overall Study|Protocol Violation|1|||
126344933|NCT02194465|454558467|FG004|Overall Study|Protocol Violation|1|||
126344934|NCT02194465|454558468|FG005|Overall Study|Protocol Violation|0|||
126344935|NCT02194465|454558469|FG006|Overall Study|Protocol Violation|0|||
126344936|NCT02194465|454558463|FG000|Overall Study|Withdrawal by Subject|1|||
126344937|NCT02194465|454558464|FG001|Overall Study|Withdrawal by Subject|3|||
126344938|NCT02194465|454558465|FG002|Overall Study|Withdrawal by Subject|1|||
126344939|NCT02194465|454558466|FG003|Overall Study|Withdrawal by Subject|2|||
126344940|NCT02194465|454558467|FG004|Overall Study|Withdrawal by Subject|2|||
126344941|NCT02194465|454558468|FG005|Overall Study|Withdrawal by Subject|1|||
126344942|NCT02194465|454558469|FG006|Overall Study|Withdrawal by Subject|2|||
126344943|NCT02194465|454558463|FG000|Overall Study|Discontinued follow-up period|0|||
126344944|NCT02194465|454558464|FG001|Overall Study|Discontinued follow-up period|2|||
126344945|NCT02194465|454558465|FG002|Overall Study|Discontinued follow-up period|1|||
126344946|NCT02194465|454558466|FG003|Overall Study|Discontinued follow-up period|0|||
126344947|NCT02194465|454558467|FG004|Overall Study|Discontinued follow-up period|2|||
126344948|NCT02194465|454558468|FG005|Overall Study|Discontinued follow-up period|0|||
126344949|NCT02194465|454558469|FG006|Overall Study|Discontinued follow-up period|0|||
126344950|NCT01408641|454558470|FG000|Overall Study|Physician Decision|1|||
126344951|NCT01408641|454558471|FG001|Overall Study|Physician Decision|0|||
126344952|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
126344953|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
126344954|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
126344955|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
126344956|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
126011244|NCT04364269|453333461|FG002|Overall Study|Withdrawal by Subject|0|||
126011245|NCT00383188|453333462|FG000|Overall Study|Adverse Event|4|||
126011246|NCT00383188|453333463|FG001|Overall Study|Adverse Event|7|||
126011247|NCT00383188|453333464|FG002|Overall Study|Adverse Event|9|||
126011248|NCT00383188|453333465|FG003|Overall Study|Adverse Event|8|||
126011249|NCT00383188|453333466|FG004|Overall Study|Adverse Event|8|||
126011250|NCT00383188|453333462|FG000|Overall Study|Lack of Efficacy|9|||
126011251|NCT00383188|453333463|FG001|Overall Study|Lack of Efficacy|3|||
126011252|NCT00383188|453333464|FG002|Overall Study|Lack of Efficacy|3|||
126011253|NCT00383188|453333465|FG003|Overall Study|Lack of Efficacy|2|||
126011254|NCT00383188|453333466|FG004|Overall Study|Lack of Efficacy|6|||
126011255|NCT00383188|453333462|FG000|Overall Study|Other|3|||
126011256|NCT00383188|453333463|FG001|Overall Study|Other|1|||
126011257|NCT00383188|453333464|FG002|Overall Study|Other|0|||
126011258|NCT00383188|453333465|FG003|Overall Study|Other|2|||
126011259|NCT00383188|453333466|FG004|Overall Study|Other|6|||
126011260|NCT00383188|453333462|FG000|Overall Study|No longer willing to participate|1|||
126011261|NCT00383188|453333463|FG001|Overall Study|No longer willing to participate|0|||
126011262|NCT00383188|453333464|FG002|Overall Study|No longer willing to participate|1|||
126011263|NCT00383188|453333465|FG003|Overall Study|No longer willing to participate|0|||
126011264|NCT00383188|453333466|FG004|Overall Study|No longer willing to participate|2|||
126011265|NCT00383188|453333462|FG000|Overall Study|Lost to Follow-up|0|||
126011266|NCT00383188|453333463|FG001|Overall Study|Lost to Follow-up|0|||
126011267|NCT00383188|453333464|FG002|Overall Study|Lost to Follow-up|0|||
126011268|NCT00383188|453333465|FG003|Overall Study|Lost to Follow-up|0|||
126011269|NCT00383188|453333466|FG004|Overall Study|Lost to Follow-up|1|||
126011270|NCT00835380|453333467|FG000|Overall Study|Withdrawal by Subject|2|||
126011271|NCT01227707|453333470|FG000|Overall Study|Adverse Event|10|||
126011272|NCT01227707|453333470|FG000|Overall Study|Progression of disease|3|||
126011273|NCT01227707|453333470|FG000|Overall Study|Withdrawal by Subject|1|||
126011274|NCT01227707|453333470|FG000|Overall Study|Patient non-compliance|3|||
126011275|NCT01227707|453333470|FG000|Overall Study|Medical decision|6|||
126011276|NCT01227707|453333470|FG000|Overall Study|Death|1|||
126011277|NCT01093534|453333476|FG000|Overall Study|Adverse Event|2|||
126011278|NCT01093534|453333477|FG001|Overall Study|Adverse Event|5|||
126011279|NCT01093534|453333478|FG002|Overall Study|Adverse Event|2|||
126011280|NCT01093534|453333476|FG000|Overall Study|Lack of Efficacy|2|||
126011281|NCT01093534|453333477|FG001|Overall Study|Lack of Efficacy|1|||
126011282|NCT01093534|453333478|FG002|Overall Study|Lack of Efficacy|1|||
126011283|NCT01093534|453333476|FG000|Overall Study|Withdrawal by Subject|5|||
126011284|NCT01093534|453333477|FG001|Overall Study|Withdrawal by Subject|7|||
126011285|NCT01093534|453333478|FG002|Overall Study|Withdrawal by Subject|2|||
126011286|NCT01093534|453333476|FG000|Overall Study|Other|1|||
126011287|NCT01093534|453333477|FG001|Overall Study|Other|3|||
126011288|NCT01093534|453333478|FG002|Overall Study|Other|4|||
126011289|NCT01837641|453333483|FG000|Overall Study|Sponsor decision|1|||
126011290|NCT01837641|453333484|FG001|Overall Study|Sponsor decision|0|||
126011291|NCT01837641|453333485|FG002|Overall Study|Sponsor decision|0|||
126011292|NCT01837641|453333486|FG003|Overall Study|Sponsor decision|0|||
126011293|NCT01837641|453333487|FG004|Overall Study|Sponsor decision|0|||
126011294|NCT01837641|453333488|FG005|Overall Study|Sponsor decision|1|||
126011295|NCT01837641|453333489|FG006|Overall Study|Sponsor decision|0|||
126011296|NCT01837641|453333490|FG007|Overall Study|Sponsor decision|0|||
126011297|NCT01837641|453333483|FG000|Overall Study|Adverse Event|0|||
126011298|NCT01837641|453333484|FG001|Overall Study|Adverse Event|0|||
126011299|NCT01837641|453333485|FG002|Overall Study|Adverse Event|0|||
126011300|NCT01837641|453333486|FG003|Overall Study|Adverse Event|0|||
126344957|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
126344958|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
126344959|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
126344960|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
126344961|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
126344962|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
126344963|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
126344964|NCT03979313|454558472|FG000|All Subjects|Any Other Reason|16|||
126344965|NCT03979313|454558473|FG001|All Subjects|Any Other Reason|23|||
126344966|NCT03979313|454558472|FG000|All Subjects|Covid-19|1|||
126344967|NCT03979313|454558473|FG001|All Subjects|Covid-19|3|||
126344968|NCT03979313|454558472|FG000|All Subjects|Withdrawal by Subject|35|||
126344969|NCT03979313|454558473|FG001|All Subjects|Withdrawal by Subject|44|||
126344970|NCT03979313|454558472|FG000|All Subjects|Death|0|||
126344971|NCT03979313|454558473|FG001|All Subjects|Death|5|||
126344972|NCT03979313|454558472|FG000|All Subjects|Lost to Follow-up|28|||
126344973|NCT03979313|454558473|FG001|All Subjects|Lost to Follow-up|61|||
126344974|NCT00089648|454558474|FG000|Overall Study|Adverse Event|7|||
126344975|NCT00089648|454558474|FG000|Overall Study|Withdrawal by Subject|1|||
126344976|NCT00089648|454558474|FG000|Overall Study|Lack of Efficacy|33|||
126344977|NCT00423605|454558475|FG000|Overall Study|Adverse Event|129|||
126344978|NCT00423605|454558475|FG000|Overall Study|Withdrawal by Subject|36|||
126344979|NCT00423605|454558475|FG000|Overall Study|Lost to Follow-up|15|||
126344980|NCT00423605|454558475|FG000|Overall Study|Lack of Efficacy|38|||
126344981|NCT00423605|454558475|FG000|Overall Study|Sponsor Decision|3|||
126344982|NCT00423605|454558475|FG000|Overall Study|Physician Decision|8|||
126344983|NCT00423605|454558475|FG000|Overall Study|Protocol Violation|7|||
126344984|NCT00423605|454558475|FG000|Overall Study|Not one of the pre-specified options|5|||
126344985|NCT03183908|454558481|FG000|Overall Study|Missing Symptom Diary Data|0|||
126344986|NCT03183908|454558482|FG001|Overall Study|Missing Symptom Diary Data|2|||
126344987|NCT01240746|454558483|FG000|Overall Study|Adverse Event|2|||
126344988|NCT01240746|454558484|FG001|Overall Study|Adverse Event|0|||
126344989|NCT01240746|454558485|FG002|Overall Study|Adverse Event|10|||
126344990|NCT01240746|454558483|FG000|Overall Study|Lost to Follow-up|23|||
126344991|NCT01240746|454558484|FG001|Overall Study|Lost to Follow-up|20|||
126344992|NCT01240746|454558485|FG002|Overall Study|Lost to Follow-up|102|||
126344993|NCT01240746|454558483|FG000|Overall Study|Protocol Violation|24|||
126344994|NCT01240746|454558484|FG001|Overall Study|Protocol Violation|15|||
126344995|NCT01240746|454558485|FG002|Overall Study|Protocol Violation|72|||
126344996|NCT01240746|454558483|FG000|Overall Study|Withdrawal by Subject|10|||
126344997|NCT01240746|454558484|FG001|Overall Study|Withdrawal by Subject|13|||
126344998|NCT01240746|454558485|FG002|Overall Study|Withdrawal by Subject|59|||
126344999|NCT03738696|454558486|FG000|Overall Study|Withdrawal by Subject|0|||
126345000|NCT03738696|454558487|FG001|Overall Study|Withdrawal by Subject|1|||
126345001|NCT03738696|454558486|FG000|Overall Study|Lost to Follow-up|8|||
126345002|NCT03738696|454558487|FG001|Overall Study|Lost to Follow-up|14|||
126345003|NCT02566005|454558488|FG000|Overall Study|vaginal bleeding|0|||
126345004|NCT02566005|454558489|FG001|Overall Study|vaginal bleeding|1|||
126345005|NCT02566005|454558488|FG000|Overall Study|received foley|8|||
126345006|NCT02566005|454558489|FG001|Overall Study|received foley|0|||
126345007|NCT02566005|454558488|FG000|Overall Study|did not receive foley|0|||
126345008|NCT02566005|454558489|FG001|Overall Study|did not receive foley|1|||
126345009|NCT02566005|454558488|FG000|Overall Study|labor after randomization|0|||
126345010|NCT02566005|454558489|FG001|Overall Study|labor after randomization|4|||
126345011|NCT03617588|454558490|FG000|Overall Study|Withdrawal by Subject|1|||
126345012|NCT03617588|454558491|FG001|Overall Study|Withdrawal by Subject|0|||
126345013|NCT01294514|454558492|FG000|Overall Study|Excluded due to Arrhythmia|1|||
126345014|NCT02690727|454558493|FG000|Overall Study|Adverse Event|2|||
126345015|NCT02690727|454558494|FG001|Overall Study|Adverse Event|2|||
126345016|NCT00785629|454558499|FG000|Overall Study|Adverse Event|2|||
126345017|NCT00785629|454558500|FG001|Overall Study|Adverse Event|1|||
126345018|NCT00785629|454558501|FG002|Overall Study|Adverse Event|1|||
126345019|NCT00785629|454558502|FG003|Overall Study|Adverse Event|5|||
126345020|NCT00785629|454558499|FG000|Overall Study|Protocol Violation|1|||
126345021|NCT00785629|454558500|FG001|Overall Study|Protocol Violation|2|||
126345022|NCT00785629|454558501|FG002|Overall Study|Protocol Violation|4|||
126345023|NCT00785629|454558502|FG003|Overall Study|Protocol Violation|5|||
126345024|NCT00785629|454558499|FG000|Overall Study|administrative decision|5|||
126345025|NCT00785629|454558500|FG001|Overall Study|administrative decision|1|||
126345026|NCT00785629|454558501|FG002|Overall Study|administrative decision|3|||
126345027|NCT00785629|454558502|FG003|Overall Study|administrative decision|4|||
126345028|NCT00785629|454558499|FG000|Overall Study|Withdrawal by Subject|0|||
126345029|NCT00785629|454558500|FG001|Overall Study|Withdrawal by Subject|1|||
126345030|NCT00785629|454558501|FG002|Overall Study|Withdrawal by Subject|2|||
126345031|NCT00785629|454558502|FG003|Overall Study|Withdrawal by Subject|2|||
126345032|NCT00851591|454558504|FG000|Overall Study|Withdrawal by Subject|2|||
126345033|NCT00851591|454558505|FG001|Overall Study|Withdrawal by Subject|0|||
126011301|NCT01837641|453333487|FG004|Overall Study|Adverse Event|0|||
126011302|NCT01837641|453333488|FG005|Overall Study|Adverse Event|1|||
126011303|NCT01837641|453333489|FG006|Overall Study|Adverse Event|0|||
126011304|NCT01837641|453333490|FG007|Overall Study|Adverse Event|0|||
126011305|NCT01837641|453333483|FG000|Overall Study|Withdrawal by Subject|0|||
126011306|NCT01837641|453333484|FG001|Overall Study|Withdrawal by Subject|0|||
126011307|NCT01837641|453333485|FG002|Overall Study|Withdrawal by Subject|0|||
126011308|NCT01837641|453333486|FG003|Overall Study|Withdrawal by Subject|0|||
126011309|NCT01837641|453333487|FG004|Overall Study|Withdrawal by Subject|1|||
126011310|NCT01837641|453333488|FG005|Overall Study|Withdrawal by Subject|0|||
126011311|NCT01837641|453333489|FG006|Overall Study|Withdrawal by Subject|1|||
126345034|NCT04009837|454558510|FG000|Overall Study|Withdrawal by Subject|5|||
126345035|NCT04009837|454558511|FG001|Overall Study|Withdrawal by Subject|4|||
126345036|NCT04009837|454558510|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
126345037|NCT04009837|454558511|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
126345038|NCT01129128|454558514|FG000|Overall Study|Lost to Follow-up|2|||
126345039|NCT01129128|454558515|FG001|Overall Study|Lost to Follow-up|2|||
126345040|NCT01129128|454558516|FG002|Overall Study|Lost to Follow-up|1|||
126345041|NCT01129128|454558514|FG000|Overall Study|Protocol Violation|0|||
126345042|NCT01129128|454558515|FG001|Overall Study|Protocol Violation|1|||
126345043|NCT01129128|454558516|FG002|Overall Study|Protocol Violation|0|||
126345044|NCT01129128|454558514|FG000|Overall Study|Withdrawal by Subject|0|||
126345045|NCT01129128|454558515|FG001|Overall Study|Withdrawal by Subject|1|||
126345046|NCT01129128|454558516|FG002|Overall Study|Withdrawal by Subject|3|||
126345047|NCT01129128|454558514|FG000|Overall Study|Physician Decision|1|||
126345048|NCT01129128|454558515|FG001|Overall Study|Physician Decision|0|||
126345049|NCT01129128|454558516|FG002|Overall Study|Physician Decision|0|||
126345050|NCT02763566|454558524|FG000|Overall Study|Lost to Follow-up|1|||
126345051|NCT02763566|454558525|FG001|Overall Study|Lost to Follow-up|4|||
126345052|NCT02763566|454558526|FG002|Overall Study|Lost to Follow-up|0|||
126345053|NCT02763566|454558527|FG003|Overall Study|Lost to Follow-up|1|||
126345054|NCT02763566|454558524|FG000|Overall Study|On study treatment at study conclusion|114|||
126345055|NCT02763566|454558525|FG001|Overall Study|On study treatment at study conclusion|34|||
126345056|NCT02763566|454558526|FG002|Overall Study|On study treatment at study conclusion|54|||
126345057|NCT02763566|454558527|FG003|Overall Study|On study treatment at study conclusion|13|||
126345058|NCT02763566|454558524|FG000|Overall Study|Withdrawal by Subject|3|||
126345059|NCT02763566|454558525|FG001|Overall Study|Withdrawal by Subject|1|||
126011312|NCT01837641|453333490|FG007|Overall Study|Withdrawal by Subject|0|||
126011313|NCT01768676|453333505|FG000|Overall Study|Adverse Event|3|||
126011314|NCT01768676|453333506|FG001|Overall Study|Adverse Event|3|||
126011315|NCT01768676|453333505|FG000|Overall Study|Lost to Follow-up|13|||
126011316|NCT01768676|453333506|FG001|Overall Study|Lost to Follow-up|16|||
126011317|NCT01768676|453333505|FG000|Overall Study|Protocol Violation|1|||
126011318|NCT01768676|453333506|FG001|Overall Study|Protocol Violation|1|||
126345060|NCT02763566|454558526|FG002|Overall Study|Withdrawal by Subject|0|||
126345061|NCT02763566|454558527|FG003|Overall Study|Withdrawal by Subject|0|||
126345062|NCT01933594|454558532|FG000|Overall Study|Lost to Follow-up|1|||
126345063|NCT01933594|454558533|FG001|Overall Study|Lost to Follow-up|0|||
126345064|NCT01933594|454558534|FG002|Overall Study|Lost to Follow-up|0|||
126011319|NCT01768676|453333505|FG000|Overall Study|Physician Decision|4|||
126011320|NCT01768676|453333506|FG001|Overall Study|Physician Decision|1|||
126011321|NCT01768676|453333505|FG000|Overall Study|Withdrawal by Subject|3|||
126011322|NCT01768676|453333506|FG001|Overall Study|Withdrawal by Subject|10|||
126011323|NCT01196429|453333507|FG000|Overall Study|Ineligible - inadequate pathology|1|||
126011324|NCT01196429|453333508|FG001|Overall Study|Ineligible - inadequate pathology|0|||
126011325|NCT01196429|453333507|FG000|Overall Study|Ineligible - wrong cell type|1|||
126011326|NCT01196429|453333508|FG001|Overall Study|Ineligible - wrong cell type|0|||
126011327|NCT01196429|453333507|FG000|Overall Study|Refused - Never Treated|1|||
126011328|NCT01196429|453333508|FG001|Overall Study|Refused - Never Treated|0|||
126011329|NCT04248829|453333509|FG000|Overall Study|Disease progression|44|||
126011330|NCT04248829|453333510|FG001|Overall Study|Disease progression|109|||
126011331|NCT04248829|453333509|FG000|Overall Study|Adverse Event|19|||
126011332|NCT04248829|453333510|FG001|Overall Study|Adverse Event|18|||
126011333|NCT04248829|453333509|FG000|Overall Study|Withdrawal by Subject|11|||
126345065|NCT01933594|454558535|FG003|Overall Study|Lost to Follow-up|0|||
126345066|NCT01933594|454558536|FG004|Overall Study|Lost to Follow-up|1|||
126345067|NCT01933594|454558537|FG005|Overall Study|Lost to Follow-up|0|||
126345068|NCT01933594|454558532|FG000|Overall Study|Ineligible for subsequent study step|0|||
126345069|NCT01933594|454558533|FG001|Overall Study|Ineligible for subsequent study step|0|||
126345070|NCT01933594|454558534|FG002|Overall Study|Ineligible for subsequent study step|0|||
126345071|NCT01933594|454558535|FG003|Overall Study|Ineligible for subsequent study step|0|||
126345072|NCT01933594|454558536|FG004|Overall Study|Ineligible for subsequent study step|1|||
126345073|NCT01933594|454558537|FG005|Overall Study|Ineligible for subsequent study step|0|||
126345074|NCT02657551|454558546|FG000|Overall Study|Adverse Event|2|||
126011334|NCT04248829|453333510|FG001|Overall Study|Withdrawal by Subject|2|||
126011335|NCT04248829|453333509|FG000|Overall Study|Lost to Follow-up|0|||
126011336|NCT04248829|453333510|FG001|Overall Study|Lost to Follow-up|1|||
126345075|NCT02657551|454558546|FG000|Overall Study|Withdrawal by Subject|1|||
126345076|NCT02657551|454558546|FG000|Overall Study|Non-Compliance|1|||
126345077|NCT02657551|454558546|FG000|Overall Study|Progression / Relapse|4|||
126011337|NCT04248829|453333509|FG000|Overall Study|Death|12|||
126345078|NCT00315445|454558547|FG000|Overall Study|Adverse Event|7|||
126345079|NCT00315445|454558548|FG001|Overall Study|Adverse Event|12|||
126345080|NCT00315445|454558549|FG002|Overall Study|Adverse Event|15|||
126345081|NCT00315445|454558547|FG000|Overall Study|Lack of Efficacy|16|||
126345082|NCT00315445|454558548|FG001|Overall Study|Lack of Efficacy|1|||
126345083|NCT00315445|454558549|FG002|Overall Study|Lack of Efficacy|7|||
126345084|NCT00315445|454558547|FG000|Overall Study|Lost to Follow-up|1|||
126345085|NCT00315445|454558548|FG001|Overall Study|Lost to Follow-up|0|||
126345086|NCT00315445|454558549|FG002|Overall Study|Lost to Follow-up|1|||
126345087|NCT00315445|454558547|FG000|Overall Study|Protocol Violation|2|||
126345088|NCT00315445|454558548|FG001|Overall Study|Protocol Violation|0|||
126345089|NCT00315445|454558549|FG002|Overall Study|Protocol Violation|1|||
126345090|NCT00315445|454558547|FG000|Overall Study|Other|1|||
126345091|NCT00315445|454558548|FG001|Overall Study|Other|3|||
126345092|NCT00315445|454558549|FG002|Overall Study|Other|0|||
126345093|NCT01035138|454558550|FG000|Overall Study|Adverse Event|4|||
126345094|NCT01035138|454558551|FG001|Overall Study|Adverse Event|0|||
126345095|NCT01035138|454558552|FG002|Overall Study|Adverse Event|2|||
126345096|NCT01035138|454558550|FG000|Overall Study|Caregiver Decision|2|||
126345097|NCT01035138|454558551|FG001|Overall Study|Caregiver Decision|0|||
126345098|NCT01035138|454558552|FG002|Overall Study|Caregiver Decision|1|||
126345099|NCT01035138|454558550|FG000|Overall Study|Withdrawal by Subject|1|||
126345100|NCT01035138|454558551|FG001|Overall Study|Withdrawal by Subject|0|||
126345101|NCT01035138|454558552|FG002|Overall Study|Withdrawal by Subject|0|||
126345102|NCT01035138|454558550|FG000|Overall Study|Physician Decision|0|||
126345103|NCT01035138|454558551|FG001|Overall Study|Physician Decision|0|||
126345104|NCT01035138|454558552|FG002|Overall Study|Physician Decision|1|||
126345105|NCT01035138|454558550|FG000|Overall Study|Sponsor Decision|66|||
126345106|NCT01035138|454558551|FG001|Overall Study|Sponsor Decision|60|||
126345107|NCT01035138|454558552|FG002|Overall Study|Sponsor Decision|42|||
126345108|NCT01035138|454558550|FG000|Overall Study|Lost to Follow-up|0|||
126345109|NCT01035138|454558551|FG001|Overall Study|Lost to Follow-up|0|||
126345110|NCT01035138|454558552|FG002|Overall Study|Lost to Follow-up|1|||
126345111|NCT01811238|454558553|FG000|Overall Study|Withdrawal by Subject|42|||
126011338|NCT04248829|453333510|FG001|Overall Study|Death|14|||
126011339|NCT04248829|453333509|FG000|Overall Study|Physician Decision|2|||
126011340|NCT04248829|453333510|FG001|Overall Study|Physician Decision|4|||
126011341|NCT04248829|453333509|FG000|Overall Study|Any reason not specifically recorded|0|||
126011342|NCT04248829|453333510|FG001|Overall Study|Any reason not specifically recorded|2|||
126011343|NCT02685033|453333511|FG000|Overall Study|Withdrawal of Consent|0|||
126345112|NCT01811238|454558553|FG000|Overall Study|Adverse Event|25|||
126345113|NCT01811238|454558553|FG000|Overall Study|Protocol Violation|4|||
126345114|NCT01811238|454558553|FG000|Overall Study|Lack of Efficacy|4|||
126345115|NCT01811238|454558553|FG000|Overall Study|subject refused study medication|6|||
126345116|NCT02164916|454558556|FG000|Overall Study|Adverse Event|3|||
126345117|NCT02164916|454558557|FG001|Overall Study|Adverse Event|8|||
126345118|NCT02164916|454558556|FG000|Overall Study|Death|1|||
126345119|NCT02164916|454558557|FG001|Overall Study|Death|1|||
126345120|NCT02164916|454558556|FG000|Overall Study|Refusal unrelated to adverse event|3|||
126345121|NCT02164916|454558557|FG001|Overall Study|Refusal unrelated to adverse event|7|||
126345122|NCT02164916|454558556|FG000|Overall Study|Progression|37|||
126345123|NCT02164916|454558557|FG001|Overall Study|Progression|26|||
126345124|NCT02164916|454558556|FG000|Overall Study|Not protocol specified|5|||
126345125|NCT02164916|454558557|FG001|Overall Study|Not protocol specified|1|||
126345126|NCT02164916|454558556|FG000|Overall Study|Reason under review|1|||
126345127|NCT02164916|454558557|FG001|Overall Study|Reason under review|6|||
126345128|NCT02164916|454558556|FG000|Overall Study|Not eligible|2|||
126345129|NCT02164916|454558557|FG001|Overall Study|Not eligible|5|||
126345130|NCT02916927|454558560|FG000|Overall Study|Discharged prior to study drug receipt|0|||
126345131|NCT02916927|454558561|FG001|Overall Study|Discharged prior to study drug receipt|2|||
126345132|NCT02916927|454558560|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
126345133|NCT02916927|454558561|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
126345134|NCT02916927|454558560|FG000|Overall Study|Withdrawal before first time point|1|||
126345135|NCT02916927|454558561|FG001|Overall Study|Withdrawal before first time point|0|||
126345136|NCT01925417|454558568|FG000|Overall Study|Withdrawal by Subject|2|||
126345137|NCT01925417|454558568|FG000|Overall Study|Death|1|||
126345138|NCT00655889|454558569|FG000|Overall Study|Inadequate cell growth|1|||
126345139|NCT00655889|454558569|FG000|Overall Study|Protocol Violation|1|||
126345140|NCT03479905|454558570|FG000|Overall Study|Other airway method used|4|||
126345141|NCT03479905|454558571|FG001|Overall Study|Other airway method used|5|||
126345142|NCT03479905|454558572|FG002|Overall Study|Other airway method used|5|||
126345143|NCT00720759|454558573|FG000|Overall Study|Lost to Follow-up|0|||
126345144|NCT00720759|454558574|FG001|Overall Study|Lost to Follow-up|1|||
126345145|NCT00720759|454558575|FG002|Overall Study|Lost to Follow-up|1|||
126345146|NCT00720759|454558576|FG003|Overall Study|Lost to Follow-up|0|||
126345147|NCT02318940|454558577|FG000|Overall Study|lost the record|1|||
126345148|NCT02318940|454558578|FG001|Overall Study|lost the record|0|||
126345149|NCT01047319|454558579|FG000|Overall Study|Teva requested participant withdrawal|3|||
126345150|NCT01047319|454558580|FG001|Overall Study|Teva requested participant withdrawal|0|||
126345151|NCT01047319|454558581|FG002|Overall Study|Teva requested participant withdrawal|1|||
126345152|NCT01047319|454558579|FG000|Overall Study|Protocol Violation|3|||
126345153|NCT01047319|454558580|FG001|Overall Study|Protocol Violation|2|||
126345154|NCT01047319|454558581|FG002|Overall Study|Protocol Violation|4|||
126345155|NCT01047319|454558579|FG000|Overall Study|Lack of Efficacy|4|||
126345156|NCT01047319|454558580|FG001|Overall Study|Lack of Efficacy|3|||
126345157|NCT01047319|454558581|FG002|Overall Study|Lack of Efficacy|3|||
126345158|NCT01047319|454558579|FG000|Overall Study|Death|5|||
126345159|NCT01047319|454558580|FG001|Overall Study|Death|1|||
126345160|NCT01047319|454558581|FG002|Overall Study|Death|5|||
126345161|NCT01047319|454558579|FG000|Overall Study|Pregnancy|13|||
126345162|NCT01047319|454558580|FG001|Overall Study|Pregnancy|8|||
126345163|NCT01047319|454558581|FG002|Overall Study|Pregnancy|8|||
126345164|NCT01047319|454558579|FG000|Overall Study|Physician Decision|12|||
126345165|NCT01047319|454558580|FG001|Overall Study|Physician Decision|9|||
126345166|NCT01047319|454558581|FG002|Overall Study|Physician Decision|10|||
126345167|NCT01047319|454558579|FG000|Overall Study|Lost to Follow-up|14|||
126345168|NCT01047319|454558580|FG001|Overall Study|Lost to Follow-up|10|||
126345169|NCT01047319|454558581|FG002|Overall Study|Lost to Follow-up|10|||
126345170|NCT01047319|454558579|FG000|Overall Study|Adverse Event|16|||
126345171|NCT01047319|454558580|FG001|Overall Study|Adverse Event|27|||
126345172|NCT01047319|454558581|FG002|Overall Study|Adverse Event|21|||
126345173|NCT01047319|454558579|FG000|Overall Study|Withdrawal by Subject|77|||
126345174|NCT01047319|454558580|FG001|Overall Study|Withdrawal by Subject|75|||
126345175|NCT01047319|454558581|FG002|Overall Study|Withdrawal by Subject|87|||
126345176|NCT01047319|454558579|FG000|Overall Study|Study terminated by Sponsor|198|||
126345177|NCT01047319|454558580|FG001|Overall Study|Study terminated by Sponsor|215|||
126345178|NCT01047319|454558581|FG002|Overall Study|Study terminated by Sponsor|203|||
126345179|NCT02598661|454558584|FG000|Overall Study|Death|27|||
126345180|NCT02598661|454558585|FG001|Overall Study|Death|34|||
126345181|NCT02598661|454558586|FG002|Overall Study|Death|14|||
126345182|NCT02598661|454558587|FG003|Overall Study|Death|1|||
126345183|NCT02598661|454558588|FG004|Overall Study|Death|0|||
126345184|NCT02598661|454558584|FG000|Overall Study|Lost to Follow-up|2|||
126345185|NCT02598661|454558585|FG001|Overall Study|Lost to Follow-up|3|||
126345186|NCT02598661|454558586|FG002|Overall Study|Lost to Follow-up|2|||
126345187|NCT02598661|454558587|FG003|Overall Study|Lost to Follow-up|0|||
126345188|NCT02598661|454558588|FG004|Overall Study|Lost to Follow-up|0|||
126011344|NCT02685033|453333512|FG001|Overall Study|Withdrawal of Consent|1|||
126345189|NCT02598661|454558584|FG000|Overall Study|Withdrawal by Subject|13|||
126345190|NCT02598661|454558585|FG001|Overall Study|Withdrawal by Subject|24|||
126345191|NCT02598661|454558586|FG002|Overall Study|Withdrawal by Subject|14|||
126345192|NCT02598661|454558587|FG003|Overall Study|Withdrawal by Subject|1|||
126345193|NCT02598661|454558588|FG004|Overall Study|Withdrawal by Subject|1|||
126345194|NCT02598661|454558584|FG000|Overall Study|Adverse Event|0|||
126345195|NCT02598661|454558585|FG001|Overall Study|Adverse Event|0|||
126345196|NCT02598661|454558586|FG002|Overall Study|Adverse Event|1|||
126345197|NCT02598661|454558587|FG003|Overall Study|Adverse Event|0|||
126345198|NCT02598661|454558588|FG004|Overall Study|Adverse Event|0|||
126345199|NCT02598661|454558584|FG000|Overall Study|Randomized, Never Treated|0|||
126345200|NCT02598661|454558585|FG001|Overall Study|Randomized, Never Treated|0|||
126011345|NCT02685033|453333511|FG000|Overall Study|Lost to Follow-up|2|||
126345201|NCT02598661|454558586|FG002|Overall Study|Randomized, Never Treated|0|||
126345202|NCT02598661|454558587|FG003|Overall Study|Randomized, Never Treated|0|||
126345203|NCT02598661|454558588|FG004|Overall Study|Randomized, Never Treated|1|||
126345204|NCT01366092|454558589|FG000|Overall Study|Progressive cGVHD|2|||
126011346|NCT02685033|453333512|FG001|Overall Study|Lost to Follow-up|1|||
126011347|NCT02685033|453333511|FG000|Overall Study|Adverse Event|1|||
126011348|NCT02685033|453333512|FG001|Overall Study|Adverse Event|0|||
126011349|NCT01066923|453333513|FG000|Overall Study|Withdrawal by Subject|3|||
126011350|NCT01066923|453333514|FG001|Overall Study|Withdrawal by Subject|3|||
126011351|NCT01066923|453333515|FG002|Overall Study|Withdrawal by Subject|8|||
126011352|NCT01066923|453333516|FG003|Overall Study|Withdrawal by Subject|8|||
126011353|NCT03227757|453335165|FG000|Overall Study|Death|25|||
126011354|NCT03227757|453335165|FG000|Overall Study|Withdrawal|10|||
126011355|NCT03227757|453335165|FG000|Overall Study|Missed visits|1|||
126011356|NCT03227757|453335165|FG000|Overall Study|Lost to Follow-up|2|||
126011357|NCT01144468|453335166|FG000|Overall Study|Lost to Follow-up|4|||
126011358|NCT01144468|453335167|FG001|Overall Study|Lost to Follow-up|7|||
126011359|NCT01144468|453335166|FG000|Overall Study|Adverse Event|3|||
126011360|NCT01144468|453335167|FG001|Overall Study|Adverse Event|2|||
126011361|NCT01144468|453335166|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
126011362|NCT01144468|453335167|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
126011363|NCT03140176|453335173|FG000|Overall Study|Reason missing|23|||
126011364|NCT03140176|453335173|FG000|Overall Study|Death|33|||
126011365|NCT03140176|453335173|FG000|Overall Study|Disease progression|1|||
126011366|NCT03140176|453335173|FG000|Overall Study|Physician Decision|1|||
126011367|NCT03140176|453335173|FG000|Overall Study|Withdrawal by Subject|1|||
126011368|NCT03140176|453335173|FG000|Overall Study|Lost to Follow-up|15|||
126011369|NCT00149630|453335174|FG000|Overall Study|Incarceration|2|||
126011370|NCT00149630|453335175|FG001|Overall Study|Incarceration|0|||
126011371|NCT00149630|453335174|FG000|Overall Study|Treatment Programs|4|||
126011372|NCT00149630|453335175|FG001|Overall Study|Treatment Programs|5|||
126011373|NCT00149630|453335174|FG000|Overall Study|Adverse Event|2|||
126011374|NCT00149630|453335175|FG001|Overall Study|Adverse Event|0|||
126011375|NCT05298111|453335180|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
126011376|NCT05298111|453335181|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
126345205|NCT01366092|454558589|FG000|Overall Study|Physician Decision|1|||
126345206|NCT01366092|454558589|FG000|Overall Study|Withdrawal by Subject|1|||
126345207|NCT02659865|454560105|FG000|Period 1|Withdrawal by Subject|1|||
126345208|NCT02659865|454560106|FG001|Period 1|Withdrawal by Subject|0|||
126345209|NCT02659865|454560107|FG002|Period 1|Withdrawal by Subject|0|||
126345210|NCT02659865|454560108|FG003|Period 1|Withdrawal by Subject|0|||
126345211|NCT02659865|454560109|FG004|Period 1|Withdrawal by Subject|0|||
126345212|NCT02659865|454560105|FG000|Period 1|Adverse Event|0|||
126345213|NCT02659865|454560106|FG001|Period 1|Adverse Event|0|||
126345214|NCT02659865|454560107|FG002|Period 1|Adverse Event|0|||
126345215|NCT02659865|454560108|FG003|Period 1|Adverse Event|0|||
126345216|NCT02659865|454560109|FG004|Period 1|Adverse Event|1|||
126345217|NCT01288430|454560111|FG000|Part 1|Progressive disease|2|||
126345218|NCT01288430|454560112|FG001|Part 1|Progressive disease|1|||
126345219|NCT01288430|454560113|FG002|Part 1|Progressive disease|1|||
126345220|NCT01288430|454560114|FG003|Part 1|Progressive disease|6|||
126345221|NCT01288430|454560115|FG004|Part 1|Progressive disease|2|||
126345222|NCT01288430|454560116|FG005|Part 1|Progressive disease|4|||
126345223|NCT01288430|454560117|FG006|Part 1|Progressive disease|2|||
126345224|NCT01288430|454560118|FG007|Part 1|Progressive disease|0|||
126345225|NCT01288430|454560119|FG008|Part 1|Progressive disease|0|||
126345226|NCT01288430|454560120|FG009|Part 1|Progressive disease|0|||
126345227|NCT01288430|454560111|FG000|Part 1|Clinical disease progression|0|||
126345228|NCT01288430|454560112|FG001|Part 1|Clinical disease progression|0|||
126345229|NCT01288430|454560113|FG002|Part 1|Clinical disease progression|1|||
126345230|NCT01288430|454560114|FG003|Part 1|Clinical disease progression|0|||
126345231|NCT01288430|454560115|FG004|Part 1|Clinical disease progression|0|||
126345232|NCT01288430|454560116|FG005|Part 1|Clinical disease progression|2|||
126345233|NCT01288430|454560117|FG006|Part 1|Clinical disease progression|2|||
126345234|NCT01288430|454560118|FG007|Part 1|Clinical disease progression|0|||
126345235|NCT01288430|454560119|FG008|Part 1|Clinical disease progression|0|||
126345236|NCT01288430|454560120|FG009|Part 1|Clinical disease progression|0|||
126345237|NCT01288430|454560111|FG000|Part 1|Death due to disease progression|0|||
126345238|NCT01288430|454560112|FG001|Part 1|Death due to disease progression|0|||
126345239|NCT01288430|454560113|FG002|Part 1|Death due to disease progression|0|||
126011377|NCT02689349|453335182|FG000|Overall Study|Not implanted|4|||
126011378|NCT02689349|453335183|FG001|Overall Study|Not implanted|0|||
126011379|NCT02689349|453335182|FG000|Overall Study|Withdrawal by Subject|9|||
126011380|NCT02689349|453335183|FG001|Overall Study|Withdrawal by Subject|0|||
126345240|NCT01288430|454560114|FG003|Part 1|Death due to disease progression|0|||
126345241|NCT01288430|454560115|FG004|Part 1|Death due to disease progression|1|||
126345242|NCT01288430|454560116|FG005|Part 1|Death due to disease progression|0|||
126345243|NCT01288430|454560117|FG006|Part 1|Death due to disease progression|0|||
126345244|NCT01288430|454560118|FG007|Part 1|Death due to disease progression|0|||
126011381|NCT03518112|453335184|FG000|Overall Study|Withdrawal by Subject|1|||
126011382|NCT01185522|453335185|FG000|Overall Study|Lack of Efficacy|28|||
126011383|NCT01185522|453335185|FG000|Overall Study|Lost to Follow-up|19|||
126011384|NCT01185522|453335185|FG000|Overall Study|Withdrawal by Subject|10|||
126011385|NCT01185522|453335185|FG000|Overall Study|Poor tolerance|39|||
126011386|NCT01185522|453335185|FG000|Overall Study|Other reasons|12|||
126011387|NCT00771667|453335186|FG000|Induction Phase|Adverse Event|5|||
126011388|NCT00771667|453335187|FG001|Induction Phase|Adverse Event|2|||
126011389|NCT00771667|453335188|FG002|Induction Phase|Adverse Event|4|||
126011390|NCT00771667|453335189|FG003|Induction Phase|Adverse Event|1|||
126011391|NCT00771667|453335190|FG004|Induction Phase|Adverse Event|0|||
126011392|NCT00771667|453335191|FG005|Induction Phase|Adverse Event|0|||
126011393|NCT00771667|453335192|FG006|Induction Phase|Adverse Event|0|||
126011394|NCT00771667|453335193|FG007|Induction Phase|Adverse Event|0|||
126011395|NCT00771667|453335194|FG008|Induction Phase|Adverse Event|0|||
126011396|NCT00771667|453335195|FG009|Induction Phase|Adverse Event|0|||
126011397|NCT00771667|453335186|FG000|Induction Phase|Lack of Efficacy|9|||
126011398|NCT00771667|453335187|FG001|Induction Phase|Lack of Efficacy|2|||
126011399|NCT00771667|453335188|FG002|Induction Phase|Lack of Efficacy|4|||
126011400|NCT00771667|453335189|FG003|Induction Phase|Lack of Efficacy|3|||
126011401|NCT00771667|453335190|FG004|Induction Phase|Lack of Efficacy|0|||
126011402|NCT00771667|453335191|FG005|Induction Phase|Lack of Efficacy|0|||
126011403|NCT00771667|453335192|FG006|Induction Phase|Lack of Efficacy|0|||
126011404|NCT00771667|453335193|FG007|Induction Phase|Lack of Efficacy|0|||
126011405|NCT00771667|453335194|FG008|Induction Phase|Lack of Efficacy|0|||
126011406|NCT00771667|453335195|FG009|Induction Phase|Lack of Efficacy|0|||
126011407|NCT00771667|453335186|FG000|Induction Phase|Lost to Follow-up|1|||
126011408|NCT00771667|453335187|FG001|Induction Phase|Lost to Follow-up|0|||
126011409|NCT00771667|453335188|FG002|Induction Phase|Lost to Follow-up|1|||
126011410|NCT00771667|453335189|FG003|Induction Phase|Lost to Follow-up|0|||
126011411|NCT00771667|453335190|FG004|Induction Phase|Lost to Follow-up|0|||
126011412|NCT00771667|453335191|FG005|Induction Phase|Lost to Follow-up|0|||
126011413|NCT00771667|453335192|FG006|Induction Phase|Lost to Follow-up|0|||
126011414|NCT00771667|453335193|FG007|Induction Phase|Lost to Follow-up|0|||
126011415|NCT00771667|453335194|FG008|Induction Phase|Lost to Follow-up|0|||
126011416|NCT00771667|453335195|FG009|Induction Phase|Lost to Follow-up|0|||
126011417|NCT00771667|453335186|FG000|Induction Phase|Other|4|||
126011418|NCT00771667|453335187|FG001|Induction Phase|Other|6|||
126011419|NCT00771667|453335188|FG002|Induction Phase|Other|3|||
126011420|NCT00771667|453335189|FG003|Induction Phase|Other|4|||
126011421|NCT00771667|453335190|FG004|Induction Phase|Other|0|||
126011422|NCT00771667|453335191|FG005|Induction Phase|Other|0|||
126011423|NCT00771667|453335192|FG006|Induction Phase|Other|0|||
126011424|NCT00771667|453335193|FG007|Induction Phase|Other|0|||
126011425|NCT00771667|453335194|FG008|Induction Phase|Other|0|||
126011426|NCT00771667|453335195|FG009|Induction Phase|Other|0|||
126011427|NCT00771667|453335186|FG000|Maintenance Phase|Adverse Event|0|||
126011428|NCT00771667|453335187|FG001|Maintenance Phase|Adverse Event|0|||
126011429|NCT00771667|453335188|FG002|Maintenance Phase|Adverse Event|0|||
126011430|NCT00771667|453335189|FG003|Maintenance Phase|Adverse Event|0|||
126011431|NCT00771667|453335190|FG004|Maintenance Phase|Adverse Event|1|||
126011432|NCT00771667|453335191|FG005|Maintenance Phase|Adverse Event|3|||
126011433|NCT00771667|453335192|FG006|Maintenance Phase|Adverse Event|5|||
126011434|NCT00771667|453335193|FG007|Maintenance Phase|Adverse Event|1|||
126011435|NCT00771667|453335194|FG008|Maintenance Phase|Adverse Event|8|||
126011436|NCT00771667|453335195|FG009|Maintenance Phase|Adverse Event|7|||
126011437|NCT00771667|453335186|FG000|Maintenance Phase|Lack of Efficacy|0|||
126011438|NCT00771667|453335187|FG001|Maintenance Phase|Lack of Efficacy|0|||
126011439|NCT00771667|453335188|FG002|Maintenance Phase|Lack of Efficacy|0|||
126011440|NCT00771667|453335189|FG003|Maintenance Phase|Lack of Efficacy|0|||
126011441|NCT00771667|453335190|FG004|Maintenance Phase|Lack of Efficacy|1|||
126011442|NCT00771667|453335191|FG005|Maintenance Phase|Lack of Efficacy|3|||
126011443|NCT00771667|453335192|FG006|Maintenance Phase|Lack of Efficacy|3|||
126011444|NCT00771667|453335193|FG007|Maintenance Phase|Lack of Efficacy|2|||
126011445|NCT00771667|453335194|FG008|Maintenance Phase|Lack of Efficacy|11|||
126011446|NCT00771667|453335195|FG009|Maintenance Phase|Lack of Efficacy|7|||
126011447|NCT00771667|453335186|FG000|Maintenance Phase|Other|0|||
126011448|NCT00771667|453335187|FG001|Maintenance Phase|Other|0|||
126011449|NCT00771667|453335188|FG002|Maintenance Phase|Other|0|||
126011450|NCT00771667|453335189|FG003|Maintenance Phase|Other|0|||
126011451|NCT00771667|453335190|FG004|Maintenance Phase|Other|0|||
126011452|NCT00771667|453335191|FG005|Maintenance Phase|Other|1|||
126011453|NCT00771667|453335192|FG006|Maintenance Phase|Other|2|||
126011454|NCT00771667|453335193|FG007|Maintenance Phase|Other|2|||
126011455|NCT00771667|453335194|FG008|Maintenance Phase|Other|3|||
126011456|NCT00771667|453335195|FG009|Maintenance Phase|Other|3|||
126011457|NCT00109967|453335196|FG000|Overall Study|Cancel Prior to Treatment|2|||
126011458|NCT00109967|453335197|FG001|Overall Study|Cancel Prior to Treatment|0|||
126011459|NCT00109967|453335196|FG000|Overall Study|Adverse Event|12|||
126011460|NCT00109967|453335197|FG001|Overall Study|Adverse Event|1|||
126011461|NCT00109967|453335196|FG000|Overall Study|Withdrawal by Subject|5|||
126011462|NCT00109967|453335197|FG001|Overall Study|Withdrawal by Subject|0|||
126011463|NCT00109967|453335196|FG000|Overall Study|Physician Decision|1|||
126011464|NCT00109967|453335197|FG001|Overall Study|Physician Decision|3|||
126011465|NCT00109967|453335196|FG000|Overall Study|Death|0|||
126011466|NCT00109967|453335197|FG001|Overall Study|Death|2|||
126011467|NCT00628862|453335204|FG000|Overall Study|Adverse Event|6|||
126011468|NCT00628862|453335205|FG001|Overall Study|Adverse Event|8|||
126011469|NCT00628862|453335206|FG002|Overall Study|Adverse Event|10|||
126011470|NCT00628862|453335204|FG000|Overall Study|Withdrawal by Subject|4|||
126011471|NCT00628862|453335205|FG001|Overall Study|Withdrawal by Subject|6|||
126011472|NCT00628862|453335206|FG002|Overall Study|Withdrawal by Subject|11|||
126011473|NCT00628862|453335204|FG000|Overall Study|Lost to Follow-up|0|||
126011474|NCT00628862|453335205|FG001|Overall Study|Lost to Follow-up|2|||
126011475|NCT00628862|453335206|FG002|Overall Study|Lost to Follow-up|1|||
126011476|NCT00628862|453335204|FG000|Overall Study|Protocol Violation|1|||
126011477|NCT00628862|453335205|FG001|Overall Study|Protocol Violation|0|||
126011478|NCT00628862|453335206|FG002|Overall Study|Protocol Violation|0|||
126011479|NCT00628862|453335204|FG000|Overall Study|COPD Exacerbation|0|||
126011480|NCT00628862|453335205|FG001|Overall Study|COPD Exacerbation|1|||
126011481|NCT00628862|453335206|FG002|Overall Study|COPD Exacerbation|0|||
126011482|NCT01063036|453335207|FG000|Participants Treated With Study Drug|Adverse Event|1|||
126011483|NCT01063036|453335207|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
126011484|NCT01063036|453335207|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
126011485|NCT01063036|453335207|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
126011486|NCT01063036|453335207|FG000|Participants Treated With Study Drug|Pregnancy|1|||
126011487|NCT01063036|453335207|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
126011488|NCT01063036|453335207|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
126011489|NCT01063036|453335207|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
126011490|NCT00918957|453335208|FG000|Overall Study|Adverse Event|2|||
126091106|NCT03820947|453626918|FG000|Overall Study|Procedure Not Attempted|0|||
126091107|NCT03820947|453626919|FG001|Overall Study|Procedure Not Attempted|2|||
126091108|NCT03820947|453626920|FG002|Overall Study|Procedure Not Attempted|1|||
126091109|NCT03820947|453626921|FG003|Overall Study|Procedure Not Attempted|0|||
126091110|NCT03820947|453626922|FG004|Overall Study|Procedure Not Attempted|0|||
126091111|NCT03820947|453626918|FG000|Overall Study|Other Exit|1|||
126091112|NCT03820947|453626919|FG001|Overall Study|Other Exit|3|||
126091113|NCT03820947|453626920|FG002|Overall Study|Other Exit|3|||
126091114|NCT03820947|453626921|FG003|Overall Study|Other Exit|3|||
126091115|NCT03820947|453626922|FG004|Overall Study|Other Exit|0|||
126091116|NCT03820947|453626918|FG000|Overall Study|Follow-up Not Done|10|||
126091117|NCT03820947|453626919|FG001|Overall Study|Follow-up Not Done|13|||
126091118|NCT03820947|453626920|FG002|Overall Study|Follow-up Not Done|2|||
126091119|NCT03820947|453626921|FG003|Overall Study|Follow-up Not Done|3|||
126091120|NCT03820947|453626922|FG004|Overall Study|Follow-up Not Done|12|||
126091121|NCT03820947|453626918|FG000|Overall Study|Death|0|||
126011491|NCT00918957|453335209|FG001|Overall Study|Adverse Event|0|||
126091122|NCT03820947|453626919|FG001|Overall Study|Death|0|||
126091123|NCT03820947|453626920|FG002|Overall Study|Death|0|||
126345245|NCT01288430|454560119|FG008|Part 1|Death due to disease progression|0|||
126345246|NCT01288430|454560120|FG009|Part 1|Death due to disease progression|0|||
126345247|NCT01288430|454560111|FG000|Part 1|Adverse Event|0|||
126345248|NCT01288430|454560112|FG001|Part 1|Adverse Event|0|||
126345249|NCT01288430|454560113|FG002|Part 1|Adverse Event|3|||
126345250|NCT01288430|454560114|FG003|Part 1|Adverse Event|1|||
126345251|NCT01288430|454560115|FG004|Part 1|Adverse Event|0|||
126011492|NCT00918957|453335208|FG000|Overall Study|Withdrawal by Subject|1|||
126011493|NCT00918957|453335209|FG001|Overall Study|Withdrawal by Subject|0|||
126011494|NCT01803646|453335210|FG000|Overall Study|Protocol Violation|1|||
126011495|NCT01803646|453335211|FG001|Overall Study|Protocol Violation|0|||
126011496|NCT01803646|453335210|FG000|Overall Study|Adverse Event|1|||
126011497|NCT01803646|453335211|FG001|Overall Study|Adverse Event|1|||
126011498|NCT01803646|453335210|FG000|Overall Study|Withdrawal by Subject|9|||
126011499|NCT01803646|453335211|FG001|Overall Study|Withdrawal by Subject|6|||
126011500|NCT01803646|453335210|FG000|Overall Study|Randomization error|1|||
126011501|NCT01803646|453335211|FG001|Overall Study|Randomization error|2|||
126011502|NCT01803646|453335210|FG000|Overall Study|Lost to Follow-up|5|||
126011503|NCT01803646|453335211|FG001|Overall Study|Lost to Follow-up|1|||
126011504|NCT01131494|453335212|FG000|Overall Study|Withdrawal by Subject|2|||
126011505|NCT02614560|453335215|FG000|Overall Study|Death|6|||
126011506|NCT02614560|453335216|FG001|Overall Study|Death|2|||
126011507|NCT00703911|453335217|FG000|Overall Study|Death|1|||
126011508|NCT00703911|453335217|FG000|Overall Study|Physician Decision|6|||
126011509|NCT00703911|453335217|FG000|Overall Study|Lost to Follow-up|1|||
126011510|NCT00703911|453335217|FG000|Overall Study|Withdrawal by Subject|2|||
126011511|NCT03923491|453335225|FG000|Overall Study|Lost to Follow-up|5|||
126011512|NCT03923491|453335226|FG001|Overall Study|Lost to Follow-up|8|||
126011513|NCT03923491|453335225|FG000|Overall Study|Withdrawal by Subject|4|||
126011514|NCT03923491|453335226|FG001|Overall Study|Withdrawal by Subject|6|||
126011515|NCT02174562|453335227|FG000|Overall Study|Withdrawal by Subject|7|||
126011516|NCT02174562|453335228|FG001|Overall Study|Withdrawal by Subject|2|||
126011517|NCT02174562|453335227|FG000|Overall Study|Death|2|||
126011518|NCT02174562|453335228|FG001|Overall Study|Death|0|||
126011519|NCT02174562|453335227|FG000|Overall Study|Lost to Follow-up|0|||
126011520|NCT02174562|453335228|FG001|Overall Study|Lost to Follow-up|3|||
126011521|NCT05193318|453335229|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
126011522|NCT05193318|453335229|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
126011523|NCT00798096|453335230|FG000|Overall Study|Ongoing|2|||
126011524|NCT01833065|453335231|FG000|Overall Study|Adverse Event|6|||
126011525|NCT01833065|453335232|FG001|Overall Study|Adverse Event|1|||
126011526|NCT01833065|453335233|FG002|Overall Study|Adverse Event|0|||
126011527|NCT01833065|453335234|FG003|Overall Study|Adverse Event|2|||
126011528|NCT01833065|453335235|FG004|Overall Study|Adverse Event|3|||
126345252|NCT01288430|454560116|FG005|Part 1|Adverse Event|0|||
126345253|NCT01288430|454560117|FG006|Part 1|Adverse Event|2|||
126011529|NCT01833065|453335231|FG000|Overall Study|Protocol Violation|1|||
126011530|NCT01833065|453335232|FG001|Overall Study|Protocol Violation|0|||
126011531|NCT01833065|453335233|FG002|Overall Study|Protocol Violation|0|||
126011532|NCT01833065|453335234|FG003|Overall Study|Protocol Violation|0|||
126345254|NCT01288430|454560118|FG007|Part 1|Adverse Event|0|||
126345255|NCT01288430|454560119|FG008|Part 1|Adverse Event|0|||
126345256|NCT01288430|454560120|FG009|Part 1|Adverse Event|0|||
126345257|NCT01288430|454560111|FG000|Part 1|Other|0|||
126345258|NCT01288430|454560112|FG001|Part 1|Other|2|||
126345259|NCT01288430|454560113|FG002|Part 1|Other|0|||
126345260|NCT01288430|454560114|FG003|Part 1|Other|0|||
126345261|NCT01288430|454560115|FG004|Part 1|Other|0|||
126345262|NCT01288430|454560116|FG005|Part 1|Other|0|||
126345263|NCT01288430|454560117|FG006|Part 1|Other|1|||
126345264|NCT01288430|454560118|FG007|Part 1|Other|0|||
126345265|NCT01288430|454560119|FG008|Part 1|Other|0|||
126345266|NCT01288430|454560120|FG009|Part 1|Other|0|||
126345267|NCT01288430|454560111|FG000|Part 2|Progressive disease|0|||
126345268|NCT01288430|454560112|FG001|Part 2|Progressive disease|0|||
126345269|NCT01288430|454560113|FG002|Part 2|Progressive disease|0|||
126345270|NCT01288430|454560114|FG003|Part 2|Progressive disease|0|||
126345271|NCT01288430|454560115|FG004|Part 2|Progressive disease|0|||
126011533|NCT01833065|453335235|FG004|Overall Study|Protocol Violation|2|||
126011534|NCT01833065|453335231|FG000|Overall Study|Lost to Follow-up|1|||
126011535|NCT01833065|453335232|FG001|Overall Study|Lost to Follow-up|0|||
126345272|NCT01288430|454560116|FG005|Part 2|Progressive disease|0|||
126345273|NCT01288430|454560117|FG006|Part 2|Progressive disease|0|||
126345274|NCT01288430|454560118|FG007|Part 2|Progressive disease|8|||
126345275|NCT01288430|454560119|FG008|Part 2|Progressive disease|7|||
126345276|NCT01288430|454560120|FG009|Part 2|Progressive disease|2|||
126345277|NCT01288430|454560111|FG000|Part 2|Clinical disease progression|0|||
126011536|NCT01833065|453335233|FG002|Overall Study|Lost to Follow-up|0|||
126011537|NCT01833065|453335234|FG003|Overall Study|Lost to Follow-up|0|||
126345278|NCT01288430|454560112|FG001|Part 2|Clinical disease progression|0|||
126345279|NCT01288430|454560113|FG002|Part 2|Clinical disease progression|0|||
126345280|NCT01288430|454560114|FG003|Part 2|Clinical disease progression|0|||
126345281|NCT01288430|454560115|FG004|Part 2|Clinical disease progression|0|||
126345282|NCT01288430|454560116|FG005|Part 2|Clinical disease progression|0|||
126345283|NCT01288430|454560117|FG006|Part 2|Clinical disease progression|0|||
126345284|NCT01288430|454560118|FG007|Part 2|Clinical disease progression|2|||
126345285|NCT01288430|454560119|FG008|Part 2|Clinical disease progression|0|||
126345286|NCT01288430|454560120|FG009|Part 2|Clinical disease progression|0|||
126345287|NCT01288430|454560111|FG000|Part 2|Withdrawal by Subject|0|||
126011538|NCT01833065|453335235|FG004|Overall Study|Lost to Follow-up|3|||
126011539|NCT01833065|453335231|FG000|Overall Study|Withdrawal by Subject|6|||
126011540|NCT01833065|453335232|FG001|Overall Study|Withdrawal by Subject|2|||
126011541|NCT01833065|453335233|FG002|Overall Study|Withdrawal by Subject|4|||
126011542|NCT01833065|453335234|FG003|Overall Study|Withdrawal by Subject|3|||
126011543|NCT01833065|453335235|FG004|Overall Study|Withdrawal by Subject|11|||
126345288|NCT01288430|454560112|FG001|Part 2|Withdrawal by Subject|0|||
126345289|NCT01288430|454560113|FG002|Part 2|Withdrawal by Subject|0|||
126345290|NCT01288430|454560114|FG003|Part 2|Withdrawal by Subject|0|||
126345291|NCT01288430|454560115|FG004|Part 2|Withdrawal by Subject|0|||
126011544|NCT01833065|453335231|FG000|Overall Study|Subject's substantial non-compliance|0|||
126011545|NCT01833065|453335232|FG001|Overall Study|Subject's substantial non-compliance|1|||
126011546|NCT01833065|453335233|FG002|Overall Study|Subject's substantial non-compliance|0|||
126345292|NCT01288430|454560116|FG005|Part 2|Withdrawal by Subject|0|||
126345293|NCT01288430|454560117|FG006|Part 2|Withdrawal by Subject|0|||
126345294|NCT01288430|454560118|FG007|Part 2|Withdrawal by Subject|1|||
126345295|NCT01288430|454560119|FG008|Part 2|Withdrawal by Subject|4|||
126011547|NCT01833065|453335234|FG003|Overall Study|Subject's substantial non-compliance|0|||
126011548|NCT01833065|453335235|FG004|Overall Study|Subject's substantial non-compliance|0|||
126011549|NCT01833065|453335231|FG000|Overall Study|Trial terminated by sponsor|8|||
126011550|NCT01833065|453335232|FG001|Overall Study|Trial terminated by sponsor|8|||
126011551|NCT01833065|453335233|FG002|Overall Study|Trial terminated by sponsor|7|||
126011552|NCT01833065|453335234|FG003|Overall Study|Trial terminated by sponsor|3|||
126011553|NCT01833065|453335235|FG004|Overall Study|Trial terminated by sponsor|13|||
126011554|NCT01833065|453335231|FG000|Overall Study|Others|2|||
126011555|NCT01833065|453335232|FG001|Overall Study|Others|1|||
126011556|NCT01833065|453335233|FG002|Overall Study|Others|1|||
126011557|NCT01833065|453335234|FG003|Overall Study|Others|1|||
126011558|NCT01833065|453335235|FG004|Overall Study|Others|4|||
126011559|NCT00241644|453335239|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
126011560|NCT00241644|453335240|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
126011561|NCT00241644|453335241|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
126011562|NCT00241644|453335242|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
126011563|NCT00241644|453335239|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
126011564|NCT00241644|453335240|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
126011565|NCT00241644|453335241|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
126011566|NCT00241644|453335242|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
126011567|NCT00241644|453335239|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
126011568|NCT00241644|453335240|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
126011569|NCT00241644|453335241|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
126011570|NCT00241644|453335242|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
126011571|NCT00241644|453335239|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
126011572|NCT00241644|453335240|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
126011573|NCT00241644|453335241|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
126011574|NCT00241644|453335242|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
126011575|NCT00241644|453335239|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
126011576|NCT00241644|453335240|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
126011577|NCT00241644|453335241|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
126011578|NCT00241644|453335242|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
126011579|NCT00241644|453335239|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
126011580|NCT00241644|453335240|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
126011581|NCT00241644|453335241|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
126011582|NCT00241644|453335242|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
126011583|NCT00241644|453335239|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
126011584|NCT00241644|453335240|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
126011585|NCT00241644|453335241|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
126011586|NCT00241644|453335242|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
126345296|NCT01288430|454560120|FG009|Part 2|Withdrawal by Subject|0|||
126345297|NCT01288430|454560111|FG000|Part 2|Adverse Event|0|||
126345298|NCT01288430|454560112|FG001|Part 2|Adverse Event|0|||
126345299|NCT01288430|454560113|FG002|Part 2|Adverse Event|0|||
126345300|NCT01288430|454560114|FG003|Part 2|Adverse Event|0|||
126345301|NCT01288430|454560115|FG004|Part 2|Adverse Event|0|||
126345302|NCT01288430|454560116|FG005|Part 2|Adverse Event|0|||
126345303|NCT01288430|454560117|FG006|Part 2|Adverse Event|0|||
126345304|NCT01288430|454560118|FG007|Part 2|Adverse Event|1|||
126345305|NCT01288430|454560119|FG008|Part 2|Adverse Event|1|||
126345306|NCT01288430|454560120|FG009|Part 2|Adverse Event|0|||
126345307|NCT01288430|454560111|FG000|Part 2|Other|0|||
126345308|NCT01288430|454560112|FG001|Part 2|Other|0|||
126345309|NCT01288430|454560113|FG002|Part 2|Other|0|||
126345310|NCT01288430|454560114|FG003|Part 2|Other|0|||
126345311|NCT01288430|454560115|FG004|Part 2|Other|0|||
126345312|NCT01288430|454560116|FG005|Part 2|Other|0|||
126345313|NCT01288430|454560117|FG006|Part 2|Other|0|||
126345314|NCT01288430|454560118|FG007|Part 2|Other|0|||
126345315|NCT01288430|454560119|FG008|Part 2|Other|0|||
126345316|NCT01288430|454560120|FG009|Part 2|Other|1|||
126345317|NCT03836053|454560126|FG000|Overall Study|Protocol-specified criteria|0|||
126345318|NCT03836053|454560127|FG001|Overall Study|Protocol-specified criteria|2|||
126345319|NCT03836053|454560128|FG002|Overall Study|Protocol-specified criteria|1|||
126345320|NCT03836053|454560126|FG000|Overall Study|Death|1|||
126345321|NCT03836053|454560127|FG001|Overall Study|Death|6|||
126345322|NCT03836053|454560128|FG002|Overall Study|Death|4|||
126345323|NCT03836053|454560126|FG000|Overall Study|Withdrawal of consent from study|0|||
126345324|NCT03836053|454560127|FG001|Overall Study|Withdrawal of consent from study|0|||
126345325|NCT03836053|454560128|FG002|Overall Study|Withdrawal of consent from study|1|||
126345326|NCT03836053|454560126|FG000|Overall Study|Decision by sponsor|0|||
126345327|NCT03836053|454560127|FG001|Overall Study|Decision by sponsor|2|||
126345328|NCT03836053|454560128|FG002|Overall Study|Decision by sponsor|4|||
126345329|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
126345330|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
126345331|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
126345332|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Death|1|||
126345333|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Death|1|||
126345334|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Death|0|||
126345335|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
126345336|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
126345337|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
126345338|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
126345339|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
126345340|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
126345341|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
126011587|NCT00241644|453335239|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
126011588|NCT00241644|453335240|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
126011589|NCT00241644|453335241|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
126011590|NCT00241644|453335242|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
126011591|NCT00241644|453335239|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
126011592|NCT00241644|453335240|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
126011593|NCT00241644|453335241|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
126345342|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
126345343|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
126345344|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
126345345|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
126345346|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
126345347|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
126345348|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
126345349|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
126345350|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
126345351|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
126345352|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
126345353|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
126345354|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
126345355|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
126345356|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
126345357|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
126345358|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
126345359|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Other|10|||
126345360|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Other|4|||
126345361|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Other|0|||
126345362|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
126345363|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
126345364|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
126345365|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
126345366|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
126345367|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
126345368|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
126345369|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
126345370|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
126345371|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
126345372|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
126345373|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
126345374|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
126345375|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
126345376|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
126345377|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
126345378|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
126345379|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
126345380|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Other|2|||
126345381|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Other|3|||
126345382|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Other|0|||
126345383|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
126345384|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
126345385|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
126345386|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Ongoing|86|||
126345387|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Ongoing|96|||
126345388|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Ongoing|0|||
126345389|NCT04006457|454560129|FG000|Main Study Observation Period|Adverse Event|1|||
126345390|NCT04006457|454560130|FG001|Main Study Observation Period|Adverse Event|1|||
126345391|NCT04006457|454560131|FG002|Main Study Observation Period|Adverse Event|0|||
126345392|NCT04006457|454560129|FG000|Main Study Observation Period|Lost to Follow-up|0|||
126345393|NCT04006457|454560130|FG001|Main Study Observation Period|Lost to Follow-up|1|||
126345394|NCT04006457|454560131|FG002|Main Study Observation Period|Lost to Follow-up|0|||
126345395|NCT04006457|454560129|FG000|Main Study Observation Period|Pregnancy|1|||
126345396|NCT04006457|454560130|FG001|Main Study Observation Period|Pregnancy|0|||
126345397|NCT04006457|454560131|FG002|Main Study Observation Period|Pregnancy|0|||
126345398|NCT04006457|454560129|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
126345399|NCT04006457|454560130|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
126011594|NCT00241644|453335242|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
126011595|NCT00241644|453335239|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
126011596|NCT00241644|453335240|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
126011597|NCT00241644|453335241|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
126011598|NCT00241644|453335242|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
126011599|NCT00241644|453335239|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
126011600|NCT00241644|453335240|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
126011601|NCT00241644|453335241|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
126011602|NCT00241644|453335242|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
126011603|NCT00241644|453335239|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
126011604|NCT00241644|453335240|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
126011605|NCT00241644|453335241|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
126011606|NCT00241644|453335242|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
126011607|NCT00241644|453335239|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
126011608|NCT00241644|453335240|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
126011609|NCT00241644|453335241|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
126011610|NCT00241644|453335242|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
126011611|NCT01027286|453335243|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
126011612|NCT01027286|453335244|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
126011613|NCT01027286|453335243|FG000|Overall Study|Lost to Follow-up|0|||
126011614|NCT01027286|453335244|FG001|Overall Study|Lost to Follow-up|1|||
126011615|NCT00545844|453335245|FG000|Overall Study|Lost to Follow-up|9|||
126011616|NCT00545844|453335245|FG000|Overall Study|Protocol Violation|1|||
126011617|NCT00545844|453335245|FG000|Overall Study|Withdrawal by Subject|2|||
126011618|NCT00975806|453335246|FG000|Overall Study|Adverse Event|2|||
126011619|NCT00975806|453335247|FG001|Overall Study|Adverse Event|1|||
126011620|NCT00975806|453335248|FG002|Overall Study|Adverse Event|2|||
126011621|NCT00975806|453335246|FG000|Overall Study|Disease Progression|1|||
126011622|NCT00975806|453335247|FG001|Overall Study|Disease Progression|5|||
126011623|NCT00975806|453335248|FG002|Overall Study|Disease Progression|1|||
126011624|NCT00975806|453335246|FG000|Overall Study|Withdrawal by Subject|1|||
126011625|NCT00975806|453335247|FG001|Overall Study|Withdrawal by Subject|0|||
126011626|NCT00975806|453335248|FG002|Overall Study|Withdrawal by Subject|0|||
126011627|NCT00975806|453335246|FG000|Overall Study|Death|0|||
126011628|NCT00975806|453335247|FG001|Overall Study|Death|1|||
126011629|NCT00975806|453335248|FG002|Overall Study|Death|0|||
126011630|NCT00975806|453335246|FG000|Overall Study|Physician decision and disease related|1|||
126011631|NCT00975806|453335247|FG001|Overall Study|Physician decision and disease related|0|||
126011632|NCT00975806|453335248|FG002|Overall Study|Physician decision and disease related|1|||
126011633|NCT00094809|453335249|FG000|Overall Study|Protocol deviation|2|||
126011634|NCT00094809|453335250|FG001|Overall Study|Protocol deviation|2|||
126011635|NCT00094809|453335249|FG000|Overall Study|Noncompliance|1|||
126345400|NCT04006457|454560131|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
126345401|NCT04006457|454560129|FG000|Main Study Observation Period|Other|8|||
126345402|NCT04006457|454560130|FG001|Main Study Observation Period|Other|16|||
126345403|NCT04006457|454560131|FG002|Main Study Observation Period|Other|0|||
126011636|NCT00094809|453335250|FG001|Overall Study|Noncompliance|0|||
126011637|NCT00094809|453335249|FG000|Overall Study|Adverse Event|3|||
126011638|NCT00094809|453335250|FG001|Overall Study|Adverse Event|1|||
126011639|NCT00094809|453335249|FG000|Overall Study|Withdrawal by Subject|8|||
126011640|NCT00094809|453335250|FG001|Overall Study|Withdrawal by Subject|9|||
126011641|NCT00094809|453335249|FG000|Overall Study|Disease progression|3|||
126011642|NCT00094809|453335250|FG001|Overall Study|Disease progression|3|||
126011643|NCT00094809|453335249|FG000|Overall Study|Physician Decision|3|||
126011644|NCT00094809|453335250|FG001|Overall Study|Physician Decision|5|||
126345404|NCT04006457|454560129|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
126345405|NCT04006457|454560130|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
126345406|NCT04006457|454560131|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
126345407|NCT04006457|454560129|FG000|Main Study Observation Period|Ongoing|2|||
126345408|NCT04006457|454560130|FG001|Main Study Observation Period|Ongoing|1|||
126345409|NCT04006457|454560131|FG002|Main Study Observation Period|Ongoing|0|||
126345410|NCT04006457|454560129|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
126011645|NCT00094809|453335249|FG000|Overall Study|Lost to Follow-up|6|||
126011646|NCT00094809|453335250|FG001|Overall Study|Lost to Follow-up|6|||
126345411|NCT04006457|454560130|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
126011647|NCT00094809|453335249|FG000|Overall Study|Death|19|||
126011648|NCT00094809|453335250|FG001|Overall Study|Death|25|||
126011649|NCT00094809|453335249|FG000|Overall Study|Protocol-specified criteria|1|||
126011650|NCT00094809|453335250|FG001|Overall Study|Protocol-specified criteria|1|||
126011651|NCT00094809|453335249|FG000|Overall Study|Other|2|||
126011652|NCT00094809|453335250|FG001|Overall Study|Other|4|||
126011653|NCT00094809|453335249|FG000|Overall Study|Informed consent signed after treatment|1|||
126091124|NCT03820947|453626921|FG003|Overall Study|Death|0|||
126345412|NCT04006457|454560131|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
126011654|NCT00094809|453335250|FG001|Overall Study|Informed consent signed after treatment|0|||
126011655|NCT00094809|453335249|FG000|Overall Study|Study drug not received|2|||
126011656|NCT00094809|453335250|FG001|Overall Study|Study drug not received|8|||
126345413|NCT04486716|454560132|FG000|Core Phase|Subject decision|6|||
126345414|NCT04486716|454560132|FG000|Core Phase|Adverse Event|5|||
126345415|NCT04486716|454560132|FG000|Core Phase|Lost to Follow-up|1|||
126345416|NCT04486716|454560132|FG000|Core Phase|Physician Decision|1|||
126345417|NCT04486716|454560132|FG000|Core Phase|Enrolled subjects not treated|9|||
126345418|NCT02332707|454560133|FG000|Overall Study|Adverse Event|0|||
126345419|NCT02332707|454560134|FG001|Overall Study|Adverse Event|0|||
126345420|NCT02332707|454560135|FG002|Overall Study|Adverse Event|0|||
126345421|NCT02332707|454560136|FG003|Overall Study|Adverse Event|0|||
126345422|NCT02332707|454560137|FG004|Overall Study|Adverse Event|0|||
126345423|NCT02332707|454560138|FG005|Overall Study|Adverse Event|0|||
126345424|NCT02332707|454560139|FG006|Overall Study|Adverse Event|0|||
126345425|NCT02332707|454560140|FG007|Overall Study|Adverse Event|0|||
126345426|NCT02332707|454560141|FG008|Overall Study|Adverse Event|0|||
126345427|NCT02332707|454560142|FG009|Overall Study|Adverse Event|0|||
126345428|NCT02332707|454560143|FG010|Overall Study|Adverse Event|0|||
126345429|NCT02332707|454560144|FG011|Overall Study|Adverse Event|0|||
126345430|NCT02332707|454560145|FG012|Overall Study|Adverse Event|1|||
126345431|NCT02332707|454560146|FG013|Overall Study|Adverse Event|0|||
126345432|NCT02332707|454560147|FG014|Overall Study|Adverse Event|0|||
126345433|NCT02332707|454560148|FG015|Overall Study|Adverse Event|0|||
126345434|NCT02332707|454560149|FG016|Overall Study|Adverse Event|0|||
126345435|NCT02332707|454560150|FG017|Overall Study|Adverse Event|0|||
126345436|NCT02332707|454560133|FG000|Overall Study|Lost to Follow-up|0|||
126345437|NCT02332707|454560134|FG001|Overall Study|Lost to Follow-up|0|||
126345438|NCT02332707|454560135|FG002|Overall Study|Lost to Follow-up|0|||
126345439|NCT02332707|454560136|FG003|Overall Study|Lost to Follow-up|0|||
126345440|NCT02332707|454560137|FG004|Overall Study|Lost to Follow-up|0|||
126345441|NCT02332707|454560138|FG005|Overall Study|Lost to Follow-up|1|||
126345442|NCT02332707|454560139|FG006|Overall Study|Lost to Follow-up|0|||
126345443|NCT02332707|454560140|FG007|Overall Study|Lost to Follow-up|0|||
126345444|NCT02332707|454560141|FG008|Overall Study|Lost to Follow-up|0|||
126345445|NCT02332707|454560142|FG009|Overall Study|Lost to Follow-up|0|||
126345446|NCT02332707|454560143|FG010|Overall Study|Lost to Follow-up|2|||
126345447|NCT02332707|454560144|FG011|Overall Study|Lost to Follow-up|0|||
126345448|NCT02332707|454560145|FG012|Overall Study|Lost to Follow-up|3|||
126345449|NCT02332707|454560146|FG013|Overall Study|Lost to Follow-up|0|||
126345450|NCT02332707|454560147|FG014|Overall Study|Lost to Follow-up|0|||
126345451|NCT02332707|454560148|FG015|Overall Study|Lost to Follow-up|0|||
126345452|NCT02332707|454560149|FG016|Overall Study|Lost to Follow-up|0|||
126345453|NCT02332707|454560150|FG017|Overall Study|Lost to Follow-up|0|||
126345454|NCT02332707|454560133|FG000|Overall Study|Physician Decision|0|||
126345455|NCT02332707|454560134|FG001|Overall Study|Physician Decision|0|||
126345456|NCT02332707|454560135|FG002|Overall Study|Physician Decision|0|||
126345457|NCT02332707|454560136|FG003|Overall Study|Physician Decision|1|||
126345458|NCT02332707|454560137|FG004|Overall Study|Physician Decision|0|||
126345459|NCT02332707|454560138|FG005|Overall Study|Physician Decision|0|||
126345460|NCT02332707|454560139|FG006|Overall Study|Physician Decision|0|||
126345461|NCT02332707|454560140|FG007|Overall Study|Physician Decision|0|||
126345462|NCT02332707|454560141|FG008|Overall Study|Physician Decision|0|||
126345463|NCT02332707|454560142|FG009|Overall Study|Physician Decision|0|||
126345464|NCT02332707|454560143|FG010|Overall Study|Physician Decision|0|||
126345465|NCT02332707|454560144|FG011|Overall Study|Physician Decision|0|||
126345466|NCT02332707|454560145|FG012|Overall Study|Physician Decision|1|||
126345467|NCT02332707|454560146|FG013|Overall Study|Physician Decision|0|||
126345468|NCT02332707|454560147|FG014|Overall Study|Physician Decision|0|||
126345469|NCT02332707|454560148|FG015|Overall Study|Physician Decision|0|||
126345470|NCT02332707|454560149|FG016|Overall Study|Physician Decision|0|||
126345471|NCT02332707|454560150|FG017|Overall Study|Physician Decision|0|||
126345472|NCT02332707|454560133|FG000|Overall Study|Withdrawal by Subject|0|||
126345473|NCT02332707|454560134|FG001|Overall Study|Withdrawal by Subject|0|||
126345474|NCT02332707|454560135|FG002|Overall Study|Withdrawal by Subject|1|||
126345475|NCT02332707|454560136|FG003|Overall Study|Withdrawal by Subject|0|||
126345476|NCT02332707|454560137|FG004|Overall Study|Withdrawal by Subject|0|||
126345477|NCT02332707|454560138|FG005|Overall Study|Withdrawal by Subject|0|||
126011657|NCT00094809|453335249|FG000|Overall Study|Other|1|||
126345478|NCT02332707|454560139|FG006|Overall Study|Withdrawal by Subject|0|||
126345479|NCT02332707|454560140|FG007|Overall Study|Withdrawal by Subject|0|||
126345480|NCT02332707|454560141|FG008|Overall Study|Withdrawal by Subject|0|||
126345481|NCT02332707|454560142|FG009|Overall Study|Withdrawal by Subject|3|||
126345482|NCT02332707|454560143|FG010|Overall Study|Withdrawal by Subject|0|||
126345483|NCT02332707|454560144|FG011|Overall Study|Withdrawal by Subject|0|||
126345484|NCT02332707|454560145|FG012|Overall Study|Withdrawal by Subject|0|||
126011658|NCT00094809|453335250|FG001|Overall Study|Other|1|||
126345485|NCT02332707|454560146|FG013|Overall Study|Withdrawal by Subject|0|||
126345486|NCT02332707|454560147|FG014|Overall Study|Withdrawal by Subject|0|||
126011659|NCT02377362|453335251|FG000|Part A Second Treatment|Protocol Violation|0|||
126011660|NCT02377362|453335252|FG001|Part A Second Treatment|Protocol Violation|0|||
126011661|NCT02377362|453335253|FG002|Part A Second Treatment|Protocol Violation|0|||
126011662|NCT02377362|453335254|FG003|Part A Second Treatment|Protocol Violation|0|||
126011663|NCT02377362|453335255|FG004|Part A Second Treatment|Protocol Violation|1|||
126011664|NCT02377362|453335256|FG005|Part A Second Treatment|Protocol Violation|0|||
126011665|NCT02377362|453335257|FG006|Part A Second Treatment|Protocol Violation|0|||
126011666|NCT02377362|453335258|FG007|Part A Second Treatment|Protocol Violation|0|||
126011667|NCT02377362|453335259|FG008|Part A Second Treatment|Protocol Violation|0|||
126011668|NCT02377362|453335260|FG009|Part A Second Treatment|Protocol Violation|0|||
126011669|NCT02377362|453335261|FG010|Part A Second Treatment|Protocol Violation|0|||
126011670|NCT02377362|453335262|FG011|Part A Second Treatment|Protocol Violation|0|||
126011671|NCT02377362|453335263|FG012|Part A Second Treatment|Protocol Violation|0|||
126011672|NCT02377362|453335251|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011673|NCT02377362|453335252|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011674|NCT02377362|453335253|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011675|NCT02377362|453335254|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
126011676|NCT02377362|453335255|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
126011677|NCT02377362|453335256|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
126011678|NCT02377362|453335257|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011679|NCT02377362|453335258|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011680|NCT02377362|453335259|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011681|NCT02377362|453335260|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011682|NCT02377362|453335261|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011683|NCT02377362|453335262|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011684|NCT02377362|453335263|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
126011685|NCT02377362|453335251|FG000|Part B Overall|Protocol Violation|0|||
126011686|NCT02377362|453335252|FG001|Part B Overall|Protocol Violation|0|||
126011687|NCT02377362|453335253|FG002|Part B Overall|Protocol Violation|0|||
126011688|NCT02377362|453335254|FG003|Part B Overall|Protocol Violation|0|||
126345487|NCT02332707|454560148|FG015|Overall Study|Withdrawal by Subject|0|||
126345488|NCT02332707|454560149|FG016|Overall Study|Withdrawal by Subject|0|||
126345489|NCT02332707|454560150|FG017|Overall Study|Withdrawal by Subject|0|||
126345490|NCT04761822|454560151|FG000|Overall Study|Adverse Event|3|||
126345491|NCT04761822|454560152|FG001|Overall Study|Adverse Event|1|||
126345492|NCT04761822|454560153|FG002|Overall Study|Adverse Event|1|||
126345493|NCT04761822|454560154|FG003|Overall Study|Adverse Event|3|||
126345494|NCT04761822|454560151|FG000|Overall Study|Lost to Follow-up|1|||
126345495|NCT04761822|454560152|FG001|Overall Study|Lost to Follow-up|0|||
126345496|NCT04761822|454560153|FG002|Overall Study|Lost to Follow-up|2|||
126345497|NCT04761822|454560154|FG003|Overall Study|Lost to Follow-up|3|||
126345498|NCT04761822|454560151|FG000|Overall Study|Physician Decision|0|||
126345499|NCT04761822|454560152|FG001|Overall Study|Physician Decision|1|||
126345500|NCT04761822|454560153|FG002|Overall Study|Physician Decision|0|||
126345501|NCT04761822|454560154|FG003|Overall Study|Physician Decision|0|||
126345502|NCT04761822|454560151|FG000|Overall Study|Withdrawal by Subject|3|||
126345503|NCT04761822|454560152|FG001|Overall Study|Withdrawal by Subject|8|||
126345504|NCT04761822|454560153|FG002|Overall Study|Withdrawal by Subject|1|||
126345505|NCT04761822|454560154|FG003|Overall Study|Withdrawal by Subject|11|||
126345506|NCT04761822|454560151|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
126345507|NCT04761822|454560152|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
126345508|NCT04761822|454560153|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
126345509|NCT04761822|454560154|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
126345510|NCT04761822|454560151|FG000|Overall Study|Participant requested unblinding|0|||
126345511|NCT04761822|454560152|FG001|Overall Study|Participant requested unblinding|0|||
126345512|NCT04761822|454560153|FG002|Overall Study|Participant requested unblinding|0|||
126345513|NCT04761822|454560154|FG003|Overall Study|Participant requested unblinding|1|||
126345514|NCT02233413|454560159|FG000|Overall Study|Lost to Follow-up|7|||
126345515|NCT02233413|454560160|FG001|Overall Study|Lost to Follow-up|9|||
126345516|NCT02233413|454560159|FG000|Overall Study|Withdrawal by Subject|4|||
126345517|NCT02233413|454560160|FG001|Overall Study|Withdrawal by Subject|5|||
126345518|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
126345519|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
126345520|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
126345521|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
126345522|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
126011689|NCT02377362|453335255|FG004|Part B Overall|Protocol Violation|0|||
126011690|NCT02377362|453335256|FG005|Part B Overall|Protocol Violation|0|||
126011691|NCT02377362|453335257|FG006|Part B Overall|Protocol Violation|0|||
126011692|NCT02377362|453335258|FG007|Part B Overall|Protocol Violation|0|||
126011693|NCT02377362|453335259|FG008|Part B Overall|Protocol Violation|0|||
126011694|NCT02377362|453335260|FG009|Part B Overall|Protocol Violation|1|||
126011695|NCT02377362|453335261|FG010|Part B Overall|Protocol Violation|0|||
126011696|NCT02377362|453335262|FG011|Part B Overall|Protocol Violation|0|||
126011697|NCT02377362|453335263|FG012|Part B Overall|Protocol Violation|0|||
126011698|NCT02377362|453335251|FG000|Part B Overall|Adverse Event|0|||
126011699|NCT02377362|453335252|FG001|Part B Overall|Adverse Event|0|||
126011700|NCT02377362|453335253|FG002|Part B Overall|Adverse Event|0|||
126011701|NCT02377362|453335254|FG003|Part B Overall|Adverse Event|0|||
126011702|NCT02377362|453335255|FG004|Part B Overall|Adverse Event|0|||
126011703|NCT02377362|453335256|FG005|Part B Overall|Adverse Event|0|||
126011704|NCT02377362|453335257|FG006|Part B Overall|Adverse Event|1|||
126011705|NCT02377362|453335258|FG007|Part B Overall|Adverse Event|1|||
126011706|NCT02377362|453335259|FG008|Part B Overall|Adverse Event|0|||
126011707|NCT02377362|453335260|FG009|Part B Overall|Adverse Event|0|||
126011708|NCT02377362|453335261|FG010|Part B Overall|Adverse Event|0|||
126011709|NCT02377362|453335262|FG011|Part B Overall|Adverse Event|0|||
126011710|NCT02377362|453335263|FG012|Part B Overall|Adverse Event|0|||
126011711|NCT02377362|453335251|FG000|Part B Overall|Withdrawal by Subject|0|||
126011712|NCT02377362|453335252|FG001|Part B Overall|Withdrawal by Subject|0|||
126011713|NCT02377362|453335253|FG002|Part B Overall|Withdrawal by Subject|0|||
126011714|NCT02377362|453335254|FG003|Part B Overall|Withdrawal by Subject|0|||
126011715|NCT02377362|453335255|FG004|Part B Overall|Withdrawal by Subject|0|||
126345523|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
126345524|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
126345525|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
126011716|NCT02377362|453335256|FG005|Part B Overall|Withdrawal by Subject|0|||
126011717|NCT02377362|453335257|FG006|Part B Overall|Withdrawal by Subject|1|||
126011718|NCT02377362|453335258|FG007|Part B Overall|Withdrawal by Subject|0|||
126011719|NCT02377362|453335259|FG008|Part B Overall|Withdrawal by Subject|0|||
126345526|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
126345527|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
126345528|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
126345529|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
126345530|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
126345531|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
126345532|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
126345533|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
126345534|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
126345535|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
126345536|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
126345537|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
126345538|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
126345539|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
126345540|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
126345541|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
126345542|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
126345543|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
126345544|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
126345545|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
126345546|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
126345547|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
126345548|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
126345549|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
126345550|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
126345551|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
126345552|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
126345553|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
126345554|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
126345555|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
126345556|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
126345557|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
126345558|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
126345559|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
126345560|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
126345561|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
126345562|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
126345563|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
126345564|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
126345565|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
126345566|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
126345567|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
126345568|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
126345569|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
126345570|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
126345571|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
126345572|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
126345573|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
126345574|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
126345575|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
126345576|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
126345577|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
126345578|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
126345579|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
126345580|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
126345581|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
126345582|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
126345583|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
126345584|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
126345585|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
126011720|NCT02377362|453335260|FG009|Part B Overall|Withdrawal by Subject|0|||
126011721|NCT02377362|453335261|FG010|Part B Overall|Withdrawal by Subject|0|||
126011722|NCT02377362|453335262|FG011|Part B Overall|Withdrawal by Subject|1|||
126011723|NCT02377362|453335263|FG012|Part B Overall|Withdrawal by Subject|0|||
126011724|NCT04889664|453335264|FG000|Screen|Lost to Follow-up|1|||
126011725|NCT04889664|453335264|FG000|Screen|Failed to meet screening criteria|1|||
126011726|NCT04889664|453335264|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
126011727|NCT01585038|453335269|FG000|Overall Study|Adverse Event|2|||
126011728|NCT01585038|453335270|FG001|Overall Study|Adverse Event|2|||
126011729|NCT04107805|453335271|FG000|Overall Study|Adverse Event|0|||
126011730|NCT04107805|453335272|FG001|Overall Study|Adverse Event|0|||
126011731|NCT04107805|453335273|FG002|Overall Study|Adverse Event|0|||
126011732|NCT04107805|453335274|FG003|Overall Study|Adverse Event|1|||
126011733|NCT04107805|453335275|FG004|Overall Study|Adverse Event|0|||
126011734|NCT04107805|453335276|FG005|Overall Study|Adverse Event|1|||
126011735|NCT04107805|453335277|FG006|Overall Study|Adverse Event|0|||
126011736|NCT04107805|453335278|FG007|Overall Study|Adverse Event|0|||
126011737|NCT04107805|453335279|FG008|Overall Study|Adverse Event|1|||
126011738|NCT01191086|453335282|FG000|Overall Study|Adverse Event|20|||
126011739|NCT01191086|453335282|FG000|Overall Study|Lack of Efficacy|10|||
126011740|NCT01191086|453335282|FG000|Overall Study|Lost to Follow-up|4|||
126011741|NCT01191086|453335282|FG000|Overall Study|Physician Decision|2|||
126011742|NCT01191086|453335282|FG000|Overall Study|Withdrawal by Subject|24|||
126011743|NCT01191086|453335282|FG000|Overall Study|Discontinuation criterion met|1|||
126011744|NCT01191086|453335282|FG000|Overall Study|Other|1|||
126011745|NCT00853827|453335283|FG000|Single Blind Period (1 Week)|Other|4|||
126011746|NCT00853827|453335284|FG001|Single Blind Period (1 Week)|Other|0|||
126011747|NCT00853827|453335283|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
126011748|NCT00853827|453335284|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
126011749|NCT00853827|453335283|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
126011750|NCT00853827|453335284|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
126011751|NCT00853827|453335283|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
126011752|NCT00853827|453335284|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
126011753|NCT00853827|453335283|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
126011754|NCT00853827|453335284|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
126011755|NCT00853827|453335283|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
126011756|NCT00853827|453335284|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
126011757|NCT00853827|453335283|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
126011758|NCT00853827|453335284|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
126011759|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
126011760|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
126011761|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
126011762|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
126011763|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
126011764|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
126011765|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
126011766|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
126011767|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
126011768|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
126011769|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
126011770|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
126011771|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
126011772|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
126011773|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
126011774|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
126011775|NCT00853827|453335283|FG000|Double Blind Period (103 Weeks)|Death|1|||
126011776|NCT00853827|453335284|FG001|Double Blind Period (103 Weeks)|Death|6|||
126011777|NCT02736799|453335285|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
126011778|NCT02736799|453335286|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
126011779|NCT02736799|453335287|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
126011780|NCT02736799|453335288|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
126011781|NCT01156116|453335291|FG000|Overall Study|Withdrawal by Subject|3|||
126011782|NCT01156116|453335292|FG001|Overall Study|Withdrawal by Subject|1|||
126011783|NCT01156116|453335291|FG000|Overall Study|CPAP intolerance|2|||
126011784|NCT01156116|453335292|FG001|Overall Study|CPAP intolerance|0|||
126011785|NCT00344019|453335293|FG000|Overall Study|did not meet final inclusion criteria|0|||
126011786|NCT00344019|453335294|FG001|Overall Study|did not meet final inclusion criteria|0|||
126011787|NCT00344019|453335295|FG002|Overall Study|did not meet final inclusion criteria|74|||
126091125|NCT03820947|453626922|FG004|Overall Study|Death|9|||
126011788|NCT02057718|453335296|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
126011789|NCT02057718|453335297|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
126011790|NCT02057718|453335296|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
126011791|NCT02057718|453335297|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
126011792|NCT02057718|453335296|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
126011793|NCT02057718|453335297|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
126011794|NCT02057718|453335296|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
126011795|NCT02057718|453335297|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
126011796|NCT02057718|453335296|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
126011797|NCT02057718|453335297|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
126011798|NCT02057718|453335296|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
126011799|NCT02057718|453335297|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
126011800|NCT02057718|453335296|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
126011801|NCT02057718|453335297|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
126011802|NCT02057718|453335296|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
126011803|NCT02057718|453335297|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
126011804|NCT02057718|453335296|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
126011805|NCT02057718|453335297|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
126011806|NCT02057718|453335296|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
126011807|NCT02057718|453335297|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
126011808|NCT02057718|453335296|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
126011809|NCT02057718|453335297|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
126011810|NCT02503202|453335298|FG000|Base Study: Up to Month 6|Death|1|||
126011811|NCT02503202|453335299|FG001|Base Study: Up to Month 6|Death|1|||
126011812|NCT02503202|453335300|FG002|Base Study: Up to Month 6|Death|0|||
126011813|NCT02503202|453335301|FG003|Base Study: Up to Month 6|Death|0|||
126011814|NCT02503202|453335302|FG004|Base Study: Up to Month 6|Death|0|||
126011815|NCT02503202|453335298|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
126011816|NCT02503202|453335299|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
126011817|NCT02503202|453335300|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
126011818|NCT02503202|453335301|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
126011819|NCT02503202|453335302|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
126011820|NCT02503202|453335298|FG000|Base Study: Up to Month 6|Physician Decision|0|||
126011821|NCT02503202|453335299|FG001|Base Study: Up to Month 6|Physician Decision|0|||
126011822|NCT02503202|453335300|FG002|Base Study: Up to Month 6|Physician Decision|0|||
126011823|NCT02503202|453335301|FG003|Base Study: Up to Month 6|Physician Decision|0|||
126011824|NCT02503202|453335302|FG004|Base Study: Up to Month 6|Physician Decision|1|||
126011825|NCT02503202|453335298|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
126011826|NCT02503202|453335299|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
126011827|NCT02503202|453335300|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
126011828|NCT02503202|453335301|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
126011829|NCT02503202|453335302|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
126011830|NCT02503202|453335298|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
126011831|NCT02503202|453335299|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
126011832|NCT02503202|453335300|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
126011833|NCT02503202|453335301|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
126011834|NCT02503202|453335302|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
126011835|NCT02503202|453335298|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
126011836|NCT02503202|453335299|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
126011837|NCT02503202|453335300|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
126011838|NCT02503202|453335301|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
126011839|NCT02503202|453335302|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
126011840|NCT02503202|453335298|FG000|Extension: Month 6 to 24|Death|1|||
126011841|NCT02503202|453335299|FG001|Extension: Month 6 to 24|Death|0|||
126011842|NCT02503202|453335300|FG002|Extension: Month 6 to 24|Death|0|||
126011843|NCT02503202|453335301|FG003|Extension: Month 6 to 24|Death|0|||
126011844|NCT02503202|453335302|FG004|Extension: Month 6 to 24|Death|0|||
126011845|NCT02503202|453335298|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
126011846|NCT02503202|453335299|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
126011847|NCT02503202|453335300|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
126011848|NCT02503202|453335301|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
126011849|NCT02503202|453335302|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
126011850|NCT02503202|453335298|FG000|Extension: Month 6 to 24|Physician Decision|1|||
126345586|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
126345587|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
126011851|NCT02503202|453335299|FG001|Extension: Month 6 to 24|Physician Decision|0|||
126011852|NCT02503202|453335300|FG002|Extension: Month 6 to 24|Physician Decision|1|||
126011853|NCT02503202|453335301|FG003|Extension: Month 6 to 24|Physician Decision|3|||
126345588|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
126345589|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
126345590|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
126345591|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
126345592|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
126345593|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
126345594|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
126345595|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
126345596|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
126345597|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
126345598|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
126345599|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
126345600|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
126345601|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
126345602|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
126345603|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
126345604|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
126345605|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
126345606|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
126345607|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
126345608|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
126011854|NCT02503202|453335302|FG004|Extension: Month 6 to 24|Physician Decision|0|||
126011855|NCT02503202|453335298|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
126011856|NCT02503202|453335299|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
126011857|NCT02503202|453335300|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
126011858|NCT02503202|453335301|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
126011859|NCT02503202|453335302|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
126011860|NCT00906035|453335304|FG000|Overall Study|Withdrawal by Subject|2|||
126011861|NCT00906035|453335305|FG001|Overall Study|Withdrawal by Subject|3|||
126011862|NCT00906035|453335306|FG002|Overall Study|Withdrawal by Subject|0|||
126011863|NCT03058991|453335309|FG000|Overall Study|Lost to Follow-up|17|||
126011864|NCT03058991|453335310|FG001|Overall Study|Lost to Follow-up|12|||
126011865|NCT03058991|453335311|FG002|Overall Study|Lost to Follow-up|12|||
126011866|NCT03058991|453335309|FG000|Overall Study|Withdrawal by Subject|1|||
126345609|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
126345610|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
126345611|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
126345612|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
126345613|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
126345614|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
126011867|NCT03058991|453335310|FG001|Overall Study|Withdrawal by Subject|0|||
126011868|NCT03058991|453335311|FG002|Overall Study|Withdrawal by Subject|0|||
126011869|NCT00130637|453335312|FG000|Overall Study|Adverse Event|2|||
126011870|NCT00130637|453335312|FG000|Overall Study|Withdrawal by Subject|1|||
126011871|NCT01460342|453335314|FG000|Overall Study|Adverse Event|5|||
126011872|NCT01460342|453335315|FG001|Overall Study|Adverse Event|4|||
126345615|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
126345616|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
126345617|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
126345618|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
126345619|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
126345620|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
126345621|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
126345622|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
126345623|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
126345624|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
126345625|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
126345626|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
126345627|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
126345628|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
126345629|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
126345630|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
126345631|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
126345632|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
126345633|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
126345634|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
126345635|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
126345636|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
126345637|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
126345638|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
126345639|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
126345640|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
126345641|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
126345642|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
126345643|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
126345644|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
126345645|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
126345646|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
126345647|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
126345648|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
126345649|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
126345650|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
126345651|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
126345652|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
126345653|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
126345654|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
126345655|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
126345656|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
126345657|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
126345658|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
126345659|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Death|1|||
126345660|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Death|0|||
126345661|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Death|1|||
126345662|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
126345663|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
126345664|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
126345665|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
126345666|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
126345667|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
126345668|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
126345669|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
126345670|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
126345671|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
126345672|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
126345673|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
126345674|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
126345675|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
126011873|NCT01460342|453335314|FG000|Overall Study|Lost to Follow-up|1|||
126011874|NCT01460342|453335315|FG001|Overall Study|Lost to Follow-up|2|||
126011875|NCT01460342|453335314|FG000|Overall Study|Protocol Violation|0|||
126011876|NCT01460342|453335315|FG001|Overall Study|Protocol Violation|1|||
126011877|NCT01460342|453335314|FG000|Overall Study|Withdrawal by Subject|3|||
126011878|NCT01460342|453335315|FG001|Overall Study|Withdrawal by Subject|4|||
126011879|NCT01460342|453335314|FG000|Overall Study|Physician Decision|1|||
126011880|NCT01460342|453335315|FG001|Overall Study|Physician Decision|3|||
126011881|NCT01460342|453335314|FG000|Overall Study|Lack of Efficacy|1|||
126011882|NCT01460342|453335315|FG001|Overall Study|Lack of Efficacy|0|||
126011883|NCT01689519|453335316|FG000|Intent to Treat|Death|157|||
126011884|NCT01689519|453335317|FG001|Intent to Treat|Death|167|||
126011885|NCT01689519|453335316|FG000|Intent to Treat|Lost to Follow-up|4|||
126011886|NCT01689519|453335317|FG001|Intent to Treat|Lost to Follow-up|8|||
126011887|NCT01689519|453335316|FG000|Intent to Treat|Other|2|||
126011888|NCT01689519|453335317|FG001|Intent to Treat|Other|4|||
126011889|NCT01689519|453335316|FG000|Intent to Treat|Physician Decision|4|||
126011890|NCT01689519|453335317|FG001|Intent to Treat|Physician Decision|1|||
126011891|NCT01689519|453335316|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
126011892|NCT01689519|453335317|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
126011893|NCT01689519|453335316|FG000|Intent to Treat|Withdrawal by Subject|21|||
126011894|NCT01689519|453335317|FG001|Intent to Treat|Withdrawal by Subject|20|||
126011895|NCT01689519|453335316|FG000|Safety Population|Death|158|||
126011896|NCT01689519|453335317|FG001|Safety Population|Death|165|||
126011897|NCT01689519|453335316|FG000|Safety Population|Lost to Follow-up|4|||
126011898|NCT01689519|453335317|FG001|Safety Population|Lost to Follow-up|8|||
126011899|NCT01689519|453335316|FG000|Safety Population|Other|2|||
126011900|NCT01689519|453335317|FG001|Safety Population|Other|4|||
126011901|NCT01689519|453335316|FG000|Safety Population|Physician Decision|4|||
126011902|NCT01689519|453335317|FG001|Safety Population|Physician Decision|1|||
126011903|NCT01689519|453335316|FG000|Safety Population|Study Terminated By Sponsor|60|||
126011904|NCT01689519|453335317|FG001|Safety Population|Study Terminated By Sponsor|47|||
126011905|NCT01689519|453335316|FG000|Safety Population|Withdrawal by Subject|20|||
126011906|NCT01689519|453335317|FG001|Safety Population|Withdrawal by Subject|20|||
126011907|NCT01050569|453335320|FG000|Overall Study|Lost to Follow-up|20|||
126011908|NCT01050569|453335321|FG001|Overall Study|Lost to Follow-up|14|||
126011909|NCT01050569|453335322|FG002|Overall Study|Lost to Follow-up|16|||
126011910|NCT01050569|453335320|FG000|Overall Study|Withdrawal by Subject|9|||
126011911|NCT01050569|453335321|FG001|Overall Study|Withdrawal by Subject|3|||
126011912|NCT01050569|453335322|FG002|Overall Study|Withdrawal by Subject|11|||
126011913|NCT01050569|453335320|FG000|Overall Study|Lack of Efficacy|5|||
126011914|NCT01050569|453335321|FG001|Overall Study|Lack of Efficacy|4|||
126011915|NCT01050569|453335322|FG002|Overall Study|Lack of Efficacy|3|||
126011916|NCT01050569|453335320|FG000|Overall Study|Adverse Event|1|||
126011917|NCT01050569|453335321|FG001|Overall Study|Adverse Event|0|||
126011918|NCT01050569|453335322|FG002|Overall Study|Adverse Event|0|||
126011919|NCT01050569|453335320|FG000|Overall Study|Physician Decision|3|||
126011920|NCT01050569|453335321|FG001|Overall Study|Physician Decision|3|||
126011921|NCT01050569|453335322|FG002|Overall Study|Physician Decision|3|||
126011922|NCT03525119|453335324|FG000|Overall Study|Adverse Event|0|||
126011923|NCT03525119|453335325|FG001|Overall Study|Adverse Event|1|||
126011924|NCT03525119|453335326|FG002|Overall Study|Adverse Event|0|||
126011925|NCT03525119|453335324|FG000|Overall Study|Lost to Follow-up|32|||
126011926|NCT03525119|453335325|FG001|Overall Study|Lost to Follow-up|33|||
126011927|NCT03525119|453335326|FG002|Overall Study|Lost to Follow-up|37|||
126345676|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
126345677|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
126345678|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
126345679|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
126345680|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
126345681|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
126345682|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
126345683|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Depression|0|||
126345684|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Depression|1|||
126345685|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Depression|0|||
126345686|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
126345687|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
126345688|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
126345689|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Jailed|0|||
126345690|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Jailed|1|||
126345691|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Jailed|0|||
126345692|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Other|0|||
126345693|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Other|1|||
126345694|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Other|0|||
126345695|NCT04476043|454560168|FG000|Overall Study|Withdrawal by Subject|1|||
126345696|NCT04476043|454560169|FG001|Overall Study|Withdrawal by Subject|3|||
126345697|NCT04476043|454560170|FG002|Overall Study|Withdrawal by Subject|4|||
126345698|NCT04476043|454560171|FG003|Overall Study|Withdrawal by Subject|1|||
126345699|NCT04476043|454560168|FG000|Overall Study|Lost to Follow-up|1|||
126345700|NCT04476043|454560169|FG001|Overall Study|Lost to Follow-up|1|||
126345701|NCT04476043|454560170|FG002|Overall Study|Lost to Follow-up|2|||
126345702|NCT04476043|454560171|FG003|Overall Study|Lost to Follow-up|1|||
126345703|NCT04476043|454560168|FG000|Overall Study|Adverse Event|2|||
126345704|NCT04476043|454560169|FG001|Overall Study|Adverse Event|0|||
126345705|NCT04476043|454560170|FG002|Overall Study|Adverse Event|1|||
126345706|NCT04476043|454560171|FG003|Overall Study|Adverse Event|0|||
126345707|NCT04476043|454560168|FG000|Overall Study|Protocol Violation|0|||
126345708|NCT04476043|454560169|FG001|Overall Study|Protocol Violation|1|||
126345709|NCT04476043|454560170|FG002|Overall Study|Protocol Violation|0|||
126345710|NCT04476043|454560171|FG003|Overall Study|Protocol Violation|0|||
126345711|NCT02471183|454560174|FG000|Main Treatment Period|Adverse Event|1|||
126345712|NCT02471183|454560174|FG000|Main Treatment Period|Withdrawal by Subject|1|||
126345713|NCT02471183|454560174|FG000|Extended Treatment Period|Lack of Efficacy|1|||
126345714|NCT00141921|454560176|FG000|Overall Study|Remain on Study|28|||
126345715|NCT00141921|454560176|FG000|Overall Study|Withdrawal by Subject|42|||
126345716|NCT00141921|454560176|FG000|Overall Study|Lost to Follow-up|19|||
126345717|NCT00141921|454560176|FG000|Overall Study|Noncompliance|17|||
126345718|NCT00141921|454560176|FG000|Overall Study|Disease Progression|7|||
126345719|NCT00141921|454560176|FG000|Overall Study|Protocol Deviation|7|||
126345720|NCT00141921|454560176|FG000|Overall Study|Adverse Event|5|||
126345721|NCT00141921|454560176|FG000|Overall Study|Administrative Decision|2|||
126345722|NCT00141921|454560176|FG000|Overall Study|Pregnancy|4|||
126345723|NCT00141921|454560176|FG000|Overall Study|Ineligibility Determined|2|||
126345724|NCT00141921|454560176|FG000|Overall Study|Other|8|||
126345725|NCT02471339|454560178|FG000|Overall Study|Did not provide follow-up data|2|||
126345726|NCT02471339|454560179|FG001|Overall Study|Did not provide follow-up data|0|||
126345727|NCT00626639|454560181|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
126011928|NCT03525119|453335324|FG000|Overall Study|Withdrawal by Subject|5|||
126011929|NCT03525119|453335325|FG001|Overall Study|Withdrawal by Subject|4|||
126011930|NCT03525119|453335326|FG002|Overall Study|Withdrawal by Subject|2|||
126011931|NCT03525119|453335324|FG000|Overall Study|Reason not Specified|2|||
126011932|NCT03525119|453335325|FG001|Overall Study|Reason not Specified|1|||
126011933|NCT03525119|453335326|FG002|Overall Study|Reason not Specified|2|||
126011934|NCT03525119|453335324|FG000|Overall Study|Randomized but not Vaccinated|1|||
126011935|NCT03525119|453335325|FG001|Overall Study|Randomized but not Vaccinated|0|||
126345728|NCT00626639|454560182|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
126011936|NCT03525119|453335326|FG002|Overall Study|Randomized but not Vaccinated|2|||
126011937|NCT01713530|453335327|FG000|Overall Study|Adverse Event|0|||
126011938|NCT01713530|453335328|FG001|Overall Study|Adverse Event|5|||
126011939|NCT01713530|453335327|FG000|Overall Study|Withdrawal criteria|21|||
126011940|NCT01713530|453335328|FG001|Overall Study|Withdrawal criteria|12|||
126011941|NCT01713530|453335327|FG000|Overall Study|Unclassified|4|||
126011942|NCT01713530|453335328|FG001|Overall Study|Unclassified|2|||
126011943|NCT00619645|453335329|FG000|Overall Study|Adverse Event|1|||
126011944|NCT00597519|453335330|FG000|Overall Study|Death|1|||
126011945|NCT04246762|453335331|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
126011946|NCT00410124|453335332|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
126011947|NCT00410124|453335333|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
126011948|NCT00410124|453335332|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
126011949|NCT00410124|453335333|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
126011950|NCT00410124|453335332|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
126011951|NCT00410124|453335333|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
126011952|NCT00410124|453335332|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
126011953|NCT00410124|453335333|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
126011954|NCT00410124|453335332|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
126011955|NCT00410124|453335333|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
126011956|NCT00410124|453335332|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
126011957|NCT00410124|453335333|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
126011958|NCT00410124|453335332|FG000|Core Phase Double Blind (15 Months)|Death|7|||
126011959|NCT00410124|453335333|FG001|Core Phase Double Blind (15 Months)|Death|4|||
126011960|NCT00410124|453335332|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
126011961|NCT00410124|453335333|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
126011962|NCT00410124|453335332|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
126011963|NCT00410124|453335333|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
126011964|NCT00410124|453335332|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
126011965|NCT00410124|453335333|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
126011966|NCT00410124|453335332|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
126011967|NCT00410124|453335333|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
126011968|NCT00410124|453335332|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
126011969|NCT00410124|453335333|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
126011970|NCT00410124|453335332|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
126011971|NCT00410124|453335333|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
126011972|NCT00410124|453335332|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
126011973|NCT00410124|453335333|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
126011974|NCT00410124|453335332|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
126011975|NCT00410124|453335333|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
126011976|NCT00410124|453335332|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
126011977|NCT00410124|453335333|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
126011978|NCT00741988|453335337|FG000|Overall Study|Adverse Event|2|||
126011979|NCT00741988|453335338|FG001|Overall Study|Adverse Event|4|||
126011980|NCT00741988|453335337|FG000|Overall Study|Lack of Efficacy|2|||
126011981|NCT00741988|453335338|FG001|Overall Study|Lack of Efficacy|0|||
126011982|NCT01546155|453336640|FG000|Overall Study|could not tolerate long scan duration|3|||
126011983|NCT02715258|453336642|FG000|Overall Study|Withdrawal by Subject|6|||
126011984|NCT02715258|453336643|FG001|Overall Study|Withdrawal by Subject|1|||
126011985|NCT02715258|453336642|FG000|Overall Study|Lost to Follow-up|7|||
126345729|NCT00827567|454560183|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
126345730|NCT01461551|454560184|FG000|Overall Study|Physician Decision|2|||
126345731|NCT01461551|454560185|FG001|Overall Study|Physician Decision|1|||
126345732|NCT01461551|454560186|FG002|Overall Study|Physician Decision|2|||
126345733|NCT01155141|454560187|FG000|Overall Study|Withdrawal by Subject|1|||
126345734|NCT01155141|454560187|FG000|Overall Study|Screen Failure|1|||
126345735|NCT00303186|454560188|FG000|Overall Study|Other|52|||
126345736|NCT03473197|454560189|FG000|Overall Study|Adverse Event|4|||
126345737|NCT03473197|454560189|FG000|Overall Study|Lost to Follow-up|1|||
126345738|NCT03473197|454560189|FG000|Overall Study|Withdrawal by Subject|5|||
126345739|NCT02326883|454560192|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
126345740|NCT02326883|454560193|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
126011986|NCT02715258|453336643|FG001|Overall Study|Lost to Follow-up|1|||
126011987|NCT02715258|453336642|FG000|Overall Study|Terminated by Sponsor|0|||
126011988|NCT02715258|453336643|FG001|Overall Study|Terminated by Sponsor|1|||
126011989|NCT02715258|453336642|FG000|Overall Study|Death|0|||
126011990|NCT02715258|453336643|FG001|Overall Study|Death|1|||
126011991|NCT02715258|453336642|FG000|Overall Study|Subject non-compliant|1|||
126345741|NCT02326883|454560194|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
126011992|NCT02715258|453336643|FG001|Overall Study|Subject non-compliant|1|||
126011993|NCT02715258|453336642|FG000|Overall Study|GCP violation|2|||
126011994|NCT02715258|453336643|FG001|Overall Study|GCP violation|1|||
126011995|NCT02814643|453336644|FG000|Overall Study|Lost to Follow-up|0|||
126011996|NCT02814643|453336645|FG001|Overall Study|Lost to Follow-up|1|||
126011997|NCT02814643|453336644|FG000|Overall Study|Withdrawal by Subject|1|||
126011998|NCT02814643|453336645|FG001|Overall Study|Withdrawal by Subject|2|||
126011999|NCT02263508|453336646|FG000|Overall Study|Withdrawal by Subject|1|||
126012000|NCT02263508|453336647|FG001|Overall Study|Withdrawal by Subject|23|||
126012001|NCT02263508|453336648|FG002|Overall Study|Withdrawal by Subject|17|||
126012002|NCT02263508|453336646|FG000|Overall Study|Sponsor Decision|12|||
126012003|NCT02263508|453336647|FG001|Overall Study|Sponsor Decision|165|||
126012004|NCT02263508|453336648|FG002|Overall Study|Sponsor Decision|182|||
126012005|NCT02263508|453336646|FG000|Overall Study|Lost to Follow-up|2|||
126012006|NCT02263508|453336647|FG001|Overall Study|Lost to Follow-up|7|||
126012007|NCT02263508|453336648|FG002|Overall Study|Lost to Follow-up|7|||
126012008|NCT02263508|453336646|FG000|Overall Study|Death|6|||
126012009|NCT02263508|453336647|FG001|Overall Study|Death|151|||
126012010|NCT02263508|453336648|FG002|Overall Study|Death|140|||
126012011|NCT03265210|453336651|FG000|Overall Study|Withdrawal by Subject|7|||
126012012|NCT03265210|453336652|FG001|Overall Study|Withdrawal by Subject|9|||
126012013|NCT03265210|453336651|FG000|Overall Study|Lost to Follow-up|2|||
126012014|NCT03265210|453336652|FG001|Overall Study|Lost to Follow-up|0|||
126012015|NCT03265210|453336651|FG000|Overall Study|Physician Decision|2|||
126012016|NCT03265210|453336652|FG001|Overall Study|Physician Decision|0|||
126012017|NCT03265210|453336651|FG000|Overall Study|Adverse Event|1|||
126012018|NCT03265210|453336652|FG001|Overall Study|Adverse Event|0|||
126012019|NCT03546907|453336661|FG000|Overall Study|Lack of Efficacy|1|||
126012020|NCT03546907|453336662|FG001|Overall Study|Lack of Efficacy|1|||
126012021|NCT03546907|453336661|FG000|Overall Study|Withdrawal by Subject|8|||
126012022|NCT03546907|453336662|FG001|Overall Study|Withdrawal by Subject|9|||
126012023|NCT03546907|453336661|FG000|Overall Study|Adverse events (AEs)|7|||
126012024|NCT03546907|453336662|FG001|Overall Study|Adverse events (AEs)|10|||
126012025|NCT03546907|453336661|FG000|Overall Study|Other-unspecified|1|||
126012026|NCT03546907|453336662|FG001|Overall Study|Other-unspecified|1|||
126012027|NCT01281813|453336663|FG000|Overall Study|Adverse Event|0|||
126012028|NCT01281813|453336664|FG001|Overall Study|Adverse Event|0|||
126012029|NCT01281813|453336665|FG002|Overall Study|Adverse Event|10|||
126012030|NCT01281813|453336663|FG000|Overall Study|Lost to Follow-up|0|||
126012031|NCT01281813|453336664|FG001|Overall Study|Lost to Follow-up|0|||
126012032|NCT01281813|453336665|FG002|Overall Study|Lost to Follow-up|31|||
126012033|NCT01281813|453336663|FG000|Overall Study|Withdrawal by Subject|0|||
126012034|NCT01281813|453336664|FG001|Overall Study|Withdrawal by Subject|0|||
126091126|NCT03820947|453626918|FG000|Overall Study|Lost to Follow-up|4|||
126012035|NCT01281813|453336665|FG002|Overall Study|Withdrawal by Subject|13|||
126012036|NCT01281813|453336663|FG000|Overall Study|Subject Non-Compliant|0|||
126012037|NCT01281813|453336664|FG001|Overall Study|Subject Non-Compliant|0|||
126012038|NCT01281813|453336665|FG002|Overall Study|Subject Non-Compliant|6|||
126012039|NCT01281813|453336663|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
126012040|NCT01281813|453336664|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
126012041|NCT01281813|453336665|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
126012042|NCT01281813|453336663|FG000|Overall Study|Sponsor's Decision|4|||
126012043|NCT01281813|453336664|FG001|Overall Study|Sponsor's Decision|3|||
126012044|NCT01281813|453336665|FG002|Overall Study|Sponsor's Decision|7|||
126012045|NCT01281813|453336663|FG000|Overall Study|Switched to Commercially Available Medication|0|||
126012046|NCT01281813|453336664|FG001|Overall Study|Switched to Commercially Available Medication|0|||
126012047|NCT01281813|453336665|FG002|Overall Study|Switched to Commercially Available Medication|26|||
126012048|NCT01281813|453336663|FG000|Overall Study|Other|0|||
126012049|NCT01281813|453336664|FG001|Overall Study|Other|1|||
126012050|NCT01281813|453336665|FG002|Overall Study|Other|39|||
126012051|NCT01458210|453336666|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
126012052|NCT01458210|453336666|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
126345742|NCT02736617|454560195|FG000|Treatment|Adverse Event|1|||
126345743|NCT02736617|454560195|FG000|Treatment|Lack of Efficacy|1|||
126345744|NCT02736617|454560195|FG000|Treatment|Withdrawal by Subject|1|||
126345745|NCT02736617|454560195|FG000|Maintenance|Lack of Efficacy|4|||
126345746|NCT02736617|454560195|FG000|Maintenance|Physician Decision|1|||
126345747|NCT02911116|454560198|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126345748|NCT02911116|454560199|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126345749|NCT02911116|454560198|FG000|Overall Study|Lost to Follow-up|0|||
126345750|NCT02911116|454560199|FG001|Overall Study|Lost to Follow-up|1|||
126345751|NCT04796415|454560200|FG000|Overall Study|not interested|12|||
126345752|NCT04796415|454560200|FG000|Overall Study|health issue|8|||
126345753|NCT04796415|454560200|FG000|Overall Study|Other|4|||
126345754|NCT04796415|454560200|FG000|Overall Study|discharged from home health service|3|||
126345755|NCT04796415|454560200|FG000|Overall Study|re-hospitalization|2|||
126345756|NCT04796415|454560200|FG000|Overall Study|moving to nursing home|1|||
126345757|NCT04796415|454560200|FG000|Overall Study|lost contact|1|||
126345758|NCT02469857|454560201|FG000|Overall Study|Death|24|||
126345759|NCT02469857|454560202|FG001|Overall Study|Death|29|||
126345760|NCT02469857|454560201|FG000|Overall Study|Discontinuation|1|||
126345761|NCT02469857|454560202|FG001|Overall Study|Discontinuation|3|||
126345762|NCT02110693|454560203|FG000|Overall Study|Withdrawal by Subject|6|||
126345763|NCT02110693|454560204|FG001|Overall Study|Withdrawal by Subject|7|||
126345764|NCT02110693|454560203|FG000|Overall Study|skipped assessment|15|||
126345765|NCT02110693|454560204|FG001|Overall Study|skipped assessment|18|||
126345766|NCT02110693|454560203|FG000|Overall Study|technical difficulties|6|||
126345767|NCT02110693|454560204|FG001|Overall Study|technical difficulties|4|||
126345768|NCT02110693|454560203|FG000|Overall Study|Other|1|||
126345769|NCT02110693|454560204|FG001|Overall Study|Other|0|||
126345770|NCT04810962|454560205|FG000|Overall Study|Adverse Event|0|||
126345771|NCT04810962|454560206|FG001|Overall Study|Adverse Event|1|||
126345772|NCT04810962|454560205|FG000|Overall Study|Lost to Follow-up|2|||
126345773|NCT04810962|454560206|FG001|Overall Study|Lost to Follow-up|1|||
126345774|NCT04810962|454560205|FG000|Overall Study|Physician Decision|1|||
126345775|NCT04810962|454560206|FG001|Overall Study|Physician Decision|0|||
126345776|NCT04810962|454560205|FG000|Overall Study|Withdrawal by Subject|1|||
126345777|NCT04810962|454560206|FG001|Overall Study|Withdrawal by Subject|3|||
126345778|NCT04810962|454560205|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
126345779|NCT04810962|454560206|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
126345780|NCT00630292|454560210|FG000|Overall Study|Withdrawal by Subject|1|||
126345781|NCT00142415|454560211|FG000|Overall Study|Physician Decision|0|||
126345782|NCT00142415|454560212|FG001|Overall Study|Physician Decision|0|||
126345783|NCT00142415|454560213|FG002|Overall Study|Physician Decision|0|||
126345784|NCT00142415|454560214|FG003|Overall Study|Physician Decision|0|||
126345785|NCT00142415|454560215|FG004|Overall Study|Physician Decision|1|||
126345786|NCT00142415|454560216|FG005|Overall Study|Physician Decision|2|||
126345787|NCT01189266|454560217|FG000|Overall Study|Adverse Event|1|||
126345788|NCT01189266|454560218|FG001|Overall Study|Adverse Event|0|||
126345789|NCT01189266|454560219|FG002|Overall Study|Adverse Event|5|||
126345790|NCT01189266|454560217|FG000|Overall Study|Death|0|||
126345791|NCT01189266|454560218|FG001|Overall Study|Death|0|||
126012053|NCT01458210|453336666|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
126012054|NCT01458210|453336666|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
126012055|NCT01833832|453336667|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
126345792|NCT01189266|454560219|FG002|Overall Study|Death|5|||
126345793|NCT01189266|454560217|FG000|Overall Study|Lack of Efficacy|4|||
126345794|NCT01189266|454560218|FG001|Overall Study|Lack of Efficacy|5|||
126345795|NCT01189266|454560219|FG002|Overall Study|Lack of Efficacy|44|||
126345796|NCT01189266|454560217|FG000|Overall Study|Physician Decision|0|||
126012056|NCT05046132|453336668|FG000|Overall Study|Adverse Event|4|||
126012057|NCT05046132|453336669|FG001|Overall Study|Adverse Event|0|||
126012058|NCT05046132|453336670|FG002|Overall Study|Adverse Event|0|||
126012059|NCT05046132|453336668|FG000|Overall Study|Withdrawal by Subject|3|||
126012060|NCT05046132|453336669|FG001|Overall Study|Withdrawal by Subject|0|||
126012061|NCT05046132|453336670|FG002|Overall Study|Withdrawal by Subject|0|||
126012062|NCT05046132|453336668|FG000|Overall Study|Positive Covid19 Result.|0|||
126012063|NCT05046132|453336669|FG001|Overall Study|Positive Covid19 Result.|1|||
126012064|NCT05046132|453336670|FG002|Overall Study|Positive Covid19 Result.|0|||
126012065|NCT02148133|453336676|FG000|Overall Study|Investigator discretion|1|||
126012066|NCT02148133|453336676|FG000|Overall Study|Lack of Efficacy|1|||
126012067|NCT02148133|453336676|FG000|Overall Study|Protocol deviation|1|||
126012068|NCT02148133|453336676|FG000|Overall Study|Protocol-defined stopping criteria|2|||
126012069|NCT01161498|453336677|FG000|Overall Study|Disease Progression|0|||
126012070|NCT01161498|453336678|FG001|Overall Study|Disease Progression|1|||
126012071|NCT02807493|453336679|FG000|Overall Study|Adverse Event|5|||
126012072|NCT02807493|453336680|FG001|Overall Study|Adverse Event|2|||
126012073|NCT02807493|453336679|FG000|Overall Study|Lost to Follow-up|6|||
126012074|NCT02807493|453336680|FG001|Overall Study|Lost to Follow-up|0|||
126012075|NCT02807493|453336679|FG000|Overall Study|Physician Decision|4|||
126012076|NCT02807493|453336680|FG001|Overall Study|Physician Decision|1|||
126012077|NCT02807493|453336679|FG000|Overall Study|Protocol Violation|7|||
126012078|NCT02807493|453336680|FG001|Overall Study|Protocol Violation|0|||
126012079|NCT02807493|453336679|FG000|Overall Study|Withdrawal by Subject|17|||
126012080|NCT02807493|453336680|FG001|Overall Study|Withdrawal by Subject|10|||
126012081|NCT02807493|453336679|FG000|Overall Study|Other withdrawal|17|||
126012082|NCT02807493|453336680|FG001|Overall Study|Other withdrawal|0|||
126012083|NCT02807493|453336679|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
126012084|NCT02807493|453336680|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
126012085|NCT00811057|453336681|FG000|Overall Study|Protocol Violation|5|||
126012086|NCT00811057|453336682|FG001|Overall Study|Protocol Violation|10|||
126012087|NCT00811057|453336683|FG002|Overall Study|Protocol Violation|10|||
126012088|NCT00768651|453336688|FG000|Overall Study|Withdrawal by Subject|1|||
126012089|NCT02104765|453336689|FG000|Overall Study|Lost to Follow-up|0|||
126012090|NCT02104765|453336690|FG001|Overall Study|Lost to Follow-up|0|||
126345797|NCT01189266|454560218|FG001|Overall Study|Physician Decision|0|||
126345798|NCT01189266|454560219|FG002|Overall Study|Physician Decision|1|||
126345799|NCT01189266|454560217|FG000|Overall Study|Protocol Violation|0|||
126345800|NCT01189266|454560218|FG001|Overall Study|Protocol Violation|1|||
126012091|NCT02104765|453336691|FG002|Overall Study|Lost to Follow-up|1|||
126012092|NCT02104765|453336692|FG003|Overall Study|Lost to Follow-up|0|||
126012093|NCT02104765|453336693|FG004|Overall Study|Lost to Follow-up|0|||
126345801|NCT01189266|454560219|FG002|Overall Study|Protocol Violation|1|||
126345802|NCT01189266|454560217|FG000|Overall Study|Withdrawal by Subject|0|||
126345803|NCT01189266|454560218|FG001|Overall Study|Withdrawal by Subject|0|||
126345804|NCT01189266|454560219|FG002|Overall Study|Withdrawal by Subject|1|||
126345805|NCT01189266|454560217|FG000|Overall Study|Patient refuses further therapy|1|||
126345806|NCT01189266|454560218|FG001|Overall Study|Patient refuses further therapy|0|||
126345807|NCT01189266|454560219|FG002|Overall Study|Patient refuses further therapy|7|||
126345808|NCT01189266|454560217|FG000|Overall Study|No treatment|0|||
126345809|NCT01189266|454560218|FG001|Overall Study|No treatment|0|||
126345810|NCT01189266|454560219|FG002|Overall Study|No treatment|1|||
126345811|NCT03620162|454560220|FG000|Overall Study|Physician Decision|4|||
126345812|NCT03620162|454560221|FG001|Overall Study|Physician Decision|0|||
126345813|NCT03620162|454560222|FG002|Overall Study|Physician Decision|1|||
126345814|NCT03620162|454560223|FG003|Overall Study|Physician Decision|0|||
126345815|NCT03620162|454560224|FG004|Overall Study|Physician Decision|2|||
126345816|NCT03620162|454560220|FG000|Overall Study|Lost to Follow-up|2|||
126345817|NCT03620162|454560221|FG001|Overall Study|Lost to Follow-up|6|||
126345818|NCT03620162|454560222|FG002|Overall Study|Lost to Follow-up|7|||
126345819|NCT03620162|454560223|FG003|Overall Study|Lost to Follow-up|3|||
126012094|NCT02104765|453336694|FG005|Overall Study|Lost to Follow-up|0|||
126012095|NCT02104765|453336695|FG006|Overall Study|Lost to Follow-up|0|||
126345820|NCT03620162|454560224|FG004|Overall Study|Lost to Follow-up|2|||
126012096|NCT02104765|453336689|FG000|Overall Study|Withdrawal by Subject|0|||
126012097|NCT02104765|453336690|FG001|Overall Study|Withdrawal by Subject|0|||
126012098|NCT02104765|453336691|FG002|Overall Study|Withdrawal by Subject|0|||
126012099|NCT02104765|453336692|FG003|Overall Study|Withdrawal by Subject|1|||
126012100|NCT02104765|453336693|FG004|Overall Study|Withdrawal by Subject|1|||
126012101|NCT02104765|453336694|FG005|Overall Study|Withdrawal by Subject|0|||
126012102|NCT02104765|453336695|FG006|Overall Study|Withdrawal by Subject|1|||
126012103|NCT00995709|453336700|FG000|Overall Study|Adverse Event|4|||
126012104|NCT00995709|453336701|FG001|Overall Study|Adverse Event|2|||
126012105|NCT00995709|453336702|FG002|Overall Study|Adverse Event|0|||
126345821|NCT03620162|454560220|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
126012106|NCT00995709|453336700|FG000|Overall Study|Lack of Efficacy|0|||
126012107|NCT00995709|453336701|FG001|Overall Study|Lack of Efficacy|1|||
126012108|NCT00995709|453336702|FG002|Overall Study|Lack of Efficacy|4|||
126012109|NCT00995709|453336700|FG000|Overall Study|Withdrawal by Subject|0|||
126012110|NCT00995709|453336701|FG001|Overall Study|Withdrawal by Subject|4|||
126012111|NCT00995709|453336702|FG002|Overall Study|Withdrawal by Subject|1|||
126012112|NCT00995709|453336700|FG000|Overall Study|Lost to Follow-up|1|||
126012113|NCT00995709|453336701|FG001|Overall Study|Lost to Follow-up|0|||
126012114|NCT00995709|453336702|FG002|Overall Study|Lost to Follow-up|0|||
126012115|NCT00995709|453336700|FG000|Overall Study|Death|0|||
126012116|NCT00995709|453336701|FG001|Overall Study|Death|1|||
126012117|NCT00995709|453336702|FG002|Overall Study|Death|0|||
126012118|NCT00995709|453336700|FG000|Overall Study|Protocol Violation|2|||
126012119|NCT00995709|453336701|FG001|Overall Study|Protocol Violation|1|||
126012120|NCT00995709|453336702|FG002|Overall Study|Protocol Violation|0|||
126012121|NCT01697319|453336703|FG000|Primary Phase|Withdrawal by Subject|1|||
126012122|NCT01697319|453336703|FG000|Extension Phase|Terminated by Sponsor|15|||
126012123|NCT04222959|453336704|FG000|Overall Study|Lost to Follow-up|76|||
126012124|NCT04222959|453336705|FG001|Overall Study|Lost to Follow-up|28|||
126012125|NCT03008915|453336706|FG000|Treatment 1|Withdrawal by Subject|0|||
126012126|NCT03008915|453336707|FG001|Treatment 1|Withdrawal by Subject|1|||
126012127|NCT00712166|453336710|FG000|Overall Study|Noncompliance|0|||
126012128|NCT00712166|453336711|FG001|Overall Study|Noncompliance|1|||
126012129|NCT01773122|453336712|FG000|Overall Study|Due to amended age eligibility criteria|3|||
126012130|NCT01773122|453336713|FG001|Overall Study|Due to amended age eligibility criteria|1|||
126012131|NCT01773122|453336714|FG002|Overall Study|Due to amended age eligibility criteria|0|||
126012132|NCT01773122|453336715|FG003|Overall Study|Due to amended age eligibility criteria|1|||
126012133|NCT01264718|453336716|FG000|Overall Study|Lost to Follow-up|3|||
126012134|NCT01264718|453336717|FG001|Overall Study|Lost to Follow-up|2|||
126012135|NCT01264718|453336716|FG000|Overall Study|Withdrawal by Subject|9|||
126012136|NCT01264718|453336717|FG001|Overall Study|Withdrawal by Subject|15|||
126012137|NCT01264718|453336716|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
126012138|NCT01264718|453336717|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
126012139|NCT01769391|453336718|FG000|Overall Study|Death|10|||
126012140|NCT01769391|453336719|FG001|Overall Study|Death|1|||
126012141|NCT01769391|453336718|FG000|Overall Study|Adverse Event|0|||
126012142|NCT01769391|453336719|FG001|Overall Study|Adverse Event|3|||
126012143|NCT01769391|453336718|FG000|Overall Study|Progressive Disease|1|||
126012144|NCT01769391|453336719|FG001|Overall Study|Progressive Disease|2|||
126012145|NCT01769391|453336718|FG000|Overall Study|Withdrawal by Subject|4|||
126012146|NCT01769391|453336719|FG001|Overall Study|Withdrawal by Subject|3|||
126012147|NCT01769391|453336718|FG000|Overall Study|Investigator Decision|2|||
126012148|NCT01769391|453336719|FG001|Overall Study|Investigator Decision|0|||
126012149|NCT01144182|453336721|FG000|Overall Study|Death|5|||
126012150|NCT01144182|453336722|FG001|Overall Study|Death|6|||
126012151|NCT01144182|453336721|FG000|Overall Study|Withdrawal by Subject|3|||
126012152|NCT01144182|453336722|FG001|Overall Study|Withdrawal by Subject|6|||
126012153|NCT01144182|453336721|FG000|Overall Study|Lost to Follow-up|9|||
126012154|NCT01144182|453336722|FG001|Overall Study|Lost to Follow-up|9|||
126012155|NCT03264456|453336727|FG000|Overall Study|Withdrawal by Subject|3|||
126012156|NCT03264456|453336727|FG000|Overall Study|Lost to Follow-up|1|||
126012157|NCT03538054|453336728|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
126012158|NCT03538054|453336728|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
126012159|NCT03538054|453336728|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
126012160|NCT03254394|453336729|FG000|Overall Study|Withdrawal by Subject|0|||
126012161|NCT03254394|453336730|FG001|Overall Study|Withdrawal by Subject|2|||
126012162|NCT02351180|453336733|FG000|Overall Study|Withdrawal by Subject|1|||
126012163|NCT02351180|453336734|FG001|Overall Study|Withdrawal by Subject|0|||
126345822|NCT03620162|454560221|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
126345823|NCT03620162|454560222|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
126345824|NCT03620162|454560223|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
126345825|NCT03620162|454560224|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
126345826|NCT01838876|454560227|FG000|Overall Study|Adverse Event|49|||
126345827|NCT01838876|454560227|FG000|Overall Study|Insufficient Therapeutic Response|10|||
126345828|NCT01838876|454560227|FG000|Overall Study|Protocol Violation|34|||
126345829|NCT01838876|454560227|FG000|Overall Study|Withdrawal of Consent|33|||
126012164|NCT03418324|453336741|FG000|Overall Study|Death|0|||
126012165|NCT03418324|453336742|FG001|Overall Study|Death|1|||
126012166|NCT03418324|453336741|FG000|Overall Study|Physician Decision|1|||
126012167|NCT03418324|453336742|FG001|Overall Study|Physician Decision|1|||
126012168|NCT01751724|453336743|FG000|Overall Study|extubated bef.start assigned treatment|1|||
126012169|NCT01751724|453336744|FG001|Overall Study|extubated bef.start assigned treatment|0|||
126012170|NCT01751724|453336743|FG000|Overall Study|withdrawn by parent|0|||
126012171|NCT01751724|453336744|FG001|Overall Study|withdrawn by parent|2|||
126345830|NCT01838876|454560227|FG000|Overall Study|Lost to Follow-up|21|||
126012172|NCT03121950|453336746|FG000|Overall Study|Withdrawal by Subject|11|||
126012173|NCT03121950|453336747|FG001|Overall Study|Withdrawal by Subject|2|||
126012174|NCT01867580|453336748|FG000|Overall Study|Withdrawal by Subject|2|||
126012175|NCT01867580|453336749|FG001|Overall Study|Withdrawal by Subject|3|||
126012176|NCT01867580|453336748|FG000|Overall Study|Physician Decision|17|||
126012177|NCT01867580|453336749|FG001|Overall Study|Physician Decision|12|||
126012178|NCT01867580|453336748|FG000|Overall Study|Lost to Follow-up|3|||
126012179|NCT01867580|453336749|FG001|Overall Study|Lost to Follow-up|5|||
126012180|NCT01867580|453336748|FG000|Overall Study|Sponsor terminated study|1|||
126012181|NCT01867580|453336749|FG001|Overall Study|Sponsor terminated study|0|||
126012182|NCT01867580|453336748|FG000|Overall Study|Missed follow-up assessment|2|||
126012183|NCT01867580|453336749|FG001|Overall Study|Missed follow-up assessment|1|||
126012184|NCT01867580|453336748|FG000|Overall Study|Interruption to therapy|3|||
126012185|NCT01867580|453336749|FG001|Overall Study|Interruption to therapy|0|||
126012186|NCT01867580|453336748|FG000|Overall Study|Osteomyelitis|0|||
126012187|NCT01867580|453336749|FG001|Overall Study|Osteomyelitis|1|||
126012188|NCT01867580|453336748|FG000|Overall Study|Continuation of therapy|0|||
126012189|NCT01867580|453336749|FG001|Overall Study|Continuation of therapy|1|||
126012190|NCT01867580|453336748|FG000|Overall Study|Wound recurrence|0|||
126012191|NCT01867580|453336749|FG001|Overall Study|Wound recurrence|1|||
126012192|NCT03425643|453336752|FG000|Overall Study|Withdrawal by Subject|10|||
126012193|NCT03425643|453336753|FG001|Overall Study|Withdrawal by Subject|12|||
126012194|NCT03425643|453336752|FG000|Overall Study|Lost to Follow-up|2|||
126012195|NCT03425643|453336753|FG001|Overall Study|Lost to Follow-up|0|||
126012196|NCT03425643|453336752|FG000|Overall Study|Death|109|||
126012197|NCT03425643|453336753|FG001|Overall Study|Death|141|||
126012198|NCT03425643|453336752|FG000|Overall Study|Ongoing in study|276|||
126012199|NCT03425643|453336753|FG001|Overall Study|Ongoing in study|247|||
126012200|NCT03141788|453336754|FG000|Overall Study|Lost to Follow-up|1|||
126012201|NCT03141788|453336754|FG000|Overall Study|Protocol Violation|3|||
126012202|NCT03141788|453336754|FG000|Overall Study|Withdrawal by Subject|4|||
126012203|NCT01025843|453338386|FG000|Washout 4|Withdrawal by Subject|0|||
126012204|NCT01025843|453338387|FG001|Washout 4|Withdrawal by Subject|0|||
126012205|NCT01025843|453338388|FG002|Washout 4|Withdrawal by Subject|1|||
126012206|NCT01025843|453338389|FG003|Washout 4|Withdrawal by Subject|1|||
126012207|NCT01025843|453338390|FG004|Washout 4|Withdrawal by Subject|0|||
126012208|NCT01025843|453338391|FG005|Washout 4|Withdrawal by Subject|0|||
126012209|NCT01025843|453338392|FG006|Washout 4|Withdrawal by Subject|0|||
126012210|NCT01025843|453338393|FG007|Washout 4|Withdrawal by Subject|0|||
126012211|NCT01025843|453338394|FG008|Washout 4|Withdrawal by Subject|0|||
126012212|NCT01025843|453338395|FG009|Washout 4|Withdrawal by Subject|0|||
126012213|NCT00377455|453338398|FG000|Overall Study|Withdrawal by Subject|1|||
126012214|NCT01070888|453338399|FG000|First Intervention (14 Days)|Adverse Event|0|||
126012215|NCT01070888|453338400|FG001|First Intervention (14 Days)|Adverse Event|1|||
126012216|NCT01070888|453338399|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
126012217|NCT01070888|453338400|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
126012218|NCT01070888|453338399|FG000|Washout (14 Days)|Physician Decision|1|||
126012219|NCT01070888|453338400|FG001|Washout (14 Days)|Physician Decision|0|||
126012220|NCT01897233|453338405|FG000|Part B (24 Weeks)|Adverse Event|1|||
126012221|NCT01897233|453338405|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
126012222|NCT01897233|453338405|FG000|Part B (24 Weeks)|Physician Decision|1|||
126012223|NCT02385669|453338407|FG000|Overall Study|Adverse Event|2|||
126012224|NCT02810080|453338408|FG000|Overall Study|Adverse Event|3|||
126012225|NCT02810080|453338409|FG001|Overall Study|Adverse Event|0|||
126012226|NCT02810080|453338408|FG000|Overall Study|Death|0|||
126012227|NCT02810080|453338409|FG001|Overall Study|Death|2|||
126012228|NCT02810080|453338408|FG000|Overall Study|Physician Decision|4|||
126012229|NCT02810080|453338409|FG001|Overall Study|Physician Decision|0|||
126012230|NCT02810080|453338408|FG000|Overall Study|Withdrawal by Subject|0|||
126012231|NCT02810080|453338409|FG001|Overall Study|Withdrawal by Subject|2|||
126012232|NCT04033432|453338415|FG000|Overall Study|Progressive Disease|8|||
126012233|NCT04033432|453338415|FG000|Overall Study|Adverse Event|4|||
126012234|NCT04033432|453338415|FG000|Overall Study|Death|1|||
126345831|NCT01838876|454560227|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
126345832|NCT01838876|454560227|FG000|Overall Study|Reason not Specified|7|||
126012235|NCT02192606|453338416|FG000|Overall Study|surgery type was changed|1|||
126012236|NCT02192606|453338417|FG001|Overall Study|surgery type was changed|1|||
126012237|NCT02192606|453338416|FG000|Overall Study|Physician Decision|1|||
126012238|NCT02192606|453338417|FG001|Overall Study|Physician Decision|2|||
126012239|NCT02192606|453338416|FG000|Overall Study|3D equipment rep unable to join|0|||
126012240|NCT02192606|453338417|FG001|Overall Study|3D equipment rep unable to join|1|||
126012241|NCT02034916|453338421|FG000|Overall Study|Death|39|||
126012242|NCT02034916|453338422|FG001|Overall Study|Death|28|||
126345833|NCT01838876|454560227|FG000|Overall Study|Did not meet eligibility criteria|78|||
126345834|NCT02101294|454560228|FG000|Overall Study|Withdrawal by Subject|5|||
126345835|NCT02101294|454560228|FG000|Overall Study|Lost to Follow-up|6|||
126012243|NCT02034916|453338421|FG000|Overall Study|Withdrawal by Subject|2|||
126012244|NCT02034916|453338422|FG001|Overall Study|Withdrawal by Subject|1|||
126012245|NCT02034916|453338421|FG000|Overall Study|Lost to Follow-up|4|||
126012246|NCT02034916|453338422|FG001|Overall Study|Lost to Follow-up|1|||
126012247|NCT02034916|453338421|FG000|Overall Study|Study terminated by sponsor|4|||
126012248|NCT02034916|453338422|FG001|Overall Study|Study terminated by sponsor|5|||
126012249|NCT01616654|453338427|FG000|Overall Study|Lack of Efficacy|1|||
126012250|NCT01616654|453338428|FG001|Overall Study|Lack of Efficacy|0|||
126012251|NCT01616654|453338429|FG002|Overall Study|Lack of Efficacy|0|||
126012252|NCT01616654|453338430|FG003|Overall Study|Lack of Efficacy|0|||
126012253|NCT01616654|453338431|FG004|Overall Study|Lack of Efficacy|1|||
126012254|NCT01616654|453338427|FG000|Overall Study|Adverse Event|0|||
126012255|NCT01616654|453338428|FG001|Overall Study|Adverse Event|1|||
126012256|NCT01616654|453338429|FG002|Overall Study|Adverse Event|2|||
126012257|NCT01616654|453338430|FG003|Overall Study|Adverse Event|1|||
126012258|NCT01616654|453338431|FG004|Overall Study|Adverse Event|0|||
126012259|NCT01616654|453338427|FG000|Overall Study|Withdrawal by Subject|2|||
126012260|NCT01616654|453338428|FG001|Overall Study|Withdrawal by Subject|2|||
126012261|NCT01616654|453338429|FG002|Overall Study|Withdrawal by Subject|3|||
126012262|NCT01616654|453338430|FG003|Overall Study|Withdrawal by Subject|1|||
126012263|NCT01616654|453338431|FG004|Overall Study|Withdrawal by Subject|5|||
126012264|NCT01616654|453338427|FG000|Overall Study|Protocol Violation|0|||
126012265|NCT01616654|453338428|FG001|Overall Study|Protocol Violation|5|||
126012266|NCT01616654|453338429|FG002|Overall Study|Protocol Violation|2|||
126012267|NCT01616654|453338430|FG003|Overall Study|Protocol Violation|4|||
126012268|NCT01616654|453338431|FG004|Overall Study|Protocol Violation|4|||
126012269|NCT01616654|453338427|FG000|Overall Study|Lost to Follow-up|1|||
126012270|NCT01616654|453338428|FG001|Overall Study|Lost to Follow-up|0|||
126012271|NCT01616654|453338429|FG002|Overall Study|Lost to Follow-up|3|||
126012272|NCT01616654|453338430|FG003|Overall Study|Lost to Follow-up|2|||
126012273|NCT01616654|453338431|FG004|Overall Study|Lost to Follow-up|1|||
126012274|NCT01616654|453338427|FG000|Overall Study|Pregnancy|1|||
126012275|NCT01616654|453338428|FG001|Overall Study|Pregnancy|0|||
126012276|NCT01616654|453338429|FG002|Overall Study|Pregnancy|0|||
126012277|NCT01616654|453338430|FG003|Overall Study|Pregnancy|0|||
126012278|NCT01616654|453338431|FG004|Overall Study|Pregnancy|1|||
126012279|NCT02057692|453338435|FG000|Overall Study|Adverse Event|1|||
126012280|NCT02057692|453338436|FG001|Overall Study|Adverse Event|0|||
126012281|NCT02057692|453338437|FG002|Overall Study|Adverse Event|0|||
126012282|NCT02057692|453338438|FG003|Overall Study|Adverse Event|0|||
126012283|NCT02057692|453338435|FG000|Overall Study|Lost to Follow-up|0|||
126012284|NCT02057692|453338436|FG001|Overall Study|Lost to Follow-up|0|||
126012285|NCT02057692|453338437|FG002|Overall Study|Lost to Follow-up|0|||
126012286|NCT02057692|453338438|FG003|Overall Study|Lost to Follow-up|1|||
126012287|NCT00864682|453338441|FG000|Overall Study|Protocol Violation|2|||
126012288|NCT00864682|453338442|FG001|Overall Study|Protocol Violation|1|||
126012289|NCT00864682|453338443|FG002|Overall Study|Protocol Violation|2|||
126012290|NCT00957658|453338444|FG000|Overall Study|Death|1|||
126012291|NCT00957658|453338444|FG000|Overall Study|Lost to Follow-up|4|||
126012292|NCT00957658|453338444|FG000|Overall Study|Withdrawal by Subject|12|||
126012293|NCT00957658|453338444|FG000|Overall Study|Revision|1|||
126012294|NCT00957658|453338444|FG000|Overall Study|Incomplete 2 yr data|28|||
126012295|NCT00957658|453338444|FG000|Overall Study|Site termination|10|||
126012296|NCT00957658|453338444|FG000|Overall Study|unwilling/unable to return|2|||
126012297|NCT00957658|453338444|FG000|Overall Study|surgery cancelled|2|||
126012298|NCT00957658|453338444|FG000|Overall Study|Protocol Violation|5|||
126012299|NCT04842604|453338446|FG000|Overall Study|Death|1|||
126012300|NCT04842604|453338447|FG001|Overall Study|Death|0|||
126012301|NCT04842604|453338446|FG000|Overall Study|Other|4|||
126012302|NCT04842604|453338447|FG001|Overall Study|Other|4|||
126012303|NCT04842604|453338446|FG000|Overall Study|Randomized but not treated|1|||
126012304|NCT04842604|453338447|FG001|Overall Study|Randomized but not treated|0|||
126012305|NCT01193153|453338448|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
126012306|NCT01193153|453338449|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
126012307|NCT01193153|453338448|FG000|Open-label Lead in Period|Pregnancy|1|||
126012308|NCT01193153|453338449|FG001|Open-label Lead in Period|Pregnancy|0|||
126012309|NCT01193153|453338448|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
126012310|NCT01193153|453338449|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
126012311|NCT01193153|453338448|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
126012312|NCT01193153|453338449|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
126012313|NCT01193153|453338448|FG000|Open-label Lead in Period|Other|14|||
126012314|NCT01193153|453338449|FG001|Open-label Lead in Period|Other|0|||
126012315|NCT01193153|453338448|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
126012316|NCT01193153|453338449|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
126012317|NCT01193153|453338448|FG000|Open-label Lead in Period|Adverse Event|41|||
126012318|NCT01193153|453338449|FG001|Open-label Lead in Period|Adverse Event|0|||
126012319|NCT01193153|453338448|FG000|Open-label Lead in Period|Death|1|||
126012320|NCT01193153|453338449|FG001|Open-label Lead in Period|Death|0|||
126012321|NCT01193153|453338448|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
126012322|NCT01193153|453338449|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
126345836|NCT03416179|454560229|FG000|Overall Study|Death|90|||
126345837|NCT03416179|454560230|FG001|Overall Study|Death|87|||
126012323|NCT01193153|453338448|FG000|Open-label Stabilization Period|Adverse Event|9|||
126012324|NCT01193153|453338449|FG001|Open-label Stabilization Period|Adverse Event|0|||
126012325|NCT01193153|453338448|FG000|Open-label Stabilization Period|Death|2|||
126012326|NCT01193153|453338449|FG001|Open-label Stabilization Period|Death|0|||
126012327|NCT01193153|453338448|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
126012328|NCT01193153|453338449|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
126012329|NCT01193153|453338448|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
126012330|NCT01193153|453338449|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
126012331|NCT01193153|453338448|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
126012332|NCT01193153|453338449|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
126012333|NCT01193153|453338448|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
126012334|NCT01193153|453338449|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
126012335|NCT01193153|453338448|FG000|Open-label Stabilization Period|Other|8|||
126012336|NCT01193153|453338449|FG001|Open-label Stabilization Period|Other|0|||
126012337|NCT01193153|453338448|FG000|Double Blind Relapse Prevention Period|Other|2|||
126012338|NCT01193153|453338449|FG001|Double Blind Relapse Prevention Period|Other|3|||
126012339|NCT01193153|453338448|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
126012340|NCT01193153|453338449|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
126012341|NCT01193153|453338448|FG000|Double Blind Relapse Prevention Period|Death|2|||
126012342|NCT01193153|453338449|FG001|Double Blind Relapse Prevention Period|Death|0|||
126012343|NCT01193153|453338448|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
126012344|NCT01193153|453338449|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
126012345|NCT01193153|453338448|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
126012346|NCT01193153|453338449|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
126012347|NCT01193153|453338448|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
126012348|NCT01193153|453338449|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
126012349|NCT01193153|453338448|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
126012350|NCT01193153|453338449|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
126012351|NCT01193153|453338448|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
126012352|NCT01193153|453338449|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
126012353|NCT01648140|453338450|FG000|Overall Study|Physician Decision|1|||
126012354|NCT01648140|453338451|FG001|Overall Study|Physician Decision|0|||
126012355|NCT01648140|453338452|FG002|Overall Study|Physician Decision|0|||
126012356|NCT01648140|453338453|FG003|Overall Study|Physician Decision|0|||
126012357|NCT01648140|453338450|FG000|Overall Study|Lack of Efficacy|4|||
126012358|NCT01648140|453338451|FG001|Overall Study|Lack of Efficacy|7|||
126012359|NCT01648140|453338452|FG002|Overall Study|Lack of Efficacy|1|||
126012360|NCT01648140|453338453|FG003|Overall Study|Lack of Efficacy|0|||
126012361|NCT01648140|453338450|FG000|Overall Study|Adverse Event|3|||
126012362|NCT01648140|453338451|FG001|Overall Study|Adverse Event|1|||
126012363|NCT01648140|453338452|FG002|Overall Study|Adverse Event|2|||
126012364|NCT01648140|453338453|FG003|Overall Study|Adverse Event|0|||
126012365|NCT01648140|453338450|FG000|Overall Study|Withdrawal by Subject|2|||
126012366|NCT01648140|453338451|FG001|Overall Study|Withdrawal by Subject|3|||
126012367|NCT01648140|453338452|FG002|Overall Study|Withdrawal by Subject|3|||
126012368|NCT01648140|453338453|FG003|Overall Study|Withdrawal by Subject|2|||
126012369|NCT01648140|453338450|FG000|Overall Study|Lost to Follow-up|2|||
126012370|NCT01648140|453338451|FG001|Overall Study|Lost to Follow-up|1|||
126012371|NCT01648140|453338452|FG002|Overall Study|Lost to Follow-up|2|||
126012372|NCT01648140|453338453|FG003|Overall Study|Lost to Follow-up|0|||
126012373|NCT00608907|453338456|FG000|Overall Study|Adverse Event|6|||
126012374|NCT00608907|453338457|FG001|Overall Study|Adverse Event|0|||
126012375|NCT00608907|453338458|FG002|Overall Study|Adverse Event|1|||
126012376|NCT00608907|453338456|FG000|Overall Study|Death|1|||
126012377|NCT00608907|453338457|FG001|Overall Study|Death|0|||
126012378|NCT00608907|453338458|FG002|Overall Study|Death|0|||
126012379|NCT00608907|453338456|FG000|Overall Study|Withdrawal by Subject|4|||
126012380|NCT00608907|453338457|FG001|Overall Study|Withdrawal by Subject|0|||
126012381|NCT00608907|453338458|FG002|Overall Study|Withdrawal by Subject|0|||
126012382|NCT00608907|453338456|FG000|Overall Study|Progressive Disease|1|||
126012383|NCT00608907|453338457|FG001|Overall Study|Progressive Disease|0|||
126012384|NCT00608907|453338458|FG002|Overall Study|Progressive Disease|0|||
126012385|NCT01988233|453338461|FG000|Overall Study|Lost to Follow-up|64|||
126012386|NCT01988233|453338462|FG001|Overall Study|Lost to Follow-up|51|||
126012387|NCT03621761|453338463|FG000|Overall Study|Lost to Follow-up|1|||
126012388|NCT03621761|453338464|FG001|Overall Study|Lost to Follow-up|1|||
126012389|NCT03621761|453338465|FG002|Overall Study|Lost to Follow-up|2|||
126012390|NCT03621761|453338463|FG000|Overall Study|Withdrawal by Subject|2|||
126345838|NCT03416179|454560231|FG002|Overall Study|Death|117|||
126345839|NCT03416179|454560232|FG003|Overall Study|Death|113|||
126345840|NCT03416179|454560229|FG000|Overall Study|Withdrawal by Subject|15|||
126012391|NCT03621761|453338464|FG001|Overall Study|Withdrawal by Subject|1|||
126209510|NCT03110107|454055415|FG022|Treatment Period|Adverse Event|2|||
126209511|NCT03110107|454055416|FG023|Treatment Period|Adverse Event|2|||
126209512|NCT03110107|454055417|FG024|Treatment Period|Adverse Event|2|||
126209513|NCT03110107|454055418|FG025|Treatment Period|Adverse Event|4|||
126209514|NCT03110107|454055393|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
126209515|NCT03110107|454055394|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
126209516|NCT03110107|454055395|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
126209517|NCT03110107|454055396|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
126209518|NCT03110107|454055397|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
126209519|NCT03110107|454055398|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
126209520|NCT03110107|454055399|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
126209521|NCT03110107|454055400|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
126209522|NCT03110107|454055401|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
126209523|NCT03110107|454055402|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
126209524|NCT03110107|454055403|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
126209525|NCT03110107|454055404|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
126209526|NCT03110107|454055405|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
126209527|NCT03110107|454055406|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
126209528|NCT03110107|454055407|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
126209529|NCT03110107|454055408|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
126209530|NCT03110107|454055409|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
126209531|NCT03110107|454055410|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
126345841|NCT03416179|454560230|FG001|Overall Study|Withdrawal by Subject|20|||
126345842|NCT03416179|454560231|FG002|Overall Study|Withdrawal by Subject|6|||
126345843|NCT03416179|454560232|FG003|Overall Study|Withdrawal by Subject|9|||
126345844|NCT03416179|454560229|FG000|Overall Study|Lost to Follow-up|1|||
126345845|NCT03416179|454560230|FG001|Overall Study|Lost to Follow-up|1|||
126345846|NCT03416179|454560231|FG002|Overall Study|Lost to Follow-up|0|||
126345847|NCT03416179|454560232|FG003|Overall Study|Lost to Follow-up|3|||
126345848|NCT03416179|454560229|FG000|Overall Study|Study participation terminated by Sponsor|93|||
126345849|NCT03416179|454560230|FG001|Overall Study|Study participation terminated by Sponsor|91|||
126345850|NCT03416179|454560231|FG002|Overall Study|Study participation terminated by Sponsor|26|||
126345851|NCT03416179|454560232|FG003|Overall Study|Study participation terminated by Sponsor|31|||
126345852|NCT03416179|454560229|FG000|Overall Study|Other|2|||
126345853|NCT03416179|454560230|FG001|Overall Study|Other|3|||
126345854|NCT03416179|454560231|FG002|Overall Study|Other|1|||
126345855|NCT03416179|454560232|FG003|Overall Study|Other|0|||
126345856|NCT01682031|454560235|FG000|Overall Study|Withdrawal by Subject|0|||
126345857|NCT01682031|454560236|FG001|Overall Study|Withdrawal by Subject|1|||
126345858|NCT01682031|454560235|FG000|Overall Study|Adverse Event|0|||
126345859|NCT01682031|454560236|FG001|Overall Study|Adverse Event|2|||
126345860|NCT01682031|454560235|FG000|Overall Study|MRI results indicate increased nodul|0|||
126345861|NCT01682031|454560236|FG001|Overall Study|MRI results indicate increased nodul|1|||
126345862|NCT01682031|454560235|FG000|Overall Study|Patient could not swallow tablets|1|||
126345863|NCT01682031|454560236|FG001|Overall Study|Patient could not swallow tablets|0|||
126345864|NCT01682031|454560235|FG000|Overall Study|Patient stopped selenium on his own|0|||
126345865|NCT01682031|454560236|FG001|Overall Study|Patient stopped selenium on his own|1|||
126345866|NCT01056536|454560240|FG000|Overall Study|Lost to Follow-up|202|||
126345867|NCT01056536|454560241|FG001|Overall Study|Lost to Follow-up|116|||
126345868|NCT01056536|454560242|FG002|Overall Study|Lost to Follow-up|248|||
126345869|NCT00924898|454560243|FG000|Overall Study|Withdrawal by Subject|2|||
126345870|NCT03805841|454560244|FG000|Overall Study|Clinical Progression|2|||
126345871|NCT03805841|454560245|FG001|Overall Study|Clinical Progression|0|||
126345872|NCT03805841|454560246|FG002|Overall Study|Clinical Progression|0|||
126345873|NCT03805841|454560244|FG000|Overall Study|Death|0|||
126345874|NCT03805841|454560245|FG001|Overall Study|Death|3|||
126345875|NCT03805841|454560246|FG002|Overall Study|Death|1|||
126345876|NCT03805841|454560244|FG000|Overall Study|Lost to Follow-up|0|||
126345877|NCT03805841|454560245|FG001|Overall Study|Lost to Follow-up|0|||
126345878|NCT03805841|454560246|FG002|Overall Study|Lost to Follow-up|1|||
126345879|NCT03805841|454560244|FG000|Overall Study|Withdrawal by Subject|2|||
126345880|NCT03805841|454560245|FG001|Overall Study|Withdrawal by Subject|3|||
126345881|NCT03805841|454560246|FG002|Overall Study|Withdrawal by Subject|0|||
126345882|NCT03805841|454560244|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
126345883|NCT03805841|454560245|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
126345884|NCT03805841|454560246|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
126345885|NCT00846365|454560249|FG000|Overall Study|Adverse Event|20|||
126345886|NCT00846365|454560250|FG001|Overall Study|Adverse Event|30|||
126345887|NCT00846365|454560251|FG002|Overall Study|Adverse Event|11|||
126345888|NCT00846365|454560249|FG000|Overall Study|Protocol Violation|5|||
126345889|NCT00846365|454560250|FG001|Overall Study|Protocol Violation|4|||
126345890|NCT00846365|454560251|FG002|Overall Study|Protocol Violation|0|||
126345891|NCT00846365|454560249|FG000|Overall Study|Lost to Follow-up|8|||
126345892|NCT00846365|454560250|FG001|Overall Study|Lost to Follow-up|2|||
126345893|NCT00846365|454560251|FG002|Overall Study|Lost to Follow-up|5|||
126345894|NCT00846365|454560249|FG000|Overall Study|Withdrawal by Subject|11|||
126345895|NCT00846365|454560250|FG001|Overall Study|Withdrawal by Subject|11|||
126345896|NCT00846365|454560251|FG002|Overall Study|Withdrawal by Subject|9|||
126345897|NCT00846365|454560249|FG000|Overall Study|Pregnancy|1|||
126345898|NCT00846365|454560250|FG001|Overall Study|Pregnancy|0|||
126345899|NCT00846365|454560251|FG002|Overall Study|Pregnancy|0|||
126345900|NCT00846365|454560249|FG000|Overall Study|Lack of Efficacy|1|||
126345901|NCT00846365|454560250|FG001|Overall Study|Lack of Efficacy|1|||
126345902|NCT00846365|454560251|FG002|Overall Study|Lack of Efficacy|2|||
126345903|NCT00846365|454560249|FG000|Overall Study|Other|9|||
126345904|NCT00846365|454560250|FG001|Overall Study|Other|1|||
126345905|NCT00846365|454560251|FG002|Overall Study|Other|6|||
126345906|NCT01277861|454560255|FG000|Overall Study|Physician Decision|2|||
126345907|NCT01277861|454560256|FG001|Overall Study|Physician Decision|2|||
126345908|NCT00857389|454560257|FG000|Overall Study|Did not proceed to transplant|2|||
126345909|NCT01157845|454560258|FG000|Overall Study|Lost to Follow-up|5|||
126345910|NCT01157845|454560258|FG000|Overall Study|Withdrawal by Subject|12|||
126345911|NCT01157845|454560258|FG000|Overall Study|Physician Decision|3|||
126345912|NCT01157845|454560258|FG000|Overall Study|Protocol Violation|13|||
126345913|NCT01157845|454560258|FG000|Overall Study|Study was ended|1|||
126012392|NCT03621761|453338465|FG002|Overall Study|Withdrawal by Subject|1|||
126012393|NCT03621761|453338463|FG000|Overall Study|Became Ineligible|0|||
126012394|NCT03621761|453338464|FG001|Overall Study|Became Ineligible|2|||
126012395|NCT03621761|453338465|FG002|Overall Study|Became Ineligible|0|||
126012396|NCT00758602|453338471|FG000|Overall Study|Adverse Event|11|||
126012397|NCT00758602|453338472|FG001|Overall Study|Adverse Event|10|||
126012398|NCT00758602|453338471|FG000|Overall Study|Lost to Follow-up|4|||
126012399|NCT00758602|453338472|FG001|Overall Study|Lost to Follow-up|3|||
126012400|NCT00758602|453338471|FG000|Overall Study|Withdrawal by Subject|1|||
126012401|NCT00758602|453338472|FG001|Overall Study|Withdrawal by Subject|3|||
126012402|NCT00758602|453338471|FG000|Overall Study|Protocol Violation|0|||
126012403|NCT00758602|453338472|FG001|Overall Study|Protocol Violation|2|||
126012404|NCT00758602|453338471|FG000|Overall Study|Death|0|||
126012405|NCT00758602|453338472|FG001|Overall Study|Death|1|||
126012406|NCT00758602|453338471|FG000|Overall Study|Reason not specified|3|||
126012407|NCT00758602|453338472|FG001|Overall Study|Reason not specified|3|||
126012408|NCT03939819|453338473|FG000|Overall Study|Death|2|||
126012409|NCT03939819|453338474|FG001|Overall Study|Death|0|||
126012410|NCT01186848|453338475|FG000|Overall Study|Lost to Follow-up|4|||
126012411|NCT01186848|453338475|FG000|Overall Study|Withdrawal by Subject|2|||
126012412|NCT01186848|453338475|FG000|Overall Study|Adverse Event|2|||
126012413|NCT01183780|453338485|FG000|Overall Study|Withdrawal by Subject|25|||
126012414|NCT01183780|453338486|FG001|Overall Study|Withdrawal by Subject|14|||
126012415|NCT01183780|453338485|FG000|Overall Study|Lost to Follow-up|6|||
126012416|NCT01183780|453338486|FG001|Overall Study|Lost to Follow-up|11|||
126012417|NCT04379713|453338487|FG000|Overall Study|Adverse Event|2|||
126012418|NCT04379713|453338488|FG001|Overall Study|Adverse Event|0|||
126012419|NCT04379713|453338487|FG000|Overall Study|Physician Decision|2|||
126012420|NCT04379713|453338488|FG001|Overall Study|Physician Decision|1|||
126012421|NCT04379713|453338487|FG000|Overall Study|Protocol Violation|11|||
126012422|NCT04379713|453338488|FG001|Overall Study|Protocol Violation|6|||
126012423|NCT04379713|453338487|FG000|Overall Study|No longer met eligibility criteria|14|||
126012424|NCT04379713|453338488|FG001|Overall Study|No longer met eligibility criteria|11|||
126012425|NCT04379713|453338487|FG000|Overall Study|Withdrawal by parent/guardian|36|||
126012426|NCT04379713|453338488|FG001|Overall Study|Withdrawal by parent/guardian|15|||
126012427|NCT04379713|453338487|FG000|Overall Study|Lost to Follow-up|31|||
126012428|NCT04379713|453338488|FG001|Overall Study|Lost to Follow-up|21|||
126012429|NCT03808883|453338492|FG000|Overall Study|Withdrawal by Subject|2|||
126012430|NCT03808883|453338493|FG001|Overall Study|Withdrawal by Subject|0|||
126345914|NCT01157845|454560258|FG000|Overall Study|Device malfunction|1|||
126345915|NCT03311555|454560259|FG000|Overall Study|Adverse Event|1|||
126345916|NCT03454555|454562228|FG000|Overall Study|Death|6|||
126345917|NCT03454555|454562229|FG001|Overall Study|Death|6|||
126345918|NCT03454555|454562228|FG000|Overall Study|Lost to Follow-up|31|||
126345919|NCT03454555|454562229|FG001|Overall Study|Lost to Follow-up|12|||
126345920|NCT03454555|454562228|FG000|Overall Study|Physician Decision|2|||
126345921|NCT03454555|454562229|FG001|Overall Study|Physician Decision|6|||
126345922|NCT03454555|454562228|FG000|Overall Study|Withdrawal by Subject|34|||
126345923|NCT03454555|454562229|FG001|Overall Study|Withdrawal by Subject|5|||
126345924|NCT03454555|454562228|FG000|Overall Study|Ineligible|1|||
126345925|NCT03454555|454562229|FG001|Overall Study|Ineligible|5|||
126345926|NCT05399680|454562230|FG000|Overall Study|Lost to Follow-up|1|||
126345927|NCT05399680|454562231|FG001|Overall Study|Lost to Follow-up|0|||
126345928|NCT05399680|454562230|FG000|Overall Study|Death|0|||
126345929|NCT05399680|454562231|FG001|Overall Study|Death|1|||
126345930|NCT04530630|454562232|FG000|Overall Study|Physician Decision|1|||
126345931|NCT03737994|454562235|FG000|Overall Study|Withdrawal by Subject|0|||
126345932|NCT03737994|454562236|FG001|Overall Study|Withdrawal by Subject|0|||
126345933|NCT03737994|454562237|FG002|Overall Study|Withdrawal by Subject|0|||
126345934|NCT03737994|454562238|FG003|Overall Study|Withdrawal by Subject|0|||
126345935|NCT03737994|454562239|FG004|Overall Study|Withdrawal by Subject|0|||
126345936|NCT03737994|454562240|FG005|Overall Study|Withdrawal by Subject|0|||
126345937|NCT03737994|454562241|FG006|Overall Study|Withdrawal by Subject|1|||
126345938|NCT01473134|454562242|FG000|Overall Study|Lost to Follow-up|21|||
126345939|NCT01473134|454562243|FG001|Overall Study|Lost to Follow-up|13|||
126345940|NCT01473134|454562242|FG000|Overall Study|Protocol Violation|32|||
126012431|NCT03808883|453338492|FG000|Overall Study|Did not complete pre test or post test survey|4|||
126012432|NCT03808883|453338493|FG001|Overall Study|Did not complete pre test or post test survey|3|||
126012433|NCT00158054|453338495|FG000|Overall Study|Refused to continue|3|||
126012434|NCT00158054|453338496|FG001|Overall Study|Refused to continue|0|||
126012435|NCT00158054|453338495|FG000|Overall Study|Unavailable for follow up|7|||
126012436|NCT00158054|453338496|FG001|Overall Study|Unavailable for follow up|3|||
126012437|NCT00079183|453338512|FG000|Overall Study|Withdrawal by Subject|4|||
126012438|NCT00079183|453338512|FG000|Overall Study|Study medication non-compliance|2|||
126012439|NCT00079183|453338512|FG000|Overall Study|Specimen collection non-compliance|1|||
126345941|NCT01473134|454562243|FG001|Overall Study|Protocol Violation|19|||
126345942|NCT01473134|454562242|FG000|Overall Study|Withdrawal by Subject|1|||
126012440|NCT04567888|453338513|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
126012441|NCT04567888|453338514|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
126012442|NCT04567888|453338513|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
126012443|NCT04567888|453338514|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
126012444|NCT04567888|453338513|FG000|Overall Study|Reported Unusual Birth Year|2|||
126012445|NCT04567888|453338514|FG001|Overall Study|Reported Unusual Birth Year|3|||
126012446|NCT04567888|453338513|FG000|Overall Study|Duplicate Responses|0|||
126012447|NCT04567888|453338514|FG001|Overall Study|Duplicate Responses|1|||
126012448|NCT02613364|453338516|FG000|Overall Study|Other|19|||
126012449|NCT02613364|453338517|FG001|Overall Study|Other|29|||
126012450|NCT02613364|453338518|FG002|Overall Study|Other|17|||
126012451|NCT02613364|453338516|FG000|Overall Study|Too time consuming|21|||
126012452|NCT02613364|453338517|FG001|Overall Study|Too time consuming|26|||
126012453|NCT02613364|453338518|FG002|Overall Study|Too time consuming|26|||
126012454|NCT02613364|453338516|FG000|Overall Study|Withdrawal by Subject|13|||
126012455|NCT02613364|453338517|FG001|Overall Study|Withdrawal by Subject|18|||
126012456|NCT02613364|453338518|FG002|Overall Study|Withdrawal by Subject|17|||
126012457|NCT02613364|453338516|FG000|Overall Study|Medical|12|||
126012458|NCT02613364|453338517|FG001|Overall Study|Medical|13|||
126012459|NCT02613364|453338518|FG002|Overall Study|Medical|9|||
126012460|NCT02613364|453338516|FG000|Overall Study|Disliked Study Procedure|1|||
126012461|NCT02613364|453338517|FG001|Overall Study|Disliked Study Procedure|1|||
126012462|NCT02613364|453338518|FG002|Overall Study|Disliked Study Procedure|4|||
126012463|NCT02613364|453338516|FG000|Overall Study|Disliked Intervention|0|||
126012464|NCT02613364|453338517|FG001|Overall Study|Disliked Intervention|3|||
126012465|NCT02613364|453338518|FG002|Overall Study|Disliked Intervention|3|||
126209532|NCT03110107|454055411|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
126209533|NCT03110107|454055412|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
126209534|NCT03110107|454055413|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
126209535|NCT03110107|454055414|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
126209536|NCT03110107|454055415|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
126209537|NCT03110107|454055416|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
126209538|NCT03110107|454055417|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
126209539|NCT03110107|454055418|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
126209540|NCT03110107|454055393|FG000|Treatment Period|Participant withdrew consent|0|||
126209541|NCT03110107|454055394|FG001|Treatment Period|Participant withdrew consent|0|||
126209542|NCT03110107|454055395|FG002|Treatment Period|Participant withdrew consent|1|||
126209543|NCT03110107|454055396|FG003|Treatment Period|Participant withdrew consent|0|||
126209544|NCT03110107|454055397|FG004|Treatment Period|Participant withdrew consent|4|||
126209545|NCT03110107|454055398|FG005|Treatment Period|Participant withdrew consent|3|||
126209546|NCT03110107|454055399|FG006|Treatment Period|Participant withdrew consent|0|||
126209547|NCT03110107|454055400|FG007|Treatment Period|Participant withdrew consent|0|||
126209548|NCT03110107|454055401|FG008|Treatment Period|Participant withdrew consent|0|||
126209549|NCT03110107|454055402|FG009|Treatment Period|Participant withdrew consent|1|||
126209550|NCT03110107|454055403|FG010|Treatment Period|Participant withdrew consent|0|||
126209551|NCT03110107|454055404|FG011|Treatment Period|Participant withdrew consent|0|||
126209552|NCT03110107|454055405|FG012|Treatment Period|Participant withdrew consent|0|||
126209553|NCT03110107|454055406|FG013|Treatment Period|Participant withdrew consent|0|||
126209554|NCT03110107|454055407|FG014|Treatment Period|Participant withdrew consent|0|||
126209555|NCT03110107|454055408|FG015|Treatment Period|Participant withdrew consent|0|||
126209556|NCT03110107|454055409|FG016|Treatment Period|Participant withdrew consent|0|||
126209557|NCT03110107|454055410|FG017|Treatment Period|Participant withdrew consent|0|||
126209558|NCT03110107|454055411|FG018|Treatment Period|Participant withdrew consent|0|||
126209559|NCT03110107|454055412|FG019|Treatment Period|Participant withdrew consent|1|||
126209560|NCT03110107|454055413|FG020|Treatment Period|Participant withdrew consent|0|||
126209561|NCT03110107|454055414|FG021|Treatment Period|Participant withdrew consent|2|||
126209562|NCT03110107|454055415|FG022|Treatment Period|Participant withdrew consent|0|||
126209563|NCT03110107|454055416|FG023|Treatment Period|Participant withdrew consent|0|||
126209564|NCT03110107|454055417|FG024|Treatment Period|Participant withdrew consent|0|||
126209565|NCT03110107|454055418|FG025|Treatment Period|Participant withdrew consent|2|||
126209566|NCT03110107|454055393|FG000|Treatment Period|Participants no longer meets study criteria|0|||
126209567|NCT03110107|454055394|FG001|Treatment Period|Participants no longer meets study criteria|0|||
126209568|NCT03110107|454055395|FG002|Treatment Period|Participants no longer meets study criteria|0|||
126209569|NCT03110107|454055396|FG003|Treatment Period|Participants no longer meets study criteria|0|||
126209570|NCT03110107|454055397|FG004|Treatment Period|Participants no longer meets study criteria|0|||
126209571|NCT03110107|454055398|FG005|Treatment Period|Participants no longer meets study criteria|0|||
126209572|NCT03110107|454055399|FG006|Treatment Period|Participants no longer meets study criteria|0|||
126209573|NCT03110107|454055400|FG007|Treatment Period|Participants no longer meets study criteria|0|||
126209574|NCT03110107|454055401|FG008|Treatment Period|Participants no longer meets study criteria|0|||
126209575|NCT03110107|454055402|FG009|Treatment Period|Participants no longer meets study criteria|0|||
126345943|NCT01473134|454562243|FG001|Overall Study|Withdrawal by Subject|2|||
126345944|NCT01473134|454562242|FG000|Overall Study|Death|0|||
126345945|NCT01473134|454562243|FG001|Overall Study|Death|1|||
126345946|NCT01473134|454562242|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
126369375|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
126012466|NCT00436644|453338519|FG000|Overall Study|Adverse Event|2|||
126012467|NCT00436644|453338519|FG000|Overall Study|Death|1|||
126012468|NCT01490580|453338520|FG000|Overall Study|Parents withdrew consent|0|||
126012469|NCT01490580|453338521|FG001|Overall Study|Parents withdrew consent|2|||
126012470|NCT00371566|453338525|FG000|Treatment Phase|Withdrawal by Subject|0|||
126012471|NCT00371566|453338526|FG001|Treatment Phase|Withdrawal by Subject|1|||
126012472|NCT00371566|453338525|FG000|Treatment Phase|Adverse Event|0|||
126012473|NCT00371566|453338526|FG001|Treatment Phase|Adverse Event|1|||
126012474|NCT00371566|453338525|FG000|Treatment Phase|Protocol Violation|0|||
126012475|NCT00371566|453338526|FG001|Treatment Phase|Protocol Violation|1|||
126012476|NCT00371566|453338525|FG000|Chemoradiation Phase|Physician Decision|2|||
126012477|NCT00371566|453338526|FG001|Chemoradiation Phase|Physician Decision|0|||
126012478|NCT00371566|453338525|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
126012479|NCT00371566|453338526|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
126012480|NCT00371566|453338525|FG000|Chemoradiation Phase|Non compliant|0|||
126012481|NCT00371566|453338526|FG001|Chemoradiation Phase|Non compliant|1|||
126012482|NCT00371566|453338525|FG000|Chemoradiation Phase|Progressive Disease|1|||
126012483|NCT00371566|453338526|FG001|Chemoradiation Phase|Progressive Disease|1|||
126012484|NCT00371566|453338525|FG000|Chemoradiation Phase|Death|2|||
126012485|NCT00371566|453338526|FG001|Chemoradiation Phase|Death|0|||
126209576|NCT03110107|454055403|FG010|Treatment Period|Participants no longer meets study criteria|0|||
126209577|NCT03110107|454055404|FG011|Treatment Period|Participants no longer meets study criteria|0|||
126209578|NCT03110107|454055405|FG012|Treatment Period|Participants no longer meets study criteria|0|||
126209579|NCT03110107|454055406|FG013|Treatment Period|Participants no longer meets study criteria|0|||
126209580|NCT03110107|454055407|FG014|Treatment Period|Participants no longer meets study criteria|0|||
126209581|NCT03110107|454055408|FG015|Treatment Period|Participants no longer meets study criteria|0|||
126209582|NCT03110107|454055409|FG016|Treatment Period|Participants no longer meets study criteria|0|||
126209583|NCT03110107|454055410|FG017|Treatment Period|Participants no longer meets study criteria|0|||
126209584|NCT03110107|454055411|FG018|Treatment Period|Participants no longer meets study criteria|0|||
126209585|NCT03110107|454055412|FG019|Treatment Period|Participants no longer meets study criteria|0|||
126209586|NCT03110107|454055413|FG020|Treatment Period|Participants no longer meets study criteria|0|||
126209587|NCT03110107|454055414|FG021|Treatment Period|Participants no longer meets study criteria|0|||
126209588|NCT03110107|454055415|FG022|Treatment Period|Participants no longer meets study criteria|0|||
126209589|NCT03110107|454055416|FG023|Treatment Period|Participants no longer meets study criteria|1|||
126209590|NCT03110107|454055417|FG024|Treatment Period|Participants no longer meets study criteria|0|||
126209591|NCT03110107|454055418|FG025|Treatment Period|Participants no longer meets study criteria|0|||
126209592|NCT03110107|454055393|FG000|Treatment Period|Other Reasons|0|||
126209593|NCT03110107|454055394|FG001|Treatment Period|Other Reasons|0|||
126209594|NCT03110107|454055395|FG002|Treatment Period|Other Reasons|1|||
126209595|NCT03110107|454055396|FG003|Treatment Period|Other Reasons|1|||
126209596|NCT03110107|454055397|FG004|Treatment Period|Other Reasons|0|||
126209597|NCT03110107|454055398|FG005|Treatment Period|Other Reasons|1|||
126209598|NCT03110107|454055399|FG006|Treatment Period|Other Reasons|0|||
126209599|NCT03110107|454055400|FG007|Treatment Period|Other Reasons|0|||
126209600|NCT03110107|454055401|FG008|Treatment Period|Other Reasons|0|||
126209601|NCT03110107|454055402|FG009|Treatment Period|Other Reasons|0|||
126209602|NCT03110107|454055403|FG010|Treatment Period|Other Reasons|0|||
126209603|NCT03110107|454055404|FG011|Treatment Period|Other Reasons|0|||
126209604|NCT03110107|454055405|FG012|Treatment Period|Other Reasons|0|||
126209605|NCT03110107|454055406|FG013|Treatment Period|Other Reasons|0|||
126209606|NCT03110107|454055407|FG014|Treatment Period|Other Reasons|0|||
126209607|NCT03110107|454055408|FG015|Treatment Period|Other Reasons|0|||
126209608|NCT03110107|454055409|FG016|Treatment Period|Other Reasons|0|||
126209609|NCT03110107|454055410|FG017|Treatment Period|Other Reasons|0|||
126209610|NCT03110107|454055411|FG018|Treatment Period|Other Reasons|0|||
126209611|NCT03110107|454055412|FG019|Treatment Period|Other Reasons|0|||
126209612|NCT03110107|454055413|FG020|Treatment Period|Other Reasons|0|||
126209613|NCT03110107|454055414|FG021|Treatment Period|Other Reasons|0|||
126209614|NCT03110107|454055415|FG022|Treatment Period|Other Reasons|0|||
126209615|NCT03110107|454055416|FG023|Treatment Period|Other Reasons|0|||
126209616|NCT03110107|454055417|FG024|Treatment Period|Other Reasons|1|||
126209617|NCT03110107|454055418|FG025|Treatment Period|Other Reasons|0|||
126209618|NCT03526549|454055420|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
126209619|NCT03526549|454055421|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
126012486|NCT00371566|453338525|FG000|Follow Up Phase|Death|0|||
126012487|NCT00371566|453338526|FG001|Follow Up Phase|Death|5|||
126012488|NCT00371566|453338525|FG000|Follow Up Phase|Disease progression|1|||
126012489|NCT00371566|453338526|FG001|Follow Up Phase|Disease progression|0|||
126012490|NCT00371566|453338525|FG000|Follow Up Phase|Withdrawal by Subject|0|||
126012491|NCT00371566|453338526|FG001|Follow Up Phase|Withdrawal by Subject|1|||
126012492|NCT00371566|453338525|FG000|Follow Up Phase|Physician Decision|1|||
126012493|NCT00371566|453338526|FG001|Follow Up Phase|Physician Decision|1|||
126012494|NCT00371566|453338525|FG000|Follow Up Phase|Lost to Follow-up|1|||
126012495|NCT00371566|453338526|FG001|Follow Up Phase|Lost to Follow-up|0|||
126012496|NCT00878722|453338527|FG000|Overall Study|Progressive disease|3|||
126012497|NCT00878722|453338528|FG001|Overall Study|Progressive disease|3|||
126012498|NCT00878722|453338529|FG002|Overall Study|Progressive disease|3|||
126012499|NCT00878722|453338530|FG003|Overall Study|Progressive disease|7|||
126012500|NCT00878722|453338531|FG004|Overall Study|Progressive disease|7|||
126012501|NCT00878722|453338532|FG005|Overall Study|Progressive disease|1|||
126012502|NCT00878722|453338533|FG006|Overall Study|Progressive disease|4|||
126012503|NCT00878722|453338534|FG007|Overall Study|Progressive disease|3|||
126012504|NCT00878722|453338527|FG000|Overall Study|Death|0|||
126012505|NCT00878722|453338528|FG001|Overall Study|Death|0|||
126012506|NCT00878722|453338529|FG002|Overall Study|Death|0|||
126012507|NCT00878722|453338530|FG003|Overall Study|Death|1|||
126012508|NCT00878722|453338531|FG004|Overall Study|Death|0|||
126012509|NCT00878722|453338532|FG005|Overall Study|Death|1|||
126012510|NCT00878722|453338533|FG006|Overall Study|Death|0|||
126012511|NCT00878722|453338534|FG007|Overall Study|Death|2|||
126209620|NCT03526549|454055420|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
126209621|NCT03526549|454055421|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
126012512|NCT00878722|453338527|FG000|Overall Study|Adverse Event|0|||
126012513|NCT00878722|453338528|FG001|Overall Study|Adverse Event|0|||
126345947|NCT01473134|454562243|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
126345948|NCT06217380|454562246|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
126345949|NCT06217380|454562246|FG000|Overall Study|Physician Decision|1|||
126345950|NCT06217380|454562246|FG000|Overall Study|Withdrawal by Subject|2|||
126345951|NCT06633965|454562247|FG000|Overall Study|Withdrawal by Subject|0|||
126345952|NCT06633965|454562248|FG001|Overall Study|Withdrawal by Subject|1|||
126345953|NCT00947544|454562251|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
126345954|NCT00947544|454562252|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
126345955|NCT01963611|454562260|FG000|Overall Study|Adverse Event|1|||
126345956|NCT01963611|454562261|FG001|Overall Study|Adverse Event|1|||
126345957|NCT01963611|454562262|FG002|Overall Study|Adverse Event|3|||
126345958|NCT01963611|454562263|FG003|Overall Study|Adverse Event|4|||
126345959|NCT01963611|454562264|FG004|Overall Study|Adverse Event|3|||
126345960|NCT01963611|454562260|FG000|Overall Study|Protocol Violation|0|||
126345961|NCT01963611|454562261|FG001|Overall Study|Protocol Violation|0|||
126345962|NCT01963611|454562262|FG002|Overall Study|Protocol Violation|0|||
126345963|NCT01963611|454562263|FG003|Overall Study|Protocol Violation|1|||
126345964|NCT01963611|454562264|FG004|Overall Study|Protocol Violation|0|||
126345965|NCT01963611|454562260|FG000|Overall Study|Lack of Efficacy|0|||
126345966|NCT01963611|454562261|FG001|Overall Study|Lack of Efficacy|0|||
126345967|NCT01963611|454562262|FG002|Overall Study|Lack of Efficacy|0|||
126345968|NCT01963611|454562263|FG003|Overall Study|Lack of Efficacy|1|||
126345969|NCT01963611|454562264|FG004|Overall Study|Lack of Efficacy|0|||
126345970|NCT01963611|454562260|FG000|Overall Study|Withdrawal by Subject|3|||
126012514|NCT00878722|453338529|FG002|Overall Study|Adverse Event|0|||
126012515|NCT00878722|453338530|FG003|Overall Study|Adverse Event|0|||
126012516|NCT00878722|453338531|FG004|Overall Study|Adverse Event|0|||
126012517|NCT00878722|453338532|FG005|Overall Study|Adverse Event|0|||
126012518|NCT00878722|453338533|FG006|Overall Study|Adverse Event|2|||
126012519|NCT00878722|453338534|FG007|Overall Study|Adverse Event|0|||
126012520|NCT00878722|453338527|FG000|Overall Study|Withdrawal by Subject|0|||
126012521|NCT00878722|453338528|FG001|Overall Study|Withdrawal by Subject|0|||
126012522|NCT00878722|453338529|FG002|Overall Study|Withdrawal by Subject|0|||
126012523|NCT00878722|453338530|FG003|Overall Study|Withdrawal by Subject|0|||
126012524|NCT00878722|453338531|FG004|Overall Study|Withdrawal by Subject|0|||
126012525|NCT00878722|453338532|FG005|Overall Study|Withdrawal by Subject|0|||
126012526|NCT00878722|453338533|FG006|Overall Study|Withdrawal by Subject|0|||
126012527|NCT00878722|453338534|FG007|Overall Study|Withdrawal by Subject|2|||
126012528|NCT00878722|453338527|FG000|Overall Study|Relapse|0|||
126012529|NCT00878722|453338528|FG001|Overall Study|Relapse|0|||
126012530|NCT00878722|453338529|FG002|Overall Study|Relapse|0|||
126012531|NCT00878722|453338530|FG003|Overall Study|Relapse|1|||
126012532|NCT00878722|453338531|FG004|Overall Study|Relapse|0|||
126012533|NCT00878722|453338532|FG005|Overall Study|Relapse|0|||
126012534|NCT00878722|453338533|FG006|Overall Study|Relapse|0|||
126012535|NCT00878722|453338534|FG007|Overall Study|Relapse|0|||
126012536|NCT00949975|453338535|FG000|Overall Study|Voluntary discontinuation|6|||
126012537|NCT00949975|453338536|FG001|Overall Study|Voluntary discontinuation|5|||
126012538|NCT00949975|453338537|FG002|Overall Study|Voluntary discontinuation|3|||
126012539|NCT00949975|453338538|FG003|Overall Study|Voluntary discontinuation|6|||
126012540|NCT00949975|453338535|FG000|Overall Study|Adverse Event|11|||
126012541|NCT00949975|453338536|FG001|Overall Study|Adverse Event|11|||
126012542|NCT00949975|453338537|FG002|Overall Study|Adverse Event|10|||
126012543|NCT00949975|453338538|FG003|Overall Study|Adverse Event|10|||
126012544|NCT00949975|453338535|FG000|Overall Study|Safety reason|0|||
126012545|NCT00949975|453338536|FG001|Overall Study|Safety reason|1|||
126012546|NCT00949975|453338537|FG002|Overall Study|Safety reason|0|||
126012547|NCT00949975|453338538|FG003|Overall Study|Safety reason|0|||
126012548|NCT00949975|453338535|FG000|Overall Study|Study-specific criteria|0|||
126012549|NCT00949975|453338536|FG001|Overall Study|Study-specific criteria|1|||
126012550|NCT00949975|453338537|FG002|Overall Study|Study-specific criteria|1|||
126012551|NCT00949975|453338538|FG003|Overall Study|Study-specific criteria|0|||
126012552|NCT00949975|453338535|FG000|Overall Study|Incorrect enrolment|5|||
126012553|NCT00949975|453338536|FG001|Overall Study|Incorrect enrolment|10|||
126012554|NCT00949975|453338537|FG002|Overall Study|Incorrect enrolment|4|||
126012555|NCT00949975|453338538|FG003|Overall Study|Incorrect enrolment|7|||
126012556|NCT00949975|453338535|FG000|Overall Study|Severe non-compliance|3|||
126012557|NCT00949975|453338536|FG001|Overall Study|Severe non-compliance|1|||
126012558|NCT00949975|453338537|FG002|Overall Study|Severe non-compliance|0|||
126012559|NCT00949975|453338538|FG003|Overall Study|Severe non-compliance|2|||
126345971|NCT01963611|454562261|FG001|Overall Study|Withdrawal by Subject|2|||
126345972|NCT01963611|454562262|FG002|Overall Study|Withdrawal by Subject|1|||
126345973|NCT01963611|454562263|FG003|Overall Study|Withdrawal by Subject|1|||
126345974|NCT01963611|454562264|FG004|Overall Study|Withdrawal by Subject|3|||
126012560|NCT00949975|453338535|FG000|Overall Study|Lost to Follow-up|1|||
126012561|NCT00949975|453338536|FG001|Overall Study|Lost to Follow-up|0|||
126012562|NCT00949975|453338537|FG002|Overall Study|Lost to Follow-up|1|||
126345975|NCT01963611|454562260|FG000|Overall Study|Other|47|||
126012563|NCT00949975|453338538|FG003|Overall Study|Lost to Follow-up|3|||
126012564|NCT00949975|453338535|FG000|Overall Study|Other|1|||
126012565|NCT00949975|453338536|FG001|Overall Study|Other|0|||
126012566|NCT00949975|453338537|FG002|Overall Study|Other|0|||
126012567|NCT00949975|453338538|FG003|Overall Study|Other|0|||
126012568|NCT02873754|453338539|FG000|Overall Study|Lost to Follow-up|5|||
126209622|NCT03526549|454055420|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
126209623|NCT03526549|454055421|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
126209624|NCT03526549|454055420|FG000|Open-label Phase|Adverse Event|4|||
126209625|NCT03526549|454055421|FG001|Open-label Phase|Adverse Event|0|||
126209626|NCT03526549|454055420|FG000|Open-label Phase|Withdrawal by Subject|54|||
126209627|NCT03526549|454055421|FG001|Open-label Phase|Withdrawal by Subject|0|||
126209628|NCT03526549|454055420|FG000|Open-label Phase|Lost to Follow-up|35|||
126209629|NCT03526549|454055421|FG001|Open-label Phase|Lost to Follow-up|0|||
126209630|NCT03526549|454055420|FG000|Open-label Phase|Other than Specified|5|||
126012569|NCT02873754|453338539|FG000|Overall Study|Couldn't complete study procedures|1|||
126209631|NCT03526549|454055421|FG001|Open-label Phase|Other than Specified|0|||
126209632|NCT05981365|454055428|FG000|Period 1|Adverse Event|1|||
126012570|NCT00972504|453338540|FG000|Overall Study|Adverse Event|2|||
126012571|NCT00972504|453338540|FG000|Overall Study|Investigator discretion|1|||
126209633|NCT05981365|454055429|FG001|Period 1|Adverse Event|0|||
126209634|NCT04780776|454055430|FG000|Titration Week 1-5|Lost to Follow-up|2|||
126209635|NCT04780776|454055431|FG001|Titration Week 1-5|Lost to Follow-up|8|||
126209636|NCT04780776|454055430|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
126209637|NCT04780776|454055431|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
126209638|NCT04780776|454055430|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
126345976|NCT01963611|454562261|FG001|Overall Study|Other|46|||
126345977|NCT01963611|454562262|FG002|Overall Study|Other|48|||
126345978|NCT01963611|454562263|FG003|Overall Study|Other|45|||
126345979|NCT01963611|454562264|FG004|Overall Study|Other|45|||
126345980|NCT01126424|454562265|FG000|Overall Study|Adverse Event|0|||
126345981|NCT01126424|454562266|FG001|Overall Study|Adverse Event|0|||
126345982|NCT01126424|454562267|FG002|Overall Study|Adverse Event|0|||
126345983|NCT01126424|454562268|FG003|Overall Study|Adverse Event|0|||
126345984|NCT01126424|454562269|FG004|Overall Study|Adverse Event|1|||
126345985|NCT01126424|454562270|FG005|Overall Study|Adverse Event|0|||
126345986|NCT01126424|454562265|FG000|Overall Study|Withdrawal by Subject|0|||
126345987|NCT01126424|454562266|FG001|Overall Study|Withdrawal by Subject|0|||
126345988|NCT01126424|454562267|FG002|Overall Study|Withdrawal by Subject|1|||
126345989|NCT01126424|454562268|FG003|Overall Study|Withdrawal by Subject|3|||
126345990|NCT01126424|454562269|FG004|Overall Study|Withdrawal by Subject|1|||
126345991|NCT01126424|454562270|FG005|Overall Study|Withdrawal by Subject|0|||
126345992|NCT03801252|454562272|FG000|Overall Study|Protocol Violation|1|||
126345993|NCT03801252|454562273|FG001|Overall Study|Protocol Violation|2|||
126345994|NCT01134042|454562274|FG000|Overall Study|Adverse Event|3|||
126345995|NCT01134042|454562275|FG001|Overall Study|Adverse Event|7|||
126345996|NCT01134042|454562276|FG002|Overall Study|Adverse Event|2|||
126345997|NCT01134042|454562274|FG000|Overall Study|Lack of Efficacy|21|||
126345998|NCT01134042|454562275|FG001|Overall Study|Lack of Efficacy|6|||
126345999|NCT01134042|454562276|FG002|Overall Study|Lack of Efficacy|18|||
126346000|NCT01134042|454562274|FG000|Overall Study|Protocol Violation|5|||
126346001|NCT01134042|454562275|FG001|Overall Study|Protocol Violation|3|||
126346002|NCT01134042|454562276|FG002|Overall Study|Protocol Violation|5|||
126346003|NCT01134042|454562274|FG000|Overall Study|Lost to Follow-up|2|||
126346004|NCT01134042|454562275|FG001|Overall Study|Lost to Follow-up|0|||
126346005|NCT01134042|454562276|FG002|Overall Study|Lost to Follow-up|1|||
126346006|NCT01134042|454562274|FG000|Overall Study|Physician Decision|4|||
126346007|NCT01134042|454562275|FG001|Overall Study|Physician Decision|8|||
126346008|NCT01134042|454562276|FG002|Overall Study|Physician Decision|1|||
126346009|NCT01134042|454562274|FG000|Overall Study|Withdrawal by Subject|13|||
126346010|NCT01134042|454562275|FG001|Overall Study|Withdrawal by Subject|4|||
126346011|NCT01134042|454562276|FG002|Overall Study|Withdrawal by Subject|7|||
126346012|NCT00393367|454562277|FG000|Overall Study|Protocol Violation|2|||
126346013|NCT00393367|454562278|FG001|Overall Study|Protocol Violation|5|||
126346014|NCT00393367|454562277|FG000|Overall Study|Withdrawal by Subject|0|||
126346015|NCT00393367|454562278|FG001|Overall Study|Withdrawal by Subject|2|||
126346016|NCT03286504|454562279|FG000|Overall Study|Lost to Follow-up|19|||
126346017|NCT03286504|454562280|FG001|Overall Study|Lost to Follow-up|16|||
126346018|NCT01432327|454562281|FG000|Posttest 3 Months|depression|3|||
126346019|NCT01432327|454562282|FG001|Posttest 3 Months|depression|0|||
126346020|NCT01432327|454562283|FG002|Posttest 3 Months|depression|0|||
126346021|NCT01432327|454562284|FG003|Posttest 3 Months|depression|0|||
126346022|NCT01432327|454562281|FG000|Posttest 3 Months|Lost to Follow-up|1|||
126346023|NCT01432327|454562282|FG001|Posttest 3 Months|Lost to Follow-up|0|||
126346024|NCT01432327|454562283|FG002|Posttest 3 Months|Lost to Follow-up|2|||
126346025|NCT01432327|454562284|FG003|Posttest 3 Months|Lost to Follow-up|1|||
126346026|NCT01432327|454562281|FG000|Posttest 3 Months|Allergic reaction|0|||
126346027|NCT01432327|454562282|FG001|Posttest 3 Months|Allergic reaction|2|||
126346028|NCT01432327|454562283|FG002|Posttest 3 Months|Allergic reaction|0|||
126346029|NCT01432327|454562284|FG003|Posttest 3 Months|Allergic reaction|0|||
126209639|NCT04780776|454055431|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
126346030|NCT01432327|454562281|FG000|Posttest 6 Months|Lost to Follow-up|0|||
126346031|NCT01432327|454562282|FG001|Posttest 6 Months|Lost to Follow-up|0|||
126346032|NCT01432327|454562283|FG002|Posttest 6 Months|Lost to Follow-up|3|||
126346033|NCT01432327|454562284|FG003|Posttest 6 Months|Lost to Follow-up|2|||
126346034|NCT01432327|454562281|FG000|Posttest 6 Months|Allergic reaction|0|||
126346035|NCT01432327|454562282|FG001|Posttest 6 Months|Allergic reaction|0|||
126346036|NCT01432327|454562283|FG002|Posttest 6 Months|Allergic reaction|1|||
126346037|NCT01432327|454562284|FG003|Posttest 6 Months|Allergic reaction|0|||
126346038|NCT01432327|454562281|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
126346039|NCT01432327|454562282|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
126346040|NCT01432327|454562283|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
126346041|NCT01432327|454562284|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
126346042|NCT01432327|454562281|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
126346043|NCT01432327|454562282|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
126346044|NCT01432327|454562283|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
126346045|NCT01432327|454562284|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
126346046|NCT01432327|454562281|FG000|Posttest 1 Year|Lost to Follow-up|0|||
126209640|NCT03113760|454055432|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
126209641|NCT03113760|454055433|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
126209642|NCT03113760|454055434|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
126209643|NCT03113760|454055435|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
126209644|NCT03113760|454055432|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
126209645|NCT03113760|454055433|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
126209646|NCT03113760|454055434|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
126209647|NCT03113760|454055435|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
126209648|NCT03113760|454055432|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
126209649|NCT03113760|454055433|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
126209650|NCT03113760|454055434|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
126209651|NCT03113760|454055435|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
126209652|NCT03927989|454055436|FG000|Overall Study|Withdrawal by Subject|0|||
126209653|NCT03927989|454055437|FG001|Overall Study|Withdrawal by Subject|1|||
126209654|NCT01012609|454055443|FG000|Overall Study|Withdrawal by Subject|1|||
126012572|NCT03386929|453338549|FG000|Overall Study|Death|0|||
126012573|NCT03386929|453338550|FG001|Overall Study|Death|0|||
126012574|NCT03386929|453338551|FG002|Overall Study|Death|1|||
126012575|NCT03386929|453338549|FG000|Overall Study|Withdrawal by Subject|0|||
126012576|NCT03386929|453338550|FG001|Overall Study|Withdrawal by Subject|1|||
126012577|NCT03386929|453338551|FG002|Overall Study|Withdrawal by Subject|0|||
126012578|NCT03386929|453338549|FG000|Overall Study|Physician Decision|0|||
126012579|NCT03386929|453338550|FG001|Overall Study|Physician Decision|0|||
126012580|NCT03386929|453338551|FG002|Overall Study|Physician Decision|1|||
126012581|NCT03386929|453338549|FG000|Overall Study|Progression|4|||
126012582|NCT03386929|453338550|FG001|Overall Study|Progression|4|||
126012583|NCT03386929|453338551|FG002|Overall Study|Progression|0|||
126012584|NCT03386929|453338549|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
126012585|NCT03386929|453338550|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
126012586|NCT03386929|453338551|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
126012587|NCT03386929|453338549|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
126012588|NCT03386929|453338550|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
126012589|NCT03386929|453338551|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
126012590|NCT01123083|453338554|FG000|Overall Study|Investigator recommendation|1|||
126012591|NCT01123083|453338555|FG001|Overall Study|Investigator recommendation|1|||
126012592|NCT01123083|453338554|FG000|Overall Study|Administrative reasons|0|||
126012593|NCT01123083|453338555|FG001|Overall Study|Administrative reasons|4|||
126012594|NCT01123083|453338554|FG000|Overall Study|Lost to Follow-up|2|||
126209655|NCT01012609|454055444|FG001|Overall Study|Withdrawal by Subject|1|||
126209656|NCT01453296|454055445|FG000|Treatment Period 1|Adverse Event|0|||
126209657|NCT01453296|454055446|FG001|Treatment Period 1|Adverse Event|1|||
126209658|NCT01453296|454055445|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
126209659|NCT01453296|454055446|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
126209660|NCT01453296|454055445|FG000|Treatment Period 2|Adverse Event|1|||
126209661|NCT01453296|454055446|FG001|Treatment Period 2|Adverse Event|0|||
126209662|NCT01453296|454055445|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126209663|NCT01453296|454055446|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126209664|NCT03557775|454055447|FG000|Overall Study|Withdrawal by Subject|1|||
126209665|NCT03557775|454055448|FG001|Overall Study|Withdrawal by Subject|2|||
126209666|NCT03557775|454055449|FG002|Overall Study|Withdrawal by Subject|4|||
126209667|NCT03557775|454055447|FG000|Overall Study|Physician Decision|0|||
126209668|NCT03557775|454055448|FG001|Overall Study|Physician Decision|1|||
126209669|NCT03557775|454055449|FG002|Overall Study|Physician Decision|0|||
126209670|NCT03426995|454055457|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209671|NCT03426995|454055458|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209672|NCT03426995|454055459|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
126209673|NCT03426995|454055460|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209674|NCT03426995|454055461|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209675|NCT03426995|454055462|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209676|NCT03426995|454055463|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126346047|NCT01432327|454562282|FG001|Posttest 1 Year|Lost to Follow-up|0|||
126346048|NCT01432327|454562283|FG002|Posttest 1 Year|Lost to Follow-up|4|||
126346049|NCT01432327|454562284|FG003|Posttest 1 Year|Lost to Follow-up|2|||
126346050|NCT01432327|454562281|FG000|Posttest 1 Year|Allergic reaction|0|||
126346051|NCT01432327|454562282|FG001|Posttest 1 Year|Allergic reaction|0|||
126346052|NCT01432327|454562283|FG002|Posttest 1 Year|Allergic reaction|1|||
126346053|NCT01432327|454562284|FG003|Posttest 1 Year|Allergic reaction|1|||
126346054|NCT02030600|454562289|FG000|Treatment Period 1|Adverse Event|5|||
126346055|NCT02030600|454562290|FG001|Treatment Period 1|Adverse Event|7|||
126012595|NCT01123083|453338555|FG001|Overall Study|Lost to Follow-up|6|||
126012596|NCT01123083|453338554|FG000|Overall Study|Adverse Event|1|||
126012597|NCT01123083|453338555|FG001|Overall Study|Adverse Event|0|||
126012598|NCT01123083|453338554|FG000|Overall Study|Withdrew for another reason not covered|0|||
126012599|NCT01123083|453338555|FG001|Overall Study|Withdrew for another reason not covered|1|||
126012600|NCT01123083|453338554|FG000|Overall Study|Participant/legal representative request|7|||
126012601|NCT01123083|453338555|FG001|Overall Study|Participant/legal representative request|3|||
126012602|NCT00482729|453340884|FG000|Overall Study|Adverse Event|29|||
126012603|NCT00482729|453340885|FG001|Overall Study|Adverse Event|33|||
126012604|NCT00482729|453340884|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
126012605|NCT00482729|453340885|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
126012606|NCT00482729|453340884|FG000|Overall Study|Hyperglycemia Criteria|7|||
126012607|NCT00482729|453340885|FG001|Overall Study|Hyperglycemia Criteria|5|||
126012608|NCT00482729|453340884|FG000|Overall Study|Lack of Efficacy|4|||
126012609|NCT00482729|453340885|FG001|Overall Study|Lack of Efficacy|16|||
126012610|NCT00482729|453340884|FG000|Overall Study|Lost to Follow-up|86|||
126012611|NCT00482729|453340885|FG001|Overall Study|Lost to Follow-up|66|||
126012612|NCT00482729|453340884|FG000|Overall Study|Physician Decision|10|||
126012613|NCT00482729|453340885|FG001|Overall Study|Physician Decision|7|||
126012614|NCT00482729|453340884|FG000|Overall Study|Pregnancy|4|||
126012615|NCT00482729|453340885|FG001|Overall Study|Pregnancy|2|||
126012616|NCT00482729|453340884|FG000|Overall Study|Protocol Violation|10|||
126012617|NCT00482729|453340885|FG001|Overall Study|Protocol Violation|18|||
126012618|NCT00482729|453340884|FG000|Overall Study|Withdrawal by Subject|67|||
126012619|NCT00482729|453340885|FG001|Overall Study|Withdrawal by Subject|69|||
126012620|NCT02631148|453340889|FG000|Overall Study|8 were ineligible|8|||
126012621|NCT02631148|453340890|FG001|Overall Study|8 were ineligible|0|||
126012622|NCT02631148|453340889|FG000|Overall Study|Withdrawal by Subject|1|||
126012623|NCT02631148|453340890|FG001|Overall Study|Withdrawal by Subject|0|||
126012624|NCT02631148|453340889|FG000|Overall Study|PAH not available to study participant|1|||
126012625|NCT02631148|453340890|FG001|Overall Study|PAH not available to study participant|0|||
126012626|NCT01134562|453340892|FG000|Overall Study|Adverse Event|0|||
126012627|NCT01134562|453340893|FG001|Overall Study|Adverse Event|1|||
126012628|NCT01134562|453340894|FG002|Overall Study|Adverse Event|0|||
126012629|NCT01134562|453340895|FG003|Overall Study|Adverse Event|0|||
126012630|NCT01134562|453340896|FG004|Overall Study|Adverse Event|0|||
126012631|NCT02496702|453340898|FG000|Overall Study|Lost to Follow-up|8|||
126012632|NCT02496702|453340899|FG001|Overall Study|Lost to Follow-up|6|||
126012633|NCT02496702|453340898|FG000|Overall Study|Only partially tested|0|||
126012634|NCT02496702|453340899|FG001|Overall Study|Only partially tested|2|||
126012635|NCT02525796|453340904|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
126012636|NCT02525796|453340905|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
126012637|NCT02525796|453340906|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
126012638|NCT02525796|453340904|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
126012639|NCT02525796|453340905|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
126012640|NCT02525796|453340906|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
126012641|NCT02525796|453340904|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
126012642|NCT02525796|453340905|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
126012643|NCT02525796|453340906|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
126012644|NCT02525796|453340904|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
126012645|NCT02525796|453340905|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
126012646|NCT02525796|453340906|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
126012647|NCT02525796|453340904|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
126012648|NCT02525796|453340905|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
126012649|NCT02525796|453340906|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
126012650|NCT02488980|453340907|FG000|Overall Study|Protocol Violation|2|||
126012651|NCT02488980|453340908|FG001|Overall Study|Protocol Violation|2|||
126012652|NCT02488980|453340909|FG002|Overall Study|Protocol Violation|2|||
126012653|NCT00970307|453340912|FG000|Overall Study|Serious Adverse Event|1|||
126012654|NCT00970307|453340913|FG001|Overall Study|Serious Adverse Event|0|||
126012655|NCT00970307|453340914|FG002|Overall Study|Serious Adverse Event|0|||
126012656|NCT00970307|453340912|FG000|Overall Study|Withdrawal by Subject|2|||
126012657|NCT00970307|453340913|FG001|Overall Study|Withdrawal by Subject|3|||
126012658|NCT00970307|453340914|FG002|Overall Study|Withdrawal by Subject|2|||
126012659|NCT00393848|453340921|FG000|Overall Study|Surgical schedule|0|||
126012660|NCT00393848|453340922|FG001|Overall Study|Surgical schedule|0|||
126012661|NCT00393848|453340923|FG002|Overall Study|Surgical schedule|0|||
126012662|NCT00393848|453340924|FG003|Overall Study|Surgical schedule|1|||
126012663|NCT00393848|453340921|FG000|Overall Study|Personal reasons|0|||
126012664|NCT00393848|453340922|FG001|Overall Study|Personal reasons|0|||
126012665|NCT00393848|453340923|FG002|Overall Study|Personal reasons|2|||
126012666|NCT00393848|453340924|FG003|Overall Study|Personal reasons|0|||
126012667|NCT01329328|453340929|FG000|Overall Study|Withdrawal by Subject|2|||
126012668|NCT01329328|453340930|FG001|Overall Study|Withdrawal by Subject|4|||
126012669|NCT01329328|453340931|FG002|Overall Study|Withdrawal by Subject|3|||
126012670|NCT02393716|453340932|FG000|Overall Study|Death|29|||
126012671|NCT02393716|453340932|FG000|Overall Study|Withdrawal by Subject|8|||
126012672|NCT02393716|453340932|FG000|Overall Study|Device Explanted|8|||
126012673|NCT02393716|453340932|FG000|Overall Study|Missed visit|16|||
126012674|NCT02957539|453340933|FG000|Baseline to Week 16|Lost to Follow-up|8|||
126012675|NCT02957539|453340934|FG001|Baseline to Week 16|Lost to Follow-up|10|||
126012676|NCT02957539|453340935|FG002|Baseline to Week 16|Lost to Follow-up|16|||
126012677|NCT02957539|453340933|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
126012678|NCT02957539|453340934|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
126012679|NCT02957539|453340935|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
126012680|NCT02957539|453340933|FG000|Week 16 to 32|Withdrawal by Subject|3|||
126012681|NCT02957539|453340934|FG001|Week 16 to 32|Withdrawal by Subject|3|||
126012682|NCT02957539|453340935|FG002|Week 16 to 32|Withdrawal by Subject|1|||
126012683|NCT02957539|453340933|FG000|Week 16 to 32|Lost to Follow-up|8|||
126012684|NCT02957539|453340934|FG001|Week 16 to 32|Lost to Follow-up|7|||
126012685|NCT02957539|453340935|FG002|Week 16 to 32|Lost to Follow-up|5|||
126012686|NCT02957539|453340933|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
126012687|NCT02957539|453340934|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
126012688|NCT02957539|453340935|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
126012689|NCT02957539|453340933|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
126012690|NCT02957539|453340934|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
126012691|NCT02957539|453340935|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
126012692|NCT01563354|453340938|FG000|Core Phase|Adverse Event|5|||
126012693|NCT01563354|453340939|FG001|Core Phase|Adverse Event|15|||
126012694|NCT01563354|453340940|FG002|Core Phase|Adverse Event|13|||
126012695|NCT01563354|453340938|FG000|Core Phase|Withdrawal by Subject|1|||
126012696|NCT01563354|453340939|FG001|Core Phase|Withdrawal by Subject|0|||
126012697|NCT01563354|453340940|FG002|Core Phase|Withdrawal by Subject|3|||
126012698|NCT01563354|453340938|FG000|Core Phase|Lost to Follow-up|1|||
126012699|NCT01563354|453340939|FG001|Core Phase|Lost to Follow-up|0|||
126012700|NCT01563354|453340940|FG002|Core Phase|Lost to Follow-up|0|||
126012701|NCT01563354|453340938|FG000|Core Phase|Death|1|||
126012702|NCT01563354|453340939|FG001|Core Phase|Death|5|||
126012703|NCT01563354|453340940|FG002|Core Phase|Death|2|||
126012704|NCT01563354|453340938|FG000|Core Phase|Diseasse progression|18|||
126012705|NCT01563354|453340939|FG001|Core Phase|Diseasse progression|7|||
126012706|NCT01563354|453340940|FG002|Core Phase|Diseasse progression|8|||
126012707|NCT01563354|453340938|FG000|Core Phase|Protocol deviation|2|||
126012708|NCT01563354|453340939|FG001|Core Phase|Protocol deviation|0|||
126012709|NCT01563354|453340940|FG002|Core Phase|Protocol deviation|0|||
126012710|NCT01563354|453340938|FG000|Core Phase|PI decision - did not enter extension|0|||
126012711|NCT01563354|453340939|FG001|Core Phase|PI decision - did not enter extension|1|||
126012712|NCT01563354|453340940|FG002|Core Phase|PI decision - did not enter extension|0|||
126012713|NCT01563354|453340938|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
126012714|NCT01563354|453340939|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
126012715|NCT01563354|453340940|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
126012716|NCT01563354|453340938|FG000|Extension Phase|Adverse Event|0|||
126012717|NCT01563354|453340939|FG001|Extension Phase|Adverse Event|3|||
126012718|NCT01563354|453340940|FG002|Extension Phase|Adverse Event|2|||
126012719|NCT01563354|453340938|FG000|Extension Phase|Withdrawal by Subject|0|||
126012720|NCT01563354|453340939|FG001|Extension Phase|Withdrawal by Subject|1|||
126012721|NCT01563354|453340940|FG002|Extension Phase|Withdrawal by Subject|0|||
126209677|NCT03426995|454055464|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209678|NCT03426995|454055465|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209679|NCT03426995|454055466|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209680|NCT03426995|454055467|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209681|NCT03426995|454055468|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209682|NCT03426995|454055469|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209683|NCT03426995|454055470|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209684|NCT03426995|454055471|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209685|NCT03426995|454055472|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209686|NCT03426995|454055473|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209687|NCT03426995|454055474|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209688|NCT03426995|454055475|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126209689|NCT03426995|454055457|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209690|NCT03426995|454055458|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209691|NCT03426995|454055459|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209692|NCT03426995|454055460|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209693|NCT03426995|454055461|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209694|NCT03426995|454055462|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
126209695|NCT03426995|454055463|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209696|NCT03426995|454055464|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209697|NCT03426995|454055465|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209698|NCT03426995|454055466|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209699|NCT03426995|454055467|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209700|NCT03426995|454055468|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209701|NCT03426995|454055469|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209702|NCT03426995|454055470|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209703|NCT03426995|454055471|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209704|NCT03426995|454055472|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209705|NCT03426995|454055473|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209706|NCT03426995|454055474|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209707|NCT03426995|454055475|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126209708|NCT03426995|454055457|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209709|NCT03426995|454055458|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209710|NCT03426995|454055459|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209711|NCT03426995|454055460|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209712|NCT03426995|454055461|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
126209713|NCT03426995|454055462|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
126209714|NCT03426995|454055463|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209715|NCT03426995|454055464|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209716|NCT03426995|454055465|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209717|NCT03426995|454055466|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209718|NCT03426995|454055467|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209719|NCT03426995|454055468|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209720|NCT03426995|454055469|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209721|NCT03426995|454055470|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209722|NCT03426995|454055471|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209723|NCT03426995|454055472|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209724|NCT03426995|454055473|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209725|NCT03426995|454055474|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209726|NCT03426995|454055475|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126209727|NCT03426995|454055457|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209728|NCT03426995|454055458|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209729|NCT03426995|454055459|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209730|NCT03426995|454055460|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209731|NCT03426995|454055461|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209732|NCT03426995|454055462|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209733|NCT03426995|454055463|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209734|NCT03426995|454055464|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209735|NCT03426995|454055465|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209736|NCT03426995|454055466|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126091127|NCT03820947|453626919|FG001|Overall Study|Lost to Follow-up|6|||
126209737|NCT03426995|454055467|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
126209738|NCT03426995|454055468|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209739|NCT03426995|454055469|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209740|NCT03426995|454055470|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209741|NCT03426995|454055471|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209742|NCT03426995|454055472|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209743|NCT03426995|454055473|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209744|NCT03426995|454055474|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209745|NCT03426995|454055475|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126209746|NCT03426995|454055457|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209747|NCT03426995|454055458|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209748|NCT03426995|454055459|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209749|NCT03426995|454055460|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209750|NCT03426995|454055461|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209751|NCT03426995|454055462|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209752|NCT03426995|454055463|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209753|NCT03426995|454055464|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
126209754|NCT03426995|454055465|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209755|NCT03426995|454055466|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209756|NCT03426995|454055467|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209757|NCT03426995|454055468|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209758|NCT03426995|454055469|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209759|NCT03426995|454055470|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209760|NCT03426995|454055471|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209761|NCT03426995|454055472|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209762|NCT03426995|454055473|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209763|NCT03426995|454055474|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209764|NCT03426995|454055475|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126209765|NCT03426995|454055457|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209766|NCT03426995|454055458|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209767|NCT03426995|454055459|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209768|NCT03426995|454055460|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209769|NCT03426995|454055461|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209770|NCT03426995|454055462|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209771|NCT03426995|454055463|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209772|NCT03426995|454055464|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209773|NCT03426995|454055465|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209774|NCT03426995|454055466|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209775|NCT03426995|454055467|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209776|NCT03426995|454055468|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209777|NCT03426995|454055469|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209778|NCT03426995|454055470|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209779|NCT03426995|454055471|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
126209780|NCT03426995|454055472|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
126209781|NCT03426995|454055473|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209782|NCT03426995|454055474|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209783|NCT03426995|454055475|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126209784|NCT03426995|454055457|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209785|NCT03426995|454055458|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209786|NCT03426995|454055459|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209787|NCT03426995|454055460|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209788|NCT03426995|454055461|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209789|NCT03426995|454055462|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209790|NCT03426995|454055463|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209791|NCT03426995|454055464|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209792|NCT03426995|454055465|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209793|NCT03426995|454055466|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209794|NCT03426995|454055467|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209795|NCT03426995|454055468|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209796|NCT03426995|454055469|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209797|NCT03426995|454055470|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209798|NCT03426995|454055471|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
126209799|NCT03426995|454055472|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
126209800|NCT03426995|454055473|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209801|NCT03426995|454055474|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209802|NCT03426995|454055475|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126209803|NCT05939388|454055476|FG000|Overall Study|Lost to Follow-up|1|||
126209804|NCT00885677|454055485|FG000|Overall Study|Death|40|||
126209805|NCT00885677|454055486|FG001|Overall Study|Death|34|||
126209806|NCT00885677|454055485|FG000|Overall Study|Lost to Follow-up|15|||
126209807|NCT00885677|454055486|FG001|Overall Study|Lost to Follow-up|13|||
126209808|NCT00885677|454055485|FG000|Overall Study|Protocol Violation|54|||
126209809|NCT00885677|454055486|FG001|Overall Study|Protocol Violation|54|||
126209810|NCT00885677|454055485|FG000|Overall Study|premature study closure|41|||
126209811|NCT00885677|454055486|FG001|Overall Study|premature study closure|44|||
126209812|NCT00885677|454055485|FG000|Overall Study|device/lead revision or replacement|7|||
126209813|NCT00885677|454055486|FG001|Overall Study|device/lead revision or replacement|6|||
126209814|NCT00885677|454055485|FG000|Overall Study|Heart transplantation|1|||
126209815|NCT00885677|454055486|FG001|Overall Study|Heart transplantation|0|||
126209816|NCT00885677|454055485|FG000|Overall Study|Inclusion/exclusion not met|25|||
126209817|NCT00885677|454055486|FG001|Overall Study|Inclusion/exclusion not met|27|||
126209818|NCT00972309|454055487|FG000|Overall Study|Switched to alternative treatment|0|||
126209819|NCT00972309|454055488|FG001|Overall Study|Switched to alternative treatment|2|||
126012722|NCT01563354|453340938|FG000|Extension Phase|Administration problems|3|||
126209820|NCT00972309|454055487|FG000|Overall Study|Refused further treatment|0|||
126209821|NCT00972309|454055488|FG001|Overall Study|Refused further treatment|1|||
126209822|NCT00972309|454055487|FG000|Overall Study|Late determination of ineligibility|0|||
126209823|NCT00972309|454055488|FG001|Overall Study|Late determination of ineligibility|1|||
126209824|NCT00972309|454055487|FG000|Overall Study|Second malignancy|1|||
126209825|NCT00972309|454055488|FG001|Overall Study|Second malignancy|1|||
126209826|NCT00972309|454055487|FG000|Overall Study|Visa issues|0|||
126209827|NCT00972309|454055488|FG001|Overall Study|Visa issues|1|||
126209828|NCT00972309|454055487|FG000|Overall Study|Secondary cancer (SCC)|0|||
126209829|NCT00972309|454055488|FG001|Overall Study|Secondary cancer (SCC)|1|||
126209830|NCT00972309|454055487|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
126209831|NCT00972309|454055488|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
126209832|NCT00972309|454055487|FG000|Overall Study|Lost to Follow-up|1|||
126209833|NCT00972309|454055488|FG001|Overall Study|Lost to Follow-up|1|||
126209834|NCT00972309|454055487|FG000|Overall Study|Disease progression on study|10|||
126209835|NCT00972309|454055488|FG001|Overall Study|Disease progression on study|4|||
126209836|NCT00948896|454055492|FG000|Randomization to 24 Months of Age|Death|1|||
126209837|NCT00948896|454055493|FG001|Randomization to 24 Months of Age|Death|0|||
126209838|NCT00948896|454055494|FG002|Randomization to 24 Months of Age|Death|0|||
126209839|NCT00948896|454055495|FG003|Randomization to 24 Months of Age|Death|0|||
126209840|NCT00948896|454055496|FG004|Randomization to 24 Months of Age|Death|2|||
126209841|NCT00948896|454055497|FG005|Randomization to 24 Months of Age|Death|1|||
126209842|NCT00948896|454055498|FG006|Randomization to 24 Months of Age|Death|2|||
126209843|NCT00948896|454055499|FG007|Randomization to 24 Months of Age|Death|1|||
126209844|NCT00948896|454055492|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
126209845|NCT00948896|454055493|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
126209846|NCT00948896|454055494|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
126209847|NCT00948896|454055495|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
126209848|NCT00948896|454055496|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
126209849|NCT00948896|454055497|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
126209850|NCT00948896|454055498|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
126209851|NCT00948896|454055499|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
126209852|NCT00948896|454055492|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
126209853|NCT00948896|454055493|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
126209854|NCT00948896|454055494|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
126209855|NCT00948896|454055495|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
126209856|NCT00948896|454055496|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
126209857|NCT00948896|454055497|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
126209858|NCT00948896|454055498|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
126209859|NCT00948896|454055499|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
126209860|NCT00948896|454055492|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
126209861|NCT00948896|454055493|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
126209862|NCT00948896|454055494|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
126209863|NCT00948896|454055495|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
126209864|NCT00948896|454055496|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
126209865|NCT00948896|454055497|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
126209866|NCT00948896|454055498|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
126209867|NCT00948896|454055499|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
126209868|NCT00948896|454055492|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
126209869|NCT00948896|454055493|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
126209870|NCT00948896|454055494|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
126209871|NCT00948896|454055495|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
126209872|NCT00948896|454055496|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
126209873|NCT00948896|454055497|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
126209874|NCT00948896|454055498|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
126209875|NCT00948896|454055499|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
126209876|NCT00948896|454055492|FG000|24 Months of Age to 36 Months of Age|Death|0|||
126209877|NCT00948896|454055493|FG001|24 Months of Age to 36 Months of Age|Death|2|||
126209878|NCT00948896|454055494|FG002|24 Months of Age to 36 Months of Age|Death|2|||
126209879|NCT00948896|454055495|FG003|24 Months of Age to 36 Months of Age|Death|0|||
126209880|NCT00948896|454055496|FG004|24 Months of Age to 36 Months of Age|Death|0|||
126209881|NCT00948896|454055497|FG005|24 Months of Age to 36 Months of Age|Death|1|||
126209882|NCT00948896|454055498|FG006|24 Months of Age to 36 Months of Age|Death|0|||
126209883|NCT00948896|454055499|FG007|24 Months of Age to 36 Months of Age|Death|0|||
126209884|NCT00948896|454055492|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
126209885|NCT00948896|454055493|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126209886|NCT00948896|454055494|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
126209887|NCT00948896|454055495|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
126209888|NCT00948896|454055496|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126209889|NCT00948896|454055497|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126209890|NCT00948896|454055498|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126209891|NCT00948896|454055499|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126209892|NCT00948896|454055492|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
126209893|NCT00948896|454055493|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126209894|NCT00948896|454055494|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
126209895|NCT00948896|454055495|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126209896|NCT00948896|454055496|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
126209897|NCT00948896|454055497|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126209898|NCT00948896|454055498|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126209899|NCT00948896|454055499|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126209900|NCT00948896|454055492|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126209901|NCT00948896|454055493|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126209902|NCT00948896|454055494|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
126209903|NCT00948896|454055495|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126209904|NCT00948896|454055496|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126209905|NCT00948896|454055497|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
126209906|NCT00948896|454055498|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126209907|NCT00948896|454055499|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126209908|NCT00948896|454055492|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126209909|NCT00948896|454055493|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126209910|NCT00948896|454055494|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126209911|NCT00948896|454055495|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
126209912|NCT00948896|454055496|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126346056|NCT02030600|454562289|FG000|Treatment Period 1|Lack of Efficacy|0|||
126346057|NCT02030600|454562290|FG001|Treatment Period 1|Lack of Efficacy|1|||
126346058|NCT02030600|454562289|FG000|Treatment Period 1|Lost to Follow-up|11|||
126346059|NCT02030600|454562290|FG001|Treatment Period 1|Lost to Follow-up|3|||
126346060|NCT02030600|454562289|FG000|Treatment Period 1|Protocol Violation|22|||
126346061|NCT02030600|454562290|FG001|Treatment Period 1|Protocol Violation|17|||
126346062|NCT02030600|454562289|FG000|Treatment Period 1|Withdrawal by Subject|13|||
126012723|NCT01563354|453340939|FG001|Extension Phase|Administration problems|2|||
126012724|NCT01563354|453340940|FG002|Extension Phase|Administration problems|3|||
126012725|NCT01563354|453340938|FG000|Extension Phase|Disease progression|9|||
126209913|NCT00948896|454055497|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126209914|NCT00948896|454055498|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126209915|NCT00948896|454055499|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126209916|NCT03795233|454055500|FG000|Overall Study|Withdrawal by Subject|2|||
126209917|NCT03795233|454055501|FG001|Overall Study|Withdrawal by Subject|1|||
126209918|NCT03795233|454055500|FG000|Overall Study|Lost to Follow-up|1|||
126209919|NCT03795233|454055501|FG001|Overall Study|Lost to Follow-up|0|||
126209920|NCT03795233|454055500|FG000|Overall Study|Death|1|||
126209921|NCT03795233|454055501|FG001|Overall Study|Death|0|||
126209922|NCT01869959|454055506|FG000|Randomization Period|Physician Decision|0|||
126209923|NCT01869959|454055507|FG001|Randomization Period|Physician Decision|0|||
126209924|NCT01869959|454055508|FG002|Randomization Period|Physician Decision|0|||
126209925|NCT01869959|454055509|FG003|Randomization Period|Physician Decision|0|||
126209926|NCT01869959|454055510|FG004|Randomization Period|Physician Decision|1|||
126209927|NCT01869959|454055506|FG000|Treatment Period|Adverse Event|1|||
126209928|NCT01869959|454055507|FG001|Treatment Period|Adverse Event|0|||
126209929|NCT01869959|454055508|FG002|Treatment Period|Adverse Event|3|||
126209930|NCT01869959|454055509|FG003|Treatment Period|Adverse Event|1|||
126209931|NCT01869959|454055510|FG004|Treatment Period|Adverse Event|0|||
126209932|NCT01869959|454055506|FG000|Treatment Period|Sponsor decision|0|||
126209933|NCT01869959|454055507|FG001|Treatment Period|Sponsor decision|1|||
126209934|NCT01869959|454055508|FG002|Treatment Period|Sponsor decision|0|||
126209935|NCT01869959|454055509|FG003|Treatment Period|Sponsor decision|1|||
126209936|NCT01869959|454055510|FG004|Treatment Period|Sponsor decision|0|||
126209937|NCT01869959|454055506|FG000|Treatment Period|Withdrawal by Subject|0|||
126209938|NCT01869959|454055507|FG001|Treatment Period|Withdrawal by Subject|1|||
126209939|NCT01869959|454055508|FG002|Treatment Period|Withdrawal by Subject|0|||
126209940|NCT01869959|454055509|FG003|Treatment Period|Withdrawal by Subject|0|||
126209941|NCT01869959|454055510|FG004|Treatment Period|Withdrawal by Subject|0|||
126209942|NCT00828009|454055511|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
126209943|NCT00828009|454055511|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
126209944|NCT00828009|454055511|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
126209945|NCT00828009|454055511|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
126209946|NCT00828009|454055511|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
126209947|NCT00828009|454055511|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
126209948|NCT00828009|454055511|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
126209949|NCT00828009|454055511|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
126209950|NCT00828009|454055511|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
126209951|NCT00828009|454055511|FG000|Step 2 - Maintenance Therapy|Death|1|||
126209952|NCT00828009|454055511|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
126209953|NCT00828009|454055511|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
126209954|NCT00828009|454055511|FG000|Step 2 - Maintenance Therapy|Other|1|||
126209955|NCT02576951|454055515|FG000|Overall Study|Lost to Follow-up|0|||
126209956|NCT02576951|454055516|FG001|Overall Study|Lost to Follow-up|0|||
126209957|NCT02576951|454055517|FG002|Overall Study|Lost to Follow-up|2|||
126209958|NCT02576951|454055518|FG003|Overall Study|Lost to Follow-up|2|||
126209959|NCT02576951|454055515|FG000|Overall Study|Withdrawal by Subject|1|||
126209960|NCT02576951|454055516|FG001|Overall Study|Withdrawal by Subject|0|||
126209961|NCT02576951|454055517|FG002|Overall Study|Withdrawal by Subject|0|||
126209962|NCT02576951|454055518|FG003|Overall Study|Withdrawal by Subject|2|||
126209963|NCT02576951|454055515|FG000|Overall Study|Protocol Violation|0|||
126209964|NCT02576951|454055516|FG001|Overall Study|Protocol Violation|0|||
126346063|NCT02030600|454562290|FG001|Treatment Period 1|Withdrawal by Subject|17|||
126346064|NCT02030600|454562289|FG000|Treatment Period 1|Casebook Unsigned|1|||
126346065|NCT02030600|454562290|FG001|Treatment Period 1|Casebook Unsigned|0|||
126346066|NCT02030600|454562289|FG000|Treatment Period 1|Unclassified|1|||
126346067|NCT02030600|454562290|FG001|Treatment Period 1|Unclassified|0|||
126346068|NCT02030600|454562289|FG000|Treatment Period 2|Adverse Event|4|||
126209965|NCT02576951|454055517|FG002|Overall Study|Protocol Violation|0|||
126209966|NCT02576951|454055518|FG003|Overall Study|Protocol Violation|1|||
126209967|NCT00157820|454055524|FG000|Randomized|Physician Decision|4|||
126209968|NCT00157820|454055525|FG001|Randomized|Physician Decision|2|||
126209969|NCT00157820|454055526|FG002|Randomized|Physician Decision|3|||
126209970|NCT00157820|454055524|FG000|Randomized|Withdrawal by Subject|1|||
126209971|NCT00157820|454055525|FG001|Randomized|Withdrawal by Subject|2|||
126209972|NCT00157820|454055526|FG002|Randomized|Withdrawal by Subject|3|||
126209973|NCT00157820|454055524|FG000|Randomized|Protocol Violation|2|||
126209974|NCT00157820|454055525|FG001|Randomized|Protocol Violation|1|||
126209975|NCT00157820|454055526|FG002|Randomized|Protocol Violation|2|||
126209976|NCT00157820|454055524|FG000|1st 8 Month|Death|7|||
126209977|NCT00157820|454055525|FG001|1st 8 Month|Death|8|||
126209978|NCT00157820|454055526|FG002|1st 8 Month|Death|3|||
126209979|NCT00157820|454055524|FG000|1st 8 Month|Lost to Follow-up|1|||
126209980|NCT00157820|454055525|FG001|1st 8 Month|Lost to Follow-up|2|||
126346069|NCT02030600|454562290|FG001|Treatment Period 2|Adverse Event|4|||
126209981|NCT00157820|454055526|FG002|1st 8 Month|Lost to Follow-up|1|||
126209982|NCT00157820|454055524|FG000|1st 8 Month|Premature cross-over|0|||
126209983|NCT00157820|454055525|FG001|1st 8 Month|Premature cross-over|2|||
126209984|NCT00157820|454055526|FG002|1st 8 Month|Premature cross-over|2|||
126209985|NCT00157820|454055524|FG000|2nd 8 Months|Death|3|||
126209986|NCT00157820|454055525|FG001|2nd 8 Months|Death|1|||
126209987|NCT00157820|454055526|FG002|2nd 8 Months|Death|3|||
126209988|NCT00157820|454055524|FG000|2nd 8 Months|Lost to Follow-up|1|||
126209989|NCT00157820|454055525|FG001|2nd 8 Months|Lost to Follow-up|5|||
126209990|NCT00157820|454055526|FG002|2nd 8 Months|Lost to Follow-up|2|||
126209991|NCT00157820|454055524|FG000|2nd 8 Months|Premature cross-over|1|||
126209992|NCT00157820|454055525|FG001|2nd 8 Months|Premature cross-over|7|||
126209993|NCT00157820|454055526|FG002|2nd 8 Months|Premature cross-over|9|||
126209994|NCT01721369|454055527|FG000|Overall Study|Not initial etiological diagnosis|12|||
126209995|NCT00563706|454057498|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
126209996|NCT00563706|454057499|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
126209997|NCT00563706|454057500|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
126209998|NCT00563706|454057501|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
126209999|NCT00563706|454057502|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
126210000|NCT00563706|454057503|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
126210001|NCT00563706|454057504|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
126210002|NCT00563706|454057505|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
126210003|NCT00563706|454057506|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
126210004|NCT00563706|454057498|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
126210005|NCT00563706|454057499|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
126210006|NCT00563706|454057500|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
126210007|NCT00563706|454057501|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
126210008|NCT00563706|454057502|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
126210009|NCT00563706|454057503|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
126210010|NCT00563706|454057504|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
126210011|NCT00563706|454057505|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
126210012|NCT00563706|454057506|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
126210013|NCT00563706|454057498|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
126210014|NCT00563706|454057499|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
126210015|NCT00563706|454057500|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
126210016|NCT00563706|454057501|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
126210017|NCT00563706|454057502|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
126210018|NCT00563706|454057503|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
126210019|NCT00563706|454057504|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
126210020|NCT00563706|454057505|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
126210021|NCT00563706|454057506|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
126210022|NCT00563706|454057498|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
126210023|NCT00563706|454057499|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126210024|NCT00563706|454057500|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126210025|NCT00563706|454057501|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126210026|NCT00563706|454057502|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126210027|NCT00563706|454057503|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126210028|NCT00563706|454057504|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126306083|NCT02553499|454408869|FG000|Overall Study|Study Terminated by Sponsor|0|||
126306084|NCT02553499|454408870|FG001|Overall Study|Study Terminated by Sponsor|0|||
126306085|NCT02553499|454408871|FG002|Overall Study|Study Terminated by Sponsor|0|||
126306086|NCT02553499|454408872|FG003|Overall Study|Study Terminated by Sponsor|0|||
126306087|NCT02553499|454408873|FG004|Overall Study|Study Terminated by Sponsor|0|||
126306088|NCT02553499|454408874|FG005|Overall Study|Study Terminated by Sponsor|0|||
126306089|NCT02553499|454408875|FG006|Overall Study|Study Terminated by Sponsor|0|||
126306090|NCT02553499|454408876|FG007|Overall Study|Study Terminated by Sponsor|0|||
126306091|NCT02553499|454408877|FG008|Overall Study|Study Terminated by Sponsor|1|||
126306092|NCT02553499|454408878|FG009|Overall Study|Study Terminated by Sponsor|0|||
126306093|NCT02553499|454408879|FG010|Overall Study|Study Terminated by Sponsor|0|||
126306094|NCT02553499|454408880|FG011|Overall Study|Study Terminated by Sponsor|0|||
126306095|NCT02553499|454408881|FG012|Overall Study|Study Terminated by Sponsor|0|||
126306096|NCT02553499|454408882|FG013|Overall Study|Study Terminated by Sponsor|0|||
126306097|NCT02553499|454408869|FG000|Overall Study|Withdrawal by Subject|2|||
126306098|NCT02553499|454408870|FG001|Overall Study|Withdrawal by Subject|0|||
126306099|NCT02553499|454408871|FG002|Overall Study|Withdrawal by Subject|0|||
126306100|NCT02553499|454408872|FG003|Overall Study|Withdrawal by Subject|0|||
126306101|NCT02553499|454408873|FG004|Overall Study|Withdrawal by Subject|0|||
126306102|NCT02553499|454408874|FG005|Overall Study|Withdrawal by Subject|0|||
126306103|NCT02553499|454408875|FG006|Overall Study|Withdrawal by Subject|0|||
126210029|NCT00563706|454057505|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
126210030|NCT00563706|454057506|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126210031|NCT00563706|454057498|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126210032|NCT00563706|454057499|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126210033|NCT00563706|454057500|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126210034|NCT00563706|454057501|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126210035|NCT00563706|454057502|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126210036|NCT00563706|454057503|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126210037|NCT00563706|454057504|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126210038|NCT00563706|454057505|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
126210039|NCT00563706|454057506|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
126210040|NCT00822237|454057507|FG000|Dose 1 Vaccination|Not vaccinated|3|||
126210041|NCT00822237|454057508|FG001|Dose 1 Vaccination|Not vaccinated|0|||
126210042|NCT00822237|454057507|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
126210043|NCT00822237|454057508|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
126210044|NCT00822237|454057507|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
126210045|NCT00822237|454057508|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
126210046|NCT00822237|454057507|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
126210047|NCT00822237|454057508|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
126210048|NCT00822237|454057507|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
126210049|NCT00822237|454057508|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
126210050|NCT00299546|454057509|FG000|Overall Study|Death|3|||
126210051|NCT00299546|454057510|FG001|Overall Study|Death|2|||
126210052|NCT00299546|454057511|FG002|Overall Study|Death|0|||
126210053|NCT00299546|454057509|FG000|Overall Study|Lost to Follow-up|2|||
126210054|NCT00299546|454057510|FG001|Overall Study|Lost to Follow-up|2|||
126210055|NCT00299546|454057511|FG002|Overall Study|Lost to Follow-up|5|||
126210056|NCT00299546|454057509|FG000|Overall Study|Adverse Event|37|||
126210057|NCT00299546|454057510|FG001|Overall Study|Adverse Event|22|||
126210058|NCT00299546|454057511|FG002|Overall Study|Adverse Event|27|||
126210059|NCT00299546|454057509|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
126210060|NCT00299546|454057510|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
126210061|NCT00299546|454057511|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
126210062|NCT00299546|454057509|FG000|Overall Study|Other|24|||
126210063|NCT00299546|454057510|FG001|Overall Study|Other|26|||
126210064|NCT00299546|454057511|FG002|Overall Study|Other|19|||
126210065|NCT00299546|454057509|FG000|Overall Study|Not treated|0|||
126210066|NCT00299546|454057510|FG001|Overall Study|Not treated|1|||
126210067|NCT00299546|454057511|FG002|Overall Study|Not treated|1|||
126210068|NCT03099265|454057512|FG000|Overall Study|Adverse Event|1|||
126210069|NCT02526017|454057516|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126210070|NCT02526017|454057517|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126210071|NCT02526017|454057518|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126210072|NCT02526017|454057519|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126210073|NCT02526017|454057520|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
126210074|NCT02526017|454057521|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126210075|NCT02526017|454057522|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126210076|NCT02526017|454057523|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126210077|NCT02526017|454057524|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126210078|NCT02674568|454057529|FG000|Overall Study|Withdrawal by Subject|5|||
126210079|NCT02674568|454057529|FG000|Overall Study|Death|303|||
126210080|NCT02674568|454057529|FG000|Overall Study|Physician Decision|2|||
126210081|NCT02674568|454057529|FG000|Overall Study|Lost to Follow-up|9|||
126210082|NCT02674568|454057529|FG000|Overall Study|Other, Not Specified|20|||
126346070|NCT02030600|454562289|FG000|Treatment Period 2|Lack of Efficacy|2|||
126346071|NCT02030600|454562290|FG001|Treatment Period 2|Lack of Efficacy|1|||
126346072|NCT02030600|454562289|FG000|Treatment Period 2|Lost to Follow-up|4|||
126346073|NCT02030600|454562290|FG001|Treatment Period 2|Lost to Follow-up|2|||
126346074|NCT02030600|454562289|FG000|Treatment Period 2|Protocol Violation|1|||
126346075|NCT02030600|454562290|FG001|Treatment Period 2|Protocol Violation|2|||
126346076|NCT02030600|454562289|FG000|Treatment Period 2|Withdrawal by Subject|13|||
126346077|NCT02030600|454562290|FG001|Treatment Period 2|Withdrawal by Subject|9|||
126012726|NCT01563354|453340939|FG001|Extension Phase|Disease progression|8|||
126012727|NCT01563354|453340940|FG002|Extension Phase|Disease progression|10|||
126210083|NCT00968539|454057530|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
126210084|NCT00968539|454057531|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
126210085|NCT00457249|454057532|FG000|Overall Study|Lost to Follow-up|3|||
126210086|NCT00457249|454057533|FG001|Overall Study|Lost to Follow-up|0|||
126210087|NCT00457249|454057532|FG000|Overall Study|Protocol Violation|4|||
126210088|NCT00457249|454057533|FG001|Overall Study|Protocol Violation|1|||
126210089|NCT00457249|454057532|FG000|Overall Study|Withdrawal by Subject|3|||
126346078|NCT02030600|454562289|FG000|Treatment Period 2|Unclassified|1|||
126346079|NCT02030600|454562290|FG001|Treatment Period 2|Unclassified|0|||
126346080|NCT01155323|454562291|FG000|First Intervention|exclusion criteria|1|||
126210090|NCT00457249|454057533|FG001|Overall Study|Withdrawal by Subject|1|||
126210091|NCT00457249|454057532|FG000|Overall Study|Serious Adverse Events|2|||
126210092|NCT00457249|454057533|FG001|Overall Study|Serious Adverse Events|0|||
126210093|NCT00396318|454057534|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
126210094|NCT00326118|454057535|FG000|Active Phase|Withdrawal by Subject|4|||
126210095|NCT00326118|454057536|FG001|Active Phase|Withdrawal by Subject|1|||
126210096|NCT00938392|454057537|FG000|Overall Study|Adverse Event|0|||
126210097|NCT00938392|454057538|FG001|Overall Study|Adverse Event|1|||
126210098|NCT00938392|454057537|FG000|Overall Study|Withdrawal by Subject|0|||
126210099|NCT00938392|454057538|FG001|Overall Study|Withdrawal by Subject|1|||
126210100|NCT00938392|454057537|FG000|Overall Study|Lost to Follow-up|2|||
126210101|NCT00938392|454057538|FG001|Overall Study|Lost to Follow-up|2|||
126210102|NCT02916056|454057539|FG000|Overall Study|Adverse Event|6|||
126210103|NCT02916056|454057539|FG000|Overall Study|Lost to Follow-up|1|||
126210104|NCT02916056|454057539|FG000|Overall Study|Other|12|||
126210105|NCT02916056|454057539|FG000|Overall Study|Protocol Violation|1|||
126210106|NCT02916056|454057539|FG000|Overall Study|Withdrawal by Subject|8|||
126210107|NCT02916056|454057539|FG000|Overall Study|Study Terminated by Sponsor|269|||
126210108|NCT00290511|454057540|FG000|Overall Study|Adverse Event|1|||
126210109|NCT00290511|454057540|FG000|Overall Study|Death|1|||
126210110|NCT00290511|454057540|FG000|Overall Study|Physician Decision|1|||
126210111|NCT00290511|454057540|FG000|Overall Study|Withdrawal by Subject|1|||
126210112|NCT00124709|454057541|FG000|Overall Study|Randomized but did not take medication|3|||
126210113|NCT00124709|454057542|FG001|Overall Study|Randomized but did not take medication|1|||
126210114|NCT00124709|454057541|FG000|Overall Study|Adverse Event|3|||
126210115|NCT00124709|454057542|FG001|Overall Study|Adverse Event|0|||
126210116|NCT00124709|454057541|FG000|Overall Study|Lack of Efficacy|5|||
126210117|NCT00124709|454057542|FG001|Overall Study|Lack of Efficacy|10|||
126210118|NCT00124709|454057541|FG000|Overall Study|Protocol Violation|3|||
126210119|NCT00124709|454057542|FG001|Overall Study|Protocol Violation|5|||
126210120|NCT00124709|454057541|FG000|Overall Study|Withdrawal by Subject|127|||
126210121|NCT00124709|454057542|FG001|Overall Study|Withdrawal by Subject|136|||
126210122|NCT00124709|454057541|FG000|Overall Study|Lost to Follow-up|114|||
126210123|NCT00124709|454057542|FG001|Overall Study|Lost to Follow-up|120|||
126210124|NCT01728376|454057543|FG000|Overall Study|Adverse Event|1|||
126210125|NCT01728376|454057544|FG001|Overall Study|Adverse Event|1|||
126210126|NCT01728376|454057545|FG002|Overall Study|Adverse Event|1|||
126210127|NCT01728376|454057546|FG003|Overall Study|Adverse Event|1|||
126210128|NCT01728376|454057547|FG004|Overall Study|Adverse Event|1|||
126210129|NCT01728376|454057548|FG005|Overall Study|Adverse Event|0|||
126210130|NCT01728376|454057543|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
126210131|NCT01728376|454057544|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
126210132|NCT01728376|454057545|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
126210133|NCT01728376|454057546|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
126210134|NCT01728376|454057547|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
126210135|NCT01728376|454057548|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
126210136|NCT01728376|454057543|FG000|Overall Study|No relevant bacteria|2|||
126210137|NCT01728376|454057544|FG001|Overall Study|No relevant bacteria|0|||
126210138|NCT01728376|454057545|FG002|Overall Study|No relevant bacteria|0|||
126346081|NCT01155323|454562292|FG001|First Intervention|exclusion criteria|1|||
126346082|NCT01155323|454562291|FG000|Second Intervention|Lost to Follow-up|1|||
126346083|NCT01155323|454562292|FG001|Second Intervention|Lost to Follow-up|1|||
126346084|NCT00937950|454562302|FG000|Overall Study|Withdrawal by Subject|23|||
126346085|NCT00937950|454562302|FG000|Overall Study|Migrated/moved from study area|27|||
126346086|NCT00937950|454562302|FG000|Overall Study|Lost to Follow-up|144|||
126346087|NCT00937950|454562302|FG000|Overall Study|Missing confirmed|4|||
126346088|NCT00937950|454562302|FG000|Overall Study|Other|18|||
126346089|NCT04154956|454562303|FG000|Overall Study|Death|109|||
126346090|NCT04154956|454562304|FG001|Overall Study|Death|110|||
126346091|NCT04154956|454562303|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
126346092|NCT04154956|454562304|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
126346093|NCT04154956|454562303|FG000|Overall Study|Withdrawal by Subject|1|||
126346094|NCT04154956|454562304|FG001|Overall Study|Withdrawal by Subject|7|||
126210139|NCT01728376|454057546|FG003|Overall Study|No relevant bacteria|0|||
126210140|NCT01728376|454057547|FG004|Overall Study|No relevant bacteria|1|||
126210141|NCT01728376|454057548|FG005|Overall Study|No relevant bacteria|1|||
126210142|NCT01728376|454057543|FG000|Overall Study|Did not receive treatment|0|||
126210143|NCT01728376|454057544|FG001|Overall Study|Did not receive treatment|1|||
126210144|NCT01728376|454057545|FG002|Overall Study|Did not receive treatment|0|||
126210145|NCT01728376|454057546|FG003|Overall Study|Did not receive treatment|0|||
126346095|NCT04154956|454562303|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
126346096|NCT04154956|454562304|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
126346097|NCT00805532|454562305|FG000|Overall Study|invalid data|0|||
126346098|NCT00805532|454562306|FG001|Overall Study|invalid data|1|||
126210146|NCT01728376|454057547|FG004|Overall Study|Did not receive treatment|0|||
126210147|NCT01728376|454057548|FG005|Overall Study|Did not receive treatment|0|||
126210148|NCT01728376|454057543|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
126210149|NCT01728376|454057544|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
126210150|NCT01728376|454057545|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
126210151|NCT01728376|454057546|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
126210152|NCT01728376|454057547|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
126210153|NCT01728376|454057548|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
126210154|NCT04341727|454057563|FG000|Overall Study|Withdrawal by Subject|0|||
126210155|NCT04341727|454057564|FG001|Overall Study|Withdrawal by Subject|0|||
126210156|NCT04341727|454057565|FG002|Overall Study|Withdrawal by Subject|1|||
126210157|NCT04341727|454057566|FG003|Overall Study|Withdrawal by Subject|0|||
126210158|NCT04341727|454057563|FG000|Overall Study|Lost to Follow-up|0|||
126210159|NCT04341727|454057564|FG001|Overall Study|Lost to Follow-up|0|||
126210160|NCT04341727|454057565|FG002|Overall Study|Lost to Follow-up|0|||
126210161|NCT04341727|454057566|FG003|Overall Study|Lost to Follow-up|1|||
126210162|NCT05604521|454057567|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
126210163|NCT05604521|454057568|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
126210164|NCT05604521|454057567|FG000|Overall Study|Adverse Event|1|||
126210165|NCT05604521|454057568|FG001|Overall Study|Adverse Event|0|||
126210166|NCT01491737|454057569|FG000|Overall Study|Withdrawal by Subject|20|||
126210167|NCT01491737|454057570|FG001|Overall Study|Withdrawal by Subject|17|||
126210168|NCT01491737|454057569|FG000|Overall Study|Lost to Follow-up|2|||
126210169|NCT01491737|454057570|FG001|Overall Study|Lost to Follow-up|10|||
126210170|NCT01491737|454057569|FG000|Overall Study|Death|63|||
126210171|NCT01491737|454057570|FG001|Overall Study|Death|57|||
126210172|NCT01491737|454057569|FG000|Overall Study|Study Termination by Sponsor|36|||
126210173|NCT01491737|454057570|FG001|Overall Study|Study Termination by Sponsor|36|||
126210174|NCT01491737|454057569|FG000|Overall Study|Reason Not Specified|8|||
126210175|NCT01491737|454057570|FG001|Overall Study|Reason Not Specified|9|||
126210176|NCT04311411|454057571|FG000|Overall Study|Adverse Event|2|||
126210177|NCT04311411|454057572|FG001|Overall Study|Adverse Event|3|||
126210178|NCT04311411|454057573|FG002|Overall Study|Adverse Event|2|||
126210179|NCT04311411|454057571|FG000|Overall Study|Withdrawal by Subject|3|||
126210180|NCT04311411|454057572|FG001|Overall Study|Withdrawal by Subject|3|||
126210181|NCT04311411|454057573|FG002|Overall Study|Withdrawal by Subject|0|||
126210182|NCT01976663|454057574|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
126210183|NCT01976663|454057574|FG000|Overall Study|Personal Reasons|6|||
126210184|NCT01976663|454057574|FG000|Overall Study|Withdrawal by Subject|4|||
126210185|NCT01976663|454057574|FG000|Overall Study|Screen Failure|3|||
126210186|NCT01976663|454057574|FG000|Overall Study|Adverse Event|2|||
126210187|NCT01976663|454057574|FG000|Overall Study|Lost to Follow-up|3|||
126210188|NCT01817764|454057575|FG000|Overall Study|Adverse Event|7|||
126210189|NCT01817764|454057576|FG001|Overall Study|Adverse Event|10|||
126210190|NCT01817764|454057575|FG000|Overall Study|Lack of Efficacy|9|||
126210191|NCT01817764|454057576|FG001|Overall Study|Lack of Efficacy|7|||
126210192|NCT01817764|454057575|FG000|Overall Study|Protocol Violation|7|||
126210193|NCT01817764|454057576|FG001|Overall Study|Protocol Violation|5|||
126210194|NCT01817764|454057575|FG000|Overall Study|Lost to Follow-up|1|||
126210195|NCT01817764|454057576|FG001|Overall Study|Lost to Follow-up|4|||
126210196|NCT01817764|454057575|FG000|Overall Study|Withdrawal by Subject|10|||
126210197|NCT01817764|454057576|FG001|Overall Study|Withdrawal by Subject|12|||
126210198|NCT04888377|454057577|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
126210199|NCT04888377|454057578|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
126210200|NCT04888377|454057577|FG000|Overall Study|Physician Decision|6|||
126210201|NCT04888377|454057578|FG001|Overall Study|Physician Decision|6|||
126210202|NCT04888377|454057577|FG000|Overall Study|Withdrawal by Subject|7|||
126210203|NCT04888377|454057578|FG001|Overall Study|Withdrawal by Subject|3|||
126210204|NCT00526162|454057579|FG000|Overall Study|Device not implanted|3|||
126210205|NCT05993299|454057580|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
126210206|NCT05993299|454057580|FG000|Overall Study|Ongoing|4|||
126210207|NCT05644756|454057581|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
126210208|NCT05644756|454057581|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
126210209|NCT03985982|454057582|FG000|Double-Blind Phase|Lost to Follow-up|4|||
126210210|NCT03985982|454057583|FG001|Double-Blind Phase|Lost to Follow-up|3|||
126210211|NCT03985982|454057584|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126210212|NCT03985982|454057582|FG000|Double-Blind Phase|Physician Decision|1|||
126210213|NCT03985982|454057583|FG001|Double-Blind Phase|Physician Decision|0|||
126210214|NCT03985982|454057584|FG002|Double-Blind Phase|Physician Decision|0|||
126210215|NCT03985982|454057582|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
126210216|NCT03985982|454057583|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
126210217|NCT03985982|454057584|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126210218|NCT03985982|454057582|FG000|Double-Blind Phase|COVID-19|1|||
126210219|NCT03985982|454057583|FG001|Double-Blind Phase|COVID-19|0|||
126210220|NCT03985982|454057584|FG002|Double-Blind Phase|COVID-19|0|||
126210221|NCT03985982|454057582|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
126210222|NCT03985982|454057583|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
126210223|NCT03985982|454057584|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
126210224|NCT03985982|454057582|FG000|Open-Label Phase|Lost to Follow-up|0|||
126210225|NCT03985982|454057583|FG001|Open-Label Phase|Lost to Follow-up|0|||
126210226|NCT03985982|454057584|FG002|Open-Label Phase|Lost to Follow-up|13|||
126210227|NCT03985982|454057582|FG000|Open-Label Phase|Physician Decision|0|||
126210228|NCT03985982|454057583|FG001|Open-Label Phase|Physician Decision|0|||
126210229|NCT03985982|454057584|FG002|Open-Label Phase|Physician Decision|2|||
126210230|NCT03985982|454057582|FG000|Open-Label Phase|Withdrawal by Subject|0|||
126346099|NCT01859741|454562307|FG000|Overall Study|Death|3|||
126346100|NCT01859741|454562308|FG001|Overall Study|Death|2|||
126346101|NCT01859741|454562309|FG002|Overall Study|Death|4|||
126346102|NCT01859741|454562310|FG003|Overall Study|Death|3|||
126346103|NCT01859741|454562311|FG004|Overall Study|Death|5|||
126346104|NCT01859741|454562312|FG005|Overall Study|Death|4|||
126346105|NCT01859741|454562313|FG006|Overall Study|Death|51|||
126346106|NCT01859741|454562314|FG007|Overall Study|Death|51|||
126346107|NCT01859741|454562307|FG000|Overall Study|Lost to Follow-up|0|||
126346108|NCT01859741|454562308|FG001|Overall Study|Lost to Follow-up|0|||
126346109|NCT01859741|454562309|FG002|Overall Study|Lost to Follow-up|0|||
126346110|NCT01859741|454562310|FG003|Overall Study|Lost to Follow-up|0|||
126346111|NCT01859741|454562311|FG004|Overall Study|Lost to Follow-up|0|||
126346112|NCT01859741|454562312|FG005|Overall Study|Lost to Follow-up|1|||
126346113|NCT01859741|454562313|FG006|Overall Study|Lost to Follow-up|0|||
126346114|NCT01859741|454562314|FG007|Overall Study|Lost to Follow-up|4|||
126346115|NCT01859741|454562307|FG000|Overall Study|Withdrawal by Subject|0|||
126346116|NCT01859741|454562308|FG001|Overall Study|Withdrawal by Subject|1|||
126346117|NCT01859741|454562309|FG002|Overall Study|Withdrawal by Subject|2|||
126346118|NCT01859741|454562310|FG003|Overall Study|Withdrawal by Subject|0|||
126346119|NCT01859741|454562311|FG004|Overall Study|Withdrawal by Subject|0|||
126346120|NCT01859741|454562312|FG005|Overall Study|Withdrawal by Subject|1|||
126346121|NCT01859741|454562313|FG006|Overall Study|Withdrawal by Subject|1|||
126346122|NCT01859741|454562314|FG007|Overall Study|Withdrawal by Subject|1|||
126346123|NCT01859741|454562307|FG000|Overall Study|Study Terminated by Sponsor|0|||
126346124|NCT01859741|454562308|FG001|Overall Study|Study Terminated by Sponsor|0|||
126346125|NCT01859741|454562309|FG002|Overall Study|Study Terminated by Sponsor|0|||
126346126|NCT01859741|454562310|FG003|Overall Study|Study Terminated by Sponsor|0|||
126346127|NCT01859741|454562311|FG004|Overall Study|Study Terminated by Sponsor|1|||
126346128|NCT01859741|454562312|FG005|Overall Study|Study Terminated by Sponsor|0|||
126346129|NCT01859741|454562313|FG006|Overall Study|Study Terminated by Sponsor|16|||
126346130|NCT01859741|454562314|FG007|Overall Study|Study Terminated by Sponsor|14|||
126346131|NCT01859741|454562307|FG000|Overall Study|Other|0|||
126346132|NCT01859741|454562308|FG001|Overall Study|Other|0|||
126346133|NCT01859741|454562309|FG002|Overall Study|Other|0|||
126346134|NCT01859741|454562310|FG003|Overall Study|Other|0|||
126346135|NCT01859741|454562311|FG004|Overall Study|Other|0|||
126346136|NCT01859741|454562312|FG005|Overall Study|Other|0|||
126346137|NCT01859741|454562313|FG006|Overall Study|Other|2|||
126346138|NCT01859741|454562314|FG007|Overall Study|Other|0|||
126346139|NCT02412657|454562316|FG000|Overall Study|Lost to Follow-up|1|||
126346140|NCT02412657|454562317|FG001|Overall Study|Lost to Follow-up|0|||
126346141|NCT02412657|454562318|FG002|Overall Study|Lost to Follow-up|0|||
126346142|NCT02412657|454562316|FG000|Overall Study|Protocol Violation|0|||
126346143|NCT02412657|454562317|FG001|Overall Study|Protocol Violation|2|||
126346144|NCT02412657|454562318|FG002|Overall Study|Protocol Violation|3|||
126346145|NCT00460798|454562319|FG000|Overall Study|Death|59|||
126346146|NCT00460798|454562319|FG000|Overall Study|Adverse Event|27|||
126346147|NCT00460798|454562319|FG000|Overall Study|Lost to Follow-up|19|||
126346148|NCT00460798|454562319|FG000|Overall Study|Progressive Disease|99|||
126346149|NCT00460798|454562319|FG000|Overall Study|Other|27|||
126346150|NCT00460798|454562319|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
126210231|NCT03985982|454057583|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126210232|NCT03985982|454057584|FG002|Open-Label Phase|Withdrawal by Subject|11|||
126346151|NCT00460798|454562319|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
126346152|NCT01898130|454562320|FG000|Treatment|Withdrawal by Subject|2|||
126346153|NCT01898130|454562320|FG000|Treatment|Progressive Disease|4|||
126346154|NCT01898130|454562320|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
126346155|NCT01281306|454562327|FG000|Overall Study|Lack of Efficacy|0|||
126346156|NCT01281306|454562328|FG001|Overall Study|Lack of Efficacy|1|||
126346157|NCT01281306|454562329|FG002|Overall Study|Lack of Efficacy|3|||
126346158|NCT01281306|454562330|FG003|Overall Study|Lack of Efficacy|0|||
126346159|NCT01281306|454562331|FG004|Overall Study|Lack of Efficacy|2|||
126346160|NCT01281306|454562332|FG005|Overall Study|Lack of Efficacy|0|||
126346161|NCT01281306|454562333|FG006|Overall Study|Lack of Efficacy|1|||
126346162|NCT01281306|454562327|FG000|Overall Study|Withdrawal by Subject|1|||
126346163|NCT01281306|454562328|FG001|Overall Study|Withdrawal by Subject|0|||
126346164|NCT01281306|454562329|FG002|Overall Study|Withdrawal by Subject|2|||
126346165|NCT01281306|454562330|FG003|Overall Study|Withdrawal by Subject|4|||
126012728|NCT01565928|453340941|FG000|Overall Study|Adverse Event|3|||
126012729|NCT01565928|453340941|FG000|Overall Study|Other|3|||
126012730|NCT01565928|453340941|FG000|Overall Study|Progressive Disease|13|||
126012731|NCT01565928|453340941|FG000|Overall Study|Withdrawal by Subject|1|||
126012732|NCT01565928|453340941|FG000|Overall Study|Death|2|||
126012733|NCT01119950|453340942|FG000|Overall Study|Adverse Event|25|||
126012734|NCT01119950|453340942|FG000|Overall Study|Withdrawal by Subject|9|||
126346166|NCT01281306|454562331|FG004|Overall Study|Withdrawal by Subject|1|||
126346167|NCT01281306|454562332|FG005|Overall Study|Withdrawal by Subject|3|||
126346168|NCT01281306|454562333|FG006|Overall Study|Withdrawal by Subject|1|||
126346169|NCT01281306|454562327|FG000|Overall Study|Protocol deviation|0|||
126346170|NCT01281306|454562328|FG001|Overall Study|Protocol deviation|1|||
126346171|NCT01281306|454562329|FG002|Overall Study|Protocol deviation|1|||
126346172|NCT01281306|454562330|FG003|Overall Study|Protocol deviation|1|||
126346173|NCT01281306|454562331|FG004|Overall Study|Protocol deviation|1|||
126346174|NCT01281306|454562332|FG005|Overall Study|Protocol deviation|0|||
126346175|NCT01281306|454562333|FG006|Overall Study|Protocol deviation|0|||
126346176|NCT01281306|454562327|FG000|Overall Study|Condition no longer requires study drug|1|||
126346177|NCT01281306|454562328|FG001|Overall Study|Condition no longer requires study drug|0|||
126346178|NCT01281306|454562329|FG002|Overall Study|Condition no longer requires study drug|0|||
126346179|NCT01281306|454562330|FG003|Overall Study|Condition no longer requires study drug|0|||
126346180|NCT01281306|454562331|FG004|Overall Study|Condition no longer requires study drug|0|||
126346181|NCT01281306|454562332|FG005|Overall Study|Condition no longer requires study drug|1|||
126346182|NCT01281306|454562333|FG006|Overall Study|Condition no longer requires study drug|1|||
126346183|NCT01281306|454562327|FG000|Overall Study|Lost to Follow-up|1|||
126346184|NCT01281306|454562328|FG001|Overall Study|Lost to Follow-up|0|||
126012735|NCT01119950|453340942|FG000|Overall Study|Protocol Violation|5|||
126012736|NCT01119950|453340942|FG000|Overall Study|Lost to Follow-up|4|||
126210233|NCT00478933|454057589|FG000|Overall Study|Protocol Violation|22|||
126210234|NCT00478933|454057589|FG000|Overall Study|Informed consent not verified|3|||
126210235|NCT00478933|454057589|FG000|Overall Study|Inadequate data available|53|||
126210236|NCT03772574|454057590|FG000|Overall Study|Protocol Violation|2|||
126210237|NCT03772574|454057591|FG001|Overall Study|Protocol Violation|0|||
126210238|NCT03772574|454057592|FG002|Overall Study|Protocol Violation|0|||
126210239|NCT03772574|454057590|FG000|Overall Study|Discomfort|0|||
126012737|NCT01119950|453340942|FG000|Overall Study|Administrative|2|||
126012738|NCT01119950|453340942|FG000|Overall Study|Abnormal lab value|1|||
126012739|NCT01119950|453340942|FG000|Overall Study|Death|1|||
126012740|NCT01591616|453340945|FG000|Overall Study|Withdrawal by Subject|1|||
126012741|NCT00855465|453340946|FG000|Treatment Period|Adverse Event|4|||
126012742|NCT00855465|453340947|FG001|Treatment Period|Adverse Event|2|||
126012743|NCT00855465|453340946|FG000|Treatment Period|Death|2|||
126012744|NCT00855465|453340947|FG001|Treatment Period|Death|2|||
126012745|NCT00855465|453340946|FG000|Treatment Period|Lack of Efficacy|2|||
126012746|NCT00855465|453340947|FG001|Treatment Period|Lack of Efficacy|1|||
126012747|NCT00855465|453340946|FG000|Treatment Period|Non-compliance|1|||
126012748|NCT00855465|453340947|FG001|Treatment Period|Non-compliance|0|||
126012749|NCT00855465|453340946|FG000|Treatment Period|Protocol Violation|2|||
126012750|NCT00855465|453340947|FG001|Treatment Period|Protocol Violation|0|||
126012751|NCT00855465|453340946|FG000|Treatment Period|Withdrawal by Subject|2|||
126012752|NCT00855465|453340947|FG001|Treatment Period|Withdrawal by Subject|0|||
126012753|NCT00855465|453340946|FG000|Treatment Period|Not treated|1|||
126012754|NCT00855465|453340947|FG001|Treatment Period|Not treated|0|||
126012755|NCT00855465|453340946|FG000|Follow-up Period (FUP)|Adverse Event|0|||
126012756|NCT00855465|453340947|FG001|Follow-up Period (FUP)|Adverse Event|1|||
126012757|NCT00855465|453340946|FG000|Follow-up Period (FUP)|Death|0|||
126012758|NCT00855465|453340947|FG001|Follow-up Period (FUP)|Death|1|||
126012759|NCT00855465|453340946|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
126012760|NCT00855465|453340947|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
126012761|NCT00855465|453340946|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
126012762|NCT00855465|453340947|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
126012763|NCT00855465|453340946|FG000|Follow-up Period (FUP)|Missing|1|||
126012764|NCT00855465|453340947|FG001|Follow-up Period (FUP)|Missing|0|||
126012765|NCT02371746|453340948|FG000|Overall Study|Consent withdrawn|0|||
126012766|NCT02371746|453340949|FG001|Overall Study|Consent withdrawn|0|||
126012767|NCT02371746|453340950|FG002|Overall Study|Consent withdrawn|0|||
126012768|NCT02371746|453340951|FG003|Overall Study|Consent withdrawn|0|||
126012769|NCT02371746|453340952|FG004|Overall Study|Consent withdrawn|0|||
126012770|NCT02371746|453340953|FG005|Overall Study|Consent withdrawn|0|||
126210240|NCT03772574|454057591|FG001|Overall Study|Discomfort|5|||
126210241|NCT03772574|454057592|FG002|Overall Study|Discomfort|4|||
126210242|NCT03586427|454057595|FG000|Overall Study|Lost to Follow-up|0|||
126210243|NCT03586427|454057596|FG001|Overall Study|Lost to Follow-up|3|||
126346185|NCT01281306|454562329|FG002|Overall Study|Lost to Follow-up|0|||
126346186|NCT01281306|454562330|FG003|Overall Study|Lost to Follow-up|2|||
126346187|NCT01281306|454562331|FG004|Overall Study|Lost to Follow-up|0|||
126346188|NCT01281306|454562332|FG005|Overall Study|Lost to Follow-up|0|||
126346189|NCT01281306|454562333|FG006|Overall Study|Lost to Follow-up|1|||
126346190|NCT01281306|454562327|FG000|Overall Study|Death|1|||
126346191|NCT01281306|454562328|FG001|Overall Study|Death|0|||
126346192|NCT01281306|454562329|FG002|Overall Study|Death|0|||
126346193|NCT01281306|454562330|FG003|Overall Study|Death|0|||
126346194|NCT01281306|454562331|FG004|Overall Study|Death|0|||
126346195|NCT01281306|454562332|FG005|Overall Study|Death|0|||
126346196|NCT01281306|454562333|FG006|Overall Study|Death|0|||
126346197|NCT01281306|454562327|FG000|Overall Study|Adverse Event|3|||
126346198|NCT01281306|454562328|FG001|Overall Study|Adverse Event|2|||
126346199|NCT01281306|454562329|FG002|Overall Study|Adverse Event|2|||
126346200|NCT01281306|454562330|FG003|Overall Study|Adverse Event|3|||
126346201|NCT01281306|454562331|FG004|Overall Study|Adverse Event|5|||
126346202|NCT01281306|454562332|FG005|Overall Study|Adverse Event|3|||
126346203|NCT01281306|454562333|FG006|Overall Study|Adverse Event|3|||
126346204|NCT01281306|454562327|FG000|Overall Study|Randomized in error|1|||
126012771|NCT02371746|453340954|FG006|Overall Study|Consent withdrawn|1|||
126012772|NCT01157182|453340959|FG000|Washout of 28 Days|Adverse Event|2|||
126012773|NCT01157182|453340960|FG001|Washout of 28 Days|Adverse Event|0|||
126346205|NCT01281306|454562328|FG001|Overall Study|Randomized in error|0|||
126346206|NCT01281306|454562329|FG002|Overall Study|Randomized in error|0|||
126012774|NCT03743246|453340961|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
126012775|NCT03743246|453340962|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
126012776|NCT03743246|453340963|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
126012777|NCT03743246|453340964|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
126210244|NCT03586427|454057597|FG002|Overall Study|Lost to Follow-up|1|||
126346207|NCT01281306|454562330|FG003|Overall Study|Randomized in error|1|||
126346208|NCT01281306|454562331|FG004|Overall Study|Randomized in error|0|||
126346209|NCT01281306|454562332|FG005|Overall Study|Randomized in error|0|||
126210245|NCT03586427|454057598|FG003|Overall Study|Lost to Follow-up|3|||
126210246|NCT03586427|454057599|FG004|Overall Study|Lost to Follow-up|3|||
126210247|NCT03586427|454057595|FG000|Overall Study|Withdrawal by Subject|0|||
126210248|NCT03586427|454057596|FG001|Overall Study|Withdrawal by Subject|1|||
126210249|NCT03586427|454057597|FG002|Overall Study|Withdrawal by Subject|2|||
126210250|NCT03586427|454057598|FG003|Overall Study|Withdrawal by Subject|1|||
126210251|NCT03586427|454057599|FG004|Overall Study|Withdrawal by Subject|1|||
126210252|NCT03586427|454057595|FG000|Overall Study|Adverse Event|0|||
126210253|NCT03586427|454057596|FG001|Overall Study|Adverse Event|0|||
126210254|NCT03586427|454057597|FG002|Overall Study|Adverse Event|1|||
126210255|NCT03586427|454057598|FG003|Overall Study|Adverse Event|0|||
126210256|NCT03586427|454057599|FG004|Overall Study|Adverse Event|0|||
126012778|NCT03743246|453340961|FG000|Pre-Treatment Period|Death|0|||
126012779|NCT03743246|453340962|FG001|Pre-Treatment Period|Death|1|||
126210257|NCT03586427|454057595|FG000|Overall Study|Protocol Violation|0|||
126210258|NCT03586427|454057596|FG001|Overall Study|Protocol Violation|0|||
126210259|NCT03586427|454057597|FG002|Overall Study|Protocol Violation|1|||
126210260|NCT03586427|454057598|FG003|Overall Study|Protocol Violation|0|||
126210261|NCT03586427|454057599|FG004|Overall Study|Protocol Violation|1|||
126210262|NCT03586427|454057595|FG000|Overall Study|Noncompliance with study drug|0|||
126210263|NCT03586427|454057596|FG001|Overall Study|Noncompliance with study drug|0|||
126210264|NCT03586427|454057597|FG002|Overall Study|Noncompliance with study drug|1|||
126210265|NCT03586427|454057598|FG003|Overall Study|Noncompliance with study drug|0|||
126210266|NCT03586427|454057599|FG004|Overall Study|Noncompliance with study drug|0|||
126210267|NCT03193996|454057600|FG000|Overall Study|Withdrawal by Subject|4|||
126210268|NCT03193996|454057600|FG000|Overall Study|Lost to Follow-up|4|||
126210269|NCT03193996|454057600|FG000|Overall Study|Physician Decision|2|||
126210270|NCT03193996|454057600|FG000|Overall Study|Pregnancy|1|||
126210271|NCT03193996|454057600|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
126210272|NCT03193996|454057600|FG000|Overall Study|Complicating disease|1|||
126210273|NCT00494234|454057601|FG000|Overall Study|Withdrawal by Subject|1|||
126210274|NCT00494234|454057602|FG001|Overall Study|Withdrawal by Subject|0|||
126210275|NCT00494234|454057601|FG000|Overall Study|Disease progression|11|||
126210276|NCT00494234|454057602|FG001|Overall Study|Disease progression|8|||
126210277|NCT00494234|454057601|FG000|Overall Study|Death|2|||
126210278|NCT00494234|454057602|FG001|Overall Study|Death|1|||
126210279|NCT00423137|454057603|FG000|Overall Study|Lost to Follow-up|0|||
126210280|NCT00423137|454057604|FG001|Overall Study|Lost to Follow-up|0|||
126210281|NCT00423137|454057605|FG002|Overall Study|Lost to Follow-up|1|||
126210282|NCT00423137|454057606|FG003|Overall Study|Lost to Follow-up|0|||
126210283|NCT00423137|454057603|FG000|Overall Study|Protocol Violation|0|||
126210284|NCT00423137|454057604|FG001|Overall Study|Protocol Violation|0|||
126210285|NCT00423137|454057605|FG002|Overall Study|Protocol Violation|0|||
126210286|NCT00423137|454057606|FG003|Overall Study|Protocol Violation|1|||
126210287|NCT00423137|454057603|FG000|Overall Study|Adverse Event Study disease worse|1|||
126210288|NCT00423137|454057604|FG001|Overall Study|Adverse Event Study disease worse|0|||
126210289|NCT00423137|454057605|FG002|Overall Study|Adverse Event Study disease worse|3|||
126210290|NCT00423137|454057606|FG003|Overall Study|Adverse Event Study disease worse|1|||
126210291|NCT00423137|454057603|FG000|Overall Study|Adverse Event Other|0|||
126210292|NCT00423137|454057604|FG001|Overall Study|Adverse Event Other|0|||
126210293|NCT00423137|454057605|FG002|Overall Study|Adverse Event Other|2|||
126210294|NCT00423137|454057606|FG003|Overall Study|Adverse Event Other|0|||
126346210|NCT01281306|454562333|FG006|Overall Study|Randomized in error|0|||
126346211|NCT04491994|454562334|FG000|Overall Study|Withdrawal by Subject|10|||
126346212|NCT04491994|454562335|FG001|Overall Study|Withdrawal by Subject|5|||
126346213|NCT04491994|454562334|FG000|Overall Study|developed fever > 3 days|4|||
126346214|NCT04491994|454562335|FG001|Overall Study|developed fever > 3 days|1|||
126346215|NCT04491994|454562334|FG000|Overall Study|Protocol Violation|11|||
126346216|NCT04491994|454562335|FG001|Overall Study|Protocol Violation|2|||
126346217|NCT04491994|454562334|FG000|Overall Study|Lost to Follow-up|4|||
126346218|NCT04491994|454562335|FG001|Overall Study|Lost to Follow-up|3|||
126346219|NCT02320396|454562341|FG000|Overall Study|Adverse Event|2|||
126346220|NCT02320396|454562342|FG001|Overall Study|Adverse Event|2|||
126346221|NCT02320396|454562341|FG000|Overall Study|Pregnancy|0|||
126346222|NCT02320396|454562342|FG001|Overall Study|Pregnancy|1|||
126346223|NCT02320396|454562341|FG000|Overall Study|Protocol Violation|0|||
126346224|NCT02320396|454562342|FG001|Overall Study|Protocol Violation|1|||
126346225|NCT02320396|454562341|FG000|Overall Study|Withdrawal by Subject|2|||
126346226|NCT02320396|454562342|FG001|Overall Study|Withdrawal by Subject|0|||
126346227|NCT03331562|454562343|FG000|Overall Study|Adverse Event|2|||
126346228|NCT03331562|454562344|FG001|Overall Study|Adverse Event|0|||
126346229|NCT03331562|454562343|FG000|Overall Study|Death|1|||
126346230|NCT03331562|454562344|FG001|Overall Study|Death|0|||
126346231|NCT03718000|454562345|FG000|Overall Study|Relocation|2|||
126346232|NCT03718000|454562346|FG001|Overall Study|Relocation|4|||
126346233|NCT03718000|454562345|FG000|Overall Study|Pregnancy|0|||
126346234|NCT03718000|454562346|FG001|Overall Study|Pregnancy|1|||
126346235|NCT02441283|454562347|FG000|Overall Study|Withdrew consent|15|||
126346236|NCT02441283|454562347|FG000|Overall Study|Lost to Follow-up|42|||
126346237|NCT02441283|454562347|FG000|Overall Study|Death|1|||
126346238|NCT02441283|454562347|FG000|Overall Study|Other, not specified|32|||
126346239|NCT00537277|454562348|FG000|Overall Study|Adverse Event|1|||
126346240|NCT00537277|454562348|FG000|Overall Study|Lack of Efficacy|2|||
126346241|NCT00537277|454562348|FG000|Overall Study|Lost to Follow-up|12|||
126346242|NCT00537277|454562348|FG000|Overall Study|Protocol Violation|11|||
126346243|NCT00537277|454562348|FG000|Overall Study|Unclassified|4|||
126346244|NCT00537277|454562348|FG000|Overall Study|Inability to tolerate trial medication|4|||
126346245|NCT00537277|454562348|FG000|Overall Study|Non-compliance with trial procedures|15|||
126210295|NCT00593385|454057612|FG000|Overall Study|Death|14|||
126210296|NCT00593385|454057612|FG000|Overall Study|Lost to Follow-up|17|||
126210297|NCT00593385|454057612|FG000|Overall Study|Withdrawal by Subject|9|||
126210298|NCT00348348|454057613|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
126210299|NCT00348348|454057614|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
126210300|NCT00348348|454057613|FG000|Overall Study|Lack of Efficacy|1|||
126210301|NCT00348348|454057614|FG001|Overall Study|Lack of Efficacy|1|||
126210302|NCT00348348|454057613|FG000|Overall Study|Lost to Follow-up|8|||
126210303|NCT00348348|454057614|FG001|Overall Study|Lost to Follow-up|10|||
126210304|NCT00348348|454057613|FG000|Overall Study|Withdrawal by Subject|4|||
126210305|NCT00348348|454057614|FG001|Overall Study|Withdrawal by Subject|1|||
126210306|NCT00348348|454057613|FG000|Overall Study|Other|7|||
126210307|NCT00348348|454057614|FG001|Overall Study|Other|4|||
126210308|NCT00348348|454057613|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
126210309|NCT00348348|454057614|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
126210310|NCT00348348|454057613|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
126210311|NCT00348348|454057614|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
126210312|NCT00348348|454057613|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
126210313|NCT00348348|454057614|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
126210314|NCT00348348|454057613|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
126210315|NCT00348348|454057614|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
126210316|NCT00348348|454057613|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
126210317|NCT00348348|454057614|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
126210318|NCT00348348|454057613|FG000|Overall Study|Adverse event probably related to study|1|||
126210319|NCT00348348|454057614|FG001|Overall Study|Adverse event probably related to study|0|||
126210320|NCT01471197|454057615|FG000|Overall Study|Disease Progression|4|||
126210321|NCT01471197|454057616|FG001|Overall Study|Disease Progression|2|||
126210322|NCT01471197|454057615|FG000|Overall Study|Death|1|||
126210323|NCT01471197|454057616|FG001|Overall Study|Death|0|||
126210324|NCT01471197|454057615|FG000|Overall Study|Study Drug Toxicity|1|||
126210325|NCT01471197|454057616|FG001|Overall Study|Study Drug Toxicity|0|||
126210326|NCT00924313|454057622|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
126210327|NCT00491322|454057626|FG000|Overall Study|Protocol Violation|1|||
126210328|NCT00491322|454057627|FG001|Overall Study|Protocol Violation|0|||
126210329|NCT00491322|454057626|FG000|Overall Study|Pregnancy|0|||
126210330|NCT00491322|454057627|FG001|Overall Study|Pregnancy|1|||
126210331|NCT02331680|454057628|FG000|Overall Study|Adverse Event|3|||
126210332|NCT02331680|454057629|FG001|Overall Study|Adverse Event|0|||
126210333|NCT02331680|454057630|FG002|Overall Study|Adverse Event|2|||
126210334|NCT02331680|454057628|FG000|Overall Study|Physician Decision|1|||
126210335|NCT02331680|454057629|FG001|Overall Study|Physician Decision|1|||
126210336|NCT02331680|454057630|FG002|Overall Study|Physician Decision|2|||
126210337|NCT02331680|454057628|FG000|Overall Study|Withdrawal by Subject|0|||
126210338|NCT02331680|454057629|FG001|Overall Study|Withdrawal by Subject|1|||
126210339|NCT02331680|454057630|FG002|Overall Study|Withdrawal by Subject|2|||
126210340|NCT02331680|454057628|FG000|Overall Study|Met withdrawal criteria|2|||
126210341|NCT02331680|454057629|FG001|Overall Study|Met withdrawal criteria|2|||
126210342|NCT02331680|454057630|FG002|Overall Study|Met withdrawal criteria|5|||
126210343|NCT02331680|454057628|FG000|Overall Study|Non-compliance with study drug|0|||
126210344|NCT02331680|454057629|FG001|Overall Study|Non-compliance with study drug|0|||
126210345|NCT02331680|454057630|FG002|Overall Study|Non-compliance with study drug|1|||
126210346|NCT02331680|454057628|FG000|Overall Study|Protocol Violation|0|||
126210347|NCT02331680|454057629|FG001|Overall Study|Protocol Violation|0|||
126210348|NCT02331680|454057630|FG002|Overall Study|Protocol Violation|3|||
126210349|NCT00602667|454057633|FG000|Overall Study|Still on Therapy|0|||
126210350|NCT00602667|454057634|FG001|Overall Study|Still on Therapy|2|||
126210351|NCT00602667|454057635|FG002|Overall Study|Still on Therapy|2|||
126210352|NCT00602667|454057633|FG000|Overall Study|Death|0|||
126210353|NCT00602667|454057634|FG001|Overall Study|Death|1|||
126210354|NCT00602667|454057635|FG002|Overall Study|Death|1|||
126210355|NCT00602667|454057633|FG000|Overall Study|Family request|3|||
126210356|NCT00602667|454057634|FG001|Overall Study|Family request|25|||
126210357|NCT00602667|454057635|FG002|Overall Study|Family request|6|||
126346246|NCT00226655|454562349|FG000|Overall Study|Death|13|||
126346247|NCT00226655|454562349|FG000|Overall Study|Withdrawal by Subject|15|||
126346248|NCT00226655|454562349|FG000|Overall Study|Adverse Event|35|||
126346249|NCT00226655|454562349|FG000|Overall Study|Physician Decision|6|||
126346250|NCT00226655|454562349|FG000|Overall Study|Clinical deterioration|10|||
126346251|NCT01285518|454562353|FG000|Overall Study|Lost to Follow-up|0|||
126346252|NCT01285518|454562354|FG001|Overall Study|Lost to Follow-up|0|||
126210358|NCT00602667|454057633|FG000|Overall Study|Excessive toxicity|1|||
126210359|NCT00602667|454057634|FG001|Overall Study|Excessive toxicity|1|||
126346253|NCT01285518|454562355|FG002|Overall Study|Lost to Follow-up|0|||
126346254|NCT01285518|454562356|FG003|Overall Study|Lost to Follow-up|0|||
126346255|NCT01285518|454562357|FG004|Overall Study|Lost to Follow-up|0|||
126210360|NCT00602667|454057635|FG002|Overall Study|Excessive toxicity|0|||
126210361|NCT00602667|454057633|FG000|Overall Study|Second malignancy|0|||
126210362|NCT00602667|454057634|FG001|Overall Study|Second malignancy|1|||
126210363|NCT00602667|454057635|FG002|Overall Study|Second malignancy|0|||
126210364|NCT00602667|454057633|FG000|Overall Study|Physician Decision|2|||
126210365|NCT00602667|454057634|FG001|Overall Study|Physician Decision|3|||
126210366|NCT00602667|454057635|FG002|Overall Study|Physician Decision|8|||
126210367|NCT00602667|454057633|FG000|Overall Study|Progressive disease|13|||
126210368|NCT00602667|454057634|FG001|Overall Study|Progressive disease|48|||
126210369|NCT00602667|454057635|FG002|Overall Study|Progressive disease|45|||
126210370|NCT00602667|454057633|FG000|Overall Study|Progressive disease prior to therapy|0|||
126210371|NCT00602667|454057634|FG001|Overall Study|Progressive disease prior to therapy|0|||
126210372|NCT00602667|454057635|FG002|Overall Study|Progressive disease prior to therapy|1|||
126210373|NCT04410978|454057636|FG000|Overall Study|Poor compliance to protocol|2|||
126210374|NCT04410978|454057637|FG001|Overall Study|Poor compliance to protocol|4|||
126210375|NCT04410978|454057636|FG000|Overall Study|Withdrawal by Subject|64|||
126210376|NCT04410978|454057637|FG001|Overall Study|Withdrawal by Subject|66|||
126210377|NCT04410978|454057636|FG000|Overall Study|Other|6|||
126210378|NCT04410978|454057637|FG001|Overall Study|Other|7|||
126210379|NCT04410978|454057636|FG000|Overall Study|Missing study status|1|||
126210380|NCT04410978|454057637|FG001|Overall Study|Missing study status|0|||
126210381|NCT05153629|454057638|FG000|Overall Study|Withdrawal by Subject|0|||
126210382|NCT05153629|454057639|FG001|Overall Study|Withdrawal by Subject|2|||
126210383|NCT04115488|454057640|FG000|Overall Study|Adverse Event|8|||
126210384|NCT04115488|454057641|FG001|Overall Study|Adverse Event|4|||
126210385|NCT04115488|454057640|FG000|Overall Study|Withdrawal by Subject|3|||
126210386|NCT04115488|454057641|FG001|Overall Study|Withdrawal by Subject|6|||
126210387|NCT04115488|454057640|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
126210388|NCT04115488|454057641|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
126210389|NCT04115488|454057640|FG000|Overall Study|Patient 's location change|1|||
126210390|NCT04115488|454057641|FG001|Overall Study|Patient 's location change|0|||
126210391|NCT04115488|454057640|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
126210392|NCT04115488|454057641|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
126210393|NCT01233284|454057642|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
126210394|NCT01233284|454057643|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126210395|NCT01233284|454057644|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126210396|NCT01233284|454057645|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126210397|NCT01233284|454057646|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126210398|NCT01233284|454057642|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126210399|NCT01233284|454057643|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
126210400|NCT01233284|454057644|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126210401|NCT01233284|454057645|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126210402|NCT01233284|454057646|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126210403|NCT01233284|454057642|FG000|Period 1 (4 Weeks)|Other|0|||
126210404|NCT01233284|454057643|FG001|Period 1 (4 Weeks)|Other|0|||
126210405|NCT01233284|454057644|FG002|Period 1 (4 Weeks)|Other|1|||
126210406|NCT01233284|454057645|FG003|Period 1 (4 Weeks)|Other|0|||
126210407|NCT01233284|454057646|FG004|Period 1 (4 Weeks)|Other|0|||
126210408|NCT01233284|454057642|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126210409|NCT01233284|454057643|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126210410|NCT01233284|454057644|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
126210411|NCT01233284|454057645|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126210412|NCT01233284|454057646|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126210413|NCT01233284|454057642|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126210414|NCT01233284|454057643|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126210415|NCT01233284|454057644|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
126210416|NCT01233284|454057645|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126210417|NCT01233284|454057646|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126210418|NCT01233284|454057642|FG000|Period 3 (4 Weeks)|Other|0|||
126210419|NCT01233284|454057643|FG001|Period 3 (4 Weeks)|Other|0|||
126210420|NCT01233284|454057644|FG002|Period 3 (4 Weeks)|Other|0|||
126210421|NCT01233284|454057645|FG003|Period 3 (4 Weeks)|Other|1|||
126210422|NCT01233284|454057646|FG004|Period 3 (4 Weeks)|Other|0|||
126210423|NCT01233284|454057642|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
126210424|NCT01233284|454057643|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
126210425|NCT01233284|454057644|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
126210426|NCT01233284|454057645|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
126210427|NCT01233284|454057646|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
126210428|NCT01233284|454057642|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
126210429|NCT01233284|454057643|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
126210430|NCT01233284|454057644|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
126210431|NCT01233284|454057645|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
126210432|NCT01233284|454057646|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
126210433|NCT01058707|454057647|FG000|Overall Study|Disease Progression|15|||
126210434|NCT01058707|454057648|FG001|Overall Study|Disease Progression|20|||
126210435|NCT01058707|454057649|FG002|Overall Study|Disease Progression|20|||
126210436|NCT01058707|454057650|FG003|Overall Study|Disease Progression|15|||
126210437|NCT01058707|454057651|FG004|Overall Study|Disease Progression|23|||
126210438|NCT01058707|454057652|FG005|Overall Study|Disease Progression|10|||
126210439|NCT01058707|454057653|FG006|Overall Study|Disease Progression|12|||
126210440|NCT01058707|454057647|FG000|Overall Study|Adverse Event|11|||
126210441|NCT01058707|454057648|FG001|Overall Study|Adverse Event|4|||
126210442|NCT01058707|454057649|FG002|Overall Study|Adverse Event|7|||
126210443|NCT01058707|454057650|FG003|Overall Study|Adverse Event|6|||
126210444|NCT01058707|454057651|FG004|Overall Study|Adverse Event|7|||
126210445|NCT01058707|454057652|FG005|Overall Study|Adverse Event|3|||
126210446|NCT01058707|454057653|FG006|Overall Study|Adverse Event|1|||
126210447|NCT01058707|454057647|FG000|Overall Study|Subject Decision|5|||
126210448|NCT01058707|454057648|FG001|Overall Study|Subject Decision|3|||
126210449|NCT01058707|454057649|FG002|Overall Study|Subject Decision|3|||
126210450|NCT01058707|454057650|FG003|Overall Study|Subject Decision|1|||
126210451|NCT01058707|454057651|FG004|Overall Study|Subject Decision|2|||
126210452|NCT01058707|454057652|FG005|Overall Study|Subject Decision|3|||
126210453|NCT01058707|454057653|FG006|Overall Study|Subject Decision|6|||
126210454|NCT01058707|454057647|FG000|Overall Study|Lost to Follow-up|0|||
126210455|NCT01058707|454057648|FG001|Overall Study|Lost to Follow-up|0|||
126210456|NCT01058707|454057649|FG002|Overall Study|Lost to Follow-up|1|||
126210457|NCT01058707|454057650|FG003|Overall Study|Lost to Follow-up|0|||
126210458|NCT01058707|454057651|FG004|Overall Study|Lost to Follow-up|0|||
126210459|NCT01058707|454057652|FG005|Overall Study|Lost to Follow-up|0|||
126210460|NCT01058707|454057653|FG006|Overall Study|Lost to Follow-up|0|||
126210461|NCT01058707|454057647|FG000|Overall Study|Reason Not Specified|0|||
126210462|NCT01058707|454057648|FG001|Overall Study|Reason Not Specified|3|||
126210463|NCT01058707|454057649|FG002|Overall Study|Reason Not Specified|2|||
126210464|NCT01058707|454057650|FG003|Overall Study|Reason Not Specified|0|||
126210465|NCT01058707|454057651|FG004|Overall Study|Reason Not Specified|7|||
126210466|NCT01058707|454057652|FG005|Overall Study|Reason Not Specified|1|||
126210467|NCT01058707|454057653|FG006|Overall Study|Reason Not Specified|7|||
126210468|NCT03280628|454058932|FG000|Overall Study|Lost to Follow-up|8|||
126210469|NCT03280628|454058933|FG001|Overall Study|Lost to Follow-up|6|||
126210470|NCT03280628|454058934|FG002|Overall Study|Lost to Follow-up|11|||
126210471|NCT01361308|454058937|FG000|Overall Study|Withdrawal by Subject|9|||
126210472|NCT01361308|454058938|FG001|Overall Study|Withdrawal by Subject|13|||
126210473|NCT01361308|454058937|FG000|Overall Study|Physician Decision|3|||
126210474|NCT01361308|454058938|FG001|Overall Study|Physician Decision|3|||
126346256|NCT01285518|454562358|FG005|Overall Study|Lost to Follow-up|1|||
126346257|NCT01285518|454562359|FG006|Overall Study|Lost to Follow-up|0|||
126346258|NCT01285518|454562360|FG007|Overall Study|Lost to Follow-up|0|||
126346259|NCT00294658|454562361|FG000|Overall Study|Death|0|||
126346260|NCT00294658|454562362|FG001|Overall Study|Death|1|||
126346261|NCT00294658|454562361|FG000|Overall Study|Lost to Follow-up|4|||
126346262|NCT00294658|454562362|FG001|Overall Study|Lost to Follow-up|0|||
126346263|NCT00294658|454562361|FG000|Overall Study|Physician Decision|1|||
126346264|NCT00294658|454562362|FG001|Overall Study|Physician Decision|2|||
126346265|NCT00294658|454562361|FG000|Overall Study|Pregnancy|0|||
126346266|NCT00294658|454562362|FG001|Overall Study|Pregnancy|1|||
126346267|NCT00294658|454562361|FG000|Overall Study|Withdrawal by Subject|0|||
126346268|NCT00294658|454562362|FG001|Overall Study|Withdrawal by Subject|4|||
126346269|NCT00294658|454562361|FG000|Overall Study|Found to have invasive thymoma|1|||
126346270|NCT00294658|454562362|FG001|Overall Study|Found to have invasive thymoma|0|||
126346271|NCT00294658|454562361|FG000|Overall Study|Patient and family were not satisfied|0|||
126346272|NCT00294658|454562362|FG001|Overall Study|Patient and family were not satisfied|1|||
126346273|NCT01910441|454562368|FG000|Overall Study|Sponsor decision|0|||
126346274|NCT01910441|454562369|FG001|Overall Study|Sponsor decision|2|||
126346275|NCT01910441|454562368|FG000|Overall Study|Lost to Follow-up|6|||
126346276|NCT01910441|454562369|FG001|Overall Study|Lost to Follow-up|5|||
126346277|NCT01910441|454562368|FG000|Overall Study|Withdrawal by Subject|0|||
126346278|NCT01910441|454562369|FG001|Overall Study|Withdrawal by Subject|1|||
126346279|NCT01910441|454562368|FG000|Overall Study|Non-compliance|0|||
126346280|NCT01910441|454562369|FG001|Overall Study|Non-compliance|1|||
126346281|NCT01910441|454562368|FG000|Overall Study|Adverse Event|1|||
126346282|NCT01910441|454562369|FG001|Overall Study|Adverse Event|0|||
126346283|NCT01910441|454562368|FG000|Overall Study|Physician Decision|0|||
126210475|NCT01361308|454058937|FG000|Overall Study|Lack of Efficacy|2|||
126210476|NCT01361308|454058938|FG001|Overall Study|Lack of Efficacy|0|||
126210477|NCT01361308|454058937|FG000|Overall Study|Protocol Violation|1|||
126210478|NCT01361308|454058938|FG001|Overall Study|Protocol Violation|0|||
126346284|NCT01910441|454562369|FG001|Overall Study|Physician Decision|1|||
126346285|NCT02340949|454562370|FG000|Overall Study|Adverse Event|4|||
126346286|NCT02340949|454562371|FG001|Overall Study|Adverse Event|2|||
126346287|NCT02340949|454562370|FG000|Overall Study|Withdrawal by Subject|2|||
126346288|NCT02340949|454562371|FG001|Overall Study|Withdrawal by Subject|0|||
126346289|NCT02340949|454562370|FG000|Overall Study|Progression disease|6|||
126346290|NCT02340949|454562371|FG001|Overall Study|Progression disease|2|||
126346291|NCT02340949|454562370|FG000|Overall Study|Death|3|||
126346292|NCT02340949|454562371|FG001|Overall Study|Death|0|||
126346293|NCT02340949|454562370|FG000|Overall Study|Physician Decision|1|||
126210479|NCT01361308|454058937|FG000|Overall Study|Lost to Follow-up|5|||
126346294|NCT02340949|454562371|FG001|Overall Study|Physician Decision|0|||
126210480|NCT01361308|454058938|FG001|Overall Study|Lost to Follow-up|4|||
126210481|NCT01361308|454058937|FG000|Overall Study|Adverse Event|8|||
126210482|NCT01361308|454058938|FG001|Overall Study|Adverse Event|4|||
126210483|NCT01361308|454058937|FG000|Overall Study|Eligibility Criteria Not Met|2|||
126346295|NCT01192178|454562372|FG000|Overall Study|Withdrawal by Subject|6|||
126346296|NCT01192178|454562373|FG001|Overall Study|Withdrawal by Subject|10|||
126210484|NCT01361308|454058938|FG001|Overall Study|Eligibility Criteria Not Met|3|||
126210485|NCT01361308|454058937|FG000|Overall Study|Failed C-SSRS|5|||
126210486|NCT01361308|454058938|FG001|Overall Study|Failed C-SSRS|2|||
126210487|NCT01361308|454058937|FG000|Overall Study|Other|0|||
126210488|NCT01361308|454058938|FG001|Overall Study|Other|1|||
126210489|NCT03839693|454058943|FG000|Overall Study|Lost to Follow-up|0|||
126210490|NCT03839693|454058944|FG001|Overall Study|Lost to Follow-up|2|||
126210491|NCT03839693|454058945|FG002|Overall Study|Lost to Follow-up|2|||
126210492|NCT03839693|454058943|FG000|Overall Study|Withdrawal by Subject|1|||
126210493|NCT03839693|454058944|FG001|Overall Study|Withdrawal by Subject|0|||
126210494|NCT03839693|454058945|FG002|Overall Study|Withdrawal by Subject|2|||
126210495|NCT03839693|454058943|FG000|Overall Study|subject moved out of the area|1|||
126210496|NCT03839693|454058944|FG001|Overall Study|subject moved out of the area|0|||
126210497|NCT03839693|454058945|FG002|Overall Study|subject moved out of the area|0|||
126210498|NCT00700115|454058954|FG000|Overall Study|Withdrawal by Subject|1|||
126210499|NCT00700115|454058955|FG001|Overall Study|Withdrawal by Subject|0|||
126210500|NCT00700115|454058954|FG000|Overall Study|Lost to Follow-up|0|||
126210501|NCT00700115|454058955|FG001|Overall Study|Lost to Follow-up|1|||
126210502|NCT02983305|454058960|FG000|Overall Study|incomplete data|2|||
126210503|NCT02983305|454058961|FG001|Overall Study|incomplete data|0|||
126210504|NCT01646268|454058962|FG000|Overall Study|Adverse Event|6|||
126210505|NCT01646268|454058963|FG001|Overall Study|Adverse Event|7|||
126210506|NCT01646268|454058962|FG000|Overall Study|Lack of Efficacy|1|||
126210507|NCT01646268|454058963|FG001|Overall Study|Lack of Efficacy|3|||
126210508|NCT01646268|454058962|FG000|Overall Study|Protocol Violation|0|||
126210509|NCT01646268|454058963|FG001|Overall Study|Protocol Violation|1|||
126210510|NCT01646268|454058962|FG000|Overall Study|Withdrawal by Subject|2|||
126210511|NCT01646268|454058963|FG001|Overall Study|Withdrawal by Subject|5|||
126210512|NCT01646268|454058962|FG000|Overall Study|Other|2|||
126210513|NCT01646268|454058963|FG001|Overall Study|Other|0|||
126210514|NCT01519635|454058968|FG000|Overall Study|Withdrawal by Subject|0|||
126210515|NCT01519635|454058969|FG001|Overall Study|Withdrawal by Subject|1|||
126210516|NCT01519635|454058968|FG000|Overall Study|No possibility to put a catheter|1|||
126210517|NCT01519635|454058969|FG001|Overall Study|No possibility to put a catheter|2|||
126210518|NCT01300741|454058970|FG000|Overall Study|Lens deposits|1|||
126210519|NCT01300741|454058970|FG000|Overall Study|Lost to Follow-up|1|||
126210520|NCT01300741|454058970|FG000|Overall Study|Discomfort|1|||
126210521|NCT02325414|454058971|FG000|Overall Study|Withdrawal by Subject|3|||
126210522|NCT02325414|454058972|FG001|Overall Study|Withdrawal by Subject|1|||
126210523|NCT02325414|454058971|FG000|Overall Study|Lost to Follow-up|5|||
126210524|NCT02325414|454058972|FG001|Overall Study|Lost to Follow-up|5|||
126210525|NCT00726882|454058974|FG000|Overall Study|Withdrawal by Subject|5|||
126210526|NCT00726882|454058974|FG000|Overall Study|Lost to Follow-up|7|||
126210527|NCT00726882|454058974|FG000|Overall Study|Other|10|||
126210528|NCT00560573|454058975|FG000|Overall Study|Death|4|||
126210529|NCT00560573|454058976|FG001|Overall Study|Death|1|||
126210530|NCT00560573|454058977|FG002|Overall Study|Death|4|||
126210531|NCT00560573|454058978|FG003|Overall Study|Death|5|||
126210532|NCT00560573|454058979|FG004|Overall Study|Death|1|||
126210533|NCT00560573|454058980|FG005|Overall Study|Death|10|||
126210534|NCT00560573|454058975|FG000|Overall Study|Lost to Follow-up|0|||
126210535|NCT00560573|454058976|FG001|Overall Study|Lost to Follow-up|0|||
126210536|NCT00560573|454058977|FG002|Overall Study|Lost to Follow-up|0|||
126210537|NCT00560573|454058978|FG003|Overall Study|Lost to Follow-up|1|||
126210538|NCT00560573|454058979|FG004|Overall Study|Lost to Follow-up|1|||
126210539|NCT00560573|454058980|FG005|Overall Study|Lost to Follow-up|0|||
126210540|NCT00560573|454058975|FG000|Overall Study|Withdrawal by Subject|0|||
126346297|NCT01192178|454562372|FG000|Overall Study|Protocol Violation|10|||
126346298|NCT01192178|454562373|FG001|Overall Study|Protocol Violation|3|||
126346299|NCT01192178|454562372|FG000|Overall Study|Physician Decision|2|||
126346300|NCT01192178|454562373|FG001|Overall Study|Physician Decision|4|||
126346301|NCT01192178|454562372|FG000|Overall Study|Lost to Follow-up|3|||
126346302|NCT01192178|454562373|FG001|Overall Study|Lost to Follow-up|3|||
126346303|NCT01192178|454562372|FG000|Overall Study|Adverse Event|2|||
126346304|NCT01192178|454562373|FG001|Overall Study|Adverse Event|1|||
126346305|NCT01192178|454562372|FG000|Overall Study|Lack of Efficacy|1|||
126346306|NCT01192178|454562373|FG001|Overall Study|Lack of Efficacy|2|||
126210541|NCT00560573|454058976|FG001|Overall Study|Withdrawal by Subject|0|||
126210542|NCT00560573|454058977|FG002|Overall Study|Withdrawal by Subject|0|||
126210543|NCT00560573|454058978|FG003|Overall Study|Withdrawal by Subject|1|||
126210544|NCT00560573|454058979|FG004|Overall Study|Withdrawal by Subject|1|||
126210545|NCT00560573|454058980|FG005|Overall Study|Withdrawal by Subject|0|||
126210546|NCT00560573|454058975|FG000|Overall Study|Other|2|||
126210547|NCT00560573|454058976|FG001|Overall Study|Other|2|||
126210548|NCT00560573|454058977|FG002|Overall Study|Other|2|||
126210549|NCT00560573|454058978|FG003|Overall Study|Other|3|||
126210550|NCT00560573|454058979|FG004|Overall Study|Other|3|||
126210551|NCT00560573|454058980|FG005|Overall Study|Other|3|||
126346307|NCT01977846|454562374|FG000|Total Study - Prospective|Death|0|||
126346308|NCT01977846|454562375|FG001|Total Study - Prospective|Death|1|||
126210552|NCT00560573|454058975|FG000|Overall Study|Enrolled, not treated|0|||
126210553|NCT00560573|454058976|FG001|Overall Study|Enrolled, not treated|0|||
126210554|NCT00560573|454058977|FG002|Overall Study|Enrolled, not treated|0|||
126210555|NCT00560573|454058978|FG003|Overall Study|Enrolled, not treated|0|||
126210556|NCT00560573|454058979|FG004|Overall Study|Enrolled, not treated|1|||
126210557|NCT00560573|454058980|FG005|Overall Study|Enrolled, not treated|0|||
126210558|NCT01339273|454058981|FG000|Overall Study|Lost to Follow-up|8|||
126210559|NCT01339273|454058982|FG001|Overall Study|Lost to Follow-up|8|||
126210560|NCT00347776|454058983|FG000|1.5 Month Follow-up|Death|2|||
126210561|NCT00347776|454058984|FG001|1.5 Month Follow-up|Death|0|||
126210562|NCT00347776|454058985|FG002|1.5 Month Follow-up|Death|0|||
126210563|NCT00347776|454058983|FG000|1.5 Month Follow-up|reached the endpoint|12|||
126210564|NCT00347776|454058984|FG001|1.5 Month Follow-up|reached the endpoint|8|||
126210565|NCT00347776|454058985|FG002|1.5 Month Follow-up|reached the endpoint|12|||
126210566|NCT00347776|454058983|FG000|6 Month Follow-up|Death|2|||
126210567|NCT00347776|454058984|FG001|6 Month Follow-up|Death|1|||
126210568|NCT00347776|454058985|FG002|6 Month Follow-up|Death|3|||
126210569|NCT00347776|454058983|FG000|6 Month Follow-up|reached endpont|20|||
126210570|NCT00347776|454058984|FG001|6 Month Follow-up|reached endpont|12|||
126210571|NCT00347776|454058985|FG002|6 Month Follow-up|reached endpont|15|||
126210572|NCT00347776|454058983|FG000|12 Month Follow-up|Lost to Follow-up|7|||
126210573|NCT00347776|454058984|FG001|12 Month Follow-up|Lost to Follow-up|6|||
126210574|NCT00347776|454058985|FG002|12 Month Follow-up|Lost to Follow-up|6|||
126210575|NCT00347776|454058983|FG000|12 Month Follow-up|Death|3|||
126210576|NCT00347776|454058984|FG001|12 Month Follow-up|Death|4|||
126210577|NCT00347776|454058985|FG002|12 Month Follow-up|Death|4|||
126210578|NCT00347776|454058983|FG000|12 Month Follow-up|Reached endpoint|13|||
126210579|NCT00347776|454058984|FG001|12 Month Follow-up|Reached endpoint|6|||
126210580|NCT00347776|454058985|FG002|12 Month Follow-up|Reached endpoint|9|||
126210581|NCT00518531|454058986|FG000|Treatment Period 1|Adverse Event|5|||
126210582|NCT00518531|454058987|FG001|Treatment Period 1|Adverse Event|0|||
126210583|NCT00518531|454058986|FG000|Treatment Period 1|Lost to Follow-up|5|||
126210584|NCT00518531|454058987|FG001|Treatment Period 1|Lost to Follow-up|3|||
126210585|NCT00518531|454058986|FG000|Treatment Period 1|Physician Decision|1|||
126210586|NCT00518531|454058987|FG001|Treatment Period 1|Physician Decision|0|||
126210587|NCT00518531|454058986|FG000|Treatment Period 1|Protocol Violation|2|||
126210588|NCT00518531|454058987|FG001|Treatment Period 1|Protocol Violation|0|||
126210589|NCT00518531|454058986|FG000|Treatment Period 1|Withdrawal by Subject|4|||
126346309|NCT01977846|454562374|FG000|Total Study - Prospective|Lost to Follow-up|0|||
126210590|NCT00518531|454058987|FG001|Treatment Period 1|Withdrawal by Subject|6|||
126346310|NCT01977846|454562375|FG001|Total Study - Prospective|Lost to Follow-up|8|||
126346311|NCT01977846|454562374|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
126346312|NCT01977846|454562375|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
126346313|NCT01977846|454562374|FG000|Total Study - Prospective|Not available at time of visit|0|||
126346314|NCT01977846|454562375|FG001|Total Study - Prospective|Not available at time of visit|5|||
126346315|NCT01977846|454562374|FG000|Total Study - Prospective|No show|0|||
126346316|NCT01977846|454562375|FG001|Total Study - Prospective|No show|1|||
126346317|NCT01977846|454562374|FG000|Total Study - Prospective|Protocol Violation|0|||
126346318|NCT01977846|454562375|FG001|Total Study - Prospective|Protocol Violation|1|||
126346319|NCT02460289|454562376|FG000|Overall Study|Adverse Event|1|||
126346320|NCT02460289|454562376|FG000|Overall Study|Withdrawal by Subject|8|||
126346321|NCT02460289|454562376|FG000|Overall Study|Lost to Follow-up|1|||
126346322|NCT01155570|454562377|FG000|Overall Study|Adverse Event|39|||
126346323|NCT01155570|454562377|FG000|Overall Study|Lack of Efficacy|46|||
126346324|NCT01155570|454562377|FG000|Overall Study|Participant's Economic Reasons|17|||
126346325|NCT01155570|454562377|FG000|Overall Study|No Hospital Visits|7|||
126346326|NCT01155570|454562377|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
126346327|NCT01155570|454562377|FG000|Overall Study|Adverse Event + Other Reasons|7|||
126346328|NCT01155570|454562377|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
126346329|NCT01155570|454562377|FG000|Overall Study|Other Reasons|23|||
126346330|NCT00296517|454562378|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
126210591|NCT00518531|454058986|FG000|Treatment Period 1|Early crossover|1|||
126210592|NCT00518531|454058987|FG001|Treatment Period 1|Early crossover|3|||
126210593|NCT00518531|454058986|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126210594|NCT00518531|454058987|FG001|Treatment Period 2|Withdrawal by Subject|8|||
126346331|NCT00296517|454562379|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
126346332|NCT00296517|454562378|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
126346333|NCT00296517|454562379|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
126210595|NCT00518531|454058986|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
126210596|NCT00518531|454058987|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
126210597|NCT00518531|454058986|FG000|Treatment Period 2|Adverse Event|1|||
126346334|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
126346335|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
126346336|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
126210598|NCT00518531|454058987|FG001|Treatment Period 2|Adverse Event|7|||
126012780|NCT03743246|453340963|FG002|Pre-Treatment Period|Death|0|||
126012781|NCT03743246|453340964|FG003|Pre-Treatment Period|Death|1|||
126012782|NCT03743246|453340961|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
126012783|NCT03743246|453340962|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
126012784|NCT03743246|453340963|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
126012785|NCT03743246|453340964|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
126012786|NCT03743246|453340961|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
126091128|NCT03820947|453626920|FG002|Overall Study|Lost to Follow-up|0|||
126210599|NCT00518531|454058986|FG000|Treatment Period 2|Protocol-specified criteria|0|||
126210600|NCT00518531|454058987|FG001|Treatment Period 2|Protocol-specified criteria|1|||
126210601|NCT00518531|454058986|FG000|Treatment Period 2|Non-compliance|1|||
126210602|NCT00518531|454058987|FG001|Treatment Period 2|Non-compliance|2|||
126210603|NCT00602927|454058990|FG000|Period 1: 13 Days|Protocol Violation|2|||
126210604|NCT00602927|454058991|FG001|Period 1: 13 Days|Protocol Violation|4|||
126210605|NCT00602927|454058990|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
126210606|NCT00602927|454058991|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
126210607|NCT00602927|454058990|FG000|Period 1: 13 Days|Time|1|||
126210608|NCT00602927|454058991|FG001|Period 1: 13 Days|Time|0|||
126210609|NCT00602927|454058990|FG000|Period 1: 13 Days|Claustrophobia|0|||
126210610|NCT00602927|454058991|FG001|Period 1: 13 Days|Claustrophobia|1|||
126210611|NCT00602927|454058990|FG000|Period 2: 14 Days|Protocol Violation|0|||
126210612|NCT00602927|454058991|FG001|Period 2: 14 Days|Protocol Violation|2|||
126210613|NCT00602927|454058990|FG000|Period 3: 13 Days|Protocol Violation|0|||
126210614|NCT00602927|454058991|FG001|Period 3: 13 Days|Protocol Violation|1|||
126210615|NCT00602927|454058990|FG000|Period 3: 13 Days|MRI data quality|2|||
126210616|NCT00602927|454058991|FG001|Period 3: 13 Days|MRI data quality|2|||
126210617|NCT03722849|454059001|FG000|Overall Study|Withdrawal by Subject|1|||
126210618|NCT03722849|454059002|FG001|Overall Study|Withdrawal by Subject|1|||
126210619|NCT01298362|454059005|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
126210620|NCT01298362|454059006|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
126210621|NCT00762073|454059013|FG000|Overall Study|Lack of Efficacy|1|||
126210622|NCT00762073|454059014|FG001|Overall Study|Lack of Efficacy|1|||
126210623|NCT00762073|454059015|FG002|Overall Study|Lack of Efficacy|0|||
126210624|NCT00762073|454059016|FG003|Overall Study|Lack of Efficacy|0|||
126210625|NCT00762073|454059013|FG000|Overall Study|Adverse Event|1|||
126210626|NCT00762073|454059014|FG001|Overall Study|Adverse Event|0|||
126210627|NCT00762073|454059015|FG002|Overall Study|Adverse Event|1|||
126210628|NCT00762073|454059016|FG003|Overall Study|Adverse Event|1|||
126210629|NCT00762073|454059013|FG000|Overall Study|Significant Subject Noncompliance|0|||
126210630|NCT00762073|454059014|FG001|Overall Study|Significant Subject Noncompliance|1|||
126210631|NCT00762073|454059015|FG002|Overall Study|Significant Subject Noncompliance|0|||
126210632|NCT00762073|454059016|FG003|Overall Study|Significant Subject Noncompliance|1|||
126210633|NCT00762073|454059013|FG000|Overall Study|Withdrawal by Subject|1|||
126210634|NCT00762073|454059014|FG001|Overall Study|Withdrawal by Subject|2|||
126210635|NCT00762073|454059015|FG002|Overall Study|Withdrawal by Subject|1|||
126210636|NCT00762073|454059016|FG003|Overall Study|Withdrawal by Subject|1|||
126210637|NCT00762073|454059013|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
126210638|NCT00762073|454059014|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
126210639|NCT00762073|454059015|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
126210640|NCT00762073|454059016|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
126210641|NCT00326625|454059017|FG000|Overall Study|Adverse Event|20|||
126210642|NCT00326625|454059018|FG001|Overall Study|Adverse Event|9|||
126210643|NCT00326625|454059017|FG000|Overall Study|Withdrawal by Subject|15|||
126210644|NCT00326625|454059018|FG001|Overall Study|Withdrawal by Subject|12|||
126210645|NCT00326625|454059017|FG000|Overall Study|Death|18|||
126210646|NCT00326625|454059018|FG001|Overall Study|Death|16|||
126210647|NCT00326625|454059017|FG000|Overall Study|Lost to Follow-up|1|||
126210648|NCT00326625|454059018|FG001|Overall Study|Lost to Follow-up|0|||
126210649|NCT00326625|454059017|FG000|Overall Study|prescheduled medical intervention|0|||
126210650|NCT00326625|454059018|FG001|Overall Study|prescheduled medical intervention|1|||
126210651|NCT01265875|454059019|FG000|Overall Study|Uncooperative/unreliable|1|||
126210652|NCT05275673|454059020|FG000|Overall Study|Study Termination by Sponsor|2|||
126210653|NCT05275673|454059021|FG001|Overall Study|Study Termination by Sponsor|3|||
126210654|NCT05275673|454059020|FG000|Overall Study|Death|1|||
126210655|NCT05275673|454059021|FG001|Overall Study|Death|0|||
126210656|NCT05275673|454059020|FG000|Overall Study|Withdrawal by Subject|1|||
126210657|NCT05275673|454059021|FG001|Overall Study|Withdrawal by Subject|0|||
126210658|NCT04456998|454059022|FG000|Overall Study|Adverse Event|0|||
126210659|NCT04456998|454059023|FG001|Overall Study|Adverse Event|4|||
126210660|NCT04456998|454059022|FG000|Overall Study|Protocol Deviation|0|||
126210661|NCT04456998|454059023|FG001|Overall Study|Protocol Deviation|1|||
126210662|NCT04456998|454059022|FG000|Overall Study|Withdrawal by Subject|0|||
126210663|NCT04456998|454059023|FG001|Overall Study|Withdrawal by Subject|1|||
126210664|NCT04882085|454059024|FG000|Overall Study|Death|6|||
126210665|NCT04882085|454059025|FG001|Overall Study|Death|9|||
126210666|NCT04882085|454059024|FG000|Overall Study|Withdrawal by Subject|0|||
126210667|NCT04882085|454059025|FG001|Overall Study|Withdrawal by Subject|3|||
126210668|NCT04882085|454059024|FG000|Overall Study|Randomized not treated|1|||
126012787|NCT03743246|453340962|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
126210669|NCT04882085|454059025|FG001|Overall Study|Randomized not treated|0|||
126210670|NCT00400985|454059026|FG000|Overall Study|Withdrawal by Subject|5|||
126210671|NCT00400985|454059026|FG000|Overall Study|system modification|8|||
126210672|NCT00400985|454059026|FG000|Overall Study|Death|30|||
126210673|NCT00400985|454059026|FG000|Overall Study|Lost to Follow-up|9|||
126210674|NCT03792633|454059031|FG000|Overall Study|Alternative Treatment|17|||
126012788|NCT03743246|453340963|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
126210675|NCT03792633|454059032|FG001|Overall Study|Alternative Treatment|19|||
126210676|NCT03792633|454059031|FG000|Overall Study|Death|2|||
126210677|NCT03792633|454059032|FG001|Overall Study|Death|0|||
126210678|NCT03792633|454059031|FG000|Overall Study|Disease progression|8|||
126210679|NCT03792633|454059032|FG001|Overall Study|Disease progression|9|||
126210680|NCT03792633|454059031|FG000|Overall Study|Lost to Follow-up|1|||
126210681|NCT03792633|454059032|FG001|Overall Study|Lost to Follow-up|1|||
126210682|NCT03792633|454059031|FG000|Overall Study|Screen fail|1|||
126210683|NCT03792633|454059032|FG001|Overall Study|Screen fail|0|||
126210684|NCT03792633|454059031|FG000|Overall Study|Second malignancy|0|||
126210685|NCT03792633|454059032|FG001|Overall Study|Second malignancy|1|||
126210686|NCT03179462|454059033|FG000|Overall Study|screening failure|1|||
126210687|NCT03179462|454059034|FG001|Overall Study|screening failure|2|||
126210688|NCT03179462|454059035|FG002|Overall Study|screening failure|0|||
126210689|NCT00816166|454059036|FG000|Overall Study|Lost to Follow-up|6|||
126210690|NCT00816166|454059037|FG001|Overall Study|Lost to Follow-up|10|||
126210691|NCT00816166|454059036|FG000|Overall Study|Death|4|||
126210692|NCT00816166|454059037|FG001|Overall Study|Death|2|||
126210693|NCT03743571|454059040|FG000|Overall Study|Withdrawal by Subject|1|||
126210694|NCT03743571|454059041|FG001|Overall Study|Withdrawal by Subject|1|||
126210695|NCT03743571|454059040|FG000|Overall Study|Lost to Follow-up|1|||
126210696|NCT03743571|454059041|FG001|Overall Study|Lost to Follow-up|2|||
126210697|NCT01821391|454059054|FG000|Overall Study|Adverse Event|1|||
126210698|NCT01821391|454059055|FG001|Overall Study|Adverse Event|0|||
126210699|NCT04880850|454059064|FG000|Overall Study|Death|2|||
126210700|NCT04880850|454059065|FG001|Overall Study|Death|1|||
126210701|NCT04880850|454059064|FG000|Overall Study|Lost to Follow-up|3|||
126210702|NCT04880850|454059065|FG001|Overall Study|Lost to Follow-up|6|||
126210703|NCT04880850|454059064|FG000|Overall Study|Physician Decision|2|||
126210704|NCT04880850|454059065|FG001|Overall Study|Physician Decision|1|||
126210705|NCT04880850|454059064|FG000|Overall Study|Withdrawal by Subject|9|||
126210706|NCT04880850|454059065|FG001|Overall Study|Withdrawal by Subject|10|||
126012789|NCT03743246|453340964|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
126012790|NCT03743246|453340961|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
126210707|NCT01608321|454059066|FG000|Overall Study|Withdrawal by Subject|1|||
126210708|NCT01608321|454059067|FG001|Overall Study|Withdrawal by Subject|0|||
126210709|NCT03417102|454059068|FG000|Overall Study|Adverse Event|0|||
126210710|NCT03417102|454059069|FG001|Overall Study|Adverse Event|1|||
126210711|NCT03417102|454059068|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
126210712|NCT03417102|454059069|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
126210713|NCT03417102|454059068|FG000|Overall Study|Other|0|||
126210714|NCT03417102|454059069|FG001|Overall Study|Other|1|||
126210715|NCT02062385|454059070|FG000|Overall Study|Adverse Event|19|||
126210716|NCT02062385|454059071|FG001|Overall Study|Adverse Event|13|||
126210717|NCT02062385|454059072|FG002|Overall Study|Adverse Event|1|||
126210718|NCT02062385|454059073|FG003|Overall Study|Adverse Event|0|||
126210719|NCT02062385|454059070|FG000|Overall Study|Protocol Violation|1|||
126210720|NCT02062385|454059071|FG001|Overall Study|Protocol Violation|0|||
126210721|NCT02062385|454059072|FG002|Overall Study|Protocol Violation|0|||
126210722|NCT02062385|454059073|FG003|Overall Study|Protocol Violation|0|||
126210723|NCT02062385|454059070|FG000|Overall Study|Incomplete EPI by database lock|2|||
126210724|NCT02062385|454059071|FG001|Overall Study|Incomplete EPI by database lock|0|||
126210725|NCT02062385|454059072|FG002|Overall Study|Incomplete EPI by database lock|0|||
126346337|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
126346338|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
126346339|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
126346340|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
126346341|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
126346342|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
126346343|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
126346344|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
126346345|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
126346346|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
126346347|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
126346348|NCT00964782|454562383|FG000|Overall Study|Lost to Follow-up|1|||
126346349|NCT00964782|454562384|FG001|Overall Study|Lost to Follow-up|0|||
126346350|NCT00596635|454562388|FG000|Overall Study|Lost to Follow-up|0|||
126346351|NCT00596635|454562389|FG001|Overall Study|Lost to Follow-up|2|||
126346352|NCT00596635|454562390|FG002|Overall Study|Lost to Follow-up|0|||
126346353|NCT00596635|454562388|FG000|Overall Study|Treatment for symptomatic UTI|4|||
126346354|NCT00596635|454562389|FG001|Overall Study|Treatment for symptomatic UTI|6|||
126346355|NCT00596635|454562390|FG002|Overall Study|Treatment for symptomatic UTI|3|||
126346356|NCT00596635|454562388|FG000|Overall Study|Hip fracture|2|||
126346357|NCT00596635|454562389|FG001|Overall Study|Hip fracture|3|||
126346358|NCT00596635|454562390|FG002|Overall Study|Hip fracture|3|||
126346359|NCT00596635|454562388|FG000|Overall Study|Could not provide urine specimen|1|||
126346360|NCT00596635|454562389|FG001|Overall Study|Could not provide urine specimen|2|||
126346361|NCT00596635|454562390|FG002|Overall Study|Could not provide urine specimen|2|||
126346362|NCT01143324|454562392|FG000|Overall Study|Lost to Follow-up|11|||
126346363|NCT01143324|454562392|FG000|Overall Study|Withdrawal by Subject|4|||
126346364|NCT01143324|454562392|FG000|Overall Study|Explant of the device|4|||
126346365|NCT01101178|454562397|FG000|Period 1|Withdrawal by Subject|1|||
126346366|NCT01101178|454562398|FG001|Period 1|Withdrawal by Subject|2|||
126346367|NCT01101178|454562397|FG000|Period 1|Positive drug screen|1|||
126346368|NCT01101178|454562398|FG001|Period 1|Positive drug screen|1|||
126346369|NCT01101178|454562397|FG000|Period 1|Adverse Event|2|||
126346370|NCT01101178|454562398|FG001|Period 1|Adverse Event|1|||
126346371|NCT01101178|454562397|FG000|Period 2|Withdrawal by Subject|0|||
126346372|NCT01101178|454562398|FG001|Period 2|Withdrawal by Subject|1|||
126346373|NCT01850641|454562399|FG000|Overall Study|Physician Decision|1|||
126346374|NCT01850641|454562399|FG000|Overall Study|Decrease in serum phosphorus|1|||
126346375|NCT01850641|454562399|FG000|Overall Study|Decrease in serum calcium|2|||
126346376|NCT01850641|454562399|FG000|Overall Study|Increase in serum ferritin|1|||
126346377|NCT00141817|454562400|FG000|Overall Study|Protocol Violation|0|||
126346378|NCT00141817|454562401|FG001|Overall Study|Protocol Violation|0|||
126346379|NCT00141817|454562402|FG002|Overall Study|Protocol Violation|1|||
126346380|NCT00141817|454562403|FG003|Overall Study|Protocol Violation|0|||
126346381|NCT00141817|454562400|FG000|Overall Study|Parent request|1|||
126346382|NCT00141817|454562401|FG001|Overall Study|Parent request|0|||
126346383|NCT00141817|454562402|FG002|Overall Study|Parent request|0|||
126346384|NCT00141817|454562403|FG003|Overall Study|Parent request|0|||
126346385|NCT00127803|454562404|FG000|Overall Study|Adverse Event|2|||
126346386|NCT00127803|454562405|FG001|Overall Study|Adverse Event|0|||
126346387|NCT00127803|454562406|FG002|Overall Study|Adverse Event|0|||
126346388|NCT00127803|454562407|FG003|Overall Study|Adverse Event|0|||
126346389|NCT00127803|454562404|FG000|Overall Study|Withdrawal by Subject|1|||
126346390|NCT00127803|454562405|FG001|Overall Study|Withdrawal by Subject|0|||
126346391|NCT00127803|454562406|FG002|Overall Study|Withdrawal by Subject|0|||
126346392|NCT00127803|454562407|FG003|Overall Study|Withdrawal by Subject|0|||
126346393|NCT00127803|454562404|FG000|Overall Study|Lost to Follow-up|0|||
126346394|NCT00127803|454562405|FG001|Overall Study|Lost to Follow-up|0|||
126346395|NCT00127803|454562406|FG002|Overall Study|Lost to Follow-up|0|||
126346396|NCT00127803|454562407|FG003|Overall Study|Lost to Follow-up|1|||
126346397|NCT00862992|454562408|FG000|Overall Study|Adverse Event|2|||
126346398|NCT00862992|454562409|FG001|Overall Study|Adverse Event|1|||
126346399|NCT00862992|454562410|FG002|Overall Study|Adverse Event|1|||
126346400|NCT00862992|454562408|FG000|Overall Study|Physician Decision|1|||
126346401|NCT00862992|454562409|FG001|Overall Study|Physician Decision|0|||
126346402|NCT00862992|454562410|FG002|Overall Study|Physician Decision|0|||
126346403|NCT00862992|454562408|FG000|Overall Study|Withdrawal by Subject|0|||
126346404|NCT00862992|454562409|FG001|Overall Study|Withdrawal by Subject|0|||
126346405|NCT00862992|454562410|FG002|Overall Study|Withdrawal by Subject|2|||
126346406|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
126346407|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
126346408|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
126346409|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Death|0|||
126346410|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Death|0|||
126346411|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Death|1|||
126346412|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
126346413|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
126346414|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
126346415|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
126346416|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
126346417|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
126346418|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
126346419|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
126346420|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
126346421|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
126346422|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
126346423|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
126346424|NCT02696798|454562419|FG000|Extended Treatment Period|Adverse Event|1|||
126346425|NCT02696798|454562420|FG001|Extended Treatment Period|Adverse Event|4|||
126346426|NCT02696798|454562421|FG002|Extended Treatment Period|Adverse Event|5|||
126346427|NCT02696798|454562419|FG000|Extended Treatment Period|Lack of Efficacy|7|||
126346428|NCT02696798|454562420|FG001|Extended Treatment Period|Lack of Efficacy|2|||
126346429|NCT02696798|454562421|FG002|Extended Treatment Period|Lack of Efficacy|2|||
126346430|NCT02696798|454562419|FG000|Extended Treatment Period|Lost to Follow-up|1|||
126346431|NCT02696798|454562420|FG001|Extended Treatment Period|Lost to Follow-up|0|||
126012791|NCT03743246|453340962|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
126346432|NCT02696798|454562421|FG002|Extended Treatment Period|Lost to Follow-up|0|||
126210726|NCT02062385|454059073|FG003|Overall Study|Incomplete EPI by database lock|0|||
126210727|NCT02062385|454059070|FG000|Overall Study|Moved|10|||
126210728|NCT02062385|454059071|FG001|Overall Study|Moved|11|||
126210729|NCT02062385|454059072|FG002|Overall Study|Moved|1|||
126210730|NCT02062385|454059073|FG003|Overall Study|Moved|0|||
126210731|NCT02062385|454059070|FG000|Overall Study|Withdrawn by parent/guardian|46|||
126210732|NCT02062385|454059071|FG001|Overall Study|Withdrawn by parent/guardian|41|||
126210733|NCT02062385|454059072|FG002|Overall Study|Withdrawn by parent/guardian|9|||
126346433|NCT02696798|454562419|FG000|Extended Treatment Period|Physician Decision|0|||
126346434|NCT02696798|454562420|FG001|Extended Treatment Period|Physician Decision|1|||
126346435|NCT02696798|454562421|FG002|Extended Treatment Period|Physician Decision|0|||
126346436|NCT02696798|454562419|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
126346437|NCT02696798|454562420|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
126346438|NCT02696798|454562421|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
126346439|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
126346440|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
126346441|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
126346442|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
126346443|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
126346444|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
126346445|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
126346446|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
126346447|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
126346448|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
126346449|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
126346450|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
126346451|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
126346452|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
126346453|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
126346454|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
126346455|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
126346456|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
126346457|NCT03675308|454564535|FG000|Overall Study|Adverse Event|3|||
126346458|NCT03675308|454564536|FG001|Overall Study|Adverse Event|2|||
126346459|NCT03675308|454564535|FG000|Overall Study|Withdrawal by Subject|6|||
126346460|NCT03675308|454564536|FG001|Overall Study|Withdrawal by Subject|4|||
126346461|NCT03675308|454564535|FG000|Overall Study|Lost to Follow-up|3|||
126346462|NCT03675308|454564536|FG001|Overall Study|Lost to Follow-up|0|||
126346463|NCT03675308|454564535|FG000|Overall Study|Lack of Efficacy|1|||
126346464|NCT03675308|454564536|FG001|Overall Study|Lack of Efficacy|1|||
126346465|NCT03675308|454564535|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
126346466|NCT03675308|454564536|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
126346467|NCT03675308|454564535|FG000|Overall Study|Other|0|||
126346468|NCT03675308|454564536|FG001|Overall Study|Other|1|||
126346469|NCT01386385|454564537|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
126346470|NCT01386385|454564538|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346471|NCT01386385|454564539|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346472|NCT01386385|454564540|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346473|NCT01386385|454564541|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346474|NCT01386385|454564542|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346475|NCT01386385|454564543|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346476|NCT01386385|454564544|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346477|NCT01386385|454564537|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
126346478|NCT01386385|454564538|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346479|NCT01386385|454564539|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346480|NCT01386385|454564540|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346481|NCT01386385|454564541|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346482|NCT01386385|454564542|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346483|NCT01386385|454564543|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346484|NCT01386385|454564544|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346485|NCT01386385|454564537|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346486|NCT01386385|454564538|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346487|NCT01386385|454564539|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
126346488|NCT01386385|454564540|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346489|NCT01386385|454564541|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346490|NCT01386385|454564542|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346491|NCT01386385|454564543|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126210734|NCT02062385|454059073|FG003|Overall Study|Withdrawn by parent/guardian|8|||
126210735|NCT02062385|454059070|FG000|Overall Study|Death|0|||
126210736|NCT02062385|454059071|FG001|Overall Study|Death|0|||
126210737|NCT02062385|454059072|FG002|Overall Study|Death|0|||
126210738|NCT02062385|454059073|FG003|Overall Study|Death|1|||
126210739|NCT02062385|454059070|FG000|Overall Study|Lost to Follow-up|0|||
126210740|NCT02062385|454059071|FG001|Overall Study|Lost to Follow-up|0|||
126210741|NCT02062385|454059072|FG002|Overall Study|Lost to Follow-up|1|||
126210742|NCT02062385|454059073|FG003|Overall Study|Lost to Follow-up|0|||
126210743|NCT00526227|454059074|FG000|Overall Study|Device not implanted|1|||
126210744|NCT00526227|454059074|FG000|Overall Study|Death|1|||
126210745|NCT03222856|454059077|FG000|Overall Study|Adverse Event|6|||
126210746|NCT03222856|454059077|FG000|Overall Study|Death|1|||
126210747|NCT02503215|454061065|FG000|Overall Study|Unable to wear compression stockings|1|||
126210748|NCT02503215|454061065|FG000|Overall Study|Unable to use positive airway pressure|2|||
126210749|NCT00706901|454061066|FG000|Overall Study|Lost to Follow-up|2|||
126210750|NCT00706901|454061067|FG001|Overall Study|Lost to Follow-up|3|||
126210751|NCT00706901|454061068|FG002|Overall Study|Lost to Follow-up|2|||
126210752|NCT00706901|454061066|FG000|Overall Study|Withdrawal by Subject|4|||
126210753|NCT00706901|454061067|FG001|Overall Study|Withdrawal by Subject|2|||
126210754|NCT00706901|454061068|FG002|Overall Study|Withdrawal by Subject|5|||
126210755|NCT00706901|454061066|FG000|Overall Study|In Jail|1|||
126210756|NCT00706901|454061067|FG001|Overall Study|In Jail|0|||
126210757|NCT00706901|454061068|FG002|Overall Study|In Jail|1|||
126210758|NCT00706901|454061066|FG000|Overall Study|Death|1|||
126210759|NCT00706901|454061067|FG001|Overall Study|Death|0|||
126210760|NCT00706901|454061068|FG002|Overall Study|Death|0|||
126210761|NCT03433482|454061069|FG000|Overall Study|Lost to Follow-up|1|||
126210762|NCT03433482|454061070|FG001|Overall Study|Lost to Follow-up|0|||
126210763|NCT03433482|454061071|FG002|Overall Study|Lost to Follow-up|1|||
126210764|NCT03433482|454061072|FG003|Overall Study|Lost to Follow-up|1|||
126210765|NCT03433482|454061069|FG000|Overall Study|Withdrawal by Subject|0|||
126210766|NCT03433482|454061070|FG001|Overall Study|Withdrawal by Subject|0|||
126210767|NCT03433482|454061071|FG002|Overall Study|Withdrawal by Subject|1|||
126210768|NCT03433482|454061072|FG003|Overall Study|Withdrawal by Subject|0|||
126210769|NCT03433482|454061069|FG000|Overall Study|Unknown reason|0|||
126210770|NCT03433482|454061070|FG001|Overall Study|Unknown reason|0|||
126210771|NCT03433482|454061071|FG002|Overall Study|Unknown reason|2|||
126210772|NCT03433482|454061072|FG003|Overall Study|Unknown reason|0|||
126210773|NCT00594568|454061073|FG000|Initial Treatment|Adverse Event|51|||
126210774|NCT00594568|454061074|FG001|Initial Treatment|Adverse Event|121|||
126210775|NCT00594568|454061075|FG002|Initial Treatment|Adverse Event|144|||
126210776|NCT00594568|454061073|FG000|Initial Treatment|Death|6|||
126210777|NCT00594568|454061074|FG001|Initial Treatment|Death|11|||
126210778|NCT00594568|454061075|FG002|Initial Treatment|Death|15|||
126210779|NCT00594568|454061073|FG000|Initial Treatment|Lost to Follow-up|4|||
126210780|NCT00594568|454061074|FG001|Initial Treatment|Lost to Follow-up|1|||
126210781|NCT00594568|454061075|FG002|Initial Treatment|Lost to Follow-up|4|||
126210782|NCT00594568|454061073|FG000|Initial Treatment|Physician Decision|3|||
126210783|NCT00594568|454061074|FG001|Initial Treatment|Physician Decision|2|||
126210784|NCT00594568|454061075|FG002|Initial Treatment|Physician Decision|4|||
126210785|NCT00594568|454061073|FG000|Initial Treatment|Protocol Violation|2|||
126210786|NCT00594568|454061074|FG001|Initial Treatment|Protocol Violation|2|||
126210787|NCT00594568|454061075|FG002|Initial Treatment|Protocol Violation|5|||
126210788|NCT00594568|454061073|FG000|Initial Treatment|Withdrawal by Subject|25|||
126210789|NCT00594568|454061074|FG001|Initial Treatment|Withdrawal by Subject|31|||
126210790|NCT00594568|454061075|FG002|Initial Treatment|Withdrawal by Subject|46|||
126210791|NCT00594568|454061073|FG000|Initial Treatment|Sponsor decision|193|||
126210792|NCT00594568|454061074|FG001|Initial Treatment|Sponsor decision|142|||
126210793|NCT00594568|454061075|FG002|Initial Treatment|Sponsor decision|147|||
126210794|NCT00594568|454061073|FG000|Initial Treatment|Caregiver decision|21|||
126346492|NCT01386385|454564544|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346493|NCT01386385|454564537|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126210795|NCT00594568|454061074|FG001|Initial Treatment|Caregiver decision|36|||
126210796|NCT00594568|454061075|FG002|Initial Treatment|Caregiver decision|36|||
126210797|NCT00594568|454061073|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
126210798|NCT00594568|454061074|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
126210799|NCT00594568|454061075|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
126210800|NCT00594568|454061073|FG000|Initial Treatment|Entry criteria exclusion|0|||
126210801|NCT00594568|454061074|FG001|Initial Treatment|Entry criteria exclusion|1|||
126210802|NCT00594568|454061075|FG002|Initial Treatment|Entry criteria exclusion|1|||
126210803|NCT00594568|454061073|FG000|Delayed Start|Death|0|||
126210804|NCT00594568|454061074|FG001|Delayed Start|Death|0|||
126210805|NCT00594568|454061075|FG002|Delayed Start|Death|1|||
126210806|NCT00594568|454061073|FG000|Delayed Start|Adverse Event|12|||
126210807|NCT00594568|454061074|FG001|Delayed Start|Adverse Event|2|||
126210808|NCT00594568|454061075|FG002|Delayed Start|Adverse Event|2|||
126210809|NCT00594568|454061073|FG000|Delayed Start|Withdrawal by Subject|4|||
126210810|NCT00594568|454061074|FG001|Delayed Start|Withdrawal by Subject|3|||
126210811|NCT00594568|454061075|FG002|Delayed Start|Withdrawal by Subject|0|||
126210812|NCT00594568|454061073|FG000|Delayed Start|Physician Decision|0|||
126210813|NCT00594568|454061074|FG001|Delayed Start|Physician Decision|0|||
126210814|NCT00594568|454061075|FG002|Delayed Start|Physician Decision|1|||
126210815|NCT00594568|454061073|FG000|Delayed Start|Lost to Follow-up|0|||
126210816|NCT00594568|454061074|FG001|Delayed Start|Lost to Follow-up|0|||
126210817|NCT00594568|454061075|FG002|Delayed Start|Lost to Follow-up|1|||
126210818|NCT00594568|454061073|FG000|Delayed Start|Caregiver Decision|5|||
126210819|NCT00594568|454061074|FG001|Delayed Start|Caregiver Decision|6|||
126210820|NCT00594568|454061075|FG002|Delayed Start|Caregiver Decision|2|||
126210821|NCT00594568|454061073|FG000|Delayed Start|Sponsor Decision|77|||
126210822|NCT00594568|454061074|FG001|Delayed Start|Sponsor Decision|66|||
126210823|NCT00594568|454061075|FG002|Delayed Start|Sponsor Decision|59|||
126210824|NCT00594568|454061073|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
126210825|NCT00594568|454061074|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
126210826|NCT00594568|454061075|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
126210827|NCT00594568|454061073|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
126210828|NCT00594568|454061074|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
126210829|NCT00594568|454061075|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
126210830|NCT00594568|454061073|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
126210831|NCT00594568|454061074|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
126210832|NCT00594568|454061075|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
126210833|NCT00594568|454061073|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
126210834|NCT00594568|454061074|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
126210835|NCT00594568|454061075|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
126210836|NCT00594568|454061073|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
126210837|NCT00594568|454061074|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
126210838|NCT00594568|454061075|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
126210839|NCT00594568|454061073|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
126346494|NCT01386385|454564538|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346495|NCT01386385|454564539|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346496|NCT01386385|454564540|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346497|NCT01386385|454564541|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
126346498|NCT01386385|454564542|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346499|NCT01386385|454564543|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346500|NCT01386385|454564544|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346501|NCT01386385|454564537|FG000|Phase II Concurrent CRT|Adverse Event|0|||
126346502|NCT01386385|454564538|FG001|Phase II Concurrent CRT|Adverse Event|0|||
126346503|NCT01386385|454564539|FG002|Phase II Concurrent CRT|Adverse Event|0|||
126346504|NCT01386385|454564540|FG003|Phase II Concurrent CRT|Adverse Event|0|||
126346505|NCT01386385|454564541|FG004|Phase II Concurrent CRT|Adverse Event|0|||
126346506|NCT01386385|454564542|FG005|Phase II Concurrent CRT|Adverse Event|0|||
126346507|NCT01386385|454564543|FG006|Phase II Concurrent CRT|Adverse Event|3|||
126346508|NCT01386385|454564544|FG007|Phase II Concurrent CRT|Adverse Event|3|||
126346509|NCT01386385|454564537|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346510|NCT01386385|454564538|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346511|NCT01386385|454564539|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346512|NCT01386385|454564540|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346513|NCT01386385|454564541|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346514|NCT01386385|454564542|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346515|NCT01386385|454564543|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
126346516|NCT01386385|454564544|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346517|NCT01386385|454564537|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
126346518|NCT01386385|454564538|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
126346519|NCT01386385|454564539|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
126210840|NCT00594568|454061074|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
126210841|NCT00594568|454061075|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
126210842|NCT04478994|454061076|FG000|Overall Study|Withdrawal by Subject|1|||
126210843|NCT04478994|454061077|FG001|Overall Study|Withdrawal by Subject|1|||
126346520|NCT01386385|454564540|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
126210844|NCT01100073|454061078|FG000|Overall Study|Lack of Efficacy|4|||
126210845|NCT01100073|454061078|FG000|Overall Study|Insufficient Tolerability|21|||
126210846|NCT01100073|454061078|FG000|Overall Study|Withdrawal by Subject|13|||
126210847|NCT01100073|454061078|FG000|Overall Study|Lost to Follow-up|39|||
126210848|NCT01100073|454061078|FG000|Overall Study|Lack of effect + patient's wish|2|||
126210849|NCT01100073|454061078|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
126210850|NCT01100073|454061078|FG000|Overall Study|Other|8|||
126210851|NCT01100073|454061078|FG000|Overall Study|Missing|5|||
126210852|NCT01656850|454061079|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
126210853|NCT01656850|454061080|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
126210854|NCT01741259|454061086|FG000|Overall Study|Protocol Violation|6|||
126210855|NCT01741259|454061087|FG001|Overall Study|Protocol Violation|4|||
126210856|NCT01741259|454061086|FG000|Overall Study|Withdrawal by Subject|0|||
126210857|NCT01741259|454061087|FG001|Overall Study|Withdrawal by Subject|2|||
126210858|NCT00057330|454061093|FG000|Overall Study|Adverse Event|9|||
126210859|NCT00057330|454061094|FG001|Overall Study|Adverse Event|12|||
126210860|NCT00057330|454061093|FG000|Overall Study|Death|1|||
126210861|NCT00057330|454061094|FG001|Overall Study|Death|0|||
126210862|NCT00057330|454061093|FG000|Overall Study|Protocol Violation|1|||
126210863|NCT00057330|454061094|FG001|Overall Study|Protocol Violation|1|||
126210864|NCT00057330|454061093|FG000|Overall Study|Withdrawal by Subject|115|||
126210865|NCT00057330|454061094|FG001|Overall Study|Withdrawal by Subject|84|||
126210866|NCT00057330|454061093|FG000|Overall Study|Lost to Follow-up|745|||
126210867|NCT00057330|454061094|FG001|Overall Study|Lost to Follow-up|617|||
126210868|NCT00057330|454061093|FG000|Overall Study|Physician Decision|1|||
126210869|NCT00057330|454061094|FG001|Overall Study|Physician Decision|0|||
126210870|NCT00057330|454061093|FG000|Overall Study|Other|260|||
126210871|NCT00057330|454061094|FG001|Overall Study|Other|206|||
126210872|NCT04633434|454061097|FG000|Overall Study|Lost to Follow-up|32|||
126210873|NCT04633434|454061098|FG001|Overall Study|Lost to Follow-up|32|||
126210874|NCT00471237|454061102|FG000|Overall Study|Adverse Event|6|||
126210875|NCT00471237|454061103|FG001|Overall Study|Adverse Event|5|||
126210876|NCT00471237|454061104|FG002|Overall Study|Adverse Event|4|||
126210877|NCT00471237|454061105|FG003|Overall Study|Adverse Event|8|||
126210878|NCT00471237|454061106|FG004|Overall Study|Adverse Event|7|||
126210879|NCT00471237|454061107|FG005|Overall Study|Adverse Event|5|||
126210880|NCT00471237|454061108|FG006|Overall Study|Adverse Event|0|||
126210881|NCT00471237|454061102|FG000|Overall Study|Lost to Follow-up|1|||
126210882|NCT00471237|454061103|FG001|Overall Study|Lost to Follow-up|1|||
126210883|NCT00471237|454061104|FG002|Overall Study|Lost to Follow-up|0|||
126210884|NCT00471237|454061105|FG003|Overall Study|Lost to Follow-up|2|||
126210885|NCT00471237|454061106|FG004|Overall Study|Lost to Follow-up|3|||
126210886|NCT00471237|454061107|FG005|Overall Study|Lost to Follow-up|0|||
126210887|NCT00471237|454061108|FG006|Overall Study|Lost to Follow-up|0|||
126210888|NCT00471237|454061102|FG000|Overall Study|Protocol Violation|3|||
126210889|NCT00471237|454061103|FG001|Overall Study|Protocol Violation|6|||
126210890|NCT00471237|454061104|FG002|Overall Study|Protocol Violation|3|||
126210891|NCT00471237|454061105|FG003|Overall Study|Protocol Violation|2|||
126210892|NCT00471237|454061106|FG004|Overall Study|Protocol Violation|2|||
126210893|NCT00471237|454061107|FG005|Overall Study|Protocol Violation|4|||
126210894|NCT00471237|454061108|FG006|Overall Study|Protocol Violation|1|||
126210895|NCT00471237|454061102|FG000|Overall Study|Withdrawal by Subject|8|||
126210896|NCT00471237|454061103|FG001|Overall Study|Withdrawal by Subject|6|||
126210897|NCT00471237|454061104|FG002|Overall Study|Withdrawal by Subject|5|||
126210898|NCT00471237|454061105|FG003|Overall Study|Withdrawal by Subject|8|||
126210899|NCT00471237|454061106|FG004|Overall Study|Withdrawal by Subject|7|||
126210900|NCT00471237|454061107|FG005|Overall Study|Withdrawal by Subject|4|||
126210901|NCT00471237|454061108|FG006|Overall Study|Withdrawal by Subject|2|||
126210902|NCT00471237|454061102|FG000|Overall Study|Sponsor terminated study|20|||
126210903|NCT00471237|454061103|FG001|Overall Study|Sponsor terminated study|23|||
126210904|NCT00471237|454061104|FG002|Overall Study|Sponsor terminated study|19|||
126210905|NCT00471237|454061105|FG003|Overall Study|Sponsor terminated study|22|||
126210906|NCT00471237|454061106|FG004|Overall Study|Sponsor terminated study|18|||
126346521|NCT01386385|454564541|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
126346522|NCT01386385|454564542|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
126346523|NCT01386385|454564543|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
126012792|NCT03743246|453340963|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
126012793|NCT03743246|453340964|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
126210907|NCT00471237|454061107|FG005|Overall Study|Sponsor terminated study|24|||
126346524|NCT01386385|454564544|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
126012794|NCT03743246|453340961|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
126210908|NCT00471237|454061108|FG006|Overall Study|Sponsor terminated study|0|||
126210909|NCT00471237|454061102|FG000|Overall Study|Non-compliance|0|||
126210910|NCT00471237|454061103|FG001|Overall Study|Non-compliance|1|||
126210911|NCT00471237|454061104|FG002|Overall Study|Non-compliance|0|||
126210912|NCT00471237|454061105|FG003|Overall Study|Non-compliance|1|||
126210913|NCT00471237|454061106|FG004|Overall Study|Non-compliance|0|||
126210914|NCT00471237|454061107|FG005|Overall Study|Non-compliance|0|||
126210915|NCT00471237|454061108|FG006|Overall Study|Non-compliance|0|||
126210916|NCT00471237|454061102|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
126210917|NCT00471237|454061103|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
126210918|NCT00471237|454061104|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
126210919|NCT00471237|454061105|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
126210920|NCT00471237|454061106|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
126210921|NCT00471237|454061107|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
126210922|NCT00471237|454061108|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
126210923|NCT00471237|454061102|FG000|Overall Study|Early stopping due to non-efficacy|1|||
126210924|NCT00471237|454061103|FG001|Overall Study|Early stopping due to non-efficacy|0|||
126210925|NCT00471237|454061104|FG002|Overall Study|Early stopping due to non-efficacy|0|||
126210926|NCT00471237|454061105|FG003|Overall Study|Early stopping due to non-efficacy|0|||
126210927|NCT00471237|454061106|FG004|Overall Study|Early stopping due to non-efficacy|1|||
126210928|NCT00471237|454061107|FG005|Overall Study|Early stopping due to non-efficacy|0|||
126210929|NCT00471237|454061108|FG006|Overall Study|Early stopping due to non-efficacy|0|||
126210930|NCT00471237|454061102|FG000|Overall Study|Participant planned to travel to abraod|1|||
126210931|NCT00471237|454061103|FG001|Overall Study|Participant planned to travel to abraod|0|||
126210932|NCT00471237|454061104|FG002|Overall Study|Participant planned to travel to abraod|0|||
126210933|NCT00471237|454061105|FG003|Overall Study|Participant planned to travel to abraod|0|||
126210934|NCT00471237|454061106|FG004|Overall Study|Participant planned to travel to abraod|0|||
126210935|NCT00471237|454061107|FG005|Overall Study|Participant planned to travel to abraod|1|||
126210936|NCT00471237|454061108|FG006|Overall Study|Participant planned to travel to abraod|0|||
126210937|NCT00471237|454061102|FG000|Overall Study|High parathyroid hormone|0|||
126210938|NCT00471237|454061103|FG001|Overall Study|High parathyroid hormone|0|||
126210939|NCT00471237|454061104|FG002|Overall Study|High parathyroid hormone|1|||
126210940|NCT00471237|454061105|FG003|Overall Study|High parathyroid hormone|0|||
126210941|NCT00471237|454061106|FG004|Overall Study|High parathyroid hormone|0|||
126210942|NCT00471237|454061107|FG005|Overall Study|High parathyroid hormone|0|||
126210943|NCT00471237|454061108|FG006|Overall Study|High parathyroid hormone|0|||
126210944|NCT00471237|454061102|FG000|Overall Study|Participant lost medication|0|||
126210945|NCT00471237|454061103|FG001|Overall Study|Participant lost medication|0|||
126210946|NCT00471237|454061104|FG002|Overall Study|Participant lost medication|0|||
126210947|NCT00471237|454061105|FG003|Overall Study|Participant lost medication|0|||
126210948|NCT00471237|454061106|FG004|Overall Study|Participant lost medication|1|||
126210949|NCT00471237|454061107|FG005|Overall Study|Participant lost medication|0|||
126210950|NCT00471237|454061108|FG006|Overall Study|Participant lost medication|0|||
126210951|NCT00471237|454061102|FG000|Overall Study|Administration of prohibited medicine|0|||
126210952|NCT00471237|454061103|FG001|Overall Study|Administration of prohibited medicine|0|||
126210953|NCT00471237|454061104|FG002|Overall Study|Administration of prohibited medicine|0|||
126210954|NCT00471237|454061105|FG003|Overall Study|Administration of prohibited medicine|0|||
126210955|NCT00471237|454061106|FG004|Overall Study|Administration of prohibited medicine|1|||
126210956|NCT00471237|454061107|FG005|Overall Study|Administration of prohibited medicine|0|||
126210957|NCT00471237|454061108|FG006|Overall Study|Administration of prohibited medicine|0|||
126210958|NCT00471237|454061102|FG000|Overall Study|Participant shifted residence|0|||
126210959|NCT00471237|454061103|FG001|Overall Study|Participant shifted residence|0|||
126210960|NCT00471237|454061104|FG002|Overall Study|Participant shifted residence|0|||
126210961|NCT00471237|454061105|FG003|Overall Study|Participant shifted residence|0|||
126210962|NCT00471237|454061106|FG004|Overall Study|Participant shifted residence|1|||
126210963|NCT00471237|454061107|FG005|Overall Study|Participant shifted residence|0|||
126210964|NCT00471237|454061108|FG006|Overall Study|Participant shifted residence|0|||
126210965|NCT00471237|454061102|FG000|Overall Study|Participant's decision|0|||
126210966|NCT00471237|454061103|FG001|Overall Study|Participant's decision|0|||
126210967|NCT00471237|454061104|FG002|Overall Study|Participant's decision|0|||
126210968|NCT00471237|454061105|FG003|Overall Study|Participant's decision|0|||
126210969|NCT00471237|454061106|FG004|Overall Study|Participant's decision|0|||
126210970|NCT00471237|454061107|FG005|Overall Study|Participant's decision|1|||
126210971|NCT00471237|454061108|FG006|Overall Study|Participant's decision|0|||
126210972|NCT01605370|454061113|FG000|Overall Study|Adverse Event|1|||
126210973|NCT01605370|454061114|FG001|Overall Study|Adverse Event|0|||
126210974|NCT00585468|454061120|FG000|First Intervention|Withdrawal by Subject|1|||
126210975|NCT00585468|454061121|FG001|First Intervention|Withdrawal by Subject|1|||
126210976|NCT00943826|454061131|FG000|Concurrent Phase|Adverse Event|50|||
126210977|NCT00943826|454061132|FG001|Concurrent Phase|Adverse Event|27|||
126210978|NCT00943826|454061131|FG000|Concurrent Phase|Withdrew consent|3|||
126210979|NCT00943826|454061132|FG001|Concurrent Phase|Withdrew consent|7|||
126210980|NCT00943826|454061131|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
126346525|NCT01386385|454564537|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126091129|NCT03820947|453626921|FG003|Overall Study|Lost to Follow-up|0|||
126210981|NCT00943826|454061132|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
126346526|NCT01386385|454564538|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126210982|NCT00943826|454061131|FG000|Concurrent Phase|Administrative reasons|2|||
126210983|NCT00943826|454061132|FG001|Concurrent Phase|Administrative reasons|1|||
126210984|NCT00943826|454061131|FG000|Concurrent Phase|Protocol Violation|1|||
126210985|NCT00943826|454061132|FG001|Concurrent Phase|Protocol Violation|0|||
126210986|NCT00943826|454061131|FG000|Maintenance Phase|Adverse Event|31|||
126210987|NCT00943826|454061132|FG001|Maintenance Phase|Adverse Event|30|||
126210988|NCT00943826|454061131|FG000|Maintenance Phase|Withdrew consent|2|||
126210989|NCT00943826|454061132|FG001|Maintenance Phase|Withdrew consent|4|||
126210990|NCT00943826|454061131|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
126210991|NCT00943826|454061132|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
126210992|NCT00943826|454061131|FG000|Maintenance Phase|Administrative reasons|4|||
126210993|NCT00943826|454061132|FG001|Maintenance Phase|Administrative reasons|1|||
126210994|NCT00943826|454061131|FG000|Maintenance Phase|Failure to return|0|||
126210995|NCT00943826|454061132|FG001|Maintenance Phase|Failure to return|1|||
126210996|NCT00943826|454061131|FG000|Monotherapy Phase|Adverse Event|42|||
126210997|NCT00943826|454061132|FG001|Monotherapy Phase|Adverse Event|5|||
126210998|NCT00943826|454061131|FG000|Monotherapy Phase|Administrative reasons|11|||
126210999|NCT00943826|454061132|FG001|Monotherapy Phase|Administrative reasons|5|||
126211000|NCT00943826|454061131|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
126211001|NCT00943826|454061132|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
126211002|NCT00943826|454061131|FG000|Monotherapy Phase|Withdrew Consent|2|||
126211003|NCT00943826|454061132|FG001|Monotherapy Phase|Withdrew Consent|3|||
126211004|NCT00943826|454061131|FG000|Monotherapy Phase|Failure to return|2|||
126211005|NCT00943826|454061132|FG001|Monotherapy Phase|Failure to return|1|||
126211006|NCT00943826|454061131|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
126211007|NCT00943826|454061132|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
126211008|NCT00943826|454061131|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
126211009|NCT00943826|454061132|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
126211010|NCT00943826|454061131|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
126211011|NCT00943826|454061132|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
126211012|NCT00943826|454061131|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
126211013|NCT00943826|454061132|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
126211014|NCT00807040|454061137|FG000|Overall Study|Death|24|||
126211015|NCT00807040|454061138|FG001|Overall Study|Death|29|||
126211016|NCT00807040|454061137|FG000|Overall Study|Withdrawal by Subject|8|||
126211017|NCT00807040|454061138|FG001|Overall Study|Withdrawal by Subject|6|||
126211018|NCT00807040|454061137|FG000|Overall Study|Lost to Follow-up|4|||
126211019|NCT00807040|454061138|FG001|Overall Study|Lost to Follow-up|6|||
126211020|NCT00625846|454061139|FG000|Overall Study|Withdrawal by Subject|2|||
126211021|NCT00625846|454061140|FG001|Overall Study|Withdrawal by Subject|0|||
126211022|NCT00625846|454061141|FG002|Overall Study|Withdrawal by Subject|1|||
126211023|NCT00625846|454061142|FG003|Overall Study|Withdrawal by Subject|2|||
126211024|NCT00455923|454061147|FG000|Overall Study|Pregnancy|0|||
126211025|NCT00455923|454061148|FG001|Overall Study|Pregnancy|2|||
126211026|NCT00455923|454061147|FG000|Overall Study|Other|3|||
126211027|NCT00455923|454061148|FG001|Overall Study|Other|1|||
126211028|NCT01870921|454061150|FG000|Overall Study|Subject decision|80|||
126211029|NCT01870921|454061150|FG000|Overall Study|Severe non-compliance to protocol|7|||
126211030|NCT01870921|454061150|FG000|Overall Study|Subject Lost to Follow up|2|||
126211031|NCT01870921|454061150|FG000|Overall Study|Other|1|||
126211032|NCT04409509|454061151|FG000|Overall Study|Failure to meet randomization requirement|1|||
126211033|NCT04409509|454061152|FG001|Overall Study|Failure to meet randomization requirement|0|||
126211034|NCT04409509|454061151|FG000|Overall Study|Adverse Event|0|||
126211035|NCT04409509|454061152|FG001|Overall Study|Adverse Event|1|||
126211036|NCT04409509|454061151|FG000|Overall Study|Death|11|||
126211037|NCT04409509|454061152|FG001|Overall Study|Death|10|||
126211038|NCT04409509|454061151|FG000|Overall Study|Non-compliance with study drug|0|||
126211039|NCT04409509|454061152|FG001|Overall Study|Non-compliance with study drug|1|||
126211040|NCT04409509|454061151|FG000|Overall Study|Lost to Follow-up|0|||
126211041|NCT04409509|454061152|FG001|Overall Study|Lost to Follow-up|3|||
126346527|NCT01386385|454564539|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346528|NCT01386385|454564540|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346529|NCT01386385|454564541|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346530|NCT01386385|454564542|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346531|NCT01386385|454564543|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
126012795|NCT03743246|453340962|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
126012796|NCT03743246|453340963|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
126211042|NCT04409509|454061151|FG000|Overall Study|Withdrawal by Subject|0|||
126211043|NCT04409509|454061152|FG001|Overall Study|Withdrawal by Subject|3|||
126211044|NCT04409509|454061151|FG000|Overall Study|Randomized by mistake|0|||
126211045|NCT04409509|454061152|FG001|Overall Study|Randomized by mistake|1|||
126211046|NCT04409509|454061151|FG000|Overall Study|Other|1|||
126211047|NCT04409509|454061152|FG001|Overall Study|Other|1|||
126211048|NCT02279888|454061155|FG000|Overall Study|Death|326|||
126211049|NCT02279888|454061155|FG000|Overall Study|Withdrawal by Subject|38|||
126211050|NCT02279888|454061155|FG000|Overall Study|Lost to Follow-up|21|||
126211051|NCT02279888|454061155|FG000|Overall Study|Physician Decision|62|||
126211052|NCT02279888|454061155|FG000|Overall Study|Subject Non-compliance|43|||
126211053|NCT02279888|454061155|FG000|Overall Study|Not implanted|14|||
126211054|NCT02279888|454061155|FG000|Overall Study|Visit not performed|26|||
126211055|NCT02335411|454061156|FG000|Overall Study|Death|223|||
126211056|NCT02335411|454061157|FG001|Overall Study|Death|22|||
126211057|NCT02335411|454061158|FG002|Overall Study|Death|26|||
126211058|NCT02335411|454061156|FG000|Overall Study|Physician Decision|3|||
126211059|NCT02335411|454061157|FG001|Overall Study|Physician Decision|0|||
126211060|NCT02335411|454061158|FG002|Overall Study|Physician Decision|0|||
126211061|NCT02335411|454061156|FG000|Overall Study|Protocol Violation|1|||
126211062|NCT02335411|454061157|FG001|Overall Study|Protocol Violation|0|||
126211063|NCT02335411|454061158|FG002|Overall Study|Protocol Violation|0|||
126211064|NCT02335411|454061156|FG000|Overall Study|Withdrawal by Subject|11|||
126211065|NCT02335411|454061157|FG001|Overall Study|Withdrawal by Subject|0|||
126211066|NCT02335411|454061158|FG002|Overall Study|Withdrawal by Subject|3|||
126211067|NCT02335411|454061156|FG000|Overall Study|Sponsor Decision|12|||
126211068|NCT02335411|454061157|FG001|Overall Study|Sponsor Decision|3|||
126211069|NCT02335411|454061158|FG002|Overall Study|Sponsor Decision|2|||
126211070|NCT02335411|454061156|FG000|Overall Study|Adverse Event|9|||
126211071|NCT02335411|454061157|FG001|Overall Study|Adverse Event|0|||
126211072|NCT02335411|454061158|FG002|Overall Study|Adverse Event|0|||
126211073|NCT01891669|454061159|FG000|Overall Study|Death|0|||
126211074|NCT01891669|454061160|FG001|Overall Study|Death|0|||
126211075|NCT01891669|454061161|FG002|Overall Study|Death|0|||
126211076|NCT01891669|454061162|FG003|Overall Study|Death|0|||
126211077|NCT01891669|454061163|FG004|Overall Study|Death|0|||
126211078|NCT01891669|454061164|FG005|Overall Study|Death|0|||
126211079|NCT01891669|454061165|FG006|Overall Study|Death|0|||
126211080|NCT01891669|454061166|FG007|Overall Study|Death|1|||
126211081|NCT01891669|454061167|FG008|Overall Study|Death|0|||
126211082|NCT01891669|454061168|FG009|Overall Study|Death|1|||
126211083|NCT01891669|454061159|FG000|Overall Study|Withdrawal by Subject|1|||
126211084|NCT01891669|454061160|FG001|Overall Study|Withdrawal by Subject|1|||
126211085|NCT01891669|454061161|FG002|Overall Study|Withdrawal by Subject|0|||
126211086|NCT01891669|454061162|FG003|Overall Study|Withdrawal by Subject|0|||
126211087|NCT01891669|454061163|FG004|Overall Study|Withdrawal by Subject|0|||
126211088|NCT01891669|454061164|FG005|Overall Study|Withdrawal by Subject|0|||
126211089|NCT01891669|454061165|FG006|Overall Study|Withdrawal by Subject|1|||
126211090|NCT01891669|454061166|FG007|Overall Study|Withdrawal by Subject|2|||
126211091|NCT01891669|454061167|FG008|Overall Study|Withdrawal by Subject|1|||
126211092|NCT01891669|454061168|FG009|Overall Study|Withdrawal by Subject|1|||
126211093|NCT01891669|454061159|FG000|Overall Study|Other|1|||
126211094|NCT01891669|454061160|FG001|Overall Study|Other|0|||
126211095|NCT01891669|454061161|FG002|Overall Study|Other|0|||
126211096|NCT01891669|454061162|FG003|Overall Study|Other|0|||
126211097|NCT01891669|454061163|FG004|Overall Study|Other|0|||
126211098|NCT01891669|454061164|FG005|Overall Study|Other|0|||
126211099|NCT01891669|454061165|FG006|Overall Study|Other|0|||
126211100|NCT01891669|454061166|FG007|Overall Study|Other|1|||
126211101|NCT01891669|454061167|FG008|Overall Study|Other|0|||
126211102|NCT01891669|454061168|FG009|Overall Study|Other|0|||
126211103|NCT03075826|454061170|FG000|Overall Study|Withdrawal by Subject|1|||
126211104|NCT03075826|454061170|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
126346532|NCT01386385|454564544|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346533|NCT01386385|454564537|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346534|NCT01386385|454564538|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346535|NCT01386385|454564539|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346536|NCT01386385|454564540|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346537|NCT01386385|454564541|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346538|NCT01386385|454564542|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346539|NCT01386385|454564543|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
126346540|NCT01386385|454564544|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
126346541|NCT00788671|454564548|FG000|Overall Study|Death|2|||
126346542|NCT00788671|454564548|FG000|Overall Study|Unable to biopsy|1|||
126346543|NCT00788671|454564548|FG000|Overall Study|Withdrawal by Subject|4|||
126211105|NCT00650806|454061171|FG000|Overall Study|Adverse Event|0|||
126211106|NCT00650806|454061172|FG001|Overall Study|Adverse Event|5|||
126211107|NCT00650806|454061173|FG002|Overall Study|Adverse Event|3|||
126211108|NCT00650806|454061174|FG003|Overall Study|Adverse Event|4|||
126211109|NCT00650806|454061171|FG000|Overall Study|Lost to Follow-up|7|||
126211110|NCT00650806|454061172|FG001|Overall Study|Lost to Follow-up|6|||
126211111|NCT00650806|454061173|FG002|Overall Study|Lost to Follow-up|11|||
126211112|NCT00650806|454061174|FG003|Overall Study|Lost to Follow-up|10|||
126211113|NCT00650806|454061171|FG000|Overall Study|Protocol Violation|0|||
126211114|NCT00650806|454061172|FG001|Overall Study|Protocol Violation|0|||
126211115|NCT00650806|454061173|FG002|Overall Study|Protocol Violation|0|||
126211116|NCT00650806|454061174|FG003|Overall Study|Protocol Violation|1|||
126211117|NCT00650806|454061171|FG000|Overall Study|Pregnancy|0|||
126211118|NCT00650806|454061172|FG001|Overall Study|Pregnancy|0|||
126211119|NCT00650806|454061173|FG002|Overall Study|Pregnancy|0|||
126211120|NCT00650806|454061174|FG003|Overall Study|Pregnancy|1|||
126211121|NCT00650806|454061171|FG000|Overall Study|Withdrawal by Subject|7|||
126211122|NCT00650806|454061172|FG001|Overall Study|Withdrawal by Subject|5|||
126211123|NCT00650806|454061173|FG002|Overall Study|Withdrawal by Subject|8|||
126211124|NCT00650806|454061174|FG003|Overall Study|Withdrawal by Subject|6|||
126211125|NCT00650806|454061171|FG000|Overall Study|Noncompliance with study drug regimen|1|||
126211126|NCT00650806|454061172|FG001|Overall Study|Noncompliance with study drug regimen|1|||
126211127|NCT00650806|454061173|FG002|Overall Study|Noncompliance with study drug regimen|0|||
126211128|NCT00650806|454061174|FG003|Overall Study|Noncompliance with study drug regimen|0|||
126211129|NCT00650806|454061171|FG000|Overall Study|Study terminated by sponsor|2|||
126211130|NCT00650806|454061172|FG001|Overall Study|Study terminated by sponsor|3|||
126211131|NCT00650806|454061173|FG002|Overall Study|Study terminated by sponsor|5|||
126211132|NCT00650806|454061174|FG003|Overall Study|Study terminated by sponsor|4|||
126211133|NCT00650806|454061171|FG000|Overall Study|Other|1|||
126211134|NCT00650806|454061172|FG001|Overall Study|Other|1|||
126211135|NCT00650806|454061173|FG002|Overall Study|Other|2|||
126211136|NCT00650806|454061174|FG003|Overall Study|Other|0|||
126211137|NCT03707145|454061178|FG000|Overall Study|Lost to Follow-up|0|||
126211138|NCT03707145|454061179|FG001|Overall Study|Lost to Follow-up|1|||
126211139|NCT03707145|454061180|FG002|Overall Study|Lost to Follow-up|1|||
126211140|NCT03707145|454061181|FG003|Overall Study|Lost to Follow-up|0|||
126211141|NCT00965562|454061185|FG000|Overall Study|Lost to Follow-up|1|||
126211142|NCT00965562|454061186|FG001|Overall Study|Lost to Follow-up|2|||
126211143|NCT00965562|454061187|FG002|Overall Study|Lost to Follow-up|3|||
126211144|NCT00965562|454061185|FG000|Overall Study|Withdrawal by Subject|2|||
126211145|NCT00965562|454061186|FG001|Overall Study|Withdrawal by Subject|2|||
126211146|NCT00965562|454061187|FG002|Overall Study|Withdrawal by Subject|0|||
126211147|NCT04636437|454061188|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
126211148|NCT04636437|454061189|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
126211149|NCT04636437|454061190|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
126211150|NCT04636437|454061188|FG000|Overall Study|Started weight loss drug/program|2|||
126211151|NCT04636437|454061189|FG001|Overall Study|Started weight loss drug/program|1|||
126211152|NCT04636437|454061190|FG002|Overall Study|Started weight loss drug/program|1|||
126211153|NCT04636437|454061188|FG000|Overall Study|Lost to Follow-up|3|||
126211154|NCT04636437|454061189|FG001|Overall Study|Lost to Follow-up|1|||
126211155|NCT04636437|454061190|FG002|Overall Study|Lost to Follow-up|4|||
126211156|NCT04636437|454061188|FG000|Overall Study|Participant or physician decision|3|||
126211157|NCT04636437|454061189|FG001|Overall Study|Participant or physician decision|1|||
126211158|NCT04636437|454061190|FG002|Overall Study|Participant or physician decision|1|||
126211159|NCT00352664|454061191|FG000|Overall Study|Withdrawal by Subject|7|||
126211160|NCT00352664|454061192|FG001|Overall Study|Withdrawal by Subject|0|||
126211161|NCT03075215|454061195|FG000|12-Month Primary Endpoint|Death|152|||
126211162|NCT03075215|454061195|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
126211163|NCT03075215|454061195|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
126211164|NCT03075215|454061195|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
126211165|NCT02756182|454061196|FG000|Overall Study|StudyTechnical Difficulties|4|||
126211166|NCT02146365|454061197|FG000|Overall Study|Lost to Follow-up|2|||
126211167|NCT02146365|454061198|FG001|Overall Study|Lost to Follow-up|1|||
126211168|NCT02146365|454061199|FG002|Overall Study|Lost to Follow-up|3|||
126211169|NCT02146365|454061200|FG003|Overall Study|Lost to Follow-up|3|||
126211170|NCT02146365|454061201|FG004|Overall Study|Lost to Follow-up|1|||
126211171|NCT02146365|454061202|FG005|Overall Study|Lost to Follow-up|1|||
126211172|NCT02146365|454061203|FG006|Overall Study|Lost to Follow-up|0|||
126211173|NCT02146365|454061204|FG007|Overall Study|Lost to Follow-up|1|||
126211174|NCT02146365|454061197|FG000|Overall Study|Withdrawal by Subject|1|||
126211175|NCT02146365|454061198|FG001|Overall Study|Withdrawal by Subject|2|||
126211176|NCT02146365|454061199|FG002|Overall Study|Withdrawal by Subject|1|||
126211177|NCT02146365|454061200|FG003|Overall Study|Withdrawal by Subject|5|||
126211178|NCT02146365|454061201|FG004|Overall Study|Withdrawal by Subject|1|||
126211179|NCT02146365|454061202|FG005|Overall Study|Withdrawal by Subject|0|||
126211180|NCT02146365|454061203|FG006|Overall Study|Withdrawal by Subject|0|||
126211181|NCT02146365|454061204|FG007|Overall Study|Withdrawal by Subject|0|||
126211182|NCT02146365|454061197|FG000|Overall Study|Unable to Comply with Protocol|0|||
126211183|NCT02146365|454061198|FG001|Overall Study|Unable to Comply with Protocol|1|||
126211184|NCT02146365|454061199|FG002|Overall Study|Unable to Comply with Protocol|1|||
126211185|NCT02146365|454061200|FG003|Overall Study|Unable to Comply with Protocol|0|||
126211186|NCT02146365|454061201|FG004|Overall Study|Unable to Comply with Protocol|0|||
126211187|NCT02146365|454061202|FG005|Overall Study|Unable to Comply with Protocol|0|||
126211188|NCT02146365|454061203|FG006|Overall Study|Unable to Comply with Protocol|0|||
126346544|NCT00788671|454564548|FG000|Overall Study|IUD expulsed|1|||
126211189|NCT02146365|454061204|FG007|Overall Study|Unable to Comply with Protocol|0|||
126211190|NCT02146365|454061197|FG000|Overall Study|Other|1|||
126211191|NCT02146365|454061198|FG001|Overall Study|Other|0|||
126346545|NCT00788671|454564548|FG000|Overall Study|Lost to follow up|2|||
126346546|NCT03405870|454564549|FG000|Overall Study|Withdrawal|1|||
126346547|NCT03405870|454564550|FG001|Overall Study|Withdrawal|0|||
126346548|NCT03405870|454564551|FG002|Overall Study|Withdrawal|1|||
126346549|NCT03405870|454564552|FG003|Overall Study|Withdrawal|0|||
126346550|NCT03405870|454564553|FG004|Overall Study|Withdrawal|0|||
126346551|NCT03405870|454564554|FG005|Overall Study|Withdrawal|0|||
126346552|NCT03405870|454564555|FG006|Overall Study|Withdrawal|1|||
126346553|NCT03405870|454564556|FG007|Overall Study|Withdrawal|0|||
126346554|NCT05172609|454564557|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
126346555|NCT05172609|454564558|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
126346556|NCT05172609|454564557|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
126346557|NCT05172609|454564558|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
126346558|NCT05172609|454564557|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
126346559|NCT05172609|454564558|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
126346560|NCT00549055|454564559|FG000|Overall Study|Adverse Event|4|||
126346561|NCT00549055|454564559|FG000|Overall Study|Lack of Efficacy|18|||
126346562|NCT00549055|454564559|FG000|Overall Study|Stabilization|5|||
126346563|NCT00549055|454564559|FG000|Overall Study|Progression to fibrosis|2|||
126346564|NCT00549055|454564559|FG000|Overall Study|Decrease of size|1|||
126346565|NCT00549055|454564559|FG000|Overall Study|Active choroidal neovascula increased|1|||
126346566|NCT00549055|454564559|FG000|Overall Study|Vitreous hemorrhage|1|||
126346567|NCT00549055|454564559|FG000|Overall Study|Growth choroidal neovascularisation|1|||
126346568|NCT00549055|454564559|FG000|Overall Study|Choroidal neovascularization|1|||
126346569|NCT00549055|454564559|FG000|Overall Study|Very low visual acuity (VA)|1|||
126346570|NCT03846479|454564560|FG000|Overall Study|Death|8|||
126346571|NCT03846479|454564560|FG000|Overall Study|Lost to Follow-up|1|||
126346572|NCT05020015|454564561|FG000|Overall Study|Ongoing on study|1|||
126346573|NCT05020015|454564562|FG001|Overall Study|Ongoing on study|3|||
126346574|NCT05020015|454564563|FG002|Overall Study|Ongoing on study|4|||
126346575|NCT05020015|454564564|FG003|Overall Study|Ongoing on study|7|||
126346576|NCT05020015|454564561|FG000|Overall Study|Death|2|||
126346577|NCT05020015|454564562|FG001|Overall Study|Death|3|||
126346578|NCT05020015|454564563|FG002|Overall Study|Death|4|||
126346579|NCT05020015|454564564|FG003|Overall Study|Death|0|||
126346580|NCT05020015|454564561|FG000|Overall Study|Withdrawal by Subject|0|||
126346581|NCT05020015|454564562|FG001|Overall Study|Withdrawal by Subject|0|||
126346582|NCT05020015|454564563|FG002|Overall Study|Withdrawal by Subject|1|||
126346583|NCT05020015|454564564|FG003|Overall Study|Withdrawal by Subject|0|||
126346584|NCT05020015|454564561|FG000|Overall Study|Reason Not Specified|0|||
126346585|NCT05020015|454564562|FG001|Overall Study|Reason Not Specified|0|||
126346586|NCT05020015|454564563|FG002|Overall Study|Reason Not Specified|2|||
126346587|NCT05020015|454564564|FG003|Overall Study|Reason Not Specified|0|||
126346588|NCT00614393|454564571|FG000|Overall Study|Adverse Event|20|||
126346589|NCT00614393|454564572|FG001|Overall Study|Adverse Event|2|||
126346590|NCT00614393|454564573|FG002|Overall Study|Adverse Event|3|||
126346591|NCT00614393|454564574|FG003|Overall Study|Adverse Event|13|||
126346592|NCT00614393|454564575|FG004|Overall Study|Adverse Event|21|||
126346593|NCT00614393|454564571|FG000|Overall Study|Lost to Follow-up|0|||
126346594|NCT00614393|454564572|FG001|Overall Study|Lost to Follow-up|0|||
126346595|NCT00614393|454564573|FG002|Overall Study|Lost to Follow-up|0|||
126346596|NCT00614393|454564574|FG003|Overall Study|Lost to Follow-up|1|||
126346597|NCT00614393|454564575|FG004|Overall Study|Lost to Follow-up|2|||
126346598|NCT00614393|454564571|FG000|Overall Study|Physician Decision|17|||
126346599|NCT00614393|454564572|FG001|Overall Study|Physician Decision|0|||
126346600|NCT00614393|454564573|FG002|Overall Study|Physician Decision|1|||
126346601|NCT00614393|454564574|FG003|Overall Study|Physician Decision|8|||
126346602|NCT00614393|454564575|FG004|Overall Study|Physician Decision|9|||
126346603|NCT00614393|454564571|FG000|Overall Study|Progressive Disease|118|||
126346604|NCT00614393|454564572|FG001|Overall Study|Progressive Disease|5|||
126346605|NCT00614393|454564573|FG002|Overall Study|Progressive Disease|5|||
126346606|NCT00614393|454564574|FG003|Overall Study|Progressive Disease|138|||
126346607|NCT00614393|454564575|FG004|Overall Study|Progressive Disease|130|||
126346608|NCT00614393|454564571|FG000|Overall Study|Protocol Violation|1|||
126346609|NCT00614393|454564572|FG001|Overall Study|Protocol Violation|0|||
126346610|NCT00614393|454564573|FG002|Overall Study|Protocol Violation|0|||
126346611|NCT00614393|454564574|FG003|Overall Study|Protocol Violation|0|||
126346612|NCT00614393|454564575|FG004|Overall Study|Protocol Violation|0|||
126346613|NCT00614393|454564571|FG000|Overall Study|Terminated by Sponsor|0|||
126346614|NCT00614393|454564572|FG001|Overall Study|Terminated by Sponsor|0|||
126346615|NCT00614393|454564573|FG002|Overall Study|Terminated by Sponsor|0|||
126346616|NCT00614393|454564574|FG003|Overall Study|Terminated by Sponsor|0|||
126346617|NCT00614393|454564575|FG004|Overall Study|Terminated by Sponsor|1|||
126346618|NCT00614393|454564571|FG000|Overall Study|Withdrawal by Subject|20|||
126346619|NCT00614393|454564572|FG001|Overall Study|Withdrawal by Subject|1|||
126346620|NCT00614393|454564573|FG002|Overall Study|Withdrawal by Subject|1|||
126346621|NCT00614393|454564574|FG003|Overall Study|Withdrawal by Subject|16|||
126346622|NCT00614393|454564575|FG004|Overall Study|Withdrawal by Subject|13|||
126346623|NCT00614393|454564571|FG000|Overall Study|Other|4|||
126346624|NCT00614393|454564572|FG001|Overall Study|Other|0|||
126346625|NCT00614393|454564573|FG002|Overall Study|Other|0|||
126346626|NCT00614393|454564574|FG003|Overall Study|Other|4|||
126346627|NCT00614393|454564575|FG004|Overall Study|Other|2|||
126346628|NCT00614393|454564571|FG000|Overall Study|Not Treated|0|||
126346629|NCT00614393|454564572|FG001|Overall Study|Not Treated|0|||
126346630|NCT00614393|454564573|FG002|Overall Study|Not Treated|0|||
126346631|NCT00614393|454564574|FG003|Overall Study|Not Treated|0|||
126346632|NCT00614393|454564575|FG004|Overall Study|Not Treated|2|||
126346633|NCT02328105|454564576|FG000|Overall Study|Death|6|||
126346634|NCT02328105|454564576|FG000|Overall Study|Withdrawal by Subject|1|||
126346635|NCT02328105|454564576|FG000|Overall Study|Still On Study in Follow-Up|4|||
126346636|NCT01588509|454564577|FG000|Overall Study|Lost to Follow-up|1|||
126346637|NCT01588509|454564578|FG001|Overall Study|Lost to Follow-up|0|||
126346638|NCT00855582|454564582|FG000|Overall Study|Adverse Event|2|||
126346639|NCT00855582|454564583|FG001|Overall Study|Adverse Event|6|||
126346640|NCT00855582|454564584|FG002|Overall Study|Adverse Event|3|||
126346641|NCT00855582|454564582|FG000|Overall Study|Death|1|||
126346642|NCT00855582|454564583|FG001|Overall Study|Death|0|||
126346643|NCT00855582|454564584|FG002|Overall Study|Death|0|||
126346644|NCT00855582|454564582|FG000|Overall Study|Lack of Efficacy|1|||
126346645|NCT00855582|454564583|FG001|Overall Study|Lack of Efficacy|3|||
126346646|NCT00855582|454564584|FG002|Overall Study|Lack of Efficacy|8|||
126346647|NCT00855582|454564582|FG000|Overall Study|Lost to Follow-up|1|||
126211192|NCT02146365|454061199|FG002|Overall Study|Other|2|||
126211193|NCT02146365|454061200|FG003|Overall Study|Other|1|||
126211194|NCT02146365|454061201|FG004|Overall Study|Other|0|||
126211195|NCT02146365|454061202|FG005|Overall Study|Other|0|||
126211196|NCT02146365|454061203|FG006|Overall Study|Other|0|||
126211197|NCT02146365|454061204|FG007|Overall Study|Other|0|||
126211198|NCT01843660|454061205|FG000|Overall Study|Other|30|||
126211199|NCT01977482|454061206|FG000|Overall Study|Adverse Event|0|||
126211200|NCT01977482|454061207|FG001|Overall Study|Adverse Event|1|||
126211201|NCT01977482|454061208|FG002|Overall Study|Adverse Event|1|||
126211202|NCT01977482|454061209|FG003|Overall Study|Adverse Event|0|||
126211203|NCT01977482|454061210|FG004|Overall Study|Adverse Event|2|||
126211204|NCT01977482|454061211|FG005|Overall Study|Adverse Event|0|||
126211205|NCT01977482|454061206|FG000|Overall Study|Lost to Follow-up|1|||
126211206|NCT01977482|454061207|FG001|Overall Study|Lost to Follow-up|0|||
126211207|NCT01977482|454061208|FG002|Overall Study|Lost to Follow-up|0|||
126211208|NCT01977482|454061209|FG003|Overall Study|Lost to Follow-up|0|||
126211209|NCT01977482|454061210|FG004|Overall Study|Lost to Follow-up|0|||
126211210|NCT01977482|454061211|FG005|Overall Study|Lost to Follow-up|0|||
126211211|NCT01977482|454061206|FG000|Overall Study|Physician Decision|0|||
126211212|NCT01977482|454061207|FG001|Overall Study|Physician Decision|1|||
126211213|NCT01977482|454061208|FG002|Overall Study|Physician Decision|0|||
126211214|NCT01977482|454061209|FG003|Overall Study|Physician Decision|0|||
126211215|NCT01977482|454061210|FG004|Overall Study|Physician Decision|0|||
126211216|NCT01977482|454061211|FG005|Overall Study|Physician Decision|0|||
126211217|NCT01977482|454061206|FG000|Overall Study|Protocol Violation|0|||
126211218|NCT01977482|454061207|FG001|Overall Study|Protocol Violation|0|||
126211219|NCT01977482|454061208|FG002|Overall Study|Protocol Violation|1|||
126211220|NCT01977482|454061209|FG003|Overall Study|Protocol Violation|0|||
126211221|NCT01977482|454061210|FG004|Overall Study|Protocol Violation|0|||
126211222|NCT01977482|454061211|FG005|Overall Study|Protocol Violation|0|||
126211223|NCT01977482|454061206|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
126211224|NCT01977482|454061207|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
126211225|NCT01977482|454061208|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
126211226|NCT01977482|454061209|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
126211227|NCT01977482|454061210|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
126211228|NCT01977482|454061211|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
126211229|NCT01977482|454061206|FG000|Overall Study|Withdrawal by Subject|2|||
126211230|NCT01977482|454061207|FG001|Overall Study|Withdrawal by Subject|4|||
126211231|NCT01977482|454061208|FG002|Overall Study|Withdrawal by Subject|1|||
126211232|NCT01977482|454061209|FG003|Overall Study|Withdrawal by Subject|3|||
126211233|NCT01977482|454061210|FG004|Overall Study|Withdrawal by Subject|1|||
126211234|NCT01977482|454061211|FG005|Overall Study|Withdrawal by Subject|5|||
126211235|NCT00209560|454061212|FG000|Overall Study|Lack of Efficacy|1|||
126211236|NCT00209560|454061213|FG001|Overall Study|Lack of Efficacy|0|||
126211237|NCT00795886|454061214|FG000|Overall Study|Death|10|||
126211238|NCT05554471|454061224|FG000|Overall Study|Physician Decision|2|||
126211239|NCT05554471|454061225|FG001|Overall Study|Physician Decision|1|||
126211240|NCT05554471|454061224|FG000|Overall Study|Lost to Follow-up|2|||
126211241|NCT05554471|454061225|FG001|Overall Study|Lost to Follow-up|1|||
126211242|NCT05554471|454061224|FG000|Overall Study|Death|0|||
126211243|NCT05554471|454061225|FG001|Overall Study|Death|1|||
126211244|NCT01319994|454062196|FG000|Overall Study|Protocol Violation|7|||
126211245|NCT01319994|454062197|FG001|Overall Study|Protocol Violation|6|||
126211246|NCT01340794|454062198|FG000|Overall Study|Withdrawal by Subject|0|||
126211247|NCT01340794|454062199|FG001|Overall Study|Withdrawal by Subject|1|||
126211248|NCT01118949|454062202|FG000|Overall Study|Adverse Event|5|||
126211249|NCT01118949|454062202|FG000|Overall Study|Withdrawal by Subject|4|||
126211250|NCT00685763|454062207|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
126211251|NCT00685763|454062207|FG000|Overall Study|Protocol Violation|1|||
126211252|NCT00698009|454062208|FG000|Overall Study|Withdrawal by Subject|1|||
126346648|NCT00855582|454564583|FG001|Overall Study|Lost to Follow-up|3|||
126346649|NCT00855582|454564584|FG002|Overall Study|Lost to Follow-up|1|||
126346650|NCT00855582|454564582|FG000|Overall Study|Physician Decision|0|||
126346651|NCT00855582|454564583|FG001|Overall Study|Physician Decision|0|||
126211253|NCT02856282|454062209|FG000|Overall Study|Withdrawal by Subject|1|||
126211254|NCT02074982|454062210|FG000|Overall Study|Adverse Event|15|||
126346652|NCT00855582|454564584|FG002|Overall Study|Physician Decision|1|||
126346653|NCT00855582|454564582|FG000|Overall Study|Protocol Violation|6|||
126211255|NCT02074982|454062211|FG001|Overall Study|Adverse Event|7|||
126211256|NCT02074982|454062210|FG000|Overall Study|Lack of Efficacy|6|||
126211257|NCT02074982|454062211|FG001|Overall Study|Lack of Efficacy|1|||
126211258|NCT02074982|454062210|FG000|Overall Study|Lost to Follow-up|9|||
126211259|NCT02074982|454062211|FG001|Overall Study|Lost to Follow-up|10|||
126211260|NCT02074982|454062210|FG000|Overall Study|Non-compliance with study treatment|0|||
126211261|NCT02074982|454062211|FG001|Overall Study|Non-compliance with study treatment|2|||
126211262|NCT02074982|454062210|FG000|Overall Study|Physician Decision|1|||
126211263|NCT02074982|454062211|FG001|Overall Study|Physician Decision|1|||
126211264|NCT02074982|454062210|FG000|Overall Study|Pregnancy|1|||
126211265|NCT02074982|454062211|FG001|Overall Study|Pregnancy|2|||
126211266|NCT02074982|454062210|FG000|Overall Study|Protocol deviation|4|||
126211267|NCT02074982|454062211|FG001|Overall Study|Protocol deviation|3|||
126211268|NCT02074982|454062210|FG000|Overall Study|Technical problems|0|||
126211269|NCT02074982|454062211|FG001|Overall Study|Technical problems|2|||
126211270|NCT02074982|454062210|FG000|Overall Study|Subject/guardian decision|15|||
126211271|NCT02074982|454062211|FG001|Overall Study|Subject/guardian decision|24|||
126211272|NCT02074982|454062210|FG000|Overall Study|Death|0|||
126211273|NCT02074982|454062211|FG001|Overall Study|Death|2|||
126211274|NCT02094573|454062214|FG000|Overall Study|Adverse Event|4|||
126211275|NCT02094573|454062215|FG001|Overall Study|Adverse Event|14|||
126211276|NCT02094573|454062214|FG000|Overall Study|Clinical Progressive Disease|9|||
126211277|NCT02094573|454062215|FG001|Overall Study|Clinical Progressive Disease|13|||
126211278|NCT02094573|454062214|FG000|Overall Study|Death|11|||
126211279|NCT02094573|454062215|FG001|Overall Study|Death|3|||
126211280|NCT02094573|454062214|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
126211281|NCT02094573|454062215|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
126211282|NCT02094573|454062214|FG000|Overall Study|Non-compliance with Study Drug|1|||
126211283|NCT02094573|454062215|FG001|Overall Study|Non-compliance with Study Drug|1|||
126211284|NCT02094573|454062214|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
126211285|NCT02094573|454062215|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
126211286|NCT02094573|454062214|FG000|Overall Study|Physician Decision|4|||
126211287|NCT02094573|454062215|FG001|Overall Study|Physician Decision|4|||
126211288|NCT02094573|454062214|FG000|Overall Study|Site Terminated by Sponsor|10|||
126211289|NCT02094573|454062215|FG001|Overall Study|Site Terminated by Sponsor|17|||
126211290|NCT02094573|454062214|FG000|Overall Study|Withdrawal by Subject|6|||
126211291|NCT02094573|454062215|FG001|Overall Study|Withdrawal by Subject|8|||
126211292|NCT02094573|454062214|FG000|Overall Study|Randomized but not Treated|3|||
126211293|NCT02094573|454062215|FG001|Overall Study|Randomized but not Treated|0|||
126211294|NCT02684370|454062222|FG000|Part A|Adverse Event|2|||
126211295|NCT02684370|454062223|FG001|Part A|Adverse Event|0|||
126211296|NCT02684370|454062224|FG002|Part A|Adverse Event|1|||
126211297|NCT02684370|454062225|FG003|Part A|Adverse Event|0|||
126211298|NCT02684370|454062226|FG004|Part A|Adverse Event|0|||
126211299|NCT02684370|454062227|FG005|Part A|Adverse Event|0|||
126211300|NCT02684370|454062222|FG000|Part A|Lost to Follow-up|1|||
126346654|NCT00855582|454564583|FG001|Overall Study|Protocol Violation|2|||
126346655|NCT00855582|454564584|FG002|Overall Study|Protocol Violation|6|||
126346656|NCT00855582|454564582|FG000|Overall Study|Entry Criteria Not Met|8|||
126346657|NCT00855582|454564583|FG001|Overall Study|Entry Criteria Not Met|6|||
126346658|NCT00855582|454564584|FG002|Overall Study|Entry Criteria Not Met|3|||
126346659|NCT00855582|454564582|FG000|Overall Study|Withdrawal by Subject|7|||
126346660|NCT00855582|454564583|FG001|Overall Study|Withdrawal by Subject|4|||
126346661|NCT00855582|454564584|FG002|Overall Study|Withdrawal by Subject|8|||
126346662|NCT03345004|454564585|FG000|Overall Study|Physician Decision|1|||
126346663|NCT03345004|454564586|FG001|Overall Study|Physician Decision|0|||
126346664|NCT03345004|454564585|FG000|Overall Study|Withdrawal by Subject|0|||
126346665|NCT03345004|454564586|FG001|Overall Study|Withdrawal by Subject|1|||
126346666|NCT01013753|454564587|FG000|Overall Study|Adverse Event|8|||
126346667|NCT01013753|454564587|FG000|Overall Study|Protocol Violation|3|||
126346668|NCT01013753|454564587|FG000|Overall Study|Lost to Follow-up|1|||
126346669|NCT01013753|454564587|FG000|Overall Study|Withdrawal by Subject|2|||
126346670|NCT01013753|454564587|FG000|Overall Study|Other|2|||
126346671|NCT04757636|454564588|FG000|Overall Study|Adverse Event|25|||
126346672|NCT04757636|454564589|FG001|Overall Study|Adverse Event|8|||
126346673|NCT04757636|454564590|FG002|Overall Study|Adverse Event|11|||
126346674|NCT04757636|454564588|FG000|Overall Study|Death|9|||
126346675|NCT04757636|454564589|FG001|Overall Study|Death|12|||
126346676|NCT04757636|454564590|FG002|Overall Study|Death|6|||
126346677|NCT04757636|454564588|FG000|Overall Study|Lack of Efficacy|2|||
126211301|NCT02684370|454062223|FG001|Part A|Lost to Follow-up|1|||
126211302|NCT02684370|454062224|FG002|Part A|Lost to Follow-up|0|||
126211303|NCT02684370|454062225|FG003|Part A|Lost to Follow-up|0|||
126211304|NCT02684370|454062226|FG004|Part A|Lost to Follow-up|0|||
126211305|NCT02684370|454062227|FG005|Part A|Lost to Follow-up|0|||
126211306|NCT02684370|454062222|FG000|Part A|Subject Withdrawal|1|||
126211307|NCT02684370|454062223|FG001|Part A|Subject Withdrawal|0|||
126346678|NCT04757636|454564589|FG001|Overall Study|Lack of Efficacy|0|||
126346679|NCT04757636|454564590|FG002|Overall Study|Lack of Efficacy|0|||
126346680|NCT04757636|454564588|FG000|Overall Study|Lost to Follow-up|1|||
126346681|NCT04757636|454564589|FG001|Overall Study|Lost to Follow-up|6|||
126346682|NCT04757636|454564590|FG002|Overall Study|Lost to Follow-up|7|||
126346683|NCT04757636|454564588|FG000|Overall Study|Physician Decision|1|||
126211308|NCT02684370|454062224|FG002|Part A|Subject Withdrawal|3|||
126346684|NCT04757636|454564589|FG001|Overall Study|Physician Decision|3|||
126211309|NCT02684370|454062225|FG003|Part A|Subject Withdrawal|0|||
126211310|NCT02684370|454062226|FG004|Part A|Subject Withdrawal|0|||
126211311|NCT02684370|454062227|FG005|Part A|Subject Withdrawal|0|||
126211312|NCT02684370|454062222|FG000|Part A|Other|0|||
126346685|NCT04757636|454564590|FG002|Overall Study|Physician Decision|4|||
126211313|NCT02684370|454062223|FG001|Part A|Other|0|||
126211314|NCT02684370|454062224|FG002|Part A|Other|1|||
126211315|NCT02684370|454062225|FG003|Part A|Other|0|||
126211316|NCT02684370|454062226|FG004|Part A|Other|0|||
126211317|NCT02684370|454062227|FG005|Part A|Other|0|||
126211318|NCT02684370|454062222|FG000|Part B|Adverse Event|0|||
126211319|NCT02684370|454062223|FG001|Part B|Adverse Event|0|||
126211320|NCT02684370|454062224|FG002|Part B|Adverse Event|0|||
126211321|NCT02684370|454062225|FG003|Part B|Adverse Event|0|||
126211322|NCT02684370|454062226|FG004|Part B|Adverse Event|2|||
126211323|NCT02684370|454062227|FG005|Part B|Adverse Event|1|||
126211324|NCT02684370|454062222|FG000|Part B|Lost to Follow-up|0|||
126211325|NCT02684370|454062223|FG001|Part B|Lost to Follow-up|0|||
126211326|NCT02684370|454062224|FG002|Part B|Lost to Follow-up|0|||
126211327|NCT02684370|454062225|FG003|Part B|Lost to Follow-up|1|||
126211328|NCT02684370|454062226|FG004|Part B|Lost to Follow-up|2|||
126211329|NCT02684370|454062227|FG005|Part B|Lost to Follow-up|5|||
126211330|NCT02684370|454062222|FG000|Part B|Subject Withdrawal|0|||
126211331|NCT02684370|454062223|FG001|Part B|Subject Withdrawal|0|||
126211332|NCT02684370|454062224|FG002|Part B|Subject Withdrawal|0|||
126211333|NCT02684370|454062225|FG003|Part B|Subject Withdrawal|1|||
126211334|NCT02684370|454062226|FG004|Part B|Subject Withdrawal|1|||
126211335|NCT02684370|454062227|FG005|Part B|Subject Withdrawal|2|||
126211336|NCT04221373|454062228|FG000|Overall Study|Physician Decision|4|||
126211337|NCT04221373|454062229|FG001|Overall Study|Physician Decision|0|||
126211338|NCT00627094|454062234|FG000|Overall Study|Adverse Event|8|||
126211339|NCT00627094|454062235|FG001|Overall Study|Adverse Event|7|||
126211340|NCT00627094|454062234|FG000|Overall Study|Lost to Follow-up|1|||
126211341|NCT00627094|454062235|FG001|Overall Study|Lost to Follow-up|0|||
126211342|NCT00627094|454062234|FG000|Overall Study|Withdrawal by Subject|1|||
126211343|NCT00627094|454062235|FG001|Overall Study|Withdrawal by Subject|1|||
126211344|NCT00627094|454062234|FG000|Overall Study|ulcer healed|1|||
126211345|NCT00627094|454062235|FG001|Overall Study|ulcer healed|7|||
126211346|NCT00627094|454062234|FG000|Overall Study|Other reason|1|||
126211347|NCT00627094|454062235|FG001|Overall Study|Other reason|0|||
126211348|NCT00183170|454062237|FG000|First Intervention|Did not complete study|1|||
126211349|NCT00183170|454062238|FG001|First Intervention|Did not complete study|0|||
126211350|NCT00183170|454062237|FG000|First Intervention|Did not meet targeted BrAC|1|||
126211351|NCT00183170|454062238|FG001|First Intervention|Did not meet targeted BrAC|0|||
126211352|NCT00183170|454062237|FG000|Washout 1 Week|Did not complete study|6|||
126211353|NCT00183170|454062238|FG001|Washout 1 Week|Did not complete study|8|||
126211354|NCT00183170|454062237|FG000|Second Intervention|Did not complete study|1|||
126211355|NCT00183170|454062238|FG001|Second Intervention|Did not complete study|0|||
126211356|NCT00183170|454062237|FG000|Second Intervention|Did not meet targeted BrAC|0|||
126211357|NCT00183170|454062238|FG001|Second Intervention|Did not meet targeted BrAC|2|||
126211358|NCT00924820|454062239|FG000|Overall Study|Death|2|||
126211359|NCT00924820|454062239|FG000|Overall Study|Ineligible, Screen Failure|5|||
126211360|NCT04983589|454062240|FG000|Overall Study|Withdrawal by Subject|0|||
126211361|NCT04983589|454062241|FG001|Overall Study|Withdrawal by Subject|3|||
126211362|NCT04983589|454062240|FG000|Overall Study|COVID-19 Infection|1|||
126211363|NCT04983589|454062241|FG001|Overall Study|COVID-19 Infection|0|||
126211364|NCT04983589|454062240|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
126211365|NCT04983589|454062241|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
126211366|NCT00761969|454062242|FG000|Overall Study|Death|112|||
126211367|NCT00761969|454062243|FG001|Overall Study|Death|47|||
126211368|NCT00761969|454062242|FG000|Overall Study|Lost to Follow-up|88|||
126211369|NCT00761969|454062243|FG001|Overall Study|Lost to Follow-up|93|||
126211370|NCT01353586|454062246|FG000|Overall Study|Procedure terminated prior to ablation|3|||
126211371|NCT01353586|454062247|FG001|Overall Study|Procedure terminated prior to ablation|0|||
126211372|NCT01353586|454062246|FG000|Overall Study|Never had insertion of study catheter|4|||
126211373|NCT01353586|454062247|FG001|Overall Study|Never had insertion of study catheter|1|||
126211374|NCT01353586|454062246|FG000|Overall Study|Neurological exam not done|0|||
126346686|NCT04757636|454564588|FG000|Overall Study|Withdrawal by Subject|20|||
126346687|NCT04757636|454564589|FG001|Overall Study|Withdrawal by Subject|23|||
126346688|NCT04757636|454564590|FG002|Overall Study|Withdrawal by Subject|18|||
126346689|NCT04757636|454564588|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
126346690|NCT04757636|454564589|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
126346691|NCT04757636|454564590|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
126211375|NCT01353586|454062247|FG001|Overall Study|Neurological exam not done|1|||
126211376|NCT00978120|454062248|FG000|Overall Study|Death|0|||
126211377|NCT00978120|454062249|FG001|Overall Study|Death|0|||
126211378|NCT00978120|454062250|FG002|Overall Study|Death|0|||
126211379|NCT00978120|454062251|FG003|Overall Study|Death|1|||
126211380|NCT00978120|454062248|FG000|Overall Study|Lost to Follow-up|0|||
126211381|NCT00978120|454062249|FG001|Overall Study|Lost to Follow-up|0|||
126211382|NCT00978120|454062250|FG002|Overall Study|Lost to Follow-up|3|||
126211383|NCT00978120|454062251|FG003|Overall Study|Lost to Follow-up|0|||
126211384|NCT00978120|454062248|FG000|Overall Study|Withdrawal by Subject|2|||
126211385|NCT00978120|454062249|FG001|Overall Study|Withdrawal by Subject|0|||
126211386|NCT00978120|454062250|FG002|Overall Study|Withdrawal by Subject|0|||
126211387|NCT00978120|454062251|FG003|Overall Study|Withdrawal by Subject|0|||
126211388|NCT00978120|454062248|FG000|Overall Study|Moved out of state|0|||
126211389|NCT00978120|454062249|FG001|Overall Study|Moved out of state|0|||
126211390|NCT00978120|454062250|FG002|Overall Study|Moved out of state|0|||
126211391|NCT00978120|454062251|FG003|Overall Study|Moved out of state|1|||
126211392|NCT01068418|454062254|FG000|Overall Study|Physician Decision|12|||
126211393|NCT03155269|454062261|FG000|Overall Study|Withdrawal by Subject|4|||
126211394|NCT03155269|454062262|FG001|Overall Study|Withdrawal by Subject|5|||
126211395|NCT03155269|454062261|FG000|Overall Study|Lost to Follow-up|1|||
126211396|NCT03155269|454062262|FG001|Overall Study|Lost to Follow-up|2|||
126211397|NCT03733301|454062263|FG000|Overall Study|Screen Fail|1|||
126211398|NCT03733301|454062264|FG001|Overall Study|Screen Fail|0|||
126211399|NCT03733301|454062265|FG002|Overall Study|Screen Fail|0|||
126211400|NCT03733301|454062263|FG000|Overall Study|Non-compliance|1|||
126211401|NCT03733301|454062264|FG001|Overall Study|Non-compliance|0|||
126211402|NCT03733301|454062265|FG002|Overall Study|Non-compliance|0|||
126211403|NCT03733301|454062263|FG000|Overall Study|Lack of Efficacy|2|||
126211404|NCT03733301|454062264|FG001|Overall Study|Lack of Efficacy|3|||
126211405|NCT03733301|454062265|FG002|Overall Study|Lack of Efficacy|0|||
126211406|NCT03733301|454062263|FG000|Overall Study|Adverse Event|0|||
126211407|NCT03733301|454062264|FG001|Overall Study|Adverse Event|1|||
126211408|NCT03733301|454062265|FG002|Overall Study|Adverse Event|3|||
126211409|NCT03733301|454062263|FG000|Overall Study|Withdrawal by Subject|3|||
126211410|NCT03733301|454062264|FG001|Overall Study|Withdrawal by Subject|5|||
126211411|NCT03733301|454062265|FG002|Overall Study|Withdrawal by Subject|1|||
126211412|NCT00337727|454062266|FG000|Overall Study|Adverse Event|5|||
126211413|NCT00337727|454062267|FG001|Overall Study|Adverse Event|3|||
126211414|NCT00337727|454062266|FG000|Overall Study|Lost to Follow-up|5|||
126211415|NCT00337727|454062267|FG001|Overall Study|Lost to Follow-up|4|||
126211416|NCT00337727|454062266|FG000|Overall Study|Physician Decision|1|||
126211417|NCT00337727|454062267|FG001|Overall Study|Physician Decision|0|||
126211418|NCT00337727|454062266|FG000|Overall Study|Protocol Violation|4|||
126211419|NCT00337727|454062267|FG001|Overall Study|Protocol Violation|0|||
126211420|NCT00337727|454062266|FG000|Overall Study|Withdrawal by Subject|3|||
126211421|NCT00337727|454062267|FG001|Overall Study|Withdrawal by Subject|5|||
126211422|NCT00320801|454062268|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
126211423|NCT00320801|454062269|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
126211424|NCT00320801|454062270|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
126211425|NCT00320801|454062271|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
126211426|NCT00320801|454062268|FG000|Open-label Run-in Period|Adverse Event|33|||
126211427|NCT00320801|454062269|FG001|Open-label Run-in Period|Adverse Event|0|||
126211428|NCT00320801|454062270|FG002|Open-label Run-in Period|Adverse Event|0|||
126211429|NCT00320801|454062271|FG003|Open-label Run-in Period|Adverse Event|0|||
126211430|NCT00320801|454062268|FG000|Open-label Run-in Period|Administrative|10|||
126211431|NCT00320801|454062269|FG001|Open-label Run-in Period|Administrative|0|||
126211432|NCT00320801|454062270|FG002|Open-label Run-in Period|Administrative|0|||
126211433|NCT00320801|454062271|FG003|Open-label Run-in Period|Administrative|0|||
126211434|NCT00320801|454062268|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
126211435|NCT00320801|454062269|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
126211436|NCT00320801|454062270|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
126211437|NCT00320801|454062271|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
126211438|NCT00320801|454062268|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
126211439|NCT00320801|454062269|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
126346692|NCT04757636|454564588|FG000|Overall Study|Study Terminated by Sponsor|103|||
126346693|NCT04757636|454564589|FG001|Overall Study|Study Terminated by Sponsor|104|||
126346694|NCT04757636|454564590|FG002|Overall Study|Study Terminated by Sponsor|114|||
126346695|NCT04757636|454564588|FG000|Overall Study|Sponsor Decision|0|||
126211440|NCT00320801|454062270|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
126211441|NCT00320801|454062271|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
126211442|NCT00320801|454062268|FG000|Open-label Run-in Period|Did not qualify|1|||
126211443|NCT00320801|454062269|FG001|Open-label Run-in Period|Did not qualify|0|||
126211444|NCT00320801|454062270|FG002|Open-label Run-in Period|Did not qualify|0|||
126211445|NCT00320801|454062271|FG003|Open-label Run-in Period|Did not qualify|0|||
126346696|NCT04757636|454564589|FG001|Overall Study|Sponsor Decision|0|||
126346697|NCT04757636|454564590|FG002|Overall Study|Sponsor Decision|1|||
126346698|NCT04757636|454564588|FG000|Overall Study|Randomized in Error|0|||
126346699|NCT04757636|454564589|FG001|Overall Study|Randomized in Error|0|||
126346700|NCT04757636|454564590|FG002|Overall Study|Randomized in Error|2|||
126211446|NCT00320801|454062268|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126211447|NCT00320801|454062269|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126211448|NCT00320801|454062270|FG002|Double-blind Phase|Withdrawal by Subject|1|||
126211449|NCT00320801|454062271|FG003|Double-blind Phase|Withdrawal by Subject|0|||
126211450|NCT00320801|454062268|FG000|Double-blind Phase|Adverse Event|0|||
126211451|NCT00320801|454062269|FG001|Double-blind Phase|Adverse Event|2|||
126211452|NCT00320801|454062270|FG002|Double-blind Phase|Adverse Event|8|||
126211453|NCT00320801|454062271|FG003|Double-blind Phase|Adverse Event|0|||
126346701|NCT05350423|454564598|FG000|Overall Study|Lost to Follow-up|3|||
126211454|NCT00320801|454062268|FG000|Double-blind Phase|Administrative|0|||
126211455|NCT00320801|454062269|FG001|Double-blind Phase|Administrative|0|||
126211456|NCT00320801|454062270|FG002|Double-blind Phase|Administrative|4|||
126211457|NCT00320801|454062271|FG003|Double-blind Phase|Administrative|0|||
126211458|NCT00320801|454062268|FG000|Double-blind Phase|Lack of Efficacy|0|||
126211459|NCT00320801|454062269|FG001|Double-blind Phase|Lack of Efficacy|9|||
126211460|NCT00320801|454062270|FG002|Double-blind Phase|Lack of Efficacy|1|||
126211461|NCT00320801|454062271|FG003|Double-blind Phase|Lack of Efficacy|0|||
126211462|NCT00320801|454062268|FG000|Extension Phase|Withdrawal by Subject|0|||
126211463|NCT00320801|454062269|FG001|Extension Phase|Withdrawal by Subject|0|||
126211464|NCT00320801|454062270|FG002|Extension Phase|Withdrawal by Subject|0|||
126211465|NCT00320801|454062271|FG003|Extension Phase|Withdrawal by Subject|6|||
126211466|NCT00320801|454062268|FG000|Extension Phase|Adverse Event|0|||
126211467|NCT00320801|454062269|FG001|Extension Phase|Adverse Event|0|||
126211468|NCT00320801|454062270|FG002|Extension Phase|Adverse Event|0|||
126211469|NCT00320801|454062271|FG003|Extension Phase|Adverse Event|8|||
126211470|NCT00320801|454062268|FG000|Extension Phase|Administrative|0|||
126211471|NCT00320801|454062269|FG001|Extension Phase|Administrative|0|||
126211472|NCT00320801|454062270|FG002|Extension Phase|Administrative|0|||
126211473|NCT00320801|454062271|FG003|Extension Phase|Administrative|29|||
126211474|NCT00320801|454062268|FG000|Extension Phase|Lack of Efficacy|0|||
126211475|NCT00320801|454062269|FG001|Extension Phase|Lack of Efficacy|0|||
126211476|NCT00320801|454062270|FG002|Extension Phase|Lack of Efficacy|0|||
126211477|NCT00320801|454062271|FG003|Extension Phase|Lack of Efficacy|2|||
126211478|NCT00320801|454062268|FG000|Extension Phase|Lost to Follow-up|0|||
126211479|NCT00320801|454062269|FG001|Extension Phase|Lost to Follow-up|0|||
126211480|NCT00320801|454062270|FG002|Extension Phase|Lost to Follow-up|0|||
126211481|NCT00320801|454062271|FG003|Extension Phase|Lost to Follow-up|3|||
126211482|NCT06067191|454062272|FG000|Overall Study|Withdrawal by Subject|0|||
126211483|NCT06067191|454062273|FG001|Overall Study|Withdrawal by Subject|1|||
126211484|NCT00890409|454062275|FG000|Overall Study|Lost to Follow-up|20|||
126211485|NCT00890409|454062276|FG001|Overall Study|Lost to Follow-up|21|||
126211486|NCT00769132|454062279|FG000|Period 1|Adverse Event|1|||
126211487|NCT00769132|454062280|FG001|Period 1|Adverse Event|0|||
126211488|NCT00769132|454062281|FG002|Period 1|Adverse Event|0|||
126211489|NCT00769132|454062282|FG003|Period 1|Adverse Event|1|||
126211490|NCT00769132|454062279|FG000|Period 2|Withdrawal by Subject|0|||
126211491|NCT00769132|454062280|FG001|Period 2|Withdrawal by Subject|0|||
126211492|NCT00769132|454062281|FG002|Period 2|Withdrawal by Subject|0|||
126211493|NCT00769132|454062282|FG003|Period 2|Withdrawal by Subject|1|||
126211494|NCT00769132|454062279|FG000|Period 3|Withdrawal by Subject|1|||
126211495|NCT00769132|454062280|FG001|Period 3|Withdrawal by Subject|0|||
126211496|NCT00769132|454062281|FG002|Period 3|Withdrawal by Subject|0|||
126211497|NCT00769132|454062282|FG003|Period 3|Withdrawal by Subject|0|||
126211498|NCT00769132|454062279|FG000|Period 4|Withdrawal by Subject|0|||
126211499|NCT00769132|454062280|FG001|Period 4|Withdrawal by Subject|1|||
126211500|NCT00769132|454062281|FG002|Period 4|Withdrawal by Subject|0|||
126211501|NCT00769132|454062282|FG003|Period 4|Withdrawal by Subject|0|||
126211502|NCT00669110|454062284|FG000|Overall Study|Adverse Event|4|||
126211503|NCT00669110|454062285|FG001|Overall Study|Adverse Event|3|||
126211504|NCT00669110|454062284|FG000|Overall Study|Caregiver request|3|||
126346702|NCT05350423|454564599|FG001|Overall Study|Lost to Follow-up|3|||
126346703|NCT05350423|454564598|FG000|Overall Study|screen failure|5|||
126346704|NCT05350423|454564599|FG001|Overall Study|screen failure|6|||
126346705|NCT02097277|454564602|FG000|Overall Study|Subject no longer meets study criteria|0|||
126346706|NCT02097277|454564603|FG001|Overall Study|Subject no longer meets study criteria|1|||
126211505|NCT00669110|454062285|FG001|Overall Study|Caregiver request|2|||
126211506|NCT00669110|454062284|FG000|Overall Study|Physician Decision|0|||
126211507|NCT00669110|454062285|FG001|Overall Study|Physician Decision|1|||
126211508|NCT00669110|454062284|FG000|Overall Study|Lost to Follow-up|1|||
126346707|NCT02097277|454564604|FG002|Overall Study|Subject no longer meets study criteria|0|||
126346708|NCT02097277|454564605|FG003|Overall Study|Subject no longer meets study criteria|1|||
126346709|NCT02097277|454564606|FG004|Overall Study|Subject no longer meets study criteria|0|||
126346710|NCT02097277|454564602|FG000|Overall Study|Subject request to discontinue treatment|0|||
126346711|NCT02097277|454564603|FG001|Overall Study|Subject request to discontinue treatment|0|||
126346712|NCT02097277|454564604|FG002|Overall Study|Subject request to discontinue treatment|0|||
126346713|NCT02097277|454564605|FG003|Overall Study|Subject request to discontinue treatment|0|||
126211509|NCT00669110|454062285|FG001|Overall Study|Lost to Follow-up|0|||
126211510|NCT00669110|454062284|FG000|Overall Study|Protocol Violation|0|||
126211511|NCT00669110|454062285|FG001|Overall Study|Protocol Violation|5|||
126211512|NCT00669110|454062284|FG000|Overall Study|Withdrawal by Subject|0|||
126211513|NCT00669110|454062285|FG001|Overall Study|Withdrawal by Subject|2|||
126211514|NCT04455620|454062288|FG000|Overall Study|Withdrawal by Subject|0|||
126211515|NCT04455620|454062289|FG001|Overall Study|Withdrawal by Subject|0|||
126211516|NCT04455620|454062290|FG002|Overall Study|Withdrawal by Subject|2|||
126211517|NCT04455620|454062291|FG003|Overall Study|Withdrawal by Subject|0|||
126211518|NCT04455620|454062292|FG004|Overall Study|Withdrawal by Subject|1|||
126211519|NCT04455620|454062288|FG000|Overall Study|Lost to Follow-up|0|||
126211520|NCT04455620|454062289|FG001|Overall Study|Lost to Follow-up|0|||
126211521|NCT04455620|454062290|FG002|Overall Study|Lost to Follow-up|1|||
126211522|NCT04455620|454062291|FG003|Overall Study|Lost to Follow-up|1|||
126211523|NCT04455620|454062292|FG004|Overall Study|Lost to Follow-up|0|||
126211524|NCT04455620|454062288|FG000|Overall Study|Death|1|||
126211525|NCT04455620|454062289|FG001|Overall Study|Death|6|||
126211526|NCT04455620|454062290|FG002|Overall Study|Death|20|||
126211527|NCT04455620|454062291|FG003|Overall Study|Death|1|||
126211528|NCT04455620|454062292|FG004|Overall Study|Death|7|||
126211529|NCT04455620|454062288|FG000|Overall Study|Study Termination|0|||
126211530|NCT04455620|454062289|FG001|Overall Study|Study Termination|2|||
126211531|NCT04455620|454062290|FG002|Overall Study|Study Termination|1|||
126211532|NCT04455620|454062291|FG003|Overall Study|Study Termination|0|||
126211533|NCT04455620|454062292|FG004|Overall Study|Study Termination|6|||
126211534|NCT02851069|454062294|FG000|Overall Study|Failure to Return|3|||
126211535|NCT02851069|454062294|FG000|Overall Study|Other|3|||
126211536|NCT03539952|454062301|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
126211537|NCT03539952|454062302|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
126211538|NCT03539952|454062301|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
126211539|NCT03539952|454062302|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
126211540|NCT03539952|454062301|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
126211541|NCT03539952|454062302|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
126211542|NCT03539952|454062301|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
126211543|NCT03539952|454062302|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
126211544|NCT03539952|454062301|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
126211545|NCT03539952|454062302|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
126211546|NCT03539952|454062301|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
126211547|NCT03539952|454062302|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
126211548|NCT03539952|454062301|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
126211549|NCT03539952|454062302|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
126211550|NCT03188991|454062303|FG000|Overall Study|Withdrawal by Subject|0|||
126211551|NCT03188991|454062304|FG001|Overall Study|Withdrawal by Subject|0|||
126211552|NCT03188991|454062305|FG002|Overall Study|Withdrawal by Subject|0|||
126211553|NCT03188991|454062306|FG003|Overall Study|Withdrawal by Subject|1|||
126211554|NCT04502862|454062309|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
126211555|NCT04502862|454062310|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
126211556|NCT04502862|454062309|FG000|Overall Study|Withdrawal by Subject|1|||
126211557|NCT04502862|454062310|FG001|Overall Study|Withdrawal by Subject|0|||
126211558|NCT04502862|454062309|FG000|Overall Study|Adverse Event|1|||
126211559|NCT04502862|454062310|FG001|Overall Study|Adverse Event|1|||
126211560|NCT00798707|454063662|FG000|Overall Study|Adverse Event|6|||
126211561|NCT00798707|454063663|FG001|Overall Study|Adverse Event|8|||
126211562|NCT00798707|454063664|FG002|Overall Study|Adverse Event|8|||
126211563|NCT00798707|454063662|FG000|Overall Study|Failed to return|2|||
126211564|NCT00798707|454063663|FG001|Overall Study|Failed to return|2|||
126211565|NCT00798707|454063664|FG002|Overall Study|Failed to return|0|||
126211566|NCT00798707|454063662|FG000|Overall Study|Investigator|0|||
126211567|NCT00798707|454063663|FG001|Overall Study|Investigator|1|||
126211568|NCT00798707|454063664|FG002|Overall Study|Investigator|2|||
126211569|NCT00798707|454063662|FG000|Overall Study|Lack of Efficacy|2|||
126211570|NCT00798707|454063663|FG001|Overall Study|Lack of Efficacy|2|||
126211571|NCT00798707|454063664|FG002|Overall Study|Lack of Efficacy|1|||
126211572|NCT00798707|454063662|FG000|Overall Study|Lost to Follow-up|5|||
126211573|NCT00798707|454063663|FG001|Overall Study|Lost to Follow-up|6|||
126211574|NCT00798707|454063664|FG002|Overall Study|Lost to Follow-up|6|||
126211575|NCT00798707|454063662|FG000|Overall Study|Other|0|||
126211576|NCT00798707|454063663|FG001|Overall Study|Other|1|||
126211577|NCT00798707|454063664|FG002|Overall Study|Other|0|||
126211578|NCT00798707|454063662|FG000|Overall Study|Protocol Violation|4|||
126211579|NCT00798707|454063663|FG001|Overall Study|Protocol Violation|0|||
126211580|NCT00798707|454063664|FG002|Overall Study|Protocol Violation|2|||
126211581|NCT00798707|454063662|FG000|Overall Study|Withdrawal by Subject|3|||
126211582|NCT00798707|454063663|FG001|Overall Study|Withdrawal by Subject|8|||
126211583|NCT00798707|454063664|FG002|Overall Study|Withdrawal by Subject|2|||
126211584|NCT00798707|454063662|FG000|Overall Study|Randomized not treated|4|||
126211585|NCT00798707|454063663|FG001|Overall Study|Randomized not treated|5|||
126211586|NCT00798707|454063664|FG002|Overall Study|Randomized not treated|1|||
126211587|NCT01160770|454063667|FG000|Overall Study|Adverse Event|10|||
126211588|NCT01160770|454063667|FG000|Overall Study|Protocol Violation|2|||
126211589|NCT01160770|454063667|FG000|Overall Study|Subject/parent/caregiver request|33|||
126211590|NCT01160770|454063667|FG000|Overall Study|Physician Decision|1|||
126211591|NCT01160770|454063667|FG000|Overall Study|Lost to Follow-up|7|||
126211592|NCT01160770|454063667|FG000|Overall Study|Study termination or sponsor request|1|||
126211593|NCT01160770|454063667|FG000|Overall Study|Death|9|||
126211594|NCT01160770|454063667|FG000|Overall Study|Lack of Efficacy|15|||
126211595|NCT01160770|454063667|FG000|Overall Study|Other Reasons|1|||
126211596|NCT03606109|454063668|FG000|Overall Study|Lost to Follow-up|2|||
126211597|NCT03606109|454063669|FG001|Overall Study|Lost to Follow-up|1|||
126211598|NCT03669640|454063670|FG000|Overall Study|Study Terminated by Sponsor|0|||
126211599|NCT03669640|454063671|FG001|Overall Study|Study Terminated by Sponsor|0|||
126211600|NCT03669640|454063672|FG002|Overall Study|Study Terminated by Sponsor|0|||
126211601|NCT03669640|454063673|FG003|Overall Study|Study Terminated by Sponsor|0|||
126211602|NCT03669640|454063674|FG004|Overall Study|Study Terminated by Sponsor|1|||
126211603|NCT03669640|454063675|FG005|Overall Study|Study Terminated by Sponsor|0|||
126211604|NCT03669640|454063670|FG000|Overall Study|Lost to Follow-up|0|||
126211605|NCT03669640|454063671|FG001|Overall Study|Lost to Follow-up|0|||
126211606|NCT03669640|454063672|FG002|Overall Study|Lost to Follow-up|2|||
126211607|NCT03669640|454063673|FG003|Overall Study|Lost to Follow-up|0|||
126211608|NCT03669640|454063674|FG004|Overall Study|Lost to Follow-up|0|||
126211609|NCT03669640|454063675|FG005|Overall Study|Lost to Follow-up|0|||
126211610|NCT03669640|454063670|FG000|Overall Study|Death|0|||
126211611|NCT03669640|454063671|FG001|Overall Study|Death|0|||
126211612|NCT03669640|454063672|FG002|Overall Study|Death|1|||
126211613|NCT03669640|454063673|FG003|Overall Study|Death|0|||
126211614|NCT03669640|454063674|FG004|Overall Study|Death|0|||
126211615|NCT03669640|454063675|FG005|Overall Study|Death|0|||
126211616|NCT03669640|454063670|FG000|Overall Study|Withdrawal by Subject|1|||
126211617|NCT03669640|454063671|FG001|Overall Study|Withdrawal by Subject|2|||
126211618|NCT03669640|454063672|FG002|Overall Study|Withdrawal by Subject|1|||
126211619|NCT03669640|454063673|FG003|Overall Study|Withdrawal by Subject|0|||
126211620|NCT03669640|454063674|FG004|Overall Study|Withdrawal by Subject|1|||
126211621|NCT03669640|454063675|FG005|Overall Study|Withdrawal by Subject|3|||
126211622|NCT03669640|454063670|FG000|Overall Study|Protocol Violation|1|||
126211623|NCT03669640|454063671|FG001|Overall Study|Protocol Violation|0|||
126211624|NCT03669640|454063672|FG002|Overall Study|Protocol Violation|0|||
126211625|NCT03669640|454063673|FG003|Overall Study|Protocol Violation|0|||
126211626|NCT03669640|454063674|FG004|Overall Study|Protocol Violation|0|||
126211627|NCT03669640|454063675|FG005|Overall Study|Protocol Violation|0|||
126211628|NCT03669640|454063670|FG000|Overall Study|Physician Decision|0|||
126211629|NCT03669640|454063671|FG001|Overall Study|Physician Decision|2|||
126211630|NCT03669640|454063672|FG002|Overall Study|Physician Decision|0|||
126211631|NCT03669640|454063673|FG003|Overall Study|Physician Decision|0|||
126346714|NCT02097277|454564606|FG004|Overall Study|Subject request to discontinue treatment|1|||
126346715|NCT02097277|454564602|FG000|Overall Study|Lost to Follow-up|0|||
126346716|NCT02097277|454564603|FG001|Overall Study|Lost to Follow-up|1|||
126346717|NCT02097277|454564604|FG002|Overall Study|Lost to Follow-up|1|||
126346718|NCT02097277|454564605|FG003|Overall Study|Lost to Follow-up|0|||
126346719|NCT02097277|454564606|FG004|Overall Study|Lost to Follow-up|0|||
126346720|NCT02097277|454564602|FG000|Overall Study|Withdrawal by Subject|2|||
126346721|NCT02097277|454564603|FG001|Overall Study|Withdrawal by Subject|1|||
126346722|NCT02097277|454564604|FG002|Overall Study|Withdrawal by Subject|0|||
126346723|NCT02097277|454564605|FG003|Overall Study|Withdrawal by Subject|1|||
126346724|NCT02097277|454564606|FG004|Overall Study|Withdrawal by Subject|0|||
126346725|NCT02097277|454564602|FG000|Overall Study|Adverse Event|0|||
126346726|NCT02097277|454564603|FG001|Overall Study|Adverse Event|0|||
126346727|NCT02097277|454564604|FG002|Overall Study|Adverse Event|1|||
126346728|NCT02097277|454564605|FG003|Overall Study|Adverse Event|2|||
126346729|NCT02097277|454564606|FG004|Overall Study|Adverse Event|0|||
126346730|NCT03320369|454564607|FG000|Overall Study|Adverse Event|1|||
126346731|NCT03320369|454564607|FG000|Overall Study|Withdrawal by Subject|2|||
126346732|NCT01732692|454564608|FG000|Overall Study|Adverse Event|0|||
126346733|NCT01732692|454564609|FG001|Overall Study|Adverse Event|1|||
126346734|NCT04167462|454564612|FG000|Overall Study|Other reasons|3|||
126346735|NCT04167462|454564613|FG001|Overall Study|Other reasons|2|||
126346736|NCT04167462|454564612|FG000|Overall Study|Withdrawal by Subject|6|||
126346737|NCT04167462|454564613|FG001|Overall Study|Withdrawal by Subject|7|||
126346738|NCT04167462|454564612|FG000|Overall Study|Adverse Event|4|||
126346739|NCT04167462|454564613|FG001|Overall Study|Adverse Event|0|||
126346740|NCT04167462|454564612|FG000|Overall Study|Pregnancy|1|||
126012797|NCT03743246|453340964|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
126211632|NCT03669640|454063674|FG004|Overall Study|Physician Decision|0|||
126211633|NCT03669640|454063675|FG005|Overall Study|Physician Decision|0|||
126211634|NCT03669640|454063670|FG000|Overall Study|Disease Relapse|1|||
126211635|NCT03669640|454063671|FG001|Overall Study|Disease Relapse|0|||
126211636|NCT03669640|454063672|FG002|Overall Study|Disease Relapse|0|||
126211637|NCT03669640|454063673|FG003|Overall Study|Disease Relapse|0|||
126211638|NCT03669640|454063674|FG004|Overall Study|Disease Relapse|0|||
126211639|NCT03669640|454063675|FG005|Overall Study|Disease Relapse|0|||
126211640|NCT03669640|454063670|FG000|Overall Study|Adverse Event|2|||
126211641|NCT03669640|454063671|FG001|Overall Study|Adverse Event|1|||
126346741|NCT04167462|454564613|FG001|Overall Study|Pregnancy|0|||
126346742|NCT04167462|454564612|FG000|Overall Study|Lack of Efficacy|0|||
126211642|NCT03669640|454063672|FG002|Overall Study|Adverse Event|0|||
126211643|NCT03669640|454063673|FG003|Overall Study|Adverse Event|0|||
126211644|NCT03669640|454063674|FG004|Overall Study|Adverse Event|1|||
126211645|NCT03669640|454063675|FG005|Overall Study|Adverse Event|0|||
126211646|NCT05553600|454063676|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
126211647|NCT05553600|454063677|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
126211648|NCT05553600|454063678|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
126211649|NCT05553600|454063679|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
126211650|NCT05553600|454063676|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
126211651|NCT05553600|454063677|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
126211652|NCT05553600|454063678|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
126211653|NCT05553600|454063679|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
126211654|NCT05553600|454063676|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
126211655|NCT05553600|454063677|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
126211656|NCT05553600|454063678|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
126211657|NCT05553600|454063679|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
126211658|NCT05553600|454063676|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
126211659|NCT05553600|454063677|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
126211660|NCT05553600|454063678|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
126211661|NCT05553600|454063679|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
126211662|NCT05553600|454063676|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
126211663|NCT05553600|454063677|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
126211664|NCT05553600|454063678|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
126211665|NCT05553600|454063679|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
126211666|NCT05553600|454063676|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
126211667|NCT05553600|454063677|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
126211668|NCT05553600|454063678|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
126211669|NCT05553600|454063679|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
126211670|NCT05553600|454063676|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
126211671|NCT05553600|454063677|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
126211672|NCT05553600|454063678|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
126211673|NCT05553600|454063679|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
126211674|NCT05553600|454063676|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
126211675|NCT05553600|454063677|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
126211676|NCT05553600|454063678|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
126211677|NCT05553600|454063679|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
126211678|NCT05553600|454063676|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
126211679|NCT05553600|454063677|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
126211680|NCT05553600|454063678|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
126211681|NCT05553600|454063679|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
126211682|NCT05553600|454063676|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
126211683|NCT05553600|454063677|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
126211684|NCT05553600|454063678|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
126211685|NCT05553600|454063679|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
126211686|NCT05553600|454063676|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
126211687|NCT05553600|454063677|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
126211688|NCT05553600|454063678|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
126211689|NCT05553600|454063679|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
126211690|NCT05553600|454063676|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
126211691|NCT05553600|454063677|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
126211692|NCT05553600|454063678|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
126211693|NCT05553600|454063679|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
126211694|NCT02116309|454063684|FG000|Overall Study|Lost to Follow-up|0|||
126211695|NCT02116309|454063685|FG001|Overall Study|Lost to Follow-up|1|||
126211696|NCT00848965|454063686|FG000|Overall Study|Adverse Event|1|||
126211697|NCT00848965|454063686|FG000|Overall Study|Withdrawal by Subject|1|||
126211698|NCT03710824|454063687|FG000|Overall Study|Withdrawal by Subject|1|||
126211699|NCT03710824|454063687|FG000|Overall Study|Lost to Follow-up|3|||
126211700|NCT03710824|454063687|FG000|Overall Study|Adverse Event|25|||
126211701|NCT03710824|454063687|FG000|Overall Study|Treatment discontinuation|2|||
126211702|NCT02329834|454063688|FG000|Overall Study|Physician Decision|1|||
126211703|NCT02329834|454063689|FG001|Overall Study|Physician Decision|0|||
126346743|NCT04167462|454564613|FG001|Overall Study|Lack of Efficacy|1|||
126346744|NCT02606253|454564614|FG000|Overall Study|Adverse Event|2|||
126346745|NCT02606253|454564615|FG001|Overall Study|Adverse Event|0|||
126346746|NCT02606253|454564616|FG002|Overall Study|Adverse Event|0|||
126211704|NCT00578448|454063690|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
126211705|NCT00578448|454063690|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
126211706|NCT00578448|454063690|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
126211707|NCT00578448|454063690|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
126211708|NCT01976104|454063691|FG000|Overall Study|Adverse Event|0|||
126211709|NCT01976104|454063692|FG001|Overall Study|Adverse Event|0|||
126211710|NCT01976104|454063693|FG002|Overall Study|Adverse Event|1|||
126211711|NCT01976104|454063694|FG003|Overall Study|Adverse Event|0|||
126211712|NCT01976104|454063691|FG000|Overall Study|Lost to Follow-up|3|||
126211713|NCT01976104|454063692|FG001|Overall Study|Lost to Follow-up|0|||
126211714|NCT01976104|454063693|FG002|Overall Study|Lost to Follow-up|1|||
126211715|NCT01976104|454063694|FG003|Overall Study|Lost to Follow-up|1|||
126211716|NCT01976104|454063691|FG000|Overall Study|Subject Choice|0|||
126211717|NCT01976104|454063692|FG001|Overall Study|Subject Choice|1|||
126211718|NCT01976104|454063693|FG002|Overall Study|Subject Choice|0|||
126211719|NCT01976104|454063694|FG003|Overall Study|Subject Choice|1|||
126211720|NCT01976104|454063691|FG000|Overall Study|Withdrawal by Subject|3|||
126211721|NCT01976104|454063692|FG001|Overall Study|Withdrawal by Subject|0|||
126346747|NCT02606253|454564614|FG000|Overall Study|Protocol Violation|2|||
126346748|NCT02606253|454564615|FG001|Overall Study|Protocol Violation|1|||
126346749|NCT02606253|454564616|FG002|Overall Study|Protocol Violation|0|||
126346750|NCT02606253|454564614|FG000|Overall Study|Physician Decision|1|||
126346751|NCT02606253|454564615|FG001|Overall Study|Physician Decision|1|||
126346752|NCT02606253|454564616|FG002|Overall Study|Physician Decision|0|||
126346753|NCT02475213|454564619|FG000|Overall Study|Adverse Event|2|||
126346754|NCT02475213|454564620|FG001|Overall Study|Adverse Event|0|||
126346755|NCT02475213|454564621|FG002|Overall Study|Adverse Event|0|||
126346756|NCT02475213|454564622|FG003|Overall Study|Adverse Event|1|||
126346757|NCT02475213|454564623|FG004|Overall Study|Adverse Event|1|||
126346758|NCT02475213|454564624|FG005|Overall Study|Adverse Event|4|||
126346759|NCT02475213|454564625|FG006|Overall Study|Adverse Event|6|||
126346760|NCT02475213|454564626|FG007|Overall Study|Adverse Event|2|||
126346761|NCT02475213|454564619|FG000|Overall Study|Physician Decision|1|||
126346762|NCT02475213|454564620|FG001|Overall Study|Physician Decision|1|||
126346763|NCT02475213|454564621|FG002|Overall Study|Physician Decision|1|||
126346764|NCT02475213|454564622|FG003|Overall Study|Physician Decision|0|||
126346765|NCT02475213|454564623|FG004|Overall Study|Physician Decision|0|||
126346766|NCT02475213|454564624|FG005|Overall Study|Physician Decision|1|||
126346767|NCT02475213|454564625|FG006|Overall Study|Physician Decision|4|||
126346768|NCT02475213|454564626|FG007|Overall Study|Physician Decision|0|||
126346769|NCT02475213|454564619|FG000|Overall Study|Progressive Disease|3|||
126346770|NCT02475213|454564620|FG001|Overall Study|Progressive Disease|2|||
126346771|NCT02475213|454564621|FG002|Overall Study|Progressive Disease|2|||
126346772|NCT02475213|454564622|FG003|Overall Study|Progressive Disease|13|||
126346773|NCT02475213|454564623|FG004|Overall Study|Progressive Disease|15|||
126346774|NCT02475213|454564624|FG005|Overall Study|Progressive Disease|25|||
126346775|NCT02475213|454564625|FG006|Overall Study|Progressive Disease|30|||
126346776|NCT02475213|454564626|FG007|Overall Study|Progressive Disease|10|||
126346777|NCT02475213|454564619|FG000|Overall Study|Death|0|||
126346778|NCT02475213|454564620|FG001|Overall Study|Death|0|||
126346779|NCT02475213|454564621|FG002|Overall Study|Death|0|||
126346780|NCT02475213|454564622|FG003|Overall Study|Death|0|||
126346781|NCT02475213|454564623|FG004|Overall Study|Death|0|||
126346782|NCT02475213|454564624|FG005|Overall Study|Death|4|||
126346783|NCT02475213|454564625|FG006|Overall Study|Death|1|||
126346784|NCT02475213|454564626|FG007|Overall Study|Death|0|||
126346785|NCT02475213|454564619|FG000|Overall Study|Protocol Violation|0|||
126346786|NCT02475213|454564620|FG001|Overall Study|Protocol Violation|0|||
126346787|NCT02475213|454564621|FG002|Overall Study|Protocol Violation|0|||
126346788|NCT02475213|454564622|FG003|Overall Study|Protocol Violation|0|||
126346789|NCT02475213|454564623|FG004|Overall Study|Protocol Violation|1|||
126346790|NCT02475213|454564624|FG005|Overall Study|Protocol Violation|0|||
126346791|NCT02475213|454564625|FG006|Overall Study|Protocol Violation|0|||
126346792|NCT02475213|454564626|FG007|Overall Study|Protocol Violation|0|||
126346793|NCT02475213|454564619|FG000|Overall Study|Withdrawal by Subject|0|||
126211722|NCT01976104|454063693|FG002|Overall Study|Withdrawal by Subject|0|||
126211723|NCT01976104|454063694|FG003|Overall Study|Withdrawal by Subject|1|||
126211724|NCT01976104|454063691|FG000|Overall Study|Other|0|||
126211725|NCT01976104|454063692|FG001|Overall Study|Other|1|||
126211726|NCT01976104|454063693|FG002|Overall Study|Other|0|||
126211727|NCT01976104|454063694|FG003|Overall Study|Other|0|||
126211728|NCT01317199|454063695|FG000|Dose-escalation Phase 1|Physician Decision|5|||
126211729|NCT01317199|454063696|FG001|Dose-escalation Phase 1|Physician Decision|0|||
126346794|NCT02475213|454564620|FG001|Overall Study|Withdrawal by Subject|0|||
126346795|NCT02475213|454564621|FG002|Overall Study|Withdrawal by Subject|0|||
126346796|NCT02475213|454564622|FG003|Overall Study|Withdrawal by Subject|1|||
126211730|NCT01317199|454063697|FG002|Dose-escalation Phase 1|Physician Decision|0|||
126346797|NCT02475213|454564623|FG004|Overall Study|Withdrawal by Subject|0|||
126346798|NCT02475213|454564624|FG005|Overall Study|Withdrawal by Subject|2|||
126346799|NCT02475213|454564625|FG006|Overall Study|Withdrawal by Subject|2|||
126211731|NCT01317199|454063698|FG003|Dose-escalation Phase 1|Physician Decision|0|||
126211732|NCT01317199|454063695|FG000|Dose-escalation Phase 1|Disease progression|1|||
126211733|NCT01317199|454063696|FG001|Dose-escalation Phase 1|Disease progression|0|||
126211734|NCT01317199|454063697|FG002|Dose-escalation Phase 1|Disease progression|0|||
126211735|NCT01317199|454063698|FG003|Dose-escalation Phase 1|Disease progression|0|||
126211736|NCT01317199|454063695|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
126211737|NCT01317199|454063696|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
126211738|NCT01317199|454063697|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
126211739|NCT01317199|454063698|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
126211740|NCT01317199|454063695|FG000|Randomized Phase 2|Disease progression|0|||
126211741|NCT01317199|454063696|FG001|Randomized Phase 2|Disease progression|3|||
126211742|NCT01317199|454063697|FG002|Randomized Phase 2|Disease progression|7|||
126211743|NCT01317199|454063698|FG003|Randomized Phase 2|Disease progression|5|||
126211744|NCT01317199|454063695|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
126211745|NCT01317199|454063696|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
126211746|NCT01317199|454063697|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
126211747|NCT01317199|454063698|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
126211748|NCT01317199|454063695|FG000|Randomized Phase 2|Adverse Event|0|||
126211749|NCT01317199|454063696|FG001|Randomized Phase 2|Adverse Event|0|||
126211750|NCT01317199|454063697|FG002|Randomized Phase 2|Adverse Event|0|||
126211751|NCT01317199|454063698|FG003|Randomized Phase 2|Adverse Event|1|||
126211752|NCT01317199|454063695|FG000|Randomized Phase 2|Comorbidities|0|||
126211753|NCT01317199|454063696|FG001|Randomized Phase 2|Comorbidities|2|||
126211754|NCT01317199|454063697|FG002|Randomized Phase 2|Comorbidities|2|||
126211755|NCT01317199|454063698|FG003|Randomized Phase 2|Comorbidities|2|||
126211756|NCT01317199|454063695|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
126211757|NCT01317199|454063696|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
126211758|NCT01317199|454063697|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
126211759|NCT01317199|454063698|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
126211760|NCT01317199|454063695|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
126211761|NCT01317199|454063696|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
126211762|NCT01317199|454063697|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
126211763|NCT01317199|454063698|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
126211764|NCT01317199|454063695|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
126211765|NCT01317199|454063696|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
126211766|NCT01317199|454063697|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
126211767|NCT01317199|454063698|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
126211768|NCT01317199|454063695|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
126211769|NCT01317199|454063696|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
126211770|NCT01317199|454063697|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
126211771|NCT01317199|454063698|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
126211772|NCT01353209|454063699|FG000|Overall Study|Adverse Event|1|||
126346800|NCT02475213|454564626|FG007|Overall Study|Withdrawal by Subject|0|||
126346801|NCT02475213|454564619|FG000|Overall Study|Other|0|||
126346802|NCT02475213|454564620|FG001|Overall Study|Other|0|||
126346803|NCT02475213|454564621|FG002|Overall Study|Other|0|||
126346804|NCT02475213|454564622|FG003|Overall Study|Other|1|||
126346805|NCT02475213|454564623|FG004|Overall Study|Other|3|||
126346806|NCT02475213|454564624|FG005|Overall Study|Other|1|||
126346807|NCT02475213|454564625|FG006|Overall Study|Other|0|||
126346808|NCT02475213|454564626|FG007|Overall Study|Other|0|||
126346809|NCT05383209|454564629|FG000|Overall Study|Adverse Event: Non-ocular|0|||
126346810|NCT05383209|454564630|FG001|Overall Study|Adverse Event: Non-ocular|1|||
126346811|NCT05383209|454564631|FG002|Overall Study|Adverse Event: Non-ocular|0|||
126346812|NCT05383209|454564629|FG000|Overall Study|Lost to Follow-up|2|||
126346813|NCT05383209|454564630|FG001|Overall Study|Lost to Follow-up|1|||
126346814|NCT05383209|454564631|FG002|Overall Study|Lost to Follow-up|4|||
126346815|NCT05383209|454564629|FG000|Overall Study|Withdrawal by Subject|2|||
126346816|NCT05383209|454564630|FG001|Overall Study|Withdrawal by Subject|0|||
126346817|NCT05383209|454564631|FG002|Overall Study|Withdrawal by Subject|1|||
126346818|NCT05383209|454564629|FG000|Overall Study|Death|1|||
126346819|NCT05383209|454564630|FG001|Overall Study|Death|0|||
126211773|NCT01353209|454063700|FG001|Overall Study|Adverse Event|1|||
126211774|NCT01301625|454063712|FG000|Overall Study|Death|5|||
126211775|NCT01301625|454063712|FG000|Overall Study|Not Due|21|||
126211776|NCT01301625|454063712|FG000|Overall Study|Expected|8|||
126211777|NCT01301625|454063712|FG000|Overall Study|Lost to Follow-up|1|||
126211778|NCT03237325|454063715|FG000|Overall Study|Lost to Follow-up|3|||
126346820|NCT05383209|454564631|FG002|Overall Study|Death|0|||
126346821|NCT05383209|454564629|FG000|Overall Study|Other|0|||
126346822|NCT05383209|454564630|FG001|Overall Study|Other|1|||
126346823|NCT05383209|454564631|FG002|Overall Study|Other|0|||
126346824|NCT01582451|454564632|FG000|Overall Study|Adverse Event|1|||
126346825|NCT01582451|454564633|FG001|Overall Study|Adverse Event|3|||
126211779|NCT03237325|454063716|FG001|Overall Study|Lost to Follow-up|5|||
126211780|NCT03237325|454063715|FG000|Overall Study|Physician Decision|2|||
126211781|NCT03237325|454063716|FG001|Overall Study|Physician Decision|4|||
126211782|NCT03237325|454063715|FG000|Overall Study|Withdrawal by Subject|9|||
126211783|NCT03237325|454063716|FG001|Overall Study|Withdrawal by Subject|12|||
126211784|NCT03237325|454063715|FG000|Overall Study|Noncompliance with Study Procedures|1|||
126211785|NCT03237325|454063716|FG001|Overall Study|Noncompliance with Study Procedures|1|||
126211786|NCT03237325|454063715|FG000|Overall Study|Termination by Sponsor|0|||
126211787|NCT03237325|454063716|FG001|Overall Study|Termination by Sponsor|1|||
126211788|NCT03237325|454063715|FG000|Overall Study|Reason other than described|0|||
126211789|NCT03237325|454063716|FG001|Overall Study|Reason other than described|2|||
126211790|NCT05102162|454063720|FG000|Overall Study|Withdrawal by Subject|3|||
126211791|NCT05102162|454063721|FG001|Overall Study|Withdrawal by Subject|0|||
126211792|NCT05102162|454063720|FG000|Overall Study|Baseline cultures negative|4|||
126211793|NCT05102162|454063721|FG001|Overall Study|Baseline cultures negative|2|||
126211794|NCT05102162|454063720|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
126211795|NCT05102162|454063721|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
126211796|NCT05102162|454063720|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
126211797|NCT05102162|454063721|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
126211798|NCT01165424|454063722|FG000|Overall Study|Clinical adverse experiences|1|||
126211799|NCT01165424|454063722|FG000|Overall Study|Laboratory adverse experiences|1|||
126211800|NCT01165424|454063722|FG000|Overall Study|Did not meet entry criteria|1|||
126211801|NCT01165424|454063722|FG000|Overall Study|Participant moved (relocated)|1|||
126211802|NCT02181673|454063723|FG000|Up to Week 24|Adverse Event|2|||
126211803|NCT02181673|454063724|FG001|Up to Week 24|Adverse Event|0|||
126211804|NCT02181673|454063725|FG002|Up to Week 24|Adverse Event|3|||
126211805|NCT02181673|454063723|FG000|Up to Week 24|Death|1|||
126211806|NCT02181673|454063724|FG001|Up to Week 24|Death|0|||
126211807|NCT02181673|454063725|FG002|Up to Week 24|Death|0|||
126211808|NCT02181673|454063723|FG000|Up to Week 24|Lack of Efficacy|1|||
126211809|NCT02181673|454063724|FG001|Up to Week 24|Lack of Efficacy|0|||
126211810|NCT02181673|454063725|FG002|Up to Week 24|Lack of Efficacy|0|||
126211811|NCT02181673|454063723|FG000|Up to Week 24|Lost to Follow-up|1|||
126211812|NCT02181673|454063724|FG001|Up to Week 24|Lost to Follow-up|0|||
126211813|NCT02181673|454063725|FG002|Up to Week 24|Lost to Follow-up|0|||
126211814|NCT02181673|454063723|FG000|Up to Week 24|Physician Decision|0|||
126211815|NCT02181673|454063724|FG001|Up to Week 24|Physician Decision|0|||
126211816|NCT02181673|454063725|FG002|Up to Week 24|Physician Decision|3|||
126211817|NCT02181673|454063723|FG000|Up to Week 24|Withdrawal by Subject|10|||
126211818|NCT02181673|454063724|FG001|Up to Week 24|Withdrawal by Subject|0|||
126211819|NCT02181673|454063725|FG002|Up to Week 24|Withdrawal by Subject|1|||
126211820|NCT02181673|454063723|FG000|Up to Week 24|Other|2|||
126211821|NCT02181673|454063724|FG001|Up to Week 24|Other|0|||
126211822|NCT02181673|454063725|FG002|Up to Week 24|Other|3|||
126211823|NCT02181673|454063723|FG000|Up to Week 24|Randomized not Treated|0|||
126211824|NCT02181673|454063724|FG001|Up to Week 24|Randomized not Treated|0|||
126211825|NCT02181673|454063725|FG002|Up to Week 24|Randomized not Treated|1|||
126211826|NCT02181673|454063723|FG000|Week 24-Week 60|Adverse Event|0|||
126211827|NCT02181673|454063724|FG001|Week 24-Week 60|Adverse Event|4|||
126211828|NCT02181673|454063725|FG002|Week 24-Week 60|Adverse Event|10|||
126211829|NCT02181673|454063723|FG000|Week 24-Week 60|Other|0|||
126211830|NCT02181673|454063724|FG001|Week 24-Week 60|Other|2|||
126211831|NCT02181673|454063725|FG002|Week 24-Week 60|Other|1|||
126211832|NCT02181673|454063723|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
126012798|NCT03743246|453340961|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
126346826|NCT01582451|454564632|FG000|Overall Study|Death|3|||
126346827|NCT01582451|454564633|FG001|Overall Study|Death|3|||
126346828|NCT01582451|454564632|FG000|Overall Study|Lost to Follow-up|0|||
126346829|NCT01582451|454564633|FG001|Overall Study|Lost to Follow-up|2|||
126346830|NCT01582451|454564632|FG000|Overall Study|Protocol Violation|11|||
126346831|NCT01582451|454564633|FG001|Overall Study|Protocol Violation|3|||
126346832|NCT01582451|454564632|FG000|Overall Study|Withdrawal by Subject|13|||
126346833|NCT01582451|454564633|FG001|Overall Study|Withdrawal by Subject|9|||
126346834|NCT01582451|454564632|FG000|Overall Study|Physician Decision|3|||
126346835|NCT01582451|454564633|FG001|Overall Study|Physician Decision|0|||
126346836|NCT01582451|454564632|FG000|Overall Study|Sponsor Decision|1|||
126346837|NCT01582451|454564633|FG001|Overall Study|Sponsor Decision|0|||
126346838|NCT00717886|454564634|FG000|Overall Study|Withdrawal by Subject|3|||
126346839|NCT00717886|454564634|FG000|Overall Study|Treatment Failure|1|||
126346840|NCT01553851|454564635|FG000|Overall Study|Adverse Event|2|||
126346841|NCT01553851|454564635|FG000|Overall Study|constipation|1|||
126346842|NCT00487188|454564637|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
126346843|NCT00487188|454564638|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
126346844|NCT00487188|454564639|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
126346845|NCT00487188|454564637|FG000|Induction Phase|Adverse Event|5|||
126346846|NCT00487188|454564638|FG001|Induction Phase|Adverse Event|0|||
126346847|NCT00487188|454564639|FG002|Induction Phase|Adverse Event|0|||
126346848|NCT00487188|454564637|FG000|Induction Phase|Lack of Efficacy|0|||
126346849|NCT00487188|454564638|FG001|Induction Phase|Lack of Efficacy|1|||
126346850|NCT00487188|454564639|FG002|Induction Phase|Lack of Efficacy|0|||
126346851|NCT00487188|454564637|FG000|Induction Phase|Protocol Violation|1|||
126346852|NCT00487188|454564638|FG001|Induction Phase|Protocol Violation|0|||
126346853|NCT00487188|454564639|FG002|Induction Phase|Protocol Violation|0|||
126346854|NCT00487188|454564637|FG000|Induction Phase|Refused Treatment|1|||
126346855|NCT00487188|454564638|FG001|Induction Phase|Refused Treatment|2|||
126346856|NCT00487188|454564639|FG002|Induction Phase|Refused Treatment|0|||
126346857|NCT00487188|454564637|FG000|Induction Phase|Lost to Follow-up|2|||
126346858|NCT00487188|454564638|FG001|Induction Phase|Lost to Follow-up|2|||
126346859|NCT00487188|454564639|FG002|Induction Phase|Lost to Follow-up|0|||
126346860|NCT00487188|454564637|FG000|Induction Phase|Administrative|0|||
126346861|NCT00487188|454564638|FG001|Induction Phase|Administrative|1|||
126346862|NCT00487188|454564639|FG002|Induction Phase|Administrative|0|||
126346863|NCT00487188|454564637|FG000|Maintenance Phase|Adverse Event|1|||
126346864|NCT00487188|454564638|FG001|Maintenance Phase|Adverse Event|0|||
126346865|NCT00487188|454564639|FG002|Maintenance Phase|Adverse Event|0|||
126346866|NCT00487188|454564637|FG000|Maintenance Phase|Death|1|||
126346867|NCT00487188|454564638|FG001|Maintenance Phase|Death|0|||
126346868|NCT00487188|454564639|FG002|Maintenance Phase|Death|0|||
126346869|NCT00487188|454564637|FG000|Maintenance Phase|Lost to Follow-up|1|||
126346870|NCT00487188|454564638|FG001|Maintenance Phase|Lost to Follow-up|0|||
126346871|NCT00487188|454564639|FG002|Maintenance Phase|Lost to Follow-up|0|||
126346872|NCT00487188|454564637|FG000|Maintenance Phase|Administrative|0|||
126346873|NCT00487188|454564638|FG001|Maintenance Phase|Administrative|0|||
126346874|NCT00487188|454564639|FG002|Maintenance Phase|Administrative|1|||
126346875|NCT03822416|454564649|FG000|Overall Study|Lost to Follow-up|1|||
126346876|NCT03822416|454564650|FG001|Overall Study|Lost to Follow-up|0|||
126346877|NCT03822416|454564649|FG000|Overall Study|Withdrawal by Subject|0|||
126346878|NCT03822416|454564650|FG001|Overall Study|Withdrawal by Subject|1|||
126346879|NCT04666298|454564653|FG000|Overall Study|Subject decision|1|||
126346880|NCT04666298|454564654|FG001|Overall Study|Subject decision|0|||
126346881|NCT04666298|454564655|FG002|Overall Study|Subject decision|0|||
126346882|NCT04666298|454564656|FG003|Overall Study|Subject decision|2|||
126346883|NCT04666298|454564653|FG000|Overall Study|Death|1|||
126346884|NCT04666298|454564654|FG001|Overall Study|Death|0|||
126346885|NCT04666298|454564655|FG002|Overall Study|Death|0|||
126346886|NCT04666298|454564656|FG003|Overall Study|Death|0|||
126346887|NCT04666298|454564653|FG000|Overall Study|Lost to Follow-up|0|||
126346888|NCT04666298|454564654|FG001|Overall Study|Lost to Follow-up|0|||
126012799|NCT03743246|453340962|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
126346889|NCT04666298|454564655|FG002|Overall Study|Lost to Follow-up|0|||
126346890|NCT04666298|454564656|FG003|Overall Study|Lost to Follow-up|1|||
126346891|NCT04666298|454564653|FG000|Overall Study|Physician Decision|0|||
126346892|NCT04666298|454564654|FG001|Overall Study|Physician Decision|0|||
126346893|NCT04666298|454564655|FG002|Overall Study|Physician Decision|0|||
126346894|NCT04666298|454564656|FG003|Overall Study|Physician Decision|1|||
126346895|NCT04666298|454564653|FG000|Overall Study|Protocol deviation|0|||
126346896|NCT04666298|454564654|FG001|Overall Study|Protocol deviation|0|||
126346897|NCT04666298|454564655|FG002|Overall Study|Protocol deviation|1|||
126346898|NCT04666298|454564656|FG003|Overall Study|Protocol deviation|0|||
126346899|NCT00844519|454564657|FG000|Overall Study|Withdrawal by Subject|1|||
126346900|NCT00844519|454564658|FG001|Overall Study|Withdrawal by Subject|1|||
126346901|NCT00844519|454564657|FG000|Overall Study|Adverse Event|1|||
126346902|NCT00844519|454564658|FG001|Overall Study|Adverse Event|0|||
126346903|NCT06438601|454564659|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
126012800|NCT03743246|453340963|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
126012801|NCT03743246|453340964|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
126346904|NCT06438601|454564660|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
126346905|NCT06438601|454564659|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
126346906|NCT06438601|454564660|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
126346907|NCT01311661|454564663|FG000|Overall Study|Adverse Event|2|||
126346908|NCT01311661|454564663|FG000|Overall Study|Protocol Violation|3|||
126346909|NCT01311661|454564663|FG000|Overall Study|Withdrawal by Subject|2|||
126346910|NCT00207740|454564664|FG000|Overall Study|Adverse Event|4|||
126346911|NCT00207740|454564665|FG001|Overall Study|Adverse Event|14|||
126346912|NCT00207740|454564666|FG002|Overall Study|Adverse Event|14|||
126346913|NCT00207740|454564667|FG003|Overall Study|Adverse Event|11|||
126346914|NCT00207740|454564664|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126346915|NCT00207740|454564665|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126346916|NCT00207740|454564666|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126346917|NCT00207740|454564667|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
126346918|NCT00207740|454564664|FG000|Overall Study|Lost to Follow-up|0|||
126346919|NCT00207740|454564665|FG001|Overall Study|Lost to Follow-up|2|||
126346920|NCT00207740|454564666|FG002|Overall Study|Lost to Follow-up|1|||
126346921|NCT00207740|454564667|FG003|Overall Study|Lost to Follow-up|1|||
126346922|NCT00207740|454564664|FG000|Overall Study|Death|0|||
126346923|NCT00207740|454564665|FG001|Overall Study|Death|0|||
126346924|NCT00207740|454564666|FG002|Overall Study|Death|0|||
126346925|NCT00207740|454564667|FG003|Overall Study|Death|1|||
126346926|NCT00207740|454564664|FG000|Overall Study|Sponsor Directive|22|||
126346927|NCT00207740|454564665|FG001|Overall Study|Sponsor Directive|15|||
126346928|NCT00207740|454564666|FG002|Overall Study|Sponsor Directive|16|||
126346929|NCT00207740|454564667|FG003|Overall Study|Sponsor Directive|21|||
126346930|NCT00207740|454564664|FG000|Overall Study|Other|2|||
126346931|NCT00207740|454564665|FG001|Overall Study|Other|10|||
126346932|NCT00207740|454564666|FG002|Overall Study|Other|7|||
126346933|NCT00207740|454564667|FG003|Overall Study|Other|5|||
126346934|NCT00390013|454564668|FG000|Phase 1|tired|0|||
126346935|NCT00390013|454564669|FG001|Phase 1|tired|0|||
126346936|NCT00390013|454564670|FG002|Phase 1|tired|0|||
126346937|NCT00390013|454564671|FG003|Phase 1|tired|1|||
126346938|NCT00390013|454564668|FG000|Phase 2 First Treatment|tired|1|||
126346939|NCT00390013|454564669|FG001|Phase 2 First Treatment|tired|0|||
126346940|NCT00390013|454564670|FG002|Phase 2 First Treatment|tired|0|||
126346941|NCT00390013|454564671|FG003|Phase 2 First Treatment|tired|0|||
126346942|NCT00390013|454564668|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
126346943|NCT00390013|454564669|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
126346944|NCT00390013|454564670|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
126346945|NCT00390013|454564671|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
126346946|NCT03188822|454564674|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
126346947|NCT03188822|454564674|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
126346948|NCT02774889|454564688|FG000|Overall Study|Lost to Follow-up|2|||
126346949|NCT02774889|454564689|FG001|Overall Study|Lost to Follow-up|1|||
126346950|NCT00858988|454564690|FG000|Analysis|Lactulose unable to be detected in urine|2|||
126346951|NCT00858988|454564691|FG001|Analysis|Lactulose unable to be detected in urine|1|||
126346952|NCT01349595|454564692|FG000|Overall Study|Lack of funding|2|||
126346953|NCT01349595|454564693|FG001|Overall Study|Lack of funding|2|||
126346954|NCT04584788|454564711|FG000|Overall Study|Physician Decision|8|||
126346955|NCT04584788|454564711|FG000|Overall Study|Withdrawal by Subject|1|||
126346956|NCT04584788|454564711|FG000|Overall Study|Adverse Event|3|||
126346957|NCT00770809|454566825|FG000|Overall Study|Adverse Event|9|||
126346958|NCT00770809|454566826|FG001|Overall Study|Adverse Event|1|||
126346959|NCT00770809|454566827|FG002|Overall Study|Adverse Event|12|||
126346960|NCT00770809|454566825|FG000|Overall Study|Death|1|||
126346961|NCT00770809|454566826|FG001|Overall Study|Death|0|||
126346962|NCT00770809|454566827|FG002|Overall Study|Death|0|||
126346963|NCT00770809|454566825|FG000|Overall Study|Withdrawal by Subject|3|||
126346964|NCT00770809|454566826|FG001|Overall Study|Withdrawal by Subject|3|||
126346965|NCT00770809|454566827|FG002|Overall Study|Withdrawal by Subject|7|||
126346966|NCT00770809|454566825|FG000|Overall Study|Progression|2|||
126346967|NCT00770809|454566826|FG001|Overall Study|Progression|2|||
126091130|NCT03820947|453626922|FG004|Overall Study|Lost to Follow-up|9|||
126346968|NCT00770809|454566827|FG002|Overall Study|Progression|0|||
126346969|NCT00770809|454566825|FG000|Overall Study|Complicating illness|0|||
126346970|NCT00770809|454566826|FG001|Overall Study|Complicating illness|0|||
126346971|NCT00770809|454566827|FG002|Overall Study|Complicating illness|1|||
126346972|NCT00770809|454566825|FG000|Overall Study|Other Medical Reasons|2|||
126346973|NCT00770809|454566826|FG001|Overall Study|Other Medical Reasons|4|||
126346974|NCT00770809|454566827|FG002|Overall Study|Other Medical Reasons|3|||
126346975|NCT01091259|454566830|FG000|Overall Study|Adverse Event|3|||
126346976|NCT01091259|454566830|FG000|Overall Study|Lack of Efficacy|2|||
126346977|NCT03813654|454566831|FG000|Overall Study|Protocol Violation|0|||
126346978|NCT03813654|454566832|FG001|Overall Study|Protocol Violation|1|||
126346979|NCT03813654|454566833|FG002|Overall Study|Protocol Violation|2|||
126346980|NCT03813654|454566831|FG000|Overall Study|Withdrawal by Subject|1|||
126346981|NCT03813654|454566832|FG001|Overall Study|Withdrawal by Subject|0|||
126346982|NCT03813654|454566833|FG002|Overall Study|Withdrawal by Subject|0|||
126346983|NCT01208051|454566834|FG000|Total Enrollment|Withdrawal by Subject|0|||
126346984|NCT01208051|454566835|FG001|Total Enrollment|Withdrawal by Subject|1|||
126346985|NCT01208051|454566836|FG002|Total Enrollment|Withdrawal by Subject|0|||
126346986|NCT01208051|454566837|FG003|Total Enrollment|Withdrawal by Subject|0|||
126346987|NCT01208051|454566838|FG004|Total Enrollment|Withdrawal by Subject|2|||
126346988|NCT01208051|454566834|FG000|Total Enrollment|Brain metastases|0|||
126346989|NCT01208051|454566835|FG001|Total Enrollment|Brain metastases|0|||
126346990|NCT01208051|454566836|FG002|Total Enrollment|Brain metastases|1|||
126346991|NCT01208051|454566837|FG003|Total Enrollment|Brain metastases|0|||
126346992|NCT01208051|454566838|FG004|Total Enrollment|Brain metastases|0|||
126346993|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
126346994|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
126346995|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
126346996|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
126346997|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
126346998|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
126346999|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
126347000|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
126347001|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
126347002|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
126347003|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
126347004|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
126347005|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
126347006|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
126347007|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
126347008|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
126347009|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
126347010|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
126347011|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
126347012|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
126347013|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
126347014|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
126347015|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
126347016|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
126347017|NCT01541748|454566845|FG000|Overall Study|Lost to Follow-up|17|||
126347018|NCT01541748|454566845|FG000|Overall Study|Moved out of state|1|||
126347019|NCT01541748|454566845|FG000|Overall Study|Withdrawal by Subject|7|||
126347020|NCT01541748|454566845|FG000|Overall Study|Screen failure|5|||
126347021|NCT01541748|454566845|FG000|Overall Study|Did not receive study device|1|||
126347022|NCT06057064|454566846|FG000|Overall Study|Death|2|||
126347023|NCT06057064|454566847|FG001|Overall Study|Death|0|||
126347024|NCT06057064|454566846|FG000|Overall Study|Physician Decision|1|||
126347025|NCT06057064|454566847|FG001|Overall Study|Physician Decision|0|||
126347026|NCT06057064|454566846|FG000|Overall Study|Withdrawal by Subject|1|||
126347027|NCT06057064|454566847|FG001|Overall Study|Withdrawal by Subject|1|||
126347028|NCT02832037|454566848|FG000|Overall Study|Administrative reasons|0|||
126347029|NCT02832037|454566849|FG001|Overall Study|Administrative reasons|0|||
126347030|NCT02832037|454566850|FG002|Overall Study|Administrative reasons|1|||
126347031|NCT02832037|454566851|FG003|Overall Study|Administrative reasons|0|||
126347032|NCT02832037|454566852|FG004|Overall Study|Administrative reasons|0|||
126347033|NCT02832037|454566848|FG000|Overall Study|Protocol Violation|3|||
126347034|NCT02832037|454566849|FG001|Overall Study|Protocol Violation|0|||
126347035|NCT02832037|454566850|FG002|Overall Study|Protocol Violation|4|||
126347036|NCT02832037|454566851|FG003|Overall Study|Protocol Violation|1|||
126347037|NCT02832037|454566852|FG004|Overall Study|Protocol Violation|2|||
126347038|NCT02832037|454566848|FG000|Overall Study|Lost to Follow-up|2|||
126347039|NCT02832037|454566849|FG001|Overall Study|Lost to Follow-up|0|||
126347040|NCT02832037|454566850|FG002|Overall Study|Lost to Follow-up|3|||
126347041|NCT02832037|454566851|FG003|Overall Study|Lost to Follow-up|0|||
126347042|NCT02832037|454566852|FG004|Overall Study|Lost to Follow-up|5|||
126347043|NCT02832037|454566848|FG000|Overall Study|Withdrawal by Subject|9|||
126347044|NCT02832037|454566849|FG001|Overall Study|Withdrawal by Subject|8|||
126347045|NCT02832037|454566850|FG002|Overall Study|Withdrawal by Subject|0|||
126347046|NCT02832037|454566851|FG003|Overall Study|Withdrawal by Subject|4|||
126347047|NCT02832037|454566852|FG004|Overall Study|Withdrawal by Subject|8|||
126347048|NCT02832037|454566848|FG000|Overall Study|Adverse Event|5|||
126347049|NCT02832037|454566849|FG001|Overall Study|Adverse Event|4|||
126347050|NCT02832037|454566850|FG002|Overall Study|Adverse Event|0|||
126347051|NCT02832037|454566851|FG003|Overall Study|Adverse Event|2|||
126347052|NCT02832037|454566852|FG004|Overall Study|Adverse Event|4|||
126347053|NCT01137786|454566854|FG000|Overall Study|Lost to Follow-up|0|||
126347054|NCT01137786|454566855|FG001|Overall Study|Lost to Follow-up|2|||
126347055|NCT01137786|454566854|FG000|Overall Study|Withdrawal by Subject|1|||
126347056|NCT01137786|454566855|FG001|Overall Study|Withdrawal by Subject|1|||
126347057|NCT01531153|454566856|FG000|Overall Study|Withdrawal by Subject|10|||
126347058|NCT01531153|454566857|FG001|Overall Study|Withdrawal by Subject|9|||
126347059|NCT01531153|454566858|FG002|Overall Study|Withdrawal by Subject|15|||
126347060|NCT00770367|454566859|FG000|First Intervention|Withdrawal by Subject|0|||
126347061|NCT00770367|454566860|FG001|First Intervention|Withdrawal by Subject|2|||
126347062|NCT00770367|454566859|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
126347063|NCT00770367|454566860|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
126347064|NCT00770367|454566859|FG000|Second Intervention|Lost to Follow-up|2|||
126347065|NCT00770367|454566860|FG001|Second Intervention|Lost to Follow-up|0|||
126347066|NCT00435942|454566861|FG000|Overall Study|Death|17|||
126347067|NCT00435942|454566862|FG001|Overall Study|Death|10|||
126347068|NCT00435942|454566861|FG000|Overall Study|Withdrawal by Subject|2|||
126347069|NCT00435942|454566862|FG001|Overall Study|Withdrawal by Subject|0|||
126347070|NCT00435942|454566861|FG000|Overall Study|Lost to Follow-up|0|||
126347071|NCT00435942|454566862|FG001|Overall Study|Lost to Follow-up|16|||
126347072|NCT00435942|454566861|FG000|Overall Study|Conversion to Open Repair|1|||
126347073|NCT00435942|454566862|FG001|Overall Study|Conversion to Open Repair|0|||
126347074|NCT00435942|454566861|FG000|Overall Study|Technical Failure|3|||
126347075|NCT00435942|454566862|FG001|Overall Study|Technical Failure|0|||
126347076|NCT00435942|454566861|FG000|Overall Study|Other|0|||
126347077|NCT00435942|454566862|FG001|Overall Study|Other|1|||
126347078|NCT00920816|454566863|FG000|Overall Study|Death|116|||
126347079|NCT00920816|454566864|FG001|Overall Study|Death|63|||
126347080|NCT00920816|454566865|FG002|Overall Study|Death|8|||
126347081|NCT00920816|454566866|FG003|Overall Study|Death|3|||
126347082|NCT00920816|454566863|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
126347083|NCT00920816|454566864|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
126347084|NCT00920816|454566865|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
126347085|NCT00920816|454566866|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
126347086|NCT00920816|454566863|FG000|Overall Study|Global deterioration of health status|2|||
126347087|NCT00920816|454566864|FG001|Overall Study|Global deterioration of health status|0|||
126347088|NCT00920816|454566865|FG002|Overall Study|Global deterioration of health status|0|||
126347089|NCT00920816|454566866|FG003|Overall Study|Global deterioration of health status|0|||
126347090|NCT00920816|454566863|FG000|Overall Study|Objective progression or relapse|6|||
126347091|NCT00920816|454566864|FG001|Overall Study|Objective progression or relapse|2|||
126347092|NCT00920816|454566865|FG002|Overall Study|Objective progression or relapse|0|||
126347093|NCT00920816|454566866|FG003|Overall Study|Objective progression or relapse|0|||
126347094|NCT00920816|454566863|FG000|Overall Study|Other|26|||
126347095|NCT00920816|454566864|FG001|Overall Study|Other|15|||
126347096|NCT00920816|454566865|FG002|Overall Study|Other|1|||
126347097|NCT00920816|454566866|FG003|Overall Study|Other|2|||
126347098|NCT00920816|454566863|FG000|Overall Study|Lost to Follow-up|11|||
126347099|NCT00920816|454566864|FG001|Overall Study|Lost to Follow-up|2|||
126347100|NCT00920816|454566865|FG002|Overall Study|Lost to Follow-up|0|||
126347101|NCT00920816|454566866|FG003|Overall Study|Lost to Follow-up|0|||
126347102|NCT00920816|454566863|FG000|Overall Study|Adverse Event|1|||
126347103|NCT00920816|454566864|FG001|Overall Study|Adverse Event|1|||
126347104|NCT00920816|454566865|FG002|Overall Study|Adverse Event|1|||
126347105|NCT00920816|454566866|FG003|Overall Study|Adverse Event|0|||
126347106|NCT00920816|454566863|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
126347107|NCT00920816|454566864|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
126347108|NCT00920816|454566865|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
126347109|NCT00920816|454566866|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
126347110|NCT00920816|454566863|FG000|Overall Study|Randomized but not treated|3|||
126347111|NCT00920816|454566864|FG001|Overall Study|Randomized but not treated|0|||
126347112|NCT00920816|454566865|FG002|Overall Study|Randomized but not treated|0|||
126347113|NCT00920816|454566866|FG003|Overall Study|Randomized but not treated|0|||
126347114|NCT01180777|454566867|FG000|Overall Study|Protocol Violation|6|||
126347115|NCT01180777|454566867|FG000|Overall Study|Poor lens fit|4|||
126347116|NCT01180777|454566867|FG000|Overall Study|Lost to Follow-up|1|||
126347117|NCT01180777|454566867|FG000|Overall Study|Adverse Event|1|||
126347118|NCT05522751|454566872|FG000|Overall Study|Adverse Event|1|||
126347119|NCT00505921|454566873|FG000|Overall Study|Ineligible|1|||
126347120|NCT00505921|454566873|FG000|Overall Study|Failed to Mobilize|8|||
126347121|NCT02382939|454566879|FG000|Overall Study|Adverse Event|1|||
126347122|NCT02382939|454566880|FG001|Overall Study|Adverse Event|1|||
126347123|NCT02382939|454566879|FG000|Overall Study|Withdrawal by Subject|2|||
126347124|NCT02382939|454566880|FG001|Overall Study|Withdrawal by Subject|2|||
126347125|NCT00716417|454566881|FG000|Overall Study|Adverse Event|0|||
126347126|NCT00716417|454566882|FG001|Overall Study|Adverse Event|0|||
126347127|NCT00716417|454566883|FG002|Overall Study|Adverse Event|2|||
126347128|NCT00716417|454566884|FG003|Overall Study|Adverse Event|1|||
126347129|NCT00716417|454566885|FG004|Overall Study|Adverse Event|0|||
126347130|NCT00716417|454566886|FG005|Overall Study|Adverse Event|0|||
126347131|NCT00716417|454566887|FG006|Overall Study|Adverse Event|3|||
126347132|NCT00716417|454566888|FG007|Overall Study|Adverse Event|1|||
126347133|NCT00716417|454566889|FG008|Overall Study|Adverse Event|0|||
126347134|NCT00716417|454566890|FG009|Overall Study|Adverse Event|3|||
126347135|NCT00716417|454566881|FG000|Overall Study|Withdrawal by Subject|0|||
126347136|NCT00716417|454566882|FG001|Overall Study|Withdrawal by Subject|1|||
126347137|NCT00716417|454566883|FG002|Overall Study|Withdrawal by Subject|0|||
126347138|NCT00716417|454566884|FG003|Overall Study|Withdrawal by Subject|2|||
126347139|NCT00716417|454566885|FG004|Overall Study|Withdrawal by Subject|0|||
126347140|NCT00716417|454566886|FG005|Overall Study|Withdrawal by Subject|0|||
126347141|NCT00716417|454566887|FG006|Overall Study|Withdrawal by Subject|1|||
126347142|NCT00716417|454566888|FG007|Overall Study|Withdrawal by Subject|0|||
126347143|NCT00716417|454566889|FG008|Overall Study|Withdrawal by Subject|0|||
126347144|NCT00716417|454566890|FG009|Overall Study|Withdrawal by Subject|0|||
126347145|NCT00716417|454566881|FG000|Overall Study|Progressive disease|3|||
126347146|NCT00716417|454566882|FG001|Overall Study|Progressive disease|5|||
126347147|NCT00716417|454566883|FG002|Overall Study|Progressive disease|3|||
126347148|NCT00716417|454566884|FG003|Overall Study|Progressive disease|8|||
126347149|NCT00716417|454566885|FG004|Overall Study|Progressive disease|0|||
126347150|NCT00716417|454566886|FG005|Overall Study|Progressive disease|3|||
126347151|NCT00716417|454566887|FG006|Overall Study|Progressive disease|3|||
126347152|NCT00716417|454566888|FG007|Overall Study|Progressive disease|1|||
126347153|NCT00716417|454566889|FG008|Overall Study|Progressive disease|5|||
126347154|NCT00716417|454566890|FG009|Overall Study|Progressive disease|0|||
126347155|NCT00716417|454566881|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
126347156|NCT00716417|454566882|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
126347157|NCT00716417|454566883|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
126347158|NCT00716417|454566884|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
126347159|NCT00716417|454566885|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
126347160|NCT00716417|454566886|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
126347161|NCT00716417|454566887|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
126347162|NCT00716417|454566888|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
126347163|NCT00716417|454566889|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
126347164|NCT00716417|454566890|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
126347165|NCT00716417|454566881|FG000|Overall Study|On patient request due to toxicities|0|||
126347166|NCT00716417|454566882|FG001|Overall Study|On patient request due to toxicities|0|||
126347167|NCT00716417|454566883|FG002|Overall Study|On patient request due to toxicities|0|||
126347168|NCT00716417|454566884|FG003|Overall Study|On patient request due to toxicities|0|||
126347169|NCT00716417|454566885|FG004|Overall Study|On patient request due to toxicities|0|||
126347170|NCT00716417|454566886|FG005|Overall Study|On patient request due to toxicities|0|||
126347171|NCT00716417|454566887|FG006|Overall Study|On patient request due to toxicities|0|||
126347172|NCT00716417|454566888|FG007|Overall Study|On patient request due to toxicities|1|||
126347173|NCT00716417|454566889|FG008|Overall Study|On patient request due to toxicities|0|||
126347174|NCT00716417|454566890|FG009|Overall Study|On patient request due to toxicities|0|||
126347175|NCT01369433|454566891|FG000|Overall Study|Adverse Event|31|||
126347176|NCT01369433|454566892|FG001|Overall Study|Adverse Event|1|||
126347177|NCT01369433|454566891|FG000|Overall Study|Required significant surgical procedure|1|||
126347178|NCT01369433|454566892|FG001|Overall Study|Required significant surgical procedure|0|||
126347179|NCT01369433|454566891|FG000|Overall Study|Non-compliance|1|||
126347180|NCT01369433|454566892|FG001|Overall Study|Non-compliance|0|||
126347181|NCT01369433|454566891|FG000|Overall Study|Withdrawal by Subject|5|||
126012802|NCT03743246|453340961|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
126211833|NCT02181673|454063724|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
126211834|NCT02181673|454063725|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
126211835|NCT02181673|454063723|FG000|Week 24-Week 60|Pregnancy|0|||
126211836|NCT02181673|454063724|FG001|Week 24-Week 60|Pregnancy|0|||
126347182|NCT01369433|454566892|FG001|Overall Study|Withdrawal by Subject|2|||
126347183|NCT01369433|454566891|FG000|Overall Study|Study terminated by Sponsor|67|||
126347184|NCT01369433|454566892|FG001|Overall Study|Study terminated by Sponsor|0|||
126347185|NCT01369433|454566891|FG000|Overall Study|Lost to Follow-up|1|||
126347186|NCT01369433|454566892|FG001|Overall Study|Lost to Follow-up|0|||
126347187|NCT01369433|454566891|FG000|Overall Study|Death|5|||
126347188|NCT01369433|454566892|FG001|Overall Study|Death|0|||
126347189|NCT01369433|454566891|FG000|Overall Study|Investigator discretion|6|||
126347190|NCT01369433|454566892|FG001|Overall Study|Investigator discretion|1|||
126347191|NCT01369433|454566891|FG000|Overall Study|Progressive Disease|92|||
126347192|NCT01369433|454566892|FG001|Overall Study|Progressive Disease|12|||
126347193|NCT02178956|454566897|FG000|Overall Study|Lost to Follow-up|4|||
126347194|NCT02178956|454566898|FG001|Overall Study|Lost to Follow-up|4|||
126347195|NCT02178956|454566897|FG000|Overall Study|Sponsor terminated study|49|||
126347196|NCT02178956|454566898|FG001|Overall Study|Sponsor terminated study|58|||
126347197|NCT02178956|454566897|FG000|Overall Study|Withdrawal by Subject|15|||
126347198|NCT02178956|454566898|FG001|Overall Study|Withdrawal by Subject|11|||
126347199|NCT02178956|454566897|FG000|Overall Study|Various Reasons|3|||
126347200|NCT02178956|454566898|FG001|Overall Study|Various Reasons|5|||
126347201|NCT01138046|454566899|FG000|Overall Study|Withdrawal due to death|6|||
126347202|NCT02709369|454566901|FG000|Overall Study|Lost to Follow-up|15|||
126347203|NCT02709369|454566901|FG000|Overall Study|Withdrawal by Subject|10|||
126347204|NCT02709369|454566901|FG000|Overall Study|Did not received intervention|2|||
126347205|NCT01900314|454566902|FG000|Overall Study|Lost to Follow-up|1|||
126347206|NCT01900314|454566903|FG001|Overall Study|Lost to Follow-up|0|||
126347207|NCT01900314|454566902|FG000|Overall Study|Protocol Violation|0|||
126347208|NCT01900314|454566903|FG001|Overall Study|Protocol Violation|1|||
126347209|NCT01900314|454566902|FG000|Overall Study|Withdrawal by Subject|3|||
126347210|NCT01900314|454566903|FG001|Overall Study|Withdrawal by Subject|3|||
126347211|NCT01104766|454566904|FG000|Overall Study|Did not meet inc/exc criteria|1|||
126347212|NCT01104766|454566905|FG001|Overall Study|Did not meet inc/exc criteria|0|||
126347213|NCT01104766|454566906|FG002|Overall Study|Did not meet inc/exc criteria|0|||
126347214|NCT01104766|454566907|FG003|Overall Study|Did not meet inc/exc criteria|0|||
126347215|NCT01104766|454566904|FG000|Overall Study|Adverse Event|17|||
126347216|NCT01104766|454566905|FG001|Overall Study|Adverse Event|15|||
126347217|NCT01104766|454566906|FG002|Overall Study|Adverse Event|20|||
126347218|NCT01104766|454566907|FG003|Overall Study|Adverse Event|14|||
126347219|NCT01104766|454566904|FG000|Overall Study|Lack of Efficacy|20|||
126347220|NCT01104766|454566905|FG001|Overall Study|Lack of Efficacy|15|||
126347221|NCT01104766|454566906|FG002|Overall Study|Lack of Efficacy|14|||
126347222|NCT01104766|454566907|FG003|Overall Study|Lack of Efficacy|8|||
126347223|NCT01104766|454566904|FG000|Overall Study|Protocol Violation|2|||
126347224|NCT01104766|454566905|FG001|Overall Study|Protocol Violation|0|||
126347225|NCT01104766|454566906|FG002|Overall Study|Protocol Violation|0|||
126347226|NCT01104766|454566907|FG003|Overall Study|Protocol Violation|0|||
126347227|NCT01104766|454566904|FG000|Overall Study|Withdrawal by Subject|17|||
126347228|NCT01104766|454566905|FG001|Overall Study|Withdrawal by Subject|19|||
126347229|NCT01104766|454566906|FG002|Overall Study|Withdrawal by Subject|25|||
126347230|NCT01104766|454566907|FG003|Overall Study|Withdrawal by Subject|15|||
126347231|NCT01104766|454566904|FG000|Overall Study|Lost to Follow-up|1|||
126347232|NCT01104766|454566905|FG001|Overall Study|Lost to Follow-up|2|||
126347233|NCT01104766|454566906|FG002|Overall Study|Lost to Follow-up|1|||
126347234|NCT01104766|454566907|FG003|Overall Study|Lost to Follow-up|1|||
126347235|NCT04225832|454566909|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
126347236|NCT04225832|454566910|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
126347237|NCT04225832|454566909|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
126347238|NCT04225832|454566910|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
126347239|NCT03965923|454566913|FG000|Overall Study|Withdrawal by Subject|1|||
126347240|NCT03965923|454566914|FG001|Overall Study|Withdrawal by Subject|2|||
126347241|NCT03965923|454566915|FG002|Overall Study|Withdrawal by Subject|3|||
126347242|NCT03965923|454566916|FG003|Overall Study|Withdrawal by Subject|1|||
126347243|NCT03965923|454566917|FG004|Overall Study|Withdrawal by Subject|2|||
126347244|NCT03965923|454566918|FG005|Overall Study|Withdrawal by Subject|0|||
126347245|NCT03965923|454566919|FG006|Overall Study|Withdrawal by Subject|4|||
126347246|NCT03965923|454566920|FG007|Overall Study|Withdrawal by Subject|3|||
126347247|NCT03965923|454566921|FG008|Overall Study|Withdrawal by Subject|4|||
126347248|NCT03965923|454566922|FG009|Overall Study|Withdrawal by Subject|0|||
126347249|NCT03965923|454566923|FG010|Overall Study|Withdrawal by Subject|2|||
126347250|NCT03965923|454566924|FG011|Overall Study|Withdrawal by Subject|0|||
126347251|NCT03965923|454566913|FG000|Overall Study|Lost to Follow-up|2|||
126347252|NCT03965923|454566914|FG001|Overall Study|Lost to Follow-up|1|||
126347253|NCT03965923|454566915|FG002|Overall Study|Lost to Follow-up|1|||
126211837|NCT02181673|454063725|FG002|Week 24-Week 60|Pregnancy|1|||
126347254|NCT03965923|454566916|FG003|Overall Study|Lost to Follow-up|0|||
126091131|NCT03578887|453626923|FG000|Overall Study|Withdrawal by Subject|7|||
126091132|NCT03578887|453626924|FG001|Overall Study|Withdrawal by Subject|2|||
126091133|NCT03578887|453626925|FG002|Overall Study|Withdrawal by Subject|1|||
126091134|NCT03578887|453626923|FG000|Overall Study|Lost to Follow-up|13|||
126091135|NCT03578887|453626924|FG001|Overall Study|Lost to Follow-up|1|||
126091136|NCT03578887|453626925|FG002|Overall Study|Lost to Follow-up|4|||
126091137|NCT03578887|453626923|FG000|Overall Study|Physician Decision|0|||
126091138|NCT03578887|453626924|FG001|Overall Study|Physician Decision|1|||
126091139|NCT03578887|453626925|FG002|Overall Study|Physician Decision|1|||
126091140|NCT00387426|453628347|FG000|Overall Study|Lack of Response|7|||
126012803|NCT03743246|453340962|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
126091141|NCT00387426|453628347|FG000|Overall Study|Toxicities|4|||
126091142|NCT00387426|453628347|FG000|Overall Study|Disease Progression|3|||
126012804|NCT03743246|453340963|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
126211838|NCT02181673|454063723|FG000|Week 24-Week 60|Lack of Efficacy|0|||
126347255|NCT03965923|454566917|FG004|Overall Study|Lost to Follow-up|2|||
126347256|NCT03965923|454566918|FG005|Overall Study|Lost to Follow-up|1|||
126347257|NCT03965923|454566919|FG006|Overall Study|Lost to Follow-up|2|||
126347258|NCT03965923|454566920|FG007|Overall Study|Lost to Follow-up|1|||
126347259|NCT03965923|454566921|FG008|Overall Study|Lost to Follow-up|0|||
126347260|NCT03965923|454566922|FG009|Overall Study|Lost to Follow-up|2|||
126347261|NCT03965923|454566923|FG010|Overall Study|Lost to Follow-up|0|||
126347262|NCT03965923|454566924|FG011|Overall Study|Lost to Follow-up|0|||
126347263|NCT03965923|454566913|FG000|Overall Study|Death|0|||
126347264|NCT03965923|454566914|FG001|Overall Study|Death|0|||
126347265|NCT03965923|454566915|FG002|Overall Study|Death|0|||
126347266|NCT03965923|454566916|FG003|Overall Study|Death|0|||
126347267|NCT03965923|454566917|FG004|Overall Study|Death|0|||
126347268|NCT03965923|454566918|FG005|Overall Study|Death|0|||
126347269|NCT03965923|454566919|FG006|Overall Study|Death|0|||
126347270|NCT03965923|454566920|FG007|Overall Study|Death|1|||
126347271|NCT03965923|454566921|FG008|Overall Study|Death|4|||
126347272|NCT03965923|454566922|FG009|Overall Study|Death|0|||
126347273|NCT03965923|454566923|FG010|Overall Study|Death|4|||
126347274|NCT03965923|454566924|FG011|Overall Study|Death|0|||
126347275|NCT03965923|454566913|FG000|Overall Study|Other reason|0|||
126012805|NCT03743246|453340964|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
126012806|NCT03743246|453340961|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
126012807|NCT03743246|453340962|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
126012808|NCT03743246|453340963|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
126012809|NCT03743246|453340964|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
126012810|NCT00716144|453340977|FG000|Overall Study|Withdrawal by Subject|4|||
126012811|NCT00716144|453340978|FG001|Overall Study|Withdrawal by Subject|2|||
126012812|NCT00716144|453340979|FG002|Overall Study|Withdrawal by Subject|6|||
126012813|NCT00716144|453340980|FG003|Overall Study|Withdrawal by Subject|6|||
126012814|NCT00716144|453340977|FG000|Overall Study|Lost to Follow-up|2|||
126012815|NCT00716144|453340978|FG001|Overall Study|Lost to Follow-up|2|||
126012816|NCT00716144|453340979|FG002|Overall Study|Lost to Follow-up|1|||
126012817|NCT00716144|453340980|FG003|Overall Study|Lost to Follow-up|2|||
126012818|NCT00716144|453340977|FG000|Overall Study|Adverse Event|0|||
126012819|NCT00716144|453340978|FG001|Overall Study|Adverse Event|0|||
126012820|NCT00716144|453340979|FG002|Overall Study|Adverse Event|0|||
126012821|NCT00716144|453340980|FG003|Overall Study|Adverse Event|2|||
126012822|NCT00716144|453340977|FG000|Overall Study|Non-compliance|1|||
126012823|NCT00716144|453340978|FG001|Overall Study|Non-compliance|0|||
126012824|NCT00716144|453340979|FG002|Overall Study|Non-compliance|0|||
126347276|NCT03965923|454566914|FG001|Overall Study|Other reason|0|||
126347277|NCT03965923|454566915|FG002|Overall Study|Other reason|0|||
126347278|NCT03965923|454566916|FG003|Overall Study|Other reason|1|||
126347279|NCT03965923|454566917|FG004|Overall Study|Other reason|0|||
126347280|NCT03965923|454566918|FG005|Overall Study|Other reason|0|||
126347281|NCT03965923|454566919|FG006|Overall Study|Other reason|0|||
126347282|NCT03965923|454566920|FG007|Overall Study|Other reason|0|||
126347283|NCT03965923|454566921|FG008|Overall Study|Other reason|0|||
126347284|NCT03965923|454566922|FG009|Overall Study|Other reason|0|||
126347285|NCT03965923|454566923|FG010|Overall Study|Other reason|2|||
126347286|NCT03965923|454566924|FG011|Overall Study|Other reason|0|||
126347287|NCT03282097|454566925|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
126347288|NCT03282097|454566926|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
126347289|NCT03282097|454566925|FG000|Intervention Visit Complete|Patient Death|13|||
126347290|NCT03282097|454566926|FG001|Intervention Visit Complete|Patient Death|15|||
126347291|NCT03282097|454566925|FG000|Intervention Visit Complete|Caregiver Death|0|||
126347292|NCT03282097|454566926|FG001|Intervention Visit Complete|Caregiver Death|3|||
126347293|NCT03282097|454566925|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
126347294|NCT03282097|454566926|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
126347295|NCT03282097|454566925|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
126347296|NCT03282097|454566926|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
126347297|NCT03282097|454566925|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
126347298|NCT03282097|454566926|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
126012825|NCT00716144|453340980|FG003|Overall Study|Non-compliance|0|||
126012826|NCT00716144|453340977|FG000|Overall Study|Protocol Violation|2|||
126012827|NCT00716144|453340978|FG001|Overall Study|Protocol Violation|0|||
126347299|NCT03282097|454566925|FG000|Primary Outcome Data Collection Complete|Missing|2|||
126347300|NCT03282097|454566926|FG001|Primary Outcome Data Collection Complete|Missing|3|||
126347301|NCT03282097|454566925|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
126347302|NCT03282097|454566926|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
126347303|NCT03282097|454566925|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
126347304|NCT03282097|454566926|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
126012828|NCT00716144|453340979|FG002|Overall Study|Protocol Violation|1|||
126211839|NCT02181673|454063724|FG001|Week 24-Week 60|Lack of Efficacy|0|||
126211840|NCT02181673|454063725|FG002|Week 24-Week 60|Lack of Efficacy|1|||
126211841|NCT02181673|454063723|FG000|Week 24-Week 60|Lost to Follow-up|0|||
126012829|NCT00716144|453340980|FG003|Overall Study|Protocol Violation|0|||
126211842|NCT02181673|454063724|FG001|Week 24-Week 60|Lost to Follow-up|0|||
126211843|NCT02181673|454063725|FG002|Week 24-Week 60|Lost to Follow-up|1|||
126347305|NCT03282097|454566925|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
126347306|NCT03282097|454566926|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
126347307|NCT06001021|454566930|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
126347308|NCT06001021|454566931|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
126347309|NCT06001021|454566932|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
126347310|NCT06001021|454566933|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
126347311|NCT06001021|454566934|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
126347312|NCT06001021|454566935|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
126347313|NCT06001021|454566936|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
126347314|NCT06001021|454566930|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
126347315|NCT06001021|454566931|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
126347316|NCT06001021|454566932|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
126347317|NCT06001021|454566933|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
126347318|NCT06001021|454566934|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
126347319|NCT06001021|454566935|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
126347320|NCT06001021|454566936|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
126347321|NCT02755090|454566937|FG000|Overall Study|equipment malfunction|1|||
126347322|NCT02755090|454566938|FG001|Overall Study|equipment malfunction|0|||
126347323|NCT04797169|454566940|FG000|Overall Study|Lost to Follow-up|84|||
126347324|NCT04797169|454566941|FG001|Overall Study|Lost to Follow-up|67|||
126347325|NCT04797169|454566940|FG000|Overall Study|Pregnancy|1|||
126347326|NCT04797169|454566941|FG001|Overall Study|Pregnancy|3|||
126347327|NCT04797169|454566940|FG000|Overall Study|Withdrawal by Subject|27|||
126347328|NCT04797169|454566941|FG001|Overall Study|Withdrawal by Subject|35|||
126347329|NCT03839641|454566950|FG000|Overall Study|Withdrawal by Subject|1|||
126347330|NCT03839641|454566951|FG001|Overall Study|Withdrawal by Subject|1|||
126347331|NCT04221490|454566952|FG000|At 30 Days Follow-up|Death|7|||
126347332|NCT04221490|454566952|FG000|At 30 Days Follow-up|Missed Visit|4|||
126347333|NCT04221490|454566952|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
126347334|NCT04221490|454566952|FG000|At 6 Months Follow-up|Death|9|||
126347335|NCT04221490|454566952|FG000|At 6 Months Follow-up|Physician Decision|1|||
126347336|NCT04221490|454566952|FG000|At 6 Months Follow-up|Missed Visit|8|||
126347337|NCT04221490|454566952|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
126347338|NCT03034967|454566953|FG000|Overall Study|Withdrawal by Subject|9|||
126347339|NCT03034967|454566954|FG001|Overall Study|Withdrawal by Subject|2|||
126347340|NCT03034967|454566955|FG002|Overall Study|Withdrawal by Subject|6|||
126347341|NCT03034967|454566956|FG003|Overall Study|Withdrawal by Subject|6|||
126347342|NCT03034967|454566957|FG004|Overall Study|Withdrawal by Subject|9|||
126347343|NCT03034967|454566958|FG005|Overall Study|Withdrawal by Subject|2|||
126347344|NCT03034967|454566953|FG000|Overall Study|Physician Decision|1|||
126347345|NCT03034967|454566954|FG001|Overall Study|Physician Decision|0|||
126347346|NCT03034967|454566955|FG002|Overall Study|Physician Decision|1|||
126347347|NCT03034967|454566956|FG003|Overall Study|Physician Decision|1|||
126347348|NCT03034967|454566957|FG004|Overall Study|Physician Decision|1|||
126347349|NCT03034967|454566958|FG005|Overall Study|Physician Decision|0|||
126347350|NCT03034967|454566953|FG000|Overall Study|Lost to Follow-up|0|||
126347351|NCT03034967|454566954|FG001|Overall Study|Lost to Follow-up|0|||
126347352|NCT03034967|454566955|FG002|Overall Study|Lost to Follow-up|0|||
126347353|NCT03034967|454566956|FG003|Overall Study|Lost to Follow-up|1|||
126347354|NCT03034967|454566957|FG004|Overall Study|Lost to Follow-up|0|||
126347355|NCT03034967|454566958|FG005|Overall Study|Lost to Follow-up|2|||
126347356|NCT03034967|454566953|FG000|Overall Study|Liver function test abnormality|0|||
126347357|NCT03034967|454566954|FG001|Overall Study|Liver function test abnormality|0|||
126347358|NCT03034967|454566955|FG002|Overall Study|Liver function test abnormality|1|||
126347359|NCT03034967|454566956|FG003|Overall Study|Liver function test abnormality|0|||
126347360|NCT03034967|454566957|FG004|Overall Study|Liver function test abnormality|0|||
126347361|NCT03034967|454566958|FG005|Overall Study|Liver function test abnormality|0|||
126347362|NCT03034967|454566953|FG000|Overall Study|Protocol Violation|1|||
126347363|NCT03034967|454566954|FG001|Overall Study|Protocol Violation|0|||
126347364|NCT03034967|454566955|FG002|Overall Study|Protocol Violation|0|||
126347365|NCT03034967|454566956|FG003|Overall Study|Protocol Violation|0|||
126347366|NCT03034967|454566957|FG004|Overall Study|Protocol Violation|0|||
126347367|NCT03034967|454566958|FG005|Overall Study|Protocol Violation|2|||
126347368|NCT03034967|454566953|FG000|Overall Study|Lack of Efficacy|0|||
126347369|NCT03034967|454566954|FG001|Overall Study|Lack of Efficacy|1|||
126347370|NCT03034967|454566955|FG002|Overall Study|Lack of Efficacy|2|||
126347371|NCT03034967|454566956|FG003|Overall Study|Lack of Efficacy|1|||
126347372|NCT03034967|454566957|FG004|Overall Study|Lack of Efficacy|1|||
126347373|NCT03034967|454566958|FG005|Overall Study|Lack of Efficacy|0|||
126347374|NCT03034967|454566953|FG000|Overall Study|Adverse Event, non-fatal|3|||
126347375|NCT03034967|454566954|FG001|Overall Study|Adverse Event, non-fatal|1|||
126012830|NCT00716144|453340977|FG000|Overall Study|Physician Decision|0|||
126347376|NCT03034967|454566955|FG002|Overall Study|Adverse Event, non-fatal|2|||
126347377|NCT03034967|454566956|FG003|Overall Study|Adverse Event, non-fatal|0|||
126012831|NCT00716144|453340978|FG001|Overall Study|Physician Decision|1|||
126347378|NCT03034967|454566957|FG004|Overall Study|Adverse Event, non-fatal|2|||
126347379|NCT03034967|454566958|FG005|Overall Study|Adverse Event, non-fatal|8|||
126347380|NCT03034967|454566953|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
126347381|NCT03034967|454566954|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
126347382|NCT03034967|454566955|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
126347383|NCT03034967|454566956|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
126347384|NCT03034967|454566957|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
126347385|NCT03034967|454566958|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
126347386|NCT02550795|454566965|FG000|Overall Study|Physician Decision|0|||
126347387|NCT02550795|454566966|FG001|Overall Study|Physician Decision|1|||
126347388|NCT02550795|454566967|FG002|Overall Study|Physician Decision|0|||
126347389|NCT00879658|454566968|FG000|Overall Study|Abnormal laboratory value(s)|3|||
126347390|NCT00879658|454566969|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126347391|NCT00879658|454566970|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126347392|NCT00879658|454566971|FG003|Overall Study|Abnormal laboratory value(s)|1|||
126347393|NCT00879658|454566972|FG004|Overall Study|Abnormal laboratory value(s)|0|||
126347394|NCT00879658|454566973|FG005|Overall Study|Abnormal laboratory value(s)|0|||
126347395|NCT00879658|454566974|FG006|Overall Study|Abnormal laboratory value(s)|0|||
126347396|NCT00879658|454566968|FG000|Overall Study|Administrative problems|2|||
126347397|NCT00879658|454566969|FG001|Overall Study|Administrative problems|1|||
126347398|NCT00879658|454566970|FG002|Overall Study|Administrative problems|0|||
126347399|NCT00879658|454566971|FG003|Overall Study|Administrative problems|1|||
126347400|NCT00879658|454566972|FG004|Overall Study|Administrative problems|0|||
126347401|NCT00879658|454566973|FG005|Overall Study|Administrative problems|0|||
126347402|NCT00879658|454566974|FG006|Overall Study|Administrative problems|0|||
126347403|NCT00879658|454566968|FG000|Overall Study|Adverse Event|6|||
126347404|NCT00879658|454566969|FG001|Overall Study|Adverse Event|4|||
126347405|NCT00879658|454566970|FG002|Overall Study|Adverse Event|3|||
126012832|NCT00716144|453340979|FG002|Overall Study|Physician Decision|2|||
126012833|NCT00716144|453340980|FG003|Overall Study|Physician Decision|2|||
126012834|NCT00716144|453340977|FG000|Overall Study|Intercurrent illness|0|||
126012835|NCT00716144|453340978|FG001|Overall Study|Intercurrent illness|0|||
126012836|NCT00716144|453340979|FG002|Overall Study|Intercurrent illness|1|||
126012837|NCT00716144|453340980|FG003|Overall Study|Intercurrent illness|0|||
126012838|NCT00716144|453340977|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
126012839|NCT00716144|453340978|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
126012840|NCT00716144|453340979|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
126012841|NCT00716144|453340980|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
126012842|NCT00716144|453340977|FG000|Overall Study|Adverse event: left foot pain|0|||
126012843|NCT00716144|453340978|FG001|Overall Study|Adverse event: left foot pain|1|||
126012844|NCT00716144|453340979|FG002|Overall Study|Adverse event: left foot pain|0|||
126012845|NCT00716144|453340980|FG003|Overall Study|Adverse event: left foot pain|0|||
126012846|NCT00716144|453340977|FG000|Overall Study|Clinical Depression|0|||
126012847|NCT00716144|453340978|FG001|Overall Study|Clinical Depression|1|||
126012848|NCT00716144|453340979|FG002|Overall Study|Clinical Depression|0|||
126012849|NCT00716144|453340980|FG003|Overall Study|Clinical Depression|0|||
126012850|NCT05641311|453340981|FG000|Dosing Period 1|Adverse Event|1|||
126012851|NCT05641311|453340982|FG001|Dosing Period 1|Adverse Event|0|||
126012852|NCT00909363|453340983|FG000|Overall Study|Withdrawal by Subject|1|||
126012853|NCT00909363|453340984|FG001|Overall Study|Withdrawal by Subject|0|||
126012854|NCT00909363|453340985|FG002|Overall Study|Withdrawal by Subject|0|||
126012855|NCT00909363|453340983|FG000|Overall Study|Lack of Efficacy|1|||
126012856|NCT00909363|453340984|FG001|Overall Study|Lack of Efficacy|0|||
126347406|NCT00879658|454566971|FG003|Overall Study|Adverse Event|1|||
126347407|NCT00879658|454566972|FG004|Overall Study|Adverse Event|2|||
126347408|NCT00879658|454566973|FG005|Overall Study|Adverse Event|0|||
126347409|NCT00879658|454566974|FG006|Overall Study|Adverse Event|0|||
126347410|NCT00879658|454566968|FG000|Overall Study|Protocol Violation|1|||
126347411|NCT00879658|454566969|FG001|Overall Study|Protocol Violation|0|||
126347412|NCT00879658|454566970|FG002|Overall Study|Protocol Violation|0|||
126347413|NCT00879658|454566971|FG003|Overall Study|Protocol Violation|0|||
126347414|NCT00879658|454566972|FG004|Overall Study|Protocol Violation|0|||
126347415|NCT00879658|454566973|FG005|Overall Study|Protocol Violation|0|||
126347416|NCT00879658|454566974|FG006|Overall Study|Protocol Violation|0|||
126347417|NCT00879658|454566968|FG000|Overall Study|Withdrawal by Subject|3|||
126347418|NCT00879658|454566969|FG001|Overall Study|Withdrawal by Subject|0|||
126347419|NCT00879658|454566970|FG002|Overall Study|Withdrawal by Subject|2|||
126347420|NCT00879658|454566971|FG003|Overall Study|Withdrawal by Subject|0|||
126347421|NCT00879658|454566972|FG004|Overall Study|Withdrawal by Subject|0|||
126347422|NCT00879658|454566973|FG005|Overall Study|Withdrawal by Subject|1|||
126347423|NCT00879658|454566974|FG006|Overall Study|Withdrawal by Subject|0|||
126012857|NCT00909363|453340985|FG002|Overall Study|Lack of Efficacy|0|||
126012858|NCT00082810|453340986|FG000|Overall Study|Adverse Event|3|||
126012859|NCT00082810|453340986|FG000|Overall Study|Progressive disease|24|||
126012860|NCT00082810|453340986|FG000|Overall Study|Withdrawal by Subject|4|||
126347424|NCT00879658|454566968|FG000|Overall Study|Lack of Efficacy|0|||
126347425|NCT00879658|454566969|FG001|Overall Study|Lack of Efficacy|0|||
126347426|NCT00879658|454566970|FG002|Overall Study|Lack of Efficacy|2|||
126347427|NCT00879658|454566971|FG003|Overall Study|Lack of Efficacy|0|||
126347428|NCT00879658|454566972|FG004|Overall Study|Lack of Efficacy|0|||
126347429|NCT00879658|454566973|FG005|Overall Study|Lack of Efficacy|0|||
126347430|NCT00879658|454566974|FG006|Overall Study|Lack of Efficacy|0|||
126347431|NCT00879658|454566968|FG000|Overall Study|misrandomized (never received study med)|0|||
126347432|NCT00879658|454566969|FG001|Overall Study|misrandomized (never received study med)|0|||
126347433|NCT00879658|454566970|FG002|Overall Study|misrandomized (never received study med)|0|||
126347434|NCT00879658|454566971|FG003|Overall Study|misrandomized (never received study med)|1|||
126347435|NCT00879658|454566972|FG004|Overall Study|misrandomized (never received study med)|0|||
126347436|NCT00879658|454566973|FG005|Overall Study|misrandomized (never received study med)|0|||
126347437|NCT00879658|454566974|FG006|Overall Study|misrandomized (never received study med)|0|||
126347438|NCT00580840|454566975|FG000|Run-in|Adverse Event|17|||
126347439|NCT00580840|454566976|FG001|Run-in|Adverse Event|0|||
126347440|NCT00580840|454566977|FG002|Run-in|Adverse Event|0|||
126347441|NCT00580840|454566978|FG003|Run-in|Adverse Event|0|||
126347442|NCT00580840|454566975|FG000|Run-in|Lack of Efficacy|93|||
126347443|NCT00580840|454566976|FG001|Run-in|Lack of Efficacy|0|||
126347444|NCT00580840|454566977|FG002|Run-in|Lack of Efficacy|0|||
126347445|NCT00580840|454566978|FG003|Run-in|Lack of Efficacy|0|||
126347446|NCT00580840|454566975|FG000|Run-in|Loss of Efficacy|1|||
126347447|NCT00580840|454566976|FG001|Run-in|Loss of Efficacy|0|||
126347448|NCT00580840|454566977|FG002|Run-in|Loss of Efficacy|0|||
126347449|NCT00580840|454566978|FG003|Run-in|Loss of Efficacy|0|||
126347450|NCT00580840|454566975|FG000|Run-in|Lost to Follow-up|4|||
126347451|NCT00580840|454566976|FG001|Run-in|Lost to Follow-up|0|||
126347452|NCT00580840|454566977|FG002|Run-in|Lost to Follow-up|0|||
126347453|NCT00580840|454566978|FG003|Run-in|Lost to Follow-up|0|||
126347454|NCT00580840|454566975|FG000|Run-in|Withdrawal by Subject|5|||
126347455|NCT00580840|454566976|FG001|Run-in|Withdrawal by Subject|0|||
126347456|NCT00580840|454566977|FG002|Run-in|Withdrawal by Subject|0|||
126347457|NCT00580840|454566978|FG003|Run-in|Withdrawal by Subject|0|||
126347458|NCT00580840|454566975|FG000|Run-in|Other: Per Sponsor Request|2|||
126347459|NCT00580840|454566976|FG001|Run-in|Other: Per Sponsor Request|0|||
126347460|NCT00580840|454566977|FG002|Run-in|Other: Per Sponsor Request|0|||
126347461|NCT00580840|454566978|FG003|Run-in|Other: Per Sponsor Request|0|||
126347462|NCT00580840|454566975|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
126347463|NCT00580840|454566976|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
126347464|NCT00580840|454566977|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
126347465|NCT00580840|454566978|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
126347466|NCT00580840|454566975|FG000|Run-in|Other: Exclusionary Lab Value|1|||
126347467|NCT00580840|454566976|FG001|Run-in|Other: Exclusionary Lab Value|0|||
126347468|NCT00580840|454566977|FG002|Run-in|Other: Exclusionary Lab Value|0|||
126347469|NCT00580840|454566978|FG003|Run-in|Other: Exclusionary Lab Value|0|||
126347470|NCT00580840|454566975|FG000|Double-Blind|Adverse Event|0|||
126347471|NCT00580840|454566976|FG001|Double-Blind|Adverse Event|3|||
126347472|NCT00580840|454566977|FG002|Double-Blind|Adverse Event|4|||
126347473|NCT00580840|454566978|FG003|Double-Blind|Adverse Event|1|||
126347474|NCT00580840|454566975|FG000|Double-Blind|Loss of Efficacy|0|||
126347475|NCT00580840|454566976|FG001|Double-Blind|Loss of Efficacy|1|||
126347476|NCT00580840|454566977|FG002|Double-Blind|Loss of Efficacy|2|||
126347477|NCT00580840|454566978|FG003|Double-Blind|Loss of Efficacy|10|||
126347478|NCT00580840|454566975|FG000|Double-Blind|Lost to Follow-up|0|||
126347479|NCT00580840|454566976|FG001|Double-Blind|Lost to Follow-up|1|||
126347480|NCT00580840|454566977|FG002|Double-Blind|Lost to Follow-up|0|||
126347481|NCT00580840|454566978|FG003|Double-Blind|Lost to Follow-up|2|||
126347482|NCT00580840|454566975|FG000|Double-Blind|Withdrawal by Subject|0|||
126347483|NCT00580840|454566976|FG001|Double-Blind|Withdrawal by Subject|1|||
126347484|NCT00580840|454566977|FG002|Double-Blind|Withdrawal by Subject|2|||
126347485|NCT00580840|454566978|FG003|Double-Blind|Withdrawal by Subject|2|||
126347486|NCT00580840|454566975|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
126347487|NCT00580840|454566976|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
126347488|NCT00580840|454566977|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
126347489|NCT00580840|454566978|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
126347490|NCT00580840|454566975|FG000|Double-Blind|Other: Forbidden Medication|0|||
126347491|NCT00580840|454566976|FG001|Double-Blind|Other: Forbidden Medication|0|||
126347492|NCT00580840|454566977|FG002|Double-Blind|Other: Forbidden Medication|1|||
126347493|NCT00580840|454566978|FG003|Double-Blind|Other: Forbidden Medication|0|||
126347494|NCT01551173|454566979|FG000|Overall Study|Withdrawal by Subject|11|||
126347495|NCT01551173|454566980|FG001|Overall Study|Withdrawal by Subject|16|||
126347496|NCT01551173|454566979|FG000|Overall Study|Adverse Event|7|||
126347497|NCT01551173|454566980|FG001|Overall Study|Adverse Event|6|||
126347498|NCT01551173|454566979|FG000|Overall Study|Lost to Follow-up|5|||
126347499|NCT01551173|454566980|FG001|Overall Study|Lost to Follow-up|7|||
126347500|NCT01551173|454566979|FG000|Overall Study|Other|5|||
126347501|NCT01551173|454566980|FG001|Overall Study|Other|3|||
126347502|NCT04530344|454566981|FG000|Overall Study|Lost to Follow-up|3|||
126347503|NCT04530344|454566982|FG001|Overall Study|Lost to Follow-up|3|||
126347504|NCT04530344|454566983|FG002|Overall Study|Lost to Follow-up|3|||
126347505|NCT04530344|454566984|FG003|Overall Study|Lost to Follow-up|10|||
126347506|NCT04530344|454566981|FG000|Overall Study|Withdrawal by Subject|14|||
126347507|NCT04530344|454566982|FG001|Overall Study|Withdrawal by Subject|5|||
126347508|NCT04530344|454566983|FG002|Overall Study|Withdrawal by Subject|18|||
126347509|NCT04530344|454566984|FG003|Overall Study|Withdrawal by Subject|33|||
126347510|NCT04530344|454566981|FG000|Overall Study|Adverse Event|0|||
126347511|NCT04530344|454566982|FG001|Overall Study|Adverse Event|0|||
126347512|NCT04530344|454566983|FG002|Overall Study|Adverse Event|0|||
126347513|NCT04530344|454566984|FG003|Overall Study|Adverse Event|1|||
126347514|NCT04530344|454566981|FG000|Overall Study|Lack of Efficacy|0|||
126347515|NCT04530344|454566982|FG001|Overall Study|Lack of Efficacy|0|||
126347516|NCT04530344|454566983|FG002|Overall Study|Lack of Efficacy|0|||
126347517|NCT04530344|454566984|FG003|Overall Study|Lack of Efficacy|1|||
126347518|NCT04530344|454566981|FG000|Overall Study|Physician Decision|0|||
126347519|NCT04530344|454566982|FG001|Overall Study|Physician Decision|0|||
126347520|NCT04530344|454566983|FG002|Overall Study|Physician Decision|1|||
126347521|NCT04530344|454566984|FG003|Overall Study|Physician Decision|1|||
126347522|NCT04530344|454566981|FG000|Overall Study|Pregnancy|0|||
126347523|NCT04530344|454566982|FG001|Overall Study|Pregnancy|0|||
126347524|NCT04530344|454566983|FG002|Overall Study|Pregnancy|2|||
126347525|NCT04530344|454566984|FG003|Overall Study|Pregnancy|1|||
126347526|NCT04530344|454566981|FG000|Overall Study|Protocol Violation|0|||
126347527|NCT04530344|454566982|FG001|Overall Study|Protocol Violation|0|||
126347528|NCT04530344|454566983|FG002|Overall Study|Protocol Violation|0|||
126347529|NCT04530344|454566984|FG003|Overall Study|Protocol Violation|1|||
126347530|NCT04530344|454566981|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
126347531|NCT04530344|454566982|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
126347532|NCT04530344|454566983|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
126347533|NCT04530344|454566984|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
126347534|NCT04530344|454566981|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
126347535|NCT04530344|454566982|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
126347536|NCT04530344|454566983|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
126347537|NCT04530344|454566984|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
126347538|NCT04530344|454566981|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
126347539|NCT04530344|454566982|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
126347540|NCT04530344|454566983|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
126347541|NCT04530344|454566984|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
126347542|NCT04530344|454566981|FG000|Overall Study|Personal Reasons|0|||
126347543|NCT04530344|454566982|FG001|Overall Study|Personal Reasons|0|||
126347544|NCT04530344|454566983|FG002|Overall Study|Personal Reasons|0|||
126347545|NCT04530344|454566984|FG003|Overall Study|Personal Reasons|1|||
126347546|NCT04530344|454566981|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
126347547|NCT04530344|454566982|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
126347548|NCT04530344|454566983|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
126347549|NCT04530344|454566984|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
126347550|NCT01402700|454566985|FG000|Overall Study|Death|3|||
126347551|NCT01402700|454566985|FG000|Overall Study|Withdrawal by Subject|3|||
126347552|NCT01402700|454566985|FG000|Overall Study|Missed Visit|1|||
126347553|NCT05523297|454566991|FG000|Overall Study|Death|7|||
126347554|NCT05523297|454566992|FG001|Overall Study|Death|8|||
126347555|NCT05523297|454566991|FG000|Overall Study|Lost to Follow-up|2|||
126347556|NCT05523297|454566992|FG001|Overall Study|Lost to Follow-up|1|||
126347557|NCT03462680|454566993|FG000|Overall Study|Withdrawal by Subject|3|||
126347558|NCT03462680|454566994|FG001|Overall Study|Withdrawal by Subject|5|||
126347559|NCT02246777|454566995|FG000|Overall Study|Adverse Event|2|||
126347560|NCT02246777|454566995|FG000|Overall Study|Change of residence|1|||
126347561|NCT02401230|454566996|FG000|Overall Study|Adverse Event|3|||
126347562|NCT02401230|454566997|FG001|Overall Study|Adverse Event|2|||
126347563|NCT02401230|454566998|FG002|Overall Study|Adverse Event|0|||
126347564|NCT02401230|454566996|FG000|Overall Study|Withdrawal by Subject|2|||
126347565|NCT02401230|454566997|FG001|Overall Study|Withdrawal by Subject|1|||
126347566|NCT02401230|454566998|FG002|Overall Study|Withdrawal by Subject|1|||
126347567|NCT02401230|454566996|FG000|Overall Study|Lost to Follow-up|1|||
126347568|NCT02401230|454566997|FG001|Overall Study|Lost to Follow-up|3|||
126347569|NCT02401230|454566998|FG002|Overall Study|Lost to Follow-up|3|||
126347570|NCT04133909|454566999|FG000|Overall Study|Death|11|||
126347571|NCT04133909|454567000|FG001|Overall Study|Death|11|||
126347572|NCT04133909|454566999|FG000|Overall Study|Adverse Event|4|||
126347573|NCT04133909|454567000|FG001|Overall Study|Adverse Event|5|||
126347574|NCT04133909|454566999|FG000|Overall Study|Lost to Follow-up|3|||
126347575|NCT04133909|454567000|FG001|Overall Study|Lost to Follow-up|5|||
126347576|NCT04133909|454566999|FG000|Overall Study|Physician Decision|4|||
126012861|NCT02950558|453340987|FG000|Overall Study|Lost to Follow-up|2|||
126347577|NCT04133909|454567000|FG001|Overall Study|Physician Decision|7|||
126347578|NCT04133909|454566999|FG000|Overall Study|Withdrawal by Subject|40|||
126347579|NCT04133909|454567000|FG001|Overall Study|Withdrawal by Subject|35|||
126347580|NCT04133909|454566999|FG000|Overall Study|Lack of Efficacy|2|||
126347581|NCT04133909|454567000|FG001|Overall Study|Lack of Efficacy|7|||
126347582|NCT04133909|454566999|FG000|Overall Study|Randomized in error|1|||
126347583|NCT04133909|454567000|FG001|Overall Study|Randomized in error|1|||
126347584|NCT00830765|454567001|FG000|Overall Study|Protocol Violation|3|||
126347585|NCT00830765|454567002|FG001|Overall Study|Protocol Violation|2|||
126347586|NCT01299909|454567003|FG000|Overall Study|Lost to Follow-up|22|||
126347587|NCT01299909|454567004|FG001|Overall Study|Lost to Follow-up|18|||
126347588|NCT01299909|454567005|FG002|Overall Study|Lost to Follow-up|17|||
126347589|NCT05399485|454568468|FG000|DBT Phase|Other|6|||
126347590|NCT05399485|454568469|FG001|DBT Phase|Other|5|||
126347591|NCT05399485|454568468|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
126347592|NCT05399485|454568469|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
126347593|NCT05399485|454568468|FG000|DBT Phase|Withdrawal by Subject|3|||
126347594|NCT05399485|454568469|FG001|DBT Phase|Withdrawal by Subject|2|||
126347595|NCT05399485|454568468|FG000|DBT Phase|Protocol Violation|2|||
126347596|NCT05399485|454568469|FG001|DBT Phase|Protocol Violation|1|||
126347597|NCT05399485|454568468|FG000|DBT Phase|Physician Decision|0|||
126347598|NCT05399485|454568469|FG001|DBT Phase|Physician Decision|1|||
126347599|NCT05399485|454568468|FG000|DBT Phase|Adverse Event|2|||
126347600|NCT05399485|454568469|FG001|DBT Phase|Adverse Event|1|||
126347601|NCT05399485|454568468|FG000|OLE Phase|Not reported|0|||
126347602|NCT05399485|454568469|FG001|OLE Phase|Not reported|1|||
126347603|NCT05399485|454568468|FG000|OLE Phase|Other|3|||
126347604|NCT05399485|454568469|FG001|OLE Phase|Other|3|||
126347605|NCT05399485|454568468|FG000|OLE Phase|Withdrawal by Subject|8|||
126347606|NCT05399485|454568469|FG001|OLE Phase|Withdrawal by Subject|5|||
126347607|NCT05399485|454568468|FG000|OLE Phase|Pregnancy|0|||
126347608|NCT05399485|454568469|FG001|OLE Phase|Pregnancy|1|||
126347609|NCT05399485|454568468|FG000|OLE Phase|Physician Decision|2|||
126347610|NCT05399485|454568469|FG001|OLE Phase|Physician Decision|0|||
126347611|NCT05399485|454568468|FG000|OLE Phase|Adverse Event|0|||
126347612|NCT05399485|454568469|FG001|OLE Phase|Adverse Event|1|||
126347613|NCT05399485|454568468|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
126347614|NCT05399485|454568469|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
126347615|NCT03474107|454568472|FG000|Overall Study|Adverse Event|42|||
126347616|NCT03474107|454568473|FG001|Overall Study|Adverse Event|46|||
126347617|NCT03474107|454568472|FG000|Overall Study|Death|2|||
126347618|NCT03474107|454568473|FG001|Overall Study|Death|2|||
126347619|NCT03474107|454568472|FG000|Overall Study|Lost to Follow-up|0|||
126347620|NCT03474107|454568473|FG001|Overall Study|Lost to Follow-up|1|||
126347621|NCT03474107|454568472|FG000|Overall Study|Progressive Disease|177|||
126347622|NCT03474107|454568473|FG001|Overall Study|Progressive Disease|180|||
126347623|NCT03474107|454568472|FG000|Overall Study|Protocol Violation|1|||
126347624|NCT03474107|454568473|FG001|Overall Study|Protocol Violation|1|||
126347625|NCT03474107|454568472|FG000|Overall Study|Withdrawal by Subject|15|||
126347626|NCT03474107|454568473|FG001|Overall Study|Withdrawal by Subject|27|||
126347627|NCT03474107|454568472|FG000|Overall Study|Physician Decision|7|||
126347628|NCT03474107|454568473|FG001|Overall Study|Physician Decision|22|||
126347629|NCT03474107|454568472|FG000|Overall Study|Miscellaneous|1|||
126347630|NCT03474107|454568473|FG001|Overall Study|Miscellaneous|6|||
126347631|NCT03095287|454568474|FG000|Overall Study|Treatment Failure|1|||
126347632|NCT03095287|454568474|FG000|Overall Study|Adverse Event|1|||
126347633|NCT02127671|454568477|FG000|Overall Study|Death|2|||
126347634|NCT02127671|454568478|FG001|Overall Study|Death|2|||
126347635|NCT02127671|454568477|FG000|Overall Study|Lost to Follow-up|4|||
126347636|NCT02127671|454568478|FG001|Overall Study|Lost to Follow-up|2|||
126347637|NCT02127671|454568477|FG000|Overall Study|Physician Decision|1|||
126347638|NCT02127671|454568478|FG001|Overall Study|Physician Decision|0|||
126347639|NCT02127671|454568477|FG000|Overall Study|incarceration|0|||
126211844|NCT02181673|454063723|FG000|Week 24-Week 60|Physician Decision|0|||
126211845|NCT02181673|454063724|FG001|Week 24-Week 60|Physician Decision|0|||
126012862|NCT02950558|453340988|FG001|Overall Study|Lost to Follow-up|0|||
126211846|NCT02181673|454063725|FG002|Week 24-Week 60|Physician Decision|1|||
126211847|NCT00138658|454063726|FG000|Overall Study|Adverse Event|23|||
126347640|NCT02127671|454568478|FG001|Overall Study|incarceration|1|||
126347641|NCT02127671|454568477|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
126347642|NCT02127671|454568478|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
126347643|NCT02394275|454568479|FG000|Overall Study|Adverse Event|22|||
126347644|NCT02394275|454568479|FG000|Overall Study|Lost to Follow-up|7|||
126347645|NCT00764517|454568485|FG000|Overall Study|Adverse Event|9|||
126347646|NCT00764517|454568486|FG001|Overall Study|Adverse Event|3|||
126347647|NCT00764517|454568485|FG000|Overall Study|Death|3|||
126347648|NCT00764517|454568486|FG001|Overall Study|Death|11|||
126347649|NCT00764517|454568485|FG000|Overall Study|Physician Decision|3|||
126347650|NCT00764517|454568486|FG001|Overall Study|Physician Decision|0|||
126347651|NCT00671060|454568494|FG000|Overall Study|Protocol Violation|1|||
126347652|NCT00671060|454568495|FG001|Overall Study|Protocol Violation|0|||
126347653|NCT00671060|454568494|FG000|Overall Study|Physician Decision|0|||
126347654|NCT00671060|454568495|FG001|Overall Study|Physician Decision|1|||
126347655|NCT02020941|454568496|FG000|Overall Study|Adverse Event|1|||
126347656|NCT02020941|454568496|FG000|Overall Study|Physician Decision|2|||
126347657|NCT02020941|454568496|FG000|Overall Study|Withdrawal by Subject|1|||
126347658|NCT02020941|454568496|FG000|Overall Study|Disease Progression|4|||
126347659|NCT02107898|454568499|FG000|Overall Study|Adverse Event|4|||
126347660|NCT02107898|454568500|FG001|Overall Study|Adverse Event|7|||
126347661|NCT02107898|454568499|FG000|Overall Study|Poor compliance to protocol|0|||
126347662|NCT02107898|454568500|FG001|Overall Study|Poor compliance to protocol|1|||
126347663|NCT02107898|454568499|FG000|Overall Study|Participant moved|0|||
126347664|NCT02107898|454568500|FG001|Overall Study|Participant moved|2|||
126347665|NCT02107898|454568499|FG000|Overall Study|Consent withdrawn by participant|2|||
126347666|NCT02107898|454568500|FG001|Overall Study|Consent withdrawn by participant|1|||
126347667|NCT02107898|454568499|FG000|Overall Study|Randomized but not treated|0|||
126347668|NCT02107898|454568500|FG001|Overall Study|Randomized but not treated|1|||
126347669|NCT03329989|454568501|FG000|Overall Study|Withdrawal by Subject|9|||
126347670|NCT03329989|454568501|FG000|Overall Study|Lost to Follow-up|8|||
126347671|NCT03329989|454568501|FG000|Overall Study|Adverse Event|5|||
126347672|NCT03329989|454568501|FG000|Overall Study|Protocol Violation|1|||
126347673|NCT01283386|454568506|FG000|Overall Study|Death|2|||
126347674|NCT01283386|454568507|FG001|Overall Study|Death|0|||
126347675|NCT01283386|454568506|FG000|Overall Study|Withdrawal by Subject|2|||
126347676|NCT01283386|454568507|FG001|Overall Study|Withdrawal by Subject|1|||
126347677|NCT01283386|454568506|FG000|Overall Study|Relapse of underlying disease|1|||
126347678|NCT01283386|454568507|FG001|Overall Study|Relapse of underlying disease|3|||
126347679|NCT01283386|454568506|FG000|Overall Study|Progression of underlying disease|2|||
126347680|NCT01283386|454568507|FG001|Overall Study|Progression of underlying disease|7|||
126347681|NCT01283386|454568506|FG000|Overall Study|Reason not specified|1|||
126347682|NCT01283386|454568507|FG001|Overall Study|Reason not specified|0|||
126347683|NCT01283386|454568506|FG000|Overall Study|Protocol Violation|0|||
126347684|NCT01283386|454568507|FG001|Overall Study|Protocol Violation|1|||
126347685|NCT03483103|454568510|FG000|Pre-Treatment Phase|Other reasons|1|||
126347686|NCT03483103|454568510|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
126347687|NCT03483103|454568510|FG000|Pre-Treatment Phase|Disease-related complications|1|||
126347688|NCT03483103|454568510|FG000|Pre-Treatment Phase|Death|5|||
126347689|NCT03483103|454568510|FG000|Treatment Phase|Withdrawal by Subject|7|||
126347690|NCT03483103|454568510|FG000|Treatment Phase|Other reasons|1|||
126347691|NCT03483103|454568510|FG000|Treatment Phase|Death|23|||
126347692|NCT03483103|454568510|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
126347693|NCT03483103|454568510|FG000|Treatment Phase|Received nonconforming product|1|||
126347694|NCT04115059|454568512|FG000|Overall Study|Withdrawal by Subject|1|||
126347695|NCT04115059|454568512|FG000|Overall Study|Lack of Efficacy|2|||
126347696|NCT06420232|454568513|FG000|Overall Study|Withdrawal by Subject|3|||
126347697|NCT03881371|454568518|FG000|Overall Study|Adverse Event|8|||
126347698|NCT03881371|454568519|FG001|Overall Study|Adverse Event|9|||
126347699|NCT03881371|454568518|FG000|Overall Study|Death|1|||
126347700|NCT03881371|454568519|FG001|Overall Study|Death|0|||
126347701|NCT03881371|454568518|FG000|Overall Study|Lost to Follow-up|1|||
126347702|NCT03881371|454568519|FG001|Overall Study|Lost to Follow-up|0|||
126347703|NCT03881371|454568518|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126347704|NCT03881371|454568519|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126347705|NCT03881371|454568518|FG000|Overall Study|Physician Decision|3|||
126347706|NCT03881371|454568519|FG001|Overall Study|Physician Decision|3|||
126347707|NCT03881371|454568518|FG000|Overall Study|Withdrawal by Subject|2|||
126347708|NCT03881371|454568519|FG001|Overall Study|Withdrawal by Subject|10|||
126347709|NCT03881371|454568518|FG000|Overall Study|Discontinuation from Study|1|||
126347710|NCT03881371|454568519|FG001|Overall Study|Discontinuation from Study|0|||
126347711|NCT00933933|454568520|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
126347712|NCT00933933|454568521|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
126347713|NCT00933933|454568522|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
126347714|NCT00933933|454568520|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
126347715|NCT00933933|454568521|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
126012863|NCT00319436|453340989|FG000|Overall Study|Withdrawal by Subject|6|||
126012864|NCT00319436|453340990|FG001|Overall Study|Withdrawal by Subject|7|||
126012865|NCT01321606|453340993|FG000|Overall Study|Lost to Follow-up|0|||
126347716|NCT00933933|454568522|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
126347717|NCT03329001|454568523|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347718|NCT03329001|454568524|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347719|NCT03329001|454568525|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
126347720|NCT03329001|454568526|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
126347721|NCT03329001|454568527|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347722|NCT03329001|454568528|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347723|NCT03329001|454568529|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347724|NCT03329001|454568530|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347725|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347726|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347727|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347728|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
126347729|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347730|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347731|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347732|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347733|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347734|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347735|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347736|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
126347737|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126211848|NCT00138658|454063726|FG000|Overall Study|Death|1|||
126347738|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126369376|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
126369377|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
126369378|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
126369379|NCT04716894|454648219|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
126369380|NCT04716894|454648219|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
126369381|NCT03773484|454648220|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
126369382|NCT01889251|454648221|FG000|Overall Study|Adverse Event|1|||
126369383|NCT01889251|454648222|FG001|Overall Study|Adverse Event|0|||
126369384|NCT01344226|454648230|FG000|Overall Study|Protocol Violation|2|||
126369385|NCT01344226|454648230|FG000|Overall Study|Withdrawal by Subject|3|||
126369386|NCT01344226|454648230|FG000|Overall Study|Lack of Efficacy|3|||
126369387|NCT03211416|454648232|FG000|Overall Study|Adverse Event|7|||
126369388|NCT03211416|454648232|FG000|Overall Study|Lack of Efficacy|2|||
126369389|NCT03211416|454648232|FG000|Overall Study|Physician Decision|1|||
126369390|NCT02302222|454648234|FG000|Overall Study|Physician Decision|0|||
126369391|NCT02302222|454648235|FG001|Overall Study|Physician Decision|4|||
126369392|NCT02302222|454648234|FG000|Overall Study|Lost to Follow-up|1|||
126369393|NCT02302222|454648235|FG001|Overall Study|Lost to Follow-up|0|||
126369394|NCT02302222|454648234|FG000|Overall Study|Treatment discontinued before day 5|0|||
126369395|NCT02302222|454648235|FG001|Overall Study|Treatment discontinued before day 5|1|||
126369396|NCT02302222|454648234|FG000|Overall Study|Withdrawn prior to any treatment|0|||
126369397|NCT02302222|454648235|FG001|Overall Study|Withdrawn prior to any treatment|1|||
126369398|NCT03781570|454648241|FG000|Overall Study|Technical Issues (equipment failure)|31|||
126369399|NCT03781570|454648241|FG000|Overall Study|Withdrawal by Subject|7|||
126369400|NCT03781570|454648241|FG000|Overall Study|Physical Constraints|11|||
126369401|NCT01107496|454648242|FG000|Overall Study|Adverse Event|1|||
126369402|NCT01107496|454648243|FG001|Overall Study|Adverse Event|0|||
126369403|NCT01107496|454648242|FG000|Overall Study|Lack of Efficacy|1|||
126369404|NCT01107496|454648243|FG001|Overall Study|Lack of Efficacy|0|||
126369405|NCT01107496|454648242|FG000|Overall Study|Protocol Violation|0|||
126369406|NCT01107496|454648243|FG001|Overall Study|Protocol Violation|1|||
126369407|NCT01107496|454648242|FG000|Overall Study|Lost to Follow-up|0|||
126369408|NCT01107496|454648243|FG001|Overall Study|Lost to Follow-up|1|||
126369409|NCT03709472|454648244|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
126369410|NCT03709472|454648245|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
126369411|NCT03709472|454648244|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
126369412|NCT03709472|454648245|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
126369413|NCT03559556|454648246|FG000|Overall Study|Withdrawal by Subject|1|||
126369414|NCT02496000|454648252|FG000|Overall Study|Withdrawal by Subject|1|||
126369415|NCT02496000|454648253|FG001|Overall Study|Withdrawal by Subject|2|||
126369416|NCT02496000|454648254|FG002|Overall Study|Withdrawal by Subject|0|||
126369417|NCT02496000|454648252|FG000|Overall Study|Lost to Follow-up|1|||
126369418|NCT02496000|454648253|FG001|Overall Study|Lost to Follow-up|0|||
126211849|NCT00138658|454063726|FG000|Overall Study|Disease Progression|21|||
126012866|NCT01321606|453340994|FG001|Overall Study|Lost to Follow-up|0|||
126347739|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347740|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347741|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347742|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347743|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347744|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
126347745|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347746|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347747|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347748|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347749|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347750|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347751|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
126347752|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347753|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347754|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347755|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347756|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347757|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347758|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347759|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
126347760|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347761|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347762|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347763|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347764|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347765|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347766|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347767|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
126347768|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347769|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347770|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347771|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347772|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347773|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347774|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347775|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
126347776|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347777|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347778|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347779|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347780|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347781|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347782|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347783|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
126347784|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
126347785|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347786|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347787|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347788|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347789|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347790|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126211850|NCT00138658|454063726|FG000|Overall Study|Physician Decision|11|||
126211851|NCT00138658|454063726|FG000|Overall Study|Withdrawal by Subject|5|||
126211852|NCT04637815|454063729|FG000|Overall Study|Death|1|||
126211853|NCT04637815|454063730|FG001|Overall Study|Death|0|||
126211854|NCT04637815|454063729|FG000|Overall Study|Lost to Follow-up|5|||
126211855|NCT04637815|454063730|FG001|Overall Study|Lost to Follow-up|2|||
126211856|NCT00577031|454063731|FG000|Overall Study|Adverse Event|52|||
126211857|NCT00577031|454063731|FG000|Overall Study|Progression of disease|93|||
126211858|NCT00577031|454063731|FG000|Overall Study|Protocol Violation|5|||
126211859|NCT00577031|454063731|FG000|Overall Study|Participant withdrew consent|13|||
126347791|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
126347792|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347793|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347794|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347795|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347796|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347797|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347798|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347799|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
126347800|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
126347801|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347802|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347803|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347804|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347805|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347806|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347807|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
126347808|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
126347809|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347810|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347811|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347812|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347813|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347814|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347815|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
126347816|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
126347817|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347818|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347819|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347820|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347821|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347822|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347823|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347824|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
126347825|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347826|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347827|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347828|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347829|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347830|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347831|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347832|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
126347833|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347834|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347835|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347836|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347837|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347838|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347839|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
126347840|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347841|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347842|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126211860|NCT00577031|454063731|FG000|Overall Study|Participant non-compliance|5|||
126211861|NCT00577031|454063731|FG000|Overall Study|Need for surgery|17|||
126211862|NCT00577031|454063731|FG000|Overall Study|Medical decision|14|||
126211863|NCT00577031|454063731|FG000|Overall Study|Death|6|||
126211864|NCT04764669|454063732|FG000|Overall Study|Adverse Event|1|||
126211865|NCT04764669|454063733|FG001|Overall Study|Adverse Event|0|||
126211866|NCT04764669|454063734|FG002|Overall Study|Adverse Event|1|||
126211867|NCT04764669|454063735|FG003|Overall Study|Adverse Event|0|||
126211868|NCT04764669|454063732|FG000|Overall Study|Subject Choice|0|||
126211869|NCT04764669|454063733|FG001|Overall Study|Subject Choice|0|||
126211870|NCT04764669|454063734|FG002|Overall Study|Subject Choice|1|||
126211871|NCT04764669|454063735|FG003|Overall Study|Subject Choice|0|||
126211872|NCT04764669|454063732|FG000|Overall Study|Withdrawal by Subject|2|||
126211873|NCT04764669|454063733|FG001|Overall Study|Withdrawal by Subject|0|||
126211874|NCT04764669|454063734|FG002|Overall Study|Withdrawal by Subject|0|||
126211875|NCT04764669|454063735|FG003|Overall Study|Withdrawal by Subject|0|||
126211876|NCT01067339|454063738|FG000|Overall Study|Withdrawal by Subject|6|||
126211877|NCT01067339|454063739|FG001|Overall Study|Withdrawal by Subject|5|||
126211878|NCT02230332|454063742|FG000|Overall Study|Adverse Event|2|||
126347843|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347844|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347845|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347846|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347847|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
126347848|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
126347849|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347850|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347851|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347852|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347853|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347854|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347855|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
126347856|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347857|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347858|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347859|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347860|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347861|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347862|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347863|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
126347864|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347865|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347866|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347867|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347868|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347869|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347870|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347871|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347872|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
126347873|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347874|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347875|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347876|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347877|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347878|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347879|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347880|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347881|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347882|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
126347883|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347884|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126211879|NCT02230332|454063743|FG001|Overall Study|Adverse Event|1|||
126211880|NCT02230332|454063742|FG000|Overall Study|Lost to Follow-up|1|||
126211881|NCT02230332|454063743|FG001|Overall Study|Lost to Follow-up|0|||
126211882|NCT02230332|454063742|FG000|Overall Study|Protocol Violation|1|||
126211883|NCT02230332|454063743|FG001|Overall Study|Protocol Violation|0|||
126211884|NCT00877799|454063744|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
126347885|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347886|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347887|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347888|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347889|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
126347890|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347891|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347892|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347893|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347894|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347895|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126012867|NCT01321606|453340995|FG002|Overall Study|Lost to Follow-up|0|||
126012868|NCT01321606|453340996|FG003|Overall Study|Lost to Follow-up|1|||
126012869|NCT02914522|453340997|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
126012870|NCT02914522|453340998|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
126211885|NCT00877799|454063745|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
126211886|NCT00877799|454063746|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
126347896|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347897|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
126347898|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
126347899|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347900|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347901|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347902|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347903|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347904|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347905|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
126347906|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347907|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347908|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347909|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347910|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347911|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347912|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347913|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
126347914|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
126347915|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347916|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347917|NCT03329001|454568523|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347918|NCT03329001|454568524|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347919|NCT03329001|454568525|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347920|NCT03329001|454568526|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347921|NCT03329001|454568527|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347922|NCT03329001|454568528|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347923|NCT03329001|454568529|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
126347924|NCT03329001|454568530|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
126347925|NCT03329001|454568523|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347926|NCT03329001|454568524|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347927|NCT03329001|454568525|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347928|NCT03329001|454568526|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347929|NCT03329001|454568527|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347930|NCT03329001|454568528|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347931|NCT03329001|454568529|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
126347932|NCT03329001|454568530|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347933|NCT03329001|454568523|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347934|NCT03329001|454568524|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347935|NCT03329001|454568525|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347936|NCT03329001|454568526|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347937|NCT03329001|454568527|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347938|NCT03329001|454568528|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347939|NCT03329001|454568529|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
126347940|NCT03329001|454568530|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
126347941|NCT03329001|454568523|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347942|NCT03329001|454568524|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347943|NCT03329001|454568525|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347944|NCT03329001|454568526|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347945|NCT03329001|454568527|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347946|NCT03329001|454568528|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347947|NCT03329001|454568529|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
126347948|NCT03329001|454568530|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
126347949|NCT00963235|454568531|FG000|Overall Study|Withdrawal by Subject|22|||
126347950|NCT00963235|454568531|FG000|Overall Study|Lost to Follow-up|14|||
126347951|NCT00963235|454568531|FG000|Overall Study|Failed to return|9|||
126347952|NCT00963235|454568531|FG000|Overall Study|Protocol Violation|7|||
126347953|NCT00963235|454568531|FG000|Overall Study|Adverse Event|5|||
126347954|NCT00963235|454568531|FG000|Overall Study|Physician Decision|2|||
126347955|NCT00963235|454568531|FG000|Overall Study|Other|1|||
126211887|NCT00877799|454063747|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
126211888|NCT00877799|454063748|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
126211889|NCT00877799|454063744|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
126211890|NCT00877799|454063745|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
126347956|NCT01341470|454568533|FG000|Overall Study|Sponsor decision|0|||
126347957|NCT01341470|454568534|FG001|Overall Study|Sponsor decision|0|||
126347958|NCT01341470|454568535|FG002|Overall Study|Sponsor decision|1|||
126347959|NCT01341470|454568536|FG003|Overall Study|Sponsor decision|1|||
126347960|NCT01341470|454568537|FG004|Overall Study|Sponsor decision|0|||
126347961|NCT01341470|454568538|FG005|Overall Study|Sponsor decision|1|||
126347962|NCT01756235|454568539|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
126347963|NCT00311168|454568540|FG000|First Intervention|Withdrawal by Subject|2|||
126347964|NCT00311168|454568541|FG001|First Intervention|Withdrawal by Subject|2|||
126347965|NCT00311168|454568540|FG000|First Intervention|Lost to Follow-up|1|||
126347966|NCT00311168|454568541|FG001|First Intervention|Lost to Follow-up|1|||
126347967|NCT00311168|454568540|FG000|First Intervention|Protocol Violation|1|||
126347968|NCT00311168|454568541|FG001|First Intervention|Protocol Violation|1|||
126347969|NCT00311168|454568540|FG000|First Intervention|Adverse Event|1|||
126347970|NCT00311168|454568541|FG001|First Intervention|Adverse Event|0|||
126347971|NCT00311168|454568540|FG000|First Intervention|Other|2|||
126347972|NCT00311168|454568541|FG001|First Intervention|Other|2|||
126347973|NCT00311168|454568540|FG000|Second Intervention|Lost to Follow-up|9|||
126347974|NCT00311168|454568541|FG001|Second Intervention|Lost to Follow-up|2|||
126347975|NCT00311168|454568540|FG000|Second Intervention|Withdrawal by Subject|0|||
126347976|NCT00311168|454568541|FG001|Second Intervention|Withdrawal by Subject|1|||
126347977|NCT00311168|454568540|FG000|Second Intervention|Other|1|||
126347978|NCT00311168|454568541|FG001|Second Intervention|Other|1|||
126347979|NCT02337829|454568542|FG000|Overall Study|Death|0|||
126347980|NCT02337829|454568543|FG001|Overall Study|Death|1|||
126347981|NCT02337829|454568544|FG002|Overall Study|Death|0|||
126347982|NCT02337829|454568545|FG003|Overall Study|Death|0|||
126347983|NCT02337829|454568542|FG000|Overall Study|Study terminated by sponsor|12|||
126347984|NCT02337829|454568543|FG001|Overall Study|Study terminated by sponsor|10|||
126347985|NCT02337829|454568544|FG002|Overall Study|Study terminated by sponsor|5|||
126347986|NCT02337829|454568545|FG003|Overall Study|Study terminated by sponsor|6|||
126347987|NCT02337829|454568542|FG000|Overall Study|discontinued for other reasons|6|||
126347988|NCT02337829|454568543|FG001|Overall Study|discontinued for other reasons|3|||
126347989|NCT02337829|454568544|FG002|Overall Study|discontinued for other reasons|1|||
126347990|NCT02337829|454568545|FG003|Overall Study|discontinued for other reasons|4|||
126347991|NCT02879695|454568562|FG000|Overall Study|Did not start study treatment|2|||
126347992|NCT02879695|454568563|FG001|Overall Study|Did not start study treatment|0|||
126347993|NCT02879695|454568564|FG002|Overall Study|Did not start study treatment|3|||
126347994|NCT02879695|454568565|FG003|Overall Study|Did not start study treatment|0|||
126347995|NCT02442349|454568566|FG000|Overall Study|Death|95|||
126347996|NCT02442349|454568566|FG000|Overall Study|Withdrawal by Subject|27|||
126347997|NCT02442349|454568566|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
126347998|NCT02442349|454568566|FG000|Overall Study|Lost to Follow-up|1|||
126347999|NCT00314145|454568569|FG000|Overall Study|Withdrawal by Subject|8|||
126348000|NCT00314145|454568570|FG001|Overall Study|Withdrawal by Subject|10|||
126348001|NCT00314145|454568569|FG000|Overall Study|Lost to Follow-up|5|||
126348002|NCT00314145|454568570|FG001|Overall Study|Lost to Follow-up|12|||
126348003|NCT00314145|454568569|FG000|Overall Study|Physician Decision|3|||
126348004|NCT00314145|454568570|FG001|Overall Study|Physician Decision|4|||
126348005|NCT00314145|454568569|FG000|Overall Study|Adverse Event|0|||
126348006|NCT00314145|454568570|FG001|Overall Study|Adverse Event|3|||
126348007|NCT00314145|454568569|FG000|Overall Study|Protocol Violation|3|||
126348008|NCT00314145|454568570|FG001|Overall Study|Protocol Violation|0|||
126348009|NCT00314145|454568569|FG000|Overall Study|Sponsor Decision|2|||
126348010|NCT00314145|454568570|FG001|Overall Study|Sponsor Decision|0|||
126348011|NCT03507790|454568571|FG000|Overall Study|Adverse Event|0|||
126348012|NCT03507790|454568572|FG001|Overall Study|Adverse Event|11|||
126211891|NCT00877799|454063746|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
126211892|NCT00877799|454063747|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
126211893|NCT00877799|454063748|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
126211894|NCT00877799|454063744|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
126211895|NCT00877799|454063745|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
126211896|NCT00877799|454063746|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
126211897|NCT00877799|454063747|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
126211898|NCT00877799|454063748|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
126211899|NCT00877799|454063744|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
126211900|NCT00877799|454063745|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
126211901|NCT00877799|454063746|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
126211902|NCT00877799|454063747|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
126211903|NCT00877799|454063748|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
126211904|NCT00877799|454063744|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
126211905|NCT00877799|454063745|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
126211906|NCT00877799|454063746|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
126211907|NCT00877799|454063747|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
126211908|NCT00877799|454063748|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
126211909|NCT04054011|454063749|FG000|Overall Study|COVID|3|||
126211910|NCT00557830|454063753|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
126211911|NCT00557830|454063754|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
126211912|NCT00557830|454063755|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
126211913|NCT00557830|454063753|FG000|Screening Treatment Phase|Adverse Event|2|||
126211914|NCT00557830|454063754|FG001|Screening Treatment Phase|Adverse Event|0|||
126211915|NCT00557830|454063755|FG002|Screening Treatment Phase|Adverse Event|0|||
126211916|NCT00557830|454063753|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
126211917|NCT00557830|454063754|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
126211918|NCT00557830|454063755|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
126211919|NCT00538473|454063757|FG000|Overall Study|Adverse Event|1|||
126211920|NCT00538473|454063758|FG001|Overall Study|Adverse Event|0|||
126211921|NCT01833897|454063759|FG000|Overall Study|Lack of Efficacy|1|||
126211922|NCT00127192|454063760|FG000|Overall Study|Adverse Event|0|||
126211923|NCT00127192|454063761|FG001|Overall Study|Adverse Event|1|||
126211924|NCT00127192|454063762|FG002|Overall Study|Adverse Event|1|||
126211925|NCT00127192|454063763|FG003|Overall Study|Adverse Event|1|||
126211926|NCT00127192|454063764|FG004|Overall Study|Adverse Event|0|||
126211927|NCT00127192|454063760|FG000|Overall Study|Lack of Efficacy|2|||
126211928|NCT00127192|454063761|FG001|Overall Study|Lack of Efficacy|0|||
126211929|NCT00127192|454063762|FG002|Overall Study|Lack of Efficacy|0|||
126211930|NCT00127192|454063763|FG003|Overall Study|Lack of Efficacy|0|||
126211931|NCT00127192|454063764|FG004|Overall Study|Lack of Efficacy|2|||
126211932|NCT00127192|454063760|FG000|Overall Study|Withdrawal by Subject|0|||
126211933|NCT00127192|454063761|FG001|Overall Study|Withdrawal by Subject|0|||
126211934|NCT00127192|454063762|FG002|Overall Study|Withdrawal by Subject|1|||
126211935|NCT00127192|454063763|FG003|Overall Study|Withdrawal by Subject|0|||
126211936|NCT00127192|454063764|FG004|Overall Study|Withdrawal by Subject|3|||
126211937|NCT00127192|454063760|FG000|Overall Study|Adverse event in pre-treatment period|1|||
126211938|NCT00127192|454063761|FG001|Overall Study|Adverse event in pre-treatment period|0|||
126211939|NCT00127192|454063762|FG002|Overall Study|Adverse event in pre-treatment period|0|||
126211940|NCT00127192|454063763|FG003|Overall Study|Adverse event in pre-treatment period|0|||
126211941|NCT00127192|454063764|FG004|Overall Study|Adverse event in pre-treatment period|0|||
126211942|NCT00227591|454063767|FG000|Overall Study|Withdrawal by Subject|1|||
126211943|NCT00077766|454063768|FG000|Overall Study|Adverse Event|1|||
126211944|NCT00077766|454063769|FG001|Overall Study|Adverse Event|1|||
126211945|NCT00077766|454063768|FG000|Overall Study|Withdrawal by Subject|4|||
126211946|NCT00077766|454063769|FG001|Overall Study|Withdrawal by Subject|3|||
126211947|NCT00077766|454063768|FG000|Overall Study|Death|12|||
126211948|NCT00077766|454063769|FG001|Overall Study|Death|10|||
126211949|NCT00077766|454063768|FG000|Overall Study|Lost to Follow-up|2|||
126211950|NCT00077766|454063769|FG001|Overall Study|Lost to Follow-up|0|||
126211951|NCT00077766|454063768|FG000|Overall Study|Protocol Violation|1|||
126211952|NCT00077766|454063769|FG001|Overall Study|Protocol Violation|0|||
126211953|NCT00077766|454063768|FG000|Overall Study|Kidney Transplantation|9|||
126211954|NCT00077766|454063769|FG001|Overall Study|Kidney Transplantation|5|||
126211955|NCT00077766|454063768|FG000|Overall Study|Transplantation|5|||
126211956|NCT00077766|454063769|FG001|Overall Study|Transplantation|1|||
126211957|NCT00077766|454063768|FG000|Overall Study|Investigators Discretion|1|||
126211958|NCT00077766|454063769|FG001|Overall Study|Investigators Discretion|0|||
126211959|NCT00077766|454063768|FG000|Overall Study|Participant's decision|1|||
126211960|NCT00077766|454063769|FG001|Overall Study|Participant's decision|0|||
126211961|NCT00077766|454063768|FG000|Overall Study|Dialysis Discontinued|1|||
126211962|NCT00077766|454063769|FG001|Overall Study|Dialysis Discontinued|0|||
126211963|NCT00077766|454063768|FG000|Overall Study|Dialysis|0|||
126211964|NCT00077766|454063769|FG001|Overall Study|Dialysis|1|||
126211965|NCT00077766|454063768|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
126211966|NCT00077766|454063769|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
126211967|NCT00077766|454063768|FG000|Overall Study|Started Nocturnal Dialysis|0|||
126211968|NCT00077766|454063769|FG001|Overall Study|Started Nocturnal Dialysis|1|||
126211969|NCT00077766|454063768|FG000|Overall Study|Stop Dialysis|0|||
126211970|NCT00077766|454063769|FG001|Overall Study|Stop Dialysis|1|||
126211971|NCT00077766|454063768|FG000|Overall Study|Participants Vacation|2|||
126211972|NCT00077766|454063769|FG001|Overall Study|Participants Vacation|1|||
126211973|NCT01886105|454063770|FG000|Overall Study|Lack of Efficacy|3|||
126211974|NCT03843775|454063773|FG000|Overall Study|Adverse Event|1|||
126211975|NCT03843775|454063774|FG001|Overall Study|Adverse Event|1|||
126211976|NCT03843775|454063773|FG000|Overall Study|Lack of Efficacy|2|||
126211977|NCT03843775|454063774|FG001|Overall Study|Lack of Efficacy|6|||
126211978|NCT03843775|454063773|FG000|Overall Study|Withdrawal by Subject|0|||
126211979|NCT03843775|454063774|FG001|Overall Study|Withdrawal by Subject|1|||
126211980|NCT04150107|454063775|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
126211981|NCT04150107|454063776|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
126211982|NCT04150107|454063775|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
126211983|NCT04150107|454063776|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
126211984|NCT02184988|454063784|FG000|Overall Study|Pregnancy|2|||
126211985|NCT02184988|454063784|FG000|Overall Study|Adverse Event|2|||
126211986|NCT02184988|454063784|FG000|Overall Study|moving away/travelling/unable to complet|6|||
126211987|NCT02184988|454063784|FG000|Overall Study|work scheduling issues|4|||
126211988|NCT02184988|454063784|FG000|Overall Study|various other reasons|9|||
126211989|NCT02184988|454063784|FG000|Overall Study|Lost to Follow-up|32|||
126211990|NCT00690573|454063793|FG000|Overall Study|Lack of Efficacy|8|||
126211991|NCT00690573|454063793|FG000|Overall Study|Withdrawal by Subject|1|||
126211992|NCT02087865|454065221|FG000|Overall Study|Withdrawal by Subject|6|||
126211993|NCT02087865|454065222|FG001|Overall Study|Withdrawal by Subject|0|||
126211994|NCT02087865|454065223|FG002|Overall Study|Withdrawal by Subject|1|||
126211995|NCT02087865|454065221|FG000|Overall Study|Lost to Follow-up|0|||
126211996|NCT02087865|454065222|FG001|Overall Study|Lost to Follow-up|0|||
126211997|NCT02087865|454065223|FG002|Overall Study|Lost to Follow-up|1|||
126211998|NCT02087865|454065221|FG000|Overall Study|Drug Non-compliance|0|||
126211999|NCT02087865|454065222|FG001|Overall Study|Drug Non-compliance|2|||
126212000|NCT02087865|454065223|FG002|Overall Study|Drug Non-compliance|0|||
126212001|NCT02087865|454065221|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
126212002|NCT02087865|454065222|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
126212003|NCT02087865|454065223|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
126212004|NCT01392469|454065226|FG000|Overall Study|Adverse Event|2|||
126212005|NCT01392469|454065226|FG000|Overall Study|Withdrawal by Subject|1|||
126212006|NCT01392469|454065226|FG000|Overall Study|Protocol Violation|1|||
126212007|NCT03255226|454065227|FG000|Overall Study|Adverse Event|2|||
126212008|NCT03255226|454065227|FG000|Overall Study|Physician Decision|3|||
126212009|NCT03255226|454065227|FG000|Overall Study|Withdrawal by Subject|1|||
126212010|NCT03255226|454065227|FG000|Overall Study|Serum or blood sodium increased|4|||
126212011|NCT03255226|454065227|FG000|Overall Study|Serum or blood potassium increased|4|||
126212012|NCT01035229|454065228|FG000|Overall Study|Adverse Event|61|||
126212013|NCT01035229|454065229|FG001|Overall Study|Adverse Event|14|||
126212014|NCT01035229|454065228|FG000|Overall Study|Withdrawal by Subject|20|||
126212015|NCT01035229|454065229|FG001|Overall Study|Withdrawal by Subject|7|||
126212016|NCT01035229|454065228|FG000|Overall Study|Lost to Follow-up|1|||
126212017|NCT01035229|454065229|FG001|Overall Study|Lost to Follow-up|0|||
126212018|NCT01035229|454065228|FG000|Overall Study|Administrative problems|1|||
126212019|NCT01035229|454065229|FG001|Overall Study|Administrative problems|1|||
126212020|NCT01035229|454065228|FG000|Overall Study|Death|13|||
126212021|NCT01035229|454065229|FG001|Overall Study|Death|5|||
126212022|NCT01035229|454065228|FG000|Overall Study|New cancer therapy|2|||
126212023|NCT01035229|454065229|FG001|Overall Study|New cancer therapy|0|||
126212024|NCT01035229|454065228|FG000|Overall Study|Protocol Violation|0|||
126212025|NCT01035229|454065229|FG001|Overall Study|Protocol Violation|2|||
126212026|NCT01035229|454065228|FG000|Overall Study|Sponsor's decision to end study|3|||
126212027|NCT01035229|454065229|FG001|Overall Study|Sponsor's decision to end study|3|||
126212028|NCT01035229|454065228|FG000|Overall Study|Disease Progression|261|||
126212029|NCT01035229|454065229|FG001|Overall Study|Disease Progression|152|||
126212030|NCT00564486|454065231|FG000|Overall Study|Adverse Event|0|||
126212031|NCT00564486|454065232|FG001|Overall Study|Adverse Event|1|||
126212032|NCT00564486|454065233|FG002|Overall Study|Adverse Event|0|||
126212033|NCT00564486|454065234|FG003|Overall Study|Adverse Event|0|||
126212034|NCT00564486|454065231|FG000|Overall Study|Withdrawal by Subject|4|||
126212035|NCT00564486|454065232|FG001|Overall Study|Withdrawal by Subject|0|||
126212036|NCT00564486|454065233|FG002|Overall Study|Withdrawal by Subject|0|||
126212037|NCT00564486|454065234|FG003|Overall Study|Withdrawal by Subject|5|||
126212038|NCT00564486|454065231|FG000|Overall Study|Subject refused to have blood drawn|0|||
126212039|NCT00564486|454065232|FG001|Overall Study|Subject refused to have blood drawn|0|||
126212040|NCT00564486|454065233|FG002|Overall Study|Subject refused to have blood drawn|1|||
126212041|NCT00564486|454065234|FG003|Overall Study|Subject refused to have blood drawn|0|||
126212042|NCT00564486|454065231|FG000|Overall Study|Lost to Follow-up|3|||
126212043|NCT00564486|454065232|FG001|Overall Study|Lost to Follow-up|0|||
126212044|NCT00564486|454065233|FG002|Overall Study|Lost to Follow-up|2|||
126212045|NCT00564486|454065234|FG003|Overall Study|Lost to Follow-up|2|||
126212046|NCT03862807|454065239|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
126212047|NCT04362761|454065240|FG000|Part A (48 Weeks)|Adverse Event|2|||
126212048|NCT04362761|454065240|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
126212049|NCT04362761|454065240|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
126212050|NCT04362761|454065240|FG000|Part A (48 Weeks)|Other|5|||
126212051|NCT04362761|454065240|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
126212052|NCT04362761|454065240|FG000|Part B (86 Weeks)|Other|4|||
126212053|NCT00684645|454065241|FG000|Overall Study|Death|2|||
126212054|NCT00684645|454065241|FG000|Overall Study|Progressive disease|67|||
126212055|NCT00684645|454065241|FG000|Overall Study|Adverse Event|27|||
126212056|NCT00684645|454065241|FG000|Overall Study|Lost to Follow-up|3|||
126212057|NCT00684645|454065241|FG000|Overall Study|Other|15|||
126212058|NCT02525627|454065255|FG000|Overall Study|Revision|1|||
126212059|NCT02525627|454065256|FG001|Overall Study|Revision|1|||
126212060|NCT02525627|454065255|FG000|Overall Study|Withdrawal by Subject|1|||
126212061|NCT02525627|454065256|FG001|Overall Study|Withdrawal by Subject|2|||
126212062|NCT02525627|454065255|FG000|Overall Study|Death|1|||
126212063|NCT02525627|454065256|FG001|Overall Study|Death|0|||
126212064|NCT02525627|454065255|FG000|Overall Study|Site terminated|11|||
126212065|NCT02525627|454065256|FG001|Overall Study|Site terminated|10|||
126212066|NCT03746080|454065257|FG000|Overall Study|In follow up|2|||
126212067|NCT03746080|454065257|FG000|Overall Study|Death|15|||
126212068|NCT01473589|454065258|FG000|Overall Study|Adverse Event|1|||
126212069|NCT01473589|454065259|FG001|Overall Study|Adverse Event|1|||
126212070|NCT01473589|454065258|FG000|Overall Study|Death|2|||
126212071|NCT01473589|454065259|FG001|Overall Study|Death|0|||
126212072|NCT01473589|454065258|FG000|Overall Study|Lost to Follow-up|2|||
126212073|NCT01473589|454065259|FG001|Overall Study|Lost to Follow-up|2|||
126212074|NCT01473589|454065258|FG000|Overall Study|Protocol Violation|1|||
126212075|NCT01473589|454065259|FG001|Overall Study|Protocol Violation|0|||
126212076|NCT01473589|454065258|FG000|Overall Study|Withdrawal by Subject|5|||
126091143|NCT02218606|453628348|FG000|Overall Study|Adverse Event|1|||
126212077|NCT01473589|454065259|FG001|Overall Study|Withdrawal by Subject|11|||
126212078|NCT01473589|454065258|FG000|Overall Study|Physician Decision|0|||
126212079|NCT01473589|454065259|FG001|Overall Study|Physician Decision|1|||
126212080|NCT01473589|454065258|FG000|Overall Study|Entry criteria not met|0|||
126212081|NCT01473589|454065259|FG001|Overall Study|Entry criteria not met|1|||
126212082|NCT01819467|454065260|FG000|Overall Study|Physician Decision|20|||
126212083|NCT01819467|454065261|FG001|Overall Study|Physician Decision|9|||
126212084|NCT03256526|454065263|FG000|Overall Study|Adverse Event|1|||
126212085|NCT03256526|454065264|FG001|Overall Study|Adverse Event|0|||
126212086|NCT03256526|454065265|FG002|Overall Study|Adverse Event|1|||
126212087|NCT03256526|454065263|FG000|Overall Study|Lost to Follow-up|1|||
126212088|NCT03256526|454065264|FG001|Overall Study|Lost to Follow-up|0|||
126212089|NCT03256526|454065265|FG002|Overall Study|Lost to Follow-up|2|||
126212090|NCT02875340|454065266|FG000|Overall Study|Death|2|||
126212091|NCT02875340|454065266|FG000|Overall Study|Withdrawal by Subject|2|||
126212092|NCT02875340|454065266|FG000|Overall Study|Physician Decision|3|||
126212093|NCT02875340|454065266|FG000|Overall Study|Adverse Event|1|||
126212094|NCT01607398|454065269|FG000|Overall Study|Adverse Event|0|||
126212095|NCT01607398|454065270|FG001|Overall Study|Adverse Event|2|||
126212096|NCT01607398|454065269|FG000|Overall Study|Severe COPD|2|||
126212097|NCT01607398|454065270|FG001|Overall Study|Severe COPD|0|||
126212098|NCT03457727|454065271|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
126212099|NCT03457727|454065272|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
126212100|NCT03457727|454065273|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
126212101|NCT03457727|454065274|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
126212102|NCT00929201|454065275|FG000|Period 1|Withdrawal by Subject|0|||
126212103|NCT00929201|454065276|FG001|Period 1|Withdrawal by Subject|1|||
126212104|NCT01299272|454065279|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
126212105|NCT01299272|454065280|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
126212106|NCT01299272|454065281|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
126212107|NCT01299272|454065282|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
126348013|NCT03507790|454568573|FG002|Overall Study|Adverse Event|3|||
126348014|NCT03507790|454568571|FG000|Overall Study|Withdrawal by Subject|2|||
126212108|NCT01299272|454065279|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
126348015|NCT03507790|454568572|FG001|Overall Study|Withdrawal by Subject|0|||
126348016|NCT03507790|454568573|FG002|Overall Study|Withdrawal by Subject|0|||
126348017|NCT03507790|454568571|FG000|Overall Study|Subject moved to another location|1|||
126348018|NCT03507790|454568572|FG001|Overall Study|Subject moved to another location|2|||
126348019|NCT03507790|454568573|FG002|Overall Study|Subject moved to another location|0|||
126348020|NCT03507790|454568571|FG000|Overall Study|Non-compliance with study drug|0|||
126348021|NCT03507790|454568572|FG001|Overall Study|Non-compliance with study drug|0|||
126348022|NCT03507790|454568573|FG002|Overall Study|Non-compliance with study drug|1|||
126348023|NCT03507790|454568571|FG000|Overall Study|COVID 19 Pandemic|0|||
126348024|NCT03507790|454568572|FG001|Overall Study|COVID 19 Pandemic|1|||
126348025|NCT03507790|454568573|FG002|Overall Study|COVID 19 Pandemic|0|||
126348026|NCT03507790|454568571|FG000|Overall Study|Lost to Follow-up|0|||
126348027|NCT03507790|454568572|FG001|Overall Study|Lost to Follow-up|1|||
126348028|NCT03507790|454568573|FG002|Overall Study|Lost to Follow-up|0|||
126348029|NCT03507790|454568571|FG000|Overall Study|Discontinuation of the trial at the site|1|||
126348030|NCT03507790|454568572|FG001|Overall Study|Discontinuation of the trial at the site|1|||
126348031|NCT03507790|454568573|FG002|Overall Study|Discontinuation of the trial at the site|0|||
126348032|NCT03507790|454568571|FG000|Overall Study|Randomized in error|0|||
126348033|NCT03507790|454568572|FG001|Overall Study|Randomized in error|0|||
126348034|NCT03507790|454568573|FG002|Overall Study|Randomized in error|1|||
126348035|NCT01160614|454568576|FG000|Overall Study|Withdrawal by Subject|0|||
126348036|NCT01160614|454568577|FG001|Overall Study|Withdrawal by Subject|2|||
126348037|NCT03636477|454568578|FG000|Overall Study|Adverse Event|0|||
126348038|NCT03636477|454568579|FG001|Overall Study|Adverse Event|0|||
126348039|NCT03636477|454568580|FG002|Overall Study|Adverse Event|1|||
126348040|NCT03621592|454568581|FG000|Overall Study|Lost to Follow-up|1|||
126348041|NCT03621592|454568582|FG001|Overall Study|Lost to Follow-up|0|||
126348042|NCT03621592|454568581|FG000|Overall Study|Lack of Improvement|1|||
126348043|NCT03621592|454568582|FG001|Overall Study|Lack of Improvement|0|||
126348044|NCT03621592|454568581|FG000|Overall Study|Preference to receive wound care closer to home|1|||
126348045|NCT03621592|454568582|FG001|Overall Study|Preference to receive wound care closer to home|0|||
126348046|NCT03621592|454568581|FG000|Overall Study|Lack of healing|0|||
126348047|NCT03621592|454568582|FG001|Overall Study|Lack of healing|2|||
126348048|NCT00724945|454568590|FG000|Period 1|non-compliance|1|||
126348049|NCT00724945|454568591|FG001|Period 1|non-compliance|0|||
126348050|NCT00724945|454568590|FG000|Period 1|Adverse Event|1|||
126348051|NCT00724945|454568591|FG001|Period 1|Adverse Event|1|||
126348052|NCT00724945|454568590|FG000|Period 1|Lost to Follow-up|1|||
126348053|NCT00724945|454568591|FG001|Period 1|Lost to Follow-up|0|||
126348054|NCT00724945|454568590|FG000|Period 2|lens comfort issue|3|||
126348055|NCT00724945|454568591|FG001|Period 2|lens comfort issue|0|||
126348056|NCT00724945|454568590|FG000|Period 2|lens physiology issue|1|||
126348057|NCT00724945|454568591|FG001|Period 2|lens physiology issue|0|||
126348058|NCT03069989|454568592|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
126348059|NCT03069989|454568593|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
126348060|NCT04817410|454570923|FG000|Overall Study|Withdrawal by Subject|5|||
126348061|NCT04817410|454570923|FG000|Overall Study|Physician Decision|3|||
126348062|NCT03595748|454570925|FG000|Overall Study|Death|11|||
126348063|NCT03595748|454570926|FG001|Overall Study|Death|12|||
126348064|NCT03595748|454570925|FG000|Overall Study|Withdrawal by Subject|28|||
126348065|NCT03595748|454570926|FG001|Overall Study|Withdrawal by Subject|29|||
126348066|NCT03595748|454570925|FG000|Overall Study|Protocol Violation|0|||
126348067|NCT03595748|454570926|FG001|Overall Study|Protocol Violation|1|||
126348068|NCT04809974|454570928|FG000|Lead-in Phase|Withdrawal by Subject|3|||
126348069|NCT04809974|454570929|FG001|Lead-in Phase|Withdrawal by Subject|0|||
126348070|NCT04809974|454570930|FG002|Lead-in Phase|Withdrawal by Subject|0|||
126348071|NCT04809974|454570928|FG000|Lead-in Phase|No longer eligible|11|||
126348072|NCT04809974|454570929|FG001|Lead-in Phase|No longer eligible|0|||
126348073|NCT04809974|454570930|FG002|Lead-in Phase|No longer eligible|0|||
126348074|NCT04809974|454570928|FG000|Randomized Phase|Lost to Follow-up|0|||
126348075|NCT04809974|454570929|FG001|Randomized Phase|Lost to Follow-up|1|||
126348076|NCT04809974|454570930|FG002|Randomized Phase|Lost to Follow-up|5|||
126348077|NCT04809974|454570928|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
126348078|NCT04809974|454570929|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
126369419|NCT02496000|454648254|FG002|Overall Study|Lost to Follow-up|1|||
126369420|NCT02496000|454648252|FG000|Overall Study|Protocol Violation|0|||
126369421|NCT02496000|454648253|FG001|Overall Study|Protocol Violation|0|||
126369422|NCT02496000|454648254|FG002|Overall Study|Protocol Violation|1|||
126369423|NCT02496000|454648252|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
126369424|NCT02496000|454648253|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
126369425|NCT02496000|454648254|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
126369426|NCT02496000|454648252|FG000|Overall Study|undetermined|0|||
126369427|NCT02496000|454648253|FG001|Overall Study|undetermined|1|||
126369428|NCT02496000|454648254|FG002|Overall Study|undetermined|0|||
126369429|NCT02255656|454648255|FG000|Overall Study|Adverse Event|11|||
126369430|NCT02255656|454648255|FG000|Overall Study|Poor compliance to protocol|3|||
126369431|NCT02255656|454648255|FG000|Overall Study|Lost to Follow-up|30|||
126369432|NCT02255656|454648255|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
126369433|NCT02255656|454648255|FG000|Overall Study|Other|126|||
126369434|NCT01877278|454648256|FG000|Overall Study|Lost to Follow-up|3|||
126369435|NCT01877278|454648257|FG001|Overall Study|Lost to Follow-up|3|||
126369436|NCT05318287|454648258|FG000|Overall Study|Lost to Follow-up|8|||
126369437|NCT05185453|454648259|FG000|Overall Study|Lost to Follow-up|13|||
126369438|NCT05185453|454648260|FG001|Overall Study|Lost to Follow-up|3|||
126369439|NCT02457793|454648267|FG000|Overall Study|Reason not specified|0|||
126369440|NCT02457793|454648268|FG001|Overall Study|Reason not specified|0|||
126369441|NCT02457793|454648269|FG002|Overall Study|Reason not specified|0|||
126369442|NCT02457793|454648270|FG003|Overall Study|Reason not specified|1|||
126369443|NCT02457793|454648271|FG004|Overall Study|Reason not specified|1|||
126369444|NCT02457793|454648272|FG005|Overall Study|Reason not specified|1|||
126369445|NCT02457793|454648267|FG000|Overall Study|Withdrawal by Subject|0|||
126369446|NCT02457793|454648268|FG001|Overall Study|Withdrawal by Subject|4|||
126369447|NCT02457793|454648269|FG002|Overall Study|Withdrawal by Subject|2|||
126369448|NCT02457793|454648270|FG003|Overall Study|Withdrawal by Subject|2|||
126369449|NCT02457793|454648271|FG004|Overall Study|Withdrawal by Subject|2|||
126369450|NCT02457793|454648272|FG005|Overall Study|Withdrawal by Subject|2|||
126369451|NCT02457793|454648267|FG000|Overall Study|Adverse Event|0|||
126369452|NCT02457793|454648268|FG001|Overall Study|Adverse Event|0|||
126369453|NCT02457793|454648269|FG002|Overall Study|Adverse Event|0|||
126369454|NCT02457793|454648270|FG003|Overall Study|Adverse Event|1|||
126369455|NCT02457793|454648271|FG004|Overall Study|Adverse Event|0|||
126369456|NCT02457793|454648272|FG005|Overall Study|Adverse Event|0|||
126369457|NCT02457793|454648267|FG000|Overall Study|Physician Decision|1|||
126369458|NCT02457793|454648268|FG001|Overall Study|Physician Decision|0|||
126369459|NCT02457793|454648269|FG002|Overall Study|Physician Decision|1|||
126369460|NCT02457793|454648270|FG003|Overall Study|Physician Decision|1|||
126369461|NCT02457793|454648271|FG004|Overall Study|Physician Decision|1|||
126369462|NCT02457793|454648272|FG005|Overall Study|Physician Decision|3|||
126369463|NCT00835172|454648279|FG000|Washout|Protocol Violation|0|||
126369464|NCT00835172|454648280|FG001|Washout|Protocol Violation|1|||
126369465|NCT04890509|454648281|FG000|Overall Study|Death|4|||
126369466|NCT04890509|454648282|FG001|Overall Study|Death|4|||
126369467|NCT03274466|454648283|FG000|Overall Study|Withdrawal by Subject|7|||
126369468|NCT03274466|454648284|FG001|Overall Study|Withdrawal by Subject|3|||
126369469|NCT03274466|454648283|FG000|Overall Study|Protocol Specified Withdrawal|5|||
126369470|NCT03274466|454648284|FG001|Overall Study|Protocol Specified Withdrawal|11|||
126369471|NCT03274466|454648283|FG000|Overall Study|Lost to Follow-up|5|||
126369472|NCT03274466|454648284|FG001|Overall Study|Lost to Follow-up|7|||
126369473|NCT03274466|454648283|FG000|Overall Study|Subject Non-compliance|0|||
126369474|NCT03274466|454648284|FG001|Overall Study|Subject Non-compliance|1|||
126369475|NCT03274466|454648283|FG000|Overall Study|Adverse Event|3|||
126369476|NCT03274466|454648284|FG001|Overall Study|Adverse Event|3|||
126369477|NCT03274466|454648283|FG000|Overall Study|Physician Decision|0|||
126369478|NCT03274466|454648284|FG001|Overall Study|Physician Decision|1|||
126369479|NCT03274466|454648283|FG000|Overall Study|Protocol Violation|3|||
126369480|NCT03274466|454648284|FG001|Overall Study|Protocol Violation|3|||
126369481|NCT02989857|454650560|FG000|Randomization Phase|Not Treated|3|||
126369482|NCT02989857|454650561|FG001|Randomization Phase|Not Treated|2|||
126369483|NCT02989857|454650562|FG002|Randomization Phase|Not Treated|0|||
126369484|NCT01168596|454650567|FG000|Overall Study|Withdrawal by Subject|3|||
126369485|NCT01168596|454650568|FG001|Overall Study|Withdrawal by Subject|1|||
126012871|NCT02914522|453340999|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
126012872|NCT02914522|453341000|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
126012873|NCT02914522|453341001|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
126012874|NCT02914522|453341002|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
126012875|NCT02914522|453341003|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
126012876|NCT02914522|453341004|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
126012877|NCT02914522|453341005|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
126012878|NCT02914522|453341006|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
126012879|NCT02914522|453341007|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
126012880|NCT02914522|453340997|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
126348079|NCT04809974|454570930|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
126348080|NCT04809974|454570928|FG000|Randomized Phase|Adverse Event|0|||
126348081|NCT04809974|454570929|FG001|Randomized Phase|Adverse Event|1|||
126348082|NCT04809974|454570930|FG002|Randomized Phase|Adverse Event|4|||
126348083|NCT04809974|454570928|FG000|Randomized Phase|Withdrawal by Subject|0|||
126348084|NCT04809974|454570929|FG001|Randomized Phase|Withdrawal by Subject|0|||
126348085|NCT04809974|454570930|FG002|Randomized Phase|Withdrawal by Subject|5|||
126348086|NCT05493111|454570932|FG000|Overall Study|Adverse Event|3|||
126348087|NCT05493111|454570933|FG001|Overall Study|Adverse Event|4|||
126348088|NCT05493111|454570932|FG000|Overall Study|Withdrawal of Consent|19|||
126348089|NCT05493111|454570933|FG001|Overall Study|Withdrawal of Consent|10|||
126348090|NCT05493111|454570932|FG000|Overall Study|Non-compliance|1|||
126348091|NCT05493111|454570933|FG001|Overall Study|Non-compliance|1|||
126348092|NCT05493111|454570932|FG000|Overall Study|Lost to Follow-up|8|||
126348093|NCT05493111|454570933|FG001|Overall Study|Lost to Follow-up|1|||
126348094|NCT05493111|454570932|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
126348095|NCT05493111|454570933|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
126348096|NCT05493111|454570932|FG000|Overall Study|Withdrawal by Subject|1|||
126348097|NCT05493111|454570933|FG001|Overall Study|Withdrawal by Subject|1|||
126348098|NCT06125964|454570934|FG000|Overall Study|Lost to Follow-up|0|||
126348099|NCT06125964|454570935|FG001|Overall Study|Lost to Follow-up|1|||
126348100|NCT06125964|454570936|FG002|Overall Study|Lost to Follow-up|0|||
126348101|NCT06125964|454570937|FG003|Overall Study|Lost to Follow-up|0|||
126348102|NCT02469233|454570938|FG000|Overall Study|Death|1|||
126348103|NCT02469233|454570939|FG001|Overall Study|Death|1|||
126348104|NCT02469233|454570938|FG000|Overall Study|Lost to post or 6 month follow up|7|||
126348105|NCT02469233|454570939|FG001|Overall Study|Lost to post or 6 month follow up|2|||
126348106|NCT01787838|454570940|FG000|Overall Study|refused|1413|||
126348107|NCT01431976|454570941|FG000|Overall Study|Adverse Event|6|||
126348108|NCT01431976|454570941|FG000|Overall Study|Lack of Efficacy|2|||
126348109|NCT01431976|454570941|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
126348110|NCT01431976|454570941|FG000|Overall Study|Physician Decision|1|||
126348111|NCT01431976|454570941|FG000|Overall Study|Withdrawal by Subject|1|||
126348112|NCT01136954|454570947|FG000|Overall Study|Adverse Event|3|||
126348113|NCT01136954|454570948|FG001|Overall Study|Adverse Event|2|||
126348114|NCT01136954|454570947|FG000|Overall Study|Withdrawal by Subject|6|||
126348115|NCT01136954|454570948|FG001|Overall Study|Withdrawal by Subject|2|||
126348116|NCT01136954|454570947|FG000|Overall Study|Lack of Efficacy|14|||
126348117|NCT01136954|454570948|FG001|Overall Study|Lack of Efficacy|13|||
126348118|NCT01136954|454570947|FG000|Overall Study|Physician Decision|0|||
126348119|NCT01136954|454570948|FG001|Overall Study|Physician Decision|1|||
126348120|NCT01136954|454570947|FG000|Overall Study|Other|1|||
126348121|NCT01136954|454570948|FG001|Overall Study|Other|3|||
126348122|NCT00782067|454570949|FG000|Overall Study|Adverse Event|35|||
126348123|NCT00782067|454570949|FG000|Overall Study|Subject withdrew consent|11|||
126348124|NCT00782067|454570949|FG000|Overall Study|Lost to Follow-up|2|||
126348125|NCT00782067|454570949|FG000|Overall Study|Administrative problems|14|||
126348126|NCT00782067|454570949|FG000|Overall Study|Death|9|||
126348127|NCT00782067|454570949|FG000|Overall Study|Disease progression|43|||
126348128|NCT00782067|454570949|FG000|Overall Study|Protocol deviation|2|||
126348129|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
126348130|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
126348131|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
126348132|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
126348133|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
126348134|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
126348135|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348136|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348137|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
126348138|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
126348139|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
126348140|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
126348141|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
126348142|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
126348143|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
126212109|NCT01299272|454065280|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
126212110|NCT01299272|454065281|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
126212111|NCT01299272|454065282|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
126212112|NCT01299272|454065279|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
126212113|NCT01299272|454065280|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
126212114|NCT01299272|454065281|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
126212115|NCT01299272|454065282|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
126212116|NCT01299272|454065279|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
126212117|NCT01299272|454065280|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
126212118|NCT01299272|454065281|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
126212119|NCT01299272|454065282|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
126212120|NCT01299272|454065279|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
126212121|NCT01299272|454065280|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
126212122|NCT01299272|454065281|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
126212123|NCT01299272|454065282|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
126212124|NCT01299272|454065279|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
126212125|NCT01299272|454065280|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
126212126|NCT01299272|454065281|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
126212127|NCT01299272|454065282|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
126212128|NCT01299272|454065279|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
126212129|NCT01299272|454065280|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
126212130|NCT01299272|454065281|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
126212131|NCT01299272|454065282|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
126212132|NCT01299272|454065279|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
126212133|NCT01299272|454065280|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
126212134|NCT01299272|454065281|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
126212135|NCT01299272|454065282|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
126212136|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
126212137|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
126348144|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
126348145|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348146|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
126348147|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348148|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348149|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
126348150|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
126348151|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
126348152|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
126348153|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
126348154|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
126348155|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
126348156|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
126348157|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
126348158|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
126348159|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
126306104|NCT02553499|454408876|FG007|Overall Study|Withdrawal by Subject|1|||
126306105|NCT02553499|454408877|FG008|Overall Study|Withdrawal by Subject|1|||
126306106|NCT02553499|454408878|FG009|Overall Study|Withdrawal by Subject|0|||
126306107|NCT02553499|454408879|FG010|Overall Study|Withdrawal by Subject|1|||
126306108|NCT02553499|454408880|FG011|Overall Study|Withdrawal by Subject|0|||
126306109|NCT02553499|454408881|FG012|Overall Study|Withdrawal by Subject|0|||
126306110|NCT02553499|454408882|FG013|Overall Study|Withdrawal by Subject|0|||
126306111|NCT01323387|454408883|FG000|Overall Study|Withdrawal by Subject|41|||
126306112|NCT01323387|454408883|FG000|Overall Study|Radiographic Data Unavailable|1|||
126306113|NCT01323387|454408883|FG000|Overall Study|Revision|14|||
126306114|NCT01323387|454408883|FG000|Overall Study|Protocol Violation|12|||
126306115|NCT01323387|454408883|FG000|Overall Study|Randomized but Never Treated|16|||
126306116|NCT02073929|454408895|FG000|Overall Study|Lost to Follow-up|2|||
126306117|NCT02073929|454408896|FG001|Overall Study|Lost to Follow-up|1|||
126306118|NCT02073929|454408895|FG000|Overall Study|Adverse Event|2|||
126306119|NCT02073929|454408896|FG001|Overall Study|Adverse Event|1|||
126306120|NCT02073929|454408895|FG000|Overall Study|Withdrawal by Subject|0|||
126306121|NCT02073929|454408896|FG001|Overall Study|Withdrawal by Subject|1|||
126306122|NCT03319732|454408897|FG000|Overall Study|Adverse Event|40|||
126306123|NCT03319732|454408897|FG000|Overall Study|Withdrawal by Subject|50|||
126306124|NCT03319732|454408897|FG000|Overall Study|MS relapse|10|||
126306125|NCT03319732|454408897|FG000|Overall Study|reason not specified|5|||
126306126|NCT00430573|454408898|FG000|Overall Study|Withdrawal by Subject|5|||
126306127|NCT04463251|454408899|FG000|Overall Study|Death|1|||
126306128|NCT04463251|454408900|FG001|Overall Study|Death|0|||
126306129|NCT04463251|454408901|FG002|Overall Study|Death|1|||
126306130|NCT04463251|454408899|FG000|Overall Study|Adverse Event|0|||
126012881|NCT02914522|453340998|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
126012882|NCT02914522|453340999|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
126212138|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
126212139|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
126212140|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
126212141|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
126212142|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
126212143|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
126212144|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
126212145|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
126012883|NCT02914522|453341000|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
126012884|NCT02914522|453341001|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
126012885|NCT02914522|453341002|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
126012886|NCT02914522|453341003|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
126012887|NCT02914522|453341004|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
126012888|NCT02914522|453341005|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
126012889|NCT02914522|453341006|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
126012890|NCT02914522|453341007|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
126012891|NCT02914522|453340997|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
126012892|NCT02914522|453340998|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
126212146|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
126212147|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
126212148|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
126212149|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
126212150|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
126212151|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
126212152|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
126212153|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
126212154|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
126212155|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
126212156|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
126212157|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
126212158|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
126348160|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
126348161|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
126348162|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
126348163|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
126348164|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
126348165|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
126348166|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
126348167|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
126348168|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
126348169|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
126348170|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
126348171|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
126348172|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
126348173|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
126348174|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
126348175|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
126348176|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
126348177|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
126348178|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
126348179|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
126348180|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
126348181|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
126348182|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
126348183|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
126348184|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
126348185|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
126348186|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
126348187|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
126348188|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
126348189|NCT01970371|454570956|FG000|Overall Study|Death|8|||
126348190|NCT01970371|454570957|FG001|Overall Study|Death|13|||
126348191|NCT01970371|454570958|FG002|Overall Study|Death|12|||
126348192|NCT01970371|454570956|FG000|Overall Study|Lost to Follow-up|0|||
126348193|NCT01970371|454570957|FG001|Overall Study|Lost to Follow-up|0|||
126012893|NCT02914522|453340999|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
126348194|NCT01970371|454570958|FG002|Overall Study|Lost to Follow-up|1|||
126348195|NCT02239328|454570959|FG000|Overall Study|Benign disease noted at time of surgery|6|||
126348196|NCT02239328|454570959|FG000|Overall Study|Equipment or website malfunction|2|||
126348197|NCT04727749|454570960|FG000|Overall Study|Lost to Follow-up|10|||
126348198|NCT04727749|454570961|FG001|Overall Study|Lost to Follow-up|3|||
126348199|NCT01481779|454570962|FG000|Overall Study|Adverse Event|23|||
126348200|NCT01481779|454570963|FG001|Overall Study|Adverse Event|5|||
126348201|NCT01481779|454570962|FG000|Overall Study|Lost to Follow-up|3|||
126348202|NCT01481779|454570963|FG001|Overall Study|Lost to Follow-up|2|||
126348203|NCT01481779|454570962|FG000|Overall Study|Protocol Violation|2|||
126348204|NCT01481779|454570963|FG001|Overall Study|Protocol Violation|3|||
126348205|NCT01481779|454570962|FG000|Overall Study|Withdrawal by Subject|26|||
126348206|NCT01481779|454570963|FG001|Overall Study|Withdrawal by Subject|13|||
126348207|NCT01481779|454570962|FG000|Overall Study|Physician Decision|13|||
126348208|NCT01481779|454570963|FG001|Overall Study|Physician Decision|4|||
126348209|NCT01481779|454570962|FG000|Overall Study|Sponsor Decision|3|||
126348210|NCT01481779|454570963|FG001|Overall Study|Sponsor Decision|1|||
126348211|NCT02378181|454570964|FG000|Overall Study|Lost to Follow-up|2|||
126348212|NCT02378181|454570965|FG001|Overall Study|Lost to Follow-up|5|||
126348213|NCT02378181|454570964|FG000|Overall Study|Withdrawal by Subject|1|||
126348214|NCT02378181|454570965|FG001|Overall Study|Withdrawal by Subject|1|||
126348215|NCT02378181|454570964|FG000|Overall Study|Incarcerated|0|||
126348216|NCT02378181|454570965|FG001|Overall Study|Incarcerated|1|||
126348217|NCT03517137|454570976|FG000|Overall Study|Lack of Efficacy|1|||
126348218|NCT03517137|454570976|FG000|Overall Study|Adverse Event|2|||
126348219|NCT03517137|454570976|FG000|Overall Study|Withdrawal by Subject|2|||
126348220|NCT03517137|454570976|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
126348221|NCT02313155|454570978|FG000|Overall Study|Lost to Follow-up|0|||
126348222|NCT02313155|454570979|FG001|Overall Study|Lost to Follow-up|1|||
126348223|NCT00689936|454570980|FG000|Active Treatment Phase|Adverse Event|68|||
126348224|NCT00689936|454570981|FG001|Active Treatment Phase|Adverse Event|71|||
126348225|NCT00689936|454570982|FG002|Active Treatment Phase|Adverse Event|76|||
126348226|NCT00689936|454570980|FG000|Active Treatment Phase|Disease Progression|273|||
126348227|NCT00689936|454570981|FG001|Active Treatment Phase|Disease Progression|362|||
126348228|NCT00689936|454570982|FG002|Active Treatment Phase|Disease Progression|339|||
126348229|NCT00689936|454570980|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
126348230|NCT00689936|454570981|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
126348231|NCT00689936|454570982|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
126348232|NCT00689936|454570980|FG000|Active Treatment Phase|Death|60|||
126348233|NCT00689936|454570981|FG001|Active Treatment Phase|Death|28|||
126348234|NCT00689936|454570982|FG002|Active Treatment Phase|Death|37|||
126348235|NCT00689936|454570980|FG000|Active Treatment Phase|Lost to Follow-up|0|||
126348236|NCT00689936|454570981|FG001|Active Treatment Phase|Lost to Follow-up|2|||
126348237|NCT00689936|454570982|FG002|Active Treatment Phase|Lost to Follow-up|2|||
126348238|NCT00689936|454570980|FG000|Active Treatment Phase|Protocol Violation|2|||
126348239|NCT00689936|454570981|FG001|Active Treatment Phase|Protocol Violation|2|||
126348240|NCT00689936|454570982|FG002|Active Treatment Phase|Protocol Violation|4|||
126348241|NCT00689936|454570980|FG000|Active Treatment Phase|Study Close Out|64|||
126348242|NCT00689936|454570981|FG001|Active Treatment Phase|Study Close Out|26|||
126348243|NCT00689936|454570982|FG002|Active Treatment Phase|Study Close Out|21|||
126348244|NCT00689936|454570980|FG000|Active Treatment Phase|Miscellaneous|52|||
126348245|NCT00689936|454570981|FG001|Active Treatment Phase|Miscellaneous|34|||
126348246|NCT00689936|454570982|FG002|Active Treatment Phase|Miscellaneous|47|||
126348247|NCT00689936|454570980|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
126348248|NCT00689936|454570981|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
126348249|NCT00689936|454570982|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
126348250|NCT01303419|454570985|FG000|Overall Study|Discontinuation of study|60|||
126348251|NCT01303419|454570985|FG000|Overall Study|Did not complete both imaging methods|5|||
126348252|NCT01303419|454570985|FG000|Overall Study|Did not meet all I/E after screening|31|||
126348253|NCT01995201|454570986|FG000|From Baseline Until Week 24|Adverse Event|4|||
126348254|NCT01995201|454570987|FG001|From Baseline Until Week 24|Adverse Event|15|||
126348255|NCT01995201|454570988|FG002|From Baseline Until Week 24|Adverse Event|0|||
126348256|NCT01995201|454570989|FG003|From Baseline Until Week 24|Adverse Event|0|||
126348257|NCT01995201|454570990|FG004|From Baseline Until Week 24|Adverse Event|0|||
126348258|NCT01995201|454570991|FG005|From Baseline Until Week 24|Adverse Event|0|||
126348259|NCT01995201|454570992|FG006|From Baseline Until Week 24|Adverse Event|0|||
126348260|NCT01995201|454570986|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348261|NCT01995201|454570987|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
126348262|NCT01995201|454570988|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348263|NCT01995201|454570989|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348264|NCT01995201|454570990|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348265|NCT01995201|454570991|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126012894|NCT02914522|453341000|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
126212159|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
126212160|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
126212161|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
126212162|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
126212163|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
126212164|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
126212165|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
126212166|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
126212167|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
126212168|NCT01299272|454065279|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
126212169|NCT01299272|454065280|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
126212170|NCT01299272|454065281|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
126212171|NCT01299272|454065282|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
126212172|NCT01299272|454065279|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
126212173|NCT01299272|454065280|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
126212174|NCT01299272|454065281|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
126212175|NCT01299272|454065282|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
126212176|NCT01299272|454065279|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
126212177|NCT01299272|454065280|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
126212178|NCT01299272|454065281|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
126212179|NCT01299272|454065282|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
126212180|NCT01299272|454065279|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
126212181|NCT01299272|454065280|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
126212182|NCT01299272|454065281|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
126212183|NCT01299272|454065282|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
126212184|NCT01299272|454065279|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
126212185|NCT01299272|454065280|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
126212186|NCT01299272|454065281|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
126212187|NCT01299272|454065282|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
126212188|NCT01299272|454065279|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
126212189|NCT01299272|454065280|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
126212190|NCT01299272|454065281|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
126212191|NCT01299272|454065282|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
126212192|NCT01299272|454065279|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
126212193|NCT01299272|454065280|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
126212194|NCT01299272|454065281|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
126212195|NCT01299272|454065282|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
126212196|NCT01299272|454065279|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
126212197|NCT01299272|454065280|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
126212198|NCT01299272|454065281|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
126212199|NCT01299272|454065282|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
126212200|NCT01299272|454065279|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
126212201|NCT01299272|454065280|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
126212202|NCT01299272|454065281|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
126212203|NCT01299272|454065282|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
126212204|NCT00464308|454065283|FG000|Overall Study|Adverse Event|22|||
126212205|NCT00464308|454065284|FG001|Overall Study|Adverse Event|27|||
126212206|NCT00464308|454065285|FG002|Overall Study|Adverse Event|16|||
126212207|NCT00464308|454065283|FG000|Overall Study|Lost to Follow-up|29|||
126212208|NCT00464308|454065284|FG001|Overall Study|Lost to Follow-up|19|||
126212209|NCT00464308|454065285|FG002|Overall Study|Lost to Follow-up|20|||
126212210|NCT00464308|454065283|FG000|Overall Study|Patient discontinued and other reasons|17|||
126212211|NCT00464308|454065284|FG001|Overall Study|Patient discontinued and other reasons|17|||
126212212|NCT00464308|454065285|FG002|Overall Study|Patient discontinued and other reasons|23|||
126212213|NCT00464308|454065283|FG000|Overall Study|Physician Decision|1|||
126212214|NCT00464308|454065284|FG001|Overall Study|Physician Decision|0|||
126212215|NCT00464308|454065285|FG002|Overall Study|Physician Decision|0|||
126212216|NCT01513759|454065286|FG000|Overall Study|Protocol Violation|4|||
126212217|NCT01513759|454065286|FG000|Overall Study|Death during catheter placement|1|||
126212218|NCT00630994|454065287|FG000|Overall Study|Adverse Event|1|||
126212219|NCT00630994|454065287|FG000|Overall Study|Disease Progression|1|||
126212220|NCT00630994|454065287|FG000|Overall Study|Lack of Efficacy|1|||
126212221|NCT00630994|454065287|FG000|Overall Study|Other|1|||
126212222|NCT03533608|454065288|FG000|Overall Study|Withdrawal by Subject|3|||
126212223|NCT03533608|454065288|FG000|Overall Study|Physician Decision|2|||
126212224|NCT03286426|454065289|FG000|Overall Study|Physician Decision|3|||
126212225|NCT03514121|454065290|FG000|Overall Study|Withdrawal by Subject|0|||
126212226|NCT03514121|454065291|FG001|Overall Study|Withdrawal by Subject|0|||
126348266|NCT01995201|454570992|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348267|NCT01995201|454570986|FG000|From Baseline Until Week 24|Death|0|||
126348268|NCT01995201|454570987|FG001|From Baseline Until Week 24|Death|1|||
126348269|NCT01995201|454570988|FG002|From Baseline Until Week 24|Death|0|||
126348270|NCT01995201|454570989|FG003|From Baseline Until Week 24|Death|0|||
126348271|NCT01995201|454570990|FG004|From Baseline Until Week 24|Death|0|||
126348272|NCT01995201|454570991|FG005|From Baseline Until Week 24|Death|0|||
126348273|NCT01995201|454570992|FG006|From Baseline Until Week 24|Death|0|||
126348274|NCT01995201|454570986|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
126348275|NCT01995201|454570987|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
126348276|NCT01995201|454570988|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
126348277|NCT01995201|454570989|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
126348278|NCT01995201|454570990|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
126348279|NCT01995201|454570991|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
126348280|NCT01995201|454570992|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
126348281|NCT01995201|454570986|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
126348282|NCT01995201|454570987|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
126348283|NCT01995201|454570988|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
126348284|NCT01995201|454570989|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
126348285|NCT01995201|454570990|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
126348286|NCT01995201|454570991|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
126348287|NCT01995201|454570992|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
126348288|NCT01995201|454570986|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
126348289|NCT01995201|454570987|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
126348290|NCT01995201|454570988|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348291|NCT01995201|454570989|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348292|NCT01995201|454570990|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348293|NCT01995201|454570991|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348294|NCT01995201|454570992|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348295|NCT01995201|454570986|FG000|From Baseline Until Week 24|Physician Decision|0|||
126348296|NCT01995201|454570987|FG001|From Baseline Until Week 24|Physician Decision|2|||
126348297|NCT01995201|454570988|FG002|From Baseline Until Week 24|Physician Decision|0|||
126348298|NCT01995201|454570989|FG003|From Baseline Until Week 24|Physician Decision|0|||
126348299|NCT01995201|454570990|FG004|From Baseline Until Week 24|Physician Decision|0|||
126348300|NCT01995201|454570991|FG005|From Baseline Until Week 24|Physician Decision|0|||
126348301|NCT01995201|454570992|FG006|From Baseline Until Week 24|Physician Decision|0|||
126348302|NCT01995201|454570986|FG000|From Baseline Until Week 24|Protocol Violation|0|||
126348303|NCT01995201|454570987|FG001|From Baseline Until Week 24|Protocol Violation|9|||
126348304|NCT01995201|454570988|FG002|From Baseline Until Week 24|Protocol Violation|0|||
126348305|NCT01995201|454570989|FG003|From Baseline Until Week 24|Protocol Violation|0|||
126348306|NCT01995201|454570990|FG004|From Baseline Until Week 24|Protocol Violation|0|||
126348307|NCT01995201|454570991|FG005|From Baseline Until Week 24|Protocol Violation|0|||
126348308|NCT01995201|454570992|FG006|From Baseline Until Week 24|Protocol Violation|0|||
126348309|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Adverse Event|0|||
126348310|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Adverse Event|0|||
126348311|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Adverse Event|2|||
126348312|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Adverse Event|1|||
126348313|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Adverse Event|1|||
126348314|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Adverse Event|3|||
126348315|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Adverse Event|1|||
126348316|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Death|0|||
126348317|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Death|0|||
126348318|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Death|0|||
126348319|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Death|0|||
126348320|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Death|0|||
126348321|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Death|2|||
126348322|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Death|0|||
126348323|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
126348324|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
126348325|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
126348326|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
126348327|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
126348328|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
126348329|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
126348330|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348331|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348332|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348333|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348334|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
126348335|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
126348336|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348337|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126212227|NCT03514121|454065292|FG002|Overall Study|Withdrawal by Subject|0|||
126212228|NCT03514121|454065293|FG003|Overall Study|Withdrawal by Subject|0|||
126212229|NCT03514121|454065294|FG004|Overall Study|Withdrawal by Subject|1|||
126212230|NCT03514121|454065295|FG005|Overall Study|Withdrawal by Subject|2|||
126212231|NCT03514121|454065296|FG006|Overall Study|Withdrawal by Subject|1|||
126212232|NCT03514121|454065297|FG007|Overall Study|Withdrawal by Subject|1|||
126212233|NCT03514121|454065298|FG008|Overall Study|Withdrawal by Subject|7|||
126212234|NCT03514121|454065299|FG009|Overall Study|Withdrawal by Subject|2|||
126212235|NCT03514121|454065290|FG000|Overall Study|Death|0|||
126212236|NCT03514121|454065291|FG001|Overall Study|Death|0|||
126212237|NCT03514121|454065292|FG002|Overall Study|Death|0|||
126212238|NCT03514121|454065293|FG003|Overall Study|Death|0|||
126212239|NCT03514121|454065294|FG004|Overall Study|Death|0|||
126212240|NCT03514121|454065295|FG005|Overall Study|Death|3|||
126212241|NCT03514121|454065296|FG006|Overall Study|Death|2|||
126212242|NCT03514121|454065297|FG007|Overall Study|Death|1|||
126212243|NCT03514121|454065298|FG008|Overall Study|Death|26|||
126212244|NCT03514121|454065299|FG009|Overall Study|Death|3|||
126212245|NCT03514121|454065290|FG000|Overall Study|Lost to Follow-up|0|||
126212246|NCT03514121|454065291|FG001|Overall Study|Lost to Follow-up|0|||
126212247|NCT03514121|454065292|FG002|Overall Study|Lost to Follow-up|1|||
126212248|NCT03514121|454065293|FG003|Overall Study|Lost to Follow-up|0|||
126212249|NCT03514121|454065294|FG004|Overall Study|Lost to Follow-up|0|||
126212250|NCT03514121|454065295|FG005|Overall Study|Lost to Follow-up|0|||
126212251|NCT03514121|454065296|FG006|Overall Study|Lost to Follow-up|0|||
126212252|NCT03514121|454065297|FG007|Overall Study|Lost to Follow-up|0|||
126212253|NCT03514121|454065298|FG008|Overall Study|Lost to Follow-up|1|||
126212254|NCT03514121|454065299|FG009|Overall Study|Lost to Follow-up|0|||
126212255|NCT03514121|454065290|FG000|Overall Study|Adverse Event|0|||
126212256|NCT03514121|454065291|FG001|Overall Study|Adverse Event|0|||
126212257|NCT03514121|454065292|FG002|Overall Study|Adverse Event|0|||
126212258|NCT03514121|454065293|FG003|Overall Study|Adverse Event|0|||
126212259|NCT03514121|454065294|FG004|Overall Study|Adverse Event|0|||
126212260|NCT03514121|454065295|FG005|Overall Study|Adverse Event|0|||
126212261|NCT03514121|454065296|FG006|Overall Study|Adverse Event|1|||
126212262|NCT03514121|454065297|FG007|Overall Study|Adverse Event|0|||
126212263|NCT03514121|454065298|FG008|Overall Study|Adverse Event|0|||
126212264|NCT03514121|454065299|FG009|Overall Study|Adverse Event|0|||
126212265|NCT03514121|454065290|FG000|Overall Study|Other|0|||
126212266|NCT03514121|454065291|FG001|Overall Study|Other|1|||
126212267|NCT03514121|454065292|FG002|Overall Study|Other|1|||
126212268|NCT03514121|454065293|FG003|Overall Study|Other|0|||
126212269|NCT03514121|454065294|FG004|Overall Study|Other|1|||
126212270|NCT03514121|454065295|FG005|Overall Study|Other|2|||
126212271|NCT03514121|454065296|FG006|Overall Study|Other|3|||
126212272|NCT03514121|454065297|FG007|Overall Study|Other|2|||
126212273|NCT03514121|454065298|FG008|Overall Study|Other|7|||
126212274|NCT03514121|454065299|FG009|Overall Study|Other|3|||
126212275|NCT03514121|454065290|FG000|Overall Study|Study termination by Sponsor|0|||
126212276|NCT03514121|454065291|FG001|Overall Study|Study termination by Sponsor|0|||
126212277|NCT03514121|454065292|FG002|Overall Study|Study termination by Sponsor|0|||
126212278|NCT03514121|454065293|FG003|Overall Study|Study termination by Sponsor|0|||
126212279|NCT03514121|454065294|FG004|Overall Study|Study termination by Sponsor|0|||
126212280|NCT03514121|454065295|FG005|Overall Study|Study termination by Sponsor|0|||
126212281|NCT03514121|454065296|FG006|Overall Study|Study termination by Sponsor|0|||
126212282|NCT03514121|454065297|FG007|Overall Study|Study termination by Sponsor|0|||
126212283|NCT03514121|454065298|FG008|Overall Study|Study termination by Sponsor|11|||
126212284|NCT03514121|454065299|FG009|Overall Study|Study termination by Sponsor|3|||
126212285|NCT03514121|454065290|FG000|Overall Study|Investigator decision|0|||
126212286|NCT03514121|454065291|FG001|Overall Study|Investigator decision|0|||
126212287|NCT03514121|454065292|FG002|Overall Study|Investigator decision|0|||
126212288|NCT03514121|454065293|FG003|Overall Study|Investigator decision|0|||
126212289|NCT03514121|454065294|FG004|Overall Study|Investigator decision|0|||
126212290|NCT03514121|454065295|FG005|Overall Study|Investigator decision|0|||
126212291|NCT03514121|454065296|FG006|Overall Study|Investigator decision|0|||
126212292|NCT03514121|454065297|FG007|Overall Study|Investigator decision|0|||
126212293|NCT03514121|454065298|FG008|Overall Study|Investigator decision|1|||
126212294|NCT03514121|454065299|FG009|Overall Study|Investigator decision|0|||
126212295|NCT03286400|454065303|FG000|Overall Study|Death|10|||
126212296|NCT03286400|454065303|FG000|Overall Study|Lost to Follow-up|10|||
126212297|NCT03286400|454065303|FG000|Overall Study|Physician Decision|1|||
126212298|NCT03286400|454065303|FG000|Overall Study|Scheduling difficulty|4|||
126212299|NCT00826176|454065306|FG000|Overall Study|Lost to Follow-up|1|||
126212300|NCT00826176|454065307|FG001|Overall Study|Lost to Follow-up|0|||
126212301|NCT00826176|454065306|FG000|Overall Study|Subject Withdrew Consent|3|||
126212302|NCT00826176|454065307|FG001|Overall Study|Subject Withdrew Consent|0|||
126212303|NCT00826176|454065306|FG000|Overall Study|Administrative|9|||
126212304|NCT00826176|454065307|FG001|Overall Study|Administrative|0|||
126212305|NCT00297882|454065312|FG000|Day 14|Lack of Efficacy|12|||
126212306|NCT00297882|454065313|FG001|Day 14|Lack of Efficacy|49|||
126212307|NCT00297882|454065312|FG000|Day 28|Lost to Follow-up|13|||
126212308|NCT00297882|454065313|FG001|Day 28|Lost to Follow-up|23|||
126212309|NCT00297882|454065312|FG000|Day 28|Lack of Efficacy|3|||
126212310|NCT00297882|454065313|FG001|Day 28|Lack of Efficacy|0|||
126212311|NCT04484805|454065314|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
126212312|NCT04484805|454065315|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
126212313|NCT04484805|454065314|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
126212314|NCT04484805|454065315|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
126212315|NCT04242264|454065316|FG000|Overall Study|Lost to Follow-up|2|||
126212316|NCT04242264|454065317|FG001|Overall Study|Lost to Follow-up|2|||
126212317|NCT04242264|454065318|FG002|Overall Study|Lost to Follow-up|1|||
126212318|NCT04242264|454065319|FG003|Overall Study|Lost to Follow-up|1|||
126212319|NCT04242264|454065316|FG000|Overall Study|Withdrawal by Subject|1|||
126212320|NCT04242264|454065317|FG001|Overall Study|Withdrawal by Subject|0|||
126212321|NCT04242264|454065318|FG002|Overall Study|Withdrawal by Subject|0|||
126212322|NCT04242264|454065319|FG003|Overall Study|Withdrawal by Subject|0|||
126212323|NCT04139642|454065321|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
126212324|NCT04139642|454065322|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
126212325|NCT00433771|454065324|FG000|Overall Study|screen fail|14|||
126212326|NCT00433771|454065324|FG000|Overall Study|Treated and later found to be ineligible|2|||
126212327|NCT00433771|454065324|FG000|Overall Study|Death|2|||
126212328|NCT00433771|454065324|FG000|Overall Study|Failure to deploy stent|1|||
126212329|NCT00539006|454065328|FG000|Pre-treatment|Other|0|||
126212330|NCT00539006|454065329|FG001|Pre-treatment|Other|1|||
126212331|NCT00539006|454065330|FG002|Pre-treatment|Other|0|||
126212332|NCT00539006|454065331|FG003|Pre-treatment|Other|0|||
126212333|NCT00539006|454065328|FG000|Treatment Period 1|Lost to Follow-up|0|||
126212334|NCT00539006|454065329|FG001|Treatment Period 1|Lost to Follow-up|0|||
126212335|NCT00539006|454065330|FG002|Treatment Period 1|Lost to Follow-up|1|||
126212336|NCT00539006|454065331|FG003|Treatment Period 1|Lost to Follow-up|0|||
126212337|NCT00539006|454065328|FG000|Treatment Period 1|Protocol Violation|0|||
126212338|NCT00539006|454065329|FG001|Treatment Period 1|Protocol Violation|0|||
126212339|NCT00539006|454065330|FG002|Treatment Period 1|Protocol Violation|1|||
126212340|NCT00539006|454065331|FG003|Treatment Period 1|Protocol Violation|0|||
126212341|NCT00539006|454065328|FG000|Treatment Period 1|Lack of Efficacy|0|||
126212342|NCT00539006|454065329|FG001|Treatment Period 1|Lack of Efficacy|0|||
126212343|NCT00539006|454065330|FG002|Treatment Period 1|Lack of Efficacy|0|||
126212344|NCT00539006|454065331|FG003|Treatment Period 1|Lack of Efficacy|1|||
126212345|NCT00539006|454065328|FG000|Washout|Adverse Event|2|||
126212346|NCT00539006|454065329|FG001|Washout|Adverse Event|1|||
126212347|NCT00539006|454065330|FG002|Washout|Adverse Event|0|||
126212348|NCT00539006|454065331|FG003|Washout|Adverse Event|0|||
126212349|NCT00539006|454065328|FG000|Washout|Protocol Violation|1|||
126212350|NCT00539006|454065329|FG001|Washout|Protocol Violation|1|||
126212351|NCT00539006|454065330|FG002|Washout|Protocol Violation|0|||
126212352|NCT00539006|454065331|FG003|Washout|Protocol Violation|0|||
126212353|NCT00539006|454065328|FG000|Washout|Withdrawal by Subject|0|||
126212354|NCT00539006|454065329|FG001|Washout|Withdrawal by Subject|2|||
126212355|NCT00539006|454065330|FG002|Washout|Withdrawal by Subject|0|||
126212356|NCT00539006|454065331|FG003|Washout|Withdrawal by Subject|0|||
126212357|NCT00539006|454065328|FG000|Washout|Failed to meet continuation criteria|16|||
126212358|NCT00539006|454065329|FG001|Washout|Failed to meet continuation criteria|5|||
126212359|NCT00539006|454065330|FG002|Washout|Failed to meet continuation criteria|14|||
126212360|NCT00539006|454065331|FG003|Washout|Failed to meet continuation criteria|6|||
126212361|NCT00539006|454065328|FG000|Washout|Other|1|||
126212362|NCT00539006|454065329|FG001|Washout|Other|1|||
126212363|NCT00539006|454065330|FG002|Washout|Other|2|||
126212364|NCT00539006|454065331|FG003|Washout|Other|3|||
126212365|NCT00539006|454065328|FG000|Treatment Period 2|Protocol Violation|1|||
126212366|NCT00539006|454065329|FG001|Treatment Period 2|Protocol Violation|0|||
126212367|NCT00539006|454065330|FG002|Treatment Period 2|Protocol Violation|0|||
126212368|NCT00539006|454065331|FG003|Treatment Period 2|Protocol Violation|0|||
126212369|NCT00539006|454065328|FG000|Treatment Period 2|Other|0|||
126212370|NCT00539006|454065329|FG001|Treatment Period 2|Other|1|||
126212371|NCT00539006|454065330|FG002|Treatment Period 2|Other|0|||
126212372|NCT00539006|454065331|FG003|Treatment Period 2|Other|0|||
126212373|NCT02353572|454065332|FG000|Overall Study|Withdrawal by Subject|1|||
126212374|NCT02353572|454065332|FG000|Overall Study|Study terminated|2|||
126212375|NCT01283282|454065339|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
126212376|NCT01283282|454065340|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
126212377|NCT01283282|454065339|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
126212378|NCT01283282|454065340|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
126212379|NCT01283282|454065339|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
126212380|NCT01283282|454065340|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
126212381|NCT00777920|454065341|FG000|Overall Study|Adverse Event|39|||
126212382|NCT00777920|454065341|FG000|Overall Study|Withdrawal of Consent|4|||
126212383|NCT00777920|454065341|FG000|Overall Study|Lost to Follow-up|1|||
126212384|NCT00777920|454065341|FG000|Overall Study|Investigator's discretion|1|||
126212385|NCT00777920|454065341|FG000|Overall Study|Clinical status did not improve|1|||
126212386|NCT00777920|454065341|FG000|Overall Study|Other, not specified|4|||
126212387|NCT00483717|454065342|FG000|Overall Study|Protocol Violation|5|||
126212388|NCT00483717|454065343|FG001|Overall Study|Protocol Violation|7|||
126212389|NCT00483717|454065342|FG000|Overall Study|Time of dosing missing|1|||
126212390|NCT00483717|454065343|FG001|Overall Study|Time of dosing missing|1|||
126212391|NCT00483717|454065342|FG000|Overall Study|No treatment for migraine|16|||
126212392|NCT00483717|454065343|FG001|Overall Study|No treatment for migraine|13|||
126212393|NCT00483717|454065342|FG000|Overall Study|Lost to Follow-up|1|||
126212394|NCT00483717|454065343|FG001|Overall Study|Lost to Follow-up|0|||
126348338|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126348339|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
126212395|NCT00483717|454065342|FG000|Overall Study|Withdrawal by Subject|1|||
126212396|NCT00483717|454065343|FG001|Overall Study|Withdrawal by Subject|0|||
126212397|NCT03878108|454065344|FG000|Overall Study|Adverse Event|1|||
126212398|NCT03878108|454065345|FG001|Overall Study|Adverse Event|0|||
126212399|NCT01682681|454065346|FG000|Overall Study|Lack of Efficacy|62|||
126212400|NCT01682681|454065346|FG000|Overall Study|Withdrawal by Subject|1|||
126212401|NCT01682681|454065346|FG000|Overall Study|Moved to other hospital|10|||
126212402|NCT01682681|454065346|FG000|Overall Study|Lost to Follow-up|174|||
126212403|NCT01682681|454065346|FG000|Overall Study|Adverse Event|46|||
126212404|NCT01682681|454065346|FG000|Overall Study|tapering of topiramate|5|||
126212405|NCT01682681|454065346|FG000|Overall Study|Other|21|||
126212406|NCT01682681|454065346|FG000|Overall Study|Low compliance|13|||
126212407|NCT00975000|454065347|FG000|Overall Study|Other|1|||
126212408|NCT00975000|454065348|FG001|Overall Study|Other|0|||
126212409|NCT00975000|454065347|FG000|Overall Study|Adverse Event|1|||
126212410|NCT00975000|454065348|FG001|Overall Study|Adverse Event|1|||
126212411|NCT00975000|454065347|FG000|Overall Study|Withdrawal by Subject|2|||
126212412|NCT00975000|454065348|FG001|Overall Study|Withdrawal by Subject|2|||
126212413|NCT00975000|454065347|FG000|Overall Study|Lost to Follow-up|0|||
126212414|NCT00975000|454065348|FG001|Overall Study|Lost to Follow-up|1|||
126212415|NCT00975000|454065347|FG000|Overall Study|Protocol-specified Criteria|1|||
126212416|NCT00975000|454065348|FG001|Overall Study|Protocol-specified Criteria|0|||
126212417|NCT00975000|454065347|FG000|Overall Study|Non-compliance|0|||
126212418|NCT00975000|454065348|FG001|Overall Study|Non-compliance|1|||
126212419|NCT01525407|454065349|FG000|Overall Study|Change in recipient treatment plan|2|||
126212420|NCT01525407|454065350|FG001|Overall Study|Change in recipient treatment plan|2|||
126212421|NCT01525407|454065349|FG000|Overall Study|Withdrawal by Subject|0|||
126212422|NCT01525407|454065350|FG001|Overall Study|Withdrawal by Subject|1|||
126212423|NCT01525407|454065349|FG000|Overall Study|Transplant was delayed|0|||
126212424|NCT01525407|454065350|FG001|Overall Study|Transplant was delayed|1|||
126212425|NCT01525407|454065349|FG000|Overall Study|Delay in Transplant|1|||
126212426|NCT01525407|454065350|FG001|Overall Study|Delay in Transplant|0|||
126212427|NCT03505606|454066608|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
126212428|NCT03505606|454066609|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
126212429|NCT03505606|454066610|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
126212430|NCT03505606|454066608|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
126212431|NCT03505606|454066609|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
126212432|NCT03505606|454066610|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
126212433|NCT03505606|454066608|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
126212434|NCT03505606|454066609|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
126212435|NCT03505606|454066610|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
126212436|NCT03505606|454066608|FG000|Overall Study|Poor compliance with refractive correction|0|||
126212437|NCT03505606|454066609|FG001|Overall Study|Poor compliance with refractive correction|0|||
126212438|NCT03505606|454066610|FG002|Overall Study|Poor compliance with refractive correction|1|||
126212439|NCT03505606|454066608|FG000|Overall Study|Insufficient anisometropia|0|||
126212440|NCT03505606|454066609|FG001|Overall Study|Insufficient anisometropia|0|||
126212441|NCT03505606|454066610|FG002|Overall Study|Insufficient anisometropia|2|||
126212442|NCT03505606|454066608|FG000|Overall Study|Ectopia Lentis|0|||
126212443|NCT03505606|454066609|FG001|Overall Study|Ectopia Lentis|0|||
126212444|NCT03505606|454066610|FG002|Overall Study|Ectopia Lentis|1|||
126212445|NCT03505606|454066608|FG000|Overall Study|alternation of amblyopic eye|0|||
126212446|NCT03505606|454066609|FG001|Overall Study|alternation of amblyopic eye|1|||
126212447|NCT03505606|454066610|FG002|Overall Study|alternation of amblyopic eye|0|||
126212448|NCT00648739|454066622|FG000|Overall Study|Adverse Event|1|||
126212449|NCT00648739|454066623|FG001|Overall Study|Adverse Event|0|||
126212450|NCT00648739|454066624|FG002|Overall Study|Adverse Event|1|||
126212451|NCT00648739|454066625|FG003|Overall Study|Adverse Event|2|||
126212452|NCT00648739|454066626|FG004|Overall Study|Adverse Event|1|||
126212453|NCT00648739|454066627|FG005|Overall Study|Adverse Event|0|||
126212454|NCT00648739|454066628|FG006|Overall Study|Adverse Event|0|||
126212455|NCT00648739|454066622|FG000|Overall Study|Withdrawal by Subject|1|||
126212456|NCT00648739|454066623|FG001|Overall Study|Withdrawal by Subject|0|||
126212457|NCT00648739|454066624|FG002|Overall Study|Withdrawal by Subject|1|||
126212458|NCT00648739|454066625|FG003|Overall Study|Withdrawal by Subject|0|||
126212459|NCT00648739|454066626|FG004|Overall Study|Withdrawal by Subject|0|||
126212460|NCT00648739|454066627|FG005|Overall Study|Withdrawal by Subject|2|||
126212461|NCT00648739|454066628|FG006|Overall Study|Withdrawal by Subject|0|||
126212462|NCT00648739|454066622|FG000|Overall Study|Lack of Efficacy|0|||
126212463|NCT00648739|454066623|FG001|Overall Study|Lack of Efficacy|0|||
126212464|NCT00648739|454066624|FG002|Overall Study|Lack of Efficacy|0|||
126212465|NCT00648739|454066625|FG003|Overall Study|Lack of Efficacy|0|||
126212466|NCT00648739|454066626|FG004|Overall Study|Lack of Efficacy|1|||
126212467|NCT00648739|454066627|FG005|Overall Study|Lack of Efficacy|2|||
126212468|NCT00648739|454066628|FG006|Overall Study|Lack of Efficacy|0|||
126212469|NCT00648739|454066622|FG000|Overall Study|Investigator Considered it Advisable|0|||
126212470|NCT00648739|454066623|FG001|Overall Study|Investigator Considered it Advisable|0|||
126212471|NCT00648739|454066624|FG002|Overall Study|Investigator Considered it Advisable|0|||
126212472|NCT00648739|454066625|FG003|Overall Study|Investigator Considered it Advisable|0|||
126012895|NCT02914522|453341001|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
126012896|NCT02914522|453341002|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
126012897|NCT02914522|453341003|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
126012898|NCT02914522|453341004|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
126012899|NCT02914522|453341005|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
126012900|NCT02914522|453341006|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
126012901|NCT02914522|453341007|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
126012902|NCT02914522|453340997|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126012903|NCT02914522|453340998|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
126012904|NCT02914522|453340999|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
126012905|NCT02914522|453341000|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
126012906|NCT02914522|453341001|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126012907|NCT02914522|453341002|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126012908|NCT02914522|453341003|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126012909|NCT02914522|453341004|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126012910|NCT02914522|453341005|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126012911|NCT02914522|453341006|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126012912|NCT02914522|453341007|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126012913|NCT02914522|453340997|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012914|NCT02914522|453340998|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012915|NCT02914522|453340999|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012916|NCT02914522|453341000|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012917|NCT02914522|453341001|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
126012918|NCT02914522|453341002|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012919|NCT02914522|453341003|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012920|NCT02914522|453341004|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012921|NCT02914522|453341005|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012922|NCT02914522|453341006|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126212473|NCT00648739|454066626|FG004|Overall Study|Investigator Considered it Advisable|0|||
126212474|NCT00648739|454066627|FG005|Overall Study|Investigator Considered it Advisable|1|||
126212475|NCT00648739|454066628|FG006|Overall Study|Investigator Considered it Advisable|1|||
126212476|NCT00648739|454066622|FG000|Overall Study|Death|0|||
126012923|NCT02914522|453341007|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126012924|NCT02914522|453340997|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
126012925|NCT02914522|453340998|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126212477|NCT00648739|454066623|FG001|Overall Study|Death|1|||
126212478|NCT00648739|454066624|FG002|Overall Study|Death|0|||
126212479|NCT00648739|454066625|FG003|Overall Study|Death|0|||
126212480|NCT00648739|454066626|FG004|Overall Study|Death|0|||
126212481|NCT00648739|454066627|FG005|Overall Study|Death|0|||
126212482|NCT00648739|454066628|FG006|Overall Study|Death|0|||
126212483|NCT00648739|454066622|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
126212484|NCT00648739|454066623|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
126212485|NCT00648739|454066624|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
126212486|NCT00648739|454066625|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
126212487|NCT00648739|454066626|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
126212488|NCT00648739|454066627|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
126212489|NCT00648739|454066628|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
126212490|NCT00648739|454066622|FG000|Overall Study|Follow-up Visits Not Completed|0|||
126212491|NCT00648739|454066623|FG001|Overall Study|Follow-up Visits Not Completed|1|||
126212492|NCT00648739|454066624|FG002|Overall Study|Follow-up Visits Not Completed|0|||
126212493|NCT00648739|454066625|FG003|Overall Study|Follow-up Visits Not Completed|0|||
126212494|NCT00648739|454066626|FG004|Overall Study|Follow-up Visits Not Completed|0|||
126212495|NCT00648739|454066627|FG005|Overall Study|Follow-up Visits Not Completed|0|||
126212496|NCT00648739|454066628|FG006|Overall Study|Follow-up Visits Not Completed|0|||
126212497|NCT00242567|454066633|FG000|Overall Study|Adverse Event|70|||
126212498|NCT00242567|454066634|FG001|Overall Study|Adverse Event|43|||
126212499|NCT00242567|454066633|FG000|Overall Study|Disease Progression|17|||
126212500|NCT00242567|454066634|FG001|Overall Study|Disease Progression|22|||
126212501|NCT00242567|454066633|FG000|Overall Study|Symptomatic deterioration|9|||
126212502|NCT00242567|454066634|FG001|Overall Study|Symptomatic deterioration|3|||
126212503|NCT00242567|454066633|FG000|Overall Study|Lack of Efficacy|2|||
126212504|NCT00242567|454066634|FG001|Overall Study|Lack of Efficacy|2|||
126212505|NCT00242567|454066633|FG000|Overall Study|Lost to Follow-up|9|||
126212506|NCT00242567|454066634|FG001|Overall Study|Lost to Follow-up|19|||
126212507|NCT00242567|454066633|FG000|Overall Study|Withdrawal by Subject|33|||
126212508|NCT00242567|454066634|FG001|Overall Study|Withdrawal by Subject|28|||
126212509|NCT00242567|454066633|FG000|Overall Study|Protocol Violation|12|||
126212510|NCT00242567|454066634|FG001|Overall Study|Protocol Violation|12|||
126212511|NCT00242567|454066633|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
126212512|NCT00242567|454066634|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
126212513|NCT00242567|454066633|FG000|Overall Study|Other|14|||
126212514|NCT00242567|454066634|FG001|Overall Study|Other|9|||
126212515|NCT04930536|454066637|FG000|Overall Study|Adverse Event|1|||
126212516|NCT04930536|454066638|FG001|Overall Study|Adverse Event|0|||
126212517|NCT04930536|454066637|FG000|Overall Study|Disease Progression|2|||
126212518|NCT04930536|454066638|FG001|Overall Study|Disease Progression|0|||
126212519|NCT04930536|454066637|FG000|Overall Study|Patient Decision|4|||
126212520|NCT04930536|454066638|FG001|Overall Study|Patient Decision|2|||
126212521|NCT04930536|454066637|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
126212522|NCT04930536|454066638|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
126212523|NCT01432600|454066639|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
126212524|NCT01432600|454066640|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
126212525|NCT01432600|454066641|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
126212526|NCT01036594|454066643|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
126212527|NCT01036594|454066644|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
126212528|NCT01036594|454066643|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
126212529|NCT01036594|454066644|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
126212530|NCT01036594|454066643|FG000|Week 12 Evaluation|Adverse Event|5|||
126212531|NCT01036594|454066644|FG001|Week 12 Evaluation|Adverse Event|0|||
126212532|NCT01036594|454066643|FG000|Week 12 Evaluation|Physician Decision|1|||
126212533|NCT01036594|454066644|FG001|Week 12 Evaluation|Physician Decision|0|||
126212534|NCT01036594|454066643|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
126212535|NCT01036594|454066644|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
126212536|NCT01036594|454066643|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
126212537|NCT01036594|454066644|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
126212538|NCT01036594|454066643|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
126212539|NCT01036594|454066644|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
126212540|NCT01036594|454066643|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
126212541|NCT01036594|454066644|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
126212542|NCT01036594|454066643|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
126212543|NCT01036594|454066644|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
126212544|NCT01244516|454066647|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
126212545|NCT01244516|454066648|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
126212546|NCT01244516|454066649|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
126212547|NCT01244516|454066647|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
126212548|NCT01244516|454066648|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
126212549|NCT01244516|454066649|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
126212550|NCT01244516|454066647|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
126212551|NCT01244516|454066648|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
126212552|NCT01244516|454066649|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
126212553|NCT01244516|454066647|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
126212554|NCT01244516|454066648|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
126212555|NCT01244516|454066649|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
126212556|NCT01244516|454066647|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
126212557|NCT01244516|454066648|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
126212558|NCT01244516|454066649|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
126212559|NCT01244516|454066647|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
126212560|NCT01244516|454066648|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
126212561|NCT01244516|454066649|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
126212562|NCT01244516|454066647|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
126212563|NCT01244516|454066648|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
126212564|NCT01244516|454066649|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
126212565|NCT00244881|454066653|FG000|Overall Study|Withdrawal by Subject|3|||
126212566|NCT03664024|454066657|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
126212567|NCT03664024|454066657|FG000|Overall Study|Lost to Follow-up|2|||
126212568|NCT03664024|454066657|FG000|Overall Study|Withdrawal by Subject|2|||
126212569|NCT03664024|454066657|FG000|Overall Study|Death|80|||
126212570|NCT03159611|454066658|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
126212571|NCT03159611|454066659|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
126212572|NCT03159611|454066658|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
126212573|NCT03159611|454066659|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
126212574|NCT03159611|454066658|FG000|Overall Study|Protocol Violation|7|||
126212575|NCT03159611|454066659|FG001|Overall Study|Protocol Violation|4|||
126212576|NCT03159611|454066658|FG000|Overall Study|Adverse Event|1|||
126212577|NCT03159611|454066659|FG001|Overall Study|Adverse Event|0|||
126212578|NCT03159611|454066658|FG000|Overall Study|Withdrawal by Subject|1|||
126212579|NCT03159611|454066659|FG001|Overall Study|Withdrawal by Subject|1|||
126212580|NCT03159611|454066658|FG000|Overall Study|Non-compliance with protocol requirement|3|||
126212581|NCT03159611|454066659|FG001|Overall Study|Non-compliance with protocol requirement|2|||
126212582|NCT03159611|454066658|FG000|Overall Study|Inability to perform procedures|1|||
126212583|NCT03159611|454066659|FG001|Overall Study|Inability to perform procedures|0|||
126212584|NCT02057549|454066661|FG000|Overall Study|Lost to Follow-up|1|||
126212585|NCT02057549|454066662|FG001|Overall Study|Lost to Follow-up|0|||
126212586|NCT02057549|454066661|FG000|Overall Study|Physician Decision|1|||
126212587|NCT02057549|454066662|FG001|Overall Study|Physician Decision|0|||
126212588|NCT02057549|454066661|FG000|Overall Study|Withdrawal by Subject|1|||
126212589|NCT02057549|454066662|FG001|Overall Study|Withdrawal by Subject|0|||
126212590|NCT01418365|454066663|FG000|First Intervention|Withdrawal by Subject|0|||
126212591|NCT01418365|454066664|FG001|First Intervention|Withdrawal by Subject|1|||
126212592|NCT01418365|454066663|FG000|First Intervention|Non-compliance|1|||
126212593|NCT01418365|454066664|FG001|First Intervention|Non-compliance|0|||
126212594|NCT01418365|454066663|FG000|Second Intervention|Withdrawal by Subject|0|||
126212595|NCT01418365|454066664|FG001|Second Intervention|Withdrawal by Subject|1|||
126212596|NCT03319368|454066665|FG000|Overall Study|Discharge swabs not collected from resident|57|||
126212597|NCT03319368|454066666|FG001|Overall Study|Discharge swabs not collected from resident|46|||
126212598|NCT03000075|454066667|FG000|Part A|Adverse Event|4|||
126212599|NCT03000075|454066668|FG001|Part A|Adverse Event|0|||
126212600|NCT03000075|454066669|FG002|Part A|Adverse Event|0|||
126212601|NCT03000075|454066670|FG003|Part A|Adverse Event|0|||
126212602|NCT03000075|454066671|FG004|Part A|Adverse Event|0|||
126212603|NCT03000075|454066672|FG005|Part A|Adverse Event|0|||
126212604|NCT03000075|454066673|FG006|Part A|Adverse Event|0|||
126212605|NCT03000075|454066667|FG000|Part B|Not dosed due to AE|0|||
126212606|NCT03000075|454066668|FG001|Part B|Not dosed due to AE|0|||
126212607|NCT03000075|454066669|FG002|Part B|Not dosed due to AE|0|||
126012926|NCT02914522|453340999|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126212608|NCT03000075|454066670|FG003|Part B|Not dosed due to AE|0|||
126212609|NCT03000075|454066671|FG004|Part B|Not dosed due to AE|0|||
126212610|NCT03000075|454066672|FG005|Part B|Not dosed due to AE|2|||
126212611|NCT03000075|454066673|FG006|Part B|Not dosed due to AE|1|||
126212612|NCT03000075|454066667|FG000|Part B|Adverse Event|0|||
126212613|NCT03000075|454066668|FG001|Part B|Adverse Event|0|||
126212614|NCT03000075|454066669|FG002|Part B|Adverse Event|0|||
126212615|NCT03000075|454066670|FG003|Part B|Adverse Event|0|||
126212616|NCT03000075|454066671|FG004|Part B|Adverse Event|1|||
126212617|NCT03000075|454066672|FG005|Part B|Adverse Event|0|||
126212618|NCT03000075|454066673|FG006|Part B|Adverse Event|0|||
126212619|NCT00440193|454066674|FG000|Treatment Period|Adverse Event|74|||
126212620|NCT00440193|454066675|FG001|Treatment Period|Adverse Event|67|||
126212621|NCT00440193|454066674|FG000|Treatment Period|Death|19|||
126212622|NCT00440193|454066675|FG001|Treatment Period|Death|22|||
126212623|NCT00440193|454066674|FG000|Treatment Period|Lack of Efficacy|0|||
126212624|NCT00440193|454066675|FG001|Treatment Period|Lack of Efficacy|1|||
126212625|NCT00440193|454066674|FG000|Treatment Period|Lost to Follow-up|12|||
126212626|NCT00440193|454066675|FG001|Treatment Period|Lost to Follow-up|18|||
126212627|NCT00440193|454066674|FG000|Treatment Period|Physician Decision|3|||
126212628|NCT00440193|454066675|FG001|Treatment Period|Physician Decision|6|||
126212629|NCT00440193|454066674|FG000|Treatment Period|Protocol Violation|16|||
126212630|NCT00440193|454066675|FG001|Treatment Period|Protocol Violation|19|||
126212631|NCT00440193|454066674|FG000|Treatment Period|Withdrawal by Subject|36|||
126212632|NCT00440193|454066675|FG001|Treatment Period|Withdrawal by Subject|77|||
126212633|NCT00440193|454066674|FG000|Treatment Period|Clinical endpoint reached|28|||
126212634|NCT00440193|454066675|FG001|Treatment Period|Clinical endpoint reached|25|||
126212635|NCT00440193|454066674|FG000|Treatment Period|Study terminated by sponsor|102|||
126212636|NCT00440193|454066675|FG001|Treatment Period|Study terminated by sponsor|94|||
126212637|NCT00440193|454066674|FG000|Treatment Period|Protocol driven decision point|2|||
126212638|NCT00440193|454066675|FG001|Treatment Period|Protocol driven decision point|2|||
126212639|NCT00440193|454066674|FG000|Treatment Period|Switch to commercial drug|0|||
126212640|NCT00440193|454066675|FG001|Treatment Period|Switch to commercial drug|2|||
126212641|NCT00440193|454066674|FG000|Treatment Period|Technical problems|1|||
126212642|NCT00440193|454066675|FG001|Treatment Period|Technical problems|1|||
126212643|NCT00440193|454066674|FG000|Treatment Period|Participant convenience|5|||
126212644|NCT00440193|454066675|FG001|Treatment Period|Participant convenience|2|||
126212645|NCT00440193|454066674|FG000|Treatment Period|Participant did not receive treatment|7|||
126212646|NCT00440193|454066675|FG001|Treatment Period|Participant did not receive treatment|13|||
126212647|NCT00440193|454066674|FG000|Treatment Period|Site closed by investigator|0|||
126212648|NCT00440193|454066675|FG001|Treatment Period|Site closed by investigator|2|||
126212649|NCT00440193|454066674|FG000|Observational Period|Adverse Event|2|||
126212650|NCT00440193|454066675|FG001|Observational Period|Adverse Event|2|||
126212651|NCT00440193|454066674|FG000|Observational Period|Death|15|||
126212652|NCT00440193|454066675|FG001|Observational Period|Death|20|||
126212653|NCT00440193|454066674|FG000|Observational Period|Lost to Follow-up|12|||
126212654|NCT00440193|454066675|FG001|Observational Period|Lost to Follow-up|8|||
126212655|NCT00440193|454066674|FG000|Observational Period|Protocol Violation|1|||
126212656|NCT00440193|454066675|FG001|Observational Period|Protocol Violation|0|||
126212657|NCT00440193|454066674|FG000|Observational Period|Withdrawal by Subject|11|||
126212658|NCT00440193|454066675|FG001|Observational Period|Withdrawal by Subject|8|||
126212659|NCT00440193|454066674|FG000|Observational Period|Physician Decision|1|||
126212660|NCT00440193|454066675|FG001|Observational Period|Physician Decision|0|||
126212661|NCT00440193|454066674|FG000|Observational Period|Clinical endpoint reached|1|||
126212662|NCT00440193|454066675|FG001|Observational Period|Clinical endpoint reached|0|||
126212663|NCT00440193|454066674|FG000|Observational Period|Participant convenience|2|||
126212664|NCT00440193|454066675|FG001|Observational Period|Participant convenience|0|||
126212665|NCT00530621|454066681|FG000|Overall Study|Adverse Event|11|||
126212666|NCT00530621|454066682|FG001|Overall Study|Adverse Event|8|||
126212667|NCT00530621|454066681|FG000|Overall Study|Physician Decision|2|||
126212668|NCT00530621|454066682|FG001|Overall Study|Physician Decision|4|||
126348340|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126348341|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
126348342|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126348343|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126348344|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Physician Decision|0|||
126348345|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Physician Decision|0|||
126348346|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Physician Decision|0|||
126348347|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Physician Decision|0|||
126348348|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Physician Decision|1|||
126348349|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Physician Decision|0|||
126091144|NCT02218606|453628349|FG001|Overall Study|Adverse Event|1|||
126212669|NCT00530621|454066681|FG000|Overall Study|Progressive Disease (PD)|47|||
126212670|NCT00530621|454066682|FG001|Overall Study|Progressive Disease (PD)|40|||
126012927|NCT02914522|453341000|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126012928|NCT02914522|453341001|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126012929|NCT02914522|453341002|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126012930|NCT02914522|453341003|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126012931|NCT02914522|453341004|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126012932|NCT02914522|453341005|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126012933|NCT02914522|453341006|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126012934|NCT02914522|453341007|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126012935|NCT02914522|453340997|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
126012936|NCT02914522|453340998|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
126012937|NCT02914522|453340999|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
126012938|NCT02914522|453341000|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
126012939|NCT02914522|453341001|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
126012940|NCT02914522|453341002|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
126012941|NCT02914522|453341003|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
126012942|NCT02914522|453341004|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
126012943|NCT02914522|453341005|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
126012944|NCT02914522|453341006|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
126012945|NCT02914522|453341007|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
126012946|NCT02914522|453340997|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126012947|NCT02914522|453340998|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
126012948|NCT02914522|453340999|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126012949|NCT02914522|453341000|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126012950|NCT02914522|453341001|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
126012951|NCT02914522|453341002|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
126012952|NCT02914522|453341003|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126012953|NCT02914522|453341004|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126012954|NCT02914522|453341005|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126012955|NCT02914522|453341006|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126012956|NCT02914522|453341007|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126012957|NCT02914522|453340997|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126012958|NCT02914522|453340998|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126012959|NCT02914522|453340999|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126012960|NCT02914522|453341000|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126212671|NCT00530621|454066681|FG000|Overall Study|Sponsor Decision|12|||
126212672|NCT00530621|454066682|FG001|Overall Study|Sponsor Decision|15|||
126012961|NCT02914522|453341001|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126012962|NCT02914522|453341002|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126012963|NCT02914522|453341003|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
126012964|NCT02914522|453341004|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
126012965|NCT02914522|453341005|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
126212673|NCT00530621|454066681|FG000|Overall Study|Subject Decision|4|||
126212674|NCT00530621|454066682|FG001|Overall Study|Subject Decision|7|||
126212675|NCT00530621|454066681|FG000|Overall Study|Death|3|||
126212676|NCT00530621|454066682|FG001|Overall Study|Death|6|||
126212677|NCT00530621|454066681|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
126212678|NCT00530621|454066682|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
126212679|NCT03409328|454066683|FG000|Overall Study|Lost to Follow-up|6|||
126212680|NCT03409328|454066684|FG001|Overall Study|Lost to Follow-up|3|||
126212681|NCT00518011|454066685|FG000|Overall Study|Death|1|||
126212682|NCT00518011|454066686|FG001|Overall Study|Death|1|||
126212683|NCT00518011|454066685|FG000|Overall Study|Adverse Event|2|||
126212684|NCT00518011|454066686|FG001|Overall Study|Adverse Event|3|||
126212685|NCT00518011|454066685|FG000|Overall Study|Disease Progression|2|||
126212686|NCT00518011|454066686|FG001|Overall Study|Disease Progression|2|||
126212687|NCT00518011|454066685|FG000|Overall Study|Other Reasons|3|||
126212688|NCT00518011|454066686|FG001|Overall Study|Other Reasons|2|||
126212689|NCT00518011|454066685|FG000|Overall Study|Withdrawal by Subject|1|||
126212690|NCT00518011|454066686|FG001|Overall Study|Withdrawal by Subject|0|||
126348350|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Physician Decision|0|||
126348351|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
126212691|NCT03930615|454066689|FG000|Overall Study|Death|9|||
126212692|NCT03930615|454066690|FG001|Overall Study|Death|3|||
126348352|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
126348353|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
126348354|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
126348355|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
126348356|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
126348357|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
126348358|NCT01136915|454570996|FG000|Overall Study|Lost to Follow-up|2|||
126348359|NCT01136915|454570997|FG001|Overall Study|Lost to Follow-up|0|||
126212693|NCT03930615|454066689|FG000|Overall Study|Lost to Follow-up|1|||
126348360|NCT01136915|454570996|FG000|Overall Study|Exclusion criterion met|0|||
126212694|NCT03930615|454066690|FG001|Overall Study|Lost to Follow-up|2|||
126212695|NCT03930615|454066689|FG000|Overall Study|Physician Decision|3|||
126212696|NCT03930615|454066690|FG001|Overall Study|Physician Decision|4|||
126212697|NCT03930615|454066689|FG000|Overall Study|Withdrawal by Subject|13|||
126212698|NCT03930615|454066690|FG001|Overall Study|Withdrawal by Subject|2|||
126212699|NCT03930615|454066689|FG000|Overall Study|Not treated|1|||
126212700|NCT03930615|454066690|FG001|Overall Study|Not treated|1|||
126212701|NCT04797637|454066696|FG000|Overall Study|Lost to Follow-up|23|||
126212702|NCT04797637|454066697|FG001|Overall Study|Lost to Follow-up|32|||
126212703|NCT04797637|454066696|FG000|Overall Study|Withdrawal by Subject|0|||
126212704|NCT04797637|454066697|FG001|Overall Study|Withdrawal by Subject|1|||
126212705|NCT01023022|454066700|FG000|Overall Study|Death|5|||
126212706|NCT01023022|454066700|FG000|Overall Study|Lost to Follow-up|7|||
126212707|NCT01023022|454066700|FG000|Overall Study|due to technical issues|2|||
126212708|NCT03917654|454066701|FG000|Year 1|Withdrawal by Subject|1|||
126212709|NCT03917654|454066702|FG001|Year 1|Withdrawal by Subject|0|||
126212710|NCT03917654|454066703|FG002|Year 1|Withdrawal by Subject|0|||
126212711|NCT03917654|454066704|FG003|Year 1|Withdrawal by Subject|0|||
126212712|NCT03917654|454066705|FG004|Year 1|Withdrawal by Subject|0|||
126212713|NCT03917654|454066706|FG005|Year 1|Withdrawal by Subject|1|||
126212714|NCT03917654|454066707|FG006|Year 1|Withdrawal by Subject|6|||
126212715|NCT03917654|454066708|FG007|Year 1|Withdrawal by Subject|2|||
126212716|NCT03917654|454066709|FG008|Year 1|Withdrawal by Subject|5|||
126212717|NCT03917654|454066710|FG009|Year 1|Withdrawal by Subject|3|||
126212718|NCT03917654|454066711|FG010|Year 1|Withdrawal by Subject|1|||
126212719|NCT03917654|454066712|FG011|Year 1|Withdrawal by Subject|0|||
126212720|NCT03917654|454066701|FG000|Year 1|Travel|0|||
126212721|NCT03917654|454066702|FG001|Year 1|Travel|1|||
126212722|NCT03917654|454066703|FG002|Year 1|Travel|1|||
126212723|NCT03917654|454066704|FG003|Year 1|Travel|0|||
126212724|NCT03917654|454066705|FG004|Year 1|Travel|4|||
126212725|NCT03917654|454066706|FG005|Year 1|Travel|4|||
126212726|NCT03917654|454066707|FG006|Year 1|Travel|10|||
126212727|NCT03917654|454066708|FG007|Year 1|Travel|8|||
126212728|NCT03917654|454066709|FG008|Year 1|Travel|2|||
126212729|NCT03917654|454066710|FG009|Year 1|Travel|5|||
126212730|NCT03917654|454066711|FG010|Year 1|Travel|3|||
126212731|NCT03917654|454066712|FG011|Year 1|Travel|3|||
126212732|NCT03917654|454066701|FG000|Year 1|Subject moved away from site|0|||
126212733|NCT03917654|454066702|FG001|Year 1|Subject moved away from site|1|||
126212734|NCT03917654|454066703|FG002|Year 1|Subject moved away from site|0|||
126212735|NCT03917654|454066704|FG003|Year 1|Subject moved away from site|0|||
126212736|NCT03917654|454066705|FG004|Year 1|Subject moved away from site|0|||
126212737|NCT03917654|454066706|FG005|Year 1|Subject moved away from site|0|||
126212738|NCT03917654|454066707|FG006|Year 1|Subject moved away from site|1|||
126212739|NCT03917654|454066708|FG007|Year 1|Subject moved away from site|2|||
126212740|NCT03917654|454066709|FG008|Year 1|Subject moved away from site|1|||
126212741|NCT03917654|454066710|FG009|Year 1|Subject moved away from site|0|||
126212742|NCT03917654|454066711|FG010|Year 1|Subject moved away from site|0|||
126212743|NCT03917654|454066712|FG011|Year 1|Subject moved away from site|3|||
126212744|NCT03917654|454066701|FG000|Year 1|Spouse/Family member request|0|||
126212745|NCT03917654|454066702|FG001|Year 1|Spouse/Family member request|0|||
126212746|NCT03917654|454066703|FG002|Year 1|Spouse/Family member request|1|||
126212747|NCT03917654|454066704|FG003|Year 1|Spouse/Family member request|0|||
126212748|NCT03917654|454066705|FG004|Year 1|Spouse/Family member request|1|||
126212749|NCT03917654|454066706|FG005|Year 1|Spouse/Family member request|0|||
126212750|NCT03917654|454066707|FG006|Year 1|Spouse/Family member request|0|||
126212751|NCT03917654|454066708|FG007|Year 1|Spouse/Family member request|2|||
126212752|NCT03917654|454066709|FG008|Year 1|Spouse/Family member request|0|||
126212753|NCT03917654|454066710|FG009|Year 1|Spouse/Family member request|0|||
126212754|NCT03917654|454066711|FG010|Year 1|Spouse/Family member request|0|||
126212755|NCT03917654|454066712|FG011|Year 1|Spouse/Family member request|1|||
126212756|NCT03917654|454066701|FG000|Year 1|Death|0|||
126348361|NCT01136915|454570997|FG001|Overall Study|Exclusion criterion met|1|||
126348362|NCT05376358|454571000|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
126348363|NCT05376358|454571001|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
126348364|NCT05376358|454571000|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
126348365|NCT05376358|454571001|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
126348366|NCT05376358|454571000|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
126212757|NCT03917654|454066702|FG001|Year 1|Death|0|||
126212758|NCT03917654|454066703|FG002|Year 1|Death|0|||
126212759|NCT03917654|454066704|FG003|Year 1|Death|0|||
126212760|NCT03917654|454066705|FG004|Year 1|Death|0|||
126212761|NCT03917654|454066706|FG005|Year 1|Death|0|||
126212762|NCT03917654|454066707|FG006|Year 1|Death|0|||
126212763|NCT03917654|454066708|FG007|Year 1|Death|0|||
126212764|NCT03917654|454066709|FG008|Year 1|Death|1|||
126212765|NCT03917654|454066710|FG009|Year 1|Death|1|||
126212766|NCT03917654|454066711|FG010|Year 1|Death|0|||
126212767|NCT03917654|454066712|FG011|Year 1|Death|0|||
126212768|NCT03917654|454066701|FG000|Year 1|Lost to Follow-up|0|||
126212769|NCT03917654|454066702|FG001|Year 1|Lost to Follow-up|0|||
126212770|NCT03917654|454066703|FG002|Year 1|Lost to Follow-up|0|||
126212771|NCT03917654|454066704|FG003|Year 1|Lost to Follow-up|0|||
126212772|NCT03917654|454066705|FG004|Year 1|Lost to Follow-up|0|||
126212773|NCT03917654|454066706|FG005|Year 1|Lost to Follow-up|0|||
126212774|NCT03917654|454066707|FG006|Year 1|Lost to Follow-up|2|||
126212775|NCT03917654|454066708|FG007|Year 1|Lost to Follow-up|0|||
126212776|NCT03917654|454066709|FG008|Year 1|Lost to Follow-up|0|||
126212777|NCT03917654|454066710|FG009|Year 1|Lost to Follow-up|0|||
126212778|NCT03917654|454066711|FG010|Year 1|Lost to Follow-up|0|||
126212779|NCT03917654|454066712|FG011|Year 1|Lost to Follow-up|0|||
126212780|NCT03917654|454066701|FG000|Year 1|Missed visits|0|||
126212781|NCT03917654|454066702|FG001|Year 1|Missed visits|0|||
126212782|NCT03917654|454066703|FG002|Year 1|Missed visits|0|||
126212783|NCT03917654|454066704|FG003|Year 1|Missed visits|0|||
126212784|NCT03917654|454066705|FG004|Year 1|Missed visits|0|||
126212785|NCT03917654|454066706|FG005|Year 1|Missed visits|0|||
126212786|NCT03917654|454066707|FG006|Year 1|Missed visits|0|||
126212787|NCT03917654|454066708|FG007|Year 1|Missed visits|0|||
126212788|NCT03917654|454066709|FG008|Year 1|Missed visits|0|||
126212789|NCT03917654|454066710|FG009|Year 1|Missed visits|0|||
126212790|NCT03917654|454066711|FG010|Year 1|Missed visits|1|||
126212791|NCT03917654|454066712|FG011|Year 1|Missed visits|1|||
126212792|NCT03917654|454066701|FG000|Year 1|Pregnancy|0|||
126212793|NCT03917654|454066702|FG001|Year 1|Pregnancy|0|||
126212794|NCT03917654|454066703|FG002|Year 1|Pregnancy|0|||
126212795|NCT03917654|454066704|FG003|Year 1|Pregnancy|0|||
126212796|NCT03917654|454066705|FG004|Year 1|Pregnancy|0|||
126212797|NCT03917654|454066706|FG005|Year 1|Pregnancy|0|||
126212798|NCT03917654|454066707|FG006|Year 1|Pregnancy|0|||
126212799|NCT03917654|454066708|FG007|Year 1|Pregnancy|1|||
126212800|NCT03917654|454066709|FG008|Year 1|Pregnancy|0|||
126348367|NCT05376358|454571001|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
126348368|NCT05376358|454571000|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
126348369|NCT05376358|454571001|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
126348370|NCT05376358|454571000|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
126348371|NCT05376358|454571001|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
126348372|NCT05376358|454571000|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
126348373|NCT05376358|454571001|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
126348374|NCT02213926|454571002|FG000|Overall Study|Death|59|||
126348375|NCT02213926|454571002|FG000|Overall Study|Withdrawal by Subject|10|||
126348376|NCT02213926|454571002|FG000|Overall Study|study terminated by sponsor|51|||
126348377|NCT02213926|454571002|FG000|Overall Study|Lost to Follow-up|3|||
126348378|NCT02213926|454571002|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
126348379|NCT01044498|454571007|FG000|Overall Study|Withdrew consent|1|||
126348380|NCT01044498|454571008|FG001|Overall Study|Withdrew consent|1|||
126348381|NCT01044498|454571007|FG000|Overall Study|Adverse Event|1|||
126348382|NCT01044498|454571008|FG001|Overall Study|Adverse Event|1|||
126348383|NCT01044498|454571007|FG000|Overall Study|Other|1|||
126348384|NCT01044498|454571008|FG001|Overall Study|Other|0|||
126348385|NCT02327078|454571013|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
126348386|NCT02327078|454571014|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
126348387|NCT02327078|454571015|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
126348388|NCT02327078|454571016|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
126348389|NCT02327078|454571017|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
126348390|NCT02327078|454571018|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
126348391|NCT02327078|454571019|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
126348392|NCT02327078|454571020|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
126348393|NCT02327078|454571021|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
126348394|NCT02327078|454571013|FG000|Overall Study|Death|2|||
126348395|NCT02327078|454571014|FG001|Overall Study|Death|4|||
126348396|NCT02327078|454571015|FG002|Overall Study|Death|10|||
126348397|NCT02327078|454571016|FG003|Overall Study|Death|6|||
126348398|NCT02327078|454571017|FG004|Overall Study|Death|4|||
126348399|NCT02327078|454571018|FG005|Overall Study|Death|3|||
126348400|NCT02327078|454571019|FG006|Overall Study|Death|2|||
126348401|NCT02327078|454571020|FG007|Overall Study|Death|51|||
126348402|NCT02327078|454571021|FG008|Overall Study|Death|97|||
126212801|NCT03917654|454066710|FG009|Year 1|Pregnancy|1|||
126212802|NCT03917654|454066711|FG010|Year 1|Pregnancy|0|||
126212803|NCT03917654|454066712|FG011|Year 1|Pregnancy|0|||
126212804|NCT03917654|454066701|FG000|Year 2|Travel|1|||
126212805|NCT03917654|454066702|FG001|Year 2|Travel|0|||
126212806|NCT03917654|454066703|FG002|Year 2|Travel|0|||
126212807|NCT03917654|454066704|FG003|Year 2|Travel|0|||
126212808|NCT03917654|454066705|FG004|Year 2|Travel|1|||
126212809|NCT03917654|454066706|FG005|Year 2|Travel|1|||
126212810|NCT03917654|454066707|FG006|Year 2|Travel|2|||
126212811|NCT03917654|454066708|FG007|Year 2|Travel|1|||
126212812|NCT03917654|454066709|FG008|Year 2|Travel|0|||
126212813|NCT03917654|454066710|FG009|Year 2|Travel|1|||
126212814|NCT03917654|454066711|FG010|Year 2|Travel|0|||
126212815|NCT03917654|454066712|FG011|Year 2|Travel|1|||
126212816|NCT03917654|454066701|FG000|Year 2|Married|1|||
126212817|NCT03917654|454066702|FG001|Year 2|Married|0|||
126212818|NCT03917654|454066703|FG002|Year 2|Married|0|||
126212819|NCT03917654|454066704|FG003|Year 2|Married|0|||
126212820|NCT03917654|454066705|FG004|Year 2|Married|0|||
126212821|NCT03917654|454066706|FG005|Year 2|Married|0|||
126212822|NCT03917654|454066707|FG006|Year 2|Married|1|||
126212823|NCT03917654|454066708|FG007|Year 2|Married|1|||
126212824|NCT03917654|454066709|FG008|Year 2|Married|0|||
126212825|NCT03917654|454066710|FG009|Year 2|Married|0|||
126212826|NCT03917654|454066711|FG010|Year 2|Married|0|||
126212827|NCT03917654|454066712|FG011|Year 2|Married|0|||
126212828|NCT03917654|454066701|FG000|Year 2|Subject moved away from site|1|||
126212829|NCT03917654|454066702|FG001|Year 2|Subject moved away from site|0|||
126212830|NCT03917654|454066703|FG002|Year 2|Subject moved away from site|0|||
126212831|NCT03917654|454066704|FG003|Year 2|Subject moved away from site|0|||
126212832|NCT03917654|454066705|FG004|Year 2|Subject moved away from site|1|||
126212833|NCT03917654|454066706|FG005|Year 2|Subject moved away from site|0|||
126212834|NCT03917654|454066707|FG006|Year 2|Subject moved away from site|2|||
126212835|NCT03917654|454066708|FG007|Year 2|Subject moved away from site|3|||
126212836|NCT03917654|454066709|FG008|Year 2|Subject moved away from site|0|||
126212837|NCT03917654|454066710|FG009|Year 2|Subject moved away from site|2|||
126212838|NCT03917654|454066711|FG010|Year 2|Subject moved away from site|0|||
126212839|NCT03917654|454066712|FG011|Year 2|Subject moved away from site|1|||
126212840|NCT03917654|454066701|FG000|Year 2|Year 2 Screening failure|0|||
126212841|NCT03917654|454066702|FG001|Year 2|Year 2 Screening failure|1|||
126212842|NCT03917654|454066703|FG002|Year 2|Year 2 Screening failure|0|||
126212843|NCT03917654|454066704|FG003|Year 2|Year 2 Screening failure|0|||
126212844|NCT03917654|454066705|FG004|Year 2|Year 2 Screening failure|2|||
126212845|NCT03917654|454066706|FG005|Year 2|Year 2 Screening failure|0|||
126212846|NCT03917654|454066707|FG006|Year 2|Year 2 Screening failure|4|||
126212847|NCT03917654|454066708|FG007|Year 2|Year 2 Screening failure|3|||
126212848|NCT03917654|454066709|FG008|Year 2|Year 2 Screening failure|10|||
126212849|NCT03917654|454066710|FG009|Year 2|Year 2 Screening failure|2|||
126212850|NCT03917654|454066711|FG010|Year 2|Year 2 Screening failure|1|||
126212851|NCT03917654|454066712|FG011|Year 2|Year 2 Screening failure|1|||
126212852|NCT03917654|454066701|FG000|Year 2|Death|0|||
126212853|NCT03917654|454066702|FG001|Year 2|Death|0|||
126212854|NCT03917654|454066703|FG002|Year 2|Death|0|||
126212855|NCT03917654|454066704|FG003|Year 2|Death|0|||
126212856|NCT03917654|454066705|FG004|Year 2|Death|0|||
126212857|NCT03917654|454066706|FG005|Year 2|Death|1|||
126212858|NCT03917654|454066707|FG006|Year 2|Death|0|||
126212859|NCT03917654|454066708|FG007|Year 2|Death|0|||
126212860|NCT03917654|454066709|FG008|Year 2|Death|1|||
126212861|NCT03917654|454066710|FG009|Year 2|Death|1|||
126212862|NCT03917654|454066711|FG010|Year 2|Death|0|||
126348403|NCT02327078|454571013|FG000|Overall Study|Lost to Follow-up|0|||
126348404|NCT02327078|454571014|FG001|Overall Study|Lost to Follow-up|1|||
126348405|NCT02327078|454571015|FG002|Overall Study|Lost to Follow-up|1|||
126348406|NCT02327078|454571016|FG003|Overall Study|Lost to Follow-up|0|||
126348407|NCT02327078|454571017|FG004|Overall Study|Lost to Follow-up|0|||
126348408|NCT02327078|454571018|FG005|Overall Study|Lost to Follow-up|0|||
126348409|NCT02327078|454571019|FG006|Overall Study|Lost to Follow-up|0|||
126348410|NCT02327078|454571020|FG007|Overall Study|Lost to Follow-up|2|||
126348411|NCT02327078|454571021|FG008|Overall Study|Lost to Follow-up|5|||
126348412|NCT02327078|454571013|FG000|Overall Study|Site Terminated by Sponsor|1|||
126348413|NCT02327078|454571014|FG001|Overall Study|Site Terminated by Sponsor|0|||
126212863|NCT03917654|454066712|FG011|Year 2|Death|0|||
126212864|NCT03917654|454066701|FG000|Year 2|Withdrawal by Subject|0|||
126212865|NCT03917654|454066702|FG001|Year 2|Withdrawal by Subject|0|||
126212866|NCT03917654|454066703|FG002|Year 2|Withdrawal by Subject|0|||
126212867|NCT03917654|454066704|FG003|Year 2|Withdrawal by Subject|0|||
126212868|NCT03917654|454066705|FG004|Year 2|Withdrawal by Subject|0|||
126212869|NCT03917654|454066706|FG005|Year 2|Withdrawal by Subject|0|||
126212870|NCT03917654|454066707|FG006|Year 2|Withdrawal by Subject|3|||
126348414|NCT02327078|454571015|FG002|Overall Study|Site Terminated by Sponsor|1|||
126212871|NCT03917654|454066708|FG007|Year 2|Withdrawal by Subject|0|||
126212872|NCT03917654|454066709|FG008|Year 2|Withdrawal by Subject|2|||
126212873|NCT03917654|454066710|FG009|Year 2|Withdrawal by Subject|5|||
126212874|NCT03917654|454066711|FG010|Year 2|Withdrawal by Subject|0|||
126212875|NCT03917654|454066712|FG011|Year 2|Withdrawal by Subject|0|||
126212876|NCT03917654|454066701|FG000|Year 2|Spouse/family member request|0|||
126212877|NCT03917654|454066702|FG001|Year 2|Spouse/family member request|0|||
126212878|NCT03917654|454066703|FG002|Year 2|Spouse/family member request|0|||
126212879|NCT03917654|454066704|FG003|Year 2|Spouse/family member request|0|||
126212880|NCT03917654|454066705|FG004|Year 2|Spouse/family member request|0|||
126212881|NCT03917654|454066706|FG005|Year 2|Spouse/family member request|0|||
126212882|NCT03917654|454066707|FG006|Year 2|Spouse/family member request|1|||
126212883|NCT03917654|454066708|FG007|Year 2|Spouse/family member request|0|||
126348415|NCT02327078|454571016|FG003|Overall Study|Site Terminated by Sponsor|4|||
126212884|NCT03917654|454066709|FG008|Year 2|Spouse/family member request|0|||
126212885|NCT03917654|454066710|FG009|Year 2|Spouse/family member request|0|||
126212886|NCT03917654|454066711|FG010|Year 2|Spouse/family member request|0|||
126212887|NCT03917654|454066712|FG011|Year 2|Spouse/family member request|0|||
126212888|NCT03917654|454066701|FG000|Year 2|Lost to Follow-up|0|||
126212889|NCT03917654|454066702|FG001|Year 2|Lost to Follow-up|0|||
126212890|NCT03917654|454066703|FG002|Year 2|Lost to Follow-up|0|||
126212891|NCT03917654|454066704|FG003|Year 2|Lost to Follow-up|0|||
126212892|NCT03917654|454066705|FG004|Year 2|Lost to Follow-up|0|||
126212893|NCT03917654|454066706|FG005|Year 2|Lost to Follow-up|0|||
126212894|NCT03917654|454066707|FG006|Year 2|Lost to Follow-up|1|||
126212895|NCT03917654|454066708|FG007|Year 2|Lost to Follow-up|0|||
126212896|NCT03917654|454066709|FG008|Year 2|Lost to Follow-up|1|||
126212897|NCT03917654|454066710|FG009|Year 2|Lost to Follow-up|0|||
126212898|NCT03917654|454066711|FG010|Year 2|Lost to Follow-up|0|||
126212899|NCT03917654|454066712|FG011|Year 2|Lost to Follow-up|1|||
126212900|NCT03917654|454066701|FG000|Year 2|Adverse Event|0|||
126212901|NCT03917654|454066702|FG001|Year 2|Adverse Event|0|||
126212902|NCT03917654|454066703|FG002|Year 2|Adverse Event|0|||
126212903|NCT03917654|454066704|FG003|Year 2|Adverse Event|0|||
126212904|NCT03917654|454066705|FG004|Year 2|Adverse Event|0|||
126212905|NCT03917654|454066706|FG005|Year 2|Adverse Event|0|||
126212906|NCT03917654|454066707|FG006|Year 2|Adverse Event|0|||
126212907|NCT03917654|454066708|FG007|Year 2|Adverse Event|0|||
126212908|NCT03917654|454066709|FG008|Year 2|Adverse Event|0|||
126212909|NCT03917654|454066710|FG009|Year 2|Adverse Event|1|||
126212910|NCT03917654|454066711|FG010|Year 2|Adverse Event|0|||
126212911|NCT03917654|454066712|FG011|Year 2|Adverse Event|0|||
126212912|NCT00905437|454066714|FG000|Overall Study|Adverse Event|3|||
126348416|NCT02327078|454571017|FG004|Overall Study|Site Terminated by Sponsor|0|||
126348417|NCT02327078|454571018|FG005|Overall Study|Site Terminated by Sponsor|0|||
126348418|NCT02327078|454571019|FG006|Overall Study|Site Terminated by Sponsor|0|||
126348419|NCT02327078|454571020|FG007|Overall Study|Site Terminated by Sponsor|11|||
126348420|NCT02327078|454571021|FG008|Overall Study|Site Terminated by Sponsor|25|||
126348421|NCT02327078|454571013|FG000|Overall Study|Physician Decision|0|||
126348422|NCT02327078|454571014|FG001|Overall Study|Physician Decision|0|||
126348423|NCT02327078|454571015|FG002|Overall Study|Physician Decision|0|||
126348424|NCT02327078|454571016|FG003|Overall Study|Physician Decision|1|||
126348425|NCT02327078|454571017|FG004|Overall Study|Physician Decision|0|||
126348426|NCT02327078|454571018|FG005|Overall Study|Physician Decision|0|||
126348427|NCT02327078|454571019|FG006|Overall Study|Physician Decision|0|||
126348428|NCT02327078|454571020|FG007|Overall Study|Physician Decision|0|||
126348429|NCT02327078|454571021|FG008|Overall Study|Physician Decision|1|||
126348430|NCT02327078|454571013|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
126348431|NCT02327078|454571014|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
126348432|NCT02327078|454571015|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
126348433|NCT02327078|454571016|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
126348434|NCT02327078|454571017|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
126348435|NCT02327078|454571018|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
126348436|NCT02327078|454571019|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
126348437|NCT02327078|454571020|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
126348438|NCT02327078|454571021|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
126348439|NCT02327078|454571013|FG000|Overall Study|Reason not Specified|0|||
126348440|NCT02327078|454571014|FG001|Overall Study|Reason not Specified|0|||
126348441|NCT02327078|454571015|FG002|Overall Study|Reason not Specified|0|||
126348442|NCT02327078|454571016|FG003|Overall Study|Reason not Specified|0|||
126348443|NCT02327078|454571017|FG004|Overall Study|Reason not Specified|0|||
126348444|NCT02327078|454571018|FG005|Overall Study|Reason not Specified|0|||
126348445|NCT02327078|454571019|FG006|Overall Study|Reason not Specified|0|||
126348446|NCT02327078|454571020|FG007|Overall Study|Reason not Specified|5|||
126348447|NCT02327078|454571021|FG008|Overall Study|Reason not Specified|12|||
126348448|NCT05513950|454571022|FG000|Overall Study|Not treated due to technical reasons|0|||
126348449|NCT05513950|454571023|FG001|Overall Study|Not treated due to technical reasons|0|||
126212913|NCT00905437|454066715|FG001|Overall Study|Adverse Event|2|||
126212914|NCT00905437|454066714|FG000|Overall Study|Lost to Follow-up|0|||
126212915|NCT00905437|454066715|FG001|Overall Study|Lost to Follow-up|1|||
126212916|NCT00905437|454066714|FG000|Overall Study|Withdrawal by Subject|0|||
126212917|NCT00905437|454066715|FG001|Overall Study|Withdrawal by Subject|1|||
126212918|NCT00905437|454066714|FG000|Overall Study|Other|5|||
126212919|NCT00905437|454066715|FG001|Overall Study|Other|6|||
126212920|NCT01329562|454066718|FG000|Overall Study|Protocol Violation|5|||
126212921|NCT01329562|454066719|FG001|Overall Study|Protocol Violation|3|||
126212922|NCT01329562|454066718|FG000|Overall Study|Lost to Follow-up|1|||
126212923|NCT01329562|454066719|FG001|Overall Study|Lost to Follow-up|1|||
126348450|NCT05513950|454571024|FG002|Overall Study|Not treated due to technical reasons|1|||
126012966|NCT02914522|453341006|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
126348451|NCT05513950|454571025|FG003|Overall Study|Not treated due to technical reasons|0|||
126348452|NCT06001866|454571026|FG000|Overall Study|Withdrawal by Subject|0|||
126348453|NCT06001866|454571027|FG001|Overall Study|Withdrawal by Subject|2|||
126348454|NCT06001866|454571026|FG000|Overall Study|Protocol Violation|0|||
126348455|NCT06001866|454571027|FG001|Overall Study|Protocol Violation|2|||
126348456|NCT02903914|454571028|FG000|Overall Study|Adverse Event|0|||
126348457|NCT02903914|454571029|FG001|Overall Study|Adverse Event|0|||
126348458|NCT02903914|454571030|FG002|Overall Study|Adverse Event|1|||
126348459|NCT02903914|454571031|FG003|Overall Study|Adverse Event|0|||
126348460|NCT02903914|454571032|FG004|Overall Study|Adverse Event|0|||
126348461|NCT02903914|454571033|FG005|Overall Study|Adverse Event|0|||
126348462|NCT02903914|454571034|FG006|Overall Study|Adverse Event|2|||
126348463|NCT02903914|454571035|FG007|Overall Study|Adverse Event|0|||
126348464|NCT02903914|454571028|FG000|Overall Study|Withdrawal by Subject|3|||
126348465|NCT02903914|454571029|FG001|Overall Study|Withdrawal by Subject|1|||
126348466|NCT02903914|454571030|FG002|Overall Study|Withdrawal by Subject|28|||
126348467|NCT02903914|454571031|FG003|Overall Study|Withdrawal by Subject|0|||
126348468|NCT02903914|454571032|FG004|Overall Study|Withdrawal by Subject|1|||
126348469|NCT02903914|454571033|FG005|Overall Study|Withdrawal by Subject|2|||
126348470|NCT02903914|454571034|FG006|Overall Study|Withdrawal by Subject|12|||
126348471|NCT02903914|454571035|FG007|Overall Study|Withdrawal by Subject|0|||
126348472|NCT02903914|454571028|FG000|Overall Study|Progressive Disease|1|||
126348473|NCT02903914|454571029|FG001|Overall Study|Progressive Disease|0|||
126348474|NCT02903914|454571030|FG002|Overall Study|Progressive Disease|4|||
126348475|NCT02903914|454571031|FG003|Overall Study|Progressive Disease|0|||
126348476|NCT02903914|454571032|FG004|Overall Study|Progressive Disease|0|||
126348477|NCT02903914|454571033|FG005|Overall Study|Progressive Disease|0|||
126348478|NCT02903914|454571034|FG006|Overall Study|Progressive Disease|2|||
126348479|NCT02903914|454571035|FG007|Overall Study|Progressive Disease|0|||
126348480|NCT02903914|454571028|FG000|Overall Study|Death|0|||
126348481|NCT02903914|454571029|FG001|Overall Study|Death|0|||
126348482|NCT02903914|454571030|FG002|Overall Study|Death|9|||
126348483|NCT02903914|454571031|FG003|Overall Study|Death|0|||
126348484|NCT02903914|454571032|FG004|Overall Study|Death|1|||
126348485|NCT02903914|454571033|FG005|Overall Study|Death|3|||
126348486|NCT02903914|454571034|FG006|Overall Study|Death|24|||
126348487|NCT02903914|454571035|FG007|Overall Study|Death|2|||
126348488|NCT02903914|454571028|FG000|Overall Study|Lost to Follow-up|0|||
126348489|NCT02903914|454571029|FG001|Overall Study|Lost to Follow-up|1|||
126348490|NCT02903914|454571030|FG002|Overall Study|Lost to Follow-up|0|||
126348491|NCT02903914|454571031|FG003|Overall Study|Lost to Follow-up|0|||
126348492|NCT02903914|454571032|FG004|Overall Study|Lost to Follow-up|2|||
126348493|NCT02903914|454571033|FG005|Overall Study|Lost to Follow-up|0|||
126348494|NCT02903914|454571034|FG006|Overall Study|Lost to Follow-up|1|||
126348495|NCT02903914|454571035|FG007|Overall Study|Lost to Follow-up|0|||
126348496|NCT02903914|454571028|FG000|Overall Study|Physician Decision|0|||
126348497|NCT02903914|454571029|FG001|Overall Study|Physician Decision|0|||
126348498|NCT02903914|454571030|FG002|Overall Study|Physician Decision|1|||
126348499|NCT02903914|454571031|FG003|Overall Study|Physician Decision|0|||
126348500|NCT02903914|454571032|FG004|Overall Study|Physician Decision|0|||
126348501|NCT02903914|454571033|FG005|Overall Study|Physician Decision|0|||
126348502|NCT02903914|454571034|FG006|Overall Study|Physician Decision|1|||
126348503|NCT02903914|454571035|FG007|Overall Study|Physician Decision|0|||
126348504|NCT02903914|454571028|FG000|Overall Study|Symptomatic Deterioration|0|||
126348505|NCT02903914|454571029|FG001|Overall Study|Symptomatic Deterioration|0|||
126348506|NCT02903914|454571030|FG002|Overall Study|Symptomatic Deterioration|1|||
126348507|NCT02903914|454571031|FG003|Overall Study|Symptomatic Deterioration|0|||
126348508|NCT02903914|454571032|FG004|Overall Study|Symptomatic Deterioration|0|||
126348509|NCT02903914|454571033|FG005|Overall Study|Symptomatic Deterioration|0|||
126348510|NCT02903914|454571034|FG006|Overall Study|Symptomatic Deterioration|0|||
126348511|NCT02903914|454571035|FG007|Overall Study|Symptomatic Deterioration|0|||
126348512|NCT02903914|454571028|FG000|Overall Study|New Cancer Therapy|2|||
126348513|NCT02903914|454571029|FG001|Overall Study|New Cancer Therapy|2|||
126348514|NCT02903914|454571030|FG002|Overall Study|New Cancer Therapy|21|||
126348515|NCT02903914|454571031|FG003|Overall Study|New Cancer Therapy|4|||
126348516|NCT02903914|454571032|FG004|Overall Study|New Cancer Therapy|3|||
126348517|NCT02903914|454571033|FG005|Overall Study|New Cancer Therapy|6|||
126348518|NCT02903914|454571034|FG006|Overall Study|New Cancer Therapy|56|||
126348519|NCT02903914|454571035|FG007|Overall Study|New Cancer Therapy|3|||
126348520|NCT02903914|454571028|FG000|Overall Study|Didn't Return to Site|1|||
126348521|NCT02903914|454571029|FG001|Overall Study|Didn't Return to Site|0|||
126348522|NCT02903914|454571030|FG002|Overall Study|Didn't Return to Site|1|||
126348523|NCT02903914|454571031|FG003|Overall Study|Didn't Return to Site|1|||
126348524|NCT02903914|454571032|FG004|Overall Study|Didn't Return to Site|0|||
126348525|NCT02903914|454571033|FG005|Overall Study|Didn't Return to Site|0|||
126348526|NCT02903914|454571034|FG006|Overall Study|Didn't Return to Site|2|||
126348527|NCT02903914|454571035|FG007|Overall Study|Didn't Return to Site|0|||
126348528|NCT02903914|454571028|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
126012967|NCT02914522|453341007|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
126012968|NCT02914522|453340997|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126012969|NCT02914522|453340998|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126012970|NCT02914522|453340999|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126012971|NCT02914522|453341000|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126012972|NCT02914522|453341001|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126012973|NCT02914522|453341002|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126012974|NCT02914522|453341003|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
126012975|NCT02914522|453341004|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
126012976|NCT02914522|453341005|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
126012977|NCT02914522|453341006|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
126012978|NCT02914522|453341007|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
126012979|NCT02914522|453340997|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126012980|NCT02914522|453340998|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126012981|NCT02914522|453340999|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126012982|NCT02914522|453341000|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126012983|NCT02914522|453341001|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126012984|NCT02914522|453341002|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126012985|NCT02914522|453341003|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
126012986|NCT02914522|453341004|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
126012987|NCT02914522|453341005|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
126012988|NCT02914522|453341006|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126012989|NCT02914522|453341007|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
126012990|NCT02914522|453340997|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126012991|NCT02914522|453340998|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126012992|NCT02914522|453340999|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126012993|NCT02914522|453341000|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126012994|NCT02914522|453341001|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126212924|NCT01329562|454066718|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
126212925|NCT01329562|454066719|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
126212926|NCT01329562|454066718|FG000|Overall Study|Physician Decision|0|||
126212927|NCT01329562|454066719|FG001|Overall Study|Physician Decision|1|||
126212928|NCT03252015|454066720|FG000|Overall Study|Withdrawal by Subject|0|||
126212929|NCT03252015|454066721|FG001|Overall Study|Withdrawal by Subject|1|||
126212930|NCT03252015|454066722|FG002|Overall Study|Withdrawal by Subject|1|||
126212931|NCT03252015|454066723|FG003|Overall Study|Withdrawal by Subject|0|||
126212932|NCT03252015|454066720|FG000|Overall Study|Adverse Event|1|||
126212933|NCT03252015|454066721|FG001|Overall Study|Adverse Event|0|||
126212934|NCT03252015|454066722|FG002|Overall Study|Adverse Event|0|||
126212935|NCT03252015|454066723|FG003|Overall Study|Adverse Event|1|||
126212936|NCT03128931|454066724|FG000|Overall Study|Physician Decision|1|||
126212937|NCT03128931|454066724|FG000|Overall Study|Equipment Issues|3|||
126212938|NCT00061568|454066727|FG000|Overall Study|Lost to Follow-up|12|||
126212939|NCT00061568|454066728|FG001|Overall Study|Lost to Follow-up|0|||
126212940|NCT00061568|454066727|FG000|Overall Study|Death|6|||
126212941|NCT00061568|454066728|FG001|Overall Study|Death|0|||
126212942|NCT00061568|454066727|FG000|Overall Study|Withdrawal by Subject|1|||
126212943|NCT00061568|454066728|FG001|Overall Study|Withdrawal by Subject|0|||
126212944|NCT01071278|454066732|FG000|Overall Study|Premature Discontinuation|254|||
126212945|NCT01071278|454066732|FG000|Overall Study|Completion Status Unknown|459|||
126212946|NCT00903409|454066733|FG000|Overall Study|Adverse Event|11|||
126212947|NCT00903409|454066734|FG001|Overall Study|Adverse Event|9|||
126212948|NCT00903409|454066733|FG000|Overall Study|Non-compliance with Protocol|1|||
126212949|NCT00903409|454066734|FG001|Overall Study|Non-compliance with Protocol|1|||
126212950|NCT00903409|454066733|FG000|Overall Study|Laboratory Abnormality|2|||
126212951|NCT00903409|454066734|FG001|Overall Study|Laboratory Abnormality|0|||
126212952|NCT00903409|454066733|FG000|Overall Study|Withdrawal by Subject|8|||
126212953|NCT00903409|454066734|FG001|Overall Study|Withdrawal by Subject|8|||
126212954|NCT00903409|454066733|FG000|Overall Study|Other|2|||
126212955|NCT00903409|454066734|FG001|Overall Study|Other|3|||
126212956|NCT00903409|454066733|FG000|Overall Study|Lost to Follow-up|2|||
126212957|NCT00903409|454066734|FG001|Overall Study|Lost to Follow-up|6|||
126212958|NCT00797316|454066735|FG000|Overall Study|Administrative problems|1|||
126212959|NCT00797316|454066736|FG001|Overall Study|Administrative problems|0|||
126212960|NCT00797316|454066735|FG000|Overall Study|Adverse Event|5|||
126212961|NCT00797316|454066736|FG001|Overall Study|Adverse Event|3|||
126212962|NCT00797316|454066735|FG000|Overall Study|Lost to Follow-up|4|||
126212963|NCT00797316|454066736|FG001|Overall Study|Lost to Follow-up|8|||
126212964|NCT00797316|454066735|FG000|Overall Study|Protocol Deviation|1|||
126212965|NCT00797316|454066736|FG001|Overall Study|Protocol Deviation|2|||
126212966|NCT00797316|454066735|FG000|Overall Study|Patient withdrew consent|12|||
126212967|NCT00797316|454066736|FG001|Overall Study|Patient withdrew consent|6|||
126212968|NCT00797316|454066735|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126212969|NCT00797316|454066736|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
126212970|NCT03239340|454066739|FG000|Overall Study|Other|26|||
126306131|NCT04463251|454408900|FG001|Overall Study|Adverse Event|1|||
126212971|NCT03239340|454066739|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
126212972|NCT03239340|454066739|FG000|Overall Study|Death|40|||
126212973|NCT03239340|454066739|FG000|Overall Study|Lost to Follow-up|2|||
126212974|NCT03239340|454066739|FG000|Overall Study|Physician Decision|16|||
126212975|NCT03239340|454066739|FG000|Overall Study|Withdrawal by Subject|27|||
126212976|NCT02061293|454066743|FG000|Overall Study|Elevated Blood Pressure|1|||
126212977|NCT02061293|454066744|FG001|Overall Study|Elevated Blood Pressure|1|||
126212978|NCT04066894|454066745|FG000|Overall Study|Lack of Efficacy|1|||
126212979|NCT04066894|454066745|FG000|Overall Study|Screen Failure|1|||
126212980|NCT03494816|454066747|FG000|Overall Study|Protocol Violation|2|||
126212981|NCT03494816|454066747|FG000|Overall Study|Physician Decision|2|||
126212982|NCT03494816|454066747|FG000|Overall Study|Did not start trial treatment|1|||
126212983|NCT03494816|454066747|FG000|Overall Study|Adverse Event|1|||
126212984|NCT00314262|454066748|FG000|Overall Study|Adverse Event|2|||
126212985|NCT00314262|454066748|FG000|Overall Study|Withdrawal by Subject|2|||
126212986|NCT00314262|454066748|FG000|Overall Study|Physician Decision|1|||
126212987|NCT01126359|454066749|FG000|First Intervention (20-minutes)|Physician Decision|0|||
126212988|NCT01126359|454066750|FG001|First Intervention (20-minutes)|Physician Decision|1|||
126212989|NCT00902486|454066751|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
126212990|NCT00902486|454066752|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
126212991|NCT00902486|454066753|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
126212992|NCT00902486|454066754|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
126212993|NCT00902486|454066755|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
126212994|NCT00902486|454066756|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
126212995|NCT00902486|454066751|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
126212996|NCT00902486|454066752|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
126212997|NCT00902486|454066753|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
126212998|NCT00902486|454066754|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
126212999|NCT00902486|454066755|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
126213000|NCT00902486|454066756|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
126213001|NCT00902486|454066751|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
126213002|NCT00902486|454066752|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
126213003|NCT00902486|454066753|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
126213004|NCT00902486|454066754|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
126213005|NCT00902486|454066755|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
126213006|NCT00902486|454066756|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
126213007|NCT00902486|454066751|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126213008|NCT00902486|454066752|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126213009|NCT00902486|454066753|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126213010|NCT00902486|454066754|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
126213011|NCT00902486|454066755|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126213012|NCT00902486|454066756|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126213013|NCT00902486|454066751|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126213014|NCT00902486|454066752|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126213015|NCT00902486|454066753|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126213016|NCT00902486|454066754|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
126213017|NCT00902486|454066755|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126213018|NCT00902486|454066756|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126213019|NCT00902486|454066751|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
126213020|NCT00902486|454066752|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
126213021|NCT00902486|454066753|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
126213022|NCT00902486|454066754|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
126213023|NCT00902486|454066755|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
126213024|NCT00902486|454066756|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
126213025|NCT00902486|454066751|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
126213026|NCT00902486|454066752|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
126306132|NCT04463251|454408901|FG002|Overall Study|Adverse Event|0|||
126306133|NCT04463251|454408899|FG000|Overall Study|Lost to Follow-up|0|||
126306134|NCT04463251|454408900|FG001|Overall Study|Lost to Follow-up|1|||
126306135|NCT04463251|454408901|FG002|Overall Study|Lost to Follow-up|0|||
126306136|NCT04463251|454408899|FG000|Overall Study|Withdrawal by Subject|0|||
126306137|NCT04463251|454408900|FG001|Overall Study|Withdrawal by Subject|2|||
126306138|NCT04463251|454408901|FG002|Overall Study|Withdrawal by Subject|2|||
126306139|NCT00072280|454408902|FG000|Treatment|Found ineligible|1|||
126306140|NCT00072280|454408903|FG001|Treatment|Found ineligible|2|||
126306141|NCT00072280|454408902|FG000|Follow-up|Early termination of study|2|||
126306142|NCT00072280|454408903|FG001|Follow-up|Early termination of study|2|||
126306143|NCT05020665|454408904|FG000|Overall Study|Study terminated by Sponsor|5|||
126213027|NCT00902486|454066753|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
126213028|NCT00902486|454066754|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
126213029|NCT00902486|454066755|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
126213030|NCT00902486|454066756|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
126213031|NCT00902486|454066751|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126213032|NCT00902486|454066752|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126213033|NCT00902486|454066753|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126348529|NCT02903914|454571029|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
126348530|NCT02903914|454571030|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
126348531|NCT02903914|454571031|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
126348532|NCT02903914|454571032|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
126348533|NCT02903914|454571033|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
126348534|NCT02903914|454571034|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
126348535|NCT02903914|454571035|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
126348536|NCT02903914|454571028|FG000|Overall Study|Follow-up Did Not Occur|0|||
126348537|NCT02903914|454571029|FG001|Overall Study|Follow-up Did Not Occur|1|||
126348538|NCT02903914|454571030|FG002|Overall Study|Follow-up Did Not Occur|1|||
126348539|NCT02903914|454571031|FG003|Overall Study|Follow-up Did Not Occur|0|||
126348540|NCT02903914|454571032|FG004|Overall Study|Follow-up Did Not Occur|2|||
126348541|NCT02903914|454571033|FG005|Overall Study|Follow-up Did Not Occur|0|||
126348542|NCT02903914|454571034|FG006|Overall Study|Follow-up Did Not Occur|8|||
126348543|NCT02903914|454571035|FG007|Overall Study|Follow-up Did Not Occur|0|||
126348544|NCT02903914|454571028|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
126348545|NCT02903914|454571029|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
126348546|NCT02903914|454571030|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
126348547|NCT02903914|454571031|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
126348548|NCT02903914|454571032|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
126348549|NCT02903914|454571033|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
126348550|NCT02903914|454571034|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
126348551|NCT02903914|454571035|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
126348552|NCT02903914|454571028|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348553|NCT02903914|454571029|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348554|NCT02903914|454571030|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
126348555|NCT02903914|454571031|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348556|NCT02903914|454571032|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348557|NCT02903914|454571033|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
126348558|NCT02903914|454571034|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348559|NCT02903914|454571035|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348560|NCT02903914|454571028|FG000|Overall Study|Clinical Disease Progression|0|||
126348561|NCT02903914|454571029|FG001|Overall Study|Clinical Disease Progression|0|||
126348562|NCT02903914|454571030|FG002|Overall Study|Clinical Disease Progression|2|||
126348563|NCT02903914|454571031|FG003|Overall Study|Clinical Disease Progression|0|||
126348564|NCT02903914|454571032|FG004|Overall Study|Clinical Disease Progression|0|||
126348565|NCT02903914|454571033|FG005|Overall Study|Clinical Disease Progression|0|||
126348566|NCT02903914|454571034|FG006|Overall Study|Clinical Disease Progression|0|||
126348567|NCT02903914|454571035|FG007|Overall Study|Clinical Disease Progression|0|||
126348568|NCT02903914|454571028|FG000|Overall Study|Completed Follow-up Period|0|||
126348569|NCT02903914|454571029|FG001|Overall Study|Completed Follow-up Period|0|||
126348570|NCT02903914|454571030|FG002|Overall Study|Completed Follow-up Period|6|||
126348571|NCT02903914|454571031|FG003|Overall Study|Completed Follow-up Period|2|||
126348572|NCT02903914|454571032|FG004|Overall Study|Completed Follow-up Period|1|||
126348573|NCT02903914|454571033|FG005|Overall Study|Completed Follow-up Period|0|||
126348574|NCT02903914|454571034|FG006|Overall Study|Completed Follow-up Period|9|||
126348575|NCT02903914|454571035|FG007|Overall Study|Completed Follow-up Period|1|||
126348576|NCT02903914|454571028|FG000|Overall Study|Taken off Treatment per Protocol|0|||
126348577|NCT02903914|454571029|FG001|Overall Study|Taken off Treatment per Protocol|0|||
126348578|NCT02903914|454571030|FG002|Overall Study|Taken off Treatment per Protocol|0|||
126348579|NCT02903914|454571031|FG003|Overall Study|Taken off Treatment per Protocol|0|||
126348580|NCT02903914|454571032|FG004|Overall Study|Taken off Treatment per Protocol|0|||
126348581|NCT02903914|454571033|FG005|Overall Study|Taken off Treatment per Protocol|1|||
126348582|NCT02903914|454571034|FG006|Overall Study|Taken off Treatment per Protocol|0|||
126348583|NCT02903914|454571035|FG007|Overall Study|Taken off Treatment per Protocol|0|||
126348584|NCT02903914|454571028|FG000|Overall Study|Refused Further Treatment/Contact|0|||
126348585|NCT02903914|454571029|FG001|Overall Study|Refused Further Treatment/Contact|0|||
126348586|NCT02903914|454571030|FG002|Overall Study|Refused Further Treatment/Contact|0|||
126348587|NCT02903914|454571031|FG003|Overall Study|Refused Further Treatment/Contact|0|||
126348588|NCT02903914|454571032|FG004|Overall Study|Refused Further Treatment/Contact|0|||
126348589|NCT02903914|454571033|FG005|Overall Study|Refused Further Treatment/Contact|0|||
126213034|NCT00902486|454066754|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126213035|NCT00902486|454066755|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126213036|NCT00902486|454066756|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
126213037|NCT00902486|454066751|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126213038|NCT00902486|454066752|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126213039|NCT00902486|454066753|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126213040|NCT00902486|454066754|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
126213041|NCT00902486|454066755|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126213042|NCT00902486|454066756|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126213043|NCT00902486|454066751|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126213044|NCT00902486|454066752|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126213045|NCT00902486|454066753|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
126213046|NCT00902486|454066754|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126213047|NCT00902486|454066755|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126213048|NCT00902486|454066756|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126213049|NCT00902486|454066751|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
126213050|NCT00902486|454066752|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
126213051|NCT00902486|454066753|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
126213052|NCT00902486|454066754|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
126213053|NCT00902486|454066755|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
126213054|NCT00902486|454066756|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
126213055|NCT02332655|454066757|FG000|Overall Study|Lack of Efficacy|1|||
126213056|NCT01808508|454068609|FG000|Overall Study|Lost to Follow-up|1|||
126213057|NCT01808508|454068610|FG001|Overall Study|Lost to Follow-up|0|||
126213058|NCT01808508|454068611|FG002|Overall Study|Lost to Follow-up|0|||
126213059|NCT02729545|454068614|FG000|Overall Study|Pregnancy|1|||
126213060|NCT02729545|454068615|FG001|Overall Study|Pregnancy|1|||
126213061|NCT02729545|454068614|FG000|Overall Study|Lost to Follow-up|0|||
126213062|NCT02729545|454068615|FG001|Overall Study|Lost to Follow-up|1|||
126213063|NCT02729545|454068614|FG000|Overall Study|Withdrawal by Subject|2|||
126213064|NCT02729545|454068615|FG001|Overall Study|Withdrawal by Subject|3|||
126213065|NCT03079869|454068624|FG000|Overall Study|Adverse Event|6|||
126213066|NCT03079869|454068625|FG001|Overall Study|Adverse Event|8|||
126213067|NCT03079869|454068624|FG000|Overall Study|Withdrawal by Subject|4|||
126213068|NCT03079869|454068625|FG001|Overall Study|Withdrawal by Subject|1|||
126213069|NCT03079869|454068624|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
126213070|NCT03079869|454068625|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
126213071|NCT02411110|454068626|FG000|Treatment Period 1|Adverse Event|4|||
126213072|NCT02411110|454068627|FG001|Treatment Period 1|Adverse Event|2|||
126213073|NCT02411110|454068626|FG000|Treatment Period 1|Lost to Follow-up|1|||
126213074|NCT02411110|454068627|FG001|Treatment Period 1|Lost to Follow-up|0|||
126213075|NCT02411110|454068626|FG000|Treatment Period 1|Personal Reasons|2|||
126213076|NCT02411110|454068627|FG001|Treatment Period 1|Personal Reasons|5|||
126213077|NCT02411110|454068626|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
126213078|NCT02411110|454068627|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
126213079|NCT02411110|454068626|FG000|Treatment Period 2|Adverse Event|1|||
126213080|NCT02411110|454068627|FG001|Treatment Period 2|Adverse Event|0|||
126213081|NCT02411110|454068626|FG000|Treatment Period 2|Lost to Follow-up|0|||
126213082|NCT02411110|454068627|FG001|Treatment Period 2|Lost to Follow-up|2|||
126348590|NCT02903914|454571034|FG006|Overall Study|Refused Further Treatment/Contact|1|||
126348591|NCT02903914|454571035|FG007|Overall Study|Refused Further Treatment/Contact|0|||
126348592|NCT02903914|454571028|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348593|NCT02903914|454571029|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348594|NCT02903914|454571030|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348595|NCT02903914|454571031|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348596|NCT02903914|454571032|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348597|NCT02903914|454571033|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348598|NCT02903914|454571034|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
126348599|NCT02903914|454571035|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348600|NCT04725188|454571038|FG000|Overall Study|Death|72|||
126348601|NCT04725188|454571039|FG001|Overall Study|Death|69|||
126348602|NCT04725188|454571040|FG002|Overall Study|Death|76|||
126348603|NCT04725188|454571038|FG000|Overall Study|Lost to Follow-up|1|||
126348604|NCT04725188|454571039|FG001|Overall Study|Lost to Follow-up|0|||
126348605|NCT04725188|454571040|FG002|Overall Study|Lost to Follow-up|1|||
126213083|NCT02411110|454068626|FG000|Treatment Period 2|Personal Reasons|0|||
126213084|NCT02411110|454068627|FG001|Treatment Period 2|Personal Reasons|2|||
126213085|NCT03292731|454068628|FG000|Overall Study|Protocol Violation|4|||
126213086|NCT03292731|454068629|FG001|Overall Study|Protocol Violation|11|||
126213087|NCT03292731|454068630|FG002|Overall Study|Protocol Violation|1|||
126213088|NCT03901352|454068634|FG000|Double-blind Phase|Adverse Event|6|||
126213089|NCT03901352|454068635|FG001|Double-blind Phase|Adverse Event|4|||
126213090|NCT03901352|454068634|FG000|Double-blind Phase|Death|1|||
126213091|NCT03901352|454068635|FG001|Double-blind Phase|Death|0|||
126213092|NCT03901352|454068634|FG000|Double-blind Phase|Lack of Efficacy|0|||
126213093|NCT03901352|454068635|FG001|Double-blind Phase|Lack of Efficacy|1|||
126213094|NCT03901352|454068634|FG000|Double-blind Phase|Protocol Violation|0|||
126213095|NCT03901352|454068635|FG001|Double-blind Phase|Protocol Violation|1|||
126213096|NCT03901352|454068634|FG000|Double-blind Phase|Withdrawal by Subject|10|||
126213097|NCT03901352|454068635|FG001|Double-blind Phase|Withdrawal by Subject|8|||
126213098|NCT03901352|454068634|FG000|Open-label Extension Phase|Adverse Event|24|||
126213099|NCT03901352|454068635|FG001|Open-label Extension Phase|Adverse Event|0|||
126213100|NCT03901352|454068634|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
126213101|NCT03901352|454068635|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
126213102|NCT03901352|454068634|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
126213103|NCT03901352|454068635|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
126213104|NCT03901352|454068634|FG000|Open-label Extension Phase|Other|1|||
126213105|NCT03901352|454068635|FG001|Open-label Extension Phase|Other|0|||
126213106|NCT02871921|454068643|FG000|Overall Study|Withdrawal by Subject|34|||
126213107|NCT02871921|454068644|FG001|Overall Study|Withdrawal by Subject|27|||
126213108|NCT02871921|454068645|FG002|Overall Study|Withdrawal by Subject|27|||
126213109|NCT02871921|454068646|FG003|Overall Study|Withdrawal by Subject|30|||
126213110|NCT01803464|454068649|FG000|Overall Study|Incomplete data|0|||
126213111|NCT01803464|454068650|FG001|Overall Study|Incomplete data|0|||
126213112|NCT01803464|454068651|FG002|Overall Study|Incomplete data|4|||
126213113|NCT01803464|454068652|FG003|Overall Study|Incomplete data|0|||
126213114|NCT01803464|454068649|FG000|Overall Study|Withdrawal by Subject|1|||
126213115|NCT01803464|454068650|FG001|Overall Study|Withdrawal by Subject|0|||
126213116|NCT01803464|454068651|FG002|Overall Study|Withdrawal by Subject|0|||
126213117|NCT01803464|454068652|FG003|Overall Study|Withdrawal by Subject|0|||
126213118|NCT02860039|454068658|FG000|Overall Study|Death|4|||
126213119|NCT02860039|454068659|FG001|Overall Study|Death|0|||
126213120|NCT02860039|454068658|FG000|Overall Study|Lost to Follow-up|2|||
126213121|NCT02860039|454068659|FG001|Overall Study|Lost to Follow-up|2|||
126213122|NCT02860039|454068658|FG000|Overall Study|Protocol Violation|3|||
126213123|NCT02860039|454068659|FG001|Overall Study|Protocol Violation|1|||
126213124|NCT02860039|454068658|FG000|Overall Study|Withdrawal by Subject|1|||
126213125|NCT02860039|454068659|FG001|Overall Study|Withdrawal by Subject|0|||
126213126|NCT02860039|454068658|FG000|Overall Study|Not otherwise eligible|1|||
126213127|NCT02860039|454068659|FG001|Overall Study|Not otherwise eligible|1|||
126213128|NCT01360021|454068660|FG000|Overall Study|Eligibility criteria + other|2|||
126213129|NCT01360021|454068661|FG001|Overall Study|Eligibility criteria + other|1|||
126213130|NCT01360021|454068662|FG002|Overall Study|Eligibility criteria + other|1|||
126213131|NCT01360021|454068660|FG000|Overall Study|Protocol Violation|0|||
126213132|NCT01360021|454068661|FG001|Overall Study|Protocol Violation|0|||
126348606|NCT04725188|454571038|FG000|Overall Study|Withdrawal by Subject|2|||
126348607|NCT04725188|454571039|FG001|Overall Study|Withdrawal by Subject|2|||
126348608|NCT04725188|454571040|FG002|Overall Study|Withdrawal by Subject|1|||
126348609|NCT04725188|454571038|FG000|Overall Study|Sponsor Decision|12|||
126348610|NCT04725188|454571039|FG001|Overall Study|Sponsor Decision|12|||
126348611|NCT04725188|454571040|FG002|Overall Study|Sponsor Decision|7|||
126348612|NCT03765073|454571041|FG000|Stage 1|Lost to Follow-up|1|||
126348613|NCT03765073|454571042|FG001|Stage 1|Lost to Follow-up|0|||
126348614|NCT03765073|454571043|FG002|Stage 1|Lost to Follow-up|0|||
126348615|NCT03765073|454571044|FG003|Stage 1|Lost to Follow-up|0|||
126348616|NCT03765073|454571045|FG004|Stage 1|Lost to Follow-up|0|||
126348617|NCT03765073|454571046|FG005|Stage 1|Lost to Follow-up|0|||
126348618|NCT03765073|454571047|FG006|Stage 1|Lost to Follow-up|0|||
126348619|NCT03765073|454571048|FG007|Stage 1|Lost to Follow-up|0|||
126348620|NCT03765073|454571049|FG008|Stage 1|Lost to Follow-up|0|||
126348621|NCT03765073|454571050|FG009|Stage 1|Lost to Follow-up|0|||
126348622|NCT03765073|454571051|FG010|Stage 1|Lost to Follow-up|0|||
126348623|NCT03765073|454571052|FG011|Stage 1|Lost to Follow-up|0|||
126348624|NCT03765073|454571053|FG012|Stage 1|Lost to Follow-up|0|||
126348625|NCT03765073|454571054|FG013|Stage 1|Lost to Follow-up|0|||
126348626|NCT03765073|454571055|FG014|Stage 1|Lost to Follow-up|0|||
126012995|NCT02914522|453341002|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126213133|NCT01360021|454068662|FG002|Overall Study|Protocol Violation|1|||
126213134|NCT01360021|454068660|FG000|Overall Study|Withdrawal by Subject|4|||
126213135|NCT01360021|454068661|FG001|Overall Study|Withdrawal by Subject|0|||
126213136|NCT01360021|454068662|FG002|Overall Study|Withdrawal by Subject|2|||
126213137|NCT01360021|454068660|FG000|Overall Study|Adverse Event|2|||
126213138|NCT01360021|454068661|FG001|Overall Study|Adverse Event|3|||
126348627|NCT03765073|454571056|FG015|Stage 1|Lost to Follow-up|0|||
126213139|NCT01360021|454068662|FG002|Overall Study|Adverse Event|3|||
126348628|NCT03765073|454571057|FG016|Stage 1|Lost to Follow-up|0|||
126348629|NCT03765073|454571058|FG017|Stage 1|Lost to Follow-up|0|||
126348630|NCT03765073|454571059|FG018|Stage 1|Lost to Follow-up|0|||
126213140|NCT01257737|454068664|FG000|Overall Study|Lost to Follow-up|1|||
126213141|NCT01257737|454068665|FG001|Overall Study|Lost to Follow-up|2|||
126213142|NCT01257737|454068664|FG000|Overall Study|Liver transplant|1|||
126213143|NCT01257737|454068665|FG001|Overall Study|Liver transplant|0|||
126213144|NCT01257737|454068664|FG000|Overall Study|Relocation out of the country|0|||
126213145|NCT01257737|454068665|FG001|Overall Study|Relocation out of the country|1|||
126213146|NCT01257737|454068664|FG000|Overall Study|Withdrew from study|0|||
126213147|NCT01257737|454068665|FG001|Overall Study|Withdrew from study|1|||
126213148|NCT03170271|454068669|FG000|Overall Study|Adverse Event|7|||
126012996|NCT02914522|453341003|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
126012997|NCT02914522|453341004|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
126012998|NCT02914522|453341005|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
126012999|NCT02914522|453341006|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
126013000|NCT02914522|453341007|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
126013001|NCT02914522|453340997|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
126013002|NCT02914522|453340998|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
126013003|NCT02914522|453340999|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
126013004|NCT02914522|453341000|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
126013005|NCT02914522|453341001|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
126013006|NCT02914522|453341002|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
126013007|NCT02914522|453341003|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
126013008|NCT02914522|453341004|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
126013009|NCT02914522|453341005|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
126013010|NCT02914522|453341006|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
126013011|NCT02914522|453341007|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
126013012|NCT02914522|453340997|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013013|NCT02914522|453340998|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013014|NCT02914522|453340999|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013015|NCT02914522|453341000|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013016|NCT02914522|453341001|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013017|NCT02914522|453341002|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013018|NCT02914522|453341003|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013019|NCT02914522|453341004|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
126013020|NCT02914522|453341005|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
126013021|NCT02914522|453341006|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013022|NCT02914522|453341007|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126013023|NCT02914522|453340997|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126013024|NCT02914522|453340998|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126013025|NCT02914522|453340999|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126013026|NCT02914522|453341000|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126013027|NCT02914522|453341001|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126013028|NCT02914522|453341002|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126348631|NCT03765073|454571060|FG019|Stage 1|Lost to Follow-up|0|||
126348632|NCT03765073|454571061|FG020|Stage 1|Lost to Follow-up|0|||
126348633|NCT03765073|454571041|FG000|Stage 1|Withdrawal by participant|0|||
126348634|NCT03765073|454571042|FG001|Stage 1|Withdrawal by participant|1|||
126348635|NCT03765073|454571043|FG002|Stage 1|Withdrawal by participant|0|||
126348636|NCT03765073|454571044|FG003|Stage 1|Withdrawal by participant|0|||
126348637|NCT03765073|454571045|FG004|Stage 1|Withdrawal by participant|0|||
126348638|NCT03765073|454571046|FG005|Stage 1|Withdrawal by participant|0|||
126348639|NCT03765073|454571047|FG006|Stage 1|Withdrawal by participant|0|||
126348640|NCT03765073|454571048|FG007|Stage 1|Withdrawal by participant|0|||
126348641|NCT03765073|454571049|FG008|Stage 1|Withdrawal by participant|0|||
126348642|NCT03765073|454571050|FG009|Stage 1|Withdrawal by participant|0|||
126348643|NCT03765073|454571051|FG010|Stage 1|Withdrawal by participant|0|||
126348644|NCT03765073|454571052|FG011|Stage 1|Withdrawal by participant|0|||
126348645|NCT03765073|454571053|FG012|Stage 1|Withdrawal by participant|0|||
126348646|NCT03765073|454571054|FG013|Stage 1|Withdrawal by participant|0|||
126348647|NCT03765073|454571055|FG014|Stage 1|Withdrawal by participant|0|||
126348648|NCT03765073|454571056|FG015|Stage 1|Withdrawal by participant|0|||
126348649|NCT03765073|454571057|FG016|Stage 1|Withdrawal by participant|0|||
126348650|NCT03765073|454571058|FG017|Stage 1|Withdrawal by participant|0|||
126348651|NCT03765073|454571059|FG018|Stage 1|Withdrawal by participant|0|||
126348652|NCT03765073|454571060|FG019|Stage 1|Withdrawal by participant|0|||
126348653|NCT03765073|454571061|FG020|Stage 1|Withdrawal by participant|0|||
126348654|NCT03765073|454571041|FG000|Stage 2|Death|0|||
126348655|NCT03765073|454571042|FG001|Stage 2|Death|0|||
126348656|NCT03765073|454571043|FG002|Stage 2|Death|0|||
126348657|NCT03765073|454571044|FG003|Stage 2|Death|0|||
126091145|NCT02218606|453628348|FG000|Overall Study|Death|15|||
126348658|NCT03765073|454571045|FG004|Stage 2|Death|0|||
126348659|NCT03765073|454571046|FG005|Stage 2|Death|0|||
126348660|NCT03765073|454571047|FG006|Stage 2|Death|0|||
126348661|NCT03765073|454571048|FG007|Stage 2|Death|0|||
126348662|NCT03765073|454571049|FG008|Stage 2|Death|0|||
126013029|NCT02914522|453341003|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126013030|NCT02914522|453341004|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126013031|NCT02914522|453341005|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
126013032|NCT02914522|453341006|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
126013033|NCT02914522|453341007|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126013034|NCT02914522|453340997|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013035|NCT02914522|453340998|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013036|NCT02914522|453340999|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013037|NCT02914522|453341000|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013038|NCT02914522|453341001|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013039|NCT02914522|453341002|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013040|NCT02914522|453341003|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013041|NCT02914522|453341004|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013042|NCT02914522|453341005|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013043|NCT02914522|453341006|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
126013044|NCT02914522|453341007|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126013045|NCT00756730|453341008|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
126013046|NCT00756730|453341009|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
126013047|NCT00756730|453341008|FG000|Overall Study|persistent low-level viremmia|0|||
126013048|NCT00756730|453341009|FG001|Overall Study|persistent low-level viremmia|1|||
126013049|NCT05382104|453341011|FG000|Period 2 (2 Days)|Adverse Event|0|||
126013050|NCT05382104|453341012|FG001|Period 2 (2 Days)|Adverse Event|1|||
126013051|NCT05382104|453341013|FG002|Period 2 (2 Days)|Adverse Event|0|||
126013052|NCT05382104|453341014|FG003|Period 2 (2 Days)|Adverse Event|0|||
126013053|NCT05382104|453341015|FG004|Period 2 (2 Days)|Adverse Event|0|||
126013054|NCT05382104|453341016|FG005|Period 2 (2 Days)|Adverse Event|0|||
126013055|NCT00639002|453341017|FG000|Overall Study|Death|1|||
126013056|NCT00639002|453341017|FG000|Overall Study|Adverse Event|1|||
126013057|NCT00639002|453341017|FG000|Overall Study|Protocol Violation|1|||
126013058|NCT00639002|453341017|FG000|Overall Study|Disease progression|3|||
126013059|NCT00639002|453341017|FG000|Overall Study|Physician Decision|6|||
126013060|NCT00639002|453341017|FG000|Overall Study|Lack of Efficacy|1|||
126013061|NCT05686421|453341025|FG000|Overall Study|Screen failure|22|||
126013062|NCT05686421|453341026|FG001|Overall Study|Screen failure|0|||
126013063|NCT05686421|453341027|FG002|Overall Study|Screen failure|0|||
126013064|NCT05686421|453341028|FG003|Overall Study|Screen failure|0|||
126013065|NCT00367055|453341030|FG000|Overall Study|Adverse Event|6|||
126213149|NCT03170271|454068670|FG001|Overall Study|Adverse Event|2|||
126213150|NCT03170271|454068669|FG000|Overall Study|Lost to Follow-up|0|||
126213151|NCT03170271|454068670|FG001|Overall Study|Lost to Follow-up|1|||
126013066|NCT00367055|453341031|FG001|Overall Study|Adverse Event|3|||
126013067|NCT00367055|453341030|FG000|Overall Study|Patient's Willing|3|||
126013068|NCT00367055|453341031|FG001|Overall Study|Patient's Willing|2|||
126013069|NCT00367055|453341030|FG000|Overall Study|Lack of Efficacy|1|||
126013070|NCT00367055|453341031|FG001|Overall Study|Lack of Efficacy|2|||
126213152|NCT03170271|454068669|FG000|Overall Study|Physician Decision|1|||
126213153|NCT03170271|454068670|FG001|Overall Study|Physician Decision|0|||
126213154|NCT03170271|454068669|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
126213155|NCT03170271|454068670|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
126213156|NCT03170271|454068669|FG000|Overall Study|Withdrawal by Subject|17|||
126213157|NCT03170271|454068670|FG001|Overall Study|Withdrawal by Subject|5|||
126213158|NCT03170271|454068669|FG000|Overall Study|Other|2|||
126213159|NCT03170271|454068670|FG001|Overall Study|Other|2|||
126213160|NCT03170271|454068669|FG000|Overall Study|Randomized in error|4|||
126213161|NCT03170271|454068670|FG001|Overall Study|Randomized in error|0|||
126213162|NCT04935931|454068674|FG000|Overall Study|Withdrawal by Subject|1|||
126213163|NCT05168657|454068675|FG000|Overall Study|Adverse Event|0|||
126213164|NCT05168657|454068676|FG001|Overall Study|Adverse Event|0|||
126213165|NCT05168657|454068677|FG002|Overall Study|Adverse Event|1|||
126213166|NCT05168657|454068678|FG003|Overall Study|Adverse Event|0|||
126213167|NCT05168657|454068679|FG004|Overall Study|Adverse Event|0|||
126213168|NCT05168657|454068680|FG005|Overall Study|Adverse Event|0|||
126213169|NCT05168657|454068681|FG006|Overall Study|Adverse Event|0|||
126213170|NCT05168657|454068682|FG007|Overall Study|Adverse Event|0|||
126213171|NCT00424632|454068685|FG000|Overall Study|Death|0|||
126213172|NCT00424632|454068686|FG001|Overall Study|Death|0|||
126013071|NCT00367055|453341030|FG000|Overall Study|Lost to Follow-up|1|||
126013072|NCT00367055|453341031|FG001|Overall Study|Lost to Follow-up|1|||
126013073|NCT00367055|453341030|FG000|Overall Study|Protocol Violation|0|||
126013074|NCT00367055|453341031|FG001|Overall Study|Protocol Violation|1|||
126013075|NCT00367055|453341030|FG000|Overall Study|Stopping Criterion Met|0|||
126013076|NCT00367055|453341031|FG001|Overall Study|Stopping Criterion Met|1|||
126013077|NCT00367055|453341030|FG000|Overall Study|Participant Living too Far from Hospital|0|||
126013078|NCT00367055|453341031|FG001|Overall Study|Participant Living too Far from Hospital|1|||
126013079|NCT02459899|453341032|FG000|Overall Study|Adverse Event|1|||
126013080|NCT02459899|453341033|FG001|Overall Study|Adverse Event|1|||
126013081|NCT02459899|453341034|FG002|Overall Study|Adverse Event|0|||
126013082|NCT02459899|453341035|FG003|Overall Study|Adverse Event|0|||
126013083|NCT02459899|453341032|FG000|Overall Study|Lost to Follow-up|1|||
126013084|NCT02459899|453341033|FG001|Overall Study|Lost to Follow-up|2|||
126013085|NCT02459899|453341034|FG002|Overall Study|Lost to Follow-up|0|||
126013086|NCT02459899|453341035|FG003|Overall Study|Lost to Follow-up|1|||
126013087|NCT02459899|453341032|FG000|Overall Study|Non-compliance with the treatment|0|||
126013088|NCT02459899|453341033|FG001|Overall Study|Non-compliance with the treatment|0|||
126013089|NCT02459899|453341034|FG002|Overall Study|Non-compliance with the treatment|0|||
126013090|NCT02459899|453341035|FG003|Overall Study|Non-compliance with the treatment|1|||
126013091|NCT02459899|453341032|FG000|Overall Study|Withdrawal by Subject|1|||
126013092|NCT02459899|453341033|FG001|Overall Study|Withdrawal by Subject|3|||
126013093|NCT02459899|453341034|FG002|Overall Study|Withdrawal by Subject|0|||
126013094|NCT02459899|453341035|FG003|Overall Study|Withdrawal by Subject|0|||
126013095|NCT00940992|453341038|FG000|Overall Study|Adverse Event|2|||
126013096|NCT00940992|453341039|FG001|Overall Study|Adverse Event|0|||
126213173|NCT00424632|454068687|FG002|Overall Study|Death|0|||
126213174|NCT00424632|454068688|FG003|Overall Study|Death|0|||
126213175|NCT00424632|454068689|FG004|Overall Study|Death|0|||
126213176|NCT00424632|454068690|FG005|Overall Study|Death|2|||
126213177|NCT00424632|454068691|FG006|Overall Study|Death|0|||
126013097|NCT00940992|453341040|FG002|Overall Study|Adverse Event|1|||
126013098|NCT00940992|453341038|FG000|Overall Study|subject request|2|||
126013099|NCT00940992|453341039|FG001|Overall Study|subject request|1|||
126013100|NCT00940992|453341040|FG002|Overall Study|subject request|0|||
126013101|NCT00940992|453341038|FG000|Overall Study|Lost to Follow-up|0|||
126013102|NCT00940992|453341039|FG001|Overall Study|Lost to Follow-up|1|||
126013103|NCT00940992|453341040|FG002|Overall Study|Lost to Follow-up|1|||
126013104|NCT03612804|453341055|FG000|Overall Study|Death|0|||
126013105|NCT03612804|453341056|FG001|Overall Study|Death|7|||
126013106|NCT03612804|453341057|FG002|Overall Study|Death|0|||
126013107|NCT03612804|453341058|FG003|Overall Study|Death|8|||
126013108|NCT03612804|453341055|FG000|Overall Study|Medication copay coverage issues|0|||
126013109|NCT03612804|453341056|FG001|Overall Study|Medication copay coverage issues|0|||
126013110|NCT03612804|453341057|FG002|Overall Study|Medication copay coverage issues|0|||
126013111|NCT03612804|453341058|FG003|Overall Study|Medication copay coverage issues|17|||
126013112|NCT03612804|453341055|FG000|Overall Study|Not current smoker at time of screening|0|||
126013113|NCT03612804|453341056|FG001|Overall Study|Not current smoker at time of screening|1|||
126013114|NCT03612804|453341057|FG002|Overall Study|Not current smoker at time of screening|0|||
126013115|NCT03612804|453341058|FG003|Overall Study|Not current smoker at time of screening|3|||
126013116|NCT03612804|453341055|FG000|Overall Study|Non-veteran status|0|||
126013117|NCT03612804|453341056|FG001|Overall Study|Non-veteran status|1|||
126013118|NCT03612804|453341057|FG002|Overall Study|Non-veteran status|0|||
126013119|NCT03612804|453341058|FG003|Overall Study|Non-veteran status|0|||
126013120|NCT03612804|453341055|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
126013121|NCT03612804|453341056|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
126013122|NCT03612804|453341057|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
126013123|NCT03612804|453341058|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
126013124|NCT03612804|453341055|FG000|Overall Study|Provider retired from VA|0|||
126013125|NCT03612804|453341056|FG001|Overall Study|Provider retired from VA|0|||
126013126|NCT03612804|453341057|FG002|Overall Study|Provider retired from VA|2|||
126013127|NCT03612804|453341058|FG003|Overall Study|Provider retired from VA|0|||
126013128|NCT03612804|453341055|FG000|Overall Study|Withdrawal by Subject|0|||
126013129|NCT03612804|453341056|FG001|Overall Study|Withdrawal by Subject|0|||
126013130|NCT03612804|453341057|FG002|Overall Study|Withdrawal by Subject|7|||
126013131|NCT03612804|453341058|FG003|Overall Study|Withdrawal by Subject|0|||
126013132|NCT03612804|453341055|FG000|Overall Study|Provider involved with study activities|1|||
126013133|NCT03612804|453341056|FG001|Overall Study|Provider involved with study activities|0|||
126013134|NCT03612804|453341057|FG002|Overall Study|Provider involved with study activities|0|||
126013135|NCT03612804|453341058|FG003|Overall Study|Provider involved with study activities|0|||
126013136|NCT02781584|453341066|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
126013137|NCT02781584|453341067|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
126013138|NCT02781584|453341068|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
126013139|NCT02781584|453341069|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
126013140|NCT02781584|453341070|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
126013141|NCT02781584|453341071|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
126013142|NCT02781584|453341072|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
126013143|NCT02781584|453341073|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
126013144|NCT02781584|453341074|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
126013145|NCT02781584|453341075|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
126013146|NCT02781584|453341076|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
126013147|NCT02781584|453341077|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
126013148|NCT02781584|453341078|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
126213178|NCT00424632|454068692|FG007|Overall Study|Death|0|||
126213179|NCT00424632|454068693|FG008|Overall Study|Death|0|||
126213180|NCT00424632|454068694|FG009|Overall Study|Death|0|||
126213181|NCT00424632|454068685|FG000|Overall Study|Adverse Event|0|||
126213182|NCT00424632|454068686|FG001|Overall Study|Adverse Event|0|||
126213183|NCT00424632|454068687|FG002|Overall Study|Adverse Event|0|||
126213184|NCT00424632|454068688|FG003|Overall Study|Adverse Event|0|||
126213185|NCT00424632|454068689|FG004|Overall Study|Adverse Event|0|||
126213186|NCT00424632|454068690|FG005|Overall Study|Adverse Event|0|||
126213187|NCT00424632|454068691|FG006|Overall Study|Adverse Event|0|||
126213188|NCT00424632|454068692|FG007|Overall Study|Adverse Event|0|||
126213189|NCT00424632|454068693|FG008|Overall Study|Adverse Event|3|||
126213190|NCT00424632|454068694|FG009|Overall Study|Adverse Event|2|||
126213191|NCT00424632|454068685|FG000|Overall Study|Global deterioration of health status|0|||
126213192|NCT00424632|454068686|FG001|Overall Study|Global deterioration of health status|0|||
126213193|NCT00424632|454068687|FG002|Overall Study|Global deterioration of health status|0|||
126213194|NCT00424632|454068688|FG003|Overall Study|Global deterioration of health status|1|||
126213195|NCT00424632|454068689|FG004|Overall Study|Global deterioration of health status|1|||
126213196|NCT00424632|454068690|FG005|Overall Study|Global deterioration of health status|0|||
126213197|NCT00424632|454068691|FG006|Overall Study|Global deterioration of health status|0|||
126213198|NCT00424632|454068692|FG007|Overall Study|Global deterioration of health status|0|||
126213199|NCT00424632|454068693|FG008|Overall Study|Global deterioration of health status|0|||
126213200|NCT00424632|454068694|FG009|Overall Study|Global deterioration of health status|0|||
126213201|NCT00424632|454068685|FG000|Overall Study|Objective progression or relapse|1|||
126213202|NCT00424632|454068686|FG001|Overall Study|Objective progression or relapse|1|||
126213203|NCT00424632|454068687|FG002|Overall Study|Objective progression or relapse|1|||
126213204|NCT00424632|454068688|FG003|Overall Study|Objective progression or relapse|2|||
126213205|NCT00424632|454068689|FG004|Overall Study|Objective progression or relapse|2|||
126213206|NCT00424632|454068690|FG005|Overall Study|Objective progression or relapse|13|||
126213207|NCT00424632|454068691|FG006|Overall Study|Objective progression or relapse|7|||
126213208|NCT00424632|454068692|FG007|Overall Study|Objective progression or relapse|3|||
126213209|NCT00424632|454068693|FG008|Overall Study|Objective progression or relapse|12|||
126213210|NCT00424632|454068694|FG009|Overall Study|Objective progression or relapse|4|||
126213211|NCT00424632|454068685|FG000|Overall Study|Other|0|||
126013149|NCT02781584|453341066|FG000|Pre-treatment Phase|Adverse Event|0|||
126013150|NCT02781584|453341067|FG001|Pre-treatment Phase|Adverse Event|0|||
126013151|NCT02781584|453341068|FG002|Pre-treatment Phase|Adverse Event|0|||
126013152|NCT02781584|453341069|FG003|Pre-treatment Phase|Adverse Event|0|||
126013153|NCT02781584|453341070|FG004|Pre-treatment Phase|Adverse Event|0|||
126013154|NCT02781584|453341071|FG005|Pre-treatment Phase|Adverse Event|0|||
126013155|NCT02781584|453341072|FG006|Pre-treatment Phase|Adverse Event|0|||
126013156|NCT02781584|453341073|FG007|Pre-treatment Phase|Adverse Event|0|||
126013157|NCT02781584|453341074|FG008|Pre-treatment Phase|Adverse Event|0|||
126013158|NCT02781584|453341075|FG009|Pre-treatment Phase|Adverse Event|0|||
126013159|NCT02781584|453341076|FG010|Pre-treatment Phase|Adverse Event|0|||
126013160|NCT02781584|453341077|FG011|Pre-treatment Phase|Adverse Event|1|||
126013161|NCT02781584|453341078|FG012|Pre-treatment Phase|Adverse Event|0|||
126013162|NCT02781584|453341066|FG000|Treatment Phase|Withdrew Consent|0|||
126013163|NCT02781584|453341067|FG001|Treatment Phase|Withdrew Consent|0|||
126013164|NCT02781584|453341068|FG002|Treatment Phase|Withdrew Consent|0|||
126013165|NCT02781584|453341069|FG003|Treatment Phase|Withdrew Consent|0|||
126013166|NCT02781584|453341070|FG004|Treatment Phase|Withdrew Consent|0|||
126013167|NCT02781584|453341071|FG005|Treatment Phase|Withdrew Consent|1|||
126013168|NCT02781584|453341072|FG006|Treatment Phase|Withdrew Consent|0|||
126013169|NCT02781584|453341073|FG007|Treatment Phase|Withdrew Consent|0|||
126013170|NCT02781584|453341074|FG008|Treatment Phase|Withdrew Consent|0|||
126213212|NCT00424632|454068686|FG001|Overall Study|Other|0|||
126213213|NCT00424632|454068687|FG002|Overall Study|Other|0|||
126348663|NCT03765073|454571050|FG009|Stage 2|Death|1|||
126348664|NCT03765073|454571051|FG010|Stage 2|Death|0|||
126348665|NCT03765073|454571052|FG011|Stage 2|Death|1|||
126348666|NCT03765073|454571053|FG012|Stage 2|Death|0|||
126013171|NCT02781584|453341075|FG009|Treatment Phase|Withdrew Consent|0|||
126013172|NCT02781584|453341076|FG010|Treatment Phase|Withdrew Consent|1|||
126213214|NCT00424632|454068688|FG003|Overall Study|Other|1|||
126348667|NCT03765073|454571054|FG013|Stage 2|Death|0|||
126013173|NCT02781584|453341077|FG011|Treatment Phase|Withdrew Consent|2|||
126013174|NCT02781584|453341078|FG012|Treatment Phase|Withdrew Consent|0|||
126013175|NCT02781584|453341066|FG000|Treatment Phase|Adverse Event|0|||
126013176|NCT02781584|453341067|FG001|Treatment Phase|Adverse Event|0|||
126213215|NCT00424632|454068689|FG004|Overall Study|Other|0|||
126213216|NCT00424632|454068690|FG005|Overall Study|Other|0|||
126213217|NCT00424632|454068691|FG006|Overall Study|Other|0|||
126213218|NCT00424632|454068692|FG007|Overall Study|Other|0|||
126213219|NCT00424632|454068693|FG008|Overall Study|Other|1|||
126213220|NCT00424632|454068694|FG009|Overall Study|Other|0|||
126348668|NCT03765073|454571055|FG014|Stage 2|Death|0|||
126348669|NCT03765073|454571056|FG015|Stage 2|Death|0|||
126348670|NCT03765073|454571057|FG016|Stage 2|Death|2|||
126348671|NCT03765073|454571058|FG017|Stage 2|Death|0|||
126213221|NCT01984229|454068695|FG000|Safety Follow-up Period|Adverse Event|1|||
126213222|NCT01984229|454068696|FG001|Safety Follow-up Period|Adverse Event|1|||
126213223|NCT01984229|454068695|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
126213224|NCT01984229|454068696|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
126213225|NCT02325739|454068697|FG000|Phase I Part|Adverse Event|1|||
126213226|NCT02325739|454068698|FG001|Phase I Part|Adverse Event|0|||
126213227|NCT02325739|454068699|FG002|Phase I Part|Adverse Event|1|||
126213228|NCT02325739|454068700|FG003|Phase I Part|Adverse Event|2|||
126213229|NCT02325739|454068701|FG004|Phase I Part|Adverse Event|3|||
126213230|NCT02325739|454068702|FG005|Phase I Part|Adverse Event|1|||
126213231|NCT02325739|454068703|FG006|Phase I Part|Adverse Event|0|||
126213232|NCT02325739|454068704|FG007|Phase I Part|Adverse Event|2|||
126213233|NCT02325739|454068705|FG008|Phase I Part|Adverse Event|0|||
126213234|NCT02325739|454068706|FG009|Phase I Part|Adverse Event|0|||
126213235|NCT02325739|454068707|FG010|Phase I Part|Adverse Event|0|||
126213236|NCT02325739|454068697|FG000|Phase I Part|Progressive disease|9|||
126213237|NCT02325739|454068698|FG001|Phase I Part|Progressive disease|6|||
126213238|NCT02325739|454068699|FG002|Phase I Part|Progressive disease|3|||
126213239|NCT02325739|454068700|FG003|Phase I Part|Progressive disease|23|||
126213240|NCT02325739|454068701|FG004|Phase I Part|Progressive disease|14|||
126213241|NCT02325739|454068702|FG005|Phase I Part|Progressive disease|6|||
126213242|NCT02325739|454068703|FG006|Phase I Part|Progressive disease|6|||
126213243|NCT02325739|454068704|FG007|Phase I Part|Progressive disease|3|||
126213244|NCT02325739|454068705|FG008|Phase I Part|Progressive disease|0|||
126213245|NCT02325739|454068706|FG009|Phase I Part|Progressive disease|0|||
126213246|NCT02325739|454068707|FG010|Phase I Part|Progressive disease|0|||
126213247|NCT02325739|454068697|FG000|Phase I Part|Subject/guardian decision|1|||
126213248|NCT02325739|454068698|FG001|Phase I Part|Subject/guardian decision|0|||
126213249|NCT02325739|454068699|FG002|Phase I Part|Subject/guardian decision|1|||
126213250|NCT02325739|454068700|FG003|Phase I Part|Subject/guardian decision|1|||
126213251|NCT02325739|454068701|FG004|Phase I Part|Subject/guardian decision|0|||
126213252|NCT02325739|454068702|FG005|Phase I Part|Subject/guardian decision|0|||
126213253|NCT02325739|454068703|FG006|Phase I Part|Subject/guardian decision|0|||
126213254|NCT02325739|454068704|FG007|Phase I Part|Subject/guardian decision|1|||
126213255|NCT02325739|454068705|FG008|Phase I Part|Subject/guardian decision|0|||
126213256|NCT02325739|454068706|FG009|Phase I Part|Subject/guardian decision|0|||
126213257|NCT02325739|454068707|FG010|Phase I Part|Subject/guardian decision|0|||
126213258|NCT02325739|454068697|FG000|Phase I Part|Death|0|||
126213259|NCT02325739|454068698|FG001|Phase I Part|Death|0|||
126213260|NCT02325739|454068699|FG002|Phase I Part|Death|0|||
126213261|NCT02325739|454068700|FG003|Phase I Part|Death|0|||
126213262|NCT02325739|454068701|FG004|Phase I Part|Death|2|||
126213263|NCT02325739|454068702|FG005|Phase I Part|Death|0|||
126213264|NCT02325739|454068703|FG006|Phase I Part|Death|0|||
126213265|NCT02325739|454068704|FG007|Phase I Part|Death|0|||
126213266|NCT02325739|454068705|FG008|Phase I Part|Death|0|||
126213267|NCT02325739|454068706|FG009|Phase I Part|Death|0|||
126213268|NCT02325739|454068707|FG010|Phase I Part|Death|0|||
126213269|NCT02325739|454068697|FG000|Phase II Part|Adverse Event|0|||
126213270|NCT02325739|454068698|FG001|Phase II Part|Adverse Event|0|||
126213271|NCT02325739|454068699|FG002|Phase II Part|Adverse Event|0|||
126213272|NCT02325739|454068700|FG003|Phase II Part|Adverse Event|0|||
126213273|NCT02325739|454068701|FG004|Phase II Part|Adverse Event|0|||
126213274|NCT02325739|454068702|FG005|Phase II Part|Adverse Event|0|||
126213275|NCT02325739|454068703|FG006|Phase II Part|Adverse Event|0|||
126213276|NCT02325739|454068704|FG007|Phase II Part|Adverse Event|0|||
126213277|NCT02325739|454068705|FG008|Phase II Part|Adverse Event|4|||
126213278|NCT02325739|454068706|FG009|Phase II Part|Adverse Event|5|||
126213279|NCT02325739|454068707|FG010|Phase II Part|Adverse Event|1|||
126213280|NCT02325739|454068697|FG000|Phase II Part|Physician Decision|0|||
126213281|NCT02325739|454068698|FG001|Phase II Part|Physician Decision|0|||
126213282|NCT02325739|454068699|FG002|Phase II Part|Physician Decision|0|||
126213283|NCT02325739|454068700|FG003|Phase II Part|Physician Decision|0|||
126213284|NCT02325739|454068701|FG004|Phase II Part|Physician Decision|0|||
126213285|NCT02325739|454068702|FG005|Phase II Part|Physician Decision|0|||
126213286|NCT02325739|454068703|FG006|Phase II Part|Physician Decision|0|||
126213287|NCT02325739|454068704|FG007|Phase II Part|Physician Decision|0|||
126213288|NCT02325739|454068705|FG008|Phase II Part|Physician Decision|0|||
126213289|NCT02325739|454068706|FG009|Phase II Part|Physician Decision|1|||
126213290|NCT02325739|454068707|FG010|Phase II Part|Physician Decision|0|||
126213291|NCT02325739|454068697|FG000|Phase II Part|Progressive disease|0|||
126213292|NCT02325739|454068698|FG001|Phase II Part|Progressive disease|0|||
126213293|NCT02325739|454068699|FG002|Phase II Part|Progressive disease|0|||
126213294|NCT02325739|454068700|FG003|Phase II Part|Progressive disease|0|||
126213295|NCT02325739|454068701|FG004|Phase II Part|Progressive disease|0|||
126213296|NCT02325739|454068702|FG005|Phase II Part|Progressive disease|0|||
126213297|NCT02325739|454068703|FG006|Phase II Part|Progressive disease|0|||
126213298|NCT02325739|454068704|FG007|Phase II Part|Progressive disease|0|||
126213299|NCT02325739|454068705|FG008|Phase II Part|Progressive disease|22|||
126213300|NCT02325739|454068706|FG009|Phase II Part|Progressive disease|29|||
126213301|NCT02325739|454068707|FG010|Phase II Part|Progressive disease|18|||
126213302|NCT02325739|454068697|FG000|Phase II Part|Subject/guardian decision|0|||
126213303|NCT02325739|454068698|FG001|Phase II Part|Subject/guardian decision|0|||
126213304|NCT02325739|454068699|FG002|Phase II Part|Subject/guardian decision|0|||
126213305|NCT02325739|454068700|FG003|Phase II Part|Subject/guardian decision|0|||
126213306|NCT02325739|454068701|FG004|Phase II Part|Subject/guardian decision|0|||
126213307|NCT02325739|454068702|FG005|Phase II Part|Subject/guardian decision|0|||
126213308|NCT02325739|454068703|FG006|Phase II Part|Subject/guardian decision|0|||
126213309|NCT02325739|454068704|FG007|Phase II Part|Subject/guardian decision|0|||
126213310|NCT02325739|454068705|FG008|Phase II Part|Subject/guardian decision|4|||
126213311|NCT02325739|454068706|FG009|Phase II Part|Subject/guardian decision|1|||
126213312|NCT02325739|454068707|FG010|Phase II Part|Subject/guardian decision|1|||
126213313|NCT00824993|454068716|FG000|Overall Study|Withdrawal by Subject|1|||
126213314|NCT00824993|454068717|FG001|Overall Study|Withdrawal by Subject|1|||
126213315|NCT00824993|454068716|FG000|Overall Study|Malignancy Relapse|9|||
126213316|NCT00824993|454068717|FG001|Overall Study|Malignancy Relapse|10|||
126213317|NCT00824993|454068716|FG000|Overall Study|Rapid Bone Loss|0|||
126213318|NCT00824993|454068717|FG001|Overall Study|Rapid Bone Loss|1|||
126213319|NCT00824993|454068716|FG000|Overall Study|Non-Compliant|2|||
126213320|NCT00824993|454068717|FG001|Overall Study|Non-Compliant|1|||
126213321|NCT00824993|454068716|FG000|Overall Study|Insurance Issue|2|||
126213322|NCT00824993|454068717|FG001|Overall Study|Insurance Issue|1|||
126213323|NCT00824993|454068716|FG000|Overall Study|Death|0|||
126213324|NCT00824993|454068717|FG001|Overall Study|Death|3|||
126213325|NCT02596009|454068718|FG000|Overall Study|Administrative problems|0|||
126213326|NCT02596009|454068719|FG001|Overall Study|Administrative problems|1|||
126213327|NCT02596009|454068720|FG002|Overall Study|Administrative problems|0|||
126213328|NCT02596009|454068721|FG003|Overall Study|Administrative problems|0|||
126213329|NCT02596009|454068722|FG004|Overall Study|Administrative problems|0|||
126213330|NCT02596009|454068723|FG005|Overall Study|Administrative problems|0|||
126213331|NCT02998645|454068724|FG000|Treatment Period 1|Adverse Event|6|||
126213332|NCT02998645|454068724|FG000|Treatment Period 1|Death|5|||
126213333|NCT02998645|454068724|FG000|Treatment Period 1|Technical Problems|4|||
126213334|NCT02998645|454068724|FG000|Treatment Period 1|Lack of Efficacy|2|||
126213335|NCT02998645|454068724|FG000|Treatment Period 1|Progressive disease|1|||
126213336|NCT02998645|454068724|FG000|Treatment Period 1|Subject/guardian decision|1|||
126213337|NCT02998645|454068724|FG000|Treatment Period 2|Lack of Efficacy|5|||
126213338|NCT02998645|454068724|FG000|Treatment Period 2|Adverse Event|2|||
126213339|NCT02998645|454068724|FG000|Treatment Period 2|Progressive disease|2|||
126213340|NCT02998645|454068724|FG000|Treatment Period 2|Physician Decision|1|||
126213341|NCT04611152|454068729|FG000|Overall Study|Adverse Event|9|||
126213342|NCT04611152|454068730|FG001|Overall Study|Adverse Event|8|||
126213343|NCT04611152|454068729|FG000|Overall Study|Non-compliance with study schedule|1|||
126213344|NCT04611152|454068730|FG001|Overall Study|Non-compliance with study schedule|3|||
126213345|NCT04611152|454068729|FG000|Overall Study|Withdrawal by Subject|5|||
126213346|NCT04611152|454068730|FG001|Overall Study|Withdrawal by Subject|6|||
126213347|NCT04611152|454068729|FG000|Overall Study|Lost to Follow-up|11|||
126213348|NCT04611152|454068730|FG001|Overall Study|Lost to Follow-up|2|||
126013177|NCT02781584|453341068|FG002|Treatment Phase|Adverse Event|0|||
126013178|NCT02781584|453341069|FG003|Treatment Phase|Adverse Event|0|||
126213349|NCT03644927|454068731|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
126213350|NCT03644927|454068732|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
126213351|NCT00956813|454068733|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
126213352|NCT00956813|454068734|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
126213353|NCT00956813|454068733|FG000|Flaxseed and Placebo|Ineligible|3|||
126213354|NCT00956813|454068734|FG001|Flaxseed and Placebo|Ineligible|1|||
126213355|NCT01275170|454068739|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
126213356|NCT01275170|454068740|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
126213357|NCT01275170|454068741|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
126213358|NCT01275170|454068742|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
126213359|NCT01275170|454068743|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
125878652|NCT01972217|452853372|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
125878653|NCT01972217|452853373|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
125878654|NCT01972217|452853374|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
125878655|NCT01972217|452853371|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
125878656|NCT01972217|452853372|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
126013179|NCT02781584|453341070|FG004|Treatment Phase|Adverse Event|0|||
126013180|NCT02781584|453341071|FG005|Treatment Phase|Adverse Event|0|||
126013181|NCT02781584|453341072|FG006|Treatment Phase|Adverse Event|0|||
126013182|NCT02781584|453341073|FG007|Treatment Phase|Adverse Event|1|||
126013183|NCT02781584|453341074|FG008|Treatment Phase|Adverse Event|0|||
126013184|NCT02781584|453341075|FG009|Treatment Phase|Adverse Event|0|||
126013185|NCT02781584|453341076|FG010|Treatment Phase|Adverse Event|0|||
126013186|NCT02781584|453341077|FG011|Treatment Phase|Adverse Event|0|||
126013187|NCT02781584|453341078|FG012|Treatment Phase|Adverse Event|0|||
126013188|NCT05019729|453341079|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126013189|NCT05019729|453341080|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126013190|NCT05019729|453341081|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126013191|NCT05019729|453341082|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126013192|NCT05019729|453341083|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
126013193|NCT05019729|453341084|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126013194|NCT00387465|453341088|FG000|Overall Study|Withdrawal by Subject|0|||
126013195|NCT00387465|453341089|FG001|Overall Study|Withdrawal by Subject|1|||
126013196|NCT00387465|453341090|FG002|Overall Study|Withdrawal by Subject|0|||
126013197|NCT05052983|453341095|FG000|Overall Study|Lack of Efficacy|3|||
126013198|NCT05052983|453341096|FG001|Overall Study|Lack of Efficacy|12|||
126013199|NCT05052983|453341095|FG000|Overall Study|Adverse Event|1|||
126013200|NCT05052983|453341096|FG001|Overall Study|Adverse Event|0|||
126013201|NCT04133363|453341097|FG000|Overall Study|Lost to Follow-up|2|||
126013202|NCT04133363|453341098|FG001|Overall Study|Lost to Follow-up|1|||
126013203|NCT04133363|453341099|FG002|Overall Study|Lost to Follow-up|4|||
126013204|NCT00849147|453341103|FG000|Overall Study|Withdrawal by Subject|1|||
126013205|NCT00849147|453341103|FG000|Overall Study|Protocol Violation|2|||
126013206|NCT00849147|453341103|FG000|Overall Study|Disease Relapse/Progression|2|||
126013207|NCT04860258|453342330|FG000|Overall Study|Withdrawal by Subject|0|||
126013208|NCT04860258|453342331|FG001|Overall Study|Withdrawal by Subject|0|||
126013209|NCT04860258|453342332|FG002|Overall Study|Withdrawal by Subject|4|||
126013210|NCT04860258|453342333|FG003|Overall Study|Withdrawal by Subject|1|||
126013211|NCT04860258|453342334|FG004|Overall Study|Withdrawal by Subject|4|||
126013212|NCT04860258|453342335|FG005|Overall Study|Withdrawal by Subject|1|||
126013213|NCT04860258|453342336|FG006|Overall Study|Withdrawal by Subject|0|||
126013214|NCT00028769|453342337|FG000|Overall Study|Adverse Event|2|||
126013215|NCT00028769|453342337|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
126013216|NCT00028769|453342337|FG000|Overall Study|Progression or Death|31|||
126013217|NCT00028769|453342337|FG000|Overall Study|Other - Not Protocol Specified|1|||
126013218|NCT00028769|453342337|FG000|Overall Study|Ineligible|5|||
126013219|NCT00028769|453342337|FG000|Overall Study|Not Analyzable|1|||
126013220|NCT00357396|453342338|FG000|Overall Study|Adverse Event|1|||
126013221|NCT00357396|453342339|FG001|Overall Study|Adverse Event|0|||
126013222|NCT00487578|453342340|FG000|Overall Study|Adverse Event|1|||
126013223|NCT00487578|453342341|FG001|Overall Study|Adverse Event|2|||
126013224|NCT00487578|453342340|FG000|Overall Study|Lack of Efficacy|0|||
126013225|NCT00487578|453342341|FG001|Overall Study|Lack of Efficacy|1|||
126013226|NCT00487578|453342340|FG000|Overall Study|Lost to Follow-up|0|||
126013227|NCT00487578|453342341|FG001|Overall Study|Lost to Follow-up|1|||
126013228|NCT00726999|453342344|FG000|Overall Study|Physician Decision|0|||
126013229|NCT00726999|453342345|FG001|Overall Study|Physician Decision|1|||
126013230|NCT00726999|453342344|FG000|Overall Study|Withdrawal by Subject|2|||
126013231|NCT00726999|453342345|FG001|Overall Study|Withdrawal by Subject|0|||
126013232|NCT00726999|453342344|FG000|Overall Study|Protocol Violation|1|||
126013233|NCT00726999|453342345|FG001|Overall Study|Protocol Violation|0|||
126013234|NCT01499134|453342346|FG000|Overall Study|Withdrawal by Subject|0|||
125878657|NCT01972217|452853373|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
125878658|NCT01972217|452853374|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
126013235|NCT01499134|453342347|FG001|Overall Study|Withdrawal by Subject|1|||
126013236|NCT00955825|453342348|FG000|Overall Study|Adverse Event|15|||
126013237|NCT00955825|453342349|FG001|Overall Study|Adverse Event|2|||
126013238|NCT00955825|453342348|FG000|Overall Study|Withdrawal by Subject|4|||
125878659|NCT01972217|452853371|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
125878660|NCT01972217|452853372|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
126013239|NCT00955825|453342349|FG001|Overall Study|Withdrawal by Subject|6|||
126013240|NCT00955825|453342348|FG000|Overall Study|Any other reason not above-mentioned|7|||
126213360|NCT01275170|454068744|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
126013241|NCT00955825|453342349|FG001|Overall Study|Any other reason not above-mentioned|9|||
126013242|NCT01198275|453342350|FG000|Overall Study|Adverse Event|2|||
126013243|NCT01198275|453342351|FG001|Overall Study|Adverse Event|3|||
126013244|NCT01198275|453342350|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
126013245|NCT01198275|453342351|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
126013246|NCT00391846|453342352|FG000|Overall Study|Adverse Event|4|||
126013247|NCT00391846|453342353|FG001|Overall Study|Adverse Event|1|||
126013248|NCT00391846|453342352|FG000|Overall Study|Did not meet the required elig. crit|2|||
126013249|NCT00391846|453342353|FG001|Overall Study|Did not meet the required elig. crit|2|||
126013250|NCT00391846|453342352|FG000|Overall Study|Withdrawal by Subject|2|||
126013251|NCT00391846|453342353|FG001|Overall Study|Withdrawal by Subject|3|||
126013252|NCT00391846|453342352|FG000|Overall Study|Developed study specific DC criteria|0|||
126013253|NCT00391846|453342353|FG001|Overall Study|Developed study specific DC criteria|1|||
126013254|NCT00150176|453342354|FG000|Overall Study|Adverse Event|16|||
126213361|NCT01275170|454068745|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
126213362|NCT01275170|454068746|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
126213363|NCT02864953|454068747|FG000|Overall Study|Adverse Event|22|||
126213364|NCT02864953|454068748|FG001|Overall Study|Adverse Event|19|||
126213365|NCT02864953|454068747|FG000|Overall Study|Withdrawal by Subject|1|||
126213366|NCT02864953|454068748|FG001|Overall Study|Withdrawal by Subject|0|||
126213367|NCT02864953|454068747|FG000|Overall Study|Physician Decision|4|||
126213368|NCT02864953|454068748|FG001|Overall Study|Physician Decision|2|||
126213369|NCT02864953|454068747|FG000|Overall Study|Death|3|||
126213370|NCT02864953|454068748|FG001|Overall Study|Death|13|||
126213371|NCT02864953|454068747|FG000|Overall Study|Reason not specified|14|||
126213372|NCT02864953|454068748|FG001|Overall Study|Reason not specified|12|||
126213373|NCT02864953|454068747|FG000|Overall Study|Withdrew Prior to Dosing|9|||
126213374|NCT02864953|454068748|FG001|Overall Study|Withdrew Prior to Dosing|8|||
126213375|NCT03728257|454068749|FG000|Overall Study|Death|3|||
126213376|NCT03728257|454068750|FG001|Overall Study|Death|0|||
126213377|NCT00621309|454068752|FG000|Overall Study|Withdrawal by Subject|2|||
126213378|NCT00621309|454068753|FG001|Overall Study|Withdrawal by Subject|0|||
126213379|NCT00621309|454068754|FG002|Overall Study|Withdrawal by Subject|1|||
126213380|NCT00621309|454068755|FG003|Overall Study|Withdrawal by Subject|1|||
126213381|NCT00621309|454068756|FG004|Overall Study|Withdrawal by Subject|1|||
126213382|NCT00621309|454068757|FG005|Overall Study|Withdrawal by Subject|1|||
126213383|NCT01306968|454068760|FG000|Overall Study|Lost to Follow-up|1|||
126213384|NCT01306968|454068761|FG001|Overall Study|Lost to Follow-up|1|||
126213385|NCT01306968|454068762|FG002|Overall Study|Lost to Follow-up|0|||
126213386|NCT01306968|454068763|FG003|Overall Study|Lost to Follow-up|0|||
126213387|NCT01306968|454068760|FG000|Overall Study|Physician Decision|0|||
126213388|NCT01306968|454068761|FG001|Overall Study|Physician Decision|1|||
126213389|NCT01306968|454068762|FG002|Overall Study|Physician Decision|0|||
126213390|NCT01306968|454068763|FG003|Overall Study|Physician Decision|0|||
126213391|NCT01306968|454068760|FG000|Overall Study|Relocated and left active duty|0|||
126213392|NCT01306968|454068761|FG001|Overall Study|Relocated and left active duty|1|||
126213393|NCT01306968|454068762|FG002|Overall Study|Relocated and left active duty|1|||
126213394|NCT01306968|454068763|FG003|Overall Study|Relocated and left active duty|1|||
126213395|NCT01306968|454068760|FG000|Overall Study|Withdrew - time commitment|0|||
126213396|NCT01306968|454068761|FG001|Overall Study|Withdrew - time commitment|0|||
126213397|NCT01306968|454068762|FG002|Overall Study|Withdrew - time commitment|0|||
126213398|NCT01306968|454068763|FG003|Overall Study|Withdrew - time commitment|2|||
126213399|NCT01306968|454068760|FG000|Overall Study|Withdrew over privacy concerns|0|||
126213400|NCT01306968|454068761|FG001|Overall Study|Withdrew over privacy concerns|0|||
126213401|NCT01306968|454068762|FG002|Overall Study|Withdrew over privacy concerns|0|||
126213402|NCT01306968|454068763|FG003|Overall Study|Withdrew over privacy concerns|1|||
126213403|NCT04993339|454068764|FG000|Overall Study|Lost to Follow-up|0|||
126213404|NCT04993339|454068765|FG001|Overall Study|Lost to Follow-up|1|||
126213405|NCT04993339|454068764|FG000|Overall Study|no MRI scan|3|||
126013255|NCT00150176|453342355|FG001|Overall Study|Adverse Event|53|||
126013256|NCT00150176|453342354|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
126213406|NCT04993339|454068765|FG001|Overall Study|no MRI scan|1|||
126213407|NCT03868059|454068767|FG000|Overall Study|Adverse Event|3|||
126213408|NCT03868059|454068767|FG000|Overall Study|Lost to Follow-up|3|||
126213409|NCT03868059|454068767|FG000|Overall Study|Withdrawal by Subject|6|||
126213410|NCT02949219|454068768|FG000|Overall Study|Withdrawal by Subject|1|||
126213411|NCT02044094|454068785|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
126213412|NCT02044094|454068785|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
126213413|NCT02044094|454068785|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
126213414|NCT02044094|454068785|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
126213415|NCT02044094|454068785|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
126213416|NCT02044094|454068785|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
126213417|NCT02044094|454068785|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
126013257|NCT00150176|453342355|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
125878661|NCT01972217|452853373|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
125878662|NCT01972217|452853374|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
125878663|NCT02318706|452853377|FG000|Double-blind Phase|Adverse Event|7|||
125878664|NCT02318706|452853378|FG001|Double-blind Phase|Adverse Event|4|||
125878665|NCT02318706|452853379|FG002|Double-blind Phase|Adverse Event|3|||
125878666|NCT02318706|452853380|FG003|Double-blind Phase|Adverse Event|10|||
125878667|NCT02318706|452853381|FG004|Double-blind Phase|Adverse Event|0|||
125878668|NCT02318706|452853377|FG000|Double-blind Phase|Lost to Follow-up|1|||
125878669|NCT02318706|452853378|FG001|Double-blind Phase|Lost to Follow-up|0|||
126013258|NCT00150176|453342354|FG000|Overall Study|Withdrawal by Subject|19|||
126013259|NCT00150176|453342355|FG001|Overall Study|Withdrawal by Subject|12|||
126013260|NCT00150176|453342354|FG000|Overall Study|Lost to Follow-up|3|||
126013261|NCT00150176|453342355|FG001|Overall Study|Lost to Follow-up|3|||
126013262|NCT00150176|453342354|FG000|Overall Study|OTHER|11|||
126013263|NCT00150176|453342355|FG001|Overall Study|OTHER|13|||
126013264|NCT05257798|453342356|FG000|Follow-up Phase|Lost to Follow-up|1|||
126013265|NCT05257798|453342357|FG001|Follow-up Phase|Lost to Follow-up|0|||
126013266|NCT02082158|453342360|FG000|Overall Study|Withdrawal by Subject|0|||
126013267|NCT02082158|453342361|FG001|Overall Study|Withdrawal by Subject|0|||
126013268|NCT02082158|453342362|FG002|Overall Study|Withdrawal by Subject|0|||
126013269|NCT02082158|453342363|FG003|Overall Study|Withdrawal by Subject|0|||
126013270|NCT02082158|453342364|FG004|Overall Study|Withdrawal by Subject|1|||
126013271|NCT02082158|453342365|FG005|Overall Study|Withdrawal by Subject|0|||
126013272|NCT02082158|453342360|FG000|Overall Study|Failed Fit-testing|8|||
126013273|NCT02082158|453342361|FG001|Overall Study|Failed Fit-testing|8|||
126013274|NCT02082158|453342362|FG002|Overall Study|Failed Fit-testing|14|||
126013275|NCT02082158|453342363|FG003|Overall Study|Failed Fit-testing|4|||
126013276|NCT02082158|453342364|FG004|Overall Study|Failed Fit-testing|3|||
126013277|NCT02082158|453342365|FG005|Overall Study|Failed Fit-testing|7|||
126013278|NCT00738699|453342366|FG000|Overall Study|Withdrawal by Subject|5|||
126013279|NCT00738699|453342367|FG001|Overall Study|Withdrawal by Subject|0|||
126348672|NCT03765073|454571059|FG018|Stage 2|Death|0|||
126348673|NCT03765073|454571060|FG019|Stage 2|Death|0|||
126348674|NCT03765073|454571061|FG020|Stage 2|Death|0|||
126348675|NCT03765073|454571041|FG000|Stage 2|Lost to Follow-up|0|||
126348676|NCT03765073|454571042|FG001|Stage 2|Lost to Follow-up|0|||
126348677|NCT03765073|454571043|FG002|Stage 2|Lost to Follow-up|0|||
126348678|NCT03765073|454571044|FG003|Stage 2|Lost to Follow-up|5|||
126348679|NCT03765073|454571045|FG004|Stage 2|Lost to Follow-up|1|||
126348680|NCT03765073|454571046|FG005|Stage 2|Lost to Follow-up|0|||
126348681|NCT03765073|454571047|FG006|Stage 2|Lost to Follow-up|3|||
126348682|NCT03765073|454571048|FG007|Stage 2|Lost to Follow-up|3|||
126348683|NCT03765073|454571049|FG008|Stage 2|Lost to Follow-up|1|||
126348684|NCT03765073|454571050|FG009|Stage 2|Lost to Follow-up|6|||
126348685|NCT03765073|454571051|FG010|Stage 2|Lost to Follow-up|5|||
126348686|NCT03765073|454571052|FG011|Stage 2|Lost to Follow-up|1|||
126348687|NCT03765073|454571053|FG012|Stage 2|Lost to Follow-up|1|||
126348688|NCT03765073|454571054|FG013|Stage 2|Lost to Follow-up|3|||
126348689|NCT03765073|454571055|FG014|Stage 2|Lost to Follow-up|3|||
126348690|NCT03765073|454571056|FG015|Stage 2|Lost to Follow-up|1|||
126348691|NCT03765073|454571057|FG016|Stage 2|Lost to Follow-up|6|||
126348692|NCT03765073|454571058|FG017|Stage 2|Lost to Follow-up|0|||
126348693|NCT03765073|454571059|FG018|Stage 2|Lost to Follow-up|0|||
125878670|NCT02318706|452853379|FG002|Double-blind Phase|Lost to Follow-up|0|||
126013280|NCT00738699|453342366|FG000|Overall Study|Lost to Follow-up|1|||
126013281|NCT00738699|453342367|FG001|Overall Study|Lost to Follow-up|0|||
126013282|NCT00738699|453342366|FG000|Overall Study|Death|144|||
126013283|NCT00738699|453342367|FG001|Overall Study|Death|68|||
126348694|NCT03765073|454571060|FG019|Stage 2|Lost to Follow-up|0|||
126348695|NCT03765073|454571061|FG020|Stage 2|Lost to Follow-up|0|||
126348696|NCT03765073|454571041|FG000|Stage 2|Other|0|||
126348697|NCT03765073|454571042|FG001|Stage 2|Other|0|||
126348698|NCT03765073|454571043|FG002|Stage 2|Other|0|||
126348699|NCT03765073|454571044|FG003|Stage 2|Other|0|||
126348700|NCT03765073|454571045|FG004|Stage 2|Other|0|||
126348701|NCT03765073|454571046|FG005|Stage 2|Other|0|||
126213418|NCT02044094|454068785|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
126213419|NCT03353415|454068788|FG000|Masked CGM Wear|Lost to Follow-up|2|||
126213420|NCT03353415|454068788|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
126213421|NCT01298661|454068789|FG000|Overall Study|Withdrawal by Subject|2|||
126213422|NCT01298661|454068790|FG001|Overall Study|Withdrawal by Subject|0|||
126213423|NCT01298661|454068791|FG002|Overall Study|Withdrawal by Subject|2|||
126213424|NCT01017731|454071130|FG000|Overall Study|Lost to Follow-up|2|||
126213425|NCT01017731|454071130|FG000|Overall Study|Withdrawal by Subject|3|||
126213426|NCT01017731|454071130|FG000|Overall Study|Physician Decision|2|||
126213427|NCT01017731|454071130|FG000|Overall Study|Adverse Event|1|||
126213428|NCT05378269|454071131|FG000|Overall Study|Protocol Violation|1|||
126213429|NCT05378269|454071132|FG001|Overall Study|Protocol Violation|0|||
126213430|NCT05378269|454071133|FG002|Overall Study|Protocol Violation|2|||
126213431|NCT05378269|454071134|FG003|Overall Study|Protocol Violation|0|||
126213432|NCT05378269|454071135|FG004|Overall Study|Protocol Violation|0|||
126213433|NCT00359073|454071136|FG000|Overall Study|Withdrawal by Subject|1|||
126213434|NCT00359073|454071137|FG001|Overall Study|Withdrawal by Subject|1|||
126213435|NCT00359073|454071136|FG000|Overall Study|Eligibility criteria no longer met|3|||
126213436|NCT00359073|454071137|FG001|Overall Study|Eligibility criteria no longer met|0|||
126213437|NCT00359073|454071136|FG000|Overall Study|developed RV16 antibody|0|||
126213438|NCT00359073|454071137|FG001|Overall Study|developed RV16 antibody|1|||
126213439|NCT03387423|454071138|FG000|Overall Study|Lost to Follow-up|16|||
126213440|NCT03387423|454071139|FG001|Overall Study|Lost to Follow-up|12|||
126213441|NCT03387423|454071140|FG002|Overall Study|Lost to Follow-up|1|||
126213442|NCT03387423|454071141|FG003|Overall Study|Lost to Follow-up|0|||
126213443|NCT03387423|454071138|FG000|Overall Study|Other|0|||
126213444|NCT03387423|454071139|FG001|Overall Study|Other|3|||
126213445|NCT03387423|454071140|FG002|Overall Study|Other|0|||
126213446|NCT03387423|454071141|FG003|Overall Study|Other|0|||
126213447|NCT03387423|454071138|FG000|Overall Study|Administrative Reason|166|||
126213448|NCT03387423|454071139|FG001|Overall Study|Administrative Reason|89|||
126213449|NCT03387423|454071140|FG002|Overall Study|Administrative Reason|17|||
126213450|NCT03387423|454071141|FG003|Overall Study|Administrative Reason|19|||
126213451|NCT03387423|454071138|FG000|Overall Study|Revocation Consent|76|||
126213452|NCT03387423|454071139|FG001|Overall Study|Revocation Consent|32|||
126213453|NCT03387423|454071140|FG002|Overall Study|Revocation Consent|3|||
126213454|NCT03387423|454071141|FG003|Overall Study|Revocation Consent|5|||
126213455|NCT01371006|454071142|FG000|Overall Study|Adverse Event|1|||
126213456|NCT01371006|454071143|FG001|Overall Study|Adverse Event|0|||
126213457|NCT01721200|454071144|FG000|Overall Study|Lost to Follow-up|3|||
126213458|NCT01721200|454071145|FG001|Overall Study|Lost to Follow-up|5|||
126213459|NCT03926728|454071146|FG000|Overall Study|Withdrawal by Subject|0|||
126213460|NCT03926728|454071147|FG001|Overall Study|Withdrawal by Subject|1|||
126213461|NCT03926728|454071148|FG002|Overall Study|Withdrawal by Subject|1|||
126213462|NCT03926728|454071149|FG003|Overall Study|Withdrawal by Subject|0|||
126348702|NCT03765073|454571047|FG006|Stage 2|Other|0|||
126348703|NCT03765073|454571048|FG007|Stage 2|Other|1|||
126348704|NCT03765073|454571049|FG008|Stage 2|Other|1|||
126348705|NCT03765073|454571050|FG009|Stage 2|Other|3|||
126348706|NCT03765073|454571051|FG010|Stage 2|Other|0|||
126348707|NCT03765073|454571052|FG011|Stage 2|Other|0|||
126348708|NCT03765073|454571053|FG012|Stage 2|Other|0|||
126348709|NCT03765073|454571054|FG013|Stage 2|Other|0|||
126348710|NCT03765073|454571055|FG014|Stage 2|Other|0|||
126348711|NCT03765073|454571056|FG015|Stage 2|Other|1|||
126348712|NCT03765073|454571057|FG016|Stage 2|Other|2|||
126348713|NCT03765073|454571058|FG017|Stage 2|Other|0|||
126348714|NCT03765073|454571059|FG018|Stage 2|Other|0|||
126348715|NCT03765073|454571060|FG019|Stage 2|Other|0|||
126348716|NCT03765073|454571061|FG020|Stage 2|Other|0|||
126348717|NCT03765073|454571041|FG000|Stage 2|Withdrawal by parent/guardian|0|||
126348718|NCT03765073|454571042|FG001|Stage 2|Withdrawal by parent/guardian|0|||
126348719|NCT03765073|454571043|FG002|Stage 2|Withdrawal by parent/guardian|0|||
126348720|NCT03765073|454571044|FG003|Stage 2|Withdrawal by parent/guardian|0|||
126348721|NCT03765073|454571045|FG004|Stage 2|Withdrawal by parent/guardian|0|||
126348722|NCT03765073|454571046|FG005|Stage 2|Withdrawal by parent/guardian|0|||
126348723|NCT03765073|454571047|FG006|Stage 2|Withdrawal by parent/guardian|0|||
126213463|NCT03926728|454071150|FG004|Overall Study|Withdrawal by Subject|0|||
126213464|NCT03926728|454071151|FG005|Overall Study|Withdrawal by Subject|1|||
126213465|NCT03926728|454071152|FG006|Overall Study|Withdrawal by Subject|1|||
126213466|NCT03926728|454071153|FG007|Overall Study|Withdrawal by Subject|0|||
126213467|NCT03926728|454071154|FG008|Overall Study|Withdrawal by Subject|0|||
126213468|NCT03926728|454071155|FG009|Overall Study|Withdrawal by Subject|1|||
126213469|NCT03926728|454071156|FG010|Overall Study|Withdrawal by Subject|0|||
126213470|NCT03926728|454071157|FG011|Overall Study|Withdrawal by Subject|0|||
126213471|NCT01956123|454071162|FG000|COS Cycle 2|Protocol Violation|8|||
126213472|NCT01956123|454071163|FG001|COS Cycle 2|Protocol Violation|3|||
126213473|NCT01956123|454071164|FG002|COS Cycle 2|Protocol Violation|0|||
126348724|NCT03765073|454571048|FG007|Stage 2|Withdrawal by parent/guardian|0|||
126348725|NCT03765073|454571049|FG008|Stage 2|Withdrawal by parent/guardian|0|||
126213474|NCT01956123|454071165|FG003|COS Cycle 2|Protocol Violation|0|||
126213475|NCT01956123|454071162|FG000|COS Cycle 2|Adverse Event|3|||
126213476|NCT01956123|454071163|FG001|COS Cycle 2|Adverse Event|4|||
126213477|NCT01956123|454071164|FG002|COS Cycle 2|Adverse Event|0|||
126213478|NCT01956123|454071165|FG003|COS Cycle 2|Adverse Event|0|||
126213479|NCT01956123|454071162|FG000|COS Cycle 2|Personal Reasons|2|||
126213480|NCT01956123|454071163|FG001|COS Cycle 2|Personal Reasons|0|||
126213481|NCT01956123|454071164|FG002|COS Cycle 2|Personal Reasons|0|||
126213482|NCT01956123|454071165|FG003|COS Cycle 2|Personal Reasons|0|||
126213483|NCT01956123|454071162|FG000|COS Cycle 2|Withdrawal by Subject|1|||
126213484|NCT01956123|454071163|FG001|COS Cycle 2|Withdrawal by Subject|0|||
126213485|NCT01956123|454071164|FG002|COS Cycle 2|Withdrawal by Subject|0|||
126213486|NCT01956123|454071165|FG003|COS Cycle 2|Withdrawal by Subject|0|||
126213487|NCT01956123|454071162|FG000|COS Cycle 3|Protocol Violation|0|||
126213488|NCT01956123|454071163|FG001|COS Cycle 3|Protocol Violation|0|||
126213489|NCT01956123|454071164|FG002|COS Cycle 3|Protocol Violation|2|||
126213490|NCT01956123|454071165|FG003|COS Cycle 3|Protocol Violation|1|||
126213491|NCT01956123|454071162|FG000|COS Cycle 3|Adverse Event|0|||
126213492|NCT01956123|454071163|FG001|COS Cycle 3|Adverse Event|0|||
126213493|NCT01956123|454071164|FG002|COS Cycle 3|Adverse Event|3|||
126213494|NCT01956123|454071165|FG003|COS Cycle 3|Adverse Event|0|||
126213495|NCT01956123|454071162|FG000|COS Cycle 3|Personal Reasons|0|||
126213496|NCT01956123|454071163|FG001|COS Cycle 3|Personal Reasons|0|||
126213497|NCT01956123|454071164|FG002|COS Cycle 3|Personal Reasons|1|||
126213498|NCT01956123|454071165|FG003|COS Cycle 3|Personal Reasons|0|||
126213499|NCT01956123|454071162|FG000|COS Cycle 3|Withdrawal by Subject|0|||
126213500|NCT01956123|454071163|FG001|COS Cycle 3|Withdrawal by Subject|0|||
126213501|NCT01956123|454071164|FG002|COS Cycle 3|Withdrawal by Subject|0|||
126213502|NCT01956123|454071165|FG003|COS Cycle 3|Withdrawal by Subject|1|||
126213503|NCT00398632|454071166|FG000|Overall Study|Withdrawal by Subject|1|||
126213504|NCT00398632|454071166|FG000|Overall Study|Lack of Efficacy|1|||
126213505|NCT02118896|454071167|FG000|Overall Study|Death|4|||
126213506|NCT02118896|454071168|FG001|Overall Study|Death|0|||
126213507|NCT02118896|454071169|FG002|Overall Study|Death|4|||
126213508|NCT02118896|454071170|FG003|Overall Study|Death|6|||
126213509|NCT02118896|454071171|FG004|Overall Study|Death|3|||
126213510|NCT02118896|454071172|FG005|Overall Study|Death|1|||
126213511|NCT02118896|454071173|FG006|Overall Study|Death|0|||
126213512|NCT02118896|454071174|FG007|Overall Study|Death|0|||
126213513|NCT02118896|454071175|FG008|Overall Study|Death|0|||
126213514|NCT02118896|454071176|FG009|Overall Study|Death|0|||
126213515|NCT02118896|454071167|FG000|Overall Study|Adverse Event|5|||
126213516|NCT02118896|454071168|FG001|Overall Study|Adverse Event|4|||
126213517|NCT02118896|454071169|FG002|Overall Study|Adverse Event|4|||
126213518|NCT02118896|454071170|FG003|Overall Study|Adverse Event|5|||
126213519|NCT02118896|454071171|FG004|Overall Study|Adverse Event|5|||
126213520|NCT02118896|454071172|FG005|Overall Study|Adverse Event|9|||
126213521|NCT02118896|454071173|FG006|Overall Study|Adverse Event|1|||
126213522|NCT02118896|454071174|FG007|Overall Study|Adverse Event|1|||
126213523|NCT02118896|454071175|FG008|Overall Study|Adverse Event|4|||
126213524|NCT02118896|454071176|FG009|Overall Study|Adverse Event|0|||
126213525|NCT02118896|454071167|FG000|Overall Study|Consent withdrawn|2|||
126213526|NCT02118896|454071168|FG001|Overall Study|Consent withdrawn|0|||
126213527|NCT02118896|454071169|FG002|Overall Study|Consent withdrawn|3|||
126213528|NCT02118896|454071170|FG003|Overall Study|Consent withdrawn|4|||
126213529|NCT02118896|454071171|FG004|Overall Study|Consent withdrawn|1|||
126213530|NCT02118896|454071172|FG005|Overall Study|Consent withdrawn|4|||
126213531|NCT02118896|454071173|FG006|Overall Study|Consent withdrawn|0|||
126213532|NCT02118896|454071174|FG007|Overall Study|Consent withdrawn|0|||
126213533|NCT02118896|454071175|FG008|Overall Study|Consent withdrawn|0|||
126213534|NCT02118896|454071176|FG009|Overall Study|Consent withdrawn|0|||
126213535|NCT02118896|454071167|FG000|Overall Study|Non-compliance|2|||
126213536|NCT02118896|454071168|FG001|Overall Study|Non-compliance|1|||
126213537|NCT02118896|454071169|FG002|Overall Study|Non-compliance|1|||
126213538|NCT02118896|454071170|FG003|Overall Study|Non-compliance|5|||
126213539|NCT02118896|454071171|FG004|Overall Study|Non-compliance|0|||
126213540|NCT02118896|454071172|FG005|Overall Study|Non-compliance|1|||
126213541|NCT02118896|454071173|FG006|Overall Study|Non-compliance|0|||
126213542|NCT02118896|454071174|FG007|Overall Study|Non-compliance|1|||
126213543|NCT02118896|454071175|FG008|Overall Study|Non-compliance|0|||
126213544|NCT02118896|454071176|FG009|Overall Study|Non-compliance|0|||
126091146|NCT02218606|453628349|FG001|Overall Study|Death|28|||
126213545|NCT02118896|454071167|FG000|Overall Study|Pregnancy|1|||
126213546|NCT02118896|454071168|FG001|Overall Study|Pregnancy|1|||
126213547|NCT02118896|454071169|FG002|Overall Study|Pregnancy|0|||
126213548|NCT02118896|454071170|FG003|Overall Study|Pregnancy|0|||
126213549|NCT02118896|454071171|FG004|Overall Study|Pregnancy|1|||
126213550|NCT02118896|454071172|FG005|Overall Study|Pregnancy|3|||
126213551|NCT02118896|454071173|FG006|Overall Study|Pregnancy|1|||
126213552|NCT02118896|454071174|FG007|Overall Study|Pregnancy|0|||
126213553|NCT02118896|454071175|FG008|Overall Study|Pregnancy|0|||
126213554|NCT02118896|454071176|FG009|Overall Study|Pregnancy|0|||
126213555|NCT02118896|454071167|FG000|Overall Study|Lost to Follow-up|1|||
126213556|NCT02118896|454071168|FG001|Overall Study|Lost to Follow-up|2|||
126213557|NCT02118896|454071169|FG002|Overall Study|Lost to Follow-up|1|||
126213558|NCT02118896|454071170|FG003|Overall Study|Lost to Follow-up|0|||
126213559|NCT02118896|454071171|FG004|Overall Study|Lost to Follow-up|2|||
126213560|NCT02118896|454071172|FG005|Overall Study|Lost to Follow-up|1|||
126213561|NCT02118896|454071173|FG006|Overall Study|Lost to Follow-up|0|||
126213562|NCT02118896|454071174|FG007|Overall Study|Lost to Follow-up|0|||
126213563|NCT02118896|454071175|FG008|Overall Study|Lost to Follow-up|0|||
126213564|NCT02118896|454071176|FG009|Overall Study|Lost to Follow-up|0|||
126013284|NCT00738699|453342366|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
126013285|NCT00738699|453342367|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
126013286|NCT00738699|453342366|FG000|Overall Study|Other|2|||
126013287|NCT00738699|453342367|FG001|Overall Study|Other|0|||
126013288|NCT01376089|453342370|FG000|Overall Study|Patient received no contrast media|3|||
126013289|NCT01376089|453342371|FG001|Overall Study|Patient received no contrast media|4|||
126013290|NCT00549848|453342372|FG000|Overall Study|Death|1|||
126013291|NCT00549848|453342373|FG001|Overall Study|Death|4|||
126013292|NCT00549848|453342374|FG002|Overall Study|Death|13|||
126013293|NCT00549848|453342372|FG000|Overall Study|Physician Decision|0|||
126013294|NCT00549848|453342373|FG001|Overall Study|Physician Decision|0|||
126013295|NCT00549848|453342374|FG002|Overall Study|Physician Decision|4|||
126013296|NCT00549848|453342372|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
126013297|NCT00549848|453342373|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
126013298|NCT00549848|453342374|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
126013299|NCT00549848|453342372|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
126013300|NCT00549848|453342373|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
126013301|NCT00549848|453342374|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
126013302|NCT00549848|453342372|FG000|Overall Study|Participant/Family Withdraw|2|||
126013303|NCT00549848|453342373|FG001|Overall Study|Participant/Family Withdraw|3|||
126213565|NCT02118896|454071167|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
126213566|NCT02118896|454071168|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
126213567|NCT02118896|454071169|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
126013304|NCT00549848|453342374|FG002|Overall Study|Participant/Family Withdraw|5|||
126013305|NCT00549848|453342372|FG000|Overall Study|Second Malignancy|1|||
126013306|NCT00549848|453342373|FG001|Overall Study|Second Malignancy|0|||
126013307|NCT00549848|453342374|FG002|Overall Study|Second Malignancy|0|||
126013308|NCT00549848|453342372|FG000|Overall Study|Transplant|3|||
126013309|NCT00549848|453342373|FG001|Overall Study|Transplant|3|||
126013310|NCT00549848|453342374|FG002|Overall Study|Transplant|18|||
126013311|NCT00549848|453342372|FG000|Overall Study|Unacceptable Toxicity|1|||
126013312|NCT00549848|453342373|FG001|Overall Study|Unacceptable Toxicity|6|||
126013313|NCT00549848|453342374|FG002|Overall Study|Unacceptable Toxicity|6|||
126013314|NCT00419094|453342377|FG000|Overall Study|Adverse Event|3|||
126013315|NCT00419094|453342378|FG001|Overall Study|Adverse Event|7|||
126013316|NCT00419094|453342377|FG000|Overall Study|Lack of Efficacy|1|||
126013317|NCT00419094|453342378|FG001|Overall Study|Lack of Efficacy|0|||
126013318|NCT00419094|453342377|FG000|Overall Study|Lost to Follow-up|0|||
126013319|NCT00419094|453342378|FG001|Overall Study|Lost to Follow-up|2|||
126013320|NCT00419094|453342377|FG000|Overall Study|Protocol Violation|1|||
126013321|NCT00419094|453342378|FG001|Overall Study|Protocol Violation|14|||
126013322|NCT00419094|453342377|FG000|Overall Study|Withdrawal of consent|1|||
126013323|NCT00419094|453342378|FG001|Overall Study|Withdrawal of consent|5|||
126013324|NCT00419094|453342377|FG000|Overall Study|Other: Error determining exit criteria|1|||
126013325|NCT00419094|453342378|FG001|Overall Study|Other: Error determining exit criteria|0|||
126013326|NCT00419094|453342377|FG000|Overall Study|Other: Patient non-compliant|0|||
126013327|NCT00419094|453342378|FG001|Overall Study|Other: Patient non-compliant|1|||
126013328|NCT00419094|453342377|FG000|Overall Study|Other: No contact for extended period|0|||
126013329|NCT00419094|453342378|FG001|Overall Study|Other: No contact for extended period|1|||
126013330|NCT03262935|453342379|FG000|Overall Study|Withdrawal by Subject|6|||
126013331|NCT03262935|453342380|FG001|Overall Study|Withdrawal by Subject|7|||
126013332|NCT03262935|453342379|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
126013333|NCT03262935|453342380|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
126013334|NCT03262935|453342379|FG000|Overall Study|Death|181|||
126013335|NCT03262935|453342380|FG001|Overall Study|Death|94|||
126013336|NCT03262935|453342379|FG000|Overall Study|Lost to Follow-up|9|||
126013337|NCT03262935|453342380|FG001|Overall Study|Lost to Follow-up|4|||
126013338|NCT03262935|453342379|FG000|Overall Study|Other reason|5|||
126013339|NCT03262935|453342380|FG001|Overall Study|Other reason|0|||
126013340|NCT01811706|453342381|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
126013341|NCT01811706|453342382|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
126013342|NCT00753012|453342389|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
126013343|NCT00753012|453342390|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
126013344|NCT00753012|453342389|FG000|Overall Study|Adverse Event|2|||
126013345|NCT00753012|453342390|FG001|Overall Study|Adverse Event|0|||
126013346|NCT00753012|453342389|FG000|Overall Study|Withdrawal by Subject|0|||
126013347|NCT00753012|453342390|FG001|Overall Study|Withdrawal by Subject|1|||
126013348|NCT00753012|453342389|FG000|Overall Study|Lost to Follow-up|4|||
125878671|NCT02318706|452853380|FG003|Double-blind Phase|Lost to Follow-up|0|||
126013349|NCT00753012|453342390|FG001|Overall Study|Lost to Follow-up|0|||
126013350|NCT00753012|453342389|FG000|Overall Study|Confounded endpoint data|1|||
126013351|NCT00753012|453342390|FG001|Overall Study|Confounded endpoint data|0|||
126013352|NCT00943735|453342393|FG000|Overall Study|Adverse Event|12|||
126013353|NCT00943735|453342393|FG000|Overall Study|Withdrawal by Subject|8|||
126013354|NCT00943735|453342393|FG000|Overall Study|Death|1|||
126013355|NCT00943735|453342393|FG000|Overall Study|Other|8|||
126013356|NCT00943735|453342393|FG000|Overall Study|Other|3|||
126013357|NCT03804918|453342394|FG000|Overall Study|Participant did not use the app|1|||
126013358|NCT00964366|453342396|FG000|Overall Study|Did not qualify at Day 1|1|||
126013359|NCT00964366|453342397|FG001|Overall Study|Did not qualify at Day 1|0|||
126013360|NCT00964366|453342396|FG000|Overall Study|Withdrawal by Subject|0|||
126013361|NCT00964366|453342397|FG001|Overall Study|Withdrawal by Subject|1|||
126013362|NCT01370694|453342398|FG000|Overall Study|Switched to rituximab|4|||
126013363|NCT01370694|453342398|FG000|Overall Study|Progressive disease|2|||
126013364|NCT00217672|453342404|FG000|Allocation|Ineligible|2|||
126013365|NCT00217672|453342405|FG001|Allocation|Ineligible|0|||
126213568|NCT02118896|454071170|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
126213569|NCT02118896|454071171|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
126213570|NCT02118896|454071172|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
126213571|NCT02118896|454071173|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
126213572|NCT02118896|454071174|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
126213573|NCT02118896|454071175|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
126213574|NCT02118896|454071176|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
126213575|NCT02118896|454071167|FG000|Overall Study|Prohibited medication|0|||
126213576|NCT02118896|454071168|FG001|Overall Study|Prohibited medication|0|||
126213577|NCT02118896|454071169|FG002|Overall Study|Prohibited medication|0|||
126213578|NCT02118896|454071170|FG003|Overall Study|Prohibited medication|0|||
126213579|NCT02118896|454071171|FG004|Overall Study|Prohibited medication|1|||
126213580|NCT02118896|454071172|FG005|Overall Study|Prohibited medication|3|||
126213581|NCT02118896|454071173|FG006|Overall Study|Prohibited medication|0|||
126213582|NCT02118896|454071174|FG007|Overall Study|Prohibited medication|0|||
126213583|NCT02118896|454071175|FG008|Overall Study|Prohibited medication|0|||
126213584|NCT02118896|454071176|FG009|Overall Study|Prohibited medication|0|||
126213585|NCT02118896|454071167|FG000|Overall Study|Miscellaneous|1|||
126213586|NCT02118896|454071168|FG001|Overall Study|Miscellaneous|2|||
126213587|NCT02118896|454071169|FG002|Overall Study|Miscellaneous|0|||
126213588|NCT02118896|454071170|FG003|Overall Study|Miscellaneous|2|||
126213589|NCT02118896|454071171|FG004|Overall Study|Miscellaneous|0|||
126213590|NCT02118896|454071172|FG005|Overall Study|Miscellaneous|4|||
126213591|NCT02118896|454071173|FG006|Overall Study|Miscellaneous|0|||
126213592|NCT02118896|454071174|FG007|Overall Study|Miscellaneous|0|||
126213593|NCT02118896|454071175|FG008|Overall Study|Miscellaneous|0|||
126213594|NCT02118896|454071176|FG009|Overall Study|Miscellaneous|0|||
126213595|NCT02050373|454071177|FG000|Overall Study|Adverse Event|4|||
126213596|NCT02050373|454071178|FG001|Overall Study|Adverse Event|7|||
126213597|NCT02050373|454071177|FG000|Overall Study|Death|3|||
126213598|NCT02050373|454071178|FG001|Overall Study|Death|3|||
126213599|NCT00572910|454071181|FG000|Overall Study|Adverse Event|1|||
126213600|NCT00572910|454071182|FG001|Overall Study|Adverse Event|2|||
126213601|NCT00572910|454071183|FG002|Overall Study|Adverse Event|0|||
126213602|NCT00572910|454071184|FG003|Overall Study|Adverse Event|2|||
126213603|NCT00572910|454071185|FG004|Overall Study|Adverse Event|0|||
126213604|NCT00572910|454071186|FG005|Overall Study|Adverse Event|0|||
126213605|NCT00572910|454071187|FG006|Overall Study|Adverse Event|4|||
126213606|NCT00572910|454071188|FG007|Overall Study|Adverse Event|2|||
126213607|NCT00572910|454071189|FG008|Overall Study|Adverse Event|1|||
126213608|NCT00572910|454071190|FG009|Overall Study|Adverse Event|3|||
126213609|NCT00572910|454071191|FG010|Overall Study|Adverse Event|2|||
126213610|NCT00572910|454071181|FG000|Overall Study|Lost to Follow-up|0|||
126213611|NCT00572910|454071182|FG001|Overall Study|Lost to Follow-up|1|||
126213612|NCT00572910|454071183|FG002|Overall Study|Lost to Follow-up|1|||
126213613|NCT00572910|454071184|FG003|Overall Study|Lost to Follow-up|2|||
126213614|NCT00572910|454071185|FG004|Overall Study|Lost to Follow-up|1|||
126213615|NCT00572910|454071186|FG005|Overall Study|Lost to Follow-up|0|||
126213616|NCT00572910|454071187|FG006|Overall Study|Lost to Follow-up|0|||
126213617|NCT00572910|454071188|FG007|Overall Study|Lost to Follow-up|0|||
126013366|NCT00217672|453342404|FG000|Treatment|disease progression|33|||
126013367|NCT00217672|453342405|FG001|Treatment|disease progression|4|||
126213618|NCT00572910|454071189|FG008|Overall Study|Lost to Follow-up|0|||
126213619|NCT00572910|454071190|FG009|Overall Study|Lost to Follow-up|1|||
126213620|NCT00572910|454071191|FG010|Overall Study|Lost to Follow-up|0|||
126213621|NCT00572910|454071181|FG000|Overall Study|Withdrawal by Subject|3|||
126213622|NCT00572910|454071182|FG001|Overall Study|Withdrawal by Subject|0|||
126013368|NCT00217672|453342404|FG000|Treatment|Adverse Event|18|||
126013369|NCT00217672|453342405|FG001|Treatment|Adverse Event|2|||
126213623|NCT00572910|454071183|FG002|Overall Study|Withdrawal by Subject|1|||
126213624|NCT00572910|454071184|FG003|Overall Study|Withdrawal by Subject|0|||
126213625|NCT00572910|454071185|FG004|Overall Study|Withdrawal by Subject|1|||
126213626|NCT00572910|454071186|FG005|Overall Study|Withdrawal by Subject|3|||
126213627|NCT00572910|454071187|FG006|Overall Study|Withdrawal by Subject|0|||
126213628|NCT00572910|454071188|FG007|Overall Study|Withdrawal by Subject|2|||
126213629|NCT00572910|454071189|FG008|Overall Study|Withdrawal by Subject|2|||
126213630|NCT00572910|454071190|FG009|Overall Study|Withdrawal by Subject|2|||
126213631|NCT00572910|454071191|FG010|Overall Study|Withdrawal by Subject|1|||
126213632|NCT00592007|454071196|FG000|Overall Study|Withdrawal by Subject|1|||
126213633|NCT00592007|454071196|FG000|Overall Study|patient ineligible (out of lab range)|1|||
126213634|NCT00595127|454071197|FG000|Overall Study|Death|6|||
126213635|NCT00595127|454071197|FG000|Overall Study|Relapsed|3|||
126213636|NCT00595127|454071197|FG000|Overall Study|joined another trial|1|||
126213637|NCT02086968|454071200|FG000|Overall Study|Adverse Event|1|||
126213638|NCT02086968|454071201|FG001|Overall Study|Adverse Event|5|||
126213639|NCT02086968|454071200|FG000|Overall Study|Lost to Follow-up|2|||
126213640|NCT02086968|454071201|FG001|Overall Study|Lost to Follow-up|3|||
126213641|NCT02086968|454071200|FG000|Overall Study|Study drug received outside protocol|0|||
126213642|NCT02086968|454071201|FG001|Overall Study|Study drug received outside protocol|1|||
126213643|NCT02086968|454071200|FG000|Overall Study|Physician Decision|4|||
126213644|NCT02086968|454071201|FG001|Overall Study|Physician Decision|0|||
126213645|NCT02086968|454071200|FG000|Overall Study|Withdrawal by Subject|1|||
126213646|NCT02086968|454071201|FG001|Overall Study|Withdrawal by Subject|4|||
126213647|NCT01569074|454071202|FG000|Overall Study|Study stopped|6|||
126213648|NCT01569074|454071203|FG001|Overall Study|Study stopped|6|||
126213649|NCT01569074|454071204|FG002|Overall Study|Study stopped|8|||
126213650|NCT01569074|454071205|FG003|Overall Study|Study stopped|7|||
126213651|NCT01569074|454071206|FG004|Overall Study|Study stopped|7|||
126213652|NCT01569074|454071202|FG000|Overall Study|Study-specific discontinuation criteria|0|||
126213653|NCT01569074|454071203|FG001|Overall Study|Study-specific discontinuation criteria|1|||
126213654|NCT01569074|454071204|FG002|Overall Study|Study-specific discontinuation criteria|0|||
126213655|NCT01569074|454071205|FG003|Overall Study|Study-specific discontinuation criteria|0|||
126213656|NCT01569074|454071206|FG004|Overall Study|Study-specific discontinuation criteria|0|||
126213657|NCT01569074|454071202|FG000|Overall Study|Severe non-compliance to protocol|0|||
126213658|NCT01569074|454071203|FG001|Overall Study|Severe non-compliance to protocol|0|||
126213659|NCT01569074|454071204|FG002|Overall Study|Severe non-compliance to protocol|1|||
126213660|NCT01569074|454071205|FG003|Overall Study|Severe non-compliance to protocol|0|||
126213661|NCT01569074|454071206|FG004|Overall Study|Severe non-compliance to protocol|0|||
126213662|NCT01569074|454071202|FG000|Overall Study|eg change in circumstances|0|||
126213663|NCT01569074|454071203|FG001|Overall Study|eg change in circumstances|2|||
126213664|NCT01569074|454071204|FG002|Overall Study|eg change in circumstances|0|||
126213665|NCT01569074|454071205|FG003|Overall Study|eg change in circumstances|1|||
126213666|NCT01569074|454071206|FG004|Overall Study|eg change in circumstances|1|||
126213667|NCT01569074|454071202|FG000|Overall Study|Adverse Event|1|||
126213668|NCT01569074|454071203|FG001|Overall Study|Adverse Event|0|||
126213669|NCT01569074|454071204|FG002|Overall Study|Adverse Event|3|||
126213670|NCT01569074|454071205|FG003|Overall Study|Adverse Event|0|||
126213671|NCT01569074|454071206|FG004|Overall Study|Adverse Event|0|||
126213672|NCT03099161|454071207|FG000|Overall Study|Adverse Event|0|||
126213673|NCT03099161|454071208|FG001|Overall Study|Adverse Event|0|||
126213674|NCT03099161|454071209|FG002|Overall Study|Adverse Event|2|||
126213675|NCT03099161|454071207|FG000|Overall Study|Physician Decision|2|||
126213676|NCT03099161|454071208|FG001|Overall Study|Physician Decision|0|||
126213677|NCT03099161|454071209|FG002|Overall Study|Physician Decision|0|||
126213678|NCT03099161|454071207|FG000|Overall Study|Progressive Disease|1|||
126213679|NCT03099161|454071208|FG001|Overall Study|Progressive Disease|4|||
126213680|NCT03099161|454071209|FG002|Overall Study|Progressive Disease|1|||
126213681|NCT02723786|454071210|FG000|Overall Study|Lost to Follow-up|1|||
126213682|NCT03123120|454071211|FG000|Overall Study|Lost to Follow-up|0|||
126213683|NCT03123120|454071212|FG001|Overall Study|Lost to Follow-up|1|||
126213684|NCT03123120|454071211|FG000|Overall Study|Withdrawal by Subject|0|||
126213685|NCT03123120|454071212|FG001|Overall Study|Withdrawal by Subject|1|||
126213686|NCT00203892|454071213|FG000|Overall Study|Physician Decision|1|||
126213687|NCT00203892|454071214|FG001|Overall Study|Physician Decision|2|||
126213688|NCT00203892|454071215|FG002|Overall Study|Physician Decision|0|||
126213689|NCT00203892|454071213|FG000|Overall Study|Death|1|||
126213690|NCT00203892|454071214|FG001|Overall Study|Death|0|||
126348726|NCT03765073|454571050|FG009|Stage 2|Withdrawal by parent/guardian|0|||
126348727|NCT03765073|454571051|FG010|Stage 2|Withdrawal by parent/guardian|3|||
126348728|NCT03765073|454571052|FG011|Stage 2|Withdrawal by parent/guardian|3|||
126348729|NCT03765073|454571053|FG012|Stage 2|Withdrawal by parent/guardian|3|||
126348730|NCT03765073|454571054|FG013|Stage 2|Withdrawal by parent/guardian|1|||
126348731|NCT03765073|454571055|FG014|Stage 2|Withdrawal by parent/guardian|1|||
126348732|NCT03765073|454571056|FG015|Stage 2|Withdrawal by parent/guardian|0|||
126348733|NCT03765073|454571057|FG016|Stage 2|Withdrawal by parent/guardian|3|||
126348734|NCT03765073|454571058|FG017|Stage 2|Withdrawal by parent/guardian|0|||
126348735|NCT03765073|454571059|FG018|Stage 2|Withdrawal by parent/guardian|0|||
126213691|NCT00203892|454071215|FG002|Overall Study|Death|0|||
126213692|NCT00806416|454071216|FG000|Period 1 - Part I|Adverse Event|0|||
126213693|NCT00806416|454071217|FG001|Period 1 - Part I|Adverse Event|1|||
126213694|NCT00806416|454071218|FG002|Period 1 - Part I|Adverse Event|0|||
126213695|NCT00806416|454071219|FG003|Period 1 - Part I|Adverse Event|0|||
126213696|NCT00806416|454071216|FG000|Period 1 - Part I|Lost to Follow-up|0|||
126213697|NCT00806416|454071217|FG001|Period 1 - Part I|Lost to Follow-up|2|||
126213698|NCT00806416|454071218|FG002|Period 1 - Part I|Lost to Follow-up|0|||
126213699|NCT00806416|454071219|FG003|Period 1 - Part I|Lost to Follow-up|0|||
126213700|NCT00806416|454071216|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
126213701|NCT00806416|454071217|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
126213702|NCT00806416|454071218|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
126213703|NCT00806416|454071219|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
126213704|NCT00806416|454071216|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
126213705|NCT00806416|454071217|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
126213706|NCT00806416|454071218|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
126213707|NCT00806416|454071219|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
126213708|NCT03345485|454071231|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
126213709|NCT03345485|454071232|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
126213710|NCT03345485|454071233|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
126213711|NCT03345485|454071234|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
126213712|NCT03345485|454071235|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
126213713|NCT03345485|454071236|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
126213714|NCT03345485|454071237|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
126213715|NCT03345485|454071238|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
126213716|NCT03345485|454071239|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
126213717|NCT03345485|454071240|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
126213718|NCT03345485|454071241|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
126213719|NCT03345485|454071242|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
126213720|NCT03345485|454071243|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
126213721|NCT03359473|454071244|FG000|Overall Study|Adverse Event|0|||
126213722|NCT03359473|454071245|FG001|Overall Study|Adverse Event|2|||
126213723|NCT03359473|454071246|FG002|Overall Study|Adverse Event|5|||
126213724|NCT03359473|454071247|FG003|Overall Study|Adverse Event|3|||
126213725|NCT03359473|454071244|FG000|Overall Study|Lost to Follow-up|0|||
126213726|NCT03359473|454071245|FG001|Overall Study|Lost to Follow-up|1|||
126213727|NCT03359473|454071246|FG002|Overall Study|Lost to Follow-up|0|||
126213728|NCT03359473|454071247|FG003|Overall Study|Lost to Follow-up|0|||
126213729|NCT03359473|454071244|FG000|Overall Study|Physician Decision|0|||
126213730|NCT03359473|454071245|FG001|Overall Study|Physician Decision|1|||
126213731|NCT03359473|454071246|FG002|Overall Study|Physician Decision|0|||
126213732|NCT03359473|454071247|FG003|Overall Study|Physician Decision|1|||
126213733|NCT03359473|454071244|FG000|Overall Study|Withdrawal by Subject|1|||
126213734|NCT03359473|454071245|FG001|Overall Study|Withdrawal by Subject|2|||
126213735|NCT03359473|454071246|FG002|Overall Study|Withdrawal by Subject|1|||
126213736|NCT03359473|454071247|FG003|Overall Study|Withdrawal by Subject|0|||
126213737|NCT03359473|454071244|FG000|Overall Study|Protocol-defined stopping criteria|1|||
126213738|NCT03359473|454071245|FG001|Overall Study|Protocol-defined stopping criteria|0|||
126213739|NCT03359473|454071246|FG002|Overall Study|Protocol-defined stopping criteria|0|||
126213740|NCT03359473|454071247|FG003|Overall Study|Protocol-defined stopping criteria|1|||
126213741|NCT05302414|454071248|FG000|Pretest to Posttest|Lost to Follow-up|12|||
126213742|NCT05302414|454071249|FG001|Pretest to Posttest|Lost to Follow-up|8|||
126213743|NCT05302414|454071250|FG002|Pretest to Posttest|Lost to Follow-up|8|||
126213744|NCT05302414|454071248|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
126213745|NCT05302414|454071249|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
126213746|NCT05302414|454071250|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
126213747|NCT01610284|454071251|FG000|Randomization Phase|Adverse Event|1|||
126213748|NCT01610284|454071252|FG001|Randomization Phase|Adverse Event|0|||
126213749|NCT01610284|454071251|FG000|Randomization Phase|Physician Decision|1|||
126213750|NCT01610284|454071252|FG001|Randomization Phase|Physician Decision|1|||
126213751|NCT01610284|454071251|FG000|Randomization Phase|Death|0|||
126213752|NCT01610284|454071252|FG001|Randomization Phase|Death|1|||
126213753|NCT01610284|454071251|FG000|Treatment Phase|Adverse Event|80|||
126213754|NCT01610284|454071252|FG001|Treatment Phase|Adverse Event|12|||
126213755|NCT01610284|454071251|FG000|Treatment Phase|Lost to Follow-up|1|||
126213756|NCT01610284|454071252|FG001|Treatment Phase|Lost to Follow-up|0|||
126213757|NCT01610284|454071251|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
126213758|NCT01610284|454071252|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
126213759|NCT01610284|454071251|FG000|Treatment Phase|Physician Decision|27|||
126213760|NCT01610284|454071252|FG001|Treatment Phase|Physician Decision|24|||
126213761|NCT01610284|454071251|FG000|Treatment Phase|Progressive Disease|377|||
126213762|NCT01610284|454071252|FG001|Treatment Phase|Progressive Disease|486|||
126213763|NCT01610284|454071251|FG000|Treatment Phase|Protocol Deviation|2|||
126213764|NCT01610284|454071252|FG001|Treatment Phase|Protocol Deviation|3|||
126213765|NCT01610284|454071251|FG000|Treatment Phase|Study terminated by Sponsor|18|||
126213766|NCT01610284|454071252|FG001|Treatment Phase|Study terminated by Sponsor|15|||
126013370|NCT00217672|453342404|FG000|Treatment|reqd treatment not permitted by protocol|6|||
126213767|NCT01610284|454071251|FG000|Treatment Phase|Subject/Guardian Decision|55|||
126213768|NCT01610284|454071252|FG001|Treatment Phase|Subject/Guardian Decision|23|||
126213769|NCT01610284|454071251|FG000|Treatment Phase|Death|6|||
126213770|NCT01610284|454071252|FG001|Treatment Phase|Death|5|||
126213771|NCT01610284|454071251|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
126213772|NCT01610284|454071252|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126213773|NCT01610284|454071251|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
126213774|NCT01610284|454071252|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
126213775|NCT01610284|454071251|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
126213776|NCT01610284|454071252|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
126213777|NCT01610284|454071251|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
126213778|NCT01610284|454071252|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
126213779|NCT01610284|454071251|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
126213780|NCT01610284|454071252|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
126213781|NCT01610284|454071251|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
126213782|NCT01610284|454071252|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
126213783|NCT01102972|454071255|FG000|Overall Study|Adverse Event|8|||
126213784|NCT01102972|454071256|FG001|Overall Study|Adverse Event|2|||
126213785|NCT01102972|454071255|FG000|Overall Study|Lack of Efficacy|2|||
126213786|NCT01102972|454071256|FG001|Overall Study|Lack of Efficacy|1|||
126213787|NCT01102972|454071255|FG000|Overall Study|Protocol Violation|1|||
126213788|NCT01102972|454071256|FG001|Overall Study|Protocol Violation|0|||
126213789|NCT01102972|454071255|FG000|Overall Study|Lost to Follow-up|10|||
126213790|NCT01102972|454071256|FG001|Overall Study|Lost to Follow-up|5|||
126213791|NCT01102972|454071255|FG000|Overall Study|Investigator Discretion|2|||
126213792|NCT01102972|454071256|FG001|Overall Study|Investigator Discretion|0|||
126213793|NCT01102972|454071255|FG000|Overall Study|Withdrawal by Subject|6|||
126213794|NCT01102972|454071256|FG001|Overall Study|Withdrawal by Subject|6|||
126213795|NCT01856257|454071260|FG000|Overall Study|Death|2|||
126213796|NCT01856257|454071261|FG001|Overall Study|Death|0|||
126213797|NCT01856257|454071262|FG002|Overall Study|Death|0|||
126213798|NCT01856257|454071263|FG003|Overall Study|Death|0|||
126213799|NCT01856257|454071260|FG000|Overall Study|Physician Decision|0|||
126213800|NCT01856257|454071261|FG001|Overall Study|Physician Decision|0|||
126348736|NCT03765073|454571060|FG019|Stage 2|Withdrawal by parent/guardian|0|||
126348737|NCT03765073|454571061|FG020|Stage 2|Withdrawal by parent/guardian|0|||
126348738|NCT03765073|454571041|FG000|Stage 2|Withdrawal by Subject|0|||
126348739|NCT03765073|454571042|FG001|Stage 2|Withdrawal by Subject|0|||
126348740|NCT03765073|454571043|FG002|Stage 2|Withdrawal by Subject|0|||
126348741|NCT03765073|454571044|FG003|Stage 2|Withdrawal by Subject|3|||
126348742|NCT03765073|454571045|FG004|Stage 2|Withdrawal by Subject|3|||
126348743|NCT03765073|454571046|FG005|Stage 2|Withdrawal by Subject|3|||
126348744|NCT03765073|454571047|FG006|Stage 2|Withdrawal by Subject|0|||
126348745|NCT03765073|454571048|FG007|Stage 2|Withdrawal by Subject|1|||
126348746|NCT03765073|454571049|FG008|Stage 2|Withdrawal by Subject|0|||
126348747|NCT03765073|454571050|FG009|Stage 2|Withdrawal by Subject|5|||
126348748|NCT03765073|454571051|FG010|Stage 2|Withdrawal by Subject|0|||
126348749|NCT03765073|454571052|FG011|Stage 2|Withdrawal by Subject|0|||
126348750|NCT03765073|454571053|FG012|Stage 2|Withdrawal by Subject|0|||
126348751|NCT03765073|454571054|FG013|Stage 2|Withdrawal by Subject|0|||
126348752|NCT03765073|454571055|FG014|Stage 2|Withdrawal by Subject|0|||
126348753|NCT03765073|454571056|FG015|Stage 2|Withdrawal by Subject|0|||
126348754|NCT03765073|454571057|FG016|Stage 2|Withdrawal by Subject|0|||
126348755|NCT03765073|454571058|FG017|Stage 2|Withdrawal by Subject|0|||
126348756|NCT03765073|454571059|FG018|Stage 2|Withdrawal by Subject|0|||
126348757|NCT03765073|454571060|FG019|Stage 2|Withdrawal by Subject|0|||
126348758|NCT03765073|454571061|FG020|Stage 2|Withdrawal by Subject|0|||
126348759|NCT03765073|454571041|FG000|Stage 3|Adverse Event|0|||
126348760|NCT03765073|454571042|FG001|Stage 3|Adverse Event|0|||
126348761|NCT03765073|454571043|FG002|Stage 3|Adverse Event|0|||
126348762|NCT03765073|454571044|FG003|Stage 3|Adverse Event|0|||
126348763|NCT03765073|454571045|FG004|Stage 3|Adverse Event|0|||
126348764|NCT03765073|454571046|FG005|Stage 3|Adverse Event|0|||
126348765|NCT03765073|454571047|FG006|Stage 3|Adverse Event|0|||
126348766|NCT03765073|454571048|FG007|Stage 3|Adverse Event|0|||
126348767|NCT03765073|454571049|FG008|Stage 3|Adverse Event|0|||
126348768|NCT03765073|454571050|FG009|Stage 3|Adverse Event|0|||
126213801|NCT01856257|454071262|FG002|Overall Study|Physician Decision|0|||
126213802|NCT01856257|454071263|FG003|Overall Study|Physician Decision|1|||
126213803|NCT01856257|454071260|FG000|Overall Study|Withdrawal by Subject|1|||
126348769|NCT03765073|454571051|FG010|Stage 3|Adverse Event|0|||
126348770|NCT03765073|454571052|FG011|Stage 3|Adverse Event|0|||
126348771|NCT03765073|454571053|FG012|Stage 3|Adverse Event|0|||
126348772|NCT03765073|454571054|FG013|Stage 3|Adverse Event|0|||
126348773|NCT03765073|454571055|FG014|Stage 3|Adverse Event|0|||
126348774|NCT03765073|454571056|FG015|Stage 3|Adverse Event|0|||
126348775|NCT03765073|454571057|FG016|Stage 3|Adverse Event|0|||
126348776|NCT03765073|454571058|FG017|Stage 3|Adverse Event|0|||
126213804|NCT01856257|454071261|FG001|Overall Study|Withdrawal by Subject|1|||
126213805|NCT01856257|454071262|FG002|Overall Study|Withdrawal by Subject|0|||
126213806|NCT01856257|454071263|FG003|Overall Study|Withdrawal by Subject|0|||
126213807|NCT01856257|454071260|FG000|Overall Study|Donor complication|0|||
126213808|NCT01856257|454071261|FG001|Overall Study|Donor complication|0|||
126213809|NCT01856257|454071262|FG002|Overall Study|Donor complication|0|||
126213810|NCT01856257|454071263|FG003|Overall Study|Donor complication|1|||
126213811|NCT01125358|454071264|FG000|Overall Study|Adverse Event|3|||
126213812|NCT01125358|454071265|FG001|Overall Study|Adverse Event|0|||
126213813|NCT01125358|454071266|FG002|Overall Study|Adverse Event|0|||
126213814|NCT01125358|454071267|FG003|Overall Study|Adverse Event|2|||
126213815|NCT01125358|454071264|FG000|Overall Study|Perceived Lack of Efficacy|6|||
126213816|NCT01125358|454071265|FG001|Overall Study|Perceived Lack of Efficacy|3|||
126213817|NCT01125358|454071266|FG002|Overall Study|Perceived Lack of Efficacy|7|||
126213818|NCT01125358|454071267|FG003|Overall Study|Perceived Lack of Efficacy|4|||
126213819|NCT01125358|454071264|FG000|Overall Study|Protocol Violation|1|||
126213820|NCT01125358|454071265|FG001|Overall Study|Protocol Violation|0|||
126213821|NCT01125358|454071266|FG002|Overall Study|Protocol Violation|0|||
126213822|NCT01125358|454071267|FG003|Overall Study|Protocol Violation|0|||
126213823|NCT01125358|454071264|FG000|Overall Study|Sponsor Decision|0|||
126213824|NCT01125358|454071265|FG001|Overall Study|Sponsor Decision|0|||
126213825|NCT01125358|454071266|FG002|Overall Study|Sponsor Decision|1|||
126213826|NCT01125358|454071267|FG003|Overall Study|Sponsor Decision|1|||
126213827|NCT01125358|454071264|FG000|Overall Study|Withdrawal by Subject|2|||
126213828|NCT01125358|454071265|FG001|Overall Study|Withdrawal by Subject|1|||
126213829|NCT01125358|454071266|FG002|Overall Study|Withdrawal by Subject|1|||
126213830|NCT01125358|454071267|FG003|Overall Study|Withdrawal by Subject|1|||
126213831|NCT01157065|454071268|FG000|Overall Study|Death|0|||
126213832|NCT01157065|454071269|FG001|Overall Study|Death|1|||
126213833|NCT01060007|454071270|FG000|Overall Study|Withdrawal by Subject|1|||
126213834|NCT01060007|454071270|FG000|Overall Study|Inevaluable for response at surgery|3|||
126213835|NCT00742859|454071275|FG000|Overall Study|Adverse Event|5|||
126213836|NCT00742859|454071276|FG001|Overall Study|Adverse Event|6|||
126213837|NCT00742859|454071277|FG002|Overall Study|Adverse Event|3|||
126213838|NCT00742859|454071278|FG003|Overall Study|Adverse Event|1|||
126213839|NCT00742859|454071275|FG000|Overall Study|Death|1|||
126213840|NCT00742859|454071276|FG001|Overall Study|Death|0|||
126213841|NCT00742859|454071277|FG002|Overall Study|Death|0|||
126213842|NCT00742859|454071278|FG003|Overall Study|Death|1|||
126213843|NCT00742859|454071275|FG000|Overall Study|Physician Decision|1|||
126213844|NCT00742859|454071276|FG001|Overall Study|Physician Decision|2|||
126213845|NCT00742859|454071277|FG002|Overall Study|Physician Decision|0|||
126213846|NCT00742859|454071278|FG003|Overall Study|Physician Decision|0|||
126213847|NCT00742859|454071275|FG000|Overall Study|Withdrawal by Subject|4|||
126213848|NCT00742859|454071276|FG001|Overall Study|Withdrawal by Subject|2|||
126213849|NCT00742859|454071277|FG002|Overall Study|Withdrawal by Subject|4|||
126213850|NCT00742859|454071278|FG003|Overall Study|Withdrawal by Subject|1|||
126213851|NCT00742859|454071275|FG000|Overall Study|Endpoint|0|||
126213852|NCT00742859|454071276|FG001|Overall Study|Endpoint|1|||
126213853|NCT00742859|454071277|FG002|Overall Study|Endpoint|1|||
126213854|NCT00742859|454071278|FG003|Overall Study|Endpoint|2|||
126213855|NCT00742859|454071275|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
126213856|NCT00742859|454071276|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
126348777|NCT03765073|454571059|FG018|Stage 3|Adverse Event|1|||
126348778|NCT03765073|454571060|FG019|Stage 3|Adverse Event|0|||
126348779|NCT03765073|454571061|FG020|Stage 3|Adverse Event|0|||
126013371|NCT00217672|453342405|FG001|Treatment|reqd treatment not permitted by protocol|0|||
126013372|NCT00217672|453342404|FG000|Treatment|Physician Decision|6|||
126013373|NCT00217672|453342405|FG001|Treatment|Physician Decision|0|||
126013374|NCT00217672|453342404|FG000|Treatment|insurance issues|1|||
126013375|NCT00217672|453342405|FG001|Treatment|insurance issues|1|||
126013376|NCT00217672|453342404|FG000|Treatment|Death|2|||
126013377|NCT00217672|453342405|FG001|Treatment|Death|0|||
126348780|NCT03765073|454571041|FG000|Stage 3|Death|0|||
126348781|NCT03765073|454571042|FG001|Stage 3|Death|0|||
126213857|NCT00742859|454071277|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
126213858|NCT00742859|454071278|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
126213859|NCT00742859|454071275|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
126213860|NCT00742859|454071276|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
126213861|NCT00742859|454071277|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
126213862|NCT00742859|454071278|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
126348782|NCT03765073|454571043|FG002|Stage 3|Death|0|||
126013378|NCT00217672|453342404|FG000|Treatment|secondary malignancy|1|||
126013379|NCT00217672|453342405|FG001|Treatment|secondary malignancy|0|||
126213863|NCT00742859|454071275|FG000|Overall Study|Sponsor request patient out of town|0|||
126213864|NCT00742859|454071276|FG001|Overall Study|Sponsor request patient out of town|0|||
126213865|NCT00742859|454071277|FG002|Overall Study|Sponsor request patient out of town|1|||
126213866|NCT00742859|454071278|FG003|Overall Study|Sponsor request patient out of town|1|||
126348783|NCT03765073|454571044|FG003|Stage 3|Death|0|||
126013380|NCT00217672|453342404|FG000|Follow-up|Withdrawal by Subject|4|||
126013381|NCT00217672|453342405|FG001|Follow-up|Withdrawal by Subject|0|||
126013382|NCT00217672|453342404|FG000|Follow-up|Lost to Follow-up|1|||
126013383|NCT00217672|453342405|FG001|Follow-up|Lost to Follow-up|0|||
126013384|NCT01596504|453342410|FG000|Overall Study|Participant's Private Reason|0|||
126013385|NCT01596504|453342411|FG001|Overall Study|Participant's Private Reason|1|||
126013386|NCT01596504|453342412|FG002|Overall Study|Participant's Private Reason|0|||
126013387|NCT01596504|453342410|FG000|Overall Study|Adverse Event|1|||
126013388|NCT01596504|453342411|FG001|Overall Study|Adverse Event|2|||
126013389|NCT01596504|453342412|FG002|Overall Study|Adverse Event|1|||
126013390|NCT01596504|453342410|FG000|Overall Study|Withdrawal by Subject|1|||
126013391|NCT01596504|453342411|FG001|Overall Study|Withdrawal by Subject|0|||
126013392|NCT01596504|453342412|FG002|Overall Study|Withdrawal by Subject|0|||
126013393|NCT01901276|453342413|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
126013394|NCT01901276|453342414|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
126013395|NCT04347954|453342415|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
126013396|NCT04347954|453342416|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
126213867|NCT00742859|454071275|FG000|Overall Study|Site error|0|||
126213868|NCT00742859|454071276|FG001|Overall Study|Site error|0|||
126213869|NCT00742859|454071277|FG002|Overall Study|Site error|1|||
126213870|NCT00742859|454071278|FG003|Overall Study|Site error|1|||
126213871|NCT00962013|454071281|FG000|Overall Study|Did not have surgery|1|||
126213872|NCT00962013|454071281|FG000|Overall Study|Death|8|||
126213873|NCT00962013|454071281|FG000|Overall Study|Lost to Follow-up|12|||
126213874|NCT00962013|454071281|FG000|Overall Study|Unable/Unwilling to return|6|||
126213875|NCT00962013|454071281|FG000|Overall Study|Withdrawal by Subject|8|||
126213876|NCT00962013|454071281|FG000|Overall Study|Removal of study device|3|||
126213877|NCT00962013|454071281|FG000|Overall Study|Site Termination|24|||
126213878|NCT00962013|454071281|FG000|Overall Study|No 5 year evaluation|6|||
126213879|NCT04527549|454071282|FG000|Overall Study|Withdrawal by Subject|1|||
126213880|NCT04527549|454071283|FG001|Overall Study|Withdrawal by Subject|1|||
126213881|NCT00445458|454071296|FG000|Overall Study|Disease Progression|3|||
126213882|NCT00445458|454071297|FG001|Overall Study|Disease Progression|4|||
126213883|NCT00445458|454071298|FG002|Overall Study|Disease Progression|54|||
126213884|NCT00445458|454071299|FG003|Overall Study|Disease Progression|27|||
126213885|NCT00445458|454071296|FG000|Overall Study|Withdrawal by Subject|0|||
126213886|NCT00445458|454071297|FG001|Overall Study|Withdrawal by Subject|0|||
126213887|NCT00445458|454071298|FG002|Overall Study|Withdrawal by Subject|7|||
126213888|NCT00445458|454071299|FG003|Overall Study|Withdrawal by Subject|0|||
126213889|NCT00445458|454071296|FG000|Overall Study|Adverse Event|0|||
126213890|NCT00445458|454071297|FG001|Overall Study|Adverse Event|0|||
126213891|NCT00445458|454071298|FG002|Overall Study|Adverse Event|3|||
126213892|NCT00445458|454071299|FG003|Overall Study|Adverse Event|0|||
126213893|NCT00445458|454071296|FG000|Overall Study|Death|0|||
126213894|NCT00445458|454071297|FG001|Overall Study|Death|1|||
126213895|NCT00445458|454071298|FG002|Overall Study|Death|2|||
126213896|NCT00445458|454071299|FG003|Overall Study|Death|0|||
126213897|NCT00445458|454071296|FG000|Overall Study|Physician Decision|0|||
126213898|NCT00445458|454071297|FG001|Overall Study|Physician Decision|0|||
126213899|NCT00445458|454071298|FG002|Overall Study|Physician Decision|1|||
126213900|NCT00445458|454071299|FG003|Overall Study|Physician Decision|1|||
126213901|NCT00445458|454071296|FG000|Overall Study|Surgery|0|||
126213902|NCT00445458|454071297|FG001|Overall Study|Surgery|0|||
126213903|NCT00445458|454071298|FG002|Overall Study|Surgery|1|||
126213904|NCT00445458|454071299|FG003|Overall Study|Surgery|0|||
126213905|NCT00728988|454071304|FG000|Overall Study|Not Treated|2|||
126213906|NCT00728988|454071305|FG001|Overall Study|Not Treated|2|||
126213907|NCT00728988|454071304|FG000|Overall Study|Death|1|||
126213908|NCT00728988|454071305|FG001|Overall Study|Death|1|||
126213909|NCT00728988|454071304|FG000|Overall Study|Adverse Event|3|||
126213910|NCT00728988|454071305|FG001|Overall Study|Adverse Event|2|||
126213911|NCT00728988|454071304|FG000|Overall Study|Other|85|||
126213912|NCT00728988|454071305|FG001|Overall Study|Other|77|||
126213913|NCT00728988|454071304|FG000|Overall Study|Withdrawal by Subject|2|||
126213914|NCT00728988|454071305|FG001|Overall Study|Withdrawal by Subject|6|||
126213915|NCT03186794|454071309|FG000|Overall Study|Physician Decision|2|||
126213916|NCT03186794|454071309|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
126213917|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
126213918|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
126213919|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Death|5|||
126213920|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Death|2|||
126213921|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
126213922|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
126213923|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
126213924|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
126213925|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
126213926|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
126213927|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Relapse|1|||
126213928|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Relapse|0|||
126213929|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
126213930|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
126213931|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
126213932|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
126213933|NCT00111007|454071311|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
126213934|NCT00111007|454071312|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
126213935|NCT00111007|454071311|FG000|Active Follow-up|Adverse Event|1|||
126213936|NCT00111007|454071312|FG001|Active Follow-up|Adverse Event|0|||
126213937|NCT00111007|454071311|FG000|Active Follow-up|Death|2|||
126213938|NCT00111007|454071312|FG001|Active Follow-up|Death|0|||
126213939|NCT00111007|454071311|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
126213940|NCT00111007|454071312|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
126213941|NCT00111007|454071311|FG000|Long Term Follow-up|Death|34|||
126213942|NCT00111007|454071312|FG001|Long Term Follow-up|Death|39|||
126213943|NCT00111007|454071311|FG000|Long Term Follow-up|Lost to Follow-up|1|||
126213944|NCT00111007|454071312|FG001|Long Term Follow-up|Lost to Follow-up|1|||
126213945|NCT00111007|454071311|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
126213946|NCT00111007|454071312|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
126213947|NCT00111007|454071311|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
126213948|NCT00111007|454071312|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
126213949|NCT00111007|454071311|FG000|Long Term Follow-up|Missing|10|||
126213950|NCT00111007|454071312|FG001|Long Term Follow-up|Missing|3|||
126213951|NCT02380248|454071313|FG000|Overall Study|Lost to Follow-up|11|||
126213952|NCT02380248|454071313|FG000|Overall Study|Withdrawal by Subject|3|||
126213953|NCT00605839|454071314|FG000|Overall Study|Protocol Violation|1|||
126213954|NCT00605839|454071315|FG001|Overall Study|Protocol Violation|0|||
126213955|NCT00605839|454071316|FG002|Overall Study|Protocol Violation|0|||
126213956|NCT01381068|454071317|FG000|Overall Study|Death|1|||
126213957|NCT01381068|454071318|FG001|Overall Study|Death|0|||
126213958|NCT00083226|454071325|FG000|Overall Study|Lack of Efficacy|19|||
126213959|NCT00083226|454071325|FG000|Overall Study|Adverse Event|9|||
126213960|NCT00083226|454071325|FG000|Overall Study|Death|4|||
126213961|NCT00083226|454071325|FG000|Overall Study|Withdrawal by Subject|4|||
126213962|NCT00083226|454071325|FG000|Overall Study|Other|2|||
126213963|NCT00083226|454071325|FG000|Overall Study|ineligible or not receiving treatment|4|||
126213964|NCT00909857|454071326|FG000|Overall Study|Withdrawal by Subject|6|||
126213965|NCT00909857|454071327|FG001|Overall Study|Withdrawal by Subject|10|||
126213966|NCT00909857|454071326|FG000|Overall Study|Adverse Event|5|||
126213967|NCT00909857|454071327|FG001|Overall Study|Adverse Event|5|||
126213968|NCT00909857|454071326|FG000|Overall Study|Lost to Follow-up|2|||
126213969|NCT00909857|454071327|FG001|Overall Study|Lost to Follow-up|5|||
126213970|NCT00909857|454071326|FG000|Overall Study|Protocol Violation|2|||
126213971|NCT00909857|454071327|FG001|Overall Study|Protocol Violation|1|||
126213972|NCT00909857|454071326|FG000|Overall Study|Pregnancy|1|||
126213973|NCT00909857|454071327|FG001|Overall Study|Pregnancy|0|||
126013397|NCT04347954|453342417|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
126013398|NCT04347954|453342415|FG000|Overall Study|Lost to Follow-up|0|||
126013399|NCT04347954|453342416|FG001|Overall Study|Lost to Follow-up|1|||
126013400|NCT04347954|453342417|FG002|Overall Study|Lost to Follow-up|0|||
126013401|NCT03257813|453342421|FG000|Overall Study|Protocol Violation|6|||
126013402|NCT03257813|453342422|FG001|Overall Study|Protocol Violation|3|||
126013403|NCT02878330|453342423|FG000|Overall Study|Death|3|||
126013404|NCT02878330|453342424|FG001|Overall Study|Death|2|||
126013405|NCT02878330|453342423|FG000|Overall Study|Lost to Follow-up|11|||
126348784|NCT03765073|454571045|FG004|Stage 3|Death|0|||
126348785|NCT03765073|454571046|FG005|Stage 3|Death|0|||
126348786|NCT03765073|454571047|FG006|Stage 3|Death|0|||
126348787|NCT03765073|454571048|FG007|Stage 3|Death|0|||
126348788|NCT03765073|454571049|FG008|Stage 3|Death|0|||
126348789|NCT03765073|454571050|FG009|Stage 3|Death|0|||
126348790|NCT03765073|454571051|FG010|Stage 3|Death|0|||
126348791|NCT03765073|454571052|FG011|Stage 3|Death|0|||
126348792|NCT03765073|454571053|FG012|Stage 3|Death|0|||
126348793|NCT03765073|454571054|FG013|Stage 3|Death|0|||
126348794|NCT03765073|454571055|FG014|Stage 3|Death|0|||
126348795|NCT03765073|454571056|FG015|Stage 3|Death|0|||
126348796|NCT03765073|454571057|FG016|Stage 3|Death|0|||
126348797|NCT03765073|454571058|FG017|Stage 3|Death|0|||
126348798|NCT03765073|454571059|FG018|Stage 3|Death|0|||
126348799|NCT03765073|454571060|FG019|Stage 3|Death|3|||
126348800|NCT03765073|454571061|FG020|Stage 3|Death|2|||
126348801|NCT03765073|454571041|FG000|Stage 3|Lost to Follow-up|0|||
126348802|NCT03765073|454571042|FG001|Stage 3|Lost to Follow-up|0|||
126348803|NCT03765073|454571043|FG002|Stage 3|Lost to Follow-up|0|||
126348804|NCT03765073|454571044|FG003|Stage 3|Lost to Follow-up|0|||
126348805|NCT03765073|454571045|FG004|Stage 3|Lost to Follow-up|0|||
126348806|NCT03765073|454571046|FG005|Stage 3|Lost to Follow-up|0|||
126348807|NCT03765073|454571047|FG006|Stage 3|Lost to Follow-up|0|||
126348808|NCT03765073|454571048|FG007|Stage 3|Lost to Follow-up|0|||
126348809|NCT03765073|454571049|FG008|Stage 3|Lost to Follow-up|0|||
126348810|NCT03765073|454571050|FG009|Stage 3|Lost to Follow-up|0|||
126348811|NCT03765073|454571051|FG010|Stage 3|Lost to Follow-up|0|||
126348812|NCT03765073|454571052|FG011|Stage 3|Lost to Follow-up|0|||
126348813|NCT03765073|454571053|FG012|Stage 3|Lost to Follow-up|0|||
126348814|NCT03765073|454571054|FG013|Stage 3|Lost to Follow-up|0|||
126348815|NCT03765073|454571055|FG014|Stage 3|Lost to Follow-up|0|||
126348816|NCT03765073|454571056|FG015|Stage 3|Lost to Follow-up|0|||
126348817|NCT03765073|454571057|FG016|Stage 3|Lost to Follow-up|0|||
126348818|NCT03765073|454571058|FG017|Stage 3|Lost to Follow-up|8|||
126348819|NCT03765073|454571059|FG018|Stage 3|Lost to Follow-up|5|||
126348820|NCT03765073|454571060|FG019|Stage 3|Lost to Follow-up|7|||
126348821|NCT03765073|454571061|FG020|Stage 3|Lost to Follow-up|4|||
126348822|NCT03765073|454571041|FG000|Stage 3|No longer meets eligibility criteria|0|||
126348823|NCT03765073|454571042|FG001|Stage 3|No longer meets eligibility criteria|0|||
126348824|NCT03765073|454571043|FG002|Stage 3|No longer meets eligibility criteria|0|||
126348825|NCT03765073|454571044|FG003|Stage 3|No longer meets eligibility criteria|0|||
126348826|NCT03765073|454571045|FG004|Stage 3|No longer meets eligibility criteria|0|||
126348827|NCT03765073|454571046|FG005|Stage 3|No longer meets eligibility criteria|0|||
126348828|NCT03765073|454571047|FG006|Stage 3|No longer meets eligibility criteria|0|||
126348829|NCT03765073|454571048|FG007|Stage 3|No longer meets eligibility criteria|0|||
126348830|NCT03765073|454571049|FG008|Stage 3|No longer meets eligibility criteria|0|||
126348831|NCT03765073|454571050|FG009|Stage 3|No longer meets eligibility criteria|0|||
126348832|NCT03765073|454571051|FG010|Stage 3|No longer meets eligibility criteria|0|||
126348833|NCT03765073|454571052|FG011|Stage 3|No longer meets eligibility criteria|0|||
126348834|NCT03765073|454571053|FG012|Stage 3|No longer meets eligibility criteria|0|||
126348835|NCT03765073|454571054|FG013|Stage 3|No longer meets eligibility criteria|0|||
126348836|NCT03765073|454571055|FG014|Stage 3|No longer meets eligibility criteria|0|||
126348837|NCT03765073|454571056|FG015|Stage 3|No longer meets eligibility criteria|0|||
126348838|NCT03765073|454571057|FG016|Stage 3|No longer meets eligibility criteria|0|||
126348839|NCT03765073|454571058|FG017|Stage 3|No longer meets eligibility criteria|0|||
126348840|NCT03765073|454571059|FG018|Stage 3|No longer meets eligibility criteria|1|||
126348841|NCT03765073|454571060|FG019|Stage 3|No longer meets eligibility criteria|0|||
126348842|NCT03765073|454571061|FG020|Stage 3|No longer meets eligibility criteria|1|||
126348843|NCT03765073|454571041|FG000|Stage 3|Other|0|||
126348844|NCT03765073|454571042|FG001|Stage 3|Other|0|||
126348845|NCT03765073|454571043|FG002|Stage 3|Other|0|||
126348846|NCT03765073|454571044|FG003|Stage 3|Other|0|||
126348847|NCT03765073|454571045|FG004|Stage 3|Other|0|||
126348848|NCT03765073|454571046|FG005|Stage 3|Other|0|||
126348849|NCT03765073|454571047|FG006|Stage 3|Other|0|||
126348850|NCT03765073|454571048|FG007|Stage 3|Other|0|||
126348851|NCT03765073|454571049|FG008|Stage 3|Other|0|||
126348852|NCT03765073|454571050|FG009|Stage 3|Other|0|||
126348853|NCT03765073|454571051|FG010|Stage 3|Other|0|||
126348854|NCT03765073|454571052|FG011|Stage 3|Other|0|||
126348855|NCT03765073|454571053|FG012|Stage 3|Other|0|||
126348856|NCT03765073|454571054|FG013|Stage 3|Other|0|||
126348857|NCT03765073|454571055|FG014|Stage 3|Other|0|||
126348858|NCT03765073|454571056|FG015|Stage 3|Other|0|||
126348859|NCT03765073|454571057|FG016|Stage 3|Other|0|||
126013406|NCT02878330|453342424|FG001|Overall Study|Lost to Follow-up|26|||
126013407|NCT02878330|453342423|FG000|Overall Study|Withdrawal by Subject|11|||
126213974|NCT00909857|454071326|FG000|Overall Study|Other|1|||
126213975|NCT00909857|454071327|FG001|Overall Study|Other|0|||
126213976|NCT00909857|454071326|FG000|Overall Study|Did not receive study medication|19|||
126213977|NCT00909857|454071327|FG001|Overall Study|Did not receive study medication|24|||
126213978|NCT00604175|454071328|FG000|Entry Through Week 28|Death|2|||
126213979|NCT00604175|454071329|FG001|Entry Through Week 28|Death|0|||
126213980|NCT00604175|454071330|FG002|Entry Through Week 28|Death|0|||
126213981|NCT00604175|454071328|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
126213982|NCT00604175|454071329|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
126213983|NCT00604175|454071330|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
126213984|NCT00604175|454071328|FG000|Entry Through Week 28|Lost to Follow-up|4|||
126213985|NCT00604175|454071329|FG001|Entry Through Week 28|Lost to Follow-up|3|||
126213986|NCT00604175|454071330|FG002|Entry Through Week 28|Lost to Follow-up|0|||
126213987|NCT00604175|454071328|FG000|Entry Through Week 28|Ineligible|1|||
126213988|NCT00604175|454071329|FG001|Entry Through Week 28|Ineligible|0|||
126213989|NCT00604175|454071330|FG002|Entry Through Week 28|Ineligible|0|||
126213990|NCT00604175|454071328|FG000|Entry Through Week 28|Did not start intervention|2|||
126213991|NCT00604175|454071329|FG001|Entry Through Week 28|Did not start intervention|0|||
126213992|NCT00604175|454071330|FG002|Entry Through Week 28|Did not start intervention|1|||
126213993|NCT00604175|454071328|FG000|Week 29 Through Week 72|Death|0|||
126213994|NCT00604175|454071329|FG001|Week 29 Through Week 72|Death|0|||
126213995|NCT00604175|454071330|FG002|Week 29 Through Week 72|Death|1|||
126213996|NCT00604175|454071328|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
126213997|NCT00604175|454071329|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
126213998|NCT00604175|454071330|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
126213999|NCT00604175|454071328|FG000|Week 29 Through Week 72|Site closure|0|||
126214000|NCT00604175|454071329|FG001|Week 29 Through Week 72|Site closure|1|||
126214001|NCT00604175|454071330|FG002|Week 29 Through Week 72|Site closure|0|||
126214002|NCT00604175|454071328|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
126214003|NCT00604175|454071329|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
126214004|NCT00604175|454071330|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
126214005|NCT02392377|454071331|FG000|Overall Study|Withdrawal by Subject|0|||
126214006|NCT02392377|454071332|FG001|Overall Study|Withdrawal by Subject|1|||
126214007|NCT03205163|454071335|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
126214008|NCT03205163|454071336|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
126214009|NCT03515837|454073425|FG000|Overall Study|Death|219|||
126214010|NCT03515837|454073426|FG001|Overall Study|Death|227|||
126214011|NCT03515837|454073425|FG000|Overall Study|Lost to Follow-up|0|||
126214012|NCT03515837|454073426|FG001|Overall Study|Lost to Follow-up|1|||
126214013|NCT03515837|454073425|FG000|Overall Study|Withdrawal by Subject|0|||
126214014|NCT03515837|454073426|FG001|Overall Study|Withdrawal by Subject|4|||
126214015|NCT03515837|454073425|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
126214016|NCT03515837|454073426|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
126214017|NCT01964898|454073427|FG000|Overall Study|ineligible post-randomization|1|||
126214018|NCT01964898|454073428|FG001|Overall Study|ineligible post-randomization|1|||
126214019|NCT01964898|454073427|FG000|Overall Study|did not receive the allocated interventi|2|||
126214020|NCT01964898|454073428|FG001|Overall Study|did not receive the allocated interventi|1|||
126214021|NCT01964898|454073427|FG000|Overall Study|Lost to Follow-up|3|||
126214022|NCT01964898|454073428|FG001|Overall Study|Lost to Follow-up|5|||
126214023|NCT01964898|454073427|FG000|Overall Study|Withdrawal by Subject|1|||
126214024|NCT01964898|454073428|FG001|Overall Study|Withdrawal by Subject|0|||
126214025|NCT02325401|454073429|FG000|Overall Study|Withdrawal by Subject|0|||
126214026|NCT02325401|454073430|FG001|Overall Study|Withdrawal by Subject|1|||
126013408|NCT02878330|453342424|FG001|Overall Study|Withdrawal by Subject|21|||
126013409|NCT02878330|453342423|FG000|Overall Study|Other|4|||
126214027|NCT02325401|454073431|FG002|Overall Study|Withdrawal by Subject|1|||
126214028|NCT03526679|454073432|FG000|Overall Study|still under treatment|2|||
126214029|NCT03443973|454073433|FG000|Double-blind Treatment Period|Adverse Event|5|||
126214030|NCT03443973|454073434|FG001|Double-blind Treatment Period|Adverse Event|19|||
126214031|NCT03443973|454073435|FG002|Double-blind Treatment Period|Adverse Event|0|||
126214032|NCT03443973|454073436|FG003|Double-blind Treatment Period|Adverse Event|0|||
126214033|NCT03443973|454073433|FG000|Double-blind Treatment Period|Death|5|||
126214034|NCT03443973|454073434|FG001|Double-blind Treatment Period|Death|7|||
126214035|NCT03443973|454073435|FG002|Double-blind Treatment Period|Death|0|||
126214036|NCT03443973|454073436|FG003|Double-blind Treatment Period|Death|0|||
126214037|NCT03443973|454073433|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
126214038|NCT03443973|454073434|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
126214039|NCT03443973|454073435|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
126214040|NCT03443973|454073436|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
126214041|NCT03443973|454073433|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126214042|NCT03443973|454073434|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
126214043|NCT03443973|454073435|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126214044|NCT03443973|454073436|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126214045|NCT03443973|454073433|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
126214046|NCT03443973|454073434|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
126214047|NCT03443973|454073435|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
126214048|NCT03443973|454073436|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
126214049|NCT03443973|454073433|FG000|Double-blind Treatment Period|Physician Decision|5|||
126214050|NCT03443973|454073434|FG001|Double-blind Treatment Period|Physician Decision|6|||
126214051|NCT03443973|454073435|FG002|Double-blind Treatment Period|Physician Decision|0|||
126214052|NCT03443973|454073436|FG003|Double-blind Treatment Period|Physician Decision|0|||
126214053|NCT03443973|454073433|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
126214054|NCT03443973|454073434|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
126214055|NCT03443973|454073435|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
126214056|NCT03443973|454073436|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
126214057|NCT03443973|454073433|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
126214058|NCT03443973|454073434|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
126214059|NCT03443973|454073435|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126214060|NCT03443973|454073436|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
126214061|NCT03443973|454073433|FG000|Open-label Extension Period|Reason Not Specified|0|||
126214062|NCT03443973|454073434|FG001|Open-label Extension Period|Reason Not Specified|0|||
126214063|NCT03443973|454073435|FG002|Open-label Extension Period|Reason Not Specified|3|||
126214064|NCT03443973|454073436|FG003|Open-label Extension Period|Reason Not Specified|0|||
126214065|NCT03443973|454073433|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126214066|NCT03443973|454073434|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
126214067|NCT03443973|454073435|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
126214068|NCT03443973|454073436|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
126214069|NCT02209454|454073440|FG000|Second Period|Adverse Event|1|||
126214070|NCT02209454|454073441|FG001|Second Period|Adverse Event|0|||
126348860|NCT03765073|454571058|FG017|Stage 3|Other|1|||
126348861|NCT03765073|454571059|FG018|Stage 3|Other|2|||
126348862|NCT03765073|454571060|FG019|Stage 3|Other|2|||
126348863|NCT03765073|454571061|FG020|Stage 3|Other|2|||
126348864|NCT03765073|454571041|FG000|Stage 3|Withdrawal by parent/guardian|0|||
126348865|NCT03765073|454571042|FG001|Stage 3|Withdrawal by parent/guardian|0|||
126348866|NCT03765073|454571043|FG002|Stage 3|Withdrawal by parent/guardian|0|||
126348867|NCT03765073|454571044|FG003|Stage 3|Withdrawal by parent/guardian|0|||
126348868|NCT03765073|454571045|FG004|Stage 3|Withdrawal by parent/guardian|0|||
126348869|NCT03765073|454571046|FG005|Stage 3|Withdrawal by parent/guardian|0|||
126348870|NCT03765073|454571047|FG006|Stage 3|Withdrawal by parent/guardian|0|||
126348871|NCT03765073|454571048|FG007|Stage 3|Withdrawal by parent/guardian|0|||
126348872|NCT03765073|454571049|FG008|Stage 3|Withdrawal by parent/guardian|0|||
126348873|NCT03765073|454571050|FG009|Stage 3|Withdrawal by parent/guardian|0|||
126348874|NCT03765073|454571051|FG010|Stage 3|Withdrawal by parent/guardian|0|||
126348875|NCT03765073|454571052|FG011|Stage 3|Withdrawal by parent/guardian|0|||
126348876|NCT03765073|454571053|FG012|Stage 3|Withdrawal by parent/guardian|0|||
126348877|NCT03765073|454571054|FG013|Stage 3|Withdrawal by parent/guardian|0|||
126348878|NCT03765073|454571055|FG014|Stage 3|Withdrawal by parent/guardian|0|||
126348879|NCT03765073|454571056|FG015|Stage 3|Withdrawal by parent/guardian|0|||
126348880|NCT03765073|454571057|FG016|Stage 3|Withdrawal by parent/guardian|0|||
126348881|NCT03765073|454571058|FG017|Stage 3|Withdrawal by parent/guardian|0|||
126348882|NCT03765073|454571059|FG018|Stage 3|Withdrawal by parent/guardian|0|||
126348883|NCT03765073|454571060|FG019|Stage 3|Withdrawal by parent/guardian|6|||
126348884|NCT03765073|454571061|FG020|Stage 3|Withdrawal by parent/guardian|9|||
126348885|NCT03765073|454571041|FG000|Stage 3|Withdrawal by Subject|0|||
126348886|NCT03765073|454571042|FG001|Stage 3|Withdrawal by Subject|0|||
126348887|NCT03765073|454571043|FG002|Stage 3|Withdrawal by Subject|0|||
126348888|NCT03765073|454571044|FG003|Stage 3|Withdrawal by Subject|0|||
126348889|NCT03765073|454571045|FG004|Stage 3|Withdrawal by Subject|0|||
126348890|NCT03765073|454571046|FG005|Stage 3|Withdrawal by Subject|0|||
126348891|NCT03765073|454571047|FG006|Stage 3|Withdrawal by Subject|0|||
126214071|NCT00366678|454073446|FG000|Infant Series|Withdrawal by Subject|8|||
126214072|NCT00366678|454073447|FG001|Infant Series|Withdrawal by Subject|6|||
126214073|NCT00366678|454073448|FG002|Infant Series|Withdrawal by Subject|0|||
126214074|NCT00366678|454073446|FG000|Infant Series|Protocol Violation|4|||
126348892|NCT03765073|454571048|FG007|Stage 3|Withdrawal by Subject|0|||
126348893|NCT03765073|454571049|FG008|Stage 3|Withdrawal by Subject|0|||
126348894|NCT03765073|454571050|FG009|Stage 3|Withdrawal by Subject|0|||
126348895|NCT03765073|454571051|FG010|Stage 3|Withdrawal by Subject|0|||
126348896|NCT03765073|454571052|FG011|Stage 3|Withdrawal by Subject|0|||
126013410|NCT02878330|453342424|FG001|Overall Study|Other|7|||
126013411|NCT00361283|453342432|FG000|Overall Study|Lost to Follow-up|27|||
126013412|NCT00038103|453342433|FG000|Overall Study|Adverse Event|5|||
126013413|NCT00038103|453342434|FG001|Overall Study|Adverse Event|6|||
126013414|NCT00038103|453342433|FG000|Overall Study|Lack of Efficacy|48|||
126013415|NCT00038103|453342434|FG001|Overall Study|Lack of Efficacy|41|||
126013416|NCT00038103|453342433|FG000|Overall Study|Withdrawal by Subject|0|||
126013417|NCT00038103|453342434|FG001|Overall Study|Withdrawal by Subject|3|||
126013418|NCT00038103|453342433|FG000|Overall Study|Lost to Follow-up|0|||
126013419|NCT00038103|453342434|FG001|Overall Study|Lost to Follow-up|3|||
126013420|NCT00038103|453342433|FG000|Overall Study|Protocol Violation|0|||
126013421|NCT00038103|453342434|FG001|Overall Study|Protocol Violation|2|||
126013422|NCT00038103|453342433|FG000|Overall Study|Sponsor Decision|0|||
126013423|NCT00038103|453342434|FG001|Overall Study|Sponsor Decision|1|||
126013424|NCT00038103|453342433|FG000|Overall Study|Randomized/never treated|2|||
126013425|NCT00038103|453342434|FG001|Overall Study|Randomized/never treated|0|||
126013426|NCT00208767|453342437|FG000|Overall Study|Adverse Event|9|||
126013427|NCT00208767|453342438|FG001|Overall Study|Adverse Event|1|||
126013428|NCT00208767|453342437|FG000|Overall Study|Withdrawal by Subject|14|||
126013429|NCT00208767|453342438|FG001|Overall Study|Withdrawal by Subject|3|||
126013430|NCT00208767|453342437|FG000|Overall Study|Death|1|||
126013431|NCT00208767|453342438|FG001|Overall Study|Death|0|||
126013432|NCT00208767|453342437|FG000|Overall Study|Lost to Follow-up|3|||
126013433|NCT00208767|453342438|FG001|Overall Study|Lost to Follow-up|3|||
126013434|NCT03545984|453342439|FG000|Overall Study|CSF cases not present during rotation|11|||
126013435|NCT03545984|453342440|FG001|Overall Study|CSF cases not present during rotation|9|||
126013436|NCT01212757|453342443|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
126013437|NCT01212757|453342444|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
126013438|NCT01212757|453342445|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
126013439|NCT01212757|453342446|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126013440|NCT01212757|453342447|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126013441|NCT01212757|453342448|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126013442|NCT01212757|453342449|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126013443|NCT01212757|453342450|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126013444|NCT01212757|453342451|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126013445|NCT01212757|453342443|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
126013446|NCT01212757|453342444|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
126013447|NCT01212757|453342445|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
126013448|NCT01212757|453342446|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126013449|NCT01212757|453342447|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126013450|NCT01212757|453342448|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126013451|NCT01212757|453342449|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126214075|NCT00366678|454073447|FG001|Infant Series|Protocol Violation|3|||
126214076|NCT00366678|454073448|FG002|Infant Series|Protocol Violation|0|||
126214077|NCT00366678|454073446|FG000|Infant Series|Failed to return|1|||
126013452|NCT01212757|453342450|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126214078|NCT00366678|454073447|FG001|Infant Series|Failed to return|1|||
126013453|NCT01212757|453342451|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126013454|NCT01212757|453342443|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
126214079|NCT00366678|454073448|FG002|Infant Series|Failed to return|0|||
126214080|NCT00366678|454073446|FG000|Infant Series|Adverse Event|1|||
126214081|NCT00366678|454073447|FG001|Infant Series|Adverse Event|0|||
126214082|NCT00366678|454073448|FG002|Infant Series|Adverse Event|0|||
126214083|NCT00366678|454073446|FG000|After Infant|Withdrawal by Subject|8|||
126214084|NCT00366678|454073447|FG001|After Infant|Withdrawal by Subject|4|||
126214085|NCT00366678|454073448|FG002|After Infant|Withdrawal by Subject|0|||
126214086|NCT00366678|454073446|FG000|After Infant|Lost to Follow-up|2|||
126214087|NCT00366678|454073447|FG001|After Infant|Lost to Follow-up|1|||
126214088|NCT00366678|454073448|FG002|After Infant|Lost to Follow-up|0|||
126214089|NCT00366678|454073446|FG000|After Infant|Failed to return|5|||
126214090|NCT00366678|454073447|FG001|After Infant|Failed to return|5|||
126214091|NCT00366678|454073448|FG002|After Infant|Failed to return|0|||
126214092|NCT00366678|454073446|FG000|After Infant|Adverse Event|1|||
126214093|NCT00366678|454073447|FG001|After Infant|Adverse Event|0|||
126214094|NCT00366678|454073448|FG002|After Infant|Adverse Event|0|||
126214095|NCT00366678|454073446|FG000|After Infant|Protocol Violation|1|||
126214096|NCT00366678|454073447|FG001|After Infant|Protocol Violation|0|||
126214097|NCT00366678|454073448|FG002|After Infant|Protocol Violation|0|||
126214098|NCT00366678|454073446|FG000|Toddler Dose|Protocol Violation|2|||
126214099|NCT00366678|454073447|FG001|Toddler Dose|Protocol Violation|1|||
126214100|NCT00366678|454073448|FG002|Toddler Dose|Protocol Violation|0|||
126214101|NCT00366678|454073446|FG000|Toddler Dose|Failed to return|1|||
126214102|NCT00366678|454073447|FG001|Toddler Dose|Failed to return|0|||
126214103|NCT00366678|454073448|FG002|Toddler Dose|Failed to return|0|||
126214104|NCT00366678|454073446|FG000|Toddler Dose|Withdrawal by Subject|1|||
126214105|NCT00366678|454073447|FG001|Toddler Dose|Withdrawal by Subject|0|||
126214106|NCT00366678|454073448|FG002|Toddler Dose|Withdrawal by Subject|0|||
126214107|NCT00366678|454073446|FG000|Toddler Dose|protocol deviation|1|||
126214108|NCT00366678|454073447|FG001|Toddler Dose|protocol deviation|0|||
126214109|NCT00366678|454073448|FG002|Toddler Dose|protocol deviation|0|||
126214110|NCT04292171|454073449|FG000|Overall Study|Pharmacy error|2|||
126214111|NCT04292171|454073450|FG001|Overall Study|Pharmacy error|0|||
126214112|NCT04292171|454073449|FG000|Overall Study|Delivered prior to procedure|0|||
126214113|NCT04292171|454073450|FG001|Overall Study|Delivered prior to procedure|1|||
126214114|NCT02545868|454073451|FG000|Overall Study|Lack of Efficacy|1|||
126348897|NCT03765073|454571053|FG012|Stage 3|Withdrawal by Subject|0|||
126348898|NCT03765073|454571054|FG013|Stage 3|Withdrawal by Subject|0|||
126348899|NCT03765073|454571055|FG014|Stage 3|Withdrawal by Subject|0|||
126348900|NCT03765073|454571056|FG015|Stage 3|Withdrawal by Subject|0|||
126348901|NCT03765073|454571057|FG016|Stage 3|Withdrawal by Subject|0|||
126348902|NCT03765073|454571058|FG017|Stage 3|Withdrawal by Subject|8|||
126348903|NCT03765073|454571059|FG018|Stage 3|Withdrawal by Subject|11|||
126348904|NCT03765073|454571060|FG019|Stage 3|Withdrawal by Subject|0|||
126348905|NCT03765073|454571061|FG020|Stage 3|Withdrawal by Subject|0|||
126348906|NCT04225039|454571064|FG000|Overall Study|Withdrawal by Subject|1|||
126348907|NCT04225039|454571065|FG001|Overall Study|Withdrawal by Subject|0|||
126348908|NCT04225039|454571066|FG002|Overall Study|Withdrawal by Subject|0|||
126348909|NCT04225039|454571067|FG003|Overall Study|Withdrawal by Subject|1|||
126348910|NCT04225039|454571064|FG000|Overall Study|Currently active on study treatment|0|||
126348911|NCT04225039|454571065|FG001|Overall Study|Currently active on study treatment|1|||
126348912|NCT04225039|454571066|FG002|Overall Study|Currently active on study treatment|0|||
126348913|NCT04225039|454571067|FG003|Overall Study|Currently active on study treatment|0|||
126348914|NCT04225039|454571064|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
126348915|NCT04225039|454571065|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
126348916|NCT04225039|454571066|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
126348917|NCT04225039|454571067|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
126348918|NCT04225039|454571064|FG000|Overall Study|Ineligible for treatment|0|||
126348919|NCT04225039|454571065|FG001|Overall Study|Ineligible for treatment|0|||
126348920|NCT04225039|454571066|FG002|Overall Study|Ineligible for treatment|0|||
126348921|NCT04225039|454571067|FG003|Overall Study|Ineligible for treatment|4|||
126348922|NCT02802228|454571069|FG000|Overall Study|Withdrawal by Subject|2|||
126348923|NCT02802228|454571070|FG001|Overall Study|Withdrawal by Subject|0|||
126348924|NCT02802228|454571069|FG000|Overall Study|Lost to Follow-up|1|||
126348925|NCT02802228|454571070|FG001|Overall Study|Lost to Follow-up|0|||
126348926|NCT02802228|454571069|FG000|Overall Study|Adverse Event|1|||
126348927|NCT02802228|454571070|FG001|Overall Study|Adverse Event|0|||
126348928|NCT02802228|454571069|FG000|Overall Study|Physician Decision|1|||
126214115|NCT02545868|454073452|FG001|Overall Study|Lack of Efficacy|1|||
126214116|NCT02545868|454073453|FG002|Overall Study|Lack of Efficacy|0|||
126214117|NCT02545868|454073451|FG000|Overall Study|Lost to Follow-up|1|||
126214118|NCT02545868|454073452|FG001|Overall Study|Lost to Follow-up|5|||
126214119|NCT02545868|454073453|FG002|Overall Study|Lost to Follow-up|1|||
126214120|NCT02545868|454073451|FG000|Overall Study|Non-compliance|1|||
126348929|NCT02802228|454571070|FG001|Overall Study|Physician Decision|0|||
126348930|NCT00695019|454571071|FG000|Overall Study|Withdrawal by Subject|8|||
126348931|NCT00695019|454571072|FG001|Overall Study|Withdrawal by Subject|6|||
126214121|NCT02545868|454073452|FG001|Overall Study|Non-compliance|1|||
126214122|NCT02545868|454073453|FG002|Overall Study|Non-compliance|1|||
126214123|NCT02545868|454073451|FG000|Overall Study|Treatment change|21|||
126214124|NCT02545868|454073452|FG001|Overall Study|Treatment change|19|||
126214125|NCT02545868|454073453|FG002|Overall Study|Treatment change|22|||
126214126|NCT02545868|454073451|FG000|Overall Study|Physician Decision|1|||
126214127|NCT02545868|454073452|FG001|Overall Study|Physician Decision|1|||
126214128|NCT02545868|454073453|FG002|Overall Study|Physician Decision|1|||
126214129|NCT02545868|454073451|FG000|Overall Study|Withdrawal by Subject|6|||
126214130|NCT02545868|454073452|FG001|Overall Study|Withdrawal by Subject|7|||
126214131|NCT02545868|454073453|FG002|Overall Study|Withdrawal by Subject|9|||
126214132|NCT01777191|454073454|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
126214133|NCT01777191|454073455|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
126214134|NCT01777191|454073454|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
126214135|NCT01777191|454073455|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
126214136|NCT01777191|454073454|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
126214137|NCT01777191|454073455|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
126214138|NCT01777191|454073454|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
126214139|NCT01777191|454073455|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
126214140|NCT01777191|454073454|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
126214141|NCT01777191|454073455|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
126214142|NCT01777191|454073454|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
126214143|NCT01777191|454073455|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
126214144|NCT01777191|454073454|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
126214145|NCT01777191|454073455|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
126013455|NCT01212757|453342444|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
126013456|NCT01212757|453342445|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
126214146|NCT01777191|454073454|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
126214147|NCT01777191|454073455|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
126214148|NCT01777191|454073454|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
126214149|NCT01777191|454073455|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
126091147|NCT02218606|453628348|FG000|Overall Study|Physician Decision|0|||
126214150|NCT01777191|454073454|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
126214151|NCT01777191|454073455|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
126214152|NCT01777191|454073454|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
126214153|NCT01777191|454073455|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
126214154|NCT04465916|454073460|FG000|Overall Study|Withdrawal by Subject|0|||
126214155|NCT04465916|454073461|FG001|Overall Study|Withdrawal by Subject|1|||
126214156|NCT00468312|454073467|FG000|Overall Study|Adverse Event|2|||
126214157|NCT00468312|454073468|FG001|Overall Study|Adverse Event|1|||
126214158|NCT00468312|454073467|FG000|Overall Study|Lack of Efficacy|0|||
126214159|NCT00468312|454073468|FG001|Overall Study|Lack of Efficacy|1|||
126214160|NCT00468312|454073467|FG000|Overall Study|Withdrawal by Subject|0|||
126214161|NCT00468312|454073468|FG001|Overall Study|Withdrawal by Subject|1|||
126214162|NCT00468312|454073467|FG000|Overall Study|Protocol Violation|2|||
126214163|NCT00468312|454073468|FG001|Overall Study|Protocol Violation|1|||
126214164|NCT00468312|454073467|FG000|Overall Study|Did not meet protocol eligibility|0|||
126214165|NCT00468312|454073468|FG001|Overall Study|Did not meet protocol eligibility|1|||
126214166|NCT01052038|454073469|FG000|Overall Study|Lost to Follow-up|2|||
126214167|NCT01052038|454073470|FG001|Overall Study|Lost to Follow-up|3|||
126214168|NCT01052038|454073471|FG002|Overall Study|Lost to Follow-up|1|||
126214169|NCT01052038|454073469|FG000|Overall Study|Protocol Violation|2|||
126214170|NCT01052038|454073470|FG001|Overall Study|Protocol Violation|3|||
126214171|NCT01052038|454073471|FG002|Overall Study|Protocol Violation|3|||
126214172|NCT03976076|454073472|FG000|Overall Study|Withdrawal by Subject|2|||
126214173|NCT01325701|454073473|FG000|Overall Study|Adverse Event|12|||
126214174|NCT01325701|454073474|FG001|Overall Study|Adverse Event|0|||
126214175|NCT01325701|454073473|FG000|Overall Study|Protocol Violation|1|||
126214176|NCT01325701|454073474|FG001|Overall Study|Protocol Violation|0|||
126214177|NCT01325701|454073473|FG000|Overall Study|Physician Decision|2|||
126013457|NCT01212757|453342446|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126013458|NCT01212757|453342447|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126013459|NCT01212757|453342448|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126013460|NCT01212757|453342449|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126013461|NCT01212757|453342450|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126013462|NCT01212757|453342451|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126013463|NCT01212757|453342443|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
126013464|NCT01212757|453342444|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126013465|NCT01212757|453342445|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
126013466|NCT01212757|453342446|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126013467|NCT01212757|453342447|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126013468|NCT01212757|453342448|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126013469|NCT01212757|453342449|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126013470|NCT01212757|453342450|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126013471|NCT01212757|453342451|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126013472|NCT01212757|453342443|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126013473|NCT01212757|453342444|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126013474|NCT01212757|453342445|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
126013475|NCT01212757|453342446|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126013476|NCT01212757|453342447|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126013477|NCT01212757|453342448|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126013478|NCT01212757|453342449|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126013479|NCT01212757|453342450|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126013480|NCT01212757|453342451|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126013481|NCT01212757|453342443|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126013482|NCT01212757|453342444|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126013483|NCT01212757|453342445|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126013484|NCT01212757|453342446|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126013485|NCT01212757|453342447|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126013486|NCT01212757|453342448|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126013487|NCT01212757|453342449|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126013488|NCT01212757|453342450|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126214178|NCT01325701|454073474|FG001|Overall Study|Physician Decision|2|||
126214179|NCT01325701|454073473|FG000|Overall Study|Withdrawal by Subject|2|||
126214180|NCT01325701|454073474|FG001|Overall Study|Withdrawal by Subject|1|||
126214181|NCT01325701|454073473|FG000|Overall Study|Rollerover Extension Study|4|||
126214182|NCT01325701|454073474|FG001|Overall Study|Rollerover Extension Study|0|||
126214183|NCT00388674|454073484|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
126214184|NCT00388674|454073485|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
126214185|NCT00388674|454073484|FG000|Initial Treatment|Adverse Event|22|||
126214186|NCT00388674|454073485|FG001|Initial Treatment|Adverse Event|87|||
126214187|NCT00388674|454073484|FG000|Initial Treatment|Death|215|||
126214188|NCT00388674|454073485|FG001|Initial Treatment|Death|216|||
126214189|NCT00388674|454073484|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
126214190|NCT00388674|454073485|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
126214191|NCT00388674|454073484|FG000|Initial Treatment|HCC|12|||
126214192|NCT00388674|454073485|FG001|Initial Treatment|HCC|20|||
126214193|NCT00388674|454073484|FG000|Initial Treatment|Lost to Follow-up|526|||
126214194|NCT00388674|454073485|FG001|Initial Treatment|Lost to Follow-up|624|||
126214195|NCT00388674|454073484|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
126214196|NCT00388674|454073485|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
126214197|NCT00388674|454073484|FG000|Initial Treatment|Never Treated with Study Medication|1|||
126214198|NCT00388674|454073485|FG001|Initial Treatment|Never Treated with Study Medication|7|||
126214199|NCT00388674|454073484|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
126214200|NCT00388674|454073485|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
126214201|NCT00388674|454073484|FG000|Initial Treatment|Not Defined|125|||
126214202|NCT00388674|454073485|FG001|Initial Treatment|Not Defined|172|||
126214203|NCT00388674|454073484|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
126214204|NCT00388674|454073485|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
126214205|NCT00388674|454073484|FG000|Initial Treatment|Pregnancy|26|||
126214206|NCT00388674|454073485|FG001|Initial Treatment|Pregnancy|16|||
126214207|NCT00388674|454073484|FG000|Initial Treatment|Study Drug Toxicity|5|||
126214208|NCT00388674|454073485|FG001|Initial Treatment|Study Drug Toxicity|92|||
126214209|NCT00388674|454073484|FG000|Initial Treatment|Participant Request|501|||
126214210|NCT00388674|454073485|FG001|Initial Treatment|Participant Request|673|||
126214211|NCT00388674|454073484|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
126214212|NCT00388674|454073485|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
126214213|NCT00388674|454073484|FG000|Initial Treatment|Not Reported|10|||
126214214|NCT00388674|454073485|FG001|Initial Treatment|Not Reported|12|||
126214215|NCT00388674|454073484|FG000|End of Study|Administrative Reason By Sponsor|299|||
126214216|NCT00388674|454073485|FG001|End of Study|Administrative Reason By Sponsor|253|||
126214217|NCT00388674|454073484|FG000|End of Study|Death|239|||
126214218|NCT00388674|454073485|FG001|End of Study|Death|262|||
126214219|NCT00388674|454073484|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
126214220|NCT00388674|454073485|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
126214221|NCT00388674|454073484|FG000|End of Study|HCC|8|||
126214222|NCT00388674|454073485|FG001|End of Study|HCC|7|||
126214223|NCT00388674|454073484|FG000|End of Study|Lost to Follow-up|587|||
126214224|NCT00388674|454073485|FG001|End of Study|Lost to Follow-up|715|||
126214225|NCT00388674|454073484|FG000|End of Study|Malignancy (Non-HCC)|1|||
126214226|NCT00388674|454073485|FG001|End of Study|Malignancy (Non-HCC)|1|||
126214227|NCT00388674|454073484|FG000|End of Study|Non-Study Related Comorbidities|3|||
126214228|NCT00388674|454073485|FG001|End of Study|Non-Study Related Comorbidities|4|||
126214229|NCT00388674|454073484|FG000|End of Study|Not Defined|135|||
126214230|NCT00388674|454073485|FG001|End of Study|Not Defined|214|||
126214231|NCT00388674|454073484|FG000|End of Study|Participant Withdrew Consent|437|||
126214232|NCT00388674|454073485|FG001|End of Study|Participant Withdrew Consent|673|||
126214233|NCT00388674|454073484|FG000|End of Study|No Off-Treatment Status Data|22|||
126214234|NCT00388674|454073485|FG001|End of Study|No Off-Treatment Status Data|30|||
126214235|NCT00388674|454073484|FG000|End of Study|Not Reported|0|||
126348932|NCT00695019|454571073|FG002|Overall Study|Withdrawal by Subject|4|||
126348933|NCT00695019|454571071|FG000|Overall Study|Protocol Violation|1|||
126348934|NCT00695019|454571072|FG001|Overall Study|Protocol Violation|3|||
126348935|NCT00695019|454571073|FG002|Overall Study|Protocol Violation|1|||
126348936|NCT00695019|454571071|FG000|Overall Study|Lack of Efficacy|0|||
126348937|NCT00695019|454571072|FG001|Overall Study|Lack of Efficacy|0|||
126348938|NCT00695019|454571073|FG002|Overall Study|Lack of Efficacy|1|||
126214236|NCT00388674|454073485|FG001|End of Study|Not Reported|1|||
126214237|NCT00759174|454073486|FG000|Overall Study|Other|0|||
126214238|NCT00759174|454073487|FG001|Overall Study|Other|2|||
126214239|NCT01890109|454073488|FG000|Overall Study|Withdrawal by Subject|0|||
126214240|NCT01890109|454073489|FG001|Overall Study|Withdrawal by Subject|3|||
126214241|NCT01890109|454073488|FG000|Overall Study|Lost to Follow-up|1|||
126214242|NCT01890109|454073489|FG001|Overall Study|Lost to Follow-up|2|||
126214243|NCT01643928|454073492|FG000|Overall Study|Lost to Follow-up|1|||
126214244|NCT01643928|454073493|FG001|Overall Study|Lost to Follow-up|0|||
126348939|NCT00695019|454571071|FG000|Overall Study|Various|4|||
126348940|NCT00695019|454571072|FG001|Overall Study|Various|5|||
126348941|NCT00695019|454571073|FG002|Overall Study|Various|4|||
126214245|NCT01643928|454073494|FG002|Overall Study|Lost to Follow-up|2|||
126214246|NCT01643928|454073495|FG003|Overall Study|Lost to Follow-up|0|||
126214247|NCT01643928|454073496|FG004|Overall Study|Lost to Follow-up|0|||
126214248|NCT01643928|454073492|FG000|Overall Study|Withdrawal by Subject|2|||
126348942|NCT02225587|454571074|FG000|Overall Study|Adverse Event|5|||
126214249|NCT01643928|454073493|FG001|Overall Study|Withdrawal by Subject|0|||
126214250|NCT01643928|454073494|FG002|Overall Study|Withdrawal by Subject|0|||
126214251|NCT01643928|454073495|FG003|Overall Study|Withdrawal by Subject|1|||
126214252|NCT01643928|454073496|FG004|Overall Study|Withdrawal by Subject|0|||
126013489|NCT01212757|453342451|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126214253|NCT01643928|454073492|FG000|Overall Study|Pregnancy|0|||
126214254|NCT01643928|454073493|FG001|Overall Study|Pregnancy|0|||
126214255|NCT01643928|454073494|FG002|Overall Study|Pregnancy|0|||
126214256|NCT01643928|454073495|FG003|Overall Study|Pregnancy|1|||
126214257|NCT01643928|454073496|FG004|Overall Study|Pregnancy|0|||
126214258|NCT01643928|454073492|FG000|Overall Study|Other|5|||
126214259|NCT01643928|454073493|FG001|Overall Study|Other|1|||
126013490|NCT01212757|453342443|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
126013491|NCT01212757|453342444|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
126013492|NCT01212757|453342445|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126013493|NCT01212757|453342446|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126013494|NCT01212757|453342447|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126013495|NCT01212757|453342448|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126013496|NCT01212757|453342449|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126013497|NCT01212757|453342450|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126013498|NCT01212757|453342451|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126013499|NCT01212757|453342443|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126013500|NCT01212757|453342444|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
126013501|NCT01212757|453342445|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
126013502|NCT01212757|453342446|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
126013503|NCT01212757|453342447|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126013504|NCT01212757|453342448|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
126013505|NCT01212757|453342449|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126013506|NCT01212757|453342450|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126013507|NCT01212757|453342451|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126013508|NCT01212757|453342443|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126013509|NCT01212757|453342444|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
126013510|NCT01212757|453342445|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
126013511|NCT01212757|453342446|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
126013512|NCT01212757|453342447|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126013513|NCT01212757|453342448|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
126013514|NCT01212757|453342449|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126013515|NCT01212757|453342450|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126013516|NCT01212757|453342451|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126013517|NCT01212757|453342443|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126013518|NCT01212757|453342444|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126013519|NCT01212757|453342445|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
126013520|NCT01212757|453342446|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126013521|NCT01212757|453342447|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126013522|NCT01212757|453342448|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126013523|NCT01212757|453342449|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126013524|NCT01212757|453342450|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126013525|NCT01212757|453342451|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126013526|NCT01212757|453342443|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126013527|NCT01212757|453342444|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
126013528|NCT01212757|453342445|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
126013529|NCT01212757|453342446|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
126013530|NCT01212757|453342447|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
126013531|NCT01212757|453342448|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
126013532|NCT01212757|453342449|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126013533|NCT01212757|453342450|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126013534|NCT01212757|453342451|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126013535|NCT01212757|453342443|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126013536|NCT01212757|453342444|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
126013537|NCT01212757|453342445|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126013538|NCT01212757|453342446|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126013539|NCT01212757|453342447|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
126013540|NCT01212757|453342448|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126091148|NCT02218606|453628349|FG001|Overall Study|Physician Decision|1|||
126214260|NCT01643928|454073494|FG002|Overall Study|Other|1|||
126214261|NCT01643928|454073495|FG003|Overall Study|Other|0|||
126214262|NCT01643928|454073496|FG004|Overall Study|Other|0|||
126214263|NCT01643928|454073492|FG000|Overall Study|Adverse Event|2|||
126214264|NCT01643928|454073493|FG001|Overall Study|Adverse Event|1|||
126214265|NCT01643928|454073494|FG002|Overall Study|Adverse Event|0|||
126214266|NCT01643928|454073495|FG003|Overall Study|Adverse Event|1|||
126214267|NCT01643928|454073496|FG004|Overall Study|Adverse Event|2|||
126214268|NCT00568776|454073497|FG000|Overall Study|Adverse Event|8|||
126214269|NCT00568776|454073498|FG001|Overall Study|Adverse Event|8|||
126214270|NCT00568776|454073499|FG002|Overall Study|Adverse Event|10|||
126214271|NCT00568776|454073500|FG003|Overall Study|Adverse Event|8|||
126214272|NCT00568776|454073497|FG000|Overall Study|Death|0|||
126214273|NCT00568776|454073498|FG001|Overall Study|Death|1|||
126214274|NCT00568776|454073499|FG002|Overall Study|Death|4|||
126214275|NCT00568776|454073500|FG003|Overall Study|Death|3|||
126214276|NCT00568776|454073497|FG000|Overall Study|Physician Decision|0|||
126214277|NCT00568776|454073498|FG001|Overall Study|Physician Decision|2|||
126214278|NCT00568776|454073499|FG002|Overall Study|Physician Decision|0|||
126214279|NCT00568776|454073500|FG003|Overall Study|Physician Decision|0|||
126214280|NCT00568776|454073497|FG000|Overall Study|Lack of Efficacy|2|||
126214281|NCT00568776|454073498|FG001|Overall Study|Lack of Efficacy|2|||
126214282|NCT00568776|454073499|FG002|Overall Study|Lack of Efficacy|2|||
126214283|NCT00568776|454073500|FG003|Overall Study|Lack of Efficacy|4|||
126214284|NCT00568776|454073497|FG000|Overall Study|Lost to Follow-up|1|||
126214285|NCT00568776|454073498|FG001|Overall Study|Lost to Follow-up|1|||
126214286|NCT00568776|454073499|FG002|Overall Study|Lost to Follow-up|1|||
126214287|NCT00568776|454073500|FG003|Overall Study|Lost to Follow-up|1|||
126214288|NCT00568776|454073497|FG000|Overall Study|Protocol Violation|1|||
126214289|NCT00568776|454073498|FG001|Overall Study|Protocol Violation|0|||
126214290|NCT00568776|454073499|FG002|Overall Study|Protocol Violation|1|||
126214291|NCT00568776|454073500|FG003|Overall Study|Protocol Violation|1|||
126214292|NCT00568776|454073497|FG000|Overall Study|Withdrawal by Subject|13|||
126214293|NCT00568776|454073498|FG001|Overall Study|Withdrawal by Subject|15|||
126214294|NCT00568776|454073499|FG002|Overall Study|Withdrawal by Subject|13|||
126214295|NCT00568776|454073500|FG003|Overall Study|Withdrawal by Subject|7|||
126214296|NCT00568776|454073497|FG000|Overall Study|Loss of Caregiver|0|||
126214297|NCT00568776|454073498|FG001|Overall Study|Loss of Caregiver|2|||
126214298|NCT00568776|454073499|FG002|Overall Study|Loss of Caregiver|1|||
126214299|NCT00568776|454073500|FG003|Overall Study|Loss of Caregiver|2|||
126214300|NCT00568776|454073497|FG000|Overall Study|Sponsor Decision|2|||
126214301|NCT00568776|454073498|FG001|Overall Study|Sponsor Decision|2|||
126214302|NCT00568776|454073499|FG002|Overall Study|Sponsor Decision|41|||
126214303|NCT00568776|454073500|FG003|Overall Study|Sponsor Decision|42|||
126214304|NCT00568776|454073497|FG000|Overall Study|Miscellaeneous|3|||
126214305|NCT00568776|454073498|FG001|Overall Study|Miscellaeneous|3|||
126214306|NCT00568776|454073499|FG002|Overall Study|Miscellaeneous|1|||
126214307|NCT00568776|454073500|FG003|Overall Study|Miscellaeneous|4|||
126214308|NCT03692078|454073501|FG000|Overall Study|Adverse Event|0|||
126214309|NCT03692078|454073502|FG001|Overall Study|Adverse Event|0|||
126214310|NCT03692078|454073503|FG002|Overall Study|Adverse Event|0|||
126214311|NCT03692078|454073504|FG003|Overall Study|Adverse Event|0|||
126214312|NCT03692078|454073505|FG004|Overall Study|Adverse Event|0|||
126214313|NCT03692078|454073506|FG005|Overall Study|Adverse Event|1|||
126214314|NCT03692078|454073507|FG006|Overall Study|Adverse Event|0|||
126214315|NCT03692078|454073501|FG000|Overall Study|Enrollment Closed|5|||
126214316|NCT03692078|454073502|FG001|Overall Study|Enrollment Closed|0|||
126214317|NCT03692078|454073503|FG002|Overall Study|Enrollment Closed|0|||
126214318|NCT03692078|454073504|FG003|Overall Study|Enrollment Closed|0|||
126214319|NCT03692078|454073505|FG004|Overall Study|Enrollment Closed|0|||
126214320|NCT03692078|454073506|FG005|Overall Study|Enrollment Closed|0|||
126214321|NCT03692078|454073507|FG006|Overall Study|Enrollment Closed|0|||
126214322|NCT03692078|454073501|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
126214323|NCT03692078|454073502|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
126214324|NCT03692078|454073503|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
126214325|NCT03692078|454073504|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
126214326|NCT03692078|454073505|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
126214327|NCT03692078|454073506|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
126214328|NCT03692078|454073507|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
126214329|NCT03692078|454073501|FG000|Overall Study|Withdrawal by Subject|0|||
126214330|NCT03692078|454073502|FG001|Overall Study|Withdrawal by Subject|2|||
126214331|NCT03692078|454073503|FG002|Overall Study|Withdrawal by Subject|0|||
126214332|NCT03692078|454073504|FG003|Overall Study|Withdrawal by Subject|1|||
126214333|NCT03692078|454073505|FG004|Overall Study|Withdrawal by Subject|5|||
126214334|NCT03692078|454073506|FG005|Overall Study|Withdrawal by Subject|3|||
126214335|NCT03692078|454073507|FG006|Overall Study|Withdrawal by Subject|3|||
126214336|NCT01005680|454073508|FG000|Overall Study|Lost to Follow-up|4|||
126214337|NCT01005680|454073509|FG001|Overall Study|Lost to Follow-up|6|||
126214338|NCT01005680|454073508|FG000|Overall Study|Withdrawal by Subject|1|||
126214339|NCT01005680|454073509|FG001|Overall Study|Withdrawal by Subject|4|||
126214340|NCT01005680|454073508|FG000|Overall Study|Physician Decision|1|||
126214341|NCT01005680|454073509|FG001|Overall Study|Physician Decision|1|||
126214342|NCT03576131|454073510|FG000|Overall Study|Investigator decision|0|||
126214343|NCT03576131|454073511|FG001|Overall Study|Investigator decision|0|||
126214344|NCT03576131|454073512|FG002|Overall Study|Investigator decision|0|||
126214345|NCT03576131|454073513|FG003|Overall Study|Investigator decision|1|||
126214346|NCT03576131|454073514|FG004|Overall Study|Investigator decision|0|||
126214347|NCT03576131|454073515|FG005|Overall Study|Investigator decision|1|||
126214348|NCT03576131|454073516|FG006|Overall Study|Investigator decision|0|||
126214349|NCT03576131|454073517|FG007|Overall Study|Investigator decision|0|||
126214350|NCT03576131|454073510|FG000|Overall Study|Withdrawal by Subject|1|||
126214351|NCT03576131|454073511|FG001|Overall Study|Withdrawal by Subject|1|||
126214352|NCT03576131|454073512|FG002|Overall Study|Withdrawal by Subject|0|||
126214353|NCT03576131|454073513|FG003|Overall Study|Withdrawal by Subject|1|||
126214354|NCT03576131|454073514|FG004|Overall Study|Withdrawal by Subject|2|||
126214355|NCT03576131|454073515|FG005|Overall Study|Withdrawal by Subject|3|||
126214356|NCT03576131|454073516|FG006|Overall Study|Withdrawal by Subject|1|||
126214357|NCT03576131|454073517|FG007|Overall Study|Withdrawal by Subject|0|||
126214358|NCT03576131|454073510|FG000|Overall Study|Death|3|||
126214359|NCT03576131|454073511|FG001|Overall Study|Death|3|||
126214360|NCT03576131|454073512|FG002|Overall Study|Death|1|||
126214361|NCT03576131|454073513|FG003|Overall Study|Death|5|||
126214362|NCT03576131|454073514|FG004|Overall Study|Death|4|||
126214363|NCT03576131|454073515|FG005|Overall Study|Death|1|||
126214364|NCT03576131|454073516|FG006|Overall Study|Death|0|||
126214365|NCT03576131|454073517|FG007|Overall Study|Death|1|||
126214366|NCT03576131|454073510|FG000|Overall Study|New anti-cancer treatment|5|||
126214367|NCT03576131|454073511|FG001|Overall Study|New anti-cancer treatment|1|||
126214368|NCT03576131|454073512|FG002|Overall Study|New anti-cancer treatment|2|||
126214369|NCT03576131|454073513|FG003|Overall Study|New anti-cancer treatment|3|||
126214370|NCT03576131|454073514|FG004|Overall Study|New anti-cancer treatment|0|||
126214371|NCT03576131|454073515|FG005|Overall Study|New anti-cancer treatment|0|||
126214372|NCT03576131|454073516|FG006|Overall Study|New anti-cancer treatment|0|||
126214373|NCT03576131|454073517|FG007|Overall Study|New anti-cancer treatment|0|||
126214374|NCT03576131|454073510|FG000|Overall Study|Unspecified reason|0|||
126214375|NCT03576131|454073511|FG001|Overall Study|Unspecified reason|0|||
126214376|NCT03576131|454073512|FG002|Overall Study|Unspecified reason|1|||
126214377|NCT03576131|454073513|FG003|Overall Study|Unspecified reason|1|||
126214378|NCT03576131|454073514|FG004|Overall Study|Unspecified reason|1|||
126214379|NCT03576131|454073515|FG005|Overall Study|Unspecified reason|1|||
126214380|NCT03576131|454073516|FG006|Overall Study|Unspecified reason|0|||
126214381|NCT03576131|454073517|FG007|Overall Study|Unspecified reason|0|||
126214382|NCT03576131|454073510|FG000|Overall Study|Subject non-compliance|0|||
126214383|NCT03576131|454073511|FG001|Overall Study|Subject non-compliance|0|||
126214384|NCT03576131|454073512|FG002|Overall Study|Subject non-compliance|0|||
126214385|NCT03576131|454073513|FG003|Overall Study|Subject non-compliance|0|||
126214386|NCT03576131|454073514|FG004|Overall Study|Subject non-compliance|0|||
126214387|NCT03576131|454073515|FG005|Overall Study|Subject non-compliance|1|||
126214388|NCT03576131|454073516|FG006|Overall Study|Subject non-compliance|0|||
126214389|NCT03576131|454073517|FG007|Overall Study|Subject non-compliance|0|||
126214390|NCT03069365|454073534|FG000|Overall Study|Adverse Event|1|||
126214391|NCT01965431|454073535|FG000|Overall Study|Adverse Event|0|||
126214392|NCT01965431|454073536|FG001|Overall Study|Adverse Event|1|||
126214393|NCT01965431|454073537|FG002|Overall Study|Adverse Event|0|||
126214394|NCT01965431|454073538|FG003|Overall Study|Adverse Event|0|||
126214395|NCT01965431|454073539|FG004|Overall Study|Adverse Event|0|||
126214396|NCT01965431|454073540|FG005|Overall Study|Adverse Event|0|||
126214397|NCT01965431|454073535|FG000|Overall Study|Other than stated above|6|||
126214398|NCT01965431|454073536|FG001|Overall Study|Other than stated above|5|||
126214399|NCT01965431|454073537|FG002|Overall Study|Other than stated above|6|||
126214400|NCT01965431|454073538|FG003|Overall Study|Other than stated above|6|||
126214401|NCT01965431|454073539|FG004|Overall Study|Other than stated above|6|||
126214402|NCT01965431|454073540|FG005|Overall Study|Other than stated above|6|||
126214403|NCT04635631|454073541|FG000|Overall Study|Adverse Event|1|||
126214404|NCT04635631|454073541|FG000|Overall Study|Progressive disease|13|||
126214405|NCT04635631|454073541|FG000|Overall Study|Withdrawal by Subject|1|||
126214406|NCT03901339|454073543|FG000|Overall Study|Death|220|||
126214407|NCT03901339|454073544|FG001|Overall Study|Death|192|||
126214408|NCT03901339|454073543|FG000|Overall Study|Informed consent withdrawn|13|||
126214409|NCT03901339|454073544|FG001|Overall Study|Informed consent withdrawn|40|||
126214410|NCT03901339|454073543|FG000|Overall Study|Sponsor request|30|||
126214411|NCT03901339|454073544|FG001|Overall Study|Sponsor request|23|||
126214412|NCT03901339|454073543|FG000|Overall Study|Reason not specified|5|||
126214413|NCT03901339|454073544|FG001|Overall Study|Reason not specified|7|||
126214414|NCT03901339|454073543|FG000|Overall Study|Lost to Follow-up|4|||
126214415|NCT03901339|454073544|FG001|Overall Study|Lost to Follow-up|7|||
126214416|NCT03901339|454073543|FG000|Overall Study|Covid19|0|||
126214417|NCT03901339|454073544|FG001|Overall Study|Covid19|2|||
126214418|NCT02886494|454073545|FG000|Overall Study|Adverse Event|1|||
126214419|NCT02886494|454073546|FG001|Overall Study|Adverse Event|0|||
126214420|NCT02886494|454073545|FG000|Overall Study|Withdrawal by Subject|12|||
126013541|NCT01212757|453342449|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126013542|NCT01212757|453342450|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126013543|NCT01212757|453342451|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126013544|NCT01212757|453342443|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
125878672|NCT02318706|452853381|FG004|Double-blind Phase|Lost to Follow-up|0|||
126013545|NCT01212757|453342444|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
126013546|NCT01212757|453342445|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
126214421|NCT02886494|454073546|FG001|Overall Study|Withdrawal by Subject|3|||
126214422|NCT02886494|454073545|FG000|Overall Study|Protocol Violation|4|||
126214423|NCT02886494|454073546|FG001|Overall Study|Protocol Violation|1|||
126214424|NCT00457418|454073547|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
126214425|NCT00457418|454073547|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
126214426|NCT00457418|454073547|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
126214427|NCT00457418|454073547|FG000|Post PK Maintenance|Adverse Event|10|||
126214428|NCT00457418|454073547|FG000|Post PK Maintenance|Progression of Disease|6|||
126214429|NCT00457418|454073547|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
126214430|NCT00457418|454073547|FG000|Post PK Maintenance|Lost to Follow-up|1|||
126214431|NCT01785472|454073548|FG000|Overall Study|Adverse Event|5|||
126214432|NCT01785472|454073549|FG001|Overall Study|Adverse Event|4|||
126214433|NCT01785472|454073550|FG002|Overall Study|Adverse Event|6|||
126214434|NCT01785472|454073548|FG000|Overall Study|Lack of Efficacy|2|||
126214435|NCT01785472|454073549|FG001|Overall Study|Lack of Efficacy|0|||
126214436|NCT01785472|454073550|FG002|Overall Study|Lack of Efficacy|1|||
126214437|NCT01785472|454073548|FG000|Overall Study|Lost to Follow-up|1|||
126214438|NCT01785472|454073549|FG001|Overall Study|Lost to Follow-up|2|||
126214439|NCT01785472|454073550|FG002|Overall Study|Lost to Follow-up|0|||
126214440|NCT01785472|454073548|FG000|Overall Study|Physician Decision|1|||
126214441|NCT01785472|454073549|FG001|Overall Study|Physician Decision|1|||
126214442|NCT01785472|454073550|FG002|Overall Study|Physician Decision|1|||
126214443|NCT01785472|454073548|FG000|Overall Study|Protocol deviation|0|||
126214444|NCT01785472|454073549|FG001|Overall Study|Protocol deviation|2|||
126214445|NCT01785472|454073550|FG002|Overall Study|Protocol deviation|2|||
126214446|NCT01785472|454073548|FG000|Overall Study|Subject/guardian decision|15|||
126214447|NCT01785472|454073549|FG001|Overall Study|Subject/guardian decision|10|||
126214448|NCT01785472|454073550|FG002|Overall Study|Subject/guardian decision|11|||
126214449|NCT01785472|454073548|FG000|Overall Study|Technical problems|0|||
126214450|NCT01785472|454073549|FG001|Overall Study|Technical problems|0|||
126214451|NCT01785472|454073550|FG002|Overall Study|Technical problems|1|||
126214452|NCT00556166|454073556|FG000|Overall Study|Withdrawal by Subject|1|||
126214453|NCT03972709|454073562|FG000|Overall Study|Withdrawal by Subject|18|||
126214454|NCT03972709|454073563|FG001|Overall Study|Withdrawal by Subject|7|||
126214455|NCT03972709|454073564|FG002|Overall Study|Withdrawal by Subject|14|||
126214456|NCT03972709|454073562|FG000|Overall Study|Study Terminated by Sponsor|48|||
126214457|NCT03972709|454073563|FG001|Overall Study|Study Terminated by Sponsor|25|||
126214458|NCT03972709|454073564|FG002|Overall Study|Study Terminated by Sponsor|50|||
126214459|NCT03972709|454073562|FG000|Overall Study|Physician Decision|1|||
126214460|NCT03972709|454073563|FG001|Overall Study|Physician Decision|0|||
126214461|NCT03972709|454073564|FG002|Overall Study|Physician Decision|0|||
126214462|NCT03972709|454073562|FG000|Overall Study|COVID-19|0|||
126214463|NCT03972709|454073563|FG001|Overall Study|COVID-19|1|||
126214464|NCT03972709|454073564|FG002|Overall Study|COVID-19|1|||
126214465|NCT03972709|454073562|FG000|Overall Study|Lost to Follow-up|6|||
126214466|NCT03972709|454073563|FG001|Overall Study|Lost to Follow-up|1|||
126214467|NCT03972709|454073564|FG002|Overall Study|Lost to Follow-up|2|||
126214468|NCT03972709|454073562|FG000|Overall Study|Death|5|||
126214469|NCT03972709|454073563|FG001|Overall Study|Death|1|||
126214470|NCT03972709|454073564|FG002|Overall Study|Death|4|||
126214471|NCT03972709|454073562|FG000|Overall Study|Adverse Event|3|||
126214472|NCT03972709|454073563|FG001|Overall Study|Adverse Event|1|||
126214473|NCT03972709|454073564|FG002|Overall Study|Adverse Event|4|||
126214474|NCT03972709|454073562|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
126013547|NCT01212757|453342446|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126214475|NCT03972709|454073563|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
126214476|NCT03972709|454073564|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
126214477|NCT03972709|454073562|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
126214478|NCT03972709|454073563|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
126214479|NCT03972709|454073564|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
126214480|NCT03972709|454073562|FG000|Overall Study|Subject Unable to be Contacted|0|||
126214481|NCT03972709|454073563|FG001|Overall Study|Subject Unable to be Contacted|1|||
126214482|NCT03972709|454073564|FG002|Overall Study|Subject Unable to be Contacted|0|||
126214483|NCT03972709|454073562|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
126348943|NCT02225587|454571075|FG001|Overall Study|Adverse Event|5|||
126348944|NCT02225587|454571074|FG000|Overall Study|Lost to Follow-up|5|||
125878673|NCT02318706|452853377|FG000|Double-blind Phase|Protocol Violation|4|||
126348945|NCT02225587|454571075|FG001|Overall Study|Lost to Follow-up|5|||
126348946|NCT02225587|454571074|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126348947|NCT02225587|454571075|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126348948|NCT02225587|454571074|FG000|Overall Study|Physician Decision|2|||
126348949|NCT02225587|454571075|FG001|Overall Study|Physician Decision|0|||
126348950|NCT02225587|454571074|FG000|Overall Study|Protocol Violation|1|||
126348951|NCT02225587|454571075|FG001|Overall Study|Protocol Violation|0|||
126348952|NCT02225587|454571074|FG000|Overall Study|Participant Moved|1|||
126214484|NCT03972709|454073563|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
126214485|NCT03972709|454073564|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
126214486|NCT03972709|454073562|FG000|Overall Study|Subject Moved|0|||
126214487|NCT03972709|454073563|FG001|Overall Study|Subject Moved|1|||
126214488|NCT03972709|454073564|FG002|Overall Study|Subject Moved|0|||
126214489|NCT03972709|454073562|FG000|Overall Study|Missed Study Visits|1|||
126214490|NCT03972709|454073563|FG001|Overall Study|Missed Study Visits|0|||
126214491|NCT03972709|454073564|FG002|Overall Study|Missed Study Visits|0|||
126214492|NCT02873195|454073569|FG000|Overall Study|Ineligible|5|||
126214493|NCT02873195|454073570|FG001|Overall Study|Ineligible|0|||
126214494|NCT04278872|454073571|FG000|Overall Study|Adverse Event|1|||
126214495|NCT04278872|454073572|FG001|Overall Study|Adverse Event|0|||
126214496|NCT04278872|454073571|FG000|Overall Study|Protocol Violation|0|||
126214497|NCT04278872|454073572|FG001|Overall Study|Protocol Violation|1|||
126214498|NCT04278872|454073571|FG000|Overall Study|Study Termination|2|||
126214499|NCT04278872|454073572|FG001|Overall Study|Study Termination|0|||
126214500|NCT00752895|454073573|FG000|Overall Study|Withdrawal by Subject|8|||
126214501|NCT00752895|454073574|FG001|Overall Study|Withdrawal by Subject|3|||
126214502|NCT00096031|454073575|FG000|Overall Study|Adverse Event|3|||
126214503|NCT00096031|454073575|FG000|Overall Study|Lack of Efficacy|42|||
126214504|NCT00096031|454073575|FG000|Overall Study|Death|4|||
126214505|NCT00096031|454073575|FG000|Overall Study|Withdrawal by Subject|1|||
126214506|NCT00096031|454073575|FG000|Overall Study|Ineligible|8|||
126214507|NCT00096031|454073575|FG000|Overall Study|Not protocol specified|5|||
126214508|NCT05257109|454073576|FG000|Overall Study|Withdrawal by Subject|1|||
126214509|NCT05257109|454073577|FG001|Overall Study|Withdrawal by Subject|0|||
126214510|NCT05257109|454073578|FG002|Overall Study|Withdrawal by Subject|0|||
126214511|NCT05257109|454073579|FG003|Overall Study|Withdrawal by Subject|0|||
126214512|NCT00915473|454074677|FG000|Screening|Withdrawal by Subject|1|||
126214513|NCT00915473|454074678|FG001|Screening|Withdrawal by Subject|0|||
126214514|NCT00915473|454074677|FG000|4-week Follow Up|Lost to Follow-up|1|||
126214515|NCT00915473|454074678|FG001|4-week Follow Up|Lost to Follow-up|5|||
126214516|NCT00734617|454074681|FG000|Overall Study|Adverse Event|4|||
126214517|NCT00734617|454074682|FG001|Overall Study|Adverse Event|7|||
126214518|NCT00734617|454074681|FG000|Overall Study|Withdrawal by Subject|103|||
126214519|NCT00734617|454074682|FG001|Overall Study|Withdrawal by Subject|95|||
126348953|NCT02225587|454571075|FG001|Overall Study|Participant Moved|0|||
126214520|NCT02367729|454074683|FG000|Overall Study|Organic disorder diagnosed|2|||
126348954|NCT02225587|454571074|FG000|Overall Study|Withdrawal by Subject|13|||
126348955|NCT02225587|454571075|FG001|Overall Study|Withdrawal by Subject|28|||
126348956|NCT03197129|454571084|FG000|Overall Study|did not answer the VPT: shyness|4|||
126348957|NCT03197129|454571085|FG001|Overall Study|did not answer the VPT: shyness|5|||
126348958|NCT01564407|454571086|FG000|Overall Study|Lost to Follow-up|0|||
126348959|NCT01564407|454571087|FG001|Overall Study|Lost to Follow-up|1|||
126348960|NCT01564407|454571088|FG002|Overall Study|Lost to Follow-up|0|||
126348961|NCT01564407|454571089|FG003|Overall Study|Lost to Follow-up|0|||
126348962|NCT01564407|454571090|FG004|Overall Study|Lost to Follow-up|0|||
126348963|NCT01564407|454571086|FG000|Overall Study|Withdrawal by Subject|0|||
126348964|NCT01564407|454571087|FG001|Overall Study|Withdrawal by Subject|1|||
126348965|NCT01564407|454571088|FG002|Overall Study|Withdrawal by Subject|0|||
126348966|NCT01564407|454571089|FG003|Overall Study|Withdrawal by Subject|0|||
126348967|NCT01564407|454571090|FG004|Overall Study|Withdrawal by Subject|0|||
126348968|NCT01564407|454571086|FG000|Overall Study|funding lost, study ended|0|||
126348969|NCT01564407|454571087|FG001|Overall Study|funding lost, study ended|0|||
126348970|NCT01564407|454571088|FG002|Overall Study|funding lost, study ended|0|||
126348971|NCT01564407|454571089|FG003|Overall Study|funding lost, study ended|1|||
126348972|NCT01564407|454571090|FG004|Overall Study|funding lost, study ended|0|||
126348973|NCT02296125|454571091|FG000|Overall Study|Withdrawal by Subject|18|||
126348974|NCT02296125|454571092|FG001|Overall Study|Withdrawal by Subject|8|||
126348975|NCT02296125|454571093|FG002|Overall Study|Withdrawal by Subject|6|||
126348976|NCT02296125|454571094|FG003|Overall Study|Withdrawal by Subject|2|||
126348977|NCT02296125|454571091|FG000|Overall Study|Adverse Event|41|||
126348978|NCT02296125|454571092|FG001|Overall Study|Adverse Event|52|||
126348979|NCT02296125|454571093|FG002|Overall Study|Adverse Event|9|||
126348980|NCT02296125|454571094|FG003|Overall Study|Adverse Event|4|||
126214521|NCT02367729|454074684|FG001|Overall Study|Organic disorder diagnosed|1|||
126214522|NCT02367729|454074683|FG000|Overall Study|Adverse Event|1|||
126214523|NCT02367729|454074684|FG001|Overall Study|Adverse Event|2|||
126214524|NCT02367729|454074683|FG000|Overall Study|Withdrawal by Subject|0|||
126214525|NCT02367729|454074684|FG001|Overall Study|Withdrawal by Subject|5|||
126214526|NCT00996632|454074689|FG000|Overall Study|Physician Decision|0|||
126214527|NCT00996632|454074690|FG001|Overall Study|Physician Decision|0|||
126348981|NCT02296125|454571091|FG000|Overall Study|Severe non-compliance to protocol|0|||
126214528|NCT02861534|454074695|FG000|Overall Study|Death|541|||
126214529|NCT02861534|454074696|FG001|Overall Study|Death|552|||
126214530|NCT02861534|454074695|FG000|Overall Study|Lost to Follow-up|14|||
126214531|NCT02861534|454074696|FG001|Overall Study|Lost to Follow-up|14|||
126214532|NCT02861534|454074695|FG000|Overall Study|Site Terminated by Sponsor|4|||
126214533|NCT02861534|454074696|FG001|Overall Study|Site Terminated by Sponsor|3|||
126214534|NCT02861534|454074695|FG000|Overall Study|Withdrawal by Subject|15|||
126214535|NCT02861534|454074696|FG001|Overall Study|Withdrawal by Subject|18|||
126214536|NCT02780115|454074697|FG000|Overall Study|Withdrawal by Subject|0|||
126214537|NCT02780115|454074698|FG001|Overall Study|Withdrawal by Subject|1|||
126214538|NCT02780115|454074699|FG002|Overall Study|Withdrawal by Subject|1|||
126214539|NCT02780115|454074700|FG003|Overall Study|Withdrawal by Subject|0|||
126214540|NCT02780115|454074701|FG004|Overall Study|Withdrawal by Subject|0|||
126214541|NCT02780115|454074697|FG000|Overall Study|Adverse Event|0|||
126214542|NCT02780115|454074698|FG001|Overall Study|Adverse Event|0|||
126214543|NCT02780115|454074699|FG002|Overall Study|Adverse Event|0|||
126214544|NCT02780115|454074700|FG003|Overall Study|Adverse Event|1|||
126214545|NCT02780115|454074701|FG004|Overall Study|Adverse Event|1|||
126214546|NCT01179191|454074702|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
126214547|NCT01179191|454074702|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
126214548|NCT01179191|454074702|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
126214549|NCT01179191|454074702|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
126214550|NCT01179191|454074702|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
126214551|NCT01179191|454074702|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
126214552|NCT01179191|454074702|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
126214553|NCT01179191|454074702|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
126214554|NCT01179191|454074702|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
126214555|NCT01179191|454074702|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
126214556|NCT01179191|454074702|FG000|Maintenance Phase (8 Weeks)|Other|66|||
126214557|NCT00916617|454074706|FG000|Overall Study|Adverse Event|3|||
126214558|NCT00916617|454074707|FG001|Overall Study|Adverse Event|2|||
126214559|NCT00916617|454074708|FG002|Overall Study|Adverse Event|6|||
126214560|NCT00916617|454074709|FG003|Overall Study|Adverse Event|3|||
126214561|NCT00916617|454074706|FG000|Overall Study|Withdrawal by Subject|3|||
126214562|NCT00916617|454074707|FG001|Overall Study|Withdrawal by Subject|2|||
126214563|NCT00916617|454074708|FG002|Overall Study|Withdrawal by Subject|0|||
126214564|NCT00916617|454074709|FG003|Overall Study|Withdrawal by Subject|1|||
126214565|NCT00916617|454074706|FG000|Overall Study|Caregiver Request|3|||
126214566|NCT00916617|454074707|FG001|Overall Study|Caregiver Request|2|||
126214567|NCT00916617|454074708|FG002|Overall Study|Caregiver Request|1|||
126214568|NCT00916617|454074709|FG003|Overall Study|Caregiver Request|0|||
126214569|NCT00916617|454074706|FG000|Overall Study|Physician Decision|1|||
126214570|NCT00916617|454074707|FG001|Overall Study|Physician Decision|1|||
126214571|NCT00916617|454074708|FG002|Overall Study|Physician Decision|0|||
126214572|NCT00916617|454074709|FG003|Overall Study|Physician Decision|0|||
126214573|NCT00916617|454074706|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
126214574|NCT00916617|454074707|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
126214575|NCT00916617|454074708|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
126214576|NCT00916617|454074709|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
126214577|NCT00916617|454074706|FG000|Overall Study|Lost to Follow-up|2|||
126214578|NCT00916617|454074707|FG001|Overall Study|Lost to Follow-up|1|||
126214579|NCT00916617|454074708|FG002|Overall Study|Lost to Follow-up|0|||
126214580|NCT00916617|454074709|FG003|Overall Study|Lost to Follow-up|0|||
126214581|NCT00916617|454074706|FG000|Overall Study|Lack of Efficacy|1|||
126214582|NCT00916617|454074707|FG001|Overall Study|Lack of Efficacy|0|||
126214583|NCT00916617|454074708|FG002|Overall Study|Lack of Efficacy|0|||
126013548|NCT01212757|453342447|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126013549|NCT01212757|453342448|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126214584|NCT00916617|454074709|FG003|Overall Study|Lack of Efficacy|0|||
126214585|NCT00916617|454074706|FG000|Overall Study|Other|2|||
126214586|NCT00916617|454074707|FG001|Overall Study|Other|0|||
126214587|NCT00916617|454074708|FG002|Overall Study|Other|0|||
126214588|NCT00916617|454074709|FG003|Overall Study|Other|2|||
126214589|NCT01988337|454074712|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
126214590|NCT02742818|454074713|FG000|Overall Study|Adverse Event|0|||
126214591|NCT02742818|454074714|FG001|Overall Study|Adverse Event|1|||
126214592|NCT02742818|454074713|FG000|Overall Study|Protocol Violation|0|||
126348982|NCT02296125|454571092|FG001|Overall Study|Severe non-compliance to protocol|1|||
126348983|NCT02296125|454571093|FG002|Overall Study|Severe non-compliance to protocol|0|||
126348984|NCT02296125|454571094|FG003|Overall Study|Severe non-compliance to protocol|0|||
126348985|NCT02296125|454571091|FG000|Overall Study|Condition under investigation worsened|153|||
126348986|NCT02296125|454571092|FG001|Overall Study|Condition under investigation worsened|199|||
126348987|NCT02296125|454571093|FG002|Overall Study|Condition under investigation worsened|39|||
126348988|NCT02296125|454571094|FG003|Overall Study|Condition under investigation worsened|56|||
126348989|NCT02296125|454571091|FG000|Overall Study|Any reason not specifically recorded|6|||
126214593|NCT02742818|454074714|FG001|Overall Study|Protocol Violation|1|||
126214594|NCT01260194|454074715|FG000|Overall Study|Withdrawal of Consent|1|||
126214595|NCT04854707|454074719|FG000|Overall Study|Lack of Efficacy|78|||
126214596|NCT04854707|454074720|FG001|Overall Study|Lack of Efficacy|59|||
126214597|NCT04854707|454074721|FG002|Overall Study|Lack of Efficacy|30|||
126214598|NCT03466060|454074727|FG000|Period 1|Test Lens Damage|0|||
126214599|NCT03466060|454074728|FG001|Period 1|Test Lens Damage|2|||
126214600|NCT03466060|454074729|FG002|Period 1|Test Lens Damage|0|||
126214601|NCT03466060|454074730|FG003|Period 1|Test Lens Damage|0|||
126214602|NCT03466060|454074731|FG004|Period 1|Test Lens Damage|0|||
126214603|NCT03466060|454074732|FG005|Period 1|Test Lens Damage|0|||
126214604|NCT03466060|454074727|FG000|Period 1|Withdrawal by Subject|0|||
126214605|NCT03466060|454074728|FG001|Period 1|Withdrawal by Subject|0|||
126214606|NCT03466060|454074729|FG002|Period 1|Withdrawal by Subject|2|||
126214607|NCT03466060|454074730|FG003|Period 1|Withdrawal by Subject|0|||
126214608|NCT03466060|454074731|FG004|Period 1|Withdrawal by Subject|0|||
126214609|NCT03466060|454074732|FG005|Period 1|Withdrawal by Subject|0|||
126214610|NCT03466060|454074727|FG000|Period 1|Lost to Follow-up|0|||
126214611|NCT03466060|454074728|FG001|Period 1|Lost to Follow-up|0|||
126214612|NCT03466060|454074729|FG002|Period 1|Lost to Follow-up|0|||
126214613|NCT03466060|454074730|FG003|Period 1|Lost to Follow-up|1|||
126214614|NCT03466060|454074731|FG004|Period 1|Lost to Follow-up|0|||
126214615|NCT03466060|454074732|FG005|Period 1|Lost to Follow-up|0|||
126214616|NCT03466060|454074727|FG000|Period 1|Grade 2 Conjunctivitis|0|||
126214617|NCT03466060|454074728|FG001|Period 1|Grade 2 Conjunctivitis|0|||
126214618|NCT03466060|454074729|FG002|Period 1|Grade 2 Conjunctivitis|1|||
126214619|NCT03466060|454074730|FG003|Period 1|Grade 2 Conjunctivitis|0|||
126214620|NCT03466060|454074731|FG004|Period 1|Grade 2 Conjunctivitis|0|||
126214621|NCT03466060|454074732|FG005|Period 1|Grade 2 Conjunctivitis|0|||
126214622|NCT03466060|454074727|FG000|Period 2|Lens Handling Difficulties|0|||
126214623|NCT03466060|454074728|FG001|Period 2|Lens Handling Difficulties|0|||
126214624|NCT03466060|454074729|FG002|Period 2|Lens Handling Difficulties|1|||
126214625|NCT03466060|454074730|FG003|Period 2|Lens Handling Difficulties|0|||
126214626|NCT03466060|454074731|FG004|Period 2|Lens Handling Difficulties|0|||
126214627|NCT03466060|454074732|FG005|Period 2|Lens Handling Difficulties|0|||
126214628|NCT01612780|454074733|FG000|Overall Study|Treatment not completed|1|||
126214629|NCT01612780|454074733|FG000|Overall Study|Withdrawal by Subject|5|||
126013550|NCT01212757|453342449|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126013551|NCT01212757|453342450|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126013552|NCT01212757|453342451|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126013553|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126013554|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126013555|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126214630|NCT02985515|454074734|FG000|Olfaction Testing|Lost to Follow-up|0|||
126214631|NCT02985515|454074735|FG001|Olfaction Testing|Lost to Follow-up|5|||
126214632|NCT02985515|454074734|FG000|Olfaction Testing|Protocol Violation|0|||
126214633|NCT02985515|454074735|FG001|Olfaction Testing|Protocol Violation|3|||
126214634|NCT01339000|454074741|FG000|Overall Study|study closed due to lack of drug supply|1|||
126214635|NCT01339000|454074742|FG001|Overall Study|study closed due to lack of drug supply|0|||
126348990|NCT02296125|454571092|FG001|Overall Study|Any reason not specifically recorded|4|||
126348991|NCT02296125|454571093|FG002|Overall Study|Any reason not specifically recorded|2|||
126214636|NCT05674721|454074744|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
126214637|NCT05674721|454074745|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
126214638|NCT05674721|454074744|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
126214639|NCT05674721|454074745|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
126214640|NCT05013749|454074755|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
126214641|NCT05013749|454074756|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
126306144|NCT05020665|454408905|FG001|Overall Study|Study terminated by Sponsor|4|||
126306145|NCT05020665|454408904|FG000|Overall Study|Death|2|||
126306146|NCT05020665|454408905|FG001|Overall Study|Death|1|||
126306147|NCT05020665|454408904|FG000|Overall Study|Physician Decision|0|||
126306148|NCT05020665|454408905|FG001|Overall Study|Physician Decision|1|||
126306149|NCT05020665|454408904|FG000|Overall Study|Withdrawal by Subject|0|||
126306150|NCT05020665|454408905|FG001|Overall Study|Withdrawal by Subject|1|||
126306151|NCT05020665|454408904|FG000|Overall Study|Reason not specified|1|||
126306152|NCT05020665|454408905|FG001|Overall Study|Reason not specified|0|||
126306153|NCT03689374|454408910|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
126306154|NCT03689374|454408911|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
126306155|NCT03689374|454408912|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
126306156|NCT03689374|454408910|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
126306157|NCT03689374|454408911|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
126306158|NCT03689374|454408912|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
126306159|NCT03689374|454408910|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
126306160|NCT03689374|454408911|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
126013556|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126013557|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126013558|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126013559|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126013560|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126013561|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
126013562|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126013563|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
126013564|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
126013565|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126013566|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126013567|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126013568|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126013569|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
126013570|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
126013571|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126013572|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
126013573|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
126013574|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126013575|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126013576|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126013577|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126013578|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
126013579|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126013580|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126013581|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
126013582|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
126013583|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126013584|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126013585|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126013586|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126013587|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
126013588|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
126013589|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126013590|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126013591|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
126013592|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126013593|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126013594|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126013595|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126013596|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126013597|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126013598|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126013599|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
126013600|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
126013601|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126013602|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126013603|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126013604|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126013605|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
126013606|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126013607|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126214642|NCT05013749|454074755|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
126214643|NCT05013749|454074756|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
126214644|NCT02017535|454074759|FG000|Overall Study|Withdrawal by Subject|1|||
126214645|NCT02017535|454074760|FG001|Overall Study|Withdrawal by Subject|0|||
126214646|NCT02017535|454074761|FG002|Overall Study|Withdrawal by Subject|0|||
126214647|NCT02017535|454074762|FG003|Overall Study|Withdrawal by Subject|0|||
126214648|NCT03506425|454074763|FG000|Overall Study|Adverse Event|1|||
126214649|NCT03506425|454074764|FG001|Overall Study|Adverse Event|3|||
126214650|NCT03506425|454074765|FG002|Overall Study|Adverse Event|0|||
126214651|NCT03506425|454074763|FG000|Overall Study|Death|1|||
126214652|NCT03506425|454074764|FG001|Overall Study|Death|0|||
126214653|NCT03506425|454074765|FG002|Overall Study|Death|0|||
126214654|NCT03506425|454074763|FG000|Overall Study|Withdrawal by Subject|0|||
126214655|NCT03506425|454074764|FG001|Overall Study|Withdrawal by Subject|0|||
126214656|NCT03506425|454074765|FG002|Overall Study|Withdrawal by Subject|1|||
126214657|NCT02643394|454074768|FG000|Overall Study|Protocol Violation|4|||
126214658|NCT02643394|454074769|FG001|Overall Study|Protocol Violation|5|||
126214659|NCT04088734|454074770|FG000|Overall Study|Other, Not Specified|5|||
126214660|NCT00938015|454074774|FG000|Overall Study|Death|2|||
126214661|NCT00938015|454074774|FG000|Overall Study|Lost to Follow-up|32|||
126214662|NCT00938015|454074774|FG000|Overall Study|Adverse Event|32|||
126214663|NCT00938015|454074774|FG000|Overall Study|Non-responder|52|||
126214664|NCT00938015|454074774|FG000|Overall Study|Reason not related to Etanercept|29|||
126214665|NCT02341482|454074775|FG000|Overall Study|Adverse Event|1|||
126214666|NCT00834366|454074778|FG000|Treatment Period 1|Adverse Event|1|||
126214667|NCT00834366|454074779|FG001|Treatment Period 1|Adverse Event|1|||
126214668|NCT00090259|454074780|FG000|Overall Study|Lost to Follow-up|30|||
126214669|NCT00090259|454074781|FG001|Overall Study|Lost to Follow-up|26|||
126214670|NCT00090259|454074780|FG000|Overall Study|Withdrawal by Subject|21|||
126214671|NCT00090259|454074781|FG001|Overall Study|Withdrawal by Subject|15|||
126214672|NCT00090259|454074780|FG000|Overall Study|Investigator site closed|11|||
126214673|NCT00090259|454074781|FG001|Overall Study|Investigator site closed|7|||
126214674|NCT03083639|454074785|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
126214675|NCT03083639|454074786|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
126214676|NCT03083639|454074785|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
126214677|NCT03083639|454074786|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
126214678|NCT02125734|454074787|FG000|Period 2|Adverse Event|0|||
126214679|NCT02125734|454074788|FG001|Period 2|Adverse Event|1|||
126214680|NCT01591499|454074789|FG000|Baseline Visit|Withdrawal by Subject|0|||
126214681|NCT01591499|454074790|FG001|Baseline Visit|Withdrawal by Subject|2|||
126214682|NCT01591499|454074791|FG002|Baseline Visit|Withdrawal by Subject|0|||
126214683|NCT01591499|454074792|FG003|Baseline Visit|Withdrawal by Subject|2|||
126214684|NCT01591499|454074789|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
126214685|NCT01591499|454074790|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
126214686|NCT01591499|454074791|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
126214687|NCT01591499|454074792|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
126214688|NCT01591499|454074789|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
126214689|NCT01591499|454074790|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
126214690|NCT01591499|454074791|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
126214691|NCT01591499|454074792|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
126214692|NCT00960687|454074793|FG000|Washout Period of 7 Days|Adverse Event|3|||
126214693|NCT00960687|454074794|FG001|Washout Period of 7 Days|Adverse Event|2|||
126214694|NCT00960687|454074793|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
126214695|NCT00960687|454074794|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126214696|NCT02704130|454074795|FG000|Overall Study|Physician Decision|5|||
126214697|NCT02704130|454074796|FG001|Overall Study|Physician Decision|3|||
126214698|NCT02666768|454074797|FG000|Overall Study|Withdrawal by Subject|4|||
126214699|NCT00285012|454074800|FG000|Assigned to Study Treatment (Tx)|Other|2|||
126348992|NCT02296125|454571094|FG003|Overall Study|Any reason not specifically recorded|0|||
126348993|NCT00157755|454571095|FG000|Overall Study|Death|2|||
126348994|NCT00157755|454571096|FG001|Overall Study|Death|3|||
126348995|NCT00157755|454571097|FG002|Overall Study|Death|3|||
126348996|NCT00157755|454571098|FG003|Overall Study|Death|2|||
126348997|NCT00157755|454571099|FG004|Overall Study|Death|0|||
126348998|NCT00157755|454571100|FG005|Overall Study|Death|0|||
126348999|NCT00157755|454571095|FG000|Overall Study|Lost to Follow-up|0|||
126349000|NCT00157755|454571096|FG001|Overall Study|Lost to Follow-up|0|||
126349001|NCT00157755|454571097|FG002|Overall Study|Lost to Follow-up|1|||
126349002|NCT00157755|454571098|FG003|Overall Study|Lost to Follow-up|0|||
126214700|NCT00285012|454074801|FG001|Assigned to Study Treatment (Tx)|Other|3|||
126349003|NCT00157755|454571099|FG004|Overall Study|Lost to Follow-up|0|||
126349004|NCT00157755|454571100|FG005|Overall Study|Lost to Follow-up|0|||
126214701|NCT00285012|454074800|FG000|Received Study Tx|Death|2|||
126214702|NCT00285012|454074801|FG001|Received Study Tx|Death|1|||
126214703|NCT00285012|454074800|FG000|Received Study Tx|Adverse Event|5|||
126349005|NCT00157755|454571095|FG000|Overall Study|Withdrawal by Subject|0|||
126013608|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
126013609|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
126013610|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126013611|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126013612|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126013613|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126013614|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
126013615|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
126013616|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126013617|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126013618|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
126013619|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126013620|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126013621|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126013622|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126013623|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126013624|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126013625|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126013626|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
126013627|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
126013628|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126013629|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126013630|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126013631|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126013632|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
126013633|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
126013634|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126013635|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126013636|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126013637|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126013638|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126013639|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126013640|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126013641|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126013642|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
126013643|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126013644|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
126013645|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126013646|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126013647|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126013648|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126013649|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126013650|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126013651|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126013652|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126013653|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126013654|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
126013655|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126013656|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126013657|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126013658|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126013659|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126013660|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
126013661|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126013662|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
126013663|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126013664|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126349006|NCT00157755|454571096|FG001|Overall Study|Withdrawal by Subject|0|||
126349007|NCT00157755|454571097|FG002|Overall Study|Withdrawal by Subject|1|||
126349008|NCT00157755|454571098|FG003|Overall Study|Withdrawal by Subject|1|||
126349009|NCT00157755|454571099|FG004|Overall Study|Withdrawal by Subject|1|||
126349010|NCT00157755|454571100|FG005|Overall Study|Withdrawal by Subject|2|||
126349011|NCT00157755|454571095|FG000|Overall Study|Explant due to infection|0|||
126349012|NCT00157755|454571096|FG001|Overall Study|Explant due to infection|0|||
126013665|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126013666|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126013667|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126013668|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126214704|NCT00285012|454074801|FG001|Received Study Tx|Adverse Event|11|||
126214705|NCT00285012|454074800|FG000|Received Study Tx|Lack of Efficacy|0|||
126214706|NCT00285012|454074801|FG001|Received Study Tx|Lack of Efficacy|3|||
126214707|NCT00285012|454074800|FG000|Received Study Tx|Lost to Follow-up|29|||
126214708|NCT00285012|454074801|FG001|Received Study Tx|Lost to Follow-up|31|||
126214709|NCT00285012|454074800|FG000|Received Study Tx|Withdrawal by Subject|31|||
126214710|NCT00285012|454074801|FG001|Received Study Tx|Withdrawal by Subject|43|||
126214711|NCT00285012|454074800|FG000|Received Study Tx|Other|5|||
126214712|NCT00285012|454074801|FG001|Received Study Tx|Other|5|||
126214713|NCT05004181|454074802|FG000|Overall Study|Withdrawal of consent|0|||
126214714|NCT05004181|454074803|FG001|Overall Study|Withdrawal of consent|0|||
126214715|NCT05004181|454074804|FG002|Overall Study|Withdrawal of consent|1|||
126214716|NCT05004181|454074805|FG003|Overall Study|Withdrawal of consent|3|||
126214717|NCT05004181|454074806|FG004|Overall Study|Withdrawal of consent|3|||
126214718|NCT05004181|454074807|FG005|Overall Study|Withdrawal of consent|0|||
126214719|NCT05004181|454074808|FG006|Overall Study|Withdrawal of consent|30|||
126214720|NCT05004181|454074809|FG007|Overall Study|Withdrawal of consent|9|||
126214721|NCT05004181|454074810|FG008|Overall Study|Withdrawal of consent|3|||
126214722|NCT05004181|454074811|FG009|Overall Study|Withdrawal of consent|2|||
126214723|NCT05004181|454074812|FG010|Overall Study|Withdrawal of consent|5|||
126214724|NCT05004181|454074813|FG011|Overall Study|Withdrawal of consent|1|||
126214725|NCT05004181|454074802|FG000|Overall Study|Lost to Follow-up|2|||
126214726|NCT05004181|454074803|FG001|Overall Study|Lost to Follow-up|4|||
126214727|NCT05004181|454074804|FG002|Overall Study|Lost to Follow-up|2|||
126214728|NCT05004181|454074805|FG003|Overall Study|Lost to Follow-up|3|||
126214729|NCT05004181|454074806|FG004|Overall Study|Lost to Follow-up|5|||
126214730|NCT05004181|454074807|FG005|Overall Study|Lost to Follow-up|2|||
126214731|NCT05004181|454074808|FG006|Overall Study|Lost to Follow-up|15|||
126214732|NCT05004181|454074809|FG007|Overall Study|Lost to Follow-up|12|||
126214733|NCT05004181|454074810|FG008|Overall Study|Lost to Follow-up|38|||
126214734|NCT05004181|454074811|FG009|Overall Study|Lost to Follow-up|6|||
126214735|NCT05004181|454074812|FG010|Overall Study|Lost to Follow-up|6|||
126214736|NCT05004181|454074813|FG011|Overall Study|Lost to Follow-up|0|||
126214737|NCT05004181|454074802|FG000|Overall Study|Death|0|||
126214738|NCT05004181|454074803|FG001|Overall Study|Death|0|||
126214739|NCT05004181|454074804|FG002|Overall Study|Death|0|||
126214740|NCT05004181|454074805|FG003|Overall Study|Death|0|||
126214741|NCT05004181|454074806|FG004|Overall Study|Death|0|||
126214742|NCT05004181|454074807|FG005|Overall Study|Death|0|||
126214743|NCT05004181|454074808|FG006|Overall Study|Death|1|||
126214744|NCT05004181|454074809|FG007|Overall Study|Death|0|||
126214745|NCT05004181|454074810|FG008|Overall Study|Death|2|||
126214746|NCT05004181|454074811|FG009|Overall Study|Death|0|||
126214747|NCT05004181|454074812|FG010|Overall Study|Death|0|||
126214748|NCT05004181|454074813|FG011|Overall Study|Death|0|||
126214749|NCT05004181|454074802|FG000|Overall Study|Physician Decision|0|||
126214750|NCT05004181|454074803|FG001|Overall Study|Physician Decision|0|||
126214751|NCT05004181|454074804|FG002|Overall Study|Physician Decision|0|||
126214752|NCT05004181|454074805|FG003|Overall Study|Physician Decision|0|||
126214753|NCT05004181|454074806|FG004|Overall Study|Physician Decision|0|||
126214754|NCT05004181|454074807|FG005|Overall Study|Physician Decision|0|||
126214755|NCT05004181|454074808|FG006|Overall Study|Physician Decision|2|||
126214756|NCT05004181|454074809|FG007|Overall Study|Physician Decision|0|||
126214757|NCT05004181|454074810|FG008|Overall Study|Physician Decision|7|||
126214758|NCT05004181|454074811|FG009|Overall Study|Physician Decision|0|||
126214759|NCT05004181|454074812|FG010|Overall Study|Physician Decision|0|||
126214760|NCT05004181|454074813|FG011|Overall Study|Physician Decision|0|||
126214761|NCT05004181|454074802|FG000|Overall Study|Withdrawal by Subject|2|||
126214762|NCT05004181|454074803|FG001|Overall Study|Withdrawal by Subject|3|||
126214763|NCT05004181|454074804|FG002|Overall Study|Withdrawal by Subject|2|||
126214764|NCT05004181|454074805|FG003|Overall Study|Withdrawal by Subject|2|||
126214765|NCT05004181|454074806|FG004|Overall Study|Withdrawal by Subject|4|||
126214766|NCT05004181|454074807|FG005|Overall Study|Withdrawal by Subject|2|||
126214767|NCT05004181|454074808|FG006|Overall Study|Withdrawal by Subject|4|||
126214768|NCT05004181|454074809|FG007|Overall Study|Withdrawal by Subject|22|||
126214769|NCT05004181|454074810|FG008|Overall Study|Withdrawal by Subject|8|||
126214770|NCT05004181|454074811|FG009|Overall Study|Withdrawal by Subject|1|||
126214771|NCT05004181|454074812|FG010|Overall Study|Withdrawal by Subject|3|||
126214772|NCT05004181|454074813|FG011|Overall Study|Withdrawal by Subject|2|||
126214773|NCT05004181|454074802|FG000|Overall Study|Protocol Violation|2|||
126214774|NCT05004181|454074803|FG001|Overall Study|Protocol Violation|3|||
126214775|NCT05004181|454074804|FG002|Overall Study|Protocol Violation|0|||
126214776|NCT05004181|454074805|FG003|Overall Study|Protocol Violation|0|||
126214777|NCT05004181|454074806|FG004|Overall Study|Protocol Violation|1|||
126214778|NCT05004181|454074807|FG005|Overall Study|Protocol Violation|0|||
126214779|NCT05004181|454074808|FG006|Overall Study|Protocol Violation|16|||
126214780|NCT05004181|454074809|FG007|Overall Study|Protocol Violation|18|||
126214781|NCT05004181|454074810|FG008|Overall Study|Protocol Violation|2|||
126214782|NCT05004181|454074811|FG009|Overall Study|Protocol Violation|2|||
126214783|NCT05004181|454074812|FG010|Overall Study|Protocol Violation|2|||
126214784|NCT05004181|454074813|FG011|Overall Study|Protocol Violation|1|||
126214785|NCT05004181|454074802|FG000|Overall Study|Not further specified|1|||
126214786|NCT05004181|454074803|FG001|Overall Study|Not further specified|0|||
126214787|NCT05004181|454074804|FG002|Overall Study|Not further specified|0|||
126214788|NCT05004181|454074805|FG003|Overall Study|Not further specified|0|||
126214789|NCT05004181|454074806|FG004|Overall Study|Not further specified|0|||
126214790|NCT05004181|454074807|FG005|Overall Study|Not further specified|0|||
126214791|NCT05004181|454074808|FG006|Overall Study|Not further specified|1|||
126214792|NCT05004181|454074809|FG007|Overall Study|Not further specified|0|||
126214793|NCT05004181|454074810|FG008|Overall Study|Not further specified|2|||
126214794|NCT05004181|454074811|FG009|Overall Study|Not further specified|1|||
126214795|NCT05004181|454074812|FG010|Overall Study|Not further specified|0|||
126214796|NCT05004181|454074813|FG011|Overall Study|Not further specified|1|||
126214797|NCT00633217|454074814|FG000|Overall Study|Adverse Event|5|||
126214798|NCT00633217|454074815|FG001|Overall Study|Adverse Event|9|||
126214799|NCT00633217|454074814|FG000|Overall Study|Lack of Efficacy|0|||
126214800|NCT00633217|454074815|FG001|Overall Study|Lack of Efficacy|2|||
126214801|NCT00633217|454074814|FG000|Overall Study|Protocol Violation|3|||
126214802|NCT00633217|454074815|FG001|Overall Study|Protocol Violation|7|||
126214803|NCT00633217|454074814|FG000|Overall Study|Lost to Follow-up|2|||
126214804|NCT00633217|454074815|FG001|Overall Study|Lost to Follow-up|2|||
126214805|NCT00633217|454074814|FG000|Overall Study|Investigator Discretion|2|||
126214806|NCT00633217|454074815|FG001|Overall Study|Investigator Discretion|0|||
126214807|NCT00633217|454074814|FG000|Overall Study|Withdrew Consent|3|||
126214808|NCT00633217|454074815|FG001|Overall Study|Withdrew Consent|3|||
126214809|NCT00891527|454076864|FG000|Overall Study|Withdrawal by Subject|2|||
126214810|NCT03993288|454076865|FG000|Overall Study|Lost to Follow-up|2|||
126214811|NCT03993288|454076866|FG001|Overall Study|Lost to Follow-up|1|||
126214812|NCT03993288|454076865|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
126214813|NCT03993288|454076866|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
126214814|NCT03993288|454076865|FG000|Overall Study|wrong randomization|0|||
126214815|NCT03993288|454076866|FG001|Overall Study|wrong randomization|1|||
126214816|NCT03993288|454076865|FG000|Overall Study|improper enrollment|0|||
126214817|NCT03993288|454076866|FG001|Overall Study|improper enrollment|1|||
126214818|NCT03993288|454076865|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
126214819|NCT03993288|454076866|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
126214820|NCT03993288|454076865|FG000|Overall Study|developed SAE|2|||
126214821|NCT03993288|454076866|FG001|Overall Study|developed SAE|0|||
126214822|NCT03993288|454076865|FG000|Overall Study|consent withdrawal|1|||
126214823|NCT03993288|454076866|FG001|Overall Study|consent withdrawal|0|||
126214824|NCT03993288|454076865|FG000|Overall Study|did not follow the treatment schedule|1|||
126214825|NCT03993288|454076866|FG001|Overall Study|did not follow the treatment schedule|0|||
126214826|NCT03993288|454076865|FG000|Overall Study|did not follow the treatment regimen|1|||
126214827|NCT03993288|454076866|FG001|Overall Study|did not follow the treatment regimen|0|||
126214828|NCT03993288|454076865|FG000|Overall Study|Adverse Event|1|||
126214829|NCT03993288|454076866|FG001|Overall Study|Adverse Event|0|||
126214830|NCT03993288|454076865|FG000|Overall Study|Withdrawal by Subject|1|||
126214831|NCT03993288|454076866|FG001|Overall Study|Withdrawal by Subject|1|||
126214832|NCT01389024|454076868|FG000|Overall Study|Withdrawal by Subject|0|||
126214833|NCT01389024|454076869|FG001|Overall Study|Withdrawal by Subject|1|||
126214834|NCT01389024|454076868|FG000|Overall Study|Lost to Follow-up|1|||
126214835|NCT01389024|454076869|FG001|Overall Study|Lost to Follow-up|0|||
126214836|NCT00819091|454076870|FG000|Overall Study|Adverse Event|3|||
126214837|NCT00819091|454076871|FG001|Overall Study|Adverse Event|5|||
126214838|NCT00819091|454076870|FG000|Overall Study|Protocol Violation|0|||
126214839|NCT00819091|454076871|FG001|Overall Study|Protocol Violation|1|||
126214840|NCT00819091|454076870|FG000|Overall Study|Lost to Follow-up|2|||
126214841|NCT00819091|454076871|FG001|Overall Study|Lost to Follow-up|0|||
126214842|NCT00819091|454076870|FG000|Overall Study|Withdrawal by Subject|1|||
126214843|NCT00819091|454076871|FG001|Overall Study|Withdrawal by Subject|2|||
126214844|NCT00819091|454076870|FG000|Overall Study|Other|1|||
126214845|NCT00819091|454076871|FG001|Overall Study|Other|2|||
126214846|NCT02953262|454076873|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
126214847|NCT02953262|454076874|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
126214848|NCT02953262|454076875|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
126214849|NCT02953262|454076876|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
126214850|NCT00740480|454076877|FG000|Overall Study|Adverse Event|1|||
126214851|NCT00740480|454076877|FG000|Overall Study|Physician Decision|1|||
126013669|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
126013670|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126013671|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
126013672|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
126214852|NCT03349437|454076882|FG000|Screening|Screen Fail|4|||
126214853|NCT03349437|454076883|FG001|Screening|Screen Fail|0|||
126214854|NCT03349437|454076884|FG002|Screening|Screen Fail|0|||
126214855|NCT03349437|454076882|FG000|Screening|Withdrawn|1|||
126214856|NCT03349437|454076883|FG001|Screening|Withdrawn|0|||
126214857|NCT03349437|454076884|FG002|Screening|Withdrawn|0|||
126214858|NCT01461369|454076885|FG000|Overall Study|Lack of Efficacy|2|||
126214859|NCT01461369|454076886|FG001|Overall Study|Lack of Efficacy|0|||
126214860|NCT01461369|454076887|FG002|Overall Study|Lack of Efficacy|6|||
126214861|NCT01461369|454076885|FG000|Overall Study|Lost to Follow-up|0|||
126214862|NCT01461369|454076886|FG001|Overall Study|Lost to Follow-up|0|||
126214863|NCT01461369|454076887|FG002|Overall Study|Lost to Follow-up|3|||
126214864|NCT01461369|454076885|FG000|Overall Study|Adverse Event|9|||
126214865|NCT01461369|454076886|FG001|Overall Study|Adverse Event|12|||
126214866|NCT01461369|454076887|FG002|Overall Study|Adverse Event|4|||
126214867|NCT01461369|454076885|FG000|Overall Study|Protocol Violation|1|||
126214868|NCT01461369|454076886|FG001|Overall Study|Protocol Violation|2|||
126214869|NCT01461369|454076887|FG002|Overall Study|Protocol Violation|2|||
126214870|NCT01461369|454076885|FG000|Overall Study|Withdrawal by Subject|1|||
126214871|NCT01461369|454076886|FG001|Overall Study|Withdrawal by Subject|3|||
126214872|NCT01461369|454076887|FG002|Overall Study|Withdrawal by Subject|2|||
126214873|NCT02406742|454076894|FG000|Overall Study|Progression of Disease|5|||
126214874|NCT02406742|454076895|FG001|Overall Study|Progression of Disease|1|||
126214875|NCT02406742|454076896|FG002|Overall Study|Progression of Disease|6|||
126214876|NCT02406742|454076894|FG000|Overall Study|Adverse Event|3|||
126214877|NCT02406742|454076895|FG001|Overall Study|Adverse Event|0|||
126214878|NCT02406742|454076896|FG002|Overall Study|Adverse Event|2|||
126214879|NCT02406742|454076894|FG000|Overall Study|Death|1|||
126214880|NCT02406742|454076895|FG001|Overall Study|Death|0|||
126214881|NCT02406742|454076896|FG002|Overall Study|Death|0|||
126214882|NCT02406742|454076894|FG000|Overall Study|Lack of Efficacy|0|||
126214883|NCT02406742|454076895|FG001|Overall Study|Lack of Efficacy|0|||
126214884|NCT02406742|454076896|FG002|Overall Study|Lack of Efficacy|1|||
126214885|NCT02406742|454076894|FG000|Overall Study|Withdrawal by Participant|1|||
126214886|NCT02406742|454076895|FG001|Overall Study|Withdrawal by Participant|2|||
126214887|NCT02406742|454076896|FG002|Overall Study|Withdrawal by Participant|0|||
126214888|NCT02406742|454076894|FG000|Overall Study|Physician Decision|1|||
126214889|NCT02406742|454076895|FG001|Overall Study|Physician Decision|2|||
126214890|NCT02406742|454076896|FG002|Overall Study|Physician Decision|1|||
126214891|NCT02406742|454076894|FG000|Overall Study|Transition to other treatment|2|||
126214892|NCT02406742|454076895|FG001|Overall Study|Transition to other treatment|0|||
126214893|NCT02406742|454076896|FG002|Overall Study|Transition to other treatment|1|||
126214894|NCT02406742|454076894|FG000|Overall Study|Other Reasons|1|||
126214895|NCT02406742|454076895|FG001|Overall Study|Other Reasons|11|||
126214896|NCT02406742|454076896|FG002|Overall Study|Other Reasons|5|||
126214897|NCT01563029|454076899|FG000|Overall Study|Adverse Event|1|||
126214898|NCT01563029|454076900|FG001|Overall Study|Adverse Event|0|||
126214899|NCT01563029|454076901|FG002|Overall Study|Adverse Event|1|||
126214900|NCT01563029|454076902|FG003|Overall Study|Adverse Event|2|||
126214901|NCT01563029|454076903|FG004|Overall Study|Adverse Event|1|||
126349013|NCT00157755|454571097|FG002|Overall Study|Explant due to infection|1|||
126349014|NCT00157755|454571098|FG003|Overall Study|Explant due to infection|0|||
126349015|NCT00157755|454571099|FG004|Overall Study|Explant due to infection|0|||
126349016|NCT00157755|454571100|FG005|Overall Study|Explant due to infection|0|||
126349017|NCT00157755|454571095|FG000|Overall Study|Medical reason|0|||
126349018|NCT00157755|454571096|FG001|Overall Study|Medical reason|0|||
126349019|NCT00157755|454571097|FG002|Overall Study|Medical reason|1|||
126349020|NCT00157755|454571098|FG003|Overall Study|Medical reason|1|||
126349021|NCT00157755|454571099|FG004|Overall Study|Medical reason|0|||
126349022|NCT00157755|454571100|FG005|Overall Study|Medical reason|0|||
126349023|NCT00157755|454571095|FG000|Overall Study|Study site closure|0|||
126349024|NCT00157755|454571096|FG001|Overall Study|Study site closure|1|||
126349025|NCT00157755|454571097|FG002|Overall Study|Study site closure|0|||
126349026|NCT00157755|454571098|FG003|Overall Study|Study site closure|0|||
126349027|NCT00157755|454571099|FG004|Overall Study|Study site closure|0|||
126349028|NCT00157755|454571100|FG005|Overall Study|Study site closure|0|||
126349029|NCT00157755|454571095|FG000|Overall Study|Subject non-compliance|0|||
126349030|NCT00157755|454571096|FG001|Overall Study|Subject non-compliance|0|||
126349031|NCT00157755|454571097|FG002|Overall Study|Subject non-compliance|0|||
126349032|NCT00157755|454571098|FG003|Overall Study|Subject non-compliance|0|||
126349033|NCT00157755|454571099|FG004|Overall Study|Subject non-compliance|0|||
126349034|NCT00157755|454571100|FG005|Overall Study|Subject non-compliance|1|||
126349035|NCT00157755|454571095|FG000|Overall Study|Study completion|0|||
126349036|NCT00157755|454571096|FG001|Overall Study|Study completion|0|||
126349037|NCT00157755|454571097|FG002|Overall Study|Study completion|0|||
126349038|NCT00157755|454571098|FG003|Overall Study|Study completion|0|||
126214902|NCT01563029|454076899|FG000|Overall Study|Lack of Efficacy|42|||
126214903|NCT01563029|454076900|FG001|Overall Study|Lack of Efficacy|16|||
126214904|NCT01563029|454076901|FG002|Overall Study|Lack of Efficacy|23|||
126214905|NCT01563029|454076902|FG003|Overall Study|Lack of Efficacy|21|||
126214906|NCT01563029|454076903|FG004|Overall Study|Lack of Efficacy|19|||
126214907|NCT01563029|454076899|FG000|Overall Study|Protocol Violation|1|||
126214908|NCT01563029|454076900|FG001|Overall Study|Protocol Violation|2|||
126214909|NCT01563029|454076901|FG002|Overall Study|Protocol Violation|3|||
126214910|NCT01563029|454076902|FG003|Overall Study|Protocol Violation|1|||
126349039|NCT00157755|454571099|FG004|Overall Study|Study completion|1|||
126013673|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126013674|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126013675|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126013676|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126013677|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
126013678|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
126013679|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126013680|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
126013681|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
126013682|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126013683|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126013684|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126013685|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126013686|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
126013687|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
126013688|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126013689|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
126013690|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
126013691|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126013692|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126013693|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126214911|NCT01563029|454076903|FG004|Overall Study|Protocol Violation|3|||
126214912|NCT01563029|454076899|FG000|Overall Study|Protocol defined stopping criteria|1|||
126214913|NCT01563029|454076900|FG001|Overall Study|Protocol defined stopping criteria|0|||
126349040|NCT00157755|454571100|FG005|Overall Study|Study completion|2|||
126349041|NCT03314935|454571103|FG000|Phase 1|Death|4|||
126349042|NCT03314935|454571104|FG001|Phase 1|Death|2|||
126349043|NCT03314935|454571105|FG002|Phase 1|Death|5|||
126349044|NCT03314935|454571106|FG003|Phase 1|Death|4|||
126349045|NCT03314935|454571107|FG004|Phase 1|Death|3|||
126349046|NCT03314935|454571108|FG005|Phase 1|Death|4|||
126349047|NCT03314935|454571109|FG006|Phase 1|Death|5|||
126349048|NCT03314935|454571110|FG007|Phase 1|Death|4|||
126349049|NCT03314935|454571111|FG008|Phase 1|Death|3|||
126349050|NCT03314935|454571112|FG009|Phase 1|Death|0|||
126349051|NCT03314935|454571113|FG010|Phase 1|Death|0|||
126349052|NCT03314935|454571114|FG011|Phase 1|Death|0|||
126349053|NCT03314935|454571115|FG012|Phase 1|Death|0|||
126349054|NCT03314935|454571116|FG013|Phase 1|Death|0|||
126349055|NCT03314935|454571117|FG014|Phase 1|Death|0|||
126349056|NCT03314935|454571103|FG000|Phase 1|Withdrawal by Subject|2|||
126349057|NCT03314935|454571104|FG001|Phase 1|Withdrawal by Subject|1|||
126349058|NCT03314935|454571105|FG002|Phase 1|Withdrawal by Subject|1|||
126349059|NCT03314935|454571106|FG003|Phase 1|Withdrawal by Subject|2|||
126349060|NCT03314935|454571107|FG004|Phase 1|Withdrawal by Subject|1|||
126349061|NCT03314935|454571108|FG005|Phase 1|Withdrawal by Subject|0|||
126349062|NCT03314935|454571109|FG006|Phase 1|Withdrawal by Subject|1|||
126349063|NCT03314935|454571110|FG007|Phase 1|Withdrawal by Subject|0|||
126349064|NCT03314935|454571111|FG008|Phase 1|Withdrawal by Subject|1|||
126349065|NCT03314935|454571112|FG009|Phase 1|Withdrawal by Subject|0|||
126349066|NCT03314935|454571113|FG010|Phase 1|Withdrawal by Subject|0|||
126349067|NCT03314935|454571114|FG011|Phase 1|Withdrawal by Subject|0|||
126349068|NCT03314935|454571115|FG012|Phase 1|Withdrawal by Subject|0|||
126349069|NCT03314935|454571116|FG013|Phase 1|Withdrawal by Subject|0|||
126349070|NCT03314935|454571117|FG014|Phase 1|Withdrawal by Subject|0|||
126349071|NCT03314935|454571103|FG000|Phase 1|Progressive Disease|2|||
126349072|NCT03314935|454571104|FG001|Phase 1|Progressive Disease|0|||
126349073|NCT03314935|454571105|FG002|Phase 1|Progressive Disease|0|||
126349074|NCT03314935|454571106|FG003|Phase 1|Progressive Disease|1|||
126349075|NCT03314935|454571107|FG004|Phase 1|Progressive Disease|0|||
126349076|NCT03314935|454571108|FG005|Phase 1|Progressive Disease|0|||
126349077|NCT03314935|454571109|FG006|Phase 1|Progressive Disease|0|||
126349078|NCT03314935|454571110|FG007|Phase 1|Progressive Disease|0|||
126349079|NCT03314935|454571111|FG008|Phase 1|Progressive Disease|0|||
126349080|NCT03314935|454571112|FG009|Phase 1|Progressive Disease|0|||
126349081|NCT03314935|454571113|FG010|Phase 1|Progressive Disease|0|||
126349082|NCT03314935|454571114|FG011|Phase 1|Progressive Disease|0|||
126349083|NCT03314935|454571115|FG012|Phase 1|Progressive Disease|0|||
126349084|NCT03314935|454571116|FG013|Phase 1|Progressive Disease|0|||
126349085|NCT03314935|454571117|FG014|Phase 1|Progressive Disease|0|||
126349086|NCT03314935|454571103|FG000|Phase 1|Study Terminated by Sponsor|0|||
126349087|NCT03314935|454571104|FG001|Phase 1|Study Terminated by Sponsor|1|||
126013694|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126349088|NCT03314935|454571105|FG002|Phase 1|Study Terminated by Sponsor|0|||
126349089|NCT03314935|454571106|FG003|Phase 1|Study Terminated by Sponsor|0|||
126349090|NCT03314935|454571107|FG004|Phase 1|Study Terminated by Sponsor|0|||
126349091|NCT03314935|454571108|FG005|Phase 1|Study Terminated by Sponsor|0|||
126349092|NCT03314935|454571109|FG006|Phase 1|Study Terminated by Sponsor|0|||
126349093|NCT03314935|454571110|FG007|Phase 1|Study Terminated by Sponsor|0|||
126214914|NCT01563029|454076901|FG002|Overall Study|Protocol defined stopping criteria|0|||
126214915|NCT01563029|454076902|FG003|Overall Study|Protocol defined stopping criteria|0|||
126214916|NCT01563029|454076903|FG004|Overall Study|Protocol defined stopping criteria|0|||
126214917|NCT01563029|454076899|FG000|Overall Study|Lost to Follow-up|1|||
126214918|NCT01563029|454076900|FG001|Overall Study|Lost to Follow-up|0|||
126214919|NCT01563029|454076901|FG002|Overall Study|Lost to Follow-up|1|||
126214920|NCT01563029|454076902|FG003|Overall Study|Lost to Follow-up|1|||
126214921|NCT01563029|454076903|FG004|Overall Study|Lost to Follow-up|1|||
126214922|NCT01563029|454076899|FG000|Overall Study|Physician Decision|3|||
126214923|NCT01563029|454076900|FG001|Overall Study|Physician Decision|5|||
126214924|NCT01563029|454076901|FG002|Overall Study|Physician Decision|2|||
126013695|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
126013696|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
126013697|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
126013698|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
126013699|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
126013700|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
126013701|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
126013702|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
126013703|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
126214925|NCT01563029|454076902|FG003|Overall Study|Physician Decision|4|||
126349094|NCT03314935|454571111|FG008|Phase 1|Study Terminated by Sponsor|1|||
126349095|NCT03314935|454571112|FG009|Phase 1|Study Terminated by Sponsor|0|||
126349096|NCT03314935|454571113|FG010|Phase 1|Study Terminated by Sponsor|0|||
126349097|NCT03314935|454571114|FG011|Phase 1|Study Terminated by Sponsor|0|||
126349098|NCT03314935|454571115|FG012|Phase 1|Study Terminated by Sponsor|0|||
126349099|NCT03314935|454571116|FG013|Phase 1|Study Terminated by Sponsor|0|||
126349100|NCT03314935|454571117|FG014|Phase 1|Study Terminated by Sponsor|0|||
126349101|NCT03314935|454571103|FG000|Phase 1|"Captured as Other in Database"|0|||
126349102|NCT03314935|454571104|FG001|Phase 1|"Captured as Other in Database"|2|||
126349103|NCT03314935|454571105|FG002|Phase 1|"Captured as Other in Database"|0|||
126349104|NCT03314935|454571106|FG003|Phase 1|"Captured as Other in Database"|0|||
126349105|NCT03314935|454571107|FG004|Phase 1|"Captured as Other in Database"|0|||
126349106|NCT03314935|454571108|FG005|Phase 1|"Captured as Other in Database"|0|||
126349107|NCT03314935|454571109|FG006|Phase 1|"Captured as Other in Database"|1|||
126349108|NCT03314935|454571110|FG007|Phase 1|"Captured as Other in Database"|1|||
126349109|NCT03314935|454571111|FG008|Phase 1|"Captured as Other in Database"|1|||
126349110|NCT03314935|454571112|FG009|Phase 1|"Captured as Other in Database"|0|||
126349111|NCT03314935|454571113|FG010|Phase 1|"Captured as Other in Database"|0|||
126349112|NCT03314935|454571114|FG011|Phase 1|"Captured as Other in Database"|0|||
126349113|NCT03314935|454571115|FG012|Phase 1|"Captured as Other in Database"|0|||
126349114|NCT03314935|454571116|FG013|Phase 1|"Captured as Other in Database"|0|||
126349115|NCT03314935|454571117|FG014|Phase 1|"Captured as Other in Database"|0|||
126349116|NCT03314935|454571103|FG000|Phase 1|Lost to Follow-up|0|||
126349117|NCT03314935|454571104|FG001|Phase 1|Lost to Follow-up|0|||
126349118|NCT03314935|454571105|FG002|Phase 1|Lost to Follow-up|0|||
126349119|NCT03314935|454571106|FG003|Phase 1|Lost to Follow-up|0|||
126349120|NCT03314935|454571107|FG004|Phase 1|Lost to Follow-up|0|||
126349121|NCT03314935|454571108|FG005|Phase 1|Lost to Follow-up|0|||
126349122|NCT03314935|454571109|FG006|Phase 1|Lost to Follow-up|0|||
126349123|NCT03314935|454571110|FG007|Phase 1|Lost to Follow-up|0|||
126349124|NCT03314935|454571111|FG008|Phase 1|Lost to Follow-up|1|||
126349125|NCT03314935|454571112|FG009|Phase 1|Lost to Follow-up|0|||
126349126|NCT03314935|454571113|FG010|Phase 1|Lost to Follow-up|0|||
126349127|NCT03314935|454571114|FG011|Phase 1|Lost to Follow-up|0|||
126349128|NCT03314935|454571115|FG012|Phase 1|Lost to Follow-up|0|||
126349129|NCT03314935|454571116|FG013|Phase 1|Lost to Follow-up|0|||
126349130|NCT03314935|454571117|FG014|Phase 1|Lost to Follow-up|0|||
126349131|NCT03314935|454571103|FG000|Phase 2|Death|0|||
126349132|NCT03314935|454571104|FG001|Phase 2|Death|0|||
126349133|NCT03314935|454571105|FG002|Phase 2|Death|0|||
126349134|NCT03314935|454571106|FG003|Phase 2|Death|0|||
126349135|NCT03314935|454571107|FG004|Phase 2|Death|0|||
126349136|NCT03314935|454571108|FG005|Phase 2|Death|0|||
126349137|NCT03314935|454571109|FG006|Phase 2|Death|0|||
126349138|NCT03314935|454571110|FG007|Phase 2|Death|0|||
126349139|NCT03314935|454571111|FG008|Phase 2|Death|0|||
126349140|NCT03314935|454571112|FG009|Phase 2|Death|5|||
126349141|NCT03314935|454571113|FG010|Phase 2|Death|20|||
126349142|NCT03314935|454571114|FG011|Phase 2|Death|6|||
126349143|NCT03314935|454571115|FG012|Phase 2|Death|7|||
126349144|NCT03314935|454571116|FG013|Phase 2|Death|6|||
126349145|NCT03314935|454571117|FG014|Phase 2|Death|17|||
126349146|NCT03314935|454571103|FG000|Phase 2|Withdrawal by Subject|0|||
126349147|NCT03314935|454571104|FG001|Phase 2|Withdrawal by Subject|0|||
126349148|NCT03314935|454571105|FG002|Phase 2|Withdrawal by Subject|0|||
126349149|NCT03314935|454571106|FG003|Phase 2|Withdrawal by Subject|0|||
126349150|NCT03314935|454571107|FG004|Phase 2|Withdrawal by Subject|0|||
126013704|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
126013705|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
126349151|NCT03314935|454571108|FG005|Phase 2|Withdrawal by Subject|0|||
126214926|NCT01563029|454076903|FG004|Overall Study|Physician Decision|2|||
126214927|NCT01563029|454076899|FG000|Overall Study|Withdrawal by Subject|4|||
126214928|NCT01563029|454076900|FG001|Overall Study|Withdrawal by Subject|1|||
126214929|NCT01563029|454076901|FG002|Overall Study|Withdrawal by Subject|3|||
126214930|NCT01563029|454076902|FG003|Overall Study|Withdrawal by Subject|4|||
126214931|NCT01563029|454076903|FG004|Overall Study|Withdrawal by Subject|3|||
126214932|NCT01569594|454076904|FG000|Overall Study|Physician Decision|4|||
126214933|NCT01569594|454076904|FG000|Overall Study|Death|13|||
126214934|NCT01569594|454076904|FG000|Overall Study|Lost to Follow-up|22|||
126214935|NCT01569594|454076904|FG000|Overall Study|Adverse Event|2|||
126214936|NCT01569594|454076904|FG000|Overall Study|Withdrawal by Subject|13|||
126214937|NCT01569594|454076904|FG000|Overall Study|Other|4|||
126214938|NCT01569594|454076904|FG000|Overall Study|No ECM used|9|||
126214939|NCT01826201|454076909|FG000|Overall Study|Non compliance with protocol|4|||
126214940|NCT01615822|454076910|FG000|Period 1|Withdrawal by Subject|0|||
126214941|NCT01615822|454076911|FG001|Period 1|Withdrawal by Subject|1|||
126214942|NCT01615822|454076912|FG002|Period 1|Withdrawal by Subject|0|||
126214943|NCT01615822|454076910|FG000|Period 1|Adverse Event|1|||
126214944|NCT01615822|454076911|FG001|Period 1|Adverse Event|1|||
126214945|NCT01615822|454076912|FG002|Period 1|Adverse Event|0|||
126214946|NCT01615822|454076910|FG000|Period 2|Lost to Follow-up|0|||
126214947|NCT01615822|454076911|FG001|Period 2|Lost to Follow-up|1|||
126214948|NCT01615822|454076912|FG002|Period 2|Lost to Follow-up|2|||
126214949|NCT00537056|454076915|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
126214950|NCT02628418|454076920|FG000|Overall Study|Lost to Follow-up|1|||
126214951|NCT02628418|454076921|FG001|Overall Study|Lost to Follow-up|2|||
126214952|NCT01071083|454076922|FG000|Overall Study|Adverse Event|1|||
126214953|NCT01071083|454076923|FG001|Overall Study|Adverse Event|0|||
126214954|NCT01071083|454076924|FG002|Overall Study|Adverse Event|1|||
126214955|NCT01071083|454076925|FG003|Overall Study|Adverse Event|0|||
126214956|NCT01071083|454076926|FG004|Overall Study|Adverse Event|1|||
126214957|NCT01071083|454076922|FG000|Overall Study|Withdrawal by Subject|3|||
126214958|NCT01071083|454076923|FG001|Overall Study|Withdrawal by Subject|0|||
126214959|NCT01071083|454076924|FG002|Overall Study|Withdrawal by Subject|2|||
126214960|NCT01071083|454076925|FG003|Overall Study|Withdrawal by Subject|0|||
126214961|NCT01071083|454076926|FG004|Overall Study|Withdrawal by Subject|3|||
126214962|NCT01071083|454076922|FG000|Overall Study|Physician Decision|1|||
126214963|NCT01071083|454076923|FG001|Overall Study|Physician Decision|0|||
126214964|NCT01071083|454076924|FG002|Overall Study|Physician Decision|0|||
126214965|NCT01071083|454076925|FG003|Overall Study|Physician Decision|1|||
126214966|NCT01071083|454076926|FG004|Overall Study|Physician Decision|1|||
126214967|NCT01071083|454076922|FG000|Overall Study|Early Rescue|1|||
126214968|NCT01071083|454076923|FG001|Overall Study|Early Rescue|0|||
126214969|NCT01071083|454076924|FG002|Overall Study|Early Rescue|0|||
126214970|NCT01071083|454076925|FG003|Overall Study|Early Rescue|0|||
126214971|NCT01071083|454076926|FG004|Overall Study|Early Rescue|1|||
126214972|NCT01071083|454076922|FG000|Overall Study|Subject Moved|0|||
126214973|NCT01071083|454076923|FG001|Overall Study|Subject Moved|1|||
126214974|NCT01071083|454076924|FG002|Overall Study|Subject Moved|0|||
126214975|NCT01071083|454076925|FG003|Overall Study|Subject Moved|0|||
126214976|NCT01071083|454076926|FG004|Overall Study|Subject Moved|0|||
126214977|NCT01071083|454076922|FG000|Overall Study|Images Not Usable (Motion)|0|||
126214978|NCT01071083|454076923|FG001|Overall Study|Images Not Usable (Motion)|1|||
126013706|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126214979|NCT01071083|454076924|FG002|Overall Study|Images Not Usable (Motion)|0|||
126214980|NCT01071083|454076925|FG003|Overall Study|Images Not Usable (Motion)|0|||
126214981|NCT01071083|454076926|FG004|Overall Study|Images Not Usable (Motion)|0|||
126214982|NCT01071083|454076922|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
126214983|NCT01071083|454076923|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
126214984|NCT01071083|454076924|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
126214985|NCT01071083|454076925|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
126214986|NCT01071083|454076926|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
126214987|NCT01071083|454076922|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
126214988|NCT01071083|454076923|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
126214989|NCT01071083|454076924|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
126214990|NCT01071083|454076925|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
126214991|NCT01071083|454076926|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
126214992|NCT01071083|454076922|FG000|Overall Study|Subject Refused to Continue|1|||
126214993|NCT01071083|454076923|FG001|Overall Study|Subject Refused to Continue|0|||
126214994|NCT01071083|454076924|FG002|Overall Study|Subject Refused to Continue|0|||
126214995|NCT01071083|454076925|FG003|Overall Study|Subject Refused to Continue|0|||
126214996|NCT01071083|454076926|FG004|Overall Study|Subject Refused to Continue|0|||
126214997|NCT04732728|454076927|FG000|Overall Study|Death|12|||
126214998|NCT04732728|454076927|FG000|Overall Study|Withdrawn|136|||
126214999|NCT02072174|454076928|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
126215000|NCT02072174|454076929|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
126215001|NCT02072174|454076928|FG000|Overall Study|Protocol Violation|16|||
126215002|NCT02072174|454076929|FG001|Overall Study|Protocol Violation|23|||
126215003|NCT02072174|454076928|FG000|Overall Study|Physician Decision|0|||
126215004|NCT02072174|454076929|FG001|Overall Study|Physician Decision|1|||
126215005|NCT02072174|454076928|FG000|Overall Study|Non-compliance with protocol requirement|2|||
126215006|NCT02072174|454076929|FG001|Overall Study|Non-compliance with protocol requirement|0|||
126215007|NCT03891875|454076930|FG000|Overall Study|Withdrawal by Subject|20|||
126215008|NCT03891875|454076931|FG001|Overall Study|Withdrawal by Subject|3|||
126215009|NCT03891875|454076930|FG000|Overall Study|Adverse Event|10|||
126215010|NCT03891875|454076931|FG001|Overall Study|Adverse Event|4|||
126215011|NCT03891875|454076930|FG000|Overall Study|Physician Decision|1|||
126215012|NCT03891875|454076931|FG001|Overall Study|Physician Decision|1|||
126215013|NCT03891875|454076930|FG000|Overall Study|Protocol Violation|1|||
126215014|NCT03891875|454076931|FG001|Overall Study|Protocol Violation|0|||
126215015|NCT03891875|454076930|FG000|Overall Study|Lost to Follow-up|1|||
126215016|NCT03891875|454076931|FG001|Overall Study|Lost to Follow-up|0|||
126215017|NCT03891875|454076930|FG000|Overall Study|COVID-19 infection|1|||
126215018|NCT03891875|454076931|FG001|Overall Study|COVID-19 infection|0|||
126215019|NCT01393626|454076936|FG000|Overall Study|Adverse Event|2|||
126215020|NCT01393626|454076937|FG001|Overall Study|Adverse Event|1|||
126215021|NCT01393626|454076938|FG002|Overall Study|Adverse Event|5|||
126215022|NCT01393626|454076939|FG003|Overall Study|Adverse Event|0|||
126215023|NCT01393626|454076936|FG000|Overall Study|Did not meet entrance criteria|1|||
126215024|NCT01393626|454076937|FG001|Overall Study|Did not meet entrance criteria|0|||
126215025|NCT01393626|454076938|FG002|Overall Study|Did not meet entrance criteria|0|||
126215026|NCT01393626|454076939|FG003|Overall Study|Did not meet entrance criteria|0|||
126215027|NCT01393626|454076936|FG000|Overall Study|Lack of Efficacy|6|||
126215028|NCT01393626|454076937|FG001|Overall Study|Lack of Efficacy|6|||
126215029|NCT01393626|454076938|FG002|Overall Study|Lack of Efficacy|4|||
126215030|NCT01393626|454076939|FG003|Overall Study|Lack of Efficacy|1|||
126215031|NCT01393626|454076936|FG000|Overall Study|Lost to Follow-up|1|||
126215032|NCT01393626|454076937|FG001|Overall Study|Lost to Follow-up|1|||
126215033|NCT01393626|454076938|FG002|Overall Study|Lost to Follow-up|1|||
126215034|NCT01393626|454076939|FG003|Overall Study|Lost to Follow-up|0|||
126215035|NCT01393626|454076936|FG000|Overall Study|Withdrawal by Subject|6|||
126215036|NCT01393626|454076937|FG001|Overall Study|Withdrawal by Subject|4|||
126215037|NCT01393626|454076938|FG002|Overall Study|Withdrawal by Subject|0|||
126215038|NCT01393626|454076939|FG003|Overall Study|Withdrawal by Subject|0|||
126215039|NCT01393626|454076936|FG000|Overall Study|Other|1|||
126215040|NCT01393626|454076937|FG001|Overall Study|Other|0|||
126215041|NCT01393626|454076938|FG002|Overall Study|Other|0|||
126215042|NCT01393626|454076939|FG003|Overall Study|Other|0|||
126215043|NCT01393626|454076936|FG000|Overall Study|Protocol Violation|1|||
126215044|NCT01393626|454076937|FG001|Overall Study|Protocol Violation|0|||
126215045|NCT01393626|454076938|FG002|Overall Study|Protocol Violation|2|||
126215046|NCT01393626|454076939|FG003|Overall Study|Protocol Violation|0|||
126215047|NCT02426125|454076940|FG000|Overall Study|Lost to Follow-up|14|||
126215048|NCT02426125|454076941|FG001|Overall Study|Lost to Follow-up|12|||
126215049|NCT02426125|454076940|FG000|Overall Study|Withdrawal by Subject|13|||
126215050|NCT02426125|454076941|FG001|Overall Study|Withdrawal by Subject|14|||
126215051|NCT02426125|454076940|FG000|Overall Study|Death|185|||
126215052|NCT02426125|454076941|FG001|Overall Study|Death|200|||
126215053|NCT02426125|454076940|FG000|Overall Study|Randomized, But Never Treated|5|||
126215054|NCT02426125|454076941|FG001|Overall Study|Randomized, But Never Treated|2|||
126013707|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126215055|NCT02858076|454076942|FG000|Overall Study|Death|6|||
126215056|NCT02858076|454076943|FG001|Overall Study|Death|3|||
126013708|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126215057|NCT02858076|454076942|FG000|Overall Study|Withdrawal by Subject|1|||
126215058|NCT02858076|454076943|FG001|Overall Study|Withdrawal by Subject|5|||
126215059|NCT02858076|454076942|FG000|Overall Study|Lost to Follow-up|2|||
126215060|NCT02858076|454076943|FG001|Overall Study|Lost to Follow-up|7|||
126215061|NCT02858076|454076942|FG000|Overall Study|Completed Out of Window|1|||
126215062|NCT02858076|454076943|FG001|Overall Study|Completed Out of Window|3|||
126215063|NCT00096200|454076944|FG000|Overall Study|Adverse Event|0|||
126215064|NCT00096200|454076945|FG001|Overall Study|Adverse Event|4|||
126215065|NCT00096200|454076946|FG002|Overall Study|Adverse Event|0|||
126215066|NCT00096200|454076944|FG000|Overall Study|Withdrawal by Subject|1|||
126215067|NCT00096200|454076945|FG001|Overall Study|Withdrawal by Subject|2|||
126215068|NCT00096200|454076946|FG002|Overall Study|Withdrawal by Subject|0|||
126349152|NCT03314935|454571109|FG006|Phase 2|Withdrawal by Subject|0|||
126349153|NCT03314935|454571110|FG007|Phase 2|Withdrawal by Subject|0|||
126349154|NCT03314935|454571111|FG008|Phase 2|Withdrawal by Subject|0|||
126349155|NCT03314935|454571112|FG009|Phase 2|Withdrawal by Subject|1|||
126349156|NCT03314935|454571113|FG010|Phase 2|Withdrawal by Subject|4|||
126349157|NCT03314935|454571114|FG011|Phase 2|Withdrawal by Subject|0|||
126349158|NCT03314935|454571115|FG012|Phase 2|Withdrawal by Subject|1|||
126349159|NCT03314935|454571116|FG013|Phase 2|Withdrawal by Subject|0|||
126349160|NCT03314935|454571117|FG014|Phase 2|Withdrawal by Subject|1|||
126349161|NCT03314935|454571103|FG000|Phase 2|Progressive Disease|0|||
126215069|NCT00096200|454076944|FG000|Overall Study|Ineligible pathology|0|||
126215070|NCT00096200|454076945|FG001|Overall Study|Ineligible pathology|1|||
126215071|NCT00096200|454076946|FG002|Overall Study|Ineligible pathology|0|||
126215072|NCT00664066|454076947|FG000|Overall Study|Study terminated|3|||
126215073|NCT01495793|454076951|FG000|Overall Study|Lost to Follow-up|1|||
126215074|NCT01495793|454076951|FG000|Overall Study|Violation of inclusion criteria|1|||
126215075|NCT03014570|454076954|FG000|Overall Study|COVID-19 Restrictions|38|||
126215076|NCT03014570|454076955|FG001|Overall Study|COVID-19 Restrictions|24|||
126215077|NCT03014570|454076954|FG000|Overall Study|Death|70|||
126215078|NCT03014570|454076955|FG001|Overall Study|Death|79|||
126215079|NCT03014570|454076954|FG000|Overall Study|Transfer from facility|11|||
126215080|NCT03014570|454076955|FG001|Overall Study|Transfer from facility|14|||
126215081|NCT03014570|454076954|FG000|Overall Study|Hospitalized|5|||
126215082|NCT03014570|454076955|FG001|Overall Study|Hospitalized|3|||
126215083|NCT03014570|454076954|FG000|Overall Study|Transfer within facility|1|||
126215084|NCT03014570|454076955|FG001|Overall Study|Transfer within facility|0|||
126215085|NCT03014570|454076954|FG000|Overall Study|Site refusal|0|||
126215086|NCT03014570|454076955|FG001|Overall Study|Site refusal|11|||
126215087|NCT00478673|454076961|FG000|30-Days Post-Procedure|Death|2|||
126215088|NCT00478673|454076961|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
126215089|NCT00478673|454076961|FG000|30-Days Post-Procedure|Missed Visit|7|||
126215090|NCT00478673|454076961|FG000|12-Months Post-Procedure|Death|23|||
126215091|NCT00478673|454076961|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
126215092|NCT00478673|454076961|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
126215093|NCT00478673|454076961|FG000|12-Months Post-Procedure|Missed Visit|25|||
126215094|NCT00478673|454076961|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
126215095|NCT03701516|454076962|FG000|Period 1|Lost to Follow-up|0|||
126215096|NCT03701516|454076963|FG001|Period 1|Lost to Follow-up|1|||
126215097|NCT03701516|454076962|FG000|Period 1|Adverse Event|0|||
126215098|NCT03701516|454076963|FG001|Period 1|Adverse Event|2|||
126215099|NCT03701516|454076962|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
126215100|NCT03701516|454076963|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
126215101|NCT03701516|454076962|FG000|Period 1|Non Compliance to Protocol|2|||
126215102|NCT03701516|454076963|FG001|Period 1|Non Compliance to Protocol|1|||
125878674|NCT02318706|452853378|FG001|Double-blind Phase|Protocol Violation|2|||
125878675|NCT02318706|452853379|FG002|Double-blind Phase|Protocol Violation|4|||
125878676|NCT02318706|452853380|FG003|Double-blind Phase|Protocol Violation|3|||
125878677|NCT02318706|452853381|FG004|Double-blind Phase|Protocol Violation|0|||
125878678|NCT02318706|452853377|FG000|Double-blind Phase|Withdrawal by Subject|9|||
125878679|NCT02318706|452853378|FG001|Double-blind Phase|Withdrawal by Subject|5|||
126215103|NCT03701516|454076962|FG000|Period 1|Withdrawal by Subject|0|||
126215104|NCT03701516|454076963|FG001|Period 1|Withdrawal by Subject|1|||
126215105|NCT03701516|454076962|FG000|Period 2|failed to meet all eligibility creiteria|1|||
126215106|NCT03701516|454076963|FG001|Period 2|failed to meet all eligibility creiteria|0|||
126215107|NCT03701516|454076962|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
125878680|NCT02318706|452853379|FG002|Double-blind Phase|Withdrawal by Subject|7|||
125878681|NCT02318706|452853380|FG003|Double-blind Phase|Withdrawal by Subject|10|||
125878682|NCT02318706|452853381|FG004|Double-blind Phase|Withdrawal by Subject|0|||
125878683|NCT02318706|452853377|FG000|Double-blind Phase|Other|4|||
125878684|NCT02318706|452853378|FG001|Double-blind Phase|Other|1|||
125878685|NCT02318706|452853379|FG002|Double-blind Phase|Other|2|||
125878686|NCT02318706|452853380|FG003|Double-blind Phase|Other|1|||
125878687|NCT02318706|452853381|FG004|Double-blind Phase|Other|0|||
125878688|NCT02318706|452853377|FG000|Double-blind Phase|Death|0|||
125878689|NCT02318706|452853378|FG001|Double-blind Phase|Death|0|||
125878690|NCT02318706|452853379|FG002|Double-blind Phase|Death|2|||
125878691|NCT02318706|452853380|FG003|Double-blind Phase|Death|0|||
125878692|NCT02318706|452853381|FG004|Double-blind Phase|Death|0|||
125878693|NCT02318706|452853377|FG000|Open-label Extension Phase|Adverse Event|0|||
125878694|NCT02318706|452853378|FG001|Open-label Extension Phase|Adverse Event|0|||
126013709|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126013710|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126013711|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126013712|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126013713|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
126013714|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126013715|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126013716|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
126013717|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
126013718|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126013719|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126013720|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126013721|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126013722|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
126013723|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
126013724|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126013725|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
126013726|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
126013727|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126013728|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126013729|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126013730|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126013731|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
126013732|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126013733|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126013734|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
126013735|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
126013736|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126013737|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126013738|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126013739|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126013740|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
126013741|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
126013742|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126013743|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
126013744|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126013745|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126013746|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125878695|NCT02318706|452853379|FG002|Open-label Extension Phase|Adverse Event|0|||
125878696|NCT02318706|452853380|FG003|Open-label Extension Phase|Adverse Event|0|||
126013747|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126013748|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126013749|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126013750|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126013751|NCT01212757|453342443|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126013752|NCT01212757|453342444|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
126013753|NCT01212757|453342445|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
126013754|NCT01212757|453342446|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126013755|NCT01212757|453342447|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126013756|NCT01212757|453342448|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126013757|NCT01212757|453342449|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126013758|NCT01212757|453342450|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126013759|NCT01212757|453342451|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126013760|NCT04257058|453344272|FG000|Overall Study|Lost to Follow-up|31|||
125878697|NCT02318706|452853381|FG004|Open-label Extension Phase|Adverse Event|21|||
125878698|NCT02318706|452853377|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
126215108|NCT03701516|454076963|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
126215109|NCT00358670|454076964|FG000|Overall Study|Adverse Event|26|||
126215110|NCT00358670|454076965|FG001|Overall Study|Adverse Event|29|||
126215111|NCT00358670|454076964|FG000|Overall Study|Lack of Efficacy|20|||
126215112|NCT00358670|454076965|FG001|Overall Study|Lack of Efficacy|23|||
126215113|NCT00358670|454076964|FG000|Overall Study|Protocol Violation|6|||
126215114|NCT00358670|454076965|FG001|Overall Study|Protocol Violation|9|||
126215115|NCT00358670|454076964|FG000|Overall Study|Lost to Follow-up|4|||
126215116|NCT00358670|454076965|FG001|Overall Study|Lost to Follow-up|5|||
126215117|NCT00358670|454076964|FG000|Overall Study|Withdrawal by Subject|13|||
126215118|NCT00358670|454076965|FG001|Overall Study|Withdrawal by Subject|24|||
126215119|NCT00358670|454076964|FG000|Overall Study|Protocol Defined Clinical Event|0|||
126215120|NCT00358670|454076965|FG001|Overall Study|Protocol Defined Clinical Event|1|||
126215121|NCT00358670|454076964|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
126215122|NCT00358670|454076965|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
126215123|NCT00358670|454076964|FG000|Overall Study|Administrative|153|||
126215124|NCT00358670|454076965|FG001|Overall Study|Administrative|125|||
126215125|NCT00981019|454076966|FG000|Overall Study|Did not respond|65|||
126215126|NCT00981019|454076966|FG000|Overall Study|Did not match target population|94|||
126215127|NCT00981019|454076966|FG000|Overall Study|Inadvertent exclusion|239|||
126215128|NCT00981019|454076966|FG000|Overall Study|Hit the survey after closure|79|||
126215129|NCT05083559|454076967|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
126215130|NCT05083559|454076968|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
126215131|NCT05083559|454076967|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
126215132|NCT05083559|454076968|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
126215133|NCT05083559|454076967|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
126215134|NCT05083559|454076968|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
126215135|NCT03940742|454076970|FG000|Overall Study|Lost to Follow-up|0|||
126215136|NCT03940742|454076971|FG001|Overall Study|Lost to Follow-up|0|||
126215137|NCT03940742|454076972|FG002|Overall Study|Lost to Follow-up|0|||
126215138|NCT03940742|454076973|FG003|Overall Study|Lost to Follow-up|1|||
126215139|NCT02032823|454076974|FG000|Overall Study|Death|75|||
126215140|NCT02032823|454076975|FG001|Overall Study|Death|109|||
126215141|NCT02032823|454076974|FG000|Overall Study|Lost to Follow-up|18|||
126215142|NCT02032823|454076975|FG001|Overall Study|Lost to Follow-up|17|||
126215143|NCT02032823|454076974|FG000|Overall Study|Withdrawal by Subject|70|||
126215144|NCT02032823|454076975|FG001|Overall Study|Withdrawal by Subject|53|||
126215145|NCT02032823|454076974|FG000|Overall Study|Ongoing study at data cut-off|755|||
126215146|NCT02032823|454076975|FG001|Overall Study|Ongoing study at data cut-off|731|||
126215147|NCT02032823|454076974|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
126215148|NCT02032823|454076975|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
126215149|NCT03428217|454076976|FG000|Overall Study|Death|89|||
126215150|NCT03428217|454076977|FG001|Overall Study|Death|93|||
126215151|NCT03428217|454076976|FG000|Overall Study|Withdrawal by Subject|8|||
126215152|NCT03428217|454076977|FG001|Overall Study|Withdrawal by Subject|7|||
126215153|NCT03428217|454076976|FG000|Overall Study|Lost to Follow-up|1|||
126215154|NCT03428217|454076977|FG001|Overall Study|Lost to Follow-up|3|||
126215155|NCT03428217|454076976|FG000|Overall Study|Study terminated by sponsor|124|||
126215156|NCT03428217|454076977|FG001|Overall Study|Study terminated by sponsor|118|||
126215157|NCT03428217|454076976|FG000|Overall Study|Other, Not Specified|1|||
126215158|NCT03428217|454076977|FG001|Overall Study|Other, Not Specified|0|||
126215159|NCT03889197|454076978|FG000|Overall Study|Withdrawal by Subject|1|||
126215160|NCT03889197|454076979|FG001|Overall Study|Withdrawal by Subject|0|||
126215161|NCT03889197|454076978|FG000|Overall Study|Physician Decision|0|||
126215162|NCT03889197|454076979|FG001|Overall Study|Physician Decision|1|||
126215163|NCT03889197|454076978|FG000|Overall Study|met exclusion criteria|0|||
126215164|NCT03889197|454076979|FG001|Overall Study|met exclusion criteria|1|||
126215165|NCT03889197|454076978|FG000|Overall Study|Protocol Violation|1|||
126215166|NCT03889197|454076979|FG001|Overall Study|Protocol Violation|0|||
126215167|NCT05899218|454076980|FG000|Overall Study|Lost to Follow-up|2|||
126215168|NCT05899218|454076981|FG001|Overall Study|Lost to Follow-up|2|||
126215169|NCT05899218|454076980|FG000|Overall Study|deemed ineligible out of country|1|||
126215170|NCT05899218|454076981|FG001|Overall Study|deemed ineligible out of country|0|||
126215171|NCT05246111|454076982|FG000|Period 01|NOT ELIGIBLE IC5|1|||
126215172|NCT05246111|454076983|FG001|Period 01|NOT ELIGIBLE IC5|0|||
126215173|NCT03151226|454076984|FG000|Overall Study|Withdrawal by Subject|2|||
126349162|NCT03314935|454571104|FG001|Phase 2|Progressive Disease|0|||
126349163|NCT03314935|454571105|FG002|Phase 2|Progressive Disease|0|||
126349164|NCT03314935|454571106|FG003|Phase 2|Progressive Disease|0|||
126349165|NCT03314935|454571107|FG004|Phase 2|Progressive Disease|0|||
126349166|NCT03314935|454571108|FG005|Phase 2|Progressive Disease|0|||
126349167|NCT03314935|454571109|FG006|Phase 2|Progressive Disease|0|||
126349168|NCT03314935|454571110|FG007|Phase 2|Progressive Disease|0|||
126349169|NCT03314935|454571111|FG008|Phase 2|Progressive Disease|0|||
126349170|NCT03314935|454571112|FG009|Phase 2|Progressive Disease|1|||
126013761|NCT05147233|453344279|FG000|Overall Study|Adverse Event|0|||
126013762|NCT05147233|453344280|FG001|Overall Study|Adverse Event|1|||
126013763|NCT05147233|453344279|FG000|Overall Study|Lost to Follow-up|1|||
126013764|NCT05147233|453344280|FG001|Overall Study|Lost to Follow-up|1|||
126013765|NCT05147233|453344279|FG000|Overall Study|Protocol Violation|0|||
126013766|NCT05147233|453344280|FG001|Overall Study|Protocol Violation|1|||
126215174|NCT03151226|454076984|FG000|Overall Study|not wear device correctly|1|||
126215175|NCT02304302|454076987|FG000|Overall Study|Adverse Event|2|||
126215176|NCT02304302|454076988|FG001|Overall Study|Adverse Event|3|||
126215177|NCT02304302|454076987|FG000|Overall Study|Lost to Follow-up|1|||
126215178|NCT02304302|454076988|FG001|Overall Study|Lost to Follow-up|4|||
126215179|NCT02304302|454076987|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
126215180|NCT02304302|454076988|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
126215181|NCT00391118|454076989|FG000|Overall Study|Adverse Event|3|||
126215182|NCT00391118|454076990|FG001|Overall Study|Adverse Event|10|||
126215183|NCT00391118|454076991|FG002|Overall Study|Adverse Event|7|||
126215184|NCT00391118|454076989|FG000|Overall Study|Lost to Follow-up|0|||
126215185|NCT00391118|454076990|FG001|Overall Study|Lost to Follow-up|2|||
126215186|NCT00391118|454076991|FG002|Overall Study|Lost to Follow-up|3|||
126215187|NCT00391118|454076989|FG000|Overall Study|Withdrawal by Subject|0|||
126215188|NCT00391118|454076990|FG001|Overall Study|Withdrawal by Subject|9|||
126215189|NCT00391118|454076991|FG002|Overall Study|Withdrawal by Subject|1|||
126215190|NCT00391118|454076989|FG000|Overall Study|Death|0|||
126215191|NCT00391118|454076990|FG001|Overall Study|Death|1|||
126215192|NCT00391118|454076991|FG002|Overall Study|Death|0|||
126215193|NCT00391118|454076989|FG000|Overall Study|Physician Decision|0|||
126215194|NCT00391118|454076990|FG001|Overall Study|Physician Decision|3|||
126215195|NCT00391118|454076991|FG002|Overall Study|Physician Decision|0|||
126215196|NCT00391118|454076989|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
126349171|NCT03314935|454571113|FG010|Phase 2|Progressive Disease|1|||
126349172|NCT03314935|454571114|FG011|Phase 2|Progressive Disease|1|||
126349173|NCT03314935|454571115|FG012|Phase 2|Progressive Disease|2|||
126349174|NCT03314935|454571116|FG013|Phase 2|Progressive Disease|0|||
126349175|NCT03314935|454571117|FG014|Phase 2|Progressive Disease|1|||
126349176|NCT03314935|454571103|FG000|Phase 2|Study Terminated by Sponsor|0|||
126349177|NCT03314935|454571104|FG001|Phase 2|Study Terminated by Sponsor|0|||
126349178|NCT03314935|454571105|FG002|Phase 2|Study Terminated by Sponsor|0|||
126349179|NCT03314935|454571106|FG003|Phase 2|Study Terminated by Sponsor|0|||
126349180|NCT03314935|454571107|FG004|Phase 2|Study Terminated by Sponsor|0|||
126349181|NCT03314935|454571108|FG005|Phase 2|Study Terminated by Sponsor|0|||
126349182|NCT03314935|454571109|FG006|Phase 2|Study Terminated by Sponsor|0|||
126349183|NCT03314935|454571110|FG007|Phase 2|Study Terminated by Sponsor|0|||
126349184|NCT03314935|454571111|FG008|Phase 2|Study Terminated by Sponsor|0|||
126349185|NCT03314935|454571112|FG009|Phase 2|Study Terminated by Sponsor|0|||
126349186|NCT03314935|454571113|FG010|Phase 2|Study Terminated by Sponsor|7|||
126349187|NCT03314935|454571114|FG011|Phase 2|Study Terminated by Sponsor|2|||
126349188|NCT03314935|454571115|FG012|Phase 2|Study Terminated by Sponsor|1|||
126349189|NCT03314935|454571116|FG013|Phase 2|Study Terminated by Sponsor|4|||
126349190|NCT03314935|454571117|FG014|Phase 2|Study Terminated by Sponsor|4|||
126349191|NCT03314935|454571103|FG000|Phase 2|Lost to Follow-up|0|||
126349192|NCT03314935|454571104|FG001|Phase 2|Lost to Follow-up|0|||
126349193|NCT03314935|454571105|FG002|Phase 2|Lost to Follow-up|0|||
126349194|NCT03314935|454571106|FG003|Phase 2|Lost to Follow-up|0|||
126349195|NCT03314935|454571107|FG004|Phase 2|Lost to Follow-up|0|||
126349196|NCT03314935|454571108|FG005|Phase 2|Lost to Follow-up|0|||
126349197|NCT03314935|454571109|FG006|Phase 2|Lost to Follow-up|0|||
126349198|NCT03314935|454571110|FG007|Phase 2|Lost to Follow-up|0|||
126349199|NCT03314935|454571111|FG008|Phase 2|Lost to Follow-up|0|||
126349200|NCT03314935|454571112|FG009|Phase 2|Lost to Follow-up|1|||
126349201|NCT03314935|454571113|FG010|Phase 2|Lost to Follow-up|0|||
126349202|NCT03314935|454571114|FG011|Phase 2|Lost to Follow-up|0|||
126349203|NCT03314935|454571115|FG012|Phase 2|Lost to Follow-up|0|||
126349204|NCT03314935|454571116|FG013|Phase 2|Lost to Follow-up|0|||
126349205|NCT03314935|454571117|FG014|Phase 2|Lost to Follow-up|1|||
126349206|NCT03314935|454571103|FG000|Phase 2|Physician Decision|0|||
126349207|NCT03314935|454571104|FG001|Phase 2|Physician Decision|0|||
126349208|NCT03314935|454571105|FG002|Phase 2|Physician Decision|0|||
126215197|NCT00391118|454076990|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
126215198|NCT00391118|454076991|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
126215199|NCT00391118|454076989|FG000|Overall Study|Progressive Disease|7|||
126215200|NCT00391118|454076990|FG001|Overall Study|Progressive Disease|26|||
126349209|NCT03314935|454571106|FG003|Phase 2|Physician Decision|0|||
126349210|NCT03314935|454571107|FG004|Phase 2|Physician Decision|0|||
126349211|NCT03314935|454571108|FG005|Phase 2|Physician Decision|0|||
126349212|NCT03314935|454571109|FG006|Phase 2|Physician Decision|0|||
126349213|NCT03314935|454571110|FG007|Phase 2|Physician Decision|0|||
126349214|NCT03314935|454571111|FG008|Phase 2|Physician Decision|0|||
126349215|NCT03314935|454571112|FG009|Phase 2|Physician Decision|0|||
126013767|NCT05147233|453344279|FG000|Overall Study|Withdrawal by Subject|2|||
126349216|NCT03314935|454571113|FG010|Phase 2|Physician Decision|1|||
125878699|NCT02318706|452853378|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
125878700|NCT02318706|452853379|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
125878701|NCT02318706|452853380|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
125878702|NCT02318706|452853381|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
125878703|NCT02318706|452853377|FG000|Open-label Extension Phase|Death|0|||
125878704|NCT02318706|452853378|FG001|Open-label Extension Phase|Death|0|||
125878705|NCT02318706|452853379|FG002|Open-label Extension Phase|Death|0|||
125878706|NCT02318706|452853380|FG003|Open-label Extension Phase|Death|0|||
125878707|NCT02318706|452853381|FG004|Open-label Extension Phase|Death|1|||
125878708|NCT02318706|452853377|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
125878709|NCT02318706|452853378|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
125878710|NCT02318706|452853379|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
125878711|NCT02318706|452853380|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
125878712|NCT02318706|452853381|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
125878713|NCT00992108|452853391|FG000|Overall Study|Lost to Follow-up|0|||
125878714|NCT00992108|452853392|FG001|Overall Study|Lost to Follow-up|1|||
125878715|NCT01702311|452853393|FG000|Overall Study|Withdrawal by Subject|3|||
125878716|NCT01702311|452853394|FG001|Overall Study|Withdrawal by Subject|2|||
125878717|NCT01702311|452853393|FG000|Overall Study|Discharge less than 24 hours|10|||
125878718|NCT01702311|452853394|FG001|Overall Study|Discharge less than 24 hours|7|||
125878719|NCT01702311|452853393|FG000|Overall Study|Physician Decision|3|||
125878720|NCT01702311|452853394|FG001|Overall Study|Physician Decision|4|||
125878721|NCT04106557|452853396|FG000|Overall Study|Physician Decision|0|||
125878722|NCT04106557|452853397|FG001|Overall Study|Physician Decision|1|||
125878723|NCT04106557|452853398|FG002|Overall Study|Physician Decision|0|||
125878724|NCT04106557|452853396|FG000|Overall Study|Protocol Violation|0|||
126215201|NCT00391118|454076991|FG002|Overall Study|Progressive Disease|43|||
126215202|NCT00391118|454076989|FG000|Overall Study|Sponsor Decision|0|||
126215203|NCT00391118|454076990|FG001|Overall Study|Sponsor Decision|1|||
126215204|NCT00391118|454076991|FG002|Overall Study|Sponsor Decision|3|||
126013768|NCT05147233|453344280|FG001|Overall Study|Withdrawal by Subject|1|||
126013769|NCT04199728|453344287|FG000|Overall Study|Adverse Event|1|||
126013770|NCT04199728|453344288|FG001|Overall Study|Adverse Event|0|||
126013771|NCT04199728|453344287|FG000|Overall Study|Withdrawal by Subject|8|||
126013772|NCT04199728|453344288|FG001|Overall Study|Withdrawal by Subject|3|||
126013773|NCT04199728|453344287|FG000|Overall Study|Screen fail after consent|0|||
126013774|NCT04199728|453344288|FG001|Overall Study|Screen fail after consent|1|||
126013775|NCT04199728|453344287|FG000|Overall Study|Early withdraw criteria met|0|||
126215205|NCT00391118|454076989|FG000|Overall Study|Protocol Violation|1|||
126215206|NCT00391118|454076990|FG001|Overall Study|Protocol Violation|0|||
126215207|NCT00391118|454076991|FG002|Overall Study|Protocol Violation|0|||
126215208|NCT03078192|454076993|FG000|Overall Study|Withdrawal by Subject|2|||
126215209|NCT03078192|454076994|FG001|Overall Study|Withdrawal by Subject|1|||
126215210|NCT03078192|454076993|FG000|Overall Study|screen failure|0|||
126215211|NCT03078192|454076994|FG001|Overall Study|screen failure|3|||
126215212|NCT02508649|454076997|FG000|Overall Study|Withdrawal by Subject|4|||
126215213|NCT02508649|454076998|FG001|Overall Study|Withdrawal by Subject|6|||
126215214|NCT02508649|454076999|FG002|Overall Study|Withdrawal by Subject|5|||
126215215|NCT02508649|454077000|FG003|Overall Study|Withdrawal by Subject|6|||
126215216|NCT02508649|454076997|FG000|Overall Study|Investigator withdrew the subject|1|||
126215217|NCT02508649|454076998|FG001|Overall Study|Investigator withdrew the subject|2|||
126215218|NCT02508649|454076999|FG002|Overall Study|Investigator withdrew the subject|1|||
126215219|NCT02508649|454077000|FG003|Overall Study|Investigator withdrew the subject|0|||
126215220|NCT02508649|454076997|FG000|Overall Study|Post randomization screening failure|12|||
126215221|NCT02508649|454076998|FG001|Overall Study|Post randomization screening failure|4|||
126215222|NCT02508649|454076999|FG002|Overall Study|Post randomization screening failure|9|||
126215223|NCT02508649|454077000|FG003|Overall Study|Post randomization screening failure|3|||
126215224|NCT02508649|454076997|FG000|Overall Study|Lost to Follow-up|1|||
126215225|NCT02508649|454076998|FG001|Overall Study|Lost to Follow-up|1|||
126215226|NCT02508649|454076999|FG002|Overall Study|Lost to Follow-up|0|||
126215227|NCT02508649|454077000|FG003|Overall Study|Lost to Follow-up|1|||
126215228|NCT03594175|454077008|FG000|Overall Study|Not treated|8|||
126215229|NCT03594175|454077009|FG001|Overall Study|Not treated|1|||
126215230|NCT03594175|454077010|FG002|Overall Study|Not treated|5|||
126215231|NCT03594175|454077008|FG000|Overall Study|Adverse Event|3|||
126215232|NCT03594175|454077009|FG001|Overall Study|Adverse Event|0|||
126215233|NCT03594175|454077010|FG002|Overall Study|Adverse Event|0|||
126215234|NCT03594175|454077008|FG000|Overall Study|Withdrawal by Subject|3|||
126215235|NCT03594175|454077009|FG001|Overall Study|Withdrawal by Subject|0|||
126215236|NCT03594175|454077010|FG002|Overall Study|Withdrawal by Subject|0|||
126215237|NCT03594175|454077008|FG000|Overall Study|Protocol Violation|2|||
126215238|NCT03594175|454077009|FG001|Overall Study|Protocol Violation|2|||
126215239|NCT03594175|454077010|FG002|Overall Study|Protocol Violation|2|||
126215240|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215241|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215242|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215243|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126215244|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126215245|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215246|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215247|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215248|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215249|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126215250|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215251|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215252|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126215253|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
126215254|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126215255|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
126215256|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
126215257|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
126215258|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126215259|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215260|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215261|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215262|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126349217|NCT03314935|454571114|FG011|Phase 2|Physician Decision|0|||
126349218|NCT03314935|454571115|FG012|Phase 2|Physician Decision|0|||
126349219|NCT03314935|454571116|FG013|Phase 2|Physician Decision|0|||
126349220|NCT03314935|454571117|FG014|Phase 2|Physician Decision|0|||
126349221|NCT05845619|454571118|FG000|Overall Study|duplicate enrollment|2|||
126349222|NCT05845619|454571119|FG001|Overall Study|duplicate enrollment|2|||
126349223|NCT05845619|454571120|FG002|Overall Study|duplicate enrollment|1|||
126349224|NCT02382380|454571125|FG000|Overall Study|Withdrawal by Subject|2|||
126349225|NCT02382380|454571126|FG001|Overall Study|Withdrawal by Subject|2|||
126349226|NCT02382380|454571125|FG000|Overall Study|Lost to Follow-up|0|||
126349227|NCT02382380|454571126|FG001|Overall Study|Lost to Follow-up|1|||
126349228|NCT03785366|454571127|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
126349229|NCT03785366|454571128|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
126349230|NCT03785366|454571127|FG000|Overall Study|Lost to Follow-up|1|||
126349231|NCT03785366|454571128|FG001|Overall Study|Lost to Follow-up|0|||
126013776|NCT04199728|453344288|FG001|Overall Study|Early withdraw criteria met|1|||
126013777|NCT04199728|453344287|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
126013778|NCT04199728|453344288|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
126013779|NCT00726596|453344289|FG000|Overall Study|Adverse Event|2|||
126013780|NCT00726596|453344290|FG001|Overall Study|Adverse Event|1|||
126013781|NCT00726596|453344289|FG000|Overall Study|Withdrawal by Subject|3|||
126013782|NCT00726596|453344290|FG001|Overall Study|Withdrawal by Subject|3|||
126013783|NCT00661778|453344294|FG000|Overall Study|Disease Progression|23|||
126013784|NCT00661778|453344294|FG000|Overall Study|Adverse Event|18|||
126013785|NCT00661778|453344294|FG000|Overall Study|Reason not Specified|6|||
126013786|NCT00661778|453344294|FG000|Overall Study|Protocol Violation|2|||
126013787|NCT00661778|453344294|FG000|Overall Study|Withdrawal of Consent|1|||
126013788|NCT02962674|453344300|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
126349232|NCT03785366|454571127|FG000|Overall Study|Partial IUD Expulsion|0|||
126349233|NCT03785366|454571128|FG001|Overall Study|Partial IUD Expulsion|2|||
126349234|NCT03785366|454571127|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
126349235|NCT03785366|454571128|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
126349236|NCT04153864|454571129|FG000|Overall Study|Withdrawal by Subject|21|||
126349237|NCT04153864|454571130|FG001|Overall Study|Withdrawal by Subject|7|||
126349238|NCT04153864|454571131|FG002|Overall Study|Withdrawal by Subject|23|||
126349239|NCT04153864|454571132|FG003|Overall Study|Withdrawal by Subject|2|||
126349240|NCT04153864|454571129|FG000|Overall Study|Lost to Follow-up|4|||
126349241|NCT04153864|454571130|FG001|Overall Study|Lost to Follow-up|0|||
126349242|NCT04153864|454571131|FG002|Overall Study|Lost to Follow-up|3|||
126013789|NCT00364286|453344301|FG000|Overall Study|Withdrawal by Subject|1|||
126349243|NCT04153864|454571132|FG003|Overall Study|Lost to Follow-up|0|||
126215263|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215264|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
126215265|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215266|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215267|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215268|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
126215269|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215270|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215271|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215272|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
126215273|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
126215274|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
126215275|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
126215276|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
126215277|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126215278|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
126215279|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215280|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215281|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215282|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215283|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
126215284|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215285|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215286|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215287|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215288|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215289|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215290|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215291|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215292|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
126215293|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215294|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215295|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
126215296|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126215297|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215298|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215299|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215300|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215301|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215302|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215303|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215304|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215305|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215306|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215307|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
126215308|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215309|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215310|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
126215311|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215312|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215313|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
126215314|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
126215315|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126215316|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126215317|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
126215318|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126215319|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126013790|NCT00364286|453344301|FG000|Overall Study|Adverse Event|2|||
126013791|NCT02577523|453344304|FG000|Overall Study|Adverse Event|1|||
126013792|NCT02577523|453344305|FG001|Overall Study|Adverse Event|1|||
126013793|NCT02577523|453344304|FG000|Overall Study|Lack of Efficacy|1|||
126013794|NCT02577523|453344305|FG001|Overall Study|Lack of Efficacy|1|||
126013795|NCT02577523|453344304|FG000|Overall Study|Withdrawal by Subject|1|||
126013796|NCT02577523|453344305|FG001|Overall Study|Withdrawal by Subject|0|||
126013797|NCT01227278|453344308|FG000|Overall Study|Withdrawal by Subject|4|||
126013798|NCT01227278|453344309|FG001|Overall Study|Withdrawal by Subject|4|||
126013799|NCT01227278|453344308|FG000|Overall Study|Death|0|||
126013800|NCT01227278|453344309|FG001|Overall Study|Death|2|||
126013801|NCT01227278|453344308|FG000|Overall Study|Other|1|||
126013802|NCT01227278|453344309|FG001|Overall Study|Other|2|||
126013803|NCT04035668|453344310|FG000|Overall Study|Adverse Event|3|||
126013804|NCT04035668|453344311|FG001|Overall Study|Adverse Event|4|||
126013805|NCT04035668|453344312|FG002|Overall Study|Adverse Event|2|||
126013806|NCT04035668|453344310|FG000|Overall Study|Lost to Follow-up|0|||
126013807|NCT04035668|453344311|FG001|Overall Study|Lost to Follow-up|1|||
126013808|NCT04035668|453344312|FG002|Overall Study|Lost to Follow-up|0|||
126013809|NCT04035668|453344310|FG000|Overall Study|Physician Decision|2|||
126013810|NCT04035668|453344311|FG001|Overall Study|Physician Decision|1|||
126013811|NCT04035668|453344312|FG002|Overall Study|Physician Decision|1|||
126013812|NCT04035668|453344310|FG000|Overall Study|Subject Decision|2|||
126013813|NCT04035668|453344311|FG001|Overall Study|Subject Decision|2|||
126013814|NCT04035668|453344312|FG002|Overall Study|Subject Decision|0|||
126013815|NCT02224924|453344313|FG000|Overall Study|Withdrawal by Subject|7|||
126013816|NCT02224924|453344314|FG001|Overall Study|Withdrawal by Subject|6|||
126013817|NCT02224924|453344313|FG000|Overall Study|Biopsy cancelled|20|||
126013818|NCT02224924|453344314|FG001|Overall Study|Biopsy cancelled|14|||
126013819|NCT02224924|453344313|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
126013820|NCT02224924|453344314|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
126013821|NCT02224924|453344313|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
126013822|NCT02224924|453344314|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
126013823|NCT03020745|453344315|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013824|NCT03020745|453344316|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013825|NCT03020745|453344317|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013826|NCT03020745|453344318|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013827|NCT03020745|453344319|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013828|NCT03020745|453344320|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013829|NCT03020745|453344321|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013830|NCT03020745|453344322|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013831|NCT03020745|453344323|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
126013832|NCT03020745|453344324|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
126013833|NCT03020745|453344315|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126013834|NCT03020745|453344316|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126013835|NCT03020745|453344317|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126013836|NCT03020745|453344318|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126013837|NCT03020745|453344319|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126013838|NCT03020745|453344320|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126349244|NCT04153864|454571129|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
126349245|NCT04153864|454571130|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
126349246|NCT04153864|454571131|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
126349247|NCT04153864|454571132|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
126349248|NCT01348269|454572888|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
126349249|NCT01348269|454572889|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
126349250|NCT01348269|454572888|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
126349251|NCT01348269|454572889|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
126349252|NCT01348269|454572888|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
126349253|NCT01348269|454572889|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
126349254|NCT01697579|454572890|FG000|Base Study-Cycle 1|Adverse Event|1|||
126349255|NCT01697579|454572891|FG001|Base Study-Cycle 1|Adverse Event|0|||
126349256|NCT01697579|454572892|FG002|Base Study-Cycle 1|Adverse Event|0|||
126349257|NCT01697579|454572893|FG003|Base Study-Cycle 1|Adverse Event|0|||
126349258|NCT01697579|454572894|FG004|Base Study-Cycle 1|Adverse Event|0|||
126349259|NCT01697579|454572895|FG005|Base Study-Cycle 1|Adverse Event|0|||
126349260|NCT01697579|454572896|FG006|Base Study-Cycle 1|Adverse Event|0|||
126013839|NCT03020745|453344321|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126013840|NCT03020745|453344322|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
126013841|NCT03020745|453344323|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126013842|NCT03020745|453344324|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126013843|NCT03020745|453344315|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126013844|NCT03020745|453344316|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126013845|NCT03020745|453344317|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126215320|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126215321|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126215322|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126215323|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126215324|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126215325|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126215326|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126215327|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126215328|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126215329|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
126215330|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
126215331|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
126215332|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
126215333|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
126215334|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126215335|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215336|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126215337|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
126215338|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215339|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215340|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215341|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215342|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126215343|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126215344|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126215345|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215346|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126215347|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215348|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126215349|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215350|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126215351|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
126215352|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
126215353|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126215354|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215355|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215356|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215357|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215358|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
126215359|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215360|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215361|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215362|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215363|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
126215364|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215365|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215366|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215367|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215368|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215369|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126349261|NCT01697579|454572890|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
126349262|NCT01697579|454572891|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349263|NCT01697579|454572892|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349264|NCT01697579|454572893|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349265|NCT01697579|454572894|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349266|NCT01697579|454572895|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349267|NCT01697579|454572896|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349268|NCT01697579|454572890|FG000|Base Study-Cycle 1|Protocol Violation|0|||
126349269|NCT01697579|454572891|FG001|Base Study-Cycle 1|Protocol Violation|0|||
126349270|NCT01697579|454572892|FG002|Base Study-Cycle 1|Protocol Violation|0|||
126349271|NCT01697579|454572893|FG003|Base Study-Cycle 1|Protocol Violation|0|||
126349272|NCT01697579|454572894|FG004|Base Study-Cycle 1|Protocol Violation|3|||
126349273|NCT01697579|454572895|FG005|Base Study-Cycle 1|Protocol Violation|0|||
126349274|NCT01697579|454572896|FG006|Base Study-Cycle 1|Protocol Violation|0|||
126349275|NCT01697579|454572890|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126215370|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215371|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215372|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126215373|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
126215374|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126215375|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126215376|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126215377|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126215378|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
126215379|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126215380|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126215381|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126215382|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126215383|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
126215384|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126215385|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126215386|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
126215387|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126215388|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
126215389|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
126215390|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
126215391|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126215392|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215393|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215394|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215395|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215396|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215397|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215398|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215399|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215400|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215401|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215402|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
126215403|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215404|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215405|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215406|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215407|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215408|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215409|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215410|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126215411|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
126215412|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
126215413|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126215414|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126215415|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
126215416|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
126215417|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126215418|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
126215419|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126215420|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
126215421|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126215422|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126349276|NCT01697579|454572891|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
126349277|NCT01697579|454572892|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349278|NCT01697579|454572893|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349279|NCT01697579|454572894|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349280|NCT01697579|454572895|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349281|NCT01697579|454572896|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349282|NCT01697579|454572890|FG000|Base Study-Cycle 1|Technical Problems|0|||
126349283|NCT01697579|454572891|FG001|Base Study-Cycle 1|Technical Problems|0|||
126349284|NCT01697579|454572892|FG002|Base Study-Cycle 1|Technical Problems|1|||
126349285|NCT01697579|454572893|FG003|Base Study-Cycle 1|Technical Problems|1|||
126349286|NCT01697579|454572894|FG004|Base Study-Cycle 1|Technical Problems|0|||
126349287|NCT01697579|454572895|FG005|Base Study-Cycle 1|Technical Problems|0|||
126349288|NCT01697579|454572896|FG006|Base Study-Cycle 1|Technical Problems|0|||
126349289|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Death|0|||
126349290|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Death|0|||
126349291|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Death|0|||
126349292|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Death|0|||
126215423|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
126215424|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
126215425|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126215426|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
126215427|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
126215428|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
126215429|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
126215430|NCT01915498|454077011|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
126215431|NCT01915498|454077012|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
126215432|NCT01915498|454077013|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
126215433|NCT01915498|454077014|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
126215434|NCT01915498|454077015|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
126215435|NCT01915498|454077016|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
126215436|NCT01915498|454077017|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
126215437|NCT01915498|454077018|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
126215438|NCT01915498|454077019|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
126215439|NCT01915498|454077020|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
126215440|NCT01915498|454077021|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
126215441|NCT01915498|454077022|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
126215442|NCT01915498|454077023|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
126215443|NCT01915498|454077024|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
126215444|NCT01915498|454077025|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
126215445|NCT01915498|454077026|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
126215446|NCT01915498|454077027|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
126215447|NCT01915498|454077028|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
126215448|NCT01915498|454077029|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
126215449|NCT01915498|454077011|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215450|NCT01915498|454077012|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215451|NCT01915498|454077013|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215452|NCT01915498|454077014|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215453|NCT01915498|454077015|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215454|NCT01915498|454077016|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215455|NCT01915498|454077017|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215456|NCT01915498|454077018|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215457|NCT01915498|454077019|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215458|NCT01915498|454077020|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215459|NCT01915498|454077021|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215460|NCT01915498|454077022|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215461|NCT01915498|454077023|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215462|NCT01915498|454077024|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215463|NCT01915498|454077025|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215464|NCT01915498|454077026|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215465|NCT01915498|454077027|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215466|NCT01915498|454077028|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126215467|NCT01915498|454077029|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
126349293|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Death|0|||
126349294|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Death|0|||
126349295|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Death|2|||
126013846|NCT03020745|453344318|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126349296|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349297|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349298|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349299|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349300|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349301|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
126349302|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
126349303|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
126349304|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
126349305|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
126013847|NCT03020745|453344319|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126215468|NCT01915498|454077011|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215469|NCT01915498|454077012|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215470|NCT01915498|454077013|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215471|NCT01915498|454077014|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215472|NCT01915498|454077015|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215473|NCT01915498|454077016|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215474|NCT01915498|454077017|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215475|NCT01915498|454077018|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215476|NCT01915498|454077019|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215477|NCT01915498|454077020|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215478|NCT01915498|454077021|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215479|NCT01915498|454077022|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215480|NCT01915498|454077023|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215481|NCT01915498|454077024|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215482|NCT01915498|454077025|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215483|NCT01915498|454077026|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215484|NCT01915498|454077027|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215485|NCT01915498|454077028|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126215486|NCT01915498|454077029|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
126215487|NCT01915498|454077011|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215488|NCT01915498|454077012|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215489|NCT01915498|454077013|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215490|NCT01915498|454077014|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215491|NCT01915498|454077015|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215492|NCT01915498|454077016|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215493|NCT01915498|454077017|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215494|NCT01915498|454077018|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215495|NCT01915498|454077019|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215496|NCT01915498|454077020|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215497|NCT01915498|454077021|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215498|NCT01915498|454077022|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215499|NCT01915498|454077023|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215500|NCT01915498|454077024|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215501|NCT01915498|454077025|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215502|NCT01915498|454077026|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215503|NCT01915498|454077027|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215504|NCT01915498|454077028|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126215505|NCT01915498|454077029|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
126215506|NCT01907516|454077030|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
126215507|NCT01907516|454077031|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
125878725|NCT04106557|452853397|FG001|Overall Study|Protocol Violation|1|||
126215508|NCT01907516|454077030|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
126215509|NCT01907516|454077031|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
126215510|NCT01907516|454077030|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
126215511|NCT01907516|454077031|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
126215512|NCT01907516|454077030|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
126215513|NCT01907516|454077031|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
126215514|NCT01186744|454079098|FG000|Overall Study|Lack of Efficacy|156|||
126215515|NCT01186744|454079099|FG001|Overall Study|Lack of Efficacy|99|||
126215516|NCT01186744|454079100|FG002|Overall Study|Lack of Efficacy|0|||
126215517|NCT01186744|454079101|FG003|Overall Study|Lack of Efficacy|2|||
126215518|NCT01186744|454079102|FG004|Overall Study|Lack of Efficacy|2|||
126215519|NCT01186744|454079103|FG005|Overall Study|Lack of Efficacy|5|||
126215520|NCT01186744|454079098|FG000|Overall Study|Protocol Violation|1|||
126215521|NCT01186744|454079099|FG001|Overall Study|Protocol Violation|2|||
126215522|NCT01186744|454079100|FG002|Overall Study|Protocol Violation|0|||
126215523|NCT01186744|454079101|FG003|Overall Study|Protocol Violation|1|||
126215524|NCT01186744|454079102|FG004|Overall Study|Protocol Violation|1|||
126215525|NCT01186744|454079103|FG005|Overall Study|Protocol Violation|2|||
126215526|NCT01186744|454079098|FG000|Overall Study|Lost to Follow-up|15|||
126215527|NCT01186744|454079099|FG001|Overall Study|Lost to Follow-up|16|||
126215528|NCT01186744|454079100|FG002|Overall Study|Lost to Follow-up|2|||
126215529|NCT01186744|454079101|FG003|Overall Study|Lost to Follow-up|1|||
126215530|NCT01186744|454079102|FG004|Overall Study|Lost to Follow-up|1|||
126215531|NCT01186744|454079103|FG005|Overall Study|Lost to Follow-up|4|||
126215532|NCT01186744|454079098|FG000|Overall Study|Screen failure|1|||
126215533|NCT01186744|454079099|FG001|Overall Study|Screen failure|1|||
126215534|NCT01186744|454079100|FG002|Overall Study|Screen failure|0|||
126215535|NCT01186744|454079101|FG003|Overall Study|Screen failure|1|||
126215536|NCT01186744|454079102|FG004|Overall Study|Screen failure|0|||
126215537|NCT01186744|454079103|FG005|Overall Study|Screen failure|0|||
126215538|NCT01186744|454079098|FG000|Overall Study|Withdrawal by Subject|14|||
126215539|NCT01186744|454079099|FG001|Overall Study|Withdrawal by Subject|10|||
126215540|NCT01186744|454079100|FG002|Overall Study|Withdrawal by Subject|2|||
126215541|NCT01186744|454079101|FG003|Overall Study|Withdrawal by Subject|5|||
126215542|NCT01186744|454079102|FG004|Overall Study|Withdrawal by Subject|0|||
126215543|NCT01186744|454079103|FG005|Overall Study|Withdrawal by Subject|6|||
126215544|NCT01186744|454079098|FG000|Overall Study|Study terminated by Sponsor|1|||
126215545|NCT01186744|454079099|FG001|Overall Study|Study terminated by Sponsor|0|||
126215546|NCT01186744|454079100|FG002|Overall Study|Study terminated by Sponsor|0|||
126215547|NCT01186744|454079101|FG003|Overall Study|Study terminated by Sponsor|0|||
126215548|NCT01186744|454079102|FG004|Overall Study|Study terminated by Sponsor|0|||
126215549|NCT01186744|454079103|FG005|Overall Study|Study terminated by Sponsor|0|||
126215550|NCT01186744|454079098|FG000|Overall Study|Other|9|||
126215551|NCT01186744|454079099|FG001|Overall Study|Other|10|||
126215552|NCT01186744|454079100|FG002|Overall Study|Other|1|||
126215553|NCT01186744|454079101|FG003|Overall Study|Other|2|||
126215554|NCT01186744|454079102|FG004|Overall Study|Other|1|||
126215555|NCT01186744|454079103|FG005|Overall Study|Other|5|||
126215556|NCT01186744|454079098|FG000|Overall Study|Adverse Event|10|||
126215557|NCT01186744|454079099|FG001|Overall Study|Adverse Event|14|||
126349306|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
126349307|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
126349308|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
126013848|NCT03020745|453344320|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
126349309|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
126349310|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126349311|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126013849|NCT03020745|453344321|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126215558|NCT01186744|454079100|FG002|Overall Study|Adverse Event|1|||
126215559|NCT01186744|454079101|FG003|Overall Study|Adverse Event|0|||
126349312|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126349313|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126013850|NCT03020745|453344322|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126215560|NCT01186744|454079102|FG004|Overall Study|Adverse Event|1|||
126215561|NCT01186744|454079103|FG005|Overall Study|Adverse Event|4|||
126215562|NCT01186744|454079098|FG000|Overall Study|Death|1|||
126215563|NCT01186744|454079099|FG001|Overall Study|Death|0|||
126215564|NCT01186744|454079100|FG002|Overall Study|Death|0|||
126215565|NCT01186744|454079101|FG003|Overall Study|Death|0|||
126215566|NCT01186744|454079102|FG004|Overall Study|Death|0|||
126215567|NCT01186744|454079103|FG005|Overall Study|Death|0|||
126215568|NCT01020773|454079106|FG000|Overall Study|Withdrawal by Subject|4|||
126215569|NCT01020773|454079107|FG001|Overall Study|Withdrawal by Subject|3|||
126215570|NCT02675426|454079108|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
126215571|NCT02675426|454079109|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
126215572|NCT02675426|454079110|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
126215573|NCT02675426|454079111|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
126215574|NCT02675426|454079108|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
126215575|NCT02675426|454079109|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
126215576|NCT02675426|454079110|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
126215577|NCT02675426|454079111|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
126215578|NCT02675426|454079108|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
126215579|NCT02675426|454079109|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
126215580|NCT02675426|454079110|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
126215581|NCT02675426|454079111|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
126215582|NCT02675426|454079108|FG000|Period 1: Week 1 to Week 12|Other|2|||
126215583|NCT02675426|454079109|FG001|Period 1: Week 1 to Week 12|Other|1|||
126215584|NCT02675426|454079110|FG002|Period 1: Week 1 to Week 12|Other|0|||
126215585|NCT02675426|454079111|FG003|Period 1: Week 1 to Week 12|Other|2|||
126215586|NCT02675426|454079108|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
126215587|NCT02675426|454079109|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
126215588|NCT02675426|454079110|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
126215589|NCT02675426|454079111|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
126215590|NCT02675426|454079108|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
126215591|NCT02675426|454079109|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
126215592|NCT02675426|454079110|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
126215593|NCT02675426|454079111|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
126215594|NCT02675426|454079108|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
126215595|NCT02675426|454079109|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
126215596|NCT02675426|454079110|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
126215597|NCT02675426|454079111|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
126215598|NCT02675426|454079108|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
126215599|NCT02675426|454079109|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
126215600|NCT02675426|454079110|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
126215601|NCT02675426|454079111|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
126215602|NCT02675426|454079108|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
126215603|NCT02675426|454079109|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
126215604|NCT02675426|454079110|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
126215605|NCT02675426|454079111|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
126215606|NCT02675426|454079108|FG000|Period 2: Week 12 to Week 260|Other|8|||
126215607|NCT02675426|454079109|FG001|Period 2: Week 12 to Week 260|Other|12|||
126215608|NCT02675426|454079110|FG002|Period 2: Week 12 to Week 260|Other|23|||
126215609|NCT02675426|454079111|FG003|Period 2: Week 12 to Week 260|Other|15|||
126215610|NCT00953927|454079112|FG000|Overall Study|Lost to Follow-up|61|||
126215611|NCT00953927|454079113|FG001|Overall Study|Lost to Follow-up|65|||
126215612|NCT00953927|454079112|FG000|Overall Study|Withdrawal by Subject|36|||
126215613|NCT00953927|454079113|FG001|Overall Study|Withdrawal by Subject|25|||
126215614|NCT00953927|454079112|FG000|Overall Study|Death|7|||
126215615|NCT00953927|454079113|FG001|Overall Study|Death|4|||
126215616|NCT00953927|454079112|FG000|Overall Study|Other study discontinuation|1|||
126215617|NCT00953927|454079113|FG001|Overall Study|Other study discontinuation|1|||
126215618|NCT01652573|454079114|FG000|Overall Study|Adverse Event|0|||
126215619|NCT01652573|454079115|FG001|Overall Study|Adverse Event|1|||
126215620|NCT00934622|454079116|FG000|Overall Study|Lost to Follow-up|7|||
126215621|NCT00934622|454079116|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
126215622|NCT01856686|454079121|FG000|Overall Study|Lost to Follow-up|5|||
126215623|NCT01856686|454079122|FG001|Overall Study|Lost to Follow-up|11|||
126215624|NCT03284424|454079123|FG000|Overall Study|Death|70|||
126013851|NCT03020745|453344323|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
126013852|NCT03020745|453344324|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126013853|NCT03020745|453344315|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013854|NCT03020745|453344316|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013855|NCT03020745|453344317|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013856|NCT03020745|453344318|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013857|NCT03020745|453344319|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013858|NCT03020745|453344320|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013859|NCT03020745|453344321|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013860|NCT03020745|453344322|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013861|NCT03020745|453344323|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
126013862|NCT03020745|453344324|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126013863|NCT00139737|453344332|FG000|Overall Study|Withdrawal by Subject|190|||
126013864|NCT00139737|453344332|FG000|Overall Study|Adverse Event|58|||
126013865|NCT00139737|453344332|FG000|Overall Study|Lack of Efficacy|40|||
126013866|NCT00139737|453344332|FG000|Overall Study|Lost to Follow-up|8|||
126013867|NCT00139737|453344332|FG000|Overall Study|Death|3|||
126013868|NCT00139737|453344332|FG000|Overall Study|Laboratory Abnormality|2|||
126013869|NCT00139737|453344332|FG000|Overall Study|Protocol Violation|18|||
126013870|NCT00139737|453344332|FG000|Overall Study|Withdrew During Screening Phase|8|||
126013871|NCT00139737|453344332|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126013872|NCT00139737|453344332|FG000|Overall Study|Screened, Not Treated|13|||
126013873|NCT03781336|453344335|FG000|Overall Study|Withdrawal by Subject|2|||
126013874|NCT03781336|453344336|FG001|Overall Study|Withdrawal by Subject|2|||
126013875|NCT03460756|453344337|FG000|Overall Study|Adverse Event|0|||
126013876|NCT03460756|453344338|FG001|Overall Study|Adverse Event|0|||
126013877|NCT03460756|453344339|FG002|Overall Study|Adverse Event|0|||
126013878|NCT03460756|453344340|FG003|Overall Study|Adverse Event|1|||
126215625|NCT03284424|454079124|FG001|Overall Study|Death|24|||
126215626|NCT03284424|454079123|FG000|Overall Study|Lost to Follow-up|3|||
126349314|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126349315|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126349316|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
126349317|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349318|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349319|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349320|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349321|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349322|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
126349323|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
126349324|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349325|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349326|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349327|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349328|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349329|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
126349330|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349331|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349332|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349333|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349334|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349335|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349336|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
126349337|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
126349338|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349339|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349340|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349341|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349342|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349343|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
126215627|NCT03284424|454079124|FG001|Overall Study|Lost to Follow-up|1|||
126215628|NCT03284424|454079123|FG000|Overall Study|Physician Decision|1|||
126349344|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
126349345|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126013879|NCT03460756|453344337|FG000|Overall Study|Lack of Efficacy|0|||
126013880|NCT03460756|453344338|FG001|Overall Study|Lack of Efficacy|0|||
126013881|NCT03460756|453344339|FG002|Overall Study|Lack of Efficacy|0|||
126013882|NCT03460756|453344340|FG003|Overall Study|Lack of Efficacy|2|||
126215629|NCT03284424|454079124|FG001|Overall Study|Physician Decision|2|||
126215630|NCT03284424|454079123|FG000|Overall Study|Withdrawal by Subject|4|||
126215631|NCT03284424|454079124|FG001|Overall Study|Withdrawal by Subject|5|||
126215632|NCT03284424|454079123|FG000|Overall Study|Sponsor's decision|27|||
126215633|NCT03284424|454079124|FG001|Overall Study|Sponsor's decision|22|||
126215634|NCT00602979|454079127|FG000|Overall Study|Lost to Follow-up|3|||
126215635|NCT00602979|454079128|FG001|Overall Study|Lost to Follow-up|2|||
126215636|NCT00602979|454079129|FG002|Overall Study|Lost to Follow-up|3|||
126215637|NCT00602979|454079130|FG003|Overall Study|Lost to Follow-up|2|||
126215638|NCT00602979|454079131|FG004|Overall Study|Lost to Follow-up|3|||
126215639|NCT00602979|454079127|FG000|Overall Study|Failed Intubation|0|||
126215640|NCT00602979|454079128|FG001|Overall Study|Failed Intubation|1|||
126215641|NCT00602979|454079129|FG002|Overall Study|Failed Intubation|0|||
126215642|NCT00602979|454079130|FG003|Overall Study|Failed Intubation|1|||
126215643|NCT00602979|454079131|FG004|Overall Study|Failed Intubation|0|||
126215644|NCT02962739|454079132|FG000|Overall Study|Withdrawal by Subject|0|||
126215645|NCT02962739|454079133|FG001|Overall Study|Withdrawal by Subject|1|||
126215646|NCT02962739|454079134|FG002|Overall Study|Withdrawal by Subject|0|||
126215647|NCT02962739|454079135|FG003|Overall Study|Withdrawal by Subject|0|||
126215648|NCT02962739|454079136|FG004|Overall Study|Withdrawal by Subject|0|||
126215649|NCT02962739|454079137|FG005|Overall Study|Withdrawal by Subject|0|||
126215650|NCT02962739|454079132|FG000|Overall Study|Protocol Violation|0|||
126215651|NCT02962739|454079133|FG001|Overall Study|Protocol Violation|0|||
126215652|NCT02962739|454079134|FG002|Overall Study|Protocol Violation|1|||
126215653|NCT02962739|454079135|FG003|Overall Study|Protocol Violation|0|||
126215654|NCT02962739|454079136|FG004|Overall Study|Protocol Violation|1|||
126215655|NCT02962739|454079137|FG005|Overall Study|Protocol Violation|0|||
126215656|NCT01268683|454079141|FG000|Overall Study|Lost to Follow-up|1|||
126215657|NCT01268683|454079141|FG000|Overall Study|Death|1|||
126215658|NCT02216214|454079142|FG000|Overall Study|Randomized Never Received Study Drug|1|||
126215659|NCT02216214|454079143|FG001|Overall Study|Randomized Never Received Study Drug|0|||
126215660|NCT02216214|454079142|FG000|Overall Study|Adverse Event|10|||
126215661|NCT02216214|454079143|FG001|Overall Study|Adverse Event|8|||
126215662|NCT02216214|454079142|FG000|Overall Study|Lack of Efficacy|2|||
126215663|NCT02216214|454079143|FG001|Overall Study|Lack of Efficacy|2|||
126215664|NCT02216214|454079142|FG000|Overall Study|Lost to Follow-up|3|||
126215665|NCT02216214|454079143|FG001|Overall Study|Lost to Follow-up|2|||
126215666|NCT02216214|454079142|FG000|Overall Study|Protocol Violation|4|||
126215667|NCT02216214|454079143|FG001|Overall Study|Protocol Violation|2|||
126215668|NCT02216214|454079142|FG000|Overall Study|Withdrawal by Subject|22|||
126215669|NCT02216214|454079143|FG001|Overall Study|Withdrawal by Subject|20|||
126215670|NCT02216214|454079142|FG000|Overall Study|Study Terminated By Sponsor|0|||
126215671|NCT02216214|454079143|FG001|Overall Study|Study Terminated By Sponsor|1|||
126215672|NCT02216214|454079142|FG000|Overall Study|Miscellaneous|1|||
126215673|NCT02216214|454079143|FG001|Overall Study|Miscellaneous|1|||
126215674|NCT00713830|454079144|FG000|Overall Study|Adverse Event|23|||
126215675|NCT00713830|454079145|FG001|Overall Study|Adverse Event|71|||
126215676|NCT00713830|454079144|FG000|Overall Study|Lack of Efficacy|24|||
126215677|NCT00713830|454079145|FG001|Overall Study|Lack of Efficacy|16|||
126215678|NCT00713830|454079144|FG000|Overall Study|Lost to Follow-up|2|||
126215679|NCT00713830|454079145|FG001|Overall Study|Lost to Follow-up|9|||
126215680|NCT00713830|454079144|FG000|Overall Study|Withdrawal by Subject|13|||
126215681|NCT00713830|454079145|FG001|Overall Study|Withdrawal by Subject|23|||
126215682|NCT00713830|454079144|FG000|Overall Study|Poor Compliance to Protocol|7|||
126215683|NCT00713830|454079145|FG001|Overall Study|Poor Compliance to Protocol|14|||
126215684|NCT00713830|454079144|FG000|Overall Study|Familial and Personal Reasons|9|||
126215685|NCT00713830|454079145|FG001|Overall Study|Familial and Personal Reasons|34|||
126215686|NCT00713830|454079144|FG000|Overall Study|Sponsor Decision|4|||
126215687|NCT00713830|454079145|FG001|Overall Study|Sponsor Decision|10|||
126215688|NCT03981614|454079146|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
126215689|NCT03981614|454079147|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
126215690|NCT03981614|454079148|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
126215691|NCT00499252|454079149|FG000|Overall Study|Adverse Event|3|||
126215692|NCT00499252|454079149|FG000|Overall Study|Refused further treatment|2|||
126215693|NCT00499252|454079149|FG000|Overall Study|Ineligible|4|||
126215694|NCT00499252|454079149|FG000|Overall Study|<no further label>|3|||
126215695|NCT00566631|454079150|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
126215696|NCT00566631|454079150|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
126215697|NCT00566631|454079150|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
126215698|NCT00566631|454079150|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
126215699|NCT00566631|454079150|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
126215700|NCT00566631|454079150|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
126215701|NCT00566631|454079150|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
126215702|NCT00566631|454079150|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
126215703|NCT00566631|454079150|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
126215704|NCT00566631|454079150|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
126215705|NCT00566631|454079150|FG000|Part 2: Extension Phase|Adverse Event|11|||
126215706|NCT00566631|454079150|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
126215707|NCT00566631|454079150|FG000|Part 2: Extension Phase|Death|1|||
126215708|NCT00566631|454079150|FG000|Part 2: Extension Phase|Other|5|||
126215709|NCT03387735|454079151|FG000|Overall Study|Lost to Follow-up|4|||
126215710|NCT03387735|454079152|FG001|Overall Study|Lost to Follow-up|8|||
126215711|NCT03387735|454079151|FG000|Overall Study|Death|4|||
126215712|NCT03387735|454079152|FG001|Overall Study|Death|8|||
126215713|NCT03020966|454079154|FG000|Overall Study|Withdrawal by Subject|2|||
126215714|NCT03020966|454079155|FG001|Overall Study|Withdrawal by Subject|0|||
126215715|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
126215716|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
126215717|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
126215718|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
126215719|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
126215720|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
126215721|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
126215722|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
126349346|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349347|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349348|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349349|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349350|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349351|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
126349352|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349353|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349354|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349355|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349356|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349357|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349358|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
126349359|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349360|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349361|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349362|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349363|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349364|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349365|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
126349366|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349367|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349368|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349369|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349370|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349371|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
126349372|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
126349373|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126349374|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126013883|NCT03460756|453344337|FG000|Overall Study|Lost to Follow-up|0|||
126013884|NCT03460756|453344338|FG001|Overall Study|Lost to Follow-up|1|||
126215723|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
126215724|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
126215725|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
126349375|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126349376|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126349377|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125878726|NCT04106557|452853398|FG002|Overall Study|Protocol Violation|0|||
126215726|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
126349378|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126215727|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
126215728|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
126215729|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
126215730|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
126215731|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
126215732|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
126215733|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
126215734|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
126215735|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
126215736|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
126215737|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
126215738|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
126215739|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
126215740|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
126013885|NCT03460756|453344339|FG002|Overall Study|Lost to Follow-up|2|||
126013886|NCT03460756|453344340|FG003|Overall Study|Lost to Follow-up|1|||
126215741|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
126349379|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
126349380|NCT02452190|454572897|FG000|Overall Study|Withdrawal by Sponsor|1|||
126349381|NCT02452190|454572898|FG001|Overall Study|Withdrawal by Sponsor|3|||
126349382|NCT02452190|454572897|FG000|Overall Study|Pregnancy|1|||
126349383|NCT02452190|454572898|FG001|Overall Study|Pregnancy|0|||
126349384|NCT02452190|454572897|FG000|Overall Study|Investigator's Decision|2|||
126349385|NCT02452190|454572898|FG001|Overall Study|Investigator's Decision|0|||
126349386|NCT02452190|454572897|FG000|Overall Study|Lack of Efficacy|3|||
126349387|NCT02452190|454572898|FG001|Overall Study|Lack of Efficacy|1|||
126349388|NCT02452190|454572897|FG000|Overall Study|Lost to Follow-up|4|||
126349389|NCT02452190|454572898|FG001|Overall Study|Lost to Follow-up|3|||
126349390|NCT02452190|454572897|FG000|Overall Study|Adverse Event|2|||
126349391|NCT02452190|454572898|FG001|Overall Study|Adverse Event|5|||
126349392|NCT02452190|454572897|FG000|Overall Study|Withdrawal by Subject|20|||
126349393|NCT02452190|454572898|FG001|Overall Study|Withdrawal by Subject|11|||
126349394|NCT02452190|454572897|FG000|Overall Study|Noncompliance with study drug|1|||
126349395|NCT02452190|454572898|FG001|Overall Study|Noncompliance with study drug|0|||
126349396|NCT02452190|454572897|FG000|Overall Study|Participant traveled abroad|1|||
126349397|NCT02452190|454572898|FG001|Overall Study|Participant traveled abroad|0|||
126349398|NCT02452190|454572897|FG000|Overall Study|Death|0|||
126349399|NCT02452190|454572898|FG001|Overall Study|Death|1|||
126349400|NCT03112603|454572900|FG000|End of Randomization Period|Lost to Follow-up|3|||
126349401|NCT03112603|454572901|FG001|End of Randomization Period|Lost to Follow-up|0|||
126349402|NCT03112603|454572902|FG002|End of Randomization Period|Lost to Follow-up|0|||
126349403|NCT03112603|454572900|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
126349404|NCT03112603|454572901|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
126349405|NCT03112603|454572902|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
126349406|NCT03112603|454572900|FG000|End of Randomization Period|Physician Decision|43|||
126349407|NCT03112603|454572901|FG001|End of Randomization Period|Physician Decision|18|||
126349408|NCT03112603|454572902|FG002|End of Randomization Period|Physician Decision|0|||
126349409|NCT03112603|454572900|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
126349410|NCT03112603|454572901|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
126349411|NCT03112603|454572902|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
126349412|NCT03112603|454572900|FG000|End of Randomization Period|Death|10|||
126349413|NCT03112603|454572901|FG001|End of Randomization Period|Death|7|||
126349414|NCT03112603|454572902|FG002|End of Randomization Period|Death|0|||
126349415|NCT03112603|454572900|FG000|End of Randomization Period|Disease Relapse|12|||
126349416|NCT03112603|454572901|FG001|End of Randomization Period|Disease Relapse|7|||
126349417|NCT03112603|454572902|FG002|End of Randomization Period|Disease Relapse|0|||
126349418|NCT03112603|454572900|FG000|End of Randomization Period|Lack of Efficacy|25|||
126349419|NCT03112603|454572901|FG001|End of Randomization Period|Lack of Efficacy|77|||
126349420|NCT03112603|454572902|FG002|End of Randomization Period|Lack of Efficacy|0|||
126349421|NCT03112603|454572900|FG000|End of Randomization Period|Adverse Event|32|||
126349422|NCT03112603|454572901|FG001|End of Randomization Period|Adverse Event|12|||
126349423|NCT03112603|454572902|FG002|End of Randomization Period|Adverse Event|0|||
126349424|NCT03112603|454572900|FG000|End of Cross Over Period|Death|0|||
126349425|NCT03112603|454572901|FG001|End of Cross Over Period|Death|0|||
126349426|NCT03112603|454572902|FG002|End of Cross Over Period|Death|2|||
126349427|NCT03112603|454572900|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
126349428|NCT03112603|454572901|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
126349429|NCT03112603|454572902|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
126349430|NCT03112603|454572900|FG000|End of Cross Over Period|Physician Decision|0|||
126013887|NCT03460756|453344337|FG000|Overall Study|Pregnancy|0|||
126215742|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
126215743|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
126215744|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
126215745|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
126215746|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
126215747|NCT03747939|454079159|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
126215748|NCT03747939|454079160|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
126215749|NCT03747939|454079161|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
126215750|NCT03747939|454079162|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
126215751|NCT03747939|454079159|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
126215752|NCT03747939|454079160|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
126215753|NCT03747939|454079161|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
126215754|NCT03747939|454079162|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
126215755|NCT03747939|454079159|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
126215756|NCT03747939|454079160|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
126215757|NCT03747939|454079161|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
126215758|NCT03747939|454079162|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
126215759|NCT03747939|454079159|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
126215760|NCT03747939|454079160|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
126215761|NCT03747939|454079161|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
126215762|NCT03747939|454079162|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
126215763|NCT03747939|454079159|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
126215764|NCT03747939|454079160|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
126215765|NCT03747939|454079161|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
126215766|NCT03747939|454079162|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
126215767|NCT03747939|454079159|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
126215768|NCT03747939|454079160|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
126215769|NCT03747939|454079161|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
126215770|NCT03747939|454079162|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
126215771|NCT01215955|454079163|FG000|Overall Study|Adverse Event|1|||
126215772|NCT01215955|454079164|FG001|Overall Study|Adverse Event|4|||
126215773|NCT01215955|454079165|FG002|Overall Study|Adverse Event|2|||
126215774|NCT01215955|454079166|FG003|Overall Study|Adverse Event|3|||
126215775|NCT01215955|454079163|FG000|Overall Study|Death|2|||
126215776|NCT01215955|454079164|FG001|Overall Study|Death|0|||
126215777|NCT01215955|454079165|FG002|Overall Study|Death|1|||
126215778|NCT01215955|454079166|FG003|Overall Study|Death|3|||
126215779|NCT01215955|454079163|FG000|Overall Study|Entry Criteria Not Met|1|||
126215780|NCT01215955|454079164|FG001|Overall Study|Entry Criteria Not Met|3|||
126215781|NCT01215955|454079165|FG002|Overall Study|Entry Criteria Not Met|4|||
126215782|NCT01215955|454079166|FG003|Overall Study|Entry Criteria Not Met|7|||
126215783|NCT01215955|454079163|FG000|Overall Study|Lack of Efficacy|1|||
126215784|NCT01215955|454079164|FG001|Overall Study|Lack of Efficacy|2|||
126215785|NCT01215955|454079165|FG002|Overall Study|Lack of Efficacy|1|||
126215786|NCT01215955|454079166|FG003|Overall Study|Lack of Efficacy|0|||
126215787|NCT01215955|454079163|FG000|Overall Study|Lost to Follow-up|4|||
126215788|NCT01215955|454079164|FG001|Overall Study|Lost to Follow-up|4|||
126215789|NCT01215955|454079165|FG002|Overall Study|Lost to Follow-up|8|||
126215790|NCT01215955|454079166|FG003|Overall Study|Lost to Follow-up|9|||
126215791|NCT01215955|454079163|FG000|Overall Study|Physician Decision|4|||
126215792|NCT01215955|454079164|FG001|Overall Study|Physician Decision|10|||
126215793|NCT01215955|454079165|FG002|Overall Study|Physician Decision|8|||
126215794|NCT01215955|454079166|FG003|Overall Study|Physician Decision|11|||
126215795|NCT01215955|454079163|FG000|Overall Study|Protocol Violation|17|||
126215796|NCT01215955|454079164|FG001|Overall Study|Protocol Violation|13|||
126215797|NCT01215955|454079165|FG002|Overall Study|Protocol Violation|8|||
126215798|NCT01215955|454079166|FG003|Overall Study|Protocol Violation|8|||
126349431|NCT03112603|454572901|FG001|End of Cross Over Period|Physician Decision|0|||
126349432|NCT03112603|454572902|FG002|End of Cross Over Period|Physician Decision|29|||
126349433|NCT03112603|454572900|FG000|End of Cross Over Period|Lack of Efficacy|0|||
126349434|NCT03112603|454572901|FG001|End of Cross Over Period|Lack of Efficacy|0|||
126349435|NCT03112603|454572902|FG002|End of Cross Over Period|Lack of Efficacy|8|||
126349436|NCT03112603|454572900|FG000|End of Cross Over Period|Adverse Event|0|||
126349437|NCT03112603|454572901|FG001|End of Cross Over Period|Adverse Event|0|||
126349438|NCT03112603|454572902|FG002|End of Cross Over Period|Adverse Event|6|||
126349439|NCT03112603|454572900|FG000|End of Cross Over Period|Disease Relapse|0|||
126349440|NCT03112603|454572901|FG001|End of Cross Over Period|Disease Relapse|0|||
126349441|NCT03112603|454572902|FG002|End of Cross Over Period|Disease Relapse|2|||
126349442|NCT03916926|454572906|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
126349443|NCT03916926|454572907|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
126349444|NCT03916926|454572906|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
126349445|NCT03916926|454572907|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
126215799|NCT01215955|454079163|FG000|Overall Study|Sponsor Decision|1|||
126215800|NCT01215955|454079164|FG001|Overall Study|Sponsor Decision|2|||
126215801|NCT01215955|454079165|FG002|Overall Study|Sponsor Decision|0|||
126215802|NCT01215955|454079166|FG003|Overall Study|Sponsor Decision|1|||
126215803|NCT01215955|454079163|FG000|Overall Study|Withdrawal by Subject|14|||
126215804|NCT01215955|454079164|FG001|Overall Study|Withdrawal by Subject|15|||
126215805|NCT01215955|454079165|FG002|Overall Study|Withdrawal by Subject|13|||
126215806|NCT01215955|454079166|FG003|Overall Study|Withdrawal by Subject|9|||
126215807|NCT01215955|454079163|FG000|Overall Study|Quality Issues|0|||
126215808|NCT01215955|454079164|FG001|Overall Study|Quality Issues|0|||
126215809|NCT01215955|454079165|FG002|Overall Study|Quality Issues|3|||
126215810|NCT01215955|454079166|FG003|Overall Study|Quality Issues|2|||
126215811|NCT02494583|454079169|FG000|Overall Study|Death|224|||
126215812|NCT02494583|454079170|FG001|Overall Study|Death|214|||
126215813|NCT02494583|454079171|FG002|Overall Study|Death|225|||
126215814|NCT02494583|454079169|FG000|Overall Study|Lost to Follow-up|1|||
126215815|NCT02494583|454079170|FG001|Overall Study|Lost to Follow-up|0|||
126215816|NCT02494583|454079171|FG002|Overall Study|Lost to Follow-up|0|||
126215817|NCT02494583|454079169|FG000|Overall Study|Protocol Violation|1|||
126215818|NCT02494583|454079170|FG001|Overall Study|Protocol Violation|2|||
126215819|NCT02494583|454079171|FG002|Overall Study|Protocol Violation|0|||
126215820|NCT02494583|454079169|FG000|Overall Study|Screen Failure|0|||
126215821|NCT02494583|454079170|FG001|Overall Study|Screen Failure|1|||
126215822|NCT02494583|454079171|FG002|Overall Study|Screen Failure|0|||
126215823|NCT02494583|454079169|FG000|Overall Study|Transferred to Extension Study|15|||
126215824|NCT02494583|454079170|FG001|Overall Study|Transferred to Extension Study|15|||
126215825|NCT02494583|454079171|FG002|Overall Study|Transferred to Extension Study|6|||
126215826|NCT02494583|454079169|FG000|Overall Study|Did Not Continue on Extension Study|8|||
126215827|NCT02494583|454079170|FG001|Overall Study|Did Not Continue on Extension Study|10|||
126215828|NCT02494583|454079171|FG002|Overall Study|Did Not Continue on Extension Study|4|||
126215829|NCT02494583|454079169|FG000|Overall Study|Withdrawal by Subject|7|||
126215830|NCT02494583|454079170|FG001|Overall Study|Withdrawal by Subject|15|||
126215831|NCT02494583|454079171|FG002|Overall Study|Withdrawal by Subject|15|||
126215832|NCT01787188|454079172|FG000|Overall Study|Adverse Event|2|||
126215833|NCT01787188|454079173|FG001|Overall Study|Adverse Event|4|||
126215834|NCT01787188|454079174|FG002|Overall Study|Adverse Event|6|||
126215835|NCT01787188|454079172|FG000|Overall Study|Lack of Efficacy|7|||
126013888|NCT03460756|453344338|FG001|Overall Study|Pregnancy|0|||
126215836|NCT01787188|454079173|FG001|Overall Study|Lack of Efficacy|3|||
126215837|NCT01787188|454079174|FG002|Overall Study|Lack of Efficacy|5|||
126215838|NCT01787188|454079172|FG000|Overall Study|Non-compliance with Study Drug|0|||
126013889|NCT03460756|453344339|FG002|Overall Study|Pregnancy|0|||
126215839|NCT01787188|454079173|FG001|Overall Study|Non-compliance with Study Drug|1|||
126215840|NCT01787188|454079174|FG002|Overall Study|Non-compliance with Study Drug|0|||
126215841|NCT01787188|454079172|FG000|Overall Study|Withdrawal by Subject|4|||
126013890|NCT03460756|453344340|FG003|Overall Study|Pregnancy|1|||
126013891|NCT03460756|453344337|FG000|Overall Study|Protocol Violation|0|||
126215842|NCT01787188|454079173|FG001|Overall Study|Withdrawal by Subject|3|||
126215843|NCT01787188|454079174|FG002|Overall Study|Withdrawal by Subject|2|||
126215844|NCT01787188|454079172|FG000|Overall Study|Protocol Violation|3|||
126215845|NCT01787188|454079173|FG001|Overall Study|Protocol Violation|2|||
126215846|NCT01787188|454079174|FG002|Overall Study|Protocol Violation|3|||
126215847|NCT01787188|454079172|FG000|Overall Study|Lost to Follow-up|1|||
126215848|NCT01787188|454079173|FG001|Overall Study|Lost to Follow-up|2|||
126215849|NCT01787188|454079174|FG002|Overall Study|Lost to Follow-up|2|||
126215850|NCT01787188|454079172|FG000|Overall Study|Other, including patient moved|0|||
126215851|NCT01787188|454079173|FG001|Overall Study|Other, including patient moved|3|||
126215852|NCT01787188|454079174|FG002|Overall Study|Other, including patient moved|0|||
126215853|NCT02756078|454079177|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
126215854|NCT02756078|454079178|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
126215855|NCT02756078|454079177|FG000|Period 1|Lost to Follow-up|0|||
126215856|NCT02756078|454079178|FG001|Period 1|Lost to Follow-up|2|||
126215857|NCT02756078|454079177|FG000|Period 1|Protocol Violation|0|||
126215858|NCT02756078|454079178|FG001|Period 1|Protocol Violation|1|||
126215859|NCT02756078|454079177|FG000|Period 1|Adverse Event|1|||
126215860|NCT02756078|454079178|FG001|Period 1|Adverse Event|10|||
126215861|NCT02756078|454079177|FG000|Period 1|Withdrawal by Subject|6|||
126215862|NCT02756078|454079178|FG001|Period 1|Withdrawal by Subject|6|||
126215863|NCT02756078|454079177|FG000|Period 1|Lens Discomfort|2|||
126215864|NCT02756078|454079178|FG001|Period 1|Lens Discomfort|2|||
126215865|NCT02756078|454079177|FG000|Period 2|Adverse Event|3|||
126215866|NCT02756078|454079178|FG001|Period 2|Adverse Event|5|||
126215867|NCT02756078|454079177|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
126215868|NCT02756078|454079178|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
126215869|NCT02756078|454079177|FG000|Period 2|Withdrawal by Subject|3|||
126215870|NCT02756078|454079178|FG001|Period 2|Withdrawal by Subject|1|||
126215871|NCT05349188|454079179|FG000|Overall Study|Withdrawal by Subject|1|||
126215872|NCT05349188|454079180|FG001|Overall Study|Withdrawal by Subject|0|||
126215873|NCT00835068|454079183|FG000|Overall Study|Death|1|||
126215874|NCT00835068|454079184|FG001|Overall Study|Death|0|||
126215875|NCT00835068|454079183|FG000|Overall Study|Adverse Event|0|||
126215876|NCT00835068|454079184|FG001|Overall Study|Adverse Event|1|||
126215877|NCT00835068|454079183|FG000|Overall Study|Other|8|||
126215878|NCT00835068|454079184|FG001|Overall Study|Other|0|||
126215879|NCT00835068|454079183|FG000|Overall Study|Withdrawal by Subject|1|||
126215880|NCT00835068|454079184|FG001|Overall Study|Withdrawal by Subject|0|||
126215881|NCT02575807|454079185|FG000|Overall Study|Death|8|||
126215882|NCT02575807|454079186|FG001|Overall Study|Death|3|||
126215883|NCT02575807|454079187|FG002|Overall Study|Death|7|||
126215884|NCT02575807|454079188|FG003|Overall Study|Death|0|||
126215885|NCT02575807|454079189|FG004|Overall Study|Death|1|||
126215886|NCT02575807|454079185|FG000|Overall Study|Study terminated by Sponsor|0|||
125878727|NCT01209689|452853399|FG000|Overall Study|Insufficient Therapeutic Response|7|||
126013892|NCT03460756|453344338|FG001|Overall Study|Protocol Violation|0|||
126215887|NCT02575807|454079186|FG001|Overall Study|Study terminated by Sponsor|1|||
126215888|NCT02575807|454079187|FG002|Overall Study|Study terminated by Sponsor|7|||
126215889|NCT02575807|454079188|FG003|Overall Study|Study terminated by Sponsor|0|||
126215890|NCT02575807|454079189|FG004|Overall Study|Study terminated by Sponsor|1|||
126215891|NCT02575807|454079185|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
126215892|NCT02575807|454079186|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
126013893|NCT03460756|453344339|FG002|Overall Study|Protocol Violation|0|||
126215893|NCT02575807|454079187|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
126215894|NCT02575807|454079188|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
126215895|NCT02575807|454079189|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
126215896|NCT02575807|454079185|FG000|Overall Study|Terminated due to physician decision|0|||
126215897|NCT02575807|454079186|FG001|Overall Study|Terminated due to physician decision|0|||
126215898|NCT02575807|454079187|FG002|Overall Study|Terminated due to physician decision|1|||
126215899|NCT02575807|454079188|FG003|Overall Study|Terminated due to physician decision|0|||
126215900|NCT02575807|454079189|FG004|Overall Study|Terminated due to physician decision|0|||
126215901|NCT02575807|454079185|FG000|Overall Study|Subject ineligible - medical implant|0|||
126215902|NCT02575807|454079186|FG001|Overall Study|Subject ineligible - medical implant|0|||
126215903|NCT02575807|454079187|FG002|Overall Study|Subject ineligible - medical implant|0|||
126215904|NCT02575807|454079188|FG003|Overall Study|Subject ineligible - medical implant|1|||
126215905|NCT02575807|454079189|FG004|Overall Study|Subject ineligible - medical implant|0|||
126215906|NCT02575807|454079185|FG000|Overall Study|Withdrawal by Subject|0|||
126013894|NCT03460756|453344340|FG003|Overall Study|Protocol Violation|1|||
126013895|NCT03460756|453344337|FG000|Overall Study|Withdrawal by Subject|0|||
126013896|NCT03460756|453344338|FG001|Overall Study|Withdrawal by Subject|4|||
126215907|NCT02575807|454079186|FG001|Overall Study|Withdrawal by Subject|0|||
126215908|NCT02575807|454079187|FG002|Overall Study|Withdrawal by Subject|1|||
126215909|NCT02575807|454079188|FG003|Overall Study|Withdrawal by Subject|1|||
126215910|NCT02575807|454079189|FG004|Overall Study|Withdrawal by Subject|2|||
126215911|NCT03332212|454079190|FG000|Overall Study|Not treated|0|||
126215912|NCT03332212|454079191|FG001|Overall Study|Not treated|1|||
126215913|NCT03332212|454079192|FG002|Overall Study|Not treated|0|||
126215914|NCT03332212|454079193|FG003|Overall Study|Not treated|0|||
126215915|NCT03332212|454079190|FG000|Overall Study|Adverse Event|0|||
126215916|NCT03332212|454079191|FG001|Overall Study|Adverse Event|0|||
126215917|NCT03332212|454079192|FG002|Overall Study|Adverse Event|0|||
126215918|NCT03332212|454079193|FG003|Overall Study|Adverse Event|1|||
126215919|NCT03332212|454079190|FG000|Overall Study|worsening of disease under study|1|||
126215920|NCT03332212|454079191|FG001|Overall Study|worsening of disease under study|1|||
126215921|NCT03332212|454079192|FG002|Overall Study|worsening of disease under study|0|||
126215922|NCT03332212|454079193|FG003|Overall Study|worsening of disease under study|0|||
126215923|NCT02058368|454079194|FG000|Overall Study|Adverse Event|15|||
126215924|NCT02058368|454079195|FG001|Overall Study|Adverse Event|20|||
126013897|NCT03460756|453344339|FG002|Overall Study|Withdrawal by Subject|7|||
126013898|NCT03460756|453344340|FG003|Overall Study|Withdrawal by Subject|3|||
126013899|NCT03987451|453344341|FG000|Overall Study|Lost to Follow-up|1|||
126215925|NCT02058368|454079194|FG000|Overall Study|Lack of Efficacy|0|||
126215926|NCT02058368|454079195|FG001|Overall Study|Lack of Efficacy|1|||
126215927|NCT02058368|454079194|FG000|Overall Study|Protocol Violation|0|||
126215928|NCT02058368|454079195|FG001|Overall Study|Protocol Violation|4|||
126013900|NCT03987451|453344342|FG001|Overall Study|Lost to Follow-up|0|||
126013901|NCT03987451|453344341|FG000|Overall Study|Withdrawal by Subject|1|||
126013902|NCT03987451|453344342|FG001|Overall Study|Withdrawal by Subject|1|||
126013903|NCT02441036|453344345|FG000|Overall Study|No tissue resected|0|||
126013904|NCT02441036|453344346|FG001|Overall Study|No tissue resected|1|||
126013905|NCT02441036|453344347|FG002|Overall Study|No tissue resected|0|||
126013906|NCT02441036|453344348|FG003|Overall Study|No tissue resected|1|||
126013907|NCT02441036|453344349|FG004|Overall Study|No tissue resected|0|||
126013908|NCT02954848|453344351|FG000|Overall Study|Randomized but Not Treated|0|||
126013909|NCT02954848|453344352|FG001|Overall Study|Randomized but Not Treated|1|||
126013910|NCT02954848|453344351|FG000|Overall Study|Adverse Event|2|||
126013911|NCT02954848|453344352|FG001|Overall Study|Adverse Event|3|||
126013912|NCT02954848|453344351|FG000|Overall Study|Withdrawal by Participant|0|||
126013913|NCT02954848|453344352|FG001|Overall Study|Withdrawal by Participant|1|||
126013914|NCT01069341|453344353|FG000|Overall Study|Lost to Follow-up|1|||
126013915|NCT00922207|453344354|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
126013916|NCT00922207|453344355|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
126013917|NCT00922207|453344356|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
126013918|NCT00922207|453344354|FG000|Overall Study|Insufficient Therapeutic Response|0|||
126013919|NCT00922207|453344355|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126013920|NCT00922207|453344356|FG002|Overall Study|Insufficient Therapeutic Response|1|||
126013921|NCT00922207|453344354|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
126013922|NCT00922207|453344355|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126013923|NCT00922207|453344356|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
126013924|NCT00922207|453344354|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
126013925|NCT00922207|453344355|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
126013926|NCT00922207|453344356|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
126013927|NCT00922207|453344354|FG000|Overall Study|Withdrew Consent|2|||
126013928|NCT00922207|453344355|FG001|Overall Study|Withdrew Consent|5|||
126013929|NCT00922207|453344356|FG002|Overall Study|Withdrew Consent|2|||
126013930|NCT00922207|453344354|FG000|Overall Study|Abnormality of Laboratory Test|0|||
126013931|NCT00922207|453344355|FG001|Overall Study|Abnormality of Laboratory Test|1|||
126013932|NCT00922207|453344356|FG002|Overall Study|Abnormality of Laboratory Test|1|||
126013933|NCT01802632|453344357|FG000|Overall Study|Death|28|||
126013934|NCT01802632|453344358|FG001|Overall Study|Death|1|||
126013935|NCT01802632|453344359|FG002|Overall Study|Death|38|||
126013936|NCT01802632|453344360|FG003|Overall Study|Death|0|||
126215929|NCT02058368|454079194|FG000|Overall Study|Lost to Follow-up|2|||
126349446|NCT03916926|454572906|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
126349447|NCT03916926|454572907|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
126349448|NCT03916926|454572906|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
126349449|NCT03916926|454572907|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
126349450|NCT03330197|454572908|FG000|Overall Study|Adverse Event|0|||
126349451|NCT03330197|454572909|FG001|Overall Study|Adverse Event|1|||
126349452|NCT03330197|454572908|FG000|Overall Study|Withdrawal by Subject|0|||
126349453|NCT03330197|454572909|FG001|Overall Study|Withdrawal by Subject|1|||
126349454|NCT04537299|454572910|FG000|Overall Study|Withdrawal by Subject|2|||
126349455|NCT04537299|454572911|FG001|Overall Study|Withdrawal by Subject|0|||
126349456|NCT04537299|454572910|FG000|Overall Study|Protocol Violation|1|||
126349457|NCT04537299|454572911|FG001|Overall Study|Protocol Violation|1|||
126349458|NCT00876343|454572918|FG000|Overall Study|Adverse Event|7|||
126349459|NCT00876343|454572919|FG001|Overall Study|Adverse Event|8|||
126349460|NCT00876343|454572920|FG002|Overall Study|Adverse Event|2|||
126349461|NCT00876343|454572918|FG000|Overall Study|Withdrawal by Subject|4|||
126349462|NCT00876343|454572919|FG001|Overall Study|Withdrawal by Subject|4|||
126349463|NCT00876343|454572920|FG002|Overall Study|Withdrawal by Subject|3|||
126349464|NCT00876343|454572918|FG000|Overall Study|Lack of Efficacy|0|||
126349465|NCT00876343|454572919|FG001|Overall Study|Lack of Efficacy|0|||
126349466|NCT00876343|454572920|FG002|Overall Study|Lack of Efficacy|1|||
126349467|NCT00876343|454572918|FG000|Overall Study|Protocol Violation|4|||
126349468|NCT00876343|454572919|FG001|Overall Study|Protocol Violation|1|||
126349469|NCT00876343|454572920|FG002|Overall Study|Protocol Violation|1|||
126349470|NCT00876343|454572918|FG000|Overall Study|Physician Decision|0|||
126349471|NCT00876343|454572919|FG001|Overall Study|Physician Decision|1|||
126349472|NCT00876343|454572920|FG002|Overall Study|Physician Decision|1|||
126013937|NCT01802632|453344361|FG004|Overall Study|Death|2|||
126013938|NCT01802632|453344362|FG005|Overall Study|Death|0|||
126013939|NCT01802632|453344357|FG000|Overall Study|Withdrawal by Subject|4|||
126013940|NCT01802632|453344358|FG001|Overall Study|Withdrawal by Subject|2|||
126013941|NCT01802632|453344359|FG002|Overall Study|Withdrawal by Subject|7|||
126013942|NCT01802632|453344360|FG003|Overall Study|Withdrawal by Subject|3|||
126349473|NCT00876343|454572918|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
126349474|NCT00876343|454572919|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
126349475|NCT00876343|454572920|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
126349476|NCT00876343|454572918|FG000|Overall Study|Change of residence or other commitments|2|||
126215930|NCT02058368|454079195|FG001|Overall Study|Lost to Follow-up|0|||
126215931|NCT02058368|454079194|FG000|Overall Study|Physician Decision|2|||
126215932|NCT02058368|454079195|FG001|Overall Study|Physician Decision|3|||
126215933|NCT02058368|454079194|FG000|Overall Study|Withdrawal by Subject|22|||
126215934|NCT02058368|454079195|FG001|Overall Study|Withdrawal by Subject|26|||
126215935|NCT05473247|454079203|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
126215936|NCT02392559|454079204|FG000|Overall Study|Withdrawal by Subject|0|||
126215937|NCT02392559|454079205|FG001|Overall Study|Withdrawal by Subject|1|||
126215938|NCT01345058|454079206|FG000|Overall Study|Withdrawal by Subject|1|||
126215939|NCT01345058|454079207|FG001|Overall Study|Withdrawal by Subject|0|||
126215940|NCT01345058|454079206|FG000|Overall Study|Participant Reported Increase in Events|1|||
126215941|NCT01345058|454079207|FG001|Overall Study|Participant Reported Increase in Events|0|||
126215942|NCT01345058|454079206|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
126215943|NCT01345058|454079207|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
126215944|NCT01345058|454079206|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
126215945|NCT01345058|454079207|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
126349477|NCT00876343|454572919|FG001|Overall Study|Change of residence or other commitments|2|||
126349478|NCT00876343|454572920|FG002|Overall Study|Change of residence or other commitments|3|||
126349479|NCT01933932|454572923|FG000|Overall Study|Death|173|||
126349480|NCT01933932|454572924|FG001|Overall Study|Death|163|||
126349481|NCT01933932|454572923|FG000|Overall Study|Withdrawal by Subject|11|||
126349482|NCT01933932|454572924|FG001|Overall Study|Withdrawal by Subject|14|||
126349483|NCT01933932|454572923|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126349484|NCT01933932|454572924|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126349485|NCT01925794|454572928|FG000|180 Days|Death|2|||
126349486|NCT01925794|454572928|FG000|180 Days|Withdrawal by Subject|2|||
126349487|NCT01925794|454572928|FG000|270 Days|Death|2|||
126349488|NCT01925794|454572928|FG000|270 Days|Protocol Violation|3|||
126349489|NCT03126110|454572929|FG000|Phase 1|Death|2|||
126349490|NCT03126110|454572930|FG001|Phase 1|Death|2|||
126349491|NCT03126110|454572931|FG002|Phase 1|Death|4|||
126349492|NCT03126110|454572932|FG003|Phase 1|Death|3|||
126349493|NCT03126110|454572933|FG004|Phase 1|Death|4|||
126349494|NCT03126110|454572934|FG005|Phase 1|Death|4|||
126349495|NCT03126110|454572935|FG006|Phase 1|Death|3|||
126349496|NCT03126110|454572936|FG007|Phase 1|Death|4|||
126349497|NCT03126110|454572937|FG008|Phase 1|Death|5|||
126349498|NCT03126110|454572938|FG009|Phase 1|Death|2|||
126349499|NCT03126110|454572939|FG010|Phase 1|Death|6|||
126349500|NCT03126110|454572940|FG011|Phase 1|Death|0|||
126349501|NCT03126110|454572941|FG012|Phase 1|Death|0|||
126349502|NCT03126110|454572942|FG013|Phase 1|Death|0|||
126349503|NCT03126110|454572943|FG014|Phase 1|Death|0|||
126349504|NCT03126110|454572944|FG015|Phase 1|Death|0|||
126349505|NCT03126110|454572945|FG016|Phase 1|Death|0|||
126349506|NCT03126110|454572929|FG000|Phase 1|Lost to Follow-up|0|||
126349507|NCT03126110|454572930|FG001|Phase 1|Lost to Follow-up|1|||
126349508|NCT03126110|454572931|FG002|Phase 1|Lost to Follow-up|0|||
126349509|NCT03126110|454572932|FG003|Phase 1|Lost to Follow-up|0|||
126349510|NCT03126110|454572933|FG004|Phase 1|Lost to Follow-up|0|||
126349511|NCT03126110|454572934|FG005|Phase 1|Lost to Follow-up|0|||
126349512|NCT03126110|454572935|FG006|Phase 1|Lost to Follow-up|0|||
126349513|NCT03126110|454572936|FG007|Phase 1|Lost to Follow-up|0|||
126349514|NCT03126110|454572937|FG008|Phase 1|Lost to Follow-up|1|||
126349515|NCT03126110|454572938|FG009|Phase 1|Lost to Follow-up|0|||
126349516|NCT03126110|454572939|FG010|Phase 1|Lost to Follow-up|0|||
126349517|NCT03126110|454572940|FG011|Phase 1|Lost to Follow-up|0|||
126349518|NCT03126110|454572941|FG012|Phase 1|Lost to Follow-up|0|||
126349519|NCT03126110|454572942|FG013|Phase 1|Lost to Follow-up|0|||
126349520|NCT03126110|454572943|FG014|Phase 1|Lost to Follow-up|0|||
126349521|NCT03126110|454572944|FG015|Phase 1|Lost to Follow-up|0|||
126349522|NCT03126110|454572945|FG016|Phase 1|Lost to Follow-up|0|||
126349523|NCT03126110|454572929|FG000|Phase 1|Withdrawal by Subject|1|||
126349524|NCT03126110|454572930|FG001|Phase 1|Withdrawal by Subject|0|||
126215946|NCT01345058|454079206|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
126215947|NCT01345058|454079207|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
126215948|NCT01892020|454079213|FG000|Period 1|Adverse Event|1|||
126215949|NCT01892020|454079214|FG001|Period 1|Adverse Event|1|||
126349525|NCT03126110|454572931|FG002|Phase 1|Withdrawal by Subject|0|||
126349526|NCT03126110|454572932|FG003|Phase 1|Withdrawal by Subject|1|||
126349527|NCT03126110|454572933|FG004|Phase 1|Withdrawal by Subject|1|||
126349528|NCT03126110|454572934|FG005|Phase 1|Withdrawal by Subject|0|||
126349529|NCT03126110|454572935|FG006|Phase 1|Withdrawal by Subject|0|||
126349530|NCT03126110|454572936|FG007|Phase 1|Withdrawal by Subject|0|||
126349531|NCT03126110|454572937|FG008|Phase 1|Withdrawal by Subject|2|||
126349532|NCT03126110|454572938|FG009|Phase 1|Withdrawal by Subject|1|||
126349533|NCT03126110|454572939|FG010|Phase 1|Withdrawal by Subject|0|||
126349534|NCT03126110|454572940|FG011|Phase 1|Withdrawal by Subject|0|||
126349535|NCT03126110|454572941|FG012|Phase 1|Withdrawal by Subject|0|||
126349536|NCT03126110|454572942|FG013|Phase 1|Withdrawal by Subject|0|||
126349537|NCT03126110|454572943|FG014|Phase 1|Withdrawal by Subject|0|||
126349538|NCT03126110|454572944|FG015|Phase 1|Withdrawal by Subject|0|||
126013943|NCT01802632|453344361|FG004|Overall Study|Withdrawal by Subject|0|||
126013944|NCT01802632|453344362|FG005|Overall Study|Withdrawal by Subject|1|||
126013945|NCT01802632|453344357|FG000|Overall Study|Objective Disease Progression|1|||
126013946|NCT01802632|453344358|FG001|Overall Study|Objective Disease Progression|12|||
126013947|NCT01802632|453344359|FG002|Overall Study|Objective Disease Progression|104|||
126013948|NCT01802632|453344360|FG003|Overall Study|Objective Disease Progression|6|||
126013949|NCT01802632|453344361|FG004|Overall Study|Objective Disease Progression|4|||
126013950|NCT01802632|453344362|FG005|Overall Study|Objective Disease Progression|4|||
126013951|NCT01802632|453344357|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
126013952|NCT01802632|453344358|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
126013953|NCT01802632|453344359|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
126013954|NCT01802632|453344360|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
126013955|NCT01802632|453344361|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
126013956|NCT01802632|453344362|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
126013957|NCT01802632|453344357|FG000|Overall Study|Other (not specified)|0|||
126013958|NCT01802632|453344358|FG001|Overall Study|Other (not specified)|0|||
126013959|NCT01802632|453344359|FG002|Overall Study|Other (not specified)|7|||
126013960|NCT01802632|453344360|FG003|Overall Study|Other (not specified)|1|||
126013961|NCT01802632|453344361|FG004|Overall Study|Other (not specified)|0|||
126013962|NCT01802632|453344362|FG005|Overall Study|Other (not specified)|1|||
126215950|NCT01892020|454079213|FG000|Period 1|Protocol Violation|2|||
126215951|NCT01892020|454079214|FG001|Period 1|Protocol Violation|4|||
126215952|NCT01892020|454079213|FG000|Period 1|Unclassified|0|||
126215953|NCT01892020|454079214|FG001|Period 1|Unclassified|1|||
126349539|NCT03126110|454572945|FG016|Phase 1|Withdrawal by Subject|0|||
126349540|NCT03126110|454572929|FG000|Phase 1|Safety follow-up no longer necessary|1|||
126349541|NCT03126110|454572930|FG001|Phase 1|Safety follow-up no longer necessary|0|||
126349542|NCT03126110|454572931|FG002|Phase 1|Safety follow-up no longer necessary|0|||
126349543|NCT03126110|454572932|FG003|Phase 1|Safety follow-up no longer necessary|0|||
126349544|NCT03126110|454572933|FG004|Phase 1|Safety follow-up no longer necessary|0|||
126349545|NCT03126110|454572934|FG005|Phase 1|Safety follow-up no longer necessary|0|||
126349546|NCT03126110|454572935|FG006|Phase 1|Safety follow-up no longer necessary|0|||
126349547|NCT03126110|454572936|FG007|Phase 1|Safety follow-up no longer necessary|0|||
126349548|NCT03126110|454572937|FG008|Phase 1|Safety follow-up no longer necessary|0|||
126349549|NCT03126110|454572938|FG009|Phase 1|Safety follow-up no longer necessary|0|||
126349550|NCT03126110|454572939|FG010|Phase 1|Safety follow-up no longer necessary|0|||
126349551|NCT03126110|454572940|FG011|Phase 1|Safety follow-up no longer necessary|0|||
126349552|NCT03126110|454572941|FG012|Phase 1|Safety follow-up no longer necessary|0|||
126349553|NCT03126110|454572942|FG013|Phase 1|Safety follow-up no longer necessary|0|||
126349554|NCT03126110|454572943|FG014|Phase 1|Safety follow-up no longer necessary|0|||
126349555|NCT03126110|454572944|FG015|Phase 1|Safety follow-up no longer necessary|0|||
126349556|NCT03126110|454572945|FG016|Phase 1|Safety follow-up no longer necessary|0|||
126349557|NCT03126110|454572929|FG000|Phase 1|Survival follow-up no longer necessary|0|||
126349558|NCT03126110|454572930|FG001|Phase 1|Survival follow-up no longer necessary|0|||
126349559|NCT03126110|454572931|FG002|Phase 1|Survival follow-up no longer necessary|1|||
126349560|NCT03126110|454572932|FG003|Phase 1|Survival follow-up no longer necessary|0|||
126349561|NCT03126110|454572933|FG004|Phase 1|Survival follow-up no longer necessary|0|||
126349562|NCT03126110|454572934|FG005|Phase 1|Survival follow-up no longer necessary|0|||
126349563|NCT03126110|454572935|FG006|Phase 1|Survival follow-up no longer necessary|0|||
126349564|NCT03126110|454572936|FG007|Phase 1|Survival follow-up no longer necessary|0|||
126349565|NCT03126110|454572937|FG008|Phase 1|Survival follow-up no longer necessary|0|||
126349566|NCT03126110|454572938|FG009|Phase 1|Survival follow-up no longer necessary|0|||
126349567|NCT03126110|454572939|FG010|Phase 1|Survival follow-up no longer necessary|0|||
126349568|NCT03126110|454572940|FG011|Phase 1|Survival follow-up no longer necessary|0|||
126349569|NCT03126110|454572941|FG012|Phase 1|Survival follow-up no longer necessary|0|||
126349570|NCT03126110|454572942|FG013|Phase 1|Survival follow-up no longer necessary|0|||
126349571|NCT03126110|454572943|FG014|Phase 1|Survival follow-up no longer necessary|0|||
126349572|NCT03126110|454572944|FG015|Phase 1|Survival follow-up no longer necessary|0|||
126349573|NCT03126110|454572945|FG016|Phase 1|Survival follow-up no longer necessary|0|||
126349574|NCT03126110|454572929|FG000|Phase 2|Study terminated by the sponsor|0|||
126349575|NCT03126110|454572930|FG001|Phase 2|Study terminated by the sponsor|0|||
126349576|NCT03126110|454572931|FG002|Phase 2|Study terminated by the sponsor|0|||
126349577|NCT03126110|454572932|FG003|Phase 2|Study terminated by the sponsor|0|||
126349578|NCT03126110|454572933|FG004|Phase 2|Study terminated by the sponsor|0|||
126349579|NCT03126110|454572934|FG005|Phase 2|Study terminated by the sponsor|0|||
126349580|NCT03126110|454572935|FG006|Phase 2|Study terminated by the sponsor|0|||
126349581|NCT03126110|454572936|FG007|Phase 2|Study terminated by the sponsor|0|||
126349582|NCT03126110|454572937|FG008|Phase 2|Study terminated by the sponsor|0|||
126349583|NCT03126110|454572938|FG009|Phase 2|Study terminated by the sponsor|0|||
126349584|NCT03126110|454572939|FG010|Phase 2|Study terminated by the sponsor|0|||
126349585|NCT03126110|454572940|FG011|Phase 2|Study terminated by the sponsor|0|||
126349586|NCT03126110|454572941|FG012|Phase 2|Study terminated by the sponsor|0|||
126349587|NCT03126110|454572942|FG013|Phase 2|Study terminated by the sponsor|4|||
126349588|NCT03126110|454572943|FG014|Phase 2|Study terminated by the sponsor|0|||
126349589|NCT03126110|454572944|FG015|Phase 2|Study terminated by the sponsor|0|||
126349590|NCT03126110|454572945|FG016|Phase 2|Study terminated by the sponsor|0|||
126349591|NCT03126110|454572929|FG000|Phase 2|Withdrawal by Subject|0|||
126349592|NCT03126110|454572930|FG001|Phase 2|Withdrawal by Subject|0|||
126349593|NCT03126110|454572931|FG002|Phase 2|Withdrawal by Subject|0|||
126349594|NCT03126110|454572932|FG003|Phase 2|Withdrawal by Subject|0|||
126349595|NCT03126110|454572933|FG004|Phase 2|Withdrawal by Subject|0|||
126349596|NCT03126110|454572934|FG005|Phase 2|Withdrawal by Subject|0|||
126349597|NCT03126110|454572935|FG006|Phase 2|Withdrawal by Subject|0|||
126349598|NCT03126110|454572936|FG007|Phase 2|Withdrawal by Subject|0|||
126349599|NCT03126110|454572937|FG008|Phase 2|Withdrawal by Subject|0|||
126349600|NCT03126110|454572938|FG009|Phase 2|Withdrawal by Subject|0|||
126349601|NCT03126110|454572939|FG010|Phase 2|Withdrawal by Subject|0|||
126349602|NCT03126110|454572940|FG011|Phase 2|Withdrawal by Subject|1|||
126349603|NCT03126110|454572941|FG012|Phase 2|Withdrawal by Subject|3|||
126349604|NCT03126110|454572942|FG013|Phase 2|Withdrawal by Subject|3|||
126349605|NCT03126110|454572943|FG014|Phase 2|Withdrawal by Subject|2|||
126349606|NCT03126110|454572944|FG015|Phase 2|Withdrawal by Subject|1|||
126349607|NCT03126110|454572945|FG016|Phase 2|Withdrawal by Subject|0|||
126349608|NCT03126110|454572929|FG000|Phase 2|Lost to Follow-up|0|||
126349609|NCT03126110|454572930|FG001|Phase 2|Lost to Follow-up|0|||
126215954|NCT01892020|454079213|FG000|Period 2|Protocol Violation|1|||
126215955|NCT01892020|454079214|FG001|Period 2|Protocol Violation|0|||
126215956|NCT00402779|454079215|FG000|Overall Study|Screen Failure|77|||
126215957|NCT00402779|454079216|FG001|Overall Study|Screen Failure|76|||
126215958|NCT03107715|454079217|FG000|Overall Study|did not deliver at the home hospital|4|||
126215959|NCT03107715|454079218|FG001|Overall Study|did not deliver at the home hospital|6|||
126215960|NCT03107715|454079217|FG000|Overall Study|infant stillborn|0|||
126215961|NCT03107715|454079218|FG001|Overall Study|infant stillborn|1|||
126215962|NCT02149199|454079220|FG000|Overall Study|Study specific withdrawal criteria|4|||
126215963|NCT02149199|454079221|FG001|Overall Study|Study specific withdrawal criteria|21|||
126215964|NCT02149199|454079222|FG002|Overall Study|Study specific withdrawal criteria|6|||
126215965|NCT02149199|454079220|FG000|Overall Study|Other|20|||
126215966|NCT02149199|454079221|FG001|Overall Study|Other|25|||
126215967|NCT02149199|454079222|FG002|Overall Study|Other|20|||
126215968|NCT02149199|454079220|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
126215969|NCT02149199|454079221|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
126215970|NCT02149199|454079222|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
126215971|NCT02149199|454079220|FG000|Overall Study|Withdrawal by Subject|75|||
126215972|NCT02149199|454079221|FG001|Overall Study|Withdrawal by Subject|93|||
126215973|NCT02149199|454079222|FG002|Overall Study|Withdrawal by Subject|77|||
126215974|NCT02149199|454079220|FG000|Overall Study|Protocol Violation|16|||
126215975|NCT02149199|454079221|FG001|Overall Study|Protocol Violation|13|||
126215976|NCT02149199|454079222|FG002|Overall Study|Protocol Violation|15|||
126215977|NCT02149199|454079220|FG000|Overall Study|Lost to Follow-up|3|||
126215978|NCT02149199|454079221|FG001|Overall Study|Lost to Follow-up|12|||
126215979|NCT02149199|454079222|FG002|Overall Study|Lost to Follow-up|11|||
126013963|NCT02880241|453344375|FG000|Overall Study|Lack of Efficacy|1|||
126215980|NCT02149199|454079220|FG000|Overall Study|Death|0|||
126215981|NCT02149199|454079221|FG001|Overall Study|Death|0|||
126215982|NCT02149199|454079222|FG002|Overall Study|Death|1|||
126215983|NCT02149199|454079220|FG000|Overall Study|Adverse Event|6|||
126215984|NCT02149199|454079221|FG001|Overall Study|Adverse Event|15|||
126215985|NCT02149199|454079222|FG002|Overall Study|Adverse Event|9|||
126215986|NCT03252756|454079223|FG000|Overall Study|Protocol Violation|2|||
126215987|NCT03252756|454079224|FG001|Overall Study|Protocol Violation|4|||
126013964|NCT02880241|453344376|FG001|Overall Study|Lack of Efficacy|0|||
126013965|NCT02880241|453344377|FG002|Overall Study|Lack of Efficacy|0|||
126013966|NCT02880241|453344378|FG003|Overall Study|Lack of Efficacy|0|||
126013967|NCT02880241|453344379|FG004|Overall Study|Lack of Efficacy|0|||
126013968|NCT02880241|453344380|FG005|Overall Study|Lack of Efficacy|0|||
126013969|NCT02705586|453344382|FG000|Overall Study|Health Issues|2|||
126013970|NCT02705586|453344382|FG000|Overall Study|Transportation Difficulties|5|||
126013971|NCT02705586|453344382|FG000|Overall Study|Vacation/Planned Absence|1|||
126215988|NCT03252756|454079223|FG000|Overall Study|COVID-19 Pandemic|1|||
126215989|NCT03252756|454079224|FG001|Overall Study|COVID-19 Pandemic|1|||
126349610|NCT03126110|454572931|FG002|Phase 2|Lost to Follow-up|0|||
126349611|NCT03126110|454572932|FG003|Phase 2|Lost to Follow-up|0|||
126349612|NCT03126110|454572933|FG004|Phase 2|Lost to Follow-up|0|||
126349613|NCT03126110|454572934|FG005|Phase 2|Lost to Follow-up|0|||
126349614|NCT03126110|454572935|FG006|Phase 2|Lost to Follow-up|0|||
126349615|NCT03126110|454572936|FG007|Phase 2|Lost to Follow-up|0|||
126349616|NCT03126110|454572937|FG008|Phase 2|Lost to Follow-up|0|||
126349617|NCT03126110|454572938|FG009|Phase 2|Lost to Follow-up|0|||
126349618|NCT03126110|454572939|FG010|Phase 2|Lost to Follow-up|0|||
126349619|NCT03126110|454572940|FG011|Phase 2|Lost to Follow-up|1|||
126349620|NCT03126110|454572941|FG012|Phase 2|Lost to Follow-up|1|||
126349621|NCT03126110|454572942|FG013|Phase 2|Lost to Follow-up|1|||
126349622|NCT03126110|454572943|FG014|Phase 2|Lost to Follow-up|2|||
126349623|NCT03126110|454572944|FG015|Phase 2|Lost to Follow-up|0|||
126349624|NCT03126110|454572945|FG016|Phase 2|Lost to Follow-up|0|||
126349625|NCT03126110|454572929|FG000|Phase 2|Death|0|||
126349626|NCT03126110|454572930|FG001|Phase 2|Death|0|||
126349627|NCT03126110|454572931|FG002|Phase 2|Death|0|||
126349628|NCT03126110|454572932|FG003|Phase 2|Death|0|||
126349629|NCT03126110|454572933|FG004|Phase 2|Death|0|||
126349630|NCT03126110|454572934|FG005|Phase 2|Death|0|||
126349631|NCT03126110|454572935|FG006|Phase 2|Death|0|||
126349632|NCT03126110|454572936|FG007|Phase 2|Death|0|||
126349633|NCT03126110|454572937|FG008|Phase 2|Death|0|||
126349634|NCT03126110|454572938|FG009|Phase 2|Death|0|||
126349635|NCT03126110|454572939|FG010|Phase 2|Death|0|||
126349636|NCT03126110|454572940|FG011|Phase 2|Death|6|||
126349637|NCT03126110|454572941|FG012|Phase 2|Death|12|||
126349638|NCT03126110|454572942|FG013|Phase 2|Death|25|||
126349639|NCT03126110|454572943|FG014|Phase 2|Death|11|||
126349640|NCT03126110|454572944|FG015|Phase 2|Death|3|||
126349641|NCT03126110|454572945|FG016|Phase 2|Death|2|||
126349642|NCT03126110|454572929|FG000|Phase 2|Progressive Disease|0|||
126349643|NCT03126110|454572930|FG001|Phase 2|Progressive Disease|0|||
126349644|NCT03126110|454572931|FG002|Phase 2|Progressive Disease|0|||
126349645|NCT03126110|454572932|FG003|Phase 2|Progressive Disease|0|||
126349646|NCT03126110|454572933|FG004|Phase 2|Progressive Disease|0|||
126349647|NCT03126110|454572934|FG005|Phase 2|Progressive Disease|0|||
126349648|NCT03126110|454572935|FG006|Phase 2|Progressive Disease|0|||
126349649|NCT03126110|454572936|FG007|Phase 2|Progressive Disease|0|||
126349650|NCT03126110|454572937|FG008|Phase 2|Progressive Disease|0|||
126349651|NCT03126110|454572938|FG009|Phase 2|Progressive Disease|0|||
126349652|NCT03126110|454572939|FG010|Phase 2|Progressive Disease|0|||
126349653|NCT03126110|454572940|FG011|Phase 2|Progressive Disease|0|||
126349654|NCT03126110|454572941|FG012|Phase 2|Progressive Disease|0|||
126349655|NCT03126110|454572942|FG013|Phase 2|Progressive Disease|1|||
126349656|NCT03126110|454572943|FG014|Phase 2|Progressive Disease|0|||
126349657|NCT03126110|454572944|FG015|Phase 2|Progressive Disease|0|||
126349658|NCT03126110|454572945|FG016|Phase 2|Progressive Disease|0|||
126349659|NCT03126110|454572929|FG000|Phase 2|Started new treatment|0|||
126349660|NCT03126110|454572930|FG001|Phase 2|Started new treatment|0|||
126349661|NCT03126110|454572931|FG002|Phase 2|Started new treatment|0|||
126349662|NCT03126110|454572932|FG003|Phase 2|Started new treatment|0|||
126349663|NCT03126110|454572933|FG004|Phase 2|Started new treatment|0|||
126349664|NCT03126110|454572934|FG005|Phase 2|Started new treatment|0|||
126349665|NCT03126110|454572935|FG006|Phase 2|Started new treatment|0|||
126349666|NCT03126110|454572936|FG007|Phase 2|Started new treatment|0|||
126349667|NCT03126110|454572937|FG008|Phase 2|Started new treatment|0|||
126349668|NCT03126110|454572938|FG009|Phase 2|Started new treatment|0|||
126349669|NCT03126110|454572939|FG010|Phase 2|Started new treatment|0|||
126349670|NCT03126110|454572940|FG011|Phase 2|Started new treatment|0|||
126349671|NCT03126110|454572941|FG012|Phase 2|Started new treatment|0|||
126349672|NCT03126110|454572942|FG013|Phase 2|Started new treatment|0|||
126349673|NCT03126110|454572943|FG014|Phase 2|Started new treatment|1|||
126013972|NCT02194933|453344386|FG000|Overall Study|Lost to Follow-up|1|||
126349674|NCT03126110|454572944|FG015|Phase 2|Started new treatment|0|||
126349675|NCT03126110|454572945|FG016|Phase 2|Started new treatment|0|||
126349676|NCT04235374|454572946|FG000|Overall Study|Death|91|||
126349677|NCT04235374|454572947|FG001|Overall Study|Death|91|||
126349678|NCT04235374|454572946|FG000|Overall Study|Refused|2|||
126349679|NCT04235374|454572947|FG001|Overall Study|Refused|2|||
126349680|NCT04235374|454572946|FG000|Overall Study|Unavailable|12|||
126349681|NCT04235374|454572947|FG001|Overall Study|Unavailable|3|||
126349682|NCT04235374|454572946|FG000|Overall Study|Withdrawal by Subject|0|||
126349683|NCT04235374|454572947|FG001|Overall Study|Withdrawal by Subject|1|||
126215990|NCT03252756|454079223|FG000|Overall Study|Study Drug Expiration|0|||
126215991|NCT03252756|454079224|FG001|Overall Study|Study Drug Expiration|1|||
126215992|NCT01500434|454079227|FG000|Overall Study|Death|1|||
126215993|NCT01500434|454079227|FG000|Overall Study|Withdrawal by Subject|1|||
126215994|NCT01500434|454079227|FG000|Overall Study|Missed 12-month follow-up|5|||
126215995|NCT04881448|454079231|FG000|Overall Study|Study cancelled by sponsor|220|||
126215996|NCT04881448|454079231|FG000|Overall Study|Withdrawal by Subject|2|||
126215997|NCT04881448|454079231|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
126215998|NCT02662556|454079232|FG000|Overall Study|Adverse Event|4|||
126215999|NCT02662556|454079232|FG000|Overall Study|Lack of Efficacy|4|||
126216000|NCT00005879|454079237|FG000|Overall Study|Withdrawal by Subject|8|||
126216001|NCT00005879|454079238|FG001|Overall Study|Withdrawal by Subject|10|||
126216002|NCT05022121|454079242|FG000|Overall Study|Lack of Efficacy|1|||
126216003|NCT05022121|454079243|FG001|Overall Study|Lack of Efficacy|0|||
126216004|NCT05022121|454079242|FG000|Overall Study|Lost to Follow-up|0|||
126216005|NCT05022121|454079243|FG001|Overall Study|Lost to Follow-up|2|||
126216006|NCT02395536|454079248|FG000|Overall Study|Lost to Follow-up|4|||
126216007|NCT02395536|454079249|FG001|Overall Study|Lost to Follow-up|4|||
126216008|NCT02395536|454079248|FG000|Overall Study|Death|2|||
126216009|NCT02395536|454079249|FG001|Overall Study|Death|0|||
126216010|NCT02395536|454079248|FG000|Overall Study|Physician Decision|4|||
126216011|NCT02395536|454079249|FG001|Overall Study|Physician Decision|6|||
126216012|NCT02395536|454079248|FG000|Overall Study|Withdrawal by Subject|9|||
126216013|NCT02395536|454079249|FG001|Overall Study|Withdrawal by Subject|17|||
126216014|NCT02395536|454079248|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
126216015|NCT02395536|454079249|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
126216016|NCT02395536|454079248|FG000|Overall Study|Insurance issue|0|||
126216017|NCT02395536|454079249|FG001|Overall Study|Insurance issue|1|||
126216018|NCT00131937|454079250|FG000|Overall Study|Adverse Event|3|||
126216019|NCT00131937|454079250|FG000|Overall Study|Withdrawal by Subject|2|||
126216020|NCT00131937|454079250|FG000|Overall Study|Physician Decision|1|||
126216021|NCT00131937|454079250|FG000|Overall Study|Disease Progression|7|||
126216022|NCT00131937|454079250|FG000|Overall Study|Alternative therapy|1|||
126216023|NCT01640964|454079253|FG000|Overall Study|Lost to Follow-up|0|||
126216024|NCT01640964|454079254|FG001|Overall Study|Lost to Follow-up|0|||
126349684|NCT04235374|454572946|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
126349685|NCT04235374|454572947|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
126349686|NCT00088153|454572950|FG000|Overall Study|Physician Decision|3|||
126349687|NCT00088153|454572951|FG001|Overall Study|Physician Decision|3|||
126349688|NCT00088153|454572950|FG000|Overall Study|Withdrawal by Subject|10|||
126349689|NCT00088153|454572951|FG001|Overall Study|Withdrawal by Subject|10|||
126349690|NCT00088153|454572950|FG000|Overall Study|Lost to Follow-up|11|||
126349691|NCT00088153|454572951|FG001|Overall Study|Lost to Follow-up|12|||
126349692|NCT00976027|454572952|FG000|Overall Study|Serious Adverse Event|36|||
126349693|NCT00976027|454572953|FG001|Overall Study|Serious Adverse Event|17|||
126349694|NCT00976027|454572952|FG000|Overall Study|Adverse Event|0|||
126349695|NCT00976027|454572953|FG001|Overall Study|Adverse Event|2|||
126349696|NCT00976027|454572952|FG000|Overall Study|Protocol Violation|60|||
126349697|NCT00976027|454572953|FG001|Overall Study|Protocol Violation|27|||
126349698|NCT00976027|454572952|FG000|Overall Study|Lost to Follow-up|208|||
126349699|NCT00976027|454572953|FG001|Overall Study|Lost to Follow-up|103|||
126349700|NCT00976027|454572952|FG000|Overall Study|Withdrawal by Subject|107|||
126349701|NCT00976027|454572953|FG001|Overall Study|Withdrawal by Subject|66|||
126349702|NCT01771107|454572958|FG000|Overall Study|Adverse Event|1|||
126349703|NCT01771107|454572959|FG001|Overall Study|Adverse Event|3|||
126349704|NCT01771107|454572958|FG000|Overall Study|Withdrawal by Subject|0|||
126349705|NCT01771107|454572959|FG001|Overall Study|Withdrawal by Subject|2|||
126349706|NCT01771107|454572958|FG000|Overall Study|Lost to Follow-up|0|||
126349707|NCT01771107|454572959|FG001|Overall Study|Lost to Follow-up|1|||
126349708|NCT01771107|454572958|FG000|Overall Study|participant moved|0|||
126349709|NCT01771107|454572959|FG001|Overall Study|participant moved|1|||
126349710|NCT01771107|454572958|FG000|Overall Study|Other|0|||
126349711|NCT01771107|454572959|FG001|Overall Study|Other|1|||
126349712|NCT05168800|454572965|FG000|Time 1 Survey|Did not start T1 survey|182|||
126349713|NCT05168800|454572966|FG001|Time 1 Survey|Did not start T1 survey|150|||
126349714|NCT05168800|454572967|FG002|Time 1 Survey|Did not start T1 survey|140|||
126349715|NCT05168800|454572965|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
126349716|NCT05168800|454572966|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
126349717|NCT05168800|454572967|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
126349718|NCT05168800|454572965|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
126349719|NCT05168800|454572966|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
126349720|NCT05168800|454572967|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
126349721|NCT05168800|454572965|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
126349722|NCT05168800|454572966|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
126349723|NCT05168800|454572967|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
126349724|NCT05168800|454572965|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
126349725|NCT05168800|454572966|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
126349726|NCT05168800|454572967|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
126349727|NCT05168800|454572965|FG000|Time 1 Survey|Withdrawal by Subject|6|||
126349728|NCT05168800|454572966|FG001|Time 1 Survey|Withdrawal by Subject|3|||
126349729|NCT05168800|454572967|FG002|Time 1 Survey|Withdrawal by Subject|2|||
126216025|NCT01640964|454079255|FG002|Overall Study|Lost to Follow-up|1|||
126216026|NCT01640964|454079253|FG000|Overall Study|Protocol Deviation|1|||
126216027|NCT01640964|454079254|FG001|Overall Study|Protocol Deviation|1|||
126216028|NCT01640964|454079255|FG002|Overall Study|Protocol Deviation|2|||
126013973|NCT02194933|453344387|FG001|Overall Study|Lost to Follow-up|2|||
126013974|NCT02194933|453344386|FG000|Overall Study|Participant met withdrawal criteria|1|||
126013975|NCT02194933|453344387|FG001|Overall Study|Participant met withdrawal criteria|3|||
126013976|NCT02194933|453344386|FG000|Overall Study|Withdrawal by Subject|0|||
126013977|NCT02194933|453344387|FG001|Overall Study|Withdrawal by Subject|2|||
126013978|NCT02194933|453344386|FG000|Overall Study|Lack of Efficacy|1|||
126013979|NCT02194933|453344387|FG001|Overall Study|Lack of Efficacy|2|||
126013980|NCT02045836|453344391|FG000|Overall Study|Adverse Event|4|||
126013981|NCT02045836|453344392|FG001|Overall Study|Adverse Event|4|||
126013982|NCT02045836|453344391|FG000|Overall Study|Withdrawal by Subject|1|||
126013983|NCT02045836|453344392|FG001|Overall Study|Withdrawal by Subject|1|||
126013984|NCT02045836|453344391|FG000|Overall Study|Lost to Follow-up|4|||
126013985|NCT02045836|453344392|FG001|Overall Study|Lost to Follow-up|7|||
126013986|NCT02045836|453344391|FG000|Overall Study|Migrated from study area|0|||
126013987|NCT02045836|453344392|FG001|Overall Study|Migrated from study area|2|||
126013988|NCT03920215|453344396|FG000|Overall Study|Lost to Follow-up|1|||
126013989|NCT03920215|453344397|FG001|Overall Study|Lost to Follow-up|2|||
126013990|NCT03920215|453344398|FG002|Overall Study|Lost to Follow-up|0|||
126013991|NCT03920215|453344399|FG003|Overall Study|Lost to Follow-up|0|||
126013992|NCT03920215|453344396|FG000|Overall Study|Death|0|||
126013993|NCT03920215|453344397|FG001|Overall Study|Death|0|||
126216029|NCT02038959|454081140|FG000|Overall Study|Withdrawal by Subject|6|||
126216030|NCT02038959|454081141|FG001|Overall Study|Withdrawal by Subject|8|||
126216031|NCT01788163|454081149|FG000|Overall Study|Other|53|||
126216032|NCT01788163|454081150|FG001|Overall Study|Other|0|||
126013994|NCT03920215|453344398|FG002|Overall Study|Death|0|||
126216033|NCT01788163|454081151|FG002|Overall Study|Other|0|||
126216034|NCT01788163|454081152|FG003|Overall Study|Other|0|||
126216035|NCT01788163|454081153|FG004|Overall Study|Other|0|||
126216036|NCT01788163|454081154|FG005|Overall Study|Other|7|||
126013995|NCT03920215|453344399|FG003|Overall Study|Death|1|||
126216037|NCT01788163|454081155|FG006|Overall Study|Other|1|||
126216038|NCT01788163|454081156|FG007|Overall Study|Other|48|||
126013996|NCT02000817|453344400|FG000|Overall Study|Withdrawal by Subject|2|||
126013997|NCT02000817|453344401|FG001|Overall Study|Withdrawal by Subject|0|||
126013998|NCT02000817|453344402|FG002|Overall Study|Withdrawal by Subject|0|||
126013999|NCT02000817|453344403|FG003|Overall Study|Withdrawal by Subject|0|||
126014000|NCT02000817|453344400|FG000|Overall Study|Adverse Event|0|||
126014001|NCT02000817|453344401|FG001|Overall Study|Adverse Event|1|||
126014002|NCT02000817|453344402|FG002|Overall Study|Adverse Event|0|||
126014003|NCT02000817|453344403|FG003|Overall Study|Adverse Event|0|||
126014004|NCT02000817|453344400|FG000|Overall Study|Lost to Follow-up|0|||
126014005|NCT02000817|453344401|FG001|Overall Study|Lost to Follow-up|0|||
126014006|NCT02000817|453344402|FG002|Overall Study|Lost to Follow-up|1|||
126014007|NCT02000817|453344403|FG003|Overall Study|Lost to Follow-up|0|||
126014008|NCT00177216|453344406|FG000|Overall Study|Withdrawal by Subject|6|||
126014009|NCT00177216|453344407|FG001|Overall Study|Withdrawal by Subject|3|||
126014010|NCT00177216|453344408|FG002|Overall Study|Withdrawal by Subject|1|||
126014011|NCT03383146|453344413|FG000|Overall Study|Screen Failure|1|||
126014012|NCT03383146|453344414|FG001|Overall Study|Screen Failure|0|||
126014013|NCT03383146|453344413|FG000|Overall Study|Adverse Event|6|||
126014014|NCT03383146|453344414|FG001|Overall Study|Adverse Event|18|||
126014015|NCT03383146|453344413|FG000|Overall Study|Lack of Efficacy|0|||
126014016|NCT03383146|453344414|FG001|Overall Study|Lack of Efficacy|3|||
126014017|NCT03383146|453344413|FG000|Overall Study|Withdrawal by Subject|20|||
126014018|NCT03383146|453344414|FG001|Overall Study|Withdrawal by Subject|36|||
126014019|NCT03383146|453344413|FG000|Overall Study|Lost to Follow-up|5|||
126014020|NCT03383146|453344414|FG001|Overall Study|Lost to Follow-up|15|||
126014021|NCT03383146|453344413|FG000|Overall Study|Death|0|||
126014022|NCT03383146|453344414|FG001|Overall Study|Death|2|||
126014023|NCT03383146|453344413|FG000|Overall Study|Physician Decision|0|||
126014024|NCT03383146|453344414|FG001|Overall Study|Physician Decision|1|||
126014025|NCT03383146|453344413|FG000|Overall Study|Protocol Deviation|1|||
126014026|NCT03383146|453344414|FG001|Overall Study|Protocol Deviation|8|||
126014027|NCT03383146|453344413|FG000|Overall Study|Study Terminated by the Sponsor|48|||
126014028|NCT03383146|453344414|FG001|Overall Study|Study Terminated by the Sponsor|95|||
126014029|NCT03383146|453344413|FG000|Overall Study|Reason not Specified|4|||
126014030|NCT03383146|453344414|FG001|Overall Study|Reason not Specified|6|||
126014031|NCT02739035|453344419|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
126014032|NCT02739035|453344420|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
126014033|NCT02739035|453344419|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
126014034|NCT02739035|453344420|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
126014035|NCT02739035|453344419|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
126014036|NCT02739035|453344420|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
126014037|NCT02739035|453344419|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
126014038|NCT02739035|453344420|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
126216039|NCT01788163|454081157|FG008|Overall Study|Other|15|||
126216040|NCT01788163|454081149|FG000|Overall Study|Withdrawal by Subject|2|||
126216041|NCT01788163|454081150|FG001|Overall Study|Withdrawal by Subject|0|||
126349730|NCT05168800|454572965|FG000|Time 2 Survey|Already excluded at Time 1|228|||
126349731|NCT05168800|454572966|FG001|Time 2 Survey|Already excluded at Time 1|202|||
126349732|NCT05168800|454572967|FG002|Time 2 Survey|Already excluded at Time 1|173|||
126349733|NCT05168800|454572965|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
126349734|NCT05168800|454572966|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
126349735|NCT05168800|454572967|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
126349736|NCT05168800|454572965|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
126349737|NCT05168800|454572966|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
126349738|NCT05168800|454572967|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
126349739|NCT05168800|454572965|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
126349740|NCT05168800|454572966|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
126349741|NCT05168800|454572967|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
126349742|NCT05168800|454572965|FG000|Time 2 Survey|Withdrawal by Subject|1|||
126349743|NCT05168800|454572966|FG001|Time 2 Survey|Withdrawal by Subject|0|||
126349744|NCT05168800|454572967|FG002|Time 2 Survey|Withdrawal by Subject|1|||
126349745|NCT05168800|454572965|FG000|Time 3 Survey|Already excluded at Time 1|228|||
126349746|NCT05168800|454572966|FG001|Time 3 Survey|Already excluded at Time 1|200|||
126349747|NCT05168800|454572967|FG002|Time 3 Survey|Already excluded at Time 1|173|||
126349748|NCT05168800|454572965|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
126349749|NCT05168800|454572966|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
126349750|NCT05168800|454572967|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
126349751|NCT05168800|454572965|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
126349752|NCT05168800|454572966|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
126349753|NCT05168800|454572967|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
126349754|NCT05168800|454572965|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
126349755|NCT05168800|454572966|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
126349756|NCT05168800|454572967|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
126014039|NCT03210402|453344421|FG000|Overall Study|Withdrawal by Subject|0|||
126014040|NCT03210402|453344422|FG001|Overall Study|Withdrawal by Subject|1|||
126014041|NCT02517307|453344425|FG000|Overall Study|Withdrawal by Subject|1|||
126014042|NCT02517307|453344426|FG001|Overall Study|Withdrawal by Subject|0|||
126014043|NCT02517307|453344427|FG002|Overall Study|Withdrawal by Subject|1|||
126014044|NCT02517307|453344428|FG003|Overall Study|Withdrawal by Subject|0|||
126014045|NCT02517307|453344425|FG000|Overall Study|Protocol Violation|0|||
126014046|NCT02517307|453344426|FG001|Overall Study|Protocol Violation|0|||
126349757|NCT03240874|454572968|FG000|Overall Study|Lost to Follow-up|0|||
126216042|NCT01788163|454081151|FG002|Overall Study|Withdrawal by Subject|0|||
126216043|NCT01788163|454081152|FG003|Overall Study|Withdrawal by Subject|0|||
126216044|NCT01788163|454081153|FG004|Overall Study|Withdrawal by Subject|0|||
126216045|NCT01788163|454081154|FG005|Overall Study|Withdrawal by Subject|0|||
126216046|NCT01788163|454081155|FG006|Overall Study|Withdrawal by Subject|0|||
126216047|NCT01788163|454081156|FG007|Overall Study|Withdrawal by Subject|0|||
126216048|NCT01788163|454081157|FG008|Overall Study|Withdrawal by Subject|1|||
126216049|NCT00545441|454081158|FG000|Overall Study|Fistula draining at 6 months|2|||
126216050|NCT00545441|454081159|FG001|Overall Study|Fistula draining at 6 months|4|||
126216051|NCT00545441|454081158|FG000|Overall Study|Lost to Follow-up|9|||
126216052|NCT00545441|454081159|FG001|Overall Study|Lost to Follow-up|5|||
126216053|NCT00545441|454081158|FG000|Overall Study|Technical failure|0|||
126216054|NCT00545441|454081159|FG001|Overall Study|Technical failure|1|||
126216055|NCT00545441|454081158|FG000|Overall Study|Withdrawal by Subject|1|||
126216056|NCT00545441|454081159|FG001|Overall Study|Withdrawal by Subject|1|||
126216057|NCT00545441|454081158|FG000|Overall Study|Persistence or recurrence of fistula|5|||
126216058|NCT00545441|454081159|FG001|Overall Study|Persistence or recurrence of fistula|2|||
126216059|NCT00545441|454081158|FG000|Overall Study|Patients were not treated|1|||
126216060|NCT00545441|454081159|FG001|Overall Study|Patients were not treated|3|||
126216061|NCT00265239|454081160|FG000|Overall Study|Adverse Event|2|||
126216062|NCT00265239|454081161|FG001|Overall Study|Adverse Event|1|||
126216063|NCT02803138|454081166|FG000|Overall Study|Failure to return|38|||
126216064|NCT02803138|454081166|FG000|Overall Study|Insufficient virological response|2|||
126216065|NCT02803138|454081166|FG000|Overall Study|Withdrawn consent|1|||
126216066|NCT02803138|454081166|FG000|Overall Study|Death|1|||
126349758|NCT03240874|454572969|FG001|Overall Study|Lost to Follow-up|2|||
126349759|NCT03240874|454572970|FG002|Overall Study|Lost to Follow-up|4|||
126349760|NCT03240874|454572971|FG003|Overall Study|Lost to Follow-up|1|||
126349761|NCT04958707|454572972|FG000|Post Intervention|Withdrawal by Subject|1|||
126349762|NCT04958707|454572973|FG001|Post Intervention|Withdrawal by Subject|0|||
126349763|NCT04958707|454572974|FG002|Post Intervention|Withdrawal by Subject|0|||
126349764|NCT04958707|454572972|FG000|3 Months Follow- up|Lost to Follow-up|0|||
126349765|NCT04958707|454572973|FG001|3 Months Follow- up|Lost to Follow-up|3|||
126349766|NCT04958707|454572974|FG002|3 Months Follow- up|Lost to Follow-up|0|||
126349767|NCT04958707|454572972|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
126349768|NCT04958707|454572973|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
126349769|NCT04958707|454572974|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
126349770|NCT00569127|454572975|FG000|Overall Study|Adverse Event|57|||
126349771|NCT00569127|454572976|FG001|Overall Study|Adverse Event|47|||
126349772|NCT00569127|454572975|FG000|Overall Study|Withdrawal by Subject|13|||
126349773|NCT00569127|454572976|FG001|Overall Study|Withdrawal by Subject|27|||
126349774|NCT00569127|454572975|FG000|Overall Study|Progression|99|||
126349775|NCT00569127|454572976|FG001|Overall Study|Progression|100|||
126349776|NCT00569127|454572975|FG000|Overall Study|Death|4|||
126349777|NCT00569127|454572976|FG001|Overall Study|Death|3|||
126349778|NCT00569127|454572975|FG000|Overall Study|Other|20|||
126349779|NCT00569127|454572976|FG001|Overall Study|Other|19|||
126349780|NCT00569127|454572975|FG000|Overall Study|Lost to Follow-up|0|||
126349781|NCT00569127|454572976|FG001|Overall Study|Lost to Follow-up|3|||
126349782|NCT00569127|454572975|FG000|Overall Study|Not Eligible|14|||
126349783|NCT00569127|454572976|FG001|Overall Study|Not Eligible|11|||
126349784|NCT00569127|454572975|FG000|Overall Study|Still on Treatment|7|||
126349785|NCT00569127|454572976|FG001|Overall Study|Still on Treatment|3|||
126349786|NCT04279522|454572978|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
126349787|NCT04279522|454572979|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
126349788|NCT04279522|454572978|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
126349789|NCT04279522|454572979|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
126349790|NCT04279522|454572978|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
126349791|NCT04279522|454572979|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
126349792|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
126349793|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
126349794|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
126349795|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
126349796|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Physician Decision|0|||
126349797|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Physician Decision|3|||
126216067|NCT02803138|454081166|FG000|Overall Study|Other, not specified|28|||
126216068|NCT00424515|454081167|FG000|Overall Study|Progressive Disease|10|||
126216069|NCT00424515|454081168|FG001|Overall Study|Progressive Disease|11|||
126216070|NCT00424515|454081167|FG000|Overall Study|Adverse Event|0|||
126349798|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Adverse Event|0|||
126349799|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Adverse Event|1|||
126349800|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
126349801|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
126216071|NCT00424515|454081168|FG001|Overall Study|Adverse Event|1|||
126216072|NCT00424515|454081167|FG000|Overall Study|Intercurrent Illness|0|||
126349802|NCT02629159|454572982|FG000|Overall Study|Adverse Event|17|||
126216073|NCT00424515|454081168|FG001|Overall Study|Intercurrent Illness|1|||
126216074|NCT00424515|454081167|FG000|Overall Study|Withdrawal by Subject|1|||
126216075|NCT00424515|454081168|FG001|Overall Study|Withdrawal by Subject|0|||
126216076|NCT00267020|454081169|FG000|Overall Study|Adverse Event|22|||
126216077|NCT00267020|454081170|FG001|Overall Study|Adverse Event|5|||
126216078|NCT00267020|454081169|FG000|Overall Study|Death|2|||
126216079|NCT00267020|454081170|FG001|Overall Study|Death|1|||
126216080|NCT00267020|454081169|FG000|Overall Study|Withdrawal by Subject|17|||
126216081|NCT00267020|454081170|FG001|Overall Study|Withdrawal by Subject|7|||
126216082|NCT00267020|454081169|FG000|Overall Study|Physician Decision|3|||
126216083|NCT00267020|454081170|FG001|Overall Study|Physician Decision|2|||
126216084|NCT00267020|454081169|FG000|Overall Study|Disease Progression|39|||
126216085|NCT00267020|454081170|FG001|Overall Study|Disease Progression|25|||
126216086|NCT00267020|454081169|FG000|Overall Study|Unrelated Complication|1|||
126216087|NCT00267020|454081170|FG001|Overall Study|Unrelated Complication|1|||
126216088|NCT00267020|454081169|FG000|Overall Study|Sponsor Request|1|||
126216089|NCT00267020|454081170|FG001|Overall Study|Sponsor Request|0|||
126216090|NCT00267020|454081169|FG000|Overall Study|Other|1|||
126216091|NCT00267020|454081170|FG001|Overall Study|Other|2|||
126014047|NCT02517307|453344427|FG002|Overall Study|Protocol Violation|1|||
126014048|NCT02517307|453344428|FG003|Overall Study|Protocol Violation|1|||
126014049|NCT00823979|453344429|FG000|Overall Study|Lack of Efficacy|13|||
126014050|NCT00823979|453344430|FG001|Overall Study|Lack of Efficacy|16|||
126014051|NCT00823979|453344431|FG002|Overall Study|Lack of Efficacy|9|||
126014052|NCT00823979|453344429|FG000|Overall Study|Lost to Follow-up|2|||
126014053|NCT00823979|453344430|FG001|Overall Study|Lost to Follow-up|1|||
126014054|NCT00823979|453344431|FG002|Overall Study|Lost to Follow-up|0|||
126014055|NCT00823979|453344429|FG000|Overall Study|Withdrawal by Subject|2|||
126014056|NCT00823979|453344430|FG001|Overall Study|Withdrawal by Subject|3|||
126014057|NCT00823979|453344431|FG002|Overall Study|Withdrawal by Subject|2|||
126014058|NCT00823979|453344429|FG000|Overall Study|Protocol Violation|1|||
126216092|NCT04071366|454081171|FG000|Part 1: Open-label (29 Days)|Death|4|||
126216093|NCT04071366|454081172|FG001|Part 1: Open-label (29 Days)|Death|2|||
126216094|NCT04071366|454081173|FG002|Part 1: Open-label (29 Days)|Death|8|||
126216095|NCT04071366|454081174|FG003|Part 1: Open-label (29 Days)|Death|0|||
126216096|NCT04071366|454081175|FG004|Part 1: Open-label (29 Days)|Death|0|||
126216097|NCT04071366|454081171|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
126216098|NCT04071366|454081172|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
126216099|NCT04071366|454081173|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
126216100|NCT04071366|454081174|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
126014059|NCT00823979|453344430|FG001|Overall Study|Protocol Violation|1|||
126014060|NCT00823979|453344431|FG002|Overall Study|Protocol Violation|0|||
126014061|NCT00823979|453344429|FG000|Overall Study|Pregnancy|0|||
126014062|NCT00823979|453344430|FG001|Overall Study|Pregnancy|1|||
126014063|NCT00823979|453344431|FG002|Overall Study|Pregnancy|0|||
126014064|NCT00823979|453344429|FG000|Overall Study|Adverse Event|0|||
126014065|NCT00823979|453344430|FG001|Overall Study|Adverse Event|2|||
126014066|NCT00823979|453344431|FG002|Overall Study|Adverse Event|4|||
126014067|NCT00823979|453344429|FG000|Overall Study|Other|2|||
126014068|NCT00823979|453344430|FG001|Overall Study|Other|0|||
126014069|NCT00823979|453344431|FG002|Overall Study|Other|1|||
126014070|NCT00823979|453344429|FG000|Overall Study|Randomized but not Treated|4|||
126014071|NCT00823979|453344430|FG001|Overall Study|Randomized but not Treated|3|||
126014072|NCT00823979|453344431|FG002|Overall Study|Randomized but not Treated|1|||
126014073|NCT00823979|453344429|FG000|Overall Study|Study Terminated by Sponsor|5|||
126014074|NCT00823979|453344430|FG001|Overall Study|Study Terminated by Sponsor|5|||
126014075|NCT00823979|453344431|FG002|Overall Study|Study Terminated by Sponsor|7|||
126216101|NCT04071366|454081175|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
126216102|NCT04071366|454081171|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
126216103|NCT04071366|454081172|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
126216104|NCT04071366|454081173|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
126014076|NCT03586544|453344432|FG000|First Intervention|Adverse Event|0|||
126014077|NCT03586544|453344433|FG001|First Intervention|Adverse Event|1|||
126014078|NCT03586544|453344432|FG000|Second Intervention|Withdrawal by Subject|0|||
126014079|NCT03586544|453344433|FG001|Second Intervention|Withdrawal by Subject|1|||
126014080|NCT03523091|453344434|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
126014081|NCT03523091|453344435|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
126014082|NCT03523091|453344434|FG000|Overall Study|Withdrawal by Subject|0|||
126014083|NCT03523091|453344435|FG001|Overall Study|Withdrawal by Subject|3|||
126216105|NCT04071366|454081174|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
126216106|NCT04071366|454081175|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
126216107|NCT04071366|454081171|FG000|Part 2: Randomized (29 Days)|Death|0|||
126216108|NCT04071366|454081172|FG001|Part 2: Randomized (29 Days)|Death|0|||
126216109|NCT04071366|454081173|FG002|Part 2: Randomized (29 Days)|Death|0|||
126014084|NCT03523091|453344434|FG000|Overall Study|Increase Botox dose|0|||
126014085|NCT03523091|453344435|FG001|Overall Study|Increase Botox dose|1|||
126014086|NCT03863834|453344441|FG000|Overall Study|Lost to Follow-up|3|||
126014087|NCT02685488|453344442|FG000|Overall Study|Withdrawal by Subject|0|||
126014088|NCT02685488|453344443|FG001|Overall Study|Withdrawal by Subject|1|||
126014089|NCT00324038|453344444|FG000|Overall Study|Adverse Event|38|||
126014090|NCT00324038|453344445|FG001|Overall Study|Adverse Event|23|||
126014091|NCT00324038|453344444|FG000|Overall Study|Lack of Efficacy|5|||
126014092|NCT00324038|453344445|FG001|Overall Study|Lack of Efficacy|13|||
126014093|NCT00324038|453344444|FG000|Overall Study|Lost to Follow-up|0|||
126014094|NCT00324038|453344445|FG001|Overall Study|Lost to Follow-up|2|||
126014095|NCT00324038|453344444|FG000|Overall Study|Other|6|||
126014096|NCT00324038|453344445|FG001|Overall Study|Other|13|||
126014097|NCT02770248|453344446|FG000|Overall Study|Adverse Event|0|||
126014098|NCT02770248|453344447|FG001|Overall Study|Adverse Event|1|||
126014099|NCT02770248|453344446|FG000|Overall Study|Randomized in error, prior to treatment|0|||
126014100|NCT02770248|453344447|FG001|Overall Study|Randomized in error, prior to treatment|1|||
126014101|NCT03768206|453344450|FG000|Overall Study|Lost to Follow-up|2|||
126014102|NCT03768206|453344451|FG001|Overall Study|Lost to Follow-up|1|||
126014103|NCT03768206|453344450|FG000|Overall Study|Withdrawal by Subject|0|||
126014104|NCT03768206|453344451|FG001|Overall Study|Withdrawal by Subject|1|||
126014105|NCT04493242|453344452|FG000|Overall Study|Death|10|||
126014106|NCT04493242|453344453|FG001|Overall Study|Death|14|||
126014107|NCT04493242|453344454|FG002|Overall Study|Death|16|||
126014108|NCT04493242|453344452|FG000|Overall Study|Lost to Follow-up|1|||
126014109|NCT04493242|453344453|FG001|Overall Study|Lost to Follow-up|1|||
126014110|NCT04493242|453344454|FG002|Overall Study|Lost to Follow-up|0|||
126014111|NCT04493242|453344452|FG000|Overall Study|Withdrawal by Subject|1|||
126014112|NCT04493242|453344453|FG001|Overall Study|Withdrawal by Subject|0|||
126014113|NCT04493242|453344454|FG002|Overall Study|Withdrawal by Subject|0|||
126349803|NCT02629159|454572983|FG001|Overall Study|Adverse Event|20|||
126349804|NCT02629159|454572984|FG002|Overall Study|Adverse Event|22|||
126349805|NCT02629159|454572982|FG000|Overall Study|Withdrawal by Subject|22|||
126349806|NCT02629159|454572983|FG001|Overall Study|Withdrawal by Subject|11|||
126349807|NCT02629159|454572984|FG002|Overall Study|Withdrawal by Subject|15|||
126349808|NCT02629159|454572982|FG000|Overall Study|Lost to Follow-up|7|||
126349809|NCT02629159|454572983|FG001|Overall Study|Lost to Follow-up|4|||
126349810|NCT02629159|454572984|FG002|Overall Study|Lost to Follow-up|5|||
126349811|NCT02629159|454572982|FG000|Overall Study|Lack of Efficacy|4|||
126349812|NCT02629159|454572983|FG001|Overall Study|Lack of Efficacy|0|||
126349813|NCT02629159|454572984|FG002|Overall Study|Lack of Efficacy|1|||
126349814|NCT02629159|454572982|FG000|Overall Study|Other|6|||
126349815|NCT02629159|454572983|FG001|Overall Study|Other|4|||
126349816|NCT02629159|454572984|FG002|Overall Study|Other|8|||
126349817|NCT03036254|454572989|FG000|Overall Study|Adverse Event|6|||
126349818|NCT03036254|454572990|FG001|Overall Study|Adverse Event|4|||
126349819|NCT03036254|454572989|FG000|Overall Study|Death|3|||
126349820|NCT03036254|454572990|FG001|Overall Study|Death|1|||
126349821|NCT03036254|454572989|FG000|Overall Study|Lack of Efficacy|5|||
126349822|NCT03036254|454572990|FG001|Overall Study|Lack of Efficacy|1|||
126349823|NCT03036254|454572989|FG000|Overall Study|Withdrawal by Subject|3|||
126349824|NCT03036254|454572990|FG001|Overall Study|Withdrawal by Subject|5|||
126349825|NCT04717557|454572999|FG000|Overall Study|Withdrawal by Subject|2|||
126349826|NCT04717557|454573000|FG001|Overall Study|Withdrawal by Subject|0|||
126349827|NCT04717557|454572999|FG000|Overall Study|Death|1|||
126349828|NCT04717557|454573000|FG001|Overall Study|Death|0|||
126349829|NCT05352399|454573002|FG000|Overall Study|Discontinued intervention|6|||
126349830|NCT01802281|454573005|FG000|Overall Study|Death|1|||
126349831|NCT01802281|454573006|FG001|Overall Study|Death|2|||
126349832|NCT01802281|454573005|FG000|Overall Study|Withdrawal by Subject|2|||
126349833|NCT01802281|454573006|FG001|Overall Study|Withdrawal by Subject|1|||
126349834|NCT01802281|454573005|FG000|Overall Study|Ineligible|5|||
126349835|NCT01802281|454573006|FG001|Overall Study|Ineligible|3|||
126349836|NCT02685735|454573007|FG000|Overall Study|Surgery Cancelled|4|||
126349837|NCT02685735|454573008|FG001|Overall Study|Surgery Cancelled|9|||
126349838|NCT02685735|454573007|FG000|Overall Study|Adverse Event|10|||
126349839|NCT02685735|454573008|FG001|Overall Study|Adverse Event|3|||
126349840|NCT02685735|454573007|FG000|Overall Study|Preop testing found to be incomplete|2|||
126349841|NCT02685735|454573008|FG001|Overall Study|Preop testing found to be incomplete|2|||
126349842|NCT02685735|454573007|FG000|Overall Study|Withdrawal by Subject|1|||
126349843|NCT02685735|454573008|FG001|Overall Study|Withdrawal by Subject|2|||
126349844|NCT02685735|454573007|FG000|Overall Study|Death|1|||
126349845|NCT02685735|454573008|FG001|Overall Study|Death|0|||
126349846|NCT00927472|454573018|FG000|Overall Study|Withdrawal by Subject|10|||
126349847|NCT00927472|454573019|FG001|Overall Study|Withdrawal by Subject|11|||
126349848|NCT00927472|454573018|FG000|Overall Study|Lost to Follow-up|1|||
126349849|NCT00927472|454573019|FG001|Overall Study|Lost to Follow-up|6|||
126349850|NCT00927472|454573018|FG000|Overall Study|Protocol Violation|0|||
126349851|NCT00927472|454573019|FG001|Overall Study|Protocol Violation|1|||
126349852|NCT00927472|454573018|FG000|Overall Study|Post treatment Assessment out of window|0|||
126014114|NCT04493242|453344452|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
126014115|NCT04493242|453344453|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
126014116|NCT04493242|453344454|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
126014117|NCT04493242|453344452|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
126014118|NCT04493242|453344453|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
126014119|NCT04493242|453344454|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
126014120|NCT02812966|453344457|FG000|Overall Study|Death|1|||
126014121|NCT02812966|453344458|FG001|Overall Study|Death|0|||
126014122|NCT04517864|453346360|FG000|Placebo-Controlled Phase|Adverse Event|1|||
126216110|NCT04071366|454081174|FG003|Part 2: Randomized (29 Days)|Death|2|||
126216111|NCT04071366|454081175|FG004|Part 2: Randomized (29 Days)|Death|2|||
126216112|NCT04071366|454081171|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
126216113|NCT04071366|454081172|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
126216114|NCT04071366|454081173|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
126216115|NCT04071366|454081174|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
126216116|NCT04071366|454081175|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
126216117|NCT04071366|454081171|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
126216118|NCT04071366|454081172|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
126216119|NCT04071366|454081173|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
126216120|NCT04071366|454081174|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
126216121|NCT04071366|454081175|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
126216122|NCT04071366|454081171|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
126216123|NCT04071366|454081172|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
126216124|NCT04071366|454081173|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
126216125|NCT04071366|454081174|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
126216126|NCT04071366|454081175|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
126216127|NCT04071366|454081171|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
126216128|NCT04071366|454081172|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
126216129|NCT04071366|454081173|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
126216130|NCT04071366|454081174|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
126216131|NCT04071366|454081175|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
126216132|NCT04071366|454081171|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
126216133|NCT04071366|454081172|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
126216134|NCT04071366|454081173|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
126216135|NCT04071366|454081174|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
126216136|NCT04071366|454081175|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
126216137|NCT04071366|454081171|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
126216138|NCT04071366|454081172|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
126216139|NCT04071366|454081173|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
126216140|NCT04071366|454081174|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
126216141|NCT04071366|454081175|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
126216142|NCT00021229|454081176|FG000|Overall Study|Adverse Event|10|||
126216143|NCT00021229|454081177|FG001|Overall Study|Adverse Event|5|||
126216144|NCT00021229|454081178|FG002|Overall Study|Adverse Event|2|||
126216145|NCT00021229|454081176|FG000|Overall Study|Death|0|||
126216146|NCT00021229|454081177|FG001|Overall Study|Death|1|||
126216147|NCT00021229|454081178|FG002|Overall Study|Death|0|||
126216148|NCT00021229|454081176|FG000|Overall Study|Withdrawal by Subject|7|||
126216149|NCT00021229|454081177|FG001|Overall Study|Withdrawal by Subject|7|||
126216150|NCT00021229|454081178|FG002|Overall Study|Withdrawal by Subject|1|||
126216151|NCT00021229|454081176|FG000|Overall Study|Progressive Disease|15|||
126216152|NCT00021229|454081177|FG001|Overall Study|Progressive Disease|19|||
126216153|NCT00021229|454081178|FG002|Overall Study|Progressive Disease|12|||
126216154|NCT00021229|454081176|FG000|Overall Study|Protocol Violation|1|||
126216155|NCT00021229|454081177|FG001|Overall Study|Protocol Violation|1|||
126216156|NCT00021229|454081178|FG002|Overall Study|Protocol Violation|0|||
126216157|NCT00021229|454081176|FG000|Overall Study|Physician Decision|0|||
126216158|NCT00021229|454081177|FG001|Overall Study|Physician Decision|0|||
126216159|NCT00021229|454081178|FG002|Overall Study|Physician Decision|1|||
126216160|NCT00021229|454081176|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
126216161|NCT00021229|454081177|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
126216162|NCT00021229|454081178|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
126216163|NCT02156466|454081179|FG000|Overall Study|Adverse Event|0|||
126216164|NCT02156466|454081180|FG001|Overall Study|Adverse Event|0|||
126216165|NCT02156466|454081181|FG002|Overall Study|Adverse Event|1|||
126216166|NCT02156466|454081182|FG003|Overall Study|Adverse Event|1|||
126216167|NCT02156466|454081183|FG004|Overall Study|Adverse Event|0|||
126216168|NCT02156466|454081179|FG000|Overall Study|Quantiferon Positivity|0|||
126216169|NCT02156466|454081180|FG001|Overall Study|Quantiferon Positivity|0|||
126014123|NCT04517864|453346361|FG001|Placebo-Controlled Phase|Adverse Event|0|||
126216170|NCT02156466|454081181|FG002|Overall Study|Quantiferon Positivity|0|||
126216171|NCT02156466|454081182|FG003|Overall Study|Quantiferon Positivity|1|||
126216172|NCT02156466|454081183|FG004|Overall Study|Quantiferon Positivity|0|||
126216173|NCT02237118|454081184|FG000|Overall Study|Protocol Violation|0|||
126216174|NCT02237118|454081185|FG001|Overall Study|Protocol Violation|1|||
126216175|NCT02237118|454081184|FG000|Overall Study|consent withdrawn|1|||
126216176|NCT02237118|454081185|FG001|Overall Study|consent withdrawn|0|||
126216177|NCT00902265|454081186|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
126216178|NCT00902265|454081186|FG000|Overall Study|Adverse Event|2|||
126216179|NCT00902265|454081186|FG000|Overall Study|Lack of Efficacy|2|||
126216180|NCT00902265|454081186|FG000|Overall Study|Protocol Violation|1|||
126216181|NCT04701658|454081187|FG000|Overall Study|Lost to Follow-up|6|||
126216182|NCT01523301|454081188|FG000|Overall Study|Adverse Event|25|||
126216183|NCT01523301|454081189|FG001|Overall Study|Adverse Event|16|||
126216184|NCT01523301|454081188|FG000|Overall Study|Lack of Efficacy|0|||
126216185|NCT01523301|454081189|FG001|Overall Study|Lack of Efficacy|2|||
126216186|NCT01523301|454081188|FG000|Overall Study|Protocol Violation|3|||
126216187|NCT01523301|454081189|FG001|Overall Study|Protocol Violation|4|||
126216188|NCT01523301|454081188|FG000|Overall Study|Lost to Follow-up|1|||
126216189|NCT01523301|454081189|FG001|Overall Study|Lost to Follow-up|0|||
126216190|NCT01523301|454081188|FG000|Overall Study|Withdrawal by Subject|6|||
126216191|NCT01523301|454081189|FG001|Overall Study|Withdrawal by Subject|8|||
126216192|NCT01523301|454081188|FG000|Overall Study|Other Reason|0|||
126216193|NCT01523301|454081189|FG001|Overall Study|Other Reason|2|||
126216194|NCT01447628|454081192|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
126216195|NCT01447628|454081193|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
126216196|NCT01447628|454081194|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
126216197|NCT01447628|454081195|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
126216198|NCT00185731|454081196|FG000|Overall Study|Withdrawal by Subject|1|||
126216199|NCT00185731|454081196|FG000|Overall Study|Not Eligible|1|||
126216200|NCT03087773|454081197|FG000|Overall Study|Withdrawal by Subject|8|||
126216201|NCT03087773|454081198|FG001|Overall Study|Withdrawal by Subject|4|||
126216202|NCT03087773|454081197|FG000|Overall Study|Lost to Follow-up|12|||
126216203|NCT03087773|454081198|FG001|Overall Study|Lost to Follow-up|8|||
126216204|NCT00943384|454081203|FG000|Overall Study|Dispositioned prior to treatment|23|||
126216205|NCT00943384|454081203|FG000|Overall Study|Treated off protocol-protocol violation|5|||
126216206|NCT00943384|454081203|FG000|Overall Study|Lost to Follow-up|16|||
126216207|NCT00943384|454081203|FG000|Overall Study|Withdrawal by Subject|5|||
126216208|NCT02180659|454081204|FG000|Overall Study|Adverse Event|1|||
126216209|NCT02180659|454081205|FG001|Overall Study|Adverse Event|0|||
126216210|NCT02180659|454081204|FG000|Overall Study|Lost to Follow-up|4|||
126216211|NCT02180659|454081205|FG001|Overall Study|Lost to Follow-up|2|||
126216212|NCT02180659|454081204|FG000|Overall Study|Subject incarcerated during conduct|1|||
126216213|NCT02180659|454081205|FG001|Overall Study|Subject incarcerated during conduct|0|||
126216214|NCT02180659|454081204|FG000|Overall Study|Withdrawal by Subject|0|||
126216215|NCT02180659|454081205|FG001|Overall Study|Withdrawal by Subject|2|||
126216216|NCT02180659|454081204|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
126216217|NCT02180659|454081205|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
126216218|NCT00481871|454081208|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
126216219|NCT00481871|454081209|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
126216220|NCT00481871|454081210|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
126216221|NCT00481871|454081211|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
126216222|NCT00481871|454081212|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
126216223|NCT03151707|454081213|FG000|Overall Study|Lost to Follow-up|6|||
126216224|NCT01308762|454081214|FG000|Overall Study|Protocol Violation|0|||
126216225|NCT01308762|454081215|FG001|Overall Study|Protocol Violation|1|||
126216226|NCT01308762|454081216|FG002|Overall Study|Protocol Violation|0|||
126216227|NCT02617446|454081217|FG000|Overall Study|Withdrawal by Subject|0|||
126216228|NCT02617446|454081218|FG001|Overall Study|Withdrawal by Subject|2|||
126216229|NCT02617446|454081219|FG002|Overall Study|Withdrawal by Subject|0|||
126014124|NCT04517864|453346362|FG002|Placebo-Controlled Phase|Adverse Event|0|||
126014125|NCT04517864|453346360|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
126014126|NCT04517864|453346361|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
126216230|NCT02617446|454081217|FG000|Overall Study|Adverse Event|1|||
126014127|NCT04517864|453346362|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
126014128|NCT04517864|453346360|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
126014129|NCT04517864|453346361|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
126014130|NCT04517864|453346362|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
126216231|NCT02617446|454081218|FG001|Overall Study|Adverse Event|0|||
126216232|NCT02617446|454081219|FG002|Overall Study|Adverse Event|5|||
126216233|NCT02617446|454081217|FG000|Overall Study|Lost to Follow-up|3|||
126216234|NCT02617446|454081218|FG001|Overall Study|Lost to Follow-up|0|||
126216235|NCT02617446|454081219|FG002|Overall Study|Lost to Follow-up|0|||
126216236|NCT02617446|454081217|FG000|Overall Study|Death|0|||
126216237|NCT02617446|454081218|FG001|Overall Study|Death|0|||
126216238|NCT02617446|454081219|FG002|Overall Study|Death|2|||
126216239|NCT01652872|454081224|FG000|Overall Study|Death|36|||
126216240|NCT01652872|454081225|FG001|Overall Study|Death|39|||
126216241|NCT01652872|454081224|FG000|Overall Study|Lost to Follow-up|28|||
126216242|NCT01652872|454081225|FG001|Overall Study|Lost to Follow-up|23|||
126216243|NCT01652872|454081224|FG000|Overall Study|Decision by sponsor|5|||
126216244|NCT01652872|454081225|FG001|Overall Study|Decision by sponsor|7|||
126216245|NCT01652872|454081224|FG000|Overall Study|Withdrawal by Subject|76|||
126216246|NCT01652872|454081225|FG001|Overall Study|Withdrawal by Subject|84|||
126216247|NCT01216319|454081226|FG000|Overall Study|Lost to Follow-up|2|||
126216248|NCT01216319|454081226|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
126216249|NCT04529096|454081227|FG000|Overall Study|Adverse Event|6|||
126216250|NCT04529096|454081228|FG001|Overall Study|Adverse Event|1|||
126216251|NCT04529096|454081227|FG000|Overall Study|Lack of Efficacy|1|||
126216252|NCT04529096|454081228|FG001|Overall Study|Lack of Efficacy|0|||
126216253|NCT04529096|454081227|FG000|Overall Study|Lost to Follow-up|1|||
126216254|NCT04529096|454081228|FG001|Overall Study|Lost to Follow-up|1|||
126216255|NCT04529096|454081227|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126216256|NCT04529096|454081228|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126216257|NCT04529096|454081227|FG000|Overall Study|Physician Decision|1|||
126216258|NCT04529096|454081228|FG001|Overall Study|Physician Decision|3|||
126216259|NCT04529096|454081227|FG000|Overall Study|Withdrawal by Subject|5|||
126216260|NCT04529096|454081228|FG001|Overall Study|Withdrawal by Subject|0|||
126216261|NCT00929864|454081229|FG000|Overall Study|Death|1|||
126216262|NCT00929864|454081230|FG001|Overall Study|Death|1|||
126216263|NCT00929864|454081229|FG000|Overall Study|Adverse Event|11|||
126216264|NCT00929864|454081230|FG001|Overall Study|Adverse Event|30|||
126216265|NCT00929864|454081229|FG000|Overall Study|Lack of Efficacy|19|||
126216266|NCT00929864|454081230|FG001|Overall Study|Lack of Efficacy|16|||
126216267|NCT00929864|454081229|FG000|Overall Study|Lost to Follow-up|7|||
126216268|NCT00929864|454081230|FG001|Overall Study|Lost to Follow-up|12|||
126216269|NCT00929864|454081229|FG000|Overall Study|Withdrawal by Subject|20|||
126216270|NCT00929864|454081230|FG001|Overall Study|Withdrawal by Subject|9|||
126216271|NCT00929864|454081229|FG000|Overall Study|No longer met criteria|2|||
126216272|NCT00929864|454081230|FG001|Overall Study|No longer met criteria|1|||
126216273|NCT00929864|454081229|FG000|Overall Study|Poor or non-compliance|3|||
126216274|NCT00929864|454081230|FG001|Overall Study|Poor or non-compliance|3|||
126216275|NCT00929864|454081229|FG000|Overall Study|Pregnancy|0|||
126216276|NCT00929864|454081230|FG001|Overall Study|Pregnancy|3|||
126216277|NCT00929864|454081229|FG000|Overall Study|Administrative reason by Sponsor|1|||
126216278|NCT00929864|454081230|FG001|Overall Study|Administrative reason by Sponsor|1|||
126216279|NCT00929864|454081229|FG000|Overall Study|Non-specified|2|||
126216280|NCT00929864|454081230|FG001|Overall Study|Non-specified|7|||
126216281|NCT00390572|454081231|FG000|Overall Study|Lost to Follow-up|8|||
126216282|NCT00390572|454081232|FG001|Overall Study|Lost to Follow-up|4|||
126216283|NCT00390572|454081231|FG000|Overall Study|health condition|0|||
126216284|NCT00390572|454081232|FG001|Overall Study|health condition|1|||
126216285|NCT01966107|454081243|FG000|Overall Study|excluded from FAS|21|||
126216286|NCT01966107|454081244|FG001|Overall Study|excluded from FAS|20|||
126216287|NCT01966107|454081243|FG000|Overall Study|discontinued treatment|345|||
126216288|NCT01966107|454081244|FG001|Overall Study|discontinued treatment|372|||
126216289|NCT01966107|454081243|FG000|Overall Study|due to study closure|164|||
126216290|NCT01966107|454081244|FG001|Overall Study|due to study closure|186|||
126216291|NCT01966107|454081243|FG000|Overall Study|withdrew from the study|272|||
126216292|NCT01966107|454081244|FG001|Overall Study|withdrew from the study|303|||
126216293|NCT00532779|454081245|FG000|Overall Study|Adverse Event|122|||
126216294|NCT00532779|454081246|FG001|Overall Study|Adverse Event|112|||
126216295|NCT00532779|454081247|FG002|Overall Study|Adverse Event|56|||
126216296|NCT00532779|454081245|FG000|Overall Study|Lost to Follow-up|76|||
126216297|NCT00532779|454081246|FG001|Overall Study|Lost to Follow-up|65|||
126216298|NCT00532779|454081247|FG002|Overall Study|Lost to Follow-up|66|||
126349853|NCT00927472|454573019|FG001|Overall Study|Post treatment Assessment out of window|4|||
126349854|NCT04556097|454573020|FG000|Overall Study|Death|0|||
126349855|NCT04556097|454573021|FG001|Overall Study|Death|5|||
126216299|NCT00532779|454081245|FG000|Overall Study|Withdrawal by Subject|63|||
126216300|NCT00532779|454081246|FG001|Overall Study|Withdrawal by Subject|60|||
126216301|NCT00532779|454081247|FG002|Overall Study|Withdrawal by Subject|90|||
126216302|NCT00532779|454081245|FG000|Overall Study|Lack of Efficacy|12|||
126216303|NCT00532779|454081246|FG001|Overall Study|Lack of Efficacy|12|||
126216304|NCT00532779|454081247|FG002|Overall Study|Lack of Efficacy|40|||
126216305|NCT00532779|454081245|FG000|Overall Study|Protocol Violation|5|||
126216306|NCT00532779|454081246|FG001|Overall Study|Protocol Violation|9|||
126216307|NCT00532779|454081247|FG002|Overall Study|Protocol Violation|7|||
126216308|NCT00532779|454081245|FG000|Overall Study|Pregnancy|2|||
126216309|NCT00532779|454081246|FG001|Overall Study|Pregnancy|5|||
126349856|NCT04556097|454573022|FG002|Overall Study|Death|0|||
126216310|NCT00532779|454081247|FG002|Overall Study|Pregnancy|3|||
126216311|NCT00532779|454081245|FG000|Overall Study|Death|0|||
126216312|NCT00532779|454081246|FG001|Overall Study|Death|1|||
126349857|NCT04556097|454573023|FG003|Overall Study|Death|0|||
126216313|NCT00532779|454081247|FG002|Overall Study|Death|0|||
126216314|NCT00532779|454081245|FG000|Overall Study|Drug noncompliance, moved, other|14|||
126216315|NCT00532779|454081246|FG001|Overall Study|Drug noncompliance, moved, other|23|||
126216316|NCT00532779|454081247|FG002|Overall Study|Drug noncompliance, moved, other|29|||
126216317|NCT00689273|454081248|FG000|Overall Study|Adverse Event|3|||
126216318|NCT00689273|454081249|FG001|Overall Study|Adverse Event|1|||
126216319|NCT00689273|454081248|FG000|Overall Study|Lack of Efficacy|3|||
126216320|NCT00689273|454081249|FG001|Overall Study|Lack of Efficacy|0|||
126216321|NCT00689273|454081248|FG000|Overall Study|Lost to Follow-up|0|||
126216322|NCT00689273|454081249|FG001|Overall Study|Lost to Follow-up|2|||
126216323|NCT00689273|454081248|FG000|Overall Study|Other|6|||
126216324|NCT00689273|454081249|FG001|Overall Study|Other|2|||
126216325|NCT00689273|454081248|FG000|Overall Study|Randomized but not Treated|1|||
126216326|NCT00689273|454081249|FG001|Overall Study|Randomized but not Treated|0|||
126216327|NCT01556165|454081250|FG000|Overall Study|Adverse Event|5|||
126216328|NCT01556165|454081251|FG001|Overall Study|Adverse Event|3|||
126216329|NCT01556165|454081250|FG000|Overall Study|Protocol Violation|0|||
126216330|NCT01556165|454081251|FG001|Overall Study|Protocol Violation|3|||
126216331|NCT01556165|454081250|FG000|Overall Study|Withdrawal of Consent|7|||
126216332|NCT01556165|454081251|FG001|Overall Study|Withdrawal of Consent|1|||
126216333|NCT01238172|454081252|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
126216334|NCT01238172|454081253|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
126216335|NCT01238172|454081252|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
126216336|NCT01238172|454081253|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
126216337|NCT02531698|454081254|FG000|Overall Study|Adverse Event|2|||
126216338|NCT02531698|454081255|FG001|Overall Study|Adverse Event|1|||
126216339|NCT02531698|454081254|FG000|Overall Study|Withdrawal by Subject|6|||
126216340|NCT02531698|454081255|FG001|Overall Study|Withdrawal by Subject|1|||
126216341|NCT02531698|454081254|FG000|Overall Study|Protocol Violation|2|||
126216342|NCT02531698|454081255|FG001|Overall Study|Protocol Violation|0|||
126216343|NCT02531698|454081254|FG000|Overall Study|Lost to Follow-up|1|||
126216344|NCT02531698|454081255|FG001|Overall Study|Lost to Follow-up|0|||
126216345|NCT00701558|454081256|FG000|Overall Study|Death|7|||
126216346|NCT00701558|454081256|FG000|Overall Study|Lost to Follow-up|8|||
126216347|NCT02787746|454081257|FG000|Overall Study|Adverse Event|42|||
126216348|NCT02787746|454081257|FG000|Overall Study|Withdrawal by Subject|65|||
126216349|NCT02787746|454081257|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
126216350|NCT04822701|454081260|FG000|Overall Study|Not treated|2|||
126216351|NCT04822701|454081261|FG001|Overall Study|Not treated|0|||
126216352|NCT04822701|454081260|FG000|Overall Study|Lost to Follow-up|1|||
126216353|NCT04822701|454081261|FG001|Overall Study|Lost to Follow-up|0|||
126216354|NCT04822701|454081260|FG000|Overall Study|Withdrawal by Subject|1|||
126216355|NCT04822701|454081261|FG001|Overall Study|Withdrawal by Subject|0|||
126216356|NCT02428231|454082622|FG000|Overall Study|Other|10|||
126216357|NCT02428231|454082623|FG001|Overall Study|Other|16|||
126216358|NCT02428231|454082622|FG000|Overall Study|Required Symptomatic Therapy|0|||
126216359|NCT02428231|454082623|FG001|Overall Study|Required Symptomatic Therapy|1|||
126216360|NCT02428231|454082622|FG000|Overall Study|Adverse Event|3|||
126216361|NCT02428231|454082623|FG001|Overall Study|Adverse Event|0|||
126216362|NCT01784419|454082626|FG000|Overall Study|Adverse Event|3|||
126216363|NCT02253654|454082627|FG000|Overall Study|Withdrawal by Subject|12|||
126216364|NCT02253654|454082628|FG001|Overall Study|Withdrawal by Subject|4|||
126216365|NCT02253654|454082627|FG000|Overall Study|Decision by Sponsor|1|||
126216366|NCT02253654|454082628|FG001|Overall Study|Decision by Sponsor|1|||
126216367|NCT02253654|454082627|FG000|Overall Study|Lost to Follow-up|2|||
126216368|NCT02253654|454082628|FG001|Overall Study|Lost to Follow-up|5|||
126216369|NCT02253654|454082627|FG000|Overall Study|Death|4|||
126216370|NCT02253654|454082628|FG001|Overall Study|Death|7|||
126216371|NCT02253654|454082627|FG000|Overall Study|Did Not Receive Study Treatment|4|||
126216372|NCT02253654|454082628|FG001|Overall Study|Did Not Receive Study Treatment|1|||
126216373|NCT03456726|454082631|FG000|Overall Study|Disease Progression|6|||
126216374|NCT03456726|454082632|FG001|Overall Study|Disease Progression|1|||
126216375|NCT03456726|454082631|FG000|Overall Study|Adverse Event|4|||
126216376|NCT03456726|454082632|FG001|Overall Study|Adverse Event|2|||
126216377|NCT03456726|454082631|FG000|Overall Study|Withdrawal by Subject|1|||
126216378|NCT03456726|454082632|FG001|Overall Study|Withdrawal by Subject|0|||
126216379|NCT03456726|454082631|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
126216380|NCT03456726|454082632|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
126349858|NCT04556097|454573020|FG000|Overall Study|No caregiver|43|||
126216381|NCT04470622|454082633|FG000|Overall Study|Withdrawal by Subject|0|||
126216382|NCT04470622|454082634|FG001|Overall Study|Withdrawal by Subject|1|||
126216383|NCT04470622|454082633|FG000|Overall Study|Screen Failure|0|||
126216384|NCT04470622|454082634|FG001|Overall Study|Screen Failure|1|||
126216385|NCT04470622|454082633|FG000|Overall Study|Death|0|||
126216386|NCT04470622|454082634|FG001|Overall Study|Death|1|||
126216387|NCT00399490|454082635|FG000|Overall Study|Adverse Event|19|||
126216388|NCT00399490|454082635|FG000|Overall Study|Lack of Efficacy|31|||
126216389|NCT00399490|454082635|FG000|Overall Study|Lost to Follow-up|5|||
126216390|NCT00399490|454082635|FG000|Overall Study|Withdrawal by Subject|18|||
126216391|NCT00399490|454082635|FG000|Overall Study|Other|25|||
126216392|NCT02576054|454082636|FG000|Overall Study|Withdrawal by Subject|1|||
126216393|NCT01190098|454082637|FG000|Overall Study|Adverse Event|2|||
126216394|NCT01190098|454082638|FG001|Overall Study|Adverse Event|0|||
126216395|NCT01190098|454082637|FG000|Overall Study|Patient coomorbidity|0|||
126216396|NCT01190098|454082638|FG001|Overall Study|Patient coomorbidity|1|||
126216397|NCT01190098|454082637|FG000|Overall Study|Lack of transportation|1|||
126216398|NCT01190098|454082638|FG001|Overall Study|Lack of transportation|0|||
126216399|NCT01190098|454082637|FG000|Overall Study|Other|0|||
126216400|NCT01190098|454082638|FG001|Overall Study|Other|1|||
126216401|NCT02957682|454082639|FG000|Overall Study|Adverse Event|64|||
126216402|NCT02957682|454082640|FG001|Overall Study|Adverse Event|67|||
126216403|NCT02957682|454082639|FG000|Overall Study|Poor Compliance to Protocol|30|||
126216404|NCT02957682|454082640|FG001|Overall Study|Poor Compliance to Protocol|26|||
126216405|NCT02957682|454082639|FG000|Overall Study|Physician Decision|4|||
126216406|NCT02957682|454082640|FG001|Overall Study|Physician Decision|4|||
126216407|NCT02957682|454082639|FG000|Overall Study|Study Terminated by Sponsor|4|||
126216408|NCT02957682|454082640|FG001|Overall Study|Study Terminated by Sponsor|3|||
126216409|NCT02957682|454082639|FG000|Overall Study|Subject Moved|10|||
126216410|NCT02957682|454082640|FG001|Overall Study|Subject Moved|16|||
126216411|NCT02957682|454082639|FG000|Overall Study|Withdrawal by Subject|64|||
126216412|NCT02957682|454082640|FG001|Overall Study|Withdrawal by Subject|33|||
126216413|NCT02957682|454082639|FG000|Overall Study|Related to IMP Administration|3|||
126216414|NCT02957682|454082640|FG001|Overall Study|Related to IMP Administration|6|||
126216415|NCT02957682|454082639|FG000|Overall Study|Non-disclosed|16|||
126216416|NCT02957682|454082640|FG001|Overall Study|Non-disclosed|12|||
126216417|NCT02957682|454082639|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
126216418|NCT02957682|454082640|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
126216419|NCT02499406|454082641|FG000|Overall Study|missed 3 treatment sessions|4|||
126216420|NCT04651218|454082642|FG000|Overall Study|Withdrawal by Subject|0|||
126216421|NCT04651218|454082643|FG001|Overall Study|Withdrawal by Subject|2|||
126216422|NCT00765999|454082644|FG000|Overall Study|Adverse Event|203|||
126216423|NCT00765999|454082644|FG000|Overall Study|Insufficient Therapeutic Response|100|||
126216424|NCT00765999|454082644|FG000|Overall Study|Protocol Violation|95|||
126216425|NCT00765999|454082644|FG000|Overall Study|Consent Withdrawn|202|||
126216426|NCT00765999|454082644|FG000|Overall Study|Lost to Follow-up|131|||
126216427|NCT00765999|454082644|FG000|Overall Study|Study Terminated by Sponsor|2|||
126216428|NCT00765999|454082644|FG000|Overall Study|Other Miscellaneous Reasons|51|||
126216429|NCT00414011|454082645|FG000|Overall Study|Physician Decision|3|||
126216430|NCT00414011|454082645|FG000|Overall Study|Withdrawal by Subject|2|||
126216431|NCT02476851|454082646|FG000|Overall Study|Protocol Violation|1|||
126216432|NCT02476851|454082647|FG001|Overall Study|Protocol Violation|1|||
126216433|NCT01399125|454082648|FG000|Overall Study|Adverse Event|32|||
126216434|NCT01399125|454082649|FG001|Overall Study|Adverse Event|30|||
126014131|NCT04517864|453346360|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
126216435|NCT01399125|454082648|FG000|Overall Study|Abnormal Lab values|0|||
126216436|NCT01399125|454082649|FG001|Overall Study|Abnormal Lab values|1|||
126216437|NCT01399125|454082648|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126216438|NCT01399125|454082649|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
126216439|NCT01399125|454082648|FG000|Overall Study|Withdrawal by Subject|5|||
126216440|NCT01399125|454082649|FG001|Overall Study|Withdrawal by Subject|8|||
126216441|NCT01399125|454082648|FG000|Overall Study|Lost to Follow-up|2|||
126216442|NCT01399125|454082649|FG001|Overall Study|Lost to Follow-up|3|||
126216443|NCT01399125|454082648|FG000|Overall Study|Administrative Problems|7|||
126216444|NCT01399125|454082649|FG001|Overall Study|Administrative Problems|11|||
126216445|NCT01399125|454082648|FG000|Overall Study|Death|0|||
126216446|NCT01399125|454082649|FG001|Overall Study|Death|1|||
126216447|NCT01399125|454082648|FG000|Overall Study|Protocol Deviation|5|||
126216448|NCT01399125|454082649|FG001|Overall Study|Protocol Deviation|2|||
126216449|NCT00647426|454082652|FG000|Overall Study|Withdrawal by Subject|2|||
126216450|NCT05354206|454082657|FG000|Overall Study|Withdrawal by Subject|1|||
126216451|NCT05354206|454082658|FG001|Overall Study|Withdrawal by Subject|0|||
126216452|NCT04285983|454082659|FG000|Overall Study|Protocol Violation|6|||
126216453|NCT04936334|454082660|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
126216454|NCT00422058|454082661|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
126216455|NCT00422058|454082662|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
126216456|NCT00422058|454082663|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
126216457|NCT00422058|454082664|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
126216458|NCT00422058|454082665|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
126216459|NCT00422058|454082666|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
126216460|NCT00422058|454082661|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
126216461|NCT00422058|454082662|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
126216462|NCT00422058|454082663|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
126216463|NCT00422058|454082664|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
126216464|NCT00422058|454082665|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
126216465|NCT00422058|454082666|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
126216466|NCT00422058|454082661|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
126216467|NCT00422058|454082662|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
126216468|NCT00422058|454082663|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
126216469|NCT00422058|454082664|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
126216470|NCT00422058|454082665|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
126216471|NCT00422058|454082666|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
126216472|NCT00422058|454082661|FG000|Double-Blind, Week 0-20|Other|11|||
126216473|NCT00422058|454082662|FG001|Double-Blind, Week 0-20|Other|3|||
126216474|NCT00422058|454082663|FG002|Double-Blind, Week 0-20|Other|8|||
126216475|NCT00422058|454082664|FG003|Double-Blind, Week 0-20|Other|8|||
126216476|NCT00422058|454082665|FG004|Double-Blind, Week 0-20|Other|4|||
126216477|NCT00422058|454082666|FG005|Double-Blind, Week 0-20|Other|10|||
126216478|NCT00422058|454082661|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
126216479|NCT00422058|454082662|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
126216480|NCT00422058|454082663|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
126216481|NCT00422058|454082664|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
126216482|NCT00422058|454082665|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
126216483|NCT00422058|454082666|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
126216484|NCT00422058|454082661|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
126216485|NCT00422058|454082662|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
126216486|NCT00422058|454082663|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
126216487|NCT00422058|454082664|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
126216488|NCT00422058|454082665|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
126216489|NCT00422058|454082666|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
126216490|NCT00422058|454082661|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
126216491|NCT00422058|454082662|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
126216492|NCT00422058|454082663|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
126216493|NCT00422058|454082664|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
126216494|NCT00422058|454082665|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
126216495|NCT00422058|454082666|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
126216496|NCT00422058|454082661|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
126216497|NCT00422058|454082662|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
126216498|NCT00422058|454082663|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
126216499|NCT00422058|454082664|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
126216500|NCT00422058|454082665|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
126216501|NCT00422058|454082666|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
126216502|NCT00422058|454082661|FG000|Open-Label Extension, Week 20-104|Other|13|||
126216503|NCT00422058|454082662|FG001|Open-Label Extension, Week 20-104|Other|14|||
126216504|NCT00422058|454082663|FG002|Open-Label Extension, Week 20-104|Other|6|||
126216505|NCT00422058|454082664|FG003|Open-Label Extension, Week 20-104|Other|13|||
126216506|NCT00422058|454082665|FG004|Open-Label Extension, Week 20-104|Other|16|||
126216507|NCT00422058|454082666|FG005|Open-Label Extension, Week 20-104|Other|18|||
126216508|NCT03224234|454082671|FG000|Main Study|Lost to Follow-up|5|||
126216509|NCT03224234|454082672|FG001|Main Study|Lost to Follow-up|5|||
126216510|NCT02866695|454082673|FG000|Overall Study|Adverse Event|1|||
126216511|NCT02866695|454082673|FG000|Overall Study|Lost to Follow-up|1|||
126216512|NCT05016765|454082674|FG000|Overall Study|Lost to Follow-up|4|||
126216513|NCT01346501|454082678|FG000|Overall Study|Initiated Other Biological Agents|3|||
126216514|NCT01346501|454082679|FG001|Overall Study|Initiated Other Biological Agents|1|||
126216515|NCT01346501|454082678|FG000|Overall Study|Other|8|||
126216516|NCT01346501|454082679|FG001|Overall Study|Other|12|||
126216517|NCT02564952|454082680|FG000|Overall Study|Adverse Event|6|||
126216518|NCT02564952|454082680|FG000|Overall Study|Lost to Follow-up|1|||
126216519|NCT02564952|454082680|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
126216520|NCT02564952|454082680|FG000|Overall Study|Withdrawal by Subject|1|||
126014132|NCT04517864|453346361|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
126014133|NCT04517864|453346362|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
126014134|NCT04517864|453346360|FG000|Active Therapy Extension Phase|Adverse Event|1|||
126014135|NCT04517864|453346361|FG001|Active Therapy Extension Phase|Adverse Event|0|||
126014136|NCT04517864|453346362|FG002|Active Therapy Extension Phase|Adverse Event|0|||
126014137|NCT04517864|453346360|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
126014138|NCT04517864|453346361|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
126014139|NCT04517864|453346362|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
126014140|NCT04517864|453346360|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
126014141|NCT04517864|453346361|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
126014142|NCT04517864|453346362|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
126014143|NCT04517864|453346360|FG000|Active Therapy Extension Phase|Physician Decision|1|||
126014144|NCT04517864|453346361|FG001|Active Therapy Extension Phase|Physician Decision|0|||
126014145|NCT04517864|453346362|FG002|Active Therapy Extension Phase|Physician Decision|0|||
126014146|NCT04517864|453346360|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
126014147|NCT04517864|453346361|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
126014148|NCT04517864|453346362|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
126014149|NCT04517864|453346360|FG000|Extension Phase|Adverse Event|0|||
126014150|NCT04517864|453346361|FG001|Extension Phase|Adverse Event|0|||
126014151|NCT04517864|453346362|FG002|Extension Phase|Adverse Event|1|||
126014152|NCT04517864|453346360|FG000|Extension Phase|Lack of Efficacy|0|||
126014153|NCT04517864|453346361|FG001|Extension Phase|Lack of Efficacy|0|||
126014154|NCT04517864|453346362|FG002|Extension Phase|Lack of Efficacy|2|||
126014155|NCT04517864|453346360|FG000|Extension Phase|Study Terminated By Sponsor|0|||
126014156|NCT04517864|453346361|FG001|Extension Phase|Study Terminated By Sponsor|0|||
126014157|NCT04517864|453346362|FG002|Extension Phase|Study Terminated By Sponsor|32|||
126014158|NCT04517864|453346360|FG000|Extension Phase|Withdrawal by Subject|0|||
126014159|NCT04517864|453346361|FG001|Extension Phase|Withdrawal by Subject|0|||
126014160|NCT04517864|453346362|FG002|Extension Phase|Withdrawal by Subject|3|||
126014161|NCT04517864|453346360|FG000|Extension Phase|Approved Drug Available for Indication|0|||
126014162|NCT04517864|453346361|FG001|Extension Phase|Approved Drug Available for Indication|0|||
126014163|NCT04517864|453346362|FG002|Extension Phase|Approved Drug Available for Indication|7|||
126014164|NCT04722003|453346363|FG000|Overall Study|Lost to Follow-up|2|||
126014165|NCT04722003|453346364|FG001|Overall Study|Lost to Follow-up|0|||
126014166|NCT04722003|453346363|FG000|Overall Study|Physician Decision|1|||
126014167|NCT04722003|453346364|FG001|Overall Study|Physician Decision|0|||
126014168|NCT01049503|453346365|FG000|Overall Study|Lost to Follow-up|11|||
126014169|NCT01049503|453346366|FG001|Overall Study|Lost to Follow-up|12|||
126014170|NCT01049503|453346367|FG002|Overall Study|Lost to Follow-up|24|||
126014171|NCT01049503|453346368|FG003|Overall Study|Lost to Follow-up|26|||
126014172|NCT01049503|453346369|FG004|Overall Study|Lost to Follow-up|27|||
126014173|NCT01049503|453346370|FG005|Overall Study|Lost to Follow-up|8|||
126014174|NCT02974634|453346371|FG000|Overall Study|Advanced disease|12|||
126014175|NCT02974634|453346372|FG001|Overall Study|Advanced disease|3|||
126014176|NCT02974634|453346371|FG000|Overall Study|Noncompliance|3|||
126014177|NCT02974634|453346372|FG001|Overall Study|Noncompliance|7|||
126014178|NCT02974634|453346371|FG000|Overall Study|intervention technology related issues|5|||
126014179|NCT02974634|453346372|FG001|Overall Study|intervention technology related issues|0|||
126014180|NCT02974634|453346371|FG000|Overall Study|Death|8|||
126014181|NCT02974634|453346372|FG001|Overall Study|Death|11|||
126014182|NCT01266265|453346374|FG000|Overall Study|Death|95|||
126014183|NCT01266265|453346375|FG001|Overall Study|Death|73|||
126014184|NCT01266265|453346374|FG000|Overall Study|Lost to Follow-up|23|||
126014185|NCT01266265|453346375|FG001|Overall Study|Lost to Follow-up|28|||
126014186|NCT01266265|453346374|FG000|Overall Study|Withdrawal by Subject|13|||
126014187|NCT01266265|453346375|FG001|Overall Study|Withdrawal by Subject|11|||
126014188|NCT01266265|453346374|FG000|Overall Study|Respiratory-related adverse event|2|||
126014189|NCT01266265|453346375|FG001|Overall Study|Respiratory-related adverse event|1|||
126014190|NCT01266265|453346374|FG000|Overall Study|Transferred care to another provider|22|||
126014191|NCT01266265|453346375|FG001|Overall Study|Transferred care to another provider|28|||
126014192|NCT01266265|453346374|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
126014193|NCT01266265|453346375|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
126014194|NCT01266265|453346374|FG000|Overall Study|Enrolled in another clinical study|15|||
126349859|NCT04556097|454573021|FG001|Overall Study|No caregiver|53|||
126349860|NCT04556097|454573022|FG002|Overall Study|No caregiver|0|||
126014195|NCT01266265|453346375|FG001|Overall Study|Enrolled in another clinical study|26|||
126014196|NCT01266265|453346374|FG000|Overall Study|Non-compliance|8|||
126014197|NCT01266265|453346375|FG001|Overall Study|Non-compliance|5|||
126014198|NCT01266265|453346374|FG000|Overall Study|Lung transplant|6|||
126014199|NCT01266265|453346375|FG001|Overall Study|Lung transplant|5|||
126014200|NCT01266265|453346374|FG000|Overall Study|Site closed early|4|||
126014201|NCT01266265|453346375|FG001|Overall Study|Site closed early|3|||
126014202|NCT01266265|453346374|FG000|Overall Study|Clinical worsening|1|||
126014203|NCT01266265|453346375|FG001|Overall Study|Clinical worsening|1|||
126014204|NCT01580293|453346376|FG000|Part A_Main Trial|Adverse Event|0|||
126216521|NCT02564952|454082680|FG000|Overall Study|Low Efficacy|1|||
126216522|NCT02564952|454082680|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
126216523|NCT00756652|454082681|FG000|Original Phase|Withdrawal by Subject|864|||
126216524|NCT00756652|454082682|FG001|Original Phase|Withdrawal by Subject|23|||
126216525|NCT00756652|454082681|FG000|Original Phase|Lost to Follow-up|601|||
126216526|NCT00756652|454082682|FG001|Original Phase|Lost to Follow-up|0|||
126216527|NCT00756652|454082681|FG000|Original Phase|Other Discontinuation|797|||
126216528|NCT00756652|454082682|FG001|Original Phase|Other Discontinuation|5|||
126216529|NCT00756652|454082681|FG000|Original Phase|Participant Noncompliance|18622|||
126216530|NCT00756652|454082682|FG001|Original Phase|Participant Noncompliance|424|||
126216531|NCT00756652|454082681|FG000|Original Phase|Unknown Discontinuation Reason|2|||
126216532|NCT00756652|454082682|FG001|Original Phase|Unknown Discontinuation Reason|0|||
126216533|NCT00756652|454082681|FG000|Original Phase|Participants without data|3259|||
126216534|NCT00756652|454082682|FG001|Original Phase|Participants without data|466|||
126216535|NCT00756652|454082681|FG000|Original Phase|Death|168|||
126216536|NCT00756652|454082682|FG001|Original Phase|Death|1|||
126216537|NCT00756652|454082681|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
126216538|NCT00756652|454082682|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
126216539|NCT00756652|454082681|FG000|Re-Op Phase|Withdrawal by Subject|62|||
126216540|NCT00756652|454082682|FG001|Re-Op Phase|Withdrawal by Subject|0|||
126216541|NCT00756652|454082681|FG000|Re-Op Phase|Death|6|||
126216542|NCT00756652|454082682|FG001|Re-Op Phase|Death|0|||
126216543|NCT00756652|454082681|FG000|Re-Op Phase|Lost to Follow-up|340|||
126216544|NCT00756652|454082682|FG001|Re-Op Phase|Lost to Follow-up|0|||
126216545|NCT00756652|454082681|FG000|Re-Op Phase|Site Closed|2454|||
126216546|NCT00756652|454082682|FG001|Re-Op Phase|Site Closed|0|||
126216547|NCT00756652|454082681|FG000|Re-Op Phase|Withdrawn after explant|14|||
126216548|NCT00756652|454082682|FG001|Re-Op Phase|Withdrawn after explant|0|||
126216549|NCT01850108|454082683|FG000|Overall Study|Lost to Follow-up|4|||
126216550|NCT01850108|454082683|FG000|Overall Study|Not eligible|1|||
126216551|NCT01850108|454082683|FG000|Overall Study|Failed engraftment|2|||
126216552|NCT01850108|454082683|FG000|Overall Study|Physician Decision|1|||
126216553|NCT00038467|454082684|FG000|Overall Study|Adverse Event|170|||
126216554|NCT00038467|454082685|FG001|Overall Study|Adverse Event|145|||
126216555|NCT00038467|454082684|FG000|Overall Study|Withdrawal by Subject|150|||
126216556|NCT00038467|454082685|FG001|Overall Study|Withdrawal by Subject|107|||
126216557|NCT00038467|454082684|FG000|Overall Study|Protocol Violation|19|||
126216558|NCT00038467|454082685|FG001|Overall Study|Protocol Violation|22|||
126216559|NCT00038467|454082684|FG000|Overall Study|Death|22|||
126216560|NCT00038467|454082685|FG001|Overall Study|Death|16|||
126216561|NCT00038467|454082684|FG000|Overall Study|Lost to Follow-up|15|||
126216562|NCT00038467|454082685|FG001|Overall Study|Lost to Follow-up|10|||
126216563|NCT00038467|454082684|FG000|Overall Study|Recurrence|109|||
126216564|NCT00038467|454082685|FG001|Overall Study|Recurrence|179|||
126216565|NCT00038467|454082684|FG000|Overall Study|Randomized, but not treated|31|||
126216566|NCT00038467|454082685|FG001|Overall Study|Randomized, but not treated|35|||
126216567|NCT00038467|454082684|FG000|Overall Study|Other|26|||
126216568|NCT00038467|454082685|FG001|Overall Study|Other|28|||
126216569|NCT01988493|454082686|FG000|Overall Study|Randomized but not treated|0|||
126216570|NCT01988493|454082687|FG001|Overall Study|Randomized but not treated|0|||
126216571|NCT01988493|454082688|FG002|Overall Study|Randomized but not treated|0|||
126216572|NCT01988493|454082689|FG003|Overall Study|Randomized but not treated|0|||
126216573|NCT01988493|454082690|FG004|Overall Study|Randomized but not treated|1|||
126216574|NCT00627458|454082691|FG000|Overall Study|Migrated from study area|1|||
126216575|NCT00627458|454082692|FG001|Overall Study|Migrated from study area|0|||
126216576|NCT00627458|454082693|FG002|Overall Study|Migrated from study area|1|||
126216577|NCT00627458|454082691|FG000|Overall Study|Withdrawal by Subject|2|||
126216578|NCT00627458|454082692|FG001|Overall Study|Withdrawal by Subject|6|||
126216579|NCT00627458|454082693|FG002|Overall Study|Withdrawal by Subject|5|||
126216580|NCT00627458|454082691|FG000|Overall Study|Lost to Follow-up|1|||
126349861|NCT04556097|454573023|FG003|Overall Study|No caregiver|0|||
126216581|NCT00627458|454082692|FG001|Overall Study|Lost to Follow-up|1|||
126349862|NCT04556097|454573020|FG000|Overall Study|Ineligible, SNF|2|||
126216582|NCT00627458|454082693|FG002|Overall Study|Lost to Follow-up|0|||
126216583|NCT00530088|454082697|FG000|Overall Study|Disease Progression|4|||
126216584|NCT00530088|454082697|FG000|Overall Study|Physician Decision|4|||
126349863|NCT04556097|454573021|FG001|Overall Study|Ineligible, SNF|2|||
126349864|NCT04556097|454573022|FG002|Overall Study|Ineligible, SNF|0|||
126349865|NCT04556097|454573023|FG003|Overall Study|Ineligible, SNF|0|||
126349866|NCT04556097|454573020|FG000|Overall Study|Ineligible, health|3|||
126216585|NCT00530088|454082697|FG000|Overall Study|Other Not Specified|2|||
126216586|NCT00902278|454082698|FG000|Overall Study|Physician Decision|1|||
126216587|NCT00902278|454082699|FG001|Overall Study|Physician Decision|0|||
126216588|NCT00902278|454082700|FG002|Overall Study|Physician Decision|2|||
126216589|NCT00902278|454082701|FG003|Overall Study|Physician Decision|0|||
126216590|NCT00902278|454082702|FG004|Overall Study|Physician Decision|1|||
126216591|NCT00902278|454082698|FG000|Overall Study|Lost to Follow-up|3|||
126216592|NCT00902278|454082699|FG001|Overall Study|Lost to Follow-up|2|||
126216593|NCT00902278|454082700|FG002|Overall Study|Lost to Follow-up|3|||
126216594|NCT00902278|454082701|FG003|Overall Study|Lost to Follow-up|0|||
126216595|NCT00902278|454082702|FG004|Overall Study|Lost to Follow-up|1|||
126216596|NCT02362646|454082703|FG000|Overall Study|Death|15|||
126216597|NCT02362646|454082704|FG001|Overall Study|Death|8|||
126216598|NCT02362646|454082703|FG000|Overall Study|Withdrawal by Subject|2|||
126216599|NCT02362646|454082704|FG001|Overall Study|Withdrawal by Subject|2|||
126216600|NCT02362646|454082703|FG000|Overall Study|received transplant|21|||
126216601|NCT02362646|454082704|FG001|Overall Study|received transplant|14|||
126216602|NCT00865306|454082705|FG000|Controlled Trial|Lost to Follow-up|1|||
126216603|NCT00865306|454082706|FG001|Controlled Trial|Lost to Follow-up|1|||
126216604|NCT00865306|454082705|FG000|Controlled Trial|Difficulty commuting|2|||
126216605|NCT00865306|454082706|FG001|Controlled Trial|Difficulty commuting|0|||
126216606|NCT00865306|454082705|FG000|Controlled Trial|Improved btw baseline and first session|1|||
126216607|NCT00865306|454082706|FG001|Controlled Trial|Improved btw baseline and first session|0|||
126216608|NCT00865306|454082705|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
126216609|NCT00865306|454082706|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
126216610|NCT00865306|454082705|FG000|Controlled Trial|Withdrawal by Subject|0|||
126216611|NCT00865306|454082706|FG001|Controlled Trial|Withdrawal by Subject|1|||
126216612|NCT02181842|454082708|FG000|Overall Study|Case Report Forms Uncollected|2|||
126216613|NCT03454672|454082720|FG000|Overall Study|Adverse Event|1|||
126216614|NCT03454672|454082721|FG001|Overall Study|Adverse Event|1|||
126216615|NCT03454672|454082720|FG000|Overall Study|Lost to Follow-up|1|||
126216616|NCT03454672|454082721|FG001|Overall Study|Lost to Follow-up|3|||
126216617|NCT03454672|454082720|FG000|Overall Study|painful|1|||
126216618|NCT03454672|454082721|FG001|Overall Study|painful|2|||
126216619|NCT03454672|454082720|FG000|Overall Study|Non-compliance|2|||
126216620|NCT03454672|454082721|FG001|Overall Study|Non-compliance|4|||
126216621|NCT03454672|454082720|FG000|Overall Study|personal reasons|3|||
126216622|NCT03454672|454082721|FG001|Overall Study|personal reasons|2|||
126216623|NCT03454672|454082720|FG000|Overall Study|Withdrawal by Subject|1|||
126216624|NCT03454672|454082721|FG001|Overall Study|Withdrawal by Subject|0|||
126216625|NCT03985293|454082723|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
126216626|NCT03985293|454082724|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
126216627|NCT03985293|454082725|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
126216628|NCT03985293|454082726|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
126216629|NCT03985293|454082727|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
126216630|NCT03985293|454082728|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
126216631|NCT03985293|454082723|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
126216632|NCT03985293|454082724|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
126216633|NCT03985293|454082725|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
126216634|NCT03985293|454082726|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
126216635|NCT03985293|454082727|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
126216636|NCT03985293|454082728|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
126216637|NCT03985293|454082723|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
126216638|NCT03985293|454082724|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
126216639|NCT03985293|454082725|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
126216640|NCT03985293|454082726|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
126216641|NCT03985293|454082727|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
126216642|NCT03985293|454082728|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
126216643|NCT03985293|454082723|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
126216644|NCT03985293|454082724|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
126216645|NCT03985293|454082725|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
126216646|NCT03985293|454082726|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
126216647|NCT03985293|454082727|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
126216648|NCT03985293|454082728|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
126216649|NCT03985293|454082723|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
126216650|NCT03985293|454082724|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
126216651|NCT03985293|454082725|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
126216652|NCT03985293|454082726|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
126014205|NCT01580293|453346377|FG001|Part A_Main Trial|Adverse Event|2|||
126014206|NCT01580293|453346378|FG002|Part A_Main Trial|Adverse Event|0|||
126014207|NCT01580293|453346376|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
126014208|NCT01580293|453346377|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
126216653|NCT03985293|454082727|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
126216654|NCT03985293|454082728|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
126216655|NCT03985293|454082723|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
126216656|NCT03985293|454082724|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
126216657|NCT03985293|454082725|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
126216658|NCT03985293|454082726|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
126216659|NCT03985293|454082727|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
126216660|NCT03985293|454082728|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
126216661|NCT03985293|454082723|FG000|FOLLOW-UP|Lost to Follow-up|0|||
126216662|NCT03985293|454082724|FG001|FOLLOW-UP|Lost to Follow-up|0|||
126216663|NCT03985293|454082725|FG002|FOLLOW-UP|Lost to Follow-up|1|||
126216664|NCT03985293|454082726|FG003|FOLLOW-UP|Lost to Follow-up|0|||
126216665|NCT03985293|454082727|FG004|FOLLOW-UP|Lost to Follow-up|0|||
126216666|NCT03985293|454082728|FG005|FOLLOW-UP|Lost to Follow-up|0|||
126216667|NCT03302299|454084398|FG000|Overall Study|Protocol Violation|1|||
126216668|NCT00858234|454084399|FG000|Overall Study|Adverse Event|6|||
126216669|NCT00858234|454084399|FG000|Overall Study|Progressive disease|2|||
126216670|NCT00858234|454084399|FG000|Overall Study|Status unknown|1|||
126216671|NCT04318535|454084400|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
126216672|NCT04318535|454084401|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
126216673|NCT04318535|454084402|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
126216674|NCT01678924|454084403|FG000|Overall Study|Adverse Event|1|||
126216675|NCT01678924|454084404|FG001|Overall Study|Adverse Event|1|||
126216676|NCT01678924|454084405|FG002|Overall Study|Adverse Event|0|||
126216677|NCT01678924|454084406|FG003|Overall Study|Adverse Event|1|||
126216678|NCT01678924|454084403|FG000|Overall Study|Lack of Efficacy|7|||
126216679|NCT01678924|454084404|FG001|Overall Study|Lack of Efficacy|2|||
126216680|NCT01678924|454084405|FG002|Overall Study|Lack of Efficacy|0|||
126216681|NCT01678924|454084406|FG003|Overall Study|Lack of Efficacy|5|||
126216682|NCT01678924|454084403|FG000|Overall Study|Lost to Follow-up|0|||
126216683|NCT01678924|454084404|FG001|Overall Study|Lost to Follow-up|4|||
126216684|NCT01678924|454084405|FG002|Overall Study|Lost to Follow-up|0|||
126216685|NCT01678924|454084406|FG003|Overall Study|Lost to Follow-up|2|||
126216686|NCT01678924|454084403|FG000|Overall Study|Personal Reasons|2|||
126216687|NCT01678924|454084404|FG001|Overall Study|Personal Reasons|2|||
126216688|NCT01678924|454084405|FG002|Overall Study|Personal Reasons|2|||
126216689|NCT01678924|454084406|FG003|Overall Study|Personal Reasons|7|||
126216690|NCT01678924|454084403|FG000|Overall Study|Withdrawal by Subject|0|||
126216691|NCT01678924|454084404|FG001|Overall Study|Withdrawal by Subject|3|||
126216692|NCT01678924|454084405|FG002|Overall Study|Withdrawal by Subject|0|||
126216693|NCT01678924|454084406|FG003|Overall Study|Withdrawal by Subject|2|||
126216694|NCT01678924|454084403|FG000|Overall Study|Unable to attend scheduled visits|0|||
126216695|NCT01678924|454084404|FG001|Overall Study|Unable to attend scheduled visits|0|||
126216696|NCT01678924|454084405|FG002|Overall Study|Unable to attend scheduled visits|0|||
126216697|NCT01678924|454084406|FG003|Overall Study|Unable to attend scheduled visits|1|||
126216698|NCT00640614|454084410|FG000|Overall Study|Lost to Follow-up|1|||
126216699|NCT00640614|454084411|FG001|Overall Study|Lost to Follow-up|0|||
126216700|NCT00529802|454084412|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
126216701|NCT00529802|454084412|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
126216702|NCT00529802|454084412|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
126216703|NCT00529802|454084412|FG000|Evaluable for Primary Endpoint|Death|1|||
126216704|NCT00529802|454084412|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
126216705|NCT00529802|454084412|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
126216706|NCT00529802|454084412|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
126216707|NCT01336608|454084413|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
126216708|NCT01336608|454084414|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126216709|NCT01336608|454084415|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126216710|NCT01336608|454084416|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126216711|NCT01336608|454084413|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
126216712|NCT01336608|454084414|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126216713|NCT01336608|454084415|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126216714|NCT01336608|454084416|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126216715|NCT01336608|454084413|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
126216716|NCT01336608|454084414|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
126216717|NCT01336608|454084415|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
126216718|NCT01336608|454084416|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
126216719|NCT01336608|454084413|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
126216720|NCT01336608|454084414|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
126216721|NCT01336608|454084415|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
126216722|NCT01336608|454084416|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
126216723|NCT01336608|454084413|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
126216724|NCT01336608|454084414|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126216725|NCT01336608|454084415|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126216726|NCT01336608|454084416|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126216727|NCT01336608|454084413|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
126216728|NCT01336608|454084414|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
126216729|NCT01336608|454084415|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
126216730|NCT01336608|454084416|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
126216731|NCT01336608|454084413|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126349867|NCT04556097|454573021|FG001|Overall Study|Ineligible, health|4|||
126349868|NCT04556097|454573022|FG002|Overall Study|Ineligible, health|0|||
126349869|NCT04556097|454573023|FG003|Overall Study|Ineligible, health|0|||
126349870|NCT04556097|454573020|FG000|Overall Study|Ineligible, language|0|||
126014209|NCT01580293|453346378|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
126014210|NCT01580293|453346376|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
126014211|NCT01580293|453346377|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
126014212|NCT01580293|453346378|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
126014213|NCT01580293|453346376|FG000|Part A_Extension|Adverse Event|0|||
126014214|NCT01580293|453346377|FG001|Part A_Extension|Adverse Event|2|||
126014215|NCT01580293|453346378|FG002|Part A_Extension|Adverse Event|0|||
126014216|NCT01580293|453346376|FG000|Part A_Extension|Withdrawal by Subject|0|||
126014217|NCT01580293|453346377|FG001|Part A_Extension|Withdrawal by Subject|3|||
126014218|NCT01580293|453346378|FG002|Part A_Extension|Withdrawal by Subject|0|||
126014219|NCT01580293|453346376|FG000|Part A_Extension|Lost to Follow-up|0|||
126014220|NCT01580293|453346377|FG001|Part A_Extension|Lost to Follow-up|1|||
126014221|NCT01580293|453346378|FG002|Part A_Extension|Lost to Follow-up|0|||
126014222|NCT01580293|453346376|FG000|Part A_Extension|Other Reason|0|||
126014223|NCT01580293|453346377|FG001|Part A_Extension|Other Reason|1|||
126216732|NCT01336608|454084414|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
126216733|NCT01336608|454084415|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126349871|NCT04556097|454573021|FG001|Overall Study|Ineligible, language|1|||
126014224|NCT01580293|453346378|FG002|Part A_Extension|Other Reason|0|||
126014225|NCT01580293|453346376|FG000|Part A_Extension|Completed Japan only|0|||
126014226|NCT01580293|453346377|FG001|Part A_Extension|Completed Japan only|5|||
126014227|NCT01580293|453346378|FG002|Part A_Extension|Completed Japan only|0|||
126014228|NCT01580293|453346376|FG000|Part B|Withdrawal by Subject|0|||
126014229|NCT01580293|453346377|FG001|Part B|Withdrawal by Subject|0|||
126014230|NCT01580293|453346378|FG002|Part B|Withdrawal by Subject|1|||
126014231|NCT01580293|453346376|FG000|Part B|Other reason|0|||
126014232|NCT01580293|453346377|FG001|Part B|Other reason|0|||
126014233|NCT01580293|453346378|FG002|Part B|Other reason|1|||
126014234|NCT00768664|453346381|FG000|Overall Study|Death|57|||
126014235|NCT00768664|453346381|FG000|Overall Study|Lost to Follow-up|2|||
126014236|NCT00768664|453346381|FG000|Overall Study|Other|9|||
126014237|NCT00768664|453346381|FG000|Overall Study|Participant refused|1|||
126014238|NCT00708032|453346384|FG000|Overall Study|Adverse Event|0|||
126014239|NCT00708032|453346385|FG001|Overall Study|Adverse Event|2|||
126014240|NCT00708032|453346384|FG000|Overall Study|Lost to Follow-up|1|||
126014241|NCT00708032|453346385|FG001|Overall Study|Lost to Follow-up|2|||
126014242|NCT00708032|453346384|FG000|Overall Study|Pregnancy|0|||
126014243|NCT00708032|453346385|FG001|Overall Study|Pregnancy|1|||
126014244|NCT00708032|453346384|FG000|Overall Study|Poor vision|0|||
126014245|NCT00708032|453346385|FG001|Overall Study|Poor vision|6|||
126014246|NCT00708032|453346384|FG000|Overall Study|Visit out of range at month 12|4|||
126014247|NCT00708032|453346385|FG001|Overall Study|Visit out of range at month 12|1|||
126014248|NCT00708032|453346384|FG000|Overall Study|Did not meet protocol criteria|1|||
126014249|NCT00708032|453346385|FG001|Overall Study|Did not meet protocol criteria|2|||
126014250|NCT00708032|453346384|FG000|Overall Study|Protocol Violation|4|||
126014251|NCT00708032|453346385|FG001|Overall Study|Protocol Violation|1|||
126014252|NCT00708032|453346384|FG000|Overall Study|Withdrawal by Subject|0|||
126014253|NCT00708032|453346385|FG001|Overall Study|Withdrawal by Subject|1|||
126014254|NCT01400776|453346386|FG000|Overall Study|Adverse Event|7|||
126014255|NCT01400776|453346387|FG001|Overall Study|Adverse Event|2|||
126014256|NCT01400776|453346388|FG002|Overall Study|Adverse Event|9|||
126014257|NCT01400776|453346389|FG003|Overall Study|Adverse Event|2|||
126014258|NCT01400776|453346386|FG000|Overall Study|Lost to Follow-up|1|||
126014259|NCT01400776|453346387|FG001|Overall Study|Lost to Follow-up|0|||
126014260|NCT01400776|453346388|FG002|Overall Study|Lost to Follow-up|4|||
126014261|NCT01400776|453346389|FG003|Overall Study|Lost to Follow-up|1|||
126014262|NCT01400776|453346386|FG000|Overall Study|Withdrew Consent|4|||
126014263|NCT01400776|453346387|FG001|Overall Study|Withdrew Consent|2|||
126014264|NCT01400776|453346388|FG002|Overall Study|Withdrew Consent|6|||
126014265|NCT01400776|453346389|FG003|Overall Study|Withdrew Consent|1|||
126014266|NCT01400776|453346386|FG000|Overall Study|Protocol Deviation|6|||
126014267|NCT01400776|453346387|FG001|Overall Study|Protocol Deviation|1|||
126349872|NCT04556097|454573022|FG002|Overall Study|Ineligible, language|0|||
126349873|NCT04556097|454573023|FG003|Overall Study|Ineligible, language|0|||
126349874|NCT04556097|454573020|FG000|Overall Study|Ineligible, no longer in care management|0|||
126349875|NCT04556097|454573021|FG001|Overall Study|Ineligible, no longer in care management|2|||
126349876|NCT04556097|454573022|FG002|Overall Study|Ineligible, no longer in care management|1|||
126349877|NCT04556097|454573023|FG003|Overall Study|Ineligible, no longer in care management|0|||
126091149|NCT02218606|453628348|FG000|Overall Study|Withdrawal by Subject|4|||
126091150|NCT02218606|453628349|FG001|Overall Study|Withdrawal by Subject|0|||
126091151|NCT02218606|453628348|FG000|Overall Study|Noncompliance|1|||
126091152|NCT02218606|453628349|FG001|Overall Study|Noncompliance|0|||
126091153|NCT02218606|453628348|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
126091154|NCT02218606|453628349|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
126091155|NCT02218606|453628348|FG000|Overall Study|Other|2|||
126091156|NCT02218606|453628349|FG001|Overall Study|Other|1|||
126091157|NCT02218606|453628348|FG000|Overall Study|Never started treatment|0|||
126014268|NCT01400776|453346388|FG002|Overall Study|Protocol Deviation|5|||
126014269|NCT01400776|453346389|FG003|Overall Study|Protocol Deviation|2|||
126014270|NCT01400776|453346386|FG000|Overall Study|Reason not Specified|3|||
126014271|NCT01400776|453346387|FG001|Overall Study|Reason not Specified|0|||
126014272|NCT01400776|453346388|FG002|Overall Study|Reason not Specified|4|||
126014273|NCT01400776|453346389|FG003|Overall Study|Reason not Specified|3|||
126014274|NCT00423098|453346390|FG000|Overall Study|Adverse Event|1|||
126014275|NCT00423098|453346391|FG001|Overall Study|Adverse Event|2|||
126014276|NCT00423098|453346390|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126014277|NCT00423098|453346391|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126014278|NCT00423098|453346390|FG000|Overall Study|Administrative problems|0|||
126014279|NCT00423098|453346391|FG001|Overall Study|Administrative problems|1|||
126014280|NCT00423098|453346390|FG000|Overall Study|Death|2|||
126014281|NCT00423098|453346391|FG001|Overall Study|Death|0|||
126014282|NCT02320123|453346394|FG000|Overall Study|Lost to Follow-up|4|||
126014283|NCT02320123|453346395|FG001|Overall Study|Lost to Follow-up|6|||
126014284|NCT02320123|453346394|FG000|Overall Study|Death|6|||
126014285|NCT02320123|453346395|FG001|Overall Study|Death|5|||
126014286|NCT04480827|453346396|FG000|Overall Study|Adverse Event|0|||
126014287|NCT04480827|453346397|FG001|Overall Study|Adverse Event|0|||
126014288|NCT04480827|453346398|FG002|Overall Study|Adverse Event|0|||
126014289|NCT04480827|453346399|FG003|Overall Study|Adverse Event|0|||
126014290|NCT04480827|453346400|FG004|Overall Study|Adverse Event|0|||
126014291|NCT04480827|453346401|FG005|Overall Study|Adverse Event|1|||
126014292|NCT04480827|453346402|FG006|Overall Study|Adverse Event|0|||
126014293|NCT00465816|453346403|FG000|Overall Study|Lost to Follow-up|0|||
126014294|NCT00465816|453346404|FG001|Overall Study|Lost to Follow-up|0|||
126014295|NCT00465816|453346405|FG002|Overall Study|Lost to Follow-up|2|||
126014296|NCT00941655|453346412|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
126014297|NCT00941655|453346413|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
126014298|NCT00941655|453346412|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
126014299|NCT00941655|453346413|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
126014300|NCT00941655|453346412|FG000|Overall Study|progressed while on chemo|0|||
126014301|NCT00941655|453346413|FG001|Overall Study|progressed while on chemo|2|||
126014302|NCT00941655|453346412|FG000|Overall Study|refused further treatment|0|||
126014303|NCT00941655|453346413|FG001|Overall Study|refused further treatment|1|||
126014304|NCT00941655|453346412|FG000|Overall Study|withdrew consent|0|||
126014305|NCT00941655|453346413|FG001|Overall Study|withdrew consent|1|||
126014306|NCT00941655|453346412|FG000|Overall Study|non-compliant|0|||
126014307|NCT00941655|453346413|FG001|Overall Study|non-compliant|1|||
126014308|NCT02477670|453346417|FG000|Stage 1|Adverse Event|2|||
126014309|NCT02477670|453346418|FG001|Stage 1|Adverse Event|7|||
126014310|NCT02477670|453346419|FG002|Stage 1|Adverse Event|0|||
126014311|NCT02477670|453346420|FG003|Stage 1|Adverse Event|0|||
126014312|NCT02477670|453346421|FG004|Stage 1|Adverse Event|0|||
126014313|NCT02477670|453346422|FG005|Stage 1|Adverse Event|0|||
126014314|NCT02477670|453346423|FG006|Stage 1|Adverse Event|0|||
126014315|NCT02477670|453346417|FG000|Stage 1|Lost to Follow-up|0|||
126014316|NCT02477670|453346418|FG001|Stage 1|Lost to Follow-up|2|||
126014317|NCT02477670|453346419|FG002|Stage 1|Lost to Follow-up|0|||
126014318|NCT02477670|453346420|FG003|Stage 1|Lost to Follow-up|0|||
126014319|NCT02477670|453346421|FG004|Stage 1|Lost to Follow-up|0|||
126014320|NCT02477670|453346422|FG005|Stage 1|Lost to Follow-up|0|||
126014321|NCT02477670|453346423|FG006|Stage 1|Lost to Follow-up|0|||
126014322|NCT02477670|453346417|FG000|Stage 1|Withdrawal by Subject|1|||
126014323|NCT02477670|453346418|FG001|Stage 1|Withdrawal by Subject|2|||
126014324|NCT02477670|453346419|FG002|Stage 1|Withdrawal by Subject|0|||
126014325|NCT02477670|453346420|FG003|Stage 1|Withdrawal by Subject|0|||
126014326|NCT02477670|453346421|FG004|Stage 1|Withdrawal by Subject|0|||
126014327|NCT02477670|453346422|FG005|Stage 1|Withdrawal by Subject|0|||
126014328|NCT02477670|453346423|FG006|Stage 1|Withdrawal by Subject|0|||
126014329|NCT02477670|453346417|FG000|Stage 1|Non-compliance with Study Drug|1|||
126014330|NCT02477670|453346418|FG001|Stage 1|Non-compliance with Study Drug|2|||
126014331|NCT02477670|453346419|FG002|Stage 1|Non-compliance with Study Drug|0|||
126014332|NCT02477670|453346420|FG003|Stage 1|Non-compliance with Study Drug|0|||
126014333|NCT02477670|453346421|FG004|Stage 1|Non-compliance with Study Drug|0|||
126014334|NCT02477670|453346422|FG005|Stage 1|Non-compliance with Study Drug|0|||
126014335|NCT02477670|453346423|FG006|Stage 1|Non-compliance with Study Drug|0|||
126014336|NCT02477670|453346417|FG000|Stage 2|Adverse Event|0|||
126014337|NCT02477670|453346418|FG001|Stage 2|Adverse Event|0|||
126014338|NCT02477670|453346419|FG002|Stage 2|Adverse Event|1|||
126014339|NCT02477670|453346420|FG003|Stage 2|Adverse Event|0|||
126014340|NCT02477670|453346421|FG004|Stage 2|Adverse Event|0|||
126014341|NCT02477670|453346422|FG005|Stage 2|Adverse Event|0|||
126014342|NCT02477670|453346423|FG006|Stage 2|Adverse Event|0|||
126014343|NCT02477670|453346417|FG000|Stage 2|Antipsychotic Medication Changed|0|||
126014344|NCT02477670|453346418|FG001|Stage 2|Antipsychotic Medication Changed|0|||
126014345|NCT02477670|453346419|FG002|Stage 2|Antipsychotic Medication Changed|1|||
126014346|NCT02477670|453346420|FG003|Stage 2|Antipsychotic Medication Changed|0|||
126014347|NCT02477670|453346421|FG004|Stage 2|Antipsychotic Medication Changed|0|||
126014348|NCT02477670|453346422|FG005|Stage 2|Antipsychotic Medication Changed|0|||
126014349|NCT02477670|453346423|FG006|Stage 2|Antipsychotic Medication Changed|0|||
126014350|NCT02477670|453346417|FG000|Stage 2|Withdrawal by Subject|0|||
126014351|NCT02477670|453346418|FG001|Stage 2|Withdrawal by Subject|0|||
126014352|NCT02477670|453346419|FG002|Stage 2|Withdrawal by Subject|0|||
126014353|NCT02477670|453346420|FG003|Stage 2|Withdrawal by Subject|1|||
126014354|NCT02477670|453346421|FG004|Stage 2|Withdrawal by Subject|0|||
126014355|NCT02477670|453346422|FG005|Stage 2|Withdrawal by Subject|0|||
126014356|NCT02477670|453346423|FG006|Stage 2|Withdrawal by Subject|0|||
126014357|NCT00004124|453346424|FG000|Overall Study|Received no protocol therapy|12|||
126014358|NCT00004124|453346425|FG001|Overall Study|Received no protocol therapy|20|||
126014359|NCT00446550|453346427|FG000|Overall Study|Adverse Event|1|||
126014360|NCT00446550|453346428|FG001|Overall Study|Adverse Event|0|||
126014361|NCT02937831|453346429|FG000|Overall Study|Protocol Violation|4|||
126014362|NCT02983617|453346432|FG000|Overall Study|Adverse Event|0|||
126014363|NCT02983617|453346433|FG001|Overall Study|Adverse Event|7|||
126014364|NCT02983617|453346432|FG000|Overall Study|Death|0|||
126014365|NCT02983617|453346433|FG001|Overall Study|Death|1|||
126014366|NCT02983617|453346432|FG000|Overall Study|Investigator's Discretion|0|||
126014367|NCT02983617|453346433|FG001|Overall Study|Investigator's Discretion|1|||
126014368|NCT03720210|453346436|FG000|Overall Study|Lost to Follow-up|1|||
126014369|NCT00114244|453346441|FG000|Overall Study|Adverse Event|2|||
126014370|NCT00114244|453346442|FG001|Overall Study|Adverse Event|5|||
126014371|NCT00114244|453346441|FG000|Overall Study|Withdrawal by Subject|0|||
126014372|NCT00114244|453346442|FG001|Overall Study|Withdrawal by Subject|2|||
126014373|NCT00516386|453346443|FG000|Overall Study|not interested in the study|4|||
126014374|NCT00516386|453346443|FG000|Overall Study|Lost to Follow-up|2|||
126014375|NCT02698891|453346444|FG000|Overall Study|Withdrawal by Subject|2|||
126014376|NCT02698891|453346444|FG000|Overall Study|deemed ineligible|1|||
126014377|NCT02698891|453346444|FG000|Overall Study|Adverse Event|9|||
126014378|NCT00711958|453346445|FG000|Overall Study|Withdrawal by Subject|6|||
126014379|NCT00711958|453346446|FG001|Overall Study|Withdrawal by Subject|8|||
126014380|NCT00711958|453346445|FG000|Overall Study|Lack of Efficacy|3|||
126014381|NCT00711958|453346446|FG001|Overall Study|Lack of Efficacy|1|||
126014382|NCT00711958|453346445|FG000|Overall Study|Clinical deterioration|1|||
126014383|NCT00711958|453346446|FG001|Overall Study|Clinical deterioration|0|||
126014384|NCT00711958|453346445|FG000|Overall Study|Adverse Event|9|||
126014385|NCT00711958|453346446|FG001|Overall Study|Adverse Event|7|||
126014386|NCT00711958|453346445|FG000|Overall Study|Protocol Violation|1|||
126014387|NCT00711958|453346446|FG001|Overall Study|Protocol Violation|0|||
126014388|NCT00711958|453346445|FG000|Overall Study|Lost to Follow-up|2|||
126014389|NCT00711958|453346446|FG001|Overall Study|Lost to Follow-up|2|||
126014390|NCT00711958|453346445|FG000|Overall Study|Death|10|||
126014391|NCT00711958|453346446|FG001|Overall Study|Death|5|||
126014392|NCT00711958|453346445|FG000|Overall Study|Progression of disease|1|||
126014393|NCT00711958|453346446|FG001|Overall Study|Progression of disease|0|||
126014394|NCT02694978|453346449|FG000|Overall Study|Adverse Event|10|||
126014395|NCT02694978|453346450|FG001|Overall Study|Adverse Event|9|||
126014396|NCT02694978|453346449|FG000|Overall Study|Withdrawal by Subject|22|||
126014397|NCT02694978|453346450|FG001|Overall Study|Withdrawal by Subject|19|||
126014398|NCT02694978|453346449|FG000|Overall Study|Lost to Follow-up|14|||
126014399|NCT02694978|453346450|FG001|Overall Study|Lost to Follow-up|17|||
126014400|NCT02694978|453346449|FG000|Overall Study|Death|4|||
126014401|NCT02694978|453346450|FG001|Overall Study|Death|1|||
126014402|NCT02694978|453346449|FG000|Overall Study|Other-Decision of Participant|6|||
126014403|NCT02694978|453346450|FG001|Overall Study|Other-Decision of Participant|1|||
126014404|NCT02694978|453346449|FG000|Overall Study|Other-Investigator's decision|1|||
126014405|NCT02694978|453346450|FG001|Overall Study|Other-Investigator's decision|0|||
126014406|NCT02694978|453346449|FG000|Overall Study|Other-Unable to be reached|0|||
126014407|NCT02694978|453346450|FG001|Overall Study|Other-Unable to be reached|1|||
126014408|NCT02694978|453346449|FG000|Overall Study|Other-Protocol noncompliant|2|||
126216734|NCT01336608|454084416|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126216735|NCT01336608|454084413|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
126216736|NCT01336608|454084414|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
126014409|NCT02694978|453346450|FG001|Overall Study|Other-Protocol noncompliant|1|||
126014410|NCT02694978|453346449|FG000|Overall Study|Other-Personal reasons|3|||
126014411|NCT02694978|453346450|FG001|Overall Study|Other-Personal reasons|3|||
126014412|NCT02694978|453346449|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
126014413|NCT02694978|453346450|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
126014414|NCT00818454|453346451|FG000|Treatment Period 1|Adverse Event|0|||
126014415|NCT00818454|453346452|FG001|Treatment Period 1|Adverse Event|1|||
126014416|NCT00818454|453346453|FG002|Treatment Period 1|Adverse Event|0|||
126014417|NCT00818454|453346454|FG003|Treatment Period 1|Adverse Event|0|||
126014418|NCT00818454|453346451|FG000|Treatment Period 1|Other|3|||
126014419|NCT00818454|453346452|FG001|Treatment Period 1|Other|0|||
126014420|NCT00818454|453346453|FG002|Treatment Period 1|Other|0|||
126014421|NCT00818454|453346454|FG003|Treatment Period 1|Other|0|||
126014422|NCT00818454|453346451|FG000|Washout Period of 1 Week|Adverse Event|1|||
126014423|NCT00818454|453346452|FG001|Washout Period of 1 Week|Adverse Event|1|||
126014424|NCT00818454|453346453|FG002|Washout Period of 1 Week|Adverse Event|0|||
126014425|NCT00818454|453346454|FG003|Washout Period of 1 Week|Adverse Event|0|||
126014426|NCT00818454|453346451|FG000|Washout Period of 1 Week|Protocol Violation|2|||
126014427|NCT00818454|453346452|FG001|Washout Period of 1 Week|Protocol Violation|0|||
126014428|NCT00818454|453346453|FG002|Washout Period of 1 Week|Protocol Violation|0|||
126014429|NCT00818454|453346454|FG003|Washout Period of 1 Week|Protocol Violation|0|||
126014430|NCT00818454|453346451|FG000|Washout Period of 1 Week|Other|1|||
126014431|NCT00818454|453346452|FG001|Washout Period of 1 Week|Other|2|||
126014432|NCT00818454|453346453|FG002|Washout Period of 1 Week|Other|0|||
126014433|NCT00818454|453346454|FG003|Washout Period of 1 Week|Other|0|||
126014434|NCT00818454|453346451|FG000|Treatment Period 2|Other|2|||
126014435|NCT00818454|453346452|FG001|Treatment Period 2|Other|1|||
126014436|NCT00818454|453346453|FG002|Treatment Period 2|Other|0|||
126014437|NCT00818454|453346454|FG003|Treatment Period 2|Other|0|||
126014438|NCT00818454|453346451|FG000|Treatment Period 3|Adverse Event|0|||
126014439|NCT00818454|453346452|FG001|Treatment Period 3|Adverse Event|0|||
126014440|NCT00818454|453346453|FG002|Treatment Period 3|Adverse Event|0|||
126014441|NCT00818454|453346454|FG003|Treatment Period 3|Adverse Event|1|||
126014442|NCT01613716|453346455|FG000|Overall Study|screen failures|3|||
126014443|NCT01613716|453346455|FG000|Overall Study|Lost to Follow-up|4|||
126014444|NCT01171625|453346457|FG000|Overall Study|On-Protocol|67|||
126014445|NCT01171625|453346457|FG000|Overall Study|Death|38|||
126014446|NCT01171625|453346457|FG000|Overall Study|Withdrawal by Subject|31|||
126014447|NCT01171625|453346457|FG000|Overall Study|Explanted|10|||
126014448|NCT01171625|453346457|FG000|Overall Study|Lost to Follow-up|5|||
126014449|NCT01171625|453346457|FG000|Overall Study|Patient received valve-in-valve|3|||
126014450|NCT01171625|453346457|FG000|Overall Study|Other|1|||
126014451|NCT01171625|453346457|FG000|Overall Study|Consented but did not receive device|25|||
126014452|NCT03287622|453346464|FG000|Overall Study|Withdrawal by Subject|1|||
126014453|NCT03287622|453346465|FG001|Overall Study|Withdrawal by Subject|0|||
126014454|NCT03287622|453346464|FG000|Overall Study|Lost to Follow-up|27|||
126014455|NCT03287622|453346465|FG001|Overall Study|Lost to Follow-up|15|||
126014456|NCT03287622|453346464|FG000|Overall Study|No prescripion after surgery|28|||
126014457|NCT03287622|453346465|FG001|Overall Study|No prescripion after surgery|31|||
126014458|NCT03287622|453346464|FG000|Overall Study|prolonged Length of stay|2|||
126014459|NCT03287622|453346465|FG001|Overall Study|prolonged Length of stay|0|||
126014460|NCT03287622|453346464|FG000|Overall Study|surgery related|0|||
126014461|NCT03287622|453346465|FG001|Overall Study|surgery related|2|||
126014462|NCT03823300|453346466|FG000|Overall Study|Withdrawal by Subject|16|||
126014463|NCT03823300|453346467|FG001|Overall Study|Withdrawal by Subject|22|||
126014464|NCT03823300|453346466|FG000|Overall Study|Death|10|||
126014465|NCT03823300|453346467|FG001|Overall Study|Death|14|||
126014466|NCT03823300|453346466|FG000|Overall Study|Adverse Event|3|||
126014467|NCT03823300|453346467|FG001|Overall Study|Adverse Event|5|||
126014468|NCT03823300|453346466|FG000|Overall Study|Physician Decision|1|||
126014469|NCT03823300|453346467|FG001|Overall Study|Physician Decision|7|||
126014470|NCT03823300|453346466|FG000|Overall Study|Lost to Follow-up|1|||
126014471|NCT03823300|453346467|FG001|Overall Study|Lost to Follow-up|3|||
126014472|NCT03823300|453346466|FG000|Overall Study|Protocol Violation|1|||
126014473|NCT03823300|453346467|FG001|Overall Study|Protocol Violation|1|||
126014474|NCT03823300|453346466|FG000|Overall Study|Lack of Efficacy|1|||
126014475|NCT03823300|453346467|FG001|Overall Study|Lack of Efficacy|1|||
126014476|NCT03823300|453346466|FG000|Overall Study|Not Eligible|0|||
126014477|NCT03823300|453346467|FG001|Overall Study|Not Eligible|1|||
126014478|NCT03823300|453346466|FG000|Overall Study|Other|1|||
126014479|NCT03823300|453346467|FG001|Overall Study|Other|0|||
126306161|NCT03689374|454408912|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
126014480|NCT00507689|453346470|FG000|Pre-Randomization Period|Adverse Event|1|||
126014481|NCT00507689|453346471|FG001|Pre-Randomization Period|Adverse Event|0|||
126014482|NCT00507689|453346470|FG000|Pre-Randomization Period|Physician Decision|1|||
126216737|NCT01336608|454084415|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
126014483|NCT00507689|453346471|FG001|Pre-Randomization Period|Physician Decision|0|||
126014484|NCT00507689|453346470|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
126014485|NCT00507689|453346471|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
126014486|NCT00507689|453346470|FG000|Randomized Period|Adverse Event|1|||
126014487|NCT00507689|453346471|FG001|Randomized Period|Adverse Event|1|||
126014488|NCT00507689|453346470|FG000|Randomized Period|Withdrawal by Subject|0|||
126014489|NCT00507689|453346471|FG001|Randomized Period|Withdrawal by Subject|1|||
126014490|NCT01786564|453346472|FG000|Overall Study|Lost to Follow-up|47|||
126014491|NCT01786564|453346472|FG000|Overall Study|Ineligible|17|||
126014492|NCT03184558|453346473|FG000|Overall Study|Withdrawal by Subject|2|||
126014493|NCT03184558|453346473|FG000|Overall Study|Death|16|||
126014494|NCT03184558|453346473|FG000|Overall Study|Lost to Follow-up|2|||
126014495|NCT03184558|453346473|FG000|Overall Study|Other|9|||
126014496|NCT02506257|453346474|FG000|Overall Study|Adverse Event|0|||
126014497|NCT02506257|453346475|FG001|Overall Study|Adverse Event|2|||
126014498|NCT02506257|453346476|FG002|Overall Study|Adverse Event|3|||
126014499|NCT02506257|453346477|FG003|Overall Study|Adverse Event|0|||
126014500|NCT02506257|453346474|FG000|Overall Study|Protocol Violation|0|||
126014501|NCT02506257|453346475|FG001|Overall Study|Protocol Violation|0|||
126014502|NCT02506257|453346476|FG002|Overall Study|Protocol Violation|1|||
126014503|NCT02506257|453346477|FG003|Overall Study|Protocol Violation|0|||
126014504|NCT01924767|453346480|FG000|Overall Study|Adverse Event|1|||
126014505|NCT01924767|453346481|FG001|Overall Study|Adverse Event|0|||
126014506|NCT01924767|453346482|FG002|Overall Study|Adverse Event|1|||
126014507|NCT01924767|453346483|FG003|Overall Study|Adverse Event|0|||
126014508|NCT01924767|453346484|FG004|Overall Study|Adverse Event|0|||
126014509|NCT00723450|453346485|FG000|Open-Label Phase|Adverse Event|26|||
126014510|NCT00723450|453346486|FG001|Open-Label Phase|Adverse Event|0|||
126014511|NCT00723450|453346487|FG002|Open-Label Phase|Adverse Event|0|||
126014512|NCT00723450|453346485|FG000|Open-Label Phase|Lack of Efficacy|18|||
126014513|NCT00723450|453346486|FG001|Open-Label Phase|Lack of Efficacy|0|||
126014514|NCT00723450|453346487|FG002|Open-Label Phase|Lack of Efficacy|0|||
126014515|NCT00723450|453346485|FG000|Open-Label Phase|Protocol Violation|35|||
126014516|NCT00723450|453346486|FG001|Open-Label Phase|Protocol Violation|0|||
126014517|NCT00723450|453346487|FG002|Open-Label Phase|Protocol Violation|0|||
126014518|NCT00723450|453346485|FG000|Open-Label Phase|Lost to Follow-up|7|||
126014519|NCT00723450|453346486|FG001|Open-Label Phase|Lost to Follow-up|0|||
126014520|NCT00723450|453346487|FG002|Open-Label Phase|Lost to Follow-up|0|||
126014521|NCT00723450|453346485|FG000|Open-Label Phase|Physician Decision|2|||
126014522|NCT00723450|453346486|FG001|Open-Label Phase|Physician Decision|0|||
126014523|NCT00723450|453346487|FG002|Open-Label Phase|Physician Decision|0|||
126014524|NCT00723450|453346485|FG000|Open-Label Phase|Withdrawal by Subject|37|||
126014525|NCT00723450|453346486|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126014526|NCT00723450|453346487|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126014527|NCT00723450|453346485|FG000|Randomized Phase|Adverse Event|0|||
126014528|NCT00723450|453346486|FG001|Randomized Phase|Adverse Event|26|||
126014529|NCT00723450|453346487|FG002|Randomized Phase|Adverse Event|17|||
126014530|NCT00723450|453346485|FG000|Randomized Phase|Lack of Efficacy|0|||
126014531|NCT00723450|453346486|FG001|Randomized Phase|Lack of Efficacy|11|||
126014532|NCT00723450|453346487|FG002|Randomized Phase|Lack of Efficacy|11|||
126014533|NCT00723450|453346485|FG000|Randomized Phase|Protocol Violation|0|||
126014534|NCT00723450|453346486|FG001|Randomized Phase|Protocol Violation|9|||
126014535|NCT00723450|453346487|FG002|Randomized Phase|Protocol Violation|13|||
126014536|NCT00723450|453346485|FG000|Randomized Phase|Lost to Follow-up|0|||
126014537|NCT00723450|453346486|FG001|Randomized Phase|Lost to Follow-up|2|||
126014538|NCT00723450|453346487|FG002|Randomized Phase|Lost to Follow-up|3|||
126014539|NCT00723450|453346485|FG000|Randomized Phase|Physician Decision|0|||
126014540|NCT00723450|453346486|FG001|Randomized Phase|Physician Decision|3|||
126014541|NCT00723450|453346487|FG002|Randomized Phase|Physician Decision|1|||
126014542|NCT00723450|453346485|FG000|Randomized Phase|Withdrawal by Subject|0|||
126014543|NCT00723450|453346486|FG001|Randomized Phase|Withdrawal by Subject|14|||
126014544|NCT00723450|453346487|FG002|Randomized Phase|Withdrawal by Subject|22|||
126014545|NCT00612586|453346488|FG000|Overall Study|Adverse Event|6|||
126014546|NCT00612586|453346489|FG001|Overall Study|Adverse Event|2|||
126014547|NCT00612586|453346488|FG000|Overall Study|Death|1|||
126014548|NCT00612586|453346489|FG001|Overall Study|Death|0|||
126014549|NCT00612586|453346488|FG000|Overall Study|Entry Criteria Not Met|0|||
126014550|NCT00612586|453346489|FG001|Overall Study|Entry Criteria Not Met|2|||
126216738|NCT01336608|454084416|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
126349878|NCT04556097|454573020|FG000|Overall Study|No dementia|13|||
126014551|NCT00612586|453346488|FG000|Overall Study|Withdrawal by Subject|7|||
126014552|NCT00612586|453346489|FG001|Overall Study|Withdrawal by Subject|9|||
126014553|NCT00612586|453346488|FG000|Overall Study|Physician Decision|1|||
126014554|NCT00612586|453346489|FG001|Overall Study|Physician Decision|2|||
126014555|NCT00612586|453346488|FG000|Overall Study|Sponsor Decision|1|||
126014556|NCT00612586|453346489|FG001|Overall Study|Sponsor Decision|1|||
126014557|NCT00612586|453346488|FG000|Overall Study|Progressive Disease|26|||
126014558|NCT00612586|453346489|FG001|Overall Study|Progressive Disease|24|||
126014559|NCT00612586|453346488|FG000|Overall Study|Randomized and Not Treated|1|||
126014560|NCT00612586|453346489|FG001|Overall Study|Randomized and Not Treated|1|||
126014561|NCT03192046|453346490|FG000|Overall Study|Withdrawal by Subject|1|||
126014562|NCT03192046|453346491|FG001|Overall Study|Withdrawal by Subject|1|||
126014563|NCT00762606|453346492|FG000|Overall Study|Lost to Follow-up|18|||
126014564|NCT00762606|453346493|FG001|Overall Study|Lost to Follow-up|13|||
126014565|NCT01194154|453346494|FG000|Overall Study|Adverse Event|12|||
126014566|NCT01194154|453346495|FG001|Overall Study|Adverse Event|7|||
126014567|NCT01194154|453346494|FG000|Overall Study|Lost to Follow-up|2|||
126014568|NCT01194154|453346495|FG001|Overall Study|Lost to Follow-up|3|||
126014569|NCT01194154|453346494|FG000|Overall Study|Protocol Violation|0|||
126014570|NCT01194154|453346495|FG001|Overall Study|Protocol Violation|1|||
126014571|NCT01194154|453346494|FG000|Overall Study|Withdrawal by Subject|5|||
126014572|NCT01194154|453346495|FG001|Overall Study|Withdrawal by Subject|6|||
126014573|NCT01194154|453346494|FG000|Overall Study|Blood pressure increase|5|||
126014574|NCT01194154|453346495|FG001|Overall Study|Blood pressure increase|3|||
126014575|NCT01194154|453346494|FG000|Overall Study|Hemoglobin decrease|0|||
126014576|NCT01194154|453346495|FG001|Overall Study|Hemoglobin decrease|1|||
126014577|NCT01194154|453346494|FG000|Overall Study|Hemoglobin increase|12|||
126014578|NCT01194154|453346495|FG001|Overall Study|Hemoglobin increase|3|||
126014579|NCT01194154|453346494|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
126014580|NCT01194154|453346495|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
126014581|NCT01194154|453346494|FG000|Overall Study|Treatment with prohibited medication|4|||
126014582|NCT01194154|453346495|FG001|Overall Study|Treatment with prohibited medication|5|||
126014583|NCT01194154|453346494|FG000|Overall Study|Other|4|||
126014584|NCT01194154|453346495|FG001|Overall Study|Other|0|||
126014585|NCT01194154|453346494|FG000|Overall Study|Did not receive study medication|2|||
126014586|NCT01194154|453346495|FG001|Overall Study|Did not receive study medication|4|||
126014587|NCT01505881|453346496|FG000|Overall Study|Adverse Event|0|||
126014588|NCT01505881|453346497|FG001|Overall Study|Adverse Event|1|||
126014589|NCT01505881|453346496|FG000|Overall Study|Lost to Follow-up|2|||
126014590|NCT01505881|453346497|FG001|Overall Study|Lost to Follow-up|0|||
126014591|NCT01505881|453346496|FG000|Overall Study|Withdrawal by Subject|2|||
126014592|NCT01505881|453346497|FG001|Overall Study|Withdrawal by Subject|0|||
126014593|NCT01909336|453346498|FG000|Overall Study|Lost to Follow-up|4|||
126014594|NCT01909336|453346499|FG001|Overall Study|Lost to Follow-up|2|||
126014595|NCT01909336|453346500|FG002|Overall Study|Lost to Follow-up|2|||
126014596|NCT01909336|453346498|FG000|Overall Study|Physician Decision|0|||
126014597|NCT01909336|453346499|FG001|Overall Study|Physician Decision|1|||
126014598|NCT01909336|453346500|FG002|Overall Study|Physician Decision|1|||
126014599|NCT00842257|453346501|FG000|Overall Study|Adverse Event|1|||
126014600|NCT00395018|453346502|FG000|On-Treatment|Death|4|||
126014601|NCT00395018|453346502|FG000|On-Treatment|Other Reason|2|||
126014602|NCT00395018|453346502|FG000|On-Treatment|Poor/non-compliance|2|||
126014603|NCT00395018|453346502|FG000|On-Treatment|Subject no longer meets study criteria|2|||
126014604|NCT00395018|453346502|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
126014605|NCT00395018|453346502|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
126014606|NCT00395018|453346502|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
126014607|NCT02314117|453346503|FG000|Overall Study|Lost to Follow-up|9|||
126014608|NCT02314117|453346504|FG001|Overall Study|Lost to Follow-up|14|||
126014609|NCT02314117|453346503|FG000|Overall Study|Withdrawal by Subject|3|||
126014610|NCT02314117|453346504|FG001|Overall Study|Withdrawal by Subject|2|||
126014611|NCT02026258|453346505|FG000|Randomized|Did not start treatment|2|||
126014612|NCT02026258|453346506|FG001|Randomized|Did not start treatment|1|||
126014613|NCT02026258|453346505|FG000|Randomized|Change in treatment plan|1|||
126014614|NCT02026258|453346506|FG001|Randomized|Change in treatment plan|0|||
126014615|NCT02026258|453346505|FG000|Randomized|Presence of periodontal disease|1|||
126014616|NCT02026258|453346506|FG001|Randomized|Presence of periodontal disease|1|||
126014617|NCT02026258|453346505|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
126014618|NCT02026258|453346506|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
126014619|NCT02026258|453346505|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
126014620|NCT02026258|453346506|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
126014621|NCT04439799|453346507|FG000|Overall Study|Lost to Follow-up|6|||
126014622|NCT04439799|453346508|FG001|Overall Study|Lost to Follow-up|6|||
126014623|NCT04439799|453346507|FG000|Overall Study|Withdrawal by Subject|2|||
126014624|NCT04439799|453346508|FG001|Overall Study|Withdrawal by Subject|6|||
126014625|NCT04439799|453346507|FG000|Overall Study|Adverse Event|2|||
126014626|NCT04439799|453346508|FG001|Overall Study|Adverse Event|5|||
126014627|NCT00530842|453346514|FG000|Overall Study|Adverse Event|10|||
126014628|NCT00530842|453346515|FG001|Overall Study|Adverse Event|6|||
126014629|NCT00530842|453346514|FG000|Overall Study|Lack of Efficacy|2|||
126014630|NCT00530842|453346515|FG001|Overall Study|Lack of Efficacy|1|||
126014631|NCT00530842|453346514|FG000|Overall Study|Lost to Follow-up|0|||
126014632|NCT00530842|453346515|FG001|Overall Study|Lost to Follow-up|4|||
126014633|NCT00530842|453346514|FG000|Overall Study|Protocol Violation|3|||
126014634|NCT00530842|453346515|FG001|Overall Study|Protocol Violation|2|||
126014635|NCT00530842|453346514|FG000|Overall Study|Withdrawal by Subject|4|||
126014636|NCT00530842|453346515|FG001|Overall Study|Withdrawal by Subject|5|||
126014637|NCT00530842|453346514|FG000|Overall Study|Individual different reasons|4|||
126014638|NCT00530842|453346515|FG001|Overall Study|Individual different reasons|3|||
126014639|NCT00530842|453346514|FG000|Period 1|Adverse Event|7|||
126014640|NCT00530842|453346515|FG001|Period 1|Adverse Event|3|||
126014641|NCT00530842|453346514|FG000|Period 1|Lack of Efficacy|1|||
126014642|NCT00530842|453346515|FG001|Period 1|Lack of Efficacy|1|||
126014643|NCT00530842|453346514|FG000|Period 1|Protocol Violation|2|||
126014644|NCT00530842|453346515|FG001|Period 1|Protocol Violation|1|||
126014645|NCT00530842|453346514|FG000|Period 1|Withdrawal by Subject|2|||
126014646|NCT00530842|453346515|FG001|Period 1|Withdrawal by Subject|3|||
126014647|NCT00530842|453346514|FG000|Period 1|Individual different reasons|2|||
126014648|NCT00530842|453346515|FG001|Period 1|Individual different reasons|3|||
126014649|NCT00530842|453346514|FG000|Period 2|Adverse Event|3|||
126014650|NCT00530842|453346515|FG001|Period 2|Adverse Event|3|||
126014651|NCT00530842|453346514|FG000|Period 2|Lack of Efficacy|1|||
126216739|NCT01336608|454084413|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126216740|NCT01336608|454084414|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
126216741|NCT01336608|454084415|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
126349879|NCT04556097|454573021|FG001|Overall Study|No dementia|3|||
126014652|NCT00530842|453346515|FG001|Period 2|Lack of Efficacy|0|||
126014653|NCT00530842|453346514|FG000|Period 2|Lost to Follow-up|0|||
126014654|NCT00530842|453346515|FG001|Period 2|Lost to Follow-up|4|||
126014655|NCT00530842|453346514|FG000|Period 2|Protocol Violation|1|||
126014656|NCT00530842|453346515|FG001|Period 2|Protocol Violation|0|||
126014657|NCT00530842|453346514|FG000|Period 2|Withdrawal by Subject|1|||
126014658|NCT00530842|453346515|FG001|Period 2|Withdrawal by Subject|2|||
126014659|NCT00530842|453346514|FG000|Period 2|Individual different reasons|2|||
126014660|NCT00530842|453346515|FG001|Period 2|Individual different reasons|0|||
126014661|NCT02534350|453346516|FG000|Overall Study|Randomized But Not Treated|1|||
126014662|NCT02534350|453346517|FG001|Overall Study|Randomized But Not Treated|0|||
126349880|NCT04556097|454573022|FG002|Overall Study|No dementia|0|||
126349881|NCT04556097|454573023|FG003|Overall Study|No dementia|0|||
126349882|NCT04556097|454573020|FG000|Overall Study|Missing identifier|2|||
126014663|NCT02534350|453346516|FG000|Overall Study|Protocol Violation|1|||
126014664|NCT02534350|453346517|FG001|Overall Study|Protocol Violation|0|||
126014665|NCT02534350|453346516|FG000|Overall Study|Withdrew Consent|2|||
126014666|NCT02534350|453346517|FG001|Overall Study|Withdrew Consent|0|||
126014667|NCT04513522|453349143|FG000|Overall Study|Other reasons|1|||
126014668|NCT04513522|453349143|FG000|Overall Study|Adverse event unrelated to study drug|9|||
126014669|NCT04513522|453349143|FG000|Overall Study|Study drug toxicity|14|||
126014670|NCT04513522|453349143|FG000|Overall Study|Disease progression|39|||
126014671|NCT04513522|453349143|FG000|Overall Study|Participants withdrew consent|2|||
126014672|NCT00589667|453349144|FG000|Overall Study|Adverse Event|2|||
126014673|NCT00589667|453349144|FG000|Overall Study|Withdrawal by Subject|1|||
126014674|NCT03538041|453349147|FG000|12-Week Treatment Period|Adverse Event|1|||
126014675|NCT03538041|453349148|FG001|12-Week Treatment Period|Adverse Event|1|||
126014676|NCT03538041|453349147|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
126014677|NCT03538041|453349148|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
126014678|NCT03538041|453349147|FG000|Treatment Extension Period|Adverse Event|4|||
126014679|NCT03538041|453349148|FG001|Treatment Extension Period|Adverse Event|1|||
126014680|NCT03538041|453349147|FG000|Treatment Extension Period|Physician Decision|1|||
126014681|NCT03538041|453349148|FG001|Treatment Extension Period|Physician Decision|1|||
126014682|NCT03538041|453349147|FG000|Treatment Extension Period|Lack of Efficacy|1|||
126014683|NCT03538041|453349148|FG001|Treatment Extension Period|Lack of Efficacy|4|||
126014684|NCT03538041|453349147|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
126014685|NCT03538041|453349148|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
126014686|NCT03538041|453349147|FG000|Treatment Extension Period|Death|0|||
126014687|NCT03538041|453349148|FG001|Treatment Extension Period|Death|1|||
126014688|NCT02296424|453349151|FG000|Part 1|New therapy for study indication|0|||
126014689|NCT02296424|453349152|FG001|Part 1|New therapy for study indication|1|||
126014690|NCT02296424|453349153|FG002|Part 1|New therapy for study indication|0|||
126014691|NCT02296424|453349154|FG003|Part 1|New therapy for study indication|0|||
126014692|NCT02296424|453349151|FG000|Part 1|Protocol Violation|0|||
126014693|NCT02296424|453349152|FG001|Part 1|Protocol Violation|1|||
126091158|NCT02218606|453628349|FG001|Overall Study|Never started treatment|1|||
126091159|NCT03203473|453628350|FG000|Induction Phase|Never started primary treatment|2|||
126091160|NCT03203473|453628351|FG001|Induction Phase|Never started primary treatment|0|||
126091161|NCT03203473|453628352|FG002|Induction Phase|Never started primary treatment|0|||
126091162|NCT03203473|453628350|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
126091163|NCT03203473|453628351|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
126091164|NCT03203473|453628352|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
126091165|NCT03203473|453628350|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
126091166|NCT03203473|453628351|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
126091167|NCT03203473|453628352|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
126091168|NCT03203473|453628350|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
126091169|NCT03203473|453628351|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
126091170|NCT03203473|453628352|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
126091171|NCT03203473|453628350|FG000|Arm Allocation Phase|started salvage therapy|0|||
126091172|NCT03203473|453628351|FG001|Arm Allocation Phase|started salvage therapy|5|||
126091173|NCT03203473|453628352|FG002|Arm Allocation Phase|started salvage therapy|0|||
126091174|NCT03203473|453628350|FG000|Arm Allocation Phase|Disease progression|0|||
126091175|NCT03203473|453628351|FG001|Arm Allocation Phase|Disease progression|0|||
126091176|NCT03203473|453628352|FG002|Arm Allocation Phase|Disease progression|37|||
126091177|NCT03203473|453628350|FG000|Arm Allocation Phase|Adverse Event|0|||
126091178|NCT03203473|453628351|FG001|Arm Allocation Phase|Adverse Event|0|||
126091179|NCT03203473|453628352|FG002|Arm Allocation Phase|Adverse Event|11|||
126091180|NCT03203473|453628350|FG000|Arm Allocation Phase|Physician Decision|0|||
126091181|NCT03203473|453628351|FG001|Arm Allocation Phase|Physician Decision|0|||
126091182|NCT03203473|453628352|FG002|Arm Allocation Phase|Physician Decision|3|||
126091183|NCT03203473|453628350|FG000|Arm Allocation Phase|Death|0|||
126091184|NCT03203473|453628351|FG001|Arm Allocation Phase|Death|0|||
126091185|NCT03203473|453628352|FG002|Arm Allocation Phase|Death|1|||
126091186|NCT03203473|453628350|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
126091187|NCT03203473|453628351|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
126091188|NCT03203473|453628352|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
126091189|NCT03203473|453628350|FG000|Arm Allocation Phase|Intercurrent illness|0|||
126091190|NCT03203473|453628351|FG001|Arm Allocation Phase|Intercurrent illness|0|||
126091191|NCT03203473|453628352|FG002|Arm Allocation Phase|Intercurrent illness|1|||
126091192|NCT03203473|453628350|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
126091193|NCT03203473|453628351|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
126091194|NCT03203473|453628352|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
126014694|NCT02296424|453349153|FG002|Part 1|Protocol Violation|0|||
126014695|NCT02296424|453349154|FG003|Part 1|Protocol Violation|0|||
126014696|NCT02296424|453349151|FG000|Part 1|Withdrawal by Subject|0|||
126014697|NCT02296424|453349152|FG001|Part 1|Withdrawal by Subject|2|||
126091195|NCT00890695|453628353|FG000|Overall Study|Protocol Violation|1|||
126091196|NCT00890695|453628354|FG001|Overall Study|Protocol Violation|0|||
126014698|NCT02296424|453349153|FG002|Part 1|Withdrawal by Subject|0|||
126014699|NCT02296424|453349154|FG003|Part 1|Withdrawal by Subject|0|||
126014700|NCT02296424|453349151|FG000|Part 1|Study terminated by sponsor|0|||
126014701|NCT02296424|453349152|FG001|Part 1|Study terminated by sponsor|1|||
126014702|NCT02296424|453349153|FG002|Part 1|Study terminated by sponsor|0|||
126014703|NCT02296424|453349154|FG003|Part 1|Study terminated by sponsor|0|||
126014704|NCT02296424|453349151|FG000|Part 1|Adverse Event|2|||
126014705|NCT02296424|453349152|FG001|Part 1|Adverse Event|11|||
126014706|NCT02296424|453349153|FG002|Part 1|Adverse Event|0|||
126014707|NCT02296424|453349154|FG003|Part 1|Adverse Event|0|||
126014708|NCT02296424|453349151|FG000|Part 1|Lack of Efficacy|5|||
126014709|NCT02296424|453349152|FG001|Part 1|Lack of Efficacy|17|||
126014710|NCT02296424|453349153|FG002|Part 1|Lack of Efficacy|0|||
126014711|NCT02296424|453349154|FG003|Part 1|Lack of Efficacy|0|||
126014712|NCT02296424|453349151|FG000|Part 1|16 directly started part II|16|||
126014713|NCT02296424|453349152|FG001|Part 1|16 directly started part II|0|||
126014714|NCT02296424|453349153|FG002|Part 1|16 directly started part II|0|||
126014715|NCT02296424|453349154|FG003|Part 1|16 directly started part II|0|||
126014716|NCT02296424|453349151|FG000|Part 2|Lack of Efficacy|0|||
126014717|NCT02296424|453349152|FG001|Part 2|Lack of Efficacy|0|||
126014718|NCT02296424|453349153|FG002|Part 2|Lack of Efficacy|1|||
126014719|NCT02296424|453349154|FG003|Part 2|Lack of Efficacy|0|||
126014720|NCT02296424|453349151|FG000|Part 2|Adverse Event|0|||
126014721|NCT02296424|453349152|FG001|Part 2|Adverse Event|0|||
126014722|NCT02296424|453349153|FG002|Part 2|Adverse Event|1|||
126014723|NCT02296424|453349154|FG003|Part 2|Adverse Event|0|||
126014724|NCT02296424|453349151|FG000|Part 2|Lost to Follow-up|0|||
126014725|NCT02296424|453349152|FG001|Part 2|Lost to Follow-up|0|||
126014726|NCT02296424|453349153|FG002|Part 2|Lost to Follow-up|1|||
126014727|NCT02296424|453349154|FG003|Part 2|Lost to Follow-up|0|||
126014728|NCT00807144|453349157|FG000|Overall Study|Lost to Follow-up|0|||
126014729|NCT00807144|453349158|FG001|Overall Study|Lost to Follow-up|1|||
126216742|NCT01336608|454084416|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
126216743|NCT01336608|454084413|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
126216744|NCT01336608|454084414|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
126216745|NCT01336608|454084415|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
126216746|NCT01336608|454084416|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
126216747|NCT01336608|454084413|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126216748|NCT01336608|454084414|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
126216749|NCT01336608|454084415|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126091197|NCT01531673|453628355|FG000|Overall Study|Non-Compliance|0|||
126091198|NCT01531673|453628356|FG001|Overall Study|Non-Compliance|0|||
126091199|NCT01531673|453628357|FG002|Overall Study|Non-Compliance|0|||
126091200|NCT01531673|453628358|FG003|Overall Study|Non-Compliance|0|||
126091201|NCT01531673|453628359|FG004|Overall Study|Non-Compliance|0|||
126091202|NCT01531673|453628360|FG005|Overall Study|Non-Compliance|1|||
126091203|NCT01531673|453628361|FG006|Overall Study|Non-Compliance|0|||
126091204|NCT01531673|453628362|FG007|Overall Study|Non-Compliance|0|||
126091205|NCT01531673|453628363|FG008|Overall Study|Non-Compliance|0|||
126091206|NCT01531673|453628364|FG009|Overall Study|Non-Compliance|0|||
126091207|NCT01531673|453628365|FG010|Overall Study|Non-Compliance|0|||
126091208|NCT01531673|453628366|FG011|Overall Study|Non-Compliance|0|||
126091209|NCT01531673|453628367|FG012|Overall Study|Non-Compliance|0|||
126091210|NCT01531673|453628355|FG000|Overall Study|Adverse Event|0|||
126091211|NCT01531673|453628356|FG001|Overall Study|Adverse Event|1|||
126091212|NCT01531673|453628357|FG002|Overall Study|Adverse Event|0|||
126091213|NCT01531673|453628358|FG003|Overall Study|Adverse Event|0|||
126091214|NCT01531673|453628359|FG004|Overall Study|Adverse Event|0|||
126091215|NCT01531673|453628360|FG005|Overall Study|Adverse Event|0|||
126091216|NCT01531673|453628361|FG006|Overall Study|Adverse Event|0|||
126091217|NCT01531673|453628362|FG007|Overall Study|Adverse Event|0|||
126091218|NCT01531673|453628363|FG008|Overall Study|Adverse Event|0|||
126091219|NCT01531673|453628364|FG009|Overall Study|Adverse Event|0|||
126091220|NCT01531673|453628365|FG010|Overall Study|Adverse Event|0|||
126091221|NCT01531673|453628366|FG011|Overall Study|Adverse Event|0|||
126091222|NCT01531673|453628367|FG012|Overall Study|Adverse Event|0|||
126014730|NCT01307267|453349159|FG000|Overall Study|Death|4|||
126091223|NCT01531673|453628355|FG000|Overall Study|Lost to Follow-up|0|||
126014731|NCT01307267|453349160|FG001|Overall Study|Death|3|||
126014732|NCT01307267|453349161|FG002|Overall Study|Death|5|||
126014733|NCT01307267|453349162|FG003|Overall Study|Death|3|||
126014734|NCT01307267|453349163|FG004|Overall Study|Death|1|||
126014735|NCT01307267|453349164|FG005|Overall Study|Death|26|||
126014736|NCT01307267|453349165|FG006|Overall Study|Death|2|||
126091224|NCT01531673|453628356|FG001|Overall Study|Lost to Follow-up|0|||
126091225|NCT01531673|453628357|FG002|Overall Study|Lost to Follow-up|0|||
126216750|NCT01336608|454084416|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126091226|NCT01531673|453628358|FG003|Overall Study|Lost to Follow-up|0|||
126091227|NCT01531673|453628359|FG004|Overall Study|Lost to Follow-up|1|||
126091228|NCT01531673|453628360|FG005|Overall Study|Lost to Follow-up|0|||
126014737|NCT01307267|453349166|FG007|Overall Study|Death|2|||
126091229|NCT01531673|453628361|FG006|Overall Study|Lost to Follow-up|0|||
126091230|NCT01531673|453628362|FG007|Overall Study|Lost to Follow-up|0|||
126091231|NCT01531673|453628363|FG008|Overall Study|Lost to Follow-up|0|||
126091232|NCT01531673|453628364|FG009|Overall Study|Lost to Follow-up|0|||
126091233|NCT01531673|453628365|FG010|Overall Study|Lost to Follow-up|0|||
126091234|NCT01531673|453628366|FG011|Overall Study|Lost to Follow-up|0|||
126091235|NCT01531673|453628367|FG012|Overall Study|Lost to Follow-up|0|||
126091236|NCT01531673|453628355|FG000|Overall Study|Other|0|||
126091237|NCT01531673|453628356|FG001|Overall Study|Other|0|||
126091238|NCT01531673|453628357|FG002|Overall Study|Other|0|||
126091239|NCT01531673|453628358|FG003|Overall Study|Other|1|||
126091240|NCT01531673|453628359|FG004|Overall Study|Other|0|||
126091241|NCT01531673|453628360|FG005|Overall Study|Other|0|||
126091242|NCT01531673|453628361|FG006|Overall Study|Other|0|||
126091243|NCT01531673|453628362|FG007|Overall Study|Other|0|||
126091244|NCT01531673|453628363|FG008|Overall Study|Other|0|||
126091245|NCT01531673|453628364|FG009|Overall Study|Other|1|||
126091246|NCT01531673|453628365|FG010|Overall Study|Other|0|||
126091247|NCT01531673|453628366|FG011|Overall Study|Other|0|||
126091248|NCT01531673|453628367|FG012|Overall Study|Other|0|||
126091249|NCT00568178|453628368|FG000|Double Blind Base Study|Adverse Event|0|||
126091250|NCT00568178|453628369|FG001|Double Blind Base Study|Adverse Event|2|||
126091251|NCT00568178|453628370|FG002|Double Blind Base Study|Adverse Event|1|||
126091252|NCT00568178|453628371|FG003|Double Blind Base Study|Adverse Event|2|||
126091253|NCT00568178|453628372|FG004|Double Blind Base Study|Adverse Event|0|||
126091254|NCT00568178|453628373|FG005|Double Blind Base Study|Adverse Event|0|||
126091255|NCT00568178|453628368|FG000|Double Blind Base Study|Lost to Follow-up|1|||
126014738|NCT01307267|453349167|FG008|Overall Study|Death|21|||
126014739|NCT01307267|453349168|FG009|Overall Study|Death|2|||
126014740|NCT01307267|453349169|FG010|Overall Study|Death|3|||
126014741|NCT01307267|453349170|FG011|Overall Study|Death|9|||
126014742|NCT01307267|453349171|FG012|Overall Study|Death|0|||
126014743|NCT01307267|453349172|FG013|Overall Study|Death|0|||
126014744|NCT01307267|453349173|FG014|Overall Study|Death|0|||
126014745|NCT01307267|453349174|FG015|Overall Study|Death|0|||
126014746|NCT01307267|453349175|FG016|Overall Study|Death|1|||
126014747|NCT01307267|453349176|FG017|Overall Study|Death|1|||
126014748|NCT01307267|453349177|FG018|Overall Study|Death|2|||
126014749|NCT01307267|453349178|FG019|Overall Study|Death|8|||
126014750|NCT01307267|453349179|FG020|Overall Study|Death|1|||
126014751|NCT01307267|453349180|FG021|Overall Study|Death|2|||
126014752|NCT01307267|453349181|FG022|Overall Study|Death|2|||
126014753|NCT01307267|453349159|FG000|Overall Study|Lost to Follow-up|0|||
126014754|NCT01307267|453349160|FG001|Overall Study|Lost to Follow-up|0|||
126014755|NCT01307267|453349161|FG002|Overall Study|Lost to Follow-up|0|||
126014756|NCT01307267|453349162|FG003|Overall Study|Lost to Follow-up|0|||
126014757|NCT01307267|453349163|FG004|Overall Study|Lost to Follow-up|0|||
126014758|NCT01307267|453349164|FG005|Overall Study|Lost to Follow-up|7|||
126014759|NCT01307267|453349165|FG006|Overall Study|Lost to Follow-up|0|||
126014760|NCT01307267|453349166|FG007|Overall Study|Lost to Follow-up|0|||
126014761|NCT01307267|453349167|FG008|Overall Study|Lost to Follow-up|1|||
126014762|NCT01307267|453349168|FG009|Overall Study|Lost to Follow-up|2|||
126014763|NCT01307267|453349169|FG010|Overall Study|Lost to Follow-up|1|||
126014764|NCT01307267|453349170|FG011|Overall Study|Lost to Follow-up|0|||
126014765|NCT01307267|453349171|FG012|Overall Study|Lost to Follow-up|0|||
126014766|NCT01307267|453349172|FG013|Overall Study|Lost to Follow-up|0|||
126014767|NCT01307267|453349173|FG014|Overall Study|Lost to Follow-up|0|||
126014768|NCT01307267|453349174|FG015|Overall Study|Lost to Follow-up|0|||
126014769|NCT01307267|453349175|FG016|Overall Study|Lost to Follow-up|0|||
126014770|NCT01307267|453349176|FG017|Overall Study|Lost to Follow-up|0|||
126014771|NCT01307267|453349177|FG018|Overall Study|Lost to Follow-up|0|||
126014772|NCT01307267|453349178|FG019|Overall Study|Lost to Follow-up|2|||
126014773|NCT01307267|453349179|FG020|Overall Study|Lost to Follow-up|0|||
126014774|NCT01307267|453349180|FG021|Overall Study|Lost to Follow-up|0|||
126014775|NCT01307267|453349181|FG022|Overall Study|Lost to Follow-up|0|||
126014776|NCT01307267|453349159|FG000|Overall Study|Withdrawal by Subject|0|||
126014777|NCT01307267|453349160|FG001|Overall Study|Withdrawal by Subject|0|||
126014778|NCT01307267|453349161|FG002|Overall Study|Withdrawal by Subject|0|||
126014779|NCT01307267|453349162|FG003|Overall Study|Withdrawal by Subject|0|||
126014780|NCT01307267|453349163|FG004|Overall Study|Withdrawal by Subject|0|||
126014781|NCT01307267|453349164|FG005|Overall Study|Withdrawal by Subject|1|||
126014782|NCT01307267|453349165|FG006|Overall Study|Withdrawal by Subject|0|||
126014783|NCT01307267|453349166|FG007|Overall Study|Withdrawal by Subject|1|||
126014784|NCT01307267|453349167|FG008|Overall Study|Withdrawal by Subject|5|||
126014785|NCT01307267|453349168|FG009|Overall Study|Withdrawal by Subject|1|||
126014786|NCT01307267|453349169|FG010|Overall Study|Withdrawal by Subject|1|||
126014787|NCT01307267|453349170|FG011|Overall Study|Withdrawal by Subject|1|||
126014788|NCT01307267|453349171|FG012|Overall Study|Withdrawal by Subject|0|||
126014789|NCT01307267|453349172|FG013|Overall Study|Withdrawal by Subject|0|||
126014790|NCT01307267|453349173|FG014|Overall Study|Withdrawal by Subject|0|||
126014791|NCT01307267|453349174|FG015|Overall Study|Withdrawal by Subject|0|||
126014792|NCT01307267|453349175|FG016|Overall Study|Withdrawal by Subject|0|||
126014793|NCT01307267|453349176|FG017|Overall Study|Withdrawal by Subject|0|||
126014794|NCT01307267|453349177|FG018|Overall Study|Withdrawal by Subject|0|||
126014795|NCT01307267|453349178|FG019|Overall Study|Withdrawal by Subject|3|||
126014796|NCT01307267|453349179|FG020|Overall Study|Withdrawal by Subject|0|||
126014797|NCT01307267|453349180|FG021|Overall Study|Withdrawal by Subject|0|||
126014798|NCT01307267|453349181|FG022|Overall Study|Withdrawal by Subject|0|||
126014799|NCT01307267|453349159|FG000|Overall Study|Other|0|||
126014800|NCT01307267|453349160|FG001|Overall Study|Other|0|||
126014801|NCT01307267|453349161|FG002|Overall Study|Other|0|||
126014802|NCT01307267|453349162|FG003|Overall Study|Other|0|||
126014803|NCT01307267|453349163|FG004|Overall Study|Other|0|||
126014804|NCT01307267|453349164|FG005|Overall Study|Other|7|||
126014805|NCT01307267|453349165|FG006|Overall Study|Other|0|||
126014806|NCT01307267|453349166|FG007|Overall Study|Other|1|||
126014807|NCT01307267|453349167|FG008|Overall Study|Other|3|||
126014808|NCT01307267|453349168|FG009|Overall Study|Other|0|||
126014809|NCT01307267|453349169|FG010|Overall Study|Other|1|||
126014810|NCT01307267|453349170|FG011|Overall Study|Other|1|||
126014811|NCT01307267|453349171|FG012|Overall Study|Other|1|||
126014812|NCT01307267|453349172|FG013|Overall Study|Other|0|||
126014813|NCT01307267|453349173|FG014|Overall Study|Other|2|||
126014814|NCT01307267|453349174|FG015|Overall Study|Other|1|||
126014815|NCT01307267|453349175|FG016|Overall Study|Other|0|||
126014816|NCT01307267|453349176|FG017|Overall Study|Other|0|||
126014817|NCT01307267|453349177|FG018|Overall Study|Other|0|||
126014818|NCT01307267|453349178|FG019|Overall Study|Other|19|||
126014819|NCT01307267|453349179|FG020|Overall Study|Other|2|||
126014820|NCT01307267|453349180|FG021|Overall Study|Other|3|||
126014821|NCT01307267|453349181|FG022|Overall Study|Other|2|||
126014822|NCT05174013|453349184|FG000|Overall Study|Lost to Follow-up|0|||
126014823|NCT05174013|453349185|FG001|Overall Study|Lost to Follow-up|0|||
126014824|NCT05174013|453349186|FG002|Overall Study|Lost to Follow-up|0|||
126014825|NCT05174013|453349187|FG003|Overall Study|Lost to Follow-up|1|||
126014826|NCT05174013|453349188|FG004|Overall Study|Lost to Follow-up|0|||
126014827|NCT05174013|453349189|FG005|Overall Study|Lost to Follow-up|0|||
126014828|NCT05174013|453349184|FG000|Overall Study|Withdrawal by Subject|0|||
126014829|NCT05174013|453349185|FG001|Overall Study|Withdrawal by Subject|0|||
126216751|NCT01336608|454084413|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
126216752|NCT01336608|454084414|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
126216753|NCT01336608|454084415|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
126216754|NCT01336608|454084416|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
126216755|NCT01336608|454084413|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126216756|NCT01336608|454084414|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
126014830|NCT05174013|453349186|FG002|Overall Study|Withdrawal by Subject|1|||
126014831|NCT05174013|453349187|FG003|Overall Study|Withdrawal by Subject|0|||
126014832|NCT05174013|453349188|FG004|Overall Study|Withdrawal by Subject|0|||
126014833|NCT05174013|453349189|FG005|Overall Study|Withdrawal by Subject|0|||
126349883|NCT04556097|454573021|FG001|Overall Study|Missing identifier|4|||
126349884|NCT04556097|454573022|FG002|Overall Study|Missing identifier|0|||
126014834|NCT04956575|453349190|FG000|Overall Study|Death|1|||
126014835|NCT04956575|453349191|FG001|Overall Study|Death|0|||
126349885|NCT04556097|454573023|FG003|Overall Study|Missing identifier|0|||
126349886|NCT04556097|454573020|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
126349887|NCT04556097|454573021|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
126349888|NCT04556097|454573022|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
126349889|NCT04556097|454573023|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
126349890|NCT02516241|454573029|FG000|Overall Study|Death|255|||
126349891|NCT02516241|454573030|FG001|Overall Study|Death|262|||
126349892|NCT02516241|454573031|FG002|Overall Study|Death|270|||
126349893|NCT02516241|454573029|FG000|Overall Study|Lost to Follow-up|1|||
126349894|NCT02516241|454573030|FG001|Overall Study|Lost to Follow-up|1|||
126349895|NCT02516241|454573031|FG002|Overall Study|Lost to Follow-up|3|||
126349896|NCT02516241|454573029|FG000|Overall Study|Withdrawal by Subject|2|||
126349897|NCT02516241|454573030|FG001|Overall Study|Withdrawal by Subject|7|||
126349898|NCT02516241|454573031|FG002|Overall Study|Withdrawal by Subject|12|||
126349899|NCT02516241|454573029|FG000|Overall Study|participants ongoing at data cut-off|84|||
126349900|NCT02516241|454573030|FG001|Overall Study|participants ongoing at data cut-off|76|||
126349901|NCT02516241|454573031|FG002|Overall Study|participants ongoing at data cut-off|59|||
126349902|NCT03228537|454573032|FG000|Neoadjuvant|Adverse Event|2|||
126349903|NCT03228537|454573032|FG000|Neoadjuvant|Progression/Relapse|4|||
126349904|NCT03228537|454573032|FG000|Neoadjuvant|Death|1|||
126349905|NCT03228537|454573032|FG000|Surgery|Death|1|||
126349906|NCT03228537|454573032|FG000|Surgery|Other - Not Protocol Specified|2|||
126349907|NCT03228537|454573032|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
126349908|NCT03228537|454573032|FG000|Maintenance|Progression/Relapse|10|||
126349909|NCT05977868|454574057|FG000|Overall Study|Withdrawal by Subject|1|||
126349910|NCT05977868|454574058|FG001|Overall Study|Withdrawal by Subject|2|||
126349911|NCT05977868|454574057|FG000|Overall Study|Transitioned to comfort care|1|||
126349912|NCT05977868|454574058|FG001|Overall Study|Transitioned to comfort care|0|||
126349913|NCT03575364|454574065|FG000|Overall Study|Death|45|||
126349914|NCT03575364|454574065|FG000|Overall Study|Lost to Follow-up|114|||
126349915|NCT03575364|454574065|FG000|Overall Study|Withdrawal by Subject|21|||
126349916|NCT03575364|454574065|FG000|Overall Study|Physician Decision|11|||
126349917|NCT03575364|454574065|FG000|Overall Study|Subject Refused Follow-up|13|||
126349918|NCT03575364|454574065|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
126349919|NCT03575364|454574065|FG000|Overall Study|Patient moved out of the state|1|||
126349920|NCT03575364|454574065|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
126014836|NCT04956575|453349192|FG002|Overall Study|Death|0|||
126014837|NCT04956575|453349193|FG003|Overall Study|Death|0|||
126014838|NCT04956575|453349194|FG004|Overall Study|Death|0|||
126014839|NCT04956575|453349195|FG005|Overall Study|Death|0|||
126014840|NCT04956575|453349196|FG006|Overall Study|Death|0|||
126014841|NCT04956575|453349197|FG007|Overall Study|Death|1|||
126014842|NCT04956575|453349198|FG008|Overall Study|Death|0|||
126014843|NCT04956575|453349199|FG009|Overall Study|Death|1|||
126014844|NCT04956575|453349200|FG010|Overall Study|Death|0|||
126014845|NCT04956575|453349201|FG011|Overall Study|Death|0|||
126014846|NCT04956575|453349190|FG000|Overall Study|Lost to Follow-up|3|||
126014847|NCT04956575|453349191|FG001|Overall Study|Lost to Follow-up|4|||
126014848|NCT04956575|453349192|FG002|Overall Study|Lost to Follow-up|2|||
126014849|NCT04956575|453349193|FG003|Overall Study|Lost to Follow-up|3|||
126014850|NCT04956575|453349194|FG004|Overall Study|Lost to Follow-up|1|||
126014851|NCT04956575|453349195|FG005|Overall Study|Lost to Follow-up|10|||
126014852|NCT04956575|453349196|FG006|Overall Study|Lost to Follow-up|11|||
126014853|NCT04956575|453349197|FG007|Overall Study|Lost to Follow-up|7|||
126014854|NCT04956575|453349198|FG008|Overall Study|Lost to Follow-up|4|||
126014855|NCT04956575|453349199|FG009|Overall Study|Lost to Follow-up|2|||
126014856|NCT04956575|453349200|FG010|Overall Study|Lost to Follow-up|3|||
126014857|NCT04956575|453349201|FG011|Overall Study|Lost to Follow-up|8|||
126014858|NCT04956575|453349190|FG000|Overall Study|Withdrawal by Subject|1|||
126014859|NCT04956575|453349191|FG001|Overall Study|Withdrawal by Subject|2|||
126014860|NCT04956575|453349192|FG002|Overall Study|Withdrawal by Subject|1|||
126014861|NCT04956575|453349193|FG003|Overall Study|Withdrawal by Subject|4|||
126014862|NCT04956575|453349194|FG004|Overall Study|Withdrawal by Subject|2|||
126014863|NCT04956575|453349195|FG005|Overall Study|Withdrawal by Subject|8|||
126014864|NCT04956575|453349196|FG006|Overall Study|Withdrawal by Subject|5|||
126014865|NCT04956575|453349197|FG007|Overall Study|Withdrawal by Subject|1|||
126014866|NCT04956575|453349198|FG008|Overall Study|Withdrawal by Subject|1|||
126014867|NCT04956575|453349199|FG009|Overall Study|Withdrawal by Subject|0|||
126014868|NCT04956575|453349200|FG010|Overall Study|Withdrawal by Subject|3|||
126014869|NCT04956575|453349201|FG011|Overall Study|Withdrawal by Subject|1|||
126014870|NCT03593876|453349202|FG000|Overall Study|Withdrawal by Subject|1|||
126014871|NCT03593876|453349202|FG000|Overall Study|Discharged home before intervention completion|2|||
126014872|NCT00854906|453349208|FG000|Overall Study|One person had no ocular history|1|||
126014873|NCT00486330|453349209|FG000|Overall Study|Adverse Event|2|||
126014874|NCT01290224|453349210|FG000|Overall Study|Adverse Event|1|||
126014875|NCT01290224|453349210|FG000|Overall Study|Refused Further Treatment|4|||
126014876|NCT00346333|453349211|FG000|Overall Study|Death|1|||
126014877|NCT00346333|453349212|FG001|Overall Study|Death|0|||
126014878|NCT00346333|453349211|FG000|Overall Study|unwilling or unable to continue|4|||
126014879|NCT00346333|453349212|FG001|Overall Study|unwilling or unable to continue|8|||
126014880|NCT00880048|453349219|FG000|Overall Study|Adverse Event|2|||
126014881|NCT00880048|453349220|FG001|Overall Study|Adverse Event|3|||
126014882|NCT00880048|453349221|FG002|Overall Study|Adverse Event|5|||
126014883|NCT00880048|453349219|FG000|Overall Study|Lack of Efficacy|1|||
126014884|NCT00880048|453349220|FG001|Overall Study|Lack of Efficacy|2|||
126014885|NCT00880048|453349221|FG002|Overall Study|Lack of Efficacy|2|||
126014886|NCT00880048|453349219|FG000|Overall Study|Protocol Violation|4|||
126014887|NCT00880048|453349220|FG001|Overall Study|Protocol Violation|6|||
126014888|NCT00880048|453349221|FG002|Overall Study|Protocol Violation|5|||
126014889|NCT00880048|453349219|FG000|Overall Study|Lost to Follow-up|6|||
126014890|NCT00880048|453349220|FG001|Overall Study|Lost to Follow-up|6|||
126014891|NCT00880048|453349221|FG002|Overall Study|Lost to Follow-up|5|||
126014892|NCT00880048|453349219|FG000|Overall Study|Physician Decision|1|||
126014893|NCT00880048|453349220|FG001|Overall Study|Physician Decision|1|||
126014894|NCT00880048|453349221|FG002|Overall Study|Physician Decision|7|||
126014895|NCT00880048|453349219|FG000|Overall Study|Withdrawal by Subject|5|||
126014896|NCT00880048|453349220|FG001|Overall Study|Withdrawal by Subject|8|||
126014897|NCT00880048|453349221|FG002|Overall Study|Withdrawal by Subject|5|||
126014898|NCT00880048|453349219|FG000|Overall Study|Study closed/terminated|9|||
126014899|NCT00880048|453349220|FG001|Overall Study|Study closed/terminated|7|||
126014900|NCT00880048|453349221|FG002|Overall Study|Study closed/terminated|6|||
126014901|NCT00367991|453349226|FG000|Overall Study|Withdrawal by Subject|1|||
126014902|NCT00367991|453349227|FG001|Overall Study|Withdrawal by Subject|1|||
126014903|NCT00367991|453349226|FG000|Overall Study|Adverse Event|1|||
126014904|NCT00367991|453349227|FG001|Overall Study|Adverse Event|1|||
126014905|NCT00346151|453349229|FG000|Overall Study|Withdrawal by Subject|3|||
126014906|NCT01184508|453349230|FG000|Overall Study|Adverse Event|4|||
126014907|NCT01184508|453349231|FG001|Overall Study|Adverse Event|6|||
126014908|NCT01184508|453349230|FG000|Overall Study|Lack of Efficacy|1|||
126014909|NCT01184508|453349231|FG001|Overall Study|Lack of Efficacy|1|||
126014910|NCT01184508|453349230|FG000|Overall Study|Lost to Follow-up|1|||
126014911|NCT01184508|453349231|FG001|Overall Study|Lost to Follow-up|1|||
126014912|NCT01184508|453349230|FG000|Overall Study|Physician Decision|1|||
126014913|NCT01184508|453349231|FG001|Overall Study|Physician Decision|0|||
126014914|NCT01184508|453349230|FG000|Overall Study|Protocol Violation|3|||
126014915|NCT01184508|453349231|FG001|Overall Study|Protocol Violation|1|||
126014916|NCT01184508|453349230|FG000|Overall Study|Sponsor Decision|5|||
126014917|NCT01184508|453349231|FG001|Overall Study|Sponsor Decision|2|||
126014918|NCT01184508|453349230|FG000|Overall Study|Withdrawal by Subject|1|||
126014919|NCT01184508|453349231|FG001|Overall Study|Withdrawal by Subject|3|||
126014920|NCT01184508|453349230|FG000|Overall Study|Randomized, Not Treated|0|||
126014921|NCT01184508|453349231|FG001|Overall Study|Randomized, Not Treated|1|||
126014922|NCT00790790|453349241|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
126014923|NCT00790790|453349242|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
126014924|NCT00790790|453349243|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
126014925|NCT00790790|453349241|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
126014926|NCT00790790|453349242|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
126014927|NCT00790790|453349243|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
126014928|NCT00790790|453349241|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
126014929|NCT00790790|453349242|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
126014930|NCT00790790|453349243|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
126014931|NCT00790790|453349241|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
126014932|NCT00790790|453349242|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126014933|NCT00790790|453349243|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
126014934|NCT00790790|453349241|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
126014935|NCT00790790|453349242|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
126014936|NCT00790790|453349243|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
126014937|NCT02570711|453349244|FG000|Overall Study|Death|1|||
126014938|NCT02570711|453349245|FG001|Overall Study|Death|0|||
126014939|NCT02570711|453349244|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
126014940|NCT02570711|453349245|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
126014941|NCT02798835|453349246|FG000|Overall Study|Protocol Violation|0|||
126014942|NCT02798835|453349247|FG001|Overall Study|Protocol Violation|0|||
126014943|NCT02798835|453349248|FG002|Overall Study|Protocol Violation|3|||
126014944|NCT04707313|453349255|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
126014945|NCT04707313|453349256|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
126014946|NCT04707313|453349257|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
126014947|NCT04707313|453349258|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
126014948|NCT04707313|453349259|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
126014949|NCT04707313|453349260|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
126014950|NCT04707313|453349261|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
126014951|NCT04707313|453349262|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
126014952|NCT04707313|453349263|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
126014953|NCT04707313|453349264|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
126014954|NCT04707313|453349265|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
126014955|NCT04707313|453349266|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
126014956|NCT04707313|453349267|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
126014957|NCT04707313|453349255|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
126014958|NCT04707313|453349256|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
126014959|NCT04707313|453349257|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014960|NCT04707313|453349258|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014961|NCT04707313|453349259|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
126014962|NCT04707313|453349260|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014963|NCT04707313|453349261|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014964|NCT04707313|453349262|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014965|NCT04707313|453349263|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014966|NCT04707313|453349264|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014967|NCT04707313|453349265|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125878728|NCT01209689|452853400|FG001|Overall Study|Insufficient Therapeutic Response|2|||
126014968|NCT04707313|453349266|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014969|NCT04707313|453349267|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126014970|NCT04707313|453349255|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
126014971|NCT04707313|453349256|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
126014972|NCT04707313|453349257|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
126014973|NCT04707313|453349258|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
126014974|NCT04707313|453349259|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
126014975|NCT04707313|453349260|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
126014976|NCT04707313|453349261|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
126014977|NCT04707313|453349262|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
126014978|NCT04707313|453349263|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
126014979|NCT04707313|453349264|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
126014980|NCT04707313|453349265|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
126014981|NCT04707313|453349266|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
126014982|NCT04707313|453349267|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
126014983|NCT04707313|453349255|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014984|NCT04707313|453349256|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
126014985|NCT04707313|453349257|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
126014986|NCT04707313|453349258|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014987|NCT04707313|453349259|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
126014988|NCT04707313|453349260|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014989|NCT04707313|453349261|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014990|NCT04707313|453349262|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014991|NCT04707313|453349263|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014992|NCT04707313|453349264|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014993|NCT04707313|453349265|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014994|NCT04707313|453349266|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014995|NCT04707313|453349267|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126014996|NCT04707313|453349255|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
126014997|NCT04707313|453349256|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
126014998|NCT04707313|453349257|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
126014999|NCT04707313|453349258|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
126015000|NCT04707313|453349259|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
126015001|NCT04707313|453349260|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126015002|NCT04707313|453349261|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126015003|NCT04707313|453349262|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126015004|NCT04707313|453349263|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
126015005|NCT04707313|453349264|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126015006|NCT04707313|453349265|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126015007|NCT04707313|453349266|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126015008|NCT04707313|453349267|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126015009|NCT04707313|453349255|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
126015010|NCT04707313|453349256|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126015011|NCT04707313|453349257|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126015012|NCT04707313|453349258|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126015013|NCT04707313|453349259|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126015014|NCT04707313|453349260|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
126091256|NCT00568178|453628369|FG001|Double Blind Base Study|Lost to Follow-up|0|||
126015015|NCT04707313|453349261|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
126015016|NCT04707313|453349262|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
126015017|NCT04707313|453349263|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126091257|NCT00568178|453628370|FG002|Double Blind Base Study|Lost to Follow-up|0|||
126091258|NCT00568178|453628371|FG003|Double Blind Base Study|Lost to Follow-up|1|||
126091259|NCT00568178|453628372|FG004|Double Blind Base Study|Lost to Follow-up|0|||
126091260|NCT00568178|453628373|FG005|Double Blind Base Study|Lost to Follow-up|0|||
126091261|NCT00568178|453628368|FG000|Double Blind Base Study|Physician Decision|1|||
126091262|NCT00568178|453628369|FG001|Double Blind Base Study|Physician Decision|1|||
126091263|NCT00568178|453628370|FG002|Double Blind Base Study|Physician Decision|0|||
126091264|NCT00568178|453628371|FG003|Double Blind Base Study|Physician Decision|1|||
126091265|NCT00568178|453628372|FG004|Double Blind Base Study|Physician Decision|0|||
126091266|NCT00568178|453628373|FG005|Double Blind Base Study|Physician Decision|0|||
126091267|NCT00568178|453628368|FG000|Double Blind Base Study|Protocol Violation|3|||
126015018|NCT04707313|453349264|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126015019|NCT04707313|453349265|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126091268|NCT00568178|453628369|FG001|Double Blind Base Study|Protocol Violation|2|||
126015020|NCT04707313|453349266|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126015021|NCT04707313|453349267|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126015022|NCT04707313|453349255|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
126015023|NCT04707313|453349256|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
126015024|NCT04707313|453349257|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
126015025|NCT04707313|453349258|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
126015026|NCT04707313|453349259|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
126015027|NCT04707313|453349260|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
126015028|NCT04707313|453349261|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
126015029|NCT04707313|453349262|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
126015030|NCT04707313|453349263|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
126015031|NCT04707313|453349264|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
126015032|NCT04707313|453349265|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
126015033|NCT04707313|453349266|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
126015034|NCT04707313|453349267|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
126015035|NCT04707313|453349255|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015036|NCT04707313|453349256|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015037|NCT04707313|453349257|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
126015038|NCT04707313|453349258|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015039|NCT04707313|453349259|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015040|NCT04707313|453349260|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015041|NCT04707313|453349261|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015042|NCT04707313|453349262|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
126015043|NCT04707313|453349263|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015044|NCT04707313|453349264|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015045|NCT04707313|453349265|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015046|NCT04707313|453349266|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015047|NCT04707313|453349267|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126015048|NCT04707313|453349255|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015049|NCT04707313|453349256|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015050|NCT04707313|453349257|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015051|NCT04707313|453349258|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015052|NCT04707313|453349259|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015053|NCT04707313|453349260|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015054|NCT04707313|453349261|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015055|NCT04707313|453349262|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015056|NCT04707313|453349263|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015057|NCT04707313|453349264|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126015058|NCT04707313|453349265|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
126015059|NCT04707313|453349266|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
126015060|NCT04707313|453349267|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
126015061|NCT04707313|453349255|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015062|NCT04707313|453349256|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015063|NCT04707313|453349257|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015064|NCT04707313|453349258|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015065|NCT04707313|453349259|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015066|NCT04707313|453349260|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015067|NCT04707313|453349261|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015068|NCT04707313|453349262|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015069|NCT04707313|453349263|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015070|NCT04707313|453349264|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
126015071|NCT04707313|453349265|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
126015072|NCT04707313|453349266|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
126015073|NCT04707313|453349267|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126015074|NCT04707313|453349255|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015075|NCT04707313|453349256|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015076|NCT04707313|453349257|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015077|NCT04707313|453349258|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015078|NCT04707313|453349259|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015079|NCT04707313|453349260|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015080|NCT04707313|453349261|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015081|NCT04707313|453349262|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015082|NCT04707313|453349263|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126015083|NCT04707313|453349264|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
126015084|NCT04707313|453349265|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
126015085|NCT04707313|453349266|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
126015086|NCT04707313|453349267|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
126015087|NCT04707313|453349255|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015088|NCT04707313|453349256|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015089|NCT04707313|453349257|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015090|NCT04707313|453349258|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015091|NCT04707313|453349259|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015092|NCT04707313|453349260|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015093|NCT04707313|453349261|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015094|NCT04707313|453349262|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015095|NCT04707313|453349263|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015096|NCT04707313|453349264|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015097|NCT04707313|453349265|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
126015098|NCT04707313|453349266|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
126015099|NCT04707313|453349267|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
126015100|NCT04707313|453349255|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015101|NCT04707313|453349256|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015102|NCT04707313|453349257|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015103|NCT04707313|453349258|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015104|NCT04707313|453349259|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015105|NCT04707313|453349260|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015106|NCT04707313|453349261|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015107|NCT04707313|453349262|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015108|NCT04707313|453349263|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015109|NCT04707313|453349264|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
126015110|NCT04707313|453349265|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
126015111|NCT04707313|453349266|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015112|NCT04707313|453349267|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126015113|NCT04707313|453349255|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015114|NCT04707313|453349256|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015115|NCT04707313|453349257|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015116|NCT04707313|453349258|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015117|NCT04707313|453349259|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015118|NCT04707313|453349260|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015119|NCT04707313|453349261|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015120|NCT04707313|453349262|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015121|NCT04707313|453349263|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126015122|NCT04707313|453349264|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
126015123|NCT04707313|453349265|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
126015124|NCT04707313|453349266|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
126015125|NCT04707313|453349267|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
126015126|NCT03070483|453349271|FG000|Overall Study|Lost to Follow-up|2|||
126015127|NCT01585558|453349275|FG000|Overall Study|Withdrawal by Subject|4|||
126015128|NCT01585558|453349276|FG001|Overall Study|Withdrawal by Subject|5|||
126015129|NCT01585558|453349277|FG002|Overall Study|Withdrawal by Subject|8|||
126015130|NCT01585558|453349275|FG000|Overall Study|Lost to Follow-up|2|||
126015131|NCT01585558|453349276|FG001|Overall Study|Lost to Follow-up|0|||
126015132|NCT01585558|453349277|FG002|Overall Study|Lost to Follow-up|3|||
126015133|NCT01585558|453349275|FG000|Overall Study|Adverse Event|3|||
126015134|NCT01585558|453349276|FG001|Overall Study|Adverse Event|4|||
126015135|NCT01585558|453349277|FG002|Overall Study|Adverse Event|1|||
126015136|NCT01585558|453349275|FG000|Overall Study|Protocol Violation|4|||
126015137|NCT01585558|453349276|FG001|Overall Study|Protocol Violation|3|||
126015138|NCT01585558|453349277|FG002|Overall Study|Protocol Violation|2|||
126015139|NCT01585558|453349275|FG000|Overall Study|Lack of Efficacy|0|||
126015140|NCT01585558|453349276|FG001|Overall Study|Lack of Efficacy|0|||
126015141|NCT01585558|453349277|FG002|Overall Study|Lack of Efficacy|1|||
126015142|NCT00094575|453349282|FG000|Overall Study|Death|146|||
126015143|NCT00094575|453349283|FG001|Overall Study|Death|146|||
126015144|NCT01390402|453349284|FG000|Overall Study|Death|1|||
126015145|NCT01390402|453349284|FG000|Overall Study|Disease Progression|4|||
126015146|NCT01063517|453349287|FG000|Overall Study|Consent withdrawal|1|||
126015147|NCT01063517|453349288|FG001|Overall Study|Consent withdrawal|0|||
126015148|NCT01063517|453349287|FG000|Overall Study|Study reached data cut-off|19|||
126015149|NCT01063517|453349288|FG001|Overall Study|Study reached data cut-off|7|||
126015150|NCT01063517|453349287|FG000|Overall Study|Lost to Follow-up|4|||
126015151|NCT01063517|453349288|FG001|Overall Study|Lost to Follow-up|3|||
126015152|NCT01063517|453349287|FG000|Overall Study|Withdrawal by Subject|1|||
126015153|NCT01063517|453349288|FG001|Overall Study|Withdrawal by Subject|2|||
126015154|NCT01063517|453349287|FG000|Overall Study|Death|33|||
126015155|NCT01063517|453349288|FG001|Overall Study|Death|48|||
126015156|NCT02041104|453349289|FG000|Overall Study|Lost to Follow-up|1|||
126015157|NCT02041104|453349290|FG001|Overall Study|Lost to Follow-up|4|||
126015158|NCT02041104|453349289|FG000|Overall Study|discomfort during OGTT|0|||
126015159|NCT02041104|453349290|FG001|Overall Study|discomfort during OGTT|3|||
126015160|NCT00617201|453349293|FG000|Overall Study|Lost to Follow-up|9|||
126015161|NCT00617201|453349294|FG001|Overall Study|Lost to Follow-up|13|||
126015162|NCT00546871|453349295|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
126015163|NCT00546871|453349296|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
126015164|NCT00546871|453349295|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
126015165|NCT00546871|453349296|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
126015166|NCT00546871|453349295|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
126015167|NCT00546871|453349296|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
126015168|NCT00546871|453349295|FG000|Study Extension Period|Protocol Violation|1|||
126015169|NCT00546871|453349296|FG001|Study Extension Period|Protocol Violation|0|||
126015170|NCT00546871|453349295|FG000|Study Extension Period|Withdrawal by Subject|0|||
126015171|NCT00546871|453349296|FG001|Study Extension Period|Withdrawal by Subject|1|||
126015172|NCT01350804|453349297|FG000|Core Study|Withdrawal by Subject|11|||
126015173|NCT01350804|453349298|FG001|Core Study|Withdrawal by Subject|17|||
126015174|NCT01350804|453349299|FG002|Core Study|Withdrawal by Subject|16|||
126015175|NCT01350804|453349300|FG003|Core Study|Withdrawal by Subject|7|||
126015176|NCT01350804|453349297|FG000|Core Study|Study terminated by Sponsor|0|||
126015177|NCT01350804|453349298|FG001|Core Study|Study terminated by Sponsor|0|||
126015178|NCT01350804|453349299|FG002|Core Study|Study terminated by Sponsor|0|||
126216757|NCT01336608|454084415|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
126216758|NCT01336608|454084416|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
126091269|NCT00568178|453628370|FG002|Double Blind Base Study|Protocol Violation|0|||
126091270|NCT00568178|453628371|FG003|Double Blind Base Study|Protocol Violation|0|||
126091271|NCT00568178|453628372|FG004|Double Blind Base Study|Protocol Violation|0|||
126091272|NCT00568178|453628373|FG005|Double Blind Base Study|Protocol Violation|0|||
126091273|NCT00568178|453628368|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
126091274|NCT00568178|453628369|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
126091275|NCT00568178|453628370|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
126091276|NCT00568178|453628371|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
126091277|NCT00568178|453628372|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
126091278|NCT00568178|453628373|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
126091279|NCT00568178|453628368|FG000|Double Blind Base Study|Progressive Disease|0|||
126091280|NCT00568178|453628369|FG001|Double Blind Base Study|Progressive Disease|0|||
126091281|NCT00568178|453628370|FG002|Double Blind Base Study|Progressive Disease|0|||
126091282|NCT00568178|453628371|FG003|Double Blind Base Study|Progressive Disease|1|||
126091283|NCT00568178|453628372|FG004|Double Blind Base Study|Progressive Disease|0|||
126091284|NCT00568178|453628373|FG005|Double Blind Base Study|Progressive Disease|0|||
126091285|NCT00568178|453628368|FG000|Open Label Extension|Adverse Event|0|||
126091286|NCT00568178|453628369|FG001|Open Label Extension|Adverse Event|0|||
126091287|NCT00568178|453628370|FG002|Open Label Extension|Adverse Event|0|||
126091288|NCT00568178|453628371|FG003|Open Label Extension|Adverse Event|0|||
126091289|NCT00568178|453628372|FG004|Open Label Extension|Adverse Event|11|||
126091290|NCT00568178|453628373|FG005|Open Label Extension|Adverse Event|8|||
126015179|NCT01350804|453349300|FG003|Core Study|Study terminated by Sponsor|2|||
126015180|NCT01350804|453349297|FG000|Core Study|Protocol deviation|1|||
126015181|NCT01350804|453349298|FG001|Core Study|Protocol deviation|0|||
126015182|NCT01350804|453349299|FG002|Core Study|Protocol deviation|1|||
126015183|NCT01350804|453349300|FG003|Core Study|Protocol deviation|0|||
126015184|NCT01350804|453349297|FG000|Core Study|Physician Decision|1|||
126015185|NCT01350804|453349298|FG001|Core Study|Physician Decision|0|||
126015186|NCT01350804|453349299|FG002|Core Study|Physician Decision|1|||
126015187|NCT01350804|453349300|FG003|Core Study|Physician Decision|3|||
126015188|NCT01350804|453349297|FG000|Core Study|Lost to Follow-up|3|||
126015189|NCT01350804|453349298|FG001|Core Study|Lost to Follow-up|0|||
126015190|NCT01350804|453349299|FG002|Core Study|Lost to Follow-up|2|||
126015191|NCT01350804|453349300|FG003|Core Study|Lost to Follow-up|1|||
126015192|NCT01350804|453349297|FG000|Core Study|Lack of Efficacy|16|||
126015193|NCT01350804|453349298|FG001|Core Study|Lack of Efficacy|19|||
126015194|NCT01350804|453349299|FG002|Core Study|Lack of Efficacy|18|||
126015195|NCT01350804|453349300|FG003|Core Study|Lack of Efficacy|5|||
126015196|NCT01350804|453349297|FG000|Core Study|Death|1|||
126015197|NCT01350804|453349298|FG001|Core Study|Death|1|||
126015198|NCT01350804|453349299|FG002|Core Study|Death|1|||
126015199|NCT01350804|453349300|FG003|Core Study|Death|0|||
126015200|NCT01350804|453349297|FG000|Core Study|Adverse Event|8|||
126015201|NCT01350804|453349298|FG001|Core Study|Adverse Event|10|||
126015202|NCT01350804|453349299|FG002|Core Study|Adverse Event|8|||
126015203|NCT01350804|453349300|FG003|Core Study|Adverse Event|8|||
126015204|NCT01350804|453349297|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
126015205|NCT01350804|453349298|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
126015206|NCT01350804|453349299|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
126015207|NCT01350804|453349300|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
126015208|NCT01350804|453349297|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
126015209|NCT01350804|453349298|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
126015210|NCT01350804|453349299|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
126015211|NCT01350804|453349300|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
126015212|NCT01350804|453349297|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
126015213|NCT01350804|453349298|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
126015214|NCT01350804|453349299|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
126015215|NCT01350804|453349300|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
126015216|NCT01350804|453349297|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
126015217|NCT01350804|453349298|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
126015218|NCT01350804|453349299|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
126015219|NCT01350804|453349300|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
126015220|NCT01350804|453349297|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
126015221|NCT01350804|453349298|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
126015222|NCT01350804|453349299|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
126015223|NCT01350804|453349300|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
126015224|NCT01350804|453349297|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
126015225|NCT01350804|453349298|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
126015226|NCT01350804|453349299|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
126015227|NCT01350804|453349300|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
126015228|NCT01713946|453349301|FG000|Overall Study|Death|0|||
126015229|NCT01713946|453349302|FG001|Overall Study|Death|2|||
126015230|NCT01713946|453349303|FG002|Overall Study|Death|2|||
126015231|NCT01713946|453349301|FG000|Overall Study|Adverse Event|19|||
126015232|NCT01713946|453349302|FG001|Overall Study|Adverse Event|14|||
126015233|NCT01713946|453349303|FG002|Overall Study|Adverse Event|13|||
126015234|NCT01713946|453349301|FG000|Overall Study|Withdrawal by Subject|12|||
126015235|NCT01713946|453349302|FG001|Overall Study|Withdrawal by Subject|12|||
126015236|NCT01713946|453349303|FG002|Overall Study|Withdrawal by Subject|8|||
126015237|NCT01713946|453349301|FG000|Overall Study|Lack of Efficacy|8|||
126015238|NCT01713946|453349302|FG001|Overall Study|Lack of Efficacy|8|||
126015239|NCT01713946|453349303|FG002|Overall Study|Lack of Efficacy|14|||
126015240|NCT01713946|453349301|FG000|Overall Study|Protocol Violation|2|||
126015241|NCT01713946|453349302|FG001|Overall Study|Protocol Violation|4|||
126015242|NCT01713946|453349303|FG002|Overall Study|Protocol Violation|1|||
126015243|NCT01713946|453349301|FG000|Overall Study|Lost to Follow-up|0|||
126015244|NCT01713946|453349302|FG001|Overall Study|Lost to Follow-up|0|||
126015245|NCT01713946|453349303|FG002|Overall Study|Lost to Follow-up|1|||
126015246|NCT01713946|453349301|FG000|Overall Study|Administrative problems|1|||
126015247|NCT01713946|453349302|FG001|Overall Study|Administrative problems|0|||
126015248|NCT01713946|453349303|FG002|Overall Study|Administrative problems|0|||
126015249|NCT01713946|453349301|FG000|Overall Study|Did not continue in Ext|0|||
126216759|NCT00080288|454084417|FG000|Overall Study|Adverse Event|7|||
126015250|NCT01713946|453349302|FG001|Overall Study|Did not continue in Ext|3|||
126015251|NCT01713946|453349303|FG002|Overall Study|Did not continue in Ext|0|||
126091291|NCT00568178|453628368|FG000|Open Label Extension|Protocol Violation|0|||
126015252|NCT01713946|453349301|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
126091292|NCT00568178|453628369|FG001|Open Label Extension|Protocol Violation|0|||
126091293|NCT00568178|453628370|FG002|Open Label Extension|Protocol Violation|0|||
126091294|NCT00568178|453628371|FG003|Open Label Extension|Protocol Violation|0|||
126091295|NCT00568178|453628372|FG004|Open Label Extension|Protocol Violation|1|||
126091296|NCT00568178|453628373|FG005|Open Label Extension|Protocol Violation|0|||
126091297|NCT00568178|453628368|FG000|Open Label Extension|Lost to Follow-up|0|||
126091298|NCT00568178|453628369|FG001|Open Label Extension|Lost to Follow-up|0|||
126015253|NCT01713946|453349302|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
126015254|NCT01713946|453349303|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
126015255|NCT01713946|453349301|FG000|Overall Study|Patients never switched to everolimus|0|||
126015256|NCT01713946|453349302|FG001|Overall Study|Patients never switched to everolimus|0|||
126015257|NCT01713946|453349303|FG002|Overall Study|Patients never switched to everolimus|5|||
126015258|NCT03183518|453349304|FG000|Overall Study|Other (Not specified)|2|||
126015259|NCT03183518|453349304|FG000|Overall Study|Other (Withdrawal of consent)|1|||
126015260|NCT02299336|453349305|FG000|Overall Study|Withdrawal by Subject|11|||
126015261|NCT02299336|453349305|FG000|Overall Study|Adverse Event|1|||
126015262|NCT02299336|453349305|FG000|Overall Study|Death|1|||
126015263|NCT02299336|453349305|FG000|Overall Study|Lost to Follow-up|1|||
126015264|NCT02106442|453349307|FG000|Overall Study|Case Report Forms Uncollected|7|||
126015265|NCT02106442|453349307|FG000|Overall Study|Protocol Deviation|30|||
126015266|NCT00743444|453350817|FG000|First Intervention|Catheter placement problems|0|||
126015267|NCT00743444|453350818|FG001|First Intervention|Catheter placement problems|1|||
126015268|NCT00743444|453350817|FG000|Washout Period|Adverse Event|0|||
126015269|NCT00743444|453350818|FG001|Washout Period|Adverse Event|1|||
126015270|NCT00814346|453350819|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
126015271|NCT00814346|453350820|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
126015272|NCT00814346|453350819|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
126015273|NCT00814346|453350820|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
126015274|NCT00814346|453350819|FG000|Open Phase (17 Months)|Adverse Event|5|||
126015275|NCT00814346|453350820|FG001|Open Phase (17 Months)|Adverse Event|0|||
126015276|NCT00814346|453350819|FG000|Open Phase (17 Months)|Consent|2|||
126015277|NCT00814346|453350820|FG001|Open Phase (17 Months)|Consent|0|||
126015278|NCT00814346|453350819|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
126015279|NCT00814346|453350820|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
126015280|NCT00814346|453350819|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
126015281|NCT00814346|453350820|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
126015282|NCT05136443|453350822|FG000|Overall Study|Lost to Follow-up|2|||
126015283|NCT05136443|453350822|FG000|Overall Study|Adverse Event|2|||
126015284|NCT02613871|453350823|FG000|Overall Study|Death|2|||
126015285|NCT02613871|453350823|FG000|Overall Study|Withdrew Consent|1|||
126015286|NCT01930045|453350824|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126015287|NCT01930045|453350825|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126015288|NCT01930045|453350826|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126015289|NCT01930045|453350827|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126015290|NCT01930045|453350828|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126015291|NCT01930045|453350829|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
126015292|NCT01930045|453350824|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
126015293|NCT01930045|453350825|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
126015294|NCT01930045|453350826|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
126015295|NCT01930045|453350827|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
126015296|NCT01930045|453350828|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
126015297|NCT01930045|453350829|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
126015298|NCT00494442|453350830|FG000|Overall Study|Death|1|||
126015299|NCT00494442|453350831|FG001|Overall Study|Death|1|||
126015300|NCT00494442|453350830|FG000|Overall Study|Lack of Efficacy|16|||
126015301|NCT00494442|453350831|FG001|Overall Study|Lack of Efficacy|10|||
126015302|NCT00494442|453350830|FG000|Overall Study|Adverse Event|0|||
126015303|NCT00494442|453350831|FG001|Overall Study|Adverse Event|2|||
126015304|NCT00494442|453350830|FG000|Overall Study|Physician Decision|0|||
126015305|NCT00494442|453350831|FG001|Overall Study|Physician Decision|1|||
126015306|NCT00494442|453350830|FG000|Overall Study|Non-compliance|0|||
126015307|NCT00494442|453350831|FG001|Overall Study|Non-compliance|1|||
126015308|NCT00494442|453350830|FG000|Overall Study|Intercurrent illness|0|||
126015309|NCT00494442|453350831|FG001|Overall Study|Intercurrent illness|1|||
126015310|NCT01241292|453350834|FG000|Overall Study|Administrative Reason by Sponsor|1|||
126015311|NCT01241292|453350835|FG001|Overall Study|Administrative Reason by Sponsor|0|||
126015312|NCT01241292|453350834|FG000|Overall Study|Disease Progression|2|||
126015313|NCT01241292|453350835|FG001|Overall Study|Disease Progression|0|||
126015314|NCT01241292|453350834|FG000|Overall Study|Study Drug Toxicity|0|||
126015315|NCT01241292|453350835|FG001|Overall Study|Study Drug Toxicity|1|||
126015316|NCT01241292|453350834|FG000|Overall Study|Participant Discontinued Treatment|0|||
126015317|NCT01241292|453350835|FG001|Overall Study|Participant Discontinued Treatment|2|||
126216760|NCT00080288|454084418|FG001|Overall Study|Adverse Event|4|||
126216761|NCT00080288|454084417|FG000|Overall Study|Lost to Follow-up|3|||
126015318|NCT03034915|453350838|FG000|Overall Study|Adverse Event|29|||
126015319|NCT03034915|453350839|FG001|Overall Study|Adverse Event|32|||
126015320|NCT03034915|453350840|FG002|Overall Study|Adverse Event|22|||
126015321|NCT03034915|453350838|FG000|Overall Study|Lost to Follow-up|5|||
126015322|NCT03034915|453350839|FG001|Overall Study|Lost to Follow-up|13|||
126015323|NCT03034915|453350840|FG002|Overall Study|Lost to Follow-up|3|||
126015324|NCT03034915|453350838|FG000|Overall Study|Withdrawal by Subject|29|||
126015325|NCT03034915|453350839|FG001|Overall Study|Withdrawal by Subject|46|||
126015326|NCT03034915|453350840|FG002|Overall Study|Withdrawal by Subject|41|||
126015327|NCT03034915|453350838|FG000|Overall Study|Protocol Deviation|2|||
126015328|NCT03034915|453350839|FG001|Overall Study|Protocol Deviation|14|||
126015329|NCT03034915|453350840|FG002|Overall Study|Protocol Deviation|7|||
126015330|NCT03034915|453350838|FG000|Overall Study|Lack of Efficacy|8|||
126015331|NCT03034915|453350839|FG001|Overall Study|Lack of Efficacy|16|||
126015332|NCT03034915|453350840|FG002|Overall Study|Lack of Efficacy|18|||
126015333|NCT03034915|453350838|FG000|Overall Study|Site closed|2|||
126015334|NCT03034915|453350839|FG001|Overall Study|Site closed|2|||
126015335|NCT03034915|453350840|FG002|Overall Study|Site closed|4|||
126015336|NCT03034915|453350838|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
126015337|NCT03034915|453350839|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
126015338|NCT03034915|453350840|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
126015339|NCT03034915|453350838|FG000|Overall Study|Physician Decision|1|||
126015340|NCT03034915|453350839|FG001|Overall Study|Physician Decision|5|||
126015341|NCT03034915|453350840|FG002|Overall Study|Physician Decision|2|||
126015342|NCT03861767|453350841|FG000|Overall Study|Withdrawal by Subject|2|||
126015343|NCT03861767|453350842|FG001|Overall Study|Withdrawal by Subject|1|||
126015344|NCT03861767|453350843|FG002|Overall Study|Withdrawal by Subject|0|||
126015345|NCT03861767|453350844|FG003|Overall Study|Withdrawal by Subject|5|||
126015346|NCT03861767|453350845|FG004|Overall Study|Withdrawal by Subject|2|||
126015347|NCT03861767|453350846|FG005|Overall Study|Withdrawal by Subject|1|||
126015348|NCT03861767|453350847|FG006|Overall Study|Withdrawal by Subject|3|||
126015349|NCT03861767|453350848|FG007|Overall Study|Withdrawal by Subject|1|||
126015350|NCT03861767|453350849|FG008|Overall Study|Withdrawal by Subject|0|||
126015351|NCT03861767|453350850|FG009|Overall Study|Withdrawal by Subject|5|||
126015352|NCT01087762|453350851|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
126015353|NCT01087762|453350852|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
126015354|NCT01087762|453350853|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
126015355|NCT01087762|453350854|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
126015356|NCT01087762|453350855|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
126015357|NCT01087762|453350851|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
126015358|NCT01087762|453350852|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
126015359|NCT01087762|453350853|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
126015360|NCT01087762|453350854|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
126015361|NCT01087762|453350855|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
126015362|NCT01087762|453350851|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
125878729|NCT01209689|452853399|FG000|Overall Study|Refused Treatment|8|||
126015363|NCT01087762|453350852|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
126015364|NCT01087762|453350853|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
126015365|NCT01087762|453350854|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
126216762|NCT00080288|454084418|FG001|Overall Study|Lost to Follow-up|5|||
126015366|NCT01087762|453350855|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
126015367|NCT01087762|453350851|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
126015368|NCT01087762|453350852|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
126015369|NCT01087762|453350853|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
126015370|NCT01087762|453350854|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
126015371|NCT01087762|453350855|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
126216763|NCT00080288|454084417|FG000|Overall Study|Physician Decision|6|||
126216764|NCT00080288|454084418|FG001|Overall Study|Physician Decision|2|||
126015372|NCT01087762|453350851|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
126015373|NCT01087762|453350852|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
126015374|NCT01087762|453350853|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
126216765|NCT00080288|454084417|FG000|Overall Study|Withdrawal by Subject|3|||
126216766|NCT00080288|454084418|FG001|Overall Study|Withdrawal by Subject|16|||
126216767|NCT00080288|454084417|FG000|Overall Study|Miscellaneous|11|||
126015375|NCT01087762|453350854|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
126015376|NCT01087762|453350855|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
126015377|NCT01087762|453350851|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
126015378|NCT01087762|453350852|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
126015379|NCT01087762|453350853|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
126015380|NCT01087762|453350854|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
126015381|NCT01087762|453350855|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
126015382|NCT01087762|453350851|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
126015383|NCT01087762|453350852|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
126015384|NCT01087762|453350853|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
126015385|NCT01087762|453350854|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
126015386|NCT01087762|453350855|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
126015387|NCT01087762|453350851|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
126015388|NCT01087762|453350852|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
126216768|NCT00080288|454084418|FG001|Overall Study|Miscellaneous|11|||
126216769|NCT03044431|454084419|FG000|Overall Study|Lost to Follow-up|59|||
126216770|NCT02328547|454084420|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
126216771|NCT02328547|454084421|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
126216772|NCT02328547|454084420|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
126015389|NCT01087762|453350853|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
126015390|NCT01087762|453350854|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
126015391|NCT01087762|453350855|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
126015392|NCT01087762|453350851|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
126015393|NCT01087762|453350852|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
126015394|NCT01087762|453350853|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
126015395|NCT01087762|453350854|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
126015396|NCT01087762|453350855|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
126015397|NCT01087762|453350851|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
126015398|NCT01087762|453350852|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
126015399|NCT01087762|453350853|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
126015400|NCT01087762|453350854|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
126015401|NCT01087762|453350855|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
126015402|NCT01087762|453350851|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
126015403|NCT01087762|453350852|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
126015404|NCT01087762|453350853|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
126015405|NCT01087762|453350854|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
126015406|NCT01087762|453350855|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
126015407|NCT01087762|453350851|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
126015408|NCT01087762|453350852|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
126015409|NCT01087762|453350853|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
126015410|NCT01087762|453350854|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
126015411|NCT01087762|453350855|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
126015412|NCT01087762|453350851|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
126015413|NCT01087762|453350852|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
126015414|NCT01087762|453350853|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
126015415|NCT01087762|453350854|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
126015416|NCT01087762|453350855|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
126015417|NCT00813904|453350856|FG000|Overall Study|Death|1|||
126015418|NCT01405924|453350862|FG000|Overall Study|Protocol Violation|8|||
126015419|NCT01405924|453350862|FG000|Overall Study|Missing/Incomplete Data|2|||
126015420|NCT00770965|453350866|FG000|Safety Set|Withdrawal by Subject|0|||
126015421|NCT00770965|453350867|FG001|Safety Set|Withdrawal by Subject|0|||
126015422|NCT00770965|453350868|FG002|Safety Set|Withdrawal by Subject|0|||
126015423|NCT00770965|453350869|FG003|Safety Set|Withdrawal by Subject|1|||
126015424|NCT00770965|453350866|FG000|Safety Set|Protocol deviation|0|||
126015425|NCT00770965|453350867|FG001|Safety Set|Protocol deviation|0|||
126015426|NCT00770965|453350868|FG002|Safety Set|Protocol deviation|1|||
126015427|NCT00770965|453350869|FG003|Safety Set|Protocol deviation|0|||
126015428|NCT00770965|453350866|FG000|Excluded Set|Administrative problems|14|||
126015429|NCT00770965|453350867|FG001|Excluded Set|Administrative problems|12|||
126015430|NCT00770965|453350868|FG002|Excluded Set|Administrative problems|12|||
126216773|NCT02328547|454084421|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
126015431|NCT00770965|453350869|FG003|Excluded Set|Administrative problems|10|||
126015432|NCT00770965|453350866|FG000|Excluded Set|Withdrawal by Subject|1|||
126015433|NCT00770965|453350867|FG001|Excluded Set|Withdrawal by Subject|1|||
126015434|NCT00770965|453350868|FG002|Excluded Set|Withdrawal by Subject|2|||
126015435|NCT00770965|453350869|FG003|Excluded Set|Withdrawal by Subject|3|||
126015436|NCT01391130|453350872|FG000|Overall Study|Withdrawal by Subject|3|||
126015437|NCT01391130|453350873|FG001|Overall Study|Withdrawal by Subject|2|||
126015438|NCT01391130|453350872|FG000|Overall Study|Physician Decision|2|||
126015439|NCT01391130|453350873|FG001|Overall Study|Physician Decision|3|||
126015440|NCT01391130|453350872|FG000|Overall Study|Did not Receive Drug|1|||
126015441|NCT01391130|453350873|FG001|Overall Study|Did not Receive Drug|1|||
126015442|NCT03478696|453350874|FG000|Overall Study|Adverse Event|1|||
126015443|NCT03478696|453350875|FG001|Overall Study|Adverse Event|5|||
126015444|NCT03478696|453350874|FG000|Overall Study|Lost to Follow-up|1|||
126015445|NCT03478696|453350875|FG001|Overall Study|Lost to Follow-up|0|||
126015446|NCT03478696|453350874|FG000|Overall Study|Physician Decision|6|||
126015447|NCT03478696|453350875|FG001|Overall Study|Physician Decision|3|||
126015448|NCT03478696|453350874|FG000|Overall Study|Withdrawal by Subject|9|||
126015449|NCT03478696|453350875|FG001|Overall Study|Withdrawal by Subject|4|||
126015450|NCT03615924|453350876|FG000|Overall Study|Withdrawal by Subject|2|||
126015451|NCT03615924|453350877|FG001|Overall Study|Withdrawal by Subject|5|||
126015452|NCT03615924|453350876|FG000|Overall Study|Death|3|||
126015453|NCT03615924|453350877|FG001|Overall Study|Death|1|||
126015454|NCT03615924|453350876|FG000|Overall Study|Lost to Follow-up|1|||
126015455|NCT03615924|453350877|FG001|Overall Study|Lost to Follow-up|0|||
126015456|NCT03615924|453350876|FG000|Overall Study|Randomized in error|1|||
126015457|NCT03615924|453350877|FG001|Overall Study|Randomized in error|0|||
126015458|NCT03615924|453350876|FG000|Overall Study|Study termination by Sponsor|94|||
126015459|NCT03615924|453350877|FG001|Overall Study|Study termination by Sponsor|86|||
126015460|NCT02808338|453350880|FG000|Screening|Screen Failure|10|||
126015461|NCT02808338|453350880|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
126015462|NCT02808338|453350880|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
126015463|NCT00057837|453350881|FG000|Overall Study|Progression/relapse|12|||
126015464|NCT00057837|453350882|FG001|Overall Study|Progression/relapse|14|||
126015465|NCT00057837|453350881|FG000|Overall Study|Adverse Event|2|||
126015466|NCT00057837|453350882|FG001|Overall Study|Adverse Event|12|||
126015467|NCT00057837|453350881|FG000|Overall Study|Death|5|||
126015468|NCT00057837|453350882|FG001|Overall Study|Death|4|||
126015469|NCT00057837|453350881|FG000|Overall Study|Withdrawal by Subject|5|||
126015470|NCT00057837|453350882|FG001|Overall Study|Withdrawal by Subject|3|||
126015471|NCT00057837|453350881|FG000|Overall Study|Alternative therapy|0|||
126015472|NCT00057837|453350882|FG001|Overall Study|Alternative therapy|1|||
126015473|NCT00057837|453350881|FG000|Overall Study|Other complicating disease|2|||
126015474|NCT00057837|453350882|FG001|Overall Study|Other complicating disease|1|||
126015475|NCT00057837|453350881|FG000|Overall Study|Physician Decision|1|||
126015476|NCT00057837|453350882|FG001|Overall Study|Physician Decision|0|||
126015477|NCT00057837|453350881|FG000|Overall Study|Ineligible|3|||
126015478|NCT00057837|453350882|FG001|Overall Study|Ineligible|3|||
126015479|NCT00057837|453350881|FG000|Overall Study|Never started treatment|1|||
126015480|NCT00057837|453350882|FG001|Overall Study|Never started treatment|1|||
126015481|NCT03024606|453350886|FG000|Overall Study|Withdrawal by Subject|9|||
126015482|NCT03024606|453350887|FG001|Overall Study|Withdrawal by Subject|10|||
126015483|NCT01692938|453350889|FG000|Overall Study|Protocol Deviation|1|||
126015484|NCT01692938|453350890|FG001|Overall Study|Protocol Deviation|1|||
126015485|NCT01692938|453350889|FG000|Overall Study|Study completed prior to site completion|3|||
126015486|NCT01692938|453350890|FG001|Overall Study|Study completed prior to site completion|3|||
126015487|NCT00256243|453350896|FG000|Overall Study|Lost to Follow-up|2|||
126015488|NCT00256243|453350896|FG000|Overall Study|Death|7|||
126015489|NCT00256243|453350896|FG000|Overall Study|Not treated|1|||
126015490|NCT00547118|453350899|FG000|Overall Study|Did not qualify prior to starting drug|1|||
126015491|NCT00547118|453350900|FG001|Overall Study|Did not qualify prior to starting drug|1|||
126015492|NCT00547118|453350899|FG000|Overall Study|Study suspended|7|||
126015493|NCT00547118|453350900|FG001|Overall Study|Study suspended|8|||
126015494|NCT00834834|453350901|FG000|Overall Study|Withdrawal by Subject|4|||
126015495|NCT00834834|453350902|FG001|Overall Study|Withdrawal by Subject|3|||
126015496|NCT00539292|453350903|FG000|Overall Study|Physician Decision|1|||
126015497|NCT00539292|453350904|FG001|Overall Study|Physician Decision|0|||
126015498|NCT02020616|453350905|FG000|Overall Study|Adverse Event|0|||
126015499|NCT02020616|453350906|FG001|Overall Study|Adverse Event|0|||
126015500|NCT02020616|453350907|FG002|Overall Study|Adverse Event|0|||
126015501|NCT02020616|453350908|FG003|Overall Study|Adverse Event|0|||
126015502|NCT02020616|453350909|FG004|Overall Study|Adverse Event|0|||
126015503|NCT02020616|453350910|FG005|Overall Study|Adverse Event|1|||
126015504|NCT02020616|453350911|FG006|Overall Study|Adverse Event|1|||
126015505|NCT02020616|453350905|FG000|Overall Study|Physician Decision|0|||
126015506|NCT02020616|453350906|FG001|Overall Study|Physician Decision|0|||
126015507|NCT02020616|453350907|FG002|Overall Study|Physician Decision|0|||
126015508|NCT02020616|453350908|FG003|Overall Study|Physician Decision|0|||
126015509|NCT02020616|453350909|FG004|Overall Study|Physician Decision|0|||
126015510|NCT02020616|453350910|FG005|Overall Study|Physician Decision|1|||
126015511|NCT02020616|453350911|FG006|Overall Study|Physician Decision|2|||
126015512|NCT02020616|453350905|FG000|Overall Study|Withdrawal by Subject|0|||
126015513|NCT02020616|453350906|FG001|Overall Study|Withdrawal by Subject|0|||
126015514|NCT02020616|453350907|FG002|Overall Study|Withdrawal by Subject|1|||
126015515|NCT02020616|453350908|FG003|Overall Study|Withdrawal by Subject|0|||
126015516|NCT02020616|453350909|FG004|Overall Study|Withdrawal by Subject|0|||
126015517|NCT02020616|453350910|FG005|Overall Study|Withdrawal by Subject|1|||
126015518|NCT02020616|453350911|FG006|Overall Study|Withdrawal by Subject|1|||
126015519|NCT02020616|453350905|FG000|Overall Study|Lost to Follow-up|0|||
126015520|NCT02020616|453350906|FG001|Overall Study|Lost to Follow-up|1|||
126015521|NCT02020616|453350907|FG002|Overall Study|Lost to Follow-up|0|||
126015522|NCT02020616|453350908|FG003|Overall Study|Lost to Follow-up|1|||
126015523|NCT02020616|453350909|FG004|Overall Study|Lost to Follow-up|1|||
126015524|NCT02020616|453350910|FG005|Overall Study|Lost to Follow-up|1|||
126015525|NCT02020616|453350911|FG006|Overall Study|Lost to Follow-up|0|||
126015526|NCT02020616|453350905|FG000|Overall Study|Early Termination Criteria Met|0|||
126015527|NCT02020616|453350906|FG001|Overall Study|Early Termination Criteria Met|0|||
126015528|NCT02020616|453350907|FG002|Overall Study|Early Termination Criteria Met|1|||
126015529|NCT02020616|453350908|FG003|Overall Study|Early Termination Criteria Met|0|||
126015530|NCT02020616|453350909|FG004|Overall Study|Early Termination Criteria Met|0|||
126015531|NCT02020616|453350910|FG005|Overall Study|Early Termination Criteria Met|1|||
126015532|NCT02020616|453350911|FG006|Overall Study|Early Termination Criteria Met|0|||
126015533|NCT02020616|453350905|FG000|Overall Study|Randomized in Error|0|||
126015534|NCT02020616|453350906|FG001|Overall Study|Randomized in Error|0|||
126015535|NCT02020616|453350907|FG002|Overall Study|Randomized in Error|0|||
126015536|NCT02020616|453350908|FG003|Overall Study|Randomized in Error|1|||
126015537|NCT02020616|453350909|FG004|Overall Study|Randomized in Error|0|||
126015538|NCT02020616|453350910|FG005|Overall Study|Randomized in Error|0|||
126015539|NCT02020616|453350911|FG006|Overall Study|Randomized in Error|0|||
126015540|NCT02020616|453350905|FG000|Overall Study|Lack of Efficacy|0|||
126015541|NCT02020616|453350906|FG001|Overall Study|Lack of Efficacy|0|||
126015542|NCT02020616|453350907|FG002|Overall Study|Lack of Efficacy|0|||
126015543|NCT02020616|453350908|FG003|Overall Study|Lack of Efficacy|0|||
126015544|NCT02020616|453350909|FG004|Overall Study|Lack of Efficacy|1|||
126015545|NCT02020616|453350910|FG005|Overall Study|Lack of Efficacy|0|||
126015546|NCT02020616|453350911|FG006|Overall Study|Lack of Efficacy|0|||
126015547|NCT00305695|453350916|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
126015548|NCT00305695|453350917|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
126015549|NCT00305695|453350916|FG000|Overall Study|Did not have baseline scan|1|||
126015550|NCT00305695|453350917|FG001|Overall Study|Did not have baseline scan|1|||
126015551|NCT02031471|453350920|FG000|24 Week Treatment Period|Adverse Event|6|||
126015552|NCT02031471|453350920|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
126015553|NCT02031471|453350920|FG000|24 Week Treatment Period|Protocol Violation|1|||
126015554|NCT02031471|453350920|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
126015555|NCT02031471|453350920|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
126216774|NCT00344305|454084425|FG000|Overall Study|Lost to Follow-up|2|||
126015556|NCT02031471|453350920|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
126015557|NCT02031471|453350920|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
126015558|NCT00841035|453350921|FG000|Phase 1 Overall Study|Physician Decision|13|||
126015559|NCT00961636|453350931|FG000|Overall Study|Adverse Event|35|||
126015560|NCT00961636|453350932|FG001|Overall Study|Adverse Event|54|||
126216775|NCT00344305|454084426|FG001|Overall Study|Lost to Follow-up|0|||
126216776|NCT00344305|454084425|FG000|Overall Study|Participant was not contacted in window|0|||
126091299|NCT00568178|453628370|FG002|Open Label Extension|Lost to Follow-up|0|||
126091300|NCT00568178|453628371|FG003|Open Label Extension|Lost to Follow-up|0|||
126091301|NCT00568178|453628372|FG004|Open Label Extension|Lost to Follow-up|6|||
126091302|NCT00568178|453628373|FG005|Open Label Extension|Lost to Follow-up|11|||
126091303|NCT00568178|453628368|FG000|Open Label Extension|Physician Decision|0|||
126091304|NCT00568178|453628369|FG001|Open Label Extension|Physician Decision|0|||
126091305|NCT00568178|453628370|FG002|Open Label Extension|Physician Decision|0|||
126091306|NCT00568178|453628371|FG003|Open Label Extension|Physician Decision|0|||
126091307|NCT00568178|453628372|FG004|Open Label Extension|Physician Decision|9|||
126091308|NCT00568178|453628373|FG005|Open Label Extension|Physician Decision|8|||
126091309|NCT00568178|453628368|FG000|Open Label Extension|Pregnancy|0|||
126091310|NCT00568178|453628369|FG001|Open Label Extension|Pregnancy|0|||
126091311|NCT00568178|453628370|FG002|Open Label Extension|Pregnancy|0|||
126091312|NCT00568178|453628371|FG003|Open Label Extension|Pregnancy|0|||
126091313|NCT00568178|453628372|FG004|Open Label Extension|Pregnancy|0|||
126091314|NCT00568178|453628373|FG005|Open Label Extension|Pregnancy|1|||
126091315|NCT00568178|453628368|FG000|Open Label Extension|Progressive Disease|0|||
126091316|NCT00568178|453628369|FG001|Open Label Extension|Progressive Disease|0|||
126091317|NCT00568178|453628370|FG002|Open Label Extension|Progressive Disease|0|||
126091318|NCT00568178|453628371|FG003|Open Label Extension|Progressive Disease|0|||
126091319|NCT00568178|453628372|FG004|Open Label Extension|Progressive Disease|3|||
126091320|NCT00568178|453628373|FG005|Open Label Extension|Progressive Disease|1|||
126091321|NCT00568178|453628368|FG000|Open Label Extension|Termination of Trial|0|||
126091322|NCT00568178|453628369|FG001|Open Label Extension|Termination of Trial|0|||
126091323|NCT00568178|453628370|FG002|Open Label Extension|Termination of Trial|0|||
126091324|NCT00568178|453628371|FG003|Open Label Extension|Termination of Trial|0|||
126091325|NCT00568178|453628372|FG004|Open Label Extension|Termination of Trial|45|||
126091326|NCT00568178|453628373|FG005|Open Label Extension|Termination of Trial|47|||
126091327|NCT00568178|453628368|FG000|Open Label Extension|Withdrawal by Subject|0|||
126091328|NCT00568178|453628369|FG001|Open Label Extension|Withdrawal by Subject|0|||
126091329|NCT00568178|453628370|FG002|Open Label Extension|Withdrawal by Subject|0|||
126091330|NCT00568178|453628371|FG003|Open Label Extension|Withdrawal by Subject|0|||
126091331|NCT00568178|453628372|FG004|Open Label Extension|Withdrawal by Subject|4|||
126091332|NCT00568178|453628373|FG005|Open Label Extension|Withdrawal by Subject|4|||
126091333|NCT01008553|453628374|FG000|Period 1 (Titration Period)|Physician Decision|2|||
126091334|NCT01008553|453628375|FG001|Period 1 (Titration Period)|Physician Decision|0|||
126091335|NCT01008553|453628376|FG002|Period 1 (Titration Period)|Physician Decision|0|||
126091336|NCT01008553|453628374|FG000|Period 1 (Titration Period)|Adverse Event|33|||
126091337|NCT01008553|453628375|FG001|Period 1 (Titration Period)|Adverse Event|0|||
126091338|NCT01008553|453628376|FG002|Period 1 (Titration Period)|Adverse Event|0|||
126091339|NCT01008553|453628374|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
126091340|NCT01008553|453628375|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
126091341|NCT01008553|453628376|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
126091342|NCT01008553|453628374|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
126091343|NCT01008553|453628375|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
126091344|NCT01008553|453628376|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
126091345|NCT01008553|453628374|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
126091346|NCT01008553|453628375|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
126091347|NCT01008553|453628376|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
126091348|NCT01008553|453628374|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
126091349|NCT01008553|453628375|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
126091350|NCT01008553|453628376|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
126091351|NCT01008553|453628374|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
126091352|NCT01008553|453628375|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
126091353|NCT01008553|453628376|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
126091354|NCT01008553|453628374|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
126091355|NCT01008553|453628375|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
126091356|NCT01008553|453628376|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
126091357|NCT01008553|453628374|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
126091358|NCT01008553|453628375|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
126091359|NCT01008553|453628376|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
126091360|NCT01008553|453628374|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
126091361|NCT01008553|453628375|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
126091362|NCT01008553|453628376|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
126091363|NCT01008553|453628374|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
126091364|NCT01008553|453628375|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
126091365|NCT01008553|453628376|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
126091366|NCT01008553|453628374|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
126015561|NCT00961636|453350933|FG002|Overall Study|Adverse Event|13|||
126015562|NCT00961636|453350931|FG000|Overall Study|Flushing Symptoms|29|||
126015563|NCT00961636|453350932|FG001|Overall Study|Flushing Symptoms|46|||
126015564|NCT00961636|453350933|FG002|Overall Study|Flushing Symptoms|3|||
126015565|NCT00961636|453350931|FG000|Overall Study|Lost to Follow-up|2|||
126015566|NCT00961636|453350932|FG001|Overall Study|Lost to Follow-up|3|||
126015567|NCT00961636|453350933|FG002|Overall Study|Lost to Follow-up|1|||
126015568|NCT00961636|453350931|FG000|Overall Study|Physician Decision|3|||
126015569|NCT00961636|453350932|FG001|Overall Study|Physician Decision|1|||
126015570|NCT00961636|453350933|FG002|Overall Study|Physician Decision|1|||
126015571|NCT00961636|453350931|FG000|Overall Study|Protocol Violation|9|||
126015572|NCT00961636|453350932|FG001|Overall Study|Protocol Violation|5|||
126015573|NCT00961636|453350933|FG002|Overall Study|Protocol Violation|1|||
126015574|NCT00961636|453350931|FG000|Overall Study|Withdrawal by Subject|29|||
126015575|NCT00961636|453350932|FG001|Overall Study|Withdrawal by Subject|22|||
126015576|NCT00961636|453350933|FG002|Overall Study|Withdrawal by Subject|13|||
126015577|NCT02551055|453350936|FG000|Overall Study|Death|2|||
126015578|NCT02551055|453350937|FG001|Overall Study|Death|4|||
126015579|NCT02551055|453350938|FG002|Overall Study|Death|2|||
126015580|NCT02551055|453350939|FG003|Overall Study|Death|2|||
126015581|NCT02551055|453350940|FG004|Overall Study|Death|2|||
126015582|NCT02551055|453350941|FG005|Overall Study|Death|1|||
126015583|NCT02551055|453350942|FG006|Overall Study|Death|2|||
126015584|NCT02551055|453350943|FG007|Overall Study|Death|0|||
126015585|NCT02551055|453350936|FG000|Overall Study|Study Terminated by Sponsor|1|||
126015586|NCT02551055|453350937|FG001|Overall Study|Study Terminated by Sponsor|1|||
126015587|NCT02551055|453350938|FG002|Overall Study|Study Terminated by Sponsor|0|||
126015588|NCT02551055|453350939|FG003|Overall Study|Study Terminated by Sponsor|2|||
126015589|NCT02551055|453350940|FG004|Overall Study|Study Terminated by Sponsor|2|||
126015590|NCT02551055|453350941|FG005|Overall Study|Study Terminated by Sponsor|0|||
126015591|NCT02551055|453350942|FG006|Overall Study|Study Terminated by Sponsor|0|||
126015592|NCT02551055|453350943|FG007|Overall Study|Study Terminated by Sponsor|0|||
126015593|NCT02551055|453350936|FG000|Overall Study|Withdrawal by Subject|1|||
126015594|NCT02551055|453350937|FG001|Overall Study|Withdrawal by Subject|1|||
126015595|NCT02551055|453350938|FG002|Overall Study|Withdrawal by Subject|0|||
126015596|NCT02551055|453350939|FG003|Overall Study|Withdrawal by Subject|1|||
126015597|NCT02551055|453350940|FG004|Overall Study|Withdrawal by Subject|2|||
126015598|NCT02551055|453350941|FG005|Overall Study|Withdrawal by Subject|0|||
126015599|NCT02551055|453350942|FG006|Overall Study|Withdrawal by Subject|0|||
126015600|NCT02551055|453350943|FG007|Overall Study|Withdrawal by Subject|0|||
126015601|NCT02551055|453350936|FG000|Overall Study|Reason not specified|0|||
126015602|NCT02551055|453350937|FG001|Overall Study|Reason not specified|0|||
126015603|NCT02551055|453350938|FG002|Overall Study|Reason not specified|0|||
126015604|NCT02551055|453350939|FG003|Overall Study|Reason not specified|0|||
126015605|NCT02551055|453350940|FG004|Overall Study|Reason not specified|1|||
126015606|NCT02551055|453350941|FG005|Overall Study|Reason not specified|0|||
126015607|NCT02551055|453350942|FG006|Overall Study|Reason not specified|1|||
126015608|NCT02551055|453350943|FG007|Overall Study|Reason not specified|0|||
126216777|NCT00344305|454084426|FG001|Overall Study|Participant was not contacted in window|1|||
126216778|NCT01726335|454084433|FG000|Overall Study|Lost to Follow-up|2|||
126216779|NCT01726335|454084433|FG000|Overall Study|Withdrawal by Subject|15|||
126216780|NCT01726335|454084433|FG000|Overall Study|Adverse Event|4|||
126216781|NCT01726335|454084433|FG000|Overall Study|Lost to Follow-up|2|||
126216782|NCT01726335|454084433|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
126015609|NCT00430300|453350947|FG000|Overall Study|Adverse Event|0|||
126015610|NCT00430300|453350948|FG001|Overall Study|Adverse Event|2|||
126015611|NCT00430300|453350949|FG002|Overall Study|Adverse Event|1|||
126015612|NCT00430300|453350950|FG003|Overall Study|Adverse Event|1|||
126015613|NCT00430300|453350947|FG000|Overall Study|Withdrawal by Subject|1|||
126015614|NCT00430300|453350948|FG001|Overall Study|Withdrawal by Subject|0|||
126015615|NCT00430300|453350949|FG002|Overall Study|Withdrawal by Subject|5|||
126015616|NCT00430300|453350950|FG003|Overall Study|Withdrawal by Subject|0|||
126015617|NCT00430300|453350947|FG000|Overall Study|Laboratory abnormality|1|||
126015618|NCT00430300|453350948|FG001|Overall Study|Laboratory abnormality|0|||
126015619|NCT00430300|453350949|FG002|Overall Study|Laboratory abnormality|0|||
126015620|NCT00430300|453350950|FG003|Overall Study|Laboratory abnormality|0|||
126015621|NCT00430300|453350947|FG000|Overall Study|Other|0|||
126015622|NCT00430300|453350948|FG001|Overall Study|Other|0|||
126015623|NCT00430300|453350949|FG002|Overall Study|Other|0|||
126015624|NCT00430300|453350950|FG003|Overall Study|Other|1|||
126015625|NCT02754479|453350951|FG000|Overall Study|Lost to Follow-up|1|||
126015626|NCT05328297|453352761|FG000|Overall Study|Adverse Event|5|||
126015627|NCT05328297|453352762|FG001|Overall Study|Adverse Event|7|||
126216783|NCT01796860|454084439|FG000|Overall Study|Withdrawal by Subject|3|||
126216784|NCT02703454|454084447|FG000|Overall Study|Not treated|1|||
126216785|NCT02703454|454084448|FG001|Overall Study|Not treated|3|||
126216786|NCT02703454|454084447|FG000|Overall Study|Withdrawal by Subject|4|||
126216787|NCT02703454|454084448|FG001|Overall Study|Withdrawal by Subject|3|||
126216788|NCT02703454|454084447|FG000|Overall Study|Lost to Follow-up|1|||
126216789|NCT02703454|454084448|FG001|Overall Study|Lost to Follow-up|2|||
126216790|NCT02703454|454084447|FG000|Overall Study|Study discontinuation|5|||
126091367|NCT01008553|453628375|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
126091368|NCT01008553|453628376|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
126091369|NCT01008553|453628374|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
126091370|NCT01008553|453628375|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
126091371|NCT01008553|453628376|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
126091372|NCT01008553|453628374|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
126091373|NCT01008553|453628375|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
126091374|NCT01008553|453628376|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
126091375|NCT03563157|453628383|FG000|Overall Study|Progressive Disease|2|||
126091376|NCT02187159|453628384|FG000|Overall Study|Protocol Violation|4|||
126091377|NCT02187159|453628385|FG001|Overall Study|Protocol Violation|6|||
126091378|NCT02187159|453628386|FG002|Overall Study|Protocol Violation|3|||
126091379|NCT02187159|453628387|FG003|Overall Study|Protocol Violation|4|||
126091380|NCT02187159|453628384|FG000|Overall Study|Lack of Efficacy|10|||
126091381|NCT02187159|453628385|FG001|Overall Study|Lack of Efficacy|5|||
126091382|NCT02187159|453628386|FG002|Overall Study|Lack of Efficacy|4|||
126091383|NCT02187159|453628387|FG003|Overall Study|Lack of Efficacy|7|||
126091384|NCT02187159|453628384|FG000|Overall Study|Adverse Event|28|||
126091385|NCT02187159|453628385|FG001|Overall Study|Adverse Event|33|||
126091386|NCT02187159|453628386|FG002|Overall Study|Adverse Event|42|||
126091387|NCT02187159|453628387|FG003|Overall Study|Adverse Event|50|||
126091388|NCT02187159|453628384|FG000|Overall Study|Withdrawal by Subject|24|||
126091389|NCT02187159|453628385|FG001|Overall Study|Withdrawal by Subject|28|||
126091390|NCT02187159|453628386|FG002|Overall Study|Withdrawal by Subject|25|||
126091391|NCT02187159|453628387|FG003|Overall Study|Withdrawal by Subject|26|||
126091392|NCT02187159|453628384|FG000|Overall Study|Other|3|||
126091393|NCT02187159|453628385|FG001|Overall Study|Other|7|||
126091394|NCT02187159|453628386|FG002|Overall Study|Other|3|||
126091395|NCT02187159|453628387|FG003|Overall Study|Other|9|||
126091396|NCT00567567|453628388|FG000|Overall Study|Adverse Event|0|||
126091397|NCT00567567|453628389|FG001|Overall Study|Adverse Event|2|||
126091398|NCT00567567|453628390|FG002|Overall Study|Adverse Event|5|||
126091399|NCT00567567|453628388|FG000|Overall Study|Death|8|||
126091400|NCT00567567|453628389|FG001|Overall Study|Death|1|||
126091401|NCT00567567|453628390|FG002|Overall Study|Death|5|||
126091402|NCT00567567|453628388|FG000|Overall Study|Lack of Efficacy|16|||
126091403|NCT00567567|453628389|FG001|Overall Study|Lack of Efficacy|17|||
126091404|NCT00567567|453628390|FG002|Overall Study|Lack of Efficacy|48|||
126091405|NCT00567567|453628388|FG000|Overall Study|Lost to Follow-up|0|||
126091406|NCT00567567|453628389|FG001|Overall Study|Lost to Follow-up|0|||
126091407|NCT00567567|453628390|FG002|Overall Study|Lost to Follow-up|1|||
126091408|NCT00567567|453628388|FG000|Overall Study|Physician Decision|16|||
126091409|NCT00567567|453628389|FG001|Overall Study|Physician Decision|18|||
126091410|NCT00567567|453628390|FG002|Overall Study|Physician Decision|84|||
126091411|NCT00567567|453628388|FG000|Overall Study|Withdrawal by Subject|0|||
126091412|NCT00567567|453628389|FG001|Overall Study|Withdrawal by Subject|0|||
126091413|NCT00567567|453628390|FG002|Overall Study|Withdrawal by Subject|2|||
126015628|NCT05328297|453352761|FG000|Overall Study|Withdrawal by Subject|4|||
126216791|NCT02703454|454084448|FG001|Overall Study|Study discontinuation|8|||
126216792|NCT00791154|454084449|FG000|Overall Study|Noncompliance|0|||
126091414|NCT00567567|453628388|FG000|Overall Study|Ineligible|4|||
126091415|NCT00567567|453628389|FG001|Overall Study|Ineligible|0|||
126091416|NCT00567567|453628390|FG002|Overall Study|Ineligible|9|||
126091417|NCT00567567|453628388|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
126091418|NCT00567567|453628389|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
126091419|NCT00567567|453628390|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
126216793|NCT00791154|454084450|FG001|Overall Study|Noncompliance|1|||
126216794|NCT00791154|454084451|FG002|Overall Study|Noncompliance|0|||
126015629|NCT05328297|453352762|FG001|Overall Study|Withdrawal by Subject|3|||
126015630|NCT05328297|453352761|FG000|Overall Study|Lack of Efficacy|1|||
126015631|NCT05328297|453352762|FG001|Overall Study|Lack of Efficacy|0|||
126015632|NCT05328297|453352761|FG000|Overall Study|Lost to Follow-up|1|||
126015633|NCT05328297|453352762|FG001|Overall Study|Lost to Follow-up|0|||
126015634|NCT05328297|453352761|FG000|Overall Study|Protocol Violation|1|||
126015635|NCT05328297|453352762|FG001|Overall Study|Protocol Violation|0|||
126216795|NCT00791154|454084452|FG003|Overall Study|Noncompliance|0|||
126216796|NCT00791154|454084453|FG004|Overall Study|Noncompliance|1|||
126015636|NCT05328297|453352761|FG000|Overall Study|Randomized but not treated|1|||
126216797|NCT00791154|454084454|FG005|Overall Study|Noncompliance|1|||
126015637|NCT05328297|453352762|FG001|Overall Study|Randomized but not treated|1|||
126015638|NCT03544515|453352763|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
126015639|NCT03544515|453352764|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
126015640|NCT03544515|453352763|FG000|Overall Study|Lost to Follow-up|2|||
126015641|NCT03544515|453352764|FG001|Overall Study|Lost to Follow-up|0|||
126015642|NCT03175172|453352765|FG000|Overall Study|Death|3|||
126015643|NCT03175172|453352765|FG000|Overall Study|Withdrawal by Subject|3|||
126015644|NCT03175172|453352765|FG000|Overall Study|Lost to Follow-up|1|||
126015645|NCT03175172|453352765|FG000|Overall Study|Study Terminated by Sponsor|3|||
126015646|NCT03169244|453352766|FG000|Overall Study|Lost to Follow-up|1|||
126015647|NCT03169244|453352767|FG001|Overall Study|Lost to Follow-up|2|||
126015648|NCT03169244|453352766|FG000|Overall Study|Adverse Event|1|||
126015649|NCT03169244|453352767|FG001|Overall Study|Adverse Event|0|||
126015650|NCT03169244|453352766|FG000|Overall Study|Withdrawal by Subject|2|||
126015651|NCT03169244|453352767|FG001|Overall Study|Withdrawal by Subject|2|||
126015652|NCT03169244|453352766|FG000|Overall Study|Physician Decision|1|||
126015653|NCT03169244|453352767|FG001|Overall Study|Physician Decision|0|||
126015654|NCT01662336|453352768|FG000|Overall Study|Adverse Event|1|||
126015655|NCT01662336|453352768|FG000|Overall Study|No longer on LPV/r|30|||
126015656|NCT01662336|453352768|FG000|Overall Study|Other|29|||
126015657|NCT01662336|453352768|FG000|Overall Study|Withdrawal by Subject|6|||
126015658|NCT03622593|453352772|FG000|Overall Study|Withdrawal by Subject|11|||
126015659|NCT03622593|453352773|FG001|Overall Study|Withdrawal by Subject|9|||
126015660|NCT03622593|453352774|FG002|Overall Study|Withdrawal by Subject|13|||
126015661|NCT03622593|453352772|FG000|Overall Study|Death|12|||
126015662|NCT03622593|453352773|FG001|Overall Study|Death|9|||
126015663|NCT03622593|453352774|FG002|Overall Study|Death|10|||
126015664|NCT03622593|453352772|FG000|Overall Study|Lost to Follow-up|11|||
126015665|NCT03622593|453352773|FG001|Overall Study|Lost to Follow-up|5|||
126015666|NCT03622593|453352774|FG002|Overall Study|Lost to Follow-up|8|||
126015667|NCT03622593|453352772|FG000|Overall Study|Adverse Event|4|||
126015668|NCT03622593|453352773|FG001|Overall Study|Adverse Event|5|||
126015669|NCT03622593|453352774|FG002|Overall Study|Adverse Event|6|||
126015670|NCT03622593|453352772|FG000|Overall Study|Physician Decision|2|||
126015671|NCT03622593|453352773|FG001|Overall Study|Physician Decision|1|||
126015672|NCT03622593|453352774|FG002|Overall Study|Physician Decision|6|||
126015673|NCT03622593|453352772|FG000|Overall Study|Other|2|||
126015674|NCT03622593|453352773|FG001|Overall Study|Other|2|||
126015675|NCT03622593|453352774|FG002|Overall Study|Other|3|||
126015676|NCT03622593|453352772|FG000|Overall Study|Protocol Violation|0|||
126015677|NCT03622593|453352773|FG001|Overall Study|Protocol Violation|0|||
126015678|NCT03622593|453352774|FG002|Overall Study|Protocol Violation|1|||
126015679|NCT03622593|453352772|FG000|Overall Study|Pregnancy|0|||
126015680|NCT03622593|453352773|FG001|Overall Study|Pregnancy|0|||
126015681|NCT03622593|453352774|FG002|Overall Study|Pregnancy|1|||
126015682|NCT03762668|453352775|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
126015683|NCT03762668|453352776|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
126015684|NCT00178399|453352777|FG000|Overall Study|Physician Decision|4|||
126015685|NCT00178399|453352777|FG000|Overall Study|Withdrawal by Subject|8|||
126015686|NCT00178399|453352777|FG000|Overall Study|Lost to Follow-up|1|||
126015687|NCT01393119|453352778|FG000|Overall Study|Adverse Event|1|||
126015688|NCT01393119|453352779|FG001|Overall Study|Adverse Event|1|||
126216798|NCT00791154|454084455|FG006|Overall Study|Noncompliance|1|||
126015689|NCT01393119|453352780|FG002|Overall Study|Adverse Event|0|||
126015690|NCT01393119|453352781|FG003|Overall Study|Adverse Event|1|||
126015691|NCT01393119|453352778|FG000|Overall Study|Withdrawal by Subject|0|||
126015692|NCT01393119|453352779|FG001|Overall Study|Withdrawal by Subject|1|||
126015693|NCT01393119|453352780|FG002|Overall Study|Withdrawal by Subject|1|||
126015694|NCT01393119|453352781|FG003|Overall Study|Withdrawal by Subject|0|||
126015695|NCT01393119|453352778|FG000|Overall Study|Lack of Efficacy|1|||
126015696|NCT01393119|453352779|FG001|Overall Study|Lack of Efficacy|0|||
126015697|NCT01393119|453352780|FG002|Overall Study|Lack of Efficacy|2|||
126015698|NCT01393119|453352781|FG003|Overall Study|Lack of Efficacy|1|||
126015699|NCT01393119|453352778|FG000|Overall Study|Protocol Violation|0|||
126015700|NCT01393119|453352779|FG001|Overall Study|Protocol Violation|0|||
126015701|NCT01393119|453352780|FG002|Overall Study|Protocol Violation|1|||
126015702|NCT01393119|453352781|FG003|Overall Study|Protocol Violation|0|||
126015703|NCT01393119|453352778|FG000|Overall Study|Death|0|||
126015704|NCT01393119|453352779|FG001|Overall Study|Death|0|||
126015705|NCT01393119|453352780|FG002|Overall Study|Death|0|||
126015706|NCT01393119|453352781|FG003|Overall Study|Death|1|||
126015707|NCT01393119|453352778|FG000|Overall Study|Randomized but Not treated|1|||
126015708|NCT01393119|453352779|FG001|Overall Study|Randomized but Not treated|0|||
126015709|NCT01393119|453352780|FG002|Overall Study|Randomized but Not treated|1|||
126015710|NCT01393119|453352781|FG003|Overall Study|Randomized but Not treated|1|||
126015711|NCT01393119|453352778|FG000|Overall Study|Sponsor Termination of Study|11|||
126015712|NCT01393119|453352779|FG001|Overall Study|Sponsor Termination of Study|12|||
126015713|NCT01393119|453352780|FG002|Overall Study|Sponsor Termination of Study|9|||
126015714|NCT01393119|453352781|FG003|Overall Study|Sponsor Termination of Study|12|||
126015715|NCT02027558|453352782|FG000|Overall Study|Death|0|||
126015716|NCT02027558|453352783|FG001|Overall Study|Death|1|||
126015717|NCT02027558|453352782|FG000|Overall Study|Withdrawal by Subject|2|||
126015718|NCT02027558|453352783|FG001|Overall Study|Withdrawal by Subject|0|||
126015719|NCT02027558|453352782|FG000|Overall Study|Lost to Follow-up|4|||
126015720|NCT02027558|453352783|FG001|Overall Study|Lost to Follow-up|1|||
126216799|NCT00791154|454084449|FG000|Overall Study|Adverse Event|0|||
126216800|NCT00791154|454084450|FG001|Overall Study|Adverse Event|0|||
126216801|NCT00791154|454084451|FG002|Overall Study|Adverse Event|0|||
126015721|NCT02027558|453352782|FG000|Overall Study|Refused assessment|3|||
126015722|NCT02027558|453352783|FG001|Overall Study|Refused assessment|0|||
126015723|NCT02139046|453352784|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
126015724|NCT02139046|453352785|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
126015725|NCT02139046|453352786|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
126015726|NCT02139046|453352787|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
126015727|NCT02139046|453352788|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
126015728|NCT02139046|453352784|FG000|Overall Study|Major Protocol Deviation|9|||
126015729|NCT02139046|453352785|FG001|Overall Study|Major Protocol Deviation|10|||
126015730|NCT02139046|453352786|FG002|Overall Study|Major Protocol Deviation|16|||
126015731|NCT02139046|453352787|FG003|Overall Study|Major Protocol Deviation|12|||
126015732|NCT02139046|453352788|FG004|Overall Study|Major Protocol Deviation|6|||
126015733|NCT02139046|453352784|FG000|Overall Study|Lost to Follow-up|13|||
126015734|NCT02139046|453352785|FG001|Overall Study|Lost to Follow-up|16|||
126015735|NCT02139046|453352786|FG002|Overall Study|Lost to Follow-up|16|||
126015736|NCT02139046|453352787|FG003|Overall Study|Lost to Follow-up|18|||
126015737|NCT02139046|453352788|FG004|Overall Study|Lost to Follow-up|13|||
126015738|NCT02139046|453352784|FG000|Overall Study|Voluntary Withdrawal|20|||
126015739|NCT02139046|453352785|FG001|Overall Study|Voluntary Withdrawal|8|||
126015740|NCT02139046|453352786|FG002|Overall Study|Voluntary Withdrawal|10|||
126015741|NCT02139046|453352787|FG003|Overall Study|Voluntary Withdrawal|15|||
126015742|NCT02139046|453352788|FG004|Overall Study|Voluntary Withdrawal|16|||
126015743|NCT02139046|453352784|FG000|Overall Study|Lack of Efficacy|0|||
126015744|NCT02139046|453352785|FG001|Overall Study|Lack of Efficacy|1|||
126015745|NCT02139046|453352786|FG002|Overall Study|Lack of Efficacy|2|||
126015746|NCT02139046|453352787|FG003|Overall Study|Lack of Efficacy|1|||
126015747|NCT02139046|453352788|FG004|Overall Study|Lack of Efficacy|2|||
126015748|NCT02139046|453352784|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
126015749|NCT02139046|453352785|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
126015750|NCT02139046|453352786|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
126015751|NCT02139046|453352787|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
126015752|NCT02139046|453352788|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
126015753|NCT02139046|453352784|FG000|Overall Study|Other Miscellaneous Reasons|10|||
126015754|NCT02139046|453352785|FG001|Overall Study|Other Miscellaneous Reasons|9|||
126015755|NCT02139046|453352786|FG002|Overall Study|Other Miscellaneous Reasons|4|||
126015756|NCT02139046|453352787|FG003|Overall Study|Other Miscellaneous Reasons|9|||
126015757|NCT02139046|453352788|FG004|Overall Study|Other Miscellaneous Reasons|12|||
126015758|NCT02383472|453352789|FG000|Overall Study|Withdrawal by Subject|1|||
126015759|NCT02383472|453352790|FG001|Overall Study|Withdrawal by Subject|1|||
126015760|NCT02013830|453352791|FG000|Overall Study|Adverse Event|3|||
126015761|NCT02013830|453352791|FG000|Overall Study|Death|1|||
126015762|NCT02013830|453352791|FG000|Overall Study|Insufficient therapeutic response|25|||
126015763|NCT02013830|453352791|FG000|Overall Study|Refused treatment|1|||
126015764|NCT01111526|453352792|FG000|Overall Study|GVHD Disease Progression|0|||
126015765|NCT01111526|453352793|FG001|Overall Study|GVHD Disease Progression|1|||
126015766|NCT01111526|453352794|FG002|Overall Study|GVHD Disease Progression|2|||
126015767|NCT02015546|453352795|FG000|Overall Study|Withdrawal by Subject|1|||
126015768|NCT02015546|453352796|FG001|Overall Study|Withdrawal by Subject|1|||
126015769|NCT02015546|453352797|FG002|Overall Study|Withdrawal by Subject|1|||
126015770|NCT02015546|453352795|FG000|Overall Study|Screem Failure|2|||
126015771|NCT02015546|453352796|FG001|Overall Study|Screem Failure|1|||
126015772|NCT02015546|453352797|FG002|Overall Study|Screem Failure|3|||
126015773|NCT04424641|453352798|FG000|Overall Study|Death|1|||
126015774|NCT04424641|453352799|FG001|Overall Study|Death|2|||
126015775|NCT04424641|453352800|FG002|Overall Study|Death|3|||
126015776|NCT04424641|453352801|FG003|Overall Study|Death|0|||
126015777|NCT04424641|453352802|FG004|Overall Study|Death|3|||
126015778|NCT04424641|453352803|FG005|Overall Study|Death|0|||
126015779|NCT04424641|453352804|FG006|Overall Study|Death|1|||
126015780|NCT04424641|453352805|FG007|Overall Study|Death|2|||
126015781|NCT04424641|453352798|FG000|Overall Study|Sponsor decision|0|||
126015782|NCT04424641|453352799|FG001|Overall Study|Sponsor decision|2|||
126015783|NCT04424641|453352800|FG002|Overall Study|Sponsor decision|3|||
126015784|NCT04424641|453352801|FG003|Overall Study|Sponsor decision|7|||
126015785|NCT04424641|453352802|FG004|Overall Study|Sponsor decision|2|||
126015786|NCT04424641|453352803|FG005|Overall Study|Sponsor decision|2|||
126015787|NCT04424641|453352804|FG006|Overall Study|Sponsor decision|3|||
126015788|NCT04424641|453352805|FG007|Overall Study|Sponsor decision|4|||
126015789|NCT04424641|453352798|FG000|Overall Study|Withdrawal by Subject|0|||
126015790|NCT04424641|453352799|FG001|Overall Study|Withdrawal by Subject|0|||
126015791|NCT04424641|453352800|FG002|Overall Study|Withdrawal by Subject|0|||
126015792|NCT04424641|453352801|FG003|Overall Study|Withdrawal by Subject|0|||
126015793|NCT04424641|453352802|FG004|Overall Study|Withdrawal by Subject|1|||
126015794|NCT04424641|453352803|FG005|Overall Study|Withdrawal by Subject|0|||
126015795|NCT04424641|453352804|FG006|Overall Study|Withdrawal by Subject|0|||
126015796|NCT04424641|453352805|FG007|Overall Study|Withdrawal by Subject|0|||
126015797|NCT04424641|453352798|FG000|Overall Study|Other|0|||
126015798|NCT04424641|453352799|FG001|Overall Study|Other|0|||
126015799|NCT04424641|453352800|FG002|Overall Study|Other|1|||
126015800|NCT04424641|453352801|FG003|Overall Study|Other|0|||
126015801|NCT04424641|453352802|FG004|Overall Study|Other|0|||
126015802|NCT04424641|453352803|FG005|Overall Study|Other|0|||
126015803|NCT04424641|453352804|FG006|Overall Study|Other|0|||
126015804|NCT04424641|453352805|FG007|Overall Study|Other|0|||
126015805|NCT01337635|453352812|FG000|Overall Study|Lost to Follow-up|0|||
126015806|NCT01337635|453352813|FG001|Overall Study|Lost to Follow-up|1|||
126015807|NCT03622580|453352818|FG000|Overall Study|Death|16|||
126015808|NCT03622580|453352819|FG001|Overall Study|Death|21|||
126015809|NCT03622580|453352820|FG002|Overall Study|Death|13|||
126015810|NCT03622580|453352818|FG000|Overall Study|Adverse Event|6|||
126015811|NCT03622580|453352819|FG001|Overall Study|Adverse Event|6|||
126015812|NCT03622580|453352820|FG002|Overall Study|Adverse Event|5|||
126015813|NCT03622580|453352818|FG000|Overall Study|Withdrawal by Subject|12|||
126015814|NCT03622580|453352819|FG001|Overall Study|Withdrawal by Subject|7|||
126015815|NCT03622580|453352820|FG002|Overall Study|Withdrawal by Subject|19|||
126015816|NCT03622580|453352818|FG000|Overall Study|Lost to Follow-up|12|||
126015817|NCT03622580|453352819|FG001|Overall Study|Lost to Follow-up|9|||
126015818|NCT03622580|453352820|FG002|Overall Study|Lost to Follow-up|9|||
126015819|NCT03622580|453352818|FG000|Overall Study|Protocol Violation|1|||
126015820|NCT03622580|453352819|FG001|Overall Study|Protocol Violation|0|||
126015821|NCT03622580|453352820|FG002|Overall Study|Protocol Violation|1|||
126015822|NCT03622580|453352818|FG000|Overall Study|Physician Decision|3|||
126015823|NCT03622580|453352819|FG001|Overall Study|Physician Decision|0|||
126015824|NCT03622580|453352820|FG002|Overall Study|Physician Decision|1|||
126015825|NCT03622580|453352818|FG000|Overall Study|Pregnancy|0|||
126015826|NCT03622580|453352819|FG001|Overall Study|Pregnancy|1|||
126015827|NCT03622580|453352820|FG002|Overall Study|Pregnancy|0|||
126015828|NCT03622580|453352818|FG000|Overall Study|Lack of Efficacy|0|||
126015829|NCT03622580|453352819|FG001|Overall Study|Lack of Efficacy|0|||
126015830|NCT03622580|453352820|FG002|Overall Study|Lack of Efficacy|1|||
126015831|NCT03622580|453352818|FG000|Overall Study|Other|2|||
126015832|NCT03622580|453352819|FG001|Overall Study|Other|0|||
126015833|NCT03622580|453352820|FG002|Overall Study|Other|3|||
126015834|NCT00831415|453352825|FG000|Overall Study|Adverse Event|14|||
126015835|NCT00831415|453352825|FG000|Overall Study|Failed to return|3|||
126015836|NCT00831415|453352825|FG000|Overall Study|Physician Decision|6|||
126015837|NCT00831415|453352825|FG000|Overall Study|Lost to Follow-up|9|||
126015838|NCT00831415|453352825|FG000|Overall Study|Protocol Violation|3|||
126015839|NCT00831415|453352825|FG000|Overall Study|Withdrawal by Subject|35|||
126015840|NCT00831415|453352825|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
126015841|NCT00831415|453352825|FG000|Overall Study|Death|1|||
126015842|NCT00424762|453352828|FG000|Overall Study|Withdrawal by Subject|18|||
126015843|NCT00424762|453352829|FG001|Overall Study|Withdrawal by Subject|19|||
126015844|NCT00424762|453352828|FG000|Overall Study|Lost to Follow-up|2|||
126015845|NCT00424762|453352829|FG001|Overall Study|Lost to Follow-up|3|||
126015846|NCT01147341|453352836|FG000|Double Blind Period|Lack of Efficacy|1|||
126015847|NCT01147341|453352837|FG001|Double Blind Period|Lack of Efficacy|1|||
126015848|NCT01147341|453352836|FG000|Double Blind Period|Withdrawal by Subject|0|||
126015849|NCT01147341|453352837|FG001|Double Blind Period|Withdrawal by Subject|1|||
126015850|NCT01147341|453352836|FG000|Open Label Period|Lack of Efficacy|3|||
126015851|NCT01147341|453352837|FG001|Open Label Period|Lack of Efficacy|0|||
126015852|NCT01147341|453352836|FG000|Open Label Period|Subject moved|1|||
126015853|NCT01147341|453352837|FG001|Open Label Period|Subject moved|0|||
126015854|NCT02537522|453352840|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
126015855|NCT02537522|453352841|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
126015856|NCT02537522|453352842|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
126015857|NCT02537522|453352843|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
126015858|NCT02537522|453352840|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
126216802|NCT00791154|454084452|FG003|Overall Study|Adverse Event|0|||
126015859|NCT02537522|453352841|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
126015860|NCT02537522|453352842|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
126015861|NCT02537522|453352843|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
126015862|NCT02537522|453352840|FG000|Phase I - Contralateral|incorrect randomization|0|||
126015863|NCT02537522|453352841|FG001|Phase I - Contralateral|incorrect randomization|1|||
126015864|NCT02537522|453352842|FG002|Phase I - Contralateral|incorrect randomization|0|||
126015865|NCT02537522|453352843|FG003|Phase I - Contralateral|incorrect randomization|0|||
126015866|NCT02537522|453352840|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
126015867|NCT02537522|453352841|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
126015868|NCT02537522|453352842|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
126015869|NCT02537522|453352843|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
126015870|NCT02537522|453352840|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
126015871|NCT02537522|453352841|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
126015872|NCT02537522|453352842|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
126015873|NCT02537522|453352843|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
126015874|NCT00463788|453352844|FG000|Overall Study|Progressive Disease|86|||
126015875|NCT00463788|453352845|FG001|Overall Study|Progressive Disease|42|||
126015876|NCT00463788|453352844|FG000|Overall Study|Adverse Event|6|||
126015877|NCT00463788|453352845|FG001|Overall Study|Adverse Event|2|||
126015878|NCT00463788|453352844|FG000|Overall Study|Withdrawal by Subject|6|||
126015879|NCT00463788|453352845|FG001|Overall Study|Withdrawal by Subject|2|||
126015880|NCT00463788|453352844|FG000|Overall Study|Death|4|||
126015881|NCT00463788|453352845|FG001|Overall Study|Death|3|||
126015882|NCT00463788|453352844|FG000|Overall Study|Symptomatic Deterioration|2|||
126015883|NCT00463788|453352845|FG001|Overall Study|Symptomatic Deterioration|3|||
126015884|NCT00463788|453352844|FG000|Overall Study|Lost to Follow-up|1|||
126015885|NCT00463788|453352845|FG001|Overall Study|Lost to Follow-up|0|||
126015886|NCT00463788|453352844|FG000|Overall Study|Protocol Violation|0|||
126015887|NCT00463788|453352845|FG001|Overall Study|Protocol Violation|1|||
126015888|NCT00463788|453352844|FG000|Overall Study|Other|3|||
126015889|NCT00463788|453352845|FG001|Overall Study|Other|0|||
126015890|NCT00463788|453352844|FG000|Overall Study|Randomized but not treated|1|||
126015891|NCT00463788|453352845|FG001|Overall Study|Randomized but not treated|1|||
126015892|NCT00360698|453352846|FG000|Run-In|Physician Decision|0|||
126015893|NCT00360698|453352847|FG001|Run-In|Physician Decision|1|||
126015894|NCT00360698|453352846|FG000|Run-In|Withdrawal by Subject|0|||
126015895|NCT00360698|453352847|FG001|Run-In|Withdrawal by Subject|2|||
126015896|NCT00360698|453352846|FG000|Run-In|Non compliance with treatment procedure|0|||
126015897|NCT00360698|453352847|FG001|Run-In|Non compliance with treatment procedure|1|||
126015898|NCT00360698|453352846|FG000|Run-In|Sponsor request|0|||
126015899|NCT00360698|453352847|FG001|Run-In|Sponsor request|2|||
126015900|NCT00360698|453352846|FG000|Run-In|Patient did not meet inclusion criteria|0|||
126015901|NCT00360698|453352847|FG001|Run-In|Patient did not meet inclusion criteria|1|||
126015902|NCT00360698|453352846|FG000|Run-In|Patient personal reasons|0|||
126015903|NCT00360698|453352847|FG001|Run-In|Patient personal reasons|2|||
126015904|NCT00360698|453352846|FG000|Run-In|Need of insulin with meals|0|||
126015905|NCT00360698|453352847|FG001|Run-In|Need of insulin with meals|1|||
126015906|NCT00360698|453352846|FG000|Treatment Period|Non compliance with treatment procedure|1|||
126015907|NCT00360698|453352847|FG001|Treatment Period|Non compliance with treatment procedure|0|||
126015908|NCT00360698|453352846|FG000|Treatment Period|Early termination by error|0|||
126015909|NCT00360698|453352847|FG001|Treatment Period|Early termination by error|1|||
126015910|NCT02547922|453352850|FG000|Overall Study|Withdrawal by Subject|9|||
126015911|NCT02547922|453352851|FG001|Overall Study|Withdrawal by Subject|6|||
126015912|NCT02547922|453352852|FG002|Overall Study|Withdrawal by Subject|10|||
126015913|NCT02547922|453352850|FG000|Overall Study|Adverse Event|3|||
126015914|NCT02547922|453352851|FG001|Overall Study|Adverse Event|1|||
126015915|NCT02547922|453352852|FG002|Overall Study|Adverse Event|2|||
126015916|NCT02547922|453352850|FG000|Overall Study|Lost to Follow-up|1|||
126015917|NCT02547922|453352851|FG001|Overall Study|Lost to Follow-up|0|||
126015918|NCT02547922|453352852|FG002|Overall Study|Lost to Follow-up|0|||
126015919|NCT02547922|453352850|FG000|Overall Study|Lack of Efficacy|5|||
126015920|NCT02547922|453352851|FG001|Overall Study|Lack of Efficacy|7|||
126015921|NCT02547922|453352852|FG002|Overall Study|Lack of Efficacy|4|||
126015922|NCT02547922|453352850|FG000|Overall Study|Death|1|||
126015923|NCT02547922|453352851|FG001|Overall Study|Death|0|||
126015924|NCT02547922|453352852|FG002|Overall Study|Death|0|||
126015925|NCT02547922|453352850|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
126015926|NCT02547922|453352851|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
126015927|NCT02547922|453352852|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
126015928|NCT02547922|453352850|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
126015929|NCT02547922|453352851|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
126015930|NCT02547922|453352852|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
126015931|NCT02547922|453352850|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
126015932|NCT02547922|453352851|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
126015933|NCT02547922|453352852|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
126015934|NCT02547922|453352850|FG000|Overall Study|Physician Decision|2|||
126015935|NCT02547922|453352851|FG001|Overall Study|Physician Decision|1|||
126015936|NCT02547922|453352852|FG002|Overall Study|Physician Decision|2|||
126015937|NCT02547922|453352850|FG000|Overall Study|Patients did not receive IP|1|||
126015938|NCT02547922|453352851|FG001|Overall Study|Patients did not receive IP|1|||
126015939|NCT02547922|453352852|FG002|Overall Study|Patients did not receive IP|0|||
126015940|NCT01317420|453352857|FG000|Overall Study|Progressive disease according to RECIST|2|||
126015941|NCT01317420|453352858|FG001|Overall Study|Progressive disease according to RECIST|3|||
126015942|NCT01317420|453352859|FG002|Overall Study|Progressive disease according to RECIST|3|||
126015943|NCT01317420|453352860|FG003|Overall Study|Progressive disease according to RECIST|3|||
126015944|NCT01317420|453352861|FG004|Overall Study|Progressive disease according to RECIST|3|||
126015945|NCT01317420|453352862|FG005|Overall Study|Progressive disease according to RECIST|3|||
126015946|NCT01317420|453352863|FG006|Overall Study|Progressive disease according to RECIST|3|||
126015947|NCT01317420|453352864|FG007|Overall Study|Progressive disease according to RECIST|3|||
126015948|NCT01317420|453352865|FG008|Overall Study|Progressive disease according to RECIST|3|||
126015949|NCT01317420|453352866|FG009|Overall Study|Progressive disease according to RECIST|2|||
126015950|NCT01317420|453352867|FG010|Overall Study|Progressive disease according to RECIST|3|||
126015951|NCT01317420|453352868|FG011|Overall Study|Progressive disease according to RECIST|11|||
126015952|NCT01317420|453352869|FG012|Overall Study|Progressive disease according to RECIST|16|||
126015953|NCT01317420|453352857|FG000|Overall Study|Other adverse event|1|||
126015954|NCT01317420|453352858|FG001|Overall Study|Other adverse event|0|||
126015955|NCT01317420|453352859|FG002|Overall Study|Other adverse event|0|||
126015956|NCT01317420|453352860|FG003|Overall Study|Other adverse event|0|||
126015957|NCT01317420|453352861|FG004|Overall Study|Other adverse event|0|||
126015958|NCT01317420|453352862|FG005|Overall Study|Other adverse event|0|||
126015959|NCT01317420|453352863|FG006|Overall Study|Other adverse event|0|||
126015960|NCT01317420|453352864|FG007|Overall Study|Other adverse event|0|||
126015961|NCT01317420|453352865|FG008|Overall Study|Other adverse event|0|||
126015962|NCT01317420|453352866|FG009|Overall Study|Other adverse event|0|||
126015963|NCT01317420|453352867|FG010|Overall Study|Other adverse event|0|||
126015964|NCT01317420|453352868|FG011|Overall Study|Other adverse event|0|||
126015965|NCT01317420|453352869|FG012|Overall Study|Other adverse event|2|||
126015966|NCT01317420|453352857|FG000|Overall Study|Non-compliant with protocol|0|||
126015967|NCT01317420|453352858|FG001|Overall Study|Non-compliant with protocol|0|||
126015968|NCT01317420|453352859|FG002|Overall Study|Non-compliant with protocol|0|||
126015969|NCT01317420|453352860|FG003|Overall Study|Non-compliant with protocol|0|||
126015970|NCT01317420|453352861|FG004|Overall Study|Non-compliant with protocol|0|||
126015971|NCT01317420|453352862|FG005|Overall Study|Non-compliant with protocol|0|||
126015972|NCT01317420|453352863|FG006|Overall Study|Non-compliant with protocol|0|||
126015973|NCT01317420|453352864|FG007|Overall Study|Non-compliant with protocol|0|||
126015974|NCT01317420|453352865|FG008|Overall Study|Non-compliant with protocol|0|||
126015975|NCT01317420|453352866|FG009|Overall Study|Non-compliant with protocol|0|||
126015976|NCT01317420|453352867|FG010|Overall Study|Non-compliant with protocol|0|||
126015977|NCT01317420|453352868|FG011|Overall Study|Non-compliant with protocol|0|||
126015978|NCT01317420|453352869|FG012|Overall Study|Non-compliant with protocol|1|||
126015979|NCT01317420|453352857|FG000|Overall Study|Refused to cont. taking trial medication|0|||
126015980|NCT01317420|453352858|FG001|Overall Study|Refused to cont. taking trial medication|0|||
126015981|NCT01317420|453352859|FG002|Overall Study|Refused to cont. taking trial medication|0|||
126015982|NCT01317420|453352860|FG003|Overall Study|Refused to cont. taking trial medication|0|||
126015983|NCT01317420|453352861|FG004|Overall Study|Refused to cont. taking trial medication|0|||
126015984|NCT01317420|453352862|FG005|Overall Study|Refused to cont. taking trial medication|0|||
126015985|NCT01317420|453352863|FG006|Overall Study|Refused to cont. taking trial medication|0|||
126015986|NCT01317420|453352864|FG007|Overall Study|Refused to cont. taking trial medication|0|||
126015987|NCT01317420|453352865|FG008|Overall Study|Refused to cont. taking trial medication|0|||
126015988|NCT01317420|453352866|FG009|Overall Study|Refused to cont. taking trial medication|0|||
126015989|NCT01317420|453352867|FG010|Overall Study|Refused to cont. taking trial medication|0|||
126015990|NCT01317420|453352868|FG011|Overall Study|Refused to cont. taking trial medication|0|||
126015991|NCT01317420|453352869|FG012|Overall Study|Refused to cont. taking trial medication|1|||
126015992|NCT01317420|453352857|FG000|Overall Study|Reason other than those specified|0|||
126015993|NCT01317420|453352858|FG001|Overall Study|Reason other than those specified|0|||
126015994|NCT01317420|453352859|FG002|Overall Study|Reason other than those specified|0|||
126015995|NCT01317420|453352860|FG003|Overall Study|Reason other than those specified|0|||
126015996|NCT01317420|453352861|FG004|Overall Study|Reason other than those specified|0|||
126015997|NCT01317420|453352862|FG005|Overall Study|Reason other than those specified|0|||
126015998|NCT01317420|453352863|FG006|Overall Study|Reason other than those specified|0|||
126015999|NCT01317420|453352864|FG007|Overall Study|Reason other than those specified|0|||
126016000|NCT01317420|453352865|FG008|Overall Study|Reason other than those specified|0|||
126016001|NCT01317420|453352866|FG009|Overall Study|Reason other than those specified|1|||
126016002|NCT01317420|453352867|FG010|Overall Study|Reason other than those specified|0|||
126016003|NCT01317420|453352868|FG011|Overall Study|Reason other than those specified|0|||
126016004|NCT01317420|453352869|FG012|Overall Study|Reason other than those specified|0|||
126016005|NCT03194958|453352870|FG000|Overall Study|Death|0|||
126016006|NCT03194958|453352871|FG001|Overall Study|Death|1|||
126016007|NCT03194958|453352872|FG002|Overall Study|Death|1|||
126016008|NCT03194958|453352873|FG003|Overall Study|Death|1|||
126016009|NCT03194958|453352870|FG000|Overall Study|Withdrawal by Subject|24|||
126016010|NCT03194958|453352871|FG001|Overall Study|Withdrawal by Subject|27|||
126016011|NCT03194958|453352872|FG002|Overall Study|Withdrawal by Subject|7|||
126016012|NCT03194958|453352873|FG003|Overall Study|Withdrawal by Subject|22|||
126016013|NCT03194958|453352870|FG000|Overall Study|Lost to Follow-up|168|||
126016014|NCT03194958|453352871|FG001|Overall Study|Lost to Follow-up|196|||
126016015|NCT03194958|453352872|FG002|Overall Study|Lost to Follow-up|174|||
126016016|NCT03194958|453352873|FG003|Overall Study|Lost to Follow-up|186|||
126016017|NCT01968226|453352875|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
126016018|NCT04975308|453352883|FG000|Overall Study|Withdrawal by Subject|6|||
126016019|NCT04975308|453352884|FG001|Overall Study|Withdrawal by Subject|16|||
126016020|NCT04975308|453352885|FG002|Overall Study|Withdrawal by Subject|6|||
126016021|NCT04975308|453352883|FG000|Overall Study|Physician Decision|0|||
126016022|NCT04975308|453352884|FG001|Overall Study|Physician Decision|3|||
126016023|NCT04975308|453352885|FG002|Overall Study|Physician Decision|1|||
126016024|NCT04975308|453352883|FG000|Overall Study|Adverse Event|10|||
126016025|NCT04975308|453352884|FG001|Overall Study|Adverse Event|1|||
126016026|NCT04975308|453352885|FG002|Overall Study|Adverse Event|12|||
126016027|NCT04975308|453352883|FG000|Overall Study|On study treatment (Ongoing)|65|||
126016028|NCT04975308|453352884|FG001|Overall Study|On study treatment (Ongoing)|43|||
126016029|NCT04975308|453352885|FG002|Overall Study|On study treatment (Ongoing)|75|||
126016030|NCT04975308|453352883|FG000|Overall Study|Protocol Deviation|4|||
126016031|NCT04975308|453352884|FG001|Overall Study|Protocol Deviation|3|||
126016032|NCT04975308|453352885|FG002|Overall Study|Protocol Deviation|2|||
126016033|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
126016034|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
126016035|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
126016036|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
126016037|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
126016038|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
126016039|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
126016040|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
126016041|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
126016042|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
126016043|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
126016044|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
126016045|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
126016046|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
126016047|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
126016048|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
126016049|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
126016050|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
126016051|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
126016052|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
126016053|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
126016054|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
126016055|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
126016056|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
126016057|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
126016058|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
126016059|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
126016060|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
126016061|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
126016062|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
126016063|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
126016064|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
126016065|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
126016066|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
126016067|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
126016068|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
126016069|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
126016070|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
126016071|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
126016072|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
126016073|NCT02709655|453352886|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
126016074|NCT02709655|453352887|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
126016075|NCT02709655|453352888|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
126216803|NCT00791154|454084453|FG004|Overall Study|Adverse Event|2|||
126016076|NCT02709655|453352889|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
126016077|NCT02709655|453352890|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
126016078|NCT02709655|453352886|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
126016079|NCT02709655|453352887|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
126016080|NCT02709655|453352888|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
126016081|NCT02709655|453352889|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
126016082|NCT02709655|453352890|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
126016083|NCT02709655|453352886|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
126016084|NCT02709655|453352887|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
126016085|NCT02709655|453352888|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
126016086|NCT02709655|453352889|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
126016087|NCT02709655|453352890|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
126016088|NCT02709655|453352886|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
126016089|NCT02709655|453352887|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
126016090|NCT02709655|453352888|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
126016091|NCT02709655|453352889|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
126016092|NCT02709655|453352890|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
126016093|NCT02709655|453352886|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
126016094|NCT02709655|453352887|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
126016095|NCT02709655|453352888|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
126016096|NCT02709655|453352889|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
126016097|NCT02709655|453352890|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
126016098|NCT02709655|453352886|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
126016099|NCT02709655|453352887|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
126016100|NCT02709655|453352888|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
126016101|NCT02709655|453352889|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
126016102|NCT02709655|453352890|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
126016103|NCT02709655|453352886|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
126016104|NCT02709655|453352887|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
126016105|NCT02709655|453352888|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
126016106|NCT02709655|453352889|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
126016107|NCT02709655|453352890|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
126016108|NCT02709655|453352886|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
126016109|NCT02709655|453352887|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
126016110|NCT02709655|453352888|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
126016111|NCT02709655|453352889|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
126016112|NCT02709655|453352890|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
126016113|NCT00102063|453352891|FG000|Overall Study|Lack of Efficacy|5|||
126016114|NCT00102063|453352892|FG001|Overall Study|Lack of Efficacy|1|||
126016115|NCT00102063|453352893|FG002|Overall Study|Lack of Efficacy|1|||
126016116|NCT00102063|453352891|FG000|Overall Study|Adverse Event|7|||
126016117|NCT00102063|453352892|FG001|Overall Study|Adverse Event|4|||
126016118|NCT00102063|453352893|FG002|Overall Study|Adverse Event|2|||
126016119|NCT00102063|453352891|FG000|Overall Study|Withdrawal by Subject|4|||
126016120|NCT00102063|453352892|FG001|Overall Study|Withdrawal by Subject|12|||
126016121|NCT00102063|453352893|FG002|Overall Study|Withdrawal by Subject|5|||
126016122|NCT00102063|453352891|FG000|Overall Study|Lost to Follow-up|0|||
126016123|NCT00102063|453352892|FG001|Overall Study|Lost to Follow-up|0|||
126016124|NCT00102063|453352893|FG002|Overall Study|Lost to Follow-up|1|||
126016125|NCT00102063|453352891|FG000|Overall Study|Protocol Violation|0|||
126016126|NCT00102063|453352892|FG001|Overall Study|Protocol Violation|1|||
126016127|NCT00102063|453352893|FG002|Overall Study|Protocol Violation|1|||
126016128|NCT01493778|453352894|FG000|Overall Study|Withdrawal by Subject|8|||
126016129|NCT05082025|453352895|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
126016130|NCT04210180|453352896|FG000|Overall Study|Withdrawal by Subject|2|||
126016131|NCT01179334|453352897|FG000|Treatment Period|Adverse Event|1|||
125878730|NCT01209689|452853400|FG001|Overall Study|Refused Treatment|3|||
126016132|NCT01179334|453352898|FG001|Treatment Period|Adverse Event|0|||
126016133|NCT01179334|453352897|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
126016134|NCT01179334|453352898|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
126016135|NCT01179334|453352897|FG000|Long-term Extension (LTE) Period|Death|3|||
126016136|NCT01179334|453352898|FG001|Long-term Extension (LTE) Period|Death|0|||
126016137|NCT01179334|453352897|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
126016138|NCT01179334|453352898|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
126016139|NCT00857649|453352899|FG000|Overall Study|Adverse Event|15|||
126016140|NCT00857649|453352900|FG001|Overall Study|Adverse Event|10|||
126016141|NCT00857649|453352899|FG000|Overall Study|Non-compliance|1|||
126016142|NCT00857649|453352900|FG001|Overall Study|Non-compliance|1|||
126016143|NCT00857649|453352899|FG000|Overall Study|Protocol Violation|2|||
126016144|NCT00857649|453352900|FG001|Overall Study|Protocol Violation|2|||
126016145|NCT00857649|453352899|FG000|Overall Study|Withdrawal of Consent|10|||
126016146|NCT00857649|453352900|FG001|Overall Study|Withdrawal of Consent|7|||
126016147|NCT00857649|453352899|FG000|Overall Study|Nursing Home Placement|2|||
126016148|NCT00857649|453352900|FG001|Overall Study|Nursing Home Placement|9|||
126016149|NCT00857649|453352899|FG000|Overall Study|Other Reasons|1|||
126016150|NCT00857649|453352900|FG001|Overall Study|Other Reasons|3|||
126016151|NCT05190419|453352901|FG000|Overall Study|Lack of Efficacy|8|||
126016152|NCT05190419|453352902|FG001|Overall Study|Lack of Efficacy|0|||
126016153|NCT05190419|453352903|FG002|Overall Study|Lack of Efficacy|1|||
126016154|NCT05190419|453352904|FG003|Overall Study|Lack of Efficacy|0|||
126016155|NCT05190419|453352901|FG000|Overall Study|Withdrawal by Subject|7|||
126016156|NCT05190419|453352902|FG001|Overall Study|Withdrawal by Subject|1|||
126016157|NCT05190419|453352903|FG002|Overall Study|Withdrawal by Subject|2|||
126016158|NCT05190419|453352904|FG003|Overall Study|Withdrawal by Subject|2|||
126016159|NCT05190419|453352901|FG000|Overall Study|Adverse Event|2|||
126016160|NCT05190419|453352902|FG001|Overall Study|Adverse Event|10|||
126016161|NCT05190419|453352903|FG002|Overall Study|Adverse Event|11|||
126016162|NCT05190419|453352904|FG003|Overall Study|Adverse Event|21|||
126016163|NCT05190419|453352901|FG000|Overall Study|Lost to Follow-up|1|||
126016164|NCT05190419|453352902|FG001|Overall Study|Lost to Follow-up|2|||
126016165|NCT05190419|453352903|FG002|Overall Study|Lost to Follow-up|3|||
126016166|NCT05190419|453352904|FG003|Overall Study|Lost to Follow-up|1|||
126016167|NCT05190419|453352901|FG000|Overall Study|Other|1|||
126016168|NCT05190419|453352902|FG001|Overall Study|Other|1|||
126016169|NCT05190419|453352903|FG002|Overall Study|Other|0|||
126016170|NCT05190419|453352904|FG003|Overall Study|Other|3|||
126016171|NCT00919763|453352905|FG000|Overall Study|Adverse Event|7|||
126016172|NCT00919763|453352906|FG001|Overall Study|Adverse Event|1|||
126016173|NCT00919763|453352905|FG000|Overall Study|Lost to Follow-up|1|||
126016174|NCT00919763|453352906|FG001|Overall Study|Lost to Follow-up|0|||
126016175|NCT00919763|453352905|FG000|Overall Study|Protocol Violation|1|||
126016176|NCT00919763|453352906|FG001|Overall Study|Protocol Violation|1|||
126016177|NCT00919763|453352905|FG000|Overall Study|Withdrawal by Subject|3|||
126016178|NCT00919763|453352906|FG001|Overall Study|Withdrawal by Subject|1|||
126016179|NCT00919763|453352905|FG000|Overall Study|Non-compliance|0|||
126016180|NCT00919763|453352906|FG001|Overall Study|Non-compliance|1|||
126016181|NCT05061693|453352909|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
126016182|NCT05061693|453352910|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
126016183|NCT05061693|453352911|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
126016184|NCT05061693|453352912|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126016185|NCT05061693|453352913|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126091420|NCT00567567|453628388|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
126091421|NCT00567567|453628389|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
126091422|NCT00567567|453628390|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
126091423|NCT00567567|453628388|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
126091424|NCT00567567|453628389|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
126091425|NCT00567567|453628390|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
126091426|NCT04335591|453628391|FG000|Overall Study|Adverse Event|5|||
126091427|NCT04335591|453628392|FG001|Overall Study|Adverse Event|2|||
126091428|NCT04335591|453628393|FG002|Overall Study|Adverse Event|3|||
126016186|NCT05061693|453352914|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126016187|NCT05061693|453352915|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126016188|NCT05061693|453352916|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126016189|NCT05061693|453352917|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126091429|NCT04335591|453628394|FG003|Overall Study|Adverse Event|2|||
126091430|NCT04335591|453628391|FG000|Overall Study|Protocol Violation|1|||
126016190|NCT05061693|453352918|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126016191|NCT05061693|453352919|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126016192|NCT05061693|453352920|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126016193|NCT05061693|453352909|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
126016194|NCT05061693|453352910|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
126016195|NCT05061693|453352911|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
126016196|NCT05061693|453352912|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
126016197|NCT05061693|453352913|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
126016198|NCT05061693|453352914|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
126016199|NCT05061693|453352915|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
126016200|NCT05061693|453352916|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
126016201|NCT05061693|453352917|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
126016202|NCT05061693|453352918|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
126016203|NCT05061693|453352919|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
126016204|NCT05061693|453352920|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
126016205|NCT05061693|453352909|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
126016206|NCT05061693|453352910|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016207|NCT05061693|453352911|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016208|NCT05061693|453352912|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016209|NCT05061693|453352913|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016210|NCT05061693|453352914|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016211|NCT05061693|453352915|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016212|NCT05061693|453352916|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016213|NCT05061693|453352917|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016214|NCT05061693|453352918|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016215|NCT05061693|453352919|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016216|NCT05061693|453352920|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126016217|NCT05061693|453352909|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016218|NCT05061693|453352910|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016219|NCT05061693|453352911|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
126016220|NCT05061693|453352912|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016221|NCT05061693|453352913|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016222|NCT05061693|453352914|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016223|NCT05061693|453352915|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016224|NCT05061693|453352916|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016225|NCT05061693|453352917|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016226|NCT05061693|453352918|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016227|NCT05061693|453352919|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016228|NCT05061693|453352920|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126016229|NCT05061693|453352909|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
126016230|NCT05061693|453352910|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
126016231|NCT05061693|453352911|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
126016232|NCT05061693|453352912|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
126016233|NCT05061693|453352913|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126016234|NCT05061693|453352914|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126016235|NCT05061693|453352915|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126016236|NCT05061693|453352916|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126016237|NCT05061693|453352917|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126016238|NCT05061693|453352918|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126016239|NCT05061693|453352919|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126016240|NCT05061693|453352920|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126016241|NCT05061693|453352909|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
126016242|NCT05061693|453352910|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
126016243|NCT05061693|453352911|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
126016244|NCT05061693|453352912|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
126016245|NCT05061693|453352913|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126016246|NCT05061693|453352914|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126091431|NCT04335591|453628392|FG001|Overall Study|Protocol Violation|0|||
126091432|NCT04335591|453628393|FG002|Overall Study|Protocol Violation|0|||
126091433|NCT04335591|453628394|FG003|Overall Study|Protocol Violation|0|||
126091434|NCT04335591|453628391|FG000|Overall Study|Withdrawal by Subject|8|||
126091435|NCT04335591|453628392|FG001|Overall Study|Withdrawal by Subject|4|||
126091436|NCT04335591|453628393|FG002|Overall Study|Withdrawal by Subject|4|||
126091437|NCT04335591|453628394|FG003|Overall Study|Withdrawal by Subject|5|||
126091438|NCT04335591|453628391|FG000|Overall Study|Subject planning pregnancy|0|||
126091439|NCT04335591|453628392|FG001|Overall Study|Subject planning pregnancy|1|||
126091440|NCT04335591|453628393|FG002|Overall Study|Subject planning pregnancy|0|||
126091441|NCT04335591|453628394|FG003|Overall Study|Subject planning pregnancy|0|||
126091442|NCT04335591|453628391|FG000|Overall Study|Ukrainian Russian war conflict|4|||
126091443|NCT04335591|453628392|FG001|Overall Study|Ukrainian Russian war conflict|5|||
126091444|NCT04335591|453628393|FG002|Overall Study|Ukrainian Russian war conflict|2|||
126091445|NCT04335591|453628394|FG003|Overall Study|Ukrainian Russian war conflict|0|||
126091446|NCT03268603|453628395|FG000|Overall Study|Withdrawal by Subject|6|||
126016247|NCT05061693|453352915|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126016248|NCT05061693|453352916|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126016249|NCT05061693|453352917|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126016250|NCT05061693|453352918|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126016251|NCT05061693|453352919|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126216804|NCT00791154|454084454|FG005|Overall Study|Adverse Event|0|||
126216805|NCT00791154|454084455|FG006|Overall Study|Adverse Event|1|||
126016252|NCT05061693|453352920|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126016253|NCT05061693|453352909|FG000|24-week Extension Period|Adverse Event|0|||
126016254|NCT05061693|453352910|FG001|24-week Extension Period|Adverse Event|0|||
126016255|NCT05061693|453352911|FG002|24-week Extension Period|Adverse Event|0|||
126016256|NCT05061693|453352912|FG003|24-week Extension Period|Adverse Event|0|||
126016257|NCT05061693|453352913|FG004|24-week Extension Period|Adverse Event|0|||
126016258|NCT05061693|453352914|FG005|24-week Extension Period|Adverse Event|0|||
126016259|NCT05061693|453352915|FG006|24-week Extension Period|Adverse Event|0|||
126016260|NCT05061693|453352916|FG007|24-week Extension Period|Adverse Event|2|||
126016261|NCT05061693|453352917|FG008|24-week Extension Period|Adverse Event|2|||
126016262|NCT05061693|453352918|FG009|24-week Extension Period|Adverse Event|0|||
126016263|NCT05061693|453352919|FG010|24-week Extension Period|Adverse Event|1|||
126016264|NCT05061693|453352920|FG011|24-week Extension Period|Adverse Event|3|||
126016265|NCT05061693|453352909|FG000|24-week Extension Period|Lack of Efficacy|0|||
126016266|NCT05061693|453352910|FG001|24-week Extension Period|Lack of Efficacy|0|||
126016267|NCT05061693|453352911|FG002|24-week Extension Period|Lack of Efficacy|0|||
126016268|NCT05061693|453352912|FG003|24-week Extension Period|Lack of Efficacy|0|||
126016269|NCT05061693|453352913|FG004|24-week Extension Period|Lack of Efficacy|0|||
126016270|NCT05061693|453352914|FG005|24-week Extension Period|Lack of Efficacy|0|||
126016271|NCT05061693|453352915|FG006|24-week Extension Period|Lack of Efficacy|0|||
126016272|NCT05061693|453352916|FG007|24-week Extension Period|Lack of Efficacy|0|||
126216806|NCT00791154|454084449|FG000|Overall Study|Full Consent withdrawn|1|||
126091447|NCT03268603|453628395|FG000|Overall Study|Physician Decision|1|||
126091448|NCT03268603|453628395|FG000|Overall Study|Withdrawn due to disease progression|2|||
126091449|NCT00356408|453628396|FG000|Overall Study|Adverse Event|9|||
126091450|NCT00356408|453628396|FG000|Overall Study|Lack of Efficacy|36|||
126091451|NCT00356408|453628396|FG000|Overall Study|Lost to Follow-up|2|||
126091452|NCT00356408|453628396|FG000|Overall Study|Withdrawal by Subject|6|||
126091453|NCT00356408|453628396|FG000|Overall Study|Other: Principal investigator discretion|3|||
126091454|NCT00356408|453628396|FG000|Overall Study|Other: Sponsor request|1|||
126091455|NCT00356408|453628396|FG000|Overall Study|Other: Azathioprine stopped|1|||
126091456|NCT00356408|453628396|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
126091457|NCT00356408|453628396|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
126091458|NCT05775991|453628398|FG000|Overall Study|Withdrawal by Subject|0|||
126091459|NCT05775991|453628399|FG001|Overall Study|Withdrawal by Subject|0|||
126091460|NCT05775991|453628400|FG002|Overall Study|Withdrawal by Subject|2|||
126091461|NCT04514510|453628401|FG000|Overall Study|Lost to Follow-up|0|||
126091462|NCT04514510|453628402|FG001|Overall Study|Lost to Follow-up|1|||
126091463|NCT04514510|453628401|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
126091464|NCT04514510|453628402|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
126091465|NCT00406692|453628403|FG000|Overall Study|Withdrawal by Subject|4|||
126091466|NCT00406692|453628403|FG000|Overall Study|Physician Decision|1|||
126091467|NCT00406692|453628403|FG000|Overall Study|Adverse Event|1|||
126091468|NCT00406692|453628403|FG000|Overall Study|Lack of Efficacy|1|||
126091469|NCT01145898|453628404|FG000|3-year Treatment|medication change by treating physician|3|||
126091470|NCT01145898|453628405|FG001|3-year Treatment|medication change by treating physician|16|||
126091471|NCT00214019|453628406|FG000|Overall Study|Lost to Follow-up|11|||
126091472|NCT00214019|453628406|FG000|Overall Study|Withdrawal by Subject|2|||
126091473|NCT00214019|453628406|FG000|Overall Study|Screen Failed prior to randomization|17|||
126091474|NCT00842244|453628409|FG000|Overall Study|Death|3|||
126091475|NCT00842244|453628409|FG000|Overall Study|Withdrawal by Subject|1|||
126091476|NCT00842244|453628409|FG000|Overall Study|Other|17|||
126091477|NCT01696045|453628415|FG000|Overall Study|Study drug toxicity|1|||
126091478|NCT01696045|453628416|FG001|Overall Study|Study drug toxicity|5|||
126091479|NCT01696045|453628415|FG000|Overall Study|Disease progression|2|||
126091480|NCT01696045|453628416|FG001|Overall Study|Disease progression|2|||
126091481|NCT04445987|453628417|FG000|Overall Study|Adverse Event|0|||
126016273|NCT05061693|453352917|FG008|24-week Extension Period|Lack of Efficacy|0|||
126016274|NCT05061693|453352918|FG009|24-week Extension Period|Lack of Efficacy|0|||
126091482|NCT04445987|453628418|FG001|Overall Study|Adverse Event|0|||
126091483|NCT04445987|453628419|FG002|Overall Study|Adverse Event|1|||
126091484|NCT04445987|453628420|FG003|Overall Study|Adverse Event|0|||
126091485|NCT04445987|453628421|FG004|Overall Study|Adverse Event|4|||
126016275|NCT05061693|453352919|FG010|24-week Extension Period|Lack of Efficacy|2|||
126016276|NCT05061693|453352920|FG011|24-week Extension Period|Lack of Efficacy|0|||
126016277|NCT05061693|453352909|FG000|24-week Extension Period|Lost to Follow-up|0|||
126016278|NCT05061693|453352910|FG001|24-week Extension Period|Lost to Follow-up|0|||
126216807|NCT00791154|454084450|FG001|Overall Study|Full Consent withdrawn|3|||
126016279|NCT05061693|453352911|FG002|24-week Extension Period|Lost to Follow-up|0|||
126016280|NCT05061693|453352912|FG003|24-week Extension Period|Lost to Follow-up|0|||
126016281|NCT05061693|453352913|FG004|24-week Extension Period|Lost to Follow-up|0|||
126016282|NCT05061693|453352914|FG005|24-week Extension Period|Lost to Follow-up|0|||
126016283|NCT05061693|453352915|FG006|24-week Extension Period|Lost to Follow-up|1|||
126016284|NCT05061693|453352916|FG007|24-week Extension Period|Lost to Follow-up|0|||
126016285|NCT05061693|453352917|FG008|24-week Extension Period|Lost to Follow-up|1|||
126016286|NCT05061693|453352918|FG009|24-week Extension Period|Lost to Follow-up|1|||
126016287|NCT05061693|453352919|FG010|24-week Extension Period|Lost to Follow-up|0|||
126016288|NCT05061693|453352920|FG011|24-week Extension Period|Lost to Follow-up|0|||
126016289|NCT05061693|453352909|FG000|24-week Extension Period|Withdrawal by Subject|0|||
126016290|NCT05061693|453352910|FG001|24-week Extension Period|Withdrawal by Subject|0|||
126016291|NCT05061693|453352911|FG002|24-week Extension Period|Withdrawal by Subject|0|||
126216808|NCT00791154|454084451|FG002|Overall Study|Full Consent withdrawn|0|||
126216809|NCT00791154|454084452|FG003|Overall Study|Full Consent withdrawn|0|||
126016292|NCT05061693|453352912|FG003|24-week Extension Period|Withdrawal by Subject|0|||
126016293|NCT05061693|453352913|FG004|24-week Extension Period|Withdrawal by Subject|0|||
126016294|NCT05061693|453352914|FG005|24-week Extension Period|Withdrawal by Subject|0|||
126016295|NCT05061693|453352915|FG006|24-week Extension Period|Withdrawal by Subject|0|||
126016296|NCT05061693|453352916|FG007|24-week Extension Period|Withdrawal by Subject|0|||
126016297|NCT05061693|453352917|FG008|24-week Extension Period|Withdrawal by Subject|1|||
126016298|NCT05061693|453352918|FG009|24-week Extension Period|Withdrawal by Subject|2|||
126016299|NCT05061693|453352919|FG010|24-week Extension Period|Withdrawal by Subject|2|||
126016300|NCT05061693|453352920|FG011|24-week Extension Period|Withdrawal by Subject|1|||
126016301|NCT05061693|453352909|FG000|24-week Extension Period|Sponsor Decision|0|||
126016302|NCT05061693|453352910|FG001|24-week Extension Period|Sponsor Decision|0|||
126016303|NCT05061693|453352911|FG002|24-week Extension Period|Sponsor Decision|0|||
126016304|NCT05061693|453352912|FG003|24-week Extension Period|Sponsor Decision|0|||
126016305|NCT05061693|453352913|FG004|24-week Extension Period|Sponsor Decision|0|||
126016306|NCT05061693|453352914|FG005|24-week Extension Period|Sponsor Decision|0|||
126016307|NCT05061693|453352915|FG006|24-week Extension Period|Sponsor Decision|0|||
126016308|NCT05061693|453352916|FG007|24-week Extension Period|Sponsor Decision|1|||
126016309|NCT05061693|453352917|FG008|24-week Extension Period|Sponsor Decision|0|||
126016310|NCT05061693|453352918|FG009|24-week Extension Period|Sponsor Decision|0|||
126016311|NCT05061693|453352919|FG010|24-week Extension Period|Sponsor Decision|0|||
126016312|NCT05061693|453352920|FG011|24-week Extension Period|Sponsor Decision|0|||
126016313|NCT05061693|453352909|FG000|24-week Extension Period|Site Closure|0|||
126016314|NCT05061693|453352910|FG001|24-week Extension Period|Site Closure|0|||
126016315|NCT05061693|453352911|FG002|24-week Extension Period|Site Closure|0|||
126016316|NCT05061693|453352912|FG003|24-week Extension Period|Site Closure|0|||
126016317|NCT05061693|453352913|FG004|24-week Extension Period|Site Closure|0|||
126016318|NCT05061693|453352914|FG005|24-week Extension Period|Site Closure|0|||
126016319|NCT05061693|453352915|FG006|24-week Extension Period|Site Closure|0|||
126016320|NCT05061693|453352916|FG007|24-week Extension Period|Site Closure|0|||
126016321|NCT05061693|453352917|FG008|24-week Extension Period|Site Closure|1|||
126016322|NCT05061693|453352918|FG009|24-week Extension Period|Site Closure|0|||
126016323|NCT05061693|453352919|FG010|24-week Extension Period|Site Closure|0|||
126016324|NCT05061693|453352920|FG011|24-week Extension Period|Site Closure|1|||
126016325|NCT03823911|453352921|FG000|Overall Study|Lost to Follow-up|1|||
126016326|NCT03823911|453352922|FG001|Overall Study|Lost to Follow-up|5|||
126016327|NCT03823911|453352923|FG002|Overall Study|Lost to Follow-up|2|||
126016328|NCT03823911|453352921|FG000|Overall Study|Did not meet eligibility criteria|13|||
126016329|NCT03823911|453352922|FG001|Overall Study|Did not meet eligibility criteria|7|||
126016330|NCT03823911|453352923|FG002|Overall Study|Did not meet eligibility criteria|4|||
126016331|NCT03823911|453352921|FG000|Overall Study|Death|0|||
126016332|NCT03823911|453352922|FG001|Overall Study|Death|1|||
126016333|NCT03823911|453352923|FG002|Overall Study|Death|0|||
126016334|NCT01152190|453352924|FG000|Overall Study|Adverse Event|2|||
126016335|NCT01152190|453352925|FG001|Overall Study|Adverse Event|4|||
126016336|NCT01152190|453352924|FG000|Overall Study|Death|1|||
126016337|NCT01152190|453352925|FG001|Overall Study|Death|0|||
126016338|NCT01152190|453352924|FG000|Overall Study|Protocol Violation|1|||
126016339|NCT01152190|453352925|FG001|Overall Study|Protocol Violation|1|||
126016340|NCT01152190|453352924|FG000|Overall Study|Withdrawal by Subject|1|||
126016341|NCT01152190|453352925|FG001|Overall Study|Withdrawal by Subject|3|||
126016342|NCT00442117|453352926|FG000|Overall Study|Adverse Event|3|||
126016343|NCT00442117|453352927|FG001|Overall Study|Adverse Event|2|||
126016344|NCT00442117|453352926|FG000|Overall Study|Lack of Efficacy|2|||
126016345|NCT00442117|453352927|FG001|Overall Study|Lack of Efficacy|6|||
126016346|NCT00442117|453352926|FG000|Overall Study|Lost to Follow-up|1|||
126016347|NCT00442117|453352927|FG001|Overall Study|Lost to Follow-up|2|||
126016348|NCT00442117|453352926|FG000|Overall Study|Withdrawal by Subject|2|||
126016349|NCT00442117|453352927|FG001|Overall Study|Withdrawal by Subject|2|||
126016350|NCT00442117|453352926|FG000|Overall Study|Major Deviation|25|||
126016351|NCT00442117|453352927|FG001|Overall Study|Major Deviation|20|||
126016352|NCT00442117|453352926|FG000|Overall Study|Non compliance with protocol|3|||
126016353|NCT00442117|453352927|FG001|Overall Study|Non compliance with protocol|5|||
126016354|NCT00442117|453352926|FG000|Overall Study|Met Withdrawal Criteria|2|||
126016355|NCT00442117|453352927|FG001|Overall Study|Met Withdrawal Criteria|1|||
126016356|NCT00997386|453352933|FG000|Overall Study|Death|7|||
126016357|NCT02994654|453352935|FG000|Overall Study|Lost to Follow-up|1|||
126016358|NCT03603717|453352940|FG000|Overall Study|Lost to Follow-up|20|||
126016359|NCT03603717|453352941|FG001|Overall Study|Lost to Follow-up|20|||
126016360|NCT03603717|453352940|FG000|Overall Study|Withdrawal by Subject|16|||
126016361|NCT03603717|453352941|FG001|Overall Study|Withdrawal by Subject|10|||
126016362|NCT02544152|453354125|FG000|Overall Study|Adverse Event|0|||
126016363|NCT02544152|453354126|FG001|Overall Study|Adverse Event|4|||
126016364|NCT02544152|453354125|FG000|Overall Study|Withdrawal by Subject|0|||
126016365|NCT02544152|453354126|FG001|Overall Study|Withdrawal by Subject|3|||
126016366|NCT02544152|453354125|FG000|Overall Study|Other|1|||
126016367|NCT02544152|453354126|FG001|Overall Study|Other|0|||
126016368|NCT01759264|453354129|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
126016369|NCT01759264|453354129|FG000|Overall Study|Adverse Event|1|||
126016370|NCT01759264|453354129|FG000|Overall Study|Other|2|||
126016371|NCT01759264|453354129|FG000|Overall Study|Lost to Follow-up|2|||
126016372|NCT01759264|453354129|FG000|Overall Study|Withdrawal by Subject|3|||
126016373|NCT01759264|453354129|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
126016374|NCT00516321|453354130|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
126016375|NCT00516321|453354131|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
126016376|NCT00516321|453354132|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
126016377|NCT00516321|453354130|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
126016378|NCT00516321|453354131|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
126016379|NCT00516321|453354132|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
126016380|NCT00516321|453354130|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
126016381|NCT00516321|453354131|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
126016382|NCT00516321|453354132|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
126016383|NCT00516321|453354130|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
126016384|NCT00516321|453354131|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
126016385|NCT00516321|453354132|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
126016386|NCT00516321|453354130|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
126016387|NCT00516321|453354131|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
126016388|NCT00516321|453354132|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
126016389|NCT00516321|453354130|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
126016390|NCT00516321|453354131|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
126016391|NCT00516321|453354132|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
126016392|NCT00516321|453354130|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
126016393|NCT00516321|453354131|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
126016394|NCT00516321|453354132|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
126016395|NCT00516321|453354130|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
126016396|NCT00516321|453354131|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
126016397|NCT00516321|453354132|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
126016398|NCT00516321|453354130|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
126016399|NCT00516321|453354131|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
126016400|NCT00516321|453354132|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
126016401|NCT00516321|453354130|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
126016402|NCT00516321|453354131|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
126016403|NCT00516321|453354132|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
126016404|NCT00516321|453354130|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
126016405|NCT00516321|453354131|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
126016406|NCT00516321|453354132|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
126016407|NCT01426269|453354136|FG000|Period 1: 12 Weeks|Adverse Event|5|||
126016408|NCT01426269|453354137|FG001|Period 1: 12 Weeks|Adverse Event|0|||
126016409|NCT01426269|453354138|FG002|Period 1: 12 Weeks|Adverse Event|0|||
126016410|NCT01426269|453354136|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
126016411|NCT01426269|453354137|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
126016412|NCT01426269|453354138|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
126016413|NCT01426269|453354136|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
126016414|NCT01426269|453354137|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
126016415|NCT01426269|453354138|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
126016416|NCT01426269|453354136|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
126016417|NCT01426269|453354137|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
126016418|NCT01426269|453354138|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
126016419|NCT01426269|453354136|FG000|Period 1: 12 Weeks|Pregnancy|1|||
126016420|NCT01426269|453354137|FG001|Period 1: 12 Weeks|Pregnancy|0|||
126016421|NCT01426269|453354138|FG002|Period 1: 12 Weeks|Pregnancy|0|||
126016422|NCT01426269|453354136|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
126016423|NCT01426269|453354137|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
126016424|NCT01426269|453354138|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
126016425|NCT01426269|453354136|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
126016426|NCT01426269|453354137|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
126016427|NCT01426269|453354138|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
126016428|NCT01426269|453354136|FG000|Period 2: 40 Weeks|Adverse Event|0|||
126016429|NCT01426269|453354137|FG001|Period 2: 40 Weeks|Adverse Event|1|||
126016430|NCT01426269|453354138|FG002|Period 2: 40 Weeks|Adverse Event|2|||
126016431|NCT01426269|453354136|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
126016432|NCT01426269|453354137|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
126016433|NCT01426269|453354138|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
126016434|NCT01426269|453354136|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
126016435|NCT01426269|453354137|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
126016436|NCT01426269|453354138|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
126016437|NCT01426269|453354136|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
126016438|NCT01426269|453354137|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
126016439|NCT01426269|453354138|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
126016440|NCT01426269|453354136|FG000|Period 2: 40 Weeks|Site closed|0|||
126016441|NCT01426269|453354137|FG001|Period 2: 40 Weeks|Site closed|6|||
126016442|NCT01426269|453354138|FG002|Period 2: 40 Weeks|Site closed|5|||
126016443|NCT01426269|453354136|FG000|Period 2: 40 Weeks|Relapsed|0|||
126016444|NCT01426269|453354137|FG001|Period 2: 40 Weeks|Relapsed|9|||
126016445|NCT01426269|453354138|FG002|Period 2: 40 Weeks|Relapsed|18|||
126016446|NCT00186186|453354142|FG000|Overall Study|Lack of Efficacy|3|||
126016447|NCT00186186|453354142|FG000|Overall Study|Withdrawal by Subject|3|||
126016448|NCT00186186|453354142|FG000|Overall Study|Not reported as to reason|2|||
126016449|NCT01113931|453354143|FG000|Overall Study|Adverse Event|2|||
126016450|NCT01113931|453354144|FG001|Overall Study|Adverse Event|2|||
126016451|NCT01113931|453354143|FG000|Overall Study|Physician Decision|0|||
126016452|NCT01113931|453354144|FG001|Overall Study|Physician Decision|2|||
126016453|NCT01113931|453354143|FG000|Overall Study|Lost to Follow-up|12|||
126016454|NCT01113931|453354144|FG001|Overall Study|Lost to Follow-up|9|||
126016455|NCT01113931|453354143|FG000|Overall Study|Various|2|||
126016456|NCT01113931|453354144|FG001|Overall Study|Various|4|||
126016457|NCT01113931|453354143|FG000|Overall Study|Withdrawal by Subject|3|||
126016458|NCT01113931|453354144|FG001|Overall Study|Withdrawal by Subject|0|||
126016459|NCT02567656|453354147|FG000|Overall Study|Premature discontinuation due to PD|1|||
126016460|NCT02567656|453354148|FG001|Overall Study|Premature discontinuation due to PD|1|||
126016461|NCT02567656|453354149|FG002|Overall Study|Premature discontinuation due to PD|2|||
126016462|NCT02567656|453354150|FG003|Overall Study|Premature discontinuation due to PD|0|||
126016463|NCT02567656|453354151|FG004|Overall Study|Premature discontinuation due to PD|0|||
126016464|NCT02567656|453354152|FG005|Overall Study|Premature discontinuation due to PD|0|||
126016465|NCT03959241|453354158|FG000|Overall Study|Withdrawal by Subject|7|||
126016466|NCT03959241|453354159|FG001|Overall Study|Withdrawal by Subject|8|||
126016467|NCT03959241|453354158|FG000|Overall Study|Lost to Follow-up|1|||
126016468|NCT03959241|453354159|FG001|Overall Study|Lost to Follow-up|0|||
126016469|NCT03959241|453354158|FG000|Overall Study|Move to Hospice Care|1|||
126016470|NCT03959241|453354159|FG001|Overall Study|Move to Hospice Care|0|||
126016471|NCT03959241|453354158|FG000|Overall Study|Screen Failure|1|||
126016472|NCT03959241|453354159|FG001|Overall Study|Screen Failure|0|||
126016473|NCT03959241|453354158|FG000|Overall Study|Disease Relapse|0|||
126016474|NCT03959241|453354159|FG001|Overall Study|Disease Relapse|1|||
126016475|NCT03959241|453354158|FG000|Overall Study|Off Study|1|||
126016476|NCT03959241|453354159|FG001|Overall Study|Off Study|0|||
126016477|NCT01145885|453354160|FG000|Overall Study|Progressive Disease|7|||
126016478|NCT03691428|453354161|FG000|Overall Study|Withdrawal by Subject|6|||
126016479|NCT03691428|453354162|FG001|Overall Study|Withdrawal by Subject|8|||
126016480|NCT02527148|453354163|FG000|Overall Study|Did not receive study intervention|1|||
126016481|NCT02527148|453354164|FG001|Overall Study|Did not receive study intervention|0|||
126016482|NCT00666276|453354165|FG000|Overall Study|Protocol Violation|34|||
126016483|NCT04054635|453354172|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
126016484|NCT04054635|453354173|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
126016485|NCT04054635|453354174|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
126016486|NCT04054635|453354172|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
126016487|NCT04054635|453354173|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
126016488|NCT04054635|453354174|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
126016489|NCT00891930|453354175|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
126016490|NCT00891930|453354175|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
126016491|NCT00891930|453354175|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
126016492|NCT00891930|453354175|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
126016493|NCT00891930|453354175|FG000|Part 2 Panitumumab + AMG479|Death|30|||
126016494|NCT05001945|453354182|FG000|Overall Study|Adverse Event|0|||
126016495|NCT05001945|453354183|FG001|Overall Study|Adverse Event|0|||
126016496|NCT05001945|453354184|FG002|Overall Study|Adverse Event|0|||
126016497|NCT05001945|453354185|FG003|Overall Study|Adverse Event|1|||
126016498|NCT05001945|453354186|FG004|Overall Study|Adverse Event|0|||
126016499|NCT05001945|453354187|FG005|Overall Study|Adverse Event|0|||
126016500|NCT05001945|453354188|FG006|Overall Study|Adverse Event|0|||
126016501|NCT05001945|453354189|FG007|Overall Study|Adverse Event|0|||
126016502|NCT05001945|453354182|FG000|Overall Study|Lost to Follow-up|0|||
126016503|NCT05001945|453354183|FG001|Overall Study|Lost to Follow-up|1|||
126016504|NCT05001945|453354184|FG002|Overall Study|Lost to Follow-up|1|||
126016505|NCT05001945|453354185|FG003|Overall Study|Lost to Follow-up|2|||
126016506|NCT05001945|453354186|FG004|Overall Study|Lost to Follow-up|0|||
126016507|NCT05001945|453354187|FG005|Overall Study|Lost to Follow-up|1|||
126016508|NCT05001945|453354188|FG006|Overall Study|Lost to Follow-up|0|||
126016509|NCT05001945|453354189|FG007|Overall Study|Lost to Follow-up|0|||
126016510|NCT05001945|453354182|FG000|Overall Study|Protocol Violation|1|||
126016511|NCT05001945|453354183|FG001|Overall Study|Protocol Violation|0|||
126016512|NCT05001945|453354184|FG002|Overall Study|Protocol Violation|1|||
126016513|NCT05001945|453354185|FG003|Overall Study|Protocol Violation|1|||
126016514|NCT05001945|453354186|FG004|Overall Study|Protocol Violation|0|||
126091486|NCT04445987|453628422|FG005|Overall Study|Adverse Event|0|||
126091487|NCT04445987|453628417|FG000|Overall Study|Lost to Follow-up|4|||
126091488|NCT04445987|453628418|FG001|Overall Study|Lost to Follow-up|3|||
126091489|NCT04445987|453628419|FG002|Overall Study|Lost to Follow-up|1|||
126091490|NCT04445987|453628420|FG003|Overall Study|Lost to Follow-up|1|||
126091491|NCT04445987|453628421|FG004|Overall Study|Lost to Follow-up|29|||
126091492|NCT04445987|453628422|FG005|Overall Study|Lost to Follow-up|0|||
126091493|NCT04445987|453628417|FG000|Overall Study|Physician Decision|0|||
126091494|NCT04445987|453628418|FG001|Overall Study|Physician Decision|0|||
126091495|NCT04445987|453628419|FG002|Overall Study|Physician Decision|0|||
126091496|NCT04445987|453628420|FG003|Overall Study|Physician Decision|0|||
126091497|NCT04445987|453628421|FG004|Overall Study|Physician Decision|1|||
126091498|NCT04445987|453628422|FG005|Overall Study|Physician Decision|0|||
126091499|NCT04445987|453628417|FG000|Overall Study|Protocol Violation|1|||
126091500|NCT04445987|453628418|FG001|Overall Study|Protocol Violation|0|||
126091501|NCT04445987|453628419|FG002|Overall Study|Protocol Violation|0|||
126091502|NCT04445987|453628420|FG003|Overall Study|Protocol Violation|0|||
126091503|NCT04445987|453628421|FG004|Overall Study|Protocol Violation|2|||
126091504|NCT04445987|453628422|FG005|Overall Study|Protocol Violation|0|||
126091505|NCT04445987|453628417|FG000|Overall Study|Withdrawal by Subject|4|||
126091506|NCT04445987|453628418|FG001|Overall Study|Withdrawal by Subject|0|||
126091507|NCT04445987|453628419|FG002|Overall Study|Withdrawal by Subject|1|||
126091508|NCT04445987|453628420|FG003|Overall Study|Withdrawal by Subject|0|||
126091509|NCT04445987|453628421|FG004|Overall Study|Withdrawal by Subject|18|||
126091510|NCT04445987|453628422|FG005|Overall Study|Withdrawal by Subject|1|||
126091511|NCT04445987|453628417|FG000|Overall Study|Other reason|0|||
126091512|NCT04445987|453628418|FG001|Overall Study|Other reason|0|||
126091513|NCT04445987|453628419|FG002|Overall Study|Other reason|1|||
126091514|NCT04445987|453628420|FG003|Overall Study|Other reason|0|||
126091515|NCT04445987|453628421|FG004|Overall Study|Other reason|2|||
126091516|NCT04445987|453628422|FG005|Overall Study|Other reason|0|||
126091517|NCT04531098|453628428|FG000|Stage I|Adverse Event|0|||
126091518|NCT04531098|453628429|FG001|Stage I|Adverse Event|0|||
126091519|NCT04531098|453628430|FG002|Stage I|Adverse Event|3|||
126091520|NCT04531098|453628428|FG000|Stage I|Protocol Violation|0|||
126091521|NCT04531098|453628429|FG001|Stage I|Protocol Violation|0|||
126091522|NCT04531098|453628430|FG002|Stage I|Protocol Violation|5|||
126091523|NCT04531098|453628428|FG000|Stage I|Withdrawal by Subject|0|||
126091524|NCT04531098|453628429|FG001|Stage I|Withdrawal by Subject|5|||
126091525|NCT04531098|453628430|FG002|Stage I|Withdrawal by Subject|10|||
126091526|NCT04531098|453628428|FG000|Stage II|Adverse Event|1|||
126091527|NCT04531098|453628429|FG001|Stage II|Adverse Event|2|||
126091528|NCT04531098|453628430|FG002|Stage II|Adverse Event|0|||
126091529|NCT04531098|453628428|FG000|Stage II|Protocol Violation|1|||
126091530|NCT04531098|453628429|FG001|Stage II|Protocol Violation|2|||
126091531|NCT04531098|453628430|FG002|Stage II|Protocol Violation|0|||
126091532|NCT04531098|453628428|FG000|Stage II|Withdrawal by Subject|3|||
126091533|NCT04531098|453628429|FG001|Stage II|Withdrawal by Subject|1|||
126091534|NCT04531098|453628430|FG002|Stage II|Withdrawal by Subject|0|||
126016515|NCT05001945|453354187|FG005|Overall Study|Protocol Violation|1|||
126016516|NCT05001945|453354188|FG006|Overall Study|Protocol Violation|0|||
126016517|NCT05001945|453354189|FG007|Overall Study|Protocol Violation|0|||
126016518|NCT05001945|453354182|FG000|Overall Study|Withdrawal by Subject|0|||
126091535|NCT04531098|453628428|FG000|Stage II|Moved from study area|8|||
126091536|NCT04531098|453628429|FG001|Stage II|Moved from study area|5|||
126091537|NCT04531098|453628430|FG002|Stage II|Moved from study area|0|||
126091538|NCT02628028|453628431|FG000|Dosing Period|Withdrawal by Subject|0|||
126091539|NCT02628028|453628432|FG001|Dosing Period|Withdrawal by Subject|0|||
126016519|NCT05001945|453354183|FG001|Overall Study|Withdrawal by Subject|0|||
126016520|NCT05001945|453354184|FG002|Overall Study|Withdrawal by Subject|0|||
126016521|NCT05001945|453354185|FG003|Overall Study|Withdrawal by Subject|1|||
126016522|NCT05001945|453354186|FG004|Overall Study|Withdrawal by Subject|1|||
126016523|NCT05001945|453354187|FG005|Overall Study|Withdrawal by Subject|1|||
126016524|NCT05001945|453354188|FG006|Overall Study|Withdrawal by Subject|0|||
126016525|NCT05001945|453354189|FG007|Overall Study|Withdrawal by Subject|1|||
126016526|NCT05001945|453354182|FG000|Overall Study|Not specified by Investigator|0|||
126016527|NCT05001945|453354183|FG001|Overall Study|Not specified by Investigator|3|||
126016528|NCT05001945|453354184|FG002|Overall Study|Not specified by Investigator|0|||
126016529|NCT05001945|453354185|FG003|Overall Study|Not specified by Investigator|0|||
126016530|NCT05001945|453354186|FG004|Overall Study|Not specified by Investigator|1|||
126016531|NCT05001945|453354187|FG005|Overall Study|Not specified by Investigator|0|||
126016532|NCT05001945|453354188|FG006|Overall Study|Not specified by Investigator|0|||
126016533|NCT05001945|453354189|FG007|Overall Study|Not specified by Investigator|0|||
126016534|NCT00535145|453354191|FG000|Phase I|Adverse Event|3|||
126016535|NCT00535145|453354191|FG000|Phase I|Lost to Follow-up|7|||
126016536|NCT00535145|453354191|FG000|Phase I|Withdrawal by Subject|6|||
126016537|NCT00535145|453354191|FG000|Phase I|(eligibility)|8|||
126016538|NCT00535145|453354191|FG000|Phase I|(protocol violation)|1|||
126016539|NCT00535145|453354191|FG000|Phase I|(PI decision)|1|||
126016540|NCT00535145|453354191|FG000|Phase I|(diagnosis)|3|||
126016541|NCT00535145|453354191|FG000|Phase II|Adverse Event|2|||
126016542|NCT00535145|453354191|FG000|Phase II|Lack of Efficacy|1|||
126016543|NCT00535145|453354191|FG000|Phase II|Lost to Follow-up|5|||
126016544|NCT00535145|453354191|FG000|Phase II|Withdrawal by Subject|5|||
126016545|NCT00535145|453354191|FG000|Phase II|Subject non-compliance|2|||
126016546|NCT01202955|453354192|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
126016547|NCT01202955|453354193|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
126016548|NCT02115139|453354194|FG000|Overall Study|Protocol Violation|1|||
126016549|NCT02115139|453354194|FG000|Overall Study|treatment discontinuation|6|||
126016550|NCT01909778|453354195|FG000|Overall Study|failed screening|1|||
126016551|NCT02471755|453354197|FG000|Overall Study|Withdrawal by Subject|1|||
126016552|NCT02471755|453354198|FG001|Overall Study|Withdrawal by Subject|0|||
126016553|NCT02471755|453354197|FG000|Overall Study|Lost to Follow-up|0|||
126016554|NCT02471755|453354198|FG001|Overall Study|Lost to Follow-up|1|||
126016555|NCT04740164|453354202|FG000|Overall Study|Lack of Efficacy|4|||
126016556|NCT04740164|453354203|FG001|Overall Study|Lack of Efficacy|0|||
126016557|NCT04740164|453354202|FG000|Overall Study|Physician Decision|3|||
126016558|NCT04740164|453354203|FG001|Overall Study|Physician Decision|3|||
126016559|NCT05323734|453354204|FG000|Overall Study|Adverse Event|5|||
126016560|NCT05323734|453354205|FG001|Overall Study|Adverse Event|2|||
126016561|NCT05323734|453354204|FG000|Overall Study|Physician Decision|1|||
126016562|NCT05323734|453354205|FG001|Overall Study|Physician Decision|0|||
126016563|NCT05323734|453354204|FG000|Overall Study|Lack of Efficacy|1|||
126016564|NCT05323734|453354205|FG001|Overall Study|Lack of Efficacy|2|||
126016565|NCT05323734|453354204|FG000|Overall Study|Withdrawal by Subject|2|||
126016566|NCT05323734|453354205|FG001|Overall Study|Withdrawal by Subject|0|||
126091540|NCT02628028|453628433|FG002|Dosing Period|Withdrawal by Subject|1|||
126091541|NCT02628028|453628434|FG003|Dosing Period|Withdrawal by Subject|0|||
126091542|NCT02628028|453628435|FG004|Dosing Period|Withdrawal by Subject|2|||
126091543|NCT02628028|453628436|FG005|Dosing Period|Withdrawal by Subject|4|||
126091544|NCT02628028|453628437|FG006|Dosing Period|Withdrawal by Subject|1|||
126091545|NCT02628028|453628438|FG007|Dosing Period|Withdrawal by Subject|1|||
126091546|NCT02628028|453628431|FG000|Dosing Period|Adverse Event|0|||
126091547|NCT02628028|453628432|FG001|Dosing Period|Adverse Event|0|||
126091548|NCT02628028|453628433|FG002|Dosing Period|Adverse Event|0|||
126091549|NCT02628028|453628434|FG003|Dosing Period|Adverse Event|0|||
126091550|NCT02628028|453628435|FG004|Dosing Period|Adverse Event|2|||
126091551|NCT02628028|453628436|FG005|Dosing Period|Adverse Event|1|||
126091552|NCT02628028|453628437|FG006|Dosing Period|Adverse Event|3|||
126091553|NCT02628028|453628438|FG007|Dosing Period|Adverse Event|2|||
126091554|NCT02628028|453628431|FG000|Dosing Period|Death|0|||
126016567|NCT05323734|453354204|FG000|Overall Study|Participant Withdrawn Due|0|||
126016568|NCT05323734|453354205|FG001|Overall Study|Participant Withdrawn Due|1|||
126016569|NCT02486718|453354206|FG000|Enrollment Phase|Death|19|||
126016570|NCT02486718|453354207|FG001|Enrollment Phase|Death|0|||
126016571|NCT02486718|453354208|FG002|Enrollment Phase|Death|0|||
126016572|NCT02486718|453354206|FG000|Enrollment Phase|Symptomatic deterioration|1|||
126016573|NCT02486718|453354207|FG001|Enrollment Phase|Symptomatic deterioration|0|||
126016574|NCT02486718|453354208|FG002|Enrollment Phase|Symptomatic deterioration|0|||
126016575|NCT02486718|453354206|FG000|Enrollment Phase|Withdrawal by Subject|86|||
126016576|NCT02486718|453354207|FG001|Enrollment Phase|Withdrawal by Subject|0|||
126016577|NCT02486718|453354208|FG002|Enrollment Phase|Withdrawal by Subject|0|||
126016578|NCT02486718|453354206|FG000|Enrollment Phase|Protocol Violation|18|||
126091555|NCT02628028|453628432|FG001|Dosing Period|Death|0|||
126091556|NCT02628028|453628433|FG002|Dosing Period|Death|0|||
126016579|NCT02486718|453354207|FG001|Enrollment Phase|Protocol Violation|0|||
126016580|NCT02486718|453354208|FG002|Enrollment Phase|Protocol Violation|0|||
126016581|NCT02486718|453354206|FG000|Enrollment Phase|Physician Decision|18|||
126016582|NCT02486718|453354207|FG001|Enrollment Phase|Physician Decision|0|||
126016583|NCT02486718|453354208|FG002|Enrollment Phase|Physician Decision|0|||
126016584|NCT02486718|453354206|FG000|Enrollment Phase|Reason not provided|41|||
126016585|NCT02486718|453354207|FG001|Enrollment Phase|Reason not provided|0|||
126016586|NCT02486718|453354208|FG002|Enrollment Phase|Reason not provided|0|||
126016587|NCT02486718|453354206|FG000|Enrollment Phase|Disease relapse|54|||
126016588|NCT02486718|453354207|FG001|Enrollment Phase|Disease relapse|0|||
126016589|NCT02486718|453354208|FG002|Enrollment Phase|Disease relapse|0|||
126016590|NCT02486718|453354206|FG000|Enrollment Phase|Lost to Follow-up|4|||
126016591|NCT02486718|453354207|FG001|Enrollment Phase|Lost to Follow-up|0|||
126016592|NCT02486718|453354208|FG002|Enrollment Phase|Lost to Follow-up|0|||
126016593|NCT02486718|453354206|FG000|Enrollment Phase|Adverse Event|34|||
126016594|NCT02486718|453354207|FG001|Enrollment Phase|Adverse Event|0|||
126016595|NCT02486718|453354208|FG002|Enrollment Phase|Adverse Event|0|||
126016596|NCT02486718|453354206|FG000|Randomized Phase|Withdrawal by Subject|0|||
126016597|NCT02486718|453354207|FG001|Randomized Phase|Withdrawal by Subject|44|||
126016598|NCT02486718|453354208|FG002|Randomized Phase|Withdrawal by Subject|47|||
126016599|NCT02486718|453354206|FG000|Randomized Phase|Protocol Violation|0|||
126016600|NCT02486718|453354207|FG001|Randomized Phase|Protocol Violation|2|||
126016601|NCT02486718|453354208|FG002|Randomized Phase|Protocol Violation|0|||
126016602|NCT02486718|453354206|FG000|Randomized Phase|Physician Decision|0|||
126016603|NCT02486718|453354207|FG001|Randomized Phase|Physician Decision|0|||
126016604|NCT02486718|453354208|FG002|Randomized Phase|Physician Decision|3|||
126016605|NCT02486718|453354206|FG000|Randomized Phase|Lost to Follow-up|0|||
126016606|NCT02486718|453354207|FG001|Randomized Phase|Lost to Follow-up|5|||
126016607|NCT02486718|453354208|FG002|Randomized Phase|Lost to Follow-up|11|||
126016608|NCT02486718|453354206|FG000|Randomized Phase|Disease Relapse|0|||
126016609|NCT02486718|453354207|FG001|Randomized Phase|Disease Relapse|1|||
126016610|NCT02486718|453354208|FG002|Randomized Phase|Disease Relapse|0|||
126016611|NCT02486718|453354206|FG000|Randomized Phase|Death|0|||
126016612|NCT02486718|453354207|FG001|Randomized Phase|Death|154|||
126016613|NCT02486718|453354208|FG002|Randomized Phase|Death|155|||
126016614|NCT02486718|453354206|FG000|Randomized Phase|Ongoing|0|||
126016615|NCT02486718|453354207|FG001|Randomized Phase|Ongoing|301|||
126016616|NCT02486718|453354208|FG002|Randomized Phase|Ongoing|282|||
126016617|NCT04177394|453354209|FG000|Overall Study|Death|16|||
126016618|NCT04177394|453354209|FG000|Overall Study|Withdrawal by Subject|19|||
126016619|NCT04177394|453354209|FG000|Overall Study|Missed visits|61|||
126016620|NCT04177394|453354209|FG000|Overall Study|Expected Visits|15|||
126016621|NCT00258895|453354210|FG000|Overall Study|Lost to Follow-up|3|||
126016622|NCT00258895|453354211|FG001|Overall Study|Lost to Follow-up|1|||
126016623|NCT00258895|453354210|FG000|Overall Study|Protocol Violation|6|||
126016624|NCT00258895|453354211|FG001|Overall Study|Protocol Violation|2|||
126016625|NCT00258895|453354210|FG000|Overall Study|Withdrawal by Subject|1|||
126016626|NCT00258895|453354211|FG001|Overall Study|Withdrawal by Subject|0|||
126016627|NCT02248480|453354212|FG000|Overall Study|Lack of Efficacy|4|||
126016628|NCT02248480|453354213|FG001|Overall Study|Lack of Efficacy|6|||
126016629|NCT02248480|453354212|FG000|Overall Study|Adverse Event|11|||
126016630|NCT02248480|453354213|FG001|Overall Study|Adverse Event|2|||
126016631|NCT02248480|453354212|FG000|Overall Study|Withdrawal by Subject|2|||
126016632|NCT02248480|453354213|FG001|Overall Study|Withdrawal by Subject|4|||
126016633|NCT02248480|453354212|FG000|Overall Study|Entry Criteria Not Met|0|||
126016634|NCT02248480|453354213|FG001|Overall Study|Entry Criteria Not Met|1|||
126016635|NCT02248480|453354212|FG000|Overall Study|Other:Physician Decision|0|||
126016636|NCT02248480|453354213|FG001|Overall Study|Other:Physician Decision|1|||
126016637|NCT01595321|453354214|FG000|Overall Study|Adverse Event|1|||
126016638|NCT01595321|453354215|FG001|Overall Study|Adverse Event|1|||
126091557|NCT02628028|453628434|FG003|Dosing Period|Death|0|||
126091558|NCT02628028|453628435|FG004|Dosing Period|Death|0|||
126091559|NCT02628028|453628436|FG005|Dosing Period|Death|0|||
126091560|NCT02628028|453628437|FG006|Dosing Period|Death|0|||
126091561|NCT02628028|453628438|FG007|Dosing Period|Death|1|||
126091562|NCT02628028|453628431|FG000|Dosing Period|Lack of Efficacy|0|||
126091563|NCT02628028|453628432|FG001|Dosing Period|Lack of Efficacy|0|||
126016639|NCT01595321|453354216|FG002|Overall Study|Adverse Event|1|||
126016640|NCT01595321|453354214|FG000|Overall Study|Lack of Efficacy|0|||
126016641|NCT01595321|453354215|FG001|Overall Study|Lack of Efficacy|0|||
126016642|NCT01595321|453354216|FG002|Overall Study|Lack of Efficacy|4|||
126016643|NCT04504916|453354218|FG000|Overall Study|Study terminated|7|||
126016644|NCT04504916|453354219|FG001|Overall Study|Study terminated|8|||
126016645|NCT04504916|453354218|FG000|Overall Study|Death|54|||
126016646|NCT04504916|453354219|FG001|Overall Study|Death|18|||
126016647|NCT04504916|453354218|FG000|Overall Study|Lost to Follow-up|1|||
126016648|NCT04504916|453354219|FG001|Overall Study|Lost to Follow-up|1|||
126016649|NCT04504916|453354218|FG000|Overall Study|Withdrawal by Subject|8|||
126016650|NCT04504916|453354219|FG001|Overall Study|Withdrawal by Subject|4|||
126091564|NCT02628028|453628433|FG002|Dosing Period|Lack of Efficacy|0|||
126091565|NCT02628028|453628434|FG003|Dosing Period|Lack of Efficacy|0|||
126016651|NCT04504916|453354218|FG000|Overall Study|Did not agree to follow-up|0|||
126016652|NCT04504916|453354219|FG001|Overall Study|Did not agree to follow-up|1|||
126016653|NCT00373529|453354220|FG000|Overall Study|Physician Decision|19|||
126016654|NCT00373529|453354220|FG000|Overall Study|Withdrawal by Subject|7|||
126016655|NCT00373529|453354220|FG000|Overall Study|Adverse Event|7|||
126016656|NCT00373529|453354220|FG000|Overall Study|Treatment failure|36|||
126016657|NCT00373529|453354220|FG000|Overall Study|Disease recurrence|10|||
126016658|NCT00373529|453354220|FG000|Overall Study|Death|16|||
126016659|NCT00373529|453354220|FG000|Overall Study|Need for treatment prohibited by study|1|||
126016660|NCT00373529|453354220|FG000|Overall Study|Other|8|||
126016661|NCT00373529|453354220|FG000|Overall Study|Failed independent confirmation of AML|3|||
126016662|NCT00373529|453354220|FG000|Overall Study|Consent violation|1|||
126016663|NCT00630786|453354221|FG000|Overall Study|Physician Decision|0|||
126016664|NCT00630786|453354222|FG001|Overall Study|Physician Decision|0|||
126016665|NCT00630786|453354223|FG002|Overall Study|Physician Decision|1|||
126016666|NCT00630786|453354221|FG000|Overall Study|Withdrawal by Subject|0|||
126016667|NCT00630786|453354222|FG001|Overall Study|Withdrawal by Subject|1|||
126016668|NCT00630786|453354223|FG002|Overall Study|Withdrawal by Subject|1|||
126016669|NCT00630786|453354221|FG000|Overall Study|Lost to Follow-up|0|||
126016670|NCT00630786|453354222|FG001|Overall Study|Lost to Follow-up|1|||
126016671|NCT00630786|453354223|FG002|Overall Study|Lost to Follow-up|0|||
126016672|NCT00630786|453354221|FG000|Overall Study|Other|1|||
126016673|NCT00630786|453354222|FG001|Overall Study|Other|0|||
126016674|NCT00630786|453354223|FG002|Overall Study|Other|0|||
126016675|NCT04009577|453354224|FG000|Core Study|Adverse Event|1|||
126016676|NCT04009577|453354225|FG001|Core Study|Adverse Event|0|||
126016677|NCT04009577|453354226|FG002|Core Study|Adverse Event|2|||
126016678|NCT04009577|453354227|FG003|Core Study|Adverse Event|4|||
126016679|NCT04009577|453354224|FG000|Core Study|Withdrawal by Subject|0|||
126016680|NCT04009577|453354225|FG001|Core Study|Withdrawal by Subject|0|||
126016681|NCT04009577|453354226|FG002|Core Study|Withdrawal by Subject|2|||
126016682|NCT04009577|453354227|FG003|Core Study|Withdrawal by Subject|0|||
126016683|NCT04009577|453354224|FG000|Core Study|Other|0|||
126016684|NCT04009577|453354225|FG001|Core Study|Other|0|||
126016685|NCT04009577|453354226|FG002|Core Study|Other|0|||
126016686|NCT04009577|453354227|FG003|Core Study|Other|1|||
126016687|NCT04009577|453354224|FG000|Extension Phase|Adverse Event|0|||
126016688|NCT04009577|453354225|FG001|Extension Phase|Adverse Event|0|||
126016689|NCT04009577|453354226|FG002|Extension Phase|Adverse Event|0|||
126016690|NCT04009577|453354227|FG003|Extension Phase|Adverse Event|1|||
126016691|NCT04009577|453354224|FG000|Extension Phase|Inadequate therapeutic effect|0|||
126016692|NCT04009577|453354225|FG001|Extension Phase|Inadequate therapeutic effect|0|||
126016693|NCT04009577|453354226|FG002|Extension Phase|Inadequate therapeutic effect|1|||
126016694|NCT04009577|453354227|FG003|Extension Phase|Inadequate therapeutic effect|0|||
126016695|NCT04009577|453354224|FG000|Extension Phase|Withdrawal by Subject|0|||
126016696|NCT04009577|453354225|FG001|Extension Phase|Withdrawal by Subject|0|||
126016697|NCT04009577|453354226|FG002|Extension Phase|Withdrawal by Subject|1|||
126016698|NCT04009577|453354227|FG003|Extension Phase|Withdrawal by Subject|0|||
126016699|NCT04009577|453354224|FG000|Extension Phase|Not Treated|0|||
126016700|NCT04009577|453354225|FG001|Extension Phase|Not Treated|0|||
126016701|NCT04009577|453354226|FG002|Extension Phase|Not Treated|2|||
126016702|NCT04009577|453354227|FG003|Extension Phase|Not Treated|0|||
126016703|NCT01579916|453354235|FG000|Overall Study|Lost to Follow-up|6|||
126016704|NCT01579916|453354236|FG001|Overall Study|Lost to Follow-up|1|||
126016705|NCT01579916|453354235|FG000|Overall Study|Withdrawal by Subject|1|||
126016706|NCT01579916|453354236|FG001|Overall Study|Withdrawal by Subject|1|||
126016707|NCT01579916|453354235|FG000|Overall Study|Death|1|||
126016708|NCT01579916|453354236|FG001|Overall Study|Death|0|||
126016709|NCT00732381|453354242|FG000|Overall Study|Adverse Event|1|||
126016710|NCT00732381|453354243|FG001|Overall Study|Adverse Event|0|||
126016711|NCT00732381|453354242|FG000|Overall Study|Treatment Failure|1|||
126016712|NCT00732381|453354243|FG001|Overall Study|Treatment Failure|1|||
126016713|NCT04668339|453355442|FG000|Overall Study|Physician Decision|1|||
126016714|NCT04668339|453355443|FG001|Overall Study|Physician Decision|0|||
126016715|NCT04668339|453355444|FG002|Overall Study|Physician Decision|1|||
126016716|NCT04668339|453355445|FG003|Overall Study|Physician Decision|1|||
126016717|NCT04668339|453355442|FG000|Overall Study|Lost to Follow-up|14|||
126016718|NCT04668339|453355443|FG001|Overall Study|Lost to Follow-up|12|||
126016719|NCT04668339|453355444|FG002|Overall Study|Lost to Follow-up|8|||
126016720|NCT04668339|453355445|FG003|Overall Study|Lost to Follow-up|5|||
126016721|NCT04668339|453355442|FG000|Overall Study|Adverse Event|0|||
126016722|NCT04668339|453355443|FG001|Overall Study|Adverse Event|0|||
126016723|NCT04668339|453355444|FG002|Overall Study|Adverse Event|1|||
126016724|NCT04668339|453355445|FG003|Overall Study|Adverse Event|0|||
126016725|NCT04668339|453355442|FG000|Overall Study|Other than specified|3|||
126016726|NCT04668339|453355443|FG001|Overall Study|Other than specified|0|||
126016727|NCT04668339|453355444|FG002|Overall Study|Other than specified|1|||
126016728|NCT04668339|453355445|FG003|Overall Study|Other than specified|0|||
126016729|NCT04668339|453355442|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
126016730|NCT04668339|453355443|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
126016731|NCT04668339|453355444|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
126016732|NCT04668339|453355445|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
126016733|NCT04668339|453355442|FG000|Overall Study|Vaccine not Administered|0|||
126016734|NCT04668339|453355443|FG001|Overall Study|Vaccine not Administered|0|||
126016735|NCT04668339|453355444|FG002|Overall Study|Vaccine not Administered|1|||
126016736|NCT04668339|453355445|FG003|Overall Study|Vaccine not Administered|0|||
126016737|NCT04668339|453355442|FG000|Overall Study|Protocol Violation|18|||
126016738|NCT04668339|453355443|FG001|Overall Study|Protocol Violation|23|||
126016739|NCT04668339|453355444|FG002|Overall Study|Protocol Violation|12|||
126016740|NCT04668339|453355445|FG003|Overall Study|Protocol Violation|20|||
126016741|NCT04668339|453355442|FG000|Overall Study|Withdrawal by Subject|45|||
126016742|NCT04668339|453355443|FG001|Overall Study|Withdrawal by Subject|46|||
126016743|NCT04668339|453355444|FG002|Overall Study|Withdrawal by Subject|46|||
126016744|NCT04668339|453355445|FG003|Overall Study|Withdrawal by Subject|27|||
126016745|NCT04668339|453355442|FG000|Overall Study|Study Terminated by Sponsor|59|||
126016746|NCT04668339|453355443|FG001|Overall Study|Study Terminated by Sponsor|59|||
126016747|NCT04668339|453355444|FG002|Overall Study|Study Terminated by Sponsor|71|||
126016748|NCT04668339|453355445|FG003|Overall Study|Study Terminated by Sponsor|1|||
126016749|NCT00002842|453355448|FG000|Overall Study|ineligible for surgical resection|27|||
126016750|NCT03557008|453355449|FG000|Overall Study|Withdrawal by Subject|2|||
126016751|NCT03557008|453355450|FG001|Overall Study|Withdrawal by Subject|2|||
126016752|NCT03557008|453355449|FG000|Overall Study|Early termination from study|3|||
126016753|NCT03557008|453355450|FG001|Overall Study|Early termination from study|1|||
126016754|NCT01765543|453355452|FG000|Overall Study|Death|1|||
126016755|NCT01765543|453355452|FG000|Overall Study|Withdrawal by Subject|2|||
126016756|NCT01424397|453355453|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016757|NCT01424397|453355454|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016758|NCT01424397|453355455|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
126016759|NCT01424397|453355456|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016760|NCT01424397|453355457|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016761|NCT01424397|453355458|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016762|NCT01424397|453355459|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
126091566|NCT02628028|453628435|FG004|Dosing Period|Lack of Efficacy|3|||
126016763|NCT01424397|453355460|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016764|NCT01424397|453355461|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016765|NCT01424397|453355462|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016766|NCT01424397|453355463|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016767|NCT01424397|453355464|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
126016768|NCT05876949|453355465|FG000|Overall Study|Withdrawal by Subject|1|||
126016769|NCT05876949|453355466|FG001|Overall Study|Withdrawal by Subject|3|||
126016770|NCT05876949|453355465|FG000|Overall Study|Physician Decision|0|||
126016771|NCT05876949|453355466|FG001|Overall Study|Physician Decision|2|||
126091567|NCT02628028|453628436|FG005|Dosing Period|Lack of Efficacy|0|||
126091568|NCT02628028|453628437|FG006|Dosing Period|Lack of Efficacy|1|||
126091569|NCT02628028|453628438|FG007|Dosing Period|Lack of Efficacy|0|||
126091570|NCT02628028|453628431|FG000|Dosing Period|Study Terminated by Sponsor|0|||
126091571|NCT02628028|453628432|FG001|Dosing Period|Study Terminated by Sponsor|0|||
126091572|NCT02628028|453628433|FG002|Dosing Period|Study Terminated by Sponsor|0|||
126016772|NCT05876949|453355465|FG000|Overall Study|Death|0|||
126016773|NCT05876949|453355466|FG001|Overall Study|Death|1|||
126016774|NCT03644849|453355467|FG000|Overall Study|Lost to Follow-up|1|||
126016775|NCT03644849|453355468|FG001|Overall Study|Lost to Follow-up|3|||
126016776|NCT01140048|453355469|FG000|Overall Study|Physician Decision|1|||
126016777|NCT01140048|453355469|FG000|Overall Study|Withdrawal by Subject|13|||
126016778|NCT01140048|453355469|FG000|Overall Study|Lost to Follow-up|31|||
126016779|NCT01831791|453355470|FG000|Overall Study|Withdrawal by Subject|10|||
126016780|NCT00494780|453355471|FG000|Overall Study|Adverse Event|1|||
126016781|NCT00494780|453355472|FG001|Overall Study|Adverse Event|0|||
126016782|NCT00494780|453355471|FG000|Overall Study|Withdrew before Dosed|0|||
126016783|NCT00494780|453355472|FG001|Overall Study|Withdrew before Dosed|1|||
126016784|NCT00494780|453355471|FG000|Overall Study|Progression of Study Disease|7|||
126016785|NCT00494780|453355472|FG001|Overall Study|Progression of Study Disease|8|||
126016786|NCT00494780|453355471|FG000|Overall Study|New Treatment|2|||
126016787|NCT00494780|453355472|FG001|Overall Study|New Treatment|2|||
126016788|NCT00494780|453355471|FG000|Overall Study|Non-compliance|1|||
126016789|NCT00494780|453355472|FG001|Overall Study|Non-compliance|0|||
126016790|NCT00494780|453355471|FG000|Overall Study|Residual Tumour Mass|0|||
126016791|NCT00494780|453355472|FG001|Overall Study|Residual Tumour Mass|1|||
126016792|NCT00494780|453355471|FG000|Overall Study|Insurance Issues|0|||
126016793|NCT00494780|453355472|FG001|Overall Study|Insurance Issues|1|||
126016794|NCT00980330|453355473|FG000|Overall Study|Adverse Event|0|||
126016795|NCT00980330|453355474|FG001|Overall Study|Adverse Event|0|||
126016796|NCT00980330|453355475|FG002|Overall Study|Adverse Event|0|||
126016797|NCT00980330|453355476|FG003|Overall Study|Adverse Event|1|||
126016798|NCT00980330|453355477|FG004|Overall Study|Adverse Event|0|||
126016799|NCT00980330|453355478|FG005|Overall Study|Adverse Event|0|||
126016800|NCT00980330|453355479|FG006|Overall Study|Adverse Event|0|||
126016801|NCT00980330|453355473|FG000|Overall Study|Lost to Follow-up|1|||
126016802|NCT00980330|453355474|FG001|Overall Study|Lost to Follow-up|1|||
126016803|NCT00980330|453355475|FG002|Overall Study|Lost to Follow-up|4|||
126016804|NCT00980330|453355476|FG003|Overall Study|Lost to Follow-up|2|||
126016805|NCT00980330|453355477|FG004|Overall Study|Lost to Follow-up|1|||
126016806|NCT00980330|453355478|FG005|Overall Study|Lost to Follow-up|1|||
126016807|NCT00980330|453355479|FG006|Overall Study|Lost to Follow-up|2|||
126016808|NCT00980330|453355473|FG000|Overall Study|Withdrawal by Subject|2|||
126016809|NCT00980330|453355474|FG001|Overall Study|Withdrawal by Subject|4|||
126016810|NCT00980330|453355475|FG002|Overall Study|Withdrawal by Subject|4|||
126016811|NCT00980330|453355476|FG003|Overall Study|Withdrawal by Subject|1|||
126016812|NCT00980330|453355477|FG004|Overall Study|Withdrawal by Subject|3|||
126016813|NCT00980330|453355478|FG005|Overall Study|Withdrawal by Subject|2|||
126016814|NCT00980330|453355479|FG006|Overall Study|Withdrawal by Subject|5|||
126016815|NCT00980330|453355473|FG000|Overall Study|(not specified)|2|||
126016816|NCT00980330|453355474|FG001|Overall Study|(not specified)|0|||
126016817|NCT00980330|453355475|FG002|Overall Study|(not specified)|0|||
126016818|NCT00980330|453355476|FG003|Overall Study|(not specified)|1|||
126016819|NCT00980330|453355477|FG004|Overall Study|(not specified)|1|||
126016820|NCT00980330|453355478|FG005|Overall Study|(not specified)|1|||
126016821|NCT00980330|453355479|FG006|Overall Study|(not specified)|0|||
126016822|NCT00665444|453355480|FG000|Overall Study|Physician Decision|1|||
126016823|NCT00665444|453355480|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
126016824|NCT03299816|453355481|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
126016825|NCT03299816|453355482|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
126016826|NCT03299816|453355481|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
126016827|NCT03299816|453355482|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
126016828|NCT03299816|453355481|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
126016829|NCT03299816|453355482|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
126016830|NCT03520413|453355485|FG000|Overall Study|Lost to Follow-up|1|||
126016831|NCT03520413|453355486|FG001|Overall Study|Lost to Follow-up|1|||
126016832|NCT03520413|453355485|FG000|Overall Study|Withdrawal by Subject|1|||
126016833|NCT03520413|453355486|FG001|Overall Study|Withdrawal by Subject|2|||
126016834|NCT03520413|453355485|FG000|Overall Study|Death|0|||
126016835|NCT03520413|453355486|FG001|Overall Study|Death|1|||
126016836|NCT03520413|453355485|FG000|Overall Study|Physician Decision|3|||
126016837|NCT03520413|453355486|FG001|Overall Study|Physician Decision|3|||
126016838|NCT03520413|453355485|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
126016839|NCT03520413|453355486|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
126016840|NCT00638963|453355488|FG000|Overall Study|Withdrawal by Subject|1|||
126016841|NCT00638963|453355489|FG001|Overall Study|Withdrawal by Subject|0|||
126016842|NCT02448446|453355492|FG000|Overall Study|Withdrawal by Subject|1|||
126016843|NCT02448446|453355493|FG001|Overall Study|Withdrawal by Subject|0|||
126016844|NCT02425111|453355494|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
126016845|NCT02425111|453355494|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
126016846|NCT02425111|453355494|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
126016847|NCT02425111|453355494|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
126016848|NCT02425111|453355494|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
126016849|NCT02425111|453355494|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
126016850|NCT00545077|453355495|FG000|Overall Study|Treatment not received|5|||
126016851|NCT00545077|453355496|FG001|Overall Study|Treatment not received|1|||
126016852|NCT00545077|453355495|FG000|Overall Study|Disease Progression|131|||
126016853|NCT00545077|453355496|FG001|Overall Study|Disease Progression|98|||
126016854|NCT00545077|453355495|FG000|Overall Study|Withdrawal by Subject|3|||
126016855|NCT00545077|453355496|FG001|Overall Study|Withdrawal by Subject|14|||
126016856|NCT00545077|453355495|FG000|Overall Study|Physician Decision|6|||
126216810|NCT00791154|454084453|FG004|Overall Study|Full Consent withdrawn|1|||
126216811|NCT00791154|454084454|FG005|Overall Study|Full Consent withdrawn|3|||
126091573|NCT02628028|453628434|FG003|Dosing Period|Study Terminated by Sponsor|0|||
126091574|NCT02628028|453628435|FG004|Dosing Period|Study Terminated by Sponsor|7|||
126016857|NCT00545077|453355496|FG001|Overall Study|Physician Decision|3|||
126016858|NCT00545077|453355495|FG000|Overall Study|Lost to Follow-up|2|||
126016859|NCT00545077|453355496|FG001|Overall Study|Lost to Follow-up|0|||
126016860|NCT00545077|453355495|FG000|Overall Study|Protocol Violation|1|||
126016861|NCT00545077|453355496|FG001|Overall Study|Protocol Violation|0|||
126016862|NCT00545077|453355495|FG000|Overall Study|Adverse Event|0|||
126016863|NCT00545077|453355496|FG001|Overall Study|Adverse Event|31|||
126016864|NCT00545077|453355495|FG000|Overall Study|Death|0|||
126016865|NCT00545077|453355496|FG001|Overall Study|Death|8|||
126016866|NCT02202499|453355497|FG000|Overall Study|Cancer diagnosis|0|||
126016867|NCT02202499|453355498|FG001|Overall Study|Cancer diagnosis|0|||
126016868|NCT02202499|453355499|FG002|Overall Study|Cancer diagnosis|1|||
126016869|NCT02202499|453355497|FG000|Overall Study|Moved from area|0|||
126016870|NCT02202499|453355498|FG001|Overall Study|Moved from area|0|||
126016871|NCT02202499|453355499|FG002|Overall Study|Moved from area|1|||
126016872|NCT02202499|453355497|FG000|Overall Study|Declined before randomization|1|||
126016873|NCT02202499|453355498|FG001|Overall Study|Declined before randomization|0|||
126016874|NCT02202499|453355499|FG002|Overall Study|Declined before randomization|0|||
126016875|NCT02202499|453355497|FG000|Overall Study|Auto accident|1|||
126016876|NCT02202499|453355498|FG001|Overall Study|Auto accident|0|||
126016877|NCT02202499|453355499|FG002|Overall Study|Auto accident|0|||
126016878|NCT03260140|453355500|FG000|Overall Study|Death|4|||
126016879|NCT03260140|453355501|FG001|Overall Study|Death|1|||
126016880|NCT03260140|453355500|FG000|Overall Study|Withdrawal by Subject|1|||
126091575|NCT02628028|453628436|FG005|Dosing Period|Study Terminated by Sponsor|6|||
126091576|NCT02628028|453628437|FG006|Dosing Period|Study Terminated by Sponsor|7|||
126091577|NCT02628028|453628438|FG007|Dosing Period|Study Terminated by Sponsor|7|||
126091578|NCT02628028|453628431|FG000|Dosing Period|Physician Decision|0|||
126091579|NCT02628028|453628432|FG001|Dosing Period|Physician Decision|0|||
126091580|NCT02628028|453628433|FG002|Dosing Period|Physician Decision|0|||
126091581|NCT02628028|453628434|FG003|Dosing Period|Physician Decision|0|||
126091582|NCT02628028|453628435|FG004|Dosing Period|Physician Decision|0|||
126016881|NCT03260140|453355501|FG001|Overall Study|Withdrawal by Subject|4|||
126016882|NCT02423291|453355502|FG000|Overall Study|Lack of Efficacy|14|||
126016883|NCT02423291|453355502|FG000|Overall Study|Adverse Event|1|||
126016884|NCT05283395|453355504|FG000|Overall Study|Adverse Event|4|||
126016885|NCT05283395|453355505|FG001|Overall Study|Adverse Event|4|||
126016886|NCT05283395|453355506|FG002|Overall Study|Adverse Event|0|||
126016887|NCT05283395|453355504|FG000|Overall Study|Patient Lost to Follow-Up|0|||
126016888|NCT05283395|453355505|FG001|Overall Study|Patient Lost to Follow-Up|0|||
126016889|NCT05283395|453355506|FG002|Overall Study|Patient Lost to Follow-Up|1|||
126016890|NCT05283395|453355504|FG000|Overall Study|Patient Withdrawal|2|||
126016891|NCT05283395|453355505|FG001|Overall Study|Patient Withdrawal|4|||
126016892|NCT05283395|453355506|FG002|Overall Study|Patient Withdrawal|2|||
126016893|NCT05283395|453355504|FG000|Overall Study|Investigator Decision|1|||
126016894|NCT05283395|453355505|FG001|Overall Study|Investigator Decision|0|||
126016895|NCT05283395|453355506|FG002|Overall Study|Investigator Decision|1|||
126016896|NCT05283395|453355504|FG000|Overall Study|Enrolled in error|0|||
126016897|NCT05283395|453355505|FG001|Overall Study|Enrolled in error|0|||
126016898|NCT05283395|453355506|FG002|Overall Study|Enrolled in error|1|||
126016899|NCT00712335|453355510|FG000|Overall Study|Withdrawal by Subject|0|||
126016900|NCT00712335|453355511|FG001|Overall Study|Withdrawal by Subject|7|||
126016901|NCT00712335|453355512|FG002|Overall Study|Withdrawal by Subject|2|||
126016902|NCT00712335|453355513|FG003|Overall Study|Withdrawal by Subject|3|||
126016903|NCT00712335|453355514|FG004|Overall Study|Withdrawal by Subject|0|||
126016904|NCT00712335|453355510|FG000|Overall Study|Lost to Follow-up|2|||
126016905|NCT00712335|453355511|FG001|Overall Study|Lost to Follow-up|5|||
126016906|NCT00712335|453355512|FG002|Overall Study|Lost to Follow-up|0|||
126016907|NCT00712335|453355513|FG003|Overall Study|Lost to Follow-up|1|||
126016908|NCT00712335|453355514|FG004|Overall Study|Lost to Follow-up|0|||
126016909|NCT00712335|453355510|FG000|Overall Study|Protocol Violation|1|||
126016910|NCT00712335|453355511|FG001|Overall Study|Protocol Violation|2|||
126016911|NCT00712335|453355512|FG002|Overall Study|Protocol Violation|1|||
126016912|NCT00712335|453355513|FG003|Overall Study|Protocol Violation|0|||
126016913|NCT00712335|453355514|FG004|Overall Study|Protocol Violation|0|||
126016914|NCT00712335|453355510|FG000|Overall Study|Lack of Efficacy|0|||
126016915|NCT00712335|453355511|FG001|Overall Study|Lack of Efficacy|0|||
126016916|NCT00712335|453355512|FG002|Overall Study|Lack of Efficacy|1|||
126016917|NCT00712335|453355513|FG003|Overall Study|Lack of Efficacy|1|||
126016918|NCT00712335|453355514|FG004|Overall Study|Lack of Efficacy|0|||
126016919|NCT00712335|453355510|FG000|Overall Study|Other Reason|0|||
126091583|NCT02628028|453628436|FG005|Dosing Period|Physician Decision|1|||
126091584|NCT02628028|453628437|FG006|Dosing Period|Physician Decision|0|||
126016920|NCT00712335|453355511|FG001|Overall Study|Other Reason|3|||
126016921|NCT00712335|453355512|FG002|Overall Study|Other Reason|1|||
126216812|NCT00791154|454084455|FG006|Overall Study|Full Consent withdrawn|1|||
126216813|NCT00791154|454084449|FG000|Overall Study|Lost to Follow-up|0|||
126216814|NCT00791154|454084450|FG001|Overall Study|Lost to Follow-up|0|||
126216815|NCT00791154|454084451|FG002|Overall Study|Lost to Follow-up|0|||
126216816|NCT00791154|454084452|FG003|Overall Study|Lost to Follow-up|1|||
126216817|NCT00791154|454084453|FG004|Overall Study|Lost to Follow-up|2|||
126216818|NCT00791154|454084454|FG005|Overall Study|Lost to Follow-up|0|||
126216819|NCT00791154|454084455|FG006|Overall Study|Lost to Follow-up|4|||
126216820|NCT00791154|454084449|FG000|Overall Study|Death|5|||
126216821|NCT00791154|454084450|FG001|Overall Study|Death|4|||
126216822|NCT00791154|454084451|FG002|Overall Study|Death|4|||
126216823|NCT00791154|454084452|FG003|Overall Study|Death|7|||
126216824|NCT00791154|454084453|FG004|Overall Study|Death|54|||
126216825|NCT00791154|454084454|FG005|Overall Study|Death|54|||
126216826|NCT00791154|454084455|FG006|Overall Study|Death|52|||
126216827|NCT00791154|454084449|FG000|Overall Study|Other event|0|||
126216828|NCT00791154|454084450|FG001|Overall Study|Other event|0|||
126216829|NCT00791154|454084451|FG002|Overall Study|Other event|2|||
126216830|NCT00791154|454084452|FG003|Overall Study|Other event|0|||
126216831|NCT00791154|454084453|FG004|Overall Study|Other event|2|||
126216832|NCT00791154|454084454|FG005|Overall Study|Other event|4|||
126216833|NCT00791154|454084455|FG006|Overall Study|Other event|2|||
126216834|NCT02284373|454084456|FG000|Overall Study|Withdrawal by Subject|0|||
126216835|NCT02284373|454084457|FG001|Overall Study|Withdrawal by Subject|1|||
126216836|NCT02284373|454084458|FG002|Overall Study|Withdrawal by Subject|0|||
126216837|NCT02284373|454084456|FG000|Overall Study|Other|0|||
126016922|NCT00712335|453355513|FG003|Overall Study|Other Reason|0|||
126016923|NCT00712335|453355514|FG004|Overall Study|Other Reason|0|||
126016924|NCT03401112|453355516|FG000|Overall Study|Adverse Event|1|||
126016925|NCT03401112|453355517|FG001|Overall Study|Adverse Event|2|||
126016926|NCT03401112|453355518|FG002|Overall Study|Adverse Event|3|||
126216838|NCT02284373|454084457|FG001|Overall Study|Other|1|||
126216839|NCT02284373|454084458|FG002|Overall Study|Other|0|||
126216840|NCT02284373|454084456|FG000|Overall Study|Lost to Follow-up|0|||
126216841|NCT02284373|454084457|FG001|Overall Study|Lost to Follow-up|1|||
126216842|NCT02284373|454084458|FG002|Overall Study|Lost to Follow-up|0|||
126216843|NCT03343054|454084463|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
126216844|NCT03343054|454084464|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
126216845|NCT03343054|454084465|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
126216846|NCT03343054|454084463|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
126216847|NCT03343054|454084464|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
126216848|NCT03343054|454084465|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
126216849|NCT03343054|454084463|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
126091585|NCT02628028|453628438|FG007|Dosing Period|Physician Decision|0|||
126091586|NCT02628028|453628431|FG000|Dosing Period|Site Terminated by Sponsor|0|||
126091587|NCT02628028|453628432|FG001|Dosing Period|Site Terminated by Sponsor|0|||
126091588|NCT02628028|453628433|FG002|Dosing Period|Site Terminated by Sponsor|0|||
126091589|NCT02628028|453628434|FG003|Dosing Period|Site Terminated by Sponsor|0|||
126091590|NCT02628028|453628435|FG004|Dosing Period|Site Terminated by Sponsor|0|||
126091591|NCT02628028|453628436|FG005|Dosing Period|Site Terminated by Sponsor|1|||
126091592|NCT02628028|453628437|FG006|Dosing Period|Site Terminated by Sponsor|1|||
126091593|NCT02628028|453628438|FG007|Dosing Period|Site Terminated by Sponsor|0|||
126091594|NCT02628028|453628431|FG000|Dosing Period|Lost to Follow-up|0|||
126091595|NCT02628028|453628432|FG001|Dosing Period|Lost to Follow-up|0|||
126091596|NCT02628028|453628433|FG002|Dosing Period|Lost to Follow-up|0|||
126091597|NCT02628028|453628434|FG003|Dosing Period|Lost to Follow-up|0|||
126091598|NCT02628028|453628435|FG004|Dosing Period|Lost to Follow-up|0|||
126091599|NCT02628028|453628436|FG005|Dosing Period|Lost to Follow-up|0|||
126091600|NCT02628028|453628437|FG006|Dosing Period|Lost to Follow-up|1|||
126091601|NCT02628028|453628438|FG007|Dosing Period|Lost to Follow-up|0|||
126091602|NCT02628028|453628431|FG000|Dosing Period|Other|0|||
126091603|NCT02628028|453628432|FG001|Dosing Period|Other|0|||
126091604|NCT02628028|453628433|FG002|Dosing Period|Other|0|||
126016927|NCT03401112|453355519|FG003|Overall Study|Adverse Event|2|||
126216850|NCT03343054|454084464|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
126216851|NCT03343054|454084465|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
126216852|NCT03343054|454084463|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
126216853|NCT03343054|454084464|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
126216854|NCT03343054|454084465|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
126216855|NCT02626182|454084466|FG000|Overall Study|Adverse Event|2|||
126216856|NCT02626182|454084467|FG001|Overall Study|Adverse Event|0|||
126091605|NCT02628028|453628434|FG003|Dosing Period|Other|0|||
126091606|NCT02628028|453628435|FG004|Dosing Period|Other|2|||
126091607|NCT02628028|453628436|FG005|Dosing Period|Other|1|||
126091608|NCT02628028|453628437|FG006|Dosing Period|Other|2|||
126091609|NCT02628028|453628438|FG007|Dosing Period|Other|4|||
126091610|NCT02628028|453628431|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
126216857|NCT03578276|454084468|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
126216858|NCT03578276|454084469|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
126216859|NCT00883740|454084470|FG000|First Intervention|Lost to Follow-up|1|||
126216860|NCT00883740|454084471|FG001|First Intervention|Lost to Follow-up|0|||
126216861|NCT00883740|454084470|FG000|First Intervention|No longer willing to participate|2|||
126216862|NCT00883740|454084471|FG001|First Intervention|No longer willing to participate|0|||
126216863|NCT00883740|454084470|FG000|First Intervention|Protocol Violation|3|||
126216864|NCT00883740|454084471|FG001|First Intervention|Protocol Violation|6|||
126216865|NCT00883740|454084470|FG000|First Intervention|Adverse Event|1|||
126216866|NCT00883740|454084471|FG001|First Intervention|Adverse Event|2|||
126216867|NCT00883740|454084470|FG000|Second Intervention|Protocol Violation|1|||
126216868|NCT00883740|454084471|FG001|Second Intervention|Protocol Violation|0|||
126216869|NCT00883740|454084470|FG000|Second Intervention|No longer willing to participate|0|||
126216870|NCT00883740|454084471|FG001|Second Intervention|No longer willing to participate|1|||
126216871|NCT00981409|454084472|FG000|Overall Study|Adverse Event|4|||
126216872|NCT00981409|454084473|FG001|Overall Study|Adverse Event|0|||
126216873|NCT00981409|454084472|FG000|Overall Study|Protocol Violation|0|||
126216874|NCT00981409|454084473|FG001|Overall Study|Protocol Violation|1|||
126216875|NCT00981409|454084472|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
126216876|NCT00981409|454084473|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
126216877|NCT03869684|454084480|FG000|Overall Study|Adverse Event|0|||
126216878|NCT03869684|454084481|FG001|Overall Study|Adverse Event|3|||
126216879|NCT03869684|454084482|FG002|Overall Study|Adverse Event|1|||
126216880|NCT03869684|454084480|FG000|Overall Study|Withdrawal by Subject|1|||
126216881|NCT03869684|454084481|FG001|Overall Study|Withdrawal by Subject|0|||
126216882|NCT03869684|454084482|FG002|Overall Study|Withdrawal by Subject|0|||
126216883|NCT03869684|454084480|FG000|Overall Study|Lost to Follow-up|1|||
126216884|NCT03869684|454084481|FG001|Overall Study|Lost to Follow-up|0|||
126216885|NCT03869684|454084482|FG002|Overall Study|Lost to Follow-up|0|||
126216886|NCT03869684|454084480|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
126216887|NCT03869684|454084481|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
126216888|NCT03869684|454084482|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
126216889|NCT00078312|454084483|FG000|Overall Study|Adverse Event|43|||
126216890|NCT00078312|454084483|FG000|Overall Study|Lack of Efficacy|15|||
126216891|NCT00078312|454084483|FG000|Overall Study|Lost to Follow-up|41|||
126216892|NCT00078312|454084483|FG000|Overall Study|Physician Decision|9|||
126216893|NCT00078312|454084483|FG000|Overall Study|Protocol Violation|3|||
126216894|NCT00078312|454084483|FG000|Overall Study|Withdrawal by Subject|33|||
126216895|NCT00078312|454084483|FG000|Overall Study|Miscellaneous|33|||
126216896|NCT04840901|454084484|FG000|Overall Study|Lost to Follow-up|3|||
126091611|NCT02628028|453628432|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
126091612|NCT02628028|453628433|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
126091613|NCT02628028|453628434|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
126091614|NCT02628028|453628435|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
126091615|NCT02628028|453628436|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
126091616|NCT02628028|453628437|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
126091617|NCT02628028|453628438|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
126091618|NCT02628028|453628431|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126091619|NCT02628028|453628432|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126091620|NCT02628028|453628433|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126091621|NCT02628028|453628434|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126091622|NCT02628028|453628435|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126091623|NCT02628028|453628436|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
126091624|NCT02628028|453628437|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126091625|NCT02628028|453628438|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
126091626|NCT02628028|453628431|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126091627|NCT02628028|453628432|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126091628|NCT02628028|453628433|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126091629|NCT02628028|453628434|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126091630|NCT02628028|453628435|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126091631|NCT02628028|453628436|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
126091632|NCT02628028|453628437|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
126091633|NCT02628028|453628438|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
126091634|NCT02628028|453628431|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126091635|NCT02628028|453628432|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126216897|NCT04840901|454084485|FG001|Overall Study|Lost to Follow-up|1|||
126216898|NCT04840901|454084484|FG000|Overall Study|Moved|1|||
126216899|NCT04840901|454084485|FG001|Overall Study|Moved|0|||
126216900|NCT04840901|454084484|FG000|Overall Study|Unable to comply with study schedule|0|||
126216901|NCT04840901|454084485|FG001|Overall Study|Unable to comply with study schedule|1|||
126349921|NCT03575364|454574065|FG000|Overall Study|Patient is lost to follow up|1|||
126091636|NCT02628028|453628433|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126216902|NCT04840901|454084484|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
126216903|NCT04840901|454084485|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
126216904|NCT00110084|454084489|FG000|Overall Study|Adverse Event|9|||
126216905|NCT00110084|454084489|FG000|Overall Study|Death|1|||
126216906|NCT00110084|454084489|FG000|Overall Study|Patient Refusal|10|||
126216907|NCT00110084|454084489|FG000|Overall Study|Alternate Therapy|5|||
126216908|NCT00110084|454084489|FG000|Overall Study|Intercurrent Illness|1|||
126216909|NCT00110084|454084489|FG000|Overall Study|Other|2|||
126216910|NCT00103259|454084490|FG000|Overall Study|Death|3|||
126216911|NCT00103259|454084491|FG001|Overall Study|Death|2|||
126216912|NCT00103259|454084490|FG000|Overall Study|Withdrawal by Subject|2|||
126216913|NCT00103259|454084491|FG001|Overall Study|Withdrawal by Subject|3|||
126216914|NCT00103259|454084490|FG000|Overall Study|alternative therapy|1|||
126216915|NCT00103259|454084491|FG001|Overall Study|alternative therapy|0|||
126216916|NCT00103259|454084490|FG000|Overall Study|other (reasons were not specified)|2|||
126216917|NCT00103259|454084491|FG001|Overall Study|other (reasons were not specified)|1|||
126216918|NCT00103259|454084490|FG000|Overall Study|ineligible/no protocol therapy|4|||
126216919|NCT00103259|454084491|FG001|Overall Study|ineligible/no protocol therapy|6|||
126216920|NCT04101721|454084494|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
126216921|NCT04101721|454084495|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
126216922|NCT04101721|454084494|FG000|Overall Study|Death|0|||
126216923|NCT04101721|454084495|FG001|Overall Study|Death|1|||
126216924|NCT04101721|454084494|FG000|Overall Study|Lost to Follow-up|0|||
126216925|NCT04101721|454084495|FG001|Overall Study|Lost to Follow-up|3|||
126216926|NCT02610842|454084496|FG000|Overall Study|Lost to Follow-up|5|||
126216927|NCT04736576|454084497|FG000|Overall Study|Progressive disease|3|||
126216928|NCT04736576|454084498|FG001|Overall Study|Progressive disease|1|||
126216929|NCT04736576|454084497|FG000|Overall Study|Death|1|||
126216930|NCT04736576|454084498|FG001|Overall Study|Death|0|||
126216931|NCT04330482|454084503|FG000|Overall Study|Lost to Follow-up|2|||
126016928|NCT03401112|453355520|FG004|Overall Study|Adverse Event|0|||
126016929|NCT03401112|453355516|FG000|Overall Study|Lost to Follow-up|1|||
126016930|NCT03401112|453355517|FG001|Overall Study|Lost to Follow-up|0|||
126016931|NCT03401112|453355518|FG002|Overall Study|Lost to Follow-up|0|||
126016932|NCT03401112|453355519|FG003|Overall Study|Lost to Follow-up|0|||
126016933|NCT03401112|453355520|FG004|Overall Study|Lost to Follow-up|0|||
126216932|NCT04330482|454084504|FG001|Overall Study|Lost to Follow-up|1|||
126216933|NCT04330482|454084503|FG000|Overall Study|Withdrawal by Subject|0|||
126216934|NCT04330482|454084504|FG001|Overall Study|Withdrawal by Subject|3|||
126216935|NCT05144477|454084506|FG000|Overall Study|Withdrawal by Subject|1|||
126216936|NCT05144477|454084507|FG001|Overall Study|Withdrawal by Subject|1|||
126216937|NCT03273712|454084508|FG000|Overall Study|Death|5|||
126016934|NCT03401112|453355516|FG000|Overall Study|Noncompliance|1|||
126016935|NCT03401112|453355517|FG001|Overall Study|Noncompliance|2|||
126016936|NCT03401112|453355518|FG002|Overall Study|Noncompliance|3|||
126016937|NCT03401112|453355519|FG003|Overall Study|Noncompliance|0|||
126016938|NCT03401112|453355520|FG004|Overall Study|Noncompliance|0|||
126016939|NCT03401112|453355516|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
126216938|NCT03273712|454084508|FG000|Overall Study|Adverse Event|1|||
126216939|NCT03273712|454084508|FG000|Overall Study|Disease Progression|1|||
126216940|NCT02268045|454084511|FG000|Overall Study|Death|4|||
126216941|NCT02268045|454084512|FG001|Overall Study|Death|4|||
126216942|NCT02268045|454084511|FG000|Overall Study|Disease Progression|2|||
126216943|NCT02268045|454084512|FG001|Overall Study|Disease Progression|1|||
126016940|NCT03401112|453355517|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
126216944|NCT02268045|454084511|FG000|Overall Study|Adverse Event|7|||
126216945|NCT02268045|454084512|FG001|Overall Study|Adverse Event|7|||
126216946|NCT02268045|454084511|FG000|Overall Study|Withdrawal by Subject|2|||
126216947|NCT02268045|454084512|FG001|Overall Study|Withdrawal by Subject|6|||
126216948|NCT02268045|454084511|FG000|Overall Study|Physician Decision|0|||
126216949|NCT02268045|454084512|FG001|Overall Study|Physician Decision|1|||
126216950|NCT02268045|454084511|FG000|Overall Study|Protocol Violation|1|||
126216951|NCT02268045|454084512|FG001|Overall Study|Protocol Violation|1|||
126216952|NCT01154673|454084513|FG000|Overall Study|Lost to Follow-up|1|||
126216953|NCT01154673|454084514|FG001|Overall Study|Lost to Follow-up|0|||
126216954|NCT01154673|454084513|FG000|Overall Study|moved out of province|1|||
126216955|NCT01154673|454084514|FG001|Overall Study|moved out of province|0|||
126216956|NCT00646282|454084515|FG000|Overall Study|Protocol terminated|4|||
126216957|NCT00646282|454084516|FG001|Overall Study|Protocol terminated|4|||
126216958|NCT01289990|454084517|FG000|Overall Study|Death|0|||
126216959|NCT01289990|454084518|FG001|Overall Study|Death|0|||
126216960|NCT01289990|454084519|FG002|Overall Study|Death|0|||
126216961|NCT01289990|454084520|FG003|Overall Study|Death|1|||
126216962|NCT01289990|454084521|FG004|Overall Study|Death|2|||
126216963|NCT01289990|454084522|FG005|Overall Study|Death|1|||
126216964|NCT01289990|454084523|FG006|Overall Study|Death|0|||
126216965|NCT01289990|454084524|FG007|Overall Study|Death|0|||
126216966|NCT01289990|454084525|FG008|Overall Study|Death|0|||
126216967|NCT01289990|454084526|FG009|Overall Study|Death|0|||
126216968|NCT01289990|454084527|FG010|Overall Study|Death|0|||
126216969|NCT01289990|454084528|FG011|Overall Study|Death|1|||
126216970|NCT01289990|454084529|FG012|Overall Study|Death|0|||
126216971|NCT01289990|454084517|FG000|Overall Study|Lost to Follow-up|3|||
126216972|NCT01289990|454084518|FG001|Overall Study|Lost to Follow-up|2|||
126216973|NCT01289990|454084519|FG002|Overall Study|Lost to Follow-up|5|||
126216974|NCT01289990|454084520|FG003|Overall Study|Lost to Follow-up|5|||
126216975|NCT01289990|454084521|FG004|Overall Study|Lost to Follow-up|3|||
126216976|NCT01289990|454084522|FG005|Overall Study|Lost to Follow-up|4|||
126216977|NCT01289990|454084523|FG006|Overall Study|Lost to Follow-up|2|||
126216978|NCT01289990|454084524|FG007|Overall Study|Lost to Follow-up|2|||
126216979|NCT01289990|454084525|FG008|Overall Study|Lost to Follow-up|1|||
126216980|NCT01289990|454084526|FG009|Overall Study|Lost to Follow-up|4|||
126216981|NCT01289990|454084527|FG010|Overall Study|Lost to Follow-up|2|||
126216982|NCT01289990|454084528|FG011|Overall Study|Lost to Follow-up|1|||
126091637|NCT02628028|453628434|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126091638|NCT02628028|453628435|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126091639|NCT02628028|453628436|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
126016941|NCT03401112|453355518|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
126016942|NCT03401112|453355519|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
126016943|NCT03401112|453355520|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
126016944|NCT03401112|453355516|FG000|Overall Study|Withdrawal by Subject|0|||
126016945|NCT03401112|453355517|FG001|Overall Study|Withdrawal by Subject|3|||
126016946|NCT03401112|453355518|FG002|Overall Study|Withdrawal by Subject|2|||
126016947|NCT03401112|453355519|FG003|Overall Study|Withdrawal by Subject|1|||
126091640|NCT02628028|453628437|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
126091641|NCT02628028|453628438|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
126091642|NCT02628028|453628431|FG000|Long-term Extension (LTE) Period|Other|0|||
126091643|NCT02628028|453628432|FG001|Long-term Extension (LTE) Period|Other|0|||
126091644|NCT02628028|453628433|FG002|Long-term Extension (LTE) Period|Other|0|||
126016948|NCT03401112|453355520|FG004|Overall Study|Withdrawal by Subject|0|||
126016949|NCT03401112|453355516|FG000|Overall Study|Physician Decision|0|||
126016950|NCT03401112|453355517|FG001|Overall Study|Physician Decision|0|||
126091645|NCT02628028|453628434|FG003|Long-term Extension (LTE) Period|Other|0|||
126091646|NCT02628028|453628435|FG004|Long-term Extension (LTE) Period|Other|0|||
126091647|NCT02628028|453628436|FG005|Long-term Extension (LTE) Period|Other|3|||
126091648|NCT02628028|453628437|FG006|Long-term Extension (LTE) Period|Other|4|||
126091649|NCT02628028|453628438|FG007|Long-term Extension (LTE) Period|Other|3|||
126091650|NCT04157400|453628439|FG000|Overall Study|Withdrawal by Subject|1|||
126091651|NCT04157400|453628439|FG000|Overall Study|Lost to Follow-up|3|||
126016951|NCT03401112|453355518|FG002|Overall Study|Physician Decision|0|||
126216983|NCT01289990|454084529|FG012|Overall Study|Lost to Follow-up|2|||
126216984|NCT01289990|454084517|FG000|Overall Study|Withdrawal by Subject|15|||
126216985|NCT01289990|454084518|FG001|Overall Study|Withdrawal by Subject|14|||
126216986|NCT01289990|454084519|FG002|Overall Study|Withdrawal by Subject|12|||
126216987|NCT01289990|454084520|FG003|Overall Study|Withdrawal by Subject|13|||
126216988|NCT01289990|454084521|FG004|Overall Study|Withdrawal by Subject|8|||
126216989|NCT01289990|454084522|FG005|Overall Study|Withdrawal by Subject|7|||
126216990|NCT01289990|454084523|FG006|Overall Study|Withdrawal by Subject|13|||
126216991|NCT01289990|454084524|FG007|Overall Study|Withdrawal by Subject|9|||
126091652|NCT05543707|453628441|FG000|Overall Study|Study drug non-compliance/|5|||
126091653|NCT05543707|453628442|FG001|Overall Study|Study drug non-compliance/|0|||
126216992|NCT01289990|454084525|FG008|Overall Study|Withdrawal by Subject|12|||
126216993|NCT01289990|454084526|FG009|Overall Study|Withdrawal by Subject|13|||
126016952|NCT03401112|453355519|FG003|Overall Study|Physician Decision|2|||
126016953|NCT03401112|453355520|FG004|Overall Study|Physician Decision|0|||
126016954|NCT03401112|453355516|FG000|Overall Study|Study was Terminated by Sponsor|0|||
126016955|NCT03401112|453355517|FG001|Overall Study|Study was Terminated by Sponsor|0|||
126016956|NCT03401112|453355518|FG002|Overall Study|Study was Terminated by Sponsor|0|||
126016957|NCT03401112|453355519|FG003|Overall Study|Study was Terminated by Sponsor|1|||
126016958|NCT03401112|453355520|FG004|Overall Study|Study was Terminated by Sponsor|0|||
126016959|NCT03401112|453355516|FG000|Overall Study|Day 1 Assessment not Done|1|||
126016960|NCT03401112|453355517|FG001|Overall Study|Day 1 Assessment not Done|0|||
126016961|NCT03401112|453355518|FG002|Overall Study|Day 1 Assessment not Done|0|||
126016962|NCT03401112|453355519|FG003|Overall Study|Day 1 Assessment not Done|0|||
126016963|NCT03401112|453355520|FG004|Overall Study|Day 1 Assessment not Done|0|||
126016964|NCT03401112|453355516|FG000|Overall Study|Not Dosed|0|||
126016965|NCT03401112|453355517|FG001|Overall Study|Not Dosed|0|||
126016966|NCT03401112|453355518|FG002|Overall Study|Not Dosed|1|||
126016967|NCT03401112|453355519|FG003|Overall Study|Not Dosed|0|||
126016968|NCT03401112|453355520|FG004|Overall Study|Not Dosed|0|||
126016969|NCT03401112|453355516|FG000|Overall Study|Missed Clinical Visit|0|||
126016970|NCT03401112|453355517|FG001|Overall Study|Missed Clinical Visit|0|||
126016971|NCT03401112|453355518|FG002|Overall Study|Missed Clinical Visit|1|||
126016972|NCT03401112|453355519|FG003|Overall Study|Missed Clinical Visit|0|||
126016973|NCT03401112|453355520|FG004|Overall Study|Missed Clinical Visit|0|||
126016974|NCT03401112|453355516|FG000|Overall Study|Missed Doses|0|||
126016975|NCT03401112|453355517|FG001|Overall Study|Missed Doses|0|||
126016976|NCT03401112|453355518|FG002|Overall Study|Missed Doses|1|||
126016977|NCT03401112|453355519|FG003|Overall Study|Missed Doses|0|||
126016978|NCT03401112|453355520|FG004|Overall Study|Missed Doses|0|||
126016979|NCT03475316|453355521|FG000|6 Month Intervention|Adverse Event|2|||
126016980|NCT03475316|453355522|FG001|6 Month Intervention|Adverse Event|1|||
126016981|NCT03475316|453355521|FG000|6 Month Intervention|Withdrawal by Subject|2|||
126016982|NCT03475316|453355522|FG001|6 Month Intervention|Withdrawal by Subject|0|||
126016983|NCT03475316|453355521|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
126016984|NCT03475316|453355522|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
126016985|NCT03475316|453355521|FG000|9 Months|Study stopped due to COVID pandemic|3|||
126016986|NCT03475316|453355522|FG001|9 Months|Study stopped due to COVID pandemic|4|||
126016987|NCT00424645|453355523|FG000|Overall Study|Death|1|||
126016988|NCT00424645|453355524|FG001|Overall Study|Death|0|||
126016989|NCT02555215|453355525|FG000|Overall Study|Other|1|||
126016990|NCT02555215|453355525|FG000|Overall Study|Investigator Decision|2|||
126016991|NCT00529789|453355526|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
126016992|NCT00529789|453355526|FG000|Study Period II/III|Adverse Event|3|||
126016993|NCT00529789|453355526|FG000|Study Period II/III|Lack of Efficacy|2|||
126016994|NCT00529789|453355526|FG000|Study Period II/III|Withdrawal by Subject|1|||
126016995|NCT00529789|453355526|FG000|Study Period II/III|Protocol Violation|3|||
126016996|NCT00529789|453355526|FG000|Study Period II/III|Physician Decision|3|||
126016997|NCT00529789|453355526|FG000|Study Period II/III|Lost to Follow-up|3|||
126016998|NCT00529789|453355526|FG000|Study Period IV|Parent/Caregiver Decision|1|||
126016999|NCT00529789|453355526|FG000|Study Period IV|Adverse Event|1|||
126017000|NCT00529789|453355526|FG000|Study Period IV|Lack of Efficacy|1|||
126017001|NCT00529789|453355526|FG000|Study Period IV|Lost to Follow-up|3|||
126017002|NCT01430611|453355527|FG000|Overall Study|Adverse Event|0|||
126017003|NCT01430611|453355528|FG001|Overall Study|Adverse Event|1|||
126017004|NCT01430611|453355527|FG000|Overall Study|Protocol Violation|1|||
126017005|NCT01430611|453355528|FG001|Overall Study|Protocol Violation|0|||
126017006|NCT01430611|453355527|FG000|Overall Study|Lost to Follow-up|1|||
126017007|NCT01430611|453355528|FG001|Overall Study|Lost to Follow-up|0|||
126017008|NCT01430611|453355527|FG000|Overall Study|Withdrawal by Subject|15|||
126017009|NCT01430611|453355528|FG001|Overall Study|Withdrawal by Subject|14|||
126017010|NCT00959946|453355529|FG000|Overall Study|Adverse Event|0|||
126017011|NCT00959946|453355530|FG001|Overall Study|Adverse Event|0|||
126017012|NCT00959946|453355531|FG002|Overall Study|Adverse Event|2|||
126017013|NCT00959946|453355532|FG003|Overall Study|Adverse Event|1|||
126017014|NCT00959946|453355533|FG004|Overall Study|Adverse Event|0|||
126017015|NCT00959946|453355534|FG005|Overall Study|Adverse Event|1|||
126017016|NCT00959946|453355535|FG006|Overall Study|Adverse Event|0|||
126017017|NCT00959946|453355536|FG007|Overall Study|Adverse Event|0|||
126017018|NCT00959946|453355529|FG000|Overall Study|Death|0|||
126017019|NCT00959946|453355530|FG001|Overall Study|Death|0|||
126017020|NCT00959946|453355531|FG002|Overall Study|Death|0|||
126017021|NCT00959946|453355532|FG003|Overall Study|Death|0|||
126017022|NCT00959946|453355533|FG004|Overall Study|Death|0|||
126017023|NCT00959946|453355534|FG005|Overall Study|Death|1|||
126017024|NCT00959946|453355535|FG006|Overall Study|Death|0|||
126216994|NCT01289990|454084527|FG010|Overall Study|Withdrawal by Subject|11|||
126216995|NCT01289990|454084528|FG011|Overall Study|Withdrawal by Subject|13|||
126216996|NCT01289990|454084529|FG012|Overall Study|Withdrawal by Subject|16|||
126216997|NCT01289990|454084517|FG000|Overall Study|discontinued in preceding trial|18|||
126216998|NCT01289990|454084518|FG001|Overall Study|discontinued in preceding trial|20|||
126216999|NCT01289990|454084519|FG002|Overall Study|discontinued in preceding trial|41|||
126217000|NCT01289990|454084520|FG003|Overall Study|discontinued in preceding trial|17|||
126217001|NCT01289990|454084521|FG004|Overall Study|discontinued in preceding trial|11|||
126217002|NCT01289990|454084522|FG005|Overall Study|discontinued in preceding trial|12|||
126217003|NCT01289990|454084523|FG006|Overall Study|discontinued in preceding trial|18|||
126217004|NCT01289990|454084524|FG007|Overall Study|discontinued in preceding trial|8|||
126217005|NCT01289990|454084525|FG008|Overall Study|discontinued in preceding trial|17|||
126217006|NCT01289990|454084526|FG009|Overall Study|discontinued in preceding trial|21|||
126217007|NCT01289990|454084527|FG010|Overall Study|discontinued in preceding trial|17|||
126091654|NCT05543707|453628441|FG000|Overall Study|Withdrawal by Subject|1|||
126091655|NCT05543707|453628442|FG001|Overall Study|Withdrawal by Subject|1|||
126091656|NCT05543707|453628441|FG000|Overall Study|Adverse Event|1|||
126091657|NCT05543707|453628442|FG001|Overall Study|Adverse Event|0|||
126091658|NCT05543707|453628441|FG000|Overall Study|concurrent illness|0|||
126091659|NCT05543707|453628442|FG001|Overall Study|concurrent illness|1|||
126091660|NCT05543707|453628441|FG000|Overall Study|Pregnancy|1|||
126091661|NCT05543707|453628442|FG001|Overall Study|Pregnancy|1|||
126091662|NCT00186888|453628443|FG000|Overall Study|Toxicity|0|||
126091663|NCT00186888|453628444|FG001|Overall Study|Toxicity|1|||
126091664|NCT00186888|453628445|FG002|Overall Study|Toxicity|0|||
126091665|NCT00186888|453628443|FG000|Overall Study|Relapse or progression of disease|4|||
126091666|NCT00186888|453628444|FG001|Overall Study|Relapse or progression of disease|2|||
126091667|NCT00186888|453628445|FG002|Overall Study|Relapse or progression of disease|0|||
126091668|NCT02108964|453628446|FG000|Overall Study|Progressive disease|15|||
126091669|NCT02108964|453628447|FG001|Overall Study|Progressive disease|31|||
126091670|NCT02108964|453628448|FG002|Overall Study|Progressive disease|54|||
126091671|NCT02108964|453628449|FG003|Overall Study|Progressive disease|7|||
126091672|NCT02108964|453628450|FG004|Overall Study|Progressive disease|20|||
126091673|NCT02108964|453628451|FG005|Overall Study|Progressive disease|4|||
126091674|NCT02108964|453628452|FG006|Overall Study|Progressive disease|6|||
126091675|NCT02108964|453628453|FG007|Overall Study|Progressive disease|33|||
126091676|NCT02108964|453628446|FG000|Overall Study|Physician Decision|1|||
126091677|NCT02108964|453628447|FG001|Overall Study|Physician Decision|5|||
126091678|NCT02108964|453628448|FG002|Overall Study|Physician Decision|7|||
126091679|NCT02108964|453628449|FG003|Overall Study|Physician Decision|1|||
126091680|NCT02108964|453628450|FG004|Overall Study|Physician Decision|2|||
126091681|NCT02108964|453628451|FG005|Overall Study|Physician Decision|1|||
126091682|NCT02108964|453628452|FG006|Overall Study|Physician Decision|1|||
126091683|NCT02108964|453628453|FG007|Overall Study|Physician Decision|3|||
126091684|NCT02108964|453628446|FG000|Overall Study|Adverse Event|0|||
126091685|NCT02108964|453628447|FG001|Overall Study|Adverse Event|0|||
126091686|NCT02108964|453628448|FG002|Overall Study|Adverse Event|4|||
126091687|NCT02108964|453628449|FG003|Overall Study|Adverse Event|0|||
126091688|NCT02108964|453628450|FG004|Overall Study|Adverse Event|1|||
126091689|NCT02108964|453628451|FG005|Overall Study|Adverse Event|0|||
126091690|NCT02108964|453628452|FG006|Overall Study|Adverse Event|3|||
126091691|NCT02108964|453628453|FG007|Overall Study|Adverse Event|2|||
126091692|NCT02108964|453628446|FG000|Overall Study|Death|1|||
126091693|NCT02108964|453628447|FG001|Overall Study|Death|1|||
126091694|NCT02108964|453628448|FG002|Overall Study|Death|4|||
126091695|NCT02108964|453628449|FG003|Overall Study|Death|0|||
126091696|NCT02108964|453628450|FG004|Overall Study|Death|3|||
126091697|NCT02108964|453628451|FG005|Overall Study|Death|0|||
126091698|NCT02108964|453628452|FG006|Overall Study|Death|0|||
126091699|NCT02108964|453628453|FG007|Overall Study|Death|2|||
126091700|NCT02108964|453628446|FG000|Overall Study|Subject/Guardian decision|0|||
126091701|NCT02108964|453628447|FG001|Overall Study|Subject/Guardian decision|1|||
126091702|NCT02108964|453628448|FG002|Overall Study|Subject/Guardian decision|4|||
126091703|NCT02108964|453628449|FG003|Overall Study|Subject/Guardian decision|0|||
125878731|NCT01209689|452853399|FG000|Overall Study|Adverse Event|4|||
126217008|NCT01289990|454084528|FG011|Overall Study|discontinued in preceding trial|17|||
126217009|NCT01289990|454084529|FG012|Overall Study|discontinued in preceding trial|24|||
126091704|NCT02108964|453628450|FG004|Overall Study|Subject/Guardian decision|2|||
126091705|NCT02108964|453628451|FG005|Overall Study|Subject/Guardian decision|0|||
126091706|NCT02108964|453628452|FG006|Overall Study|Subject/Guardian decision|1|||
126091707|NCT02108964|453628453|FG007|Overall Study|Subject/Guardian decision|2|||
126091708|NCT02108964|453628446|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126091709|NCT02108964|453628447|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126091710|NCT02108964|453628448|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126091711|NCT02108964|453628449|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126217010|NCT01289990|454084517|FG000|Overall Study|did not continue in extension|41|||
126217011|NCT01289990|454084518|FG001|Overall Study|did not continue in extension|45|||
126217012|NCT01289990|454084519|FG002|Overall Study|did not continue in extension|51|||
126217013|NCT01289990|454084520|FG003|Overall Study|did not continue in extension|51|||
126217014|NCT01289990|454084521|FG004|Overall Study|did not continue in extension|48|||
126217015|NCT01289990|454084522|FG005|Overall Study|did not continue in extension|50|||
126217016|NCT01289990|454084523|FG006|Overall Study|did not continue in extension|54|||
126217017|NCT01289990|454084524|FG007|Overall Study|did not continue in extension|36|||
126217018|NCT01289990|454084525|FG008|Overall Study|did not continue in extension|44|||
126217019|NCT01289990|454084526|FG009|Overall Study|did not continue in extension|48|||
126217020|NCT01289990|454084527|FG010|Overall Study|did not continue in extension|45|||
126217021|NCT01289990|454084528|FG011|Overall Study|did not continue in extension|34|||
126217022|NCT01289990|454084529|FG012|Overall Study|did not continue in extension|56|||
126217023|NCT01289990|454084517|FG000|Overall Study|Not treated|0|||
126217024|NCT01289990|454084518|FG001|Overall Study|Not treated|0|||
126217025|NCT01289990|454084519|FG002|Overall Study|Not treated|0|||
126217026|NCT01289990|454084520|FG003|Overall Study|Not treated|0|||
126217027|NCT01289990|454084521|FG004|Overall Study|Not treated|0|||
126217028|NCT01289990|454084522|FG005|Overall Study|Not treated|0|||
126217029|NCT01289990|454084523|FG006|Overall Study|Not treated|1|||
126217030|NCT01289990|454084524|FG007|Overall Study|Not treated|0|||
126217031|NCT01289990|454084525|FG008|Overall Study|Not treated|1|||
126217032|NCT01289990|454084526|FG009|Overall Study|Not treated|0|||
126217033|NCT01289990|454084527|FG010|Overall Study|Not treated|1|||
126217034|NCT01289990|454084528|FG011|Overall Study|Not treated|2|||
126217035|NCT01289990|454084529|FG012|Overall Study|Not treated|0|||
126217036|NCT00683904|454084530|FG000|Dose Level 1|Disease progression|2|||
126217037|NCT00683904|454084531|FG001|Dose Level 1|Disease progression|0|||
126217038|NCT00683904|454084530|FG000|Dose Level 1|Adverse Event|1|||
126217039|NCT00683904|454084531|FG001|Dose Level 1|Adverse Event|0|||
126217040|NCT00683904|454084530|FG000|Dose Level 2|Adverse Event|0|||
126217041|NCT00683904|454084531|FG001|Dose Level 2|Adverse Event|2|||
126217042|NCT01488071|454084532|FG000|Overall Study|Adverse Event|15|||
126217043|NCT01488071|454084533|FG001|Overall Study|Adverse Event|23|||
126217044|NCT01488071|454084532|FG000|Overall Study|Lack of Efficacy|11|||
126217045|NCT01488071|454084533|FG001|Overall Study|Lack of Efficacy|17|||
126217046|NCT01488071|454084532|FG000|Overall Study|Non-compliance with study drug|2|||
126217047|NCT01488071|454084533|FG001|Overall Study|Non-compliance with study drug|0|||
126217048|NCT01488071|454084532|FG000|Overall Study|Protocol Violation|5|||
126217049|NCT01488071|454084533|FG001|Overall Study|Protocol Violation|7|||
126217050|NCT01488071|454084532|FG000|Overall Study|Withdrawal of Consent|14|||
126217051|NCT01488071|454084533|FG001|Overall Study|Withdrawal of Consent|12|||
126217052|NCT01488071|454084532|FG000|Overall Study|Lost to Follow-up|1|||
126217053|NCT01488071|454084533|FG001|Overall Study|Lost to Follow-up|0|||
126217054|NCT01488071|454084532|FG000|Overall Study|Administrative or Other Reason(s)|5|||
126217055|NCT01488071|454084533|FG001|Overall Study|Administrative or Other Reason(s)|4|||
126017025|NCT00959946|453355536|FG007|Overall Study|Death|0|||
126217056|NCT02587325|454084534|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
126217057|NCT02587325|454084535|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
126217058|NCT02587325|454084536|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
126217059|NCT02587325|454084537|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
126217060|NCT02587325|454084538|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
126217061|NCT02587325|454084534|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
126217062|NCT02587325|454084535|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
126217063|NCT02587325|454084536|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
126217064|NCT02587325|454084537|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
126217065|NCT02587325|454084538|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
126217066|NCT02587325|454084534|FG000|32-Week Optional Extension Part|Adverse Event|0|||
126217067|NCT02587325|454084535|FG001|32-Week Optional Extension Part|Adverse Event|0|||
126217068|NCT02587325|454084536|FG002|32-Week Optional Extension Part|Adverse Event|1|||
126217069|NCT02587325|454084537|FG003|32-Week Optional Extension Part|Adverse Event|0|||
126217070|NCT02587325|454084538|FG004|32-Week Optional Extension Part|Adverse Event|0|||
126217071|NCT02587325|454084534|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
126217072|NCT02587325|454084535|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
126217073|NCT02587325|454084536|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
126217074|NCT02587325|454084537|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
126217075|NCT02587325|454084538|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
126217076|NCT01831596|454084539|FG000|Overall Study|Other|8|||
126217077|NCT02602080|454084540|FG000|Overall Study|Protocol Violation|6|||
126217078|NCT02602080|454084541|FG001|Overall Study|Protocol Violation|1|||
126217079|NCT02602080|454084542|FG002|Overall Study|Protocol Violation|3|||
126217080|NCT04355767|454084545|FG000|Overall Study|Withdrawal by Subject|2|||
126217081|NCT04355767|454084546|FG001|Overall Study|Withdrawal by Subject|2|||
126217082|NCT04355767|454084545|FG000|Overall Study|Death|5|||
126217083|NCT04355767|454084546|FG001|Overall Study|Death|1|||
126217084|NCT01999322|454084547|FG000|Overall Study|Adverse Event|1|||
126217085|NCT01999322|454084548|FG001|Overall Study|Adverse Event|0|||
126017026|NCT00959946|453355529|FG000|Overall Study|Disease Progression|2|||
126017027|NCT00959946|453355530|FG001|Overall Study|Disease Progression|4|||
126017028|NCT00959946|453355531|FG002|Overall Study|Disease Progression|2|||
126091712|NCT02108964|453628450|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126091713|NCT02108964|453628451|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126091714|NCT02108964|453628452|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126091715|NCT02108964|453628453|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
126091716|NCT01214642|453628456|FG000|Overall Study|Progressive Disease|3|||
126091717|NCT01214642|453628457|FG001|Overall Study|Progressive Disease|2|||
126091718|NCT01214642|453628458|FG002|Overall Study|Progressive Disease|3|||
126091719|NCT01214642|453628459|FG003|Overall Study|Progressive Disease|5|||
126091720|NCT01214642|453628460|FG004|Overall Study|Progressive Disease|5|||
126091721|NCT01214642|453628461|FG005|Overall Study|Progressive Disease|3|||
126091722|NCT01214642|453628462|FG006|Overall Study|Progressive Disease|5|||
126091723|NCT01214642|453628463|FG007|Overall Study|Progressive Disease|3|||
126091724|NCT01214642|453628464|FG008|Overall Study|Progressive Disease|10|||
126091725|NCT01214642|453628465|FG009|Overall Study|Progressive Disease|2|||
126091726|NCT01214642|453628466|FG010|Overall Study|Progressive Disease|1|||
126091727|NCT01214642|453628467|FG011|Overall Study|Progressive Disease|4|||
126091728|NCT01214642|453628456|FG000|Overall Study|Adverse Event|0|||
126091729|NCT01214642|453628457|FG001|Overall Study|Adverse Event|1|||
126091730|NCT01214642|453628458|FG002|Overall Study|Adverse Event|0|||
126091731|NCT01214642|453628459|FG003|Overall Study|Adverse Event|0|||
126091732|NCT01214642|453628460|FG004|Overall Study|Adverse Event|0|||
126091733|NCT01214642|453628461|FG005|Overall Study|Adverse Event|0|||
126091734|NCT01214642|453628462|FG006|Overall Study|Adverse Event|1|||
126091735|NCT01214642|453628463|FG007|Overall Study|Adverse Event|0|||
126091736|NCT01214642|453628464|FG008|Overall Study|Adverse Event|0|||
126091737|NCT01214642|453628465|FG009|Overall Study|Adverse Event|1|||
126091738|NCT01214642|453628466|FG010|Overall Study|Adverse Event|1|||
126091739|NCT01214642|453628467|FG011|Overall Study|Adverse Event|0|||
126091740|NCT01214642|453628456|FG000|Overall Study|Death|0|||
126091741|NCT01214642|453628457|FG001|Overall Study|Death|0|||
126091742|NCT01214642|453628458|FG002|Overall Study|Death|1|||
126091743|NCT01214642|453628459|FG003|Overall Study|Death|0|||
126217086|NCT02200614|454084549|FG000|Double Blind Treatment|Adverse Event|86|||
126091744|NCT01214642|453628460|FG004|Overall Study|Death|0|||
126091745|NCT01214642|453628461|FG005|Overall Study|Death|0|||
126091746|NCT01214642|453628462|FG006|Overall Study|Death|0|||
126217087|NCT02200614|454084550|FG001|Double Blind Treatment|Adverse Event|48|||
125878732|NCT01209689|452853400|FG001|Overall Study|Adverse Event|0|||
126017029|NCT00959946|453355532|FG003|Overall Study|Disease Progression|4|||
126017030|NCT00959946|453355533|FG004|Overall Study|Disease Progression|4|||
126017031|NCT00959946|453355534|FG005|Overall Study|Disease Progression|6|||
126017032|NCT00959946|453355535|FG006|Overall Study|Disease Progression|2|||
126017033|NCT00959946|453355536|FG007|Overall Study|Disease Progression|2|||
126017034|NCT00959946|453355529|FG000|Overall Study|Withdrawal by Subject|0|||
126017035|NCT00959946|453355530|FG001|Overall Study|Withdrawal by Subject|0|||
126017036|NCT00959946|453355531|FG002|Overall Study|Withdrawal by Subject|0|||
126017037|NCT00959946|453355532|FG003|Overall Study|Withdrawal by Subject|0|||
126017038|NCT00959946|453355533|FG004|Overall Study|Withdrawal by Subject|0|||
126017039|NCT00959946|453355534|FG005|Overall Study|Withdrawal by Subject|1|||
126017040|NCT00959946|453355535|FG006|Overall Study|Withdrawal by Subject|0|||
126017041|NCT00959946|453355536|FG007|Overall Study|Withdrawal by Subject|0|||
126017042|NCT03144674|453355541|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
126017043|NCT03144674|453355542|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
126017044|NCT03144674|453355543|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
126017045|NCT03144674|453355544|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
126017046|NCT03144674|453355541|FG000|Overall Study|Death|3|||
126017047|NCT03144674|453355542|FG001|Overall Study|Death|2|||
126017048|NCT03144674|453355543|FG002|Overall Study|Death|6|||
126017049|NCT03144674|453355544|FG003|Overall Study|Death|24|||
126017050|NCT03144674|453355541|FG000|Overall Study|Lost to Follow-up|0|||
126017051|NCT03144674|453355542|FG001|Overall Study|Lost to Follow-up|1|||
126017052|NCT03144674|453355543|FG002|Overall Study|Lost to Follow-up|0|||
126017053|NCT03144674|453355544|FG003|Overall Study|Lost to Follow-up|4|||
126017054|NCT03144674|453355541|FG000|Overall Study|Withdrawal by Participant|0|||
126017055|NCT03144674|453355542|FG001|Overall Study|Withdrawal by Participant|0|||
126017056|NCT03144674|453355543|FG002|Overall Study|Withdrawal by Participant|2|||
126017057|NCT03144674|453355544|FG003|Overall Study|Withdrawal by Participant|6|||
126017058|NCT03144674|453355541|FG000|Overall Study|Discharged from the Trust|0|||
126017059|NCT03144674|453355542|FG001|Overall Study|Discharged from the Trust|0|||
126017060|NCT03144674|453355543|FG002|Overall Study|Discharged from the Trust|1|||
126017061|NCT03144674|453355544|FG003|Overall Study|Discharged from the Trust|0|||
126017062|NCT03144674|453355541|FG000|Overall Study|Exclusion Criteria Met|0|||
126017063|NCT03144674|453355542|FG001|Overall Study|Exclusion Criteria Met|0|||
126017064|NCT03144674|453355543|FG002|Overall Study|Exclusion Criteria Met|1|||
126017065|NCT03144674|453355544|FG003|Overall Study|Exclusion Criteria Met|0|||
126017066|NCT03144674|453355541|FG000|Overall Study|Changed Physicians|0|||
126017067|NCT03144674|453355542|FG001|Overall Study|Changed Physicians|0|||
126017068|NCT03144674|453355543|FG002|Overall Study|Changed Physicians|0|||
126017069|NCT03144674|453355544|FG003|Overall Study|Changed Physicians|1|||
126017070|NCT03144674|453355541|FG000|Overall Study|Removed for Safety|0|||
126017071|NCT03144674|453355542|FG001|Overall Study|Removed for Safety|0|||
126017072|NCT03144674|453355543|FG002|Overall Study|Removed for Safety|0|||
126017073|NCT03144674|453355544|FG003|Overall Study|Removed for Safety|1|||
126017074|NCT03144674|453355541|FG000|Overall Study|Site Closed|0|||
126017075|NCT03144674|453355542|FG001|Overall Study|Site Closed|0|||
126017076|NCT03144674|453355543|FG002|Overall Study|Site Closed|0|||
126017077|NCT03144674|453355544|FG003|Overall Study|Site Closed|1|||
126017078|NCT03144674|453355541|FG000|Overall Study|Histological Criteria Not Met|0|||
126017079|NCT03144674|453355542|FG001|Overall Study|Histological Criteria Not Met|0|||
126017080|NCT03144674|453355543|FG002|Overall Study|Histological Criteria Not Met|0|||
126017081|NCT03144674|453355544|FG003|Overall Study|Histological Criteria Not Met|1|||
126017082|NCT03144674|453355541|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
126017083|NCT03144674|453355542|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
126017084|NCT03144674|453355543|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
126017085|NCT03144674|453355544|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
126217088|NCT02200614|454084549|FG000|Double Blind Treatment|Confirmed metastasis|120|||
126217089|NCT02200614|454084550|FG001|Double Blind Treatment|Confirmed metastasis|140|||
126217090|NCT02200614|454084549|FG000|Double Blind Treatment|Judgment of the investigator|59|||
126217091|NCT02200614|454084550|FG001|Double Blind Treatment|Judgment of the investigator|99|||
126217092|NCT02200614|454084549|FG000|Double Blind Treatment|Metastasis by local reading|1|||
126217093|NCT02200614|454084550|FG001|Double Blind Treatment|Metastasis by local reading|3|||
126217094|NCT02200614|454084549|FG000|Double Blind Treatment|Other reason|6|||
126217095|NCT02200614|454084550|FG001|Double Blind Treatment|Other reason|2|||
126217096|NCT02200614|454084549|FG000|Double Blind Treatment|Personal reason|77|||
126217097|NCT02200614|454084550|FG001|Double Blind Treatment|Personal reason|85|||
126217098|NCT02200614|454084549|FG000|Double Blind Treatment|Protocol deviation|14|||
126217099|NCT02200614|454084550|FG001|Double Blind Treatment|Protocol deviation|7|||
126217100|NCT02200614|454084549|FG000|Double Blind Treatment|Not treated|1|||
126091747|NCT01214642|453628463|FG007|Overall Study|Death|0|||
126217101|NCT02200614|454084550|FG001|Double Blind Treatment|Not treated|0|||
126217102|NCT02200614|454084549|FG000|Open Label|Adverse Event|41|||
126217103|NCT02200614|454084550|FG001|Open Label|Adverse Event|11|||
126217104|NCT02200614|454084549|FG000|Open Label|Confirmed metastasis|1|||
126217105|NCT02200614|454084550|FG001|Open Label|Confirmed metastasis|0|||
126091748|NCT01214642|453628464|FG008|Overall Study|Death|0|||
126091749|NCT01214642|453628465|FG009|Overall Study|Death|0|||
126091750|NCT01214642|453628466|FG010|Overall Study|Death|1|||
126217106|NCT02200614|454084549|FG000|Open Label|Judgment of the investigator|29|||
126217107|NCT02200614|454084550|FG001|Open Label|Judgment of the investigator|2|||
126217108|NCT02200614|454084549|FG000|Open Label|Metastasis by local reading|138|||
126217109|NCT02200614|454084550|FG001|Open Label|Metastasis by local reading|27|||
126217110|NCT02200614|454084549|FG000|Open Label|Other reason|22|||
126091751|NCT01214642|453628467|FG011|Overall Study|Death|0|||
126091752|NCT01214642|453628456|FG000|Overall Study|Withdrawal by Subject|0|||
126091753|NCT01214642|453628457|FG001|Overall Study|Withdrawal by Subject|0|||
126091754|NCT01214642|453628458|FG002|Overall Study|Withdrawal by Subject|1|||
126091755|NCT01214642|453628459|FG003|Overall Study|Withdrawal by Subject|0|||
126091756|NCT01214642|453628460|FG004|Overall Study|Withdrawal by Subject|0|||
126091757|NCT01214642|453628461|FG005|Overall Study|Withdrawal by Subject|0|||
126091758|NCT01214642|453628462|FG006|Overall Study|Withdrawal by Subject|0|||
126091759|NCT01214642|453628463|FG007|Overall Study|Withdrawal by Subject|0|||
126091760|NCT01214642|453628464|FG008|Overall Study|Withdrawal by Subject|3|||
126091761|NCT01214642|453628465|FG009|Overall Study|Withdrawal by Subject|1|||
126091762|NCT01214642|453628466|FG010|Overall Study|Withdrawal by Subject|1|||
126091763|NCT01214642|453628467|FG011|Overall Study|Withdrawal by Subject|0|||
126091764|NCT01214642|453628456|FG000|Overall Study|Physician Decision|0|||
126091765|NCT01214642|453628457|FG001|Overall Study|Physician Decision|0|||
126091766|NCT01214642|453628458|FG002|Overall Study|Physician Decision|1|||
126091767|NCT01214642|453628459|FG003|Overall Study|Physician Decision|1|||
126091768|NCT01214642|453628460|FG004|Overall Study|Physician Decision|1|||
126091769|NCT01214642|453628461|FG005|Overall Study|Physician Decision|0|||
126217111|NCT02200614|454084550|FG001|Open Label|Other reason|4|||
126217112|NCT02200614|454084549|FG000|Open Label|Personal reason|60|||
126217113|NCT02200614|454084550|FG001|Open Label|Personal reason|8|||
126217114|NCT02200614|454084549|FG000|Open Label|Protocol deviation|3|||
126217115|NCT02200614|454084550|FG001|Open Label|Protocol deviation|2|||
126217116|NCT02200614|454084549|FG000|Open Label|Missing|2|||
126217117|NCT02200614|454084550|FG001|Open Label|Missing|2|||
126217118|NCT01898884|454084551|FG000|Multiple Dose Period|Adverse Event|0|||
126217119|NCT01898884|454084552|FG001|Multiple Dose Period|Adverse Event|0|||
126217120|NCT01898884|454084553|FG002|Multiple Dose Period|Adverse Event|0|||
126217121|NCT01898884|454084554|FG003|Multiple Dose Period|Adverse Event|0|||
126217122|NCT01898884|454084555|FG004|Multiple Dose Period|Adverse Event|0|||
126217123|NCT01898884|454084556|FG005|Multiple Dose Period|Adverse Event|0|||
126217124|NCT01898884|454084557|FG006|Multiple Dose Period|Adverse Event|1|||
126217125|NCT01898884|454084558|FG007|Multiple Dose Period|Adverse Event|0|||
126217126|NCT01898884|454084559|FG008|Multiple Dose Period|Adverse Event|0|||
126217127|NCT01898884|454084551|FG000|Multiple Dose Period|Randomized Not Treated|0|||
126217128|NCT01898884|454084552|FG001|Multiple Dose Period|Randomized Not Treated|0|||
126217129|NCT01898884|454084553|FG002|Multiple Dose Period|Randomized Not Treated|0|||
126217130|NCT01898884|454084554|FG003|Multiple Dose Period|Randomized Not Treated|0|||
126217131|NCT01898884|454084555|FG004|Multiple Dose Period|Randomized Not Treated|0|||
126217132|NCT01898884|454084556|FG005|Multiple Dose Period|Randomized Not Treated|0|||
126217133|NCT01898884|454084557|FG006|Multiple Dose Period|Randomized Not Treated|0|||
126217134|NCT01898884|454084558|FG007|Multiple Dose Period|Randomized Not Treated|0|||
126217135|NCT01898884|454084559|FG008|Multiple Dose Period|Randomized Not Treated|1|||
126217136|NCT01901146|454086623|FG000|Neoadjuvant Phase|Death|1|||
126217137|NCT01901146|454086624|FG001|Neoadjuvant Phase|Death|2|||
126217138|NCT01901146|454086625|FG002|Neoadjuvant Phase|Death|0|||
126217139|NCT01901146|454086626|FG003|Neoadjuvant Phase|Death|0|||
126217140|NCT01901146|454086627|FG004|Neoadjuvant Phase|Death|0|||
126217141|NCT01901146|454086623|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
126217142|NCT01901146|454086624|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
126217143|NCT01901146|454086625|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
126217144|NCT01901146|454086626|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
126217145|NCT01901146|454086627|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
126217146|NCT01901146|454086623|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
126217147|NCT01901146|454086624|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
126217148|NCT01901146|454086625|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
126217149|NCT01901146|454086626|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
126217150|NCT01901146|454086627|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
126217151|NCT01901146|454086623|FG000|Neoadjuvant Phase|Physician Decision|1|||
126217152|NCT01901146|454086624|FG001|Neoadjuvant Phase|Physician Decision|2|||
126217153|NCT01901146|454086625|FG002|Neoadjuvant Phase|Physician Decision|0|||
126217154|NCT01901146|454086626|FG003|Neoadjuvant Phase|Physician Decision|0|||
126217155|NCT01901146|454086627|FG004|Neoadjuvant Phase|Physician Decision|0|||
126217156|NCT01901146|454086623|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
126217157|NCT01901146|454086624|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
126217158|NCT01901146|454086625|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
126217159|NCT01901146|454086626|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
126217160|NCT01901146|454086627|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
126217161|NCT01901146|454086623|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
126017086|NCT03144674|453355541|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
126017087|NCT03144674|453355542|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
126017088|NCT03144674|453355543|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
126017089|NCT03144674|453355544|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
126017090|NCT00206375|453355545|FG000|Overall Study|Lost to Follow-up|1|||
126017091|NCT00206375|453355546|FG001|Overall Study|Lost to Follow-up|0|||
126017092|NCT00206375|453355547|FG002|Overall Study|Lost to Follow-up|0|||
126217162|NCT01901146|454086624|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
126217163|NCT01901146|454086625|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
126017093|NCT00206375|453355545|FG000|Overall Study|Withdrawal by Subject|2|||
126017094|NCT00206375|453355546|FG001|Overall Study|Withdrawal by Subject|1|||
126017095|NCT00206375|453355547|FG002|Overall Study|Withdrawal by Subject|3|||
126217164|NCT01901146|454086626|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
126217165|NCT01901146|454086627|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
126217166|NCT01901146|454086623|FG000|Adjuvant Phase|Other|0|||
126217167|NCT01901146|454086624|FG001|Adjuvant Phase|Other|0|||
126217168|NCT01901146|454086625|FG002|Adjuvant Phase|Other|1|||
126017096|NCT00206375|453355545|FG000|Overall Study|Study terminated due to lack of funds|0|||
126017097|NCT00206375|453355546|FG001|Overall Study|Study terminated due to lack of funds|1|||
126017098|NCT00206375|453355547|FG002|Overall Study|Study terminated due to lack of funds|1|||
126017099|NCT03368664|453355548|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
126017100|NCT03368664|453355548|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
126017101|NCT03368664|453355548|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
126017102|NCT03368664|453355548|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
126017103|NCT00837616|453355549|FG000|Overall Study|Withdrawal by Subject|0|||
126017104|NCT00837616|453355550|FG001|Overall Study|Withdrawal by Subject|1|||
126017105|NCT01810263|453355551|FG000|Overall Study|Lost to Follow-up|8|||
126017106|NCT01810263|453355552|FG001|Overall Study|Lost to Follow-up|7|||
126017107|NCT00457691|453355554|FG000|Overall Study|Adverse Event|4|||
126017108|NCT00457691|453355555|FG001|Overall Study|Adverse Event|1|||
126017109|NCT00457691|453355554|FG000|Overall Study|Death|163|||
126017110|NCT00457691|453355555|FG001|Overall Study|Death|148|||
126017111|NCT00457691|453355554|FG000|Overall Study|Protocol Violation|1|||
126017112|NCT00457691|453355555|FG001|Overall Study|Protocol Violation|3|||
126017113|NCT00457691|453355554|FG000|Overall Study|Lost to Follow-up|23|||
126017114|NCT00457691|453355555|FG001|Overall Study|Lost to Follow-up|14|||
126017115|NCT00457691|453355554|FG000|Overall Study|Study terminated by Sponsor|1|||
126017116|NCT00457691|453355555|FG001|Overall Study|Study terminated by Sponsor|1|||
126017117|NCT00457691|453355554|FG000|Overall Study|Subject refused (reason other than AE)|14|||
126017118|NCT00457691|453355555|FG001|Overall Study|Subject refused (reason other than AE)|19|||
126017119|NCT00457691|453355554|FG000|Overall Study|Disease progression, study terminated|180|||
126017120|NCT00457691|453355555|FG001|Overall Study|Disease progression, study terminated|196|||
126017121|NCT01121549|453355558|FG000|Overall Study|Adverse Event|10|||
126017122|NCT01121549|453355558|FG000|Overall Study|Lack of Efficacy|11|||
126017123|NCT01121549|453355558|FG000|Overall Study|Lost to Follow-up|12|||
126017124|NCT01121549|453355558|FG000|Overall Study|Did not meet entrance criteria|9|||
126017125|NCT01121549|453355558|FG000|Overall Study|Study terminated by sponsor|197|||
126017126|NCT01121549|453355558|FG000|Overall Study|Pregnancy|1|||
126017127|NCT01121549|453355558|FG000|Overall Study|Protocol Violation|33|||
126017128|NCT01121549|453355558|FG000|Overall Study|Withdrawal by Subject|16|||
126017129|NCT01121549|453355558|FG000|Overall Study|Other|58|||
126017130|NCT02999477|453355561|FG000|Overall Study|found ineligible after first dose|0|||
126017131|NCT02999477|453355562|FG001|Overall Study|found ineligible after first dose|1|||
126017132|NCT02999477|453355561|FG000|Overall Study|Withdrawal by Subject|1|||
126017133|NCT02999477|453355562|FG001|Overall Study|Withdrawal by Subject|1|||
126017134|NCT00573833|453355563|FG000|Overall Study|Not Treated|2|||
126017135|NCT03351075|453356956|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
126017136|NCT03351075|453356957|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
126017137|NCT03351075|453356956|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
126017138|NCT03351075|453356957|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
126017139|NCT03351075|453356956|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
126017140|NCT03351075|453356957|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
126017141|NCT03351075|453356956|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
126017142|NCT03351075|453356957|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
126017143|NCT00493649|453356958|FG000|Overall Study|Adverse Event|44|||
126017144|NCT00493649|453356958|FG000|Overall Study|Patient Request|21|||
126017145|NCT00493649|453356958|FG000|Overall Study|Investigator Request|2|||
126017146|NCT00493649|453356958|FG000|Overall Study|Disease Progression|1|||
126017147|NCT00493649|453356958|FG000|Overall Study|Lost to Follow-up|1|||
126017148|NCT00493649|453356958|FG000|Overall Study|Other|13|||
126017149|NCT05219253|453356959|FG000|Overall Study|Withdrawal by Subject|1|||
126017150|NCT05219253|453356960|FG001|Overall Study|Withdrawal by Subject|2|||
126017151|NCT03086369|453356961|FG000|Overall Study|Lost to Follow-up|1|||
126017152|NCT03086369|453356962|FG001|Overall Study|Lost to Follow-up|0|||
126017153|NCT03086369|453356963|FG002|Overall Study|Lost to Follow-up|0|||
126017154|NCT03086369|453356964|FG003|Overall Study|Lost to Follow-up|2|||
126017155|NCT03086369|453356965|FG004|Overall Study|Lost to Follow-up|1|||
126017156|NCT03086369|453356961|FG000|Overall Study|Physician Decision|0|||
126017157|NCT03086369|453356962|FG001|Overall Study|Physician Decision|0|||
126217169|NCT01901146|454086626|FG003|Adjuvant Phase|Other|0|||
126217170|NCT01901146|454086627|FG004|Adjuvant Phase|Other|0|||
126217171|NCT01901146|454086623|FG000|Adjuvant Phase|Death|0|||
126217172|NCT01901146|454086624|FG001|Adjuvant Phase|Death|0|||
126217173|NCT01901146|454086625|FG002|Adjuvant Phase|Death|0|||
126217174|NCT01901146|454086626|FG003|Adjuvant Phase|Death|0|||
126217175|NCT01901146|454086627|FG004|Adjuvant Phase|Death|3|||
126217176|NCT01901146|454086623|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
126217177|NCT01901146|454086624|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
126217178|NCT01901146|454086625|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
126217179|NCT01901146|454086626|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
126217180|NCT01901146|454086627|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
126217181|NCT01901146|454086623|FG000|Adjuvant Phase|Physician Decision|0|||
126217182|NCT01901146|454086624|FG001|Adjuvant Phase|Physician Decision|0|||
126217183|NCT01901146|454086625|FG002|Adjuvant Phase|Physician Decision|9|||
126217184|NCT01901146|454086626|FG003|Adjuvant Phase|Physician Decision|2|||
126217185|NCT01901146|454086627|FG004|Adjuvant Phase|Physician Decision|4|||
126217186|NCT01901146|454086623|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
126217187|NCT01901146|454086624|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
126217188|NCT01901146|454086625|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
126217189|NCT01901146|454086626|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
126217190|NCT01901146|454086627|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
126217191|NCT00606801|454086628|FG000|Intervention|Protocol Violation|3|||
126217192|NCT00606801|454086629|FG001|Intervention|Protocol Violation|3|||
126217193|NCT00303316|454086632|FG000|Overall Study|Protocol Violation|1|||
126217194|NCT00303316|454086633|FG001|Overall Study|Protocol Violation|0|||
126217195|NCT00303316|454086632|FG000|Overall Study|Lost to Follow-up|0|||
126217196|NCT00303316|454086633|FG001|Overall Study|Lost to Follow-up|1|||
126217197|NCT00303316|454086632|FG000|Overall Study|Withdrawal by Subject|1|||
126217198|NCT00303316|454086633|FG001|Overall Study|Withdrawal by Subject|2|||
126217199|NCT00306852|454086638|FG000|Overall Study|Death|14|||
126217200|NCT00306852|454086639|FG001|Overall Study|Death|14|||
126217201|NCT00306852|454086638|FG000|Overall Study|Lost to Follow-up|15|||
126217202|NCT00306852|454086639|FG001|Overall Study|Lost to Follow-up|24|||
126217203|NCT01467570|454086640|FG000|Overall Study|Lost to Follow-up|8|||
126217204|NCT01467570|454086641|FG001|Overall Study|Lost to Follow-up|9|||
126217205|NCT02766088|454086644|FG000|Overall Study|Sponsor study termination|498|||
126217206|NCT02766088|454086644|FG000|Overall Study|Migrated/moved from the study area|1|||
126217207|NCT02766088|454086644|FG000|Overall Study|Lost to Follow-up|5|||
126217208|NCT02766088|454086644|FG000|Overall Study|Other|1|||
126217209|NCT02766088|454086644|FG000|Overall Study|Death|1|||
126217210|NCT01222715|454086645|FG000|Overall Study|Adverse Event|0|||
126217211|NCT01222715|454086646|FG001|Overall Study|Adverse Event|4|||
126217212|NCT01222715|454086645|FG000|Overall Study|Death|0|||
126217213|NCT01222715|454086646|FG001|Overall Study|Death|1|||
126217214|NCT01222715|454086645|FG000|Overall Study|Lack of Efficacy|22|||
126217215|NCT01222715|454086646|FG001|Overall Study|Lack of Efficacy|14|||
126217216|NCT01222715|454086645|FG000|Overall Study|Physician Decision|12|||
126217217|NCT01222715|454086646|FG001|Overall Study|Physician Decision|2|||
126217218|NCT01222715|454086645|FG000|Overall Study|Refusal of further protocol therapy|0|||
126217219|NCT01222715|454086646|FG001|Overall Study|Refusal of further protocol therapy|4|||
126217220|NCT01222715|454086645|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
126217221|NCT01222715|454086646|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
126217222|NCT01222715|454086645|FG000|Overall Study|Ineligible|0|||
126217223|NCT01222715|454086646|FG001|Overall Study|Ineligible|1|||
126217224|NCT01222715|454086645|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
126217225|NCT01222715|454086646|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
126217226|NCT03555890|454086655|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126217227|NCT03555890|454086656|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126217228|NCT03555890|454086657|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126217229|NCT03555890|454086658|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
126217230|NCT03372369|454086659|FG000|Qualification Period|Withdrawal by Subject|16|||
126217231|NCT03372369|454086660|FG001|Qualification Period|Withdrawal by Subject|13|||
126217232|NCT03372369|454086659|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
126217233|NCT03372369|454086660|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
126217234|NCT03372369|454086659|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
126217235|NCT03372369|454086660|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
126217236|NCT02239601|454086661|FG000|Overall Study|Withdrawal by Subject|3|||
126217237|NCT02239601|454086662|FG001|Overall Study|Withdrawal by Subject|4|||
126217238|NCT02239601|454086661|FG000|Overall Study|Protocol Violation|4|||
126217239|NCT02239601|454086662|FG001|Overall Study|Protocol Violation|2|||
126217240|NCT01508325|454086663|FG000|Overall Study|Withdrawal by Subject|8|||
126091770|NCT01214642|453628462|FG006|Overall Study|Physician Decision|0|||
126091771|NCT01214642|453628463|FG007|Overall Study|Physician Decision|0|||
126217241|NCT01508325|454086664|FG001|Overall Study|Withdrawal by Subject|9|||
126217242|NCT01508325|454086663|FG000|Overall Study|Protocol Violation|0|||
126217243|NCT01508325|454086664|FG001|Overall Study|Protocol Violation|3|||
126017158|NCT03086369|453356963|FG002|Overall Study|Physician Decision|0|||
126017159|NCT03086369|453356964|FG003|Overall Study|Physician Decision|1|||
126017160|NCT03086369|453356965|FG004|Overall Study|Physician Decision|2|||
126017161|NCT03086369|453356961|FG000|Overall Study|Withdrawal by Subject|0|||
126017162|NCT03086369|453356962|FG001|Overall Study|Withdrawal by Subject|0|||
126017163|NCT03086369|453356963|FG002|Overall Study|Withdrawal by Subject|0|||
126017164|NCT03086369|453356964|FG003|Overall Study|Withdrawal by Subject|5|||
126017165|NCT03086369|453356965|FG004|Overall Study|Withdrawal by Subject|3|||
126017166|NCT03086369|453356961|FG000|Overall Study|Progressive Disease|0|||
126017167|NCT03086369|453356962|FG001|Overall Study|Progressive Disease|0|||
126017168|NCT03086369|453356963|FG002|Overall Study|Progressive Disease|0|||
126017169|NCT03086369|453356964|FG003|Overall Study|Progressive Disease|1|||
126017170|NCT03086369|453356965|FG004|Overall Study|Progressive Disease|1|||
126017171|NCT04603924|453356968|FG000|Overall Study|Not Dosed|2|||
126017172|NCT04603924|453356969|FG001|Overall Study|Not Dosed|1|||
126017173|NCT04603924|453356968|FG000|Overall Study|Withdrawal by Subject|6|||
126017174|NCT04603924|453356969|FG001|Overall Study|Withdrawal by Subject|6|||
126017175|NCT04603924|453356968|FG000|Overall Study|Adverse Event|2|||
126017176|NCT04603924|453356969|FG001|Overall Study|Adverse Event|2|||
126017177|NCT01177670|453356977|FG000|Overall Study|Study Terminated|115|||
126017178|NCT01177670|453356977|FG000|Overall Study|Physician Decision|50|||
126017179|NCT01177670|453356977|FG000|Overall Study|Withdrawal by Subject|4|||
126017180|NCT01254019|453356980|FG000|Overall Study|Adverse Event|0|||
126017181|NCT01254019|453356981|FG001|Overall Study|Adverse Event|2|||
126017182|NCT01254019|453356980|FG000|Overall Study|Protocol Violation|1|||
126017183|NCT01254019|453356981|FG001|Overall Study|Protocol Violation|0|||
126017184|NCT01254019|453356980|FG000|Overall Study|Withdrawal by Subject|0|||
126017185|NCT01254019|453356981|FG001|Overall Study|Withdrawal by Subject|2|||
126017186|NCT03061474|453356982|FG000|Overall Study|Adverse Event|2|||
126017187|NCT03061474|453356983|FG001|Overall Study|Adverse Event|0|||
126017188|NCT03061474|453356982|FG000|Overall Study|Safety Risk|0|||
126017189|NCT03061474|453356983|FG001|Overall Study|Safety Risk|1|||
126017190|NCT03061474|453356982|FG000|Overall Study|Participant unwilling or unable to participate|0|||
126017191|NCT03061474|453356983|FG001|Overall Study|Participant unwilling or unable to participate|2|||
126017192|NCT03061474|453356982|FG000|Overall Study|Lost to Follow-up|0|||
126017193|NCT03061474|453356983|FG001|Overall Study|Lost to Follow-up|1|||
126017194|NCT00189202|453356984|FG000|Overall Study|Physician Decision|5|||
126017195|NCT00869323|453356989|FG000|Maintenance Therapy|concurrent illness|1|||
126017196|NCT01135511|453356991|FG000|Overall Study|Adverse Event|0|||
126017197|NCT01135511|453356992|FG001|Overall Study|Adverse Event|1|||
126017198|NCT01135511|453356993|FG002|Overall Study|Adverse Event|2|||
126017199|NCT01135511|453356994|FG003|Overall Study|Adverse Event|0|||
126017200|NCT01135511|453356995|FG004|Overall Study|Adverse Event|0|||
126017201|NCT01135511|453356996|FG005|Overall Study|Adverse Event|1|||
126017202|NCT01135511|453356997|FG006|Overall Study|Adverse Event|0|||
126017203|NCT01135511|453356998|FG007|Overall Study|Adverse Event|1|||
126017204|NCT01135511|453356999|FG008|Overall Study|Adverse Event|0|||
126017205|NCT01135511|453356991|FG000|Overall Study|Lack of Efficacy|0|||
126017206|NCT01135511|453356992|FG001|Overall Study|Lack of Efficacy|1|||
126017207|NCT01135511|453356993|FG002|Overall Study|Lack of Efficacy|1|||
126017208|NCT01135511|453356994|FG003|Overall Study|Lack of Efficacy|2|||
126017209|NCT01135511|453356995|FG004|Overall Study|Lack of Efficacy|0|||
126017210|NCT01135511|453356996|FG005|Overall Study|Lack of Efficacy|0|||
126017211|NCT01135511|453356997|FG006|Overall Study|Lack of Efficacy|0|||
126017212|NCT01135511|453356998|FG007|Overall Study|Lack of Efficacy|0|||
126017213|NCT01135511|453356999|FG008|Overall Study|Lack of Efficacy|0|||
126017214|NCT01135511|453356991|FG000|Overall Study|Protocol Violation|0|||
126017215|NCT01135511|453356992|FG001|Overall Study|Protocol Violation|0|||
126017216|NCT01135511|453356993|FG002|Overall Study|Protocol Violation|3|||
126017217|NCT01135511|453356994|FG003|Overall Study|Protocol Violation|0|||
126091772|NCT01214642|453628464|FG008|Overall Study|Physician Decision|0|||
126091773|NCT01214642|453628465|FG009|Overall Study|Physician Decision|0|||
126091774|NCT01214642|453628466|FG010|Overall Study|Physician Decision|0|||
126091775|NCT01214642|453628467|FG011|Overall Study|Physician Decision|2|||
126091776|NCT02336451|453628468|FG000|Overall Study|Adverse Event|1|||
126091777|NCT02336451|453628469|FG001|Overall Study|Adverse Event|2|||
126091778|NCT02336451|453628470|FG002|Overall Study|Adverse Event|0|||
126091779|NCT02336451|453628471|FG003|Overall Study|Adverse Event|6|||
126091780|NCT02336451|453628472|FG004|Overall Study|Adverse Event|4|||
126017218|NCT01135511|453356995|FG004|Overall Study|Protocol Violation|0|||
126017219|NCT01135511|453356996|FG005|Overall Study|Protocol Violation|0|||
126017220|NCT01135511|453356997|FG006|Overall Study|Protocol Violation|0|||
126017221|NCT01135511|453356998|FG007|Overall Study|Protocol Violation|0|||
126017222|NCT01135511|453356999|FG008|Overall Study|Protocol Violation|0|||
126017223|NCT01135511|453356991|FG000|Overall Study|Pregnancy|0|||
126091781|NCT02336451|453628468|FG000|Overall Study|Death|6|||
126017224|NCT01135511|453356992|FG001|Overall Study|Pregnancy|0|||
126017225|NCT01135511|453356993|FG002|Overall Study|Pregnancy|0|||
126017226|NCT01135511|453356994|FG003|Overall Study|Pregnancy|1|||
126091782|NCT02336451|453628469|FG001|Overall Study|Death|2|||
126017227|NCT01135511|453356995|FG004|Overall Study|Pregnancy|0|||
126217244|NCT01508325|454086663|FG000|Overall Study|Physician Decision|2|||
126217245|NCT01508325|454086664|FG001|Overall Study|Physician Decision|1|||
126217246|NCT01508325|454086663|FG000|Overall Study|Adverse Event|1|||
126217247|NCT01508325|454086664|FG001|Overall Study|Adverse Event|0|||
126217248|NCT01508325|454086663|FG000|Overall Study|Lost to Follow-up|5|||
126217249|NCT01508325|454086664|FG001|Overall Study|Lost to Follow-up|6|||
126217250|NCT01508325|454086663|FG000|Overall Study|Other|2|||
126217251|NCT01508325|454086664|FG001|Overall Study|Other|2|||
126217252|NCT04682639|454086665|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
126217253|NCT04682639|454086666|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
126217254|NCT04682639|454086667|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
126217255|NCT04682639|454086668|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
126217256|NCT04682639|454086669|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
126217257|NCT04682639|454086665|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
126217258|NCT04682639|454086666|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
126217259|NCT04682639|454086667|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
126217260|NCT04682639|454086668|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126217261|NCT04682639|454086669|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126217262|NCT04682639|454086665|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
126217263|NCT04682639|454086666|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126217264|NCT04682639|454086667|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126217265|NCT04682639|454086668|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126217266|NCT04682639|454086669|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126217267|NCT04682639|454086665|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
126217268|NCT04682639|454086666|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
126217269|NCT04682639|454086667|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
126217270|NCT04682639|454086668|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
126217271|NCT04682639|454086669|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
126217272|NCT04682639|454086665|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
126217273|NCT04682639|454086666|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
126217274|NCT04682639|454086667|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
126217275|NCT04682639|454086668|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
126217276|NCT04682639|454086669|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
126217277|NCT04682639|454086665|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
126217278|NCT04682639|454086666|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
126217279|NCT04682639|454086667|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
126217280|NCT04682639|454086668|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126217281|NCT04682639|454086669|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126217282|NCT04682639|454086665|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
126217283|NCT04682639|454086666|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
126217284|NCT04682639|454086667|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
126217285|NCT04682639|454086668|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
126217286|NCT04682639|454086669|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
126217287|NCT04682639|454086665|FG000|OLE Period (28 Weeks)|Other|1|||
126217288|NCT04682639|454086666|FG001|OLE Period (28 Weeks)|Other|2|||
126217289|NCT04682639|454086667|FG002|OLE Period (28 Weeks)|Other|0|||
126217290|NCT04682639|454086668|FG003|OLE Period (28 Weeks)|Other|0|||
126217291|NCT04682639|454086669|FG004|OLE Period (28 Weeks)|Other|1|||
126217292|NCT04682639|454086665|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
126217293|NCT04682639|454086666|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
126217294|NCT04682639|454086667|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
126217295|NCT04682639|454086668|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
126217296|NCT04682639|454086669|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
126217297|NCT04682639|454086665|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
126217298|NCT04682639|454086666|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
126217299|NCT04682639|454086667|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126217300|NCT04682639|454086668|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126217301|NCT04682639|454086669|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126217302|NCT04682639|454086665|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
126217303|NCT04682639|454086666|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
126217304|NCT04682639|454086667|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126217305|NCT04682639|454086668|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126217306|NCT04682639|454086669|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126017228|NCT01135511|453356996|FG005|Overall Study|Pregnancy|0|||
126017229|NCT01135511|453356997|FG006|Overall Study|Pregnancy|0|||
126017230|NCT01135511|453356998|FG007|Overall Study|Pregnancy|0|||
126217307|NCT04682639|454086665|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
126217308|NCT04682639|454086666|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
126017231|NCT01135511|453356999|FG008|Overall Study|Pregnancy|0|||
126217309|NCT04682639|454086667|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
126017232|NCT01135511|453356991|FG000|Overall Study|could not visit the clinic|0|||
126217310|NCT04682639|454086668|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
126217311|NCT04682639|454086669|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
126217312|NCT01392170|454086672|FG000|Overall Study|Withdrawal by Subject|1|||
126217313|NCT01392170|454086672|FG000|Overall Study|Ineligible|1|||
126217314|NCT03543046|454086676|FG000|Overall Study|Adverse Event|1|||
126217315|NCT03543046|454086677|FG001|Overall Study|Adverse Event|1|||
126217316|NCT03543046|454086676|FG000|Overall Study|Physician Decision|1|||
126217317|NCT03543046|454086677|FG001|Overall Study|Physician Decision|1|||
126217318|NCT03543046|454086676|FG000|Overall Study|Protocol Violation|1|||
126217319|NCT03543046|454086677|FG001|Overall Study|Protocol Violation|0|||
126217320|NCT01227954|454086687|FG000|Overall Study|Protocol Violation|6|||
126217321|NCT01227954|454086687|FG000|Overall Study|No protocol treatment|7|||
126217322|NCT02748616|454086689|FG000|Overall Study|Lost to Follow-up|1|||
126217323|NCT02748616|454086689|FG000|Overall Study|Withdrawal by Subject|2|||
126217324|NCT02748616|454086689|FG000|Overall Study|Physician Decision|2|||
126217325|NCT02748616|454086689|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
126217326|NCT01296152|454086690|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
126217327|NCT01414062|454086695|FG000|Overall Study|Lost to Follow-up|3|||
126217328|NCT01414062|454086696|FG001|Overall Study|Lost to Follow-up|2|||
126217329|NCT01414062|454086695|FG000|Overall Study|Left Country|1|||
126217330|NCT01414062|454086696|FG001|Overall Study|Left Country|1|||
126217331|NCT01414062|454086695|FG000|Overall Study|Family Disapproval|1|||
126217332|NCT01414062|454086696|FG001|Overall Study|Family Disapproval|0|||
126217333|NCT01414062|454086695|FG000|Overall Study|Withdrawal by Subject|0|||
126217334|NCT01414062|454086696|FG001|Overall Study|Withdrawal by Subject|1|||
126217335|NCT04057118|454086699|FG000|Overall Study|Adverse Event|1|||
126217336|NCT04057118|454086700|FG001|Overall Study|Adverse Event|0|||
126017233|NCT01135511|453356992|FG001|Overall Study|could not visit the clinic|1|||
126017234|NCT01135511|453356993|FG002|Overall Study|could not visit the clinic|2|||
126017235|NCT01135511|453356994|FG003|Overall Study|could not visit the clinic|0|||
126017236|NCT01135511|453356995|FG004|Overall Study|could not visit the clinic|0|||
126017237|NCT01135511|453356996|FG005|Overall Study|could not visit the clinic|0|||
126017238|NCT01135511|453356997|FG006|Overall Study|could not visit the clinic|0|||
126017239|NCT01135511|453356998|FG007|Overall Study|could not visit the clinic|0|||
126017240|NCT01135511|453356999|FG008|Overall Study|could not visit the clinic|0|||
126017241|NCT01135511|453356991|FG000|Overall Study|noncompliance with study drug taken|0|||
126017242|NCT01135511|453356992|FG001|Overall Study|noncompliance with study drug taken|0|||
126017243|NCT01135511|453356993|FG002|Overall Study|noncompliance with study drug taken|0|||
126017244|NCT01135511|453356994|FG003|Overall Study|noncompliance with study drug taken|0|||
126017245|NCT01135511|453356995|FG004|Overall Study|noncompliance with study drug taken|1|||
126017246|NCT01135511|453356996|FG005|Overall Study|noncompliance with study drug taken|0|||
126017247|NCT01135511|453356997|FG006|Overall Study|noncompliance with study drug taken|0|||
126017248|NCT01135511|453356998|FG007|Overall Study|noncompliance with study drug taken|0|||
126017249|NCT01135511|453356999|FG008|Overall Study|noncompliance with study drug taken|0|||
126017250|NCT01135511|453356991|FG000|Overall Study|Withdrawal by Subject|0|||
126017251|NCT01135511|453356992|FG001|Overall Study|Withdrawal by Subject|0|||
126017252|NCT01135511|453356993|FG002|Overall Study|Withdrawal by Subject|0|||
126017253|NCT01135511|453356994|FG003|Overall Study|Withdrawal by Subject|0|||
126017254|NCT01135511|453356995|FG004|Overall Study|Withdrawal by Subject|0|||
126017255|NCT01135511|453356996|FG005|Overall Study|Withdrawal by Subject|0|||
126017256|NCT01135511|453356997|FG006|Overall Study|Withdrawal by Subject|1|||
126017257|NCT01135511|453356998|FG007|Overall Study|Withdrawal by Subject|0|||
126017258|NCT01135511|453356999|FG008|Overall Study|Withdrawal by Subject|1|||
126017259|NCT05082935|453357008|FG000|Overall Study|Lost to Follow-up|549|||
126017260|NCT05082935|453357009|FG001|Overall Study|Lost to Follow-up|631|||
126017261|NCT05082935|453357008|FG000|Overall Study|Withdrawal by Subject|27|||
126017262|NCT05082935|453357009|FG001|Overall Study|Withdrawal by Subject|58|||
126017263|NCT02957136|453357010|FG000|Overall Study|Withdrawal by Subject|2|||
126017264|NCT02957136|453357011|FG001|Overall Study|Withdrawal by Subject|1|||
126017265|NCT01444417|453357012|FG000|Overall Study|Ineligibility Determined|0|||
126017266|NCT01444417|453357013|FG001|Overall Study|Ineligibility Determined|1|||
126217337|NCT04057118|454086701|FG002|Overall Study|Adverse Event|1|||
126217338|NCT04057118|454086702|FG003|Overall Study|Adverse Event|1|||
126217339|NCT04057118|454086699|FG000|Overall Study|Physician Decision|0|||
126017267|NCT01444417|453357012|FG000|Overall Study|Withdrawal by Subject|2|||
126017268|NCT01444417|453357013|FG001|Overall Study|Withdrawal by Subject|0|||
126017269|NCT02200770|453357014|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
126017270|NCT02200770|453357015|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
126217340|NCT04057118|454086700|FG001|Overall Study|Physician Decision|0|||
126217341|NCT04057118|454086701|FG002|Overall Study|Physician Decision|1|||
126217342|NCT04057118|454086702|FG003|Overall Study|Physician Decision|1|||
126091783|NCT02336451|453628470|FG002|Overall Study|Death|3|||
126217343|NCT04057118|454086699|FG000|Overall Study|Withdrawal by Subject|2|||
126217344|NCT04057118|454086700|FG001|Overall Study|Withdrawal by Subject|2|||
126217345|NCT04057118|454086701|FG002|Overall Study|Withdrawal by Subject|0|||
126217346|NCT04057118|454086702|FG003|Overall Study|Withdrawal by Subject|2|||
126217347|NCT04057118|454086699|FG000|Overall Study|Not Specific|0|||
126217348|NCT04057118|454086700|FG001|Overall Study|Not Specific|0|||
126217349|NCT04057118|454086701|FG002|Overall Study|Not Specific|1|||
126217350|NCT04057118|454086702|FG003|Overall Study|Not Specific|1|||
126217351|NCT02787785|454086705|FG000|Overall Study|Death|3|||
126217352|NCT02787785|454086706|FG001|Overall Study|Death|4|||
126217353|NCT02787785|454086705|FG000|Overall Study|Lost to Follow-up|1|||
126217354|NCT02787785|454086706|FG001|Overall Study|Lost to Follow-up|1|||
126217355|NCT02787785|454086705|FG000|Overall Study|Withdrawal by Subject|0|||
126217356|NCT02787785|454086706|FG001|Overall Study|Withdrawal by Subject|5|||
126217357|NCT04333199|454086709|FG000|Evaluated Patients|Lost to Follow-up|0|||
126217358|NCT04333199|454086710|FG001|Evaluated Patients|Lost to Follow-up|1|||
126217359|NCT04333199|454086711|FG002|Evaluated Patients|Lost to Follow-up|2|||
126091784|NCT02336451|453628471|FG003|Overall Study|Death|6|||
126091785|NCT02336451|453628472|FG004|Overall Study|Death|6|||
126091786|NCT02336451|453628468|FG000|Overall Study|Physician Decision|9|||
126091787|NCT02336451|453628469|FG001|Overall Study|Physician Decision|6|||
126091788|NCT02336451|453628470|FG002|Overall Study|Physician Decision|7|||
126091789|NCT02336451|453628471|FG003|Overall Study|Physician Decision|16|||
126091790|NCT02336451|453628472|FG004|Overall Study|Physician Decision|3|||
126091791|NCT02336451|453628468|FG000|Overall Study|Progressive disease|23|||
126091792|NCT02336451|453628469|FG001|Overall Study|Progressive disease|26|||
126091793|NCT02336451|453628470|FG002|Overall Study|Progressive disease|2|||
126091794|NCT02336451|453628471|FG003|Overall Study|Progressive disease|14|||
126091795|NCT02336451|453628472|FG004|Overall Study|Progressive disease|4|||
126091796|NCT02336451|453628468|FG000|Overall Study|Protocol Violation|1|||
126091797|NCT02336451|453628469|FG001|Overall Study|Protocol Violation|0|||
126091798|NCT02336451|453628470|FG002|Overall Study|Protocol Violation|0|||
126091799|NCT02336451|453628471|FG003|Overall Study|Protocol Violation|0|||
126091800|NCT02336451|453628472|FG004|Overall Study|Protocol Violation|0|||
126091801|NCT02336451|453628468|FG000|Overall Study|Patient/guardian decision|2|||
126091802|NCT02336451|453628469|FG001|Overall Study|Patient/guardian decision|4|||
126091803|NCT02336451|453628470|FG002|Overall Study|Patient/guardian decision|0|||
126091804|NCT02336451|453628471|FG003|Overall Study|Patient/guardian decision|2|||
126091805|NCT02336451|453628472|FG004|Overall Study|Patient/guardian decision|1|||
126091806|NCT02344290|453628477|FG000|Overall Study|Withdrawal by Subject|315|||
126091807|NCT02344290|453628478|FG001|Overall Study|Withdrawal by Subject|324|||
126091808|NCT02344290|453628477|FG000|Overall Study|Lost to Follow-up|258|||
126091809|NCT02344290|453628478|FG001|Overall Study|Lost to Follow-up|249|||
126091810|NCT02344290|453628477|FG000|Overall Study|Unable to get to clinic|69|||
126091811|NCT02344290|453628478|FG001|Overall Study|Unable to get to clinic|60|||
126091812|NCT02344290|453628477|FG000|Overall Study|Physician Decision|25|||
126091813|NCT02344290|453628478|FG001|Overall Study|Physician Decision|25|||
126091814|NCT02344290|453628477|FG000|Overall Study|Site Closure|15|||
126091815|NCT02344290|453628478|FG001|Overall Study|Site Closure|19|||
126091816|NCT02344290|453628477|FG000|Overall Study|Other|5|||
126091817|NCT02344290|453628478|FG001|Overall Study|Other|3|||
126091818|NCT04998812|453628479|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
126091819|NCT04998812|453628480|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
126091820|NCT04998812|453628479|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
126091821|NCT04998812|453628480|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
126091822|NCT04998812|453628479|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
126091823|NCT04998812|453628480|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
126091824|NCT04998812|453628479|FG000|Vaccination Period|Ongoing in study|23|||
126091825|NCT04998812|453628480|FG001|Vaccination Period|Ongoing in study|23|||
126091826|NCT03826030|453628481|FG000|Overall Study|Withdrawal by Subject|2|||
126091827|NCT03826030|453628482|FG001|Overall Study|Withdrawal by Subject|0|||
126091828|NCT03826030|453628483|FG002|Overall Study|Withdrawal by Subject|1|||
126091829|NCT03826030|453628481|FG000|Overall Study|Lost to Follow-up|1|||
126091830|NCT03826030|453628482|FG001|Overall Study|Lost to Follow-up|1|||
126091831|NCT03826030|453628483|FG002|Overall Study|Lost to Follow-up|1|||
126091832|NCT03826030|453628481|FG000|Overall Study|Too busy to return for visits|1|||
126091833|NCT03826030|453628482|FG001|Overall Study|Too busy to return for visits|0|||
126091834|NCT03826030|453628483|FG002|Overall Study|Too busy to return for visits|0|||
126091835|NCT04893460|453628488|FG000|Overall Study|Lost to Follow-up|18|||
126091836|NCT05718466|453630416|FG000|Overall Study|Withdrawal by Subject|1|||
126091837|NCT05718466|453630417|FG001|Overall Study|Withdrawal by Subject|2|||
126091838|NCT05718466|453630416|FG000|Overall Study|Death|0|||
126091839|NCT05718466|453630417|FG001|Overall Study|Death|1|||
126091840|NCT01732822|453630422|FG000|Overall Study|Withdrawal by Subject|123|||
126091841|NCT01732822|453630423|FG001|Overall Study|Withdrawal by Subject|113|||
126091842|NCT01183260|453630424|FG000|Overall Study|Intraop screen failure|2|||
126091843|NCT01183260|453630425|FG001|Overall Study|Intraop screen failure|0|||
126091844|NCT01183260|453630424|FG000|Overall Study|Withdrawal by Subject|1|||
126217360|NCT01155284|454086720|FG000|Overall Study|Withdrawal by Subject|4|||
126217361|NCT01155284|454086721|FG001|Overall Study|Withdrawal by Subject|3|||
126217362|NCT01155284|454086720|FG000|Overall Study|Lost to Follow-up|1|||
126217363|NCT01155284|454086721|FG001|Overall Study|Lost to Follow-up|2|||
126217364|NCT01155284|454086720|FG000|Overall Study|Physician Decision|1|||
126217365|NCT01155284|454086721|FG001|Overall Study|Physician Decision|0|||
126217366|NCT01155284|454086720|FG000|Overall Study|Adverse Event|1|||
126217367|NCT01155284|454086721|FG001|Overall Study|Adverse Event|0|||
126217368|NCT01766310|454086722|FG000|Overall Study|Lost to Follow-up|1|||
126217369|NCT01766310|454086723|FG001|Overall Study|Lost to Follow-up|3|||
126217370|NCT01556490|454086732|FG000|Randomized Patients Summary|Protocol Violation|22|||
126217371|NCT01556490|454086733|FG001|Randomized Patients Summary|Protocol Violation|23|||
126217372|NCT01556490|454086732|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
126217373|NCT01556490|454086733|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
126217374|NCT04529499|454086739|FG000|Overall Study|Withdrawal by Subject|9|||
126217375|NCT04529499|454086740|FG001|Overall Study|Withdrawal by Subject|11|||
126217376|NCT04529499|454086739|FG000|Overall Study|Physician Decision|1|||
126217377|NCT04529499|454086740|FG001|Overall Study|Physician Decision|2|||
126217378|NCT04529499|454086739|FG000|Overall Study|Adverse Event|4|||
126217379|NCT04529499|454086740|FG001|Overall Study|Adverse Event|4|||
126217380|NCT04529499|454086739|FG000|Overall Study|Death|14|||
126217381|NCT04529499|454086740|FG001|Overall Study|Death|11|||
126217382|NCT04529499|454086739|FG000|Overall Study|Lost to Follow-up|1|||
126217383|NCT04529499|454086740|FG001|Overall Study|Lost to Follow-up|1|||
126217384|NCT04529499|454086739|FG000|Overall Study|Others|7|||
126217385|NCT04529499|454086740|FG001|Overall Study|Others|11|||
126217386|NCT04449354|454086741|FG000|Overall Study|Withdrawal by Subject|1|||
126217387|NCT05789420|454086742|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
126217388|NCT05789420|454086742|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
126217389|NCT02720094|454086743|FG000|Overall Study|Scheduled exit visit/end of study|2|||
126217390|NCT02720094|454086744|FG001|Overall Study|Scheduled exit visit/end of study|1|||
126217391|NCT02720094|454086743|FG000|Overall Study|Death|4|||
126217392|NCT02720094|454086744|FG001|Overall Study|Death|7|||
126217393|NCT02720094|454086743|FG000|Overall Study|Withdrawal by Subject|55|||
126217394|NCT02720094|454086744|FG001|Overall Study|Withdrawal by Subject|56|||
126217395|NCT02720094|454086743|FG000|Overall Study|Lost to Follow-up|2|||
126217396|NCT02720094|454086744|FG001|Overall Study|Lost to Follow-up|7|||
126217397|NCT02720094|454086743|FG000|Overall Study|Physician Decision|1|||
126217398|NCT02720094|454086744|FG001|Overall Study|Physician Decision|3|||
126217399|NCT02720094|454086743|FG000|Overall Study|Inappropriate enrollment|1|||
126217400|NCT02720094|454086744|FG001|Overall Study|Inappropriate enrollment|3|||
126217401|NCT02720094|454086743|FG000|Overall Study|Ongoing|2210|||
126217402|NCT02720094|454086744|FG001|Overall Study|Ongoing|2203|||
126217403|NCT02720094|454086743|FG000|Overall Study|Relocation|1|||
126217404|NCT02720094|454086744|FG001|Overall Study|Relocation|1|||
126017271|NCT02200770|453357014|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
126017272|NCT02200770|453357015|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
126017273|NCT02200770|453357014|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
126017274|NCT02200770|453357015|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
126217405|NCT01220128|454086745|FG000|Overall Study|Progressive disease|0|||
126217406|NCT01220128|454086746|FG001|Overall Study|Progressive disease|0|||
126217407|NCT01220128|454086747|FG002|Overall Study|Progressive disease|2|||
126217408|NCT01220128|454086748|FG003|Overall Study|Progressive disease|0|||
126217409|NCT01220128|454086749|FG004|Overall Study|Progressive disease|0|||
126217410|NCT01220128|454086750|FG005|Overall Study|Progressive disease|0|||
126017275|NCT02200770|453357014|FG000|Randomized-controlled Period (RCP)|Other|1|||
126217411|NCT01220128|454086751|FG006|Overall Study|Progressive disease|0|||
126017276|NCT02200770|453357015|FG001|Randomized-controlled Period (RCP)|Other|2|||
126217412|NCT01220128|454086745|FG000|Overall Study|Sponsor study termination|0|||
126217413|NCT01220128|454086746|FG001|Overall Study|Sponsor study termination|1|||
126217414|NCT01220128|454086747|FG002|Overall Study|Sponsor study termination|0|||
126017277|NCT02200770|453357014|FG000|Open-label Period (OLP)|Adverse Event|1|||
126017278|NCT02200770|453357015|FG001|Open-label Period (OLP)|Adverse Event|2|||
126017279|NCT02200770|453357014|FG000|Open-label Period (OLP)|Death|1|||
126017280|NCT02200770|453357015|FG001|Open-label Period (OLP)|Death|2|||
126017281|NCT02200770|453357014|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
126017282|NCT02200770|453357015|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
126017283|NCT02200770|453357014|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
126017284|NCT02200770|453357015|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
126017285|NCT02200770|453357014|FG000|Open-label Period (OLP)|Other|6|||
126017286|NCT02200770|453357015|FG001|Open-label Period (OLP)|Other|15|||
126017287|NCT01595061|453357020|FG000|Overall Study|Never Treated|3|||
126017288|NCT01595061|453357020|FG000|Overall Study|Inadequate Pathology|1|||
126017289|NCT00457743|453357023|FG000|Overall Study|Adverse Event|0|||
126091845|NCT01183260|453630425|FG001|Overall Study|Withdrawal by Subject|1|||
126091846|NCT01183260|453630424|FG000|Overall Study|Revised within 30 days|0|||
126091847|NCT01183260|453630425|FG001|Overall Study|Revised within 30 days|1|||
126091848|NCT01183260|453630424|FG000|Overall Study|Death|1|||
126091849|NCT01183260|453630425|FG001|Overall Study|Death|0|||
126091850|NCT01255631|453630426|FG000|Overall Study|poor enrollment, no data analyzed|9|||
126091851|NCT01255631|453630427|FG001|Overall Study|poor enrollment, no data analyzed|6|||
126091852|NCT02815579|453630437|FG000|Overall Study|Non-payment of loan down-payment|16|||
126091853|NCT02815579|453630438|FG001|Overall Study|Non-payment of loan down-payment|0|||
126091854|NCT02815579|453630437|FG000|Overall Study|Withdrawal by Subject|7|||
126091855|NCT02815579|453630438|FG001|Overall Study|Withdrawal by Subject|1|||
126091856|NCT02815579|453630437|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
126091857|NCT02815579|453630438|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
126091858|NCT02815579|453630437|FG000|Overall Study|Lost to Follow-up|7|||
126091859|NCT02815579|453630438|FG001|Overall Study|Lost to Follow-up|4|||
126091860|NCT02815579|453630437|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
126091861|NCT02815579|453630438|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
126091862|NCT02815579|453630437|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
126091863|NCT02815579|453630438|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
126091864|NCT02815579|453630437|FG000|Overall Study|Death|5|||
126091865|NCT02815579|453630438|FG001|Overall Study|Death|4|||
126091866|NCT02815579|453630437|FG000|Overall Study|Imprisoned|0|||
126091867|NCT02815579|453630438|FG001|Overall Study|Imprisoned|2|||
126091868|NCT02815579|453630437|FG000|Overall Study|Did not meet enrollment criteria|0|||
126091869|NCT02815579|453630438|FG001|Overall Study|Did not meet enrollment criteria|1|||
126091870|NCT00264303|453630439|FG000|Overall Study|Adverse Event|4|||
126091871|NCT00264303|453630440|FG001|Overall Study|Adverse Event|3|||
126091872|NCT00264303|453630439|FG000|Overall Study|Lack of Efficacy|10|||
126091873|NCT00264303|453630440|FG001|Overall Study|Lack of Efficacy|13|||
126091874|NCT00264303|453630439|FG000|Overall Study|Lost to Follow-up|3|||
126091875|NCT00264303|453630440|FG001|Overall Study|Lost to Follow-up|3|||
126091876|NCT00264303|453630439|FG000|Overall Study|Withdrawal by Subject|2|||
126091877|NCT00264303|453630440|FG001|Overall Study|Withdrawal by Subject|3|||
126091878|NCT00264303|453630439|FG000|Overall Study|Various reasons listed in study report|6|||
126091879|NCT00264303|453630440|FG001|Overall Study|Various reasons listed in study report|7|||
126091880|NCT02389452|453630441|FG000|Overall Study|Lost to Follow-up|13|||
126091881|NCT02389452|453630441|FG000|Overall Study|Adverse Event|1|||
126091882|NCT02389452|453630441|FG000|Overall Study|Withdrawal by Subject|5|||
126091883|NCT02389452|453630441|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
126091884|NCT02311673|453630442|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
126091885|NCT02311673|453630443|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
126091886|NCT02311673|453630444|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
126091887|NCT02311673|453630445|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
126091888|NCT00414908|453630451|FG000|Overall Study|Protocol Violation|1|||
126091889|NCT00414908|453630452|FG001|Overall Study|Protocol Violation|1|||
126091890|NCT00818168|453630453|FG000|Overall Study|Lack of Efficacy|18|||
126091891|NCT00818168|453630453|FG000|Overall Study|Pregnancy|2|||
126091892|NCT00818168|453630453|FG000|Overall Study|Withdrawal by Subject|16|||
126091893|NCT00818168|453630453|FG000|Overall Study|Lost to Follow-up|7|||
126091894|NCT00818168|453630453|FG000|Overall Study|Adverse Event|19|||
126091895|NCT00818168|453630453|FG000|Overall Study|Reason for Non-completion Not reported|6|||
126091896|NCT00818168|453630453|FG000|Overall Study|Participant Moved|2|||
126091897|NCT02040259|453630454|FG000|Overall Study|Death|280|||
126091898|NCT02040259|453630454|FG000|Overall Study|Lost to Follow-up|76|||
126091899|NCT02040259|453630454|FG000|Overall Study|Assessment not completed|3|||
126091900|NCT02040259|453630454|FG000|Overall Study|Withdrawal by Subject|4|||
126017290|NCT00457743|453357024|FG001|Overall Study|Adverse Event|4|||
126017291|NCT00457743|453357025|FG002|Overall Study|Adverse Event|0|||
126017292|NCT00457743|453357023|FG000|Overall Study|Lack of Efficacy|3|||
126091901|NCT04476251|453630455|FG000|Overall Study|Not treated|1|||
126091902|NCT00316602|453630465|FG000|Overall Study|Withdrawal by Subject|3|||
126217415|NCT01220128|454086748|FG003|Overall Study|Sponsor study termination|0|||
126217416|NCT01220128|454086749|FG004|Overall Study|Sponsor study termination|0|||
126217417|NCT01220128|454086750|FG005|Overall Study|Sponsor study termination|0|||
126217418|NCT01220128|454086751|FG006|Overall Study|Sponsor study termination|1|||
126217419|NCT01220128|454086745|FG000|Overall Study|Adverse event, serious fatal|2|||
126217420|NCT01220128|454086746|FG001|Overall Study|Adverse event, serious fatal|0|||
126217421|NCT01220128|454086747|FG002|Overall Study|Adverse event, serious fatal|0|||
126217422|NCT01220128|454086748|FG003|Overall Study|Adverse event, serious fatal|0|||
126217423|NCT01220128|454086749|FG004|Overall Study|Adverse event, serious fatal|0|||
126217424|NCT01220128|454086750|FG005|Overall Study|Adverse event, serious fatal|0|||
126217425|NCT01220128|454086751|FG006|Overall Study|Adverse event, serious fatal|1|||
126217426|NCT01220128|454086745|FG000|Overall Study|Adverse event, non-fatal|1|||
126217427|NCT01220128|454086746|FG001|Overall Study|Adverse event, non-fatal|0|||
126217428|NCT01220128|454086747|FG002|Overall Study|Adverse event, non-fatal|0|||
126217429|NCT01220128|454086748|FG003|Overall Study|Adverse event, non-fatal|0|||
126217430|NCT01220128|454086749|FG004|Overall Study|Adverse event, non-fatal|0|||
126217431|NCT01220128|454086750|FG005|Overall Study|Adverse event, non-fatal|0|||
126217432|NCT01220128|454086751|FG006|Overall Study|Adverse event, non-fatal|3|||
126217433|NCT01220128|454086745|FG000|Overall Study|Other|0|||
126217434|NCT01220128|454086746|FG001|Overall Study|Other|0|||
126217435|NCT01220128|454086747|FG002|Overall Study|Other|1|||
126217436|NCT01220128|454086748|FG003|Overall Study|Other|0|||
126217437|NCT01220128|454086749|FG004|Overall Study|Other|0|||
126217438|NCT01220128|454086750|FG005|Overall Study|Other|0|||
126217439|NCT01220128|454086751|FG006|Overall Study|Other|0|||
126217440|NCT01220128|454086745|FG000|Overall Study|Consent withdrawn by subject|1|||
126217441|NCT01220128|454086746|FG001|Overall Study|Consent withdrawn by subject|0|||
126217442|NCT01220128|454086747|FG002|Overall Study|Consent withdrawn by subject|0|||
126217443|NCT01220128|454086748|FG003|Overall Study|Consent withdrawn by subject|0|||
126217444|NCT01220128|454086749|FG004|Overall Study|Consent withdrawn by subject|0|||
126217445|NCT01220128|454086750|FG005|Overall Study|Consent withdrawn by subject|0|||
126217446|NCT01220128|454086751|FG006|Overall Study|Consent withdrawn by subject|0|||
126217447|NCT02913261|454086752|FG000|Overall Study|Technical problems|0|||
126217448|NCT02913261|454086753|FG001|Overall Study|Technical problems|1|||
126217449|NCT02913261|454086752|FG000|Overall Study|Lack of Efficacy|32|||
126217450|NCT02913261|454086753|FG001|Overall Study|Lack of Efficacy|69|||
126217451|NCT02913261|454086752|FG000|Overall Study|Adverse Event|27|||
126217452|NCT02913261|454086753|FG001|Overall Study|Adverse Event|5|||
126217453|NCT02913261|454086752|FG000|Overall Study|Death|25|||
126217454|NCT02913261|454086753|FG001|Overall Study|Death|22|||
126217455|NCT02913261|454086752|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
126217456|NCT02913261|454086753|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
126217457|NCT02913261|454086752|FG000|Overall Study|Disease relapse|8|||
126217458|NCT02913261|454086753|FG001|Overall Study|Disease relapse|13|||
126217459|NCT02913261|454086752|FG000|Overall Study|Physician Decision|8|||
126217460|NCT02913261|454086753|FG001|Overall Study|Physician Decision|9|||
126217461|NCT02913261|454086752|FG000|Overall Study|Subject/guardian decision|4|||
126217462|NCT02913261|454086753|FG001|Overall Study|Subject/guardian decision|6|||
126217463|NCT02913261|454086752|FG000|Overall Study|Graft loss|2|||
126217464|NCT02913261|454086753|FG001|Overall Study|Graft loss|0|||
126217465|NCT02340078|454086754|FG000|Overall Study|Protocol Violation|1|||
126217466|NCT01311505|454086755|FG000|First Intervention Period|Protocol Violation|0|||
126217467|NCT01311505|454086756|FG001|First Intervention Period|Protocol Violation|1|||
126217468|NCT00567996|454086760|FG000|Overall Study|Adverse Event|18|||
126217469|NCT00567996|454086761|FG001|Overall Study|Adverse Event|16|||
126017293|NCT00457743|453357024|FG001|Overall Study|Lack of Efficacy|23|||
126017294|NCT00457743|453357025|FG002|Overall Study|Lack of Efficacy|3|||
126217470|NCT00567996|454086762|FG002|Overall Study|Adverse Event|13|||
126217471|NCT00567996|454086760|FG000|Overall Study|Protocol Deviation|9|||
126217472|NCT00567996|454086761|FG001|Overall Study|Protocol Deviation|11|||
126217473|NCT00567996|454086762|FG002|Overall Study|Protocol Deviation|13|||
126217474|NCT00567996|454086760|FG000|Overall Study|Withdrawal by Subject|8|||
126217475|NCT00567996|454086761|FG001|Overall Study|Withdrawal by Subject|12|||
126217476|NCT00567996|454086762|FG002|Overall Study|Withdrawal by Subject|22|||
126217477|NCT00567996|454086760|FG000|Overall Study|Abnormal Lab value(s)|2|||
126217478|NCT00567996|454086761|FG001|Overall Study|Abnormal Lab value(s)|1|||
126017295|NCT00566527|453357026|FG000|Overall Study|Reason not provided|3|||
126217479|NCT00567996|454086762|FG002|Overall Study|Abnormal Lab value(s)|2|||
126217480|NCT00567996|454086760|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126217481|NCT00567996|454086761|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126217482|NCT00567996|454086762|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126217483|NCT00567996|454086760|FG000|Overall Study|Lost to Follow-up|2|||
126217484|NCT00567996|454086761|FG001|Overall Study|Lost to Follow-up|5|||
126217485|NCT00567996|454086762|FG002|Overall Study|Lost to Follow-up|2|||
126217486|NCT00567996|454086760|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126217487|NCT00567996|454086761|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126217488|NCT00567996|454086762|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
126217489|NCT00567996|454086760|FG000|Overall Study|Administrative problems|1|||
126217490|NCT00567996|454086761|FG001|Overall Study|Administrative problems|1|||
126217491|NCT00567996|454086762|FG002|Overall Study|Administrative problems|0|||
126217492|NCT00567996|454086760|FG000|Overall Study|Death|1|||
126217493|NCT00567996|454086761|FG001|Overall Study|Death|0|||
126217494|NCT00567996|454086762|FG002|Overall Study|Death|2|||
126217495|NCT00567996|454086760|FG000|Overall Study|Patient's inability to use the device|0|||
126217496|NCT00567996|454086761|FG001|Overall Study|Patient's inability to use the device|1|||
126217497|NCT00567996|454086762|FG002|Overall Study|Patient's inability to use the device|0|||
126217498|NCT02524665|454086765|FG000|Overall Study|Lost to Follow-up|1|||
126217499|NCT03022799|454086766|FG000|Overall Study|Adverse Event|0|||
126217500|NCT03022799|454086767|FG001|Overall Study|Adverse Event|0|||
126217501|NCT03022799|454086768|FG002|Overall Study|Adverse Event|0|||
126217502|NCT03022799|454086769|FG003|Overall Study|Adverse Event|0|||
126217503|NCT03022799|454086770|FG004|Overall Study|Adverse Event|0|||
126217504|NCT03022799|454086771|FG005|Overall Study|Adverse Event|0|||
126217505|NCT03022799|454086772|FG006|Overall Study|Adverse Event|0|||
126217506|NCT03022799|454086773|FG007|Overall Study|Adverse Event|0|||
126217507|NCT03022799|454086774|FG008|Overall Study|Adverse Event|0|||
126217508|NCT03022799|454086775|FG009|Overall Study|Adverse Event|1|||
126217509|NCT03022799|454086776|FG010|Overall Study|Adverse Event|1|||
126217510|NCT03022799|454086777|FG011|Overall Study|Adverse Event|0|||
126217511|NCT03022799|454086778|FG012|Overall Study|Adverse Event|0|||
126217512|NCT00883129|454086781|FG000|Overall Study|Adverse Event|7|||
126217513|NCT00883129|454086782|FG001|Overall Study|Adverse Event|15|||
126217514|NCT00883129|454086781|FG000|Overall Study|Withdrawal by Subject|8|||
126217515|NCT00883129|454086782|FG001|Overall Study|Withdrawal by Subject|9|||
126217516|NCT00883129|454086781|FG000|Overall Study|Non-compliance|3|||
126217517|NCT00883129|454086782|FG001|Overall Study|Non-compliance|6|||
126217518|NCT00883129|454086781|FG000|Overall Study|Lost to Follow-up|1|||
126217519|NCT00883129|454086782|FG001|Overall Study|Lost to Follow-up|2|||
126217520|NCT00883129|454086781|FG000|Overall Study|Death|1|||
126217521|NCT00883129|454086782|FG001|Overall Study|Death|2|||
126217522|NCT00883129|454086781|FG000|Overall Study|Defined Treatment Failure|0|||
126217523|NCT00883129|454086782|FG001|Overall Study|Defined Treatment Failure|2|||
126217524|NCT03273257|454086784|FG000|Overall Study|Death|0|||
126217525|NCT03273257|454086785|FG001|Overall Study|Death|1|||
126217526|NCT03273257|454086784|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
126217527|NCT03273257|454086785|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
126217528|NCT03273257|454086784|FG000|Overall Study|Study terminated|3|||
126217529|NCT03273257|454086785|FG001|Overall Study|Study terminated|2|||
126217530|NCT00759759|454086787|FG000|Overall Study|didn't return for period 2|1|||
126217531|NCT00759759|454086788|FG001|Overall Study|didn't return for period 2|0|||
126217532|NCT00759759|454086787|FG000|Overall Study|Didn't receive drug in period 2|1|||
126217533|NCT00759759|454086788|FG001|Overall Study|Didn't receive drug in period 2|0|||
126217534|NCT00759759|454086787|FG000|Overall Study|Withdrawal by Subject|2|||
126217535|NCT00759759|454086788|FG001|Overall Study|Withdrawal by Subject|1|||
126217536|NCT03911960|454088434|FG000|Overall Study|Lost to Follow-up|5|||
126217537|NCT03911960|454088435|FG001|Overall Study|Lost to Follow-up|3|||
126217538|NCT00391092|454088436|FG000|Overall Study|Death|78|||
126217539|NCT00391092|454088437|FG001|Overall Study|Death|81|||
126091903|NCT00316602|453630466|FG001|Overall Study|Withdrawal by Subject|2|||
126091904|NCT00316602|453630465|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
126091905|NCT00316602|453630466|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
126091906|NCT00316602|453630465|FG000|Overall Study|Adverse Event|1|||
126091907|NCT00316602|453630466|FG001|Overall Study|Adverse Event|0|||
126091908|NCT00316602|453630465|FG000|Overall Study|Other|3|||
126091909|NCT00316602|453630466|FG001|Overall Study|Other|6|||
126091910|NCT00626990|453630467|FG000|Overall Study|Lack of Efficacy|6|||
126091911|NCT00626990|453630468|FG001|Overall Study|Lack of Efficacy|7|||
126217540|NCT00391092|454088436|FG000|Overall Study|Lost to Follow-up|13|||
126217541|NCT00391092|454088437|FG001|Overall Study|Lost to Follow-up|18|||
126217542|NCT00391092|454088436|FG000|Overall Study|Alive on treatment|29|||
126217543|NCT00391092|454088437|FG001|Overall Study|Alive on treatment|33|||
126091912|NCT00626990|453630469|FG002|Overall Study|Lack of Efficacy|49|||
126091913|NCT00626990|453630470|FG003|Overall Study|Lack of Efficacy|40|||
126217544|NCT00391092|454088436|FG000|Overall Study|Alive in follow-up|88|||
126217545|NCT00391092|454088437|FG001|Overall Study|Alive in follow-up|84|||
126217546|NCT02239692|454088438|FG000|Overall Study|Incomplete colonoscopy|1|||
126217547|NCT02239692|454088439|FG001|Overall Study|Incomplete colonoscopy|2|||
126217548|NCT02239692|454088438|FG000|Overall Study|Adverse Event|0|||
126217549|NCT02239692|454088439|FG001|Overall Study|Adverse Event|1|||
126217550|NCT02239692|454088438|FG000|Overall Study|Physician Decision|0|||
126217551|NCT02239692|454088439|FG001|Overall Study|Physician Decision|1|||
126217552|NCT02239692|454088438|FG000|Overall Study|Lost to Follow-up|1|||
126217553|NCT02239692|454088439|FG001|Overall Study|Lost to Follow-up|4|||
126217554|NCT02239692|454088438|FG000|Overall Study|Withdrawal by Subject|3|||
126217555|NCT02239692|454088439|FG001|Overall Study|Withdrawal by Subject|5|||
126217556|NCT02239692|454088438|FG000|Overall Study|Other reason|1|||
126217557|NCT02239692|454088439|FG001|Overall Study|Other reason|0|||
126217558|NCT00297492|454088441|FG000|Set Quit Date|Lost to Follow-up|7|||
126217559|NCT00297492|454088442|FG001|Set Quit Date|Lost to Follow-up|13|||
126217560|NCT00297492|454088443|FG002|Set Quit Date|Lost to Follow-up|5|||
126217561|NCT00297492|454088441|FG000|6 Month Follow-up|Lost to Follow-up|63|||
126217562|NCT00297492|454088442|FG001|6 Month Follow-up|Lost to Follow-up|49|||
126217563|NCT00297492|454088443|FG002|6 Month Follow-up|Lost to Follow-up|27|||
126217564|NCT01614925|454088444|FG000|Overall Study|Withdrawal by Subject|1|||
126217565|NCT01614925|454088445|FG001|Overall Study|Withdrawal by Subject|0|||
126217566|NCT01614925|454088444|FG000|Overall Study|Protocol Violation|3|||
126217567|NCT01614925|454088445|FG001|Overall Study|Protocol Violation|2|||
126217568|NCT02437890|454088450|FG000|Overall Study|Non-compliance to study drug|0|||
126217569|NCT02437890|454088451|FG001|Overall Study|Non-compliance to study drug|1|||
126217570|NCT02437890|454088452|FG002|Overall Study|Non-compliance to study drug|0|||
126217571|NCT02437890|454088453|FG003|Overall Study|Non-compliance to study drug|0|||
126217572|NCT02437890|454088454|FG004|Overall Study|Non-compliance to study drug|1|||
126217573|NCT02437890|454088450|FG000|Overall Study|Sponsor's decision|1|||
126217574|NCT02437890|454088451|FG001|Overall Study|Sponsor's decision|1|||
126217575|NCT02437890|454088452|FG002|Overall Study|Sponsor's decision|4|||
126217576|NCT02437890|454088453|FG003|Overall Study|Sponsor's decision|0|||
126217577|NCT02437890|454088454|FG004|Overall Study|Sponsor's decision|2|||
126217578|NCT02437890|454088450|FG000|Overall Study|Physician Decision|0|||
126217579|NCT02437890|454088451|FG001|Overall Study|Physician Decision|0|||
126017296|NCT00566527|453357027|FG001|Overall Study|Reason not provided|11|||
126017297|NCT00566527|453357028|FG002|Overall Study|Reason not provided|10|||
126017298|NCT00566527|453357026|FG000|Overall Study|Adverse Event|2|||
126017299|NCT00566527|453357027|FG001|Overall Study|Adverse Event|0|||
126017300|NCT00566527|453357028|FG002|Overall Study|Adverse Event|1|||
126017301|NCT00566527|453357026|FG000|Overall Study|Physician Decision|3|||
126017302|NCT00566527|453357027|FG001|Overall Study|Physician Decision|8|||
126017303|NCT00566527|453357028|FG002|Overall Study|Physician Decision|20|||
126017304|NCT00566527|453357026|FG000|Overall Study|Lost to Follow-up|3|||
126017305|NCT00566527|453357027|FG001|Overall Study|Lost to Follow-up|4|||
126017306|NCT00566527|453357028|FG002|Overall Study|Lost to Follow-up|4|||
126017307|NCT00566527|453357026|FG000|Overall Study|Withdrawal by Subject|6|||
126017308|NCT00566527|453357027|FG001|Overall Study|Withdrawal by Subject|43|||
126017309|NCT00566527|453357028|FG002|Overall Study|Withdrawal by Subject|43|||
126017310|NCT00356265|453357029|FG000|Overall Study|Withdrawal by Subject|0|||
126017311|NCT00356265|453357030|FG001|Overall Study|Withdrawal by Subject|0|||
126017312|NCT00356265|453357031|FG002|Overall Study|Withdrawal by Subject|1|||
126017313|NCT01837966|453357032|FG000|Overall Study|Withdrawal by Subject|2|||
126017314|NCT01837966|453357033|FG001|Overall Study|Withdrawal by Subject|1|||
126017315|NCT01278394|453357037|FG000|Overall Study|Lost to Follow-up|1|||
126017316|NCT00658996|453357040|FG000|First Intervention|Positive slit lamp finding|1|||
126017317|NCT00658996|453357041|FG001|First Intervention|Positive slit lamp finding|0|||
126017318|NCT00658996|453357040|FG000|First Intervention|Lack of lenses|0|||
126017319|NCT00658996|453357041|FG001|First Intervention|Lack of lenses|1|||
126017320|NCT00658996|453357040|FG000|Crossover Period|Physician Decision|1|||
126017321|NCT00658996|453357041|FG001|Crossover Period|Physician Decision|0|||
126091914|NCT00626990|453630467|FG000|Overall Study|Adverse Event|1|||
126091915|NCT00626990|453630468|FG001|Overall Study|Adverse Event|7|||
126091916|NCT00626990|453630469|FG002|Overall Study|Adverse Event|14|||
126091917|NCT00626990|453630470|FG003|Overall Study|Adverse Event|28|||
126217580|NCT02437890|454088452|FG002|Overall Study|Physician Decision|0|||
126217581|NCT02437890|454088453|FG003|Overall Study|Physician Decision|1|||
126091918|NCT00626990|453630467|FG000|Overall Study|Death|0|||
126091919|NCT00626990|453630468|FG001|Overall Study|Death|1|||
126091920|NCT00626990|453630469|FG002|Overall Study|Death|0|||
126091921|NCT00626990|453630470|FG003|Overall Study|Death|0|||
126091922|NCT00626990|453630467|FG000|Overall Study|Withdrawal by Subject|3|||
126091923|NCT00626990|453630468|FG001|Overall Study|Withdrawal by Subject|1|||
126091924|NCT00626990|453630469|FG002|Overall Study|Withdrawal by Subject|5|||
126091925|NCT00626990|453630470|FG003|Overall Study|Withdrawal by Subject|11|||
126091926|NCT00626990|453630467|FG000|Overall Study|Protocol Violation|0|||
126091927|NCT00626990|453630468|FG001|Overall Study|Protocol Violation|1|||
126091928|NCT00626990|453630469|FG002|Overall Study|Protocol Violation|1|||
126091929|NCT00626990|453630470|FG003|Overall Study|Protocol Violation|0|||
126091930|NCT00626990|453630467|FG000|Overall Study|Various different reasons/missing|4|||
126217582|NCT02437890|454088454|FG004|Overall Study|Physician Decision|0|||
126217583|NCT02437890|454088450|FG000|Overall Study|Unable to attend visit(s)|1|||
126217584|NCT02437890|454088451|FG001|Overall Study|Unable to attend visit(s)|0|||
126217585|NCT02437890|454088452|FG002|Overall Study|Unable to attend visit(s)|0|||
126217586|NCT02437890|454088453|FG003|Overall Study|Unable to attend visit(s)|0|||
126217587|NCT02437890|454088454|FG004|Overall Study|Unable to attend visit(s)|0|||
126217588|NCT02437890|454088450|FG000|Overall Study|Lack of Efficacy|1|||
126217589|NCT02437890|454088451|FG001|Overall Study|Lack of Efficacy|3|||
126217590|NCT02437890|454088452|FG002|Overall Study|Lack of Efficacy|0|||
126217591|NCT02437890|454088453|FG003|Overall Study|Lack of Efficacy|3|||
126217592|NCT02437890|454088454|FG004|Overall Study|Lack of Efficacy|1|||
126217593|NCT02437890|454088450|FG000|Overall Study|Adverse Event|4|||
126217594|NCT02437890|454088451|FG001|Overall Study|Adverse Event|9|||
126217595|NCT02437890|454088452|FG002|Overall Study|Adverse Event|5|||
126217596|NCT02437890|454088453|FG003|Overall Study|Adverse Event|11|||
126217597|NCT02437890|454088454|FG004|Overall Study|Adverse Event|7|||
126217598|NCT02437890|454088450|FG000|Overall Study|Withdrawal by Subject|1|||
126217599|NCT02437890|454088451|FG001|Overall Study|Withdrawal by Subject|2|||
126217600|NCT02437890|454088452|FG002|Overall Study|Withdrawal by Subject|6|||
126217601|NCT02437890|454088453|FG003|Overall Study|Withdrawal by Subject|5|||
126217602|NCT02437890|454088454|FG004|Overall Study|Withdrawal by Subject|5|||
126217603|NCT02437890|454088450|FG000|Overall Study|Death|0|||
126217604|NCT02437890|454088451|FG001|Overall Study|Death|0|||
126217605|NCT02437890|454088452|FG002|Overall Study|Death|0|||
126217606|NCT02437890|454088453|FG003|Overall Study|Death|2|||
126217607|NCT02437890|454088454|FG004|Overall Study|Death|0|||
126217608|NCT02414854|454088455|FG000|Overall Study|Adverse Event|9|||
126217609|NCT02414854|454088456|FG001|Overall Study|Adverse Event|7|||
126217610|NCT02414854|454088457|FG002|Overall Study|Adverse Event|1|||
126217611|NCT02414854|454088458|FG003|Overall Study|Adverse Event|12|||
126217612|NCT02414854|454088455|FG000|Overall Study|Poor compliance to protocol|1|||
126217613|NCT02414854|454088456|FG001|Overall Study|Poor compliance to protocol|1|||
126217614|NCT02414854|454088457|FG002|Overall Study|Poor compliance to protocol|2|||
126217615|NCT02414854|454088458|FG003|Overall Study|Poor compliance to protocol|2|||
126217616|NCT02414854|454088455|FG000|Overall Study|Other than specified above|12|||
126217617|NCT02414854|454088456|FG001|Overall Study|Other than specified above|37|||
126217618|NCT02414854|454088457|FG002|Overall Study|Other than specified above|17|||
126217619|NCT02414854|454088458|FG003|Overall Study|Other than specified above|37|||
126217620|NCT04723173|454088459|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
126217621|NCT02996448|454088460|FG000|Overall Study|Study terminated due to adverse effects|3|||
126217622|NCT01586624|454088461|FG000|Overall Study|Adverse Event|3|||
126217623|NCT01586624|454088462|FG001|Overall Study|Adverse Event|0|||
126217624|NCT01586624|454088463|FG002|Overall Study|Adverse Event|2|||
126217625|NCT01586624|454088464|FG003|Overall Study|Adverse Event|1|||
126217626|NCT01586624|454088465|FG004|Overall Study|Adverse Event|3|||
126217627|NCT01586624|454088466|FG005|Overall Study|Adverse Event|3|||
126217628|NCT01586624|454088467|FG006|Overall Study|Adverse Event|2|||
126217629|NCT01586624|454088468|FG007|Overall Study|Adverse Event|3|||
126217630|NCT01586624|454088461|FG000|Overall Study|Physician Decision|0|||
126217631|NCT01586624|454088462|FG001|Overall Study|Physician Decision|1|||
126217632|NCT01586624|454088463|FG002|Overall Study|Physician Decision|1|||
126217633|NCT01586624|454088464|FG003|Overall Study|Physician Decision|0|||
126217634|NCT01586624|454088465|FG004|Overall Study|Physician Decision|2|||
126217635|NCT01586624|454088466|FG005|Overall Study|Physician Decision|0|||
126217636|NCT01586624|454088467|FG006|Overall Study|Physician Decision|1|||
126217637|NCT01586624|454088468|FG007|Overall Study|Physician Decision|1|||
126217638|NCT01586624|454088461|FG000|Overall Study|Withdrawal by Subject|0|||
126217639|NCT01586624|454088462|FG001|Overall Study|Withdrawal by Subject|0|||
126217640|NCT01586624|454088463|FG002|Overall Study|Withdrawal by Subject|0|||
126217641|NCT01586624|454088464|FG003|Overall Study|Withdrawal by Subject|1|||
126017322|NCT00658996|453357040|FG000|Crossover Period|Ineligible|1|||
126217642|NCT01586624|454088465|FG004|Overall Study|Withdrawal by Subject|0|||
126217643|NCT01586624|454088466|FG005|Overall Study|Withdrawal by Subject|0|||
126217644|NCT01586624|454088467|FG006|Overall Study|Withdrawal by Subject|0|||
126217645|NCT01586624|454088468|FG007|Overall Study|Withdrawal by Subject|0|||
126217646|NCT01586624|454088461|FG000|Overall Study|Evidence of disease progression|1|||
126017323|NCT00658996|453357041|FG001|Crossover Period|Ineligible|1|||
126217647|NCT01586624|454088462|FG001|Overall Study|Evidence of disease progression|3|||
126217648|NCT01586624|454088463|FG002|Overall Study|Evidence of disease progression|2|||
126217649|NCT01586624|454088464|FG003|Overall Study|Evidence of disease progression|5|||
126217650|NCT01586624|454088465|FG004|Overall Study|Evidence of disease progression|3|||
126217651|NCT01586624|454088466|FG005|Overall Study|Evidence of disease progression|5|||
126217652|NCT01586624|454088467|FG006|Overall Study|Evidence of disease progression|4|||
126217653|NCT01586624|454088468|FG007|Overall Study|Evidence of disease progression|6|||
126217654|NCT01586624|454088461|FG000|Overall Study|Screen failure (no treatment received)|0|||
126217655|NCT01586624|454088462|FG001|Overall Study|Screen failure (no treatment received)|0|||
126217656|NCT01586624|454088463|FG002|Overall Study|Screen failure (no treatment received)|0|||
126217657|NCT01586624|454088464|FG003|Overall Study|Screen failure (no treatment received)|0|||
126217658|NCT01586624|454088465|FG004|Overall Study|Screen failure (no treatment received)|0|||
126217659|NCT01586624|454088466|FG005|Overall Study|Screen failure (no treatment received)|0|||
126217660|NCT01586624|454088467|FG006|Overall Study|Screen failure (no treatment received)|1|||
126217661|NCT01586624|454088468|FG007|Overall Study|Screen failure (no treatment received)|0|||
126217662|NCT01160198|454088469|FG000|Overall Study|Withdrawal by Subject|2|||
126217663|NCT01160198|454088470|FG001|Overall Study|Withdrawal by Subject|1|||
126217664|NCT01160198|454088471|FG002|Overall Study|Withdrawal by Subject|0|||
126217665|NCT01160198|454088469|FG000|Overall Study|Adverse Event|0|||
126217666|NCT01160198|454088470|FG001|Overall Study|Adverse Event|1|||
126217667|NCT01160198|454088471|FG002|Overall Study|Adverse Event|0|||
126217668|NCT01160198|454088469|FG000|Overall Study|Lost to Follow-up|0|||
126217669|NCT01160198|454088470|FG001|Overall Study|Lost to Follow-up|1|||
126217670|NCT01160198|454088471|FG002|Overall Study|Lost to Follow-up|0|||
126217671|NCT01160198|454088469|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
126217672|NCT01160198|454088470|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
126217673|NCT01160198|454088471|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
126217674|NCT02016755|454088473|FG000|Overall Study|Major amputation of index limb|2|||
126217675|NCT02016755|454088473|FG000|Overall Study|Adverse Event|2|||
126217676|NCT02016755|454088473|FG000|Overall Study|Physician Decision|1|||
126217677|NCT02016755|454088473|FG000|Overall Study|Death|2|||
126217678|NCT01396161|454088478|FG000|Overall Study|Withdrawal by Subject|0|||
126217679|NCT01396161|454088479|FG001|Overall Study|Withdrawal by Subject|0|||
126217680|NCT01396161|454088480|FG002|Overall Study|Withdrawal by Subject|0|||
126217681|NCT01396161|454088481|FG003|Overall Study|Withdrawal by Subject|0|||
126217682|NCT01396161|454088482|FG004|Overall Study|Withdrawal by Subject|1|||
126217683|NCT01396161|454088483|FG005|Overall Study|Withdrawal by Subject|0|||
126217684|NCT01396161|454088484|FG006|Overall Study|Withdrawal by Subject|0|||
126217685|NCT01396161|454088478|FG000|Overall Study|Other|0|||
126217686|NCT01396161|454088479|FG001|Overall Study|Other|0|||
126217687|NCT01396161|454088480|FG002|Overall Study|Other|0|||
126217688|NCT01396161|454088481|FG003|Overall Study|Other|0|||
126217689|NCT01396161|454088482|FG004|Overall Study|Other|0|||
126217690|NCT01396161|454088483|FG005|Overall Study|Other|0|||
126217691|NCT01396161|454088484|FG006|Overall Study|Other|1|||
126217692|NCT00552617|454088485|FG000|Overall Study|Not Treated|0|||
126217693|NCT00552617|454088486|FG001|Overall Study|Not Treated|0|||
126217694|NCT00552617|454088487|FG002|Overall Study|Not Treated|1|||
126217695|NCT00552617|454088488|FG003|Overall Study|Not Treated|0|||
126217696|NCT00552617|454088489|FG004|Overall Study|Not Treated|0|||
126217697|NCT00552617|454088490|FG005|Overall Study|Not Treated|0|||
126217698|NCT00552617|454088491|FG006|Overall Study|Not Treated|0|||
126217699|NCT00552617|454088492|FG007|Overall Study|Not Treated|0|||
126217700|NCT00552617|454088493|FG008|Overall Study|Not Treated|0|||
126217701|NCT00552617|454088494|FG009|Overall Study|Not Treated|1|||
126217702|NCT00552617|454088485|FG000|Overall Study|Lost to Follow-up|0|||
126217703|NCT00552617|454088486|FG001|Overall Study|Lost to Follow-up|0|||
126217704|NCT00552617|454088487|FG002|Overall Study|Lost to Follow-up|0|||
126217705|NCT00552617|454088488|FG003|Overall Study|Lost to Follow-up|1|||
126217706|NCT00552617|454088489|FG004|Overall Study|Lost to Follow-up|0|||
126217707|NCT00552617|454088490|FG005|Overall Study|Lost to Follow-up|2|||
126217708|NCT00552617|454088491|FG006|Overall Study|Lost to Follow-up|0|||
126217709|NCT00552617|454088492|FG007|Overall Study|Lost to Follow-up|0|||
126217710|NCT00552617|454088493|FG008|Overall Study|Lost to Follow-up|2|||
126217711|NCT00552617|454088494|FG009|Overall Study|Lost to Follow-up|0|||
126217712|NCT00337129|454088495|FG000|Overall Study|Adverse Event|4|||
126091931|NCT00626990|453630468|FG001|Overall Study|Various different reasons/missing|8|||
126091932|NCT00626990|453630469|FG002|Overall Study|Various different reasons/missing|8|||
126091933|NCT00626990|453630470|FG003|Overall Study|Various different reasons/missing|16|||
126091934|NCT04138576|453630475|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
126217713|NCT00337129|454088495|FG000|Overall Study|Withdrawal by Subject|1|||
126217714|NCT00337129|454088495|FG000|Overall Study|Lack of Efficacy|32|||
126217715|NCT00337129|454088495|FG000|Overall Study|Death|2|||
126217716|NCT00337129|454088495|FG000|Overall Study|not protocol specified|1|||
126217717|NCT01286207|454088499|FG000|Overall Study|Adverse Event|27|||
126217718|NCT01286207|454088500|FG001|Overall Study|Adverse Event|41|||
126217719|NCT01286207|454088501|FG002|Overall Study|Adverse Event|8|||
126217720|NCT01286207|454088499|FG000|Overall Study|Lost to Follow-up|49|||
126217721|NCT01286207|454088500|FG001|Overall Study|Lost to Follow-up|43|||
126217722|NCT01286207|454088501|FG002|Overall Study|Lost to Follow-up|20|||
126217723|NCT01286207|454088499|FG000|Overall Study|Withdrawal by Subject|93|||
126217724|NCT01286207|454088500|FG001|Overall Study|Withdrawal by Subject|79|||
126217725|NCT01286207|454088501|FG002|Overall Study|Withdrawal by Subject|41|||
126217726|NCT01286207|454088499|FG000|Overall Study|Lack of Response|92|||
126217727|NCT01286207|454088500|FG001|Overall Study|Lack of Response|38|||
126217728|NCT01286207|454088501|FG002|Overall Study|Lack of Response|8|||
126217729|NCT01286207|454088499|FG000|Overall Study|Other|37|||
126217730|NCT01286207|454088500|FG001|Overall Study|Other|47|||
126217731|NCT01286207|454088501|FG002|Overall Study|Other|13|||
126217732|NCT01383954|454088502|FG000|Overall Study|Lack of Efficacy|2|||
126217733|NCT01383954|454088502|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
126217734|NCT01383954|454088502|FG000|Overall Study|Adverse Event|1|||
126217735|NCT01383954|454088502|FG000|Overall Study|Reason Not Specified|9|||
126217736|NCT00450177|454088503|FG000|Overall Study|Adverse Event|7|||
126217737|NCT00450177|454088504|FG001|Overall Study|Adverse Event|4|||
126217738|NCT00450177|454088503|FG000|Overall Study|Withdrawal by Subject|1|||
126217739|NCT00450177|454088504|FG001|Overall Study|Withdrawal by Subject|6|||
126217740|NCT00450177|454088503|FG000|Overall Study|Withdrawal by Primary Team|1|||
126217741|NCT00450177|454088504|FG001|Overall Study|Withdrawal by Primary Team|1|||
126217742|NCT00763269|454088506|FG000|Overall Study|Lost to Follow-up|12|||
126217743|NCT00763269|454088507|FG001|Overall Study|Lost to Follow-up|13|||
126217744|NCT03174925|454088512|FG000|Overall Study|Elastographic images not retrievable|2|||
126217745|NCT03174925|454088512|FG000|Overall Study|Elastography image not interpretable|1|||
126217746|NCT04247594|454088515|FG000|Overall Study|Withdrawal by Subject|4|||
126217747|NCT00589693|454088520|FG000|Overall Study|randomized in error|12|||
126217748|NCT00589693|454088521|FG001|Overall Study|randomized in error|6|||
126217749|NCT00589693|454088520|FG000|Overall Study|Adverse Event|4|||
126217750|NCT00589693|454088521|FG001|Overall Study|Adverse Event|4|||
126217751|NCT00589693|454088520|FG000|Overall Study|Death|26|||
126217752|NCT00589693|454088521|FG001|Overall Study|Death|16|||
126217753|NCT00589693|454088520|FG000|Overall Study|Lack of Efficacy|0|||
126217754|NCT00589693|454088521|FG001|Overall Study|Lack of Efficacy|1|||
126217755|NCT00589693|454088520|FG000|Overall Study|Lost to Follow-up|1|||
126217756|NCT00589693|454088521|FG001|Overall Study|Lost to Follow-up|0|||
126217757|NCT00589693|454088520|FG000|Overall Study|Physician Decision|0|||
126217758|NCT00589693|454088521|FG001|Overall Study|Physician Decision|1|||
126217759|NCT00589693|454088520|FG000|Overall Study|Protocol Violation|1|||
126217760|NCT00589693|454088521|FG001|Overall Study|Protocol Violation|1|||
126217761|NCT02609178|454088522|FG000|First Crown|Withdrawal by Subject|0|||
126217762|NCT02609178|454088523|FG001|First Crown|Withdrawal by Subject|0|||
126217763|NCT02609178|454088524|FG002|First Crown|Withdrawal by Subject|1|||
126217764|NCT02609178|454088525|FG003|First Crown|Withdrawal by Subject|1|||
126217765|NCT02609178|454088526|FG004|First Crown|Withdrawal by Subject|0|||
126217766|NCT02609178|454088527|FG005|First Crown|Withdrawal by Subject|0|||
126217767|NCT01128153|454088528|FG000|Overall Study|Adverse Event|1|||
126217768|NCT01128153|454088529|FG001|Overall Study|Adverse Event|3|||
126217769|NCT01128153|454088528|FG000|Overall Study|Condition under investigation worsened|8|||
126217770|NCT01128153|454088529|FG001|Overall Study|Condition under investigation worsened|7|||
126217771|NCT01128153|454088528|FG000|Overall Study|Withdrawal by Subject|2|||
126217772|NCT01128153|454088529|FG001|Overall Study|Withdrawal by Subject|3|||
126217773|NCT01128153|454088528|FG000|Overall Study|Incorrect enrolment to study|2|||
126217774|NCT01128153|454088529|FG001|Overall Study|Incorrect enrolment to study|1|||
126217775|NCT01128153|454088528|FG000|Overall Study|Protocol Violation|2|||
126217776|NCT01128153|454088529|FG001|Overall Study|Protocol Violation|0|||
126217777|NCT01128153|454088528|FG000|Overall Study|Developed discontinuation criteria|1|||
126217778|NCT01128153|454088529|FG001|Overall Study|Developed discontinuation criteria|1|||
126217779|NCT01682512|454088530|FG000|Overall Study|Adverse Event|6|||
126217780|NCT01682512|454088531|FG001|Overall Study|Adverse Event|5|||
126217781|NCT01682512|454088532|FG002|Overall Study|Adverse Event|2|||
126217782|NCT01682512|454088530|FG000|Overall Study|Withdrawal by Subject|2|||
126217783|NCT01682512|454088531|FG001|Overall Study|Withdrawal by Subject|6|||
126217784|NCT01682512|454088532|FG002|Overall Study|Withdrawal by Subject|3|||
126217785|NCT01682512|454088530|FG000|Overall Study|Physician Decision|0|||
126217786|NCT01682512|454088531|FG001|Overall Study|Physician Decision|2|||
126217787|NCT01682512|454088532|FG002|Overall Study|Physician Decision|0|||
126217788|NCT01682512|454088530|FG000|Overall Study|Study terminated by sponsor|46|||
126217789|NCT01682512|454088531|FG001|Overall Study|Study terminated by sponsor|43|||
126217790|NCT01682512|454088532|FG002|Overall Study|Study terminated by sponsor|0|||
126217791|NCT01682512|454088530|FG000|Overall Study|Lost to Follow-up|3|||
126217792|NCT01682512|454088531|FG001|Overall Study|Lost to Follow-up|0|||
126217793|NCT01682512|454088532|FG002|Overall Study|Lost to Follow-up|2|||
126217794|NCT01682512|454088530|FG000|Overall Study|Protocol Violation|2|||
126217795|NCT01682512|454088531|FG001|Overall Study|Protocol Violation|3|||
126217796|NCT01682512|454088532|FG002|Overall Study|Protocol Violation|2|||
126217797|NCT01682512|454088530|FG000|Overall Study|Primary lack of efficacy|10|||
126217798|NCT01682512|454088531|FG001|Overall Study|Primary lack of efficacy|7|||
126217799|NCT01682512|454088532|FG002|Overall Study|Primary lack of efficacy|7|||
126217800|NCT01682512|454088530|FG000|Overall Study|Secondary lack of efficacy|1|||
126217801|NCT01682512|454088531|FG001|Overall Study|Secondary lack of efficacy|1|||
126217802|NCT01682512|454088532|FG002|Overall Study|Secondary lack of efficacy|0|||
126217803|NCT01682512|454088530|FG000|Overall Study|Other than stated above|2|||
126217804|NCT01682512|454088531|FG001|Overall Study|Other than stated above|4|||
126217805|NCT01682512|454088532|FG002|Overall Study|Other than stated above|2|||
126217806|NCT00054275|454088533|FG000|Overall Study|Withdrawal by Subject|4|||
126217807|NCT00054275|454088533|FG000|Overall Study|Adverse Event|5|||
126217808|NCT00054275|454088533|FG000|Overall Study|Progressive disease in cycle 1|1|||
126217809|NCT00054275|454088533|FG000|Overall Study|Physician Decision|1|||
126217810|NCT02030834|454088541|FG000|Overall Study|Death|4|||
126217811|NCT02030834|454088542|FG001|Overall Study|Death|0|||
126217812|NCT02030834|454088543|FG002|Overall Study|Death|0|||
126217813|NCT02030834|454088541|FG000|Overall Study|Manufacturing failure|2|||
126217814|NCT02030834|454088542|FG001|Overall Study|Manufacturing failure|0|||
126217815|NCT02030834|454088543|FG002|Overall Study|Manufacturing failure|1|||
126217816|NCT02030834|454088541|FG000|Overall Study|Disease progression|2|||
126217817|NCT02030834|454088542|FG001|Overall Study|Disease progression|0|||
126217818|NCT02030834|454088543|FG002|Overall Study|Disease progression|2|||
126217819|NCT02030834|454088541|FG000|Overall Study|Lost to Follow-up|1|||
126217820|NCT02030834|454088542|FG001|Overall Study|Lost to Follow-up|0|||
126217821|NCT02030834|454088543|FG002|Overall Study|Lost to Follow-up|0|||
126217822|NCT02030834|454088541|FG000|Overall Study|Withdrawal by Subject|1|||
126217823|NCT02030834|454088542|FG001|Overall Study|Withdrawal by Subject|0|||
126217824|NCT02030834|454088543|FG002|Overall Study|Withdrawal by Subject|0|||
126217825|NCT02030834|454088541|FG000|Overall Study|Lack of funding|1|||
126217826|NCT02030834|454088542|FG001|Overall Study|Lack of funding|0|||
126217827|NCT02030834|454088543|FG002|Overall Study|Lack of funding|0|||
126217828|NCT00996918|454088546|FG000|Overall Study|Lack of Efficacy|1|||
126217829|NCT00996918|454088547|FG001|Overall Study|Lack of Efficacy|1|||
126217830|NCT00996918|454088548|FG002|Overall Study|Lack of Efficacy|2|||
126217831|NCT00996918|454088549|FG003|Overall Study|Lack of Efficacy|2|||
126217832|NCT00996918|454088550|FG004|Overall Study|Lack of Efficacy|0|||
126217833|NCT00996918|454088546|FG000|Overall Study|Adverse Event|2|||
126217834|NCT00996918|454088547|FG001|Overall Study|Adverse Event|5|||
126217835|NCT00996918|454088548|FG002|Overall Study|Adverse Event|2|||
126217836|NCT00996918|454088549|FG003|Overall Study|Adverse Event|6|||
126217837|NCT00996918|454088550|FG004|Overall Study|Adverse Event|0|||
126217838|NCT00996918|454088546|FG000|Overall Study|Withdrawal by Subject|1|||
126217839|NCT00996918|454088547|FG001|Overall Study|Withdrawal by Subject|4|||
126217840|NCT00996918|454088548|FG002|Overall Study|Withdrawal by Subject|3|||
126217841|NCT00996918|454088549|FG003|Overall Study|Withdrawal by Subject|3|||
126217842|NCT00996918|454088550|FG004|Overall Study|Withdrawal by Subject|2|||
126217843|NCT00996918|454088546|FG000|Overall Study|Physician Decision|1|||
126217844|NCT00996918|454088547|FG001|Overall Study|Physician Decision|0|||
126217845|NCT00996918|454088548|FG002|Overall Study|Physician Decision|0|||
126217846|NCT00996918|454088549|FG003|Overall Study|Physician Decision|0|||
126217847|NCT00996918|454088550|FG004|Overall Study|Physician Decision|0|||
126217848|NCT00996918|454088546|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
126217849|NCT00996918|454088547|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
126217850|NCT00996918|454088548|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
126217851|NCT00996918|454088549|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
126217852|NCT00996918|454088550|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
126217853|NCT00996918|454088546|FG000|Overall Study|Loss of Caregiver|0|||
126217854|NCT00996918|454088547|FG001|Overall Study|Loss of Caregiver|1|||
126217855|NCT00996918|454088548|FG002|Overall Study|Loss of Caregiver|0|||
126217856|NCT00996918|454088549|FG003|Overall Study|Loss of Caregiver|0|||
126217857|NCT00996918|454088550|FG004|Overall Study|Loss of Caregiver|0|||
126217858|NCT00996918|454088546|FG000|Overall Study|Other|3|||
126217859|NCT00996918|454088547|FG001|Overall Study|Other|1|||
126217860|NCT00996918|454088548|FG002|Overall Study|Other|0|||
126217861|NCT00996918|454088549|FG003|Overall Study|Other|0|||
126217862|NCT00996918|454088550|FG004|Overall Study|Other|0|||
126217863|NCT04440007|454088555|FG000|Overall Study|Adverse Event|0|||
126217864|NCT04440007|454088556|FG001|Overall Study|Adverse Event|1|||
126217865|NCT04440007|454088555|FG000|Overall Study|Lost to Follow-up|1|||
126217866|NCT04440007|454088556|FG001|Overall Study|Lost to Follow-up|3|||
126217867|NCT04440007|454088555|FG000|Overall Study|Death|7|||
126217868|NCT04440007|454088556|FG001|Overall Study|Death|2|||
126217869|NCT04440007|454088555|FG000|Overall Study|Physician Decision|1|||
126217870|NCT04440007|454088556|FG001|Overall Study|Physician Decision|1|||
126217871|NCT04440007|454088555|FG000|Overall Study|Withdrawal by Subject|2|||
126217872|NCT04440007|454088556|FG001|Overall Study|Withdrawal by Subject|1|||
126217873|NCT04440007|454088555|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
126217874|NCT04440007|454088556|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
126217875|NCT04440007|454088555|FG000|Overall Study|Discontinued prior to dosing|0|||
126217876|NCT04440007|454088556|FG001|Overall Study|Discontinued prior to dosing|2|||
126217877|NCT01466673|454088557|FG000|Overall Study|Non-compliance with study treatment|2|||
126217878|NCT01466673|454088558|FG001|Overall Study|Non-compliance with study treatment|0|||
126217879|NCT01466673|454088557|FG000|Overall Study|Lost to Follow-up|3|||
126217880|NCT01466673|454088558|FG001|Overall Study|Lost to Follow-up|5|||
126217881|NCT01466673|454088557|FG000|Overall Study|Adverse Event|2|||
126217882|NCT01466673|454088558|FG001|Overall Study|Adverse Event|1|||
126217883|NCT00854607|454088559|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
126217884|NCT03959137|454088562|FG000|Overall Study|Protocol Violation|6|||
126217885|NCT00190684|454088563|FG000|Overall Study|Adverse Event|86|||
126217886|NCT00190684|454088563|FG000|Overall Study|Satisfactory response|80|||
126217887|NCT00190684|454088563|FG000|Overall Study|Lack of efficacy|204|||
126217888|NCT00190684|454088563|FG000|Overall Study|Lost to Follow-up|232|||
126217889|NCT00190684|454088563|FG000|Overall Study|Patient moved|60|||
126217890|NCT00190684|454088563|FG000|Overall Study|Patient Decision|432|||
126217891|NCT00190684|454088563|FG000|Overall Study|Clinical relapse|67|||
126217892|NCT00190684|454088563|FG000|Overall Study|Sponsor's decision|17|||
126217893|NCT00190684|454088563|FG000|Overall Study|Physician Decision|84|||
126217894|NCT00190684|454088563|FG000|Overall Study|Protocol Violation|123|||
126217895|NCT00190684|454088563|FG000|Overall Study|Study Period III Completed|103|||
126217896|NCT00190684|454088563|FG000|Overall Study|Study Period V Completed|1|||
126217897|NCT00829439|454088569|FG000|Overall Study|Adverse Event|0|||
126217898|NCT00829439|454088570|FG001|Overall Study|Adverse Event|0|||
126217899|NCT00829439|454088571|FG002|Overall Study|Adverse Event|1|||
126217900|NCT00829439|454088572|FG003|Overall Study|Adverse Event|0|||
126217901|NCT00758706|454088573|FG000|Overall Study|Adverse Event|4|||
126217902|NCT00758706|454088574|FG001|Overall Study|Adverse Event|4|||
126217903|NCT01039584|454088575|FG000|Overall Study|Withdrawal by Subject|4|||
126217904|NCT01039584|454088576|FG001|Overall Study|Withdrawal by Subject|2|||
126217905|NCT01039584|454088577|FG002|Overall Study|Withdrawal by Subject|1|||
126217906|NCT01039584|454088575|FG000|Overall Study|Protocol Violation|10|||
126217907|NCT01039584|454088576|FG001|Overall Study|Protocol Violation|4|||
126217908|NCT01039584|454088577|FG002|Overall Study|Protocol Violation|6|||
126217909|NCT01039584|454088575|FG000|Overall Study|Lost to Follow-up|5|||
126217910|NCT01039584|454088576|FG001|Overall Study|Lost to Follow-up|3|||
126217911|NCT01039584|454088577|FG002|Overall Study|Lost to Follow-up|4|||
126217912|NCT01039584|454088575|FG000|Overall Study|Negative Baseline culture for Candida|59|||
126217913|NCT01039584|454088576|FG001|Overall Study|Negative Baseline culture for Candida|59|||
126217914|NCT01039584|454088577|FG002|Overall Study|Negative Baseline culture for Candida|24|||
126217915|NCT01039584|454088575|FG000|Overall Study|Lack of Efficacy|7|||
126217916|NCT01039584|454088576|FG001|Overall Study|Lack of Efficacy|6|||
126217917|NCT01039584|454088577|FG002|Overall Study|Lack of Efficacy|10|||
126217918|NCT01039584|454088575|FG000|Overall Study|other|1|||
126217919|NCT01039584|454088576|FG001|Overall Study|other|3|||
126217920|NCT01039584|454088577|FG002|Overall Study|other|1|||
126217921|NCT01039584|454088575|FG000|Overall Study|Pap smear with significant pathology|10|||
126217922|NCT01039584|454088576|FG001|Overall Study|Pap smear with significant pathology|10|||
126091935|NCT01008410|453630477|FG000|Overall Study|Adverse Event|13|||
126017324|NCT00658996|453357040|FG000|Second Intervention|Developed a stye on upper lid|1|||
126017325|NCT00658996|453357041|FG001|Second Intervention|Developed a stye on upper lid|0|||
126017326|NCT00658996|453357040|FG000|Second Intervention|Positive slit lamp finding|0|||
126017327|NCT00658996|453357041|FG001|Second Intervention|Positive slit lamp finding|1|||
126017328|NCT00688519|453357050|FG000|Overall Study|Adverse Event|2|||
126017329|NCT00688519|453357051|FG001|Overall Study|Adverse Event|3|||
126017330|NCT00688519|453357050|FG000|Overall Study|Lost to Follow-up|3|||
126091936|NCT01008410|453630478|FG001|Overall Study|Adverse Event|7|||
126217923|NCT01039584|454088577|FG002|Overall Study|Pap smear with significant pathology|3|||
126217924|NCT01039584|454088575|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
126217925|NCT01039584|454088576|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
126217926|NCT01039584|454088577|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
126217927|NCT01494649|454088578|FG000|Overall Study|Lost to Follow-up|0|||
126217928|NCT01494649|454088579|FG001|Overall Study|Lost to Follow-up|1|||
126217929|NCT03467971|454088580|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126217930|NCT03467971|454088581|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126217931|NCT01174368|454088584|FG000|Overall Study|Withdrawal by Subject|1|||
126217932|NCT00000135|454088607|FG000|Overall Study|Death|27|||
126217933|NCT00000135|454088608|FG001|Overall Study|Death|14|||
126217934|NCT04639310|454088613|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
126217935|NCT04639310|454088614|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
126217936|NCT01211613|454090060|FG000|Overall Study|Lost to Follow-up|2|||
126217937|NCT01211613|454090061|FG001|Overall Study|Lost to Follow-up|2|||
126217938|NCT01211613|454090062|FG002|Overall Study|Lost to Follow-up|2|||
126217939|NCT01211613|454090060|FG000|Overall Study|Withdrawal by Subject|1|||
126217940|NCT01211613|454090061|FG001|Overall Study|Withdrawal by Subject|0|||
126217941|NCT01211613|454090062|FG002|Overall Study|Withdrawal by Subject|0|||
126217942|NCT03853213|454090063|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
126217943|NCT03853213|454090064|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
126217944|NCT03853213|454090063|FG000|Overall Study|Other (e.g., too busy)|0|||
126217945|NCT03853213|454090064|FG001|Overall Study|Other (e.g., too busy)|2|||
126217946|NCT01458132|454090065|FG000|Overall Study|Other|15|||
126217947|NCT01458132|454090066|FG001|Overall Study|Other|3|||
126217948|NCT00833976|454090067|FG000|Overall Study|Withdrawal by Subject|5|||
126217949|NCT00833976|454090067|FG000|Overall Study|Lost to Follow-up|4|||
126217950|NCT00833976|454090067|FG000|Overall Study|Did not meet eligibility criteria|41|||
126217951|NCT00833976|454090067|FG000|Overall Study|Physician Decision|1|||
126217952|NCT01422720|454090068|FG000|Overall Study|Adverse Event|16|||
126217953|NCT01422720|454090068|FG000|Overall Study|Lack of Efficacy|1|||
126217954|NCT01422720|454090068|FG000|Overall Study|Withdrawal by Subject|4|||
126217955|NCT01422720|454090068|FG000|Overall Study|Ineligibility|1|||
126217956|NCT02082262|454090069|FG000|Overall Study|Withdrawal by Subject|3|||
126217957|NCT02082262|454090069|FG000|Overall Study|Adverse Event|48|||
126217958|NCT01074307|454090071|FG000|Overall Study|No primary endpoint evaluation|14|||
126217959|NCT01074307|454090072|FG001|Overall Study|No primary endpoint evaluation|6|||
126217960|NCT01074307|454090071|FG000|Overall Study|Exclusion criterion|0|||
126217961|NCT01074307|454090072|FG001|Overall Study|Exclusion criterion|1|||
126217962|NCT01074307|454090071|FG000|Overall Study|Protocol Violation|8|||
126217963|NCT01074307|454090072|FG001|Overall Study|Protocol Violation|5|||
126217964|NCT02162511|454090077|FG000|Overall Study|Lack of Efficacy|0|||
126217965|NCT02162511|454090078|FG001|Overall Study|Lack of Efficacy|0|||
126217966|NCT02162511|454090079|FG002|Overall Study|Lack of Efficacy|2|||
126217967|NCT01408576|454090080|FG000|Overall Study|Lack of Efficacy|17|||
126217968|NCT01408576|454090081|FG001|Overall Study|Lack of Efficacy|30|||
126217969|NCT01408576|454090082|FG002|Overall Study|Lack of Efficacy|48|||
126217970|NCT01408576|454090080|FG000|Overall Study|Protocol Violation|1|||
126217971|NCT01408576|454090081|FG001|Overall Study|Protocol Violation|2|||
126217972|NCT01408576|454090082|FG002|Overall Study|Protocol Violation|2|||
126217973|NCT01408576|454090080|FG000|Overall Study|Lost to Follow-up|10|||
126217974|NCT01408576|454090081|FG001|Overall Study|Lost to Follow-up|9|||
126217975|NCT01408576|454090082|FG002|Overall Study|Lost to Follow-up|17|||
126217976|NCT01408576|454090080|FG000|Overall Study|Withdrawal by Subject|34|||
126217977|NCT01408576|454090081|FG001|Overall Study|Withdrawal by Subject|60|||
126217978|NCT01408576|454090082|FG002|Overall Study|Withdrawal by Subject|66|||
126217979|NCT01408576|454090080|FG000|Overall Study|Sponsor terminated study|89|||
126217980|NCT01408576|454090081|FG001|Overall Study|Sponsor terminated study|333|||
126217981|NCT01408576|454090082|FG002|Overall Study|Sponsor terminated study|330|||
126217982|NCT01408576|454090080|FG000|Overall Study|AE, serious fatal|4|||
126217983|NCT01408576|454090081|FG001|Overall Study|AE, serious fatal|4|||
126217984|NCT01408576|454090082|FG002|Overall Study|AE, serious fatal|1|||
126217985|NCT01408576|454090080|FG000|Overall Study|SAE, non-fatal|11|||
126217986|NCT01408576|454090081|FG001|Overall Study|SAE, non-fatal|23|||
126217987|NCT01408576|454090082|FG002|Overall Study|SAE, non-fatal|14|||
126217988|NCT01408576|454090080|FG000|Overall Study|AE, non-serious non-fatal|12|||
126217989|NCT01408576|454090081|FG001|Overall Study|AE, non-serious non-fatal|19|||
126217990|NCT01408576|454090082|FG002|Overall Study|AE, non-serious non-fatal|11|||
126217991|NCT01408576|454090080|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126217992|NCT01408576|454090081|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126217993|NCT01408576|454090082|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126217994|NCT01408576|454090080|FG000|Overall Study|AE, unknown type|0|||
126217995|NCT01408576|454090081|FG001|Overall Study|AE, unknown type|1|||
126217996|NCT01408576|454090082|FG002|Overall Study|AE, unknown type|0|||
126217997|NCT01408576|454090080|FG000|Overall Study|Other|10|||
126217998|NCT01408576|454090081|FG001|Overall Study|Other|16|||
126217999|NCT01408576|454090082|FG002|Overall Study|Other|18|||
126218000|NCT00802529|454090083|FG000|Overall Study|Lost to Follow-up|0|||
126091937|NCT01008410|453630477|FG000|Overall Study|Withdrawal by Subject|6|||
126091938|NCT01008410|453630478|FG001|Overall Study|Withdrawal by Subject|2|||
126091939|NCT01008410|453630477|FG000|Overall Study|Lost to Follow-up|1|||
126091940|NCT01008410|453630478|FG001|Overall Study|Lost to Follow-up|0|||
126091941|NCT01008410|453630477|FG000|Overall Study|Noncompliance|1|||
126218001|NCT00802529|454090084|FG001|Overall Study|Lost to Follow-up|1|||
126218002|NCT00563524|454090092|FG000|Overall Study|Adverse Event|0|||
126218003|NCT00563524|454090093|FG001|Overall Study|Adverse Event|1|||
126091942|NCT01008410|453630478|FG001|Overall Study|Noncompliance|0|||
126091943|NCT01008410|453630477|FG000|Overall Study|Low Cortisol|2|||
126218004|NCT00563524|454090094|FG002|Overall Study|Adverse Event|0|||
126218005|NCT00563524|454090095|FG003|Overall Study|Adverse Event|0|||
126218006|NCT00563524|454090096|FG004|Overall Study|Adverse Event|2|||
126218007|NCT00563524|454090097|FG005|Overall Study|Adverse Event|0|||
126218008|NCT00563524|454090092|FG000|Overall Study|Lost to Follow-up|1|||
126218009|NCT00563524|454090093|FG001|Overall Study|Lost to Follow-up|0|||
126218010|NCT00563524|454090094|FG002|Overall Study|Lost to Follow-up|0|||
126218011|NCT00563524|454090095|FG003|Overall Study|Lost to Follow-up|0|||
126017331|NCT00688519|453357051|FG001|Overall Study|Lost to Follow-up|3|||
126017332|NCT00688519|453357050|FG000|Overall Study|Lack of Efficacy|3|||
126017333|NCT00688519|453357051|FG001|Overall Study|Lack of Efficacy|1|||
126017334|NCT00688519|453357050|FG000|Overall Study|Withdrawal by Subject|7|||
126017335|NCT00688519|453357051|FG001|Overall Study|Withdrawal by Subject|6|||
126017336|NCT00688519|453357050|FG000|Overall Study|Prohibited medication|1|||
126017337|NCT00688519|453357051|FG001|Overall Study|Prohibited medication|0|||
126017338|NCT00688519|453357050|FG000|Overall Study|Non-compliance|0|||
126017339|NCT00688519|453357051|FG001|Overall Study|Non-compliance|1|||
126017340|NCT00688519|453357050|FG000|Overall Study|Subject moved out of state|1|||
126017341|NCT00688519|453357051|FG001|Overall Study|Subject moved out of state|0|||
126218012|NCT00563524|454090096|FG004|Overall Study|Lost to Follow-up|0|||
126218013|NCT00563524|454090097|FG005|Overall Study|Lost to Follow-up|0|||
126218014|NCT00563524|454090092|FG000|Overall Study|Protocol Violation|0|||
126218015|NCT00563524|454090093|FG001|Overall Study|Protocol Violation|1|||
126218016|NCT00563524|454090094|FG002|Overall Study|Protocol Violation|0|||
126218017|NCT00563524|454090095|FG003|Overall Study|Protocol Violation|0|||
126218018|NCT00563524|454090096|FG004|Overall Study|Protocol Violation|0|||
126218019|NCT00563524|454090097|FG005|Overall Study|Protocol Violation|0|||
126218020|NCT00563524|454090092|FG000|Overall Study|Withdrawal by Subject|1|||
126218021|NCT00563524|454090093|FG001|Overall Study|Withdrawal by Subject|1|||
126218022|NCT00563524|454090094|FG002|Overall Study|Withdrawal by Subject|3|||
126218023|NCT00563524|454090095|FG003|Overall Study|Withdrawal by Subject|0|||
126218024|NCT00563524|454090096|FG004|Overall Study|Withdrawal by Subject|0|||
126218025|NCT00563524|454090097|FG005|Overall Study|Withdrawal by Subject|1|||
126218026|NCT00817778|454090101|FG000|Overall Study|Adverse Event|1|||
126218027|NCT00817778|454090102|FG001|Overall Study|Adverse Event|0|||
126218028|NCT00817778|454090101|FG000|Overall Study|Withdrawal by Subject|1|||
126218029|NCT00817778|454090102|FG001|Overall Study|Withdrawal by Subject|1|||
126218030|NCT00817778|454090101|FG000|Overall Study|Protocol Violation|0|||
126218031|NCT00817778|454090102|FG001|Overall Study|Protocol Violation|1|||
126218032|NCT00817778|454090101|FG000|Overall Study|Study-specific discontinuation criteria|0|||
126218033|NCT00817778|454090102|FG001|Overall Study|Study-specific discontinuation criteria|1|||
126218034|NCT00817778|454090101|FG000|Overall Study|Poor venous access|1|||
126218035|NCT00817778|454090102|FG001|Overall Study|Poor venous access|0|||
126218036|NCT02360397|454090104|FG000|Overall Study|Incomplete screening|3|||
126218037|NCT02360397|454090104|FG000|Overall Study|Adverse Event|1|||
126218038|NCT01537549|454090105|FG000|Overall Study|Lost to Follow-up|1|||
126218039|NCT01537549|454090105|FG000|Overall Study|Withdrawal by Subject|2|||
126218040|NCT02923115|454090113|FG000|Overall Study|Lost to Follow-up|0|||
126218041|NCT02923115|454090114|FG001|Overall Study|Lost to Follow-up|0|||
126218042|NCT02923115|454090115|FG002|Overall Study|Lost to Follow-up|0|||
126218043|NCT02923115|454090116|FG003|Overall Study|Lost to Follow-up|1|||
126218044|NCT02923115|454090117|FG004|Overall Study|Lost to Follow-up|0|||
126218045|NCT02923115|454090118|FG005|Overall Study|Lost to Follow-up|0|||
126218046|NCT02923115|454090113|FG000|Overall Study|Withdrawal by Subject|0|||
126218047|NCT02923115|454090114|FG001|Overall Study|Withdrawal by Subject|1|||
126218048|NCT02923115|454090115|FG002|Overall Study|Withdrawal by Subject|0|||
126218049|NCT02923115|454090116|FG003|Overall Study|Withdrawal by Subject|0|||
126218050|NCT02923115|454090117|FG004|Overall Study|Withdrawal by Subject|0|||
126218051|NCT02923115|454090118|FG005|Overall Study|Withdrawal by Subject|0|||
126218052|NCT02923115|454090113|FG000|Overall Study|Randomized, but not dosed|0|||
126218053|NCT02923115|454090114|FG001|Overall Study|Randomized, but not dosed|0|||
126218054|NCT02923115|454090115|FG002|Overall Study|Randomized, but not dosed|3|||
126218055|NCT02923115|454090116|FG003|Overall Study|Randomized, but not dosed|1|||
126218056|NCT02923115|454090117|FG004|Overall Study|Randomized, but not dosed|5|||
126218057|NCT02923115|454090118|FG005|Overall Study|Randomized, but not dosed|0|||
126218058|NCT04056299|454090119|FG000|Overall Study|Sponsor discontinued study|3|||
126218059|NCT04056299|454090120|FG001|Overall Study|Sponsor discontinued study|3|||
126218060|NCT00068406|454090122|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
126218061|NCT00068406|454090122|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
126218062|NCT03231709|454090123|FG000|Treatment Period 1|Reason not Specified|0|||
126218063|NCT03231709|454090124|FG001|Treatment Period 1|Reason not Specified|1|||
126218064|NCT03231709|454090123|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
126218065|NCT03231709|454090124|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
126218066|NCT03451331|454090125|FG000|Overall Study|Withdrawal by Subject|1|||
126218067|NCT03451331|454090126|FG001|Overall Study|Withdrawal by Subject|0|||
126017342|NCT00688519|453357050|FG000|Overall Study|Investigator decision|1|||
126017343|NCT00688519|453357051|FG001|Overall Study|Investigator decision|0|||
126017344|NCT00688519|453357050|FG000|Overall Study|Subject moved out of area|1|||
126017345|NCT00688519|453357051|FG001|Overall Study|Subject moved out of area|0|||
126017346|NCT00688519|453357050|FG000|Overall Study|Pregnancy|0|||
126218068|NCT03451331|454090125|FG000|Overall Study|Unable to start treatment.|1|||
126218069|NCT03451331|454090126|FG001|Overall Study|Unable to start treatment.|1|||
126218070|NCT01875991|454090127|FG000|Overall Study|Withdrawal by Subject|6|||
126218071|NCT01875991|454090128|FG001|Overall Study|Withdrawal by Subject|6|||
126218072|NCT01875991|454090127|FG000|Overall Study|Sponsor Decision|1|||
126218073|NCT01875991|454090128|FG001|Overall Study|Sponsor Decision|0|||
126218074|NCT02419469|454090129|FG000|Overall Study|Withdrawal by Subject|1|||
126218075|NCT02454972|454090130|FG000|Overall Study|Progressive disease|17|||
126218076|NCT02454972|454090131|FG001|Overall Study|Progressive disease|16|||
126218077|NCT02454972|454090132|FG002|Overall Study|Progressive disease|59|||
126218078|NCT02454972|454090133|FG003|Overall Study|Progressive disease|23|||
126218079|NCT02454972|454090134|FG004|Overall Study|Progressive disease|16|||
126218080|NCT02454972|454090135|FG005|Overall Study|Progressive disease|12|||
126218081|NCT02454972|454090136|FG006|Overall Study|Progressive disease|19|||
126218082|NCT02454972|454090137|FG007|Overall Study|Progressive disease|27|||
126218083|NCT02454972|454090138|FG008|Overall Study|Progressive disease|0|||
126218084|NCT02454972|454090130|FG000|Overall Study|Death|0|||
126218085|NCT02454972|454090131|FG001|Overall Study|Death|0|||
126218086|NCT02454972|454090132|FG002|Overall Study|Death|5|||
126218087|NCT02454972|454090133|FG003|Overall Study|Death|1|||
126218088|NCT02454972|454090134|FG004|Overall Study|Death|0|||
126218089|NCT02454972|454090135|FG005|Overall Study|Death|0|||
126218090|NCT02454972|454090136|FG006|Overall Study|Death|0|||
126218091|NCT02454972|454090137|FG007|Overall Study|Death|0|||
126218092|NCT02454972|454090138|FG008|Overall Study|Death|95|||
126218093|NCT02454972|454090130|FG000|Overall Study|Physician Decision|0|||
126218094|NCT02454972|454090131|FG001|Overall Study|Physician Decision|1|||
126218095|NCT02454972|454090132|FG002|Overall Study|Physician Decision|2|||
126218096|NCT02454972|454090133|FG003|Overall Study|Physician Decision|1|||
126218097|NCT02454972|454090134|FG004|Overall Study|Physician Decision|2|||
126218098|NCT02454972|454090135|FG005|Overall Study|Physician Decision|0|||
126218099|NCT02454972|454090136|FG006|Overall Study|Physician Decision|0|||
126218100|NCT02454972|454090137|FG007|Overall Study|Physician Decision|1|||
126218101|NCT02454972|454090138|FG008|Overall Study|Physician Decision|0|||
126218102|NCT02454972|454090130|FG000|Overall Study|Non treatment-related adverse event|2|||
126218103|NCT02454972|454090131|FG001|Overall Study|Non treatment-related adverse event|0|||
126218104|NCT02454972|454090132|FG002|Overall Study|Non treatment-related adverse event|1|||
126218105|NCT02454972|454090133|FG003|Overall Study|Non treatment-related adverse event|0|||
126218106|NCT02454972|454090134|FG004|Overall Study|Non treatment-related adverse event|0|||
126218107|NCT02454972|454090135|FG005|Overall Study|Non treatment-related adverse event|1|||
126218108|NCT02454972|454090136|FG006|Overall Study|Non treatment-related adverse event|0|||
126218109|NCT02454972|454090137|FG007|Overall Study|Non treatment-related adverse event|1|||
126218110|NCT02454972|454090138|FG008|Overall Study|Non treatment-related adverse event|0|||
126218111|NCT02454972|454090130|FG000|Overall Study|Treatment-related adverse events|0|||
126218112|NCT02454972|454090131|FG001|Overall Study|Treatment-related adverse events|1|||
126218113|NCT02454972|454090132|FG002|Overall Study|Treatment-related adverse events|1|||
126218114|NCT02454972|454090133|FG003|Overall Study|Treatment-related adverse events|0|||
126218115|NCT02454972|454090134|FG004|Overall Study|Treatment-related adverse events|2|||
126218116|NCT02454972|454090135|FG005|Overall Study|Treatment-related adverse events|0|||
126218117|NCT02454972|454090136|FG006|Overall Study|Treatment-related adverse events|0|||
126218118|NCT02454972|454090137|FG007|Overall Study|Treatment-related adverse events|2|||
126218119|NCT02454972|454090138|FG008|Overall Study|Treatment-related adverse events|0|||
126218120|NCT02454972|454090130|FG000|Overall Study|Patient moves to compassionate use|0|||
126218121|NCT02454972|454090131|FG001|Overall Study|Patient moves to compassionate use|0|||
126091944|NCT01008410|453630478|FG001|Overall Study|Low Cortisol|0|||
126091945|NCT01008410|453630477|FG000|Overall Study|Lack of Efficacy|2|||
126091946|NCT01008410|453630478|FG001|Overall Study|Lack of Efficacy|6|||
126091947|NCT01008410|453630477|FG000|Overall Study|Met Exclusion Criterion|0|||
126091948|NCT01008410|453630478|FG001|Overall Study|Met Exclusion Criterion|1|||
126091949|NCT03056300|453630479|FG000|Overall Study|Surgical reason per study protocol|3|||
126091950|NCT03248882|453630480|FG000|Overall Study|Adverse Event|3|||
126091951|NCT03248882|453630481|FG001|Overall Study|Adverse Event|3|||
126017347|NCT00688519|453357051|FG001|Overall Study|Pregnancy|1|||
126218122|NCT02454972|454090132|FG002|Overall Study|Patient moves to compassionate use|0|||
126218123|NCT02454972|454090133|FG003|Overall Study|Patient moves to compassionate use|0|||
126218124|NCT02454972|454090134|FG004|Overall Study|Patient moves to compassionate use|0|||
126218125|NCT02454972|454090135|FG005|Overall Study|Patient moves to compassionate use|0|||
126091952|NCT03248882|453630482|FG002|Overall Study|Adverse Event|2|||
126091953|NCT03248882|453630483|FG003|Overall Study|Adverse Event|6|||
126017348|NCT01353963|453357052|FG000|Overall Study|Adverse Event|2|||
126218126|NCT02454972|454090136|FG006|Overall Study|Patient moves to compassionate use|2|||
126218127|NCT02454972|454090137|FG007|Overall Study|Patient moves to compassionate use|0|||
126218128|NCT02454972|454090138|FG008|Overall Study|Patient moves to compassionate use|0|||
126218129|NCT02454972|454090130|FG000|Overall Study|Withdrawal by Subject|0|||
126218130|NCT02454972|454090131|FG001|Overall Study|Withdrawal by Subject|1|||
126218131|NCT02454972|454090132|FG002|Overall Study|Withdrawal by Subject|5|||
126218132|NCT02454972|454090133|FG003|Overall Study|Withdrawal by Subject|2|||
126218133|NCT02454972|454090134|FG004|Overall Study|Withdrawal by Subject|3|||
126218134|NCT02454972|454090135|FG005|Overall Study|Withdrawal by Subject|2|||
126218135|NCT02454972|454090136|FG006|Overall Study|Withdrawal by Subject|0|||
126218136|NCT02454972|454090137|FG007|Overall Study|Withdrawal by Subject|1|||
126218137|NCT02454972|454090138|FG008|Overall Study|Withdrawal by Subject|2|||
126218138|NCT02454972|454090130|FG000|Overall Study|Multiple delay/holds on treatment|0|||
126218139|NCT02454972|454090131|FG001|Overall Study|Multiple delay/holds on treatment|0|||
126218140|NCT02454972|454090132|FG002|Overall Study|Multiple delay/holds on treatment|0|||
126218141|NCT02454972|454090133|FG003|Overall Study|Multiple delay/holds on treatment|1|||
126218142|NCT02454972|454090134|FG004|Overall Study|Multiple delay/holds on treatment|0|||
126218143|NCT02454972|454090135|FG005|Overall Study|Multiple delay/holds on treatment|0|||
126218144|NCT02454972|454090136|FG006|Overall Study|Multiple delay/holds on treatment|0|||
126218145|NCT02454972|454090137|FG007|Overall Study|Multiple delay/holds on treatment|0|||
126218146|NCT02454972|454090138|FG008|Overall Study|Multiple delay/holds on treatment|0|||
126218147|NCT02454972|454090130|FG000|Overall Study|Never treated|0|||
126218148|NCT02454972|454090131|FG001|Overall Study|Never treated|0|||
126218149|NCT02454972|454090132|FG002|Overall Study|Never treated|3|||
126218150|NCT02454972|454090133|FG003|Overall Study|Never treated|1|||
126218151|NCT02454972|454090134|FG004|Overall Study|Never treated|1|||
126218152|NCT02454972|454090135|FG005|Overall Study|Never treated|0|||
126218153|NCT02454972|454090136|FG006|Overall Study|Never treated|0|||
126218154|NCT02454972|454090137|FG007|Overall Study|Never treated|0|||
126218155|NCT02454972|454090138|FG008|Overall Study|Never treated|5|||
126218156|NCT02454972|454090130|FG000|Overall Study|Lost to Follow-up|0|||
126218157|NCT02454972|454090131|FG001|Overall Study|Lost to Follow-up|0|||
126218158|NCT02454972|454090132|FG002|Overall Study|Lost to Follow-up|0|||
126218159|NCT02454972|454090133|FG003|Overall Study|Lost to Follow-up|0|||
126218160|NCT02454972|454090134|FG004|Overall Study|Lost to Follow-up|0|||
126218161|NCT02454972|454090135|FG005|Overall Study|Lost to Follow-up|0|||
126218162|NCT02454972|454090136|FG006|Overall Study|Lost to Follow-up|0|||
126218163|NCT02454972|454090137|FG007|Overall Study|Lost to Follow-up|0|||
126218164|NCT02454972|454090138|FG008|Overall Study|Lost to Follow-up|2|||
126218165|NCT02454972|454090130|FG000|Overall Study|Study termination|0|||
126218166|NCT02454972|454090131|FG001|Overall Study|Study termination|0|||
126218167|NCT02454972|454090132|FG002|Overall Study|Study termination|0|||
126218168|NCT02454972|454090133|FG003|Overall Study|Study termination|0|||
126218169|NCT02454972|454090134|FG004|Overall Study|Study termination|0|||
126218170|NCT02454972|454090135|FG005|Overall Study|Study termination|0|||
126218171|NCT02454972|454090136|FG006|Overall Study|Study termination|0|||
126218172|NCT02454972|454090137|FG007|Overall Study|Study termination|0|||
126218173|NCT02454972|454090138|FG008|Overall Study|Study termination|6|||
126218174|NCT01377233|454090139|FG000|Open-label|Adverse Event|1|||
126218175|NCT01377233|454090140|FG001|Open-label|Adverse Event|0|||
126218176|NCT01377233|454090141|FG002|Open-label|Adverse Event|0|||
126218177|NCT01377233|454090142|FG003|Open-label|Adverse Event|0|||
126218178|NCT01377233|454090143|FG004|Open-label|Adverse Event|0|||
126218179|NCT01377233|454090139|FG000|Open-label|Withdrawal by Subject|3|||
126218180|NCT01377233|454090140|FG001|Open-label|Withdrawal by Subject|0|||
126218181|NCT01377233|454090141|FG002|Open-label|Withdrawal by Subject|0|||
126218182|NCT01377233|454090142|FG003|Open-label|Withdrawal by Subject|0|||
126218183|NCT01377233|454090143|FG004|Open-label|Withdrawal by Subject|0|||
126218184|NCT01377233|454090139|FG000|Double-blind|Adverse Event|0|||
126218185|NCT01377233|454090140|FG001|Double-blind|Adverse Event|1|||
126218186|NCT01377233|454090141|FG002|Double-blind|Adverse Event|2|||
126218187|NCT01377233|454090142|FG003|Double-blind|Adverse Event|2|||
126218188|NCT01377233|454090143|FG004|Double-blind|Adverse Event|0|||
126218189|NCT01377233|454090139|FG000|Double-blind|Protocol Violation|0|||
126218190|NCT01377233|454090140|FG001|Double-blind|Protocol Violation|0|||
126218191|NCT01377233|454090141|FG002|Double-blind|Protocol Violation|0|||
126218192|NCT01377233|454090142|FG003|Double-blind|Protocol Violation|0|||
126218193|NCT01377233|454090143|FG004|Double-blind|Protocol Violation|1|||
126218194|NCT01377233|454090139|FG000|Double-blind|Withdrawal by Subject|0|||
126218195|NCT01377233|454090140|FG001|Double-blind|Withdrawal by Subject|0|||
126218196|NCT01377233|454090141|FG002|Double-blind|Withdrawal by Subject|0|||
126218197|NCT01377233|454090142|FG003|Double-blind|Withdrawal by Subject|1|||
126218198|NCT01377233|454090143|FG004|Double-blind|Withdrawal by Subject|0|||
126218199|NCT01377233|454090139|FG000|Double-blind|Administrative or other|0|||
126218200|NCT01377233|454090140|FG001|Double-blind|Administrative or other|0|||
126218201|NCT01377233|454090141|FG002|Double-blind|Administrative or other|0|||
126218202|NCT01377233|454090142|FG003|Double-blind|Administrative or other|1|||
126017349|NCT04789408|453357053|FG000|Overall Study|Death|4|||
126218203|NCT01377233|454090143|FG004|Double-blind|Administrative or other|1|||
126218204|NCT01785875|454090144|FG000|Overall Study|Withdrawal by Subject|41|||
126218205|NCT01785875|454090145|FG001|Overall Study|Withdrawal by Subject|34|||
126218206|NCT01785875|454090146|FG002|Overall Study|Withdrawal by Subject|36|||
126218207|NCT01785875|454090144|FG000|Overall Study|Lost to Follow-up|19|||
126218208|NCT01785875|454090145|FG001|Overall Study|Lost to Follow-up|22|||
126218209|NCT01785875|454090146|FG002|Overall Study|Lost to Follow-up|6|||
126218210|NCT01785875|454090144|FG000|Overall Study|Death|27|||
126218211|NCT01785875|454090145|FG001|Overall Study|Death|16|||
126218212|NCT01785875|454090146|FG002|Overall Study|Death|7|||
126218213|NCT01785875|454090144|FG000|Overall Study|Sponsor Decision|0|||
126218214|NCT01785875|454090145|FG001|Overall Study|Sponsor Decision|2|||
126218215|NCT01785875|454090146|FG002|Overall Study|Sponsor Decision|0|||
126218216|NCT01785875|454090144|FG000|Overall Study|Protocol Specified Criteria|207|||
126218217|NCT01785875|454090145|FG001|Overall Study|Protocol Specified Criteria|214|||
126218218|NCT01785875|454090146|FG002|Overall Study|Protocol Specified Criteria|55|||
126218219|NCT01785875|454090144|FG000|Overall Study|Missing|0|||
126218220|NCT01785875|454090145|FG001|Overall Study|Missing|1|||
126218221|NCT01785875|454090146|FG002|Overall Study|Missing|3|||
126218222|NCT04991311|454090149|FG000|Overall Study|Adverse Event|1|||
126218223|NCT00755937|454090150|FG000|Recruitment|Unknown if infliximab received|164|||
126218224|NCT00755937|454090150|FG000|Observational Follow-up|Lost to Follow-up|148|||
126218225|NCT00572156|454090153|FG000|Overall Study|Adverse Event|3|||
126218226|NCT00572156|454090154|FG001|Overall Study|Adverse Event|1|||
126218227|NCT00572156|454090155|FG002|Overall Study|Adverse Event|5|||
126218228|NCT00572156|454090156|FG003|Overall Study|Adverse Event|1|||
126218229|NCT00572156|454090153|FG000|Overall Study|Lost to Follow-up|1|||
126218230|NCT00572156|454090154|FG001|Overall Study|Lost to Follow-up|1|||
126218231|NCT00572156|454090155|FG002|Overall Study|Lost to Follow-up|1|||
126218232|NCT00572156|454090156|FG003|Overall Study|Lost to Follow-up|0|||
126218233|NCT00572156|454090153|FG000|Overall Study|Protocol Violation|1|||
126218234|NCT00572156|454090154|FG001|Overall Study|Protocol Violation|2|||
126218235|NCT00572156|454090155|FG002|Overall Study|Protocol Violation|0|||
126218236|NCT00572156|454090156|FG003|Overall Study|Protocol Violation|2|||
126218237|NCT00572156|454090153|FG000|Overall Study|Patient/Parent Decision|1|||
126218238|NCT00572156|454090154|FG001|Overall Study|Patient/Parent Decision|6|||
126218239|NCT00572156|454090155|FG002|Overall Study|Patient/Parent Decision|4|||
126218240|NCT00572156|454090156|FG003|Overall Study|Patient/Parent Decision|3|||
126218241|NCT00572156|454090153|FG000|Overall Study|Sponsor Decision|20|||
126218242|NCT00572156|454090154|FG001|Overall Study|Sponsor Decision|16|||
126218243|NCT00572156|454090155|FG002|Overall Study|Sponsor Decision|17|||
126218244|NCT00572156|454090156|FG003|Overall Study|Sponsor Decision|19|||
126218245|NCT02261974|454090157|FG000|Overall Study|Withdrawal by Subject|3|||
126218246|NCT02261974|454090158|FG001|Overall Study|Withdrawal by Subject|2|||
126218247|NCT02261974|454090157|FG000|Overall Study|Pregnancy|0|||
126218248|NCT02261974|454090158|FG001|Overall Study|Pregnancy|1|||
126218249|NCT02261974|454090157|FG000|Overall Study|Missed treatment cut-off date|6|||
126218250|NCT02261974|454090158|FG001|Overall Study|Missed treatment cut-off date|3|||
126218251|NCT02261974|454090157|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
126218252|NCT02261974|454090158|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
126218253|NCT02261974|454090157|FG000|Overall Study|Lost to Follow-up|2|||
126218254|NCT02261974|454090158|FG001|Overall Study|Lost to Follow-up|0|||
126091954|NCT03248882|453630484|FG004|Overall Study|Adverse Event|9|||
126091955|NCT03248882|453630480|FG000|Overall Study|Lost to Follow-up|0|||
126091956|NCT03248882|453630481|FG001|Overall Study|Lost to Follow-up|0|||
126091957|NCT03248882|453630482|FG002|Overall Study|Lost to Follow-up|0|||
126091958|NCT03248882|453630483|FG003|Overall Study|Lost to Follow-up|0|||
126091959|NCT03248882|453630484|FG004|Overall Study|Lost to Follow-up|1|||
126091960|NCT03248882|453630480|FG000|Overall Study|Protocol Violation|2|||
126091961|NCT03248882|453630481|FG001|Overall Study|Protocol Violation|0|||
126091962|NCT03248882|453630482|FG002|Overall Study|Protocol Violation|2|||
126091963|NCT03248882|453630483|FG003|Overall Study|Protocol Violation|0|||
126091964|NCT03248882|453630484|FG004|Overall Study|Protocol Violation|1|||
126091965|NCT03248882|453630480|FG000|Overall Study|Withdrawal by Subject|2|||
126091966|NCT03248882|453630481|FG001|Overall Study|Withdrawal by Subject|2|||
126091967|NCT03248882|453630482|FG002|Overall Study|Withdrawal by Subject|3|||
126091968|NCT03248882|453630483|FG003|Overall Study|Withdrawal by Subject|4|||
126091969|NCT03248882|453630484|FG004|Overall Study|Withdrawal by Subject|2|||
126091970|NCT01656200|453630485|FG000|Overall Study|Withdrawal by Subject|1|||
126017350|NCT04789408|453357054|FG001|Overall Study|Death|3|||
126091971|NCT03174431|453630486|FG000|Overall Study|Withdrawal by Subject|14|||
126091972|NCT03174431|453630487|FG001|Overall Study|Withdrawal by Subject|11|||
126218255|NCT02261974|454090157|FG000|Overall Study|Adverse Event|1|||
126218256|NCT02261974|454090158|FG001|Overall Study|Adverse Event|0|||
126218257|NCT01440595|454090159|FG000|Overall Study|Lost to Follow-up|0|||
126218258|NCT01440595|454090160|FG001|Overall Study|Lost to Follow-up|1|||
126218259|NCT01440595|454090161|FG002|Overall Study|Lost to Follow-up|0|||
126218260|NCT01440595|454090159|FG000|Overall Study|Study terminated by sponsor.|1|||
126218261|NCT01440595|454090160|FG001|Overall Study|Study terminated by sponsor.|2|||
126218262|NCT01440595|454090161|FG002|Overall Study|Study terminated by sponsor.|1|||
126218263|NCT01347879|454090162|FG000|Overall Study|Adverse Event|0|||
126218264|NCT01347879|454090163|FG001|Overall Study|Adverse Event|12|||
126218265|NCT01347879|454090162|FG000|Overall Study|Lost to Follow-up|2|||
126218266|NCT01347879|454090163|FG001|Overall Study|Lost to Follow-up|0|||
126218267|NCT01347879|454090162|FG000|Overall Study|Withdrawal by Subject|3|||
126218268|NCT01347879|454090163|FG001|Overall Study|Withdrawal by Subject|2|||
126218269|NCT01347879|454090162|FG000|Overall Study|Other|2|||
126218270|NCT01347879|454090163|FG001|Overall Study|Other|3|||
126218271|NCT01223196|454090164|FG000|Overall Study|Lost to Follow-up|2|||
126218272|NCT01223196|454090165|FG001|Overall Study|Lost to Follow-up|0|||
126218273|NCT01223196|454090164|FG000|Overall Study|Physician Decision|1|||
126218274|NCT01223196|454090165|FG001|Overall Study|Physician Decision|0|||
126218275|NCT01223196|454090164|FG000|Overall Study|Withdrawal by Subject|1|||
126218276|NCT01223196|454090165|FG001|Overall Study|Withdrawal by Subject|0|||
126218277|NCT01238822|454090170|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
126218278|NCT05180630|454090174|FG000|First Intervention|Physician Decision|0|||
126218279|NCT05180630|454090175|FG001|First Intervention|Physician Decision|0|||
126218280|NCT05180630|454090176|FG002|First Intervention|Physician Decision|3|||
126218281|NCT02725671|454090182|FG000|Overall Study|Lost to Follow-up|1|||
126218282|NCT00965263|454090183|FG000|Overall Study|Physician Decision|2|||
126218283|NCT00965263|454090184|FG001|Overall Study|Physician Decision|0|||
126218284|NCT00965263|454090183|FG000|Overall Study|Family emergency|0|||
126218285|NCT00965263|454090184|FG001|Overall Study|Family emergency|1|||
126218286|NCT00965263|454090183|FG000|Overall Study|Protocol Violation|0|||
126218287|NCT00965263|454090184|FG001|Overall Study|Protocol Violation|2|||
126218288|NCT00963599|454090185|FG000|Overall Study|Adverse Event|2|||
126017351|NCT04789408|453357055|FG002|Overall Study|Death|6|||
126218289|NCT00963599|454090186|FG001|Overall Study|Adverse Event|0|||
126017352|NCT04789408|453357053|FG000|Overall Study|Did not meet eligibility criteria|1|||
126218290|NCT00963599|454090187|FG002|Overall Study|Adverse Event|1|||
126218291|NCT00963599|454090188|FG003|Overall Study|Adverse Event|2|||
126218292|NCT00963599|454090185|FG000|Overall Study|Lack of Efficacy|0|||
126218293|NCT00963599|454090186|FG001|Overall Study|Lack of Efficacy|2|||
126218294|NCT00963599|454090187|FG002|Overall Study|Lack of Efficacy|1|||
126218295|NCT00963599|454090188|FG003|Overall Study|Lack of Efficacy|4|||
126218296|NCT00963599|454090185|FG000|Overall Study|Lost to Follow-up|0|||
126218297|NCT00963599|454090186|FG001|Overall Study|Lost to Follow-up|1|||
126218298|NCT00963599|454090187|FG002|Overall Study|Lost to Follow-up|1|||
126218299|NCT00963599|454090188|FG003|Overall Study|Lost to Follow-up|1|||
126218300|NCT00963599|454090185|FG000|Overall Study|Protocol Violation|2|||
126218301|NCT00963599|454090186|FG001|Overall Study|Protocol Violation|2|||
126218302|NCT00963599|454090187|FG002|Overall Study|Protocol Violation|3|||
126218303|NCT00963599|454090188|FG003|Overall Study|Protocol Violation|4|||
126218304|NCT00963599|454090185|FG000|Overall Study|Withdrawal by Subject|2|||
126218305|NCT00963599|454090186|FG001|Overall Study|Withdrawal by Subject|1|||
126218306|NCT00963599|454090187|FG002|Overall Study|Withdrawal by Subject|3|||
126218307|NCT00963599|454090188|FG003|Overall Study|Withdrawal by Subject|3|||
126218308|NCT03496207|454090191|FG000|Base Study|Adverse Event|0|||
126218309|NCT03496207|454090192|FG001|Base Study|Adverse Event|0|||
126218310|NCT03496207|454090193|FG002|Base Study|Adverse Event|1|||
126218311|NCT03496207|454090194|FG003|Base Study|Adverse Event|1|||
126218312|NCT03496207|454090195|FG004|Base Study|Adverse Event|4|||
126218313|NCT03496207|454090191|FG000|Base Study|Death|0|||
126218314|NCT03496207|454090192|FG001|Base Study|Death|0|||
126218315|NCT03496207|454090193|FG002|Base Study|Death|0|||
126218316|NCT03496207|454090194|FG003|Base Study|Death|0|||
126218317|NCT03496207|454090195|FG004|Base Study|Death|1|||
126218318|NCT03496207|454090191|FG000|Base Study|Withdrawal by Subject|0|||
126218319|NCT03496207|454090192|FG001|Base Study|Withdrawal by Subject|0|||
126218320|NCT03496207|454090193|FG002|Base Study|Withdrawal by Subject|1|||
126218321|NCT03496207|454090194|FG003|Base Study|Withdrawal by Subject|0|||
126218322|NCT03496207|454090195|FG004|Base Study|Withdrawal by Subject|1|||
126218323|NCT03496207|454090191|FG000|Extension Period|Adverse Event|0|||
126218324|NCT03496207|454090192|FG001|Extension Period|Adverse Event|0|||
126218325|NCT03496207|454090193|FG002|Extension Period|Adverse Event|0|||
126218326|NCT03496207|454090194|FG003|Extension Period|Adverse Event|1|||
126218327|NCT03496207|454090195|FG004|Extension Period|Adverse Event|1|||
126218328|NCT03496207|454090191|FG000|Extension Period|Death|1|||
126218329|NCT03496207|454090192|FG001|Extension Period|Death|0|||
126218330|NCT03496207|454090193|FG002|Extension Period|Death|0|||
126218331|NCT03496207|454090194|FG003|Extension Period|Death|1|||
126218332|NCT03496207|454090195|FG004|Extension Period|Death|2|||
126218333|NCT03496207|454090191|FG000|Extension Period|Withdrawal by Subject|1|||
126218334|NCT03496207|454090192|FG001|Extension Period|Withdrawal by Subject|0|||
126218335|NCT03496207|454090193|FG002|Extension Period|Withdrawal by Subject|0|||
126218336|NCT03496207|454090194|FG003|Extension Period|Withdrawal by Subject|1|||
126218337|NCT03496207|454090195|FG004|Extension Period|Withdrawal by Subject|1|||
126218338|NCT03496207|454090191|FG000|Extension Period|Elevated hemoglobin levels|0|||
126218339|NCT03496207|454090192|FG001|Extension Period|Elevated hemoglobin levels|0|||
126218340|NCT03496207|454090193|FG002|Extension Period|Elevated hemoglobin levels|0|||
126218341|NCT03496207|454090194|FG003|Extension Period|Elevated hemoglobin levels|0|||
126218342|NCT03496207|454090195|FG004|Extension Period|Elevated hemoglobin levels|1|||
126218343|NCT00123487|454090196|FG000|Randomized|Death prior to starting treatment|0|||
126218344|NCT00123487|454090197|FG001|Randomized|Death prior to starting treatment|1|||
126218345|NCT00123487|454090196|FG000|Randomized|SAE prior to starting treatment|1|||
126218346|NCT00123487|454090197|FG001|Randomized|SAE prior to starting treatment|0|||
126218347|NCT00123487|454090196|FG000|Treated With Study Drug|Adverse Event|23|||
126218348|NCT00123487|454090197|FG001|Treated With Study Drug|Adverse Event|22|||
126218349|NCT00123487|454090196|FG000|Treated With Study Drug|Disease Progression|141|||
126218350|NCT00123487|454090197|FG001|Treated With Study Drug|Disease Progression|122|||
126218351|NCT00123487|454090196|FG000|Treated With Study Drug|Physician Decision|8|||
126218352|NCT00123487|454090197|FG001|Treated With Study Drug|Physician Decision|9|||
126218353|NCT00123487|454090196|FG000|Treated With Study Drug|Other|59|||
126218354|NCT00123487|454090197|FG001|Treated With Study Drug|Other|58|||
126218355|NCT00123487|454090196|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
126218356|NCT00123487|454090197|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
126218357|NCT00123487|454090196|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
126218358|NCT00123487|454090197|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
126218359|NCT00123487|454090196|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
126218360|NCT00123487|454090197|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
126218361|NCT00995488|454090198|FG000|Overall Study|Withdrawal by Subject|1|||
126218362|NCT03672396|454090201|FG000|Overall Study|Withdrawal by Subject|4|||
126218363|NCT03672396|454090201|FG000|Overall Study|Physician Decision|1|||
126218364|NCT03672396|454090201|FG000|Overall Study|Adverse Event|1|||
126218365|NCT01084603|454091734|FG000|Baseline|Withdrawal by Subject|2|||
126218366|NCT01084603|454091734|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
126218367|NCT01084603|454091734|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
126218368|NCT01084603|454091734|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
126218369|NCT01084603|454091734|FG000|Washout Period 4|Adverse Event|1|||
126218370|NCT03862625|454091736|FG000|Overall Study|Lost to Follow-up|0|||
126218371|NCT03862625|454091737|FG001|Overall Study|Lost to Follow-up|1|||
126218372|NCT01791127|454091738|FG000|Overall Study|Death|356|||
126218373|NCT01791127|454091738|FG000|Overall Study|Patient has withdrawn from study|293|||
126017353|NCT04789408|453357054|FG001|Overall Study|Did not meet eligibility criteria|0|||
126017354|NCT04789408|453357055|FG002|Overall Study|Did not meet eligibility criteria|0|||
126017355|NCT04789408|453357053|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
126017356|NCT04789408|453357054|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
126017357|NCT04789408|453357055|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
126017358|NCT02079844|453357056|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
126017359|NCT02079844|453357057|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
126017360|NCT02079844|453357058|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
126017361|NCT02079844|453357056|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
126017362|NCT02079844|453357057|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
126017363|NCT02079844|453357058|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
126017364|NCT01420549|453357059|FG000|Overall Study|Adverse Event|1|||
126017365|NCT01420549|453357060|FG001|Overall Study|Adverse Event|1|||
126017366|NCT01420549|453357059|FG000|Overall Study|Lost to Follow-up|2|||
126017367|NCT01420549|453357060|FG001|Overall Study|Lost to Follow-up|2|||
126017368|NCT01420549|453357059|FG000|Overall Study|Protocol Violation|0|||
126017369|NCT01420549|453357060|FG001|Overall Study|Protocol Violation|1|||
126017370|NCT01420549|453357059|FG000|Overall Study|Non-adherence to medication|4|||
126017371|NCT01420549|453357060|FG001|Overall Study|Non-adherence to medication|1|||
126017372|NCT00925899|453358816|FG000|Part 1|Death|1|||
126017373|NCT00925899|453358817|FG001|Part 1|Death|2|||
126017374|NCT00925899|453358816|FG000|Part 1|Withdrawal by Subject|10|||
126017375|NCT00925899|453358817|FG001|Part 1|Withdrawal by Subject|9|||
126017376|NCT00683696|453358818|FG000|Overall Study|Withdrawn due to study closure|337|||
126017377|NCT00683696|453358819|FG001|Overall Study|Withdrawn due to study closure|338|||
126017378|NCT00683696|453358818|FG000|Overall Study|Withdrawn prior to study closure|13|||
126017379|NCT00683696|453358819|FG001|Overall Study|Withdrawn prior to study closure|28|||
126017380|NCT00683696|453358818|FG000|Overall Study|Lost to Follow-up|5|||
126017381|NCT00683696|453358819|FG001|Overall Study|Lost to Follow-up|6|||
126017382|NCT00683696|453358818|FG000|Overall Study|Vital status follow-up only|3|||
126017383|NCT00683696|453358819|FG001|Overall Study|Vital status follow-up only|3|||
126017384|NCT00683696|453358818|FG000|Overall Study|Death|46|||
126017385|NCT00683696|453358819|FG001|Overall Study|Death|30|||
126017386|NCT02396316|453358820|FG000|Overall Study|Physician Decision|1|||
126017387|NCT02396316|453358821|FG001|Overall Study|Physician Decision|0|||
126017388|NCT02396316|453358820|FG000|Overall Study|Progressive disease|6|||
126017389|NCT02396316|453358821|FG001|Overall Study|Progressive disease|3|||
126017390|NCT02396316|453358820|FG000|Overall Study|Protocol Violation|0|||
126017391|NCT02396316|453358821|FG001|Overall Study|Protocol Violation|1|||
126017392|NCT02396316|453358820|FG000|Overall Study|Treatment unblinded|0|||
126017393|NCT02396316|453358821|FG001|Overall Study|Treatment unblinded|1|||
126017394|NCT00566735|453358822|FG000|Overall Study|Withdrawal by Subject|0|||
126017395|NCT00566735|453358823|FG001|Overall Study|Withdrawal by Subject|1|||
126017396|NCT00566735|453358822|FG000|Overall Study|Refused neuropsychological testing|2|||
126017397|NCT00566735|453358823|FG001|Overall Study|Refused neuropsychological testing|5|||
126017398|NCT00566735|453358822|FG000|Overall Study|Switched into a manic episode|0|||
126017399|NCT00566735|453358823|FG001|Overall Study|Switched into a manic episode|1|||
126017400|NCT00925587|453358825|FG000|Overall Study|Protocol Specified Criteria|6|||
126017401|NCT00925587|453358826|FG001|Overall Study|Protocol Specified Criteria|6|||
126017402|NCT00925587|453358825|FG000|Overall Study|Physician Decision|4|||
126017403|NCT00925587|453358826|FG001|Overall Study|Physician Decision|1|||
126017404|NCT00925587|453358825|FG000|Overall Study|Protocol Violation|6|||
126017405|NCT00925587|453358826|FG001|Overall Study|Protocol Violation|4|||
126017406|NCT00925587|453358825|FG000|Overall Study|Withdrawal by Subject|9|||
126017407|NCT00925587|453358826|FG001|Overall Study|Withdrawal by Subject|6|||
126017408|NCT00925587|453358825|FG000|Overall Study|Death|5|||
126017409|NCT00925587|453358826|FG001|Overall Study|Death|5|||
126017410|NCT00925587|453358825|FG000|Overall Study|Adverse Event|6|||
126091973|NCT03174431|453630486|FG000|Overall Study|alternative treatment|2|||
126091974|NCT03174431|453630487|FG001|Overall Study|alternative treatment|0|||
126091975|NCT03174431|453630486|FG000|Overall Study|Lost to Follow-up|1|||
126017411|NCT00925587|453358826|FG001|Overall Study|Adverse Event|2|||
126017412|NCT00925587|453358825|FG000|Overall Study|Lost to Follow-up|0|||
126017413|NCT00925587|453358826|FG001|Overall Study|Lost to Follow-up|1|||
126017414|NCT00071799|453358834|FG000|Overall Study|Adverse Event|19|||
126017415|NCT00071799|453358835|FG001|Overall Study|Adverse Event|10|||
126017416|NCT00071799|453358834|FG000|Overall Study|Protocol Violation|1|||
126017417|NCT00071799|453358835|FG001|Overall Study|Protocol Violation|7|||
126017418|NCT00071799|453358834|FG000|Overall Study|Lost to Follow-up|1|||
126017419|NCT00071799|453358835|FG001|Overall Study|Lost to Follow-up|1|||
126017420|NCT00071799|453358834|FG000|Overall Study|Withdrawal by Subject|15|||
126017421|NCT00071799|453358835|FG001|Overall Study|Withdrawal by Subject|37|||
126017422|NCT00071799|453358834|FG000|Overall Study|Physician Decision|0|||
126017423|NCT00071799|453358835|FG001|Overall Study|Physician Decision|2|||
126017424|NCT00071799|453358834|FG000|Overall Study|Lack of Efficacy|11|||
126017425|NCT00071799|453358835|FG001|Overall Study|Lack of Efficacy|18|||
126017426|NCT00071799|453358834|FG000|Overall Study|Disease Progression|23|||
126017427|NCT00071799|453358835|FG001|Overall Study|Disease Progression|20|||
126017428|NCT00071799|453358834|FG000|Overall Study|Different Central+Local Pathology Review|0|||
126017429|NCT00071799|453358835|FG001|Overall Study|Different Central+Local Pathology Review|1|||
126017430|NCT00071799|453358834|FG000|Overall Study|Not Documented|0|||
126017431|NCT00071799|453358835|FG001|Overall Study|Not Documented|2|||
126017432|NCT00979992|453358836|FG000|Overall Study|Ineligible - inadequate pathology|1|||
126017433|NCT00979992|453358836|FG000|Overall Study|Ineligible - wrong cell type|2|||
126017434|NCT00979992|453358836|FG000|Overall Study|Refused - Never Treated|2|||
126017435|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
126017436|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
126017437|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
126017438|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
126017439|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
126017440|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
126017441|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
126017442|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
126017443|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
126017444|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
126017445|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
126017446|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
126017447|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
126017448|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
126017449|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
126017450|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
126017451|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
126017452|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
126017453|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
126017454|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
126017455|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
126017456|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
126017457|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
126017458|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
126017459|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
126017460|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
126017461|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
126017462|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
126017463|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
126017464|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
126017465|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
126017466|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
126017467|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
126017468|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
126017469|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
126017470|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
126017471|NCT03593213|453358837|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
126017472|NCT03593213|453358838|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
126017473|NCT03593213|453358839|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
126017474|NCT03593213|453358840|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
126017475|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
126017476|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
126017477|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
126017478|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
126218374|NCT01791127|454091738|FG000|Overall Study|Lost to Follow-up|42|||
126218375|NCT01791127|454091738|FG000|Overall Study|All Siello leads are explanted|31|||
126218376|NCT01791127|454091738|FG000|Overall Study|Completion of 30 day safety registry|1|||
126218377|NCT01791127|454091738|FG000|Overall Study|Study terminated for EP Passion|749|||
126091976|NCT03174431|453630487|FG001|Overall Study|Lost to Follow-up|5|||
126091977|NCT01867333|453630488|FG000|Overall Study|Withdrawal by Subject|1|||
126091978|NCT01867333|453630489|FG001|Overall Study|Withdrawal by Subject|0|||
126017479|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
126017480|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
126017481|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
126017482|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
126218378|NCT00520494|454091739|FG000|Overall Study|Withdrawal by Subject|1|||
126218379|NCT03471182|454091743|FG000|Overall Study|Withdrawal by Subject|1|||
126218380|NCT03471182|454091744|FG001|Overall Study|Withdrawal by Subject|1|||
126218381|NCT03471182|454091745|FG002|Overall Study|Withdrawal by Subject|0|||
126218382|NCT03471182|454091743|FG000|Overall Study|Technical failure|2|||
126218383|NCT03471182|454091744|FG001|Overall Study|Technical failure|0|||
126218384|NCT03471182|454091745|FG002|Overall Study|Technical failure|0|||
126218385|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
126218386|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
126218387|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
126218388|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
126218389|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
126218390|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
126218391|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
126218392|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
126218393|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126218394|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126218395|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126218396|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
126218397|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
126218398|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126218399|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126218400|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126218401|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
126218402|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
126218403|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
126218404|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
126218405|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
126218406|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
126218407|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
126218408|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
126218409|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
126218410|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126218411|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
126218412|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126218413|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
126218414|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126218415|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126218416|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126218417|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
126218418|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
126218419|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
126218420|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
126218421|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
126218422|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
126218423|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
126218424|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
126218425|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
126218426|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
126218427|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
126218428|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
126218429|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
126218430|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
126218431|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
126218432|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
126218433|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
126218434|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
126218435|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126218436|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
126218437|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126218438|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126218439|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126218440|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126218441|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
126017483|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
126218442|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
126218443|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
126218444|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
126218445|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
126218446|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
126218447|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
126218448|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
126218449|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
126218450|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
126218451|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
126218452|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
126218453|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
126218454|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
126218455|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
126218456|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
126218457|NCT04440163|454091746|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
126218458|NCT04440163|454091747|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
126218459|NCT04440163|454091748|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
126218460|NCT04440163|454091749|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
126218461|NCT04440163|454091750|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
126218462|NCT04440163|454091751|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
126218463|NCT04440163|454091752|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
126218464|NCT04440163|454091753|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
126218465|NCT04440163|454091746|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
126218466|NCT04440163|454091747|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
126218467|NCT04440163|454091748|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
126218468|NCT04440163|454091749|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
126218469|NCT04440163|454091750|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
126218470|NCT04440163|454091751|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
126218471|NCT04440163|454091752|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
126218472|NCT04440163|454091753|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
126218473|NCT04440163|454091746|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126218474|NCT04440163|454091747|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126218475|NCT04440163|454091748|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126218476|NCT04440163|454091749|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
126218477|NCT04440163|454091750|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126218478|NCT04440163|454091751|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126218479|NCT04440163|454091752|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126218480|NCT04440163|454091753|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126218481|NCT02018042|454091756|FG000|Overall Study|Withdrawal by Subject|1|||
126218482|NCT01954082|454091757|FG000|Overall Study|Study Suspension|42|||
126218483|NCT01954082|454091758|FG001|Overall Study|Study Suspension|36|||
126218484|NCT01954082|454091757|FG000|Overall Study|Adverse Event|10|||
126218485|NCT01954082|454091758|FG001|Overall Study|Adverse Event|4|||
126218486|NCT01954082|454091757|FG000|Overall Study|Intolerance|0|||
126218487|NCT01954082|454091758|FG001|Overall Study|Intolerance|1|||
126218488|NCT01954082|454091757|FG000|Overall Study|Non-compliance|6|||
126218489|NCT01954082|454091758|FG001|Overall Study|Non-compliance|4|||
126218490|NCT01954082|454091757|FG000|Overall Study|Physician Decision|2|||
126218491|NCT01954082|454091758|FG001|Overall Study|Physician Decision|0|||
126218492|NCT01954082|454091757|FG000|Overall Study|Parent Decision|1|||
126218493|NCT01954082|454091758|FG001|Overall Study|Parent Decision|0|||
126218494|NCT01954082|454091757|FG000|Overall Study|Withdrawal by Subject|0|||
126218495|NCT01954082|454091758|FG001|Overall Study|Withdrawal by Subject|1|||
126218496|NCT01954082|454091757|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
126218497|NCT01954082|454091758|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
126218498|NCT01954082|454091757|FG000|Overall Study|Redirection of Care|0|||
126218499|NCT01954082|454091758|FG001|Overall Study|Redirection of Care|2|||
126218500|NCT01954082|454091757|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
126218501|NCT01954082|454091758|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
126218502|NCT01954082|454091757|FG000|Overall Study|Comfort Care|0|||
126218503|NCT01954082|454091758|FG001|Overall Study|Comfort Care|1|||
126218504|NCT01954082|454091757|FG000|Overall Study|Infant Moved|0|||
126218505|NCT01954082|454091758|FG001|Overall Study|Infant Moved|1|||
126218506|NCT01954082|454091757|FG000|Overall Study|Randomized not Treated|4|||
126218507|NCT01954082|454091758|FG001|Overall Study|Randomized not Treated|2|||
126218508|NCT00707174|454091761|FG000|Overall Study|Adverse Event|1|||
126218509|NCT00707174|454091762|FG001|Overall Study|Adverse Event|6|||
126218510|NCT00707174|454091761|FG000|Overall Study|Withdrawal by Subject|4|||
126218511|NCT00707174|454091762|FG001|Overall Study|Withdrawal by Subject|1|||
126017484|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
126017485|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
126218512|NCT01453374|454091763|FG000|Overall Study|Adverse Event|7|||
126218513|NCT01453374|454091763|FG000|Overall Study|Lack of Efficacy|1|||
126218514|NCT01453374|454091763|FG000|Overall Study|Lost to Follow-up|3|||
126218515|NCT01453374|454091763|FG000|Overall Study|Withdrawal by Subject|5|||
126218516|NCT01453374|454091763|FG000|Overall Study|Incarcerated|2|||
126218517|NCT00709735|454091771|FG000|Overall Study|Lost to Follow-up|1|||
126218518|NCT00709735|454091772|FG001|Overall Study|Lost to Follow-up|1|||
126218519|NCT00709735|454091771|FG000|Overall Study|Relapse into Opioid Abuse|0|||
126218520|NCT00709735|454091772|FG001|Overall Study|Relapse into Opioid Abuse|1|||
126218521|NCT00709735|454091771|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
126218522|NCT00709735|454091772|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
126218523|NCT00666718|454091773|FG000|Overall Study|Adverse Event|0|||
126218524|NCT00666718|454091774|FG001|Overall Study|Adverse Event|1|||
126218525|NCT00666718|454091773|FG000|Overall Study|Death|1|||
126218526|NCT00666718|454091774|FG001|Overall Study|Death|0|||
126218527|NCT00666718|454091773|FG000|Overall Study|Lost to Follow-up|1|||
126218528|NCT00666718|454091774|FG001|Overall Study|Lost to Follow-up|0|||
126218529|NCT00666718|454091773|FG000|Overall Study|Entry Criteria Not Met|2|||
126218530|NCT00666718|454091774|FG001|Overall Study|Entry Criteria Not Met|0|||
126218531|NCT00666718|454091773|FG000|Overall Study|Protocol Violation|1|||
126218532|NCT00666718|454091774|FG001|Overall Study|Protocol Violation|3|||
126218533|NCT00666718|454091773|FG000|Overall Study|Withdrawal by Subject|7|||
126218534|NCT00666718|454091774|FG001|Overall Study|Withdrawal by Subject|12|||
126218535|NCT00666718|454091773|FG000|Overall Study|Physician Decision|0|||
126218536|NCT00666718|454091774|FG001|Overall Study|Physician Decision|2|||
126218537|NCT00810615|454091777|FG000|Overall Study|Withdrawal by Subject|1|||
126218538|NCT00810615|454091778|FG001|Overall Study|Withdrawal by Subject|1|||
126218539|NCT02525562|454091779|FG000|Overall Study|Death|9|||
126218540|NCT02525562|454091780|FG001|Overall Study|Death|0|||
126218541|NCT02525562|454091781|FG002|Overall Study|Death|0|||
126218542|NCT02525562|454091779|FG000|Overall Study|Lost to Follow-up|19|||
126218543|NCT02525562|454091780|FG001|Overall Study|Lost to Follow-up|0|||
126218544|NCT02525562|454091781|FG002|Overall Study|Lost to Follow-up|0|||
126218545|NCT02525562|454091779|FG000|Overall Study|Withdrawal by Subject|37|||
126218546|NCT02525562|454091780|FG001|Overall Study|Withdrawal by Subject|0|||
126218547|NCT02525562|454091781|FG002|Overall Study|Withdrawal by Subject|0|||
126218548|NCT02525562|454091779|FG000|Overall Study|Revision/Removal of Study Device|4|||
126218549|NCT02525562|454091780|FG001|Overall Study|Revision/Removal of Study Device|0|||
126218550|NCT02525562|454091781|FG002|Overall Study|Revision/Removal of Study Device|0|||
126218551|NCT02525562|454091779|FG000|Overall Study|Study Closed by Sponsor|154|||
126218552|NCT02525562|454091780|FG001|Overall Study|Study Closed by Sponsor|0|||
126218553|NCT02525562|454091781|FG002|Overall Study|Study Closed by Sponsor|0|||
126218554|NCT02567266|454091782|FG000|Overall Study|Withdrawal by Subject|10|||
126218555|NCT02567266|454091783|FG001|Overall Study|Withdrawal by Subject|7|||
126218556|NCT02567266|454091784|FG002|Overall Study|Withdrawal by Subject|6|||
126218557|NCT02567266|454091782|FG000|Overall Study|Lost to Follow-up|13|||
126017486|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
126017487|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
126218558|NCT02567266|454091783|FG001|Overall Study|Lost to Follow-up|8|||
126218559|NCT02567266|454091784|FG002|Overall Study|Lost to Follow-up|10|||
126218560|NCT01255722|454091785|FG000|Overall Study|Adverse Event|0|||
126218561|NCT01255722|454091786|FG001|Overall Study|Adverse Event|1|||
126218562|NCT01255722|454091787|FG002|Overall Study|Adverse Event|1|||
126218563|NCT01255722|454091785|FG000|Overall Study|asymptomatic patient|1|||
126218564|NCT01255722|454091786|FG001|Overall Study|asymptomatic patient|0|||
126218565|NCT01255722|454091787|FG002|Overall Study|asymptomatic patient|0|||
126218566|NCT01255722|454091785|FG000|Overall Study|beta-blocker contraindicated|2|||
126218567|NCT01255722|454091786|FG001|Overall Study|beta-blocker contraindicated|0|||
126218568|NCT01255722|454091787|FG002|Overall Study|beta-blocker contraindicated|0|||
126091979|NCT01867333|453630488|FG000|Overall Study|Adverse Event|1|||
126091980|NCT01867333|453630489|FG001|Overall Study|Adverse Event|0|||
126091981|NCT01867333|453630488|FG000|Overall Study|Participant choice|1|||
126017488|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
126017489|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
126017490|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
126091982|NCT01867333|453630489|FG001|Overall Study|Participant choice|2|||
126091983|NCT01867333|453630488|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
126091984|NCT01867333|453630489|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
126091985|NCT01867333|453630488|FG000|Overall Study|Death|0|||
126091986|NCT01867333|453630489|FG001|Overall Study|Death|1|||
126091987|NCT01867333|453630488|FG000|Overall Study|Physician Decision|3|||
126091988|NCT01867333|453630489|FG001|Overall Study|Physician Decision|2|||
126091989|NCT01867333|453630488|FG000|Overall Study|Switched to alternative treatment|1|||
126091990|NCT01867333|453630489|FG001|Overall Study|Switched to alternative treatment|0|||
126091991|NCT00951015|453630492|FG000|Randomization Phase 96 Week|Adverse Event|1|||
126091992|NCT00951015|453630493|FG001|Randomization Phase 96 Week|Adverse Event|1|||
126091993|NCT00951015|453630494|FG002|Randomization Phase 96 Week|Adverse Event|2|||
126091994|NCT00951015|453630495|FG003|Randomization Phase 96 Week|Adverse Event|5|||
126091995|NCT00951015|453630496|FG004|Randomization Phase 96 Week|Adverse Event|0|||
126091996|NCT00951015|453630492|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
126091997|NCT00951015|453630493|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
126091998|NCT00951015|453630494|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
126091999|NCT00951015|453630495|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
126092000|NCT00951015|453630496|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
126092001|NCT00951015|453630492|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
126092002|NCT00951015|453630493|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
126092003|NCT00951015|453630494|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
126092004|NCT00951015|453630495|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
126092005|NCT00951015|453630496|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
126092006|NCT00951015|453630492|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
126092007|NCT00951015|453630493|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
126092008|NCT00951015|453630494|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
126092009|NCT00951015|453630495|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
126092010|NCT00951015|453630496|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
126092011|NCT00951015|453630492|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
126092012|NCT00951015|453630493|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
126092013|NCT00951015|453630494|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
126092014|NCT00951015|453630495|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
126092015|NCT00951015|453630496|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
126092016|NCT00951015|453630492|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
126092017|NCT00951015|453630493|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
126092018|NCT00951015|453630494|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
126092019|NCT00951015|453630495|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
126092020|NCT00951015|453630496|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
126092021|NCT00951015|453630492|FG000|Open-label Phase|Adverse Event|0|||
126092022|NCT00951015|453630493|FG001|Open-label Phase|Adverse Event|0|||
126092023|NCT00951015|453630494|FG002|Open-label Phase|Adverse Event|0|||
126092024|NCT00951015|453630495|FG003|Open-label Phase|Adverse Event|0|||
126092025|NCT00951015|453630496|FG004|Open-label Phase|Adverse Event|3|||
126092026|NCT00951015|453630492|FG000|Open-label Phase|Lack of Efficacy|0|||
126092027|NCT00951015|453630493|FG001|Open-label Phase|Lack of Efficacy|0|||
126092028|NCT00951015|453630494|FG002|Open-label Phase|Lack of Efficacy|0|||
126092029|NCT00951015|453630495|FG003|Open-label Phase|Lack of Efficacy|0|||
126092030|NCT00951015|453630496|FG004|Open-label Phase|Lack of Efficacy|1|||
126092031|NCT00951015|453630492|FG000|Open-label Phase|Protocol Violation|0|||
126092032|NCT00951015|453630493|FG001|Open-label Phase|Protocol Violation|0|||
126092033|NCT00951015|453630494|FG002|Open-label Phase|Protocol Violation|0|||
126092034|NCT00951015|453630495|FG003|Open-label Phase|Protocol Violation|0|||
126092035|NCT00951015|453630496|FG004|Open-label Phase|Protocol Violation|12|||
126092036|NCT00951015|453630492|FG000|Open-label Phase|Lost to Follow-up|0|||
126092037|NCT00951015|453630493|FG001|Open-label Phase|Lost to Follow-up|0|||
126092038|NCT00951015|453630494|FG002|Open-label Phase|Lost to Follow-up|0|||
126092039|NCT00951015|453630495|FG003|Open-label Phase|Lost to Follow-up|0|||
126092040|NCT00951015|453630496|FG004|Open-label Phase|Lost to Follow-up|12|||
126092041|NCT00951015|453630492|FG000|Open-label Phase|Withdrawal by Subject|0|||
126092042|NCT00951015|453630493|FG001|Open-label Phase|Withdrawal by Subject|0|||
126092043|NCT00951015|453630494|FG002|Open-label Phase|Withdrawal by Subject|0|||
126092044|NCT00951015|453630495|FG003|Open-label Phase|Withdrawal by Subject|0|||
126017491|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
126017492|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
126092045|NCT00951015|453630496|FG004|Open-label Phase|Withdrawal by Subject|14|||
126092046|NCT00951015|453630492|FG000|Open-label Phase|Physician Decision|0|||
126218569|NCT02164539|454091788|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
126218570|NCT02164539|454091789|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
126218571|NCT02164539|454091790|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
126218572|NCT02164539|454091791|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
126218573|NCT02164539|454091792|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
126218574|NCT02164539|454091793|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
126218575|NCT02164539|454091794|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
126218576|NCT02164539|454091788|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
126218577|NCT02164539|454091789|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
126218578|NCT02164539|454091790|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
126218579|NCT02164539|454091791|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
126218580|NCT02164539|454091792|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
126218581|NCT02164539|454091793|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
126218582|NCT02164539|454091794|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
126218583|NCT02164539|454091788|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
126218584|NCT02164539|454091789|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
126218585|NCT02164539|454091790|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
126218586|NCT02164539|454091791|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
126218587|NCT02164539|454091792|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
126218588|NCT02164539|454091793|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
126218589|NCT02164539|454091794|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
126218590|NCT02164539|454091788|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
126218591|NCT02164539|454091789|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126218592|NCT02164539|454091790|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126218593|NCT02164539|454091791|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126218594|NCT02164539|454091792|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126218595|NCT02164539|454091793|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126218596|NCT02164539|454091794|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126218597|NCT02164539|454091788|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
126218598|NCT02164539|454091789|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
126218599|NCT02164539|454091790|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
126218600|NCT02164539|454091791|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
126218601|NCT02164539|454091792|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
126218602|NCT02164539|454091793|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
126218603|NCT02164539|454091794|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
126218604|NCT02164539|454091788|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
126218605|NCT02164539|454091789|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
126218606|NCT02164539|454091790|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
126218607|NCT02164539|454091791|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
126218608|NCT02164539|454091792|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
126218609|NCT02164539|454091793|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
126218610|NCT02164539|454091794|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
126218611|NCT02643966|454091795|FG000|First Screening Round|ineligible|1|||
126218612|NCT02643966|454091795|FG000|First Screening Round|excluded from analysis|2|||
126218613|NCT02643966|454091795|FG000|First Screening Round|Lost to Follow-up|56|||
126218614|NCT02643966|454091795|FG000|First Screening Round|Withdrawal by Subject|28|||
126218615|NCT02643966|454091795|FG000|First Screening Round|Death|1|||
126218616|NCT02643966|454091795|FG000|Between First and Second Screening|Lost to Follow-up|65|||
126218617|NCT02643966|454091795|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
126218618|NCT02643966|454091795|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
126218619|NCT02643966|454091795|FG000|Second Screening Round|Withdrawal by Subject|20|||
126218620|NCT02643966|454091795|FG000|Second Screening Round|Lost to Follow-up|57|||
126218621|NCT02643966|454091795|FG000|Second Screening Round|Physician Decision|2|||
126017493|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
126017494|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
126218622|NCT02643966|454091795|FG000|Second Screening Round|Death|4|||
126218623|NCT02643966|454091795|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
126218624|NCT02643966|454091795|FG000|Between Second and Third Screening|Death|1|||
126218625|NCT02643966|454091795|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
126218626|NCT02643966|454091795|FG000|Third Screening Round|PI excluded|2|||
126218627|NCT02643966|454091795|FG000|Third Screening Round|Lost to Follow-up|241|||
126218628|NCT03835975|454091798|FG000|Overall Study|Lost to Follow-up|1|||
126218629|NCT03835975|454091799|FG001|Overall Study|Lost to Follow-up|1|||
126218630|NCT03835975|454091800|FG002|Overall Study|Lost to Follow-up|0|||
126218631|NCT03835975|454091801|FG003|Overall Study|Lost to Follow-up|0|||
126218632|NCT03835975|454091802|FG004|Overall Study|Lost to Follow-up|0|||
126218633|NCT03835975|454091798|FG000|Overall Study|No longer met eligibility criteria|0|||
126218634|NCT03835975|454091799|FG001|Overall Study|No longer met eligibility criteria|1|||
126218635|NCT03835975|454091800|FG002|Overall Study|No longer met eligibility criteria|0|||
126218636|NCT03835975|454091801|FG003|Overall Study|No longer met eligibility criteria|0|||
126218637|NCT03835975|454091802|FG004|Overall Study|No longer met eligibility criteria|0|||
126218638|NCT03835975|454091798|FG000|Overall Study|Protocol Violation|1|||
126218639|NCT03835975|454091799|FG001|Overall Study|Protocol Violation|1|||
126218640|NCT03835975|454091800|FG002|Overall Study|Protocol Violation|2|||
126218641|NCT03835975|454091801|FG003|Overall Study|Protocol Violation|0|||
126218642|NCT03835975|454091802|FG004|Overall Study|Protocol Violation|0|||
126218643|NCT03835975|454091798|FG000|Overall Study|Withdrawal by Subject|1|||
126218644|NCT03835975|454091799|FG001|Overall Study|Withdrawal by Subject|0|||
126218645|NCT03835975|454091800|FG002|Overall Study|Withdrawal by Subject|1|||
126218646|NCT03835975|454091801|FG003|Overall Study|Withdrawal by Subject|1|||
126218647|NCT03835975|454091802|FG004|Overall Study|Withdrawal by Subject|0|||
126218648|NCT00061945|454091807|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
126218649|NCT00061945|454091808|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
126218650|NCT00061945|454091807|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
126218651|NCT00061945|454091808|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
126218652|NCT00061945|454091807|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
126218653|NCT00061945|454091808|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
126218654|NCT00061945|454091807|FG000|Course IV: Alemtuzumab|Early exits|6|||
126218655|NCT00061945|454091808|FG001|Course IV: Alemtuzumab|Early exits|15|||
126218656|NCT03611751|454091809|FG000|Pre-treatment|Randomized but not treated|1|||
126218657|NCT03611751|454091810|FG001|Pre-treatment|Randomized but not treated|1|||
126218658|NCT03611751|454091811|FG002|Pre-treatment|Randomized but not treated|0|||
126218659|NCT03611751|454091809|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
126218660|NCT03611751|454091810|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
126218661|NCT03611751|454091811|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
126218662|NCT03611751|454091809|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
126218663|NCT03611751|454091810|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
126218664|NCT03611751|454091811|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
126218665|NCT03611751|454091809|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
126218666|NCT03611751|454091810|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
126218667|NCT03611751|454091811|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
126218668|NCT03611751|454091809|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
126218669|NCT03611751|454091810|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
126218670|NCT03611751|454091811|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
126218671|NCT03611751|454091809|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
126218672|NCT03611751|454091810|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
126218673|NCT03611751|454091811|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
126218674|NCT03611751|454091809|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
126218675|NCT03611751|454091810|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
126218676|NCT03611751|454091811|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
126218677|NCT03611751|454091809|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
126218678|NCT03611751|454091810|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
126218679|NCT03611751|454091811|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
126218680|NCT03611751|454091809|FG000|Treatment Week 0 - Week 16|Death|0|||
126218681|NCT03611751|454091810|FG001|Treatment Week 0 - Week 16|Death|0|||
126218682|NCT03611751|454091811|FG002|Treatment Week 0 - Week 16|Death|1|||
126218683|NCT03611751|454091809|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
126218684|NCT03611751|454091810|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
126218685|NCT03611751|454091811|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
126218686|NCT03611751|454091809|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
126218687|NCT03611751|454091810|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
126218688|NCT03611751|454091811|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
126218689|NCT03611751|454091809|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
126218690|NCT03611751|454091810|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
126218691|NCT03611751|454091811|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
126218692|NCT03611751|454091809|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
126218693|NCT03611751|454091810|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
126218694|NCT03611751|454091811|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
126218695|NCT03611751|454091809|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
126218696|NCT03611751|454091810|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
126218697|NCT03611751|454091811|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
126218698|NCT03611751|454091809|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
126218699|NCT03611751|454091810|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
126218700|NCT03611751|454091811|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
126218701|NCT03611751|454091809|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
126218702|NCT03611751|454091810|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
126218703|NCT03611751|454091811|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
126218704|NCT03611751|454091809|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
126218705|NCT03611751|454091810|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
126218706|NCT03611751|454091811|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
126218707|NCT03611751|454091809|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
126218708|NCT03611751|454091810|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
126092047|NCT00951015|453630493|FG001|Open-label Phase|Physician Decision|0|||
126218709|NCT03611751|454091811|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
126218710|NCT03611751|454091809|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
126218711|NCT03611751|454091810|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
126218712|NCT03611751|454091811|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
126218713|NCT03611751|454091809|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
126218714|NCT03611751|454091810|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
126218715|NCT03611751|454091811|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
126218716|NCT03611751|454091809|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
126218717|NCT03611751|454091810|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
126218718|NCT03611751|454091811|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
126218719|NCT03611751|454091809|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
126218720|NCT03611751|454091810|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
126218721|NCT03611751|454091811|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
126218722|NCT03611751|454091809|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
126218723|NCT03611751|454091810|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
126218724|NCT03611751|454091811|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
126218725|NCT02441179|454091813|FG000|Overall Study|Withdrawal by Subject|1|||
126218726|NCT02441179|454091814|FG001|Overall Study|Withdrawal by Subject|1|||
126218727|NCT02702271|454091815|FG000|Overall Study|Death|36|||
126218728|NCT02702271|454091816|FG001|Overall Study|Death|7|||
126218729|NCT02702271|454091815|FG000|Overall Study|Lost to Follow-up|12|||
126218730|NCT02702271|454091816|FG001|Overall Study|Lost to Follow-up|0|||
126218731|NCT02702271|454091815|FG000|Overall Study|Withdrawal by Subject|8|||
126218732|NCT02702271|454091816|FG001|Overall Study|Withdrawal by Subject|1|||
126218733|NCT02702271|454091815|FG000|Overall Study|Physician Decision|2|||
126218734|NCT02702271|454091816|FG001|Overall Study|Physician Decision|0|||
126218735|NCT02702271|454091815|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
126218736|NCT02702271|454091816|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
126218737|NCT03091400|454091817|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
126218738|NCT03091400|454091818|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
126218739|NCT00051636|454091819|FG000|Period 1 - Core|Adverse Event|2|||
126218740|NCT00051636|454091820|FG001|Period 1 - Core|Adverse Event|2|||
126218741|NCT00051636|454091819|FG000|Period 1 - Core|Protocol Violation|1|||
126218742|NCT00051636|454091820|FG001|Period 1 - Core|Protocol Violation|0|||
126218743|NCT00051636|454091819|FG000|Period 1 - Core|Withdrawal by Subject|1|||
126218744|NCT00051636|454091820|FG001|Period 1 - Core|Withdrawal by Subject|2|||
126218745|NCT00051636|454091819|FG000|Period 1 - Core|Lost to Follow-up|0|||
126218746|NCT00051636|454091820|FG001|Period 1 - Core|Lost to Follow-up|2|||
126218747|NCT00051636|454091819|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
126218748|NCT00051636|454091820|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
126218749|NCT00051636|454091819|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
126218750|NCT00051636|454091820|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
126218751|NCT00051636|454091819|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
126218752|NCT00051636|454091820|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
126218753|NCT00051636|454091819|FG000|Period 2- Extended Observation Period|Death|4|||
126218754|NCT00051636|454091820|FG001|Period 2- Extended Observation Period|Death|5|||
126017495|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
126092048|NCT00951015|453630494|FG002|Open-label Phase|Physician Decision|0|||
126092049|NCT00951015|453630495|FG003|Open-label Phase|Physician Decision|0|||
126092050|NCT00951015|453630496|FG004|Open-label Phase|Physician Decision|8|||
126218755|NCT00051636|454091819|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
126218756|NCT00051636|454091820|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
126092051|NCT03819634|453630498|FG000|Overall Study|Physician Decision|2|||
126092052|NCT01208103|453630499|FG000|Overall Study|Adverse Event|1|||
126092053|NCT01208103|453630499|FG000|Overall Study|Withdrawal by Subject|1|||
126218757|NCT01656967|454091821|FG000|Overall Study|faulty monitor|1|||
126218758|NCT01656967|454091822|FG001|Overall Study|faulty monitor|0|||
126218759|NCT01656967|454091821|FG000|Overall Study|unsuccessful ETT insertion|3|||
126218760|NCT01656967|454091822|FG001|Overall Study|unsuccessful ETT insertion|2|||
126218761|NCT00975884|454091823|FG000|Overall Study|Adverse Event|1|||
126218762|NCT00975884|454091824|FG001|Overall Study|Adverse Event|0|||
126092054|NCT00299494|453630500|FG000|Overall Study|Withdrawal by Subject|0|||
126092055|NCT00299494|453630501|FG001|Overall Study|Withdrawal by Subject|0|||
126092056|NCT00299494|453630502|FG002|Overall Study|Withdrawal by Subject|0|||
126092057|NCT00299494|453630503|FG003|Overall Study|Withdrawal by Subject|3|||
126092058|NCT00299494|453630504|FG004|Overall Study|Withdrawal by Subject|1|||
126092059|NCT00299494|453630505|FG005|Overall Study|Withdrawal by Subject|4|||
126092060|NCT00299494|453630500|FG000|Overall Study|Physician Decision|0|||
126218763|NCT00975884|454091823|FG000|Overall Study|Lost to Follow-up|5|||
126218764|NCT00975884|454091824|FG001|Overall Study|Lost to Follow-up|3|||
126092061|NCT00299494|453630501|FG001|Overall Study|Physician Decision|0|||
126092062|NCT00299494|453630502|FG002|Overall Study|Physician Decision|0|||
126092063|NCT00299494|453630503|FG003|Overall Study|Physician Decision|0|||
126218765|NCT00975884|454091823|FG000|Overall Study|Withdrawal by Subject|9|||
126218766|NCT00975884|454091824|FG001|Overall Study|Withdrawal by Subject|9|||
126218767|NCT00975884|454091823|FG000|Overall Study|Other|1|||
126218768|NCT00975884|454091824|FG001|Overall Study|Other|3|||
126218769|NCT00479765|454091825|FG000|Overall Study|study terminated|4|||
126218770|NCT05166512|454091826|FG000|Randomized|Lost to Follow-up|2|||
126218771|NCT05166512|454091827|FG001|Randomized|Lost to Follow-up|0|||
126218772|NCT05166512|454091826|FG000|Randomized|Withdrawal by Subject|1|||
126218773|NCT05166512|454091827|FG001|Randomized|Withdrawal by Subject|0|||
126218774|NCT05166512|454091826|FG000|Baseline Data Collection|Lost to Follow-up|0|||
126218775|NCT05166512|454091827|FG001|Baseline Data Collection|Lost to Follow-up|3|||
126218776|NCT05166512|454091826|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
126218777|NCT05166512|454091827|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
126218778|NCT05166512|454091826|FG000|Baseline Data Collection|Protocol Violation|2|||
126218779|NCT05166512|454091827|FG001|Baseline Data Collection|Protocol Violation|0|||
126218780|NCT05166512|454091826|FG000|4 Month Data Collection|Lost to Follow-up|1|||
126218781|NCT05166512|454091827|FG001|4 Month Data Collection|Lost to Follow-up|0|||
126218782|NCT05166512|454091826|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
126218783|NCT05166512|454091827|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
126218784|NCT05166512|454091826|FG000|12 Month Data Collection|Lost to Follow-up|3|||
126218785|NCT05166512|454091827|FG001|12 Month Data Collection|Lost to Follow-up|1|||
126218786|NCT05166512|454091826|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
126218787|NCT05166512|454091827|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
126218788|NCT02139306|454091830|FG000|Overall Study|Withdrawal by Subject|4|||
126218789|NCT02139306|454091831|FG001|Overall Study|Withdrawal by Subject|6|||
126218790|NCT02139306|454091830|FG000|Overall Study|Adverse Event|3|||
126218791|NCT02139306|454091831|FG001|Overall Study|Adverse Event|4|||
126218792|NCT02139306|454091830|FG000|Overall Study|Physician Decision|0|||
126218793|NCT02139306|454091831|FG001|Overall Study|Physician Decision|1|||
126218794|NCT02139306|454091830|FG000|Overall Study|Other Unspecified|2|||
126218795|NCT02139306|454091831|FG001|Overall Study|Other Unspecified|3|||
126218796|NCT02139306|454091830|FG000|Overall Study|Protocol Violation|4|||
126218797|NCT02139306|454091831|FG001|Overall Study|Protocol Violation|0|||
126218798|NCT02956005|454091832|FG000|Overall Study|Not eligible|1|||
126218799|NCT02956005|454091832|FG000|Overall Study|Withdrawal by Subject|3|||
126092064|NCT00299494|453630504|FG004|Overall Study|Physician Decision|1|||
126092065|NCT00299494|453630505|FG005|Overall Study|Physician Decision|0|||
126092066|NCT00299494|453630500|FG000|Overall Study|Death|3|||
126092067|NCT00299494|453630501|FG001|Overall Study|Death|1|||
126092068|NCT00299494|453630502|FG002|Overall Study|Death|4|||
126092069|NCT00299494|453630503|FG003|Overall Study|Death|6|||
126092070|NCT00299494|453630504|FG004|Overall Study|Death|18|||
126092071|NCT00299494|453630505|FG005|Overall Study|Death|19|||
126092072|NCT00299494|453630500|FG000|Overall Study|Lost to Follow-up|0|||
126092073|NCT00299494|453630501|FG001|Overall Study|Lost to Follow-up|0|||
126092074|NCT00299494|453630502|FG002|Overall Study|Lost to Follow-up|0|||
126092075|NCT00299494|453630503|FG003|Overall Study|Lost to Follow-up|0|||
126092076|NCT00299494|453630504|FG004|Overall Study|Lost to Follow-up|3|||
126092077|NCT00299494|453630505|FG005|Overall Study|Lost to Follow-up|1|||
126092078|NCT00299494|453630500|FG000|Overall Study|Other - Unspecified|0|||
126092079|NCT00299494|453630501|FG001|Overall Study|Other - Unspecified|0|||
126092080|NCT00299494|453630502|FG002|Overall Study|Other - Unspecified|0|||
126092081|NCT00299494|453630503|FG003|Overall Study|Other - Unspecified|0|||
126092082|NCT00299494|453630504|FG004|Overall Study|Other - Unspecified|3|||
126092083|NCT00299494|453630505|FG005|Overall Study|Other - Unspecified|1|||
126092084|NCT00299494|453630500|FG000|Overall Study|Other - site closure|0|||
126092085|NCT00299494|453630501|FG001|Overall Study|Other - site closure|0|||
126092086|NCT00299494|453630502|FG002|Overall Study|Other - site closure|0|||
126092087|NCT00299494|453630503|FG003|Overall Study|Other - site closure|1|||
126092088|NCT00299494|453630504|FG004|Overall Study|Other - site closure|1|||
126092089|NCT00299494|453630505|FG005|Overall Study|Other - site closure|1|||
126218800|NCT02956005|454091832|FG000|Overall Study|Physician Decision|12|||
126218801|NCT03909971|454091833|FG000|Overall Study|Other Reasons Not Specified|0|||
126218802|NCT03909971|454091834|FG001|Overall Study|Other Reasons Not Specified|1|||
126092090|NCT00416195|453630506|FG000|Overall Study|Adverse Event|1|||
126092091|NCT00416195|453630507|FG001|Overall Study|Adverse Event|2|||
126092092|NCT00416195|453630506|FG000|Overall Study|Protocol Violation|1|||
126092093|NCT00416195|453630507|FG001|Overall Study|Protocol Violation|1|||
126092094|NCT00416195|453630506|FG000|Overall Study|Other|0|||
126092095|NCT00416195|453630507|FG001|Overall Study|Other|1|||
126092096|NCT01417104|453630512|FG000|Overall Study|Withdrawal by Subject|5|||
126092097|NCT01417104|453630513|FG001|Overall Study|Withdrawal by Subject|1|||
126218803|NCT03909971|454091833|FG000|Overall Study|Global Deterioration of Health Status|2|||
126218804|NCT03909971|454091834|FG001|Overall Study|Global Deterioration of Health Status|1|||
126092098|NCT01417104|453630512|FG000|Overall Study|Failure to make contact|0|||
126092099|NCT01417104|453630513|FG001|Overall Study|Failure to make contact|1|||
126092100|NCT01417104|453630512|FG000|Overall Study|Adverse Event|1|||
126092101|NCT01417104|453630513|FG001|Overall Study|Adverse Event|0|||
126092102|NCT03101462|453630514|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
126092103|NCT03101462|453630515|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
126218805|NCT03909971|454091833|FG000|Overall Study|Progressive Disease|6|||
126218806|NCT03909971|454091834|FG001|Overall Study|Progressive Disease|14|||
126218807|NCT03909971|454091833|FG000|Overall Study|Death|2|||
126218808|NCT03909971|454091834|FG001|Overall Study|Death|6|||
126218809|NCT01185639|454091835|FG000|Overall Study|Progressed and didn't receive therapy|2|||
126218810|NCT01861717|454091840|FG000|Overall Study|Lost to Follow-up|1|||
126218811|NCT01861717|454091840|FG000|Overall Study|Withdrawal by Subject|1|||
126218812|NCT03033069|454091841|FG000|Overall Study|Adverse Event|6|||
126218813|NCT03033069|454091842|FG001|Overall Study|Adverse Event|7|||
126218814|NCT03033069|454091843|FG002|Overall Study|Adverse Event|4|||
126218815|NCT03033069|454091844|FG003|Overall Study|Adverse Event|6|||
126218816|NCT03033069|454091841|FG000|Overall Study|Lack of Efficacy|0|||
126218817|NCT03033069|454091842|FG001|Overall Study|Lack of Efficacy|0|||
126218818|NCT03033069|454091843|FG002|Overall Study|Lack of Efficacy|1|||
126218819|NCT03033069|454091844|FG003|Overall Study|Lack of Efficacy|0|||
126218820|NCT03033069|454091841|FG000|Overall Study|Lost to Follow-up|6|||
126218821|NCT03033069|454091842|FG001|Overall Study|Lost to Follow-up|5|||
126218822|NCT03033069|454091843|FG002|Overall Study|Lost to Follow-up|5|||
126218823|NCT03033069|454091844|FG003|Overall Study|Lost to Follow-up|6|||
126218824|NCT03033069|454091841|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126218825|NCT03033069|454091842|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126218826|NCT03033069|454091843|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126218827|NCT03033069|454091844|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126218828|NCT03033069|454091841|FG000|Overall Study|Protocol Deviation|0|||
126218829|NCT03033069|454091842|FG001|Overall Study|Protocol Deviation|1|||
126017496|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
126017497|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
126218830|NCT03033069|454091843|FG002|Overall Study|Protocol Deviation|0|||
126017498|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
126218831|NCT03033069|454091844|FG003|Overall Study|Protocol Deviation|0|||
126218832|NCT03033069|454091841|FG000|Overall Study|Withdrawal by Subject|10|||
126218833|NCT03033069|454091842|FG001|Overall Study|Withdrawal by Subject|10|||
126218834|NCT03033069|454091843|FG002|Overall Study|Withdrawal by Subject|11|||
126218835|NCT03033069|454091844|FG003|Overall Study|Withdrawal by Subject|6|||
126218836|NCT03033069|454091841|FG000|Overall Study|Withdrawal By Caregiver|1|||
126218837|NCT03033069|454091842|FG001|Overall Study|Withdrawal By Caregiver|0|||
126218838|NCT03033069|454091843|FG002|Overall Study|Withdrawal By Caregiver|0|||
126017499|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
126017500|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
126017501|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
126017502|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
126017503|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
126017504|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
126017505|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
126017506|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
126017507|NCT03593213|453358837|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
126017508|NCT03593213|453358838|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
126218839|NCT03033069|454091844|FG003|Overall Study|Withdrawal By Caregiver|0|||
126218840|NCT03033069|454091841|FG000|Overall Study|Reason not Specified|0|||
126218841|NCT03033069|454091842|FG001|Overall Study|Reason not Specified|1|||
126218842|NCT03033069|454091843|FG002|Overall Study|Reason not Specified|0|||
126218843|NCT03033069|454091844|FG003|Overall Study|Reason not Specified|1|||
126218844|NCT00430638|454091845|FG000|Overall Study|Adverse Event|15|||
126218845|NCT00430638|454091846|FG001|Overall Study|Adverse Event|15|||
126218846|NCT00430638|454091845|FG000|Overall Study|Uncontrolled blood pressure|48|||
126218847|NCT00430638|454091846|FG001|Overall Study|Uncontrolled blood pressure|13|||
126218848|NCT00430638|454091845|FG000|Overall Study|Lost to Follow-up|1|||
126218849|NCT00430638|454091846|FG001|Overall Study|Lost to Follow-up|7|||
126218850|NCT00430638|454091845|FG000|Overall Study|Protocol Violation|6|||
126218851|NCT00430638|454091846|FG001|Overall Study|Protocol Violation|4|||
126218852|NCT00430638|454091845|FG000|Overall Study|Withdrawal by Subject|4|||
126017509|NCT03593213|453358839|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
126017510|NCT03593213|453358840|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
126017511|NCT02888080|453358845|FG000|Overall Study|Subject / Guardian decision|1|||
126218853|NCT00430638|454091846|FG001|Overall Study|Withdrawal by Subject|6|||
126218854|NCT00430638|454091845|FG000|Overall Study|Non-compliant|2|||
126218855|NCT00430638|454091846|FG001|Overall Study|Non-compliant|1|||
126218856|NCT00430638|454091845|FG000|Overall Study|Other|2|||
126218857|NCT00430638|454091846|FG001|Overall Study|Other|2|||
126218858|NCT05458895|454091848|FG000|Overall Study|Withdrawal by Subject|8|||
126218859|NCT05458895|454091848|FG000|Overall Study|Lost to Follow-up|17|||
126218860|NCT05458895|454091848|FG000|Overall Study|Pregnancy|2|||
126218861|NCT05458895|454091848|FG000|Overall Study|Withdrawal by Study Team|1|||
126218862|NCT03724968|454093521|FG000|Overall Study|Insurance issues|0|||
126218863|NCT03724968|454093522|FG001|Overall Study|Insurance issues|1|||
126218864|NCT03724968|454093521|FG000|Overall Study|Study closed|0|||
126218865|NCT03724968|454093522|FG001|Overall Study|Study closed|1|||
126218866|NCT01142466|454093523|FG000|Overall Study|Adverse Event|2|||
126218867|NCT01142466|454093524|FG001|Overall Study|Adverse Event|1|||
126218868|NCT01142466|454093523|FG000|Overall Study|Withdrawal by Subject|1|||
126218869|NCT01142466|454093524|FG001|Overall Study|Withdrawal by Subject|1|||
126218870|NCT00681824|454093525|FG000|Overall Study|withdrawn by investigator|0|||
126218871|NCT00681824|454093526|FG001|Overall Study|withdrawn by investigator|0|||
126218872|NCT00681824|454093527|FG002|Overall Study|withdrawn by investigator|1|||
126218873|NCT00681824|454093525|FG000|Overall Study|scheduling conflict|1|||
126218874|NCT00681824|454093526|FG001|Overall Study|scheduling conflict|0|||
126218875|NCT00681824|454093527|FG002|Overall Study|scheduling conflict|0|||
126218876|NCT00681824|454093525|FG000|Overall Study|Death|0|||
126218877|NCT00681824|454093526|FG001|Overall Study|Death|1|||
126218878|NCT00681824|454093527|FG002|Overall Study|Death|0|||
126218879|NCT03724916|454093528|FG000|Overall Study|Withdrawal by Subject|0|||
126218880|NCT03724916|454093529|FG001|Overall Study|Withdrawal by Subject|1|||
126017512|NCT02888080|453358846|FG001|Overall Study|Subject / Guardian decision|3|||
126017513|NCT02888080|453358845|FG000|Overall Study|New Therapy for study indication|1|||
126218881|NCT03724916|454093530|FG002|Overall Study|Withdrawal by Subject|1|||
126218882|NCT03724916|454093531|FG003|Overall Study|Withdrawal by Subject|2|||
126218883|NCT03724916|454093528|FG000|Overall Study|Randomized but not Treated|1|||
126218884|NCT03724916|454093529|FG001|Overall Study|Randomized but not Treated|0|||
126218885|NCT03724916|454093530|FG002|Overall Study|Randomized but not Treated|0|||
126218886|NCT03724916|454093531|FG003|Overall Study|Randomized but not Treated|0|||
126218887|NCT03591107|454093536|FG000|Overall Study|Same patient in both arms|1|||
126218888|NCT03591107|454093537|FG001|Overall Study|Same patient in both arms|1|||
126218889|NCT03591107|454093536|FG000|Overall Study|Sought care at other clinics|0|||
126218890|NCT03591107|454093537|FG001|Overall Study|Sought care at other clinics|2|||
126218891|NCT03591107|454093536|FG000|Overall Study|Discharged from clinic|0|||
126218892|NCT03591107|454093537|FG001|Overall Study|Discharged from clinic|1|||
126218893|NCT03591107|454093536|FG000|Overall Study|Withdrawal by Subject|0|||
126218894|NCT03591107|454093537|FG001|Overall Study|Withdrawal by Subject|1|||
126218895|NCT03836729|454093546|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
126218896|NCT01270841|454093547|FG000|Overall Study|Adverse Event|0|||
126218897|NCT01270841|454093548|FG001|Overall Study|Adverse Event|1|||
126218898|NCT01270841|454093549|FG002|Overall Study|Adverse Event|0|||
126218899|NCT01270841|454093550|FG003|Overall Study|Adverse Event|3|||
126218900|NCT01270841|454093547|FG000|Overall Study|Withdrawal by Subject|3|||
126218901|NCT01270841|454093548|FG001|Overall Study|Withdrawal by Subject|2|||
126218902|NCT01270841|454093549|FG002|Overall Study|Withdrawal by Subject|3|||
126218903|NCT01270841|454093550|FG003|Overall Study|Withdrawal by Subject|3|||
126218904|NCT01270841|454093547|FG000|Overall Study|Lost to Follow-up|3|||
126218905|NCT01270841|454093548|FG001|Overall Study|Lost to Follow-up|1|||
126218906|NCT01270841|454093549|FG002|Overall Study|Lost to Follow-up|4|||
126218907|NCT01270841|454093550|FG003|Overall Study|Lost to Follow-up|2|||
126218908|NCT01270841|454093547|FG000|Overall Study|Physician Decision|0|||
126218909|NCT01270841|454093548|FG001|Overall Study|Physician Decision|1|||
126092104|NCT00635661|453630516|FG000|Overall Study|Withdrawal by Subject|4|||
126092105|NCT01696955|453630519|FG000|Main Study|Protocol Violation|1|||
126092106|NCT01696955|453630520|FG001|Main Study|Protocol Violation|0|||
126092107|NCT01696955|453630519|FG000|Main Study|Withdrawal by Subject|1|||
126092108|NCT01696955|453630520|FG001|Main Study|Withdrawal by Subject|1|||
126092109|NCT03192475|453630521|FG000|Overall Study|Death|0|||
126092110|NCT03192475|453630522|FG001|Overall Study|Death|1|||
126092111|NCT03192475|453630521|FG000|Overall Study|Lost to Follow-up|13|||
126092112|NCT03192475|453630522|FG001|Overall Study|Lost to Follow-up|8|||
126092113|NCT00573859|453630525|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
126092114|NCT00573859|453630525|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
126092115|NCT03541200|453630534|FG000|Overall Study|Adverse Event|19|||
126092116|NCT03541200|453630534|FG000|Overall Study|Death|1|||
126092117|NCT03541200|453630534|FG000|Overall Study|Lost to Follow-up|10|||
126092118|NCT03541200|453630534|FG000|Overall Study|Physician Decision|1|||
126092119|NCT03541200|453630534|FG000|Overall Study|Protocol Violation|51|||
126092120|NCT03541200|453630534|FG000|Overall Study|Withdrawal by Subject|23|||
126017514|NCT02888080|453358846|FG001|Overall Study|New Therapy for study indication|0|||
126092121|NCT03541200|453630534|FG000|Overall Study|other|8|||
126092122|NCT01204710|453630536|FG000|Randomization Treatment|Lost to Follow-up|1|||
126017515|NCT02888080|453358845|FG000|Overall Study|Lack of Efficacy|0|||
126017516|NCT02888080|453358846|FG001|Overall Study|Lack of Efficacy|1|||
126218910|NCT01270841|454093549|FG002|Overall Study|Physician Decision|0|||
126218911|NCT01270841|454093550|FG003|Overall Study|Physician Decision|0|||
126218912|NCT01270841|454093547|FG000|Overall Study|Did not qualify|6|||
126218913|NCT01270841|454093548|FG001|Overall Study|Did not qualify|3|||
126218914|NCT01270841|454093549|FG002|Overall Study|Did not qualify|4|||
126218915|NCT01270841|454093550|FG003|Overall Study|Did not qualify|5|||
126218916|NCT01270841|454093547|FG000|Overall Study|Protocol Violation|1|||
126218917|NCT01270841|454093548|FG001|Overall Study|Protocol Violation|5|||
126218918|NCT01270841|454093549|FG002|Overall Study|Protocol Violation|0|||
126218919|NCT01270841|454093550|FG003|Overall Study|Protocol Violation|0|||
126218920|NCT01270841|454093547|FG000|Overall Study|Enrolled in error|0|||
126218921|NCT01270841|454093548|FG001|Overall Study|Enrolled in error|1|||
126218922|NCT01270841|454093549|FG002|Overall Study|Enrolled in error|0|||
126218923|NCT01270841|454093550|FG003|Overall Study|Enrolled in error|0|||
126218924|NCT04388527|454093551|FG000|Overall Study|Death|14|||
126218925|NCT04388527|454093551|FG000|Overall Study|Withdrawal by Subject|2|||
126218926|NCT04388527|454093551|FG000|Overall Study|Lost to Follow-up|1|||
126218927|NCT01612702|454093552|FG000|Overall Study|Protocol Violation|11|||
126218928|NCT01612702|454093553|FG001|Overall Study|Protocol Violation|11|||
126218929|NCT01542736|454093554|FG000|Overall Study|Death|1|||
126218930|NCT03674827|454093555|FG000|Treatment Phase|Adverse Event|0|||
126218931|NCT03674827|454093556|FG001|Treatment Phase|Adverse Event|0|||
126218932|NCT03674827|454093557|FG002|Treatment Phase|Adverse Event|0|||
126218933|NCT03674827|454093558|FG003|Treatment Phase|Adverse Event|0|||
126218934|NCT03674827|454093559|FG004|Treatment Phase|Adverse Event|0|||
126218935|NCT03674827|454093560|FG005|Treatment Phase|Adverse Event|2|||
126218936|NCT03674827|454093555|FG000|Treatment Phase|Death|2|||
126218937|NCT03674827|454093556|FG001|Treatment Phase|Death|0|||
126218938|NCT03674827|454093557|FG002|Treatment Phase|Death|0|||
126218939|NCT03674827|454093558|FG003|Treatment Phase|Death|0|||
126218940|NCT03674827|454093559|FG004|Treatment Phase|Death|1|||
126218941|NCT03674827|454093560|FG005|Treatment Phase|Death|0|||
126218942|NCT03674827|454093555|FG000|Treatment Phase|Progressive Disease|0|||
126218943|NCT03674827|454093556|FG001|Treatment Phase|Progressive Disease|4|||
126218944|NCT03674827|454093557|FG002|Treatment Phase|Progressive Disease|3|||
126218945|NCT03674827|454093558|FG003|Treatment Phase|Progressive Disease|4|||
126218946|NCT03674827|454093559|FG004|Treatment Phase|Progressive Disease|4|||
126218947|NCT03674827|454093560|FG005|Treatment Phase|Progressive Disease|9|||
126218948|NCT03674827|454093555|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
126218949|NCT03674827|454093556|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
126218950|NCT03674827|454093557|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
126218951|NCT03674827|454093558|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
126218952|NCT03674827|454093559|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
126218953|NCT03674827|454093560|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
126218954|NCT03674827|454093555|FG000|Treatment Phase|Withdrawal by Subject|0|||
126218955|NCT03674827|454093556|FG001|Treatment Phase|Withdrawal by Subject|0|||
126218956|NCT03674827|454093557|FG002|Treatment Phase|Withdrawal by Subject|0|||
126218957|NCT03674827|454093558|FG003|Treatment Phase|Withdrawal by Subject|0|||
126218958|NCT03674827|454093559|FG004|Treatment Phase|Withdrawal by Subject|0|||
126218959|NCT03674827|454093560|FG005|Treatment Phase|Withdrawal by Subject|1|||
126218960|NCT03674827|454093555|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
126218961|NCT03674827|454093556|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
126218962|NCT03674827|454093557|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
126218963|NCT03674827|454093558|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
126218964|NCT03674827|454093559|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
126218965|NCT03674827|454093560|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
126218966|NCT03674827|454093555|FG000|Treatment Phase|Other|0|||
126218967|NCT03674827|454093556|FG001|Treatment Phase|Other|1|||
126218968|NCT03674827|454093557|FG002|Treatment Phase|Other|0|||
126218969|NCT03674827|454093558|FG003|Treatment Phase|Other|0|||
126218970|NCT03674827|454093559|FG004|Treatment Phase|Other|0|||
126218971|NCT03674827|454093560|FG005|Treatment Phase|Other|1|||
126218972|NCT03674827|454093555|FG000|Long-Term Follow-up Phase|Death|2|||
126218973|NCT03674827|454093556|FG001|Long-Term Follow-up Phase|Death|4|||
126218974|NCT03674827|454093557|FG002|Long-Term Follow-up Phase|Death|2|||
126218975|NCT03674827|454093558|FG003|Long-Term Follow-up Phase|Death|3|||
126218976|NCT03674827|454093559|FG004|Long-Term Follow-up Phase|Death|2|||
126218977|NCT03674827|454093560|FG005|Long-Term Follow-up Phase|Death|6|||
126218978|NCT03674827|454093555|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
126218979|NCT03674827|454093556|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
126218980|NCT03674827|454093557|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
126218981|NCT03674827|454093558|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
126218982|NCT03674827|454093559|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
126218983|NCT03674827|454093560|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
126218984|NCT03674827|454093555|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
126218985|NCT03674827|454093556|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
126218986|NCT03674827|454093557|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
126218987|NCT03674827|454093558|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
126218988|NCT03674827|454093559|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
126092123|NCT01204710|453630537|FG001|Randomization Treatment|Lost to Follow-up|0|||
126092124|NCT01204710|453630536|FG000|Randomization Treatment|Withdrawal by Subject|6|||
126092125|NCT01204710|453630537|FG001|Randomization Treatment|Withdrawal by Subject|5|||
126092126|NCT01204710|453630536|FG000|Randomization Treatment|Physician Decision|3|||
126218989|NCT03674827|454093560|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
126218990|NCT01783483|454093561|FG000|Overall Study|Death|3|||
126218991|NCT01783483|454093562|FG001|Overall Study|Death|3|||
126218992|NCT01783483|454093561|FG000|Overall Study|Lost to Follow-up|14|||
126218993|NCT01783483|454093562|FG001|Overall Study|Lost to Follow-up|10|||
126218994|NCT01783483|454093561|FG000|Overall Study|Withdrawal by Subject|2|||
126218995|NCT01783483|454093562|FG001|Overall Study|Withdrawal by Subject|1|||
126218996|NCT01783483|454093561|FG000|Overall Study|Physician Decision|1|||
126218997|NCT01783483|454093562|FG001|Overall Study|Physician Decision|1|||
126218998|NCT00370396|454093565|FG000|Overall Study|Withdrawal by Subject|0|||
126218999|NCT00370396|454093566|FG001|Overall Study|Withdrawal by Subject|0|||
126219000|NCT00370396|454093567|FG002|Overall Study|Withdrawal by Subject|1|||
126219001|NCT00370396|454093565|FG000|Overall Study|Lost to Follow-up|11|||
126219002|NCT00370396|454093566|FG001|Overall Study|Lost to Follow-up|1|||
126219003|NCT00370396|454093567|FG002|Overall Study|Lost to Follow-up|0|||
126219004|NCT01462695|454093568|FG000|Overall Study|Adverse Event|1|||
126219005|NCT01462695|454093569|FG001|Overall Study|Adverse Event|1|||
126219006|NCT01462695|454093568|FG000|Overall Study|Death|2|||
126219007|NCT01462695|454093569|FG001|Overall Study|Death|0|||
126219008|NCT01462695|454093568|FG000|Overall Study|Lack of Efficacy|6|||
126219009|NCT01462695|454093569|FG001|Overall Study|Lack of Efficacy|12|||
126219010|NCT01462695|454093568|FG000|Overall Study|Physician Decision|5|||
126219011|NCT01462695|454093569|FG001|Overall Study|Physician Decision|0|||
126219012|NCT01462695|454093568|FG000|Overall Study|Withdrawal by Subject|2|||
126219013|NCT01462695|454093569|FG001|Overall Study|Withdrawal by Subject|0|||
126219014|NCT01462695|454093568|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
126219015|NCT01462695|454093569|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
126219016|NCT02400905|454093570|FG000|Overall Study|Death|24|||
126219017|NCT02400905|454093570|FG000|Overall Study|Lost to Follow-up|18|||
126219018|NCT02400905|454093570|FG000|Overall Study|Withdrawal by Subject|16|||
126219019|NCT02400905|454093570|FG000|Overall Study|Physician Decision|4|||
126219020|NCT02400905|454093570|FG000|Overall Study|Other|1|||
126219021|NCT01358708|454093573|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
126219022|NCT01358708|454093574|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126219023|NCT01358708|454093573|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
126219024|NCT01358708|454093574|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
126219025|NCT03056001|454093577|FG000|Overall Study|Death|24|||
126219026|NCT01364298|454093580|FG000|Overall Study|Adverse Event|3|||
126219027|NCT01364298|454093581|FG001|Overall Study|Adverse Event|4|||
126219028|NCT01364298|454093580|FG000|Overall Study|Lack of adherence to treatment|1|||
126219029|NCT01364298|454093581|FG001|Overall Study|Lack of adherence to treatment|3|||
126219030|NCT01364298|454093580|FG000|Overall Study|Lack of Efficacy|1|||
126219031|NCT01364298|454093581|FG001|Overall Study|Lack of Efficacy|0|||
126219032|NCT01364298|454093580|FG000|Overall Study|Lost to Follow-up|5|||
126219033|NCT01364298|454093581|FG001|Overall Study|Lost to Follow-up|10|||
126219034|NCT01364298|454093580|FG000|Overall Study|Withdrawal by Subject|3|||
126219035|NCT01364298|454093581|FG001|Overall Study|Withdrawal by Subject|3|||
126219036|NCT01364298|454093580|FG000|Overall Study|Other|1|||
126219037|NCT01364298|454093581|FG001|Overall Study|Other|3|||
126219038|NCT03707522|454093584|FG000|Overall Study|Lost to Follow-up|24|||
126219039|NCT03707522|454093585|FG001|Overall Study|Lost to Follow-up|27|||
126219040|NCT03707522|454093586|FG002|Overall Study|Lost to Follow-up|41|||
126219041|NCT03707522|454093587|FG003|Overall Study|Lost to Follow-up|36|||
126219042|NCT04363736|454093588|FG000|Overall Study|Withdrawal by Subject|1|||
126219043|NCT04363736|454093589|FG001|Overall Study|Withdrawal by Subject|0|||
126219044|NCT04363736|454093588|FG000|Overall Study|Lost to Follow-up|10|||
126219045|NCT04363736|454093589|FG001|Overall Study|Lost to Follow-up|7|||
126219046|NCT04363736|454093588|FG000|Overall Study|Death|8|||
126219047|NCT04363736|454093589|FG001|Overall Study|Death|6|||
126219048|NCT00420849|454093590|FG000|Overall Study|Lack of Efficacy|154|||
126219049|NCT00420849|454093590|FG000|Overall Study|Adverse Event|107|||
126219050|NCT00420849|454093590|FG000|Overall Study|Withdrawal by Subject|28|||
126219051|NCT00420849|454093590|FG000|Overall Study|Death|18|||
126219052|NCT00420849|454093590|FG000|Overall Study|Other|14|||
126219053|NCT00420849|454093590|FG000|Overall Study|Transplant|8|||
126219054|NCT00420849|454093590|FG000|Overall Study|Protocol Violation|1|||
126219055|NCT00420849|454093590|FG000|Overall Study|Lost to Follow-up|1|||
126219056|NCT00659581|454093592|FG000|Overall Study|Adverse Event|1006|||
126219057|NCT00659581|454093592|FG000|Overall Study|Lack of Efficacy|1183|||
126017517|NCT02888080|453358845|FG000|Overall Study|Adverse Event|0|||
126017518|NCT02888080|453358846|FG001|Overall Study|Adverse Event|1|||
126219058|NCT00659581|454093592|FG000|Overall Study|Other|6393|||
126219059|NCT00944125|454093598|FG000|3 to 6 Months|Withdrawal by Subject|0|||
126219060|NCT00944125|454093599|FG001|3 to 6 Months|Withdrawal by Subject|2|||
126219061|NCT00944125|454093598|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
126219062|NCT00944125|454093599|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
126219063|NCT00446134|454093600|FG000|Overall Study|Adverse Event|7|||
126219064|NCT00446134|454093601|FG001|Overall Study|Adverse Event|17|||
126219065|NCT00446134|454093602|FG002|Overall Study|Adverse Event|13|||
126017519|NCT00845832|453358847|FG000|Treatment Period|Adverse Event|0|||
126017520|NCT00845832|453358848|FG001|Treatment Period|Adverse Event|2|||
126017521|NCT00845832|453358849|FG002|Treatment Period|Adverse Event|0|||
126017522|NCT00845832|453358847|FG000|Treatment Period|Protocol Violation|1|||
126017523|NCT00845832|453358848|FG001|Treatment Period|Protocol Violation|1|||
126017524|NCT00845832|453358849|FG002|Treatment Period|Protocol Violation|0|||
126017525|NCT00845832|453358847|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
126017526|NCT00845832|453358848|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
126017527|NCT00845832|453358849|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
126017528|NCT00845832|453358847|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
126017529|NCT00845832|453358848|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
126017530|NCT00845832|453358849|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
126017531|NCT01039688|453358856|FG000|Overall Study|Adverse Event|38|||
126017532|NCT01039688|453358857|FG001|Overall Study|Adverse Event|39|||
126017533|NCT01039688|453358858|FG002|Overall Study|Adverse Event|24|||
126017534|NCT01039688|453358856|FG000|Overall Study|Lack of Efficacy|20|||
126017535|NCT01039688|453358857|FG001|Overall Study|Lack of Efficacy|11|||
126017536|NCT01039688|453358858|FG002|Overall Study|Lack of Efficacy|26|||
126017537|NCT01039688|453358856|FG000|Overall Study|Lost to Follow-up|11|||
126017538|NCT01039688|453358857|FG001|Overall Study|Lost to Follow-up|9|||
126017539|NCT01039688|453358858|FG002|Overall Study|Lost to Follow-up|5|||
126017540|NCT01039688|453358856|FG000|Overall Study|Other|13|||
126017541|NCT01039688|453358857|FG001|Overall Study|Other|25|||
126017542|NCT01039688|453358858|FG002|Overall Study|Other|12|||
126017543|NCT01039688|453358856|FG000|Overall Study|Withdrawal by Subject|23|||
126017544|NCT01039688|453358857|FG001|Overall Study|Withdrawal by Subject|27|||
126017545|NCT01039688|453358858|FG002|Overall Study|Withdrawal by Subject|13|||
126017546|NCT01039688|453358856|FG000|Overall Study|Death|2|||
126017547|NCT01039688|453358857|FG001|Overall Study|Death|0|||
126017548|NCT01039688|453358858|FG002|Overall Study|Death|0|||
126017549|NCT00668863|453358859|FG000|Overall Study|Objective Progression or Relapse|42|||
126017550|NCT00668863|453358859|FG000|Overall Study|Adverse Event|13|||
126017551|NCT00668863|453358859|FG000|Overall Study|Study Terminated by Sponsor|8|||
126017552|NCT00668863|453358859|FG000|Overall Study|Global Deterioration of Health Status|4|||
126017553|NCT00668863|453358859|FG000|Overall Study|Withdrawal by Subject|1|||
126017554|NCT00668863|453358859|FG000|Overall Study|Surgery|1|||
126017555|NCT00668863|453358859|FG000|Overall Study|Subject's work scheduling problem|1|||
126017556|NCT00668863|453358859|FG000|Overall Study|Physician Decision|1|||
126017557|NCT03844269|453358864|FG000|Overall Study|Withdrawal pre-intervention|1|||
126017558|NCT03844269|453358864|FG000|Overall Study|Did not complete the intervention|2|||
126017559|NCT00101010|453358865|FG000|Overall Study|Physician Decision|1|||
126017560|NCT00439569|453358876|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
126017561|NCT00439569|453358876|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
126017562|NCT00439569|453358876|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
126017563|NCT02214160|453358877|FG000|Overall Study|Withdrawal by Subject|1|||
126017564|NCT02214160|453358878|FG001|Overall Study|Withdrawal by Subject|0|||
126017565|NCT02214160|453358879|FG002|Overall Study|Withdrawal by Subject|6|||
126017566|NCT02214160|453358877|FG000|Overall Study|Death|2|||
126017567|NCT02214160|453358878|FG001|Overall Study|Death|2|||
126017568|NCT02214160|453358879|FG002|Overall Study|Death|1|||
126017569|NCT02214160|453358877|FG000|Overall Study|Subject Non-Compliance|0|||
126017570|NCT02214160|453358878|FG001|Overall Study|Subject Non-Compliance|3|||
126017571|NCT02214160|453358879|FG002|Overall Study|Subject Non-Compliance|1|||
126017572|NCT02214160|453358877|FG000|Overall Study|Adverse Event|0|||
126017573|NCT02214160|453358878|FG001|Overall Study|Adverse Event|1|||
126017574|NCT02214160|453358879|FG002|Overall Study|Adverse Event|1|||
126017575|NCT02214160|453358877|FG000|Overall Study|Sponsor Decision|0|||
126017576|NCT02214160|453358878|FG001|Overall Study|Sponsor Decision|2|||
125878733|NCT01209689|452853399|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
126017577|NCT02214160|453358879|FG002|Overall Study|Sponsor Decision|0|||
126017578|NCT02214160|453358877|FG000|Overall Study|Protocol Violation|1|||
126017579|NCT02214160|453358878|FG001|Overall Study|Protocol Violation|0|||
126017580|NCT02214160|453358879|FG002|Overall Study|Protocol Violation|0|||
126017581|NCT02214160|453358877|FG000|Overall Study|Physician Decision|0|||
126017582|NCT02214160|453358878|FG001|Overall Study|Physician Decision|0|||
126017583|NCT02214160|453358879|FG002|Overall Study|Physician Decision|1|||
126017584|NCT02423798|453358880|FG000|Overall Study|Withdrawal by Subject|3|||
126017585|NCT01063972|453358881|FG000|Overall Study|Death|12|||
126017586|NCT01063972|453358882|FG001|Overall Study|Death|11|||
126219066|NCT00446134|454093603|FG003|Overall Study|Adverse Event|18|||
126219067|NCT00446134|454093600|FG000|Overall Study|Lack of Efficacy|19|||
126219068|NCT00446134|454093601|FG001|Overall Study|Lack of Efficacy|19|||
126219069|NCT00446134|454093602|FG002|Overall Study|Lack of Efficacy|24|||
126219070|NCT00446134|454093603|FG003|Overall Study|Lack of Efficacy|19|||
126219071|NCT00446134|454093600|FG000|Overall Study|Protocol Violation|0|||
126219072|NCT00446134|454093601|FG001|Overall Study|Protocol Violation|2|||
126219073|NCT00446134|454093602|FG002|Overall Study|Protocol Violation|1|||
126219074|NCT00446134|454093603|FG003|Overall Study|Protocol Violation|0|||
126219075|NCT00446134|454093600|FG000|Overall Study|Lost to Follow-up|1|||
126219076|NCT00446134|454093601|FG001|Overall Study|Lost to Follow-up|3|||
126219077|NCT00446134|454093602|FG002|Overall Study|Lost to Follow-up|1|||
126219078|NCT00446134|454093603|FG003|Overall Study|Lost to Follow-up|1|||
126219079|NCT00446134|454093600|FG000|Overall Study|Withdrawal by Subject|3|||
126219080|NCT00446134|454093601|FG001|Overall Study|Withdrawal by Subject|3|||
126219081|NCT00446134|454093602|FG002|Overall Study|Withdrawal by Subject|1|||
126219082|NCT00446134|454093603|FG003|Overall Study|Withdrawal by Subject|3|||
126219083|NCT00446134|454093600|FG000|Overall Study|Physician Decision|0|||
126219084|NCT00446134|454093601|FG001|Overall Study|Physician Decision|0|||
126219085|NCT00446134|454093602|FG002|Overall Study|Physician Decision|0|||
126219086|NCT00446134|454093603|FG003|Overall Study|Physician Decision|2|||
126219087|NCT00446134|454093600|FG000|Overall Study|Adverse Event-Diarrhea|1|||
126219088|NCT00446134|454093601|FG001|Overall Study|Adverse Event-Diarrhea|1|||
126219089|NCT00446134|454093602|FG002|Overall Study|Adverse Event-Diarrhea|2|||
126219090|NCT00446134|454093603|FG003|Overall Study|Adverse Event-Diarrhea|0|||
126219091|NCT00446134|454093600|FG000|Overall Study|Reason Not Completed|3|||
126219092|NCT00446134|454093601|FG001|Overall Study|Reason Not Completed|0|||
126219093|NCT00446134|454093602|FG002|Overall Study|Reason Not Completed|1|||
126219094|NCT00446134|454093603|FG003|Overall Study|Reason Not Completed|2|||
126219095|NCT03125629|454093604|FG000|Overall Study|Withdrawal by Subject|2|||
126219096|NCT03125629|454093604|FG000|Overall Study|Equipment malfunction|1|||
126219097|NCT00743119|454093605|FG000|Overall Study|unreliable|3|||
126219098|NCT00743119|454093605|FG000|Overall Study|Withdrawal by Subject|1|||
126219099|NCT04816877|454093606|FG000|Overall Study|Withdrawal by Subject|1|||
126219100|NCT04816877|454093607|FG001|Overall Study|Withdrawal by Subject|0|||
126219101|NCT02176642|454093611|FG000|Overall Study|Withdrawal by Subject|0|||
126219102|NCT02176642|454093612|FG001|Overall Study|Withdrawal by Subject|1|||
126219103|NCT00295620|454093613|FG000|Overall Study|Lost to Follow-up|9|||
126219104|NCT00295620|454093614|FG001|Overall Study|Lost to Follow-up|5|||
126219105|NCT00295620|454093613|FG000|Overall Study|Withdrawal by Subject|37|||
126219106|NCT00295620|454093614|FG001|Overall Study|Withdrawal by Subject|50|||
126219107|NCT00295620|454093613|FG000|Overall Study|Death|206|||
126219108|NCT00295620|454093614|FG001|Overall Study|Death|207|||
126219109|NCT00295620|454093613|FG000|Overall Study|Other reasons|10|||
126219110|NCT00295620|454093614|FG001|Overall Study|Other reasons|9|||
126219111|NCT00295620|454093613|FG000|Overall Study|Discontinuation by sponsor|580|||
126219112|NCT00295620|454093614|FG001|Overall Study|Discontinuation by sponsor|593|||
126219113|NCT00295620|454093613|FG000|Overall Study|Protocol Violation|30|||
126219114|NCT00295620|454093614|FG001|Overall Study|Protocol Violation|32|||
126219115|NCT01309828|454093615|FG000|Overall Study|Adverse Event|10|||
126219116|NCT01309828|454093616|FG001|Overall Study|Adverse Event|11|||
126219117|NCT01309828|454093615|FG000|Overall Study|Voluntary Withdrawal|5|||
126219118|NCT01309828|454093616|FG001|Overall Study|Voluntary Withdrawal|4|||
126219119|NCT01309828|454093615|FG000|Overall Study|Major Protocol Deviation|0|||
126219120|NCT01309828|454093616|FG001|Overall Study|Major Protocol Deviation|1|||
126219121|NCT01309828|454093615|FG000|Overall Study|Other|1|||
126219122|NCT01309828|454093616|FG001|Overall Study|Other|0|||
126219123|NCT00217971|454093617|FG000|Overall Study|Adverse Event|1|||
126219124|NCT00217971|454093618|FG001|Overall Study|Adverse Event|1|||
126219125|NCT00217971|454093617|FG000|Overall Study|Lost to Follow-up|15|||
126219126|NCT00217971|454093618|FG001|Overall Study|Lost to Follow-up|19|||
126219127|NCT00217971|454093617|FG000|Overall Study|Physician Decision|0|||
126219128|NCT00217971|454093618|FG001|Overall Study|Physician Decision|1|||
126219129|NCT00217971|454093617|FG000|Overall Study|Withdrawal by Subject|7|||
126219130|NCT00217971|454093618|FG001|Overall Study|Withdrawal by Subject|12|||
126219131|NCT00217971|454093617|FG000|Overall Study|non compliant|1|||
126219132|NCT00217971|454093618|FG001|Overall Study|non compliant|0|||
126219133|NCT02989610|454093619|FG000|Overall Study|Withdrawal by Subject|20|||
126219134|NCT02989610|454093619|FG000|Overall Study|Departure of PI from Site|8|||
126219135|NCT02989610|454093619|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
126219136|NCT02989610|454093619|FG000|Overall Study|Lost to Follow-up|3|||
126219137|NCT02989610|454093619|FG000|Overall Study|Death|3|||
126219138|NCT02989610|454093619|FG000|Overall Study|System Explant|3|||
126219139|NCT02989610|454093619|FG000|Overall Study|Subject Non-Compliance|2|||
126219140|NCT02989610|454093619|FG000|Overall Study|System Revision|2|||
126219141|NCT02989610|454093619|FG000|Overall Study|PI Left, Study Closing|1|||
126219142|NCT02989610|454093619|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
126219143|NCT02989610|454093619|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
126219144|NCT02556632|454093624|FG000|Overall Study|Lost to Follow-up|1|||
126219145|NCT02556632|454093625|FG001|Overall Study|Lost to Follow-up|0|||
126219146|NCT02556632|454093626|FG002|Overall Study|Lost to Follow-up|0|||
126219147|NCT02556632|454093624|FG000|Overall Study|Disliked Intervention|1|||
126219148|NCT02556632|454093625|FG001|Overall Study|Disliked Intervention|1|||
126219149|NCT02556632|454093626|FG002|Overall Study|Disliked Intervention|1|||
126219150|NCT02556632|454093624|FG000|Overall Study|No Reason|1|||
126219151|NCT02556632|454093625|FG001|Overall Study|No Reason|0|||
126219152|NCT02556632|454093626|FG002|Overall Study|No Reason|1|||
126219153|NCT02556632|454093624|FG000|Overall Study|Personal Issues|0|||
126219154|NCT02556632|454093625|FG001|Overall Study|Personal Issues|1|||
126219155|NCT02556632|454093626|FG002|Overall Study|Personal Issues|1|||
126219156|NCT02556632|454093624|FG000|Overall Study|Changed Mind|0|||
126219157|NCT02556632|454093625|FG001|Overall Study|Changed Mind|1|||
126219158|NCT02556632|454093626|FG002|Overall Study|Changed Mind|0|||
126219159|NCT02556632|454093624|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
126219160|NCT02556632|454093625|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
126219161|NCT02556632|454093626|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
126219162|NCT02556632|454093624|FG000|Overall Study|Unrelated Adverse Event|1|||
126219163|NCT02556632|454093625|FG001|Overall Study|Unrelated Adverse Event|0|||
126219164|NCT02556632|454093626|FG002|Overall Study|Unrelated Adverse Event|3|||
126219165|NCT02556632|454093624|FG000|Overall Study|Related Adverse Event|0|||
126219166|NCT02556632|454093625|FG001|Overall Study|Related Adverse Event|1|||
126219167|NCT02556632|454093626|FG002|Overall Study|Related Adverse Event|0|||
126219168|NCT02556632|454093624|FG000|Overall Study|Possibly Related Adverse Event|0|||
126219169|NCT02556632|454093625|FG001|Overall Study|Possibly Related Adverse Event|0|||
126219170|NCT02556632|454093626|FG002|Overall Study|Possibly Related Adverse Event|1|||
126219171|NCT02556632|454093624|FG000|Overall Study|Did Not Start RT|0|||
126219172|NCT02556632|454093625|FG001|Overall Study|Did Not Start RT|1|||
126219173|NCT02556632|454093626|FG002|Overall Study|Did Not Start RT|0|||
126219174|NCT02556632|454093624|FG000|Overall Study|Ineligible|0|||
126219175|NCT02556632|454093625|FG001|Overall Study|Ineligible|1|||
126219176|NCT02556632|454093626|FG002|Overall Study|Ineligible|0|||
126219177|NCT02556632|454093624|FG000|Overall Study|Disliked Study Procedures|0|||
126219178|NCT02556632|454093625|FG001|Overall Study|Disliked Study Procedures|0|||
126219179|NCT02556632|454093626|FG002|Overall Study|Disliked Study Procedures|1|||
126219180|NCT02556632|454093624|FG000|Overall Study|Treatment or Change Delay|0|||
126219181|NCT02556632|454093625|FG001|Overall Study|Treatment or Change Delay|0|||
126219182|NCT02556632|454093626|FG002|Overall Study|Treatment or Change Delay|1|||
126219183|NCT01066039|454093629|FG000|Overall Study|Adverse Event|6|||
126219184|NCT01066039|454093629|FG000|Overall Study|Withdrawal by Subject|17|||
126219185|NCT01066039|454093629|FG000|Overall Study|Protocol Violation|2|||
126219186|NCT01066039|454093629|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
126219187|NCT01066039|454093629|FG000|Overall Study|Investigator's Request|1|||
126219188|NCT01066039|454093629|FG000|Overall Study|Dropout due to Insulin Administration|1|||
126219189|NCT01066039|454093629|FG000|Overall Study|Additional Antihypertensive Required|4|||
126219190|NCT01066039|454093629|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
126219191|NCT01066039|454093629|FG000|Overall Study|Failure to Control Blood Pressure|1|||
126219192|NCT01066039|454093629|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
126219193|NCT02574260|454093630|FG000|Overall Study|Disease Progression|1|||
126219194|NCT04508621|454093632|FG000|Overall Study|Adverse Event|39|||
126219195|NCT04508621|454093633|FG001|Overall Study|Adverse Event|16|||
126219196|NCT04508621|454093632|FG000|Overall Study|Lack of Efficacy|2|||
126219197|NCT04508621|454093633|FG001|Overall Study|Lack of Efficacy|8|||
126219198|NCT04508621|454093632|FG000|Overall Study|Physician Decision|0|||
126219199|NCT04508621|454093633|FG001|Overall Study|Physician Decision|1|||
126219200|NCT04508621|454093632|FG000|Overall Study|Withdrawal by Subject|10|||
126219201|NCT04508621|454093633|FG001|Overall Study|Withdrawal by Subject|14|||
126219202|NCT04508621|454093632|FG000|Overall Study|Lost to Follow-up|12|||
126219203|NCT04508621|454093633|FG001|Overall Study|Lost to Follow-up|9|||
126219204|NCT04508621|454093632|FG000|Overall Study|COVID-19 related crisis|3|||
126219205|NCT04508621|454093633|FG001|Overall Study|COVID-19 related crisis|0|||
126219206|NCT04508621|454093632|FG000|Overall Study|Subject non-compliance|1|||
126219207|NCT04508621|454093633|FG001|Overall Study|Subject non-compliance|0|||
126219208|NCT00808015|454093634|FG000|Overall Study|Death|1|||
126219209|NCT00808015|454093634|FG000|Overall Study|Lack of Efficacy|58|||
126219210|NCT00808015|454093634|FG000|Overall Study|Lost to Follow-up|76|||
126219211|NCT00808015|454093634|FG000|Overall Study|Participants not willing to participate|158|||
126219212|NCT00808015|454093634|FG000|Overall Study|Adverse Event|22|||
126219213|NCT00808015|454093634|FG000|Overall Study|Other|25|||
126219214|NCT00808015|454093634|FG000|Overall Study|Enrolled but not treated|4|||
126219215|NCT00084617|454093649|FG000|Overall Study|Withdrawal by Subject|7|||
126219216|NCT00084617|454093649|FG000|Overall Study|Lack of Efficacy|1|||
126219217|NCT00084617|454093649|FG000|Overall Study|Protocol Violation|1|||
126219218|NCT01625286|454093650|FG000|Overall Study|Adverse Event|0|||
126219219|NCT01625286|454093651|FG001|Overall Study|Adverse Event|0|||
126219220|NCT01625286|454093652|FG002|Overall Study|Adverse Event|0|||
126219221|NCT01625286|454093653|FG003|Overall Study|Adverse Event|0|||
126219222|NCT01625286|454093654|FG004|Overall Study|Adverse Event|1|||
126219223|NCT01625286|454093655|FG005|Overall Study|Adverse Event|2|||
126219224|NCT01625286|454093656|FG006|Overall Study|Adverse Event|1|||
126219225|NCT01625286|454093650|FG000|Overall Study|Death|0|||
126219226|NCT01625286|454093651|FG001|Overall Study|Death|0|||
126219227|NCT01625286|454093652|FG002|Overall Study|Death|1|||
126219228|NCT01625286|454093653|FG003|Overall Study|Death|1|||
126219229|NCT01625286|454093654|FG004|Overall Study|Death|0|||
126219230|NCT01625286|454093655|FG005|Overall Study|Death|11|||
126219231|NCT01625286|454093656|FG006|Overall Study|Death|16|||
126219232|NCT01625286|454093650|FG000|Overall Study|Withdrawal by Subject|0|||
126219233|NCT01625286|454093651|FG001|Overall Study|Withdrawal by Subject|1|||
126092127|NCT01204710|453630537|FG001|Randomization Treatment|Physician Decision|2|||
126092128|NCT01204710|453630536|FG000|Randomization Treatment|Entry criteria not met|0|||
126092129|NCT01204710|453630537|FG001|Randomization Treatment|Entry criteria not met|1|||
126092130|NCT01204710|453630536|FG000|Randomization Treatment|Adverse Event|4|||
126092131|NCT01204710|453630537|FG001|Randomization Treatment|Adverse Event|2|||
126092132|NCT01204710|453630536|FG000|Randomization Treatment|Sponsor Decision|0|||
126092133|NCT01204710|453630537|FG001|Randomization Treatment|Sponsor Decision|1|||
126092134|NCT01204710|453630536|FG000|Randomization Treatment|Worsening of General condition|0|||
126092135|NCT01204710|453630537|FG001|Randomization Treatment|Worsening of General condition|1|||
126092136|NCT01204710|453630536|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
126092137|NCT01204710|453630537|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
126219234|NCT01625286|454093652|FG002|Overall Study|Withdrawal by Subject|0|||
126219235|NCT01625286|454093653|FG003|Overall Study|Withdrawal by Subject|1|||
126219236|NCT01625286|454093654|FG004|Overall Study|Withdrawal by Subject|0|||
126219237|NCT01625286|454093655|FG005|Overall Study|Withdrawal by Subject|0|||
126219238|NCT01625286|454093656|FG006|Overall Study|Withdrawal by Subject|1|||
126219239|NCT01625286|454093650|FG000|Overall Study|Any reason not specifically recorded|0|||
126219240|NCT01625286|454093651|FG001|Overall Study|Any reason not specifically recorded|0|||
126219241|NCT01625286|454093652|FG002|Overall Study|Any reason not specifically recorded|0|||
126219242|NCT01625286|454093653|FG003|Overall Study|Any reason not specifically recorded|0|||
126219243|NCT01625286|454093654|FG004|Overall Study|Any reason not specifically recorded|0|||
126219244|NCT01625286|454093655|FG005|Overall Study|Any reason not specifically recorded|1|||
126219245|NCT01625286|454093656|FG006|Overall Study|Any reason not specifically recorded|0|||
126219246|NCT01625286|454093650|FG000|Overall Study|Progressive disease|6|||
126219247|NCT01625286|454093651|FG001|Overall Study|Progressive disease|3|||
126219248|NCT01625286|454093652|FG002|Overall Study|Progressive disease|4|||
126219249|NCT01625286|454093653|FG003|Overall Study|Progressive disease|5|||
126219250|NCT01625286|454093654|FG004|Overall Study|Progressive disease|5|||
126219251|NCT01625286|454093655|FG005|Overall Study|Progressive disease|0|||
126219252|NCT01625286|454093656|FG006|Overall Study|Progressive disease|0|||
126219253|NCT01625286|454093650|FG000|Overall Study|Lost to Follow-up|0|||
126219254|NCT01625286|454093651|FG001|Overall Study|Lost to Follow-up|0|||
126219255|NCT01625286|454093652|FG002|Overall Study|Lost to Follow-up|0|||
126219256|NCT01625286|454093653|FG003|Overall Study|Lost to Follow-up|0|||
126219257|NCT01625286|454093654|FG004|Overall Study|Lost to Follow-up|0|||
126219258|NCT01625286|454093655|FG005|Overall Study|Lost to Follow-up|0|||
126219259|NCT01625286|454093656|FG006|Overall Study|Lost to Follow-up|1|||
126219260|NCT00928135|454093657|FG000|Overall Study|Withdrawal by Subject|1|||
126219261|NCT00928135|454093658|FG001|Overall Study|Withdrawal by Subject|0|||
126219262|NCT03338673|454093661|FG000|Overall Study|Lost to Follow-up|1|||
126219263|NCT03338673|454093662|FG001|Overall Study|Lost to Follow-up|1|||
126219264|NCT00434148|454093663|FG000|Overall Study|Adverse Event|18|||
126219265|NCT00434148|454093664|FG001|Overall Study|Adverse Event|18|||
126219266|NCT00434148|454093663|FG000|Overall Study|Lack of Efficacy|25|||
126219267|NCT00434148|454093664|FG001|Overall Study|Lack of Efficacy|28|||
126219268|NCT00434148|454093663|FG000|Overall Study|Withdrawal by Subject|15|||
126219269|NCT00434148|454093664|FG001|Overall Study|Withdrawal by Subject|15|||
126219270|NCT00434148|454093663|FG000|Overall Study|Protocol Violation|4|||
126219271|NCT00434148|454093664|FG001|Overall Study|Protocol Violation|0|||
126219272|NCT00434148|454093663|FG000|Overall Study|Administrative problems|6|||
126219273|NCT00434148|454093664|FG001|Overall Study|Administrative problems|10|||
126219274|NCT00434148|454093663|FG000|Overall Study|Lost to Follow-up|0|||
126219275|NCT00434148|454093664|FG001|Overall Study|Lost to Follow-up|1|||
126219276|NCT00434148|454093663|FG000|Overall Study|Condition no longer requires study drug|1|||
126219277|NCT00434148|454093664|FG001|Overall Study|Condition no longer requires study drug|0|||
126219278|NCT00434148|454093663|FG000|Overall Study|Abnormal test procedure result|0|||
126219279|NCT00434148|454093664|FG001|Overall Study|Abnormal test procedure result|1|||
126219280|NCT00828516|454093667|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
126219281|NCT04523831|454093674|FG000|Overall Study|Lost to Follow-up|15|||
126219282|NCT04523831|454093675|FG001|Overall Study|Lost to Follow-up|17|||
126219283|NCT04523831|454093674|FG000|Overall Study|Death|0|||
126219284|NCT04523831|454093675|FG001|Overall Study|Death|3|||
126219285|NCT04523831|454093674|FG000|Overall Study|Adverse Event|2|||
126219286|NCT04523831|454093675|FG001|Overall Study|Adverse Event|0|||
126219287|NCT02367781|454093682|FG000|Overall Study|Withdrawal by Subject|20|||
126219288|NCT02367781|454093683|FG001|Overall Study|Withdrawal by Subject|13|||
126219289|NCT02367781|454093682|FG000|Overall Study|Protocol Violation|0|||
126219290|NCT02367781|454093683|FG001|Overall Study|Protocol Violation|1|||
126219291|NCT02367781|454093682|FG000|Overall Study|Physician Decision|7|||
126219292|NCT02367781|454093683|FG001|Overall Study|Physician Decision|0|||
126219293|NCT02367781|454093682|FG000|Overall Study|Randomized in Error|5|||
126219294|NCT02367781|454093683|FG001|Overall Study|Randomized in Error|4|||
126219295|NCT02367781|454093682|FG000|Overall Study|Non-Compliance|1|||
126219296|NCT02367781|454093683|FG001|Overall Study|Non-Compliance|0|||
126219297|NCT02367781|454093682|FG000|Overall Study|Lost to Follow-up|1|||
126219298|NCT02367781|454093683|FG001|Overall Study|Lost to Follow-up|2|||
126219299|NCT02367781|454093682|FG000|Overall Study|Death|330|||
126219300|NCT02367781|454093683|FG001|Overall Study|Death|176|||
126219301|NCT02367781|454093682|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
126219302|NCT02367781|454093683|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
126219303|NCT02367781|454093682|FG000|Overall Study|Prolonged Hospitalization|1|||
126219304|NCT02367781|454093683|FG001|Overall Study|Prolonged Hospitalization|0|||
126092138|NCT01204710|453630536|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
126092139|NCT01204710|453630537|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
126092140|NCT01204710|453630536|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
126092141|NCT01204710|453630537|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
126092142|NCT01204710|453630536|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
126092143|NCT01204710|453630537|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
126092144|NCT01276379|453630538|FG000|Overall Study|Screening failure|40|||
126219305|NCT02367781|454093682|FG000|Overall Study|Death Prior First Dose|1|||
126219306|NCT02367781|454093683|FG001|Overall Study|Death Prior First Dose|0|||
126219307|NCT02367781|454093682|FG000|Overall Study|Administrative-Change Facility|1|||
126219308|NCT02367781|454093683|FG001|Overall Study|Administrative-Change Facility|0|||
126219309|NCT02367781|454093682|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
126219310|NCT02367781|454093683|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
126219311|NCT02367781|454093682|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
126219312|NCT02367781|454093683|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
126219313|NCT02367781|454093682|FG000|Overall Study|Study Terminated by Sponsor|3|||
126219314|NCT02367781|454093683|FG001|Overall Study|Study Terminated by Sponsor|1|||
126219315|NCT02367781|454093682|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
126219316|NCT02367781|454093683|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
126219317|NCT02367781|454093682|FG000|Overall Study|Sponsor Decision|2|||
126219318|NCT02367781|454093683|FG001|Overall Study|Sponsor Decision|0|||
126219319|NCT02367781|454093682|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
126219320|NCT02367781|454093683|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
126219321|NCT02623426|454093684|FG000|Overall Study|Lost to Follow-up|0|||
126219322|NCT02623426|454093685|FG001|Overall Study|Lost to Follow-up|0|||
126219323|NCT02623426|454093686|FG002|Overall Study|Lost to Follow-up|1|||
126219324|NCT02623426|454093684|FG000|Overall Study|Withdrawal by Subject|1|||
126219325|NCT02623426|454093685|FG001|Overall Study|Withdrawal by Subject|2|||
126219326|NCT02623426|454093686|FG002|Overall Study|Withdrawal by Subject|2|||
126219327|NCT03185949|454093689|FG000|ITT Analysis|Withdrawal by Subject|4|||
126219328|NCT03185949|454093690|FG001|ITT Analysis|Withdrawal by Subject|3|||
126219329|NCT03185949|454093689|FG000|PP Analysis|Protocol Violation|2|||
126219330|NCT03185949|454093690|FG001|PP Analysis|Protocol Violation|2|||
126219331|NCT03185949|454093689|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
126219332|NCT03185949|454093690|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
126219333|NCT05166421|454093699|FG000|Overall Study|Other|3|||
126219334|NCT05166421|454093700|FG001|Overall Study|Other|1|||
126219335|NCT05166421|454093701|FG002|Overall Study|Other|1|||
126219336|NCT05166421|454093699|FG000|Overall Study|Withdrawal by Subject|5|||
126219337|NCT05166421|454093700|FG001|Overall Study|Withdrawal by Subject|3|||
126219338|NCT05166421|454093701|FG002|Overall Study|Withdrawal by Subject|6|||
126219339|NCT05166421|454093699|FG000|Overall Study|Lost to Follow-up|4|||
126219340|NCT05166421|454093700|FG001|Overall Study|Lost to Follow-up|1|||
126219341|NCT05166421|454093701|FG002|Overall Study|Lost to Follow-up|7|||
126219342|NCT00569231|454095485|FG000|Overall Study|Study unrelated surgery|1|||
126219343|NCT00569231|454095485|FG000|Overall Study|Airfare expense|2|||
126219344|NCT00569231|454095485|FG000|Overall Study|Withdrawal by Subject|1|||
126219345|NCT00569231|454095485|FG000|Overall Study|Car accident injury|1|||
126219346|NCT00569231|454095485|FG000|Overall Study|Non-compliance|2|||
126219347|NCT00700310|454095488|FG000|Overall Study|Adverse Event|6|||
126219348|NCT00700310|454095489|FG001|Overall Study|Adverse Event|10|||
126219349|NCT00700310|454095490|FG002|Overall Study|Adverse Event|5|||
126219350|NCT00700310|454095491|FG003|Overall Study|Adverse Event|11|||
126219351|NCT00700310|454095488|FG000|Overall Study|Lost to Follow-up|4|||
126219352|NCT00700310|454095489|FG001|Overall Study|Lost to Follow-up|1|||
126219353|NCT00700310|454095490|FG002|Overall Study|Lost to Follow-up|0|||
126219354|NCT00700310|454095491|FG003|Overall Study|Lost to Follow-up|1|||
126219355|NCT00700310|454095488|FG000|Overall Study|Withdrawal by Subject|8|||
126219356|NCT00700310|454095489|FG001|Overall Study|Withdrawal by Subject|9|||
126219357|NCT00700310|454095490|FG002|Overall Study|Withdrawal by Subject|8|||
126219358|NCT00700310|454095491|FG003|Overall Study|Withdrawal by Subject|8|||
126219359|NCT00700310|454095488|FG000|Overall Study|Lack of Efficacy|0|||
126219360|NCT00700310|454095489|FG001|Overall Study|Lack of Efficacy|3|||
126219361|NCT00700310|454095490|FG002|Overall Study|Lack of Efficacy|0|||
126219362|NCT00700310|454095491|FG003|Overall Study|Lack of Efficacy|1|||
126219363|NCT00700310|454095488|FG000|Overall Study|Administrative/Other|1|||
126219364|NCT00700310|454095489|FG001|Overall Study|Administrative/Other|3|||
126219365|NCT00700310|454095490|FG002|Overall Study|Administrative/Other|1|||
126219366|NCT00700310|454095491|FG003|Overall Study|Administrative/Other|3|||
126219367|NCT00700310|454095488|FG000|Overall Study|Randomized, Not Treated|2|||
126219368|NCT00700310|454095489|FG001|Overall Study|Randomized, Not Treated|0|||
126219369|NCT00700310|454095490|FG002|Overall Study|Randomized, Not Treated|2|||
126219370|NCT00700310|454095491|FG003|Overall Study|Randomized, Not Treated|2|||
126219371|NCT02598622|454095497|FG000|Overall Study|Withdrawal by Subject|3|||
126219372|NCT02598622|454095498|FG001|Overall Study|Withdrawal by Subject|0|||
126219373|NCT02598622|454095497|FG000|Overall Study|Physician Decision|3|||
126219374|NCT02598622|454095498|FG001|Overall Study|Physician Decision|0|||
126219375|NCT04575038|454095499|FG000|Overall Study|Withdrawal by Subject|1|||
126092145|NCT00864253|453630539|FG000|Overall Study|Adverse Event|56|||
126092146|NCT00864253|453630540|FG001|Overall Study|Adverse Event|11|||
126092147|NCT00864253|453630539|FG000|Overall Study|Unrelated Adverse Event|3|||
126219376|NCT04575038|454095500|FG001|Overall Study|Withdrawal by Subject|1|||
126219377|NCT01902134|454095502|FG000|Overall Study|Adverse Event|3|||
126219378|NCT01902134|454095503|FG001|Overall Study|Adverse Event|1|||
126017587|NCT01063972|453358881|FG000|Overall Study|Incarcerated|2|||
126219379|NCT01902134|454095504|FG002|Overall Study|Adverse Event|2|||
126219380|NCT01902134|454095505|FG003|Overall Study|Adverse Event|1|||
126219381|NCT01902134|454095506|FG004|Overall Study|Adverse Event|1|||
126219382|NCT01902134|454095507|FG005|Overall Study|Adverse Event|3|||
126219383|NCT01902134|454095502|FG000|Overall Study|Lack of Efficacy|0|||
126219384|NCT01902134|454095503|FG001|Overall Study|Lack of Efficacy|0|||
126219385|NCT01902134|454095504|FG002|Overall Study|Lack of Efficacy|2|||
126219386|NCT01902134|454095505|FG003|Overall Study|Lack of Efficacy|0|||
126219387|NCT01902134|454095506|FG004|Overall Study|Lack of Efficacy|0|||
126219388|NCT01902134|454095507|FG005|Overall Study|Lack of Efficacy|1|||
126219389|NCT01902134|454095502|FG000|Overall Study|Physician Decision|0|||
126219390|NCT01902134|454095503|FG001|Overall Study|Physician Decision|1|||
126219391|NCT01902134|454095504|FG002|Overall Study|Physician Decision|0|||
126219392|NCT01902134|454095505|FG003|Overall Study|Physician Decision|0|||
126219393|NCT01902134|454095506|FG004|Overall Study|Physician Decision|0|||
126219394|NCT01902134|454095507|FG005|Overall Study|Physician Decision|0|||
126219395|NCT01902134|454095502|FG000|Overall Study|Protocol Violation|0|||
126219396|NCT01902134|454095503|FG001|Overall Study|Protocol Violation|0|||
126219397|NCT01902134|454095504|FG002|Overall Study|Protocol Violation|0|||
126219398|NCT01902134|454095505|FG003|Overall Study|Protocol Violation|0|||
126219399|NCT01902134|454095506|FG004|Overall Study|Protocol Violation|0|||
126219400|NCT01902134|454095507|FG005|Overall Study|Protocol Violation|1|||
126219401|NCT01902134|454095502|FG000|Overall Study|Withdrawal by Subject|4|||
126219402|NCT01902134|454095503|FG001|Overall Study|Withdrawal by Subject|8|||
126219403|NCT01902134|454095504|FG002|Overall Study|Withdrawal by Subject|9|||
126219404|NCT01902134|454095505|FG003|Overall Study|Withdrawal by Subject|1|||
126219405|NCT01902134|454095506|FG004|Overall Study|Withdrawal by Subject|5|||
126017588|NCT01063972|453358882|FG001|Overall Study|Incarcerated|1|||
126219406|NCT01902134|454095507|FG005|Overall Study|Withdrawal by Subject|4|||
126219407|NCT01902134|454095502|FG000|Overall Study|no compliance|1|||
126219408|NCT01902134|454095503|FG001|Overall Study|no compliance|0|||
126219409|NCT01902134|454095504|FG002|Overall Study|no compliance|0|||
126219410|NCT01902134|454095505|FG003|Overall Study|no compliance|0|||
126219411|NCT01902134|454095506|FG004|Overall Study|no compliance|0|||
126219412|NCT01902134|454095507|FG005|Overall Study|no compliance|0|||
126219413|NCT01902134|454095502|FG000|Overall Study|Other|0|||
126017589|NCT01510717|453358884|FG000|Overall Study|Adverse Event|1|||
126219414|NCT01902134|454095503|FG001|Overall Study|Other|1|||
126017590|NCT01510717|453358885|FG001|Overall Study|Adverse Event|2|||
126017591|NCT01510717|453358884|FG000|Overall Study|Death|1|||
126017592|NCT01510717|453358885|FG001|Overall Study|Death|0|||
126017593|NCT01510717|453358884|FG000|Overall Study|Lost to Follow-up|0|||
126017594|NCT01510717|453358885|FG001|Overall Study|Lost to Follow-up|1|||
126017595|NCT01510717|453358884|FG000|Overall Study|Withdrawal by Subject|0|||
126017596|NCT01510717|453358885|FG001|Overall Study|Withdrawal by Subject|2|||
126017597|NCT01264679|453358886|FG000|Overall Study|Participation in Another Clinical Trial|1|||
126017598|NCT01264679|453358886|FG000|Overall Study|Physician Decision|1|||
126017599|NCT01264679|453358886|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
126017600|NCT01264679|453358886|FG000|Overall Study|Withdrawal by Subject|1|||
126017601|NCT00468052|453358891|FG000|Overall Study|Protocol Violation|7|||
126017602|NCT00468052|453358892|FG001|Overall Study|Protocol Violation|8|||
126017603|NCT02204982|453358895|FG000|Overall Study|Patient ineligible-medical monitor|1|||
126017604|NCT02204982|453358896|FG001|Overall Study|Patient ineligible-medical monitor|0|||
126017605|NCT02204982|453358895|FG000|Overall Study|Withdrawal by Subject|1|||
126017606|NCT02204982|453358896|FG001|Overall Study|Withdrawal by Subject|0|||
126017607|NCT02204982|453358895|FG000|Overall Study|Adverse Event|1|||
126017608|NCT02204982|453358896|FG001|Overall Study|Adverse Event|0|||
126017609|NCT02204982|453358895|FG000|Overall Study|Adverse Event and Investigator decision|1|||
126017610|NCT02204982|453358896|FG001|Overall Study|Adverse Event and Investigator decision|0|||
126017611|NCT02204982|453358895|FG000|Overall Study|Physician Decision|0|||
126017612|NCT02204982|453358896|FG001|Overall Study|Physician Decision|2|||
126017613|NCT02204982|453358895|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
126017614|NCT02204982|453358896|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
126017615|NCT02204982|453358895|FG000|Overall Study|Termination of Study bySponsor|0|||
126017616|NCT02204982|453358896|FG001|Overall Study|Termination of Study bySponsor|1|||
126017617|NCT00960141|453358897|FG000|Overall Study|Adverse Event|4|||
126017618|NCT00960141|453358898|FG001|Overall Study|Adverse Event|8|||
126017619|NCT00960141|453358899|FG002|Overall Study|Adverse Event|2|||
126017620|NCT00960141|453358897|FG000|Overall Study|Lack of Efficacy|3|||
126017621|NCT00960141|453358898|FG001|Overall Study|Lack of Efficacy|4|||
126017622|NCT00960141|453358899|FG002|Overall Study|Lack of Efficacy|2|||
126017623|NCT00960141|453358897|FG000|Overall Study|Lost to Follow-up|1|||
126017624|NCT00960141|453358898|FG001|Overall Study|Lost to Follow-up|0|||
126017625|NCT00960141|453358899|FG002|Overall Study|Lost to Follow-up|0|||
126017626|NCT00960141|453358897|FG000|Overall Study|Protocol Violation|1|||
126017627|NCT00960141|453358898|FG001|Overall Study|Protocol Violation|3|||
126017628|NCT00960141|453358899|FG002|Overall Study|Protocol Violation|2|||
126017629|NCT00960141|453358897|FG000|Overall Study|Withdrawal by Subject|1|||
126017630|NCT00960141|453358898|FG001|Overall Study|Withdrawal by Subject|2|||
126017631|NCT00960141|453358899|FG002|Overall Study|Withdrawal by Subject|1|||
126017632|NCT00159783|453358900|FG000|Overall Study|Adverse Event|5|||
126017633|NCT00159783|453358901|FG001|Overall Study|Adverse Event|7|||
126017634|NCT00159783|453358902|FG002|Overall Study|Adverse Event|9|||
126017635|NCT00159783|453358900|FG000|Overall Study|Lack of Efficacy|1|||
126017636|NCT00159783|453358901|FG001|Overall Study|Lack of Efficacy|2|||
126017637|NCT00159783|453358902|FG002|Overall Study|Lack of Efficacy|3|||
126017638|NCT00159783|453358900|FG000|Overall Study|Withdrawal by Subject|7|||
126017639|NCT00159783|453358901|FG001|Overall Study|Withdrawal by Subject|11|||
126017640|NCT00159783|453358902|FG002|Overall Study|Withdrawal by Subject|12|||
126017641|NCT00159783|453358900|FG000|Overall Study|Lost to Follow-up|6|||
126092148|NCT00864253|453630540|FG001|Overall Study|Unrelated Adverse Event|1|||
126092149|NCT00864253|453630539|FG000|Overall Study|Physician Decision|11|||
126017642|NCT00159783|453358901|FG001|Overall Study|Lost to Follow-up|5|||
126017643|NCT00159783|453358902|FG002|Overall Study|Lost to Follow-up|11|||
126017644|NCT00159783|453358900|FG000|Overall Study|Other|0|||
126017645|NCT00159783|453358901|FG001|Overall Study|Other|2|||
126017646|NCT00159783|453358902|FG002|Overall Study|Other|4|||
126017647|NCT02928224|453358903|FG000|Overall Study|Lost to Follow-up|1|||
126017648|NCT02928224|453358904|FG001|Overall Study|Lost to Follow-up|1|||
126017649|NCT02928224|453358905|FG002|Overall Study|Lost to Follow-up|3|||
126092150|NCT00864253|453630540|FG001|Overall Study|Physician Decision|15|||
126092151|NCT00864253|453630539|FG000|Overall Study|Protocol Violation|0|||
126092152|NCT00864253|453630540|FG001|Overall Study|Protocol Violation|2|||
126092153|NCT00864253|453630539|FG000|Overall Study|Lost to Follow-up|1|||
126092154|NCT00864253|453630540|FG001|Overall Study|Lost to Follow-up|1|||
126092155|NCT00864253|453630539|FG000|Overall Study|Withdrawal by Subject|18|||
126092156|NCT00864253|453630540|FG001|Overall Study|Withdrawal by Subject|18|||
126017650|NCT02928224|453358906|FG003|Overall Study|Lost to Follow-up|0|||
126017651|NCT02928224|453358903|FG000|Overall Study|Death|30|||
126017652|NCT02928224|453358904|FG001|Overall Study|Death|209|||
126017653|NCT02928224|453358905|FG002|Overall Study|Death|193|||
126017654|NCT02928224|453358906|FG003|Overall Study|Death|198|||
126017655|NCT02928224|453358903|FG000|Overall Study|Withdrawal by Subject|0|||
126092157|NCT00864253|453630539|FG000|Overall Study|Death|1|||
126092158|NCT00864253|453630540|FG001|Overall Study|Death|0|||
126219415|NCT01902134|454095504|FG002|Overall Study|Other|2|||
126219416|NCT01902134|454095505|FG003|Overall Study|Other|0|||
126219417|NCT01902134|454095506|FG004|Overall Study|Other|1|||
126219418|NCT01902134|454095507|FG005|Overall Study|Other|0|||
126219419|NCT00305110|454095508|FG000|Overall Study|Missing data|29|||
126219420|NCT00678379|454095509|FG000|Overall Study|Injection performed after tonsillectomy|2|||
126219421|NCT00678379|454095510|FG001|Overall Study|Injection performed after tonsillectomy|0|||
126219422|NCT00678379|454095511|FG002|Overall Study|Injection performed after tonsillectomy|1|||
126219423|NCT00678379|454095509|FG000|Overall Study|Incomplete Data|4|||
126219424|NCT00678379|454095510|FG001|Overall Study|Incomplete Data|3|||
126219425|NCT00678379|454095511|FG002|Overall Study|Incomplete Data|3|||
126219426|NCT00350519|454095512|FG000|Overall Study|Death|0|||
126219427|NCT00350519|454095513|FG001|Overall Study|Death|1|||
126219428|NCT00350519|454095512|FG000|Overall Study|Physician Decision|0|||
126219429|NCT00350519|454095513|FG001|Overall Study|Physician Decision|1|||
126219430|NCT00350519|454095512|FG000|Overall Study|Protocol Violation|1|||
126219431|NCT00350519|454095513|FG001|Overall Study|Protocol Violation|2|||
126219432|NCT00350519|454095512|FG000|Overall Study|Withdrawal by Subject|3|||
126219433|NCT00350519|454095513|FG001|Overall Study|Withdrawal by Subject|2|||
126219434|NCT02595528|454095514|FG000|Overall Study|Withdrawal by Subject|1|||
126219435|NCT02595528|454095515|FG001|Overall Study|Withdrawal by Subject|2|||
126219436|NCT02595528|454095516|FG002|Overall Study|Withdrawal by Subject|1|||
126219437|NCT02595528|454095517|FG003|Overall Study|Withdrawal by Subject|3|||
126219438|NCT02595528|454095514|FG000|Overall Study|Lost to Follow-up|1|||
126219439|NCT02595528|454095515|FG001|Overall Study|Lost to Follow-up|1|||
126219440|NCT02595528|454095516|FG002|Overall Study|Lost to Follow-up|0|||
126219441|NCT02595528|454095517|FG003|Overall Study|Lost to Follow-up|1|||
126219442|NCT03101293|454095521|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
126219443|NCT03101293|454095522|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
126219444|NCT03333382|454095524|FG000|Overall Study|Lost to Follow-up|1|||
126219445|NCT03333382|454095525|FG001|Overall Study|Lost to Follow-up|0|||
126219446|NCT00550420|454095526|FG000|Overall Study|Adverse Event|28|||
126219447|NCT00550420|454095526|FG000|Overall Study|Lost to Follow-up|8|||
126219448|NCT00550420|454095526|FG000|Overall Study|Protocol Violation|11|||
126219449|NCT00550420|454095526|FG000|Overall Study|Withdrawal by Subject|30|||
126219450|NCT00550420|454095526|FG000|Overall Study|Still in study at termination|206|||
126219451|NCT00550420|454095526|FG000|Overall Study|Missing|2|||
126219452|NCT00550420|454095526|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
126219453|NCT00550420|454095526|FG000|Overall Study|Investigators opinion|1|||
126219454|NCT00550420|454095526|FG000|Overall Study|Lack of curative effect|1|||
126219455|NCT00550420|454095526|FG000|Overall Study|Unethical stop of enrollment|2|||
126219456|NCT00550420|454095526|FG000|Overall Study|Caregiver's decision to withdraw|1|||
126219457|NCT00550420|454095526|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
126219458|NCT00550420|454095526|FG000|Overall Study|Exclusion criteria|1|||
126219459|NCT00550420|454095526|FG000|Overall Study|Prohibited medicine|1|||
126219460|NCT00782275|454095530|FG000|Overall Study|Adverse Event|11|||
126219461|NCT00782275|454095530|FG000|Overall Study|Withdrawal by Subject|1|||
126219462|NCT00782275|454095530|FG000|Overall Study|Progressive Disease|21|||
126219463|NCT00782275|454095530|FG000|Overall Study|Physician Decision|4|||
126219464|NCT00782275|454095530|FG000|Overall Study|Not started treatment|1|||
126219465|NCT00782275|454095530|FG000|Overall Study|Other|3|||
126219466|NCT02773446|454095537|FG000|First Admission|Withdrawal by Subject|0|||
126219467|NCT02773446|454095538|FG001|First Admission|Withdrawal by Subject|0|||
126219468|NCT02773446|454095539|FG002|First Admission|Withdrawal by Subject|0|||
126219469|NCT02773446|454095540|FG003|First Admission|Withdrawal by Subject|1|||
126219470|NCT02773446|454095541|FG004|First Admission|Withdrawal by Subject|0|||
126219471|NCT02773446|454095542|FG005|First Admission|Withdrawal by Subject|0|||
126219472|NCT02773446|454095537|FG000|First Admission|Lost to Follow-up|1|||
126219473|NCT02773446|454095538|FG001|First Admission|Lost to Follow-up|0|||
126219474|NCT02773446|454095539|FG002|First Admission|Lost to Follow-up|0|||
126219475|NCT02773446|454095540|FG003|First Admission|Lost to Follow-up|0|||
126092159|NCT00864253|453630539|FG000|Overall Study|Ongoing|2|||
126092160|NCT00864253|453630540|FG001|Overall Study|Ongoing|3|||
126092161|NCT00864253|453630539|FG000|Overall Study|Untreated|7|||
126092162|NCT00864253|453630540|FG001|Overall Study|Untreated|7|||
126219476|NCT02773446|454095541|FG004|First Admission|Lost to Follow-up|0|||
126219477|NCT02773446|454095542|FG005|First Admission|Lost to Follow-up|0|||
126092163|NCT01896726|453630541|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
126092164|NCT01896726|453630541|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
126092165|NCT01128114|453630542|FG000|Overall Study|Treatment Withdrawn|6|||
126092166|NCT01128114|453630542|FG000|Overall Study|Screening Failed|2|||
126092167|NCT00208325|453630543|FG000|Overall Study|Death|18|||
126219478|NCT03237611|454095543|FG000|Overall Study|Withdrawal by Subject|1|||
126219479|NCT03237611|454095543|FG000|Overall Study|Ineligible|1|||
126219480|NCT01613131|454095544|FG000|Overall Study|Withdrawal by Subject|3|||
126219481|NCT01613131|454095545|FG001|Overall Study|Withdrawal by Subject|5|||
126219482|NCT00787566|454095548|FG000|Overall Study|AE related to chemotherapy|0|||
126219483|NCT00787566|454095549|FG001|Overall Study|AE related to chemotherapy|1|||
126219484|NCT00787566|454095550|FG002|Overall Study|AE related to chemotherapy|0|||
126219485|NCT01814761|454095551|FG000|Overall Study|Other Reasons|1|||
126219486|NCT01814761|454095552|FG001|Overall Study|Other Reasons|10|||
126219487|NCT01814761|454095551|FG000|Overall Study|Ocular Adverse Event|6|||
126219488|NCT01814761|454095552|FG001|Overall Study|Ocular Adverse Event|15|||
126219489|NCT01814761|454095551|FG000|Overall Study|Lost to Follow-up|1|||
126219490|NCT01814761|454095552|FG001|Overall Study|Lost to Follow-up|5|||
126219491|NCT00417027|454095553|FG000|Overall Study|Protocol Violation|0|||
126219492|NCT00417027|454095554|FG001|Overall Study|Protocol Violation|5|||
126219493|NCT00417027|454095555|FG002|Overall Study|Protocol Violation|5|||
126219494|NCT03137082|454095556|FG000|Overall Study|Withdrawal by Subject|1|||
126219495|NCT03137082|454095557|FG001|Overall Study|Withdrawal by Subject|1|||
126219496|NCT03137082|454095556|FG000|Overall Study|Lost to Follow-up|1|||
126219497|NCT03137082|454095557|FG001|Overall Study|Lost to Follow-up|0|||
126219498|NCT00544557|454095558|FG000|Overall Study|Adverse Event|140|||
126219499|NCT00544557|454095558|FG000|Overall Study|Lack of Efficacy|196|||
126219500|NCT00544557|454095558|FG000|Overall Study|Other|98|||
126219501|NCT01020305|454095566|FG000|Overall Study|Adverse Event|2|||
126219502|NCT01017029|454095570|FG000|Overall Study|Lost to Follow-up|1|||
126219503|NCT01017029|454095571|FG001|Overall Study|Lost to Follow-up|0|||
126219504|NCT01017029|454095570|FG000|Overall Study|Administrative problem|0|||
126219505|NCT01017029|454095571|FG001|Overall Study|Administrative problem|1|||
126219506|NCT01017029|454095570|FG000|Overall Study|Death|3|||
126219507|NCT01017029|454095571|FG001|Overall Study|Death|1|||
126219508|NCT00618774|454095572|FG000|Overall Study|Adverse Event|5|||
126219509|NCT00618774|454095573|FG001|Overall Study|Adverse Event|3|||
126219510|NCT00618774|454095572|FG000|Overall Study|Withdrawal by Subject|1|||
126219511|NCT00618774|454095573|FG001|Overall Study|Withdrawal by Subject|0|||
126219512|NCT02753400|454095575|FG000|Overall Study|Adverse Event|3|||
126219513|NCT02753400|454095576|FG001|Overall Study|Adverse Event|0|||
126219514|NCT02753400|454095575|FG000|Overall Study|Withdrawal by Subject|2|||
126219515|NCT02753400|454095576|FG001|Overall Study|Withdrawal by Subject|1|||
126219516|NCT01415921|454095577|FG000|Overall Study|Adverse Event|0|||
126219517|NCT01415921|454095578|FG001|Overall Study|Adverse Event|1|||
126219518|NCT01415921|454095577|FG000|Overall Study|Physician Decision|1|||
126219519|NCT01415921|454095578|FG001|Overall Study|Physician Decision|1|||
126219520|NCT01415921|454095577|FG000|Overall Study|Withdrawal by Subject|0|||
126219521|NCT01415921|454095578|FG001|Overall Study|Withdrawal by Subject|1|||
126219522|NCT01415921|454095577|FG000|Overall Study|Other|2|||
126219523|NCT01415921|454095578|FG001|Overall Study|Other|0|||
126219524|NCT01830920|454095583|FG000|Overall Study|Adverse Event|1|||
126219525|NCT01830920|454095584|FG001|Overall Study|Adverse Event|0|||
126219526|NCT01830920|454095585|FG002|Overall Study|Adverse Event|1|||
126219527|NCT01830920|454095586|FG003|Overall Study|Adverse Event|0|||
126219528|NCT01830920|454095587|FG004|Overall Study|Adverse Event|0|||
126219529|NCT01830920|454095583|FG000|Overall Study|Withdrawal by Subject|2|||
126219530|NCT01830920|454095584|FG001|Overall Study|Withdrawal by Subject|2|||
126219531|NCT01830920|454095585|FG002|Overall Study|Withdrawal by Subject|1|||
126219532|NCT01830920|454095586|FG003|Overall Study|Withdrawal by Subject|7|||
126219533|NCT01830920|454095587|FG004|Overall Study|Withdrawal by Subject|1|||
126219534|NCT01830920|454095583|FG000|Overall Study|Death|3|||
126219535|NCT01830920|454095584|FG001|Overall Study|Death|3|||
126219536|NCT01830920|454095585|FG002|Overall Study|Death|5|||
126219537|NCT01830920|454095586|FG003|Overall Study|Death|4|||
126219538|NCT01830920|454095587|FG004|Overall Study|Death|4|||
126219539|NCT01830920|454095583|FG000|Overall Study|Other|15|||
126219540|NCT01830920|454095584|FG001|Overall Study|Other|1|||
126017656|NCT02928224|453358904|FG001|Overall Study|Withdrawal by Subject|3|||
126017657|NCT02928224|453358905|FG002|Overall Study|Withdrawal by Subject|7|||
126017658|NCT02928224|453358906|FG003|Overall Study|Withdrawal by Subject|20|||
126219541|NCT01830920|454095585|FG002|Overall Study|Other|1|||
126219542|NCT01830920|454095586|FG003|Overall Study|Other|5|||
126219543|NCT01830920|454095587|FG004|Overall Study|Other|3|||
126219544|NCT03876873|454095588|FG000|Overall Study|Physician Decision|0|||
126219545|NCT03876873|454095589|FG001|Overall Study|Physician Decision|1|||
126219546|NCT03547531|454095590|FG000|Overall Study|not coming in data collection : sick|2|||
126219547|NCT03547531|454095591|FG001|Overall Study|not coming in data collection : sick|2|||
126219548|NCT03547531|454095590|FG000|Overall Study|having family occasion|0|||
126219549|NCT03547531|454095591|FG001|Overall Study|having family occasion|2|||
126219550|NCT03402126|454095600|FG000|Overall Study|Lost to Follow-up|6|||
126219551|NCT03402126|454095600|FG000|Overall Study|Protocol Violation|10|||
126219552|NCT03402126|454095600|FG000|Overall Study|Sponsor request/Study termination|29|||
126219553|NCT03402126|454095600|FG000|Overall Study|Study product no longer in use|1|||
126219554|NCT03402126|454095600|FG000|Overall Study|Technical problems|1|||
126219555|NCT03402126|454095600|FG000|Overall Study|Withdrawal by Subject|6|||
126219556|NCT03402126|454095600|FG000|Overall Study|Physician Decision|2|||
126219557|NCT03402126|454095600|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
126219558|NCT03402126|454095600|FG000|Overall Study|Death|4|||
126219559|NCT02117479|454095601|FG000|Overall Study|Death|13|||
126219560|NCT02117479|454095602|FG001|Overall Study|Death|8|||
126219561|NCT02117479|454095601|FG000|Overall Study|Adverse Event|8|||
126219562|NCT02117479|454095602|FG001|Overall Study|Adverse Event|16|||
126219563|NCT02117479|454095601|FG000|Overall Study|Subject decision|8|||
126219564|NCT02117479|454095602|FG001|Overall Study|Subject decision|9|||
126219565|NCT02117479|454095601|FG000|Overall Study|Disease progression|104|||
126219566|NCT02117479|454095602|FG001|Overall Study|Disease progression|108|||
126219567|NCT02117479|454095601|FG000|Overall Study|Noncompliance with study treatment|1|||
126219568|NCT02117479|454095602|FG001|Overall Study|Noncompliance with study treatment|0|||
126219569|NCT02117479|454095601|FG000|Overall Study|Study terminated by the sponsor|4|||
126219570|NCT02117479|454095602|FG001|Overall Study|Study terminated by the sponsor|6|||
126219571|NCT02117479|454095601|FG000|Overall Study|Physician Decision|7|||
126219572|NCT02117479|454095602|FG001|Overall Study|Physician Decision|2|||
126219573|NCT02117479|454095601|FG000|Overall Study|Other unspecified|11|||
126219574|NCT02117479|454095602|FG001|Overall Study|Other unspecified|7|||
126219575|NCT01959230|454095603|FG000|Overall Study|Failure to follow study procedures|0|||
126219576|NCT01959230|454095604|FG001|Overall Study|Failure to follow study procedures|1|||
126219577|NCT01959230|454095603|FG000|Overall Study|Administrative reasons|2|||
126219578|NCT01959230|454095604|FG001|Overall Study|Administrative reasons|0|||
126092168|NCT00208325|453630544|FG001|Overall Study|Death|19|||
126092169|NCT00208325|453630545|FG002|Overall Study|Death|7|||
126092170|NCT00208325|453630546|FG003|Overall Study|Death|5|||
126092171|NCT00208325|453630543|FG000|Overall Study|Withdrawal by Subject|0|||
126092172|NCT00208325|453630544|FG001|Overall Study|Withdrawal by Subject|1|||
126092173|NCT00208325|453630545|FG002|Overall Study|Withdrawal by Subject|0|||
126219579|NCT01959230|454095603|FG000|Overall Study|Withdrawal by Subject|2|||
126219580|NCT01959230|454095604|FG001|Overall Study|Withdrawal by Subject|0|||
126219581|NCT00720304|454095605|FG000|Overall Study|Withdrawal by Subject|14|||
126219582|NCT00720304|454095606|FG001|Overall Study|Withdrawal by Subject|1|||
126219583|NCT00720304|454095605|FG000|Overall Study|Death|1|||
126219584|NCT00720304|454095606|FG001|Overall Study|Death|0|||
126219585|NCT00720304|454095605|FG000|Overall Study|Physician Decision|5|||
126219586|NCT00720304|454095606|FG001|Overall Study|Physician Decision|2|||
126219587|NCT00720304|454095605|FG000|Overall Study|Adverse Event|3|||
126219588|NCT00720304|454095606|FG001|Overall Study|Adverse Event|1|||
126219589|NCT00720304|454095605|FG000|Overall Study|Disease progression|6|||
126219590|NCT00720304|454095606|FG001|Overall Study|Disease progression|1|||
126219591|NCT01333475|454095607|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
126219592|NCT01333475|454095608|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
126219593|NCT01333475|454095607|FG000|Overall Study|Toxicity|1|||
126219594|NCT01333475|454095608|FG001|Overall Study|Toxicity|3|||
126219595|NCT02981602|454095609|FG000|Overall Study|Adverse Event|0|||
126219596|NCT02981602|454095610|FG001|Overall Study|Adverse Event|0|||
126219597|NCT02981602|454095611|FG002|Overall Study|Adverse Event|0|||
126219598|NCT02981602|454095612|FG003|Overall Study|Adverse Event|1|||
126219599|NCT02981602|454095613|FG004|Overall Study|Adverse Event|0|||
126219600|NCT01169987|454095614|FG000|Overall Study|Withdrawal by Subject|3|||
126219601|NCT01169987|454095614|FG000|Overall Study|Lost to Follow-up|24|||
126219602|NCT01169987|454095614|FG000|Overall Study|Other|4|||
126092174|NCT00208325|453630546|FG003|Overall Study|Withdrawal by Subject|0|||
126092175|NCT00208325|453630543|FG000|Overall Study|Revision|4|||
126092176|NCT00208325|453630544|FG001|Overall Study|Revision|1|||
126219603|NCT00386100|454095615|FG000|Overall Study|Did not receive study medication|6|||
126219604|NCT00386100|454095616|FG001|Overall Study|Did not receive study medication|4|||
126219605|NCT00386100|454095615|FG000|Overall Study|Adverse Event|15|||
126219606|NCT00386100|454095616|FG001|Overall Study|Adverse Event|25|||
126219607|NCT00386100|454095615|FG000|Overall Study|Death|0|||
126092177|NCT00208325|453630545|FG002|Overall Study|Revision|0|||
126092178|NCT00208325|453630546|FG003|Overall Study|Revision|4|||
126092179|NCT00208325|453630543|FG000|Overall Study|Lost to Follow-up|1|||
126092180|NCT00208325|453630544|FG001|Overall Study|Lost to Follow-up|0|||
126219608|NCT00386100|454095616|FG001|Overall Study|Death|1|||
126219609|NCT00386100|454095615|FG000|Overall Study|Insufficient therapeutic effect|30|||
126219610|NCT00386100|454095616|FG001|Overall Study|Insufficient therapeutic effect|6|||
126092181|NCT00208325|453630545|FG002|Overall Study|Lost to Follow-up|2|||
126219611|NCT00386100|454095615|FG000|Overall Study|Lost to Follow-up|29|||
126092182|NCT00208325|453630546|FG003|Overall Study|Lost to Follow-up|0|||
126092183|NCT00208325|453630543|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
126219612|NCT00386100|454095616|FG001|Overall Study|Lost to Follow-up|29|||
126219613|NCT00386100|454095615|FG000|Overall Study|Non-compliance|18|||
126219614|NCT00386100|454095616|FG001|Overall Study|Non-compliance|19|||
126219615|NCT00386100|454095615|FG000|Overall Study|Protocol Violation|5|||
126219616|NCT00386100|454095616|FG001|Overall Study|Protocol Violation|3|||
126219617|NCT00386100|454095615|FG000|Overall Study|Withdrawal by Subject|32|||
126219618|NCT00386100|454095616|FG001|Overall Study|Withdrawal by Subject|31|||
126219619|NCT00386100|454095615|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
126219620|NCT00386100|454095616|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
126219621|NCT00386100|454095615|FG000|Overall Study|BMD <2.5|1|||
126219622|NCT00386100|454095616|FG001|Overall Study|BMD <2.5|0|||
126219623|NCT00386100|454095615|FG000|Overall Study|Consecutive elevated Hba1C|1|||
126219624|NCT00386100|454095616|FG001|Overall Study|Consecutive elevated Hba1C|0|||
126219625|NCT00386100|454095615|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
126219626|NCT00386100|454095616|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
126219627|NCT00386100|454095615|FG000|Overall Study|Laboratory findings|1|||
126219628|NCT00386100|454095616|FG001|Overall Study|Laboratory findings|0|||
126219629|NCT00386100|454095615|FG000|Overall Study|Participant's concern due to CPK levels|1|||
126219630|NCT00386100|454095616|FG001|Overall Study|Participant's concern due to CPK levels|0|||
126219631|NCT00386100|454095615|FG000|Overall Study|Participant moving out of state|2|||
126219632|NCT00386100|454095616|FG001|Overall Study|Participant moving out of state|0|||
126219633|NCT00386100|454095615|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
126219634|NCT00386100|454095616|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
126219635|NCT00386100|454095615|FG000|Overall Study|Didn't meet entry criteria|1|||
126219636|NCT00386100|454095616|FG001|Overall Study|Didn't meet entry criteria|1|||
126219637|NCT00386100|454095615|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
126219638|NCT00386100|454095616|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
126219639|NCT00386100|454095615|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
126219640|NCT00386100|454095616|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
126219641|NCT00386100|454095615|FG000|Overall Study|Bad metabolic control & patient security|1|||
126219642|NCT00386100|454095616|FG001|Overall Study|Bad metabolic control & patient security|0|||
126219643|NCT00386100|454095615|FG000|Overall Study|Bone loss by DXA bone scan|1|||
126219644|NCT00386100|454095616|FG001|Overall Study|Bone loss by DXA bone scan|0|||
126219645|NCT00386100|454095615|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
126219646|NCT00386100|454095616|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
126219647|NCT00386100|454095615|FG000|Overall Study|7.6% bone loss|1|||
126219648|NCT00386100|454095616|FG001|Overall Study|7.6% bone loss|0|||
126219649|NCT00386100|454095615|FG000|Overall Study|Osteoporosis|0|||
126219650|NCT00386100|454095616|FG001|Overall Study|Osteoporosis|1|||
126219651|NCT00386100|454095615|FG000|Overall Study|Positive pregnancy test|1|||
126219652|NCT00386100|454095616|FG001|Overall Study|Positive pregnancy test|3|||
126219653|NCT00386100|454095615|FG000|Overall Study|Out of country for 5 months|1|||
126219654|NCT00386100|454095616|FG001|Overall Study|Out of country for 5 months|0|||
126219655|NCT00386100|454095615|FG000|Overall Study|Hb1Ac >8%|0|||
126219656|NCT00386100|454095616|FG001|Overall Study|Hb1Ac >8%|1|||
126219657|NCT00386100|454095615|FG000|Overall Study|Participant randomized in error|1|||
126219658|NCT00386100|454095616|FG001|Overall Study|Participant randomized in error|0|||
126219659|NCT01706770|454095619|FG000|Overall Study|Lost to Follow-up|1|||
126219660|NCT01706770|454095620|FG001|Overall Study|Lost to Follow-up|0|||
126219661|NCT01706770|454095619|FG000|Overall Study|Physician Decision|1|||
126219662|NCT01706770|454095620|FG001|Overall Study|Physician Decision|0|||
126219663|NCT00886782|454095626|FG000|Overall Study|Disease progression|3|||
126219664|NCT00886782|454095627|FG001|Overall Study|Disease progression|3|||
126219665|NCT00886782|454095628|FG002|Overall Study|Disease progression|3|||
126219666|NCT00886782|454095626|FG000|Overall Study|Study drug toxicity|0|||
126219667|NCT00886782|454095627|FG001|Overall Study|Study drug toxicity|0|||
126092184|NCT00208325|453630544|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
126092185|NCT00208325|453630545|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
126092186|NCT00208325|453630546|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
126092187|NCT00208325|453630543|FG000|Overall Study|Does not wish to Continue in Study|5|||
126092188|NCT00208325|453630544|FG001|Overall Study|Does not wish to Continue in Study|8|||
126092189|NCT00208325|453630545|FG002|Overall Study|Does not wish to Continue in Study|3|||
126092190|NCT00208325|453630546|FG003|Overall Study|Does not wish to Continue in Study|2|||
126092191|NCT00208325|453630543|FG000|Overall Study|Other|2|||
126092192|NCT00208325|453630544|FG001|Overall Study|Other|1|||
125878734|NCT01209689|452853400|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
126219668|NCT00886782|454095628|FG002|Overall Study|Study drug toxicity|1|||
126219669|NCT00886782|454095626|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
126219670|NCT00886782|454095627|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
126219671|NCT00886782|454095628|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
126219672|NCT03636542|454095629|FG000|Overall Study|Lost to Follow-up|1|||
126219673|NCT03636542|454095630|FG001|Overall Study|Lost to Follow-up|1|||
126219674|NCT03636542|454095629|FG000|Overall Study|Physician Decision|0|||
126092193|NCT00208325|453630545|FG002|Overall Study|Other|1|||
126092194|NCT00208325|453630546|FG003|Overall Study|Other|0|||
126219675|NCT03636542|454095630|FG001|Overall Study|Physician Decision|1|||
126092195|NCT00208325|453630543|FG000|Overall Study|Mis-Randomized|17|||
126219676|NCT03636542|454095629|FG000|Overall Study|Withdrawal by Subject|1|||
126219677|NCT03636542|454095630|FG001|Overall Study|Withdrawal by Subject|0|||
126219678|NCT04130919|454095633|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
126219679|NCT04130919|454095634|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
126219680|NCT04130919|454095635|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
126219681|NCT04130919|454095636|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
126219682|NCT04130919|454095637|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
126219683|NCT04130919|454095638|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
126219684|NCT04130919|454095633|FG000|Blinded Treatment Phase|Adverse Event|0|||
126219685|NCT04130919|454095634|FG001|Blinded Treatment Phase|Adverse Event|0|||
126219686|NCT04130919|454095635|FG002|Blinded Treatment Phase|Adverse Event|1|||
126219687|NCT04130919|454095636|FG003|Blinded Treatment Phase|Adverse Event|0|||
126219688|NCT04130919|454095637|FG004|Blinded Treatment Phase|Adverse Event|0|||
126219689|NCT04130919|454095638|FG005|Blinded Treatment Phase|Adverse Event|0|||
126219690|NCT04130919|454095633|FG000|Blinded Treatment Phase|Disease worsening|0|||
126219691|NCT04130919|454095634|FG001|Blinded Treatment Phase|Disease worsening|0|||
126219692|NCT04130919|454095635|FG002|Blinded Treatment Phase|Disease worsening|1|||
126219693|NCT04130919|454095636|FG003|Blinded Treatment Phase|Disease worsening|0|||
126219694|NCT04130919|454095637|FG004|Blinded Treatment Phase|Disease worsening|0|||
126219695|NCT04130919|454095638|FG005|Blinded Treatment Phase|Disease worsening|0|||
126219696|NCT04130919|454095633|FG000|Blinded Treatment Phase|Investigator's decision|0|||
126219697|NCT04130919|454095634|FG001|Blinded Treatment Phase|Investigator's decision|1|||
126219698|NCT04130919|454095635|FG002|Blinded Treatment Phase|Investigator's decision|0|||
126219699|NCT04130919|454095636|FG003|Blinded Treatment Phase|Investigator's decision|0|||
126219700|NCT04130919|454095637|FG004|Blinded Treatment Phase|Investigator's decision|0|||
126219701|NCT04130919|454095638|FG005|Blinded Treatment Phase|Investigator's decision|0|||
126219702|NCT04130919|454095633|FG000|Blinded Treatment Phase|Withdrew consent|1|||
126219703|NCT04130919|454095634|FG001|Blinded Treatment Phase|Withdrew consent|0|||
126219704|NCT04130919|454095635|FG002|Blinded Treatment Phase|Withdrew consent|0|||
126219705|NCT04130919|454095636|FG003|Blinded Treatment Phase|Withdrew consent|0|||
126219706|NCT04130919|454095637|FG004|Blinded Treatment Phase|Withdrew consent|0|||
126219707|NCT04130919|454095638|FG005|Blinded Treatment Phase|Withdrew consent|0|||
126219708|NCT04130919|454095633|FG000|Open-label Treatment Phase|Withdrew consent|0|||
126219709|NCT04130919|454095634|FG001|Open-label Treatment Phase|Withdrew consent|0|||
126219710|NCT04130919|454095635|FG002|Open-label Treatment Phase|Withdrew consent|0|||
126219711|NCT04130919|454095636|FG003|Open-label Treatment Phase|Withdrew consent|1|||
126219712|NCT04130919|454095637|FG004|Open-label Treatment Phase|Withdrew consent|1|||
126219713|NCT04130919|454095638|FG005|Open-label Treatment Phase|Withdrew consent|1|||
126219714|NCT04130919|454095633|FG000|Open-label Treatment Phase|Disease worsening|0|||
126219715|NCT04130919|454095634|FG001|Open-label Treatment Phase|Disease worsening|0|||
126219716|NCT04130919|454095635|FG002|Open-label Treatment Phase|Disease worsening|0|||
126219717|NCT04130919|454095636|FG003|Open-label Treatment Phase|Disease worsening|1|||
126017659|NCT02928224|453358903|FG000|Overall Study|Study participation terminated by sponsor|3|||
126017660|NCT02928224|453358904|FG001|Overall Study|Study participation terminated by sponsor|8|||
126017661|NCT02928224|453358905|FG002|Overall Study|Study participation terminated by sponsor|12|||
126017662|NCT02928224|453358906|FG003|Overall Study|Study participation terminated by sponsor|3|||
126017663|NCT02928224|453358903|FG000|Overall Study|Other|3|||
126017664|NCT02928224|453358904|FG001|Overall Study|Other|3|||
126017665|NCT02928224|453358905|FG002|Overall Study|Other|5|||
126017666|NCT02928224|453358906|FG003|Overall Study|Other|0|||
126017667|NCT01236560|453358907|FG000|Overall Study|Adverse Event|0|||
126017668|NCT01236560|453358908|FG001|Overall Study|Adverse Event|2|||
126219718|NCT04130919|454095637|FG004|Open-label Treatment Phase|Disease worsening|0|||
126219719|NCT04130919|454095638|FG005|Open-label Treatment Phase|Disease worsening|1|||
126219720|NCT04130919|454095633|FG000|Open-label Treatment Phase|Investigator's decision|0|||
126092196|NCT00208325|453630544|FG001|Overall Study|Mis-Randomized|20|||
126092197|NCT00208325|453630545|FG002|Overall Study|Mis-Randomized|0|||
126092198|NCT00208325|453630546|FG003|Overall Study|Mis-Randomized|0|||
126092199|NCT00586612|453630547|FG000|Primary Phase|Protocol Violation|1|||
126092200|NCT00586612|453630548|FG001|Primary Phase|Protocol Violation|0|||
126092201|NCT00586612|453630547|FG000|Primary Phase|Lost to Follow-up|0|||
126092202|NCT00586612|453630548|FG001|Primary Phase|Lost to Follow-up|1|||
126092203|NCT00586612|453630547|FG000|Primary Phase|Withdrawal by Subject|0|||
126092204|NCT00586612|453630548|FG001|Primary Phase|Withdrawal by Subject|2|||
126092205|NCT00586612|453630547|FG000|Booster Phase|Lost to Follow-up|3|||
126092206|NCT00586612|453630548|FG001|Booster Phase|Lost to Follow-up|1|||
126092207|NCT02001064|453630551|FG000|Overall Study|Withdrawal by Subject|2|||
126017669|NCT01236560|453358909|FG002|Overall Study|Adverse Event|1|||
126092208|NCT02001064|453630552|FG001|Overall Study|Withdrawal by Subject|1|||
126219721|NCT04130919|454095634|FG001|Open-label Treatment Phase|Investigator's decision|0|||
126219722|NCT04130919|454095635|FG002|Open-label Treatment Phase|Investigator's decision|0|||
126092209|NCT01609062|453630553|FG000|Extension Phase|Terminated by Sponsor|14|||
126219723|NCT04130919|454095636|FG003|Open-label Treatment Phase|Investigator's decision|1|||
126092210|NCT01609062|453630554|FG001|Extension Phase|Terminated by Sponsor|9|||
126092211|NCT01609062|453630553|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
126219724|NCT04130919|454095637|FG004|Open-label Treatment Phase|Investigator's decision|0|||
126219725|NCT04130919|454095638|FG005|Open-label Treatment Phase|Investigator's decision|0|||
126219726|NCT04130919|454095633|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
126219727|NCT04130919|454095634|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
126219728|NCT04130919|454095635|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
126219729|NCT04130919|454095636|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
126219730|NCT04130919|454095637|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
126219731|NCT04130919|454095638|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
126219732|NCT04130919|454095633|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126219733|NCT04130919|454095634|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126219734|NCT04130919|454095635|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126219735|NCT04130919|454095636|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126219736|NCT04130919|454095637|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
126219737|NCT04130919|454095638|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126219738|NCT02624518|454095639|FG000|Overall Study|Physician Decision|1|||
126219739|NCT00990093|454095640|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
126219740|NCT00990093|454095641|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
126219741|NCT00990093|454095640|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
126219742|NCT00990093|454095641|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
126219743|NCT00990093|454095640|FG000|Test Period 1 (1-14 Days)|Other|1|||
126219744|NCT00990093|454095641|FG001|Test Period 1 (1-14 Days)|Other|0|||
126219745|NCT00990093|454095640|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
126219746|NCT00990093|454095641|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
126219747|NCT00990093|454095640|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
126219748|NCT00990093|454095641|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
126219749|NCT00990093|454095640|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
126219750|NCT00990093|454095641|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
126219751|NCT00990093|454095640|FG000|Test Period 2 (15-28 Days)|Other|0|||
126219752|NCT00990093|454095641|FG001|Test Period 2 (15-28 Days)|Other|1|||
126219753|NCT04556838|454095642|FG000|Overall Study|Withdrawal by Subject|3|||
126219754|NCT04556838|454095643|FG001|Overall Study|Withdrawal by Subject|1|||
126219755|NCT04556838|454095644|FG002|Overall Study|Withdrawal by Subject|2|||
126219756|NCT04556838|454095642|FG000|Overall Study|Adverse Event|0|||
126219757|NCT04556838|454095643|FG001|Overall Study|Adverse Event|1|||
126219758|NCT04556838|454095644|FG002|Overall Study|Adverse Event|1|||
126219759|NCT04556838|454095642|FG000|Overall Study|Lost to Follow-up|0|||
126219760|NCT04556838|454095643|FG001|Overall Study|Lost to Follow-up|0|||
126219761|NCT04556838|454095644|FG002|Overall Study|Lost to Follow-up|2|||
126219762|NCT04556838|454095642|FG000|Overall Study|Subject travel|0|||
126219763|NCT04556838|454095643|FG001|Overall Study|Subject travel|1|||
126219764|NCT04556838|454095644|FG002|Overall Study|Subject travel|0|||
126219765|NCT04556838|454095642|FG000|Overall Study|Physician Decision|1|||
126219766|NCT04556838|454095643|FG001|Overall Study|Physician Decision|0|||
126219767|NCT04556838|454095644|FG002|Overall Study|Physician Decision|0|||
126219768|NCT00995930|454095645|FG000|Overall Study|Protocol deviation|2|||
126219769|NCT00995930|454095646|FG001|Overall Study|Protocol deviation|5|||
126219770|NCT00995930|454095645|FG000|Overall Study|Death|0|||
126219771|NCT00995930|454095646|FG001|Overall Study|Death|1|||
126219772|NCT00995930|454095645|FG000|Overall Study|Administrative problems|4|||
126219773|NCT00995930|454095646|FG001|Overall Study|Administrative problems|2|||
126219774|NCT00995930|454095645|FG000|Overall Study|Lost to Follow-up|1|||
126219775|NCT00995930|454095646|FG001|Overall Study|Lost to Follow-up|2|||
126017670|NCT01236560|453358910|FG003|Overall Study|Adverse Event|3|||
126017671|NCT01236560|453358911|FG004|Overall Study|Adverse Event|0|||
126017672|NCT01236560|453358912|FG005|Overall Study|Adverse Event|0|||
126017673|NCT01236560|453358907|FG000|Overall Study|Death|0|||
126017674|NCT01236560|453358908|FG001|Overall Study|Death|1|||
126017675|NCT01236560|453358909|FG002|Overall Study|Death|0|||
126017676|NCT01236560|453358910|FG003|Overall Study|Death|1|||
126219776|NCT00995930|454095645|FG000|Overall Study|Withdrawal by Subject|3|||
126219777|NCT00995930|454095646|FG001|Overall Study|Withdrawal by Subject|4|||
126219778|NCT00995930|454095645|FG000|Overall Study|Adverse Event|11|||
126219779|NCT00995930|454095646|FG001|Overall Study|Adverse Event|14|||
126017677|NCT01236560|453358911|FG004|Overall Study|Death|0|||
126219780|NCT05003167|454095647|FG000|Overall Study|Withdrawal by Subject|1|||
126219781|NCT02842086|454095648|FG000|Overall Study|Randomized but Never Treated|6|||
126219782|NCT02842086|454095649|FG001|Overall Study|Randomized but Never Treated|6|||
126219783|NCT02842086|454095648|FG000|Overall Study|Still in Double-Blind Phase|7|||
126219784|NCT02842086|454095649|FG001|Overall Study|Still in Double-Blind Phase|3|||
126219785|NCT02842086|454095648|FG000|Overall Study|Adverse Event|18|||
126219786|NCT02842086|454095649|FG001|Overall Study|Adverse Event|20|||
126219787|NCT02842086|454095648|FG000|Overall Study|Death|3|||
126219788|NCT02842086|454095649|FG001|Overall Study|Death|3|||
126219789|NCT02842086|454095648|FG000|Overall Study|Investigator's Discretion|9|||
126219790|NCT02842086|454095649|FG001|Overall Study|Investigator's Discretion|13|||
126219791|NCT02842086|454095648|FG000|Overall Study|Non-Compliance with Study Drug|9|||
126219792|NCT02842086|454095649|FG001|Overall Study|Non-Compliance with Study Drug|8|||
126219793|NCT02842086|454095648|FG000|Overall Study|Protocol Violation|8|||
126219794|NCT02842086|454095649|FG001|Overall Study|Protocol Violation|4|||
126219795|NCT02842086|454095648|FG000|Overall Study|Withdrew Consent|205|||
126219796|NCT02842086|454095649|FG001|Overall Study|Withdrew Consent|194|||
126219797|NCT02842086|454095648|FG000|Overall Study|Lost to Follow-up|274|||
126219798|NCT02842086|454095649|FG001|Overall Study|Lost to Follow-up|236|||
126219799|NCT02842086|454095648|FG000|Overall Study|HIV-1 Infection|5|||
126219800|NCT02842086|454095649|FG001|Overall Study|HIV-1 Infection|6|||
126219801|NCT03751124|454095650|FG000|Overall Study|Adverse Event|4|||
126219802|NCT03751124|454095651|FG001|Overall Study|Adverse Event|3|||
126219803|NCT03751124|454095650|FG000|Overall Study|Protocol Deviation|0|||
126219804|NCT03751124|454095651|FG001|Overall Study|Protocol Deviation|1|||
126219805|NCT03751124|454095650|FG000|Overall Study|Lost to Follow-up|6|||
126219806|NCT03751124|454095651|FG001|Overall Study|Lost to Follow-up|4|||
126219807|NCT03751124|454095650|FG000|Overall Study|Withdrawal by Subject|6|||
126219808|NCT03751124|454095651|FG001|Overall Study|Withdrawal by Subject|8|||
126219809|NCT03751124|454095650|FG000|Overall Study|Lack of Efficacy|1|||
126219810|NCT03751124|454095651|FG001|Overall Study|Lack of Efficacy|1|||
126219811|NCT03751124|454095650|FG000|Overall Study|Pregnancy|0|||
126219812|NCT03751124|454095651|FG001|Overall Study|Pregnancy|1|||
126219813|NCT03751124|454095650|FG000|Overall Study|Other|9|||
126219814|NCT03751124|454095651|FG001|Overall Study|Other|9|||
126219815|NCT03751124|454095650|FG000|Overall Study|Participants who did not receive any study drug|0|||
126219816|NCT03751124|454095651|FG001|Overall Study|Participants who did not receive any study drug|1|||
126219817|NCT00555399|454095654|FG000|Overall Study|Withdrawal by Subject|0|||
126219818|NCT00555399|454095655|FG001|Overall Study|Withdrawal by Subject|0|||
126219819|NCT00555399|454095656|FG002|Overall Study|Withdrawal by Subject|1|||
126219820|NCT00555399|454095657|FG003|Overall Study|Withdrawal by Subject|0|||
126219821|NCT00555399|454095658|FG004|Overall Study|Withdrawal by Subject|0|||
126219822|NCT00555399|454095659|FG005|Overall Study|Withdrawal by Subject|0|||
126219823|NCT00555399|454095660|FG006|Overall Study|Withdrawal by Subject|0|||
126017678|NCT01236560|453358912|FG005|Overall Study|Death|0|||
126017679|NCT01236560|453358907|FG000|Overall Study|Lost to Follow-up|0|||
126017680|NCT01236560|453358908|FG001|Overall Study|Lost to Follow-up|1|||
126017681|NCT01236560|453358909|FG002|Overall Study|Lost to Follow-up|1|||
126017682|NCT01236560|453358910|FG003|Overall Study|Lost to Follow-up|0|||
126017683|NCT01236560|453358911|FG004|Overall Study|Lost to Follow-up|0|||
126017684|NCT01236560|453358912|FG005|Overall Study|Lost to Follow-up|0|||
126017685|NCT01236560|453358907|FG000|Overall Study|Physician Decision|0|||
126017686|NCT01236560|453358908|FG001|Overall Study|Physician Decision|1|||
126017687|NCT01236560|453358909|FG002|Overall Study|Physician Decision|8|||
126017688|NCT01236560|453358910|FG003|Overall Study|Physician Decision|0|||
126219824|NCT00555399|454095661|FG007|Overall Study|Withdrawal by Subject|0|||
126017689|NCT01236560|453358911|FG004|Overall Study|Physician Decision|0|||
126017690|NCT01236560|453358912|FG005|Overall Study|Physician Decision|0|||
126017691|NCT01236560|453358907|FG000|Overall Study|Withdrawal by Subject|0|||
126219825|NCT00555399|454095662|FG008|Overall Study|Withdrawal by Subject|0|||
126092212|NCT01609062|453630554|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
126092213|NCT01609062|453630553|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
126092214|NCT01609062|453630554|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
126092215|NCT02738853|453630555|FG000|Enrollment|Inclusion/Exclusion not met|21|||
126092216|NCT02738853|453630555|FG000|Enrollment|Withdrawal by Subject|3|||
126092217|NCT02738853|453630555|FG000|Enrollment|Subject treated with commercially available device|6|||
126092218|NCT02738853|453630555|FG000|Enrollment|Study Enrollment Closed|3|||
126092219|NCT02738853|453630555|FG000|Procedure|Death|1|||
126092220|NCT02738853|453630555|FG000|1 Month|Death|2|||
126092221|NCT02738853|453630555|FG000|6 Month|Death|4|||
126092222|NCT02738853|453630555|FG000|6 Month|Withdrawal by Subject|2|||
126092223|NCT02738853|453630555|FG000|1 Year|Death|6|||
126092224|NCT02738853|453630555|FG000|1 Year|Withdrawal by Subject|1|||
126092225|NCT02738853|453630555|FG000|2 Year|Death|2|||
126017692|NCT01236560|453358908|FG001|Overall Study|Withdrawal by Subject|0|||
126017693|NCT01236560|453358909|FG002|Overall Study|Withdrawal by Subject|1|||
126017694|NCT01236560|453358910|FG003|Overall Study|Withdrawal by Subject|2|||
126219826|NCT00555399|454095663|FG009|Overall Study|Withdrawal by Subject|0|||
126219827|NCT00555399|454095664|FG010|Overall Study|Withdrawal by Subject|0|||
126219828|NCT00555399|454095665|FG011|Overall Study|Withdrawal by Subject|1|||
126219829|NCT00555399|454095654|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
126219830|NCT00555399|454095655|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
126219831|NCT00555399|454095656|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
126219832|NCT00555399|454095657|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
126219833|NCT00555399|454095658|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
126219834|NCT00555399|454095659|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
126219835|NCT00555399|454095660|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
126219836|NCT00555399|454095661|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
126219837|NCT00555399|454095662|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
126219838|NCT00555399|454095663|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
126219839|NCT00555399|454095664|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
126219840|NCT00555399|454095665|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
126219841|NCT01858558|454097407|FG000|Overall Study|Death|1|||
126219842|NCT01858558|454097408|FG001|Overall Study|Death|1|||
126219843|NCT01858558|454097407|FG000|Overall Study|Lost to Follow-up|1|||
126219844|NCT01858558|454097408|FG001|Overall Study|Lost to Follow-up|0|||
126219845|NCT01858558|454097407|FG000|Overall Study|Disease progression|3|||
126219846|NCT01858558|454097408|FG001|Overall Study|Disease progression|1|||
126219847|NCT01858558|454097407|FG000|Overall Study|Product contamination|2|||
126219848|NCT01858558|454097408|FG001|Overall Study|Product contamination|0|||
126219849|NCT01858558|454097407|FG000|Overall Study|Failed expansion of cell product|2|||
126219850|NCT01858558|454097408|FG001|Overall Study|Failed expansion of cell product|0|||
126219851|NCT00343642|454097409|FG000|Overall Study|Lost to Follow-up|0|||
126219852|NCT00343642|454097410|FG001|Overall Study|Lost to Follow-up|1|||
126219853|NCT00343642|454097411|FG002|Overall Study|Lost to Follow-up|0|||
126219854|NCT00343642|454097409|FG000|Overall Study|Pregnancy|1|||
126219855|NCT00343642|454097410|FG001|Overall Study|Pregnancy|0|||
126219856|NCT00343642|454097411|FG002|Overall Study|Pregnancy|2|||
126219857|NCT00343642|454097409|FG000|Overall Study|Withdrawal by Subject|2|||
126219858|NCT00343642|454097410|FG001|Overall Study|Withdrawal by Subject|3|||
126219859|NCT00343642|454097411|FG002|Overall Study|Withdrawal by Subject|4|||
126219860|NCT00343642|454097409|FG000|Overall Study|Adverse Event|0|||
126219861|NCT00343642|454097410|FG001|Overall Study|Adverse Event|0|||
126219862|NCT00343642|454097411|FG002|Overall Study|Adverse Event|1|||
126219863|NCT00343642|454097409|FG000|Overall Study|Flare up|6|||
126219864|NCT00343642|454097410|FG001|Overall Study|Flare up|4|||
126219865|NCT00343642|454097411|FG002|Overall Study|Flare up|0|||
126219866|NCT03053622|454097416|FG000|Overall Study|Lost to Follow-up|0|||
126219867|NCT03053622|454097417|FG001|Overall Study|Lost to Follow-up|0|||
126219868|NCT03053622|454097418|FG002|Overall Study|Lost to Follow-up|0|||
126219869|NCT03053622|454097419|FG003|Overall Study|Lost to Follow-up|1|||
126219870|NCT01835470|454097420|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
126219871|NCT01835470|454097420|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
126219872|NCT04335110|454097438|FG000|Overall Study|Withdrawal by Subject|1|||
126219873|NCT04335110|454097439|FG001|Overall Study|Withdrawal by Subject|1|||
126219874|NCT04335110|454097438|FG000|Overall Study|Death|0|||
126219875|NCT04335110|454097439|FG001|Overall Study|Death|1|||
126219876|NCT00948025|454097440|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
126219877|NCT00948025|454097441|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
126219878|NCT00948025|454097440|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
126219879|NCT00948025|454097441|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
126219880|NCT00948025|454097440|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
126219881|NCT00948025|454097441|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
126219882|NCT01637961|454097442|FG000|Overall Study|Ineligible: wrong primary|1|||
126219883|NCT01637961|454097442|FG000|Overall Study|Ineligible: inadequate pathology|1|||
126219884|NCT00289731|454097449|FG000|Overall Study|Adverse Event|1|||
126219885|NCT00289731|454097450|FG001|Overall Study|Adverse Event|2|||
126219886|NCT00289731|454097451|FG002|Overall Study|Adverse Event|2|||
126219887|NCT00289731|454097449|FG000|Overall Study|Other|1|||
126219888|NCT00289731|454097450|FG001|Overall Study|Other|0|||
126219889|NCT00289731|454097451|FG002|Overall Study|Other|0|||
126219890|NCT04378010|454097452|FG000|Overall Study|Adverse Event|8|||
126219891|NCT04378010|454097453|FG001|Overall Study|Adverse Event|14|||
126219892|NCT04378010|454097454|FG002|Overall Study|Adverse Event|4|||
126219893|NCT04378010|454097452|FG000|Overall Study|Withdrawal by Subject|0|||
126092226|NCT02738853|453630555|FG000|2 Year|Lost to Follow-up|1|||
126092227|NCT02738853|453630555|FG000|3 Year|Death|2|||
126219894|NCT04378010|454097453|FG001|Overall Study|Withdrawal by Subject|2|||
126219895|NCT04378010|454097454|FG002|Overall Study|Withdrawal by Subject|1|||
126219896|NCT04378010|454097452|FG000|Overall Study|Protocol Violation|2|||
126219897|NCT04378010|454097453|FG001|Overall Study|Protocol Violation|1|||
126219898|NCT04378010|454097454|FG002|Overall Study|Protocol Violation|4|||
126219899|NCT04378010|454097452|FG000|Overall Study|Study terminated by Sponsor|22|||
126219900|NCT04378010|454097453|FG001|Overall Study|Study terminated by Sponsor|16|||
126219901|NCT04378010|454097454|FG002|Overall Study|Study terminated by Sponsor|22|||
126219902|NCT04378010|454097452|FG000|Overall Study|Subject inability to complete study visit|0|||
126219903|NCT04378010|454097453|FG001|Overall Study|Subject inability to complete study visit|0|||
126219904|NCT04378010|454097454|FG002|Overall Study|Subject inability to complete study visit|1|||
126219905|NCT04378010|454097452|FG000|Overall Study|Subject never dosed|0|||
126092228|NCT02738853|453630555|FG000|3 Year|Withdrawal by Subject|1|||
126092229|NCT02738853|453630555|FG000|4 Year|Death|9|||
126219906|NCT04378010|454097453|FG001|Overall Study|Subject never dosed|1|||
126219907|NCT04378010|454097454|FG002|Overall Study|Subject never dosed|0|||
126219908|NCT02019979|454097455|FG000|Overall Study|study terminated|14|||
126219909|NCT02513459|454097456|FG000|Overall Study|Adverse Event|7|||
126219910|NCT02513459|454097456|FG000|Overall Study|Withdrew consent|5|||
126219911|NCT02513459|454097456|FG000|Overall Study|Loss of efficacy|2|||
126219912|NCT02513459|454097456|FG000|Overall Study|Pregnancy|2|||
126219913|NCT02513459|454097456|FG000|Overall Study|Subject decision|2|||
126219914|NCT02513459|454097456|FG000|Overall Study|Lack of response|1|||
126219915|NCT02513459|454097456|FG000|Overall Study|Reproductive plans|1|||
126219916|NCT02513459|454097456|FG000|Overall Study|Surgery planned-- not done|1|||
126219917|NCT04023994|454097460|FG000|Overall Study|Lost to Follow-up|0|||
126219918|NCT04023994|454097461|FG001|Overall Study|Lost to Follow-up|1|||
126219919|NCT04023994|454097462|FG002|Overall Study|Lost to Follow-up|2|||
126219920|NCT04023994|454097463|FG003|Overall Study|Lost to Follow-up|0|||
126219921|NCT04023994|454097464|FG004|Overall Study|Lost to Follow-up|0|||
126219922|NCT04023994|454097465|FG005|Overall Study|Lost to Follow-up|0|||
126219923|NCT04023994|454097460|FG000|Overall Study|Withdrawal by Subject|0|||
126219924|NCT04023994|454097461|FG001|Overall Study|Withdrawal by Subject|0|||
126219925|NCT04023994|454097462|FG002|Overall Study|Withdrawal by Subject|0|||
126219926|NCT04023994|454097463|FG003|Overall Study|Withdrawal by Subject|1|||
126219927|NCT04023994|454097464|FG004|Overall Study|Withdrawal by Subject|0|||
126219928|NCT04023994|454097465|FG005|Overall Study|Withdrawal by Subject|0|||
126219929|NCT00923195|454097466|FG000|Overall Study|Death|0|||
126219930|NCT00923195|454097467|FG001|Overall Study|Death|1|||
126219931|NCT00467818|454097470|FG000|Overall Study|Adverse Event|1|||
126219932|NCT00467818|454097471|FG001|Overall Study|Adverse Event|0|||
126219933|NCT00467818|454097470|FG000|Overall Study|Lost to Follow-up|2|||
126219934|NCT00467818|454097471|FG001|Overall Study|Lost to Follow-up|2|||
126219935|NCT02143947|454097475|FG000|Overall Study|Lost to Follow-up|4|||
126219936|NCT02143947|454097476|FG001|Overall Study|Lost to Follow-up|2|||
126219937|NCT01244815|454097477|FG000|Overall Study|Not Treated|0|||
126219938|NCT01244815|454097478|FG001|Overall Study|Not Treated|1|||
126219939|NCT01244815|454097479|FG002|Overall Study|Not Treated|0|||
126219940|NCT01244815|454097480|FG003|Overall Study|Not Treated|0|||
126219941|NCT01244815|454097477|FG000|Overall Study|Adverse Event|4|||
126092230|NCT02738853|453630555|FG000|5 Year|Lost to Follow-up|4|||
126092231|NCT01803282|453630556|FG000|Overall Study|Progressive Disease|4|||
126219942|NCT01244815|454097478|FG001|Overall Study|Adverse Event|7|||
126219943|NCT01244815|454097479|FG002|Overall Study|Adverse Event|5|||
126219944|NCT01244815|454097480|FG003|Overall Study|Adverse Event|5|||
126219945|NCT01244815|454097477|FG000|Overall Study|Treatment Failure|0|||
126219946|NCT01244815|454097478|FG001|Overall Study|Treatment Failure|0|||
126219947|NCT01244815|454097479|FG002|Overall Study|Treatment Failure|0|||
126219948|NCT01244815|454097480|FG003|Overall Study|Treatment Failure|1|||
126219949|NCT01244815|454097477|FG000|Overall Study|Lost to Follow-up|3|||
126219950|NCT01244815|454097478|FG001|Overall Study|Lost to Follow-up|2|||
126219951|NCT01244815|454097479|FG002|Overall Study|Lost to Follow-up|3|||
126219952|NCT01244815|454097480|FG003|Overall Study|Lost to Follow-up|2|||
126219953|NCT01244815|454097477|FG000|Overall Study|Withdrawal by Subject|0|||
126219954|NCT01244815|454097478|FG001|Overall Study|Withdrawal by Subject|2|||
126219955|NCT01244815|454097479|FG002|Overall Study|Withdrawal by Subject|0|||
126219956|NCT01244815|454097480|FG003|Overall Study|Withdrawal by Subject|3|||
126219957|NCT01244815|454097477|FG000|Overall Study|Protocol Violation|7|||
126219958|NCT01244815|454097478|FG001|Overall Study|Protocol Violation|4|||
126219959|NCT01244815|454097479|FG002|Overall Study|Protocol Violation|3|||
126219960|NCT01244815|454097480|FG003|Overall Study|Protocol Violation|1|||
126219961|NCT01244815|454097477|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
126219962|NCT01244815|454097478|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
126219963|NCT01244815|454097479|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
126219964|NCT01244815|454097480|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
126219965|NCT01313728|454097482|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
126219966|NCT02444182|454097488|FG000|Overall Study|non-compliance|2|||
126219967|NCT02444182|454097489|FG001|Overall Study|non-compliance|1|||
126219968|NCT02444182|454097488|FG000|Overall Study|Lost to Follow-up|0|||
126219969|NCT02444182|454097489|FG001|Overall Study|Lost to Follow-up|4|||
126219970|NCT02487979|454097494|FG000|Overall Study|Physician Decision|2|||
126219971|NCT02487979|454097494|FG000|Overall Study|Withdrawal by Subject|2|||
126219972|NCT02487979|454097494|FG000|Overall Study|Progressive Disease|17|||
126219973|NCT00447694|454097495|FG000|Overall Study|Adverse Event|2|||
126219974|NCT00447694|454097495|FG000|Overall Study|Abnormal laboratory value|1|||
126219975|NCT00447694|454097495|FG000|Overall Study|Abnormal test procedure result|1|||
126219976|NCT00447694|454097495|FG000|Overall Study|Withdrawal by Subject|2|||
126219977|NCT00423488|454097497|FG000|Overall Study|No evidence of study drug intake|2|||
126219978|NCT00423488|454097498|FG001|Overall Study|No evidence of study drug intake|1|||
126219979|NCT00423488|454097497|FG000|Overall Study|No post baseline data|3|||
126219980|NCT00423488|454097498|FG001|Overall Study|No post baseline data|0|||
126219981|NCT00527397|454097499|FG000|Overall Study|Adverse Event|3|||
126219982|NCT00527397|454097499|FG000|Overall Study|Lack of Efficacy|1|||
126219983|NCT00527397|454097499|FG000|Overall Study|Protocol Violation|1|||
126219984|NCT00527397|454097499|FG000|Overall Study|Withdrawal by Subject|6|||
126219985|NCT00527397|454097499|FG000|Overall Study|Study terminated by sponsor|13|||
126219986|NCT01749033|454097502|FG000|Overall Study|Did not receive allocated intervention|3|||
126219987|NCT01749033|454097503|FG001|Overall Study|Did not receive allocated intervention|3|||
126219988|NCT01749033|454097504|FG002|Overall Study|Did not receive allocated intervention|0|||
126219989|NCT01749033|454097502|FG000|Overall Study|Lost to Follow-up|0|||
126219990|NCT01749033|454097503|FG001|Overall Study|Lost to Follow-up|2|||
126219991|NCT01749033|454097504|FG002|Overall Study|Lost to Follow-up|1|||
126219992|NCT00068237|454097505|FG000|Overall Study|Ineligible|3|||
126219993|NCT00068237|454097505|FG000|Overall Study|No protocol treatment received|2|||
126219994|NCT04380701|454097506|FG000|Overall Study|Pregnancy|0|||
126219995|NCT04380701|454097507|FG001|Overall Study|Pregnancy|0|||
126219996|NCT04380701|454097508|FG002|Overall Study|Pregnancy|0|||
126219997|NCT04380701|454097509|FG003|Overall Study|Pregnancy|0|||
126219998|NCT04380701|454097510|FG004|Overall Study|Pregnancy|0|||
126219999|NCT04380701|454097511|FG005|Overall Study|Pregnancy|0|||
126220000|NCT04380701|454097512|FG006|Overall Study|Pregnancy|0|||
126220001|NCT04380701|454097513|FG007|Overall Study|Pregnancy|0|||
126220002|NCT04380701|454097514|FG008|Overall Study|Pregnancy|0|||
126220003|NCT04380701|454097515|FG009|Overall Study|Pregnancy|0|||
126220004|NCT04380701|454097516|FG010|Overall Study|Pregnancy|0|||
126220005|NCT04380701|454097517|FG011|Overall Study|Pregnancy|0|||
126220006|NCT04380701|454097518|FG012|Overall Study|Pregnancy|0|||
126220007|NCT04380701|454097519|FG013|Overall Study|Pregnancy|0|||
126220008|NCT04380701|454097520|FG014|Overall Study|Pregnancy|0|||
126220009|NCT04380701|454097521|FG015|Overall Study|Pregnancy|0|||
126220010|NCT04380701|454097522|FG016|Overall Study|Pregnancy|0|||
126220011|NCT04380701|454097523|FG017|Overall Study|Pregnancy|0|||
126220012|NCT04380701|454097524|FG018|Overall Study|Pregnancy|0|||
126220013|NCT04380701|454097525|FG019|Overall Study|Pregnancy|0|||
126220014|NCT04380701|454097526|FG020|Overall Study|Pregnancy|0|||
126017695|NCT01236560|453358911|FG004|Overall Study|Withdrawal by Subject|0|||
126017696|NCT01236560|453358912|FG005|Overall Study|Withdrawal by Subject|0|||
126017697|NCT01236560|453358907|FG000|Overall Study|Progressive disease|5|||
126017698|NCT01236560|453358908|FG001|Overall Study|Progressive disease|19|||
126220015|NCT04380701|454097527|FG021|Overall Study|Pregnancy|0|||
126220016|NCT04380701|454097528|FG022|Overall Study|Pregnancy|0|||
126220017|NCT04380701|454097529|FG023|Overall Study|Pregnancy|0|||
126220018|NCT04380701|454097530|FG024|Overall Study|Pregnancy|0|||
126220019|NCT04380701|454097531|FG025|Overall Study|Pregnancy|0|||
126220020|NCT04380701|454097532|FG026|Overall Study|Pregnancy|0|||
126017699|NCT01236560|453358909|FG002|Overall Study|Progressive disease|9|||
126220021|NCT04380701|454097533|FG027|Overall Study|Pregnancy|0|||
126220022|NCT04380701|454097534|FG028|Overall Study|Pregnancy|0|||
126220023|NCT04380701|454097535|FG029|Overall Study|Pregnancy|0|||
126220024|NCT04380701|454097536|FG030|Overall Study|Pregnancy|0|||
126220025|NCT04380701|454097537|FG031|Overall Study|Pregnancy|0|||
126017700|NCT01236560|453358910|FG003|Overall Study|Progressive disease|16|||
126220026|NCT04380701|454097538|FG032|Overall Study|Pregnancy|1|||
126220027|NCT04380701|454097539|FG033|Overall Study|Pregnancy|0|||
126017701|NCT01236560|453358911|FG004|Overall Study|Progressive disease|0|||
126017702|NCT01236560|453358912|FG005|Overall Study|Progressive disease|0|||
126017703|NCT00468910|453358913|FG000|Overall Study|Lost to Follow-up|2|||
126017704|NCT00468910|453358914|FG001|Overall Study|Lost to Follow-up|1|||
126017705|NCT00468910|453358913|FG000|Overall Study|Withdrawal by Subject|2|||
126017706|NCT00468910|453358914|FG001|Overall Study|Withdrawal by Subject|1|||
126017707|NCT00468910|453358913|FG000|Overall Study|Medical Contraindication|0|||
126017708|NCT00468910|453358914|FG001|Overall Study|Medical Contraindication|1|||
126017709|NCT01792830|453358918|FG000|Overall Study|Withdrawal by Subject|22|||
126017710|NCT01792830|453358919|FG001|Overall Study|Withdrawal by Subject|0|||
126017711|NCT01792830|453358920|FG002|Overall Study|Withdrawal by Subject|0|||
126017712|NCT01792830|453358921|FG003|Overall Study|Withdrawal by Subject|2|||
126017713|NCT01792830|453358922|FG004|Overall Study|Withdrawal by Subject|1|||
126017714|NCT01792830|453358923|FG005|Overall Study|Withdrawal by Subject|1|||
126017715|NCT01792830|453358924|FG006|Overall Study|Withdrawal by Subject|1|||
126017716|NCT01792830|453358925|FG007|Overall Study|Withdrawal by Subject|1|||
126017717|NCT01792830|453358926|FG008|Overall Study|Withdrawal by Subject|7|||
126017718|NCT01792830|453358927|FG009|Overall Study|Withdrawal by Subject|0|||
126017719|NCT01792830|453358928|FG010|Overall Study|Withdrawal by Subject|2|||
126017720|NCT01792830|453358918|FG000|Overall Study|Death|3|||
126017721|NCT01792830|453358919|FG001|Overall Study|Death|0|||
126017722|NCT01792830|453358920|FG002|Overall Study|Death|0|||
126017723|NCT01792830|453358921|FG003|Overall Study|Death|1|||
126017724|NCT01792830|453358922|FG004|Overall Study|Death|0|||
126017725|NCT01792830|453358923|FG005|Overall Study|Death|0|||
126092232|NCT01803282|453630557|FG001|Overall Study|Progressive Disease|3|||
126017726|NCT01792830|453358924|FG006|Overall Study|Death|1|||
126017727|NCT01792830|453358925|FG007|Overall Study|Death|0|||
126017728|NCT01792830|453358926|FG008|Overall Study|Death|1|||
126017729|NCT01792830|453358927|FG009|Overall Study|Death|0|||
126017730|NCT01792830|453358928|FG010|Overall Study|Death|1|||
126017731|NCT01792830|453358918|FG000|Overall Study|Adverse Event|0|||
126017732|NCT01792830|453358919|FG001|Overall Study|Adverse Event|0|||
126017733|NCT01792830|453358920|FG002|Overall Study|Adverse Event|0|||
126017734|NCT01792830|453358921|FG003|Overall Study|Adverse Event|0|||
126017735|NCT01792830|453358922|FG004|Overall Study|Adverse Event|0|||
126017736|NCT01792830|453358923|FG005|Overall Study|Adverse Event|0|||
126092233|NCT01803282|453630558|FG002|Overall Study|Progressive Disease|6|||
126092234|NCT01803282|453630559|FG003|Overall Study|Progressive Disease|22|||
126092235|NCT01803282|453630560|FG004|Overall Study|Progressive Disease|5|||
126092236|NCT01803282|453630561|FG005|Overall Study|Progressive Disease|8|||
126092237|NCT01803282|453630562|FG006|Overall Study|Progressive Disease|23|||
126092238|NCT01803282|453630563|FG007|Overall Study|Progressive Disease|24|||
126092239|NCT01803282|453630564|FG008|Overall Study|Progressive Disease|3|||
126092240|NCT01803282|453630565|FG009|Overall Study|Progressive Disease|29|||
126092241|NCT01803282|453630566|FG010|Overall Study|Progressive Disease|6|||
126092242|NCT01803282|453630567|FG011|Overall Study|Progressive Disease|11|||
126092243|NCT01803282|453630556|FG000|Overall Study|Death|0|||
126092244|NCT01803282|453630557|FG001|Overall Study|Death|0|||
126092245|NCT01803282|453630558|FG002|Overall Study|Death|0|||
126092246|NCT01803282|453630559|FG003|Overall Study|Death|0|||
126092247|NCT01803282|453630560|FG004|Overall Study|Death|2|||
126092248|NCT01803282|453630561|FG005|Overall Study|Death|1|||
126092249|NCT01803282|453630562|FG006|Overall Study|Death|1|||
126092250|NCT01803282|453630563|FG007|Overall Study|Death|5|||
126092251|NCT01803282|453630564|FG008|Overall Study|Death|1|||
126092252|NCT01803282|453630565|FG009|Overall Study|Death|1|||
126092253|NCT01803282|453630566|FG010|Overall Study|Death|0|||
126092254|NCT01803282|453630567|FG011|Overall Study|Death|0|||
126092255|NCT01803282|453630556|FG000|Overall Study|Withdrew Consent|0|||
126092256|NCT01803282|453630557|FG001|Overall Study|Withdrew Consent|0|||
126092257|NCT01803282|453630558|FG002|Overall Study|Withdrew Consent|0|||
126092258|NCT01803282|453630559|FG003|Overall Study|Withdrew Consent|6|||
126017737|NCT01792830|453358924|FG006|Overall Study|Adverse Event|0|||
126017738|NCT01792830|453358925|FG007|Overall Study|Adverse Event|0|||
126017739|NCT01792830|453358926|FG008|Overall Study|Adverse Event|1|||
126017740|NCT01792830|453358927|FG009|Overall Study|Adverse Event|0|||
126017741|NCT01792830|453358928|FG010|Overall Study|Adverse Event|0|||
126092259|NCT01803282|453630560|FG004|Overall Study|Withdrew Consent|1|||
126092260|NCT01803282|453630561|FG005|Overall Study|Withdrew Consent|0|||
126017742|NCT01198028|453358946|FG000|Overall Study|Adverse Event|5|||
126017743|NCT01198028|453358946|FG000|Overall Study|Death|3|||
126092261|NCT01803282|453630562|FG006|Overall Study|Withdrew Consent|8|||
126092262|NCT01803282|453630563|FG007|Overall Study|Withdrew Consent|3|||
126092263|NCT01803282|453630564|FG008|Overall Study|Withdrew Consent|1|||
126092264|NCT01803282|453630565|FG009|Overall Study|Withdrew Consent|5|||
126092265|NCT01803282|453630566|FG010|Overall Study|Withdrew Consent|0|||
126092266|NCT01803282|453630567|FG011|Overall Study|Withdrew Consent|1|||
126220028|NCT04380701|454097506|FG000|Overall Study|Lost to Follow-up|0|||
126220029|NCT04380701|454097507|FG001|Overall Study|Lost to Follow-up|0|||
126220030|NCT04380701|454097508|FG002|Overall Study|Lost to Follow-up|0|||
126220031|NCT04380701|454097509|FG003|Overall Study|Lost to Follow-up|0|||
126220032|NCT04380701|454097510|FG004|Overall Study|Lost to Follow-up|0|||
126220033|NCT04380701|454097511|FG005|Overall Study|Lost to Follow-up|0|||
126220034|NCT04380701|454097512|FG006|Overall Study|Lost to Follow-up|0|||
126220035|NCT04380701|454097513|FG007|Overall Study|Lost to Follow-up|0|||
126220036|NCT04380701|454097514|FG008|Overall Study|Lost to Follow-up|0|||
126220037|NCT04380701|454097515|FG009|Overall Study|Lost to Follow-up|0|||
126220038|NCT04380701|454097516|FG010|Overall Study|Lost to Follow-up|0|||
126220039|NCT04380701|454097517|FG011|Overall Study|Lost to Follow-up|0|||
126220040|NCT04380701|454097518|FG012|Overall Study|Lost to Follow-up|0|||
126220041|NCT04380701|454097519|FG013|Overall Study|Lost to Follow-up|0|||
126220042|NCT04380701|454097520|FG014|Overall Study|Lost to Follow-up|0|||
126220043|NCT04380701|454097521|FG015|Overall Study|Lost to Follow-up|0|||
126220044|NCT04380701|454097522|FG016|Overall Study|Lost to Follow-up|0|||
126220045|NCT04380701|454097523|FG017|Overall Study|Lost to Follow-up|0|||
126220046|NCT04380701|454097524|FG018|Overall Study|Lost to Follow-up|0|||
126220047|NCT04380701|454097525|FG019|Overall Study|Lost to Follow-up|0|||
126220048|NCT04380701|454097526|FG020|Overall Study|Lost to Follow-up|1|||
126220049|NCT04380701|454097527|FG021|Overall Study|Lost to Follow-up|0|||
126220050|NCT04380701|454097528|FG022|Overall Study|Lost to Follow-up|0|||
126220051|NCT04380701|454097529|FG023|Overall Study|Lost to Follow-up|1|||
126220052|NCT04380701|454097530|FG024|Overall Study|Lost to Follow-up|0|||
126220053|NCT04380701|454097531|FG025|Overall Study|Lost to Follow-up|0|||
126220054|NCT04380701|454097532|FG026|Overall Study|Lost to Follow-up|0|||
126220055|NCT04380701|454097533|FG027|Overall Study|Lost to Follow-up|0|||
126220056|NCT04380701|454097534|FG028|Overall Study|Lost to Follow-up|0|||
126220057|NCT04380701|454097535|FG029|Overall Study|Lost to Follow-up|1|||
126220058|NCT04380701|454097536|FG030|Overall Study|Lost to Follow-up|0|||
126220059|NCT04380701|454097537|FG031|Overall Study|Lost to Follow-up|0|||
126220060|NCT04380701|454097538|FG032|Overall Study|Lost to Follow-up|0|||
126220061|NCT04380701|454097539|FG033|Overall Study|Lost to Follow-up|1|||
126220062|NCT04380701|454097506|FG000|Overall Study|Private reason(s)|0|||
126220063|NCT04380701|454097507|FG001|Overall Study|Private reason(s)|0|||
126220064|NCT04380701|454097508|FG002|Overall Study|Private reason(s)|0|||
126220065|NCT04380701|454097509|FG003|Overall Study|Private reason(s)|0|||
126220066|NCT04380701|454097510|FG004|Overall Study|Private reason(s)|0|||
126220067|NCT04380701|454097511|FG005|Overall Study|Private reason(s)|0|||
126220068|NCT04380701|454097512|FG006|Overall Study|Private reason(s)|1|||
126220069|NCT04380701|454097513|FG007|Overall Study|Private reason(s)|0|||
126220070|NCT04380701|454097514|FG008|Overall Study|Private reason(s)|1|||
126220071|NCT04380701|454097515|FG009|Overall Study|Private reason(s)|1|||
126220072|NCT04380701|454097516|FG010|Overall Study|Private reason(s)|0|||
126220073|NCT04380701|454097517|FG011|Overall Study|Private reason(s)|0|||
126220074|NCT04380701|454097518|FG012|Overall Study|Private reason(s)|0|||
126220075|NCT04380701|454097519|FG013|Overall Study|Private reason(s)|0|||
126220076|NCT04380701|454097520|FG014|Overall Study|Private reason(s)|0|||
126220077|NCT04380701|454097521|FG015|Overall Study|Private reason(s)|0|||
126220078|NCT04380701|454097522|FG016|Overall Study|Private reason(s)|0|||
126220079|NCT04380701|454097523|FG017|Overall Study|Private reason(s)|0|||
126220080|NCT04380701|454097524|FG018|Overall Study|Private reason(s)|0|||
126220081|NCT04380701|454097525|FG019|Overall Study|Private reason(s)|0|||
126220082|NCT04380701|454097526|FG020|Overall Study|Private reason(s)|0|||
126220083|NCT04380701|454097527|FG021|Overall Study|Private reason(s)|0|||
126092267|NCT01803282|453630556|FG000|Overall Study|Investigator's Discretion|0|||
126220084|NCT04380701|454097528|FG022|Overall Study|Private reason(s)|0|||
126220085|NCT04380701|454097529|FG023|Overall Study|Private reason(s)|1|||
126220086|NCT04380701|454097530|FG024|Overall Study|Private reason(s)|0|||
126220087|NCT04380701|454097531|FG025|Overall Study|Private reason(s)|0|||
126220088|NCT04380701|454097532|FG026|Overall Study|Private reason(s)|0|||
126220089|NCT04380701|454097533|FG027|Overall Study|Private reason(s)|0|||
126220090|NCT04380701|454097534|FG028|Overall Study|Private reason(s)|0|||
126220091|NCT04380701|454097535|FG029|Overall Study|Private reason(s)|1|||
126220092|NCT04380701|454097536|FG030|Overall Study|Private reason(s)|0|||
126220093|NCT04380701|454097537|FG031|Overall Study|Private reason(s)|0|||
126220094|NCT04380701|454097538|FG032|Overall Study|Private reason(s)|0|||
126220095|NCT04380701|454097539|FG033|Overall Study|Private reason(s)|0|||
126220096|NCT04380701|454097506|FG000|Overall Study|Withdrawal by Subject|0|||
126220097|NCT04380701|454097507|FG001|Overall Study|Withdrawal by Subject|0|||
126220098|NCT04380701|454097508|FG002|Overall Study|Withdrawal by Subject|0|||
126220099|NCT04380701|454097509|FG003|Overall Study|Withdrawal by Subject|0|||
126220100|NCT04380701|454097510|FG004|Overall Study|Withdrawal by Subject|0|||
126220101|NCT04380701|454097511|FG005|Overall Study|Withdrawal by Subject|0|||
126220102|NCT04380701|454097512|FG006|Overall Study|Withdrawal by Subject|1|||
126220103|NCT04380701|454097513|FG007|Overall Study|Withdrawal by Subject|1|||
126220104|NCT04380701|454097514|FG008|Overall Study|Withdrawal by Subject|0|||
126220105|NCT04380701|454097515|FG009|Overall Study|Withdrawal by Subject|0|||
126220106|NCT04380701|454097516|FG010|Overall Study|Withdrawal by Subject|0|||
126220107|NCT04380701|454097517|FG011|Overall Study|Withdrawal by Subject|1|||
126220108|NCT04380701|454097518|FG012|Overall Study|Withdrawal by Subject|0|||
126220109|NCT04380701|454097519|FG013|Overall Study|Withdrawal by Subject|1|||
126220110|NCT04380701|454097520|FG014|Overall Study|Withdrawal by Subject|0|||
126220111|NCT04380701|454097521|FG015|Overall Study|Withdrawal by Subject|0|||
126220112|NCT04380701|454097522|FG016|Overall Study|Withdrawal by Subject|1|||
126220113|NCT04380701|454097523|FG017|Overall Study|Withdrawal by Subject|0|||
126220114|NCT04380701|454097524|FG018|Overall Study|Withdrawal by Subject|0|||
126220115|NCT04380701|454097525|FG019|Overall Study|Withdrawal by Subject|0|||
126220116|NCT04380701|454097526|FG020|Overall Study|Withdrawal by Subject|0|||
126220117|NCT04380701|454097527|FG021|Overall Study|Withdrawal by Subject|0|||
126220118|NCT04380701|454097528|FG022|Overall Study|Withdrawal by Subject|2|||
126220119|NCT04380701|454097529|FG023|Overall Study|Withdrawal by Subject|2|||
126220120|NCT04380701|454097530|FG024|Overall Study|Withdrawal by Subject|1|||
126220121|NCT04380701|454097531|FG025|Overall Study|Withdrawal by Subject|1|||
126220122|NCT04380701|454097532|FG026|Overall Study|Withdrawal by Subject|0|||
126220123|NCT04380701|454097533|FG027|Overall Study|Withdrawal by Subject|0|||
126220124|NCT04380701|454097534|FG028|Overall Study|Withdrawal by Subject|0|||
126220125|NCT04380701|454097535|FG029|Overall Study|Withdrawal by Subject|0|||
126220126|NCT04380701|454097536|FG030|Overall Study|Withdrawal by Subject|0|||
126220127|NCT04380701|454097537|FG031|Overall Study|Withdrawal by Subject|0|||
126220128|NCT04380701|454097538|FG032|Overall Study|Withdrawal by Subject|0|||
126220129|NCT04380701|454097539|FG033|Overall Study|Withdrawal by Subject|0|||
126220130|NCT04380701|454097506|FG000|Overall Study|Adverse Event|0|||
126220131|NCT04380701|454097507|FG001|Overall Study|Adverse Event|0|||
126017744|NCT01198028|453358946|FG000|Overall Study|Physician Decision|2|||
126017745|NCT02674750|453358954|FG000|Overall Study|Death|4|||
126220132|NCT04380701|454097508|FG002|Overall Study|Adverse Event|0|||
126220133|NCT04380701|454097509|FG003|Overall Study|Adverse Event|0|||
126220134|NCT04380701|454097510|FG004|Overall Study|Adverse Event|0|||
126220135|NCT04380701|454097511|FG005|Overall Study|Adverse Event|1|||
126220136|NCT04380701|454097512|FG006|Overall Study|Adverse Event|0|||
126220137|NCT04380701|454097513|FG007|Overall Study|Adverse Event|0|||
126220138|NCT04380701|454097514|FG008|Overall Study|Adverse Event|0|||
126220139|NCT04380701|454097515|FG009|Overall Study|Adverse Event|0|||
126220140|NCT04380701|454097516|FG010|Overall Study|Adverse Event|0|||
126220141|NCT04380701|454097517|FG011|Overall Study|Adverse Event|0|||
126220142|NCT04380701|454097518|FG012|Overall Study|Adverse Event|0|||
126220143|NCT04380701|454097519|FG013|Overall Study|Adverse Event|0|||
126220144|NCT04380701|454097520|FG014|Overall Study|Adverse Event|0|||
126220145|NCT04380701|454097521|FG015|Overall Study|Adverse Event|1|||
126220146|NCT04380701|454097522|FG016|Overall Study|Adverse Event|0|||
126220147|NCT04380701|454097523|FG017|Overall Study|Adverse Event|0|||
126220148|NCT04380701|454097524|FG018|Overall Study|Adverse Event|0|||
126220149|NCT04380701|454097525|FG019|Overall Study|Adverse Event|1|||
126220150|NCT04380701|454097526|FG020|Overall Study|Adverse Event|0|||
126220151|NCT04380701|454097527|FG021|Overall Study|Adverse Event|0|||
126220152|NCT04380701|454097528|FG022|Overall Study|Adverse Event|0|||
126220153|NCT04380701|454097529|FG023|Overall Study|Adverse Event|0|||
126220154|NCT04380701|454097530|FG024|Overall Study|Adverse Event|0|||
126220155|NCT04380701|454097531|FG025|Overall Study|Adverse Event|0|||
126220156|NCT04380701|454097532|FG026|Overall Study|Adverse Event|0|||
126220157|NCT04380701|454097533|FG027|Overall Study|Adverse Event|0|||
126220158|NCT04380701|454097534|FG028|Overall Study|Adverse Event|0|||
126220159|NCT04380701|454097535|FG029|Overall Study|Adverse Event|0|||
126220160|NCT04380701|454097536|FG030|Overall Study|Adverse Event|0|||
126220161|NCT04380701|454097537|FG031|Overall Study|Adverse Event|0|||
126220162|NCT04380701|454097538|FG032|Overall Study|Adverse Event|0|||
126220163|NCT04380701|454097539|FG033|Overall Study|Adverse Event|0|||
126220164|NCT04380701|454097506|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
126220165|NCT04380701|454097507|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
126220166|NCT04380701|454097508|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
126017746|NCT02674750|453358955|FG001|Overall Study|Death|5|||
126017747|NCT02674750|453358956|FG002|Overall Study|Death|8|||
126220167|NCT04380701|454097509|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
126220168|NCT04380701|454097510|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
126220169|NCT04380701|454097511|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
126220170|NCT04380701|454097512|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
126220171|NCT04380701|454097513|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
126220172|NCT04380701|454097514|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
126220173|NCT04380701|454097515|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
126220174|NCT04380701|454097516|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
126220175|NCT04380701|454097517|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
126220176|NCT04380701|454097518|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
126220177|NCT04380701|454097519|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
125878735|NCT01209689|452853399|FG000|Overall Study|Failure to Return|3|||
126220178|NCT04380701|454097520|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
126220179|NCT04380701|454097521|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
126220180|NCT04380701|454097522|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
126220181|NCT04380701|454097523|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
126220182|NCT04380701|454097524|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
126220183|NCT04380701|454097525|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
126220184|NCT04380701|454097526|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
126220185|NCT04380701|454097527|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
126220186|NCT04380701|454097528|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
126220187|NCT04380701|454097529|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
126220188|NCT04380701|454097530|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
126220189|NCT04380701|454097531|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
126220190|NCT04380701|454097532|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
126220191|NCT04380701|454097533|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
126220192|NCT04380701|454097534|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
126220193|NCT04380701|454097535|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
126220194|NCT04380701|454097536|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
126220195|NCT04380701|454097537|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
126220196|NCT04380701|454097538|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
126220197|NCT04380701|454097539|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
126220198|NCT04380701|454097506|FG000|Overall Study|Physician Decision|0|||
126220199|NCT04380701|454097507|FG001|Overall Study|Physician Decision|0|||
126220200|NCT04380701|454097508|FG002|Overall Study|Physician Decision|0|||
126220201|NCT04380701|454097509|FG003|Overall Study|Physician Decision|0|||
126220202|NCT04380701|454097510|FG004|Overall Study|Physician Decision|0|||
126220203|NCT04380701|454097511|FG005|Overall Study|Physician Decision|0|||
126220204|NCT04380701|454097512|FG006|Overall Study|Physician Decision|0|||
126220205|NCT04380701|454097513|FG007|Overall Study|Physician Decision|0|||
126220206|NCT04380701|454097514|FG008|Overall Study|Physician Decision|0|||
126220207|NCT04380701|454097515|FG009|Overall Study|Physician Decision|0|||
126220208|NCT04380701|454097516|FG010|Overall Study|Physician Decision|0|||
126220209|NCT04380701|454097517|FG011|Overall Study|Physician Decision|0|||
126220210|NCT04380701|454097518|FG012|Overall Study|Physician Decision|0|||
126220211|NCT04380701|454097519|FG013|Overall Study|Physician Decision|0|||
126220212|NCT04380701|454097520|FG014|Overall Study|Physician Decision|0|||
126220213|NCT04380701|454097521|FG015|Overall Study|Physician Decision|0|||
126220214|NCT04380701|454097522|FG016|Overall Study|Physician Decision|0|||
126220215|NCT04380701|454097523|FG017|Overall Study|Physician Decision|0|||
126220216|NCT04380701|454097524|FG018|Overall Study|Physician Decision|0|||
126220217|NCT04380701|454097525|FG019|Overall Study|Physician Decision|0|||
126220218|NCT04380701|454097526|FG020|Overall Study|Physician Decision|0|||
126220219|NCT04380701|454097527|FG021|Overall Study|Physician Decision|0|||
126220220|NCT04380701|454097528|FG022|Overall Study|Physician Decision|0|||
126220221|NCT04380701|454097529|FG023|Overall Study|Physician Decision|0|||
126220222|NCT04380701|454097530|FG024|Overall Study|Physician Decision|2|||
126220223|NCT04380701|454097531|FG025|Overall Study|Physician Decision|0|||
126220224|NCT04380701|454097532|FG026|Overall Study|Physician Decision|0|||
126220225|NCT04380701|454097533|FG027|Overall Study|Physician Decision|0|||
126220226|NCT04380701|454097534|FG028|Overall Study|Physician Decision|0|||
126220227|NCT04380701|454097535|FG029|Overall Study|Physician Decision|0|||
126220228|NCT04380701|454097536|FG030|Overall Study|Physician Decision|0|||
126220229|NCT04380701|454097537|FG031|Overall Study|Physician Decision|0|||
126220230|NCT04380701|454097538|FG032|Overall Study|Physician Decision|0|||
126220231|NCT04380701|454097539|FG033|Overall Study|Physician Decision|0|||
126220232|NCT04380701|454097506|FG000|Overall Study|Death|0|||
126220233|NCT04380701|454097507|FG001|Overall Study|Death|0|||
126220234|NCT04380701|454097508|FG002|Overall Study|Death|0|||
126220235|NCT04380701|454097509|FG003|Overall Study|Death|0|||
126220236|NCT04380701|454097510|FG004|Overall Study|Death|0|||
126092268|NCT01803282|453630557|FG001|Overall Study|Investigator's Discretion|0|||
126092269|NCT01803282|453630558|FG002|Overall Study|Investigator's Discretion|0|||
126092270|NCT01803282|453630559|FG003|Overall Study|Investigator's Discretion|7|||
126092271|NCT01803282|453630560|FG004|Overall Study|Investigator's Discretion|2|||
126092272|NCT01803282|453630561|FG005|Overall Study|Investigator's Discretion|1|||
126092273|NCT01803282|453630562|FG006|Overall Study|Investigator's Discretion|7|||
126017748|NCT02674750|453358954|FG000|Overall Study|Lost to Follow-up|0|||
126220237|NCT04380701|454097511|FG005|Overall Study|Death|0|||
126220238|NCT04380701|454097512|FG006|Overall Study|Death|0|||
126092274|NCT01803282|453630563|FG007|Overall Study|Investigator's Discretion|10|||
126092275|NCT01803282|453630564|FG008|Overall Study|Investigator's Discretion|6|||
126220239|NCT04380701|454097513|FG007|Overall Study|Death|0|||
126220240|NCT04380701|454097514|FG008|Overall Study|Death|0|||
126220241|NCT04380701|454097515|FG009|Overall Study|Death|0|||
126220242|NCT04380701|454097516|FG010|Overall Study|Death|0|||
126220243|NCT04380701|454097517|FG011|Overall Study|Death|0|||
126220244|NCT04380701|454097518|FG012|Overall Study|Death|0|||
126220245|NCT04380701|454097519|FG013|Overall Study|Death|0|||
126220246|NCT04380701|454097520|FG014|Overall Study|Death|0|||
126220247|NCT04380701|454097521|FG015|Overall Study|Death|0|||
125878736|NCT01209689|452853400|FG001|Overall Study|Failure to Return|0|||
126220248|NCT04380701|454097522|FG016|Overall Study|Death|0|||
126220249|NCT04380701|454097523|FG017|Overall Study|Death|0|||
126220250|NCT04380701|454097524|FG018|Overall Study|Death|0|||
126220251|NCT04380701|454097525|FG019|Overall Study|Death|0|||
126220252|NCT04380701|454097526|FG020|Overall Study|Death|0|||
126220253|NCT04380701|454097527|FG021|Overall Study|Death|0|||
126220254|NCT04380701|454097528|FG022|Overall Study|Death|0|||
126220255|NCT04380701|454097529|FG023|Overall Study|Death|0|||
126220256|NCT04380701|454097530|FG024|Overall Study|Death|1|||
126220257|NCT04380701|454097531|FG025|Overall Study|Death|0|||
126220258|NCT04380701|454097532|FG026|Overall Study|Death|0|||
126220259|NCT04380701|454097533|FG027|Overall Study|Death|0|||
126220260|NCT04380701|454097534|FG028|Overall Study|Death|0|||
126220261|NCT04380701|454097535|FG029|Overall Study|Death|0|||
126220262|NCT04380701|454097536|FG030|Overall Study|Death|0|||
126220263|NCT04380701|454097537|FG031|Overall Study|Death|0|||
126220264|NCT04380701|454097538|FG032|Overall Study|Death|0|||
126220265|NCT04380701|454097539|FG033|Overall Study|Death|0|||
126220266|NCT04380701|454097506|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220267|NCT04380701|454097507|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220268|NCT04380701|454097508|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220269|NCT04380701|454097509|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220270|NCT04380701|454097510|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220271|NCT04380701|454097511|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220272|NCT04380701|454097512|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220273|NCT04380701|454097513|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220274|NCT04380701|454097514|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220275|NCT04380701|454097515|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220276|NCT04380701|454097516|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220277|NCT04380701|454097517|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220278|NCT04380701|454097518|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220279|NCT04380701|454097519|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220280|NCT04380701|454097520|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220281|NCT04380701|454097521|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220282|NCT04380701|454097522|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220283|NCT04380701|454097523|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220284|NCT04380701|454097524|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220285|NCT04380701|454097525|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220286|NCT04380701|454097526|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220287|NCT04380701|454097527|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
126220288|NCT04380701|454097528|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
126220289|NCT04380701|454097529|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
126220290|NCT04380701|454097530|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
126220291|NCT04380701|454097531|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220292|NCT04380701|454097532|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220293|NCT04380701|454097533|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220294|NCT04380701|454097534|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220295|NCT04380701|454097535|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220296|NCT04380701|454097536|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220297|NCT04380701|454097537|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220298|NCT04380701|454097538|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220299|NCT04380701|454097539|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126220300|NCT00363129|454097540|FG000|Overall Study|Withdrawal by Subject|11|||
126220301|NCT00363129|454097541|FG001|Overall Study|Withdrawal by Subject|18|||
126220302|NCT00363129|454097540|FG000|Overall Study|Adverse Event|8|||
126220303|NCT00363129|454097541|FG001|Overall Study|Adverse Event|3|||
126220304|NCT00363129|454097540|FG000|Overall Study|Alternate Treatment|2|||
126220305|NCT00363129|454097541|FG001|Overall Study|Alternate Treatment|4|||
126220306|NCT00363129|454097540|FG000|Overall Study|Other Medical Problems|2|||
126220307|NCT00363129|454097541|FG001|Overall Study|Other Medical Problems|4|||
126220308|NCT00363129|454097540|FG000|Overall Study|Death|0|||
126220309|NCT00363129|454097541|FG001|Overall Study|Death|1|||
126220310|NCT00363129|454097540|FG000|Overall Study|Other Reasons|6|||
126220311|NCT00363129|454097541|FG001|Overall Study|Other Reasons|3|||
126220312|NCT02713243|454097542|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
126220313|NCT02713243|454097543|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
126220314|NCT02713243|454097542|FG000|Overall Study|Administrative problems|0|||
126017749|NCT02674750|453358955|FG001|Overall Study|Lost to Follow-up|8|||
126017750|NCT02674750|453358956|FG002|Overall Study|Lost to Follow-up|0|||
126017751|NCT02674750|453358954|FG000|Overall Study|Lack of Efficacy|1|||
126220315|NCT02713243|454097543|FG001|Overall Study|Administrative problems|1|||
126220316|NCT02713243|454097542|FG000|Overall Study|Protocol deviation|0|||
126220317|NCT02713243|454097543|FG001|Overall Study|Protocol deviation|1|||
126220318|NCT00383019|454097544|FG000|Overall Study|Adverse Event|5|||
126092276|NCT01803282|453630565|FG009|Overall Study|Investigator's Discretion|7|||
126092277|NCT01803282|453630566|FG010|Overall Study|Investigator's Discretion|1|||
126092278|NCT01803282|453630567|FG011|Overall Study|Investigator's Discretion|0|||
126092279|NCT01803282|453630556|FG000|Overall Study|Adverse Event|0|||
126092280|NCT01803282|453630557|FG001|Overall Study|Adverse Event|0|||
126092281|NCT01803282|453630558|FG002|Overall Study|Adverse Event|0|||
126092282|NCT01803282|453630559|FG003|Overall Study|Adverse Event|0|||
126092283|NCT01803282|453630560|FG004|Overall Study|Adverse Event|0|||
126092284|NCT01803282|453630561|FG005|Overall Study|Adverse Event|0|||
126092285|NCT01803282|453630562|FG006|Overall Study|Adverse Event|1|||
126092286|NCT01803282|453630563|FG007|Overall Study|Adverse Event|2|||
126092287|NCT01803282|453630564|FG008|Overall Study|Adverse Event|0|||
126092288|NCT01803282|453630565|FG009|Overall Study|Adverse Event|1|||
126092289|NCT01803282|453630566|FG010|Overall Study|Adverse Event|0|||
126092290|NCT01803282|453630567|FG011|Overall Study|Adverse Event|3|||
126092291|NCT01803282|453630556|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126092292|NCT01803282|453630557|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126092293|NCT01803282|453630558|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126092294|NCT01803282|453630559|FG003|Overall Study|Non-Compliance with Study Drug|1|||
126092295|NCT01803282|453630560|FG004|Overall Study|Non-Compliance with Study Drug|0|||
126092296|NCT01803282|453630561|FG005|Overall Study|Non-Compliance with Study Drug|0|||
126092297|NCT01803282|453630562|FG006|Overall Study|Non-Compliance with Study Drug|0|||
126092298|NCT01803282|453630563|FG007|Overall Study|Non-Compliance with Study Drug|0|||
126092299|NCT01803282|453630564|FG008|Overall Study|Non-Compliance with Study Drug|0|||
126092300|NCT01803282|453630565|FG009|Overall Study|Non-Compliance with Study Drug|0|||
126092301|NCT01803282|453630566|FG010|Overall Study|Non-Compliance with Study Drug|0|||
126092302|NCT01803282|453630567|FG011|Overall Study|Non-Compliance with Study Drug|0|||
126092303|NCT01803282|453630556|FG000|Overall Study|Unknown Reason|0|||
126092304|NCT01803282|453630557|FG001|Overall Study|Unknown Reason|0|||
126092305|NCT01803282|453630558|FG002|Overall Study|Unknown Reason|0|||
126092306|NCT01803282|453630559|FG003|Overall Study|Unknown Reason|0|||
126092307|NCT01803282|453630560|FG004|Overall Study|Unknown Reason|0|||
126092308|NCT01803282|453630561|FG005|Overall Study|Unknown Reason|0|||
126092309|NCT01803282|453630562|FG006|Overall Study|Unknown Reason|0|||
126092310|NCT01803282|453630563|FG007|Overall Study|Unknown Reason|1|||
126092311|NCT01803282|453630564|FG008|Overall Study|Unknown Reason|0|||
126092312|NCT01803282|453630565|FG009|Overall Study|Unknown Reason|0|||
126092313|NCT01803282|453630566|FG010|Overall Study|Unknown Reason|0|||
126092314|NCT01803282|453630567|FG011|Overall Study|Unknown Reason|0|||
126092315|NCT01803282|453630556|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
126092316|NCT01803282|453630557|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
126092317|NCT01803282|453630558|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
126092318|NCT01803282|453630559|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
126092319|NCT01803282|453630560|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
126092320|NCT01803282|453630561|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
126092321|NCT01803282|453630562|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
126092322|NCT01803282|453630563|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
126092323|NCT01803282|453630564|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
126092324|NCT01803282|453630565|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
126092325|NCT01803282|453630566|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
126092326|NCT01803282|453630567|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
126092327|NCT01803282|453630556|FG000|Overall Study|Enrolled but Never Treated|0|||
126092328|NCT01803282|453630557|FG001|Overall Study|Enrolled but Never Treated|0|||
126092329|NCT01803282|453630558|FG002|Overall Study|Enrolled but Never Treated|0|||
126092330|NCT01803282|453630559|FG003|Overall Study|Enrolled but Never Treated|0|||
126092331|NCT01803282|453630560|FG004|Overall Study|Enrolled but Never Treated|1|||
126092332|NCT01803282|453630561|FG005|Overall Study|Enrolled but Never Treated|0|||
126092333|NCT01803282|453630562|FG006|Overall Study|Enrolled but Never Treated|1|||
126092334|NCT01803282|453630563|FG007|Overall Study|Enrolled but Never Treated|1|||
126092335|NCT01803282|453630564|FG008|Overall Study|Enrolled but Never Treated|0|||
126092336|NCT01803282|453630565|FG009|Overall Study|Enrolled but Never Treated|1|||
126092337|NCT01803282|453630566|FG010|Overall Study|Enrolled but Never Treated|0|||
126092338|NCT01803282|453630567|FG011|Overall Study|Enrolled but Never Treated|0|||
126092339|NCT01743989|453630568|FG000|Treatment Phase|Unstable MR4.0|0|||
126092340|NCT01743989|453630569|FG001|Treatment Phase|Unstable MR4.0|6|||
126092341|NCT01743989|453630570|FG002|Treatment Phase|Unstable MR4.0|263|||
126092342|NCT01743989|453630568|FG000|Treatment Phase|Adverse Event|0|||
126092343|NCT01743989|453630569|FG001|Treatment Phase|Adverse Event|4|||
126220319|NCT00383019|454097545|FG001|Overall Study|Adverse Event|1|||
126220320|NCT00383019|454097544|FG000|Overall Study|Withdrawal by Subject|0|||
126220321|NCT00383019|454097545|FG001|Overall Study|Withdrawal by Subject|1|||
126220322|NCT03797222|454097546|FG000|Overall Study|Withdrawal by Subject|1|||
126220323|NCT00725725|454097548|FG000|Overall Study|Adverse Event|1|||
126220324|NCT00725725|454097549|FG001|Overall Study|Adverse Event|3|||
126220325|NCT00725725|454097550|FG002|Overall Study|Adverse Event|2|||
126220326|NCT00725725|454097548|FG000|Overall Study|Lost to Follow-up|2|||
126220327|NCT00725725|454097549|FG001|Overall Study|Lost to Follow-up|0|||
126220328|NCT00725725|454097550|FG002|Overall Study|Lost to Follow-up|2|||
126220329|NCT00725725|454097548|FG000|Overall Study|Withdrawal by Subject|1|||
126220330|NCT00725725|454097549|FG001|Overall Study|Withdrawal by Subject|0|||
126220331|NCT00725725|454097550|FG002|Overall Study|Withdrawal by Subject|1|||
126220332|NCT00725725|454097548|FG000|Overall Study|Protocol Violation|0|||
126220333|NCT00725725|454097549|FG001|Overall Study|Protocol Violation|1|||
126220334|NCT00725725|454097550|FG002|Overall Study|Protocol Violation|0|||
126220335|NCT01619085|454097551|FG000|Overall Study|Adverse Event|231|||
126220336|NCT01619085|454097551|FG000|Overall Study|Protocol Violation|4|||
126220337|NCT01619085|454097551|FG000|Overall Study|Lost to Follow-up|3|||
126220338|NCT01619085|454097551|FG000|Overall Study|Withdrawal by Subject|45|||
126220339|NCT01619085|454097551|FG000|Overall Study|Other than specified|96|||
126220340|NCT01619085|454097551|FG000|Overall Study|Not treated|1|||
126220341|NCT01619085|454097551|FG000|Overall Study|Death|145|||
126220342|NCT03125915|454097554|FG000|1 Month Follow up|Lost to Follow-up|3|||
126220343|NCT03125915|454097555|FG001|1 Month Follow up|Lost to Follow-up|3|||
126220344|NCT03125915|454097556|FG002|1 Month Follow up|Lost to Follow-up|2|||
126220345|NCT03125915|454097557|FG003|1 Month Follow up|Lost to Follow-up|3|||
126220346|NCT03125915|454097554|FG000|3 Month Follow-up|Lost to Follow-up|6|||
126220347|NCT03125915|454097555|FG001|3 Month Follow-up|Lost to Follow-up|4|||
126220348|NCT03125915|454097556|FG002|3 Month Follow-up|Lost to Follow-up|4|||
126220349|NCT03125915|454097557|FG003|3 Month Follow-up|Lost to Follow-up|2|||
126220350|NCT03125915|454097554|FG000|6 Month Follow-up|Lost to Follow-up|7|||
126220351|NCT03125915|454097555|FG001|6 Month Follow-up|Lost to Follow-up|3|||
126220352|NCT03125915|454097556|FG002|6 Month Follow-up|Lost to Follow-up|6|||
126220353|NCT03125915|454097557|FG003|6 Month Follow-up|Lost to Follow-up|3|||
126220354|NCT01458119|454097558|FG000|Overall Study|Physician Decision|4|||
126220355|NCT01458119|454097558|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
126220356|NCT01458119|454097558|FG000|Overall Study|Pregnancy|1|||
126220357|NCT01458119|454097558|FG000|Overall Study|Death|2|||
126220358|NCT01458119|454097558|FG000|Overall Study|Adverse Event|1|||
126220359|NCT01458119|454097558|FG000|Overall Study|Consent Withdrawn by Participant|8|||
126220360|NCT01458119|454097558|FG000|Overall Study|Non-compliance With Study Drug|3|||
126220361|NCT01123980|454097561|FG000|Overall Study|Adverse Event|1|||
126220362|NCT01123980|454097562|FG001|Overall Study|Adverse Event|1|||
126220363|NCT01123980|454097561|FG000|Overall Study|Lack of Efficacy|1|||
126220364|NCT01123980|454097562|FG001|Overall Study|Lack of Efficacy|0|||
126220365|NCT01123980|454097561|FG000|Overall Study|Physician Decision|0|||
126220366|NCT01123980|454097562|FG001|Overall Study|Physician Decision|1|||
126220367|NCT01123980|454097561|FG000|Overall Study|Lost to Follow-up|0|||
126220368|NCT01123980|454097562|FG001|Overall Study|Lost to Follow-up|6|||
126220369|NCT01123980|454097561|FG000|Overall Study|Protocol Violation|6|||
126220370|NCT01123980|454097562|FG001|Overall Study|Protocol Violation|6|||
126220371|NCT01123980|454097561|FG000|Overall Study|Withdrawal by Subject|5|||
126220372|NCT01123980|454097562|FG001|Overall Study|Withdrawal by Subject|3|||
126220373|NCT01123980|454097561|FG000|Overall Study|Unclassified|6|||
126220374|NCT01123980|454097562|FG001|Overall Study|Unclassified|7|||
126220375|NCT01225991|454097563|FG000|Overall Study|Withdrawal by Subject|6|||
126220376|NCT00789828|454097564|FG000|Core Period (48 Weeks)|Administrative problems|0|||
126220377|NCT00789828|454097565|FG001|Core Period (48 Weeks)|Administrative problems|1|||
126220378|NCT00789828|454097564|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
126092344|NCT01743989|453630570|FG002|Treatment Phase|Adverse Event|67|||
126220379|NCT00789828|454097565|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
126220380|NCT00789828|454097564|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
126220381|NCT00789828|454097565|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
126092345|NCT01743989|453630568|FG000|Treatment Phase|Withdrawal by Subject|1|||
126092346|NCT01743989|453630569|FG001|Treatment Phase|Withdrawal by Subject|3|||
126220382|NCT00789828|454097564|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
126220383|NCT00789828|454097565|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
126220384|NCT00789828|454097564|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
126220385|NCT00789828|454097565|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
126220386|NCT00789828|454097564|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
126092347|NCT01743989|453630570|FG002|Treatment Phase|Withdrawal by Subject|28|||
126220387|NCT00789828|454097565|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
126220388|NCT00789828|454097564|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
126220389|NCT00789828|454097565|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
126220390|NCT00789828|454097564|FG000|Open-label Extension Period (4 Years)|Death|1|||
126017752|NCT02674750|453358955|FG001|Overall Study|Lack of Efficacy|17|||
126017753|NCT02674750|453358956|FG002|Overall Study|Lack of Efficacy|3|||
126017754|NCT02674750|453358954|FG000|Overall Study|Withdrawal by Subject|0|||
126017755|NCT02674750|453358955|FG001|Overall Study|Withdrawal by Subject|7|||
126017756|NCT02674750|453358956|FG002|Overall Study|Withdrawal by Subject|1|||
126017757|NCT02674750|453358954|FG000|Overall Study|Other|0|||
126017758|NCT02674750|453358955|FG001|Overall Study|Other|8|||
126017759|NCT02674750|453358956|FG002|Overall Study|Other|0|||
126017760|NCT01685606|453358957|FG000|Overall Study|Withdrawal by Subject|1|||
126017761|NCT01597258|453358960|FG000|Overall Study|No Drug Administration|1|||
126017762|NCT01415349|453358961|FG000|Treatment Period 1|Adverse Event|0|||
126017763|NCT01415349|453358962|FG001|Treatment Period 1|Adverse Event|1|||
126017764|NCT01415349|453358961|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126017765|NCT01415349|453358962|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126017766|NCT01616459|453358963|FG000|Overall Study|Adverse Event|1|||
126017767|NCT01616459|453358964|FG001|Overall Study|Adverse Event|1|||
126017768|NCT01616459|453358965|FG002|Overall Study|Adverse Event|2|||
126017769|NCT01616459|453358966|FG003|Overall Study|Adverse Event|0|||
126017770|NCT01616459|453358963|FG000|Overall Study|Lost to Follow-up|1|||
126017771|NCT01616459|453358964|FG001|Overall Study|Lost to Follow-up|11|||
126017772|NCT01616459|453358965|FG002|Overall Study|Lost to Follow-up|3|||
126017773|NCT01616459|453358966|FG003|Overall Study|Lost to Follow-up|2|||
126017774|NCT01616459|453358963|FG000|Overall Study|Protocol Violation|0|||
126017775|NCT01616459|453358964|FG001|Overall Study|Protocol Violation|0|||
126017776|NCT01616459|453358965|FG002|Overall Study|Protocol Violation|0|||
126017777|NCT01616459|453358966|FG003|Overall Study|Protocol Violation|2|||
126017778|NCT01616459|453358963|FG000|Overall Study|Withdrawal by Subject|2|||
126017779|NCT01616459|453358964|FG001|Overall Study|Withdrawal by Subject|4|||
126017780|NCT01616459|453358965|FG002|Overall Study|Withdrawal by Subject|4|||
126017781|NCT01616459|453358966|FG003|Overall Study|Withdrawal by Subject|4|||
126017782|NCT01616459|453358963|FG000|Overall Study|Other reason|0|||
126017783|NCT01616459|453358964|FG001|Overall Study|Other reason|1|||
126017784|NCT01616459|453358965|FG002|Overall Study|Other reason|1|||
126017785|NCT01616459|453358966|FG003|Overall Study|Other reason|0|||
126017786|NCT04980755|453358967|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
126017787|NCT04980755|453358967|FG000|Body Reprogramming Courses|Work commitment|2|||
126017788|NCT04980755|453358967|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
126017789|NCT04980755|453358967|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
126017790|NCT01599104|453360489|FG000|Overall Study|Withdrawal by Subject|1|||
126017791|NCT01599104|453360490|FG001|Overall Study|Withdrawal by Subject|1|||
126017792|NCT01599104|453360491|FG002|Overall Study|Withdrawal by Subject|2|||
126017793|NCT01599104|453360489|FG000|Overall Study|Technical Problems|1|||
126017794|NCT01599104|453360490|FG001|Overall Study|Technical Problems|0|||
126017795|NCT01599104|453360491|FG002|Overall Study|Technical Problems|0|||
126017796|NCT01599104|453360489|FG000|Overall Study|Physician Decision|3|||
126017797|NCT01599104|453360490|FG001|Overall Study|Physician Decision|2|||
126017798|NCT01599104|453360491|FG002|Overall Study|Physician Decision|2|||
126017799|NCT01599104|453360489|FG000|Overall Study|Non-compliance with study treatment|0|||
126017800|NCT01599104|453360490|FG001|Overall Study|Non-compliance with study treatment|1|||
126017801|NCT01599104|453360491|FG002|Overall Study|Non-compliance with study treatment|0|||
126017802|NCT01599104|453360489|FG000|Overall Study|Lack of Efficacy|4|||
126017803|NCT01599104|453360490|FG001|Overall Study|Lack of Efficacy|4|||
126017804|NCT01599104|453360491|FG002|Overall Study|Lack of Efficacy|10|||
126017805|NCT01599104|453360489|FG000|Overall Study|Adverse Event|7|||
126017806|NCT01599104|453360490|FG001|Overall Study|Adverse Event|6|||
126017807|NCT01599104|453360491|FG002|Overall Study|Adverse Event|12|||
126017808|NCT00714714|453360492|FG000|Overall Study|Adverse Event|1|||
126017809|NCT01308567|453360503|FG000|Overall Study|Lost to Follow-up|2|||
126017810|NCT01308567|453360504|FG001|Overall Study|Lost to Follow-up|4|||
126017811|NCT01308567|453360505|FG002|Overall Study|Lost to Follow-up|4|||
126017812|NCT03454529|453360515|FG000|Overall Study|Did not receive treatment|6|||
126017813|NCT03454529|453360515|FG000|Overall Study|Received < 80% doses|1|||
126017814|NCT01582100|453360519|FG000|Overall Study|Adverse Event|1|||
126092348|NCT01743989|453630568|FG000|Treatment Phase|Death|0|||
126092349|NCT01743989|453630569|FG001|Treatment Phase|Death|1|||
126092350|NCT01743989|453630570|FG002|Treatment Phase|Death|3|||
126092351|NCT01743989|453630568|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
126092352|NCT01743989|453630569|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
126092353|NCT01743989|453630570|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
126092354|NCT01743989|453630568|FG000|Treatment Phase|Protocol deviation|0|||
126092355|NCT01743989|453630569|FG001|Treatment Phase|Protocol deviation|0|||
126092356|NCT01743989|453630570|FG002|Treatment Phase|Protocol deviation|3|||
126092357|NCT01743989|453630568|FG000|Treatment Phase|Pregnancy|0|||
126092358|NCT01743989|453630569|FG001|Treatment Phase|Pregnancy|0|||
126092359|NCT01743989|453630570|FG002|Treatment Phase|Pregnancy|2|||
126092360|NCT01743989|453630568|FG000|Treatment Phase|Lost to Follow-up|0|||
126092361|NCT01743989|453630569|FG001|Treatment Phase|Lost to Follow-up|0|||
126092362|NCT01743989|453630570|FG002|Treatment Phase|Lost to Follow-up|2|||
126092363|NCT01743989|453630568|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
126092364|NCT01743989|453630569|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
125878737|NCT01209689|452853399|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
126017815|NCT01582100|453360519|FG000|Overall Study|Withdrawal by Subject|1|||
126017816|NCT01149369|453360520|FG000|Overall Study|Adverse Event|6|||
126017817|NCT01149369|453360521|FG001|Overall Study|Adverse Event|3|||
126017818|NCT01040689|453360528|FG000|Overall Study|Adverse Event|0|||
126017819|NCT01040689|453360529|FG001|Overall Study|Adverse Event|0|||
126017820|NCT01040689|453360530|FG002|Overall Study|Adverse Event|2|||
126092365|NCT01743989|453630570|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
126092366|NCT01743989|453630568|FG000|Treatment Phase|Administrative problems|0|||
126092367|NCT01743989|453630569|FG001|Treatment Phase|Administrative problems|0|||
126220391|NCT00789828|454097565|FG001|Open-label Extension Period (4 Years)|Death|0|||
126220392|NCT00789828|454097564|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
126220393|NCT00789828|454097565|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
126220394|NCT00789828|454097564|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
126220395|NCT00789828|454097565|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
126220396|NCT02094937|454097566|FG000|8 Weeks in Period 1|Adverse Event|9|||
126220397|NCT02094937|454097567|FG001|8 Weeks in Period 1|Adverse Event|0|||
126220398|NCT02094937|454097568|FG002|8 Weeks in Period 1|Adverse Event|0|||
126220399|NCT02094937|454097569|FG003|8 Weeks in Period 1|Adverse Event|0|||
126220400|NCT02094937|454097566|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
126220401|NCT02094937|454097567|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
126220402|NCT02094937|454097568|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
126220403|NCT02094937|454097569|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
126220404|NCT02094937|454097566|FG000|8 Weeks in Period 1|Protocol Violation|2|||
126220405|NCT02094937|454097567|FG001|8 Weeks in Period 1|Protocol Violation|0|||
126220406|NCT02094937|454097568|FG002|8 Weeks in Period 1|Protocol Violation|0|||
126220407|NCT02094937|454097569|FG003|8 Weeks in Period 1|Protocol Violation|0|||
126220408|NCT02094937|454097566|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
126220409|NCT02094937|454097567|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
126220410|NCT02094937|454097568|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
126220411|NCT02094937|454097569|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
126220412|NCT02094937|454097566|FG000|8 Weeks in Period 1|Physician Decision|1|||
126220413|NCT02094937|454097567|FG001|8 Weeks in Period 1|Physician Decision|0|||
126220414|NCT02094937|454097568|FG002|8 Weeks in Period 1|Physician Decision|0|||
126220415|NCT02094937|454097569|FG003|8 Weeks in Period 1|Physician Decision|0|||
126220416|NCT02094937|454097566|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
126220417|NCT02094937|454097567|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
126220418|NCT02094937|454097568|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
126220419|NCT02094937|454097569|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
126220420|NCT02094937|454097566|FG000|12 Weeks in Period 2|Adverse Event|0|||
126220421|NCT02094937|454097567|FG001|12 Weeks in Period 2|Adverse Event|2|||
126220422|NCT02094937|454097568|FG002|12 Weeks in Period 2|Adverse Event|4|||
126017821|NCT01040689|453360531|FG003|Overall Study|Adverse Event|4|||
126017822|NCT01040689|453360528|FG000|Overall Study|Lack of Efficacy|0|||
126220423|NCT02094937|454097569|FG003|12 Weeks in Period 2|Adverse Event|1|||
126220424|NCT02094937|454097566|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
126092368|NCT01743989|453630570|FG002|Treatment Phase|Administrative problems|1|||
126092369|NCT01743989|453630568|FG000|Treatment Phase|New cancer (CML) therapy|0|||
126092370|NCT01743989|453630569|FG001|Treatment Phase|New cancer (CML) therapy|1|||
126092371|NCT01743989|453630570|FG002|Treatment Phase|New cancer (CML) therapy|0|||
126092372|NCT01743989|453630568|FG000|Treatment Phase|Physician Decision|0|||
126092373|NCT01743989|453630569|FG001|Treatment Phase|Physician Decision|0|||
126092374|NCT01743989|453630570|FG002|Treatment Phase|Physician Decision|3|||
126092375|NCT01743989|453630568|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
126092376|NCT01743989|453630569|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
126092377|NCT01743989|453630570|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
126092378|NCT01743989|453630568|FG000|Treatment Phase|Not randomized by mistake|0|||
126092379|NCT01743989|453630569|FG001|Treatment Phase|Not randomized by mistake|0|||
126092380|NCT01743989|453630570|FG002|Treatment Phase|Not randomized by mistake|1|||
126092381|NCT01743989|453630568|FG000|Treatment Phase|Included by mistake|0|||
126092382|NCT01743989|453630569|FG001|Treatment Phase|Included by mistake|0|||
126092383|NCT01743989|453630570|FG002|Treatment Phase|Included by mistake|1|||
126092384|NCT01743989|453630568|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
126092385|NCT01743989|453630569|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
126092386|NCT01743989|453630570|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
126092387|NCT01743989|453630568|FG000|TFR Phase|Adverse Event|0|||
126092388|NCT01743989|453630569|FG001|TFR Phase|Adverse Event|1|||
126092389|NCT01743989|453630570|FG002|TFR Phase|Adverse Event|0|||
126092390|NCT01743989|453630568|FG000|TFR Phase|Lost to Follow-up|0|||
126092391|NCT01743989|453630569|FG001|TFR Phase|Lost to Follow-up|2|||
126092392|NCT01743989|453630570|FG002|TFR Phase|Lost to Follow-up|0|||
126092393|NCT01743989|453630568|FG000|TFR Phase|Physician Decision|0|||
126092394|NCT01743989|453630569|FG001|TFR Phase|Physician Decision|1|||
126092395|NCT01743989|453630570|FG002|TFR Phase|Physician Decision|0|||
126092396|NCT01743989|453630568|FG000|TFR Phase|Logistical problems|0|||
126092397|NCT01743989|453630569|FG001|TFR Phase|Logistical problems|2|||
126092398|NCT01743989|453630570|FG002|TFR Phase|Logistical problems|0|||
126092399|NCT01743989|453630568|FG000|TFR Phase|Protocol deviation|0|||
126092400|NCT01743989|453630569|FG001|TFR Phase|Protocol deviation|1|||
126092401|NCT01743989|453630570|FG002|TFR Phase|Protocol deviation|0|||
126092402|NCT01743989|453630568|FG000|TFR Phase|Withdrawal by Subject|0|||
126092403|NCT01743989|453630569|FG001|TFR Phase|Withdrawal by Subject|2|||
126092404|NCT01743989|453630570|FG002|TFR Phase|Withdrawal by Subject|0|||
126220425|NCT02094937|454097567|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
126092405|NCT01743989|453630568|FG000|Re-treatment Phase|Adverse Event|8|||
126017823|NCT01040689|453360529|FG001|Overall Study|Lack of Efficacy|0|||
126017824|NCT01040689|453360530|FG002|Overall Study|Lack of Efficacy|1|||
126017825|NCT01040689|453360531|FG003|Overall Study|Lack of Efficacy|0|||
126017826|NCT01040689|453360528|FG000|Overall Study|Lost to Follow-up|1|||
126017827|NCT01040689|453360529|FG001|Overall Study|Lost to Follow-up|0|||
126017828|NCT01040689|453360530|FG002|Overall Study|Lost to Follow-up|0|||
126017829|NCT01040689|453360531|FG003|Overall Study|Lost to Follow-up|0|||
126017830|NCT01040689|453360528|FG000|Overall Study|Withdrawal by Subject|2|||
126017831|NCT01040689|453360529|FG001|Overall Study|Withdrawal by Subject|1|||
126220426|NCT02094937|454097568|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
126017832|NCT01040689|453360530|FG002|Overall Study|Withdrawal by Subject|1|||
126017833|NCT01040689|453360531|FG003|Overall Study|Withdrawal by Subject|0|||
126220427|NCT02094937|454097569|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
126220428|NCT02094937|454097566|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
126220429|NCT02094937|454097567|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
126220430|NCT02094937|454097568|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
126220431|NCT02094937|454097569|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
126017834|NCT01040689|453360528|FG000|Overall Study|Other reasons not listed above|0|||
126017835|NCT01040689|453360529|FG001|Overall Study|Other reasons not listed above|1|||
126220432|NCT02094937|454097566|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
126220433|NCT02094937|454097567|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
126220434|NCT02094937|454097568|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
126220435|NCT02094937|454097569|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
126220436|NCT02094937|454097566|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
126220437|NCT02094937|454097567|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
126220438|NCT02094937|454097568|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
126220439|NCT02094937|454097569|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
126017836|NCT01040689|453360530|FG002|Overall Study|Other reasons not listed above|0|||
126017837|NCT01040689|453360531|FG003|Overall Study|Other reasons not listed above|0|||
126017838|NCT01185561|453360532|FG000|Overall Study|Lost to Follow-up|0|||
126017839|NCT01185561|453360533|FG001|Overall Study|Lost to Follow-up|4|||
126017840|NCT01185561|453360532|FG000|Overall Study|Withdrawal by Subject|2|||
126017841|NCT01185561|453360533|FG001|Overall Study|Withdrawal by Subject|8|||
126017842|NCT01078116|453360534|FG000|Overall Study|Lost to Follow-up|17|||
126092406|NCT01743989|453630569|FG001|Re-treatment Phase|Adverse Event|4|||
126092407|NCT01743989|453630570|FG002|Re-treatment Phase|Adverse Event|0|||
126092408|NCT01743989|453630568|FG000|Re-treatment Phase|Death|1|||
126092409|NCT01743989|453630569|FG001|Re-treatment Phase|Death|1|||
126092410|NCT01743989|453630570|FG002|Re-treatment Phase|Death|0|||
126092411|NCT01743989|453630568|FG000|Re-treatment Phase|Administrative problems|1|||
126092412|NCT01743989|453630569|FG001|Re-treatment Phase|Administrative problems|1|||
126092413|NCT01743989|453630570|FG002|Re-treatment Phase|Administrative problems|0|||
126092414|NCT01743989|453630568|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
126092415|NCT01743989|453630569|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
126092416|NCT01743989|453630570|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
126092417|NCT01743989|453630568|FG000|Re-treatment Phase|Unstable MR|1|||
126092418|NCT01743989|453630569|FG001|Re-treatment Phase|Unstable MR|0|||
126092419|NCT01743989|453630570|FG002|Re-treatment Phase|Unstable MR|0|||
126092420|NCT01743989|453630568|FG000|Re-treatment Phase|Physician Decision|0|||
126092421|NCT01743989|453630569|FG001|Re-treatment Phase|Physician Decision|1|||
126092422|NCT01743989|453630570|FG002|Re-treatment Phase|Physician Decision|0|||
126092423|NCT01743989|453630568|FG000|Re-treatment Phase|Lost to Follow-up|0|||
126092424|NCT01743989|453630569|FG001|Re-treatment Phase|Lost to Follow-up|1|||
126092425|NCT01743989|453630570|FG002|Re-treatment Phase|Lost to Follow-up|0|||
126092426|NCT02235311|453630577|FG000|Overall Study|Lost to Follow-up|0|||
126092427|NCT02235311|453630578|FG001|Overall Study|Lost to Follow-up|1|||
126092428|NCT02235311|453630577|FG000|Overall Study|Protocol Violation|0|||
126092429|NCT02235311|453630578|FG001|Overall Study|Protocol Violation|1|||
126092430|NCT03006848|453630579|FG000|Overall Study|Adverse Event|1|||
126017843|NCT01078116|453360534|FG000|Overall Study|Adverse Event|5|||
126017844|NCT01078116|453360534|FG000|Overall Study|Withdrawal by Subject|8|||
126017845|NCT01078116|453360534|FG000|Overall Study|Lack of effectiveness|15|||
126017846|NCT01078116|453360534|FG000|Overall Study|Case report form not completed|3|||
126017847|NCT02616900|453360535|FG000|Overall Study|Lack of Efficacy|7|||
126017848|NCT02616900|453360535|FG000|Overall Study|Lost to Follow-up|2|||
126017849|NCT02616900|453360535|FG000|Overall Study|Protocol Violation|5|||
126017850|NCT02616900|453360535|FG000|Overall Study|Withdrawal by Subject|3|||
126017851|NCT02616900|453360535|FG000|Overall Study|Incomplete data|6|||
126017852|NCT02499159|453360536|FG000|Randomization|Protocol Violation|1|||
126017853|NCT02499159|453360537|FG001|Randomization|Protocol Violation|1|||
126017854|NCT02499159|453360536|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
126017855|NCT02499159|453360537|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
126017856|NCT02499159|453360536|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
126017857|NCT02499159|453360537|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
126017858|NCT02499159|453360536|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
126017859|NCT02499159|453360537|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
126017860|NCT02499159|453360536|FG000|30-Day Follow-Up Phone Call|Other|1|||
126017861|NCT02499159|453360537|FG001|30-Day Follow-Up Phone Call|Other|0|||
126017862|NCT02601820|453360538|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
126017863|NCT02601820|453360538|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
126017864|NCT02601820|453360538|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
126017865|NCT02601820|453360538|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
126017866|NCT02242487|453360539|FG000|Overall Study|Adverse Event|13|||
126017867|NCT02242487|453360540|FG001|Overall Study|Adverse Event|15|||
126017868|NCT02242487|453360539|FG000|Overall Study|Lack of Efficacy|4|||
126017869|NCT02242487|453360540|FG001|Overall Study|Lack of Efficacy|6|||
126017870|NCT02242487|453360539|FG000|Overall Study|Protocol Violation|2|||
126017871|NCT02242487|453360540|FG001|Overall Study|Protocol Violation|0|||
126017872|NCT02242487|453360539|FG000|Overall Study|Lost to Follow-up|2|||
126017873|NCT02242487|453360540|FG001|Overall Study|Lost to Follow-up|1|||
126017874|NCT02242487|453360539|FG000|Overall Study|Other - Miscellaneous|4|||
126017875|NCT02242487|453360540|FG001|Overall Study|Other - Miscellaneous|6|||
126017876|NCT02242487|453360539|FG000|Overall Study|Withdrawal by Subject|37|||
126017877|NCT02242487|453360540|FG001|Overall Study|Withdrawal by Subject|19|||
126017878|NCT01599793|453360541|FG000|Overall Study|Adverse Event|2|||
126017879|NCT02564744|453360544|FG000|Overall Study|Investigator decision|0|||
126017880|NCT02564744|453360545|FG001|Overall Study|Investigator decision|0|||
126017881|NCT02564744|453360546|FG002|Overall Study|Investigator decision|0|||
126017882|NCT02564744|453360547|FG003|Overall Study|Investigator decision|0|||
126092431|NCT03006848|453630579|FG000|Overall Study|Physician Decision|1|||
126092432|NCT03006848|453630579|FG000|Overall Study|Lack of Efficacy|16|||
126092433|NCT00384397|453630581|FG000|Overall Study|Adverse Event|0|||
126092434|NCT00384397|453630582|FG001|Overall Study|Adverse Event|1|||
126092435|NCT00384397|453630583|FG002|Overall Study|Adverse Event|2|||
126092436|NCT00384397|453630581|FG000|Overall Study|Protocol Violation|7|||
126092437|NCT00384397|453630582|FG001|Overall Study|Protocol Violation|15|||
126017883|NCT02564744|453360548|FG004|Overall Study|Investigator decision|1|||
126017884|NCT02564744|453360544|FG000|Overall Study|Death|10|||
126017885|NCT02564744|453360545|FG001|Overall Study|Death|5|||
126017886|NCT02564744|453360546|FG002|Overall Study|Death|4|||
126092438|NCT00384397|453630583|FG002|Overall Study|Protocol Violation|13|||
126017887|NCT02564744|453360547|FG003|Overall Study|Death|16|||
126017888|NCT02564744|453360548|FG004|Overall Study|Death|16|||
126017889|NCT02564744|453360544|FG000|Overall Study|End of study Page Missing|0|||
126017890|NCT02564744|453360545|FG001|Overall Study|End of study Page Missing|0|||
126017891|NCT02564744|453360546|FG002|Overall Study|End of study Page Missing|3|||
126017892|NCT02564744|453360547|FG003|Overall Study|End of study Page Missing|3|||
126017893|NCT02564744|453360548|FG004|Overall Study|End of study Page Missing|0|||
126017894|NCT02564744|453360544|FG000|Overall Study|Subject Withdrew Consent|1|||
126017895|NCT02564744|453360545|FG001|Overall Study|Subject Withdrew Consent|1|||
126017896|NCT02564744|453360546|FG002|Overall Study|Subject Withdrew Consent|1|||
126017897|NCT02564744|453360547|FG003|Overall Study|Subject Withdrew Consent|0|||
126017898|NCT02564744|453360548|FG004|Overall Study|Subject Withdrew Consent|2|||
126017899|NCT02564744|453360544|FG000|Overall Study|Lost to Follow-up|0|||
126017900|NCT02564744|453360545|FG001|Overall Study|Lost to Follow-up|1|||
126017901|NCT02564744|453360546|FG002|Overall Study|Lost to Follow-up|0|||
126017902|NCT02564744|453360547|FG003|Overall Study|Lost to Follow-up|0|||
126017903|NCT02564744|453360548|FG004|Overall Study|Lost to Follow-up|1|||
126017904|NCT02564744|453360544|FG000|Overall Study|Reason not specified|1|||
126017905|NCT02564744|453360545|FG001|Overall Study|Reason not specified|0|||
126017906|NCT02564744|453360546|FG002|Overall Study|Reason not specified|0|||
126017907|NCT02564744|453360547|FG003|Overall Study|Reason not specified|0|||
126017908|NCT02564744|453360548|FG004|Overall Study|Reason not specified|0|||
126017909|NCT00508924|453360552|FG000|Overall Study|Protocol Violation|0|||
126017910|NCT00508924|453360553|FG001|Overall Study|Protocol Violation|0|||
126017911|NCT00508924|453360554|FG002|Overall Study|Protocol Violation|1|||
126092439|NCT00384397|453630581|FG000|Overall Study|Lost to Follow-up|11|||
126017912|NCT00508924|453360555|FG003|Overall Study|Protocol Violation|1|||
126017913|NCT02755805|453360556|FG000|Overall Study|Lost to Follow-up|1|||
126017914|NCT02755805|453360557|FG001|Overall Study|Lost to Follow-up|2|||
126017915|NCT02755805|453360556|FG000|Overall Study|Refused assessments|1|||
126017916|NCT02755805|453360557|FG001|Overall Study|Refused assessments|0|||
126017917|NCT02755805|453360556|FG000|Overall Study|Withdrawal by Subject|0|||
126017918|NCT02755805|453360557|FG001|Overall Study|Withdrawal by Subject|2|||
126017919|NCT02252042|453360560|FG000|Overall Study|Adverse Event|9|||
126017920|NCT02252042|453360561|FG001|Overall Study|Adverse Event|6|||
126017921|NCT02252042|453360560|FG000|Overall Study|Death|209|||
126017922|NCT02252042|453360561|FG001|Overall Study|Death|217|||
126017923|NCT02252042|453360560|FG000|Overall Study|Physician Decision|0|||
126017924|NCT02252042|453360561|FG001|Overall Study|Physician Decision|2|||
126017925|NCT02252042|453360560|FG000|Overall Study|Transferred to Extension Study|7|||
126017926|NCT02252042|453360561|FG001|Overall Study|Transferred to Extension Study|1|||
126017927|NCT02252042|453360560|FG000|Overall Study|Did Not Continue on Extension Study|7|||
126092440|NCT00384397|453630582|FG001|Overall Study|Lost to Follow-up|13|||
126092441|NCT00384397|453630583|FG002|Overall Study|Lost to Follow-up|3|||
126092442|NCT00384397|453630581|FG000|Overall Study|Withdrawal by Subject|14|||
126092443|NCT00384397|453630582|FG001|Overall Study|Withdrawal by Subject|17|||
126092444|NCT00384397|453630583|FG002|Overall Study|Withdrawal by Subject|15|||
126092445|NCT04372121|453630588|FG000|Overall Study|Lost to Follow-up|0|||
126092446|NCT04372121|453630589|FG001|Overall Study|Lost to Follow-up|0|||
126092447|NCT04372121|453630590|FG002|Overall Study|Lost to Follow-up|0|||
126092448|NCT04372121|453630591|FG003|Overall Study|Lost to Follow-up|1|||
126092449|NCT04372121|453630588|FG000|Overall Study|Protocol Violation|0|||
126092450|NCT04372121|453630589|FG001|Overall Study|Protocol Violation|0|||
126092451|NCT04372121|453630590|FG002|Overall Study|Protocol Violation|1|||
126092452|NCT04372121|453630591|FG003|Overall Study|Protocol Violation|0|||
126092453|NCT04372121|453630588|FG000|Overall Study|Withdrawal by Subject|3|||
126092454|NCT04372121|453630589|FG001|Overall Study|Withdrawal by Subject|1|||
126092455|NCT04372121|453630590|FG002|Overall Study|Withdrawal by Subject|0|||
126092456|NCT04372121|453630591|FG003|Overall Study|Withdrawal by Subject|0|||
126092457|NCT04372121|453630588|FG000|Overall Study|Study termination|6|||
126092458|NCT04372121|453630589|FG001|Overall Study|Study termination|5|||
126092459|NCT04372121|453630590|FG002|Overall Study|Study termination|1|||
126092460|NCT04372121|453630591|FG003|Overall Study|Study termination|1|||
126092461|NCT04372121|453630588|FG000|Overall Study|Hysterectomy planned|1|||
126092462|NCT04372121|453630589|FG001|Overall Study|Hysterectomy planned|0|||
126092463|NCT04372121|453630590|FG002|Overall Study|Hysterectomy planned|0|||
126092464|NCT04372121|453630591|FG003|Overall Study|Hysterectomy planned|0|||
126092465|NCT03345576|453630592|FG000|Overall Study|Withdrawal by Subject|2|||
126092466|NCT03345576|453630593|FG001|Overall Study|Withdrawal by Subject|2|||
126092467|NCT03345576|453630592|FG000|Overall Study|Adverse Event|1|||
126017928|NCT02252042|453360561|FG001|Overall Study|Did Not Continue on Extension Study|2|||
126017929|NCT02252042|453360560|FG000|Overall Study|Withdrawal by Subject|15|||
126092468|NCT03345576|453630593|FG001|Overall Study|Adverse Event|0|||
126092469|NCT04500769|453632761|FG000|Overall Study|Withdrawal by Subject|5|||
126349922|NCT03575364|454574065|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
126017930|NCT02252042|453360561|FG001|Overall Study|Withdrawal by Subject|20|||
126092470|NCT01967147|453632762|FG000|Overall Study|Adverse Event|5|||
126220440|NCT01133392|454097570|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
126220441|NCT01133392|454097571|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
126220442|NCT01133392|454097570|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
126220443|NCT01133392|454097571|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
126220444|NCT00378482|454097572|FG000|Overall Study|Lost to Follow-up|1|||
126220445|NCT00378482|454097572|FG000|Overall Study|Lack of Efficacy|8|||
126220446|NCT00378482|454097572|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
126220447|NCT00378482|454097572|FG000|Overall Study|Withdrawal by Subject|4|||
126220448|NCT00378482|454097572|FG000|Overall Study|Adverse Event|9|||
126220449|NCT05788237|454097573|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
126220450|NCT05788237|454097574|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
126220451|NCT05788237|454097575|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
126220452|NCT05788237|454097576|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
126220453|NCT05788237|454097573|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
126220454|NCT05788237|454097574|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
126220455|NCT05788237|454097575|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
126220456|NCT05788237|454097576|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
126220457|NCT05788237|454097573|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
126220458|NCT05788237|454097574|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
126220459|NCT05788237|454097575|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
126220460|NCT05788237|454097576|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
126220461|NCT05788237|454097573|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
126220462|NCT05788237|454097574|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
126220463|NCT05788237|454097575|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
126220464|NCT05788237|454097576|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
126220465|NCT05788237|454097573|FG000|SSA (Approximately 2 Months)|Death|0|||
126220466|NCT05788237|454097574|FG001|SSA (Approximately 2 Months)|Death|1|||
126220467|NCT05788237|454097575|FG002|SSA (Approximately 2 Months)|Death|0|||
126220468|NCT05788237|454097576|FG003|SSA (Approximately 2 Months)|Death|0|||
126220469|NCT05788237|454097573|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
126220470|NCT05788237|454097574|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
126220471|NCT05788237|454097575|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
126220472|NCT05788237|454097576|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
126220473|NCT05788237|454097573|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
126220474|NCT05788237|454097574|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
126220475|NCT05788237|454097575|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
126220476|NCT05788237|454097576|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
126220477|NCT05788237|454097573|FG000|SSB (Approximately 1 Month)|Other|0|||
126220478|NCT05788237|454097574|FG001|SSB (Approximately 1 Month)|Other|0|||
126220479|NCT05788237|454097575|FG002|SSB (Approximately 1 Month)|Other|0|||
126220480|NCT05788237|454097576|FG003|SSB (Approximately 1 Month)|Other|1|||
126220481|NCT01355523|454098772|FG000|Overall Study|Withdrawal by Subject|1|||
126220482|NCT01355523|454098773|FG001|Overall Study|Withdrawal by Subject|4|||
126220483|NCT01355523|454098772|FG000|Overall Study|Lost to Follow-up|0|||
126220484|NCT01355523|454098773|FG001|Overall Study|Lost to Follow-up|2|||
126220485|NCT01355523|454098772|FG000|Overall Study|Protocol Violation|0|||
126220486|NCT01355523|454098773|FG001|Overall Study|Protocol Violation|2|||
126220487|NCT01355523|454098772|FG000|Overall Study|Adverse Event|0|||
126220488|NCT01355523|454098773|FG001|Overall Study|Adverse Event|2|||
126220489|NCT01011907|454098774|FG000|Overall Study|Withdrawal by Subject|13|||
126220490|NCT01011907|454098775|FG001|Overall Study|Withdrawal by Subject|11|||
126220491|NCT01011907|454098774|FG000|Overall Study|Adverse Event|1|||
126220492|NCT01011907|454098775|FG001|Overall Study|Adverse Event|4|||
126220493|NCT01272193|454098776|FG000|Overall Study|Adverse Event|1|||
126220494|NCT01272193|454098777|FG001|Overall Study|Adverse Event|1|||
126220495|NCT01272193|454098776|FG000|Overall Study|Lack of Efficacy|0|||
126220496|NCT01272193|454098777|FG001|Overall Study|Lack of Efficacy|3|||
126220497|NCT01272193|454098776|FG000|Overall Study|Withdrawal Criteria|1|||
126220498|NCT01272193|454098777|FG001|Overall Study|Withdrawal Criteria|1|||
126220499|NCT01272193|454098776|FG000|Overall Study|Unclassified|8|||
126220500|NCT01272193|454098777|FG001|Overall Study|Unclassified|7|||
126220501|NCT01440647|454098780|FG000|Overall Study|Death|2|||
126220502|NCT01440647|454098781|FG001|Overall Study|Death|3|||
126220503|NCT01406873|454098790|FG000|Overall Study|Withdrawal by Subject|1|||
126220504|NCT01406873|454098791|FG001|Overall Study|Withdrawal by Subject|1|||
126220505|NCT00207714|454098792|FG000|Overall Study|Adverse Event|6|||
126220506|NCT00207714|454098793|FG001|Overall Study|Adverse Event|2|||
126220507|NCT00207714|454098794|FG002|Overall Study|Adverse Event|4|||
126349923|NCT04092777|454574069|FG000|Overall Study|Lost to Follow-up|28|||
126349924|NCT04092777|454574070|FG001|Overall Study|Lost to Follow-up|46|||
126349925|NCT04092777|454574069|FG000|Overall Study|Withdrawal by Subject|8|||
126220508|NCT00207714|454098795|FG003|Overall Study|Adverse Event|3|||
126220509|NCT00207714|454098796|FG004|Overall Study|Adverse Event|1|||
126220510|NCT00207714|454098792|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126220511|NCT00207714|454098793|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126220512|NCT00207714|454098794|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
126220513|NCT00207714|454098795|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
126220514|NCT00207714|454098796|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
126220515|NCT00207714|454098792|FG000|Overall Study|Other|3|||
126220516|NCT00207714|454098793|FG001|Overall Study|Other|2|||
126220517|NCT00207714|454098794|FG002|Overall Study|Other|5|||
126220518|NCT00207714|454098795|FG003|Overall Study|Other|1|||
126220519|NCT00207714|454098796|FG004|Overall Study|Other|0|||
126220520|NCT03627195|454098797|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
126220521|NCT03627195|454098798|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126220522|NCT03627195|454098799|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126220523|NCT03627195|454098800|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126220524|NCT03627195|454098801|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126220525|NCT03627195|454098802|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126220526|NCT00736099|454098805|FG000|Overall Study|Adverse Event|61|||
126220527|NCT00736099|454098806|FG001|Overall Study|Adverse Event|18|||
126220528|NCT00736099|454098805|FG000|Overall Study|Protocol Violation|10|||
126220529|NCT00736099|454098806|FG001|Overall Study|Protocol Violation|4|||
126220530|NCT00736099|454098805|FG000|Overall Study|Lost to Follow-up|12|||
126220531|NCT00736099|454098806|FG001|Overall Study|Lost to Follow-up|5|||
126220532|NCT00736099|454098805|FG000|Overall Study|Withdrawal by Subject|42|||
126220533|NCT00736099|454098806|FG001|Overall Study|Withdrawal by Subject|13|||
126220534|NCT00736099|454098805|FG000|Overall Study|Lack of Efficacy|15|||
126220535|NCT00736099|454098806|FG001|Overall Study|Lack of Efficacy|8|||
126220536|NCT00736099|454098805|FG000|Overall Study|Other reason|43|||
126220537|NCT00736099|454098806|FG001|Overall Study|Other reason|10|||
126220538|NCT02290028|454098810|FG000|Overall Study|Death|217|||
126220539|NCT02290028|454098810|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
126220540|NCT02290028|454098810|FG000|Overall Study|No longer under care of study physician|76|||
126220541|NCT02290028|454098810|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
126220542|NCT02290028|454098810|FG000|Overall Study|Withdrawal by Subject|52|||
126220543|NCT02290028|454098810|FG000|Overall Study|Study site closure|44|||
126220544|NCT02290028|454098810|FG000|Overall Study|Lost to Follow-up|34|||
126220545|NCT02290028|454098810|FG000|Overall Study|Miscellaneous|10|||
126220546|NCT02290028|454098810|FG000|Overall Study|Transition to EP PASSION|1295|||
126220547|NCT02290028|454098810|FG000|Overall Study|Planned study completion at 12 months|257|||
126220548|NCT03202511|454098811|FG000|Overall Study|Withdrawal by Subject|1|||
126220549|NCT03202511|454098812|FG001|Overall Study|Withdrawal by Subject|0|||
126220550|NCT00833547|454098813|FG000|Overall Study|Withdrawal by Subject|2|||
126220551|NCT00833547|454098814|FG001|Overall Study|Withdrawal by Subject|2|||
126220552|NCT00686790|454098819|FG000|Overall Study|Adverse Event|2|||
126220553|NCT00686790|454098819|FG000|Overall Study|Withdrawal by Subject|1|||
126220554|NCT00686790|454098819|FG000|Overall Study|Death|1|||
126220555|NCT00686790|454098819|FG000|Overall Study|Lost to Follow-up|12|||
126220556|NCT00096382|454098820|FG000|Overall Study|Not treated|1|||
126220557|NCT00096382|454098821|FG001|Overall Study|Not treated|0|||
126220558|NCT00096382|454098820|FG000|Overall Study|Death during treatment|1|||
126220559|NCT00096382|454098821|FG001|Overall Study|Death during treatment|0|||
126220560|NCT02082912|454098825|FG000|Overall Study|Physician Decision|0|||
126220561|NCT02082912|454098826|FG001|Overall Study|Physician Decision|1|||
126220562|NCT00697112|454098843|FG000|Overall Study|Adverse Event|8|||
126220563|NCT00697112|454098843|FG000|Overall Study|Lost to Follow-up|1|||
126220564|NCT00697112|454098843|FG000|Overall Study|Did not meet inclusion criteria|1|||
126220565|NCT00736333|454098844|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
126220566|NCT00736333|454098844|FG000|Overall Study|Data Missing|2|||
126220567|NCT00736333|454098844|FG000|Overall Study|Tumor Progression|75|||
126220568|NCT00736333|454098844|FG000|Overall Study|Toxicity|6|||
126220569|NCT00736333|454098844|FG000|Overall Study|Withdrawal by Subject|10|||
126220570|NCT00736333|454098844|FG000|Overall Study|Death|7|||
126220571|NCT00736333|454098844|FG000|Overall Study|Other|4|||
126220572|NCT04126733|454098845|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
126220573|NCT04126733|454098845|FG000|Treatment Period|Adverse Event|8|||
126220574|NCT04126733|454098845|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
126220575|NCT04126733|454098845|FG000|Treatment Period|Physician Decision|5|||
126220576|NCT04126733|454098845|FG000|Treatment Period|Death|1|||
126220577|NCT04126733|454098845|FG000|Treatment Period|Other Reasons|2|||
126220578|NCT04126733|454098845|FG000|Active Follow-up Period|Death|13|||
126220579|NCT04126733|454098845|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
126220580|NCT04126733|454098845|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
126220581|NCT04126733|454098845|FG000|Active Follow-up Period|Other Reasons|1|||
126220582|NCT04126733|454098845|FG000|Long-term Follow-up Period|Death|22|||
126220583|NCT04126733|454098845|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
126220584|NCT04126733|454098845|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
126220585|NCT02629133|454098847|FG000|Overall Study|Lost to Follow-up|3|||
126220586|NCT02629133|454098848|FG001|Overall Study|Lost to Follow-up|1|||
126220587|NCT02629133|454098847|FG000|Overall Study|Withdrawal by Subject|1|||
126220588|NCT02629133|454098848|FG001|Overall Study|Withdrawal by Subject|1|||
126220589|NCT03216954|454098849|FG000|Overall Study|Adverse Event|0|||
126220590|NCT03216954|454098850|FG001|Overall Study|Adverse Event|0|||
126220591|NCT03216954|454098851|FG002|Overall Study|Adverse Event|1|||
126220592|NCT03216954|454098852|FG003|Overall Study|Adverse Event|0|||
126220593|NCT03216954|454098853|FG004|Overall Study|Adverse Event|1|||
126220594|NCT03216954|454098849|FG000|Overall Study|Withdrawal by Subject|2|||
126220595|NCT03216954|454098850|FG001|Overall Study|Withdrawal by Subject|0|||
126220596|NCT03216954|454098851|FG002|Overall Study|Withdrawal by Subject|0|||
126220597|NCT03216954|454098852|FG003|Overall Study|Withdrawal by Subject|0|||
126220598|NCT03216954|454098853|FG004|Overall Study|Withdrawal by Subject|0|||
126220599|NCT03216954|454098849|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
126220600|NCT03216954|454098850|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
126220601|NCT03216954|454098851|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
126220602|NCT03216954|454098852|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
126220603|NCT03216954|454098853|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
126220604|NCT02598193|454098854|FG000|Overall Study|Adverse Event|13|||
126220605|NCT02598193|454098854|FG000|Overall Study|Withdrawal by Subject|1|||
126220606|NCT02598193|454098854|FG000|Overall Study|Listed in active lung transplant list|1|||
126220607|NCT02598193|454098854|FG000|Overall Study|Does not want to take Nintedanib|1|||
126220608|NCT02354976|454098860|FG000|Overall Study|Other - reason not specified|1|||
126220609|NCT02354976|454098861|FG001|Overall Study|Other - reason not specified|0|||
126220610|NCT02354976|454098862|FG002|Overall Study|Other - reason not specified|1|||
126220611|NCT02354976|454098860|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
126220612|NCT02354976|454098861|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
126220613|NCT02354976|454098862|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
126220614|NCT02354976|454098860|FG000|Overall Study|Adverse Event|1|||
126220615|NCT02354976|454098861|FG001|Overall Study|Adverse Event|0|||
126220616|NCT02354976|454098862|FG002|Overall Study|Adverse Event|2|||
126220617|NCT00986154|454098863|FG000|Overall Study|Death|136|||
126220618|NCT00986154|454098864|FG001|Overall Study|Death|127|||
126220619|NCT00986154|454098863|FG000|Overall Study|Lost to Follow-up|7|||
126220620|NCT00986154|454098864|FG001|Overall Study|Lost to Follow-up|4|||
126220621|NCT00986154|454098863|FG000|Overall Study|Withdrawal by Subject|32|||
126220622|NCT00986154|454098864|FG001|Overall Study|Withdrawal by Subject|33|||
126220623|NCT00986154|454098863|FG000|Overall Study|investigator/subject decide not continue|6|||
126220624|NCT00986154|454098864|FG001|Overall Study|investigator/subject decide not continue|3|||
126220625|NCT00986154|454098863|FG000|Overall Study|never received study drug|25|||
126220626|NCT00986154|454098864|FG001|Overall Study|never received study drug|27|||
126220627|NCT03726437|454098865|FG000|Overall Study|Lost to Follow-up|85|||
126220628|NCT03726437|454098866|FG001|Overall Study|Lost to Follow-up|76|||
126220629|NCT00068445|454098867|FG000|Randomization|Cancel|1|||
126349926|NCT04092777|454574070|FG001|Overall Study|Withdrawal by Subject|5|||
126349927|NCT02306161|454574071|FG000|Overall Study|Death|1|||
126017931|NCT02593149|453360562|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
126017932|NCT02593149|453360563|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
126017933|NCT02593149|453360562|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
126017934|NCT02593149|453360563|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
126017935|NCT04532528|453360568|FG000|Overall Study|Adverse Event|12|||
126017936|NCT04532528|453360569|FG001|Overall Study|Adverse Event|17|||
126017937|NCT04532528|453360568|FG000|Overall Study|Withdrawal of consent|16|||
126017938|NCT04532528|453360569|FG001|Overall Study|Withdrawal of consent|17|||
126220630|NCT00068445|454098868|FG001|Randomization|Cancel|3|||
126220631|NCT00068445|454098867|FG000|Randomization|Ineligible|1|||
126220632|NCT00068445|454098868|FG001|Randomization|Ineligible|1|||
126349928|NCT02306161|454574072|FG001|Overall Study|Death|3|||
126349929|NCT02306161|454574071|FG000|Overall Study|Lack of Efficacy|20|||
126349930|NCT02306161|454574072|FG001|Overall Study|Lack of Efficacy|43|||
126349931|NCT02306161|454574071|FG000|Overall Study|Physician Decision|30|||
126349932|NCT02306161|454574072|FG001|Overall Study|Physician Decision|18|||
126349933|NCT02306161|454574071|FG000|Overall Study|Withdrawal by Subject|4|||
126349934|NCT02306161|454574072|FG001|Overall Study|Withdrawal by Subject|0|||
126349935|NCT02306161|454574071|FG000|Overall Study|Ineligible|9|||
126349936|NCT02306161|454574072|FG001|Overall Study|Ineligible|5|||
126349937|NCT01081951|454574073|FG000|Overall Study|Death|54|||
126349938|NCT01081951|454574074|FG001|Overall Study|Death|47|||
126349939|NCT01081951|454574073|FG000|Overall Study|Withdrawal by Subject|2|||
126349940|NCT01081951|454574074|FG001|Overall Study|Withdrawal by Subject|6|||
126349941|NCT01081951|454574073|FG000|Overall Study|Allocated treatment but did not take it|0|||
126017939|NCT04532528|453360568|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
126220633|NCT00068445|454098867|FG000|Treatment|Refused Further Treatment|13|||
126220634|NCT00068445|454098868|FG001|Treatment|Refused Further Treatment|10|||
126220635|NCT00068445|454098867|FG000|Treatment|Adverse Event|7|||
126220636|NCT00068445|454098868|FG001|Treatment|Adverse Event|1|||
126220637|NCT00068445|454098867|FG000|Treatment|Other (Specifics not available)|9|||
126220638|NCT00068445|454098868|FG001|Treatment|Other (Specifics not available)|5|||
126220639|NCT01896700|454098869|FG000|Overall Study|Adverse Event|4|||
126220640|NCT01896700|454098870|FG001|Overall Study|Adverse Event|5|||
126220641|NCT01896700|454098869|FG000|Overall Study|Withdrawal by Subject|0|||
126220642|NCT01896700|454098870|FG001|Overall Study|Withdrawal by Subject|1|||
126220643|NCT03118765|454098872|FG000|Overall Study|Withdrawal by Subject|0|||
126220644|NCT03118765|454098873|FG001|Overall Study|Withdrawal by Subject|0|||
126220645|NCT03118765|454098874|FG002|Overall Study|Withdrawal by Subject|1|||
126220646|NCT03118765|454098875|FG003|Overall Study|Withdrawal by Subject|0|||
126220647|NCT03118765|454098876|FG004|Overall Study|Withdrawal by Subject|0|||
126220648|NCT03118765|454098872|FG000|Overall Study|Adverse Event|1|||
126220649|NCT03118765|454098873|FG001|Overall Study|Adverse Event|1|||
126220650|NCT03118765|454098874|FG002|Overall Study|Adverse Event|1|||
126220651|NCT03118765|454098875|FG003|Overall Study|Adverse Event|1|||
126220652|NCT03118765|454098876|FG004|Overall Study|Adverse Event|1|||
126220653|NCT03118765|454098872|FG000|Overall Study|Non compliance with Study Procedures|0|||
126220654|NCT03118765|454098873|FG001|Overall Study|Non compliance with Study Procedures|0|||
126220655|NCT03118765|454098874|FG002|Overall Study|Non compliance with Study Procedures|0|||
126220656|NCT03118765|454098875|FG003|Overall Study|Non compliance with Study Procedures|1|||
126220657|NCT03118765|454098876|FG004|Overall Study|Non compliance with Study Procedures|0|||
126220658|NCT03118765|454098872|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
126220659|NCT03118765|454098873|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
126220660|NCT03118765|454098874|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
126220661|NCT03118765|454098875|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
126220662|NCT03118765|454098876|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
126220663|NCT03118765|454098872|FG000|Overall Study|COPD Exacerbation|1|||
126220664|NCT03118765|454098873|FG001|Overall Study|COPD Exacerbation|0|||
126220665|NCT03118765|454098874|FG002|Overall Study|COPD Exacerbation|0|||
126220666|NCT03118765|454098875|FG003|Overall Study|COPD Exacerbation|1|||
126220667|NCT03118765|454098876|FG004|Overall Study|COPD Exacerbation|0|||
126220668|NCT03118765|454098872|FG000|Overall Study|Lost to Follow-up|1|||
126220669|NCT03118765|454098873|FG001|Overall Study|Lost to Follow-up|0|||
126220670|NCT03118765|454098874|FG002|Overall Study|Lost to Follow-up|1|||
126220671|NCT03118765|454098875|FG003|Overall Study|Lost to Follow-up|0|||
126220672|NCT03118765|454098876|FG004|Overall Study|Lost to Follow-up|0|||
126220673|NCT03118765|454098872|FG000|Overall Study|Sponsor Decision|1|||
126220674|NCT03118765|454098873|FG001|Overall Study|Sponsor Decision|0|||
126220675|NCT03118765|454098874|FG002|Overall Study|Sponsor Decision|1|||
126220676|NCT03118765|454098875|FG003|Overall Study|Sponsor Decision|0|||
126220677|NCT03118765|454098876|FG004|Overall Study|Sponsor Decision|1|||
126220678|NCT00849524|454098877|FG000|Overall Study|Lack of Efficacy|3|||
126220679|NCT01507831|454098883|FG000|Overall Study|Randomized but not treated|0|||
126092471|NCT01967147|453632763|FG001|Overall Study|Adverse Event|2|||
126092472|NCT01967147|453632762|FG000|Overall Study|Lack of Efficacy|1|||
126092473|NCT01967147|453632763|FG001|Overall Study|Lack of Efficacy|4|||
126092474|NCT01967147|453632762|FG000|Overall Study|Lost to Follow-up|1|||
126092475|NCT01967147|453632763|FG001|Overall Study|Lost to Follow-up|2|||
126092476|NCT01967147|453632762|FG000|Overall Study|Withdrawal by Subject|2|||
126092477|NCT01967147|453632763|FG001|Overall Study|Withdrawal by Subject|4|||
126092478|NCT01967147|453632762|FG000|Overall Study|Non-compliance with Study Drug|0|||
126092479|NCT01967147|453632763|FG001|Overall Study|Non-compliance with Study Drug|3|||
126092480|NCT01967147|453632762|FG000|Overall Study|Other|4|||
126220680|NCT01507831|454098884|FG001|Overall Study|Randomized but not treated|3|||
126220681|NCT01507831|454098883|FG000|Overall Study|Adverse Event|48|||
126220682|NCT01507831|454098884|FG001|Overall Study|Adverse Event|113|||
126220683|NCT01507831|454098883|FG000|Overall Study|Death|6|||
126220684|NCT01507831|454098884|FG001|Overall Study|Death|2|||
126220685|NCT01507831|454098883|FG000|Overall Study|Poor compliance to protocol|38|||
126220686|NCT01507831|454098884|FG001|Overall Study|Poor compliance to protocol|60|||
126220687|NCT01507831|454098883|FG000|Overall Study|Physician Decision|0|||
126092481|NCT01967147|453632763|FG001|Overall Study|Other|5|||
126092482|NCT02314780|453632764|FG000|Overall Study|organizational reasons|0|||
126092483|NCT02314780|453632765|FG001|Overall Study|organizational reasons|2|||
126220688|NCT01507831|454098884|FG001|Overall Study|Physician Decision|4|||
126220689|NCT01507831|454098883|FG000|Overall Study|Participant moved|5|||
126220690|NCT01507831|454098884|FG001|Overall Study|Participant moved|19|||
126220691|NCT01507831|454098883|FG000|Overall Study|Consent withdrawn by participant|34|||
126220692|NCT01507831|454098884|FG001|Overall Study|Consent withdrawn by participant|72|||
126220693|NCT01507831|454098883|FG000|Overall Study|Related to study drug administration|5|||
126220694|NCT01507831|454098884|FG001|Overall Study|Related to study drug administration|14|||
126220695|NCT01507831|454098883|FG000|Overall Study|Last visit outside protocol visit window|51|||
126220696|NCT01507831|454098884|FG001|Overall Study|Last visit outside protocol visit window|143|||
126220697|NCT01507831|454098883|FG000|Overall Study|Selection criteria finally not met|0|||
126220698|NCT01507831|454098884|FG001|Overall Study|Selection criteria finally not met|1|||
126220699|NCT01507831|454098883|FG000|Overall Study|Site closure|0|||
126220700|NCT01507831|454098884|FG001|Overall Study|Site closure|3|||
126220701|NCT01507831|454098883|FG000|Overall Study|Potential lost to follow-up|3|||
126220702|NCT01507831|454098884|FG001|Overall Study|Potential lost to follow-up|0|||
126220703|NCT01507831|454098883|FG000|Overall Study|Other|3|||
126220704|NCT01507831|454098884|FG001|Overall Study|Other|6|||
126220705|NCT00879970|454098885|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
126220706|NCT00879970|454098886|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
126220707|NCT00879970|454098887|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
126220708|NCT00879970|454098888|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
126220709|NCT00879970|454098889|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
126220710|NCT00879970|454098885|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
126220711|NCT00879970|454098886|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
126220712|NCT00879970|454098887|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
126220713|NCT00879970|454098888|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
126220714|NCT00879970|454098889|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
126220715|NCT00879970|454098885|FG000|Period 1 TZD Randomization|Death|2|||
126220716|NCT00879970|454098886|FG001|Period 1 TZD Randomization|Death|1|||
126220717|NCT00879970|454098887|FG002|Period 1 TZD Randomization|Death|0|||
126220718|NCT00879970|454098888|FG003|Period 1 TZD Randomization|Death|0|||
126220719|NCT00879970|454098889|FG004|Period 1 TZD Randomization|Death|0|||
126220720|NCT00879970|454098885|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
126220721|NCT00879970|454098886|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
126220722|NCT00879970|454098887|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
126220723|NCT00879970|454098888|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
126220724|NCT00879970|454098889|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
126220725|NCT00879970|454098885|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
126220726|NCT00879970|454098886|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
126220727|NCT00879970|454098887|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
126220728|NCT00879970|454098888|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
126220729|NCT00879970|454098889|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
126220730|NCT00879970|454098885|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
126220731|NCT00879970|454098886|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
126220732|NCT00879970|454098887|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
126220733|NCT00879970|454098888|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
126220734|NCT00879970|454098889|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
126220735|NCT00879970|454098885|FG000|Period 2 Vitamin D Randomization|Death|0|||
126220736|NCT00879970|454098886|FG001|Period 2 Vitamin D Randomization|Death|0|||
126220737|NCT00879970|454098887|FG002|Period 2 Vitamin D Randomization|Death|0|||
126220738|NCT00879970|454098888|FG003|Period 2 Vitamin D Randomization|Death|2|||
126220739|NCT00879970|454098889|FG004|Period 2 Vitamin D Randomization|Death|0|||
126220740|NCT01610167|454098891|FG000|Overall Study|Scheduling conflict.|0|||
126220741|NCT01610167|454098892|FG001|Overall Study|Scheduling conflict.|0|||
126220742|NCT01610167|454098893|FG002|Overall Study|Scheduling conflict.|2|||
126220743|NCT03296553|454098894|FG000|Overall Study|Withdrawal by Subject|1|||
126220744|NCT03296553|454098895|FG001|Overall Study|Withdrawal by Subject|1|||
126220745|NCT03296553|454098894|FG000|Overall Study|Death|1|||
126220746|NCT03296553|454098895|FG001|Overall Study|Death|0|||
126220747|NCT01021137|454098897|FG000|Overall Study|Lost to Follow-up|9|||
126220748|NCT01021137|454098898|FG001|Overall Study|Lost to Follow-up|4|||
126220749|NCT01021137|454098899|FG002|Overall Study|Lost to Follow-up|2|||
126220750|NCT01021137|454098900|FG003|Overall Study|Lost to Follow-up|6|||
126220751|NCT01021137|454098897|FG000|Overall Study|Withdrawal by Subject|1|||
126220752|NCT01021137|454098898|FG001|Overall Study|Withdrawal by Subject|0|||
126220753|NCT01021137|454098899|FG002|Overall Study|Withdrawal by Subject|0|||
126220754|NCT01021137|454098900|FG003|Overall Study|Withdrawal by Subject|3|||
126220755|NCT03439293|454098901|FG000|Overall Study|Death|22|||
126220756|NCT03439293|454098901|FG000|Overall Study|Withdrawal by Subject|8|||
126017940|NCT04532528|453360569|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
126220757|NCT03439293|454098901|FG000|Overall Study|Lost to Follow-up|2|||
126220758|NCT03439293|454098901|FG000|Overall Study|Reason Not Specified|28|||
126220759|NCT03439293|454098901|FG000|Overall Study|Missing|1|||
126220760|NCT00435825|454098907|FG000|Overall Study|Abnormality of Laboratory Test|0|||
126220761|NCT00435825|454098908|FG001|Overall Study|Abnormality of Laboratory Test|1|||
126220762|NCT00435825|454098909|FG002|Overall Study|Abnormality of Laboratory Test|0|||
126220763|NCT00435825|454098910|FG003|Overall Study|Abnormality of Laboratory Test|0|||
126220764|NCT00435825|454098907|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126220765|NCT00435825|454098908|FG001|Overall Study|Insufficient Therapeutic Response|1|||
126220766|NCT00435825|454098909|FG002|Overall Study|Insufficient Therapeutic Response|0|||
126220767|NCT00435825|454098910|FG003|Overall Study|Insufficient Therapeutic Response|3|||
126220768|NCT00435825|454098907|FG000|Overall Study|Other Protocol Violation|1|||
126220769|NCT00435825|454098908|FG001|Overall Study|Other Protocol Violation|0|||
126220770|NCT00435825|454098909|FG002|Overall Study|Other Protocol Violation|0|||
126220771|NCT00435825|454098910|FG003|Overall Study|Other Protocol Violation|0|||
126220772|NCT00435825|454098907|FG000|Overall Study|Refused treatment|2|||
126220773|NCT00435825|454098908|FG001|Overall Study|Refused treatment|0|||
126220774|NCT00435825|454098909|FG002|Overall Study|Refused treatment|0|||
126220775|NCT00435825|454098910|FG003|Overall Study|Refused treatment|5|||
126220776|NCT00435825|454098907|FG000|Overall Study|Failure to return|5|||
126220777|NCT00435825|454098908|FG001|Overall Study|Failure to return|0|||
126220778|NCT00435825|454098909|FG002|Overall Study|Failure to return|4|||
126220779|NCT00435825|454098910|FG003|Overall Study|Failure to return|0|||
126220780|NCT00435825|454098907|FG000|Overall Study|Did not receive study drug|1|||
126220781|NCT00435825|454098908|FG001|Overall Study|Did not receive study drug|0|||
126220782|NCT00435825|454098909|FG002|Overall Study|Did not receive study drug|2|||
126220783|NCT00435825|454098910|FG003|Overall Study|Did not receive study drug|0|||
126220784|NCT00435825|454098907|FG000|Overall Study|Did not enter follow-up|0|||
126220785|NCT00435825|454098908|FG001|Overall Study|Did not enter follow-up|4|||
126220786|NCT00435825|454098909|FG002|Overall Study|Did not enter follow-up|1|||
126220787|NCT00435825|454098910|FG003|Overall Study|Did not enter follow-up|3|||
126220788|NCT00435825|454098907|FG000|Overall Study|Did not complete full follow-up period|6|||
126220789|NCT00435825|454098908|FG001|Overall Study|Did not complete full follow-up period|6|||
126220790|NCT00435825|454098909|FG002|Overall Study|Did not complete full follow-up period|4|||
126220791|NCT00435825|454098910|FG003|Overall Study|Did not complete full follow-up period|5|||
126220792|NCT00860574|454100478|FG000|Overall Study|Death|2|||
126220793|NCT00860574|454100478|FG000|Overall Study|Relapse|1|||
126220794|NCT01246986|454100479|FG000|Overall Study|Lost to Follow-up|0|||
126220795|NCT01246986|454100480|FG001|Overall Study|Lost to Follow-up|1|||
126220796|NCT01246986|454100481|FG002|Overall Study|Lost to Follow-up|3|||
126220797|NCT01246986|454100482|FG003|Overall Study|Lost to Follow-up|0|||
126220798|NCT01246986|454100483|FG004|Overall Study|Lost to Follow-up|0|||
126220799|NCT01246986|454100484|FG005|Overall Study|Lost to Follow-up|1|||
126220800|NCT01246986|454100485|FG006|Overall Study|Lost to Follow-up|0|||
126220801|NCT01246986|454100479|FG000|Overall Study|Withdrawal by Subject|3|||
126220802|NCT01246986|454100480|FG001|Overall Study|Withdrawal by Subject|4|||
126220803|NCT01246986|454100481|FG002|Overall Study|Withdrawal by Subject|3|||
126220804|NCT01246986|454100482|FG003|Overall Study|Withdrawal by Subject|0|||
126220805|NCT01246986|454100483|FG004|Overall Study|Withdrawal by Subject|4|||
126220806|NCT01246986|454100484|FG005|Overall Study|Withdrawal by Subject|0|||
126220807|NCT01246986|454100485|FG006|Overall Study|Withdrawal by Subject|0|||
126220808|NCT01416142|454100489|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
126220809|NCT01416142|454100490|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
126220810|NCT01416142|454100491|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
126220811|NCT01335399|454100492|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
126220812|NCT01335399|454100493|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
126220813|NCT01335399|454100492|FG000|Pre-treatment Period|Participant request to discontinue|0|||
126220814|NCT01335399|454100493|FG001|Pre-treatment Period|Participant request to discontinue|1|||
126220815|NCT01335399|454100492|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
126220816|NCT01335399|454100493|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
126220817|NCT01335399|454100492|FG000|Pre-treatment Period|Consent withdrawal|3|||
126220818|NCT01335399|454100493|FG001|Pre-treatment Period|Consent withdrawal|0|||
126220819|NCT01335399|454100492|FG000|Treatment Period|Disease progression|117|||
126220820|NCT01335399|454100493|FG001|Treatment Period|Disease progression|145|||
126220821|NCT01335399|454100492|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
126220822|NCT01335399|454100493|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
126220823|NCT01335399|454100492|FG000|Treatment Period|Study drug toxicity|52|||
126220824|NCT01335399|454100493|FG001|Treatment Period|Study drug toxicity|64|||
126220825|NCT01335399|454100492|FG000|Treatment Period|Participant request to discontinue|30|||
126220826|NCT01335399|454100493|FG001|Treatment Period|Participant request to discontinue|22|||
126220827|NCT01335399|454100492|FG000|Treatment Period|Other reasons|30|||
126220828|NCT01335399|454100493|FG001|Treatment Period|Other reasons|30|||
126220829|NCT01335399|454100492|FG000|Treatment Period|Consent withdrawal|10|||
126220830|NCT01335399|454100493|FG001|Treatment Period|Consent withdrawal|7|||
126220831|NCT01335399|454100492|FG000|Treatment Period|Death|7|||
126220832|NCT01335399|454100493|FG001|Treatment Period|Death|6|||
126220833|NCT01335399|454100492|FG000|Treatment Period|Poor/Non-compliance|3|||
126220834|NCT01335399|454100493|FG001|Treatment Period|Poor/Non-compliance|4|||
126220835|NCT01335399|454100492|FG000|Treatment Period|Lost to Follow-up|2|||
126220836|NCT01335399|454100493|FG001|Treatment Period|Lost to Follow-up|2|||
126220837|NCT01335399|454100492|FG000|Treatment Period|Maximum clinical benefit|1|||
126220838|NCT01335399|454100493|FG001|Treatment Period|Maximum clinical benefit|1|||
126220839|NCT01335399|454100492|FG000|Treatment Period|No longer meet study criteria|1|||
126220840|NCT01335399|454100493|FG001|Treatment Period|No longer meet study criteria|1|||
126220841|NCT01335399|454100492|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
126220842|NCT01335399|454100493|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
126220843|NCT02464059|454100494|FG000|Overall Study|Lost to Follow-up|6|||
126220844|NCT00304954|454100497|FG000|Overall Study|Withdrawal by Subject|0|||
126220845|NCT00304954|454100498|FG001|Overall Study|Withdrawal by Subject|0|||
126220846|NCT00304954|454100499|FG002|Overall Study|Withdrawal by Subject|1|||
126220847|NCT00304954|454100500|FG003|Overall Study|Withdrawal by Subject|0|||
126220848|NCT00304954|454100497|FG000|Overall Study|Adverse Event|1|||
126220849|NCT00304954|454100498|FG001|Overall Study|Adverse Event|0|||
126220850|NCT00304954|454100499|FG002|Overall Study|Adverse Event|0|||
126220851|NCT00304954|454100500|FG003|Overall Study|Adverse Event|0|||
126220852|NCT03990389|454100503|FG000|Overall Study|Lost to Follow-up|3|||
126017941|NCT04532528|453360568|FG000|Overall Study|Lost to Follow-up|69|||
126017942|NCT04532528|453360569|FG001|Overall Study|Lost to Follow-up|68|||
126017943|NCT04532528|453360568|FG000|Overall Study|Administrative problems|12|||
126017944|NCT04532528|453360569|FG001|Overall Study|Administrative problems|14|||
126017945|NCT04532528|453360568|FG000|Overall Study|Death|3|||
126017946|NCT04532528|453360569|FG001|Overall Study|Death|3|||
126017947|NCT04532528|453360568|FG000|Overall Study|Other|38|||
126017948|NCT04532528|453360569|FG001|Overall Study|Other|46|||
126017949|NCT01636687|453360570|FG000|Induction Period|Withdrawal by Subject|1|||
126017950|NCT01636687|453360571|FG001|Induction Period|Withdrawal by Subject|0|||
126017951|NCT01636687|453360572|FG002|Induction Period|Withdrawal by Subject|0|||
126017952|NCT01636687|453360573|FG003|Induction Period|Withdrawal by Subject|0|||
126017953|NCT01636687|453360574|FG004|Induction Period|Withdrawal by Subject|0|||
126017954|NCT01636687|453360570|FG000|Induction Period|Adverse Event|1|||
126017955|NCT01636687|453360571|FG001|Induction Period|Adverse Event|0|||
126017956|NCT01636687|453360572|FG002|Induction Period|Adverse Event|0|||
126017957|NCT01636687|453360573|FG003|Induction Period|Adverse Event|0|||
126017958|NCT01636687|453360574|FG004|Induction Period|Adverse Event|1|||
126017959|NCT01636687|453360570|FG000|Induction Period|Lack of Efficacy|0|||
126017960|NCT01636687|453360571|FG001|Induction Period|Lack of Efficacy|0|||
126017961|NCT01636687|453360572|FG002|Induction Period|Lack of Efficacy|0|||
126017962|NCT01636687|453360573|FG003|Induction Period|Lack of Efficacy|0|||
126017963|NCT01636687|453360574|FG004|Induction Period|Lack of Efficacy|1|||
126017964|NCT01636687|453360570|FG000|Induction Period|Physician Decision|1|||
126017965|NCT01636687|453360571|FG001|Induction Period|Physician Decision|0|||
126017966|NCT01636687|453360572|FG002|Induction Period|Physician Decision|0|||
126017967|NCT01636687|453360573|FG003|Induction Period|Physician Decision|0|||
126017968|NCT01636687|453360574|FG004|Induction Period|Physician Decision|0|||
126017969|NCT01636687|453360570|FG000|Maintenance Period|Withdrawal by Subject|2|||
126017970|NCT01636687|453360571|FG001|Maintenance Period|Withdrawal by Subject|0|||
126092484|NCT02314780|453632766|FG002|Overall Study|organizational reasons|0|||
126220853|NCT03990389|454100504|FG001|Overall Study|Lost to Follow-up|0|||
126017971|NCT01636687|453360572|FG002|Maintenance Period|Withdrawal by Subject|2|||
126017972|NCT01636687|453360573|FG003|Maintenance Period|Withdrawal by Subject|0|||
126017973|NCT01636687|453360574|FG004|Maintenance Period|Withdrawal by Subject|0|||
126017974|NCT01636687|453360570|FG000|Maintenance Period|Adverse Event|1|||
126017975|NCT01636687|453360571|FG001|Maintenance Period|Adverse Event|0|||
126017976|NCT01636687|453360572|FG002|Maintenance Period|Adverse Event|0|||
126017977|NCT01636687|453360573|FG003|Maintenance Period|Adverse Event|0|||
126220854|NCT01326702|454100505|FG000|Overall Study|Other|1|||
126220855|NCT01326702|454100506|FG001|Overall Study|Other|0|||
126220856|NCT01326702|454100507|FG002|Overall Study|Other|0|||
126220857|NCT01326702|454100508|FG003|Overall Study|Other|0|||
126220858|NCT01326702|454100509|FG004|Overall Study|Other|0|||
126220859|NCT01326702|454100510|FG005|Overall Study|Other|1|||
126220860|NCT01326702|454100511|FG006|Overall Study|Other|0|||
126220861|NCT01326702|454100505|FG000|Overall Study|progressive disease|1|||
126220862|NCT01326702|454100506|FG001|Overall Study|progressive disease|1|||
126220863|NCT01326702|454100507|FG002|Overall Study|progressive disease|3|||
126220864|NCT01326702|454100508|FG003|Overall Study|progressive disease|1|||
126220865|NCT01326702|454100509|FG004|Overall Study|progressive disease|3|||
126220866|NCT01326702|454100510|FG005|Overall Study|progressive disease|2|||
126220867|NCT01326702|454100511|FG006|Overall Study|progressive disease|3|||
126220868|NCT01326702|454100505|FG000|Overall Study|Death|0|||
126220869|NCT01326702|454100506|FG001|Overall Study|Death|1|||
126220870|NCT01326702|454100507|FG002|Overall Study|Death|0|||
126220871|NCT01326702|454100508|FG003|Overall Study|Death|0|||
126220872|NCT01326702|454100509|FG004|Overall Study|Death|0|||
126220873|NCT01326702|454100510|FG005|Overall Study|Death|0|||
126220874|NCT01326702|454100511|FG006|Overall Study|Death|0|||
126220875|NCT01326702|454100505|FG000|Overall Study|Adverse Event|0|||
126220876|NCT01326702|454100506|FG001|Overall Study|Adverse Event|0|||
126220877|NCT01326702|454100507|FG002|Overall Study|Adverse Event|1|||
126220878|NCT01326702|454100508|FG003|Overall Study|Adverse Event|1|||
126220879|NCT01326702|454100509|FG004|Overall Study|Adverse Event|0|||
126220880|NCT01326702|454100510|FG005|Overall Study|Adverse Event|3|||
126220881|NCT01326702|454100511|FG006|Overall Study|Adverse Event|1|||
126220882|NCT01326702|454100505|FG000|Overall Study|Withdrawal by Subject|0|||
126220883|NCT01326702|454100506|FG001|Overall Study|Withdrawal by Subject|0|||
126220884|NCT01326702|454100507|FG002|Overall Study|Withdrawal by Subject|1|||
126220885|NCT01326702|454100508|FG003|Overall Study|Withdrawal by Subject|0|||
126220886|NCT01326702|454100509|FG004|Overall Study|Withdrawal by Subject|1|||
126220887|NCT01326702|454100510|FG005|Overall Study|Withdrawal by Subject|1|||
126220888|NCT01326702|454100511|FG006|Overall Study|Withdrawal by Subject|3|||
126220889|NCT01326702|454100505|FG000|Overall Study|Not Treated|0|||
126220890|NCT01326702|454100506|FG001|Overall Study|Not Treated|0|||
126220891|NCT01326702|454100507|FG002|Overall Study|Not Treated|0|||
126220892|NCT01326702|454100508|FG003|Overall Study|Not Treated|1|||
126220893|NCT01326702|454100509|FG004|Overall Study|Not Treated|0|||
126220894|NCT01326702|454100510|FG005|Overall Study|Not Treated|1|||
126220895|NCT01326702|454100511|FG006|Overall Study|Not Treated|0|||
126220896|NCT01835132|454100513|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
126349942|NCT01081951|454574074|FG001|Overall Study|Allocated treatment but did not take it|1|||
126349943|NCT01081951|454574073|FG000|Overall Study|Lost to Follow-up|0|||
126349944|NCT01081951|454574074|FG001|Overall Study|Lost to Follow-up|1|||
126349945|NCT03806296|454574080|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
126349946|NCT03806296|454574081|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
126349947|NCT03806296|454574082|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
126349948|NCT03806296|454574080|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
126349949|NCT03806296|454574081|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
126349950|NCT03806296|454574082|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
126349951|NCT03806296|454574080|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
126349952|NCT03806296|454574081|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
126349953|NCT03806296|454574082|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
126349954|NCT04896385|454574083|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
126349955|NCT04896385|454574084|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
126349956|NCT04896385|454574085|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
126349957|NCT04896385|454574086|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
126349958|NCT04896385|454574083|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
126349959|NCT04896385|454574084|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
126349960|NCT04896385|454574085|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
126349961|NCT04896385|454574086|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
126349962|NCT04896385|454574083|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
126349963|NCT04896385|454574084|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
126349964|NCT04896385|454574085|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
126349965|NCT04896385|454574086|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
126349966|NCT04896385|454574083|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
126349967|NCT04896385|454574084|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
126349968|NCT04896385|454574085|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
126349969|NCT04896385|454574086|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
126349970|NCT04896385|454574083|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
126349971|NCT04896385|454574084|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
126349972|NCT04896385|454574085|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
126349973|NCT04896385|454574086|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
126349974|NCT04896385|454574083|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
126220897|NCT00856778|454100514|FG000|Overall Study|Adverse Event|7|||
126220898|NCT00856778|454100514|FG000|Overall Study|Withdrawal by Subject|10|||
126220899|NCT00856778|454100514|FG000|Overall Study|Study deviation|2|||
126220900|NCT00856778|454100514|FG000|Overall Study|Lost to Follow-up|5|||
126220901|NCT03208933|454100515|FG000|Overall Study|Death|3|||
126220902|NCT03208933|454100515|FG000|Overall Study|Withdrawal by Subject|3|||
126220903|NCT03208933|454100515|FG000|Overall Study|Adverse Event|1|||
126220904|NCT03208933|454100515|FG000|Overall Study|Lost to Follow-up|2|||
126220905|NCT03208933|454100515|FG000|Overall Study|Physician Decision|3|||
126220906|NCT03208933|454100515|FG000|Overall Study|Protocol Violation|1|||
126220907|NCT00331773|454100516|FG000|Overall Study|Withdrawal by Subject|6|||
126220908|NCT00331773|454100517|FG001|Overall Study|Withdrawal by Subject|4|||
126220909|NCT00331773|454100516|FG000|Overall Study|Protocol Violation|10|||
126220910|NCT00331773|454100517|FG001|Overall Study|Protocol Violation|3|||
126220911|NCT00379587|454100518|FG000|Overall Study|Lost to Follow-up|2|||
126220912|NCT00525031|454100523|FG000|Overall Study|Disease Progression|1|||
126220913|NCT00525031|454100524|FG001|Overall Study|Disease Progression|1|||
126220914|NCT00830063|454100525|FG000|Overall Study|Adverse Event|7|||
126220915|NCT00830063|454100526|FG001|Overall Study|Adverse Event|13|||
126220916|NCT00830063|454100527|FG002|Overall Study|Adverse Event|16|||
126220917|NCT00830063|454100528|FG003|Overall Study|Adverse Event|13|||
126220918|NCT00830063|454100525|FG000|Overall Study|Death|1|||
126220919|NCT00830063|454100526|FG001|Overall Study|Death|0|||
126220920|NCT00830063|454100527|FG002|Overall Study|Death|0|||
126220921|NCT00830063|454100528|FG003|Overall Study|Death|0|||
126220922|NCT00830063|454100525|FG000|Overall Study|Lost to Follow-up|0|||
126220923|NCT00830063|454100526|FG001|Overall Study|Lost to Follow-up|0|||
126220924|NCT00830063|454100527|FG002|Overall Study|Lost to Follow-up|3|||
126220925|NCT00830063|454100528|FG003|Overall Study|Lost to Follow-up|1|||
126220926|NCT00830063|454100525|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
126220927|NCT00830063|454100526|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
126220928|NCT00830063|454100527|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
126220929|NCT00830063|454100528|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
126220930|NCT00830063|454100525|FG000|Overall Study|Lack of Efficacy|51|||
126220931|NCT00830063|454100526|FG001|Overall Study|Lack of Efficacy|23|||
126220932|NCT00830063|454100527|FG002|Overall Study|Lack of Efficacy|25|||
126220933|NCT00830063|454100528|FG003|Overall Study|Lack of Efficacy|32|||
126220934|NCT00830063|454100525|FG000|Overall Study|Other|5|||
126220935|NCT00830063|454100526|FG001|Overall Study|Other|5|||
126220936|NCT00830063|454100527|FG002|Overall Study|Other|8|||
126220937|NCT00830063|454100528|FG003|Overall Study|Other|6|||
126220938|NCT00830063|454100525|FG000|Overall Study|Withdrawal by Subject|16|||
126220939|NCT00830063|454100526|FG001|Overall Study|Withdrawal by Subject|10|||
126220940|NCT00830063|454100527|FG002|Overall Study|Withdrawal by Subject|16|||
126220941|NCT00830063|454100528|FG003|Overall Study|Withdrawal by Subject|13|||
126220942|NCT00830063|454100525|FG000|Overall Study|Protocol Violation|1|||
126220943|NCT00830063|454100526|FG001|Overall Study|Protocol Violation|0|||
126220944|NCT00830063|454100527|FG002|Overall Study|Protocol Violation|3|||
126220945|NCT00830063|454100528|FG003|Overall Study|Protocol Violation|2|||
126220946|NCT00830063|454100525|FG000|Overall Study|Randomized But Not Treated|0|||
126220947|NCT00830063|454100526|FG001|Overall Study|Randomized But Not Treated|2|||
126220948|NCT00830063|454100527|FG002|Overall Study|Randomized But Not Treated|0|||
126220949|NCT00830063|454100528|FG003|Overall Study|Randomized But Not Treated|2|||
126220950|NCT02140164|454100529|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
126220951|NCT01872689|454100540|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
126220952|NCT01872689|454100541|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
126220953|NCT01872689|454100542|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
126220954|NCT01872689|454100543|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
126220955|NCT01872689|454100540|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
126220956|NCT01872689|454100541|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
126220957|NCT01872689|454100542|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
126220958|NCT01872689|454100543|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
126220959|NCT01872689|454100540|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
126220960|NCT01872689|454100541|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
126220961|NCT01872689|454100542|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
126220962|NCT01872689|454100543|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
126220963|NCT01872689|454100540|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
126220964|NCT01872689|454100541|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
126220965|NCT01872689|454100542|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
126220966|NCT01872689|454100543|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
126220967|NCT01872689|454100540|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
126220968|NCT01872689|454100541|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
126220969|NCT01872689|454100542|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
126220970|NCT01872689|454100543|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
126220971|NCT01872689|454100540|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
126220972|NCT01872689|454100541|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
126220973|NCT01872689|454100542|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
126220974|NCT01872689|454100543|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
126220975|NCT01872689|454100540|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
126220976|NCT01872689|454100541|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
126220977|NCT01872689|454100542|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
126220978|NCT01872689|454100543|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
126220979|NCT01872689|454100540|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
126220980|NCT01872689|454100541|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
126220981|NCT01872689|454100542|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
126220982|NCT01872689|454100543|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
126220983|NCT01872689|454100540|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
126220984|NCT01872689|454100541|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
126220985|NCT01872689|454100542|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
126220986|NCT01872689|454100543|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
126220987|NCT01872689|454100540|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
126220988|NCT01872689|454100541|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
126220989|NCT01872689|454100542|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
126220990|NCT01872689|454100543|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
126220991|NCT01872689|454100540|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
126220992|NCT01872689|454100541|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
126220993|NCT01872689|454100542|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
126220994|NCT01872689|454100543|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
126220995|NCT01872689|454100540|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
126220996|NCT01872689|454100541|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
126220997|NCT01872689|454100542|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
126220998|NCT01872689|454100543|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
126220999|NCT01872689|454100540|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
126221000|NCT01872689|454100541|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
126221001|NCT01872689|454100542|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
126221002|NCT01872689|454100543|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
126221003|NCT01872689|454100540|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
126221004|NCT01872689|454100541|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
126221005|NCT01872689|454100542|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
126221006|NCT01872689|454100543|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
126221007|NCT00881959|454100546|FG000|Overall Study|Lost to Follow-up|2|||
126221008|NCT00881959|454100547|FG001|Overall Study|Lost to Follow-up|4|||
126221009|NCT00686374|454100549|FG000|Overall Study|Lack of Efficacy|10|||
126221010|NCT00686374|454100549|FG000|Overall Study|Adverse Event|8|||
126221011|NCT00686374|454100549|FG000|Overall Study|Withdrew consent|5|||
126221012|NCT00686374|454100549|FG000|Overall Study|Lost to Follow-up|1|||
126221013|NCT00686374|454100549|FG000|Overall Study|Missing reason|33|||
126221014|NCT00686374|454100549|FG000|Overall Study|Other, not specified|4|||
126221015|NCT01070966|454100550|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
126221016|NCT01070966|454100550|FG000|Participants for Safety Evaluation|Off-label use|9|||
126221017|NCT01070966|454100550|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
126221018|NCT01070966|454100550|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
126221019|NCT01070966|454100550|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
126221020|NCT01070966|454100550|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
126221021|NCT01070966|454100550|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
126221022|NCT01070966|454100550|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
126221023|NCT01725113|454100551|FG000|Overall Study|Kidney Transplant|1|||
126221024|NCT01725113|454100552|FG001|Overall Study|Kidney Transplant|1|||
126221025|NCT01725113|454100551|FG000|Overall Study|Withdrawal by Subject|0|||
126221026|NCT01725113|454100552|FG001|Overall Study|Withdrawal by Subject|1|||
126221027|NCT01808209|454100553|FG000|Overall Study|Lost to Follow-up|0|||
126221028|NCT01808209|454100554|FG001|Overall Study|Lost to Follow-up|1|||
126221029|NCT03066440|454100555|FG000|Overall Study|Physician Decision|1|||
126221030|NCT03066440|454100556|FG001|Overall Study|Physician Decision|1|||
126349975|NCT04896385|454574084|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
126349976|NCT04896385|454574085|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
126349977|NCT04896385|454574086|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
126349978|NCT01931098|454574090|FG000|Overall Study|Withdrawal by Subject|0|||
126349979|NCT01931098|454574091|FG001|Overall Study|Withdrawal by Subject|1|||
126349980|NCT01931098|454574090|FG000|Overall Study|Enrolled in different protocol|0|||
126017978|NCT01636687|453360574|FG004|Maintenance Period|Adverse Event|0|||
126017979|NCT01636687|453360570|FG000|Maintenance Period|Lack of Efficacy|4|||
126017980|NCT01636687|453360571|FG001|Maintenance Period|Lack of Efficacy|1|||
126092485|NCT02314780|453632764|FG000|Overall Study|Adverse Event|0|||
126221031|NCT03066440|454100555|FG000|Overall Study|Protocol Violation|0|||
126221032|NCT03066440|454100556|FG001|Overall Study|Protocol Violation|2|||
126221033|NCT01106352|454100564|FG000|Overall Study|Subjects untreated|0|||
126221034|NCT01106352|454100565|FG001|Overall Study|Subjects untreated|0|||
126221035|NCT01106352|454100566|FG002|Overall Study|Subjects untreated|0|||
126221036|NCT01106352|454100567|FG003|Overall Study|Subjects untreated|3|||
126221037|NCT01106352|454100568|FG004|Overall Study|Subjects untreated|4|||
126221038|NCT01106352|454100564|FG000|Overall Study|Sponsor Decision|1|||
126221039|NCT01106352|454100565|FG001|Overall Study|Sponsor Decision|0|||
126221040|NCT01106352|454100566|FG002|Overall Study|Sponsor Decision|0|||
126221041|NCT01106352|454100567|FG003|Overall Study|Sponsor Decision|0|||
126221042|NCT01106352|454100568|FG004|Overall Study|Sponsor Decision|0|||
126221043|NCT01106352|454100564|FG000|Overall Study|Too ill to come in for the visit|0|||
126221044|NCT01106352|454100565|FG001|Overall Study|Too ill to come in for the visit|0|||
126221045|NCT01106352|454100566|FG002|Overall Study|Too ill to come in for the visit|1|||
126221046|NCT01106352|454100567|FG003|Overall Study|Too ill to come in for the visit|0|||
126221047|NCT01106352|454100568|FG004|Overall Study|Too ill to come in for the visit|0|||
126221048|NCT01106352|454100564|FG000|Overall Study|Lost to Follow-up|0|||
126221049|NCT01106352|454100565|FG001|Overall Study|Lost to Follow-up|0|||
126221050|NCT01106352|454100566|FG002|Overall Study|Lost to Follow-up|0|||
126221051|NCT01106352|454100567|FG003|Overall Study|Lost to Follow-up|0|||
126221052|NCT01106352|454100568|FG004|Overall Study|Lost to Follow-up|1|||
126221053|NCT01106352|454100564|FG000|Overall Study|Death|0|||
126221054|NCT01106352|454100565|FG001|Overall Study|Death|0|||
126221055|NCT01106352|454100566|FG002|Overall Study|Death|1|||
126221056|NCT01106352|454100567|FG003|Overall Study|Death|3|||
126221057|NCT01106352|454100568|FG004|Overall Study|Death|1|||
126221058|NCT01106352|454100564|FG000|Overall Study|Disease progression|0|||
126221059|NCT01106352|454100565|FG001|Overall Study|Disease progression|0|||
126221060|NCT01106352|454100566|FG002|Overall Study|Disease progression|0|||
126221061|NCT01106352|454100567|FG003|Overall Study|Disease progression|1|||
126221062|NCT01106352|454100568|FG004|Overall Study|Disease progression|0|||
126221063|NCT01106352|454100564|FG000|Overall Study|Withdrawal by Subject|0|||
126221064|NCT01106352|454100565|FG001|Overall Study|Withdrawal by Subject|0|||
126221065|NCT01106352|454100566|FG002|Overall Study|Withdrawal by Subject|0|||
126221066|NCT01106352|454100567|FG003|Overall Study|Withdrawal by Subject|3|||
126221067|NCT01106352|454100568|FG004|Overall Study|Withdrawal by Subject|2|||
126221068|NCT01106352|454100564|FG000|Overall Study|Went on hospice|0|||
126221069|NCT01106352|454100565|FG001|Overall Study|Went on hospice|0|||
126221070|NCT01106352|454100566|FG002|Overall Study|Went on hospice|0|||
126017981|NCT01636687|453360572|FG002|Maintenance Period|Lack of Efficacy|0|||
126221071|NCT01106352|454100567|FG003|Overall Study|Went on hospice|1|||
126221072|NCT01106352|454100568|FG004|Overall Study|Went on hospice|0|||
126221073|NCT01106352|454100564|FG000|Overall Study|Subject entered hospice|0|||
126221074|NCT01106352|454100565|FG001|Overall Study|Subject entered hospice|0|||
126221075|NCT01106352|454100566|FG002|Overall Study|Subject entered hospice|0|||
126349981|NCT01931098|454574091|FG001|Overall Study|Enrolled in different protocol|1|||
126349982|NCT01931098|454574090|FG000|Overall Study|Unable to begin trmt:active infection|0|||
126349983|NCT01931098|454574091|FG001|Overall Study|Unable to begin trmt:active infection|1|||
126349984|NCT01931098|454574090|FG000|Overall Study|Refused further treatment|0|||
126349985|NCT01931098|454574091|FG001|Overall Study|Refused further treatment|1|||
126349986|NCT01901562|454574095|FG000|Overall Study|Protocol Violation|5|||
126349987|NCT01901562|454574095|FG000|Overall Study|Excluded intraoperatively|4|||
126349988|NCT00790036|454574096|FG000|Overall Study|Abnormal lab values|3|||
126349989|NCT00790036|454574097|FG001|Overall Study|Abnormal lab values|2|||
126349990|NCT00790036|454574096|FG000|Overall Study|Administrative problems|5|||
126349991|NCT00790036|454574097|FG001|Overall Study|Administrative problems|9|||
126349992|NCT00790036|454574096|FG000|Overall Study|Adverse Event|113|||
126349993|NCT00790036|454574097|FG001|Overall Study|Adverse Event|44|||
126349994|NCT00790036|454574096|FG000|Overall Study|Death|1|||
126349995|NCT00790036|454574097|FG001|Overall Study|Death|0|||
126349996|NCT00790036|454574096|FG000|Overall Study|Disease progression|24|||
126349997|NCT00790036|454574097|FG001|Overall Study|Disease progression|48|||
126349998|NCT00790036|454574096|FG000|Overall Study|Lost to Follow-up|1|||
126349999|NCT00790036|454574097|FG001|Overall Study|Lost to Follow-up|2|||
126350000|NCT00790036|454574096|FG000|Overall Study|Protocol Violation|10|||
126350001|NCT00790036|454574097|FG001|Overall Study|Protocol Violation|2|||
126350002|NCT00790036|454574096|FG000|Overall Study|Withdrawal by Subject|18|||
126350003|NCT00790036|454574097|FG001|Overall Study|Withdrawal by Subject|7|||
126017982|NCT01636687|453360573|FG003|Maintenance Period|Lack of Efficacy|0|||
126350004|NCT00790036|454574096|FG000|Overall Study|Subject/guardian decision|20|||
126350005|NCT00790036|454574097|FG001|Overall Study|Subject/guardian decision|7|||
126350006|NCT02572167|454574100|FG000|Overall Study|Withdrawal by Subject|0|||
126017983|NCT01636687|453360574|FG004|Maintenance Period|Lack of Efficacy|0|||
126350007|NCT02572167|454574101|FG001|Overall Study|Withdrawal by Subject|3|||
126221076|NCT01106352|454100567|FG003|Overall Study|Subject entered hospice|1|||
126221077|NCT01106352|454100568|FG004|Overall Study|Subject entered hospice|0|||
126221078|NCT01106352|454100564|FG000|Overall Study|Home hospice since July 2013|0|||
126017984|NCT01636687|453360570|FG000|Maintenance Period|Lost to Follow-up|1|||
126017985|NCT01636687|453360571|FG001|Maintenance Period|Lost to Follow-up|1|||
126017986|NCT01636687|453360572|FG002|Maintenance Period|Lost to Follow-up|0|||
126017987|NCT01636687|453360573|FG003|Maintenance Period|Lost to Follow-up|0|||
126017988|NCT01636687|453360574|FG004|Maintenance Period|Lost to Follow-up|1|||
126017989|NCT01636687|453360570|FG000|Maintenance Period|Physician Decision|0|||
126017990|NCT01636687|453360571|FG001|Maintenance Period|Physician Decision|0|||
126017991|NCT01636687|453360572|FG002|Maintenance Period|Physician Decision|0|||
126017992|NCT01636687|453360573|FG003|Maintenance Period|Physician Decision|0|||
126017993|NCT01636687|453360574|FG004|Maintenance Period|Physician Decision|1|||
126017994|NCT01636687|453360570|FG000|Extension Period|technical problems|0|||
126017995|NCT01636687|453360571|FG001|Extension Period|technical problems|1|||
126017996|NCT01636687|453360572|FG002|Extension Period|technical problems|2|||
126017997|NCT01636687|453360573|FG003|Extension Period|technical problems|1|||
126017998|NCT01636687|453360574|FG004|Extension Period|technical problems|0|||
126017999|NCT01636687|453360570|FG000|Extension Period|Adverse Event|4|||
126018000|NCT01636687|453360571|FG001|Extension Period|Adverse Event|3|||
126018001|NCT01636687|453360572|FG002|Extension Period|Adverse Event|2|||
126018002|NCT01636687|453360573|FG003|Extension Period|Adverse Event|1|||
126018003|NCT01636687|453360574|FG004|Extension Period|Adverse Event|0|||
126018004|NCT01636687|453360570|FG000|Extension Period|Lack of Efficacy|7|||
126018005|NCT01636687|453360571|FG001|Extension Period|Lack of Efficacy|0|||
126018006|NCT01636687|453360572|FG002|Extension Period|Lack of Efficacy|2|||
126018007|NCT01636687|453360573|FG003|Extension Period|Lack of Efficacy|1|||
126018008|NCT01636687|453360574|FG004|Extension Period|Lack of Efficacy|0|||
126018009|NCT01636687|453360570|FG000|Extension Period|Lost to Follow-up|1|||
126018010|NCT01636687|453360571|FG001|Extension Period|Lost to Follow-up|0|||
126018011|NCT01636687|453360572|FG002|Extension Period|Lost to Follow-up|1|||
126018012|NCT01636687|453360573|FG003|Extension Period|Lost to Follow-up|0|||
126018013|NCT01636687|453360574|FG004|Extension Period|Lost to Follow-up|0|||
126018014|NCT01636687|453360570|FG000|Extension Period|Physician Decision|1|||
126018015|NCT01636687|453360571|FG001|Extension Period|Physician Decision|0|||
126018016|NCT01636687|453360572|FG002|Extension Period|Physician Decision|0|||
126018017|NCT01636687|453360573|FG003|Extension Period|Physician Decision|1|||
126018018|NCT01636687|453360574|FG004|Extension Period|Physician Decision|0|||
126018019|NCT01636687|453360570|FG000|Extension Period|study terminated by sponsor|33|||
126018020|NCT01636687|453360571|FG001|Extension Period|study terminated by sponsor|50|||
126018021|NCT01636687|453360572|FG002|Extension Period|study terminated by sponsor|17|||
126018022|NCT01636687|453360573|FG003|Extension Period|study terminated by sponsor|23|||
126018023|NCT01636687|453360574|FG004|Extension Period|study terminated by sponsor|0|||
126018024|NCT01636687|453360570|FG000|Extension Period|Withdrawal by Subject|1|||
126018025|NCT01636687|453360571|FG001|Extension Period|Withdrawal by Subject|0|||
126018026|NCT01636687|453360572|FG002|Extension Period|Withdrawal by Subject|1|||
126018027|NCT01636687|453360573|FG003|Extension Period|Withdrawal by Subject|1|||
126018028|NCT01636687|453360574|FG004|Extension Period|Withdrawal by Subject|0|||
126018029|NCT01636687|453360570|FG000|Follow-up Period|Withdrawal by Subject|1|||
126018030|NCT01636687|453360571|FG001|Follow-up Period|Withdrawal by Subject|0|||
126018031|NCT01636687|453360572|FG002|Follow-up Period|Withdrawal by Subject|0|||
126018032|NCT01636687|453360573|FG003|Follow-up Period|Withdrawal by Subject|0|||
126018033|NCT01636687|453360574|FG004|Follow-up Period|Withdrawal by Subject|1|||
126018034|NCT01460290|453360582|FG000|Overall Study|Adverse Event|3|||
126018035|NCT01460290|453360582|FG000|Overall Study|Elevated liver function|1|||
126018036|NCT01190007|453360587|FG000|Overall Study|Withdrawal by Subject|4|||
126018037|NCT01190007|453360587|FG000|Overall Study|Adverse Event|8|||
126018038|NCT01190007|453360587|FG000|Overall Study|Difficulty of visit for complications|1|||
126018039|NCT01190007|453360587|FG000|Overall Study|Participant was arrested|1|||
126018040|NCT01254188|453360591|FG000|Overall Study|Disease Progression|6|||
126018041|NCT01254188|453360591|FG000|Overall Study|Protocol Violation|6|||
126018042|NCT01254188|453360591|FG000|Overall Study|Pregnancy|2|||
126018043|NCT01254188|453360591|FG000|Overall Study|Death|4|||
126092486|NCT02314780|453632765|FG001|Overall Study|Adverse Event|1|||
126092487|NCT02314780|453632766|FG002|Overall Study|Adverse Event|0|||
126221079|NCT01106352|454100565|FG001|Overall Study|Home hospice since July 2013|0|||
126221080|NCT01106352|454100566|FG002|Overall Study|Home hospice since July 2013|0|||
126221081|NCT01106352|454100567|FG003|Overall Study|Home hospice since July 2013|1|||
126018044|NCT01254188|453360591|FG000|Overall Study|Lost to Follow-up|5|||
126092488|NCT00215137|453632770|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
126221082|NCT01106352|454100568|FG004|Overall Study|Home hospice since July 2013|0|||
126018045|NCT01254188|453360591|FG000|Overall Study|Withdrawal by Subject|7|||
126018046|NCT01254188|453360591|FG000|Overall Study|Adverse Event|43|||
126018047|NCT01254188|453360591|FG000|Overall Study|per investigator discretion|20|||
126018048|NCT02755116|453360593|FG000|Overall Study|surgery converted to open, pt admitted|3|||
126018049|NCT02755116|453360594|FG001|Overall Study|surgery converted to open, pt admitted|1|||
126018050|NCT01124734|453360595|FG000|Overall Study|Disease progression|13|||
126018051|NCT01124734|453360595|FG000|Overall Study|Adverse Event|1|||
126092489|NCT00215137|453632771|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
126350008|NCT02572167|454574102|FG002|Overall Study|Withdrawal by Subject|0|||
126350009|NCT02572167|454574100|FG000|Overall Study|Lost to Follow-up|2|||
126018052|NCT01124734|453360595|FG000|Overall Study|Withdrawal by Subject|1|||
126018053|NCT01124734|453360595|FG000|Overall Study|Elected for alternative treatment|2|||
126018054|NCT03482011|453360596|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
126018055|NCT03482011|453360597|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
126018056|NCT03482011|453360598|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
126018057|NCT03482011|453360599|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
126018058|NCT03482011|453360600|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
126018059|NCT03482011|453360601|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
126018060|NCT03482011|453360602|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
126018061|NCT03482011|453360603|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
126018062|NCT03482011|453360596|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
126018063|NCT03482011|453360597|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
126018064|NCT03482011|453360598|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126018065|NCT03482011|453360599|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126018066|NCT03482011|453360600|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126018067|NCT03482011|453360601|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126018068|NCT03482011|453360602|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126018069|NCT03482011|453360603|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126018070|NCT03482011|453360596|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126018071|NCT03482011|453360597|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
126018072|NCT03482011|453360598|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126018073|NCT03482011|453360599|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126018074|NCT03482011|453360600|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126018075|NCT03482011|453360601|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126018076|NCT03482011|453360602|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126018077|NCT03482011|453360603|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126018078|NCT03482011|453360596|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
126018079|NCT03482011|453360597|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
126018080|NCT03482011|453360598|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
126018081|NCT03482011|453360599|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
126018082|NCT03482011|453360600|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
126018083|NCT03482011|453360601|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
126018084|NCT03482011|453360602|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
126018085|NCT03482011|453360603|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
126018086|NCT03482011|453360596|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
126018087|NCT03482011|453360597|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
126018088|NCT03482011|453360598|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126018089|NCT03482011|453360599|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126018090|NCT03482011|453360600|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126018091|NCT03482011|453360601|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126018092|NCT03482011|453360602|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126018093|NCT03482011|453360603|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126018094|NCT03482011|453360596|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
126018095|NCT03482011|453360597|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
126018096|NCT03482011|453360598|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
126018097|NCT03482011|453360599|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
126018098|NCT03482011|453360600|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
126018099|NCT03482011|453360601|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
126018100|NCT03482011|453360602|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
126018101|NCT03482011|453360603|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
126018102|NCT03482011|453360596|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126018103|NCT03482011|453360597|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126018104|NCT03482011|453360598|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
126018105|NCT03482011|453360599|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
126350010|NCT02572167|454574101|FG001|Overall Study|Lost to Follow-up|5|||
126350011|NCT02572167|454574102|FG002|Overall Study|Lost to Follow-up|3|||
126350012|NCT02572167|454574100|FG000|Overall Study|Death|0|||
126350013|NCT02572167|454574101|FG001|Overall Study|Death|8|||
126018106|NCT03482011|453360600|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
126018107|NCT03482011|453360601|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
126018108|NCT03482011|453360602|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126018109|NCT03482011|453360603|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
126018110|NCT03482011|453360596|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126018111|NCT03482011|453360597|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126018112|NCT03482011|453360598|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126018113|NCT03482011|453360599|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126018114|NCT03482011|453360600|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
126350014|NCT02572167|454574102|FG002|Overall Study|Death|3|||
126350015|NCT02572167|454574100|FG000|Overall Study|Did not meet inclusion criteria|0|||
126221083|NCT03944707|454100569|FG000|Overall Study|Adverse Event|0|||
126221084|NCT03944707|454100570|FG001|Overall Study|Adverse Event|2|||
126221085|NCT03944707|454100569|FG000|Overall Study|Study terminated by sponsor|12|||
126221086|NCT03944707|454100570|FG001|Overall Study|Study terminated by sponsor|7|||
126221087|NCT03944707|454100569|FG000|Overall Study|Subject decision|0|||
126221088|NCT03944707|454100570|FG001|Overall Study|Subject decision|1|||
126221089|NCT00751998|454100578|FG000|Overall Study|Lost to Follow-up|7|||
126221090|NCT00751998|454100578|FG000|Overall Study|Death|11|||
126221091|NCT00751998|454100578|FG000|Overall Study|Withdrawal by Subject|2|||
126221092|NCT01965535|454100579|FG000|Overall Study|Lack of Efficacy|2|||
126221093|NCT01965535|454100580|FG001|Overall Study|Lack of Efficacy|1|||
126221094|NCT02983227|454100581|FG000|Overall Study|Adverse Event|21|||
126221095|NCT02983227|454100582|FG001|Overall Study|Adverse Event|3|||
126221096|NCT02983227|454100581|FG000|Overall Study|Death|3|||
126221097|NCT02983227|454100582|FG001|Overall Study|Death|0|||
126221098|NCT02983227|454100581|FG000|Overall Study|Lack of Efficacy|8|||
126221099|NCT02983227|454100582|FG001|Overall Study|Lack of Efficacy|1|||
126221100|NCT02983227|454100581|FG000|Overall Study|Lost to Follow-up|3|||
126221101|NCT02983227|454100582|FG001|Overall Study|Lost to Follow-up|0|||
126221102|NCT02983227|454100581|FG000|Overall Study|Multiple Reasons|2|||
126221103|NCT02983227|454100582|FG001|Overall Study|Multiple Reasons|1|||
126221104|NCT02983227|454100581|FG000|Overall Study|Physician Decision|3|||
126221105|NCT02983227|454100582|FG001|Overall Study|Physician Decision|1|||
126221106|NCT02983227|454100581|FG000|Overall Study|Withdrawal by Subject|19|||
126221107|NCT02983227|454100582|FG001|Overall Study|Withdrawal by Subject|8|||
126221108|NCT01946282|454100585|FG000|Year 1|Did not return FIT kit|4186|||
126221109|NCT01946282|454100586|FG001|Year 1|Did not return FIT kit|608|||
126221110|NCT01946282|454100587|FG002|Year 1|Did not return FIT kit|654|||
126221111|NCT01946282|454100585|FG000|Year 2|Did not return FIT kit|803|||
126221112|NCT01946282|454100586|FG001|Year 2|Did not return FIT kit|131|||
126221113|NCT01946282|454100587|FG002|Year 2|Did not return FIT kit|115|||
126221114|NCT01946282|454100585|FG000|Year 3|Did not return FIT kit|288|||
126221115|NCT01946282|454100586|FG001|Year 3|Did not return FIT kit|43|||
126221116|NCT01946282|454100587|FG002|Year 3|Did not return FIT kit|30|||
126221117|NCT01493531|454100588|FG000|Overall Study|Adverse Event|4|||
126221118|NCT01493531|454100589|FG001|Overall Study|Adverse Event|12|||
126221119|NCT01493531|454100590|FG002|Overall Study|Adverse Event|9|||
126221120|NCT01493531|454100588|FG000|Overall Study|Gout flare|3|||
126221121|NCT01493531|454100589|FG001|Overall Study|Gout flare|0|||
126221122|NCT01493531|454100590|FG002|Overall Study|Gout flare|2|||
126221123|NCT01493531|454100588|FG000|Overall Study|Protocol Violation|8|||
126221124|NCT01493531|454100589|FG001|Overall Study|Protocol Violation|15|||
126221125|NCT01493531|454100590|FG002|Overall Study|Protocol Violation|12|||
126221126|NCT01493531|454100588|FG000|Overall Study|Sponsor terminated study|5|||
126221127|NCT01493531|454100589|FG001|Overall Study|Sponsor terminated study|2|||
126221128|NCT01493531|454100590|FG002|Overall Study|Sponsor terminated study|3|||
126221129|NCT01493531|454100588|FG000|Overall Study|Lost to Follow-up|5|||
126221130|NCT01493531|454100589|FG001|Overall Study|Lost to Follow-up|7|||
126221131|NCT01493531|454100590|FG002|Overall Study|Lost to Follow-up|11|||
126221132|NCT01493531|454100588|FG000|Overall Study|Withdrawal by Subject|16|||
126221133|NCT01493531|454100589|FG001|Overall Study|Withdrawal by Subject|13|||
126221134|NCT01493531|454100590|FG002|Overall Study|Withdrawal by Subject|11|||
126221135|NCT01493531|454100588|FG000|Overall Study|Death|0|||
126221136|NCT01493531|454100589|FG001|Overall Study|Death|1|||
126221137|NCT01493531|454100590|FG002|Overall Study|Death|0|||
126221138|NCT02766400|454100593|FG000|Overall Study|Death|1|||
126221139|NCT02766400|454100594|FG001|Overall Study|Death|2|||
126221140|NCT02766400|454100593|FG000|Overall Study|Withdrawal by Subject|1|||
126221141|NCT02766400|454100594|FG001|Overall Study|Withdrawal by Subject|0|||
126221142|NCT03499249|454100599|FG000|Overall Study|Physician Decision|1|||
126221143|NCT01559818|454100606|FG000|Overall Study|Physician Decision|1|||
126221144|NCT01559818|454100606|FG000|Overall Study|Pregnancy|1|||
126221145|NCT01559818|454100606|FG000|Overall Study|Study terminated by Sponsor|4|||
126221146|NCT01559818|454100606|FG000|Overall Study|Withdrawal by Subject|1|||
126221147|NCT04071626|454100607|FG000|Overall Study|Withdrawal by Subject|1|||
126221148|NCT04071626|454100608|FG001|Overall Study|Withdrawal by Subject|1|||
126221149|NCT04071626|454100607|FG000|Overall Study|Protocol Violation|0|||
126221150|NCT04071626|454100608|FG001|Overall Study|Protocol Violation|1|||
126221151|NCT01374906|454100609|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126221152|NCT01374906|454100610|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126221153|NCT01374906|454100609|FG000|Overall Study|Administrative problems|2|||
126018115|NCT03482011|453360601|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126221154|NCT01374906|454100610|FG001|Overall Study|Administrative problems|2|||
126018116|NCT03482011|453360602|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126018117|NCT03482011|453360603|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
126221155|NCT01374906|454100609|FG000|Overall Study|Adverse Event|10|||
126221156|NCT01374906|454100610|FG001|Overall Study|Adverse Event|11|||
126221157|NCT01374906|454100609|FG000|Overall Study|Death|0|||
126221158|NCT01374906|454100610|FG001|Overall Study|Death|2|||
126221159|NCT01374906|454100609|FG000|Overall Study|Protocol Violation|2|||
126221160|NCT01374906|454100610|FG001|Overall Study|Protocol Violation|2|||
126350016|NCT02572167|454574101|FG001|Overall Study|Did not meet inclusion criteria|0|||
126350017|NCT02572167|454574102|FG002|Overall Study|Did not meet inclusion criteria|1|||
126350018|NCT02572167|454574100|FG000|Overall Study|Study closure by Sponsor|4|||
126350019|NCT02572167|454574101|FG001|Overall Study|Study closure by Sponsor|40|||
126350020|NCT02572167|454574102|FG002|Overall Study|Study closure by Sponsor|24|||
126350021|NCT00005047|454574103|FG000|Overall Study|Withdrawal by Subject|12|||
126018118|NCT03482011|453360596|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
126018119|NCT03482011|453360597|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
126018120|NCT03482011|453360598|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
126018121|NCT03482011|453360599|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
126018122|NCT03482011|453360600|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
126018123|NCT03482011|453360601|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
126018124|NCT03482011|453360602|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
126018125|NCT03482011|453360603|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
126018126|NCT03482011|453360596|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126018127|NCT03482011|453360597|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126018128|NCT03482011|453360598|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126018129|NCT03482011|453360599|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
126018130|NCT03482011|453360600|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
126018131|NCT03482011|453360601|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
126018132|NCT03482011|453360602|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
126018133|NCT03482011|453360603|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
126018134|NCT03482011|453360596|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126018135|NCT03482011|453360597|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126018136|NCT03482011|453360598|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126018137|NCT03482011|453360599|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
126018138|NCT03482011|453360600|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126018139|NCT03482011|453360601|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
126018140|NCT03482011|453360602|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
126018141|NCT03482011|453360603|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
126018142|NCT03482011|453360596|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
126018143|NCT03482011|453360597|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
126018144|NCT03482011|453360598|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
126018145|NCT03482011|453360599|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
126018146|NCT03482011|453360600|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
126018147|NCT03482011|453360601|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
126018148|NCT03482011|453360602|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
126018149|NCT03482011|453360603|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
126018150|NCT03482011|453360596|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126018151|NCT03482011|453360597|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126018152|NCT03482011|453360598|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
126018153|NCT03482011|453360599|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
126018154|NCT03482011|453360600|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126018155|NCT03482011|453360601|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126018156|NCT03482011|453360602|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126018157|NCT03482011|453360603|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
126018158|NCT03482011|453360596|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
126018159|NCT03482011|453360597|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
126018160|NCT03482011|453360598|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
126018161|NCT03482011|453360599|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
126018162|NCT03482011|453360600|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
126018163|NCT03482011|453360601|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
126018164|NCT03482011|453360602|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
126018165|NCT03482011|453360603|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
126018166|NCT03482011|453360596|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126018167|NCT03482011|453360597|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126018168|NCT03482011|453360598|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126018169|NCT03482011|453360599|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126018170|NCT03482011|453360600|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126018171|NCT03482011|453360601|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126018172|NCT03482011|453360602|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126018173|NCT03482011|453360603|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
126018174|NCT01576484|453360605|FG000|Overall Study|Adverse Event|1|||
126018175|NCT01576484|453360606|FG001|Overall Study|Adverse Event|1|||
126350022|NCT00005047|454574104|FG001|Overall Study|Withdrawal by Subject|0|||
126350023|NCT00005047|454574105|FG002|Overall Study|Withdrawal by Subject|0|||
126350024|NCT00005047|454574106|FG003|Overall Study|Withdrawal by Subject|0|||
126350025|NCT00005047|454574103|FG000|Overall Study|Adverse Event|5|||
126018176|NCT01576484|453360605|FG000|Overall Study|Protocol Violation|0|||
126018177|NCT01576484|453360606|FG001|Overall Study|Protocol Violation|2|||
126018178|NCT01576484|453360605|FG000|Overall Study|Sponsor Decision|2|||
126221161|NCT01374906|454100609|FG000|Overall Study|Withdrawal by Subject|15|||
126221162|NCT01374906|454100610|FG001|Overall Study|Withdrawal by Subject|9|||
126221163|NCT01374906|454100609|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
126221164|NCT01374906|454100610|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
126221165|NCT02475980|454100613|FG000|Overall Study|Lost to Follow-up|4|||
126221166|NCT02475980|454100613|FG000|Overall Study|Withdrawal by Subject|1|||
126221167|NCT00665626|454100619|FG000|Overall Study|Lack of Efficacy|8|||
126221168|NCT00665626|454100620|FG001|Overall Study|Lack of Efficacy|5|||
126221169|NCT00665626|454100619|FG000|Overall Study|Lost to Follow-up|0|||
126221170|NCT00665626|454100620|FG001|Overall Study|Lost to Follow-up|2|||
126221171|NCT00665626|454100619|FG000|Overall Study|Withdrawal by Subject|0|||
126221172|NCT00665626|454100620|FG001|Overall Study|Withdrawal by Subject|1|||
126221173|NCT00665626|454100619|FG000|Overall Study|Protocol Violation|0|||
126221174|NCT00665626|454100620|FG001|Overall Study|Protocol Violation|2|||
126221175|NCT00665626|454100619|FG000|Overall Study|Adverse Event|1|||
126221176|NCT00665626|454100620|FG001|Overall Study|Adverse Event|9|||
126221177|NCT00665626|454100619|FG000|Overall Study|Due to exclusion criteria|0|||
126221178|NCT00665626|454100620|FG001|Overall Study|Due to exclusion criteria|1|||
126221179|NCT00665626|454100619|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
126221180|NCT00665626|454100620|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
126221181|NCT00665626|454100619|FG000|Overall Study|Unably to comply with dosing regimen|0|||
126221182|NCT00665626|454100620|FG001|Overall Study|Unably to comply with dosing regimen|1|||
126221183|NCT00665626|454100619|FG000|Overall Study|Death|1|||
126221184|NCT00665626|454100620|FG001|Overall Study|Death|0|||
126221185|NCT04147611|454100621|FG000|Overall Study|Physician Decision|0|||
126221186|NCT04147611|454100622|FG001|Overall Study|Physician Decision|1|||
126221187|NCT01010230|454100623|FG000|Overall Study|Withdrawal by Subject|6|||
126221188|NCT01010230|454100624|FG001|Overall Study|Withdrawal by Subject|5|||
126221189|NCT01010230|454100623|FG000|Overall Study|Lost to Follow-up|4|||
126221190|NCT01010230|454100624|FG001|Overall Study|Lost to Follow-up|2|||
126221191|NCT00530439|454100625|FG000|Overall Study|GDM|9|||
126221192|NCT00530439|454100626|FG001|Overall Study|GDM|3|||
126221193|NCT00530439|454100625|FG000|Overall Study|Withdraw|18|||
126221194|NCT00530439|454100626|FG001|Overall Study|Withdraw|14|||
126221195|NCT00530439|454100625|FG000|Overall Study|Missed abortion|1|||
126221196|NCT00530439|454100626|FG001|Overall Study|Missed abortion|4|||
126221197|NCT00530439|454100625|FG000|Overall Study|Misclassification|2|||
126221198|NCT00530439|454100626|FG001|Overall Study|Misclassification|0|||
126221199|NCT00530439|454100625|FG000|Overall Study|Twin pregnancy|0|||
126221200|NCT00530439|454100626|FG001|Overall Study|Twin pregnancy|2|||
126221201|NCT00530439|454100625|FG000|Overall Study|Severe malformation/abortion|0|||
126221202|NCT00530439|454100626|FG001|Overall Study|Severe malformation/abortion|3|||
126221203|NCT01629693|454100629|FG000|Overall Study|Lost to Follow-up|2|||
126221204|NCT01629693|454100630|FG001|Overall Study|Lost to Follow-up|4|||
126221205|NCT01629693|454100629|FG000|Overall Study|Withdrawal by Subject|2|||
126221206|NCT01629693|454100630|FG001|Overall Study|Withdrawal by Subject|2|||
126221207|NCT01629693|454100629|FG000|Overall Study|Adverse Event|1|||
126221208|NCT01629693|454100630|FG001|Overall Study|Adverse Event|0|||
126221209|NCT01629693|454100629|FG000|Overall Study|Investigator decision|0|||
126221210|NCT01629693|454100630|FG001|Overall Study|Investigator decision|1|||
126221211|NCT01629693|454100629|FG000|Overall Study|Poor comfort of study lenses|0|||
126221212|NCT01629693|454100630|FG001|Overall Study|Poor comfort of study lenses|2|||
126350026|NCT00005047|454574104|FG001|Overall Study|Adverse Event|0|||
126350027|NCT00005047|454574105|FG002|Overall Study|Adverse Event|0|||
126350028|NCT00005047|454574106|FG003|Overall Study|Adverse Event|0|||
126350029|NCT00005047|454574103|FG000|Overall Study|Lost to Follow-up|1|||
126350030|NCT00005047|454574104|FG001|Overall Study|Lost to Follow-up|0|||
126350031|NCT00005047|454574105|FG002|Overall Study|Lost to Follow-up|0|||
126350032|NCT00005047|454574106|FG003|Overall Study|Lost to Follow-up|0|||
126350033|NCT00005047|454574103|FG000|Overall Study|Lack of Efficacy|1|||
126350034|NCT00005047|454574104|FG001|Overall Study|Lack of Efficacy|0|||
126350035|NCT00005047|454574105|FG002|Overall Study|Lack of Efficacy|0|||
126350036|NCT00005047|454574106|FG003|Overall Study|Lack of Efficacy|0|||
126350037|NCT05248386|454574110|FG000|Overall Study|Technical problems|0|||
126350038|NCT05248386|454574111|FG001|Overall Study|Technical problems|1|||
126350039|NCT05248386|454574110|FG000|Overall Study|Withdrawal by Subject|15|||
126350040|NCT05248386|454574111|FG001|Overall Study|Withdrawal by Subject|10|||
126221213|NCT01629693|454100629|FG000|Overall Study|Subject decision unrelated to AE|0|||
126350041|NCT05248386|454574110|FG000|Overall Study|Physician Decision|0|||
126350042|NCT05248386|454574111|FG001|Overall Study|Physician Decision|1|||
126350043|NCT05248386|454574110|FG000|Overall Study|Adverse Event|2|||
126221214|NCT01629693|454100630|FG001|Overall Study|Subject decision unrelated to AE|1|||
126221215|NCT01529749|454100631|FG000|Overall Study|Lost to Follow-up|0|||
126221216|NCT01529749|454100632|FG001|Overall Study|Lost to Follow-up|1|||
126221217|NCT01529749|454100633|FG002|Overall Study|Lost to Follow-up|1|||
126221218|NCT01529749|454100634|FG003|Overall Study|Lost to Follow-up|0|||
126221219|NCT01529749|454100631|FG000|Overall Study|Physician Decision|0|||
126221220|NCT01529749|454100632|FG001|Overall Study|Physician Decision|0|||
126350044|NCT05248386|454574111|FG001|Overall Study|Adverse Event|4|||
126221221|NCT01529749|454100633|FG002|Overall Study|Physician Decision|0|||
126221222|NCT01529749|454100634|FG003|Overall Study|Physician Decision|1|||
126221223|NCT01529749|454100631|FG000|Overall Study|Withdrawal by Subject|0|||
126221224|NCT01529749|454100632|FG001|Overall Study|Withdrawal by Subject|1|||
126221225|NCT01529749|454100633|FG002|Overall Study|Withdrawal by Subject|1|||
126221226|NCT01529749|454100634|FG003|Overall Study|Withdrawal by Subject|0|||
126221227|NCT01529749|454100631|FG000|Overall Study|Protocol Violation|0|||
126221228|NCT01529749|454100632|FG001|Overall Study|Protocol Violation|0|||
126221229|NCT01529749|454100633|FG002|Overall Study|Protocol Violation|0|||
126221230|NCT01529749|454100634|FG003|Overall Study|Protocol Violation|1|||
126221231|NCT04385199|454100635|FG000|Overall Study|Withdrawal by Subject|1|||
126221232|NCT04385199|454100636|FG001|Overall Study|Withdrawal by Subject|0|||
126221233|NCT00265083|454102171|FG000|Overall Study|Adverse Event|5|||
126221234|NCT00265083|454102172|FG001|Overall Study|Adverse Event|13|||
126221235|NCT00265083|454102173|FG002|Overall Study|Adverse Event|15|||
126221236|NCT00265083|454102171|FG000|Overall Study|Lost to Follow-up|3|||
126221237|NCT00265083|454102172|FG001|Overall Study|Lost to Follow-up|4|||
126221238|NCT00265083|454102173|FG002|Overall Study|Lost to Follow-up|4|||
126221239|NCT00265083|454102171|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
126221240|NCT00265083|454102172|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
126221241|NCT00265083|454102173|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
126221242|NCT00265083|454102171|FG000|Overall Study|Other|1|||
126221243|NCT00265083|454102172|FG001|Overall Study|Other|12|||
126221244|NCT00265083|454102173|FG002|Overall Study|Other|9|||
126221245|NCT04242186|454102174|FG000|Overall Study|Death|5|||
126221246|NCT00534092|454102175|FG000|Overall Study|Lost to Follow-up|1|||
126221247|NCT00534092|454102176|FG001|Overall Study|Lost to Follow-up|0|||
126221248|NCT00534092|454102175|FG000|Overall Study|personal reasons/family concerns|1|||
126221249|NCT00534092|454102176|FG001|Overall Study|personal reasons/family concerns|0|||
126221250|NCT02323295|454102177|FG000|Overall Study|Adverse Event|0|||
126221251|NCT02323295|454102178|FG001|Overall Study|Adverse Event|1|||
126221252|NCT02323295|454102177|FG000|Overall Study|Withdrawal by Subject|0|||
126221253|NCT02323295|454102178|FG001|Overall Study|Withdrawal by Subject|1|||
126221254|NCT02323295|454102177|FG000|Overall Study|Patient did not have surgery as planned.|0|||
126221255|NCT02323295|454102178|FG001|Overall Study|Patient did not have surgery as planned.|1|||
126221256|NCT01155063|454102179|FG000|Overall Study|Adverse Event|1|||
126221257|NCT01155063|454102179|FG000|Overall Study|Withdrawal by Subject|1|||
126221258|NCT01155063|454102179|FG000|Overall Study|Study terminated by sponsor|87|||
126221259|NCT01314703|454102180|FG000|Overall Study|screen failure and closed enrollment|8|||
126221260|NCT02770716|454102187|FG000|Overall Study|Death|101|||
126221261|NCT02770716|454102188|FG001|Overall Study|Death|45|||
126221262|NCT02770716|454102187|FG000|Overall Study|Withdrawal by Subject|4|||
126221263|NCT02770716|454102188|FG001|Overall Study|Withdrawal by Subject|2|||
126221264|NCT02770716|454102187|FG000|Overall Study|Lost to Follow-up|1|||
126221265|NCT02770716|454102188|FG001|Overall Study|Lost to Follow-up|0|||
126221266|NCT02770716|454102187|FG000|Overall Study|Various reasons|6|||
126221267|NCT02770716|454102188|FG001|Overall Study|Various reasons|2|||
126221268|NCT03989115|454102189|FG000|Overall Study|Withdrawal by Subject|2|||
126221269|NCT03989115|454102190|FG001|Overall Study|Withdrawal by Subject|1|||
126221270|NCT03989115|454102191|FG002|Overall Study|Withdrawal by Subject|3|||
126221271|NCT03989115|454102192|FG003|Overall Study|Withdrawal by Subject|0|||
126221272|NCT03989115|454102193|FG004|Overall Study|Withdrawal by Subject|17|||
126350045|NCT05248386|454574110|FG000|Overall Study|Other|1|||
126350046|NCT05248386|454574111|FG001|Overall Study|Other|0|||
126350047|NCT05248386|454574110|FG000|Overall Study|Lack of Efficacy|14|||
126350048|NCT05248386|454574111|FG001|Overall Study|Lack of Efficacy|12|||
126350049|NCT04967222|454574115|FG000|Randomized|Lost to Follow-up|0|||
126350050|NCT04967222|454574116|FG001|Randomized|Lost to Follow-up|1|||
126350051|NCT04967222|454574117|FG002|Randomized|Lost to Follow-up|1|||
126350052|NCT04967222|454574115|FG000|Randomized|Physician Decision|0|||
126350053|NCT04967222|454574116|FG001|Randomized|Physician Decision|0|||
126350054|NCT04967222|454574117|FG002|Randomized|Physician Decision|1|||
126350055|NCT04967222|454574115|FG000|Randomized|Withdrawal by Subject|0|||
126350056|NCT04967222|454574116|FG001|Randomized|Withdrawal by Subject|0|||
126350057|NCT04967222|454574117|FG002|Randomized|Withdrawal by Subject|2|||
126350058|NCT04967222|454574115|FG000|Randomized|abnormal finding in MRI|0|||
126350059|NCT04967222|454574116|FG001|Randomized|abnormal finding in MRI|2|||
126350060|NCT04967222|454574117|FG002|Randomized|abnormal finding in MRI|0|||
126350061|NCT01295944|454574118|FG000|Overall Study|Switched to alternative treatment|1|||
126221273|NCT03989115|454102194|FG005|Overall Study|Withdrawal by Subject|1|||
126221274|NCT03989115|454102195|FG006|Overall Study|Withdrawal by Subject|0|||
126221275|NCT03989115|454102196|FG007|Overall Study|Withdrawal by Subject|0|||
126221276|NCT03989115|454102189|FG000|Overall Study|Sponsor decision to terminate the study|1|||
126221277|NCT03989115|454102190|FG001|Overall Study|Sponsor decision to terminate the study|1|||
126221278|NCT03989115|454102191|FG002|Overall Study|Sponsor decision to terminate the study|0|||
126221279|NCT03989115|454102192|FG003|Overall Study|Sponsor decision to terminate the study|1|||
126350062|NCT01295944|454574118|FG000|Overall Study|Ineligible|9|||
126221280|NCT03989115|454102193|FG004|Overall Study|Sponsor decision to terminate the study|11|||
126221281|NCT03989115|454102194|FG005|Overall Study|Sponsor decision to terminate the study|0|||
126221282|NCT03989115|454102195|FG006|Overall Study|Sponsor decision to terminate the study|2|||
126221283|NCT03989115|454102196|FG007|Overall Study|Sponsor decision to terminate the study|1|||
126221284|NCT03989115|454102189|FG000|Overall Study|Lost to Follow-up|2|||
126221285|NCT03989115|454102190|FG001|Overall Study|Lost to Follow-up|0|||
126221286|NCT03989115|454102191|FG002|Overall Study|Lost to Follow-up|0|||
126221287|NCT03989115|454102192|FG003|Overall Study|Lost to Follow-up|0|||
126221288|NCT03989115|454102193|FG004|Overall Study|Lost to Follow-up|1|||
126221289|NCT03989115|454102194|FG005|Overall Study|Lost to Follow-up|0|||
126221290|NCT03989115|454102195|FG006|Overall Study|Lost to Follow-up|0|||
126221291|NCT03989115|454102196|FG007|Overall Study|Lost to Follow-up|0|||
126221292|NCT03989115|454102189|FG000|Overall Study|Death|2|||
126221293|NCT03989115|454102190|FG001|Overall Study|Death|2|||
126221294|NCT03989115|454102191|FG002|Overall Study|Death|9|||
126221295|NCT03989115|454102192|FG003|Overall Study|Death|6|||
126221296|NCT03989115|454102193|FG004|Overall Study|Death|31|||
126221297|NCT03989115|454102194|FG005|Overall Study|Death|6|||
126221298|NCT03989115|454102195|FG006|Overall Study|Death|2|||
126221299|NCT03989115|454102196|FG007|Overall Study|Death|3|||
126221300|NCT03989115|454102189|FG000|Overall Study|Other|1|||
126221301|NCT03989115|454102190|FG001|Overall Study|Other|2|||
126221302|NCT03989115|454102191|FG002|Overall Study|Other|0|||
126221303|NCT03989115|454102192|FG003|Overall Study|Other|0|||
126221304|NCT03989115|454102193|FG004|Overall Study|Other|5|||
126221305|NCT03989115|454102194|FG005|Overall Study|Other|0|||
126221306|NCT03989115|454102195|FG006|Overall Study|Other|0|||
126221307|NCT03989115|454102196|FG007|Overall Study|Other|0|||
126221308|NCT02499354|454102197|FG000|Overall Study|Withdrawal by Subject|1|||
126221309|NCT02499354|454102198|FG001|Overall Study|Withdrawal by Subject|0|||
126221310|NCT01759381|454102202|FG000|Overall Study|Death|1|||
126221311|NCT01759381|454102203|FG001|Overall Study|Death|0|||
126221312|NCT00447603|454102205|FG000|Screening|Withdrawal by Subject|1|||
126221313|NCT00447603|454102206|FG001|Screening|Withdrawal by Subject|0|||
126221314|NCT00447603|454102207|FG002|Screening|Withdrawal by Subject|0|||
126221315|NCT00447603|454102205|FG000|Screening|Protocol Violation|1|||
126221316|NCT00447603|454102206|FG001|Screening|Protocol Violation|0|||
126221317|NCT00447603|454102207|FG002|Screening|Protocol Violation|0|||
126221318|NCT00447603|454102205|FG000|Screening|Screen Failure|4|||
126221319|NCT00447603|454102206|FG001|Screening|Screen Failure|0|||
126221320|NCT00447603|454102207|FG002|Screening|Screen Failure|0|||
126221321|NCT00447603|454102205|FG000|Screening|Study Terminated by Sponsor|15|||
126221322|NCT00447603|454102206|FG001|Screening|Study Terminated by Sponsor|0|||
126221323|NCT00447603|454102207|FG002|Screening|Study Terminated by Sponsor|0|||
126221324|NCT00447603|454102205|FG000|Filter Period|Adverse Event|0|||
126221325|NCT00447603|454102206|FG001|Filter Period|Adverse Event|0|||
126221326|NCT00447603|454102207|FG002|Filter Period|Adverse Event|1|||
126221327|NCT00447603|454102205|FG000|Filter Period|Screen Failure|0|||
126221328|NCT00447603|454102206|FG001|Filter Period|Screen Failure|3|||
126221329|NCT00447603|454102207|FG002|Filter Period|Screen Failure|4|||
126221330|NCT00447603|454102205|FG000|Filter Period|Study terminated by Sponsor|0|||
126221331|NCT00447603|454102206|FG001|Filter Period|Study terminated by Sponsor|1|||
126221332|NCT00447603|454102207|FG002|Filter Period|Study terminated by Sponsor|10|||
126221333|NCT02410837|454102212|FG000|Overall Study|Death|387|||
126221334|NCT02410837|454102212|FG000|Overall Study|Lost to Follow-up|50|||
126221335|NCT02410837|454102212|FG000|Overall Study|Withdrawal by Subject|44|||
126221336|NCT02410837|454102212|FG000|Overall Study|Physician Decision|6|||
126221337|NCT02410837|454102212|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
126221338|NCT03031431|454102213|FG000|Overall Study|Infant removed by maternal request|1|||
126221339|NCT01205529|454102214|FG000|Overall Study|Procedure Cancelled|4|||
126221340|NCT01205529|454102214|FG000|Overall Study|Withdrawal by Subject|2|||
126221341|NCT01205529|454102214|FG000|Overall Study|Physician Decision|4|||
126221342|NCT01205529|454102214|FG000|Overall Study|Unstable post op|15|||
126221343|NCT01205529|454102214|FG000|Overall Study|No longer met criteria|30|||
126221344|NCT01027884|454102219|FG000|Overall Study|Adverse Event|2|||
126221345|NCT01027884|454102220|FG001|Overall Study|Adverse Event|1|||
126221346|NCT01027884|454102219|FG000|Overall Study|Protocol Violation|1|||
126221347|NCT01027884|454102220|FG001|Overall Study|Protocol Violation|0|||
126221348|NCT01027884|454102219|FG000|Overall Study|Non-compliance|1|||
126221349|NCT01027884|454102220|FG001|Overall Study|Non-compliance|1|||
126221350|NCT01027884|454102219|FG000|Overall Study|Withdrawal by Subject|0|||
126221351|NCT01027884|454102220|FG001|Overall Study|Withdrawal by Subject|1|||
126221352|NCT01027884|454102219|FG000|Overall Study|Lost to Follow-up|0|||
126221353|NCT01027884|454102220|FG001|Overall Study|Lost to Follow-up|1|||
126221354|NCT01027884|454102219|FG000|Overall Study|Spinal fixation surgery|0|||
126221355|NCT01027884|454102220|FG001|Overall Study|Spinal fixation surgery|3|||
126221356|NCT03670537|454102221|FG000|Overall Study|Protocol Violation|1|||
126221357|NCT02059187|454102222|FG000|Overall Study|Adverse Event|0|||
126221358|NCT02059187|454102223|FG001|Overall Study|Adverse Event|3|||
126221359|NCT02059187|454102222|FG000|Overall Study|Death|1|||
126221360|NCT02059187|454102223|FG001|Overall Study|Death|1|||
126221361|NCT02059187|454102222|FG000|Overall Study|Lost to Follow-up|9|||
126221362|NCT02059187|454102223|FG001|Overall Study|Lost to Follow-up|8|||
126221363|NCT02059187|454102222|FG000|Overall Study|Non-compliance with study drug|1|||
126221364|NCT02059187|454102223|FG001|Overall Study|Non-compliance with study drug|0|||
126221365|NCT02059187|454102222|FG000|Overall Study|Physician Decision|1|||
126221366|NCT02059187|454102223|FG001|Overall Study|Physician Decision|2|||
126221367|NCT02059187|454102222|FG000|Overall Study|Protocol Violation|1|||
126221368|NCT02059187|454102223|FG001|Overall Study|Protocol Violation|0|||
126221369|NCT02059187|454102222|FG000|Overall Study|Withdrawal by Subject|12|||
126221370|NCT02059187|454102223|FG001|Overall Study|Withdrawal by Subject|8|||
126221371|NCT03070431|454102224|FG000|Overall Study|Withdrawal by Subject|2|||
126221372|NCT03070431|454102224|FG000|Overall Study|Lost to Follow-up|2|||
126221373|NCT01889862|454102225|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
126221374|NCT01889862|454102226|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
126221375|NCT01889862|454102227|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
126221376|NCT01889862|454102228|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
126221377|NCT01889862|454102229|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
126221378|NCT01889862|454102225|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
126221379|NCT01889862|454102226|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
126221380|NCT01889862|454102227|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
126221381|NCT01889862|454102228|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
126221382|NCT01889862|454102229|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
126221383|NCT01889862|454102225|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
126221384|NCT01889862|454102226|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
126221385|NCT01889862|454102227|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
126221386|NCT01889862|454102228|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
126221387|NCT01889862|454102229|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
126221388|NCT01889862|454102225|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
126221389|NCT01889862|454102226|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
126221390|NCT01889862|454102227|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
126221391|NCT01889862|454102228|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
126221392|NCT01889862|454102229|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
126221393|NCT01889862|454102225|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
126221394|NCT01889862|454102226|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
126221395|NCT01889862|454102227|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
126221396|NCT01889862|454102228|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
126221397|NCT01889862|454102229|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
126221398|NCT01889862|454102225|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
126221399|NCT01889862|454102226|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
126221400|NCT01889862|454102227|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
126221401|NCT01889862|454102228|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
126221402|NCT01889862|454102229|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
126221403|NCT01889862|454102225|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
126221404|NCT01889862|454102226|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
126221405|NCT01889862|454102227|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
126221406|NCT01889862|454102228|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
126221407|NCT01889862|454102229|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
126221408|NCT01889862|454102225|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
126221409|NCT01889862|454102226|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
126221410|NCT01889862|454102227|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
126350063|NCT01295944|454574118|FG000|Overall Study|Withdrawal by Subject|1|||
126350064|NCT01295944|454574118|FG000|Overall Study|Participant chose to be treated in Peru|1|||
126350065|NCT01295944|454574118|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
126350066|NCT01295944|454574118|FG000|Overall Study|Physician Decision|1|||
126221411|NCT01889862|454102228|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
126221412|NCT01889862|454102229|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
126350067|NCT01295944|454574118|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
126350068|NCT01295944|454574118|FG000|Overall Study|Disease progression|4|||
126350069|NCT01295944|454574118|FG000|Overall Study|Transferred care before starting new treatment|1|||
126350070|NCT02783274|454574120|FG000|Overall Study|Withdrawal by Subject|16|||
126350071|NCT02783274|454574120|FG000|Overall Study|Physician Decision|6|||
126350072|NCT02783274|454574120|FG000|Overall Study|Death|9|||
126350073|NCT02783274|454574120|FG000|Overall Study|Lost to Follow-up|22|||
126350074|NCT02783274|454574120|FG000|Overall Study|Other|22|||
126350075|NCT04635423|454574125|FG000|Overall Study|Ongoing|493|||
126350076|NCT04635423|454574126|FG001|Overall Study|Ongoing|501|||
126221413|NCT01889862|454102225|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
126221414|NCT01889862|454102226|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
126221415|NCT01889862|454102227|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
126221416|NCT01889862|454102228|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
126350077|NCT04635423|454574125|FG000|Overall Study|Withdrawal by Subject|36|||
126221417|NCT01889862|454102229|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
126350078|NCT04635423|454574126|FG001|Overall Study|Withdrawal by Subject|29|||
126221418|NCT01889862|454102225|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
126221419|NCT01889862|454102226|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
126221420|NCT01889862|454102227|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
126221421|NCT01889862|454102228|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
126221422|NCT01889862|454102229|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
126221423|NCT00845026|454102230|FG000|Study Period III|Adverse Event|23|||
126221424|NCT00845026|454102231|FG001|Study Period III|Adverse Event|19|||
126221425|NCT00845026|454102230|FG000|Study Period III|Perceived lack of efficacy|27|||
126221426|NCT00845026|454102231|FG001|Study Period III|Perceived lack of efficacy|15|||
126221427|NCT00845026|454102230|FG000|Study Period III|Withdrawal by Subject|19|||
126221428|NCT00845026|454102231|FG001|Study Period III|Withdrawal by Subject|15|||
126221429|NCT00845026|454102230|FG000|Study Period III|Entry Criteria not met|8|||
126221430|NCT00845026|454102231|FG001|Study Period III|Entry Criteria not met|11|||
126221431|NCT00845026|454102230|FG000|Study Period III|Lost to Follow-up|4|||
126221432|NCT00845026|454102231|FG001|Study Period III|Lost to Follow-up|5|||
126221433|NCT00845026|454102230|FG000|Study Period III|Protocol Violation|8|||
126221434|NCT00845026|454102231|FG001|Study Period III|Protocol Violation|1|||
126221435|NCT00845026|454102230|FG000|Study Period III|Scheduled conflict|3|||
126221436|NCT00845026|454102231|FG001|Study Period III|Scheduled conflict|1|||
126221437|NCT00845026|454102230|FG000|Study Period III|Subject is moving or has moved|2|||
126221438|NCT00845026|454102231|FG001|Study Period III|Subject is moving or has moved|4|||
126221439|NCT00845026|454102230|FG000|Study Period III|Transportation issues|1|||
126221440|NCT00845026|454102231|FG001|Study Period III|Transportation issues|1|||
126221441|NCT00845026|454102230|FG000|Study Period IV|Adverse Event|4|||
126221442|NCT00845026|454102231|FG001|Study Period IV|Adverse Event|0|||
126221443|NCT00845026|454102230|FG000|Study Period IV|Perceived lack of efficacy|2|||
126221444|NCT00845026|454102231|FG001|Study Period IV|Perceived lack of efficacy|1|||
126221445|NCT00845026|454102230|FG000|Study Period IV|Protocol Violation|3|||
126221446|NCT00845026|454102231|FG001|Study Period IV|Protocol Violation|1|||
126221447|NCT00845026|454102230|FG000|Study Period IV|Lost to Follow-up|1|||
126221448|NCT00845026|454102231|FG001|Study Period IV|Lost to Follow-up|0|||
126221449|NCT00845026|454102230|FG000|Study Period IV|Withdrawal by Subject|4|||
126221450|NCT00845026|454102231|FG001|Study Period IV|Withdrawal by Subject|1|||
126221451|NCT00845026|454102230|FG000|Study Period IV|Entry Criteria Not Met|1|||
126221452|NCT00845026|454102231|FG001|Study Period IV|Entry Criteria Not Met|0|||
126221453|NCT00845026|454102230|FG000|Study Period IV|Subject is moving or has moved|0|||
126221454|NCT00845026|454102231|FG001|Study Period IV|Subject is moving or has moved|1|||
126221455|NCT00845026|454102230|FG000|Study Period IV|Scheduling conflict|1|||
126221456|NCT00845026|454102231|FG001|Study Period IV|Scheduling conflict|0|||
126221457|NCT01325532|454102232|FG000|Overall Study|Withdrawal by Subject|2|||
126221458|NCT01325532|454102233|FG001|Overall Study|Withdrawal by Subject|0|||
126221459|NCT03012815|454102234|FG000|Overall Study|Lost to Follow-up|1|||
126221460|NCT03012815|454102235|FG001|Overall Study|Lost to Follow-up|0|||
126221461|NCT03012815|454102234|FG000|Overall Study|Physician Decision|3|||
126221462|NCT03012815|454102235|FG001|Overall Study|Physician Decision|2|||
126221463|NCT03012815|454102234|FG000|Overall Study|Adverse Event|1|||
126221464|NCT03012815|454102235|FG001|Overall Study|Adverse Event|0|||
126221465|NCT01252238|454102236|FG000|Overall Study|Sponsor terminated study|4|||
126221466|NCT01252238|454102237|FG001|Overall Study|Sponsor terminated study|4|||
126221467|NCT01252238|454102238|FG002|Overall Study|Sponsor terminated study|4|||
126221468|NCT00106028|454102248|FG000|Overall Study|Adverse Event|3|||
126221469|NCT00106028|454102249|FG001|Overall Study|Adverse Event|2|||
126221470|NCT00106028|454102248|FG000|Overall Study|Protocol Violation|1|||
126221471|NCT00106028|454102249|FG001|Overall Study|Protocol Violation|1|||
126221472|NCT00106028|454102248|FG000|Overall Study|Withdrawal by Subject|2|||
126221473|NCT00106028|454102249|FG001|Overall Study|Withdrawal by Subject|8|||
126221474|NCT00106028|454102248|FG000|Overall Study|Lost to Follow-up|0|||
126221475|NCT00106028|454102249|FG001|Overall Study|Lost to Follow-up|1|||
126350079|NCT05119569|454574131|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
126350080|NCT05119569|454574132|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
126350081|NCT05119569|454574133|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
126350082|NCT05119569|454574134|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
126350083|NCT05119569|454574131|FG000|Double Blind Treatment Phase|Adverse Event|6|||
126350084|NCT05119569|454574132|FG001|Double Blind Treatment Phase|Adverse Event|0|||
126350085|NCT05119569|454574133|FG002|Double Blind Treatment Phase|Adverse Event|0|||
126221476|NCT01280981|454102250|FG000|Overall Study|Withdrawal by Subject|11|||
126221477|NCT01280981|454102250|FG000|Overall Study|Protocol Violation|2|||
126221478|NCT01280981|454102250|FG000|Overall Study|Lack of Efficacy|13|||
126221479|NCT01280981|454102250|FG000|Overall Study|Lost to Follow-up|3|||
126350086|NCT05119569|454574134|FG003|Double Blind Treatment Phase|Adverse Event|0|||
126350087|NCT05119569|454574131|FG000|Open Label Extension Phase|Ongoing in the study|0|||
126350088|NCT05119569|454574132|FG001|Open Label Extension Phase|Ongoing in the study|0|||
126221480|NCT01280981|454102250|FG000|Overall Study|Adverse Event|6|||
126221481|NCT01280981|454102250|FG000|Overall Study|Irregular or discontinued menses|3|||
126221482|NCT01280981|454102250|FG000|Overall Study|Failed to return|45|||
126221483|NCT01280981|454102250|FG000|Overall Study|Non-compliance with protocol|3|||
126221484|NCT01280981|454102250|FG000|Overall Study|Withdrawal of consent|3|||
126221485|NCT01280981|454102250|FG000|Overall Study|Elective surgery|2|||
126221486|NCT01280981|454102250|FG000|Overall Study|Study site closure|1|||
126221487|NCT06371079|454102252|FG000|Overall Study|Missing data|88|||
126221488|NCT06371079|454102253|FG001|Overall Study|Missing data|247|||
126221489|NCT01256398|454102254|FG000|Overall Study|Withdrawal by Subject|1|||
126221490|NCT00411762|454102256|FG000|Overall Study|Withdrawal by Subject|5|||
126221491|NCT03276962|454102257|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
126221492|NCT03276962|454102258|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
126221493|NCT03276962|454102259|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
126221494|NCT03276962|454102260|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
126221495|NCT03276962|454102261|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
126221496|NCT03276962|454102257|FG000|Overall Study|Protocol Deviation|2|||
126221497|NCT03276962|454102258|FG001|Overall Study|Protocol Deviation|0|||
126221498|NCT03276962|454102259|FG002|Overall Study|Protocol Deviation|1|||
126221499|NCT03276962|454102260|FG003|Overall Study|Protocol Deviation|2|||
126221500|NCT03276962|454102261|FG004|Overall Study|Protocol Deviation|1|||
126221501|NCT03276962|454102257|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
126221502|NCT03276962|454102258|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
126221503|NCT03276962|454102259|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
126221504|NCT03276962|454102260|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
126221505|NCT03276962|454102261|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
126221506|NCT03276962|454102257|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
126221507|NCT03276962|454102258|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
126221508|NCT03276962|454102259|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
126221509|NCT03276962|454102260|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
126221510|NCT03276962|454102261|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
126221511|NCT03276962|454102257|FG000|Overall Study|Lost to Follow-up|10|||
126221512|NCT03276962|454102258|FG001|Overall Study|Lost to Follow-up|10|||
126221513|NCT03276962|454102259|FG002|Overall Study|Lost to Follow-up|4|||
126221514|NCT03276962|454102260|FG003|Overall Study|Lost to Follow-up|6|||
126221515|NCT03276962|454102261|FG004|Overall Study|Lost to Follow-up|10|||
126221516|NCT03276962|454102257|FG000|Overall Study|Other|0|||
126221517|NCT03276962|454102258|FG001|Overall Study|Other|2|||
126221518|NCT03276962|454102259|FG002|Overall Study|Other|0|||
126221519|NCT03276962|454102260|FG003|Overall Study|Other|2|||
126221520|NCT03276962|454102261|FG004|Overall Study|Other|1|||
126221521|NCT01238211|454102262|FG000|Overall Study|Continues active treatment|31|||
126221522|NCT01238211|454102262|FG000|Overall Study|Adverse Event|7|||
126221523|NCT01238211|454102262|FG000|Overall Study|Death|4|||
126221524|NCT01238211|454102262|FG000|Overall Study|Relapse/Progression|2|||
126221525|NCT01238211|454102262|FG000|Overall Study|Withdrawal by Subject|7|||
126221526|NCT01238211|454102262|FG000|Overall Study|Non-protocol treatment|4|||
126221527|NCT01238211|454102262|FG000|Overall Study|Investigator/Patient Decision|3|||
126221528|NCT04428502|454102263|FG000|Overall Study|Did not meet entrance criteria|14|||
126221529|NCT03550794|454102274|FG000|Overall Study|No longer met inclusion criteria|1|||
126221530|NCT03550794|454102275|FG001|Overall Study|No longer met inclusion criteria|2|||
126221531|NCT03550794|454102274|FG000|Overall Study|Goals of care changed|1|||
126221532|NCT03550794|454102275|FG001|Overall Study|Goals of care changed|0|||
126221533|NCT03550794|454102274|FG000|Overall Study|Withdrawal by Subject|2|||
126221534|NCT03550794|454102275|FG001|Overall Study|Withdrawal by Subject|0|||
126221535|NCT03550794|454102274|FG000|Overall Study|Death|0|||
126221536|NCT03550794|454102275|FG001|Overall Study|Death|1|||
126221537|NCT00449930|454102276|FG000|Overall Study|Adverse Event|9|||
126221538|NCT00449930|454102277|FG001|Overall Study|Adverse Event|19|||
126221539|NCT00449930|454102276|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
126221540|NCT00449930|454102277|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
126221541|NCT00449930|454102276|FG000|Overall Study|Lack of Efficacy|10|||
126221542|NCT00449930|454102277|FG001|Overall Study|Lack of Efficacy|1|||
126221543|NCT00449930|454102276|FG000|Overall Study|Lost to Follow-up|9|||
126221544|NCT00449930|454102277|FG001|Overall Study|Lost to Follow-up|14|||
126221545|NCT00449930|454102276|FG000|Overall Study|Physician Decision|1|||
126221546|NCT00449930|454102277|FG001|Overall Study|Physician Decision|2|||
126221547|NCT00449930|454102276|FG000|Overall Study|Protocol Violation|14|||
126221548|NCT00449930|454102277|FG001|Overall Study|Protocol Violation|15|||
126221549|NCT00449930|454102276|FG000|Overall Study|Withdrawal by Subject|16|||
126221550|NCT00449930|454102277|FG001|Overall Study|Withdrawal by Subject|23|||
126221551|NCT00449930|454102276|FG000|Overall Study|Glycemic discontinuation criteria|1|||
126221552|NCT00449930|454102277|FG001|Overall Study|Glycemic discontinuation criteria|1|||
126221553|NCT01864525|454102278|FG000|Overall Study|Adverse Event|1|||
126221554|NCT01864525|454102279|FG001|Overall Study|Adverse Event|0|||
126221555|NCT03712228|454102280|FG000|Treatment Period 1|Lack of Efficacy|0|||
126221556|NCT03712228|454102281|FG001|Treatment Period 1|Lack of Efficacy|0|||
126221557|NCT03712228|454102282|FG002|Treatment Period 1|Lack of Efficacy|0|||
126221558|NCT03712228|454102283|FG003|Treatment Period 1|Lack of Efficacy|0|||
126221559|NCT03712228|454102284|FG004|Treatment Period 1|Lack of Efficacy|0|||
126221560|NCT03712228|454102285|FG005|Treatment Period 1|Lack of Efficacy|1|||
126221561|NCT03712228|454102280|FG000|Treatment Period 2|Pregnancy|0|||
126221562|NCT03712228|454102281|FG001|Treatment Period 2|Pregnancy|0|||
126221563|NCT03712228|454102282|FG002|Treatment Period 2|Pregnancy|0|||
126221564|NCT03712228|454102283|FG003|Treatment Period 2|Pregnancy|1|||
126221565|NCT03712228|454102284|FG004|Treatment Period 2|Pregnancy|0|||
126221566|NCT03712228|454102285|FG005|Treatment Period 2|Pregnancy|0|||
126221567|NCT03712228|454102280|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126221568|NCT03712228|454102281|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126221569|NCT03712228|454102282|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126221570|NCT03712228|454102283|FG003|Treatment Period 2|Withdrawal by Subject|1|||
126221571|NCT03712228|454102284|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126221572|NCT03712228|454102285|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126221573|NCT01964105|454102286|FG000|Overall Study|Lost to Follow-up|2|||
126221574|NCT01964105|454102287|FG001|Overall Study|Lost to Follow-up|13|||
126221575|NCT01964105|454102288|FG002|Overall Study|Lost to Follow-up|0|||
126221576|NCT02295280|454102289|FG000|Overall Study|Adverse Event|0|||
126221577|NCT02295280|454102290|FG001|Overall Study|Adverse Event|1|||
126221578|NCT00558519|454102291|FG000|Overall Study|Ph+|20|||
126221579|NCT00558519|454102291|FG000|Overall Study|Ineligible|1|||
126221580|NCT00558519|454102291|FG000|Overall Study|Insufficient data|1|||
126221581|NCT00558519|454102291|FG000|Overall Study|Never received treatment|1|||
126221582|NCT03001011|454102292|FG000|Overall Study|Adverse Event|9|||
126221583|NCT03001011|454102293|FG001|Overall Study|Adverse Event|3|||
126221584|NCT03001011|454102292|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
126221585|NCT03001011|454102293|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
126221586|NCT03001011|454102292|FG000|Overall Study|Other than specified above|3|||
126221587|NCT03001011|454102293|FG001|Overall Study|Other than specified above|8|||
126221588|NCT02875067|454102294|FG000|Overall Study|Withdrawal by Subject|1|||
126221589|NCT02875067|454102294|FG000|Overall Study|Withdrawal by Termination of Study|5|||
126221590|NCT00065065|454102295|FG000|Overall Study|Adverse Event|3|||
126221591|NCT00065065|454102296|FG001|Overall Study|Adverse Event|2|||
126221592|NCT00065065|454102295|FG000|Overall Study|Withdrawal by Subject|1|||
126221593|NCT00065065|454102296|FG001|Overall Study|Withdrawal by Subject|5|||
126221594|NCT00065065|454102295|FG000|Overall Study|Lack of Efficacy|4|||
126221595|NCT00065065|454102296|FG001|Overall Study|Lack of Efficacy|11|||
126221596|NCT00065065|454102295|FG000|Overall Study|Other|2|||
126221597|NCT00065065|454102296|FG001|Overall Study|Other|2|||
126221598|NCT05288673|454102300|FG000|Overall Study|Consent withdrawn by subject|0|||
126221599|NCT05288673|454102301|FG001|Overall Study|Consent withdrawn by subject|0|||
126221600|NCT05288673|454102302|FG002|Overall Study|Consent withdrawn by subject|1|||
126221601|NCT01050673|454102303|FG000|Overall Study|Physician Decision|4|||
126221602|NCT01050673|454102304|FG001|Overall Study|Physician Decision|5|||
126221603|NCT03056352|454102305|FG000|Overall Study|Lost to Follow-up|1|||
126221604|NCT00124449|454102310|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
126221605|NCT00124449|454102311|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
126221606|NCT00124449|454102310|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
126350089|NCT05119569|454574133|FG002|Open Label Extension Phase|Ongoing in the study|65|||
126350090|NCT05119569|454574134|FG003|Open Label Extension Phase|Ongoing in the study|34|||
126350091|NCT03980223|454574135|FG000|Overall Study|Lost to Follow-up|3|||
126350092|NCT03980223|454574136|FG001|Overall Study|Lost to Follow-up|7|||
126221607|NCT00124449|454102311|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
126221608|NCT00124449|454102310|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
126221609|NCT00124449|454102311|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
126221610|NCT00124449|454102310|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
126221611|NCT00124449|454102311|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
126221612|NCT00124449|454102310|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
126221613|NCT00124449|454102311|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
126221614|NCT00124449|454102310|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
126221615|NCT00124449|454102311|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
126221616|NCT00124449|454102310|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
126221617|NCT00124449|454102311|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
126221618|NCT00124449|454102310|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
126221619|NCT00124449|454102311|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
126221620|NCT00124449|454102310|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
126221621|NCT00124449|454102311|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
126221622|NCT00124449|454102310|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
126221623|NCT00124449|454102311|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
126221624|NCT00124449|454102310|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
126221625|NCT00124449|454102311|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
126221626|NCT00124449|454102310|FG000|18-Month Untreated Observation Period|Relocated|1|||
126221627|NCT00124449|454102311|FG001|18-Month Untreated Observation Period|Relocated|0|||
126221628|NCT01254045|454102312|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
126221629|NCT01254045|454102313|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126221630|NCT01254045|454102314|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126221631|NCT01254045|454102315|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126221632|NCT01254045|454102316|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126221633|NCT01254045|454102317|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126221634|NCT02971605|454102318|FG000|Overall Study|Withdrawal by Subject|1|||
126221635|NCT00597207|454102319|FG000|Overall Study|Lost to Follow-up|5|||
126221636|NCT00597207|454102320|FG001|Overall Study|Lost to Follow-up|7|||
126221637|NCT00520351|454102321|FG000|First Intervention|Withdrawal by Subject|1|||
126221638|NCT00520351|454102322|FG001|First Intervention|Withdrawal by Subject|1|||
126221639|NCT02278952|454102323|FG000|Overall Study|Insufficient Sample|6|||
126221640|NCT00869089|454102329|FG000|Overall Study|Lost to Follow-up|1|||
126221641|NCT00869089|454102329|FG000|Overall Study|Withdrawal by Subject|1|||
126221642|NCT00869089|454102329|FG000|Overall Study|Screen Fail|1|||
126221643|NCT01963676|454103763|FG000|Overall Study|Withdrawal by Subject|1|||
126221644|NCT01963676|454103764|FG001|Overall Study|Withdrawal by Subject|0|||
126221645|NCT01246973|454103765|FG000|Overall Study|Other|38|||
126221646|NCT01246973|454103766|FG001|Overall Study|Other|25|||
126221647|NCT01246973|454103765|FG000|Overall Study|Adverse Event|16|||
126221648|NCT01246973|454103766|FG001|Overall Study|Adverse Event|9|||
126221649|NCT01246973|454103765|FG000|Overall Study|Withdrawal by Subject|7|||
126221650|NCT01246973|454103766|FG001|Overall Study|Withdrawal by Subject|13|||
126221651|NCT00766506|454103767|FG000|Overall Study|Use rescue medication after 3 hours|3|||
126221652|NCT00766506|454103768|FG001|Overall Study|Use rescue medication after 3 hours|0|||
126221653|NCT00766506|454103767|FG000|Overall Study|Other|2|||
126221654|NCT00766506|454103768|FG001|Overall Study|Other|2|||
126221655|NCT02496221|454103769|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
126221656|NCT02496221|454103770|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
126221657|NCT02496221|454103769|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
126221658|NCT02496221|454103770|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
126221659|NCT02496221|454103769|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
126221660|NCT02496221|454103770|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
126221661|NCT03262233|454103771|FG000|Overall Study|Withdrawal by Subject|12|||
126221662|NCT03262233|454103772|FG001|Overall Study|Withdrawal by Subject|8|||
126221663|NCT03262233|454103773|FG002|Overall Study|Withdrawal by Subject|21|||
126221664|NCT03262233|454103774|FG003|Overall Study|Withdrawal by Subject|13|||
126221665|NCT03262233|454103771|FG000|Overall Study|Declined due to shock|1|||
126018179|NCT01576484|453360606|FG001|Overall Study|Sponsor Decision|8|||
126018180|NCT01576484|453360605|FG000|Overall Study|Withdrawal by Subject|0|||
126018181|NCT01576484|453360606|FG001|Overall Study|Withdrawal by Subject|3|||
126221666|NCT03262233|454103772|FG001|Overall Study|Declined due to shock|2|||
126018182|NCT01576484|453360605|FG000|Overall Study|Other|2|||
126221667|NCT03262233|454103773|FG002|Overall Study|Declined due to shock|2|||
126221668|NCT03262233|454103774|FG003|Overall Study|Declined due to shock|3|||
126221669|NCT03262233|454103771|FG000|Overall Study|Protocol Violation|5|||
126221670|NCT03262233|454103772|FG001|Overall Study|Protocol Violation|10|||
126221671|NCT03262233|454103773|FG002|Overall Study|Protocol Violation|2|||
126221672|NCT03262233|454103774|FG003|Overall Study|Protocol Violation|13|||
126018183|NCT01576484|453360606|FG001|Overall Study|Other|5|||
126221673|NCT03262233|454103771|FG000|Overall Study|data collection artifact|0|||
126221674|NCT03262233|454103772|FG001|Overall Study|data collection artifact|1|||
126221675|NCT03262233|454103773|FG002|Overall Study|data collection artifact|0|||
126221676|NCT03262233|454103774|FG003|Overall Study|data collection artifact|0|||
126221677|NCT01120600|454103777|FG000|Overall Study|Adverse Event|7|||
126221678|NCT01120600|454103778|FG001|Overall Study|Adverse Event|7|||
126221679|NCT01120600|454103777|FG000|Overall Study|Excessive Bone Loss|0|||
126221680|NCT01120600|454103778|FG001|Overall Study|Excessive Bone Loss|4|||
126221681|NCT01120600|454103777|FG000|Overall Study|Lost to Follow-up|1|||
126221682|NCT01120600|454103778|FG001|Overall Study|Lost to Follow-up|3|||
126221683|NCT01120600|454103777|FG000|Overall Study|Physician Decision|1|||
126221684|NCT01120600|454103778|FG001|Overall Study|Physician Decision|3|||
126221685|NCT01120600|454103777|FG000|Overall Study|Protocol Violation|0|||
126221686|NCT01120600|454103778|FG001|Overall Study|Protocol Violation|4|||
126221687|NCT01120600|454103777|FG000|Overall Study|Withdrawal by Subject|10|||
126221688|NCT01120600|454103778|FG001|Overall Study|Withdrawal by Subject|11|||
126221689|NCT01165242|454103779|FG000|Overall Study|Unreachable Subjects|1|||
126221690|NCT01165242|454103780|FG001|Overall Study|Unreachable Subjects|0|||
126221691|NCT01165242|454103781|FG002|Overall Study|Unreachable Subjects|0|||
126221692|NCT01165242|454103779|FG000|Overall Study|Incarcerated Subjects|0|||
126221693|NCT01165242|454103780|FG001|Overall Study|Incarcerated Subjects|1|||
126221694|NCT01165242|454103781|FG002|Overall Study|Incarcerated Subjects|0|||
126221695|NCT01165242|454103779|FG000|Overall Study|Visit 2 Declined by Subject|0|||
126221696|NCT01165242|454103780|FG001|Overall Study|Visit 2 Declined by Subject|0|||
126221697|NCT01165242|454103781|FG002|Overall Study|Visit 2 Declined by Subject|1|||
126221698|NCT01165242|454103779|FG000|Overall Study|Withdrawal by Subject|0|||
126221699|NCT01165242|454103780|FG001|Overall Study|Withdrawal by Subject|2|||
126221700|NCT01165242|454103781|FG002|Overall Study|Withdrawal by Subject|2|||
126221701|NCT01165242|454103779|FG000|Overall Study|Extended Holiday|0|||
126221702|NCT01165242|454103780|FG001|Overall Study|Extended Holiday|0|||
126221703|NCT01165242|454103781|FG002|Overall Study|Extended Holiday|1|||
126221704|NCT01165242|454103779|FG000|Overall Study|Lost to Follow-up|9|||
126221705|NCT01165242|454103780|FG001|Overall Study|Lost to Follow-up|7|||
126221706|NCT01165242|454103781|FG002|Overall Study|Lost to Follow-up|10|||
126221707|NCT03770000|454103782|FG000|Overall Study|Premature discontinuation due to PD|0|||
126221708|NCT03770000|454103783|FG001|Overall Study|Premature discontinuation due to PD|0|||
126221709|NCT03770000|454103784|FG002|Overall Study|Premature discontinuation due to PD|1|||
126221710|NCT03770000|454103785|FG003|Overall Study|Premature discontinuation due to PD|3|||
126221711|NCT03770000|454103786|FG004|Overall Study|Premature discontinuation due to PD|2|||
126221712|NCT03877237|454103787|FG000|Overall Study|Adverse Event|1|||
126221713|NCT03877237|454103788|FG001|Overall Study|Adverse Event|2|||
126221714|NCT03877237|454103787|FG000|Overall Study|Death|3|||
126221715|NCT03877237|454103788|FG001|Overall Study|Death|2|||
126221716|NCT03877237|454103787|FG000|Overall Study|Physician Decision|1|||
126221717|NCT03877237|454103788|FG001|Overall Study|Physician Decision|0|||
126221718|NCT03877237|454103787|FG000|Overall Study|Withdrawal by Subject|0|||
126221719|NCT03877237|454103788|FG001|Overall Study|Withdrawal by Subject|2|||
126221720|NCT00566098|454103791|FG000|Collection of MILs|Withdrawal by Subject|1|||
126221721|NCT00566098|454103791|FG000|Collection of MILs|Relapsed|1|||
126221722|NCT00566098|454103791|FG000|Generation of MILs Product|Relapsed|1|||
126221723|NCT00566098|454103791|FG000|Administration of ASCT+MILs|Death|10|||
126221724|NCT00566098|454103791|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
126221725|NCT01690520|454103794|FG000|Overall Study|Death|25|||
126221726|NCT01690520|454103795|FG001|Overall Study|Death|21|||
126221727|NCT01690520|454103794|FG000|Overall Study|Lost to Follow-up|2|||
126221728|NCT01690520|454103795|FG001|Overall Study|Lost to Follow-up|3|||
126221729|NCT01690520|454103794|FG000|Overall Study|Withdrawal by Subject|2|||
126350093|NCT03980223|454574137|FG002|Overall Study|Lost to Follow-up|10|||
126350094|NCT03980223|454574138|FG003|Overall Study|Lost to Follow-up|8|||
126350095|NCT03980223|454574135|FG000|Overall Study|Withdrawal by Subject|0|||
126350096|NCT03980223|454574136|FG001|Overall Study|Withdrawal by Subject|0|||
126350097|NCT03980223|454574137|FG002|Overall Study|Withdrawal by Subject|1|||
126350098|NCT03980223|454574138|FG003|Overall Study|Withdrawal by Subject|2|||
126221730|NCT01690520|454103795|FG001|Overall Study|Withdrawal by Subject|0|||
126221731|NCT01690520|454103794|FG000|Overall Study|Relapse|0|||
126221732|NCT01690520|454103795|FG001|Overall Study|Relapse|1|||
126221733|NCT01690520|454103794|FG000|Overall Study|Other|0|||
126221734|NCT01690520|454103795|FG001|Overall Study|Other|1|||
126221735|NCT01690520|454103794|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
126221736|NCT01690520|454103795|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
126221737|NCT02236754|454103796|FG000|Overall Study|Withdrawal by Subject|1|||
126350099|NCT03980223|454574135|FG000|Overall Study|Physician Decision|0|||
126221738|NCT02236754|454103797|FG001|Overall Study|Withdrawal by Subject|0|||
126221739|NCT04006847|454103798|FG000|Overall Study|Product issue|1|||
126221740|NCT00382291|454103799|FG000|Overall Study|Adverse Event|1|||
126221741|NCT00382291|454103800|FG001|Overall Study|Adverse Event|2|||
126221742|NCT00382291|454103801|FG002|Overall Study|Adverse Event|2|||
126221743|NCT00382291|454103799|FG000|Overall Study|Protocol Violation|1|||
126221744|NCT00382291|454103800|FG001|Overall Study|Protocol Violation|0|||
126221745|NCT00382291|454103801|FG002|Overall Study|Protocol Violation|0|||
126221746|NCT00382291|454103799|FG000|Overall Study|Temporary study suspension|2|||
126221747|NCT00382291|454103800|FG001|Overall Study|Temporary study suspension|2|||
126221748|NCT00382291|454103801|FG002|Overall Study|Temporary study suspension|5|||
126221749|NCT00382291|454103799|FG000|Overall Study|Withdrawal by Subject|0|||
126221750|NCT00382291|454103800|FG001|Overall Study|Withdrawal by Subject|2|||
126221751|NCT00382291|454103801|FG002|Overall Study|Withdrawal by Subject|0|||
126221752|NCT00382291|454103799|FG000|Overall Study|Physician Decision|0|||
126221753|NCT00382291|454103800|FG001|Overall Study|Physician Decision|1|||
126221754|NCT00382291|454103801|FG002|Overall Study|Physician Decision|0|||
126221755|NCT00382291|454103799|FG000|Overall Study|Lack of Efficacy|0|||
126221756|NCT00382291|454103800|FG001|Overall Study|Lack of Efficacy|0|||
126221757|NCT00382291|454103801|FG002|Overall Study|Lack of Efficacy|1|||
126221758|NCT01375010|454103802|FG000|Overall Study|Lost to Follow-up|8|||
126221759|NCT01375010|454103803|FG001|Overall Study|Lost to Follow-up|2|||
126221760|NCT01375010|454103802|FG000|Overall Study|Withdrawal by Subject|4|||
126221761|NCT01375010|454103803|FG001|Overall Study|Withdrawal by Subject|2|||
126221762|NCT02614703|454103804|FG000|Overall Study|Withdrawal by Subject|7|||
126221763|NCT02614703|454103805|FG001|Overall Study|Withdrawal by Subject|1|||
126221764|NCT02402933|454103806|FG000|Overall Study|Withdrawal by Subject|4|||
126221765|NCT02402933|454103806|FG000|Overall Study|Discontinued; Site Termination|10|||
126221766|NCT01681771|454103811|FG000|Overall Study|Lost to Follow-up|4|||
126221767|NCT01681771|454103812|FG001|Overall Study|Lost to Follow-up|2|||
126221768|NCT02919475|454103820|FG000|Overall Study|Adverse Event|3|||
126221769|NCT02919475|454103821|FG001|Overall Study|Adverse Event|3|||
126221770|NCT02919475|454103822|FG002|Overall Study|Adverse Event|3|||
126221771|NCT02919475|454103823|FG003|Overall Study|Adverse Event|9|||
126221772|NCT02919475|454103824|FG004|Overall Study|Adverse Event|2|||
126221773|NCT02919475|454103820|FG000|Overall Study|Death|0|||
126221774|NCT02919475|454103821|FG001|Overall Study|Death|1|||
126221775|NCT02919475|454103822|FG002|Overall Study|Death|0|||
126221776|NCT02919475|454103823|FG003|Overall Study|Death|0|||
126221777|NCT02919475|454103824|FG004|Overall Study|Death|0|||
126221778|NCT02919475|454103820|FG000|Overall Study|Lost to Follow-up|0|||
126221779|NCT02919475|454103821|FG001|Overall Study|Lost to Follow-up|0|||
126221780|NCT02919475|454103822|FG002|Overall Study|Lost to Follow-up|0|||
126221781|NCT02919475|454103823|FG003|Overall Study|Lost to Follow-up|1|||
126221782|NCT02919475|454103824|FG004|Overall Study|Lost to Follow-up|0|||
126221783|NCT02919475|454103820|FG000|Overall Study|Withdrawal by Subject|2|||
126221784|NCT02919475|454103821|FG001|Overall Study|Withdrawal by Subject|3|||
126221785|NCT02919475|454103822|FG002|Overall Study|Withdrawal by Subject|1|||
126221786|NCT02919475|454103823|FG003|Overall Study|Withdrawal by Subject|2|||
126221787|NCT02919475|454103824|FG004|Overall Study|Withdrawal by Subject|2|||
126221788|NCT02919475|454103820|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126221789|NCT02919475|454103821|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126221790|NCT02919475|454103822|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126221791|NCT02919475|454103823|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126221792|NCT02919475|454103824|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126221793|NCT01847313|454103828|FG000|Overall Study|Death|0|||
126221794|NCT01847313|454103829|FG001|Overall Study|Death|1|||
126221795|NCT01847313|454103828|FG000|Overall Study|Withdrawal by Subject|0|||
126221796|NCT01847313|454103829|FG001|Overall Study|Withdrawal by Subject|1|||
126221797|NCT00775983|454103830|FG000|Overall Study|Protocol Violation|1|||
126221798|NCT00775983|454103831|FG001|Overall Study|Protocol Violation|2|||
126221799|NCT02962882|454103832|FG000|Overall Study|Adverse Event|2|||
126221800|NCT02962882|454103832|FG000|Overall Study|Withdrawal by Subject|2|||
126221801|NCT02962882|454103832|FG000|Overall Study|Transfer from ICU|32|||
126221802|NCT01663714|454103835|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
126221803|NCT01663714|454103835|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
126221804|NCT01663714|454103835|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
126221805|NCT01663714|454103835|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
126221806|NCT01663714|454103835|FG000|Long-Term Follow-Up|Death|4|||
126221807|NCT01663714|454103835|FG000|Long-Term Follow-Up|Non-compliance|1|||
126221808|NCT00597584|454103836|FG000|Overall Study|Adverse Event|4|||
126221809|NCT00597584|454103837|FG001|Overall Study|Adverse Event|2|||
126221810|NCT00597584|454103836|FG000|Overall Study|Death|53|||
126221811|NCT00597584|454103837|FG001|Overall Study|Death|30|||
126221812|NCT00597584|454103836|FG000|Overall Study|Lack of Efficacy|1|||
126221813|NCT00597584|454103837|FG001|Overall Study|Lack of Efficacy|0|||
126221814|NCT00597584|454103836|FG000|Overall Study|Lost to Follow-up|2|||
126221815|NCT00597584|454103837|FG001|Overall Study|Lost to Follow-up|4|||
126221816|NCT00597584|454103836|FG000|Overall Study|Physician Decision|3|||
126221817|NCT00597584|454103837|FG001|Overall Study|Physician Decision|0|||
126221818|NCT00597584|454103836|FG000|Overall Study|Pregnancy|2|||
126221819|NCT00597584|454103837|FG001|Overall Study|Pregnancy|0|||
126221820|NCT00597584|454103836|FG000|Overall Study|Withdrawal by Subject|44|||
126221821|NCT00597584|454103837|FG001|Overall Study|Withdrawal by Subject|12|||
126221822|NCT00597584|454103836|FG000|Overall Study|Discontinued Dialysis|0|||
126221823|NCT00597584|454103837|FG001|Overall Study|Discontinued Dialysis|1|||
126221824|NCT00597584|454103836|FG000|Overall Study|Lost ability to consent|1|||
126221825|NCT00597584|454103837|FG001|Overall Study|Lost ability to consent|1|||
126221826|NCT00597584|454103836|FG000|Overall Study|Never dosed|1|||
126221827|NCT00597584|454103837|FG001|Overall Study|Never dosed|0|||
126221828|NCT00597584|454103836|FG000|Overall Study|Relocation|8|||
126221829|NCT00597584|454103837|FG001|Overall Study|Relocation|6|||
126221830|NCT00597584|454103836|FG000|Overall Study|Renal transplant|9|||
126221831|NCT00597584|454103837|FG001|Overall Study|Renal transplant|7|||
126221832|NCT00660790|454103838|FG000|Baseline to 3 Months|Death|1|||
126221833|NCT00660790|454103838|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
126221834|NCT00660790|454103838|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
126221835|NCT02791659|454103839|FG000|Overall Study|Protocol Violation|0|||
126221836|NCT02791659|454103840|FG001|Overall Study|Protocol Violation|1|||
126221837|NCT03840811|454103841|FG000|Overall Study|Lost to Follow-up|0|||
126221838|NCT03840811|454103842|FG001|Overall Study|Lost to Follow-up|0|||
126221839|NCT03840811|454103843|FG002|Overall Study|Lost to Follow-up|1|||
126221840|NCT01904383|454103844|FG000|Overall Study|CRF not collected|117|||
126221841|NCT01904383|454103844|FG000|Overall Study|Reason not listed|147|||
126221842|NCT01904383|454103844|FG000|Overall Study|Lost to Follow-up|674|||
126221843|NCT01904383|454103844|FG000|Overall Study|Lack of Efficacy|370|||
126221844|NCT01904383|454103844|FG000|Overall Study|Improvement|141|||
126221845|NCT01904383|454103844|FG000|Overall Study|Adverse Event|271|||
126221846|NCT01904383|454103844|FG000|Overall Study|No patient visit after entry|54|||
126221847|NCT01625845|454103845|FG000|Overall Study|Adverse Event|1|||
126221848|NCT01625845|454103846|FG001|Overall Study|Adverse Event|2|||
126221849|NCT01625845|454103845|FG000|Overall Study|Lost to Follow-up|2|||
126221850|NCT01625845|454103846|FG001|Overall Study|Lost to Follow-up|1|||
126221851|NCT01625845|454103845|FG000|Overall Study|Withdrawal by Subject|2|||
126221852|NCT01625845|454103846|FG001|Overall Study|Withdrawal by Subject|0|||
126221853|NCT01294592|454103847|FG000|Overall Study|Adverse Event|28|||
126221854|NCT01294592|454103848|FG001|Overall Study|Adverse Event|13|||
126221855|NCT01294592|454103847|FG000|Overall Study|Lack of Efficacy|7|||
126221856|NCT01294592|454103848|FG001|Overall Study|Lack of Efficacy|5|||
126221857|NCT01294592|454103847|FG000|Overall Study|Protocol Violation|1|||
126221858|NCT01294592|454103848|FG001|Overall Study|Protocol Violation|7|||
126221859|NCT01294592|454103847|FG000|Overall Study|Lost to Follow-up|7|||
126221860|NCT01294592|454103848|FG001|Overall Study|Lost to Follow-up|9|||
126221861|NCT01294592|454103847|FG000|Overall Study|Physician Decision|6|||
126221862|NCT01294592|454103848|FG001|Overall Study|Physician Decision|11|||
126221863|NCT01294592|454103847|FG000|Overall Study|Withdrawal by Subject|28|||
126221864|NCT01294592|454103848|FG001|Overall Study|Withdrawal by Subject|28|||
126221865|NCT02762565|454103849|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
126221866|NCT03549130|454103850|FG000|Overall Study|Adverse Event|0|||
126221867|NCT03549130|454103851|FG001|Overall Study|Adverse Event|1|||
126221868|NCT03549130|454103850|FG000|Overall Study|Lost to Follow-up|0|||
126221869|NCT03549130|454103851|FG001|Overall Study|Lost to Follow-up|1|||
126221870|NCT01078623|454103852|FG000|Treatment Period 1|Adverse Event|1|||
126221871|NCT01078623|454103853|FG001|Treatment Period 1|Adverse Event|1|||
126350100|NCT03980223|454574136|FG001|Overall Study|Physician Decision|0|||
126350101|NCT03980223|454574137|FG002|Overall Study|Physician Decision|1|||
126350102|NCT03980223|454574138|FG003|Overall Study|Physician Decision|0|||
126350103|NCT03980223|454574135|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
126350104|NCT03980223|454574136|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
126350105|NCT03980223|454574137|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
126350106|NCT03980223|454574138|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
126350107|NCT06239610|454574139|FG000|Overall Study|no usable migration data for minimum of one day|11|||
126350108|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
126350109|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
126350110|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
126221872|NCT01078623|454103854|FG002|Treatment Period 1|Adverse Event|1|||
126018184|NCT01943799|453360608|FG000|Overall Study|Lost to Follow-up|0|||
126018185|NCT01943799|453360609|FG001|Overall Study|Lost to Follow-up|1|||
126221873|NCT01078623|454103855|FG003|Treatment Period 1|Adverse Event|0|||
126221874|NCT01078623|454103856|FG004|Treatment Period 1|Adverse Event|0|||
126221875|NCT01078623|454103857|FG005|Treatment Period 1|Adverse Event|0|||
126221876|NCT01078623|454103858|FG006|Treatment Period 1|Adverse Event|1|||
126221877|NCT01078623|454103859|FG007|Treatment Period 1|Adverse Event|0|||
126221878|NCT01078623|454103860|FG008|Treatment Period 1|Adverse Event|1|||
126221879|NCT01078623|454103861|FG009|Treatment Period 1|Adverse Event|1|||
126221880|NCT01078623|454103862|FG010|Treatment Period 1|Adverse Event|0|||
126221881|NCT01078623|454103863|FG011|Treatment Period 1|Adverse Event|0|||
126221882|NCT01078623|454103864|FG012|Treatment Period 1|Adverse Event|0|||
126221883|NCT01078623|454103865|FG013|Treatment Period 1|Adverse Event|0|||
126221884|NCT01078623|454103866|FG014|Treatment Period 1|Adverse Event|0|||
126221885|NCT01078623|454103867|FG015|Treatment Period 1|Adverse Event|0|||
126221886|NCT01078623|454103868|FG016|Treatment Period 1|Adverse Event|0|||
126221887|NCT01078623|454103869|FG017|Treatment Period 1|Adverse Event|0|||
126221888|NCT01078623|454103870|FG018|Treatment Period 1|Adverse Event|0|||
126221889|NCT01078623|454103871|FG019|Treatment Period 1|Adverse Event|0|||
126221890|NCT01078623|454103852|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126018186|NCT01943799|453360610|FG002|Overall Study|Lost to Follow-up|1|||
126018187|NCT01943799|453360611|FG003|Overall Study|Lost to Follow-up|0|||
126018188|NCT01943799|453360608|FG000|Overall Study|Protocol Violation|1|||
126018189|NCT01943799|453360609|FG001|Overall Study|Protocol Violation|0|||
126018190|NCT01943799|453360610|FG002|Overall Study|Protocol Violation|0|||
126018191|NCT01943799|453360611|FG003|Overall Study|Protocol Violation|0|||
126018192|NCT01943799|453360608|FG000|Overall Study|Withdrawal by Subject|4|||
126018193|NCT01943799|453360609|FG001|Overall Study|Withdrawal by Subject|2|||
126018194|NCT01943799|453360610|FG002|Overall Study|Withdrawal by Subject|1|||
126018195|NCT01943799|453360611|FG003|Overall Study|Withdrawal by Subject|0|||
126018196|NCT04594759|453360612|FG000|Overall Study|Lost to Follow-up|3|||
126018197|NCT03811574|453360613|FG000|Overall Study|Withdrawal by Subject|2|||
126018198|NCT03811574|453360614|FG001|Overall Study|Withdrawal by Subject|4|||
126018199|NCT03811574|453360615|FG002|Overall Study|Withdrawal by Subject|0|||
126018200|NCT01832480|453360616|FG000|Overall Study|Lost to Follow-up|33|||
126018201|NCT01832480|453360617|FG001|Overall Study|Lost to Follow-up|30|||
126221891|NCT01078623|454103853|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126221892|NCT01078623|454103854|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126018202|NCT01832480|453360616|FG000|Overall Study|Withdrawal by Subject|0|||
126018203|NCT01832480|453360617|FG001|Overall Study|Withdrawal by Subject|2|||
126018204|NCT01832480|453360616|FG000|Overall Study|post randomization ineligible|8|||
126018205|NCT01832480|453360617|FG001|Overall Study|post randomization ineligible|10|||
126018206|NCT00958633|453360618|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
126018207|NCT00958633|453360619|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
126018208|NCT00958633|453360620|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
126018209|NCT00958633|453360618|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
126018210|NCT00958633|453360619|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
126018211|NCT00958633|453360620|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
126221893|NCT01078623|454103855|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126221894|NCT01078623|454103856|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126221895|NCT01078623|454103857|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126221896|NCT01078623|454103858|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126221897|NCT01078623|454103859|FG007|Treatment Period 1|Withdrawal by Subject|1|||
126221898|NCT01078623|454103860|FG008|Treatment Period 1|Withdrawal by Subject|0|||
126018212|NCT00958633|453360618|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
126018213|NCT00958633|453360619|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
126221899|NCT01078623|454103861|FG009|Treatment Period 1|Withdrawal by Subject|0|||
126221900|NCT01078623|454103862|FG010|Treatment Period 1|Withdrawal by Subject|1|||
126221901|NCT01078623|454103863|FG011|Treatment Period 1|Withdrawal by Subject|0|||
126221902|NCT01078623|454103864|FG012|Treatment Period 1|Withdrawal by Subject|0|||
126221903|NCT01078623|454103865|FG013|Treatment Period 1|Withdrawal by Subject|0|||
126221904|NCT01078623|454103866|FG014|Treatment Period 1|Withdrawal by Subject|0|||
126018214|NCT00958633|453360620|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
126221905|NCT01078623|454103867|FG015|Treatment Period 1|Withdrawal by Subject|0|||
126221906|NCT01078623|454103868|FG016|Treatment Period 1|Withdrawal by Subject|0|||
126018215|NCT00958633|453360618|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
126018216|NCT00958633|453360619|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
126018217|NCT00958633|453360620|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
126221907|NCT01078623|454103869|FG017|Treatment Period 1|Withdrawal by Subject|0|||
126221908|NCT01078623|454103870|FG018|Treatment Period 1|Withdrawal by Subject|0|||
126221909|NCT01078623|454103871|FG019|Treatment Period 1|Withdrawal by Subject|0|||
126221910|NCT01078623|454103852|FG000|Treatment Period 1|Protocol Violation|0|||
126221911|NCT01078623|454103853|FG001|Treatment Period 1|Protocol Violation|0|||
126018218|NCT00958633|453360618|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
126221912|NCT01078623|454103854|FG002|Treatment Period 1|Protocol Violation|0|||
126018219|NCT00958633|453360619|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
126018220|NCT00958633|453360620|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
126018221|NCT00958633|453360618|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
126018222|NCT00958633|453360619|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
126018223|NCT00958633|453360620|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
126018224|NCT00958633|453360618|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
126046464|NCT02467270|453468226|FG000|Overall Study|Non-compliance With Study Drug|0|||
126221913|NCT01078623|454103855|FG003|Treatment Period 1|Protocol Violation|0|||
126221914|NCT01078623|454103856|FG004|Treatment Period 1|Protocol Violation|0|||
126221915|NCT01078623|454103857|FG005|Treatment Period 1|Protocol Violation|1|||
126221916|NCT01078623|454103858|FG006|Treatment Period 1|Protocol Violation|0|||
126221917|NCT01078623|454103859|FG007|Treatment Period 1|Protocol Violation|0|||
126221918|NCT01078623|454103860|FG008|Treatment Period 1|Protocol Violation|0|||
126221919|NCT01078623|454103861|FG009|Treatment Period 1|Protocol Violation|0|||
126221920|NCT01078623|454103862|FG010|Treatment Period 1|Protocol Violation|0|||
126221921|NCT01078623|454103863|FG011|Treatment Period 1|Protocol Violation|0|||
126221922|NCT01078623|454103864|FG012|Treatment Period 1|Protocol Violation|0|||
126221923|NCT01078623|454103865|FG013|Treatment Period 1|Protocol Violation|0|||
126221924|NCT01078623|454103866|FG014|Treatment Period 1|Protocol Violation|0|||
126221925|NCT01078623|454103867|FG015|Treatment Period 1|Protocol Violation|0|||
126221926|NCT01078623|454103868|FG016|Treatment Period 1|Protocol Violation|0|||
126221927|NCT01078623|454103869|FG017|Treatment Period 1|Protocol Violation|0|||
126221928|NCT01078623|454103870|FG018|Treatment Period 1|Protocol Violation|0|||
126221929|NCT01078623|454103871|FG019|Treatment Period 1|Protocol Violation|0|||
126221930|NCT01078623|454103852|FG000|Treatment Period 2|Adverse Event|0|||
126221931|NCT01078623|454103853|FG001|Treatment Period 2|Adverse Event|0|||
126221932|NCT01078623|454103854|FG002|Treatment Period 2|Adverse Event|0|||
126221933|NCT01078623|454103855|FG003|Treatment Period 2|Adverse Event|0|||
126221934|NCT01078623|454103856|FG004|Treatment Period 2|Adverse Event|0|||
126221935|NCT01078623|454103857|FG005|Treatment Period 2|Adverse Event|0|||
126221936|NCT01078623|454103858|FG006|Treatment Period 2|Adverse Event|1|||
126221937|NCT01078623|454103859|FG007|Treatment Period 2|Adverse Event|0|||
126221938|NCT01078623|454103860|FG008|Treatment Period 2|Adverse Event|0|||
126221939|NCT01078623|454103861|FG009|Treatment Period 2|Adverse Event|0|||
126221940|NCT01078623|454103862|FG010|Treatment Period 2|Adverse Event|0|||
126221941|NCT01078623|454103863|FG011|Treatment Period 2|Adverse Event|0|||
126221942|NCT01078623|454103864|FG012|Treatment Period 2|Adverse Event|0|||
126221943|NCT01078623|454103865|FG013|Treatment Period 2|Adverse Event|0|||
126221944|NCT01078623|454103866|FG014|Treatment Period 2|Adverse Event|0|||
126221945|NCT01078623|454103867|FG015|Treatment Period 2|Adverse Event|0|||
126221946|NCT01078623|454103868|FG016|Treatment Period 2|Adverse Event|0|||
126221947|NCT01078623|454103869|FG017|Treatment Period 2|Adverse Event|0|||
126221948|NCT01078623|454103870|FG018|Treatment Period 2|Adverse Event|1|||
126221949|NCT01078623|454103871|FG019|Treatment Period 2|Adverse Event|0|||
126221950|NCT01078623|454103852|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126221951|NCT01078623|454103853|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126221952|NCT01078623|454103854|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126221953|NCT01078623|454103855|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126221954|NCT01078623|454103856|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126221955|NCT01078623|454103857|FG005|Treatment Period 2|Withdrawal by Subject|1|||
126221956|NCT01078623|454103858|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126221957|NCT01078623|454103859|FG007|Treatment Period 2|Withdrawal by Subject|0|||
126221958|NCT01078623|454103860|FG008|Treatment Period 2|Withdrawal by Subject|0|||
126221959|NCT01078623|454103861|FG009|Treatment Period 2|Withdrawal by Subject|0|||
126221960|NCT01078623|454103862|FG010|Treatment Period 2|Withdrawal by Subject|0|||
126221961|NCT01078623|454103863|FG011|Treatment Period 2|Withdrawal by Subject|0|||
126221962|NCT01078623|454103864|FG012|Treatment Period 2|Withdrawal by Subject|0|||
126221963|NCT01078623|454103865|FG013|Treatment Period 2|Withdrawal by Subject|0|||
126221964|NCT01078623|454103866|FG014|Treatment Period 2|Withdrawal by Subject|0|||
126221965|NCT01078623|454103867|FG015|Treatment Period 2|Withdrawal by Subject|0|||
126221966|NCT01078623|454103868|FG016|Treatment Period 2|Withdrawal by Subject|0|||
126221967|NCT01078623|454103869|FG017|Treatment Period 2|Withdrawal by Subject|0|||
126221968|NCT01078623|454103870|FG018|Treatment Period 2|Withdrawal by Subject|0|||
126221969|NCT01078623|454103871|FG019|Treatment Period 2|Withdrawal by Subject|0|||
126221970|NCT01078623|454103852|FG000|Treatment Period 3|Adverse Event|0|||
126221971|NCT01078623|454103853|FG001|Treatment Period 3|Adverse Event|0|||
126221972|NCT01078623|454103854|FG002|Treatment Period 3|Adverse Event|0|||
126350111|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
126350112|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
126350113|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
126350114|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
126350115|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
126350116|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
126350117|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
126350118|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
126350119|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
126350120|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
126350121|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
126221973|NCT01078623|454103855|FG003|Treatment Period 3|Adverse Event|0|||
126221974|NCT01078623|454103856|FG004|Treatment Period 3|Adverse Event|1|||
126221975|NCT01078623|454103857|FG005|Treatment Period 3|Adverse Event|0|||
126221976|NCT01078623|454103858|FG006|Treatment Period 3|Adverse Event|0|||
126221977|NCT01078623|454103859|FG007|Treatment Period 3|Adverse Event|0|||
126221978|NCT01078623|454103860|FG008|Treatment Period 3|Adverse Event|0|||
126221979|NCT01078623|454103861|FG009|Treatment Period 3|Adverse Event|0|||
126221980|NCT01078623|454103862|FG010|Treatment Period 3|Adverse Event|0|||
126221981|NCT01078623|454103863|FG011|Treatment Period 3|Adverse Event|0|||
126221982|NCT01078623|454103864|FG012|Treatment Period 3|Adverse Event|0|||
126221983|NCT01078623|454103865|FG013|Treatment Period 3|Adverse Event|1|||
126221984|NCT01078623|454103866|FG014|Treatment Period 3|Adverse Event|0|||
126221985|NCT01078623|454103867|FG015|Treatment Period 3|Adverse Event|0|||
126221986|NCT01078623|454103868|FG016|Treatment Period 3|Adverse Event|0|||
126221987|NCT01078623|454103869|FG017|Treatment Period 3|Adverse Event|0|||
126221988|NCT01078623|454103870|FG018|Treatment Period 3|Adverse Event|0|||
126221989|NCT01078623|454103871|FG019|Treatment Period 3|Adverse Event|0|||
126221990|NCT01078623|454103852|FG000|Treatment Period 4|Adverse Event|0|||
126221991|NCT01078623|454103853|FG001|Treatment Period 4|Adverse Event|0|||
126221992|NCT01078623|454103854|FG002|Treatment Period 4|Adverse Event|1|||
126221993|NCT01078623|454103855|FG003|Treatment Period 4|Adverse Event|0|||
126221994|NCT01078623|454103856|FG004|Treatment Period 4|Adverse Event|0|||
126221995|NCT01078623|454103857|FG005|Treatment Period 4|Adverse Event|0|||
126221996|NCT01078623|454103858|FG006|Treatment Period 4|Adverse Event|0|||
126221997|NCT01078623|454103859|FG007|Treatment Period 4|Adverse Event|0|||
126221998|NCT01078623|454103860|FG008|Treatment Period 4|Adverse Event|0|||
126221999|NCT01078623|454103861|FG009|Treatment Period 4|Adverse Event|0|||
126222000|NCT01078623|454103862|FG010|Treatment Period 4|Adverse Event|0|||
126222001|NCT01078623|454103863|FG011|Treatment Period 4|Adverse Event|0|||
126222002|NCT01078623|454103864|FG012|Treatment Period 4|Adverse Event|0|||
126222003|NCT01078623|454103865|FG013|Treatment Period 4|Adverse Event|0|||
126222004|NCT01078623|454103866|FG014|Treatment Period 4|Adverse Event|0|||
126222005|NCT01078623|454103867|FG015|Treatment Period 4|Adverse Event|0|||
126222006|NCT01078623|454103868|FG016|Treatment Period 4|Adverse Event|0|||
126222007|NCT01078623|454103869|FG017|Treatment Period 4|Adverse Event|0|||
126222008|NCT01078623|454103870|FG018|Treatment Period 4|Adverse Event|0|||
126222009|NCT01078623|454103871|FG019|Treatment Period 4|Adverse Event|0|||
126222010|NCT01078623|454103852|FG000|Treatment Period 4|Withdrawal by Subject|0|||
126222011|NCT01078623|454103853|FG001|Treatment Period 4|Withdrawal by Subject|0|||
126222012|NCT01078623|454103854|FG002|Treatment Period 4|Withdrawal by Subject|0|||
126222013|NCT01078623|454103855|FG003|Treatment Period 4|Withdrawal by Subject|0|||
126222014|NCT01078623|454103856|FG004|Treatment Period 4|Withdrawal by Subject|0|||
126222015|NCT01078623|454103857|FG005|Treatment Period 4|Withdrawal by Subject|0|||
126222016|NCT01078623|454103858|FG006|Treatment Period 4|Withdrawal by Subject|0|||
126222017|NCT01078623|454103859|FG007|Treatment Period 4|Withdrawal by Subject|0|||
126222018|NCT01078623|454103860|FG008|Treatment Period 4|Withdrawal by Subject|0|||
126222019|NCT01078623|454103861|FG009|Treatment Period 4|Withdrawal by Subject|0|||
126222020|NCT01078623|454103862|FG010|Treatment Period 4|Withdrawal by Subject|0|||
126222021|NCT01078623|454103863|FG011|Treatment Period 4|Withdrawal by Subject|0|||
126222022|NCT01078623|454103864|FG012|Treatment Period 4|Withdrawal by Subject|0|||
126222023|NCT01078623|454103865|FG013|Treatment Period 4|Withdrawal by Subject|0|||
126222024|NCT01078623|454103866|FG014|Treatment Period 4|Withdrawal by Subject|0|||
126222025|NCT01078623|454103867|FG015|Treatment Period 4|Withdrawal by Subject|1|||
126222026|NCT01078623|454103868|FG016|Treatment Period 4|Withdrawal by Subject|0|||
126222027|NCT01078623|454103869|FG017|Treatment Period 4|Withdrawal by Subject|0|||
126222028|NCT01078623|454103870|FG018|Treatment Period 4|Withdrawal by Subject|0|||
126222029|NCT01078623|454103871|FG019|Treatment Period 4|Withdrawal by Subject|0|||
126222030|NCT00623623|454103872|FG000|Overall Study|Previous enrolment into this study|1|||
126222031|NCT00623623|454103873|FG001|Overall Study|Previous enrolment into this study|1|||
126222032|NCT01427920|454103876|FG000|Overall Study|Adverse Event|1|||
126222033|NCT01427920|454103877|FG001|Overall Study|Adverse Event|2|||
126222034|NCT01427920|454103876|FG000|Overall Study|Lack of Efficacy|1|||
126222035|NCT01427920|454103877|FG001|Overall Study|Lack of Efficacy|0|||
126222036|NCT01427920|454103876|FG000|Overall Study|Protocol Violation|1|||
126222037|NCT01427920|454103877|FG001|Overall Study|Protocol Violation|3|||
126222038|NCT01427920|454103876|FG000|Overall Study|Withdrawal Criteria|4|||
126222039|NCT01427920|454103877|FG001|Overall Study|Withdrawal Criteria|4|||
126222040|NCT01427920|454103876|FG000|Overall Study|Unclassified|2|||
126222041|NCT01427920|454103877|FG001|Overall Study|Unclassified|8|||
126350122|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
126350123|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
126350124|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
126350125|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
126350126|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Removal|1|||
126350127|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Removal|0|||
126350128|NCT05166876|454574147|FG000|Overall Study|Withdrawal by Subject|1|||
126350129|NCT05166876|454574148|FG001|Overall Study|Withdrawal by Subject|0|||
126350130|NCT05166876|454574149|FG002|Overall Study|Withdrawal by Subject|0|||
126350131|NCT00385840|454574151|FG000|Overall Study|Adverse Event|1|||
126222042|NCT02732561|454103879|FG000|Overall Study|Lost to Follow-up|1|||
126222043|NCT02732561|454103880|FG001|Overall Study|Lost to Follow-up|1|||
126222044|NCT02732561|454103879|FG000|Overall Study|Withdrawal by Subject|1|||
126222045|NCT02732561|454103880|FG001|Overall Study|Withdrawal by Subject|0|||
126222046|NCT00837577|454103887|FG000|Double-blind Period|Clinical Adverse Event|1|||
126222047|NCT00837577|454103888|FG001|Double-blind Period|Clinical Adverse Event|0|||
126350132|NCT00385840|454574152|FG001|Overall Study|Adverse Event|1|||
126350133|NCT00385840|454574151|FG000|Overall Study|Lost to Follow-up|3|||
126222048|NCT00837577|454103887|FG000|Double-blind Period|Withdrawal by Subject|1|||
126222049|NCT00837577|454103888|FG001|Double-blind Period|Withdrawal by Subject|0|||
126222050|NCT00837577|454103887|FG000|Open-label Period|Clinical Adverse Event|2|||
126222051|NCT00837577|454103888|FG001|Open-label Period|Clinical Adverse Event|2|||
126222052|NCT00837577|454103887|FG000|Open-label Period|Laboratory Adverse Event|0|||
126222053|NCT00837577|454103888|FG001|Open-label Period|Laboratory Adverse Event|1|||
126222054|NCT00837577|454103887|FG000|Open-label Period|Lack of Efficacy|4|||
126222055|NCT00837577|454103888|FG001|Open-label Period|Lack of Efficacy|3|||
126222056|NCT00837577|454103887|FG000|Open-label Period|Withdrawal by Subject|1|||
126222057|NCT00837577|454103888|FG001|Open-label Period|Withdrawal by Subject|2|||
126222058|NCT00837577|454103887|FG000|Open-label Period|Other Reason|1|||
126222059|NCT00837577|454103888|FG001|Open-label Period|Other Reason|1|||
126222060|NCT00272961|454103893|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
126222061|NCT00272961|454103894|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
126222062|NCT00272961|454103895|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
126222063|NCT00272961|454103896|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
126222064|NCT00272961|454103897|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
126222065|NCT00272961|454103893|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
126222066|NCT00272961|454103894|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
126222067|NCT00272961|454103895|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
126222068|NCT00272961|454103896|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
126222069|NCT00272961|454103897|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
126222070|NCT00272961|454103893|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
126222071|NCT00272961|454103894|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
126222072|NCT00272961|454103895|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
126222073|NCT00272961|454103896|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
126222074|NCT00272961|454103897|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
126222075|NCT00272961|454103893|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
126222076|NCT00272961|454103894|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
126222077|NCT00272961|454103895|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
126222078|NCT00272961|454103896|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
126222079|NCT00272961|454103897|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
126222080|NCT00272961|454103893|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
126222081|NCT00272961|454103894|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
126222082|NCT00272961|454103895|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
126222083|NCT00272961|454103896|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
126222084|NCT00272961|454103897|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
126222085|NCT00272961|454103893|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
126222086|NCT00272961|454103894|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
126222087|NCT00272961|454103895|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
126222088|NCT00272961|454103896|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
126222089|NCT00272961|454103897|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
126222090|NCT00272961|454103893|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
126222091|NCT00272961|454103894|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
126350134|NCT00385840|454574152|FG001|Overall Study|Lost to Follow-up|13|||
126350135|NCT00832975|454574154|FG000|Overall Study|Lost to Follow-up|7|||
126350136|NCT00832975|454574154|FG000|Overall Study|Protocol Violation|6|||
126350137|NCT00832975|454574154|FG000|Overall Study|Death|5|||
126350138|NCT00832975|454574154|FG000|Overall Study|Physician Decision|4|||
126350139|NCT00832975|454574154|FG000|Overall Study|Withdrawal by Subject|3|||
126350140|NCT00832975|454574154|FG000|Overall Study|Other reasons|14|||
126350141|NCT02101853|454574158|FG000|Block 1 Induction|Adverse Event|11|||
126350142|NCT02101853|454574159|FG001|Block 1 Induction|Adverse Event|0|||
126350143|NCT02101853|454574160|FG002|Block 1 Induction|Adverse Event|0|||
126350144|NCT02101853|454574161|FG003|Block 1 Induction|Adverse Event|0|||
126222092|NCT00272961|454103895|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
126222093|NCT00272961|454103896|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
126350145|NCT02101853|454574162|FG004|Block 1 Induction|Adverse Event|0|||
126350146|NCT02101853|454574163|FG005|Block 1 Induction|Adverse Event|0|||
126350147|NCT02101853|454574158|FG000|Block 1 Induction|Death|20|||
126350148|NCT02101853|454574159|FG001|Block 1 Induction|Death|0|||
126222094|NCT00272961|454103897|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
126222095|NCT00272961|454103893|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
126222096|NCT00272961|454103894|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
126222097|NCT00272961|454103895|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
126222098|NCT00272961|454103896|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
126222099|NCT00272961|454103897|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
126222100|NCT02065791|454103898|FG000|Overall Study|Closed Site|1|||
126222101|NCT02065791|454103899|FG001|Overall Study|Closed Site|1|||
126222102|NCT02065791|454103898|FG000|Overall Study|Withdrawal by Subject|11|||
126222103|NCT02065791|454103899|FG001|Overall Study|Withdrawal by Subject|5|||
126222104|NCT02065791|454103898|FG000|Overall Study|Lost to Follow-up|13|||
126222105|NCT02065791|454103899|FG001|Overall Study|Lost to Follow-up|9|||
126222106|NCT00575328|454103902|FG000|Overall Study|Adverse Event|1|||
126222107|NCT00575328|454103903|FG001|Overall Study|Adverse Event|1|||
126222108|NCT00575328|454103902|FG000|Overall Study|Lost to Follow-up|2|||
126222109|NCT00575328|454103903|FG001|Overall Study|Lost to Follow-up|1|||
126222110|NCT01298596|454103915|FG000|Overall Study|Withdrawal by Subject|1|||
126222111|NCT01298596|454103916|FG001|Overall Study|Withdrawal by Subject|1|||
126222112|NCT01298596|454103915|FG000|Overall Study|Death|5|||
126222113|NCT01298596|454103916|FG001|Overall Study|Death|3|||
126222114|NCT01298596|454103915|FG000|Overall Study|Lost to Follow-up|6|||
126222115|NCT01298596|454103916|FG001|Overall Study|Lost to Follow-up|14|||
126222116|NCT01298596|454103915|FG000|Overall Study|Referred for further management|16|||
126222117|NCT01298596|454103916|FG001|Overall Study|Referred for further management|15|||
126222118|NCT04128696|454103919|FG000|Overall Study|Lost to Follow-up|3|||
126222119|NCT04128696|454103920|FG001|Overall Study|Lost to Follow-up|7|||
126222120|NCT04128696|454103919|FG000|Overall Study|Withdrawal by Subject|12|||
126222121|NCT04128696|454103920|FG001|Overall Study|Withdrawal by Subject|11|||
126222122|NCT04128696|454103919|FG000|Overall Study|Study Closed/Terminated|26|||
126222123|NCT04128696|454103920|FG001|Overall Study|Study Closed/Terminated|38|||
126222124|NCT04128696|454103919|FG000|Overall Study|Physician Decision|2|||
126222125|NCT04128696|454103920|FG001|Overall Study|Physician Decision|3|||
126222126|NCT00585039|454103921|FG000|Overall Study|medication spilled|2|||
126222127|NCT00585039|454103922|FG001|Overall Study|medication spilled|0|||
126222128|NCT01585831|454103929|FG000|Overall Study|Physician Decision|0|||
126222129|NCT01585831|454103930|FG001|Overall Study|Physician Decision|1|||
126222130|NCT01585831|454103929|FG000|Overall Study|Withdrawal by Subject|2|||
126222131|NCT01585831|454103930|FG001|Overall Study|Withdrawal by Subject|1|||
126222132|NCT02046369|454103931|FG000|Overall Study|Adverse Event|3|||
126222133|NCT02046369|454103932|FG001|Overall Study|Adverse Event|3|||
126222134|NCT02046369|454103931|FG000|Overall Study|Lack of Efficacy|3|||
126222135|NCT02046369|454103932|FG001|Overall Study|Lack of Efficacy|3|||
126222136|NCT02046369|454103931|FG000|Overall Study|Lost to Follow-up|3|||
126222137|NCT02046369|454103932|FG001|Overall Study|Lost to Follow-up|3|||
126222138|NCT02046369|454103931|FG000|Overall Study|Protocol Violation|1|||
126222139|NCT02046369|454103932|FG001|Overall Study|Protocol Violation|2|||
126222140|NCT02046369|454103931|FG000|Overall Study|Withdrawal by Subject|3|||
126222141|NCT02046369|454103932|FG001|Overall Study|Withdrawal by Subject|6|||
126222142|NCT02046369|454103931|FG000|Overall Study|never received study drug|0|||
126222143|NCT02046369|454103932|FG001|Overall Study|never received study drug|1|||
126222144|NCT02046369|454103931|FG000|Overall Study|non compliance|1|||
126222145|NCT02046369|454103932|FG001|Overall Study|non compliance|0|||
126222146|NCT03120520|454103933|FG000|Overall Study|Lost to Follow-up|1|||
126222147|NCT03120520|454103934|FG001|Overall Study|Lost to Follow-up|1|||
126222148|NCT03120520|454103935|FG002|Overall Study|Lost to Follow-up|1|||
126222149|NCT03120520|454103936|FG003|Overall Study|Lost to Follow-up|1|||
126222150|NCT03120520|454103933|FG000|Overall Study|Withdrawal by Subject|3|||
126222151|NCT03120520|454103934|FG001|Overall Study|Withdrawal by Subject|2|||
126222152|NCT03120520|454103935|FG002|Overall Study|Withdrawal by Subject|3|||
126222153|NCT03120520|454103936|FG003|Overall Study|Withdrawal by Subject|2|||
126222154|NCT03120520|454103933|FG000|Overall Study|Other|0|||
126222155|NCT03120520|454103934|FG001|Overall Study|Other|1|||
126222156|NCT03120520|454103935|FG002|Overall Study|Other|0|||
126222157|NCT03120520|454103936|FG003|Overall Study|Other|0|||
126222158|NCT02133352|454103940|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
126222159|NCT00579254|454103941|FG000|Overall Study|Lost to Follow-up|39|||
126222160|NCT00579254|454103941|FG000|Overall Study|Discontinued when study terminated|73|||
126222161|NCT02557672|454103942|FG000|Overall Study|Withdrawal by Subject|4|||
126222162|NCT02557672|454103943|FG001|Overall Study|Withdrawal by Subject|2|||
126222163|NCT03705169|454103944|FG000|Overall Study|Lost to Follow-up|0|||
126222164|NCT03705169|454103945|FG001|Overall Study|Lost to Follow-up|0|||
126222165|NCT03705169|454103946|FG002|Overall Study|Lost to Follow-up|0|||
126222166|NCT03705169|454103947|FG003|Overall Study|Lost to Follow-up|2|||
126222167|NCT03705169|454103948|FG004|Overall Study|Lost to Follow-up|0|||
126222168|NCT03705169|454103949|FG005|Overall Study|Lost to Follow-up|2|||
126222169|NCT03705169|454103950|FG006|Overall Study|Lost to Follow-up|1|||
126222170|NCT03705169|454103951|FG007|Overall Study|Lost to Follow-up|0|||
126222171|NCT03705169|454103952|FG008|Overall Study|Lost to Follow-up|0|||
126222172|NCT03705169|454103953|FG009|Overall Study|Lost to Follow-up|1|||
126222173|NCT03705169|454103944|FG000|Overall Study|Adverse Event|0|||
126222174|NCT03705169|454103945|FG001|Overall Study|Adverse Event|0|||
126222175|NCT03705169|454103946|FG002|Overall Study|Adverse Event|0|||
126222176|NCT03705169|454103947|FG003|Overall Study|Adverse Event|1|||
126222177|NCT03705169|454103948|FG004|Overall Study|Adverse Event|0|||
126222178|NCT03705169|454103949|FG005|Overall Study|Adverse Event|0|||
126222179|NCT03705169|454103950|FG006|Overall Study|Adverse Event|0|||
126222180|NCT03705169|454103951|FG007|Overall Study|Adverse Event|0|||
126222181|NCT03705169|454103952|FG008|Overall Study|Adverse Event|0|||
126222182|NCT03705169|454103953|FG009|Overall Study|Adverse Event|0|||
126222183|NCT03705169|454103944|FG000|Overall Study|Site Closure|0|||
126222184|NCT03705169|454103945|FG001|Overall Study|Site Closure|0|||
126222185|NCT03705169|454103946|FG002|Overall Study|Site Closure|0|||
126222186|NCT03705169|454103947|FG003|Overall Study|Site Closure|1|||
126222187|NCT03705169|454103948|FG004|Overall Study|Site Closure|0|||
126222188|NCT03705169|454103949|FG005|Overall Study|Site Closure|0|||
126222189|NCT03705169|454103950|FG006|Overall Study|Site Closure|0|||
126222190|NCT03705169|454103951|FG007|Overall Study|Site Closure|0|||
126222191|NCT03705169|454103952|FG008|Overall Study|Site Closure|0|||
126222192|NCT03705169|454103953|FG009|Overall Study|Site Closure|0|||
126222193|NCT03705169|454103944|FG000|Overall Study|Did not receive study treatment|0|||
126222194|NCT03705169|454103945|FG001|Overall Study|Did not receive study treatment|0|||
126222195|NCT03705169|454103946|FG002|Overall Study|Did not receive study treatment|0|||
126222196|NCT03705169|454103947|FG003|Overall Study|Did not receive study treatment|1|||
126222197|NCT03705169|454103948|FG004|Overall Study|Did not receive study treatment|0|||
126222198|NCT03705169|454103949|FG005|Overall Study|Did not receive study treatment|0|||
126222199|NCT03705169|454103950|FG006|Overall Study|Did not receive study treatment|0|||
126222200|NCT03705169|454103951|FG007|Overall Study|Did not receive study treatment|0|||
126222201|NCT03705169|454103952|FG008|Overall Study|Did not receive study treatment|0|||
126222202|NCT03705169|454103953|FG009|Overall Study|Did not receive study treatment|0|||
126222203|NCT03705169|454103944|FG000|Overall Study|Concerns about study visit compliance|0|||
126222204|NCT03705169|454103945|FG001|Overall Study|Concerns about study visit compliance|0|||
126222205|NCT03705169|454103946|FG002|Overall Study|Concerns about study visit compliance|0|||
126222206|NCT03705169|454103947|FG003|Overall Study|Concerns about study visit compliance|1|||
126222207|NCT03705169|454103948|FG004|Overall Study|Concerns about study visit compliance|0|||
126222208|NCT03705169|454103949|FG005|Overall Study|Concerns about study visit compliance|0|||
126222209|NCT03705169|454103950|FG006|Overall Study|Concerns about study visit compliance|0|||
126222210|NCT03705169|454103951|FG007|Overall Study|Concerns about study visit compliance|0|||
126222211|NCT03705169|454103952|FG008|Overall Study|Concerns about study visit compliance|0|||
126222212|NCT03705169|454103953|FG009|Overall Study|Concerns about study visit compliance|0|||
126222213|NCT00420290|454103954|FG000|Overall Study|Adverse Event|3|||
126222214|NCT00420290|454103955|FG001|Overall Study|Adverse Event|1|||
126222215|NCT00420290|454103954|FG000|Overall Study|Withdrawal by Subject|0|||
126222216|NCT00420290|454103955|FG001|Overall Study|Withdrawal by Subject|2|||
126222217|NCT00420290|454103954|FG000|Overall Study|did not meet inclusion/exclusion|1|||
126222218|NCT00420290|454103955|FG001|Overall Study|did not meet inclusion/exclusion|1|||
126350149|NCT02101853|454574160|FG002|Block 1 Induction|Death|0|||
126350150|NCT02101853|454574161|FG003|Block 1 Induction|Death|0|||
126350151|NCT02101853|454574162|FG004|Block 1 Induction|Death|0|||
126350152|NCT02101853|454574163|FG005|Block 1 Induction|Death|0|||
126350153|NCT02101853|454574158|FG000|Block 1 Induction|Lack of Efficacy|6|||
126350154|NCT02101853|454574159|FG001|Block 1 Induction|Lack of Efficacy|0|||
126350155|NCT02101853|454574160|FG002|Block 1 Induction|Lack of Efficacy|0|||
126350156|NCT02101853|454574161|FG003|Block 1 Induction|Lack of Efficacy|0|||
126350157|NCT02101853|454574162|FG004|Block 1 Induction|Lack of Efficacy|0|||
126350158|NCT02101853|454574163|FG005|Block 1 Induction|Lack of Efficacy|0|||
126350159|NCT02101853|454574158|FG000|Block 1 Induction|Physician Decision|61|||
126350160|NCT02101853|454574159|FG001|Block 1 Induction|Physician Decision|0|||
126222219|NCT02092961|454105441|FG000|Overall Study|Not reported|1|||
126222220|NCT02092961|454105442|FG001|Overall Study|Not reported|0|||
126222221|NCT02092961|454105443|FG002|Overall Study|Not reported|1|||
126222222|NCT02092961|454105441|FG000|Overall Study|Study stopped|13|||
126222223|NCT02092961|454105442|FG001|Overall Study|Study stopped|9|||
126222224|NCT02092961|454105443|FG002|Overall Study|Study stopped|12|||
126222225|NCT02092961|454105441|FG000|Overall Study|Lack of therapeutic response|2|||
126222226|NCT02092961|454105442|FG001|Overall Study|Lack of therapeutic response|1|||
126222227|NCT02092961|454105443|FG002|Overall Study|Lack of therapeutic response|3|||
126222228|NCT02092961|454105441|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
126222229|NCT02092961|454105442|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
126222230|NCT02092961|454105443|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
126222231|NCT02092961|454105441|FG000|Overall Study|Adverse Event|2|||
126350161|NCT02101853|454574160|FG002|Block 1 Induction|Physician Decision|0|||
126350162|NCT02101853|454574161|FG003|Block 1 Induction|Physician Decision|0|||
126350163|NCT02101853|454574162|FG004|Block 1 Induction|Physician Decision|0|||
126222232|NCT02092961|454105442|FG001|Overall Study|Adverse Event|4|||
126222233|NCT02092961|454105443|FG002|Overall Study|Adverse Event|0|||
126222234|NCT00854620|454105444|FG000|Overall Study|Adverse Event|1|||
126222235|NCT01792284|454105445|FG000|Lead-in Period|Adverse Event|15|||
126222236|NCT01792284|454105446|FG001|Lead-in Period|Adverse Event|0|||
126222237|NCT01792284|454105447|FG002|Lead-in Period|Adverse Event|0|||
126222238|NCT01792284|454105445|FG000|Lead-in Period|Lost to Follow-up|2|||
126222239|NCT01792284|454105446|FG001|Lead-in Period|Lost to Follow-up|0|||
126222240|NCT01792284|454105447|FG002|Lead-in Period|Lost to Follow-up|0|||
126222241|NCT01792284|454105445|FG000|Lead-in Period|Protocol Violation|1|||
126222242|NCT01792284|454105446|FG001|Lead-in Period|Protocol Violation|0|||
126222243|NCT01792284|454105447|FG002|Lead-in Period|Protocol Violation|0|||
126222244|NCT01792284|454105445|FG000|Lead-in Period|Withdrawal by Subject|10|||
126222245|NCT01792284|454105446|FG001|Lead-in Period|Withdrawal by Subject|0|||
126222246|NCT01792284|454105447|FG002|Lead-in Period|Withdrawal by Subject|0|||
126222247|NCT01792284|454105445|FG000|Lead-in Period|Physician Decision|1|||
126222248|NCT01792284|454105446|FG001|Lead-in Period|Physician Decision|0|||
126222249|NCT01792284|454105447|FG002|Lead-in Period|Physician Decision|0|||
126222250|NCT01792284|454105445|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
126222251|NCT01792284|454105446|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
126222252|NCT01792284|454105447|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
126222253|NCT01792284|454105445|FG000|Randomization Period 1|Withdrawal by Subject|0|||
126222254|NCT01792284|454105446|FG001|Randomization Period 1|Withdrawal by Subject|1|||
126222255|NCT01792284|454105447|FG002|Randomization Period 1|Withdrawal by Subject|1|||
126350164|NCT02101853|454574163|FG005|Block 1 Induction|Physician Decision|0|||
126350165|NCT02101853|454574158|FG000|Block 1 Induction|Protocol Violation|2|||
126350166|NCT02101853|454574159|FG001|Block 1 Induction|Protocol Violation|0|||
126350167|NCT02101853|454574160|FG002|Block 1 Induction|Protocol Violation|0|||
126350168|NCT02101853|454574161|FG003|Block 1 Induction|Protocol Violation|0|||
126350169|NCT02101853|454574162|FG004|Block 1 Induction|Protocol Violation|0|||
126350170|NCT02101853|454574163|FG005|Block 1 Induction|Protocol Violation|0|||
126350171|NCT02101853|454574158|FG000|Block 1 Induction|Withdrawal by Subject|65|||
126350172|NCT02101853|454574159|FG001|Block 1 Induction|Withdrawal by Subject|0|||
126350173|NCT02101853|454574160|FG002|Block 1 Induction|Withdrawal by Subject|0|||
126350174|NCT02101853|454574161|FG003|Block 1 Induction|Withdrawal by Subject|0|||
126350175|NCT02101853|454574162|FG004|Block 1 Induction|Withdrawal by Subject|0|||
126350176|NCT02101853|454574163|FG005|Block 1 Induction|Withdrawal by Subject|0|||
126350177|NCT02101853|454574158|FG000|Block 1 Induction|Ineligible|8|||
126350178|NCT02101853|454574159|FG001|Block 1 Induction|Ineligible|0|||
126350179|NCT02101853|454574160|FG002|Block 1 Induction|Ineligible|0|||
126350180|NCT02101853|454574161|FG003|Block 1 Induction|Ineligible|0|||
126350181|NCT02101853|454574162|FG004|Block 1 Induction|Ineligible|0|||
126350182|NCT02101853|454574163|FG005|Block 1 Induction|Ineligible|0|||
126350183|NCT02101853|454574158|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
126350184|NCT02101853|454574159|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350185|NCT02101853|454574160|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350186|NCT02101853|454574161|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350187|NCT02101853|454574162|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350188|NCT02101853|454574163|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350189|NCT02101853|454574158|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
126350190|NCT02101853|454574159|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350191|NCT02101853|454574160|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350192|NCT02101853|454574161|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350193|NCT02101853|454574162|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350194|NCT02101853|454574163|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350195|NCT02101853|454574158|FG000|Post Induction Randomization|Adverse Event|0|||
126350196|NCT02101853|454574159|FG001|Post Induction Randomization|Adverse Event|3|||
126350197|NCT02101853|454574160|FG002|Post Induction Randomization|Adverse Event|8|||
126350198|NCT02101853|454574161|FG003|Post Induction Randomization|Adverse Event|4|||
126350199|NCT02101853|454574162|FG004|Post Induction Randomization|Adverse Event|4|||
126350200|NCT02101853|454574163|FG005|Post Induction Randomization|Adverse Event|0|||
126350201|NCT02101853|454574158|FG000|Post Induction Randomization|Death|0|||
126350202|NCT02101853|454574159|FG001|Post Induction Randomization|Death|9|||
126350203|NCT02101853|454574160|FG002|Post Induction Randomization|Death|2|||
126350204|NCT02101853|454574161|FG003|Post Induction Randomization|Death|2|||
126222256|NCT01792284|454105445|FG000|Randomization Period 1|Physician Decision|0|||
126222257|NCT01792284|454105446|FG001|Randomization Period 1|Physician Decision|1|||
126222258|NCT01792284|454105447|FG002|Randomization Period 1|Physician Decision|1|||
126222259|NCT01792284|454105445|FG000|Randomization Period 1|Adverse Event|0|||
126222260|NCT01792284|454105446|FG001|Randomization Period 1|Adverse Event|0|||
126222261|NCT01792284|454105447|FG002|Randomization Period 1|Adverse Event|2|||
126222262|NCT01792284|454105445|FG000|Randomization Period 1|Lost to Follow-up|0|||
126222263|NCT01792284|454105446|FG001|Randomization Period 1|Lost to Follow-up|0|||
126222264|NCT01792284|454105447|FG002|Randomization Period 1|Lost to Follow-up|1|||
126222265|NCT01792284|454105445|FG000|Randomization Period 2|Protocol Violation|0|||
126222266|NCT01792284|454105446|FG001|Randomization Period 2|Protocol Violation|1|||
126222267|NCT01792284|454105447|FG002|Randomization Period 2|Protocol Violation|0|||
126222268|NCT01792284|454105445|FG000|Randomization Period 2|Withdrawal by Subject|0|||
126222269|NCT01792284|454105446|FG001|Randomization Period 2|Withdrawal by Subject|2|||
126222270|NCT01792284|454105447|FG002|Randomization Period 2|Withdrawal by Subject|0|||
126222271|NCT02370784|454105451|FG000|Overall Study|Patient started prohibited medication|0|||
126222272|NCT02370784|454105452|FG001|Overall Study|Patient started prohibited medication|1|||
126222273|NCT01312779|454105454|FG000|Overall Study|Withdrawal by Subject|2|||
126222274|NCT01312779|454105454|FG000|Overall Study|Death|3|||
126222275|NCT01312779|454105454|FG000|Overall Study|Not Implanted with Device|27|||
126222276|NCT02853929|454105455|FG000|Overall Study|Lost to Follow-up|3|||
126222277|NCT02853929|454105456|FG001|Overall Study|Lost to Follow-up|0|||
126222278|NCT02853929|454105455|FG000|Overall Study|Withdrawal by Subject|1|||
126222279|NCT02853929|454105456|FG001|Overall Study|Withdrawal by Subject|0|||
126222280|NCT02853929|454105455|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
126222281|NCT02853929|454105456|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
126222282|NCT01113710|454105457|FG000|Overall Study|Adverse Event|64|||
126222283|NCT01113710|454105457|FG000|Overall Study|Lack of Efficacy|41|||
126222284|NCT01113710|454105457|FG000|Overall Study|No Information Available|40|||
126222285|NCT01113710|454105457|FG000|Overall Study|Withdrawal by Subject|28|||
126222286|NCT01113710|454105457|FG000|Overall Study|Lost to Follow-up|20|||
126222287|NCT01113710|454105457|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
126222288|NCT01113710|454105457|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
126222289|NCT01113710|454105457|FG000|Overall Study|Lack of Patient's Compliance|8|||
126222290|NCT01113710|454105457|FG000|Overall Study|Other|7|||
126222291|NCT01113710|454105457|FG000|Overall Study|Adverse Event/Other|5|||
126222292|NCT01113710|454105457|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
126222293|NCT01113710|454105457|FG000|Overall Study|Lack of Efficacy/Other|4|||
126222294|NCT01113710|454105457|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
126222295|NCT01113710|454105457|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
126222296|NCT01113710|454105457|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
126222297|NCT01113710|454105457|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
126222298|NCT01113710|454105457|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
126222299|NCT01113710|454105457|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
126222300|NCT01113710|454105457|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
126222301|NCT01113710|454105457|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
126222302|NCT01113710|454105457|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
126222303|NCT01113710|454105457|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
126222304|NCT01113710|454105457|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
126222305|NCT01113710|454105457|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
126222306|NCT01113710|454105457|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
126222307|NCT00463866|454105458|FG000|Overall Study|Adverse Event|70|||
126222308|NCT00463866|454105459|FG001|Overall Study|Adverse Event|93|||
126222309|NCT00463866|454105458|FG000|Overall Study|Withdrawal by Subject|81|||
126222310|NCT00463866|454105459|FG001|Overall Study|Withdrawal by Subject|79|||
126222311|NCT00463866|454105458|FG000|Overall Study|Lost to Follow-up|46|||
126222312|NCT00463866|454105459|FG001|Overall Study|Lost to Follow-up|55|||
126222313|NCT00463866|454105458|FG000|Overall Study|Incorrect Enrolment|64|||
126222314|NCT00463866|454105459|FG001|Overall Study|Incorrect Enrolment|66|||
126222315|NCT00463866|454105458|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
126222316|NCT00463866|454105459|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
126222317|NCT00463866|454105458|FG000|Overall Study|Safety Reason|1|||
126222318|NCT00463866|454105459|FG001|Overall Study|Safety Reason|3|||
126222319|NCT00463866|454105458|FG000|Overall Study|Mis-Randomization of subject|0|||
126222320|NCT00463866|454105459|FG001|Overall Study|Mis-Randomization of subject|1|||
126222321|NCT00463866|454105458|FG000|Overall Study|Other|22|||
126222322|NCT00463866|454105459|FG001|Overall Study|Other|22|||
126222323|NCT02265952|454105461|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
126222324|NCT02265952|454105462|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
126222325|NCT02265952|454105461|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
126350205|NCT02101853|454574162|FG004|Post Induction Randomization|Death|0|||
126350206|NCT02101853|454574163|FG005|Post Induction Randomization|Death|0|||
126222326|NCT02265952|454105462|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
126222327|NCT01042977|454105463|FG000|Overall Study|Adverse Event|4|||
126222328|NCT01042977|454105464|FG001|Overall Study|Adverse Event|12|||
126222329|NCT01042977|454105463|FG000|Overall Study|Death|2|||
126222330|NCT01042977|454105464|FG001|Overall Study|Death|1|||
126222331|NCT01042977|454105463|FG000|Overall Study|Withdrawal by Subject|8|||
126350207|NCT02101853|454574158|FG000|Post Induction Randomization|Lack of Efficacy|0|||
126018225|NCT00958633|453360619|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
126018226|NCT00958633|453360620|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
126018227|NCT00304031|453361964|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
126018228|NCT00304031|453361965|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
126018229|NCT00304031|453361966|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
126018230|NCT00304031|453361964|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
126018231|NCT00304031|453361965|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
126018232|NCT00304031|453361966|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
126018233|NCT00304031|453361964|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
126018234|NCT00304031|453361965|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
126018235|NCT00304031|453361966|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
126018236|NCT00304031|453361964|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
126018237|NCT00304031|453361965|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
126018238|NCT00304031|453361966|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
126018239|NCT00304031|453361964|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
126018240|NCT00304031|453361965|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
126018241|NCT00304031|453361966|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
126018242|NCT00304031|453361964|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
126018243|NCT00304031|453361965|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
126018244|NCT00304031|453361966|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
126018245|NCT00304031|453361964|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
126018246|NCT00304031|453361965|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
126018247|NCT00304031|453361966|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
126018248|NCT00304031|453361964|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
126018249|NCT00304031|453361965|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
126018250|NCT00304031|453361966|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
126018251|NCT00304031|453361964|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
126018252|NCT00304031|453361965|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
126018253|NCT00304031|453361966|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
126018254|NCT01188655|453361967|FG000|Overall Study|Lack of Efficacy|1|||
126018255|NCT01188655|453361967|FG000|Overall Study|Lost to Follow-up|1|||
126018256|NCT01188655|453361967|FG000|Overall Study|Other|11|||
126018257|NCT03648762|453361971|FG000|Overall Study|Lost to Follow-up|1|||
126018258|NCT03648762|453361972|FG001|Overall Study|Lost to Follow-up|2|||
126018259|NCT03648762|453361973|FG002|Overall Study|Lost to Follow-up|0|||
126018260|NCT03648762|453361971|FG000|Overall Study|Withdrawal by Subject|5|||
126018261|NCT03648762|453361972|FG001|Overall Study|Withdrawal by Subject|2|||
126018262|NCT03648762|453361973|FG002|Overall Study|Withdrawal by Subject|1|||
126018263|NCT01875848|453361983|FG000|Overall Study|Withdrawal by Subject|2|||
126018264|NCT01875848|453361984|FG001|Overall Study|Withdrawal by Subject|0|||
126018265|NCT02189252|453361985|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
126018266|NCT02189252|453361986|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
126018267|NCT02189252|453361987|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
126018268|NCT02189252|453361988|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
126018269|NCT02189252|453361985|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
126018270|NCT02189252|453361986|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
126018271|NCT02189252|453361987|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
126018272|NCT02189252|453361988|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
126018273|NCT00840177|453361989|FG000|Overall Study|Adverse Event|5|||
126018274|NCT00840177|453361990|FG001|Overall Study|Adverse Event|1|||
126018275|NCT00840177|453361991|FG002|Overall Study|Adverse Event|1|||
126018276|NCT00840177|453361989|FG000|Overall Study|Refusal unrelated to adverse events|1|||
126018277|NCT00840177|453361990|FG001|Overall Study|Refusal unrelated to adverse events|0|||
126018278|NCT00840177|453361991|FG002|Overall Study|Refusal unrelated to adverse events|1|||
126018279|NCT00840177|453361989|FG000|Overall Study|Progression/relapse|2|||
126018280|NCT00840177|453361990|FG001|Overall Study|Progression/relapse|0|||
126018281|NCT00840177|453361991|FG002|Overall Study|Progression/relapse|0|||
126018282|NCT00840177|453361989|FG000|Overall Study|Death|4|||
126018283|NCT00840177|453361990|FG001|Overall Study|Death|5|||
126018284|NCT00840177|453361991|FG002|Overall Study|Death|5|||
126018285|NCT00840177|453361989|FG000|Overall Study|not protocol specified|6|||
126018286|NCT00840177|453361990|FG001|Overall Study|not protocol specified|3|||
126018287|NCT00840177|453361991|FG002|Overall Study|not protocol specified|0|||
126018288|NCT00840177|453361989|FG000|Overall Study|Ineligible|0|||
126018289|NCT00840177|453361990|FG001|Overall Study|Ineligible|0|||
126018290|NCT00840177|453361991|FG002|Overall Study|Ineligible|3|||
126018291|NCT00840177|453361989|FG000|Overall Study|Did not start treatment|0|||
126018292|NCT00840177|453361990|FG001|Overall Study|Did not start treatment|0|||
126018293|NCT00840177|453361991|FG002|Overall Study|Did not start treatment|1|||
126018294|NCT01391832|453361992|FG000|Overall Study|Withdrawal by Subject|21|||
126222332|NCT01042977|454105464|FG001|Overall Study|Withdrawal by Subject|16|||
126222333|NCT01042977|454105463|FG000|Overall Study|Lost to Follow-up|0|||
126222334|NCT01042977|454105464|FG001|Overall Study|Lost to Follow-up|2|||
126222335|NCT01042977|454105463|FG000|Overall Study|Poor/non-compliance|3|||
126222336|NCT01042977|454105464|FG001|Overall Study|Poor/non-compliance|4|||
126222337|NCT01042977|454105463|FG000|Overall Study|Subject no longer meets study criteria|15|||
126222338|NCT01042977|454105464|FG001|Overall Study|Subject no longer meets study criteria|13|||
126222339|NCT01042977|454105463|FG000|Overall Study|Incorrect enrollment|6|||
126222340|NCT01042977|454105464|FG001|Overall Study|Incorrect enrollment|4|||
126222341|NCT01042977|454105463|FG000|Overall Study|Safety|0|||
126222342|NCT01042977|454105464|FG001|Overall Study|Safety|2|||
126222343|NCT01042977|454105463|FG000|Overall Study|Administrative reason by sponsor|0|||
126222344|NCT01042977|454105464|FG001|Overall Study|Administrative reason by sponsor|1|||
126222345|NCT01042977|454105463|FG000|Overall Study|Various|3|||
126222346|NCT01042977|454105464|FG001|Overall Study|Various|0|||
126222347|NCT04356573|454105467|FG000|Overall Study|Didn't Qualify|1|||
126222348|NCT04356573|454105468|FG001|Overall Study|Didn't Qualify|0|||
126222349|NCT02424565|454105469|FG000|Period 1 (D0)|Protocol Violation|0|||
126222350|NCT02424565|454105470|FG001|Period 1 (D0)|Protocol Violation|1|||
126222351|NCT03568500|454105471|FG000|Overall Study|Lost to Follow-up|1|||
126222352|NCT03568500|454105472|FG001|Overall Study|Lost to Follow-up|1|||
126222353|NCT03568500|454105473|FG002|Overall Study|Lost to Follow-up|2|||
126222354|NCT03568500|454105471|FG000|Overall Study|Adverse Event|1|||
126222355|NCT03568500|454105472|FG001|Overall Study|Adverse Event|1|||
126222356|NCT03568500|454105473|FG002|Overall Study|Adverse Event|2|||
126222357|NCT03568500|454105471|FG000|Overall Study|Physician Decision|1|||
126222358|NCT03568500|454105472|FG001|Overall Study|Physician Decision|0|||
126222359|NCT03568500|454105473|FG002|Overall Study|Physician Decision|0|||
126222360|NCT03568500|454105471|FG000|Overall Study|Withdrawal by Subject|4|||
126222361|NCT03568500|454105472|FG001|Overall Study|Withdrawal by Subject|2|||
126222362|NCT03568500|454105473|FG002|Overall Study|Withdrawal by Subject|0|||
126222363|NCT03568500|454105471|FG000|Overall Study|Technical Problems|2|||
126222364|NCT03568500|454105472|FG001|Overall Study|Technical Problems|1|||
126222365|NCT03568500|454105473|FG002|Overall Study|Technical Problems|0|||
126222366|NCT03568500|454105471|FG000|Overall Study|Participant Noncompliance|1|||
126222367|NCT03568500|454105472|FG001|Overall Study|Participant Noncompliance|1|||
126222368|NCT03568500|454105473|FG002|Overall Study|Participant Noncompliance|0|||
126222369|NCT03650400|454105474|FG000|Overall Study|Study terminated by sponsor|0|||
126222370|NCT03650400|454105475|FG001|Overall Study|Study terminated by sponsor|5|||
126222371|NCT04132232|454105487|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
126222372|NCT04132232|454105488|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
126222373|NCT04132232|454105487|FG000|Overall Study|Lost to Follow-up|6|||
126222374|NCT04132232|454105488|FG001|Overall Study|Lost to Follow-up|7|||
126222375|NCT00368537|454105489|FG000|Randomization|No study drug dosed|13|||
126222376|NCT00368537|454105490|FG001|Randomization|No study drug dosed|6|||
126222377|NCT00368537|454105489|FG000|Baseline Participants|Lost to Follow-up|16|||
126222378|NCT00368537|454105490|FG001|Baseline Participants|Lost to Follow-up|17|||
126222379|NCT00368537|454105489|FG000|Baseline Participants|Withdrawal by Subject|6|||
126222380|NCT00368537|454105490|FG001|Baseline Participants|Withdrawal by Subject|4|||
126222381|NCT00368537|454105489|FG000|Baseline Participants|Death|1|||
126222382|NCT00368537|454105490|FG001|Baseline Participants|Death|2|||
126222383|NCT00368537|454105489|FG000|Baseline Participants|No susceptibility|1|||
126222384|NCT00368537|454105490|FG001|Baseline Participants|No susceptibility|0|||
126222385|NCT00368537|454105489|FG000|Baseline Participants|Patient uncompliant|0|||
126222386|NCT00368537|454105490|FG001|Baseline Participants|Patient uncompliant|1|||
126222387|NCT01368276|454105502|FG000|Overall Study|Death|1|||
126222388|NCT01368276|454105503|FG001|Overall Study|Death|10|||
126222389|NCT04228302|454105505|FG000|Overall Study|Adverse Event|0|||
126350208|NCT02101853|454574159|FG001|Post Induction Randomization|Lack of Efficacy|14|||
126350209|NCT02101853|454574160|FG002|Post Induction Randomization|Lack of Efficacy|23|||
126018295|NCT01391832|453361993|FG001|Overall Study|Withdrawal by Subject|22|||
126018296|NCT01391832|453361992|FG000|Overall Study|Lost to Follow-up|0|||
126018297|NCT01391832|453361993|FG001|Overall Study|Lost to Follow-up|1|||
126018298|NCT00686855|453361997|FG000|Overall Study|Lost to Follow-up|1|||
126018299|NCT00686855|453361998|FG001|Overall Study|Lost to Follow-up|0|||
126018300|NCT00686855|453361997|FG000|Overall Study|Progressive GVHD|0|||
126222390|NCT04228302|454105506|FG001|Overall Study|Adverse Event|0|||
126222391|NCT04228302|454105507|FG002|Overall Study|Adverse Event|0|||
126222392|NCT04228302|454105508|FG003|Overall Study|Adverse Event|0|||
126222393|NCT04228302|454105509|FG004|Overall Study|Adverse Event|1|||
126222394|NCT04228302|454105510|FG005|Overall Study|Adverse Event|0|||
126222395|NCT01886300|454105517|FG000|Overall Study|Trial terminated by sponsor|16|||
126222396|NCT02008721|454105518|FG000|Overall Study|Withdrawal by Subject|5|||
126222397|NCT02008721|454105519|FG001|Overall Study|Withdrawal by Subject|1|||
126222398|NCT02008721|454105518|FG000|Overall Study|Death|4|||
126222399|NCT02008721|454105519|FG001|Overall Study|Death|2|||
126222400|NCT02008721|454105518|FG000|Overall Study|Adverse Event|3|||
126222401|NCT02008721|454105519|FG001|Overall Study|Adverse Event|5|||
126222402|NCT02008721|454105518|FG000|Overall Study|Protocol Violation|3|||
126222403|NCT02008721|454105519|FG001|Overall Study|Protocol Violation|2|||
126222404|NCT00267007|454105522|FG000|Overall Study|Withdrawal by Subject|6|||
126222405|NCT00267007|454105523|FG001|Overall Study|Withdrawal by Subject|0|||
126222406|NCT00267007|454105522|FG000|Overall Study|Lost to Follow-up|1|||
126222407|NCT00267007|454105523|FG001|Overall Study|Lost to Follow-up|0|||
126222408|NCT00267007|454105522|FG000|Overall Study|Non-compliance|0|||
126222409|NCT00267007|454105523|FG001|Overall Study|Non-compliance|1|||
126222410|NCT00267007|454105522|FG000|Overall Study|Adverse Event|1|||
126222411|NCT00267007|454105523|FG001|Overall Study|Adverse Event|0|||
126222412|NCT01825876|454105525|FG000|Period 2|Withdrawal by Subject|0|||
126222413|NCT01825876|454105526|FG001|Period 2|Withdrawal by Subject|1|||
126222414|NCT04133519|454105531|FG000|Overall Study|Withdrawal by Subject|5|||
126222415|NCT04133519|454105532|FG001|Overall Study|Withdrawal by Subject|4|||
126222416|NCT04133519|454105531|FG000|Overall Study|Protocol Violation|0|||
126222417|NCT04133519|454105532|FG001|Overall Study|Protocol Violation|1|||
126222418|NCT04133519|454105531|FG000|Overall Study|Never started treatment|1|||
126222419|NCT04133519|454105532|FG001|Overall Study|Never started treatment|1|||
126222420|NCT02436135|454105533|FG000|Overall Study|Progressive Disease|3|||
126222421|NCT02436135|454105534|FG001|Overall Study|Progressive Disease|1|||
126222422|NCT02436135|454105533|FG000|Overall Study|Investigator Discretion|1|||
126222423|NCT02436135|454105534|FG001|Overall Study|Investigator Discretion|2|||
126222424|NCT02436135|454105533|FG000|Overall Study|Adverse Event|1|||
126222425|NCT02436135|454105534|FG001|Overall Study|Adverse Event|0|||
126222426|NCT02436135|454105533|FG000|Overall Study|Withdrawal by Participant|1|||
126222427|NCT02436135|454105534|FG001|Overall Study|Withdrawal by Participant|0|||
126222428|NCT02436135|454105533|FG000|Overall Study|Study Terminated By Sponsor|0|||
126222429|NCT02436135|454105534|FG001|Overall Study|Study Terminated By Sponsor|1|||
126222430|NCT00475852|454105537|FG000|Overall Study|Death|444|||
126222431|NCT00475852|454105538|FG001|Overall Study|Death|456|||
126222432|NCT00475852|454105537|FG000|Overall Study|Withdrawal by Subject|19|||
126222433|NCT00475852|454105538|FG001|Overall Study|Withdrawal by Subject|24|||
126222434|NCT00475852|454105537|FG000|Overall Study|Lost to Follow-up|54|||
126222435|NCT00475852|454105538|FG001|Overall Study|Lost to Follow-up|68|||
126222436|NCT00297479|454105540|FG000|Overall Study|Lost to Follow-up|37|||
126222437|NCT00297479|454105541|FG001|Overall Study|Lost to Follow-up|54|||
126222438|NCT00297479|454105542|FG002|Overall Study|Lost to Follow-up|51|||
126222439|NCT01664494|454105543|FG000|Overall Study|Withdrawal by Subject|27|||
126222440|NCT01664494|454105543|FG000|Overall Study|Death|18|||
126222441|NCT01664494|454105543|FG000|Overall Study|Other|49|||
126222442|NCT01664494|454105543|FG000|Overall Study|Lost to Follow-up|99|||
126222443|NCT03196791|454105544|FG000|Overall Study|Protocol Violation|7|||
126222444|NCT03196791|454105545|FG001|Overall Study|Protocol Violation|3|||
126222445|NCT03196791|454105544|FG000|Overall Study|Withdrawal by Subject|3|||
126222446|NCT03196791|454105545|FG001|Overall Study|Withdrawal by Subject|2|||
126222447|NCT00373685|454105550|FG000|Overall Study|Death|2|||
126222448|NCT00373685|454105551|FG001|Overall Study|Death|1|||
126222449|NCT00373685|454105550|FG000|Overall Study|Adverse Event|278|||
126222450|NCT00373685|454105551|FG001|Overall Study|Adverse Event|253|||
126222451|NCT00373685|454105550|FG000|Overall Study|Insufficient clinical response|169|||
126222452|NCT00373685|454105551|FG001|Overall Study|Insufficient clinical response|119|||
126222453|NCT00373685|454105550|FG000|Overall Study|Did not meet entrance criteria|167|||
126222454|NCT00373685|454105551|FG001|Overall Study|Did not meet entrance criteria|184|||
126222455|NCT00373685|454105550|FG000|Overall Study|Lost to follow up|83|||
126222456|NCT00373685|454105551|FG001|Overall Study|Lost to follow up|103|||
126222457|NCT00373685|454105550|FG000|Overall Study|No longer willing to participate|337|||
126222458|NCT00373685|454105551|FG001|Overall Study|No longer willing to participate|352|||
126222459|NCT00373685|454105550|FG000|Overall Study|Other|149|||
126350210|NCT02101853|454574161|FG003|Post Induction Randomization|Lack of Efficacy|18|||
126018301|NCT00686855|453361998|FG001|Overall Study|Progressive GVHD|1|||
126350211|NCT02101853|454574162|FG004|Post Induction Randomization|Lack of Efficacy|21|||
126350212|NCT02101853|454574163|FG005|Post Induction Randomization|Lack of Efficacy|0|||
126350213|NCT02101853|454574158|FG000|Post Induction Randomization|Physician Decision|0|||
126350214|NCT02101853|454574159|FG001|Post Induction Randomization|Physician Decision|43|||
126222460|NCT00373685|454105551|FG001|Overall Study|Other|146|||
126222461|NCT00373685|454105550|FG000|Overall Study|Protocol Violation|191|||
126222462|NCT00373685|454105551|FG001|Overall Study|Protocol Violation|182|||
126222463|NCT00373685|454105550|FG000|Overall Study|Final Status Unknown|12|||
126222464|NCT00373685|454105551|FG001|Overall Study|Final Status Unknown|4|||
126222465|NCT00373685|454105550|FG000|Overall Study|Randomized, not treated|51|||
126222466|NCT00373685|454105551|FG001|Overall Study|Randomized, not treated|77|||
126222467|NCT01789281|454105552|FG000|Overall Study|Disease progression|15|||
126222468|NCT01789281|454105553|FG001|Overall Study|Disease progression|4|||
126222469|NCT01789281|454105552|FG000|Overall Study|Adverse Event|5|||
126222470|NCT01789281|454105553|FG001|Overall Study|Adverse Event|5|||
126222471|NCT01789281|454105552|FG000|Overall Study|Withdrawal by Subject|1|||
126222472|NCT01789281|454105553|FG001|Overall Study|Withdrawal by Subject|0|||
126222473|NCT01789281|454105552|FG000|Overall Study|Lost to Follow-up|1|||
126018302|NCT01460446|453362004|FG000|Overall Study|Non-compliance|2|||
126018303|NCT01460446|453362005|FG001|Overall Study|Non-compliance|9|||
126018304|NCT01460446|453362004|FG000|Overall Study|Consent Withdrawn|0|||
126018305|NCT01460446|453362005|FG001|Overall Study|Consent Withdrawn|4|||
126018306|NCT01460446|453362004|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
126018307|NCT01460446|453362005|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
126018308|NCT01460446|453362004|FG000|Overall Study|Surgery/Illness|1|||
126018309|NCT01460446|453362005|FG001|Overall Study|Surgery/Illness|1|||
126018310|NCT01460446|453362004|FG000|Overall Study|Pregnancy|1|||
126018311|NCT01460446|453362005|FG001|Overall Study|Pregnancy|0|||
126018312|NCT01460446|453362004|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
126018313|NCT01460446|453362005|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
126018314|NCT01318382|453362006|FG000|Overall Study|Physician Decision|2|||
126018315|NCT01318382|453362006|FG000|Overall Study|Device Malfunction|10|||
126018316|NCT01318382|453362006|FG000|Overall Study|Protocol Violation|1|||
126018317|NCT01867216|453362009|FG000|Overall Study|Withdrawal by Subject|2|||
126018318|NCT01867216|453362010|FG001|Overall Study|Withdrawal by Subject|0|||
126018319|NCT01867216|453362011|FG002|Overall Study|Withdrawal by Subject|0|||
126018320|NCT01867216|453362012|FG003|Overall Study|Withdrawal by Subject|0|||
126018321|NCT01867216|453362013|FG004|Overall Study|Withdrawal by Subject|1|||
126018322|NCT01867216|453362014|FG005|Overall Study|Withdrawal by Subject|0|||
126018323|NCT01867216|453362015|FG006|Overall Study|Withdrawal by Subject|1|||
126018324|NCT01867216|453362009|FG000|Overall Study|Physician Decision|1|||
126018325|NCT01867216|453362010|FG001|Overall Study|Physician Decision|0|||
126018326|NCT01867216|453362011|FG002|Overall Study|Physician Decision|0|||
126018327|NCT01867216|453362012|FG003|Overall Study|Physician Decision|0|||
126018328|NCT01867216|453362013|FG004|Overall Study|Physician Decision|0|||
126018329|NCT01867216|453362014|FG005|Overall Study|Physician Decision|0|||
126018330|NCT01867216|453362015|FG006|Overall Study|Physician Decision|0|||
126018331|NCT01867216|453362009|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
126018332|NCT01867216|453362010|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126018333|NCT01867216|453362011|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126018334|NCT01867216|453362012|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126018335|NCT01867216|453362013|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126018336|NCT01867216|453362014|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126018337|NCT01867216|453362015|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126018338|NCT00542789|453362016|FG000|Overall Study|Adverse Event|18|||
126018339|NCT00542789|453362017|FG001|Overall Study|Adverse Event|17|||
126018340|NCT00542789|453362016|FG000|Overall Study|Withdrawal by Subject|7|||
126018341|NCT00542789|453362017|FG001|Overall Study|Withdrawal by Subject|3|||
126018342|NCT00542789|453362016|FG000|Overall Study|Protocol Violation|8|||
126018343|NCT00542789|453362017|FG001|Overall Study|Protocol Violation|1|||
126018344|NCT00542789|453362016|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
126018345|NCT00542789|453362017|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
126018346|NCT00636207|453362018|FG000|Overall Study|Adverse Event|1|||
126018347|NCT00636207|453362019|FG001|Overall Study|Adverse Event|0|||
126018348|NCT00636207|453362020|FG002|Overall Study|Adverse Event|0|||
126018349|NCT00636207|453362021|FG003|Overall Study|Adverse Event|0|||
126018350|NCT00636207|453362022|FG004|Overall Study|Adverse Event|0|||
126018351|NCT00636207|453362023|FG005|Overall Study|Adverse Event|0|||
126018352|NCT00636207|453362024|FG006|Overall Study|Adverse Event|0|||
126018353|NCT00636207|453362018|FG000|Overall Study|Withdrawal by Subject|0|||
126018354|NCT00636207|453362019|FG001|Overall Study|Withdrawal by Subject|1|||
126018355|NCT00636207|453362020|FG002|Overall Study|Withdrawal by Subject|0|||
126018356|NCT00636207|453362021|FG003|Overall Study|Withdrawal by Subject|0|||
126222474|NCT01789281|454105553|FG001|Overall Study|Lost to Follow-up|0|||
126222475|NCT01789281|454105552|FG000|Overall Study|Administrative problems|0|||
126222476|NCT01789281|454105553|FG001|Overall Study|Administrative problems|1|||
126222477|NCT01890785|454105554|FG000|Third Intervention|Withdrawal by Subject|0|||
126222478|NCT01890785|454105555|FG001|Third Intervention|Withdrawal by Subject|1|||
126222479|NCT01890785|454105556|FG002|Third Intervention|Withdrawal by Subject|0|||
126222480|NCT01890785|454105557|FG003|Third Intervention|Withdrawal by Subject|0|||
126222481|NCT01890785|454105558|FG004|Third Intervention|Withdrawal by Subject|0|||
126222482|NCT01890785|454105559|FG005|Third Intervention|Withdrawal by Subject|0|||
126222483|NCT02746705|454105560|FG000|Overall Study|Physician Decision|1|||
126222484|NCT02746705|454105561|FG001|Overall Study|Physician Decision|1|||
126222485|NCT02746705|454105560|FG000|Overall Study|Lost to Follow-up|1|||
126222486|NCT02746705|454105561|FG001|Overall Study|Lost to Follow-up|0|||
126222487|NCT02746705|454105560|FG000|Overall Study|outlier scores deemed not valid|0|||
126222488|NCT02746705|454105561|FG001|Overall Study|outlier scores deemed not valid|1|||
126222489|NCT02124746|454105562|FG000|Overall Study|Adverse Event|2|||
126222490|NCT02124746|454105563|FG001|Overall Study|Adverse Event|1|||
126222491|NCT02124746|454105564|FG002|Overall Study|Adverse Event|2|||
126222492|NCT02124746|454105562|FG000|Overall Study|Death|2|||
126222493|NCT02124746|454105563|FG001|Overall Study|Death|1|||
126222494|NCT02124746|454105564|FG002|Overall Study|Death|3|||
126222495|NCT02124746|454105562|FG000|Overall Study|Lack of Efficacy|3|||
126222496|NCT02124746|454105563|FG001|Overall Study|Lack of Efficacy|2|||
126222497|NCT02124746|454105564|FG002|Overall Study|Lack of Efficacy|2|||
126222498|NCT02124746|454105562|FG000|Overall Study|Physician Decision|6|||
126222499|NCT02124746|454105563|FG001|Overall Study|Physician Decision|4|||
126222500|NCT02124746|454105564|FG002|Overall Study|Physician Decision|5|||
126222501|NCT02124746|454105562|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126222502|NCT02124746|454105563|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126222503|NCT02124746|454105564|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126222504|NCT02124746|454105562|FG000|Overall Study|Withdrawal by Subject|3|||
126222505|NCT02124746|454105563|FG001|Overall Study|Withdrawal by Subject|3|||
126222506|NCT02124746|454105564|FG002|Overall Study|Withdrawal by Subject|0|||
126222507|NCT02124746|454105562|FG000|Overall Study|Study Terminated by Sponsor|0|||
126222508|NCT02124746|454105563|FG001|Overall Study|Study Terminated by Sponsor|0|||
126222509|NCT02124746|454105564|FG002|Overall Study|Study Terminated by Sponsor|6|||
126222510|NCT02124746|454105562|FG000|Overall Study|Disease Progression|3|||
126222511|NCT02124746|454105563|FG001|Overall Study|Disease Progression|6|||
126222512|NCT02124746|454105564|FG002|Overall Study|Disease Progression|4|||
126222513|NCT00571922|454105565|FG000|Overall Study|Completion unknown|36|||
126222514|NCT00571922|454105566|FG001|Overall Study|Completion unknown|36|||
126222515|NCT02191579|454105573|FG000|Treatment 1|Multiple Reasons Specified|27|||
126222516|NCT02191579|454105574|FG001|Treatment 1|Multiple Reasons Specified|58|||
126350215|NCT02101853|454574160|FG002|Post Induction Randomization|Physician Decision|23|||
126350216|NCT02101853|454574161|FG003|Post Induction Randomization|Physician Decision|14|||
126350217|NCT02101853|454574162|FG004|Post Induction Randomization|Physician Decision|14|||
126350218|NCT02101853|454574163|FG005|Post Induction Randomization|Physician Decision|0|||
126350219|NCT02101853|454574158|FG000|Post Induction Randomization|Protocol Violation|0|||
126350220|NCT02101853|454574159|FG001|Post Induction Randomization|Protocol Violation|3|||
126350221|NCT02101853|454574160|FG002|Post Induction Randomization|Protocol Violation|0|||
126350222|NCT02101853|454574161|FG003|Post Induction Randomization|Protocol Violation|0|||
126350223|NCT02101853|454574162|FG004|Post Induction Randomization|Protocol Violation|0|||
126350224|NCT02101853|454574163|FG005|Post Induction Randomization|Protocol Violation|0|||
126350225|NCT02101853|454574158|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
126350226|NCT02101853|454574159|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
126350227|NCT02101853|454574160|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
126350228|NCT02101853|454574161|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
126350229|NCT02101853|454574162|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
126350230|NCT02101853|454574163|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
126369486|NCT00876447|454650571|FG000|Overall Study|Other miscellaneous reasons|3|||
126369487|NCT00876447|454650572|FG001|Overall Study|Other miscellaneous reasons|8|||
126369488|NCT00876447|454650571|FG000|Overall Study|Site closure|19|||
126018357|NCT00636207|453362022|FG004|Overall Study|Withdrawal by Subject|1|||
126222517|NCT02191579|454105573|FG000|Treatment 2|Multiple Reasons Specified|0|||
126222518|NCT02191579|454105574|FG001|Treatment 2|Multiple Reasons Specified|25|||
126222519|NCT03940586|454105577|FG000|Overall Study|Death|3|||
126222520|NCT03940586|454105578|FG001|Overall Study|Death|2|||
126222521|NCT03940586|454105579|FG002|Overall Study|Death|0|||
126222522|NCT03940586|454105577|FG000|Overall Study|Physician Decision|1|||
126222523|NCT03940586|454105578|FG001|Overall Study|Physician Decision|0|||
126222524|NCT03940586|454105579|FG002|Overall Study|Physician Decision|1|||
126222525|NCT03940586|454105577|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
126369489|NCT00876447|454650572|FG001|Overall Study|Site closure|14|||
126369490|NCT00876447|454650571|FG000|Overall Study|Protocol Violation|9|||
126369491|NCT00876447|454650572|FG001|Overall Study|Protocol Violation|3|||
126369492|NCT00876447|454650571|FG000|Overall Study|Personal reasons|30|||
126222526|NCT03940586|454105578|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
126222527|NCT03940586|454105579|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
126222528|NCT03940586|454105577|FG000|Overall Study|Not Treated|0|||
126222529|NCT03940586|454105578|FG001|Overall Study|Not Treated|2|||
126222530|NCT03940586|454105579|FG002|Overall Study|Not Treated|0|||
126222531|NCT00964223|454105580|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
126222532|NCT03077828|454105581|FG000|Treatment Cycles|Death|1|||
126222533|NCT03077828|454105581|FG000|Treatment Cycles|Withdrawal by Subject|1|||
126222534|NCT03077828|454105581|FG000|Treatment Cycles|Screen Fail|2|||
126222535|NCT03077828|454105581|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
126222536|NCT03077828|454105581|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
126222537|NCT03077828|454105581|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
126222538|NCT03077828|454105581|FG000|Follow-up|Patients still in follow-up|15|||
126222539|NCT00345683|454105585|FG000|Overall Study|Lost to Follow-up|19|||
126222540|NCT00345683|454105586|FG001|Overall Study|Lost to Follow-up|7|||
126222541|NCT00345683|454105585|FG000|Overall Study|Other|6|||
126222542|NCT00345683|454105586|FG001|Overall Study|Other|2|||
126222543|NCT04288115|454105587|FG000|Overall Study|Withdrawal by Subject|0|||
126222544|NCT04288115|454105588|FG001|Overall Study|Withdrawal by Subject|1|||
126222545|NCT04288115|454105587|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
126222546|NCT04288115|454105588|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
126222547|NCT00729365|454105590|FG000|Overall Study|Physician Decision|33|||
126222548|NCT00729365|454105591|FG001|Overall Study|Physician Decision|6|||
126222549|NCT00729365|454105592|FG002|Overall Study|Physician Decision|7|||
126222550|NCT01697449|454105593|FG000|Overall Study|Disease progression|47|||
126222551|NCT01697449|454105593|FG000|Overall Study|Adverse Event|7|||
126222552|NCT01697449|454105593|FG000|Overall Study|Lost to Follow-up|5|||
126222553|NCT01697449|454105593|FG000|Overall Study|Withdrawal by Subject|2|||
126222554|NCT01697449|454105593|FG000|Overall Study|Physician Decision|1|||
126222555|NCT01697449|454105593|FG000|Overall Study|Death|2|||
126222556|NCT01697449|454105593|FG000|Overall Study|Other|1|||
126222557|NCT01697449|454105593|FG000|Overall Study|Missing|25|||
126222558|NCT00811070|454105595|FG000|Overall Study|Death|0|||
126222559|NCT00811070|454105596|FG001|Overall Study|Death|0|||
126222560|NCT00811070|454105597|FG002|Overall Study|Death|0|||
126222561|NCT00811070|454105598|FG003|Overall Study|Death|2|||
126222562|NCT00811070|454105599|FG004|Overall Study|Death|5|||
126222563|NCT00811070|454105600|FG005|Overall Study|Death|0|||
126222564|NCT00811070|454105595|FG000|Overall Study|Other|1|||
126222565|NCT00811070|454105596|FG001|Overall Study|Other|0|||
126222566|NCT00811070|454105597|FG002|Overall Study|Other|0|||
126222567|NCT00811070|454105598|FG003|Overall Study|Other|0|||
126222568|NCT00811070|454105599|FG004|Overall Study|Other|0|||
126222569|NCT00811070|454105600|FG005|Overall Study|Other|0|||
126222570|NCT00811070|454105595|FG000|Overall Study|Withdrawal by Subject|0|||
126222571|NCT00811070|454105596|FG001|Overall Study|Withdrawal by Subject|1|||
126222572|NCT00811070|454105597|FG002|Overall Study|Withdrawal by Subject|0|||
126222573|NCT00811070|454105598|FG003|Overall Study|Withdrawal by Subject|0|||
126222574|NCT00811070|454105599|FG004|Overall Study|Withdrawal by Subject|0|||
126222575|NCT00811070|454105600|FG005|Overall Study|Withdrawal by Subject|0|||
126222576|NCT00811070|454105595|FG000|Overall Study|Physician Decision|0|||
126222577|NCT00811070|454105596|FG001|Overall Study|Physician Decision|0|||
126222578|NCT00811070|454105597|FG002|Overall Study|Physician Decision|0|||
126222579|NCT00811070|454105598|FG003|Overall Study|Physician Decision|0|||
126222580|NCT00811070|454105599|FG004|Overall Study|Physician Decision|0|||
126222581|NCT00811070|454105600|FG005|Overall Study|Physician Decision|1|||
126222582|NCT01759537|454105603|FG000|Overall Study|Death|1|||
126222583|NCT01759537|454105604|FG001|Overall Study|Death|1|||
126222584|NCT01759537|454105603|FG000|Overall Study|Pregnancy|1|||
126222585|NCT01759537|454105604|FG001|Overall Study|Pregnancy|1|||
126222586|NCT01759537|454105603|FG000|Overall Study|Lost to Follow-up|9|||
126222587|NCT01759537|454105604|FG001|Overall Study|Lost to Follow-up|9|||
126222588|NCT01759537|454105603|FG000|Overall Study|Accident involving jaw fracture|1|||
126222589|NCT01759537|454105604|FG001|Overall Study|Accident involving jaw fracture|1|||
126222590|NCT01759537|454105603|FG000|Overall Study|Subcrestal implant too coronal|1|||
126222591|NCT01759537|454105604|FG001|Overall Study|Subcrestal implant too coronal|1|||
126222592|NCT02270983|454107694|FG000|Overall Study|Adverse Event|3|||
126222593|NCT02270983|454107695|FG001|Overall Study|Adverse Event|2|||
126222594|NCT02270983|454107696|FG002|Overall Study|Adverse Event|6|||
126222595|NCT02270983|454107694|FG000|Overall Study|Lack of Efficacy|2|||
126222596|NCT02270983|454107695|FG001|Overall Study|Lack of Efficacy|1|||
126222597|NCT02270983|454107696|FG002|Overall Study|Lack of Efficacy|1|||
126222598|NCT02270983|454107694|FG000|Overall Study|Withdrawal by Subject|1|||
126222599|NCT02270983|454107695|FG001|Overall Study|Withdrawal by Subject|0|||
126222600|NCT02270983|454107696|FG002|Overall Study|Withdrawal by Subject|2|||
126222601|NCT02270983|454107694|FG000|Overall Study|Lost to Follow-up|1|||
126222602|NCT02270983|454107695|FG001|Overall Study|Lost to Follow-up|1|||
126222603|NCT02270983|454107696|FG002|Overall Study|Lost to Follow-up|2|||
126222604|NCT02270983|454107694|FG000|Overall Study|Protocol Violation|1|||
126222605|NCT02270983|454107695|FG001|Overall Study|Protocol Violation|1|||
126222606|NCT02270983|454107696|FG002|Overall Study|Protocol Violation|1|||
126222607|NCT02270983|454107694|FG000|Overall Study|family emergency|0|||
126222608|NCT02270983|454107695|FG001|Overall Study|family emergency|1|||
126222609|NCT02270983|454107696|FG002|Overall Study|family emergency|0|||
126222610|NCT02270983|454107694|FG000|Overall Study|study procedure non-compliance|1|||
126222611|NCT02270983|454107695|FG001|Overall Study|study procedure non-compliance|0|||
126222612|NCT02270983|454107696|FG002|Overall Study|study procedure non-compliance|0|||
126222613|NCT02270983|454107694|FG000|Overall Study|moved away from study site|0|||
126222614|NCT02270983|454107695|FG001|Overall Study|moved away from study site|1|||
126222615|NCT02270983|454107696|FG002|Overall Study|moved away from study site|0|||
126222616|NCT01623830|454107702|FG000|Overall Study|Withdrawal by Subject|6|||
126222617|NCT01623830|454107703|FG001|Overall Study|Withdrawal by Subject|7|||
126222618|NCT01623830|454107702|FG000|Overall Study|Exclusion from Study|1|||
126222619|NCT01623830|454107703|FG001|Overall Study|Exclusion from Study|2|||
126222620|NCT00928252|454107704|FG000|Overall Study|Physician Decision|3|||
126222621|NCT01605461|454107706|FG000|Overall Study|Lost to Follow-up|3|||
126222622|NCT01605461|454107706|FG000|Overall Study|Withdrawal by Subject|1|||
126222623|NCT02024698|454107707|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
126222624|NCT02024698|454107708|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
126222625|NCT01169649|454107709|FG000|Overall Study|Patient Not Treated|3|||
126222626|NCT00515073|454107712|FG000|Overall Study|Withdrawal by Subject|1|||
126222627|NCT00515073|454107712|FG000|Overall Study|Physician Decision|1|||
126222628|NCT01456052|454107713|FG000|Overall Study|Adverse Event|1|||
126222629|NCT01456052|454107714|FG001|Overall Study|Adverse Event|1|||
126222630|NCT01456052|454107715|FG002|Overall Study|Adverse Event|2|||
126222631|NCT01456052|454107713|FG000|Overall Study|Consent withdrawn|0|||
126222632|NCT01456052|454107714|FG001|Overall Study|Consent withdrawn|2|||
126222633|NCT01456052|454107715|FG002|Overall Study|Consent withdrawn|1|||
126222634|NCT01456052|454107713|FG000|Overall Study|Protocol Violation|0|||
126222635|NCT01456052|454107714|FG001|Overall Study|Protocol Violation|1|||
126222636|NCT01456052|454107715|FG002|Overall Study|Protocol Violation|0|||
126222637|NCT01456052|454107713|FG000|Overall Study|Physician Decision|1|||
126222638|NCT01456052|454107714|FG001|Overall Study|Physician Decision|0|||
126222639|NCT01456052|454107715|FG002|Overall Study|Physician Decision|1|||
126222640|NCT01456052|454107713|FG000|Overall Study|Treatment Failure|0|||
126222641|NCT01456052|454107714|FG001|Overall Study|Treatment Failure|1|||
126222642|NCT01456052|454107715|FG002|Overall Study|Treatment Failure|1|||
126222643|NCT00693784|454107716|FG000|Overall Study|Lost to Follow-up|2|||
126222644|NCT00693784|454107716|FG000|Overall Study|Withdrawal by Subject|2|||
126222645|NCT00326885|454107718|FG000|Overall Study|Adverse Event|1|||
126018358|NCT00636207|453362023|FG005|Overall Study|Withdrawal by Subject|0|||
126018359|NCT00636207|453362024|FG006|Overall Study|Withdrawal by Subject|0|||
126018360|NCT02594735|453362027|FG000|Overall Study|Adverse Event|1|||
126018361|NCT01075217|453362031|FG000|Overall Study|Adverse Event|1|||
126018362|NCT01075217|453362032|FG001|Overall Study|Adverse Event|1|||
126018363|NCT01075217|453362031|FG000|Overall Study|Physician Decision|1|||
126018364|NCT01075217|453362032|FG001|Overall Study|Physician Decision|0|||
126018365|NCT02969863|453362033|FG000|Overall Study|Physician Decision|1|||
126018366|NCT02969863|453362034|FG001|Overall Study|Physician Decision|0|||
126018367|NCT02969863|453362035|FG002|Overall Study|Physician Decision|0|||
126018368|NCT02969863|453362036|FG003|Overall Study|Physician Decision|0|||
126018369|NCT02969863|453362037|FG004|Overall Study|Physician Decision|0|||
126222646|NCT00326885|454107718|FG000|Overall Study|Withdrawal by Subject|3|||
126222647|NCT00326885|454107718|FG000|Overall Study|Physician Decision|1|||
126222648|NCT00326885|454107718|FG000|Overall Study|Hospice withdrew consent|2|||
126222649|NCT01473758|454107719|FG000|Cycle 1|Adverse Event|10|||
126222650|NCT01473758|454107720|FG001|Cycle 1|Adverse Event|2|||
126222651|NCT01473758|454107721|FG002|Cycle 1|Adverse Event|0|||
126222652|NCT01473758|454107722|FG003|Cycle 1|Adverse Event|0|||
126222653|NCT01473758|454107719|FG000|Cycle 1|Withdrawal by Subject|1|||
126222654|NCT01473758|454107720|FG001|Cycle 1|Withdrawal by Subject|1|||
126222655|NCT01473758|454107721|FG002|Cycle 1|Withdrawal by Subject|0|||
126222656|NCT01473758|454107722|FG003|Cycle 1|Withdrawal by Subject|0|||
126222657|NCT01473758|454107719|FG000|Cycle 2|Adverse Event|0|||
126222658|NCT01473758|454107720|FG001|Cycle 2|Adverse Event|0|||
126222659|NCT01473758|454107721|FG002|Cycle 2|Adverse Event|5|||
126222660|NCT01473758|454107722|FG003|Cycle 2|Adverse Event|0|||
126018370|NCT02969863|453362038|FG005|Overall Study|Physician Decision|0|||
126018371|NCT03737240|453362039|FG000|Overall Study|Lost to Follow-up|16|||
126018372|NCT03737240|453362040|FG001|Overall Study|Lost to Follow-up|15|||
126222661|NCT01677910|454107723|FG000|Double-Blind Treatment Period|Adverse Event|6|||
126222662|NCT01677910|454107724|FG001|Double-Blind Treatment Period|Adverse Event|2|||
126222663|NCT01677910|454107725|FG002|Double-Blind Treatment Period|Adverse Event|3|||
126222664|NCT01677910|454107726|FG003|Double-Blind Treatment Period|Adverse Event|0|||
126222665|NCT01677910|454107723|FG000|Double-Blind Treatment Period|Physician Decision|0|||
126222666|NCT01677910|454107724|FG001|Double-Blind Treatment Period|Physician Decision|0|||
126222667|NCT01677910|454107725|FG002|Double-Blind Treatment Period|Physician Decision|1|||
126222668|NCT01677910|454107726|FG003|Double-Blind Treatment Period|Physician Decision|0|||
126222669|NCT01677910|454107723|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
126222670|NCT01677910|454107724|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
126222671|NCT01677910|454107725|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
126222672|NCT01677910|454107726|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
126222673|NCT01677910|454107723|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
126222674|NCT01677910|454107724|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
126222675|NCT01677910|454107725|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
126222676|NCT01677910|454107726|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
126222677|NCT01677910|454107723|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
126222678|NCT01677910|454107724|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
126222679|NCT01677910|454107725|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
126222680|NCT01677910|454107726|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
126222681|NCT01677910|454107723|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126222682|NCT01677910|454107724|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126222683|NCT01677910|454107725|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126222684|NCT01677910|454107726|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
126222685|NCT01677910|454107723|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126222686|NCT01677910|454107724|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126222687|NCT01677910|454107725|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126222688|NCT01677910|454107726|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
126222689|NCT01677910|454107723|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126222690|NCT01677910|454107724|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126222691|NCT01677910|454107725|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126222692|NCT01677910|454107726|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
126222693|NCT01677910|454107723|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
126222694|NCT01677910|454107724|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
126222695|NCT01677910|454107725|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
126222696|NCT01677910|454107726|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
126222697|NCT01677910|454107723|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
126222698|NCT01677910|454107724|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
126222699|NCT01677910|454107725|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
126222700|NCT01677910|454107726|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
126222701|NCT03341273|454107729|FG000|Overall Study|Lost to Follow-up|7|||
126222702|NCT03341273|454107730|FG001|Overall Study|Lost to Follow-up|7|||
126222703|NCT03341273|454107729|FG000|Overall Study|Withdrawal by Subject|4|||
126222704|NCT03341273|454107730|FG001|Overall Study|Withdrawal by Subject|2|||
126222705|NCT03341273|454107729|FG000|Overall Study|Physician Decision|1|||
126222706|NCT03341273|454107730|FG001|Overall Study|Physician Decision|0|||
126222707|NCT03341273|454107729|FG000|Overall Study|Protocol Violation|0|||
126222708|NCT03341273|454107730|FG001|Overall Study|Protocol Violation|1|||
126222709|NCT03341273|454107729|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
126222710|NCT03341273|454107730|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
126222711|NCT03341273|454107729|FG000|Overall Study|Became ineligible after enrollment|1|||
126222712|NCT03341273|454107730|FG001|Overall Study|Became ineligible after enrollment|0|||
126222713|NCT03341273|454107729|FG000|Overall Study|Not Eligible at Enrollment|0|||
126222714|NCT03341273|454107730|FG001|Overall Study|Not Eligible at Enrollment|1|||
126222715|NCT03341273|454107729|FG000|Overall Study|Participant incarcerated|1|||
126222716|NCT03341273|454107730|FG001|Overall Study|Participant incarcerated|0|||
126222717|NCT02041494|454107731|FG000|Overall Study|Death|1|||
126222718|NCT02041494|454107732|FG001|Overall Study|Death|3|||
126222719|NCT02041494|454107731|FG000|Overall Study|Lost to Follow-up|2|||
126222720|NCT02041494|454107732|FG001|Overall Study|Lost to Follow-up|6|||
126222721|NCT02041494|454107731|FG000|Overall Study|study terminated|16|||
126222722|NCT02041494|454107732|FG001|Overall Study|study terminated|11|||
126092490|NCT00215137|453632772|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
126222723|NCT00685919|454107733|FG000|Overall Study|Withdrawal by Subject|0|||
126222724|NCT00685919|454107734|FG001|Overall Study|Withdrawal by Subject|0|||
126222725|NCT00685919|454107735|FG002|Overall Study|Withdrawal by Subject|1|||
126222726|NCT00685919|454107736|FG003|Overall Study|Withdrawal by Subject|0|||
126222727|NCT00685919|454107733|FG000|Overall Study|Physician Decision|1|||
126222728|NCT00685919|454107734|FG001|Overall Study|Physician Decision|0|||
126222729|NCT00685919|454107735|FG002|Overall Study|Physician Decision|0|||
126222730|NCT00685919|454107736|FG003|Overall Study|Physician Decision|0|||
126222731|NCT01717456|454107737|FG000|End of Treatment|Physician Decision|0|||
126222732|NCT01717456|454107738|FG001|End of Treatment|Physician Decision|1|||
126222733|NCT01717456|454107737|FG000|End of Treatment|Lost to Follow-up|0|||
126222734|NCT01717456|454107738|FG001|End of Treatment|Lost to Follow-up|1|||
126222735|NCT01717456|454107737|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
126222736|NCT01717456|454107738|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
126222737|NCT03751020|454107741|FG000|Overall Study|Withdrawal by Subject|2|||
126222738|NCT03751020|454107742|FG001|Overall Study|Withdrawal by Subject|0|||
126222739|NCT03751020|454107743|FG002|Overall Study|Withdrawal by Subject|0|||
126222740|NCT03751020|454107741|FG000|Overall Study|Lost to Follow-up|7|||
126222741|NCT03751020|454107742|FG001|Overall Study|Lost to Follow-up|4|||
126222742|NCT03751020|454107743|FG002|Overall Study|Lost to Follow-up|10|||
126222743|NCT00033631|454107744|FG000|Overall Study|Protocol Violation|14|||
126222744|NCT00033631|454107745|FG001|Overall Study|Protocol Violation|11|||
126222745|NCT00033631|454107744|FG000|Overall Study|Withdrawal by Subject|4|||
126222746|NCT00033631|454107745|FG001|Overall Study|Withdrawal by Subject|4|||
126222747|NCT00528879|454107746|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
126222748|NCT00528879|454107747|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
126222749|NCT00528879|454107748|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
126222750|NCT00528879|454107749|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
126222751|NCT00528879|454107746|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
126222752|NCT00528879|454107747|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
126222753|NCT00528879|454107748|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
126222754|NCT00528879|454107749|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
126222755|NCT00528879|454107746|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
126222756|NCT00528879|454107747|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
126222757|NCT00528879|454107748|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
126222758|NCT00528879|454107749|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
126222759|NCT00528879|454107746|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
126222760|NCT00528879|454107747|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
126222761|NCT00528879|454107748|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
126222762|NCT00528879|454107749|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
126222763|NCT00528879|454107746|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
126222764|NCT00528879|454107747|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
126222765|NCT00528879|454107748|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
126222766|NCT00528879|454107749|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
126222767|NCT00528879|454107746|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
126222768|NCT00528879|454107747|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
126222769|NCT00528879|454107748|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
126222770|NCT00528879|454107749|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
126222771|NCT00528879|454107746|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
126018373|NCT00364013|453362041|FG000|Overall Study|Ineligibility determined|4|||
126018374|NCT00364013|453362042|FG001|Overall Study|Ineligibility determined|2|||
126018375|NCT00364013|453362041|FG000|Overall Study|Adverse Event|4|||
126018376|NCT00364013|453362042|FG001|Overall Study|Adverse Event|3|||
126018377|NCT00364013|453362041|FG000|Overall Study|Withdrawal by Subject|13|||
126018378|NCT00364013|453362042|FG001|Overall Study|Withdrawal by Subject|18|||
126018379|NCT00364013|453362041|FG000|Overall Study|Physician Decision|3|||
126018380|NCT00364013|453362042|FG001|Overall Study|Physician Decision|3|||
126018381|NCT00364013|453362041|FG000|Overall Study|Lost to Follow-up|10|||
126222772|NCT00528879|454107747|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
126018382|NCT00364013|453362042|FG001|Overall Study|Lost to Follow-up|3|||
126018383|NCT00364013|453362041|FG000|Overall Study|Protocol-specified criteria|6|||
126018384|NCT00364013|453362042|FG001|Overall Study|Protocol-specified criteria|6|||
126222773|NCT00528879|454107748|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
126222774|NCT00528879|454107749|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
126222775|NCT00528879|454107746|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
126222776|NCT00528879|454107747|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
126018385|NCT00364013|453362041|FG000|Overall Study|Other|41|||
126018386|NCT00364013|453362042|FG001|Overall Study|Other|47|||
126018387|NCT00364013|453362041|FG000|Overall Study|Ongoing|20|||
126018388|NCT00364013|453362042|FG001|Overall Study|Ongoing|13|||
126018389|NCT00585533|453362043|FG000|Overall Study|objective or symptomatic progression|9|||
126018390|NCT01369498|453362044|FG000|Overall Study|Lack of Efficacy|9|||
126018391|NCT01369498|453362045|FG001|Overall Study|Lack of Efficacy|9|||
126018392|NCT01369498|453362046|FG002|Overall Study|Lack of Efficacy|1|||
126018393|NCT01369498|453362047|FG003|Overall Study|Lack of Efficacy|3|||
126018394|NCT01369498|453362044|FG000|Overall Study|Adverse Event|1|||
126018395|NCT01369498|453362045|FG001|Overall Study|Adverse Event|2|||
126018396|NCT01369498|453362046|FG002|Overall Study|Adverse Event|0|||
126018397|NCT01369498|453362047|FG003|Overall Study|Adverse Event|1|||
126018398|NCT01369498|453362044|FG000|Overall Study|Withdrawal of Consent|0|||
126018399|NCT01369498|453362045|FG001|Overall Study|Withdrawal of Consent|1|||
126018400|NCT01369498|453362046|FG002|Overall Study|Withdrawal of Consent|1|||
126018401|NCT01369498|453362047|FG003|Overall Study|Withdrawal of Consent|1|||
126018402|NCT01369498|453362044|FG000|Overall Study|Death|0|||
126018403|NCT01369498|453362045|FG001|Overall Study|Death|0|||
126018404|NCT01369498|453362046|FG002|Overall Study|Death|1|||
126222777|NCT00528879|454107748|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
126222778|NCT00528879|454107749|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
126222779|NCT00528879|454107746|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
126222780|NCT00528879|454107747|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
126222781|NCT00528879|454107748|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
126222782|NCT00528879|454107749|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
126018405|NCT01369498|453362047|FG003|Overall Study|Death|0|||
126018406|NCT01369498|453362044|FG000|Overall Study|Investigator's Discretion|1|||
126018407|NCT01369498|453362045|FG001|Overall Study|Investigator's Discretion|0|||
126018408|NCT01369498|453362046|FG002|Overall Study|Investigator's Discretion|1|||
126018409|NCT01369498|453362047|FG003|Overall Study|Investigator's Discretion|3|||
126018410|NCT01369498|453362044|FG000|Overall Study|Unknown Reason|1|||
126018411|NCT01369498|453362045|FG001|Overall Study|Unknown Reason|0|||
126018412|NCT01369498|453362046|FG002|Overall Study|Unknown Reason|11|||
126018413|NCT01369498|453362047|FG003|Overall Study|Unknown Reason|6|||
126222783|NCT00528879|454107746|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
126222784|NCT00528879|454107747|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
126350231|NCT02101853|454574158|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350232|NCT02101853|454574159|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126018414|NCT01369498|453362044|FG000|Overall Study|Disease Progression|0|||
126018415|NCT01369498|453362045|FG001|Overall Study|Disease Progression|0|||
126018416|NCT01369498|453362046|FG002|Overall Study|Disease Progression|0|||
126018417|NCT01369498|453362047|FG003|Overall Study|Disease Progression|1|||
126018418|NCT02538107|453362050|FG000|Overall Study|Did not receive any Mircera dose|11|||
126018419|NCT02538107|453362050|FG000|Overall Study|Missing|5|||
126018420|NCT02538107|453362050|FG000|Overall Study|Necessity of dialysis|20|||
126018421|NCT02538107|453362050|FG000|Overall Study|Administration of other ESA|11|||
126018422|NCT02538107|453362050|FG000|Overall Study|No further treatment necessary|18|||
126018423|NCT02538107|453362050|FG000|Overall Study|Withdrawal by Subject|17|||
126018424|NCT02538107|453362050|FG000|Overall Study|Death|4|||
126018425|NCT02538107|453362050|FG000|Overall Study|Administrative reason|5|||
126018426|NCT02538107|453362050|FG000|Overall Study|Adverse Event|4|||
126018427|NCT02538107|453362050|FG000|Overall Study|Surgery|1|||
126018428|NCT02538107|453362050|FG000|Overall Study|Other|7|||
126018429|NCT02538107|453362050|FG000|Overall Study|Not recorded|7|||
126018430|NCT01943916|453362051|FG000|Overall Study|Technically invalid images|10|||
126018431|NCT01943916|453362051|FG000|Overall Study|Enrollment Failure|23|||
126018432|NCT01943916|453362051|FG000|Overall Study|Pilot Phase exclusion|100|||
126018433|NCT01943916|453362051|FG000|Overall Study|Quality Assurance Reader Fail|130|||
126018434|NCT01943916|453362051|FG000|Overall Study|Technical Failure|39|||
126018435|NCT01943916|453362051|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
126018436|NCT01943916|453362051|FG000|Overall Study|No Truth Panel Review|38|||
126350233|NCT02101853|454574160|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350234|NCT02101853|454574161|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
126350235|NCT02101853|454574162|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350236|NCT02101853|454574163|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126018437|NCT01943916|453362051|FG000|Overall Study|Protocol Deviation|1|||
126018438|NCT05782231|453362052|FG000|Overall Study|Withdrawal by Subject|1|||
126018439|NCT05274217|453362053|FG000|Overall Study|Study terminated.|11|||
126018440|NCT05274217|453362054|FG001|Overall Study|Study terminated.|0|||
126018441|NCT05609032|453362057|FG000|Overall Study|Lost to Follow-up|3|||
126018442|NCT05609032|453362058|FG001|Overall Study|Lost to Follow-up|1|||
126018443|NCT05609032|453362057|FG000|Overall Study|Withdrawal by Subject|1|||
126018444|NCT05609032|453362058|FG001|Overall Study|Withdrawal by Subject|0|||
126018445|NCT01373346|453362062|FG000|Overall Study|Death|1|||
126018446|NCT01395758|453362064|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
126018447|NCT01395758|453362065|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126222785|NCT00528879|454107748|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
126018448|NCT01395758|453362066|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
126018449|NCT00433199|453362067|FG000|Double-Blind Period|Adverse Event|0|||
126018450|NCT00433199|453362068|FG001|Double-Blind Period|Adverse Event|25|||
126018451|NCT00433199|453362067|FG000|Double-Blind Period|Lack of Efficacy|0|||
126018452|NCT00433199|453362068|FG001|Double-Blind Period|Lack of Efficacy|2|||
126018453|NCT00433199|453362067|FG000|Double-Blind Period|Lost to Follow-up|2|||
126018454|NCT00433199|453362068|FG001|Double-Blind Period|Lost to Follow-up|5|||
126018455|NCT00433199|453362067|FG000|Double-Blind Period|Withdrawal by Subject|8|||
126018456|NCT00433199|453362068|FG001|Double-Blind Period|Withdrawal by Subject|19|||
126018457|NCT00433199|453362067|FG000|Double-Blind Period|Protocol Violation|1|||
126018458|NCT00433199|453362068|FG001|Double-Blind Period|Protocol Violation|10|||
126018459|NCT00433199|453362067|FG000|Double-Blind Period|Administrative|1|||
126018460|NCT00433199|453362068|FG001|Double-Blind Period|Administrative|5|||
126018461|NCT00433199|453362067|FG000|Open-Label Period|Adverse Event|0|||
126018462|NCT00433199|453362068|FG001|Open-Label Period|Adverse Event|19|||
126018463|NCT00433199|453362067|FG000|Open-Label Period|Lack of Efficacy|0|||
126018464|NCT00433199|453362068|FG001|Open-Label Period|Lack of Efficacy|2|||
126018465|NCT00433199|453362067|FG000|Open-Label Period|Lost to Follow-up|0|||
126018466|NCT00433199|453362068|FG001|Open-Label Period|Lost to Follow-up|3|||
126018467|NCT00433199|453362067|FG000|Open-Label Period|Withdrawal by Subject|0|||
126018468|NCT00433199|453362068|FG001|Open-Label Period|Withdrawal by Subject|7|||
126018469|NCT00433199|453362067|FG000|Open-Label Period|Protocol Violation|0|||
126018470|NCT00433199|453362068|FG001|Open-Label Period|Protocol Violation|2|||
126018471|NCT00433199|453362067|FG000|Open-Label Period|Administrative|0|||
126018472|NCT00433199|453362068|FG001|Open-Label Period|Administrative|1|||
126222786|NCT00528879|454107749|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
126222787|NCT00528879|454107746|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
126222788|NCT00528879|454107747|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
126222789|NCT00528879|454107748|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
126222790|NCT00528879|454107749|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
126222791|NCT00528879|454107746|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
126222792|NCT00528879|454107747|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
126222793|NCT00528879|454107748|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
126222794|NCT00528879|454107749|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
126222795|NCT00528879|454107746|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
126222796|NCT00528879|454107747|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
126222797|NCT00528879|454107748|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
126222798|NCT00528879|454107749|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
126222799|NCT00528879|454107746|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
126222800|NCT00528879|454107747|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
126222801|NCT00528879|454107748|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
126222802|NCT00528879|454107749|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
126350237|NCT02101853|454574158|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
126350238|NCT02101853|454574159|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
126350239|NCT02101853|454574160|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
126350240|NCT02101853|454574161|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
126350241|NCT02101853|454574162|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
126350242|NCT02101853|454574163|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
126350243|NCT02101853|454574158|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350244|NCT02101853|454574159|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
126350245|NCT02101853|454574160|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350246|NCT02101853|454574161|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350247|NCT02101853|454574162|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350248|NCT02101853|454574163|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350249|NCT02101853|454574158|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
126350250|NCT02101853|454574159|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
126350251|NCT02101853|454574160|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
126350252|NCT02101853|454574161|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
126350253|NCT02101853|454574162|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
126350254|NCT02101853|454574163|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
126018473|NCT00357097|453362069|FG000|Overall Study|Did not meet inclusion criteria|5|||
126018474|NCT00357097|453362070|FG001|Overall Study|Did not meet inclusion criteria|3|||
126018475|NCT00357097|453362069|FG000|Overall Study|Adverse Event|34|||
126018476|NCT00357097|453362070|FG001|Overall Study|Adverse Event|6|||
126018477|NCT00357097|453362069|FG000|Overall Study|Withdrawal by Subject|8|||
126018478|NCT00357097|453362070|FG001|Overall Study|Withdrawal by Subject|7|||
126222803|NCT00528879|454107746|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
126222804|NCT00528879|454107747|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
126222805|NCT00528879|454107748|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
126222806|NCT00528879|454107749|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
126222807|NCT00528879|454107746|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
126222808|NCT00528879|454107747|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
126222809|NCT00528879|454107748|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
126222810|NCT00528879|454107749|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
126222811|NCT00078819|454107750|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
126222812|NCT00078819|454107751|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
126222813|NCT00078819|454107752|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
126222814|NCT00078819|454107753|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
126222815|NCT00078819|454107750|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
126222816|NCT00078819|454107751|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
126222817|NCT00078819|454107752|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
126222818|NCT00078819|454107753|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
126222819|NCT00078819|454107750|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
126222820|NCT00078819|454107751|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
126222821|NCT00078819|454107752|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
126222822|NCT00078819|454107753|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
126222823|NCT00078819|454107750|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
126222824|NCT00078819|454107751|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
126222825|NCT00078819|454107752|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
126222826|NCT00078819|454107753|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
126222827|NCT00078819|454107750|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
126222828|NCT00078819|454107751|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
126222829|NCT00078819|454107752|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
126350255|NCT02101853|454574158|FG000|Blinatumomab Salvage Therapy|Death|0|||
126350256|NCT02101853|454574159|FG001|Blinatumomab Salvage Therapy|Death|0|||
126350257|NCT02101853|454574160|FG002|Blinatumomab Salvage Therapy|Death|0|||
126350258|NCT02101853|454574161|FG003|Blinatumomab Salvage Therapy|Death|0|||
126350259|NCT02101853|454574162|FG004|Blinatumomab Salvage Therapy|Death|0|||
126350260|NCT02101853|454574163|FG005|Blinatumomab Salvage Therapy|Death|2|||
126350261|NCT02101853|454574158|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350262|NCT02101853|454574159|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350263|NCT02101853|454574160|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350264|NCT02101853|454574161|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350265|NCT02101853|454574162|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350266|NCT02101853|454574163|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
126350267|NCT02101853|454574158|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350268|NCT02101853|454574159|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350269|NCT02101853|454574160|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350270|NCT02101853|454574161|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350271|NCT02101853|454574162|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350272|NCT02101853|454574163|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
126350273|NCT02101853|454574158|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350274|NCT02101853|454574159|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350275|NCT02101853|454574160|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350276|NCT02101853|454574161|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350277|NCT02101853|454574162|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350278|NCT02101853|454574163|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
126350279|NCT02112916|454574164|FG000|Overall Study|Adverse Event|6|||
126350280|NCT02112916|454574165|FG001|Overall Study|Adverse Event|9|||
126350281|NCT02112916|454574166|FG002|Overall Study|Adverse Event|3|||
126350282|NCT02112916|454574167|FG003|Overall Study|Adverse Event|2|||
126350283|NCT02112916|454574164|FG000|Overall Study|Death|9|||
126350284|NCT02112916|454574165|FG001|Overall Study|Death|9|||
126350285|NCT02112916|454574166|FG002|Overall Study|Death|3|||
126350286|NCT02112916|454574167|FG003|Overall Study|Death|4|||
126350287|NCT02112916|454574164|FG000|Overall Study|Lost to Follow-up|1|||
126350288|NCT02112916|454574165|FG001|Overall Study|Lost to Follow-up|0|||
126350289|NCT02112916|454574166|FG002|Overall Study|Lost to Follow-up|0|||
126350290|NCT02112916|454574167|FG003|Overall Study|Lost to Follow-up|0|||
126350291|NCT02112916|454574164|FG000|Overall Study|Physician Decision|94|||
126350292|NCT02112916|454574165|FG001|Overall Study|Physician Decision|72|||
126350293|NCT02112916|454574166|FG002|Overall Study|Physician Decision|24|||
126350294|NCT02112916|454574167|FG003|Overall Study|Physician Decision|15|||
126350295|NCT02112916|454574164|FG000|Overall Study|Withdrawal by Subject|5|||
126350296|NCT02112916|454574165|FG001|Overall Study|Withdrawal by Subject|3|||
126350297|NCT02112916|454574166|FG002|Overall Study|Withdrawal by Subject|1|||
126350298|NCT02112916|454574167|FG003|Overall Study|Withdrawal by Subject|1|||
126350299|NCT02112916|454574164|FG000|Overall Study|Ineligible|4|||
126018479|NCT00357097|453362069|FG000|Overall Study|Non-compliance|1|||
126018480|NCT00357097|453362070|FG001|Overall Study|Non-compliance|2|||
126018481|NCT00357097|453362069|FG000|Overall Study|Lack of Efficacy|2|||
126018482|NCT00357097|453362070|FG001|Overall Study|Lack of Efficacy|8|||
126018483|NCT00357097|453362069|FG000|Overall Study|Met Exclusion Criteria|3|||
126018484|NCT00357097|453362070|FG001|Overall Study|Met Exclusion Criteria|1|||
126018485|NCT00357097|453362069|FG000|Overall Study|Other|1|||
126018486|NCT00357097|453362070|FG001|Overall Study|Other|1|||
126018487|NCT00357097|453362069|FG000|Overall Study|Increase of RLS Symptoms|0|||
126018488|NCT00357097|453362070|FG001|Overall Study|Increase of RLS Symptoms|1|||
126018489|NCT00794118|453362071|FG000|Overall Study|Lost to Follow-up|16|||
126018490|NCT00794118|453362071|FG000|Overall Study|Withdrawal by Subject|9|||
126018491|NCT00794118|453362071|FG000|Overall Study|Changed hospital center|2|||
126018492|NCT04305405|453362072|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126018493|NCT04305405|453362073|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126018494|NCT00529659|453362074|FG000|Overall Study|Adverse Event|8|||
126018495|NCT00529659|453362075|FG001|Overall Study|Adverse Event|7|||
126018496|NCT00529659|453362074|FG000|Overall Study|Lost to Follow-up|0|||
126222830|NCT00078819|454107753|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
126222831|NCT00078819|454107750|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
126222832|NCT00078819|454107751|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
126222833|NCT00078819|454107752|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
126222834|NCT00078819|454107753|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
126222835|NCT00078819|454107750|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
126222836|NCT00078819|454107751|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
126222837|NCT00078819|454107752|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
126222838|NCT00078819|454107753|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
126222839|NCT00078819|454107750|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
126018497|NCT00529659|453362075|FG001|Overall Study|Lost to Follow-up|2|||
126018498|NCT00529659|453362074|FG000|Overall Study|Physician Decision|0|||
126018499|NCT00529659|453362075|FG001|Overall Study|Physician Decision|2|||
126018500|NCT00529659|453362074|FG000|Overall Study|Protocol Violation|2|||
126018501|NCT00529659|453362075|FG001|Overall Study|Protocol Violation|6|||
126018502|NCT00529659|453362074|FG000|Overall Study|Withdrawal by Subject|1|||
126018503|NCT00529659|453362075|FG001|Overall Study|Withdrawal by Subject|6|||
126018504|NCT01170962|453362077|FG000|Treatment Period|Lack of Efficacy|96|||
126018505|NCT01170962|453362078|FG001|Treatment Period|Lack of Efficacy|91|||
126018506|NCT01170962|453362079|FG002|Treatment Period|Lack of Efficacy|7|||
126018507|NCT01170962|453362077|FG000|Treatment Period|Adverse Event|11|||
126018508|NCT01170962|453362078|FG001|Treatment Period|Adverse Event|12|||
126018509|NCT01170962|453362079|FG002|Treatment Period|Adverse Event|3|||
126018510|NCT01170962|453362077|FG000|Treatment Period|Withdrawal by Subject|2|||
126018511|NCT01170962|453362078|FG001|Treatment Period|Withdrawal by Subject|1|||
126018512|NCT01170962|453362079|FG002|Treatment Period|Withdrawal by Subject|0|||
126018513|NCT01170962|453362077|FG000|Treatment Period|Lost to Follow-up|1|||
126018514|NCT01170962|453362078|FG001|Treatment Period|Lost to Follow-up|1|||
126018515|NCT01170962|453362079|FG002|Treatment Period|Lost to Follow-up|1|||
126222840|NCT00078819|454107751|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
126222841|NCT00078819|454107752|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
126018516|NCT01170962|453362077|FG000|Treatment Period|Participant no longer meets criteria|0|||
126018517|NCT01170962|453362078|FG001|Treatment Period|Participant no longer meets criteria|1|||
126018518|NCT01170962|453362079|FG002|Treatment Period|Participant no longer meets criteria|0|||
126018519|NCT01170962|453362077|FG000|Treatment Period|Request to discontinue treatment|7|||
126018520|NCT01170962|453362078|FG001|Treatment Period|Request to discontinue treatment|3|||
126018521|NCT01170962|453362079|FG002|Treatment Period|Request to discontinue treatment|1|||
126018522|NCT01170962|453362077|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
126018523|NCT01170962|453362078|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
126018524|NCT01170962|453362079|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
126018525|NCT01170962|453362077|FG000|Follow up Period|Withdrawal by Subject|14|||
126222842|NCT00078819|454107753|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
126222843|NCT00323609|454107754|FG000|Overall Study|Death|16|||
126222844|NCT00323609|454107755|FG001|Overall Study|Death|21|||
126222845|NCT00323609|454107756|FG002|Overall Study|Death|0|||
126222846|NCT00323609|454107757|FG003|Overall Study|Death|0|||
126222847|NCT00323609|454107754|FG000|Overall Study|Lost to Follow-up|9|||
126222848|NCT00323609|454107755|FG001|Overall Study|Lost to Follow-up|10|||
126222849|NCT00323609|454107756|FG002|Overall Study|Lost to Follow-up|0|||
126222850|NCT00323609|454107757|FG003|Overall Study|Lost to Follow-up|0|||
126222851|NCT00323609|454107754|FG000|Overall Study|Physician Decision|2|||
126222852|NCT00323609|454107755|FG001|Overall Study|Physician Decision|0|||
126222853|NCT00323609|454107756|FG002|Overall Study|Physician Decision|0|||
126222854|NCT00323609|454107757|FG003|Overall Study|Physician Decision|1|||
126222855|NCT00323609|454107754|FG000|Overall Study|Withdrawal by Subject|11|||
126222856|NCT00323609|454107755|FG001|Overall Study|Withdrawal by Subject|23|||
126222857|NCT00323609|454107756|FG002|Overall Study|Withdrawal by Subject|4|||
126222858|NCT00323609|454107757|FG003|Overall Study|Withdrawal by Subject|4|||
126222859|NCT00323609|454107754|FG000|Overall Study|Other non-VCF-related medical condition|3|||
126222860|NCT00323609|454107755|FG001|Overall Study|Other non-VCF-related medical condition|2|||
126018526|NCT01170962|453362078|FG001|Follow up Period|Withdrawal by Subject|10|||
126018527|NCT01170962|453362079|FG002|Follow up Period|Withdrawal by Subject|2|||
126018528|NCT01170962|453362077|FG000|Follow up Period|Lost to Follow-up|13|||
126018529|NCT01170962|453362078|FG001|Follow up Period|Lost to Follow-up|8|||
126018530|NCT01170962|453362079|FG002|Follow up Period|Lost to Follow-up|1|||
126222861|NCT00323609|454107756|FG002|Overall Study|Other non-VCF-related medical condition|0|||
126222862|NCT00323609|454107757|FG003|Overall Study|Other non-VCF-related medical condition|0|||
126222863|NCT00323609|454107754|FG000|Overall Study|Sponsor discontinued trial|29|||
126222864|NCT00323609|454107755|FG001|Overall Study|Sponsor discontinued trial|29|||
126222865|NCT00323609|454107756|FG002|Overall Study|Sponsor discontinued trial|0|||
126222866|NCT00323609|454107757|FG003|Overall Study|Sponsor discontinued trial|0|||
126222867|NCT00323609|454107754|FG000|Overall Study|Unrelenting or severe back pain|1|||
126018531|NCT01170962|453362077|FG000|Follow up Period|Death|2|||
126222868|NCT00323609|454107755|FG001|Overall Study|Unrelenting or severe back pain|1|||
126222869|NCT00323609|454107756|FG002|Overall Study|Unrelenting or severe back pain|0|||
126222870|NCT00323609|454107757|FG003|Overall Study|Unrelenting or severe back pain|0|||
126222871|NCT00323609|454107754|FG000|Overall Study|Logistical withdrawal|9|||
126222872|NCT00323609|454107755|FG001|Overall Study|Logistical withdrawal|5|||
126222873|NCT00323609|454107756|FG002|Overall Study|Logistical withdrawal|0|||
126222874|NCT00323609|454107757|FG003|Overall Study|Logistical withdrawal|1|||
126222875|NCT00323609|454107754|FG000|Overall Study|Other reason|11|||
126222876|NCT00323609|454107755|FG001|Overall Study|Other reason|8|||
126018532|NCT01170962|453362078|FG001|Follow up Period|Death|2|||
126018533|NCT01170962|453362079|FG002|Follow up Period|Death|0|||
126018534|NCT01170962|453362077|FG000|Follow up Period|Others|10|||
126018535|NCT01170962|453362078|FG001|Follow up Period|Others|7|||
126018536|NCT01170962|453362079|FG002|Follow up Period|Others|3|||
126018537|NCT03887650|453362080|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
126018538|NCT03887650|453362081|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
126018539|NCT03887650|453362080|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
126018540|NCT03887650|453362081|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
126222877|NCT00323609|454107756|FG002|Overall Study|Other reason|4|||
126222878|NCT00323609|454107757|FG003|Overall Study|Other reason|9|||
126222879|NCT02217345|454107758|FG000|Overall Study|Lost to Follow-up|2|||
126222880|NCT02217345|454107759|FG001|Overall Study|Lost to Follow-up|1|||
126018541|NCT03887650|453362080|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
126018542|NCT03887650|453362081|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
126222881|NCT02217345|454107758|FG000|Overall Study|Withdrawal by Subject|3|||
126222882|NCT02217345|454107759|FG001|Overall Study|Withdrawal by Subject|2|||
126222883|NCT02217345|454107758|FG000|Overall Study|Adverse Event|2|||
126018543|NCT03512756|453362088|FG000|Part 1|Death|23|||
126222884|NCT02217345|454107759|FG001|Overall Study|Adverse Event|1|||
126222885|NCT02217345|454107758|FG000|Overall Study|Physician Decision|0|||
126018544|NCT03512756|453362089|FG001|Part 1|Death|18|||
126222886|NCT02217345|454107759|FG001|Overall Study|Physician Decision|1|||
126092491|NCT00215137|453632770|FG000|Randomization Period|Lost to Follow-up|0|||
126092492|NCT00215137|453632771|FG001|Randomization Period|Lost to Follow-up|1|||
126092493|NCT00215137|453632772|FG002|Randomization Period|Lost to Follow-up|0|||
126092494|NCT00215137|453632770|FG000|Randomization Period|Withdrawal by Subject|0|||
126092495|NCT00215137|453632771|FG001|Randomization Period|Withdrawal by Subject|1|||
126092496|NCT00215137|453632772|FG002|Randomization Period|Withdrawal by Subject|0|||
126092497|NCT01076153|453632779|FG000|Overall Study|Symptoms improved/resolved|10|||
126092498|NCT01076153|453632779|FG000|Overall Study|Adverse Event|1|||
126092499|NCT01142232|453632783|FG000|Overall Study|Adverse Event|1|||
126092500|NCT01142232|453632784|FG001|Overall Study|Adverse Event|2|||
126092501|NCT01142232|453632785|FG002|Overall Study|Adverse Event|1|||
126092502|NCT01142232|453632786|FG003|Overall Study|Adverse Event|0|||
126092503|NCT01142232|453632787|FG004|Overall Study|Adverse Event|4|||
126092504|NCT01142232|453632783|FG000|Overall Study|Death|0|||
126092505|NCT01142232|453632784|FG001|Overall Study|Death|0|||
126092506|NCT01142232|453632785|FG002|Overall Study|Death|0|||
126092507|NCT01142232|453632786|FG003|Overall Study|Death|0|||
126092508|NCT01142232|453632787|FG004|Overall Study|Death|1|||
126092509|NCT01142232|453632783|FG000|Overall Study|Disease Progression|2|||
126092510|NCT01142232|453632784|FG001|Overall Study|Disease Progression|0|||
126092511|NCT01142232|453632785|FG002|Overall Study|Disease Progression|1|||
126092512|NCT01142232|453632786|FG003|Overall Study|Disease Progression|2|||
126092513|NCT01142232|453632787|FG004|Overall Study|Disease Progression|12|||
126092514|NCT01142232|453632783|FG000|Overall Study|Withdrawal by Subject|0|||
126092515|NCT01142232|453632784|FG001|Overall Study|Withdrawal by Subject|0|||
126092516|NCT01142232|453632785|FG002|Overall Study|Withdrawal by Subject|0|||
126092517|NCT01142232|453632786|FG003|Overall Study|Withdrawal by Subject|1|||
126092518|NCT01142232|453632787|FG004|Overall Study|Withdrawal by Subject|3|||
126092519|NCT01142232|453632783|FG000|Overall Study|Physician Decision|0|||
126092520|NCT01142232|453632784|FG001|Overall Study|Physician Decision|1|||
126092521|NCT01142232|453632785|FG002|Overall Study|Physician Decision|0|||
126092522|NCT01142232|453632786|FG003|Overall Study|Physician Decision|2|||
126092523|NCT01142232|453632787|FG004|Overall Study|Physician Decision|10|||
126092524|NCT01142232|453632783|FG000|Overall Study|Alternative Therapy|0|||
126092525|NCT01142232|453632784|FG001|Overall Study|Alternative Therapy|1|||
126092526|NCT01142232|453632785|FG002|Overall Study|Alternative Therapy|1|||
126092527|NCT01142232|453632786|FG003|Overall Study|Alternative Therapy|0|||
126092528|NCT01142232|453632787|FG004|Overall Study|Alternative Therapy|1|||
126092529|NCT01142232|453632783|FG000|Overall Study|Off Trt for other complicating disease|0|||
126092530|NCT01142232|453632784|FG001|Overall Study|Off Trt for other complicating disease|0|||
126092531|NCT01142232|453632785|FG002|Overall Study|Off Trt for other complicating disease|0|||
126092532|NCT01142232|453632786|FG003|Overall Study|Off Trt for other complicating disease|0|||
126092533|NCT01142232|453632787|FG004|Overall Study|Off Trt for other complicating disease|1|||
126092534|NCT01142232|453632783|FG000|Overall Study|Noncompliance|0|||
126092535|NCT01142232|453632784|FG001|Overall Study|Noncompliance|0|||
126092536|NCT01142232|453632785|FG002|Overall Study|Noncompliance|0|||
126092537|NCT01142232|453632786|FG003|Overall Study|Noncompliance|0|||
126222887|NCT00950599|454107763|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222888|NCT00950599|454107764|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222889|NCT00950599|454107765|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222890|NCT00950599|454107766|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
126222891|NCT00950599|454107767|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222892|NCT00950599|454107768|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222893|NCT00950599|454107769|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222894|NCT00950599|454107770|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222895|NCT00950599|454107771|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222896|NCT00950599|454107772|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126222897|NCT00950599|454107763|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126222898|NCT00950599|454107764|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126222899|NCT00950599|454107765|FG002|Double-Blind Treatment Period|Adverse Event|1|||
126222900|NCT00950599|454107766|FG003|Double-Blind Treatment Period|Adverse Event|1|||
126350300|NCT02112916|454574165|FG001|Overall Study|Ineligible|8|||
126350301|NCT02112916|454574166|FG002|Overall Study|Ineligible|3|||
126350302|NCT02112916|454574167|FG003|Overall Study|Ineligible|8|||
126350303|NCT02112916|454574164|FG000|Overall Study|Inevaluable|6|||
126350304|NCT02112916|454574165|FG001|Overall Study|Inevaluable|4|||
126092538|NCT01142232|453632787|FG004|Overall Study|Noncompliance|2|||
126092539|NCT00297427|453632792|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
126092540|NCT00297427|453632793|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
126092541|NCT00297427|453632792|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
126092542|NCT00297427|453632793|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
126092543|NCT00297427|453632792|FG000|Phase 1: Initial Intervention|Death|0|||
126092544|NCT00297427|453632793|FG001|Phase 1: Initial Intervention|Death|1|||
126092545|NCT00297427|453632792|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
126222901|NCT00950599|454107767|FG004|Double-Blind Treatment Period|Adverse Event|1|||
126018545|NCT03512756|453362090|FG002|Part 1|Death|0|||
126018546|NCT03512756|453362091|FG003|Part 1|Death|0|||
126018547|NCT03512756|453362088|FG000|Part 1|Lost to Follow-up|0|||
126018548|NCT03512756|453362089|FG001|Part 1|Lost to Follow-up|3|||
126018549|NCT03512756|453362090|FG002|Part 1|Lost to Follow-up|0|||
126018550|NCT03512756|453362091|FG003|Part 1|Lost to Follow-up|0|||
126018551|NCT03512756|453362088|FG000|Part 1|Physician Decision|0|||
126018552|NCT03512756|453362089|FG001|Part 1|Physician Decision|1|||
126018553|NCT03512756|453362090|FG002|Part 1|Physician Decision|0|||
126018554|NCT03512756|453362091|FG003|Part 1|Physician Decision|0|||
126018555|NCT03512756|453362088|FG000|Part 1|Withdrawal by Subject|2|||
126018556|NCT03512756|453362089|FG001|Part 1|Withdrawal by Subject|2|||
126018557|NCT03512756|453362090|FG002|Part 1|Withdrawal by Subject|0|||
126018558|NCT03512756|453362091|FG003|Part 1|Withdrawal by Subject|0|||
126018559|NCT03512756|453362088|FG000|Part 2|Death|0|||
126018560|NCT03512756|453362089|FG001|Part 2|Death|0|||
126018561|NCT03512756|453362090|FG002|Part 2|Death|32|||
126018562|NCT03512756|453362091|FG003|Part 2|Death|21|||
126018563|NCT03512756|453362088|FG000|Part 2|Lost to Follow-up|0|||
126018564|NCT03512756|453362089|FG001|Part 2|Lost to Follow-up|0|||
126018565|NCT03512756|453362090|FG002|Part 2|Lost to Follow-up|1|||
126018566|NCT03512756|453362091|FG003|Part 2|Lost to Follow-up|0|||
126018567|NCT03512756|453362088|FG000|Part 2|Physician Decision|0|||
126018568|NCT03512756|453362089|FG001|Part 2|Physician Decision|0|||
126222902|NCT00950599|454107768|FG005|Double-Blind Treatment Period|Adverse Event|1|||
126222903|NCT00950599|454107769|FG006|Double-Blind Treatment Period|Adverse Event|0|||
126222904|NCT00950599|454107770|FG007|Double-Blind Treatment Period|Adverse Event|0|||
126222905|NCT00950599|454107771|FG008|Double-Blind Treatment Period|Adverse Event|0|||
126222906|NCT00950599|454107772|FG009|Double-Blind Treatment Period|Adverse Event|0|||
126222907|NCT00950599|454107763|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
126222908|NCT00950599|454107764|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
126222909|NCT00950599|454107765|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
126222910|NCT00950599|454107766|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
126222911|NCT00950599|454107767|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
126018569|NCT03512756|453362090|FG002|Part 2|Physician Decision|2|||
126018570|NCT03512756|453362091|FG003|Part 2|Physician Decision|4|||
126018571|NCT03512756|453362088|FG000|Part 2|Study Terminated by Sponsor|0|||
126018572|NCT03512756|453362089|FG001|Part 2|Study Terminated by Sponsor|0|||
126018573|NCT03512756|453362090|FG002|Part 2|Study Terminated by Sponsor|2|||
126092546|NCT00297427|453632793|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
126092547|NCT00297427|453632792|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
126222912|NCT00950599|454107768|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
126222913|NCT00950599|454107769|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
126222914|NCT00950599|454107770|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
126222915|NCT00950599|454107771|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
126222916|NCT00950599|454107772|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
126222917|NCT00950599|454107763|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126222918|NCT00950599|454107764|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
126222919|NCT00950599|454107765|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
126222920|NCT00950599|454107766|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
126222921|NCT00950599|454107767|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
126222922|NCT00950599|454107768|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
126222923|NCT00950599|454107769|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
126222924|NCT00950599|454107770|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
126018574|NCT03512756|453362091|FG003|Part 2|Study Terminated by Sponsor|6|||
126092548|NCT00297427|453632793|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
126092549|NCT00297427|453632792|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
126092550|NCT00297427|453632793|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
126092551|NCT00297427|453632792|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
126092552|NCT00297427|453632793|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
126018575|NCT03512756|453362088|FG000|Part 2|Protocol Violation|0|||
126018576|NCT03512756|453362089|FG001|Part 2|Protocol Violation|0|||
126018577|NCT03512756|453362090|FG002|Part 2|Protocol Violation|1|||
126018578|NCT03512756|453362091|FG003|Part 2|Protocol Violation|0|||
126222925|NCT00950599|454107771|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
126018579|NCT03512756|453362088|FG000|Part 2|Withdrawal by Subject|0|||
126018580|NCT03512756|453362089|FG001|Part 2|Withdrawal by Subject|0|||
126018581|NCT03512756|453362090|FG002|Part 2|Withdrawal by Subject|3|||
126018582|NCT03512756|453362091|FG003|Part 2|Withdrawal by Subject|9|||
126018583|NCT00736853|453362092|FG000|Open-Label Period|Physician Decision|2|||
126018584|NCT00736853|453362093|FG001|Open-Label Period|Physician Decision|0|||
126018585|NCT00736853|453362094|FG002|Open-Label Period|Physician Decision|0|||
126018586|NCT00736853|453362092|FG000|Open-Label Period|Adverse Event|31|||
126018587|NCT00736853|453362093|FG001|Open-Label Period|Adverse Event|0|||
126018588|NCT00736853|453362094|FG002|Open-Label Period|Adverse Event|0|||
126018589|NCT00736853|453362092|FG000|Open-Label Period|Withdrawal by Subject|16|||
126018590|NCT00736853|453362093|FG001|Open-Label Period|Withdrawal by Subject|0|||
126018591|NCT00736853|453362094|FG002|Open-Label Period|Withdrawal by Subject|0|||
126018592|NCT00736853|453362092|FG000|Open-Label Period|Started but not treated|42|||
126018593|NCT00736853|453362093|FG001|Open-Label Period|Started but not treated|0|||
126018594|NCT00736853|453362094|FG002|Open-Label Period|Started but not treated|0|||
126018595|NCT00736853|453362092|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
126018596|NCT00736853|453362093|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
126018597|NCT00736853|453362094|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
126018598|NCT00736853|453362092|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
126018599|NCT00736853|453362093|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
126018600|NCT00736853|453362094|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
126018601|NCT00736853|453362092|FG000|Double-Blind Period|Lack of Efficacy|0|||
126018602|NCT00736853|453362093|FG001|Double-Blind Period|Lack of Efficacy|19|||
126018603|NCT00736853|453362094|FG002|Double-Blind Period|Lack of Efficacy|42|||
126018604|NCT00736853|453362092|FG000|Double-Blind Period|Adverse Event|0|||
126018605|NCT00736853|453362093|FG001|Double-Blind Period|Adverse Event|3|||
126018606|NCT00736853|453362094|FG002|Double-Blind Period|Adverse Event|2|||
126018607|NCT00736853|453362092|FG000|Double-Blind Period|Withdrawal by Subject|0|||
126018608|NCT00736853|453362093|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126018609|NCT00736853|453362094|FG002|Double-Blind Period|Withdrawal by Subject|4|||
126018610|NCT00736853|453362092|FG000|Double-Blind Period|Ineligible to participate the study|0|||
126018611|NCT00736853|453362093|FG001|Double-Blind Period|Ineligible to participate the study|1|||
126018612|NCT00736853|453362094|FG002|Double-Blind Period|Ineligible to participate the study|0|||
126018613|NCT01199705|453362095|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
126018614|NCT03215927|453364129|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
126018615|NCT03215927|453364130|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
126018616|NCT03215927|453364129|FG000|Open Label Extension|Adverse Event|1|||
126018617|NCT03215927|453364130|FG001|Open Label Extension|Adverse Event|0|||
126018618|NCT03215927|453364129|FG000|Open Label Extension|Lack of Efficacy|1|||
126018619|NCT03215927|453364130|FG001|Open Label Extension|Lack of Efficacy|0|||
126018620|NCT03215927|453364129|FG000|Open Label Extension|Death|0|||
126018621|NCT03215927|453364130|FG001|Open Label Extension|Death|1|||
126018622|NCT03889925|453364133|FG000|Overall Study|Lost to Follow-up|11|||
126018623|NCT03889925|453364134|FG001|Overall Study|Lost to Follow-up|10|||
126018624|NCT03073941|453364135|FG000|Overall Study|Received non-study device intraoperatively|0|||
126018625|NCT03073941|453364136|FG001|Overall Study|Received non-study device intraoperatively|2|||
126018626|NCT03073941|453364135|FG000|Overall Study|Death|1|||
126018627|NCT03073941|453364136|FG001|Overall Study|Death|0|||
126018628|NCT03073941|453364135|FG000|Overall Study|Withdrawal by Subject|1|||
126018629|NCT03073941|453364136|FG001|Overall Study|Withdrawal by Subject|3|||
126018630|NCT03073941|453364135|FG000|Overall Study|Lost to Follow-up|5|||
126018631|NCT03073941|453364136|FG001|Overall Study|Lost to Follow-up|4|||
126018632|NCT03073941|453364135|FG000|Overall Study|Adverse Event|4|||
126018633|NCT03073941|453364136|FG001|Overall Study|Adverse Event|2|||
126018634|NCT03073941|453364135|FG000|Overall Study|Met an exclusion criterion|0|||
126018635|NCT03073941|453364136|FG001|Overall Study|Met an exclusion criterion|1|||
126018636|NCT04250883|453364137|FG000|Overall Study|Lost to Follow-up|1|||
126018637|NCT04250883|453364138|FG001|Overall Study|Lost to Follow-up|0|||
126018638|NCT01823536|453364139|FG000|Overall Study|Lost to Follow-up|1|||
126018639|NCT01823536|453364140|FG001|Overall Study|Lost to Follow-up|0|||
126018640|NCT01823536|453364141|FG002|Overall Study|Lost to Follow-up|0|||
126018641|NCT01823536|453364142|FG003|Overall Study|Lost to Follow-up|1|||
126018642|NCT01823536|453364143|FG004|Overall Study|Lost to Follow-up|1|||
126018643|NCT01823536|453364144|FG005|Overall Study|Lost to Follow-up|0|||
126018644|NCT01823536|453364139|FG000|Overall Study|Protocol Violation|0|||
126018645|NCT01823536|453364140|FG001|Overall Study|Protocol Violation|1|||
126018646|NCT01823536|453364141|FG002|Overall Study|Protocol Violation|0|||
126018647|NCT01823536|453364142|FG003|Overall Study|Protocol Violation|0|||
126018648|NCT01823536|453364143|FG004|Overall Study|Protocol Violation|0|||
126018649|NCT01823536|453364144|FG005|Overall Study|Protocol Violation|0|||
126018650|NCT01823536|453364139|FG000|Overall Study|Withdrawal by Subject|1|||
126018651|NCT01823536|453364140|FG001|Overall Study|Withdrawal by Subject|1|||
126018652|NCT01823536|453364141|FG002|Overall Study|Withdrawal by Subject|0|||
126018653|NCT01823536|453364142|FG003|Overall Study|Withdrawal by Subject|0|||
126103460|NCT04620811|453672167|FG000|Overall Study|Withdrawal by Subject|18|||
126018654|NCT01823536|453364143|FG004|Overall Study|Withdrawal by Subject|0|||
126018655|NCT01823536|453364144|FG005|Overall Study|Withdrawal by Subject|0|||
126018656|NCT01823536|453364139|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126018657|NCT01823536|453364140|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126018658|NCT01823536|453364141|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
126018659|NCT01823536|453364142|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126018660|NCT01823536|453364143|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126018661|NCT01823536|453364144|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126018662|NCT01823536|453364139|FG000|Overall Study|Met exclusion criterion No 6|0|||
126018663|NCT01823536|453364140|FG001|Overall Study|Met exclusion criterion No 6|0|||
126018664|NCT01823536|453364141|FG002|Overall Study|Met exclusion criterion No 6|0|||
126018665|NCT01823536|453364142|FG003|Overall Study|Met exclusion criterion No 6|1|||
126018666|NCT01823536|453364143|FG004|Overall Study|Met exclusion criterion No 6|0|||
126018667|NCT01823536|453364144|FG005|Overall Study|Met exclusion criterion No 6|0|||
126018668|NCT01823536|453364139|FG000|Overall Study|Subject moved out of the state|0|||
126018669|NCT01823536|453364140|FG001|Overall Study|Subject moved out of the state|0|||
126018670|NCT01823536|453364141|FG002|Overall Study|Subject moved out of the state|0|||
126018671|NCT01823536|453364142|FG003|Overall Study|Subject moved out of the state|0|||
126018672|NCT01823536|453364143|FG004|Overall Study|Subject moved out of the state|1|||
126018673|NCT01823536|453364144|FG005|Overall Study|Subject moved out of the state|0|||
126018674|NCT02407249|453364145|FG000|Overall Study|Did not complete 12-month follow-up|13|||
126018675|NCT02407249|453364145|FG000|Overall Study|Not treated|13|||
126018676|NCT03345901|453364148|FG000|Overall Study|The study was terminated|18|||
126018677|NCT00722046|453364149|FG000|Overall Study|Adverse Event|0|||
126018678|NCT00722046|453364150|FG001|Overall Study|Adverse Event|1|||
126018679|NCT00722046|453364151|FG002|Overall Study|Adverse Event|2|||
126018680|NCT00722046|453364152|FG003|Overall Study|Adverse Event|1|||
126018681|NCT00722046|453364153|FG004|Overall Study|Adverse Event|2|||
126018682|NCT00722046|453364154|FG005|Overall Study|Adverse Event|1|||
126018683|NCT00722046|453364155|FG006|Overall Study|Adverse Event|0|||
126018684|NCT00722046|453364149|FG000|Overall Study|Death|0|||
126018685|NCT00722046|453364150|FG001|Overall Study|Death|1|||
126018686|NCT00722046|453364151|FG002|Overall Study|Death|0|||
126018687|NCT00722046|453364152|FG003|Overall Study|Death|0|||
126018688|NCT00722046|453364153|FG004|Overall Study|Death|0|||
126018689|NCT00722046|453364154|FG005|Overall Study|Death|0|||
126018690|NCT00722046|453364155|FG006|Overall Study|Death|2|||
126018691|NCT00722046|453364149|FG000|Overall Study|Protocol Violation|1|||
126018692|NCT00722046|453364150|FG001|Overall Study|Protocol Violation|0|||
126018693|NCT00722046|453364151|FG002|Overall Study|Protocol Violation|0|||
126018694|NCT00722046|453364152|FG003|Overall Study|Protocol Violation|0|||
126018695|NCT00722046|453364153|FG004|Overall Study|Protocol Violation|0|||
126018696|NCT00722046|453364154|FG005|Overall Study|Protocol Violation|1|||
126018697|NCT00722046|453364155|FG006|Overall Study|Protocol Violation|0|||
126018698|NCT00722046|453364149|FG000|Overall Study|Withdrawal by Subject|3|||
126018699|NCT00722046|453364150|FG001|Overall Study|Withdrawal by Subject|3|||
126018700|NCT00722046|453364151|FG002|Overall Study|Withdrawal by Subject|4|||
126018701|NCT00722046|453364152|FG003|Overall Study|Withdrawal by Subject|4|||
126018702|NCT00722046|453364153|FG004|Overall Study|Withdrawal by Subject|4|||
126018703|NCT00722046|453364154|FG005|Overall Study|Withdrawal by Subject|7|||
126018704|NCT00722046|453364155|FG006|Overall Study|Withdrawal by Subject|3|||
126018705|NCT00722046|453364149|FG000|Overall Study|Randomized, but not treated|1|||
126018706|NCT00722046|453364150|FG001|Overall Study|Randomized, but not treated|1|||
126018707|NCT00722046|453364151|FG002|Overall Study|Randomized, but not treated|0|||
126018708|NCT00722046|453364152|FG003|Overall Study|Randomized, but not treated|2|||
126018709|NCT00722046|453364153|FG004|Overall Study|Randomized, but not treated|0|||
126018710|NCT00722046|453364154|FG005|Overall Study|Randomized, but not treated|0|||
126018711|NCT00722046|453364155|FG006|Overall Study|Randomized, but not treated|0|||
126018712|NCT00722046|453364149|FG000|Overall Study|Other|0|||
126018713|NCT00722046|453364150|FG001|Overall Study|Other|0|||
126018714|NCT00722046|453364151|FG002|Overall Study|Other|1|||
126018715|NCT00722046|453364152|FG003|Overall Study|Other|1|||
126018716|NCT00722046|453364153|FG004|Overall Study|Other|3|||
126018717|NCT00722046|453364154|FG005|Overall Study|Other|2|||
126018718|NCT00722046|453364155|FG006|Overall Study|Other|1|||
126018719|NCT02731755|453364156|FG000|First Intervention|Withdrawal by Subject|0|||
126018720|NCT02731755|453364157|FG001|First Intervention|Withdrawal by Subject|2|||
126018721|NCT04425629|453364158|FG000|Overall Study|Adverse Event|0|||
126018722|NCT04425629|453364159|FG001|Overall Study|Adverse Event|0|||
126018723|NCT04425629|453364160|FG002|Overall Study|Adverse Event|0|||
126018724|NCT04425629|453364161|FG003|Overall Study|Adverse Event|0|||
126018725|NCT04425629|453364162|FG004|Overall Study|Adverse Event|1|||
126018726|NCT04425629|453364163|FG005|Overall Study|Adverse Event|0|||
126222926|NCT00950599|454107772|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
126018727|NCT04425629|453364164|FG006|Overall Study|Adverse Event|0|||
126018728|NCT04425629|453364165|FG007|Overall Study|Adverse Event|0|||
126018729|NCT04425629|453364166|FG008|Overall Study|Adverse Event|0|||
126018730|NCT04425629|453364167|FG009|Overall Study|Adverse Event|3|||
126018731|NCT04425629|453364168|FG010|Overall Study|Adverse Event|2|||
126018732|NCT04425629|453364169|FG011|Overall Study|Adverse Event|1|||
126018733|NCT04425629|453364170|FG012|Overall Study|Adverse Event|1|||
126018734|NCT04425629|453364171|FG013|Overall Study|Adverse Event|0|||
126018735|NCT04425629|453364172|FG014|Overall Study|Adverse Event|0|||
126018736|NCT04425629|453364173|FG015|Overall Study|Adverse Event|0|||
126350305|NCT02112916|454574166|FG002|Overall Study|Inevaluable|5|||
126018737|NCT04425629|453364174|FG016|Overall Study|Adverse Event|0|||
126092553|NCT00297427|453632792|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
126092554|NCT00297427|453632793|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
126092555|NCT00574873|453632795|FG000|Overall Study|Withdrawal by Subject|18|||
126092556|NCT00574873|453632796|FG001|Overall Study|Withdrawal by Subject|19|||
126092557|NCT00574873|453632795|FG000|Overall Study|Investigator request|18|||
126092558|NCT00574873|453632796|FG001|Overall Study|Investigator request|8|||
126092559|NCT00574873|453632795|FG000|Overall Study|Death|15|||
126092560|NCT00574873|453632796|FG001|Overall Study|Death|14|||
126018738|NCT04425629|453364175|FG017|Overall Study|Adverse Event|0|||
126092561|NCT00574873|453632795|FG000|Overall Study|Lost to Follow-up|14|||
126092562|NCT00574873|453632796|FG001|Overall Study|Lost to Follow-up|5|||
126092563|NCT00574873|453632795|FG000|Overall Study|Other|40|||
126092564|NCT00574873|453632796|FG001|Overall Study|Other|4|||
126092565|NCT00574873|453632795|FG000|Overall Study|Discontinuation of study by sponsor|5|||
126092566|NCT00574873|453632796|FG001|Overall Study|Discontinuation of study by sponsor|199|||
126092567|NCT00574873|453632795|FG000|Overall Study|Blank, site closed per local regulations|2|||
126092568|NCT00574873|453632796|FG001|Overall Study|Blank, site closed per local regulations|2|||
126092569|NCT00574873|453632795|FG000|Overall Study|Extension Study|126|||
126092570|NCT00574873|453632796|FG001|Overall Study|Extension Study|0|||
126092571|NCT00201643|453632798|FG000|Overall Study|Withdrawal by Subject|5|||
126092572|NCT00201643|453632799|FG001|Overall Study|Withdrawal by Subject|4|||
126092573|NCT02787044|453632806|FG000|Overall Study|Lost to Follow-up|15|||
126092574|NCT02787044|453632807|FG001|Overall Study|Lost to Follow-up|19|||
126092575|NCT02182947|453632808|FG000|Overall Study|Withdrawal by Subject|7|||
126092576|NCT02182947|453632808|FG000|Overall Study|Lost to Follow-up|3|||
126092577|NCT02182947|453632808|FG000|Overall Study|Failed screening activities|8|||
126092578|NCT02236988|453632811|FG000|Overall Study|Lost to Follow-up|0|||
126092579|NCT02236988|453632812|FG001|Overall Study|Lost to Follow-up|0|||
126092580|NCT02236988|453632813|FG002|Overall Study|Lost to Follow-up|0|||
126092581|NCT02236988|453632814|FG003|Overall Study|Lost to Follow-up|1|||
126092582|NCT02236988|453632811|FG000|Overall Study|Unable to Comply with Study Visits|0|||
126092583|NCT02236988|453632812|FG001|Overall Study|Unable to Comply with Study Visits|0|||
126092584|NCT02236988|453632813|FG002|Overall Study|Unable to Comply with Study Visits|0|||
126092585|NCT02236988|453632814|FG003|Overall Study|Unable to Comply with Study Visits|2|||
126092586|NCT00730275|453632815|FG000|Overall Study|Withdrawal by Subject|0|||
126092587|NCT00730275|453632816|FG001|Overall Study|Withdrawal by Subject|0|||
126092588|NCT00730275|453632817|FG002|Overall Study|Withdrawal by Subject|0|||
126092589|NCT00730275|453632818|FG003|Overall Study|Withdrawal by Subject|1|||
126092590|NCT04032613|453632820|FG000|Overall Study|Did not complete post-program assessment|5|||
126222927|NCT00950599|454107763|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
126222928|NCT00950599|454107764|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
126222929|NCT00950599|454107765|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126018739|NCT04425629|453364176|FG018|Overall Study|Adverse Event|0|||
126018740|NCT04425629|453364158|FG000|Overall Study|Lost to Follow-up|1|||
126018741|NCT04425629|453364159|FG001|Overall Study|Lost to Follow-up|3|||
126018742|NCT04425629|453364160|FG002|Overall Study|Lost to Follow-up|1|||
126018743|NCT04425629|453364161|FG003|Overall Study|Lost to Follow-up|7|||
126018744|NCT04425629|453364162|FG004|Overall Study|Lost to Follow-up|1|||
126018745|NCT04425629|453364163|FG005|Overall Study|Lost to Follow-up|2|||
126018746|NCT04425629|453364164|FG006|Overall Study|Lost to Follow-up|1|||
126018747|NCT04425629|453364165|FG007|Overall Study|Lost to Follow-up|0|||
126018748|NCT04425629|453364166|FG008|Overall Study|Lost to Follow-up|1|||
126018749|NCT04425629|453364167|FG009|Overall Study|Lost to Follow-up|64|||
126018750|NCT04425629|453364168|FG010|Overall Study|Lost to Follow-up|70|||
126018751|NCT04425629|453364169|FG011|Overall Study|Lost to Follow-up|98|||
126018752|NCT04425629|453364170|FG012|Overall Study|Lost to Follow-up|30|||
126018753|NCT04425629|453364171|FG013|Overall Study|Lost to Follow-up|0|||
126018754|NCT04425629|453364172|FG014|Overall Study|Lost to Follow-up|5|||
126018755|NCT04425629|453364173|FG015|Overall Study|Lost to Follow-up|4|||
126018756|NCT04425629|453364174|FG016|Overall Study|Lost to Follow-up|0|||
126018757|NCT04425629|453364175|FG017|Overall Study|Lost to Follow-up|3|||
126222930|NCT00950599|454107766|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126222931|NCT00950599|454107767|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126222932|NCT00950599|454107768|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126222933|NCT00950599|454107769|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126222934|NCT00950599|454107770|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
126350306|NCT02112916|454574167|FG003|Overall Study|Inevaluable|5|||
126350307|NCT02112916|454574164|FG000|Overall Study|Refusal of further protocol therapy|19|||
126018758|NCT04425629|453364176|FG018|Overall Study|Lost to Follow-up|1|||
126018759|NCT04425629|453364158|FG000|Overall Study|Subject Decision|0|||
126018760|NCT04425629|453364159|FG001|Overall Study|Subject Decision|2|||
126092591|NCT04032613|453632821|FG001|Overall Study|Did not complete post-program assessment|2|||
126092592|NCT03053518|453632826|FG000|Overall Study|Withdrawal by Subject|3|||
126092593|NCT03053518|453632826|FG000|Overall Study|Lost to Follow-up|2|||
126350308|NCT02112916|454574165|FG001|Overall Study|Refusal of further protocol therapy|16|||
126018761|NCT04425629|453364160|FG002|Overall Study|Subject Decision|1|||
126018762|NCT04425629|453364161|FG003|Overall Study|Subject Decision|3|||
126018763|NCT04425629|453364162|FG004|Overall Study|Subject Decision|6|||
126018764|NCT04425629|453364163|FG005|Overall Study|Subject Decision|6|||
126018765|NCT04425629|453364164|FG006|Overall Study|Subject Decision|3|||
126018766|NCT04425629|453364165|FG007|Overall Study|Subject Decision|3|||
126018767|NCT04425629|453364166|FG008|Overall Study|Subject Decision|1|||
126018768|NCT04425629|453364167|FG009|Overall Study|Subject Decision|70|||
126018769|NCT04425629|453364168|FG010|Overall Study|Subject Decision|95|||
126018770|NCT04425629|453364169|FG011|Overall Study|Subject Decision|124|||
126018771|NCT04425629|453364170|FG012|Overall Study|Subject Decision|25|||
126018772|NCT04425629|453364171|FG013|Overall Study|Subject Decision|0|||
126018773|NCT04425629|453364172|FG014|Overall Study|Subject Decision|1|||
126018774|NCT04425629|453364173|FG015|Overall Study|Subject Decision|4|||
126018775|NCT04425629|453364174|FG016|Overall Study|Subject Decision|1|||
126018776|NCT04425629|453364175|FG017|Overall Study|Subject Decision|0|||
126018777|NCT04425629|453364176|FG018|Overall Study|Subject Decision|2|||
126018778|NCT04425629|453364158|FG000|Overall Study|Death|0|||
126018779|NCT04425629|453364159|FG001|Overall Study|Death|0|||
126018780|NCT04425629|453364160|FG002|Overall Study|Death|0|||
126018781|NCT04425629|453364161|FG003|Overall Study|Death|0|||
126018782|NCT04425629|453364162|FG004|Overall Study|Death|0|||
126018783|NCT04425629|453364163|FG005|Overall Study|Death|0|||
126018784|NCT04425629|453364164|FG006|Overall Study|Death|0|||
126018785|NCT04425629|453364165|FG007|Overall Study|Death|0|||
126018786|NCT04425629|453364166|FG008|Overall Study|Death|0|||
126018787|NCT04425629|453364167|FG009|Overall Study|Death|11|||
126018788|NCT04425629|453364168|FG010|Overall Study|Death|2|||
126018789|NCT04425629|453364169|FG011|Overall Study|Death|4|||
126018790|NCT04425629|453364170|FG012|Overall Study|Death|0|||
126018791|NCT04425629|453364171|FG013|Overall Study|Death|0|||
126018792|NCT04425629|453364172|FG014|Overall Study|Death|0|||
126018793|NCT04425629|453364173|FG015|Overall Study|Death|0|||
126018794|NCT04425629|453364174|FG016|Overall Study|Death|0|||
126018795|NCT04425629|453364175|FG017|Overall Study|Death|0|||
126018796|NCT04425629|453364176|FG018|Overall Study|Death|0|||
126018797|NCT04425629|453364158|FG000|Overall Study|Sponsor Request|0|||
126018798|NCT04425629|453364159|FG001|Overall Study|Sponsor Request|0|||
126018799|NCT04425629|453364160|FG002|Overall Study|Sponsor Request|0|||
126018800|NCT04425629|453364161|FG003|Overall Study|Sponsor Request|2|||
126018801|NCT04425629|453364162|FG004|Overall Study|Sponsor Request|2|||
126018802|NCT04425629|453364163|FG005|Overall Study|Sponsor Request|2|||
126018803|NCT04425629|453364164|FG006|Overall Study|Sponsor Request|1|||
126018804|NCT04425629|453364165|FG007|Overall Study|Sponsor Request|0|||
126018805|NCT04425629|453364166|FG008|Overall Study|Sponsor Request|0|||
126018806|NCT04425629|453364167|FG009|Overall Study|Sponsor Request|9|||
126018807|NCT04425629|453364168|FG010|Overall Study|Sponsor Request|9|||
126018808|NCT04425629|453364169|FG011|Overall Study|Sponsor Request|10|||
126018809|NCT04425629|453364170|FG012|Overall Study|Sponsor Request|8|||
126018810|NCT04425629|453364171|FG013|Overall Study|Sponsor Request|0|||
126018811|NCT04425629|453364172|FG014|Overall Study|Sponsor Request|0|||
126018812|NCT04425629|453364173|FG015|Overall Study|Sponsor Request|1|||
126018813|NCT04425629|453364174|FG016|Overall Study|Sponsor Request|0|||
126018814|NCT04425629|453364175|FG017|Overall Study|Sponsor Request|0|||
126018815|NCT04425629|453364176|FG018|Overall Study|Sponsor Request|0|||
126018816|NCT04425629|453364158|FG000|Overall Study|Physician Decision|0|||
126018817|NCT04425629|453364159|FG001|Overall Study|Physician Decision|0|||
126018818|NCT04425629|453364160|FG002|Overall Study|Physician Decision|0|||
126018819|NCT04425629|453364161|FG003|Overall Study|Physician Decision|0|||
126018820|NCT04425629|453364162|FG004|Overall Study|Physician Decision|0|||
126092594|NCT03053518|453632826|FG000|Overall Study|Ineligible|5|||
126222935|NCT00950599|454107771|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126222936|NCT00950599|454107772|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126222937|NCT00950599|454107763|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126222938|NCT00950599|454107764|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126350309|NCT02112916|454574166|FG002|Overall Study|Refusal of further protocol therapy|1|||
126018821|NCT04425629|453364163|FG005|Overall Study|Physician Decision|0|||
126092595|NCT01156376|453632827|FG000|Overall Study|Adverse Event|1|||
126018822|NCT04425629|453364164|FG006|Overall Study|Physician Decision|0|||
126092596|NCT01156376|453632828|FG001|Overall Study|Adverse Event|0|||
126018823|NCT04425629|453364165|FG007|Overall Study|Physician Decision|0|||
126018824|NCT04425629|453364166|FG008|Overall Study|Physician Decision|0|||
126018825|NCT04425629|453364167|FG009|Overall Study|Physician Decision|4|||
126018826|NCT04425629|453364168|FG010|Overall Study|Physician Decision|3|||
126018827|NCT04425629|453364169|FG011|Overall Study|Physician Decision|5|||
126018828|NCT04425629|453364170|FG012|Overall Study|Physician Decision|1|||
126018829|NCT04425629|453364171|FG013|Overall Study|Physician Decision|0|||
126018830|NCT04425629|453364172|FG014|Overall Study|Physician Decision|0|||
126092597|NCT01156376|453632829|FG002|Overall Study|Adverse Event|1|||
126018831|NCT04425629|453364173|FG015|Overall Study|Physician Decision|1|||
126018832|NCT04425629|453364174|FG016|Overall Study|Physician Decision|0|||
126092598|NCT01156376|453632827|FG000|Overall Study|Withdrawal by Subject|0|||
126092599|NCT01156376|453632828|FG001|Overall Study|Withdrawal by Subject|0|||
126092600|NCT01156376|453632829|FG002|Overall Study|Withdrawal by Subject|3|||
126092601|NCT02071290|453632830|FG000|Overall Study|Death|1|||
126092602|NCT02071290|453632831|FG001|Overall Study|Death|0|||
126092603|NCT02071290|453632830|FG000|Overall Study|Withdrawal by Subject|0|||
126092604|NCT02071290|453632831|FG001|Overall Study|Withdrawal by Subject|1|||
126092605|NCT02071290|453632830|FG000|Overall Study|Protocol Violation|3|||
126018833|NCT04425629|453364175|FG017|Overall Study|Physician Decision|0|||
126018834|NCT04425629|453364176|FG018|Overall Study|Physician Decision|0|||
126018835|NCT04425629|453364158|FG000|Overall Study|Lack of Efficacy|0|||
126018836|NCT04425629|453364159|FG001|Overall Study|Lack of Efficacy|0|||
126018837|NCT04425629|453364160|FG002|Overall Study|Lack of Efficacy|0|||
126018838|NCT04425629|453364161|FG003|Overall Study|Lack of Efficacy|0|||
126018839|NCT04425629|453364162|FG004|Overall Study|Lack of Efficacy|0|||
126018840|NCT04425629|453364163|FG005|Overall Study|Lack of Efficacy|0|||
126018841|NCT04425629|453364164|FG006|Overall Study|Lack of Efficacy|0|||
126018842|NCT04425629|453364165|FG007|Overall Study|Lack of Efficacy|0|||
126018843|NCT04425629|453364166|FG008|Overall Study|Lack of Efficacy|0|||
126018844|NCT04425629|453364167|FG009|Overall Study|Lack of Efficacy|0|||
126018845|NCT04425629|453364168|FG010|Overall Study|Lack of Efficacy|1|||
126018846|NCT04425629|453364169|FG011|Overall Study|Lack of Efficacy|0|||
126092606|NCT02071290|453632831|FG001|Overall Study|Protocol Violation|5|||
126092607|NCT02071290|453632830|FG000|Overall Study|Physician Decision|0|||
126092608|NCT02071290|453632831|FG001|Overall Study|Physician Decision|1|||
126092609|NCT04488770|453632834|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092610|NCT04488770|453632835|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126018847|NCT04425629|453364170|FG012|Overall Study|Lack of Efficacy|0|||
126018848|NCT04425629|453364171|FG013|Overall Study|Lack of Efficacy|0|||
126092611|NCT04488770|453632836|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092612|NCT04488770|453632837|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
126092613|NCT04488770|453632838|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092614|NCT04488770|453632839|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092615|NCT04488770|453632840|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092616|NCT04488770|453632841|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092617|NCT04488770|453632842|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092618|NCT04488770|453632843|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092619|NCT04488770|453632844|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092620|NCT04488770|453632845|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092621|NCT04488770|453632846|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126092622|NCT04488770|453632834|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
126092623|NCT04488770|453632835|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092624|NCT04488770|453632836|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092625|NCT04488770|453632837|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092626|NCT04488770|453632838|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092627|NCT04488770|453632839|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092628|NCT04488770|453632840|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092629|NCT04488770|453632841|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092630|NCT04488770|453632842|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092631|NCT04488770|453632843|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092632|NCT04488770|453632844|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092633|NCT04488770|453632845|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126092634|NCT04488770|453632846|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125878738|NCT01209689|452853400|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
125878739|NCT03175367|452853401|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
126018849|NCT04425629|453364172|FG014|Overall Study|Lack of Efficacy|0|||
126018850|NCT04425629|453364173|FG015|Overall Study|Lack of Efficacy|0|||
126092635|NCT04488770|453632834|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092636|NCT04488770|453632835|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092637|NCT04488770|453632836|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092638|NCT04488770|453632837|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092639|NCT04488770|453632838|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092640|NCT04488770|453632839|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
126092641|NCT04488770|453632840|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
126092642|NCT04488770|453632841|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126222939|NCT00950599|454107765|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126222940|NCT00950599|454107766|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126018851|NCT04425629|453364174|FG016|Overall Study|Lack of Efficacy|0|||
126018852|NCT04425629|453364175|FG017|Overall Study|Lack of Efficacy|0|||
126018853|NCT04425629|453364176|FG018|Overall Study|Lack of Efficacy|0|||
126018854|NCT04218110|453364177|FG000|Overall Study|Withdrawal by Subject|0|||
126018855|NCT04218110|453364178|FG001|Overall Study|Withdrawal by Subject|0|||
126018856|NCT04218110|453364179|FG002|Overall Study|Withdrawal by Subject|0|||
126018857|NCT04218110|453364180|FG003|Overall Study|Withdrawal by Subject|1|||
126018858|NCT00414544|453364183|FG000|Overall Study|Lost to Follow-up|14|||
126018859|NCT00799396|453364185|FG000|Clopidogrel Treatment|Adverse Event|6|||
126018860|NCT00799396|453364185|FG000|Clopidogrel Treatment|Physician Decision|5|||
126018861|NCT00799396|453364185|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
126018862|NCT00799396|453364185|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
126018863|NCT00799396|453364185|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
126018864|NCT02271854|453364186|FG000|Overall Study|Withdrawal by Subject|2|||
126018865|NCT02271854|453364186|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
126018866|NCT02271854|453364186|FG000|Overall Study|Lost to Follow-up|1|||
126018867|NCT00446459|453364188|FG000|8 Months|Protocol Violation|12|||
126018868|NCT00446459|453364188|FG000|12 Months|Protocol Violation|4|||
126018869|NCT00446459|453364188|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
126018870|NCT02918279|453364191|FG000|Overall Study|Lost to Follow-up|3|||
126018871|NCT02918279|453364192|FG001|Overall Study|Lost to Follow-up|6|||
126018872|NCT02918279|453364191|FG000|Overall Study|Withdrawal by Subject|5|||
126018873|NCT02918279|453364192|FG001|Overall Study|Withdrawal by Subject|15|||
126018874|NCT02918279|453364191|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126018875|NCT02918279|453364192|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126018876|NCT02918279|453364191|FG000|Overall Study|Other|3|||
126018877|NCT02918279|453364192|FG001|Overall Study|Other|1|||
126018878|NCT00309907|453364193|FG000|Overall Study|Death|4|||
126018879|NCT00309907|453364193|FG000|Overall Study|Physician Decision|1|||
126018880|NCT00309907|453364193|FG000|Overall Study|Ineligible|11|||
126018881|NCT00309907|453364193|FG000|Overall Study|Major infectious event|4|||
126018882|NCT00244855|453364194|FG000|Overall Study|Withdrawal by Subject|0|||
126018883|NCT00244855|453364195|FG001|Overall Study|Withdrawal by Subject|1|||
126018884|NCT01641198|453364196|FG000|After 12 Months of Function|Lost to Follow-up|3|||
126018885|NCT01641198|453364197|FG001|After 12 Months of Function|Lost to Follow-up|2|||
126018886|NCT01641198|453364198|FG002|After 12 Months of Function|Lost to Follow-up|2|||
126018887|NCT01641198|453364196|FG000|After 12 Months of Function|Protocol Violation|1|||
126018888|NCT01641198|453364197|FG001|After 12 Months of Function|Protocol Violation|0|||
126018889|NCT01641198|453364198|FG002|After 12 Months of Function|Protocol Violation|0|||
126018890|NCT01641198|453364196|FG000|After 12 Months of Function|Adverse Event|0|||
126018891|NCT01641198|453364197|FG001|After 12 Months of Function|Adverse Event|1|||
126018892|NCT01641198|453364198|FG002|After 12 Months of Function|Adverse Event|0|||
126018893|NCT01641198|453364196|FG000|After 24 Months of Function|Lost to Follow-up|4|||
126018894|NCT01641198|453364197|FG001|After 24 Months of Function|Lost to Follow-up|9|||
126018895|NCT01641198|453364198|FG002|After 24 Months of Function|Lost to Follow-up|6|||
126018896|NCT01641198|453364196|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
126018897|NCT01641198|453364197|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
126018898|NCT01641198|453364198|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
126018899|NCT01641198|453364196|FG000|At 15-20 Years of Function|Death|1|||
126018900|NCT01641198|453364197|FG001|At 15-20 Years of Function|Death|0|||
126018901|NCT01641198|453364198|FG002|At 15-20 Years of Function|Death|1|||
126018902|NCT02529995|453364200|FG000|Part A|Ongoing Study at Data Cut-off|14|||
126018903|NCT02529995|453364201|FG001|Part A|Ongoing Study at Data Cut-off|16|||
126018904|NCT02529995|453364200|FG000|Part A|Discontinued Study|1|||
126018905|NCT02529995|453364201|FG001|Part A|Discontinued Study|0|||
126018906|NCT02529995|453364200|FG000|Part B|Ongoing Study at Data Cut-off|0|||
126018907|NCT02529995|453364201|FG001|Part B|Ongoing Study at Data Cut-off|7|||
126018908|NCT02529995|453364200|FG000|Part B|Discontinued Study|6|||
126018909|NCT02529995|453364201|FG001|Part B|Discontinued Study|5|||
126018910|NCT01068743|453364202|FG000|Period 3|Adverse Event|0|||
126018911|NCT01068743|453364203|FG001|Period 3|Adverse Event|1|||
126018912|NCT01068743|453364204|FG002|Period 3|Adverse Event|0|||
126018913|NCT01068743|453364205|FG003|Period 3|Adverse Event|0|||
126350310|NCT02112916|454574167|FG003|Overall Study|Refusal of further protocol therapy|7|||
126350311|NCT02112916|454574164|FG000|Overall Study|Development of SMN|1|||
126350312|NCT02112916|454574165|FG001|Overall Study|Development of SMN|0|||
126350313|NCT02112916|454574166|FG002|Overall Study|Development of SMN|0|||
126350314|NCT02112916|454574167|FG003|Overall Study|Development of SMN|1|||
126018914|NCT01236001|453364208|FG000|Overall Study|Adverse Event|5|||
126018915|NCT01236001|453364209|FG001|Overall Study|Adverse Event|14|||
126018916|NCT01236001|453364208|FG000|Overall Study|Lack of Efficacy|6|||
126018917|NCT01236001|453364209|FG001|Overall Study|Lack of Efficacy|6|||
126018918|NCT01236001|453364208|FG000|Overall Study|Lost to Follow-up|6|||
126018919|NCT01236001|453364209|FG001|Overall Study|Lost to Follow-up|1|||
126018920|NCT01236001|453364208|FG000|Overall Study|Incompliance|1|||
126018921|NCT01236001|453364209|FG001|Overall Study|Incompliance|0|||
126018922|NCT01236001|453364208|FG000|Overall Study|Planned Visit After End of Study|0|||
126018923|NCT01236001|453364209|FG001|Overall Study|Planned Visit After End of Study|1|||
126018924|NCT02261467|453364218|FG000|Overall Study|Enrolled in Error|1|||
126018925|NCT02261467|453364219|FG001|Overall Study|Enrolled in Error|0|||
126350315|NCT02112916|454574164|FG000|Overall Study|Relapse/Progression|10|||
126350316|NCT02112916|454574165|FG001|Overall Study|Relapse/Progression|18|||
126092643|NCT04488770|453632842|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092644|NCT04488770|453632843|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092645|NCT04488770|453632844|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092646|NCT04488770|453632845|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092647|NCT04488770|453632846|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126092648|NCT04488770|453632834|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092649|NCT04488770|453632835|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092650|NCT04488770|453632836|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092651|NCT04488770|453632837|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092652|NCT04488770|453632838|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
126092653|NCT04488770|453632839|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092654|NCT04488770|453632840|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092655|NCT04488770|453632841|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092656|NCT04488770|453632842|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092657|NCT04488770|453632843|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092658|NCT04488770|453632844|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092659|NCT04488770|453632845|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092660|NCT04488770|453632846|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126092661|NCT02075073|453632847|FG000|Overall Study|Withdrawal by Subject|0|||
126092662|NCT02075073|453632848|FG001|Overall Study|Withdrawal by Subject|1|||
126092663|NCT02075073|453632849|FG002|Overall Study|Withdrawal by Subject|0|||
126092664|NCT02797080|453632855|FG000|Overall Study|Lost to Follow-up|1|||
126092665|NCT02797080|453632855|FG000|Overall Study|Withdrawal by Subject|1|||
126092666|NCT01305408|453632856|FG000|Overall Study|Adverse Event|10|||
126092667|NCT01305408|453632857|FG001|Overall Study|Adverse Event|7|||
126092668|NCT01305408|453632856|FG000|Overall Study|Lack of Efficacy|3|||
126092669|NCT01305408|453632857|FG001|Overall Study|Lack of Efficacy|4|||
126092670|NCT01305408|453632856|FG000|Overall Study|Withdrawal by Subject|9|||
126092671|NCT01305408|453632857|FG001|Overall Study|Withdrawal by Subject|9|||
126092672|NCT01305408|453632856|FG000|Overall Study|Protocol Violation|4|||
126092673|NCT01305408|453632857|FG001|Overall Study|Protocol Violation|6|||
126092674|NCT01305408|453632856|FG000|Overall Study|Lost to Follow-up|5|||
126092675|NCT01305408|453632857|FG001|Overall Study|Lost to Follow-up|3|||
126092676|NCT01305408|453632856|FG000|Overall Study|Noncompliance with study medication|0|||
126092677|NCT01305408|453632857|FG001|Overall Study|Noncompliance with study medication|1|||
126092678|NCT01305408|453632856|FG000|Overall Study|Noncompliance with study procedures|0|||
126092679|NCT01305408|453632857|FG001|Overall Study|Noncompliance with study procedures|1|||
126092680|NCT01305408|453632856|FG000|Overall Study|Other|1|||
126092681|NCT01305408|453632857|FG001|Overall Study|Other|0|||
126092682|NCT02530970|453632858|FG000|Overall Study|Adverse Event|8|||
126092683|NCT02530970|453632858|FG000|Overall Study|Lost to Follow-up|88|||
126092684|NCT02530970|453632858|FG000|Overall Study|Physician Decision|5|||
126092685|NCT02530970|453632858|FG000|Overall Study|Withdrawal by Subject|14|||
126092686|NCT02530970|453632858|FG000|Overall Study|Death|6|||
126092687|NCT02530970|453632858|FG000|Overall Study|Hospitalization|1|||
126092688|NCT02530970|453632858|FG000|Overall Study|Insurance|2|||
126092689|NCT02530970|453632858|FG000|Overall Study|Explant|2|||
126092690|NCT02530970|453632858|FG000|Overall Study|Change in Provider|5|||
126092691|NCT02530970|453632858|FG000|Overall Study|Relocation|3|||
126092692|NCT01365481|453632865|FG000|Overall Study|Adverse Event|6|||
126092693|NCT01365481|453632866|FG001|Overall Study|Adverse Event|9|||
126092694|NCT01365481|453632867|FG002|Overall Study|Adverse Event|0|||
126092695|NCT01365481|453632868|FG003|Overall Study|Adverse Event|2|||
126092696|NCT01365481|453632865|FG000|Overall Study|Withdrawal by Subject|0|||
126092697|NCT01365481|453632866|FG001|Overall Study|Withdrawal by Subject|2|||
126092698|NCT01365481|453632867|FG002|Overall Study|Withdrawal by Subject|1|||
126092699|NCT01365481|453632868|FG003|Overall Study|Withdrawal by Subject|1|||
126350317|NCT02112916|454574166|FG002|Overall Study|Relapse/Progression|15|||
126350318|NCT02112916|454574167|FG003|Overall Study|Relapse/Progression|2|||
126350319|NCT02112916|454574164|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
126350320|NCT02112916|454574165|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
126350321|NCT02112916|454574166|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
126350322|NCT02112916|454574167|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
126350323|NCT02112916|454574164|FG000|Overall Study|Still on Therapy|44|||
126092700|NCT01365481|453632865|FG000|Overall Study|Lost to Follow-up|1|||
126092701|NCT01365481|453632866|FG001|Overall Study|Lost to Follow-up|1|||
126092702|NCT01365481|453632867|FG002|Overall Study|Lost to Follow-up|2|||
126092703|NCT01365481|453632868|FG003|Overall Study|Lost to Follow-up|3|||
126092704|NCT01365481|453632865|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126092705|NCT01365481|453632866|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126350324|NCT02112916|454574165|FG001|Overall Study|Still on Therapy|47|||
126018926|NCT02261467|453364218|FG000|Overall Study|Protocol Violation|0|||
126018927|NCT02261467|453364219|FG001|Overall Study|Protocol Violation|1|||
126018928|NCT02261467|453364218|FG000|Overall Study|Personal Reasons|17|||
126018929|NCT02261467|453364219|FG001|Overall Study|Personal Reasons|22|||
126018930|NCT02261467|453364218|FG000|Overall Study|Lost to Follow-up|2|||
126018931|NCT02261467|453364219|FG001|Overall Study|Lost to Follow-up|13|||
126018932|NCT02261467|453364218|FG000|Overall Study|Adverse Event|1|||
126018933|NCT02261467|453364219|FG001|Overall Study|Adverse Event|1|||
126018934|NCT02528188|453364220|FG000|Overall Study|Adverse Event|23|||
126018935|NCT02528188|453364221|FG001|Overall Study|Adverse Event|22|||
126018936|NCT02528188|453364222|FG002|Overall Study|Adverse Event|8|||
126018937|NCT02528188|453364220|FG000|Overall Study|Protocol Violation|4|||
126018938|NCT02528188|453364221|FG001|Overall Study|Protocol Violation|6|||
126018939|NCT02528188|453364222|FG002|Overall Study|Protocol Violation|4|||
126018940|NCT02528188|453364220|FG000|Overall Study|Lack of Efficacy|19|||
126018941|NCT02528188|453364221|FG001|Overall Study|Lack of Efficacy|21|||
126018942|NCT02528188|453364222|FG002|Overall Study|Lack of Efficacy|22|||
126018943|NCT02528188|453364220|FG000|Overall Study|Withdrawal by Subject|97|||
126222941|NCT00950599|454107767|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
126222942|NCT00950599|454107768|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
126222943|NCT00950599|454107769|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126222944|NCT00950599|454107770|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126222945|NCT00950599|454107771|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126222946|NCT00950599|454107772|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126222947|NCT00950599|454107763|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
126222948|NCT00950599|454107764|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
126222949|NCT00950599|454107765|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
126222950|NCT00950599|454107766|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
126222951|NCT00950599|454107767|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
126222952|NCT00950599|454107768|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
126222953|NCT00950599|454107769|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
126222954|NCT00950599|454107770|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
126222955|NCT00950599|454107771|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
126222956|NCT00950599|454107772|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
126222957|NCT00950599|454107763|FG000|Follow-Up Period|Adverse Event|0|||
126018944|NCT02528188|453364221|FG001|Overall Study|Withdrawal by Subject|104|||
126018945|NCT02528188|453364222|FG002|Overall Study|Withdrawal by Subject|100|||
126018946|NCT02528188|453364220|FG000|Overall Study|Lost to Follow-up|25|||
126018947|NCT02528188|453364221|FG001|Overall Study|Lost to Follow-up|21|||
126018948|NCT02528188|453364222|FG002|Overall Study|Lost to Follow-up|31|||
126018949|NCT02528188|453364220|FG000|Overall Study|Death|4|||
126018950|NCT02528188|453364221|FG001|Overall Study|Death|4|||
126018951|NCT02528188|453364222|FG002|Overall Study|Death|0|||
126018952|NCT02528188|453364220|FG000|Overall Study|Other|89|||
126018953|NCT02528188|453364221|FG001|Overall Study|Other|91|||
126018954|NCT02528188|453364222|FG002|Overall Study|Other|74|||
126018955|NCT02528188|453364220|FG000|Overall Study|Randomized but not treated|6|||
126018956|NCT02528188|453364221|FG001|Overall Study|Randomized but not treated|7|||
126018957|NCT02528188|453364222|FG002|Overall Study|Randomized but not treated|12|||
126018958|NCT01692730|453364228|FG000|Overall Study|Lost to Follow-up|225|||
126018959|NCT01692730|453364229|FG001|Overall Study|Lost to Follow-up|227|||
126018960|NCT00933400|453364230|FG000|Overall Study|Withdrawal by Subject|21|||
126350325|NCT02112916|454574166|FG002|Overall Study|Still on Therapy|3|||
126350326|NCT02112916|454574167|FG003|Overall Study|Still on Therapy|2|||
126350327|NCT02112916|454574164|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
126018961|NCT00933400|453364231|FG001|Overall Study|Withdrawal by Subject|1|||
126018962|NCT01041417|453364234|FG000|Overall Study|Adverse Event|5|||
126018963|NCT01041417|453364235|FG001|Overall Study|Adverse Event|2|||
126018964|NCT01041417|453364234|FG000|Overall Study|Lost to Follow-up|1|||
126018965|NCT01041417|453364235|FG001|Overall Study|Lost to Follow-up|1|||
126018966|NCT01041417|453364234|FG000|Overall Study|Death|1|||
126018967|NCT01041417|453364235|FG001|Overall Study|Death|0|||
126018968|NCT02299375|453364236|FG000|Overall Study|Adverse Event, serious fatal|1|||
126018969|NCT02299375|453364237|FG001|Overall Study|Adverse Event, serious fatal|3|||
126018970|NCT02299375|453364236|FG000|Overall Study|Adverse Event, non-fatal|8|||
126018971|NCT02299375|453364237|FG001|Overall Study|Adverse Event, non-fatal|9|||
126018972|NCT02299375|453364236|FG000|Overall Study|Lack of Efficacy|1|||
126018973|NCT02299375|453364237|FG001|Overall Study|Lack of Efficacy|3|||
126018974|NCT02299375|453364236|FG000|Overall Study|Protocol Violation|1|||
126018975|NCT02299375|453364237|FG001|Overall Study|Protocol Violation|3|||
126018976|NCT02299375|453364236|FG000|Overall Study|Other: Met stopping criteria|1|||
126018977|NCT02299375|453364237|FG001|Overall Study|Other: Met stopping criteria|0|||
126018978|NCT02299375|453364236|FG000|Overall Study|Other: Study closed/terminated|66|||
126018979|NCT02299375|453364237|FG001|Overall Study|Other: Study closed/terminated|55|||
126018980|NCT02299375|453364236|FG000|Overall Study|Lost to Follow-up|0|||
126018981|NCT02299375|453364237|FG001|Overall Study|Lost to Follow-up|2|||
126018982|NCT02299375|453364236|FG000|Overall Study|Physician Decision|1|||
126018983|NCT02299375|453364237|FG001|Overall Study|Physician Decision|1|||
126018984|NCT02299375|453364236|FG000|Overall Study|Withdrawal by Subject|1|||
126018985|NCT02299375|453364237|FG001|Overall Study|Withdrawal by Subject|4|||
126018986|NCT00704184|453364238|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
126018987|NCT00704184|453364239|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
126018988|NCT00704184|453364240|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
126018989|NCT00704184|453364241|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
126018990|NCT00704184|453364242|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
126018991|NCT00704184|453364238|FG000|Open-Label Treatment|Adverse Event|0|||
126018992|NCT00704184|453364239|FG001|Open-Label Treatment|Adverse Event|0|||
126018993|NCT00704184|453364240|FG002|Open-Label Treatment|Adverse Event|2|||
126018994|NCT00704184|453364241|FG003|Open-Label Treatment|Adverse Event|0|||
126018995|NCT00704184|453364242|FG004|Open-Label Treatment|Adverse Event|1|||
126018996|NCT00704184|453364238|FG000|Open-Label Treatment|Lack of Efficacy|0|||
126018997|NCT00704184|453364239|FG001|Open-Label Treatment|Lack of Efficacy|2|||
126018998|NCT00704184|453364240|FG002|Open-Label Treatment|Lack of Efficacy|2|||
126018999|NCT00704184|453364241|FG003|Open-Label Treatment|Lack of Efficacy|2|||
126019000|NCT00704184|453364242|FG004|Open-Label Treatment|Lack of Efficacy|1|||
126019001|NCT00704184|453364238|FG000|Open-Label Treatment|Physician Decision|0|||
126019002|NCT00704184|453364239|FG001|Open-Label Treatment|Physician Decision|0|||
126019003|NCT00704184|453364240|FG002|Open-Label Treatment|Physician Decision|0|||
126019004|NCT00704184|453364241|FG003|Open-Label Treatment|Physician Decision|0|||
126019005|NCT00704184|453364242|FG004|Open-Label Treatment|Physician Decision|1|||
126019006|NCT00704184|453364238|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
126019007|NCT00704184|453364239|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
126019008|NCT00704184|453364240|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
126019009|NCT00704184|453364241|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
126019010|NCT00704184|453364242|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
126019011|NCT01764464|453364243|FG000|First Intervention|Withdrawal by Subject|1|||
126019012|NCT01764464|453364244|FG001|First Intervention|Withdrawal by Subject|0|||
126019013|NCT01764464|453364243|FG000|First Intervention|Lost to Follow-up|1|||
126019014|NCT01764464|453364244|FG001|First Intervention|Lost to Follow-up|0|||
126019015|NCT01764464|453364243|FG000|First Intervention|Adverse Event|0|||
126019016|NCT01764464|453364244|FG001|First Intervention|Adverse Event|2|||
126019017|NCT01764464|453364243|FG000|First Intervention|did not receive study drug|0|||
126019018|NCT01764464|453364244|FG001|First Intervention|did not receive study drug|1|||
126019019|NCT01764464|453364243|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
126019020|NCT01764464|453364244|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
126019021|NCT03473340|453364254|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
126019022|NCT03473340|453364255|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
126019023|NCT03473340|453364254|FG000|Overall Study|Withdrawal by Subject|1|||
126019024|NCT03473340|453364255|FG001|Overall Study|Withdrawal by Subject|0|||
126019025|NCT03473340|453364254|FG000|Overall Study|Lost to Follow-up|1|||
126019026|NCT03473340|453364255|FG001|Overall Study|Lost to Follow-up|2|||
126019027|NCT03394885|453364257|FG000|Overall Study|Adverse Event|4|||
126019028|NCT03394885|453364257|FG000|Overall Study|Lack of Efficacy|1|||
126019029|NCT03394885|453364257|FG000|Overall Study|Physician Decision|1|||
126019030|NCT03394885|453364257|FG000|Overall Study|Withdrawal by Subject|8|||
126019031|NCT03394885|453364257|FG000|Overall Study|Alternative Therapy|1|||
126019032|NCT01170026|453365354|FG000|Overall Study|Lost to Follow-up|4|||
126019033|NCT01170026|453365355|FG001|Overall Study|Lost to Follow-up|2|||
126019034|NCT03785782|453365356|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
126019035|NCT03785782|453365357|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
126019036|NCT03785782|453365356|FG000|Overall Study|Withdrawal by Subject|1|||
126019037|NCT03785782|453365357|FG001|Overall Study|Withdrawal by Subject|1|||
126019038|NCT03785782|453365356|FG000|Overall Study|insufficient image quality.|3|||
126019039|NCT03785782|453365357|FG001|Overall Study|insufficient image quality.|0|||
126019040|NCT05777785|453365358|FG000|Overall Study|Withdrawal by Subject|5|||
126019041|NCT05777785|453365358|FG000|Overall Study|Lost to Follow-up|1|||
126019042|NCT02763319|453365363|FG000|Overall Study|Adverse Event|12|||
126019043|NCT02763319|453365364|FG001|Overall Study|Adverse Event|3|||
126019044|NCT02763319|453365363|FG000|Overall Study|Death|123|||
126019045|NCT02763319|453365364|FG001|Overall Study|Death|123|||
126019046|NCT02763319|453365363|FG000|Overall Study|Lost to Follow-up|6|||
126019047|NCT02763319|453365364|FG001|Overall Study|Lost to Follow-up|7|||
126019048|NCT02763319|453365363|FG000|Overall Study|Noncompliance with Study Drug|2|||
126019049|NCT02763319|453365364|FG001|Overall Study|Noncompliance with Study Drug|0|||
126019050|NCT02763319|453365363|FG000|Overall Study|"Captured as Other in Database"|29|||
126019051|NCT02763319|453365364|FG001|Overall Study|"Captured as Other in Database"|34|||
126019052|NCT02763319|453365363|FG000|Overall Study|Physician Decision|1|||
126019053|NCT02763319|453365364|FG001|Overall Study|Physician Decision|7|||
126019054|NCT02763319|453365363|FG000|Overall Study|Progressive Disease|24|||
126019055|NCT02763319|453365364|FG001|Overall Study|Progressive Disease|27|||
126019056|NCT02763319|453365363|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
126019057|NCT02763319|453365364|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
126019058|NCT02763319|453365363|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
126019059|NCT02763319|453365364|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
126019060|NCT02763319|453365363|FG000|Overall Study|Withdrawal by Subject|26|||
126019061|NCT02763319|453365364|FG001|Overall Study|Withdrawal by Subject|25|||
126019062|NCT00089544|453365365|FG000|Overall Study|Ineligible|1|||
126019063|NCT00089544|453365366|FG001|Overall Study|Ineligible|0|||
126019064|NCT01622868|453365372|FG000|Overall Study|Protocol Violation|7|||
126019065|NCT01622868|453365373|FG001|Overall Study|Protocol Violation|0|||
126019066|NCT00610649|453365375|FG000|Overall Study|Adverse Event|1|||
126019067|NCT00610649|453365376|FG001|Overall Study|Adverse Event|0|||
126019068|NCT00610649|453365377|FG002|Overall Study|Adverse Event|0|||
126019069|NCT00610649|453365378|FG003|Overall Study|Adverse Event|0|||
126019070|NCT00610649|453365379|FG004|Overall Study|Adverse Event|0|||
126019071|NCT00610649|453365380|FG005|Overall Study|Adverse Event|0|||
126019072|NCT00610649|453365381|FG006|Overall Study|Adverse Event|0|||
126019073|NCT00610649|453365382|FG007|Overall Study|Adverse Event|0|||
126019074|NCT00610649|453365383|FG008|Overall Study|Adverse Event|0|||
126092706|NCT01365481|453632867|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126092707|NCT01365481|453632868|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126092708|NCT01365481|453632865|FG000|Overall Study|Administrative problems|0|||
126092709|NCT01365481|453632866|FG001|Overall Study|Administrative problems|1|||
126092710|NCT01365481|453632867|FG002|Overall Study|Administrative problems|0|||
126222958|NCT00950599|454107764|FG001|Follow-Up Period|Adverse Event|0|||
126222959|NCT00950599|454107765|FG002|Follow-Up Period|Adverse Event|0|||
126222960|NCT00950599|454107766|FG003|Follow-Up Period|Adverse Event|0|||
126222961|NCT00950599|454107767|FG004|Follow-Up Period|Adverse Event|0|||
126222962|NCT00950599|454107768|FG005|Follow-Up Period|Adverse Event|0|||
126222963|NCT00950599|454107769|FG006|Follow-Up Period|Adverse Event|0|||
126222964|NCT00950599|454107770|FG007|Follow-Up Period|Adverse Event|0|||
126222965|NCT00950599|454107771|FG008|Follow-Up Period|Adverse Event|1|||
126222966|NCT00950599|454107772|FG009|Follow-Up Period|Adverse Event|0|||
126222967|NCT00950599|454107763|FG000|Follow-Up Period|Lack of Efficacy|0|||
126222968|NCT00950599|454107764|FG001|Follow-Up Period|Lack of Efficacy|0|||
126222969|NCT00950599|454107765|FG002|Follow-Up Period|Lack of Efficacy|0|||
126222970|NCT00950599|454107766|FG003|Follow-Up Period|Lack of Efficacy|0|||
126222971|NCT00950599|454107767|FG004|Follow-Up Period|Lack of Efficacy|0|||
126222972|NCT00950599|454107768|FG005|Follow-Up Period|Lack of Efficacy|0|||
126222973|NCT00950599|454107769|FG006|Follow-Up Period|Lack of Efficacy|0|||
126222974|NCT00950599|454107770|FG007|Follow-Up Period|Lack of Efficacy|0|||
126222975|NCT00950599|454107771|FG008|Follow-Up Period|Lack of Efficacy|3|||
126222976|NCT00950599|454107772|FG009|Follow-Up Period|Lack of Efficacy|0|||
126222977|NCT00950599|454107763|FG000|Follow-Up Period|Lost to Follow-up|0|||
126222978|NCT00950599|454107764|FG001|Follow-Up Period|Lost to Follow-up|0|||
126222979|NCT00950599|454107765|FG002|Follow-Up Period|Lost to Follow-up|0|||
126222980|NCT00950599|454107766|FG003|Follow-Up Period|Lost to Follow-up|0|||
126222981|NCT00950599|454107767|FG004|Follow-Up Period|Lost to Follow-up|0|||
126222982|NCT00950599|454107768|FG005|Follow-Up Period|Lost to Follow-up|0|||
126222983|NCT00950599|454107769|FG006|Follow-Up Period|Lost to Follow-up|0|||
126222984|NCT00950599|454107770|FG007|Follow-Up Period|Lost to Follow-up|0|||
126222985|NCT00950599|454107771|FG008|Follow-Up Period|Lost to Follow-up|5|||
126222986|NCT00950599|454107772|FG009|Follow-Up Period|Lost to Follow-up|1|||
126222987|NCT00950599|454107763|FG000|Follow-Up Period|Physician Decision|0|||
126222988|NCT00950599|454107764|FG001|Follow-Up Period|Physician Decision|0|||
126222989|NCT00950599|454107765|FG002|Follow-Up Period|Physician Decision|0|||
126222990|NCT00950599|454107766|FG003|Follow-Up Period|Physician Decision|0|||
126222991|NCT00950599|454107767|FG004|Follow-Up Period|Physician Decision|0|||
126222992|NCT00950599|454107768|FG005|Follow-Up Period|Physician Decision|0|||
126222993|NCT00950599|454107769|FG006|Follow-Up Period|Physician Decision|0|||
126222994|NCT00950599|454107770|FG007|Follow-Up Period|Physician Decision|0|||
126019075|NCT00610649|453365384|FG009|Overall Study|Adverse Event|0|||
126019076|NCT00610649|453365385|FG010|Overall Study|Adverse Event|1|||
126019077|NCT00610649|453365375|FG000|Overall Study|Family Emergency|0|||
126019078|NCT00610649|453365376|FG001|Overall Study|Family Emergency|1|||
126019079|NCT00610649|453365377|FG002|Overall Study|Family Emergency|0|||
126019080|NCT00610649|453365378|FG003|Overall Study|Family Emergency|0|||
126019081|NCT00610649|453365379|FG004|Overall Study|Family Emergency|0|||
126019082|NCT00610649|453365380|FG005|Overall Study|Family Emergency|0|||
126019083|NCT00610649|453365381|FG006|Overall Study|Family Emergency|0|||
126092711|NCT01365481|453632868|FG003|Overall Study|Administrative problems|0|||
126222995|NCT00950599|454107771|FG008|Follow-Up Period|Physician Decision|1|||
126222996|NCT00950599|454107772|FG009|Follow-Up Period|Physician Decision|0|||
126019084|NCT00610649|453365382|FG007|Overall Study|Family Emergency|0|||
126092712|NCT01365481|453632865|FG000|Overall Study|Protocol deviation|0|||
126222997|NCT00950599|454107763|FG000|Follow-Up Period|Poor/Noncompliance|0|||
126222998|NCT00950599|454107764|FG001|Follow-Up Period|Poor/Noncompliance|0|||
126019085|NCT00610649|453365383|FG008|Overall Study|Family Emergency|0|||
126019086|NCT00610649|453365384|FG009|Overall Study|Family Emergency|0|||
126019087|NCT00610649|453365385|FG010|Overall Study|Family Emergency|0|||
126019088|NCT00610649|453365375|FG000|Overall Study|Withdrawal by Subject|0|||
126019089|NCT00610649|453365376|FG001|Overall Study|Withdrawal by Subject|0|||
126019090|NCT00610649|453365377|FG002|Overall Study|Withdrawal by Subject|0|||
126019091|NCT00610649|453365378|FG003|Overall Study|Withdrawal by Subject|0|||
126019092|NCT00610649|453365379|FG004|Overall Study|Withdrawal by Subject|0|||
126019093|NCT00610649|453365380|FG005|Overall Study|Withdrawal by Subject|0|||
126019094|NCT00610649|453365381|FG006|Overall Study|Withdrawal by Subject|0|||
126019095|NCT00610649|453365382|FG007|Overall Study|Withdrawal by Subject|0|||
126019096|NCT00610649|453365383|FG008|Overall Study|Withdrawal by Subject|0|||
126019097|NCT00610649|453365384|FG009|Overall Study|Withdrawal by Subject|1|||
126019098|NCT00610649|453365385|FG010|Overall Study|Withdrawal by Subject|0|||
126019099|NCT04252586|453365386|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126019100|NCT04252586|453365386|FG000|Overall Study|Adverse Event|1|||
126019101|NCT04252586|453365386|FG000|Overall Study|Death|2|||
126019102|NCT04252586|453365386|FG000|Overall Study|Study terminated by sponsor|4|||
126019103|NCT04252586|453365386|FG000|Overall Study|Sponsor request|10|||
126019104|NCT04252586|453365386|FG000|Overall Study|Did not complete treatment period|1|||
126019105|NCT00869258|453365389|FG000|Overall Study|Physician Decision|1|||
126019106|NCT02706717|453365390|FG000|Overall Study|Withdrawal by Subject|1|||
126019107|NCT02706717|453365391|FG001|Overall Study|Withdrawal by Subject|8|||
126019108|NCT02706717|453365390|FG000|Overall Study|Lost to Follow-up|0|||
126019109|NCT02706717|453365391|FG001|Overall Study|Lost to Follow-up|1|||
126019110|NCT02706717|453365390|FG000|Overall Study|Physician Decision|0|||
126019111|NCT02706717|453365391|FG001|Overall Study|Physician Decision|1|||
126019112|NCT02706717|453365390|FG000|Overall Study|Death|0|||
126019113|NCT02706717|453365391|FG001|Overall Study|Death|1|||
126019114|NCT02507752|453365393|FG000|Overall Study|Adverse Event|1|||
126019115|NCT02507752|453365393|FG000|Overall Study|Protocol Violation|6|||
126019116|NCT02507752|453365393|FG000|Overall Study|Lost to Follow-up|7|||
126019117|NCT02507752|453365393|FG000|Overall Study|Infusion reaction at first infusion|1|||
126019118|NCT02507752|453365393|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
126019119|NCT02507752|453365393|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
126019120|NCT03740009|453365398|FG000|Overall Study|Physician Decision|9|||
126019121|NCT03740009|453365398|FG000|Overall Study|Lost to Follow-up|1|||
126019122|NCT01061151|453365399|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
126019123|NCT01061151|453365400|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
126019124|NCT01061151|453365401|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
126019125|NCT01061151|453365402|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
126019126|NCT01061151|453365399|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
126019127|NCT01061151|453365400|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
126019128|NCT01061151|453365401|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
126019129|NCT01061151|453365402|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
126019130|NCT01061151|453365399|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
126019131|NCT01061151|453365400|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
126019132|NCT01061151|453365401|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
126019133|NCT01061151|453365402|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
126019134|NCT01061151|453365399|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
126019135|NCT01061151|453365400|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
126019136|NCT01061151|453365401|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
126019137|NCT01061151|453365402|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
126019138|NCT01061151|453365399|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
126019139|NCT01061151|453365400|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
126019140|NCT01061151|453365401|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
126019141|NCT01061151|453365402|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
126019142|NCT01061151|453365399|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
126019143|NCT01061151|453365400|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
126019144|NCT01061151|453365401|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
126019145|NCT01061151|453365402|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
126019146|NCT01061151|453365399|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
126019147|NCT01061151|453365400|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
126019148|NCT01061151|453365401|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
126019149|NCT01061151|453365402|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
126019150|NCT01061151|453365399|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
126019151|NCT01061151|453365400|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
126019152|NCT01061151|453365401|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
126019153|NCT01061151|453365402|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
126019154|NCT01061151|453365399|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
126019155|NCT01061151|453365400|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
126222999|NCT00950599|454107765|FG002|Follow-Up Period|Poor/Noncompliance|0|||
126223000|NCT00950599|454107766|FG003|Follow-Up Period|Poor/Noncompliance|0|||
126019156|NCT01061151|453365401|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
126019157|NCT01061151|453365402|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
126223001|NCT00950599|454107767|FG004|Follow-Up Period|Poor/Noncompliance|0|||
126223002|NCT00950599|454107768|FG005|Follow-Up Period|Poor/Noncompliance|0|||
126223003|NCT00950599|454107769|FG006|Follow-Up Period|Poor/Noncompliance|0|||
126019158|NCT01061151|453365399|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
126019159|NCT01061151|453365400|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
126019160|NCT01061151|453365401|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
126019161|NCT01061151|453365402|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
126019162|NCT01061151|453365399|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
126019163|NCT01061151|453365400|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
126019164|NCT01061151|453365401|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
126019165|NCT01061151|453365402|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
126019166|NCT01061151|453365399|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
126019167|NCT01061151|453365400|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
126019168|NCT01061151|453365401|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
126019169|NCT01061151|453365402|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
126019170|NCT01061151|453365399|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
126019171|NCT01061151|453365400|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
126019172|NCT01061151|453365401|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
126019173|NCT01061151|453365402|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
126019174|NCT01061151|453365399|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
126019175|NCT01061151|453365400|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
126019176|NCT01061151|453365401|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
126019177|NCT01061151|453365402|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
126019178|NCT01061151|453365399|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
126019179|NCT01061151|453365400|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
126019180|NCT01061151|453365401|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
126019181|NCT01061151|453365402|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
126019182|NCT04530747|453365413|FG000|Overall Study|Withdrawal by Subject|1|||
126019183|NCT04530747|453365414|FG001|Overall Study|Withdrawal by Subject|0|||
126019184|NCT03752151|453365415|FG000|Overall Study|Withdrawal by Subject|1|||
126019185|NCT03752151|453365415|FG000|Overall Study|Protocol Violation|1|||
126019186|NCT00529516|453365416|FG000|Overall Study|Adverse Event|2|||
126019187|NCT00529516|453365417|FG001|Overall Study|Adverse Event|1|||
126019188|NCT00529516|453365418|FG002|Overall Study|Adverse Event|0|||
126019189|NCT00529516|453365416|FG000|Overall Study|Withdrawal by Subject|1|||
126019190|NCT00529516|453365417|FG001|Overall Study|Withdrawal by Subject|1|||
126019191|NCT00529516|453365418|FG002|Overall Study|Withdrawal by Subject|0|||
126019192|NCT00529516|453365416|FG000|Overall Study|Lost to Follow-up|0|||
126019193|NCT00529516|453365417|FG001|Overall Study|Lost to Follow-up|0|||
126019194|NCT00529516|453365418|FG002|Overall Study|Lost to Follow-up|1|||
126019195|NCT01787760|453365427|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
126223004|NCT00950599|454107770|FG007|Follow-Up Period|Poor/Noncompliance|0|||
126223005|NCT00950599|454107771|FG008|Follow-Up Period|Poor/Noncompliance|1|||
126223006|NCT00950599|454107772|FG009|Follow-Up Period|Poor/Noncompliance|0|||
126223007|NCT00950599|454107763|FG000|Follow-Up Period|Subject withdrew Consent|0|||
126223008|NCT00950599|454107764|FG001|Follow-Up Period|Subject withdrew Consent|0|||
126223009|NCT00950599|454107765|FG002|Follow-Up Period|Subject withdrew Consent|0|||
126223010|NCT00950599|454107766|FG003|Follow-Up Period|Subject withdrew Consent|0|||
126223011|NCT00950599|454107767|FG004|Follow-Up Period|Subject withdrew Consent|0|||
126223012|NCT00950599|454107768|FG005|Follow-Up Period|Subject withdrew Consent|0|||
126223013|NCT00950599|454107769|FG006|Follow-Up Period|Subject withdrew Consent|0|||
126223014|NCT00950599|454107770|FG007|Follow-Up Period|Subject withdrew Consent|0|||
126223015|NCT00950599|454107771|FG008|Follow-Up Period|Subject withdrew Consent|2|||
126223016|NCT00950599|454107772|FG009|Follow-Up Period|Subject withdrew Consent|1|||
126223017|NCT00971204|454107774|FG000|Overall Study|Did not meet all criteria-not treated|14|||
126223018|NCT00971204|454107774|FG000|Overall Study|Lost to Follow-up|10|||
126019196|NCT01787760|453365428|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
126019197|NCT01787760|453365429|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
126223019|NCT02729194|454107775|FG000|Overall Study|Withdrawal by Subject|3|||
126019198|NCT01787760|453365427|FG000|Overall Study|Decompensated on left exotropia|0|||
126019199|NCT01787760|453365428|FG001|Overall Study|Decompensated on left exotropia|0|||
126223020|NCT01401478|454107778|FG000|Overall Study|Study drug not available|6|||
126223021|NCT01401478|454107778|FG000|Overall Study|Adverse Event|5|||
126223022|NCT01401478|454107778|FG000|Overall Study|Hyperphosphatemia|5|||
126223023|NCT01401478|454107778|FG000|Overall Study|Lost to Follow-up|5|||
126223024|NCT01401478|454107778|FG000|Overall Study|Kidney transplantation|3|||
126019200|NCT01787760|453365429|FG002|Overall Study|Decompensated on left exotropia|1|||
126019201|NCT01787760|453365427|FG000|Overall Study|Dryness|0|||
126019202|NCT01787760|453365428|FG001|Overall Study|Dryness|1|||
126019203|NCT01787760|453365429|FG002|Overall Study|Dryness|0|||
126019204|NCT01787760|453365427|FG000|Overall Study|Relocation|1|||
126019205|NCT01787760|453365428|FG001|Overall Study|Relocation|1|||
126019206|NCT01787760|453365429|FG002|Overall Study|Relocation|0|||
126019207|NCT01787760|453365427|FG000|Overall Study|Lens discomfort|3|||
126019208|NCT01787760|453365428|FG001|Overall Study|Lens discomfort|0|||
126019209|NCT01787760|453365429|FG002|Overall Study|Lens discomfort|0|||
126019210|NCT01787760|453365427|FG000|Overall Study|Lens handling difficulty|1|||
126019211|NCT01787760|453365428|FG001|Overall Study|Lens handling difficulty|2|||
126019212|NCT01787760|453365429|FG002|Overall Study|Lens handling difficulty|0|||
126019213|NCT01787760|453365427|FG000|Overall Study|Protocol Violation|6|||
126019214|NCT01787760|453365428|FG001|Overall Study|Protocol Violation|0|||
126019215|NCT01787760|453365429|FG002|Overall Study|Protocol Violation|1|||
126019216|NCT01787760|453365427|FG000|Overall Study|Withdrawal by Subject|5|||
126019217|NCT01787760|453365428|FG001|Overall Study|Withdrawal by Subject|1|||
126019218|NCT01787760|453365429|FG002|Overall Study|Withdrawal by Subject|2|||
126019219|NCT01787760|453365427|FG000|Overall Study|Lost to Follow-up|1|||
126019220|NCT01787760|453365428|FG001|Overall Study|Lost to Follow-up|0|||
126019221|NCT01787760|453365429|FG002|Overall Study|Lost to Follow-up|1|||
126019222|NCT01787760|453365427|FG000|Overall Study|Stroke|1|||
126019223|NCT01787760|453365428|FG001|Overall Study|Stroke|0|||
126019224|NCT01787760|453365429|FG002|Overall Study|Stroke|0|||
126019225|NCT01787760|453365427|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
126019226|NCT01787760|453365428|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
126019227|NCT01787760|453365429|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
126019228|NCT01787760|453365427|FG000|Overall Study|Unsatisfactory physiological response|2|||
126019229|NCT01787760|453365428|FG001|Overall Study|Unsatisfactory physiological response|4|||
126019230|NCT01787760|453365429|FG002|Overall Study|Unsatisfactory physiological response|0|||
126223025|NCT01401478|454107778|FG000|Overall Study|Withdrawal by Subject|3|||
126223026|NCT01401478|454107778|FG000|Overall Study|Blood samples not available|1|||
126223027|NCT01401478|454107778|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
126223028|NCT01401478|454107778|FG000|Overall Study|Low intact parathyroid hormone|1|||
126223029|NCT01401478|454107778|FG000|Overall Study|Serious adverse event|1|||
126223030|NCT01684722|454107779|FG000|Overall Study|Lost to Follow-up|78|||
126223031|NCT01684722|454107780|FG001|Overall Study|Lost to Follow-up|56|||
126223032|NCT01684722|454107781|FG002|Overall Study|Lost to Follow-up|75|||
126223033|NCT01684722|454107782|FG003|Overall Study|Lost to Follow-up|89|||
126223034|NCT01684722|454107779|FG000|Overall Study|Death|19|||
126223035|NCT01684722|454107780|FG001|Overall Study|Death|21|||
126223036|NCT01684722|454107781|FG002|Overall Study|Death|19|||
126223037|NCT01684722|454107782|FG003|Overall Study|Death|21|||
126223038|NCT00863057|454107787|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
126223039|NCT00863057|454107788|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
126223040|NCT00863057|454107789|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
126223041|NCT00863057|454107790|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
126223042|NCT00863057|454107787|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
126223043|NCT00863057|454107788|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
126223044|NCT00863057|454107789|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
126223045|NCT00863057|454107790|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
126223046|NCT00863057|454107787|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
126223047|NCT00863057|454107788|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
126223048|NCT00863057|454107789|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
126223049|NCT00863057|454107790|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
126223050|NCT00863057|454107787|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
126223051|NCT00863057|454107788|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
126223052|NCT00863057|454107789|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
126223053|NCT00863057|454107790|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
126019231|NCT01787760|453365427|FG000|Overall Study|Unsatisfactory visual response|1|||
126223054|NCT03063632|454107792|FG000|Overall Study|Death|4|||
126223055|NCT03063632|454107793|FG001|Overall Study|Death|6|||
126019232|NCT01787760|453365428|FG001|Overall Study|Unsatisfactory visual response|1|||
126019233|NCT01787760|453365429|FG002|Overall Study|Unsatisfactory visual response|0|||
126223056|NCT03063632|454107792|FG000|Overall Study|Lost to Follow-up|0|||
126223057|NCT03063632|454107793|FG001|Overall Study|Lost to Follow-up|1|||
126223058|NCT03063632|454107792|FG000|Overall Study|Withdrawal by Subject|0|||
126223059|NCT03063632|454107793|FG001|Overall Study|Withdrawal by Subject|2|||
126019234|NCT01787760|453365427|FG000|Overall Study|Near vision blur|1|||
126019235|NCT01787760|453365428|FG001|Overall Study|Near vision blur|0|||
126019236|NCT01787760|453365429|FG002|Overall Study|Near vision blur|0|||
126019237|NCT01212991|453365434|FG000|Double-blind|Lost to Follow-up|8|||
126019238|NCT01212991|453365435|FG001|Double-blind|Lost to Follow-up|4|||
126019239|NCT01212991|453365436|FG002|Double-blind|Lost to Follow-up|0|||
126019240|NCT01212991|453365434|FG000|Double-blind|Death|699|||
126019241|NCT01212991|453365435|FG001|Double-blind|Death|550|||
126223060|NCT03063632|454107792|FG000|Overall Study|Physician Decision|2|||
126223061|NCT03063632|454107793|FG001|Overall Study|Physician Decision|0|||
126223062|NCT03063632|454107792|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
126223063|NCT03063632|454107793|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
126223064|NCT02570165|454107796|FG000|Overall Study|Adverse Event|1|||
126223065|NCT02570165|454107797|FG001|Overall Study|Adverse Event|0|||
126223066|NCT02570165|454107798|FG002|Overall Study|Adverse Event|2|||
126223067|NCT02570165|454107799|FG003|Overall Study|Adverse Event|0|||
126223068|NCT02570165|454107800|FG004|Overall Study|Adverse Event|0|||
126223069|NCT02570165|454107801|FG005|Overall Study|Adverse Event|0|||
126223070|NCT02570165|454107802|FG006|Overall Study|Adverse Event|0|||
126019242|NCT01212991|453365436|FG002|Double-blind|Death|0|||
126019243|NCT01212991|453365434|FG000|Double-blind|Withdrawal by Subject|16|||
126019244|NCT01212991|453365435|FG001|Double-blind|Withdrawal by Subject|19|||
126019245|NCT01212991|453365436|FG002|Double-blind|Withdrawal by Subject|0|||
126019246|NCT01212991|453365434|FG000|Double-blind|Other|7|||
126019247|NCT01212991|453365435|FG001|Double-blind|Other|0|||
126019248|NCT01212991|453365436|FG002|Double-blind|Other|0|||
126019249|NCT01212991|453365434|FG000|Double-blind|Sponsor decision|142|||
126019250|NCT01212991|453365435|FG001|Double-blind|Sponsor decision|38|||
126019251|NCT01212991|453365436|FG002|Double-blind|Sponsor decision|0|||
126019252|NCT01212991|453365434|FG000|Open-label|Death|0|||
126019253|NCT01212991|453365435|FG001|Open-label|Death|0|||
126019254|NCT01212991|453365436|FG002|Open-label|Death|166|||
126019255|NCT01212991|453365434|FG000|Open-label|Lost to Follow-up|0|||
126019256|NCT01212991|453365435|FG001|Open-label|Lost to Follow-up|0|||
126019257|NCT01212991|453365436|FG002|Open-label|Lost to Follow-up|5|||
126019258|NCT01212991|453365434|FG000|Open-label|Withdrawal by Subject|0|||
126019259|NCT01212991|453365435|FG001|Open-label|Withdrawal by Subject|0|||
126019260|NCT01212991|453365436|FG002|Open-label|Withdrawal by Subject|7|||
126019261|NCT01212991|453365434|FG000|Open-label|Sponsor decision|0|||
126019262|NCT01212991|453365435|FG001|Open-label|Sponsor decision|0|||
126019263|NCT01212991|453365436|FG002|Open-label|Sponsor decision|53|||
126019264|NCT01212991|453365434|FG000|Open-label|Other|0|||
126019265|NCT01212991|453365435|FG001|Open-label|Other|0|||
126019266|NCT01212991|453365436|FG002|Open-label|Other|3|||
126019267|NCT00801983|453365439|FG000|Period 1|Lost to Follow-up|2|||
126019268|NCT00801983|453365440|FG001|Period 1|Lost to Follow-up|0|||
126019269|NCT00801983|453365439|FG000|Period 1|Withdrawal by Subject|2|||
126019270|NCT00801983|453365440|FG001|Period 1|Withdrawal by Subject|8|||
126019271|NCT00801983|453365439|FG000|Period 2|Withdrawal by Subject|2|||
126019272|NCT00801983|453365440|FG001|Period 2|Withdrawal by Subject|1|||
126223071|NCT02570165|454107796|FG000|Overall Study|Lack of Efficacy|0|||
126223072|NCT02570165|454107797|FG001|Overall Study|Lack of Efficacy|1|||
126019273|NCT01251354|453365441|FG000|Overall Study|Adverse Event|1|||
126019274|NCT01251354|453365441|FG000|Overall Study|Investigator's Decision|1|||
126019275|NCT01251354|453365441|FG000|Overall Study|Disease Progression|4|||
126223073|NCT02570165|454107798|FG002|Overall Study|Lack of Efficacy|0|||
126223074|NCT02570165|454107799|FG003|Overall Study|Lack of Efficacy|0|||
126019276|NCT03807778|453365449|FG000|Overall Study|Adverse Event|0|||
126223075|NCT02570165|454107800|FG004|Overall Study|Lack of Efficacy|4|||
126019277|NCT03807778|453365450|FG001|Overall Study|Adverse Event|0|||
126019278|NCT03807778|453365451|FG002|Overall Study|Adverse Event|3|||
126019279|NCT03807778|453365452|FG003|Overall Study|Adverse Event|5|||
126019280|NCT03807778|453365449|FG000|Overall Study|Progressive Disease|4|||
126019281|NCT03807778|453365450|FG001|Overall Study|Progressive Disease|2|||
126019282|NCT03807778|453365451|FG002|Overall Study|Progressive Disease|8|||
126019283|NCT03807778|453365452|FG003|Overall Study|Progressive Disease|15|||
126019284|NCT03807778|453365449|FG000|Overall Study|Symptomatic Deterioration|0|||
126019285|NCT03807778|453365450|FG001|Overall Study|Symptomatic Deterioration|1|||
126019286|NCT03807778|453365451|FG002|Overall Study|Symptomatic Deterioration|0|||
126019287|NCT03807778|453365452|FG003|Overall Study|Symptomatic Deterioration|1|||
126019288|NCT03807778|453365449|FG000|Overall Study|Withdrawal by Subject|0|||
126019289|NCT03807778|453365450|FG001|Overall Study|Withdrawal by Subject|1|||
126019290|NCT03807778|453365451|FG002|Overall Study|Withdrawal by Subject|0|||
126019291|NCT03807778|453365452|FG003|Overall Study|Withdrawal by Subject|1|||
126019292|NCT03807778|453365449|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
126019293|NCT03807778|453365450|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
126019294|NCT03807778|453365451|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
126019295|NCT03807778|453365452|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
126019296|NCT05135000|453365453|FG000|Overall Study|Adverse Event|2|||
126019297|NCT05135000|453365454|FG001|Overall Study|Adverse Event|0|||
126019298|NCT05135000|453365453|FG000|Overall Study|Lost to Follow-up|1|||
126019299|NCT05135000|453365454|FG001|Overall Study|Lost to Follow-up|0|||
126019300|NCT05135000|453365453|FG000|Overall Study|Study Terminated by Sponsor|6|||
126019301|NCT05135000|453365454|FG001|Overall Study|Study Terminated by Sponsor|3|||
126019302|NCT05094141|453365462|FG000|Overall Study|Death|0|||
126019303|NCT05094141|453365463|FG001|Overall Study|Death|0|||
126019304|NCT05094141|453365464|FG002|Overall Study|Death|1|||
126019305|NCT05094141|453365462|FG000|Overall Study|Withdrawal by Subject|0|||
126019306|NCT05094141|453365463|FG001|Overall Study|Withdrawal by Subject|0|||
126019307|NCT05094141|453365464|FG002|Overall Study|Withdrawal by Subject|1|||
126019308|NCT05094141|453365462|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
126019309|NCT05094141|453365463|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
126019310|NCT05094141|453365464|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
126019311|NCT05094141|453365462|FG000|Overall Study|Did not participate in randomization|0|||
126019312|NCT05094141|453365463|FG001|Overall Study|Did not participate in randomization|0|||
126019313|NCT05094141|453365464|FG002|Overall Study|Did not participate in randomization|33|||
126019314|NCT04623008|453366908|FG000|Baseline to T2|Withdrawal by Subject|4|||
126019315|NCT04623008|453366909|FG001|Baseline to T2|Withdrawal by Subject|2|||
126019316|NCT04623008|453366908|FG000|Baseline to T3|Withdrawal by Subject|4|||
126019317|NCT04623008|453366909|FG001|Baseline to T3|Withdrawal by Subject|2|||
126019318|NCT03779048|453366919|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
126019319|NCT03779048|453366920|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
126019320|NCT03779048|453366921|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
126019321|NCT03779048|453366919|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
126019322|NCT03779048|453366920|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
126019323|NCT03779048|453366921|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
126019324|NCT03779048|453366919|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
126019325|NCT03779048|453366920|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
126019326|NCT03779048|453366921|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
126019327|NCT00232180|453366924|FG000|Double-blind (DB) Phase|Death|186|||
126019328|NCT00232180|453366925|FG001|Double-blind (DB) Phase|Death|222|||
126019329|NCT00232180|453366926|FG002|Double-blind (DB) Phase|Death|0|||
126019330|NCT00232180|453366924|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
126019331|NCT00232180|453366925|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
126019332|NCT00232180|453366926|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
126019333|NCT00232180|453366924|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
126019334|NCT00232180|453366925|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
126019335|NCT00232180|453366926|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
126019336|NCT00232180|453366924|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
126019337|NCT00232180|453366925|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
126019338|NCT00232180|453366926|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
126019339|NCT00232180|453366924|FG000|Double-blind (DB) Phase|Adverse Event|83|||
126019340|NCT00232180|453366925|FG001|Double-blind (DB) Phase|Adverse Event|100|||
126019341|NCT00232180|453366926|FG002|Double-blind (DB) Phase|Adverse Event|0|||
126019342|NCT00232180|453366924|FG000|Double-blind (DB) Phase|Other|70|||
126019343|NCT00232180|453366925|FG001|Double-blind (DB) Phase|Other|75|||
126019344|NCT00232180|453366926|FG002|Double-blind (DB) Phase|Other|0|||
126019345|NCT00232180|453366924|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
126019346|NCT00232180|453366925|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
126019347|NCT00232180|453366926|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
126019348|NCT00232180|453366924|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
126019349|NCT00232180|453366925|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
126019350|NCT00232180|453366926|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
126019351|NCT00232180|453366924|FG000|Open Label Phase|Death|0|||
126019352|NCT00232180|453366925|FG001|Open Label Phase|Death|0|||
126019353|NCT00232180|453366926|FG002|Open Label Phase|Death|48|||
126019354|NCT00232180|453366924|FG000|Open Label Phase|Lost to Follow-up|0|||
126019355|NCT00232180|453366925|FG001|Open Label Phase|Lost to Follow-up|0|||
126019356|NCT00232180|453366926|FG002|Open Label Phase|Lost to Follow-up|5|||
126019357|NCT00232180|453366924|FG000|Open Label Phase|Protocol Violation|0|||
126019358|NCT00232180|453366925|FG001|Open Label Phase|Protocol Violation|0|||
126019359|NCT00232180|453366926|FG002|Open Label Phase|Protocol Violation|3|||
126019360|NCT00232180|453366924|FG000|Open Label Phase|Study terminated by sponsor|0|||
126019361|NCT00232180|453366925|FG001|Open Label Phase|Study terminated by sponsor|0|||
126019362|NCT00232180|453366926|FG002|Open Label Phase|Study terminated by sponsor|3|||
126019363|NCT00232180|453366924|FG000|Open Label Phase|Withdrawal by Subject|0|||
126019364|NCT00232180|453366925|FG001|Open Label Phase|Withdrawal by Subject|0|||
126019365|NCT00232180|453366926|FG002|Open Label Phase|Withdrawal by Subject|37|||
126019366|NCT00232180|453366924|FG000|Open Label Phase|Other|0|||
126019367|NCT00232180|453366925|FG001|Open Label Phase|Other|0|||
126019368|NCT00232180|453366926|FG002|Open Label Phase|Other|16|||
126019369|NCT00232180|453366924|FG000|Open Label Phase|Adverse Event|0|||
126019370|NCT00232180|453366925|FG001|Open Label Phase|Adverse Event|0|||
126019371|NCT00232180|453366926|FG002|Open Label Phase|Adverse Event|25|||
126019372|NCT00232180|453366924|FG000|Open Label Phase|Laboratory abnormality|0|||
126019373|NCT00232180|453366925|FG001|Open Label Phase|Laboratory abnormality|0|||
126019374|NCT00232180|453366926|FG002|Open Label Phase|Laboratory abnormality|10|||
126019375|NCT00232180|453366924|FG000|Open Label Phase|Randomized but not treated|0|||
126019376|NCT00232180|453366925|FG001|Open Label Phase|Randomized but not treated|0|||
126019377|NCT00232180|453366926|FG002|Open Label Phase|Randomized but not treated|1|||
126019378|NCT03452189|453366927|FG000|First Intervention (3 Months)|Adverse Event|1|||
126019379|NCT03452189|453366928|FG001|First Intervention (3 Months)|Adverse Event|0|||
126019380|NCT03452189|453366927|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
126019381|NCT03452189|453366928|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
126019382|NCT01571596|453366935|FG000|Overall Study|Adverse Event|2|||
126019383|NCT01571596|453366936|FG001|Overall Study|Adverse Event|0|||
126019384|NCT01571596|453366937|FG002|Overall Study|Adverse Event|0|||
126019385|NCT01571596|453366935|FG000|Overall Study|Study Terminated by the Sponsor|0|||
126019386|NCT01571596|453366936|FG001|Overall Study|Study Terminated by the Sponsor|1|||
126019387|NCT01571596|453366937|FG002|Overall Study|Study Terminated by the Sponsor|1|||
126019388|NCT02767765|453366943|FG000|Overall Study|Adverse Event|4|||
126019389|NCT02767765|453366943|FG000|Overall Study|Death|1|||
126019390|NCT02767765|453366943|FG000|Overall Study|Insufficient response|1|||
126019391|NCT02767765|453366943|FG000|Overall Study|Lost to Follow-up|2|||
126019392|NCT02767765|453366943|FG000|Overall Study|Investigator decision|1|||
126019393|NCT02767765|453366943|FG000|Overall Study|Non-Compliance|1|||
126019394|NCT02767765|453366943|FG000|Overall Study|Withdrawal by Subject|1|||
126019395|NCT01951170|453366945|FG000|Overall Study|Investigator decision|1|||
126019396|NCT04512482|453366950|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
126019397|NCT04512482|453366951|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
126019398|NCT00774397|453366954|FG000|Overall Study|Adverse Event|1|||
126019399|NCT00774397|453366955|FG001|Overall Study|Adverse Event|3|||
126019400|NCT00774397|453366956|FG002|Overall Study|Adverse Event|16|||
126019401|NCT00774397|453366957|FG003|Overall Study|Adverse Event|8|||
126019402|NCT00774397|453366958|FG004|Overall Study|Adverse Event|8|||
126019403|NCT00774397|453366959|FG005|Overall Study|Adverse Event|3|||
126019404|NCT00774397|453366960|FG006|Overall Study|Adverse Event|16|||
126019405|NCT00774397|453366954|FG000|Overall Study|Lack of Efficacy|11|||
126019406|NCT00774397|453366955|FG001|Overall Study|Lack of Efficacy|4|||
126019407|NCT00774397|453366956|FG002|Overall Study|Lack of Efficacy|5|||
126019408|NCT00774397|453366957|FG003|Overall Study|Lack of Efficacy|3|||
126019409|NCT00774397|453366958|FG004|Overall Study|Lack of Efficacy|27|||
126019410|NCT00774397|453366959|FG005|Overall Study|Lack of Efficacy|15|||
126019411|NCT00774397|453366960|FG006|Overall Study|Lack of Efficacy|9|||
126019412|NCT00774397|453366954|FG000|Overall Study|Protocol Violation|0|||
126019413|NCT00774397|453366955|FG001|Overall Study|Protocol Violation|1|||
126350328|NCT02112916|454574165|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
126019414|NCT00774397|453366956|FG002|Overall Study|Protocol Violation|3|||
126019415|NCT00774397|453366957|FG003|Overall Study|Protocol Violation|1|||
126019416|NCT00774397|453366958|FG004|Overall Study|Protocol Violation|2|||
126019417|NCT00774397|453366959|FG005|Overall Study|Protocol Violation|1|||
126019418|NCT00774397|453366960|FG006|Overall Study|Protocol Violation|0|||
126019419|NCT00774397|453366954|FG000|Overall Study|Lost to Follow-up|0|||
126019420|NCT00774397|453366955|FG001|Overall Study|Lost to Follow-up|1|||
126019421|NCT00774397|453366956|FG002|Overall Study|Lost to Follow-up|1|||
126019422|NCT00774397|453366957|FG003|Overall Study|Lost to Follow-up|1|||
126019423|NCT00774397|453366958|FG004|Overall Study|Lost to Follow-up|0|||
126019424|NCT00774397|453366959|FG005|Overall Study|Lost to Follow-up|1|||
126019425|NCT00774397|453366960|FG006|Overall Study|Lost to Follow-up|0|||
126092713|NCT01365481|453632866|FG001|Overall Study|Protocol deviation|1|||
126019426|NCT00774397|453366954|FG000|Overall Study|Refused to continue trial medication|1|||
126019427|NCT00774397|453366955|FG001|Overall Study|Refused to continue trial medication|3|||
126019428|NCT00774397|453366956|FG002|Overall Study|Refused to continue trial medication|2|||
126019429|NCT00774397|453366957|FG003|Overall Study|Refused to continue trial medication|2|||
126019430|NCT00774397|453366958|FG004|Overall Study|Refused to continue trial medication|6|||
126019431|NCT00774397|453366959|FG005|Overall Study|Refused to continue trial medication|2|||
126019432|NCT00774397|453366960|FG006|Overall Study|Refused to continue trial medication|3|||
126019433|NCT00774397|453366954|FG000|Overall Study|Not treated|0|||
126019434|NCT00774397|453366955|FG001|Overall Study|Not treated|0|||
126019435|NCT00774397|453366956|FG002|Overall Study|Not treated|0|||
126019436|NCT00774397|453366957|FG003|Overall Study|Not treated|0|||
126019437|NCT00774397|453366958|FG004|Overall Study|Not treated|1|||
126019438|NCT00774397|453366959|FG005|Overall Study|Not treated|0|||
126019439|NCT00774397|453366960|FG006|Overall Study|Not treated|1|||
126019440|NCT00774397|453366954|FG000|Overall Study|Other than those stated above|1|||
126019441|NCT00774397|453366955|FG001|Overall Study|Other than those stated above|1|||
126019442|NCT00774397|453366956|FG002|Overall Study|Other than those stated above|3|||
126019443|NCT00774397|453366957|FG003|Overall Study|Other than those stated above|2|||
126019444|NCT00774397|453366958|FG004|Overall Study|Other than those stated above|2|||
126019445|NCT00774397|453366959|FG005|Overall Study|Other than those stated above|0|||
126019446|NCT00774397|453366960|FG006|Overall Study|Other than those stated above|1|||
126019447|NCT00077675|453366961|FG000|Overall Study|Adverse Event|1|||
126019448|NCT00077675|453366962|FG001|Overall Study|Adverse Event|2|||
126019449|NCT00077675|453366961|FG000|Overall Study|Lost to Follow-up|6|||
126019450|NCT00077675|453366962|FG001|Overall Study|Lost to Follow-up|3|||
126019451|NCT00077675|453366961|FG000|Overall Study|Withdrawal by Subject|1|||
126019452|NCT00077675|453366962|FG001|Overall Study|Withdrawal by Subject|0|||
126019453|NCT00077675|453366961|FG000|Overall Study|Other|0|||
126019454|NCT00077675|453366962|FG001|Overall Study|Other|1|||
126019455|NCT00077675|453366961|FG000|Overall Study|Never received study treatment|3|||
126019456|NCT00077675|453366962|FG001|Overall Study|Never received study treatment|3|||
126019457|NCT00391898|453366973|FG000|Overall Study|Adverse Event|3|||
126019458|NCT00391898|453366974|FG001|Overall Study|Adverse Event|0|||
126019459|NCT00391898|453366973|FG000|Overall Study|Other|8|||
126019460|NCT00391898|453366974|FG001|Overall Study|Other|10|||
126019461|NCT02512965|453366979|FG000|Overall Study|Withdrawal by Subject|0|||
126019462|NCT02512965|453366980|FG001|Overall Study|Withdrawal by Subject|4|||
126019463|NCT00835770|453366984|FG000|Overall Study|MS Relapse|17|||
126019464|NCT00835770|453366985|FG001|Overall Study|MS Relapse|23|||
126019465|NCT00835770|453366984|FG000|Overall Study|MS Progression|14|||
126019466|NCT00835770|453366985|FG001|Overall Study|MS Progression|9|||
126019467|NCT00835770|453366984|FG000|Overall Study|Adverse Event|113|||
126019468|NCT00835770|453366985|FG001|Overall Study|Adverse Event|124|||
126019469|NCT00835770|453366984|FG000|Overall Study|Lost to Follow-up|22|||
126019470|NCT00835770|453366985|FG001|Overall Study|Lost to Follow-up|19|||
126019471|NCT00835770|453366984|FG000|Overall Study|Consent Withdrawn|144|||
126019472|NCT00835770|453366985|FG001|Overall Study|Consent Withdrawn|156|||
126019473|NCT00835770|453366984|FG000|Overall Study|Investigator Decision|42|||
126019474|NCT00835770|453366985|FG001|Overall Study|Investigator Decision|42|||
126019475|NCT00835770|453366984|FG000|Overall Study|Participant Non-Compliance|11|||
126019476|NCT00835770|453366985|FG001|Overall Study|Participant Non-Compliance|9|||
126019477|NCT00835770|453366984|FG000|Overall Study|Death|4|||
126019478|NCT00835770|453366985|FG001|Overall Study|Death|6|||
126019479|NCT00835770|453366984|FG000|Overall Study|Other|115|||
126019480|NCT00835770|453366985|FG001|Overall Study|Other|104|||
126019481|NCT00835770|453366984|FG000|Overall Study|Other|2|||
126019482|NCT00835770|453366985|FG001|Overall Study|Other|1|||
126092714|NCT01365481|453632867|FG002|Overall Study|Protocol deviation|0|||
126092715|NCT01365481|453632868|FG003|Overall Study|Protocol deviation|1|||
126350329|NCT02112916|454574166|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
126350330|NCT02112916|454574167|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
126350331|NCT02112916|454574164|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
126019483|NCT01185782|453366986|FG000|Overall Study|Adverse Event|0|||
126019484|NCT01185782|453366987|FG001|Overall Study|Adverse Event|1|||
126019485|NCT01185782|453366986|FG000|Overall Study|Protocol Violation|1|||
126019486|NCT01185782|453366987|FG001|Overall Study|Protocol Violation|0|||
126019487|NCT01185782|453366986|FG000|Overall Study|Poor Response to Treatment|3|||
126019488|NCT01185782|453366987|FG001|Overall Study|Poor Response to Treatment|1|||
126019489|NCT01185782|453366986|FG000|Overall Study|Other|2|||
126019490|NCT01185782|453366987|FG001|Overall Study|Other|5|||
126019491|NCT01185782|453366986|FG000|Overall Study|Randomized but not treated|0|||
126019492|NCT01185782|453366987|FG001|Overall Study|Randomized but not treated|4|||
126019493|NCT02092116|453366989|FG000|Overall Study|Withdrawal by Subject|0|||
126019494|NCT02092116|453366990|FG001|Overall Study|Withdrawal by Subject|3|||
126019495|NCT02092116|453366989|FG000|Overall Study|Adverse Event|0|||
126223076|NCT02570165|454107801|FG005|Overall Study|Lack of Efficacy|0|||
126223077|NCT02570165|454107802|FG006|Overall Study|Lack of Efficacy|0|||
126019496|NCT02092116|453366990|FG001|Overall Study|Adverse Event|1|||
126019497|NCT01546753|453366991|FG000|Overall Study|anxiety|1|||
126350332|NCT02112916|454574165|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
126369493|NCT00876447|454650572|FG001|Overall Study|Personal reasons|28|||
126019498|NCT01546753|453366992|FG001|Overall Study|anxiety|1|||
126019499|NCT01546753|453366991|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
126019500|NCT01546753|453366992|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
126019501|NCT00939510|453366993|FG000|Overall Study|Withdrawal by Subject|1|||
126019502|NCT00546754|453367001|FG000|Overall Study|Serious Adverse Event|1|||
126019503|NCT00546754|453367002|FG001|Overall Study|Serious Adverse Event|1|||
126019504|NCT00546754|453367001|FG000|Overall Study|Adverse Event|11|||
126019505|NCT00546754|453367002|FG001|Overall Study|Adverse Event|16|||
126019506|NCT00546754|453367001|FG000|Overall Study|Lack of Efficacy|1|||
126019507|NCT00546754|453367002|FG001|Overall Study|Lack of Efficacy|1|||
126019508|NCT00546754|453367001|FG000|Overall Study|Lost to Follow-up|9|||
126019509|NCT00546754|453367002|FG001|Overall Study|Lost to Follow-up|15|||
126019510|NCT00546754|453367001|FG000|Overall Study|Protocol Violation|3|||
126019511|NCT00546754|453367002|FG001|Overall Study|Protocol Violation|0|||
126019512|NCT00546754|453367001|FG000|Overall Study|Withdrawal by Subject|6|||
126019513|NCT00546754|453367002|FG001|Overall Study|Withdrawal by Subject|7|||
126019514|NCT00546754|453367001|FG000|Overall Study|Dyspnea|1|||
126019515|NCT00546754|453367002|FG001|Overall Study|Dyspnea|0|||
126019516|NCT00546754|453367001|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
126019517|NCT00546754|453367002|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
126019518|NCT00546754|453367001|FG000|Overall Study|Hip Replacement|1|||
126019519|NCT00546754|453367002|FG001|Overall Study|Hip Replacement|0|||
126019520|NCT00546754|453367001|FG000|Overall Study|Suicide|1|||
126019521|NCT00546754|453367002|FG001|Overall Study|Suicide|0|||
126019522|NCT00546754|453367001|FG000|Overall Study|Missing Cooperation|1|||
126019523|NCT00546754|453367002|FG001|Overall Study|Missing Cooperation|0|||
126019524|NCT00546754|453367001|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
126019525|NCT00546754|453367002|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
126019526|NCT00546754|453367001|FG000|Overall Study|Patient's Decision|0|||
126019527|NCT00546754|453367002|FG001|Overall Study|Patient's Decision|1|||
126019528|NCT00546754|453367001|FG000|Overall Study|Missing|14|||
126019529|NCT00546754|453367002|FG001|Overall Study|Missing|7|||
126019530|NCT03830866|453367005|FG000|Overall Study|Death|90|||
126019531|NCT03830866|453367006|FG001|Overall Study|Death|111|||
126019532|NCT03830866|453367005|FG000|Overall Study|Lost to Follow-up|7|||
126019533|NCT03830866|453367006|FG001|Overall Study|Lost to Follow-up|7|||
126019534|NCT03830866|453367005|FG000|Overall Study|Withdrawal by Subject|19|||
126019535|NCT03830866|453367006|FG001|Overall Study|Withdrawal by Subject|16|||
126019536|NCT03830866|453367005|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
126019537|NCT03830866|453367006|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
126019538|NCT03830866|453367005|FG000|Overall Study|Other|1|||
126019539|NCT03830866|453367006|FG001|Overall Study|Other|1|||
126019540|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
126019541|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
126019542|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
126019543|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
126019544|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
126019545|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
126019546|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
126019547|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
126019548|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
126019549|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
126019550|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
126019551|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
126019552|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
126019553|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
126019554|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
126019555|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
126350333|NCT02112916|454574166|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
126350334|NCT02112916|454574167|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
126350335|NCT04409002|454574168|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
126350336|NCT04835441|454574169|FG000|Overall Study|Physician Decision|4|||
126350337|NCT04835441|454574170|FG001|Overall Study|Physician Decision|4|||
126350338|NCT04835441|454574169|FG000|Overall Study|Other|1|||
126350339|NCT04835441|454574170|FG001|Overall Study|Other|1|||
126019556|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
126019557|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
126019558|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
126223078|NCT02570165|454107796|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
126350340|NCT04835441|454574169|FG000|Overall Study|Lost to Follow-up|0|||
126350341|NCT04835441|454574170|FG001|Overall Study|Lost to Follow-up|1|||
126350342|NCT05032196|454574171|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126019559|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
126019560|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
126019561|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
126019562|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
126019563|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
126019564|NCT00311363|453367007|FG000|24-Week Single-Blind Treatment Period|Death|1|||
126019565|NCT00311363|453367008|FG001|24-Week Single-Blind Treatment Period|Death|0|||
126019566|NCT00311363|453367009|FG002|24-Week Single-Blind Treatment Period|Death|0|||
126019567|NCT00311363|453367007|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
126019568|NCT00311363|453367008|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
126019569|NCT00311363|453367009|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
126019570|NCT00311363|453367007|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
126019571|NCT00311363|453367008|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
126019572|NCT00311363|453367009|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
126019573|NCT00311363|453367007|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
126019574|NCT00311363|453367008|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
126019575|NCT00311363|453367009|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
126019576|NCT00311363|453367007|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
126019577|NCT00311363|453367008|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
126019578|NCT00311363|453367009|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
126019579|NCT00311363|453367007|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
126019580|NCT00311363|453367008|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
126019581|NCT00311363|453367009|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
126019582|NCT00311363|453367007|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
126019583|NCT00311363|453367008|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
126019584|NCT00311363|453367009|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
126019585|NCT01759771|453367012|FG000|Overall Study|Withdrawal by Subject|1|||
126019586|NCT01759771|453367013|FG001|Overall Study|Withdrawal by Subject|1|||
126019587|NCT03942042|453367014|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
126019588|NCT03942042|453367015|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
126019589|NCT03942042|453367014|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
126019590|NCT03942042|453367015|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
126019591|NCT01849055|453367018|FG000|Overall Study|Withdrawal by Subject|0|||
126019592|NCT01849055|453367019|FG001|Overall Study|Withdrawal by Subject|0|||
126019593|NCT01849055|453367020|FG002|Overall Study|Withdrawal by Subject|1|||
126019594|NCT01849055|453367021|FG003|Overall Study|Withdrawal by Subject|0|||
126019595|NCT01849055|453367022|FG004|Overall Study|Withdrawal by Subject|0|||
126019596|NCT01849055|453367023|FG005|Overall Study|Withdrawal by Subject|0|||
126019597|NCT02139943|453367024|FG000|Overall Study|Adverse Event|0|||
126019598|NCT02139943|453367025|FG001|Overall Study|Adverse Event|1|||
126019599|NCT02139943|453367026|FG002|Overall Study|Adverse Event|2|||
126019600|NCT02139943|453367024|FG000|Overall Study|Lost to Follow-up|3|||
126019601|NCT02139943|453367025|FG001|Overall Study|Lost to Follow-up|2|||
126019602|NCT02139943|453367026|FG002|Overall Study|Lost to Follow-up|2|||
126019603|NCT02139943|453367024|FG000|Overall Study|Withdrawal by Subject|4|||
126019604|NCT02139943|453367025|FG001|Overall Study|Withdrawal by Subject|3|||
126019605|NCT02139943|453367026|FG002|Overall Study|Withdrawal by Subject|0|||
126019606|NCT02139943|453367024|FG000|Overall Study|Other|0|||
126019607|NCT02139943|453367025|FG001|Overall Study|Other|0|||
126019608|NCT02139943|453367026|FG002|Overall Study|Other|1|||
126019609|NCT02139943|453367024|FG000|Overall Study|Participant wishes to discontinue|2|||
126019610|NCT02139943|453367025|FG001|Overall Study|Participant wishes to discontinue|0|||
126019611|NCT02139943|453367026|FG002|Overall Study|Participant wishes to discontinue|0|||
126019612|NCT02139943|453367024|FG000|Overall Study|Participant in Poor Compliance|1|||
126019613|NCT02139943|453367025|FG001|Overall Study|Participant in Poor Compliance|0|||
126019614|NCT02139943|453367026|FG002|Overall Study|Participant in Poor Compliance|1|||
126019615|NCT02139943|453367024|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
126019616|NCT02139943|453367025|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
126019617|NCT02139943|453367026|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
126019618|NCT00716859|453367027|FG000|Overall Study|Adverse Event|4|||
126019619|NCT00716859|453367028|FG001|Overall Study|Adverse Event|1|||
126019620|NCT00716859|453367027|FG000|Overall Study|Lack of Efficacy|3|||
126019621|NCT00716859|453367028|FG001|Overall Study|Lack of Efficacy|0|||
126019622|NCT00716859|453367027|FG000|Overall Study|Withdrawal by Subject|1|||
126019623|NCT00716859|453367028|FG001|Overall Study|Withdrawal by Subject|3|||
126019624|NCT00716859|453367027|FG000|Overall Study|Not treated|1|||
126019625|NCT00716859|453367028|FG001|Overall Study|Not treated|1|||
126019626|NCT03750968|453367029|FG000|Overall Study|Adverse Event|2|||
126019627|NCT03750968|453367030|FG001|Overall Study|Adverse Event|0|||
126019628|NCT03750968|453367029|FG000|Overall Study|Lost to Follow-up|1|||
126019629|NCT03750968|453367030|FG001|Overall Study|Lost to Follow-up|3|||
126019630|NCT00411216|453367034|FG000|Overall Study|Ten participants were entered into the c|0|||
126019631|NCT00411216|453367035|FG001|Overall Study|Ten participants were entered into the c|2|||
126019632|NCT02918071|453367036|FG000|Overall Study|Withdrawal by Subject|2|||
126019633|NCT02918071|453367036|FG000|Overall Study|Lost to Follow-up|1|||
126019634|NCT00203411|453367039|FG000|Follow-up|Progressive Disease|4|||
126019635|NCT00632424|453367042|FG000|Overall Study|Disease Progression|17|||
126019636|NCT00632424|453367042|FG000|Overall Study|Study Drug Toxicity|1|||
126019637|NCT02531113|453367043|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
126019638|NCT02531113|453367043|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
126019639|NCT02531113|453367043|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
126019640|NCT02531113|453367043|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
126019641|NCT02531113|453367043|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
126019642|NCT02531113|453367043|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
126019643|NCT02531113|453367043|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
126019644|NCT02531113|453367043|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
126019645|NCT04411056|453368551|FG000|Overall Study|surgery cancelled|1|||
126019646|NCT04411056|453368552|FG001|Overall Study|surgery cancelled|0|||
126019647|NCT04411056|453368551|FG000|Overall Study|Equipment problem during intubation|0|||
126019648|NCT04411056|453368552|FG001|Overall Study|Equipment problem during intubation|1|||
126019649|NCT03122886|453368555|FG000|Overall Study|Withdrawal by Subject|1|||
126019650|NCT03122886|453368556|FG001|Overall Study|Withdrawal by Subject|2|||
126019651|NCT03422276|453368557|FG000|Overall Study|Withdrawal by Subject|21|||
126019652|NCT03422276|453368558|FG001|Overall Study|Withdrawal by Subject|25|||
126019653|NCT03422276|453368559|FG002|Overall Study|Withdrawal by Subject|14|||
126019654|NCT03422276|453368560|FG003|Overall Study|Withdrawal by Subject|16|||
126019655|NCT03422276|453368557|FG000|Overall Study|Death|14|||
126019656|NCT03422276|453368558|FG001|Overall Study|Death|21|||
126019657|NCT03422276|453368559|FG002|Overall Study|Death|3|||
126019658|NCT03422276|453368560|FG003|Overall Study|Death|1|||
126019659|NCT03422276|453368557|FG000|Overall Study|Discontinued, ineligible|4|||
126019660|NCT03422276|453368558|FG001|Overall Study|Discontinued, ineligible|3|||
126019661|NCT03422276|453368559|FG002|Overall Study|Discontinued, ineligible|0|||
126019662|NCT03422276|453368560|FG003|Overall Study|Discontinued, ineligible|0|||
126019663|NCT03422276|453368557|FG000|Overall Study|Lost to Follow-up|15|||
126019664|NCT03422276|453368558|FG001|Overall Study|Lost to Follow-up|8|||
126019665|NCT03422276|453368559|FG002|Overall Study|Lost to Follow-up|13|||
126019666|NCT03422276|453368560|FG003|Overall Study|Lost to Follow-up|4|||
126019667|NCT03422276|453368557|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
126019668|NCT03422276|453368558|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
126019669|NCT03422276|453368559|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
126223079|NCT02570165|454107797|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
126019670|NCT03422276|453368560|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
126019671|NCT03422276|453368557|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
126019672|NCT03422276|453368558|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
126019673|NCT03422276|453368559|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
126019674|NCT03422276|453368560|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
126019675|NCT03422276|453368557|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
126019676|NCT03422276|453368558|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
126019677|NCT03422276|453368559|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
126019678|NCT03422276|453368560|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
126019679|NCT03422276|453368557|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
126019680|NCT03422276|453368558|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
126019681|NCT03422276|453368559|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
126019682|NCT03422276|453368560|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
126223080|NCT02570165|454107798|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
126223081|NCT02570165|454107799|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
126223082|NCT02570165|454107800|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
126223083|NCT02570165|454107801|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
126223084|NCT02570165|454107802|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
126350343|NCT05032196|454574172|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
126350344|NCT05032196|454574173|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126019683|NCT03422276|453368557|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
126019684|NCT03422276|453368558|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
126019685|NCT03422276|453368559|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
126019686|NCT03422276|453368560|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
126019687|NCT05985044|453368561|FG000|Overall Study|Death|6|||
126019688|NCT05985044|453368561|FG000|Overall Study|Lost to Follow-up|4|||
126350345|NCT05032196|454574174|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126350346|NCT05032196|454574175|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126019689|NCT05985044|453368561|FG000|Overall Study|Incapacitation|3|||
126019690|NCT05985044|453368561|FG000|Overall Study|Withdrawal by Subject|2|||
126019691|NCT05644444|453368562|FG000|Tolerance Phase|Adverse Event|0|||
126019692|NCT05644444|453368563|FG001|Tolerance Phase|Adverse Event|2|||
126019693|NCT05644444|453368562|FG000|Treatment Phase|Adverse Event|0|||
126019694|NCT05644444|453368563|FG001|Treatment Phase|Adverse Event|2|||
126019695|NCT04588259|453368564|FG000|Run-in Period|Run-in failure|0|||
126019696|NCT04588259|453368565|FG001|Run-in Period|Run-in failure|23|||
126019697|NCT04588259|453368564|FG000|Run-in Period|Withdrawn before randomisation|0|||
126019698|NCT04588259|453368565|FG001|Run-in Period|Withdrawn before randomisation|8|||
126019699|NCT04588259|453368564|FG000|Treatment Period|Withdrawal by Subject|6|||
126019700|NCT04588259|453368565|FG001|Treatment Period|Withdrawal by Subject|6|||
126019701|NCT03936660|453368566|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
126019702|NCT03936660|453368567|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
126019703|NCT04723394|453368571|FG000|Overall Study|Adverse Event|0|||
126019704|NCT04723394|453368572|FG001|Overall Study|Adverse Event|3|||
126019705|NCT04723394|453368571|FG000|Overall Study|Death|8|||
126019706|NCT04723394|453368572|FG001|Overall Study|Death|8|||
126019707|NCT04723394|453368571|FG000|Overall Study|Lost to Follow-up|20|||
126019708|NCT04723394|453368572|FG001|Overall Study|Lost to Follow-up|17|||
126019709|NCT04723394|453368571|FG000|Overall Study|Physician Decision|1|||
126019710|NCT04723394|453368572|FG001|Overall Study|Physician Decision|0|||
126019711|NCT04723394|453368571|FG000|Overall Study|Withdrawal by Subject|20|||
126019712|NCT04723394|453368572|FG001|Overall Study|Withdrawal by Subject|34|||
126019713|NCT04723394|453368571|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
126019714|NCT04723394|453368572|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
126019715|NCT02765100|453368580|FG000|Overall Study|subject found ineligible after baseline|1|||
126019716|NCT02765100|453368581|FG001|Overall Study|subject found ineligible after baseline|1|||
126019717|NCT02765100|453368580|FG000|Overall Study|Lost to Follow-up|0|||
126019718|NCT02765100|453368581|FG001|Overall Study|Lost to Follow-up|1|||
126019719|NCT02675244|453368582|FG000|Overall Study|Death|9|||
126019720|NCT02675244|453368583|FG001|Overall Study|Death|6|||
126019721|NCT02675244|453368582|FG000|Overall Study|Withdrawal by Subject|3|||
126019722|NCT02675244|453368583|FG001|Overall Study|Withdrawal by Subject|6|||
126019723|NCT02675244|453368582|FG000|Overall Study|Lost to Follow-up|1|||
126019724|NCT02675244|453368583|FG001|Overall Study|Lost to Follow-up|1|||
126019725|NCT02675244|453368582|FG000|Overall Study|Ongoing at 2 Years|190|||
126019726|NCT02675244|453368583|FG001|Overall Study|Ongoing at 2 Years|185|||
126019727|NCT02652442|453368584|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
126019728|NCT00293293|453368587|FG000|Overall Study|Withdrawal by Subject|1|||
126019729|NCT00293293|453368588|FG001|Overall Study|Withdrawal by Subject|1|||
126019730|NCT00293293|453368587|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
126019731|NCT00293293|453368588|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
126019732|NCT00293293|453368587|FG000|Overall Study|Patient discontinued chemotherapy|0|||
126019733|NCT00293293|453368588|FG001|Overall Study|Patient discontinued chemotherapy|1|||
126019734|NCT02988817|453368589|FG000|Overall Study|Withdrawal by Subject|1|||
126019735|NCT02988817|453368590|FG001|Overall Study|Withdrawal by Subject|0|||
126350347|NCT05032196|454574176|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126350348|NCT05032196|454574171|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126350349|NCT05032196|454574172|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126350350|NCT05032196|454574173|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126350351|NCT05032196|454574174|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
126350352|NCT05032196|454574175|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126019736|NCT02988817|453368591|FG002|Overall Study|Withdrawal by Subject|0|||
126019737|NCT02988817|453368592|FG003|Overall Study|Withdrawal by Subject|1|||
126019738|NCT02988817|453368593|FG004|Overall Study|Withdrawal by Subject|3|||
126019739|NCT02988817|453368594|FG005|Overall Study|Withdrawal by Subject|1|||
126019740|NCT02988817|453368595|FG006|Overall Study|Withdrawal by Subject|2|||
126019741|NCT02988817|453368596|FG007|Overall Study|Withdrawal by Subject|1|||
126019742|NCT02988817|453368597|FG008|Overall Study|Withdrawal by Subject|1|||
126019743|NCT02988817|453368598|FG009|Overall Study|Withdrawal by Subject|1|||
126019744|NCT02988817|453368599|FG010|Overall Study|Withdrawal by Subject|1|||
126019745|NCT02988817|453368600|FG011|Overall Study|Withdrawal by Subject|12|||
126019746|NCT02988817|453368601|FG012|Overall Study|Withdrawal by Subject|6|||
126019747|NCT02988817|453368602|FG013|Overall Study|Withdrawal by Subject|6|||
126019748|NCT02988817|453368603|FG014|Overall Study|Withdrawal by Subject|4|||
126019749|NCT02988817|453368604|FG015|Overall Study|Withdrawal by Subject|5|||
126019750|NCT02988817|453368605|FG016|Overall Study|Withdrawal by Subject|4|||
126019751|NCT02988817|453368606|FG017|Overall Study|Withdrawal by Subject|11|||
126019752|NCT02988817|453368607|FG018|Overall Study|Withdrawal by Subject|4|||
126019753|NCT02988817|453368608|FG019|Overall Study|Withdrawal by Subject|2|||
126019754|NCT02988817|453368589|FG000|Overall Study|Death|0|||
126350353|NCT05032196|454574176|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126350354|NCT05032196|454574171|FG000|Period 2 (Multidose)|Physician Decision|0|||
126019755|NCT02988817|453368590|FG001|Overall Study|Death|1|||
126019756|NCT02988817|453368591|FG002|Overall Study|Death|3|||
126019757|NCT02988817|453368592|FG003|Overall Study|Death|1|||
126019758|NCT02988817|453368593|FG004|Overall Study|Death|6|||
126019759|NCT02988817|453368594|FG005|Overall Study|Death|10|||
126019760|NCT02988817|453368595|FG006|Overall Study|Death|1|||
126019761|NCT02988817|453368596|FG007|Overall Study|Death|2|||
126019762|NCT02988817|453368597|FG008|Overall Study|Death|1|||
126019763|NCT02988817|453368598|FG009|Overall Study|Death|5|||
126019764|NCT02988817|453368599|FG010|Overall Study|Death|1|||
126019765|NCT02988817|453368600|FG011|Overall Study|Death|8|||
126223085|NCT02570165|454107796|FG000|Overall Study|Lost to Follow-up|0|||
126223086|NCT02570165|454107797|FG001|Overall Study|Lost to Follow-up|0|||
126223087|NCT02570165|454107798|FG002|Overall Study|Lost to Follow-up|1|||
126223088|NCT02570165|454107799|FG003|Overall Study|Lost to Follow-up|1|||
126223089|NCT02570165|454107800|FG004|Overall Study|Lost to Follow-up|0|||
126223090|NCT02570165|454107801|FG005|Overall Study|Lost to Follow-up|0|||
126223091|NCT02570165|454107802|FG006|Overall Study|Lost to Follow-up|0|||
126223092|NCT02570165|454107796|FG000|Overall Study|Physician Decision|0|||
126223093|NCT02570165|454107797|FG001|Overall Study|Physician Decision|1|||
126223094|NCT02570165|454107798|FG002|Overall Study|Physician Decision|0|||
126223095|NCT02570165|454107799|FG003|Overall Study|Physician Decision|0|||
126223096|NCT02570165|454107800|FG004|Overall Study|Physician Decision|0|||
126223097|NCT02570165|454107801|FG005|Overall Study|Physician Decision|0|||
126223098|NCT02570165|454107802|FG006|Overall Study|Physician Decision|0|||
126223099|NCT02570165|454107796|FG000|Overall Study|Withdrawal by Subject|0|||
126223100|NCT02570165|454107797|FG001|Overall Study|Withdrawal by Subject|0|||
126223101|NCT02570165|454107798|FG002|Overall Study|Withdrawal by Subject|0|||
126223102|NCT02570165|454107799|FG003|Overall Study|Withdrawal by Subject|2|||
126223103|NCT02570165|454107800|FG004|Overall Study|Withdrawal by Subject|1|||
126223104|NCT02570165|454107801|FG005|Overall Study|Withdrawal by Subject|0|||
126223105|NCT02570165|454107802|FG006|Overall Study|Withdrawal by Subject|0|||
126223106|NCT02570165|454107796|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
126223107|NCT02570165|454107797|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
126223108|NCT02570165|454107798|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
126019766|NCT02988817|453368601|FG012|Overall Study|Death|9|||
126019767|NCT02988817|453368602|FG013|Overall Study|Death|17|||
126019768|NCT02988817|453368603|FG014|Overall Study|Death|18|||
126019769|NCT02988817|453368604|FG015|Overall Study|Death|30|||
126019770|NCT02988817|453368605|FG016|Overall Study|Death|17|||
126019771|NCT02988817|453368606|FG017|Overall Study|Death|38|||
126019772|NCT02988817|453368607|FG018|Overall Study|Death|14|||
126019773|NCT02988817|453368608|FG019|Overall Study|Death|16|||
126019774|NCT02988817|453368589|FG000|Overall Study|Other|0|||
126019775|NCT02988817|453368590|FG001|Overall Study|Other|0|||
126019776|NCT02988817|453368591|FG002|Overall Study|Other|0|||
126019777|NCT02988817|453368592|FG003|Overall Study|Other|1|||
126019778|NCT02988817|453368593|FG004|Overall Study|Other|1|||
126019779|NCT02988817|453368594|FG005|Overall Study|Other|0|||
126019780|NCT02988817|453368595|FG006|Overall Study|Other|0|||
126019781|NCT02988817|453368596|FG007|Overall Study|Other|0|||
126019782|NCT02988817|453368597|FG008|Overall Study|Other|0|||
126019783|NCT02988817|453368598|FG009|Overall Study|Other|0|||
126019784|NCT02988817|453368599|FG010|Overall Study|Other|0|||
126019785|NCT02988817|453368600|FG011|Overall Study|Other|0|||
126019786|NCT02988817|453368601|FG012|Overall Study|Other|0|||
126019787|NCT02988817|453368602|FG013|Overall Study|Other|0|||
126019788|NCT02988817|453368603|FG014|Overall Study|Other|0|||
126019789|NCT02988817|453368604|FG015|Overall Study|Other|1|||
126019790|NCT02988817|453368605|FG016|Overall Study|Other|0|||
126019791|NCT02988817|453368606|FG017|Overall Study|Other|0|||
126019792|NCT02988817|453368607|FG018|Overall Study|Other|0|||
126019793|NCT02988817|453368608|FG019|Overall Study|Other|0|||
126223109|NCT02570165|454107799|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
126019794|NCT02988817|453368589|FG000|Overall Study|Lost to Follow-up|0|||
126019795|NCT02988817|453368590|FG001|Overall Study|Lost to Follow-up|0|||
126019796|NCT02988817|453368591|FG002|Overall Study|Lost to Follow-up|0|||
126019797|NCT02988817|453368592|FG003|Overall Study|Lost to Follow-up|0|||
126019798|NCT02988817|453368593|FG004|Overall Study|Lost to Follow-up|0|||
126223110|NCT02570165|454107800|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
126223111|NCT02570165|454107801|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
126223112|NCT02570165|454107802|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
126223113|NCT02570165|454107796|FG000|Overall Study|Withdrawal Request by GSK|0|||
126223114|NCT02570165|454107797|FG001|Overall Study|Withdrawal Request by GSK|0|||
126223115|NCT02570165|454107798|FG002|Overall Study|Withdrawal Request by GSK|2|||
126019799|NCT02988817|453368594|FG005|Overall Study|Lost to Follow-up|0|||
126019800|NCT02988817|453368595|FG006|Overall Study|Lost to Follow-up|0|||
126019801|NCT02988817|453368596|FG007|Overall Study|Lost to Follow-up|0|||
126019802|NCT02988817|453368597|FG008|Overall Study|Lost to Follow-up|1|||
126019803|NCT02988817|453368598|FG009|Overall Study|Lost to Follow-up|0|||
126019804|NCT02988817|453368599|FG010|Overall Study|Lost to Follow-up|1|||
126019805|NCT02988817|453368600|FG011|Overall Study|Lost to Follow-up|1|||
126223116|NCT02570165|454107799|FG003|Overall Study|Withdrawal Request by GSK|0|||
126223117|NCT02570165|454107800|FG004|Overall Study|Withdrawal Request by GSK|0|||
126223118|NCT02570165|454107801|FG005|Overall Study|Withdrawal Request by GSK|0|||
126223119|NCT02570165|454107802|FG006|Overall Study|Withdrawal Request by GSK|0|||
126223120|NCT02862535|454107811|FG000|Overall Study|Death|7|||
126223121|NCT02862535|454107812|FG001|Overall Study|Death|3|||
126223122|NCT02862535|454107813|FG002|Overall Study|Death|2|||
126223123|NCT02862535|454107814|FG003|Overall Study|Death|5|||
126223124|NCT02862535|454107811|FG000|Overall Study|Study Terminated by Sponsor|1|||
126223125|NCT02862535|454107812|FG001|Overall Study|Study Terminated by Sponsor|3|||
126223126|NCT02862535|454107813|FG002|Overall Study|Study Terminated by Sponsor|8|||
126223127|NCT02862535|454107814|FG003|Overall Study|Study Terminated by Sponsor|5|||
126223128|NCT02862535|454107811|FG000|Overall Study|Enrolled, not Treated|1|||
126223129|NCT02862535|454107812|FG001|Overall Study|Enrolled, not Treated|0|||
126223130|NCT02862535|454107813|FG002|Overall Study|Enrolled, not Treated|0|||
126223131|NCT02862535|454107814|FG003|Overall Study|Enrolled, not Treated|1|||
126223132|NCT04304950|454107817|FG000|Overall Study|Lost to Follow-up|1|||
126223133|NCT04304950|454107818|FG001|Overall Study|Lost to Follow-up|1|||
126223134|NCT05478603|454107819|FG000|Overall Study|Withdrawal by Subject|0|||
126223135|NCT05478603|454107820|FG001|Overall Study|Withdrawal by Subject|1|||
126223136|NCT05478603|454107821|FG002|Overall Study|Withdrawal by Subject|0|||
126223137|NCT05478603|454107822|FG003|Overall Study|Withdrawal by Subject|0|||
126223138|NCT02418910|454107823|FG000|Overall Study|Lost to Follow-up|3|||
126223139|NCT02418910|454107823|FG000|Overall Study|Withdrawal by Subject|4|||
126223140|NCT03634488|454107825|FG000|Overall Study|Death|1|||
126223141|NCT03634488|454107826|FG001|Overall Study|Death|0|||
126223142|NCT03634488|454107827|FG002|Overall Study|Death|0|||
126223143|NCT03634488|454107825|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
126223144|NCT03634488|454107826|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
126223145|NCT03634488|454107827|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
126223146|NCT03182686|454107828|FG000|Overall Study|Lost to Follow-up|2|||
126223147|NCT03182686|454107829|FG001|Overall Study|Lost to Follow-up|0|||
126223148|NCT03182686|454107828|FG000|Overall Study|Adverse Event|2|||
126223149|NCT03182686|454107829|FG001|Overall Study|Adverse Event|0|||
126223150|NCT03182686|454107828|FG000|Overall Study|Withdrawal by Subject|3|||
126223151|NCT03182686|454107829|FG001|Overall Study|Withdrawal by Subject|0|||
126223152|NCT01154127|454107830|FG000|Period 1 (21 Days)|Adverse Event|3|||
126223153|NCT01154127|454107831|FG001|Period 1 (21 Days)|Adverse Event|4|||
126223154|NCT01154127|454107830|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
126223155|NCT01154127|454107831|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
126223156|NCT01154127|454107830|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
126223157|NCT01154127|454107831|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
126223158|NCT01154127|454107830|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
126223159|NCT01154127|454107831|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
126223160|NCT01154127|454107830|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
126019806|NCT02988817|453368601|FG012|Overall Study|Lost to Follow-up|0|||
126019807|NCT02988817|453368602|FG013|Overall Study|Lost to Follow-up|0|||
126019808|NCT02988817|453368603|FG014|Overall Study|Lost to Follow-up|1|||
126223161|NCT01154127|454107831|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
126223162|NCT02390219|454107832|FG000|Overall Study|Death|1|||
126223163|NCT02390219|454107832|FG000|Overall Study|Physician Decision|1|||
126223164|NCT02390219|454107832|FG000|Overall Study|Adverse Event|6|||
126223165|NCT02390219|454107832|FG000|Overall Study|Withdrawal by Subject|1|||
126223166|NCT02390219|454107832|FG000|Overall Study|Lost to Follow-up|2|||
126223167|NCT02390219|454107832|FG000|Overall Study|Other|2|||
126223168|NCT01169844|454107833|FG000|Overall Study|Adverse Event|0|||
126019809|NCT02988817|453368604|FG015|Overall Study|Lost to Follow-up|1|||
126223169|NCT01169844|454107834|FG001|Overall Study|Adverse Event|1|||
126223170|NCT01169844|454107833|FG000|Overall Study|Patient withdrew consent|4|||
126223171|NCT01169844|454107834|FG001|Overall Study|Patient withdrew consent|0|||
126223172|NCT01169844|454107833|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126223173|NCT01169844|454107834|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126223174|NCT05037409|454107835|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
126223175|NCT05037409|454107836|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
126223176|NCT05037409|454107837|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
126223177|NCT00529568|454107838|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
126223178|NCT00529568|454107839|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
126223179|NCT00529568|454107840|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
126223180|NCT00529568|454107838|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
126223181|NCT00529568|454107839|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
126223182|NCT00529568|454107840|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
126223183|NCT00529568|454107838|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
126223184|NCT00529568|454107839|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
126223185|NCT00529568|454107840|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
126223186|NCT00529568|454107838|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
126223187|NCT00529568|454107839|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
126223188|NCT00529568|454107840|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
126223189|NCT00529568|454107838|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
126223190|NCT00529568|454107839|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
126223191|NCT00529568|454107840|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
126223192|NCT00529568|454107838|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
126223193|NCT00529568|454107839|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
126223194|NCT00529568|454107840|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
126223195|NCT00529568|454107838|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
126223196|NCT00529568|454107839|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
126223197|NCT00529568|454107840|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
126223198|NCT00529568|454107838|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
126223199|NCT00529568|454107839|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
126019810|NCT02988817|453368605|FG016|Overall Study|Lost to Follow-up|2|||
126019811|NCT02988817|453368606|FG017|Overall Study|Lost to Follow-up|3|||
126019812|NCT02988817|453368607|FG018|Overall Study|Lost to Follow-up|0|||
126019813|NCT02988817|453368608|FG019|Overall Study|Lost to Follow-up|0|||
126019814|NCT02988817|453368589|FG000|Overall Study|Sponsor decision|0|||
126019815|NCT02988817|453368590|FG001|Overall Study|Sponsor decision|0|||
126019816|NCT02988817|453368591|FG002|Overall Study|Sponsor decision|0|||
126019817|NCT02988817|453368592|FG003|Overall Study|Sponsor decision|0|||
126019818|NCT02988817|453368593|FG004|Overall Study|Sponsor decision|0|||
126019819|NCT02988817|453368594|FG005|Overall Study|Sponsor decision|0|||
126019820|NCT02988817|453368595|FG006|Overall Study|Sponsor decision|0|||
126019821|NCT02988817|453368596|FG007|Overall Study|Sponsor decision|0|||
126019822|NCT02988817|453368597|FG008|Overall Study|Sponsor decision|0|||
126019823|NCT02988817|453368598|FG009|Overall Study|Sponsor decision|0|||
126019824|NCT02988817|453368599|FG010|Overall Study|Sponsor decision|0|||
126019825|NCT02988817|453368600|FG011|Overall Study|Sponsor decision|1|||
126019826|NCT02988817|453368601|FG012|Overall Study|Sponsor decision|1|||
126019827|NCT02988817|453368602|FG013|Overall Study|Sponsor decision|2|||
126019828|NCT02988817|453368603|FG014|Overall Study|Sponsor decision|2|||
126019829|NCT02988817|453368604|FG015|Overall Study|Sponsor decision|6|||
126019830|NCT02988817|453368605|FG016|Overall Study|Sponsor decision|2|||
126019831|NCT02988817|453368606|FG017|Overall Study|Sponsor decision|3|||
126019832|NCT02988817|453368607|FG018|Overall Study|Sponsor decision|2|||
126019833|NCT02988817|453368608|FG019|Overall Study|Sponsor decision|7|||
126019834|NCT02988817|453368589|FG000|Overall Study|Physician Decision|0|||
126019835|NCT02988817|453368590|FG001|Overall Study|Physician Decision|0|||
126019836|NCT02988817|453368591|FG002|Overall Study|Physician Decision|0|||
126019837|NCT02988817|453368592|FG003|Overall Study|Physician Decision|0|||
126019838|NCT02988817|453368593|FG004|Overall Study|Physician Decision|0|||
126223200|NCT00529568|454107840|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
126350355|NCT05032196|454574172|FG001|Period 2 (Multidose)|Physician Decision|0|||
126350356|NCT05032196|454574173|FG002|Period 2 (Multidose)|Physician Decision|0|||
126350357|NCT05032196|454574174|FG003|Period 2 (Multidose)|Physician Decision|0|||
126350358|NCT05032196|454574175|FG004|Period 2 (Multidose)|Physician Decision|1|||
126350359|NCT05032196|454574176|FG005|Period 2 (Multidose)|Physician Decision|0|||
126350360|NCT05260008|454574177|FG000|Overall Study|Physician Decision|0|||
126019839|NCT02988817|453368594|FG005|Overall Study|Physician Decision|0|||
126019840|NCT02988817|453368595|FG006|Overall Study|Physician Decision|0|||
126019841|NCT02988817|453368596|FG007|Overall Study|Physician Decision|0|||
126019842|NCT02988817|453368597|FG008|Overall Study|Physician Decision|0|||
126019843|NCT02988817|453368598|FG009|Overall Study|Physician Decision|0|||
126223201|NCT00529568|454107838|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
126223202|NCT00529568|454107839|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
126223203|NCT00529568|454107840|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
126223204|NCT00529568|454107838|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
126223205|NCT00529568|454107839|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
126223206|NCT00529568|454107840|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
126223207|NCT00529568|454107838|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
126223208|NCT00529568|454107839|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
126223209|NCT00529568|454107840|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
126223210|NCT00931385|454107841|FG000|Overall Study|Adverse Event|2|||
126223211|NCT00931385|454107842|FG001|Overall Study|Adverse Event|1|||
126223212|NCT00931385|454107843|FG002|Overall Study|Adverse Event|0|||
126223213|NCT00931385|454107844|FG003|Overall Study|Adverse Event|3|||
126223214|NCT00931385|454107841|FG000|Overall Study|Protocol Violation|0|||
126223215|NCT00931385|454107842|FG001|Overall Study|Protocol Violation|0|||
126223216|NCT00931385|454107843|FG002|Overall Study|Protocol Violation|1|||
126223217|NCT00931385|454107844|FG003|Overall Study|Protocol Violation|0|||
126223218|NCT00931385|454107841|FG000|Overall Study|Withdrawal by Subject|0|||
126223219|NCT00931385|454107842|FG001|Overall Study|Withdrawal by Subject|1|||
126223220|NCT00931385|454107843|FG002|Overall Study|Withdrawal by Subject|0|||
126223221|NCT00931385|454107844|FG003|Overall Study|Withdrawal by Subject|1|||
126223222|NCT00931385|454107841|FG000|Overall Study|Lost to Follow-up|0|||
126223223|NCT00931385|454107842|FG001|Overall Study|Lost to Follow-up|0|||
126223224|NCT00931385|454107843|FG002|Overall Study|Lost to Follow-up|0|||
126223225|NCT00931385|454107844|FG003|Overall Study|Lost to Follow-up|1|||
126223226|NCT01201356|454107845|FG000|Overall Study|Adverse Event|170|||
126223227|NCT01201356|454107845|FG000|Overall Study|Abnormal laboratory value(s)|51|||
126223228|NCT01201356|454107845|FG000|Overall Study|Abnormal test procedure result(s)|3|||
126223229|NCT01201356|454107845|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
126223230|NCT01201356|454107845|FG000|Overall Study|Condition no longer requires study drug|12|||
126223231|NCT01201356|454107845|FG000|Overall Study|Withdrawal by Subject|144|||
126223232|NCT01201356|454107845|FG000|Overall Study|Lost to Follow-up|50|||
126223233|NCT01201356|454107845|FG000|Overall Study|administrative problems|74|||
126223234|NCT01201356|454107845|FG000|Overall Study|Death|16|||
126223235|NCT01201356|454107845|FG000|Overall Study|Protocol Violation|12|||
126223236|NCT00738920|454107847|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
126223237|NCT00738920|454107848|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
126223238|NCT00738920|454107849|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
126223239|NCT00738920|454107847|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
126223240|NCT00738920|454107848|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
126223241|NCT00738920|454107849|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
126223242|NCT00738920|454107847|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
126223243|NCT00738920|454107848|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
126223244|NCT00738920|454107849|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
126223245|NCT00738920|454107847|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
126223246|NCT00738920|454107848|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
126223247|NCT00738920|454107849|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
126223248|NCT00738920|454107847|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
126223249|NCT00738920|454107848|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
126223250|NCT00738920|454107849|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
126223251|NCT00738920|454107847|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
126223252|NCT00738920|454107848|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
126223253|NCT00738920|454107849|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
126223254|NCT00738920|454107847|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
126223255|NCT00738920|454107848|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
126223256|NCT00738920|454107849|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
126223257|NCT00738920|454107847|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
126223258|NCT00738920|454107848|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
126223259|NCT00738920|454107849|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
126223260|NCT00738920|454107847|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
126223261|NCT00738920|454107848|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
126223262|NCT00738920|454107849|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
126223263|NCT00738920|454107847|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
126223264|NCT00738920|454107848|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
126223265|NCT00738920|454107849|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
126223266|NCT01025193|454107851|FG000|Overall Study|Protocol Violation|1|||
126223267|NCT01025193|454107851|FG000|Overall Study|Adverse Event|3|||
126223268|NCT04079842|454107852|FG000|Overall Study|Request of subject|2|||
126223269|NCT04079842|454107852|FG000|Overall Study|Unable to draw Arterial samples|1|||
126223270|NCT02904200|454107853|FG000|Overall Study|Withdrawal by Subject|1|||
126223271|NCT02904200|454107854|FG001|Overall Study|Withdrawal by Subject|0|||
126223272|NCT04444752|454107855|FG000|Overall Study|Adverse Event|1|||
126223273|NCT04444752|454107856|FG001|Overall Study|Adverse Event|0|||
126223274|NCT04444752|454107857|FG002|Overall Study|Adverse Event|0|||
126223275|NCT04444752|454107858|FG003|Overall Study|Adverse Event|2|||
126223276|NCT04444752|454107855|FG000|Overall Study|Lost to Follow-up|2|||
126223277|NCT04444752|454107856|FG001|Overall Study|Lost to Follow-up|6|||
126223278|NCT04444752|454107857|FG002|Overall Study|Lost to Follow-up|2|||
126223279|NCT04444752|454107858|FG003|Overall Study|Lost to Follow-up|5|||
126223280|NCT04444752|454107855|FG000|Overall Study|Physician Decision|0|||
126223281|NCT04444752|454107856|FG001|Overall Study|Physician Decision|0|||
126223282|NCT04444752|454107857|FG002|Overall Study|Physician Decision|0|||
126223283|NCT04444752|454107858|FG003|Overall Study|Physician Decision|2|||
126223284|NCT04444752|454107855|FG000|Overall Study|Pregnancy|0|||
126223285|NCT04444752|454107856|FG001|Overall Study|Pregnancy|0|||
126223286|NCT04444752|454107857|FG002|Overall Study|Pregnancy|0|||
126223287|NCT04444752|454107858|FG003|Overall Study|Pregnancy|1|||
126223288|NCT04444752|454107855|FG000|Overall Study|Withdrawal by Subject|6|||
126223289|NCT04444752|454107856|FG001|Overall Study|Withdrawal by Subject|5|||
126223290|NCT04444752|454107857|FG002|Overall Study|Withdrawal by Subject|3|||
126223291|NCT04444752|454107858|FG003|Overall Study|Withdrawal by Subject|4|||
126223292|NCT04444752|454107855|FG000|Overall Study|Protocol Violation|1|||
126223293|NCT04444752|454107856|FG001|Overall Study|Protocol Violation|1|||
126223294|NCT04444752|454107857|FG002|Overall Study|Protocol Violation|0|||
126223295|NCT04444752|454107858|FG003|Overall Study|Protocol Violation|0|||
126223296|NCT04444752|454107855|FG000|Overall Study|Patient moving out of town|1|||
126223297|NCT04444752|454107856|FG001|Overall Study|Patient moving out of town|0|||
126223298|NCT04444752|454107857|FG002|Overall Study|Patient moving out of town|0|||
126223299|NCT04444752|454107858|FG003|Overall Study|Patient moving out of town|1|||
126223300|NCT04444752|454107855|FG000|Overall Study|Lack of Efficacy|0|||
126223301|NCT04444752|454107856|FG001|Overall Study|Lack of Efficacy|0|||
126223302|NCT04444752|454107857|FG002|Overall Study|Lack of Efficacy|0|||
126223303|NCT04444752|454107858|FG003|Overall Study|Lack of Efficacy|1|||
126223304|NCT04444752|454107855|FG000|Overall Study|Death|0|||
126223305|NCT04444752|454107856|FG001|Overall Study|Death|0|||
126223306|NCT04444752|454107857|FG002|Overall Study|Death|1|||
126223307|NCT04444752|454107858|FG003|Overall Study|Death|0|||
126223308|NCT00185211|454107859|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
126223309|NCT00185211|454107860|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
126223310|NCT00185211|454107859|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
126223311|NCT00185211|454107860|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
126223312|NCT00185211|454107859|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
126223313|NCT00185211|454107860|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
126223314|NCT00185211|454107859|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
126223315|NCT00185211|454107860|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
126223316|NCT00185211|454107859|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
126223317|NCT00185211|454107860|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
126223318|NCT00185211|454107859|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
126223319|NCT00185211|454107860|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
126223320|NCT00185211|454107859|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
126223321|NCT00185211|454107860|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
126223322|NCT00185211|454107859|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
126223323|NCT00185211|454107860|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
126223324|NCT00185211|454107859|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
126223325|NCT00185211|454107860|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
126223326|NCT00185211|454107859|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
126223327|NCT00185211|454107860|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
126223328|NCT00185211|454107859|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
126223329|NCT00185211|454107860|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
126223330|NCT00185211|454107859|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
126019844|NCT02988817|453368599|FG010|Overall Study|Physician Decision|0|||
126019845|NCT02988817|453368600|FG011|Overall Study|Physician Decision|0|||
126223331|NCT00185211|454107860|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
126223332|NCT02266706|454109660|FG000|Overall Study|Withdrawal by Subject|0|||
126223333|NCT02266706|454109661|FG001|Overall Study|Withdrawal by Subject|1|||
126350361|NCT05260008|454574178|FG001|Overall Study|Physician Decision|1|||
126350362|NCT05260008|454574179|FG002|Overall Study|Physician Decision|0|||
126350363|NCT05260008|454574180|FG003|Overall Study|Physician Decision|0|||
126350364|NCT05696847|454575316|FG000|Overall Study|Withdrawal by Subject|1|||
126350365|NCT05696847|454575317|FG001|Overall Study|Withdrawal by Subject|0|||
126019846|NCT02988817|453368601|FG012|Overall Study|Physician Decision|0|||
126019847|NCT02988817|453368602|FG013|Overall Study|Physician Decision|0|||
126019848|NCT02988817|453368603|FG014|Overall Study|Physician Decision|0|||
126019849|NCT02988817|453368604|FG015|Overall Study|Physician Decision|1|||
126223334|NCT02266706|454109662|FG002|Overall Study|Withdrawal by Subject|1|||
126223335|NCT02266706|454109663|FG003|Overall Study|Withdrawal by Subject|0|||
126223336|NCT02266706|454109664|FG004|Overall Study|Withdrawal by Subject|0|||
126223337|NCT02266706|454109665|FG005|Overall Study|Withdrawal by Subject|1|||
126223338|NCT02266706|454109666|FG006|Overall Study|Withdrawal by Subject|0|||
126223339|NCT02266706|454109667|FG007|Overall Study|Withdrawal by Subject|0|||
126223340|NCT02266706|454109668|FG008|Overall Study|Withdrawal by Subject|0|||
126223341|NCT02266706|454109660|FG000|Overall Study|Screen failure|0|||
126223342|NCT02266706|454109661|FG001|Overall Study|Screen failure|0|||
126223343|NCT02266706|454109662|FG002|Overall Study|Screen failure|0|||
126223344|NCT02266706|454109663|FG003|Overall Study|Screen failure|0|||
126223345|NCT02266706|454109664|FG004|Overall Study|Screen failure|0|||
126223346|NCT02266706|454109665|FG005|Overall Study|Screen failure|1|||
126223347|NCT02266706|454109666|FG006|Overall Study|Screen failure|1|||
126223348|NCT02266706|454109667|FG007|Overall Study|Screen failure|0|||
126223349|NCT02266706|454109668|FG008|Overall Study|Screen failure|0|||
126223350|NCT02266706|454109660|FG000|Overall Study|Enrollment in another study|0|||
126223351|NCT02266706|454109661|FG001|Overall Study|Enrollment in another study|0|||
126223352|NCT02266706|454109662|FG002|Overall Study|Enrollment in another study|0|||
126223353|NCT02266706|454109663|FG003|Overall Study|Enrollment in another study|1|||
126223354|NCT02266706|454109664|FG004|Overall Study|Enrollment in another study|0|||
126223355|NCT02266706|454109665|FG005|Overall Study|Enrollment in another study|0|||
126223356|NCT02266706|454109666|FG006|Overall Study|Enrollment in another study|0|||
126223357|NCT02266706|454109667|FG007|Overall Study|Enrollment in another study|0|||
126223358|NCT02266706|454109668|FG008|Overall Study|Enrollment in another study|0|||
126223359|NCT02544633|454109669|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
126223360|NCT02544633|454109670|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
126223361|NCT02544633|454109671|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
126223362|NCT02544633|454109672|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
126223363|NCT02544633|454109669|FG000|Treatment Period|Adverse Event|7|||
126223364|NCT02544633|454109670|FG001|Treatment Period|Adverse Event|4|||
126223365|NCT02544633|454109671|FG002|Treatment Period|Adverse Event|0|||
126223366|NCT02544633|454109672|FG003|Treatment Period|Adverse Event|5|||
126223367|NCT02544633|454109669|FG000|Treatment Period|Lack of Efficacy|17|||
126223368|NCT02544633|454109670|FG001|Treatment Period|Lack of Efficacy|11|||
126223369|NCT02544633|454109671|FG002|Treatment Period|Lack of Efficacy|5|||
126223370|NCT02544633|454109672|FG003|Treatment Period|Lack of Efficacy|5|||
126223371|NCT02544633|454109669|FG000|Treatment Period|Global Deterioration of Health|3|||
126223372|NCT02544633|454109670|FG001|Treatment Period|Global Deterioration of Health|3|||
126223373|NCT02544633|454109671|FG002|Treatment Period|Global Deterioration of Health|0|||
126223374|NCT02544633|454109672|FG003|Treatment Period|Global Deterioration of Health|1|||
126223375|NCT02544633|454109669|FG000|Treatment Period|Withdrawal by Subject|1|||
126223376|NCT02544633|454109670|FG001|Treatment Period|Withdrawal by Subject|0|||
126223377|NCT02544633|454109671|FG002|Treatment Period|Withdrawal by Subject|0|||
126223378|NCT02544633|454109672|FG003|Treatment Period|Withdrawal by Subject|0|||
126223379|NCT02544633|454109669|FG000|Treatment Period|Lost to Follow-up|0|||
126223380|NCT02544633|454109670|FG001|Treatment Period|Lost to Follow-up|1|||
126223381|NCT02544633|454109671|FG002|Treatment Period|Lost to Follow-up|0|||
126223382|NCT02544633|454109672|FG003|Treatment Period|Lost to Follow-up|0|||
126223383|NCT02544633|454109669|FG000|Treatment Period|Death|0|||
126223384|NCT02544633|454109670|FG001|Treatment Period|Death|0|||
126223385|NCT02544633|454109671|FG002|Treatment Period|Death|1|||
126223386|NCT02544633|454109672|FG003|Treatment Period|Death|0|||
126223387|NCT02544633|454109669|FG000|Treatment Period|Non-compliance|0|||
126223388|NCT02544633|454109670|FG001|Treatment Period|Non-compliance|0|||
126223389|NCT02544633|454109671|FG002|Treatment Period|Non-compliance|1|||
126223390|NCT02544633|454109672|FG003|Treatment Period|Non-compliance|0|||
126223391|NCT02544633|454109669|FG000|Treatment Period|Clinical Disease Progression|0|||
126223392|NCT02544633|454109670|FG001|Treatment Period|Clinical Disease Progression|0|||
126223393|NCT02544633|454109671|FG002|Treatment Period|Clinical Disease Progression|0|||
126223394|NCT02544633|454109672|FG003|Treatment Period|Clinical Disease Progression|1|||
126223395|NCT02544633|454109669|FG000|Survival Follow-up Period|Death|12|||
126223396|NCT02544633|454109670|FG001|Survival Follow-up Period|Death|14|||
126223397|NCT02544633|454109671|FG002|Survival Follow-up Period|Death|3|||
126223398|NCT02544633|454109672|FG003|Survival Follow-up Period|Death|9|||
126223399|NCT02544633|454109669|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
126223400|NCT02544633|454109670|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
126223401|NCT02544633|454109671|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
126223402|NCT02544633|454109672|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
126223403|NCT02544633|454109669|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
126223404|NCT02544633|454109670|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
126223405|NCT02544633|454109671|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
126223406|NCT02544633|454109672|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
126223407|NCT02544633|454109669|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
126223408|NCT02544633|454109670|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
126223409|NCT02544633|454109671|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
126223410|NCT02544633|454109672|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
126223411|NCT01977352|454109673|FG000|Overall Study|Lost to Follow-up|1|||
126223412|NCT01977352|454109674|FG001|Overall Study|Lost to Follow-up|2|||
126223413|NCT02257632|454109678|FG000|Overall Study|Withdrawal by Subject|0|||
126223414|NCT02257632|454109679|FG001|Overall Study|Withdrawal by Subject|1|||
126223415|NCT02257632|454109678|FG000|Overall Study|Adverse Event|1|||
126223416|NCT02257632|454109679|FG001|Overall Study|Adverse Event|2|||
126223417|NCT00331630|454109680|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
126223418|NCT00331630|454109680|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
126223419|NCT00331630|454109680|FG000|Follow up for 5 Years|Death|5|||
126223420|NCT00331630|454109680|FG000|Follow up for 5 Years|Data collection was stopped|24|||
126223421|NCT01059071|454109681|FG000|Overall Study|Lack of Efficacy|1|||
126223422|NCT01059071|454109682|FG001|Overall Study|Lack of Efficacy|4|||
126223423|NCT01059071|454109683|FG002|Overall Study|Lack of Efficacy|2|||
126223424|NCT01059071|454109684|FG003|Overall Study|Lack of Efficacy|3|||
126223425|NCT01059071|454109681|FG000|Overall Study|Withdrawal by Subject|1|||
126223426|NCT01059071|454109682|FG001|Overall Study|Withdrawal by Subject|0|||
126223427|NCT01059071|454109683|FG002|Overall Study|Withdrawal by Subject|0|||
126223428|NCT01059071|454109684|FG003|Overall Study|Withdrawal by Subject|2|||
126223429|NCT01059071|454109681|FG000|Overall Study|Physician Decision|0|||
126223430|NCT01059071|454109682|FG001|Overall Study|Physician Decision|0|||
126223431|NCT01059071|454109683|FG002|Overall Study|Physician Decision|0|||
126223432|NCT01059071|454109684|FG003|Overall Study|Physician Decision|1|||
126223433|NCT03763331|454109685|FG000|Overall Study|Lost to Follow-up|1|||
126223434|NCT03763331|454109686|FG001|Overall Study|Lost to Follow-up|0|||
126223435|NCT03763331|454109685|FG000|Overall Study|Withdrawal by Subject|1|||
126223436|NCT03763331|454109686|FG001|Overall Study|Withdrawal by Subject|0|||
126223437|NCT03763331|454109685|FG000|Overall Study|Non-compliance|0|||
126223438|NCT03763331|454109686|FG001|Overall Study|Non-compliance|3|||
126223439|NCT00936884|454109687|FG000|Double-blind|Withdrawal by Subject|6|||
126223440|NCT00936884|454109688|FG001|Double-blind|Withdrawal by Subject|4|||
126223441|NCT00936884|454109689|FG002|Double-blind|Withdrawal by Subject|0|||
126223442|NCT00936884|454109687|FG000|Double-blind|Death|2|||
126223443|NCT00936884|454109688|FG001|Double-blind|Death|1|||
126223444|NCT00936884|454109689|FG002|Double-blind|Death|0|||
126223445|NCT00936884|454109687|FG000|Double-blind|Lack of Efficacy|1|||
126223446|NCT00936884|454109688|FG001|Double-blind|Lack of Efficacy|1|||
126223447|NCT00936884|454109689|FG002|Double-blind|Lack of Efficacy|0|||
126223448|NCT00936884|454109687|FG000|Double-blind|Adverse Event|1|||
126223449|NCT00936884|454109688|FG001|Double-blind|Adverse Event|0|||
126223450|NCT00936884|454109689|FG002|Double-blind|Adverse Event|0|||
126223451|NCT00936884|454109687|FG000|Double-blind|Physician Decision|1|||
126223452|NCT00936884|454109688|FG001|Double-blind|Physician Decision|0|||
126223453|NCT00936884|454109689|FG002|Double-blind|Physician Decision|0|||
126223454|NCT00936884|454109687|FG000|Double-blind|No post baseline diary entry|1|||
126223455|NCT00936884|454109688|FG001|Double-blind|No post baseline diary entry|0|||
126223456|NCT00936884|454109689|FG002|Double-blind|No post baseline diary entry|0|||
126223457|NCT00936884|454109687|FG000|Double-blind|Did not receive study drug|0|||
126223458|NCT00936884|454109688|FG001|Double-blind|Did not receive study drug|1|||
126223459|NCT00936884|454109689|FG002|Double-blind|Did not receive study drug|0|||
126223460|NCT04741503|454109690|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
126223461|NCT04741503|454109691|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
126223462|NCT04741503|454109692|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
126223463|NCT04741503|454109690|FG000|Initial Enrollment|Overquotas removed|0|||
126223464|NCT04741503|454109691|FG001|Initial Enrollment|Overquotas removed|0|||
126223465|NCT04741503|454109692|FG002|Initial Enrollment|Overquotas removed|186|||
126223466|NCT04741503|454109690|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
126223467|NCT04741503|454109691|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
126223468|NCT04741503|454109692|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
126223469|NCT02280421|454109693|FG000|Washout (2 Weeks)|Adverse Event|0|||
126223470|NCT02280421|454109694|FG001|Washout (2 Weeks)|Adverse Event|1|||
126223471|NCT02280421|454109693|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
126223472|NCT02280421|454109694|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
126223473|NCT01859390|454109701|FG000|Overall Study|Insufficient Sputum Collected|1|||
126223474|NCT01859390|454109702|FG001|Overall Study|Insufficient Sputum Collected|3|||
126223475|NCT01859390|454109701|FG000|Overall Study|Sample Missing Collection Date|0|||
126223476|NCT01859390|454109702|FG001|Overall Study|Sample Missing Collection Date|1|||
126223477|NCT01859390|454109701|FG000|Overall Study|Tube Cracked|0|||
126223478|NCT01859390|454109702|FG001|Overall Study|Tube Cracked|2|||
126223479|NCT01859390|454109701|FG000|Overall Study|Shipment Error|0|||
126223480|NCT01859390|454109702|FG001|Overall Study|Shipment Error|1|||
126223481|NCT02764489|454109707|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
126223482|NCT02764489|454109708|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
126223483|NCT02764489|454109707|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
126223484|NCT02764489|454109708|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
126223485|NCT02764489|454109707|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
126019850|NCT02988817|453368605|FG016|Overall Study|Physician Decision|0|||
126019851|NCT02988817|453368606|FG017|Overall Study|Physician Decision|0|||
126223486|NCT02764489|454109708|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
126223487|NCT02764489|454109707|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
126223488|NCT02764489|454109708|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
126223489|NCT02038634|454109709|FG000|Overall Study|Lost to Follow-up|0|||
126223490|NCT02038634|454109710|FG001|Overall Study|Lost to Follow-up|1|||
126223491|NCT01664052|454109711|FG000|Phase 1|No device placement|6|||
126223492|NCT01664052|454109712|FG001|Phase 1|No device placement|0|||
126223493|NCT01664052|454109711|FG000|Phase 1|No HSG 1 hr post placement|1|||
126223494|NCT01664052|454109712|FG001|Phase 1|No HSG 1 hr post placement|0|||
126223495|NCT01664052|454109711|FG000|Phase 2|No device placement|0|||
126223496|NCT01664052|454109712|FG001|Phase 2|No device placement|4|||
126223497|NCT01706198|454109715|FG000|Overall Study|Adverse Event|12|||
126223498|NCT01706198|454109716|FG001|Overall Study|Adverse Event|15|||
126223499|NCT01706198|454109715|FG000|Overall Study|Protocol Violation|7|||
126223500|NCT01706198|454109716|FG001|Overall Study|Protocol Violation|5|||
126223501|NCT01706198|454109715|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
126223502|NCT01706198|454109716|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
126223503|NCT01706198|454109715|FG000|Overall Study|Lost to Follow-up|97|||
126223504|NCT01706198|454109716|FG001|Overall Study|Lost to Follow-up|93|||
126223505|NCT01706198|454109715|FG000|Overall Study|Physician Decision|23|||
126223506|NCT01706198|454109716|FG001|Overall Study|Physician Decision|37|||
126223507|NCT01706198|454109715|FG000|Overall Study|Withdrawal by Subject|23|||
126223508|NCT01706198|454109716|FG001|Overall Study|Withdrawal by Subject|31|||
126223509|NCT04313283|454109718|FG000|Overall Study|did not complete intervention|4|||
126223510|NCT00606684|454109732|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
126223511|NCT00606684|454109733|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126223512|NCT00606684|454109734|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126223513|NCT00606684|454109735|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126223514|NCT00606684|454109736|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126223515|NCT00606684|454109737|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126223516|NCT00606684|454109738|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126223517|NCT00606684|454109732|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
126223518|NCT00606684|454109733|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126223519|NCT00606684|454109734|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126223520|NCT00606684|454109735|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126223521|NCT00606684|454109736|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126350366|NCT05696847|454575318|FG002|Overall Study|Withdrawal by Subject|0|||
126350367|NCT05696847|454575319|FG003|Overall Study|Withdrawal by Subject|0|||
126350368|NCT05696847|454575320|FG004|Overall Study|Withdrawal by Subject|0|||
126019852|NCT02988817|453368607|FG018|Overall Study|Physician Decision|1|||
126223522|NCT00606684|454109737|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126223523|NCT00606684|454109738|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126223524|NCT00606684|454109732|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
126223525|NCT00606684|454109733|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
126223526|NCT00606684|454109734|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
126223527|NCT00606684|454109735|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
126223528|NCT00606684|454109736|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
126350369|NCT05696847|454575321|FG005|Overall Study|Withdrawal by Subject|0|||
126350370|NCT05696847|454575316|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126350371|NCT05696847|454575317|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126350372|NCT05696847|454575318|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126350373|NCT05696847|454575319|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126350374|NCT05696847|454575320|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126350375|NCT05696847|454575321|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126350376|NCT05696847|454575316|FG000|Overall Study|Adverse Event|0|||
126350377|NCT05696847|454575317|FG001|Overall Study|Adverse Event|0|||
126350378|NCT05696847|454575318|FG002|Overall Study|Adverse Event|0|||
126350379|NCT05696847|454575319|FG003|Overall Study|Adverse Event|0|||
126350380|NCT05696847|454575320|FG004|Overall Study|Adverse Event|0|||
126350381|NCT05696847|454575321|FG005|Overall Study|Adverse Event|1|||
126350382|NCT05696847|454575316|FG000|Overall Study|Sponsor Decision|0|||
126350383|NCT05696847|454575317|FG001|Overall Study|Sponsor Decision|0|||
126350384|NCT05696847|454575318|FG002|Overall Study|Sponsor Decision|0|||
126350385|NCT05696847|454575319|FG003|Overall Study|Sponsor Decision|1|||
126350386|NCT05696847|454575320|FG004|Overall Study|Sponsor Decision|0|||
126350387|NCT05696847|454575321|FG005|Overall Study|Sponsor Decision|0|||
126350388|NCT03323502|454575322|FG000|Overall Study|Resident could not be linked to CMS data|594|||
126350389|NCT03323502|454575323|FG001|Overall Study|Resident could not be linked to CMS data|435|||
126350390|NCT03323502|454575322|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
126350391|NCT03323502|454575323|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
126019853|NCT02988817|453368608|FG019|Overall Study|Physician Decision|1|||
126019854|NCT03292913|453368609|FG000|Overall Study|Death|9|||
126019855|NCT03292913|453368610|FG001|Overall Study|Death|3|||
126019856|NCT03292913|453368609|FG000|Overall Study|Lost to Follow-up|49|||
126019857|NCT03292913|453368610|FG001|Overall Study|Lost to Follow-up|49|||
126019858|NCT03292913|453368609|FG000|Overall Study|Withdrawal by Subject|2|||
126019859|NCT03292913|453368610|FG001|Overall Study|Withdrawal by Subject|0|||
126019860|NCT03292913|453368609|FG000|Overall Study|Clinic closed due to COVID|22|||
126019861|NCT03292913|453368610|FG001|Overall Study|Clinic closed due to COVID|36|||
126019862|NCT03950622|453368611|FG000|Overall Study|Withdrawal by Subject|1|||
126019863|NCT03950622|453368612|FG001|Overall Study|Withdrawal by Subject|0|||
126019864|NCT03950622|453368611|FG000|Overall Study|Protocol Deviation|0|||
126019865|NCT03950622|453368612|FG001|Overall Study|Protocol Deviation|1|||
126019866|NCT03950622|453368611|FG000|Overall Study|Physician Decision|1|||
126019867|NCT03950622|453368612|FG001|Overall Study|Physician Decision|0|||
126019868|NCT03950622|453368611|FG000|Overall Study|Lost to Follow-up|5|||
126019869|NCT03950622|453368612|FG001|Overall Study|Lost to Follow-up|5|||
126019870|NCT03950622|453368611|FG000|Overall Study|Death|1|||
126019871|NCT03950622|453368612|FG001|Overall Study|Death|1|||
126019872|NCT03051165|453368614|FG000|Overall Study|Withdrawal by Subject|1|||
126019873|NCT03051165|453368614|FG000|Overall Study|Early termination of study|12|||
126019874|NCT03074331|453368616|FG000|Overall Study|Enrolled but Not Treated|1|||
126019875|NCT03074331|453368616|FG000|Overall Study|Lost to Follow-up|5|||
126019876|NCT03074331|453368616|FG000|Overall Study|Withdrew Consent|1|||
126019877|NCT00914589|453368620|FG000|Overall Study|Adverse Event|1|||
126019878|NCT00914589|453368621|FG001|Overall Study|Adverse Event|0|||
126019879|NCT00914589|453368622|FG002|Overall Study|Adverse Event|1|||
126019880|NCT00914589|453368620|FG000|Overall Study|Protocol Violation|8|||
126019881|NCT00914589|453368621|FG001|Overall Study|Protocol Violation|6|||
126019882|NCT00914589|453368622|FG002|Overall Study|Protocol Violation|3|||
126019883|NCT00914589|453368620|FG000|Overall Study|unclassified|16|||
126019884|NCT00914589|453368621|FG001|Overall Study|unclassified|9|||
126019885|NCT00914589|453368622|FG002|Overall Study|unclassified|7|||
126019886|NCT00914589|453368620|FG000|Overall Study|Death|0|||
126019887|NCT00914589|453368621|FG001|Overall Study|Death|1|||
126019888|NCT00914589|453368622|FG002|Overall Study|Death|1|||
126019889|NCT03036813|453368627|FG000|Overall Study|Adverse Event|6|||
126019890|NCT03036813|453368628|FG001|Overall Study|Adverse Event|11|||
126019891|NCT03036813|453368629|FG002|Overall Study|Adverse Event|6|||
126019892|NCT03036813|453368627|FG000|Overall Study|Withdrawal by Subject|12|||
126019893|NCT03036813|453368628|FG001|Overall Study|Withdrawal by Subject|6|||
126019894|NCT03036813|453368629|FG002|Overall Study|Withdrawal by Subject|10|||
126019895|NCT03036813|453368627|FG000|Overall Study|Lost to Follow-up|1|||
126019896|NCT03036813|453368628|FG001|Overall Study|Lost to Follow-up|1|||
126019897|NCT03036813|453368629|FG002|Overall Study|Lost to Follow-up|0|||
126019898|NCT03036813|453368627|FG000|Overall Study|Physician Decision|2|||
126019899|NCT03036813|453368628|FG001|Overall Study|Physician Decision|1|||
126019900|NCT03036813|453368629|FG002|Overall Study|Physician Decision|1|||
126019901|NCT03036813|453368627|FG000|Overall Study|Non-Compliance|1|||
126019902|NCT03036813|453368628|FG001|Overall Study|Non-Compliance|5|||
126019903|NCT03036813|453368629|FG002|Overall Study|Non-Compliance|3|||
126019904|NCT03036813|453368627|FG000|Overall Study|Pregnancy|0|||
126019905|NCT03036813|453368628|FG001|Overall Study|Pregnancy|0|||
126019906|NCT03036813|453368629|FG002|Overall Study|Pregnancy|1|||
126019907|NCT03036813|453368627|FG000|Overall Study|Other|0|||
126019908|NCT03036813|453368628|FG001|Overall Study|Other|3|||
126019909|NCT03036813|453368629|FG002|Overall Study|Other|5|||
126019910|NCT01102231|453368630|FG000|Overall Study|Protocol Violation|3|||
126019911|NCT01102231|453368630|FG000|Overall Study|Lack of Efficacy|2|||
126019912|NCT01102231|453368630|FG000|Overall Study|Death|2|||
126019913|NCT01102231|453368630|FG000|Overall Study|Adverse Event|3|||
126019914|NCT01102231|453368630|FG000|Overall Study|Withdrawal by Subject|1|||
126019915|NCT01102231|453368630|FG000|Overall Study|Did not received the treatment|4|||
126019916|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
126019917|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
126019918|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
126019919|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
126019920|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
126019921|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
126019922|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
126019923|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
126019924|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126369494|NCT00876447|454650571|FG000|Overall Study|Lost to Follow-up|6|||
126019925|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126019926|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126019927|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126369495|NCT00876447|454650572|FG001|Overall Study|Lost to Follow-up|15|||
126369496|NCT00876447|454650571|FG000|Overall Study|Pregnancy|4|||
126369497|NCT00876447|454650572|FG001|Overall Study|Pregnancy|2|||
126369498|NCT00876447|454650571|FG000|Overall Study|Lack of Efficacy|5|||
126223529|NCT00606684|454109737|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
126223530|NCT00606684|454109738|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
126223531|NCT00606684|454109732|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
126223532|NCT00606684|454109733|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126223533|NCT00606684|454109734|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126223534|NCT00606684|454109735|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126223535|NCT00606684|454109736|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126223536|NCT00606684|454109737|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126223537|NCT00606684|454109738|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126223538|NCT00606684|454109732|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
126223539|NCT00606684|454109733|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126223540|NCT00606684|454109734|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126223541|NCT00606684|454109735|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126223542|NCT00606684|454109736|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126223543|NCT00606684|454109737|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126223544|NCT00606684|454109738|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126223545|NCT00606684|454109732|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
126223546|NCT00606684|454109733|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
126223547|NCT00606684|454109734|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
126223548|NCT00606684|454109735|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
126223549|NCT00606684|454109736|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
126223550|NCT00606684|454109737|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
126223551|NCT00606684|454109738|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
126223552|NCT00606684|454109732|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
126223553|NCT00606684|454109733|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126223554|NCT00606684|454109734|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126223555|NCT00606684|454109735|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126223556|NCT00606684|454109736|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126223557|NCT00606684|454109737|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126223558|NCT00606684|454109738|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126223559|NCT00606684|454109732|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126223560|NCT00606684|454109733|FG001|Double-Blind Treatment Period|Adverse Event|3|||
126223561|NCT00606684|454109734|FG002|Double-Blind Treatment Period|Adverse Event|2|||
126223562|NCT00606684|454109735|FG003|Double-Blind Treatment Period|Adverse Event|4|||
126223563|NCT00606684|454109736|FG004|Double-Blind Treatment Period|Adverse Event|2|||
126223564|NCT00606684|454109737|FG005|Double-Blind Treatment Period|Adverse Event|0|||
126223565|NCT00606684|454109738|FG006|Double-Blind Treatment Period|Adverse Event|1|||
126223566|NCT00606684|454109732|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126223567|NCT00606684|454109733|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
126223568|NCT00606684|454109734|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
126223569|NCT00606684|454109735|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
126223570|NCT00606684|454109736|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
126223571|NCT00606684|454109737|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
126223572|NCT00606684|454109738|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
126223573|NCT00606684|454109732|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126223574|NCT00606684|454109733|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
126223575|NCT00606684|454109734|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
126223576|NCT00606684|454109735|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
126223577|NCT00606684|454109736|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
126223578|NCT00606684|454109737|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
126223579|NCT00606684|454109738|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
126223580|NCT00606684|454109732|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
126223581|NCT00606684|454109733|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
126223582|NCT00606684|454109734|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
126223583|NCT00606684|454109735|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
126223584|NCT00606684|454109736|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
126223585|NCT00606684|454109737|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
126223586|NCT00606684|454109738|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
126223587|NCT00606684|454109732|FG000|Double-Blind Treatment Period|Physician Decision|0|||
126223588|NCT00606684|454109733|FG001|Double-Blind Treatment Period|Physician Decision|5|||
126223589|NCT00606684|454109734|FG002|Double-Blind Treatment Period|Physician Decision|1|||
126223590|NCT00606684|454109735|FG003|Double-Blind Treatment Period|Physician Decision|0|||
126223591|NCT00606684|454109736|FG004|Double-Blind Treatment Period|Physician Decision|3|||
126223592|NCT00606684|454109737|FG005|Double-Blind Treatment Period|Physician Decision|1|||
126350392|NCT03323502|454575322|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
126369499|NCT00876447|454650572|FG001|Overall Study|Lack of Efficacy|3|||
126223593|NCT00606684|454109738|FG006|Double-Blind Treatment Period|Physician Decision|2|||
126223594|NCT00606684|454109732|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126223595|NCT00606684|454109733|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126019928|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
126019929|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
126019930|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126019931|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126019932|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126019933|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126019934|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126019935|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126019936|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126019937|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126019938|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
126019939|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
126019940|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
126019941|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
126019942|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
126019943|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
126019944|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
126019945|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
126019946|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
126019947|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
126019948|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
126019949|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
126019950|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
126019951|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
126019952|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
126019953|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
126019954|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
126019955|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
126019956|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126019957|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126019958|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126019959|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
126019960|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126019961|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126019962|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126019963|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126019964|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
126019965|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
126019966|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
126019967|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
126019968|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
126019969|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
126019970|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
126019971|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
126019972|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
126019973|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126019974|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126019975|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126019976|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126019977|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
126019978|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126019979|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126019980|NCT03903822|453368631|FG000|Treatment Phase (6 Weeks)|Other|2|||
126019981|NCT03903822|453368632|FG001|Treatment Phase (6 Weeks)|Other|1|||
126019982|NCT03903822|453368633|FG002|Treatment Phase (6 Weeks)|Other|0|||
126019983|NCT03903822|453368634|FG003|Treatment Phase (6 Weeks)|Other|0|||
126223596|NCT00606684|454109734|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126223597|NCT00606684|454109735|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126019984|NCT03903822|453368635|FG004|Treatment Phase (6 Weeks)|Other|1|||
126019985|NCT03903822|453368636|FG005|Treatment Phase (6 Weeks)|Other|1|||
126019986|NCT03903822|453368637|FG006|Treatment Phase (6 Weeks)|Other|0|||
126019987|NCT03903822|453368638|FG007|Treatment Phase (6 Weeks)|Other|0|||
126019988|NCT03903822|453368631|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
126019989|NCT03903822|453368632|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
126092716|NCT01365481|453632865|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126223598|NCT00606684|454109736|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126223599|NCT00606684|454109737|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126223600|NCT00606684|454109738|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126223601|NCT02763579|454109739|FG000|Global Period|Death|167|||
126223602|NCT02763579|454109740|FG001|Global Period|Death|151|||
126223603|NCT02763579|454109741|FG002|Global Period|Death|0|||
126223604|NCT02763579|454109742|FG003|Global Period|Death|0|||
126223605|NCT02763579|454109739|FG000|Global Period|Lost to Follow-up|2|||
126223606|NCT02763579|454109740|FG001|Global Period|Lost to Follow-up|4|||
126223607|NCT02763579|454109741|FG002|Global Period|Lost to Follow-up|0|||
126223608|NCT02763579|454109742|FG003|Global Period|Lost to Follow-up|0|||
126223609|NCT02763579|454109739|FG000|Global Period|Physician Decision|0|||
126223610|NCT02763579|454109740|FG001|Global Period|Physician Decision|2|||
126223611|NCT02763579|454109741|FG002|Global Period|Physician Decision|0|||
126223612|NCT02763579|454109742|FG003|Global Period|Physician Decision|0|||
126223613|NCT02763579|454109739|FG000|Global Period|Study Terminated By Sponsor|21|||
126223614|NCT02763579|454109740|FG001|Global Period|Study Terminated By Sponsor|26|||
126223615|NCT02763579|454109741|FG002|Global Period|Study Terminated By Sponsor|0|||
126223616|NCT02763579|454109742|FG003|Global Period|Study Terminated By Sponsor|0|||
126223617|NCT02763579|454109739|FG000|Global Period|Withdrawal by Subject|12|||
126223618|NCT02763579|454109740|FG001|Global Period|Withdrawal by Subject|18|||
126223619|NCT02763579|454109741|FG002|Global Period|Withdrawal by Subject|0|||
126223620|NCT02763579|454109742|FG003|Global Period|Withdrawal by Subject|0|||
126223621|NCT02763579|454109739|FG000|China Period|Death|0|||
126223622|NCT02763579|454109740|FG001|China Period|Death|0|||
126223623|NCT02763579|454109741|FG002|China Period|Death|46|||
126223624|NCT02763579|454109742|FG003|China Period|Death|48|||
126223625|NCT02763579|454109739|FG000|China Period|Lost to Follow-up|0|||
126223626|NCT02763579|454109740|FG001|China Period|Lost to Follow-up|0|||
126223627|NCT02763579|454109741|FG002|China Period|Lost to Follow-up|1|||
126223628|NCT02763579|454109742|FG003|China Period|Lost to Follow-up|1|||
126223629|NCT02763579|454109739|FG000|China Period|Physician Decision|0|||
126223630|NCT02763579|454109740|FG001|China Period|Physician Decision|0|||
126223631|NCT02763579|454109741|FG002|China Period|Physician Decision|0|||
126223632|NCT02763579|454109742|FG003|China Period|Physician Decision|1|||
126223633|NCT02763579|454109739|FG000|China Period|Study Terminated By Sponsor|0|||
126223634|NCT02763579|454109740|FG001|China Period|Study Terminated By Sponsor|0|||
126223635|NCT02763579|454109741|FG002|China Period|Study Terminated By Sponsor|3|||
126223636|NCT02763579|454109742|FG003|China Period|Study Terminated By Sponsor|4|||
126223637|NCT02763579|454109739|FG000|China Period|Withdrawal by Subject|0|||
126223638|NCT02763579|454109740|FG001|China Period|Withdrawal by Subject|0|||
126223639|NCT02763579|454109741|FG002|China Period|Withdrawal by Subject|3|||
126223640|NCT02763579|454109742|FG003|China Period|Withdrawal by Subject|3|||
126223641|NCT00910858|454109747|FG000|Pharmacokinetic Phase|Adverse Event|1|||
126223642|NCT00910858|454109748|FG001|Pharmacokinetic Phase|Adverse Event|0|||
126223643|NCT00910858|454109749|FG002|Pharmacokinetic Phase|Adverse Event|0|||
126223644|NCT00910858|454109747|FG000|Monotherapy Phase|Adverse Event|3|||
126223645|NCT00910858|454109748|FG001|Monotherapy Phase|Adverse Event|2|||
126223646|NCT00910858|454109749|FG002|Monotherapy Phase|Adverse Event|0|||
126223647|NCT00910858|454109747|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
126223648|NCT00910858|454109748|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
126223649|NCT00910858|454109749|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
126223650|NCT00910858|454109747|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
126223651|NCT00910858|454109748|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
126223652|NCT00910858|454109749|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
126223653|NCT00910858|454109747|FG000|Monotherapy Phase|Protocol Violation|1|||
126223654|NCT00910858|454109748|FG001|Monotherapy Phase|Protocol Violation|0|||
126223655|NCT00910858|454109749|FG002|Monotherapy Phase|Protocol Violation|0|||
126223656|NCT00910858|454109747|FG000|Monotherapy Phase|Other|3|||
126223657|NCT00910858|454109748|FG001|Monotherapy Phase|Other|4|||
126223658|NCT00910858|454109749|FG002|Monotherapy Phase|Other|2|||
126223659|NCT00910858|454109747|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
126223660|NCT00910858|454109748|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
126223661|NCT00910858|454109749|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
126223662|NCT00910858|454109747|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
126223663|NCT00910858|454109748|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
126223664|NCT00910858|454109749|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
126223665|NCT00910858|454109747|FG000|Combined Treatment Phase|Protocol Violation|1|||
126223666|NCT00910858|454109748|FG001|Combined Treatment Phase|Protocol Violation|0|||
126223667|NCT00910858|454109749|FG002|Combined Treatment Phase|Protocol Violation|0|||
126223668|NCT00910858|454109747|FG000|Combined Treatment Phase|Other|0|||
126223669|NCT00910858|454109748|FG001|Combined Treatment Phase|Other|2|||
126223670|NCT00910858|454109749|FG002|Combined Treatment Phase|Other|1|||
126223671|NCT01703741|454109757|FG000|Overall Study|Withdrawal by Subject|6|||
126223672|NCT01703741|454109757|FG000|Overall Study|Adverse Event|2|||
126223673|NCT01703741|454109757|FG000|Overall Study|Physician Decision|2|||
126223674|NCT01703741|454109757|FG000|Overall Study|Protocol Violation|1|||
126019990|NCT03903822|453368633|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
126223675|NCT01703741|454109757|FG000|Overall Study|Lost to Follow-up|3|||
126223676|NCT01703741|454109757|FG000|Overall Study|Subject did not want to continue|2|||
126223677|NCT01703741|454109757|FG000|Overall Study|Subject cannot comply with study visits|1|||
126223678|NCT01703741|454109757|FG000|Overall Study|Subject started testosterone injections|1|||
126223679|NCT01170364|454109758|FG000|Overall Study|Protocol Violation|4|||
126223680|NCT01170364|454109759|FG001|Overall Study|Protocol Violation|1|||
126223681|NCT01381900|454109760|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
126223682|NCT01381900|454109761|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
126223683|NCT01381900|454109762|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
126223684|NCT01381900|454109760|FG000|Overall Study|Adverse Event|4|||
126223685|NCT01381900|454109761|FG001|Overall Study|Adverse Event|6|||
126223686|NCT01381900|454109762|FG002|Overall Study|Adverse Event|7|||
126223687|NCT01381900|454109760|FG000|Overall Study|Noncompliance with study drug|0|||
126223688|NCT01381900|454109761|FG001|Overall Study|Noncompliance with study drug|0|||
126223689|NCT01381900|454109762|FG002|Overall Study|Noncompliance with study drug|1|||
126223690|NCT01381900|454109760|FG000|Overall Study|Physician Decision|0|||
126223691|NCT01381900|454109761|FG001|Overall Study|Physician Decision|1|||
126223692|NCT01381900|454109762|FG002|Overall Study|Physician Decision|1|||
126223693|NCT01381900|454109760|FG000|Overall Study|Protocol Violation|0|||
126223694|NCT01381900|454109761|FG001|Overall Study|Protocol Violation|1|||
126223695|NCT01381900|454109762|FG002|Overall Study|Protocol Violation|1|||
126223696|NCT01381900|454109760|FG000|Overall Study|Withdrawal by Subject|0|||
126223697|NCT01381900|454109761|FG001|Overall Study|Withdrawal by Subject|0|||
126223698|NCT01381900|454109762|FG002|Overall Study|Withdrawal by Subject|1|||
126223699|NCT01381900|454109760|FG000|Overall Study|Early withdraw|3|||
126223700|NCT01381900|454109761|FG001|Overall Study|Early withdraw|1|||
126223701|NCT01381900|454109762|FG002|Overall Study|Early withdraw|1|||
126223702|NCT02965820|454109764|FG000|Period 2, Second 30 Days|Adverse Event|1|||
126223703|NCT02965820|454109765|FG001|Period 2, Second 30 Days|Adverse Event|1|||
126223704|NCT03870997|454109768|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
126223705|NCT03870997|454109769|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
126223706|NCT03870997|454109770|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
126223707|NCT03870997|454109771|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
126223708|NCT03870997|454109772|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
126223709|NCT03870997|454109773|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
126350393|NCT03323502|454575323|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
126350394|NCT03323502|454575322|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
126350395|NCT03323502|454575323|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
126350396|NCT03323502|454575322|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
126019991|NCT03903822|453368634|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
126019992|NCT03903822|453368635|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
126019993|NCT03903822|453368636|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
126019994|NCT03903822|453368637|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
126019995|NCT03903822|453368638|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
126019996|NCT03903822|453368631|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126019997|NCT03903822|453368632|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126019998|NCT03903822|453368633|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126019999|NCT03903822|453368634|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126020000|NCT03903822|453368635|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
126020001|NCT03903822|453368636|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126020002|NCT03903822|453368637|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126223710|NCT00667719|454109774|FG000|Overall Study|Adverse Event|39|||
126223711|NCT00667719|454109774|FG000|Overall Study|Abnormal Test Procedure|1|||
126223712|NCT00667719|454109774|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126350397|NCT03323502|454575323|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
126350398|NCT00975923|454575324|FG000|Overall Study|Withdrawal by Subject|0|||
126350399|NCT00975923|454575325|FG001|Overall Study|Withdrawal by Subject|1|||
126350400|NCT05291689|454575328|FG000|Overall Study|Adverse Event|3|||
126020003|NCT03903822|453368638|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126223713|NCT00667719|454109774|FG000|Overall Study|Protocol Violation|3|||
126020004|NCT03903822|453368631|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
126020005|NCT03903822|453368632|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126020006|NCT03903822|453368633|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126223714|NCT00667719|454109774|FG000|Overall Study|Withdrawal by Subject|17|||
126223715|NCT00667719|454109774|FG000|Overall Study|Lost to Follow-up|8|||
126223716|NCT01814137|454109775|FG000|Overall Study|Adverse Event|0|||
126223717|NCT01814137|454109776|FG001|Overall Study|Adverse Event|1|||
126223718|NCT01814137|454109775|FG000|Overall Study|Withdrawal by Subject|2|||
126223719|NCT01814137|454109776|FG001|Overall Study|Withdrawal by Subject|2|||
126223720|NCT01814137|454109775|FG000|Overall Study|Physician Decision|1|||
126223721|NCT01814137|454109776|FG001|Overall Study|Physician Decision|1|||
126223722|NCT01814137|454109775|FG000|Overall Study|Unclassified|2|||
126223723|NCT01814137|454109776|FG001|Overall Study|Unclassified|1|||
126223724|NCT03412019|454109777|FG000|Overall Study|Withdrawal by Subject|1|||
126223725|NCT03412019|454109778|FG001|Overall Study|Withdrawal by Subject|1|||
126223726|NCT02741271|454109783|FG000|Overall Study|Lost to Follow-up|2|||
126223727|NCT02741271|454109784|FG001|Overall Study|Lost to Follow-up|0|||
126223728|NCT02741271|454109783|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126223729|NCT02741271|454109784|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126223730|NCT01612156|454109785|FG000|Overall Study|Protocol Violation|2|||
126223731|NCT01612156|454109786|FG001|Overall Study|Protocol Violation|0|||
126223732|NCT01023269|454109787|FG000|Overall Study|early termination of the study|2|||
126223733|NCT01023269|454109788|FG001|Overall Study|early termination of the study|0|||
126223734|NCT00947011|454109790|FG000|Overall Study|Study was terminated,PI left institution|12|||
126223735|NCT00814658|454109791|FG000|Overall Study|Lost to Follow-up|0|||
126223736|NCT00814658|454109792|FG001|Overall Study|Lost to Follow-up|1|||
126223737|NCT00814658|454109791|FG000|Overall Study|Physician Decision|1|||
126223738|NCT00814658|454109792|FG001|Overall Study|Physician Decision|0|||
126223739|NCT00814658|454109791|FG000|Overall Study|Adverse Event|3|||
126223740|NCT00814658|454109792|FG001|Overall Study|Adverse Event|3|||
126223741|NCT05266456|454109793|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
126223742|NCT05266456|454109794|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
126223743|NCT05266456|454109795|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
126223744|NCT05266456|454109796|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
126223745|NCT05266456|454109793|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
126223746|NCT05266456|454109794|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
126223747|NCT05266456|454109795|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
126223748|NCT05266456|454109796|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
126223749|NCT05266456|454109793|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
126223750|NCT05266456|454109794|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
126020007|NCT03903822|453368634|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126020008|NCT03903822|453368635|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126223751|NCT05266456|454109795|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
126223752|NCT05266456|454109796|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
126223753|NCT05266456|454109793|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
126223754|NCT05266456|454109794|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
126223755|NCT05266456|454109795|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
126223756|NCT05266456|454109796|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
126223757|NCT05266456|454109793|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
126223758|NCT05266456|454109794|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
126223759|NCT05266456|454109795|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
126223760|NCT05266456|454109796|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
126223761|NCT01141283|454109797|FG000|Overall Study|Adverse Event|56|||
126223762|NCT01141283|454109797|FG000|Overall Study|Lost to Follow-up|4|||
126223763|NCT01141283|454109797|FG000|Overall Study|Withdrawal by Subject|14|||
126223764|NCT01141283|454109797|FG000|Overall Study|Administrative|4|||
126223765|NCT01141283|454109797|FG000|Overall Study|Lack of Efficacy|10|||
126223766|NCT00479401|454109801|FG000|Overall Study|Adverse Event|24|||
126223767|NCT00479401|454109802|FG001|Overall Study|Adverse Event|20|||
126223768|NCT00479401|454109803|FG002|Overall Study|Adverse Event|4|||
126223769|NCT00479401|454109801|FG000|Overall Study|Lack of Efficacy|2|||
126223770|NCT00479401|454109802|FG001|Overall Study|Lack of Efficacy|2|||
126223771|NCT00479401|454109803|FG002|Overall Study|Lack of Efficacy|4|||
126223772|NCT00479401|454109801|FG000|Overall Study|Protocol Violation|2|||
126223773|NCT00479401|454109802|FG001|Overall Study|Protocol Violation|1|||
126223774|NCT00479401|454109803|FG002|Overall Study|Protocol Violation|1|||
126223775|NCT00479401|454109801|FG000|Overall Study|Lost to Follow-up|1|||
126223776|NCT00479401|454109802|FG001|Overall Study|Lost to Follow-up|1|||
126223777|NCT00479401|454109803|FG002|Overall Study|Lost to Follow-up|1|||
126223778|NCT00479401|454109801|FG000|Overall Study|Withdrawal by Subject|16|||
126223779|NCT00479401|454109802|FG001|Overall Study|Withdrawal by Subject|10|||
126223780|NCT00479401|454109803|FG002|Overall Study|Withdrawal by Subject|2|||
126223781|NCT00479401|454109801|FG000|Overall Study|Exclusion criteria, relocation|4|||
126223782|NCT00479401|454109802|FG001|Overall Study|Exclusion criteria, relocation|3|||
126223783|NCT00479401|454109803|FG002|Overall Study|Exclusion criteria, relocation|0|||
126223784|NCT01430104|454109806|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
126223785|NCT01571635|454109807|FG000|Overall Study|Adverse Event|3|||
126223786|NCT01571635|454109808|FG001|Overall Study|Adverse Event|0|||
126223787|NCT01571635|454109809|FG002|Overall Study|Adverse Event|2|||
126223788|NCT01571635|454109810|FG003|Overall Study|Adverse Event|3|||
126223789|NCT01571635|454109811|FG004|Overall Study|Adverse Event|5|||
126223790|NCT01571635|454109807|FG000|Overall Study|Other reasons|2|||
126223791|NCT01571635|454109808|FG001|Overall Study|Other reasons|1|||
126223792|NCT01571635|454109809|FG002|Overall Study|Other reasons|2|||
126223793|NCT01571635|454109810|FG003|Overall Study|Other reasons|2|||
126223794|NCT01571635|454109811|FG004|Overall Study|Other reasons|1|||
126223795|NCT01571635|454109807|FG000|Overall Study|Study terminated by sponsor|0|||
126223796|NCT01571635|454109808|FG001|Overall Study|Study terminated by sponsor|4|||
126223797|NCT01571635|454109809|FG002|Overall Study|Study terminated by sponsor|1|||
126223798|NCT01571635|454109810|FG003|Overall Study|Study terminated by sponsor|3|||
126223799|NCT01571635|454109811|FG004|Overall Study|Study terminated by sponsor|1|||
126223800|NCT01571635|454109807|FG000|Overall Study|Withdrew consent|1|||
126223801|NCT01571635|454109808|FG001|Overall Study|Withdrew consent|1|||
126223802|NCT01571635|454109809|FG002|Overall Study|Withdrew consent|2|||
126223803|NCT01571635|454109810|FG003|Overall Study|Withdrew consent|3|||
126223804|NCT01571635|454109811|FG004|Overall Study|Withdrew consent|0|||
126223805|NCT01571635|454109807|FG000|Overall Study|Lack of Efficacy|0|||
126223806|NCT01571635|454109808|FG001|Overall Study|Lack of Efficacy|2|||
126223807|NCT01571635|454109809|FG002|Overall Study|Lack of Efficacy|0|||
126223808|NCT01571635|454109810|FG003|Overall Study|Lack of Efficacy|1|||
126223809|NCT01571635|454109811|FG004|Overall Study|Lack of Efficacy|2|||
126223810|NCT02868281|454109812|FG000|Overall Study|Adverse Event|2|||
126223811|NCT02868281|454109813|FG001|Overall Study|Adverse Event|2|||
126223812|NCT02868281|454109812|FG000|Overall Study|Protocol Violation|13|||
126223813|NCT02868281|454109813|FG001|Overall Study|Protocol Violation|10|||
126223814|NCT02868281|454109812|FG000|Overall Study|Lost to Follow-up|3|||
126223815|NCT02868281|454109813|FG001|Overall Study|Lost to Follow-up|6|||
126223816|NCT02868281|454109812|FG000|Overall Study|Withdrawal by Subject|11|||
126223817|NCT02868281|454109813|FG001|Overall Study|Withdrawal by Subject|15|||
126223818|NCT02868281|454109812|FG000|Overall Study|Physician Decision|2|||
126350401|NCT05291689|454575328|FG000|Overall Study|Lack of Efficacy|10|||
126350402|NCT05291689|454575328|FG000|Overall Study|Withdrawal by Subject|4|||
126350403|NCT02278354|454575329|FG000|Overall Study|Lost to Follow-up|2|||
126350404|NCT02278354|454575330|FG001|Overall Study|Lost to Follow-up|2|||
126350405|NCT02278354|454575329|FG000|Overall Study|Withdrawal by Subject|0|||
126223819|NCT02868281|454109813|FG001|Overall Study|Physician Decision|0|||
126223820|NCT02868281|454109812|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
126223821|NCT02868281|454109813|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
126223822|NCT02868281|454109812|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
126223823|NCT02868281|454109813|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
126223824|NCT02868281|454109812|FG000|Overall Study|Long journey/moving away|1|||
126223825|NCT02868281|454109813|FG001|Overall Study|Long journey/moving away|1|||
126350406|NCT02278354|454575330|FG001|Overall Study|Withdrawal by Subject|1|||
126223826|NCT01722266|454109814|FG000|Overall Study|Withdrawal by Subject|1|||
126223827|NCT01722266|454109815|FG001|Overall Study|Withdrawal by Subject|2|||
126223828|NCT01722266|454109816|FG002|Overall Study|Withdrawal by Subject|0|||
126223829|NCT01722266|454109817|FG003|Overall Study|Withdrawal by Subject|0|||
126223830|NCT01722266|454109814|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
126223831|NCT01722266|454109815|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
126223832|NCT01722266|454109816|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
126223833|NCT01722266|454109817|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
126223834|NCT01722266|454109814|FG000|Overall Study|Dropped out due to Nausea|0|||
126223835|NCT01722266|454109815|FG001|Overall Study|Dropped out due to Nausea|0|||
126223836|NCT01722266|454109816|FG002|Overall Study|Dropped out due to Nausea|2|||
126223837|NCT01722266|454109817|FG003|Overall Study|Dropped out due to Nausea|0|||
126223838|NCT03124381|454109818|FG000|Overall Study|Lost to Follow-up|1|||
126223839|NCT03124381|454109819|FG001|Overall Study|Lost to Follow-up|1|||
126223840|NCT03124381|454109818|FG000|Overall Study|Withdrawal by Subject|6|||
126223841|NCT03124381|454109819|FG001|Overall Study|Withdrawal by Subject|3|||
126223842|NCT03124381|454109818|FG000|Overall Study|Protocol Violation|0|||
126223843|NCT03124381|454109819|FG001|Overall Study|Protocol Violation|1|||
126223844|NCT03124381|454109818|FG000|Overall Study|Adverse Event|1|||
126223845|NCT03124381|454109819|FG001|Overall Study|Adverse Event|1|||
126223846|NCT03124381|454109818|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
126223847|NCT03124381|454109819|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
126223848|NCT02533999|454109822|FG000|Overall Study|Lost to Follow-up|3|||
126223849|NCT02533999|454109823|FG001|Overall Study|Lost to Follow-up|5|||
126223850|NCT02533999|454109822|FG000|Overall Study|Protocol Violation|3|||
126223851|NCT02533999|454109823|FG001|Overall Study|Protocol Violation|0|||
126223852|NCT02533999|454109822|FG000|Overall Study|Adverse Event|0|||
126223853|NCT02533999|454109823|FG001|Overall Study|Adverse Event|1|||
126223854|NCT02533999|454109822|FG000|Overall Study|Randomized but intervention not received|0|||
126223855|NCT02533999|454109823|FG001|Overall Study|Randomized but intervention not received|1|||
126223856|NCT01875445|454109824|FG000|Overall Study|Lost to Follow-up|5|||
126223857|NCT01875445|454109825|FG001|Overall Study|Lost to Follow-up|0|||
126223858|NCT01875445|454109824|FG000|Overall Study|Withdrawal by Subject|2|||
126223859|NCT01875445|454109825|FG001|Overall Study|Withdrawal by Subject|0|||
126223860|NCT02472977|454109829|FG000|Overall Study|Disease progression|4|||
126223861|NCT02472977|454109830|FG001|Overall Study|Disease progression|25|||
126223862|NCT02472977|454109831|FG002|Overall Study|Disease progression|6|||
126223863|NCT02472977|454109829|FG000|Overall Study|Withdrawal by Subject|0|||
126223864|NCT02472977|454109830|FG001|Overall Study|Withdrawal by Subject|1|||
126223865|NCT02472977|454109831|FG002|Overall Study|Withdrawal by Subject|0|||
126223866|NCT02472977|454109829|FG000|Overall Study|Study drug toxicity|2|||
126223867|NCT02472977|454109830|FG001|Overall Study|Study drug toxicity|0|||
126223868|NCT02472977|454109831|FG002|Overall Study|Study drug toxicity|2|||
126223869|NCT02472977|454109829|FG000|Overall Study|Subject request to discontinue treatment|0|||
126223870|NCT02472977|454109830|FG001|Overall Study|Subject request to discontinue treatment|1|||
126223871|NCT02472977|454109831|FG002|Overall Study|Subject request to discontinue treatment|0|||
126223872|NCT02378506|454109840|FG000|Overall Study|Lack of Efficacy|3|||
126223873|NCT02378506|454109840|FG000|Overall Study|Withdrawal by Subject|4|||
126223874|NCT02378506|454109840|FG000|Overall Study|Protocol Violation|2|||
126223875|NCT02378506|454109840|FG000|Overall Study|Death|1|||
126223876|NCT02378506|454109840|FG000|Overall Study|Adverse Event|14|||
126223877|NCT02378506|454109840|FG000|Overall Study|Randomized But Not Treated|1|||
126223878|NCT01606137|454109841|FG000|Overall Study|Adverse Event|85|||
126223879|NCT01606137|454109841|FG000|Overall Study|Withdrawal by Subject|74|||
126223880|NCT01606137|454109841|FG000|Overall Study|Lack of Efficacy|56|||
126223881|NCT01606137|454109841|FG000|Overall Study|Lost to Follow-up|15|||
126223882|NCT01606137|454109841|FG000|Overall Study|Protocol Violation|1|||
126223883|NCT01606137|454109841|FG000|Overall Study|Patient non-compliance|9|||
126223884|NCT01606137|454109841|FG000|Overall Study|Death|1|||
126092717|NCT01365481|453632866|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126092718|NCT01365481|453632867|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
126092719|NCT01365481|453632868|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126092720|NCT01641159|453632879|FG000|Overall Study|Lost to Follow-up|2|||
126223885|NCT01606137|454109841|FG000|Overall Study|Decreased/no pain|4|||
126223886|NCT01606137|454109841|FG000|Overall Study|Issues with driving|4|||
126223887|NCT01606137|454109841|FG000|Overall Study|multiple sclerosis less stable|1|||
126223888|NCT01606137|454109841|FG000|Overall Study|Increased bilirubin|1|||
126223889|NCT01606137|454109841|FG000|Overall Study|Spray causes nausea|1|||
126223890|NCT01606137|454109841|FG000|Overall Study|Not enough improvement|4|||
126223891|NCT01606137|454109841|FG000|Overall Study|Wanted to try another treatment|1|||
126223892|NCT01606137|454109841|FG000|Overall Study|Patient leaving country|1|||
126223893|NCT01606137|454109841|FG000|Overall Study|Personal reasons|1|||
126223894|NCT01606137|454109841|FG000|Overall Study|Unable to tolerate study med. taste|1|||
126223895|NCT01606137|454109841|FG000|Overall Study|Patient moving|1|||
126223896|NCT01606137|454109841|FG000|Overall Study|Unable to collect consistent data|1|||
126350407|NCT02278354|454575329|FG000|Overall Study|<10 professional fights|2|||
126092721|NCT01641159|453632880|FG001|Overall Study|Lost to Follow-up|1|||
126092722|NCT01641159|453632879|FG000|Overall Study|Withdrawal by Subject|0|||
126092723|NCT01641159|453632880|FG001|Overall Study|Withdrawal by Subject|1|||
126092724|NCT03653208|453632884|FG000|Overall Study|Withdrawal by Subject|0|||
126092725|NCT03653208|453632885|FG001|Overall Study|Withdrawal by Subject|0|||
126092726|NCT03653208|453632886|FG002|Overall Study|Withdrawal by Subject|0|||
126092727|NCT03653208|453632887|FG003|Overall Study|Withdrawal by Subject|0|||
126092728|NCT03653208|453632888|FG004|Overall Study|Withdrawal by Subject|1|||
126092729|NCT03653208|453632889|FG005|Overall Study|Withdrawal by Subject|0|||
126092730|NCT03653208|453632890|FG006|Overall Study|Withdrawal by Subject|0|||
126092731|NCT03653208|453632891|FG007|Overall Study|Withdrawal by Subject|1|||
126092732|NCT03653208|453632892|FG008|Overall Study|Withdrawal by Subject|1|||
126092733|NCT03752970|453632894|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
126092734|NCT03752970|453632895|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
126092735|NCT03752970|453632896|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
126092736|NCT03752970|453632894|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
126092737|NCT03752970|453632895|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
126092738|NCT03752970|453632896|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
126092739|NCT03752970|453632894|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
126092740|NCT03752970|453632895|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
126092741|NCT03752970|453632896|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
126092742|NCT03752970|453632894|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
126092743|NCT03752970|453632895|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
126092744|NCT03752970|453632896|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
126092745|NCT03752970|453632894|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
126092746|NCT03752970|453632895|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
126092747|NCT03752970|453632896|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
126092748|NCT01152814|453632898|FG000|Overall Study|Lost to Follow-up|2|||
126223897|NCT01084005|454111522|FG000|Overall Study|Adverse Event|1|||
126223898|NCT01084005|454111523|FG001|Overall Study|Adverse Event|8|||
126223899|NCT01084005|454111522|FG000|Overall Study|Protocol Violation|3|||
126223900|NCT01084005|454111523|FG001|Overall Study|Protocol Violation|7|||
126223901|NCT01084005|454111522|FG000|Overall Study|Withdrawal by Subject|1|||
126092749|NCT01669577|453632902|FG000|Overall Study|Death|22|||
126092750|NCT01669577|453632902|FG000|Overall Study|Lost to Follow-up|78|||
126092751|NCT01669577|453632902|FG000|Overall Study|Physician Decision|34|||
126092752|NCT01283516|453632903|FG000|Overall Study|Adverse Event|0|||
126092753|NCT01283516|453632904|FG001|Overall Study|Adverse Event|0|||
126092754|NCT01283516|453632905|FG002|Overall Study|Adverse Event|0|||
126092755|NCT01283516|453632906|FG003|Overall Study|Adverse Event|0|||
126092756|NCT01283516|453632907|FG004|Overall Study|Adverse Event|0|||
126092757|NCT01283516|453632908|FG005|Overall Study|Adverse Event|0|||
126092758|NCT01283516|453632909|FG006|Overall Study|Adverse Event|2|||
126092759|NCT01283516|453632910|FG007|Overall Study|Adverse Event|0|||
126092760|NCT01283516|453632911|FG008|Overall Study|Adverse Event|28|||
126092761|NCT01283516|453632903|FG000|Overall Study|Death|0|||
126092762|NCT01283516|453632904|FG001|Overall Study|Death|0|||
126092763|NCT01283516|453632905|FG002|Overall Study|Death|0|||
126092764|NCT01283516|453632906|FG003|Overall Study|Death|0|||
126092765|NCT01283516|453632907|FG004|Overall Study|Death|0|||
126092766|NCT01283516|453632908|FG005|Overall Study|Death|1|||
126092767|NCT01283516|453632909|FG006|Overall Study|Death|0|||
126092768|NCT01283516|453632910|FG007|Overall Study|Death|1|||
126092769|NCT01283516|453632911|FG008|Overall Study|Death|12|||
126092770|NCT01283516|453632903|FG000|Overall Study|Disease Progression|2|||
126092771|NCT01283516|453632904|FG001|Overall Study|Disease Progression|2|||
126092772|NCT01283516|453632905|FG002|Overall Study|Disease Progression|3|||
126092773|NCT01283516|453632906|FG003|Overall Study|Disease Progression|3|||
126092774|NCT01283516|453632907|FG004|Overall Study|Disease Progression|13|||
126092775|NCT01283516|453632908|FG005|Overall Study|Disease Progression|8|||
126092776|NCT01283516|453632909|FG006|Overall Study|Disease Progression|6|||
126223902|NCT01084005|454111523|FG001|Overall Study|Withdrawal by Subject|1|||
126223903|NCT02480010|454111524|FG000|Overall Study|Adverse Event|3|||
126223904|NCT02480010|454111525|FG001|Overall Study|Adverse Event|1|||
126092777|NCT01283516|453632910|FG007|Overall Study|Disease Progression|3|||
126092778|NCT01283516|453632911|FG008|Overall Study|Disease Progression|139|||
126092779|NCT01283516|453632903|FG000|Overall Study|Withdrawal by Subject|0|||
126092780|NCT01283516|453632904|FG001|Overall Study|Withdrawal by Subject|0|||
126092781|NCT01283516|453632905|FG002|Overall Study|Withdrawal by Subject|0|||
126092782|NCT01283516|453632906|FG003|Overall Study|Withdrawal by Subject|0|||
126092783|NCT01283516|453632907|FG004|Overall Study|Withdrawal by Subject|1|||
126092784|NCT01283516|453632908|FG005|Overall Study|Withdrawal by Subject|0|||
126092785|NCT01283516|453632909|FG006|Overall Study|Withdrawal by Subject|1|||
126223905|NCT02480010|454111524|FG000|Overall Study|Death|1|||
126223906|NCT02480010|454111525|FG001|Overall Study|Death|0|||
126223907|NCT02480010|454111524|FG000|Overall Study|Insufficient therapeutic response|31|||
126020009|NCT03903822|453368636|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126020010|NCT03903822|453368637|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
126020011|NCT03903822|453368638|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
126020012|NCT03903822|453368631|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
126020013|NCT03903822|453368632|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
126020014|NCT03903822|453368633|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
126020015|NCT03903822|453368634|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
126020016|NCT03903822|453368635|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
126020017|NCT03903822|453368636|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
126020018|NCT03903822|453368637|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
126020019|NCT03903822|453368638|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
126020020|NCT03903822|453368631|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
126020021|NCT03903822|453368632|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
126020022|NCT03903822|453368633|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
126020023|NCT03903822|453368634|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
126020024|NCT03903822|453368635|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
126020025|NCT03903822|453368636|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
126020026|NCT03903822|453368637|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
126020027|NCT03903822|453368638|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
126020028|NCT03903822|453368631|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126020029|NCT03903822|453368632|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126020030|NCT03903822|453368633|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126020031|NCT03903822|453368634|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126020032|NCT03903822|453368635|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126020033|NCT03903822|453368636|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
126020034|NCT03903822|453368637|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126020035|NCT03903822|453368638|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126020036|NCT03903822|453368631|FG000|Follow up Phase (4 Weeks)|Other|1|||
126020037|NCT03903822|453368632|FG001|Follow up Phase (4 Weeks)|Other|1|||
126020038|NCT03903822|453368633|FG002|Follow up Phase (4 Weeks)|Other|0|||
126020039|NCT03903822|453368634|FG003|Follow up Phase (4 Weeks)|Other|0|||
126020040|NCT03903822|453368635|FG004|Follow up Phase (4 Weeks)|Other|0|||
126020041|NCT03903822|453368636|FG005|Follow up Phase (4 Weeks)|Other|0|||
126020042|NCT03903822|453368637|FG006|Follow up Phase (4 Weeks)|Other|0|||
126020043|NCT03903822|453368638|FG007|Follow up Phase (4 Weeks)|Other|0|||
126020044|NCT00785512|453368639|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
126020045|NCT00785512|453368640|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
126020046|NCT00785512|453368639|FG000|Overall Study|Adverse Event|0|||
126020047|NCT00785512|453368640|FG001|Overall Study|Adverse Event|0|||
126020048|NCT00785512|453368639|FG000|Overall Study|Lack of Efficacy|0|||
126020049|NCT00785512|453368640|FG001|Overall Study|Lack of Efficacy|2|||
126020050|NCT00785512|453368639|FG000|Overall Study|Withdrawal by Subject|0|||
126020051|NCT00785512|453368640|FG001|Overall Study|Withdrawal by Subject|1|||
126020052|NCT00785512|453368639|FG000|Overall Study|Lost to Follow-up|3|||
126020053|NCT00785512|453368640|FG001|Overall Study|Lost to Follow-up|0|||
126020054|NCT00785512|453368639|FG000|Overall Study|Precedure Refused|0|||
126020055|NCT00785512|453368640|FG001|Overall Study|Precedure Refused|0|||
126020056|NCT00785512|453368639|FG000|Overall Study|IVRS Programing Error|0|||
126020057|NCT00785512|453368640|FG001|Overall Study|IVRS Programing Error|0|||
126020058|NCT00785512|453368639|FG000|Overall Study|Physician Decision|0|||
126020059|NCT00785512|453368640|FG001|Overall Study|Physician Decision|0|||
126020060|NCT00785512|453368639|FG000|Overall Study|Lack of compliance|0|||
126020061|NCT00785512|453368640|FG001|Overall Study|Lack of compliance|1|||
126020062|NCT00529100|453368644|FG000|Overall Study|Adverse Event|0|||
126020063|NCT00529100|453368645|FG001|Overall Study|Adverse Event|5|||
126020064|NCT00529100|453368644|FG000|Overall Study|Protocol Violation|0|||
126020065|NCT00529100|453368645|FG001|Overall Study|Protocol Violation|1|||
126020066|NCT00529100|453368644|FG000|Overall Study|Progressive Disease|0|||
126020067|NCT00529100|453368645|FG001|Overall Study|Progressive Disease|1|||
126020068|NCT00529100|453368644|FG000|Overall Study|Withdrawal by Subject|0|||
126020069|NCT00529100|453368645|FG001|Overall Study|Withdrawal by Subject|1|||
126020070|NCT00529100|453368644|FG000|Overall Study|Participant Ineligibility|0|||
126020071|NCT00529100|453368645|FG001|Overall Study|Participant Ineligibility|1|||
126020072|NCT03733119|453368646|FG000|Overall Study|Physician Decision|2|||
126020073|NCT03733119|453368647|FG001|Overall Study|Physician Decision|1|||
126020074|NCT03733119|453368646|FG000|Overall Study|ineligible to treat per protocol|0|||
126020075|NCT03733119|453368647|FG001|Overall Study|ineligible to treat per protocol|1|||
126020076|NCT00807937|453368654|FG000|Overall Study|Adverse Event|12|||
126020077|NCT00807937|453368655|FG001|Overall Study|Adverse Event|12|||
126020078|NCT00807937|453368656|FG002|Overall Study|Adverse Event|5|||
126020079|NCT00807937|453368657|FG003|Overall Study|Adverse Event|4|||
126020080|NCT00807937|453368654|FG000|Overall Study|Protocol Violation|4|||
126020081|NCT00807937|453368655|FG001|Overall Study|Protocol Violation|5|||
126020082|NCT00807937|453368656|FG002|Overall Study|Protocol Violation|3|||
126020083|NCT00807937|453368657|FG003|Overall Study|Protocol Violation|3|||
126223908|NCT02480010|454111525|FG001|Overall Study|Insufficient therapeutic response|29|||
126223909|NCT02480010|454111524|FG000|Overall Study|Refused Treatment|0|||
126223910|NCT02480010|454111525|FG001|Overall Study|Refused Treatment|3|||
126223911|NCT01034137|454111529|FG000|Overall Study|Adverse Event|9|||
126223912|NCT01034137|454111530|FG001|Overall Study|Adverse Event|10|||
126223913|NCT01034137|454111531|FG002|Overall Study|Adverse Event|8|||
126223914|NCT01034137|454111529|FG000|Overall Study|Withdrawal by Subject|4|||
126223915|NCT01034137|454111530|FG001|Overall Study|Withdrawal by Subject|3|||
126223916|NCT01034137|454111531|FG002|Overall Study|Withdrawal by Subject|3|||
126223917|NCT01034137|454111529|FG000|Overall Study|Lack of Efficacy|9|||
126223918|NCT01034137|454111530|FG001|Overall Study|Lack of Efficacy|4|||
126223919|NCT01034137|454111531|FG002|Overall Study|Lack of Efficacy|13|||
126223920|NCT01034137|454111529|FG000|Overall Study|Protocol Violation|2|||
126223921|NCT01034137|454111530|FG001|Overall Study|Protocol Violation|2|||
126223922|NCT01034137|454111531|FG002|Overall Study|Protocol Violation|1|||
126223923|NCT01034137|454111529|FG000|Overall Study|Refused treatment or did not cooperate|2|||
126223924|NCT01034137|454111530|FG001|Overall Study|Refused treatment or did not cooperate|0|||
126223925|NCT01034137|454111531|FG002|Overall Study|Refused treatment or did not cooperate|1|||
126223926|NCT01034137|454111529|FG000|Overall Study|Administrative or other|2|||
126223927|NCT01034137|454111530|FG001|Overall Study|Administrative or other|3|||
126223928|NCT01034137|454111531|FG002|Overall Study|Administrative or other|4|||
126223929|NCT01764854|454111535|FG000|Overall Study|Adverse Event|0|||
126223930|NCT01764854|454111536|FG001|Overall Study|Adverse Event|0|||
126223931|NCT01764854|454111537|FG002|Overall Study|Adverse Event|2|||
126223932|NCT01764854|454111538|FG003|Overall Study|Adverse Event|0|||
126223933|NCT01764854|454111535|FG000|Overall Study|Withdrawal by Subject|0|||
126223934|NCT01764854|454111536|FG001|Overall Study|Withdrawal by Subject|0|||
126223935|NCT01764854|454111537|FG002|Overall Study|Withdrawal by Subject|1|||
126223936|NCT01764854|454111538|FG003|Overall Study|Withdrawal by Subject|0|||
126223937|NCT01764854|454111535|FG000|Overall Study|relocation|0|||
126223938|NCT01764854|454111536|FG001|Overall Study|relocation|0|||
126223939|NCT01764854|454111537|FG002|Overall Study|relocation|2|||
126223940|NCT01764854|454111538|FG003|Overall Study|relocation|0|||
126223941|NCT01764854|454111535|FG000|Overall Study|Protocol Violation|0|||
126223942|NCT01764854|454111536|FG001|Overall Study|Protocol Violation|0|||
126223943|NCT01764854|454111537|FG002|Overall Study|Protocol Violation|1|||
126223944|NCT01764854|454111538|FG003|Overall Study|Protocol Violation|2|||
126223945|NCT03377556|454111547|FG000|Overall Study|Adverse Event|5|||
126223946|NCT03377556|454111547|FG000|Overall Study|Refusal unrelated to adverse events|1|||
126223947|NCT03377556|454111547|FG000|Overall Study|Progression/relapse|38|||
126223948|NCT03377556|454111547|FG000|Overall Study|Death|3|||
126223949|NCT01967888|454111552|FG000|Overall Study|Lost to Follow-up|6|||
126223950|NCT01967888|454111553|FG001|Overall Study|Lost to Follow-up|4|||
126223951|NCT01967888|454111552|FG000|Overall Study|Withdrawal by Subject|1|||
126223952|NCT01967888|454111553|FG001|Overall Study|Withdrawal by Subject|1|||
126223953|NCT01967888|454111552|FG000|Overall Study|Did Not Have Transplant|1|||
126223954|NCT01967888|454111553|FG001|Overall Study|Did Not Have Transplant|0|||
126223955|NCT01967888|454111552|FG000|Overall Study|Research visit not done, data recorded|1|||
126223956|NCT01967888|454111553|FG001|Overall Study|Research visit not done, data recorded|0|||
126223957|NCT01967888|454111552|FG000|Overall Study|Subject excluded after randomization|1|||
126223958|NCT01967888|454111553|FG001|Overall Study|Subject excluded after randomization|0|||
126223959|NCT01967888|454111552|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
126223960|NCT01967888|454111553|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
126223961|NCT01967888|454111552|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
126223962|NCT01967888|454111553|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
126350408|NCT02278354|454575330|FG001|Overall Study|<10 professional fights|0|||
126350409|NCT02612155|454575332|FG000|Overall Study|Death|1|||
126350410|NCT02612155|454575333|FG001|Overall Study|Death|1|||
126020084|NCT00807937|453368654|FG000|Overall Study|Withdrawal by Subject|5|||
126020085|NCT00807937|453368655|FG001|Overall Study|Withdrawal by Subject|4|||
126223963|NCT00553540|454111554|FG000|Overall Study|discharged after first visit|2|||
126223964|NCT00553540|454111555|FG001|Overall Study|discharged after first visit|5|||
126223965|NCT02622074|454111556|FG000|Overall Study|Death|4|||
126223966|NCT02622074|454111557|FG001|Overall Study|Death|0|||
126223967|NCT02622074|454111558|FG002|Overall Study|Death|0|||
126350411|NCT02612155|454575332|FG000|Overall Study|Lost to Follow-up|2|||
126350412|NCT02612155|454575333|FG001|Overall Study|Lost to Follow-up|2|||
126223968|NCT02622074|454111559|FG003|Overall Study|Death|1|||
126223969|NCT02622074|454111560|FG004|Overall Study|Death|1|||
126223970|NCT02622074|454111561|FG005|Overall Study|Death|0|||
126223971|NCT02622074|454111556|FG000|Overall Study|Withdrawal by Subject|0|||
126223972|NCT02622074|454111557|FG001|Overall Study|Withdrawal by Subject|1|||
126223973|NCT02622074|454111558|FG002|Overall Study|Withdrawal by Subject|0|||
126223974|NCT02622074|454111559|FG003|Overall Study|Withdrawal by Subject|0|||
126223975|NCT02622074|454111560|FG004|Overall Study|Withdrawal by Subject|0|||
126223976|NCT02622074|454111561|FG005|Overall Study|Withdrawal by Subject|0|||
126350413|NCT04435626|454575336|FG000|Overall Study|Lost to Follow-up|1|||
126223977|NCT02114931|454111562|FG000|Overall Study|Withdrawal by Subject|15|||
126223978|NCT02114931|454111563|FG001|Overall Study|Withdrawal by Subject|18|||
126223979|NCT02114931|454111562|FG000|Overall Study|Adverse Event|4|||
126223980|NCT02114931|454111563|FG001|Overall Study|Adverse Event|6|||
126223981|NCT02114931|454111562|FG000|Overall Study|Lost to Follow-up|3|||
126223982|NCT02114931|454111563|FG001|Overall Study|Lost to Follow-up|3|||
126223983|NCT02114931|454111562|FG000|Overall Study|Physician Decision|1|||
126223984|NCT02114931|454111563|FG001|Overall Study|Physician Decision|2|||
126223985|NCT02114931|454111562|FG000|Overall Study|Other|2|||
126223986|NCT02114931|454111563|FG001|Overall Study|Other|1|||
126223987|NCT03565211|454111568|FG000|Overall Study|Withdrawal by Subject|2|||
126223988|NCT03565211|454111568|FG000|Overall Study|Lost to Follow-up|1|||
126223989|NCT03565211|454111568|FG000|Overall Study|Adverse Event|44|||
126223990|NCT03565211|454111568|FG000|Overall Study|Personal issues|1|||
126223991|NCT01894984|454111569|FG000|Overall Study|Other|314|||
126223992|NCT01894984|454111570|FG001|Overall Study|Other|175|||
126223993|NCT03840135|454111572|FG000|Overall Study|Protocol Violation|6|||
126223994|NCT03840135|454111573|FG001|Overall Study|Protocol Violation|1|||
126223995|NCT03840135|454111572|FG000|Overall Study|Withdrawal by Subject|1|||
126223996|NCT03840135|454111573|FG001|Overall Study|Withdrawal by Subject|0|||
126223997|NCT01827371|454111575|FG000|Overall Study|Adverse Event|0|||
126223998|NCT01827371|454111576|FG001|Overall Study|Adverse Event|0|||
126223999|NCT01827371|454111577|FG002|Overall Study|Adverse Event|4|||
126224000|NCT01827371|454111578|FG003|Overall Study|Adverse Event|2|||
126224001|NCT01827371|454111575|FG000|Overall Study|Lost to Follow-up|0|||
126224002|NCT01827371|454111576|FG001|Overall Study|Lost to Follow-up|2|||
126224003|NCT01827371|454111577|FG002|Overall Study|Lost to Follow-up|0|||
126224004|NCT01827371|454111578|FG003|Overall Study|Lost to Follow-up|4|||
126224005|NCT01827371|454111575|FG000|Overall Study|Protocol Violation|1|||
126224006|NCT01827371|454111576|FG001|Overall Study|Protocol Violation|0|||
126224007|NCT01827371|454111577|FG002|Overall Study|Protocol Violation|0|||
126224008|NCT01827371|454111578|FG003|Overall Study|Protocol Violation|0|||
126224009|NCT01827371|454111575|FG000|Overall Study|Withdrawal by Subject|1|||
126224010|NCT01827371|454111576|FG001|Overall Study|Withdrawal by Subject|2|||
126224011|NCT01827371|454111577|FG002|Overall Study|Withdrawal by Subject|2|||
126224012|NCT01827371|454111578|FG003|Overall Study|Withdrawal by Subject|3|||
126224013|NCT01827371|454111575|FG000|Overall Study|Physician Decision|0|||
126224014|NCT01827371|454111576|FG001|Overall Study|Physician Decision|1|||
126224015|NCT01827371|454111577|FG002|Overall Study|Physician Decision|0|||
126224016|NCT01827371|454111578|FG003|Overall Study|Physician Decision|1|||
126224017|NCT01827371|454111575|FG000|Overall Study|Temporary study halt to vaccinations|11|||
126224018|NCT01827371|454111576|FG001|Overall Study|Temporary study halt to vaccinations|2|||
126224019|NCT01827371|454111577|FG002|Overall Study|Temporary study halt to vaccinations|5|||
126224020|NCT01827371|454111578|FG003|Overall Study|Temporary study halt to vaccinations|13|||
126224021|NCT01361607|454111580|FG000|Overall Study|Adverse Event|38|||
126224022|NCT01361607|454111581|FG001|Overall Study|Adverse Event|29|||
126224023|NCT01361607|454111580|FG000|Overall Study|Withdrawal by Subject|19|||
126224024|NCT01361607|454111581|FG001|Overall Study|Withdrawal by Subject|8|||
126224025|NCT01361607|454111580|FG000|Overall Study|Withdrawal by Investigator|5|||
126224026|NCT01361607|454111581|FG001|Overall Study|Withdrawal by Investigator|3|||
126224027|NCT01361607|454111580|FG000|Overall Study|Lost to Follow-up|1|||
126224028|NCT01361607|454111581|FG001|Overall Study|Lost to Follow-up|0|||
126224029|NCT01361607|454111580|FG000|Overall Study|Met Withdrawal Criteria|1|||
126224030|NCT01361607|454111581|FG001|Overall Study|Met Withdrawal Criteria|1|||
126224031|NCT01809314|454111582|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
126224032|NCT01809314|454111582|FG000|Overall Study|Adverse Event|6|||
126224033|NCT01809314|454111582|FG000|Overall Study|Insufficient Therapeutic Response|14|||
126224034|NCT01809314|454111582|FG000|Overall Study|Lost to Follow-up|724|||
126224035|NCT00219557|454111583|FG000|Phase 1|Lack of Efficacy|3|||
126224036|NCT00219557|454111584|FG001|Phase 1|Lack of Efficacy|0|||
126224037|NCT00219557|454111585|FG002|Phase 1|Lack of Efficacy|0|||
126224038|NCT00219557|454111583|FG000|Phase 1|Adverse Event|2|||
126224039|NCT00219557|454111584|FG001|Phase 1|Adverse Event|0|||
126224040|NCT00219557|454111585|FG002|Phase 1|Adverse Event|0|||
126224041|NCT00219557|454111583|FG000|Phase 1|Withdrawal by Subject|1|||
126224042|NCT00219557|454111584|FG001|Phase 1|Withdrawal by Subject|0|||
126224043|NCT00219557|454111585|FG002|Phase 1|Withdrawal by Subject|0|||
126224044|NCT00219557|454111583|FG000|Phase 1|Started chemotherapy at other institute|1|||
126224045|NCT00219557|454111584|FG001|Phase 1|Started chemotherapy at other institute|0|||
126224046|NCT00219557|454111585|FG002|Phase 1|Started chemotherapy at other institute|0|||
126224047|NCT00219557|454111583|FG000|Phase 2|Lack of Efficacy|0|||
126224048|NCT00219557|454111584|FG001|Phase 2|Lack of Efficacy|21|||
126224049|NCT00219557|454111585|FG002|Phase 2|Lack of Efficacy|15|||
126224050|NCT00219557|454111583|FG000|Phase 2|Adverse Event|0|||
126224051|NCT00219557|454111584|FG001|Phase 2|Adverse Event|22|||
126224052|NCT00219557|454111585|FG002|Phase 2|Adverse Event|2|||
126224053|NCT00219557|454111583|FG000|Phase 2|Death|0|||
126224054|NCT00219557|454111584|FG001|Phase 2|Death|8|||
126224055|NCT00219557|454111585|FG002|Phase 2|Death|2|||
126224056|NCT00219557|454111583|FG000|Phase 2|Other|0|||
126224057|NCT00219557|454111584|FG001|Phase 2|Other|8|||
126224058|NCT00219557|454111585|FG002|Phase 2|Other|6|||
126224059|NCT00219557|454111583|FG000|Phase 2|Withdrawal by Subject|0|||
126224060|NCT00219557|454111584|FG001|Phase 2|Withdrawal by Subject|9|||
126224061|NCT00219557|454111585|FG002|Phase 2|Withdrawal by Subject|5|||
126224062|NCT00219557|454111583|FG000|Phase 2|Treatment not received|0|||
126224063|NCT00219557|454111584|FG001|Phase 2|Treatment not received|1|||
126224064|NCT00219557|454111585|FG002|Phase 2|Treatment not received|3|||
126224065|NCT01427803|454111590|FG000|Overall Study|Lost to Follow-up|32|||
126224066|NCT01427803|454111591|FG001|Overall Study|Lost to Follow-up|26|||
126224067|NCT01427803|454111590|FG000|Overall Study|Withdrawal by Subject|20|||
126224068|NCT01427803|454111591|FG001|Overall Study|Withdrawal by Subject|0|||
126224069|NCT01427803|454111590|FG000|Overall Study|Unable to complete full treatment period|6|||
126224070|NCT01427803|454111591|FG001|Overall Study|Unable to complete full treatment period|0|||
126224071|NCT01427803|454111590|FG000|Overall Study|Protocol Violation|1|||
126224072|NCT01427803|454111591|FG001|Overall Study|Protocol Violation|0|||
126224073|NCT01427803|454111590|FG000|Overall Study|Physician Decision|3|||
126224074|NCT01427803|454111591|FG001|Overall Study|Physician Decision|0|||
126224075|NCT01427803|454111590|FG000|Overall Study|did not take product|1|||
126224076|NCT01427803|454111591|FG001|Overall Study|did not take product|0|||
126224077|NCT00410410|454111592|FG000|Induction Period (IP)|Death|1|||
126224078|NCT00410410|454111593|FG001|Induction Period (IP)|Death|0|||
126224079|NCT00410410|454111594|FG002|Induction Period (IP)|Death|0|||
126224080|NCT00410410|454111595|FG003|Induction Period (IP)|Death|0|||
126224081|NCT00410410|454111596|FG004|Induction Period (IP)|Death|0|||
126224082|NCT00410410|454111597|FG005|Induction Period (IP)|Death|0|||
126224083|NCT00410410|454111598|FG006|Induction Period (IP)|Death|0|||
126224084|NCT00410410|454111599|FG007|Induction Period (IP)|Death|0|||
126224085|NCT00410410|454111600|FG008|Induction Period (IP)|Death|0|||
126224086|NCT00410410|454111592|FG000|Induction Period (IP)|Adverse Event|3|||
126224087|NCT00410410|454111593|FG001|Induction Period (IP)|Adverse Event|4|||
126224088|NCT00410410|454111594|FG002|Induction Period (IP)|Adverse Event|2|||
126224089|NCT00410410|454111595|FG003|Induction Period (IP)|Adverse Event|4|||
126224090|NCT00410410|454111596|FG004|Induction Period (IP)|Adverse Event|1|||
126224091|NCT00410410|454111597|FG005|Induction Period (IP)|Adverse Event|0|||
126224092|NCT00410410|454111598|FG006|Induction Period (IP)|Adverse Event|0|||
126224093|NCT00410410|454111599|FG007|Induction Period (IP)|Adverse Event|0|||
126224094|NCT00410410|454111600|FG008|Induction Period (IP)|Adverse Event|0|||
126224095|NCT00410410|454111592|FG000|Induction Period (IP)|Lack of Efficacy|26|||
126224096|NCT00410410|454111593|FG001|Induction Period (IP)|Lack of Efficacy|24|||
126224097|NCT00410410|454111594|FG002|Induction Period (IP)|Lack of Efficacy|8|||
126224098|NCT00410410|454111595|FG003|Induction Period (IP)|Lack of Efficacy|8|||
126224099|NCT00410410|454111596|FG004|Induction Period (IP)|Lack of Efficacy|7|||
126224100|NCT00410410|454111597|FG005|Induction Period (IP)|Lack of Efficacy|7|||
126224101|NCT00410410|454111598|FG006|Induction Period (IP)|Lack of Efficacy|0|||
126224102|NCT00410410|454111599|FG007|Induction Period (IP)|Lack of Efficacy|0|||
126224103|NCT00410410|454111600|FG008|Induction Period (IP)|Lack of Efficacy|0|||
126224104|NCT00410410|454111592|FG000|Induction Period (IP)|Lost to Follow-up|2|||
126224105|NCT00410410|454111593|FG001|Induction Period (IP)|Lost to Follow-up|2|||
126224106|NCT00410410|454111594|FG002|Induction Period (IP)|Lost to Follow-up|2|||
126224107|NCT00410410|454111595|FG003|Induction Period (IP)|Lost to Follow-up|3|||
126224108|NCT00410410|454111596|FG004|Induction Period (IP)|Lost to Follow-up|0|||
126224109|NCT00410410|454111597|FG005|Induction Period (IP)|Lost to Follow-up|1|||
126224110|NCT00410410|454111598|FG006|Induction Period (IP)|Lost to Follow-up|0|||
126224111|NCT00410410|454111599|FG007|Induction Period (IP)|Lost to Follow-up|0|||
126224112|NCT00410410|454111600|FG008|Induction Period (IP)|Lost to Follow-up|0|||
126224113|NCT00410410|454111592|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
126224114|NCT00410410|454111593|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
126224115|NCT00410410|454111594|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
126224116|NCT00410410|454111595|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
126224117|NCT00410410|454111596|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
126020086|NCT00807937|453368656|FG002|Overall Study|Withdrawal by Subject|1|||
126020087|NCT00807937|453368657|FG003|Overall Study|Withdrawal by Subject|4|||
126020088|NCT00807937|453368654|FG000|Overall Study|Lost to Follow-up|4|||
126224118|NCT00410410|454111597|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
126224119|NCT00410410|454111598|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
126020089|NCT00807937|453368655|FG001|Overall Study|Lost to Follow-up|0|||
126224120|NCT00410410|454111599|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
126224121|NCT00410410|454111600|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
126224122|NCT00410410|454111592|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126224123|NCT00410410|454111593|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126224124|NCT00410410|454111594|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
126224125|NCT00410410|454111595|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126224126|NCT00410410|454111596|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126224127|NCT00410410|454111597|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126224128|NCT00410410|454111598|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126224129|NCT00410410|454111599|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126224130|NCT00410410|454111600|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126224131|NCT00410410|454111592|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126224132|NCT00410410|454111593|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126224133|NCT00410410|454111594|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126224134|NCT00410410|454111595|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126224135|NCT00410410|454111596|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
126224136|NCT00410410|454111597|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
126224137|NCT00410410|454111598|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126224138|NCT00410410|454111599|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126224139|NCT00410410|454111600|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126224140|NCT00410410|454111592|FG000|Induction Period (IP)|Other|0|||
126224141|NCT00410410|454111593|FG001|Induction Period (IP)|Other|0|||
126224142|NCT00410410|454111594|FG002|Induction Period (IP)|Other|1|||
126224143|NCT00410410|454111595|FG003|Induction Period (IP)|Other|0|||
126224144|NCT00410410|454111596|FG004|Induction Period (IP)|Other|0|||
126224145|NCT00410410|454111597|FG005|Induction Period (IP)|Other|0|||
126224146|NCT00410410|454111598|FG006|Induction Period (IP)|Other|0|||
126224147|NCT00410410|454111599|FG007|Induction Period (IP)|Other|0|||
126224148|NCT00410410|454111600|FG008|Induction Period (IP)|Other|0|||
126224149|NCT00410410|454111592|FG000|Maintenance Period (MP)|Death|0|||
126224150|NCT00410410|454111593|FG001|Maintenance Period (MP)|Death|0|||
126224151|NCT00410410|454111594|FG002|Maintenance Period (MP)|Death|0|||
126224152|NCT00410410|454111595|FG003|Maintenance Period (MP)|Death|0|||
126224153|NCT00410410|454111596|FG004|Maintenance Period (MP)|Death|0|||
126224154|NCT00410410|454111597|FG005|Maintenance Period (MP)|Death|0|||
126224155|NCT00410410|454111598|FG006|Maintenance Period (MP)|Death|1|||
126224156|NCT00410410|454111599|FG007|Maintenance Period (MP)|Death|0|||
126224157|NCT00410410|454111600|FG008|Maintenance Period (MP)|Death|0|||
126224158|NCT00410410|454111592|FG000|Maintenance Period (MP)|Adverse Event|0|||
126224159|NCT00410410|454111593|FG001|Maintenance Period (MP)|Adverse Event|0|||
126224160|NCT00410410|454111594|FG002|Maintenance Period (MP)|Adverse Event|0|||
126224161|NCT00410410|454111595|FG003|Maintenance Period (MP)|Adverse Event|0|||
126224162|NCT00410410|454111596|FG004|Maintenance Period (MP)|Adverse Event|0|||
126224163|NCT00410410|454111597|FG005|Maintenance Period (MP)|Adverse Event|0|||
126224164|NCT00410410|454111598|FG006|Maintenance Period (MP)|Adverse Event|1|||
126224165|NCT00410410|454111599|FG007|Maintenance Period (MP)|Adverse Event|3|||
126224166|NCT00410410|454111600|FG008|Maintenance Period (MP)|Adverse Event|0|||
126224167|NCT00410410|454111592|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
126224168|NCT00410410|454111593|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
126224169|NCT00410410|454111594|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
126224170|NCT00410410|454111595|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
126224171|NCT00410410|454111596|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
126224172|NCT00410410|454111597|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
126224173|NCT00410410|454111598|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
126224174|NCT00410410|454111599|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
126224175|NCT00410410|454111600|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
126224176|NCT00410410|454111592|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
126224177|NCT00410410|454111593|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
126224178|NCT00410410|454111594|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
126224179|NCT00410410|454111595|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
126224180|NCT00410410|454111596|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
126224181|NCT00410410|454111597|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
126224182|NCT00410410|454111598|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
126224183|NCT00410410|454111599|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
126224184|NCT00410410|454111600|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
126224185|NCT00410410|454111592|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
126224186|NCT00410410|454111593|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
126224187|NCT00410410|454111594|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
126224188|NCT00410410|454111595|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
126224189|NCT00410410|454111596|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
126224190|NCT00410410|454111597|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
126224191|NCT00410410|454111598|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
126224192|NCT00410410|454111599|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
126224193|NCT00410410|454111600|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
126224194|NCT00410410|454111592|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126224195|NCT00410410|454111593|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126224196|NCT00410410|454111594|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126020090|NCT00807937|453368656|FG002|Overall Study|Lost to Follow-up|2|||
126020091|NCT00807937|453368657|FG003|Overall Study|Lost to Follow-up|1|||
126224197|NCT00410410|454111595|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126224198|NCT00410410|454111596|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126224199|NCT00410410|454111597|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126020092|NCT00807937|453368654|FG000|Overall Study|Lack of Efficacy|0|||
126020093|NCT00807937|453368655|FG001|Overall Study|Lack of Efficacy|0|||
126224200|NCT00410410|454111598|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
126224201|NCT00410410|454111599|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
126020094|NCT00807937|453368656|FG002|Overall Study|Lack of Efficacy|1|||
126020095|NCT00807937|453368657|FG003|Overall Study|Lack of Efficacy|2|||
126020096|NCT00807937|453368654|FG000|Overall Study|Intake of prohibited medicine|0|||
126020097|NCT00807937|453368655|FG001|Overall Study|Intake of prohibited medicine|0|||
126020098|NCT00807937|453368656|FG002|Overall Study|Intake of prohibited medicine|2|||
126020099|NCT00807937|453368657|FG003|Overall Study|Intake of prohibited medicine|0|||
126020100|NCT00807937|453368654|FG000|Overall Study|All other reasons (not provided)|2|||
126020101|NCT00807937|453368655|FG001|Overall Study|All other reasons (not provided)|4|||
126020102|NCT00807937|453368656|FG002|Overall Study|All other reasons (not provided)|0|||
126020103|NCT00807937|453368657|FG003|Overall Study|All other reasons (not provided)|1|||
126020104|NCT03485950|453368669|FG000|Overall Study|Adverse Event|1|||
126020105|NCT03485950|453368670|FG001|Overall Study|Adverse Event|0|||
126020106|NCT03485950|453368669|FG000|Overall Study|Death|3|||
126020107|NCT03485950|453368670|FG001|Overall Study|Death|2|||
126020108|NCT03485950|453368669|FG000|Overall Study|Withdrawal by Subject|3|||
126020109|NCT03485950|453368670|FG001|Overall Study|Withdrawal by Subject|0|||
126020110|NCT00988858|453368672|FG000|Overall Study|Adverse Event|7|||
126020111|NCT00988858|453368672|FG000|Overall Study|Death|1|||
126020112|NCT00988858|453368672|FG000|Overall Study|Physician Decision|1|||
126020113|NCT00988858|453368672|FG000|Overall Study|Sponsor Decision|1|||
126020114|NCT03764475|453368673|FG000|Overall Study|Adverse Event|11|||
126020115|NCT03764475|453368674|FG001|Overall Study|Adverse Event|2|||
126224202|NCT00410410|454111600|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126224203|NCT00410410|454111592|FG000|Open-Label Period (OL)|Death|0|||
126224204|NCT00410410|454111593|FG001|Open-Label Period (OL)|Death|0|||
126224205|NCT00410410|454111594|FG002|Open-Label Period (OL)|Death|0|||
126224206|NCT00410410|454111595|FG003|Open-Label Period (OL)|Death|0|||
126020116|NCT03764475|453368673|FG000|Overall Study|Lost to Follow-up|24|||
126020117|NCT03764475|453368674|FG001|Overall Study|Lost to Follow-up|10|||
126224207|NCT00410410|454111596|FG004|Open-Label Period (OL)|Death|0|||
126224208|NCT00410410|454111597|FG005|Open-Label Period (OL)|Death|0|||
126020118|NCT03764475|453368673|FG000|Overall Study|Withdrawal by Subject|26|||
126020119|NCT03764475|453368674|FG001|Overall Study|Withdrawal by Subject|10|||
126020120|NCT03764475|453368673|FG000|Overall Study|Lack of Efficacy|3|||
126020121|NCT03764475|453368674|FG001|Overall Study|Lack of Efficacy|0|||
126020122|NCT03764475|453368673|FG000|Overall Study|COVID-19 Disruption|2|||
126020123|NCT03764475|453368674|FG001|Overall Study|COVID-19 Disruption|0|||
126092786|NCT01283516|453632910|FG007|Overall Study|Withdrawal by Subject|0|||
126224209|NCT00410410|454111598|FG006|Open-Label Period (OL)|Death|0|||
126224210|NCT00410410|454111599|FG007|Open-Label Period (OL)|Death|0|||
126224211|NCT00410410|454111600|FG008|Open-Label Period (OL)|Death|1|||
126224212|NCT00410410|454111592|FG000|Open-Label Period (OL)|Adverse Event|0|||
126224213|NCT00410410|454111593|FG001|Open-Label Period (OL)|Adverse Event|0|||
126224214|NCT00410410|454111594|FG002|Open-Label Period (OL)|Adverse Event|0|||
126224215|NCT00410410|454111595|FG003|Open-Label Period (OL)|Adverse Event|0|||
126224216|NCT00410410|454111596|FG004|Open-Label Period (OL)|Adverse Event|0|||
126224217|NCT00410410|454111597|FG005|Open-Label Period (OL)|Adverse Event|0|||
126224218|NCT00410410|454111598|FG006|Open-Label Period (OL)|Adverse Event|0|||
126224219|NCT00410410|454111599|FG007|Open-Label Period (OL)|Adverse Event|0|||
126224220|NCT00410410|454111600|FG008|Open-Label Period (OL)|Adverse Event|10|||
126224221|NCT00410410|454111592|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
126224222|NCT00410410|454111593|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
126224223|NCT00410410|454111594|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
126350414|NCT04435626|454575337|FG001|Overall Study|Lost to Follow-up|5|||
126020124|NCT05510245|453368678|FG000|Overall Study|Withdrawal by Subject|1|||
126020125|NCT05510245|453368679|FG001|Overall Study|Withdrawal by Subject|0|||
126092787|NCT01283516|453632911|FG008|Overall Study|Withdrawal by Subject|36|||
126092788|NCT01283516|453632903|FG000|Overall Study|Administrative problems|0|||
126020126|NCT05510245|453368680|FG002|Overall Study|Withdrawal by Subject|0|||
126020127|NCT01239316|453368682|FG000|Overall Study|Progression/Relapse|11|||
126020128|NCT01239316|453368682|FG000|Overall Study|Adverse Event|1|||
126020129|NCT00088413|453368686|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
126020130|NCT00088413|453368687|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
126020131|NCT00088413|453368688|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
126020132|NCT00088413|453368689|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
126224224|NCT00410410|454111595|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
126224225|NCT00410410|454111596|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
126224226|NCT00410410|454111597|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
126224227|NCT00410410|454111598|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
126224228|NCT00410410|454111599|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
126224229|NCT00410410|454111600|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
126224230|NCT00410410|454111592|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
126224231|NCT00410410|454111593|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
126224232|NCT00410410|454111594|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
126224233|NCT00410410|454111595|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
126224234|NCT00410410|454111596|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
126224235|NCT00410410|454111597|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
126224236|NCT00410410|454111598|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
126020133|NCT00088413|453368686|FG000|Overall Study|Adverse Events/Side Effects|0|||
126020134|NCT00088413|453368687|FG001|Overall Study|Adverse Events/Side Effects|1|||
126020135|NCT00088413|453368688|FG002|Overall Study|Adverse Events/Side Effects|1|||
126020136|NCT00088413|453368689|FG003|Overall Study|Adverse Events/Side Effects|0|||
126020137|NCT00088413|453368686|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
126020138|NCT00088413|453368687|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
126020139|NCT00088413|453368688|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
126224237|NCT00410410|454111599|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
126224238|NCT00410410|454111600|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
126224239|NCT00410410|454111592|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
126224240|NCT00410410|454111593|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
126224241|NCT00410410|454111594|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
126224242|NCT00410410|454111595|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
126224243|NCT00410410|454111596|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
126224244|NCT00410410|454111597|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
126224245|NCT00410410|454111598|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
126224246|NCT00410410|454111599|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
126224247|NCT00410410|454111600|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
126224248|NCT00410410|454111592|FG000|Open-Label Period (OL)|Pregnancy|0|||
126224249|NCT00410410|454111593|FG001|Open-Label Period (OL)|Pregnancy|0|||
126224250|NCT00410410|454111594|FG002|Open-Label Period (OL)|Pregnancy|0|||
126224251|NCT00410410|454111595|FG003|Open-Label Period (OL)|Pregnancy|0|||
126224252|NCT00410410|454111596|FG004|Open-Label Period (OL)|Pregnancy|0|||
126224253|NCT00410410|454111597|FG005|Open-Label Period (OL)|Pregnancy|0|||
126020140|NCT00088413|453368689|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
126020141|NCT00088413|453368686|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
126020142|NCT00088413|453368687|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
126020143|NCT00088413|453368688|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
126020144|NCT00088413|453368689|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
126020145|NCT00088413|453368686|FG000|Overall Study|Death|0|||
126224254|NCT00410410|454111598|FG006|Open-Label Period (OL)|Pregnancy|0|||
126224255|NCT00410410|454111599|FG007|Open-Label Period (OL)|Pregnancy|0|||
126224256|NCT00410410|454111600|FG008|Open-Label Period (OL)|Pregnancy|1|||
126224257|NCT00410410|454111592|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126224258|NCT00410410|454111593|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126224259|NCT00410410|454111594|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126224260|NCT00410410|454111595|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126350415|NCT04435626|454575336|FG000|Overall Study|Withdrawal by Subject|6|||
126350416|NCT04435626|454575337|FG001|Overall Study|Withdrawal by Subject|7|||
126350417|NCT04435626|454575336|FG000|Overall Study|major GCP violations|8|||
126350418|NCT04435626|454575337|FG001|Overall Study|major GCP violations|7|||
126350419|NCT02864992|454575341|FG000|Overall Study|still on treatment|15|||
126350420|NCT02864992|454575342|FG001|Overall Study|still on treatment|1|||
126350421|NCT02864992|454575343|FG002|Overall Study|still on treatment|33|||
126350422|NCT05252702|454575344|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
126350423|NCT05252702|454575344|FG000|Overall Study|Death|16|||
126020146|NCT00088413|453368687|FG001|Overall Study|Death|1|||
126350424|NCT05252702|454575344|FG000|Overall Study|System explant|5|||
126350425|NCT05252702|454575344|FG000|Overall Study|Lost to Follow-up|1|||
126350426|NCT05252702|454575344|FG000|Overall Study|Withdrawn by investigator|1|||
126020147|NCT00088413|453368688|FG002|Overall Study|Death|0|||
126020148|NCT00088413|453368689|FG003|Overall Study|Death|0|||
126020149|NCT00088413|453368686|FG000|Overall Study|Progressive disease|9|||
126350427|NCT05252702|454575344|FG000|Overall Study|Visit not due|306|||
126350428|NCT05252702|454575344|FG000|Overall Study|Visit within window but not completed|92|||
126350429|NCT05252702|454575344|FG000|Overall Study|Unsuccessful implant|1|||
126350430|NCT00098475|454575350|FG000|Step 1|Progressive disease|33|||
126350431|NCT00098475|454575351|FG001|Step 1|Progressive disease|35|||
126020150|NCT00088413|453368687|FG001|Overall Study|Progressive disease|11|||
126020151|NCT00088413|453368688|FG002|Overall Study|Progressive disease|8|||
126020152|NCT00088413|453368689|FG003|Overall Study|Progressive disease|14|||
126020153|NCT00088413|453368686|FG000|Overall Study|Other|0|||
126224261|NCT00410410|454111596|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126224262|NCT00410410|454111597|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126224263|NCT00410410|454111598|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126224264|NCT00410410|454111599|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126224265|NCT00410410|454111600|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
126224266|NCT00410410|454111592|FG000|Open-Label Period (OL)|Other|0|||
126224267|NCT00410410|454111593|FG001|Open-Label Period (OL)|Other|0|||
126224268|NCT00410410|454111594|FG002|Open-Label Period (OL)|Other|0|||
126224269|NCT00410410|454111595|FG003|Open-Label Period (OL)|Other|0|||
126224270|NCT00410410|454111596|FG004|Open-Label Period (OL)|Other|0|||
126224271|NCT00410410|454111597|FG005|Open-Label Period (OL)|Other|0|||
126224272|NCT00410410|454111598|FG006|Open-Label Period (OL)|Other|0|||
126224273|NCT00410410|454111599|FG007|Open-Label Period (OL)|Other|0|||
126224274|NCT00410410|454111600|FG008|Open-Label Period (OL)|Other|7|||
126224275|NCT01783730|454111605|FG000|Overall Study|Failed to meet inclusion criteria|6|||
126224276|NCT01841359|454111606|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
126224277|NCT01841359|454111606|FG000|Overall Study|Concommitant medical issues|2|||
126224278|NCT01841359|454111606|FG000|Overall Study|Adverse Event|3|||
126224279|NCT01841359|454111606|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
126224280|NCT02151461|454111607|FG000|Overall Study|Adverse Event|5|||
126224281|NCT02151461|454111608|FG001|Overall Study|Adverse Event|1|||
126224282|NCT02151461|454111609|FG002|Overall Study|Adverse Event|0|||
126224283|NCT02151461|454111610|FG003|Overall Study|Adverse Event|2|||
126224284|NCT02151461|454111607|FG000|Overall Study|Lost to Follow-up|0|||
126224285|NCT02151461|454111608|FG001|Overall Study|Lost to Follow-up|0|||
126224286|NCT02151461|454111609|FG002|Overall Study|Lost to Follow-up|1|||
126224287|NCT02151461|454111610|FG003|Overall Study|Lost to Follow-up|1|||
126224288|NCT02151461|454111607|FG000|Overall Study|Withdrawal by Subject|1|||
126224289|NCT02151461|454111608|FG001|Overall Study|Withdrawal by Subject|0|||
126224290|NCT02151461|454111609|FG002|Overall Study|Withdrawal by Subject|1|||
126224291|NCT02151461|454111610|FG003|Overall Study|Withdrawal by Subject|1|||
126224292|NCT02151461|454111607|FG000|Overall Study|Treatment discontinuation|0|||
126224293|NCT02151461|454111608|FG001|Overall Study|Treatment discontinuation|0|||
126224294|NCT02151461|454111609|FG002|Overall Study|Treatment discontinuation|1|||
126224295|NCT02151461|454111610|FG003|Overall Study|Treatment discontinuation|0|||
126224296|NCT02168270|454111611|FG000|Overall Study|Lack of Efficacy|4|||
126224297|NCT01102777|454111612|FG000|Overall Study|Death|2|||
126224298|NCT01102777|454111613|FG001|Overall Study|Death|6|||
126224299|NCT01102777|454111612|FG000|Overall Study|Lost to Follow-up|7|||
126224300|NCT01102777|454111613|FG001|Overall Study|Lost to Follow-up|10|||
126224301|NCT00771901|454111614|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
126224302|NCT00771901|454111615|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
126224303|NCT00771901|454111616|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
126224304|NCT01965652|454111617|FG000|Overall Study|Adverse Event|40|||
126224305|NCT01965652|454111618|FG001|Overall Study|Adverse Event|37|||
126350432|NCT00098475|454575352|FG002|Step 1|Progressive disease|2|||
126350433|NCT00098475|454575353|FG003|Step 1|Progressive disease|1|||
126350434|NCT00098475|454575350|FG000|Step 1|Adverse Event|56|||
126350435|NCT00098475|454575351|FG001|Step 1|Adverse Event|37|||
126350436|NCT00098475|454575352|FG002|Step 1|Adverse Event|0|||
126350437|NCT00098475|454575353|FG003|Step 1|Adverse Event|1|||
126350438|NCT00098475|454575350|FG000|Step 1|Death|8|||
126350439|NCT00098475|454575351|FG001|Step 1|Death|5|||
126020154|NCT00088413|453368687|FG001|Overall Study|Other|1|||
126020155|NCT00088413|453368688|FG002|Overall Study|Other|0|||
126020156|NCT00088413|453368689|FG003|Overall Study|Other|0|||
126020157|NCT00088413|453368686|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
126020158|NCT00088413|453368687|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
126020159|NCT00088413|453368688|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
126020160|NCT00088413|453368689|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
126224306|NCT01965652|454111617|FG000|Overall Study|Withdrawal by Subject|62|||
126224307|NCT01965652|454111618|FG001|Overall Study|Withdrawal by Subject|69|||
126224308|NCT01965652|454111617|FG000|Overall Study|Lost to Follow-up|53|||
126224309|NCT01965652|454111618|FG001|Overall Study|Lost to Follow-up|40|||
126224310|NCT01965652|454111617|FG000|Overall Study|Protocol Violation|34|||
126224311|NCT01965652|454111618|FG001|Overall Study|Protocol Violation|38|||
126224312|NCT01965652|454111617|FG000|Overall Study|Death|3|||
126224313|NCT01965652|454111618|FG001|Overall Study|Death|4|||
126224314|NCT01965652|454111617|FG000|Overall Study|Other - Miscellaneous|18|||
126224315|NCT01965652|454111618|FG001|Overall Study|Other - Miscellaneous|21|||
126020161|NCT01551355|453368690|FG000|Overall Study|Lost to Follow-up|51|||
126020162|NCT01551355|453368691|FG001|Overall Study|Lost to Follow-up|49|||
126020163|NCT01551355|453368692|FG002|Overall Study|Lost to Follow-up|34|||
126020164|NCT01551355|453368693|FG003|Overall Study|Lost to Follow-up|24|||
126020165|NCT01551355|453368694|FG004|Overall Study|Lost to Follow-up|9|||
126224316|NCT01965652|454111617|FG000|Overall Study|Pregnancy|0|||
126350440|NCT00098475|454575352|FG002|Step 1|Death|0|||
126020166|NCT01551355|453368695|FG005|Overall Study|Lost to Follow-up|6|||
126224317|NCT01965652|454111618|FG001|Overall Study|Pregnancy|1|||
126224318|NCT01121900|454111619|FG000|First Intervention Period|Adverse Event|1|||
126350441|NCT00098475|454575353|FG003|Step 1|Death|1|||
126350442|NCT00098475|454575350|FG000|Step 1|Withdrawal by Subject|14|||
126224319|NCT01121900|454111620|FG001|First Intervention Period|Adverse Event|1|||
126224320|NCT01121900|454111619|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126224321|NCT01121900|454111620|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126224322|NCT01328054|454111621|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
126224323|NCT01328054|454111622|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
126224324|NCT01328054|454111621|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
126224325|NCT01328054|454111622|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
126224326|NCT01328054|454111621|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
126224327|NCT01328054|454111622|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
126224328|NCT03493698|454111623|FG000|Treatment Period C|Adverse Event|1|||
126224329|NCT03493698|454111623|FG000|Treatment Period C|Withdrawal by Subject|1|||
126224330|NCT03760510|454111624|FG000|Overall Study|Not ventilated for 24 hours|105|||
126224331|NCT03760510|454111625|FG001|Overall Study|Not ventilated for 24 hours|97|||
126224332|NCT00291330|454111628|FG000|Overall Study|Adverse Event|47|||
126224333|NCT00291330|454111629|FG001|Overall Study|Adverse Event|40|||
126224334|NCT00291330|454111628|FG000|Overall Study|Protocol Violation|13|||
126224335|NCT00291330|454111629|FG001|Overall Study|Protocol Violation|20|||
126224336|NCT00291330|454111628|FG000|Overall Study|Lost to Follow-up|16|||
126224337|NCT00291330|454111629|FG001|Overall Study|Lost to Follow-up|11|||
126224338|NCT00291330|454111628|FG000|Overall Study|Withdrawal by Subject|22|||
126224339|NCT00291330|454111629|FG001|Overall Study|Withdrawal by Subject|25|||
126224340|NCT00291330|454111628|FG000|Overall Study|Other|3|||
126224341|NCT00291330|454111629|FG001|Overall Study|Other|1|||
126224342|NCT00566709|454111632|FG000|Overall Study|Protocol Violation|5|||
126224343|NCT00566709|454111633|FG001|Overall Study|Protocol Violation|0|||
126224344|NCT01829295|454111634|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
126224345|NCT01829295|454111635|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
126224346|NCT01829295|454111636|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
126224347|NCT01829295|454111637|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
126224348|NCT01829295|454111634|FG000|6-12 Months|Adverse Event|0|||
126224349|NCT01829295|454111635|FG001|6-12 Months|Adverse Event|0|||
126224350|NCT01829295|454111636|FG002|6-12 Months|Adverse Event|3|||
126224351|NCT01829295|454111637|FG003|6-12 Months|Adverse Event|2|||
126224352|NCT01829295|454111634|FG000|6-12 Months|Lost to Follow-up|2|||
126224353|NCT01829295|454111635|FG001|6-12 Months|Lost to Follow-up|0|||
126224354|NCT01829295|454111636|FG002|6-12 Months|Lost to Follow-up|0|||
126224355|NCT01829295|454111637|FG003|6-12 Months|Lost to Follow-up|0|||
126224356|NCT01829295|454111634|FG000|6-12 Months|Withdrawal by Subject|2|||
126224357|NCT01829295|454111635|FG001|6-12 Months|Withdrawal by Subject|2|||
126224358|NCT01829295|454111636|FG002|6-12 Months|Withdrawal by Subject|0|||
126224359|NCT01829295|454111637|FG003|6-12 Months|Withdrawal by Subject|0|||
126224360|NCT03443869|454111638|FG000|Overall Study|Death|3|||
126224361|NCT03443869|454111639|FG001|Overall Study|Death|3|||
126224362|NCT03443869|454111638|FG000|Overall Study|Withdrawal by Subject|34|||
126224363|NCT03443869|454111639|FG001|Overall Study|Withdrawal by Subject|22|||
126224364|NCT03443869|454111638|FG000|Overall Study|Lost to Follow-up|1|||
126224365|NCT03443869|454111639|FG001|Overall Study|Lost to Follow-up|2|||
126224366|NCT03443869|454111638|FG000|Overall Study|Physician Decision|3|||
126224367|NCT03443869|454111639|FG001|Overall Study|Physician Decision|3|||
126224368|NCT03443869|454111638|FG000|Overall Study|Other|4|||
126350443|NCT00098475|454575351|FG001|Step 1|Withdrawal by Subject|11|||
126350444|NCT00098475|454575352|FG002|Step 1|Withdrawal by Subject|0|||
126350445|NCT00098475|454575353|FG003|Step 1|Withdrawal by Subject|0|||
126350446|NCT00098475|454575350|FG000|Step 1|Physician Decision|5|||
126092789|NCT01283516|453632904|FG001|Overall Study|Administrative problems|0|||
126092790|NCT01283516|453632905|FG002|Overall Study|Administrative problems|0|||
126092791|NCT01283516|453632906|FG003|Overall Study|Administrative problems|0|||
126092792|NCT01283516|453632907|FG004|Overall Study|Administrative problems|0|||
126092793|NCT01283516|453632908|FG005|Overall Study|Administrative problems|1|||
126092794|NCT01283516|453632909|FG006|Overall Study|Administrative problems|1|||
126092795|NCT01283516|453632910|FG007|Overall Study|Administrative problems|1|||
126350447|NCT00098475|454575351|FG001|Step 1|Physician Decision|2|||
126224369|NCT03443869|454111639|FG001|Overall Study|Other|4|||
126224370|NCT00299728|454111640|FG000|Overall Study|Lost to Follow-up|0|||
126224371|NCT00299728|454111641|FG001|Overall Study|Lost to Follow-up|1|||
126350448|NCT00098475|454575352|FG002|Step 1|Physician Decision|0|||
126350449|NCT00098475|454575353|FG003|Step 1|Physician Decision|0|||
126350450|NCT00098475|454575350|FG000|Step 1|Alternative therapy|31|||
126092796|NCT01283516|453632911|FG008|Overall Study|Administrative problems|39|||
126224372|NCT00299728|454111640|FG000|Overall Study|Withdrawal by Subject|0|||
126224373|NCT00299728|454111641|FG001|Overall Study|Withdrawal by Subject|1|||
126224374|NCT00299728|454111640|FG000|Overall Study|Progressive disease|0|||
126224375|NCT00299728|454111641|FG001|Overall Study|Progressive disease|1|||
126224376|NCT02826603|454111642|FG000|Overall Study|Adverse Event|17|||
126224377|NCT02826603|454111643|FG001|Overall Study|Adverse Event|9|||
126224378|NCT02826603|454111642|FG000|Overall Study|Lack of Efficacy|4|||
126350451|NCT00098475|454575351|FG001|Step 1|Alternative therapy|43|||
126224379|NCT02826603|454111643|FG001|Overall Study|Lack of Efficacy|9|||
126224380|NCT02826603|454111642|FG000|Overall Study|Lost to Follow-up|13|||
126224381|NCT02826603|454111643|FG001|Overall Study|Lost to Follow-up|12|||
126224382|NCT02826603|454111642|FG000|Overall Study|Noncompliance with treatment|0|||
126224383|NCT02826603|454111643|FG001|Overall Study|Noncompliance with treatment|2|||
126224384|NCT02826603|454111642|FG000|Overall Study|Physician Decision|1|||
126224385|NCT02826603|454111643|FG001|Overall Study|Physician Decision|7|||
126224386|NCT02826603|454111642|FG000|Overall Study|Pregnancy|1|||
126224387|NCT02826603|454111643|FG001|Overall Study|Pregnancy|2|||
126224388|NCT02826603|454111642|FG000|Overall Study|Protocol Violation|3|||
126224389|NCT02826603|454111643|FG001|Overall Study|Protocol Violation|3|||
126224390|NCT02826603|454111642|FG000|Overall Study|Withdrawal by Subject|20|||
126224391|NCT02826603|454111643|FG001|Overall Study|Withdrawal by Subject|19|||
126224392|NCT02826603|454111642|FG000|Overall Study|Death|2|||
126224393|NCT02826603|454111643|FG001|Overall Study|Death|0|||
126224394|NCT02826603|454111642|FG000|Overall Study|New therapy for study indication|0|||
126224395|NCT02826603|454111643|FG001|Overall Study|New therapy for study indication|1|||
126224396|NCT01337050|454111647|FG000|Overall Study|Death|0|||
126224397|NCT01337050|454111648|FG001|Overall Study|Death|0|||
126224398|NCT01337050|454111649|FG002|Overall Study|Death|4|||
126224399|NCT01337050|454111647|FG000|Overall Study|Other|4|||
126224400|NCT01337050|454111648|FG001|Overall Study|Other|6|||
126224401|NCT01337050|454111649|FG002|Overall Study|Other|8|||
126224402|NCT01337050|454111647|FG000|Overall Study|Participants refused further follow-up|0|||
126224403|NCT01337050|454111648|FG001|Overall Study|Participants refused further follow-up|7|||
126224404|NCT01337050|454111649|FG002|Overall Study|Participants refused further follow-up|7|||
126224405|NCT00003102|454111650|FG000|Overall Study|Physician Decision|1|||
126224406|NCT00003102|454111651|FG001|Overall Study|Physician Decision|1|||
126224407|NCT00003102|454111652|FG002|Overall Study|Physician Decision|0|||
126224408|NCT00003102|454111650|FG000|Overall Study|Progressive Disease|0|||
126224409|NCT00003102|454111651|FG001|Overall Study|Progressive Disease|1|||
126224410|NCT00003102|454111652|FG002|Overall Study|Progressive Disease|0|||
126224411|NCT00003102|454111650|FG000|Overall Study|Adverse Event|0|||
126224412|NCT00003102|454111651|FG001|Overall Study|Adverse Event|1|||
126224413|NCT00003102|454111652|FG002|Overall Study|Adverse Event|1|||
126224414|NCT00003102|454111650|FG000|Overall Study|Death|0|||
126224415|NCT00003102|454111651|FG001|Overall Study|Death|0|||
126224416|NCT00003102|454111652|FG002|Overall Study|Death|1|||
126224417|NCT00583596|454111653|FG000|Overall Study|Lost to Follow-up|110|||
126224418|NCT00583596|454111653|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
126224419|NCT00583596|454111653|FG000|Overall Study|Death|2|||
126224420|NCT00583596|454111653|FG000|Overall Study|Withdrawal by Subject|6|||
126224421|NCT00583596|454111653|FG000|Overall Study|Lost to Follow-up|94|||
126224422|NCT00583596|454111653|FG000|Overall Study|Data not complete|1|||
126224423|NCT00583596|454111653|FG000|Overall Study|Not consented|15|||
126224424|NCT00583596|454111653|FG000|Overall Study|Outside f-up window|26|||
126224425|NCT00656019|454111654|FG000|Overall Study|Not Eligible|10|||
126224426|NCT00656019|454111655|FG001|Overall Study|Not Eligible|0|||
126224427|NCT00656019|454111656|FG002|Overall Study|Not Eligible|0|||
126224428|NCT00656019|454111657|FG003|Overall Study|Not Eligible|0|||
126224429|NCT00656019|454111654|FG000|Overall Study|Withdrawal by Subject|2|||
126224430|NCT00656019|454111655|FG001|Overall Study|Withdrawal by Subject|0|||
126224431|NCT00656019|454111656|FG002|Overall Study|Withdrawal by Subject|0|||
126224432|NCT00656019|454111657|FG003|Overall Study|Withdrawal by Subject|0|||
126224433|NCT00656019|454111654|FG000|Overall Study|Lost to Follow-up|2|||
126224434|NCT00656019|454111655|FG001|Overall Study|Lost to Follow-up|1|||
126224435|NCT00656019|454111656|FG002|Overall Study|Lost to Follow-up|0|||
126224436|NCT00656019|454111657|FG003|Overall Study|Lost to Follow-up|0|||
126224437|NCT00096486|454111658|FG000|Overall Study|Withdrawal by Subject|0|||
126224438|NCT00096486|454111659|FG001|Overall Study|Withdrawal by Subject|0|||
126224439|NCT00096486|454111660|FG002|Overall Study|Withdrawal by Subject|1|||
126224440|NCT00096486|454111661|FG003|Overall Study|Withdrawal by Subject|1|||
126224441|NCT00096486|454111658|FG000|Overall Study|Not Treated|0|||
126224442|NCT00096486|454111659|FG001|Overall Study|Not Treated|0|||
126020167|NCT02279095|453369971|FG000|Overall Study|Non-Compliance|1|||
126224443|NCT00096486|454111660|FG002|Overall Study|Not Treated|1|||
126224444|NCT00096486|454111661|FG003|Overall Study|Not Treated|1|||
126224445|NCT03558997|454111662|FG000|Overall Study|Adverse Event|0|||
126224446|NCT03558997|454111663|FG001|Overall Study|Adverse Event|2|||
126224447|NCT03558997|454111664|FG002|Overall Study|Adverse Event|5|||
126224448|NCT03558997|454111665|FG003|Overall Study|Adverse Event|1|||
126224449|NCT03558997|454111662|FG000|Overall Study|Physician Decision|0|||
126224450|NCT03558997|454111663|FG001|Overall Study|Physician Decision|0|||
126224451|NCT03558997|454111664|FG002|Overall Study|Physician Decision|1|||
126224452|NCT03558997|454111665|FG003|Overall Study|Physician Decision|0|||
126224453|NCT03558997|454111662|FG000|Overall Study|Withdrawal by Subject|1|||
126224454|NCT03558997|454111663|FG001|Overall Study|Withdrawal by Subject|0|||
126224455|NCT03558997|454111664|FG002|Overall Study|Withdrawal by Subject|1|||
126224456|NCT03558997|454111665|FG003|Overall Study|Withdrawal by Subject|1|||
126224457|NCT03558997|454111662|FG000|Overall Study|Lost to Follow-up|0|||
126224458|NCT03558997|454111663|FG001|Overall Study|Lost to Follow-up|0|||
126224459|NCT03558997|454111664|FG002|Overall Study|Lost to Follow-up|1|||
126224460|NCT03558997|454111665|FG003|Overall Study|Lost to Follow-up|0|||
126224461|NCT02230085|454111668|FG000|Overall Study|Physician Decision|1|||
126224462|NCT02230085|454111668|FG000|Overall Study|Withdrawal by Subject|3|||
126224463|NCT01360632|454111672|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
126224464|NCT01360632|454111673|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
126224465|NCT01360632|454111674|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
126224466|NCT01360632|454111675|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
126224467|NCT01360632|454111676|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
126224468|NCT01360632|454111672|FG000|Phase A (8 Weeks)|Adverse Event|60|||
126224469|NCT01360632|454111673|FG001|Phase A (8 Weeks)|Adverse Event|0|||
126224470|NCT01360632|454111674|FG002|Phase A (8 Weeks)|Adverse Event|0|||
126224471|NCT01360632|454111675|FG003|Phase A (8 Weeks)|Adverse Event|0|||
126224472|NCT01360632|454111676|FG004|Phase A (8 Weeks)|Adverse Event|0|||
126224473|NCT01360632|454111672|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
126224474|NCT01360632|454111673|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
126224475|NCT01360632|454111674|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
126224476|NCT01360632|454111675|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
126224477|NCT01360632|454111676|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
126224478|NCT01360632|454111672|FG000|Phase A (8 Weeks)|Physician Decision|10|||
126224479|NCT01360632|454111673|FG001|Phase A (8 Weeks)|Physician Decision|0|||
126224480|NCT01360632|454111674|FG002|Phase A (8 Weeks)|Physician Decision|0|||
126224481|NCT01360632|454111675|FG003|Phase A (8 Weeks)|Physician Decision|0|||
126224482|NCT01360632|454111676|FG004|Phase A (8 Weeks)|Physician Decision|0|||
126224483|NCT01360632|454111672|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
126224484|NCT01360632|454111673|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
126224485|NCT01360632|454111674|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
126224486|NCT01360632|454111675|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
126224487|NCT01360632|454111676|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
126224488|NCT01360632|454111672|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
126224489|NCT01360632|454111673|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
126224490|NCT01360632|454111674|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
126224491|NCT01360632|454111675|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
126224492|NCT01360632|454111676|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
126224493|NCT01360632|454111672|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
126224494|NCT01360632|454111673|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
126224495|NCT01360632|454111674|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
126224496|NCT01360632|454111675|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
126224497|NCT01360632|454111676|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
126224498|NCT01360632|454111672|FG000|Phase B (6 Weeks)|Adverse Event|0|||
126224499|NCT01360632|454111673|FG001|Phase B (6 Weeks)|Adverse Event|3|||
126224500|NCT01360632|454111674|FG002|Phase B (6 Weeks)|Adverse Event|9|||
126224501|NCT01360632|454111675|FG003|Phase B (6 Weeks)|Adverse Event|3|||
126224502|NCT01360632|454111676|FG004|Phase B (6 Weeks)|Adverse Event|0|||
126224503|NCT01360632|454111672|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126224504|NCT01360632|454111673|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126224505|NCT01360632|454111674|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
126224506|NCT01360632|454111675|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
126224507|NCT01360632|454111676|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126224508|NCT01360632|454111672|FG000|Phase B (6 Weeks)|Physician Decision|0|||
126224509|NCT01360632|454111673|FG001|Phase B (6 Weeks)|Physician Decision|0|||
126224510|NCT01360632|454111674|FG002|Phase B (6 Weeks)|Physician Decision|0|||
126224511|NCT01360632|454111675|FG003|Phase B (6 Weeks)|Physician Decision|1|||
126224512|NCT01360632|454111676|FG004|Phase B (6 Weeks)|Physician Decision|0|||
126224513|NCT01360632|454111672|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
126224514|NCT01360632|454111673|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
126224515|NCT01360632|454111674|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
126224516|NCT01360632|454111675|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
126224517|NCT01360632|454111676|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
126224518|NCT01360632|454111672|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
126224519|NCT01360632|454111673|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
126224520|NCT01360632|454111674|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
126224521|NCT01360632|454111675|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
126224522|NCT01360632|454111676|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
126224523|NCT01360632|454111672|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
126224524|NCT01360632|454111673|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
126020168|NCT02279095|453369971|FG000|Overall Study|Withdrawal by Subject|8|||
126020169|NCT02279095|453369971|FG000|Overall Study|Adverse Event|2|||
126020170|NCT02279095|453369971|FG000|Overall Study|Other|7|||
126224525|NCT01360632|454111674|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
126224526|NCT01360632|454111675|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
126224527|NCT01360632|454111676|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
126224528|NCT01360632|454111672|FG000|Phase A+|Lost to Follow-up|0|||
126224529|NCT01360632|454111673|FG001|Phase A+|Lost to Follow-up|0|||
126224530|NCT01360632|454111674|FG002|Phase A+|Lost to Follow-up|0|||
126224531|NCT01360632|454111675|FG003|Phase A+|Lost to Follow-up|0|||
126224532|NCT01360632|454111676|FG004|Phase A+|Lost to Follow-up|2|||
126224533|NCT01360632|454111672|FG000|Phase A+|Adverse Event|0|||
126224534|NCT01360632|454111673|FG001|Phase A+|Adverse Event|0|||
126224535|NCT01360632|454111674|FG002|Phase A+|Adverse Event|0|||
126224536|NCT01360632|454111675|FG003|Phase A+|Adverse Event|0|||
126224537|NCT01360632|454111676|FG004|Phase A+|Adverse Event|2|||
126224538|NCT01360632|454111672|FG000|Phase A+|Met Withdrawal Criteria|0|||
126224539|NCT01360632|454111673|FG001|Phase A+|Met Withdrawal Criteria|0|||
126224540|NCT01360632|454111674|FG002|Phase A+|Met Withdrawal Criteria|0|||
126224541|NCT01360632|454111675|FG003|Phase A+|Met Withdrawal Criteria|0|||
126224542|NCT01360632|454111676|FG004|Phase A+|Met Withdrawal Criteria|7|||
126224543|NCT01360632|454111672|FG000|Phase A+|Physician Decision|0|||
126224544|NCT01360632|454111673|FG001|Phase A+|Physician Decision|0|||
126224545|NCT01360632|454111674|FG002|Phase A+|Physician Decision|0|||
126224546|NCT01360632|454111675|FG003|Phase A+|Physician Decision|0|||
126224547|NCT01360632|454111676|FG004|Phase A+|Physician Decision|3|||
126224548|NCT01360632|454111672|FG000|Phase A+|Withdrawal by Subject|0|||
126224549|NCT01360632|454111673|FG001|Phase A+|Withdrawal by Subject|0|||
126224550|NCT01360632|454111674|FG002|Phase A+|Withdrawal by Subject|0|||
126350452|NCT00098475|454575352|FG002|Step 1|Alternative therapy|1|||
126350453|NCT00098475|454575353|FG003|Step 1|Alternative therapy|0|||
126350454|NCT00098475|454575350|FG000|Step 1|Other disease|2|||
126350455|NCT00098475|454575351|FG001|Step 1|Other disease|1|||
126350456|NCT00098475|454575352|FG002|Step 1|Other disease|1|||
126350457|NCT00098475|454575353|FG003|Step 1|Other disease|0|||
126350458|NCT00098475|454575350|FG000|Step 1|Never started treatment|0|||
126350459|NCT00098475|454575351|FG001|Step 1|Never started treatment|2|||
126350460|NCT00098475|454575352|FG002|Step 1|Never started treatment|0|||
126350461|NCT00098475|454575353|FG003|Step 1|Never started treatment|0|||
126350462|NCT00098475|454575350|FG000|Step 1|Still on treatment as of this analysis|14|||
126350463|NCT00098475|454575351|FG001|Step 1|Still on treatment as of this analysis|27|||
126350464|NCT00098475|454575352|FG002|Step 1|Still on treatment as of this analysis|0|||
126350465|NCT00098475|454575353|FG003|Step 1|Still on treatment as of this analysis|0|||
126350466|NCT00098475|454575350|FG000|Step 1|Knee surgery|1|||
126350467|NCT00098475|454575351|FG001|Step 1|Knee surgery|0|||
126350468|NCT00098475|454575352|FG002|Step 1|Knee surgery|0|||
126350469|NCT00098475|454575353|FG003|Step 1|Knee surgery|0|||
126350470|NCT00098475|454575350|FG000|Step 1|Complications|1|||
126350471|NCT00098475|454575351|FG001|Step 1|Complications|0|||
126350472|NCT00098475|454575352|FG002|Step 1|Complications|0|||
126350473|NCT00098475|454575353|FG003|Step 1|Complications|0|||
126350474|NCT00098475|454575350|FG000|Step 1|Cannot comply due to other tx|0|||
126350475|NCT00098475|454575351|FG001|Step 1|Cannot comply due to other tx|1|||
126350476|NCT00098475|454575352|FG002|Step 1|Cannot comply due to other tx|0|||
126350477|NCT00098475|454575353|FG003|Step 1|Cannot comply due to other tx|0|||
126350478|NCT00098475|454575350|FG000|Step 1|Both patient and physician's decision|2|||
126350479|NCT00098475|454575351|FG001|Step 1|Both patient and physician's decision|1|||
126350480|NCT00098475|454575352|FG002|Step 1|Both patient and physician's decision|0|||
126350481|NCT00098475|454575353|FG003|Step 1|Both patient and physician's decision|0|||
126350482|NCT00098475|454575350|FG000|Step 1|Incorrect disease assessment|2|||
126020171|NCT02279095|453369971|FG000|Overall Study|Lost to Follow-up|1|||
126020172|NCT05938413|453369972|FG000|Overall Study|Lost to Follow-up|1|||
126224551|NCT01360632|454111675|FG003|Phase A+|Withdrawal by Subject|0|||
126224552|NCT01360632|454111676|FG004|Phase A+|Withdrawal by Subject|8|||
126224553|NCT01360632|454111672|FG000|Phase A+|Protocol Deviation|0|||
126224554|NCT01360632|454111673|FG001|Phase A+|Protocol Deviation|0|||
126224555|NCT01360632|454111674|FG002|Phase A+|Protocol Deviation|0|||
126350483|NCT00098475|454575351|FG001|Step 1|Incorrect disease assessment|0|||
126350484|NCT00098475|454575352|FG002|Step 1|Incorrect disease assessment|0|||
126350485|NCT00098475|454575353|FG003|Step 1|Incorrect disease assessment|0|||
126224556|NCT01360632|454111675|FG003|Phase A+|Protocol Deviation|0|||
126224557|NCT01360632|454111676|FG004|Phase A+|Protocol Deviation|3|||
126350486|NCT00098475|454575350|FG000|Step 1|Off treatment for > specified timeframe|1|||
126350487|NCT00098475|454575351|FG001|Step 1|Off treatment for > specified timeframe|1|||
126350488|NCT00098475|454575352|FG002|Step 1|Off treatment for > specified timeframe|0|||
126350489|NCT00098475|454575353|FG003|Step 1|Off treatment for > specified timeframe|0|||
126224558|NCT02173301|454111679|FG000|Overall Study|Adverse Event|7|||
126224559|NCT02173301|454111680|FG001|Overall Study|Adverse Event|8|||
126224560|NCT02173301|454111681|FG002|Overall Study|Adverse Event|13|||
126224561|NCT02173301|454111682|FG003|Overall Study|Adverse Event|5|||
126224562|NCT02173301|454111679|FG000|Overall Study|Withdrawal by Subject|8|||
126224563|NCT02173301|454111680|FG001|Overall Study|Withdrawal by Subject|10|||
126224564|NCT02173301|454111681|FG002|Overall Study|Withdrawal by Subject|4|||
126224565|NCT02173301|454111682|FG003|Overall Study|Withdrawal by Subject|8|||
126224566|NCT02173301|454111679|FG000|Overall Study|Lost to Follow-up|4|||
126224567|NCT02173301|454111680|FG001|Overall Study|Lost to Follow-up|4|||
126224568|NCT02173301|454111681|FG002|Overall Study|Lost to Follow-up|2|||
126224569|NCT02173301|454111682|FG003|Overall Study|Lost to Follow-up|2|||
126224570|NCT02173301|454111679|FG000|Overall Study|Protocol Violation|0|||
126224571|NCT02173301|454111680|FG001|Overall Study|Protocol Violation|1|||
126224572|NCT02173301|454111681|FG002|Overall Study|Protocol Violation|0|||
126224573|NCT02173301|454111682|FG003|Overall Study|Protocol Violation|0|||
126224574|NCT02173301|454111679|FG000|Overall Study|Physician Decision|0|||
126224575|NCT02173301|454111680|FG001|Overall Study|Physician Decision|0|||
126224576|NCT02173301|454111681|FG002|Overall Study|Physician Decision|1|||
126224577|NCT02173301|454111682|FG003|Overall Study|Physician Decision|0|||
126224578|NCT02173301|454111679|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
126224579|NCT02173301|454111680|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
126224580|NCT02173301|454111681|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
126224581|NCT02173301|454111682|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
126224582|NCT03016078|454111684|FG000|Overall Study|Protocol Violation|1|||
126224583|NCT03016078|454111684|FG000|Overall Study|Protocol Violation|1|||
126224584|NCT00409188|454113418|FG000|Overall Study|Ongoing at data cut-off|383|||
126224585|NCT00409188|454113419|FG001|Overall Study|Ongoing at data cut-off|175|||
126224586|NCT01393990|454113423|FG000|Overall Study|Adverse Event|0|||
126224587|NCT01393990|454113424|FG001|Overall Study|Adverse Event|0|||
126224588|NCT01393990|454113425|FG002|Overall Study|Adverse Event|0|||
126224589|NCT01393990|454113426|FG003|Overall Study|Adverse Event|0|||
126224590|NCT01393990|454113427|FG004|Overall Study|Adverse Event|0|||
126224591|NCT01393990|454113428|FG005|Overall Study|Adverse Event|0|||
126224592|NCT01393990|454113429|FG006|Overall Study|Adverse Event|0|||
126224593|NCT01393990|454113430|FG007|Overall Study|Adverse Event|0|||
126224594|NCT01393990|454113431|FG008|Overall Study|Adverse Event|0|||
126224595|NCT01393990|454113432|FG009|Overall Study|Adverse Event|0|||
126224596|NCT01393990|454113433|FG010|Overall Study|Adverse Event|0|||
126224597|NCT01393990|454113434|FG011|Overall Study|Adverse Event|0|||
126224598|NCT01393990|454113435|FG012|Overall Study|Adverse Event|0|||
126224599|NCT01393990|454113436|FG013|Overall Study|Adverse Event|0|||
126224600|NCT01393990|454113437|FG014|Overall Study|Adverse Event|1|||
126224601|NCT01393990|454113438|FG015|Overall Study|Adverse Event|1|||
126224602|NCT01393990|454113439|FG016|Overall Study|Adverse Event|0|||
126224603|NCT01393990|454113440|FG017|Overall Study|Adverse Event|0|||
126224604|NCT01393990|454113423|FG000|Overall Study|Progressive Disease|1|||
126224605|NCT01393990|454113424|FG001|Overall Study|Progressive Disease|0|||
126224606|NCT01393990|454113425|FG002|Overall Study|Progressive Disease|0|||
126224607|NCT01393990|454113426|FG003|Overall Study|Progressive Disease|1|||
126224608|NCT01393990|454113427|FG004|Overall Study|Progressive Disease|1|||
126224609|NCT01393990|454113428|FG005|Overall Study|Progressive Disease|1|||
126224610|NCT01393990|454113429|FG006|Overall Study|Progressive Disease|1|||
126224611|NCT01393990|454113430|FG007|Overall Study|Progressive Disease|1|||
126224612|NCT01393990|454113431|FG008|Overall Study|Progressive Disease|3|||
126224613|NCT01393990|454113432|FG009|Overall Study|Progressive Disease|1|||
126224614|NCT01393990|454113433|FG010|Overall Study|Progressive Disease|0|||
126224615|NCT01393990|454113434|FG011|Overall Study|Progressive Disease|0|||
126020173|NCT05938413|453369973|FG001|Overall Study|Lost to Follow-up|7|||
126020174|NCT05938413|453369972|FG000|Overall Study|Withdrawal by Subject|1|||
126020175|NCT05938413|453369973|FG001|Overall Study|Withdrawal by Subject|1|||
126020176|NCT04817670|453369978|FG000|Overall Study|Withdrawal by Subject|1|||
126020177|NCT04817670|453369979|FG001|Overall Study|Withdrawal by Subject|0|||
126224616|NCT01393990|454113435|FG012|Overall Study|Progressive Disease|0|||
126224617|NCT01393990|454113436|FG013|Overall Study|Progressive Disease|1|||
126224618|NCT01393990|454113437|FG014|Overall Study|Progressive Disease|6|||
126224619|NCT01393990|454113438|FG015|Overall Study|Progressive Disease|1|||
126020178|NCT04817670|453369980|FG002|Overall Study|Withdrawal by Subject|0|||
126224620|NCT01393990|454113439|FG016|Overall Study|Progressive Disease|0|||
126020179|NCT04817670|453369981|FG003|Overall Study|Withdrawal by Subject|0|||
126224621|NCT01393990|454113440|FG017|Overall Study|Progressive Disease|0|||
126224622|NCT01393990|454113423|FG000|Overall Study|Death|0|||
126224623|NCT01393990|454113424|FG001|Overall Study|Death|0|||
126224624|NCT01393990|454113425|FG002|Overall Study|Death|0|||
126020180|NCT04817670|453369982|FG004|Overall Study|Withdrawal by Subject|0|||
126020181|NCT04817670|453369978|FG000|Overall Study|Lost to Follow-up|0|||
126020182|NCT04817670|453369979|FG001|Overall Study|Lost to Follow-up|0|||
126020183|NCT04817670|453369980|FG002|Overall Study|Lost to Follow-up|1|||
126020184|NCT04817670|453369981|FG003|Overall Study|Lost to Follow-up|0|||
126020185|NCT04817670|453369982|FG004|Overall Study|Lost to Follow-up|0|||
126020186|NCT03312907|453369983|FG000|Overall Study|Adverse Event|1|||
126020187|NCT03312907|453369984|FG001|Overall Study|Adverse Event|6|||
126092797|NCT01283516|453632903|FG000|Overall Study|Lost to Follow-up|0|||
126092798|NCT01283516|453632904|FG001|Overall Study|Lost to Follow-up|0|||
126092799|NCT01283516|453632905|FG002|Overall Study|Lost to Follow-up|0|||
126092800|NCT01283516|453632906|FG003|Overall Study|Lost to Follow-up|0|||
126224625|NCT01393990|454113426|FG003|Overall Study|Death|0|||
126224626|NCT01393990|454113427|FG004|Overall Study|Death|1|||
126224627|NCT01393990|454113428|FG005|Overall Study|Death|0|||
126224628|NCT01393990|454113429|FG006|Overall Study|Death|0|||
126224629|NCT01393990|454113430|FG007|Overall Study|Death|0|||
126224630|NCT01393990|454113431|FG008|Overall Study|Death|0|||
126224631|NCT01393990|454113432|FG009|Overall Study|Death|0|||
126224632|NCT01393990|454113433|FG010|Overall Study|Death|0|||
126224633|NCT01393990|454113434|FG011|Overall Study|Death|0|||
126224634|NCT01393990|454113435|FG012|Overall Study|Death|0|||
126224635|NCT01393990|454113436|FG013|Overall Study|Death|1|||
126224636|NCT01393990|454113437|FG014|Overall Study|Death|1|||
126224637|NCT01393990|454113438|FG015|Overall Study|Death|0|||
126224638|NCT01393990|454113439|FG016|Overall Study|Death|0|||
126224639|NCT01393990|454113440|FG017|Overall Study|Death|0|||
126224640|NCT01393990|454113423|FG000|Overall Study|Withdrawal by Subject|0|||
126224641|NCT01393990|454113424|FG001|Overall Study|Withdrawal by Subject|0|||
126224642|NCT01393990|454113425|FG002|Overall Study|Withdrawal by Subject|0|||
126224643|NCT01393990|454113426|FG003|Overall Study|Withdrawal by Subject|0|||
126224644|NCT01393990|454113427|FG004|Overall Study|Withdrawal by Subject|0|||
126224645|NCT01393990|454113428|FG005|Overall Study|Withdrawal by Subject|0|||
126224646|NCT01393990|454113429|FG006|Overall Study|Withdrawal by Subject|0|||
126224647|NCT01393990|454113430|FG007|Overall Study|Withdrawal by Subject|0|||
126224648|NCT01393990|454113431|FG008|Overall Study|Withdrawal by Subject|0|||
126224649|NCT01393990|454113432|FG009|Overall Study|Withdrawal by Subject|0|||
126224650|NCT01393990|454113433|FG010|Overall Study|Withdrawal by Subject|0|||
126224651|NCT01393990|454113434|FG011|Overall Study|Withdrawal by Subject|0|||
126224652|NCT01393990|454113435|FG012|Overall Study|Withdrawal by Subject|0|||
126224653|NCT01393990|454113436|FG013|Overall Study|Withdrawal by Subject|0|||
126224654|NCT01393990|454113437|FG014|Overall Study|Withdrawal by Subject|1|||
126224655|NCT01393990|454113438|FG015|Overall Study|Withdrawal by Subject|1|||
126224656|NCT01393990|454113439|FG016|Overall Study|Withdrawal by Subject|0|||
126224657|NCT01393990|454113440|FG017|Overall Study|Withdrawal by Subject|0|||
126224658|NCT00275028|454113441|FG000|Overall Study|Withdrew consent before treatment began|1|||
126224659|NCT00275028|454113441|FG000|Overall Study|Withdrawal by Subject|5|||
126224660|NCT00275028|454113441|FG000|Overall Study|Adverse Event|9|||
126224661|NCT00275028|454113441|FG000|Overall Study|Progressive Disease|30|||
126224662|NCT00275028|454113441|FG000|Overall Study|Physician Decision|2|||
126224663|NCT00720798|454113443|FG000|Overall Study|Adverse Event|304|||
126224664|NCT00720798|454113443|FG000|Overall Study|Death|39|||
126224665|NCT00720798|454113443|FG000|Overall Study|Insufficient Therapeutic Response|129|||
126224666|NCT00720798|454113443|FG000|Overall Study|Protocol Violation|4|||
126224667|NCT00720798|454113443|FG000|Overall Study|Refused Treatment|151|||
126224668|NCT00720798|454113443|FG000|Overall Study|Failure to Return|46|||
126224669|NCT00720798|454113443|FG000|Overall Study|Reason not Specified|83|||
126224670|NCT00433381|454113444|FG000|Overall Study|Ineligible / no protocol treatment|3|||
126224671|NCT00433381|454113445|FG001|Overall Study|Ineligible / no protocol treatment|3|||
126224672|NCT00549198|454113450|FG000|Overall Study|Adverse Event|28|||
126224673|NCT00549198|454113451|FG001|Overall Study|Adverse Event|26|||
126224674|NCT00549198|454113450|FG000|Overall Study|Insufficient Viral Load Response|4|||
126020188|NCT03312907|453369985|FG002|Overall Study|Adverse Event|1|||
126092801|NCT01283516|453632907|FG004|Overall Study|Lost to Follow-up|0|||
126224675|NCT00549198|454113451|FG001|Overall Study|Insufficient Viral Load Response|2|||
126224676|NCT00549198|454113450|FG000|Overall Study|Protocol-defined Virological Failure|7|||
126224677|NCT00549198|454113451|FG001|Overall Study|Protocol-defined Virological Failure|0|||
126224678|NCT00549198|454113450|FG000|Overall Study|Non-compliance|2|||
126224679|NCT00549198|454113451|FG001|Overall Study|Non-compliance|4|||
126224680|NCT00549198|454113450|FG000|Overall Study|Lost to Follow-up|7|||
126224681|NCT00549198|454113451|FG001|Overall Study|Lost to Follow-up|8|||
126092802|NCT01283516|453632908|FG005|Overall Study|Lost to Follow-up|0|||
126224682|NCT00549198|454113450|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
126224683|NCT00549198|454113451|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126224684|NCT00549198|454113450|FG000|Overall Study|Protocol Violation|7|||
126224685|NCT00549198|454113451|FG001|Overall Study|Protocol Violation|2|||
126224686|NCT00549198|454113450|FG000|Overall Study|Investigator Decision|4|||
126224687|NCT00549198|454113451|FG001|Overall Study|Investigator Decision|3|||
126020189|NCT03312907|453369983|FG000|Overall Study|Protocol Violation|2|||
126020190|NCT03312907|453369984|FG001|Overall Study|Protocol Violation|3|||
126020191|NCT03312907|453369985|FG002|Overall Study|Protocol Violation|4|||
126020192|NCT03312907|453369983|FG000|Overall Study|Lost to Follow-up|2|||
126020193|NCT03312907|453369984|FG001|Overall Study|Lost to Follow-up|3|||
126020194|NCT03312907|453369985|FG002|Overall Study|Lost to Follow-up|2|||
126224688|NCT00549198|454113450|FG000|Overall Study|Withdrawal by Subject|7|||
126224689|NCT00549198|454113451|FG001|Overall Study|Withdrawal by Subject|7|||
126224690|NCT00549198|454113450|FG000|Overall Study|Disease Progression|1|||
126224691|NCT00549198|454113451|FG001|Overall Study|Disease Progression|0|||
126224692|NCT00549198|454113450|FG000|Overall Study|Participant Moved|2|||
126224693|NCT00549198|454113451|FG001|Overall Study|Participant Moved|0|||
126224694|NCT00549198|454113450|FG000|Overall Study|Participant not able to perform Week 96|1|||
126224695|NCT00549198|454113451|FG001|Overall Study|Participant not able to perform Week 96|0|||
126224696|NCT00549198|454113450|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
126224697|NCT00549198|454113451|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
126224698|NCT00549198|454113450|FG000|Overall Study|Prohibited Medication|1|||
126224699|NCT00549198|454113451|FG001|Overall Study|Prohibited Medication|2|||
126224700|NCT00549198|454113450|FG000|Overall Study|Participant planning pregnancy|1|||
126224701|NCT00549198|454113451|FG001|Overall Study|Participant planning pregnancy|0|||
126224702|NCT00549198|454113450|FG000|Overall Study|Participant overweight, no scan possible|1|||
126224703|NCT00549198|454113451|FG001|Overall Study|Participant overweight, no scan possible|0|||
126224704|NCT00549198|454113450|FG000|Overall Study|No scan facilities|0|||
126224705|NCT00549198|454113451|FG001|Overall Study|No scan facilities|2|||
126224706|NCT00549198|454113450|FG000|Overall Study|Pregnancy|0|||
126020195|NCT03312907|453369983|FG000|Overall Study|Physician Decision|3|||
126020196|NCT03312907|453369984|FG001|Overall Study|Physician Decision|4|||
126020197|NCT03312907|453369985|FG002|Overall Study|Physician Decision|2|||
126020198|NCT03312907|453369983|FG000|Overall Study|Withdrawal by Subject|9|||
126020199|NCT03312907|453369984|FG001|Overall Study|Withdrawal by Subject|14|||
126020200|NCT03312907|453369985|FG002|Overall Study|Withdrawal by Subject|10|||
126020201|NCT01780298|453369990|FG000|Overall Study|Physician Decision|1|||
126020202|NCT01780298|453369991|FG001|Overall Study|Physician Decision|5|||
126020203|NCT01780298|453369992|FG002|Overall Study|Physician Decision|1|||
126020204|NCT01780298|453369993|FG003|Overall Study|Physician Decision|1|||
126224707|NCT00549198|454113451|FG001|Overall Study|Pregnancy|3|||
126020205|NCT01780298|453369990|FG000|Overall Study|Subject not matched|1|||
126224708|NCT00549198|454113450|FG000|Overall Study|Not Exposed to Study Drug|3|||
126224709|NCT00549198|454113451|FG001|Overall Study|Not Exposed to Study Drug|4|||
126224710|NCT00472446|454113452|FG000|Overall Study|Protocol Violation|0|||
126224711|NCT00472446|454113453|FG001|Overall Study|Protocol Violation|0|||
126224712|NCT00472446|454113454|FG002|Overall Study|Protocol Violation|0|||
126350490|NCT00098475|454575350|FG000|Step 1|Declining performance status|0|||
126350491|NCT00098475|454575351|FG001|Step 1|Declining performance status|1|||
126350492|NCT00098475|454575352|FG002|Step 1|Declining performance status|0|||
126350493|NCT00098475|454575353|FG003|Step 1|Declining performance status|0|||
126350494|NCT00098475|454575350|FG000|Step 1|Insurance issue|0|||
126020206|NCT01780298|453369991|FG001|Overall Study|Subject not matched|0|||
126020207|NCT01780298|453369992|FG002|Overall Study|Subject not matched|1|||
126020208|NCT01780298|453369993|FG003|Overall Study|Subject not matched|0|||
126020209|NCT01780298|453369990|FG000|Overall Study|Adverse Event|0|||
126020210|NCT01780298|453369991|FG001|Overall Study|Adverse Event|0|||
126020211|NCT01780298|453369992|FG002|Overall Study|Adverse Event|2|||
126020212|NCT01780298|453369993|FG003|Overall Study|Adverse Event|0|||
126020213|NCT04907474|453369998|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
126020214|NCT04907474|453369999|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
126020215|NCT04259450|453370002|FG000|Overall Study|Adverse event/ Toxicity|0|||
126020216|NCT04259450|453370003|FG001|Overall Study|Adverse event/ Toxicity|3|||
126020217|NCT04259450|453370004|FG002|Overall Study|Adverse event/ Toxicity|0|||
126020218|NCT04259450|453370005|FG003|Overall Study|Adverse event/ Toxicity|1|||
126020219|NCT04259450|453370006|FG004|Overall Study|Adverse event/ Toxicity|0|||
126020220|NCT04259450|453370007|FG005|Overall Study|Adverse event/ Toxicity|0|||
126020221|NCT04259450|453370008|FG006|Overall Study|Adverse event/ Toxicity|0|||
126020222|NCT04259450|453370009|FG007|Overall Study|Adverse event/ Toxicity|1|||
126020223|NCT04259450|453370010|FG008|Overall Study|Adverse event/ Toxicity|0|||
126224713|NCT00472446|454113455|FG003|Overall Study|Protocol Violation|1|||
126224714|NCT00472446|454113452|FG000|Overall Study|Reintervention|0|||
126224715|NCT00472446|454113453|FG001|Overall Study|Reintervention|0|||
126224716|NCT00472446|454113454|FG002|Overall Study|Reintervention|1|||
126224717|NCT00472446|454113455|FG003|Overall Study|Reintervention|1|||
126350495|NCT00098475|454575351|FG001|Step 1|Insurance issue|1|||
126350496|NCT00098475|454575352|FG002|Step 1|Insurance issue|0|||
126350497|NCT00098475|454575353|FG003|Step 1|Insurance issue|0|||
126224718|NCT00472446|454113452|FG000|Overall Study|Questionnaires not returned|5|||
126350498|NCT00098475|454575350|FG000|Step 1|Rising paraprotein|0|||
126224719|NCT00472446|454113453|FG001|Overall Study|Questionnaires not returned|6|||
126224720|NCT00472446|454113454|FG002|Overall Study|Questionnaires not returned|6|||
126224721|NCT00472446|454113455|FG003|Overall Study|Questionnaires not returned|4|||
126224722|NCT01165684|454113456|FG000|Overall Study|Adverse Event|1|||
126224723|NCT01165684|454113457|FG001|Overall Study|Adverse Event|1|||
126224724|NCT01165684|454113456|FG000|Overall Study|Lack of Efficacy|2|||
126224725|NCT01165684|454113457|FG001|Overall Study|Lack of Efficacy|1|||
126224726|NCT01165684|454113456|FG000|Overall Study|Protocol Violation|7|||
126224727|NCT01165684|454113457|FG001|Overall Study|Protocol Violation|15|||
126224728|NCT01165684|454113456|FG000|Overall Study|Withdrawal Criteria|2|||
126224729|NCT01165684|454113457|FG001|Overall Study|Withdrawal Criteria|13|||
126224730|NCT01165684|454113456|FG000|Overall Study|Unclassified|16|||
126224731|NCT01165684|454113457|FG001|Overall Study|Unclassified|22|||
126224732|NCT00671879|454113460|FG000|Overall Study|Withdrawal by Subject|0|||
126020224|NCT04259450|453370011|FG009|Overall Study|Adverse event/ Toxicity|3|||
126020225|NCT04259450|453370002|FG000|Overall Study|Disease progression|2|||
126224733|NCT00671879|454113461|FG001|Overall Study|Withdrawal by Subject|4|||
126224734|NCT00671879|454113462|FG002|Overall Study|Withdrawal by Subject|6|||
126020226|NCT04259450|453370003|FG001|Overall Study|Disease progression|3|||
126224735|NCT04633837|454113463|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
126224736|NCT04633837|454113464|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
126224737|NCT00901628|454113465|FG000|Overall Study|disconnection of catheter|4|||
126224738|NCT00901628|454113466|FG001|Overall Study|disconnection of catheter|8|||
126224739|NCT00901628|454113465|FG000|Overall Study|disconnection of drain|0|||
126350499|NCT00098475|454575351|FG001|Step 1|Rising paraprotein|1|||
126350500|NCT00098475|454575352|FG002|Step 1|Rising paraprotein|0|||
126020227|NCT04259450|453370004|FG002|Overall Study|Disease progression|4|||
126350501|NCT00098475|454575353|FG003|Step 1|Rising paraprotein|0|||
126350502|NCT00098475|454575350|FG000|Step 1|Referred to other physicians|0|||
126350503|NCT00098475|454575351|FG001|Step 1|Referred to other physicians|1|||
126350504|NCT00098475|454575352|FG002|Step 1|Referred to other physicians|0|||
126350505|NCT00098475|454575353|FG003|Step 1|Referred to other physicians|0|||
126350506|NCT00098475|454575350|FG000|Step 1|Criteria to continue treatment not met|0|||
126350507|NCT00098475|454575351|FG001|Step 1|Criteria to continue treatment not met|1|||
126350508|NCT00098475|454575352|FG002|Step 1|Criteria to continue treatment not met|0|||
126350509|NCT00098475|454575353|FG003|Step 1|Criteria to continue treatment not met|0|||
126350510|NCT00098475|454575350|FG000|Step 1|Misinterpretation of lab data|0|||
126350511|NCT00098475|454575351|FG001|Step 1|Misinterpretation of lab data|1|||
126350512|NCT00098475|454575352|FG002|Step 1|Misinterpretation of lab data|0|||
126350513|NCT00098475|454575353|FG003|Step 1|Misinterpretation of lab data|0|||
126350514|NCT00098475|454575350|FG000|Step 1|Patient fell with fracture|1|||
126350515|NCT00098475|454575351|FG001|Step 1|Patient fell with fracture|0|||
126350516|NCT00098475|454575352|FG002|Step 1|Patient fell with fracture|0|||
126350517|NCT00098475|454575353|FG003|Step 1|Patient fell with fracture|0|||
126350518|NCT00098475|454575350|FG000|Step 1|Not documented|0|||
126350519|NCT00098475|454575351|FG001|Step 1|Not documented|1|||
126350520|NCT00098475|454575352|FG002|Step 1|Not documented|0|||
126350521|NCT00098475|454575353|FG003|Step 1|Not documented|0|||
126350522|NCT00098475|454575350|FG000|Step 2|Disease progression|1|||
126350523|NCT00098475|454575351|FG001|Step 2|Disease progression|4|||
126350524|NCT00098475|454575352|FG002|Step 2|Disease progression|0|||
126350525|NCT00098475|454575353|FG003|Step 2|Disease progression|0|||
126350526|NCT00098475|454575350|FG000|Step 2|Adverse Event|2|||
126350527|NCT00098475|454575351|FG001|Step 2|Adverse Event|0|||
126350528|NCT00098475|454575352|FG002|Step 2|Adverse Event|0|||
126350529|NCT00098475|454575353|FG003|Step 2|Adverse Event|0|||
126350530|NCT00098475|454575350|FG000|Step 2|Withdrawal by Subject|0|||
126350531|NCT00098475|454575351|FG001|Step 2|Withdrawal by Subject|2|||
126350532|NCT00098475|454575352|FG002|Step 2|Withdrawal by Subject|0|||
126350533|NCT00098475|454575353|FG003|Step 2|Withdrawal by Subject|0|||
126350534|NCT00098475|454575350|FG000|Step 2|Physician Decision|0|||
126350535|NCT00098475|454575351|FG001|Step 2|Physician Decision|1|||
126350536|NCT00098475|454575352|FG002|Step 2|Physician Decision|0|||
126350537|NCT00098475|454575353|FG003|Step 2|Physician Decision|0|||
126350538|NCT00098475|454575350|FG000|Step 2|Alternative therapy|1|||
126350539|NCT00098475|454575351|FG001|Step 2|Alternative therapy|2|||
126350540|NCT00098475|454575352|FG002|Step 2|Alternative therapy|0|||
126350541|NCT00098475|454575353|FG003|Step 2|Alternative therapy|0|||
126350542|NCT00098475|454575350|FG000|Step 2|Never started treatment|1|||
126350543|NCT00098475|454575351|FG001|Step 2|Never started treatment|1|||
126350544|NCT00098475|454575352|FG002|Step 2|Never started treatment|0|||
126350545|NCT00098475|454575353|FG003|Step 2|Never started treatment|0|||
126350546|NCT06354257|454575354|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126350547|NCT06354257|454575354|FG000|Treatment Period 2|Adverse Event|1|||
126350548|NCT03168672|454575355|FG000|Overall Study|Withdrawal by Subject|13|||
126350549|NCT03168672|454575355|FG000|Overall Study|Death|3|||
126350550|NCT03168672|454575355|FG000|Overall Study|Investigator's Decision|137|||
126224740|NCT00901628|454113466|FG001|Overall Study|disconnection of drain|1|||
126224741|NCT00901628|454113465|FG000|Overall Study|peroneal nerve palsy|0|||
126224742|NCT00901628|454113466|FG001|Overall Study|peroneal nerve palsy|1|||
126224743|NCT00608205|454113469|FG000|Overall Study|Adverse Event|3|||
126224744|NCT00608205|454113470|FG001|Overall Study|Adverse Event|2|||
126224745|NCT00608205|454113469|FG000|Overall Study|Patient non-compliant|0|||
126224746|NCT00608205|454113470|FG001|Overall Study|Patient non-compliant|1|||
126224747|NCT01797120|454113471|FG000|Overall Study|Disesae progression|37|||
126224748|NCT01797120|454113472|FG001|Overall Study|Disesae progression|49|||
126224749|NCT01797120|454113471|FG000|Overall Study|Adverse Event|13|||
126224750|NCT01797120|454113472|FG001|Overall Study|Adverse Event|5|||
126224751|NCT01797120|454113471|FG000|Overall Study|Withdrawal by Subject|6|||
126224752|NCT01797120|454113472|FG001|Overall Study|Withdrawal by Subject|6|||
126020228|NCT04259450|453370005|FG003|Overall Study|Disease progression|4|||
126020229|NCT04259450|453370006|FG004|Overall Study|Disease progression|6|||
126020230|NCT04259450|453370007|FG005|Overall Study|Disease progression|6|||
126020231|NCT04259450|453370008|FG006|Overall Study|Disease progression|6|||
126020232|NCT04259450|453370009|FG007|Overall Study|Disease progression|15|||
126020233|NCT04259450|453370010|FG008|Overall Study|Disease progression|6|||
126020234|NCT04259450|453370011|FG009|Overall Study|Disease progression|18|||
126020235|NCT04259450|453370002|FG000|Overall Study|Death|0|||
126020236|NCT04259450|453370003|FG001|Overall Study|Death|0|||
126020237|NCT04259450|453370004|FG002|Overall Study|Death|0|||
126020238|NCT04259450|453370005|FG003|Overall Study|Death|0|||
126020239|NCT04259450|453370006|FG004|Overall Study|Death|0|||
126020240|NCT04259450|453370007|FG005|Overall Study|Death|0|||
126020241|NCT04259450|453370008|FG006|Overall Study|Death|0|||
126020242|NCT04259450|453370009|FG007|Overall Study|Death|1|||
126020243|NCT04259450|453370010|FG008|Overall Study|Death|1|||
126020244|NCT04259450|453370011|FG009|Overall Study|Death|0|||
126020245|NCT04259450|453370002|FG000|Overall Study|Withdrawal by Subject|0|||
126020246|NCT04259450|453370003|FG001|Overall Study|Withdrawal by Subject|0|||
126020247|NCT04259450|453370004|FG002|Overall Study|Withdrawal by Subject|0|||
126020248|NCT04259450|453370005|FG003|Overall Study|Withdrawal by Subject|0|||
126020249|NCT04259450|453370006|FG004|Overall Study|Withdrawal by Subject|0|||
126020250|NCT04259450|453370007|FG005|Overall Study|Withdrawal by Subject|0|||
126020251|NCT04259450|453370008|FG006|Overall Study|Withdrawal by Subject|0|||
126020252|NCT04259450|453370009|FG007|Overall Study|Withdrawal by Subject|1|||
126020253|NCT04259450|453370010|FG008|Overall Study|Withdrawal by Subject|0|||
126020254|NCT04259450|453370011|FG009|Overall Study|Withdrawal by Subject|0|||
126020255|NCT04259450|453370002|FG000|Overall Study|Other than listed|0|||
126020256|NCT04259450|453370003|FG001|Overall Study|Other than listed|0|||
126020257|NCT04259450|453370004|FG002|Overall Study|Other than listed|0|||
126020258|NCT04259450|453370005|FG003|Overall Study|Other than listed|0|||
126020259|NCT04259450|453370006|FG004|Overall Study|Other than listed|0|||
126020260|NCT04259450|453370007|FG005|Overall Study|Other than listed|0|||
126020261|NCT04259450|453370008|FG006|Overall Study|Other than listed|0|||
126020262|NCT04259450|453370009|FG007|Overall Study|Other than listed|1|||
126020263|NCT04259450|453370010|FG008|Overall Study|Other than listed|1|||
126020264|NCT04259450|453370011|FG009|Overall Study|Other than listed|2|||
126020265|NCT01534494|453370012|FG000|Overall Study|Withdrawal by Subject|1|||
126020266|NCT02724592|453370013|FG000|Overall Study|Lost to Follow-up|4|||
126020267|NCT02724592|453370014|FG001|Overall Study|Lost to Follow-up|1|||
126020268|NCT02584829|453370015|FG000|Overall Study|Physician Decision|1|||
126020269|NCT02584829|453370016|FG001|Overall Study|Physician Decision|0|||
126020270|NCT02584829|453370015|FG000|Overall Study|Withdrawal by Subject|0|||
126020271|NCT02584829|453370016|FG001|Overall Study|Withdrawal by Subject|1|||
126020272|NCT02584829|453370015|FG000|Overall Study|Progressive Disease|0|||
126020273|NCT02584829|453370016|FG001|Overall Study|Progressive Disease|3|||
126020274|NCT01939899|453370018|FG000|Lead-in Dose Finding Phase|Death|0|||
126350551|NCT03168672|454575355|FG000|Overall Study|Adverse Event|1|||
126350552|NCT03168672|454575355|FG000|Overall Study|Other|2|||
126350553|NCT03168672|454575355|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
126350554|NCT00433537|454575356|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
126350555|NCT00433537|454575357|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
126350556|NCT00433537|454575358|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
126350557|NCT00433537|454575356|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
126350558|NCT00433537|454575357|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
126350559|NCT00433537|454575358|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
126350560|NCT00433537|454575356|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
126350561|NCT00433537|454575357|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
126350562|NCT00433537|454575358|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
126350563|NCT00433537|454575356|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
126350564|NCT00433537|454575357|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
126350565|NCT00433537|454575358|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
126020275|NCT01939899|453370019|FG001|Lead-in Dose Finding Phase|Death|3|||
126224753|NCT01797120|454113471|FG000|Overall Study|Symptomatic progression|2|||
126224754|NCT01797120|454113472|FG001|Overall Study|Symptomatic progression|1|||
126224755|NCT01797120|454113471|FG000|Overall Study|Non-compliance|1|||
126224756|NCT01797120|454113472|FG001|Overall Study|Non-compliance|0|||
126224757|NCT01797120|454113471|FG000|Overall Study|Physician Decision|3|||
126224758|NCT01797120|454113472|FG001|Overall Study|Physician Decision|0|||
126224759|NCT01797120|454113471|FG000|Overall Study|still on treatment|2|||
126224760|NCT01797120|454113472|FG001|Overall Study|still on treatment|4|||
126224761|NCT01797120|454113471|FG000|Overall Study|never start protocol therapy|2|||
126224762|NCT01797120|454113472|FG001|Overall Study|never start protocol therapy|0|||
126224763|NCT01909466|454113478|FG000|Overall Study|Lost to Follow-up|5|||
126224764|NCT01909466|454113479|FG001|Overall Study|Lost to Follow-up|7|||
126020276|NCT01939899|453370020|FG002|Lead-in Dose Finding Phase|Death|1|||
126020277|NCT01939899|453370021|FG003|Lead-in Dose Finding Phase|Death|0|||
126020278|NCT01939899|453370022|FG004|Lead-in Dose Finding Phase|Death|0|||
126020279|NCT01939899|453370018|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
126020280|NCT01939899|453370019|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
126020281|NCT01939899|453370020|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
126020282|NCT01939899|453370021|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
126020283|NCT01939899|453370022|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
126020284|NCT01939899|453370018|FG000|Lead-in Dose Finding Phase|Other|0|||
126020285|NCT01939899|453370019|FG001|Lead-in Dose Finding Phase|Other|0|||
126020286|NCT01939899|453370020|FG002|Lead-in Dose Finding Phase|Other|1|||
126020287|NCT01939899|453370021|FG003|Lead-in Dose Finding Phase|Other|0|||
126020288|NCT01939899|453370022|FG004|Lead-in Dose Finding Phase|Other|0|||
126020289|NCT01939899|453370018|FG000|Phase 2|Withdrawal by Subject|0|||
126224765|NCT01909466|454113478|FG000|Overall Study|Adverse Event|3|||
126224766|NCT01909466|454113479|FG001|Overall Study|Adverse Event|4|||
126224767|NCT01909466|454113478|FG000|Overall Study|Met Withdrawal Criteria|0|||
126224768|NCT01909466|454113479|FG001|Overall Study|Met Withdrawal Criteria|3|||
126224769|NCT01909466|454113478|FG000|Overall Study|Physician Decision|2|||
126224770|NCT01909466|454113479|FG001|Overall Study|Physician Decision|0|||
126350566|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
126350567|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
126350568|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
126350569|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
126350570|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
126350571|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
126350572|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
126350573|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
126350574|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
126350575|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
126350576|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
126350577|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
126350578|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
126350579|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
126350580|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
126350581|NCT03370276|454575359|FG000|Overall Study|Death|0|||
126350582|NCT03370276|454575360|FG001|Overall Study|Death|2|||
126350583|NCT03370276|454575361|FG002|Overall Study|Death|5|||
126350584|NCT00831844|454575362|FG000|Overall Study|Adverse Event|2|||
126350585|NCT00831844|454575363|FG001|Overall Study|Adverse Event|0|||
126350586|NCT00831844|454575364|FG002|Overall Study|Adverse Event|0|||
126350587|NCT00831844|454575365|FG003|Overall Study|Adverse Event|0|||
126350588|NCT00831844|454575366|FG004|Overall Study|Adverse Event|1|||
126350589|NCT00831844|454575367|FG005|Overall Study|Adverse Event|1|||
126350590|NCT00831844|454575368|FG006|Overall Study|Adverse Event|2|||
126350591|NCT00831844|454575369|FG007|Overall Study|Adverse Event|0|||
126350592|NCT00831844|454575370|FG008|Overall Study|Adverse Event|0|||
126350593|NCT00831844|454575371|FG009|Overall Study|Adverse Event|0|||
126350594|NCT00831844|454575362|FG000|Overall Study|Death|0|||
126350595|NCT00831844|454575363|FG001|Overall Study|Death|0|||
126350596|NCT00831844|454575364|FG002|Overall Study|Death|0|||
126350597|NCT00831844|454575365|FG003|Overall Study|Death|1|||
126350598|NCT00831844|454575366|FG004|Overall Study|Death|0|||
126350599|NCT00831844|454575367|FG005|Overall Study|Death|0|||
126350600|NCT00831844|454575368|FG006|Overall Study|Death|0|||
126020290|NCT01939899|453370019|FG001|Phase 2|Withdrawal by Subject|0|||
126020291|NCT01939899|453370020|FG002|Phase 2|Withdrawal by Subject|0|||
126350601|NCT00831844|454575369|FG007|Overall Study|Death|0|||
126350602|NCT00831844|454575370|FG008|Overall Study|Death|0|||
126350603|NCT00831844|454575371|FG009|Overall Study|Death|0|||
126350604|NCT00831844|454575362|FG000|Overall Study|Lack of Efficacy|8|||
126350605|NCT00831844|454575363|FG001|Overall Study|Lack of Efficacy|10|||
126350606|NCT00831844|454575364|FG002|Overall Study|Lack of Efficacy|15|||
126224771|NCT01909466|454113478|FG000|Overall Study|Withdrawal by Subject|11|||
126224772|NCT01909466|454113479|FG001|Overall Study|Withdrawal by Subject|9|||
126224773|NCT01909466|454113478|FG000|Overall Study|Lack of Efficacy|1|||
126224774|NCT01909466|454113479|FG001|Overall Study|Lack of Efficacy|0|||
126020292|NCT01939899|453370021|FG003|Phase 2|Withdrawal by Subject|2|||
126020293|NCT01939899|453370022|FG004|Phase 2|Withdrawal by Subject|0|||
126020294|NCT01939899|453370018|FG000|Phase 2|Disease Progression|0|||
126020295|NCT01939899|453370019|FG001|Phase 2|Disease Progression|0|||
126020296|NCT01939899|453370020|FG002|Phase 2|Disease Progression|0|||
126020297|NCT01939899|453370021|FG003|Phase 2|Disease Progression|9|||
126020298|NCT01939899|453370022|FG004|Phase 2|Disease Progression|1|||
126020299|NCT00585052|453370023|FG000|Overall Study|Withdrawal by Subject|1|||
126020300|NCT04056624|453370026|FG000|Overall Study|Withdrawal by Subject|0|||
126020301|NCT04056624|453370027|FG001|Overall Study|Withdrawal by Subject|0|||
126020302|NCT04056624|453370028|FG002|Overall Study|Withdrawal by Subject|1|||
126020303|NCT04056624|453370026|FG000|Overall Study|Protocol Violation|1|||
126020304|NCT04056624|453370027|FG001|Overall Study|Protocol Violation|2|||
126020305|NCT04056624|453370028|FG002|Overall Study|Protocol Violation|0|||
126020306|NCT02267824|453370029|FG000|Overall Study|Pregnancy|1|||
126020307|NCT02267824|453370030|FG001|Overall Study|Pregnancy|1|||
126020308|NCT02267824|453370029|FG000|Overall Study|Lost to Follow-up|4|||
126020309|NCT02267824|453370030|FG001|Overall Study|Lost to Follow-up|0|||
126020310|NCT02267824|453370029|FG000|Overall Study|Protocol Violation|3|||
126020311|NCT02267824|453370030|FG001|Overall Study|Protocol Violation|0|||
126020312|NCT02267824|453370029|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
126020313|NCT02267824|453370030|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
126020314|NCT01290341|453370031|FG000|Overall Study|Protocol Violation|7|||
126020315|NCT01290341|453370032|FG001|Overall Study|Protocol Violation|3|||
126020316|NCT01290341|453370031|FG000|Overall Study|Adverse Event|1|||
126020317|NCT01290341|453370032|FG001|Overall Study|Adverse Event|0|||
126020318|NCT01290341|453370031|FG000|Overall Study|Lost to Follow-up|21|||
126020319|NCT01290341|453370032|FG001|Overall Study|Lost to Follow-up|10|||
126020320|NCT01290341|453370031|FG000|Overall Study|Withdrawal by Subject|19|||
126020321|NCT01290341|453370032|FG001|Overall Study|Withdrawal by Subject|5|||
126020322|NCT01290341|453370031|FG000|Overall Study|Negative baseline culture and others|44|||
126020323|NCT01290341|453370032|FG001|Overall Study|Negative baseline culture and others|11|||
126020324|NCT00510887|453370035|FG000|Overall Study|Lost to Follow-up|1|||
126020325|NCT00390299|453370041|FG000|Overall Study|Cancellation|1|||
126020326|NCT00390299|453370042|FG001|Overall Study|Cancellation|0|||
126020327|NCT00390299|453370043|FG002|Overall Study|Cancellation|0|||
126020328|NCT00390299|453370044|FG003|Overall Study|Cancellation|0|||
126020329|NCT00390299|453370045|FG004|Overall Study|Cancellation|0|||
126020330|NCT00970359|453370050|FG000|Overall Study|Not Treated|4|||
126020331|NCT01565148|453370051|FG000|Overall Study|Withdrawal by Subject|1|||
126020332|NCT01565148|453370052|FG001|Overall Study|Withdrawal by Subject|1|||
126020333|NCT01565148|453370053|FG002|Overall Study|Withdrawal by Subject|1|||
126020334|NCT01565148|453370054|FG003|Overall Study|Withdrawal by Subject|2|||
126020335|NCT01565148|453370051|FG000|Overall Study|Lost to Follow-up|4|||
126020336|NCT01565148|453370052|FG001|Overall Study|Lost to Follow-up|4|||
126020337|NCT01565148|453370053|FG002|Overall Study|Lost to Follow-up|0|||
126020338|NCT01565148|453370054|FG003|Overall Study|Lost to Follow-up|3|||
126020339|NCT01565148|453370051|FG000|Overall Study|Rescue Therapy|8|||
126020340|NCT01565148|453370052|FG001|Overall Study|Rescue Therapy|5|||
126020341|NCT01565148|453370053|FG002|Overall Study|Rescue Therapy|5|||
126020342|NCT01565148|453370054|FG003|Overall Study|Rescue Therapy|8|||
126020343|NCT01565148|453370051|FG000|Overall Study|Death|0|||
126020344|NCT01565148|453370052|FG001|Overall Study|Death|0|||
126020345|NCT01565148|453370053|FG002|Overall Study|Death|1|||
126020346|NCT01565148|453370054|FG003|Overall Study|Death|0|||
126020347|NCT01565148|453370051|FG000|Overall Study|Physician Decision|2|||
126020348|NCT01565148|453370052|FG001|Overall Study|Physician Decision|5|||
126224775|NCT01339910|454113480|FG000|Overall Study|Withdrawal by Subject|1|||
126224776|NCT01339910|454113481|FG001|Overall Study|Withdrawal by Subject|0|||
126224777|NCT01339910|454113480|FG000|Overall Study|Physician Decision|1|||
126224778|NCT01339910|454113481|FG001|Overall Study|Physician Decision|0|||
126224779|NCT01339910|454113480|FG000|Overall Study|Disease relapse|1|||
126224780|NCT01339910|454113481|FG001|Overall Study|Disease relapse|4|||
126224781|NCT01567306|454113483|FG000|Overall Study|Protocol Violation|2|||
126224782|NCT01567306|454113484|FG001|Overall Study|Protocol Violation|2|||
126224783|NCT01567306|454113485|FG002|Overall Study|Protocol Violation|0|||
126224784|NCT01567306|454113486|FG003|Overall Study|Protocol Violation|3|||
126020349|NCT01565148|453370053|FG002|Overall Study|Physician Decision|0|||
126020350|NCT01565148|453370054|FG003|Overall Study|Physician Decision|0|||
126020351|NCT00068601|453370056|FG000|Overall Study|Ineligible|11|||
126020352|NCT00068601|453370057|FG001|Overall Study|Ineligible|13|||
126020353|NCT00068601|453370056|FG000|Overall Study|Not evaluable: withdrew consent|5|||
126020354|NCT00068601|453370057|FG001|Overall Study|Not evaluable: withdrew consent|4|||
126020355|NCT00068601|453370056|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
126020356|NCT00068601|453370057|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
126020357|NCT00068601|453370056|FG000|Overall Study|Death|11|||
126224785|NCT01567306|454113487|FG004|Overall Study|Protocol Violation|1|||
126224786|NCT01567306|454113488|FG005|Overall Study|Protocol Violation|1|||
126224787|NCT01567306|454113483|FG000|Overall Study|Change site living|1|||
126224788|NCT01567306|454113484|FG001|Overall Study|Change site living|0|||
126224789|NCT01567306|454113485|FG002|Overall Study|Change site living|0|||
126224790|NCT01567306|454113486|FG003|Overall Study|Change site living|0|||
126224791|NCT01567306|454113487|FG004|Overall Study|Change site living|0|||
126224792|NCT01567306|454113488|FG005|Overall Study|Change site living|0|||
126224793|NCT01567306|454113483|FG000|Overall Study|Adverse Event|0|||
126224794|NCT01567306|454113484|FG001|Overall Study|Adverse Event|0|||
126224795|NCT01567306|454113485|FG002|Overall Study|Adverse Event|0|||
126224796|NCT01567306|454113486|FG003|Overall Study|Adverse Event|2|||
126224797|NCT01567306|454113487|FG004|Overall Study|Adverse Event|4|||
126224798|NCT01567306|454113488|FG005|Overall Study|Adverse Event|1|||
126224799|NCT01567306|454113483|FG000|Overall Study|Lost to Follow-up|0|||
126224800|NCT01567306|454113484|FG001|Overall Study|Lost to Follow-up|0|||
126350607|NCT00831844|454575365|FG003|Overall Study|Lack of Efficacy|8|||
126350608|NCT00831844|454575366|FG004|Overall Study|Lack of Efficacy|11|||
126350609|NCT00831844|454575367|FG005|Overall Study|Lack of Efficacy|17|||
126350610|NCT00831844|454575368|FG006|Overall Study|Lack of Efficacy|8|||
126350611|NCT00831844|454575369|FG007|Overall Study|Lack of Efficacy|9|||
126350612|NCT00831844|454575370|FG008|Overall Study|Lack of Efficacy|7|||
126350613|NCT00831844|454575371|FG009|Overall Study|Lack of Efficacy|0|||
126350614|NCT00831844|454575362|FG000|Overall Study|Physician Decision|0|||
126350615|NCT00831844|454575363|FG001|Overall Study|Physician Decision|1|||
126350616|NCT00831844|454575364|FG002|Overall Study|Physician Decision|3|||
126350617|NCT00831844|454575365|FG003|Overall Study|Physician Decision|1|||
126350618|NCT00831844|454575366|FG004|Overall Study|Physician Decision|1|||
126350619|NCT00831844|454575367|FG005|Overall Study|Physician Decision|1|||
126350620|NCT00831844|454575368|FG006|Overall Study|Physician Decision|0|||
126350621|NCT00831844|454575369|FG007|Overall Study|Physician Decision|0|||
126350622|NCT00831844|454575370|FG008|Overall Study|Physician Decision|1|||
126350623|NCT00831844|454575371|FG009|Overall Study|Physician Decision|0|||
126350624|NCT00831844|454575362|FG000|Overall Study|Withdrawal by Subject|0|||
126350625|NCT00831844|454575363|FG001|Overall Study|Withdrawal by Subject|0|||
126350626|NCT00831844|454575364|FG002|Overall Study|Withdrawal by Subject|1|||
126350627|NCT00831844|454575365|FG003|Overall Study|Withdrawal by Subject|0|||
126350628|NCT00831844|454575366|FG004|Overall Study|Withdrawal by Subject|0|||
126350629|NCT00831844|454575367|FG005|Overall Study|Withdrawal by Subject|0|||
126350630|NCT00831844|454575368|FG006|Overall Study|Withdrawal by Subject|0|||
126350631|NCT00831844|454575369|FG007|Overall Study|Withdrawal by Subject|1|||
126350632|NCT00831844|454575370|FG008|Overall Study|Withdrawal by Subject|1|||
126350633|NCT00831844|454575371|FG009|Overall Study|Withdrawal by Subject|0|||
126350634|NCT00831844|454575362|FG000|Overall Study|Ineligible|0|||
126350635|NCT00831844|454575363|FG001|Overall Study|Ineligible|1|||
126350636|NCT00831844|454575364|FG002|Overall Study|Ineligible|1|||
126350637|NCT00831844|454575365|FG003|Overall Study|Ineligible|0|||
126350638|NCT00831844|454575366|FG004|Overall Study|Ineligible|1|||
126350639|NCT00831844|454575367|FG005|Overall Study|Ineligible|0|||
126350640|NCT00831844|454575368|FG006|Overall Study|Ineligible|0|||
126350641|NCT00831844|454575369|FG007|Overall Study|Ineligible|0|||
126350642|NCT00831844|454575370|FG008|Overall Study|Ineligible|0|||
126350643|NCT00831844|454575371|FG009|Overall Study|Ineligible|0|||
126350644|NCT05436613|454575374|FG000|Overall Study|Lost to Follow-up|9|||
126350645|NCT05436613|454575374|FG000|Overall Study|Withdrawal by Subject|3|||
126350646|NCT04057365|454575375|FG000|Overall Study|Withdrawal by Subject|2|||
126350647|NCT04057365|454575376|FG001|Overall Study|Withdrawal by Subject|0|||
126350648|NCT04738487|454575377|FG000|Overall Study|Participant Ongoing in Study|298|||
126350649|NCT04738487|454575378|FG001|Overall Study|Participant Ongoing in Study|297|||
126350650|NCT04738487|454575377|FG000|Overall Study|Withdrawal by Subject|7|||
126350651|NCT04738487|454575378|FG001|Overall Study|Withdrawal by Subject|9|||
126350652|NCT04738487|454575377|FG000|Overall Study|Lost to Follow-up|2|||
126350653|NCT04738487|454575378|FG001|Overall Study|Lost to Follow-up|0|||
126350654|NCT04738487|454575377|FG000|Overall Study|Death|287|||
126350655|NCT04738487|454575378|FG001|Overall Study|Death|306|||
126350656|NCT03976375|454575379|FG000|Overall Study|Death|158|||
126092803|NCT01283516|453632909|FG006|Overall Study|Lost to Follow-up|0|||
126092804|NCT01283516|453632910|FG007|Overall Study|Lost to Follow-up|0|||
126092805|NCT01283516|453632911|FG008|Overall Study|Lost to Follow-up|1|||
126350657|NCT03976375|454575380|FG001|Overall Study|Death|160|||
126350658|NCT03976375|454575381|FG002|Overall Study|Death|42|||
126350659|NCT03976375|454575379|FG000|Overall Study|Lost to Follow-up|2|||
126350660|NCT03976375|454575380|FG001|Overall Study|Lost to Follow-up|1|||
126350661|NCT03976375|454575381|FG002|Overall Study|Lost to Follow-up|1|||
126092806|NCT00132873|453632915|FG000|Overall Study|Adverse Event|3|||
126224801|NCT01567306|454113485|FG002|Overall Study|Lost to Follow-up|0|||
126224802|NCT01567306|454113486|FG003|Overall Study|Lost to Follow-up|0|||
126224803|NCT01567306|454113487|FG004|Overall Study|Lost to Follow-up|2|||
126350662|NCT03976375|454575379|FG000|Overall Study|Withdrawal by Subject|5|||
126350663|NCT03976375|454575380|FG001|Overall Study|Withdrawal by Subject|9|||
126350664|NCT03976375|454575381|FG002|Overall Study|Withdrawal by Subject|4|||
126350665|NCT03976375|454575379|FG000|Overall Study|Sponsor decision|20|||
126350666|NCT03976375|454575380|FG001|Overall Study|Sponsor decision|19|||
126020358|NCT00068601|453370057|FG001|Overall Study|Death|3|||
126020359|NCT00068601|453370056|FG000|Overall Study|Lost to Follow-up|3|||
126020360|NCT00068601|453370057|FG001|Overall Study|Lost to Follow-up|2|||
126020361|NCT00068601|453370056|FG000|Overall Study|Missing primary outcome data|30|||
126020362|NCT00068601|453370057|FG001|Overall Study|Missing primary outcome data|34|||
126020363|NCT01061671|453370058|FG000|Overall Study|Withdrawal by Subject|16|||
126020364|NCT01061671|453370059|FG001|Overall Study|Withdrawal by Subject|20|||
126020365|NCT01061671|453370058|FG000|Overall Study|Lost to Follow-up|3|||
126020366|NCT01061671|453370059|FG001|Overall Study|Lost to Follow-up|5|||
126020367|NCT01061671|453370058|FG000|Overall Study|Death|28|||
126020368|NCT01061671|453370059|FG001|Overall Study|Death|30|||
126020369|NCT05368831|453370060|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
126020370|NCT01199575|453370066|FG000|Overall Study|Withdrawal by Subject|5|||
126020371|NCT00223795|453370072|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
126020372|NCT00223795|453370073|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
126020373|NCT00223795|453370072|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
126224804|NCT01567306|454113488|FG005|Overall Study|Lost to Follow-up|0|||
126224805|NCT01567306|454113483|FG000|Overall Study|Withdrawal by Subject|0|||
126224806|NCT01567306|454113484|FG001|Overall Study|Withdrawal by Subject|0|||
126224807|NCT01567306|454113485|FG002|Overall Study|Withdrawal by Subject|0|||
126020374|NCT00223795|453370073|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
126020375|NCT04732338|453370074|FG000|Overall Study|Lost to Follow-up|3|||
126020376|NCT04732338|453370075|FG001|Overall Study|Lost to Follow-up|3|||
126020377|NCT01803555|453370079|FG000|Overall Study|Adverse Event|3|||
126020378|NCT01803555|453370080|FG001|Overall Study|Adverse Event|2|||
126020379|NCT01803555|453370079|FG000|Overall Study|Withdrawal by Subject|3|||
126020380|NCT01803555|453370080|FG001|Overall Study|Withdrawal by Subject|3|||
126020381|NCT01803555|453370079|FG000|Overall Study|Non-compliance|1|||
126020382|NCT01803555|453370080|FG001|Overall Study|Non-compliance|1|||
126020383|NCT01803555|453370079|FG000|Overall Study|Protocol Violation|3|||
126020384|NCT01803555|453370080|FG001|Overall Study|Protocol Violation|5|||
126020385|NCT01803555|453370079|FG000|Overall Study|Lost to Follow-up|0|||
126020386|NCT01803555|453370080|FG001|Overall Study|Lost to Follow-up|2|||
126020387|NCT01803555|453370079|FG000|Overall Study|Other than specified|3|||
126020388|NCT01803555|453370080|FG001|Overall Study|Other than specified|5|||
126020389|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
126020390|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
126020391|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
126020392|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
126020393|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
126020394|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
126020395|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
126020396|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
126020397|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
126020398|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
126020399|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
126020400|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
126020401|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
126020402|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
126020403|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
126020404|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
126020405|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
126020406|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
126020407|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
126020408|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
126020409|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
126020410|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
126020411|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
126020412|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
126020413|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
126224808|NCT01567306|454113486|FG003|Overall Study|Withdrawal by Subject|0|||
126224809|NCT01567306|454113487|FG004|Overall Study|Withdrawal by Subject|0|||
126020414|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
126020415|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
126020416|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
126020417|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
126020418|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
126224810|NCT01567306|454113488|FG005|Overall Study|Withdrawal by Subject|1|||
126224811|NCT00738673|454113493|FG000|Overall Study|Adverse Event|1|||
126224812|NCT00738673|454113494|FG001|Overall Study|Adverse Event|0|||
126224813|NCT00738673|454113493|FG000|Overall Study|Lack of Efficacy|19|||
126224814|NCT00738673|454113494|FG001|Overall Study|Lack of Efficacy|8|||
126224815|NCT00738673|454113493|FG000|Overall Study|Protocol Violation|1|||
126224816|NCT00738673|454113494|FG001|Overall Study|Protocol Violation|2|||
126224817|NCT00738673|454113493|FG000|Overall Study|Withdrawal by Subject|3|||
126224818|NCT00738673|454113494|FG001|Overall Study|Withdrawal by Subject|1|||
126350667|NCT03976375|454575381|FG002|Overall Study|Sponsor decision|1|||
126020419|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
126020420|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
126020421|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
126020422|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
126020423|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
126020424|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
126020425|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
126020426|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
126020427|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
126020428|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
126020429|NCT02409667|453370081|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
126020430|NCT02409667|453370082|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
126020431|NCT02409667|453370083|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
126020432|NCT02409667|453370084|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
126020433|NCT02409667|453370085|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
126020434|NCT02409667|453370081|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
126020435|NCT02409667|453370082|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
126020436|NCT02409667|453370083|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
126020437|NCT02409667|453370084|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
126020438|NCT02409667|453370085|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
126020439|NCT02409667|453370081|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
126020440|NCT02409667|453370082|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
126020441|NCT02409667|453370083|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
126020442|NCT02409667|453370084|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
126020443|NCT02409667|453370085|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
126350668|NCT05350202|454575382|FG000|Visit 1 - Baseline|Not-treated|18|||
126350669|NCT05350202|454575383|FG001|Visit 1 - Baseline|Not-treated|0|||
126350670|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
126350671|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
126350672|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
126350673|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
126350674|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
126350675|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
126350676|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
126350677|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
126350678|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
126350679|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
126350680|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
126350681|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
126350682|NCT03683030|454575392|FG000|Overall Study|Enrolled but screen failures|12|||
126350683|NCT03683030|454575393|FG001|Overall Study|Enrolled but screen failures|7|||
126350684|NCT03683030|454575392|FG000|Overall Study|Enrolled but no catheter inserted|11|||
126350685|NCT03683030|454575393|FG001|Overall Study|Enrolled but no catheter inserted|13|||
126350686|NCT03683030|454575392|FG000|Overall Study|Withdrawal by Subject|0|||
126350687|NCT03683030|454575393|FG001|Overall Study|Withdrawal by Subject|2|||
126350688|NCT03683030|454575392|FG000|Overall Study|Early termination by subject|1|||
126350689|NCT03683030|454575393|FG001|Overall Study|Early termination by subject|0|||
126350690|NCT03683030|454575392|FG000|Overall Study|Lost to Follow-up|0|||
126350691|NCT03683030|454575393|FG001|Overall Study|Lost to Follow-up|6|||
126350692|NCT03683030|454575392|FG000|Overall Study|Death|0|||
126350693|NCT03683030|454575393|FG001|Overall Study|Death|2|||
126350694|NCT03683030|454575392|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
126350695|NCT03683030|454575393|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
126350696|NCT02390284|454575394|FG000|Overall Study|Physician Decision|0|||
126020444|NCT02409667|453370081|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
126020445|NCT02409667|453370082|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
126020446|NCT02409667|453370083|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
126020447|NCT02409667|453370084|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
126224819|NCT02736227|454113497|FG000|Overall Study|Withdrawal by Subject|0|||
126092807|NCT00132873|453632915|FG000|Overall Study|Lost to Follow-up|1|||
126224820|NCT02736227|454113498|FG001|Overall Study|Withdrawal by Subject|0|||
126224821|NCT02736227|454113499|FG002|Overall Study|Withdrawal by Subject|1|||
126224822|NCT02736227|454113497|FG000|Overall Study|Physician Decision|0|||
126224823|NCT02736227|454113498|FG001|Overall Study|Physician Decision|0|||
126224824|NCT02736227|454113499|FG002|Overall Study|Physician Decision|5|||
126224825|NCT02736227|454113497|FG000|Overall Study|Non Compliant|0|||
126224826|NCT02736227|454113498|FG001|Overall Study|Non Compliant|0|||
126224827|NCT02736227|454113499|FG002|Overall Study|Non Compliant|2|||
126350697|NCT02390284|454575395|FG001|Overall Study|Physician Decision|0|||
126020448|NCT02409667|453370085|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
126020449|NCT02409667|453370081|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
126020450|NCT02409667|453370082|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
126020451|NCT02409667|453370083|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
126020452|NCT02409667|453370084|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
126350698|NCT02390284|454575396|FG002|Overall Study|Physician Decision|9|||
126350699|NCT01922934|454575397|FG000|Eligible Patients|Death|0|||
126350700|NCT01922934|454575398|FG001|Eligible Patients|Death|7|||
126350701|NCT01922934|454575397|FG000|Eligible Patients|Physician Decision|17|||
126350702|NCT01922934|454575398|FG001|Eligible Patients|Physician Decision|0|||
126350703|NCT01922934|454575397|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
126350704|NCT01922934|454575398|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
126350705|NCT01922934|454575397|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
126224828|NCT04120194|454113500|FG000|Overall Study|Lost to Follow-up|11|||
126224829|NCT04120194|454113501|FG001|Overall Study|Lost to Follow-up|8|||
126224830|NCT04120194|454113500|FG000|Overall Study|Adverse Event|4|||
126224831|NCT04120194|454113501|FG001|Overall Study|Adverse Event|5|||
126224832|NCT04120194|454113500|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
126224833|NCT04120194|454113501|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
126224834|NCT04120194|454113500|FG000|Overall Study|Miscellaneous|4|||
126224835|NCT04120194|454113501|FG001|Overall Study|Miscellaneous|5|||
126224836|NCT00827359|454113505|FG000|Overall Study|Progressive Diseas|19|||
126224837|NCT00827359|454113505|FG000|Overall Study|Unacceptable Toxicity|5|||
126224838|NCT00827359|454113505|FG000|Overall Study|Ineligible|1|||
126224839|NCT01159769|454113506|FG000|Overall Study|Adverse Event|1|||
126224840|NCT02555618|454113507|FG000|Overall Study|Sponsor's Circumstances|1|||
126224841|NCT02555618|454113508|FG001|Overall Study|Sponsor's Circumstances|0|||
126350706|NCT01922934|454575398|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
126350707|NCT01922934|454575397|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
126350708|NCT01922934|454575398|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
126350709|NCT01922934|454575397|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
126350710|NCT01922934|454575398|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
126350711|NCT00658528|454575401|FG000|Overall Study|Adverse Event|5|||
126350712|NCT00658528|454575402|FG001|Overall Study|Adverse Event|7|||
126350713|NCT00658528|454575401|FG000|Overall Study|Lost to Follow-up|14|||
126350714|NCT00658528|454575402|FG001|Overall Study|Lost to Follow-up|22|||
126350715|NCT00658528|454575401|FG000|Overall Study|Withdrawal by Subject|8|||
126350716|NCT00658528|454575402|FG001|Overall Study|Withdrawal by Subject|6|||
126350717|NCT00658528|454575401|FG000|Overall Study|Withdrawal of consent|5|||
126350718|NCT00658528|454575402|FG001|Overall Study|Withdrawal of consent|6|||
126350719|NCT00658528|454575401|FG000|Overall Study|Other|8|||
126350720|NCT00658528|454575402|FG001|Overall Study|Other|4|||
126350721|NCT04017962|454575403|FG000|Overall Study|Death|2|||
126350722|NCT04017962|454575404|FG001|Overall Study|Death|0|||
126350723|NCT04017962|454575403|FG000|Overall Study|Lost to Follow-up|2|||
126350724|NCT04017962|454575404|FG001|Overall Study|Lost to Follow-up|0|||
126350725|NCT04017962|454575403|FG000|Overall Study|Physician Decision|1|||
126350726|NCT04017962|454575404|FG001|Overall Study|Physician Decision|0|||
126350727|NCT04017962|454575403|FG000|Overall Study|Discontinued LTV|5|||
126350728|NCT04017962|454575404|FG001|Overall Study|Discontinued LTV|0|||
126350729|NCT00462462|454575412|FG000|Overall Study|Physician Decision|0|||
126350730|NCT00462462|454575413|FG001|Overall Study|Physician Decision|1|||
126350731|NCT01163617|454575414|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350732|NCT01163617|454575415|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
126350733|NCT01163617|454575416|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350734|NCT01163617|454575417|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350735|NCT01163617|454575418|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350736|NCT01163617|454575419|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350737|NCT01163617|454575420|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350738|NCT01163617|454575421|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350739|NCT01163617|454575414|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350740|NCT01163617|454575415|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
126350741|NCT01163617|454575416|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350742|NCT01163617|454575417|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350743|NCT01163617|454575418|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350744|NCT01163617|454575419|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126020453|NCT02409667|453370085|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
126020454|NCT02409667|453370081|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
126020455|NCT02409667|453370082|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
126020456|NCT02409667|453370083|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
126020457|NCT02409667|453370084|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
126020458|NCT02409667|453370085|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
126020459|NCT02409667|453370081|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
126020460|NCT02409667|453370082|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
126020461|NCT02409667|453370083|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
126020462|NCT02409667|453370084|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
126020463|NCT02409667|453370085|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
126020464|NCT02409667|453370081|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
126092808|NCT00132873|453632915|FG000|Overall Study|Lack of Efficacy|1|||
126092809|NCT00132873|453632915|FG000|Overall Study|Withdrawal by Subject|3|||
126224842|NCT02063698|454113509|FG000|Overall Study|did not complete booklet for days 2-8|1|||
126224843|NCT02063698|454113510|FG001|Overall Study|did not complete booklet for days 2-8|2|||
126224844|NCT01953783|454113511|FG000|Overall Study|Progressive disease|2|||
126224845|NCT01271933|454113515|FG000|Single-Blind Phase|Lack of Efficacy|37|||
126224846|NCT01271933|454113516|FG001|Single-Blind Phase|Lack of Efficacy|0|||
126224847|NCT01271933|454113517|FG002|Single-Blind Phase|Lack of Efficacy|0|||
126224848|NCT01271933|454113515|FG000|Single-Blind Phase|Lost to Follow-up|10|||
126350745|NCT01163617|454575420|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350746|NCT01163617|454575421|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350747|NCT01163617|454575414|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350748|NCT01163617|454575415|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350749|NCT01163617|454575416|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
126350750|NCT01163617|454575417|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350751|NCT01163617|454575418|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350752|NCT01163617|454575419|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350753|NCT01163617|454575420|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350754|NCT01163617|454575421|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350755|NCT02394756|454575422|FG000|Period 1|Lens Discomfort|0|||
126350756|NCT02394756|454575423|FG001|Period 1|Lens Discomfort|0|||
126350757|NCT02394756|454575424|FG002|Period 1|Lens Discomfort|0|||
126350758|NCT02394756|454575425|FG003|Period 1|Lens Discomfort|0|||
126350759|NCT02394756|454575426|FG004|Period 1|Lens Discomfort|0|||
126350760|NCT02394756|454575427|FG005|Period 1|Lens Discomfort|1|||
126350761|NCT02394756|454575422|FG000|Period 1|Withdrawal by Subject|0|||
126350762|NCT02394756|454575423|FG001|Period 1|Withdrawal by Subject|1|||
126350763|NCT02394756|454575424|FG002|Period 1|Withdrawal by Subject|1|||
126350764|NCT02394756|454575425|FG003|Period 1|Withdrawal by Subject|1|||
126350765|NCT02394756|454575426|FG004|Period 1|Withdrawal by Subject|0|||
126350766|NCT02394756|454575427|FG005|Period 1|Withdrawal by Subject|0|||
126350767|NCT02394756|454575422|FG000|Period 2|Unsatisfactory Visual Response|0|||
126350768|NCT02394756|454575423|FG001|Period 2|Unsatisfactory Visual Response|0|||
126350769|NCT02394756|454575424|FG002|Period 2|Unsatisfactory Visual Response|0|||
126350770|NCT02394756|454575425|FG003|Period 2|Unsatisfactory Visual Response|0|||
126350771|NCT02394756|454575426|FG004|Period 2|Unsatisfactory Visual Response|1|||
126350772|NCT02394756|454575427|FG005|Period 2|Unsatisfactory Visual Response|0|||
126350773|NCT02335944|454575428|FG000|Treatment Phase|Progressive Disease|2|||
126350774|NCT02335944|454575429|FG001|Treatment Phase|Progressive Disease|5|||
126350775|NCT02335944|454575430|FG002|Treatment Phase|Progressive Disease|2|||
126350776|NCT02335944|454575431|FG003|Treatment Phase|Progressive Disease|11|||
126350777|NCT02335944|454575432|FG004|Treatment Phase|Progressive Disease|4|||
126350778|NCT02335944|454575433|FG005|Treatment Phase|Progressive Disease|25|||
126350779|NCT02335944|454575434|FG006|Treatment Phase|Progressive Disease|2|||
126350780|NCT02335944|454575435|FG007|Treatment Phase|Progressive Disease|30|||
126350781|NCT02335944|454575436|FG008|Treatment Phase|Progressive Disease|27|||
126350782|NCT02335944|454575437|FG009|Treatment Phase|Progressive Disease|0|||
126350783|NCT02335944|454575428|FG000|Treatment Phase|Adverse Event|2|||
126350784|NCT02335944|454575429|FG001|Treatment Phase|Adverse Event|0|||
126350785|NCT02335944|454575430|FG002|Treatment Phase|Adverse Event|0|||
126350786|NCT02335944|454575431|FG003|Treatment Phase|Adverse Event|2|||
126350787|NCT02335944|454575432|FG004|Treatment Phase|Adverse Event|1|||
126350788|NCT02335944|454575433|FG005|Treatment Phase|Adverse Event|15|||
126020465|NCT02409667|453370082|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
126224849|NCT01271933|454113516|FG001|Single-Blind Phase|Lost to Follow-up|0|||
126350789|NCT02335944|454575434|FG006|Treatment Phase|Adverse Event|0|||
126350790|NCT02335944|454575435|FG007|Treatment Phase|Adverse Event|5|||
126350791|NCT02335944|454575436|FG008|Treatment Phase|Adverse Event|7|||
126020466|NCT02409667|453370083|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
126020467|NCT02409667|453370084|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
126092810|NCT00132873|453632915|FG000|Overall Study|Planned Pregnancy|1|||
126092811|NCT00444275|453632916|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
126092812|NCT00444275|453632917|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
126092813|NCT00444275|453632918|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
126092814|NCT00444275|453632919|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
126092815|NCT00444275|453632920|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
126092816|NCT00444275|453632916|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
126092817|NCT00444275|453632917|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
126224850|NCT01271933|454113517|FG002|Single-Blind Phase|Lost to Follow-up|0|||
126224851|NCT01271933|454113515|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
126092818|NCT00444275|453632918|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
126224852|NCT01271933|454113516|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
126224853|NCT01271933|454113517|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
126224854|NCT01271933|454113515|FG000|Single-Blind Phase|Protocol Violation|3|||
126224855|NCT01271933|454113516|FG001|Single-Blind Phase|Protocol Violation|0|||
126224856|NCT01271933|454113517|FG002|Single-Blind Phase|Protocol Violation|0|||
126224857|NCT01271933|454113515|FG000|Single-Blind Phase|Adverse Event|52|||
126224858|NCT01271933|454113516|FG001|Single-Blind Phase|Adverse Event|0|||
126224859|NCT01271933|454113517|FG002|Single-Blind Phase|Adverse Event|0|||
126224860|NCT01271933|454113515|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
126224861|NCT01271933|454113516|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
126224862|NCT01271933|454113517|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
126224863|NCT01271933|454113515|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
126224864|NCT01271933|454113516|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
126224865|NCT01271933|454113517|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
126224866|NCT01271933|454113515|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
126224867|NCT01271933|454113516|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
126224868|NCT01271933|454113517|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
126224869|NCT01271933|454113515|FG000|Double-Blind Phase|Randomized but not treated|0|||
126224870|NCT01271933|454113516|FG001|Double-Blind Phase|Randomized but not treated|0|||
126224871|NCT01271933|454113517|FG002|Double-Blind Phase|Randomized but not treated|1|||
126224872|NCT01271933|454113515|FG000|Double-Blind Phase|Lack of Efficacy|0|||
126224873|NCT01271933|454113516|FG001|Double-Blind Phase|Lack of Efficacy|6|||
126224874|NCT01271933|454113517|FG002|Double-Blind Phase|Lack of Efficacy|9|||
126224875|NCT01271933|454113515|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126224876|NCT01271933|454113516|FG001|Double-Blind Phase|Lost to Follow-up|1|||
126224877|NCT01271933|454113517|FG002|Double-Blind Phase|Lost to Follow-up|1|||
126224878|NCT01271933|454113515|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126224879|NCT01271933|454113516|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
126224880|NCT01271933|454113517|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
126224881|NCT01271933|454113515|FG000|Double-Blind Phase|Adverse Event|0|||
126350792|NCT02335944|454575437|FG009|Treatment Phase|Adverse Event|0|||
126350793|NCT02335944|454575428|FG000|Treatment Phase|Physician Decision|0|||
126350794|NCT02335944|454575429|FG001|Treatment Phase|Physician Decision|0|||
126092819|NCT00444275|453632919|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
126224882|NCT01271933|454113516|FG001|Double-Blind Phase|Adverse Event|3|||
126224883|NCT01271933|454113517|FG002|Double-Blind Phase|Adverse Event|0|||
126350795|NCT02335944|454575430|FG002|Treatment Phase|Physician Decision|0|||
126350796|NCT02335944|454575431|FG003|Treatment Phase|Physician Decision|1|||
126350797|NCT02335944|454575432|FG004|Treatment Phase|Physician Decision|0|||
126350798|NCT02335944|454575433|FG005|Treatment Phase|Physician Decision|6|||
126350799|NCT02335944|454575434|FG006|Treatment Phase|Physician Decision|1|||
126350800|NCT02335944|454575435|FG007|Treatment Phase|Physician Decision|2|||
126350801|NCT02335944|454575436|FG008|Treatment Phase|Physician Decision|1|||
126350802|NCT02335944|454575437|FG009|Treatment Phase|Physician Decision|0|||
126350803|NCT02335944|454575428|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
126350804|NCT02335944|454575429|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
126350805|NCT02335944|454575430|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
126350806|NCT02335944|454575431|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
126350807|NCT02335944|454575432|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
126350808|NCT02335944|454575433|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
126350809|NCT02335944|454575434|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
126350810|NCT02335944|454575435|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
126350811|NCT02335944|454575436|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
126224884|NCT01271933|454113515|FG000|Double-Blind Phase|Participant request-personal reason|0|||
126224885|NCT01271933|454113516|FG001|Double-Blind Phase|Participant request-personal reason|1|||
126224886|NCT01271933|454113517|FG002|Double-Blind Phase|Participant request-personal reason|0|||
126224887|NCT01138150|454113518|FG000|Overall Study|blood unable to be processed|0|||
126224888|NCT01138150|454113519|FG001|Overall Study|blood unable to be processed|1|||
126224889|NCT01138150|454113518|FG000|Overall Study|Physician Decision|1|||
126350812|NCT02335944|454575437|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
126350813|NCT02335944|454575428|FG000|Treatment Phase|Subject/Guardian Decision|0|||
126224890|NCT01138150|454113519|FG001|Overall Study|Physician Decision|0|||
126224891|NCT05085964|454113520|FG000|Overall Study|Premature termination of study|21|||
126224892|NCT05085964|454113521|FG001|Overall Study|Premature termination of study|0|||
126224893|NCT03156270|454113524|FG000|Overall Study|Failed pre-treatment screening|1|||
126224894|NCT03156270|454113524|FG000|Overall Study|Lost to Follow-up|1|||
126020468|NCT02409667|453370085|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
126020469|NCT00774852|453370087|FG000|Overall Study|Adverse Event|9|||
126020470|NCT00774852|453370088|FG001|Overall Study|Adverse Event|6|||
126020471|NCT00774852|453370087|FG000|Overall Study|Death|2|||
126020472|NCT00774852|453370088|FG001|Overall Study|Death|1|||
126020473|NCT00774852|453370087|FG000|Overall Study|Lack of Efficacy|3|||
126020474|NCT00774852|453370088|FG001|Overall Study|Lack of Efficacy|7|||
126020475|NCT00774852|453370087|FG000|Overall Study|Lost to Follow-up|9|||
126020476|NCT00774852|453370088|FG001|Overall Study|Lost to Follow-up|5|||
126020477|NCT00774852|453370087|FG000|Overall Study|Physician Decision|2|||
126020478|NCT00774852|453370088|FG001|Overall Study|Physician Decision|6|||
126020479|NCT00774852|453370087|FG000|Overall Study|Pregnancy|1|||
126020480|NCT00774852|453370088|FG001|Overall Study|Pregnancy|2|||
126020481|NCT00774852|453370087|FG000|Overall Study|Withdrawal by Subject|2|||
126020482|NCT00774852|453370088|FG001|Overall Study|Withdrawal by Subject|2|||
126020483|NCT00774852|453370087|FG000|Overall Study|Non-responder|15|||
126020484|NCT00774852|453370088|FG001|Overall Study|Non-responder|11|||
126020485|NCT00774852|453370087|FG000|Overall Study|Subject non-compliance|0|||
126020486|NCT00774852|453370088|FG001|Overall Study|Subject non-compliance|1|||
126020487|NCT00774852|453370087|FG000|Overall Study|Protocol Violation|1|||
126020488|NCT00774852|453370088|FG001|Overall Study|Protocol Violation|0|||
126020489|NCT00774852|453370087|FG000|Overall Study|Subject received prohibited medication|1|||
126020490|NCT00774852|453370088|FG001|Overall Study|Subject received prohibited medication|0|||
126020491|NCT03997916|453370089|FG000|Overall Study|Protocol Violation|35|||
126020492|NCT03482635|453370093|FG000|Overall Study|Lack of Efficacy|0|||
126020493|NCT03482635|453370094|FG001|Overall Study|Lack of Efficacy|0|||
126020494|NCT03482635|453370095|FG002|Overall Study|Lack of Efficacy|1|||
126020495|NCT03482635|453370096|FG003|Overall Study|Lack of Efficacy|3|||
126020496|NCT03482635|453370093|FG000|Overall Study|Adverse Event|2|||
126020497|NCT03482635|453370094|FG001|Overall Study|Adverse Event|2|||
126020498|NCT03482635|453370095|FG002|Overall Study|Adverse Event|0|||
126224895|NCT00591253|454113527|FG000|Overall Study|Adverse Event|3|||
126020499|NCT03482635|453370096|FG003|Overall Study|Adverse Event|3|||
126020500|NCT03482635|453370093|FG000|Overall Study|Withdrawal by Subject|2|||
126020501|NCT03482635|453370094|FG001|Overall Study|Withdrawal by Subject|1|||
126020502|NCT03482635|453370095|FG002|Overall Study|Withdrawal by Subject|0|||
126224896|NCT00591253|454113528|FG001|Overall Study|Adverse Event|3|||
126224897|NCT00591253|454113529|FG002|Overall Study|Adverse Event|1|||
126224898|NCT00591253|454113527|FG000|Overall Study|Protocol Violation|2|||
126224899|NCT00591253|454113528|FG001|Overall Study|Protocol Violation|2|||
126224900|NCT00591253|454113529|FG002|Overall Study|Protocol Violation|2|||
126224901|NCT00591253|454113527|FG000|Overall Study|Lost to Follow-up|2|||
126020503|NCT03482635|453370096|FG003|Overall Study|Withdrawal by Subject|1|||
126224902|NCT00591253|454113528|FG001|Overall Study|Lost to Follow-up|4|||
126224903|NCT00591253|454113529|FG002|Overall Study|Lost to Follow-up|0|||
126224904|NCT00591253|454113527|FG000|Overall Study|Withdrawal by Subject|1|||
126020504|NCT03482635|453370093|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
126020505|NCT03482635|453370094|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
126020506|NCT03482635|453370095|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
126020507|NCT03482635|453370096|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
126020508|NCT03482635|453370093|FG000|Overall Study|Not treated|0|||
126020509|NCT03482635|453370094|FG001|Overall Study|Not treated|0|||
126020510|NCT03482635|453370095|FG002|Overall Study|Not treated|0|||
126020511|NCT03482635|453370096|FG003|Overall Study|Not treated|1|||
126020512|NCT02581215|453371362|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
126020513|NCT02581215|453371363|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
126020514|NCT02581215|453371362|FG000|Overall Study|Eligibility Criteria Not Met|0|||
126020515|NCT02581215|453371363|FG001|Overall Study|Eligibility Criteria Not Met|1|||
126020516|NCT00802464|453371367|FG000|Month 0 - Month 8|Adverse Event|0|||
126020517|NCT00802464|453371368|FG001|Month 0 - Month 8|Adverse Event|1|||
126020518|NCT00802464|453371369|FG002|Month 0 - Month 8|Adverse Event|1|||
126020519|NCT00802464|453371370|FG003|Month 0 - Month 8|Adverse Event|2|||
126020520|NCT00802464|453371367|FG000|Month 0 - Month 8|Protocol Violation|0|||
126020521|NCT00802464|453371368|FG001|Month 0 - Month 8|Protocol Violation|0|||
126020522|NCT00802464|453371369|FG002|Month 0 - Month 8|Protocol Violation|1|||
126020523|NCT00802464|453371370|FG003|Month 0 - Month 8|Protocol Violation|0|||
126020524|NCT00802464|453371367|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
126020525|NCT00802464|453371368|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
126224905|NCT00591253|454113528|FG001|Overall Study|Withdrawal by Subject|7|||
126224906|NCT00591253|454113529|FG002|Overall Study|Withdrawal by Subject|6|||
126224907|NCT00591253|454113527|FG000|Overall Study|Lack of Efficacy|1|||
126020526|NCT00802464|453371369|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
126020527|NCT00802464|453371370|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
126020528|NCT00802464|453371367|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
126020529|NCT00802464|453371368|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
126020530|NCT00802464|453371369|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
126020531|NCT00802464|453371370|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
126020532|NCT00802464|453371367|FG000|Month 0 - Month 8|Other|0|||
126020533|NCT00802464|453371368|FG001|Month 0 - Month 8|Other|0|||
126020534|NCT00802464|453371369|FG002|Month 0 - Month 8|Other|1|||
126020535|NCT00802464|453371370|FG003|Month 0 - Month 8|Other|0|||
126020536|NCT00802464|453371367|FG000|Month 8 - Month 14|Adverse Event|0|||
126020537|NCT00802464|453371368|FG001|Month 8 - Month 14|Adverse Event|1|||
126020538|NCT00802464|453371369|FG002|Month 8 - Month 14|Adverse Event|0|||
126020539|NCT00802464|453371370|FG003|Month 8 - Month 14|Adverse Event|0|||
126020540|NCT00802464|453371367|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
126020541|NCT00802464|453371368|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
126020542|NCT00802464|453371369|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
126020543|NCT00802464|453371370|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
126020544|NCT00802464|453371367|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
126020545|NCT00802464|453371368|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
126020546|NCT00802464|453371369|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
126020547|NCT00802464|453371370|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
126020548|NCT00402246|453371371|FG000|Overall Study|Death|62|||
126350814|NCT02335944|454575429|FG001|Treatment Phase|Subject/Guardian Decision|0|||
126350815|NCT02335944|454575430|FG002|Treatment Phase|Subject/Guardian Decision|1|||
126350816|NCT02335944|454575431|FG003|Treatment Phase|Subject/Guardian Decision|0|||
126350817|NCT02335944|454575432|FG004|Treatment Phase|Subject/Guardian Decision|0|||
126350818|NCT02335944|454575433|FG005|Treatment Phase|Subject/Guardian Decision|1|||
126350819|NCT02335944|454575434|FG006|Treatment Phase|Subject/Guardian Decision|0|||
126350820|NCT02335944|454575435|FG007|Treatment Phase|Subject/Guardian Decision|4|||
126350821|NCT02335944|454575436|FG008|Treatment Phase|Subject/Guardian Decision|0|||
126350822|NCT02335944|454575437|FG009|Treatment Phase|Subject/Guardian Decision|0|||
126350823|NCT02335944|454575428|FG000|Post-treatment Follow-up|Progressive Disease|0|||
126350824|NCT02335944|454575429|FG001|Post-treatment Follow-up|Progressive Disease|0|||
126350825|NCT02335944|454575430|FG002|Post-treatment Follow-up|Progressive Disease|0|||
126350826|NCT02335944|454575431|FG003|Post-treatment Follow-up|Progressive Disease|1|||
126350827|NCT02335944|454575432|FG004|Post-treatment Follow-up|Progressive Disease|0|||
126350828|NCT02335944|454575433|FG005|Post-treatment Follow-up|Progressive Disease|9|||
126224908|NCT00591253|454113528|FG001|Overall Study|Lack of Efficacy|0|||
126350829|NCT02335944|454575434|FG006|Post-treatment Follow-up|Progressive Disease|0|||
126350830|NCT02335944|454575435|FG007|Post-treatment Follow-up|Progressive Disease|2|||
126350831|NCT02335944|454575436|FG008|Post-treatment Follow-up|Progressive Disease|3|||
126020549|NCT00402246|453371372|FG001|Overall Study|Death|58|||
126020550|NCT00402246|453371371|FG000|Overall Study|Lost to Follow-up|20|||
126020551|NCT00402246|453371372|FG001|Overall Study|Lost to Follow-up|28|||
126020552|NCT00402246|453371371|FG000|Overall Study|Withdrawal by Subject|72|||
126020553|NCT00402246|453371372|FG001|Overall Study|Withdrawal by Subject|87|||
126020554|NCT00402246|453371371|FG000|Overall Study|Physician Decision|24|||
126020555|NCT00402246|453371372|FG001|Overall Study|Physician Decision|26|||
126020556|NCT00402246|453371371|FG000|Overall Study|Protocol Violation|25|||
126020557|NCT00402246|453371372|FG001|Overall Study|Protocol Violation|24|||
126224909|NCT00591253|454113529|FG002|Overall Study|Lack of Efficacy|3|||
126020558|NCT00402246|453371371|FG000|Overall Study|Missed Final Visit|1|||
126020559|NCT00402246|453371372|FG001|Overall Study|Missed Final Visit|2|||
126020560|NCT00402246|453371371|FG000|Overall Study|Insurance Issues|2|||
126020561|NCT00402246|453371372|FG001|Overall Study|Insurance Issues|1|||
126020562|NCT00402246|453371371|FG000|Overall Study|Heart Transplant|0|||
126020563|NCT00402246|453371372|FG001|Overall Study|Heart Transplant|1|||
126350832|NCT02335944|454575437|FG009|Post-treatment Follow-up|Progressive Disease|0|||
126350833|NCT02335944|454575428|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350834|NCT02335944|454575429|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350835|NCT02335944|454575430|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350836|NCT02335944|454575431|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350837|NCT02335944|454575432|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350838|NCT02335944|454575433|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
126350839|NCT02335944|454575434|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350840|NCT02335944|454575435|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350841|NCT02335944|454575436|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350842|NCT02335944|454575437|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350843|NCT02335944|454575428|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350844|NCT02335944|454575429|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350845|NCT02335944|454575430|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350846|NCT02335944|454575431|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350847|NCT02335944|454575432|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350848|NCT02335944|454575433|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350849|NCT02335944|454575434|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350850|NCT02335944|454575435|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
126350851|NCT02335944|454575436|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
126020564|NCT00402246|453371371|FG000|Overall Study|Patient's device explanted|6|||
126020565|NCT00402246|453371372|FG001|Overall Study|Patient's device explanted|2|||
126350852|NCT02335944|454575437|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350853|NCT02335944|454575428|FG000|Post-treatment Follow-up|Adverse Event|0|||
126350854|NCT02335944|454575429|FG001|Post-treatment Follow-up|Adverse Event|0|||
126350855|NCT02335944|454575430|FG002|Post-treatment Follow-up|Adverse Event|0|||
126020566|NCT00402246|453371371|FG000|Overall Study|Center Closure|5|||
126020567|NCT00402246|453371372|FG001|Overall Study|Center Closure|3|||
126020568|NCT00402246|453371371|FG000|Overall Study|Deterioriating Condition|3|||
126020569|NCT00402246|453371372|FG001|Overall Study|Deterioriating Condition|2|||
126020570|NCT00434304|453371377|FG000|Overall Study|Adverse Event|14|||
126020571|NCT00434304|453371377|FG000|Overall Study|Lack of Efficacy|2|||
126020572|NCT00434304|453371377|FG000|Overall Study|Withdrawal by Subject|4|||
126020573|NCT00371787|453371384|FG000|Overall Study|Withdrawal by Subject|3|||
126020574|NCT00371787|453371385|FG001|Overall Study|Withdrawal by Subject|1|||
126020575|NCT01854385|453371387|FG000|Pre-Treatment|Withdrawal by Subject|4|||
126020576|NCT01854385|453371387|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
126020577|NCT01854385|453371387|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
126020578|NCT01854385|453371387|FG000|Pre-Treatment|Unable to come for study visits|1|||
126020579|NCT01854385|453371387|FG000|Treatment|Lost to Follow-up|1|||
126020580|NCT00277355|453371390|FG000|Overall Study|Withdrawal by Subject|3|||
126020581|NCT00277355|453371391|FG001|Overall Study|Withdrawal by Subject|3|||
126224910|NCT00591253|454113527|FG000|Overall Study|Other|5|||
126020582|NCT00277355|453371390|FG000|Overall Study|Lost to Follow-up|2|||
126020583|NCT00277355|453371391|FG001|Overall Study|Lost to Follow-up|2|||
126020584|NCT00277355|453371390|FG000|Overall Study|Adverse Event|5|||
126020585|NCT00277355|453371391|FG001|Overall Study|Adverse Event|0|||
126020586|NCT00277355|453371390|FG000|Overall Study|Death|3|||
126020587|NCT00277355|453371391|FG001|Overall Study|Death|0|||
126224911|NCT00591253|454113528|FG001|Overall Study|Other|5|||
126224912|NCT00591253|454113529|FG002|Overall Study|Other|3|||
126224913|NCT00871169|454113530|FG000|Overall Study|Protocol Violation|1|||
126224914|NCT00871169|454113530|FG000|Overall Study|Patient did not receive study treatment|2|||
126224915|NCT02110706|454113534|FG000|Overall Study|Adverse Event|2|||
126224916|NCT02110706|454113535|FG001|Overall Study|Adverse Event|3|||
126224917|NCT02110706|454113534|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
126224918|NCT02110706|454113535|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
126224919|NCT03210259|454113536|FG000|12-Week Run-in Period|Adverse Event|1|||
126224920|NCT03210259|454113537|FG001|12-Week Run-in Period|Adverse Event|0|||
126224921|NCT03210259|454113538|FG002|12-Week Run-in Period|Adverse Event|0|||
126224922|NCT03210259|454113536|FG000|12-Week Run-in Period|Death|1|||
126224923|NCT03210259|454113537|FG001|12-Week Run-in Period|Death|0|||
126224924|NCT03210259|454113538|FG002|12-Week Run-in Period|Death|0|||
126224925|NCT03210259|454113536|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
126350856|NCT02335944|454575431|FG003|Post-treatment Follow-up|Adverse Event|0|||
126350857|NCT02335944|454575432|FG004|Post-treatment Follow-up|Adverse Event|0|||
126350858|NCT02335944|454575433|FG005|Post-treatment Follow-up|Adverse Event|1|||
126350859|NCT02335944|454575434|FG006|Post-treatment Follow-up|Adverse Event|0|||
126350860|NCT02335944|454575435|FG007|Post-treatment Follow-up|Adverse Event|0|||
126350861|NCT02335944|454575436|FG008|Post-treatment Follow-up|Adverse Event|0|||
126350862|NCT02335944|454575437|FG009|Post-treatment Follow-up|Adverse Event|0|||
126350863|NCT02335944|454575428|FG000|Post-treatment Follow-up|Death|0|||
126350864|NCT02335944|454575429|FG001|Post-treatment Follow-up|Death|0|||
126350865|NCT02335944|454575430|FG002|Post-treatment Follow-up|Death|0|||
126350866|NCT02335944|454575431|FG003|Post-treatment Follow-up|Death|1|||
126350867|NCT02335944|454575432|FG004|Post-treatment Follow-up|Death|0|||
126350868|NCT02335944|454575433|FG005|Post-treatment Follow-up|Death|1|||
126350869|NCT02335944|454575434|FG006|Post-treatment Follow-up|Death|0|||
126350870|NCT02335944|454575435|FG007|Post-treatment Follow-up|Death|0|||
126350871|NCT02335944|454575436|FG008|Post-treatment Follow-up|Death|0|||
126350872|NCT02335944|454575437|FG009|Post-treatment Follow-up|Death|0|||
126350873|NCT02335944|454575428|FG000|Post-treatment Follow-up|Physician Decision|1|||
126350874|NCT02335944|454575429|FG001|Post-treatment Follow-up|Physician Decision|0|||
126350875|NCT02335944|454575430|FG002|Post-treatment Follow-up|Physician Decision|0|||
126350876|NCT02335944|454575431|FG003|Post-treatment Follow-up|Physician Decision|0|||
126350877|NCT02335944|454575432|FG004|Post-treatment Follow-up|Physician Decision|0|||
126350878|NCT02335944|454575433|FG005|Post-treatment Follow-up|Physician Decision|0|||
126350879|NCT02335944|454575434|FG006|Post-treatment Follow-up|Physician Decision|0|||
126350880|NCT02335944|454575435|FG007|Post-treatment Follow-up|Physician Decision|1|||
126350881|NCT02335944|454575436|FG008|Post-treatment Follow-up|Physician Decision|0|||
126350882|NCT02335944|454575437|FG009|Post-treatment Follow-up|Physician Decision|0|||
126350883|NCT01706328|454575443|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
126350884|NCT01706328|454575444|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126369500|NCT00876447|454650571|FG000|Overall Study|Adverse Event|4|||
126020588|NCT00277355|453371390|FG000|Overall Study|Physician Decision|1|||
126020589|NCT00277355|453371391|FG001|Overall Study|Physician Decision|0|||
126020590|NCT02597920|453371394|FG000|Overall Study|Worsening of other pre-existing disease|0|||
126224926|NCT03210259|454113537|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
126224927|NCT03210259|454113538|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
126224928|NCT03210259|454113536|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
126224929|NCT03210259|454113537|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
126224930|NCT03210259|454113538|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
126224931|NCT03210259|454113536|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
126224932|NCT03210259|454113537|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
126224933|NCT03210259|454113538|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
126224934|NCT03210259|454113536|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
126350885|NCT01706328|454575445|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126350886|NCT01706328|454575443|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
126020591|NCT02597920|453371395|FG001|Overall Study|Worsening of other pre-existing disease|1|||
126020592|NCT02597920|453371396|FG002|Overall Study|Worsening of other pre-existing disease|0|||
126020593|NCT02597920|453371394|FG000|Overall Study|Other adverse event|20|||
126020594|NCT02597920|453371395|FG001|Overall Study|Other adverse event|30|||
126020595|NCT02597920|453371396|FG002|Overall Study|Other adverse event|0|||
126020596|NCT02597920|453371394|FG000|Overall Study|Lost to Follow-up|7|||
126020597|NCT02597920|453371395|FG001|Overall Study|Lost to Follow-up|9|||
126020598|NCT02597920|453371396|FG002|Overall Study|Lost to Follow-up|0|||
126020599|NCT02597920|453371394|FG000|Overall Study|Refuse to continue in the study|3|||
126020600|NCT02597920|453371395|FG001|Overall Study|Refuse to continue in the study|13|||
126020601|NCT02597920|453371396|FG002|Overall Study|Refuse to continue in the study|1|||
126020602|NCT02597920|453371394|FG000|Overall Study|Other than specified|10|||
126020603|NCT02597920|453371395|FG001|Overall Study|Other than specified|31|||
126020604|NCT02597920|453371396|FG002|Overall Study|Other than specified|5|||
126020605|NCT02597920|453371394|FG000|Overall Study|Other|1|||
126020606|NCT02597920|453371395|FG001|Overall Study|Other|0|||
126350887|NCT01706328|454575444|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126350888|NCT01706328|454575445|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126350889|NCT01706328|454575443|FG000|2-week Run-in Period|Physician Decision|4|||
126350890|NCT01706328|454575444|FG001|2-week Run-in Period|Physician Decision|0|||
126350891|NCT01706328|454575445|FG002|2-week Run-in Period|Physician Decision|0|||
126350892|NCT01706328|454575443|FG000|2-week Run-in Period|Adverse Event|4|||
126350893|NCT01706328|454575444|FG001|2-week Run-in Period|Adverse Event|0|||
126350894|NCT01706328|454575445|FG002|2-week Run-in Period|Adverse Event|0|||
126350895|NCT01706328|454575443|FG000|2-week Run-in Period|Lost to Follow-up|2|||
126350896|NCT01706328|454575444|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126350897|NCT01706328|454575445|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126350898|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
126224935|NCT03210259|454113537|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
126224936|NCT03210259|454113538|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
126224937|NCT03210259|454113536|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
126224938|NCT03210259|454113537|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
126224939|NCT03210259|454113538|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
126224940|NCT03210259|454113536|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
126224941|NCT03210259|454113537|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
126224942|NCT03210259|454113538|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
126224943|NCT03210259|454113536|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
126224944|NCT03210259|454113537|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
126020607|NCT02597920|453371396|FG002|Overall Study|Other|0|||
126020608|NCT05489484|453371400|FG000|Overall Study|withdrawn|1|||
126020609|NCT00444600|453371403|FG000|Overall Study|Death|7|||
126020610|NCT00444600|453371404|FG001|Overall Study|Death|5|||
126020611|NCT00444600|453371405|FG002|Overall Study|Death|3|||
126020612|NCT00444600|453371406|FG003|Overall Study|Death|2|||
126020613|NCT00444600|453371403|FG000|Overall Study|Dropped|11|||
126020614|NCT00444600|453371404|FG001|Overall Study|Dropped|11|||
126020615|NCT00444600|453371405|FG002|Overall Study|Dropped|7|||
126020616|NCT00444600|453371406|FG003|Overall Study|Dropped|7|||
126020617|NCT00444600|453371403|FG000|Overall Study|Missed visit|1|||
126020618|NCT00444600|453371404|FG001|Overall Study|Missed visit|0|||
126020619|NCT00444600|453371405|FG002|Overall Study|Missed visit|0|||
126020620|NCT00444600|453371406|FG003|Overall Study|Missed visit|1|||
126020621|NCT05132478|453371407|FG000|Overall Study|did not complete survey after consent|1|||
126020622|NCT05132478|453371408|FG001|Overall Study|did not complete survey after consent|1|||
126020623|NCT05132478|453371407|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
126020624|NCT05132478|453371408|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
126020625|NCT00106080|453371409|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
126020626|NCT00106080|453371410|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
126020627|NCT02549170|453371411|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
126020628|NCT02549170|453371412|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
126092820|NCT00444275|453632920|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
126092821|NCT00444275|453632916|FG000|Maintenance Treatment Phase|Adverse Event|0|||
126092822|NCT00444275|453632917|FG001|Maintenance Treatment Phase|Adverse Event|0|||
126092823|NCT00444275|453632918|FG002|Maintenance Treatment Phase|Adverse Event|3|||
126350899|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
126350900|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
126350901|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
126350902|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
126350903|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
126350904|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
126350905|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
126350906|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
126350907|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
126350908|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
126350909|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
126350910|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
126350911|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
126350912|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
126350913|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
126350914|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
126350915|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
126350916|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126350917|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
126350918|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
126350919|NCT03018938|454575448|FG000|Overall Study|Death|0|||
126350920|NCT03018938|454575449|FG001|Overall Study|Death|1|||
126350921|NCT03018938|454575448|FG000|Overall Study|Lost to Follow-up|21|||
126350922|NCT03018938|454575449|FG001|Overall Study|Lost to Follow-up|32|||
126350923|NCT03018938|454575448|FG000|Overall Study|Withdrawal by Subject|38|||
126350924|NCT03018938|454575449|FG001|Overall Study|Withdrawal by Subject|45|||
126350925|NCT03018938|454575448|FG000|Overall Study|Physician Decision|3|||
126350926|NCT03018938|454575449|FG001|Overall Study|Physician Decision|2|||
126350927|NCT03018938|454575448|FG000|Overall Study|Sponsor Decision|0|||
126020629|NCT02549170|453371413|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
126020630|NCT02549170|453371414|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
126020631|NCT02549170|453371415|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
126224945|NCT03210259|454113538|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
126092824|NCT00444275|453632919|FG003|Maintenance Treatment Phase|Adverse Event|2|||
126092825|NCT00444275|453632920|FG004|Maintenance Treatment Phase|Adverse Event|13|||
126092826|NCT00444275|453632916|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
126092827|NCT00444275|453632917|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
126092828|NCT00444275|453632918|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
126092829|NCT00444275|453632919|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
126092830|NCT00444275|453632920|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
126092831|NCT00444275|453632916|FG000|Maintenance Treatment Phase|Patient's wish|0|||
126092832|NCT00444275|453632917|FG001|Maintenance Treatment Phase|Patient's wish|0|||
126092833|NCT00444275|453632918|FG002|Maintenance Treatment Phase|Patient's wish|19|||
126092834|NCT00444275|453632919|FG003|Maintenance Treatment Phase|Patient's wish|9|||
126092835|NCT00444275|453632920|FG004|Maintenance Treatment Phase|Patient's wish|20|||
126092836|NCT00444275|453632916|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
126092837|NCT00444275|453632917|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
126092838|NCT00444275|453632918|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
126350928|NCT03018938|454575449|FG001|Overall Study|Sponsor Decision|1|||
126092839|NCT00444275|453632919|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
126092840|NCT00444275|453632920|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
126350929|NCT03018938|454575448|FG000|Overall Study|Screen failure-After randomization|4|||
126350930|NCT03018938|454575449|FG001|Overall Study|Screen failure-After randomization|2|||
126350931|NCT03018938|454575448|FG000|Overall Study|Not recorded|0|||
126350932|NCT03018938|454575449|FG001|Overall Study|Not recorded|2|||
126350933|NCT02811159|454575452|FG000|Treatment Course 1|Lost to Follow-up|1|||
126350934|NCT00191100|454575453|FG000|Overall Study|Adverse Event|18|||
126350935|NCT00191100|454575454|FG001|Overall Study|Adverse Event|1|||
126350936|NCT00191100|454575453|FG000|Overall Study|Lost to Follow-up|2|||
126350937|NCT00191100|454575454|FG001|Overall Study|Lost to Follow-up|0|||
126350938|NCT00191100|454575453|FG000|Overall Study|Patient Moved|0|||
126350939|NCT00191100|454575454|FG001|Overall Study|Patient Moved|1|||
126350940|NCT00191100|454575453|FG000|Overall Study|Withdrawal by Subject|9|||
126350941|NCT00191100|454575454|FG001|Overall Study|Withdrawal by Subject|3|||
126350942|NCT00191100|454575453|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
126350943|NCT00191100|454575454|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
126350944|NCT00191100|454575453|FG000|Overall Study|Clinical Relapse|2|||
126350945|NCT00191100|454575454|FG001|Overall Study|Clinical Relapse|1|||
126350946|NCT00191100|454575453|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
126350947|NCT00191100|454575454|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
126020632|NCT02549170|453371411|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
126020633|NCT02549170|453371412|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
126020634|NCT02549170|453371413|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
126020635|NCT02549170|453371414|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
126020636|NCT02549170|453371415|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
126020637|NCT02549170|453371411|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
126224946|NCT03210259|454113536|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
126224947|NCT03210259|454113537|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
126020638|NCT02549170|453371412|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
126020639|NCT02549170|453371413|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
126224948|NCT03210259|454113538|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
126350948|NCT00191100|454575453|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
126350949|NCT00191100|454575454|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
126350950|NCT00191100|454575453|FG000|Overall Study|Physician Decision|3|||
126350951|NCT00191100|454575454|FG001|Overall Study|Physician Decision|1|||
126350952|NCT00191100|454575453|FG000|Overall Study|Death from Study Drug Toxicity|2|||
126350953|NCT00191100|454575454|FG001|Overall Study|Death from Study Drug Toxicity|0|||
126350954|NCT00191100|454575453|FG000|Overall Study|Protocol Violation|1|||
126350955|NCT00191100|454575454|FG001|Overall Study|Protocol Violation|1|||
126350956|NCT00191100|454575453|FG000|Overall Study|Death from Other Cause|1|||
126350957|NCT00191100|454575454|FG001|Overall Study|Death from Other Cause|0|||
126350958|NCT00191100|454575453|FG000|Overall Study|Reason Not Specified|0|||
126350959|NCT00191100|454575454|FG001|Overall Study|Reason Not Specified|1|||
126350960|NCT02916771|454575455|FG000|Overall Study|Withdrawal by Subject|9|||
126350961|NCT02916771|454575455|FG000|Overall Study|Physician Decision|1|||
126350962|NCT02916771|454575455|FG000|Overall Study|Began treatment for another active malignancy|1|||
126350963|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
126350964|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
126350965|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
126350966|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
126350967|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
126350968|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
126350969|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
126350970|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
126350971|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
126350972|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
126350973|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
126350974|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
126350975|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
126350976|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
126350977|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
126350978|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
126350979|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
126350980|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
126350981|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
126350982|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
126350983|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
126350984|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
126350985|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
126350986|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
126350987|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
126350988|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
126350989|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
126350990|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
126350991|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
126350992|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
126350993|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
126350994|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
126350995|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
126350996|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
126350997|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
126350998|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
126350999|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
126351000|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
126369501|NCT00876447|454650572|FG001|Overall Study|Adverse Event|8|||
126369502|NCT00366457|454650578|FG000|Overall Study|never began study therapy|2|||
126369503|NCT02538614|454650579|FG000|Overall Study|Progressive Disease|2|||
126046465|NCT02467270|453468227|FG001|Overall Study|Non-compliance With Study Drug|2|||
126020640|NCT02549170|453371414|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
126020641|NCT02549170|453371415|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
126020642|NCT01414738|453371416|FG000|Overall Study|Death|26|||
126020643|NCT01414738|453371416|FG000|Overall Study|Refused testing|5|||
126020644|NCT01414738|453371416|FG000|Overall Study|Lost to Follow-up|2|||
126020645|NCT01414738|453371416|FG000|Overall Study|Refused, disease progression|8|||
126020646|NCT01414738|453371416|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
126020647|NCT01839331|453371417|FG000|Overall Study|Early Termination|3|||
126020648|NCT01839331|453371418|FG001|Overall Study|Early Termination|0|||
126020649|NCT01839331|453371419|FG002|Overall Study|Early Termination|1|||
126020650|NCT01839331|453371420|FG003|Overall Study|Early Termination|2|||
126020651|NCT01839331|453371417|FG000|Overall Study|Protocol Violation|1|||
126020652|NCT01839331|453371418|FG001|Overall Study|Protocol Violation|6|||
126224949|NCT03210259|454113536|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
126224950|NCT03210259|454113537|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
126224951|NCT03210259|454113538|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
126224952|NCT02087059|454113539|FG000|Overall Study|Disease Progression|1|||
126020653|NCT01839331|453371419|FG002|Overall Study|Protocol Violation|4|||
126020654|NCT01839331|453371420|FG003|Overall Study|Protocol Violation|3|||
126020655|NCT00703820|453371423|FG000|Overall Study|Adverse Event|12|||
126020656|NCT00703820|453371424|FG001|Overall Study|Adverse Event|17|||
126020657|NCT00703820|453371423|FG000|Overall Study|Death|5|||
126020658|NCT00703820|453371424|FG001|Overall Study|Death|0|||
126020659|NCT00703820|453371423|FG000|Overall Study|Lack of Efficacy|11|||
126020660|NCT00703820|453371424|FG001|Overall Study|Lack of Efficacy|11|||
126020661|NCT00703820|453371423|FG000|Overall Study|Received non-protocol therapy|1|||
126020662|NCT00703820|453371424|FG001|Overall Study|Received non-protocol therapy|0|||
126020663|NCT00703820|453371423|FG000|Overall Study|Physician Decision|4|||
126351001|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
126351002|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
126351003|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
126351004|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
126351005|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
126351006|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
126351007|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
126351008|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
126351009|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
126020664|NCT00703820|453371424|FG001|Overall Study|Physician Decision|5|||
126020665|NCT00703820|453371423|FG000|Overall Study|Withdrawal by Subject|2|||
126020666|NCT00703820|453371424|FG001|Overall Study|Withdrawal by Subject|1|||
126020667|NCT03531840|453371429|FG000|Overall Study|Death on study|3|||
126020668|NCT03531840|453371430|FG001|Overall Study|Death on study|2|||
126020669|NCT03531840|453371431|FG002|Overall Study|Death on study|1|||
126020670|NCT03531840|453371432|FG003|Overall Study|Death on study|2|||
126020671|NCT03531840|453371429|FG000|Overall Study|Death during follow up|2|||
126020672|NCT03531840|453371430|FG001|Overall Study|Death during follow up|3|||
126020673|NCT03531840|453371431|FG002|Overall Study|Death during follow up|4|||
126020674|NCT03531840|453371432|FG003|Overall Study|Death during follow up|1|||
126020675|NCT00761605|453371434|FG000|Overall Study|Adverse Event|26|||
126020676|NCT00761605|453371434|FG000|Overall Study|Death|2|||
126020677|NCT00761605|453371434|FG000|Overall Study|Lack of Efficacy|26|||
126020678|NCT00761605|453371434|FG000|Overall Study|Lost to Follow-up|29|||
126020679|NCT00761605|453371434|FG000|Overall Study|Withdrawal by Subject|37|||
126020680|NCT00761605|453371434|FG000|Overall Study|Other|21|||
126020681|NCT03451721|453371435|FG000|Overall Study|Death|1|||
126020682|NCT00350792|453371436|FG000|Overall Study|Adverse Event|11|||
126020683|NCT00350792|453371436|FG000|Overall Study|Death from Study Disease|1|||
126020684|NCT00350792|453371436|FG000|Overall Study|Death from Study Drug Toxicity|1|||
126020685|NCT00350792|453371436|FG000|Overall Study|Death Not Study Drug Related|2|||
126351010|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
126351011|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
126351012|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
126351013|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
126351014|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
126351015|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
126351016|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
126351017|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
126351018|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
126351019|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
126351020|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
126351021|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
126351022|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
126351023|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
126351024|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
126351025|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
126351026|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
126351027|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
126351028|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
126351029|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
126351030|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
126351031|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
126351032|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
126351033|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
126351034|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
126351035|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
126351036|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
126351037|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
126351038|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
126351039|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Study suspension|0|||
126351040|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Study suspension|45|||
126351041|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Study suspension|0|||
126351042|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Study suspension|0|||
126351043|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
126351044|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
126351045|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
126351046|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
126351047|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Death|2|||
126351048|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Death|3|||
126351049|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Death|0|||
126351050|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Death|0|||
126351051|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
126351052|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
126351053|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
126351054|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
126351055|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
126351056|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
126351057|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
126351058|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
126351059|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
126351060|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
126351061|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
126351062|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
126351063|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
126351064|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
126351065|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
126351066|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
126351067|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
126351068|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
126351069|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
126020686|NCT00350792|453371436|FG000|Overall Study|Protocol Violation|1|||
126020687|NCT00350792|453371436|FG000|Overall Study|Withdrawal by Subject|4|||
126224953|NCT02087059|454113539|FG000|Overall Study|Adverse Event|5|||
126224954|NCT02087059|454113539|FG000|Overall Study|Lost to Follow-up|1|||
126224955|NCT00252187|454113540|FG000|Overall Study|Adverse Event|3|||
126224956|NCT00252187|454113541|FG001|Overall Study|Adverse Event|1|||
126224957|NCT00252187|454113540|FG000|Overall Study|Withdrawal by Subject|1|||
126224958|NCT00252187|454113541|FG001|Overall Study|Withdrawal by Subject|0|||
126224959|NCT00706706|454113544|FG000|Overall Study|Death|53|||
126224960|NCT00706706|454113544|FG000|Overall Study|Lost to Follow-up|7|||
126020688|NCT00350792|453371436|FG000|Overall Study|Physician Decision|2|||
126020689|NCT00350792|453371436|FG000|Overall Study|Lack of Efficacy|11|||
126020690|NCT01985334|453371437|FG000|Overall Study|Administrative problems|1|||
126224961|NCT00706706|454113544|FG000|Overall Study|Study endpoint had reached|45|||
126224962|NCT05017493|454113545|FG000|Overall Study|Withdrawal by Subject|26|||
126224963|NCT05017493|454113546|FG001|Overall Study|Withdrawal by Subject|0|||
126020691|NCT01985334|453371438|FG001|Overall Study|Administrative problems|1|||
126224964|NCT05017493|454113545|FG000|Overall Study|Physician Decision|15|||
126224965|NCT05017493|454113546|FG001|Overall Study|Physician Decision|0|||
126224966|NCT05017493|454113545|FG000|Overall Study|Protocol Violation|81|||
126020692|NCT01985334|453371439|FG002|Overall Study|Administrative problems|0|||
126020693|NCT01985334|453371440|FG003|Overall Study|Administrative problems|2|||
126351070|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
126351071|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
126351072|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
126351073|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
126351074|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
126351075|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
126351076|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
126351077|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
126351078|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
126351079|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Other|1|||
126351080|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Other|2|||
126351081|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Other|0|||
126351082|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Other|0|||
126351083|NCT04132050|454576209|FG000|Period I (Double-blind Period)|Adverse Event|3|||
126351084|NCT04132050|454576210|FG001|Period I (Double-blind Period)|Adverse Event|0|||
126351085|NCT04132050|454576209|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
126351086|NCT04132050|454576210|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
126351087|NCT04132050|454576209|FG000|R788 Treatment Period|Adverse Event|5|||
126351088|NCT04132050|454576210|FG001|R788 Treatment Period|Adverse Event|0|||
126351089|NCT04132050|454576209|FG000|R788 Treatment Period|Lack of Efficacy|5|||
126351090|NCT04132050|454576210|FG001|R788 Treatment Period|Lack of Efficacy|0|||
126351091|NCT04132050|454576209|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
126351092|NCT04132050|454576210|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
126351093|NCT03506477|454576211|FG000|Overall Study|Withdrawal by Subject|1|||
126351094|NCT03506477|454576212|FG001|Overall Study|Withdrawal by Subject|0|||
126351095|NCT01757847|454576213|FG000|Overall Study|Withdrawal by Subject|3|||
126351096|NCT01757847|454576214|FG001|Overall Study|Withdrawal by Subject|4|||
126351097|NCT00843882|454576215|FG000|Step 1|Lack of Efficacy|14|||
126351098|NCT00843882|454576216|FG001|Step 1|Lack of Efficacy|10|||
126351099|NCT00843882|454576217|FG002|Step 1|Lack of Efficacy|21|||
126351100|NCT00843882|454576215|FG000|Step 1|Adverse Event|8|||
126351101|NCT00843882|454576216|FG001|Step 1|Adverse Event|17|||
126351102|NCT00843882|454576217|FG002|Step 1|Adverse Event|20|||
126351103|NCT00843882|454576215|FG000|Step 1|Death|1|||
126351104|NCT00843882|454576216|FG001|Step 1|Death|2|||
126351105|NCT00843882|454576217|FG002|Step 1|Death|4|||
126351106|NCT00843882|454576215|FG000|Step 1|Withdrawal by Subject|6|||
126351107|NCT00843882|454576216|FG001|Step 1|Withdrawal by Subject|12|||
126351108|NCT00843882|454576217|FG002|Step 1|Withdrawal by Subject|9|||
126351109|NCT00843882|454576215|FG000|Step 1|Physician Decision|0|||
126351110|NCT00843882|454576216|FG001|Step 1|Physician Decision|5|||
126351111|NCT00843882|454576217|FG002|Step 1|Physician Decision|1|||
126351112|NCT00843882|454576215|FG000|Step 1|Patient and physician's decision|0|||
126351113|NCT00843882|454576216|FG001|Step 1|Patient and physician's decision|0|||
126351114|NCT00843882|454576217|FG002|Step 1|Patient and physician's decision|1|||
126351115|NCT00843882|454576215|FG000|Step 1|Other complicating disease|1|||
126351116|NCT00843882|454576216|FG001|Step 1|Other complicating disease|3|||
126351117|NCT00843882|454576217|FG002|Step 1|Other complicating disease|4|||
126351118|NCT00843882|454576215|FG000|Step 1|Alternative therapy|0|||
126351119|NCT00843882|454576216|FG001|Step 1|Alternative therapy|1|||
126351120|NCT00843882|454576217|FG002|Step 1|Alternative therapy|1|||
126351121|NCT00843882|454576215|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
126351122|NCT00843882|454576216|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
126351123|NCT00843882|454576217|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
126351124|NCT00843882|454576215|FG000|Step 1|Off treatment reason unknown|0|||
126351125|NCT00843882|454576216|FG001|Step 1|Off treatment reason unknown|1|||
126351126|NCT00843882|454576217|FG002|Step 1|Off treatment reason unknown|4|||
126351127|NCT00843882|454576215|FG000|Step 1|Never started treatment|2|||
126351128|NCT00843882|454576216|FG001|Step 1|Never started treatment|0|||
126351129|NCT00843882|454576217|FG002|Step 1|Never started treatment|0|||
126351130|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
126351131|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
126351132|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
126351133|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
126351134|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
126351135|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
126351136|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
126351137|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
126351138|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
126351139|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
126351140|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
126351141|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
126092841|NCT00444275|453632916|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
126092842|NCT00444275|453632917|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
126092843|NCT00444275|453632918|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
126092844|NCT00444275|453632919|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
126092845|NCT00444275|453632920|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
126092846|NCT02045875|453632921|FG000|Overall Study|Lost to Follow-up|3|||
126092847|NCT02045875|453632922|FG001|Overall Study|Lost to Follow-up|0|||
126092848|NCT02045875|453632921|FG000|Overall Study|Withdrawal by Subject|4|||
126092849|NCT02045875|453632922|FG001|Overall Study|Withdrawal by Subject|3|||
126092850|NCT01114880|453632926|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
126092851|NCT01114880|453632927|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
126092852|NCT01114880|453632926|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
126092853|NCT01114880|453632927|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
126092854|NCT01114880|453632926|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
126092855|NCT01114880|453632927|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
126092856|NCT01114880|453632926|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
126092857|NCT01114880|453632927|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
126020694|NCT01985334|453371441|FG004|Overall Study|Administrative problems|0|||
126020695|NCT01985334|453371442|FG005|Overall Study|Administrative problems|1|||
126020696|NCT01985334|453371443|FG006|Overall Study|Administrative problems|1|||
126092858|NCT01114880|453632926|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
126092859|NCT01114880|453632927|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
126224967|NCT05017493|454113546|FG001|Overall Study|Protocol Violation|0|||
126020697|NCT01985334|453371444|FG007|Overall Study|Administrative problems|3|||
126020698|NCT01985334|453371437|FG000|Overall Study|Death|1|||
126020699|NCT01985334|453371438|FG001|Overall Study|Death|0|||
126020700|NCT01985334|453371439|FG002|Overall Study|Death|0|||
126020701|NCT01985334|453371440|FG003|Overall Study|Death|3|||
126020702|NCT01985334|453371441|FG004|Overall Study|Death|0|||
126020703|NCT01985334|453371442|FG005|Overall Study|Death|0|||
126020704|NCT01985334|453371443|FG006|Overall Study|Death|1|||
126020705|NCT01985334|453371444|FG007|Overall Study|Death|2|||
126020706|NCT01985334|453371437|FG000|Overall Study|Worsening of disease|0|||
126020707|NCT01985334|453371438|FG001|Overall Study|Worsening of disease|0|||
126020708|NCT01985334|453371439|FG002|Overall Study|Worsening of disease|0|||
126020709|NCT01985334|453371440|FG003|Overall Study|Worsening of disease|1|||
126020710|NCT01985334|453371441|FG004|Overall Study|Worsening of disease|0|||
126020711|NCT01985334|453371442|FG005|Overall Study|Worsening of disease|3|||
126020712|NCT01985334|453371443|FG006|Overall Study|Worsening of disease|0|||
126020713|NCT01985334|453371444|FG007|Overall Study|Worsening of disease|1|||
126020714|NCT01985334|453371437|FG000|Overall Study|Other|2|||
126020715|NCT01985334|453371438|FG001|Overall Study|Other|9|||
126092860|NCT01114880|453632926|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
126092861|NCT01114880|453632927|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
126020716|NCT01985334|453371439|FG002|Overall Study|Other|7|||
126020717|NCT01985334|453371440|FG003|Overall Study|Other|17|||
126020718|NCT01985334|453371441|FG004|Overall Study|Other|4|||
126020719|NCT01985334|453371442|FG005|Overall Study|Other|8|||
126020720|NCT01985334|453371443|FG006|Overall Study|Other|4|||
126020721|NCT01985334|453371444|FG007|Overall Study|Other|7|||
126020722|NCT01985334|453371437|FG000|Overall Study|Protocol deviation|6|||
126020723|NCT01985334|453371438|FG001|Overall Study|Protocol deviation|31|||
126092862|NCT02626455|453632928|FG000|Overall Study|Other|1|||
126092863|NCT02626455|453632929|FG001|Overall Study|Other|1|||
126092864|NCT02626455|453632930|FG002|Overall Study|Other|0|||
126092865|NCT02626455|453632931|FG003|Overall Study|Other|0|||
126092866|NCT02626455|453632932|FG004|Overall Study|Other|0|||
126092867|NCT02626455|453632933|FG005|Overall Study|Other|17|||
126092868|NCT02626455|453632934|FG006|Overall Study|Other|23|||
126092869|NCT02626455|453632928|FG000|Overall Study|Withdrawal by Subject|1|||
126092870|NCT02626455|453632929|FG001|Overall Study|Withdrawal by Subject|0|||
126092871|NCT02626455|453632930|FG002|Overall Study|Withdrawal by Subject|0|||
126092872|NCT02626455|453632931|FG003|Overall Study|Withdrawal by Subject|0|||
126092873|NCT02626455|453632932|FG004|Overall Study|Withdrawal by Subject|0|||
126092874|NCT02626455|453632933|FG005|Overall Study|Withdrawal by Subject|10|||
126092875|NCT02626455|453632934|FG006|Overall Study|Withdrawal by Subject|6|||
126092876|NCT02626455|453632928|FG000|Overall Study|Physician Decision|0|||
126092877|NCT02626455|453632929|FG001|Overall Study|Physician Decision|2|||
126092878|NCT02626455|453632930|FG002|Overall Study|Physician Decision|2|||
126092879|NCT02626455|453632931|FG003|Overall Study|Physician Decision|2|||
126092880|NCT02626455|453632932|FG004|Overall Study|Physician Decision|1|||
126092881|NCT02626455|453632933|FG005|Overall Study|Physician Decision|10|||
126092882|NCT02626455|453632934|FG006|Overall Study|Physician Decision|3|||
126092883|NCT02626455|453632928|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126092884|NCT02626455|453632929|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126092885|NCT02626455|453632930|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126092886|NCT02626455|453632931|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126092887|NCT02626455|453632932|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126092888|NCT02626455|453632933|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126092889|NCT02626455|453632934|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
126092890|NCT02626455|453632928|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126092891|NCT02626455|453632929|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126092892|NCT02626455|453632930|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126092893|NCT02626455|453632931|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126224968|NCT01261325|454113557|FG000|Overall Study|Lack of Efficacy|1|||
126224969|NCT01261325|454113558|FG001|Overall Study|Lack of Efficacy|1|||
126224970|NCT01261325|454113559|FG002|Overall Study|Lack of Efficacy|0|||
126224971|NCT01261325|454113557|FG000|Overall Study|Withdrawal by Subject|2|||
126224972|NCT01261325|454113558|FG001|Overall Study|Withdrawal by Subject|2|||
126224973|NCT01261325|454113559|FG002|Overall Study|Withdrawal by Subject|4|||
126224974|NCT01261325|454113557|FG000|Overall Study|SAE, non-fatal|1|||
126224975|NCT01261325|454113558|FG001|Overall Study|SAE, non-fatal|5|||
126224976|NCT01261325|454113559|FG002|Overall Study|SAE, non-fatal|1|||
126224977|NCT01261325|454113557|FG000|Overall Study|AE, non-serious non-fatal|9|||
126224978|NCT01261325|454113558|FG001|Overall Study|AE, non-serious non-fatal|15|||
126224979|NCT01261325|454113559|FG002|Overall Study|AE, non-serious non-fatal|13|||
126224980|NCT01261325|454113557|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126224981|NCT01261325|454113558|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126224982|NCT01261325|454113559|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126224983|NCT01261325|454113557|FG000|Overall Study|Non Compliance|2|||
126224984|NCT01261325|454113558|FG001|Overall Study|Non Compliance|0|||
126224985|NCT01261325|454113559|FG002|Overall Study|Non Compliance|0|||
126224986|NCT01261325|454113557|FG000|Overall Study|Patient Randomized by Mistake|0|||
126224987|NCT01261325|454113558|FG001|Overall Study|Patient Randomized by Mistake|1|||
126224988|NCT01261325|454113559|FG002|Overall Study|Patient Randomized by Mistake|0|||
126224989|NCT01261325|454113557|FG000|Overall Study|Erroneously Randomized|1|||
126224990|NCT01261325|454113558|FG001|Overall Study|Erroneously Randomized|0|||
126224991|NCT01261325|454113559|FG002|Overall Study|Erroneously Randomized|0|||
126224992|NCT01261325|454113557|FG000|Overall Study|Screen Failure|1|||
126224993|NCT01261325|454113558|FG001|Overall Study|Screen Failure|0|||
126224994|NCT01261325|454113559|FG002|Overall Study|Screen Failure|0|||
126224995|NCT01261325|454113557|FG000|Overall Study|Randomized in Error|0|||
126224996|NCT01261325|454113558|FG001|Overall Study|Randomized in Error|0|||
126224997|NCT01261325|454113559|FG002|Overall Study|Randomized in Error|1|||
126224998|NCT01261325|454113557|FG000|Overall Study|Protocol Violation|0|||
126092894|NCT02626455|453632932|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126224999|NCT01261325|454113558|FG001|Overall Study|Protocol Violation|3|||
126092895|NCT02626455|453632933|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126092896|NCT02626455|453632934|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
126092897|NCT02626455|453632928|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126092898|NCT02626455|453632929|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126092899|NCT02626455|453632930|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126225000|NCT01261325|454113559|FG002|Overall Study|Protocol Violation|1|||
126225001|NCT01261325|454113557|FG000|Overall Study|Lost to Follow-up|0|||
126225002|NCT01261325|454113558|FG001|Overall Study|Lost to Follow-up|1|||
126225003|NCT01261325|454113559|FG002|Overall Study|Lost to Follow-up|3|||
126225004|NCT01261325|454113557|FG000|Overall Study|AE, serious fatal|0|||
126225005|NCT01261325|454113558|FG001|Overall Study|AE, serious fatal|0|||
126225006|NCT01261325|454113559|FG002|Overall Study|AE, serious fatal|2|||
126225007|NCT03469271|454113564|FG000|Overall Study|Withdrawal by Subject|2|||
126225008|NCT03469271|454113565|FG001|Overall Study|Withdrawal by Subject|0|||
126225009|NCT03469271|454113566|FG002|Overall Study|Withdrawal by Subject|0|||
126020724|NCT01985334|453371439|FG002|Overall Study|Protocol deviation|25|||
126020725|NCT01985334|453371440|FG003|Overall Study|Protocol deviation|84|||
126020726|NCT01985334|453371441|FG004|Overall Study|Protocol deviation|17|||
126020727|NCT01985334|453371442|FG005|Overall Study|Protocol deviation|47|||
126020728|NCT01985334|453371443|FG006|Overall Study|Protocol deviation|15|||
126020729|NCT01985334|453371444|FG007|Overall Study|Protocol deviation|42|||
126225010|NCT03469271|454113567|FG003|Overall Study|Withdrawal by Subject|1|||
126225011|NCT03404206|454113572|FG000|Overall Study|Withdrawal by Subject|1|||
126225012|NCT03404206|454113573|FG001|Overall Study|Withdrawal by Subject|1|||
126225013|NCT03404206|454113574|FG002|Overall Study|Withdrawal by Subject|0|||
126225014|NCT03404206|454113572|FG000|Overall Study|Lost to Follow-up|3|||
126225015|NCT03404206|454113573|FG001|Overall Study|Lost to Follow-up|1|||
126225016|NCT03404206|454113574|FG002|Overall Study|Lost to Follow-up|0|||
126225017|NCT02330081|454113585|FG000|Overall Study|Adverse Event|1|||
126225018|NCT02330081|454113585|FG000|Overall Study|Donation did not meet criteria|1|||
126225019|NCT02330081|454113585|FG000|Overall Study|Protocol Violation|6|||
126225020|NCT02123459|454113590|FG000|Washout Period (1 Day)|Adverse Event|1|||
126225021|NCT02123459|454113591|FG001|Washout Period (1 Day)|Adverse Event|0|||
126225022|NCT00254397|454113592|FG000|Overall Study|Disease Progression|4|||
126225023|NCT00254397|454113593|FG001|Overall Study|Disease Progression|1|||
126225024|NCT00254397|454113594|FG002|Overall Study|Disease Progression|16|||
126225025|NCT00254397|454113595|FG003|Overall Study|Disease Progression|23|||
126225026|NCT00254397|454113592|FG000|Overall Study|Non-Compliant|0|||
126225027|NCT00254397|454113593|FG001|Overall Study|Non-Compliant|0|||
126225028|NCT00254397|454113594|FG002|Overall Study|Non-Compliant|0|||
126020730|NCT01985334|453371437|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
126020731|NCT01985334|453371438|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
126020732|NCT01985334|453371439|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
126020733|NCT01985334|453371440|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
126020734|NCT01985334|453371441|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
126020735|NCT01985334|453371442|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
126020736|NCT01985334|453371443|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
126020737|NCT01985334|453371444|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
126020738|NCT01985334|453371437|FG000|Overall Study|Subject withdrawal of consent|3|||
126020739|NCT01985334|453371438|FG001|Overall Study|Subject withdrawal of consent|6|||
126020740|NCT01985334|453371439|FG002|Overall Study|Subject withdrawal of consent|2|||
126020741|NCT01985334|453371440|FG003|Overall Study|Subject withdrawal of consent|28|||
126020742|NCT01985334|453371441|FG004|Overall Study|Subject withdrawal of consent|4|||
126020743|NCT01985334|453371442|FG005|Overall Study|Subject withdrawal of consent|19|||
126020744|NCT01985334|453371443|FG006|Overall Study|Subject withdrawal of consent|0|||
126020745|NCT01985334|453371444|FG007|Overall Study|Subject withdrawal of consent|20|||
126020746|NCT01985334|453371437|FG000|Overall Study|Adverse Event|0|||
126020747|NCT01985334|453371438|FG001|Overall Study|Adverse Event|8|||
126020748|NCT01985334|453371439|FG002|Overall Study|Adverse Event|2|||
126020749|NCT01985334|453371440|FG003|Overall Study|Adverse Event|26|||
126225029|NCT00254397|454113595|FG003|Overall Study|Non-Compliant|1|||
126225030|NCT00254397|454113592|FG000|Overall Study|Adverse Event|2|||
126225031|NCT00254397|454113593|FG001|Overall Study|Adverse Event|0|||
126225032|NCT00254397|454113594|FG002|Overall Study|Adverse Event|3|||
126225033|NCT00254397|454113595|FG003|Overall Study|Adverse Event|1|||
126020750|NCT01985334|453371441|FG004|Overall Study|Adverse Event|3|||
126020751|NCT01985334|453371442|FG005|Overall Study|Adverse Event|18|||
126020752|NCT01985334|453371443|FG006|Overall Study|Adverse Event|3|||
126020753|NCT01985334|453371444|FG007|Overall Study|Adverse Event|15|||
126020754|NCT01985334|453371437|FG000|Overall Study|Other|4|||
126020755|NCT01985334|453371438|FG001|Overall Study|Other|2|||
126020756|NCT01985334|453371439|FG002|Overall Study|Other|3|||
126225034|NCT00972153|454113608|FG000|Overall Study|Equipment malfunction during case|0|||
126225035|NCT00972153|454113609|FG001|Overall Study|Equipment malfunction during case|1|||
126225036|NCT00972153|454113610|FG002|Overall Study|Equipment malfunction during case|0|||
126225037|NCT04136626|454113611|FG000|Treatment Phase|Withdrawal by Subject|1|||
126020757|NCT01985334|453371440|FG003|Overall Study|Other|10|||
126225038|NCT04136626|454113612|FG001|Treatment Phase|Withdrawal by Subject|9|||
126225039|NCT04136626|454113611|FG000|Treatment Phase|Adverse Event|1|||
126225040|NCT04136626|454113612|FG001|Treatment Phase|Adverse Event|0|||
126225041|NCT04136626|454113611|FG000|Treatment Phase|Lost to Follow-up|1|||
126225042|NCT04136626|454113612|FG001|Treatment Phase|Lost to Follow-up|5|||
126225043|NCT04136626|454113611|FG000|12-month Follow-up|Lost to Follow-up|8|||
126225044|NCT04136626|454113612|FG001|12-month Follow-up|Lost to Follow-up|7|||
126225045|NCT03372083|454115933|FG000|Overall Study|Adverse Event|3|||
126225046|NCT03372083|454115933|FG000|Overall Study|Physician Decision|1|||
126225047|NCT03372083|454115933|FG000|Overall Study|Withdrawal by Subject|1|||
126225048|NCT00827827|454115934|FG000|Overall Study|Lost to Follow-up|3|||
126225049|NCT00827827|454115935|FG001|Overall Study|Lost to Follow-up|0|||
126225050|NCT00827827|454115934|FG000|Overall Study|Fall at home- hospitalization|1|||
126225051|NCT00827827|454115935|FG001|Overall Study|Fall at home- hospitalization|0|||
126225052|NCT00827827|454115934|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
126225053|NCT00827827|454115935|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
126225054|NCT00827827|454115934|FG000|Overall Study|Gout|1|||
126225055|NCT00827827|454115935|FG001|Overall Study|Gout|0|||
126225056|NCT00827827|454115934|FG000|Overall Study|Transportation issues|1|||
126225057|NCT00827827|454115935|FG001|Overall Study|Transportation issues|0|||
126225058|NCT00827827|454115934|FG000|Overall Study|Burned with water at home|1|||
126225059|NCT00827827|454115935|FG001|Overall Study|Burned with water at home|0|||
126225060|NCT02884206|454115936|FG000|Valsartan Run-in Period|Death|1|||
126225061|NCT02884206|454115937|FG001|Valsartan Run-in Period|Death|0|||
126225062|NCT02884206|454115938|FG002|Valsartan Run-in Period|Death|0|||
126225063|NCT02884206|454115936|FG000|Valsartan Run-in Period|Adverse Event|31|||
126225064|NCT02884206|454115937|FG001|Valsartan Run-in Period|Adverse Event|0|||
126225065|NCT02884206|454115938|FG002|Valsartan Run-in Period|Adverse Event|0|||
126225066|NCT02884206|454115936|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
126225067|NCT02884206|454115937|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
126225068|NCT02884206|454115938|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
126020758|NCT01985334|453371441|FG004|Overall Study|Other|1|||
126020759|NCT01985334|453371442|FG005|Overall Study|Other|6|||
126020760|NCT01985334|453371443|FG006|Overall Study|Other|2|||
126020761|NCT01985334|453371444|FG007|Overall Study|Other|2|||
126020762|NCT01985334|453371437|FG000|Overall Study|Medication non-compliance|0|||
126020763|NCT01985334|453371438|FG001|Overall Study|Medication non-compliance|4|||
126020764|NCT01985334|453371439|FG002|Overall Study|Medication non-compliance|1|||
126020765|NCT01985334|453371440|FG003|Overall Study|Medication non-compliance|6|||
126020766|NCT01985334|453371441|FG004|Overall Study|Medication non-compliance|2|||
126020767|NCT01985334|453371442|FG005|Overall Study|Medication non-compliance|3|||
126092900|NCT02626455|453632931|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126351142|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
126092901|NCT02626455|453632932|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126092902|NCT02626455|453632933|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
126351143|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
126351144|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
126351145|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
126351146|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
126351147|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
126351148|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
126351149|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
126351150|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
126351151|NCT05317546|454576218|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
126351152|NCT05317546|454576219|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
126351153|NCT03331250|454576220|FG000|Overall Study|Withdrawal by Subject|1|||
126351154|NCT04590963|454576221|FG000|Overall Study|Death|118|||
126351155|NCT04590963|454576222|FG001|Overall Study|Death|59|||
126351156|NCT04590963|454576221|FG000|Overall Study|Lost to Follow-up|1|||
126351157|NCT04590963|454576222|FG001|Overall Study|Lost to Follow-up|1|||
126351158|NCT04590963|454576221|FG000|Overall Study|Progressive disease|0|||
126351159|NCT04590963|454576222|FG001|Overall Study|Progressive disease|1|||
126351160|NCT04590963|454576221|FG000|Overall Study|Study terminated by sponsor|103|||
126351161|NCT04590963|454576222|FG001|Overall Study|Study terminated by sponsor|50|||
126351162|NCT04590963|454576221|FG000|Overall Study|Withdrawal by Subject|15|||
126351163|NCT04590963|454576222|FG001|Overall Study|Withdrawal by Subject|8|||
126351164|NCT04590963|454576221|FG000|Overall Study|Ongoing at data cut-off|9|||
126351165|NCT04590963|454576222|FG001|Overall Study|Ongoing at data cut-off|4|||
126351166|NCT04590963|454576221|FG000|Overall Study|Screen failure|1|||
126351167|NCT04590963|454576222|FG001|Overall Study|Screen failure|0|||
126351168|NCT01063114|454576223|FG000|Overall Study|Lost to Follow-up|1|||
126351169|NCT05556057|454576224|FG000|Overall Study|Lost to Follow-up|5|||
126351170|NCT05556057|454576225|FG001|Overall Study|Lost to Follow-up|4|||
126351171|NCT05556057|454576224|FG000|Overall Study|Withdrawal by Subject|0|||
126351172|NCT05556057|454576225|FG001|Overall Study|Withdrawal by Subject|2|||
126351173|NCT02466971|454576229|FG000|Overall Study|eligible and never treated|14|||
126351174|NCT02466971|454576230|FG001|Overall Study|eligible and never treated|20|||
126351175|NCT02466971|454576229|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
126351176|NCT02466971|454576230|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
126351177|NCT02466971|454576229|FG000|Overall Study|ineligible and treated|1|||
126351178|NCT02466971|454576230|FG001|Overall Study|ineligible and treated|0|||
126092903|NCT02626455|453632934|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
126351179|NCT02466971|454576229|FG000|Overall Study|ineligible and never treated|0|||
126351180|NCT02466971|454576230|FG001|Overall Study|ineligible and never treated|1|||
126351181|NCT04818112|454576235|FG000|Overall Study|Withdrawal by Subject|54|||
126351182|NCT04818112|454576236|FG001|Overall Study|Withdrawal by Subject|12|||
126092904|NCT02626455|453632928|FG000|Overall Study|Patient decision|0|||
126092905|NCT02626455|453632929|FG001|Overall Study|Patient decision|1|||
126092906|NCT02626455|453632930|FG002|Overall Study|Patient decision|0|||
126092907|NCT02626455|453632931|FG003|Overall Study|Patient decision|0|||
126092908|NCT02626455|453632932|FG004|Overall Study|Patient decision|1|||
126351183|NCT04818112|454576235|FG000|Overall Study|Lost to Follow-up|38|||
126351184|NCT04818112|454576236|FG001|Overall Study|Lost to Follow-up|10|||
126351185|NCT01937299|454576243|FG000|Overall Study|Adverse Event|13|||
126351186|NCT01937299|454576244|FG001|Overall Study|Adverse Event|0|||
126351187|NCT01937299|454576243|FG000|Overall Study|Lack of Efficacy|0|||
126351188|NCT01937299|454576244|FG001|Overall Study|Lack of Efficacy|4|||
126351189|NCT01937299|454576243|FG000|Overall Study|Withdrawal by Subject|1|||
126351190|NCT01937299|454576244|FG001|Overall Study|Withdrawal by Subject|0|||
126351191|NCT01260948|454576245|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
126351192|NCT01260948|454576246|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
126351193|NCT01260948|454576245|FG000|Second Intervention|Emesis|0|||
126351194|NCT01260948|454576246|FG001|Second Intervention|Emesis|1|||
126351195|NCT02406612|454576247|FG000|Overall Study|Screening Failure|3|||
126351196|NCT02406612|454576248|FG001|Overall Study|Screening Failure|0|||
126351197|NCT02406612|454576247|FG000|Overall Study|Intra-procedural Exclusion|1|||
126351198|NCT02406612|454576248|FG001|Overall Study|Intra-procedural Exclusion|3|||
126351199|NCT02406612|454576247|FG000|Overall Study|Guidewire Failure|0|||
126351200|NCT02406612|454576248|FG001|Overall Study|Guidewire Failure|1|||
126351201|NCT01525589|454576253|FG000|Overall Study|Non-treatment-related AE|1|||
126351202|NCT01525589|454576254|FG001|Overall Study|Non-treatment-related AE|0|||
126351203|NCT01525589|454576255|FG002|Overall Study|Non-treatment-related AE|0|||
126351204|NCT01525589|454576253|FG000|Overall Study|Progressive disease|48|||
126351205|NCT01525589|454576254|FG001|Overall Study|Progressive disease|15|||
126351206|NCT01525589|454576255|FG002|Overall Study|Progressive disease|29|||
126351207|NCT01525589|454576253|FG000|Overall Study|Never treated|2|||
126351208|NCT01525589|454576254|FG001|Overall Study|Never treated|0|||
126351209|NCT01525589|454576255|FG002|Overall Study|Never treated|0|||
126351210|NCT01525589|454576253|FG000|Overall Study|Physician Decision|4|||
126351211|NCT01525589|454576254|FG001|Overall Study|Physician Decision|2|||
126351212|NCT01525589|454576255|FG002|Overall Study|Physician Decision|2|||
126351213|NCT01525589|454576253|FG000|Overall Study|Death|0|||
126351214|NCT01525589|454576254|FG001|Overall Study|Death|0|||
126351215|NCT01525589|454576255|FG002|Overall Study|Death|2|||
126351216|NCT01525589|454576253|FG000|Overall Study|Treatment-related AE|1|||
126351217|NCT01525589|454576254|FG001|Overall Study|Treatment-related AE|1|||
126351218|NCT01525589|454576255|FG002|Overall Study|Treatment-related AE|2|||
126351219|NCT01525589|454576253|FG000|Overall Study|Other reasons|0|||
126351220|NCT01525589|454576254|FG001|Overall Study|Other reasons|1|||
126351221|NCT01525589|454576255|FG002|Overall Study|Other reasons|0|||
126351222|NCT01525589|454576253|FG000|Overall Study|Withdrawal by Subject|0|||
126351223|NCT01525589|454576254|FG001|Overall Study|Withdrawal by Subject|1|||
126351224|NCT01525589|454576255|FG002|Overall Study|Withdrawal by Subject|0|||
126351225|NCT05759338|454576256|FG000|Overall Study|Withdrawal by Subject|3|||
126351226|NCT02924376|454576257|FG000|Overall Study|Progressive Disease|4|||
126351227|NCT02924376|454576258|FG001|Overall Study|Progressive Disease|0|||
126351228|NCT02924376|454576259|FG002|Overall Study|Progressive Disease|1|||
126351229|NCT02924376|454576260|FG003|Overall Study|Progressive Disease|0|||
126351230|NCT02924376|454576257|FG000|Overall Study|Death|73|||
126351231|NCT02924376|454576258|FG001|Overall Study|Death|18|||
126351232|NCT02924376|454576259|FG002|Overall Study|Death|15|||
126351233|NCT02924376|454576260|FG003|Overall Study|Death|2|||
126351234|NCT02924376|454576257|FG000|Overall Study|Lost to Follow-up|3|||
126351235|NCT02924376|454576258|FG001|Overall Study|Lost to Follow-up|0|||
126351236|NCT02924376|454576259|FG002|Overall Study|Lost to Follow-up|0|||
126351237|NCT02924376|454576260|FG003|Overall Study|Lost to Follow-up|0|||
126351238|NCT02924376|454576257|FG000|Overall Study|Study Terminated by Sponsor|19|||
126351239|NCT02924376|454576258|FG001|Overall Study|Study Terminated by Sponsor|0|||
126092909|NCT02626455|453632933|FG005|Overall Study|Patient decision|36|||
126092910|NCT02626455|453632934|FG006|Overall Study|Patient decision|22|||
126092911|NCT02626455|453632928|FG000|Overall Study|Protocol Violation|0|||
126351240|NCT02924376|454576259|FG002|Overall Study|Study Terminated by Sponsor|0|||
126351241|NCT02924376|454576260|FG003|Overall Study|Study Terminated by Sponsor|0|||
126351242|NCT02924376|454576257|FG000|Overall Study|Physician Decision|1|||
126092912|NCT02626455|453632929|FG001|Overall Study|Protocol Violation|0|||
126092913|NCT02626455|453632930|FG002|Overall Study|Protocol Violation|0|||
126351243|NCT02924376|454576258|FG001|Overall Study|Physician Decision|0|||
126351244|NCT02924376|454576259|FG002|Overall Study|Physician Decision|0|||
126351245|NCT02924376|454576260|FG003|Overall Study|Physician Decision|0|||
126351246|NCT02924376|454576257|FG000|Overall Study|Withdrawal by Subject|7|||
126351247|NCT02924376|454576258|FG001|Overall Study|Withdrawal by Subject|2|||
126351248|NCT02924376|454576259|FG002|Overall Study|Withdrawal by Subject|1|||
126351249|NCT02924376|454576260|FG003|Overall Study|Withdrawal by Subject|0|||
126351250|NCT02924376|454576257|FG000|Overall Study|Rolled Over to Another Study|1|||
126351251|NCT02924376|454576258|FG001|Overall Study|Rolled Over to Another Study|0|||
126369504|NCT00189423|454650584|FG000|Overall Study|Death|746|||
126225069|NCT02884206|454115936|FG000|Valsartan Run-in Period|Protocol deviation|4|||
126225070|NCT02884206|454115937|FG001|Valsartan Run-in Period|Protocol deviation|0|||
126351252|NCT02924376|454576259|FG002|Overall Study|Rolled Over to Another Study|0|||
126351253|NCT02924376|454576260|FG003|Overall Study|Rolled Over to Another Study|0|||
126351254|NCT06481579|454576262|FG000|Overall Study|Death|1|||
126351255|NCT06481579|454576263|FG001|Overall Study|Death|0|||
126351256|NCT06481579|454576262|FG000|Overall Study|Withdrawal by Subject|3|||
126351257|NCT06481579|454576263|FG001|Overall Study|Withdrawal by Subject|0|||
126351258|NCT06481579|454576262|FG000|Overall Study|Other|1|||
126351259|NCT06481579|454576263|FG001|Overall Study|Other|1|||
126351260|NCT06170827|454576264|FG000|Overall Study|Withdrawal by Subject|1|||
126351261|NCT06170827|454576265|FG001|Overall Study|Withdrawal by Subject|1|||
126351262|NCT04611126|454576266|FG000|Overall Study|TIL expansion unsuccessful|1|||
126351263|NCT04611126|454576267|FG001|Overall Study|TIL expansion unsuccessful|0|||
126351264|NCT03459846|454576272|FG000|Overall Study|Death|52|||
126351265|NCT03459846|454576273|FG001|Overall Study|Death|46|||
126351266|NCT03459846|454576272|FG000|Overall Study|Study terminated by sponsor|24|||
126351267|NCT03459846|454576273|FG001|Overall Study|Study terminated by sponsor|28|||
126351268|NCT03459846|454576272|FG000|Overall Study|Withdrawal by Subject|2|||
126351269|NCT03459846|454576273|FG001|Overall Study|Withdrawal by Subject|2|||
126351270|NCT06455111|454576276|FG000|Overall Study|Withdrawal by Subject|11|||
126351271|NCT06455111|454576277|FG001|Overall Study|Withdrawal by Subject|4|||
126351272|NCT05763875|454576282|FG000|Overall Study|Subject decision|5|||
126351273|NCT05763875|454576283|FG001|Overall Study|Subject decision|2|||
126351274|NCT05763875|454576284|FG002|Overall Study|Subject decision|1|||
126351275|NCT05763875|454576282|FG000|Overall Study|Lost to Follow-up|4|||
126351276|NCT05763875|454576283|FG001|Overall Study|Lost to Follow-up|1|||
126351277|NCT05763875|454576284|FG002|Overall Study|Lost to Follow-up|2|||
126351278|NCT05763875|454576282|FG000|Overall Study|Adverse Event|1|||
126351279|NCT05763875|454576283|FG001|Overall Study|Adverse Event|0|||
126351280|NCT05763875|454576284|FG002|Overall Study|Adverse Event|0|||
126351281|NCT05578872|454576287|FG000|Overall Study|Withdrawal by Subject|2|||
126351282|NCT05578872|454576288|FG001|Overall Study|Withdrawal by Subject|1|||
126351283|NCT05578872|454576287|FG000|Overall Study|Adverse Event|1|||
126351284|NCT05578872|454576288|FG001|Overall Study|Adverse Event|1|||
126351285|NCT05578872|454576287|FG000|Overall Study|Physician Decision|1|||
126351286|NCT05578872|454576288|FG001|Overall Study|Physician Decision|2|||
126351287|NCT05578872|454576287|FG000|Overall Study|Progressive disease|10|||
126351288|NCT05578872|454576288|FG001|Overall Study|Progressive disease|9|||
126351289|NCT05578872|454576287|FG000|Overall Study|Sponsor decision|0|||
126351290|NCT05578872|454576288|FG001|Overall Study|Sponsor decision|1|||
126351291|NCT05578872|454576287|FG000|Overall Study|Toxicity and Patient's decision|0|||
126351292|NCT05578872|454576288|FG001|Overall Study|Toxicity and Patient's decision|1|||
126351293|NCT02717611|454577047|FG000|Overall Study|Death|13|||
126351294|NCT02717611|454577047|FG000|Overall Study|Withdrawal by Subject|6|||
126351295|NCT02717611|454577047|FG000|Overall Study|Active, not recruiting|40|||
126351296|NCT02717611|454577047|FG000|Overall Study|Complicating disease|1|||
126351297|NCT06187909|454577048|FG000|Overall Study|Withdrawal by Subject|2|||
126351298|NCT06187909|454577049|FG001|Overall Study|Withdrawal by Subject|2|||
126351299|NCT02676973|454577050|FG000|Overall Study|Withdrawal by Subject|9|||
126351300|NCT02676973|454577051|FG001|Overall Study|Withdrawal by Subject|8|||
126351301|NCT02676973|454577052|FG002|Overall Study|Withdrawal by Subject|11|||
126351302|NCT02676973|454577050|FG000|Overall Study|Lost to Follow-up|8|||
126351303|NCT02676973|454577051|FG001|Overall Study|Lost to Follow-up|12|||
126351304|NCT02676973|454577052|FG002|Overall Study|Lost to Follow-up|8|||
126351305|NCT02676973|454577050|FG000|Overall Study|Death|2|||
126351306|NCT02676973|454577051|FG001|Overall Study|Death|1|||
126351307|NCT02676973|454577052|FG002|Overall Study|Death|5|||
126351308|NCT05020743|454577054|FG000|Overall Study|Enrollment in Interventional Study|2|||
126351309|NCT05020743|454577055|FG001|Overall Study|Enrollment in Interventional Study|9|||
126351310|NCT05020743|454577056|FG002|Overall Study|Enrollment in Interventional Study|0|||
126351311|NCT05020743|454577054|FG000|Overall Study|Withdrawal by Subject|0|||
126351312|NCT05020743|454577055|FG001|Overall Study|Withdrawal by Subject|3|||
126351313|NCT05020743|454577056|FG002|Overall Study|Withdrawal by Subject|1|||
126351314|NCT05020743|454577054|FG000|Overall Study|Lost to Follow-up|1|||
126351315|NCT05020743|454577055|FG001|Overall Study|Lost to Follow-up|0|||
126351316|NCT05020743|454577056|FG002|Overall Study|Lost to Follow-up|0|||
126351317|NCT05020743|454577054|FG000|Overall Study|Study Termination by Sponsor|10|||
126351318|NCT05020743|454577055|FG001|Overall Study|Study Termination by Sponsor|11|||
126351319|NCT05020743|454577056|FG002|Overall Study|Study Termination by Sponsor|10|||
126351320|NCT03488524|454577057|FG000|Overall Study|Withdrawal by Subject|51|||
126351321|NCT03488524|454577057|FG000|Overall Study|Death|19|||
126351322|NCT03488524|454577057|FG000|Overall Study|Study Sponsor|11|||
126092914|NCT02626455|453632931|FG003|Overall Study|Protocol Violation|0|||
126351323|NCT03488524|454577057|FG000|Overall Study|Physician Decision|4|||
126351324|NCT03488524|454577057|FG000|Overall Study|Lost to Follow-up|3|||
126351325|NCT00325416|454577058|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
126351326|NCT00325416|454577059|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
126020768|NCT01985334|453371443|FG006|Overall Study|Medication non-compliance|1|||
126020769|NCT01985334|453371444|FG007|Overall Study|Medication non-compliance|3|||
126020770|NCT01985334|453371437|FG000|Overall Study|Use of prohibited treatment|1|||
126020771|NCT01985334|453371438|FG001|Overall Study|Use of prohibited treatment|4|||
126020772|NCT01985334|453371439|FG002|Overall Study|Use of prohibited treatment|1|||
126020773|NCT01985334|453371440|FG003|Overall Study|Use of prohibited treatment|2|||
126020774|NCT01985334|453371441|FG004|Overall Study|Use of prohibited treatment|1|||
126020775|NCT01985334|453371442|FG005|Overall Study|Use of prohibited treatment|6|||
126092915|NCT02626455|453632932|FG004|Overall Study|Protocol Violation|0|||
126225071|NCT02884206|454115938|FG002|Valsartan Run-in Period|Protocol deviation|0|||
126225072|NCT02884206|454115936|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
126225073|NCT02884206|454115937|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
126225074|NCT02884206|454115938|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
126225075|NCT02884206|454115936|FG000|Valsartan Run-in Period|Physician Decision|1|||
126225076|NCT02884206|454115937|FG001|Valsartan Run-in Period|Physician Decision|0|||
126351327|NCT00325416|454577058|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
126351328|NCT00325416|454577059|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
126351329|NCT00325416|454577058|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
126351330|NCT00325416|454577059|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
126351331|NCT00325416|454577058|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
126351332|NCT00325416|454577059|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
126351333|NCT00325416|454577058|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
126351334|NCT00325416|454577059|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
126351335|NCT00325416|454577058|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
126351336|NCT00325416|454577059|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
126351337|NCT02324153|454577060|FG000|Overall Study|Withdrawal by Subject|4|||
126351338|NCT02324153|454577061|FG001|Overall Study|Withdrawal by Subject|1|||
126351339|NCT02324153|454577060|FG000|Overall Study|Surgery postponed after randomization|3|||
126351340|NCT02324153|454577061|FG001|Overall Study|Surgery postponed after randomization|0|||
126351341|NCT02324153|454577060|FG000|Overall Study|Developed delirium preoperatively|1|||
126351342|NCT02324153|454577061|FG001|Overall Study|Developed delirium preoperatively|0|||
126351343|NCT03122106|454577064|FG000|Overall Study|Not enough tissue|1|||
126351344|NCT03122106|454577064|FG000|Overall Study|Disease progression during screening|2|||
126351345|NCT03122106|454577064|FG000|Overall Study|Poor RNA quality for vaccine|1|||
126351346|NCT01913353|454577066|FG000|Overall Study|Adverse Event|2|||
126351347|NCT01913353|454577067|FG001|Overall Study|Adverse Event|0|||
126351348|NCT01913353|454577066|FG000|Overall Study|Physician Decision|0|||
126351349|NCT01913353|454577067|FG001|Overall Study|Physician Decision|2|||
126351350|NCT01913353|454577066|FG000|Overall Study|Withdrawal by Subject|20|||
126351351|NCT01913353|454577067|FG001|Overall Study|Withdrawal by Subject|6|||
126351352|NCT01913353|454577066|FG000|Overall Study|multiple reasons|10|||
126351353|NCT01913353|454577067|FG001|Overall Study|multiple reasons|7|||
126351354|NCT01147458|454577069|FG000|First Intervention|Study terminated by sponsor|8|||
126351355|NCT01147458|454577070|FG001|First Intervention|Study terminated by sponsor|8|||
126351356|NCT01147458|454577071|FG002|First Intervention|Study terminated by sponsor|7|||
126351357|NCT01147458|454577072|FG003|First Intervention|Study terminated by sponsor|8|||
126351358|NCT01147458|454577069|FG000|First Intervention|Protocol Violation|2|||
126351359|NCT01147458|454577070|FG001|First Intervention|Protocol Violation|3|||
126351360|NCT01147458|454577071|FG002|First Intervention|Protocol Violation|2|||
126351361|NCT01147458|454577072|FG003|First Intervention|Protocol Violation|3|||
126351362|NCT01147458|454577069|FG000|First Intervention|Withdrawal by Subject|3|||
126351363|NCT01147458|454577070|FG001|First Intervention|Withdrawal by Subject|0|||
126351364|NCT01147458|454577071|FG002|First Intervention|Withdrawal by Subject|1|||
126351365|NCT01147458|454577072|FG003|First Intervention|Withdrawal by Subject|0|||
126351366|NCT01147458|454577069|FG000|First Intervention|Adverse Event|0|||
126351367|NCT01147458|454577070|FG001|First Intervention|Adverse Event|3|||
126351368|NCT01147458|454577071|FG002|First Intervention|Adverse Event|2|||
126351369|NCT01147458|454577072|FG003|First Intervention|Adverse Event|3|||
126351370|NCT01147458|454577069|FG000|First Intervention|Other|1|||
126351371|NCT01147458|454577070|FG001|First Intervention|Other|2|||
126351372|NCT01147458|454577071|FG002|First Intervention|Other|0|||
126351373|NCT01147458|454577072|FG003|First Intervention|Other|0|||
126351374|NCT01147458|454577069|FG000|Second Intervention|Study terminated by sponsor|7|||
126351375|NCT01147458|454577070|FG001|Second Intervention|Study terminated by sponsor|5|||
126351376|NCT01147458|454577071|FG002|Second Intervention|Study terminated by sponsor|5|||
126351377|NCT01147458|454577072|FG003|Second Intervention|Study terminated by sponsor|3|||
126351378|NCT01147458|454577069|FG000|Second Intervention|Protocol Violation|0|||
126020776|NCT01985334|453371443|FG006|Overall Study|Use of prohibited treatment|2|||
126351379|NCT01147458|454577070|FG001|Second Intervention|Protocol Violation|1|||
126351380|NCT01147458|454577071|FG002|Second Intervention|Protocol Violation|1|||
126351381|NCT01147458|454577072|FG003|Second Intervention|Protocol Violation|0|||
126351382|NCT01147458|454577069|FG000|Second Intervention|Withdrawal by Subject|0|||
126020777|NCT01985334|453371444|FG007|Overall Study|Use of prohibited treatment|0|||
126092916|NCT02626455|453632933|FG005|Overall Study|Protocol Violation|0|||
126092917|NCT02626455|453632934|FG006|Overall Study|Protocol Violation|1|||
126092918|NCT02626455|453632928|FG000|Overall Study|Progressive disease - radiological progression|0|||
126092919|NCT02626455|453632929|FG001|Overall Study|Progressive disease - radiological progression|0|||
126092920|NCT02626455|453632930|FG002|Overall Study|Progressive disease - radiological progression|0|||
126092921|NCT02626455|453632931|FG003|Overall Study|Progressive disease - radiological progression|0|||
126092922|NCT02626455|453632932|FG004|Overall Study|Progressive disease - radiological progression|0|||
126092923|NCT02626455|453632933|FG005|Overall Study|Progressive disease - radiological progression|11|||
126092924|NCT02626455|453632934|FG006|Overall Study|Progressive disease - radiological progression|22|||
126092925|NCT02626455|453632928|FG000|Overall Study|Progressive disease - clinical progression|0|||
126092926|NCT02626455|453632929|FG001|Overall Study|Progressive disease - clinical progression|0|||
126369505|NCT00189423|454650585|FG001|Overall Study|Death|747|||
126369506|NCT00189423|454650584|FG000|Overall Study|Withdrawal by Subject|9|||
126369507|NCT00189423|454650585|FG001|Overall Study|Withdrawal by Subject|9|||
126369508|NCT00189423|454650584|FG000|Overall Study|Lost to Follow-up|10|||
126369509|NCT00189423|454650585|FG001|Overall Study|Lost to Follow-up|10|||
126369510|NCT04622592|454650588|FG000|Overall Study|Death|0|||
126369511|NCT04622592|454650589|FG001|Overall Study|Death|0|||
126369512|NCT04622592|454650590|FG002|Overall Study|Death|1|||
126369513|NCT04622592|454650591|FG003|Overall Study|Death|0|||
126369514|NCT04622592|454650592|FG004|Overall Study|Death|0|||
126369515|NCT04622592|454650593|FG005|Overall Study|Death|0|||
126369516|NCT04622592|454650594|FG006|Overall Study|Death|0|||
126369517|NCT04622592|454650595|FG007|Overall Study|Death|1|||
126369518|NCT04622592|454650588|FG000|Overall Study|Lost to Follow-up|0|||
126369519|NCT04622592|454650589|FG001|Overall Study|Lost to Follow-up|0|||
126369520|NCT04622592|454650590|FG002|Overall Study|Lost to Follow-up|0|||
126369521|NCT04622592|454650591|FG003|Overall Study|Lost to Follow-up|3|||
126369522|NCT04622592|454650592|FG004|Overall Study|Lost to Follow-up|1|||
126369523|NCT04622592|454650593|FG005|Overall Study|Lost to Follow-up|0|||
126369524|NCT04622592|454650594|FG006|Overall Study|Lost to Follow-up|2|||
126369525|NCT04622592|454650595|FG007|Overall Study|Lost to Follow-up|2|||
126369526|NCT04622592|454650588|FG000|Overall Study|Physician Decision|0|||
126369527|NCT04622592|454650589|FG001|Overall Study|Physician Decision|0|||
126369528|NCT04622592|454650590|FG002|Overall Study|Physician Decision|0|||
126369529|NCT04622592|454650591|FG003|Overall Study|Physician Decision|0|||
126369530|NCT04622592|454650592|FG004|Overall Study|Physician Decision|1|||
126369531|NCT04622592|454650593|FG005|Overall Study|Physician Decision|0|||
126369532|NCT04622592|454650594|FG006|Overall Study|Physician Decision|0|||
126369533|NCT04622592|454650595|FG007|Overall Study|Physician Decision|0|||
126369534|NCT04622592|454650588|FG000|Overall Study|Withdrawal by Subject|1|||
126369535|NCT04622592|454650589|FG001|Overall Study|Withdrawal by Subject|0|||
126369536|NCT04622592|454650590|FG002|Overall Study|Withdrawal by Subject|2|||
126369537|NCT04622592|454650591|FG003|Overall Study|Withdrawal by Subject|0|||
126369538|NCT04622592|454650592|FG004|Overall Study|Withdrawal by Subject|0|||
126369539|NCT04622592|454650593|FG005|Overall Study|Withdrawal by Subject|0|||
126369540|NCT04622592|454650594|FG006|Overall Study|Withdrawal by Subject|1|||
126369541|NCT04622592|454650595|FG007|Overall Study|Withdrawal by Subject|4|||
126369542|NCT04622592|454650588|FG000|Overall Study|Other than specified above|0|||
126369543|NCT04622592|454650589|FG001|Overall Study|Other than specified above|0|||
126369544|NCT04622592|454650590|FG002|Overall Study|Other than specified above|1|||
126369545|NCT04622592|454650591|FG003|Overall Study|Other than specified above|0|||
126369546|NCT04622592|454650592|FG004|Overall Study|Other than specified above|0|||
126369547|NCT04622592|454650593|FG005|Overall Study|Other than specified above|0|||
126369548|NCT04622592|454650594|FG006|Overall Study|Other than specified above|0|||
126369549|NCT04622592|454650595|FG007|Overall Study|Other than specified above|0|||
126369550|NCT01497197|454650596|FG000|Overall Study|Lost to Follow-up|1|||
126225077|NCT02884206|454115938|FG002|Valsartan Run-in Period|Physician Decision|0|||
126225078|NCT02884206|454115936|FG000|LCZ696 Run-in Period|Adverse Event|38|||
126351383|NCT01147458|454577070|FG001|Second Intervention|Withdrawal by Subject|1|||
126351384|NCT01147458|454577071|FG002|Second Intervention|Withdrawal by Subject|0|||
126351385|NCT01147458|454577072|FG003|Second Intervention|Withdrawal by Subject|0|||
126351386|NCT01147458|454577069|FG000|Second Intervention|Adverse Event|2|||
126351387|NCT01147458|454577070|FG001|Second Intervention|Adverse Event|0|||
126351388|NCT01147458|454577071|FG002|Second Intervention|Adverse Event|1|||
126351389|NCT01147458|454577072|FG003|Second Intervention|Adverse Event|1|||
126351390|NCT01147458|454577069|FG000|Second Intervention|Other|0|||
126351391|NCT01147458|454577070|FG001|Second Intervention|Other|0|||
126351392|NCT01147458|454577071|FG002|Second Intervention|Other|1|||
126351393|NCT01147458|454577072|FG003|Second Intervention|Other|0|||
126351394|NCT03550209|454577073|FG000|Overall Study|Lost to Follow-up|1|||
126351395|NCT03550209|454577074|FG001|Overall Study|Lost to Follow-up|0|||
126351396|NCT03550209|454577075|FG002|Overall Study|Lost to Follow-up|1|||
126351397|NCT03550209|454577076|FG003|Overall Study|Lost to Follow-up|0|||
126351398|NCT03550209|454577073|FG000|Overall Study|Withdrawal by Subject|0|||
126351399|NCT03550209|454577074|FG001|Overall Study|Withdrawal by Subject|3|||
126351400|NCT03550209|454577075|FG002|Overall Study|Withdrawal by Subject|1|||
126351401|NCT03550209|454577076|FG003|Overall Study|Withdrawal by Subject|2|||
126351402|NCT03550209|454577073|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
126351403|NCT03550209|454577074|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
126351404|NCT03550209|454577075|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
126351405|NCT03550209|454577076|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
126351406|NCT02555878|454577077|FG000|Overall Study|Lost to Follow-up|2|||
126351407|NCT02555878|454577078|FG001|Overall Study|Lost to Follow-up|3|||
126351408|NCT02555878|454577077|FG000|Overall Study|Withdrawal by Subject|48|||
126351409|NCT02555878|454577078|FG001|Overall Study|Withdrawal by Subject|48|||
126351410|NCT02555878|454577077|FG000|Overall Study|Adverse Event|12|||
126351411|NCT02555878|454577078|FG001|Overall Study|Adverse Event|8|||
126351412|NCT02555878|454577077|FG000|Overall Study|Death|74|||
126351413|NCT02555878|454577078|FG001|Overall Study|Death|59|||
126351414|NCT02555878|454577077|FG000|Overall Study|Protocol Violation|1|||
126351415|NCT02555878|454577078|FG001|Overall Study|Protocol Violation|2|||
126351416|NCT02555878|454577077|FG000|Overall Study|Physician Decision|12|||
126351417|NCT02555878|454577078|FG001|Overall Study|Physician Decision|13|||
126351418|NCT02555878|454577077|FG000|Overall Study|Other|17|||
126351419|NCT02555878|454577078|FG001|Overall Study|Other|17|||
126351420|NCT00765076|454577079|FG000|Overall Study|Adverse Event|1|||
126351421|NCT00765076|454577080|FG001|Overall Study|Adverse Event|0|||
126351422|NCT00765076|454577081|FG002|Overall Study|Adverse Event|0|||
126351423|NCT00765076|454577079|FG000|Overall Study|Withdrawal by Subject|0|||
126351424|NCT00765076|454577080|FG001|Overall Study|Withdrawal by Subject|0|||
126351425|NCT00765076|454577081|FG002|Overall Study|Withdrawal by Subject|1|||
126351426|NCT02875080|454577082|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
126351427|NCT02875080|454577083|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
126351428|NCT02875080|454577084|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
126351429|NCT00768053|454577085|FG000|Overall Study|Adverse Event|10|||
126351430|NCT00768053|454577085|FG000|Overall Study|Lost to Follow-up|1|||
126351431|NCT01164475|454577086|FG000|Overall Study|Lack of Efficacy|1|||
126351432|NCT01164475|454577087|FG001|Overall Study|Lack of Efficacy|0|||
126351433|NCT01164475|454577086|FG000|Overall Study|Other|0|||
126351434|NCT01164475|454577087|FG001|Overall Study|Other|1|||
126351435|NCT01164475|454577086|FG000|Overall Study|Progressive disease|0|||
126351436|NCT01164475|454577087|FG001|Overall Study|Progressive disease|1|||
126351437|NCT01164475|454577086|FG000|Overall Study|Protocol Violation|1|||
126351438|NCT01164475|454577087|FG001|Overall Study|Protocol Violation|0|||
126351439|NCT04603066|454577089|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
126351440|NCT04603066|454577090|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
126351441|NCT04134845|454577091|FG000|Overall Study|withdrawl by PI|12|||
126351442|NCT04134845|454577092|FG001|Overall Study|withdrawl by PI|5|||
126351443|NCT01371981|454577093|FG000|Overall Study|Adverse Event|12|||
126351444|NCT01371981|454577094|FG001|Overall Study|Adverse Event|17|||
126351445|NCT01371981|454577095|FG002|Overall Study|Adverse Event|0|||
126351446|NCT01371981|454577096|FG003|Overall Study|Adverse Event|4|||
126351447|NCT01371981|454577097|FG004|Overall Study|Adverse Event|1|||
126351448|NCT01371981|454577098|FG005|Overall Study|Adverse Event|0|||
126351449|NCT01371981|454577093|FG000|Overall Study|Death|22|||
126225079|NCT02884206|454115937|FG001|LCZ696 Run-in Period|Adverse Event|0|||
126351450|NCT01371981|454577094|FG001|Overall Study|Death|16|||
126351451|NCT01371981|454577095|FG002|Overall Study|Death|0|||
126351452|NCT01371981|454577096|FG003|Overall Study|Death|0|||
126351453|NCT01371981|454577097|FG004|Overall Study|Death|2|||
126351454|NCT01371981|454577098|FG005|Overall Study|Death|2|||
126020778|NCT01985334|453371437|FG000|Overall Study|Investigator decision|0|||
126225080|NCT02884206|454115938|FG002|LCZ696 Run-in Period|Adverse Event|0|||
126225081|NCT02884206|454115936|FG000|LCZ696 Run-in Period|Death|2|||
126225082|NCT02884206|454115937|FG001|LCZ696 Run-in Period|Death|0|||
126225083|NCT02884206|454115938|FG002|LCZ696 Run-in Period|Death|0|||
126020779|NCT01985334|453371438|FG001|Overall Study|Investigator decision|3|||
126225084|NCT02884206|454115936|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
126225085|NCT02884206|454115937|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
126351455|NCT01371981|454577093|FG000|Overall Study|Lack of Efficacy|69|||
126351456|NCT01371981|454577094|FG001|Overall Study|Lack of Efficacy|61|||
126351457|NCT01371981|454577095|FG002|Overall Study|Lack of Efficacy|4|||
126351458|NCT01371981|454577096|FG003|Overall Study|Lack of Efficacy|8|||
126351459|NCT01371981|454577097|FG004|Overall Study|Lack of Efficacy|5|||
126351460|NCT01371981|454577098|FG005|Overall Study|Lack of Efficacy|0|||
126351461|NCT01371981|454577093|FG000|Overall Study|Physician Decision|48|||
126351462|NCT01371981|454577094|FG001|Overall Study|Physician Decision|63|||
126351463|NCT01371981|454577095|FG002|Overall Study|Physician Decision|1|||
126351464|NCT01371981|454577096|FG003|Overall Study|Physician Decision|7|||
126351465|NCT01371981|454577097|FG004|Overall Study|Physician Decision|14|||
126351466|NCT01371981|454577098|FG005|Overall Study|Physician Decision|3|||
126351467|NCT01371981|454577093|FG000|Overall Study|Withdrawal by Subject|12|||
126351468|NCT01371981|454577094|FG001|Overall Study|Withdrawal by Subject|19|||
126351469|NCT01371981|454577095|FG002|Overall Study|Withdrawal by Subject|1|||
126351470|NCT01371981|454577096|FG003|Overall Study|Withdrawal by Subject|2|||
126351471|NCT01371981|454577097|FG004|Overall Study|Withdrawal by Subject|10|||
126351472|NCT01371981|454577098|FG005|Overall Study|Withdrawal by Subject|3|||
126351473|NCT01371981|454577093|FG000|Overall Study|Ineligible|19|||
126351474|NCT01371981|454577094|FG001|Overall Study|Ineligible|13|||
126351475|NCT01371981|454577095|FG002|Overall Study|Ineligible|0|||
126351476|NCT01371981|454577096|FG003|Overall Study|Ineligible|0|||
126351477|NCT01371981|454577097|FG004|Overall Study|Ineligible|0|||
126351478|NCT01371981|454577098|FG005|Overall Study|Ineligible|4|||
126351479|NCT01371981|454577093|FG000|Overall Study|Did not start treatment|2|||
126351480|NCT01371981|454577094|FG001|Overall Study|Did not start treatment|3|||
126351481|NCT01371981|454577095|FG002|Overall Study|Did not start treatment|0|||
126351482|NCT01371981|454577096|FG003|Overall Study|Did not start treatment|0|||
126351483|NCT01371981|454577097|FG004|Overall Study|Did not start treatment|0|||
126351484|NCT01371981|454577098|FG005|Overall Study|Did not start treatment|2|||
126351485|NCT03244189|454577099|FG000|Overall Study|Death|0|||
126351486|NCT03244189|454577100|FG001|Overall Study|Death|2|||
126351487|NCT03244189|454577099|FG000|Overall Study|Lost to Follow-up|92|||
126351488|NCT03244189|454577100|FG001|Overall Study|Lost to Follow-up|107|||
126351489|NCT03244189|454577099|FG000|Overall Study|Physician Decision|4|||
126351490|NCT03244189|454577100|FG001|Overall Study|Physician Decision|2|||
126351491|NCT03244189|454577099|FG000|Overall Study|Pregnancy|7|||
126351492|NCT03244189|454577100|FG001|Overall Study|Pregnancy|5|||
126351493|NCT03244189|454577099|FG000|Overall Study|Protocol Violation|0|||
126351494|NCT03244189|454577100|FG001|Overall Study|Protocol Violation|2|||
126351495|NCT03244189|454577099|FG000|Overall Study|Withdrawal by Subject|45|||
126351496|NCT03244189|454577100|FG001|Overall Study|Withdrawal by Subject|23|||
126351497|NCT03244189|454577099|FG000|Overall Study|Technical Problems|2|||
126351498|NCT03244189|454577100|FG001|Overall Study|Technical Problems|0|||
126351499|NCT05253807|454577101|FG000|Overall Study|Death|1|||
126351500|NCT05253807|454577102|FG001|Overall Study|Death|4|||
126351501|NCT05253807|454577101|FG000|Overall Study|Withdrawal by Subject|1|||
126351502|NCT05253807|454577102|FG001|Overall Study|Withdrawal by Subject|0|||
126351503|NCT05253807|454577101|FG000|Overall Study|Study Terminated by Sponsor|1|||
126351504|NCT05253807|454577102|FG001|Overall Study|Study Terminated by Sponsor|1|||
126351505|NCT02145390|454577111|FG000|Overall Study|Withdrawal by Subject|1|||
126351506|NCT01732783|454577963|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
126351507|NCT01732783|454577964|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
126351508|NCT01732783|454577965|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
126351509|NCT01732783|454577963|FG000|Overall Study|Death|13|||
126351510|NCT01732783|454577964|FG001|Overall Study|Death|4|||
126351511|NCT01732783|454577965|FG002|Overall Study|Death|1|||
126351512|NCT01732783|454577963|FG000|Overall Study|Lost to Follow-up|7|||
126351513|NCT01732783|454577964|FG001|Overall Study|Lost to Follow-up|1|||
126351514|NCT01732783|454577965|FG002|Overall Study|Lost to Follow-up|1|||
126351515|NCT01732783|454577963|FG000|Overall Study|Administrative Decision|8|||
126092927|NCT02626455|453632930|FG002|Overall Study|Progressive disease - clinical progression|0|||
126351516|NCT01732783|454577964|FG001|Overall Study|Administrative Decision|2|||
126351517|NCT01732783|454577965|FG002|Overall Study|Administrative Decision|1|||
126351518|NCT01732783|454577963|FG000|Overall Study|Withdrawal by Subject|1|||
126351519|NCT01732783|454577964|FG001|Overall Study|Withdrawal by Subject|0|||
126351520|NCT01732783|454577965|FG002|Overall Study|Withdrawal by Subject|0|||
126351521|NCT04598828|454577966|FG000|Overall Study|Physician Decision|1|||
126351522|NCT04598828|454577967|FG001|Overall Study|Physician Decision|0|||
126351523|NCT04598828|454577966|FG000|Overall Study|Withdrawal by Subject|0|||
126351524|NCT04598828|454577967|FG001|Overall Study|Withdrawal by Subject|1|||
126351525|NCT04598828|454577966|FG000|Overall Study|Withdrawal by Subject|0|||
126351526|NCT04598828|454577967|FG001|Overall Study|Withdrawal by Subject|1|||
126351527|NCT01078662|454577968|FG000|Overall Study|Death|41|||
126351528|NCT01078662|454577969|FG001|Overall Study|Death|103|||
126351529|NCT01078662|454577970|FG002|Overall Study|Death|18|||
126351530|NCT01078662|454577971|FG003|Overall Study|Death|5|||
126351531|NCT01078662|454577972|FG004|Overall Study|Death|8|||
126351532|NCT01078662|454577968|FG000|Overall Study|Patients reached data cut-off|12|||
126369551|NCT01497197|454650597|FG001|Overall Study|Lost to Follow-up|0|||
126020780|NCT01985334|453371439|FG002|Overall Study|Investigator decision|0|||
126020781|NCT01985334|453371440|FG003|Overall Study|Investigator decision|7|||
126020782|NCT01985334|453371441|FG004|Overall Study|Investigator decision|1|||
126020783|NCT01985334|453371442|FG005|Overall Study|Investigator decision|1|||
126020784|NCT01985334|453371443|FG006|Overall Study|Investigator decision|0|||
126020785|NCT01985334|453371444|FG007|Overall Study|Investigator decision|4|||
126351533|NCT01078662|454577969|FG001|Overall Study|Patients reached data cut-off|53|||
126351534|NCT01078662|454577970|FG002|Overall Study|Patients reached data cut-off|2|||
126351535|NCT01078662|454577971|FG003|Overall Study|Patients reached data cut-off|2|||
126351536|NCT01078662|454577972|FG004|Overall Study|Patients reached data cut-off|3|||
126351537|NCT01078662|454577968|FG000|Overall Study|Withdrawal by Subject|4|||
126351538|NCT01078662|454577969|FG001|Overall Study|Withdrawal by Subject|11|||
126351539|NCT01078662|454577970|FG002|Overall Study|Withdrawal by Subject|1|||
126351540|NCT01078662|454577971|FG003|Overall Study|Withdrawal by Subject|0|||
126351541|NCT01078662|454577972|FG004|Overall Study|Withdrawal by Subject|0|||
126351542|NCT01078662|454577968|FG000|Overall Study|Protocol Violation|0|||
126351543|NCT01078662|454577969|FG001|Overall Study|Protocol Violation|1|||
126351544|NCT01078662|454577970|FG002|Overall Study|Protocol Violation|0|||
126351545|NCT01078662|454577971|FG003|Overall Study|Protocol Violation|0|||
126351546|NCT01078662|454577972|FG004|Overall Study|Protocol Violation|0|||
126351547|NCT01078662|454577968|FG000|Overall Study|Lost to Follow-up|1|||
126351548|NCT01078662|454577969|FG001|Overall Study|Lost to Follow-up|0|||
126351549|NCT01078662|454577970|FG002|Overall Study|Lost to Follow-up|0|||
126351550|NCT01078662|454577971|FG003|Overall Study|Lost to Follow-up|0|||
126351551|NCT01078662|454577972|FG004|Overall Study|Lost to Follow-up|0|||
126351552|NCT04589650|454577973|FG000|Overall Study|Subject decision|6|||
126351553|NCT04589650|454577974|FG001|Overall Study|Subject decision|2|||
126351554|NCT04589650|454577975|FG002|Overall Study|Subject decision|2|||
126351555|NCT04589650|454577976|FG003|Overall Study|Subject decision|0|||
126351556|NCT04589650|454577977|FG004|Overall Study|Subject decision|0|||
126351557|NCT04589650|454577978|FG005|Overall Study|Subject decision|0|||
126351558|NCT04589650|454577973|FG000|Overall Study|Adverse Event|3|||
126351559|NCT04589650|454577974|FG001|Overall Study|Adverse Event|1|||
126351560|NCT04589650|454577975|FG002|Overall Study|Adverse Event|1|||
126351561|NCT04589650|454577976|FG003|Overall Study|Adverse Event|1|||
126351562|NCT04589650|454577977|FG004|Overall Study|Adverse Event|0|||
126351563|NCT04589650|454577978|FG005|Overall Study|Adverse Event|1|||
126351564|NCT04589650|454577973|FG000|Overall Study|Physician Decision|1|||
126351565|NCT04589650|454577974|FG001|Overall Study|Physician Decision|1|||
126351566|NCT04589650|454577975|FG002|Overall Study|Physician Decision|0|||
126351567|NCT04589650|454577976|FG003|Overall Study|Physician Decision|0|||
126351568|NCT04589650|454577977|FG004|Overall Study|Physician Decision|0|||
126351569|NCT04589650|454577978|FG005|Overall Study|Physician Decision|0|||
126351570|NCT04589650|454577973|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126351571|NCT04589650|454577974|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126351572|NCT04589650|454577975|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126351573|NCT04589650|454577976|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126351574|NCT04589650|454577977|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
126351575|NCT04589650|454577978|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
126020786|NCT01985334|453371437|FG000|Overall Study|Lost to Follow-up|0|||
126020787|NCT01985334|453371438|FG001|Overall Study|Lost to Follow-up|2|||
126351576|NCT04589650|454577973|FG000|Overall Study|Death|0|||
126351577|NCT04589650|454577974|FG001|Overall Study|Death|0|||
126351578|NCT04589650|454577975|FG002|Overall Study|Death|0|||
126351579|NCT04589650|454577976|FG003|Overall Study|Death|1|||
126351580|NCT04589650|454577977|FG004|Overall Study|Death|0|||
126351581|NCT04589650|454577978|FG005|Overall Study|Death|0|||
126351582|NCT04589650|454577973|FG000|Overall Study|Guardian Decision|0|||
126351583|NCT04589650|454577974|FG001|Overall Study|Guardian Decision|0|||
126351584|NCT04589650|454577975|FG002|Overall Study|Guardian Decision|0|||
126351585|NCT04589650|454577976|FG003|Overall Study|Guardian Decision|1|||
126351586|NCT04589650|454577977|FG004|Overall Study|Guardian Decision|0|||
126351587|NCT04589650|454577978|FG005|Overall Study|Guardian Decision|0|||
126225086|NCT02884206|454115938|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
126225087|NCT02884206|454115936|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
126225088|NCT02884206|454115937|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
126225089|NCT02884206|454115938|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
126225090|NCT02884206|454115936|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
126225091|NCT02884206|454115937|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
126225092|NCT02884206|454115938|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
126225093|NCT02884206|454115936|FG000|LCZ696 Run-in Period|Physician Decision|1|||
126225094|NCT02884206|454115937|FG001|LCZ696 Run-in Period|Physician Decision|0|||
126225095|NCT02884206|454115938|FG002|LCZ696 Run-in Period|Physician Decision|0|||
126225096|NCT02884206|454115936|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
126351588|NCT04937387|454577979|FG000|Overall Study|Adverse Event|1|||
126351589|NCT04937387|454577980|FG001|Overall Study|Adverse Event|0|||
126351590|NCT04937387|454577981|FG002|Overall Study|Adverse Event|2|||
126351591|NCT04937387|454577982|FG003|Overall Study|Adverse Event|0|||
126351592|NCT04937387|454577979|FG000|Overall Study|Lack of Efficacy|1|||
126020788|NCT01985334|453371439|FG002|Overall Study|Lost to Follow-up|0|||
126225097|NCT02884206|454115937|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
126225098|NCT02884206|454115938|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
126225099|NCT02884206|454115936|FG000|Double-Blind Period|Death|0|||
126351593|NCT04937387|454577980|FG001|Overall Study|Lack of Efficacy|0|||
126351594|NCT04937387|454577981|FG002|Overall Study|Lack of Efficacy|0|||
126351595|NCT04937387|454577982|FG003|Overall Study|Lack of Efficacy|1|||
126020789|NCT01985334|453371440|FG003|Overall Study|Lost to Follow-up|3|||
126020790|NCT01985334|453371441|FG004|Overall Study|Lost to Follow-up|1|||
126020791|NCT01985334|453371442|FG005|Overall Study|Lost to Follow-up|4|||
126020792|NCT01985334|453371443|FG006|Overall Study|Lost to Follow-up|0|||
126020793|NCT01985334|453371444|FG007|Overall Study|Lost to Follow-up|3|||
126225100|NCT02884206|454115937|FG001|Double-Blind Period|Death|28|||
126351596|NCT04937387|454577979|FG000|Overall Study|Withdrawal by Subject|1|||
126351597|NCT04937387|454577980|FG001|Overall Study|Withdrawal by Subject|0|||
126351598|NCT04937387|454577981|FG002|Overall Study|Withdrawal by Subject|1|||
126351599|NCT04937387|454577982|FG003|Overall Study|Withdrawal by Subject|1|||
126351600|NCT04937387|454577979|FG000|Overall Study|Randomized in error|0|||
126351601|NCT04937387|454577980|FG001|Overall Study|Randomized in error|0|||
126351602|NCT04937387|454577981|FG002|Overall Study|Randomized in error|0|||
126351603|NCT04937387|454577982|FG003|Overall Study|Randomized in error|1|||
126020794|NCT03988023|453371445|FG000|Overall Study|Non-compliance|3|||
126020795|NCT03988023|453371446|FG001|Overall Study|Non-compliance|0|||
126351604|NCT03421808|454577987|FG000|Overall Study|COVID related problems|2|||
126225101|NCT02884206|454115938|FG002|Double-Blind Period|Death|39|||
126225102|NCT02884206|454115936|FG000|Double-Blind Period|Patient/guardian decision|0|||
126020796|NCT03988023|453371445|FG000|Overall Study|Withdrawal by Subject|39|||
126092928|NCT02626455|453632931|FG003|Overall Study|Progressive disease - clinical progression|0|||
126092929|NCT02626455|453632932|FG004|Overall Study|Progressive disease - clinical progression|0|||
126092930|NCT02626455|453632933|FG005|Overall Study|Progressive disease - clinical progression|1|||
126092931|NCT02626455|453632934|FG006|Overall Study|Progressive disease - clinical progression|2|||
126092932|NCT02626455|453632928|FG000|Overall Study|Lost to Follow-up|0|||
126092933|NCT02626455|453632929|FG001|Overall Study|Lost to Follow-up|0|||
126092934|NCT02626455|453632930|FG002|Overall Study|Lost to Follow-up|0|||
126092935|NCT02626455|453632931|FG003|Overall Study|Lost to Follow-up|0|||
126092936|NCT02626455|453632932|FG004|Overall Study|Lost to Follow-up|0|||
126092937|NCT02626455|453632933|FG005|Overall Study|Lost to Follow-up|1|||
126092938|NCT02626455|453632934|FG006|Overall Study|Lost to Follow-up|0|||
126092939|NCT02626455|453632928|FG000|Overall Study|AE not associated with clinical disease progression|1|||
126092940|NCT02626455|453632929|FG001|Overall Study|AE not associated with clinical disease progression|1|||
126092941|NCT02626455|453632930|FG002|Overall Study|AE not associated with clinical disease progression|0|||
126092942|NCT02626455|453632931|FG003|Overall Study|AE not associated with clinical disease progression|2|||
126092943|NCT02626455|453632932|FG004|Overall Study|AE not associated with clinical disease progression|1|||
126092944|NCT02626455|453632933|FG005|Overall Study|AE not associated with clinical disease progression|65|||
126092945|NCT02626455|453632934|FG006|Overall Study|AE not associated with clinical disease progression|21|||
126092946|NCT02626455|453632928|FG000|Overall Study|AE associated with clinical disease progression|0|||
126092947|NCT02626455|453632929|FG001|Overall Study|AE associated with clinical disease progression|0|||
126092948|NCT02626455|453632930|FG002|Overall Study|AE associated with clinical disease progression|0|||
126092949|NCT02626455|453632931|FG003|Overall Study|AE associated with clinical disease progression|0|||
126092950|NCT02626455|453632932|FG004|Overall Study|AE associated with clinical disease progression|0|||
126092951|NCT02626455|453632933|FG005|Overall Study|AE associated with clinical disease progression|1|||
126092952|NCT02626455|453632934|FG006|Overall Study|AE associated with clinical disease progression|2|||
126092953|NCT02626455|453632928|FG000|Overall Study|Study intervention never administered|0|||
126092954|NCT02626455|453632929|FG001|Overall Study|Study intervention never administered|0|||
126092955|NCT02626455|453632930|FG002|Overall Study|Study intervention never administered|0|||
126092956|NCT02626455|453632931|FG003|Overall Study|Study intervention never administered|0|||
126092957|NCT02626455|453632932|FG004|Overall Study|Study intervention never administered|0|||
126092958|NCT02626455|453632933|FG005|Overall Study|Study intervention never administered|1|||
126092959|NCT02626455|453632934|FG006|Overall Study|Study intervention never administered|3|||
126092960|NCT03002220|453634451|FG000|Overall Study|Lack of Efficacy|2|||
126092961|NCT03002220|453634451|FG000|Overall Study|Withdrawal by Subject|3|||
126092962|NCT03002220|453634451|FG000|Overall Study|Adverse Event|2|||
126092963|NCT03002220|453634451|FG000|Overall Study|Disease progression|13|||
126092964|NCT03002220|453634451|FG000|Overall Study|Physician Decision|1|||
126092965|NCT01015560|453634454|FG000|Overall Study|Adverse Event|1|||
126092966|NCT01015560|453634454|FG000|Overall Study|Not protocol specified|1|||
126092967|NCT01015560|453634454|FG000|Overall Study|Withdrawal by Subject|1|||
126020797|NCT03988023|453371446|FG001|Overall Study|Withdrawal by Subject|37|||
126020798|NCT03988023|453371445|FG000|Overall Study|Adverse Event|0|||
126020799|NCT03988023|453371446|FG001|Overall Study|Adverse Event|2|||
126020800|NCT03988023|453371445|FG000|Overall Study|Physician Decision|0|||
126020801|NCT03988023|453371446|FG001|Overall Study|Physician Decision|1|||
126020802|NCT03988023|453371445|FG000|Overall Study|Lost to Follow-up|5|||
126020803|NCT03988023|453371446|FG001|Overall Study|Lost to Follow-up|8|||
126020804|NCT03988023|453371445|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
126020805|NCT03988023|453371446|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
126020806|NCT03988023|453371445|FG000|Overall Study|Lack of Efficacy|3|||
126020807|NCT03988023|453371446|FG001|Overall Study|Lack of Efficacy|1|||
126020808|NCT03988023|453371445|FG000|Overall Study|COVID-19 pandemic|225|||
126020809|NCT03988023|453371446|FG001|Overall Study|COVID-19 pandemic|227|||
126020810|NCT00396084|453371449|FG000|Overall Study|Adverse Event|0|||
126092968|NCT00640133|453634455|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
126092969|NCT00640133|453634456|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
126092970|NCT00640133|453634455|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
126092971|NCT00640133|453634456|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
126092972|NCT00640133|453634455|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
126092973|NCT00640133|453634456|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
126092974|NCT00128102|453634457|FG000|Overall Study|Site Discontinued|3|||
126092975|NCT00128102|453634458|FG001|Overall Study|Site Discontinued|6|||
126092976|NCT00128102|453634457|FG000|Overall Study|Other|0|||
126092977|NCT00128102|453634458|FG001|Overall Study|Other|1|||
126092978|NCT00128102|453634457|FG000|Overall Study|Progressive Disease|255|||
126092979|NCT00128102|453634458|FG001|Overall Study|Progressive Disease|285|||
126020811|NCT00396084|453371450|FG001|Overall Study|Adverse Event|0|||
126020812|NCT00396084|453371451|FG002|Overall Study|Adverse Event|0|||
126020813|NCT00396084|453371452|FG003|Overall Study|Adverse Event|0|||
126020814|NCT00396084|453371453|FG004|Overall Study|Adverse Event|1|||
126020815|NCT00396084|453371454|FG005|Overall Study|Adverse Event|2|||
126225103|NCT02884206|454115937|FG001|Double-Blind Period|Patient/guardian decision|10|||
126225104|NCT02884206|454115938|FG002|Double-Blind Period|Patient/guardian decision|13|||
126225105|NCT02884206|454115936|FG000|Double-Blind Period|Lost to Follow-up|0|||
126225106|NCT02884206|454115937|FG001|Double-Blind Period|Lost to Follow-up|4|||
126225107|NCT02884206|454115938|FG002|Double-Blind Period|Lost to Follow-up|4|||
126225108|NCT02884206|454115936|FG000|Double-Blind Period|Physician Decision|0|||
126225109|NCT02884206|454115937|FG001|Double-Blind Period|Physician Decision|2|||
126225110|NCT02884206|454115938|FG002|Double-Blind Period|Physician Decision|0|||
126225111|NCT02884206|454115936|FG000|Double-Blind Period|Adverse Event|0|||
126225112|NCT02884206|454115937|FG001|Double-Blind Period|Adverse Event|0|||
126225113|NCT02884206|454115938|FG002|Double-Blind Period|Adverse Event|3|||
126225114|NCT02884206|454115936|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
126225115|NCT02884206|454115937|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
126225116|NCT02884206|454115938|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
126225117|NCT03038113|454115939|FG000|Overall Study|Withdrawal by Subject|0|||
126225118|NCT03038113|454115940|FG001|Overall Study|Withdrawal by Subject|0|||
126225119|NCT03038113|454115941|FG002|Overall Study|Withdrawal by Subject|1|||
126225120|NCT03038113|454115942|FG003|Overall Study|Withdrawal by Subject|0|||
126225121|NCT03038113|454115943|FG004|Overall Study|Withdrawal by Subject|0|||
126225122|NCT03038113|454115944|FG005|Overall Study|Withdrawal by Subject|0|||
126225123|NCT03038113|454115945|FG006|Overall Study|Withdrawal by Subject|0|||
126225124|NCT03038113|454115946|FG007|Overall Study|Withdrawal by Subject|0|||
126092980|NCT00128102|453634457|FG000|Overall Study|Adverse Event|34|||
126092981|NCT00128102|453634458|FG001|Overall Study|Adverse Event|11|||
126225125|NCT03038113|454115947|FG008|Overall Study|Withdrawal by Subject|0|||
126225126|NCT03038113|454115948|FG009|Overall Study|Withdrawal by Subject|0|||
126225127|NCT03038113|454115949|FG010|Overall Study|Withdrawal by Subject|0|||
126092982|NCT00128102|453634457|FG000|Overall Study|Death|12|||
126225128|NCT03038113|454115950|FG011|Overall Study|Withdrawal by Subject|0|||
126225129|NCT03038113|454115951|FG012|Overall Study|Withdrawal by Subject|0|||
126225130|NCT03038113|454115952|FG013|Overall Study|Withdrawal by Subject|1|||
126225131|NCT03038113|454115939|FG000|Overall Study|Lost to Follow-up|0|||
126225132|NCT03038113|454115940|FG001|Overall Study|Lost to Follow-up|0|||
126020816|NCT00396084|453371449|FG000|Overall Study|Withdrawal by Subject|0|||
126020817|NCT00396084|453371450|FG001|Overall Study|Withdrawal by Subject|0|||
126225133|NCT03038113|454115941|FG002|Overall Study|Lost to Follow-up|0|||
126225134|NCT03038113|454115942|FG003|Overall Study|Lost to Follow-up|0|||
126225135|NCT03038113|454115943|FG004|Overall Study|Lost to Follow-up|0|||
126225136|NCT03038113|454115944|FG005|Overall Study|Lost to Follow-up|0|||
126225137|NCT03038113|454115945|FG006|Overall Study|Lost to Follow-up|1|||
126225138|NCT03038113|454115946|FG007|Overall Study|Lost to Follow-up|0|||
126225139|NCT03038113|454115947|FG008|Overall Study|Lost to Follow-up|0|||
126225140|NCT03038113|454115948|FG009|Overall Study|Lost to Follow-up|0|||
126225141|NCT03038113|454115949|FG010|Overall Study|Lost to Follow-up|0|||
126225142|NCT03038113|454115950|FG011|Overall Study|Lost to Follow-up|0|||
126225143|NCT03038113|454115951|FG012|Overall Study|Lost to Follow-up|0|||
126225144|NCT03038113|454115952|FG013|Overall Study|Lost to Follow-up|0|||
126020818|NCT00396084|453371451|FG002|Overall Study|Withdrawal by Subject|0|||
126020819|NCT00396084|453371452|FG003|Overall Study|Withdrawal by Subject|1|||
126020820|NCT00396084|453371453|FG004|Overall Study|Withdrawal by Subject|0|||
126020821|NCT00396084|453371454|FG005|Overall Study|Withdrawal by Subject|0|||
126020822|NCT02708108|453371455|FG000|Overall Study|Death|1|||
126020823|NCT02708108|453371456|FG001|Overall Study|Death|2|||
126020824|NCT02708108|453371455|FG000|Overall Study|Regimen change|1|||
126020825|NCT02708108|453371456|FG001|Overall Study|Regimen change|0|||
126020826|NCT02708108|453371455|FG000|Overall Study|No MRD and no imaging available|0|||
126020827|NCT02708108|453371456|FG001|Overall Study|No MRD and no imaging available|1|||
126020828|NCT02568683|453371457|FG000|Overall Study|Death|0|||
126020829|NCT02568683|453371458|FG001|Overall Study|Death|2|||
126020830|NCT02568683|453371457|FG000|Overall Study|Withdrew Consent|1|||
126020831|NCT02568683|453371458|FG001|Overall Study|Withdrew Consent|0|||
126020832|NCT02568683|453371457|FG000|Overall Study|Study Terminated By Sponsor|5|||
126020833|NCT02568683|453371458|FG001|Overall Study|Study Terminated By Sponsor|2|||
126020834|NCT01736215|453371459|FG000|Overall Study|Early termination of erythropoietin use|1|||
126020835|NCT01736215|453371459|FG000|Overall Study|Adverse Event|4|||
126020836|NCT01736215|453371459|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
126020837|NCT01736215|453371459|FG000|Overall Study|Insufficient data to perform analysis|8|||
126020838|NCT01248936|453371465|FG000|Overall Study|Sponsor Decision|259|||
126020839|NCT01248936|453371465|FG000|Overall Study|Progression of Disease|50|||
126020840|NCT01248936|453371465|FG000|Overall Study|Death|26|||
126020841|NCT01248936|453371465|FG000|Overall Study|Withdrawal of Consent|20|||
126020842|NCT01248936|453371465|FG000|Overall Study|Adverse Event|8|||
126020843|NCT01248936|453371465|FG000|Overall Study|Lost to Follow-up|7|||
126020844|NCT01248936|453371465|FG000|Overall Study|Refused Treatment|1|||
126020845|NCT01248936|453371465|FG000|Overall Study|Other reason|3|||
126020846|NCT03930420|453371466|FG000|Overall Study|Withdrawal by Subject|7|||
126020847|NCT03930420|453371467|FG001|Overall Study|Withdrawal by Subject|9|||
126020848|NCT04556981|453371468|FG000|Overall Study|Death|0|||
126020849|NCT04556981|453371469|FG001|Overall Study|Death|1|||
126225145|NCT01418352|454115955|FG000|Overall Study|Lost to Follow-up|2|||
126225146|NCT01418352|454115956|FG001|Overall Study|Lost to Follow-up|0|||
126225147|NCT01418352|454115957|FG002|Overall Study|Lost to Follow-up|0|||
126225148|NCT01418352|454115958|FG003|Overall Study|Lost to Follow-up|0|||
126225149|NCT01418352|454115955|FG000|Overall Study|Adverse Event|0|||
126225150|NCT01418352|454115956|FG001|Overall Study|Adverse Event|1|||
126225151|NCT01418352|454115957|FG002|Overall Study|Adverse Event|0|||
126225152|NCT01418352|454115958|FG003|Overall Study|Adverse Event|0|||
126225153|NCT01418352|454115955|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
126225154|NCT01418352|454115956|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
126225155|NCT01418352|454115957|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
126351605|NCT03421808|454577988|FG001|Overall Study|COVID related problems|0|||
126351606|NCT03421808|454577987|FG000|Overall Study|Withdrawal by Subject|1|||
126351607|NCT03421808|454577988|FG001|Overall Study|Withdrawal by Subject|0|||
126020850|NCT04556981|453371468|FG000|Overall Study|Lost to Follow-up|2|||
126020851|NCT04556981|453371469|FG001|Overall Study|Lost to Follow-up|11|||
126020852|NCT04556981|453371468|FG000|Overall Study|Moved from the study area|1|||
126020853|NCT04556981|453371469|FG001|Overall Study|Moved from the study area|4|||
126020854|NCT04556981|453371468|FG000|Overall Study|Withdrawal by Subject|2|||
126225156|NCT01418352|454115958|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
126020855|NCT04556981|453371469|FG001|Overall Study|Withdrawal by Subject|2|||
126020856|NCT04556981|453371468|FG000|Overall Study|Other|2|||
126020857|NCT04556981|453371469|FG001|Overall Study|Other|1|||
126020858|NCT00440011|453371481|FG000|Overall Study|Adverse Event|2|||
126020859|NCT00440011|453371482|FG001|Overall Study|Adverse Event|0|||
126225157|NCT01418352|454115955|FG000|Overall Study|Subject Withdrew Consent|0|||
126225158|NCT01418352|454115956|FG001|Overall Study|Subject Withdrew Consent|1|||
126020860|NCT00440011|453371481|FG000|Overall Study|Lost to Follow-up|0|||
126020861|NCT00440011|453371482|FG001|Overall Study|Lost to Follow-up|2|||
126020862|NCT00440011|453371481|FG000|Overall Study|Protocol Violation|1|||
126225159|NCT01418352|454115957|FG002|Overall Study|Subject Withdrew Consent|2|||
126225160|NCT01418352|454115958|FG003|Overall Study|Subject Withdrew Consent|1|||
126225161|NCT01418352|454115955|FG000|Overall Study|Protocol Deviation|0|||
126225162|NCT01418352|454115956|FG001|Overall Study|Protocol Deviation|0|||
126225163|NCT01418352|454115957|FG002|Overall Study|Protocol Deviation|1|||
126020863|NCT00440011|453371482|FG001|Overall Study|Protocol Violation|1|||
126020864|NCT00440011|453371481|FG000|Overall Study|Withdrawal by Subject|1|||
126225164|NCT01418352|454115958|FG003|Overall Study|Protocol Deviation|0|||
126225165|NCT01418352|454115955|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
126225166|NCT01418352|454115956|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
126225167|NCT01418352|454115957|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
126225168|NCT01418352|454115958|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
126225169|NCT00619619|454115959|FG000|Overall Study|Physician Decision|0|||
126225170|NCT00619619|454115960|FG001|Overall Study|Physician Decision|0|||
126225171|NCT00619619|454115961|FG002|Overall Study|Physician Decision|1|||
126225172|NCT00619619|454115962|FG003|Overall Study|Physician Decision|0|||
126225173|NCT00619619|454115963|FG004|Overall Study|Physician Decision|0|||
126225174|NCT00619619|454115964|FG005|Overall Study|Physician Decision|0|||
126225175|NCT00619619|454115965|FG006|Overall Study|Physician Decision|0|||
126020865|NCT00440011|453371482|FG001|Overall Study|Withdrawal by Subject|0|||
126020866|NCT00419341|453371483|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
126020867|NCT00419341|453371483|FG000|Wash in/Wash Out Period|Adverse Event|2|||
126020868|NCT00419341|453371483|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
126020869|NCT00419341|453371483|FG000|Efficacy Period|Withdrawal by Subject|6|||
126020870|NCT00419341|453371483|FG000|Efficacy Period|Protocol Violation|1|||
126020871|NCT00419341|453371483|FG000|Efficacy Period|Lost to Follow-up|1|||
126020872|NCT00419341|453371483|FG000|Efficacy Period|Non-compliance|1|||
126020873|NCT00419341|453371483|FG000|Efficacy Period|Termination of study site|1|||
126020874|NCT01925339|453371491|FG000|Overall Study|Adverse Event|2|||
126225176|NCT00619619|454115966|FG007|Overall Study|Physician Decision|0|||
126225177|NCT00619619|454115959|FG000|Overall Study|Protocol Violation|0|||
126225178|NCT00619619|454115960|FG001|Overall Study|Protocol Violation|0|||
126225179|NCT00619619|454115961|FG002|Overall Study|Protocol Violation|0|||
126225180|NCT00619619|454115962|FG003|Overall Study|Protocol Violation|1|||
126225181|NCT00619619|454115963|FG004|Overall Study|Protocol Violation|0|||
126225182|NCT00619619|454115964|FG005|Overall Study|Protocol Violation|0|||
126225183|NCT00619619|454115965|FG006|Overall Study|Protocol Violation|1|||
126225184|NCT00619619|454115966|FG007|Overall Study|Protocol Violation|1|||
126225185|NCT00619619|454115959|FG000|Overall Study|Adverse Event|0|||
126225186|NCT00619619|454115960|FG001|Overall Study|Adverse Event|0|||
126225187|NCT00619619|454115961|FG002|Overall Study|Adverse Event|0|||
126225188|NCT00619619|454115962|FG003|Overall Study|Adverse Event|0|||
126225189|NCT00619619|454115963|FG004|Overall Study|Adverse Event|2|||
126225190|NCT00619619|454115964|FG005|Overall Study|Adverse Event|0|||
126225191|NCT00619619|454115965|FG006|Overall Study|Adverse Event|0|||
126225192|NCT00619619|454115966|FG007|Overall Study|Adverse Event|2|||
126225193|NCT01092702|454115967|FG000|Overall Study|Withdrawal by Subject|7|||
126225194|NCT01092702|454115967|FG000|Overall Study|Lost to Follow-up|2|||
126225195|NCT03263819|454115968|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
126225196|NCT03263819|454115969|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
126225197|NCT03652961|454115972|FG000|Overall Study|Lost to Follow-up|3|||
126225198|NCT03652961|454115972|FG000|Overall Study|Screen Failure|1|||
126225199|NCT01783496|454115973|FG000|Overall Study|Lost to Follow-up|0|||
126225200|NCT01783496|454115974|FG001|Overall Study|Lost to Follow-up|0|||
126225201|NCT01783496|454115975|FG002|Overall Study|Lost to Follow-up|0|||
126225202|NCT01783496|454115976|FG003|Overall Study|Lost to Follow-up|2|||
126225203|NCT01783496|454115977|FG004|Overall Study|Lost to Follow-up|0|||
126225204|NCT01783496|454115978|FG005|Overall Study|Lost to Follow-up|1|||
126225205|NCT01783496|454115973|FG000|Overall Study|Withdrawal by Subject|1|||
126225206|NCT01783496|454115974|FG001|Overall Study|Withdrawal by Subject|0|||
126225207|NCT01783496|454115975|FG002|Overall Study|Withdrawal by Subject|0|||
126225208|NCT01783496|454115976|FG003|Overall Study|Withdrawal by Subject|0|||
126225209|NCT01783496|454115977|FG004|Overall Study|Withdrawal by Subject|0|||
126225210|NCT01783496|454115978|FG005|Overall Study|Withdrawal by Subject|0|||
126225211|NCT00686920|454115984|FG000|Overall Study|Death|45|||
126225212|NCT00686920|454115985|FG001|Overall Study|Death|14|||
126225213|NCT00686920|454115984|FG000|Overall Study|Liver Transplant|23|||
126225214|NCT00686920|454115985|FG001|Overall Study|Liver Transplant|8|||
126020875|NCT01925339|453371492|FG001|Overall Study|Adverse Event|0|||
126225215|NCT00686920|454115984|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
126225216|NCT00686920|454115985|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
126225217|NCT00686920|454115984|FG000|Overall Study|Withdrawal by Subject|23|||
126351608|NCT03421808|454577987|FG000|Overall Study|Protocol Violation|0|||
126092983|NCT00128102|453634458|FG001|Overall Study|Death|13|||
126020876|NCT01538719|453371493|FG000|Overall Study|Lost to Follow-up|2|||
126020877|NCT01538719|453371494|FG001|Overall Study|Lost to Follow-up|0|||
126020878|NCT03664960|453371495|FG000|Overall Study|Adverse Event|0|||
126020879|NCT03664960|453371496|FG001|Overall Study|Adverse Event|3|||
126020880|NCT03664960|453371495|FG000|Overall Study|Lost to Follow-up|3|||
126020881|NCT03664960|453371496|FG001|Overall Study|Lost to Follow-up|2|||
126020882|NCT03664960|453371495|FG000|Overall Study|Physician Decision|1|||
126020883|NCT03664960|453371496|FG001|Overall Study|Physician Decision|0|||
126020884|NCT03664960|453371495|FG000|Overall Study|Withdrawal by Subject|3|||
126020885|NCT03664960|453371496|FG001|Overall Study|Withdrawal by Subject|14|||
126020886|NCT03664960|453371495|FG000|Overall Study|Sponsor Decision|1|||
126020887|NCT03664960|453371496|FG001|Overall Study|Sponsor Decision|1|||
126020888|NCT03664960|453371495|FG000|Overall Study|Other|1|||
126020889|NCT03664960|453371496|FG001|Overall Study|Other|2|||
126020890|NCT03783026|453373057|FG000|Treatment Phase|Adverse Event|15|||
126020891|NCT03783026|453373057|FG000|Treatment Phase|Lack of Efficacy|11|||
126020892|NCT03783026|453373057|FG000|Treatment Phase|Withdrawal by Subject|6|||
126020893|NCT03783026|453373057|FG000|Treatment Phase|Lost to Follow-up|2|||
126020894|NCT03783026|453373057|FG000|Treatment Phase|Protocol Deviation|8|||
126020895|NCT03783026|453373057|FG000|Treatment Phase|Did Not Receive Treatment|1|||
126020896|NCT03783026|453373057|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
126020897|NCT03960463|453373076|FG000|Overall Study|Withdrawal by Subject|2|||
126020898|NCT03960463|453373077|FG001|Overall Study|Withdrawal by Subject|0|||
126020899|NCT05568615|453373078|FG000|Overall Study|Death|1|||
126020900|NCT05568615|453373078|FG000|Overall Study|Physician Decision|1|||
126020901|NCT03529110|453373079|FG000|Overall Study|Progressive Disease|66|||
126020902|NCT03529110|453373080|FG001|Overall Study|Progressive Disease|158|||
126020903|NCT03529110|453373079|FG000|Overall Study|Clinical Progression|4|||
126020904|NCT03529110|453373080|FG001|Overall Study|Clinical Progression|12|||
126020905|NCT03529110|453373079|FG000|Overall Study|Adverse Event|35|||
126020906|NCT03529110|453373080|FG001|Overall Study|Adverse Event|17|||
126020907|NCT03529110|453373079|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
126020908|NCT03529110|453373080|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
126020909|NCT03529110|453373079|FG000|Overall Study|Lack of Efficacy|3|||
126020910|NCT03529110|453373080|FG001|Overall Study|Lack of Efficacy|3|||
126020911|NCT03529110|453373079|FG000|Overall Study|Physician Decision|2|||
126020912|NCT03529110|453373080|FG001|Overall Study|Physician Decision|8|||
126020913|NCT03529110|453373079|FG000|Overall Study|Miscellaneous|2|||
126020914|NCT03529110|453373080|FG001|Overall Study|Miscellaneous|5|||
126020915|NCT03237481|453373083|FG000|Overall Study|Lost to Follow-up|1|||
126020916|NCT03237481|453373084|FG001|Overall Study|Lost to Follow-up|0|||
126020917|NCT03237481|453373085|FG002|Overall Study|Lost to Follow-up|0|||
126020918|NCT03237481|453373083|FG000|Overall Study|Protocol Violation|1|||
126020919|NCT03237481|453373084|FG001|Overall Study|Protocol Violation|0|||
126020920|NCT03237481|453373085|FG002|Overall Study|Protocol Violation|0|||
126020921|NCT03237481|453373083|FG000|Overall Study|Withdrawal by Subject|3|||
126020922|NCT03237481|453373084|FG001|Overall Study|Withdrawal by Subject|2|||
126020923|NCT03237481|453373085|FG002|Overall Study|Withdrawal by Subject|1|||
126020924|NCT02980276|453373089|FG000|Overall Study|Withdrawal by Subject|4|||
126020925|NCT02980276|453373090|FG001|Overall Study|Withdrawal by Subject|4|||
126020926|NCT02980276|453373089|FG000|Overall Study|Physician Decision|0|||
126020927|NCT02980276|453373090|FG001|Overall Study|Physician Decision|1|||
126020928|NCT02980276|453373089|FG000|Overall Study|Lost to Follow-up|18|||
126020929|NCT02980276|453373090|FG001|Overall Study|Lost to Follow-up|18|||
126020930|NCT02980276|453373089|FG000|Overall Study|Death|1|||
126020931|NCT02980276|453373090|FG001|Overall Study|Death|0|||
126020932|NCT02980276|453373089|FG000|Overall Study|Miscellaneous other|10|||
126020933|NCT02980276|453373090|FG001|Overall Study|Miscellaneous other|4|||
126020934|NCT04139668|453373091|FG000|Overall Study|Withdrawal by Subject|1|||
126020935|NCT03025789|453373092|FG000|Overall Study|Lack of Efficacy|6|||
126020936|NCT03025789|453373093|FG001|Overall Study|Lack of Efficacy|1|||
126092984|NCT00128102|453634457|FG000|Overall Study|Physician Decision|3|||
126092985|NCT00128102|453634458|FG001|Overall Study|Physician Decision|3|||
126092986|NCT00128102|453634457|FG000|Overall Study|Withdrawal by Subject|19|||
126092987|NCT00128102|453634458|FG001|Overall Study|Withdrawal by Subject|11|||
126092988|NCT00128102|453634457|FG000|Overall Study|Protocol Violation|2|||
126092989|NCT00128102|453634458|FG001|Overall Study|Protocol Violation|2|||
126092990|NCT01202903|453634460|FG000|Overall Study|Administrative Probelms|1|||
126020937|NCT03025789|453373092|FG000|Overall Study|Death|1|||
126020938|NCT03025789|453373093|FG001|Overall Study|Death|0|||
126020939|NCT03025789|453373092|FG000|Overall Study|Withdrawal by Subject|0|||
126020940|NCT03025789|453373093|FG001|Overall Study|Withdrawal by Subject|2|||
126020941|NCT04999085|453373095|FG000|Overall Study|Death|1|||
126020942|NCT03873779|453373097|FG000|Overall Study|Withdrawal by Subject|1|||
126020943|NCT03613740|453373100|FG000|Overall Study|Lost to Follow-up|1|||
126020944|NCT03613740|453373101|FG001|Overall Study|Lost to Follow-up|1|||
126020945|NCT04279574|453373102|FG000|Overall Study|Death|1|||
126020946|NCT04279574|453373103|FG001|Overall Study|Death|0|||
126020947|NCT04279574|453373102|FG000|Overall Study|lost restoration, tooth fracture|1|||
126092991|NCT01202903|453634461|FG001|Overall Study|Administrative Probelms|4|||
126092992|NCT01202903|453634460|FG000|Overall Study|Protocol Violation|0|||
126092993|NCT01202903|453634461|FG001|Overall Study|Protocol Violation|1|||
126092994|NCT01202903|453634460|FG000|Overall Study|Death|1|||
126092995|NCT01202903|453634461|FG001|Overall Study|Death|0|||
126092996|NCT01202903|453634460|FG000|Overall Study|Lost to Follow-up|1|||
126092997|NCT01202903|453634461|FG001|Overall Study|Lost to Follow-up|1|||
126092998|NCT01202903|453634460|FG000|Overall Study|Lack of Efficacy|1|||
126225218|NCT00686920|454115985|FG001|Overall Study|Withdrawal by Subject|5|||
126225219|NCT00686920|454115984|FG000|Overall Study|Protocol Violation|2|||
126225220|NCT00686920|454115985|FG001|Overall Study|Protocol Violation|1|||
126225221|NCT00686920|454115984|FG000|Overall Study|Adverse Event|10|||
126225222|NCT00686920|454115985|FG001|Overall Study|Adverse Event|2|||
126225223|NCT00686920|454115984|FG000|Overall Study|Personal Reason|0|||
126225224|NCT00686920|454115985|FG001|Overall Study|Personal Reason|1|||
126225225|NCT00686920|454115984|FG000|Overall Study|Lost to Follow-up|15|||
126225226|NCT00686920|454115985|FG001|Overall Study|Lost to Follow-up|3|||
126225227|NCT00686920|454115984|FG000|Overall Study|Moved to Another State|1|||
126225228|NCT00686920|454115985|FG001|Overall Study|Moved to Another State|0|||
126225229|NCT00686920|454115984|FG000|Overall Study|Transferred to Nursing Home|1|||
126092999|NCT01202903|453634461|FG001|Overall Study|Lack of Efficacy|3|||
126093000|NCT01202903|453634460|FG000|Overall Study|Adverse Event|3|||
126093001|NCT01202903|453634461|FG001|Overall Study|Adverse Event|3|||
126225230|NCT00686920|454115985|FG001|Overall Study|Transferred to Nursing Home|0|||
126225231|NCT00686920|454115984|FG000|Overall Study|Noncompliance|9|||
126225232|NCT00686920|454115985|FG001|Overall Study|Noncompliance|0|||
126225233|NCT00686920|454115984|FG000|Overall Study|Principal Investigator Decision|2|||
126225234|NCT00686920|454115985|FG001|Overall Study|Principal Investigator Decision|0|||
126225235|NCT01620983|454115988|FG000|Overall Study|Lost to Follow-up|8|||
126225236|NCT01620983|454115989|FG001|Overall Study|Lost to Follow-up|4|||
126225237|NCT01620983|454115990|FG002|Overall Study|Lost to Follow-up|9|||
126225238|NCT01620983|454115988|FG000|Overall Study|Withdrawal by Subject|6|||
126225239|NCT01620983|454115989|FG001|Overall Study|Withdrawal by Subject|8|||
126225240|NCT01620983|454115990|FG002|Overall Study|Withdrawal by Subject|1|||
126351609|NCT03421808|454577988|FG001|Overall Study|Protocol Violation|1|||
126351610|NCT00632359|454577991|FG000|Overall Study|Withdrawal by Subject|2|||
126020948|NCT04279574|453373103|FG001|Overall Study|lost restoration, tooth fracture|0|||
126020949|NCT04279574|453373102|FG000|Overall Study|Lost to Follow-up|0|||
126020950|NCT04279574|453373103|FG001|Overall Study|Lost to Follow-up|1|||
126020951|NCT04188379|453373104|FG000|Overall Study|Withdrawal by Subject|10|||
126225241|NCT01620983|454115988|FG000|Overall Study|Death|2|||
126225242|NCT01620983|454115989|FG001|Overall Study|Death|0|||
126225243|NCT01620983|454115990|FG002|Overall Study|Death|0|||
126225244|NCT01620983|454115988|FG000|Overall Study|Physician Decision|3|||
126351611|NCT06717399|454577992|FG000|Overall Study|Death|1|||
126351612|NCT02180867|454577995|FG000|Overall Study|Adverse Event|3|||
126351613|NCT02180867|454577996|FG001|Overall Study|Adverse Event|4|||
126351614|NCT02180867|454577997|FG002|Overall Study|Adverse Event|1|||
126351615|NCT02180867|454577998|FG003|Overall Study|Adverse Event|5|||
126020952|NCT04188379|453373105|FG001|Overall Study|Withdrawal by Subject|3|||
126020953|NCT04188379|453373104|FG000|Overall Study|Physician Decision|0|||
126020954|NCT04188379|453373105|FG001|Overall Study|Physician Decision|1|||
126020955|NCT04188379|453373104|FG000|Overall Study|Adverse Event|3|||
126020956|NCT04188379|453373105|FG001|Overall Study|Adverse Event|1|||
126020957|NCT04188379|453373104|FG000|Overall Study|Pregnancy|1|||
126020958|NCT04188379|453373105|FG001|Overall Study|Pregnancy|0|||
126093002|NCT01202903|453634460|FG000|Overall Study|Withdrawal by Subject|4|||
126093003|NCT01202903|453634461|FG001|Overall Study|Withdrawal by Subject|4|||
126093004|NCT01302080|453634462|FG000|Overall Study|Withdrew Consent|92|||
126093005|NCT01302080|453634463|FG001|Overall Study|Withdrew Consent|39|||
126225245|NCT01620983|454115989|FG001|Overall Study|Physician Decision|10|||
126225246|NCT01620983|454115990|FG002|Overall Study|Physician Decision|5|||
126225247|NCT00545233|454115992|FG000|Overall Study|Adverse Event|10|||
126225248|NCT00545233|454115993|FG001|Overall Study|Adverse Event|5|||
126225249|NCT00545233|454115992|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
126225250|NCT00545233|454115993|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126225251|NCT00545233|454115992|FG000|Overall Study|Protocol Violation|2|||
126225252|NCT00545233|454115993|FG001|Overall Study|Protocol Violation|0|||
126225253|NCT00545233|454115992|FG000|Overall Study|Refused Treatment|9|||
126225254|NCT00545233|454115993|FG001|Overall Study|Refused Treatment|7|||
126225255|NCT00545233|454115992|FG000|Overall Study|Failure to Return|4|||
126225256|NCT00545233|454115993|FG001|Overall Study|Failure to Return|6|||
126225257|NCT00545233|454115992|FG000|Overall Study|Insufficient response|14|||
126225258|NCT00545233|454115993|FG001|Overall Study|Insufficient response|15|||
126225259|NCT00545233|454115992|FG000|Overall Study|Physician Decision|2|||
126225260|NCT00545233|454115993|FG001|Overall Study|Physician Decision|1|||
126225261|NCT01208402|454115994|FG000|Overall Study|Withdrawal by Subject|1|||
126225262|NCT01208402|454115995|FG001|Overall Study|Withdrawal by Subject|0|||
126225263|NCT00446654|454115996|FG000|Overall Study|Withdrawal by Subject|1|||
126225264|NCT00446654|454115997|FG001|Overall Study|Withdrawal by Subject|0|||
126225265|NCT00446654|454115996|FG000|Overall Study|Adverse Event|1|||
126225266|NCT00446654|454115997|FG001|Overall Study|Adverse Event|0|||
126225267|NCT03811249|454115998|FG000|Overall Study|Withdrawal by Subject|44|||
126225268|NCT03811249|454115998|FG000|Overall Study|Missed Visit|24|||
126225269|NCT01504867|454116002|FG000|Overall Study|Inclusion criteria not met|2|||
126225270|NCT01504867|454116003|FG001|Overall Study|Inclusion criteria not met|2|||
126225271|NCT01504867|454116002|FG000|Overall Study|Consent revoked|5|||
126225272|NCT01504867|454116003|FG001|Overall Study|Consent revoked|1|||
126225273|NCT02175966|454116005|FG000|Follow-up Period|Lack of Efficacy|10|||
126225274|NCT02175966|454116006|FG001|Follow-up Period|Lack of Efficacy|6|||
126225275|NCT01154153|454116007|FG000|Overall Study|Poor compliance to protocol|2|||
126225276|NCT01154153|454116008|FG001|Overall Study|Poor compliance to protocol|0|||
126225277|NCT01154153|454116007|FG000|Overall Study|Unable to use labs|2|||
126225278|NCT01154153|454116008|FG001|Overall Study|Unable to use labs|3|||
126225279|NCT01154153|454116007|FG000|Overall Study|Withdrew consent|1|||
126225280|NCT01154153|454116008|FG001|Overall Study|Withdrew consent|0|||
126225281|NCT00210626|454116009|FG000|Overall Study|Adverse Event|1|||
126225282|NCT00210626|454116010|FG001|Overall Study|Adverse Event|2|||
126225283|NCT00210626|454116009|FG000|Overall Study|Protocol Violation|1|||
126225284|NCT00210626|454116010|FG001|Overall Study|Protocol Violation|5|||
126225285|NCT00210626|454116009|FG000|Overall Study|Lost to Follow-up|11|||
126225286|NCT00210626|454116010|FG001|Overall Study|Lost to Follow-up|11|||
126225287|NCT00210626|454116009|FG000|Overall Study|Death|1|||
126225288|NCT00210626|454116010|FG001|Overall Study|Death|0|||
126225289|NCT00210626|454116009|FG000|Overall Study|Withdrawal by Subject|29|||
126225290|NCT00210626|454116010|FG001|Overall Study|Withdrawal by Subject|20|||
126225291|NCT00210626|454116009|FG000|Overall Study|Physician Decision|0|||
126225292|NCT00210626|454116010|FG001|Overall Study|Physician Decision|2|||
126225293|NCT00210626|454116009|FG000|Overall Study|Sponser Request|1|||
126225294|NCT00210626|454116010|FG001|Overall Study|Sponser Request|0|||
126225295|NCT00210626|454116009|FG000|Overall Study|Other|4|||
126225296|NCT00210626|454116010|FG001|Overall Study|Other|5|||
126225297|NCT01227668|454116011|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
126225298|NCT01227668|454116012|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
126225299|NCT01227668|454116011|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
126225300|NCT01227668|454116012|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
126225301|NCT01227668|454116011|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
126225302|NCT01227668|454116012|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
126225303|NCT01227668|454116011|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
126225304|NCT01227668|454116012|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
126020959|NCT04188379|453373104|FG000|Overall Study|Lack of Efficacy|8|||
126020960|NCT04188379|453373105|FG001|Overall Study|Lack of Efficacy|5|||
126020961|NCT04188379|453373104|FG000|Overall Study|Other|0|||
126020962|NCT04188379|453373105|FG001|Overall Study|Other|3|||
126020963|NCT02566902|453373109|FG000|Overall Study|Protocol Violation|2|||
126020964|NCT02566902|453373110|FG001|Overall Study|Protocol Violation|1|||
126020965|NCT02411084|453373111|FG000|Overall Study|Lack of Efficacy|6|||
126020966|NCT02411084|453373112|FG001|Overall Study|Lack of Efficacy|3|||
126225305|NCT01227668|454116011|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
126225306|NCT01227668|454116012|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
126225307|NCT01227668|454116011|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
126225308|NCT01227668|454116012|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
126225309|NCT01227668|454116011|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
126225310|NCT01227668|454116012|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
126225311|NCT01227668|454116011|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
126225312|NCT01227668|454116012|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
126225313|NCT01227668|454116011|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
126225314|NCT01227668|454116012|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
126225315|NCT01227668|454116011|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
126225316|NCT01227668|454116012|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
126225317|NCT01227668|454116011|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
126225318|NCT01227668|454116012|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
126225319|NCT01227668|454116011|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
126225320|NCT01227668|454116012|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
126225321|NCT02473510|454116013|FG000|Overall Study|Lost to Follow-up|1|||
126225322|NCT02473510|454116014|FG001|Overall Study|Lost to Follow-up|2|||
126225323|NCT01306253|454116015|FG000|Overall Study|Lost to Follow-up|1|||
126225324|NCT01306253|454116016|FG001|Overall Study|Lost to Follow-up|1|||
126225325|NCT02280356|454116020|FG000|Overall Study|Not Treated|2|||
126225326|NCT02280356|454116020|FG000|Overall Study|Withdrawal by Subject|1|||
126225327|NCT02280356|454116020|FG000|Overall Study|Not evaluable|2|||
126225328|NCT01086215|454116021|FG000|Overall Study|Death|14|||
126225329|NCT01086215|454116022|FG001|Overall Study|Death|8|||
126225330|NCT01086215|454116023|FG002|Overall Study|Death|8|||
126225331|NCT01086215|454116024|FG003|Overall Study|Death|1|||
126225332|NCT01086215|454116021|FG000|Overall Study|Lost to Follow-up|22|||
126225333|NCT01086215|454116022|FG001|Overall Study|Lost to Follow-up|39|||
126225334|NCT01086215|454116023|FG002|Overall Study|Lost to Follow-up|18|||
126225335|NCT01086215|454116024|FG003|Overall Study|Lost to Follow-up|2|||
126225336|NCT00408876|454116025|FG000|Overall Study|Adverse Event|9|||
126225337|NCT00408876|454116026|FG001|Overall Study|Adverse Event|17|||
126225338|NCT00408876|454116027|FG002|Overall Study|Adverse Event|27|||
126225339|NCT00408876|454116028|FG003|Overall Study|Adverse Event|10|||
126225340|NCT00408876|454116025|FG000|Overall Study|Withdrawal by Subject|3|||
126225341|NCT00408876|454116026|FG001|Overall Study|Withdrawal by Subject|6|||
126225342|NCT00408876|454116027|FG002|Overall Study|Withdrawal by Subject|6|||
126225343|NCT00408876|454116028|FG003|Overall Study|Withdrawal by Subject|14|||
126225344|NCT00408876|454116025|FG000|Overall Study|Lack of Efficacy|2|||
126225345|NCT00408876|454116026|FG001|Overall Study|Lack of Efficacy|4|||
126225346|NCT00408876|454116027|FG002|Overall Study|Lack of Efficacy|5|||
126225347|NCT00408876|454116028|FG003|Overall Study|Lack of Efficacy|6|||
126225348|NCT00408876|454116025|FG000|Overall Study|Lost to Follow-up|1|||
126225349|NCT00408876|454116026|FG001|Overall Study|Lost to Follow-up|6|||
126225350|NCT00408876|454116027|FG002|Overall Study|Lost to Follow-up|5|||
126225351|NCT00408876|454116028|FG003|Overall Study|Lost to Follow-up|2|||
126225352|NCT00408876|454116025|FG000|Overall Study|Protocol Violation|0|||
126225353|NCT00408876|454116026|FG001|Overall Study|Protocol Violation|3|||
126225354|NCT00408876|454116027|FG002|Overall Study|Protocol Violation|4|||
126225355|NCT00408876|454116028|FG003|Overall Study|Protocol Violation|3|||
126225356|NCT00408876|454116025|FG000|Overall Study|Physician Decision|1|||
126225357|NCT00408876|454116026|FG001|Overall Study|Physician Decision|0|||
126225358|NCT00408876|454116027|FG002|Overall Study|Physician Decision|3|||
126225359|NCT00408876|454116028|FG003|Overall Study|Physician Decision|0|||
126225360|NCT02006147|454116029|FG000|Overall Study|Protocol Violation|1|||
126351616|NCT02180867|454577999|FG004|Overall Study|Adverse Event|0|||
126351617|NCT02180867|454578000|FG005|Overall Study|Adverse Event|0|||
126351618|NCT02180867|454578001|FG006|Overall Study|Adverse Event|0|||
126351619|NCT02180867|454577995|FG000|Overall Study|Death|0|||
126351620|NCT02180867|454577996|FG001|Overall Study|Death|0|||
126351621|NCT02180867|454577997|FG002|Overall Study|Death|0|||
126351622|NCT02180867|454577998|FG003|Overall Study|Death|0|||
126225361|NCT02006147|454116030|FG001|Overall Study|Protocol Violation|1|||
126225362|NCT02006147|454116031|FG002|Overall Study|Protocol Violation|0|||
126225363|NCT02006147|454116032|FG003|Overall Study|Protocol Violation|0|||
126351623|NCT02180867|454577999|FG004|Overall Study|Death|1|||
126351624|NCT02180867|454578000|FG005|Overall Study|Death|0|||
126225364|NCT02006147|454116029|FG000|Overall Study|Withdrawal by Subject|0|||
126225365|NCT02006147|454116030|FG001|Overall Study|Withdrawal by Subject|1|||
126225366|NCT02006147|454116031|FG002|Overall Study|Withdrawal by Subject|0|||
126225367|NCT02006147|454116032|FG003|Overall Study|Withdrawal by Subject|0|||
126225368|NCT02006147|454116029|FG000|Overall Study|Withdrawal by Sponsor|1|||
126225369|NCT02006147|454116030|FG001|Overall Study|Withdrawal by Sponsor|0|||
126225370|NCT02006147|454116031|FG002|Overall Study|Withdrawal by Sponsor|0|||
126225371|NCT02006147|454116032|FG003|Overall Study|Withdrawal by Sponsor|0|||
126351625|NCT02180867|454578001|FG006|Overall Study|Death|0|||
126225372|NCT03361956|454116033|FG000|Overall Study|Adverse Event|1|||
126225373|NCT03361956|454116034|FG001|Overall Study|Adverse Event|0|||
126225374|NCT03361956|454116035|FG002|Overall Study|Adverse Event|1|||
126225375|NCT03361956|454116036|FG003|Overall Study|Adverse Event|1|||
126225376|NCT03361956|454116037|FG004|Overall Study|Adverse Event|0|||
126225377|NCT03361956|454116033|FG000|Overall Study|Other|0|||
126225378|NCT03361956|454116034|FG001|Overall Study|Other|0|||
126225379|NCT03361956|454116035|FG002|Overall Study|Other|0|||
126225380|NCT03361956|454116036|FG003|Overall Study|Other|1|||
126225381|NCT03361956|454116037|FG004|Overall Study|Other|0|||
126225382|NCT03361956|454116033|FG000|Overall Study|Withdrawal by Subject|2|||
126225383|NCT03361956|454116034|FG001|Overall Study|Withdrawal by Subject|2|||
126225384|NCT03361956|454116035|FG002|Overall Study|Withdrawal by Subject|2|||
126225385|NCT03361956|454116036|FG003|Overall Study|Withdrawal by Subject|0|||
126225386|NCT03361956|454116037|FG004|Overall Study|Withdrawal by Subject|3|||
126225387|NCT03361956|454116033|FG000|Overall Study|Disease Relapse|0|||
126225388|NCT03361956|454116034|FG001|Overall Study|Disease Relapse|0|||
126225389|NCT03361956|454116035|FG002|Overall Study|Disease Relapse|1|||
126225390|NCT03361956|454116036|FG003|Overall Study|Disease Relapse|0|||
126225391|NCT03361956|454116037|FG004|Overall Study|Disease Relapse|0|||
126225392|NCT03361956|454116033|FG000|Overall Study|Physician Decision|0|||
126225393|NCT03361956|454116034|FG001|Overall Study|Physician Decision|2|||
126225394|NCT03361956|454116035|FG002|Overall Study|Physician Decision|0|||
126225395|NCT03361956|454116036|FG003|Overall Study|Physician Decision|1|||
126225396|NCT03361956|454116037|FG004|Overall Study|Physician Decision|0|||
126225397|NCT03361956|454116033|FG000|Overall Study|Lost to Follow-up|0|||
126225398|NCT03361956|454116034|FG001|Overall Study|Lost to Follow-up|0|||
126225399|NCT03361956|454116035|FG002|Overall Study|Lost to Follow-up|1|||
126225400|NCT03361956|454116036|FG003|Overall Study|Lost to Follow-up|1|||
126225401|NCT03361956|454116037|FG004|Overall Study|Lost to Follow-up|2|||
126225402|NCT00871728|454116043|FG000|Overall Study|Adverse Event|1|||
126225403|NCT00871728|454116043|FG000|Overall Study|Protocol Violation|7|||
126225404|NCT00871728|454116043|FG000|Overall Study|Lost to Follow-up|2|||
126225405|NCT00871728|454116043|FG000|Overall Study|Failed to Visit Hospital|4|||
126225406|NCT00871728|454116043|FG000|Overall Study|Participant Non-compliance|1|||
126225407|NCT00871728|454116043|FG000|Overall Study|Withdrawal of Informed Consent|5|||
126225408|NCT04147715|454116044|FG000|Overall Study|Adverse Event|0|||
126225409|NCT04147715|454116045|FG001|Overall Study|Adverse Event|0|||
126225410|NCT04147715|454116046|FG002|Overall Study|Adverse Event|0|||
126225411|NCT04147715|454116047|FG003|Overall Study|Adverse Event|0|||
126225412|NCT04147715|454116048|FG004|Overall Study|Adverse Event|0|||
126093006|NCT01302080|453634462|FG000|Overall Study|Patient/Family Moved|28|||
126093007|NCT01302080|453634463|FG001|Overall Study|Patient/Family Moved|3|||
126225413|NCT04147715|454116049|FG005|Overall Study|Adverse Event|0|||
126225414|NCT04147715|454116050|FG006|Overall Study|Adverse Event|0|||
126225415|NCT04147715|454116051|FG007|Overall Study|Adverse Event|2|||
126225416|NCT04147715|454116052|FG008|Overall Study|Adverse Event|1|||
126225417|NCT04147715|454116053|FG009|Overall Study|Adverse Event|0|||
126225418|NCT04147715|454116054|FG010|Overall Study|Adverse Event|0|||
126225419|NCT04147715|454116055|FG011|Overall Study|Adverse Event|0|||
126225420|NCT01626859|454116056|FG000|Overall Study|Adverse Event|1|||
126225421|NCT01626859|454116057|FG001|Overall Study|Adverse Event|3|||
126225422|NCT01626859|454116058|FG002|Overall Study|Adverse Event|2|||
126225423|NCT01626859|454116056|FG000|Overall Study|Physician Decision|0|||
126225424|NCT01626859|454116057|FG001|Overall Study|Physician Decision|1|||
126225425|NCT01626859|454116058|FG002|Overall Study|Physician Decision|0|||
126225426|NCT01626859|454116056|FG000|Overall Study|Withdrawal by Subject|1|||
126225427|NCT01626859|454116057|FG001|Overall Study|Withdrawal by Subject|4|||
126225428|NCT01626859|454116058|FG002|Overall Study|Withdrawal by Subject|2|||
126225429|NCT02629965|454116059|FG000|Period 1|Adverse Event|1|||
126225430|NCT02629965|454116060|FG001|Period 1|Adverse Event|0|||
126225431|NCT02629965|454116059|FG000|Period 1|Unexpected worsening of disease|2|||
126225432|NCT02629965|454116060|FG001|Period 1|Unexpected worsening of disease|0|||
126225433|NCT02629965|454116059|FG000|Period 1|Other than listed above|1|||
126225434|NCT02629965|454116060|FG001|Period 1|Other than listed above|2|||
126225435|NCT02629965|454116059|FG000|Period 2|Adverse Event|1|||
126225436|NCT02629965|454116060|FG001|Period 2|Adverse Event|0|||
126225437|NCT00905489|454116063|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
126225438|NCT00905489|454116063|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
126225439|NCT00905489|454116063|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
126225440|NCT00895583|454116071|FG000|Overall Study|Adverse Event|28|||
126225441|NCT00895583|454116072|FG001|Overall Study|Adverse Event|4|||
126225442|NCT00895583|454116071|FG000|Overall Study|Death|2|||
126225443|NCT00895583|454116072|FG001|Overall Study|Death|1|||
126225444|NCT00895583|454116071|FG000|Overall Study|Physician Decision|3|||
126225445|NCT00895583|454116072|FG001|Overall Study|Physician Decision|1|||
126225446|NCT00895583|454116071|FG000|Overall Study|Lost to Follow-up|1|||
126225447|NCT00895583|454116072|FG001|Overall Study|Lost to Follow-up|3|||
126225448|NCT00895583|454116071|FG000|Overall Study|Protocol Violation|1|||
126225449|NCT00895583|454116072|FG001|Overall Study|Protocol Violation|0|||
126225450|NCT00895583|454116071|FG000|Overall Study|Withdrawal by Subject|4|||
126225451|NCT00895583|454116072|FG001|Overall Study|Withdrawal by Subject|2|||
126225452|NCT00895583|454116071|FG000|Overall Study|Lack of Efficacy|5|||
126225453|NCT00895583|454116072|FG001|Overall Study|Lack of Efficacy|0|||
126225454|NCT00895583|454116071|FG000|Overall Study|Other|0|||
126225455|NCT00895583|454116072|FG001|Overall Study|Other|1|||
126225456|NCT00616928|454116073|FG000|Overall Study|Adverse Event|6|||
126225457|NCT00616928|454116074|FG001|Overall Study|Adverse Event|3|||
126225458|NCT00616928|454116075|FG002|Overall Study|Adverse Event|2|||
126225459|NCT00616928|454116076|FG003|Overall Study|Adverse Event|2|||
126351626|NCT02180867|454577995|FG000|Overall Study|Lack of Efficacy|0|||
126351627|NCT02180867|454577996|FG001|Overall Study|Lack of Efficacy|2|||
126351628|NCT02180867|454577997|FG002|Overall Study|Lack of Efficacy|0|||
126351629|NCT02180867|454577998|FG003|Overall Study|Lack of Efficacy|1|||
126351630|NCT02180867|454577999|FG004|Overall Study|Lack of Efficacy|6|||
126351631|NCT02180867|454578000|FG005|Overall Study|Lack of Efficacy|0|||
126351632|NCT02180867|454578001|FG006|Overall Study|Lack of Efficacy|1|||
126351633|NCT02180867|454577995|FG000|Overall Study|Physician Decision|1|||
126351634|NCT02180867|454577996|FG001|Overall Study|Physician Decision|3|||
126351635|NCT02180867|454577997|FG002|Overall Study|Physician Decision|1|||
126351636|NCT02180867|454577998|FG003|Overall Study|Physician Decision|10|||
126351637|NCT02180867|454577999|FG004|Overall Study|Physician Decision|9|||
126351638|NCT02180867|454578000|FG005|Overall Study|Physician Decision|3|||
126351639|NCT02180867|454578001|FG006|Overall Study|Physician Decision|4|||
126351640|NCT02180867|454577995|FG000|Overall Study|Withdrawal by Subject|0|||
126351641|NCT02180867|454577996|FG001|Overall Study|Withdrawal by Subject|0|||
126351642|NCT02180867|454577997|FG002|Overall Study|Withdrawal by Subject|0|||
126351643|NCT02180867|454577998|FG003|Overall Study|Withdrawal by Subject|1|||
126351644|NCT02180867|454577999|FG004|Overall Study|Withdrawal by Subject|1|||
126351645|NCT02180867|454578000|FG005|Overall Study|Withdrawal by Subject|0|||
126351646|NCT02180867|454578001|FG006|Overall Study|Withdrawal by Subject|0|||
126351647|NCT02180867|454577995|FG000|Overall Study|Ineligible|1|||
126351648|NCT02180867|454577996|FG001|Overall Study|Ineligible|2|||
126351649|NCT02180867|454577997|FG002|Overall Study|Ineligible|0|||
126351650|NCT02180867|454577998|FG003|Overall Study|Ineligible|3|||
126351651|NCT02180867|454577999|FG004|Overall Study|Ineligible|5|||
126351652|NCT02180867|454578000|FG005|Overall Study|Ineligible|0|||
126351653|NCT02180867|454578001|FG006|Overall Study|Ineligible|0|||
126351654|NCT02180867|454577995|FG000|Overall Study|Repeat Eligibility Studies|0|||
126351655|NCT02180867|454577996|FG001|Overall Study|Repeat Eligibility Studies|0|||
126225460|NCT00616928|454116073|FG000|Overall Study|Other|51|||
126351656|NCT02180867|454577997|FG002|Overall Study|Repeat Eligibility Studies|0|||
126351657|NCT02180867|454577998|FG003|Overall Study|Repeat Eligibility Studies|0|||
126225461|NCT00616928|454116074|FG001|Overall Study|Other|8|||
126225462|NCT00616928|454116075|FG002|Overall Study|Other|15|||
126225463|NCT00616928|454116076|FG003|Overall Study|Other|5|||
126225464|NCT00616928|454116073|FG000|Overall Study|Lost to Follow-up|5|||
126225465|NCT00616928|454116074|FG001|Overall Study|Lost to Follow-up|7|||
126225466|NCT00616928|454116075|FG002|Overall Study|Lost to Follow-up|0|||
126225467|NCT00616928|454116076|FG003|Overall Study|Lost to Follow-up|0|||
126225468|NCT04535583|454116077|FG000|Overall Study|Lost to Follow-up|1|||
126225469|NCT04535583|454116077|FG000|Overall Study|Physician Decision|1|||
126225470|NCT04535583|454116077|FG000|Overall Study|Withdrawal by Subject|1|||
126225471|NCT04049552|454116079|FG000|Overall Study|Lost to Follow-up|1|||
126225472|NCT02196506|454116084|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
126225473|NCT02196506|454116085|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
126225474|NCT02196506|454116086|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
126225475|NCT02196506|454116087|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
126225476|NCT02196506|454116084|FG000|Phase A|Withdrawal by Subject|34|||
126225477|NCT02196506|454116085|FG001|Phase A|Withdrawal by Subject|0|||
126225478|NCT02196506|454116086|FG002|Phase A|Withdrawal by Subject|0|||
126225479|NCT02196506|454116087|FG003|Phase A|Withdrawal by Subject|0|||
126225480|NCT02196506|454116084|FG000|Phase A|Adverse Event|22|||
126225481|NCT02196506|454116085|FG001|Phase A|Adverse Event|0|||
126225482|NCT02196506|454116086|FG002|Phase A|Adverse Event|0|||
126225483|NCT02196506|454116087|FG003|Phase A|Adverse Event|0|||
126225484|NCT02196506|454116084|FG000|Phase A|Lost to Follow-up|9|||
126225485|NCT02196506|454116085|FG001|Phase A|Lost to Follow-up|0|||
126225486|NCT02196506|454116086|FG002|Phase A|Lost to Follow-up|0|||
126225487|NCT02196506|454116087|FG003|Phase A|Lost to Follow-up|0|||
126225488|NCT02196506|454116084|FG000|Phase A|Protocol deviation|12|||
126225489|NCT02196506|454116085|FG001|Phase A|Protocol deviation|0|||
126225490|NCT02196506|454116086|FG002|Phase A|Protocol deviation|0|||
126225491|NCT02196506|454116087|FG003|Phase A|Protocol deviation|0|||
126225492|NCT02196506|454116084|FG000|Phase A|Participant withdrawn by investigator|10|||
126225493|NCT02196506|454116085|FG001|Phase A|Participant withdrawn by investigator|0|||
126225494|NCT02196506|454116086|FG002|Phase A|Participant withdrawn by investigator|0|||
126225495|NCT02196506|454116087|FG003|Phase A|Participant withdrawn by investigator|0|||
126225496|NCT02196506|454116084|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
126225497|NCT02196506|454116085|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
126225498|NCT02196506|454116086|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
126225499|NCT02196506|454116087|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
126225500|NCT02196506|454116084|FG000|Phase B|Lack of Efficacy|0|||
126225501|NCT02196506|454116085|FG001|Phase B|Lack of Efficacy|1|||
126225502|NCT02196506|454116086|FG002|Phase B|Lack of Efficacy|2|||
126225503|NCT02196506|454116087|FG003|Phase B|Lack of Efficacy|0|||
126225504|NCT02196506|454116084|FG000|Phase B|Withdrawal by Participant|0|||
126225505|NCT02196506|454116085|FG001|Phase B|Withdrawal by Participant|8|||
126225506|NCT02196506|454116086|FG002|Phase B|Withdrawal by Participant|1|||
126225507|NCT02196506|454116087|FG003|Phase B|Withdrawal by Participant|0|||
126225508|NCT02196506|454116084|FG000|Phase B|Adverse Event|0|||
126225509|NCT02196506|454116085|FG001|Phase B|Adverse Event|4|||
126225510|NCT02196506|454116086|FG002|Phase B|Adverse Event|1|||
126225511|NCT02196506|454116087|FG003|Phase B|Adverse Event|0|||
126225512|NCT02196506|454116084|FG000|Phase B|Lost to Follow-up|0|||
126225513|NCT02196506|454116085|FG001|Phase B|Lost to Follow-up|2|||
126225514|NCT02196506|454116086|FG002|Phase B|Lost to Follow-up|1|||
126225515|NCT02196506|454116087|FG003|Phase B|Lost to Follow-up|0|||
126351658|NCT02180867|454577999|FG004|Overall Study|Repeat Eligibility Studies|1|||
126351659|NCT02180867|454578000|FG005|Overall Study|Repeat Eligibility Studies|0|||
126351660|NCT02180867|454578001|FG006|Overall Study|Repeat Eligibility Studies|0|||
126351661|NCT02180867|454577995|FG000|Overall Study|Refusal of further protocol therapy|1|||
126351662|NCT02180867|454577996|FG001|Overall Study|Refusal of further protocol therapy|0|||
126351663|NCT02180867|454577997|FG002|Overall Study|Refusal of further protocol therapy|2|||
126351664|NCT02180867|454577998|FG003|Overall Study|Refusal of further protocol therapy|6|||
126351665|NCT02180867|454577999|FG004|Overall Study|Refusal of further protocol therapy|4|||
126351666|NCT02180867|454578000|FG005|Overall Study|Refusal of further protocol therapy|0|||
126351667|NCT02180867|454578001|FG006|Overall Study|Refusal of further protocol therapy|0|||
126351668|NCT02337686|454578002|FG000|Overall Study|Adverse Event|1|||
126351669|NCT00177671|454578867|FG000|Overall Study|Withdrawal by Subject|5|||
126351670|NCT00177671|454578868|FG001|Overall Study|Withdrawal by Subject|6|||
126351671|NCT00177671|454578867|FG000|Overall Study|medical complications|2|||
126351672|NCT00177671|454578868|FG001|Overall Study|medical complications|0|||
126351673|NCT00177671|454578867|FG000|Overall Study|Adverse Event|6|||
126351674|NCT00177671|454578868|FG001|Overall Study|Adverse Event|0|||
126351675|NCT00177671|454578867|FG000|Overall Study|Physician Decision|12|||
126351676|NCT00177671|454578868|FG001|Overall Study|Physician Decision|8|||
126351677|NCT02293499|454578869|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
126369552|NCT01497197|454650596|FG000|Overall Study|Protocol Violation|0|||
126225516|NCT02196506|454116084|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
126225517|NCT02196506|454116085|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
126225518|NCT02196506|454116086|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
126225519|NCT02196506|454116087|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
126225520|NCT02196506|454116084|FG000|Phase A+|Withdrawal by Participant|0|||
126225521|NCT02196506|454116085|FG001|Phase A+|Withdrawal by Participant|0|||
126225522|NCT02196506|454116086|FG002|Phase A+|Withdrawal by Participant|0|||
126225523|NCT02196506|454116087|FG003|Phase A+|Withdrawal by Participant|5|||
126225524|NCT02196506|454116084|FG000|Phase A+|Adverse Event|0|||
126225525|NCT02196506|454116085|FG001|Phase A+|Adverse Event|0|||
126225526|NCT02196506|454116086|FG002|Phase A+|Adverse Event|0|||
126225527|NCT02196506|454116087|FG003|Phase A+|Adverse Event|1|||
126225528|NCT02196506|454116084|FG000|Phase A+|Lost to Follow-up|0|||
126225529|NCT02196506|454116085|FG001|Phase A+|Lost to Follow-up|0|||
126225530|NCT02196506|454116086|FG002|Phase A+|Lost to Follow-up|0|||
126225531|NCT02196506|454116087|FG003|Phase A+|Lost to Follow-up|6|||
126225532|NCT02196506|454116084|FG000|Phase A+|Participant withdrawn by investigator|0|||
126225533|NCT02196506|454116085|FG001|Phase A+|Participant withdrawn by investigator|0|||
126225534|NCT02196506|454116086|FG002|Phase A+|Participant withdrawn by investigator|0|||
126225535|NCT02196506|454116087|FG003|Phase A+|Participant withdrawn by investigator|1|||
126225536|NCT01715415|454116088|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
126225537|NCT01715415|454116089|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
126225538|NCT01715415|454116088|FG000|Double-blind Treatment|Adverse Event|3|||
126225539|NCT01715415|454116089|FG001|Double-blind Treatment|Adverse Event|0|||
126225540|NCT01715415|454116088|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
126225541|NCT01715415|454116089|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
126225542|NCT01715415|454116088|FG000|Double-blind Treatment|Other|1|||
126225543|NCT01715415|454116089|FG001|Double-blind Treatment|Other|0|||
126225544|NCT01715415|454116088|FG000|Open-label Treatment|Adverse Event|0|||
126225545|NCT01715415|454116089|FG001|Open-label Treatment|Adverse Event|1|||
126225546|NCT01715415|454116088|FG000|Open-label Treatment|Subject Noncompliant|0|||
126225547|NCT01715415|454116089|FG001|Open-label Treatment|Subject Noncompliant|1|||
126225548|NCT01015612|454116090|FG000|Overall Study|Death|113|||
126225549|NCT01015612|454116090|FG000|Overall Study|Withdrawal by Subject|40|||
126225550|NCT00066807|454116091|FG000|Overall Study|Study was terminated early|14|||
126225551|NCT00066807|454116092|FG001|Overall Study|Study was terminated early|15|||
126225552|NCT05028751|454116093|FG000|Overall Study|Study Terminated by Sponsor|3|||
126225553|NCT05028751|454116094|FG001|Overall Study|Study Terminated by Sponsor|0|||
126225554|NCT05028751|454116095|FG002|Overall Study|Study Terminated by Sponsor|0|||
126225555|NCT05028751|454116096|FG003|Overall Study|Study Terminated by Sponsor|0|||
126225556|NCT05028751|454116093|FG000|Overall Study|Death|9|||
126225557|NCT05028751|454116094|FG001|Overall Study|Death|3|||
126225558|NCT05028751|454116095|FG002|Overall Study|Death|2|||
126225559|NCT05028751|454116096|FG003|Overall Study|Death|4|||
126225560|NCT05028751|454116093|FG000|Overall Study|Withdrawal by Subject|0|||
126225561|NCT05028751|454116094|FG001|Overall Study|Withdrawal by Subject|0|||
126225562|NCT05028751|454116095|FG002|Overall Study|Withdrawal by Subject|1|||
126225563|NCT05028751|454116096|FG003|Overall Study|Withdrawal by Subject|0|||
126225564|NCT05028751|454116093|FG000|Overall Study|Miscellaneous|2|||
126225565|NCT05028751|454116094|FG001|Overall Study|Miscellaneous|0|||
126225566|NCT05028751|454116095|FG002|Overall Study|Miscellaneous|0|||
126225567|NCT05028751|454116096|FG003|Overall Study|Miscellaneous|0|||
126225568|NCT03586830|454116097|FG000|Overall Study|Site terminated by Sponsor|1|||
126093008|NCT01302080|453634462|FG000|Overall Study|Lost to Follow-up|192|||
126093009|NCT01302080|453634463|FG001|Overall Study|Lost to Follow-up|93|||
126225569|NCT03586830|454116098|FG001|Overall Study|Site terminated by Sponsor|4|||
126225570|NCT03586830|454116099|FG002|Overall Study|Site terminated by Sponsor|3|||
126225571|NCT03586830|454116100|FG003|Overall Study|Site terminated by Sponsor|3|||
126225572|NCT03586830|454116097|FG000|Overall Study|Lost to Follow-up|0|||
126225573|NCT03586830|454116098|FG001|Overall Study|Lost to Follow-up|2|||
126225574|NCT03586830|454116099|FG002|Overall Study|Lost to Follow-up|2|||
126225575|NCT03586830|454116100|FG003|Overall Study|Lost to Follow-up|1|||
126225576|NCT03586830|454116097|FG000|Overall Study|Withdrawal by Subject|1|||
126225577|NCT03586830|454116098|FG001|Overall Study|Withdrawal by Subject|0|||
126225578|NCT03586830|454116099|FG002|Overall Study|Withdrawal by Subject|3|||
126225579|NCT03586830|454116100|FG003|Overall Study|Withdrawal by Subject|1|||
126225580|NCT04578548|454116101|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
126225581|NCT04578548|454116102|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
126225582|NCT04578548|454116101|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
126225583|NCT04578548|454116102|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
126225584|NCT04578548|454116101|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
126225585|NCT04578548|454116102|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
126225586|NCT04578548|454116101|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
126225587|NCT04578548|454116102|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
126225588|NCT04578548|454116101|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
126225589|NCT04578548|454116102|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
126351678|NCT02293499|454578870|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
126225590|NCT04578548|454116101|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
126225591|NCT04578548|454116102|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
126225592|NCT00395083|454116105|FG000|Overall Study|Withdrawal by Subject|6|||
126225593|NCT00395083|454116106|FG001|Overall Study|Withdrawal by Subject|5|||
126225594|NCT00395083|454116105|FG000|Overall Study|Developed another disease|4|||
126225595|NCT00395083|454116106|FG001|Overall Study|Developed another disease|3|||
126225596|NCT00628745|454116107|FG000|Overall Study|Withdrawal by Subject|63|||
126225597|NCT00628745|454116108|FG001|Overall Study|Withdrawal by Subject|3|||
126020967|NCT02411084|453373111|FG000|Overall Study|Death|5|||
126020968|NCT02411084|453373112|FG001|Overall Study|Death|4|||
126020969|NCT02411084|453373111|FG000|Overall Study|Adverse Event|2|||
126020970|NCT02411084|453373112|FG001|Overall Study|Adverse Event|1|||
126020971|NCT02411084|453373111|FG000|Overall Study|Other reasons|0|||
126020972|NCT02411084|453373112|FG001|Overall Study|Other reasons|5|||
126020973|NCT03112174|453373115|FG000|Overall Study|Withdrawal by Subject|3|||
126020974|NCT03112174|453373116|FG001|Overall Study|Withdrawal by Subject|0|||
126020975|NCT03112174|453373117|FG002|Overall Study|Withdrawal by Subject|11|||
126020976|NCT03112174|453373118|FG003|Overall Study|Withdrawal by Subject|9|||
126020977|NCT03112174|453373119|FG004|Overall Study|Withdrawal by Subject|7|||
126020978|NCT03112174|453373115|FG000|Overall Study|Lost to Follow-up|1|||
126020979|NCT03112174|453373116|FG001|Overall Study|Lost to Follow-up|1|||
126020980|NCT03112174|453373117|FG002|Overall Study|Lost to Follow-up|2|||
126020981|NCT03112174|453373118|FG003|Overall Study|Lost to Follow-up|3|||
126020982|NCT03112174|453373119|FG004|Overall Study|Lost to Follow-up|2|||
126020983|NCT03112174|453373115|FG000|Overall Study|Death|8|||
126020984|NCT03112174|453373116|FG001|Overall Study|Death|3|||
126020985|NCT03112174|453373117|FG002|Overall Study|Death|67|||
126020986|NCT03112174|453373118|FG003|Overall Study|Death|73|||
126020987|NCT03112174|453373119|FG004|Overall Study|Death|18|||
126020988|NCT03112174|453373115|FG000|Overall Study|Other, Not Specified|1|||
126020989|NCT03112174|453373116|FG001|Overall Study|Other, Not Specified|0|||
126020990|NCT03112174|453373117|FG002|Overall Study|Other, Not Specified|1|||
126020991|NCT03112174|453373118|FG003|Overall Study|Other, Not Specified|2|||
126020992|NCT03112174|453373119|FG004|Overall Study|Other, Not Specified|0|||
126020993|NCT05773313|453373122|FG000|Overall Study|Lost to Follow-up|3|||
126020994|NCT02748317|453373123|FG000|Overall Study|Withdrawal by Subject|14|||
126020995|NCT02748317|453373123|FG000|Overall Study|Lost to Follow-up|8|||
126020996|NCT02748317|453373123|FG000|Overall Study|Death|1|||
126020997|NCT00332241|453373124|FG000|Overall Study|Lack of Efficacy|6|||
126020998|NCT00332241|453373125|FG001|Overall Study|Lack of Efficacy|1|||
126020999|NCT00332241|453373124|FG000|Overall Study|Adverse Event|3|||
126021000|NCT00332241|453373125|FG001|Overall Study|Adverse Event|5|||
126021001|NCT00332241|453373124|FG000|Overall Study|Withdrawal by Subject|2|||
126021002|NCT00332241|453373125|FG001|Overall Study|Withdrawal by Subject|1|||
126021003|NCT00332241|453373124|FG000|Overall Study|Lost to Follow-up|4|||
126021004|NCT00332241|453373125|FG001|Overall Study|Lost to Follow-up|1|||
126021005|NCT05262738|453373126|FG000|Overall Study|Withdrawal by Subject|1|||
126021006|NCT05262738|453373127|FG001|Overall Study|Withdrawal by Subject|0|||
126021007|NCT02374463|453373129|FG000|Overall Study|Withdrawal by Subject|3|||
126021008|NCT02374463|453373130|FG001|Overall Study|Withdrawal by Subject|3|||
126021009|NCT01471691|453373133|FG000|Overall Study|Lack of Efficacy|0|||
126021010|NCT01471691|453373134|FG001|Overall Study|Lack of Efficacy|1|||
126021011|NCT01808339|453373135|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126021012|NCT01808339|453373136|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126021013|NCT01808339|453373137|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126021014|NCT01808339|453373138|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
126021015|NCT01808339|453373139|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
126021016|NCT01808339|453373140|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
126021017|NCT01808339|453373135|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126021018|NCT01808339|453373136|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126351679|NCT02293499|454578871|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
126351680|NCT02293499|454578869|FG000|Intervention - Camp|Withdrawal by Subject|3|||
126351681|NCT02293499|454578870|FG001|Intervention - Camp|Withdrawal by Subject|6|||
126351682|NCT02293499|454578871|FG002|Intervention - Camp|Withdrawal by Subject|2|||
126351683|NCT02293499|454578869|FG000|Intervention - Camp|these are those not showing up at camp|24|||
126351684|NCT02293499|454578870|FG001|Intervention - Camp|these are those not showing up at camp|28|||
126351685|NCT02293499|454578871|FG002|Intervention - Camp|these are those not showing up at camp|4|||
126351686|NCT02293499|454578869|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
126351687|NCT02293499|454578870|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
126351688|NCT02293499|454578871|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
126351689|NCT02293499|454578869|FG000|3 Month Follow Up|Lost to Follow-up|14|||
126351690|NCT02293499|454578870|FG001|3 Month Follow Up|Lost to Follow-up|15|||
126351691|NCT02293499|454578871|FG002|3 Month Follow Up|Lost to Follow-up|6|||
126351692|NCT02293499|454578869|FG000|6 Month Follow Up|Lost to Follow-up|17|||
126351693|NCT02293499|454578870|FG001|6 Month Follow Up|Lost to Follow-up|27|||
126351694|NCT02293499|454578871|FG002|6 Month Follow Up|Lost to Follow-up|6|||
126351695|NCT02293499|454578869|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
126351696|NCT02293499|454578870|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
126351697|NCT02293499|454578871|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
126351698|NCT02293499|454578869|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
126351699|NCT02293499|454578870|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
126021019|NCT01808339|453373137|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126225598|NCT00628745|454116109|FG002|Overall Study|Withdrawal by Subject|9|||
126225599|NCT00628745|454116110|FG003|Overall Study|Withdrawal by Subject|2|||
126225600|NCT00628745|454116111|FG004|Overall Study|Withdrawal by Subject|69|||
126225601|NCT00628745|454116107|FG000|Overall Study|Does not meet inclusion criteria|0|||
126225602|NCT00628745|454116108|FG001|Overall Study|Does not meet inclusion criteria|12|||
126225603|NCT00628745|454116109|FG002|Overall Study|Does not meet inclusion criteria|0|||
126225604|NCT00628745|454116110|FG003|Overall Study|Does not meet inclusion criteria|0|||
126225605|NCT00628745|454116111|FG004|Overall Study|Does not meet inclusion criteria|18|||
126225606|NCT00628745|454116107|FG000|Overall Study|Participation in an interventional clinical trial|81|||
126225607|NCT00628745|454116108|FG001|Overall Study|Participation in an interventional clinical trial|4|||
126225608|NCT00628745|454116109|FG002|Overall Study|Participation in an interventional clinical trial|7|||
126225609|NCT00628745|454116110|FG003|Overall Study|Participation in an interventional clinical trial|0|||
126225610|NCT00628745|454116111|FG004|Overall Study|Participation in an interventional clinical trial|63|||
126225611|NCT00628745|454116107|FG000|Overall Study|Physician Decision|8|||
126225612|NCT00628745|454116108|FG001|Overall Study|Physician Decision|4|||
126225613|NCT00628745|454116109|FG002|Overall Study|Physician Decision|3|||
126225614|NCT00628745|454116110|FG003|Overall Study|Physician Decision|0|||
126225615|NCT00628745|454116111|FG004|Overall Study|Physician Decision|30|||
126225616|NCT00628745|454116107|FG000|Overall Study|Lost to Follow-up|109|||
126225617|NCT00628745|454116108|FG001|Overall Study|Lost to Follow-up|7|||
126225618|NCT00628745|454116109|FG002|Overall Study|Lost to Follow-up|7|||
126225619|NCT00628745|454116110|FG003|Overall Study|Lost to Follow-up|0|||
126225620|NCT00628745|454116111|FG004|Overall Study|Lost to Follow-up|498|||
126225621|NCT00628745|454116107|FG000|Overall Study|Death|197|||
126225622|NCT00628745|454116108|FG001|Overall Study|Death|81|||
126225623|NCT00628745|454116109|FG002|Overall Study|Death|12|||
126225624|NCT00628745|454116110|FG003|Overall Study|Death|4|||
126225625|NCT00628745|454116111|FG004|Overall Study|Death|939|||
126225626|NCT00628745|454116107|FG000|Overall Study|Participant transferred to another THAOS site|6|||
126225627|NCT00628745|454116108|FG001|Overall Study|Participant transferred to another THAOS site|0|||
126225628|NCT00628745|454116109|FG002|Overall Study|Participant transferred to another THAOS site|0|||
126225629|NCT00628745|454116110|FG003|Overall Study|Participant transferred to another THAOS site|0|||
126225630|NCT00628745|454116111|FG004|Overall Study|Participant transferred to another THAOS site|7|||
126225631|NCT00628745|454116107|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
126225632|NCT00628745|454116108|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
126225633|NCT00628745|454116109|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
126225634|NCT00628745|454116110|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
126225635|NCT00628745|454116111|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
126225636|NCT00628745|454116107|FG000|Overall Study|Site closure|152|||
126225637|NCT00628745|454116108|FG001|Overall Study|Site closure|146|||
126225638|NCT00628745|454116109|FG002|Overall Study|Site closure|6|||
126225639|NCT00628745|454116110|FG003|Overall Study|Site closure|8|||
126225640|NCT00628745|454116111|FG004|Overall Study|Site closure|691|||
126225641|NCT00628745|454116107|FG000|Overall Study|Duplicate participant|0|||
126225642|NCT00628745|454116108|FG001|Overall Study|Duplicate participant|0|||
126225643|NCT00628745|454116109|FG002|Overall Study|Duplicate participant|0|||
126225644|NCT00628745|454116110|FG003|Overall Study|Duplicate participant|0|||
126225645|NCT00628745|454116111|FG004|Overall Study|Duplicate participant|1|||
126225646|NCT00628745|454116107|FG000|Overall Study|Missing|4|||
126225647|NCT00628745|454116108|FG001|Overall Study|Missing|3|||
126225648|NCT00628745|454116109|FG002|Overall Study|Missing|0|||
126225649|NCT00628745|454116110|FG003|Overall Study|Missing|0|||
126225650|NCT00628745|454116111|FG004|Overall Study|Missing|10|||
126225651|NCT00628745|454116107|FG000|Overall Study|Othe reasons|987|||
126225652|NCT00628745|454116108|FG001|Overall Study|Othe reasons|373|||
126225653|NCT00628745|454116109|FG002|Overall Study|Othe reasons|105|||
126225654|NCT00628745|454116110|FG003|Overall Study|Othe reasons|1|||
126225655|NCT00628745|454116111|FG004|Overall Study|Othe reasons|1772|||
126225656|NCT03322462|454117536|FG000|Overall Study|Technical difficulties|2|||
126225657|NCT03322462|454117536|FG000|Overall Study|Other|1|||
126225658|NCT00598559|454117537|FG000|Overall Study|Adverse Event|11|||
126225659|NCT00598559|454117538|FG001|Overall Study|Adverse Event|7|||
126225660|NCT00598559|454117539|FG002|Overall Study|Adverse Event|0|||
126225661|NCT00598559|454117537|FG000|Overall Study|Withdrawal by Subject|2|||
126351700|NCT02293499|454578871|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
126225662|NCT00598559|454117538|FG001|Overall Study|Withdrawal by Subject|2|||
126225663|NCT00598559|454117539|FG002|Overall Study|Withdrawal by Subject|0|||
126225664|NCT00598559|454117537|FG000|Overall Study|Protocol Non-compliance|1|||
126225665|NCT00598559|454117538|FG001|Overall Study|Protocol Non-compliance|0|||
126225666|NCT00598559|454117539|FG002|Overall Study|Protocol Non-compliance|0|||
126225667|NCT00598559|454117537|FG000|Overall Study|Early discharge from hospital|9|||
126225668|NCT00598559|454117538|FG001|Overall Study|Early discharge from hospital|12|||
126225669|NCT00598559|454117539|FG002|Overall Study|Early discharge from hospital|3|||
126351701|NCT02293499|454578869|FG000|9 Month Follow Up|Lost to Follow-up|24|||
126351702|NCT02293499|454578870|FG001|9 Month Follow Up|Lost to Follow-up|28|||
126351703|NCT02293499|454578871|FG002|9 Month Follow Up|Lost to Follow-up|4|||
126351704|NCT02293499|454578869|FG000|12 Month Follow Up|Lost to Follow-up|26|||
126351705|NCT02293499|454578870|FG001|12 Month Follow Up|Lost to Follow-up|25|||
126351706|NCT02293499|454578871|FG002|12 Month Follow Up|Lost to Follow-up|6|||
126351707|NCT02293499|454578869|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
126351708|NCT02293499|454578870|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
126351709|NCT02293499|454578871|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
126351710|NCT02293499|454578869|FG000|15 Month Follow Up|Lost to Follow-up|22|||
126351711|NCT02293499|454578870|FG001|15 Month Follow Up|Lost to Follow-up|22|||
126351712|NCT02293499|454578871|FG002|15 Month Follow Up|Lost to Follow-up|7|||
126351713|NCT00690898|454578872|FG000|SCREENING|Screen failure|18|||
126351714|NCT00690898|454578872|FG000|TREATMENT|Adverse Event|3|||
126351715|NCT00690898|454578872|FG000|TREATMENT|Lack of Efficacy|18|||
126351716|NCT00690898|454578872|FG000|TREATMENT|Withdrawal by Subject|4|||
126351717|NCT00690898|454578872|FG000|TREATMENT|Other (not otherwise specified)|1|||
126351718|NCT01847209|454578875|FG000|Overall Study|Withdrawal by Subject|1|||
126351719|NCT01847209|454578875|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
126351720|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
126351721|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
126351722|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
126351723|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
126351724|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
126351725|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
126351726|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
126351727|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
126351728|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
126351729|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
126351730|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Death|0|||
126351731|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Death|0|||
126351732|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Death|1|||
126021020|NCT01808339|453373138|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126021021|NCT01808339|453373139|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126021022|NCT01808339|453373140|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126021023|NCT01808339|453373135|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126021024|NCT01808339|453373136|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126021025|NCT01808339|453373137|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
126021026|NCT01808339|453373138|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126021027|NCT01808339|453373139|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126021028|NCT01808339|453373140|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126021029|NCT02622568|453373143|FG000|Overall Study|Lost to Follow-up|5|||
126021030|NCT02622568|453373144|FG001|Overall Study|Lost to Follow-up|5|||
126225670|NCT00598559|454117537|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
126225671|NCT00598559|454117538|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
126225672|NCT00598559|454117539|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
126225673|NCT03381248|454117540|FG000|0-6 Months|Withdrawal by Subject|4|||
126225674|NCT03381248|454117541|FG001|0-6 Months|Withdrawal by Subject|1|||
126225675|NCT03381248|454117540|FG000|0-6 Months|Lost to Follow-up|3|||
126225676|NCT03381248|454117541|FG001|0-6 Months|Lost to Follow-up|2|||
126225677|NCT03381248|454117540|FG000|0-6 Months|Lack of Efficacy|1|||
126225678|NCT03381248|454117541|FG001|0-6 Months|Lack of Efficacy|0|||
126225679|NCT03381248|454117540|FG000|0-6 Months|Adverse Event|1|||
126225680|NCT03381248|454117541|FG001|0-6 Months|Adverse Event|0|||
126225681|NCT03381248|454117540|FG000|0-6 Months|Protocol Violation|2|||
126225682|NCT03381248|454117541|FG001|0-6 Months|Protocol Violation|1|||
126225683|NCT03381248|454117540|FG000|0-6 Months|Physician Decision|1|||
126225684|NCT03381248|454117541|FG001|0-6 Months|Physician Decision|0|||
126225685|NCT03381248|454117540|FG000|0-6 Months|Planning another procedure|1|||
126225686|NCT03381248|454117541|FG001|0-6 Months|Planning another procedure|2|||
126225687|NCT03381248|454117540|FG000|6-12 Months|Withdrawal by Subject|1|||
126225688|NCT03381248|454117541|FG001|6-12 Months|Withdrawal by Subject|3|||
126225689|NCT03381248|454117540|FG000|6-12 Months|Lost to Follow-up|0|||
126225690|NCT03381248|454117541|FG001|6-12 Months|Lost to Follow-up|2|||
126225691|NCT03381248|454117540|FG000|6-12 Months|Protocol Violation|3|||
126225692|NCT03381248|454117541|FG001|6-12 Months|Protocol Violation|2|||
126225693|NCT03381248|454117540|FG000|6-12 Months|Planning another procedure|6|||
126225694|NCT03381248|454117541|FG001|6-12 Months|Planning another procedure|2|||
126225695|NCT03381248|454117540|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
126225696|NCT03381248|454117541|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
126225697|NCT03381248|454117540|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
126351733|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Death|0|||
126351734|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Death|0|||
126351735|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
126225698|NCT03381248|454117541|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
126225699|NCT03381248|454117540|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
126225700|NCT03381248|454117541|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
126225701|NCT01466686|454117550|FG000|Overall Study|Withdrawal by Subject|1|||
126225702|NCT02180061|454117551|FG000|Overall Study|Adverse Event|4|||
126225703|NCT02180061|454117552|FG001|Overall Study|Adverse Event|2|||
126225704|NCT02180061|454117551|FG000|Overall Study|Clinical Progression|5|||
126225705|NCT02180061|454117552|FG001|Overall Study|Clinical Progression|1|||
126225706|NCT02180061|454117551|FG000|Overall Study|Progressive Disease|15|||
126225707|NCT02180061|454117552|FG001|Overall Study|Progressive Disease|5|||
126225708|NCT02180061|454117551|FG000|Overall Study|Physician Decision|1|||
126225709|NCT02180061|454117552|FG001|Overall Study|Physician Decision|0|||
126225710|NCT01405950|454117553|FG000|Overall Study|Withdrawal by Subject|1|||
126225711|NCT01405950|454117554|FG001|Overall Study|Withdrawal by Subject|0|||
126225712|NCT01405950|454117555|FG002|Overall Study|Withdrawal by Subject|0|||
126225713|NCT01405950|454117556|FG003|Overall Study|Withdrawal by Subject|0|||
126225714|NCT02410252|454117557|FG000|Overall Study|Withdrawal by Subject|4|||
126225715|NCT02410252|454117557|FG000|Overall Study|Physician Decision|2|||
126225716|NCT00112489|454117585|FG000|Overall Study|Refused further treatment|8|||
126225717|NCT00112489|454117585|FG000|Overall Study|Adverse Event|12|||
126225718|NCT00112489|454117585|FG000|Overall Study|Death|2|||
126225719|NCT00112489|454117585|FG000|Overall Study|Other, Not Specified|9|||
126225720|NCT00112489|454117585|FG000|Overall Study|Patient never treated|2|||
126225721|NCT00112489|454117585|FG000|Overall Study|Ineligible|7|||
126225722|NCT03907280|454117586|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
126225723|NCT03907280|454117587|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
126225724|NCT03907280|454117588|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
126225725|NCT05751629|454117589|FG000|Overall Study|Withdrawal by Subject|6|||
126225726|NCT05751629|454117589|FG000|Overall Study|Death|25|||
126225727|NCT05751629|454117589|FG000|Overall Study|Study Site Closed|9|||
126225728|NCT05751629|454117589|FG000|Overall Study|Physician Decision|1|||
126225729|NCT02231710|454117591|FG000|Overall Study|Physician Decision|1|||
126225730|NCT00295854|454117593|FG000|Overall Study|Adverse Event|7|||
126225731|NCT00295854|454117594|FG001|Overall Study|Adverse Event|7|||
126225732|NCT00295854|454117595|FG002|Overall Study|Adverse Event|6|||
126225733|NCT00295854|454117593|FG000|Overall Study|Protocol Violation|1|||
126225734|NCT00295854|454117594|FG001|Overall Study|Protocol Violation|1|||
126225735|NCT00295854|454117595|FG002|Overall Study|Protocol Violation|1|||
126225736|NCT00295854|454117593|FG000|Overall Study|Lost to Follow-up|2|||
126225737|NCT00295854|454117594|FG001|Overall Study|Lost to Follow-up|0|||
126225738|NCT00295854|454117595|FG002|Overall Study|Lost to Follow-up|1|||
126225739|NCT00295854|454117593|FG000|Overall Study|Withdrawal by Subject|3|||
126225740|NCT00295854|454117594|FG001|Overall Study|Withdrawal by Subject|7|||
126225741|NCT00295854|454117595|FG002|Overall Study|Withdrawal by Subject|4|||
126225742|NCT00295854|454117593|FG000|Overall Study|did not continue to meet criteria|1|||
126225743|NCT00295854|454117594|FG001|Overall Study|did not continue to meet criteria|1|||
126225744|NCT00295854|454117595|FG002|Overall Study|did not continue to meet criteria|2|||
126225745|NCT00295854|454117593|FG000|Overall Study|required a prohibited medication|1|||
126225746|NCT00295854|454117594|FG001|Overall Study|required a prohibited medication|0|||
126225747|NCT00295854|454117595|FG002|Overall Study|required a prohibited medication|0|||
126225748|NCT00295854|454117593|FG000|Overall Study|Other|3|||
126225749|NCT00295854|454117594|FG001|Overall Study|Other|5|||
126225750|NCT00295854|454117595|FG002|Overall Study|Other|1|||
126225751|NCT00772577|454117596|FG000|Overall Study|Adverse Event|6|||
126225752|NCT00772577|454117597|FG001|Overall Study|Adverse Event|3|||
126225753|NCT00772577|454117596|FG000|Overall Study|Abnormal laboratory values|0|||
126225754|NCT00772577|454117597|FG001|Overall Study|Abnormal laboratory values|1|||
126225755|NCT00772577|454117596|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126225756|NCT00772577|454117597|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126225757|NCT00772577|454117596|FG000|Overall Study|Patient withdrew consent|8|||
126225758|NCT00772577|454117597|FG001|Overall Study|Patient withdrew consent|5|||
126225759|NCT00772577|454117596|FG000|Overall Study|Lost to Follow-up|4|||
126225760|NCT00772577|454117597|FG001|Overall Study|Lost to Follow-up|3|||
126225761|NCT00772577|454117596|FG000|Overall Study|Administrative problems|2|||
126225762|NCT00772577|454117597|FG001|Overall Study|Administrative problems|1|||
126225763|NCT00772577|454117596|FG000|Overall Study|Protocol Deviation|3|||
126225764|NCT00772577|454117597|FG001|Overall Study|Protocol Deviation|2|||
126225765|NCT00672620|454117598|FG000|Overall Study|Adverse Event|7|||
126225766|NCT00672620|454117599|FG001|Overall Study|Adverse Event|7|||
126225767|NCT00672620|454117600|FG002|Overall Study|Adverse Event|12|||
126225768|NCT00672620|454117601|FG003|Overall Study|Adverse Event|17|||
126225769|NCT00672620|454117598|FG000|Overall Study|Lack of Efficacy|1|||
126225770|NCT00672620|454117599|FG001|Overall Study|Lack of Efficacy|2|||
126225771|NCT00672620|454117600|FG002|Overall Study|Lack of Efficacy|2|||
126225772|NCT00672620|454117601|FG003|Overall Study|Lack of Efficacy|0|||
126225773|NCT00672620|454117598|FG000|Overall Study|Noncompliance with Study Drug|3|||
126225774|NCT00672620|454117599|FG001|Overall Study|Noncompliance with Study Drug|4|||
126225775|NCT00672620|454117600|FG002|Overall Study|Noncompliance with Study Drug|0|||
126225776|NCT00672620|454117601|FG003|Overall Study|Noncompliance with Study Drug|2|||
126225777|NCT00672620|454117598|FG000|Overall Study|Protocol Deviations|5|||
126225778|NCT00672620|454117599|FG001|Overall Study|Protocol Deviations|7|||
126225779|NCT00672620|454117600|FG002|Overall Study|Protocol Deviations|2|||
126225780|NCT00672620|454117601|FG003|Overall Study|Protocol Deviations|5|||
126225781|NCT00672620|454117598|FG000|Overall Study|Withdrawal of Consent|6|||
126225782|NCT00672620|454117599|FG001|Overall Study|Withdrawal of Consent|12|||
126225783|NCT00672620|454117600|FG002|Overall Study|Withdrawal of Consent|5|||
126225784|NCT00672620|454117601|FG003|Overall Study|Withdrawal of Consent|6|||
126225785|NCT00672620|454117598|FG000|Overall Study|Lost to Follow-up|8|||
126225786|NCT00672620|454117599|FG001|Overall Study|Lost to Follow-up|19|||
126225787|NCT00672620|454117600|FG002|Overall Study|Lost to Follow-up|8|||
126225788|NCT00672620|454117601|FG003|Overall Study|Lost to Follow-up|11|||
126225789|NCT00672620|454117598|FG000|Overall Study|Reason not Specified|3|||
126225790|NCT00672620|454117599|FG001|Overall Study|Reason not Specified|3|||
126225791|NCT00672620|454117600|FG002|Overall Study|Reason not Specified|2|||
126225792|NCT00672620|454117601|FG003|Overall Study|Reason not Specified|1|||
126225793|NCT03211156|454117602|FG000|Overall Study|Withdrawal by Subject|0|||
126225794|NCT03211156|454117603|FG001|Overall Study|Withdrawal by Subject|2|||
126225795|NCT03211156|454117602|FG000|Overall Study|Lost to Follow-up|1|||
126225796|NCT03211156|454117603|FG001|Overall Study|Lost to Follow-up|1|||
126225797|NCT03211156|454117602|FG000|Overall Study|Adverse Event|1|||
126225798|NCT03211156|454117603|FG001|Overall Study|Adverse Event|0|||
126225799|NCT00829413|454117604|FG000|Overall Study|No study drug admimnistered|13|||
126225800|NCT00829413|454117604|FG000|Overall Study|Training Patients|67|||
126225801|NCT00829413|454117604|FG000|Overall Study|No truth standard procedure available|9|||
126225802|NCT00829413|454117604|FG000|Overall Study|Technically inadequate truth standard|2|||
126225803|NCT00829413|454117604|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
126225804|NCT03487796|454117606|FG000|Overall Study|Lost to Follow-up|18|||
126225805|NCT03487796|454117607|FG001|Overall Study|Lost to Follow-up|6|||
126225806|NCT04272775|454117608|FG000|Overall Study|Study Terminated by Sponsor|1|||
126225807|NCT04272775|454117609|FG001|Overall Study|Study Terminated by Sponsor|0|||
126225808|NCT04272775|454117608|FG000|Overall Study|Protocol Violation|0|||
126225809|NCT04272775|454117609|FG001|Overall Study|Protocol Violation|1|||
126225810|NCT04272775|454117608|FG000|Overall Study|Symptomatic Deterioration|1|||
126225811|NCT04272775|454117609|FG001|Overall Study|Symptomatic Deterioration|1|||
126225812|NCT04272775|454117608|FG000|Overall Study|Withdrawal by Subject|1|||
126225813|NCT04272775|454117609|FG001|Overall Study|Withdrawal by Subject|2|||
126225814|NCT04272775|454117608|FG000|Overall Study|Adverse Event|1|||
126225815|NCT04272775|454117609|FG001|Overall Study|Adverse Event|2|||
126225816|NCT04272775|454117608|FG000|Overall Study|Progressive Disease|3|||
126225817|NCT04272775|454117609|FG001|Overall Study|Progressive Disease|1|||
126225818|NCT00124020|454117610|FG000|Overall Study|Death|67|||
126225819|NCT00124020|454117611|FG001|Overall Study|Death|71|||
126225820|NCT00124020|454117610|FG000|Overall Study|Withdrawal by Subject|13|||
126225821|NCT00124020|454117611|FG001|Overall Study|Withdrawal by Subject|11|||
126225822|NCT00124020|454117610|FG000|Overall Study|Lost to Follow-up|5|||
126225823|NCT00124020|454117611|FG001|Overall Study|Lost to Follow-up|8|||
126225824|NCT00124020|454117610|FG000|Overall Study|Other|1|||
126225825|NCT00124020|454117611|FG001|Overall Study|Other|1|||
126225826|NCT00124020|454117610|FG000|Overall Study|Transfer to another hospital|2|||
126225827|NCT00124020|454117611|FG001|Overall Study|Transfer to another hospital|0|||
126225828|NCT02043366|454117612|FG000|Overall Study|Lost to Follow-up|2|||
126225829|NCT02043366|454117613|FG001|Overall Study|Lost to Follow-up|2|||
126225830|NCT02043366|454117614|FG002|Overall Study|Lost to Follow-up|2|||
126225831|NCT02043366|454117615|FG003|Overall Study|Lost to Follow-up|2|||
126225832|NCT02043366|454117616|FG004|Overall Study|Lost to Follow-up|2|||
126225833|NCT02043366|454117617|FG005|Overall Study|Lost to Follow-up|2|||
126225834|NCT01489956|454117620|FG000|Overall Study|Lost to Follow-up|1|||
126225835|NCT01489956|454117621|FG001|Overall Study|Lost to Follow-up|0|||
126225836|NCT01489956|454117622|FG002|Overall Study|Lost to Follow-up|0|||
126225837|NCT01489956|454117620|FG000|Overall Study|Withdrawal by Subject|0|||
126225838|NCT01489956|454117621|FG001|Overall Study|Withdrawal by Subject|0|||
126225839|NCT01489956|454117622|FG002|Overall Study|Withdrawal by Subject|1|||
126225840|NCT00891774|454117623|FG000|Overall Study|Lost to Follow-up|5|||
126225841|NCT00891774|454117623|FG000|Overall Study|Illness (Self/Mother)|3|||
126225842|NCT00891774|454117623|FG000|Overall Study|Withdrawal by Subject|2|||
126225843|NCT00891774|454117623|FG000|Overall Study|Protocol Violation|4|||
126225844|NCT01977092|454117625|FG000|Overall Study|Death|3|||
126225845|NCT01977092|454117626|FG001|Overall Study|Death|4|||
126225846|NCT01977092|454117625|FG000|Overall Study|Lost to Follow-up|23|||
126225847|NCT01977092|454117626|FG001|Overall Study|Lost to Follow-up|14|||
126225848|NCT01977092|454117625|FG000|Overall Study|Withdrawal by Subject|2|||
126225849|NCT01977092|454117626|FG001|Overall Study|Withdrawal by Subject|1|||
126225850|NCT01977092|454117625|FG000|Overall Study|In prison|3|||
126225851|NCT01977092|454117626|FG001|Overall Study|In prison|11|||
126225852|NCT02927847|454117627|FG000|Overall Study|Lost to Follow-up|1|||
126225853|NCT02927847|454117628|FG001|Overall Study|Lost to Follow-up|0|||
126225854|NCT02927847|454117627|FG000|Overall Study|Withdrawal by Subject|4|||
126225855|NCT02927847|454117628|FG001|Overall Study|Withdrawal by Subject|2|||
126225856|NCT02927847|454117627|FG000|Overall Study|PI withdrawn due to missed visits|1|||
126225857|NCT02927847|454117628|FG001|Overall Study|PI withdrawn due to missed visits|1|||
126225858|NCT00723554|454117629|FG000|Overall Study|Adverse Event|12|||
126225859|NCT00723554|454117629|FG000|Overall Study|Investigator's judgement|5|||
126225860|NCT00723554|454117629|FG000|Overall Study|Inhaled medication other than iloprost|4|||
126225861|NCT00723554|454117629|FG000|Overall Study|Withdrawal of consent|3|||
126225862|NCT00723554|454117629|FG000|Overall Study|Other|3|||
126225863|NCT00723554|454117629|FG000|Overall Study|Lost to Follow-up|1|||
126225864|NCT00723554|454117629|FG000|Overall Study|Non-compliance|1|||
126225865|NCT01405820|454117630|FG000|Randomized Treatment Period|Adverse Event|3|||
126351736|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
126351737|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
126351738|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
126351739|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
126351740|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Other|2|||
126351741|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Other|1|||
126225866|NCT01405820|454117631|FG001|Randomized Treatment Period|Adverse Event|3|||
126225867|NCT01405820|454117632|FG002|Randomized Treatment Period|Adverse Event|3|||
126225868|NCT01405820|454117633|FG003|Randomized Treatment Period|Adverse Event|0|||
126225869|NCT01405820|454117634|FG004|Randomized Treatment Period|Adverse Event|2|||
126351742|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Other|0|||
126225870|NCT01405820|454117635|FG005|Randomized Treatment Period|Adverse Event|1|||
126225871|NCT01405820|454117630|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
126225872|NCT01405820|454117631|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
126225873|NCT01405820|454117632|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
126225874|NCT01405820|454117633|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
126225875|NCT01405820|454117634|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
126225876|NCT01405820|454117635|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
126225877|NCT01405820|454117630|FG000|Randomized Treatment Period|Other|2|||
126225878|NCT01405820|454117631|FG001|Randomized Treatment Period|Other|2|||
126225879|NCT01405820|454117632|FG002|Randomized Treatment Period|Other|1|||
126225880|NCT01405820|454117633|FG003|Randomized Treatment Period|Other|1|||
126225881|NCT01405820|454117634|FG004|Randomized Treatment Period|Other|0|||
126225882|NCT01405820|454117635|FG005|Randomized Treatment Period|Other|0|||
126225883|NCT01405820|454117630|FG000|Randomized Treatment Period|Physician Decision|0|||
126225884|NCT01405820|454117631|FG001|Randomized Treatment Period|Physician Decision|2|||
126225885|NCT01405820|454117632|FG002|Randomized Treatment Period|Physician Decision|1|||
126225886|NCT01405820|454117633|FG003|Randomized Treatment Period|Physician Decision|0|||
126225887|NCT01405820|454117634|FG004|Randomized Treatment Period|Physician Decision|0|||
126225888|NCT01405820|454117635|FG005|Randomized Treatment Period|Physician Decision|0|||
126225889|NCT01405820|454117630|FG000|Randomized Treatment Period|Rescue|0|||
126225890|NCT01405820|454117631|FG001|Randomized Treatment Period|Rescue|1|||
126225891|NCT01405820|454117632|FG002|Randomized Treatment Period|Rescue|13|||
126225892|NCT01405820|454117633|FG003|Randomized Treatment Period|Rescue|10|||
126225893|NCT01405820|454117634|FG004|Randomized Treatment Period|Rescue|8|||
126225894|NCT01405820|454117635|FG005|Randomized Treatment Period|Rescue|8|||
126225895|NCT01405820|454117630|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
126225896|NCT01405820|454117631|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
126225897|NCT01405820|454117632|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
126225898|NCT01405820|454117633|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
126225899|NCT01405820|454117634|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
126225900|NCT01405820|454117635|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
126225901|NCT01405820|454117630|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
126225902|NCT01405820|454117631|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
126225903|NCT01405820|454117632|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
126225904|NCT01405820|454117633|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
126225905|NCT01405820|454117634|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
126225906|NCT01405820|454117635|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
126225907|NCT01405820|454117630|FG000|Randomized Treatment Period|Death|0|||
126225908|NCT01405820|454117631|FG001|Randomized Treatment Period|Death|0|||
126225909|NCT01405820|454117632|FG002|Randomized Treatment Period|Death|0|||
126225910|NCT01405820|454117633|FG003|Randomized Treatment Period|Death|1|||
126225911|NCT01405820|454117634|FG004|Randomized Treatment Period|Death|0|||
126225912|NCT01405820|454117635|FG005|Randomized Treatment Period|Death|0|||
126225913|NCT01405820|454117630|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126225914|NCT01405820|454117631|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126225915|NCT01405820|454117632|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126225916|NCT01405820|454117633|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
126225917|NCT01405820|454117634|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126225918|NCT01405820|454117635|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126225919|NCT01405820|454117630|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
126225920|NCT01405820|454117631|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
126225921|NCT01405820|454117632|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
126225922|NCT01405820|454117633|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
126225923|NCT01405820|454117634|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
126225924|NCT01405820|454117635|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
126225925|NCT01405820|454117630|FG000|Open-Label Treatment Period|Other|1|||
126225926|NCT01405820|454117631|FG001|Open-Label Treatment Period|Other|1|||
126225927|NCT01405820|454117632|FG002|Open-Label Treatment Period|Other|1|||
126225928|NCT01405820|454117633|FG003|Open-Label Treatment Period|Other|1|||
126225929|NCT01405820|454117634|FG004|Open-Label Treatment Period|Other|1|||
126225930|NCT01405820|454117635|FG005|Open-Label Treatment Period|Other|1|||
126225931|NCT01405820|454117630|FG000|Open-Label Treatment Period|Physician Decision|0|||
126225932|NCT01405820|454117631|FG001|Open-Label Treatment Period|Physician Decision|0|||
126225933|NCT01405820|454117632|FG002|Open-Label Treatment Period|Physician Decision|1|||
126225934|NCT01405820|454117633|FG003|Open-Label Treatment Period|Physician Decision|2|||
126225935|NCT01405820|454117634|FG004|Open-Label Treatment Period|Physician Decision|1|||
126225936|NCT01405820|454117635|FG005|Open-Label Treatment Period|Physician Decision|0|||
126225937|NCT01405820|454117630|FG000|Open-Label Treatment Period|Adverse Event|0|||
126225938|NCT01405820|454117631|FG001|Open-Label Treatment Period|Adverse Event|0|||
126225939|NCT01405820|454117632|FG002|Open-Label Treatment Period|Adverse Event|0|||
126021031|NCT00858117|453373145|FG000|Treatment on Study|Adverse Event|2|||
126225940|NCT01405820|454117633|FG003|Open-Label Treatment Period|Adverse Event|1|||
126225941|NCT01405820|454117634|FG004|Open-Label Treatment Period|Adverse Event|0|||
126225942|NCT01405820|454117635|FG005|Open-Label Treatment Period|Adverse Event|0|||
126225943|NCT03255031|454117642|FG000|Overall Study|Adverse Event|5|||
126225944|NCT03255031|454117643|FG001|Overall Study|Adverse Event|3|||
126225945|NCT03255031|454117642|FG000|Overall Study|Physician Decision|2|||
126225946|NCT03255031|454117643|FG001|Overall Study|Physician Decision|1|||
126225947|NCT03255031|454117642|FG000|Overall Study|Withdrawal by Subject|9|||
126225948|NCT03255031|454117643|FG001|Overall Study|Withdrawal by Subject|3|||
126225949|NCT01689974|454117644|FG000|Overall Study|Termination of Study|5|||
126225950|NCT01689974|454117645|FG001|Overall Study|Termination of Study|5|||
126225951|NCT00415532|454117649|FG000|Treatment Period|Adverse Event|2|||
126225952|NCT00415532|454117650|FG001|Treatment Period|Adverse Event|3|||
126225953|NCT00415532|454117649|FG000|Treatment Period|Death|2|||
126225954|NCT00415532|454117650|FG001|Treatment Period|Death|1|||
126225955|NCT00415532|454117649|FG000|Treatment Period|Lost to Follow-up|1|||
126225956|NCT00415532|454117650|FG001|Treatment Period|Lost to Follow-up|1|||
126225957|NCT00415532|454117649|FG000|Treatment Period|Protocol Violation|1|||
126225958|NCT00415532|454117650|FG001|Treatment Period|Protocol Violation|0|||
126225959|NCT00415532|454117649|FG000|Treatment Period|Withdrawal by Subject|6|||
126225960|NCT00415532|454117650|FG001|Treatment Period|Withdrawal by Subject|6|||
126225961|NCT00415532|454117649|FG000|Treatment Period|Other|2|||
126225962|NCT00415532|454117650|FG001|Treatment Period|Other|2|||
126225963|NCT00415532|454117649|FG000|Treatment Period|Ineligibility determined|1|||
126225964|NCT00415532|454117650|FG001|Treatment Period|Ineligibility determined|1|||
126225965|NCT00415532|454117649|FG000|Treatment Period|Noncompliance|1|||
126225966|NCT00415532|454117650|FG001|Treatment Period|Noncompliance|1|||
126225967|NCT00415532|454117649|FG000|Treatment Period|Requirement for alternative therapy|1|||
126225968|NCT00415532|454117650|FG001|Treatment Period|Requirement for alternative therapy|0|||
126225969|NCT00415532|454117649|FG000|Safety Follow Up Period|Adverse Event|1|||
126225970|NCT00415532|454117650|FG001|Safety Follow Up Period|Adverse Event|3|||
126225971|NCT00415532|454117649|FG000|Safety Follow Up Period|Death|3|||
126225972|NCT00415532|454117650|FG001|Safety Follow Up Period|Death|0|||
126225973|NCT00415532|454117649|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
126225974|NCT00415532|454117650|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
126225975|NCT00415532|454117649|FG000|Safety Follow Up Period|Other|1|||
126225976|NCT00415532|454117650|FG001|Safety Follow Up Period|Other|4|||
126225977|NCT00415532|454117649|FG000|Safety Follow Up Period|Ineligibility determined|1|||
126225978|NCT00415532|454117650|FG001|Safety Follow Up Period|Ineligibility determined|1|||
126225979|NCT00415532|454117649|FG000|Safety Follow Up Period|Noncompliance|1|||
126225980|NCT00415532|454117650|FG001|Safety Follow Up Period|Noncompliance|0|||
126225981|NCT00415532|454117649|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
126225982|NCT00415532|454117650|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
126351743|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Other|0|||
126351744|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Other|0|||
126351745|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
126351746|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
126021032|NCT00858117|453373145|FG000|Follow up for 5 Years|Death|4|||
126021033|NCT00858117|453373145|FG000|Follow up for 5 Years|No further data collected for study|9|||
126021034|NCT04425863|453373146|FG000|Overall Study|Death|0|||
126021035|NCT04425863|453373147|FG001|Overall Study|Death|0|||
126021036|NCT04425863|453373148|FG002|Overall Study|Death|1|||
126225983|NCT01698320|454117651|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
126225984|NCT01698320|454117652|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
126351747|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
126351748|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
126351749|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
126351750|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
126351751|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
126351752|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
126351753|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
126351754|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
126351755|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
126351756|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
126351757|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
126351758|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
126021037|NCT00642850|453373151|FG000|Overall Study|Death|7|||
126021038|NCT00642850|453373151|FG000|Overall Study|Adverse Event|2|||
126021039|NCT00642850|453373151|FG000|Overall Study|Lack of Efficacy|1|||
126021040|NCT00642850|453373151|FG000|Overall Study|Protocol Violation|2|||
126093010|NCT01302080|453634462|FG000|Overall Study|Death|1|||
126225985|NCT01698320|454117653|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
126225986|NCT01698320|454117651|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
126225987|NCT01698320|454117652|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
126351759|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
126351760|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
126225988|NCT01698320|454117653|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
126225989|NCT01698320|454117651|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
126225990|NCT01698320|454117652|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
126225991|NCT01698320|454117653|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
126225992|NCT01698320|454117651|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
126225993|NCT01698320|454117652|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
126225994|NCT01698320|454117653|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
126225995|NCT01698320|454117651|FG000|12-Week Double-Blind Period|Adverse Event|0|||
126225996|NCT01698320|454117652|FG001|12-Week Double-Blind Period|Adverse Event|1|||
126225997|NCT01698320|454117653|FG002|12-Week Double-Blind Period|Adverse Event|1|||
126021041|NCT00642850|453373151|FG000|Overall Study|Kidney transplantation|8|||
126225998|NCT01698320|454117651|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
126225999|NCT01698320|454117652|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
126226000|NCT01698320|454117653|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
126351761|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
126351762|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
126351763|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
126351764|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
126351765|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
126351766|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
126351767|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
126351768|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
126351769|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
126351770|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
126351771|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
126226001|NCT01698320|454117651|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
126226002|NCT01698320|454117652|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
126226003|NCT01698320|454117653|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
126226004|NCT01698320|454117651|FG000|12-Week Double-Blind Period|Pregnancy|0|||
126226005|NCT01698320|454117652|FG001|12-Week Double-Blind Period|Pregnancy|1|||
126226006|NCT01698320|454117653|FG002|12-Week Double-Blind Period|Pregnancy|1|||
126226007|NCT01698320|454117651|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
126226008|NCT01698320|454117652|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
126226009|NCT01698320|454117653|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
126226010|NCT01698320|454117651|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
126226011|NCT01698320|454117652|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
126226012|NCT01698320|454117653|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
126226013|NCT01698320|454117651|FG000|40-Week Open-Label Period|Adverse Event|0|||
126226014|NCT01698320|454117652|FG001|40-Week Open-Label Period|Adverse Event|3|||
126226015|NCT01698320|454117653|FG002|40-Week Open-Label Period|Adverse Event|2|||
126226016|NCT01698320|454117651|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
126226017|NCT01698320|454117652|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
126226018|NCT01698320|454117653|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
126226019|NCT01698320|454117651|FG000|40-Week Open-Label Period|Pregnancy|0|||
126226020|NCT01698320|454117652|FG001|40-Week Open-Label Period|Pregnancy|2|||
126226021|NCT01698320|454117653|FG002|40-Week Open-Label Period|Pregnancy|1|||
126226022|NCT01698320|454117651|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
126226023|NCT01698320|454117652|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
126226024|NCT01698320|454117653|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
126226025|NCT01698320|454117651|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
126226026|NCT01698320|454117652|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
126226027|NCT01698320|454117653|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
126226028|NCT01952574|454117654|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
126226029|NCT01952574|454117655|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
126226030|NCT01952574|454117656|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
126226031|NCT01952574|454117657|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
126226032|NCT01952574|454117658|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126226033|NCT01952574|454117659|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126226034|NCT01952574|454117660|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126226035|NCT01952574|454117654|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
126226036|NCT01952574|454117655|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
126226037|NCT01952574|454117656|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
126226038|NCT01952574|454117657|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
126226039|NCT01952574|454117658|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
126226040|NCT01952574|454117659|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
126226041|NCT01952574|454117660|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
126226042|NCT01952574|454117654|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
126226043|NCT01952574|454117655|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
126226044|NCT01952574|454117656|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
126226045|NCT01952574|454117657|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
126226046|NCT01952574|454117658|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
126226047|NCT01952574|454117659|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
126226048|NCT01952574|454117660|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
126226049|NCT01952574|454117654|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
126226050|NCT01952574|454117655|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
126226051|NCT01952574|454117656|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
126226052|NCT01952574|454117657|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
126226053|NCT01952574|454117658|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
126226054|NCT01952574|454117659|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
126226055|NCT01952574|454117660|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
126226056|NCT01952574|454117654|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
126226057|NCT01952574|454117655|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
126226058|NCT01952574|454117656|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
126226059|NCT01952574|454117657|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
126226060|NCT01952574|454117658|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
126226061|NCT01952574|454117659|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
126226062|NCT01952574|454117660|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
126226063|NCT01952574|454117654|FG000|Open-label Treatment Phase|Missing|0|||
126226064|NCT01952574|454117655|FG001|Open-label Treatment Phase|Missing|0|||
126226065|NCT01952574|454117656|FG002|Open-label Treatment Phase|Missing|0|||
126226066|NCT01952574|454117657|FG003|Open-label Treatment Phase|Missing|0|||
126021042|NCT00642850|453373151|FG000|Overall Study|Blood transfusion|6|||
126021043|NCT00642850|453373151|FG000|Overall Study|Other reasons|7|||
126226067|NCT01952574|454117658|FG004|Open-label Treatment Phase|Missing|4|||
126226068|NCT01952574|454117659|FG005|Open-label Treatment Phase|Missing|0|||
126226069|NCT01952574|454117660|FG006|Open-label Treatment Phase|Missing|0|||
126226070|NCT01952574|454117654|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
126226071|NCT01952574|454117655|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
126226072|NCT01952574|454117656|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
126226073|NCT01952574|454117657|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
126226074|NCT01952574|454117658|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
126226075|NCT01952574|454117659|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
126226076|NCT01952574|454117660|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
126226077|NCT01952574|454117654|FG000|Open-label Treatment Phase|Death|0|||
126226078|NCT01952574|454117655|FG001|Open-label Treatment Phase|Death|0|||
126226079|NCT01952574|454117656|FG002|Open-label Treatment Phase|Death|0|||
126226080|NCT01952574|454117657|FG003|Open-label Treatment Phase|Death|0|||
126226081|NCT01952574|454117658|FG004|Open-label Treatment Phase|Death|1|||
126226082|NCT01952574|454117659|FG005|Open-label Treatment Phase|Death|0|||
126226083|NCT01952574|454117660|FG006|Open-label Treatment Phase|Death|0|||
126226084|NCT01952574|454117654|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126226085|NCT01952574|454117655|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126226086|NCT01952574|454117656|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126226087|NCT01952574|454117657|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126226088|NCT01952574|454117658|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126226089|NCT01952574|454117659|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
126226090|NCT01952574|454117660|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126226091|NCT01952574|454117654|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
126226092|NCT01952574|454117655|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
126226093|NCT01952574|454117656|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
126226094|NCT01952574|454117657|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
126226095|NCT01952574|454117658|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
126226096|NCT01952574|454117659|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
126226097|NCT01952574|454117660|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
126226098|NCT02974114|454117666|FG000|Overall Study|Other (Not specified)|0|||
126226099|NCT02974114|454117667|FG001|Overall Study|Other (Not specified)|1|||
126226100|NCT02974114|454117668|FG002|Overall Study|Other (Not specified)|2|||
126226101|NCT01580020|454117669|FG000|Overall Study|Lack of Efficacy|0|||
126226102|NCT01580020|454117670|FG001|Overall Study|Lack of Efficacy|5|||
126226103|NCT01580020|454117671|FG002|Overall Study|Lack of Efficacy|0|||
126226104|NCT01580020|454117672|FG003|Overall Study|Lack of Efficacy|1|||
126226105|NCT01580020|454117669|FG000|Overall Study|Withdrawal by Subject|0|||
126226106|NCT01580020|454117670|FG001|Overall Study|Withdrawal by Subject|1|||
126226107|NCT01580020|454117671|FG002|Overall Study|Withdrawal by Subject|1|||
126226108|NCT01580020|454117672|FG003|Overall Study|Withdrawal by Subject|0|||
126226109|NCT01580020|454117669|FG000|Overall Study|Adverse Event|1|||
126021044|NCT01266122|453373155|FG000|Overall Study|Lost to Follow-up|6|||
126021045|NCT01266122|453373156|FG001|Overall Study|Lost to Follow-up|6|||
126226110|NCT01580020|454117670|FG001|Overall Study|Adverse Event|1|||
126226111|NCT01580020|454117671|FG002|Overall Study|Adverse Event|1|||
126226112|NCT01580020|454117672|FG003|Overall Study|Adverse Event|1|||
126226113|NCT01580020|454117669|FG000|Overall Study|Administrative Problems|0|||
126226114|NCT01580020|454117670|FG001|Overall Study|Administrative Problems|0|||
126226115|NCT01580020|454117671|FG002|Overall Study|Administrative Problems|1|||
126226116|NCT01580020|454117672|FG003|Overall Study|Administrative Problems|0|||
126226117|NCT01580020|454117669|FG000|Overall Study|Lost to Follow-up|0|||
126226118|NCT01580020|454117670|FG001|Overall Study|Lost to Follow-up|0|||
126226119|NCT01580020|454117671|FG002|Overall Study|Lost to Follow-up|1|||
126226120|NCT01580020|454117672|FG003|Overall Study|Lost to Follow-up|0|||
126226121|NCT01724359|454117673|FG000|Overall Study|Adverse Event|10|||
126226122|NCT01724359|454117673|FG000|Overall Study|Death|1|||
126226123|NCT01724359|454117673|FG000|Overall Study|Other|20|||
126226124|NCT01335464|454117680|FG000|Overall Study|Adverse Event|15|||
126226125|NCT01335464|454117681|FG001|Overall Study|Adverse Event|25|||
126226126|NCT01335464|454117680|FG000|Overall Study|Non compliant with protocol|2|||
126226127|NCT01335464|454117681|FG001|Overall Study|Non compliant with protocol|0|||
126226128|NCT01335464|454117680|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
126226129|NCT01335464|454117681|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
126226130|NCT01335464|454117680|FG000|Overall Study|Not treated|2|||
126226131|NCT01335464|454117681|FG001|Overall Study|Not treated|0|||
126226132|NCT01335464|454117680|FG000|Overall Study|Reason other than those stated above|1|||
126226133|NCT01335464|454117681|FG001|Overall Study|Reason other than those stated above|1|||
126226134|NCT00593333|454117685|FG000|Overall Study|Lost to Follow-up|10|||
126226135|NCT00593333|454117686|FG001|Overall Study|Lost to Follow-up|11|||
126226136|NCT01752920|454117687|FG000|Overall Study|Adverse Event|1|||
126226137|NCT01752920|454117688|FG001|Overall Study|Adverse Event|0|||
126226138|NCT01752920|454117689|FG002|Overall Study|Adverse Event|5|||
126226139|NCT01752920|454117690|FG003|Overall Study|Adverse Event|10|||
126226140|NCT01752920|454117687|FG000|Overall Study|Clinical Disease Progression|6|||
126226141|NCT01752920|454117688|FG001|Overall Study|Clinical Disease Progression|4|||
126226142|NCT01752920|454117689|FG002|Overall Study|Clinical Disease Progression|1|||
126226143|NCT01752920|454117690|FG003|Overall Study|Clinical Disease Progression|13|||
126226144|NCT01752920|454117687|FG000|Overall Study|Physician Decision|1|||
126226145|NCT01752920|454117688|FG001|Overall Study|Physician Decision|0|||
126226146|NCT01752920|454117689|FG002|Overall Study|Physician Decision|0|||
126226147|NCT01752920|454117690|FG003|Overall Study|Physician Decision|3|||
126226148|NCT01752920|454117687|FG000|Overall Study|Radiographic Disease Progression|20|||
126226149|NCT01752920|454117688|FG001|Overall Study|Radiographic Disease Progression|7|||
126226150|NCT01752920|454117689|FG002|Overall Study|Radiographic Disease Progression|12|||
126226151|NCT01752920|454117690|FG003|Overall Study|Radiographic Disease Progression|29|||
126226152|NCT01752920|454117687|FG000|Overall Study|Study Terminated by Sponsor|0|||
126226153|NCT01752920|454117688|FG001|Overall Study|Study Terminated by Sponsor|0|||
126226154|NCT01752920|454117689|FG002|Overall Study|Study Terminated by Sponsor|0|||
126226155|NCT01752920|454117690|FG003|Overall Study|Study Terminated by Sponsor|1|||
126226156|NCT01752920|454117687|FG000|Overall Study|Withdrawal by Subject|0|||
126226157|NCT01752920|454117688|FG001|Overall Study|Withdrawal by Subject|1|||
126226158|NCT01752920|454117689|FG002|Overall Study|Withdrawal by Subject|0|||
126226159|NCT01752920|454117690|FG003|Overall Study|Withdrawal by Subject|1|||
126226160|NCT01752920|454117687|FG000|Overall Study|Lack of clinical benefit|1|||
126226161|NCT01752920|454117688|FG001|Overall Study|Lack of clinical benefit|1|||
126226162|NCT01752920|454117689|FG002|Overall Study|Lack of clinical benefit|1|||
126226163|NCT01752920|454117690|FG003|Overall Study|Lack of clinical benefit|1|||
126226164|NCT01738581|454117691|FG000|Overall Study|Lost to Follow-up|1|||
126226165|NCT01738581|454117692|FG001|Overall Study|Lost to Follow-up|0|||
126226166|NCT00696709|454117693|FG000|Overall Study|Withdrawal by Subject|1|||
126226167|NCT00696709|454117694|FG001|Overall Study|Withdrawal by Subject|2|||
126226168|NCT00696709|454117695|FG002|Overall Study|Withdrawal by Subject|1|||
126226169|NCT00696709|454117696|FG003|Overall Study|Withdrawal by Subject|4|||
126226170|NCT00696709|454117697|FG004|Overall Study|Withdrawal by Subject|3|||
126226171|NCT00696709|454117693|FG000|Overall Study|Protocol Violation|1|||
126226172|NCT00696709|454117694|FG001|Overall Study|Protocol Violation|0|||
126226173|NCT00696709|454117695|FG002|Overall Study|Protocol Violation|0|||
126226174|NCT00696709|454117696|FG003|Overall Study|Protocol Violation|0|||
126351772|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
126351773|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
126351774|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
126351775|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
126351776|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
126351777|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
126226175|NCT00696709|454117697|FG004|Overall Study|Protocol Violation|0|||
126226176|NCT00696709|454117693|FG000|Overall Study|Lost to Follow-up|1|||
126226177|NCT00696709|454117694|FG001|Overall Study|Lost to Follow-up|1|||
126226178|NCT00696709|454117695|FG002|Overall Study|Lost to Follow-up|0|||
126226179|NCT00696709|454117696|FG003|Overall Study|Lost to Follow-up|0|||
126226180|NCT00696709|454117697|FG004|Overall Study|Lost to Follow-up|0|||
126226181|NCT00696709|454117693|FG000|Overall Study|Adverse Event|0|||
126226182|NCT00696709|454117694|FG001|Overall Study|Adverse Event|0|||
126226183|NCT00696709|454117695|FG002|Overall Study|Adverse Event|0|||
126226184|NCT00696709|454117696|FG003|Overall Study|Adverse Event|1|||
126226185|NCT00696709|454117697|FG004|Overall Study|Adverse Event|0|||
126226186|NCT01186978|454117698|FG000|Overall Study|Withdrawal by Subject|1|||
126351778|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
126226187|NCT01709383|454117708|FG000|Overall Study|Lost to Follow-up|1|||
126226188|NCT01709383|454117709|FG001|Overall Study|Lost to Follow-up|0|||
126226189|NCT03264066|454117710|FG000|Overall Study|Adverse Event|1|||
126226190|NCT03264066|454117711|FG001|Overall Study|Adverse Event|1|||
126226191|NCT03264066|454117712|FG002|Overall Study|Adverse Event|0|||
126226192|NCT03264066|454117713|FG003|Overall Study|Adverse Event|0|||
126226193|NCT03264066|454117714|FG004|Overall Study|Adverse Event|0|||
126226194|NCT03264066|454117715|FG005|Overall Study|Adverse Event|0|||
126226195|NCT03264066|454117710|FG000|Overall Study|Death|12|||
126226196|NCT03264066|454117711|FG001|Overall Study|Death|12|||
126226197|NCT03264066|454117712|FG002|Overall Study|Death|8|||
126226198|NCT03264066|454117713|FG003|Overall Study|Death|10|||
126226199|NCT03264066|454117714|FG004|Overall Study|Death|6|||
126226200|NCT03264066|454117715|FG005|Overall Study|Death|1|||
126226201|NCT03264066|454117710|FG000|Overall Study|Lost to Follow-up|1|||
126226202|NCT03264066|454117711|FG001|Overall Study|Lost to Follow-up|0|||
126226203|NCT03264066|454117712|FG002|Overall Study|Lost to Follow-up|0|||
126226204|NCT03264066|454117713|FG003|Overall Study|Lost to Follow-up|0|||
126226205|NCT03264066|454117714|FG004|Overall Study|Lost to Follow-up|0|||
126226206|NCT03264066|454117715|FG005|Overall Study|Lost to Follow-up|0|||
126226207|NCT03264066|454117710|FG000|Overall Study|Progressive Disease|0|||
126226208|NCT03264066|454117711|FG001|Overall Study|Progressive Disease|2|||
126226209|NCT03264066|454117712|FG002|Overall Study|Progressive Disease|1|||
126226210|NCT03264066|454117713|FG003|Overall Study|Progressive Disease|0|||
126226211|NCT03264066|454117714|FG004|Overall Study|Progressive Disease|0|||
126226212|NCT03264066|454117715|FG005|Overall Study|Progressive Disease|0|||
126226213|NCT03264066|454117710|FG000|Overall Study|Study Terminated by Sponsor|5|||
126226214|NCT03264066|454117711|FG001|Overall Study|Study Terminated by Sponsor|5|||
126226215|NCT03264066|454117712|FG002|Overall Study|Study Terminated by Sponsor|8|||
126226216|NCT03264066|454117713|FG003|Overall Study|Study Terminated by Sponsor|5|||
126226217|NCT03264066|454117714|FG004|Overall Study|Study Terminated by Sponsor|1|||
126226218|NCT03264066|454117715|FG005|Overall Study|Study Terminated by Sponsor|2|||
126226219|NCT03264066|454117710|FG000|Overall Study|Withdrawal by Subject|1|||
126226220|NCT03264066|454117711|FG001|Overall Study|Withdrawal by Subject|0|||
126226221|NCT03264066|454117712|FG002|Overall Study|Withdrawal by Subject|0|||
126226222|NCT03264066|454117713|FG003|Overall Study|Withdrawal by Subject|5|||
126226223|NCT03264066|454117714|FG004|Overall Study|Withdrawal by Subject|0|||
126226224|NCT03264066|454117715|FG005|Overall Study|Withdrawal by Subject|0|||
126226225|NCT02668302|454117721|FG000|Overall Study|Withdrawal by Subject|1|||
126226226|NCT02668302|454117722|FG001|Overall Study|Withdrawal by Subject|0|||
126226227|NCT01078090|454117723|FG000|Overall Study|Lost to Follow-up|2363|||
126226228|NCT01078090|454117723|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
126226229|NCT01078090|454117723|FG000|Overall Study|Lack of Efficacy|1193|||
126226230|NCT01078090|454117723|FG000|Overall Study|ADR and lack of efficacy|61|||
126226231|NCT01078090|454117723|FG000|Overall Study|Other|523|||
126226232|NCT02468557|454119295|FG000|Overall Study|Adverse Event|1|||
126226233|NCT02468557|454119295|FG000|Overall Study|Death|1|||
126226234|NCT02468557|454119295|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
126226235|NCT02468557|454119295|FG000|Overall Study|All Enrolled but Never Dosed|4|||
126226236|NCT00982410|454119296|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
126226237|NCT00982410|454119297|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
126226238|NCT00982410|454119296|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
126226239|NCT00982410|454119297|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
126226240|NCT00982410|454119296|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
126226241|NCT00982410|454119297|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
126226242|NCT00982410|454119296|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
126226243|NCT00982410|454119297|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
126226244|NCT00982410|454119296|FG000|6-month Follow-up Assessment|participant no transportation|1|||
126021046|NCT03756571|453373157|FG000|Overall Study|Lost to Follow-up|1|||
126226245|NCT00982410|454119297|FG001|6-month Follow-up Assessment|participant no transportation|0|||
126226246|NCT00982410|454119296|FG000|6-month Follow-up Assessment|incarceration|0|||
126021047|NCT03756571|453373158|FG001|Overall Study|Lost to Follow-up|1|||
126021048|NCT00421889|453373159|FG000|Overall Study|Adverse Event|1|||
126226247|NCT00982410|454119297|FG001|6-month Follow-up Assessment|incarceration|2|||
126226248|NCT00982410|454119296|FG000|6-month Follow-up Assessment|patent surgery|0|||
126226249|NCT00982410|454119297|FG001|6-month Follow-up Assessment|patent surgery|1|||
126226250|NCT00982410|454119296|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
126226251|NCT00982410|454119297|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
126021049|NCT00421889|453373160|FG001|Overall Study|Adverse Event|0|||
126226252|NCT00982410|454119296|FG000|12-month Follow-up Assessment|Death|0|||
126226253|NCT00982410|454119297|FG001|12-month Follow-up Assessment|Death|2|||
126226254|NCT00982410|454119296|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
126369553|NCT01497197|454650597|FG001|Overall Study|Protocol Violation|2|||
126369554|NCT01497197|454650596|FG000|Overall Study|Withdrawal by Subject|2|||
126369555|NCT01497197|454650597|FG001|Overall Study|Withdrawal by Subject|1|||
126226255|NCT00982410|454119297|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
126226256|NCT00982410|454119296|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
126226257|NCT00982410|454119297|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
126226258|NCT00982410|454119296|FG000|12-month Follow-up Assessment|incarceration|2|||
126226259|NCT00982410|454119297|FG001|12-month Follow-up Assessment|incarceration|1|||
126226260|NCT00982410|454119296|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
126226261|NCT00982410|454119297|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
126226262|NCT04014959|454119301|FG000|Baseline MRI and Assessments|Physician Decision|2|||
126226263|NCT04014959|454119301|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
126226264|NCT04014959|454119301|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
126226265|NCT02034799|454119305|FG000|Overall Study|Withdrawal by Subject|0|||
126226266|NCT02034799|454119306|FG001|Overall Study|Withdrawal by Subject|2|||
126226267|NCT02034799|454119305|FG000|Overall Study|Lost to Follow-up|0|||
126226268|NCT02034799|454119306|FG001|Overall Study|Lost to Follow-up|1|||
126226269|NCT02034799|454119305|FG000|Overall Study|Death|2|||
126226270|NCT02034799|454119306|FG001|Overall Study|Death|1|||
126226271|NCT01133821|454119311|FG000|Overall Study|Lost to Follow-up|8|||
126226272|NCT01133821|454119312|FG001|Overall Study|Lost to Follow-up|11|||
126226273|NCT01133821|454119311|FG000|Overall Study|Withdrawal by Subject|8|||
126226274|NCT01133821|454119312|FG001|Overall Study|Withdrawal by Subject|3|||
126226275|NCT01133821|454119311|FG000|Overall Study|preferred other treatment|1|||
126226276|NCT01133821|454119312|FG001|Overall Study|preferred other treatment|1|||
126226277|NCT01133821|454119311|FG000|Overall Study|Protocol Violation|0|||
126226278|NCT01133821|454119312|FG001|Overall Study|Protocol Violation|1|||
126226279|NCT01133821|454119311|FG000|Overall Study|Refused participation|1|||
126226280|NCT01133821|454119312|FG001|Overall Study|Refused participation|3|||
126226281|NCT03572933|454119314|FG000|Overall Study|Adverse Event|4|||
126226282|NCT03572933|454119315|FG001|Overall Study|Adverse Event|1|||
126226283|NCT03572933|454119314|FG000|Overall Study|Withdrawal by Subject|0|||
126226284|NCT03572933|454119315|FG001|Overall Study|Withdrawal by Subject|1|||
126226285|NCT00633152|454119322|FG000|Overall Study|Adverse Event|1|||
126226286|NCT00633152|454119323|FG001|Overall Study|Adverse Event|0|||
126226287|NCT00633152|454119322|FG000|Overall Study|Randomized, did not receive study drug|5|||
126226288|NCT00633152|454119323|FG001|Overall Study|Randomized, did not receive study drug|2|||
126226289|NCT00633152|454119322|FG000|Overall Study|Withdrawal by Subject|1|||
126226290|NCT00633152|454119323|FG001|Overall Study|Withdrawal by Subject|1|||
126226291|NCT00633152|454119322|FG000|Overall Study|Lost to Follow-up|4|||
126226292|NCT00633152|454119323|FG001|Overall Study|Lost to Follow-up|1|||
126226293|NCT00633152|454119322|FG000|Overall Study|Miscellaneous Other|3|||
126226294|NCT00633152|454119323|FG001|Overall Study|Miscellaneous Other|2|||
126226295|NCT02049359|454119324|FG000|Overall Study|Lost to Follow-up|26|||
126226296|NCT02049359|454119325|FG001|Overall Study|Lost to Follow-up|19|||
126226297|NCT03273387|454119326|FG000|Overall Study|Death|2|||
126226298|NCT03273387|454119327|FG001|Overall Study|Death|2|||
126226299|NCT03273387|454119326|FG000|Overall Study|Withdrawal by Subject|1|||
126226300|NCT03273387|454119327|FG001|Overall Study|Withdrawal by Subject|1|||
126226301|NCT01907087|454119328|FG000|Overall Study|Withdrawal by Subject|1|||
126226302|NCT05216978|454119329|FG000|Overall Study|Withdrawal by Subject|3|||
126226303|NCT05216978|454119329|FG000|Overall Study|Lost to Follow-up|5|||
126226304|NCT00658320|454119333|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
126226305|NCT00658320|454119334|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
126226306|NCT00658320|454119333|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
126351779|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
126351780|NCT03317496|454578896|FG000|Phase 2: Treatment|Adverse Event|0|||
126351781|NCT03317496|454578897|FG001|Phase 2: Treatment|Adverse Event|0|||
126351782|NCT03317496|454578898|FG002|Phase 2: Treatment|Adverse Event|0|||
126351783|NCT03317496|454578899|FG003|Phase 2: Treatment|Adverse Event|0|||
126351784|NCT03317496|454578900|FG004|Phase 2: Treatment|Adverse Event|6|||
126351785|NCT03317496|454578896|FG000|Phase 2: Treatment|Progressive disease|0|||
126351786|NCT03317496|454578897|FG001|Phase 2: Treatment|Progressive disease|0|||
126351787|NCT03317496|454578898|FG002|Phase 2: Treatment|Progressive disease|0|||
126351788|NCT03317496|454578899|FG003|Phase 2: Treatment|Progressive disease|0|||
126351789|NCT03317496|454578900|FG004|Phase 2: Treatment|Progressive disease|22|||
126226307|NCT00658320|454119334|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
126226308|NCT00658320|454119333|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
126226309|NCT00658320|454119334|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
126226310|NCT00658320|454119333|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
126226311|NCT00658320|454119334|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
126226312|NCT00387712|454119353|FG000|Overall Study|Physician Decision|6|||
126226313|NCT00387712|454119354|FG001|Overall Study|Physician Decision|4|||
126226314|NCT00387712|454119353|FG000|Overall Study|Lost to Follow-up|17|||
126226315|NCT00387712|454119354|FG001|Overall Study|Lost to Follow-up|20|||
126351790|NCT03317496|454578896|FG000|Phase 2: Treatment|Other|0|||
126351791|NCT03317496|454578897|FG001|Phase 2: Treatment|Other|0|||
126351792|NCT03317496|454578898|FG002|Phase 2: Treatment|Other|0|||
126226316|NCT00387712|454119353|FG000|Overall Study|Withdrawal by Subject|6|||
126226317|NCT00387712|454119354|FG001|Overall Study|Withdrawal by Subject|12|||
126226318|NCT01907737|454119359|FG000|Overall Study|Withdrawal by Subject|1|||
126226319|NCT01772368|454119361|FG000|Overall Study|Adverse Event|1|||
126226320|NCT01772368|454119361|FG000|Overall Study|Withdrawal by Subject|3|||
126226321|NCT01772368|454119361|FG000|Overall Study|Protocol Violation|2|||
126226322|NCT01772368|454119361|FG000|Overall Study|Other|1|||
126226323|NCT01452529|454119362|FG000|Run-in Period|Adverse Event|96|||
126226324|NCT01452529|454119363|FG001|Run-in Period|Adverse Event|0|||
126226325|NCT01452529|454119364|FG002|Run-in Period|Adverse Event|0|||
126226326|NCT01452529|454119362|FG000|Run-in Period|Withdrawal by Subject|49|||
126226327|NCT01452529|454119363|FG001|Run-in Period|Withdrawal by Subject|0|||
126226328|NCT01452529|454119364|FG002|Run-in Period|Withdrawal by Subject|0|||
126226329|NCT01452529|454119362|FG000|Run-in Period|Lost to Follow-up|19|||
126226330|NCT01452529|454119363|FG001|Run-in Period|Lost to Follow-up|0|||
126226331|NCT01452529|454119364|FG002|Run-in Period|Lost to Follow-up|0|||
126226332|NCT01452529|454119362|FG000|Run-in Period|Lack of Efficacy|46|||
126226333|NCT01452529|454119363|FG001|Run-in Period|Lack of Efficacy|0|||
126226334|NCT01452529|454119364|FG002|Run-in Period|Lack of Efficacy|0|||
126226335|NCT01452529|454119362|FG000|Run-in Period|Confirmed or suspected diversion|23|||
126226336|NCT01452529|454119363|FG001|Run-in Period|Confirmed or suspected diversion|0|||
126226337|NCT01452529|454119364|FG002|Run-in Period|Confirmed or suspected diversion|0|||
126226338|NCT01452529|454119362|FG000|Run-in Period|Administrative|21|||
126226339|NCT01452529|454119363|FG001|Run-in Period|Administrative|0|||
126226340|NCT01452529|454119364|FG002|Run-in Period|Administrative|0|||
126226341|NCT01452529|454119362|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
126226342|NCT01452529|454119363|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
126226343|NCT01452529|454119364|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
126226344|NCT01452529|454119362|FG000|Double-blind (DB) Period|Adverse Event|0|||
126226345|NCT01452529|454119363|FG001|Double-blind (DB) Period|Adverse Event|18|||
126226346|NCT01452529|454119364|FG002|Double-blind (DB) Period|Adverse Event|11|||
126226347|NCT01452529|454119362|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
126226348|NCT01452529|454119363|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
126226349|NCT01452529|454119364|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
126226350|NCT01452529|454119362|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
126226351|NCT01452529|454119363|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
126226352|NCT01452529|454119364|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
126226353|NCT01452529|454119362|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
126226354|NCT01452529|454119363|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
126226355|NCT01452529|454119364|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
126226356|NCT01452529|454119362|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
126226357|NCT01452529|454119363|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
126226358|NCT01452529|454119364|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
126226359|NCT01452529|454119362|FG000|Double-blind (DB) Period|Administrative|0|||
126226360|NCT01452529|454119363|FG001|Double-blind (DB) Period|Administrative|11|||
126226361|NCT01452529|454119364|FG002|Double-blind (DB) Period|Administrative|7|||
126226362|NCT03551730|454119368|FG000|Overall Study|Adverse Event|1|||
126351793|NCT03317496|454578899|FG003|Phase 2: Treatment|Other|0|||
126351794|NCT03317496|454578900|FG004|Phase 2: Treatment|Other|4|||
126351795|NCT03317496|454578896|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
126351796|NCT03317496|454578897|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
126351797|NCT03317496|454578898|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
126351798|NCT03317496|454578899|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
126351799|NCT03317496|454578900|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
126351800|NCT03317496|454578896|FG000|Phase 2: Treatment|Physician Decision|0|||
126351801|NCT03317496|454578897|FG001|Phase 2: Treatment|Physician Decision|0|||
126351802|NCT03317496|454578898|FG002|Phase 2: Treatment|Physician Decision|0|||
126351803|NCT03317496|454578899|FG003|Phase 2: Treatment|Physician Decision|0|||
126351804|NCT03317496|454578900|FG004|Phase 2: Treatment|Physician Decision|1|||
126351805|NCT03317496|454578896|FG000|Phase 2: Treatment|Death|0|||
126351806|NCT03317496|454578897|FG001|Phase 2: Treatment|Death|0|||
126351807|NCT03317496|454578898|FG002|Phase 2: Treatment|Death|0|||
126351808|NCT03317496|454578899|FG003|Phase 2: Treatment|Death|0|||
126351809|NCT03317496|454578900|FG004|Phase 2: Treatment|Death|1|||
126351810|NCT03317496|454578896|FG000|Phase 2: Follow-up|Death|0|||
126351811|NCT03317496|454578897|FG001|Phase 2: Follow-up|Death|0|||
126351812|NCT03317496|454578898|FG002|Phase 2: Follow-up|Death|0|||
126226363|NCT03551730|454119369|FG001|Overall Study|Adverse Event|0|||
126226364|NCT03551730|454119370|FG002|Overall Study|Adverse Event|0|||
126226365|NCT03551730|454119371|FG003|Overall Study|Adverse Event|0|||
126226366|NCT03347695|454119372|FG000|Overall Study|Death|0|||
126226367|NCT03347695|454119373|FG001|Overall Study|Death|4|||
126226368|NCT03347695|454119372|FG000|Overall Study|Lost to Follow-up|0|||
126351813|NCT03317496|454578899|FG003|Phase 2: Follow-up|Death|0|||
126351814|NCT03317496|454578900|FG004|Phase 2: Follow-up|Death|24|||
126351815|NCT03317496|454578896|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
126351816|NCT03317496|454578897|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
126226369|NCT03347695|454119373|FG001|Overall Study|Lost to Follow-up|1|||
126226370|NCT02668783|454119374|FG000|Overall Study|Pregnancy|0|||
126226371|NCT02668783|454119375|FG001|Overall Study|Pregnancy|1|||
126226372|NCT02668783|454119374|FG000|Overall Study|Protocol Violation|2|||
126226373|NCT02668783|454119375|FG001|Overall Study|Protocol Violation|1|||
126226374|NCT02668783|454119374|FG000|Overall Study|Study terminated by sponsor|9|||
126226375|NCT02668783|454119375|FG001|Overall Study|Study terminated by sponsor|10|||
126226376|NCT02668783|454119374|FG000|Overall Study|Subject moved|1|||
126226377|NCT02668783|454119375|FG001|Overall Study|Subject moved|0|||
126226378|NCT02668783|454119374|FG000|Overall Study|Withdrawal by Subject|1|||
126226379|NCT02668783|454119375|FG001|Overall Study|Withdrawal by Subject|0|||
126226380|NCT01003886|454119378|FG000|Overall Study|Lack of Efficacy|5|||
126226381|NCT01003886|454119378|FG000|Overall Study|Lost to Follow-up|169|||
126226382|NCT01003886|454119378|FG000|Overall Study|Withdrawal by Subject|39|||
126226383|NCT01003886|454119378|FG000|Overall Study|Other|14|||
126226384|NCT01003886|454119378|FG000|Overall Study|Adverse Event|3|||
126226385|NCT04467697|454119379|FG000|Overall Study|Adverse Event|2|||
126226386|NCT04467697|454119379|FG000|Overall Study|Lost to Follow-up|6|||
126226387|NCT04467697|454119379|FG000|Overall Study|Withdrawal by Subject|9|||
126226388|NCT04467697|454119379|FG000|Overall Study|Protocol Violation|3|||
126226389|NCT00909727|454119382|FG000|Overall Study|Adverse Event|1|||
126226390|NCT00909727|454119383|FG001|Overall Study|Adverse Event|0|||
126226391|NCT00909727|454119382|FG000|Overall Study|Wrong Genotype|1|||
126226392|NCT00909727|454119383|FG001|Overall Study|Wrong Genotype|0|||
126226393|NCT00909727|454119382|FG000|Overall Study|Withdrawal of Consent|1|||
126351817|NCT03317496|454578898|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
126351818|NCT03317496|454578899|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
126351819|NCT03317496|454578900|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
126351820|NCT03317496|454578896|FG000|Phase 2: Follow-up|Other|0|||
126351821|NCT03317496|454578897|FG001|Phase 2: Follow-up|Other|0|||
126351822|NCT03317496|454578898|FG002|Phase 2: Follow-up|Other|0|||
126351823|NCT03317496|454578899|FG003|Phase 2: Follow-up|Other|0|||
126351824|NCT03317496|454578900|FG004|Phase 2: Follow-up|Other|1|||
126351825|NCT03317496|454578896|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
126351826|NCT03317496|454578897|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
126351827|NCT03317496|454578898|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
126351828|NCT03317496|454578899|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
126351829|NCT03317496|454578900|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
126351830|NCT02737618|454578901|FG000|Overall Study|Withdrawal by Subject|9|||
126351831|NCT00817063|454578904|FG000|Overall Study|Adverse Event|32|||
126351832|NCT00817063|454578905|FG001|Overall Study|Adverse Event|13|||
126351833|NCT00817063|454578904|FG000|Overall Study|Death|1|||
126351834|NCT00817063|454578905|FG001|Overall Study|Death|1|||
126351835|NCT00817063|454578904|FG000|Overall Study|Lack of Efficacy|33|||
126351836|NCT00817063|454578905|FG001|Overall Study|Lack of Efficacy|86|||
126351837|NCT00817063|454578904|FG000|Overall Study|Failure to Return|13|||
126351838|NCT00817063|454578905|FG001|Overall Study|Failure to Return|12|||
126351839|NCT00817063|454578904|FG000|Overall Study|Violation of Selection at Entry|7|||
126351840|NCT00817063|454578905|FG001|Overall Study|Violation of Selection at Entry|4|||
126351841|NCT00817063|454578904|FG000|Overall Study|Protocol Violation|3|||
126351842|NCT00817063|454578905|FG001|Overall Study|Protocol Violation|8|||
126351843|NCT00817063|454578904|FG000|Overall Study|Withdrawal by Subject|17|||
126351844|NCT00817063|454578905|FG001|Overall Study|Withdrawal by Subject|37|||
126351845|NCT00817063|454578904|FG000|Overall Study|Early Improvement|19|||
126351846|NCT00817063|454578905|FG001|Overall Study|Early Improvement|4|||
126351847|NCT00817063|454578904|FG000|Overall Study|Administrative|10|||
126351848|NCT00817063|454578905|FG001|Overall Study|Administrative|4|||
126351849|NCT00817063|454578904|FG000|Overall Study|Abnormality of Laboratory Test|2|||
126351850|NCT00817063|454578905|FG001|Overall Study|Abnormality of Laboratory Test|1|||
126351851|NCT02362451|454578907|FG000|Overall Study|Withdrawal by Subject|0|||
126351852|NCT02362451|454578908|FG001|Overall Study|Withdrawal by Subject|1|||
126351853|NCT02362451|454578907|FG000|Overall Study|Lack of Efficacy|2|||
126351854|NCT02362451|454578908|FG001|Overall Study|Lack of Efficacy|0|||
126351855|NCT02362451|454578907|FG000|Overall Study|Progression|1|||
126351856|NCT02362451|454578908|FG001|Overall Study|Progression|0|||
126351857|NCT02362451|454578907|FG000|Overall Study|Participant chose other therapy.|1|||
126351858|NCT02362451|454578908|FG001|Overall Study|Participant chose other therapy.|0|||
126226394|NCT00909727|454119383|FG001|Overall Study|Withdrawal of Consent|0|||
126226395|NCT00909727|454119382|FG000|Overall Study|Prohibited Medication|1|||
126226396|NCT00909727|454119383|FG001|Overall Study|Prohibited Medication|0|||
126226397|NCT04081337|454119384|FG000|Overall Study|Adverse Event|0|||
126226398|NCT04081337|454119385|FG001|Overall Study|Adverse Event|1|||
126351859|NCT01879852|454578909|FG000|Overall Study|Withdrawal by Subject|2|||
126351860|NCT01879852|454578910|FG001|Overall Study|Withdrawal by Subject|0|||
126351861|NCT02696616|454578912|FG000|Overall Study|Adverse Event|0|||
126226399|NCT04081337|454119384|FG000|Overall Study|Withdrawal by Subject|2|||
126351862|NCT02696616|454578913|FG001|Overall Study|Adverse Event|1|||
126226400|NCT04081337|454119385|FG001|Overall Study|Withdrawal by Subject|0|||
126226401|NCT04081337|454119384|FG000|Overall Study|Physician Decision|1|||
126226402|NCT04081337|454119385|FG001|Overall Study|Physician Decision|2|||
126226403|NCT04081337|454119384|FG000|Overall Study|Lost to Follow-up|1|||
126226404|NCT04081337|454119385|FG001|Overall Study|Lost to Follow-up|0|||
126226405|NCT00673361|454119392|FG000|Overall Study|Screen Failure|2|||
126226406|NCT01464827|454119393|FG000|Overall Study|Adverse Event|0|||
126226407|NCT01464827|454119394|FG001|Overall Study|Adverse Event|0|||
126226408|NCT01464827|454119395|FG002|Overall Study|Adverse Event|0|||
126226409|NCT01464827|454119396|FG003|Overall Study|Adverse Event|0|||
126226410|NCT01464827|454119397|FG004|Overall Study|Adverse Event|0|||
126226411|NCT01464827|454119398|FG005|Overall Study|Adverse Event|0|||
126226412|NCT01464827|454119399|FG006|Overall Study|Adverse Event|0|||
126226413|NCT01464827|454119400|FG007|Overall Study|Adverse Event|0|||
126226414|NCT01464827|454119401|FG008|Overall Study|Adverse Event|0|||
126226415|NCT01464827|454119402|FG009|Overall Study|Adverse Event|0|||
126226416|NCT01464827|454119403|FG010|Overall Study|Adverse Event|0|||
126226417|NCT01464827|454119404|FG011|Overall Study|Adverse Event|0|||
126226418|NCT01464827|454119405|FG012|Overall Study|Adverse Event|1|||
126226419|NCT01464827|454119406|FG013|Overall Study|Adverse Event|0|||
126226420|NCT01464827|454119393|FG000|Overall Study|Withdrawal by Subject|1|||
126226421|NCT01464827|454119394|FG001|Overall Study|Withdrawal by Subject|0|||
126226422|NCT01464827|454119395|FG002|Overall Study|Withdrawal by Subject|0|||
126226423|NCT01464827|454119396|FG003|Overall Study|Withdrawal by Subject|0|||
126226424|NCT01464827|454119397|FG004|Overall Study|Withdrawal by Subject|1|||
126226425|NCT01464827|454119398|FG005|Overall Study|Withdrawal by Subject|0|||
126226426|NCT01464827|454119399|FG006|Overall Study|Withdrawal by Subject|0|||
126226427|NCT01464827|454119400|FG007|Overall Study|Withdrawal by Subject|1|||
126226428|NCT01464827|454119401|FG008|Overall Study|Withdrawal by Subject|0|||
126226429|NCT01464827|454119402|FG009|Overall Study|Withdrawal by Subject|0|||
126226430|NCT01464827|454119403|FG010|Overall Study|Withdrawal by Subject|0|||
126226431|NCT01464827|454119404|FG011|Overall Study|Withdrawal by Subject|0|||
126226432|NCT01464827|454119405|FG012|Overall Study|Withdrawal by Subject|0|||
126226433|NCT01464827|454119406|FG013|Overall Study|Withdrawal by Subject|0|||
126226434|NCT01464827|454119393|FG000|Overall Study|Lost to Follow-up|0|||
126226435|NCT01464827|454119394|FG001|Overall Study|Lost to Follow-up|2|||
126226436|NCT01464827|454119395|FG002|Overall Study|Lost to Follow-up|0|||
126226437|NCT01464827|454119396|FG003|Overall Study|Lost to Follow-up|2|||
126226438|NCT01464827|454119397|FG004|Overall Study|Lost to Follow-up|3|||
126226439|NCT01464827|454119398|FG005|Overall Study|Lost to Follow-up|1|||
126226440|NCT01464827|454119399|FG006|Overall Study|Lost to Follow-up|2|||
126226441|NCT01464827|454119400|FG007|Overall Study|Lost to Follow-up|2|||
126226442|NCT01464827|454119401|FG008|Overall Study|Lost to Follow-up|0|||
126226443|NCT01464827|454119402|FG009|Overall Study|Lost to Follow-up|0|||
126226444|NCT01464827|454119403|FG010|Overall Study|Lost to Follow-up|0|||
126226445|NCT01464827|454119404|FG011|Overall Study|Lost to Follow-up|1|||
126226446|NCT01464827|454119405|FG012|Overall Study|Lost to Follow-up|0|||
126226447|NCT01464827|454119406|FG013|Overall Study|Lost to Follow-up|1|||
126226448|NCT01464827|454119393|FG000|Overall Study|Other|2|||
126226449|NCT01464827|454119394|FG001|Overall Study|Other|3|||
126226450|NCT01464827|454119395|FG002|Overall Study|Other|0|||
126226451|NCT01464827|454119396|FG003|Overall Study|Other|2|||
126226452|NCT01464827|454119397|FG004|Overall Study|Other|3|||
126226453|NCT01464827|454119398|FG005|Overall Study|Other|0|||
126226454|NCT01464827|454119399|FG006|Overall Study|Other|1|||
126226455|NCT01464827|454119400|FG007|Overall Study|Other|0|||
126226456|NCT01464827|454119401|FG008|Overall Study|Other|3|||
126226457|NCT01464827|454119402|FG009|Overall Study|Other|1|||
126226458|NCT01464827|454119403|FG010|Overall Study|Other|2|||
126226459|NCT01464827|454119404|FG011|Overall Study|Other|0|||
126226460|NCT01464827|454119405|FG012|Overall Study|Other|1|||
126226461|NCT01464827|454119406|FG013|Overall Study|Other|0|||
126226462|NCT01464827|454119393|FG000|Overall Study|Not Treated|0|||
126226463|NCT01464827|454119394|FG001|Overall Study|Not Treated|2|||
126226464|NCT01464827|454119395|FG002|Overall Study|Not Treated|0|||
126226465|NCT01464827|454119396|FG003|Overall Study|Not Treated|0|||
126226466|NCT01464827|454119397|FG004|Overall Study|Not Treated|1|||
126226467|NCT01464827|454119398|FG005|Overall Study|Not Treated|0|||
126226468|NCT01464827|454119399|FG006|Overall Study|Not Treated|1|||
126226469|NCT01464827|454119400|FG007|Overall Study|Not Treated|0|||
126226470|NCT01464827|454119401|FG008|Overall Study|Not Treated|0|||
126226471|NCT01464827|454119402|FG009|Overall Study|Not Treated|2|||
126226472|NCT01464827|454119403|FG010|Overall Study|Not Treated|0|||
126226473|NCT01464827|454119404|FG011|Overall Study|Not Treated|1|||
126226474|NCT01464827|454119405|FG012|Overall Study|Not Treated|0|||
126226475|NCT01464827|454119406|FG013|Overall Study|Not Treated|2|||
126226476|NCT01799590|454119409|FG000|Overall Study|Adverse Event|13|||
126226477|NCT01799590|454119410|FG001|Overall Study|Adverse Event|7|||
126226478|NCT01799590|454119411|FG002|Overall Study|Adverse Event|5|||
126226479|NCT01799590|454119409|FG000|Overall Study|Pregnancy|2|||
126226480|NCT01799590|454119410|FG001|Overall Study|Pregnancy|0|||
126226481|NCT01799590|454119411|FG002|Overall Study|Pregnancy|0|||
126226482|NCT01799590|454119409|FG000|Overall Study|Lack of Efficacy|3|||
126226483|NCT01799590|454119410|FG001|Overall Study|Lack of Efficacy|1|||
126226484|NCT01799590|454119411|FG002|Overall Study|Lack of Efficacy|3|||
126226485|NCT01799590|454119409|FG000|Overall Study|Participants convenience|4|||
126226486|NCT01799590|454119410|FG001|Overall Study|Participants convenience|4|||
126226487|NCT01799590|454119411|FG002|Overall Study|Participants convenience|2|||
126226488|NCT01799590|454119409|FG000|Overall Study|Aggravation of complications|0|||
126226489|NCT01799590|454119410|FG001|Overall Study|Aggravation of complications|1|||
126226490|NCT01799590|454119411|FG002|Overall Study|Aggravation of complications|1|||
126226491|NCT01799590|454119409|FG000|Overall Study|Using drugs with restricted days of use|0|||
126226492|NCT01799590|454119410|FG001|Overall Study|Using drugs with restricted days of use|3|||
126226493|NCT01799590|454119411|FG002|Overall Study|Using drugs with restricted days of use|2|||
126226494|NCT01799590|454119409|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
126226495|NCT01799590|454119410|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
126226496|NCT01799590|454119411|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
126226497|NCT01799590|454119409|FG000|Overall Study|Other|3|||
126226498|NCT01799590|454119410|FG001|Overall Study|Other|0|||
126226499|NCT01799590|454119411|FG002|Overall Study|Other|1|||
126226500|NCT03175120|454119414|FG000|Overall Study|Adverse Event|2|||
126226501|NCT03175120|454119415|FG001|Overall Study|Adverse Event|2|||
126226502|NCT03175120|454119414|FG000|Overall Study|Protocol Violation|5|||
126226503|NCT03175120|454119415|FG001|Overall Study|Protocol Violation|2|||
126226504|NCT03175120|454119414|FG000|Overall Study|Lost to Follow-up|1|||
126226505|NCT03175120|454119415|FG001|Overall Study|Lost to Follow-up|0|||
126226506|NCT03175120|454119414|FG000|Overall Study|Withdrawal by Subject|2|||
126226507|NCT03175120|454119415|FG001|Overall Study|Withdrawal by Subject|5|||
126226508|NCT03175120|454119414|FG000|Overall Study|Other|2|||
126226509|NCT03175120|454119415|FG001|Overall Study|Other|3|||
126226510|NCT00678392|454119416|FG000|Overall Study|Adverse Event|0|||
126226511|NCT00678392|454119417|FG001|Overall Study|Adverse Event|6|||
126226512|NCT00678392|454119416|FG000|Overall Study|Death|280|||
126226513|NCT00678392|454119417|FG001|Overall Study|Death|269|||
126226514|NCT00678392|454119416|FG000|Overall Study|Lost to Follow-up|15|||
126021050|NCT00421889|453373161|FG002|Overall Study|Adverse Event|1|||
126021051|NCT00421889|453373162|FG003|Overall Study|Adverse Event|1|||
126226515|NCT00678392|454119417|FG001|Overall Study|Lost to Follow-up|13|||
126226516|NCT00678392|454119416|FG000|Overall Study|Objective Progression or Relapse|3|||
126226517|NCT00678392|454119417|FG001|Overall Study|Objective Progression or Relapse|8|||
126226518|NCT00678392|454119416|FG000|Overall Study|Sponsor's Decision|1|||
126226519|NCT00678392|454119417|FG001|Overall Study|Sponsor's Decision|2|||
126226520|NCT00678392|454119416|FG000|Overall Study|Withdrawal by Subject|4|||
126226521|NCT00678392|454119417|FG001|Overall Study|Withdrawal by Subject|4|||
126226522|NCT00678392|454119416|FG000|Overall Study|Randomized But Not Treated|2|||
126226523|NCT00678392|454119417|FG001|Overall Study|Randomized But Not Treated|7|||
126226524|NCT00678392|454119416|FG000|Overall Study|Other|56|||
126226525|NCT00678392|454119417|FG001|Overall Study|Other|53|||
126226526|NCT03341507|454119419|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
126226527|NCT03882047|454119420|FG000|Overall Study|Adverse Event|0|||
126226528|NCT03882047|454119421|FG001|Overall Study|Adverse Event|2|||
126226529|NCT03882047|454119422|FG002|Overall Study|Adverse Event|2|||
126226530|NCT03882047|454119420|FG000|Overall Study|Treatment Failure|3|||
126226531|NCT03882047|454119421|FG001|Overall Study|Treatment Failure|3|||
126226532|NCT03882047|454119422|FG002|Overall Study|Treatment Failure|12|||
126226533|NCT03882047|454119420|FG000|Overall Study|Lost to Follow-up|0|||
126226534|NCT03882047|454119421|FG001|Overall Study|Lost to Follow-up|1|||
126226535|NCT03882047|454119422|FG002|Overall Study|Lost to Follow-up|0|||
126226536|NCT03882047|454119420|FG000|Overall Study|Did Not Wish to Continue|1|||
126226537|NCT03882047|454119421|FG001|Overall Study|Did Not Wish to Continue|4|||
126226538|NCT03882047|454119422|FG002|Overall Study|Did Not Wish to Continue|1|||
126226539|NCT03882047|454119420|FG000|Overall Study|Noncompliance With Protocol|2|||
126226540|NCT03882047|454119421|FG001|Overall Study|Noncompliance With Protocol|0|||
126226541|NCT03882047|454119422|FG002|Overall Study|Noncompliance With Protocol|0|||
126226542|NCT03882047|454119420|FG000|Overall Study|Did Not Meet Eligibility|0|||
126226543|NCT03882047|454119421|FG001|Overall Study|Did Not Meet Eligibility|0|||
126226544|NCT03882047|454119422|FG002|Overall Study|Did Not Meet Eligibility|1|||
126226545|NCT00441584|454119425|FG000|Overall Study|Lack of Efficacy|79|||
126226546|NCT00441584|454119425|FG000|Overall Study|Withdrawal by Subject|8|||
126226547|NCT00441584|454119425|FG000|Overall Study|Adverse Event|6|||
126226548|NCT00441584|454119425|FG000|Overall Study|Protocol Violation|5|||
126226549|NCT00441584|454119425|FG000|Overall Study|Lost to Follow-up|4|||
126226550|NCT00441584|454119425|FG000|Overall Study|Failure to meet eligibility criteria|3|||
126226551|NCT00770991|454119430|FG000|Overall Study|Physician Decision|2|||
126226552|NCT00770991|454119431|FG001|Overall Study|Physician Decision|0|||
126226553|NCT00770991|454119430|FG000|Overall Study|Withdrawal by Subject|1|||
126226554|NCT00770991|454119431|FG001|Overall Study|Withdrawal by Subject|0|||
126226555|NCT00770991|454119430|FG000|Overall Study|Adverse Event|1|||
126226556|NCT00770991|454119431|FG001|Overall Study|Adverse Event|5|||
126021052|NCT00421889|453373163|FG004|Overall Study|Adverse Event|1|||
126226557|NCT00770991|454119430|FG000|Overall Study|Pregnancy|1|||
126226558|NCT00770991|454119431|FG001|Overall Study|Pregnancy|0|||
126226559|NCT03465891|454119432|FG000|Overall Study|Withdrawal by Subject|0|||
126226560|NCT03465891|454119433|FG001|Overall Study|Withdrawal by Subject|1|||
126226561|NCT03465891|454119432|FG000|Overall Study|Disease progression|1|||
126226562|NCT03465891|454119433|FG001|Overall Study|Disease progression|0|||
126226563|NCT01001169|454119434|FG000|Overall Study|Withdrawal by Subject|2|||
126226564|NCT01001169|454119435|FG001|Overall Study|Withdrawal by Subject|1|||
126226565|NCT02040766|454119438|FG000|Overall Study|Adverse Event|1|||
126226566|NCT02040766|454119439|FG001|Overall Study|Adverse Event|1|||
126226567|NCT02040766|454119440|FG002|Overall Study|Adverse Event|1|||
126226568|NCT02040766|454119441|FG003|Overall Study|Adverse Event|0|||
126226569|NCT02040766|454119442|FG004|Overall Study|Adverse Event|2|||
126226570|NCT02040766|454119438|FG000|Overall Study|Withdrawal by Subject|4|||
126226571|NCT02040766|454119439|FG001|Overall Study|Withdrawal by Subject|3|||
126226572|NCT02040766|454119440|FG002|Overall Study|Withdrawal by Subject|2|||
126226573|NCT02040766|454119441|FG003|Overall Study|Withdrawal by Subject|3|||
126351863|NCT02696616|454578914|FG002|Overall Study|Adverse Event|0|||
126351864|NCT02696616|454578915|FG003|Overall Study|Adverse Event|0|||
126351865|NCT02696616|454578916|FG004|Overall Study|Adverse Event|0|||
126351866|NCT02696616|454578917|FG005|Overall Study|Adverse Event|0|||
126351867|NCT02696616|454578918|FG006|Overall Study|Adverse Event|0|||
126351868|NCT01500083|454578919|FG000|Overall Study|Adverse Event|4|||
126226574|NCT02040766|454119442|FG004|Overall Study|Withdrawal by Subject|2|||
126226575|NCT02040766|454119438|FG000|Overall Study|Non-compliance|0|||
126226576|NCT02040766|454119439|FG001|Overall Study|Non-compliance|1|||
126226577|NCT02040766|454119440|FG002|Overall Study|Non-compliance|0|||
126226578|NCT02040766|454119441|FG003|Overall Study|Non-compliance|0|||
126226579|NCT02040766|454119442|FG004|Overall Study|Non-compliance|0|||
126226580|NCT02040766|454119438|FG000|Overall Study|Protocol Violation|2|||
126226581|NCT02040766|454119439|FG001|Overall Study|Protocol Violation|1|||
126226582|NCT02040766|454119440|FG002|Overall Study|Protocol Violation|2|||
126226583|NCT02040766|454119441|FG003|Overall Study|Protocol Violation|3|||
126351869|NCT01500083|454578920|FG001|Overall Study|Adverse Event|17|||
126351870|NCT01500083|454578919|FG000|Overall Study|Death|0|||
126351871|NCT01500083|454578920|FG001|Overall Study|Death|2|||
126351872|NCT01500083|454578919|FG000|Overall Study|Lost to Follow-up|1|||
126351873|NCT01500083|454578920|FG001|Overall Study|Lost to Follow-up|0|||
126351874|NCT01500083|454578919|FG000|Overall Study|Withdrawal of Consent|0|||
126351875|NCT01500083|454578920|FG001|Overall Study|Withdrawal of Consent|1|||
126351876|NCT01500083|454578919|FG000|Overall Study|Disease Progression|2|||
126351877|NCT01500083|454578920|FG001|Overall Study|Disease Progression|10|||
126351878|NCT01500083|454578919|FG000|Overall Study|Investigator Discretion|3|||
126351879|NCT01500083|454578920|FG001|Overall Study|Investigator Discretion|8|||
126351880|NCT01500083|454578919|FG000|Overall Study|Other Reasons|2|||
126351881|NCT01500083|454578920|FG001|Overall Study|Other Reasons|5|||
126351882|NCT01555931|454578921|FG000|Overall Study|Lost to Follow-up|2|||
126351883|NCT01555931|454578922|FG001|Overall Study|Lost to Follow-up|5|||
126351884|NCT01922011|454578923|FG000|Overall Study|Protocol Violation|0|||
126351885|NCT01922011|454578924|FG001|Overall Study|Protocol Violation|1|||
126351886|NCT01922011|454578923|FG000|Overall Study|Physician Decision|0|||
126351887|NCT01922011|454578924|FG001|Overall Study|Physician Decision|1|||
126351888|NCT01922011|454578923|FG000|Overall Study|Parent/Guardian Decision|3|||
126351889|NCT01922011|454578924|FG001|Overall Study|Parent/Guardian Decision|0|||
126351890|NCT01922011|454578923|FG000|Overall Study|Lost to Follow-up|0|||
126351891|NCT01922011|454578924|FG001|Overall Study|Lost to Follow-up|1|||
126351892|NCT01922011|454578923|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
126351893|NCT01922011|454578924|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
126351894|NCT01922011|454578923|FG000|Overall Study|Not Treated|1|||
126351895|NCT01922011|454578924|FG001|Overall Study|Not Treated|0|||
126351896|NCT01922011|454578923|FG000|Overall Study|Lack of willing home health agency|1|||
126351897|NCT01922011|454578924|FG001|Overall Study|Lack of willing home health agency|0|||
126351898|NCT01922011|454578923|FG000|Overall Study|Randomized in error|1|||
126351899|NCT01922011|454578924|FG001|Overall Study|Randomized in error|0|||
126351900|NCT02299167|454578927|FG000|Overall Study|patients were excluded from the study|11|||
126021053|NCT00421889|453373164|FG005|Overall Study|Adverse Event|4|||
126226584|NCT02040766|454119442|FG004|Overall Study|Protocol Violation|0|||
126226585|NCT02040766|454119438|FG000|Overall Study|Lost to Follow-up|4|||
126226586|NCT02040766|454119439|FG001|Overall Study|Lost to Follow-up|1|||
126226587|NCT02040766|454119440|FG002|Overall Study|Lost to Follow-up|3|||
126226588|NCT02040766|454119441|FG003|Overall Study|Lost to Follow-up|1|||
126226589|NCT02040766|454119442|FG004|Overall Study|Lost to Follow-up|4|||
126351901|NCT04615507|454578928|FG000|Period 1|Covid-19 exposure|2|||
126226590|NCT02040766|454119438|FG000|Overall Study|Not reported|1|||
126226591|NCT02040766|454119439|FG001|Overall Study|Not reported|0|||
126351902|NCT04615507|454578929|FG001|Period 1|Covid-19 exposure|1|||
126351903|NCT04615507|454578928|FG000|Period 2|Covid-19 exposure|0|||
126226592|NCT02040766|454119440|FG002|Overall Study|Not reported|0|||
126226593|NCT02040766|454119441|FG003|Overall Study|Not reported|0|||
126226594|NCT02040766|454119442|FG004|Overall Study|Not reported|0|||
126226595|NCT02040766|454119438|FG000|Overall Study|Lack of Efficacy|6|||
126226596|NCT02040766|454119439|FG001|Overall Study|Lack of Efficacy|3|||
126226597|NCT02040766|454119440|FG002|Overall Study|Lack of Efficacy|4|||
126226598|NCT02040766|454119441|FG003|Overall Study|Lack of Efficacy|6|||
126226599|NCT02040766|454119442|FG004|Overall Study|Lack of Efficacy|5|||
126226600|NCT00926289|454119445|FG000|Overall Study|Adverse Event|9|||
126226601|NCT00926289|454119446|FG001|Overall Study|Adverse Event|11|||
126226602|NCT00926289|454119445|FG000|Overall Study|Protocol Violation|8|||
126226603|NCT00926289|454119446|FG001|Overall Study|Protocol Violation|12|||
126226604|NCT00926289|454119445|FG000|Overall Study|Lost to Follow-up|3|||
126226605|NCT00926289|454119446|FG001|Overall Study|Lost to Follow-up|6|||
126226606|NCT00926289|454119445|FG000|Overall Study|Withdrawal by Subject|4|||
126226607|NCT00926289|454119446|FG001|Overall Study|Withdrawal by Subject|4|||
126226608|NCT00926289|454119445|FG000|Overall Study|Other|1|||
126226609|NCT00926289|454119446|FG001|Overall Study|Other|3|||
126226610|NCT01193517|454119447|FG000|Overall Study|Early Progression|1|||
126226611|NCT01193517|454119448|FG001|Overall Study|Early Progression|0|||
126226612|NCT01193517|454119449|FG002|Overall Study|Early Progression|0|||
126226613|NCT02115256|454119450|FG000|Overall Study|Withdrawal by Subject|0|||
126226614|NCT02115256|454119451|FG001|Overall Study|Withdrawal by Subject|1|||
126226615|NCT00526890|454119453|FG000|Overall Study|Adverse Event|2|||
126226616|NCT03529955|454119454|FG000|Overall Study|Adverse Event|1|||
126226617|NCT03529955|454119454|FG000|Overall Study|Lack of Efficacy|1|||
126226618|NCT00580983|454119455|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
126226619|NCT03740100|454119456|FG000|Overall Study|Adverse Event|1|||
126226620|NCT03740100|454119456|FG000|Overall Study|Death|1|||
126226621|NCT03387059|454119458|FG000|Overall Study|Study termination|5|||
126226622|NCT03387059|454119459|FG001|Overall Study|Study termination|4|||
126226623|NCT01859702|454119460|FG000|Overall Study|Protocol deviation|3|||
126226624|NCT01859702|454119460|FG000|Overall Study|Adverse Event|2|||
126226625|NCT02004847|454121085|FG000|Overall Study|Protocol Violation|1|||
126226626|NCT02004847|454121086|FG001|Overall Study|Protocol Violation|1|||
126226627|NCT02806232|454121095|FG000|Overall Study|Lost to Follow-up|1|||
126226628|NCT02806232|454121096|FG001|Overall Study|Lost to Follow-up|2|||
126226629|NCT02806232|454121097|FG002|Overall Study|Lost to Follow-up|1|||
126226630|NCT02806232|454121098|FG003|Overall Study|Lost to Follow-up|0|||
126226631|NCT02806232|454121099|FG004|Overall Study|Lost to Follow-up|0|||
126226632|NCT02806232|454121100|FG005|Overall Study|Lost to Follow-up|1|||
126226633|NCT02806232|454121101|FG006|Overall Study|Lost to Follow-up|0|||
126226634|NCT02806232|454121102|FG007|Overall Study|Lost to Follow-up|0|||
126226635|NCT02806232|454121103|FG008|Overall Study|Lost to Follow-up|0|||
126226636|NCT02806232|454121095|FG000|Overall Study|Withdrawal by Subject|0|||
126226637|NCT02806232|454121096|FG001|Overall Study|Withdrawal by Subject|2|||
126226638|NCT02806232|454121097|FG002|Overall Study|Withdrawal by Subject|0|||
126226639|NCT02806232|454121098|FG003|Overall Study|Withdrawal by Subject|0|||
126226640|NCT02806232|454121099|FG004|Overall Study|Withdrawal by Subject|2|||
126226641|NCT02806232|454121100|FG005|Overall Study|Withdrawal by Subject|1|||
126226642|NCT02806232|454121101|FG006|Overall Study|Withdrawal by Subject|0|||
126226643|NCT02806232|454121102|FG007|Overall Study|Withdrawal by Subject|0|||
126226644|NCT02806232|454121103|FG008|Overall Study|Withdrawal by Subject|0|||
126226645|NCT00759148|454121104|FG000|Overall Study|Adverse Event|1|||
126351904|NCT04615507|454578929|FG001|Period 2|Covid-19 exposure|1|||
126226646|NCT00759148|454121105|FG001|Overall Study|Adverse Event|6|||
126226647|NCT00759148|454121104|FG000|Overall Study|Withdrawal by Subject|3|||
126226648|NCT00759148|454121105|FG001|Overall Study|Withdrawal by Subject|7|||
126226649|NCT00759148|454121104|FG000|Overall Study|Lost to Follow-up|3|||
126226650|NCT00759148|454121105|FG001|Overall Study|Lost to Follow-up|9|||
126226651|NCT00759148|454121104|FG000|Overall Study|Treatment Failure|6|||
126226652|NCT00759148|454121105|FG001|Overall Study|Treatment Failure|10|||
126226653|NCT00759148|454121104|FG000|Overall Study|Reason not given|1|||
126226654|NCT00759148|454121105|FG001|Overall Study|Reason not given|0|||
126226655|NCT00434161|454121108|FG000|Overall Study|Adverse Event|5|||
126226656|NCT00434161|454121109|FG001|Overall Study|Adverse Event|1|||
126226657|NCT00434161|454121110|FG002|Overall Study|Adverse Event|4|||
126226658|NCT00434161|454121108|FG000|Overall Study|Lost to Follow-up|0|||
126226659|NCT00434161|454121109|FG001|Overall Study|Lost to Follow-up|1|||
126226660|NCT00434161|454121110|FG002|Overall Study|Lost to Follow-up|0|||
126226661|NCT00434161|454121108|FG000|Overall Study|Death|1|||
126226662|NCT00434161|454121109|FG001|Overall Study|Death|0|||
126226663|NCT00434161|454121110|FG002|Overall Study|Death|1|||
126226664|NCT00434161|454121108|FG000|Overall Study|Non-Compliance|1|||
126226665|NCT00434161|454121109|FG001|Overall Study|Non-Compliance|1|||
126226666|NCT00434161|454121110|FG002|Overall Study|Non-Compliance|0|||
126226667|NCT00434161|454121108|FG000|Overall Study|Withdrawal by Subject|2|||
126226668|NCT00434161|454121109|FG001|Overall Study|Withdrawal by Subject|0|||
126226669|NCT00434161|454121110|FG002|Overall Study|Withdrawal by Subject|3|||
126226670|NCT00434161|454121108|FG000|Overall Study|Logistical error study assessments|1|||
126226671|NCT00434161|454121109|FG001|Overall Study|Logistical error study assessments|0|||
126226672|NCT00434161|454121110|FG002|Overall Study|Logistical error study assessments|3|||
126226673|NCT03342898|454121111|FG000|Overall Study|Adverse Event|3|||
126226674|NCT03342898|454121112|FG001|Overall Study|Adverse Event|1|||
126226675|NCT03342898|454121113|FG002|Overall Study|Adverse Event|0|||
126226676|NCT03342898|454121111|FG000|Overall Study|Lost to Follow-up|44|||
126226677|NCT03342898|454121112|FG001|Overall Study|Lost to Follow-up|40|||
126226678|NCT03342898|454121113|FG002|Overall Study|Lost to Follow-up|42|||
126226679|NCT03342898|454121111|FG000|Overall Study|Withdrawal of Consent|5|||
126226680|NCT03342898|454121112|FG001|Overall Study|Withdrawal of Consent|9|||
126226681|NCT03342898|454121113|FG002|Overall Study|Withdrawal of Consent|11|||
126226682|NCT03342898|454121111|FG000|Overall Study|Death|0|||
126226683|NCT03342898|454121112|FG001|Overall Study|Death|1|||
126226684|NCT03342898|454121113|FG002|Overall Study|Death|1|||
126226685|NCT03342898|454121111|FG000|Overall Study|Reason not Specified|2|||
126226686|NCT03342898|454121112|FG001|Overall Study|Reason not Specified|2|||
126226687|NCT03342898|454121113|FG002|Overall Study|Reason not Specified|0|||
126226688|NCT01387282|454121114|FG000|Overall Study|Death|47|||
126226689|NCT01387282|454121115|FG001|Overall Study|Death|16|||
126226690|NCT01387282|454121114|FG000|Overall Study|Other|5|||
126226691|NCT01387282|454121115|FG001|Overall Study|Other|1|||
126226692|NCT01387282|454121114|FG000|Overall Study|Unrelated AE|6|||
126226693|NCT01387282|454121115|FG001|Overall Study|Unrelated AE|4|||
126226694|NCT01387282|454121114|FG000|Overall Study|Withdrawal by patient|33|||
126226695|NCT01387282|454121115|FG001|Overall Study|Withdrawal by patient|23|||
126226696|NCT01387282|454121114|FG000|Overall Study|Study drug-related AE|2|||
126226697|NCT01387282|454121115|FG001|Overall Study|Study drug-related AE|2|||
126226698|NCT01387282|454121114|FG000|Overall Study|Lost to Follow-up|4|||
126226699|NCT01387282|454121115|FG001|Overall Study|Lost to Follow-up|1|||
126226700|NCT03997448|454121116|FG000|Study Treatment|Disease Progression|1|||
126226701|NCT03997448|454121116|FG000|Study Treatment|Symptomatic Deterioration|1|||
126226702|NCT03997448|454121116|FG000|Follow up|Death|2|||
126226703|NCT03997448|454121116|FG000|Follow up|study terminated|1|||
126226704|NCT01267266|454121119|FG000|Enrollment Phase|Withdrawal by Subject|2|||
126226705|NCT01267266|454121120|FG001|Enrollment Phase|Withdrawal by Subject|0|||
126226706|NCT01267266|454121119|FG000|Lead-in Phase|Lack of Efficacy|20|||
126226707|NCT01267266|454121120|FG001|Lead-in Phase|Lack of Efficacy|0|||
126226708|NCT01267266|454121119|FG000|Lead-in Phase|Adverse Event|2|||
126226709|NCT01267266|454121120|FG001|Lead-in Phase|Adverse Event|0|||
126226710|NCT01267266|454121119|FG000|Lead-in Phase|Withdrawal by Subject|1|||
126226711|NCT01267266|454121120|FG001|Lead-in Phase|Withdrawal by Subject|0|||
126226712|NCT02497391|454121121|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
126226713|NCT02497391|454121122|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
126226714|NCT02497391|454121123|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
126226715|NCT02497391|454121124|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
126226716|NCT02497391|454121125|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
126226717|NCT02497391|454121126|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
126226718|NCT02497391|454121121|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
126226719|NCT02497391|454121122|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
126226720|NCT02497391|454121123|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
126226721|NCT02497391|454121124|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
126226722|NCT02497391|454121125|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
126226723|NCT02497391|454121126|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
126226724|NCT02497391|454121121|FG000|Period 3 (14 Days)|Adverse Event|0|||
126226725|NCT02497391|454121122|FG001|Period 3 (14 Days)|Adverse Event|1|||
126226726|NCT02497391|454121123|FG002|Period 3 (14 Days)|Adverse Event|0|||
126226727|NCT02497391|454121124|FG003|Period 3 (14 Days)|Adverse Event|0|||
126226728|NCT02497391|454121125|FG004|Period 3 (14 Days)|Adverse Event|0|||
126226729|NCT02497391|454121126|FG005|Period 3 (14 Days)|Adverse Event|0|||
126226730|NCT02497391|454121121|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
126226731|NCT02497391|454121122|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
126226732|NCT02497391|454121123|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
126226733|NCT02497391|454121124|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
126226734|NCT02497391|454121125|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
126226735|NCT02497391|454121126|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
126226736|NCT02497391|454121121|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
126226737|NCT02497391|454121122|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
126226738|NCT02497391|454121123|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
126226739|NCT02497391|454121124|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
126226740|NCT02497391|454121125|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
126226741|NCT02497391|454121126|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
126226742|NCT00268346|454121140|FG000|Overall Study|Adverse Event|0|||
126226743|NCT00268346|454121141|FG001|Overall Study|Adverse Event|1|||
126226744|NCT00268346|454121140|FG000|Overall Study|Death|0|||
126226745|NCT00268346|454121141|FG001|Overall Study|Death|1|||
126226746|NCT00268346|454121140|FG000|Overall Study|Withdrawal by Subject|0|||
126226747|NCT00268346|454121141|FG001|Overall Study|Withdrawal by Subject|1|||
126226748|NCT05487456|454121142|FG000|Overall Study|Withdrawal by Subject|0|||
126226749|NCT05487456|454121143|FG001|Overall Study|Withdrawal by Subject|0|||
126226750|NCT05487456|454121144|FG002|Overall Study|Withdrawal by Subject|1|||
126226751|NCT05487456|454121145|FG003|Overall Study|Withdrawal by Subject|0|||
126226752|NCT00294723|454121148|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
126226753|NCT00294723|454121149|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
126226754|NCT00294723|454121150|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
126226755|NCT00294723|454121148|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
126226756|NCT00294723|454121149|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
126226757|NCT00294723|454121150|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
126226758|NCT00294723|454121148|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
126226759|NCT00294723|454121149|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
126226760|NCT00294723|454121150|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
126226761|NCT00294723|454121148|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
126226762|NCT00294723|454121149|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
126226763|NCT00294723|454121150|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
126226764|NCT00294723|454121148|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
126226765|NCT00294723|454121149|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
126226766|NCT00294723|454121150|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
126226767|NCT00294723|454121148|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
126226768|NCT00294723|454121149|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
126226769|NCT00294723|454121150|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
126226770|NCT00294723|454121148|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
126226771|NCT00294723|454121149|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
126226772|NCT00294723|454121150|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
126226773|NCT00294723|454121148|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
126226774|NCT00294723|454121149|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
126226775|NCT00294723|454121150|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
126226776|NCT00294723|454121148|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
126226777|NCT00294723|454121149|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
126226778|NCT00294723|454121150|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
126226779|NCT00294723|454121148|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
126226780|NCT00294723|454121149|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
126226781|NCT00294723|454121150|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
126226782|NCT00294723|454121148|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
126226783|NCT00294723|454121149|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
126226784|NCT00294723|454121150|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
126226785|NCT00294723|454121148|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
126226786|NCT00294723|454121149|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
126226787|NCT00294723|454121150|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
126226788|NCT00752791|454121151|FG000|Overall Study|Adverse Event|7|||
126226789|NCT00752791|454121151|FG000|Overall Study|Withdrawal by Subject|1|||
126226790|NCT00752791|454121151|FG000|Overall Study|Physician Decision|1|||
126226791|NCT00752791|454121151|FG000|Overall Study|Death|1|||
126226792|NCT00752791|454121151|FG000|Overall Study|Renal transplant|3|||
126226793|NCT00752791|454121151|FG000|Overall Study|Switched to hemodialysis|2|||
126226794|NCT00752791|454121151|FG000|Overall Study|Protocol deviation|1|||
126226795|NCT01958281|454121152|FG000|Overall Study|Lack of Efficacy|5|||
126226796|NCT01958281|454121153|FG001|Overall Study|Lack of Efficacy|2|||
126226797|NCT01958281|454121154|FG002|Overall Study|Lack of Efficacy|0|||
126226798|NCT01958281|454121152|FG000|Overall Study|Adverse Event|0|||
126226799|NCT01958281|454121153|FG001|Overall Study|Adverse Event|2|||
126226800|NCT01958281|454121154|FG002|Overall Study|Adverse Event|0|||
126226801|NCT01958281|454121152|FG000|Overall Study|Withdrew Consent|1|||
126226802|NCT01958281|454121153|FG001|Overall Study|Withdrew Consent|0|||
126226803|NCT01958281|454121154|FG002|Overall Study|Withdrew Consent|0|||
126226804|NCT02784106|454121155|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
126226805|NCT02784106|454121156|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
126226806|NCT02784106|454121157|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
126226807|NCT02784106|454121158|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
126226808|NCT02784106|454121155|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
126226809|NCT02784106|454121156|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
126226810|NCT02784106|454121157|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126226811|NCT02784106|454121158|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126226812|NCT02784106|454121155|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
126226813|NCT02784106|454121156|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
126226814|NCT02784106|454121157|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
126226815|NCT02784106|454121158|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
126226816|NCT02784106|454121155|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
126226817|NCT02784106|454121156|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126226818|NCT02784106|454121157|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126226819|NCT02784106|454121158|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126226820|NCT02784106|454121155|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
126226821|NCT02784106|454121156|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
126226822|NCT02784106|454121157|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
126226823|NCT02784106|454121158|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
126226824|NCT02784106|454121155|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
126226825|NCT02784106|454121156|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
126226826|NCT02784106|454121157|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
126226827|NCT02784106|454121158|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
126226828|NCT03222141|454121159|FG000|Overall Study|Death|15|||
126226829|NCT03222141|454121159|FG000|Overall Study|Lost to Follow-up|3|||
126226830|NCT02536378|454121160|FG000|Overall Study|Physician Decision|0|||
126226831|NCT02536378|454121161|FG001|Overall Study|Physician Decision|2|||
126226832|NCT02536378|454121160|FG000|Overall Study|Withdrawal by Subject|0|||
126226833|NCT02536378|454121161|FG001|Overall Study|Withdrawal by Subject|1|||
126226834|NCT02536378|454121160|FG000|Overall Study|Death|1|||
126226835|NCT02536378|454121161|FG001|Overall Study|Death|2|||
126226836|NCT02536378|454121160|FG000|Overall Study|Patient refused further follow up|6|||
126226837|NCT02536378|454121161|FG001|Overall Study|Patient refused further follow up|2|||
126226838|NCT00798889|454121162|FG000|Overall Study|Adverse Event|53|||
126226839|NCT00798889|454121162|FG000|Overall Study|Protocol Violation|2|||
126226840|NCT00798889|454121162|FG000|Overall Study|Withdrawal by Subject|31|||
126226841|NCT00798889|454121162|FG000|Overall Study|Lost to Follow-up|1|||
126226842|NCT00798889|454121162|FG000|Overall Study|Lack of Efficacy|213|||
126226843|NCT00798889|454121162|FG000|Overall Study|Decision of Sponsor|11|||
126351905|NCT04615507|454578928|FG000|Period 2|Protocol Violation|1|||
126351906|NCT04615507|454578929|FG001|Period 2|Protocol Violation|0|||
126351907|NCT04615507|454578928|FG000|Period 2|Withdrawal by Subject|1|||
126226844|NCT00798889|454121162|FG000|Overall Study|Enrolled, Not treated|3|||
126226845|NCT00617461|454121163|FG000|First Treatment Intervention Period|Adverse Event|2|||
126351908|NCT04615507|454578929|FG001|Period 2|Withdrawal by Subject|0|||
126226846|NCT00617461|454121164|FG001|First Treatment Intervention Period|Adverse Event|0|||
126351909|NCT04615507|454578928|FG000|Period 2|Adverse Event|0|||
126351910|NCT04615507|454578929|FG001|Period 2|Adverse Event|1|||
126093011|NCT01302080|453634463|FG001|Overall Study|Death|0|||
126351911|NCT04615507|454578928|FG000|Period 3|Covid-19 exposure|0|||
126351912|NCT04615507|454578929|FG001|Period 3|Covid-19 exposure|1|||
126351913|NCT00700635|454578930|FG000|Overall Study|Adverse Event|1|||
126021054|NCT00421889|453373165|FG006|Overall Study|Adverse Event|1|||
126021055|NCT00421889|453373166|FG007|Overall Study|Adverse Event|0|||
126021056|NCT00421889|453373167|FG008|Overall Study|Adverse Event|2|||
126351914|NCT00700635|454578931|FG001|Overall Study|Adverse Event|0|||
126351915|NCT00700635|454578932|FG002|Overall Study|Adverse Event|0|||
126351916|NCT00700635|454578930|FG000|Overall Study|Lost to Follow-up|1|||
126021057|NCT00421889|453373159|FG000|Overall Study|Withdrawal by Subject|1|||
126021058|NCT00421889|453373160|FG001|Overall Study|Withdrawal by Subject|3|||
126021059|NCT00421889|453373161|FG002|Overall Study|Withdrawal by Subject|0|||
126021060|NCT00421889|453373162|FG003|Overall Study|Withdrawal by Subject|0|||
126021061|NCT00421889|453373163|FG004|Overall Study|Withdrawal by Subject|2|||
126021062|NCT00421889|453373164|FG005|Overall Study|Withdrawal by Subject|0|||
126021063|NCT00421889|453373165|FG006|Overall Study|Withdrawal by Subject|0|||
126021064|NCT00421889|453373166|FG007|Overall Study|Withdrawal by Subject|0|||
126021065|NCT00421889|453373167|FG008|Overall Study|Withdrawal by Subject|0|||
126021066|NCT00421889|453373159|FG000|Overall Study|Death|0|||
126021067|NCT00421889|453373160|FG001|Overall Study|Death|0|||
126021068|NCT00421889|453373161|FG002|Overall Study|Death|0|||
126021069|NCT00421889|453373162|FG003|Overall Study|Death|0|||
126021070|NCT00421889|453373163|FG004|Overall Study|Death|1|||
126021071|NCT00421889|453373164|FG005|Overall Study|Death|1|||
126021072|NCT00421889|453373165|FG006|Overall Study|Death|0|||
126021073|NCT00421889|453373166|FG007|Overall Study|Death|0|||
126021074|NCT00421889|453373167|FG008|Overall Study|Death|0|||
126021075|NCT00421889|453373159|FG000|Overall Study|Progressive disease|3|||
126021076|NCT00421889|453373160|FG001|Overall Study|Progressive disease|2|||
126021077|NCT00421889|453373161|FG002|Overall Study|Progressive disease|2|||
126021078|NCT00421889|453373162|FG003|Overall Study|Progressive disease|3|||
126021079|NCT00421889|453373163|FG004|Overall Study|Progressive disease|2|||
126021080|NCT00421889|453373164|FG005|Overall Study|Progressive disease|21|||
126021081|NCT00421889|453373165|FG006|Overall Study|Progressive disease|3|||
126021082|NCT00421889|453373166|FG007|Overall Study|Progressive disease|1|||
126021083|NCT00421889|453373167|FG008|Overall Study|Progressive disease|5|||
126021084|NCT00421889|453373159|FG000|Overall Study|Patient/Investigator request|0|||
126021085|NCT00421889|453373160|FG001|Overall Study|Patient/Investigator request|0|||
126021086|NCT00421889|453373161|FG002|Overall Study|Patient/Investigator request|0|||
126021087|NCT00421889|453373162|FG003|Overall Study|Patient/Investigator request|0|||
126021088|NCT00421889|453373163|FG004|Overall Study|Patient/Investigator request|0|||
126021089|NCT00421889|453373164|FG005|Overall Study|Patient/Investigator request|9|||
126021090|NCT00421889|453373165|FG006|Overall Study|Patient/Investigator request|0|||
126021091|NCT00421889|453373166|FG007|Overall Study|Patient/Investigator request|1|||
126021092|NCT00421889|453373167|FG008|Overall Study|Patient/Investigator request|3|||
126021093|NCT00421889|453373159|FG000|Overall Study|Lost to Follow-up|0|||
126021094|NCT00421889|453373160|FG001|Overall Study|Lost to Follow-up|0|||
126021095|NCT00421889|453373161|FG002|Overall Study|Lost to Follow-up|0|||
126021096|NCT00421889|453373162|FG003|Overall Study|Lost to Follow-up|0|||
126021097|NCT00421889|453373163|FG004|Overall Study|Lost to Follow-up|0|||
126021098|NCT00421889|453373164|FG005|Overall Study|Lost to Follow-up|0|||
126021099|NCT00421889|453373165|FG006|Overall Study|Lost to Follow-up|0|||
126021100|NCT00421889|453373166|FG007|Overall Study|Lost to Follow-up|0|||
126021101|NCT00421889|453373167|FG008|Overall Study|Lost to Follow-up|1|||
126021102|NCT00978042|453373168|FG000|Initial Treatment Period|Treated in Error|0|||
126021103|NCT00978042|453373169|FG001|Initial Treatment Period|Treated in Error|3|||
126021104|NCT00978042|453373168|FG000|Initial Treatment Period|Ineligibility|1|||
126021105|NCT00978042|453373169|FG001|Initial Treatment Period|Ineligibility|0|||
126021106|NCT00978042|453373168|FG000|Initial Treatment Period|Lost to Follow-up|21|||
126021107|NCT00978042|453373169|FG001|Initial Treatment Period|Lost to Follow-up|3|||
126021108|NCT00978042|453373168|FG000|Initial Treatment Period|Adverse Event|2|||
126021109|NCT00978042|453373169|FG001|Initial Treatment Period|Adverse Event|0|||
126021110|NCT00978042|453373168|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
126351917|NCT00700635|454578931|FG001|Overall Study|Lost to Follow-up|3|||
126351918|NCT00700635|454578932|FG002|Overall Study|Lost to Follow-up|0|||
126021111|NCT00978042|453373169|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
126021112|NCT00978042|453373168|FG000|Initial Treatment Period|Consent withdrawn|22|||
126021113|NCT00978042|453373169|FG001|Initial Treatment Period|Consent withdrawn|9|||
126021114|NCT00978042|453373168|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
126021115|NCT00978042|453373169|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
126021116|NCT02379819|453373170|FG000|Overall Study|Withdrawal by Subject|10|||
126021117|NCT02379819|453373170|FG000|Overall Study|Death|2|||
126021118|NCT02379819|453373170|FG000|Overall Study|Lack of Efficacy|1|||
126021119|NCT02379819|453373170|FG000|Overall Study|Lost to Follow-up|1|||
126021120|NCT00520546|453373171|FG000|Overall Study|Withdrawal by Subject|1|||
126021121|NCT00520546|453373171|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
126021122|NCT02101281|453373175|FG000|Overall Study|Adverse Event|0|||
126021123|NCT02101281|453373176|FG001|Overall Study|Adverse Event|1|||
126351919|NCT00700635|454578930|FG000|Overall Study|Protocol Violation|2|||
126021124|NCT04452318|453373177|FG000|Overall Study|Physician Decision|1|||
126021125|NCT04452318|453373178|FG001|Overall Study|Physician Decision|2|||
126021126|NCT04452318|453373179|FG002|Overall Study|Physician Decision|0|||
126021127|NCT04452318|453373180|FG003|Overall Study|Physician Decision|2|||
126021128|NCT04452318|453373181|FG004|Overall Study|Physician Decision|0|||
126021129|NCT04452318|453373182|FG005|Overall Study|Physician Decision|2|||
126021130|NCT04452318|453373183|FG006|Overall Study|Physician Decision|5|||
126021131|NCT04452318|453373177|FG000|Overall Study|Death|2|||
126021132|NCT04452318|453373178|FG001|Overall Study|Death|3|||
126021133|NCT04452318|453373179|FG002|Overall Study|Death|0|||
126021134|NCT04452318|453373180|FG003|Overall Study|Death|0|||
126021135|NCT04452318|453373181|FG004|Overall Study|Death|0|||
126021136|NCT04452318|453373182|FG005|Overall Study|Death|0|||
126021137|NCT04452318|453373183|FG006|Overall Study|Death|0|||
126021138|NCT04452318|453373177|FG000|Overall Study|Lost to Follow-up|38|||
126021139|NCT04452318|453373178|FG001|Overall Study|Lost to Follow-up|28|||
126021140|NCT04452318|453373179|FG002|Overall Study|Lost to Follow-up|0|||
126351920|NCT00700635|454578931|FG001|Overall Study|Protocol Violation|2|||
126351921|NCT00700635|454578932|FG002|Overall Study|Protocol Violation|0|||
126351922|NCT00700635|454578930|FG000|Overall Study|Withdrawal by Subject|7|||
126351923|NCT00700635|454578931|FG001|Overall Study|Withdrawal by Subject|3|||
126351924|NCT00700635|454578932|FG002|Overall Study|Withdrawal by Subject|1|||
126351925|NCT05172570|454578933|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
126351926|NCT05172570|454578934|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
126351927|NCT05172570|454578935|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
126351928|NCT05172570|454578933|FG000|Overall Study|PI Decision due to equipment shortages|0|||
126351929|NCT05172570|454578934|FG001|Overall Study|PI Decision due to equipment shortages|0|||
126351930|NCT05172570|454578935|FG002|Overall Study|PI Decision due to equipment shortages|1|||
126351931|NCT02872714|454578938|FG000|Overall Study|Progressive Disease|1|||
126351932|NCT02872714|454578939|FG001|Overall Study|Progressive Disease|2|||
126351933|NCT02872714|454578940|FG002|Overall Study|Progressive Disease|0|||
126351934|NCT02872714|454578941|FG003|Overall Study|Progressive Disease|0|||
126351935|NCT02872714|454578942|FG004|Overall Study|Progressive Disease|0|||
126351936|NCT02872714|454578938|FG000|Overall Study|Death|87|||
126351937|NCT02872714|454578939|FG001|Overall Study|Death|36|||
126351938|NCT02872714|454578940|FG002|Overall Study|Death|8|||
126351939|NCT02872714|454578941|FG003|Overall Study|Death|81|||
126351940|NCT02872714|454578942|FG004|Overall Study|Death|2|||
126351941|NCT02872714|454578938|FG000|Overall Study|Lost to Follow-up|2|||
126351942|NCT02872714|454578939|FG001|Overall Study|Lost to Follow-up|1|||
126351943|NCT02872714|454578940|FG002|Overall Study|Lost to Follow-up|0|||
126351944|NCT02872714|454578941|FG003|Overall Study|Lost to Follow-up|3|||
126351945|NCT02872714|454578942|FG004|Overall Study|Lost to Follow-up|0|||
126351946|NCT02872714|454578938|FG000|Overall Study|Physician Decision|0|||
126351947|NCT02872714|454578939|FG001|Overall Study|Physician Decision|0|||
126351948|NCT02872714|454578940|FG002|Overall Study|Physician Decision|0|||
126351949|NCT02872714|454578941|FG003|Overall Study|Physician Decision|1|||
126351950|NCT02872714|454578942|FG004|Overall Study|Physician Decision|0|||
126351951|NCT02872714|454578938|FG000|Overall Study|Withdrawal by Subject|1|||
126351952|NCT02872714|454578939|FG001|Overall Study|Withdrawal by Subject|3|||
126351953|NCT02872714|454578940|FG002|Overall Study|Withdrawal by Subject|0|||
126351954|NCT02872714|454578941|FG003|Overall Study|Withdrawal by Subject|2|||
126351955|NCT02872714|454578942|FG004|Overall Study|Withdrawal by Subject|0|||
126351956|NCT02872714|454578938|FG000|Overall Study|Captured as Other|2|||
126351957|NCT02872714|454578939|FG001|Overall Study|Captured as Other|0|||
126351958|NCT02872714|454578940|FG002|Overall Study|Captured as Other|0|||
126351959|NCT02872714|454578941|FG003|Overall Study|Captured as Other|1|||
126351960|NCT02872714|454578942|FG004|Overall Study|Captured as Other|0|||
126351961|NCT00980460|454578943|FG000|Overall Study|Death|0|||
126351962|NCT00980460|454578944|FG001|Overall Study|Death|0|||
126351963|NCT00980460|454578945|FG002|Overall Study|Death|1|||
126351964|NCT00980460|454578946|FG003|Overall Study|Death|2|||
126351965|NCT00980460|454578947|FG004|Overall Study|Death|1|||
126351966|NCT00980460|454578943|FG000|Overall Study|Lack of Efficacy|0|||
126351967|NCT00980460|454578944|FG001|Overall Study|Lack of Efficacy|0|||
126351968|NCT00980460|454578945|FG002|Overall Study|Lack of Efficacy|10|||
126351969|NCT00980460|454578946|FG003|Overall Study|Lack of Efficacy|6|||
126351970|NCT00980460|454578947|FG004|Overall Study|Lack of Efficacy|8|||
126021141|NCT04452318|453373180|FG003|Overall Study|Lost to Follow-up|3|||
126021142|NCT04452318|453373181|FG004|Overall Study|Lost to Follow-up|3|||
126021143|NCT04452318|453373182|FG005|Overall Study|Lost to Follow-up|2|||
126351971|NCT00980460|454578943|FG000|Overall Study|Lost to Follow-up|0|||
126351972|NCT00980460|454578944|FG001|Overall Study|Lost to Follow-up|0|||
126351973|NCT00980460|454578945|FG002|Overall Study|Lost to Follow-up|0|||
126351974|NCT00980460|454578946|FG003|Overall Study|Lost to Follow-up|1|||
126021144|NCT04452318|453373183|FG006|Overall Study|Lost to Follow-up|1|||
126351975|NCT00980460|454578947|FG004|Overall Study|Lost to Follow-up|0|||
126021145|NCT04452318|453373177|FG000|Overall Study|Withdrawal by Subject|46|||
126021146|NCT04452318|453373178|FG001|Overall Study|Withdrawal by Subject|40|||
126226847|NCT00617461|454121163|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
126226848|NCT00617461|454121164|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
126226849|NCT00617461|454121163|FG000|First Treatment Intervention Period|Protocol Violation|2|||
126226850|NCT00617461|454121164|FG001|First Treatment Intervention Period|Protocol Violation|1|||
126226851|NCT00617461|454121163|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
126226852|NCT00617461|454121164|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
126226853|NCT00617461|454121163|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
126226854|NCT00617461|454121164|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
126226855|NCT00617461|454121163|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
126226856|NCT00617461|454121164|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
126226857|NCT00617461|454121163|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
126226858|NCT00617461|454121164|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
126226859|NCT00617461|454121163|FG000|Second Treatment Intervention Period|Adverse Event|0|||
126226860|NCT00617461|454121164|FG001|Second Treatment Intervention Period|Adverse Event|1|||
126226861|NCT00617461|454121163|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
126226862|NCT00617461|454121164|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
126226863|NCT00617461|454121163|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
126226864|NCT00617461|454121164|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
126226865|NCT00617461|454121163|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
126226866|NCT00617461|454121164|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
126226867|NCT00358826|454121165|FG000|Core Study|Adverse Event|1|||
126226868|NCT00358826|454121166|FG001|Core Study|Adverse Event|3|||
126226869|NCT00358826|454121167|FG002|Core Study|Adverse Event|1|||
126226870|NCT00358826|454121168|FG003|Core Study|Adverse Event|1|||
126226871|NCT00358826|454121169|FG004|Core Study|Adverse Event|0|||
126226872|NCT00358826|454121170|FG005|Core Study|Adverse Event|0|||
126226873|NCT00358826|454121171|FG006|Core Study|Adverse Event|0|||
126226874|NCT00358826|454121172|FG007|Core Study|Adverse Event|0|||
126226875|NCT00358826|454121165|FG000|Core Study|Withdrawal by Subject|2|||
126226876|NCT00358826|454121166|FG001|Core Study|Withdrawal by Subject|2|||
126226877|NCT00358826|454121167|FG002|Core Study|Withdrawal by Subject|0|||
126226878|NCT00358826|454121168|FG003|Core Study|Withdrawal by Subject|0|||
126226879|NCT00358826|454121169|FG004|Core Study|Withdrawal by Subject|0|||
126226880|NCT00358826|454121170|FG005|Core Study|Withdrawal by Subject|0|||
126226881|NCT00358826|454121171|FG006|Core Study|Withdrawal by Subject|0|||
126226882|NCT00358826|454121172|FG007|Core Study|Withdrawal by Subject|0|||
126226883|NCT00358826|454121165|FG000|Core Study|Lost to Follow-up|0|||
126226884|NCT00358826|454121166|FG001|Core Study|Lost to Follow-up|0|||
126226885|NCT00358826|454121167|FG002|Core Study|Lost to Follow-up|0|||
126226886|NCT00358826|454121168|FG003|Core Study|Lost to Follow-up|1|||
126226887|NCT00358826|454121169|FG004|Core Study|Lost to Follow-up|0|||
126226888|NCT00358826|454121170|FG005|Core Study|Lost to Follow-up|0|||
126226889|NCT00358826|454121171|FG006|Core Study|Lost to Follow-up|0|||
126226890|NCT00358826|454121172|FG007|Core Study|Lost to Follow-up|0|||
126226891|NCT00358826|454121165|FG000|Core Study|Physician Decision|0|||
126351976|NCT00980460|454578943|FG000|Overall Study|Physician Decision|0|||
126351977|NCT00980460|454578944|FG001|Overall Study|Physician Decision|0|||
126351978|NCT00980460|454578945|FG002|Overall Study|Physician Decision|11|||
126351979|NCT00980460|454578946|FG003|Overall Study|Physician Decision|5|||
126351980|NCT00980460|454578947|FG004|Overall Study|Physician Decision|3|||
126351981|NCT00980460|454578943|FG000|Overall Study|Withdrawal by Subject|0|||
126351982|NCT00980460|454578944|FG001|Overall Study|Withdrawal by Subject|0|||
126351983|NCT00980460|454578945|FG002|Overall Study|Withdrawal by Subject|1|||
126351984|NCT00980460|454578946|FG003|Overall Study|Withdrawal by Subject|0|||
126351985|NCT00980460|454578947|FG004|Overall Study|Withdrawal by Subject|0|||
126351986|NCT00980460|454578943|FG000|Overall Study|Ineligible|0|||
126351987|NCT00980460|454578944|FG001|Overall Study|Ineligible|2|||
126351988|NCT00980460|454578945|FG002|Overall Study|Ineligible|3|||
126351989|NCT00980460|454578946|FG003|Overall Study|Ineligible|1|||
126351990|NCT00980460|454578947|FG004|Overall Study|Ineligible|4|||
126351991|NCT00980460|454578943|FG000|Overall Study|Refusal of further therapy|0|||
126351992|NCT00980460|454578944|FG001|Overall Study|Refusal of further therapy|2|||
126351993|NCT00980460|454578945|FG002|Overall Study|Refusal of further therapy|3|||
126351994|NCT00980460|454578946|FG003|Overall Study|Refusal of further therapy|2|||
126351995|NCT00980460|454578947|FG004|Overall Study|Refusal of further therapy|0|||
126351996|NCT00980460|454578943|FG000|Overall Study|No therapy within 42 days of resection|0|||
126351997|NCT00980460|454578944|FG001|Overall Study|No therapy within 42 days of resection|0|||
126351998|NCT00980460|454578945|FG002|Overall Study|No therapy within 42 days of resection|3|||
126351999|NCT00980460|454578946|FG003|Overall Study|No therapy within 42 days of resection|1|||
126226892|NCT00358826|454121166|FG001|Core Study|Physician Decision|0|||
126226893|NCT00358826|454121167|FG002|Core Study|Physician Decision|1|||
126226894|NCT00358826|454121168|FG003|Core Study|Physician Decision|0|||
126226895|NCT00358826|454121169|FG004|Core Study|Physician Decision|0|||
126352000|NCT00980460|454578947|FG004|Overall Study|No therapy within 42 days of resection|0|||
126352001|NCT00980460|454578943|FG000|Overall Study|No transplant by protocol timepoints|0|||
126226896|NCT00358826|454121170|FG005|Core Study|Physician Decision|0|||
126226897|NCT00358826|454121171|FG006|Core Study|Physician Decision|0|||
126226898|NCT00358826|454121172|FG007|Core Study|Physician Decision|0|||
126226899|NCT00358826|454121165|FG000|MDCT Substudy|Adverse Event|0|||
126226900|NCT00358826|454121166|FG001|MDCT Substudy|Adverse Event|0|||
126226901|NCT00358826|454121167|FG002|MDCT Substudy|Adverse Event|0|||
126226902|NCT00358826|454121168|FG003|MDCT Substudy|Adverse Event|0|||
126226903|NCT00358826|454121169|FG004|MDCT Substudy|Adverse Event|1|||
126226904|NCT00358826|454121170|FG005|MDCT Substudy|Adverse Event|0|||
126226905|NCT00358826|454121171|FG006|MDCT Substudy|Adverse Event|0|||
126226906|NCT00358826|454121172|FG007|MDCT Substudy|Adverse Event|0|||
126226907|NCT00358826|454121165|FG000|MDCT Substudy|Lost to Follow-up|0|||
126226908|NCT00358826|454121166|FG001|MDCT Substudy|Lost to Follow-up|0|||
126226909|NCT00358826|454121167|FG002|MDCT Substudy|Lost to Follow-up|0|||
126226910|NCT00358826|454121168|FG003|MDCT Substudy|Lost to Follow-up|0|||
126226911|NCT00358826|454121169|FG004|MDCT Substudy|Lost to Follow-up|0|||
126226912|NCT00358826|454121170|FG005|MDCT Substudy|Lost to Follow-up|1|||
126226913|NCT00358826|454121171|FG006|MDCT Substudy|Lost to Follow-up|0|||
126226914|NCT00358826|454121172|FG007|MDCT Substudy|Lost to Follow-up|0|||
126226915|NCT00358826|454121165|FG000|MDCT Substudy|Withdrawal by Subject|0|||
126226916|NCT00358826|454121166|FG001|MDCT Substudy|Withdrawal by Subject|0|||
126226917|NCT00358826|454121167|FG002|MDCT Substudy|Withdrawal by Subject|0|||
126226918|NCT00358826|454121168|FG003|MDCT Substudy|Withdrawal by Subject|0|||
126226919|NCT00358826|454121169|FG004|MDCT Substudy|Withdrawal by Subject|0|||
126226920|NCT00358826|454121170|FG005|MDCT Substudy|Withdrawal by Subject|1|||
126226921|NCT00358826|454121171|FG006|MDCT Substudy|Withdrawal by Subject|0|||
126226922|NCT00358826|454121172|FG007|MDCT Substudy|Withdrawal by Subject|0|||
126226923|NCT00903383|454121176|FG000|Overall Study|Adverse Event|1|||
126226924|NCT00903383|454121177|FG001|Overall Study|Adverse Event|2|||
126226925|NCT00903383|454121178|FG002|Overall Study|Adverse Event|3|||
126226926|NCT00903383|454121179|FG003|Overall Study|Adverse Event|1|||
126226927|NCT00903383|454121176|FG000|Overall Study|Physician Decision|1|||
126226928|NCT00903383|454121177|FG001|Overall Study|Physician Decision|2|||
126226929|NCT00903383|454121178|FG002|Overall Study|Physician Decision|0|||
126226930|NCT00903383|454121179|FG003|Overall Study|Physician Decision|0|||
126226931|NCT00903383|454121176|FG000|Overall Study|Lost to Follow-up|0|||
126226932|NCT00903383|454121177|FG001|Overall Study|Lost to Follow-up|0|||
126226933|NCT00903383|454121178|FG002|Overall Study|Lost to Follow-up|0|||
126226934|NCT00903383|454121179|FG003|Overall Study|Lost to Follow-up|1|||
126226935|NCT00903383|454121176|FG000|Overall Study|Decision of Sponsor|1|||
126226936|NCT00903383|454121177|FG001|Overall Study|Decision of Sponsor|0|||
126226937|NCT00903383|454121178|FG002|Overall Study|Decision of Sponsor|0|||
126226938|NCT00903383|454121179|FG003|Overall Study|Decision of Sponsor|0|||
126226939|NCT00903383|454121176|FG000|Overall Study|Withdrawal by Subject|4|||
126226940|NCT00903383|454121177|FG001|Overall Study|Withdrawal by Subject|1|||
126226941|NCT00903383|454121178|FG002|Overall Study|Withdrawal by Subject|0|||
126226942|NCT00903383|454121179|FG003|Overall Study|Withdrawal by Subject|2|||
126226943|NCT00903383|454121176|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
126226944|NCT00903383|454121177|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
126226945|NCT00903383|454121178|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
126226946|NCT00903383|454121179|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
126226947|NCT00903383|454121176|FG000|Overall Study|Patient Decision|0|||
126226948|NCT00903383|454121177|FG001|Overall Study|Patient Decision|0|||
126226949|NCT00903383|454121178|FG002|Overall Study|Patient Decision|0|||
126226950|NCT00903383|454121179|FG003|Overall Study|Patient Decision|1|||
126226951|NCT01821625|454121182|FG000|Overall Study|Withdrawal by Subject|2|||
126226952|NCT01821625|454121182|FG000|Overall Study|Lack of Efficacy|2|||
126226953|NCT01821625|454121182|FG000|Overall Study|Adverse Event|1|||
126226954|NCT01821625|454121182|FG000|Overall Study|Medical contraindication|1|||
126226955|NCT00320593|454121185|FG000|Overall Study|Lost to Follow-up|3|||
126226956|NCT00320593|454121186|FG001|Overall Study|Lost to Follow-up|0|||
126226957|NCT00320593|454121185|FG000|Overall Study|Moved to another state|1|||
126226958|NCT00320593|454121186|FG001|Overall Study|Moved to another state|0|||
126226959|NCT00320593|454121185|FG000|Overall Study|Withdrawal by Subject|2|||
126226960|NCT00320593|454121186|FG001|Overall Study|Withdrawal by Subject|1|||
126226961|NCT00320593|454121185|FG000|Overall Study|Withdrawal by clinical center|1|||
126226962|NCT00320593|454121186|FG001|Overall Study|Withdrawal by clinical center|0|||
126226963|NCT00481247|454121191|FG000|Overall Study|Death|0|||
126226964|NCT00481247|454121192|FG001|Overall Study|Death|1|||
126226965|NCT00481247|454121191|FG000|Overall Study|Disease progression|18|||
126226966|NCT00481247|454121192|FG001|Overall Study|Disease progression|22|||
126226967|NCT00481247|454121191|FG000|Overall Study|Intolerance|42|||
126226968|NCT00481247|454121192|FG001|Overall Study|Intolerance|17|||
126226969|NCT00481247|454121191|FG000|Overall Study|Treatment failure|10|||
126226970|NCT00481247|454121192|FG001|Overall Study|Treatment failure|14|||
126226971|NCT00481247|454121191|FG000|Overall Study|AE unrelated to study drug|13|||
126226972|NCT00481247|454121192|FG001|Overall Study|AE unrelated to study drug|4|||
126226973|NCT00481247|454121191|FG000|Overall Study|Withdrawal by Subject|8|||
126226974|NCT00481247|454121192|FG001|Overall Study|Withdrawal by Subject|13|||
126226975|NCT00481247|454121191|FG000|Overall Study|Pregnancy|2|||
126226976|NCT00481247|454121192|FG001|Overall Study|Pregnancy|1|||
126226977|NCT00481247|454121191|FG000|Overall Study|Lost to Follow-up|1|||
126226978|NCT00481247|454121192|FG001|Overall Study|Lost to Follow-up|2|||
126226979|NCT00481247|454121191|FG000|Overall Study|Poor compliance/noncompliance|1|||
126226980|NCT00481247|454121192|FG001|Overall Study|Poor compliance/noncompliance|7|||
126226981|NCT00481247|454121191|FG000|Overall Study|Administrative reason by sponsor|157|||
126226982|NCT00481247|454121192|FG001|Overall Study|Administrative reason by sponsor|162|||
126226983|NCT00481247|454121191|FG000|Overall Study|Varied|6|||
126226984|NCT00481247|454121192|FG001|Overall Study|Varied|15|||
126226985|NCT00481247|454121191|FG000|Overall Study|Did not receive treatment|1|||
126226986|NCT00481247|454121192|FG001|Overall Study|Did not receive treatment|2|||
126226987|NCT01716754|454121193|FG000|Overall Study|Death|0|||
126226988|NCT01716754|454121194|FG001|Overall Study|Death|0|||
126226989|NCT01716754|454121195|FG002|Overall Study|Death|0|||
126226990|NCT01716754|454121196|FG003|Overall Study|Death|1|||
126226991|NCT01716754|454121193|FG000|Overall Study|Protocol deviation|0|||
126226992|NCT01716754|454121194|FG001|Overall Study|Protocol deviation|2|||
126226993|NCT01716754|454121195|FG002|Overall Study|Protocol deviation|7|||
126226994|NCT01716754|454121196|FG003|Overall Study|Protocol deviation|2|||
126226995|NCT01716754|454121193|FG000|Overall Study|Non-compliance with study treatment|0|||
126226996|NCT01716754|454121194|FG001|Overall Study|Non-compliance with study treatment|0|||
126226997|NCT01716754|454121195|FG002|Overall Study|Non-compliance with study treatment|1|||
126226998|NCT01716754|454121196|FG003|Overall Study|Non-compliance with study treatment|0|||
126226999|NCT01716754|454121193|FG000|Overall Study|Physician Decision|1|||
126227000|NCT01716754|454121194|FG001|Overall Study|Physician Decision|0|||
126227001|NCT01716754|454121195|FG002|Overall Study|Physician Decision|0|||
126227002|NCT01716754|454121196|FG003|Overall Study|Physician Decision|0|||
126227003|NCT01716754|454121193|FG000|Overall Study|Lost to Follow-up|1|||
126227004|NCT01716754|454121194|FG001|Overall Study|Lost to Follow-up|0|||
126227005|NCT01716754|454121195|FG002|Overall Study|Lost to Follow-up|0|||
126227006|NCT01716754|454121196|FG003|Overall Study|Lost to Follow-up|1|||
126227007|NCT01716754|454121193|FG000|Overall Study|Adverse Event|4|||
126227008|NCT01716754|454121194|FG001|Overall Study|Adverse Event|2|||
126227009|NCT01716754|454121195|FG002|Overall Study|Adverse Event|2|||
126227010|NCT01716754|454121196|FG003|Overall Study|Adverse Event|1|||
126227011|NCT01716754|454121193|FG000|Overall Study|Withdrawal by Subject|5|||
126227012|NCT01716754|454121194|FG001|Overall Study|Withdrawal by Subject|0|||
126227013|NCT01716754|454121195|FG002|Overall Study|Withdrawal by Subject|4|||
126227014|NCT01716754|454121196|FG003|Overall Study|Withdrawal by Subject|3|||
126227015|NCT02535000|454121197|FG000|Overall Study|Cancellation of surgery.|1|||
126227016|NCT02535000|454121198|FG001|Overall Study|Cancellation of surgery.|2|||
126227017|NCT04317781|454121200|FG000|Overall Study|Adverse Event|1|||
126227018|NCT04317781|454121200|FG000|Overall Study|Disease relapse|1|||
126227019|NCT04317781|454121200|FG000|Overall Study|Withdrawal by Subject|1|||
126227020|NCT01620489|454121201|FG000|Overall Study|Adverse Event|17|||
126227021|NCT01620489|454121202|FG001|Overall Study|Adverse Event|4|||
126227022|NCT01620489|454121201|FG000|Overall Study|Protocol Violation|0|||
126227023|NCT01620489|454121202|FG001|Overall Study|Protocol Violation|3|||
126227024|NCT01620489|454121201|FG000|Overall Study|Withdrawal Criteria|17|||
126227025|NCT01620489|454121202|FG001|Overall Study|Withdrawal Criteria|25|||
126227026|NCT01620489|454121201|FG000|Overall Study|Unclassified|1|||
126227027|NCT01620489|454121202|FG001|Overall Study|Unclassified|2|||
126227028|NCT02611752|454121207|FG000|Overall Study|Adverse Event|0|||
126227029|NCT02611752|454121208|FG001|Overall Study|Adverse Event|1|||
126227030|NCT00321711|454121209|FG000|Part A|Adverse Event|3|||
126227031|NCT00321711|454121210|FG001|Part A|Adverse Event|3|||
126227032|NCT00321711|454121211|FG002|Part A|Adverse Event|2|||
126227033|NCT00321711|454121212|FG003|Part A|Adverse Event|0|||
126227034|NCT00321711|454121213|FG004|Part A|Adverse Event|0|||
126227035|NCT00321711|454121209|FG000|Part A|Withdrawal by Subject|1|||
126227036|NCT00321711|454121210|FG001|Part A|Withdrawal by Subject|1|||
126227037|NCT00321711|454121211|FG002|Part A|Withdrawal by Subject|1|||
126227038|NCT00321711|454121212|FG003|Part A|Withdrawal by Subject|0|||
126227039|NCT00321711|454121213|FG004|Part A|Withdrawal by Subject|0|||
126227040|NCT00321711|454121209|FG000|Part A|Disease progression|0|||
126227041|NCT00321711|454121210|FG001|Part A|Disease progression|1|||
126352002|NCT00980460|454578944|FG001|Overall Study|No transplant by protocol timepoints|0|||
126352003|NCT00980460|454578945|FG002|Overall Study|No transplant by protocol timepoints|3|||
126352004|NCT00980460|454578946|FG003|Overall Study|No transplant by protocol timepoints|0|||
126352005|NCT00980460|454578947|FG004|Overall Study|No transplant by protocol timepoints|0|||
126352006|NCT02008370|454579571|FG000|Overall Study|Lost to Follow-up|7|||
126227042|NCT00321711|454121211|FG002|Part A|Disease progression|0|||
126227043|NCT00321711|454121212|FG003|Part A|Disease progression|0|||
126227044|NCT00321711|454121213|FG004|Part A|Disease progression|0|||
126227045|NCT00321711|454121209|FG000|Part A|Requirement for alternative therapy|0|||
126227046|NCT00321711|454121210|FG001|Part A|Requirement for alternative therapy|2|||
126227047|NCT00321711|454121211|FG002|Part A|Requirement for alternative therapy|1|||
126227048|NCT00321711|454121212|FG003|Part A|Requirement for alternative therapy|0|||
126352007|NCT01001104|454579576|FG000|Overall Study|Adverse Event|2|||
126352008|NCT01001104|454579577|FG001|Overall Study|Adverse Event|1|||
126227049|NCT00321711|454121213|FG004|Part A|Requirement for alternative therapy|0|||
126227050|NCT00321711|454121209|FG000|Part A|Physician Decision|0|||
126227051|NCT00321711|454121210|FG001|Part A|Physician Decision|1|||
126227052|NCT00321711|454121211|FG002|Part A|Physician Decision|3|||
126227053|NCT00321711|454121212|FG003|Part A|Physician Decision|0|||
126227054|NCT00321711|454121213|FG004|Part A|Physician Decision|0|||
126227055|NCT00321711|454121209|FG000|Part A|Other|1|||
126227056|NCT00321711|454121210|FG001|Part A|Other|2|||
126227057|NCT00321711|454121211|FG002|Part A|Other|3|||
126227058|NCT00321711|454121212|FG003|Part A|Other|0|||
126227059|NCT00321711|454121213|FG004|Part A|Other|0|||
126227060|NCT00321711|454121209|FG000|Part A|Protocol deviation|0|||
126227061|NCT00321711|454121210|FG001|Part A|Protocol deviation|0|||
126227062|NCT00321711|454121211|FG002|Part A|Protocol deviation|1|||
126352009|NCT01001104|454579578|FG002|Overall Study|Adverse Event|0|||
126227063|NCT00321711|454121212|FG003|Part A|Protocol deviation|0|||
126227064|NCT00321711|454121213|FG004|Part A|Protocol deviation|0|||
126227065|NCT00321711|454121209|FG000|Part B|Noncompliance|0|||
126227066|NCT00321711|454121210|FG001|Part B|Noncompliance|0|||
126227067|NCT00321711|454121211|FG002|Part B|Noncompliance|0|||
126227068|NCT00321711|454121212|FG003|Part B|Noncompliance|0|||
126227069|NCT00321711|454121213|FG004|Part B|Noncompliance|1|||
126227070|NCT00321711|454121209|FG000|Part B|Adverse Event|0|||
126227071|NCT00321711|454121210|FG001|Part B|Adverse Event|0|||
126227072|NCT00321711|454121211|FG002|Part B|Adverse Event|0|||
126352010|NCT01001104|454579579|FG003|Overall Study|Adverse Event|0|||
126352011|NCT01001104|454579576|FG000|Overall Study|Lost to Follow-up|0|||
126352012|NCT01001104|454579577|FG001|Overall Study|Lost to Follow-up|0|||
126352013|NCT01001104|454579578|FG002|Overall Study|Lost to Follow-up|1|||
126352014|NCT01001104|454579579|FG003|Overall Study|Lost to Follow-up|0|||
126352015|NCT01001104|454579576|FG000|Overall Study|Entry Criteria Not Met|0|||
126352016|NCT01001104|454579577|FG001|Overall Study|Entry Criteria Not Met|0|||
126352017|NCT01001104|454579578|FG002|Overall Study|Entry Criteria Not Met|0|||
126352018|NCT01001104|454579579|FG003|Overall Study|Entry Criteria Not Met|1|||
126352019|NCT01001104|454579576|FG000|Overall Study|Withdrawal by Subject|0|||
126352020|NCT01001104|454579577|FG001|Overall Study|Withdrawal by Subject|0|||
126352021|NCT01001104|454579578|FG002|Overall Study|Withdrawal by Subject|0|||
126352022|NCT01001104|454579579|FG003|Overall Study|Withdrawal by Subject|2|||
126352023|NCT02397837|454579581|FG000|Overall Study|Withdrawal by Subject|6|||
126352024|NCT02397837|454579582|FG001|Overall Study|Withdrawal by Subject|5|||
126352025|NCT02397837|454579581|FG000|Overall Study|Physician Decision|1|||
126352026|NCT02397837|454579582|FG001|Overall Study|Physician Decision|1|||
126352027|NCT00599313|454579583|FG000|Overall Study|Adverse Event|19|||
126352028|NCT00599313|454579583|FG000|Overall Study|Disease Progression|12|||
126352029|NCT00599313|454579583|FG000|Overall Study|Patient Request|4|||
126352030|NCT00599313|454579583|FG000|Overall Study|Ineligible|1|||
126352031|NCT02536794|454579584|FG000|Reached 1st Response Assessment|Adverse Event|2|||
126352032|NCT02536794|454579584|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
126352033|NCT02536794|454579584|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
126352034|NCT02536794|454579584|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
126352035|NCT02536794|454579584|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
126352036|NCT02536794|454579584|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
126352037|NCT01496456|454579591|FG000|Overall Study|Protocol Violation|1|||
126352038|NCT01496456|454579591|FG000|Overall Study|Lost to Follow-up|7|||
126352039|NCT01695746|454579594|FG000|Overall Study|Adverse Event|1|||
126352040|NCT01695746|454579594|FG000|Overall Study|Non-compliance by the participant|3|||
126352041|NCT01695746|454579594|FG000|Overall Study|Protocol Violation|5|||
126352042|NCT01695746|454579594|FG000|Overall Study|Participant not willing to participate|3|||
126352043|NCT01202591|454579596|FG000|Overall Study|Adverse Event|2|||
126352044|NCT01202591|454579597|FG001|Overall Study|Adverse Event|1|||
126352045|NCT01202591|454579598|FG002|Overall Study|Adverse Event|4|||
126352046|NCT01202591|454579599|FG003|Overall Study|Adverse Event|4|||
126352047|NCT01202591|454579600|FG004|Overall Study|Adverse Event|0|||
126227073|NCT00321711|454121212|FG003|Part B|Adverse Event|2|||
126227074|NCT00321711|454121213|FG004|Part B|Adverse Event|1|||
126227075|NCT00321711|454121209|FG000|Part B|Disease progression|0|||
126227076|NCT00321711|454121210|FG001|Part B|Disease progression|0|||
126227077|NCT00321711|454121211|FG002|Part B|Disease progression|0|||
126227078|NCT00321711|454121212|FG003|Part B|Disease progression|1|||
126227079|NCT00321711|454121213|FG004|Part B|Disease progression|0|||
126227080|NCT00321711|454121209|FG000|Part B|Physician Decision|0|||
126227081|NCT00321711|454121210|FG001|Part B|Physician Decision|0|||
126227082|NCT00321711|454121211|FG002|Part B|Physician Decision|0|||
126227083|NCT00321711|454121212|FG003|Part B|Physician Decision|1|||
126227084|NCT00321711|454121213|FG004|Part B|Physician Decision|2|||
126227085|NCT00321711|454121209|FG000|Part B|Death|0|||
126227086|NCT00321711|454121210|FG001|Part B|Death|0|||
126227087|NCT00321711|454121211|FG002|Part B|Death|0|||
126227088|NCT00321711|454121212|FG003|Part B|Death|2|||
126227089|NCT00321711|454121213|FG004|Part B|Death|1|||
126227090|NCT00947856|454121216|FG000|Treatment Period|Progressive Disease|33|||
126227091|NCT00947856|454121217|FG001|Treatment Period|Progressive Disease|12|||
126227092|NCT00947856|454121216|FG000|Treatment Period|Adverse Event|15|||
126227093|NCT00947856|454121217|FG001|Treatment Period|Adverse Event|9|||
126227094|NCT00947856|454121216|FG000|Treatment Period|Physician Decision|14|||
126227095|NCT00947856|454121217|FG001|Treatment Period|Physician Decision|6|||
126227096|NCT00947856|454121216|FG000|Treatment Period|Study Stopped by Sponsor|4|||
126227097|NCT00947856|454121217|FG001|Treatment Period|Study Stopped by Sponsor|4|||
126227098|NCT00947856|454121216|FG000|Treatment Period|Withdrawal by Subject|12|||
126227099|NCT00947856|454121217|FG001|Treatment Period|Withdrawal by Subject|1|||
126227100|NCT00947856|454121216|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
126227101|NCT00947856|454121217|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
126227102|NCT00947856|454121216|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
126227103|NCT00947856|454121217|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
126227104|NCT00947856|454121216|FG000|Follow-up Period|Lost to Follow-up|7|||
126227105|NCT00947856|454121217|FG001|Follow-up Period|Lost to Follow-up|0|||
126227106|NCT00947856|454121216|FG000|Follow-up Period|Patient unavailable for site visits|1|||
126227107|NCT00947856|454121217|FG001|Follow-up Period|Patient unavailable for site visits|0|||
126227108|NCT00947856|454121216|FG000|Follow-up Period|Withdrawal by Subject|1|||
126227109|NCT00947856|454121217|FG001|Follow-up Period|Withdrawal by Subject|0|||
126227110|NCT01211769|454121218|FG000|Overall Study|Lost to Follow-up|7|||
126227111|NCT01211769|454121219|FG001|Overall Study|Lost to Follow-up|9|||
126227112|NCT01211769|454121220|FG002|Overall Study|Lost to Follow-up|5|||
126227113|NCT01211769|454121221|FG003|Overall Study|Lost to Follow-up|9|||
126227114|NCT01211769|454121218|FG000|Overall Study|Physician Decision|2|||
126227115|NCT01211769|454121219|FG001|Overall Study|Physician Decision|0|||
126227116|NCT01211769|454121220|FG002|Overall Study|Physician Decision|2|||
126227117|NCT01211769|454121221|FG003|Overall Study|Physician Decision|1|||
126227118|NCT01211769|454121218|FG000|Overall Study|Adverse Event|0|||
126227119|NCT01211769|454121219|FG001|Overall Study|Adverse Event|1|||
126227120|NCT01211769|454121220|FG002|Overall Study|Adverse Event|1|||
126021147|NCT04452318|453373179|FG002|Overall Study|Withdrawal by Subject|0|||
126021148|NCT04452318|453373180|FG003|Overall Study|Withdrawal by Subject|18|||
126021149|NCT04452318|453373181|FG004|Overall Study|Withdrawal by Subject|6|||
126021150|NCT04452318|453373182|FG005|Overall Study|Withdrawal by Subject|8|||
126021151|NCT04452318|453373183|FG006|Overall Study|Withdrawal by Subject|6|||
126227121|NCT01211769|454121221|FG003|Overall Study|Adverse Event|1|||
126227122|NCT01348542|454121222|FG000|Overall Study|Withdrawal by Subject|3|||
126227123|NCT01348542|454121223|FG001|Overall Study|Withdrawal by Subject|0|||
126227124|NCT03402893|454121224|FG000|Overall Study|Withdrawal by Subject|1|||
126227125|NCT01484028|454121225|FG000|Period 1|Lost to Follow-up|0|||
126227126|NCT01484028|454121226|FG001|Period 1|Lost to Follow-up|1|||
126352048|NCT01202591|454579601|FG005|Overall Study|Adverse Event|0|||
126352049|NCT01202591|454579596|FG000|Overall Study|Other reason as per investigator|3|||
126352050|NCT01202591|454579597|FG001|Overall Study|Other reason as per investigator|4|||
126352051|NCT01202591|454579598|FG002|Overall Study|Other reason as per investigator|7|||
126352052|NCT01202591|454579599|FG003|Overall Study|Other reason as per investigator|3|||
126352053|NCT01202591|454579600|FG004|Overall Study|Other reason as per investigator|1|||
126352054|NCT01202591|454579601|FG005|Overall Study|Other reason as per investigator|3|||
126021152|NCT03951805|453373185|FG000|Overall Study|Adverse Event|1|||
126021153|NCT03951805|453373186|FG001|Overall Study|Adverse Event|0|||
126227127|NCT01484028|454121227|FG002|Period 1|Lost to Follow-up|0|||
126227128|NCT01484028|454121228|FG003|Period 1|Lost to Follow-up|0|||
126227129|NCT01484028|454121225|FG000|Period 1|Non-Compliance to Protocol|0|||
126227130|NCT01484028|454121226|FG001|Period 1|Non-Compliance to Protocol|1|||
126227131|NCT01484028|454121227|FG002|Period 1|Non-Compliance to Protocol|0|||
126227132|NCT01484028|454121228|FG003|Period 1|Non-Compliance to Protocol|1|||
126227133|NCT01484028|454121225|FG000|Period 1|Lens Discomfort|0|||
126227134|NCT01484028|454121226|FG001|Period 1|Lens Discomfort|1|||
126227135|NCT01484028|454121227|FG002|Period 1|Lens Discomfort|0|||
126227136|NCT01484028|454121228|FG003|Period 1|Lens Discomfort|0|||
126227137|NCT00146770|454121231|FG000|Overall Study|Adverse Event|2|||
126227138|NCT00146770|454121232|FG001|Overall Study|Adverse Event|0|||
126227139|NCT00146770|454121231|FG000|Overall Study|Pregnancy|1|||
126227140|NCT00146770|454121232|FG001|Overall Study|Pregnancy|0|||
126227141|NCT00146770|454121231|FG000|Overall Study|Withdrawal by Subject|2|||
126227142|NCT00146770|454121232|FG001|Overall Study|Withdrawal by Subject|0|||
126227143|NCT03775681|454121237|FG000|Overall Study|Physician Decision|3|||
126227144|NCT01855126|454121238|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
126227145|NCT01855126|454121239|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
126227146|NCT01855126|454121238|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
126227147|NCT01855126|454121239|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
126227148|NCT01512979|454121248|FG000|Overall Study|Adverse Event|2|||
126227149|NCT01512979|454121249|FG001|Overall Study|Adverse Event|2|||
126227150|NCT01512979|454121248|FG000|Overall Study|Protocol Violation|1|||
126227151|NCT01512979|454121249|FG001|Overall Study|Protocol Violation|4|||
126227152|NCT01512979|454121248|FG000|Overall Study|Lost to Follow-up|2|||
126227153|NCT01512979|454121249|FG001|Overall Study|Lost to Follow-up|5|||
126227154|NCT01512979|454121248|FG000|Overall Study|Withdrawal by Subject|1|||
126227155|NCT01512979|454121249|FG001|Overall Study|Withdrawal by Subject|2|||
126227156|NCT01512979|454121248|FG000|Overall Study|Reason other than stated above|13|||
126227157|NCT01512979|454121249|FG001|Overall Study|Reason other than stated above|9|||
126227158|NCT01748890|454121259|FG000|Overall Study|Insufficient recruitment for analysis|4|||
126227159|NCT00874757|454121264|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
126227160|NCT02482805|454122783|FG000|Overall Study|Lost to Follow-up|4|||
126227161|NCT02482805|454122784|FG001|Overall Study|Lost to Follow-up|4|||
126227162|NCT02482805|454122785|FG002|Overall Study|Lost to Follow-up|0|||
126227163|NCT03433001|454122787|FG000|Overall Study|Lack of Efficacy|109|||
126227164|NCT03433001|454122787|FG000|Overall Study|Adverse Event|69|||
126227165|NCT03433001|454122787|FG000|Overall Study|Withdrawal by Subject|10|||
126227166|NCT03433001|454122787|FG000|Overall Study|Death|12|||
126227167|NCT03433001|454122787|FG000|Overall Study|Lost to Follow-up|4|||
126227168|NCT03433001|454122787|FG000|Overall Study|Other|25|||
126227169|NCT01007916|454122788|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
126227170|NCT01007916|454122789|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
126227171|NCT01007916|454122788|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
126227172|NCT01007916|454122789|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
126021154|NCT03951805|453373187|FG002|Overall Study|Adverse Event|0|||
126021155|NCT03951805|453373188|FG003|Overall Study|Adverse Event|0|||
126021156|NCT00604669|453373189|FG000|Overall Study|lack of information in chart|7|||
126021157|NCT01695954|453373190|FG000|Overall Study|Withdrawal by Subject|4|||
126021158|NCT01695954|453373191|FG001|Overall Study|Withdrawal by Subject|0|||
126021159|NCT01695954|453373190|FG000|Overall Study|Adverse Event|0|||
126021160|NCT01695954|453373191|FG001|Overall Study|Adverse Event|2|||
126227173|NCT01165996|454122806|FG000|Overall Study|Death|1|||
126227174|NCT01165996|454122806|FG000|Overall Study|Physician Decision|1|||
126227175|NCT01927757|454122807|FG000|Overall Study|Withdrawal by Subject|14|||
126227176|NCT01927757|454122807|FG000|Overall Study|Lost to Follow-up|2|||
126227177|NCT01927757|454122807|FG000|Overall Study|Decision by Sponsor|2|||
126227178|NCT01927757|454122807|FG000|Overall Study|Other|1|||
126227179|NCT01927757|454122807|FG000|Overall Study|Ethical Reasons|4|||
126021161|NCT04328727|453373193|FG000|Overall Study|Guardian Decision|1|||
126227180|NCT01399723|454122808|FG000|Overall Study|Lost to Follow-up|0|||
126227181|NCT01399723|454122809|FG001|Overall Study|Lost to Follow-up|1|||
126227182|NCT02022007|454122813|FG000|Overall Study|Withdrawal by Subject|1|||
126227183|NCT02022007|454122814|FG001|Overall Study|Withdrawal by Subject|1|||
126227184|NCT02022007|454122815|FG002|Overall Study|Withdrawal by Subject|1|||
126227185|NCT02022007|454122813|FG000|Overall Study|Noncompliant|0|||
126227186|NCT02022007|454122814|FG001|Overall Study|Noncompliant|0|||
126227187|NCT02022007|454122815|FG002|Overall Study|Noncompliant|1|||
126227188|NCT02087046|454122816|FG000|Overall Study|Adverse Event|4|||
126227189|NCT02087046|454122816|FG000|Overall Study|Death|1|||
126227190|NCT02087046|454122816|FG000|Overall Study|Lost to Follow-up|3|||
126227191|NCT02087046|454122816|FG000|Overall Study|Withdrawal by Subject|2|||
126227192|NCT02087046|454122816|FG000|Overall Study|Physician Decision|1|||
126227193|NCT01107535|454122817|FG000|Overall Study|Death|5|||
126227194|NCT01507896|454122818|FG000|Overall Study|Withdrawal by Subject|1|||
126227195|NCT01507896|454122818|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
126227196|NCT00192296|454122825|FG000|Overall Study|Withdrawal by Subject|0|||
126227197|NCT00192296|454122826|FG001|Overall Study|Withdrawal by Subject|1|||
126227198|NCT00192296|454122827|FG002|Overall Study|Withdrawal by Subject|0|||
126227199|NCT00192296|454122828|FG003|Overall Study|Withdrawal by Subject|0|||
126227200|NCT00818623|454122829|FG000|Overall Study|Adverse Event|1|||
126227201|NCT00818623|454122830|FG001|Overall Study|Adverse Event|0|||
126227202|NCT00818623|454122831|FG002|Overall Study|Adverse Event|1|||
126227203|NCT00818623|454122832|FG003|Overall Study|Adverse Event|0|||
126227204|NCT00818623|454122833|FG004|Overall Study|Adverse Event|0|||
126227205|NCT00818623|454122834|FG005|Overall Study|Adverse Event|1|||
126227206|NCT00818623|454122835|FG006|Overall Study|Adverse Event|0|||
126227207|NCT00818623|454122836|FG007|Overall Study|Adverse Event|0|||
126227208|NCT00818623|454122829|FG000|Overall Study|Bad prostate specific antigen response|0|||
126227209|NCT00818623|454122830|FG001|Overall Study|Bad prostate specific antigen response|3|||
126227210|NCT00818623|454122831|FG002|Overall Study|Bad prostate specific antigen response|2|||
126227211|NCT00818623|454122832|FG003|Overall Study|Bad prostate specific antigen response|5|||
126227212|NCT00818623|454122833|FG004|Overall Study|Bad prostate specific antigen response|0|||
126227213|NCT00818623|454122834|FG005|Overall Study|Bad prostate specific antigen response|1|||
126227214|NCT00818623|454122835|FG006|Overall Study|Bad prostate specific antigen response|0|||
126227215|NCT00818623|454122836|FG007|Overall Study|Bad prostate specific antigen response|0|||
126227216|NCT00818623|454122829|FG000|Overall Study|Withdrawal by Subject|0|||
126227217|NCT00818623|454122830|FG001|Overall Study|Withdrawal by Subject|1|||
126227218|NCT00818623|454122831|FG002|Overall Study|Withdrawal by Subject|1|||
126227219|NCT00818623|454122832|FG003|Overall Study|Withdrawal by Subject|0|||
126227220|NCT00818623|454122833|FG004|Overall Study|Withdrawal by Subject|0|||
126227221|NCT00818623|454122834|FG005|Overall Study|Withdrawal by Subject|1|||
126227222|NCT00818623|454122835|FG006|Overall Study|Withdrawal by Subject|1|||
126227223|NCT00818623|454122836|FG007|Overall Study|Withdrawal by Subject|1|||
126227224|NCT00818623|454122829|FG000|Overall Study|Protocol Violation|1|||
126227225|NCT00818623|454122830|FG001|Overall Study|Protocol Violation|0|||
126227226|NCT00818623|454122831|FG002|Overall Study|Protocol Violation|0|||
126227227|NCT00818623|454122832|FG003|Overall Study|Protocol Violation|0|||
126227228|NCT00818623|454122833|FG004|Overall Study|Protocol Violation|1|||
126227229|NCT00818623|454122834|FG005|Overall Study|Protocol Violation|0|||
126227230|NCT00818623|454122835|FG006|Overall Study|Protocol Violation|1|||
126227231|NCT00818623|454122836|FG007|Overall Study|Protocol Violation|0|||
126227232|NCT00818623|454122829|FG000|Overall Study|Need of additional treatment|0|||
126227233|NCT00818623|454122830|FG001|Overall Study|Need of additional treatment|0|||
126227234|NCT00818623|454122831|FG002|Overall Study|Need of additional treatment|0|||
126352055|NCT01202591|454579596|FG000|Overall Study|Withdrawal by Subject|0|||
126352056|NCT01202591|454579597|FG001|Overall Study|Withdrawal by Subject|0|||
126352057|NCT01202591|454579598|FG002|Overall Study|Withdrawal by Subject|0|||
126352058|NCT01202591|454579599|FG003|Overall Study|Withdrawal by Subject|0|||
126352059|NCT01202591|454579600|FG004|Overall Study|Withdrawal by Subject|2|||
126352060|NCT01202591|454579601|FG005|Overall Study|Withdrawal by Subject|1|||
126352061|NCT01202591|454579596|FG000|Overall Study|Objective Disease Progression|0|||
126352062|NCT01202591|454579597|FG001|Overall Study|Objective Disease Progression|0|||
126352063|NCT01202591|454579598|FG002|Overall Study|Objective Disease Progression|0|||
126352064|NCT01202591|454579599|FG003|Overall Study|Objective Disease Progression|0|||
126352065|NCT01202591|454579600|FG004|Overall Study|Objective Disease Progression|2|||
126227235|NCT00818623|454122832|FG003|Overall Study|Need of additional treatment|0|||
126227236|NCT00818623|454122833|FG004|Overall Study|Need of additional treatment|1|||
126227237|NCT00818623|454122834|FG005|Overall Study|Need of additional treatment|0|||
126227238|NCT00818623|454122835|FG006|Overall Study|Need of additional treatment|0|||
126227239|NCT00818623|454122836|FG007|Overall Study|Need of additional treatment|0|||
126227240|NCT00818623|454122829|FG000|Overall Study|Lack of trial drug at site|0|||
126227241|NCT00818623|454122830|FG001|Overall Study|Lack of trial drug at site|0|||
126227242|NCT00818623|454122831|FG002|Overall Study|Lack of trial drug at site|0|||
126227243|NCT00818623|454122832|FG003|Overall Study|Lack of trial drug at site|0|||
126227244|NCT00818623|454122833|FG004|Overall Study|Lack of trial drug at site|2|||
126227245|NCT00818623|454122834|FG005|Overall Study|Lack of trial drug at site|0|||
126227246|NCT00818623|454122835|FG006|Overall Study|Lack of trial drug at site|1|||
126227247|NCT00818623|454122836|FG007|Overall Study|Lack of trial drug at site|0|||
126227248|NCT00818623|454122829|FG000|Overall Study|Disease progression|0|||
126227249|NCT00818623|454122830|FG001|Overall Study|Disease progression|0|||
126227250|NCT00818623|454122831|FG002|Overall Study|Disease progression|0|||
126227251|NCT00818623|454122832|FG003|Overall Study|Disease progression|0|||
126227252|NCT00818623|454122833|FG004|Overall Study|Disease progression|0|||
126227253|NCT00818623|454122834|FG005|Overall Study|Disease progression|0|||
126227254|NCT00818623|454122835|FG006|Overall Study|Disease progression|1|||
126227255|NCT00818623|454122836|FG007|Overall Study|Disease progression|0|||
126227256|NCT00457665|454122837|FG000|12 Months|Drug allergy|1|||
126227257|NCT00457665|454122838|FG001|12 Months|Drug allergy|1|||
126227258|NCT00457665|454122837|FG000|12 Months|High HIV viral load|5|||
126227259|NCT00457665|454122838|FG001|12 Months|High HIV viral load|1|||
126227260|NCT00457665|454122837|FG000|12 Months|Lipodystrophy|2|||
126227261|NCT00457665|454122838|FG001|12 Months|Lipodystrophy|0|||
126227262|NCT00457665|454122837|FG000|12 Months|Withdrawal by Subject|0|||
126227263|NCT00457665|454122838|FG001|12 Months|Withdrawal by Subject|2|||
126227264|NCT00457665|454122837|FG000|12 Months|Abnormal Liver function tests|0|||
126227265|NCT00457665|454122838|FG001|12 Months|Abnormal Liver function tests|5|||
126227266|NCT00457665|454122837|FG000|24 Months|Withdrawal by Subject|3|||
126227267|NCT00457665|454122838|FG001|24 Months|Withdrawal by Subject|2|||
126227268|NCT00457665|454122837|FG000|24 Months|Lipodystrophy|1|||
126227269|NCT00457665|454122838|FG001|24 Months|Lipodystrophy|1|||
126227270|NCT00457665|454122837|FG000|24 Months|Abnormal liver function tests|1|||
126227271|NCT00457665|454122838|FG001|24 Months|Abnormal liver function tests|5|||
126227272|NCT00638157|454122859|FG000|Overall Study|Adverse Event|0|||
126227273|NCT00638157|454122860|FG001|Overall Study|Adverse Event|1|||
126227274|NCT00638157|454122859|FG000|Overall Study|Clinical (symptomatic) failure|1|||
126227275|NCT00638157|454122860|FG001|Overall Study|Clinical (symptomatic) failure|1|||
126227276|NCT00638157|454122859|FG000|Overall Study|Microbiological failure|1|||
126227277|NCT00638157|454122860|FG001|Overall Study|Microbiological failure|0|||
126227278|NCT00638157|454122859|FG000|Overall Study|Lost to Follow-up|1|||
126227279|NCT00638157|454122860|FG001|Overall Study|Lost to Follow-up|0|||
126227280|NCT00638157|454122859|FG000|Overall Study|Physician Decision|1|||
126227281|NCT00638157|454122860|FG001|Overall Study|Physician Decision|0|||
126227282|NCT00638157|454122859|FG000|Overall Study|Other|1|||
126227283|NCT00638157|454122860|FG001|Overall Study|Other|2|||
126227284|NCT00638157|454122859|FG000|Overall Study|Randomized, not treated|2|||
126227285|NCT00638157|454122860|FG001|Overall Study|Randomized, not treated|0|||
126227286|NCT02649231|454122861|FG000|Overall Study|Adverse Event|0|||
126227287|NCT02649231|454122862|FG001|Overall Study|Adverse Event|0|||
126227288|NCT02649231|454122863|FG002|Overall Study|Adverse Event|0|||
126227289|NCT02649231|454122864|FG003|Overall Study|Adverse Event|1|||
126227290|NCT02649231|454122861|FG000|Overall Study|Lost to Follow-up|2|||
126227291|NCT02649231|454122862|FG001|Overall Study|Lost to Follow-up|1|||
126227292|NCT02649231|454122863|FG002|Overall Study|Lost to Follow-up|1|||
126227293|NCT02649231|454122864|FG003|Overall Study|Lost to Follow-up|0|||
126227294|NCT02649231|454122861|FG000|Overall Study|Withdrawal by Subject|0|||
126227295|NCT02649231|454122862|FG001|Overall Study|Withdrawal by Subject|1|||
126227296|NCT02649231|454122863|FG002|Overall Study|Withdrawal by Subject|0|||
126227297|NCT02649231|454122864|FG003|Overall Study|Withdrawal by Subject|1|||
126227298|NCT02649231|454122861|FG000|Overall Study|Protocol Violation|2|||
126227299|NCT02649231|454122862|FG001|Overall Study|Protocol Violation|1|||
126227300|NCT02649231|454122863|FG002|Overall Study|Protocol Violation|1|||
126227301|NCT02649231|454122864|FG003|Overall Study|Protocol Violation|0|||
126227302|NCT01851590|454122867|FG000|Overall Study|Withdrawal by Subject|0|||
126227303|NCT01851590|454122868|FG001|Overall Study|Withdrawal by Subject|0|||
126227304|NCT01851590|454122869|FG002|Overall Study|Withdrawal by Subject|1|||
126227305|NCT01851590|454122867|FG000|Overall Study|Adverse Event|0|||
126227306|NCT01851590|454122868|FG001|Overall Study|Adverse Event|0|||
126227307|NCT01851590|454122869|FG002|Overall Study|Adverse Event|2|||
126227308|NCT01851590|454122867|FG000|Overall Study|Lack of Efficacy|0|||
126227309|NCT01851590|454122868|FG001|Overall Study|Lack of Efficacy|1|||
126227310|NCT01851590|454122869|FG002|Overall Study|Lack of Efficacy|0|||
126227311|NCT00310856|454122870|FG000|Overall Study|Withdrawal by Subject|2|||
126227312|NCT00310856|454122871|FG001|Overall Study|Withdrawal by Subject|2|||
126227313|NCT00310856|454122872|FG002|Overall Study|Withdrawal by Subject|2|||
126227314|NCT00310856|454122870|FG000|Overall Study|Lost to Follow-up|1|||
126227315|NCT00310856|454122871|FG001|Overall Study|Lost to Follow-up|2|||
126227316|NCT00310856|454122872|FG002|Overall Study|Lost to Follow-up|6|||
126227317|NCT00310856|454122870|FG000|Overall Study|Inappropriate enrollment|1|||
126227318|NCT00310856|454122871|FG001|Overall Study|Inappropriate enrollment|1|||
126227319|NCT00310856|454122872|FG002|Overall Study|Inappropriate enrollment|0|||
126227320|NCT00310856|454122870|FG000|Overall Study|Unable to classify|1|||
126227321|NCT00310856|454122871|FG001|Overall Study|Unable to classify|0|||
126227322|NCT00310856|454122872|FG002|Overall Study|Unable to classify|0|||
126227323|NCT02843074|454122876|FG000|Overall Study|Withdrawal by Subject|5|||
126227324|NCT02843074|454122876|FG000|Overall Study|Progressive disease|1|||
126227325|NCT02843074|454122876|FG000|Overall Study|Physician Decision|1|||
126227326|NCT02843074|454122876|FG000|Overall Study|Lost to Follow-up|1|||
126227327|NCT02843074|454122876|FG000|Overall Study|Death|9|||
126227328|NCT01214330|454122877|FG000|Overall Study|Withdrawal by Subject|2|||
126227329|NCT01214330|454122877|FG000|Overall Study|Withdrawal by Subject|2|||
126227330|NCT00686036|454122879|FG000|Overall Study|Adverse Event|3|||
126227331|NCT00686036|454122880|FG001|Overall Study|Adverse Event|0|||
126227332|NCT00686036|454122879|FG000|Overall Study|Withdrawal by Subject|3|||
126227333|NCT00686036|454122880|FG001|Overall Study|Withdrawal by Subject|1|||
126227334|NCT00686036|454122879|FG000|Overall Study|Study terminated by AstraZeneca|2|||
126227335|NCT00686036|454122880|FG001|Overall Study|Study terminated by AstraZeneca|1|||
126227336|NCT00686036|454122879|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
126227337|NCT00686036|454122880|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
126227338|NCT00686036|454122879|FG000|Overall Study|Other reasons not identified|0|||
126227339|NCT00686036|454122880|FG001|Overall Study|Other reasons not identified|4|||
126227340|NCT01199601|454122884|FG000|Overall Study|Lost to Follow-up|47|||
126227341|NCT01199601|454122885|FG001|Overall Study|Lost to Follow-up|66|||
126227342|NCT01199601|454122884|FG000|Overall Study|Withdrawal by Subject|15|||
126227343|NCT01199601|454122885|FG001|Overall Study|Withdrawal by Subject|3|||
126227344|NCT01199601|454122884|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
126227345|NCT01199601|454122885|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
126227346|NCT02669264|454122886|FG000|Overall Study|Death|5|||
126227347|NCT02669264|454122887|FG001|Overall Study|Death|5|||
126227348|NCT02669264|454122888|FG002|Overall Study|Death|3|||
126227349|NCT02669264|454122889|FG003|Overall Study|Death|3|||
126227350|NCT02669264|454122890|FG004|Overall Study|Death|3|||
126227351|NCT02669264|454122891|FG005|Overall Study|Death|6|||
126227352|NCT02669264|454122892|FG006|Overall Study|Death|3|||
126227353|NCT02669264|454122886|FG000|Overall Study|Withdrawal by Subject|0|||
126227354|NCT02669264|454122887|FG001|Overall Study|Withdrawal by Subject|1|||
126227355|NCT02669264|454122888|FG002|Overall Study|Withdrawal by Subject|0|||
126227356|NCT02669264|454122889|FG003|Overall Study|Withdrawal by Subject|0|||
126227357|NCT02669264|454122890|FG004|Overall Study|Withdrawal by Subject|1|||
126227358|NCT02669264|454122891|FG005|Overall Study|Withdrawal by Subject|0|||
126227359|NCT02669264|454122892|FG006|Overall Study|Withdrawal by Subject|0|||
126227360|NCT02669264|454122886|FG000|Overall Study|Lost to Follow-up|0|||
126227361|NCT02669264|454122887|FG001|Overall Study|Lost to Follow-up|0|||
126227362|NCT02669264|454122888|FG002|Overall Study|Lost to Follow-up|0|||
126352066|NCT01202591|454579601|FG005|Overall Study|Objective Disease Progression|0|||
126352067|NCT02830087|454579604|FG000|Overall Study|No study staff to follow-up patients|4|||
126352068|NCT02830087|454579605|FG001|Overall Study|No study staff to follow-up patients|4|||
126352069|NCT02830087|454579606|FG002|Overall Study|No study staff to follow-up patients|4|||
126352070|NCT02830087|454579607|FG003|Overall Study|No study staff to follow-up patients|3|||
126352071|NCT02830087|454579608|FG004|Overall Study|No study staff to follow-up patients|3|||
126352072|NCT02830087|454579609|FG005|Overall Study|No study staff to follow-up patients|3|||
126352073|NCT02583269|454579610|FG000|Overall Study|Patient hospitalized prior to start|1|||
126352074|NCT02583269|454579611|FG001|Overall Study|Patient hospitalized prior to start|0|||
126227363|NCT02669264|454122889|FG003|Overall Study|Lost to Follow-up|0|||
126227364|NCT02669264|454122890|FG004|Overall Study|Lost to Follow-up|1|||
126352075|NCT02583269|454579612|FG002|Overall Study|Patient hospitalized prior to start|0|||
126227365|NCT02669264|454122891|FG005|Overall Study|Lost to Follow-up|0|||
126227366|NCT02669264|454122892|FG006|Overall Study|Lost to Follow-up|0|||
126227367|NCT02669264|454122886|FG000|Overall Study|Miscellaneous|0|||
126227368|NCT02669264|454122887|FG001|Overall Study|Miscellaneous|0|||
126227369|NCT02669264|454122888|FG002|Overall Study|Miscellaneous|0|||
126227370|NCT02669264|454122889|FG003|Overall Study|Miscellaneous|0|||
126227371|NCT02669264|454122890|FG004|Overall Study|Miscellaneous|0|||
126227372|NCT02669264|454122891|FG005|Overall Study|Miscellaneous|0|||
126227373|NCT02669264|454122892|FG006|Overall Study|Miscellaneous|2|||
126227374|NCT01688037|454122893|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
126227375|NCT01688037|454122894|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
126227376|NCT01688037|454122895|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
126227377|NCT01688037|454122893|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
126227378|NCT01688037|454122894|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
126227379|NCT01688037|454122895|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
126227380|NCT01688037|454122893|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
126227381|NCT01688037|454122894|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
126227382|NCT01688037|454122895|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
126227383|NCT01688037|454122893|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
126227384|NCT01688037|454122894|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
126227385|NCT01688037|454122895|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
126227386|NCT01688037|454122893|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
126227387|NCT01688037|454122894|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
126227388|NCT01688037|454122895|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
126227389|NCT01688037|454122893|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
126227390|NCT01688037|454122894|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
126227391|NCT01688037|454122895|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
126227392|NCT01688037|454122893|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
126227393|NCT01688037|454122894|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
126227394|NCT01688037|454122895|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
126227395|NCT01688037|454122893|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
126227396|NCT01688037|454122894|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
126227397|NCT01688037|454122895|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
126227398|NCT01688037|454122893|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
126227399|NCT01688037|454122894|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
126227400|NCT01688037|454122895|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
126227401|NCT01688037|454122893|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
126227402|NCT01688037|454122894|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
126227403|NCT01688037|454122895|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
126227404|NCT02100956|454122896|FG000|At Least One Week Between Injections|Adverse Event|0|||
126227405|NCT02100956|454122897|FG001|At Least One Week Between Injections|Adverse Event|1|||
126227406|NCT03035227|454122898|FG000|Overall Study|study stopped due to PI leaving institut|1|||
126227407|NCT03035227|454122899|FG001|Overall Study|study stopped due to PI leaving institut|1|||
126227408|NCT00859469|454122901|FG000|Overall Study|Adverse Event|2|||
126227409|NCT00859469|454122901|FG000|Overall Study|Lack of Efficacy|9|||
126227410|NCT00859469|454122901|FG000|Overall Study|Withdrawal by Subject|1|||
126227411|NCT00859469|454122901|FG000|Overall Study|Death|16|||
126227412|NCT02220907|454122902|FG000|Overall Study|Adverse Event|7|||
126227413|NCT02220907|454122902|FG000|Overall Study|Physician Decision|1|||
126227414|NCT02220907|454122902|FG000|Overall Study|Withdrawal by Subject|2|||
126227415|NCT02220907|454122902|FG000|Overall Study|Conflict with the stopping criteria|1|||
126227416|NCT03111147|454122903|FG000|Overall Study|Lost to Follow-up|2|||
126227417|NCT03111147|454122904|FG001|Overall Study|Lost to Follow-up|5|||
126227418|NCT03111147|454122903|FG000|Overall Study|Withdrawal by Subject|4|||
126227419|NCT03111147|454122904|FG001|Overall Study|Withdrawal by Subject|3|||
126227420|NCT03111147|454122903|FG000|Overall Study|Protocol Violation|2|||
126227421|NCT03111147|454122904|FG001|Overall Study|Protocol Violation|1|||
126227422|NCT03111147|454122903|FG000|Overall Study|Death|1|||
126227423|NCT03111147|454122904|FG001|Overall Study|Death|1|||
126227424|NCT00095199|454122907|FG000|Overall Study|Adverse Event|40|||
126227425|NCT00095199|454122908|FG001|Overall Study|Adverse Event|22|||
126227426|NCT00095199|454122909|FG002|Overall Study|Adverse Event|26|||
126227427|NCT00095199|454122910|FG003|Overall Study|Adverse Event|11|||
126227428|NCT00095199|454122907|FG000|Overall Study|Progressive disease|213|||
126227429|NCT00095199|454122908|FG001|Overall Study|Progressive disease|179|||
126227430|NCT00095199|454122909|FG002|Overall Study|Progressive disease|105|||
126227431|NCT00095199|454122910|FG003|Overall Study|Progressive disease|98|||
126227432|NCT00095199|454122907|FG000|Overall Study|Death|10|||
126227433|NCT00095199|454122908|FG001|Overall Study|Death|6|||
126227434|NCT00095199|454122909|FG002|Overall Study|Death|11|||
126227435|NCT00095199|454122910|FG003|Overall Study|Death|9|||
126227436|NCT00095199|454122907|FG000|Overall Study|Withdrawal by Subject|21|||
126227437|NCT00095199|454122908|FG001|Overall Study|Withdrawal by Subject|16|||
126227438|NCT00095199|454122909|FG002|Overall Study|Withdrawal by Subject|13|||
126227439|NCT00095199|454122910|FG003|Overall Study|Withdrawal by Subject|22|||
126227440|NCT00095199|454122907|FG000|Overall Study|Protocol Violation|4|||
126227441|NCT00095199|454122908|FG001|Overall Study|Protocol Violation|4|||
126227442|NCT00095199|454122909|FG002|Overall Study|Protocol Violation|2|||
126227443|NCT00095199|454122910|FG003|Overall Study|Protocol Violation|0|||
126227444|NCT00095199|454122907|FG000|Overall Study|Liver function test results elevated|0|||
126227445|NCT00095199|454122908|FG001|Overall Study|Liver function test results elevated|0|||
126227446|NCT00095199|454122909|FG002|Overall Study|Liver function test results elevated|1|||
126227447|NCT00095199|454122910|FG003|Overall Study|Liver function test results elevated|1|||
126227448|NCT00095199|454122907|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
126227449|NCT00095199|454122908|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
126227450|NCT00095199|454122909|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
126227451|NCT00095199|454122910|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
126227452|NCT00095199|454122907|FG000|Overall Study|Physician Decision|5|||
126227453|NCT00095199|454122908|FG001|Overall Study|Physician Decision|6|||
126227454|NCT00095199|454122909|FG002|Overall Study|Physician Decision|1|||
126227455|NCT00095199|454122910|FG003|Overall Study|Physician Decision|1|||
126227456|NCT00095199|454122907|FG000|Overall Study|Not eligible|1|||
126227457|NCT00095199|454122908|FG001|Overall Study|Not eligible|7|||
126227458|NCT00095199|454122909|FG002|Overall Study|Not eligible|0|||
126227459|NCT00095199|454122910|FG003|Overall Study|Not eligible|1|||
126227460|NCT00095199|454122907|FG000|Overall Study|Started Palliative Radiotherapy|1|||
126227461|NCT00095199|454122908|FG001|Overall Study|Started Palliative Radiotherapy|0|||
126227462|NCT00095199|454122909|FG002|Overall Study|Started Palliative Radiotherapy|0|||
126227463|NCT00095199|454122910|FG003|Overall Study|Started Palliative Radiotherapy|0|||
126227464|NCT00095199|454122907|FG000|Overall Study|Started radiotherapy regimen|0|||
126227465|NCT00095199|454122908|FG001|Overall Study|Started radiotherapy regimen|1|||
126227466|NCT00095199|454122909|FG002|Overall Study|Started radiotherapy regimen|0|||
126227467|NCT00095199|454122910|FG003|Overall Study|Started radiotherapy regimen|0|||
126227468|NCT00095199|454122907|FG000|Overall Study|Primary tumor removed in other surgery|0|||
126227469|NCT00095199|454122908|FG001|Overall Study|Primary tumor removed in other surgery|1|||
126227470|NCT00095199|454122909|FG002|Overall Study|Primary tumor removed in other surgery|0|||
126227471|NCT00095199|454122910|FG003|Overall Study|Primary tumor removed in other surgery|0|||
126227472|NCT00095199|454122907|FG000|Overall Study|Data inadvertently lost by site|1|||
126227473|NCT00095199|454122908|FG001|Overall Study|Data inadvertently lost by site|0|||
126227474|NCT00095199|454122909|FG002|Overall Study|Data inadvertently lost by site|0|||
126227475|NCT00095199|454122910|FG003|Overall Study|Data inadvertently lost by site|0|||
126227476|NCT01896297|454122913|FG000|Overall Study|Died in post treatment phase|1|||
126227477|NCT01070394|454122914|FG000|Overall Study|Adverse Event|6|||
126227478|NCT01070394|454122914|FG000|Overall Study|Withdrawal by Subject|1|||
126227479|NCT01098240|454122915|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
126227480|NCT01098240|454122916|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
126227481|NCT01098240|454122917|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
126227482|NCT01098240|454122915|FG000|Open-Label Phase|Protocol Violation|4|||
126227483|NCT01098240|454122916|FG001|Open-Label Phase|Protocol Violation|0|||
126227484|NCT01098240|454122917|FG002|Open-Label Phase|Protocol Violation|0|||
126227485|NCT01098240|454122915|FG000|Open-Label Phase|Lost to Follow-up|13|||
126227486|NCT01098240|454122916|FG001|Open-Label Phase|Lost to Follow-up|0|||
126227487|NCT01098240|454122917|FG002|Open-Label Phase|Lost to Follow-up|0|||
126227488|NCT01098240|454122915|FG000|Open-Label Phase|Other|19|||
126227489|NCT01098240|454122916|FG001|Open-Label Phase|Other|0|||
126227490|NCT01098240|454122917|FG002|Open-Label Phase|Other|0|||
126227491|NCT01098240|454122915|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
126227492|NCT01098240|454122916|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126227493|NCT01098240|454122917|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126227494|NCT01098240|454122915|FG000|Open-Label Phase|Pregnancy|1|||
126227495|NCT01098240|454122916|FG001|Open-Label Phase|Pregnancy|0|||
126227496|NCT01098240|454122917|FG002|Open-Label Phase|Pregnancy|0|||
126227497|NCT01098240|454122915|FG000|Open-Label Phase|Withdrawal by Subject|9|||
126227498|NCT01098240|454122916|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126227499|NCT01098240|454122917|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126227500|NCT01098240|454122915|FG000|Open-Label Phase|Adverse Event|12|||
126227501|NCT01098240|454122916|FG001|Open-Label Phase|Adverse Event|0|||
126227502|NCT01098240|454122917|FG002|Open-Label Phase|Adverse Event|0|||
126227503|NCT01098240|454122915|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
126227504|NCT01098240|454122916|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
126021162|NCT04328727|453373193|FG000|Overall Study|Participant decision|4|||
126021163|NCT04328727|453373193|FG000|Overall Study|Death|3|||
126021164|NCT03684044|453373194|FG000|Overall Study|Adverse Event|3|||
126021165|NCT03684044|453373195|FG001|Overall Study|Adverse Event|0|||
126227505|NCT01098240|454122917|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
126227506|NCT01098240|454122915|FG000|Double-Blind Phase|Protocol Violation|0|||
126227507|NCT01098240|454122916|FG001|Double-Blind Phase|Protocol Violation|2|||
126227508|NCT01098240|454122917|FG002|Double-Blind Phase|Protocol Violation|4|||
126021166|NCT03684044|453373194|FG000|Overall Study|Death|4|||
126227509|NCT01098240|454122915|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126227510|NCT01098240|454122916|FG001|Double-Blind Phase|Lost to Follow-up|2|||
126227511|NCT01098240|454122917|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126021167|NCT03684044|453373195|FG001|Overall Study|Death|7|||
126021168|NCT03684044|453373194|FG000|Overall Study|Lost to Follow-up|3|||
126227512|NCT01098240|454122915|FG000|Double-Blind Phase|Other|0|||
126227513|NCT01098240|454122916|FG001|Double-Blind Phase|Other|2|||
126227514|NCT01098240|454122917|FG002|Double-Blind Phase|Other|2|||
126227515|NCT01098240|454122915|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
126227516|NCT01098240|454122916|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
126227517|NCT01098240|454122917|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
126227518|NCT01098240|454122915|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
126227519|NCT01098240|454122916|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
126227520|NCT01098240|454122917|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
126227521|NCT01098240|454122915|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126227522|NCT01098240|454122916|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
126227523|NCT01098240|454122917|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
126227524|NCT01098240|454122915|FG000|Double-Blind Phase|Adverse Event|0|||
126227525|NCT01098240|454122916|FG001|Double-Blind Phase|Adverse Event|3|||
126227526|NCT01098240|454122917|FG002|Double-Blind Phase|Adverse Event|3|||
126227527|NCT03280537|454122918|FG000|Overall Study|Withdrawal by Subject|2|||
126227528|NCT03280537|454122919|FG001|Overall Study|Withdrawal by Subject|4|||
126227529|NCT01588106|454122921|FG000|Overall Study|Withdrawal by Subject|5|||
126227530|NCT01588106|454122922|FG001|Overall Study|Withdrawal by Subject|4|||
126227531|NCT03083132|454122923|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
126227532|NCT03083132|454122924|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
126227533|NCT03083132|454122923|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
126227534|NCT03083132|454122924|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
126227535|NCT03083132|454122923|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
126227536|NCT03083132|454122924|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
126227537|NCT02995837|454122925|FG000|Overall Study|Lost to Follow-up|9|||
126227538|NCT02995837|454122926|FG001|Overall Study|Lost to Follow-up|8|||
126227539|NCT03118739|454122927|FG000|Overall Study|Physician Decision|0|||
126227540|NCT03118739|454122928|FG001|Overall Study|Physician Decision|1|||
126227541|NCT03118739|454122927|FG000|Overall Study|Withdrawal by Subject|5|||
126227542|NCT03118739|454122928|FG001|Overall Study|Withdrawal by Subject|3|||
126227543|NCT03118739|454122927|FG000|Overall Study|Lost to Follow-up|2|||
126227544|NCT03118739|454122928|FG001|Overall Study|Lost to Follow-up|0|||
126227545|NCT00669955|454122929|FG000|Overall Study|Adverse Event|3|||
126227546|NCT00669955|454122930|FG001|Overall Study|Adverse Event|5|||
126227547|NCT00669955|454122929|FG000|Overall Study|Death|0|||
126227548|NCT00669955|454122930|FG001|Overall Study|Death|1|||
126227549|NCT00669955|454122929|FG000|Overall Study|Withdrawal by Subject|2|||
126227550|NCT00669955|454122930|FG001|Overall Study|Withdrawal by Subject|3|||
126227551|NCT00669955|454122929|FG000|Overall Study|Lost to Follow-up|5|||
126227552|NCT00669955|454122930|FG001|Overall Study|Lost to Follow-up|7|||
126227553|NCT00669955|454122929|FG000|Overall Study|Protocol Violation|2|||
126227554|NCT00669955|454122930|FG001|Overall Study|Protocol Violation|7|||
126227555|NCT00669955|454122929|FG000|Overall Study|Investigator Sponsor Judgement|0|||
126227556|NCT00669955|454122930|FG001|Overall Study|Investigator Sponsor Judgement|1|||
126227557|NCT00669955|454122929|FG000|Overall Study|not compliant with study drug/visit|2|||
126227558|NCT00669955|454122930|FG001|Overall Study|not compliant with study drug/visit|3|||
126227559|NCT01077713|454122935|FG000|Overall Study|Withdrawal by Subject|1|||
126227560|NCT01077713|454122936|FG001|Overall Study|Withdrawal by Subject|2|||
126227561|NCT01077713|454122935|FG000|Overall Study|Progressive Disease (PD)|0|||
126227562|NCT01077713|454122936|FG001|Overall Study|Progressive Disease (PD)|1|||
126227563|NCT01077713|454122935|FG000|Overall Study|Death|28|||
126227564|NCT01077713|454122936|FG001|Overall Study|Death|29|||
126227565|NCT01077713|454122935|FG000|Overall Study|Lost to Follow-up|1|||
126227566|NCT01077713|454122936|FG001|Overall Study|Lost to Follow-up|1|||
126227567|NCT01077713|454122935|FG000|Overall Study|Adverse Event|2|||
126227568|NCT01077713|454122936|FG001|Overall Study|Adverse Event|1|||
126227569|NCT01077713|454122935|FG000|Overall Study|Other|4|||
126227570|NCT01077713|454122936|FG001|Overall Study|Other|2|||
126227571|NCT04274192|454122937|FG000|Overall Study|Protocol Violation|1|||
126227572|NCT04274192|454122938|FG001|Overall Study|Protocol Violation|0|||
126227573|NCT03507439|454122939|FG000|Overall Study|Other|2|||
126227574|NCT03507439|454122940|FG001|Overall Study|Other|1|||
126227575|NCT03507439|454122939|FG000|Overall Study|Withdrawal by Subject|1|||
126227576|NCT03507439|454122940|FG001|Overall Study|Withdrawal by Subject|0|||
126227577|NCT03507439|454122939|FG000|Overall Study|Death|1|||
126227578|NCT03507439|454122940|FG001|Overall Study|Death|1|||
126227579|NCT00289458|454122941|FG000|Overall Study|Death|1|||
126227580|NCT00289458|454122942|FG001|Overall Study|Death|0|||
126227581|NCT00289458|454122943|FG002|Overall Study|Death|0|||
126227582|NCT00289458|454122941|FG000|Overall Study|Physician Decision|3|||
126227583|NCT00289458|454122942|FG001|Overall Study|Physician Decision|4|||
126227584|NCT00289458|454122943|FG002|Overall Study|Physician Decision|2|||
126227585|NCT00289458|454122941|FG000|Overall Study|Withdrawal by Subject|2|||
126227586|NCT00289458|454122942|FG001|Overall Study|Withdrawal by Subject|2|||
126227587|NCT00289458|454122943|FG002|Overall Study|Withdrawal by Subject|4|||
126227588|NCT01144663|454124506|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
126227589|NCT01144663|454124507|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
126227590|NCT01144663|454124508|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
126227591|NCT01144663|454124509|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
126227592|NCT01144663|454124506|FG000|Primary Vaccination Phase|Adverse Event|1|||
126227593|NCT01144663|454124507|FG001|Primary Vaccination Phase|Adverse Event|0|||
126227594|NCT01144663|454124508|FG002|Primary Vaccination Phase|Adverse Event|0|||
126227595|NCT01144663|454124509|FG003|Primary Vaccination Phase|Adverse Event|1|||
126227596|NCT01144663|454124506|FG000|Primary Vaccination Phase|Protocol Violation|2|||
126227597|NCT01144663|454124507|FG001|Primary Vaccination Phase|Protocol Violation|0|||
126227598|NCT01144663|454124508|FG002|Primary Vaccination Phase|Protocol Violation|1|||
126227599|NCT01144663|454124509|FG003|Primary Vaccination Phase|Protocol Violation|0|||
126227600|NCT01144663|454124506|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
126227601|NCT01144663|454124507|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
126227602|NCT01144663|454124508|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
126227603|NCT01144663|454124509|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
126227604|NCT01144663|454124506|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
126227605|NCT01144663|454124507|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
126227606|NCT01144663|454124508|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
126227607|NCT01144663|454124509|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
126227608|NCT01144663|454124506|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
126227609|NCT01144663|454124507|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
126227610|NCT01144663|454124508|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
126227611|NCT01144663|454124509|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
126227612|NCT01144663|454124506|FG000|Primary Vaccination Phase|Other|0|||
126227613|NCT01144663|454124507|FG001|Primary Vaccination Phase|Other|1|||
126227614|NCT01144663|454124508|FG002|Primary Vaccination Phase|Other|0|||
126227615|NCT01144663|454124509|FG003|Primary Vaccination Phase|Other|2|||
126227616|NCT01144663|454124506|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
126227617|NCT01144663|454124507|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
126227618|NCT01144663|454124508|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
126227619|NCT01144663|454124509|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
126227620|NCT01144663|454124506|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
126227621|NCT01144663|454124507|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
126227622|NCT01144663|454124508|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
126227623|NCT01144663|454124509|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
126227624|NCT01144663|454124506|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
126227625|NCT01144663|454124507|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
126227626|NCT01144663|454124508|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
126227627|NCT01144663|454124509|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
126227628|NCT01144663|454124506|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
126227629|NCT01144663|454124507|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
126227630|NCT01144663|454124508|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
126227631|NCT01144663|454124509|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
126227632|NCT01144663|454124506|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
126227633|NCT01144663|454124507|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
126227634|NCT01144663|454124508|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
126227635|NCT01144663|454124509|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
126227636|NCT01144663|454124506|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
126227637|NCT01144663|454124507|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
126227638|NCT01144663|454124508|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
126227639|NCT01144663|454124509|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
126227640|NCT01335477|454124510|FG000|Overall Study|Adverse Event|30|||
126227641|NCT01335477|454124511|FG001|Overall Study|Adverse Event|42|||
126227642|NCT01335477|454124510|FG000|Overall Study|Non compliant with protocol|0|||
126227643|NCT01335477|454124511|FG001|Overall Study|Non compliant with protocol|2|||
126227644|NCT01335477|454124510|FG000|Overall Study|Lost to Follow-up|1|||
126227645|NCT01335477|454124511|FG001|Overall Study|Lost to Follow-up|2|||
126227646|NCT01335477|454124510|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
126227647|NCT01335477|454124511|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
126227648|NCT01335477|454124510|FG000|Overall Study|Not treated|1|||
126227649|NCT01335477|454124511|FG001|Overall Study|Not treated|2|||
126227650|NCT01335477|454124510|FG000|Overall Study|Reason other than those stated above|2|||
126227651|NCT01335477|454124511|FG001|Overall Study|Reason other than those stated above|2|||
126227652|NCT03031899|454124514|FG000|Overall Study|Protocol Violation|1|||
126352076|NCT02583269|454579613|FG003|Overall Study|Patient hospitalized prior to start|0|||
126352077|NCT02583269|454579614|FG004|Overall Study|Patient hospitalized prior to start|0|||
126352078|NCT03611946|454579618|FG000|Overall Study|Withdrawal by Subject|0|||
126352079|NCT03611946|454579619|FG001|Overall Study|Withdrawal by Subject|0|||
126352080|NCT03611946|454579620|FG002|Overall Study|Withdrawal by Subject|1|||
126021169|NCT03684044|453373195|FG001|Overall Study|Lost to Follow-up|2|||
126227653|NCT03031899|454124514|FG000|Overall Study|lesion disappeared after stopping habit|1|||
126227654|NCT03740698|454124515|FG000|Overall Study|Physician Decision|0|||
126227655|NCT03740698|454124516|FG001|Overall Study|Physician Decision|1|||
126227656|NCT03740698|454124517|FG002|Overall Study|Physician Decision|1|||
126227657|NCT01469364|454124519|FG000|Overall Study|Adverse Event|1|||
126227658|NCT01469364|454124519|FG000|Overall Study|Withdrawal by Subject|1|||
126227659|NCT01162499|454124522|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
126227660|NCT01162499|454124523|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
126227661|NCT02040428|454124524|FG000|Overall Study|Death|4|||
126227662|NCT02040428|454124525|FG001|Overall Study|Death|3|||
126227663|NCT02040428|454124524|FG000|Overall Study|Withdrawal by Subject|1|||
126227664|NCT02040428|454124525|FG001|Overall Study|Withdrawal by Subject|1|||
126227665|NCT00449072|454124543|FG000|Overall Study|Adverse Event|3|||
126227666|NCT00449072|454124544|FG001|Overall Study|Adverse Event|1|||
126227667|NCT00449072|454124543|FG000|Overall Study|Protocol Violation|14|||
126227668|NCT00449072|454124544|FG001|Overall Study|Protocol Violation|12|||
126227669|NCT00449072|454124543|FG000|Overall Study|Lost to Follow-up|5|||
126227670|NCT00449072|454124544|FG001|Overall Study|Lost to Follow-up|7|||
126227671|NCT00449072|454124543|FG000|Overall Study|Withdrawal by Subject|11|||
126227672|NCT00449072|454124544|FG001|Overall Study|Withdrawal by Subject|8|||
126227673|NCT00449072|454124543|FG000|Overall Study|Lack of Efficacy|1|||
126227674|NCT00449072|454124544|FG001|Overall Study|Lack of Efficacy|1|||
126227675|NCT00449072|454124543|FG000|Overall Study|Physician Decision|1|||
126227676|NCT00449072|454124544|FG001|Overall Study|Physician Decision|0|||
126227677|NCT00449072|454124543|FG000|Overall Study|Not treated|0|||
126227678|NCT00449072|454124544|FG001|Overall Study|Not treated|1|||
126227679|NCT00449072|454124543|FG000|Overall Study|Excluded medication|0|||
126227680|NCT00449072|454124544|FG001|Overall Study|Excluded medication|2|||
126227681|NCT00449072|454124543|FG000|Overall Study|Non-compliance|2|||
126227682|NCT00449072|454124544|FG001|Overall Study|Non-compliance|5|||
126227683|NCT00449072|454124543|FG000|Overall Study|Sponsor decision|1|||
126227684|NCT00449072|454124544|FG001|Overall Study|Sponsor decision|3|||
126227685|NCT00449072|454124543|FG000|Overall Study|Relocation|3|||
126227686|NCT00449072|454124544|FG001|Overall Study|Relocation|2|||
126227687|NCT00989261|454124545|FG000|Overall Study|Still in follow up|12|||
126227688|NCT00989261|454124546|FG001|Overall Study|Still in follow up|21|||
126227689|NCT00989261|454124545|FG000|Overall Study|Withdrawal by Subject|0|||
126227690|NCT00989261|454124546|FG001|Overall Study|Withdrawal by Subject|1|||
126227691|NCT00989261|454124545|FG000|Overall Study|Lost to Follow-up|3|||
126227692|NCT00989261|454124546|FG001|Overall Study|Lost to Follow-up|0|||
126227693|NCT00718159|454124547|FG000|Overall Study|Progressive Disease|3|||
126227694|NCT00718159|454124548|FG001|Overall Study|Progressive Disease|3|||
126227695|NCT00718159|454124549|FG002|Overall Study|Progressive Disease|2|||
126227696|NCT00718159|454124550|FG003|Overall Study|Progressive Disease|0|||
126227697|NCT00718159|454124551|FG004|Overall Study|Progressive Disease|6|||
126227698|NCT00718159|454124552|FG005|Overall Study|Progressive Disease|0|||
126227699|NCT00718159|454124553|FG006|Overall Study|Progressive Disease|0|||
126227700|NCT00718159|454124547|FG000|Overall Study|Death due to Adverse Event|0|||
126227701|NCT00718159|454124548|FG001|Overall Study|Death due to Adverse Event|0|||
126227702|NCT00718159|454124549|FG002|Overall Study|Death due to Adverse Event|0|||
126227703|NCT00718159|454124550|FG003|Overall Study|Death due to Adverse Event|2|||
126227704|NCT00718159|454124551|FG004|Overall Study|Death due to Adverse Event|2|||
126227705|NCT00718159|454124552|FG005|Overall Study|Death due to Adverse Event|0|||
126227706|NCT00718159|454124553|FG006|Overall Study|Death due to Adverse Event|0|||
126227707|NCT00718159|454124547|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
126227708|NCT00718159|454124548|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
126227709|NCT00718159|454124549|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
126227710|NCT00718159|454124550|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
126227711|NCT00718159|454124551|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
126227712|NCT00718159|454124552|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
126352081|NCT03611946|454579621|FG003|Overall Study|Withdrawal by Subject|0|||
126021170|NCT03684044|453373194|FG000|Overall Study|Patient Not Available|0|||
126021171|NCT03684044|453373195|FG001|Overall Study|Patient Not Available|2|||
126352082|NCT02207608|454579625|FG000|Overall Study|Adverse Event|1|||
126021172|NCT03684044|453373194|FG000|Overall Study|Physician Decision|1|||
126227713|NCT00718159|454124553|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
126227714|NCT00718159|454124547|FG000|Overall Study|Investigator Decision|0|||
126227715|NCT00718159|454124548|FG001|Overall Study|Investigator Decision|0|||
126227716|NCT00718159|454124549|FG002|Overall Study|Investigator Decision|0|||
126227717|NCT00718159|454124550|FG003|Overall Study|Investigator Decision|0|||
126227718|NCT00718159|454124551|FG004|Overall Study|Investigator Decision|0|||
126227719|NCT00718159|454124552|FG005|Overall Study|Investigator Decision|1|||
126227720|NCT00718159|454124553|FG006|Overall Study|Investigator Decision|1|||
126227721|NCT03532009|454124558|FG000|Overall Study|Other|1|||
126227722|NCT03532009|454124559|FG001|Overall Study|Other|1|||
126227723|NCT03532009|454124558|FG000|Overall Study|Death|1|||
126227724|NCT03532009|454124559|FG001|Overall Study|Death|1|||
126227725|NCT03532009|454124558|FG000|Overall Study|Withdrawal by Patient|0|||
126227726|NCT03532009|454124559|FG001|Overall Study|Withdrawal by Patient|2|||
126227727|NCT01798485|454124562|FG000|Overall Study|Adverse Event|32|||
126227728|NCT01798485|454124563|FG001|Overall Study|Adverse Event|40|||
126227729|NCT01798485|454124562|FG000|Overall Study|Withdrawal by Subject|27|||
126227730|NCT01798485|454124563|FG001|Overall Study|Withdrawal by Subject|31|||
126227731|NCT01798485|454124562|FG000|Overall Study|Lost to Follow-up|0|||
126227732|NCT01798485|454124563|FG001|Overall Study|Lost to Follow-up|3|||
126227733|NCT01798485|454124562|FG000|Overall Study|Physician Decision|14|||
126227734|NCT01798485|454124563|FG001|Overall Study|Physician Decision|10|||
126227735|NCT01798485|454124562|FG000|Overall Study|Objective Disease Progression|152|||
126227736|NCT01798485|454124563|FG001|Overall Study|Objective Disease Progression|106|||
126227737|NCT01798485|454124562|FG000|Overall Study|Death|25|||
126227738|NCT01798485|454124563|FG001|Overall Study|Death|22|||
126227739|NCT01798485|454124562|FG000|Overall Study|Sponsor Decision|61|||
126227740|NCT01798485|454124563|FG001|Overall Study|Sponsor Decision|54|||
126227741|NCT01798485|454124562|FG000|Overall Study|Clinical Progression|35|||
126227742|NCT01798485|454124563|FG001|Overall Study|Clinical Progression|24|||
126227743|NCT00681863|454124564|FG000|Overall Study|Adverse Event|1|||
126227744|NCT00681863|454124564|FG000|Overall Study|Lost to Follow-up|2|||
126227745|NCT00681863|454124564|FG000|Overall Study|Lack of Efficacy|2|||
126227746|NCT00681863|454124564|FG000|Overall Study|Other|18|||
126227747|NCT01333033|454124565|FG000|Overall Study|Ineligible|0|||
126227748|NCT01333033|454124566|FG001|Overall Study|Ineligible|0|||
126227749|NCT01333033|454124567|FG002|Overall Study|Ineligible|0|||
126227750|NCT01333033|454124568|FG003|Overall Study|Ineligible|0|||
126227751|NCT01333033|454124569|FG004|Overall Study|Ineligible|6|||
126227752|NCT01333033|454124570|FG005|Overall Study|Ineligible|8|||
126227753|NCT01333033|454124565|FG000|Overall Study|Withdrawal by Subject|0|||
126227754|NCT01333033|454124566|FG001|Overall Study|Withdrawal by Subject|0|||
126227755|NCT01333033|454124567|FG002|Overall Study|Withdrawal by Subject|0|||
126227756|NCT01333033|454124568|FG003|Overall Study|Withdrawal by Subject|0|||
126227757|NCT01333033|454124569|FG004|Overall Study|Withdrawal by Subject|4|||
126227758|NCT01333033|454124570|FG005|Overall Study|Withdrawal by Subject|2|||
126227759|NCT01333033|454124565|FG000|Overall Study|PET inevaluable|0|||
126021173|NCT03684044|453373195|FG001|Overall Study|Physician Decision|0|||
126021174|NCT03684044|453373194|FG000|Overall Study|Withdrawal by Subject|11|||
126227760|NCT01333033|454124566|FG001|Overall Study|PET inevaluable|0|||
126227761|NCT01333033|454124567|FG002|Overall Study|PET inevaluable|0|||
126227762|NCT01333033|454124568|FG003|Overall Study|PET inevaluable|0|||
126227763|NCT01333033|454124569|FG004|Overall Study|PET inevaluable|2|||
126227764|NCT01333033|454124570|FG005|Overall Study|PET inevaluable|4|||
126227765|NCT01333033|454124565|FG000|Overall Study|Adverse Event|0|||
126227766|NCT01333033|454124566|FG001|Overall Study|Adverse Event|0|||
126227767|NCT01333033|454124567|FG002|Overall Study|Adverse Event|0|||
126227768|NCT01333033|454124568|FG003|Overall Study|Adverse Event|0|||
126227769|NCT01333033|454124569|FG004|Overall Study|Adverse Event|2|||
126227770|NCT01333033|454124570|FG005|Overall Study|Adverse Event|1|||
126227771|NCT01333033|454124565|FG000|Overall Study|Progression|0|||
126227772|NCT01333033|454124566|FG001|Overall Study|Progression|0|||
126227773|NCT01333033|454124567|FG002|Overall Study|Progression|0|||
126227774|NCT01333033|454124568|FG003|Overall Study|Progression|0|||
126227775|NCT01333033|454124569|FG004|Overall Study|Progression|0|||
126227776|NCT01333033|454124570|FG005|Overall Study|Progression|1|||
126227777|NCT01333033|454124565|FG000|Overall Study|MD Decision|0|||
126227778|NCT01333033|454124566|FG001|Overall Study|MD Decision|0|||
126227779|NCT01333033|454124567|FG002|Overall Study|MD Decision|0|||
126227780|NCT01333033|454124568|FG003|Overall Study|MD Decision|0|||
126227781|NCT01333033|454124569|FG004|Overall Study|MD Decision|0|||
126227782|NCT01333033|454124570|FG005|Overall Study|MD Decision|2|||
126227783|NCT03687125|454124571|FG000|Overall Study|Progressive Disease|2|||
126227784|NCT03687125|454124572|FG001|Overall Study|Progressive Disease|1|||
126227785|NCT03687125|454124571|FG000|Overall Study|Protocol Violation|1|||
126227786|NCT03687125|454124572|FG001|Overall Study|Protocol Violation|0|||
126227787|NCT01992107|454124573|FG000|Overall Study|Administrative reasons|2|||
126227788|NCT01992107|454124574|FG001|Overall Study|Administrative reasons|0|||
126227789|NCT01992107|454124575|FG002|Overall Study|Administrative reasons|0|||
126227790|NCT01992107|454124573|FG000|Overall Study|Adverse Event|0|||
126227791|NCT01992107|454124574|FG001|Overall Study|Adverse Event|1|||
126227792|NCT01992107|454124575|FG002|Overall Study|Adverse Event|0|||
126227793|NCT01992107|454124573|FG000|Overall Study|Lost to Follow-up|46|||
126227794|NCT01992107|454124574|FG001|Overall Study|Lost to Follow-up|22|||
126227795|NCT01992107|454124575|FG002|Overall Study|Lost to Follow-up|26|||
126227796|NCT01992107|454124573|FG000|Overall Study|noncompliance and were unavailable|7|||
126227797|NCT01992107|454124574|FG001|Overall Study|noncompliance and were unavailable|3|||
126227798|NCT01992107|454124575|FG002|Overall Study|noncompliance and were unavailable|2|||
126227799|NCT01992107|454124573|FG000|Overall Study|Withdrawal by Subject|13|||
126227800|NCT01992107|454124574|FG001|Overall Study|Withdrawal by Subject|7|||
126227801|NCT01992107|454124575|FG002|Overall Study|Withdrawal by Subject|8|||
126227802|NCT02035137|454124578|FG000|Overall Study|Physician Decision|0|||
126227803|NCT02035137|454124579|FG001|Overall Study|Physician Decision|0|||
126227804|NCT02035137|454124580|FG002|Overall Study|Physician Decision|1|||
126227805|NCT02035137|454124578|FG000|Overall Study|Withdrawal by Subject|0|||
126227806|NCT02035137|454124579|FG001|Overall Study|Withdrawal by Subject|1|||
126227807|NCT02035137|454124580|FG002|Overall Study|Withdrawal by Subject|2|||
126227808|NCT02035137|454124578|FG000|Overall Study|Ineligible|0|||
126227809|NCT02035137|454124579|FG001|Overall Study|Ineligible|1|||
126227810|NCT02035137|454124580|FG002|Overall Study|Ineligible|2|||
126227811|NCT02035137|454124578|FG000|Overall Study|Disease progression prior to treatment start|2|||
126227812|NCT02035137|454124579|FG001|Overall Study|Disease progression prior to treatment start|0|||
126227813|NCT02035137|454124580|FG002|Overall Study|Disease progression prior to treatment start|0|||
126227814|NCT01214603|454124596|FG000|Overall Study|Adverse Event|0|||
126227815|NCT01214603|454124597|FG001|Overall Study|Adverse Event|0|||
126227816|NCT01214603|454124598|FG002|Overall Study|Adverse Event|1|||
126227817|NCT01214603|454124596|FG000|Overall Study|Death|1|||
126227818|NCT01214603|454124597|FG001|Overall Study|Death|0|||
126227819|NCT01214603|454124598|FG002|Overall Study|Death|0|||
126227820|NCT01214603|454124596|FG000|Overall Study|Progressive Disease|4|||
126227821|NCT01214603|454124597|FG001|Overall Study|Progressive Disease|1|||
126227822|NCT01214603|454124598|FG002|Overall Study|Progressive Disease|3|||
126227823|NCT01388647|454124599|FG000|Overall Study|Adverse Event|1|||
126227824|NCT01388647|454124600|FG001|Overall Study|Adverse Event|2|||
126227825|NCT02444533|454124601|FG000|Overall Study|Not able to complete forms|0|||
126227826|NCT02444533|454124602|FG001|Overall Study|Not able to complete forms|2|||
126227827|NCT02444533|454124601|FG000|Overall Study|Only gave post-procedure complications|2|||
126227828|NCT02444533|454124602|FG001|Overall Study|Only gave post-procedure complications|2|||
126227829|NCT03567057|454124604|FG000|Overall Study|Adverse Event|56|||
126227830|NCT03567057|454124605|FG001|Overall Study|Adverse Event|53|||
126227831|NCT03567057|454124606|FG002|Overall Study|Adverse Event|28|||
126227832|NCT03567057|454124604|FG000|Overall Study|Withdrawal by Subject|22|||
126227833|NCT03567057|454124605|FG001|Overall Study|Withdrawal by Subject|24|||
126352083|NCT02207608|454579626|FG001|Overall Study|Adverse Event|0|||
126352084|NCT03580928|454579630|FG000|Overall Study|Death|0|||
126352085|NCT03580928|454579631|FG001|Overall Study|Death|3|||
126352086|NCT03580928|454579630|FG000|Overall Study|Withdrawal by Subject|2|||
126352087|NCT03580928|454579631|FG001|Overall Study|Withdrawal by Subject|1|||
126352088|NCT03580928|454579630|FG000|Overall Study|Lost to Follow-up|2|||
126352089|NCT03580928|454579631|FG001|Overall Study|Lost to Follow-up|0|||
126352090|NCT03580928|454579630|FG000|Overall Study|Progressive Disease|0|||
126352091|NCT03580928|454579631|FG001|Overall Study|Progressive Disease|1|||
126352092|NCT05800145|454579632|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
126352093|NCT05800145|454579633|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126352094|NCT05800145|454579634|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126352095|NCT05800145|454579635|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
126352096|NCT05800145|454579636|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126227834|NCT03567057|454124606|FG002|Overall Study|Withdrawal by Subject|13|||
126227835|NCT03567057|454124604|FG000|Overall Study|Lost to Follow-up|3|||
126227836|NCT03567057|454124605|FG001|Overall Study|Lost to Follow-up|5|||
126227837|NCT03567057|454124606|FG002|Overall Study|Lost to Follow-up|2|||
126227838|NCT03567057|454124604|FG000|Overall Study|COVID-19 pandemic|4|||
126227839|NCT03567057|454124605|FG001|Overall Study|COVID-19 pandemic|3|||
126227840|NCT03567057|454124606|FG002|Overall Study|COVID-19 pandemic|0|||
126227841|NCT03567057|454124604|FG000|Overall Study|Non-compliance with study drug|4|||
126227842|NCT03567057|454124605|FG001|Overall Study|Non-compliance with study drug|2|||
126227843|NCT03567057|454124606|FG002|Overall Study|Non-compliance with study drug|0|||
126227844|NCT03567057|454124604|FG000|Overall Study|Lack of Efficacy|3|||
126227845|NCT03567057|454124605|FG001|Overall Study|Lack of Efficacy|0|||
126227846|NCT03567057|454124606|FG002|Overall Study|Lack of Efficacy|1|||
126227847|NCT03567057|454124604|FG000|Overall Study|Death|1|||
126227848|NCT03567057|454124605|FG001|Overall Study|Death|0|||
126227849|NCT03567057|454124606|FG002|Overall Study|Death|0|||
126227850|NCT03567057|454124604|FG000|Overall Study|Physician Decision|1|||
126227851|NCT03567057|454124605|FG001|Overall Study|Physician Decision|0|||
126227852|NCT03567057|454124606|FG002|Overall Study|Physician Decision|0|||
126227853|NCT03567057|454124604|FG000|Overall Study|Unstable medical condition|1|||
126227854|NCT03567057|454124605|FG001|Overall Study|Unstable medical condition|0|||
126227855|NCT03567057|454124606|FG002|Overall Study|Unstable medical condition|0|||
126227856|NCT03567057|454124604|FG000|Overall Study|Medical history event|0|||
126227857|NCT03567057|454124605|FG001|Overall Study|Medical history event|0|||
126227858|NCT03567057|454124606|FG002|Overall Study|Medical history event|1|||
126227859|NCT03567057|454124604|FG000|Overall Study|Other|0|||
126227860|NCT03567057|454124605|FG001|Overall Study|Other|0|||
126227861|NCT03567057|454124606|FG002|Overall Study|Other|1|||
126227862|NCT01006707|454124607|FG000|Study Session 1|Lost to Follow-up|2|||
126227863|NCT01006707|454124608|FG001|Study Session 1|Lost to Follow-up|0|||
126227864|NCT01006707|454124609|FG002|Study Session 1|Lost to Follow-up|0|||
126227865|NCT01006707|454124607|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
126227866|NCT01006707|454124608|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
126227867|NCT01006707|454124609|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
126227868|NCT00490061|454124610|FG000|Overall Study|Physician Decision|1|||
126227869|NCT01155583|454124611|FG000|Phase I|Screen failure - did not start treatment|0|||
126227870|NCT01155583|454124612|FG001|Phase I|Screen failure - did not start treatment|0|||
126227871|NCT01155583|454124613|FG002|Phase I|Screen failure - did not start treatment|0|||
126227872|NCT01155583|454124614|FG003|Phase I|Screen failure - did not start treatment|0|||
126227873|NCT01155583|454124615|FG004|Phase I|Screen failure - did not start treatment|1|||
126227874|NCT01155583|454124616|FG005|Phase I|Screen failure - did not start treatment|0|||
126227875|NCT01155583|454124617|FG006|Phase I|Screen failure - did not start treatment|0|||
126227876|NCT01155583|454124618|FG007|Phase I|Screen failure - did not start treatment|2|||
126227877|NCT01155583|454124619|FG008|Phase I|Screen failure - did not start treatment|0|||
126227878|NCT01155583|454124611|FG000|Phase I|Withdrawal by Subject|0|||
126227879|NCT01155583|454124612|FG001|Phase I|Withdrawal by Subject|0|||
126227880|NCT01155583|454124613|FG002|Phase I|Withdrawal by Subject|0|||
126227881|NCT01155583|454124614|FG003|Phase I|Withdrawal by Subject|0|||
126227882|NCT01155583|454124615|FG004|Phase I|Withdrawal by Subject|0|||
126227883|NCT01155583|454124616|FG005|Phase I|Withdrawal by Subject|0|||
126227884|NCT01155583|454124617|FG006|Phase I|Withdrawal by Subject|0|||
126227885|NCT01155583|454124618|FG007|Phase I|Withdrawal by Subject|1|||
126227886|NCT01155583|454124619|FG008|Phase I|Withdrawal by Subject|0|||
126227887|NCT00952484|454124624|FG000|Overall Study|Withdrawal by Subject|0|||
126227888|NCT00952484|454124625|FG001|Overall Study|Withdrawal by Subject|1|||
126227889|NCT00952484|454124626|FG002|Overall Study|Withdrawal by Subject|0|||
126227890|NCT00886483|454124628|FG000|Overall Study|Lost to Follow-up|0|||
126227891|NCT00886483|454124629|FG001|Overall Study|Lost to Follow-up|1|||
126227892|NCT00886483|454124628|FG000|Overall Study|Pursue medications|1|||
126227893|NCT00886483|454124629|FG001|Overall Study|Pursue medications|2|||
126227894|NCT00886483|454124628|FG000|Overall Study|Distance to center, poor grades|1|||
126227895|NCT00886483|454124629|FG001|Overall Study|Distance to center, poor grades|0|||
126227896|NCT00585351|454124632|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
126227897|NCT00585351|454124633|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
126227898|NCT00585351|454124634|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
126227899|NCT00585351|454124635|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
126227900|NCT00585351|454124636|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
126227901|NCT00585351|454124637|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
126227902|NCT00585351|454124638|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
126227903|NCT00585351|454124639|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
126227904|NCT00585351|454124632|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
126227905|NCT00585351|454124633|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
126227906|NCT00585351|454124634|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
126227907|NCT00585351|454124635|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
126227908|NCT00585351|454124636|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
126227909|NCT00585351|454124637|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
126227910|NCT00585351|454124638|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
126227911|NCT00585351|454124639|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
126227912|NCT00585351|454124632|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
126227913|NCT00585351|454124633|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
126227914|NCT00585351|454124634|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
126227915|NCT00585351|454124635|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
126227916|NCT00585351|454124636|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
126227917|NCT00585351|454124637|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
126227918|NCT00585351|454124638|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
126227919|NCT00585351|454124639|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
126227920|NCT00585351|454124632|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
126227921|NCT00585351|454124633|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
126227922|NCT00585351|454124634|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126227923|NCT00585351|454124635|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126227924|NCT00585351|454124636|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126227925|NCT00585351|454124637|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126227926|NCT00585351|454124638|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126227927|NCT00585351|454124639|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126227928|NCT00585351|454124632|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126227929|NCT00585351|454124633|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126227930|NCT00585351|454124634|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126227931|NCT00585351|454124635|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126227932|NCT00585351|454124636|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126227933|NCT00585351|454124637|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126227934|NCT00585351|454124638|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
126227935|NCT00585351|454124639|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
126227936|NCT00585351|454124632|FG000|Enrollment Period (Intervention)|Death|0|||
126227937|NCT00585351|454124633|FG001|Enrollment Period (Intervention)|Death|0|||
126227938|NCT00585351|454124634|FG002|Enrollment Period (Intervention)|Death|0|||
126227939|NCT00585351|454124635|FG003|Enrollment Period (Intervention)|Death|0|||
126227940|NCT00585351|454124636|FG004|Enrollment Period (Intervention)|Death|1|||
126227941|NCT00585351|454124637|FG005|Enrollment Period (Intervention)|Death|0|||
126227942|NCT00585351|454124638|FG006|Enrollment Period (Intervention)|Death|1|||
126227943|NCT00585351|454124639|FG007|Enrollment Period (Intervention)|Death|0|||
126227944|NCT00585351|454124632|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126227945|NCT00585351|454124633|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126227946|NCT00585351|454124634|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126227947|NCT00585351|454124635|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126227948|NCT00585351|454124636|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
126227949|NCT00585351|454124637|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
126227950|NCT00585351|454124638|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126093012|NCT01302080|453634462|FG000|Overall Study|Other|52|||
126093013|NCT01302080|453634463|FG001|Overall Study|Other|8|||
126093014|NCT01302080|453634462|FG000|Overall Study|Reason Missing For Discontinuation|1|||
126093015|NCT01302080|453634463|FG001|Overall Study|Reason Missing For Discontinuation|0|||
126093016|NCT00490490|453634468|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
126093017|NCT00490490|453634468|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
126093018|NCT01638429|453634469|FG000|Overall Study|Withdrawal by Subject|1|||
126093019|NCT03207451|453634471|FG000|Overall Study|scheduling conflict|1|||
126093020|NCT03207451|453634472|FG001|Overall Study|scheduling conflict|0|||
126093021|NCT03207451|453634473|FG002|Overall Study|scheduling conflict|2|||
126093022|NCT03207451|453634474|FG003|Overall Study|scheduling conflict|2|||
126093023|NCT03207451|453634471|FG000|Overall Study|Adverse Event|0|||
126093024|NCT03207451|453634472|FG001|Overall Study|Adverse Event|0|||
126093025|NCT03207451|453634473|FG002|Overall Study|Adverse Event|0|||
126093026|NCT03207451|453634474|FG003|Overall Study|Adverse Event|1|||
126093027|NCT02040584|453634476|FG000|Overall Study|Adverse Event|13|||
126093028|NCT02040584|453634477|FG001|Overall Study|Adverse Event|6|||
126227951|NCT00585351|454124639|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126227952|NCT01842958|454124641|FG000|Overall Study|Lost to Follow-up|1|||
126227953|NCT01842958|454124642|FG001|Overall Study|Lost to Follow-up|1|||
126227954|NCT01829477|454124643|FG000|Overall Study|Study Terminated by Sponsor|15|||
126227955|NCT01829477|454124644|FG001|Overall Study|Study Terminated by Sponsor|15|||
126227956|NCT01829477|454124643|FG000|Overall Study|Withdrawal by Subject|1|||
126227957|NCT01829477|454124644|FG001|Overall Study|Withdrawal by Subject|0|||
126227958|NCT05034731|454124647|FG000|Overall Study|Screen fail|1|||
126227959|NCT05034731|454124648|FG001|Overall Study|Screen fail|1|||
126227960|NCT00602030|454124651|FG000|Lead-in Phase|Disease Progression|2|||
126227961|NCT00602030|454124652|FG001|Lead-in Phase|Disease Progression|3|||
126227962|NCT00602030|454124653|FG002|Lead-in Phase|Disease Progression|0|||
126227963|NCT00602030|454124654|FG003|Lead-in Phase|Disease Progression|0|||
126227964|NCT00602030|454124655|FG004|Lead-in Phase|Disease Progression|0|||
126227965|NCT00602030|454124651|FG000|Lead-in Phase|Adverse Event|0|||
126227966|NCT00602030|454124652|FG001|Lead-in Phase|Adverse Event|2|||
126227967|NCT00602030|454124653|FG002|Lead-in Phase|Adverse Event|0|||
126227968|NCT00602030|454124654|FG003|Lead-in Phase|Adverse Event|0|||
126227969|NCT00602030|454124655|FG004|Lead-in Phase|Adverse Event|0|||
126227970|NCT00602030|454124651|FG000|Double-blind Phase|Disease progression|0|||
126227971|NCT00602030|454124652|FG001|Double-blind Phase|Disease progression|0|||
126227972|NCT00602030|454124653|FG002|Double-blind Phase|Disease progression|33|||
126227973|NCT00602030|454124654|FG003|Double-blind Phase|Disease progression|30|||
126227974|NCT00602030|454124655|FG004|Double-blind Phase|Disease progression|0|||
126227975|NCT00602030|454124651|FG000|Double-blind Phase|Adverse Event|0|||
126227976|NCT00602030|454124652|FG001|Double-blind Phase|Adverse Event|0|||
126227977|NCT00602030|454124653|FG002|Double-blind Phase|Adverse Event|9|||
126227978|NCT00602030|454124654|FG003|Double-blind Phase|Adverse Event|18|||
126227979|NCT00602030|454124655|FG004|Double-blind Phase|Adverse Event|0|||
126227980|NCT00602030|454124651|FG000|Double-blind Phase|Consent withdrawal|0|||
126227981|NCT00602030|454124652|FG001|Double-blind Phase|Consent withdrawal|0|||
126227982|NCT00602030|454124653|FG002|Double-blind Phase|Consent withdrawal|4|||
126227983|NCT00602030|454124654|FG003|Double-blind Phase|Consent withdrawal|3|||
126227984|NCT00602030|454124655|FG004|Double-blind Phase|Consent withdrawal|0|||
126227985|NCT00602030|454124651|FG000|Double-blind Phase|Death|0|||
126227986|NCT00602030|454124652|FG001|Double-blind Phase|Death|0|||
126227987|NCT00602030|454124653|FG002|Double-blind Phase|Death|3|||
126227988|NCT00602030|454124654|FG003|Double-blind Phase|Death|3|||
126227989|NCT00602030|454124655|FG004|Double-blind Phase|Death|0|||
126227990|NCT00602030|454124651|FG000|Double-blind Phase|Administrative decision|0|||
126227991|NCT00602030|454124652|FG001|Double-blind Phase|Administrative decision|0|||
126227992|NCT00602030|454124653|FG002|Double-blind Phase|Administrative decision|0|||
126227993|NCT00602030|454124654|FG003|Double-blind Phase|Administrative decision|2|||
126227994|NCT00602030|454124655|FG004|Double-blind Phase|Administrative decision|0|||
126227995|NCT00602030|454124651|FG000|Double-blind Phase|Ineligibility|0|||
126227996|NCT00602030|454124652|FG001|Double-blind Phase|Ineligibility|0|||
126227997|NCT00602030|454124653|FG002|Double-blind Phase|Ineligibility|0|||
126227998|NCT00602030|454124654|FG003|Double-blind Phase|Ineligibility|1|||
126227999|NCT00602030|454124655|FG004|Double-blind Phase|Ineligibility|0|||
126228000|NCT00602030|454124651|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
126228001|NCT00602030|454124652|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
126228002|NCT00602030|454124653|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
126228003|NCT00602030|454124654|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
126228004|NCT00602030|454124655|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
126228005|NCT00602030|454124651|FG000|Double-blind Phase|Reason not specified|0|||
126228006|NCT00602030|454124652|FG001|Double-blind Phase|Reason not specified|0|||
126228007|NCT00602030|454124653|FG002|Double-blind Phase|Reason not specified|4|||
126228008|NCT00602030|454124654|FG003|Double-blind Phase|Reason not specified|2|||
126228009|NCT00602030|454124655|FG004|Double-blind Phase|Reason not specified|0|||
126228010|NCT00602030|454124651|FG000|Crossover Phase|Disease Progression|0|||
126228011|NCT00602030|454124652|FG001|Crossover Phase|Disease Progression|0|||
126228012|NCT00602030|454124653|FG002|Crossover Phase|Disease Progression|0|||
126228013|NCT00602030|454124654|FG003|Crossover Phase|Disease Progression|0|||
126228014|NCT00602030|454124655|FG004|Crossover Phase|Disease Progression|11|||
126228015|NCT00602030|454124651|FG000|Crossover Phase|Adverse Event|0|||
126228016|NCT00602030|454124652|FG001|Crossover Phase|Adverse Event|0|||
126228017|NCT00602030|454124653|FG002|Crossover Phase|Adverse Event|0|||
126228018|NCT00602030|454124654|FG003|Crossover Phase|Adverse Event|0|||
126228019|NCT00602030|454124655|FG004|Crossover Phase|Adverse Event|3|||
126228020|NCT00602030|454124651|FG000|Crossover Phase|Consent withdrawal|0|||
126228021|NCT00602030|454124652|FG001|Crossover Phase|Consent withdrawal|0|||
126228022|NCT00602030|454124653|FG002|Crossover Phase|Consent withdrawal|0|||
126228023|NCT00602030|454124654|FG003|Crossover Phase|Consent withdrawal|0|||
126228024|NCT00602030|454124655|FG004|Crossover Phase|Consent withdrawal|2|||
126228025|NCT00543439|454124659|FG000|Period 1|Adverse Event|0|||
126228026|NCT00543439|454124660|FG001|Period 1|Adverse Event|2|||
126228027|NCT00543439|454124661|FG002|Period 1|Adverse Event|1|||
126228028|NCT00543439|454124659|FG000|Period 1|Withdrawal by Subject|1|||
126228029|NCT00543439|454124660|FG001|Period 1|Withdrawal by Subject|1|||
126228030|NCT00543439|454124661|FG002|Period 1|Withdrawal by Subject|0|||
126228031|NCT00543439|454124659|FG000|Period 1|Physician Decision|0|||
126228032|NCT00543439|454124660|FG001|Period 1|Physician Decision|0|||
126228033|NCT00543439|454124661|FG002|Period 1|Physician Decision|1|||
126228034|NCT00543439|454124659|FG000|Period 2|Protocol Violation|1|||
126228035|NCT00543439|454124660|FG001|Period 2|Protocol Violation|0|||
126228036|NCT00543439|454124661|FG002|Period 2|Protocol Violation|1|||
126228037|NCT00543439|454124659|FG000|Period 2|Adverse Event|0|||
126228038|NCT00543439|454124660|FG001|Period 2|Adverse Event|1|||
126228039|NCT00543439|454124661|FG002|Period 2|Adverse Event|1|||
126228040|NCT05476679|454124662|FG000|Overall Study|Withdrawal by Subject|0|||
126228041|NCT05476679|454124663|FG001|Overall Study|Withdrawal by Subject|0|||
126228042|NCT05476679|454124664|FG002|Overall Study|Withdrawal by Subject|0|||
126228043|NCT05476679|454124665|FG003|Overall Study|Withdrawal by Subject|1|||
126228044|NCT05476679|454124666|FG004|Overall Study|Withdrawal by Subject|0|||
126228045|NCT05476679|454124662|FG000|Overall Study|Lost to Follow-up|0|||
126228046|NCT05476679|454124663|FG001|Overall Study|Lost to Follow-up|0|||
126228047|NCT05476679|454124664|FG002|Overall Study|Lost to Follow-up|0|||
126228048|NCT05476679|454124665|FG003|Overall Study|Lost to Follow-up|1|||
126228049|NCT05476679|454124666|FG004|Overall Study|Lost to Follow-up|0|||
126228050|NCT00319956|454124669|FG000|Overall Study|Death|20|||
126228051|NCT00319956|454124670|FG001|Overall Study|Death|24|||
126228052|NCT02607800|454124672|FG000|Overall Study|Lost to Follow-up|7|||
126228053|NCT02607800|454124673|FG001|Overall Study|Lost to Follow-up|10|||
126228054|NCT02607800|454124672|FG000|Overall Study|Withdrew Consent|2|||
126228055|NCT02607800|454124673|FG001|Overall Study|Withdrew Consent|0|||
126228056|NCT02607800|454124672|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
126228057|NCT02607800|454124673|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
126228058|NCT00753714|454124674|FG000|Overall Study|Lack of Efficacy|21|||
126228059|NCT00753714|454124675|FG001|Overall Study|Lack of Efficacy|34|||
126228060|NCT00753714|454124674|FG000|Overall Study|Adverse Event|26|||
126228061|NCT00753714|454124675|FG001|Overall Study|Adverse Event|18|||
126228062|NCT00753714|454124674|FG000|Overall Study|Protocol Violation|1|||
126228063|NCT00753714|454124675|FG001|Overall Study|Protocol Violation|0|||
126228064|NCT00753714|454124674|FG000|Overall Study|Lost to Follow-up|0|||
126228065|NCT00753714|454124675|FG001|Overall Study|Lost to Follow-up|1|||
126228066|NCT00753714|454124674|FG000|Overall Study|Withdrawal by Subject|2|||
126228067|NCT00753714|454124675|FG001|Overall Study|Withdrawal by Subject|1|||
126228068|NCT00753714|454124674|FG000|Overall Study|Death|3|||
126228069|NCT00753714|454124675|FG001|Overall Study|Death|3|||
126228070|NCT00753714|454124674|FG000|Overall Study|Other|7|||
126228071|NCT00753714|454124675|FG001|Overall Study|Other|5|||
126228072|NCT01185288|454124676|FG000|Overall Study|Adverse Event|7|||
126228073|NCT01185288|454124677|FG001|Overall Study|Adverse Event|6|||
126228074|NCT01185288|454124676|FG000|Overall Study|Withdrawal by Subject|6|||
126228075|NCT01185288|454124677|FG001|Overall Study|Withdrawal by Subject|4|||
126228076|NCT01185288|454124676|FG000|Overall Study|Lost to Follow-up|2|||
126228077|NCT01185288|454124677|FG001|Overall Study|Lost to Follow-up|5|||
126228078|NCT01185288|454124676|FG000|Overall Study|Lack of Efficacy|2|||
126228079|NCT01185288|454124677|FG001|Overall Study|Lack of Efficacy|0|||
126228080|NCT01185288|454124676|FG000|Overall Study|Investigator discretion|1|||
126228081|NCT01185288|454124677|FG001|Overall Study|Investigator discretion|0|||
126228082|NCT01185288|454124676|FG000|Overall Study|Did not meet inclusion criteria|1|||
126228083|NCT01185288|454124677|FG001|Overall Study|Did not meet inclusion criteria|0|||
126228084|NCT01185288|454124676|FG000|Overall Study|Noncompliance|0|||
126228085|NCT01185288|454124677|FG001|Overall Study|Noncompliance|1|||
126228086|NCT01626885|454124680|FG000|Overall Study|Adverse Event|8|||
126228087|NCT01626885|454124680|FG000|Overall Study|Withdrawal by Subject|4|||
126228088|NCT00673790|454124681|FG000|Overall Study|Adverse Event|23|||
126228089|NCT00673790|454124682|FG001|Overall Study|Adverse Event|14|||
126228090|NCT00673790|454124683|FG002|Overall Study|Adverse Event|2|||
126228091|NCT00673790|454124681|FG000|Overall Study|Lack of Efficacy|2|||
126228092|NCT00673790|454124682|FG001|Overall Study|Lack of Efficacy|2|||
126228093|NCT00673790|454124683|FG002|Overall Study|Lack of Efficacy|2|||
126228094|NCT00673790|454124681|FG000|Overall Study|Protocol Violation|6|||
126228095|NCT00673790|454124682|FG001|Overall Study|Protocol Violation|9|||
126228096|NCT00673790|454124683|FG002|Overall Study|Protocol Violation|1|||
126228097|NCT00673790|454124681|FG000|Overall Study|Withdrawal by Subject|7|||
126228098|NCT00673790|454124682|FG001|Overall Study|Withdrawal by Subject|4|||
126228099|NCT00673790|454124683|FG002|Overall Study|Withdrawal by Subject|1|||
126228100|NCT00673790|454124681|FG000|Overall Study|Lost to Follow-up|6|||
126228101|NCT00673790|454124682|FG001|Overall Study|Lost to Follow-up|6|||
126228102|NCT00673790|454124683|FG002|Overall Study|Lost to Follow-up|5|||
126228103|NCT00673790|454124681|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
126228104|NCT00673790|454124682|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
126228105|NCT00673790|454124683|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
126228106|NCT00673790|454124681|FG000|Overall Study|Poor compliance|1|||
126228107|NCT00673790|454124682|FG001|Overall Study|Poor compliance|0|||
126228108|NCT00673790|454124683|FG002|Overall Study|Poor compliance|0|||
126228109|NCT00673790|454124681|FG000|Overall Study|Participated in two Nebivolol studies|0|||
126228110|NCT00673790|454124682|FG001|Overall Study|Participated in two Nebivolol studies|0|||
126228111|NCT00673790|454124683|FG002|Overall Study|Participated in two Nebivolol studies|1|||
126228112|NCT00673790|454124681|FG000|Overall Study|Unconfirmed pregnancy|0|||
126228113|NCT00673790|454124682|FG001|Overall Study|Unconfirmed pregnancy|1|||
126228114|NCT00673790|454124683|FG002|Overall Study|Unconfirmed pregnancy|0|||
126228115|NCT00673790|454124681|FG000|Overall Study|Randomization criteria not met|0|||
126228116|NCT00673790|454124682|FG001|Overall Study|Randomization criteria not met|1|||
126228117|NCT00673790|454124683|FG002|Overall Study|Randomization criteria not met|0|||
126228118|NCT01533428|454124686|FG000|Overall Study|Adverse Event|0|||
126228119|NCT01533428|454124687|FG001|Overall Study|Adverse Event|1|||
126228120|NCT01533428|454124686|FG000|Overall Study|Lost to Follow-up|2|||
126228121|NCT01533428|454124687|FG001|Overall Study|Lost to Follow-up|1|||
126228122|NCT01533428|454124686|FG000|Overall Study|Withdrawal by Subject|7|||
126228123|NCT01533428|454124687|FG001|Overall Study|Withdrawal by Subject|6|||
126228124|NCT01364870|454124690|FG000|Overall Study|Withdrawal by Subject|13|||
126228125|NCT01364870|454124691|FG001|Overall Study|Withdrawal by Subject|24|||
126228126|NCT01364870|454124692|FG002|Overall Study|Withdrawal by Subject|10|||
126228127|NCT01364870|454124690|FG000|Overall Study|Adverse Event|8|||
126228128|NCT01364870|454124691|FG001|Overall Study|Adverse Event|6|||
126228129|NCT01364870|454124692|FG002|Overall Study|Adverse Event|4|||
126228130|NCT01364870|454124690|FG000|Overall Study|Protocol Violation|1|||
126228131|NCT01364870|454124691|FG001|Overall Study|Protocol Violation|0|||
126228132|NCT01364870|454124692|FG002|Overall Study|Protocol Violation|0|||
126228133|NCT01200394|454124693|FG000|Overall Study|Adverse Event|0|||
126228134|NCT01200394|454124694|FG001|Overall Study|Adverse Event|14|||
126228135|NCT01200394|454124693|FG000|Overall Study|Death|1|||
126228136|NCT01200394|454124694|FG001|Overall Study|Death|0|||
126228137|NCT01200394|454124693|FG000|Overall Study|Lost to Follow-up|0|||
126228138|NCT01200394|454124694|FG001|Overall Study|Lost to Follow-up|1|||
126228139|NCT01200394|454124693|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126228140|NCT01200394|454124694|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
126228141|NCT01200394|454124693|FG000|Overall Study|Protocol Violation|0|||
126228142|NCT01200394|454124694|FG001|Overall Study|Protocol Violation|3|||
126228143|NCT01200394|454124693|FG000|Overall Study|Withdrawal by Subject|0|||
126228144|NCT01200394|454124694|FG001|Overall Study|Withdrawal by Subject|5|||
126228145|NCT01200394|454124693|FG000|Overall Study|Other|0|||
126228146|NCT01200394|454124694|FG001|Overall Study|Other|1|||
126228147|NCT02666430|454124695|FG000|Period 1|Lost to Follow-up|1|||
126228148|NCT02666430|454124696|FG001|Period 1|Lost to Follow-up|0|||
126228149|NCT02666430|454124695|FG000|Period 1|Adverse Event|0|||
126228150|NCT02666430|454124696|FG001|Period 1|Adverse Event|1|||
126228151|NCT02666430|454124695|FG000|Period 2|Withdrawal by Subject|1|||
126228152|NCT02666430|454124696|FG001|Period 2|Withdrawal by Subject|4|||
126228153|NCT02666430|454124695|FG000|Period 3|Lost to Follow-up|1|||
126228154|NCT02666430|454124696|FG001|Period 3|Lost to Follow-up|0|||
126228155|NCT03828461|454124697|FG000|Overall Study|Lost to Follow-up|1|||
126228156|NCT03828461|454124697|FG000|Overall Study|Withdrawal by Subject|3|||
126228157|NCT00576199|454124698|FG000|Overall Study|Adverse Event|12|||
126228158|NCT00576199|454124698|FG000|Overall Study|Insufficient Therapeutic Response|14|||
126228159|NCT00576199|454124698|FG000|Overall Study|Refused Treatment|2|||
126228160|NCT00576199|454124698|FG000|Overall Study|Reason Unspecified|2|||
126228161|NCT04317053|454124699|FG000|Overall Study|Withdrawn (screen failure)|4|||
126228162|NCT04317053|454124700|FG001|Overall Study|Withdrawn (screen failure)|2|||
126228163|NCT01621490|454126605|FG000|Overall Study|Subject no longer meets study criteria|0|||
126228164|NCT01621490|454126606|FG001|Overall Study|Subject no longer meets study criteria|0|||
126228165|NCT01621490|454126607|FG002|Overall Study|Subject no longer meets study criteria|0|||
126228166|NCT01621490|454126608|FG003|Overall Study|Subject no longer meets study criteria|0|||
126228167|NCT01621490|454126609|FG004|Overall Study|Subject no longer meets study criteria|1|||
126228168|NCT01621490|454126610|FG005|Overall Study|Subject no longer meets study criteria|0|||
126228169|NCT01621490|454126611|FG006|Overall Study|Subject no longer meets study criteria|0|||
126228170|NCT01621490|454126612|FG007|Overall Study|Subject no longer meets study criteria|0|||
126228171|NCT01621490|454126613|FG008|Overall Study|Subject no longer meets study criteria|0|||
126228172|NCT01621490|454126614|FG009|Overall Study|Subject no longer meets study criteria|0|||
126228173|NCT01621490|454126615|FG010|Overall Study|Subject no longer meets study criteria|0|||
126228174|NCT01621490|454126605|FG000|Overall Study|Maximum clinical benefit|3|||
126228175|NCT01621490|454126606|FG001|Overall Study|Maximum clinical benefit|2|||
126228176|NCT01621490|454126607|FG002|Overall Study|Maximum clinical benefit|0|||
126228177|NCT01621490|454126608|FG003|Overall Study|Maximum clinical benefit|0|||
126228178|NCT01621490|454126609|FG004|Overall Study|Maximum clinical benefit|0|||
126228179|NCT01621490|454126610|FG005|Overall Study|Maximum clinical benefit|0|||
126228180|NCT01621490|454126611|FG006|Overall Study|Maximum clinical benefit|1|||
126228181|NCT01621490|454126612|FG007|Overall Study|Maximum clinical benefit|2|||
126228182|NCT01621490|454126613|FG008|Overall Study|Maximum clinical benefit|2|||
126228183|NCT01621490|454126614|FG009|Overall Study|Maximum clinical benefit|0|||
126228184|NCT01621490|454126615|FG010|Overall Study|Maximum clinical benefit|0|||
126228185|NCT01621490|454126605|FG000|Overall Study|Withdrawal by Subject|1|||
126228186|NCT01621490|454126606|FG001|Overall Study|Withdrawal by Subject|0|||
126228187|NCT01621490|454126607|FG002|Overall Study|Withdrawal by Subject|0|||
126228188|NCT01621490|454126608|FG003|Overall Study|Withdrawal by Subject|0|||
126228189|NCT01621490|454126609|FG004|Overall Study|Withdrawal by Subject|0|||
126228190|NCT01621490|454126610|FG005|Overall Study|Withdrawal by Subject|1|||
126228191|NCT01621490|454126611|FG006|Overall Study|Withdrawal by Subject|0|||
126228192|NCT01621490|454126612|FG007|Overall Study|Withdrawal by Subject|0|||
126228193|NCT01621490|454126613|FG008|Overall Study|Withdrawal by Subject|0|||
126228194|NCT01621490|454126614|FG009|Overall Study|Withdrawal by Subject|0|||
126228195|NCT01621490|454126615|FG010|Overall Study|Withdrawal by Subject|0|||
126228196|NCT01621490|454126605|FG000|Overall Study|Subject request to discontinue study|1|||
126228197|NCT01621490|454126606|FG001|Overall Study|Subject request to discontinue study|3|||
126228198|NCT01621490|454126607|FG002|Overall Study|Subject request to discontinue study|1|||
126228199|NCT01621490|454126608|FG003|Overall Study|Subject request to discontinue study|1|||
126228200|NCT01621490|454126609|FG004|Overall Study|Subject request to discontinue study|0|||
126228201|NCT01621490|454126610|FG005|Overall Study|Subject request to discontinue study|2|||
126228202|NCT01621490|454126611|FG006|Overall Study|Subject request to discontinue study|1|||
126228203|NCT01621490|454126612|FG007|Overall Study|Subject request to discontinue study|0|||
126228204|NCT01621490|454126613|FG008|Overall Study|Subject request to discontinue study|1|||
126228205|NCT01621490|454126614|FG009|Overall Study|Subject request to discontinue study|0|||
126228206|NCT01621490|454126615|FG010|Overall Study|Subject request to discontinue study|0|||
126228207|NCT01621490|454126605|FG000|Overall Study|Adverse event unrelated to study drug|1|||
126228208|NCT01621490|454126606|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126228209|NCT01621490|454126607|FG002|Overall Study|Adverse event unrelated to study drug|0|||
126228210|NCT01621490|454126608|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126228211|NCT01621490|454126609|FG004|Overall Study|Adverse event unrelated to study drug|0|||
126228212|NCT01621490|454126610|FG005|Overall Study|Adverse event unrelated to study drug|0|||
126228213|NCT01621490|454126611|FG006|Overall Study|Adverse event unrelated to study drug|0|||
126228214|NCT01621490|454126612|FG007|Overall Study|Adverse event unrelated to study drug|2|||
126228215|NCT01621490|454126613|FG008|Overall Study|Adverse event unrelated to study drug|0|||
126228216|NCT01621490|454126614|FG009|Overall Study|Adverse event unrelated to study drug|0|||
126228217|NCT01621490|454126615|FG010|Overall Study|Adverse event unrelated to study drug|0|||
126228218|NCT01621490|454126605|FG000|Overall Study|Disease progression|27|||
126228219|NCT01621490|454126606|FG001|Overall Study|Disease progression|28|||
126228220|NCT01621490|454126607|FG002|Overall Study|Disease progression|1|||
126228221|NCT01621490|454126608|FG003|Overall Study|Disease progression|5|||
126228222|NCT01621490|454126609|FG004|Overall Study|Disease progression|3|||
126228223|NCT01621490|454126610|FG005|Overall Study|Disease progression|8|||
126228224|NCT01621490|454126611|FG006|Overall Study|Disease progression|7|||
126228225|NCT01621490|454126612|FG007|Overall Study|Disease progression|1|||
126228226|NCT01621490|454126613|FG008|Overall Study|Disease progression|4|||
126228227|NCT01621490|454126614|FG009|Overall Study|Disease progression|1|||
126228228|NCT01621490|454126615|FG010|Overall Study|Disease progression|1|||
126228229|NCT01621490|454126605|FG000|Overall Study|Study drug toxicity|1|||
126228230|NCT01621490|454126606|FG001|Overall Study|Study drug toxicity|4|||
126228231|NCT01621490|454126607|FG002|Overall Study|Study drug toxicity|5|||
126228232|NCT01621490|454126608|FG003|Overall Study|Study drug toxicity|3|||
126228233|NCT01621490|454126609|FG004|Overall Study|Study drug toxicity|1|||
126228234|NCT01621490|454126610|FG005|Overall Study|Study drug toxicity|10|||
126228235|NCT01621490|454126611|FG006|Overall Study|Study drug toxicity|1|||
126228236|NCT01621490|454126612|FG007|Overall Study|Study drug toxicity|4|||
126228237|NCT01621490|454126613|FG008|Overall Study|Study drug toxicity|1|||
126228238|NCT01621490|454126614|FG009|Overall Study|Study drug toxicity|0|||
126228239|NCT01621490|454126615|FG010|Overall Study|Study drug toxicity|0|||
126228240|NCT01621490|454126605|FG000|Overall Study|Death|0|||
126228241|NCT01621490|454126606|FG001|Overall Study|Death|0|||
126228242|NCT01621490|454126607|FG002|Overall Study|Death|0|||
126228243|NCT01621490|454126608|FG003|Overall Study|Death|0|||
126228244|NCT01621490|454126609|FG004|Overall Study|Death|0|||
126228245|NCT01621490|454126610|FG005|Overall Study|Death|0|||
126228246|NCT01621490|454126611|FG006|Overall Study|Death|0|||
126228247|NCT01621490|454126612|FG007|Overall Study|Death|0|||
126228248|NCT01621490|454126613|FG008|Overall Study|Death|1|||
126228249|NCT01621490|454126614|FG009|Overall Study|Death|0|||
126228250|NCT01621490|454126615|FG010|Overall Study|Death|0|||
126228251|NCT01621490|454126605|FG000|Overall Study|Other reasons|7|||
126228252|NCT01621490|454126606|FG001|Overall Study|Other reasons|6|||
126228253|NCT01621490|454126607|FG002|Overall Study|Other reasons|4|||
126228254|NCT01621490|454126608|FG003|Overall Study|Other reasons|1|||
126228255|NCT01621490|454126609|FG004|Overall Study|Other reasons|1|||
126228256|NCT01621490|454126610|FG005|Overall Study|Other reasons|3|||
126228257|NCT01621490|454126611|FG006|Overall Study|Other reasons|1|||
126228258|NCT01621490|454126612|FG007|Overall Study|Other reasons|1|||
126228259|NCT01621490|454126613|FG008|Overall Study|Other reasons|1|||
126228260|NCT01621490|454126614|FG009|Overall Study|Other reasons|0|||
126021175|NCT03684044|453373195|FG001|Overall Study|Withdrawal by Subject|9|||
126021176|NCT03703336|453373196|FG000|Overall Study|Parent withdrew consent|29|||
126021177|NCT03703336|453373197|FG001|Overall Study|Parent withdrew consent|8|||
126021178|NCT03703336|453373196|FG000|Overall Study|Migration|3|||
126021179|NCT03703336|453373197|FG001|Overall Study|Migration|3|||
126021180|NCT03703336|453373196|FG000|Overall Study|Protocol Violation|3|||
126228261|NCT01621490|454126615|FG010|Overall Study|Other reasons|0|||
126228262|NCT00461500|454126616|FG000|Overall Study|Adverse Event|1|||
126228263|NCT00461500|454126617|FG001|Overall Study|Adverse Event|0|||
126228264|NCT00461500|454126616|FG000|Overall Study|Lack of Efficacy|0|||
126228265|NCT00461500|454126617|FG001|Overall Study|Lack of Efficacy|1|||
126228266|NCT00461500|454126616|FG000|Overall Study|Expired Drug Treatment|1|||
126021181|NCT03703336|453373197|FG001|Overall Study|Protocol Violation|1|||
126228267|NCT00461500|454126617|FG001|Overall Study|Expired Drug Treatment|1|||
126228268|NCT00461500|454126616|FG000|Overall Study|Study Stopped|1|||
126228269|NCT00461500|454126617|FG001|Overall Study|Study Stopped|2|||
126228270|NCT00461500|454126616|FG000|Overall Study|Drug Treatment Misuse|1|||
126228271|NCT00461500|454126617|FG001|Overall Study|Drug Treatment Misuse|0|||
126228272|NCT00461500|454126616|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
126228273|NCT00461500|454126617|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
126228274|NCT00461500|454126616|FG000|Overall Study|Lost to Follow-up|2|||
126228275|NCT00461500|454126617|FG001|Overall Study|Lost to Follow-up|2|||
126228276|NCT01806597|454126618|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
126228277|NCT01806597|454126619|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
126228278|NCT01806597|454126620|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
126228279|NCT01806597|454126621|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
126228280|NCT01806597|454126622|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
126228281|NCT01806597|454126623|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
126228282|NCT01806597|454126618|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
126228283|NCT01806597|454126619|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
126228284|NCT01806597|454126620|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
126228285|NCT01806597|454126621|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
126228286|NCT01806597|454126622|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
126228287|NCT01806597|454126623|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
126228288|NCT01806597|454126618|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126228289|NCT01806597|454126619|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
126228290|NCT01806597|454126620|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126228291|NCT01806597|454126621|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126228292|NCT01806597|454126622|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126228293|NCT01806597|454126623|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126228294|NCT01806597|454126618|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
126228295|NCT01806597|454126619|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
126228296|NCT01806597|454126620|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
126352097|NCT05800145|454579637|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126352098|NCT05800145|454579632|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
126352099|NCT05800145|454579633|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
126352100|NCT05800145|454579634|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
126352101|NCT05800145|454579635|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
126352102|NCT05800145|454579636|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
126352103|NCT05800145|454579637|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
126352104|NCT05800145|454579632|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
126352105|NCT05800145|454579633|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
126093029|NCT02040584|453634476|FG000|Overall Study|Protocol Violation|9|||
126228297|NCT01806597|454126621|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
126228298|NCT01806597|454126622|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
126228299|NCT01806597|454126623|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
126228300|NCT01806597|454126618|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126228301|NCT01806597|454126619|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
126228302|NCT01806597|454126620|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126228303|NCT01806597|454126621|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126228304|NCT01806597|454126622|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126228305|NCT01806597|454126623|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126228306|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
126228307|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
126228308|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
126228309|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
126228310|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
126228311|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
126228312|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
126228313|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
126228314|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
126228315|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
126228316|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
126093030|NCT02040584|453634477|FG001|Overall Study|Protocol Violation|11|||
126228317|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
126228318|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
126228319|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126228320|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126228321|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126352106|NCT05800145|454579634|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
126352107|NCT05800145|454579635|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
126352108|NCT05800145|454579636|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
126352109|NCT05800145|454579637|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
126352110|NCT02850406|454579638|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352111|NCT02850406|454579639|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352112|NCT02850406|454579640|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352113|NCT02850406|454579641|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
126352114|NCT02850406|454579642|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352115|NCT02850406|454579643|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
126228322|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126228323|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126228324|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
126228325|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
126228326|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
126228327|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
126228328|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
126228329|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
126228330|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
126228331|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126228332|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126228333|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126228334|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126228335|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126228336|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
126228337|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
126228338|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
126228339|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
126228340|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
126228341|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
126228342|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
126228343|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
126228344|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
126228345|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
126228346|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
126228347|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
126228348|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
126228349|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
126228350|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
126228351|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
126228352|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
126228353|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
126228354|NCT01806597|454126618|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
126228355|NCT01806597|454126619|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126228356|NCT01806597|454126620|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126228357|NCT01806597|454126621|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126228358|NCT01806597|454126622|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126228359|NCT01806597|454126623|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126228360|NCT01806597|454126618|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126228361|NCT01806597|454126619|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126228362|NCT01806597|454126620|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126228363|NCT01806597|454126621|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126228364|NCT01806597|454126622|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126228365|NCT01806597|454126623|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
126228366|NCT01806597|454126618|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126228367|NCT01806597|454126619|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126228368|NCT01806597|454126620|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126228369|NCT01806597|454126621|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126228370|NCT01806597|454126622|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126228371|NCT01806597|454126623|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
126228372|NCT01806597|454126618|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126228373|NCT01806597|454126619|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126228374|NCT01806597|454126620|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126228375|NCT01806597|454126621|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126228376|NCT01806597|454126622|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126228377|NCT01806597|454126623|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
126228378|NCT01806597|454126618|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126228379|NCT01806597|454126619|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126228380|NCT01806597|454126620|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126228381|NCT01806597|454126621|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126228382|NCT01806597|454126622|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126228383|NCT01806597|454126623|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
126228384|NCT01806597|454126618|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126228385|NCT01806597|454126619|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126228386|NCT01806597|454126620|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126228387|NCT01806597|454126621|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126228388|NCT01806597|454126622|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126228389|NCT01806597|454126623|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
126228390|NCT02247479|454126625|FG000|Overall Study|Adverse Event|8|||
126228391|NCT02247479|454126626|FG001|Overall Study|Adverse Event|9|||
126228392|NCT02247479|454126627|FG002|Overall Study|Adverse Event|8|||
126228393|NCT02247479|454126625|FG000|Overall Study|Death|5|||
126228394|NCT02247479|454126626|FG001|Overall Study|Death|4|||
126228395|NCT02247479|454126627|FG002|Overall Study|Death|6|||
126228396|NCT02247479|454126625|FG000|Overall Study|Lost to Follow-up|3|||
126228397|NCT02247479|454126626|FG001|Overall Study|Lost to Follow-up|3|||
126228398|NCT02247479|454126627|FG002|Overall Study|Lost to Follow-up|1|||
126228399|NCT02247479|454126625|FG000|Overall Study|Non-compliance|0|||
126228400|NCT02247479|454126626|FG001|Overall Study|Non-compliance|0|||
126228401|NCT02247479|454126627|FG002|Overall Study|Non-compliance|1|||
126228402|NCT02247479|454126625|FG000|Overall Study|Withdrawal by Subject|25|||
126228403|NCT02247479|454126626|FG001|Overall Study|Withdrawal by Subject|29|||
126228404|NCT02247479|454126627|FG002|Overall Study|Withdrawal by Subject|24|||
126228405|NCT02247479|454126625|FG000|Overall Study|Study Terminated by Sponsor|98|||
126228406|NCT02247479|454126626|FG001|Overall Study|Study Terminated by Sponsor|88|||
126228407|NCT02247479|454126627|FG002|Overall Study|Study Terminated by Sponsor|94|||
126228408|NCT02247479|454126625|FG000|Overall Study|Physician Decision|1|||
126228409|NCT02247479|454126626|FG001|Overall Study|Physician Decision|0|||
126228410|NCT02247479|454126627|FG002|Overall Study|Physician Decision|2|||
126228411|NCT02247479|454126625|FG000|Overall Study|Unspecified Reason|2|||
126228412|NCT02247479|454126626|FG001|Overall Study|Unspecified Reason|5|||
126228413|NCT02247479|454126627|FG002|Overall Study|Unspecified Reason|2|||
126228414|NCT01073020|454126628|FG000|Overall Study|Withdrawal by Subject|6|||
126228415|NCT01073020|454126629|FG001|Overall Study|Withdrawal by Subject|4|||
126228416|NCT01073020|454126630|FG002|Overall Study|Withdrawal by Subject|1|||
126228417|NCT01073020|454126631|FG003|Overall Study|Withdrawal by Subject|2|||
126228418|NCT01073020|454126628|FG000|Overall Study|Physician Decision|1|||
126228419|NCT01073020|454126629|FG001|Overall Study|Physician Decision|0|||
126228420|NCT01073020|454126630|FG002|Overall Study|Physician Decision|2|||
126228421|NCT01073020|454126631|FG003|Overall Study|Physician Decision|0|||
126228422|NCT01073020|454126628|FG000|Overall Study|Death|0|||
126228423|NCT01073020|454126629|FG001|Overall Study|Death|1|||
126228424|NCT01073020|454126630|FG002|Overall Study|Death|0|||
126228425|NCT01073020|454126631|FG003|Overall Study|Death|0|||
126228426|NCT01590433|454126637|FG000|Overall Study|Lost to Follow-up|20|||
126228427|NCT01590433|454126638|FG001|Overall Study|Lost to Follow-up|8|||
126228428|NCT01590433|454126637|FG000|Overall Study|Withdrawal by Subject|21|||
126228429|NCT01590433|454126638|FG001|Overall Study|Withdrawal by Subject|11|||
126228430|NCT01590433|454126637|FG000|Overall Study|Adverse Event|11|||
126228431|NCT01590433|454126638|FG001|Overall Study|Adverse Event|3|||
126228432|NCT00555009|454126639|FG000|Overall Study|Withdrawal by Subject|0|||
126228433|NCT00555009|454126640|FG001|Overall Study|Withdrawal by Subject|1|||
126228434|NCT00555009|454126639|FG000|Overall Study|Terminated by Sponsor|2|||
126228435|NCT00555009|454126640|FG001|Overall Study|Terminated by Sponsor|5|||
126228436|NCT01787825|454126642|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
126228437|NCT01787825|454126643|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
126228438|NCT01787825|454126642|FG000|Overall Study|Data Not Analyzable|5|||
126352116|NCT02850406|454579644|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352117|NCT02850406|454579645|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352118|NCT02850406|454579638|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126021182|NCT03703336|453373196|FG000|Overall Study|Physician Decision|2|||
126021183|NCT03703336|453373197|FG001|Overall Study|Physician Decision|0|||
126228439|NCT01787825|454126643|FG001|Overall Study|Data Not Analyzable|1|||
126228440|NCT01338636|454126652|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
126228441|NCT02385526|454126653|FG000|Overall Study|Withdrawal by Subject|0|||
126228442|NCT02385526|454126654|FG001|Overall Study|Withdrawal by Subject|2|||
126228443|NCT02385526|454126655|FG002|Overall Study|Withdrawal by Subject|0|||
126228444|NCT02385526|454126653|FG000|Overall Study|Lost to Follow-up|0|||
126228445|NCT02385526|454126654|FG001|Overall Study|Lost to Follow-up|1|||
126228446|NCT02385526|454126655|FG002|Overall Study|Lost to Follow-up|0|||
126228447|NCT02385526|454126653|FG000|Overall Study|Physician Decision|1|||
126228448|NCT02385526|454126654|FG001|Overall Study|Physician Decision|0|||
126228449|NCT02385526|454126655|FG002|Overall Study|Physician Decision|0|||
126228450|NCT02385526|454126653|FG000|Overall Study|Protocol Violation|1|||
126228451|NCT02385526|454126654|FG001|Overall Study|Protocol Violation|0|||
126228452|NCT02385526|454126655|FG002|Overall Study|Protocol Violation|0|||
126228453|NCT03361423|454126660|FG000|Overall Study|Withdrawal by Subject|4|||
126021184|NCT03703336|453373196|FG000|Overall Study|Adverse Event|0|||
126021185|NCT03703336|453373197|FG001|Overall Study|Adverse Event|2|||
126228454|NCT03361423|454126661|FG001|Overall Study|Withdrawal by Subject|3|||
126228455|NCT03361423|454126660|FG000|Overall Study|Did not treat|19|||
126228456|NCT03361423|454126661|FG001|Overall Study|Did not treat|18|||
126228457|NCT03361423|454126660|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
126228458|NCT03361423|454126661|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
126228459|NCT03361423|454126660|FG000|Overall Study|Missing data|4|||
126228460|NCT03361423|454126661|FG001|Overall Study|Missing data|1|||
126228461|NCT01336894|454126662|FG000|Follow-up|Study terminated prematurely|2|||
126228462|NCT01336894|454126663|FG001|Follow-up|Study terminated prematurely|7|||
126228463|NCT01325207|454126664|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126228464|NCT01325207|454126665|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126228465|NCT01325207|454126666|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126228466|NCT01325207|454126667|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126228467|NCT01325207|454126668|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
126228468|NCT01325207|454126669|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126228469|NCT01325207|454126664|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
126228470|NCT01325207|454126665|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
126228471|NCT01325207|454126666|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
126228472|NCT01325207|454126667|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
126228473|NCT01325207|454126668|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
126228474|NCT01325207|454126669|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
126228475|NCT01325207|454126664|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
126228476|NCT01325207|454126665|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
126228477|NCT01325207|454126666|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
126228478|NCT01325207|454126667|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
126228479|NCT01325207|454126668|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
126228480|NCT01325207|454126669|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
126228481|NCT01325207|454126664|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126228482|NCT01325207|454126665|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
126228483|NCT01325207|454126666|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126228484|NCT01325207|454126667|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126228485|NCT01325207|454126668|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126228486|NCT01325207|454126669|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126228487|NCT01325207|454126664|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126228488|NCT01325207|454126665|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126228489|NCT01325207|454126666|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126228490|NCT01325207|454126667|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126228491|NCT01325207|454126668|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126228492|NCT01325207|454126669|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
126228493|NCT01325207|454126664|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126228494|NCT01325207|454126665|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126228495|NCT01325207|454126666|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126228496|NCT01325207|454126667|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126228497|NCT01325207|454126668|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126228498|NCT01325207|454126669|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
126228499|NCT01325207|454126664|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126228500|NCT01325207|454126665|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126228501|NCT01325207|454126666|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126228502|NCT01325207|454126667|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126228503|NCT01325207|454126668|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
126228504|NCT01325207|454126669|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126228505|NCT01254409|454126670|FG000|Overall Study|Adverse Event|0|||
126228506|NCT01254409|454126671|FG001|Overall Study|Adverse Event|1|||
126352119|NCT02850406|454579639|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352120|NCT02850406|454579640|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
126352121|NCT02850406|454579641|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
126352122|NCT02850406|454579642|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352123|NCT02850406|454579643|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352124|NCT02850406|454579644|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352125|NCT02850406|454579645|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352126|NCT02850406|454579638|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352127|NCT02850406|454579639|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352128|NCT02850406|454579640|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
126352129|NCT02850406|454579641|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126228507|NCT01254409|454126672|FG002|Overall Study|Adverse Event|0|||
126352130|NCT02850406|454579642|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352131|NCT02850406|454579643|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126228508|NCT01254409|454126673|FG003|Overall Study|Adverse Event|0|||
126228509|NCT00283686|454126675|FG000|Overall Study|Death|1|||
126228510|NCT00283686|454126676|FG001|Overall Study|Death|1|||
126228511|NCT00283686|454126677|FG002|Overall Study|Death|1|||
126228512|NCT00283686|454126678|FG003|Overall Study|Death|0|||
126228513|NCT00283686|454126675|FG000|Overall Study|Lost to Follow-up|21|||
126228514|NCT00283686|454126676|FG001|Overall Study|Lost to Follow-up|31|||
126228515|NCT00283686|454126677|FG002|Overall Study|Lost to Follow-up|26|||
126228516|NCT00283686|454126678|FG003|Overall Study|Lost to Follow-up|20|||
126228517|NCT00283686|454126675|FG000|Overall Study|Less than full participation|7|||
126228518|NCT00283686|454126676|FG001|Overall Study|Less than full participation|9|||
126228519|NCT00283686|454126677|FG002|Overall Study|Less than full participation|6|||
126228520|NCT00283686|454126678|FG003|Overall Study|Less than full participation|12|||
126228521|NCT01076166|454126679|FG000|Overall Study|Adverse Event|3|||
126228522|NCT01076166|454126679|FG000|Overall Study|Symptoms improved/resolved|6|||
126228523|NCT02970669|454126684|FG000|Double-blind Period|Adverse Event|4|||
126228524|NCT02970669|454126685|FG001|Double-blind Period|Adverse Event|0|||
126228525|NCT02970669|454126684|FG000|Double-blind Period|Death|1|||
126228526|NCT02970669|454126685|FG001|Double-blind Period|Death|0|||
126228527|NCT02970669|454126684|FG000|Double-blind Period|Study terminated by sponsor|1|||
126228528|NCT02970669|454126685|FG001|Double-blind Period|Study terminated by sponsor|2|||
126228529|NCT02970669|454126684|FG000|Double-blind Period|Physician Decision|0|||
126228530|NCT02970669|454126685|FG001|Double-blind Period|Physician Decision|2|||
126228531|NCT02970669|454126684|FG000|Double-blind Period|Withdrawal by Subject|2|||
126228532|NCT02970669|454126685|FG001|Double-blind Period|Withdrawal by Subject|2|||
126228533|NCT02970669|454126684|FG000|Open-label Period|Withdrawal by Subject|2|||
126228534|NCT02970669|454126685|FG001|Open-label Period|Withdrawal by Subject|2|||
126228535|NCT02970669|454126684|FG000|Open-label Period|Adverse Event|1|||
126228536|NCT02970669|454126685|FG001|Open-label Period|Adverse Event|0|||
126228537|NCT02970669|454126684|FG000|Open-label Period|Physician Decision|1|||
126228538|NCT02970669|454126685|FG001|Open-label Period|Physician Decision|0|||
126228539|NCT00876733|454126686|FG000|Overall Study|Adverse Event|34|||
126228540|NCT00876733|454126687|FG001|Overall Study|Adverse Event|20|||
126228541|NCT00876733|454126688|FG002|Overall Study|Adverse Event|10|||
126228542|NCT00876733|454126689|FG003|Overall Study|Adverse Event|3|||
126228543|NCT00876733|454126686|FG000|Overall Study|Lack of Efficacy|17|||
126228544|NCT00876733|454126687|FG001|Overall Study|Lack of Efficacy|9|||
126228545|NCT00876733|454126688|FG002|Overall Study|Lack of Efficacy|10|||
126228546|NCT00876733|454126689|FG003|Overall Study|Lack of Efficacy|1|||
126228547|NCT00876733|454126686|FG000|Overall Study|Lost to Follow-up|26|||
126228548|NCT00876733|454126687|FG001|Overall Study|Lost to Follow-up|10|||
126228549|NCT00876733|454126688|FG002|Overall Study|Lost to Follow-up|3|||
126228550|NCT00876733|454126689|FG003|Overall Study|Lost to Follow-up|2|||
126228551|NCT00876733|454126686|FG000|Overall Study|Data not available|14|||
126228552|NCT00876733|454126687|FG001|Overall Study|Data not available|3|||
126228553|NCT00876733|454126688|FG002|Overall Study|Data not available|7|||
126228554|NCT00876733|454126689|FG003|Overall Study|Data not available|1|||
126228555|NCT03521999|454126690|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
126228556|NCT03521999|454126691|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
126228557|NCT03521999|454126690|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
126228558|NCT03521999|454126691|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
126228559|NCT03521999|454126690|FG000|Completed 3 Month Follow up|Death|0|||
126228560|NCT03521999|454126691|FG001|Completed 3 Month Follow up|Death|1|||
126228561|NCT03521999|454126690|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
126228562|NCT03521999|454126691|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
126228563|NCT01564758|454126692|FG000|Overall Study|Death|8|||
126228564|NCT01564758|454126692|FG000|Overall Study|Adverse Event|3|||
126228565|NCT01564758|454126692|FG000|Overall Study|Other|3|||
126228566|NCT00249821|454126693|FG000|Overall Study|Technical problem|0|||
126228567|NCT00249821|454126694|FG001|Overall Study|Technical problem|1|||
126228568|NCT00467584|454126699|FG000|Overall Study|Withdrawal by Subject|4|||
126228569|NCT00467584|454126700|FG001|Overall Study|Withdrawal by Subject|5|||
126228570|NCT00467584|454126701|FG002|Overall Study|Withdrawal by Subject|1|||
126228571|NCT01498484|454126705|FG000|Overall Study|Death|6|||
126228572|NCT01498484|454126706|FG001|Overall Study|Death|3|||
126228573|NCT01498484|454126707|FG002|Overall Study|Death|1|||
126228574|NCT01498484|454126708|FG003|Overall Study|Death|1|||
126228575|NCT01498484|454126709|FG004|Overall Study|Death|0|||
126228576|NCT01498484|454126710|FG005|Overall Study|Death|0|||
126228577|NCT01498484|454126711|FG006|Overall Study|Death|10|||
126228578|NCT01498484|454126712|FG007|Overall Study|Death|1|||
126228579|NCT01498484|454126713|FG008|Overall Study|Death|0|||
126228580|NCT01498484|454126705|FG000|Overall Study|Physician Decision|3|||
126228581|NCT01498484|454126706|FG001|Overall Study|Physician Decision|2|||
126228582|NCT01498484|454126707|FG002|Overall Study|Physician Decision|1|||
126228583|NCT01498484|454126708|FG003|Overall Study|Physician Decision|1|||
126228584|NCT01498484|454126709|FG004|Overall Study|Physician Decision|0|||
126228585|NCT01498484|454126710|FG005|Overall Study|Physician Decision|0|||
126228586|NCT01498484|454126711|FG006|Overall Study|Physician Decision|8|||
126228587|NCT01498484|454126712|FG007|Overall Study|Physician Decision|13|||
126228588|NCT01498484|454126713|FG008|Overall Study|Physician Decision|1|||
126228589|NCT01498484|454126705|FG000|Overall Study|Adverse Event|0|||
126228590|NCT01498484|454126706|FG001|Overall Study|Adverse Event|0|||
126228591|NCT01498484|454126707|FG002|Overall Study|Adverse Event|0|||
126228592|NCT01498484|454126708|FG003|Overall Study|Adverse Event|0|||
126228593|NCT01498484|454126709|FG004|Overall Study|Adverse Event|0|||
126228594|NCT01498484|454126710|FG005|Overall Study|Adverse Event|1|||
126228595|NCT01498484|454126711|FG006|Overall Study|Adverse Event|0|||
126228596|NCT01498484|454126712|FG007|Overall Study|Adverse Event|0|||
126228597|NCT01498484|454126713|FG008|Overall Study|Adverse Event|0|||
126228598|NCT01498484|454126705|FG000|Overall Study|Withdrawal by Subject|0|||
126228599|NCT01498484|454126706|FG001|Overall Study|Withdrawal by Subject|0|||
126228600|NCT01498484|454126707|FG002|Overall Study|Withdrawal by Subject|0|||
126228601|NCT01498484|454126708|FG003|Overall Study|Withdrawal by Subject|1|||
126228602|NCT01498484|454126709|FG004|Overall Study|Withdrawal by Subject|0|||
126228603|NCT01498484|454126710|FG005|Overall Study|Withdrawal by Subject|0|||
126228604|NCT01498484|454126711|FG006|Overall Study|Withdrawal by Subject|1|||
126228605|NCT01498484|454126712|FG007|Overall Study|Withdrawal by Subject|0|||
126228606|NCT01498484|454126713|FG008|Overall Study|Withdrawal by Subject|0|||
126228607|NCT01498484|454126705|FG000|Overall Study|Other|5|||
126228608|NCT01498484|454126706|FG001|Overall Study|Other|2|||
126228609|NCT01498484|454126707|FG002|Overall Study|Other|0|||
126228610|NCT01498484|454126708|FG003|Overall Study|Other|0|||
126228611|NCT01498484|454126709|FG004|Overall Study|Other|1|||
126228612|NCT01498484|454126710|FG005|Overall Study|Other|0|||
126228613|NCT01498484|454126711|FG006|Overall Study|Other|3|||
126228614|NCT01498484|454126712|FG007|Overall Study|Other|0|||
126228615|NCT01498484|454126713|FG008|Overall Study|Other|1|||
126228616|NCT02486796|454126714|FG000|Overall Study|Withdrawal by Subject|1|||
126228617|NCT02486796|454126715|FG001|Overall Study|Withdrawal by Subject|1|||
126228618|NCT02486796|454126714|FG000|Overall Study|Physician Decision|1|||
126228619|NCT02486796|454126715|FG001|Overall Study|Physician Decision|0|||
126228620|NCT00278512|454126716|FG000|Overall Study|Death|1|||
126228621|NCT00278512|454126717|FG001|Overall Study|Death|0|||
126228622|NCT01202747|454126718|FG000|Overall Study|Withdrawal by Subject|1|||
126228623|NCT01620177|454126719|FG000|Overall Study|Failure at Screening Visit|43|||
126228624|NCT01620177|454126719|FG000|Overall Study|Withdrawal by Subject|26|||
126228625|NCT01620177|454126719|FG000|Overall Study|Lost to Follow-up|7|||
126228626|NCT01620177|454126719|FG000|Overall Study|Physician Decision|2|||
126228627|NCT01620177|454126719|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
126228628|NCT02292238|454126723|FG000|Overall Study|Protocol Violation|1|||
126228629|NCT02292238|454126724|FG001|Overall Study|Protocol Violation|2|||
126228630|NCT02292238|454126723|FG000|Overall Study|Withdrawal by Subject|2|||
126228631|NCT02292238|454126724|FG001|Overall Study|Withdrawal by Subject|1|||
126228632|NCT02292238|454126723|FG000|Overall Study|Lost to Follow-up|1|||
126228633|NCT02292238|454126724|FG001|Overall Study|Lost to Follow-up|0|||
126228634|NCT02292238|454126723|FG000|Overall Study|Physician Decision|0|||
126228635|NCT02292238|454126724|FG001|Overall Study|Physician Decision|1|||
126228636|NCT01789320|454126725|FG000|Overall Study|Re-enrolled into study|1|||
126228637|NCT01789320|454126725|FG000|Overall Study|Lost to Follow-up|1|||
126228638|NCT00814320|454126728|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
126228639|NCT00814320|454126729|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
126228640|NCT00814320|454126728|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
126228641|NCT00814320|454126729|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
126228642|NCT00814320|454126728|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
126228643|NCT00814320|454126729|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
126228644|NCT00814320|454126728|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
126228645|NCT00814320|454126729|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
126228646|NCT00814320|454126728|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
126228647|NCT00814320|454126729|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
126228648|NCT00814320|454126728|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
126228649|NCT00814320|454126729|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
126228650|NCT00814320|454126728|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
126228651|NCT00814320|454126729|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
126228652|NCT00814320|454126728|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
126228653|NCT00814320|454126729|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
126228654|NCT00814320|454126728|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
126228655|NCT00814320|454126729|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
126228656|NCT00814320|454126728|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
126228657|NCT00814320|454126729|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
126228658|NCT00491504|454126730|FG000|Overall Study|Adverse Event|0|||
126228659|NCT00491504|454126731|FG001|Overall Study|Adverse Event|1|||
126228660|NCT00491504|454126732|FG002|Overall Study|Adverse Event|0|||
126228661|NCT00491504|454126733|FG003|Overall Study|Adverse Event|0|||
126228662|NCT00491504|454126730|FG000|Overall Study|Withdrawal by Subject|0|||
126228663|NCT00491504|454126731|FG001|Overall Study|Withdrawal by Subject|0|||
126228664|NCT00491504|454126732|FG002|Overall Study|Withdrawal by Subject|1|||
126228665|NCT00491504|454126733|FG003|Overall Study|Withdrawal by Subject|2|||
126228666|NCT00491504|454126730|FG000|Overall Study|Protocol Violation|0|||
126228667|NCT00491504|454126731|FG001|Overall Study|Protocol Violation|0|||
126228668|NCT00491504|454126732|FG002|Overall Study|Protocol Violation|3|||
126228669|NCT00491504|454126733|FG003|Overall Study|Protocol Violation|2|||
126228670|NCT02789111|454126736|FG000|Overall Study|Withdrawal by Subject|1|||
126228671|NCT02789111|454126737|FG001|Overall Study|Withdrawal by Subject|4|||
126228672|NCT00601484|454126741|FG000|Overall Study|Adverse Event|0|||
126228673|NCT00601484|454126742|FG001|Overall Study|Adverse Event|1|||
126228674|NCT00601484|454126741|FG000|Overall Study|Lost to Follow-up|4|||
126228675|NCT00601484|454126742|FG001|Overall Study|Lost to Follow-up|3|||
126228676|NCT00601484|454126741|FG000|Overall Study|Lack of Efficacy|0|||
126228677|NCT00601484|454126742|FG001|Overall Study|Lack of Efficacy|2|||
126228678|NCT00601484|454126741|FG000|Overall Study|Withdrawal by Subject|1|||
126228679|NCT00601484|454126742|FG001|Overall Study|Withdrawal by Subject|1|||
126228680|NCT00601484|454126741|FG000|Overall Study|Randomized, but not treated|0|||
126228681|NCT00601484|454126742|FG001|Overall Study|Randomized, but not treated|1|||
126228682|NCT01463683|454126747|FG000|Overall Study|Adverse Event|2|||
126228683|NCT01463683|454126748|FG001|Overall Study|Adverse Event|0|||
126228684|NCT01463683|454126749|FG002|Overall Study|Adverse Event|0|||
126228685|NCT01463683|454126747|FG000|Overall Study|Lost to Follow-up|10|||
126228686|NCT01463683|454126748|FG001|Overall Study|Lost to Follow-up|9|||
126228687|NCT01463683|454126749|FG002|Overall Study|Lost to Follow-up|7|||
126228688|NCT01463683|454126747|FG000|Overall Study|Physician Decision|0|||
126228689|NCT01463683|454126748|FG001|Overall Study|Physician Decision|3|||
126228690|NCT01463683|454126749|FG002|Overall Study|Physician Decision|1|||
126228691|NCT01463683|454126747|FG000|Overall Study|Pregnancy|2|||
126228692|NCT01463683|454126748|FG001|Overall Study|Pregnancy|2|||
126228693|NCT01463683|454126749|FG002|Overall Study|Pregnancy|1|||
126228694|NCT01463683|454126747|FG000|Overall Study|Withdrawal by Subject|5|||
126228695|NCT01463683|454126748|FG001|Overall Study|Withdrawal by Subject|17|||
126228696|NCT01463683|454126749|FG002|Overall Study|Withdrawal by Subject|2|||
126228697|NCT01618305|454126750|FG000|Overall Study|Death|0|||
126228698|NCT01618305|454126751|FG001|Overall Study|Death|1|||
126228699|NCT01618305|454126750|FG000|Overall Study|Lost to Follow-up|11|||
126228700|NCT01618305|454126751|FG001|Overall Study|Lost to Follow-up|7|||
126228701|NCT01618305|454126750|FG000|Overall Study|Protocol Violation|1|||
126228702|NCT01618305|454126751|FG001|Overall Study|Protocol Violation|0|||
126228703|NCT01618305|454126750|FG000|Overall Study|Withdrawal by Subject|3|||
126228704|NCT01618305|454126751|FG001|Overall Study|Withdrawal by Subject|2|||
126228705|NCT02708277|454126753|FG000|Overall Study|Lost to Follow-up|7|||
126228706|NCT02708277|454126754|FG001|Overall Study|Lost to Follow-up|4|||
126228707|NCT01960816|454126755|FG000|Overall Study|Lost to Follow-up|1|||
126228708|NCT01118728|454126759|FG000|Overall Study|Adverse Event|17|||
126228709|NCT01118728|454126759|FG000|Overall Study|Lack of Efficacy|27|||
126228710|NCT01118728|454126759|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
126228711|NCT01118728|454126759|FG000|Overall Study|Withdrawal by Subject|3|||
126228712|NCT01118728|454126759|FG000|Overall Study|Lost to Follow-up|4|||
126228713|NCT04345471|454126760|FG000|Overall Study|Adverse Event|8|||
126228714|NCT04345471|454126761|FG001|Overall Study|Adverse Event|5|||
126228715|NCT04345471|454126762|FG002|Overall Study|Adverse Event|6|||
126228716|NCT04345471|454126760|FG000|Overall Study|Lack of Efficacy|1|||
126228717|NCT04345471|454126761|FG001|Overall Study|Lack of Efficacy|1|||
126228718|NCT04345471|454126762|FG002|Overall Study|Lack of Efficacy|0|||
126228719|NCT04345471|454126760|FG000|Overall Study|Protocol Violation|0|||
126228720|NCT04345471|454126761|FG001|Overall Study|Protocol Violation|1|||
126228721|NCT04345471|454126762|FG002|Overall Study|Protocol Violation|2|||
126228722|NCT04345471|454126760|FG000|Overall Study|Withdrawal by Subject|10|||
126228723|NCT04345471|454126761|FG001|Overall Study|Withdrawal by Subject|5|||
126228724|NCT04345471|454126762|FG002|Overall Study|Withdrawal by Subject|10|||
126228725|NCT03896490|454126797|FG000|Overall Study|Withdrawal by Subject|1|||
126228726|NCT03896490|454126798|FG001|Overall Study|Withdrawal by Subject|1|||
126228727|NCT00003782|454126799|FG000|Overall Study|No follow up data|30|||
126228728|NCT00003782|454126800|FG001|Overall Study|No follow up data|31|||
126228729|NCT00003782|454126801|FG002|Overall Study|No follow up data|26|||
126228730|NCT01890707|454126802|FG000|Overall Study|Lost to Follow-up|1|||
126228731|NCT01890707|454126803|FG001|Overall Study|Lost to Follow-up|1|||
126228732|NCT00385541|454126805|FG000|Overall Study|severe pain, clinician requested unblind|0|||
126228733|NCT00385541|454126806|FG001|Overall Study|severe pain, clinician requested unblind|1|||
126228734|NCT00929708|454126807|FG000|Overall Study|Protocol Violation|2|||
126228735|NCT00929708|454126808|FG001|Overall Study|Protocol Violation|1|||
126228736|NCT00929708|454126809|FG002|Overall Study|Protocol Violation|1|||
126228737|NCT00929708|454126810|FG003|Overall Study|Protocol Violation|1|||
126228738|NCT00929708|454126811|FG004|Overall Study|Protocol Violation|1|||
126228739|NCT00929708|454126807|FG000|Overall Study|Withdrawal by Subject|2|||
126228740|NCT00929708|454126808|FG001|Overall Study|Withdrawal by Subject|0|||
126228741|NCT00929708|454126809|FG002|Overall Study|Withdrawal by Subject|0|||
126228742|NCT00929708|454126810|FG003|Overall Study|Withdrawal by Subject|2|||
126228743|NCT00929708|454126811|FG004|Overall Study|Withdrawal by Subject|1|||
126228744|NCT00929708|454126807|FG000|Overall Study|Adverse Event|0|||
126228745|NCT00929708|454126808|FG001|Overall Study|Adverse Event|0|||
126228746|NCT00929708|454126809|FG002|Overall Study|Adverse Event|0|||
126228747|NCT00929708|454126810|FG003|Overall Study|Adverse Event|0|||
126228748|NCT00929708|454126811|FG004|Overall Study|Adverse Event|3|||
126228749|NCT00929708|454126807|FG000|Overall Study|Physician Decision|0|||
126228750|NCT00929708|454126808|FG001|Overall Study|Physician Decision|2|||
126228751|NCT00929708|454126809|FG002|Overall Study|Physician Decision|2|||
126352132|NCT02850406|454579644|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352133|NCT02850406|454579645|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352134|NCT02850406|454579638|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
126352135|NCT02850406|454579639|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
126352136|NCT02850406|454579640|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
126228752|NCT00929708|454126810|FG003|Overall Study|Physician Decision|2|||
126228753|NCT00929708|454126811|FG004|Overall Study|Physician Decision|1|||
126228754|NCT00929708|454126807|FG000|Overall Study|Lost to Follow-up|0|||
126228755|NCT00929708|454126808|FG001|Overall Study|Lost to Follow-up|0|||
126228756|NCT00929708|454126809|FG002|Overall Study|Lost to Follow-up|0|||
126228757|NCT00929708|454126810|FG003|Overall Study|Lost to Follow-up|1|||
126228758|NCT00929708|454126811|FG004|Overall Study|Lost to Follow-up|0|||
126228759|NCT01326026|454126812|FG000|Overall Study|Adverse Event|4|||
126228760|NCT01326026|454126813|FG001|Overall Study|Adverse Event|3|||
126228761|NCT01326026|454126812|FG000|Overall Study|Withdrawal Criteria|5|||
126228762|NCT01326026|454126813|FG001|Overall Study|Withdrawal Criteria|7|||
126228763|NCT01326026|454126812|FG000|Overall Study|Other|3|||
126352137|NCT02850406|454579641|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
126352138|NCT02850406|454579642|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
126352139|NCT02850406|454579643|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
126228764|NCT01326026|454126813|FG001|Overall Study|Other|3|||
126306162|NCT03689374|454408910|FG000|Treatment Period (Week 0 to 52)|Death|0|||
126306163|NCT03689374|454408911|FG001|Treatment Period (Week 0 to 52)|Death|11|||
126306164|NCT03689374|454408912|FG002|Treatment Period (Week 0 to 52)|Death|1|||
126306165|NCT00078767|454410213|FG000|Overall Study|Withdrawal by Subject|1|||
126306166|NCT00078767|454410214|FG001|Overall Study|Withdrawal by Subject|1|||
126306167|NCT02282631|454410215|FG000|Overall Study|Lost to Follow-up|2|||
126306168|NCT02282631|454410216|FG001|Overall Study|Lost to Follow-up|0|||
126306169|NCT00831311|454410217|FG000|Overall Study|Definitive Contraindication|3|||
126306170|NCT00831311|454410218|FG001|Overall Study|Definitive Contraindication|3|||
126306171|NCT00831311|454410217|FG000|Overall Study|Lost to Follow-up|3|||
126306172|NCT00831311|454410218|FG001|Overall Study|Lost to Follow-up|0|||
126306173|NCT00831311|454410217|FG000|Overall Study|Physician Decision|0|||
126306174|NCT00831311|454410218|FG001|Overall Study|Physician Decision|1|||
126306175|NCT00831311|454410217|FG000|Overall Study|Withdrawal by Subject|6|||
126306176|NCT00831311|454410218|FG001|Overall Study|Withdrawal by Subject|4|||
126306177|NCT01841762|454410220|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
126306178|NCT01841762|454410220|FG000|Treatment Period|Adverse Event|16|||
126306179|NCT01841762|454410220|FG000|Treatment Period|Death|1|||
126306180|NCT01841762|454410220|FG000|Treatment Period|Withdrawal by Subject|7|||
126306181|NCT01841762|454410220|FG000|Treatment Period|Lost to Follow-up|1|||
126306182|NCT01841762|454410220|FG000|Treatment Period|Physician Decision|2|||
126306183|NCT01841762|454410220|FG000|Treatment Period|Other, including non-compliance|5|||
126306184|NCT01841762|454410220|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
126306185|NCT01841762|454410220|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
126352140|NCT02850406|454579644|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
126352141|NCT02850406|454579645|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
126021186|NCT03703336|453373196|FG000|Overall Study|Lost to Follow-up|1|||
126021187|NCT03703336|453373197|FG001|Overall Study|Lost to Follow-up|0|||
126021188|NCT00595413|453373198|FG000|Overall Study|Adverse Event|0|||
126021189|NCT00595413|453373199|FG001|Overall Study|Adverse Event|2|||
126021190|NCT00595413|453373200|FG002|Overall Study|Adverse Event|1|||
126021191|NCT00595413|453373201|FG003|Overall Study|Adverse Event|1|||
126021192|NCT00595413|453373198|FG000|Overall Study|Lost to Follow-up|2|||
126306186|NCT01841762|454410220|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
126306187|NCT01841762|454410220|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
126306188|NCT03260244|454410221|FG000|Overall Study|Death|19|||
126306189|NCT03260244|454410221|FG000|Overall Study|Lost to Follow-up|60|||
126306190|NCT03260244|454410221|FG000|Overall Study|Withdrawal by Subject|48|||
126306191|NCT03260244|454410221|FG000|Overall Study|Procedure Not Performed|21|||
126352142|NCT02850406|454579638|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
126021193|NCT00595413|453373199|FG001|Overall Study|Lost to Follow-up|2|||
126228765|NCT00506753|454128584|FG000|Overall Study|Lost to Follow-up|21|||
126228766|NCT00506753|454128585|FG001|Overall Study|Lost to Follow-up|15|||
126228767|NCT00125359|454128586|FG000|Overall Study|Death|4|||
126228768|NCT00125359|454128586|FG000|Overall Study|Adverse Event|5|||
126228769|NCT00125359|454128586|FG000|Overall Study|Physician Decision|14|||
126228770|NCT02451670|454128587|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
126228771|NCT02451670|454128588|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
126228772|NCT01513551|454128589|FG000|Overall Study|Death|0|||
126228773|NCT01513551|454128590|FG001|Overall Study|Death|1|||
126228774|NCT01513551|454128591|FG002|Overall Study|Death|0|||
126228775|NCT01513551|454128589|FG000|Overall Study|Lost to Follow-up|3|||
126228776|NCT01513551|454128590|FG001|Overall Study|Lost to Follow-up|5|||
126228777|NCT01513551|454128591|FG002|Overall Study|Lost to Follow-up|2|||
126228778|NCT01513551|454128589|FG000|Overall Study|Withdrawal by Subject|1|||
126228779|NCT01513551|454128590|FG001|Overall Study|Withdrawal by Subject|0|||
126228780|NCT01513551|454128591|FG002|Overall Study|Withdrawal by Subject|2|||
126228781|NCT01513551|454128589|FG000|Overall Study|Randomized but not vaccinated|0|||
126228782|NCT01513551|454128590|FG001|Overall Study|Randomized but not vaccinated|0|||
126228783|NCT01513551|454128591|FG002|Overall Study|Randomized but not vaccinated|1|||
126228784|NCT00094302|454128595|FG000|Overall Study|Lost to Follow-up|43|||
126228785|NCT00094302|454128596|FG001|Overall Study|Lost to Follow-up|41|||
126228786|NCT00094302|454128595|FG000|Overall Study|Physician Decision|5|||
126228787|NCT00094302|454128596|FG001|Overall Study|Physician Decision|8|||
126228788|NCT00094302|454128595|FG000|Overall Study|Withdrawal by Subject|103|||
126228789|NCT00094302|454128596|FG001|Overall Study|Withdrawal by Subject|111|||
126228790|NCT00094302|454128595|FG000|Overall Study|Death|266|||
126228791|NCT00094302|454128596|FG001|Overall Study|Death|246|||
126228792|NCT03705351|454128597|FG000|Overall Study|Study termination|3|||
126228793|NCT03705351|454128597|FG000|Overall Study|Death|1|||
126228794|NCT03705351|454128597|FG000|Overall Study|Lack of Efficacy|2|||
126228795|NCT03705351|454128597|FG000|Overall Study|Withdrawal by Subject|1|||
126228796|NCT00322556|454128609|FG000|Overall Study|Adverse Event|1|||
126228797|NCT00322556|454128609|FG000|Overall Study|Withdrawal by Subject|1|||
126228798|NCT00322556|454128609|FG000|Overall Study|Lost to Follow-up|3|||
126228799|NCT00322556|454128609|FG000|Overall Study|Other Reason|7|||
126228800|NCT02058628|454128610|FG000|Overall Study|Adverse Event|1|||
126228801|NCT02058628|454128611|FG001|Overall Study|Adverse Event|0|||
126228802|NCT02058628|454128610|FG000|Overall Study|Withdrawal by Subject|2|||
126228803|NCT02058628|454128611|FG001|Overall Study|Withdrawal by Subject|2|||
126228804|NCT02058628|454128610|FG000|Overall Study|Lost to Follow-up|2|||
126228805|NCT02058628|454128611|FG001|Overall Study|Lost to Follow-up|4|||
126228806|NCT02058628|454128610|FG000|Overall Study|Not in time schedule|0|||
126228807|NCT02058628|454128611|FG001|Overall Study|Not in time schedule|1|||
126228808|NCT02058628|454128610|FG000|Overall Study|The visit date was not in timeline|0|||
126228809|NCT02058628|454128611|FG001|Overall Study|The visit date was not in timeline|1|||
126228810|NCT02058628|454128610|FG000|Overall Study|A lot of time for study for participant|1|||
126228811|NCT02058628|454128611|FG001|Overall Study|A lot of time for study for participant|0|||
126228812|NCT02058628|454128610|FG000|Overall Study|Non compliance|1|||
126228813|NCT02058628|454128611|FG001|Overall Study|Non compliance|0|||
126228814|NCT01767597|454128612|FG000|Overall Study|Incomplete intervention|3|||
126228815|NCT01767597|454128613|FG001|Overall Study|Incomplete intervention|1|||
126228816|NCT01767597|454128612|FG000|Overall Study|Withdrawal by Subject|1|||
126228817|NCT01767597|454128613|FG001|Overall Study|Withdrawal by Subject|0|||
126228818|NCT03355742|454128614|FG000|Overall Study|Lost to Follow-up|4|||
126228819|NCT03355742|454128614|FG000|Overall Study|Withdrawal by Subject|29|||
126228820|NCT03355742|454128614|FG000|Overall Study|Physician Decision|6|||
126228821|NCT03355742|454128614|FG000|Overall Study|Death|55|||
126228822|NCT03355742|454128614|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
126228823|NCT02961920|454128615|FG000|Overall Study|did not achive stydy protocol schedule|1|||
126228824|NCT02961920|454128616|FG001|Overall Study|did not achive stydy protocol schedule|1|||
126228825|NCT04527471|454128619|FG000|Overall Study|Adverse Event|1|||
126228826|NCT04527471|454128620|FG001|Overall Study|Adverse Event|0|||
126228827|NCT04527471|454128619|FG000|Overall Study|Lost to Follow-up|1|||
126228828|NCT04527471|454128620|FG001|Overall Study|Lost to Follow-up|0|||
126228829|NCT00096265|454128628|FG000|Overall Study|Ineligible|1|||
126228830|NCT00096265|454128629|FG001|Overall Study|Ineligible|0|||
126228831|NCT00096265|454128630|FG002|Overall Study|Ineligible|0|||
126228832|NCT01506323|454128631|FG000|Overall Study|Lost to Follow-up|5|||
126228833|NCT01506323|454128632|FG001|Overall Study|Lost to Follow-up|4|||
126228834|NCT01506323|454128631|FG000|Overall Study|Withdrawal by Subject|4|||
126228835|NCT01506323|454128632|FG001|Overall Study|Withdrawal by Subject|4|||
126228836|NCT01506323|454128631|FG000|Overall Study|Lack of Efficacy|1|||
126228837|NCT01506323|454128632|FG001|Overall Study|Lack of Efficacy|3|||
126228838|NCT01506323|454128631|FG000|Overall Study|Moved out of area|5|||
126228839|NCT01506323|454128632|FG001|Overall Study|Moved out of area|2|||
126228840|NCT01506323|454128631|FG000|Overall Study|Schedule or Transportation conflict|8|||
126228841|NCT01506323|454128632|FG001|Overall Study|Schedule or Transportation conflict|0|||
126228842|NCT01506323|454128631|FG000|Overall Study|Started another treatment|1|||
126228843|NCT01506323|454128632|FG001|Overall Study|Started another treatment|0|||
126228844|NCT02891200|454128633|FG000|Overall Study|Lost to Follow-up|31|||
126228845|NCT02891200|454128634|FG001|Overall Study|Lost to Follow-up|36|||
126228846|NCT02891200|454128633|FG000|Overall Study|Death|10|||
126228847|NCT02891200|454128634|FG001|Overall Study|Death|9|||
126228848|NCT02891200|454128633|FG000|Overall Study|Withdrawal by Subject|1|||
126228849|NCT02891200|454128634|FG001|Overall Study|Withdrawal by Subject|4|||
126228850|NCT02192905|454128637|FG000|Overall Study|Lost to Follow-up|1|||
126228851|NCT04480463|454128638|FG000|Overall Study|Death|0|||
126228852|NCT04480463|454128639|FG001|Overall Study|Death|1|||
126228853|NCT04480463|454128638|FG000|Overall Study|Adverse Event|6|||
126228854|NCT04480463|454128639|FG001|Overall Study|Adverse Event|8|||
126228855|NCT04480463|454128638|FG000|Overall Study|Lost to Follow-up|3|||
126228856|NCT04480463|454128639|FG001|Overall Study|Lost to Follow-up|2|||
126228857|NCT04480463|454128638|FG000|Overall Study|Physician Decision|2|||
126228858|NCT04480463|454128639|FG001|Overall Study|Physician Decision|5|||
126228859|NCT04480463|454128638|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
126228860|NCT04480463|454128639|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
126228861|NCT04480463|454128638|FG000|Overall Study|Protocol Violation|2|||
126228862|NCT04480463|454128639|FG001|Overall Study|Protocol Violation|1|||
126228863|NCT04480463|454128638|FG000|Overall Study|Withdrawal by Subject|6|||
126228864|NCT04480463|454128639|FG001|Overall Study|Withdrawal by Subject|7|||
126228865|NCT04480463|454128638|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
126228866|NCT04480463|454128639|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
126228867|NCT04480463|454128638|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
126228868|NCT04480463|454128639|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
126228869|NCT04480463|454128638|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
126228870|NCT04480463|454128639|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
126228871|NCT04480463|454128638|FG000|Overall Study|Other|6|||
126228872|NCT04480463|454128639|FG001|Overall Study|Other|4|||
126228873|NCT00444795|454128641|FG000|Overall Study|Not Treated|1|||
126228874|NCT00444795|454128641|FG000|Overall Study|Treated Prior to the Contract Date|2|||
126228875|NCT00988169|454128642|FG000|Overall Study|Withdrawal by Subject|1|||
126228876|NCT00704418|454128643|FG000|Overall Study|Withdrawal by Subject|2|||
126228877|NCT00704418|454128644|FG001|Overall Study|Withdrawal by Subject|0|||
126228878|NCT00704418|454128643|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
126228879|NCT00704418|454128644|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
126228880|NCT02322879|454128646|FG000|First Intervention|Physician Decision|1|||
126228881|NCT02322879|454128647|FG001|First Intervention|Physician Decision|0|||
126228882|NCT02637076|454128648|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
126228883|NCT02637076|454128649|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
126228884|NCT02637076|454128648|FG000|Overall Study|Withdrawal by Subject|0|||
126228885|NCT02637076|454128649|FG001|Overall Study|Withdrawal by Subject|4|||
126228886|NCT02710071|454128654|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
126228887|NCT02710071|454128655|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
126228888|NCT02710071|454128654|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
126228889|NCT02710071|454128655|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
126228890|NCT02637557|454128662|FG000|Overall Study|Adverse Event|3|||
126228891|NCT02637557|454128663|FG001|Overall Study|Adverse Event|1|||
126228892|NCT02637557|454128664|FG002|Overall Study|Adverse Event|3|||
126228893|NCT02637557|454128665|FG003|Overall Study|Adverse Event|3|||
126228894|NCT02637557|454128662|FG000|Overall Study|Lost to Follow-up|1|||
126228895|NCT02637557|454128663|FG001|Overall Study|Lost to Follow-up|1|||
126228896|NCT02637557|454128664|FG002|Overall Study|Lost to Follow-up|0|||
126228897|NCT02637557|454128665|FG003|Overall Study|Lost to Follow-up|1|||
126228898|NCT02637557|454128662|FG000|Overall Study|Physician Decision|1|||
126228899|NCT02637557|454128663|FG001|Overall Study|Physician Decision|0|||
126228900|NCT02637557|454128664|FG002|Overall Study|Physician Decision|0|||
126228901|NCT02637557|454128665|FG003|Overall Study|Physician Decision|0|||
126228902|NCT02637557|454128662|FG000|Overall Study|Protocol Violation|2|||
126228903|NCT02637557|454128663|FG001|Overall Study|Protocol Violation|0|||
126228904|NCT02637557|454128664|FG002|Overall Study|Protocol Violation|2|||
126228905|NCT02637557|454128665|FG003|Overall Study|Protocol Violation|1|||
126352143|NCT02850406|454579639|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352144|NCT02850406|454579640|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
126228906|NCT02637557|454128662|FG000|Overall Study|Withdrawal by Subject|1|||
126228907|NCT02637557|454128663|FG001|Overall Study|Withdrawal by Subject|3|||
126228908|NCT02637557|454128664|FG002|Overall Study|Withdrawal by Subject|4|||
126352145|NCT02850406|454579641|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352146|NCT02850406|454579642|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
126228909|NCT02637557|454128665|FG003|Overall Study|Withdrawal by Subject|2|||
126228910|NCT00613574|454128666|FG000|Overall Study|Adverse Event|3|||
126228911|NCT00613574|454128666|FG000|Overall Study|Lost to Follow-up|2|||
126228912|NCT00613574|454128666|FG000|Overall Study|Other|1|||
126228913|NCT04604184|454128673|FG000|Overall Study|Adverse Event|5|||
126228914|NCT04604184|454128674|FG001|Overall Study|Adverse Event|5|||
126228915|NCT04604184|454128673|FG000|Overall Study|Death|2|||
126228916|NCT04604184|454128674|FG001|Overall Study|Death|1|||
126228917|NCT04604184|454128673|FG000|Overall Study|Withdrawal by Subject|1|||
126228918|NCT04604184|454128674|FG001|Overall Study|Withdrawal by Subject|3|||
126228919|NCT04604184|454128673|FG000|Overall Study|Not treated|2|||
126228920|NCT04604184|454128674|FG001|Overall Study|Not treated|2|||
126228921|NCT04604184|454128673|FG000|Overall Study|Due to sponsor decision|9|||
126228922|NCT04604184|454128674|FG001|Overall Study|Due to sponsor decision|7|||
126228923|NCT04604184|454128673|FG000|Overall Study|Physician Decision|0|||
126228924|NCT04604184|454128674|FG001|Overall Study|Physician Decision|1|||
126228925|NCT04604184|454128673|FG000|Overall Study|Transfer to healthcare|1|||
126228926|NCT04604184|454128674|FG001|Overall Study|Transfer to healthcare|0|||
126228927|NCT01751412|454128675|FG000|Overall Study|Disease Progression Before Treatment|1|||
126228928|NCT02711956|454128678|FG000|Overall Study|Adverse Event|0|||
126228929|NCT02711956|454128679|FG001|Overall Study|Adverse Event|0|||
126228930|NCT02711956|454128680|FG002|Overall Study|Adverse Event|0|||
126228931|NCT02711956|454128681|FG003|Overall Study|Adverse Event|1|||
126228932|NCT02711956|454128682|FG004|Overall Study|Adverse Event|2|||
126228933|NCT02711956|454128683|FG005|Overall Study|Adverse Event|0|||
126228934|NCT02711956|454128684|FG006|Overall Study|Adverse Event|0|||
126228935|NCT02711956|454128685|FG007|Overall Study|Adverse Event|1|||
126228936|NCT02711956|454128686|FG008|Overall Study|Adverse Event|1|||
126228937|NCT02711956|454128687|FG009|Overall Study|Adverse Event|1|||
126228938|NCT02711956|454128688|FG010|Overall Study|Adverse Event|1|||
126228939|NCT02711956|454128689|FG011|Overall Study|Adverse Event|0|||
126228940|NCT02711956|454128690|FG012|Overall Study|Adverse Event|0|||
126228941|NCT02711956|454128691|FG013|Overall Study|Adverse Event|0|||
126228942|NCT02711956|454128692|FG014|Overall Study|Adverse Event|2|||
126228943|NCT02711956|454128678|FG000|Overall Study|Physician Decision|0|||
126228944|NCT02711956|454128679|FG001|Overall Study|Physician Decision|0|||
126228945|NCT02711956|454128680|FG002|Overall Study|Physician Decision|0|||
126228946|NCT02711956|454128681|FG003|Overall Study|Physician Decision|2|||
126228947|NCT02711956|454128682|FG004|Overall Study|Physician Decision|0|||
126228948|NCT02711956|454128683|FG005|Overall Study|Physician Decision|0|||
126228949|NCT02711956|454128684|FG006|Overall Study|Physician Decision|0|||
126228950|NCT02711956|454128685|FG007|Overall Study|Physician Decision|0|||
126228951|NCT02711956|454128686|FG008|Overall Study|Physician Decision|0|||
126228952|NCT02711956|454128687|FG009|Overall Study|Physician Decision|0|||
126228953|NCT02711956|454128688|FG010|Overall Study|Physician Decision|0|||
126228954|NCT02711956|454128689|FG011|Overall Study|Physician Decision|0|||
126228955|NCT02711956|454128690|FG012|Overall Study|Physician Decision|0|||
126228956|NCT02711956|454128691|FG013|Overall Study|Physician Decision|0|||
126228957|NCT02711956|454128692|FG014|Overall Study|Physician Decision|0|||
126228958|NCT02711956|454128678|FG000|Overall Study|Withdrawal by Subject|0|||
126228959|NCT02711956|454128679|FG001|Overall Study|Withdrawal by Subject|0|||
126228960|NCT02711956|454128680|FG002|Overall Study|Withdrawal by Subject|0|||
126228961|NCT02711956|454128681|FG003|Overall Study|Withdrawal by Subject|0|||
126228962|NCT02711956|454128682|FG004|Overall Study|Withdrawal by Subject|0|||
126228963|NCT02711956|454128683|FG005|Overall Study|Withdrawal by Subject|0|||
126228964|NCT02711956|454128684|FG006|Overall Study|Withdrawal by Subject|1|||
126228965|NCT02711956|454128685|FG007|Overall Study|Withdrawal by Subject|0|||
126228966|NCT02711956|454128686|FG008|Overall Study|Withdrawal by Subject|0|||
126228967|NCT02711956|454128687|FG009|Overall Study|Withdrawal by Subject|0|||
126228968|NCT02711956|454128688|FG010|Overall Study|Withdrawal by Subject|0|||
126228969|NCT02711956|454128689|FG011|Overall Study|Withdrawal by Subject|1|||
126228970|NCT02711956|454128690|FG012|Overall Study|Withdrawal by Subject|6|||
126228971|NCT02711956|454128691|FG013|Overall Study|Withdrawal by Subject|0|||
126228972|NCT02711956|454128692|FG014|Overall Study|Withdrawal by Subject|1|||
126228973|NCT02711956|454128678|FG000|Overall Study|Clinical progression|1|||
126228974|NCT02711956|454128679|FG001|Overall Study|Clinical progression|0|||
126228975|NCT02711956|454128680|FG002|Overall Study|Clinical progression|0|||
126228976|NCT02711956|454128681|FG003|Overall Study|Clinical progression|0|||
126228977|NCT02711956|454128682|FG004|Overall Study|Clinical progression|0|||
126228978|NCT02711956|454128683|FG005|Overall Study|Clinical progression|0|||
126228979|NCT02711956|454128684|FG006|Overall Study|Clinical progression|1|||
126228980|NCT02711956|454128685|FG007|Overall Study|Clinical progression|0|||
126228981|NCT02711956|454128686|FG008|Overall Study|Clinical progression|1|||
126228982|NCT02711956|454128687|FG009|Overall Study|Clinical progression|0|||
126228983|NCT02711956|454128688|FG010|Overall Study|Clinical progression|0|||
126228984|NCT02711956|454128689|FG011|Overall Study|Clinical progression|2|||
126228985|NCT02711956|454128690|FG012|Overall Study|Clinical progression|4|||
126228986|NCT02711956|454128691|FG013|Overall Study|Clinical progression|1|||
126228987|NCT02711956|454128692|FG014|Overall Study|Clinical progression|1|||
126228988|NCT02711956|454128678|FG000|Overall Study|Radiographic progression|1|||
126228989|NCT02711956|454128679|FG001|Overall Study|Radiographic progression|1|||
126228990|NCT02711956|454128680|FG002|Overall Study|Radiographic progression|2|||
126228991|NCT02711956|454128681|FG003|Overall Study|Radiographic progression|0|||
126228992|NCT02711956|454128682|FG004|Overall Study|Radiographic progression|1|||
126228993|NCT02711956|454128683|FG005|Overall Study|Radiographic progression|0|||
126228994|NCT02711956|454128684|FG006|Overall Study|Radiographic progression|0|||
126228995|NCT02711956|454128685|FG007|Overall Study|Radiographic progression|0|||
126228996|NCT02711956|454128686|FG008|Overall Study|Radiographic progression|2|||
126352147|NCT02850406|454579643|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
126352148|NCT02850406|454579644|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352149|NCT02850406|454579645|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352150|NCT02850406|454579638|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352151|NCT02850406|454579639|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352152|NCT02850406|454579640|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352153|NCT02850406|454579641|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352154|NCT02850406|454579642|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
126352155|NCT02850406|454579643|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
126352156|NCT02850406|454579644|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126228997|NCT02711956|454128687|FG009|Overall Study|Radiographic progression|1|||
126228998|NCT02711956|454128688|FG010|Overall Study|Radiographic progression|0|||
126228999|NCT02711956|454128689|FG011|Overall Study|Radiographic progression|5|||
126352157|NCT02850406|454579645|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352158|NCT02850406|454579638|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352159|NCT02850406|454579639|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352160|NCT02850406|454579640|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
126229000|NCT02711956|454128690|FG012|Overall Study|Radiographic progression|3|||
126229001|NCT02711956|454128691|FG013|Overall Study|Radiographic progression|0|||
126229002|NCT02711956|454128692|FG014|Overall Study|Radiographic progression|1|||
126229003|NCT02711956|454128678|FG000|Overall Study|PSA progression with clinical progression|0|||
126229004|NCT02711956|454128679|FG001|Overall Study|PSA progression with clinical progression|0|||
126229005|NCT02711956|454128680|FG002|Overall Study|PSA progression with clinical progression|0|||
126229006|NCT02711956|454128681|FG003|Overall Study|PSA progression with clinical progression|0|||
126229007|NCT02711956|454128682|FG004|Overall Study|PSA progression with clinical progression|1|||
126229008|NCT02711956|454128683|FG005|Overall Study|PSA progression with clinical progression|0|||
126229009|NCT02711956|454128684|FG006|Overall Study|PSA progression with clinical progression|0|||
126229010|NCT02711956|454128685|FG007|Overall Study|PSA progression with clinical progression|0|||
126229011|NCT02711956|454128686|FG008|Overall Study|PSA progression with clinical progression|0|||
126229012|NCT02711956|454128687|FG009|Overall Study|PSA progression with clinical progression|0|||
126229013|NCT02711956|454128688|FG010|Overall Study|PSA progression with clinical progression|0|||
126229014|NCT02711956|454128689|FG011|Overall Study|PSA progression with clinical progression|0|||
126229015|NCT02711956|454128690|FG012|Overall Study|PSA progression with clinical progression|1|||
126229016|NCT02711956|454128691|FG013|Overall Study|PSA progression with clinical progression|1|||
126229017|NCT02711956|454128692|FG014|Overall Study|PSA progression with clinical progression|0|||
126229018|NCT02711956|454128678|FG000|Overall Study|PSA progression with radiographic progression|0|||
126352161|NCT02850406|454579641|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352162|NCT02850406|454579642|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
126352163|NCT02850406|454579643|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352164|NCT02850406|454579644|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352165|NCT02850406|454579645|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352166|NCT02850406|454579638|FG000|Part C (Up to 52 Weeks)|Other|0|||
126352167|NCT02850406|454579639|FG001|Part C (Up to 52 Weeks)|Other|0|||
126352168|NCT02850406|454579640|FG002|Part C (Up to 52 Weeks)|Other|0|||
126352169|NCT02850406|454579641|FG003|Part C (Up to 52 Weeks)|Other|0|||
126021194|NCT00595413|453373200|FG002|Overall Study|Lost to Follow-up|1|||
126021195|NCT00595413|453373201|FG003|Overall Study|Lost to Follow-up|3|||
126021196|NCT00595413|453373198|FG000|Overall Study|Death|0|||
126021197|NCT00595413|453373199|FG001|Overall Study|Death|0|||
126229019|NCT02711956|454128679|FG001|Overall Study|PSA progression with radiographic progression|1|||
126229020|NCT02711956|454128680|FG002|Overall Study|PSA progression with radiographic progression|0|||
126229021|NCT02711956|454128681|FG003|Overall Study|PSA progression with radiographic progression|0|||
126352170|NCT02850406|454579642|FG004|Part C (Up to 52 Weeks)|Other|1|||
126352171|NCT02850406|454579643|FG005|Part C (Up to 52 Weeks)|Other|3|||
126352172|NCT02850406|454579644|FG006|Part C (Up to 52 Weeks)|Other|0|||
126021198|NCT00595413|453373200|FG002|Overall Study|Death|1|||
126021199|NCT00595413|453373201|FG003|Overall Study|Death|0|||
126229022|NCT02711956|454128682|FG004|Overall Study|PSA progression with radiographic progression|0|||
126229023|NCT02711956|454128683|FG005|Overall Study|PSA progression with radiographic progression|2|||
126229024|NCT02711956|454128684|FG006|Overall Study|PSA progression with radiographic progression|2|||
126229025|NCT02711956|454128685|FG007|Overall Study|PSA progression with radiographic progression|1|||
126229026|NCT02711956|454128686|FG008|Overall Study|PSA progression with radiographic progression|0|||
126229027|NCT02711956|454128687|FG009|Overall Study|PSA progression with radiographic progression|1|||
126229028|NCT02711956|454128688|FG010|Overall Study|PSA progression with radiographic progression|0|||
126229029|NCT02711956|454128689|FG011|Overall Study|PSA progression with radiographic progression|1|||
126229030|NCT02711956|454128690|FG012|Overall Study|PSA progression with radiographic progression|2|||
126229031|NCT02711956|454128691|FG013|Overall Study|PSA progression with radiographic progression|3|||
126229032|NCT02711956|454128692|FG014|Overall Study|PSA progression with radiographic progression|3|||
126229033|NCT03734237|454128693|FG000|Overall Study|Lost to Follow-up|1|||
126229034|NCT03734237|454128694|FG001|Overall Study|Lost to Follow-up|3|||
126229035|NCT03734237|454128695|FG002|Overall Study|Lost to Follow-up|0|||
126229036|NCT03734237|454128693|FG000|Overall Study|Withdrawal by Subject|7|||
126229037|NCT03734237|454128694|FG001|Overall Study|Withdrawal by Subject|9|||
126229038|NCT03734237|454128695|FG002|Overall Study|Withdrawal by Subject|10|||
126229039|NCT01844583|454128696|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
126229040|NCT01844583|454128697|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
126229041|NCT01625377|454128698|FG000|Overall Study|Death|1|||
126229042|NCT01625377|454128699|FG001|Overall Study|Death|1|||
126229043|NCT01625377|454128698|FG000|Overall Study|Administrative Problem|1|||
126229044|NCT01625377|454128699|FG001|Overall Study|Administrative Problem|1|||
126229045|NCT01625377|454128698|FG000|Overall Study|Protocol Violation|0|||
126229046|NCT01625377|454128699|FG001|Overall Study|Protocol Violation|3|||
126229047|NCT01625377|454128698|FG000|Overall Study|Adverse Event|3|||
126229048|NCT01625377|454128699|FG001|Overall Study|Adverse Event|16|||
126229049|NCT01625377|454128698|FG000|Overall Study|Graft loss|1|||
126229050|NCT01625377|454128699|FG001|Overall Study|Graft loss|0|||
126229051|NCT01625377|454128698|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126229052|NCT01625377|454128699|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126229053|NCT01625377|454128698|FG000|Overall Study|Abnormal laboratory values|1|||
126229054|NCT01625377|454128699|FG001|Overall Study|Abnormal laboratory values|0|||
126229055|NCT03294538|454128704|FG000|Overall Study|Adverse Event|0|||
126229056|NCT03294538|454128705|FG001|Overall Study|Adverse Event|1|||
126229057|NCT03294538|454128706|FG002|Overall Study|Adverse Event|1|||
126229058|NCT03294538|454128704|FG000|Overall Study|Lost to Follow-up|1|||
126229059|NCT03294538|454128705|FG001|Overall Study|Lost to Follow-up|0|||
126229060|NCT03294538|454128706|FG002|Overall Study|Lost to Follow-up|0|||
126229061|NCT03294538|454128704|FG000|Overall Study|Outside of Visit Window|4|||
126229062|NCT03294538|454128705|FG001|Overall Study|Outside of Visit Window|4|||
126229063|NCT03294538|454128706|FG002|Overall Study|Outside of Visit Window|1|||
126229064|NCT02207621|454128709|FG000|Overall Study|Adverse Event|71|||
126229065|NCT02207621|454128710|FG001|Overall Study|Adverse Event|15|||
126229066|NCT02207621|454128711|FG002|Overall Study|Adverse Event|132|||
126229067|NCT02207621|454128709|FG000|Overall Study|Withdrawal by Subject|9|||
126229068|NCT02207621|454128710|FG001|Overall Study|Withdrawal by Subject|9|||
126229069|NCT02207621|454128711|FG002|Overall Study|Withdrawal by Subject|13|||
126229070|NCT02207621|454128709|FG000|Overall Study|Non-Compliant|3|||
126229071|NCT02207621|454128710|FG001|Overall Study|Non-Compliant|3|||
126229072|NCT02207621|454128711|FG002|Overall Study|Non-Compliant|1|||
126229073|NCT02207621|454128709|FG000|Overall Study|Lost to Follow-up|1|||
126229074|NCT02207621|454128710|FG001|Overall Study|Lost to Follow-up|0|||
126229075|NCT02207621|454128711|FG002|Overall Study|Lost to Follow-up|3|||
126229076|NCT02207621|454128709|FG000|Overall Study|Lack of Efficacy|10|||
126229077|NCT02207621|454128710|FG001|Overall Study|Lack of Efficacy|2|||
126229078|NCT02207621|454128711|FG002|Overall Study|Lack of Efficacy|4|||
126229079|NCT02207621|454128709|FG000|Overall Study|Disallowed Concurrent Medication|2|||
126229080|NCT02207621|454128710|FG001|Overall Study|Disallowed Concurrent Medication|5|||
126352173|NCT02850406|454579645|FG007|Part C (Up to 52 Weeks)|Other|0|||
126352174|NCT02850406|454579638|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352175|NCT02850406|454579639|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352176|NCT02850406|454579640|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352177|NCT02850406|454579641|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352178|NCT02850406|454579642|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352179|NCT02850406|454579643|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
126229081|NCT02207621|454128711|FG002|Overall Study|Disallowed Concurrent Medication|2|||
126229082|NCT02207621|454128709|FG000|Overall Study|Physician Decision|1|||
126229083|NCT02207621|454128710|FG001|Overall Study|Physician Decision|2|||
126229084|NCT02207621|454128711|FG002|Overall Study|Physician Decision|2|||
126229085|NCT02207621|454128709|FG000|Overall Study|Protocol Violation|4|||
126352180|NCT02850406|454579644|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
126352181|NCT02850406|454579645|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
126229086|NCT02207621|454128710|FG001|Overall Study|Protocol Violation|10|||
126229087|NCT02207621|454128711|FG002|Overall Study|Protocol Violation|6|||
126229088|NCT02207621|454128709|FG000|Overall Study|Death|2|||
126229089|NCT02207621|454128710|FG001|Overall Study|Death|0|||
126229090|NCT02207621|454128711|FG002|Overall Study|Death|0|||
126229091|NCT02207621|454128709|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
126229092|NCT02207621|454128710|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
126229093|NCT02207621|454128711|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
126229094|NCT01769378|454128714|FG000|Overall Study|Adverse Event|10|||
126229095|NCT01769378|454128715|FG001|Overall Study|Adverse Event|0|||
126229096|NCT01769378|454128714|FG000|Overall Study|Entry criteria not met|1|||
126229097|NCT01769378|454128715|FG001|Overall Study|Entry criteria not met|0|||
126229098|NCT01769378|454128714|FG000|Overall Study|Protocol Violation|1|||
126229099|NCT01769378|454128715|FG001|Overall Study|Protocol Violation|1|||
126229100|NCT01769378|454128714|FG000|Overall Study|Withdrawal by Subject|10|||
126229101|NCT01769378|454128715|FG001|Overall Study|Withdrawal by Subject|3|||
126229102|NCT01769378|454128714|FG000|Overall Study|Sponsor Decision|1|||
126229103|NCT01769378|454128715|FG001|Overall Study|Sponsor Decision|0|||
126229104|NCT01769378|454128714|FG000|Overall Study|Lost to Follow-up|2|||
126229105|NCT01769378|454128715|FG001|Overall Study|Lost to Follow-up|0|||
126229106|NCT01238848|454128719|FG000|Overall Study|Physician Decision|13|||
126229107|NCT01238848|454128720|FG001|Overall Study|Physician Decision|5|||
126229108|NCT00576901|454128722|FG000|Overall Study|Withdrawal by Subject|1|||
126229109|NCT00576901|454128722|FG000|Overall Study|Disease course|1|||
126229110|NCT00576901|454128722|FG000|Overall Study|Protocol Violation|1|||
126229111|NCT01755858|454128725|FG000|Overall Study|Adverse Event|1|||
126229112|NCT01755858|454128726|FG001|Overall Study|Adverse Event|1|||
126229113|NCT01259869|454128727|FG000|Overall Study|Duplicated registration|1|||
126229114|NCT00175019|454128728|FG000|Overall Study|Adverse Event|54|||
126229115|NCT00175019|454128729|FG001|Overall Study|Adverse Event|22|||
126229116|NCT00175019|454128730|FG002|Overall Study|Adverse Event|2|||
126229117|NCT00175019|454128728|FG000|Overall Study|Protocol Violation|6|||
126229118|NCT00175019|454128729|FG001|Overall Study|Protocol Violation|3|||
126229119|NCT00175019|454128730|FG002|Overall Study|Protocol Violation|3|||
126229120|NCT00175019|454128728|FG000|Overall Study|Lost to Follow-up|42|||
126229121|NCT00175019|454128729|FG001|Overall Study|Lost to Follow-up|39|||
126229122|NCT00175019|454128730|FG002|Overall Study|Lost to Follow-up|9|||
126229123|NCT00175019|454128728|FG000|Overall Study|Did not continue under Amendment 4|1|||
126229124|NCT00175019|454128729|FG001|Overall Study|Did not continue under Amendment 4|1|||
126229125|NCT00175019|454128730|FG002|Overall Study|Did not continue under Amendment 4|2|||
126229126|NCT00175019|454128728|FG000|Overall Study|Personal Reason(s)|39|||
126352182|NCT02850406|454579638|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352183|NCT02850406|454579639|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352184|NCT02850406|454579640|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352185|NCT02850406|454579641|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352186|NCT02850406|454579642|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352187|NCT02850406|454579643|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352188|NCT02850406|454579644|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352189|NCT02850406|454579645|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
126352190|NCT02850406|454579638|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352191|NCT02850406|454579639|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352192|NCT02850406|454579640|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352193|NCT02850406|454579641|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352194|NCT02850406|454579642|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352195|NCT02850406|454579643|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352196|NCT02850406|454579644|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
126352197|NCT02850406|454579645|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
126352198|NCT02850406|454579638|FG000|Part D (Up to 52 Weeks)|Other|0|||
126352199|NCT02850406|454579639|FG001|Part D (Up to 52 Weeks)|Other|0|||
126352200|NCT02850406|454579640|FG002|Part D (Up to 52 Weeks)|Other|0|||
126352201|NCT02850406|454579641|FG003|Part D (Up to 52 Weeks)|Other|0|||
126352202|NCT02850406|454579642|FG004|Part D (Up to 52 Weeks)|Other|0|||
126352203|NCT02850406|454579643|FG005|Part D (Up to 52 Weeks)|Other|0|||
126352204|NCT02850406|454579644|FG006|Part D (Up to 52 Weeks)|Other|0|||
126352205|NCT02850406|454579645|FG007|Part D (Up to 52 Weeks)|Other|1|||
126352206|NCT04167670|454580665|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
126352207|NCT04167670|454580666|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
126352208|NCT04167670|454580667|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
126229127|NCT00175019|454128729|FG001|Overall Study|Personal Reason(s)|31|||
126229128|NCT00175019|454128730|FG002|Overall Study|Personal Reason(s)|8|||
126229129|NCT00175019|454128728|FG000|Overall Study|Therapeutic Failure|10|||
126229130|NCT00175019|454128729|FG001|Overall Study|Therapeutic Failure|38|||
126352209|NCT04167670|454580665|FG000|Overall Study|Significant protocol deviation|3|||
126352210|NCT04167670|454580666|FG001|Overall Study|Significant protocol deviation|1|||
126352211|NCT04167670|454580667|FG002|Overall Study|Significant protocol deviation|0|||
126229131|NCT00175019|454128730|FG002|Overall Study|Therapeutic Failure|22|||
126229132|NCT00175019|454128728|FG000|Overall Study|Gout Flare|2|||
126229133|NCT00175019|454128729|FG001|Overall Study|Gout Flare|3|||
126229134|NCT00175019|454128730|FG002|Overall Study|Gout Flare|0|||
126229135|NCT00175019|454128728|FG000|Overall Study|Reason Not Specified|40|||
126229136|NCT00175019|454128729|FG001|Overall Study|Reason Not Specified|34|||
126229137|NCT00175019|454128730|FG002|Overall Study|Reason Not Specified|11|||
126229138|NCT03209570|454128731|FG000|Overall Study|Death|1|||
126229139|NCT03209570|454128732|FG001|Overall Study|Death|0|||
126229140|NCT03209570|454128731|FG000|Overall Study|Incomplete Data|8|||
126229141|NCT03209570|454128732|FG001|Overall Study|Incomplete Data|10|||
126229142|NCT03209570|454128731|FG000|Overall Study|Protocol Violation|1|||
126229143|NCT03209570|454128732|FG001|Overall Study|Protocol Violation|0|||
126229144|NCT03209570|454128731|FG000|Overall Study|Withdrawal by Subject|0|||
126229145|NCT03209570|454128732|FG001|Overall Study|Withdrawal by Subject|3|||
126229146|NCT00220701|454128743|FG000|Overall Study|Lost to Follow-up|5|||
126229147|NCT00220701|454128744|FG001|Overall Study|Lost to Follow-up|4|||
126229148|NCT00755326|454128745|FG000|Overall Study|Lost to Follow-up|2|||
126229149|NCT00755326|454128746|FG001|Overall Study|Lost to Follow-up|3|||
126229150|NCT02482571|454128751|FG000|Overall Study|Adverse Event|1|||
126229151|NCT02482571|454128751|FG000|Overall Study|Scanner or Respiract failure|3|||
126229152|NCT02482571|454128751|FG000|Overall Study|Withdrawal by Subject|4|||
126229153|NCT01446913|454128752|FG000|Overall Study|Significant illness|1|||
126229154|NCT01446913|454128753|FG001|Overall Study|Significant illness|1|||
126229155|NCT01446913|454128754|FG002|Overall Study|Significant illness|1|||
126229156|NCT01446913|454128752|FG000|Overall Study|Withdrawal by Subject|5|||
126229157|NCT01446913|454128753|FG001|Overall Study|Withdrawal by Subject|3|||
126229158|NCT01446913|454128754|FG002|Overall Study|Withdrawal by Subject|5|||
126229159|NCT01446913|454128752|FG000|Overall Study|Physician Decision|0|||
126352212|NCT04167670|454580665|FG000|Overall Study|Lost to Follow-up|0|||
126352213|NCT04167670|454580666|FG001|Overall Study|Lost to Follow-up|3|||
126352214|NCT04167670|454580667|FG002|Overall Study|Lost to Follow-up|3|||
126352215|NCT04167670|454580665|FG000|Overall Study|Voluntary Withdrawal|0|||
126352216|NCT04167670|454580666|FG001|Overall Study|Voluntary Withdrawal|1|||
126352217|NCT04167670|454580667|FG002|Overall Study|Voluntary Withdrawal|1|||
126352218|NCT04167670|454580665|FG000|Overall Study|Withdrawal of Consent|4|||
126229160|NCT01446913|454128753|FG001|Overall Study|Physician Decision|0|||
126229161|NCT01446913|454128754|FG002|Overall Study|Physician Decision|2|||
126229162|NCT01446913|454128752|FG000|Overall Study|Lost to Follow-up|3|||
126229163|NCT01446913|454128753|FG001|Overall Study|Lost to Follow-up|5|||
126229164|NCT01446913|454128754|FG002|Overall Study|Lost to Follow-up|3|||
126229165|NCT00745251|454128755|FG000|Overall Study|Adverse Event|1|||
126229166|NCT00745251|454128756|FG001|Overall Study|Adverse Event|2|||
126229167|NCT00745251|454128755|FG000|Overall Study|Withdrawal by Subject|1|||
126229168|NCT00745251|454128756|FG001|Overall Study|Withdrawal by Subject|1|||
126352219|NCT04167670|454580666|FG001|Overall Study|Withdrawal of Consent|1|||
126352220|NCT04167670|454580667|FG002|Overall Study|Withdrawal of Consent|3|||
126352221|NCT04167670|454580665|FG000|Overall Study|Miscellaneous|7|||
126352222|NCT04167670|454580666|FG001|Overall Study|Miscellaneous|5|||
126352223|NCT04167670|454580667|FG002|Overall Study|Miscellaneous|3|||
126352224|NCT00876395|454580672|FG000|Overall Study|Untreated|8|||
126352225|NCT00876395|454580673|FG001|Overall Study|Untreated|1|||
126352226|NCT00876395|454580672|FG000|Overall Study|Adverse Event|63|||
126352227|NCT00876395|454580673|FG001|Overall Study|Adverse Event|11|||
126352228|NCT00876395|454580672|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126352229|NCT00876395|454580673|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126352230|NCT00876395|454580672|FG000|Overall Study|Disease progression|259|||
126352231|NCT00876395|454580673|FG001|Overall Study|Disease progression|162|||
126352232|NCT00876395|454580672|FG000|Overall Study|New cancer therapy|25|||
126352233|NCT00876395|454580673|FG001|Overall Study|New cancer therapy|7|||
126352234|NCT00876395|454580672|FG000|Overall Study|Protocol Violation|5|||
126352235|NCT00876395|454580673|FG001|Overall Study|Protocol Violation|2|||
126352236|NCT00876395|454580672|FG000|Overall Study|Withdrawal by Subject|66|||
126352237|NCT00876395|454580673|FG001|Overall Study|Withdrawal by Subject|33|||
126352238|NCT00876395|454580672|FG000|Overall Study|Lost to Follow-up|2|||
126352239|NCT00876395|454580673|FG001|Overall Study|Lost to Follow-up|0|||
126352240|NCT00876395|454580672|FG000|Overall Study|Administrative problems|39|||
126352241|NCT00876395|454580673|FG001|Overall Study|Administrative problems|23|||
126352242|NCT00876395|454580672|FG000|Overall Study|Death|12|||
126352243|NCT00876395|454580673|FG001|Overall Study|Death|0|||
126352244|NCT03807843|454580674|FG000|Overall Study|Lost to Follow-up|1|||
126352245|NCT03807843|454580675|FG001|Overall Study|Lost to Follow-up|0|||
126229169|NCT01893138|454128757|FG000|Double-Blind Period|Withdrawal by Subject|1|||
126229170|NCT01893138|454128758|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126352246|NCT01312129|454580676|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
126229171|NCT01893138|454128757|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
126229172|NCT01893138|454128758|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
126352247|NCT01312129|454580677|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
126229173|NCT01893138|454128757|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
126352248|NCT00729586|454580678|FG000|Overall Study|Ineligible|0|||
126352249|NCT00729586|454580679|FG001|Overall Study|Ineligible|1|||
126352250|NCT00729586|454580678|FG000|Overall Study|never treated|1|||
126352251|NCT00729586|454580679|FG001|Overall Study|never treated|0|||
126352252|NCT00662259|454580680|FG000|Overall Study|Adverse Event|2|||
126352253|NCT00662259|454580681|FG001|Overall Study|Adverse Event|0|||
126352254|NCT01750346|454580682|FG000|Overall Study|Adverse Event|1|||
126021200|NCT00595413|453373198|FG000|Overall Study|Other|5|||
126021201|NCT00595413|453373199|FG001|Overall Study|Other|1|||
126021202|NCT00595413|453373200|FG002|Overall Study|Other|5|||
126021203|NCT00595413|453373201|FG003|Overall Study|Other|0|||
126021204|NCT04149002|453373202|FG000|Overall Study|Lost to Follow-up|1|||
126229174|NCT01893138|454128758|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
126229175|NCT01893138|454128757|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
126229176|NCT01893138|454128758|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
126229177|NCT01893138|454128757|FG000|Open Label - Unblinded Period|Adverse Event|1|||
126229178|NCT01893138|454128758|FG001|Open Label - Unblinded Period|Adverse Event|0|||
126229179|NCT05188521|454130744|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
126229180|NCT05188521|454130745|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
126229181|NCT01341639|454130746|FG000|Infant Series|Protocol Violation|1|||
126229182|NCT01341639|454130747|FG001|Infant Series|Protocol Violation|0|||
126229183|NCT01341639|454130746|FG000|Infant Series|Not Vaccinated|0|||
126229184|NCT01341639|454130747|FG001|Infant Series|Not Vaccinated|1|||
126229185|NCT01341639|454130746|FG000|Infant Series|Adverse Event|0|||
126229186|NCT01341639|454130747|FG001|Infant Series|Adverse Event|5|||
126229187|NCT01341639|454130746|FG000|Infant Series|Withdrawal by Subject|11|||
126229188|NCT01341639|454130747|FG001|Infant Series|Withdrawal by Subject|8|||
126229189|NCT01341639|454130746|FG000|Infant Series|Lost to Follow-up|0|||
126229190|NCT01341639|454130747|FG001|Infant Series|Lost to Follow-up|2|||
126229191|NCT01341639|454130746|FG000|Infant Series|Site 0048 Participants|17|||
126229192|NCT01341639|454130747|FG001|Infant Series|Site 0048 Participants|16|||
126229193|NCT01341639|454130746|FG000|Interim Period|Withdrawal by Subject|6|||
126229194|NCT01341639|454130747|FG001|Interim Period|Withdrawal by Subject|7|||
126229195|NCT01341639|454130746|FG000|Interim Period|Lost to Follow-up|2|||
126229196|NCT01341639|454130747|FG001|Interim Period|Lost to Follow-up|0|||
126229197|NCT01341639|454130746|FG000|Interim Period|Physician Decision|0|||
126229198|NCT01341639|454130747|FG001|Interim Period|Physician Decision|1|||
126229199|NCT01341639|454130746|FG000|Interim Period|Protocol Violation|0|||
126229200|NCT01341639|454130747|FG001|Interim Period|Protocol Violation|1|||
126229201|NCT01341639|454130746|FG000|Post-Treatment|Withdrawal by Subject|0|||
126229202|NCT01341639|454130747|FG001|Post-Treatment|Withdrawal by Subject|1|||
126229203|NCT01341639|454130746|FG000|Post-Treatment|Adverse Event|0|||
126229204|NCT01341639|454130747|FG001|Post-Treatment|Adverse Event|2|||
126229205|NCT04582266|454130748|FG000|Overall Study|Lost to Follow-up|7|||
126229206|NCT04582266|454130749|FG001|Overall Study|Lost to Follow-up|5|||
126229207|NCT04582266|454130748|FG000|Overall Study|Withdrawal by Subject|1|||
126229208|NCT04582266|454130749|FG001|Overall Study|Withdrawal by Subject|0|||
126229209|NCT04582266|454130748|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
126229210|NCT04582266|454130749|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
126229211|NCT01132118|454130750|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
126229212|NCT01132118|454130751|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
126229213|NCT01132118|454130750|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
126229214|NCT01132118|454130751|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
126229215|NCT01132118|454130750|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
126229216|NCT01132118|454130751|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
126229217|NCT02742090|454130752|FG000|Overall Study|Adverse Event|10|||
126229218|NCT02742090|454130752|FG000|Overall Study|Death|3|||
126229219|NCT02742090|454130752|FG000|Overall Study|Disease Progression|25|||
126229220|NCT02742090|454130752|FG000|Overall Study|Investigator's Decision|1|||
126229221|NCT02742090|454130752|FG000|Overall Study|Lost to Follow-up|1|||
126229222|NCT02742090|454130752|FG000|Overall Study|Non-compliance with Study|1|||
126229223|NCT02742090|454130752|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
126229224|NCT02742090|454130752|FG000|Overall Study|Withdrawal by Subject|4|||
126229225|NCT02742090|454130752|FG000|Overall Study|Reason Not Specified|1|||
126229226|NCT01299038|454130753|FG000|Overall Study|Withdrawal by Subject|1|||
126229227|NCT01299038|454130754|FG001|Overall Study|Withdrawal by Subject|0|||
126229228|NCT00832078|454130755|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
126229229|NCT00832078|454130756|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
126229230|NCT00832078|454130755|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
126229231|NCT00832078|454130756|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
126352255|NCT01750346|454580683|FG001|Overall Study|Adverse Event|0|||
126352256|NCT01750346|454580684|FG002|Overall Study|Adverse Event|0|||
126352257|NCT02034591|454580685|FG000|Overall Study|Withdrawal by Subject|0|||
126352258|NCT02034591|454580686|FG001|Overall Study|Withdrawal by Subject|0|||
126352259|NCT02034591|454580687|FG002|Overall Study|Withdrawal by Subject|0|||
126021205|NCT04149002|453373203|FG001|Overall Study|Lost to Follow-up|0|||
126229232|NCT01628120|454130760|FG000|Overall Study|Withdrawal by Subject|7|||
126229233|NCT01628120|454130760|FG000|Overall Study|Adverse Event|12|||
126229234|NCT01628120|454130760|FG000|Overall Study|Lost to Follow-up|1|||
126229235|NCT01628120|454130760|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
126229236|NCT01628120|454130760|FG000|Overall Study|Non-compliant with Study Procedures|1|||
126352260|NCT02034591|454580688|FG003|Overall Study|Withdrawal by Subject|0|||
126021206|NCT04149002|453373202|FG000|Overall Study|Withdrawal by Subject|1|||
126229237|NCT01628120|454130760|FG000|Overall Study|Not Treated|3|||
126229238|NCT01628120|454130760|FG000|Overall Study|Sponsor Decision|5|||
126229239|NCT01628120|454130760|FG000|Overall Study|Switched Dialysis Method|2|||
126229240|NCT01628120|454130760|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
126229241|NCT01628120|454130760|FG000|Overall Study|Moved or Relocated|5|||
126229242|NCT01628120|454130760|FG000|Overall Study|Kidney Transplant|2|||
126229243|NCT01628120|454130760|FG000|Overall Study|Use of Standard of Care|1|||
126229244|NCT02232074|454130763|FG000|Overall Study|Withdrawal by Subject|5|||
126229245|NCT02232074|454130764|FG001|Overall Study|Withdrawal by Subject|3|||
126229246|NCT02232074|454130763|FG000|Overall Study|No legal concerns at baseline|36|||
126229247|NCT02232074|454130764|FG001|Overall Study|No legal concerns at baseline|41|||
126229248|NCT02232074|454130763|FG000|Overall Study|deemed ineligible|0|||
126229249|NCT02232074|454130764|FG001|Overall Study|deemed ineligible|1|||
126229250|NCT01579474|454130767|FG000|Overall Study|Adverse Event|1|||
126229251|NCT01579474|454130768|FG001|Overall Study|Adverse Event|13|||
126229252|NCT01579474|454130769|FG002|Overall Study|Adverse Event|2|||
126229253|NCT01579474|454130770|FG003|Overall Study|Adverse Event|0|||
126229254|NCT01579474|454130771|FG004|Overall Study|Adverse Event|0|||
126229255|NCT01579474|454130772|FG005|Overall Study|Adverse Event|1|||
126229256|NCT01579474|454130767|FG000|Overall Study|Lack of Efficacy|1|||
126229257|NCT01579474|454130768|FG001|Overall Study|Lack of Efficacy|0|||
126229258|NCT01579474|454130769|FG002|Overall Study|Lack of Efficacy|0|||
126229259|NCT01579474|454130770|FG003|Overall Study|Lack of Efficacy|0|||
126229260|NCT01579474|454130771|FG004|Overall Study|Lack of Efficacy|1|||
126229261|NCT01579474|454130772|FG005|Overall Study|Lack of Efficacy|0|||
126093031|NCT02040584|453634476|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126229262|NCT01579474|454130767|FG000|Overall Study|Withdrawal by Subject|1|||
126229263|NCT01579474|454130768|FG001|Overall Study|Withdrawal by Subject|0|||
126229264|NCT01579474|454130769|FG002|Overall Study|Withdrawal by Subject|0|||
126229265|NCT01579474|454130770|FG003|Overall Study|Withdrawal by Subject|0|||
126229266|NCT01579474|454130771|FG004|Overall Study|Withdrawal by Subject|0|||
126093032|NCT02040584|453634477|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126093033|NCT02040584|453634476|FG000|Overall Study|Death|6|||
126021207|NCT04149002|453373203|FG001|Overall Study|Withdrawal by Subject|0|||
126021208|NCT04629950|453373204|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
126021209|NCT04629950|453373205|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
126021210|NCT04629950|453373206|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
126021211|NCT04629950|453373207|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
126021212|NCT04629950|453373204|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
126021213|NCT04629950|453373205|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
126021214|NCT04629950|453373206|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
126021215|NCT04629950|453373207|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
126021216|NCT04629950|453373204|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
126021217|NCT04629950|453373205|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
126021218|NCT04629950|453373206|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
126021219|NCT04629950|453373207|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
126021220|NCT04629950|453373204|FG000|Extension Study|Withdrawal by Subject|0|||
126021221|NCT04629950|453373205|FG001|Extension Study|Withdrawal by Subject|0|||
126021222|NCT04629950|453373206|FG002|Extension Study|Withdrawal by Subject|1|||
126021223|NCT04629950|453373207|FG003|Extension Study|Withdrawal by Subject|0|||
126021224|NCT04629950|453373204|FG000|Extension Study|Adverse Event|0|||
126021225|NCT04629950|453373205|FG001|Extension Study|Adverse Event|0|||
126021226|NCT04629950|453373206|FG002|Extension Study|Adverse Event|0|||
126021227|NCT04629950|453373207|FG003|Extension Study|Adverse Event|1|||
126021228|NCT03233633|453373208|FG000|Overall Study|Adverse Event|2|||
126021229|NCT03233633|453373208|FG000|Overall Study|Less Than 3 Days of Data|6|||
126021230|NCT02088853|453373209|FG000|Overall Study|Pregnancy|1|||
126021231|NCT02088853|453373210|FG001|Overall Study|Pregnancy|0|||
126021232|NCT01198145|453373212|FG000|Overall Study|Withdrawal by Subject|1|||
126021233|NCT01198145|453373213|FG001|Overall Study|Withdrawal by Subject|1|||
126021234|NCT01697969|453373216|FG000|Overall Study|Did not meet inc/exc criteria|3|||
126021235|NCT01561989|453373217|FG000|Overall Study|accural target not met.|5|||
126021236|NCT01561989|453373218|FG001|Overall Study|accural target not met.|6|||
126021237|NCT03447249|453373221|FG000|Overall Study|Adverse Event|1|||
126021238|NCT03447249|453373222|FG001|Overall Study|Adverse Event|0|||
126021239|NCT03447249|453373221|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
126021240|NCT03447249|453373222|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
126021241|NCT03447249|453373221|FG000|Overall Study|Other|3|||
126021242|NCT03447249|453373222|FG001|Overall Study|Other|0|||
126021243|NCT04814186|453375302|FG000|Treatment Phase|Adverse Event|1|||
126021244|NCT04814186|453375302|FG000|Treatment Phase|Death|6|||
126021245|NCT04814186|453375302|FG000|Treatment Phase|Withdrawal by Subject|2|||
126021246|NCT04814186|453375302|FG000|Treatment Phase|Other|1|||
126021247|NCT04814186|453375302|FG000|Follow-Up Phase|Adverse Event|1|||
126021248|NCT04814186|453375302|FG000|Follow-Up Phase|Death|6|||
126021249|NCT04814186|453375302|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
126021250|NCT04814186|453375302|FG000|Follow-Up Phase|Other|1|||
126021251|NCT04043455|453375317|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
126021252|NCT04043455|453375318|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
126021253|NCT04043455|453375319|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
126021254|NCT04043455|453375320|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
126093034|NCT02040584|453634477|FG001|Overall Study|Death|3|||
126093035|NCT02040584|453634476|FG000|Overall Study|Transplant rejection/retransplant|0|||
126093036|NCT02040584|453634477|FG001|Overall Study|Transplant rejection/retransplant|1|||
126093037|NCT02040584|453634476|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
126093038|NCT02040584|453634477|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
126093039|NCT00996476|453634478|FG000|Overall Study|Withdrawal by Subject|1|||
126093040|NCT00996476|453634479|FG001|Overall Study|Withdrawal by Subject|2|||
126093041|NCT00996476|453634480|FG002|Overall Study|Withdrawal by Subject|1|||
126093042|NCT00996476|453634481|FG003|Overall Study|Withdrawal by Subject|0|||
126093043|NCT00996476|453634482|FG004|Overall Study|Withdrawal by Subject|1|||
126093044|NCT00996476|453634478|FG000|Overall Study|Adverse Event|0|||
126093045|NCT00996476|453634479|FG001|Overall Study|Adverse Event|1|||
126093046|NCT00996476|453634480|FG002|Overall Study|Adverse Event|0|||
126093047|NCT00996476|453634481|FG003|Overall Study|Adverse Event|0|||
126093048|NCT00996476|453634482|FG004|Overall Study|Adverse Event|1|||
126093049|NCT05540717|453634483|FG000|Overall Study|Lost to Follow-up|2|||
126093050|NCT05540717|453634484|FG001|Overall Study|Lost to Follow-up|5|||
126352261|NCT02034591|454580689|FG004|Overall Study|Withdrawal by Subject|1|||
126352262|NCT02034591|454580690|FG005|Overall Study|Withdrawal by Subject|0|||
126352263|NCT01121926|454580693|FG000|First Intervention Period|Adverse Event|1|||
126021255|NCT04043455|453375321|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
126021256|NCT04043455|453375322|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
126021257|NCT04043455|453375317|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
126021258|NCT04043455|453375318|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
126021259|NCT04043455|453375319|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
126229267|NCT01579474|454130772|FG005|Overall Study|Withdrawal by Subject|0|||
126229268|NCT00130520|454130773|FG000|Overall Study|Adverse Event|11|||
126229269|NCT00130520|454130773|FG000|Overall Study|Death|1|||
126229270|NCT00130520|454130773|FG000|Overall Study|Physician Decision|1|||
126229271|NCT00130520|454130773|FG000|Overall Study|Withdrawal by Subject|1|||
126229272|NCT00130520|454130773|FG000|Overall Study|Disease Progression|23|||
126021260|NCT04043455|453375320|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
126021261|NCT04043455|453375321|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
126021262|NCT04043455|453375322|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
126021263|NCT04043455|453375317|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
126229273|NCT00130520|454130773|FG000|Overall Study|Protocol non-compliance|1|||
126021264|NCT04043455|453375318|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
126021265|NCT04043455|453375319|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
126021266|NCT04043455|453375320|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
126021267|NCT04043455|453375321|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
126021268|NCT04043455|453375322|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
126021269|NCT04043455|453375317|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
126021270|NCT04043455|453375318|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
126021271|NCT04043455|453375319|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
126021272|NCT04043455|453375320|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
126021273|NCT04043455|453375321|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
126021274|NCT04043455|453375322|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
126021275|NCT04043455|453375317|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126021276|NCT04043455|453375318|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
126021277|NCT04043455|453375319|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126021278|NCT04043455|453375320|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126021279|NCT04043455|453375321|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126021280|NCT04043455|453375322|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126021281|NCT04043455|453375317|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
126021282|NCT04043455|453375318|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126021283|NCT04043455|453375319|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126021284|NCT04043455|453375320|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126021285|NCT04043455|453375321|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126021286|NCT04043455|453375322|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126021287|NCT04043455|453375317|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126021288|NCT04043455|453375318|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
126021289|NCT04043455|453375319|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126021290|NCT04043455|453375320|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126021291|NCT04043455|453375321|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126021292|NCT04043455|453375322|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126021293|NCT04043455|453375317|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
126021294|NCT04043455|453375318|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
126021295|NCT04043455|453375319|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
126021296|NCT04043455|453375320|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
126021297|NCT04043455|453375321|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
126021298|NCT04043455|453375322|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
126021299|NCT04043455|453375317|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
126021300|NCT04043455|453375318|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
126021301|NCT04043455|453375319|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
126021302|NCT04043455|453375320|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
126021303|NCT04043455|453375321|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
126021304|NCT04043455|453375322|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
126021305|NCT04043455|453375317|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126021306|NCT04043455|453375318|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126021307|NCT04043455|453375319|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126021308|NCT04043455|453375320|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126021309|NCT04043455|453375321|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
126021310|NCT04043455|453375322|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126021311|NCT04043455|453375317|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
126021312|NCT04043455|453375318|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
126021313|NCT04043455|453375319|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
126021314|NCT04043455|453375320|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
126021315|NCT04043455|453375321|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
126021316|NCT04043455|453375322|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
126021317|NCT05194917|453375323|FG000|Overall Study|Lost to Follow-up|7|||
126021318|NCT05194917|453375324|FG001|Overall Study|Lost to Follow-up|5|||
126021319|NCT05194917|453375325|FG002|Overall Study|Lost to Follow-up|6|||
126021320|NCT05194917|453375326|FG003|Overall Study|Lost to Follow-up|5|||
126021321|NCT04922021|453375331|FG000|Overall Study|Withdrawal by Subject|4|||
126021322|NCT04922021|453375332|FG001|Overall Study|Withdrawal by Subject|10|||
126021323|NCT04922021|453375331|FG000|Overall Study|Adverse Event|2|||
126021324|NCT04922021|453375332|FG001|Overall Study|Adverse Event|2|||
126021325|NCT04922021|453375331|FG000|Overall Study|Lack of Efficacy|0|||
126093051|NCT05540717|453634483|FG000|Overall Study|Withdrawal by Subject|6|||
126093052|NCT05540717|453634484|FG001|Overall Study|Withdrawal by Subject|6|||
126021326|NCT04922021|453375332|FG001|Overall Study|Lack of Efficacy|1|||
126021327|NCT04922021|453375331|FG000|Overall Study|Multiple reasons|1|||
126021328|NCT04922021|453375332|FG001|Overall Study|Multiple reasons|0|||
126021329|NCT02544074|453375344|FG000|Overall Study|Withdrawal by Subject|0|||
126021330|NCT02544074|453375345|FG001|Overall Study|Withdrawal by Subject|1|||
126021331|NCT02544074|453375346|FG002|Overall Study|Withdrawal by Subject|0|||
126021332|NCT02544074|453375347|FG003|Overall Study|Withdrawal by Subject|0|||
126021333|NCT02544074|453375348|FG004|Overall Study|Withdrawal by Subject|0|||
126021334|NCT02544074|453375349|FG005|Overall Study|Withdrawal by Subject|0|||
126021335|NCT02544074|453375350|FG006|Overall Study|Withdrawal by Subject|0|||
126021336|NCT02544074|453375351|FG007|Overall Study|Withdrawal by Subject|0|||
126021337|NCT02544074|453375352|FG008|Overall Study|Withdrawal by Subject|0|||
126021338|NCT02544074|453375353|FG009|Overall Study|Withdrawal by Subject|0|||
126021339|NCT02544074|453375354|FG010|Overall Study|Withdrawal by Subject|0|||
126021340|NCT02544074|453375355|FG011|Overall Study|Withdrawal by Subject|0|||
126021341|NCT02544074|453375356|FG012|Overall Study|Withdrawal by Subject|0|||
126021342|NCT02544074|453375357|FG013|Overall Study|Withdrawal by Subject|0|||
126021343|NCT02544074|453375358|FG014|Overall Study|Withdrawal by Subject|0|||
126021344|NCT02544074|453375359|FG015|Overall Study|Withdrawal by Subject|0|||
126021345|NCT02544074|453375360|FG016|Overall Study|Withdrawal by Subject|0|||
126021346|NCT02544074|453375361|FG017|Overall Study|Withdrawal by Subject|0|||
126021347|NCT02544074|453375362|FG018|Overall Study|Withdrawal by Subject|0|||
126021348|NCT02544074|453375363|FG019|Overall Study|Withdrawal by Subject|0|||
126021349|NCT02544074|453375364|FG020|Overall Study|Withdrawal by Subject|0|||
126021350|NCT02544074|453375344|FG000|Overall Study|Tablet error|0|||
126021351|NCT02544074|453375345|FG001|Overall Study|Tablet error|0|||
126021352|NCT02544074|453375346|FG002|Overall Study|Tablet error|0|||
126021353|NCT02544074|453375347|FG003|Overall Study|Tablet error|0|||
126021354|NCT02544074|453375348|FG004|Overall Study|Tablet error|0|||
126021355|NCT02544074|453375349|FG005|Overall Study|Tablet error|1|||
126021356|NCT02544074|453375350|FG006|Overall Study|Tablet error|0|||
126021357|NCT02544074|453375351|FG007|Overall Study|Tablet error|0|||
126021358|NCT02544074|453375352|FG008|Overall Study|Tablet error|0|||
126021359|NCT02544074|453375353|FG009|Overall Study|Tablet error|1|||
126021360|NCT02544074|453375354|FG010|Overall Study|Tablet error|0|||
126021361|NCT02544074|453375355|FG011|Overall Study|Tablet error|0|||
126021362|NCT02544074|453375356|FG012|Overall Study|Tablet error|0|||
126021363|NCT02544074|453375357|FG013|Overall Study|Tablet error|0|||
126021364|NCT02544074|453375358|FG014|Overall Study|Tablet error|0|||
126021365|NCT02544074|453375359|FG015|Overall Study|Tablet error|0|||
126021366|NCT02544074|453375360|FG016|Overall Study|Tablet error|0|||
126021367|NCT02544074|453375361|FG017|Overall Study|Tablet error|0|||
126021368|NCT02544074|453375362|FG018|Overall Study|Tablet error|0|||
126021369|NCT02544074|453375363|FG019|Overall Study|Tablet error|0|||
126021370|NCT02544074|453375364|FG020|Overall Study|Tablet error|0|||
126021371|NCT03189524|453375365|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
126021372|NCT03189524|453375366|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
126021373|NCT03189524|453375367|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
126021374|NCT03189524|453375365|FG000|Overall Study|Death|2|||
126021375|NCT03189524|453375366|FG001|Overall Study|Death|2|||
126021376|NCT03189524|453375367|FG002|Overall Study|Death|1|||
126021377|NCT03189524|453375365|FG000|Overall Study|Lost to Follow-up|1|||
126021378|NCT03189524|453375366|FG001|Overall Study|Lost to Follow-up|0|||
126021379|NCT03189524|453375367|FG002|Overall Study|Lost to Follow-up|8|||
126021380|NCT03189524|453375365|FG000|Overall Study|Withdrawal by Subject|1|||
126021381|NCT03189524|453375366|FG001|Overall Study|Withdrawal by Subject|1|||
126021382|NCT03189524|453375367|FG002|Overall Study|Withdrawal by Subject|3|||
126021383|NCT03189524|453375365|FG000|Overall Study|Progressive Disease|0|||
126093053|NCT05540717|453634483|FG000|Overall Study|Sponsor request|1|||
126229274|NCT00130520|454130773|FG000|Overall Study|Did not meet re-treatment criteria|1|||
126229275|NCT03083483|454130780|FG000|Overall Study|Adverse Event|1|||
126229276|NCT03083483|454130781|FG001|Overall Study|Adverse Event|1|||
126229277|NCT03083483|454130782|FG002|Overall Study|Adverse Event|1|||
126229278|NCT03083483|454130780|FG000|Overall Study|Lost to Follow-up|2|||
126229279|NCT03083483|454130781|FG001|Overall Study|Lost to Follow-up|1|||
126093054|NCT05540717|453634484|FG001|Overall Study|Sponsor request|0|||
126093055|NCT05540717|453634483|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
126229280|NCT03083483|454130782|FG002|Overall Study|Lost to Follow-up|1|||
126021384|NCT03189524|453375366|FG001|Overall Study|Progressive Disease|2|||
126021385|NCT03189524|453375367|FG002|Overall Study|Progressive Disease|0|||
126021386|NCT02723955|453375368|FG000|Escalation Phase|Death|1|||
126021387|NCT02723955|453375369|FG001|Escalation Phase|Death|1|||
126021388|NCT02723955|453375370|FG002|Escalation Phase|Death|2|||
126021389|NCT02723955|453375371|FG003|Escalation Phase|Death|7|||
126021390|NCT02723955|453375372|FG004|Escalation Phase|Death|18|||
126021391|NCT02723955|453375373|FG005|Escalation Phase|Death|17|||
126021392|NCT02723955|453375374|FG006|Escalation Phase|Death|11|||
126352264|NCT01121926|454580694|FG001|First Intervention Period|Adverse Event|0|||
126352265|NCT01121926|454580693|FG000|Washout Period|Adverse Event|0|||
126352266|NCT01121926|454580694|FG001|Washout Period|Adverse Event|1|||
126352267|NCT01121926|454580693|FG000|Washout Period|Positive pregnancy test|0|||
126352268|NCT01121926|454580694|FG001|Washout Period|Positive pregnancy test|1|||
126021393|NCT02723955|453375375|FG007|Escalation Phase|Death|21|||
126229281|NCT03083483|454130780|FG000|Overall Study|technological issues|1|||
126229282|NCT03083483|454130781|FG001|Overall Study|technological issues|0|||
126229283|NCT03083483|454130782|FG002|Overall Study|technological issues|1|||
126229284|NCT01673009|454130783|FG000|Overall Study|Physician Decision|5|||
126229285|NCT01673009|454130783|FG000|Overall Study|Withdrawal by Subject|8|||
126229286|NCT02398188|454130786|FG000|Overall Study|Adverse Event|2|||
126229287|NCT02398188|454130787|FG001|Overall Study|Adverse Event|3|||
126229288|NCT02398188|454130786|FG000|Overall Study|Lost to Follow-up|5|||
126229289|NCT02398188|454130787|FG001|Overall Study|Lost to Follow-up|0|||
126229290|NCT02398188|454130786|FG000|Overall Study|Non-compliance|4|||
126229291|NCT02398188|454130787|FG001|Overall Study|Non-compliance|4|||
126229292|NCT02398188|454130786|FG000|Overall Study|Protocol Violation|6|||
126229293|NCT02398188|454130787|FG001|Overall Study|Protocol Violation|10|||
126229294|NCT02398188|454130786|FG000|Overall Study|Sponsor Decision|2|||
126229295|NCT02398188|454130787|FG001|Overall Study|Sponsor Decision|1|||
126229296|NCT02398188|454130786|FG000|Overall Study|Pregnancy|1|||
126229297|NCT02398188|454130787|FG001|Overall Study|Pregnancy|0|||
126229298|NCT02398188|454130786|FG000|Overall Study|Withdrawal by Subject|7|||
126352269|NCT00416949|454580695|FG000|Overall Study|Patients refused to participate|5|||
126352270|NCT02782468|454580696|FG000|Overall Study|Progressive Disease|2|||
126352271|NCT02782468|454580697|FG001|Overall Study|Progressive Disease|5|||
126352272|NCT02782468|454580698|FG002|Overall Study|Progressive Disease|0|||
126229299|NCT02398188|454130787|FG001|Overall Study|Withdrawal by Subject|16|||
126352273|NCT02782468|454580699|FG003|Overall Study|Progressive Disease|4|||
126352274|NCT02782468|454580696|FG000|Overall Study|Adverse Event|0|||
126352275|NCT02782468|454580697|FG001|Overall Study|Adverse Event|2|||
126352276|NCT02782468|454580698|FG002|Overall Study|Adverse Event|2|||
126352277|NCT02782468|454580699|FG003|Overall Study|Adverse Event|3|||
126352278|NCT02782468|454580696|FG000|Overall Study|Other|0|||
126352279|NCT02782468|454580697|FG001|Overall Study|Other|0|||
126352280|NCT02782468|454580698|FG002|Overall Study|Other|1|||
126352281|NCT02782468|454580699|FG003|Overall Study|Other|1|||
126352282|NCT02782468|454580696|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
126352283|NCT02782468|454580697|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
126352284|NCT02782468|454580698|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
126352285|NCT02782468|454580699|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
126352286|NCT02782468|454580696|FG000|Overall Study|Symptomatic Deterioration|0|||
126229300|NCT00782509|454130788|FG000|Overall Study|Adverse Event|20|||
126229301|NCT00782509|454130789|FG001|Overall Study|Adverse Event|10|||
126352287|NCT02782468|454580697|FG001|Overall Study|Symptomatic Deterioration|0|||
126352288|NCT02782468|454580698|FG002|Overall Study|Symptomatic Deterioration|0|||
126352289|NCT02782468|454580699|FG003|Overall Study|Symptomatic Deterioration|1|||
126103461|NCT04620811|453672168|FG001|Overall Study|Withdrawal by Subject|15|||
126229302|NCT00782509|454130790|FG002|Overall Study|Adverse Event|20|||
126229303|NCT00782509|454130788|FG000|Overall Study|Lost to Follow-up|1|||
126229304|NCT00782509|454130789|FG001|Overall Study|Lost to Follow-up|2|||
126021394|NCT02723955|453375376|FG008|Escalation Phase|Death|3|||
126021395|NCT02723955|453375377|FG009|Escalation Phase|Death|0|||
126021396|NCT02723955|453375378|FG010|Escalation Phase|Death|0|||
126021397|NCT02723955|453375379|FG011|Escalation Phase|Death|0|||
126021398|NCT02723955|453375380|FG012|Escalation Phase|Death|2|||
126021399|NCT02723955|453375381|FG013|Escalation Phase|Death|4|||
126021400|NCT02723955|453375382|FG014|Escalation Phase|Death|5|||
126021401|NCT02723955|453375383|FG015|Escalation Phase|Death|6|||
126021402|NCT02723955|453375384|FG016|Escalation Phase|Death|6|||
126021403|NCT02723955|453375385|FG017|Escalation Phase|Death|7|||
126021404|NCT02723955|453375386|FG018|Escalation Phase|Death|1|||
126021405|NCT02723955|453375387|FG019|Escalation Phase|Death|3|||
126021406|NCT02723955|453375388|FG020|Escalation Phase|Death|13|||
126021407|NCT02723955|453375389|FG021|Escalation Phase|Death|3|||
126021408|NCT02723955|453375390|FG022|Escalation Phase|Death|2|||
126021409|NCT02723955|453375391|FG023|Escalation Phase|Death|4|||
126021410|NCT02723955|453375392|FG024|Escalation Phase|Death|31|||
126021411|NCT02723955|453375393|FG025|Escalation Phase|Death|7|||
126021412|NCT02723955|453375394|FG026|Escalation Phase|Death|13|||
126229305|NCT00782509|454130790|FG002|Overall Study|Lost to Follow-up|3|||
126229306|NCT00782509|454130788|FG000|Overall Study|Withdrawal by Subject|3|||
126229307|NCT00782509|454130789|FG001|Overall Study|Withdrawal by Subject|5|||
126229308|NCT00782509|454130790|FG002|Overall Study|Withdrawal by Subject|8|||
126229309|NCT00782509|454130788|FG000|Overall Study|Non compliance with protocol|2|||
126021413|NCT02723955|453375395|FG027|Escalation Phase|Death|0|||
126021414|NCT02723955|453375396|FG028|Escalation Phase|Death|1|||
126021415|NCT02723955|453375397|FG029|Escalation Phase|Death|0|||
126021416|NCT02723955|453375398|FG030|Escalation Phase|Death|0|||
126021417|NCT02723955|453375399|FG031|Escalation Phase|Death|0|||
126021418|NCT02723955|453375400|FG032|Escalation Phase|Death|0|||
126021419|NCT02723955|453375401|FG033|Escalation Phase|Death|0|||
126021420|NCT02723955|453375402|FG034|Escalation Phase|Death|0|||
126021421|NCT02723955|453375403|FG035|Escalation Phase|Death|0|||
126021422|NCT02723955|453375404|FG036|Escalation Phase|Death|0|||
126021423|NCT02723955|453375405|FG037|Escalation Phase|Death|0|||
126021424|NCT02723955|453375406|FG038|Escalation Phase|Death|0|||
126021425|NCT02723955|453375407|FG039|Escalation Phase|Death|0|||
126021426|NCT02723955|453375408|FG040|Escalation Phase|Death|0|||
126021427|NCT02723955|453375409|FG041|Escalation Phase|Death|0|||
126021428|NCT02723955|453375410|FG042|Escalation Phase|Death|0|||
126021429|NCT02723955|453375368|FG000|Escalation Phase|Lost to Follow-up|0|||
126021430|NCT02723955|453375369|FG001|Escalation Phase|Lost to Follow-up|0|||
126021431|NCT02723955|453375370|FG002|Escalation Phase|Lost to Follow-up|0|||
126021432|NCT02723955|453375371|FG003|Escalation Phase|Lost to Follow-up|0|||
126021433|NCT02723955|453375372|FG004|Escalation Phase|Lost to Follow-up|0|||
126021434|NCT02723955|453375373|FG005|Escalation Phase|Lost to Follow-up|2|||
126021435|NCT02723955|453375374|FG006|Escalation Phase|Lost to Follow-up|1|||
126021436|NCT02723955|453375375|FG007|Escalation Phase|Lost to Follow-up|1|||
126021437|NCT02723955|453375376|FG008|Escalation Phase|Lost to Follow-up|1|||
126021438|NCT02723955|453375377|FG009|Escalation Phase|Lost to Follow-up|0|||
126021439|NCT02723955|453375378|FG010|Escalation Phase|Lost to Follow-up|0|||
126021440|NCT02723955|453375379|FG011|Escalation Phase|Lost to Follow-up|0|||
126021441|NCT02723955|453375380|FG012|Escalation Phase|Lost to Follow-up|1|||
126021442|NCT02723955|453375381|FG013|Escalation Phase|Lost to Follow-up|0|||
126021443|NCT02723955|453375382|FG014|Escalation Phase|Lost to Follow-up|0|||
126021444|NCT02723955|453375383|FG015|Escalation Phase|Lost to Follow-up|0|||
126021445|NCT02723955|453375384|FG016|Escalation Phase|Lost to Follow-up|1|||
126021446|NCT02723955|453375385|FG017|Escalation Phase|Lost to Follow-up|2|||
126021447|NCT02723955|453375386|FG018|Escalation Phase|Lost to Follow-up|0|||
126021448|NCT02723955|453375387|FG019|Escalation Phase|Lost to Follow-up|1|||
126021449|NCT02723955|453375388|FG020|Escalation Phase|Lost to Follow-up|2|||
126229310|NCT00782509|454130789|FG001|Overall Study|Non compliance with protocol|0|||
126229311|NCT00782509|454130790|FG002|Overall Study|Non compliance with protocol|0|||
126229312|NCT00782509|454130788|FG000|Overall Study|Other reasons not stated above|5|||
126229313|NCT00782509|454130789|FG001|Overall Study|Other reasons not stated above|2|||
126229314|NCT00782509|454130790|FG002|Overall Study|Other reasons not stated above|3|||
126229315|NCT00782509|454130788|FG000|Overall Study|Lack of Efficacy|10|||
126229316|NCT00782509|454130789|FG001|Overall Study|Lack of Efficacy|5|||
126021450|NCT02723955|453375389|FG021|Escalation Phase|Lost to Follow-up|1|||
126021451|NCT02723955|453375390|FG022|Escalation Phase|Lost to Follow-up|0|||
126021452|NCT02723955|453375391|FG023|Escalation Phase|Lost to Follow-up|0|||
126021453|NCT02723955|453375392|FG024|Escalation Phase|Lost to Follow-up|1|||
126021454|NCT02723955|453375393|FG025|Escalation Phase|Lost to Follow-up|1|||
126021455|NCT02723955|453375394|FG026|Escalation Phase|Lost to Follow-up|3|||
126021456|NCT02723955|453375395|FG027|Escalation Phase|Lost to Follow-up|0|||
126021457|NCT02723955|453375396|FG028|Escalation Phase|Lost to Follow-up|1|||
126021458|NCT02723955|453375397|FG029|Escalation Phase|Lost to Follow-up|0|||
126021459|NCT02723955|453375398|FG030|Escalation Phase|Lost to Follow-up|0|||
126021460|NCT02723955|453375399|FG031|Escalation Phase|Lost to Follow-up|0|||
126021461|NCT02723955|453375400|FG032|Escalation Phase|Lost to Follow-up|0|||
126229317|NCT00782509|454130790|FG002|Overall Study|Lack of Efficacy|2|||
126229318|NCT04041570|454130795|FG000|Overall Study|Moved from Area|0|||
126229319|NCT04041570|454130796|FG001|Overall Study|Moved from Area|2|||
126229320|NCT00384033|454130799|FG000|Overall Study|Adverse Event|10|||
126352290|NCT02782468|454580696|FG000|Overall Study|Withdrawal by Subject|1|||
126352291|NCT02782468|454580697|FG001|Overall Study|Withdrawal by Subject|0|||
126352292|NCT02782468|454580698|FG002|Overall Study|Withdrawal by Subject|0|||
126352293|NCT02782468|454580699|FG003|Overall Study|Withdrawal by Subject|0|||
126352294|NCT01410604|454580701|FG000|Overall Study|Adverse Event|2|||
126352295|NCT01410604|454580702|FG001|Overall Study|Adverse Event|1|||
126352296|NCT01410604|454580701|FG000|Overall Study|Lost to Follow-up|1|||
126352297|NCT01410604|454580702|FG001|Overall Study|Lost to Follow-up|0|||
126352298|NCT01410604|454580701|FG000|Overall Study|Physician Decision|0|||
126352299|NCT01410604|454580702|FG001|Overall Study|Physician Decision|1|||
126352300|NCT00356590|454580703|FG000|Overall Study|Adverse Event|54|||
126352301|NCT00356590|454580703|FG000|Overall Study|Death|10|||
126352302|NCT00356590|454580703|FG000|Overall Study|Lost to Follow-up|35|||
126352303|NCT00356590|454580703|FG000|Overall Study|Physician Decision|46|||
126352304|NCT00356590|454580703|FG000|Overall Study|Withdrawal by Subject|41|||
126352305|NCT00356590|454580703|FG000|Overall Study|Completed month 12 only|2|||
126352306|NCT00356590|454580703|FG000|Overall Study|Protocol issues|6|||
126352307|NCT00356590|454580703|FG000|Overall Study|Response status|28|||
126352308|NCT00356590|454580703|FG000|Overall Study|Other|52|||
126352309|NCT00898807|454580711|FG000|Overall Study|Withdrawal by Subject|5|||
126352310|NCT00898807|454580712|FG001|Overall Study|Withdrawal by Subject|3|||
126352311|NCT00898807|454580711|FG000|Overall Study|Family pressure to discontinue|2|||
126352312|NCT00898807|454580712|FG001|Overall Study|Family pressure to discontinue|2|||
126352313|NCT00898807|454580711|FG000|Overall Study|Lost to Follow-up|1|||
126352314|NCT00898807|454580712|FG001|Overall Study|Lost to Follow-up|3|||
126352315|NCT00898807|454580711|FG000|Overall Study|Death|0|||
126352316|NCT00898807|454580712|FG001|Overall Study|Death|1|||
126352317|NCT04919161|454580713|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
126352318|NCT04919161|454580714|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
126352319|NCT04919161|454580713|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
126352320|NCT04919161|454580714|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
126352321|NCT04919161|454580713|FG000|Overall Study|Acute ankle sprain after session 1|0|||
126352322|NCT04919161|454580714|FG001|Overall Study|Acute ankle sprain after session 1|1|||
126352323|NCT00712920|454580715|FG000|Overall Study|Adverse Event|3|||
126352324|NCT00712920|454580716|FG001|Overall Study|Adverse Event|4|||
126352325|NCT00712920|454580717|FG002|Overall Study|Adverse Event|7|||
126352326|NCT00712920|454580715|FG000|Overall Study|Withdrawal by Subject|4|||
126352327|NCT00712920|454580716|FG001|Overall Study|Withdrawal by Subject|2|||
126352328|NCT00712920|454580717|FG002|Overall Study|Withdrawal by Subject|1|||
126352329|NCT00712920|454580715|FG000|Overall Study|Lost to Follow-up|1|||
126352330|NCT00712920|454580716|FG001|Overall Study|Lost to Follow-up|4|||
126352331|NCT00712920|454580717|FG002|Overall Study|Lost to Follow-up|0|||
126352332|NCT00712920|454580715|FG000|Overall Study|Lack of Efficacy|1|||
126352333|NCT00712920|454580716|FG001|Overall Study|Lack of Efficacy|0|||
126352334|NCT00712920|454580717|FG002|Overall Study|Lack of Efficacy|1|||
126352335|NCT00712920|454580715|FG000|Overall Study|Other|5|||
126352336|NCT00712920|454580716|FG001|Overall Study|Other|7|||
126352337|NCT00712920|454580717|FG002|Overall Study|Other|3|||
126352338|NCT00712920|454580715|FG000|Overall Study|Non-compliance|3|||
126352339|NCT00712920|454580716|FG001|Overall Study|Non-compliance|0|||
126352340|NCT00712920|454580717|FG002|Overall Study|Non-compliance|0|||
126352341|NCT02489773|454580718|FG000|Overall Study|Lost to Follow-up|4|||
126352342|NCT02489773|454580719|FG001|Overall Study|Lost to Follow-up|1|||
126352343|NCT02489773|454580718|FG000|Overall Study|Physician Decision|1|||
126352344|NCT02489773|454580719|FG001|Overall Study|Physician Decision|0|||
126352345|NCT02489773|454580718|FG000|Overall Study|Withdrawal by Subject|1|||
126352346|NCT02489773|454580719|FG001|Overall Study|Withdrawal by Subject|0|||
126352347|NCT02489773|454580718|FG000|Overall Study|Leave the country or the state|1|||
126352348|NCT02489773|454580719|FG001|Overall Study|Leave the country or the state|1|||
126352349|NCT02115386|454580722|FG000|Overall Study|Protocol Violation|1|||
126352350|NCT02115386|454580722|FG000|Overall Study|Administrative - trial was terminated|6|||
126352351|NCT02493855|454580723|FG000|Overall Study|Non-compliance|1|||
126352352|NCT02493855|454580724|FG001|Overall Study|Non-compliance|0|||
126352353|NCT02493855|454580725|FG002|Overall Study|Non-compliance|0|||
126352354|NCT02493855|454580723|FG000|Overall Study|Adverse Event|0|||
126352355|NCT02493855|454580724|FG001|Overall Study|Adverse Event|1|||
126229321|NCT00384033|454130800|FG001|Overall Study|Adverse Event|8|||
126229322|NCT00384033|454130801|FG002|Overall Study|Adverse Event|11|||
126352356|NCT02493855|454580725|FG002|Overall Study|Adverse Event|0|||
126352357|NCT02493855|454580723|FG000|Overall Study|Withdrawal by Subject|1|||
126352358|NCT02493855|454580724|FG001|Overall Study|Withdrawal by Subject|0|||
126021462|NCT02723955|453375401|FG033|Escalation Phase|Lost to Follow-up|0|||
126021463|NCT02723955|453375402|FG034|Escalation Phase|Lost to Follow-up|0|||
126021464|NCT02723955|453375403|FG035|Escalation Phase|Lost to Follow-up|0|||
126021465|NCT02723955|453375404|FG036|Escalation Phase|Lost to Follow-up|0|||
126021466|NCT02723955|453375405|FG037|Escalation Phase|Lost to Follow-up|0|||
126021467|NCT02723955|453375406|FG038|Escalation Phase|Lost to Follow-up|0|||
126021468|NCT02723955|453375407|FG039|Escalation Phase|Lost to Follow-up|0|||
126021469|NCT02723955|453375408|FG040|Escalation Phase|Lost to Follow-up|0|||
126021470|NCT02723955|453375409|FG041|Escalation Phase|Lost to Follow-up|0|||
126021471|NCT02723955|453375410|FG042|Escalation Phase|Lost to Follow-up|0|||
126021472|NCT02723955|453375368|FG000|Escalation Phase|Physician Decision|0|||
126021473|NCT02723955|453375369|FG001|Escalation Phase|Physician Decision|0|||
126021474|NCT02723955|453375370|FG002|Escalation Phase|Physician Decision|0|||
126021475|NCT02723955|453375371|FG003|Escalation Phase|Physician Decision|0|||
126021476|NCT02723955|453375372|FG004|Escalation Phase|Physician Decision|0|||
126021477|NCT02723955|453375373|FG005|Escalation Phase|Physician Decision|2|||
126021478|NCT02723955|453375374|FG006|Escalation Phase|Physician Decision|0|||
126021479|NCT02723955|453375375|FG007|Escalation Phase|Physician Decision|0|||
126021480|NCT02723955|453375376|FG008|Escalation Phase|Physician Decision|0|||
126021481|NCT02723955|453375377|FG009|Escalation Phase|Physician Decision|0|||
126021482|NCT02723955|453375378|FG010|Escalation Phase|Physician Decision|0|||
126021483|NCT02723955|453375379|FG011|Escalation Phase|Physician Decision|0|||
126021484|NCT02723955|453375380|FG012|Escalation Phase|Physician Decision|0|||
126021485|NCT02723955|453375381|FG013|Escalation Phase|Physician Decision|0|||
126021486|NCT02723955|453375382|FG014|Escalation Phase|Physician Decision|0|||
126021487|NCT02723955|453375383|FG015|Escalation Phase|Physician Decision|0|||
126021488|NCT02723955|453375384|FG016|Escalation Phase|Physician Decision|0|||
126021489|NCT02723955|453375385|FG017|Escalation Phase|Physician Decision|0|||
126021490|NCT02723955|453375386|FG018|Escalation Phase|Physician Decision|0|||
126021491|NCT02723955|453375387|FG019|Escalation Phase|Physician Decision|0|||
126021492|NCT02723955|453375388|FG020|Escalation Phase|Physician Decision|0|||
126021493|NCT02723955|453375389|FG021|Escalation Phase|Physician Decision|0|||
126021494|NCT02723955|453375390|FG022|Escalation Phase|Physician Decision|0|||
126021495|NCT02723955|453375391|FG023|Escalation Phase|Physician Decision|0|||
126021496|NCT02723955|453375392|FG024|Escalation Phase|Physician Decision|0|||
126229323|NCT00384033|454130802|FG003|Overall Study|Adverse Event|20|||
126229324|NCT00384033|454130799|FG000|Overall Study|Failed to return|1|||
126229325|NCT00384033|454130800|FG001|Overall Study|Failed to return|3|||
126229326|NCT00384033|454130801|FG002|Overall Study|Failed to return|2|||
126229327|NCT00384033|454130802|FG003|Overall Study|Failed to return|2|||
126229328|NCT00384033|454130799|FG000|Overall Study|Physician Decision|1|||
126229329|NCT00384033|454130800|FG001|Overall Study|Physician Decision|0|||
126229330|NCT00384033|454130801|FG002|Overall Study|Physician Decision|0|||
126229331|NCT00384033|454130802|FG003|Overall Study|Physician Decision|0|||
126229332|NCT00384033|454130799|FG000|Overall Study|Lost to Follow-up|6|||
126229333|NCT00384033|454130800|FG001|Overall Study|Lost to Follow-up|12|||
126229334|NCT00384033|454130801|FG002|Overall Study|Lost to Follow-up|7|||
126229335|NCT00384033|454130802|FG003|Overall Study|Lost to Follow-up|7|||
126229336|NCT00384033|454130799|FG000|Overall Study|Other|2|||
126229337|NCT00384033|454130800|FG001|Overall Study|Other|0|||
126229338|NCT00384033|454130801|FG002|Overall Study|Other|0|||
126229339|NCT00384033|454130802|FG003|Overall Study|Other|0|||
126229340|NCT00384033|454130799|FG000|Overall Study|Protocol Violation|5|||
126229341|NCT00384033|454130800|FG001|Overall Study|Protocol Violation|0|||
126229342|NCT00384033|454130801|FG002|Overall Study|Protocol Violation|5|||
126229343|NCT00384033|454130802|FG003|Overall Study|Protocol Violation|6|||
126229344|NCT00384033|454130799|FG000|Overall Study|Withdrawal by Subject|6|||
126229345|NCT00384033|454130800|FG001|Overall Study|Withdrawal by Subject|2|||
126229346|NCT00384033|454130801|FG002|Overall Study|Withdrawal by Subject|5|||
126229347|NCT00384033|454130802|FG003|Overall Study|Withdrawal by Subject|2|||
126229348|NCT00384033|454130799|FG000|Overall Study|Lack of Efficacy|7|||
126229349|NCT00384033|454130800|FG001|Overall Study|Lack of Efficacy|3|||
126229350|NCT00384033|454130801|FG002|Overall Study|Lack of Efficacy|3|||
126021497|NCT02723955|453375393|FG025|Escalation Phase|Physician Decision|0|||
126021498|NCT02723955|453375394|FG026|Escalation Phase|Physician Decision|2|||
126229351|NCT00384033|454130802|FG003|Overall Study|Lack of Efficacy|1|||
126021499|NCT02723955|453375395|FG027|Escalation Phase|Physician Decision|0|||
126021500|NCT02723955|453375396|FG028|Escalation Phase|Physician Decision|0|||
126021501|NCT02723955|453375397|FG029|Escalation Phase|Physician Decision|0|||
126021502|NCT02723955|453375398|FG030|Escalation Phase|Physician Decision|0|||
126021503|NCT02723955|453375399|FG031|Escalation Phase|Physician Decision|0|||
126021504|NCT02723955|453375400|FG032|Escalation Phase|Physician Decision|0|||
126021505|NCT02723955|453375401|FG033|Escalation Phase|Physician Decision|0|||
126229352|NCT00384033|454130799|FG000|Overall Study|Randomized but not treated|3|||
126229353|NCT00384033|454130800|FG001|Overall Study|Randomized but not treated|7|||
126021506|NCT02723955|453375402|FG034|Escalation Phase|Physician Decision|0|||
126229354|NCT00384033|454130801|FG002|Overall Study|Randomized but not treated|10|||
126229355|NCT00384033|454130802|FG003|Overall Study|Randomized but not treated|2|||
126021507|NCT02723955|453375403|FG035|Escalation Phase|Physician Decision|0|||
126021508|NCT02723955|453375404|FG036|Escalation Phase|Physician Decision|0|||
126021509|NCT02723955|453375405|FG037|Escalation Phase|Physician Decision|0|||
126021510|NCT02723955|453375406|FG038|Escalation Phase|Physician Decision|0|||
126021511|NCT02723955|453375407|FG039|Escalation Phase|Physician Decision|0|||
126021512|NCT02723955|453375408|FG040|Escalation Phase|Physician Decision|0|||
126021513|NCT02723955|453375409|FG041|Escalation Phase|Physician Decision|0|||
126021514|NCT02723955|453375410|FG042|Escalation Phase|Physician Decision|0|||
126021515|NCT02723955|453375368|FG000|Escalation Phase|Withdrawal by Subject|0|||
126021516|NCT02723955|453375369|FG001|Escalation Phase|Withdrawal by Subject|0|||
126021517|NCT02723955|453375370|FG002|Escalation Phase|Withdrawal by Subject|0|||
126021518|NCT02723955|453375371|FG003|Escalation Phase|Withdrawal by Subject|0|||
126021519|NCT02723955|453375372|FG004|Escalation Phase|Withdrawal by Subject|1|||
126021520|NCT02723955|453375373|FG005|Escalation Phase|Withdrawal by Subject|1|||
126021521|NCT02723955|453375374|FG006|Escalation Phase|Withdrawal by Subject|1|||
126021522|NCT02723955|453375375|FG007|Escalation Phase|Withdrawal by Subject|1|||
126021523|NCT02723955|453375376|FG008|Escalation Phase|Withdrawal by Subject|0|||
126021524|NCT02723955|453375377|FG009|Escalation Phase|Withdrawal by Subject|0|||
126021525|NCT02723955|453375378|FG010|Escalation Phase|Withdrawal by Subject|0|||
126021526|NCT02723955|453375379|FG011|Escalation Phase|Withdrawal by Subject|0|||
126021527|NCT02723955|453375380|FG012|Escalation Phase|Withdrawal by Subject|1|||
126021528|NCT02723955|453375381|FG013|Escalation Phase|Withdrawal by Subject|0|||
126021529|NCT02723955|453375382|FG014|Escalation Phase|Withdrawal by Subject|0|||
126021530|NCT02723955|453375383|FG015|Escalation Phase|Withdrawal by Subject|0|||
126021531|NCT02723955|453375384|FG016|Escalation Phase|Withdrawal by Subject|1|||
126021532|NCT02723955|453375385|FG017|Escalation Phase|Withdrawal by Subject|0|||
126021533|NCT02723955|453375386|FG018|Escalation Phase|Withdrawal by Subject|0|||
126021534|NCT02723955|453375387|FG019|Escalation Phase|Withdrawal by Subject|0|||
126021535|NCT02723955|453375388|FG020|Escalation Phase|Withdrawal by Subject|0|||
126021536|NCT02723955|453375389|FG021|Escalation Phase|Withdrawal by Subject|0|||
126021537|NCT02723955|453375390|FG022|Escalation Phase|Withdrawal by Subject|0|||
126021538|NCT02723955|453375391|FG023|Escalation Phase|Withdrawal by Subject|2|||
126021539|NCT02723955|453375392|FG024|Escalation Phase|Withdrawal by Subject|0|||
126021540|NCT02723955|453375393|FG025|Escalation Phase|Withdrawal by Subject|1|||
126021541|NCT02723955|453375394|FG026|Escalation Phase|Withdrawal by Subject|0|||
126021542|NCT02723955|453375395|FG027|Escalation Phase|Withdrawal by Subject|0|||
126021543|NCT02723955|453375396|FG028|Escalation Phase|Withdrawal by Subject|1|||
126021544|NCT02723955|453375397|FG029|Escalation Phase|Withdrawal by Subject|0|||
126021545|NCT02723955|453375398|FG030|Escalation Phase|Withdrawal by Subject|0|||
126021546|NCT02723955|453375399|FG031|Escalation Phase|Withdrawal by Subject|0|||
126021547|NCT02723955|453375400|FG032|Escalation Phase|Withdrawal by Subject|0|||
126021548|NCT02723955|453375401|FG033|Escalation Phase|Withdrawal by Subject|0|||
126021549|NCT02723955|453375402|FG034|Escalation Phase|Withdrawal by Subject|0|||
126021550|NCT02723955|453375403|FG035|Escalation Phase|Withdrawal by Subject|0|||
126021551|NCT02723955|453375404|FG036|Escalation Phase|Withdrawal by Subject|0|||
126021552|NCT02723955|453375405|FG037|Escalation Phase|Withdrawal by Subject|0|||
126021553|NCT02723955|453375406|FG038|Escalation Phase|Withdrawal by Subject|0|||
126021554|NCT02723955|453375407|FG039|Escalation Phase|Withdrawal by Subject|0|||
126021555|NCT02723955|453375408|FG040|Escalation Phase|Withdrawal by Subject|0|||
126021556|NCT02723955|453375409|FG041|Escalation Phase|Withdrawal by Subject|0|||
126021557|NCT02723955|453375410|FG042|Escalation Phase|Withdrawal by Subject|0|||
126021558|NCT02723955|453375368|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021559|NCT02723955|453375369|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021560|NCT02723955|453375370|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021561|NCT02723955|453375371|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021562|NCT02723955|453375372|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
126021563|NCT02723955|453375373|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
126021564|NCT02723955|453375374|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
126021565|NCT02723955|453375375|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
126021566|NCT02723955|453375376|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
126021567|NCT02723955|453375377|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126229356|NCT03349333|454130803|FG000|Overall Study|Progression of Disease|36|||
126021568|NCT02723955|453375378|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021569|NCT02723955|453375379|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126229357|NCT03349333|454130803|FG000|Overall Study|Adverse Event|11|||
126021570|NCT02723955|453375380|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021571|NCT02723955|453375381|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021572|NCT02723955|453375382|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021573|NCT02723955|453375383|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021574|NCT02723955|453375384|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021575|NCT02723955|453375385|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021576|NCT02723955|453375386|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021577|NCT02723955|453375387|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021578|NCT02723955|453375388|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021579|NCT02723955|453375389|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021580|NCT02723955|453375390|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021581|NCT02723955|453375391|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021582|NCT02723955|453375392|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021583|NCT02723955|453375393|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021584|NCT02723955|453375394|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021585|NCT02723955|453375395|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021586|NCT02723955|453375396|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021587|NCT02723955|453375397|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021588|NCT02723955|453375398|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021589|NCT02723955|453375399|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021590|NCT02723955|453375400|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021591|NCT02723955|453375401|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021592|NCT02723955|453375402|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021593|NCT02723955|453375403|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021594|NCT02723955|453375404|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021595|NCT02723955|453375405|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021596|NCT02723955|453375406|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021597|NCT02723955|453375407|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021598|NCT02723955|453375408|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021599|NCT02723955|453375409|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021600|NCT02723955|453375410|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126021601|NCT02723955|453375368|FG000|Escalation Phase|Site Closed|0|||
126021602|NCT02723955|453375369|FG001|Escalation Phase|Site Closed|0|||
126021603|NCT02723955|453375370|FG002|Escalation Phase|Site Closed|0|||
126021604|NCT02723955|453375371|FG003|Escalation Phase|Site Closed|0|||
126021605|NCT02723955|453375372|FG004|Escalation Phase|Site Closed|0|||
126021606|NCT02723955|453375373|FG005|Escalation Phase|Site Closed|0|||
126021607|NCT02723955|453375374|FG006|Escalation Phase|Site Closed|0|||
126021608|NCT02723955|453375375|FG007|Escalation Phase|Site Closed|0|||
126021609|NCT02723955|453375376|FG008|Escalation Phase|Site Closed|0|||
126021610|NCT02723955|453375377|FG009|Escalation Phase|Site Closed|0|||
126021611|NCT02723955|453375378|FG010|Escalation Phase|Site Closed|0|||
126021612|NCT02723955|453375379|FG011|Escalation Phase|Site Closed|0|||
126021613|NCT02723955|453375380|FG012|Escalation Phase|Site Closed|0|||
126021614|NCT02723955|453375381|FG013|Escalation Phase|Site Closed|0|||
126021615|NCT02723955|453375382|FG014|Escalation Phase|Site Closed|0|||
126021616|NCT02723955|453375383|FG015|Escalation Phase|Site Closed|1|||
126021617|NCT02723955|453375384|FG016|Escalation Phase|Site Closed|0|||
126229358|NCT03349333|454130803|FG000|Overall Study|Other|6|||
126229359|NCT03349333|454130803|FG000|Overall Study|Withdrawal by Subject|5|||
126229360|NCT03349333|454130803|FG000|Overall Study|Conditions interfere with participation|2|||
126229361|NCT03349333|454130803|FG000|Overall Study|Physician Decision|2|||
126229362|NCT03349333|454130803|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
126229363|NCT03349333|454130803|FG000|Overall Study|Patients in treatment less than 24 month|8|||
126229364|NCT00290745|454130804|FG000|Overall Study|Withdrawal by Subject|4|||
126229365|NCT00290745|454130804|FG000|Overall Study|Physician Decision|2|||
126229366|NCT00290745|454130804|FG000|Overall Study|Surgery after 3 months for progression|3|||
126229367|NCT00290745|454130804|FG000|Overall Study|Baseline MRI not available|3|||
126229368|NCT02750306|454130805|FG000|Overall Study|Withdrawal by Subject|5|||
126229369|NCT02750306|454130806|FG001|Overall Study|Withdrawal by Subject|2|||
126229370|NCT02750306|454130805|FG000|Overall Study|Protocol Violation|1|||
126229371|NCT02750306|454130806|FG001|Overall Study|Protocol Violation|0|||
126229372|NCT02737306|454130808|FG000|Overall Study|Adverse Event|3|||
126229373|NCT02737306|454130809|FG001|Overall Study|Adverse Event|0|||
126229374|NCT02737306|454130808|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
126229375|NCT02737306|454130809|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
126229376|NCT03267264|454130810|FG000|Overall Study|Withdrawal by Subject|1|||
126229377|NCT03267264|454130811|FG001|Overall Study|Withdrawal by Subject|0|||
126229378|NCT03267264|454130812|FG002|Overall Study|Withdrawal by Subject|2|||
126229379|NCT03267264|454130813|FG003|Overall Study|Withdrawal by Subject|4|||
126229380|NCT03937466|454130814|FG000|Overall Study|not eligbile after the 2-week diary|9|||
126229381|NCT03937466|454130814|FG000|Overall Study|never returned their diary|6|||
126229382|NCT03937466|454130814|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
126229383|NCT03937466|454130814|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
126229384|NCT00622908|454130815|FG000|Overall Study|Protocol Violation|1|||
126229385|NCT00622908|454130816|FG001|Overall Study|Protocol Violation|0|||
126229386|NCT00622908|454130815|FG000|Overall Study|Adverse Event|0|||
126229387|NCT00622908|454130816|FG001|Overall Study|Adverse Event|1|||
126229388|NCT00622908|454130815|FG000|Overall Study|Lack of Efficacy|1|||
126229389|NCT00622908|454130816|FG001|Overall Study|Lack of Efficacy|7|||
126229390|NCT00622908|454130815|FG000|Overall Study|Lost to Follow-up|1|||
126229391|NCT00622908|454130816|FG001|Overall Study|Lost to Follow-up|0|||
126229392|NCT00622908|454130815|FG000|Overall Study|Refusal|0|||
126229393|NCT00622908|454130816|FG001|Overall Study|Refusal|1|||
126229394|NCT00622908|454130815|FG000|Overall Study|Termination by study sponser|0|||
126229395|NCT00622908|454130816|FG001|Overall Study|Termination by study sponser|1|||
126229396|NCT00113490|454130817|FG000|Overall Study|Withdrawal by Subject|1|||
126229397|NCT00113490|454130818|FG001|Overall Study|Withdrawal by Subject|3|||
126229398|NCT00113490|454130817|FG000|Overall Study|Lost to Follow-up|1|||
126229399|NCT00113490|454130818|FG001|Overall Study|Lost to Follow-up|0|||
126229400|NCT02162758|454130819|FG000|Overall Study|Study termination|0|||
126229401|NCT02162758|454130820|FG001|Overall Study|Study termination|1|||
126229402|NCT04471935|454130821|FG000|Overall Study|Withdrawal by Subject|1|||
126229403|NCT04471935|454130821|FG000|Overall Study|Deemed ineligible to participate|1|||
126229404|NCT03019965|454130824|FG000|Overall Study|Withdrawal by Subject|1|||
126229405|NCT03019965|454130825|FG001|Overall Study|Withdrawal by Subject|0|||
126229406|NCT03019965|454130824|FG000|Overall Study|Protocol Violation|1|||
126229407|NCT03019965|454130825|FG001|Overall Study|Protocol Violation|3|||
126229408|NCT03019965|454130824|FG000|Overall Study|viral or fungal infection|3|||
126229409|NCT03019965|454130825|FG001|Overall Study|viral or fungal infection|4|||
126229410|NCT03019965|454130824|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
126229411|NCT03019965|454130825|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
126229412|NCT03019965|454130824|FG000|Overall Study|Physician Decision|1|||
126229413|NCT03019965|454130825|FG001|Overall Study|Physician Decision|1|||
126229414|NCT01659567|454130826|FG000|Overall Study|Lack of Efficacy|22|||
126229415|NCT01659567|454130826|FG000|Overall Study|Switched to Pegferon|6|||
126229416|NCT01659567|454130826|FG000|Overall Study|Adverse Event|12|||
126229417|NCT01659567|454130826|FG000|Overall Study|Good result at early stage of treatment|5|||
126229418|NCT01659567|454130826|FG000|Overall Study|Withdrawal by Subject|64|||
126229419|NCT01659567|454130826|FG000|Overall Study|Progression of the main disease|1|||
126229420|NCT01659567|454130826|FG000|Overall Study|Other|13|||
126229421|NCT03213210|454130827|FG000|Overall Study|Lost to Follow-up|2|||
126229422|NCT03213210|454130827|FG000|Overall Study|Study termination|3|||
126229423|NCT01915732|454130835|FG000|Overall Study|Withdrawal by Subject|18|||
126229424|NCT01915732|454130836|FG001|Overall Study|Withdrawal by Subject|18|||
126229425|NCT01915732|454130835|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
126229426|NCT01915732|454130836|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126229427|NCT01915732|454130835|FG000|Overall Study|Adverse Event|12|||
126229428|NCT01915732|454130836|FG001|Overall Study|Adverse Event|4|||
126229429|NCT01915732|454130835|FG000|Overall Study|Protocol Violation|5|||
126229430|NCT01915732|454130836|FG001|Overall Study|Protocol Violation|5|||
126229431|NCT01915732|454130835|FG000|Overall Study|Lack of Efficacy|6|||
126229432|NCT01915732|454130836|FG001|Overall Study|Lack of Efficacy|11|||
126229433|NCT01915732|454130835|FG000|Overall Study|Lost to Follow-up|22|||
126229434|NCT01915732|454130836|FG001|Overall Study|Lost to Follow-up|26|||
126229435|NCT01915732|454130835|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
126229436|NCT01915732|454130836|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
126229437|NCT01915732|454130835|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
126229438|NCT01915732|454130836|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
126229439|NCT01915732|454130835|FG000|Overall Study|Drug Release Error|1|||
126229440|NCT01915732|454130836|FG001|Overall Study|Drug Release Error|0|||
126229441|NCT01915732|454130835|FG000|Overall Study|Recovered|1|||
126229442|NCT01915732|454130836|FG001|Overall Study|Recovered|0|||
126229443|NCT01915732|454130835|FG000|Overall Study|Pregnancy|1|||
126229444|NCT01915732|454130836|FG001|Overall Study|Pregnancy|0|||
126229445|NCT01915732|454130835|FG000|Overall Study|Poor Perceived Efficacy|1|||
126229446|NCT01915732|454130836|FG001|Overall Study|Poor Perceived Efficacy|0|||
126229447|NCT01915732|454130835|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
126229448|NCT01915732|454130836|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
126229449|NCT01915732|454130835|FG000|Overall Study|Got Well|0|||
126229450|NCT01915732|454130836|FG001|Overall Study|Got Well|1|||
126229451|NCT01915732|454130835|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
126229452|NCT01915732|454130836|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
126229453|NCT01915732|454130835|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
126229454|NCT01915732|454130836|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
126229455|NCT01915732|454130835|FG000|Overall Study|Job Transfer|0|||
126229456|NCT01915732|454130836|FG001|Overall Study|Job Transfer|1|||
126229457|NCT01915732|454130835|FG000|Overall Study|Improper Facial Procedure|0|||
126229458|NCT01915732|454130836|FG001|Overall Study|Improper Facial Procedure|1|||
126229459|NCT01915732|454130835|FG000|Overall Study|Poor Conscious Effect|0|||
126229460|NCT01915732|454130836|FG001|Overall Study|Poor Conscious Effect|1|||
126229461|NCT00708422|454130837|FG000|Overall Study|Adverse Event|3|||
126229462|NCT00708422|454130838|FG001|Overall Study|Adverse Event|1|||
126229463|NCT00708422|454130837|FG000|Overall Study|Withdrawal by Subject|1|||
126229464|NCT00708422|454130838|FG001|Overall Study|Withdrawal by Subject|0|||
126229465|NCT00299156|454130841|FG000|Period 2 (Randomized)|Screen Failure|0|||
126229466|NCT00299156|454130842|FG001|Period 2 (Randomized)|Screen Failure|1|||
126229467|NCT00299156|454130843|FG002|Period 2 (Randomized)|Screen Failure|0|||
126229468|NCT01166568|454130857|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
126229469|NCT01166568|454130858|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
126229470|NCT01166568|454130859|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
126229471|NCT01166568|454130857|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
126229472|NCT01166568|454130858|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
126229473|NCT01166568|454130859|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
126229474|NCT01166568|454130857|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
126229475|NCT01166568|454130858|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
126229476|NCT01166568|454130859|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
126229477|NCT01654380|454130860|FG000|Part B, Period 1|Physician Decision|0|||
126229478|NCT01654380|454130861|FG001|Part B, Period 1|Physician Decision|0|||
126229479|NCT01654380|454130862|FG002|Part B, Period 1|Physician Decision|1|||
126229480|NCT01654380|454130863|FG003|Part B, Period 1|Physician Decision|0|||
126229481|NCT03335371|454130864|FG000|Overall Study|Lost to Follow-up|0|||
126229482|NCT03335371|454130865|FG001|Overall Study|Lost to Follow-up|0|||
126229483|NCT03335371|454130866|FG002|Overall Study|Lost to Follow-up|0|||
126229484|NCT03335371|454130867|FG003|Overall Study|Lost to Follow-up|0|||
126229485|NCT03335371|454130868|FG004|Overall Study|Lost to Follow-up|1|||
126229486|NCT03335371|454130864|FG000|Overall Study|Withdrawal by Subject|0|||
126229487|NCT03335371|454130865|FG001|Overall Study|Withdrawal by Subject|0|||
126229488|NCT03335371|454130866|FG002|Overall Study|Withdrawal by Subject|0|||
126229489|NCT03335371|454130867|FG003|Overall Study|Withdrawal by Subject|0|||
126229490|NCT03335371|454130868|FG004|Overall Study|Withdrawal by Subject|1|||
126352359|NCT02493855|454580725|FG002|Overall Study|Withdrawal by Subject|0|||
126352360|NCT02453048|454580726|FG000|Overall Study|Only part of initial 6 mo. study|0|||
126352361|NCT02453048|454580727|FG001|Overall Study|Only part of initial 6 mo. study|0|||
126229491|NCT03335371|454130864|FG000|Overall Study|Randomization Error|0|||
126229492|NCT03335371|454130865|FG001|Overall Study|Randomization Error|0|||
126229493|NCT03335371|454130866|FG002|Overall Study|Randomization Error|1|||
126229494|NCT03335371|454130867|FG003|Overall Study|Randomization Error|0|||
126229495|NCT03335371|454130868|FG004|Overall Study|Randomization Error|0|||
126352362|NCT02453048|454580728|FG002|Overall Study|Only part of initial 6 mo. study|0|||
126229496|NCT00684671|454130869|FG000|Overall Study|Adverse Event|1|||
126229497|NCT00684671|454130870|FG001|Overall Study|Adverse Event|0|||
126229498|NCT00684671|454130871|FG002|Overall Study|Adverse Event|0|||
126229499|NCT00684671|454130869|FG000|Overall Study|Lost to Follow-up|1|||
126352363|NCT02453048|454580729|FG003|Overall Study|Only part of initial 6 mo. study|0|||
126352364|NCT02453048|454580730|FG004|Overall Study|Only part of initial 6 mo. study|6|||
126229500|NCT00684671|454130870|FG001|Overall Study|Lost to Follow-up|0|||
126093056|NCT05540717|453634484|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
126229501|NCT00684671|454130871|FG002|Overall Study|Lost to Follow-up|0|||
126229502|NCT00684671|454130869|FG000|Overall Study|Alcoholic dependance|1|||
126229503|NCT00684671|454130870|FG001|Overall Study|Alcoholic dependance|0|||
126229504|NCT00684671|454130871|FG002|Overall Study|Alcoholic dependance|0|||
126229505|NCT01725451|454130873|FG000|Period 1|Withdrawal by Subject|1|||
126229506|NCT01725451|454130874|FG001|Period 1|Withdrawal by Subject|0|||
126229507|NCT01725451|454130875|FG002|Period 1|Withdrawal by Subject|0|||
126229508|NCT01725451|454130876|FG003|Period 1|Withdrawal by Subject|0|||
126229509|NCT01725451|454130873|FG000|Washout From Period 3|Protocol Violation|0|||
126229510|NCT01725451|454130874|FG001|Washout From Period 3|Protocol Violation|0|||
126093057|NCT05540717|453634483|FG000|Overall Study|Other|0|||
126093058|NCT05540717|453634484|FG001|Overall Study|Other|1|||
126093059|NCT00473265|453634485|FG000|Overall Study|Unrelated adverse event|5|||
126093060|NCT00473265|453634485|FG000|Overall Study|Off treatment early|15|||
126229511|NCT01725451|454130875|FG002|Washout From Period 3|Protocol Violation|1|||
126229512|NCT01725451|454130876|FG003|Washout From Period 3|Protocol Violation|0|||
126093061|NCT01802567|453634486|FG000|Overall Study|Withdrawal by Subject|2|||
126229513|NCT01725451|454130873|FG000|Washout From Period 3|Adverse Event|0|||
126229514|NCT01725451|454130874|FG001|Washout From Period 3|Adverse Event|1|||
126093062|NCT01802567|453634486|FG000|Overall Study|Physician Decision|1|||
126093063|NCT01802567|453634486|FG000|Overall Study|Lack of Efficacy|7|||
126229515|NCT01725451|454130875|FG002|Washout From Period 3|Adverse Event|0|||
126229516|NCT01725451|454130876|FG003|Washout From Period 3|Adverse Event|0|||
126021618|NCT02723955|453375385|FG017|Escalation Phase|Site Closed|2|||
126021619|NCT02723955|453375386|FG018|Escalation Phase|Site Closed|0|||
126021620|NCT02723955|453375387|FG019|Escalation Phase|Site Closed|0|||
126021621|NCT02723955|453375388|FG020|Escalation Phase|Site Closed|1|||
126021622|NCT02723955|453375389|FG021|Escalation Phase|Site Closed|0|||
126021623|NCT02723955|453375390|FG022|Escalation Phase|Site Closed|0|||
126021624|NCT02723955|453375391|FG023|Escalation Phase|Site Closed|0|||
126021625|NCT02723955|453375392|FG024|Escalation Phase|Site Closed|3|||
126021626|NCT02723955|453375393|FG025|Escalation Phase|Site Closed|1|||
126021627|NCT02723955|453375394|FG026|Escalation Phase|Site Closed|3|||
126021628|NCT02723955|453375395|FG027|Escalation Phase|Site Closed|1|||
126021629|NCT02723955|453375396|FG028|Escalation Phase|Site Closed|1|||
126021630|NCT02723955|453375397|FG029|Escalation Phase|Site Closed|0|||
126021631|NCT02723955|453375398|FG030|Escalation Phase|Site Closed|0|||
126021632|NCT02723955|453375399|FG031|Escalation Phase|Site Closed|0|||
126021633|NCT02723955|453375400|FG032|Escalation Phase|Site Closed|0|||
126021634|NCT02723955|453375401|FG033|Escalation Phase|Site Closed|0|||
126021635|NCT02723955|453375402|FG034|Escalation Phase|Site Closed|0|||
126021636|NCT02723955|453375403|FG035|Escalation Phase|Site Closed|0|||
126021637|NCT02723955|453375404|FG036|Escalation Phase|Site Closed|0|||
126021638|NCT02723955|453375405|FG037|Escalation Phase|Site Closed|0|||
126021639|NCT02723955|453375406|FG038|Escalation Phase|Site Closed|0|||
126021640|NCT02723955|453375407|FG039|Escalation Phase|Site Closed|0|||
126021641|NCT02723955|453375408|FG040|Escalation Phase|Site Closed|0|||
126021642|NCT02723955|453375409|FG041|Escalation Phase|Site Closed|0|||
126021643|NCT02723955|453375410|FG042|Escalation Phase|Site Closed|0|||
126021644|NCT02723955|453375368|FG000|Expansion Phase|Death|0|||
126021645|NCT02723955|453375369|FG001|Expansion Phase|Death|0|||
126021646|NCT02723955|453375370|FG002|Expansion Phase|Death|0|||
126021647|NCT02723955|453375371|FG003|Expansion Phase|Death|0|||
126021648|NCT02723955|453375372|FG004|Expansion Phase|Death|0|||
126021649|NCT02723955|453375373|FG005|Expansion Phase|Death|0|||
126021650|NCT02723955|453375374|FG006|Expansion Phase|Death|0|||
126021651|NCT02723955|453375375|FG007|Expansion Phase|Death|0|||
126021652|NCT02723955|453375376|FG008|Expansion Phase|Death|0|||
126021653|NCT02723955|453375377|FG009|Expansion Phase|Death|25|||
126021654|NCT02723955|453375378|FG010|Expansion Phase|Death|69|||
126021655|NCT02723955|453375379|FG011|Expansion Phase|Death|48|||
126229517|NCT01725451|454130873|FG000|Period 4|Adverse Event|0|||
126229518|NCT01725451|454130874|FG001|Period 4|Adverse Event|0|||
126229519|NCT01725451|454130875|FG002|Period 4|Adverse Event|1|||
126229520|NCT01725451|454130876|FG003|Period 4|Adverse Event|0|||
126229521|NCT02015793|454130877|FG000|Overall Study|Adverse Event|3|||
126229522|NCT02015793|454130878|FG001|Overall Study|Adverse Event|3|||
126229523|NCT02015793|454130877|FG000|Overall Study|Withdrawal by Subject|1|||
126229524|NCT02015793|454130878|FG001|Overall Study|Withdrawal by Subject|1|||
126229525|NCT00437281|454130879|FG000|Overall Study|Adverse Event|0|||
126021656|NCT02723955|453375380|FG012|Expansion Phase|Death|0|||
126021657|NCT02723955|453375381|FG013|Expansion Phase|Death|0|||
126021658|NCT02723955|453375382|FG014|Expansion Phase|Death|0|||
126021659|NCT02723955|453375383|FG015|Expansion Phase|Death|0|||
126021660|NCT02723955|453375384|FG016|Expansion Phase|Death|0|||
126021661|NCT02723955|453375385|FG017|Expansion Phase|Death|0|||
126021662|NCT02723955|453375386|FG018|Expansion Phase|Death|0|||
126021663|NCT02723955|453375387|FG019|Expansion Phase|Death|0|||
126021664|NCT02723955|453375388|FG020|Expansion Phase|Death|0|||
126021665|NCT02723955|453375389|FG021|Expansion Phase|Death|0|||
126021666|NCT02723955|453375390|FG022|Expansion Phase|Death|0|||
126021667|NCT02723955|453375391|FG023|Expansion Phase|Death|0|||
126021668|NCT02723955|453375392|FG024|Expansion Phase|Death|0|||
126021669|NCT02723955|453375393|FG025|Expansion Phase|Death|0|||
126021670|NCT02723955|453375394|FG026|Expansion Phase|Death|0|||
126021671|NCT02723955|453375395|FG027|Expansion Phase|Death|0|||
126021672|NCT02723955|453375396|FG028|Expansion Phase|Death|0|||
126021673|NCT02723955|453375397|FG029|Expansion Phase|Death|12|||
126021674|NCT02723955|453375398|FG030|Expansion Phase|Death|202|||
126021675|NCT02723955|453375399|FG031|Expansion Phase|Death|31|||
126021676|NCT02723955|453375400|FG032|Expansion Phase|Death|17|||
126021677|NCT02723955|453375401|FG033|Expansion Phase|Death|2|||
126229526|NCT00437281|454130880|FG001|Overall Study|Adverse Event|0|||
126229527|NCT00437281|454130881|FG002|Overall Study|Adverse Event|0|||
126021678|NCT02723955|453375402|FG034|Expansion Phase|Death|3|||
126021679|NCT02723955|453375403|FG035|Expansion Phase|Death|3|||
126021680|NCT02723955|453375404|FG036|Expansion Phase|Death|1|||
126021681|NCT02723955|453375405|FG037|Expansion Phase|Death|0|||
126021682|NCT02723955|453375406|FG038|Expansion Phase|Death|0|||
126021683|NCT02723955|453375407|FG039|Expansion Phase|Death|0|||
126021684|NCT02723955|453375408|FG040|Expansion Phase|Death|0|||
126021685|NCT02723955|453375409|FG041|Expansion Phase|Death|0|||
126021686|NCT02723955|453375410|FG042|Expansion Phase|Death|0|||
126021687|NCT02723955|453375368|FG000|Expansion Phase|Lost to Follow-up|0|||
126229528|NCT00437281|454130882|FG003|Overall Study|Adverse Event|1|||
126021688|NCT02723955|453375369|FG001|Expansion Phase|Lost to Follow-up|0|||
126021689|NCT02723955|453375370|FG002|Expansion Phase|Lost to Follow-up|0|||
126021690|NCT02723955|453375371|FG003|Expansion Phase|Lost to Follow-up|0|||
126021691|NCT02723955|453375372|FG004|Expansion Phase|Lost to Follow-up|0|||
126021692|NCT02723955|453375373|FG005|Expansion Phase|Lost to Follow-up|0|||
126021693|NCT02723955|453375374|FG006|Expansion Phase|Lost to Follow-up|0|||
126021694|NCT02723955|453375375|FG007|Expansion Phase|Lost to Follow-up|0|||
126021695|NCT02723955|453375376|FG008|Expansion Phase|Lost to Follow-up|0|||
126021696|NCT02723955|453375377|FG009|Expansion Phase|Lost to Follow-up|0|||
126021697|NCT02723955|453375378|FG010|Expansion Phase|Lost to Follow-up|4|||
126021698|NCT02723955|453375379|FG011|Expansion Phase|Lost to Follow-up|1|||
126021699|NCT02723955|453375380|FG012|Expansion Phase|Lost to Follow-up|0|||
126021700|NCT02723955|453375381|FG013|Expansion Phase|Lost to Follow-up|0|||
126021701|NCT02723955|453375382|FG014|Expansion Phase|Lost to Follow-up|0|||
126021702|NCT02723955|453375383|FG015|Expansion Phase|Lost to Follow-up|0|||
126021703|NCT02723955|453375384|FG016|Expansion Phase|Lost to Follow-up|0|||
126021704|NCT02723955|453375385|FG017|Expansion Phase|Lost to Follow-up|0|||
126021705|NCT02723955|453375386|FG018|Expansion Phase|Lost to Follow-up|0|||
126229529|NCT00437281|454130883|FG004|Overall Study|Adverse Event|0|||
126229530|NCT00437281|454130884|FG005|Overall Study|Adverse Event|1|||
126229531|NCT00437281|454130885|FG006|Overall Study|Adverse Event|0|||
126229532|NCT00437281|454130886|FG007|Overall Study|Adverse Event|0|||
126229533|NCT00437281|454130887|FG008|Overall Study|Adverse Event|0|||
126229534|NCT00437281|454130888|FG009|Overall Study|Adverse Event|1|||
126229535|NCT00437281|454130889|FG010|Overall Study|Adverse Event|0|||
126229536|NCT00437281|454130890|FG011|Overall Study|Adverse Event|0|||
126229537|NCT00437281|454130891|FG012|Overall Study|Adverse Event|0|||
126229538|NCT00437281|454130892|FG013|Overall Study|Adverse Event|1|||
126229539|NCT00437281|454130893|FG014|Overall Study|Adverse Event|1|||
126229540|NCT00437281|454130894|FG015|Overall Study|Adverse Event|0|||
126229541|NCT00437281|454130895|FG016|Overall Study|Adverse Event|0|||
126229542|NCT00437281|454130896|FG017|Overall Study|Adverse Event|0|||
126229543|NCT00437281|454130897|FG018|Overall Study|Adverse Event|1|||
126229544|NCT00437281|454130898|FG019|Overall Study|Adverse Event|0|||
126229545|NCT00437281|454130879|FG000|Overall Study|Lost to Follow-up|0|||
126229546|NCT00437281|454130880|FG001|Overall Study|Lost to Follow-up|0|||
126229547|NCT00437281|454130881|FG002|Overall Study|Lost to Follow-up|0|||
126229548|NCT00437281|454130882|FG003|Overall Study|Lost to Follow-up|0|||
126229549|NCT00437281|454130883|FG004|Overall Study|Lost to Follow-up|0|||
126021706|NCT02723955|453375387|FG019|Expansion Phase|Lost to Follow-up|0|||
126229550|NCT00437281|454130884|FG005|Overall Study|Lost to Follow-up|0|||
126229551|NCT00437281|454130885|FG006|Overall Study|Lost to Follow-up|0|||
126229552|NCT00437281|454130886|FG007|Overall Study|Lost to Follow-up|0|||
126229553|NCT00437281|454130887|FG008|Overall Study|Lost to Follow-up|0|||
126352365|NCT02453048|454580726|FG000|Overall Study|Lost to Follow-up|0|||
126352366|NCT02453048|454580727|FG001|Overall Study|Lost to Follow-up|1|||
126352367|NCT02453048|454580728|FG002|Overall Study|Lost to Follow-up|2|||
126352368|NCT02453048|454580729|FG003|Overall Study|Lost to Follow-up|0|||
126352369|NCT02453048|454580730|FG004|Overall Study|Lost to Follow-up|0|||
126352370|NCT01482221|454580731|FG000|Overall Study|Lack of Efficacy|1|||
126352371|NCT01482221|454580732|FG001|Overall Study|Lack of Efficacy|0|||
126352372|NCT01482221|454580733|FG002|Overall Study|Lack of Efficacy|1|||
126352373|NCT01482221|454580731|FG000|Overall Study|Lost to Follow-up|3|||
126352374|NCT01482221|454580732|FG001|Overall Study|Lost to Follow-up|2|||
126352375|NCT01482221|454580733|FG002|Overall Study|Lost to Follow-up|1|||
126352376|NCT01482221|454580731|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
126352377|NCT01482221|454580732|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
126352378|NCT01482221|454580733|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
126352379|NCT01482221|454580731|FG000|Overall Study|Condition under Investigation Worsened|3|||
126352380|NCT01482221|454580732|FG001|Overall Study|Condition under Investigation Worsened|2|||
126352381|NCT01482221|454580733|FG002|Overall Study|Condition under Investigation Worsened|4|||
126352382|NCT01482221|454580731|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
126352383|NCT01482221|454580732|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
126352384|NCT01482221|454580733|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
126352385|NCT01482221|454580731|FG000|Overall Study|Adverse Event|1|||
126352386|NCT01482221|454580732|FG001|Overall Study|Adverse Event|7|||
126352387|NCT01482221|454580733|FG002|Overall Study|Adverse Event|3|||
126352388|NCT01482221|454580731|FG000|Overall Study|Withdrawal by Subject|10|||
126352389|NCT01482221|454580732|FG001|Overall Study|Withdrawal by Subject|7|||
126352390|NCT01482221|454580733|FG002|Overall Study|Withdrawal by Subject|12|||
126352391|NCT01482221|454580731|FG000|Overall Study|Incorrect randomization|0|||
126352392|NCT01482221|454580732|FG001|Overall Study|Incorrect randomization|1|||
126352393|NCT01482221|454580733|FG002|Overall Study|Incorrect randomization|0|||
126352394|NCT01482221|454580731|FG000|Overall Study|Physician Decision|0|||
126352395|NCT01482221|454580732|FG001|Overall Study|Physician Decision|1|||
126352396|NCT01482221|454580733|FG002|Overall Study|Physician Decision|0|||
126021707|NCT02723955|453375388|FG020|Expansion Phase|Lost to Follow-up|0|||
126021708|NCT02723955|453375389|FG021|Expansion Phase|Lost to Follow-up|0|||
126229554|NCT00437281|454130888|FG009|Overall Study|Lost to Follow-up|0|||
126021709|NCT02723955|453375390|FG022|Expansion Phase|Lost to Follow-up|0|||
126021710|NCT02723955|453375391|FG023|Expansion Phase|Lost to Follow-up|0|||
126021711|NCT02723955|453375392|FG024|Expansion Phase|Lost to Follow-up|0|||
126021712|NCT02723955|453375393|FG025|Expansion Phase|Lost to Follow-up|0|||
126021713|NCT02723955|453375394|FG026|Expansion Phase|Lost to Follow-up|0|||
126021714|NCT02723955|453375395|FG027|Expansion Phase|Lost to Follow-up|0|||
126021715|NCT02723955|453375396|FG028|Expansion Phase|Lost to Follow-up|0|||
126021716|NCT02723955|453375397|FG029|Expansion Phase|Lost to Follow-up|1|||
126021717|NCT02723955|453375398|FG030|Expansion Phase|Lost to Follow-up|19|||
126021718|NCT02723955|453375399|FG031|Expansion Phase|Lost to Follow-up|2|||
126021719|NCT02723955|453375400|FG032|Expansion Phase|Lost to Follow-up|1|||
126021720|NCT02723955|453375401|FG033|Expansion Phase|Lost to Follow-up|0|||
126021721|NCT02723955|453375402|FG034|Expansion Phase|Lost to Follow-up|0|||
126093064|NCT01802567|453634486|FG000|Overall Study|Consented but did not start therapy|7|||
126093065|NCT01802567|453634486|FG000|Overall Study|Protocol Violation|1|||
126093066|NCT01940939|453634489|FG000|Overall Study|Withdrawal by Subject|2|||
126093067|NCT01940939|453634490|FG001|Overall Study|Withdrawal by Subject|8|||
126093068|NCT01470001|453634491|FG000|Overall Study|Lost to Follow-up|1|||
126093069|NCT01470001|453634492|FG001|Overall Study|Lost to Follow-up|1|||
126093070|NCT01470001|453634491|FG000|Overall Study|Physician Decision|2|||
126093071|NCT01470001|453634492|FG001|Overall Study|Physician Decision|0|||
126093072|NCT01470001|453634491|FG000|Overall Study|Withdrawal by Subject|2|||
126093073|NCT01470001|453634492|FG001|Overall Study|Withdrawal by Subject|1|||
126093074|NCT01895101|453634493|FG000|Overall Study|OPCAB procedure|1|||
126093075|NCT01895101|453634494|FG001|Overall Study|OPCAB procedure|1|||
126093076|NCT01895101|453634495|FG002|Overall Study|OPCAB procedure|3|||
126093077|NCT01895101|453634493|FG000|Overall Study|Withdrawal by Subject|0|||
126093078|NCT01895101|453634494|FG001|Overall Study|Withdrawal by Subject|1|||
126093079|NCT01895101|453634495|FG002|Overall Study|Withdrawal by Subject|2|||
126093080|NCT01895101|453634493|FG000|Overall Study|another study, enrolled in other study|0|||
126093081|NCT01895101|453634494|FG001|Overall Study|another study, enrolled in other study|1|||
126093082|NCT01895101|453634495|FG002|Overall Study|another study, enrolled in other study|0|||
126093083|NCT01895101|453634493|FG000|Overall Study|Death|0|||
126093084|NCT01895101|453634494|FG001|Overall Study|Death|1|||
126093085|NCT01895101|453634495|FG002|Overall Study|Death|0|||
126093086|NCT01895101|453634493|FG000|Overall Study|coagulation disorder|0|||
126093087|NCT01895101|453634494|FG001|Overall Study|coagulation disorder|1|||
126093088|NCT01895101|453634495|FG002|Overall Study|coagulation disorder|0|||
126093089|NCT02591953|453634498|FG000|Overall Study|Lost to Follow-up|6|||
126093090|NCT02591953|453634499|FG001|Overall Study|Lost to Follow-up|6|||
126093091|NCT03167359|453634502|FG000|Overall Study|Physician Decision|1|||
126021722|NCT02723955|453375403|FG035|Expansion Phase|Lost to Follow-up|0|||
126021723|NCT02723955|453375404|FG036|Expansion Phase|Lost to Follow-up|0|||
126021724|NCT02723955|453375405|FG037|Expansion Phase|Lost to Follow-up|0|||
126093092|NCT03167359|453634502|FG000|Overall Study|Lost to Follow-up|1|||
126093093|NCT01896557|453634503|FG000|Clopidogrel Alone|Adverse Event|1|||
126093094|NCT01896557|453634504|FG001|Clopidogrel Alone|Adverse Event|0|||
126093095|NCT01896557|453634503|FG000|Clopidogrel + GI Protector|low adherence|1|||
126093096|NCT01896557|453634504|FG001|Clopidogrel + GI Protector|low adherence|1|||
126352397|NCT03086343|454580734|FG000|Period 1|Adverse Event|7|||
126352398|NCT03086343|454580735|FG001|Period 1|Adverse Event|7|||
126352399|NCT03086343|454580736|FG002|Period 1|Adverse Event|0|||
126352400|NCT03086343|454580737|FG003|Period 1|Adverse Event|1|||
126352401|NCT03086343|454580734|FG000|Period 1|Withdrawal by Subject|6|||
126352402|NCT03086343|454580735|FG001|Period 1|Withdrawal by Subject|10|||
126352403|NCT03086343|454580736|FG002|Period 1|Withdrawal by Subject|0|||
126352404|NCT03086343|454580737|FG003|Period 1|Withdrawal by Subject|0|||
126352405|NCT03086343|454580734|FG000|Period 1|Lost to Follow-up|1|||
126352406|NCT03086343|454580735|FG001|Period 1|Lost to Follow-up|3|||
126352407|NCT03086343|454580736|FG002|Period 1|Lost to Follow-up|1|||
126352408|NCT03086343|454580737|FG003|Period 1|Lost to Follow-up|0|||
126352409|NCT03086343|454580734|FG000|Period 1|Other, Not Specified|10|||
126352410|NCT03086343|454580735|FG001|Period 1|Other, Not Specified|12|||
126352411|NCT03086343|454580736|FG002|Period 1|Other, Not Specified|2|||
126352412|NCT03086343|454580737|FG003|Period 1|Other, Not Specified|1|||
126352413|NCT03086343|454580734|FG000|Period 1|Missing|1|||
126352414|NCT03086343|454580735|FG001|Period 1|Missing|0|||
126352415|NCT03086343|454580736|FG002|Period 1|Missing|0|||
126352416|NCT03086343|454580737|FG003|Period 1|Missing|0|||
126352417|NCT03086343|454580734|FG000|Period 2|Adverse Event|20|||
126352418|NCT03086343|454580735|FG001|Period 2|Adverse Event|11|||
126352419|NCT03086343|454580736|FG002|Period 2|Adverse Event|1|||
126352420|NCT03086343|454580737|FG003|Period 2|Adverse Event|2|||
126352421|NCT03086343|454580734|FG000|Period 2|Withdrawal by Subject|15|||
126352422|NCT03086343|454580735|FG001|Period 2|Withdrawal by Subject|25|||
126352423|NCT03086343|454580736|FG002|Period 2|Withdrawal by Subject|2|||
126352424|NCT03086343|454580737|FG003|Period 2|Withdrawal by Subject|2|||
126021725|NCT02723955|453375406|FG038|Expansion Phase|Lost to Follow-up|0|||
126352425|NCT03086343|454580734|FG000|Period 2|Lost to Follow-up|6|||
126352426|NCT03086343|454580735|FG001|Period 2|Lost to Follow-up|11|||
126352427|NCT03086343|454580736|FG002|Period 2|Lost to Follow-up|1|||
126021726|NCT02723955|453375407|FG039|Expansion Phase|Lost to Follow-up|0|||
126021727|NCT02723955|453375408|FG040|Expansion Phase|Lost to Follow-up|0|||
126229555|NCT00437281|454130889|FG010|Overall Study|Lost to Follow-up|0|||
126229556|NCT00437281|454130890|FG011|Overall Study|Lost to Follow-up|0|||
126229557|NCT00437281|454130891|FG012|Overall Study|Lost to Follow-up|0|||
126229558|NCT00437281|454130892|FG013|Overall Study|Lost to Follow-up|0|||
126229559|NCT00437281|454130893|FG014|Overall Study|Lost to Follow-up|0|||
126229560|NCT00437281|454130894|FG015|Overall Study|Lost to Follow-up|0|||
126229561|NCT00437281|454130895|FG016|Overall Study|Lost to Follow-up|0|||
126229562|NCT00437281|454130896|FG017|Overall Study|Lost to Follow-up|0|||
126229563|NCT00437281|454130897|FG018|Overall Study|Lost to Follow-up|0|||
126229564|NCT00437281|454130898|FG019|Overall Study|Lost to Follow-up|1|||
126229565|NCT00601354|454130899|FG000|Overall Study|Lost to Follow-up|4|||
126229566|NCT00601354|454130900|FG001|Overall Study|Lost to Follow-up|5|||
126229567|NCT01862328|454130901|FG000|Overall Study|Progressive Disease|3|||
126229568|NCT01862328|454130902|FG001|Overall Study|Progressive Disease|11|||
126229569|NCT01862328|454130903|FG002|Overall Study|Progressive Disease|5|||
126229570|NCT01862328|454130904|FG003|Overall Study|Progressive Disease|6|||
126229571|NCT01862328|454130905|FG004|Overall Study|Progressive Disease|7|||
126229572|NCT01862328|454130906|FG005|Overall Study|Progressive Disease|4|||
126229573|NCT01862328|454130907|FG006|Overall Study|Progressive Disease|3|||
126229574|NCT01862328|454130901|FG000|Overall Study|Adverse Event|0|||
126229575|NCT01862328|454130902|FG001|Overall Study|Adverse Event|4|||
126229576|NCT01862328|454130903|FG002|Overall Study|Adverse Event|0|||
126229577|NCT01862328|454130904|FG003|Overall Study|Adverse Event|1|||
126229578|NCT01862328|454130905|FG004|Overall Study|Adverse Event|0|||
126229579|NCT01862328|454130906|FG005|Overall Study|Adverse Event|2|||
126229580|NCT01862328|454130907|FG006|Overall Study|Adverse Event|4|||
126229581|NCT01862328|454130901|FG000|Overall Study|Other|0|||
126229582|NCT01862328|454130902|FG001|Overall Study|Other|2|||
126229583|NCT01862328|454130903|FG002|Overall Study|Other|1|||
126229584|NCT01862328|454130904|FG003|Overall Study|Other|0|||
126229585|NCT01862328|454130905|FG004|Overall Study|Other|4|||
126229586|NCT01862328|454130906|FG005|Overall Study|Other|0|||
126229587|NCT01862328|454130907|FG006|Overall Study|Other|1|||
126229588|NCT01862328|454130901|FG000|Overall Study|Withdrawal by Subject|1|||
126229589|NCT01862328|454130902|FG001|Overall Study|Withdrawal by Subject|1|||
126229590|NCT01862328|454130903|FG002|Overall Study|Withdrawal by Subject|0|||
126229591|NCT01862328|454130904|FG003|Overall Study|Withdrawal by Subject|0|||
126229592|NCT01862328|454130905|FG004|Overall Study|Withdrawal by Subject|1|||
126229593|NCT01862328|454130906|FG005|Overall Study|Withdrawal by Subject|1|||
126229594|NCT01862328|454130907|FG006|Overall Study|Withdrawal by Subject|1|||
126229595|NCT01862328|454130901|FG000|Overall Study|Symptomatic Deterioration|0|||
126229596|NCT01862328|454130902|FG001|Overall Study|Symptomatic Deterioration|0|||
126229597|NCT01862328|454130903|FG002|Overall Study|Symptomatic Deterioration|0|||
126229598|NCT01862328|454130904|FG003|Overall Study|Symptomatic Deterioration|0|||
126229599|NCT01862328|454130905|FG004|Overall Study|Symptomatic Deterioration|0|||
126229600|NCT01862328|454130906|FG005|Overall Study|Symptomatic Deterioration|0|||
126229601|NCT01862328|454130907|FG006|Overall Study|Symptomatic Deterioration|1|||
126229602|NCT01656889|454130909|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
126229603|NCT01656889|454130910|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
126229604|NCT01656889|454130909|FG000|Treatment Period, 12 Weeks|Death|0|||
126229605|NCT01656889|454130910|FG001|Treatment Period, 12 Weeks|Death|1|||
126021728|NCT02723955|453375409|FG041|Expansion Phase|Lost to Follow-up|0|||
126021729|NCT02723955|453375410|FG042|Expansion Phase|Lost to Follow-up|0|||
126229606|NCT01656889|454130909|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
126229607|NCT01656889|454130910|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
126229608|NCT01656889|454130909|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
126229609|NCT01656889|454130910|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
126229610|NCT01656889|454130909|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
126229611|NCT01656889|454130910|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
126229612|NCT01656889|454130909|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
126229613|NCT01656889|454130910|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
126229614|NCT01656889|454130909|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
126229615|NCT01656889|454130910|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
126229616|NCT01656889|454130909|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
126229617|NCT01656889|454130910|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
126229618|NCT01656889|454130909|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
126229619|NCT01656889|454130910|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
126229620|NCT01656889|454130909|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
126229621|NCT01656889|454130910|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
126229622|NCT02521948|454130911|FG000|Overall Study|Adverse Event|2|||
126229623|NCT02521948|454130911|FG000|Overall Study|Death|4|||
126229624|NCT02521948|454130911|FG000|Overall Study|Lost to Follow-up|1|||
126229625|NCT02521948|454130911|FG000|Overall Study|Did not attend one or both follow-ups|6|||
126021730|NCT02723955|453375368|FG000|Expansion Phase|Physician Decision|0|||
126021731|NCT02723955|453375369|FG001|Expansion Phase|Physician Decision|0|||
126021732|NCT02723955|453375370|FG002|Expansion Phase|Physician Decision|0|||
126229626|NCT02427607|454130912|FG000|Overall Study|Withdrawal by Subject|1|||
126229627|NCT00423800|454130913|FG000|Overall Study|Protocol Violation|0|||
126229628|NCT00423800|454130914|FG001|Overall Study|Protocol Violation|1|||
126229629|NCT04000009|454130915|FG000|Overall Study|Adverse Event|13|||
126229630|NCT04000009|454130915|FG000|Overall Study|Lack of Efficacy|7|||
126229631|NCT04000009|454130915|FG000|Overall Study|Lost to Follow-up|8|||
126229632|NCT04000009|454130915|FG000|Overall Study|Noncompliance with study drug|4|||
126229633|NCT04000009|454130915|FG000|Overall Study|Physician Decision|1|||
126229634|NCT04000009|454130915|FG000|Overall Study|Use of prohibited medication|3|||
126229635|NCT04000009|454130915|FG000|Overall Study|Pregnancy|1|||
126021733|NCT02723955|453375371|FG003|Expansion Phase|Physician Decision|0|||
126021734|NCT02723955|453375372|FG004|Expansion Phase|Physician Decision|0|||
126021735|NCT02723955|453375373|FG005|Expansion Phase|Physician Decision|0|||
126021736|NCT02723955|453375374|FG006|Expansion Phase|Physician Decision|0|||
126021737|NCT02723955|453375375|FG007|Expansion Phase|Physician Decision|0|||
126229636|NCT04000009|454130915|FG000|Overall Study|Withdrawal by Subject|22|||
126021738|NCT02723955|453375376|FG008|Expansion Phase|Physician Decision|0|||
126021739|NCT02723955|453375377|FG009|Expansion Phase|Physician Decision|0|||
126021740|NCT02723955|453375378|FG010|Expansion Phase|Physician Decision|0|||
126021741|NCT02723955|453375379|FG011|Expansion Phase|Physician Decision|0|||
126021742|NCT02723955|453375380|FG012|Expansion Phase|Physician Decision|0|||
126021743|NCT02723955|453375381|FG013|Expansion Phase|Physician Decision|0|||
126021744|NCT02723955|453375382|FG014|Expansion Phase|Physician Decision|0|||
126021745|NCT02723955|453375383|FG015|Expansion Phase|Physician Decision|0|||
126021746|NCT02723955|453375384|FG016|Expansion Phase|Physician Decision|0|||
126021747|NCT02723955|453375385|FG017|Expansion Phase|Physician Decision|0|||
126021748|NCT02723955|453375386|FG018|Expansion Phase|Physician Decision|0|||
126021749|NCT02723955|453375387|FG019|Expansion Phase|Physician Decision|0|||
126021750|NCT02723955|453375388|FG020|Expansion Phase|Physician Decision|0|||
126021751|NCT02723955|453375389|FG021|Expansion Phase|Physician Decision|0|||
126021752|NCT02723955|453375390|FG022|Expansion Phase|Physician Decision|0|||
126021753|NCT02723955|453375391|FG023|Expansion Phase|Physician Decision|0|||
126021754|NCT02723955|453375392|FG024|Expansion Phase|Physician Decision|0|||
126021755|NCT02723955|453375393|FG025|Expansion Phase|Physician Decision|0|||
126021756|NCT02723955|453375394|FG026|Expansion Phase|Physician Decision|0|||
126021757|NCT02723955|453375395|FG027|Expansion Phase|Physician Decision|0|||
126021758|NCT02723955|453375396|FG028|Expansion Phase|Physician Decision|0|||
126021759|NCT02723955|453375397|FG029|Expansion Phase|Physician Decision|0|||
126021760|NCT02723955|453375398|FG030|Expansion Phase|Physician Decision|1|||
126021761|NCT02723955|453375399|FG031|Expansion Phase|Physician Decision|1|||
126021762|NCT02723955|453375400|FG032|Expansion Phase|Physician Decision|0|||
126021763|NCT02723955|453375401|FG033|Expansion Phase|Physician Decision|0|||
126021764|NCT02723955|453375402|FG034|Expansion Phase|Physician Decision|0|||
126021765|NCT02723955|453375403|FG035|Expansion Phase|Physician Decision|0|||
126021766|NCT02723955|453375404|FG036|Expansion Phase|Physician Decision|0|||
126021767|NCT02723955|453375405|FG037|Expansion Phase|Physician Decision|0|||
126021768|NCT02723955|453375406|FG038|Expansion Phase|Physician Decision|0|||
126021769|NCT02723955|453375407|FG039|Expansion Phase|Physician Decision|0|||
126021770|NCT02723955|453375408|FG040|Expansion Phase|Physician Decision|0|||
126021771|NCT02723955|453375409|FG041|Expansion Phase|Physician Decision|0|||
126021772|NCT02723955|453375410|FG042|Expansion Phase|Physician Decision|0|||
126021773|NCT02723955|453375368|FG000|Expansion Phase|Withdrawal by Subject|0|||
126021774|NCT02723955|453375369|FG001|Expansion Phase|Withdrawal by Subject|0|||
126021775|NCT02723955|453375370|FG002|Expansion Phase|Withdrawal by Subject|0|||
126021776|NCT02723955|453375371|FG003|Expansion Phase|Withdrawal by Subject|0|||
126021777|NCT02723955|453375372|FG004|Expansion Phase|Withdrawal by Subject|0|||
126021778|NCT02723955|453375373|FG005|Expansion Phase|Withdrawal by Subject|0|||
126021779|NCT02723955|453375374|FG006|Expansion Phase|Withdrawal by Subject|0|||
126021780|NCT02723955|453375375|FG007|Expansion Phase|Withdrawal by Subject|0|||
126021781|NCT02723955|453375376|FG008|Expansion Phase|Withdrawal by Subject|0|||
126021782|NCT02723955|453375377|FG009|Expansion Phase|Withdrawal by Subject|2|||
126021783|NCT02723955|453375378|FG010|Expansion Phase|Withdrawal by Subject|1|||
126021784|NCT02723955|453375379|FG011|Expansion Phase|Withdrawal by Subject|0|||
126021785|NCT02723955|453375380|FG012|Expansion Phase|Withdrawal by Subject|0|||
126021786|NCT02723955|453375381|FG013|Expansion Phase|Withdrawal by Subject|0|||
126021787|NCT02723955|453375382|FG014|Expansion Phase|Withdrawal by Subject|0|||
126021788|NCT02723955|453375383|FG015|Expansion Phase|Withdrawal by Subject|0|||
126021789|NCT02723955|453375384|FG016|Expansion Phase|Withdrawal by Subject|0|||
126021790|NCT02723955|453375385|FG017|Expansion Phase|Withdrawal by Subject|0|||
126021791|NCT02723955|453375386|FG018|Expansion Phase|Withdrawal by Subject|0|||
126093097|NCT01896557|453634503|FG000|Clopidogrel + GI Protector|Reading error|1|||
126093098|NCT01896557|453634504|FG001|Clopidogrel + GI Protector|Reading error|3|||
126093099|NCT01517295|453634505|FG000|Overall Study|Physician Decision|1|||
126093100|NCT01517295|453634506|FG001|Overall Study|Physician Decision|0|||
126093101|NCT01659853|453634507|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
126093102|NCT01659853|453634508|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
126229637|NCT04000009|454130915|FG000|Overall Study|Study terminated by sponsor|98|||
126021792|NCT02723955|453375387|FG019|Expansion Phase|Withdrawal by Subject|0|||
126021793|NCT02723955|453375388|FG020|Expansion Phase|Withdrawal by Subject|0|||
126021794|NCT02723955|453375389|FG021|Expansion Phase|Withdrawal by Subject|0|||
126021795|NCT02723955|453375390|FG022|Expansion Phase|Withdrawal by Subject|0|||
126021796|NCT02723955|453375391|FG023|Expansion Phase|Withdrawal by Subject|0|||
126021797|NCT02723955|453375392|FG024|Expansion Phase|Withdrawal by Subject|0|||
126021798|NCT02723955|453375393|FG025|Expansion Phase|Withdrawal by Subject|0|||
126021799|NCT02723955|453375394|FG026|Expansion Phase|Withdrawal by Subject|0|||
126021800|NCT02723955|453375395|FG027|Expansion Phase|Withdrawal by Subject|0|||
126021801|NCT02723955|453375396|FG028|Expansion Phase|Withdrawal by Subject|0|||
126021802|NCT02723955|453375397|FG029|Expansion Phase|Withdrawal by Subject|0|||
126093103|NCT01659853|453634507|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
126021803|NCT02723955|453375398|FG030|Expansion Phase|Withdrawal by Subject|8|||
126093104|NCT01659853|453634508|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
126229638|NCT04000009|454130915|FG000|Overall Study|Not further specified|8|||
126229639|NCT00679783|454130917|FG000|Overall Study|Adverse Event|0|||
126229640|NCT00679783|454130918|FG001|Overall Study|Adverse Event|0|||
126229641|NCT00679783|454130919|FG002|Overall Study|Adverse Event|0|||
126229642|NCT00679783|454130920|FG003|Overall Study|Adverse Event|3|||
126229643|NCT00679783|454130921|FG004|Overall Study|Adverse Event|0|||
126229644|NCT00679783|454130922|FG005|Overall Study|Adverse Event|0|||
126229645|NCT00679783|454130923|FG006|Overall Study|Adverse Event|1|||
126229646|NCT00679783|454130917|FG000|Overall Study|Lack of Efficacy|0|||
126229647|NCT00679783|454130918|FG001|Overall Study|Lack of Efficacy|1|||
126229648|NCT00679783|454130919|FG002|Overall Study|Lack of Efficacy|0|||
126229649|NCT00679783|454130920|FG003|Overall Study|Lack of Efficacy|2|||
126229650|NCT00679783|454130921|FG004|Overall Study|Lack of Efficacy|0|||
126229651|NCT00679783|454130922|FG005|Overall Study|Lack of Efficacy|0|||
126229652|NCT00679783|454130923|FG006|Overall Study|Lack of Efficacy|0|||
126229653|NCT00679783|454130917|FG000|Overall Study|Withdrawal by Subject|0|||
126229654|NCT00679783|454130918|FG001|Overall Study|Withdrawal by Subject|0|||
126229655|NCT00679783|454130919|FG002|Overall Study|Withdrawal by Subject|1|||
126229656|NCT00679783|454130920|FG003|Overall Study|Withdrawal by Subject|1|||
126352428|NCT03086343|454580737|FG003|Period 2|Lost to Follow-up|0|||
126352429|NCT03086343|454580734|FG000|Period 2|COVID-19 Infection|5|||
126352430|NCT03086343|454580735|FG001|Period 2|COVID-19 Infection|0|||
126352431|NCT03086343|454580736|FG002|Period 2|COVID-19 Infection|0|||
126352432|NCT03086343|454580737|FG003|Period 2|COVID-19 Infection|0|||
126021804|NCT02723955|453375399|FG031|Expansion Phase|Withdrawal by Subject|4|||
126021805|NCT02723955|453375400|FG032|Expansion Phase|Withdrawal by Subject|0|||
126021806|NCT02723955|453375401|FG033|Expansion Phase|Withdrawal by Subject|0|||
126352433|NCT03086343|454580734|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
126352434|NCT03086343|454580735|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
126352435|NCT03086343|454580736|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
126352436|NCT03086343|454580737|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
126352437|NCT03086343|454580734|FG000|Period 2|Other, Not Specified|23|||
126352438|NCT03086343|454580735|FG001|Period 2|Other, Not Specified|22|||
126352439|NCT03086343|454580736|FG002|Period 2|Other, Not Specified|2|||
126352440|NCT03086343|454580737|FG003|Period 2|Other, Not Specified|4|||
126352441|NCT01047501|454580738|FG000|Overall Study|Adverse Event|7|||
126352442|NCT01047501|454580739|FG001|Overall Study|Adverse Event|8|||
126352443|NCT01047501|454580740|FG002|Overall Study|Adverse Event|5|||
126352444|NCT01047501|454580738|FG000|Overall Study|Withdrew Consent|6|||
126352445|NCT01047501|454580739|FG001|Overall Study|Withdrew Consent|2|||
126352446|NCT01047501|454580740|FG002|Overall Study|Withdrew Consent|4|||
126352447|NCT01047501|454580738|FG000|Overall Study|Lost to Follow-up|0|||
126352448|NCT01047501|454580739|FG001|Overall Study|Lost to Follow-up|1|||
126352449|NCT01047501|454580740|FG002|Overall Study|Lost to Follow-up|1|||
126352450|NCT01047501|454580738|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
126352451|NCT01047501|454580739|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
126352452|NCT01047501|454580740|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
126352453|NCT01047501|454580738|FG000|Overall Study|Death|1|||
126352454|NCT01047501|454580739|FG001|Overall Study|Death|0|||
126352455|NCT01047501|454580740|FG002|Overall Study|Death|0|||
126352456|NCT01047501|454580738|FG000|Overall Study|Other discontinuation|1|||
126352457|NCT01047501|454580739|FG001|Overall Study|Other discontinuation|0|||
126352458|NCT01047501|454580740|FG002|Overall Study|Other discontinuation|1|||
126352459|NCT01047501|454580738|FG000|Overall Study|Investigator judgement|0|||
126352460|NCT01047501|454580739|FG001|Overall Study|Investigator judgement|0|||
126352461|NCT01047501|454580740|FG002|Overall Study|Investigator judgement|1|||
126352462|NCT00741611|454580741|FG000|Overall Study|Death|0|||
126352463|NCT00741611|454580742|FG001|Overall Study|Death|0|||
126352464|NCT00741611|454580743|FG002|Overall Study|Death|1|||
126352465|NCT00741611|454580741|FG000|Overall Study|Withdrawal by Subject|0|||
126352466|NCT00741611|454580742|FG001|Overall Study|Withdrawal by Subject|2|||
126352467|NCT00741611|454580743|FG002|Overall Study|Withdrawal by Subject|2|||
126352468|NCT01510756|454580746|FG000|Overall Study|Death|1|||
126352469|NCT01510756|454580746|FG000|Overall Study|Lack of Efficacy|2|||
126352470|NCT01510756|454580746|FG000|Overall Study|Physician Decision|1|||
126352471|NCT03600428|454580750|FG000|Overall Study|Not eligible|0|||
126021807|NCT02723955|453375402|FG034|Expansion Phase|Withdrawal by Subject|0|||
126352472|NCT03600428|454580751|FG001|Overall Study|Not eligible|1|||
126352473|NCT03600428|454580750|FG000|Overall Study|Lost to Follow-up|5|||
126229657|NCT00679783|454130921|FG004|Overall Study|Withdrawal by Subject|0|||
126229658|NCT00679783|454130922|FG005|Overall Study|Withdrawal by Subject|0|||
126229659|NCT00679783|454130923|FG006|Overall Study|Withdrawal by Subject|0|||
126352474|NCT03600428|454580751|FG001|Overall Study|Lost to Follow-up|4|||
126352475|NCT04398134|454580752|FG000|Overall Study|Adverse Event|0|||
126352476|NCT04398134|454580753|FG001|Overall Study|Adverse Event|0|||
126352477|NCT04398134|454580754|FG002|Overall Study|Adverse Event|1|||
126352478|NCT04398134|454580755|FG003|Overall Study|Adverse Event|0|||
126352479|NCT04398134|454580752|FG000|Overall Study|Withdrawal by Subject|2|||
126352480|NCT04398134|454580753|FG001|Overall Study|Withdrawal by Subject|0|||
126229660|NCT00679783|454130917|FG000|Overall Study|Not Captured|0|||
126229661|NCT00679783|454130918|FG001|Overall Study|Not Captured|0|||
126229662|NCT00679783|454130919|FG002|Overall Study|Not Captured|0|||
126229663|NCT00679783|454130920|FG003|Overall Study|Not Captured|5|||
126229664|NCT00679783|454130921|FG004|Overall Study|Not Captured|0|||
126229665|NCT00679783|454130922|FG005|Overall Study|Not Captured|0|||
126229666|NCT00679783|454130923|FG006|Overall Study|Not Captured|0|||
126229667|NCT00679783|454130917|FG000|Overall Study|Ongoing at data cut-off|2|||
126229668|NCT00679783|454130918|FG001|Overall Study|Ongoing at data cut-off|2|||
126229669|NCT00679783|454130919|FG002|Overall Study|Ongoing at data cut-off|0|||
126229670|NCT00679783|454130920|FG003|Overall Study|Ongoing at data cut-off|9|||
126229671|NCT00679783|454130921|FG004|Overall Study|Ongoing at data cut-off|1|||
126229672|NCT00679783|454130922|FG005|Overall Study|Ongoing at data cut-off|0|||
126229673|NCT00679783|454130923|FG006|Overall Study|Ongoing at data cut-off|0|||
126229674|NCT01754259|454130926|FG000|Overall Study|Withdrawal by Subject|2|||
126229675|NCT01754259|454130927|FG001|Overall Study|Withdrawal by Subject|4|||
126229676|NCT01754259|454130926|FG000|Overall Study|Adverse Event|3|||
126229677|NCT01754259|454130927|FG001|Overall Study|Adverse Event|1|||
126229678|NCT01754259|454130926|FG000|Overall Study|Lost to Follow-up|0|||
126229679|NCT01754259|454130927|FG001|Overall Study|Lost to Follow-up|1|||
126229680|NCT00306384|454130928|FG000|Overall Study|Adverse Event|103|||
126229681|NCT00306384|454130929|FG001|Overall Study|Adverse Event|87|||
126229682|NCT00306384|454130930|FG002|Overall Study|Adverse Event|40|||
126229683|NCT00306384|454130928|FG000|Overall Study|Major protocol deviation|43|||
126229684|NCT00306384|454130929|FG001|Overall Study|Major protocol deviation|51|||
126229685|NCT00306384|454130930|FG002|Overall Study|Major protocol deviation|18|||
126229686|NCT00306384|454130928|FG000|Overall Study|Lost to Follow-up|57|||
126229687|NCT00306384|454130929|FG001|Overall Study|Lost to Follow-up|41|||
126229688|NCT00306384|454130930|FG002|Overall Study|Lost to Follow-up|35|||
126229689|NCT00306384|454130928|FG000|Overall Study|Voluntary withdrawal|199|||
126229690|NCT00306384|454130929|FG001|Overall Study|Voluntary withdrawal|187|||
126229691|NCT00306384|454130930|FG002|Overall Study|Voluntary withdrawal|91|||
126229692|NCT00306384|454130928|FG000|Overall Study|Study termination|1|||
126229693|NCT00306384|454130929|FG001|Overall Study|Study termination|0|||
126229694|NCT00306384|454130930|FG002|Overall Study|Study termination|1|||
126229695|NCT00306384|454130928|FG000|Overall Study|Pregnancy|3|||
126229696|NCT00306384|454130929|FG001|Overall Study|Pregnancy|1|||
126229697|NCT00306384|454130930|FG002|Overall Study|Pregnancy|1|||
126229698|NCT00306384|454130928|FG000|Overall Study|Lack of Efficacy|26|||
126229699|NCT00306384|454130929|FG001|Overall Study|Lack of Efficacy|40|||
126229700|NCT00306384|454130930|FG002|Overall Study|Lack of Efficacy|38|||
126229701|NCT00306384|454130928|FG000|Overall Study|Investigator discretion|28|||
126229702|NCT00306384|454130929|FG001|Overall Study|Investigator discretion|31|||
126229703|NCT00306384|454130930|FG002|Overall Study|Investigator discretion|21|||
126229704|NCT00306384|454130928|FG000|Overall Study|Other|80|||
126229705|NCT00306384|454130929|FG001|Overall Study|Other|70|||
126229706|NCT00306384|454130930|FG002|Overall Study|Other|32|||
126229707|NCT00306384|454130928|FG000|Overall Study|Site closure|2|||
126229708|NCT00306384|454130929|FG001|Overall Study|Site closure|0|||
126229709|NCT00306384|454130930|FG002|Overall Study|Site closure|0|||
126352481|NCT04398134|454580754|FG002|Overall Study|Withdrawal by Subject|0|||
126229710|NCT02154529|454130931|FG000|Overall Study|Death|1|||
126229711|NCT02154529|454130932|FG001|Overall Study|Death|1|||
126352482|NCT04398134|454580755|FG003|Overall Study|Withdrawal by Subject|1|||
126352483|NCT04398134|454580752|FG000|Overall Study|Study Terminated by Sponsor|30|||
126352484|NCT04398134|454580753|FG001|Overall Study|Study Terminated by Sponsor|11|||
126352485|NCT04398134|454580754|FG002|Overall Study|Study Terminated by Sponsor|32|||
126352486|NCT04398134|454580755|FG003|Overall Study|Study Terminated by Sponsor|11|||
126352487|NCT00153920|454580757|FG000|Overall Study|Adverse Event|9|||
126352488|NCT00153920|454580757|FG000|Overall Study|Progressive Disease|9|||
126352489|NCT00153920|454580757|FG000|Overall Study|Physician Decision|3|||
126352490|NCT00153920|454580757|FG000|Overall Study|Lack of Response|3|||
126352491|NCT00153920|454580757|FG000|Overall Study|Death|2|||
126352492|NCT00153920|454580757|FG000|Overall Study|Withdrawal by Subject|1|||
126352493|NCT00153920|454580757|FG000|Overall Study|Non-Protocol Therapy|1|||
126352494|NCT00153920|454580757|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
126021808|NCT02723955|453375403|FG035|Expansion Phase|Withdrawal by Subject|1|||
126021809|NCT02723955|453375404|FG036|Expansion Phase|Withdrawal by Subject|0|||
126021810|NCT02723955|453375405|FG037|Expansion Phase|Withdrawal by Subject|0|||
126229712|NCT02154529|454130933|FG002|Overall Study|Death|5|||
126021811|NCT02723955|453375406|FG038|Expansion Phase|Withdrawal by Subject|0|||
126229713|NCT02154529|454130934|FG003|Overall Study|Death|1|||
126229714|NCT02154529|454130931|FG000|Overall Study|Termination of study by sponsor|2|||
126229715|NCT02154529|454130932|FG001|Overall Study|Termination of study by sponsor|2|||
126229716|NCT02154529|454130933|FG002|Overall Study|Termination of study by sponsor|3|||
126229717|NCT02154529|454130934|FG003|Overall Study|Termination of study by sponsor|1|||
126021812|NCT02723955|453375407|FG039|Expansion Phase|Withdrawal by Subject|0|||
126021813|NCT02723955|453375408|FG040|Expansion Phase|Withdrawal by Subject|0|||
126021814|NCT02723955|453375409|FG041|Expansion Phase|Withdrawal by Subject|0|||
126021815|NCT02723955|453375410|FG042|Expansion Phase|Withdrawal by Subject|0|||
126229718|NCT02154529|454130931|FG000|Overall Study|Lost to Follow-up|1|||
126229719|NCT02154529|454130932|FG001|Overall Study|Lost to Follow-up|0|||
126229720|NCT02154529|454130933|FG002|Overall Study|Lost to Follow-up|0|||
126229721|NCT02154529|454130934|FG003|Overall Study|Lost to Follow-up|0|||
126229722|NCT00458302|454132281|FG000|Overall Study|Adverse Event|4|||
126229723|NCT00458302|454132282|FG001|Overall Study|Adverse Event|14|||
126229724|NCT00458302|454132281|FG000|Overall Study|Pregnancy|2|||
126229725|NCT00458302|454132282|FG001|Overall Study|Pregnancy|1|||
126229726|NCT00458302|454132281|FG000|Overall Study|Protocol Violation|0|||
126229727|NCT00458302|454132282|FG001|Overall Study|Protocol Violation|2|||
126229728|NCT00458302|454132281|FG000|Overall Study|Withdrawal by Subject|6|||
126229729|NCT00458302|454132282|FG001|Overall Study|Withdrawal by Subject|4|||
126229730|NCT00458302|454132281|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
126229731|NCT00458302|454132282|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
126229732|NCT00458302|454132281|FG000|Overall Study|Study Termination By Sponsor|1|||
126229733|NCT00458302|454132282|FG001|Overall Study|Study Termination By Sponsor|0|||
126229734|NCT00458302|454132281|FG000|Overall Study|Lost to Follow-up|2|||
126229735|NCT00458302|454132282|FG001|Overall Study|Lost to Follow-up|0|||
126229736|NCT00458302|454132281|FG000|Overall Study|Other|4|||
126229737|NCT00458302|454132282|FG001|Overall Study|Other|2|||
126229738|NCT02178709|454132283|FG000|Overall Study|Adverse Event|5|||
126229739|NCT02178709|454132283|FG000|Overall Study|Death|2|||
126229740|NCT02178709|454132283|FG000|Overall Study|Withdrawal by Subject|2|||
126229741|NCT02178709|454132283|FG000|Overall Study|Physician Decision|2|||
126229742|NCT02178709|454132283|FG000|Overall Study|Disease Progression|5|||
126229743|NCT01241461|454132284|FG000|Overall Study|Progressive Disease|3|||
126229744|NCT01241461|454132285|FG001|Overall Study|Progressive Disease|6|||
126229745|NCT01379781|454132289|FG000|Overall Study|Lost to Follow-up|11|||
126229746|NCT01379781|454132290|FG001|Overall Study|Lost to Follow-up|8|||
126229747|NCT03329027|454132293|FG000|Overall Study|Lost to Follow-up|1|||
126229748|NCT03329027|454132294|FG001|Overall Study|Lost to Follow-up|0|||
126229749|NCT03329027|454132295|FG002|Overall Study|Lost to Follow-up|1|||
126229750|NCT03329027|454132293|FG000|Overall Study|Protocol Violation|9|||
126229751|NCT03329027|454132294|FG001|Overall Study|Protocol Violation|5|||
126229752|NCT03329027|454132295|FG002|Overall Study|Protocol Violation|7|||
126229753|NCT04849988|454132300|FG000|Overall Study|Lack of Efficacy|3|||
126229754|NCT04849988|454132301|FG001|Overall Study|Lack of Efficacy|4|||
126229755|NCT04849988|454132302|FG002|Overall Study|Lack of Efficacy|1|||
126229756|NCT04849988|454132303|FG003|Overall Study|Lack of Efficacy|4|||
126229757|NCT04849988|454132300|FG000|Overall Study|Other reasons|1|||
126229758|NCT04849988|454132301|FG001|Overall Study|Other reasons|2|||
126229759|NCT04849988|454132302|FG002|Overall Study|Other reasons|2|||
126229760|NCT04849988|454132303|FG003|Overall Study|Other reasons|1|||
126229761|NCT01052116|454132313|FG000|Overall Study|Lost to Follow-up|11|||
126229762|NCT01052116|454132314|FG001|Overall Study|Lost to Follow-up|17|||
126229763|NCT01052116|454132313|FG000|Overall Study|Withdrawal by Subject|3|||
126229764|NCT01052116|454132314|FG001|Overall Study|Withdrawal by Subject|6|||
126229765|NCT01052116|454132313|FG000|Overall Study|Spirometry not performed|0|||
126229766|NCT01052116|454132314|FG001|Overall Study|Spirometry not performed|4|||
126229767|NCT00836927|454132319|FG000|Overall Study|Progressive disease|2|||
126229768|NCT00836927|454132320|FG001|Overall Study|Progressive disease|0|||
126229769|NCT00836927|454132321|FG002|Overall Study|Progressive disease|0|||
126229770|NCT00836927|454132322|FG003|Overall Study|Progressive disease|1|||
126229771|NCT00836927|454132323|FG004|Overall Study|Progressive disease|1|||
126229772|NCT00836927|454132319|FG000|Overall Study|Withdrawal by Subject|1|||
126229773|NCT00836927|454132320|FG001|Overall Study|Withdrawal by Subject|0|||
126229774|NCT00836927|454132321|FG002|Overall Study|Withdrawal by Subject|0|||
126229775|NCT00836927|454132322|FG003|Overall Study|Withdrawal by Subject|0|||
126229776|NCT00836927|454132323|FG004|Overall Study|Withdrawal by Subject|0|||
126229777|NCT00614055|454132327|FG000|Overall Study|Adverse Event|1|||
126229778|NCT00614055|454132328|FG001|Overall Study|Adverse Event|0|||
126229779|NCT00614055|454132329|FG002|Overall Study|Adverse Event|0|||
126229780|NCT00614055|454132327|FG000|Overall Study|Protocol Violation|2|||
126229781|NCT00614055|454132328|FG001|Overall Study|Protocol Violation|2|||
126229782|NCT00614055|454132329|FG002|Overall Study|Protocol Violation|1|||
126229783|NCT00614055|454132327|FG000|Overall Study|Lack of Efficacy|0|||
126021816|NCT02723955|453375368|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126229784|NCT00614055|454132328|FG001|Overall Study|Lack of Efficacy|0|||
126229785|NCT00614055|454132329|FG002|Overall Study|Lack of Efficacy|2|||
126229786|NCT00614055|454132327|FG000|Overall Study|Unclassified|1|||
126229787|NCT00614055|454132328|FG001|Overall Study|Unclassified|4|||
126229788|NCT00614055|454132329|FG002|Overall Study|Unclassified|2|||
126229789|NCT01296932|454132332|FG000|Overall Study|Dose limiting toxicity|0|||
126229790|NCT01296932|454132333|FG001|Overall Study|Dose limiting toxicity|0|||
126229791|NCT01296932|454132334|FG002|Overall Study|Dose limiting toxicity|0|||
126229792|NCT01296932|454132335|FG003|Overall Study|Dose limiting toxicity|0|||
126229793|NCT01296932|454132336|FG004|Overall Study|Dose limiting toxicity|0|||
126229794|NCT01296932|454132337|FG005|Overall Study|Dose limiting toxicity|0|||
126229795|NCT01296932|454132338|FG006|Overall Study|Dose limiting toxicity|1|||
126229796|NCT01296932|454132339|FG007|Overall Study|Dose limiting toxicity|0|||
126229797|NCT01296932|454132340|FG008|Overall Study|Dose limiting toxicity|1|||
126229798|NCT01296932|454132332|FG000|Overall Study|Progressive disease|2|||
126229799|NCT01296932|454132333|FG001|Overall Study|Progressive disease|0|||
126229800|NCT01296932|454132334|FG002|Overall Study|Progressive disease|1|||
126229801|NCT01296932|454132335|FG003|Overall Study|Progressive disease|1|||
126229802|NCT01296932|454132336|FG004|Overall Study|Progressive disease|2|||
126229803|NCT01296932|454132337|FG005|Overall Study|Progressive disease|3|||
126229804|NCT01296932|454132338|FG006|Overall Study|Progressive disease|1|||
126229805|NCT01296932|454132339|FG007|Overall Study|Progressive disease|0|||
126229806|NCT01296932|454132340|FG008|Overall Study|Progressive disease|0|||
126229807|NCT01296932|454132332|FG000|Overall Study|Withdrawal by Subject|0|||
126229808|NCT01296932|454132333|FG001|Overall Study|Withdrawal by Subject|0|||
126229809|NCT01296932|454132334|FG002|Overall Study|Withdrawal by Subject|1|||
126229810|NCT01296932|454132335|FG003|Overall Study|Withdrawal by Subject|1|||
126352495|NCT00153920|454580757|FG000|Overall Study|Progressive Disease before Trt|1|||
126352496|NCT01666652|454580763|FG000|Overall Study|Serious Adverse Event|0|||
126352497|NCT01666652|454580764|FG001|Overall Study|Serious Adverse Event|0|||
126352498|NCT01666652|454580765|FG002|Overall Study|Serious Adverse Event|0|||
126352499|NCT01666652|454580766|FG003|Overall Study|Serious Adverse Event|1|||
126352500|NCT01666652|454580767|FG004|Overall Study|Serious Adverse Event|0|||
126352501|NCT01666652|454580763|FG000|Overall Study|Withdrawal by Subject|0|||
126352502|NCT01666652|454580764|FG001|Overall Study|Withdrawal by Subject|0|||
126352503|NCT01666652|454580765|FG002|Overall Study|Withdrawal by Subject|0|||
126352504|NCT01666652|454580766|FG003|Overall Study|Withdrawal by Subject|0|||
126352505|NCT01666652|454580767|FG004|Overall Study|Withdrawal by Subject|1|||
126352506|NCT01666652|454580763|FG000|Overall Study|Moved from study area|1|||
126352507|NCT01666652|454580764|FG001|Overall Study|Moved from study area|0|||
126352508|NCT01666652|454580765|FG002|Overall Study|Moved from study area|0|||
126352509|NCT01666652|454580766|FG003|Overall Study|Moved from study area|2|||
126352510|NCT01666652|454580767|FG004|Overall Study|Moved from study area|0|||
126352511|NCT01666652|454580763|FG000|Overall Study|Lost to Follow-up|1|||
126352512|NCT01666652|454580764|FG001|Overall Study|Lost to Follow-up|1|||
126352513|NCT01666652|454580765|FG002|Overall Study|Lost to Follow-up|1|||
126352514|NCT01666652|454580766|FG003|Overall Study|Lost to Follow-up|1|||
126352515|NCT01666652|454580767|FG004|Overall Study|Lost to Follow-up|0|||
126352516|NCT01018979|454580768|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
126352517|NCT01018979|454580769|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
126352518|NCT01018979|454580768|FG000|Overall Study|Not received at least one dose|0|||
126352519|NCT01018979|454580769|FG001|Overall Study|Not received at least one dose|1|||
126352520|NCT03010501|454580772|FG000|Study Week 1|Withdrawal by Subject|2|||
126352521|NCT03010501|454580773|FG001|Study Week 1|Withdrawal by Subject|1|||
126352522|NCT03010501|454580774|FG002|Study Week 1|Withdrawal by Subject|0|||
126352523|NCT03010501|454580775|FG003|Study Week 1|Withdrawal by Subject|2|||
126352524|NCT03010501|454580776|FG004|Study Week 1|Withdrawal by Subject|0|||
126352525|NCT03010501|454580777|FG005|Study Week 1|Withdrawal by Subject|0|||
126352526|NCT03010501|454580772|FG000|Study Week 3|Withdrawal by Subject|0|||
126352527|NCT03010501|454580773|FG001|Study Week 3|Withdrawal by Subject|0|||
126352528|NCT03010501|454580774|FG002|Study Week 3|Withdrawal by Subject|0|||
126352529|NCT03010501|454580775|FG003|Study Week 3|Withdrawal by Subject|1|||
126352530|NCT03010501|454580776|FG004|Study Week 3|Withdrawal by Subject|0|||
126352531|NCT03010501|454580777|FG005|Study Week 3|Withdrawal by Subject|0|||
126352532|NCT00640289|454580778|FG000|Overall Study|Death|3|||
126352533|NCT00640289|454580778|FG000|Overall Study|Withdrawal by Subject|1|||
126352534|NCT00640289|454580778|FG000|Overall Study|Lost to Follow-up|1|||
126352535|NCT00640289|454580778|FG000|Overall Study|Data collected under different amendment|2|||
126352536|NCT00640289|454580778|FG000|Overall Study|Transferred to another center|1|||
126229811|NCT01296932|454132336|FG004|Overall Study|Withdrawal by Subject|0|||
126352537|NCT00640289|454580778|FG000|Overall Study|Missing status|5|||
126352538|NCT00544882|454580781|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
126352539|NCT00544882|454580782|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
126352540|NCT00544882|454580783|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
126229812|NCT01296932|454132337|FG005|Overall Study|Withdrawal by Subject|0|||
126229813|NCT01296932|454132338|FG006|Overall Study|Withdrawal by Subject|3|||
126229814|NCT01296932|454132339|FG007|Overall Study|Withdrawal by Subject|0|||
126229815|NCT01296932|454132340|FG008|Overall Study|Withdrawal by Subject|0|||
126229816|NCT01296932|454132332|FG000|Overall Study|Adverse Event|1|||
126229817|NCT01296932|454132333|FG001|Overall Study|Adverse Event|1|||
126229818|NCT01296932|454132334|FG002|Overall Study|Adverse Event|1|||
126229819|NCT01296932|454132335|FG003|Overall Study|Adverse Event|2|||
126229820|NCT01296932|454132336|FG004|Overall Study|Adverse Event|1|||
126229821|NCT01296932|454132337|FG005|Overall Study|Adverse Event|0|||
126229822|NCT01296932|454132338|FG006|Overall Study|Adverse Event|0|||
126229823|NCT01296932|454132339|FG007|Overall Study|Adverse Event|0|||
126229824|NCT01296932|454132340|FG008|Overall Study|Adverse Event|1|||
126229825|NCT01296932|454132332|FG000|Overall Study|Investigator decision|0|||
126229826|NCT01296932|454132333|FG001|Overall Study|Investigator decision|1|||
126229827|NCT01296932|454132334|FG002|Overall Study|Investigator decision|0|||
126229828|NCT01296932|454132335|FG003|Overall Study|Investigator decision|1|||
126229829|NCT01296932|454132336|FG004|Overall Study|Investigator decision|0|||
126229830|NCT01296932|454132337|FG005|Overall Study|Investigator decision|0|||
126229831|NCT01296932|454132338|FG006|Overall Study|Investigator decision|1|||
126229832|NCT01296932|454132339|FG007|Overall Study|Investigator decision|0|||
126229833|NCT01296932|454132340|FG008|Overall Study|Investigator decision|1|||
126229834|NCT01296932|454132332|FG000|Overall Study|No clinical benefit anymore|0|||
126229835|NCT01296932|454132333|FG001|Overall Study|No clinical benefit anymore|1|||
126229836|NCT01296932|454132334|FG002|Overall Study|No clinical benefit anymore|0|||
126229837|NCT01296932|454132335|FG003|Overall Study|No clinical benefit anymore|0|||
126229838|NCT01296932|454132336|FG004|Overall Study|No clinical benefit anymore|0|||
126229839|NCT01296932|454132337|FG005|Overall Study|No clinical benefit anymore|0|||
126229840|NCT01296932|454132338|FG006|Overall Study|No clinical benefit anymore|0|||
126229841|NCT01296932|454132339|FG007|Overall Study|No clinical benefit anymore|0|||
126229842|NCT01296932|454132340|FG008|Overall Study|No clinical benefit anymore|0|||
126229843|NCT01296932|454132332|FG000|Overall Study|Physician Decision|0|||
126229844|NCT01296932|454132333|FG001|Overall Study|Physician Decision|0|||
126229845|NCT01296932|454132334|FG002|Overall Study|Physician Decision|1|||
126229846|NCT01296932|454132335|FG003|Overall Study|Physician Decision|0|||
126229847|NCT01296932|454132336|FG004|Overall Study|Physician Decision|0|||
126229848|NCT01296932|454132337|FG005|Overall Study|Physician Decision|0|||
126352541|NCT00544882|454580781|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
126352542|NCT00544882|454580782|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
126352543|NCT00544882|454580783|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
126352544|NCT00544882|454580781|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
126352545|NCT00544882|454580782|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
126352546|NCT00544882|454580783|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
126352547|NCT00544882|454580781|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
126352548|NCT00544882|454580782|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
126352549|NCT00544882|454580783|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
126352550|NCT00544882|454580781|FG000|Cycle 3: Follow-up|Noncompliance|0|||
126352551|NCT00544882|454580782|FG001|Cycle 3: Follow-up|Noncompliance|1|||
126352552|NCT00544882|454580783|FG002|Cycle 3: Follow-up|Noncompliance|0|||
126352553|NCT00544882|454580781|FG000|Cycle 3: Follow-up|Pregnancy|0|||
126352554|NCT00544882|454580782|FG001|Cycle 3: Follow-up|Pregnancy|1|||
126352555|NCT00544882|454580783|FG002|Cycle 3: Follow-up|Pregnancy|0|||
126352556|NCT03043573|454580784|FG000|Overall Study|Lost to Follow-up|3|||
126352557|NCT03043573|454580785|FG001|Overall Study|Lost to Follow-up|3|||
126352558|NCT03043573|454580784|FG000|Overall Study|Physician Decision|0|||
126352559|NCT03043573|454580785|FG001|Overall Study|Physician Decision|5|||
126352560|NCT03043573|454580784|FG000|Overall Study|Withdrawal by Subject|0|||
126352561|NCT03043573|454580785|FG001|Overall Study|Withdrawal by Subject|4|||
126352562|NCT01251861|454580788|FG000|Overall Study|Disease progression|6|||
126352563|NCT01251861|454580789|FG001|Overall Study|Disease progression|6|||
126352564|NCT01251861|454580788|FG000|Overall Study|Adverse Event|2|||
126352565|NCT01251861|454580789|FG001|Overall Study|Adverse Event|17|||
126352566|NCT01251861|454580788|FG000|Overall Study|Withdrawal by Subject|2|||
126352567|NCT01251861|454580789|FG001|Overall Study|Withdrawal by Subject|2|||
126352568|NCT01251861|454580788|FG000|Overall Study|Alternative therapy|1|||
126229849|NCT01296932|454132338|FG006|Overall Study|Physician Decision|0|||
126229850|NCT01296932|454132339|FG007|Overall Study|Physician Decision|0|||
126229851|NCT01296932|454132340|FG008|Overall Study|Physician Decision|0|||
126229852|NCT01296932|454132332|FG000|Overall Study|IV problems, administration not possible|0|||
126229853|NCT01296932|454132333|FG001|Overall Study|IV problems, administration not possible|0|||
126229854|NCT01296932|454132334|FG002|Overall Study|IV problems, administration not possible|1|||
126229855|NCT01296932|454132335|FG003|Overall Study|IV problems, administration not possible|0|||
126229856|NCT01296932|454132336|FG004|Overall Study|IV problems, administration not possible|0|||
126352569|NCT01251861|454580789|FG001|Overall Study|Alternative therapy|0|||
126021817|NCT02723955|453375369|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021818|NCT02723955|453375370|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021819|NCT02723955|453375371|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021820|NCT02723955|453375372|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021821|NCT02723955|453375373|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126229857|NCT01296932|454132337|FG005|Overall Study|IV problems, administration not possible|0|||
126229858|NCT01296932|454132338|FG006|Overall Study|IV problems, administration not possible|0|||
126229859|NCT01296932|454132339|FG007|Overall Study|IV problems, administration not possible|0|||
126229860|NCT01296932|454132340|FG008|Overall Study|IV problems, administration not possible|0|||
126229861|NCT01296932|454132332|FG000|Overall Study|per protocol|0|||
126229862|NCT01296932|454132333|FG001|Overall Study|per protocol|0|||
126229863|NCT01296932|454132334|FG002|Overall Study|per protocol|1|||
126229864|NCT01296932|454132335|FG003|Overall Study|per protocol|1|||
126229865|NCT01296932|454132336|FG004|Overall Study|per protocol|0|||
126229866|NCT01296932|454132337|FG005|Overall Study|per protocol|0|||
126021822|NCT02723955|453375374|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021823|NCT02723955|453375375|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021824|NCT02723955|453375376|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021825|NCT02723955|453375377|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
126021826|NCT02723955|453375378|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
126021827|NCT02723955|453375379|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
126021828|NCT02723955|453375380|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021829|NCT02723955|453375381|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021830|NCT02723955|453375382|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021831|NCT02723955|453375383|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021832|NCT02723955|453375384|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021833|NCT02723955|453375385|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021834|NCT02723955|453375386|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021835|NCT02723955|453375387|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021836|NCT02723955|453375388|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021837|NCT02723955|453375389|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021838|NCT02723955|453375390|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021839|NCT02723955|453375391|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021840|NCT02723955|453375392|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021841|NCT02723955|453375393|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021842|NCT02723955|453375394|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021843|NCT02723955|453375395|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021844|NCT02723955|453375396|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021845|NCT02723955|453375397|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021846|NCT02723955|453375398|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
126021847|NCT02723955|453375399|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021848|NCT02723955|453375400|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021849|NCT02723955|453375401|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021850|NCT02723955|453375402|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021851|NCT02723955|453375403|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021852|NCT02723955|453375404|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021853|NCT02723955|453375405|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021854|NCT02723955|453375406|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021855|NCT02723955|453375407|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021856|NCT02723955|453375408|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126103462|NCT04620811|453672167|FG000|Overall Study|Adverse Event|6|||
126229867|NCT01296932|454132338|FG006|Overall Study|per protocol|0|||
126229868|NCT01296932|454132339|FG007|Overall Study|per protocol|0|||
126229869|NCT01296932|454132340|FG008|Overall Study|per protocol|0|||
126352570|NCT01251861|454580788|FG000|Overall Study|Other complicating disease|0|||
126352571|NCT01251861|454580789|FG001|Overall Study|Other complicating disease|1|||
126352572|NCT01251861|454580788|FG000|Overall Study|Physician Decision|1|||
126352573|NCT01251861|454580789|FG001|Overall Study|Physician Decision|0|||
126229870|NCT01296932|454132332|FG000|Overall Study|Low benefit and too many side effects|0|||
126229871|NCT01296932|454132333|FG001|Overall Study|Low benefit and too many side effects|0|||
126229872|NCT01296932|454132334|FG002|Overall Study|Low benefit and too many side effects|0|||
126229873|NCT01296932|454132335|FG003|Overall Study|Low benefit and too many side effects|0|||
126229874|NCT01296932|454132336|FG004|Overall Study|Low benefit and too many side effects|0|||
126229875|NCT01296932|454132337|FG005|Overall Study|Low benefit and too many side effects|0|||
126229876|NCT01296932|454132338|FG006|Overall Study|Low benefit and too many side effects|0|||
126229877|NCT01296932|454132339|FG007|Overall Study|Low benefit and too many side effects|1|||
126229878|NCT01296932|454132340|FG008|Overall Study|Low benefit and too many side effects|0|||
126229879|NCT01296932|454132332|FG000|Overall Study|No adequate treatment response|0|||
126229880|NCT01296932|454132333|FG001|Overall Study|No adequate treatment response|0|||
126229881|NCT01296932|454132334|FG002|Overall Study|No adequate treatment response|0|||
126229882|NCT01296932|454132335|FG003|Overall Study|No adequate treatment response|0|||
126229883|NCT01296932|454132336|FG004|Overall Study|No adequate treatment response|0|||
126229884|NCT01296932|454132337|FG005|Overall Study|No adequate treatment response|0|||
126229885|NCT01296932|454132338|FG006|Overall Study|No adequate treatment response|0|||
126229886|NCT01296932|454132339|FG007|Overall Study|No adequate treatment response|1|||
126229887|NCT01296932|454132340|FG008|Overall Study|No adequate treatment response|0|||
126229888|NCT01296932|454132332|FG000|Overall Study|Dosage already reduced, AE still present|0|||
126229889|NCT01296932|454132333|FG001|Overall Study|Dosage already reduced, AE still present|0|||
126229890|NCT01296932|454132334|FG002|Overall Study|Dosage already reduced, AE still present|0|||
126229891|NCT01296932|454132335|FG003|Overall Study|Dosage already reduced, AE still present|0|||
126229892|NCT01296932|454132336|FG004|Overall Study|Dosage already reduced, AE still present|0|||
126229893|NCT01296932|454132337|FG005|Overall Study|Dosage already reduced, AE still present|0|||
126229894|NCT01296932|454132338|FG006|Overall Study|Dosage already reduced, AE still present|0|||
126229895|NCT01296932|454132339|FG007|Overall Study|Dosage already reduced, AE still present|0|||
126229896|NCT01296932|454132340|FG008|Overall Study|Dosage already reduced, AE still present|1|||
126229897|NCT02688400|454132345|FG000|Overall Study|Protocol Violation|2|||
126229898|NCT02688400|454132346|FG001|Overall Study|Protocol Violation|5|||
126229899|NCT02688400|454132345|FG000|Overall Study|Lack of Efficacy|7|||
126021857|NCT02723955|453375409|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021858|NCT02723955|453375410|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126021859|NCT02723955|453375368|FG000|Expansion Phase|Site Closed|0|||
126229900|NCT02688400|454132346|FG001|Overall Study|Lack of Efficacy|7|||
126229901|NCT02688400|454132345|FG000|Overall Study|Adverse Event|21|||
126352574|NCT01251861|454580788|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
126352575|NCT01251861|454580789|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
126352576|NCT01251861|454580788|FG000|Overall Study|Other|1|||
126352577|NCT01251861|454580789|FG001|Overall Study|Other|0|||
126352578|NCT01251861|454580788|FG000|Overall Study|Never started therapy|4|||
126352579|NCT01251861|454580789|FG001|Overall Study|Never started therapy|1|||
126352580|NCT01251861|454580788|FG000|Overall Study|Potential interaction of drugs|0|||
126352581|NCT01251861|454580789|FG001|Overall Study|Potential interaction of drugs|1|||
126352582|NCT00479232|454582045|FG000|Overall Study|Adverse Event|0|||
126352583|NCT00479232|454582046|FG001|Overall Study|Adverse Event|0|||
126352584|NCT00479232|454582047|FG002|Overall Study|Adverse Event|5|||
126352585|NCT00479232|454582048|FG003|Overall Study|Adverse Event|0|||
126352586|NCT00479232|454582049|FG004|Overall Study|Adverse Event|0|||
126352587|NCT00479232|454582050|FG005|Overall Study|Adverse Event|10|||
126352588|NCT00479232|454582045|FG000|Overall Study|Deviation from Protocol|0|||
126352589|NCT00479232|454582046|FG001|Overall Study|Deviation from Protocol|0|||
126352590|NCT00479232|454582047|FG002|Overall Study|Deviation from Protocol|1|||
126352591|NCT00479232|454582048|FG003|Overall Study|Deviation from Protocol|0|||
126352592|NCT00479232|454582049|FG004|Overall Study|Deviation from Protocol|0|||
126352593|NCT00479232|454582050|FG005|Overall Study|Deviation from Protocol|0|||
126352594|NCT00479232|454582045|FG000|Overall Study|Lack of Efficacy|0|||
126352595|NCT00479232|454582046|FG001|Overall Study|Lack of Efficacy|0|||
126352596|NCT00479232|454582047|FG002|Overall Study|Lack of Efficacy|2|||
126352597|NCT00479232|454582048|FG003|Overall Study|Lack of Efficacy|0|||
126352598|NCT00479232|454582049|FG004|Overall Study|Lack of Efficacy|0|||
126352599|NCT00479232|454582050|FG005|Overall Study|Lack of Efficacy|4|||
126021860|NCT02723955|453375369|FG001|Expansion Phase|Site Closed|0|||
126229902|NCT02688400|454132346|FG001|Overall Study|Adverse Event|12|||
126352600|NCT00479232|454582045|FG000|Overall Study|Physician Decision|0|||
126352601|NCT00479232|454582046|FG001|Overall Study|Physician Decision|0|||
126352602|NCT00479232|454582047|FG002|Overall Study|Physician Decision|2|||
126352603|NCT00479232|454582048|FG003|Overall Study|Physician Decision|0|||
126352604|NCT00479232|454582049|FG004|Overall Study|Physician Decision|0|||
126352605|NCT00479232|454582050|FG005|Overall Study|Physician Decision|1|||
126352606|NCT00479232|454582045|FG000|Overall Study|Progressive Disease|3|||
126021861|NCT02723955|453375370|FG002|Expansion Phase|Site Closed|0|||
126021862|NCT02723955|453375371|FG003|Expansion Phase|Site Closed|0|||
126021863|NCT02723955|453375372|FG004|Expansion Phase|Site Closed|0|||
126229903|NCT02688400|454132345|FG000|Overall Study|Withdrawal by Subject|15|||
126229904|NCT02688400|454132346|FG001|Overall Study|Withdrawal by Subject|13|||
126229905|NCT02688400|454132345|FG000|Overall Study|No study medication intake|1|||
126229906|NCT02688400|454132346|FG001|Overall Study|No study medication intake|4|||
126229907|NCT02688400|454132345|FG000|Overall Study|Lost to Follow-up|0|||
126229908|NCT02688400|454132346|FG001|Overall Study|Lost to Follow-up|3|||
126229909|NCT02295774|454132348|FG000|Overall Study|Physician Decision|1|||
126229910|NCT02295774|454132348|FG000|Overall Study|Withdrawal by Subject|2|||
126229911|NCT01075763|454132349|FG000|Overall Study|Lost to Follow-up|2|||
126229912|NCT01075763|454132350|FG001|Overall Study|Lost to Follow-up|1|||
126229913|NCT01075763|454132349|FG000|Overall Study|Lack of Efficacy|0|||
126229914|NCT01075763|454132350|FG001|Overall Study|Lack of Efficacy|1|||
126229915|NCT01075763|454132349|FG000|Overall Study|Withdrawal by Subject|2|||
126229916|NCT01075763|454132350|FG001|Overall Study|Withdrawal by Subject|2|||
126229917|NCT00586521|454132351|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
126229918|NCT03731182|454132359|FG000|Overall Study|Lost to Follow-up|2|||
126229919|NCT03731182|454132360|FG001|Overall Study|Lost to Follow-up|0|||
126229920|NCT03731182|454132359|FG000|Overall Study|Physician Decision|1|||
126229921|NCT03731182|454132360|FG001|Overall Study|Physician Decision|0|||
126229922|NCT03731182|454132359|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
126229923|NCT03731182|454132360|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
126229924|NCT02006706|454132361|FG000|Overall Study|Lost to Follow-up|1|||
126229925|NCT00582036|454132362|FG000|Overall Study|Withdrawal by Subject|0|||
126229926|NCT00582036|454132363|FG001|Overall Study|Withdrawal by Subject|1|||
126229927|NCT04161144|454132364|FG000|Overall Study|Withdrawal by Subject|0|||
126229928|NCT04161144|454132365|FG001|Overall Study|Withdrawal by Subject|1|||
126229929|NCT04161144|454132364|FG000|Overall Study|Protocol Violation|1|||
126229930|NCT04161144|454132365|FG001|Overall Study|Protocol Violation|0|||
126229931|NCT00958256|454132367|FG000|Overall Study|Adverse Event|3|||
126229932|NCT03036579|454132371|FG000|2 Years|Lost to Follow-up|1|||
126229933|NCT03036579|454132372|FG001|2 Years|Lost to Follow-up|0|||
126229934|NCT03036579|454132371|FG000|3 Years|Lost to Follow-up|0|||
126229935|NCT03036579|454132372|FG001|3 Years|Lost to Follow-up|1|||
126229936|NCT02848599|454132373|FG000|Overall Study|Protocol Violation|7|||
126229937|NCT02848599|454132374|FG001|Overall Study|Protocol Violation|9|||
126229938|NCT02352337|454132375|FG000|Overall Study|Patients never treated|4|||
126229939|NCT02352337|454132376|FG001|Overall Study|Patients never treated|1|||
126229940|NCT02352337|454132377|FG002|Overall Study|Patients never treated|2|||
126229941|NCT00992407|454132380|FG000|Overall Study|Protocol Violation|2|||
126229942|NCT00992407|454132381|FG001|Overall Study|Protocol Violation|1|||
126229943|NCT00992407|454132380|FG000|Overall Study|Lost to Follow-up|3|||
126229944|NCT00992407|454132381|FG001|Overall Study|Lost to Follow-up|3|||
126229945|NCT00992407|454132380|FG000|Overall Study|Adverse Event|3|||
126229946|NCT00992407|454132381|FG001|Overall Study|Adverse Event|2|||
126229947|NCT00992407|454132380|FG000|Overall Study|protocol Violation & Adverse events|2|||
126229948|NCT00992407|454132381|FG001|Overall Study|protocol Violation & Adverse events|4|||
126229949|NCT00992407|454132380|FG000|Overall Study|Other|2|||
126229950|NCT00992407|454132381|FG001|Overall Study|Other|0|||
126229951|NCT00992407|454132380|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
126229952|NCT00992407|454132381|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
126229953|NCT00992407|454132380|FG000|Overall Study|Study medication not administered|17|||
126229954|NCT00992407|454132381|FG001|Overall Study|Study medication not administered|13|||
126229955|NCT02918162|454132383|FG000|Overall Study|Withdrawal by Subject|1|||
126229956|NCT02918162|454132383|FG000|Overall Study|Omental Disease|1|||
126229957|NCT00395226|454132384|FG000|Overall Study|Adverse Event|4|||
126229958|NCT00395226|454132385|FG001|Overall Study|Adverse Event|3|||
126229959|NCT00395226|454132384|FG000|Overall Study|Withdrawal by Subject|0|||
126229960|NCT00395226|454132385|FG001|Overall Study|Withdrawal by Subject|1|||
126229961|NCT00395226|454132384|FG000|Overall Study|Lost to Follow-up|0|||
126229962|NCT00395226|454132385|FG001|Overall Study|Lost to Follow-up|1|||
126229963|NCT01000337|454132389|FG000|Overall Study|Lost to Follow-up|4|||
126229964|NCT01000337|454132390|FG001|Overall Study|Lost to Follow-up|3|||
126229965|NCT01612000|454132391|FG000|Overall Study|Lost to Follow-up|6|||
126229966|NCT01612000|454132392|FG001|Overall Study|Lost to Follow-up|4|||
126229967|NCT01612000|454132393|FG002|Overall Study|Lost to Follow-up|4|||
126229968|NCT01612000|454132394|FG003|Overall Study|Lost to Follow-up|8|||
126229969|NCT01612000|454132391|FG000|Overall Study|Physician Decision|0|||
126229970|NCT01612000|454132392|FG001|Overall Study|Physician Decision|0|||
126229971|NCT01612000|454132393|FG002|Overall Study|Physician Decision|1|||
126229972|NCT01612000|454132394|FG003|Overall Study|Physician Decision|0|||
126229973|NCT01612000|454132391|FG000|Overall Study|Withdrawal by Subject|3|||
126229974|NCT01612000|454132392|FG001|Overall Study|Withdrawal by Subject|1|||
126229975|NCT01612000|454132393|FG002|Overall Study|Withdrawal by Subject|2|||
126229976|NCT01612000|454132394|FG003|Overall Study|Withdrawal by Subject|2|||
126229977|NCT02173704|454132395|FG000|Overall Study|Adverse Event|1|||
126021864|NCT02723955|453375373|FG005|Expansion Phase|Site Closed|0|||
126021865|NCT02723955|453375374|FG006|Expansion Phase|Site Closed|0|||
126021866|NCT02723955|453375375|FG007|Expansion Phase|Site Closed|0|||
126021867|NCT02723955|453375376|FG008|Expansion Phase|Site Closed|0|||
126021868|NCT02723955|453375377|FG009|Expansion Phase|Site Closed|1|||
126021869|NCT02723955|453375378|FG010|Expansion Phase|Site Closed|2|||
126021870|NCT02723955|453375379|FG011|Expansion Phase|Site Closed|6|||
126021871|NCT02723955|453375380|FG012|Expansion Phase|Site Closed|0|||
126021872|NCT02723955|453375381|FG013|Expansion Phase|Site Closed|0|||
126021873|NCT02723955|453375382|FG014|Expansion Phase|Site Closed|0|||
126021874|NCT02723955|453375383|FG015|Expansion Phase|Site Closed|0|||
126021875|NCT02723955|453375384|FG016|Expansion Phase|Site Closed|0|||
126021876|NCT02723955|453375385|FG017|Expansion Phase|Site Closed|0|||
126021877|NCT02723955|453375386|FG018|Expansion Phase|Site Closed|0|||
126021878|NCT02723955|453375387|FG019|Expansion Phase|Site Closed|0|||
126021879|NCT02723955|453375388|FG020|Expansion Phase|Site Closed|0|||
126021880|NCT02723955|453375389|FG021|Expansion Phase|Site Closed|0|||
126021881|NCT02723955|453375390|FG022|Expansion Phase|Site Closed|0|||
126021882|NCT02723955|453375391|FG023|Expansion Phase|Site Closed|0|||
126021883|NCT02723955|453375392|FG024|Expansion Phase|Site Closed|0|||
126021884|NCT02723955|453375393|FG025|Expansion Phase|Site Closed|0|||
126021885|NCT02723955|453375394|FG026|Expansion Phase|Site Closed|0|||
126021886|NCT02723955|453375395|FG027|Expansion Phase|Site Closed|0|||
126021887|NCT02723955|453375396|FG028|Expansion Phase|Site Closed|0|||
126021888|NCT02723955|453375397|FG029|Expansion Phase|Site Closed|0|||
126021889|NCT02723955|453375398|FG030|Expansion Phase|Site Closed|8|||
126021890|NCT02723955|453375399|FG031|Expansion Phase|Site Closed|4|||
126021891|NCT02723955|453375400|FG032|Expansion Phase|Site Closed|2|||
126021892|NCT02723955|453375401|FG033|Expansion Phase|Site Closed|2|||
126021893|NCT02723955|453375402|FG034|Expansion Phase|Site Closed|0|||
126021894|NCT02723955|453375403|FG035|Expansion Phase|Site Closed|0|||
126021895|NCT02723955|453375404|FG036|Expansion Phase|Site Closed|0|||
126021896|NCT02723955|453375405|FG037|Expansion Phase|Site Closed|0|||
126021897|NCT02723955|453375406|FG038|Expansion Phase|Site Closed|0|||
126021898|NCT02723955|453375407|FG039|Expansion Phase|Site Closed|0|||
126021899|NCT02723955|453375408|FG040|Expansion Phase|Site Closed|0|||
126021900|NCT02723955|453375409|FG041|Expansion Phase|Site Closed|0|||
126021901|NCT02723955|453375410|FG042|Expansion Phase|Site Closed|0|||
126021902|NCT02723955|453375368|FG000|Crossover/ Re-treatment Phase|Death|0|||
126021903|NCT02723955|453375369|FG001|Crossover/ Re-treatment Phase|Death|0|||
126021904|NCT02723955|453375370|FG002|Crossover/ Re-treatment Phase|Death|0|||
126021905|NCT02723955|453375371|FG003|Crossover/ Re-treatment Phase|Death|0|||
126021906|NCT02723955|453375372|FG004|Crossover/ Re-treatment Phase|Death|0|||
126021907|NCT02723955|453375373|FG005|Crossover/ Re-treatment Phase|Death|0|||
126021908|NCT02723955|453375374|FG006|Crossover/ Re-treatment Phase|Death|0|||
126021909|NCT02723955|453375375|FG007|Crossover/ Re-treatment Phase|Death|0|||
126021910|NCT02723955|453375376|FG008|Crossover/ Re-treatment Phase|Death|0|||
126021911|NCT02723955|453375377|FG009|Crossover/ Re-treatment Phase|Death|0|||
126021912|NCT02723955|453375378|FG010|Crossover/ Re-treatment Phase|Death|0|||
126021913|NCT02723955|453375379|FG011|Crossover/ Re-treatment Phase|Death|0|||
126021914|NCT02723955|453375380|FG012|Crossover/ Re-treatment Phase|Death|0|||
126021915|NCT02723955|453375381|FG013|Crossover/ Re-treatment Phase|Death|0|||
126021916|NCT02723955|453375382|FG014|Crossover/ Re-treatment Phase|Death|0|||
126021917|NCT02723955|453375383|FG015|Crossover/ Re-treatment Phase|Death|0|||
126021918|NCT02723955|453375384|FG016|Crossover/ Re-treatment Phase|Death|0|||
126021919|NCT02723955|453375385|FG017|Crossover/ Re-treatment Phase|Death|0|||
126021920|NCT02723955|453375386|FG018|Crossover/ Re-treatment Phase|Death|0|||
126021921|NCT02723955|453375387|FG019|Crossover/ Re-treatment Phase|Death|0|||
126021922|NCT02723955|453375388|FG020|Crossover/ Re-treatment Phase|Death|0|||
126021923|NCT02723955|453375389|FG021|Crossover/ Re-treatment Phase|Death|0|||
126021924|NCT02723955|453375390|FG022|Crossover/ Re-treatment Phase|Death|0|||
126021925|NCT02723955|453375391|FG023|Crossover/ Re-treatment Phase|Death|0|||
126021926|NCT02723955|453375392|FG024|Crossover/ Re-treatment Phase|Death|0|||
126021927|NCT02723955|453375393|FG025|Crossover/ Re-treatment Phase|Death|0|||
126021928|NCT02723955|453375394|FG026|Crossover/ Re-treatment Phase|Death|0|||
126021929|NCT02723955|453375395|FG027|Crossover/ Re-treatment Phase|Death|0|||
126021930|NCT02723955|453375396|FG028|Crossover/ Re-treatment Phase|Death|0|||
126021931|NCT02723955|453375397|FG029|Crossover/ Re-treatment Phase|Death|0|||
126021932|NCT02723955|453375398|FG030|Crossover/ Re-treatment Phase|Death|0|||
126021933|NCT02723955|453375399|FG031|Crossover/ Re-treatment Phase|Death|0|||
126021934|NCT02723955|453375400|FG032|Crossover/ Re-treatment Phase|Death|0|||
126021935|NCT02723955|453375401|FG033|Crossover/ Re-treatment Phase|Death|0|||
126021936|NCT02723955|453375402|FG034|Crossover/ Re-treatment Phase|Death|0|||
126021937|NCT02723955|453375403|FG035|Crossover/ Re-treatment Phase|Death|0|||
126021938|NCT02723955|453375404|FG036|Crossover/ Re-treatment Phase|Death|0|||
126021939|NCT02723955|453375405|FG037|Crossover/ Re-treatment Phase|Death|1|||
126021940|NCT02723955|453375406|FG038|Crossover/ Re-treatment Phase|Death|14|||
126021941|NCT02723955|453375407|FG039|Crossover/ Re-treatment Phase|Death|32|||
126021942|NCT02723955|453375408|FG040|Crossover/ Re-treatment Phase|Death|2|||
126021943|NCT02723955|453375409|FG041|Crossover/ Re-treatment Phase|Death|1|||
126021944|NCT02723955|453375410|FG042|Crossover/ Re-treatment Phase|Death|0|||
126021945|NCT02723955|453375368|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021946|NCT02723955|453375369|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021947|NCT02723955|453375370|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021948|NCT02723955|453375371|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021949|NCT02723955|453375372|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021950|NCT02723955|453375373|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021951|NCT02723955|453375374|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126229978|NCT02173704|454132396|FG001|Overall Study|Adverse Event|0|||
126229979|NCT02173704|454132395|FG000|Overall Study|Lost to Follow-up|1|||
126229980|NCT02173704|454132396|FG001|Overall Study|Lost to Follow-up|0|||
126229981|NCT02173704|454132395|FG000|Overall Study|Other|1|||
126229982|NCT02173704|454132396|FG001|Overall Study|Other|0|||
126229983|NCT02173704|454132395|FG000|Overall Study|Protocol Violation|1|||
126229984|NCT02173704|454132396|FG001|Overall Study|Protocol Violation|0|||
126229985|NCT02173704|454132395|FG000|Overall Study|Withdrawal by Subject|9|||
126229986|NCT02173704|454132396|FG001|Overall Study|Withdrawal by Subject|4|||
126229987|NCT00419926|454132397|FG000|Overall Study|Withdrawal by Subject|7|||
126229988|NCT00419926|454132398|FG001|Overall Study|Withdrawal by Subject|3|||
126229989|NCT00419926|454132397|FG000|Overall Study|Administrative Problem|4|||
126229990|NCT00419926|454132398|FG001|Overall Study|Administrative Problem|4|||
126229991|NCT00419926|454132397|FG000|Overall Study|Lost to Follow-up|1|||
126229992|NCT00419926|454132398|FG001|Overall Study|Lost to Follow-up|2|||
126229993|NCT00419926|454132397|FG000|Overall Study|Death|2|||
126352607|NCT00479232|454582046|FG001|Overall Study|Progressive Disease|1|||
126229994|NCT00419926|454132398|FG001|Overall Study|Death|1|||
126229995|NCT02374918|454132403|FG000|Overall Study|Protocol Violation|2|||
126352608|NCT00479232|454582047|FG002|Overall Study|Progressive Disease|12|||
126021952|NCT02723955|453375375|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021953|NCT02723955|453375376|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021954|NCT02723955|453375377|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126229996|NCT02374918|454132404|FG001|Overall Study|Protocol Violation|0|||
126229997|NCT02374918|454132405|FG002|Overall Study|Protocol Violation|2|||
126352609|NCT00479232|454582048|FG003|Overall Study|Progressive Disease|3|||
126021955|NCT02723955|453375378|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021956|NCT02723955|453375379|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021957|NCT02723955|453375380|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126229998|NCT02374918|454132406|FG003|Overall Study|Protocol Violation|1|||
126021958|NCT02723955|453375381|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021959|NCT02723955|453375382|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021960|NCT02723955|453375383|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021961|NCT02723955|453375384|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021962|NCT02723955|453375385|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021963|NCT02723955|453375386|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021964|NCT02723955|453375387|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021965|NCT02723955|453375388|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021966|NCT02723955|453375389|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021967|NCT02723955|453375390|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021968|NCT02723955|453375391|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021969|NCT02723955|453375392|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021970|NCT02723955|453375393|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021971|NCT02723955|453375394|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021972|NCT02723955|453375395|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021973|NCT02723955|453375396|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021974|NCT02723955|453375397|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021975|NCT02723955|453375398|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021976|NCT02723955|453375399|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021977|NCT02723955|453375400|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021978|NCT02723955|453375401|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021979|NCT02723955|453375402|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021980|NCT02723955|453375403|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021981|NCT02723955|453375404|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021982|NCT02723955|453375405|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126093105|NCT05560243|453634510|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
126229999|NCT02374918|454132403|FG000|Overall Study|Withdrawal by Subject|1|||
126230000|NCT02374918|454132404|FG001|Overall Study|Withdrawal by Subject|1|||
126230001|NCT02374918|454132405|FG002|Overall Study|Withdrawal by Subject|1|||
126230002|NCT02374918|454132406|FG003|Overall Study|Withdrawal by Subject|0|||
126230003|NCT02374918|454132403|FG000|Overall Study|Lack of Efficacy|0|||
126230004|NCT02374918|454132404|FG001|Overall Study|Lack of Efficacy|0|||
126230005|NCT02374918|454132405|FG002|Overall Study|Lack of Efficacy|1|||
126230006|NCT02374918|454132406|FG003|Overall Study|Lack of Efficacy|1|||
126230007|NCT01180244|454132407|FG000|Overall Study|Lack of Efficacy|0|||
126230008|NCT01180244|454132408|FG001|Overall Study|Lack of Efficacy|7|||
126230009|NCT01180244|454132407|FG000|Overall Study|Physician Decision|3|||
126230010|NCT01180244|454132408|FG001|Overall Study|Physician Decision|0|||
126230011|NCT01180244|454132407|FG000|Overall Study|Adverse Event|1|||
126021983|NCT02723955|453375406|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021984|NCT02723955|453375407|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
126230012|NCT01180244|454132408|FG001|Overall Study|Adverse Event|0|||
126230013|NCT01180244|454132407|FG000|Overall Study|Withdrawal by Subject|0|||
126352610|NCT00479232|454582049|FG004|Overall Study|Progressive Disease|3|||
126352611|NCT00479232|454582050|FG005|Overall Study|Progressive Disease|12|||
126352612|NCT00479232|454582045|FG000|Overall Study|Withdrew Consent|0|||
126352613|NCT00479232|454582046|FG001|Overall Study|Withdrew Consent|2|||
126352614|NCT00479232|454582047|FG002|Overall Study|Withdrew Consent|6|||
126352615|NCT00479232|454582048|FG003|Overall Study|Withdrew Consent|0|||
126352616|NCT00479232|454582049|FG004|Overall Study|Withdrew Consent|1|||
126352617|NCT00479232|454582050|FG005|Overall Study|Withdrew Consent|3|||
126352618|NCT01373229|454582051|FG000|Overall Study|Death|3|||
126352619|NCT01373229|454582051|FG000|Overall Study|Physician Decision|3|||
126352620|NCT00587457|454582052|FG000|Overall Study|Adverse Event|1|||
126352621|NCT00587457|454582053|FG001|Overall Study|Adverse Event|2|||
126352622|NCT00587457|454582054|FG002|Overall Study|Adverse Event|1|||
126352623|NCT00587457|454582052|FG000|Overall Study|Disease progression|2|||
126352624|NCT00587457|454582053|FG001|Overall Study|Disease progression|0|||
126352625|NCT00587457|454582054|FG002|Overall Study|Disease progression|2|||
126352626|NCT00587457|454582052|FG000|Overall Study|Initiation of alternative therapy|0|||
126352627|NCT00587457|454582053|FG001|Overall Study|Initiation of alternative therapy|1|||
126352628|NCT00587457|454582054|FG002|Overall Study|Initiation of alternative therapy|0|||
126352629|NCT00587457|454582052|FG000|Overall Study|Undefined|0|||
126352630|NCT00587457|454582053|FG001|Overall Study|Undefined|0|||
126352631|NCT00587457|454582054|FG002|Overall Study|Undefined|1|||
126352632|NCT00587457|454582052|FG000|Overall Study|Development of neutralizing Abs|0|||
126352633|NCT00587457|454582053|FG001|Overall Study|Development of neutralizing Abs|0|||
126352634|NCT00587457|454582054|FG002|Overall Study|Development of neutralizing Abs|1|||
126352635|NCT00924651|454582057|FG000|Overall Study|Chemo started too soon|2|||
126352636|NCT00924651|454582058|FG001|Overall Study|Chemo started too soon|3|||
126352637|NCT00924651|454582057|FG000|Overall Study|No Reason|3|||
126352638|NCT00924651|454582058|FG001|Overall Study|No Reason|7|||
126352639|NCT00924651|454582057|FG000|Overall Study|Overwhelmed|6|||
126352640|NCT00924651|454582058|FG001|Overall Study|Overwhelmed|6|||
126230014|NCT01180244|454132408|FG001|Overall Study|Withdrawal by Subject|1|||
126230015|NCT01180244|454132407|FG000|Overall Study|Protocol Violation|1|||
126230016|NCT01180244|454132408|FG001|Overall Study|Protocol Violation|0|||
126230017|NCT01180244|454132407|FG000|Overall Study|Lost to Follow-up|1|||
126230018|NCT01180244|454132408|FG001|Overall Study|Lost to Follow-up|0|||
126230019|NCT00729859|454132409|FG000|Overall Study|Adverse Event|0|||
126230020|NCT00729859|454132410|FG001|Overall Study|Adverse Event|1|||
126230021|NCT00729859|454132411|FG002|Overall Study|Adverse Event|0|||
126230022|NCT00729859|454132409|FG000|Overall Study|Withdrawal by Subject|0|||
126230023|NCT00729859|454132410|FG001|Overall Study|Withdrawal by Subject|1|||
126230024|NCT00729859|454132411|FG002|Overall Study|Withdrawal by Subject|0|||
126230025|NCT02623829|454132412|FG000|Overall Study|Lost to Follow-up|1|||
126230026|NCT02623829|454132413|FG001|Overall Study|Lost to Follow-up|1|||
126230027|NCT00783796|454132414|FG000|Overall Study|Did not receive any stent|4|||
126230028|NCT00783796|454132414|FG000|Overall Study|Received non-XIENCE V stent|1|||
126230029|NCT00783796|454132414|FG000|Overall Study|Received commercial XIENCE V stent|1|||
126230030|NCT01816477|454132415|FG000|Overall Study|Withdrawal by Subject|13|||
126230031|NCT01816477|454132416|FG001|Overall Study|Withdrawal by Subject|1|||
126230032|NCT01816477|454132415|FG000|Overall Study|Unable to tolerate catheter placement|3|||
126230033|NCT01816477|454132416|FG001|Overall Study|Unable to tolerate catheter placement|0|||
126230034|NCT01766921|454132417|FG000|Overall Study|Administrative Reason|5|||
126230035|NCT01766921|454132418|FG001|Overall Study|Administrative Reason|5|||
126230036|NCT01766921|454132417|FG000|Overall Study|Death|1|||
126230037|NCT01766921|454132418|FG001|Overall Study|Death|1|||
126230038|NCT01766921|454132417|FG000|Overall Study|Lost to Follow-up|1|||
126230039|NCT01766921|454132418|FG001|Overall Study|Lost to Follow-up|3|||
126230040|NCT01766921|454132417|FG000|Overall Study|Unclassified|2|||
126230041|NCT01766921|454132418|FG001|Overall Study|Unclassified|2|||
126352641|NCT00924651|454582057|FG000|Overall Study|Noncompliant|1|||
126352642|NCT00924651|454582058|FG001|Overall Study|Noncompliant|4|||
126352643|NCT00924651|454582057|FG000|Overall Study|Medical|1|||
126352644|NCT00924651|454582058|FG001|Overall Study|Medical|3|||
126352645|NCT00924651|454582057|FG000|Overall Study|Changed Mind|10|||
126352646|NCT00924651|454582058|FG001|Overall Study|Changed Mind|1|||
126352647|NCT00924651|454582057|FG000|Overall Study|Incomplete Form|2|||
126352648|NCT00924651|454582058|FG001|Overall Study|Incomplete Form|1|||
126352649|NCT01991314|454582059|FG000|Overall Study|Adverse Event|5|||
126352650|NCT01991314|454582060|FG001|Overall Study|Adverse Event|1|||
126352651|NCT01991314|454582059|FG000|Overall Study|Lost to Follow-up|6|||
126352652|NCT01991314|454582060|FG001|Overall Study|Lost to Follow-up|10|||
126352653|NCT00970944|454582062|FG000|Overall Study|Death|1|||
126352654|NCT00970944|454582063|FG001|Overall Study|Death|0|||
126352655|NCT00970944|454582062|FG000|Overall Study|Physician Decision|0|||
126352656|NCT00970944|454582063|FG001|Overall Study|Physician Decision|2|||
126352657|NCT00972738|454582064|FG000|Overall Study|Adverse Event|7|||
126352658|NCT00972738|454582065|FG001|Overall Study|Adverse Event|1|||
126352659|NCT00972738|454582066|FG002|Overall Study|Adverse Event|8|||
126352660|NCT00972738|454582064|FG000|Overall Study|Protocol Violation|2|||
126352661|NCT00972738|454582065|FG001|Overall Study|Protocol Violation|1|||
126352662|NCT00972738|454582066|FG002|Overall Study|Protocol Violation|3|||
126352663|NCT00972738|454582064|FG000|Overall Study|Lost to Follow-up|1|||
126352664|NCT00972738|454582065|FG001|Overall Study|Lost to Follow-up|0|||
126352665|NCT00972738|454582066|FG002|Overall Study|Lost to Follow-up|1|||
126352666|NCT00972738|454582064|FG000|Overall Study|Lack of Efficacy|5|||
126352667|NCT00972738|454582065|FG001|Overall Study|Lack of Efficacy|1|||
126352668|NCT00972738|454582066|FG002|Overall Study|Lack of Efficacy|11|||
126352669|NCT00972738|454582064|FG000|Overall Study|Withdrawal by Subject|5|||
126352670|NCT00972738|454582065|FG001|Overall Study|Withdrawal by Subject|1|||
126352671|NCT00972738|454582066|FG002|Overall Study|Withdrawal by Subject|4|||
126352672|NCT00972738|454582064|FG000|Overall Study|Moved|0|||
126352673|NCT00972738|454582065|FG001|Overall Study|Moved|0|||
126352674|NCT00972738|454582066|FG002|Overall Study|Moved|1|||
126352675|NCT00972738|454582064|FG000|Overall Study|Other|1|||
126352676|NCT00972738|454582065|FG001|Overall Study|Other|2|||
126352677|NCT00972738|454582066|FG002|Overall Study|Other|1|||
126352678|NCT03915067|454582067|FG000|Overall Study|Adverse Event|0|||
126352679|NCT03915067|454582068|FG001|Overall Study|Adverse Event|0|||
126352680|NCT03915067|454582069|FG002|Overall Study|Adverse Event|1|||
126352681|NCT03915067|454582067|FG000|Overall Study|Withdrawal by Subject|4|||
126230042|NCT01766921|454132417|FG000|Overall Study|Protocol Violation|1|||
126230043|NCT01766921|454132418|FG001|Overall Study|Protocol Violation|1|||
126230044|NCT01766921|454132417|FG000|Overall Study|Withdrawal by Subject|14|||
126230045|NCT01766921|454132418|FG001|Overall Study|Withdrawal by Subject|5|||
126230046|NCT00619385|454132432|FG000|Overall Study|Adverse Event|0|||
126352682|NCT03915067|454582068|FG001|Overall Study|Withdrawal by Subject|3|||
126352683|NCT03915067|454582069|FG002|Overall Study|Withdrawal by Subject|0|||
126352684|NCT03915067|454582067|FG000|Overall Study|Lost to Follow-up|3|||
126230047|NCT00619385|454132433|FG001|Overall Study|Adverse Event|0|||
126230048|NCT00619385|454132434|FG002|Overall Study|Adverse Event|3|||
126352685|NCT03915067|454582068|FG001|Overall Study|Lost to Follow-up|2|||
126352686|NCT03915067|454582069|FG002|Overall Study|Lost to Follow-up|0|||
126021985|NCT02723955|453375408|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021986|NCT02723955|453375409|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021987|NCT02723955|453375410|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126021988|NCT02723955|453375368|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021989|NCT02723955|453375369|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021990|NCT02723955|453375370|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021991|NCT02723955|453375371|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021992|NCT02723955|453375372|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
126230049|NCT00619385|454132432|FG000|Overall Study|Other|1|||
126230050|NCT00619385|454132433|FG001|Overall Study|Other|2|||
126230051|NCT00619385|454132434|FG002|Overall Study|Other|1|||
126230052|NCT02041702|454132437|FG000|Overall Study|Lost to Follow-up|1|||
126230053|NCT02041702|454132438|FG001|Overall Study|Lost to Follow-up|6|||
126230054|NCT02041702|454132437|FG000|Overall Study|Death|4|||
126230055|NCT02041702|454132438|FG001|Overall Study|Death|0|||
126230056|NCT02041702|454132437|FG000|Overall Study|Withdrawal by Subject|4|||
126230057|NCT02041702|454132438|FG001|Overall Study|Withdrawal by Subject|3|||
126230058|NCT02041702|454132437|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
126230059|NCT02041702|454132438|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
126230060|NCT02041702|454132437|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
126230061|NCT02041702|454132438|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
126230062|NCT00717756|454132442|FG000|Overall Study|Withdrawal by Subject|1|||
126230063|NCT01873859|454132443|FG000|Overall Study|Withdrawal by Subject|0|||
126230064|NCT01873859|454132444|FG001|Overall Study|Withdrawal by Subject|4|||
126230065|NCT03977584|454132445|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
126230066|NCT03977584|454132446|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
126230067|NCT03977584|454132447|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
126230068|NCT02146430|454134370|FG000|Overall Study|Protocol Violation|5|||
126230069|NCT02146430|454134371|FG001|Overall Study|Protocol Violation|4|||
126230070|NCT02146430|454134372|FG002|Overall Study|Protocol Violation|8|||
126230071|NCT02146430|454134373|FG003|Overall Study|Protocol Violation|6|||
126230072|NCT02146430|454134370|FG000|Overall Study|Lack of Efficacy|13|||
126230073|NCT02146430|454134371|FG001|Overall Study|Lack of Efficacy|11|||
126230074|NCT02146430|454134372|FG002|Overall Study|Lack of Efficacy|8|||
126230075|NCT02146430|454134373|FG003|Overall Study|Lack of Efficacy|5|||
126230076|NCT02146430|454134370|FG000|Overall Study|Adverse Event|20|||
126230077|NCT02146430|454134371|FG001|Overall Study|Adverse Event|40|||
126230078|NCT02146430|454134372|FG002|Overall Study|Adverse Event|32|||
126230079|NCT02146430|454134373|FG003|Overall Study|Adverse Event|49|||
126230080|NCT02146430|454134370|FG000|Overall Study|Reason missing or not reported|2|||
126230081|NCT02146430|454134371|FG001|Overall Study|Reason missing or not reported|3|||
126230082|NCT02146430|454134372|FG002|Overall Study|Reason missing or not reported|4|||
126230083|NCT02146430|454134373|FG003|Overall Study|Reason missing or not reported|5|||
126230084|NCT02146430|454134370|FG000|Overall Study|Withdrawal by Subject|27|||
126230085|NCT02146430|454134371|FG001|Overall Study|Withdrawal by Subject|29|||
126230086|NCT02146430|454134372|FG002|Overall Study|Withdrawal by Subject|30|||
126230087|NCT02146430|454134373|FG003|Overall Study|Withdrawal by Subject|34|||
126230088|NCT01893905|454134374|FG000|Overall Study|Withdrawal by Subject|1|||
126230089|NCT01893905|454134375|FG001|Overall Study|Withdrawal by Subject|0|||
126230090|NCT01893905|454134374|FG000|Overall Study|Adverse Event|9|||
126230091|NCT01893905|454134375|FG001|Overall Study|Adverse Event|3|||
126230092|NCT01893905|454134374|FG000|Overall Study|Lack of Efficacy|5|||
126230093|NCT01893905|454134375|FG001|Overall Study|Lack of Efficacy|7|||
126230094|NCT01893905|454134374|FG000|Overall Study|Lost to Follow-up|1|||
126230095|NCT01893905|454134375|FG001|Overall Study|Lost to Follow-up|0|||
126230096|NCT01893905|454134374|FG000|Overall Study|Protocol Violation|6|||
126230097|NCT01893905|454134375|FG001|Overall Study|Protocol Violation|1|||
126230098|NCT01893905|454134374|FG000|Overall Study|Lack of adherence to treatment|2|||
126230099|NCT01893905|454134375|FG001|Overall Study|Lack of adherence to treatment|0|||
126352687|NCT03915067|454582067|FG000|Overall Study|Protocol Deviation|0|||
126021993|NCT02723955|453375373|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021994|NCT02723955|453375374|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
126093106|NCT00939822|453634513|FG000|Overall Study|Lost to Follow-up|1|||
126093107|NCT00939822|453634514|FG001|Overall Study|Lost to Follow-up|0|||
126230100|NCT01893905|454134374|FG000|Overall Study|Other reason|1|||
126352688|NCT03915067|454582068|FG001|Overall Study|Protocol Deviation|0|||
126352689|NCT03915067|454582069|FG002|Overall Study|Protocol Deviation|1|||
126352690|NCT03915067|454582067|FG000|Overall Study|Covid-19 Related Issues|2|||
126230101|NCT01893905|454134375|FG001|Overall Study|Other reason|3|||
126230102|NCT01768858|454134376|FG000|Overall Study|Lost to Follow-up|9|||
126230103|NCT01768858|454134376|FG000|Overall Study|Lack of Efficacy|8|||
126230104|NCT01768858|454134376|FG000|Overall Study|Serious Adverse Event|1|||
126230105|NCT01768858|454134376|FG000|Overall Study|Participant moved to Germany|1|||
126230106|NCT01768858|454134376|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
126352691|NCT03915067|454582068|FG001|Overall Study|Covid-19 Related Issues|4|||
126352692|NCT03915067|454582069|FG002|Overall Study|Covid-19 Related Issues|4|||
126230107|NCT01768858|454134376|FG000|Overall Study|Exanthema|1|||
126230108|NCT01768858|454134376|FG000|Overall Study|Withdrawal by Subject|1|||
126230109|NCT03312530|454134377|FG000|Overall Study|Death|5|||
126230110|NCT03312530|454134378|FG001|Overall Study|Death|5|||
126230111|NCT03312530|454134379|FG002|Overall Study|Death|4|||
126230112|NCT03312530|454134380|FG003|Overall Study|Death|10|||
126230113|NCT03312530|454134381|FG004|Overall Study|Death|8|||
126230114|NCT03312530|454134377|FG000|Overall Study|Lost to Follow-up|0|||
126230115|NCT03312530|454134378|FG001|Overall Study|Lost to Follow-up|0|||
126230116|NCT03312530|454134379|FG002|Overall Study|Lost to Follow-up|0|||
126230117|NCT03312530|454134380|FG003|Overall Study|Lost to Follow-up|1|||
126230118|NCT03312530|454134381|FG004|Overall Study|Lost to Follow-up|0|||
126230119|NCT03312530|454134377|FG000|Overall Study|Participant in another sponsor study.|0|||
126230120|NCT03312530|454134378|FG001|Overall Study|Participant in another sponsor study.|0|||
126230121|NCT03312530|454134379|FG002|Overall Study|Participant in another sponsor study.|0|||
126230122|NCT03312530|454134380|FG003|Overall Study|Participant in another sponsor study.|1|||
126230123|NCT03312530|454134381|FG004|Overall Study|Participant in another sponsor study.|0|||
126230124|NCT03312530|454134377|FG000|Overall Study|Study terminated by sponsor|1|||
126230125|NCT03312530|454134378|FG001|Overall Study|Study terminated by sponsor|0|||
126230126|NCT03312530|454134379|FG002|Overall Study|Study terminated by sponsor|2|||
126230127|NCT03312530|454134380|FG003|Overall Study|Study terminated by sponsor|3|||
126230128|NCT03312530|454134381|FG004|Overall Study|Study terminated by sponsor|7|||
126230129|NCT03312530|454134377|FG000|Overall Study|Withdrawal by Subject|0|||
126230130|NCT03312530|454134378|FG001|Overall Study|Withdrawal by Subject|1|||
126230131|NCT03312530|454134379|FG002|Overall Study|Withdrawal by Subject|0|||
126230132|NCT03312530|454134380|FG003|Overall Study|Withdrawal by Subject|0|||
126230133|NCT03312530|454134381|FG004|Overall Study|Withdrawal by Subject|0|||
126230134|NCT03312530|454134377|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
126230135|NCT03312530|454134378|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
126230136|NCT03312530|454134379|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
126230137|NCT03312530|454134380|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
126230138|NCT03312530|454134381|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
126230139|NCT01691859|454134384|FG000|Overall Study|Adverse Event|19|||
126230140|NCT01691859|454134384|FG000|Overall Study|Lack of Efficacy|11|||
126230141|NCT01691859|454134384|FG000|Overall Study|Protocol Violation|4|||
126230142|NCT01691859|454134384|FG000|Overall Study|Product commercially available|221|||
126230143|NCT01691859|454134384|FG000|Overall Study|Study closed/terminated|50|||
126230144|NCT01691859|454134384|FG000|Overall Study|Lost to Follow-up|5|||
126230145|NCT01691859|454134384|FG000|Overall Study|Physician Decision|6|||
126230146|NCT01691859|454134384|FG000|Overall Study|Withdrawal by Subject|31|||
126230147|NCT04820842|454134385|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126230148|NCT04820842|454134386|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
126230149|NCT04820842|454134387|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
126230150|NCT04820842|454134388|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126230151|NCT04820842|454134389|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126230152|NCT04820842|454134390|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126230153|NCT04820842|454134391|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126230154|NCT04820842|454134385|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
126230155|NCT04820842|454134386|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
126230156|NCT04820842|454134387|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
126230157|NCT04820842|454134388|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126230158|NCT04820842|454134389|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126230159|NCT04820842|454134390|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126230160|NCT04820842|454134391|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126352693|NCT03915067|454582067|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
126352694|NCT03915067|454582068|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
126352695|NCT03915067|454582069|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
126352696|NCT01033942|454582070|FG000|Overall Study|Withdrawal by Subject|1|||
126352697|NCT01033942|454582071|FG001|Overall Study|Withdrawal by Subject|1|||
126352698|NCT01033942|454582072|FG002|Overall Study|Withdrawal by Subject|1|||
126352699|NCT01033942|454582070|FG000|Overall Study|Lost to Follow-up|1|||
126352700|NCT01033942|454582071|FG001|Overall Study|Lost to Follow-up|0|||
126352701|NCT01033942|454582072|FG002|Overall Study|Lost to Follow-up|0|||
126093108|NCT00939822|453634513|FG000|Overall Study|withdrew from study due to busy schedule|1|||
126093109|NCT00939822|453634514|FG001|Overall Study|withdrew from study due to busy schedule|1|||
126230161|NCT04820842|454134385|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126230162|NCT04820842|454134386|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
126230163|NCT04820842|454134387|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126230164|NCT04820842|454134388|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126230165|NCT04820842|454134389|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126230166|NCT04820842|454134390|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126230167|NCT04820842|454134391|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126230168|NCT04820842|454134385|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126230169|NCT04820842|454134386|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126306192|NCT03260244|454410221|FG000|Overall Study|Enrollment Criteria Not Met|31|||
126021995|NCT02723955|453375375|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021996|NCT02723955|453375376|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021997|NCT02723955|453375377|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021998|NCT02723955|453375378|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
126021999|NCT02723955|453375379|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022000|NCT02723955|453375380|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022001|NCT02723955|453375381|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022002|NCT02723955|453375382|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022003|NCT02723955|453375383|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022004|NCT02723955|453375384|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022005|NCT02723955|453375385|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022006|NCT02723955|453375386|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022007|NCT02723955|453375387|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022008|NCT02723955|453375388|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022009|NCT02723955|453375389|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022010|NCT02723955|453375390|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022011|NCT02723955|453375391|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022012|NCT02723955|453375392|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022013|NCT02723955|453375393|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
126230170|NCT04820842|454134387|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126230171|NCT04820842|454134388|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
126230172|NCT04820842|454134389|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126230173|NCT04820842|454134390|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126230174|NCT04820842|454134391|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
126230175|NCT01090765|454134394|FG000|Overall Study|Patient withdrew consent|0|||
126230176|NCT01090765|454134395|FG001|Overall Study|Patient withdrew consent|0|||
126230177|NCT01090765|454134396|FG002|Overall Study|Patient withdrew consent|0|||
126230178|NCT01090765|454134397|FG003|Overall Study|Patient withdrew consent|0|||
126230179|NCT01090765|454134398|FG004|Overall Study|Patient withdrew consent|1|||
126230180|NCT01090765|454134399|FG005|Overall Study|Patient withdrew consent|1|||
126230181|NCT01090765|454134394|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
126230182|NCT01090765|454134395|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
126230183|NCT01090765|454134396|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
126230184|NCT01090765|454134397|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
126230185|NCT01090765|454134398|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
126230186|NCT01090765|454134399|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
126230187|NCT01090765|454134394|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
126230188|NCT01090765|454134395|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
126230189|NCT01090765|454134396|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
126230190|NCT01090765|454134397|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
126230191|NCT01090765|454134398|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
126230192|NCT01090765|454134399|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
126230193|NCT02623959|454134403|FG000|Overall Study|Progression|0|||
126230194|NCT02623959|454134404|FG001|Overall Study|Progression|1|||
126230195|NCT02336737|454134407|FG000|Overall Study|Withdrawal by Subject|5|||
126230196|NCT02336737|454134407|FG000|Overall Study|Physician Decision|8|||
126230197|NCT02396381|454134408|FG000|Overall Study|Adverse Event|3|||
126230198|NCT02396381|454134409|FG001|Overall Study|Adverse Event|2|||
126230199|NCT02396381|454134408|FG000|Overall Study|Withdrawal by Subject|33|||
126230200|NCT02396381|454134409|FG001|Overall Study|Withdrawal by Subject|24|||
126230201|NCT02396381|454134408|FG000|Overall Study|Lost to Follow-up|49|||
126230202|NCT02396381|454134409|FG001|Overall Study|Lost to Follow-up|31|||
126230203|NCT02396381|454134408|FG000|Overall Study|Protocol Violation|1|||
126230204|NCT02396381|454134409|FG001|Overall Study|Protocol Violation|0|||
126230205|NCT02396381|454134408|FG000|Overall Study|Site terminated by sponsor|7|||
126230206|NCT02396381|454134409|FG001|Overall Study|Site terminated by sponsor|8|||
126230207|NCT02396381|454134408|FG000|Overall Study|Physician Decision|5|||
126230208|NCT02396381|454134409|FG001|Overall Study|Physician Decision|5|||
126230209|NCT02396381|454134408|FG000|Overall Study|Pregnancy|2|||
126230210|NCT02396381|454134409|FG001|Overall Study|Pregnancy|0|||
126230211|NCT02396381|454134408|FG000|Overall Study|Non-compliance with study procedures|1|||
126230212|NCT02396381|454134409|FG001|Overall Study|Non-compliance with study procedures|0|||
126230213|NCT02396381|454134408|FG000|Overall Study|Moved out of town/state|1|||
126230214|NCT02396381|454134409|FG001|Overall Study|Moved out of town/state|3|||
126230215|NCT02396381|454134408|FG000|Overall Study|Could not complete visit|1|||
126230216|NCT02396381|454134409|FG001|Overall Study|Could not complete visit|0|||
126230217|NCT02396381|454134408|FG000|Overall Study|Possible conflict of interest|1|||
126230218|NCT02396381|454134409|FG001|Overall Study|Possible conflict of interest|0|||
126230219|NCT02396381|454134408|FG000|Overall Study|Randomization/Screening Error|3|||
126230220|NCT02396381|454134409|FG001|Overall Study|Randomization/Screening Error|1|||
126230221|NCT00635778|454134411|FG000|Overall Study|Adverse Event|1|||
126230222|NCT00635778|454134412|FG001|Overall Study|Adverse Event|0|||
126230223|NCT00635778|454134413|FG002|Overall Study|Adverse Event|0|||
126230224|NCT00635778|454134414|FG003|Overall Study|Adverse Event|3|||
126230225|NCT00635778|454134415|FG004|Overall Study|Adverse Event|3|||
126230226|NCT00635778|454134416|FG005|Overall Study|Adverse Event|6|||
126230227|NCT00635778|454134417|FG006|Overall Study|Adverse Event|1|||
126352702|NCT01033942|454582070|FG000|Overall Study|Enrolled in Extension Study|0|||
126352703|NCT01033942|454582071|FG001|Overall Study|Enrolled in Extension Study|3|||
126352704|NCT01033942|454582072|FG002|Overall Study|Enrolled in Extension Study|0|||
126352705|NCT02693418|454582073|FG000|Overall Study|Lost to Follow-up|1|||
126230228|NCT00635778|454134411|FG000|Overall Study|Withdrawal by Subject|0|||
126230229|NCT00635778|454134412|FG001|Overall Study|Withdrawal by Subject|0|||
126230230|NCT00635778|454134413|FG002|Overall Study|Withdrawal by Subject|0|||
126230231|NCT00635778|454134414|FG003|Overall Study|Withdrawal by Subject|1|||
126352706|NCT02693418|454582074|FG001|Overall Study|Lost to Follow-up|2|||
126352707|NCT02693418|454582075|FG002|Overall Study|Lost to Follow-up|0|||
126352708|NCT02693418|454582076|FG003|Overall Study|Lost to Follow-up|0|||
126352709|NCT02693418|454582077|FG004|Overall Study|Lost to Follow-up|0|||
126352710|NCT02693418|454582073|FG000|Overall Study|Menses during study period|0|||
126230232|NCT00635778|454134415|FG004|Overall Study|Withdrawal by Subject|0|||
126230233|NCT00635778|454134416|FG005|Overall Study|Withdrawal by Subject|1|||
126230234|NCT00635778|454134417|FG006|Overall Study|Withdrawal by Subject|1|||
126230235|NCT00635778|454134411|FG000|Overall Study|Progressive disease|0|||
126230236|NCT00635778|454134412|FG001|Overall Study|Progressive disease|3|||
126230237|NCT00635778|454134413|FG002|Overall Study|Progressive disease|3|||
126230238|NCT00635778|454134414|FG003|Overall Study|Progressive disease|4|||
126230239|NCT00635778|454134415|FG004|Overall Study|Progressive disease|5|||
126230240|NCT00635778|454134416|FG005|Overall Study|Progressive disease|14|||
126230241|NCT00635778|454134417|FG006|Overall Study|Progressive disease|4|||
126230242|NCT01884025|454134418|FG000|Overall Study|Lost to Follow-up|3|||
126230243|NCT01884025|454134419|FG001|Overall Study|Lost to Follow-up|4|||
126230244|NCT02324465|454134420|FG000|Overall Study|device failure|0|||
126230245|NCT02324465|454134421|FG001|Overall Study|device failure|1|||
126230246|NCT02655237|454134424|FG000|Overall Study|Adverse Event|10|||
126230247|NCT02655237|454134425|FG001|Overall Study|Adverse Event|7|||
126230248|NCT02655237|454134424|FG000|Overall Study|Protocol Deviation|2|||
126230249|NCT02655237|454134425|FG001|Overall Study|Protocol Deviation|0|||
126230250|NCT02655237|454134424|FG000|Overall Study|Withdrawal by Participant|1|||
126230251|NCT02655237|454134425|FG001|Overall Study|Withdrawal by Participant|2|||
126230252|NCT02655237|454134424|FG000|Overall Study|Lack of Efficacy|0|||
126230253|NCT02655237|454134425|FG001|Overall Study|Lack of Efficacy|1|||
126230254|NCT02655237|454134424|FG000|Overall Study|Recovery Leading to Surgery|2|||
126230255|NCT02655237|454134425|FG001|Overall Study|Recovery Leading to Surgery|1|||
126230256|NCT02655237|454134424|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
126230257|NCT02655237|454134425|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
126230258|NCT02655237|454134424|FG000|Overall Study|Randomized but Not Treated|1|||
126230259|NCT02655237|454134425|FG001|Overall Study|Randomized but Not Treated|0|||
126230260|NCT01860976|454134428|FG000|Blinded Treatment|Adverse Event|1|||
126230261|NCT01860976|454134429|FG001|Blinded Treatment|Adverse Event|3|||
126230262|NCT01860976|454134428|FG000|Blinded Treatment|Lack of Efficacy|5|||
126230263|NCT01860976|454134429|FG001|Blinded Treatment|Lack of Efficacy|12|||
126230264|NCT01860976|454134428|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
126230265|NCT01860976|454134429|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
126230266|NCT01860976|454134428|FG000|Blinded Treatment|Withdrawal by Subject|3|||
126230267|NCT01860976|454134429|FG001|Blinded Treatment|Withdrawal by Subject|5|||
126230268|NCT01860976|454134428|FG000|Blinded Treatment|Subject no longer met criteria|1|||
126230269|NCT01860976|454134429|FG001|Blinded Treatment|Subject no longer met criteria|0|||
126230270|NCT01860976|454134428|FG000|Blinded Treatment|Entered Open-Label in error|0|||
126230271|NCT01860976|454134429|FG001|Blinded Treatment|Entered Open-Label in error|1|||
126230272|NCT01860976|454134428|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
126230273|NCT01860976|454134429|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
126230274|NCT01860976|454134428|FG000|Open-Label|Adverse Event|2|||
126230275|NCT01860976|454134429|FG001|Open-Label|Adverse Event|4|||
126230276|NCT01860976|454134428|FG000|Open-Label|Lack of Efficacy|16|||
126230277|NCT01860976|454134429|FG001|Open-Label|Lack of Efficacy|8|||
126230278|NCT01860976|454134428|FG000|Open-Label|Lost to Follow-up|1|||
126230279|NCT01860976|454134429|FG001|Open-Label|Lost to Follow-up|2|||
126230280|NCT01860976|454134428|FG000|Open-Label|Subject request discontinue treatment|4|||
126230281|NCT01860976|454134429|FG001|Open-Label|Subject request discontinue treatment|3|||
126230282|NCT01860976|454134428|FG000|Open-Label|Withdrawal by Subject|4|||
126230283|NCT01860976|454134429|FG001|Open-Label|Withdrawal by Subject|1|||
126230284|NCT01860976|454134428|FG000|Open-Label|Other Reasons|1|||
126230285|NCT01860976|454134429|FG001|Open-Label|Other Reasons|1|||
126230286|NCT01860976|454134428|FG000|Long Term Extension|Adverse Event|4|||
126230287|NCT01860976|454134429|FG001|Long Term Extension|Adverse Event|0|||
126230288|NCT01860976|454134428|FG000|Long Term Extension|Lack of Efficacy|2|||
126230289|NCT01860976|454134429|FG001|Long Term Extension|Lack of Efficacy|0|||
126230290|NCT01860976|454134428|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
126230291|NCT01860976|454134429|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
126230292|NCT01860976|454134428|FG000|Long Term Extension|Lost to Follow-up|2|||
126230293|NCT01860976|454134429|FG001|Long Term Extension|Lost to Follow-up|0|||
126230294|NCT01860976|454134428|FG000|Long Term Extension|subject withdrew consent|7|||
126230295|NCT01860976|454134429|FG001|Long Term Extension|subject withdrew consent|0|||
126230296|NCT02227862|454134430|FG000|Overall Study|Protocol Violation|7|||
126230297|NCT02227862|454134431|FG001|Overall Study|Protocol Violation|9|||
126230298|NCT02227862|454134430|FG000|Overall Study|Other|0|||
126230299|NCT02227862|454134431|FG001|Overall Study|Other|2|||
126230300|NCT02227862|454134430|FG000|Overall Study|Adverse Event|4|||
126230301|NCT02227862|454134431|FG001|Overall Study|Adverse Event|3|||
126230302|NCT02227862|454134430|FG000|Overall Study|Withdrawal by Subject|7|||
126230303|NCT02227862|454134431|FG001|Overall Study|Withdrawal by Subject|6|||
126230304|NCT02227862|454134430|FG000|Overall Study|Lost to Follow-up|1|||
126230305|NCT02227862|454134431|FG001|Overall Study|Lost to Follow-up|2|||
126230306|NCT02419313|454134437|FG000|First Intervention|Lost to Follow-up|2|||
126230307|NCT02419313|454134438|FG001|First Intervention|Lost to Follow-up|0|||
126230308|NCT02419313|454134437|FG000|Second Intervention|Lost to Follow-up|1|||
126230309|NCT02419313|454134438|FG001|Second Intervention|Lost to Follow-up|0|||
126230310|NCT00620763|454134439|FG000|Period: First Intervention|Withdrawal by Subject|0|||
126230311|NCT00620763|454134440|FG001|Period: First Intervention|Withdrawal by Subject|2|||
126230312|NCT00620763|454134439|FG000|Period: First Intervention|Protocol Violation|0|||
126230313|NCT00620763|454134440|FG001|Period: First Intervention|Protocol Violation|3|||
126230314|NCT00620763|454134439|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
126230315|NCT00620763|454134440|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
126230316|NCT04956666|454134444|FG000|Overall Study|Adverse Event|18|||
126230317|NCT04956666|454134444|FG000|Overall Study|Physician Decision|5|||
126230318|NCT02907203|454134445|FG000|Overall Study|Death|1|||
126230319|NCT02907203|454134445|FG000|Overall Study|Lost to Follow-up|3|||
126230320|NCT02907203|454134445|FG000|Overall Study|Withdrawal by Subject|3|||
126230321|NCT02907203|454134445|FG000|Overall Study|Surgical bypass|1|||
126230322|NCT00760383|454134449|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
126230323|NCT00760383|454134450|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
126230324|NCT00819247|454134454|FG000|Overall Study|Adverse Event|0|||
126230325|NCT00819247|454134455|FG001|Overall Study|Adverse Event|5|||
126230326|NCT00819247|454134456|FG002|Overall Study|Adverse Event|3|||
126230327|NCT00819247|454134454|FG000|Overall Study|Insufficient testosterone response|5|||
126230328|NCT00819247|454134455|FG001|Overall Study|Insufficient testosterone response|8|||
126103463|NCT04620811|453672168|FG001|Overall Study|Adverse Event|11|||
126230329|NCT00819247|454134456|FG002|Overall Study|Insufficient testosterone response|10|||
126230330|NCT00819247|454134454|FG000|Overall Study|Withdrawal by Subject|1|||
126230331|NCT00819247|454134455|FG001|Overall Study|Withdrawal by Subject|0|||
126230332|NCT00819247|454134456|FG002|Overall Study|Withdrawal by Subject|0|||
126230333|NCT00819247|454134454|FG000|Overall Study|Protocol Violation|1|||
126230334|NCT00819247|454134455|FG001|Overall Study|Protocol Violation|0|||
126230335|NCT00819247|454134456|FG002|Overall Study|Protocol Violation|1|||
126230336|NCT00819247|454134454|FG000|Overall Study|Mistakenly withdrawn|0|||
126230337|NCT00819247|454134455|FG001|Overall Study|Mistakenly withdrawn|1|||
126230338|NCT00819247|454134456|FG002|Overall Study|Mistakenly withdrawn|0|||
126230339|NCT00819247|454134454|FG000|Overall Study|Bad prostate-specific antigen response|3|||
126230340|NCT00819247|454134455|FG001|Overall Study|Bad prostate-specific antigen response|2|||
126230341|NCT00819247|454134456|FG002|Overall Study|Bad prostate-specific antigen response|0|||
126230342|NCT00819247|454134454|FG000|Overall Study|Other|1|||
126230343|NCT00819247|454134455|FG001|Overall Study|Other|0|||
126230344|NCT00819247|454134456|FG002|Overall Study|Other|0|||
126230345|NCT00282256|454134457|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
126230346|NCT00282256|454134457|FG000|Extension Treatment Period|Adverse Event|2|||
126230347|NCT00698685|454134458|FG000|Overall Study|Sister withdrew as donor|1|||
126230348|NCT00698685|454134458|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
126230349|NCT02540356|454134459|FG000|Overall Study|Terminated due to disease progression|1|||
126230350|NCT02540356|454134460|FG001|Overall Study|Terminated due to disease progression|0|||
126230351|NCT01513148|454134461|FG000|Overall Study|Protocol Violation|2|||
126230352|NCT01513148|454134462|FG001|Overall Study|Protocol Violation|2|||
126230353|NCT04652453|454134463|FG000|Overall Study|Death|8|||
126230354|NCT04652453|454134464|FG001|Overall Study|Death|2|||
126230355|NCT04652453|454134465|FG002|Overall Study|Death|0|||
126230356|NCT04652453|454134463|FG000|Overall Study|Hospice|5|||
126230357|NCT04652453|454134464|FG001|Overall Study|Hospice|5|||
126230358|NCT04652453|454134465|FG002|Overall Study|Hospice|0|||
126230359|NCT04652453|454134463|FG000|Overall Study|Withdrawal by Subject|2|||
126230360|NCT04652453|454134464|FG001|Overall Study|Withdrawal by Subject|0|||
126230361|NCT04652453|454134465|FG002|Overall Study|Withdrawal by Subject|0|||
126230362|NCT02978326|454134472|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
126230363|NCT02978326|454134473|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
126230364|NCT02978326|454134474|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
126230365|NCT02978326|454134472|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
126230366|NCT02978326|454134473|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
126230367|NCT02978326|454134474|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
126230368|NCT02978326|454134472|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
126230369|NCT02978326|454134473|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
126230370|NCT02978326|454134474|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
126230371|NCT02978326|454134472|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
126230372|NCT02978326|454134473|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
126230373|NCT02978326|454134474|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
126230374|NCT00947427|454134478|FG000|Overall Study|Withdrawal by Subject|1|||
126230375|NCT00947427|454134479|FG001|Overall Study|Withdrawal by Subject|3|||
126230376|NCT00947427|454134478|FG000|Overall Study|Protocol Violation|0|||
126230377|NCT00947427|454134479|FG001|Overall Study|Protocol Violation|1|||
126230378|NCT01411995|454134482|FG000|Overall Study|Failed IUD insertion|0|||
126230379|NCT01411995|454134483|FG001|Overall Study|Failed IUD insertion|1|||
126230380|NCT01937364|454134484|FG000|Overall Study|Adverse Event|2|||
126230381|NCT01937364|454134485|FG001|Overall Study|Adverse Event|1|||
126230382|NCT00936975|454134486|FG000|Overall Study|Withdrawal by Subject|1|||
126230383|NCT00936975|454134486|FG000|Overall Study|Disease progression|3|||
126230384|NCT00936975|454134486|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
126230385|NCT04104646|454134487|FG000|Overall Study|Withdrawal by Subject|1|||
126230386|NCT04104646|454134488|FG001|Overall Study|Withdrawal by Subject|1|||
126230387|NCT04104646|454134487|FG000|Overall Study|Lost to Follow-up|1|||
126230388|NCT04104646|454134488|FG001|Overall Study|Lost to Follow-up|0|||
126230389|NCT04104646|454134487|FG000|Overall Study|Physician Decision|2|||
126352711|NCT02693418|454582074|FG001|Overall Study|Menses during study period|0|||
126352712|NCT02693418|454582075|FG002|Overall Study|Menses during study period|2|||
126352713|NCT02693418|454582076|FG003|Overall Study|Menses during study period|0|||
126230390|NCT04104646|454134488|FG001|Overall Study|Physician Decision|0|||
126230391|NCT02974153|454134489|FG000|Overall Study|Adverse Event|6|||
126230392|NCT02974153|454134490|FG001|Overall Study|Adverse Event|0|||
126230393|NCT02974153|454134491|FG002|Overall Study|Adverse Event|1|||
126352714|NCT02693418|454582077|FG004|Overall Study|Menses during study period|0|||
126352715|NCT02260986|454582083|FG000|Overall Study|Adverse Event|24|||
126352716|NCT02260986|454582084|FG001|Overall Study|Adverse Event|0|||
126352717|NCT02260986|454582085|FG002|Overall Study|Adverse Event|11|||
126352718|NCT02260986|454582083|FG000|Overall Study|Lack of Efficacy|27|||
126230394|NCT02974153|454134489|FG000|Overall Study|Lack of Efficacy|6|||
126230395|NCT02974153|454134490|FG001|Overall Study|Lack of Efficacy|5|||
126230396|NCT02974153|454134491|FG002|Overall Study|Lack of Efficacy|10|||
126230397|NCT02974153|454134489|FG000|Overall Study|Lost to Follow-up|9|||
126230398|NCT02974153|454134490|FG001|Overall Study|Lost to Follow-up|10|||
126230399|NCT02974153|454134491|FG002|Overall Study|Lost to Follow-up|17|||
126352719|NCT02260986|454582084|FG001|Overall Study|Lack of Efficacy|3|||
126230400|NCT02974153|454134489|FG000|Overall Study|Physician Decision|0|||
126230401|NCT02974153|454134490|FG001|Overall Study|Physician Decision|2|||
126352720|NCT02260986|454582085|FG002|Overall Study|Lack of Efficacy|0|||
126230402|NCT02974153|454134491|FG002|Overall Study|Physician Decision|1|||
126230403|NCT02974153|454134489|FG000|Overall Study|Withdrawal by Subject|9|||
126230404|NCT02974153|454134490|FG001|Overall Study|Withdrawal by Subject|16|||
126230405|NCT02974153|454134491|FG002|Overall Study|Withdrawal by Subject|11|||
126230406|NCT02974153|454134489|FG000|Overall Study|Study Burden|8|||
126230407|NCT02974153|454134490|FG001|Overall Study|Study Burden|7|||
126230408|NCT02974153|454134491|FG002|Overall Study|Study Burden|3|||
126230409|NCT02974153|454134489|FG000|Overall Study|Other|14|||
126230410|NCT02974153|454134490|FG001|Overall Study|Other|8|||
126230411|NCT02974153|454134491|FG002|Overall Study|Other|7|||
126230412|NCT02277769|454134492|FG000|Overall Study|Protocol Violation|3|||
126230413|NCT02277769|454134493|FG001|Overall Study|Protocol Violation|3|||
126230414|NCT02277769|454134494|FG002|Overall Study|Protocol Violation|5|||
126022014|NCT02723955|453375394|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
126230415|NCT02277769|454134492|FG000|Overall Study|Lack of Efficacy|17|||
126230416|NCT02277769|454134493|FG001|Overall Study|Lack of Efficacy|0|||
126230417|NCT02277769|454134494|FG002|Overall Study|Lack of Efficacy|4|||
126230418|NCT02277769|454134492|FG000|Overall Study|Adverse Event|14|||
126230419|NCT02277769|454134493|FG001|Overall Study|Adverse Event|2|||
126230420|NCT02277769|454134494|FG002|Overall Study|Adverse Event|4|||
126230421|NCT02277769|454134492|FG000|Overall Study|Other than specified above|12|||
126230422|NCT02277769|454134493|FG001|Overall Study|Other than specified above|8|||
126230423|NCT02277769|454134494|FG002|Overall Study|Other than specified above|5|||
126230424|NCT00203307|454134497|FG000|First Intervention|Adverse Event|2|||
126230425|NCT00203307|454134498|FG001|First Intervention|Adverse Event|0|||
126230426|NCT03730103|454134499|FG000|Overall Study|Did not meet inclusion criteria|0|||
126230427|NCT03730103|454134500|FG001|Overall Study|Did not meet inclusion criteria|5|||
126230428|NCT01488578|454134501|FG000|Overall Study|Protocol Violation|1836|||
126352721|NCT02260986|454582083|FG000|Overall Study|Protocol Violation|14|||
126352722|NCT02260986|454582084|FG001|Overall Study|Protocol Violation|5|||
126352723|NCT02260986|454582085|FG002|Overall Study|Protocol Violation|16|||
126352724|NCT02260986|454582083|FG000|Overall Study|Car accident|0|||
126352725|NCT02260986|454582084|FG001|Overall Study|Car accident|0|||
126352726|NCT02260986|454582085|FG002|Overall Study|Car accident|1|||
126352727|NCT02260986|454582083|FG000|Overall Study|Withdrawal by Subject|17|||
126352728|NCT02260986|454582084|FG001|Overall Study|Withdrawal by Subject|4|||
126352729|NCT02260986|454582085|FG002|Overall Study|Withdrawal by Subject|9|||
126352730|NCT02260986|454582083|FG000|Overall Study|Incorrect randomization|0|||
126352731|NCT02260986|454582084|FG001|Overall Study|Incorrect randomization|1|||
126352732|NCT02260986|454582085|FG002|Overall Study|Incorrect randomization|0|||
126352733|NCT02260986|454582083|FG000|Overall Study|Lack of investigation product supply|2|||
126352734|NCT02260986|454582084|FG001|Overall Study|Lack of investigation product supply|0|||
126352735|NCT02260986|454582085|FG002|Overall Study|Lack of investigation product supply|1|||
126352736|NCT02260986|454582083|FG000|Overall Study|Lost to Follow-up|4|||
126352737|NCT02260986|454582084|FG001|Overall Study|Lost to Follow-up|0|||
126352738|NCT02260986|454582085|FG002|Overall Study|Lost to Follow-up|3|||
126352739|NCT02260986|454582083|FG000|Overall Study|Pregnancy|2|||
126352740|NCT02260986|454582084|FG001|Overall Study|Pregnancy|0|||
126352741|NCT02260986|454582085|FG002|Overall Study|Pregnancy|0|||
126352742|NCT01793935|454582088|FG000|Overall Study|Pregnancy|1|||
126352743|NCT01793935|454582089|FG001|Overall Study|Pregnancy|0|||
126352744|NCT01793935|454582088|FG000|Overall Study|Protocol Violation|2|||
126352745|NCT01793935|454582089|FG001|Overall Study|Protocol Violation|1|||
126352746|NCT01793935|454582088|FG000|Overall Study|Adverse Event|2|||
126352747|NCT01793935|454582089|FG001|Overall Study|Adverse Event|0|||
126352748|NCT01793935|454582088|FG000|Overall Study|Patient did not take study medication|1|||
126352749|NCT01793935|454582089|FG001|Overall Study|Patient did not take study medication|1|||
126352750|NCT01793935|454582088|FG000|Overall Study|Lost to Follow-up|0|||
126352751|NCT01793935|454582089|FG001|Overall Study|Lost to Follow-up|1|||
126352752|NCT01771913|454582091|FG000|Overall Study|Withdrawal by Subject|1|||
126352753|NCT01771913|454582092|FG001|Overall Study|Withdrawal by Subject|0|||
126352754|NCT04307394|454582093|FG000|Overall Study|Lost to Follow-up|3|||
126352755|NCT04307394|454582093|FG000|Overall Study|Withdrawal by Subject|2|||
126352756|NCT00313170|454582095|FG000|Overall Study|Death|2|||
126352757|NCT00313170|454582096|FG001|Overall Study|Death|4|||
126352758|NCT00313170|454582097|FG002|Overall Study|Death|2|||
126352759|NCT00313170|454582095|FG000|Overall Study|Adverse Event|1|||
126352760|NCT00313170|454582096|FG001|Overall Study|Adverse Event|2|||
126352761|NCT00313170|454582097|FG002|Overall Study|Adverse Event|0|||
126352762|NCT00313170|454582095|FG000|Overall Study|Disease progression|31|||
126352763|NCT00313170|454582096|FG001|Overall Study|Disease progression|26|||
126352764|NCT00313170|454582097|FG002|Overall Study|Disease progression|27|||
126230429|NCT02308111|454134502|FG000|Overall Study|Adverse Event|31|||
126230430|NCT02308111|454134503|FG001|Overall Study|Adverse Event|19|||
126230431|NCT02308111|454134502|FG000|Overall Study|Death|9|||
126352765|NCT00313170|454582095|FG000|Overall Study|Withdrawal by Subject|1|||
126352766|NCT00313170|454582096|FG001|Overall Study|Withdrawal by Subject|0|||
126352767|NCT00313170|454582097|FG002|Overall Study|Withdrawal by Subject|1|||
126352768|NCT00313170|454582095|FG000|Overall Study|Incorrect enrollment|0|||
126230432|NCT02308111|454134503|FG001|Overall Study|Death|6|||
126230433|NCT02308111|454134502|FG000|Overall Study|Lost to Follow-up|2|||
126230434|NCT02308111|454134503|FG001|Overall Study|Lost to Follow-up|7|||
126230435|NCT02308111|454134502|FG000|Overall Study|Physician Decision|6|||
126230436|NCT02308111|454134503|FG001|Overall Study|Physician Decision|17|||
126230437|NCT02308111|454134502|FG000|Overall Study|Protocol Violation|0|||
126230438|NCT02308111|454134503|FG001|Overall Study|Protocol Violation|1|||
126230439|NCT02308111|454134502|FG000|Overall Study|Withdrawal by Subject|28|||
126230440|NCT02308111|454134503|FG001|Overall Study|Withdrawal by Subject|38|||
126230441|NCT02308111|454134502|FG000|Overall Study|Study Terminated by Sponsor|72|||
126230442|NCT02308111|454134503|FG001|Overall Study|Study Terminated by Sponsor|61|||
126230443|NCT02308111|454134502|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
126230444|NCT02308111|454134503|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
126230445|NCT02308111|454134502|FG000|Overall Study|Site Closure|3|||
126230446|NCT02308111|454134503|FG001|Overall Study|Site Closure|3|||
126230447|NCT02308111|454134502|FG000|Overall Study|Non-compliance with Study Drug|3|||
126230448|NCT02308111|454134503|FG001|Overall Study|Non-compliance with Study Drug|1|||
126230449|NCT02308111|454134502|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
126230450|NCT02308111|454134503|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
126230451|NCT02308111|454134502|FG000|Overall Study|Liver Transplant|3|||
126230452|NCT02308111|454134503|FG001|Overall Study|Liver Transplant|3|||
126230453|NCT02308111|454134502|FG000|Overall Study|Liver Transplant Waitlist|2|||
126230454|NCT02308111|454134503|FG001|Overall Study|Liver Transplant Waitlist|2|||
126230455|NCT02308111|454134502|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
126230456|NCT02308111|454134503|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
126230457|NCT03271528|454134504|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
126230458|NCT03271528|454134505|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
126230459|NCT03271528|454134504|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
126230460|NCT03271528|454134505|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
126230461|NCT03271528|454134504|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
126230462|NCT03271528|454134505|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
126230463|NCT03271528|454134504|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
126230464|NCT03271528|454134505|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
126230465|NCT03271528|454134504|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
126230466|NCT03271528|454134505|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
126230467|NCT03271528|454134504|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
126230468|NCT03271528|454134505|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
126230469|NCT03271528|454134504|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
126230470|NCT03271528|454134505|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
126230471|NCT03504852|454134511|FG000|Overall Study|Withdrawal of informed consent|2|||
126230472|NCT03504852|454134512|FG001|Overall Study|Withdrawal of informed consent|1|||
126230473|NCT03504852|454134513|FG002|Overall Study|Withdrawal of informed consent|0|||
126230474|NCT03504852|454134511|FG000|Overall Study|Withdrawal by Subject|5|||
126230475|NCT03504852|454134512|FG001|Overall Study|Withdrawal by Subject|5|||
126230476|NCT03504852|454134513|FG002|Overall Study|Withdrawal by Subject|1|||
126230477|NCT03504852|454134511|FG000|Overall Study|Lost to Follow-up|4|||
126230478|NCT03504852|454134512|FG001|Overall Study|Lost to Follow-up|1|||
126230479|NCT03504852|454134513|FG002|Overall Study|Lost to Follow-up|0|||
126230480|NCT03504852|454134511|FG000|Overall Study|New therapy for study indication|1|||
126230481|NCT03504852|454134512|FG001|Overall Study|New therapy for study indication|0|||
126230482|NCT03504852|454134513|FG002|Overall Study|New therapy for study indication|0|||
126230483|NCT03504852|454134511|FG000|Overall Study|Lack of Efficacy|1|||
126230484|NCT03504852|454134512|FG001|Overall Study|Lack of Efficacy|2|||
126230485|NCT03504852|454134513|FG002|Overall Study|Lack of Efficacy|0|||
126230486|NCT03504852|454134511|FG000|Overall Study|Death|0|||
126230487|NCT03504852|454134512|FG001|Overall Study|Death|1|||
126230488|NCT03504852|454134513|FG002|Overall Study|Death|0|||
126230489|NCT03504852|454134511|FG000|Overall Study|Adverse Event|4|||
126352769|NCT00313170|454582096|FG001|Overall Study|Incorrect enrollment|2|||
126352770|NCT00313170|454582097|FG002|Overall Study|Incorrect enrollment|1|||
126352771|NCT00313170|454582095|FG000|Overall Study|Lost to Follow-up|0|||
126352772|NCT00313170|454582096|FG001|Overall Study|Lost to Follow-up|0|||
126352773|NCT00313170|454582097|FG002|Overall Study|Lost to Follow-up|1|||
126352774|NCT00313170|454582095|FG000|Overall Study|Progression (investigators opinion)|1|||
126230490|NCT03504852|454134512|FG001|Overall Study|Adverse Event|8|||
126230491|NCT03504852|454134513|FG002|Overall Study|Adverse Event|2|||
126230492|NCT01066052|454134514|FG000|Overall Study|Enrolled But Not Treated|3|||
126230493|NCT01066052|454134515|FG001|Overall Study|Enrolled But Not Treated|0|||
126230494|NCT02928848|454134516|FG000|Arm 2|Withdrawal by Subject|1|||
126230495|NCT02928848|454134517|FG001|Arm 2|Withdrawal by Subject|0|||
126352775|NCT00313170|454582096|FG001|Overall Study|Progression (investigators opinion)|0|||
126352776|NCT00313170|454582097|FG002|Overall Study|Progression (investigators opinion)|0|||
126230496|NCT03850509|454134518|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
126230497|NCT03850509|454134519|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
126230498|NCT00969332|454134520|FG000|Overall Study|Physician Decision|8|||
126230499|NCT00969332|454134520|FG000|Overall Study|Withdrawal by Subject|3|||
126230500|NCT01835145|454134523|FG000|Overall Study|Ineligible prior to treatment|1|||
126230501|NCT01835145|454134524|FG001|Overall Study|Ineligible prior to treatment|0|||
126230502|NCT02729896|454134525|FG000|Overall Study|Death|0|||
126230503|NCT02729896|454134526|FG001|Overall Study|Death|2|||
126230504|NCT02729896|454134527|FG002|Overall Study|Death|13|||
126230505|NCT02729896|454134525|FG000|Overall Study|Lost to Follow-up|0|||
126230506|NCT02729896|454134526|FG001|Overall Study|Lost to Follow-up|2|||
126230507|NCT02729896|454134527|FG002|Overall Study|Lost to Follow-up|3|||
126230508|NCT02729896|454134525|FG000|Overall Study|Other|0|||
126230509|NCT02729896|454134526|FG001|Overall Study|Other|2|||
126230510|NCT02729896|454134527|FG002|Overall Study|Other|0|||
126230511|NCT02729896|454134525|FG000|Overall Study|Physician Decision|1|||
126230512|NCT02729896|454134526|FG001|Overall Study|Physician Decision|2|||
126230513|NCT02729896|454134527|FG002|Overall Study|Physician Decision|3|||
126230514|NCT02729896|454134525|FG000|Overall Study|Progressive Disease|0|||
126230515|NCT02729896|454134526|FG001|Overall Study|Progressive Disease|1|||
126230516|NCT02729896|454134527|FG002|Overall Study|Progressive Disease|0|||
126230517|NCT02729896|454134525|FG000|Overall Study|Withdrawal by Subject|1|||
126230518|NCT02729896|454134526|FG001|Overall Study|Withdrawal by Subject|0|||
126230519|NCT02729896|454134527|FG002|Overall Study|Withdrawal by Subject|3|||
126230520|NCT00582309|454134528|FG000|Overall Study|Protocol Violation|0|||
126230521|NCT00582309|454134529|FG001|Overall Study|Protocol Violation|0|||
126230522|NCT00582309|454134530|FG002|Overall Study|Protocol Violation|2|||
126230523|NCT01565083|454134531|FG000|Overall Study|Withdrawal by Subject|6|||
126230524|NCT01565083|454134532|FG001|Overall Study|Withdrawal by Subject|4|||
126230525|NCT01565083|454134531|FG000|Overall Study|Lost to Follow-up|2|||
126230526|NCT01565083|454134532|FG001|Overall Study|Lost to Follow-up|7|||
126230527|NCT01565083|454134531|FG000|Overall Study|Death|22|||
126230528|NCT01565083|454134532|FG001|Overall Study|Death|23|||
126230529|NCT01565083|454134531|FG000|Overall Study|Other|3|||
126230530|NCT01565083|454134532|FG001|Overall Study|Other|5|||
126230531|NCT01058421|454134533|FG000|1 Month Outcomes|Death|10|||
126230532|NCT01058421|454134534|FG001|1 Month Outcomes|Death|6|||
126022015|NCT02723955|453375395|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022016|NCT02723955|453375396|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022017|NCT02723955|453375397|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022018|NCT02723955|453375398|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022019|NCT02723955|453375399|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
126230533|NCT01058421|454134533|FG000|1 Month Outcomes|Lost to Follow-up|8|||
126230534|NCT01058421|454134534|FG001|1 Month Outcomes|Lost to Follow-up|7|||
126230535|NCT01058421|454134533|FG000|1 Month Outcomes|Remained in Hospital|5|||
126230536|NCT01058421|454134534|FG001|1 Month Outcomes|Remained in Hospital|12|||
126352777|NCT04900272|454582098|FG000|Overall Study|Lost to Follow-up|2|||
126352778|NCT04900272|454582098|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
126352779|NCT04900272|454582098|FG000|Overall Study|Withdrawal by Subject|1|||
126352780|NCT05059080|454582100|FG000|Overall Study|Withdrawal by Subject|3|||
126352781|NCT05059080|454582100|FG000|Overall Study|Study Terminated by Sponsor|64|||
126352782|NCT05607043|454582101|FG000|Overall Study|Lost to Follow-up|2|||
126352783|NCT00429299|454582109|FG000|Overall Study|Disease Progression|1|||
126352784|NCT00429299|454582110|FG001|Overall Study|Disease Progression|1|||
126352785|NCT00429299|454582111|FG002|Overall Study|Disease Progression|0|||
126352786|NCT00429299|454582109|FG000|Overall Study|Adverse Event|2|||
126352787|NCT00429299|454582110|FG001|Overall Study|Adverse Event|5|||
126352788|NCT00429299|454582111|FG002|Overall Study|Adverse Event|1|||
126352789|NCT00429299|454582109|FG000|Overall Study|Protocol Violation|1|||
126352790|NCT00429299|454582110|FG001|Overall Study|Protocol Violation|0|||
126352791|NCT00429299|454582111|FG002|Overall Study|Protocol Violation|0|||
126352792|NCT00429299|454582109|FG000|Overall Study|Withdrawal by Subject|0|||
126352793|NCT00429299|454582110|FG001|Overall Study|Withdrawal by Subject|1|||
126352794|NCT00429299|454582111|FG002|Overall Study|Withdrawal by Subject|3|||
126352795|NCT04871113|454582112|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352796|NCT04871113|454582113|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126230537|NCT01058421|454134533|FG000|1 Month Outcomes|Remained in Other Facility|16|||
126230538|NCT01058421|454134534|FG001|1 Month Outcomes|Remained in Other Facility|17|||
126230539|NCT01058421|454134533|FG000|3 Month Outcomes|Death|3|||
126352797|NCT04871113|454582114|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352798|NCT04871113|454582115|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126103464|NCT04620811|453672167|FG000|Overall Study|Lost to Follow-up|4|||
126230540|NCT01058421|454134534|FG001|3 Month Outcomes|Death|5|||
126230541|NCT01058421|454134533|FG000|3 Month Outcomes|Lost to Follow-up|12|||
126230542|NCT01058421|454134534|FG001|3 Month Outcomes|Lost to Follow-up|11|||
126230543|NCT01058421|454134533|FG000|3 Month Outcomes|Remained in Hospital|0|||
126230544|NCT01058421|454134534|FG001|3 Month Outcomes|Remained in Hospital|2|||
126022020|NCT02723955|453375400|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022021|NCT02723955|453375401|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022022|NCT02723955|453375402|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022023|NCT02723955|453375403|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
126352799|NCT04871113|454582116|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352800|NCT04871113|454582117|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
126352801|NCT04871113|454582118|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352802|NCT04871113|454582119|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352803|NCT04871113|454582120|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352804|NCT04871113|454582121|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352805|NCT04871113|454582112|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352806|NCT04871113|454582113|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352807|NCT04871113|454582114|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352808|NCT04871113|454582115|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352809|NCT04871113|454582116|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352810|NCT04871113|454582117|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352811|NCT04871113|454582118|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
126352812|NCT04871113|454582119|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
126352813|NCT04871113|454582120|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352814|NCT04871113|454582121|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352815|NCT01257542|454582124|FG000|Overall Study|Protocol Violation|3|||
126352816|NCT01257542|454582125|FG001|Overall Study|Protocol Violation|5|||
126352817|NCT01257542|454582124|FG000|Overall Study|Withdrawal by Subject|0|||
126352818|NCT01257542|454582125|FG001|Overall Study|Withdrawal by Subject|2|||
126352819|NCT00770484|454582128|FG000|Overall Study|Withdrawal by Subject|1|||
126352820|NCT00770484|454582129|FG001|Overall Study|Withdrawal by Subject|0|||
126352821|NCT04327271|454582130|FG000|Overall Study|Death|1|||
126352822|NCT04327271|454582131|FG001|Overall Study|Death|0|||
126352823|NCT04327271|454582130|FG000|Overall Study|Withdrawal by Subject|1|||
126352824|NCT04327271|454582131|FG001|Overall Study|Withdrawal by Subject|0|||
126352825|NCT04327271|454582130|FG000|Overall Study|randomization error (data capture)|4|||
126352826|NCT04327271|454582131|FG001|Overall Study|randomization error (data capture)|3|||
126352827|NCT01479530|454582133|FG000|Overall Study|Adverse Event|5|||
126352828|NCT01479530|454582134|FG001|Overall Study|Adverse Event|6|||
126352829|NCT01479530|454582133|FG000|Overall Study|Lack of Efficacy|0|||
126352830|NCT01479530|454582134|FG001|Overall Study|Lack of Efficacy|1|||
126352831|NCT01479530|454582133|FG000|Overall Study|Protocol Violation|2|||
126352832|NCT01479530|454582134|FG001|Overall Study|Protocol Violation|3|||
126352833|NCT01479530|454582133|FG000|Overall Study|Withdrawal of Consent|3|||
126230545|NCT01058421|454134533|FG000|3 Month Outcomes|Remained in Other Facility|5|||
126093110|NCT00939822|453634513|FG000|Overall Study|Mental health issues|0|||
126230546|NCT01058421|454134534|FG001|3 Month Outcomes|Remained in Other Facility|8|||
126230547|NCT01058421|454134533|FG000|6 Month Outcomes|Death|2|||
126230548|NCT01058421|454134534|FG001|6 Month Outcomes|Death|2|||
126230549|NCT01058421|454134533|FG000|6 Month Outcomes|Lost to Follow-up|16|||
126230550|NCT01058421|454134534|FG001|6 Month Outcomes|Lost to Follow-up|21|||
126230551|NCT01058421|454134533|FG000|6 Month Outcomes|Remained in Other Facility|1|||
126230552|NCT01058421|454134534|FG001|6 Month Outcomes|Remained in Other Facility|3|||
126230553|NCT01309919|454134555|FG000|Overall Study|Did not receive a postpartum IUD|17|||
126230554|NCT01309919|454134556|FG001|Overall Study|Did not receive a postpartum IUD|48|||
126352834|NCT01479530|454582134|FG001|Overall Study|Withdrawal of Consent|2|||
126352835|NCT00303628|454582135|FG000|Overall Study|Disease progression|0|||
126352836|NCT00303628|454582136|FG001|Overall Study|Disease progression|1|||
126352837|NCT00303628|454582135|FG000|Overall Study|Adverse Event|26|||
126352838|NCT00303628|454582136|FG001|Overall Study|Adverse Event|36|||
126352839|NCT00303628|454582135|FG000|Overall Study|Death|0|||
126352840|NCT00303628|454582136|FG001|Overall Study|Death|1|||
126352841|NCT00303628|454582135|FG000|Overall Study|Withdrawal by Subject|11|||
126352842|NCT00303628|454582136|FG001|Overall Study|Withdrawal by Subject|20|||
126352843|NCT00303628|454582135|FG000|Overall Study|Alternative therapy|2|||
126352844|NCT00303628|454582136|FG001|Overall Study|Alternative therapy|0|||
126352845|NCT00303628|454582135|FG000|Overall Study|Other complicating disease|0|||
126352846|NCT00303628|454582136|FG001|Overall Study|Other complicating disease|1|||
126352847|NCT00303628|454582135|FG000|Overall Study|Not start protocol therapy|3|||
126352848|NCT00303628|454582136|FG001|Overall Study|Not start protocol therapy|5|||
126352849|NCT00303628|454582135|FG000|Overall Study|Other|8|||
126352850|NCT00303628|454582136|FG001|Overall Study|Other|9|||
126352851|NCT00776997|454582138|FG000|Overall Study|Adverse Event|2|||
126352852|NCT02948400|454582139|FG000|Overall Study|Withdrawal by Subject|17|||
126352853|NCT02948400|454582140|FG001|Overall Study|Withdrawal by Subject|10|||
126352854|NCT02948400|454582139|FG000|Overall Study|failed to attend appointments|47|||
126352855|NCT02948400|454582140|FG001|Overall Study|failed to attend appointments|34|||
126352856|NCT02948400|454582139|FG000|Overall Study|COVID-related closure|6|||
126352857|NCT02948400|454582140|FG001|Overall Study|COVID-related closure|2|||
126352858|NCT02948400|454582139|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
126352859|NCT02948400|454582140|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
126352860|NCT02948400|454582139|FG000|Overall Study|motion sickness in virtual reality|2|||
126352861|NCT02948400|454582140|FG001|Overall Study|motion sickness in virtual reality|0|||
126352862|NCT02403271|454582141|FG000|Period 1|Other varied reasons|1|||
126352863|NCT02403271|454582142|FG001|Period 1|Other varied reasons|0|||
126352864|NCT02403271|454582141|FG000|Period 2|Withdrawal by Subject|0|||
126352865|NCT02403271|454582142|FG001|Period 2|Withdrawal by Subject|14|||
126352866|NCT02403271|454582141|FG000|Period 2|Death|0|||
126352867|NCT02403271|454582142|FG001|Period 2|Death|84|||
126352868|NCT02403271|454582141|FG000|Period 2|Lost to Follow-up|0|||
126352869|NCT02403271|454582142|FG001|Period 2|Lost to Follow-up|2|||
126352870|NCT02403271|454582141|FG000|Period 2|Study Terminated by Sponsor|0|||
126352871|NCT02403271|454582142|FG001|Period 2|Study Terminated by Sponsor|14|||
126352872|NCT02403271|454582141|FG000|Period 2|Other varied reasons|0|||
126352873|NCT02403271|454582142|FG001|Period 2|Other varied reasons|10|||
126352874|NCT03487445|454582143|FG000|Randomization|Not treated for administrative reasons|1|||
126352875|NCT03487445|454582144|FG001|Randomization|Not treated for administrative reasons|0|||
126352876|NCT03301714|454582145|FG000|Overall Study|Lost to Follow-up|10|||
126352877|NCT03301714|454582146|FG001|Overall Study|Lost to Follow-up|4|||
126352878|NCT03301714|454582147|FG002|Overall Study|Lost to Follow-up|4|||
126352879|NCT03301714|454582145|FG000|Overall Study|Did not receive allocated intervention|0|||
126352880|NCT03301714|454582146|FG001|Overall Study|Did not receive allocated intervention|2|||
126352881|NCT03301714|454582147|FG002|Overall Study|Did not receive allocated intervention|3|||
126352882|NCT03599713|454582159|FG000|Overall Study|Death|38|||
126352883|NCT03599713|454582160|FG001|Overall Study|Death|3|||
126352884|NCT03599713|454582159|FG000|Overall Study|Withdrawal by Subject|17|||
126352885|NCT03599713|454582160|FG001|Overall Study|Withdrawal by Subject|0|||
126352886|NCT03599713|454582159|FG000|Overall Study|Lost to Follow-up|4|||
126352887|NCT03599713|454582160|FG001|Overall Study|Lost to Follow-up|0|||
126352888|NCT03599713|454582159|FG000|Overall Study|Discontinued Due to End of Study|42|||
126352889|NCT03599713|454582160|FG001|Overall Study|Discontinued Due to End of Study|3|||
126352890|NCT01127061|454583323|FG000|Overall Study|Lost to Follow-up|7|||
126352891|NCT01127061|454583324|FG001|Overall Study|Lost to Follow-up|10|||
126352892|NCT01127061|454583323|FG000|Overall Study|Physician Decision|3|||
126352893|NCT01127061|454583324|FG001|Overall Study|Physician Decision|3|||
126352894|NCT04827446|454583325|FG000|Overall Study|Lost to Follow-up|1|||
126352895|NCT04827446|454583326|FG001|Overall Study|Lost to Follow-up|1|||
126352896|NCT04827446|454583325|FG000|Overall Study|Death|2|||
126352897|NCT04827446|454583326|FG001|Overall Study|Death|0|||
126352898|NCT04827446|454583325|FG000|Overall Study|Withdrawal by Subject|2|||
126352899|NCT04827446|454583326|FG001|Overall Study|Withdrawal by Subject|2|||
126352900|NCT00003456|454583329|FG000|Overall Study|Not evaluable|8|||
126022024|NCT02723955|453375404|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022025|NCT02723955|453375405|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022026|NCT02723955|453375406|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
126022027|NCT02723955|453375407|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
126022028|NCT02723955|453375408|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022029|NCT02723955|453375409|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
126022030|NCT02723955|453375410|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
126022031|NCT02723955|453375368|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
126022032|NCT02723955|453375369|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
126022033|NCT02723955|453375370|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
126022034|NCT02723955|453375371|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
126022035|NCT02723955|453375372|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
126022036|NCT02723955|453375373|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
126022037|NCT02723955|453375374|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
126022038|NCT02723955|453375375|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
126022039|NCT02723955|453375376|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
126022040|NCT02723955|453375377|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
126022041|NCT02723955|453375378|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
126022042|NCT02723955|453375379|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
126022043|NCT02723955|453375380|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
126022044|NCT02723955|453375381|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
126022045|NCT02723955|453375382|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
126352901|NCT05399771|454583330|FG000|Overall Study|Physician Decision|3|||
126352902|NCT05399771|454583330|FG000|Overall Study|Adverse Event|1|||
126352903|NCT00143507|454583333|FG000|Overall Study|Death|572|||
126352904|NCT00143507|454583334|FG001|Overall Study|Death|547|||
126352905|NCT00143507|454583333|FG000|Overall Study|Withdrawal by Subject|114|||
126352906|NCT00143507|454583334|FG001|Overall Study|Withdrawal by Subject|102|||
126352907|NCT00143507|454583333|FG000|Overall Study|Lost to Follow-up|1|||
126352908|NCT00143507|454583334|FG001|Overall Study|Lost to Follow-up|0|||
126352909|NCT00143507|454583333|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
126352910|NCT00143507|454583334|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
126352911|NCT00484159|454583335|FG000|Overall Study|Lost to Follow-up|1|||
126352912|NCT00484159|454583336|FG001|Overall Study|Lost to Follow-up|1|||
126352913|NCT00484159|454583337|FG002|Overall Study|Lost to Follow-up|0|||
126352914|NCT03234881|454583338|FG000|Overall Study|Lost to Follow-up|9|||
126352915|NCT03234881|454583339|FG001|Overall Study|Lost to Follow-up|3|||
126352916|NCT02513199|454583342|FG000|Treatment|Death|1|||
126352917|NCT02513199|454583342|FG000|Treatment|Lost to Follow-up|1|||
126352918|NCT02513199|454583342|FG000|Follow-Up|Death|11|||
126352919|NCT00407511|454583354|FG000|Overall Study|Adverse Event|9|||
126352920|NCT00407511|454583354|FG000|Overall Study|Lost to Follow-up|4|||
126352921|NCT00407511|454583354|FG000|Overall Study|Other|5|||
126352922|NCT00407511|454583354|FG000|Overall Study|Withdrawal by Subject|4|||
126352923|NCT00529035|454583355|FG000|Overall Study|Withdrawal by Subject|1|||
126352924|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Other|4|||
126352925|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Other|1|||
126352926|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
126352927|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126352928|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
126352929|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
126352930|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
126352931|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
126352932|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Death|1|||
126352933|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Death|2|||
126352934|NCT02175758|454583358|FG000|Treatment Phase|Lost to Follow-up|0|||
126352935|NCT02175758|454583359|FG001|Treatment Phase|Lost to Follow-up|1|||
126352936|NCT02175758|454583360|FG002|Treatment Phase|Lost to Follow-up|0|||
126352937|NCT02175758|454583361|FG003|Treatment Phase|Lost to Follow-up|0|||
126352938|NCT02175758|454583362|FG004|Treatment Phase|Lost to Follow-up|0|||
126352939|NCT02175758|454583363|FG005|Treatment Phase|Lost to Follow-up|0|||
126352940|NCT02175758|454583358|FG000|Treatment Phase|Adverse Event|0|||
126352941|NCT02175758|454583359|FG001|Treatment Phase|Adverse Event|0|||
126352942|NCT02175758|454583360|FG002|Treatment Phase|Adverse Event|0|||
126352943|NCT02175758|454583361|FG003|Treatment Phase|Adverse Event|0|||
126352944|NCT02175758|454583362|FG004|Treatment Phase|Adverse Event|1|||
126352945|NCT02175758|454583363|FG005|Treatment Phase|Adverse Event|0|||
126352946|NCT00800540|454583366|FG000|Period One: 6 Weeks|Noncompliance|1|||
126352947|NCT00800540|454583367|FG001|Period One: 6 Weeks|Noncompliance|0|||
126352948|NCT00800540|454583366|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
126352949|NCT00800540|454583367|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
126352950|NCT00800540|454583366|FG000|Period 2: 6 Weeks|Adverse Event|0|||
126352951|NCT00800540|454583367|FG001|Period 2: 6 Weeks|Adverse Event|1|||
126352952|NCT03927157|454583368|FG000|Overall Study|Adverse Event|1|||
126352953|NCT03927157|454583369|FG001|Overall Study|Adverse Event|3|||
126352954|NCT03927157|454583368|FG000|Overall Study|Protocol Violation|1|||
126230555|NCT00319449|454134557|FG000|Overall Study|Subject did not wish to continue|1|||
126230556|NCT00319449|454134558|FG001|Overall Study|Subject did not wish to continue|0|||
126230557|NCT00319449|454134557|FG000|Overall Study|Noncompliance with the protocol|1|||
126230558|NCT00319449|454134558|FG001|Overall Study|Noncompliance with the protocol|0|||
126230559|NCT02102490|454134559|FG000|Overall Study|Death|6|||
126230560|NCT02102490|454134559|FG000|Overall Study|Lost to Follow-up|1|||
126230561|NCT01346410|454134560|FG000|Overall Study|Death|1|||
126230562|NCT00979628|454134561|FG000|Overall Study|received regimen < 24 hours|7|||
126230563|NCT00979628|454134562|FG001|Overall Study|received regimen < 24 hours|6|||
126230564|NCT00979628|454134563|FG002|Overall Study|received regimen < 24 hours|5|||
126230565|NCT00979628|454134561|FG000|Overall Study|received steroids|1|||
126230566|NCT00979628|454134562|FG001|Overall Study|received steroids|1|||
126230567|NCT00979628|454134563|FG002|Overall Study|received steroids|0|||
126230568|NCT00979628|454134561|FG000|Overall Study|transferred to ICU|1|||
126230569|NCT00979628|454134562|FG001|Overall Study|transferred to ICU|2|||
126230570|NCT00979628|454134563|FG002|Overall Study|transferred to ICU|1|||
126230571|NCT02224456|454136266|FG000|Overall Study|Lack of Efficacy|1|||
126230572|NCT02224456|454136266|FG000|Overall Study|Lost to Follow-up|15|||
126230573|NCT02224456|454136266|FG000|Overall Study|Withdrawal by Subject|9|||
126230574|NCT02224456|454136266|FG000|Overall Study|Physician Decision|3|||
126352955|NCT03927157|454583369|FG001|Overall Study|Protocol Violation|2|||
126352956|NCT03927157|454583368|FG000|Overall Study|Withdrawal by Subject|8|||
126352957|NCT03927157|454583369|FG001|Overall Study|Withdrawal by Subject|21|||
126352958|NCT03927157|454583368|FG000|Overall Study|Due to COVID-19 pandemic|5|||
126352959|NCT03927157|454583369|FG001|Overall Study|Due to COVID-19 pandemic|2|||
126352960|NCT03927157|454583368|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
126352961|NCT03927157|454583369|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
126352962|NCT03927157|454583368|FG000|Overall Study|Other than above|0|||
126352963|NCT03927157|454583369|FG001|Overall Study|Other than above|1|||
126352964|NCT02447029|454583370|FG000|Overall Study|Withdrawal by Subject|3|||
126352965|NCT02447029|454583371|FG001|Overall Study|Withdrawal by Subject|2|||
126352966|NCT01239745|454583372|FG000|Overall Study|Study terminated by sponsor|45|||
126352967|NCT01239745|454583372|FG000|Overall Study|Adverse Event|1|||
126352968|NCT00726557|454583373|FG000|Overall Study|Screening failure|4|||
126352969|NCT00726557|454583373|FG000|Overall Study|No end of treatment documentation|37|||
126352970|NCT00726557|454583373|FG000|Overall Study|No follow-up documentation available|55|||
126352971|NCT00726557|454583373|FG000|Overall Study|Treatment less than 3 months|17|||
126352972|NCT00726557|454583373|FG000|Overall Study|Inclusion criteria not met|15|||
126352973|NCT00081458|454583374|FG000|Overall Study|Adverse Event|1|||
126352974|NCT00081458|454583375|FG001|Overall Study|Adverse Event|5|||
126352975|NCT00081458|454583376|FG002|Overall Study|Adverse Event|2|||
126352976|NCT00081458|454583374|FG000|Overall Study|Withdrawal by Subject|0|||
126352977|NCT00081458|454583375|FG001|Overall Study|Withdrawal by Subject|3|||
126352978|NCT00081458|454583376|FG002|Overall Study|Withdrawal by Subject|1|||
126352979|NCT00081458|454583374|FG000|Overall Study|Randomized but not dosed|0|||
126230575|NCT02224456|454136266|FG000|Overall Study|Death|2|||
126352980|NCT00081458|454583375|FG001|Overall Study|Randomized but not dosed|0|||
126352981|NCT00081458|454583376|FG002|Overall Study|Randomized but not dosed|1|||
126352982|NCT00549328|454583377|FG000|Overall Study|Adverse Event|2|||
126352983|NCT00549328|454583377|FG000|Overall Study|Disease Progression|10|||
126103465|NCT04620811|453672168|FG001|Overall Study|Lost to Follow-up|8|||
126230576|NCT02224456|454136266|FG000|Overall Study|Pregnancy|4|||
126352984|NCT00549328|454583377|FG000|Overall Study|Death|1|||
126022046|NCT02723955|453375383|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
126230577|NCT02224456|454136266|FG000|Overall Study|Protocol Violation|1|||
126230578|NCT02224456|454136266|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
126230579|NCT01644890|454136267|FG000|Overall Study|Adverse Event|7|||
126230580|NCT01644890|454136268|FG001|Overall Study|Adverse Event|20|||
126230581|NCT01644890|454136267|FG000|Overall Study|Death|1|||
126230582|NCT01644890|454136268|FG001|Overall Study|Death|3|||
126230583|NCT01644890|454136267|FG000|Overall Study|Physician Decision|3|||
126230584|NCT01644890|454136268|FG001|Overall Study|Physician Decision|9|||
126230585|NCT01644890|454136267|FG000|Overall Study|Protocol Violation|6|||
126230586|NCT01644890|454136268|FG001|Overall Study|Protocol Violation|7|||
126230587|NCT01644890|454136267|FG000|Overall Study|Withdrawal by Subject|19|||
126022047|NCT02723955|453375384|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
126022048|NCT02723955|453375385|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
126230588|NCT01644890|454136268|FG001|Overall Study|Withdrawal by Subject|27|||
126022049|NCT02723955|453375386|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
126022050|NCT02723955|453375387|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
126230589|NCT01644890|454136267|FG000|Overall Study|Progression Disease|160|||
126230590|NCT01644890|454136268|FG001|Overall Study|Progression Disease|131|||
126230591|NCT01644890|454136267|FG000|Overall Study|Clinical Progression|6|||
126230592|NCT01644890|454136268|FG001|Overall Study|Clinical Progression|6|||
126352985|NCT00549328|454583377|FG000|Overall Study|Use of Prohibited Medication|1|||
126352986|NCT01946802|454583382|FG000|Overall Study|Death|1|||
126352987|NCT01946802|454583382|FG000|Overall Study|Withdrawal by Subject|2|||
126352988|NCT01946802|454583382|FG000|Overall Study|Combined septic shock|1|||
126352989|NCT01946802|454583382|FG000|Overall Study|Protocol Violation|1|||
126352990|NCT03097315|454583383|FG000|Overall Study|Withdrawal by Subject|1|||
126352991|NCT03384966|454583384|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
126352992|NCT03384966|454583385|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
126352993|NCT03384966|454583386|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
126352994|NCT03384966|454583384|FG000|Follow-up Period|Adverse Event|1|||
126352995|NCT03384966|454583385|FG001|Follow-up Period|Adverse Event|0|||
126352996|NCT03384966|454583386|FG002|Follow-up Period|Adverse Event|0|||
126352997|NCT02202616|454583387|FG000|Overall Study|Screen failed|24|||
126352998|NCT02202616|454583387|FG000|Overall Study|Adverse Event|32|||
126230593|NCT01644890|454136267|FG000|Overall Study|> 28 days since last dose of study drug|6|||
126230594|NCT01644890|454136268|FG001|Overall Study|> 28 days since last dose of study drug|3|||
126352999|NCT02202616|454583387|FG000|Overall Study|Protocol deviation|18|||
126353000|NCT02202616|454583387|FG000|Overall Study|Patient withdrew consent|12|||
126353001|NCT02202616|454583387|FG000|Overall Study|Lost to Follow-up|6|||
126022051|NCT02723955|453375388|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
126230595|NCT01644890|454136267|FG000|Overall Study|Other|8|||
126230596|NCT01644890|454136268|FG001|Overall Study|Other|9|||
126230597|NCT02761980|454136271|FG000|Overall Study|Adverse Event|4|||
126230598|NCT02761980|454136272|FG001|Overall Study|Adverse Event|6|||
126230599|NCT02761980|454136273|FG002|Overall Study|Adverse Event|5|||
126230600|NCT02761980|454136274|FG003|Overall Study|Adverse Event|6|||
126230601|NCT02761980|454136271|FG000|Overall Study|Withdrawal by Subject|0|||
126230602|NCT02761980|454136272|FG001|Overall Study|Withdrawal by Subject|1|||
126230603|NCT02761980|454136273|FG002|Overall Study|Withdrawal by Subject|0|||
126230604|NCT02761980|454136274|FG003|Overall Study|Withdrawal by Subject|0|||
126230605|NCT02761980|454136271|FG000|Overall Study|Other|0|||
126230606|NCT02761980|454136272|FG001|Overall Study|Other|0|||
126230607|NCT02761980|454136273|FG002|Overall Study|Other|1|||
126230608|NCT02761980|454136274|FG003|Overall Study|Other|0|||
126230609|NCT00101582|454136275|FG000|Overall Study|Ineligibility determined|0|||
126230610|NCT00101582|454136276|FG001|Overall Study|Ineligibility determined|1|||
126230611|NCT00101582|454136275|FG000|Overall Study|Adverse Event|1|||
126230612|NCT00101582|454136276|FG001|Overall Study|Adverse Event|4|||
126230613|NCT00101582|454136275|FG000|Overall Study|Withdrawal by Subject|6|||
126230614|NCT00101582|454136276|FG001|Overall Study|Withdrawal by Subject|4|||
126230615|NCT00101582|454136275|FG000|Overall Study|Physician Decision|1|||
126230616|NCT00101582|454136276|FG001|Overall Study|Physician Decision|0|||
126230617|NCT00101582|454136275|FG000|Overall Study|Death|3|||
126230618|NCT00101582|454136276|FG001|Overall Study|Death|5|||
126230619|NCT00101582|454136275|FG000|Overall Study|Other|0|||
126230620|NCT00101582|454136276|FG001|Overall Study|Other|1|||
126230621|NCT00056160|454136277|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
126230622|NCT00056160|454136278|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
126230623|NCT00056160|454136277|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
126230624|NCT00056160|454136278|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
126230625|NCT00056160|454136277|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
126230626|NCT00056160|454136278|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
126230627|NCT00056160|454136277|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
126230628|NCT00056160|454136278|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
126230629|NCT00056160|454136277|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
126230630|NCT00056160|454136278|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
126230631|NCT00056160|454136277|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
126230632|NCT00056160|454136278|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
126230633|NCT00056160|454136277|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
126230634|NCT00056160|454136278|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
126230635|NCT00056160|454136277|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
126230636|NCT00056160|454136278|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
126230637|NCT00056160|454136277|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
126230638|NCT00056160|454136278|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
126230639|NCT00056160|454136277|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
126230640|NCT00056160|454136278|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
126230641|NCT00056160|454136277|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
126230642|NCT00056160|454136278|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
126230643|NCT00056160|454136277|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
126230644|NCT00056160|454136278|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
126230645|NCT00056160|454136277|FG000|Final Follow-up|Transferred into expanded access study.|3|||
126230646|NCT00056160|454136278|FG001|Final Follow-up|Transferred into expanded access study.|0|||
126230647|NCT00056160|454136277|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
126230648|NCT00056160|454136278|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
126230649|NCT00056160|454136277|FG000|Final Follow-up|Adverse Event|1|||
126230650|NCT00056160|454136278|FG001|Final Follow-up|Adverse Event|0|||
126230651|NCT03093324|454136280|FG000|Overall Study|Adverse Event|4|||
126230652|NCT03093324|454136281|FG001|Overall Study|Adverse Event|15|||
126022052|NCT02723955|453375389|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
126022053|NCT02723955|453375390|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
126230653|NCT03093324|454136280|FG000|Overall Study|Lost to Follow-up|1|||
126230654|NCT03093324|454136281|FG001|Overall Study|Lost to Follow-up|0|||
126230655|NCT03093324|454136280|FG000|Overall Study|Protocol Deviation|2|||
126230656|NCT03093324|454136281|FG001|Overall Study|Protocol Deviation|2|||
126230657|NCT03093324|454136280|FG000|Overall Study|Withdrawal by Subject|2|||
126230658|NCT03093324|454136281|FG001|Overall Study|Withdrawal by Subject|2|||
126022054|NCT02723955|453375391|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
126022055|NCT02723955|453375392|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
126022056|NCT02723955|453375393|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
126230659|NCT04583579|454136282|FG000|Overall Study|Lost to Follow-up|4|||
126230660|NCT00278200|454136283|FG000|Overall Study|Death|1|||
126230661|NCT00278200|454136284|FG001|Overall Study|Death|3|||
126230662|NCT00278200|454136283|FG000|Overall Study|Physician Decision|0|||
126230663|NCT00278200|454136284|FG001|Overall Study|Physician Decision|1|||
126022057|NCT02723955|453375394|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
126022058|NCT02723955|453375395|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
126022059|NCT02723955|453375396|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
126022060|NCT02723955|453375397|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
126022061|NCT02723955|453375398|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
126022062|NCT02723955|453375399|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
126022063|NCT02723955|453375400|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
126022064|NCT02723955|453375401|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
126022065|NCT02723955|453375402|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
126022066|NCT02723955|453375403|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
126022067|NCT02723955|453375404|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
126022068|NCT02723955|453375405|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
126022069|NCT02723955|453375406|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
126022070|NCT02723955|453375407|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
126230664|NCT00135707|454136287|FG000|Overall Study|Lost to Follow-up|94|||
126230665|NCT00135707|454136288|FG001|Overall Study|Lost to Follow-up|89|||
126022071|NCT02723955|453375408|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
126022072|NCT02723955|453375409|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
126022073|NCT02723955|453375410|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
126022074|NCT04300647|453375411|FG000|Pre-Crossover|Death|19|||
126022075|NCT04300647|453375412|FG001|Pre-Crossover|Death|58|||
126022076|NCT04300647|453375413|FG002|Pre-Crossover|Death|0|||
126022077|NCT04300647|453375411|FG000|Pre-Crossover|Lost to Follow-up|0|||
126022078|NCT04300647|453375412|FG001|Pre-Crossover|Lost to Follow-up|3|||
126022079|NCT04300647|453375413|FG002|Pre-Crossover|Lost to Follow-up|0|||
126230666|NCT00135707|454136287|FG000|Overall Study|Withdrawal by Subject|0|||
126230667|NCT00135707|454136288|FG001|Overall Study|Withdrawal by Subject|1|||
126230668|NCT00135707|454136287|FG000|Overall Study|Institutional review board request|1|||
126230669|NCT00135707|454136288|FG001|Overall Study|Institutional review board request|0|||
126230670|NCT00421174|454136292|FG000|Overall Study|Withdrawal by Subject|0|||
126230671|NCT00421174|454136293|FG001|Overall Study|Withdrawal by Subject|1|||
126230672|NCT00421174|454136292|FG000|Overall Study|Ineligible due to infection|2|||
126230673|NCT00421174|454136293|FG001|Overall Study|Ineligible due to infection|0|||
126230674|NCT02524379|454136294|FG000|Overall Study|Death|1|||
126230675|NCT01829464|454136295|FG000|Overall Study|Adverse Event|1|||
126230676|NCT01829464|454136296|FG001|Overall Study|Adverse Event|0|||
126230677|NCT01829464|454136297|FG002|Overall Study|Adverse Event|0|||
126230678|NCT01829464|454136295|FG000|Overall Study|Lost to Follow-up|0|||
126230679|NCT01829464|454136296|FG001|Overall Study|Lost to Follow-up|0|||
126230680|NCT01829464|454136297|FG002|Overall Study|Lost to Follow-up|1|||
126230681|NCT01829464|454136295|FG000|Overall Study|Withdrawal by Subject|2|||
126230682|NCT01829464|454136296|FG001|Overall Study|Withdrawal by Subject|0|||
126230683|NCT01829464|454136297|FG002|Overall Study|Withdrawal by Subject|0|||
126230684|NCT01829464|454136295|FG000|Overall Study|Study terminated by sponsor|25|||
126230685|NCT01829464|454136296|FG001|Overall Study|Study terminated by sponsor|28|||
126230686|NCT01829464|454136297|FG002|Overall Study|Study terminated by sponsor|25|||
126230687|NCT01829464|454136295|FG000|Overall Study|Lack of Efficacy|0|||
126230688|NCT01829464|454136296|FG001|Overall Study|Lack of Efficacy|1|||
126230689|NCT01829464|454136297|FG002|Overall Study|Lack of Efficacy|0|||
126230690|NCT02228382|454136302|FG000|Overall Study|Death|5|||
126230691|NCT02228382|454136303|FG001|Overall Study|Death|7|||
126230692|NCT02228382|454136304|FG002|Overall Study|Death|5|||
126230693|NCT02228382|454136305|FG003|Overall Study|Death|0|||
126230694|NCT02228382|454136306|FG004|Overall Study|Death|2|||
126230695|NCT02228382|454136302|FG000|Overall Study|Participant refused further follow-up|0|||
126230696|NCT02228382|454136303|FG001|Overall Study|Participant refused further follow-up|0|||
126230697|NCT02228382|454136304|FG002|Overall Study|Participant refused further follow-up|1|||
126230698|NCT02228382|454136305|FG003|Overall Study|Participant refused further follow-up|0|||
126230699|NCT02228382|454136306|FG004|Overall Study|Participant refused further follow-up|0|||
126230700|NCT02228382|454136302|FG000|Overall Study|Study terminated by sponsor|3|||
126230701|NCT02228382|454136303|FG001|Overall Study|Study terminated by sponsor|5|||
126230702|NCT02228382|454136304|FG002|Overall Study|Study terminated by sponsor|7|||
126230703|NCT02228382|454136305|FG003|Overall Study|Study terminated by sponsor|0|||
126022080|NCT04300647|453375411|FG000|Pre-Crossover|Withdrawal by Subject|2|||
126022081|NCT04300647|453375412|FG001|Pre-Crossover|Withdrawal by Subject|4|||
126022082|NCT04300647|453375413|FG002|Pre-Crossover|Withdrawal by Subject|0|||
126093111|NCT00939822|453634514|FG001|Overall Study|Mental health issues|2|||
126093112|NCT01232738|453634515|FG000|Overall Study|Death|3|||
126230704|NCT02228382|454136306|FG004|Overall Study|Study terminated by sponsor|0|||
126230705|NCT02228382|454136302|FG000|Overall Study|Lost to Follow-up|0|||
126230706|NCT02228382|454136303|FG001|Overall Study|Lost to Follow-up|0|||
126230707|NCT02228382|454136304|FG002|Overall Study|Lost to Follow-up|3|||
126230708|NCT02228382|454136305|FG003|Overall Study|Lost to Follow-up|1|||
126230709|NCT02228382|454136306|FG004|Overall Study|Lost to Follow-up|0|||
126230710|NCT02228382|454136302|FG000|Overall Study|Withdrawal by Subject|0|||
126022083|NCT04300647|453375411|FG000|Pre-Crossover|On-going in Study|24|||
126230711|NCT02228382|454136303|FG001|Overall Study|Withdrawal by Subject|3|||
126230712|NCT02228382|454136304|FG002|Overall Study|Withdrawal by Subject|2|||
126230713|NCT02228382|454136305|FG003|Overall Study|Withdrawal by Subject|1|||
126230714|NCT02228382|454136306|FG004|Overall Study|Withdrawal by Subject|0|||
126230715|NCT02228382|454136302|FG000|Overall Study|Other|2|||
126230716|NCT02228382|454136303|FG001|Overall Study|Other|3|||
126230717|NCT02228382|454136304|FG002|Overall Study|Other|3|||
126230718|NCT02228382|454136305|FG003|Overall Study|Other|0|||
126230719|NCT02228382|454136306|FG004|Overall Study|Other|0|||
126230720|NCT00356200|454136308|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
126230721|NCT00356200|454136309|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
126230722|NCT00356200|454136308|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
126230723|NCT00356200|454136309|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
126230724|NCT00812253|454136310|FG000|Overall Study|Withdrawal by Subject|3|||
126230725|NCT00812253|454136311|FG001|Overall Study|Withdrawal by Subject|2|||
126230726|NCT00812253|454136310|FG000|Overall Study|Protocol Violation|1|||
126230727|NCT00812253|454136311|FG001|Overall Study|Protocol Violation|1|||
126230728|NCT00812253|454136310|FG000|Overall Study|Lost to Follow-up|2|||
126230729|NCT00812253|454136311|FG001|Overall Study|Lost to Follow-up|0|||
126230730|NCT03679741|454136312|FG000|Period 1|No longer meet eligibility criteria|1|||
126230731|NCT03679741|454136313|FG001|Period 1|No longer meet eligibility criteria|0|||
126230732|NCT03679741|454136312|FG000|Period 1|Lost to Follow-up|0|||
126230733|NCT03679741|454136313|FG001|Period 1|Lost to Follow-up|1|||
126230734|NCT03679741|454136312|FG000|Period 1|Adverse Event|1|||
126230735|NCT03679741|454136313|FG001|Period 1|Adverse Event|1|||
126230736|NCT03679741|454136312|FG000|Period 1|Withdrawal by Subject|0|||
126230737|NCT03679741|454136313|FG001|Period 1|Withdrawal by Subject|1|||
126230738|NCT03679741|454136312|FG000|Period 2|Adverse Event|2|||
126230739|NCT03679741|454136313|FG001|Period 2|Adverse Event|1|||
126230740|NCT03679741|454136312|FG000|Period 2|Withdrawal by Subject|1|||
126230741|NCT03679741|454136313|FG001|Period 2|Withdrawal by Subject|1|||
126230742|NCT02204371|454136323|FG000|Overall Study|Adverse Event|1|||
126230743|NCT00368966|454136326|FG000|Infant Series|Withdrawal by Subject|11|||
126230744|NCT00368966|454136327|FG001|Infant Series|Withdrawal by Subject|6|||
126230745|NCT00368966|454136326|FG000|Infant Series|Protocol Violation|2|||
126230746|NCT00368966|454136327|FG001|Infant Series|Protocol Violation|1|||
126230747|NCT00368966|454136326|FG000|Infant Series|Lost to Follow-up|2|||
126230748|NCT00368966|454136327|FG001|Infant Series|Lost to Follow-up|0|||
126230749|NCT00368966|454136326|FG000|Infant Series|Randomization error|0|||
126230750|NCT00368966|454136327|FG001|Infant Series|Randomization error|1|||
126230751|NCT00368966|454136326|FG000|Infant Series|Failed to meet eligibility criteria|0|||
126230752|NCT00368966|454136327|FG001|Infant Series|Failed to meet eligibility criteria|1|||
126230753|NCT00368966|454136326|FG000|Infant Series|Adverse Event|0|||
126230754|NCT00368966|454136327|FG001|Infant Series|Adverse Event|1|||
126230755|NCT00368966|454136326|FG000|Infant Series|Failed to return|1|||
126230756|NCT00368966|454136327|FG001|Infant Series|Failed to return|0|||
126230757|NCT00368966|454136326|FG000|After Infant|Failed to return|3|||
126230758|NCT00368966|454136327|FG001|After Infant|Failed to return|1|||
126230759|NCT00368966|454136326|FG000|After Infant|Adverse Event|1|||
126230760|NCT00368966|454136327|FG001|After Infant|Adverse Event|2|||
126353002|NCT02202616|454583387|FG000|Overall Study|Administrative problems|6|||
126022084|NCT04300647|453375412|FG001|Pre-Crossover|On-going in Study|61|||
126022085|NCT04300647|453375413|FG002|Pre-Crossover|On-going in Study|0|||
126022086|NCT04300647|453375411|FG000|Post-Crossover|Death|0|||
126353003|NCT02202616|454583387|FG000|Overall Study|Abnormal test procedure result|1|||
126353004|NCT02202616|454583387|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126353005|NCT01334515|454583388|FG000|Overall Study|Adverse Event|1|||
126353006|NCT01334515|454583389|FG001|Overall Study|Adverse Event|6|||
126022087|NCT04300647|453375412|FG001|Post-Crossover|Death|0|||
126022088|NCT04300647|453375413|FG002|Post-Crossover|Death|3|||
126022089|NCT04300647|453375411|FG000|Post-Crossover|Lost to Follow-up|0|||
126022090|NCT04300647|453375412|FG001|Post-Crossover|Lost to Follow-up|0|||
126022091|NCT04300647|453375413|FG002|Post-Crossover|Lost to Follow-up|1|||
126022092|NCT04300647|453375411|FG000|Post-Crossover|Withdrawal by Subject|0|||
126022093|NCT04300647|453375412|FG001|Post-Crossover|Withdrawal by Subject|0|||
126022094|NCT04300647|453375413|FG002|Post-Crossover|Withdrawal by Subject|1|||
126230761|NCT00368966|454136326|FG000|After Infant|Withdrawal by Subject|1|||
126022095|NCT04300647|453375411|FG000|Post-Crossover|On-going in Study|0|||
126022096|NCT04300647|453375412|FG001|Post-Crossover|On-going in Study|0|||
126093113|NCT01232738|453634515|FG000|Overall Study|Physician Decision|2|||
126230762|NCT00368966|454136327|FG001|After Infant|Withdrawal by Subject|1|||
126230763|NCT00368966|454136326|FG000|After Infant|Death|1|||
126230764|NCT00368966|454136327|FG001|After Infant|Death|0|||
126230765|NCT00368966|454136326|FG000|After Infant|Lost to Follow-up|0|||
126230766|NCT00368966|454136327|FG001|After Infant|Lost to Follow-up|1|||
126022097|NCT04300647|453375413|FG002|Post-Crossover|On-going in Study|8|||
126230767|NCT00368966|454136326|FG000|Toddler Dose|Withdrawal by Subject|1|||
126230768|NCT00368966|454136327|FG001|Toddler Dose|Withdrawal by Subject|1|||
126353007|NCT01334515|454583388|FG000|Overall Study|Death|1|||
126353008|NCT01334515|454583389|FG001|Overall Study|Death|0|||
126022098|NCT02824029|453375417|FG000|Overall Study|Didn't receive treatment|2|||
126022099|NCT02824029|453375417|FG000|Overall Study|Patient decision to discontinue treatment|3|||
126022100|NCT02824029|453375417|FG000|Overall Study|Non-compliant|5|||
126022101|NCT02824029|453375417|FG000|Overall Study|Progression of disease|15|||
126022102|NCT02824029|453375417|FG000|Overall Study|Inadequate response to therapy|2|||
126022103|NCT02824029|453375417|FG000|Overall Study|Possible progression per treating physician|1|||
126022104|NCT03990649|453375428|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
126022105|NCT03990649|453375429|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
126022106|NCT03990649|453375430|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
126022107|NCT03990649|453375428|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
126022108|NCT03990649|453375429|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
126022109|NCT03990649|453375430|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
126022110|NCT03990649|453375428|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
126022111|NCT03990649|453375429|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
126022112|NCT03990649|453375430|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
126022113|NCT03990649|453375428|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
126022114|NCT03990649|453375429|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
126022115|NCT03990649|453375430|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
126022116|NCT03990649|453375428|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
126022117|NCT03990649|453375429|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
126022118|NCT03990649|453375430|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
126022119|NCT03990649|453375428|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
126022120|NCT03990649|453375429|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
126022121|NCT03990649|453375430|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
126022122|NCT03990649|453375428|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
126022123|NCT03990649|453375429|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
126022124|NCT03990649|453375430|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
126022125|NCT00505934|453375431|FG000|Overall Study|Adverse Event|1|||
126022126|NCT00505934|453375431|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
126022127|NCT00505934|453375431|FG000|Overall Study|Other: IV dose needed to be changed|1|||
126022128|NCT01443845|453375432|FG000|Overall Study|Protocol Violation|43|||
126022129|NCT01443845|453375433|FG001|Overall Study|Protocol Violation|45|||
126022130|NCT01443845|453375432|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
126022131|NCT01443845|453375433|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
126022132|NCT01443845|453375432|FG000|Overall Study|Deterioration in pulmonary function|1|||
126022133|NCT01443845|453375433|FG001|Overall Study|Deterioration in pulmonary function|4|||
126022134|NCT01443845|453375432|FG000|Overall Study|Lack of Efficacy|10|||
126022135|NCT01443845|453375433|FG001|Overall Study|Lack of Efficacy|5|||
126022136|NCT01443845|453375432|FG000|Overall Study|Adverse Event|64|||
126022137|NCT01443845|453375433|FG001|Overall Study|Adverse Event|138|||
126022138|NCT01443845|453375432|FG000|Overall Study|Withdrawal by Subject|63|||
126022139|NCT01443845|453375433|FG001|Overall Study|Withdrawal by Subject|67|||
126022140|NCT01443845|453375432|FG000|Overall Study|Military Conflict - Site Terminated|20|||
126022141|NCT01443845|453375433|FG001|Overall Study|Military Conflict - Site Terminated|21|||
126022142|NCT01443845|453375432|FG000|Overall Study|Lost to Follow-up|9|||
126022143|NCT01443845|453375433|FG001|Overall Study|Lost to Follow-up|13|||
126022144|NCT00609336|453375435|FG000|Overall Study|Protocol Violation|3|||
126022145|NCT00609336|453375435|FG000|Overall Study|Death|1|||
126022146|NCT00609336|453375435|FG000|Overall Study|LA or Met at Surgery|9|||
126022147|NCT02238483|453375436|FG000|Overall Study|Withdrawal by Subject|2|||
126022148|NCT02238483|453375437|FG001|Overall Study|Withdrawal by Subject|7|||
126022149|NCT02238483|453375436|FG000|Overall Study|Lost to Follow-up|1|||
126022150|NCT02238483|453375437|FG001|Overall Study|Lost to Follow-up|1|||
126022151|NCT02238483|453375436|FG000|Overall Study|Protocol Violation|1|||
126022152|NCT02238483|453375437|FG001|Overall Study|Protocol Violation|2|||
126022153|NCT02238483|453375436|FG000|Overall Study|Death|1|||
126022154|NCT02238483|453375437|FG001|Overall Study|Death|0|||
126022155|NCT02238483|453375436|FG000|Overall Study|Adverse Event|7|||
126022156|NCT02238483|453375437|FG001|Overall Study|Adverse Event|3|||
126022157|NCT02238483|453375436|FG000|Overall Study|Withdrawn due to physician decision|1|||
126022158|NCT02238483|453375437|FG001|Overall Study|Withdrawn due to physician decision|0|||
126230769|NCT00368966|454136326|FG000|Toddler Dose|Lost to Follow-up|0|||
126230770|NCT00368966|454136327|FG001|Toddler Dose|Lost to Follow-up|2|||
126230771|NCT02866175|454136328|FG000|Overall Study|Adverse Event|56|||
126093114|NCT01232738|453634515|FG000|Overall Study|Lost to Follow-up|1|||
126093115|NCT01232738|453634515|FG000|Overall Study|Withdrawal by Subject|2|||
126230772|NCT02866175|454136329|FG001|Overall Study|Adverse Event|54|||
126230773|NCT02866175|454136328|FG000|Overall Study|Withdrawal by Subject|31|||
126230774|NCT02866175|454136329|FG001|Overall Study|Withdrawal by Subject|52|||
126230775|NCT02866175|454136328|FG000|Overall Study|Death|30|||
126230776|NCT02866175|454136329|FG001|Overall Study|Death|23|||
126230777|NCT02866175|454136328|FG000|Overall Study|Other|7|||
126230778|NCT02866175|454136329|FG001|Overall Study|Other|14|||
126230779|NCT02866175|454136328|FG000|Overall Study|Progressive disease|1|||
126230780|NCT02866175|454136329|FG001|Overall Study|Progressive disease|1|||
126230781|NCT02866175|454136328|FG000|Overall Study|Lost to Follow-up|2|||
126230782|NCT02866175|454136329|FG001|Overall Study|Lost to Follow-up|0|||
126230783|NCT02866175|454136328|FG000|Overall Study|Lack of Efficacy|0|||
126230784|NCT02866175|454136329|FG001|Overall Study|Lack of Efficacy|1|||
126230785|NCT02866175|454136328|FG000|Overall Study|Physician Decision|3|||
126230786|NCT02866175|454136329|FG001|Overall Study|Physician Decision|15|||
126230787|NCT02866175|454136328|FG000|Overall Study|Did not receive treatment|5|||
126230788|NCT02866175|454136329|FG001|Overall Study|Did not receive treatment|15|||
126230789|NCT01694485|454136330|FG000|Overall Study|Withdrawal by Subject|20|||
126230790|NCT01694485|454136331|FG001|Overall Study|Withdrawal by Subject|6|||
126230791|NCT01694485|454136332|FG002|Overall Study|Withdrawal by Subject|7|||
126230792|NCT01694485|454136333|FG003|Overall Study|Withdrawal by Subject|25|||
126230793|NCT01694485|454136334|FG004|Overall Study|Withdrawal by Subject|18|||
126230794|NCT01694485|454136330|FG000|Overall Study|Sponsor Decision|3|||
126230795|NCT01694485|454136331|FG001|Overall Study|Sponsor Decision|0|||
126230796|NCT01694485|454136332|FG002|Overall Study|Sponsor Decision|0|||
126230797|NCT01694485|454136333|FG003|Overall Study|Sponsor Decision|2|||
126230798|NCT01694485|454136334|FG004|Overall Study|Sponsor Decision|0|||
126230799|NCT01694485|454136330|FG000|Overall Study|Lost to Follow-up|9|||
126230800|NCT01694485|454136331|FG001|Overall Study|Lost to Follow-up|1|||
126230801|NCT01694485|454136332|FG002|Overall Study|Lost to Follow-up|6|||
126230802|NCT01694485|454136333|FG003|Overall Study|Lost to Follow-up|10|||
126230803|NCT01694485|454136334|FG004|Overall Study|Lost to Follow-up|7|||
126230804|NCT01694485|454136330|FG000|Overall Study|Death|1|||
126230805|NCT01694485|454136331|FG001|Overall Study|Death|0|||
126230806|NCT01694485|454136332|FG002|Overall Study|Death|0|||
126230807|NCT01694485|454136333|FG003|Overall Study|Death|1|||
126230808|NCT01694485|454136334|FG004|Overall Study|Death|0|||
126230809|NCT01595009|454136335|FG000|Core|Patients completed per protocol|85|||
126230810|NCT01595009|454136336|FG001|Core|Patients completed per protocol|44|||
126230811|NCT01595009|454136337|FG002|Core|Patients completed per protocol|0|||
126230812|NCT01595009|454136338|FG003|Core|Patients completed per protocol|0|||
126230813|NCT01595009|454136335|FG000|Core|Adverse Event|19|||
126230814|NCT01595009|454136336|FG001|Core|Adverse Event|23|||
126230815|NCT01595009|454136337|FG002|Core|Adverse Event|0|||
126230816|NCT01595009|454136338|FG003|Core|Adverse Event|0|||
126230817|NCT01595009|454136335|FG000|Core|Disease progression|14|||
126230818|NCT01595009|454136336|FG001|Core|Disease progression|26|||
126230819|NCT01595009|454136337|FG002|Core|Disease progression|0|||
126230820|NCT01595009|454136338|FG003|Core|Disease progression|0|||
126230821|NCT01595009|454136335|FG000|Core|Withdrawal by Subject|4|||
126230822|NCT01595009|454136336|FG001|Core|Withdrawal by Subject|17|||
126230823|NCT01595009|454136337|FG002|Core|Withdrawal by Subject|0|||
126230824|NCT01595009|454136338|FG003|Core|Withdrawal by Subject|0|||
126230825|NCT01595009|454136335|FG000|Core|Death|3|||
126230826|NCT01595009|454136336|FG001|Core|Death|6|||
126230827|NCT01595009|454136337|FG002|Core|Death|0|||
126230828|NCT01595009|454136338|FG003|Core|Death|0|||
126230829|NCT01595009|454136335|FG000|Core|Lost to Follow-up|1|||
126230830|NCT01595009|454136336|FG001|Core|Lost to Follow-up|2|||
126230831|NCT01595009|454136337|FG002|Core|Lost to Follow-up|0|||
126230832|NCT01595009|454136338|FG003|Core|Lost to Follow-up|0|||
126353009|NCT01334515|454583388|FG000|Overall Study|Lack of Efficacy|8|||
126353010|NCT01334515|454583389|FG001|Overall Study|Lack of Efficacy|21|||
126353011|NCT01334515|454583388|FG000|Overall Study|Physician Decision|1|||
126353012|NCT01334515|454583389|FG001|Overall Study|Physician Decision|1|||
126353013|NCT01334515|454583388|FG000|Overall Study|Withdrawal by Subject|1|||
126353014|NCT01334515|454583389|FG001|Overall Study|Withdrawal by Subject|1|||
126353015|NCT03637374|454583390|FG000|Overall Study|Death|2|||
126353016|NCT03637374|454583391|FG001|Overall Study|Death|0|||
126353017|NCT02836769|454583395|FG000|Overall Study|Lost to Follow-up|10|||
126353018|NCT02836769|454583395|FG000|Overall Study|Medical withdrawal|2|||
126353019|NCT02836769|454583395|FG000|Overall Study|Withdrawal by Subject|3|||
126353020|NCT00376506|454583404|FG000|Overall Study|Death|0|||
126353021|NCT00376506|454583405|FG001|Overall Study|Death|2|||
126353022|NCT00221104|454583407|FG000|Overall Study|Adverse Event|1|||
126353023|NCT00221104|454583408|FG001|Overall Study|Adverse Event|0|||
126353024|NCT00221104|454583407|FG000|Overall Study|Physician Decision|1|||
126353025|NCT00221104|454583408|FG001|Overall Study|Physician Decision|0|||
126353026|NCT00221104|454583407|FG000|Overall Study|Protocol Violation|2|||
126353027|NCT00221104|454583408|FG001|Overall Study|Protocol Violation|0|||
126093116|NCT01232738|453634515|FG000|Overall Study|Adverse Event|5|||
126230833|NCT01595009|454136335|FG000|Core|Protocol deviation|0|||
126230834|NCT01595009|454136336|FG001|Core|Protocol deviation|1|||
126230835|NCT01595009|454136337|FG002|Core|Protocol deviation|0|||
126230836|NCT01595009|454136338|FG003|Core|Protocol deviation|0|||
126230837|NCT01595009|454136335|FG000|Core|Administrative problems|0|||
126230838|NCT01595009|454136336|FG001|Core|Administrative problems|1|||
126230839|NCT01595009|454136337|FG002|Core|Administrative problems|0|||
126230840|NCT01595009|454136338|FG003|Core|Administrative problems|0|||
126230841|NCT01595009|454136335|FG000|Extension|Administrative problems|0|||
126230842|NCT01595009|454136336|FG001|Extension|Administrative problems|0|||
126230843|NCT01595009|454136337|FG002|Extension|Administrative problems|0|||
126230844|NCT01595009|454136338|FG003|Extension|Administrative problems|1|||
126353028|NCT00221104|454583407|FG000|Overall Study|Withdrawal by Subject|42|||
126353029|NCT00221104|454583408|FG001|Overall Study|Withdrawal by Subject|29|||
126353030|NCT00221104|454583407|FG000|Overall Study|Others|37|||
126353031|NCT00221104|454583408|FG001|Overall Study|Others|47|||
126353032|NCT02989389|454583409|FG000|Period 1|Lost to Follow-up|0|||
126353033|NCT02989389|454583410|FG001|Period 1|Lost to Follow-up|1|||
126230845|NCT01595009|454136335|FG000|Extension|Patients completed per protocol|0|||
126230846|NCT01595009|454136336|FG001|Extension|Patients completed per protocol|0|||
126230847|NCT01595009|454136337|FG002|Extension|Patients completed per protocol|0|||
126230848|NCT01595009|454136338|FG003|Extension|Patients completed per protocol|2|||
126230849|NCT01595009|454136335|FG000|Extension|Disease progression|0|||
126230850|NCT01595009|454136336|FG001|Extension|Disease progression|0|||
126230851|NCT01595009|454136337|FG002|Extension|Disease progression|4|||
126230852|NCT01595009|454136338|FG003|Extension|Disease progression|7|||
126230853|NCT01595009|454136335|FG000|Extension|Adverse Event|0|||
126230854|NCT01595009|454136336|FG001|Extension|Adverse Event|0|||
126230855|NCT01595009|454136337|FG002|Extension|Adverse Event|0|||
126230856|NCT01595009|454136338|FG003|Extension|Adverse Event|1|||
126230857|NCT00662025|454136340|FG000|Overall Study|Objective progression or relapse|51|||
126230858|NCT00662025|454136340|FG000|Overall Study|Adverse Event|7|||
126230859|NCT00662025|454136340|FG000|Overall Study|Withdrawal by Subject|1|||
126230860|NCT00662025|454136340|FG000|Overall Study|Results of other clinical study|2|||
126230861|NCT00662025|454136340|FG000|Overall Study|Target lesion cannot be evaluated|1|||
126230862|NCT00662025|454136340|FG000|Overall Study|Domestic circumstances|1|||
126230863|NCT00626925|454136349|FG000|Overall Study|Lost to Follow-up|1|||
126230864|NCT00626925|454136350|FG001|Overall Study|Lost to Follow-up|2|||
126230865|NCT00626925|454136349|FG000|Overall Study|relapse|1|||
126230866|NCT00626925|454136350|FG001|Overall Study|relapse|0|||
126230867|NCT00626925|454136349|FG000|Overall Study|Adverse effect|6|||
126230868|NCT00626925|454136350|FG001|Overall Study|Adverse effect|2|||
126230869|NCT00626925|454136349|FG000|Overall Study|Lack of Efficacy|1|||
126230870|NCT00626925|454136350|FG001|Overall Study|Lack of Efficacy|4|||
126230871|NCT00626925|454136349|FG000|Overall Study|Time constraints|3|||
126230872|NCT00626925|454136350|FG001|Overall Study|Time constraints|1|||
126230873|NCT01215942|454136354|FG000|Treatment Period|Adverse Event|15|||
126230874|NCT01215942|454136355|FG001|Treatment Period|Adverse Event|26|||
126230875|NCT01215942|454136354|FG000|Treatment Period|Death|2|||
126230876|NCT01215942|454136355|FG001|Treatment Period|Death|4|||
126230877|NCT01215942|454136354|FG000|Treatment Period|Lack of Efficacy|23|||
126230878|NCT01215942|454136355|FG001|Treatment Period|Lack of Efficacy|62|||
126230879|NCT01215942|454136354|FG000|Treatment Period|Lost to Follow-up|3|||
126230880|NCT01215942|454136355|FG001|Treatment Period|Lost to Follow-up|4|||
126230881|NCT01215942|454136354|FG000|Treatment Period|Withdrawal by Subject|17|||
126230882|NCT01215942|454136355|FG001|Treatment Period|Withdrawal by Subject|40|||
126230883|NCT01215942|454136354|FG000|Treatment Period|Physician Decision|5|||
126230884|NCT01215942|454136355|FG001|Treatment Period|Physician Decision|5|||
126230885|NCT01215942|454136354|FG000|Treatment Period|Protocol Violation|0|||
126230886|NCT01215942|454136355|FG001|Treatment Period|Protocol Violation|1|||
126353034|NCT02989389|454583411|FG002|Period 1|Lost to Follow-up|0|||
126353035|NCT02989389|454583412|FG003|Period 1|Lost to Follow-up|0|||
126353036|NCT02989389|454583413|FG004|Period 1|Lost to Follow-up|0|||
126353037|NCT02989389|454583414|FG005|Period 1|Lost to Follow-up|0|||
126353038|NCT02989389|454583415|FG006|Period 1|Lost to Follow-up|0|||
126353039|NCT02989389|454583416|FG007|Period 1|Lost to Follow-up|0|||
126353040|NCT02989389|454583417|FG008|Period 1|Lost to Follow-up|0|||
126353041|NCT02989389|454583418|FG009|Period 1|Lost to Follow-up|0|||
126353042|NCT02989389|454583409|FG000|Period 1|Physician Decision|0|||
126353043|NCT02989389|454583410|FG001|Period 1|Physician Decision|0|||
126353044|NCT02989389|454583411|FG002|Period 1|Physician Decision|0|||
126353045|NCT02989389|454583412|FG003|Period 1|Physician Decision|0|||
126353046|NCT02989389|454583413|FG004|Period 1|Physician Decision|0|||
126353047|NCT02989389|454583414|FG005|Period 1|Physician Decision|0|||
126353048|NCT02989389|454583415|FG006|Period 1|Physician Decision|0|||
126353049|NCT02989389|454583416|FG007|Period 1|Physician Decision|0|||
126353050|NCT02989389|454583417|FG008|Period 1|Physician Decision|1|||
126022159|NCT02238483|453375436|FG000|Overall Study|Completion status not recorded|1|||
126230887|NCT01215942|454136354|FG000|Treatment Period|Sponsor Decision|349|||
126230888|NCT01215942|454136355|FG001|Treatment Period|Sponsor Decision|530|||
126230889|NCT01215942|454136354|FG000|Post-Treatment Follow-Up Period|Death|0|||
126230890|NCT01215942|454136355|FG001|Post-Treatment Follow-Up Period|Death|1|||
126230891|NCT01215942|454136354|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
126230892|NCT01215942|454136355|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
126230893|NCT01215942|454136354|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
126230894|NCT01215942|454136355|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
126230895|NCT01215942|454136354|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
126230896|NCT01215942|454136355|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
126230897|NCT01215942|454136354|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
126230898|NCT01215942|454136355|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
126353051|NCT02989389|454583418|FG009|Period 1|Physician Decision|0|||
126353052|NCT00374868|454583419|FG000|Overall Study|Adverse Event|12|||
126230899|NCT01966042|454136356|FG000|Overall Study|Death|2|||
126230900|NCT03522948|454136357|FG000|Overall Study|Lost to Follow-up|1|||
126353053|NCT00374868|454583419|FG000|Overall Study|Progressive Disease|7|||
126022160|NCT02238483|453375437|FG001|Overall Study|Completion status not recorded|1|||
126022161|NCT02238483|453375436|FG000|Overall Study|Illness in family member|1|||
126022162|NCT02238483|453375437|FG001|Overall Study|Illness in family member|0|||
126022163|NCT02574455|453375438|FG000|Overall Study|Death|197|||
126022164|NCT02574455|453375439|FG001|Overall Study|Death|210|||
126022165|NCT02574455|453375438|FG000|Overall Study|Withdrawal of Consent|11|||
126022166|NCT02574455|453375439|FG001|Overall Study|Withdrawal of Consent|28|||
126022167|NCT02574455|453375438|FG000|Overall Study|Lost to Follow-up|4|||
126022168|NCT02574455|453375439|FG001|Overall Study|Lost to Follow-up|4|||
126022169|NCT02574455|453375438|FG000|Overall Study|Sponsor's Decision|55|||
126022170|NCT02574455|453375439|FG001|Overall Study|Sponsor's Decision|20|||
126022171|NCT02677896|453375441|FG000|Double Blind Period (up to 35 Months)|Death|117|||
126022172|NCT02677896|453375442|FG001|Double Blind Period (up to 35 Months)|Death|197|||
126022173|NCT02677896|453375441|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
126022174|NCT02677896|453375442|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
126022175|NCT02677896|453375441|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
126022176|NCT02677896|453375442|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
126022177|NCT02677896|453375441|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
126022178|NCT02677896|453375442|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
126022179|NCT02677896|453375441|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
126022180|NCT02677896|453375442|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
126022181|NCT02677896|453375441|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
126022182|NCT02677896|453375442|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
126022183|NCT02677896|453375441|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
126022184|NCT02677896|453375442|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
126022185|NCT02677896|453375441|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
126022186|NCT02677896|453375442|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
126022187|NCT02677896|453375441|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
126230901|NCT03305055|454136358|FG000|Overall Study|Withdrawal by Subject|0|||
126230902|NCT03305055|454136359|FG001|Overall Study|Withdrawal by Subject|1|||
126230903|NCT03305055|454136358|FG000|Overall Study|Adverse Event|1|||
126230904|NCT03305055|454136359|FG001|Overall Study|Adverse Event|1|||
126230905|NCT01802879|454136360|FG000|Overall Study|Administrative problems|2|||
126230906|NCT01802879|454136360|FG000|Overall Study|Disease progression|6|||
126230907|NCT01047345|454136365|FG000|Base Study|Adverse Event|3|||
126230908|NCT01047345|454136366|FG001|Base Study|Adverse Event|0|||
126230909|NCT01047345|454136367|FG002|Base Study|Adverse Event|0|||
126022188|NCT02677896|453375442|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
126022189|NCT02677896|453375441|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
126022190|NCT02677896|453375442|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
126022191|NCT02677896|453375441|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
126230910|NCT01047345|454136365|FG000|Base Study|Lost to Follow-up|4|||
126230911|NCT01047345|454136366|FG001|Base Study|Lost to Follow-up|1|||
126230912|NCT01047345|454136367|FG002|Base Study|Lost to Follow-up|0|||
126230913|NCT01047345|454136365|FG000|Base Study|Protocol Violation|3|||
126230914|NCT01047345|454136366|FG001|Base Study|Protocol Violation|1|||
126230915|NCT01047345|454136367|FG002|Base Study|Protocol Violation|0|||
126230916|NCT01047345|454136365|FG000|Base Study|Withdrawal by Subject|12|||
126230917|NCT01047345|454136366|FG001|Base Study|Withdrawal by Subject|4|||
126353054|NCT00374868|454583419|FG000|Overall Study|Physician Decision|13|||
126353055|NCT00374868|454583419|FG000|Overall Study|Lost to Follow-up|1|||
126353056|NCT00374868|454583419|FG000|Overall Study|Death|2|||
126353057|NCT00374868|454583419|FG000|Overall Study|Other - Not Specified|1|||
126353058|NCT04470427|454583420|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
126353059|NCT04470427|454583421|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
126353060|NCT04470427|454583422|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
126353061|NCT04470427|454583423|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
126353062|NCT04470427|454583424|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
126353063|NCT04470427|454583425|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
126353064|NCT04470427|454583420|FG000|Part B :Open-label|Other than specified|0|||
126353065|NCT04470427|454583421|FG001|Part B :Open-label|Other than specified|0|||
126353066|NCT04470427|454583422|FG002|Part B :Open-label|Other than specified|788|||
126353067|NCT04470427|454583423|FG003|Part B :Open-label|Other than specified|0|||
126022192|NCT02677896|453375442|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
126022193|NCT02677896|453375441|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
126022194|NCT02677896|453375442|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
126230918|NCT01047345|454136367|FG002|Base Study|Withdrawal by Subject|0|||
126230919|NCT01047345|454136365|FG000|Extension|Withdrawal by Subject|0|||
126230920|NCT01047345|454136366|FG001|Extension|Withdrawal by Subject|0|||
126230921|NCT01047345|454136367|FG002|Extension|Withdrawal by Subject|1|||
126353068|NCT04470427|454583424|FG004|Part B :Open-label|Other than specified|523|||
126230922|NCT01047345|454136365|FG000|Extension|Lost to Follow-up|0|||
126230923|NCT01047345|454136366|FG001|Extension|Lost to Follow-up|0|||
126230924|NCT01047345|454136367|FG002|Extension|Lost to Follow-up|5|||
126230925|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
126230926|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
126230927|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
126230928|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
126230929|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
126230930|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
126230931|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
126230932|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
126230933|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
126230934|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
126230935|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
126230936|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
126230937|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
126230938|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
126230939|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
126230940|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
126230941|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
126230942|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
126230943|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
126230944|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
126230945|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
126230946|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
126230947|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
126230948|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
126230949|NCT00455533|454136370|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
126230950|NCT00455533|454136371|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
126230951|NCT00455533|454136372|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
126230952|NCT00455533|454136370|FG000|Period Two: Randomized Period|Death|0|||
126230953|NCT00455533|454136371|FG001|Period Two: Randomized Period|Death|0|||
126230954|NCT00455533|454136372|FG002|Period Two: Randomized Period|Death|3|||
126230955|NCT00455533|454136370|FG000|Period Two: Randomized Period|Disease Progression|0|||
126230956|NCT00455533|454136371|FG001|Period Two: Randomized Period|Disease Progression|1|||
126230957|NCT00455533|454136372|FG002|Period Two: Randomized Period|Disease Progression|1|||
126230958|NCT00455533|454136370|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
126230959|NCT00455533|454136371|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
126230960|NCT00455533|454136372|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
126230961|NCT00455533|454136370|FG000|Period Two: Randomized Period|Other - need reasons|0|||
126230962|NCT00455533|454136371|FG001|Period Two: Randomized Period|Other - need reasons|1|||
126230963|NCT00455533|454136372|FG002|Period Two: Randomized Period|Other - need reasons|0|||
126230964|NCT00455533|454136370|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
126230965|NCT00455533|454136371|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
126230966|NCT00455533|454136372|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
126230967|NCT00455533|454136370|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
126230968|NCT00455533|454136371|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
126230969|NCT00455533|454136372|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
126230970|NCT02576990|454136377|FG000|Overall Study|Death|29|||
126230971|NCT02576990|454136378|FG001|Overall Study|Death|18|||
126230972|NCT02576990|454136377|FG000|Overall Study|Physician Decision|1|||
126230973|NCT02576990|454136378|FG001|Overall Study|Physician Decision|0|||
126230974|NCT02576990|454136377|FG000|Overall Study|Screen failure|2|||
126230975|NCT02576990|454136378|FG001|Overall Study|Screen failure|0|||
126230976|NCT02576990|454136377|FG000|Overall Study|Sponsor's decision|24|||
126230977|NCT02576990|454136378|FG001|Overall Study|Sponsor's decision|4|||
126230978|NCT02576990|454136377|FG000|Overall Study|Withdrawal by Subject|0|||
126230979|NCT02576990|454136378|FG001|Overall Study|Withdrawal by Subject|2|||
126230980|NCT01736553|454136383|FG000|Overall Study|Death|12|||
126230981|NCT01736553|454136384|FG001|Overall Study|Death|0|||
126230982|NCT01736553|454136383|FG000|Overall Study|Withdrawal by Subject|5|||
126230983|NCT01736553|454136384|FG001|Overall Study|Withdrawal by Subject|2|||
126353069|NCT04470427|454583425|FG005|Part B :Open-label|Other than specified|0|||
126230984|NCT01736553|454136383|FG000|Overall Study|Lost to Follow-up|2|||
126230985|NCT01736553|454136384|FG001|Overall Study|Lost to Follow-up|2|||
126230986|NCT02415959|454136385|FG000|Overall Study|Adverse Event|0|||
126353070|NCT04470427|454583420|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
126353071|NCT04470427|454583421|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
126230987|NCT02415959|454136386|FG001|Overall Study|Adverse Event|1|||
126230988|NCT02415959|454136387|FG002|Overall Study|Adverse Event|0|||
126230989|NCT02415959|454136388|FG003|Overall Study|Adverse Event|0|||
126230990|NCT02415959|454136389|FG004|Overall Study|Adverse Event|0|||
126230991|NCT02415959|454136385|FG000|Overall Study|Protocol Violation|0|||
126230992|NCT02415959|454136386|FG001|Overall Study|Protocol Violation|0|||
126230993|NCT02415959|454136387|FG002|Overall Study|Protocol Violation|0|||
126230994|NCT02415959|454136388|FG003|Overall Study|Protocol Violation|1|||
126230995|NCT02415959|454136389|FG004|Overall Study|Protocol Violation|0|||
126230996|NCT00911859|454136390|FG000|Treatment Period|Adverse Event|3|||
126230997|NCT00911859|454136391|FG001|Treatment Period|Adverse Event|3|||
126230998|NCT00911859|454136392|FG002|Treatment Period|Adverse Event|7|||
126230999|NCT00911859|454136390|FG000|Treatment Period|Death|1|||
126231000|NCT00911859|454136391|FG001|Treatment Period|Death|3|||
126231001|NCT00911859|454136392|FG002|Treatment Period|Death|5|||
126231002|NCT00911859|454136390|FG000|Treatment Period|Lack of Efficacy|1|||
126231003|NCT00911859|454136391|FG001|Treatment Period|Lack of Efficacy|7|||
126231004|NCT00911859|454136392|FG002|Treatment Period|Lack of Efficacy|5|||
126231005|NCT00911859|454136390|FG000|Treatment Period|Physician Decision|3|||
126231006|NCT00911859|454136391|FG001|Treatment Period|Physician Decision|3|||
126231007|NCT00911859|454136392|FG002|Treatment Period|Physician Decision|3|||
126231008|NCT00911859|454136390|FG000|Treatment Period|Withdrawal by Subject|0|||
126231009|NCT00911859|454136391|FG001|Treatment Period|Withdrawal by Subject|4|||
126231010|NCT00911859|454136392|FG002|Treatment Period|Withdrawal by Subject|5|||
126231011|NCT00911859|454136390|FG000|Treatment Period|Did not receive study treatment|0|||
126231012|NCT00911859|454136391|FG001|Treatment Period|Did not receive study treatment|1|||
126231013|NCT00911859|454136392|FG002|Treatment Period|Did not receive study treatment|0|||
126231014|NCT00911859|454136390|FG000|Maintainance Period|Lack of Efficacy|0|||
126231015|NCT00911859|454136391|FG001|Maintainance Period|Lack of Efficacy|0|||
126231016|NCT00911859|454136392|FG002|Maintainance Period|Lack of Efficacy|9|||
126231017|NCT00911859|454136390|FG000|Maintainance Period|Physician Decision|0|||
126231018|NCT00911859|454136391|FG001|Maintainance Period|Physician Decision|0|||
126231019|NCT00911859|454136392|FG002|Maintainance Period|Physician Decision|9|||
126231020|NCT00911859|454136390|FG000|Maintainance Period|Withdrawal by Subject|0|||
126231021|NCT00911859|454136391|FG001|Maintainance Period|Withdrawal by Subject|0|||
126231022|NCT00911859|454136392|FG002|Maintainance Period|Withdrawal by Subject|3|||
126231023|NCT00911859|454136390|FG000|Follow-up Period|Death|5|||
126231024|NCT00911859|454136391|FG001|Follow-up Period|Death|8|||
126231025|NCT00911859|454136392|FG002|Follow-up Period|Death|10|||
126231026|NCT00911859|454136390|FG000|Follow-up Period|Lost to Follow-up|1|||
126231027|NCT00911859|454136391|FG001|Follow-up Period|Lost to Follow-up|1|||
126231028|NCT00911859|454136392|FG002|Follow-up Period|Lost to Follow-up|0|||
126231029|NCT00911859|454136390|FG000|Follow-up Period|Withdrawal by Subject|0|||
126231030|NCT00911859|454136391|FG001|Follow-up Period|Withdrawal by Subject|4|||
126231031|NCT00911859|454136392|FG002|Follow-up Period|Withdrawal by Subject|4|||
126231032|NCT00911859|454136390|FG000|Follow-up Period|Study terminated by sponsor|5|||
126231033|NCT00911859|454136391|FG001|Follow-up Period|Study terminated by sponsor|33|||
126231034|NCT00911859|454136392|FG002|Follow-up Period|Study terminated by sponsor|27|||
126231035|NCT01048333|454136393|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126231036|NCT01048333|454136394|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
126231037|NCT01048333|454136395|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126231038|NCT01048333|454136396|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126231039|NCT01048333|454136397|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126231040|NCT01048333|454136398|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126231041|NCT00634179|454136406|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
126231042|NCT00767325|454136409|FG000|Overall Study|Lack of Efficacy|2|||
126231043|NCT00767325|454136409|FG000|Overall Study|Adverse Event|7|||
126231044|NCT00767325|454136409|FG000|Overall Study|Lost to Follow-up|3|||
126231045|NCT00767325|454136409|FG000|Overall Study|No longer met study criteria|2|||
126231046|NCT00767325|454136409|FG000|Overall Study|Missed visit due to family reasons|1|||
126231047|NCT03538756|454136410|FG000|Long-Term Follow-up|Adverse Event|0|||
126231048|NCT03538756|454136411|FG001|Long-Term Follow-up|Adverse Event|0|||
126231049|NCT03538756|454136412|FG002|Long-Term Follow-up|Adverse Event|6|||
126231050|NCT03538756|454136410|FG000|Long-Term Follow-up|Death|0|||
126231051|NCT03538756|454136411|FG001|Long-Term Follow-up|Death|0|||
126231052|NCT03538756|454136412|FG002|Long-Term Follow-up|Death|1|||
126231053|NCT03538756|454136410|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
126231054|NCT03538756|454136411|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
126231055|NCT03538756|454136412|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
126231056|NCT03538756|454136410|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
126231057|NCT03538756|454136411|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
126231058|NCT03538756|454136412|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
126231059|NCT03538756|454136410|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
126231060|NCT03538756|454136411|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
126231061|NCT03538756|454136412|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
126231062|NCT00752856|454136413|FG000|Overall Study|randomized but did not do viral kinetics|0|||
126231063|NCT00752856|454136414|FG001|Overall Study|randomized but did not do viral kinetics|1|||
126231064|NCT02260492|454136415|FG000|Overall Study|Adverse Event|6|||
126022195|NCT02677896|453375441|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
126022196|NCT02677896|453375442|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
126022197|NCT02677896|453375441|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
126022198|NCT02677896|453375442|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
126231065|NCT02260492|454136416|FG001|Overall Study|Adverse Event|1|||
126231066|NCT02260492|454136417|FG002|Overall Study|Adverse Event|2|||
126231067|NCT02260492|454136415|FG000|Overall Study|Death|0|||
126231068|NCT02260492|454136416|FG001|Overall Study|Death|1|||
126231069|NCT02260492|454136417|FG002|Overall Study|Death|0|||
126231070|NCT02260492|454136415|FG000|Overall Study|Lost to Follow-up|12|||
126231071|NCT02260492|454136416|FG001|Overall Study|Lost to Follow-up|9|||
126231072|NCT02260492|454136417|FG002|Overall Study|Lost to Follow-up|0|||
126231073|NCT02260492|454136415|FG000|Overall Study|Physician Decision|2|||
126231074|NCT02260492|454136416|FG001|Overall Study|Physician Decision|0|||
126231075|NCT02260492|454136417|FG002|Overall Study|Physician Decision|1|||
126231076|NCT02260492|454136415|FG000|Overall Study|Withdrawal by Subject|3|||
126231077|NCT02260492|454136416|FG001|Overall Study|Withdrawal by Subject|2|||
126231078|NCT02260492|454136417|FG002|Overall Study|Withdrawal by Subject|2|||
126231079|NCT03131999|454136418|FG000|Overall Study|Withdrawal by Subject|0|||
126231080|NCT03131999|454136419|FG001|Overall Study|Withdrawal by Subject|1|||
126231081|NCT00996736|454136425|FG000|Overall Study|Death|1|||
126231082|NCT00996736|454136426|FG001|Overall Study|Death|1|||
126231083|NCT00996736|454136425|FG000|Overall Study|Lost to Follow-up|15|||
126231084|NCT00996736|454136426|FG001|Overall Study|Lost to Follow-up|14|||
126231085|NCT00996736|454136425|FG000|Overall Study|Visit not within 3-month window|5|||
126231086|NCT00996736|454136426|FG001|Overall Study|Visit not within 3-month window|3|||
126231087|NCT02688608|454136427|FG000|Overall Study|Lost to Follow-up|1|||
126231088|NCT02456909|454136428|FG000|Overall Study|Did not receive allocated intervention|24|||
126231089|NCT02456909|454136429|FG001|Overall Study|Did not receive allocated intervention|26|||
126231090|NCT02456909|454136428|FG000|Overall Study|Did not complete the primary outcome|0|||
126231091|NCT02456909|454136429|FG001|Overall Study|Did not complete the primary outcome|1|||
126231092|NCT01497938|454136430|FG000|Overall Study|Adverse Event|0|||
126231093|NCT01497938|454136431|FG001|Overall Study|Adverse Event|1|||
126022199|NCT01388361|453375443|FG000|Overall Study|Adverse Event|0|||
126022200|NCT01388361|453375444|FG001|Overall Study|Adverse Event|5|||
126022201|NCT01388361|453375445|FG002|Overall Study|Adverse Event|1|||
126022202|NCT01388361|453375443|FG000|Overall Study|Protocol Violation|0|||
126022203|NCT01388361|453375444|FG001|Overall Study|Protocol Violation|0|||
126022204|NCT01388361|453375445|FG002|Overall Study|Protocol Violation|2|||
126022205|NCT01388361|453375443|FG000|Overall Study|Withdrawal criteria|12|||
126022206|NCT01388361|453375444|FG001|Overall Study|Withdrawal criteria|7|||
126022207|NCT01388361|453375445|FG002|Overall Study|Withdrawal criteria|10|||
126022208|NCT01388361|453375443|FG000|Overall Study|Unclassified|0|||
126022209|NCT01388361|453375444|FG001|Overall Study|Unclassified|0|||
126022210|NCT01388361|453375445|FG002|Overall Study|Unclassified|1|||
126022211|NCT00539734|453375446|FG000|Overall Study|Protocol Violation|1|||
126022212|NCT01070069|453375447|FG000|Overall Study|Death|1|||
126022213|NCT01070069|453375448|FG001|Overall Study|Death|0|||
126022214|NCT01070069|453375449|FG002|Overall Study|Death|2|||
126231094|NCT01497938|454136430|FG000|Overall Study|Physician Decision|0|||
126231095|NCT01497938|454136431|FG001|Overall Study|Physician Decision|1|||
126231096|NCT01497938|454136430|FG000|Overall Study|Withdrawal by Subject|4|||
126231097|NCT01497938|454136431|FG001|Overall Study|Withdrawal by Subject|0|||
126231098|NCT01497938|454136430|FG000|Overall Study|Device Violation|1|||
126231099|NCT01497938|454136431|FG001|Overall Study|Device Violation|0|||
126231100|NCT00365352|454136432|FG000|Overall Study|Adverse Event|6|||
126231101|NCT00365352|454136433|FG001|Overall Study|Adverse Event|7|||
126231102|NCT00365352|454136434|FG002|Overall Study|Adverse Event|8|||
126231103|NCT00365352|454136432|FG000|Overall Study|Participant Withdrew Consent|8|||
126231104|NCT00365352|454136433|FG001|Overall Study|Participant Withdrew Consent|3|||
126231105|NCT00365352|454136434|FG002|Overall Study|Participant Withdrew Consent|4|||
126231106|NCT00365352|454136432|FG000|Overall Study|Lack of Efficacy|3|||
126231107|NCT00365352|454136433|FG001|Overall Study|Lack of Efficacy|0|||
126231108|NCT00365352|454136434|FG002|Overall Study|Lack of Efficacy|0|||
126231109|NCT00365352|454136432|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
126231110|NCT00365352|454136433|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
126231111|NCT00365352|454136434|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
126231112|NCT00365352|454136432|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
126231113|NCT00365352|454136433|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
126231114|NCT00365352|454136434|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
126022215|NCT01070069|453375450|FG003|Overall Study|Death|0|||
126022216|NCT01070069|453375451|FG004|Overall Study|Death|1|||
126022217|NCT01070069|453375447|FG000|Overall Study|Withdrawal by Subject|1|||
126022218|NCT01070069|453375448|FG001|Overall Study|Withdrawal by Subject|1|||
126022219|NCT01070069|453375449|FG002|Overall Study|Withdrawal by Subject|4|||
126022220|NCT01070069|453375450|FG003|Overall Study|Withdrawal by Subject|0|||
126022221|NCT01070069|453375451|FG004|Overall Study|Withdrawal by Subject|0|||
126022222|NCT01070069|453375447|FG000|Overall Study|Lost to Follow-up|4|||
126022223|NCT01070069|453375448|FG001|Overall Study|Lost to Follow-up|1|||
126022224|NCT01070069|453375449|FG002|Overall Study|Lost to Follow-up|0|||
126022225|NCT01070069|453375450|FG003|Overall Study|Lost to Follow-up|0|||
126022226|NCT01070069|453375451|FG004|Overall Study|Lost to Follow-up|3|||
126022227|NCT03565315|453375454|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
126022228|NCT03565315|453375455|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
126022229|NCT03565315|453375456|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
126231115|NCT00365352|454136432|FG000|Overall Study|Lost to Follow-up|1|||
126231116|NCT00365352|454136433|FG001|Overall Study|Lost to Follow-up|1|||
126231117|NCT00365352|454136434|FG002|Overall Study|Lost to Follow-up|0|||
126231118|NCT00365352|454136432|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
126022230|NCT03565315|453375457|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
126022231|NCT04200365|453375458|FG000|Overall Study|Adverse Event|2|||
126231119|NCT00365352|454136433|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
126231120|NCT00365352|454136434|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
126231121|NCT02946385|454138191|FG000|Overall Study|Lost to Follow-up|0|||
126231122|NCT02946385|454138192|FG001|Overall Study|Lost to Follow-up|0|||
126231123|NCT02946385|454138193|FG002|Overall Study|Lost to Follow-up|3|||
126231124|NCT02946385|454138194|FG003|Overall Study|Lost to Follow-up|0|||
126231125|NCT02946385|454138195|FG004|Overall Study|Lost to Follow-up|2|||
126231126|NCT02946385|454138196|FG005|Overall Study|Lost to Follow-up|1|||
126231127|NCT01060670|454138197|FG000|Run In|screen failure|0|||
126231128|NCT01060670|454138198|FG001|Run In|screen failure|238|||
126231129|NCT03519256|454138202|FG000|Overall Study|Disease recurrence|4|||
126231130|NCT03519256|454138203|FG001|Overall Study|Disease recurrence|4|||
126231131|NCT03519256|454138204|FG002|Overall Study|Disease recurrence|5|||
126231132|NCT03519256|454138205|FG003|Overall Study|Disease recurrence|2|||
126231133|NCT03519256|454138202|FG000|Overall Study|Study drug toxicity|0|||
126231134|NCT03519256|454138203|FG001|Overall Study|Study drug toxicity|2|||
126231135|NCT03519256|454138204|FG002|Overall Study|Study drug toxicity|5|||
126231136|NCT03519256|454138205|FG003|Overall Study|Study drug toxicity|2|||
126231137|NCT03519256|454138202|FG000|Overall Study|Adverse event unrelated to study drug|0|||
126231138|NCT03519256|454138203|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126231139|NCT03519256|454138204|FG002|Overall Study|Adverse event unrelated to study drug|1|||
126231140|NCT03519256|454138205|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126231141|NCT03519256|454138202|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126231142|NCT03519256|454138203|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126231143|NCT03519256|454138204|FG002|Overall Study|Participant request to discontinue study treatment|0|||
126231144|NCT03519256|454138205|FG003|Overall Study|Participant request to discontinue study treatment|2|||
126231145|NCT03519256|454138202|FG000|Overall Study|Other reasons|0|||
126231146|NCT03519256|454138203|FG001|Overall Study|Other reasons|0|||
126231147|NCT03519256|454138204|FG002|Overall Study|Other reasons|2|||
126231148|NCT03519256|454138205|FG003|Overall Study|Other reasons|0|||
126231149|NCT03519256|454138202|FG000|Overall Study|Disease progression|6|||
126231150|NCT03519256|454138203|FG001|Overall Study|Disease progression|3|||
126231151|NCT03519256|454138204|FG002|Overall Study|Disease progression|2|||
126231152|NCT03519256|454138205|FG003|Overall Study|Disease progression|1|||
126231153|NCT03519256|454138202|FG000|Overall Study|Lost to Follow-up|0|||
126231154|NCT03519256|454138203|FG001|Overall Study|Lost to Follow-up|1|||
126231155|NCT03519256|454138204|FG002|Overall Study|Lost to Follow-up|0|||
126231156|NCT03519256|454138205|FG003|Overall Study|Lost to Follow-up|0|||
126231157|NCT05431153|454138206|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126231158|NCT05431153|454138207|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126231159|NCT05431153|454138208|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126231160|NCT05431153|454138209|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126022232|NCT04200365|453375458|FG000|Overall Study|Progressive Disease|4|||
126231161|NCT05431153|454138210|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
126231162|NCT05431153|454138211|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126231163|NCT04828161|454138212|FG000|Overall Study|Withdrawal by Subject|0|||
126231164|NCT04828161|454138213|FG001|Overall Study|Withdrawal by Subject|3|||
126231165|NCT04828161|454138214|FG002|Overall Study|Withdrawal by Subject|3|||
126231166|NCT04828161|454138215|FG003|Overall Study|Withdrawal by Subject|4|||
126231167|NCT04828161|454138212|FG000|Overall Study|Lost to Follow-up|1|||
126231168|NCT04828161|454138213|FG001|Overall Study|Lost to Follow-up|4|||
126231169|NCT04828161|454138214|FG002|Overall Study|Lost to Follow-up|2|||
126231170|NCT04828161|454138215|FG003|Overall Study|Lost to Follow-up|2|||
126022233|NCT04200365|453375458|FG000|Overall Study|Lack of Efficacy|1|||
126022234|NCT04200365|453375458|FG000|Overall Study|Study Closure|4|||
126022235|NCT01499199|453375459|FG000|Overall Study|Adverse Event|1|||
126022236|NCT01499199|453375459|FG000|Overall Study|Lack of Efficacy|1|||
126022237|NCT02692417|453375460|FG000|Overall Study|Withdrawal by Subject|5|||
126022238|NCT02692417|453375461|FG001|Overall Study|Withdrawal by Subject|1|||
126022239|NCT02692417|453375460|FG000|Overall Study|Adverse Event|1|||
126022240|NCT02692417|453375461|FG001|Overall Study|Adverse Event|0|||
126022241|NCT02539225|453375469|FG000|Part A|Adverse Event|13|||
126022242|NCT02539225|453375470|FG001|Part A|Adverse Event|4|||
126022243|NCT02539225|453375469|FG000|Part A|Withdrawal by Subject|2|||
126022244|NCT02539225|453375470|FG001|Part A|Withdrawal by Subject|4|||
126022245|NCT02539225|453375469|FG000|Part A|Physician Decision|4|||
126022246|NCT02539225|453375470|FG001|Part A|Physician Decision|7|||
126022247|NCT02539225|453375469|FG000|Part A|Did Not Receive study Drug|1|||
126022248|NCT02539225|453375470|FG001|Part A|Did Not Receive study Drug|1|||
126022249|NCT02539225|453375469|FG000|Pre Treatment for Part B|Progressive disease|1|||
126022250|NCT02539225|453375470|FG001|Pre Treatment for Part B|Progressive disease|1|||
126022251|NCT02539225|453375469|FG000|Pre Treatment for Part B|Adverse Event|1|||
126022252|NCT02539225|453375470|FG001|Pre Treatment for Part B|Adverse Event|1|||
126022253|NCT02539225|453375469|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
126022254|NCT02539225|453375470|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
126022255|NCT02539225|453375469|FG000|Pre Treatment for Part B|Physician Decision|2|||
126022256|NCT02539225|453375470|FG001|Pre Treatment for Part B|Physician Decision|0|||
126022257|NCT02539225|453375469|FG000|Part B|Adverse Event|4|||
126022258|NCT02539225|453375470|FG001|Part B|Adverse Event|4|||
126231171|NCT04828161|454138212|FG000|Overall Study|Other|2|||
126231172|NCT04828161|454138213|FG001|Overall Study|Other|0|||
126231173|NCT04828161|454138214|FG002|Overall Study|Other|2|||
126231174|NCT04828161|454138215|FG003|Overall Study|Other|0|||
126231175|NCT04828161|454138212|FG000|Overall Study|Death|0|||
126231176|NCT04828161|454138213|FG001|Overall Study|Death|0|||
126231177|NCT04828161|454138214|FG002|Overall Study|Death|0|||
126231178|NCT04828161|454138215|FG003|Overall Study|Death|2|||
126231179|NCT02458638|454138218|FG000|Overall Study|Death|309|||
126231180|NCT02458638|454138218|FG000|Overall Study|End of Cohort/End of Study|67|||
126231181|NCT02458638|454138218|FG000|Overall Study|Lost to Follow-up|31|||
126231182|NCT02458638|454138218|FG000|Overall Study|Other Reasons|4|||
126353072|NCT04470427|454583422|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
126353073|NCT04470427|454583423|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
126353074|NCT04470427|454583424|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
126353075|NCT04470427|454583425|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
126353076|NCT04470427|454583420|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
126353077|NCT04470427|454583421|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
126353078|NCT04470427|454583422|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
126353079|NCT04470427|454583423|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
126353080|NCT04470427|454583424|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
126353081|NCT04470427|454583425|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
126353082|NCT01179516|454583426|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
126353083|NCT01179516|454583427|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
126353084|NCT01179516|454583428|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
126353085|NCT01179516|454583426|FG000|Overall Study|Lack of Efficacy|4|||
126353086|NCT01179516|454583427|FG001|Overall Study|Lack of Efficacy|2|||
126353087|NCT01179516|454583428|FG002|Overall Study|Lack of Efficacy|0|||
126353088|NCT01179516|454583426|FG000|Overall Study|Noncompliance with Study Drug|2|||
126353089|NCT01179516|454583427|FG001|Overall Study|Noncompliance with Study Drug|0|||
126353090|NCT01179516|454583428|FG002|Overall Study|Noncompliance with Study Drug|1|||
126353091|NCT01179516|454583426|FG000|Overall Study|Protocol Deviations|4|||
126353092|NCT01179516|454583427|FG001|Overall Study|Protocol Deviations|3|||
126353093|NCT01179516|454583428|FG002|Overall Study|Protocol Deviations|3|||
126353094|NCT01179516|454583426|FG000|Overall Study|Withdrawal of Consent|2|||
126022259|NCT02539225|453375469|FG000|Part B|Withdrawal by Subject|0|||
126022260|NCT02539225|453375470|FG001|Part B|Withdrawal by Subject|3|||
126022261|NCT02539225|453375469|FG000|Part B|Physician Decision|0|||
126022262|NCT02539225|453375470|FG001|Part B|Physician Decision|9|||
126022263|NCT02318134|453375471|FG000|Overall Study|Withdrawal by Subject|2|||
126022264|NCT02318134|453375472|FG001|Overall Study|Withdrawal by Subject|1|||
126231183|NCT02458638|454138218|FG000|Overall Study|Physician Decision|1|||
126353095|NCT01179516|454583427|FG001|Overall Study|Withdrawal of Consent|6|||
126353096|NCT01179516|454583428|FG002|Overall Study|Withdrawal of Consent|10|||
126231184|NCT02458638|454138218|FG000|Overall Study|Withdrawal by Subject|47|||
126353097|NCT01179516|454583426|FG000|Overall Study|Lost to Follow-up|7|||
126353098|NCT01179516|454583427|FG001|Overall Study|Lost to Follow-up|7|||
126022265|NCT04766034|453375473|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
126022266|NCT04766034|453375474|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
126231185|NCT03093454|454138227|FG000|Overall Study|Withdrawal by Subject|1|||
126022267|NCT04766034|453375475|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
126022268|NCT04766034|453375476|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
126022269|NCT04766034|453375477|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
126022270|NCT04766034|453375473|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
126022271|NCT04766034|453375474|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
126022272|NCT04766034|453375475|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
126022273|NCT04766034|453375476|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
126022274|NCT04766034|453375477|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
126022275|NCT04766034|453375473|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
126022276|NCT04766034|453375474|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
126022277|NCT04766034|453375475|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
126022278|NCT04766034|453375476|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
126022279|NCT04766034|453375477|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
126022280|NCT04766034|453375473|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
126022281|NCT04766034|453375474|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
126022282|NCT04766034|453375475|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
126022283|NCT04766034|453375476|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
126022284|NCT04766034|453375477|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
126022285|NCT01976312|453375478|FG000|Overall Study|Pregnancy|0|||
126022286|NCT01976312|453375479|FG001|Overall Study|Pregnancy|1|||
126022287|NCT01976312|453375478|FG000|Overall Study|Lost to Follow-up|2|||
126022288|NCT01976312|453375479|FG001|Overall Study|Lost to Follow-up|0|||
126022289|NCT01976312|453375478|FG000|Overall Study|Withdrawal by Subject|7|||
126022290|NCT01976312|453375479|FG001|Overall Study|Withdrawal by Subject|2|||
126022291|NCT01976312|453375478|FG000|Overall Study|Adverse Event|6|||
126022292|NCT01976312|453375479|FG001|Overall Study|Adverse Event|6|||
126022293|NCT01976312|453375478|FG000|Overall Study|Protocol Violation|2|||
126022294|NCT01976312|453375479|FG001|Overall Study|Protocol Violation|0|||
126022295|NCT04048382|453375484|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
126022296|NCT04048382|453375485|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
126022297|NCT04048382|453375484|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
126022298|NCT04048382|453375485|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
126022299|NCT04048382|453375484|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
126022300|NCT04048382|453375485|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
126022301|NCT02556138|453375486|FG000|Overall Study|Withdrawal by Subject|1|||
126022302|NCT01205048|453375491|FG000|Overall Study|Withdrawal by Subject|14|||
126022303|NCT01205048|453375491|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
126022304|NCT01205048|453375491|FG000|Overall Study|Lost to Follow-up|4|||
126022305|NCT01205048|453375491|FG000|Overall Study|Other|2|||
126022306|NCT01255670|453375492|FG000|Overall Study|Adverse Event|10|||
126022307|NCT01255670|453375493|FG001|Overall Study|Adverse Event|10|||
126022308|NCT01255670|453375492|FG000|Overall Study|Lost to Follow-up|16|||
126022309|NCT01255670|453375493|FG001|Overall Study|Lost to Follow-up|10|||
126022310|NCT01037985|453375494|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
126022311|NCT01037985|453375495|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
126022312|NCT01037985|453375494|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
126022313|NCT01037985|453375495|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
126022314|NCT01037985|453375494|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
126022315|NCT01037985|453375495|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
126022316|NCT01037985|453375494|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
126022317|NCT01037985|453375495|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
126022318|NCT02269475|453375496|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
126022319|NCT02269475|453375497|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
126022320|NCT02269475|453375496|FG000|Overall Study|Withdrawal by Subject|0|||
126022321|NCT02269475|453375497|FG001|Overall Study|Withdrawal by Subject|1|||
126022322|NCT02730871|453375498|FG000|Overall Study|Adverse Event|6|||
126093117|NCT03046121|453634516|FG000|Overall Study|Death|32|||
126093118|NCT03046121|453634517|FG001|Overall Study|Death|60|||
126093119|NCT03046121|453634516|FG000|Overall Study|Withdrawal by Subject|14|||
126093120|NCT03046121|453634517|FG001|Overall Study|Withdrawal by Subject|12|||
126353099|NCT01179516|454583428|FG002|Overall Study|Lost to Follow-up|3|||
126022323|NCT02730871|453375499|FG001|Overall Study|Adverse Event|0|||
126022324|NCT00823472|453375500|FG000|Overall Study|Physician Decision|24|||
126022325|NCT00823472|453375501|FG001|Overall Study|Physician Decision|28|||
126022326|NCT01609218|453375502|FG000|Period 1|Adverse Event|3|||
126093121|NCT04155047|453634520|FG000|Overall Study|Adverse Event|1|||
126022327|NCT01609218|453375503|FG001|Period 1|Adverse Event|5|||
126022328|NCT01609218|453375502|FG000|Period 1|Sponsor Decision|0|||
126022329|NCT01609218|453375503|FG001|Period 1|Sponsor Decision|1|||
126022330|NCT01609218|453375502|FG000|Period 2|Adverse Event|1|||
126022331|NCT01609218|453375503|FG001|Period 2|Adverse Event|0|||
126022332|NCT04428112|453375509|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
126022333|NCT04428112|453375510|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
126022334|NCT04428112|453375509|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
126022335|NCT04428112|453375510|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
126022336|NCT04428112|453375509|FG000|Overall Study|Withdrawal by Subject|9|||
126022337|NCT04428112|453375510|FG001|Overall Study|Withdrawal by Subject|4|||
126022338|NCT04428112|453375509|FG000|Overall Study|Lost to Follow-up|27|||
126022339|NCT04428112|453375510|FG001|Overall Study|Lost to Follow-up|7|||
126022340|NCT01207492|453375511|FG000|Overall Study|Still on study|1|||
126022341|NCT01207492|453375511|FG000|Overall Study|Withdrawal by Subject|9|||
126022342|NCT01207492|453375511|FG000|Overall Study|Physician Decision|1|||
126022343|NCT01207492|453375511|FG000|Overall Study|Progressive disease|3|||
126022344|NCT01207492|453375511|FG000|Overall Study|Toxicity|1|||
126022345|NCT02769858|453375512|FG000|Overall Study|Withdrawal by Subject|2|||
126022346|NCT02807779|453375513|FG000|Overall Study|Lost to Follow-up|1|||
126022347|NCT02807779|453375514|FG001|Overall Study|Lost to Follow-up|0|||
126022348|NCT02807779|453375515|FG002|Overall Study|Lost to Follow-up|0|||
126022349|NCT02807779|453375513|FG000|Overall Study|Physician Decision|2|||
126022350|NCT02807779|453375514|FG001|Overall Study|Physician Decision|0|||
126022351|NCT02807779|453375515|FG002|Overall Study|Physician Decision|1|||
126022352|NCT02807779|453375513|FG000|Overall Study|Death|1|||
126022353|NCT02807779|453375514|FG001|Overall Study|Death|1|||
126231186|NCT03093454|454138228|FG001|Overall Study|Withdrawal by Subject|1|||
126231187|NCT03093454|454138227|FG000|Overall Study|Scheduling conflict|3|||
126231188|NCT03093454|454138228|FG001|Overall Study|Scheduling conflict|1|||
126231189|NCT03093454|454138227|FG000|Overall Study|Physician Decision|2|||
126231190|NCT03093454|454138228|FG001|Overall Study|Physician Decision|1|||
126231191|NCT04540497|454138229|FG000|Overall Study|Adverse Event|0|||
126231192|NCT04540497|454138230|FG001|Overall Study|Adverse Event|2|||
126022354|NCT02807779|453375515|FG002|Overall Study|Death|0|||
126022355|NCT01853748|453377076|FG000|Allocation|Withdrawal by Subject|1|||
126022356|NCT01853748|453377077|FG001|Allocation|Withdrawal by Subject|13|||
126022357|NCT01853748|453377076|FG000|Allocation|not sufficient to receive intervention|0|||
126022358|NCT01853748|453377077|FG001|Allocation|not sufficient to receive intervention|1|||
126022359|NCT01853748|453377076|FG000|Follow-Up|Withdrawal by Subject|7|||
126231193|NCT04540497|454138229|FG000|Overall Study|Lost to Follow-up|1|||
126353100|NCT01179516|454583426|FG000|Overall Study|Other|2|||
126353101|NCT01179516|454583427|FG001|Overall Study|Other|0|||
126353102|NCT01179516|454583428|FG002|Overall Study|Other|2|||
126353103|NCT03349515|454583430|FG000|Overall Study|Lack of Efficacy|2|||
126353104|NCT03349515|454583431|FG001|Overall Study|Lack of Efficacy|0|||
126353105|NCT03349515|454583430|FG000|Overall Study|Physician Decision|3|||
126353106|NCT03349515|454583431|FG001|Overall Study|Physician Decision|1|||
126353107|NCT03412890|454583432|FG000|Overall Study|Adverse Event|5|||
126353108|NCT03412890|454583433|FG001|Overall Study|Adverse Event|5|||
126353109|NCT03412890|454583434|FG002|Overall Study|Adverse Event|9|||
126353110|NCT03412890|454583432|FG000|Overall Study|Protocol deviation|2|||
126353111|NCT03412890|454583433|FG001|Overall Study|Protocol deviation|1|||
126353112|NCT03412890|454583434|FG002|Overall Study|Protocol deviation|2|||
126353113|NCT03412890|454583432|FG000|Overall Study|Lost to Follow-up|7|||
126353114|NCT03412890|454583433|FG001|Overall Study|Lost to Follow-up|10|||
126353115|NCT03412890|454583434|FG002|Overall Study|Lost to Follow-up|10|||
126353116|NCT03412890|454583432|FG000|Overall Study|Withdrawal by Subject|9|||
126353117|NCT03412890|454583433|FG001|Overall Study|Withdrawal by Subject|12|||
126353118|NCT03412890|454583434|FG002|Overall Study|Withdrawal by Subject|11|||
126353119|NCT03412890|454583432|FG000|Overall Study|Lack of Efficacy|2|||
126353120|NCT03412890|454583433|FG001|Overall Study|Lack of Efficacy|7|||
126353121|NCT03412890|454583434|FG002|Overall Study|Lack of Efficacy|5|||
126022360|NCT01853748|453377077|FG001|Follow-Up|Withdrawal by Subject|6|||
126231194|NCT04540497|454138230|FG001|Overall Study|Lost to Follow-up|0|||
126353122|NCT03412890|454583432|FG000|Overall Study|Other|5|||
126353123|NCT03412890|454583433|FG001|Overall Study|Other|6|||
126353124|NCT03412890|454583434|FG002|Overall Study|Other|5|||
126353125|NCT03412890|454583432|FG000|Overall Study|Participants who did not receive any study drug|0|||
126353126|NCT03412890|454583433|FG001|Overall Study|Participants who did not receive any study drug|1|||
126022361|NCT01853748|453377076|FG000|Follow-Up|Adverse Event|67|||
126022362|NCT01853748|453377077|FG001|Follow-Up|Adverse Event|7|||
126022363|NCT01853748|453377076|FG000|Follow-Up|not available for data collection|16|||
126022364|NCT01853748|453377077|FG001|Follow-Up|not available for data collection|4|||
126353127|NCT03412890|454583434|FG002|Overall Study|Participants who did not receive any study drug|0|||
126353128|NCT02315625|454583435|FG000|First Intervention|Disease Progression|1|||
126353129|NCT02315625|454583436|FG001|First Intervention|Disease Progression|0|||
126022365|NCT01693120|453377084|FG000|Enrollment|Lost to Follow-up|1|||
126022366|NCT01693120|453377084|FG000|Enrollment|Withdrawal by Subject|10|||
126231195|NCT04540497|454138229|FG000|Overall Study|Withdrawal by Subject|1|||
126231196|NCT04540497|454138230|FG001|Overall Study|Withdrawal by Subject|1|||
126231197|NCT04540497|454138229|FG000|Overall Study|Miscellaneous|2|||
126231198|NCT04540497|454138230|FG001|Overall Study|Miscellaneous|1|||
126231199|NCT01290263|454138237|FG000|Overall Study|Adverse Event|0|||
126231200|NCT01290263|454138238|FG001|Overall Study|Adverse Event|0|||
126231201|NCT01290263|454138239|FG002|Overall Study|Adverse Event|0|||
126231202|NCT01290263|454138240|FG003|Overall Study|Adverse Event|1|||
126231203|NCT01290263|454138241|FG004|Overall Study|Adverse Event|1|||
126231204|NCT01290263|454138237|FG000|Overall Study|Lack of Efficacy|8|||
126231205|NCT01290263|454138238|FG001|Overall Study|Lack of Efficacy|2|||
126231206|NCT01290263|454138239|FG002|Overall Study|Lack of Efficacy|7|||
126231207|NCT01290263|454138240|FG003|Overall Study|Lack of Efficacy|24|||
126231208|NCT01290263|454138241|FG004|Overall Study|Lack of Efficacy|33|||
126231209|NCT01290263|454138237|FG000|Overall Study|Withdrawal by Subject|3|||
126231210|NCT01290263|454138238|FG001|Overall Study|Withdrawal by Subject|1|||
126231211|NCT01290263|454138239|FG002|Overall Study|Withdrawal by Subject|0|||
126231212|NCT01290263|454138240|FG003|Overall Study|Withdrawal by Subject|1|||
126231213|NCT01290263|454138241|FG004|Overall Study|Withdrawal by Subject|2|||
126231214|NCT01290263|454138237|FG000|Overall Study|Participant Non-Compliance|0|||
126231215|NCT01290263|454138238|FG001|Overall Study|Participant Non-Compliance|0|||
126231216|NCT01290263|454138239|FG002|Overall Study|Participant Non-Compliance|0|||
126231217|NCT01290263|454138240|FG003|Overall Study|Participant Non-Compliance|1|||
126231218|NCT01290263|454138241|FG004|Overall Study|Participant Non-Compliance|1|||
126231219|NCT03738332|454138242|FG000|Overall Study|Withdrawal by Subject|1|||
126231220|NCT04700449|454138243|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
126231221|NCT04700449|454138244|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
126231222|NCT04700449|454138245|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
126231223|NCT04700449|454138246|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
126231224|NCT04700449|454138243|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
126231225|NCT04700449|454138244|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
126231226|NCT04700449|454138245|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
126231227|NCT04700449|454138246|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
126231228|NCT04700449|454138243|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
126231229|NCT04700449|454138244|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
126231230|NCT04700449|454138245|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
126231231|NCT04700449|454138246|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
126231232|NCT04700449|454138243|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
126231233|NCT04700449|454138244|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
126231234|NCT04700449|454138245|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
126231235|NCT04700449|454138246|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
126231236|NCT04700449|454138243|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
126231237|NCT04700449|454138244|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
126231238|NCT04700449|454138245|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
126231239|NCT04700449|454138246|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
126231240|NCT04700449|454138243|FG000|Stage 1: Double-Blind Period|Other|0|||
126231241|NCT04700449|454138244|FG001|Stage 1: Double-Blind Period|Other|0|||
126353130|NCT02315625|454583435|FG000|Second Intervention|Physician Decision|2|||
126353131|NCT02315625|454583436|FG001|Second Intervention|Physician Decision|1|||
126353132|NCT02315625|454583435|FG000|Second Intervention|Study closure|1|||
126353133|NCT02315625|454583436|FG001|Second Intervention|Study closure|0|||
126353134|NCT02315625|454583435|FG000|Second Intervention|Disease Progression|1|||
126353135|NCT02315625|454583436|FG001|Second Intervention|Disease Progression|0|||
126353136|NCT00021255|454583437|FG000|Overall Study|Death|1|||
126353137|NCT00021255|454583438|FG001|Overall Study|Death|0|||
126353138|NCT00021255|454583439|FG002|Overall Study|Death|2|||
126353139|NCT00021255|454583437|FG000|Overall Study|Breast cancer relapse|5|||
126353140|NCT00021255|454583438|FG001|Overall Study|Breast cancer relapse|18|||
126353141|NCT00021255|454583439|FG002|Overall Study|Breast cancer relapse|11|||
126353142|NCT00021255|454583437|FG000|Overall Study|Second primary malignancy|0|||
126353143|NCT00021255|454583438|FG001|Overall Study|Second primary malignancy|4|||
126022367|NCT01693120|453377084|FG000|Enrollment|Protocol Violation|46|||
126231242|NCT04700449|454138245|FG002|Stage 1: Double-Blind Period|Other|1|||
126231243|NCT04700449|454138246|FG003|Stage 1: Double-Blind Period|Other|0|||
126353144|NCT00021255|454583439|FG002|Overall Study|Second primary malignancy|1|||
126353145|NCT00021255|454583437|FG000|Overall Study|Withdrawal by Subject|41|||
126022368|NCT01693120|453377084|FG000|Enrollment|Physician Decision|3|||
126231244|NCT04700449|454138243|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
126353146|NCT00021255|454583438|FG001|Overall Study|Withdrawal by Subject|64|||
126353147|NCT00021255|454583439|FG002|Overall Study|Withdrawal by Subject|26|||
126353148|NCT00021255|454583437|FG000|Overall Study|Lost to Follow-up|0|||
126353149|NCT00021255|454583438|FG001|Overall Study|Lost to Follow-up|2|||
126353150|NCT00021255|454583439|FG002|Overall Study|Lost to Follow-up|3|||
126353151|NCT00021255|454583437|FG000|Overall Study|Cardiac toxicity|0|||
126022369|NCT01693120|453377084|FG000|Enrollment|Adverse Event|1|||
126022370|NCT01693120|453377084|FG000|Enrollment|Study closed|8|||
126022371|NCT01693120|453377084|FG000|Enrollment|Other|1|||
126353152|NCT00021255|454583438|FG001|Overall Study|Cardiac toxicity|61|||
126353153|NCT00021255|454583439|FG002|Overall Study|Cardiac toxicity|32|||
126353154|NCT00021255|454583437|FG000|Overall Study|Herceptin toxicity|0|||
126353155|NCT00021255|454583438|FG001|Overall Study|Herceptin toxicity|22|||
126353156|NCT00021255|454583439|FG002|Overall Study|Herceptin toxicity|6|||
126353157|NCT00021255|454583437|FG000|Overall Study|Adverse Event|46|||
126353158|NCT00021255|454583438|FG001|Overall Study|Adverse Event|30|||
126353159|NCT00021255|454583439|FG002|Overall Study|Adverse Event|18|||
126353160|NCT00021255|454583437|FG000|Overall Study|Protocol Violation|0|||
126353161|NCT00021255|454583438|FG001|Overall Study|Protocol Violation|2|||
126353162|NCT00021255|454583439|FG002|Overall Study|Protocol Violation|0|||
126353163|NCT00021255|454583437|FG000|Overall Study|Other than specified above|0|||
126353164|NCT00021255|454583438|FG001|Overall Study|Other than specified above|38|||
126353165|NCT00021255|454583439|FG002|Overall Study|Other than specified above|19|||
126353166|NCT00021255|454583437|FG000|Overall Study|Missing|0|||
126353167|NCT00021255|454583438|FG001|Overall Study|Missing|27|||
126353168|NCT00021255|454583439|FG002|Overall Study|Missing|13|||
126353169|NCT00021255|454583437|FG000|Overall Study|Randomized but not treated|28|||
126353170|NCT00021255|454583438|FG001|Overall Study|Randomized but not treated|2|||
126353171|NCT00021255|454583439|FG002|Overall Study|Randomized but not treated|18|||
126022372|NCT01693120|453377084|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
126353172|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
126353173|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
126353174|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
126353175|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
126093122|NCT04155047|453634521|FG001|Overall Study|Adverse Event|0|||
126353176|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
126353177|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
126353178|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
126353179|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
126353180|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
126353181|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
126353182|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
126353183|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
126353184|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
126353185|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
126353186|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
126353187|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
126353188|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
126353189|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
126353190|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
126353191|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
126353192|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
126353193|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
126353194|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
126353195|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
126353196|NCT02337946|454583442|FG000|In-between Period|Without Informed Consent|1|||
126353197|NCT02337946|454583443|FG001|In-between Period|Without Informed Consent|0|||
126353198|NCT02337946|454583444|FG002|In-between Period|Without Informed Consent|0|||
126353199|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
126353200|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
126353201|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
126353202|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
126353203|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
126353204|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
126353205|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
126353206|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
126353207|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
126353208|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
126353209|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
126353210|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
126353211|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
126353212|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
126353213|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
126353214|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
126353215|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
126353216|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
126353217|NCT05324371|454583446|FG000|Overall Study|Withdrawal by Subject|1|||
126353218|NCT05324371|454583446|FG000|Overall Study|Death|1|||
126353219|NCT02949934|454583448|FG000|Natural Drinking Period|Adverse Event|1|||
126353220|NCT02949934|454583449|FG001|Natural Drinking Period|Adverse Event|0|||
126353221|NCT02949934|454583450|FG002|Natural Drinking Period|Adverse Event|0|||
126353222|NCT02949934|454583451|FG003|Natural Drinking Period|Adverse Event|1|||
126353223|NCT02949934|454583452|FG004|Natural Drinking Period|Adverse Event|0|||
126353224|NCT02949934|454583453|FG005|Natural Drinking Period|Adverse Event|0|||
126353225|NCT02949934|454583448|FG000|Natural Drinking Period|Lost to Follow-up|0|||
126353226|NCT02949934|454583449|FG001|Natural Drinking Period|Lost to Follow-up|0|||
126353227|NCT02949934|454583450|FG002|Natural Drinking Period|Lost to Follow-up|0|||
126353228|NCT02949934|454583451|FG003|Natural Drinking Period|Lost to Follow-up|0|||
126353229|NCT02949934|454583452|FG004|Natural Drinking Period|Lost to Follow-up|1|||
126353230|NCT02949934|454583453|FG005|Natural Drinking Period|Lost to Follow-up|0|||
126093123|NCT04155047|453634520|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
126103466|NCT04620811|453672167|FG000|Overall Study|Physician Decision|1|||
126353231|NCT02949934|454583448|FG000|Neuroimaging|Protocol Violation|2|||
126353232|NCT02949934|454583449|FG001|Neuroimaging|Protocol Violation|0|||
126353233|NCT02949934|454583450|FG002|Neuroimaging|Protocol Violation|0|||
126353234|NCT02949934|454583451|FG003|Neuroimaging|Protocol Violation|0|||
126353235|NCT02949934|454583452|FG004|Neuroimaging|Protocol Violation|1|||
126353236|NCT02949934|454583453|FG005|Neuroimaging|Protocol Violation|0|||
126353237|NCT02949934|454583448|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
126353238|NCT02949934|454583449|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
126022373|NCT01693120|453377084|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
126022374|NCT01693120|453377084|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
126022375|NCT01693120|453377084|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
126022376|NCT01693120|453377084|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
126022377|NCT04153565|453377085|FG000|Overall Study|Death|13|||
126022378|NCT03050814|453377088|FG000|Overall Study|Screen failures|0|||
126022379|NCT03050814|453377089|FG001|Overall Study|Screen failures|0|||
126022380|NCT03050814|453377090|FG002|Overall Study|Screen failures|4|||
126022381|NCT05137236|453377094|FG000|Part A|Other than Specified|1|||
126022382|NCT05137236|453377095|FG001|Part A|Other than Specified|0|||
126022383|NCT05137236|453377096|FG002|Part A|Other than Specified|0|||
126022384|NCT05137236|453377097|FG003|Part A|Other than Specified|0|||
126022385|NCT05137236|453377098|FG004|Part A|Other than Specified|0|||
126022386|NCT05137236|453377099|FG005|Part A|Other than Specified|0|||
126022387|NCT05137236|453377100|FG006|Part A|Other than Specified|0|||
126022388|NCT05137236|453377101|FG007|Part A|Other than Specified|0|||
126022389|NCT05137236|453377094|FG000|Part A|Withdrawal by Subject|0|||
126022390|NCT05137236|453377095|FG001|Part A|Withdrawal by Subject|4|||
126022391|NCT05137236|453377096|FG002|Part A|Withdrawal by Subject|1|||
126022392|NCT05137236|453377097|FG003|Part A|Withdrawal by Subject|1|||
126022393|NCT05137236|453377098|FG004|Part A|Withdrawal by Subject|3|||
126022394|NCT05137236|453377099|FG005|Part A|Withdrawal by Subject|2|||
126022395|NCT05137236|453377100|FG006|Part A|Withdrawal by Subject|0|||
126022396|NCT05137236|453377101|FG007|Part A|Withdrawal by Subject|0|||
126022397|NCT05137236|453377094|FG000|Part A|Lost to Follow-up|5|||
126022398|NCT05137236|453377095|FG001|Part A|Lost to Follow-up|7|||
126022399|NCT05137236|453377096|FG002|Part A|Lost to Follow-up|1|||
126022400|NCT05137236|453377097|FG003|Part A|Lost to Follow-up|3|||
126022401|NCT05137236|453377098|FG004|Part A|Lost to Follow-up|3|||
126022402|NCT05137236|453377099|FG005|Part A|Lost to Follow-up|8|||
126022403|NCT05137236|453377100|FG006|Part A|Lost to Follow-up|0|||
126022404|NCT05137236|453377101|FG007|Part A|Lost to Follow-up|0|||
126022405|NCT05137236|453377094|FG000|Part B|Withdrawal by Subject|0|||
126022406|NCT05137236|453377095|FG001|Part B|Withdrawal by Subject|0|||
126022407|NCT05137236|453377096|FG002|Part B|Withdrawal by Subject|0|||
126022408|NCT05137236|453377097|FG003|Part B|Withdrawal by Subject|0|||
126231245|NCT04700449|454138244|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
126231246|NCT04700449|454138245|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
126022409|NCT05137236|453377098|FG004|Part B|Withdrawal by Subject|0|||
126022410|NCT05137236|453377099|FG005|Part B|Withdrawal by Subject|0|||
126022411|NCT05137236|453377100|FG006|Part B|Withdrawal by Subject|0|||
126231247|NCT04700449|454138246|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
126353239|NCT02949934|454583450|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
126353240|NCT02949934|454583451|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
126353241|NCT02949934|454583452|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
126353242|NCT02949934|454583453|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
126353243|NCT02949934|454583448|FG000|Neuroimaging|Not scanned|0|||
126353244|NCT02949934|454583449|FG001|Neuroimaging|Not scanned|0|||
126353245|NCT02949934|454583450|FG002|Neuroimaging|Not scanned|1|||
126353246|NCT02949934|454583451|FG003|Neuroimaging|Not scanned|0|||
126353247|NCT02949934|454583452|FG004|Neuroimaging|Not scanned|0|||
126353248|NCT02949934|454583453|FG005|Neuroimaging|Not scanned|2|||
126353249|NCT02949934|454583448|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
126353250|NCT02949934|454583449|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
126353251|NCT02949934|454583450|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
126353252|NCT02949934|454583451|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
126353253|NCT02949934|454583452|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
126353254|NCT02949934|454583453|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
126022412|NCT05137236|453377101|FG007|Part B|Withdrawal by Subject|2|||
126022413|NCT05137236|453377094|FG000|Part B|Lost to Follow-up|0|||
126022414|NCT05137236|453377095|FG001|Part B|Lost to Follow-up|0|||
126022415|NCT05137236|453377096|FG002|Part B|Lost to Follow-up|0|||
126022416|NCT05137236|453377097|FG003|Part B|Lost to Follow-up|0|||
126022417|NCT05137236|453377098|FG004|Part B|Lost to Follow-up|0|||
126231248|NCT04700449|454138243|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
126231249|NCT04700449|454138244|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
126353255|NCT02949934|454583448|FG000|Bar Laboratory|Adverse Event|1|||
126022418|NCT05137236|453377099|FG005|Part B|Lost to Follow-up|0|||
126022419|NCT05137236|453377100|FG006|Part B|Lost to Follow-up|5|||
126022420|NCT05137236|453377101|FG007|Part B|Lost to Follow-up|5|||
126022421|NCT05137236|453377094|FG000|Part B|Death|0|||
126022422|NCT05137236|453377095|FG001|Part B|Death|0|||
126353256|NCT02949934|454583449|FG001|Bar Laboratory|Adverse Event|0|||
126353257|NCT02949934|454583450|FG002|Bar Laboratory|Adverse Event|2|||
126022423|NCT05137236|453377096|FG002|Part B|Death|0|||
126022424|NCT05137236|453377097|FG003|Part B|Death|0|||
126022425|NCT05137236|453377098|FG004|Part B|Death|0|||
126022426|NCT05137236|453377099|FG005|Part B|Death|0|||
126022427|NCT05137236|453377100|FG006|Part B|Death|0|||
126022428|NCT05137236|453377101|FG007|Part B|Death|2|||
126022429|NCT02724956|453377102|FG000|Overall Study|Physician Decision|1|||
126022430|NCT02724956|453377103|FG001|Overall Study|Physician Decision|0|||
126022431|NCT02724956|453377102|FG000|Overall Study|Lack of Efficacy|0|||
126022432|NCT02724956|453377103|FG001|Overall Study|Lack of Efficacy|1|||
126022433|NCT02724956|453377102|FG000|Overall Study|Withdrawal by Subject|0|||
126022434|NCT02724956|453377103|FG001|Overall Study|Withdrawal by Subject|1|||
126022435|NCT02647905|453377106|FG000|Overall Study|Lost to Follow-up|1|||
126022436|NCT02647905|453377106|FG000|Overall Study|Withdrawal by Subject|2|||
126022437|NCT02015520|453377107|FG000|Overall Study|Lack of Efficacy|1|||
126022438|NCT02015520|453377108|FG001|Overall Study|Lack of Efficacy|0|||
126022439|NCT02015520|453377109|FG002|Overall Study|Lack of Efficacy|3|||
126022440|NCT02015520|453377110|FG003|Overall Study|Lack of Efficacy|2|||
126022441|NCT02015520|453377107|FG000|Overall Study|Adverse Event|0|||
126022442|NCT02015520|453377108|FG001|Overall Study|Adverse Event|0|||
126022443|NCT02015520|453377109|FG002|Overall Study|Adverse Event|0|||
126022444|NCT02015520|453377110|FG003|Overall Study|Adverse Event|1|||
126022445|NCT02015520|453377107|FG000|Overall Study|Withdrawal by Subject|2|||
126022446|NCT02015520|453377108|FG001|Overall Study|Withdrawal by Subject|2|||
126022447|NCT02015520|453377109|FG002|Overall Study|Withdrawal by Subject|1|||
126022448|NCT02015520|453377110|FG003|Overall Study|Withdrawal by Subject|0|||
126022449|NCT02015520|453377107|FG000|Overall Study|Death|1|||
126022450|NCT02015520|453377108|FG001|Overall Study|Death|0|||
126022451|NCT02015520|453377109|FG002|Overall Study|Death|0|||
126022452|NCT02015520|453377110|FG003|Overall Study|Death|0|||
126022453|NCT02015520|453377107|FG000|Overall Study|Lost to Follow-up|0|||
126022454|NCT02015520|453377108|FG001|Overall Study|Lost to Follow-up|0|||
126022455|NCT02015520|453377109|FG002|Overall Study|Lost to Follow-up|1|||
126022456|NCT02015520|453377110|FG003|Overall Study|Lost to Follow-up|0|||
126022457|NCT02015520|453377107|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
126022458|NCT02015520|453377108|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
126022459|NCT02015520|453377109|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
126022460|NCT02015520|453377110|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
126022461|NCT02015520|453377107|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
126022462|NCT02015520|453377108|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
126022463|NCT02015520|453377109|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
126022464|NCT02015520|453377110|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
126022465|NCT05119855|453377111|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
126022466|NCT05119855|453377112|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
126022467|NCT05119855|453377111|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
126022468|NCT05119855|453377112|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
126022469|NCT05119855|453377111|FG000|Overall Study|Lost to Follow-up|6|||
126022470|NCT05119855|453377112|FG001|Overall Study|Lost to Follow-up|8|||
126022471|NCT02932579|453377113|FG000|Overall Study|Withdrawal by Subject|4|||
126022472|NCT02932579|453377114|FG001|Overall Study|Withdrawal by Subject|1|||
126022473|NCT01972724|453377115|FG000|Double-Blind|Rescue Criteria Met|1|||
126022474|NCT01972724|453377116|FG001|Double-Blind|Rescue Criteria Met|0|||
126022475|NCT01972724|453377117|FG002|Double-Blind|Rescue Criteria Met|0|||
126022476|NCT01972724|453377115|FG000|Double-Blind|Adverse Event|1|||
126022477|NCT01972724|453377116|FG001|Double-Blind|Adverse Event|0|||
126022478|NCT01972724|453377117|FG002|Double-Blind|Adverse Event|0|||
126022479|NCT01972724|453377115|FG000|Double-Blind|Withdrawal of Consent|2|||
126022480|NCT01972724|453377116|FG001|Double-Blind|Withdrawal of Consent|1|||
126022481|NCT01972724|453377117|FG002|Double-Blind|Withdrawal of Consent|0|||
126022482|NCT01972724|453377115|FG000|Double-Blind|Significant Protocol Deviation|5|||
126022483|NCT01972724|453377116|FG001|Double-Blind|Significant Protocol Deviation|8|||
126022484|NCT01972724|453377117|FG002|Double-Blind|Significant Protocol Deviation|0|||
126022485|NCT01972724|453377115|FG000|Open-Label|Withdrew Consent|0|||
126022486|NCT01972724|453377116|FG001|Open-Label|Withdrew Consent|0|||
126022487|NCT01972724|453377117|FG002|Open-Label|Withdrew Consent|3|||
126022488|NCT01972724|453377115|FG000|Open-Label|Significant Protocol Deviation|0|||
126022489|NCT01972724|453377116|FG001|Open-Label|Significant Protocol Deviation|0|||
126022490|NCT01972724|453377117|FG002|Open-Label|Significant Protocol Deviation|2|||
126022491|NCT00111813|453377124|FG000|Overall Study|Adverse Event|1|||
126022492|NCT00111813|453377125|FG001|Overall Study|Adverse Event|2|||
126022493|NCT00111813|453377126|FG002|Overall Study|Adverse Event|4|||
126022494|NCT00111813|453377127|FG003|Overall Study|Adverse Event|2|||
126022495|NCT00111813|453377128|FG004|Overall Study|Adverse Event|2|||
126022496|NCT00111813|453377129|FG005|Overall Study|Adverse Event|2|||
126022497|NCT00111813|453377124|FG000|Overall Study|Progressive disease|2|||
126022498|NCT00111813|453377125|FG001|Overall Study|Progressive disease|1|||
126022499|NCT00111813|453377126|FG002|Overall Study|Progressive disease|5|||
126022500|NCT00111813|453377127|FG003|Overall Study|Progressive disease|3|||
126231250|NCT04700449|454138245|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
126231251|NCT04700449|454138246|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
126231252|NCT04700449|454138243|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
126231253|NCT04700449|454138244|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
126231254|NCT04700449|454138245|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
126231255|NCT04700449|454138246|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
126231256|NCT04700449|454138243|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
126231257|NCT04700449|454138244|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
126231258|NCT04700449|454138245|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
126231259|NCT04700449|454138246|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
126231260|NCT04700449|454138243|FG000|Stage 2 Sub-study 1|Other|1|||
126231261|NCT04700449|454138244|FG001|Stage 2 Sub-study 1|Other|2|||
126231262|NCT04700449|454138245|FG002|Stage 2 Sub-study 1|Other|0|||
126231263|NCT04700449|454138246|FG003|Stage 2 Sub-study 1|Other|0|||
126231264|NCT04700449|454138243|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
126231265|NCT04700449|454138244|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
126231266|NCT04700449|454138245|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
126231267|NCT04700449|454138246|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
126231268|NCT04700449|454138243|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
126231269|NCT04700449|454138244|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
126231270|NCT04700449|454138245|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
126231271|NCT04700449|454138246|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
126231272|NCT04700449|454138243|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
126231273|NCT04700449|454138244|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
126231274|NCT04700449|454138245|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
126231275|NCT04700449|454138246|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
126231276|NCT04700449|454138243|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
126231277|NCT04700449|454138244|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
126231278|NCT04700449|454138245|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
126231279|NCT04700449|454138246|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
126231280|NCT04700449|454138243|FG000|Stage 2 Sub-study 2|Other|0|||
126231281|NCT04700449|454138244|FG001|Stage 2 Sub-study 2|Other|0|||
126231282|NCT04700449|454138245|FG002|Stage 2 Sub-study 2|Other|0|||
126231283|NCT04700449|454138246|FG003|Stage 2 Sub-study 2|Other|5|||
126231284|NCT01521559|454138247|FG000|Overall Study|Adverse Event|0|||
126231285|NCT01521559|454138248|FG001|Overall Study|Adverse Event|4|||
126231286|NCT01521559|454138247|FG000|Overall Study|Death|1|||
126231287|NCT01521559|454138248|FG001|Overall Study|Death|0|||
126231288|NCT01521559|454138247|FG000|Overall Study|Withdrawal by Subject|9|||
126231289|NCT01521559|454138248|FG001|Overall Study|Withdrawal by Subject|11|||
126231290|NCT01521559|454138247|FG000|Overall Study|Lost to Follow-up|3|||
126231291|NCT01521559|454138248|FG001|Overall Study|Lost to Follow-up|1|||
126231292|NCT01521559|454138247|FG000|Overall Study|Protocol Violation|1|||
126231293|NCT01521559|454138248|FG001|Overall Study|Protocol Violation|0|||
126231294|NCT01521559|454138247|FG000|Overall Study|Other|1|||
126231295|NCT01521559|454138248|FG001|Overall Study|Other|2|||
126353258|NCT02949934|454583451|FG003|Bar Laboratory|Adverse Event|0|||
126353259|NCT02949934|454583452|FG004|Bar Laboratory|Adverse Event|1|||
126353260|NCT02949934|454583453|FG005|Bar Laboratory|Adverse Event|0|||
126353261|NCT02949934|454583448|FG000|Bar Laboratory|Protocol Violation|0|||
126353262|NCT02949934|454583449|FG001|Bar Laboratory|Protocol Violation|0|||
126353263|NCT02949934|454583450|FG002|Bar Laboratory|Protocol Violation|0|||
126353264|NCT02949934|454583451|FG003|Bar Laboratory|Protocol Violation|1|||
126353265|NCT02949934|454583452|FG004|Bar Laboratory|Protocol Violation|0|||
126353266|NCT02949934|454583453|FG005|Bar Laboratory|Protocol Violation|0|||
126353267|NCT03720847|454584386|FG000|Washout|Physician Decision|1|||
126353268|NCT03720847|454584387|FG001|Washout|Physician Decision|2|||
126353269|NCT01239680|454584388|FG000|Overall Study|Withdrawal by Subject|2|||
126353270|NCT01239680|454584389|FG001|Overall Study|Withdrawal by Subject|0|||
126353271|NCT03033901|454584390|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
126353272|NCT03033901|454584390|FG000|Overall Study|Refused PSG|23|||
126353273|NCT03033901|454584390|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
126353274|NCT03033901|454584390|FG000|Overall Study|Missing Oximetry Data|3|||
126231296|NCT00275002|454138249|FG000|Overall Study|Death|1|||
126353275|NCT01521364|454584398|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
126353276|NCT01521364|454584398|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
126353277|NCT02636283|454584399|FG000|Overall Study|Adverse Event|2|||
126353278|NCT02636283|454584400|FG001|Overall Study|Adverse Event|0|||
126022501|NCT00111813|453377128|FG004|Overall Study|Progressive disease|4|||
126022502|NCT00111813|453377129|FG005|Overall Study|Progressive disease|3|||
126231297|NCT00275002|454138250|FG001|Overall Study|Death|0|||
126231298|NCT00275002|454138249|FG000|Overall Study|Disease progression|21|||
126231299|NCT00275002|454138250|FG001|Overall Study|Disease progression|15|||
126231300|NCT00275002|454138249|FG000|Overall Study|Adverse Event|0|||
126231301|NCT00275002|454138250|FG001|Overall Study|Adverse Event|1|||
126353279|NCT02636283|454584399|FG000|Overall Study|Trial Terminated Prematurely|0|||
126353280|NCT02636283|454584400|FG001|Overall Study|Trial Terminated Prematurely|3|||
126353281|NCT00195429|454584403|FG000|Overall Study|Adverse Event|2|||
126353282|NCT00195429|454584404|FG001|Overall Study|Adverse Event|4|||
126231302|NCT00576381|454138257|FG000|Overall Study|Reoperation|3|||
126231303|NCT00576381|454138257|FG000|Overall Study|Adverse Event|4|||
126231304|NCT01031537|454138261|FG000|Overall Study|medical reasons not related to study|3|||
126231305|NCT01031537|454138261|FG000|Overall Study|Lack of Efficacy|1|||
126231306|NCT01031537|454138261|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
126231307|NCT01031537|454138261|FG000|Overall Study|moved, met exclusion criteria|10|||
126231308|NCT01031537|454138261|FG000|Overall Study|Withdrawal by Subject|5|||
126231309|NCT01031537|454138261|FG000|Overall Study|PI removal, no longer met eligibility|12|||
126231310|NCT02132247|454138262|FG000|Overall Study|Protocol Violation|1|||
126231311|NCT02132247|454138263|FG001|Overall Study|Protocol Violation|0|||
126231312|NCT00520741|454138264|FG000|Overall Study|Adverse Event|16|||
126231313|NCT00520741|454138265|FG001|Overall Study|Adverse Event|56|||
126231314|NCT00520741|454138264|FG000|Overall Study|Lack of Efficacy|11|||
126231315|NCT00520741|454138265|FG001|Overall Study|Lack of Efficacy|30|||
126231316|NCT00520741|454138264|FG000|Overall Study|Withdrawal by Subject|0|||
126231317|NCT00520741|454138265|FG001|Overall Study|Withdrawal by Subject|11|||
126231318|NCT00520741|454138264|FG000|Overall Study|Protocol Violation|2|||
126231319|NCT00520741|454138265|FG001|Overall Study|Protocol Violation|15|||
126353283|NCT00195429|454584403|FG000|Overall Study|Lack of Efficacy|2|||
126022503|NCT00111813|453377124|FG000|Overall Study|Lack of Efficacy|0|||
126022504|NCT00111813|453377125|FG001|Overall Study|Lack of Efficacy|0|||
126022505|NCT00111813|453377126|FG002|Overall Study|Lack of Efficacy|0|||
126022506|NCT00111813|453377127|FG003|Overall Study|Lack of Efficacy|0|||
126022507|NCT00111813|453377128|FG004|Overall Study|Lack of Efficacy|0|||
126022508|NCT00111813|453377129|FG005|Overall Study|Lack of Efficacy|1|||
126022509|NCT00111813|453377124|FG000|Overall Study|Other|0|||
126022510|NCT00111813|453377125|FG001|Overall Study|Other|0|||
126022511|NCT00111813|453377126|FG002|Overall Study|Other|1|||
126022512|NCT00111813|453377127|FG003|Overall Study|Other|0|||
126022513|NCT00111813|453377128|FG004|Overall Study|Other|0|||
126022514|NCT00111813|453377129|FG005|Overall Study|Other|0|||
126353284|NCT00195429|454584404|FG001|Overall Study|Lack of Efficacy|1|||
126353285|NCT00195429|454584403|FG000|Overall Study|Lost to Follow-up|1|||
126353286|NCT00195429|454584404|FG001|Overall Study|Lost to Follow-up|0|||
126353287|NCT02541903|454584405|FG000|Overall Study|Death|1|||
126353288|NCT04795323|454584406|FG000|Overall Study|Did not interact with TARA|1|||
126353289|NCT04795323|454584407|FG001|Overall Study|Did not interact with TARA|0|||
126353290|NCT02691663|454584409|FG000|Overall Study|Screen failure after baseline|2|||
126353291|NCT02691663|454584410|FG001|Overall Study|Screen failure after baseline|2|||
126353292|NCT02691663|454584409|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
126353293|NCT02691663|454584410|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
126353294|NCT02691663|454584409|FG000|Overall Study|Withdrawn after Follow up 2|1|||
126353295|NCT02691663|454584410|FG001|Overall Study|Withdrawn after Follow up 2|1|||
126353296|NCT02691663|454584409|FG000|Overall Study|Lost to Follow-up|3|||
126353297|NCT02691663|454584410|FG001|Overall Study|Lost to Follow-up|2|||
126353298|NCT03142750|454584411|FG000|Overall Study|Lost to Follow-up|4|||
126353299|NCT03142750|454584412|FG001|Overall Study|Lost to Follow-up|1|||
126353300|NCT04925934|454584413|FG000|Overall Study|Adverse Event|1|||
126353301|NCT04925934|454584414|FG001|Overall Study|Adverse Event|0|||
126353302|NCT04925934|454584415|FG002|Overall Study|Adverse Event|0|||
126353303|NCT04925934|454584413|FG000|Overall Study|Lost to Follow-up|2|||
126353304|NCT04925934|454584414|FG001|Overall Study|Lost to Follow-up|0|||
126353305|NCT04925934|454584415|FG002|Overall Study|Lost to Follow-up|1|||
126353306|NCT04925934|454584413|FG000|Overall Study|Death|0|||
126353307|NCT04925934|454584414|FG001|Overall Study|Death|1|||
126353308|NCT04925934|454584415|FG002|Overall Study|Death|0|||
126353309|NCT04925934|454584413|FG000|Overall Study|Withdrawal by Subject|8|||
126353310|NCT04925934|454584414|FG001|Overall Study|Withdrawal by Subject|5|||
126353311|NCT04925934|454584415|FG002|Overall Study|Withdrawal by Subject|9|||
126353312|NCT04925934|454584413|FG000|Overall Study|Other|2|||
126353313|NCT04925934|454584414|FG001|Overall Study|Other|2|||
126353314|NCT04925934|454584415|FG002|Overall Study|Other|2|||
126022515|NCT02121002|453377131|FG000|Overall Study|Physician Decision|2|||
126022516|NCT02121002|453377132|FG001|Overall Study|Physician Decision|0|||
126022517|NCT02121002|453377133|FG002|Overall Study|Physician Decision|0|||
126353315|NCT04925934|454584413|FG000|Overall Study|Eastern European Conflict|7|||
126353316|NCT04925934|454584414|FG001|Overall Study|Eastern European Conflict|3|||
126353317|NCT04925934|454584415|FG002|Overall Study|Eastern European Conflict|2|||
126353318|NCT03158688|454584416|FG000|Overall Study|Withdrawal by Subject|14|||
126353319|NCT03158688|454584417|FG001|Overall Study|Withdrawal by Subject|28|||
126353320|NCT03158688|454584416|FG000|Overall Study|Decision by sponsor|13|||
126353321|NCT03158688|454584417|FG001|Overall Study|Decision by sponsor|37|||
126022518|NCT02121002|453377131|FG000|Overall Study|Withdrawal by Subject|3|||
126231320|NCT00520741|454138264|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
126231321|NCT00520741|454138265|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
126353322|NCT03158688|454584416|FG000|Overall Study|Lost to Follow-up|4|||
126353323|NCT03158688|454584417|FG001|Overall Study|Lost to Follow-up|3|||
126022519|NCT02121002|453377132|FG001|Overall Study|Withdrawal by Subject|1|||
126022520|NCT02121002|453377133|FG002|Overall Study|Withdrawal by Subject|4|||
126022521|NCT02121002|453377131|FG000|Overall Study|Protocol Violation|1|||
126022522|NCT02121002|453377132|FG001|Overall Study|Protocol Violation|2|||
126022523|NCT02121002|453377133|FG002|Overall Study|Protocol Violation|4|||
126022524|NCT02121002|453377131|FG000|Overall Study|Concomitant therapy|0|||
126022525|NCT02121002|453377132|FG001|Overall Study|Concomitant therapy|1|||
126022526|NCT02121002|453377133|FG002|Overall Study|Concomitant therapy|1|||
126022527|NCT02121002|453377131|FG000|Overall Study|Others|1|||
126022528|NCT02121002|453377132|FG001|Overall Study|Others|0|||
126022529|NCT02121002|453377133|FG002|Overall Study|Others|1|||
126022530|NCT01000480|453377135|FG000|Induction Phase|Adverse Event|2|||
126022531|NCT01000480|453377135|FG000|Induction Phase|Lost to Follow-up|1|||
126022532|NCT01000480|453377135|FG000|Induction Phase|Physician Decision|1|||
126022533|NCT01000480|453377135|FG000|Induction Phase|Entry Criteria Not Met|3|||
126022534|NCT01000480|453377135|FG000|Concurrent Therapy Phase|Adverse Event|4|||
126022535|NCT01000480|453377135|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
126022536|NCT01000480|453377135|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
126022537|NCT01000480|453377135|FG000|Concurrent Therapy Phase|Physician Decision|1|||
126022538|NCT00174382|453377136|FG000|Overall Study|Death|2|||
126022539|NCT00174382|453377136|FG000|Overall Study|Adverse Event|19|||
126022540|NCT00174382|453377136|FG000|Overall Study|Withdrawal by Subject|6|||
126022541|NCT00174382|453377136|FG000|Overall Study|Protocol Violation|3|||
126022542|NCT00174382|453377136|FG000|Overall Study|Arrived early for last visit in error|1|||
126022543|NCT00174382|453377136|FG000|Overall Study|Subject felt pill not effective enough|1|||
126022544|NCT00174382|453377136|FG000|Overall Study|Lost to Follow-up|1|||
126022545|NCT00296036|453377137|FG000|Overall Study|Withdrawal by Subject|1|||
126022546|NCT00296036|453377138|FG001|Overall Study|Withdrawal by Subject|0|||
126022547|NCT00296036|453377139|FG002|Overall Study|Withdrawal by Subject|2|||
126022548|NCT00296036|453377140|FG003|Overall Study|Withdrawal by Subject|1|||
126022549|NCT00296036|453377141|FG004|Overall Study|Withdrawal by Subject|2|||
126022550|NCT00296036|453377142|FG005|Overall Study|Withdrawal by Subject|1|||
126353324|NCT03158688|454584416|FG000|Overall Study|Death|74|||
126353325|NCT03158688|454584417|FG001|Overall Study|Death|142|||
126353326|NCT01944774|454584425|FG000|Overall Study|Withdrawal by Subject|2|||
126353327|NCT01944774|454584426|FG001|Overall Study|Withdrawal by Subject|3|||
126353328|NCT01944774|454584427|FG002|Overall Study|Withdrawal by Subject|3|||
126353329|NCT01944774|454584425|FG000|Overall Study|Adverse Event|3|||
126353330|NCT01944774|454584426|FG001|Overall Study|Adverse Event|2|||
126353331|NCT01944774|454584427|FG002|Overall Study|Adverse Event|3|||
126353332|NCT01944774|454584425|FG000|Overall Study|Lack of Efficacy|1|||
126353333|NCT01944774|454584426|FG001|Overall Study|Lack of Efficacy|2|||
126353334|NCT01944774|454584427|FG002|Overall Study|Lack of Efficacy|2|||
126353335|NCT01944774|454584425|FG000|Overall Study|Lost to Follow-up|0|||
126353336|NCT01944774|454584426|FG001|Overall Study|Lost to Follow-up|1|||
126353337|NCT01944774|454584427|FG002|Overall Study|Lost to Follow-up|0|||
126353338|NCT03188185|454584428|FG000|Stage 1|Adverse Event|4|||
126353339|NCT03188185|454584429|FG001|Stage 1|Adverse Event|12|||
126353340|NCT03188185|454584430|FG002|Stage 1|Adverse Event|0|||
126353341|NCT03188185|454584431|FG003|Stage 1|Adverse Event|0|||
126353342|NCT03188185|454584428|FG000|Stage 1|Lack of Efficacy|0|||
126353343|NCT03188185|454584429|FG001|Stage 1|Lack of Efficacy|2|||
126353344|NCT03188185|454584430|FG002|Stage 1|Lack of Efficacy|0|||
126353345|NCT03188185|454584431|FG003|Stage 1|Lack of Efficacy|0|||
126353346|NCT03188185|454584428|FG000|Stage 1|Lost to Follow-up|6|||
126353347|NCT03188185|454584429|FG001|Stage 1|Lost to Follow-up|1|||
126353348|NCT03188185|454584430|FG002|Stage 1|Lost to Follow-up|0|||
126353349|NCT03188185|454584431|FG003|Stage 1|Lost to Follow-up|0|||
126353350|NCT03188185|454584428|FG000|Stage 1|Withdrawal by Subject|9|||
126353351|NCT03188185|454584429|FG001|Stage 1|Withdrawal by Subject|0|||
126022551|NCT00296036|453377137|FG000|Overall Study|Protocol Violation|0|||
126022552|NCT00296036|453377138|FG001|Overall Study|Protocol Violation|0|||
126022553|NCT00296036|453377139|FG002|Overall Study|Protocol Violation|0|||
126022554|NCT00296036|453377140|FG003|Overall Study|Protocol Violation|0|||
126022555|NCT00296036|453377141|FG004|Overall Study|Protocol Violation|0|||
126353352|NCT03188185|454584430|FG002|Stage 1|Withdrawal by Subject|0|||
126353353|NCT03188185|454584431|FG003|Stage 1|Withdrawal by Subject|0|||
126353354|NCT03188185|454584428|FG000|Stage 1|Identified as a professional patient|0|||
126353355|NCT03188185|454584429|FG001|Stage 1|Identified as a professional patient|1|||
126353356|NCT03188185|454584430|FG002|Stage 1|Identified as a professional patient|0|||
126353357|NCT03188185|454584431|FG003|Stage 1|Identified as a professional patient|0|||
126353358|NCT03188185|454584428|FG000|Stage 2|Adverse Event|0|||
126353359|NCT03188185|454584429|FG001|Stage 2|Adverse Event|0|||
126353360|NCT03188185|454584430|FG002|Stage 2|Adverse Event|2|||
126353361|NCT03188185|454584431|FG003|Stage 2|Adverse Event|4|||
126353362|NCT03188185|454584428|FG000|Stage 2|Lack of Efficacy|0|||
126022556|NCT00296036|453377142|FG005|Overall Study|Protocol Violation|3|||
126022557|NCT03403413|453377143|FG000|Overall Study|Lack of Efficacy|2|||
126353363|NCT03188185|454584429|FG001|Stage 2|Lack of Efficacy|0|||
126353364|NCT03188185|454584430|FG002|Stage 2|Lack of Efficacy|3|||
126022558|NCT03655262|453377144|FG000|Overall Study|Withdrawal by Subject|0|||
126022559|NCT03655262|453377145|FG001|Overall Study|Withdrawal by Subject|0|||
126022560|NCT03655262|453377146|FG002|Overall Study|Withdrawal by Subject|1|||
126022561|NCT04583423|453377149|FG000|Overall Study|Lost to Follow-up|0|||
126022562|NCT04583423|453377150|FG001|Overall Study|Lost to Follow-up|1|||
126022563|NCT04583423|453377151|FG002|Overall Study|Lost to Follow-up|0|||
126022564|NCT04583423|453377152|FG003|Overall Study|Lost to Follow-up|2|||
126353365|NCT03188185|454584431|FG003|Stage 2|Lack of Efficacy|0|||
126353366|NCT03188185|454584428|FG000|Stage 2|Lost to Follow-up|0|||
126353367|NCT03188185|454584429|FG001|Stage 2|Lost to Follow-up|0|||
126353368|NCT03188185|454584430|FG002|Stage 2|Lost to Follow-up|1|||
126353369|NCT03188185|454584431|FG003|Stage 2|Lost to Follow-up|0|||
126353370|NCT03188185|454584428|FG000|Stage 2|Physician Decision|0|||
126353371|NCT03188185|454584429|FG001|Stage 2|Physician Decision|0|||
126353372|NCT03188185|454584430|FG002|Stage 2|Physician Decision|0|||
126353373|NCT03188185|454584431|FG003|Stage 2|Physician Decision|1|||
126353374|NCT03188185|454584428|FG000|Stage 2|Withdrawal by Subject|0|||
126353375|NCT03188185|454584429|FG001|Stage 2|Withdrawal by Subject|0|||
126353376|NCT03188185|454584430|FG002|Stage 2|Withdrawal by Subject|3|||
126353377|NCT03188185|454584431|FG003|Stage 2|Withdrawal by Subject|1|||
126353378|NCT02503865|454584434|FG000|Overall Study|Moved out of area|1|||
126353379|NCT02503865|454584435|FG001|Overall Study|Moved out of area|8|||
126353380|NCT02503865|454584436|FG002|Overall Study|Moved out of area|0|||
126353381|NCT02503865|454584434|FG000|Overall Study|Refused treatment|4|||
126353382|NCT02503865|454584435|FG001|Overall Study|Refused treatment|39|||
126353383|NCT02503865|454584436|FG002|Overall Study|Refused treatment|2|||
126353384|NCT01132755|454584439|FG000|Overall Study|Procedure not done due to medical reason|23|||
126353385|NCT01132755|454584439|FG000|Overall Study|Protocol Violation|15|||
126353386|NCT01132755|454584439|FG000|Overall Study|Withdrawal by Subject|4|||
126353387|NCT02232698|454584440|FG000|Overall Study|Pregnancy|1|||
126353388|NCT02232698|454584441|FG001|Overall Study|Pregnancy|1|||
126353389|NCT02232698|454584440|FG000|Overall Study|Met exclusion criteria|1|||
126353390|NCT02232698|454584441|FG001|Overall Study|Met exclusion criteria|1|||
126353391|NCT02232698|454584440|FG000|Overall Study|Had device-associated symptoms|7|||
126353392|NCT02232698|454584441|FG001|Overall Study|Had device-associated symptoms|0|||
126353393|NCT02232698|454584440|FG000|Overall Study|Non-compliance with study device|1|||
126353394|NCT02232698|454584441|FG001|Overall Study|Non-compliance with study device|4|||
126353395|NCT02232698|454584440|FG000|Overall Study|Allocated to control group|0|||
126353396|NCT02232698|454584441|FG001|Overall Study|Allocated to control group|3|||
126353397|NCT02232698|454584440|FG000|Overall Study|Withdrawal by Subject|0|||
126353398|NCT02232698|454584441|FG001|Overall Study|Withdrawal by Subject|11|||
126353399|NCT02393755|454584442|FG000|Overall Study|Withdrawal by Subject|0|||
126353400|NCT02393755|454584443|FG001|Overall Study|Withdrawal by Subject|3|||
126353401|NCT02393755|454584442|FG000|Overall Study|Adverse Event|0|||
126353402|NCT02393755|454584443|FG001|Overall Study|Adverse Event|2|||
126353403|NCT02393755|454584442|FG000|Overall Study|Physician Decision|0|||
126353404|NCT02393755|454584443|FG001|Overall Study|Physician Decision|2|||
126353405|NCT01786109|454584444|FG000|Overall Study|fail manometry barostat tube placement|1|||
126353406|NCT01786109|454584445|FG001|Overall Study|fail manometry barostat tube placement|0|||
126353407|NCT01786109|454584446|FG002|Overall Study|fail manometry barostat tube placement|0|||
126353408|NCT01786109|454584444|FG000|Overall Study|unrelated illness|0|||
126353409|NCT01786109|454584445|FG001|Overall Study|unrelated illness|0|||
126353410|NCT01786109|454584446|FG002|Overall Study|unrelated illness|1|||
126353411|NCT01786109|454584444|FG000|Overall Study|adverse effects colon preparation|0|||
126353412|NCT01786109|454584445|FG001|Overall Study|adverse effects colon preparation|0|||
126353413|NCT01786109|454584446|FG002|Overall Study|adverse effects colon preparation|1|||
126353414|NCT04069520|454584456|FG000|Overall Study|Lost to Follow-up|0|||
126353415|NCT04069520|454584457|FG001|Overall Study|Lost to Follow-up|2|||
126353416|NCT04069520|454584456|FG000|Overall Study|Withdrawal by Subject|0|||
126353417|NCT04069520|454584457|FG001|Overall Study|Withdrawal by Subject|1|||
126353418|NCT04069520|454584456|FG000|Overall Study|Prior Injury|1|||
126353419|NCT04069520|454584457|FG001|Overall Study|Prior Injury|0|||
126353420|NCT04069520|454584456|FG000|Overall Study|Orthodontia|1|||
126353421|NCT04069520|454584457|FG001|Overall Study|Orthodontia|0|||
126353422|NCT04069520|454584456|FG000|Overall Study|Cut from team|0|||
126353423|NCT04069520|454584457|FG001|Overall Study|Cut from team|2|||
126353424|NCT01068912|454584458|FG000|Overall Study|Adverse Event|2|||
126353425|NCT01068912|454584459|FG001|Overall Study|Adverse Event|3|||
126353426|NCT01068912|454584460|FG002|Overall Study|Adverse Event|2|||
126353427|NCT01068912|454584458|FG000|Overall Study|Withdrawal by Subject|5|||
126353428|NCT01068912|454584459|FG001|Overall Study|Withdrawal by Subject|6|||
126353429|NCT01068912|454584460|FG002|Overall Study|Withdrawal by Subject|6|||
126353430|NCT01068912|454584458|FG000|Overall Study|Lost to Follow-up|3|||
126353431|NCT01068912|454584459|FG001|Overall Study|Lost to Follow-up|7|||
126353432|NCT01068912|454584460|FG002|Overall Study|Lost to Follow-up|3|||
126022565|NCT04583423|453377149|FG000|Overall Study|Study Terminated by Sponsor|32|||
126353433|NCT01068912|454584458|FG000|Overall Study|Protocol Violation|0|||
126353434|NCT01068912|454584459|FG001|Overall Study|Protocol Violation|2|||
126022566|NCT04583423|453377150|FG001|Overall Study|Study Terminated by Sponsor|35|||
126022567|NCT04583423|453377151|FG002|Overall Study|Study Terminated by Sponsor|36|||
126231322|NCT00520741|454138264|FG000|Overall Study|Lost to Follow-up|4|||
126231323|NCT00520741|454138265|FG001|Overall Study|Lost to Follow-up|4|||
126231324|NCT00520741|454138264|FG000|Overall Study|Other reasons for premature termination|0|||
126231325|NCT00520741|454138265|FG001|Overall Study|Other reasons for premature termination|6|||
126231326|NCT02750761|454138266|FG000|Overall Study|Lost to Follow-up|0|||
126231327|NCT02750761|454138267|FG001|Overall Study|Lost to Follow-up|0|||
126231328|NCT02750761|454138268|FG002|Overall Study|Lost to Follow-up|1|||
126231329|NCT02750761|454138269|FG003|Overall Study|Lost to Follow-up|0|||
126231330|NCT02750761|454138270|FG004|Overall Study|Lost to Follow-up|0|||
126231331|NCT02750761|454138271|FG005|Overall Study|Lost to Follow-up|0|||
126231332|NCT02354586|454138274|FG000|Overall Study|Death|230|||
126231333|NCT02354586|454138274|FG000|Overall Study|Withdrawal by Subject|59|||
126231334|NCT02354586|454138274|FG000|Overall Study|Lost to Follow-up|11|||
126231335|NCT02354586|454138274|FG000|Overall Study|Sponsor decision|51|||
126231336|NCT02354586|454138274|FG000|Overall Study|Site closure|2|||
126231337|NCT02354586|454138274|FG000|Overall Study|Intercurrent illness|1|||
126231338|NCT02354586|454138274|FG000|Overall Study|Protocol Violation|3|||
126231339|NCT02354586|454138274|FG000|Overall Study|Physician Decision|13|||
126231340|NCT02354586|454138274|FG000|Overall Study|Lack of Efficacy|86|||
126231341|NCT02354586|454138274|FG000|Overall Study|Adverse Event|7|||
126231342|NCT00634907|454138275|FG000|Overall Study|Withdrawal by Subject|3|||
126231343|NCT00634907|454138276|FG001|Overall Study|Withdrawal by Subject|0|||
126231344|NCT00634907|454138275|FG000|Overall Study|Physician Decision|3|||
126231345|NCT00634907|454138276|FG001|Overall Study|Physician Decision|9|||
126231346|NCT00634907|454138275|FG000|Overall Study|Withdrawal by Subject|11|||
126231347|NCT00634907|454138276|FG001|Overall Study|Withdrawal by Subject|8|||
126231348|NCT02720510|454138277|FG000|Overall Study|Study Terminated by the sponsor|2|||
126231349|NCT02720510|454138278|FG001|Overall Study|Study Terminated by the sponsor|0|||
126231350|NCT02720510|454138277|FG000|Overall Study|Adverse Event|0|||
126231351|NCT02720510|454138278|FG001|Overall Study|Adverse Event|1|||
126231352|NCT02720510|454138277|FG000|Overall Study|Physician Decision|1|||
126231353|NCT02720510|454138278|FG001|Overall Study|Physician Decision|2|||
126231354|NCT02985151|454138282|FG000|Original Randomization|Withdrawal by Subject|0|||
126231355|NCT02985151|454138283|FG001|Original Randomization|Withdrawal by Subject|1|||
126231356|NCT00625807|454138286|FG000|Overall Study|schedule conflict|2|||
126231357|NCT00625807|454138287|FG001|Overall Study|schedule conflict|8|||
126231358|NCT00108732|454138289|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
126231359|NCT00108732|454138289|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
126231360|NCT00108732|454138289|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
126231361|NCT00108732|454138289|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
126231362|NCT00108732|454138289|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
126231363|NCT00108732|454138289|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
126231364|NCT00108732|454138289|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
126231365|NCT02116803|454138290|FG000|Overall Study|Adverse Event|2|||
126231366|NCT02116803|454138291|FG001|Overall Study|Adverse Event|1|||
126231367|NCT02116803|454138290|FG000|Overall Study|Physician Decision|1|||
126231368|NCT02116803|454138291|FG001|Overall Study|Physician Decision|0|||
126231369|NCT02116803|454138290|FG000|Overall Study|Progressive disease|4|||
126231370|NCT02116803|454138291|FG001|Overall Study|Progressive disease|0|||
126231371|NCT02116803|454138290|FG000|Overall Study|Study terminated by sponsor|2|||
126353435|NCT01068912|454584460|FG002|Overall Study|Protocol Violation|0|||
126353436|NCT01068912|454584458|FG000|Overall Study|aggravation influenza|1|||
126353437|NCT01068912|454584459|FG001|Overall Study|aggravation influenza|1|||
126353438|NCT01068912|454584460|FG002|Overall Study|aggravation influenza|1|||
126353439|NCT01068912|454584458|FG000|Overall Study|other underlying illness|0|||
126353440|NCT01068912|454584459|FG001|Overall Study|other underlying illness|3|||
126353441|NCT01068912|454584460|FG002|Overall Study|other underlying illness|3|||
126353442|NCT04822194|454584461|FG000|Overall Study|Withdrawal by Subject|5|||
126353443|NCT04822194|454584462|FG001|Overall Study|Withdrawal by Subject|4|||
126353444|NCT04822194|454584461|FG000|Overall Study|Technical issues with MR scanner|1|||
126353445|NCT04822194|454584462|FG001|Overall Study|Technical issues with MR scanner|0|||
126353446|NCT04822194|454584461|FG000|Overall Study|Lost to Follow-up|5|||
126353447|NCT04822194|454584462|FG001|Overall Study|Lost to Follow-up|7|||
126353448|NCT01947933|454584464|FG000|Overall Study|Withdrawal by Subject|0|||
126353449|NCT01947933|454584465|FG001|Overall Study|Withdrawal by Subject|0|||
126353450|NCT01947933|454584466|FG002|Overall Study|Withdrawal by Subject|1|||
126353451|NCT01947933|454584467|FG003|Overall Study|Withdrawal by Subject|0|||
126353452|NCT01947933|454584468|FG004|Overall Study|Withdrawal by Subject|0|||
126353453|NCT01947933|454584469|FG005|Overall Study|Withdrawal by Subject|0|||
126353454|NCT01947933|454584470|FG006|Overall Study|Withdrawal by Subject|0|||
126353455|NCT01947933|454584471|FG007|Overall Study|Withdrawal by Subject|0|||
126353456|NCT01947933|454584472|FG008|Overall Study|Withdrawal by Subject|0|||
126353457|NCT01947933|454584464|FG000|Overall Study|Lost to Follow-up|0|||
126353458|NCT01947933|454584465|FG001|Overall Study|Lost to Follow-up|0|||
126231372|NCT02116803|454138291|FG001|Overall Study|Study terminated by sponsor|1|||
126231373|NCT02116803|454138290|FG000|Overall Study|Death|1|||
126231374|NCT02116803|454138291|FG001|Overall Study|Death|0|||
126231375|NCT01974895|454138294|FG000|Overall Study|Protocol Violation|1|||
126231376|NCT01974895|454138295|FG001|Overall Study|Protocol Violation|0|||
126231377|NCT01974895|454138294|FG000|Overall Study|Lost to Follow-up|4|||
126231378|NCT01974895|454138295|FG001|Overall Study|Lost to Follow-up|6|||
126231379|NCT01974895|454138294|FG000|Overall Study|Withdrawal by Subject|0|||
126231380|NCT01974895|454138295|FG001|Overall Study|Withdrawal by Subject|1|||
126231381|NCT01974895|454138294|FG000|Overall Study|Other (Missed Visit)|1|||
126231382|NCT01974895|454138295|FG001|Overall Study|Other (Missed Visit)|0|||
126231383|NCT01974895|454138294|FG000|Overall Study|Other (Reason unknown)|9|||
126231384|NCT01974895|454138295|FG001|Overall Study|Other (Reason unknown)|8|||
126231385|NCT01984242|454138296|FG000|Overall Study|Death|52|||
126231386|NCT01984242|454138297|FG001|Overall Study|Death|50|||
126231387|NCT01984242|454138298|FG002|Overall Study|Death|52|||
126231388|NCT01984242|454138296|FG000|Overall Study|Withdrawal by Subject|5|||
126231389|NCT01984242|454138297|FG001|Overall Study|Withdrawal by Subject|3|||
126231390|NCT01984242|454138298|FG002|Overall Study|Withdrawal by Subject|10|||
126231391|NCT01984242|454138296|FG000|Overall Study|Physician Decision|0|||
126231392|NCT01984242|454138297|FG001|Overall Study|Physician Decision|0|||
126231393|NCT01984242|454138298|FG002|Overall Study|Physician Decision|1|||
126231394|NCT01984242|454138296|FG000|Overall Study|Lost to Follow-up|4|||
126231395|NCT01984242|454138297|FG001|Overall Study|Lost to Follow-up|0|||
126231396|NCT01984242|454138298|FG002|Overall Study|Lost to Follow-up|3|||
126231397|NCT01984242|454138296|FG000|Overall Study|Sponsor Decision|1|||
126231398|NCT01984242|454138297|FG001|Overall Study|Sponsor Decision|0|||
126231399|NCT01984242|454138298|FG002|Overall Study|Sponsor Decision|0|||
126231400|NCT01984242|454138296|FG000|Overall Study|Non-Compliance|1|||
126231401|NCT01984242|454138297|FG001|Overall Study|Non-Compliance|0|||
126231402|NCT01984242|454138298|FG002|Overall Study|Non-Compliance|0|||
126231403|NCT01984242|454138296|FG000|Overall Study|Study terminated by Sponsor|38|||
126231404|NCT01984242|454138297|FG001|Overall Study|Study terminated by Sponsor|50|||
126231405|NCT01984242|454138298|FG002|Overall Study|Study terminated by Sponsor|34|||
126231406|NCT01984242|454138296|FG000|Overall Study|Disease Progression|0|||
126231407|NCT01984242|454138297|FG001|Overall Study|Disease Progression|0|||
126231408|NCT01984242|454138298|FG002|Overall Study|Disease Progression|1|||
126231409|NCT04543136|454138301|FG000|Overall Study|Withdrawal by Subject|0|||
126231410|NCT04543136|454138302|FG001|Overall Study|Withdrawal by Subject|1|||
126231411|NCT04543136|454138303|FG002|Overall Study|Withdrawal by Subject|0|||
126231412|NCT04543136|454138304|FG003|Overall Study|Withdrawal by Subject|1|||
126231413|NCT04543136|454138305|FG004|Overall Study|Withdrawal by Subject|0|||
126231414|NCT04543136|454138306|FG005|Overall Study|Withdrawal by Subject|0|||
126231415|NCT00865709|454138307|FG000|Treatment|Adverse Event|9|||
126231416|NCT00865709|454138308|FG001|Treatment|Adverse Event|6|||
126231417|NCT00865709|454138307|FG000|Treatment|Withdrawal by Subject|10|||
126231418|NCT00865709|454138308|FG001|Treatment|Withdrawal by Subject|7|||
126231419|NCT00865709|454138307|FG000|Treatment|Physician Decision|3|||
126231420|NCT00865709|454138308|FG001|Treatment|Physician Decision|2|||
126231421|NCT00865709|454138307|FG000|Treatment|Surgery|8|||
126231422|NCT00865709|454138308|FG001|Treatment|Surgery|3|||
126231423|NCT00429923|454138309|FG000|Overall Study|Adverse Event|0|||
126231424|NCT00429923|454138310|FG001|Overall Study|Adverse Event|2|||
126231425|NCT00429923|454138311|FG002|Overall Study|Adverse Event|3|||
126231426|NCT00429923|454138309|FG000|Overall Study|Lack of Efficacy|4|||
126231427|NCT00429923|454138310|FG001|Overall Study|Lack of Efficacy|1|||
126231428|NCT00429923|454138311|FG002|Overall Study|Lack of Efficacy|33|||
126231429|NCT00429923|454138309|FG000|Overall Study|Lost to Follow-up|0|||
126231430|NCT00429923|454138310|FG001|Overall Study|Lost to Follow-up|0|||
126231431|NCT00429923|454138311|FG002|Overall Study|Lost to Follow-up|2|||
126231432|NCT00429923|454138309|FG000|Overall Study|Withdrew Consent|1|||
126231433|NCT00429923|454138310|FG001|Overall Study|Withdrew Consent|0|||
126231434|NCT00429923|454138311|FG002|Overall Study|Withdrew Consent|1|||
126231435|NCT00429923|454138309|FG000|Overall Study|Early Termination|0|||
126231436|NCT00429923|454138310|FG001|Overall Study|Early Termination|1|||
126231437|NCT00429923|454138311|FG002|Overall Study|Early Termination|0|||
126231438|NCT00662129|454138318|FG000|Overall Study|Protocol Violation|1|||
126231439|NCT00662129|454138318|FG000|Overall Study|Cancel prior to beginning treatment|1|||
126231440|NCT00662129|454138318|FG000|Overall Study|Ineligible|1|||
126231441|NCT02153736|454138319|FG000|Overall Study|Lost to Follow-up|1|||
126231442|NCT02153736|454138320|FG001|Overall Study|Lost to Follow-up|0|||
126231443|NCT02153736|454138319|FG000|Overall Study|Medical status change made ineligible|1|||
126231444|NCT02153736|454138320|FG001|Overall Study|Medical status change made ineligible|0|||
126231445|NCT02153736|454138319|FG000|Overall Study|Death|0|||
126231446|NCT02153736|454138320|FG001|Overall Study|Death|1|||
126231447|NCT02153736|454138319|FG000|Overall Study|Withdrawal by Subject|0|||
126231448|NCT02153736|454138320|FG001|Overall Study|Withdrawal by Subject|1|||
126231449|NCT00720122|454138333|FG000|Overall Study|Lost to Follow-up|1|||
126231450|NCT00720122|454138333|FG000|Overall Study|Physician Decision|1|||
126231451|NCT00720122|454138333|FG000|Overall Study|Withdrawal by Subject|7|||
126022568|NCT04583423|453377152|FG003|Overall Study|Study Terminated by Sponsor|33|||
126022569|NCT04583423|453377149|FG000|Overall Study|Withdrawal by Subject|3|||
126022570|NCT04583423|453377150|FG001|Overall Study|Withdrawal by Subject|1|||
126022571|NCT04583423|453377151|FG002|Overall Study|Withdrawal by Subject|2|||
126022572|NCT04583423|453377152|FG003|Overall Study|Withdrawal by Subject|1|||
126022573|NCT00603954|453377155|FG000|Overall Study|Protocol Violation|1|||
126022574|NCT00603954|453377156|FG001|Overall Study|Protocol Violation|2|||
126022575|NCT00580866|453377158|FG000|Overall Study|Lost to Follow-up|2|||
126022576|NCT00580866|453377159|FG001|Overall Study|Lost to Follow-up|2|||
126022577|NCT02477605|453377160|FG000|Overall Study|Discontinued prior to treatment|1|||
126022578|NCT02477605|453377161|FG001|Overall Study|Discontinued prior to treatment|0|||
126022579|NCT02477605|453377160|FG000|Overall Study|Lost to Follow-up|0|||
126022580|NCT02477605|453377161|FG001|Overall Study|Lost to Follow-up|2|||
126022581|NCT02477605|453377160|FG000|Overall Study|Withdrawal by Subject|0|||
126022582|NCT02477605|453377161|FG001|Overall Study|Withdrawal by Subject|1|||
126022583|NCT02477605|453377160|FG000|Overall Study|Administered gas during surgery|0|||
126022584|NCT02477605|453377161|FG001|Overall Study|Administered gas during surgery|1|||
126022585|NCT00567489|453377162|FG000|Overall Study|Adverse Event|6|||
126022586|NCT00567489|453377163|FG001|Overall Study|Adverse Event|14|||
126231452|NCT02579096|454138334|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
126022587|NCT00567489|453377162|FG000|Overall Study|Physician Decision|0|||
126022588|NCT00567489|453377163|FG001|Overall Study|Physician Decision|4|||
126022589|NCT00567489|453377162|FG000|Overall Study|Withdrawal by Subject|0|||
126022590|NCT00567489|453377163|FG001|Overall Study|Withdrawal by Subject|2|||
126022591|NCT00567489|453377162|FG000|Overall Study|Renal Transplantation|0|||
126022592|NCT00567489|453377163|FG001|Overall Study|Renal Transplantation|3|||
126022593|NCT00567489|453377162|FG000|Overall Study|Other|1|||
126022594|NCT00567489|453377163|FG001|Overall Study|Other|0|||
126022595|NCT03101930|453377173|FG000|Overall Study|Withdrawal by Subject|2|||
126022596|NCT03101930|453377174|FG001|Overall Study|Withdrawal by Subject|1|||
126022597|NCT03101930|453377175|FG002|Overall Study|Withdrawal by Subject|2|||
126022598|NCT01083316|453377176|FG000|Overall Study|Adverse Event|2|||
126022599|NCT01083316|453377176|FG000|Overall Study|Withdrawal by Subject|1|||
126022600|NCT02372253|453377182|FG000|Overall Study|Non Compliance|2|||
126022601|NCT02372253|453377183|FG001|Overall Study|Non Compliance|0|||
126022602|NCT00393484|453377184|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
126022603|NCT00393484|453377185|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
126022604|NCT00393484|453377184|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
126022605|NCT00393484|453377185|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
126022606|NCT00393484|453377184|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
126022607|NCT00393484|453377185|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
126022608|NCT00393484|453377184|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
126022609|NCT00393484|453377185|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
126022610|NCT00393484|453377184|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
126022611|NCT00393484|453377185|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
126231453|NCT02579096|454138335|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
126231454|NCT02579096|454138334|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
126231455|NCT02579096|454138335|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
126231456|NCT02579096|454138334|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
126231457|NCT02579096|454138335|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
126231458|NCT02579096|454138334|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
126231459|NCT02579096|454138335|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
126231460|NCT02579096|454138334|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
126231461|NCT02579096|454138335|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
126231462|NCT02579096|454138334|FG000|Phase 2, Weeks 25 - 48|Death|2|||
126231463|NCT02579096|454138335|FG001|Phase 2, Weeks 25 - 48|Death|4|||
126231464|NCT02579096|454138334|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
126231465|NCT02579096|454138335|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
126231466|NCT02579096|454138334|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
126231467|NCT02579096|454138335|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
126231468|NCT02579096|454138334|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
126231469|NCT02579096|454138335|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
126231470|NCT02579096|454138334|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
126231471|NCT02579096|454138335|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
126231472|NCT02579096|454138334|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
126022612|NCT00393484|453377184|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
126022613|NCT00393484|453377185|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
126022614|NCT00393484|453377184|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
126022615|NCT00393484|453377185|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
126231473|NCT02579096|454138335|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
126231474|NCT02579096|454138334|FG000|Phase 3, Weeks 49 - 72|Death|3|||
126231475|NCT02579096|454138335|FG001|Phase 3, Weeks 49 - 72|Death|2|||
126231476|NCT02579096|454138334|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
126231477|NCT02579096|454138335|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
126231478|NCT02579096|454138334|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
126231479|NCT02579096|454138335|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
126231480|NCT02579096|454138334|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
126231481|NCT02579096|454138335|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
126231482|NCT02579096|454138334|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
126231483|NCT02579096|454138335|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
126231484|NCT02579096|454138334|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
126231485|NCT02579096|454138335|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
126231486|NCT02579096|454138334|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
126231487|NCT02579096|454138335|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
126231488|NCT01361126|454138336|FG000|Overall Study|Sponsor decision|0|||
126231489|NCT01361126|454138337|FG001|Overall Study|Sponsor decision|2|||
126231490|NCT00663871|454138339|FG000|Overall Study|Lost to Follow-up|5|||
126231491|NCT00663871|454138340|FG001|Overall Study|Lost to Follow-up|5|||
126231492|NCT00663871|454138339|FG000|Overall Study|Withdrawal by Subject|5|||
126231493|NCT00663871|454138340|FG001|Overall Study|Withdrawal by Subject|2|||
126231494|NCT04094870|454138341|FG000|Overall Study|Lost to Follow-up|1|||
126231495|NCT04094870|454138342|FG001|Overall Study|Lost to Follow-up|1|||
126231496|NCT03384745|454138343|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
126231497|NCT03384745|454138344|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
126231498|NCT03384745|454138345|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
126231499|NCT03384745|454138346|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
126231500|NCT03384745|454138347|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
126231501|NCT03384745|454138348|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
126231502|NCT03384745|454138343|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
126231503|NCT03384745|454138344|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
126231504|NCT03384745|454138345|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
126231505|NCT03384745|454138346|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
126231506|NCT03384745|454138347|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
126231507|NCT03384745|454138348|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
126231508|NCT03384745|454138343|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
126231509|NCT03384745|454138344|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
126231510|NCT03384745|454138345|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
126231511|NCT03384745|454138346|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
126231512|NCT03384745|454138347|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
126231513|NCT03384745|454138348|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
126231514|NCT03384745|454138343|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126231515|NCT03384745|454138344|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126231516|NCT03384745|454138345|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
126231517|NCT03384745|454138346|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126231518|NCT03384745|454138347|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126231519|NCT03384745|454138348|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126231520|NCT03384745|454138343|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
126231521|NCT03384745|454138344|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
126231522|NCT03384745|454138345|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
126231523|NCT03384745|454138346|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
126231524|NCT03384745|454138347|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
126231525|NCT03384745|454138348|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
126231526|NCT03384745|454138343|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126231527|NCT03384745|454138344|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126231528|NCT03384745|454138345|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126231529|NCT03384745|454138346|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126231530|NCT03384745|454138347|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
126231531|NCT03384745|454138348|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126231532|NCT03384745|454138343|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
126231533|NCT03384745|454138344|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
126231534|NCT03384745|454138345|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
126231535|NCT03384745|454138346|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
126231536|NCT03384745|454138347|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
126231537|NCT03384745|454138348|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
126231538|NCT03384745|454138343|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
126231539|NCT03384745|454138344|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
126231540|NCT03384745|454138345|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
126231541|NCT03384745|454138346|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
126231542|NCT03384745|454138347|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
126231543|NCT03384745|454138348|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
126231544|NCT03384745|454138343|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
126231545|NCT03384745|454138344|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
126231546|NCT03384745|454138345|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
126231547|NCT03384745|454138346|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
126231548|NCT03384745|454138347|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
126231549|NCT03384745|454138348|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
126231550|NCT03384745|454138343|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126231551|NCT03384745|454138344|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126231552|NCT03384745|454138345|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126231553|NCT03384745|454138346|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
126231554|NCT03384745|454138347|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126231555|NCT03384745|454138348|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126231556|NCT03384745|454138343|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
126231557|NCT03384745|454138344|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
126231558|NCT03384745|454138345|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
126231559|NCT03384745|454138346|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
126231560|NCT03384745|454138347|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
126231561|NCT03384745|454138348|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
126231562|NCT02984683|454138349|FG000|Overall Study|Adverse Event|3|||
126231563|NCT02984683|454138350|FG001|Overall Study|Adverse Event|3|||
126231564|NCT02984683|454138349|FG000|Overall Study|Withdrawal by Subject|1|||
126231565|NCT02984683|454138350|FG001|Overall Study|Withdrawal by Subject|0|||
126231566|NCT02984683|454138349|FG000|Overall Study|Disease progression|7|||
126231567|NCT02984683|454138350|FG001|Overall Study|Disease progression|9|||
126231568|NCT02742181|454138351|FG000|Overall Study|Physician Decision|1|||
126231569|NCT02742181|454138352|FG001|Overall Study|Physician Decision|0|||
126231570|NCT02739984|454138353|FG000|Overall Study|Sponsor Decision|1|||
126231571|NCT02739984|454138354|FG001|Overall Study|Sponsor Decision|0|||
126231572|NCT02739984|454138353|FG000|Overall Study|Withdrawal by Subject|1|||
126231573|NCT02739984|454138354|FG001|Overall Study|Withdrawal by Subject|1|||
126231574|NCT02739984|454138353|FG000|Overall Study|Death|0|||
126231575|NCT02739984|454138354|FG001|Overall Study|Death|1|||
126231576|NCT02739984|454138353|FG000|Overall Study|Lost to Follow-up|3|||
126231577|NCT02739984|454138354|FG001|Overall Study|Lost to Follow-up|0|||
126231578|NCT05200858|454138360|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
126231579|NCT05200858|454138361|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
126231580|NCT05200858|454138362|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
126231581|NCT05200858|454138363|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
126231582|NCT00313703|454140370|FG000|Overall Study|Lost to Follow-up|11|||
126231583|NCT00313703|454140371|FG001|Overall Study|Lost to Follow-up|2|||
126231584|NCT00313703|454140372|FG002|Overall Study|Lost to Follow-up|5|||
126231585|NCT00313703|454140373|FG003|Overall Study|Lost to Follow-up|12|||
126231586|NCT01691508|454140377|FG000|Overall Study|Adverse Event|3|||
126231587|NCT01691508|454140378|FG001|Overall Study|Adverse Event|3|||
126231588|NCT01691508|454140377|FG000|Overall Study|Withdrawal by Subject|1|||
126231589|NCT01691508|454140378|FG001|Overall Study|Withdrawal by Subject|0|||
126231590|NCT02309099|454140384|FG000|Overall Study|Adverse Event|2|||
126231591|NCT02309099|454140385|FG001|Overall Study|Adverse Event|0|||
126231592|NCT00527423|454140398|FG000|Overall Study|Protocol Violation|1|||
126231593|NCT00527423|454140398|FG000|Overall Study|Adverse Event|5|||
126231594|NCT00527423|454140398|FG000|Overall Study|Physician Decision|4|||
126231595|NCT00527423|454140398|FG000|Overall Study|Withdrawal by Subject|10|||
126231596|NCT00527423|454140398|FG000|Overall Study|Lost to Follow-up|4|||
126231597|NCT00527423|454140398|FG000|Overall Study|OTHER|4|||
126231598|NCT00527423|454140398|FG000|Overall Study|Death|9|||
126231599|NCT01957488|454140399|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
126231600|NCT01957488|454140400|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
126231601|NCT01957488|454140401|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
126231602|NCT01957488|454140402|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
126353459|NCT01947933|454584466|FG002|Overall Study|Lost to Follow-up|0|||
126353460|NCT01947933|454584467|FG003|Overall Study|Lost to Follow-up|0|||
126353461|NCT01947933|454584468|FG004|Overall Study|Lost to Follow-up|0|||
126353462|NCT01947933|454584469|FG005|Overall Study|Lost to Follow-up|0|||
126231603|NCT01957488|454140403|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
126231604|NCT01957488|454140404|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
126231605|NCT01957488|454140399|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
126231606|NCT01957488|454140400|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
126231607|NCT01957488|454140401|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
126231608|NCT01957488|454140402|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
126231609|NCT01957488|454140403|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
126231610|NCT01957488|454140404|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
126231611|NCT01957488|454140399|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
126231612|NCT01957488|454140400|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
126231613|NCT01957488|454140401|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
126022616|NCT00393484|453377184|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
126022617|NCT00393484|453377185|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
126022618|NCT00393484|453377184|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
126022619|NCT00393484|453377185|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
126022620|NCT00393484|453377184|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
126022621|NCT00393484|453377185|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
126022622|NCT03201562|453377188|FG000|Overall Study|Physician Decision|0|||
126022623|NCT03201562|453377189|FG001|Overall Study|Physician Decision|0|||
126022624|NCT03201562|453377190|FG002|Overall Study|Physician Decision|1|||
126022625|NCT03201562|453377188|FG000|Overall Study|Adverse Event|0|||
126022626|NCT03201562|453377189|FG001|Overall Study|Adverse Event|0|||
126022627|NCT03201562|453377190|FG002|Overall Study|Adverse Event|1|||
126022628|NCT03201562|453377188|FG000|Overall Study|Lost to Follow-up|0|||
126022629|NCT03201562|453377189|FG001|Overall Study|Lost to Follow-up|1|||
126022630|NCT03201562|453377190|FG002|Overall Study|Lost to Follow-up|2|||
126022631|NCT00065260|453377191|FG000|Overall Study|Death|0|||
126022632|NCT00065260|453377192|FG001|Overall Study|Death|1|||
126022633|NCT00001277|453377193|FG000|Overall Study|Adverse Event|0|||
126022634|NCT00001277|453377194|FG001|Overall Study|Adverse Event|0|||
126022635|NCT00001277|453377195|FG002|Overall Study|Adverse Event|1|||
126231614|NCT01957488|454140402|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
126231615|NCT01957488|454140403|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
126231616|NCT01957488|454140404|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
126231617|NCT01957488|454140399|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126231618|NCT01957488|454140400|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126231619|NCT01957488|454140401|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126231620|NCT01957488|454140402|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
126231621|NCT01957488|454140403|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
126231622|NCT01957488|454140404|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
126231623|NCT01957488|454140399|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126231624|NCT01957488|454140400|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126231625|NCT01957488|454140401|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126231626|NCT01957488|454140402|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126231627|NCT01957488|454140403|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
126231628|NCT01957488|454140404|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126231629|NCT01957488|454140399|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
126231630|NCT01957488|454140400|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
126231631|NCT01957488|454140401|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
126231632|NCT01957488|454140402|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
126231633|NCT01957488|454140403|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
126231634|NCT01957488|454140404|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
126231635|NCT01957488|454140399|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
126231636|NCT01957488|454140400|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
126231637|NCT01957488|454140401|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
126231638|NCT01957488|454140402|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
126022636|NCT00001277|453377193|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
126022637|NCT00001277|453377194|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
126022638|NCT00001277|453377195|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
126022639|NCT02178098|453377199|FG000|Overall Study|Withdrawal by Subject|0|||
126022640|NCT02178098|453377200|FG001|Overall Study|Withdrawal by Subject|6|||
126093124|NCT04155047|453634521|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
126093125|NCT03361605|453634528|FG000|Overall Study|Analyzable data not available|3|||
126093126|NCT02770612|453634529|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
126093127|NCT00958841|453634532|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126103467|NCT04620811|453672168|FG001|Overall Study|Physician Decision|4|||
126231639|NCT01957488|454140403|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
126231640|NCT01957488|454140404|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
126231641|NCT01957488|454140399|FG000|Test Period 2 (2 Weeks)|Other|1|||
126231642|NCT01957488|454140400|FG001|Test Period 2 (2 Weeks)|Other|0|||
126231643|NCT01957488|454140401|FG002|Test Period 2 (2 Weeks)|Other|0|||
126353463|NCT01947933|454584470|FG006|Overall Study|Lost to Follow-up|0|||
126353464|NCT01947933|454584471|FG007|Overall Study|Lost to Follow-up|0|||
126353465|NCT01947933|454584472|FG008|Overall Study|Lost to Follow-up|1|||
126353466|NCT00294398|454584475|FG000|Overall Study|Lost to Follow-up|21|||
126353467|NCT00294398|454584476|FG001|Overall Study|Lost to Follow-up|26|||
126353468|NCT02965833|454584477|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
126353469|NCT02965833|454584478|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
126353470|NCT02965833|454584477|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
126353471|NCT02965833|454584478|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
126022641|NCT02178098|453377199|FG000|Overall Study|Adverse Event|1|||
126022642|NCT02178098|453377200|FG001|Overall Study|Adverse Event|2|||
126231644|NCT01957488|454140402|FG003|Test Period 2 (2 Weeks)|Other|0|||
126231645|NCT01957488|454140403|FG004|Test Period 2 (2 Weeks)|Other|0|||
126231646|NCT01957488|454140404|FG005|Test Period 2 (2 Weeks)|Other|0|||
126231647|NCT01957488|454140399|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126231648|NCT01957488|454140400|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
126231649|NCT01957488|454140401|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126231650|NCT01957488|454140402|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126231651|NCT01957488|454140403|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126231652|NCT01957488|454140404|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126231653|NCT01957488|454140399|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
126231654|NCT01957488|454140400|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
126231655|NCT01957488|454140401|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
126231656|NCT01957488|454140402|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
126231657|NCT01957488|454140403|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
126231658|NCT01957488|454140404|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
126231659|NCT01957488|454140399|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126231660|NCT01957488|454140400|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126231661|NCT01957488|454140401|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126231662|NCT01957488|454140402|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126231663|NCT01957488|454140403|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126231664|NCT01957488|454140404|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
126231665|NCT01957488|454140399|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
126231666|NCT01957488|454140400|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126231667|NCT01957488|454140401|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126231668|NCT01957488|454140402|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126231669|NCT01957488|454140403|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126231670|NCT01957488|454140404|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126231671|NCT01957488|454140399|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126231672|NCT01957488|454140400|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
126231673|NCT01957488|454140401|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126231674|NCT01957488|454140402|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126231675|NCT01957488|454140403|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126231676|NCT01957488|454140404|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126231677|NCT01439165|454140406|FG000|Overall Study|Protocol Violation|3|||
126231678|NCT01439165|454140407|FG001|Overall Study|Protocol Violation|0|||
126231679|NCT01439165|454140406|FG000|Overall Study|Lost to Follow-up|11|||
126231680|NCT01439165|454140407|FG001|Overall Study|Lost to Follow-up|1|||
126231681|NCT01439165|454140406|FG000|Overall Study|Withdrawal by Subject|7|||
126231682|NCT01439165|454140407|FG001|Overall Study|Withdrawal by Subject|1|||
126231683|NCT00623103|454140408|FG000|Overall Study|Adverse Event|70|||
126231684|NCT00623103|454140409|FG001|Overall Study|Adverse Event|60|||
126231685|NCT00623103|454140408|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126231686|NCT00623103|454140409|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
126231687|NCT00623103|454140408|FG000|Overall Study|Withdrawal by Subject|18|||
126231688|NCT00623103|454140409|FG001|Overall Study|Withdrawal by Subject|24|||
126231689|NCT00623103|454140408|FG000|Overall Study|Lost to Follow-up|4|||
126353472|NCT02965833|454584477|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
126353473|NCT02965833|454584478|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
126353474|NCT02965833|454584477|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
126353475|NCT02965833|454584478|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
126353476|NCT02965833|454584477|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
126353477|NCT02965833|454584478|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
126353478|NCT00118287|454584482|FG000|Overall Study|Intracranial haemorrhage|1|||
126353479|NCT00118287|454584482|FG000|Overall Study|Muscle pain|1|||
126353480|NCT03407482|454584483|FG000|Overall Study|Adverse Event|12|||
126231690|NCT00623103|454140409|FG001|Overall Study|Lost to Follow-up|1|||
126231691|NCT00623103|454140408|FG000|Overall Study|Administrative problems|2|||
126231692|NCT00623103|454140409|FG001|Overall Study|Administrative problems|4|||
126231693|NCT00623103|454140408|FG000|Overall Study|Death|11|||
126231694|NCT00623103|454140409|FG001|Overall Study|Death|11|||
126231695|NCT00623103|454140408|FG000|Overall Study|Protocol deviation|2|||
126231696|NCT00623103|454140409|FG001|Overall Study|Protocol deviation|1|||
126231697|NCT00688064|454140411|FG000|Overall Study|Protocol Violation|0|||
126231698|NCT00688064|454140412|FG001|Overall Study|Protocol Violation|1|||
126231699|NCT00688064|454140411|FG000|Overall Study|Adverse Event|2|||
126231700|NCT00688064|454140412|FG001|Overall Study|Adverse Event|4|||
126231701|NCT00688064|454140411|FG000|Overall Study|Withdrawal by Subject|7|||
126231702|NCT00688064|454140412|FG001|Overall Study|Withdrawal by Subject|7|||
126022643|NCT02178098|453377199|FG000|Overall Study|Protocol Violation|1|||
126022644|NCT02178098|453377200|FG001|Overall Study|Protocol Violation|1|||
126022645|NCT02178098|453377199|FG000|Overall Study|Lost to Follow-up|0|||
126022646|NCT02178098|453377200|FG001|Overall Study|Lost to Follow-up|1|||
126231703|NCT00688064|454140411|FG000|Overall Study|Lost to Follow-up|10|||
126231704|NCT00688064|454140412|FG001|Overall Study|Lost to Follow-up|10|||
126231705|NCT00688064|454140411|FG000|Overall Study|Lack of Efficacy|0|||
126231706|NCT00688064|454140412|FG001|Overall Study|Lack of Efficacy|1|||
126231707|NCT00688064|454140411|FG000|Overall Study|Pregnancy|1|||
126231708|NCT00688064|454140412|FG001|Overall Study|Pregnancy|0|||
126231709|NCT00688064|454140411|FG000|Overall Study|Any other reasons|1|||
126231710|NCT00688064|454140412|FG001|Overall Study|Any other reasons|3|||
126231711|NCT00001849|454140413|FG000|Overall Study|Death|4|||
126231712|NCT00001849|454140413|FG000|Overall Study|Lost to Follow-up|2|||
126231713|NCT00001849|454140413|FG000|Overall Study|Withdrawal by Subject|2|||
126231714|NCT00001849|454140413|FG000|Overall Study|tumor remained occult|6|||
126231715|NCT00442936|454140414|FG000|Overall Study|Protocol Violation|1|||
126231716|NCT00442936|454140415|FG001|Overall Study|Protocol Violation|0|||
126231717|NCT00442936|454140416|FG002|Overall Study|Protocol Violation|1|||
126231718|NCT00442936|454140417|FG003|Overall Study|Protocol Violation|1|||
126231719|NCT02433678|454140419|FG000|Overall Study|Lost to Follow-up|1|||
126231720|NCT02433678|454140420|FG001|Overall Study|Lost to Follow-up|2|||
126231721|NCT01506947|454140424|FG000|Overall Study|Lost to Follow-up|7|||
126231722|NCT01506947|454140424|FG000|Overall Study|Adverse Event|5|||
126231723|NCT01506947|454140424|FG000|Overall Study|Death|1|||
126231724|NCT01506947|454140424|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
126231725|NCT01700621|454140425|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
126353481|NCT03407482|454584483|FG000|Overall Study|Disease Relapse|1|||
126353482|NCT03407482|454584483|FG000|Overall Study|Lost to Follow-up|1|||
126353483|NCT03407482|454584483|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126353484|NCT03407482|454584483|FG000|Overall Study|Pregnancy|2|||
126353485|NCT03407482|454584483|FG000|Overall Study|Protocol Violation|1|||
126353486|NCT03407482|454584483|FG000|Overall Study|Study Terminated By Sponsor|106|||
126353487|NCT03407482|454584483|FG000|Overall Study|Withdrawal by Subject|6|||
126353488|NCT03407482|454584483|FG000|Overall Study|Data Entry Error|1|||
126353489|NCT03442569|454584486|FG000|Overall Study|Subject was ineligible after enrollment|1|||
126353490|NCT01214720|454584489|FG000|Overall Study|Alive and still on treatment|34|||
126353491|NCT01214720|454584490|FG001|Overall Study|Alive and still on treatment|18|||
126353492|NCT01214720|454584489|FG000|Overall Study|Alive and in follow-up|45|||
126353493|NCT01214720|454584490|FG001|Overall Study|Alive and in follow-up|48|||
126353494|NCT01214720|454584489|FG000|Overall Study|Lost to Follow-up|6|||
126353495|NCT01214720|454584490|FG001|Overall Study|Lost to Follow-up|2|||
126353496|NCT02347787|454584491|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
126353497|NCT02347787|454584492|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
126353498|NCT02347787|454584491|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
126353499|NCT02347787|454584492|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
126353500|NCT02347787|454584491|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
126353501|NCT02347787|454584492|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
126353502|NCT02347787|454584491|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
126353503|NCT02347787|454584492|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
126353504|NCT05643794|454585791|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
126353505|NCT05643794|454585792|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
126353506|NCT05643794|454585793|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
126353507|NCT05643794|454585791|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126353508|NCT05643794|454585792|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126353509|NCT05643794|454585793|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126353510|NCT05643794|454585791|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
126353511|NCT05643794|454585792|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
126353512|NCT05643794|454585793|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
126353513|NCT05643794|454585791|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126353514|NCT05643794|454585792|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
126353515|NCT05643794|454585793|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126353516|NCT05643794|454585791|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
126353517|NCT05643794|454585792|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
126353518|NCT05643794|454585793|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
126231726|NCT01700621|454140426|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
126231727|NCT01700621|454140425|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
126231728|NCT01700621|454140426|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
126231729|NCT01700621|454140425|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
126231730|NCT01700621|454140426|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
126231731|NCT02166697|454140427|FG000|Overall Study|Protocol Violation|347|||
126231732|NCT01618266|454140433|FG000|Overall Study|Lost to Follow-up|9|||
126231733|NCT01618266|454140433|FG000|Overall Study|Treatment satisfaction|10|||
126231734|NCT01618266|454140433|FG000|Overall Study|Other reasons|11|||
126231735|NCT01618266|454140433|FG000|Overall Study|Lack of Efficacy|23|||
126231736|NCT01618266|454140433|FG000|Overall Study|Protocol Violation|43|||
126353519|NCT05643794|454585791|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
126353520|NCT05643794|454585792|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
126353521|NCT05643794|454585793|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
126353522|NCT01363076|454585798|FG000|Overall Study|Withdrawal by Subject|0|||
126353523|NCT01363076|454585799|FG001|Overall Study|Withdrawal by Subject|1|||
126353524|NCT04706403|454585800|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
126353525|NCT04706403|454585801|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
126353526|NCT04706403|454585802|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
126353527|NCT04706403|454585803|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
126353528|NCT04706403|454585804|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
126353529|NCT00182637|454585805|FG000|Overall Study|Adverse Event|2|||
126353530|NCT00182637|454585805|FG000|Overall Study|Disease Progression|1|||
126353531|NCT04766333|454585807|FG000|Overall Study|Lost to Follow-up|40|||
126353532|NCT04766333|454585808|FG001|Overall Study|Lost to Follow-up|826|||
126353533|NCT00639379|454585812|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
126353534|NCT00639379|454585813|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
126353535|NCT00639379|454585812|FG000|Period 1 - 2 Weeks|lens issue|3|||
126353536|NCT00639379|454585813|FG001|Period 1 - 2 Weeks|lens issue|0|||
126353537|NCT00723944|454585814|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
126353538|NCT00723944|454585815|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
126353539|NCT00723944|454585814|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
126353540|NCT00723944|454585815|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
126353541|NCT00723944|454585814|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
126353542|NCT00723944|454585815|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
126353543|NCT05177094|454585816|FG000|Overall Study|Adverse Event|5|||
126353544|NCT05177094|454585817|FG001|Overall Study|Adverse Event|5|||
126353545|NCT05177094|454585816|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
126353546|NCT05177094|454585817|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
126353547|NCT05177094|454585816|FG000|Overall Study|Protocol Deviation|3|||
126353548|NCT05177094|454585817|FG001|Overall Study|Protocol Deviation|0|||
126353549|NCT05177094|454585816|FG000|Overall Study|Withdrawal by Subject|6|||
126353550|NCT05177094|454585817|FG001|Overall Study|Withdrawal by Subject|3|||
126353551|NCT05177094|454585816|FG000|Overall Study|Participant could not tolerate long study visits|1|||
126353552|NCT05177094|454585817|FG001|Overall Study|Participant could not tolerate long study visits|0|||
126353553|NCT02400736|454585818|FG000|Overall Study|Lost to Follow-up|6|||
126353554|NCT02400736|454585819|FG001|Overall Study|Lost to Follow-up|6|||
126353555|NCT02400736|454585818|FG000|Overall Study|Withdrawal by Subject|2|||
126353556|NCT02400736|454585819|FG001|Overall Study|Withdrawal by Subject|1|||
126353557|NCT02400736|454585818|FG000|Overall Study|Moved from the area|3|||
126353558|NCT02400736|454585819|FG001|Overall Study|Moved from the area|1|||
126353559|NCT02383173|454585822|FG000|Overall Study|Palliative Care Team withdrew|0|||
126353560|NCT02383173|454585823|FG001|Overall Study|Palliative Care Team withdrew|2|||
126353561|NCT01297244|454585824|FG000|Overall Study|Progressive disease|22|||
126353562|NCT01297244|454585825|FG001|Overall Study|Progressive disease|3|||
126353563|NCT01297244|454585824|FG000|Overall Study|Adverse Event|9|||
126353564|NCT01297244|454585825|FG001|Overall Study|Adverse Event|1|||
126353565|NCT01297244|454585824|FG000|Overall Study|Death|1|||
126353566|NCT01297244|454585825|FG001|Overall Study|Death|1|||
126353567|NCT01297244|454585824|FG000|Overall Study|Clinical progression|1|||
126353568|NCT01297244|454585825|FG001|Overall Study|Clinical progression|1|||
126353569|NCT01297244|454585824|FG000|Overall Study|Withdrawal by Subject|2|||
126353570|NCT01297244|454585825|FG001|Overall Study|Withdrawal by Subject|0|||
126353571|NCT03677401|454585826|FG000|Overall Study|Adverse Event|4|||
126353572|NCT03677401|454585827|FG001|Overall Study|Adverse Event|14|||
126353573|NCT03677401|454585826|FG000|Overall Study|Lack of Efficacy|3|||
126353574|NCT03677401|454585827|FG001|Overall Study|Lack of Efficacy|1|||
126353575|NCT03677401|454585826|FG000|Overall Study|Withdrawal by Subject|2|||
126353576|NCT03677401|454585827|FG001|Overall Study|Withdrawal by Subject|2|||
126353577|NCT03677401|454585826|FG000|Overall Study|Sponsor decision|0|||
126353578|NCT03677401|454585827|FG001|Overall Study|Sponsor decision|1|||
126353579|NCT03677401|454585826|FG000|Overall Study|Reason Unspecified|1|||
126353580|NCT03677401|454585827|FG001|Overall Study|Reason Unspecified|0|||
126353581|NCT01177410|454585830|FG000|Overall Study|Adverse Event|0|||
126353582|NCT01177410|454585831|FG001|Overall Study|Adverse Event|2|||
126353583|NCT01177410|454585832|FG002|Overall Study|Adverse Event|2|||
126353584|NCT01177410|454585830|FG000|Overall Study|Withdrawal by Subject|1|||
126353585|NCT01177410|454585831|FG001|Overall Study|Withdrawal by Subject|4|||
126353586|NCT01177410|454585832|FG002|Overall Study|Withdrawal by Subject|3|||
126353587|NCT01177410|454585830|FG000|Overall Study|Lost to Follow-up|0|||
126022647|NCT02178098|453377199|FG000|Overall Study|Sponsor Request|1|||
126022648|NCT02178098|453377200|FG001|Overall Study|Sponsor Request|0|||
126022649|NCT02178098|453377199|FG000|Overall Study|Other|2|||
126231737|NCT02224391|454140434|FG000|Overall Study|Lost to Follow-up|26|||
126231738|NCT02224391|454140435|FG001|Overall Study|Lost to Follow-up|19|||
126231739|NCT02224391|454140434|FG000|Overall Study|Withdrawal by Subject|6|||
126231740|NCT02224391|454140435|FG001|Overall Study|Withdrawal by Subject|5|||
126231741|NCT00084084|454140436|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
126231742|NCT00084084|454140436|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
126231743|NCT02187042|454140440|FG000|Overall Study|Death|1|||
126231744|NCT02187042|454140441|FG001|Overall Study|Death|1|||
126231745|NCT02187042|454140440|FG000|Overall Study|Toxicity|6|||
126231746|NCT02187042|454140441|FG001|Overall Study|Toxicity|5|||
126022650|NCT02178098|453377200|FG001|Overall Study|Other|2|||
126022651|NCT01109524|453377205|FG000|Overall Study|Disease Progression|29|||
126022652|NCT01109524|453377205|FG000|Overall Study|Study Drug toxicity|6|||
126022653|NCT01109524|453377205|FG000|Overall Study|Adverse Event|4|||
126022654|NCT01109524|453377205|FG000|Overall Study|Withdrawal by Subject|2|||
126022655|NCT01109524|453377205|FG000|Overall Study|Maximum clinical benefit|3|||
126022656|NCT01109524|453377205|FG000|Overall Study|Death|2|||
126022657|NCT01109524|453377205|FG000|Overall Study|No longer meets criteria|2|||
126022658|NCT01109524|453377205|FG000|Overall Study|Participant requested to end treatment|4|||
126022659|NCT01109524|453377205|FG000|Overall Study|Other|5|||
126022660|NCT03101371|453377215|FG000|Overall Study|Physician Decision|0|||
126022661|NCT03101371|453377216|FG001|Overall Study|Physician Decision|1|||
126022662|NCT03101371|453377215|FG000|Overall Study|Lost to Follow-up|1|||
126022663|NCT03101371|453377216|FG001|Overall Study|Lost to Follow-up|4|||
126022664|NCT03101371|453377215|FG000|Overall Study|Did not meet eligibility criteria|2|||
126022665|NCT03101371|453377216|FG001|Overall Study|Did not meet eligibility criteria|1|||
126022666|NCT00031694|453377219|FG000|Overall Study|Adverse Event|12|||
126022667|NCT00031694|453377219|FG000|Overall Study|Death|2|||
126022668|NCT00031694|453377219|FG000|Overall Study|Withdrawal by Subject|5|||
126231747|NCT02187042|454140440|FG000|Overall Study|Participant choice|1|||
126022669|NCT04019444|453377224|FG000|Overall Study|Withdrawal by Subject|0|||
126022670|NCT04019444|453377225|FG001|Overall Study|Withdrawal by Subject|1|||
126022671|NCT04019444|453377226|FG002|Overall Study|Withdrawal by Subject|0|||
126022672|NCT04019444|453377227|FG003|Overall Study|Withdrawal by Subject|1|||
126022673|NCT04019444|453377224|FG000|Overall Study|Solicited Event|0|||
126022674|NCT04019444|453377225|FG001|Overall Study|Solicited Event|0|||
126022675|NCT04019444|453377226|FG002|Overall Study|Solicited Event|2|||
126022676|NCT04019444|453377227|FG003|Overall Study|Solicited Event|0|||
126022677|NCT04939246|453377230|FG000|After Treatment|Death|4|||
126022678|NCT04939246|453377230|FG000|After Treatment|Lost to Follow-up|1|||
126022679|NCT04939246|453377230|FG000|After Treatment|Discharged to hospice|2|||
126022680|NCT04994509|453377231|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
126022681|NCT04994509|453377232|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
126022682|NCT04994509|453377233|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
126022683|NCT04994509|453377231|FG000|Overall Study|Withdrew Consent|73|||
126022684|NCT04994509|453377232|FG001|Overall Study|Withdrew Consent|72|||
126022685|NCT04994509|453377233|FG002|Overall Study|Withdrew Consent|46|||
126022686|NCT04994509|453377231|FG000|Overall Study|Lost to Follow-up|39|||
126022687|NCT04994509|453377232|FG001|Overall Study|Lost to Follow-up|36|||
126022688|NCT04994509|453377233|FG002|Overall Study|Lost to Follow-up|26|||
126022689|NCT04994509|453377231|FG000|Overall Study|HIV-1 Infection|4|||
126022690|NCT04994509|453377232|FG001|Overall Study|HIV-1 Infection|20|||
126022691|NCT04994509|453377233|FG002|Overall Study|HIV-1 Infection|12|||
126022692|NCT04994509|453377231|FG000|Overall Study|Investigator's Discretion|9|||
126022693|NCT04994509|453377232|FG001|Overall Study|Investigator's Discretion|8|||
126022694|NCT04994509|453377233|FG002|Overall Study|Investigator's Discretion|11|||
126022695|NCT04994509|453377231|FG000|Overall Study|Randomized but Never Treated|10|||
126022696|NCT04994509|453377232|FG001|Overall Study|Randomized but Never Treated|10|||
126022697|NCT04994509|453377233|FG002|Overall Study|Randomized but Never Treated|3|||
126022698|NCT04994509|453377231|FG000|Overall Study|Pregnancy|5|||
126022699|NCT04994509|453377232|FG001|Overall Study|Pregnancy|5|||
126022700|NCT04994509|453377233|FG002|Overall Study|Pregnancy|0|||
126022701|NCT04994509|453377231|FG000|Overall Study|Death|0|||
126022702|NCT04994509|453377232|FG001|Overall Study|Death|5|||
126022703|NCT04994509|453377233|FG002|Overall Study|Death|0|||
126022704|NCT04994509|453377231|FG000|Overall Study|Adverse Event|2|||
126022705|NCT04994509|453377232|FG001|Overall Study|Adverse Event|1|||
126022706|NCT04994509|453377233|FG002|Overall Study|Adverse Event|0|||
126022707|NCT04994509|453377231|FG000|Overall Study|Non-compliance With Study Drug|1|||
126022708|NCT04994509|453377232|FG001|Overall Study|Non-compliance With Study Drug|1|||
126022709|NCT04994509|453377233|FG002|Overall Study|Non-compliance With Study Drug|1|||
126022710|NCT04994509|453377231|FG000|Overall Study|Withdrew Assent|3|||
126022711|NCT04994509|453377232|FG001|Overall Study|Withdrew Assent|0|||
126022712|NCT04994509|453377233|FG002|Overall Study|Withdrew Assent|0|||
126022713|NCT04994509|453377231|FG000|Overall Study|Protocol Violation|1|||
126022714|NCT04994509|453377232|FG001|Overall Study|Protocol Violation|0|||
126022715|NCT04994509|453377233|FG002|Overall Study|Protocol Violation|0|||
126022716|NCT02576509|453378571|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
126022717|NCT02576509|453378572|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
126022718|NCT02576509|453378571|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
126022719|NCT02576509|453378572|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
126022720|NCT02576509|453378571|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
126022721|NCT02576509|453378572|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
126231748|NCT02187042|454140441|FG001|Overall Study|Participant choice|0|||
126231749|NCT02187042|454140440|FG000|Overall Study|Doctor choice|1|||
126231750|NCT02187042|454140441|FG001|Overall Study|Doctor choice|0|||
126231751|NCT02187042|454140440|FG000|Overall Study|Progressive disease|4|||
126231752|NCT02187042|454140441|FG001|Overall Study|Progressive disease|8|||
126231753|NCT00536575|454140443|FG000|Overall Study|Withdrawal by Subject|1|||
126231754|NCT00536575|454140443|FG000|Overall Study|Death|1|||
126231755|NCT01626079|454140444|FG000|Overall Study|Death|167|||
126231756|NCT01626079|454140445|FG001|Overall Study|Death|192|||
126231757|NCT01626079|454140446|FG002|Overall Study|Death|39|||
126231758|NCT01626079|454140444|FG000|Overall Study|Withdrawal by Subject|23|||
126022722|NCT02576509|453378571|FG000|Treatment Period|Disease progression|263|||
126022723|NCT02576509|453378572|FG001|Treatment Period|Disease progression|244|||
126022724|NCT02576509|453378571|FG000|Treatment Period|Study drug toxicity|37|||
126022725|NCT02576509|453378572|FG001|Treatment Period|Study drug toxicity|41|||
126231759|NCT01626079|454140445|FG001|Overall Study|Withdrawal by Subject|37|||
126231760|NCT01626079|454140446|FG002|Overall Study|Withdrawal by Subject|5|||
126231761|NCT01626079|454140444|FG000|Overall Study|Lost to Follow-up|7|||
126231762|NCT01626079|454140445|FG001|Overall Study|Lost to Follow-up|4|||
126231763|NCT01626079|454140446|FG002|Overall Study|Lost to Follow-up|2|||
126231764|NCT01626079|454140444|FG000|Overall Study|Missed Visits|1|||
126231765|NCT01626079|454140445|FG001|Overall Study|Missed Visits|4|||
126231766|NCT01626079|454140446|FG002|Overall Study|Missed Visits|6|||
126231767|NCT01457053|454140448|FG000|Overall Study|Unable to undergo selected treatment|1|||
126231768|NCT01457053|454140449|FG001|Overall Study|Unable to undergo selected treatment|1|||
126231769|NCT03922477|454140452|FG000|Overall Study|Death|9|||
126231770|NCT03922477|454140452|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
126231771|NCT03922477|454140452|FG000|Overall Study|Physician Decision|1|||
126231772|NCT03922477|454140452|FG000|Overall Study|Withdrawal by Subject|2|||
126231773|NCT00788957|454140460|FG000|Part 1|Death|8|||
126231774|NCT00788957|454140461|FG001|Part 1|Death|0|||
126231775|NCT00788957|454140462|FG002|Part 1|Death|0|||
126231776|NCT00788957|454140463|FG003|Part 1|Death|0|||
126231777|NCT00788957|454140464|FG004|Part 1|Death|0|||
126231778|NCT00788957|454140465|FG005|Part 1|Death|0|||
126231779|NCT00788957|454140460|FG000|Part 1|Lost to Follow-up|1|||
126231780|NCT00788957|454140461|FG001|Part 1|Lost to Follow-up|0|||
126231781|NCT00788957|454140462|FG002|Part 1|Lost to Follow-up|0|||
126231782|NCT00788957|454140463|FG003|Part 1|Lost to Follow-up|0|||
126231783|NCT00788957|454140464|FG004|Part 1|Lost to Follow-up|0|||
126231784|NCT00788957|454140465|FG005|Part 1|Lost to Follow-up|0|||
126231785|NCT00788957|454140460|FG000|Part 2|Withdrawal by Subject|0|||
126231786|NCT00788957|454140461|FG001|Part 2|Withdrawal by Subject|9|||
126231787|NCT00788957|454140462|FG002|Part 2|Withdrawal by Subject|5|||
126231788|NCT00788957|454140463|FG003|Part 2|Withdrawal by Subject|3|||
126231789|NCT00788957|454140464|FG004|Part 2|Withdrawal by Subject|0|||
126231790|NCT00788957|454140465|FG005|Part 2|Withdrawal by Subject|0|||
126231791|NCT00788957|454140460|FG000|Part 2|Death|0|||
126231792|NCT00788957|454140461|FG001|Part 2|Death|32|||
126231793|NCT00788957|454140462|FG002|Part 2|Death|35|||
126231794|NCT00788957|454140463|FG003|Part 2|Death|37|||
126231795|NCT00788957|454140464|FG004|Part 2|Death|0|||
126231796|NCT00788957|454140465|FG005|Part 2|Death|0|||
126231797|NCT00788957|454140460|FG000|Part 2|Lost to Follow-up|0|||
126231798|NCT00788957|454140461|FG001|Part 2|Lost to Follow-up|0|||
126231799|NCT00788957|454140462|FG002|Part 2|Lost to Follow-up|3|||
126231800|NCT00788957|454140463|FG003|Part 2|Lost to Follow-up|0|||
126231801|NCT00788957|454140464|FG004|Part 2|Lost to Follow-up|0|||
126231802|NCT00788957|454140465|FG005|Part 2|Lost to Follow-up|0|||
126231803|NCT00788957|454140460|FG000|Part 2|On-study at time of data cut-off|0|||
126231804|NCT00788957|454140461|FG001|Part 2|On-study at time of data cut-off|1|||
126231805|NCT00788957|454140462|FG002|Part 2|On-study at time of data cut-off|1|||
126231806|NCT00788957|454140463|FG003|Part 2|On-study at time of data cut-off|1|||
126231807|NCT00788957|454140464|FG004|Part 2|On-study at time of data cut-off|0|||
126231808|NCT00788957|454140465|FG005|Part 2|On-study at time of data cut-off|0|||
126231809|NCT00788957|454140460|FG000|Part 3|Withdrawal by Subject|0|||
126231810|NCT00788957|454140461|FG001|Part 3|Withdrawal by Subject|0|||
126231811|NCT00788957|454140462|FG002|Part 3|Withdrawal by Subject|0|||
126231812|NCT00788957|454140463|FG003|Part 3|Withdrawal by Subject|0|||
126231813|NCT00788957|454140464|FG004|Part 3|Withdrawal by Subject|0|||
126231814|NCT00788957|454140465|FG005|Part 3|Withdrawal by Subject|2|||
126231815|NCT00788957|454140460|FG000|Part 3|Death|0|||
126231816|NCT00788957|454140461|FG001|Part 3|Death|0|||
126231817|NCT00788957|454140462|FG002|Part 3|Death|0|||
126231818|NCT00788957|454140463|FG003|Part 3|Death|0|||
126231819|NCT00788957|454140464|FG004|Part 3|Death|8|||
126231820|NCT00788957|454140465|FG005|Part 3|Death|8|||
126231821|NCT00788957|454140460|FG000|Part 3|On-study at time of data cut-off|0|||
126231822|NCT00788957|454140461|FG001|Part 3|On-study at time of data cut-off|0|||
126231823|NCT00788957|454140462|FG002|Part 3|On-study at time of data cut-off|0|||
126231824|NCT00788957|454140463|FG003|Part 3|On-study at time of data cut-off|0|||
126231825|NCT00788957|454140464|FG004|Part 3|On-study at time of data cut-off|1|||
126022726|NCT02576509|453378571|FG000|Treatment Period|Death|1|||
126231826|NCT00788957|454140465|FG005|Part 3|On-study at time of data cut-off|0|||
126231827|NCT03387098|454140466|FG000|Overall Study|progressive disease|1|||
126231828|NCT03387098|454140466|FG000|Overall Study|Withdrawal by Subject|2|||
126231829|NCT03387098|454140466|FG000|Overall Study|study terminated by sponsor|1|||
126231830|NCT03276975|454140467|FG000|Overall Study|Withdrawal by Subject|1|||
126231831|NCT03276975|454140468|FG001|Overall Study|Withdrawal by Subject|0|||
126231832|NCT00918567|454140471|FG000|Overall Study|Lack of Efficacy|3|||
126231833|NCT00918567|454140472|FG001|Overall Study|Lack of Efficacy|1|||
126231834|NCT00918567|454140471|FG000|Overall Study|Withdrawal by Subject|1|||
126231835|NCT00918567|454140472|FG001|Overall Study|Withdrawal by Subject|1|||
126231836|NCT00918567|454140471|FG000|Overall Study|Adverse Event|1|||
126231837|NCT00918567|454140472|FG001|Overall Study|Adverse Event|0|||
126231838|NCT02568384|454140473|FG000|Overall Study|Mobile devices incompatible with App|2|||
126231839|NCT01485536|454140475|FG000|Overall Study|Withdrawal by Subject|3|||
126231840|NCT01485536|454140475|FG000|Overall Study|Adverse Event|1|||
126231841|NCT00796510|454140476|FG000|Overall Study|Death|1|||
126231842|NCT00796510|454140477|FG001|Overall Study|Death|0|||
126231843|NCT00796510|454140476|FG000|Overall Study|Study Terminated|2|||
126231844|NCT00796510|454140477|FG001|Overall Study|Study Terminated|0|||
126231845|NCT02799602|454140478|FG000|Overall Study|Protocol Violation|1|||
126231846|NCT02799602|454140479|FG001|Overall Study|Protocol Violation|0|||
126231847|NCT02799602|454140478|FG000|Overall Study|Physician Decision|5|||
126231848|NCT02799602|454140479|FG001|Overall Study|Physician Decision|6|||
126231849|NCT02799602|454140478|FG000|Overall Study|Lost to Follow-up|4|||
126231850|NCT02799602|454140479|FG001|Overall Study|Lost to Follow-up|2|||
126231851|NCT02799602|454140478|FG000|Overall Study|Additional primary malignancy|11|||
126231852|NCT02799602|454140479|FG001|Overall Study|Additional primary malignancy|6|||
126231853|NCT02799602|454140478|FG000|Overall Study|Non-compliance with study drug|14|||
126231854|NCT02799602|454140479|FG001|Overall Study|Non-compliance with study drug|12|||
126231855|NCT02799602|454140478|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
126231856|NCT02799602|454140479|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
126231857|NCT02799602|454140478|FG000|Overall Study|Withdrawal by Subject|26|||
126231858|NCT02799602|454140479|FG001|Overall Study|Withdrawal by Subject|40|||
126231859|NCT02799602|454140478|FG000|Overall Study|Progressive disease - clinical progression|131|||
126231860|NCT02799602|454140479|FG001|Overall Study|Progressive disease - clinical progression|276|||
126231861|NCT02799602|454140478|FG000|Overall Study|Progressive disease - radiological progression|90|||
126231862|NCT02799602|454140479|FG001|Overall Study|Progressive disease - radiological progression|133|||
126231863|NCT02799602|454140478|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
126231864|NCT02799602|454140479|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
126231865|NCT02799602|454140478|FG000|Overall Study|Death|9|||
126231866|NCT02799602|454140479|FG001|Overall Study|Death|5|||
126231867|NCT02799602|454140478|FG000|Overall Study|Other|287|||
126231868|NCT02799602|454140479|FG001|Overall Study|Other|118|||
126231869|NCT02799602|454140478|FG000|Overall Study|Study drug never administered|0|||
126022727|NCT02576509|453378572|FG001|Treatment Period|Death|1|||
126231870|NCT02799602|454140479|FG001|Overall Study|Study drug never administered|3|||
126231871|NCT02626949|454140480|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
126231872|NCT02626949|454140481|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
126231873|NCT02626949|454140480|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
126231874|NCT02626949|454140481|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
126231875|NCT02626949|454140480|FG000|Enrolled|Lost to Follow-up|7|||
126231876|NCT02626949|454140481|FG001|Enrolled|Lost to Follow-up|6|||
126231877|NCT02626949|454140480|FG000|Enrolled|Withdrawal by Subject|3|||
126231878|NCT02626949|454140481|FG001|Enrolled|Withdrawal by Subject|2|||
126231879|NCT03072459|454140482|FG000|Overall Study|Device revised/removed|1|||
126231880|NCT03072459|454140482|FG000|Overall Study|Subject not able to return|1|||
126231881|NCT00329602|454140483|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
126231882|NCT00329602|454140484|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
126231883|NCT00329602|454140485|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
126231884|NCT00329602|454140483|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
126022728|NCT02576509|453378571|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
126022729|NCT02576509|453378572|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
126022730|NCT02576509|453378571|FG000|Treatment Period|Participant request to stop treatment|8|||
126231885|NCT00329602|454140484|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
126022731|NCT02576509|453378572|FG001|Treatment Period|Participant request to stop treatment|18|||
126022732|NCT02576509|453378571|FG000|Treatment Period|Participant withdrew consent|3|||
126022733|NCT02576509|453378572|FG001|Treatment Period|Participant withdrew consent|7|||
126353588|NCT01177410|454585831|FG001|Overall Study|Lost to Follow-up|1|||
126353589|NCT01177410|454585832|FG002|Overall Study|Lost to Follow-up|0|||
126353590|NCT00875667|454585836|FG000|Overall Study|Adverse Event|29|||
126353591|NCT00875667|454585837|FG001|Overall Study|Adverse Event|10|||
126353592|NCT00875667|454585836|FG000|Overall Study|Withdrawal by Subject|17|||
126353593|NCT00875667|454585837|FG001|Overall Study|Withdrawal by Subject|5|||
126353594|NCT00875667|454585836|FG000|Overall Study|Death|7|||
126353595|NCT00875667|454585837|FG001|Overall Study|Death|2|||
126353596|NCT00875667|454585836|FG000|Overall Study|Protocol Violation|2|||
126353597|NCT00875667|454585837|FG001|Overall Study|Protocol Violation|0|||
126353598|NCT00875667|454585836|FG000|Overall Study|Disease Progression|100|||
126353599|NCT00875667|454585837|FG001|Overall Study|Disease Progression|49|||
126353600|NCT00875667|454585836|FG000|Overall Study|Miscellaneous|12|||
126353601|NCT00875667|454585837|FG001|Overall Study|Miscellaneous|6|||
126353602|NCT00875667|454585836|FG000|Overall Study|Randomized but no Study Drug Given|3|||
126353603|NCT00875667|454585837|FG001|Overall Study|Randomized but no Study Drug Given|1|||
126353604|NCT00894647|454585838|FG000|Overall Study|Adverse Event|5|||
126231886|NCT00329602|454140485|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
126231887|NCT00329602|454140483|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
126231888|NCT00329602|454140484|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
126231889|NCT00329602|454140485|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
126231890|NCT00329602|454140483|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
126231891|NCT00329602|454140484|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
126231892|NCT00329602|454140485|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
126231893|NCT00329602|454140483|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
126231894|NCT00329602|454140484|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
126231895|NCT00329602|454140485|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
126231896|NCT00329602|454140483|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
126231897|NCT00329602|454140484|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
126231898|NCT00329602|454140485|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
126231899|NCT02275364|454140486|FG000|Period 1|Withdrawal by Subject|1|||
126231900|NCT02275364|454140487|FG001|Period 1|Withdrawal by Subject|0|||
126231901|NCT02275364|454140486|FG000|Period 1|Other reason|1|||
126231902|NCT02275364|454140487|FG001|Period 1|Other reason|0|||
126231903|NCT03008460|454140496|FG000|Overall Study|Protocol deviation|0|||
126231904|NCT03008460|454140497|FG001|Overall Study|Protocol deviation|2|||
126231905|NCT03008460|454140496|FG000|Overall Study|Study drug not dispensed|0|||
126231906|NCT03008460|454140497|FG001|Overall Study|Study drug not dispensed|1|||
126231907|NCT03008460|454140496|FG000|Overall Study|Adverse Event|0|||
126231908|NCT03008460|454140497|FG001|Overall Study|Adverse Event|1|||
126231909|NCT03008460|454140496|FG000|Overall Study|Withdrawal by Subject|5|||
126231910|NCT03008460|454140497|FG001|Overall Study|Withdrawal by Subject|6|||
126231911|NCT03008460|454140496|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
126231912|NCT03008460|454140497|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
126231913|NCT03008460|454140496|FG000|Overall Study|End of study visit outside permitted time window|0|||
126231914|NCT03008460|454140497|FG001|Overall Study|End of study visit outside permitted time window|1|||
126231915|NCT03008460|454140496|FG000|Overall Study|Lost to Follow-up|1|||
126231916|NCT03008460|454140497|FG001|Overall Study|Lost to Follow-up|3|||
126231917|NCT04947579|454140500|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126231918|NCT04947579|454140501|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126231919|NCT04947579|454140502|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126231920|NCT04947579|454140503|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
126231921|NCT04947579|454140504|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126231922|NCT04947579|454140505|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126231923|NCT04947579|454140500|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126231924|NCT04947579|454140501|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126231925|NCT04947579|454140502|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
126231926|NCT04947579|454140503|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126231927|NCT04947579|454140504|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126231928|NCT04947579|454140505|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126231929|NCT04947579|454140500|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
126231930|NCT04947579|454140501|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
126231931|NCT04947579|454140502|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
126231932|NCT04947579|454140503|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
126231933|NCT04947579|454140504|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
126231934|NCT04947579|454140505|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
126231935|NCT04947579|454140500|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
126231936|NCT04947579|454140501|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
126231937|NCT04947579|454140502|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
126231938|NCT04947579|454140503|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
126231939|NCT04947579|454140504|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
126231940|NCT04947579|454140505|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
126231941|NCT04947579|454140500|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
126231942|NCT04947579|454140501|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126231943|NCT04947579|454140502|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126022734|NCT02576509|453378571|FG000|Treatment Period|Lost to Follow-up|0|||
126022735|NCT02576509|453378572|FG001|Treatment Period|Lost to Follow-up|1|||
126022736|NCT02576509|453378571|FG000|Treatment Period|Maximum clinical benefit|1|||
126231944|NCT04947579|454140503|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126231945|NCT04947579|454140504|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126231946|NCT04947579|454140505|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126231947|NCT04947579|454140500|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126231948|NCT04947579|454140501|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126231949|NCT04947579|454140502|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
126231950|NCT04947579|454140503|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126231951|NCT04947579|454140504|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126231952|NCT04947579|454140505|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126231953|NCT04947579|454140500|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
126231954|NCT04947579|454140501|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
126231955|NCT04947579|454140502|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
126231956|NCT04947579|454140503|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
126231957|NCT04947579|454140504|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
126231958|NCT04947579|454140505|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
126231959|NCT04947579|454140500|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126231960|NCT04947579|454140501|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126231961|NCT04947579|454140502|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
126231962|NCT04947579|454140503|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126231963|NCT04947579|454140504|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126231964|NCT04947579|454140505|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126231965|NCT04947579|454140500|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
126231966|NCT04947579|454140501|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
126231967|NCT04947579|454140502|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
126231968|NCT04947579|454140503|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
126353605|NCT00894647|454585839|FG001|Overall Study|Adverse Event|4|||
126353606|NCT00894647|454585838|FG000|Overall Study|Withdrawal by Subject|4|||
126022737|NCT02576509|453378572|FG001|Treatment Period|Maximum clinical benefit|0|||
126022738|NCT02576509|453378571|FG000|Treatment Period|Poor/non-compliance|1|||
126353607|NCT00894647|454585839|FG001|Overall Study|Withdrawal by Subject|4|||
126353608|NCT00894647|454585838|FG000|Overall Study|Lost to Follow-up|0|||
126353609|NCT00894647|454585839|FG001|Overall Study|Lost to Follow-up|2|||
126353610|NCT00894647|454585838|FG000|Overall Study|Non-compliance with study procedures|0|||
126353611|NCT00894647|454585839|FG001|Overall Study|Non-compliance with study procedures|2|||
126353612|NCT00894647|454585838|FG000|Overall Study|Other, not due to AE|1|||
126353613|NCT00894647|454585839|FG001|Overall Study|Other, not due to AE|2|||
126353614|NCT02143778|454585845|FG000|Overall Study|Withdrawal by Subject|2|||
126353615|NCT02143778|454585845|FG000|Overall Study|Device malfunction|1|||
126353616|NCT00625378|454585847|FG000|Overall Study|Adverse Event|22|||
126353617|NCT00625378|454585848|FG001|Overall Study|Adverse Event|0|||
126353618|NCT00625378|454585847|FG000|Overall Study|Withdrawal by Subject|16|||
126353619|NCT00625378|454585848|FG001|Overall Study|Withdrawal by Subject|0|||
126353620|NCT00625378|454585847|FG000|Overall Study|Death|38|||
126353621|NCT00625378|454585848|FG001|Overall Study|Death|0|||
126353622|NCT00625378|454585847|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
126353623|NCT00625378|454585848|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
126353624|NCT00625378|454585847|FG000|Overall Study|Lost to Follow-up|17|||
126353625|NCT00625378|454585848|FG001|Overall Study|Lost to Follow-up|0|||
126353626|NCT00625378|454585847|FG000|Overall Study|Non-compliant with study medication|3|||
126353627|NCT00625378|454585848|FG001|Overall Study|Non-compliant with study medication|0|||
126353628|NCT00625378|454585847|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
126353629|NCT00625378|454585848|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
126353630|NCT00625378|454585847|FG000|Overall Study|Medical decision|1|||
126353631|NCT00625378|454585848|FG001|Overall Study|Medical decision|0|||
126353632|NCT00625378|454585847|FG000|Overall Study|Multiple toxicities|1|||
126353633|NCT00625378|454585848|FG001|Overall Study|Multiple toxicities|0|||
126353634|NCT00625378|454585847|FG000|Overall Study|New cancer|1|||
126353635|NCT00625378|454585848|FG001|Overall Study|New cancer|0|||
126353636|NCT00625378|454585847|FG000|Overall Study|PTA program|2|||
126353637|NCT00625378|454585848|FG001|Overall Study|PTA program|0|||
126353638|NCT00625378|454585847|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
126353639|NCT00625378|454585848|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
126353640|NCT00625378|454585847|FG000|Overall Study|Sponsor decision|1|||
126353641|NCT00625378|454585848|FG001|Overall Study|Sponsor decision|0|||
126353642|NCT00625378|454585847|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
126353643|NCT00625378|454585848|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
126353644|NCT00625378|454585847|FG000|Overall Study|Switch to commercial drug|6|||
126231969|NCT04947579|454140504|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
126231970|NCT04947579|454140505|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
126231971|NCT04947579|454140500|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
126231972|NCT04947579|454140501|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
126231973|NCT04947579|454140502|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
126231974|NCT04947579|454140503|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
126231975|NCT04947579|454140504|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
126231976|NCT04947579|454140505|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
126231977|NCT04947579|454140500|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
126231978|NCT04947579|454140501|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
126231979|NCT04947579|454140502|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
126231980|NCT04947579|454140503|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
126231981|NCT04947579|454140504|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
126231982|NCT04947579|454140505|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
126231983|NCT01575054|454140506|FG000|Overall Study|Other Reasons|5|||
126231984|NCT01575054|454140507|FG001|Overall Study|Other Reasons|3|||
126231985|NCT01575054|454140506|FG000|Overall Study|Protocol Violation|2|||
126231986|NCT01575054|454140507|FG001|Overall Study|Protocol Violation|1|||
126231987|NCT01575054|454140506|FG000|Overall Study|Personal Reasons|10|||
126231988|NCT01575054|454140507|FG001|Overall Study|Personal Reasons|11|||
126231989|NCT01575054|454140506|FG000|Overall Study|Lost to Follow-up|3|||
126231990|NCT01575054|454140507|FG001|Overall Study|Lost to Follow-up|3|||
126231991|NCT01575054|454140506|FG000|Overall Study|Adverse Event|9|||
126231992|NCT01575054|454140507|FG001|Overall Study|Adverse Event|8|||
126231993|NCT00462982|454140511|FG000|Overall Study|Adverse Event|1|||
126231994|NCT00462982|454140511|FG000|Overall Study|Patient Not Treated|2|||
126231995|NCT00409578|454140512|FG000|Overall Study|Adverse Event|27|||
126231996|NCT00409578|454140513|FG001|Overall Study|Adverse Event|37|||
126231997|NCT00409578|454140514|FG002|Overall Study|Adverse Event|25|||
126231998|NCT00409578|454140515|FG003|Overall Study|Adverse Event|33|||
126231999|NCT00409578|454140512|FG000|Overall Study|Abnormal laboratory value(s)|2|||
126232000|NCT00409578|454140513|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126232001|NCT00409578|454140514|FG002|Overall Study|Abnormal laboratory value(s)|2|||
126232002|NCT00409578|454140515|FG003|Overall Study|Abnormal laboratory value(s)|4|||
126232003|NCT00409578|454140512|FG000|Overall Study|Lack of Efficacy|0|||
126232004|NCT00409578|454140513|FG001|Overall Study|Lack of Efficacy|0|||
126232005|NCT00409578|454140514|FG002|Overall Study|Lack of Efficacy|0|||
126232006|NCT00409578|454140515|FG003|Overall Study|Lack of Efficacy|2|||
126232007|NCT00409578|454140512|FG000|Overall Study|Subject no longer requires study drug|0|||
126232008|NCT00409578|454140513|FG001|Overall Study|Subject no longer requires study drug|0|||
126232009|NCT00409578|454140514|FG002|Overall Study|Subject no longer requires study drug|0|||
126232010|NCT00409578|454140515|FG003|Overall Study|Subject no longer requires study drug|1|||
126232011|NCT00409578|454140512|FG000|Overall Study|Withdrawal by Subject|8|||
126232012|NCT00409578|454140513|FG001|Overall Study|Withdrawal by Subject|15|||
126232013|NCT00409578|454140514|FG002|Overall Study|Withdrawal by Subject|16|||
126232014|NCT00409578|454140515|FG003|Overall Study|Withdrawal by Subject|17|||
126232015|NCT00409578|454140512|FG000|Overall Study|Lost to Follow-up|2|||
126232016|NCT00409578|454140513|FG001|Overall Study|Lost to Follow-up|0|||
126232017|NCT00409578|454140514|FG002|Overall Study|Lost to Follow-up|2|||
126232018|NCT00409578|454140515|FG003|Overall Study|Lost to Follow-up|2|||
126232019|NCT00409578|454140512|FG000|Overall Study|Administrative problems|8|||
126232020|NCT00409578|454140513|FG001|Overall Study|Administrative problems|9|||
126232021|NCT00409578|454140514|FG002|Overall Study|Administrative problems|2|||
126232022|NCT00409578|454140515|FG003|Overall Study|Administrative problems|4|||
126232023|NCT00409578|454140512|FG000|Overall Study|Death|2|||
126232024|NCT00409578|454140513|FG001|Overall Study|Death|4|||
126232025|NCT00409578|454140514|FG002|Overall Study|Death|4|||
126232026|NCT00409578|454140515|FG003|Overall Study|Death|2|||
126232027|NCT00409578|454140512|FG000|Overall Study|Protocol Violation|3|||
126232028|NCT00409578|454140513|FG001|Overall Study|Protocol Violation|2|||
126232029|NCT00409578|454140514|FG002|Overall Study|Protocol Violation|3|||
126232030|NCT00409578|454140515|FG003|Overall Study|Protocol Violation|1|||
126232031|NCT00409578|454140512|FG000|Overall Study|Missing|0|||
126232032|NCT00409578|454140513|FG001|Overall Study|Missing|1|||
126232033|NCT00409578|454140514|FG002|Overall Study|Missing|0|||
126232034|NCT00409578|454140515|FG003|Overall Study|Missing|1|||
126232035|NCT02109133|454140516|FG000|Overall Study|Lost to Follow-up|1|||
126232036|NCT02109133|454140517|FG001|Overall Study|Lost to Follow-up|0|||
126232037|NCT00770315|454140518|FG000|Overall Study|Adverse Event|11|||
126232038|NCT00770315|454140519|FG001|Overall Study|Adverse Event|17|||
126232039|NCT00770315|454140520|FG002|Overall Study|Adverse Event|16|||
126232040|NCT00770315|454140521|FG003|Overall Study|Adverse Event|6|||
126232041|NCT00770315|454140518|FG000|Overall Study|Lost to Follow-up|9|||
126232042|NCT00770315|454140519|FG001|Overall Study|Lost to Follow-up|5|||
126232043|NCT00770315|454140520|FG002|Overall Study|Lost to Follow-up|10|||
126232044|NCT00770315|454140521|FG003|Overall Study|Lost to Follow-up|3|||
126232045|NCT00770315|454140518|FG000|Overall Study|Withdrawal by Subject|13|||
126232046|NCT00770315|454140519|FG001|Overall Study|Withdrawal by Subject|17|||
126232047|NCT00770315|454140520|FG002|Overall Study|Withdrawal by Subject|24|||
126232048|NCT00770315|454140521|FG003|Overall Study|Withdrawal by Subject|20|||
126232049|NCT00770315|454140518|FG000|Overall Study|Noncompliance with Protocol|7|||
126232050|NCT00770315|454140519|FG001|Overall Study|Noncompliance with Protocol|4|||
126232051|NCT00770315|454140520|FG002|Overall Study|Noncompliance with Protocol|7|||
126232052|NCT00770315|454140521|FG003|Overall Study|Noncompliance with Protocol|9|||
126232053|NCT02322047|454142485|FG000|Overall Study|Physician Decision|1|||
126232054|NCT02322047|454142486|FG001|Overall Study|Physician Decision|0|||
126232055|NCT02322047|454142487|FG002|Overall Study|Physician Decision|0|||
126232056|NCT02322047|454142488|FG003|Overall Study|Physician Decision|0|||
126232057|NCT02322047|454142485|FG000|Overall Study|Withdrawal by Subject|1|||
126232058|NCT02322047|454142486|FG001|Overall Study|Withdrawal by Subject|0|||
126232059|NCT02322047|454142487|FG002|Overall Study|Withdrawal by Subject|0|||
126232060|NCT02322047|454142488|FG003|Overall Study|Withdrawal by Subject|1|||
126232061|NCT02322047|454142485|FG000|Overall Study|Adverse Event|0|||
126232062|NCT02322047|454142486|FG001|Overall Study|Adverse Event|1|||
126232063|NCT02322047|454142487|FG002|Overall Study|Adverse Event|0|||
126232064|NCT02322047|454142488|FG003|Overall Study|Adverse Event|0|||
126232065|NCT02322047|454142485|FG000|Overall Study|Lost to Follow-up|0|||
126232066|NCT02322047|454142486|FG001|Overall Study|Lost to Follow-up|0|||
126232067|NCT02322047|454142487|FG002|Overall Study|Lost to Follow-up|1|||
126232068|NCT02322047|454142488|FG003|Overall Study|Lost to Follow-up|1|||
126232069|NCT02207231|454142489|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
126232070|NCT02207231|454142490|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
126232071|NCT02207231|454142491|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
126232072|NCT02207231|454142492|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
126232073|NCT02207231|454142489|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
126232074|NCT02207231|454142490|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
126232075|NCT02207231|454142491|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
126232076|NCT02207231|454142492|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
126232077|NCT02207231|454142489|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
126232078|NCT02207231|454142490|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
126232079|NCT02207231|454142491|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
126232080|NCT02207231|454142492|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
126232081|NCT02207231|454142489|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
126232082|NCT02207231|454142490|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
126232083|NCT02207231|454142491|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
126232084|NCT02207231|454142492|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
126232085|NCT02207231|454142489|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
126232086|NCT02207231|454142490|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
126232087|NCT02207231|454142491|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
126232088|NCT02207231|454142492|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
126232089|NCT02207231|454142489|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
126232090|NCT02207231|454142490|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
126232091|NCT02207231|454142491|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
126232092|NCT02207231|454142492|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
126232093|NCT02207231|454142489|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
126232094|NCT02207231|454142490|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
126232095|NCT02207231|454142491|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
126232096|NCT02207231|454142492|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
126232097|NCT02207231|454142489|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
126232098|NCT02207231|454142490|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
126232099|NCT02207231|454142491|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
126232100|NCT02207231|454142492|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
126232101|NCT02207231|454142489|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
126232102|NCT02207231|454142490|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
126232103|NCT02207231|454142491|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
126232104|NCT02207231|454142492|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
126232105|NCT02207231|454142489|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
126022739|NCT02576509|453378572|FG001|Treatment Period|Poor/non-compliance|1|||
126232106|NCT02207231|454142490|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
126232107|NCT02207231|454142491|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
126232108|NCT02207231|454142492|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
126232109|NCT02207231|454142489|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
126232110|NCT02207231|454142490|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
126232111|NCT02207231|454142491|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
126232112|NCT02207231|454142492|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
126232113|NCT02207231|454142489|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
126232114|NCT02207231|454142490|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
126232115|NCT02207231|454142491|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
126232116|NCT02207231|454142492|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
126232117|NCT02207231|454142489|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
126232118|NCT02207231|454142490|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
126232119|NCT02207231|454142491|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
126232120|NCT02207231|454142492|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
126232121|NCT02207231|454142489|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
126232122|NCT02207231|454142490|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
126232123|NCT02207231|454142491|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
126353645|NCT00625378|454585848|FG001|Overall Study|Switch to commercial drug|1|||
126353646|NCT00625378|454585847|FG000|Overall Study|Missing|2|||
126353647|NCT00625378|454585848|FG001|Overall Study|Missing|0|||
126353648|NCT00625378|454585847|FG000|Overall Study|End of treatment not available|2|||
126353649|NCT00625378|454585848|FG001|Overall Study|End of treatment not available|0|||
126353650|NCT00625378|454585847|FG000|Overall Study|Never treated|2|||
126353651|NCT00625378|454585848|FG001|Overall Study|Never treated|0|||
126353652|NCT02639559|454585850|FG000|Overall Study|Mobilization failure|0|||
126353653|NCT02639559|454585851|FG001|Overall Study|Mobilization failure|3|||
126353654|NCT02639559|454585850|FG000|Overall Study|Issues with vascular acess|1|||
126353655|NCT02639559|454585851|FG001|Overall Study|Issues with vascular acess|0|||
126353656|NCT03880565|454585852|FG000|Overall Study|Withdrawal by Subject|1|||
126353657|NCT03880565|454585853|FG001|Overall Study|Withdrawal by Subject|0|||
126353658|NCT02969018|454585858|FG000|Overall Study|Adverse Event|2|||
126353659|NCT02969018|454585859|FG001|Overall Study|Adverse Event|4|||
126022740|NCT02576509|453378571|FG000|Treatment Period|Participant no longer meets criteria|1|||
126022741|NCT02576509|453378572|FG001|Treatment Period|Participant no longer meets criteria|0|||
126232124|NCT02207231|454142492|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
126353660|NCT02969018|454585860|FG002|Overall Study|Adverse Event|1|||
126353661|NCT02969018|454585861|FG003|Overall Study|Adverse Event|2|||
126353662|NCT02969018|454585862|FG004|Overall Study|Adverse Event|0|||
126353663|NCT02969018|454585863|FG005|Overall Study|Adverse Event|1|||
126232125|NCT02207231|454142489|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
126232126|NCT02207231|454142490|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
126232127|NCT02207231|454142491|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
126232128|NCT02207231|454142492|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
126232129|NCT02207231|454142489|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
126232130|NCT02207231|454142490|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
126232131|NCT02207231|454142491|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
126232132|NCT02207231|454142492|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
126232133|NCT02207231|454142489|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
126232134|NCT02207231|454142490|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
126232135|NCT02207231|454142491|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
126232136|NCT02207231|454142492|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
126232137|NCT02207231|454142489|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
126232138|NCT02207231|454142490|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
126232139|NCT02207231|454142491|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
126232140|NCT02207231|454142492|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
126232141|NCT02207231|454142489|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
126232142|NCT02207231|454142490|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
126232143|NCT02207231|454142491|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
126232144|NCT02207231|454142492|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
126232145|NCT02207231|454142489|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
126232146|NCT02207231|454142490|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
126232147|NCT02207231|454142491|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
126232148|NCT02207231|454142492|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
126232149|NCT02207231|454142489|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
126232150|NCT02207231|454142490|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
126232151|NCT02207231|454142491|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
126232152|NCT02207231|454142492|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
126232153|NCT02016300|454142496|FG000|Overall Study|Lost to Follow-up|0|||
126232154|NCT02016300|454142497|FG001|Overall Study|Lost to Follow-up|3|||
126232155|NCT06165744|454142498|FG000|Overall Study|Non device-related adverse event|1|||
126232156|NCT05456529|454142499|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
126232157|NCT05456529|454142499|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
126232158|NCT05456529|454142499|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
126232159|NCT05456529|454142499|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
126232160|NCT05456529|454142499|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
126232161|NCT05456529|454142499|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
126232162|NCT05456529|454142499|FG000|44-week Long-term Safety Period|Physician Decision|2|||
126232163|NCT05456529|454142499|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
126232164|NCT05456529|454142499|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
126232165|NCT05456529|454142499|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
126232166|NCT05456529|454142499|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
126232167|NCT01631864|454142500|FG000|Overall Study|Withdrawal by Subject|0|||
126232168|NCT01631864|454142501|FG001|Overall Study|Withdrawal by Subject|1|||
126232169|NCT01631864|454142500|FG000|Overall Study|Adverse Event|2|||
126232170|NCT01631864|454142501|FG001|Overall Study|Adverse Event|3|||
126232171|NCT03702621|454142518|FG000|Overall Study|Physician Decision|6|||
126232172|NCT03702621|454142519|FG001|Overall Study|Physician Decision|6|||
126232173|NCT03194464|454142521|FG000|Overall Study|data not usable|2|||
126232174|NCT03103100|454142522|FG000|Overall Study|Adverse Event|1|||
126232175|NCT03103100|454142523|FG001|Overall Study|Adverse Event|0|||
126232176|NCT03103100|454142524|FG002|Overall Study|Adverse Event|0|||
126022742|NCT02576509|453378571|FG000|Treatment Period|Other reason|12|||
126232177|NCT03103100|454142522|FG000|Overall Study|Physician Decision|1|||
126232178|NCT03103100|454142523|FG001|Overall Study|Physician Decision|0|||
126232179|NCT03103100|454142524|FG002|Overall Study|Physician Decision|2|||
126232180|NCT00436007|454142527|FG000|Overall Study|Withdrawal by Subject|5|||
126232181|NCT00436007|454142528|FG001|Overall Study|Withdrawal by Subject|3|||
126232182|NCT00436007|454142529|FG002|Overall Study|Withdrawal by Subject|4|||
126232183|NCT00436007|454142527|FG000|Overall Study|Lost to Follow-up|14|||
126232184|NCT00436007|454142528|FG001|Overall Study|Lost to Follow-up|10|||
126232185|NCT00436007|454142529|FG002|Overall Study|Lost to Follow-up|13|||
126232186|NCT00436007|454142527|FG000|Overall Study|Physician Decision|0|||
126232187|NCT00436007|454142528|FG001|Overall Study|Physician Decision|0|||
126232188|NCT00436007|454142529|FG002|Overall Study|Physician Decision|2|||
126232189|NCT00436007|454142527|FG000|Overall Study|Death|0|||
126232190|NCT00436007|454142528|FG001|Overall Study|Death|1|||
126232191|NCT00436007|454142529|FG002|Overall Study|Death|3|||
126232192|NCT00436007|454142527|FG000|Overall Study|Other|0|||
126232193|NCT00436007|454142528|FG001|Overall Study|Other|0|||
126232194|NCT00436007|454142529|FG002|Overall Study|Other|1|||
126232195|NCT00810368|454142530|FG000|Overall Study|Lost to Follow-up|4|||
126232196|NCT00810368|454142531|FG001|Overall Study|Lost to Follow-up|2|||
126232197|NCT00810368|454142530|FG000|Overall Study|Lack of Efficacy|2|||
126232198|NCT00810368|454142531|FG001|Overall Study|Lack of Efficacy|0|||
126232199|NCT03365375|454142536|FG000|Overall Study|Withdrawal by Subject|0|||
126232200|NCT03365375|454142537|FG001|Overall Study|Withdrawal by Subject|1|||
126232201|NCT03365375|454142536|FG000|Overall Study|Lost to Follow-up|0|||
126232202|NCT03365375|454142537|FG001|Overall Study|Lost to Follow-up|4|||
126232203|NCT00266409|454142541|FG000|Overall Study|Lack of Efficacy|2|||
126232204|NCT00266409|454142542|FG001|Overall Study|Lack of Efficacy|6|||
126232205|NCT00266409|454142543|FG002|Overall Study|Lack of Efficacy|1|||
126232206|NCT00266409|454142544|FG003|Overall Study|Lack of Efficacy|2|||
126232207|NCT00266409|454142541|FG000|Overall Study|Adverse Event|7|||
126232208|NCT00266409|454142542|FG001|Overall Study|Adverse Event|2|||
126353664|NCT02969018|454585864|FG006|Overall Study|Adverse Event|2|||
126353665|NCT02969018|454585865|FG007|Overall Study|Adverse Event|0|||
126353666|NCT02969018|454585858|FG000|Overall Study|Lack of Efficacy|0|||
126353667|NCT02969018|454585859|FG001|Overall Study|Lack of Efficacy|1|||
126353668|NCT02969018|454585860|FG002|Overall Study|Lack of Efficacy|0|||
126353669|NCT02969018|454585861|FG003|Overall Study|Lack of Efficacy|0|||
126022743|NCT02576509|453378572|FG001|Treatment Period|Other reason|8|||
126232209|NCT00266409|454142543|FG002|Overall Study|Adverse Event|1|||
126232210|NCT00266409|454142544|FG003|Overall Study|Adverse Event|1|||
126353670|NCT02969018|454585862|FG004|Overall Study|Lack of Efficacy|1|||
126353671|NCT02969018|454585863|FG005|Overall Study|Lack of Efficacy|1|||
126353672|NCT02969018|454585864|FG006|Overall Study|Lack of Efficacy|1|||
126353673|NCT02969018|454585865|FG007|Overall Study|Lack of Efficacy|1|||
126353674|NCT02969018|454585858|FG000|Overall Study|Lost to Follow-up|1|||
126353675|NCT02969018|454585859|FG001|Overall Study|Lost to Follow-up|2|||
126353676|NCT02969018|454585860|FG002|Overall Study|Lost to Follow-up|2|||
126353677|NCT02969018|454585861|FG003|Overall Study|Lost to Follow-up|0|||
126353678|NCT02969018|454585862|FG004|Overall Study|Lost to Follow-up|1|||
126353679|NCT02969018|454585863|FG005|Overall Study|Lost to Follow-up|1|||
126353680|NCT02969018|454585864|FG006|Overall Study|Lost to Follow-up|0|||
126353681|NCT02969018|454585865|FG007|Overall Study|Lost to Follow-up|1|||
126353682|NCT02969018|454585858|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353683|NCT02969018|454585859|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353684|NCT02969018|454585860|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353685|NCT02969018|454585861|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353686|NCT02969018|454585862|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353687|NCT02969018|454585863|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
126232211|NCT00266409|454142541|FG000|Overall Study|Lost to Follow-up|18|||
126232212|NCT00266409|454142542|FG001|Overall Study|Lost to Follow-up|21|||
126232213|NCT00266409|454142543|FG002|Overall Study|Lost to Follow-up|6|||
126232214|NCT00266409|454142544|FG003|Overall Study|Lost to Follow-up|8|||
126232215|NCT00266409|454142541|FG000|Overall Study|Withdrawal by Subject|6|||
126232216|NCT00266409|454142542|FG001|Overall Study|Withdrawal by Subject|10|||
126232217|NCT00266409|454142543|FG002|Overall Study|Withdrawal by Subject|3|||
126232218|NCT00266409|454142544|FG003|Overall Study|Withdrawal by Subject|9|||
126232219|NCT00266409|454142541|FG000|Overall Study|Protocol Violation|5|||
126232220|NCT00266409|454142542|FG001|Overall Study|Protocol Violation|3|||
126232221|NCT00266409|454142543|FG002|Overall Study|Protocol Violation|4|||
126232222|NCT00266409|454142544|FG003|Overall Study|Protocol Violation|2|||
126232223|NCT00266409|454142541|FG000|Overall Study|Other|7|||
126353688|NCT02969018|454585864|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
126353689|NCT02969018|454585865|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
126232224|NCT00266409|454142542|FG001|Overall Study|Other|4|||
126232225|NCT00266409|454142543|FG002|Overall Study|Other|2|||
126232226|NCT00266409|454142544|FG003|Overall Study|Other|0|||
126232227|NCT00635154|454142545|FG000|Overall Study|Alternative Treatment|8|||
126232228|NCT00635154|454142545|FG000|Overall Study|Other|4|||
126232229|NCT00635154|454142545|FG000|Overall Study|Still on treatment|21|||
126232230|NCT01399736|454142546|FG000|Overall Study|Withdrawal by Subject|4|||
126232231|NCT01399736|454142547|FG001|Overall Study|Withdrawal by Subject|2|||
126232232|NCT01399736|454142546|FG000|Overall Study|Lost to Follow-up|0|||
126232233|NCT01399736|454142547|FG001|Overall Study|Lost to Follow-up|2|||
126232234|NCT03500484|454142548|FG000|Overall Study|Adverse Event|2|||
126232235|NCT03500484|454142549|FG001|Overall Study|Adverse Event|0|||
126232236|NCT03500484|454142548|FG000|Overall Study|Physician Decision|1|||
126232237|NCT03500484|454142549|FG001|Overall Study|Physician Decision|0|||
126232238|NCT03500484|454142548|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
126232239|NCT03500484|454142549|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
126232240|NCT02795104|454142550|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
126232241|NCT02795104|454142551|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
126232242|NCT02795104|454142552|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
126232243|NCT02795104|454142550|FG000|Overall Study|Withdrawal by Subject|0|||
126232244|NCT02795104|454142551|FG001|Overall Study|Withdrawal by Subject|2|||
126232245|NCT02795104|454142552|FG002|Overall Study|Withdrawal by Subject|0|||
126022744|NCT02576509|453378571|FG000|Treatment Period|NOT REPORTED|1|||
126022745|NCT02576509|453378572|FG001|Treatment Period|NOT REPORTED|0|||
126022746|NCT02576509|453378571|FG000|Treatment Period|Administrative reason by sponsor|0|||
126022747|NCT02576509|453378572|FG001|Treatment Period|Administrative reason by sponsor|1|||
126022748|NCT04688450|453378573|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
126232246|NCT02795104|454142550|FG000|Overall Study|Lost to Follow-up|0|||
126232247|NCT02795104|454142551|FG001|Overall Study|Lost to Follow-up|0|||
126232248|NCT02795104|454142552|FG002|Overall Study|Lost to Follow-up|1|||
126232249|NCT00770510|454142553|FG000|Overall Study|Lost to Follow-up|2|||
126232250|NCT00770510|454142553|FG000|Overall Study|Pregnancy|1|||
126232251|NCT00770510|454142553|FG000|Overall Study|Withdrawal by Subject|2|||
126022749|NCT04688450|453378573|FG000|Overall Study|Withdrawal by Subject|1|||
126022750|NCT04278586|453378575|FG000|Overall Study|Withdrawal by Subject|13|||
126103468|NCT04620811|453672167|FG000|Overall Study|Sponsor Decision|0|||
126022751|NCT04278586|453378576|FG001|Overall Study|Withdrawal by Subject|6|||
126022752|NCT04278586|453378575|FG000|Overall Study|Lost to Follow-up|37|||
126022753|NCT04278586|453378576|FG001|Overall Study|Lost to Follow-up|24|||
126022754|NCT05386238|453378582|FG000|Overall Study|Lost to Follow-up|3|||
126022755|NCT05386238|453378583|FG001|Overall Study|Lost to Follow-up|2|||
126022756|NCT05386238|453378582|FG000|Overall Study|Withdrawal by Subject|0|||
126022757|NCT05386238|453378583|FG001|Overall Study|Withdrawal by Subject|1|||
126022758|NCT05057897|453378584|FG000|Overall Study|Site closure|2|||
126022759|NCT05057897|453378585|FG001|Overall Study|Site closure|2|||
126232252|NCT00995553|454142557|FG000|Overall Study|Withdrawal by Subject|2|||
126232253|NCT00995553|454142558|FG001|Overall Study|Withdrawal by Subject|6|||
126353690|NCT02969018|454585858|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126353691|NCT02969018|454585859|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126353692|NCT02969018|454585860|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126353693|NCT02969018|454585861|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126353694|NCT02969018|454585862|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126353695|NCT02969018|454585863|FG005|Overall Study|Non-Compliance With Study Drug|0|||
126353696|NCT02969018|454585864|FG006|Overall Study|Non-Compliance With Study Drug|0|||
126353697|NCT02969018|454585865|FG007|Overall Study|Non-Compliance With Study Drug|0|||
126353698|NCT02969018|454585858|FG000|Overall Study|Other|0|||
126353699|NCT02969018|454585859|FG001|Overall Study|Other|0|||
126353700|NCT02969018|454585860|FG002|Overall Study|Other|0|||
126353701|NCT02969018|454585861|FG003|Overall Study|Other|1|||
126353702|NCT02969018|454585862|FG004|Overall Study|Other|0|||
126353703|NCT02969018|454585863|FG005|Overall Study|Other|0|||
126353704|NCT02969018|454585864|FG006|Overall Study|Other|0|||
126353705|NCT02969018|454585865|FG007|Overall Study|Other|2|||
126353706|NCT02969018|454585858|FG000|Overall Study|Pregnancy|0|||
126353707|NCT02969018|454585859|FG001|Overall Study|Pregnancy|0|||
126353708|NCT02969018|454585860|FG002|Overall Study|Pregnancy|0|||
126353709|NCT02969018|454585861|FG003|Overall Study|Pregnancy|0|||
126353710|NCT02969018|454585862|FG004|Overall Study|Pregnancy|0|||
126353711|NCT02969018|454585863|FG005|Overall Study|Pregnancy|1|||
126353712|NCT02969018|454585864|FG006|Overall Study|Pregnancy|0|||
126353713|NCT02969018|454585865|FG007|Overall Study|Pregnancy|0|||
126353714|NCT02969018|454585858|FG000|Overall Study|Protocol Violation|0|||
126353715|NCT02969018|454585859|FG001|Overall Study|Protocol Violation|0|||
126353716|NCT02969018|454585860|FG002|Overall Study|Protocol Violation|1|||
126353717|NCT02969018|454585861|FG003|Overall Study|Protocol Violation|1|||
126353718|NCT02969018|454585862|FG004|Overall Study|Protocol Violation|0|||
126353719|NCT02969018|454585863|FG005|Overall Study|Protocol Violation|0|||
126353720|NCT02969018|454585864|FG006|Overall Study|Protocol Violation|0|||
126353721|NCT02969018|454585865|FG007|Overall Study|Protocol Violation|0|||
126353722|NCT02969018|454585858|FG000|Overall Study|Withdrawal by Subject|0|||
126353723|NCT02969018|454585859|FG001|Overall Study|Withdrawal by Subject|1|||
126353724|NCT02969018|454585860|FG002|Overall Study|Withdrawal by Subject|2|||
126353725|NCT02969018|454585861|FG003|Overall Study|Withdrawal by Subject|1|||
126353726|NCT02969018|454585862|FG004|Overall Study|Withdrawal by Subject|0|||
126353727|NCT02969018|454585863|FG005|Overall Study|Withdrawal by Subject|4|||
126353728|NCT02969018|454585864|FG006|Overall Study|Withdrawal by Subject|4|||
126353729|NCT02969018|454585865|FG007|Overall Study|Withdrawal by Subject|3|||
126353730|NCT00367458|454585866|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
126353731|NCT00367458|454585867|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
126353732|NCT05762679|454585873|FG000|Overall Study|Withdrawal by Subject|1|||
126353733|NCT05762679|454585873|FG000|Overall Study|No analyzable imaging data|1|||
126353734|NCT03670628|454585874|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
126353735|NCT03670628|454585875|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
126353736|NCT03670628|454585874|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
126353737|NCT03670628|454585875|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
126353738|NCT01716156|454585877|FG000|Overall Study|Protocol Violation|1|||
126353739|NCT01716156|454585878|FG001|Overall Study|Protocol Violation|0|||
126353740|NCT01716156|454585879|FG002|Overall Study|Protocol Violation|0|||
126353741|NCT01716156|454585877|FG000|Overall Study|Withdrawal by Subject|0|||
126353742|NCT01716156|454585878|FG001|Overall Study|Withdrawal by Subject|1|||
126353743|NCT01716156|454585879|FG002|Overall Study|Withdrawal by Subject|2|||
126022760|NCT05057897|453378584|FG000|Overall Study|Death|1|||
126353744|NCT01716156|454585877|FG000|Overall Study|Lost to Follow-up|1|||
126353745|NCT01716156|454585878|FG001|Overall Study|Lost to Follow-up|0|||
126353746|NCT01716156|454585879|FG002|Overall Study|Lost to Follow-up|0|||
126353747|NCT03925220|454585880|FG000|Overall Study|Withdrawal by Subject|4|||
126353748|NCT03925220|454585881|FG001|Overall Study|Withdrawal by Subject|4|||
126353749|NCT03925220|454585882|FG002|Overall Study|Withdrawal by Subject|4|||
126353750|NCT03925220|454585883|FG003|Overall Study|Withdrawal by Subject|4|||
126022761|NCT05057897|453378585|FG001|Overall Study|Death|0|||
126232254|NCT01089647|454142559|FG000|Overall Study|Lost to Follow-up|2|||
126022762|NCT04714320|453378586|FG000|Overall Study|Voluntary Withdrawal|4|||
126022763|NCT04714320|453378587|FG001|Overall Study|Voluntary Withdrawal|1|||
126022764|NCT04714320|453378588|FG002|Overall Study|Voluntary Withdrawal|2|||
126022765|NCT04714320|453378586|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
126232255|NCT01089647|454142560|FG001|Overall Study|Lost to Follow-up|2|||
126232256|NCT01089647|454142559|FG000|Overall Study|Withdrawal by Subject|2|||
126353751|NCT03925220|454585880|FG000|Overall Study|Lost to Follow-up|40|||
126103469|NCT04620811|453672168|FG001|Overall Study|Sponsor Decision|1|||
126353752|NCT03925220|454585881|FG001|Overall Study|Lost to Follow-up|46|||
126353753|NCT03925220|454585882|FG002|Overall Study|Lost to Follow-up|37|||
126353754|NCT03925220|454585883|FG003|Overall Study|Lost to Follow-up|38|||
126353755|NCT05561140|454585884|FG000|Randomized Treatment Period|Adverse Event|1|||
126353756|NCT05561140|454585885|FG001|Randomized Treatment Period|Adverse Event|0|||
126353757|NCT05561140|454585884|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
126353758|NCT05561140|454585885|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
126353759|NCT05561140|454585884|FG000|Open Label Treatment Period|Adverse Event|6|||
126353760|NCT05561140|454585885|FG001|Open Label Treatment Period|Adverse Event|4|||
126353761|NCT05561140|454585884|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
126353762|NCT05561140|454585885|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
126353763|NCT05561140|454585884|FG000|Open Label Treatment Period|Physician Decision|0|||
126353764|NCT05561140|454585885|FG001|Open Label Treatment Period|Physician Decision|1|||
126353765|NCT05561140|454585884|FG000|Open Label Treatment Period|Pregnancy|1|||
126353766|NCT05561140|454585885|FG001|Open Label Treatment Period|Pregnancy|0|||
126353767|NCT05561140|454585884|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
126353768|NCT05561140|454585885|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
126353769|NCT05561140|454585884|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
126353770|NCT05561140|454585885|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
126353771|NCT05561140|454585884|FG000|Open Label Treatment Period|Other|1|||
126353772|NCT05561140|454585885|FG001|Open Label Treatment Period|Other|0|||
126353773|NCT06377488|454585886|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
126353774|NCT06377488|454585886|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
126353775|NCT06377488|454585886|FG000|Overall Study|Protocol Violation|1|||
126353776|NCT06377488|454585886|FG000|Overall Study|Lost to Follow-up|1|||
126353777|NCT06377488|454585886|FG000|Overall Study|Incorrect Lens Dispensed|2|||
126353778|NCT03325439|454585887|FG000|Overall Study|Ineligibility|3|||
126353779|NCT00774748|454585890|FG000|Overall Study|Lost to Follow-up|3|||
126353780|NCT00303953|454585891|FG000|Overall Study|Ineligible|1|||
126353781|NCT00303953|454585891|FG000|Overall Study|Death|1|||
126353782|NCT00303953|454585891|FG000|Overall Study|Adverse Event|4|||
126353783|NCT00303953|454585891|FG000|Overall Study|Lack of Efficacy|12|||
126353784|NCT00303953|454585891|FG000|Overall Study|Physician Decision|1|||
126353785|NCT00387127|454585892|FG000|Overall Study|Lost to Follow-up|0|||
126353786|NCT00387127|454585893|FG001|Overall Study|Lost to Follow-up|4|||
126353787|NCT00387127|454585892|FG000|Overall Study|Death|16|||
126353788|NCT00387127|454585893|FG001|Overall Study|Death|16|||
126353789|NCT00387127|454585892|FG000|Overall Study|Physician Decision|0|||
126353790|NCT00387127|454585893|FG001|Overall Study|Physician Decision|1|||
126353791|NCT00387127|454585892|FG000|Overall Study|Withdrawal by Subject|3|||
126353792|NCT00387127|454585893|FG001|Overall Study|Withdrawal by Subject|2|||
126353793|NCT00387127|454585892|FG000|Overall Study|Required by Protocol Amendment #4|12|||
126353794|NCT00387127|454585893|FG001|Overall Study|Required by Protocol Amendment #4|10|||
126353795|NCT00387127|454585892|FG000|Overall Study|Serious Adverse Event|1|||
126353796|NCT00387127|454585893|FG001|Overall Study|Serious Adverse Event|1|||
126353797|NCT00387127|454585892|FG000|Overall Study|Sponsor Unblinded|1|||
126353798|NCT00387127|454585893|FG001|Overall Study|Sponsor Unblinded|0|||
126353799|NCT05089357|454585894|FG000|Overall Study|Withdrawal by Subject|23|||
126353800|NCT05089357|454585894|FG000|Overall Study|Lost to Follow-up|6|||
126353801|NCT05089357|454585894|FG000|Overall Study|Medical reason|1|||
126353802|NCT05089357|454585894|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
126353803|NCT05089357|454585894|FG000|Overall Study|Pregnancy|2|||
126353804|NCT05537571|454585895|FG000|Overall Study|Withdrawal by Subject|1|||
126353805|NCT05537571|454585896|FG001|Overall Study|Withdrawal by Subject|1|||
126353806|NCT05537571|454585897|FG002|Overall Study|Withdrawal by Subject|0|||
126353807|NCT05537571|454585898|FG003|Overall Study|Withdrawal by Subject|0|||
126353808|NCT05537571|454585899|FG004|Overall Study|Withdrawal by Subject|0|||
126353809|NCT05537571|454585895|FG000|Overall Study|Adverse Event|2|||
126353810|NCT05537571|454585896|FG001|Overall Study|Adverse Event|0|||
126353811|NCT05537571|454585897|FG002|Overall Study|Adverse Event|0|||
126353812|NCT05537571|454585898|FG003|Overall Study|Adverse Event|0|||
126353813|NCT05537571|454585899|FG004|Overall Study|Adverse Event|0|||
126353814|NCT05537571|454585895|FG000|Overall Study|Hepatitis A screening result|2|||
126353815|NCT05537571|454585896|FG001|Overall Study|Hepatitis A screening result|0|||
126353816|NCT05537571|454585897|FG002|Overall Study|Hepatitis A screening result|0|||
126022766|NCT04714320|453378587|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
126022767|NCT04714320|453378588|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
126022768|NCT04714320|453378586|FG000|Overall Study|Reason Not Specified|1|||
126022769|NCT04714320|453378587|FG001|Overall Study|Reason Not Specified|3|||
126232257|NCT01089647|454142560|FG001|Overall Study|Withdrawal by Subject|1|||
126232258|NCT01089647|454142559|FG000|Overall Study|Adverse Event|0|||
126022770|NCT04714320|453378588|FG002|Overall Study|Reason Not Specified|3|||
126022771|NCT03346538|453378589|FG000|Overall Study|Physician Decision|0|||
126022772|NCT03346538|453378590|FG001|Overall Study|Physician Decision|1|||
126022773|NCT03346538|453378591|FG002|Overall Study|Physician Decision|0|||
126022774|NCT03346538|453378589|FG000|Overall Study|Withdrawal by Subject|3|||
126022775|NCT03346538|453378590|FG001|Overall Study|Withdrawal by Subject|2|||
126022776|NCT03346538|453378591|FG002|Overall Study|Withdrawal by Subject|0|||
126022777|NCT03346538|453378589|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
126022778|NCT03346538|453378590|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
126022779|NCT03346538|453378591|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
126022780|NCT01353313|453378592|FG000|Overall Study|Lost to Follow-up|22|||
126022781|NCT01353313|453378593|FG001|Overall Study|Lost to Follow-up|23|||
126022782|NCT01353313|453378592|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
126022783|NCT01353313|453378593|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
126022784|NCT04755660|453378594|FG000|Overall Study|Lost to Follow-up|1|||
126022785|NCT04755660|453378595|FG001|Overall Study|Lost to Follow-up|1|||
126022786|NCT04755660|453378596|FG002|Overall Study|Lost to Follow-up|0|||
126022787|NCT04755660|453378594|FG000|Overall Study|Withdrawal by Subject|0|||
126232259|NCT01089647|454142560|FG001|Overall Study|Adverse Event|1|||
126232260|NCT00927810|454142561|FG000|Overall Study|Withdrawal by Subject|0|||
126232261|NCT00927810|454142562|FG001|Overall Study|Withdrawal by Subject|3|||
126232262|NCT00927810|454142563|FG002|Overall Study|Withdrawal by Subject|0|||
126232263|NCT00927810|454142564|FG003|Overall Study|Withdrawal by Subject|1|||
126232264|NCT00927810|454142561|FG000|Overall Study|Lost to Follow-up|0|||
126232265|NCT00927810|454142562|FG001|Overall Study|Lost to Follow-up|2|||
126232266|NCT00927810|454142563|FG002|Overall Study|Lost to Follow-up|1|||
126232267|NCT00927810|454142564|FG003|Overall Study|Lost to Follow-up|1|||
126232268|NCT00927810|454142561|FG000|Overall Study|Death|0|||
126232269|NCT00927810|454142562|FG001|Overall Study|Death|2|||
126232270|NCT00927810|454142563|FG002|Overall Study|Death|0|||
126232271|NCT00927810|454142564|FG003|Overall Study|Death|0|||
126232272|NCT00927810|454142561|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126232273|NCT00927810|454142562|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126232274|NCT00927810|454142563|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126232275|NCT00927810|454142564|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126232276|NCT00198029|454142570|FG000|Overall Study|Withdrawal by Subject|4|||
126232277|NCT00814463|454142573|FG000|Overall Study|Lost to Follow-up|1|||
126232278|NCT03982433|454142574|FG000|Overall Study|Lost to Follow-up|1|||
126232279|NCT00368277|454142575|FG000|Overall Study|Adverse Event|33|||
126232280|NCT00368277|454142576|FG001|Overall Study|Adverse Event|49|||
126232281|NCT00368277|454142575|FG000|Overall Study|Death|2|||
126232282|NCT00368277|454142576|FG001|Overall Study|Death|1|||
126232283|NCT00368277|454142575|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
126232284|NCT00368277|454142576|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
126232285|NCT00368277|454142575|FG000|Overall Study|Protocol deviation|7|||
126232286|NCT00368277|454142576|FG001|Overall Study|Protocol deviation|0|||
126232287|NCT00368277|454142575|FG000|Overall Study|Patient withdrew consent|32|||
126232288|NCT00368277|454142576|FG001|Overall Study|Patient withdrew consent|28|||
126353817|NCT05537571|454585898|FG003|Overall Study|Hepatitis A screening result|0|||
126353818|NCT05537571|454585899|FG004|Overall Study|Hepatitis A screening result|0|||
126353819|NCT05537571|454585895|FG000|Overall Study|Lost to Follow-up|0|||
126353820|NCT05537571|454585896|FG001|Overall Study|Lost to Follow-up|0|||
126353821|NCT05537571|454585897|FG002|Overall Study|Lost to Follow-up|1|||
126353822|NCT05537571|454585898|FG003|Overall Study|Lost to Follow-up|0|||
126353823|NCT05537571|454585899|FG004|Overall Study|Lost to Follow-up|1|||
126353824|NCT05752487|454585904|FG000|Overall Study|Enrolled, not treated|9|||
126353825|NCT05752487|454585904|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
126353826|NCT05752487|454585904|FG000|Overall Study|Withdrawal by Subject|2|||
126353827|NCT03091439|454585905|FG000|Overall Study|Study Terminated by the Sponsor|1|||
126353828|NCT03091439|454585906|FG001|Overall Study|Study Terminated by the Sponsor|0|||
126353829|NCT01860989|454585907|FG000|Overall Study|Unsatisfactory therapeutic|5|||
126353830|NCT01685437|454585910|FG000|Overall Study|Withdrawal by Subject|22|||
126353831|NCT01685437|454585910|FG000|Overall Study|Lost to Follow-up|3|||
126353832|NCT01685437|454585910|FG000|Overall Study|Adverse Event|1|||
126353833|NCT01685437|454585910|FG000|Overall Study|Protocol Violation|4|||
126353834|NCT01685437|454585910|FG000|Overall Study|Unable to make visits due to work|1|||
126353835|NCT03770455|454585917|FG000|Overall Study|Screen failures|3|||
126353836|NCT01039675|454585920|FG000|Overall Study|Adverse Event|0|||
126353837|NCT01039675|454585921|FG001|Overall Study|Adverse Event|2|||
126353838|NCT01039675|454585920|FG000|Overall Study|Lack of Efficacy|0|||
126353839|NCT01039675|454585921|FG001|Overall Study|Lack of Efficacy|2|||
126353840|NCT01039675|454585920|FG000|Overall Study|Withdrawal by Subject|0|||
126353841|NCT01039675|454585921|FG001|Overall Study|Withdrawal by Subject|1|||
126353842|NCT01039675|454585920|FG000|Overall Study|Lost to Follow-up|0|||
126353843|NCT01039675|454585921|FG001|Overall Study|Lost to Follow-up|1|||
126353844|NCT01039675|454585920|FG000|Overall Study|Physician Decision|0|||
126353845|NCT01039675|454585921|FG001|Overall Study|Physician Decision|1|||
126353846|NCT00134719|454587495|FG000|Primary Vaccination Phase|Adverse Event|4|||
126353847|NCT00134719|454587496|FG001|Primary Vaccination Phase|Adverse Event|0|||
126353848|NCT00134719|454587497|FG002|Primary Vaccination Phase|Adverse Event|0|||
126353849|NCT00134719|454587495|FG000|Primary Vaccination Phase|Protocol Violation|1|||
126353850|NCT00134719|454587496|FG001|Primary Vaccination Phase|Protocol Violation|0|||
126353851|NCT00134719|454587497|FG002|Primary Vaccination Phase|Protocol Violation|0|||
126353852|NCT00134719|454587495|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
126353853|NCT00134719|454587496|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
126353854|NCT00134719|454587497|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
126353855|NCT00134719|454587495|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
126353856|NCT00134719|454587496|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
126353857|NCT00134719|454587497|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
126353858|NCT00134719|454587495|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
126353859|NCT00134719|454587496|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
126353860|NCT00134719|454587497|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
126353861|NCT00134719|454587495|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
126353862|NCT00134719|454587496|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
126353863|NCT00134719|454587497|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
126353864|NCT03439839|454587498|FG000|Overall Study|Death|3|||
126353865|NCT03439839|454587499|FG001|Overall Study|Death|0|||
126353866|NCT02582632|454587505|FG000|Overall Study|Other|1|||
126353867|NCT03298061|454587506|FG000|Overall Study|Adverse Event|3|||
126353868|NCT03298061|454587506|FG000|Overall Study|Lack of Efficacy|6|||
126353869|NCT03298061|454587506|FG000|Overall Study|Protocol Violation|1|||
126353870|NCT03298061|454587506|FG000|Overall Study|Physician Decision|7|||
126353871|NCT03298061|454587506|FG000|Overall Study|Withdrawal by Subject|10|||
126353872|NCT00992836|454587509|FG000|Overall Study|Lost to Follow-up|1|||
126353873|NCT00992836|454587509|FG000|Overall Study|Withdrawal by Subject|2|||
126353874|NCT00992836|454587509|FG000|Overall Study|Protocol Violation|2|||
126353875|NCT01617967|454587513|FG000|Overall Study|Protocol Violation|0|||
126353876|NCT01617967|454587514|FG001|Overall Study|Protocol Violation|0|||
126353877|NCT01617967|454587515|FG002|Overall Study|Protocol Violation|0|||
126353878|NCT01617967|454587516|FG003|Overall Study|Protocol Violation|1|||
126353879|NCT01617967|454587517|FG004|Overall Study|Protocol Violation|0|||
126353880|NCT01617967|454587518|FG005|Overall Study|Protocol Violation|0|||
126353881|NCT01617967|454587513|FG000|Overall Study|Withdrawal by Subject|0|||
126353882|NCT01617967|454587514|FG001|Overall Study|Withdrawal by Subject|0|||
126353883|NCT01617967|454587515|FG002|Overall Study|Withdrawal by Subject|0|||
126353884|NCT01617967|454587516|FG003|Overall Study|Withdrawal by Subject|0|||
126353885|NCT01617967|454587517|FG004|Overall Study|Withdrawal by Subject|0|||
126353886|NCT01617967|454587518|FG005|Overall Study|Withdrawal by Subject|1|||
126353887|NCT01617967|454587513|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
126353888|NCT01617967|454587514|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
126022788|NCT04755660|453378595|FG001|Overall Study|Withdrawal by Subject|1|||
126022789|NCT04755660|453378596|FG002|Overall Study|Withdrawal by Subject|1|||
126022790|NCT04755660|453378594|FG000|Overall Study|Physician Decision|0|||
126022791|NCT04755660|453378595|FG001|Overall Study|Physician Decision|0|||
126022792|NCT04755660|453378596|FG002|Overall Study|Physician Decision|1|||
126022793|NCT05672667|453378598|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
126022794|NCT04524390|453378599|FG000|Double Blind|Consent Withdrawal by subject|2|||
126022795|NCT04524390|453378600|FG001|Double Blind|Consent Withdrawal by subject|1|||
126022796|NCT04524390|453378601|FG002|Double Blind|Consent Withdrawal by subject|0|||
126022797|NCT04524390|453378599|FG000|Double Blind|Adverse Event|5|||
126022798|NCT04524390|453378600|FG001|Double Blind|Adverse Event|3|||
126022799|NCT04524390|453378601|FG002|Double Blind|Adverse Event|0|||
126022800|NCT04524390|453378599|FG000|Double Blind|Liver Transplant|5|||
126022801|NCT04524390|453378600|FG001|Double Blind|Liver Transplant|6|||
126022802|NCT04524390|453378601|FG002|Double Blind|Liver Transplant|0|||
126022803|NCT04524390|453378599|FG000|Double Blind|Disease Progression|0|||
126022804|NCT04524390|453378600|FG001|Double Blind|Disease Progression|1|||
126022805|NCT04524390|453378601|FG002|Double Blind|Disease Progression|0|||
126022806|NCT04524390|453378599|FG000|Open-Label|Drug interruption criteria|0|||
126022807|NCT04524390|453378600|FG001|Open-Label|Drug interruption criteria|0|||
126022808|NCT04524390|453378601|FG002|Open-Label|Drug interruption criteria|1|||
126022809|NCT04524390|453378599|FG000|Open-Label|Liver Transplant|0|||
126022810|NCT04524390|453378600|FG001|Open-Label|Liver Transplant|0|||
126022811|NCT04524390|453378601|FG002|Open-Label|Liver Transplant|1|||
126022812|NCT04524390|453378599|FG000|Open-Label|Disease Progression|0|||
126022813|NCT04524390|453378600|FG001|Open-Label|Disease Progression|0|||
126022814|NCT04524390|453378601|FG002|Open-Label|Disease Progression|1|||
126022815|NCT04524390|453378599|FG000|Open-Label|Adverse Event|0|||
126022816|NCT04524390|453378600|FG001|Open-Label|Adverse Event|0|||
126022817|NCT04524390|453378601|FG002|Open-Label|Adverse Event|3|||
126022818|NCT04524390|453378599|FG000|Open-Label|Study Termination by sponsor|0|||
126022819|NCT04524390|453378600|FG001|Open-Label|Study Termination by sponsor|0|||
126022820|NCT04524390|453378601|FG002|Open-Label|Study Termination by sponsor|45|||
126232289|NCT00368277|454142575|FG000|Overall Study|Lost to Follow-up|8|||
126022821|NCT04540913|453378614|FG000|Overall Study|Withdrawal by Subject|14|||
126022822|NCT04540913|453378615|FG001|Overall Study|Withdrawal by Subject|3|||
126022823|NCT03438188|453378616|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
126022824|NCT03438188|453378617|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
126022825|NCT03438188|453378618|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
126022826|NCT03438188|453378616|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
126022827|NCT03438188|453378617|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
126232290|NCT00368277|454142576|FG001|Overall Study|Lost to Follow-up|6|||
126232291|NCT00984295|454142577|FG000|Overall Study|Lost to Follow-up|31|||
126232292|NCT00984295|454142578|FG001|Overall Study|Lost to Follow-up|12|||
126232293|NCT00984295|454142579|FG002|Overall Study|Lost to Follow-up|13|||
126232294|NCT00984295|454142577|FG000|Overall Study|Protocol Violation|2|||
126232295|NCT00984295|454142578|FG001|Overall Study|Protocol Violation|1|||
126353889|NCT01617967|454587515|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
126022828|NCT03438188|453378618|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
126022829|NCT03438188|453378616|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
126022830|NCT03438188|453378617|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
126353890|NCT01617967|454587516|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
126353891|NCT01617967|454587517|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
126353892|NCT01617967|454587518|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
126353893|NCT05276804|454587523|FG000|Overall Study|screen failure|23|||
126353894|NCT05276804|454587524|FG001|Overall Study|screen failure|0|||
126353895|NCT02827708|454587525|FG000|Overall Study|Lost to Follow-up|3|||
126353896|NCT02827708|454587526|FG001|Overall Study|Lost to Follow-up|1|||
126353897|NCT02827708|454587525|FG000|Overall Study|Withdrawal by Subject|1|||
126353898|NCT02827708|454587526|FG001|Overall Study|Withdrawal by Subject|2|||
126353899|NCT02827708|454587525|FG000|Overall Study|Death|1|||
126353900|NCT02827708|454587526|FG001|Overall Study|Death|2|||
126353901|NCT01137812|454587527|FG000|Overall Study|Adverse Event|21|||
126353902|NCT01137812|454587528|FG001|Overall Study|Adverse Event|14|||
126353903|NCT01137812|454587527|FG000|Overall Study|Lost to Follow-up|6|||
126353904|NCT01137812|454587528|FG001|Overall Study|Lost to Follow-up|8|||
126353905|NCT01137812|454587527|FG000|Overall Study|Physician Decision|25|||
126353906|NCT01137812|454587528|FG001|Overall Study|Physician Decision|17|||
126022831|NCT03438188|453378618|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
126022832|NCT03438188|453378616|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
126022833|NCT03438188|453378617|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
126232296|NCT00984295|454142579|FG002|Overall Study|Protocol Violation|4|||
126232297|NCT00984295|454142577|FG000|Overall Study|Withdrawal by Subject|18|||
126232298|NCT00984295|454142578|FG001|Overall Study|Withdrawal by Subject|9|||
126353907|NCT01137812|454587527|FG000|Overall Study|Protocol Violation|5|||
126353908|NCT01137812|454587528|FG001|Overall Study|Protocol Violation|4|||
126022834|NCT03438188|453378618|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
126022835|NCT03438188|453378616|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
126022836|NCT03438188|453378617|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
126022837|NCT03438188|453378618|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
126022838|NCT00670046|453378619|FG000|Overall Study|Lost to Follow-up|1|||
126022839|NCT00670046|453378620|FG001|Overall Study|Lost to Follow-up|1|||
126022840|NCT00670046|453378619|FG000|Overall Study|Withdrawal by Subject|0|||
126022841|NCT00670046|453378620|FG001|Overall Study|Withdrawal by Subject|1|||
126022842|NCT00431834|453378627|FG000|Overall Study|Withdrawal by Subject|7|||
126022843|NCT00431834|453378627|FG000|Overall Study|Death|3|||
126022844|NCT00431834|453378627|FG000|Overall Study|Missed Endpoint Visit|2|||
126022845|NCT00431834|453378627|FG000|Overall Study|Lost to Follow-up|1|||
126022846|NCT02461628|453378633|FG000|Overall Study|Refused to complete survey|4|||
126022847|NCT02461628|453378634|FG001|Overall Study|Refused to complete survey|7|||
126022848|NCT05052996|453378635|FG000|Overall Study|Still on study|0|||
126022849|NCT05052996|453378636|FG001|Overall Study|Still on study|0|||
126022850|NCT05052996|453378637|FG002|Overall Study|Still on study|47|||
126022851|NCT05052996|453378638|FG003|Overall Study|Still on study|44|||
126022852|NCT05052996|453378635|FG000|Overall Study|Cohort terminated by sponsor|21|||
126022853|NCT05052996|453378636|FG001|Overall Study|Cohort terminated by sponsor|12|||
126022854|NCT05052996|453378637|FG002|Overall Study|Cohort terminated by sponsor|0|||
126022855|NCT05052996|453378638|FG003|Overall Study|Cohort terminated by sponsor|0|||
126022856|NCT05052996|453378635|FG000|Overall Study|Withdrew consent|1|||
126022857|NCT05052996|453378636|FG001|Overall Study|Withdrew consent|0|||
126022858|NCT05052996|453378637|FG002|Overall Study|Withdrew consent|1|||
126022859|NCT05052996|453378638|FG003|Overall Study|Withdrew consent|2|||
126022860|NCT05052996|453378635|FG000|Overall Study|Lost to Follow-up|1|||
126022861|NCT05052996|453378636|FG001|Overall Study|Lost to Follow-up|0|||
126022862|NCT05052996|453378637|FG002|Overall Study|Lost to Follow-up|0|||
126022863|NCT05052996|453378638|FG003|Overall Study|Lost to Follow-up|2|||
126022864|NCT05052996|453378635|FG000|Overall Study|Adverse Event|0|||
126022865|NCT05052996|453378636|FG001|Overall Study|Adverse Event|0|||
126022866|NCT05052996|453378637|FG002|Overall Study|Adverse Event|2|||
126022867|NCT05052996|453378638|FG003|Overall Study|Adverse Event|0|||
126022868|NCT05052996|453378635|FG000|Overall Study|Randomized but never treated|0|||
126022869|NCT05052996|453378636|FG001|Overall Study|Randomized but never treated|0|||
126022870|NCT05052996|453378637|FG002|Overall Study|Randomized but never treated|1|||
126022871|NCT05052996|453378638|FG003|Overall Study|Randomized but never treated|1|||
126022872|NCT05052996|453378635|FG000|Overall Study|Protocol Violation|1|||
126022873|NCT05052996|453378636|FG001|Overall Study|Protocol Violation|0|||
126232299|NCT00984295|454142579|FG002|Overall Study|Withdrawal by Subject|12|||
126022874|NCT05052996|453378637|FG002|Overall Study|Protocol Violation|0|||
126022875|NCT05052996|453378638|FG003|Overall Study|Protocol Violation|0|||
126022876|NCT04704284|453378644|FG000|Overall Study|Withdrawal by Subject|1|||
126022877|NCT00087139|453378648|FG000|Overall Study|Adverse Event|18|||
126022878|NCT00087139|453378649|FG001|Overall Study|Adverse Event|17|||
126022879|NCT00087139|453378650|FG002|Overall Study|Adverse Event|13|||
126022880|NCT00087139|453378648|FG000|Overall Study|Death|2|||
126022881|NCT00087139|453378649|FG001|Overall Study|Death|1|||
126022882|NCT00087139|453378650|FG002|Overall Study|Death|0|||
126022883|NCT00087139|453378648|FG000|Overall Study|Withdrawal by Subject|3|||
126022884|NCT00087139|453378649|FG001|Overall Study|Withdrawal by Subject|2|||
126022885|NCT00087139|453378650|FG002|Overall Study|Withdrawal by Subject|2|||
126022886|NCT00087139|453378648|FG000|Overall Study|Physician Decision|1|||
126022887|NCT00087139|453378649|FG001|Overall Study|Physician Decision|1|||
126022888|NCT00087139|453378650|FG002|Overall Study|Physician Decision|1|||
126022889|NCT00087139|453378648|FG000|Overall Study|Disease progression|9|||
126022890|NCT00087139|453378649|FG001|Overall Study|Disease progression|19|||
126022891|NCT00087139|453378650|FG002|Overall Study|Disease progression|12|||
126022892|NCT00087139|453378648|FG000|Overall Study|Ineligible|4|||
126022893|NCT00087139|453378649|FG001|Overall Study|Ineligible|7|||
126022894|NCT00087139|453378650|FG002|Overall Study|Ineligible|4|||
126022895|NCT00087139|453378648|FG000|Overall Study|Symptomatic deterioration|1|||
126022896|NCT00087139|453378649|FG001|Overall Study|Symptomatic deterioration|1|||
126022897|NCT00087139|453378650|FG002|Overall Study|Symptomatic deterioration|3|||
126232300|NCT00984295|454142577|FG000|Overall Study|CAE - discontinued test vaccine|0|||
126232301|NCT00984295|454142578|FG001|Overall Study|CAE - discontinued test vaccine|1|||
126232302|NCT00984295|454142579|FG002|Overall Study|CAE - discontinued test vaccine|3|||
126232303|NCT00984295|454142577|FG000|Overall Study|Missed one or more blood samplings|3|||
126232304|NCT00984295|454142578|FG001|Overall Study|Missed one or more blood samplings|7|||
126232305|NCT00984295|454142579|FG002|Overall Study|Missed one or more blood samplings|2|||
126232306|NCT00984295|454142577|FG000|Overall Study|Incomplete safety follow-up|11|||
126232307|NCT00984295|454142578|FG001|Overall Study|Incomplete safety follow-up|2|||
126232308|NCT00984295|454142579|FG002|Overall Study|Incomplete safety follow-up|3|||
126232309|NCT04799158|454142580|FG000|Run-In Period|Adverse Event|6|||
126232310|NCT04799158|454142581|FG001|Run-In Period|Adverse Event|0|||
126232311|NCT04799158|454142582|FG002|Run-In Period|Adverse Event|0|||
126232312|NCT04799158|454142583|FG003|Run-In Period|Adverse Event|0|||
126232313|NCT04799158|454142584|FG004|Run-In Period|Adverse Event|0|||
126232314|NCT04799158|454142580|FG000|Run-In Period|Lost to Follow-up|4|||
126232315|NCT04799158|454142581|FG001|Run-In Period|Lost to Follow-up|0|||
126232316|NCT04799158|454142582|FG002|Run-In Period|Lost to Follow-up|0|||
126232317|NCT04799158|454142583|FG003|Run-In Period|Lost to Follow-up|0|||
126232318|NCT04799158|454142584|FG004|Run-In Period|Lost to Follow-up|0|||
126232319|NCT04799158|454142580|FG000|Run-In Period|Significant Protocol Deviation|1|||
126232320|NCT04799158|454142581|FG001|Run-In Period|Significant Protocol Deviation|0|||
126232321|NCT04799158|454142582|FG002|Run-In Period|Significant Protocol Deviation|0|||
126232322|NCT04799158|454142583|FG003|Run-In Period|Significant Protocol Deviation|0|||
126232323|NCT04799158|454142584|FG004|Run-In Period|Significant Protocol Deviation|0|||
126232324|NCT04799158|454142580|FG000|Run-In Period|Withdrawal by Subject|11|||
126232325|NCT04799158|454142581|FG001|Run-In Period|Withdrawal by Subject|0|||
126232326|NCT04799158|454142582|FG002|Run-In Period|Withdrawal by Subject|0|||
126232327|NCT04799158|454142583|FG003|Run-In Period|Withdrawal by Subject|0|||
126232328|NCT04799158|454142584|FG004|Run-In Period|Withdrawal by Subject|0|||
126232329|NCT04799158|454142580|FG000|Run-In Period|Miscellaneous|3|||
126232330|NCT04799158|454142581|FG001|Run-In Period|Miscellaneous|0|||
126232331|NCT04799158|454142582|FG002|Run-In Period|Miscellaneous|0|||
126232332|NCT04799158|454142583|FG003|Run-In Period|Miscellaneous|0|||
126232333|NCT04799158|454142584|FG004|Run-In Period|Miscellaneous|0|||
126232334|NCT04799158|454142580|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
126232335|NCT04799158|454142581|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
126232336|NCT04799158|454142582|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
126232337|NCT04799158|454142583|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
126232338|NCT04799158|454142584|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
126232339|NCT04799158|454142580|FG000|On-Demand Treatment Period|Adverse Event|0|||
126232340|NCT04799158|454142581|FG001|On-Demand Treatment Period|Adverse Event|1|||
126232341|NCT04799158|454142582|FG002|On-Demand Treatment Period|Adverse Event|0|||
126232342|NCT04799158|454142583|FG003|On-Demand Treatment Period|Adverse Event|0|||
126232343|NCT04799158|454142584|FG004|On-Demand Treatment Period|Adverse Event|1|||
126232344|NCT04799158|454142580|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
126232345|NCT04799158|454142581|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
126232346|NCT04799158|454142582|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
126232347|NCT04799158|454142583|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
126232348|NCT04799158|454142584|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
126232349|NCT04799158|454142580|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
126232350|NCT04799158|454142581|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
126232351|NCT04799158|454142582|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
126232352|NCT04799158|454142583|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
126232353|NCT04799158|454142584|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
126232354|NCT04799158|454142580|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
126232355|NCT04799158|454142581|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
126232356|NCT04799158|454142582|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
126353909|NCT01137812|454587527|FG000|Overall Study|Withdrawal by Subject|5|||
126353910|NCT01137812|454587528|FG001|Overall Study|Withdrawal by Subject|13|||
126353911|NCT01137812|454587527|FG000|Overall Study|Death|2|||
126353912|NCT01137812|454587528|FG001|Overall Study|Death|0|||
126353913|NCT01137812|454587527|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
126353914|NCT01137812|454587528|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
126353915|NCT01137812|454587527|FG000|Overall Study|Other|19|||
126353916|NCT01137812|454587528|FG001|Overall Study|Other|27|||
126353917|NCT04621760|454587532|FG000|Overall Study|Lost to Follow-up|2|||
126353918|NCT04621760|454587533|FG001|Overall Study|Lost to Follow-up|4|||
126353919|NCT04621760|454587532|FG000|Overall Study|Withdrawal by Subject|1|||
126353920|NCT04621760|454587533|FG001|Overall Study|Withdrawal by Subject|0|||
126353921|NCT04602000|454587534|FG000|Overall Study|Withdrawal by Subject|3|||
126353922|NCT04602000|454587535|FG001|Overall Study|Withdrawal by Subject|6|||
126353923|NCT04602000|454587536|FG002|Overall Study|Withdrawal by Subject|3|||
126353924|NCT04602000|454587537|FG003|Overall Study|Withdrawal by Subject|27|||
126353925|NCT04602000|454587538|FG004|Overall Study|Withdrawal by Subject|39|||
126022898|NCT00087139|453378648|FG000|Overall Study|Use of coumadin|1|||
126232357|NCT04799158|454142583|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
126232358|NCT04799158|454142584|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
126232359|NCT04799158|454142580|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
126232360|NCT04799158|454142581|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
126232361|NCT04799158|454142582|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
126232362|NCT04799158|454142583|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
126232363|NCT04799158|454142584|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
126232364|NCT04799158|454142580|FG000|On-Demand Treatment Period|Miscellaneous|0|||
126232365|NCT04799158|454142581|FG001|On-Demand Treatment Period|Miscellaneous|0|||
126232366|NCT04799158|454142582|FG002|On-Demand Treatment Period|Miscellaneous|0|||
126232367|NCT04799158|454142583|FG003|On-Demand Treatment Period|Miscellaneous|0|||
126232368|NCT04799158|454142584|FG004|On-Demand Treatment Period|Miscellaneous|1|||
126232369|NCT03283709|454142600|FG000|Overall Study|trial terminated|0|||
126232370|NCT03283709|454142601|FG001|Overall Study|trial terminated|1|||
126232371|NCT01734772|454142602|FG000|Overall Study|Adverse Event|1|||
126232372|NCT01734772|454142603|FG001|Overall Study|Adverse Event|2|||
126232373|NCT01734772|454142602|FG000|Overall Study|Withdrawal by Subject|0|||
126232374|NCT01734772|454142603|FG001|Overall Study|Withdrawal by Subject|1|||
126232375|NCT02097121|454142606|FG000|Overall Study|Other, not specified|4|||
126232376|NCT02097121|454142607|FG001|Overall Study|Other, not specified|2|||
126232377|NCT02097121|454142608|FG002|Overall Study|Other, not specified|3|||
126232378|NCT02097121|454142606|FG000|Overall Study|Lack of Efficacy|2|||
126232379|NCT02097121|454142607|FG001|Overall Study|Lack of Efficacy|1|||
126232380|NCT02097121|454142608|FG002|Overall Study|Lack of Efficacy|3|||
126232381|NCT02097121|454142606|FG000|Overall Study|Withdrawal by Subject|0|||
126232382|NCT02097121|454142607|FG001|Overall Study|Withdrawal by Subject|1|||
126353926|NCT04602000|454587534|FG000|Overall Study|Physician Decision|1|||
126353927|NCT04602000|454587535|FG001|Overall Study|Physician Decision|0|||
126353928|NCT04602000|454587536|FG002|Overall Study|Physician Decision|0|||
126353929|NCT04602000|454587537|FG003|Overall Study|Physician Decision|2|||
126353930|NCT04602000|454587538|FG004|Overall Study|Physician Decision|2|||
126353931|NCT04602000|454587534|FG000|Overall Study|Death|0|||
126353932|NCT04602000|454587535|FG001|Overall Study|Death|1|||
126353933|NCT04602000|454587536|FG002|Overall Study|Death|0|||
126353934|NCT04602000|454587537|FG003|Overall Study|Death|1|||
126353935|NCT04602000|454587538|FG004|Overall Study|Death|2|||
126353936|NCT04602000|454587534|FG000|Overall Study|Lost to Follow-up|0|||
126353937|NCT04602000|454587535|FG001|Overall Study|Lost to Follow-up|0|||
126353938|NCT04602000|454587536|FG002|Overall Study|Lost to Follow-up|0|||
126353939|NCT04602000|454587537|FG003|Overall Study|Lost to Follow-up|3|||
126353940|NCT04602000|454587538|FG004|Overall Study|Lost to Follow-up|4|||
126353941|NCT04602000|454587534|FG000|Overall Study|Other|4|||
126353942|NCT04602000|454587535|FG001|Overall Study|Other|1|||
126353943|NCT04602000|454587536|FG002|Overall Study|Other|2|||
126353944|NCT04602000|454587537|FG003|Overall Study|Other|5|||
126353945|NCT04602000|454587538|FG004|Overall Study|Other|4|||
126353946|NCT04602000|454587534|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
126353947|NCT04602000|454587535|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
126353948|NCT04602000|454587536|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
126353949|NCT04602000|454587537|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
126353950|NCT04602000|454587538|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
126353951|NCT00471354|454587540|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
126353952|NCT00471354|454587540|FG000|Overall Study|Adverse Event|13|||
126353953|NCT00471354|454587540|FG000|Overall Study|Protocol Violation|12|||
126353954|NCT00471354|454587540|FG000|Overall Study|Withdrawal by Subject|1|||
126353955|NCT00471354|454587540|FG000|Overall Study|Physician Decision|4|||
126353956|NCT00471354|454587540|FG000|Overall Study|Sponsor Decision|1|||
126353957|NCT00471354|454587540|FG000|Overall Study|Lost to Follow-up|3|||
126353958|NCT00471354|454587540|FG000|Overall Study|Lack of Efficacy|5|||
126353959|NCT00471354|454587540|FG000|Overall Study|Patient/Caregiver Decision|12|||
126353960|NCT01875237|454587541|FG000|Overall Study|GVDH before DLI|1|||
126353961|NCT01875237|454587542|FG001|Overall Study|GVDH before DLI|0|||
126353962|NCT01875237|454587541|FG000|Overall Study|DLI cells could not be produced|1|||
126353963|NCT01875237|454587542|FG001|Overall Study|DLI cells could not be produced|0|||
126353964|NCT01913470|454587546|FG000|Overall Study|Lost to Follow-up|0|||
126353965|NCT01913470|454587547|FG001|Overall Study|Lost to Follow-up|1|||
126353966|NCT01913470|454587546|FG000|Overall Study|Physician Decision|0|||
126353967|NCT01913470|454587547|FG001|Overall Study|Physician Decision|1|||
126353968|NCT01913470|454587546|FG000|Overall Study|Withdrawal by Subject|0|||
126232383|NCT02097121|454142608|FG002|Overall Study|Withdrawal by Subject|2|||
126232384|NCT02097121|454142606|FG000|Overall Study|Adverse Event|0|||
126232385|NCT02097121|454142607|FG001|Overall Study|Adverse Event|1|||
126232386|NCT02097121|454142608|FG002|Overall Study|Adverse Event|0|||
126232387|NCT02097121|454142606|FG000|Overall Study|Lost to Follow-up|1|||
126232388|NCT02097121|454142607|FG001|Overall Study|Lost to Follow-up|1|||
126232389|NCT02097121|454142608|FG002|Overall Study|Lost to Follow-up|2|||
126232390|NCT03066999|454142609|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
126232391|NCT03066999|454142610|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
126232392|NCT00661999|454142611|FG000|Overall Study|Adverse Event|11|||
126232393|NCT00661999|454142612|FG001|Overall Study|Adverse Event|5|||
126232394|NCT00661999|454142613|FG002|Overall Study|Adverse Event|8|||
126232395|NCT00661999|454142611|FG000|Overall Study|Death|8|||
126232396|NCT00661999|454142612|FG001|Overall Study|Death|6|||
126232397|NCT00661999|454142613|FG002|Overall Study|Death|3|||
126232398|NCT00661999|454142611|FG000|Overall Study|Other Reasons|5|||
126232399|NCT00661999|454142612|FG001|Overall Study|Other Reasons|12|||
126232400|NCT00661999|454142613|FG002|Overall Study|Other Reasons|23|||
126232401|NCT00661999|454142611|FG000|Overall Study|Withdrawal by Subject|30|||
126232402|NCT00661999|454142612|FG001|Overall Study|Withdrawal by Subject|23|||
126232403|NCT00661999|454142613|FG002|Overall Study|Withdrawal by Subject|14|||
126232404|NCT00661999|454142611|FG000|Overall Study|Alternative Treatment|1|||
126232405|NCT00661999|454142612|FG001|Overall Study|Alternative Treatment|0|||
126232406|NCT00661999|454142613|FG002|Overall Study|Alternative Treatment|0|||
126232407|NCT00661999|454142611|FG000|Overall Study|Other Medical Problems|4|||
126232408|NCT00661999|454142612|FG001|Overall Study|Other Medical Problems|4|||
126232409|NCT00661999|454142613|FG002|Overall Study|Other Medical Problems|9|||
126093128|NCT00958841|453634532|FG000|Overall Study|Abnormal test procedure result(s)|3|||
126093129|NCT00958841|453634532|FG000|Overall Study|Administrative problems|1|||
126232410|NCT00510510|454142614|FG000|Overall Study|Adverse Event|4|||
126232411|NCT00510510|454142615|FG001|Overall Study|Adverse Event|3|||
126093130|NCT00958841|453634532|FG000|Overall Study|Adverse Event|8|||
126093131|NCT00958841|453634532|FG000|Overall Study|New cancer therapy|5|||
126093132|NCT00958841|453634532|FG000|Overall Study|Withdrawal by Subject|1|||
126093133|NCT00958841|453634532|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
126232412|NCT00510510|454142616|FG002|Overall Study|Adverse Event|6|||
126232413|NCT00510510|454142614|FG000|Overall Study|Lack of Efficacy|0|||
126232414|NCT00510510|454142615|FG001|Overall Study|Lack of Efficacy|1|||
126232415|NCT00510510|454142616|FG002|Overall Study|Lack of Efficacy|1|||
126232416|NCT00510510|454142614|FG000|Overall Study|Subjects no longer requires study drug|0|||
126232417|NCT00510510|454142615|FG001|Overall Study|Subjects no longer requires study drug|0|||
126232418|NCT00510510|454142616|FG002|Overall Study|Subjects no longer requires study drug|2|||
126232419|NCT00510510|454142614|FG000|Overall Study|Withdrawal by Subject|1|||
126232420|NCT00510510|454142615|FG001|Overall Study|Withdrawal by Subject|2|||
126232421|NCT00510510|454142616|FG002|Overall Study|Withdrawal by Subject|3|||
126232422|NCT00510510|454142614|FG000|Overall Study|Lost to Follow-up|0|||
126232423|NCT00510510|454142615|FG001|Overall Study|Lost to Follow-up|0|||
126232424|NCT00510510|454142616|FG002|Overall Study|Lost to Follow-up|1|||
126232425|NCT00510510|454142614|FG000|Overall Study|Protocol Violation|0|||
126232426|NCT00510510|454142615|FG001|Overall Study|Protocol Violation|3|||
126232427|NCT00510510|454142616|FG002|Overall Study|Protocol Violation|4|||
126232428|NCT01790568|454142617|FG000|Overall Study|Progression prior to transplant|0|||
126232429|NCT01790568|454142618|FG001|Overall Study|Progression prior to transplant|1|||
126232430|NCT03595657|454142619|FG000|Overall Study|Adverse Event|14|||
126232431|NCT03595657|454142619|FG000|Overall Study|Death|1|||
126232432|NCT03595657|454142619|FG000|Overall Study|Lack of Efficacy|40|||
126232433|NCT03595657|454142619|FG000|Overall Study|Withdrawal by Subject|10|||
126232434|NCT03595657|454142619|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
126232435|NCT03595657|454142619|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
126232436|NCT02994056|454142620|FG000|Overall Study|Death|8|||
126232437|NCT02994056|454142620|FG000|Overall Study|Withdrew Consent|1|||
126232438|NCT03481309|454142626|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
126232439|NCT03481309|454142627|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126232440|NCT03481309|454142628|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126232441|NCT03481309|454142629|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126232442|NCT03481309|454142630|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126232443|NCT03481309|454142631|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126232444|NCT03495869|454142632|FG000|Overall Study|Lost to Follow-up|4|||
126232445|NCT03495869|454142633|FG001|Overall Study|Lost to Follow-up|17|||
126232446|NCT03495869|454142634|FG002|Overall Study|Lost to Follow-up|8|||
126232447|NCT03495869|454142635|FG003|Overall Study|Lost to Follow-up|14|||
126232448|NCT03495869|454142632|FG000|Overall Study|Withdrawal by Subject|0|||
126232449|NCT03495869|454142633|FG001|Overall Study|Withdrawal by Subject|3|||
126232450|NCT03495869|454142634|FG002|Overall Study|Withdrawal by Subject|0|||
126232451|NCT03495869|454142635|FG003|Overall Study|Withdrawal by Subject|3|||
126232452|NCT03495869|454142632|FG000|Overall Study|Dropped from study|0|||
126232453|NCT03495869|454142633|FG001|Overall Study|Dropped from study|7|||
126232454|NCT03495869|454142634|FG002|Overall Study|Dropped from study|2|||
126022899|NCT00087139|453378649|FG001|Overall Study|Use of coumadin|0|||
126022900|NCT00087139|453378650|FG002|Overall Study|Use of coumadin|0|||
126022901|NCT00087139|453378648|FG000|Overall Study|Response achieved|0|||
126232455|NCT03495869|454142635|FG003|Overall Study|Dropped from study|4|||
126022902|NCT00087139|453378649|FG001|Overall Study|Response achieved|1|||
126232456|NCT02346201|454142637|FG000|Overall Study|Adverse Event|3|||
126232457|NCT02346201|454142638|FG001|Overall Study|Adverse Event|2|||
126232458|NCT02346201|454142637|FG000|Overall Study|Lost to Follow-up|1|||
126232459|NCT02346201|454142638|FG001|Overall Study|Lost to Follow-up|0|||
126232460|NCT02346201|454142637|FG000|Overall Study|Withdrawal by Subject|6|||
126022903|NCT00087139|453378650|FG002|Overall Study|Response achieved|0|||
126022904|NCT00087139|453378648|FG000|Overall Study|Extradural disease|0|||
126022905|NCT00087139|453378649|FG001|Overall Study|Extradural disease|0|||
126022906|NCT00087139|453378650|FG002|Overall Study|Extradural disease|1|||
126022907|NCT00976495|453378651|FG000|Overall Study|Withdrawal by Subject|0|||
126022908|NCT00976495|453378652|FG001|Overall Study|Withdrawal by Subject|1|||
126022909|NCT00976495|453378653|FG002|Overall Study|Withdrawal by Subject|0|||
126022910|NCT00331136|453378654|FG000|Overall Study|Adverse Event|3|||
126022911|NCT00331136|453378655|FG001|Overall Study|Adverse Event|5|||
126022912|NCT00331136|453378656|FG002|Overall Study|Adverse Event|0|||
126022913|NCT00331136|453378657|FG003|Overall Study|Adverse Event|1|||
126022914|NCT00331136|453378654|FG000|Overall Study|Withdrawal by Subject|0|||
126022915|NCT00331136|453378655|FG001|Overall Study|Withdrawal by Subject|1|||
126022916|NCT00331136|453378656|FG002|Overall Study|Withdrawal by Subject|0|||
126022917|NCT00331136|453378657|FG003|Overall Study|Withdrawal by Subject|0|||
126022918|NCT00331136|453378654|FG000|Overall Study|Lost to Follow-up|0|||
126022919|NCT00331136|453378655|FG001|Overall Study|Lost to Follow-up|1|||
126022920|NCT00331136|453378656|FG002|Overall Study|Lost to Follow-up|0|||
126232461|NCT02346201|454142638|FG001|Overall Study|Withdrawal by Subject|3|||
126232462|NCT02346201|454142637|FG000|Overall Study|Unavailable for future follow-up|0|||
126232463|NCT02346201|454142638|FG001|Overall Study|Unavailable for future follow-up|1|||
126353969|NCT01913470|454587547|FG001|Overall Study|Withdrawal by Subject|1|||
126022921|NCT00331136|453378657|FG003|Overall Study|Lost to Follow-up|0|||
126022922|NCT00331136|453378654|FG000|Overall Study|Protocol Violation|1|||
126022923|NCT00331136|453378655|FG001|Overall Study|Protocol Violation|0|||
126022924|NCT00331136|453378656|FG002|Overall Study|Protocol Violation|0|||
126022925|NCT00331136|453378657|FG003|Overall Study|Protocol Violation|0|||
126022926|NCT00331136|453378654|FG000|Overall Study|Not treated|1|||
126022927|NCT00331136|453378655|FG001|Overall Study|Not treated|0|||
126022928|NCT00331136|453378656|FG002|Overall Study|Not treated|0|||
126022929|NCT00331136|453378657|FG003|Overall Study|Not treated|0|||
126022930|NCT03432858|453378664|FG000|Overall Study|Protocol Violation|2|||
126022931|NCT03432858|453378665|FG001|Overall Study|Protocol Violation|1|||
126022932|NCT03432858|453378666|FG002|Overall Study|Protocol Violation|9|||
126022933|NCT03432858|453378664|FG000|Overall Study|Withdrawal by Subject|0|||
126022934|NCT03432858|453378665|FG001|Overall Study|Withdrawal by Subject|1|||
126022935|NCT03432858|453378666|FG002|Overall Study|Withdrawal by Subject|1|||
126022936|NCT03432858|453378664|FG000|Overall Study|Procedure canceled/rescheduled|0|||
126353970|NCT02573467|454587548|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
126353971|NCT02573467|454587549|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
126353972|NCT02573467|454587550|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
126353973|NCT02573467|454587551|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
126353974|NCT02573467|454587548|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
126353975|NCT02573467|454587549|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
126353976|NCT02573467|454587550|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
126353977|NCT02573467|454587551|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
126353978|NCT02573467|454587548|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
126353979|NCT02573467|454587549|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
126353980|NCT02573467|454587550|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
126353981|NCT02573467|454587551|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
126353982|NCT02573467|454587548|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
126353983|NCT02573467|454587549|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
126353984|NCT02573467|454587550|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
126353985|NCT02573467|454587551|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
126353986|NCT02573467|454587548|FG000|Post-treatment Follow up Epoch|Death|1|||
126353987|NCT02573467|454587549|FG001|Post-treatment Follow up Epoch|Death|1|||
126353988|NCT02573467|454587550|FG002|Post-treatment Follow up Epoch|Death|0|||
126353989|NCT02573467|454587551|FG003|Post-treatment Follow up Epoch|Death|1|||
126353990|NCT02573467|454587548|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
126353991|NCT02573467|454587549|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
126353992|NCT02573467|454587550|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
126353993|NCT02573467|454587551|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
126353994|NCT02573467|454587548|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
126353995|NCT02573467|454587549|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
126353996|NCT02573467|454587550|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
126022937|NCT03432858|453378665|FG001|Overall Study|Procedure canceled/rescheduled|9|||
126022938|NCT03432858|453378666|FG002|Overall Study|Procedure canceled/rescheduled|6|||
126022939|NCT03432858|453378664|FG000|Overall Study|Required postop mobilization with splinting|0|||
126022940|NCT03432858|453378665|FG001|Overall Study|Required postop mobilization with splinting|0|||
126022941|NCT03432858|453378666|FG002|Overall Study|Required postop mobilization with splinting|1|||
126022942|NCT01044303|453378670|FG000|Overall Study|Lost to Follow-up|2|||
126022943|NCT04992390|453378683|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
126046466|NCT02467270|453468228|FG002|Overall Study|Non-compliance With Study Drug|1|||
126232464|NCT02346201|454142637|FG000|Overall Study|Physician Decision|0|||
126232465|NCT02346201|454142638|FG001|Overall Study|Physician Decision|1|||
126232466|NCT02346201|454142637|FG000|Overall Study|Missed final visit|0|||
126232467|NCT02346201|454142638|FG001|Overall Study|Missed final visit|2|||
126232468|NCT03708211|454142639|FG000|Overall Study|Progressive Disease|10|||
126232469|NCT03708211|454142640|FG001|Overall Study|Progressive Disease|7|||
126232470|NCT03708211|454142639|FG000|Overall Study|Withdrawal by Subject|0|||
126232471|NCT03708211|454142640|FG001|Overall Study|Withdrawal by Subject|1|||
126232472|NCT03708211|454142639|FG000|Overall Study|Other|2|||
126232473|NCT03708211|454142640|FG001|Overall Study|Other|0|||
126232474|NCT01508936|454142641|FG000|Overall Study|Adverse Event|11|||
126232475|NCT01508936|454142642|FG001|Overall Study|Adverse Event|32|||
126232476|NCT01508936|454142641|FG000|Overall Study|Lack of Efficacy|0|||
126232477|NCT01508936|454142642|FG001|Overall Study|Lack of Efficacy|1|||
126232478|NCT01508936|454142641|FG000|Overall Study|Withdrawal by Subject|4|||
126232479|NCT01508936|454142642|FG001|Overall Study|Withdrawal by Subject|18|||
126232480|NCT01508936|454142641|FG000|Overall Study|Protocol Violation|2|||
126232481|NCT01508936|454142642|FG001|Overall Study|Protocol Violation|3|||
126353997|NCT02573467|454587551|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
126353998|NCT00923702|454587552|FG000|Overall Study|Ongoing enrollment|0|||
126353999|NCT00923702|454587553|FG001|Overall Study|Ongoing enrollment|0|||
126354000|NCT00923702|454587554|FG002|Overall Study|Ongoing enrollment|0|||
126354001|NCT00923702|454587555|FG003|Overall Study|Ongoing enrollment|0|||
126354002|NCT00923702|454587556|FG004|Overall Study|Ongoing enrollment|354|||
126354003|NCT02153827|454587557|FG000|Overall Study|Lost to Follow-up|3|||
126354004|NCT02153827|454587558|FG001|Overall Study|Lost to Follow-up|9|||
126354005|NCT04790201|454587559|FG000|Overall Study|Lost to Follow-up|0|||
126354006|NCT04790201|454587560|FG001|Overall Study|Lost to Follow-up|0|||
126354007|NCT04790201|454587561|FG002|Overall Study|Lost to Follow-up|2|||
126354008|NCT04790201|454587559|FG000|Overall Study|Death|0|||
126354009|NCT04790201|454587560|FG001|Overall Study|Death|1|||
126354010|NCT04790201|454587561|FG002|Overall Study|Death|0|||
126354011|NCT04790201|454587559|FG000|Overall Study|Protocol Violation|1|||
126354012|NCT04790201|454587560|FG001|Overall Study|Protocol Violation|0|||
126354013|NCT04790201|454587561|FG002|Overall Study|Protocol Violation|1|||
126354014|NCT04339972|454587565|FG000|Overall Study|Scheduling Issues|3|||
126354015|NCT04339972|454587566|FG001|Overall Study|Scheduling Issues|3|||
126354016|NCT04339972|454587565|FG000|Overall Study|dropout|1|||
126354017|NCT04339972|454587566|FG001|Overall Study|dropout|1|||
126354018|NCT04339972|454587565|FG000|Overall Study|Technical issues|1|||
126354019|NCT04339972|454587566|FG001|Overall Study|Technical issues|0|||
126354020|NCT04339972|454587565|FG000|Overall Study|Claustraphobia|0|||
126354021|NCT04339972|454587566|FG001|Overall Study|Claustraphobia|1|||
126354022|NCT02942407|454587568|FG000|Overall Study|Lost to Follow-up|3|||
126354023|NCT02942407|454587569|FG001|Overall Study|Lost to Follow-up|2|||
126354024|NCT02942407|454587568|FG000|Overall Study|Withdrawal by Subject|7|||
126354025|NCT02942407|454587569|FG001|Overall Study|Withdrawal by Subject|9|||
126354026|NCT02942407|454587568|FG000|Overall Study|Death|16|||
126354027|NCT02942407|454587569|FG001|Overall Study|Death|13|||
126354028|NCT05221866|454587570|FG000|Overall Study|Withdrawal by Subject|5|||
126354029|NCT05221866|454587571|FG001|Overall Study|Withdrawal by Subject|7|||
126354030|NCT05221866|454587572|FG002|Overall Study|Withdrawal by Subject|6|||
126354031|NCT05221866|454587573|FG003|Overall Study|Withdrawal by Subject|4|||
126354032|NCT05221866|454587570|FG000|Overall Study|Physician Decision|3|||
126354033|NCT05221866|454587571|FG001|Overall Study|Physician Decision|2|||
126354034|NCT05221866|454587572|FG002|Overall Study|Physician Decision|1|||
126354035|NCT05221866|454587573|FG003|Overall Study|Physician Decision|4|||
126354036|NCT05221866|454587570|FG000|Overall Study|Lost to Follow-up|12|||
126354037|NCT05221866|454587571|FG001|Overall Study|Lost to Follow-up|17|||
126354038|NCT05221866|454587572|FG002|Overall Study|Lost to Follow-up|14|||
126354039|NCT05221866|454587573|FG003|Overall Study|Lost to Follow-up|14|||
126354040|NCT05221866|454587570|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
126354041|NCT05221866|454587571|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
126354042|NCT05221866|454587572|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
126354043|NCT05221866|454587573|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
126022944|NCT04992390|453378684|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
126354044|NCT00866320|454587575|FG000|Overall Study|Withdrawal by Subject|4|||
126354045|NCT00866320|454587575|FG000|Overall Study|Death|2|||
126354046|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
126354047|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
126232482|NCT01508936|454142641|FG000|Overall Study|Lost to Follow-up|2|||
126232483|NCT01508936|454142642|FG001|Overall Study|Lost to Follow-up|9|||
126232484|NCT01508936|454142641|FG000|Overall Study|Other|0|||
126232485|NCT01508936|454142642|FG001|Overall Study|Other|5|||
126232486|NCT01508936|454142641|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
126232487|NCT01508936|454142642|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
126022945|NCT04992390|453378685|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
126022946|NCT04992390|453378683|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
126022947|NCT04992390|453378684|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
126022948|NCT04992390|453378685|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
126022949|NCT04992390|453378683|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
126022950|NCT04992390|453378684|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
126022951|NCT04992390|453378685|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
126022952|NCT04992390|453378683|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
126022953|NCT04992390|453378684|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
126022954|NCT04992390|453378685|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
126022955|NCT04992390|453378683|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
126022956|NCT04992390|453378684|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
126022957|NCT04992390|453378685|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
126022958|NCT04992390|453378683|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
126022959|NCT04992390|453378684|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
126022960|NCT04992390|453378685|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
126022961|NCT04992390|453378683|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
126022962|NCT04992390|453378684|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
126022963|NCT04992390|453378685|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
126022964|NCT04992390|453378683|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
126022965|NCT04992390|453378684|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
126022966|NCT04992390|453378685|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
126022967|NCT04992390|453378683|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
126022968|NCT04992390|453378684|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
126022969|NCT04992390|453378685|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
126022970|NCT04992390|453378683|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
126022971|NCT04992390|453378684|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
126022972|NCT04992390|453378685|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
126022973|NCT04992390|453378683|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
126022974|NCT04992390|453378684|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
126022975|NCT04992390|453378685|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
126022976|NCT04992390|453378683|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
126022977|NCT04992390|453378684|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
126022978|NCT04992390|453378685|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
126022979|NCT04992390|453378683|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
126022980|NCT04992390|453378684|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
126022981|NCT04992390|453378685|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
126022982|NCT04992390|453378683|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
126022983|NCT04992390|453378684|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
126022984|NCT04992390|453378685|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
126022985|NCT04992390|453378683|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
126022986|NCT04992390|453378684|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
126022987|NCT04992390|453378685|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
126022988|NCT04992390|453378683|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
126022989|NCT04992390|453378684|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
126022990|NCT04992390|453378685|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
126022991|NCT01303445|453378686|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
126022992|NCT01303445|453378687|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
126022993|NCT01303445|453378686|FG000|Second Intervention (7 Days)|Adverse Event|0|||
126022994|NCT01303445|453378687|FG001|Second Intervention (7 Days)|Adverse Event|2|||
126022995|NCT01303445|453378686|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
126022996|NCT01303445|453378687|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
126022997|NCT01303445|453378686|FG000|Washout (14 Days)|Protocol Violation|1|||
126022998|NCT01303445|453378687|FG001|Washout (14 Days)|Protocol Violation|0|||
126022999|NCT01303445|453378686|FG000|Washout (14 Days)|Lost to Follow-up|0|||
126023000|NCT01303445|453378687|FG001|Washout (14 Days)|Lost to Follow-up|2|||
126023001|NCT01303445|453378686|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
126023002|NCT01303445|453378687|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
126023003|NCT01303445|453378686|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
126023004|NCT01303445|453378687|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
126023005|NCT05505045|453380568|FG000|Overall Study|Withdrawal by Subject|2|||
126023006|NCT05505045|453380569|FG001|Overall Study|Withdrawal by Subject|1|||
126023007|NCT01643070|453380570|FG000|Overall Study|Withdrawal by Subject|3|||
126023008|NCT01643070|453380571|FG001|Overall Study|Withdrawal by Subject|1|||
126023009|NCT01643070|453380570|FG000|Overall Study|Death|1|||
126023010|NCT01643070|453380571|FG001|Overall Study|Death|0|||
126023011|NCT01643070|453380570|FG000|Overall Study|Pregressive disease|0|||
126023012|NCT01643070|453380571|FG001|Overall Study|Pregressive disease|2|||
126023013|NCT03481777|453380574|FG000|Overall Study|Withdrawal by Subject|36|||
126023014|NCT03481777|453380575|FG001|Overall Study|Withdrawal by Subject|31|||
126023015|NCT03481777|453380574|FG000|Overall Study|Non stroke = non target population|277|||
126023016|NCT03481777|453380575|FG001|Overall Study|Non stroke = non target population|254|||
126023017|NCT04038957|453380579|FG000|Overall Study|Withdrawal by Subject|1|||
126023018|NCT04038957|453380579|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
126023019|NCT03821844|453380580|FG000|Overall Study|Death|37|||
126023020|NCT03821844|453380581|FG001|Overall Study|Death|31|||
126023021|NCT03821844|453380580|FG000|Overall Study|Discharged|10|||
126023022|NCT03821844|453380581|FG001|Overall Study|Discharged|14|||
126023023|NCT03821844|453380580|FG000|Overall Study|Not present in facility at followup|2|||
126023024|NCT03821844|453380581|FG001|Overall Study|Not present in facility at followup|3|||
126023025|NCT01998984|453380586|FG000|Overall Study|Adverse Event|0|||
126023026|NCT01998984|453380587|FG001|Overall Study|Adverse Event|0|||
126023027|NCT01998984|453380588|FG002|Overall Study|Adverse Event|0|||
126023028|NCT01998984|453380589|FG003|Overall Study|Adverse Event|1|||
126023029|NCT01998984|453380586|FG000|Overall Study|Lost to Follow-up|0|||
126023030|NCT01998984|453380587|FG001|Overall Study|Lost to Follow-up|1|||
126023031|NCT01998984|453380588|FG002|Overall Study|Lost to Follow-up|0|||
126023032|NCT01998984|453380589|FG003|Overall Study|Lost to Follow-up|1|||
126023033|NCT01998984|453380586|FG000|Overall Study|Withdrawal by Subject|0|||
126023034|NCT01998984|453380587|FG001|Overall Study|Withdrawal by Subject|0|||
126023035|NCT01998984|453380588|FG002|Overall Study|Withdrawal by Subject|1|||
126023036|NCT01998984|453380589|FG003|Overall Study|Withdrawal by Subject|0|||
126023037|NCT01998984|453380586|FG000|Overall Study|Other|0|||
126023038|NCT01998984|453380587|FG001|Overall Study|Other|0|||
126023039|NCT01998984|453380588|FG002|Overall Study|Other|0|||
126023040|NCT01998984|453380589|FG003|Overall Study|Other|1|||
126023041|NCT01843374|453380591|FG000|Overall Study|Death|155|||
126023042|NCT01843374|453380592|FG001|Overall Study|Death|313|||
126023043|NCT01843374|453380591|FG000|Overall Study|Withdrawal by Subject|14|||
126023044|NCT01843374|453380592|FG001|Overall Study|Withdrawal by Subject|20|||
126023045|NCT01843374|453380591|FG000|Overall Study|Withdrawing due to Other reason|20|||
126023046|NCT01843374|453380592|FG001|Overall Study|Withdrawing due to Other reason|46|||
126023047|NCT03397108|453380593|FG000|Overall Study|Lost to Follow-up|15|||
126023048|NCT03397108|453380594|FG001|Overall Study|Lost to Follow-up|0|||
126023049|NCT03397108|453380593|FG000|Overall Study|Insufficient milk production|3|||
126023050|NCT03397108|453380594|FG001|Overall Study|Insufficient milk production|2|||
126023051|NCT03397108|453380593|FG000|Overall Study|Withdrawal by Subject|2|||
126023052|NCT03397108|453380594|FG001|Overall Study|Withdrawal by Subject|0|||
126023053|NCT03554265|453380595|FG000|Overall Study|Withdrawal by Subject|2|||
126023054|NCT03554265|453380596|FG001|Overall Study|Withdrawal by Subject|2|||
126023055|NCT03554265|453380597|FG002|Overall Study|Withdrawal by Subject|3|||
126023056|NCT03554265|453380595|FG000|Overall Study|Physician Decision|0|||
126023057|NCT03554265|453380596|FG001|Overall Study|Physician Decision|0|||
126023058|NCT03554265|453380597|FG002|Overall Study|Physician Decision|1|||
126023059|NCT02605837|453380598|FG000|Overall Study|Adverse Event|3|||
126023060|NCT02605837|453380599|FG001|Overall Study|Adverse Event|1|||
126023061|NCT02605837|453380598|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126023062|NCT02605837|453380599|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126023063|NCT02605837|453380598|FG000|Overall Study|Withdrawal by Subject|8|||
126232488|NCT00679367|454142643|FG000|Overall Study|Adverse Event|7|||
126232489|NCT00679367|454142643|FG000|Overall Study|inability to swallow oral drugs|1|||
126232490|NCT00679367|454142643|FG000|Overall Study|Lack of Efficacy|3|||
126232491|NCT00679367|454142643|FG000|Overall Study|Withdrawal by Subject|1|||
126232492|NCT04603937|454142644|FG000|Overall Study|Adverse Event|9|||
126232493|NCT04603937|454142645|FG001|Overall Study|Adverse Event|10|||
126232494|NCT04603937|454142644|FG000|Overall Study|Withdrawal by Subject|7|||
126232495|NCT04603937|454142645|FG001|Overall Study|Withdrawal by Subject|6|||
126232496|NCT04603937|454142644|FG000|Overall Study|Lost to Follow-up|5|||
126232497|NCT04603937|454142645|FG001|Overall Study|Lost to Follow-up|6|||
126232498|NCT04603937|454142644|FG000|Overall Study|Physician Decision|0|||
126232499|NCT04603937|454142645|FG001|Overall Study|Physician Decision|1|||
126232500|NCT04603937|454142644|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
126232501|NCT04603937|454142645|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
126232502|NCT02518685|454142646|FG000|Overall Study|Adverse Event|29|||
126232503|NCT02518685|454142647|FG001|Overall Study|Adverse Event|1|||
126232504|NCT02518685|454142646|FG000|Overall Study|Withdrawal by Subject|10|||
126232505|NCT02518685|454142647|FG001|Overall Study|Withdrawal by Subject|3|||
126232506|NCT02518685|454142646|FG000|Overall Study|relocation, study fatigue|7|||
126232507|NCT02518685|454142647|FG001|Overall Study|relocation, study fatigue|2|||
126232508|NCT02518685|454142646|FG000|Overall Study|Pregnancy|1|||
126232509|NCT02518685|454142647|FG001|Overall Study|Pregnancy|0|||
126232510|NCT02518685|454142646|FG000|Overall Study|Physician Decision|1|||
126232511|NCT02518685|454142647|FG001|Overall Study|Physician Decision|0|||
126232512|NCT02518685|454142646|FG000|Overall Study|Lost to Follow-up|1|||
126232513|NCT02518685|454142647|FG001|Overall Study|Lost to Follow-up|4|||
126232514|NCT00922779|454142648|FG000|Overall Study|Adverse Event|67|||
126232515|NCT00922779|454142648|FG000|Overall Study|Pregnancy|7|||
126232516|NCT00922779|454142648|FG000|Overall Study|Withdrawal by Subject|308|||
126232517|NCT00922779|454142648|FG000|Overall Study|Lost to Follow-up|44|||
126232518|NCT00922779|454142648|FG000|Overall Study|Other|27|||
126232519|NCT00922779|454142648|FG000|Overall Study|Missing|1874|||
126232520|NCT01611090|454142649|FG000|Randomized Period|Lost to Follow-up|8|||
126232521|NCT01611090|454142650|FG001|Randomized Period|Lost to Follow-up|3|||
126232522|NCT01611090|454142651|FG002|Randomized Period|Lost to Follow-up|0|||
126232523|NCT01611090|454142649|FG000|Randomized Period|Withdrawal by Subject|22|||
126232524|NCT01611090|454142650|FG001|Randomized Period|Withdrawal by Subject|26|||
126232525|NCT01611090|454142651|FG002|Randomized Period|Withdrawal by Subject|0|||
126232526|NCT01611090|454142649|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
126023064|NCT02605837|453380599|FG001|Overall Study|Withdrawal by Subject|8|||
126232527|NCT01611090|454142650|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
126232528|NCT01611090|454142651|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
126232529|NCT01611090|454142649|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
126232530|NCT01611090|454142650|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
126232531|NCT01611090|454142651|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
126232532|NCT01922349|454142652|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
126023065|NCT02605837|453380598|FG000|Overall Study|Physician Decision|0|||
126232533|NCT01922349|454142653|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
126232534|NCT01922349|454142654|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
126232535|NCT01922349|454142655|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
126232536|NCT02448771|454142656|FG000|Overall Study|Disease Progression|30|||
126232537|NCT02448771|454142656|FG000|Overall Study|Unacceptable Toxicity|1|||
126232538|NCT02448771|454142656|FG000|Overall Study|Physician Decision|3|||
126232539|NCT02448771|454142656|FG000|Overall Study|Started new therapy|2|||
126232540|NCT02683187|454142657|FG000|Overall Study|Failed IV access|3|||
126232541|NCT02683187|454142657|FG000|Overall Study|Withdrawal by Subject|5|||
126232542|NCT02585258|454142658|FG000|Overall Study|Adverse Event|28|||
126232543|NCT02585258|454142659|FG001|Overall Study|Adverse Event|29|||
126232544|NCT02585258|454142658|FG000|Overall Study|Death|3|||
126232545|NCT02585258|454142659|FG001|Overall Study|Death|2|||
126232546|NCT02585258|454142658|FG000|Overall Study|Lack of Efficacy|7|||
126232547|NCT02585258|454142659|FG001|Overall Study|Lack of Efficacy|9|||
126232548|NCT02585258|454142658|FG000|Overall Study|includes covid-related access problems|42|||
126232549|NCT02585258|454142659|FG001|Overall Study|includes covid-related access problems|46|||
126232550|NCT02585258|454142658|FG000|Overall Study|Lost to Follow-up|5|||
126232551|NCT02585258|454142659|FG001|Overall Study|Lost to Follow-up|2|||
126232552|NCT01919190|454144983|FG000|Overall Study|Intra-op findings, etc.|3|||
126232553|NCT01919190|454144984|FG001|Overall Study|Intra-op findings, etc.|0|||
126232554|NCT00797108|454144989|FG000|Overall Study|Adverse Event|1|||
126232555|NCT00797108|454144990|FG001|Overall Study|Adverse Event|0|||
126232556|NCT00797108|454144991|FG002|Overall Study|Adverse Event|3|||
126232557|NCT00797108|454144989|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
126232558|NCT00797108|454144990|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
126232559|NCT00797108|454144991|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
126232560|NCT00797108|454144989|FG000|Overall Study|Global Deterioration of Health Status|0|||
126232561|NCT00797108|454144990|FG001|Overall Study|Global Deterioration of Health Status|1|||
126232562|NCT00797108|454144991|FG002|Overall Study|Global Deterioration of Health Status|0|||
126232563|NCT00797108|454144989|FG000|Overall Study|Lack of Efficacy|1|||
126232564|NCT00797108|454144990|FG001|Overall Study|Lack of Efficacy|0|||
126232565|NCT00797108|454144991|FG002|Overall Study|Lack of Efficacy|1|||
126232566|NCT00797108|454144989|FG000|Overall Study|Other|0|||
126232567|NCT00797108|454144990|FG001|Overall Study|Other|0|||
126232568|NCT00797108|454144991|FG002|Overall Study|Other|2|||
126232569|NCT00797108|454144989|FG000|Overall Study|Randomized but not Treated|2|||
126232570|NCT00797108|454144990|FG001|Overall Study|Randomized but not Treated|0|||
126232571|NCT00797108|454144991|FG002|Overall Study|Randomized but not Treated|0|||
126232572|NCT02518113|454144992|FG000|Overall Study|Adverse Event|1|||
126232573|NCT02518113|454144993|FG001|Overall Study|Adverse Event|0|||
126232574|NCT02518113|454144994|FG002|Overall Study|Adverse Event|1|||
126232575|NCT02518113|454144995|FG003|Overall Study|Adverse Event|0|||
126232576|NCT02518113|454144992|FG000|Overall Study|Death|1|||
126232577|NCT02518113|454144993|FG001|Overall Study|Death|2|||
126232578|NCT02518113|454144994|FG002|Overall Study|Death|0|||
126232579|NCT02518113|454144995|FG003|Overall Study|Death|0|||
126232580|NCT02518113|454144992|FG000|Overall Study|Physician Decision|0|||
126232581|NCT02518113|454144993|FG001|Overall Study|Physician Decision|1|||
126232582|NCT02518113|454144994|FG002|Overall Study|Physician Decision|0|||
126232583|NCT02518113|454144995|FG003|Overall Study|Physician Decision|0|||
126232584|NCT02518113|454144992|FG000|Overall Study|Progressive Disease|1|||
126232585|NCT02518113|454144993|FG001|Overall Study|Progressive Disease|2|||
126232586|NCT02518113|454144994|FG002|Overall Study|Progressive Disease|3|||
126232587|NCT02518113|454144995|FG003|Overall Study|Progressive Disease|0|||
126232588|NCT02270736|454144996|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
126232589|NCT02270736|454144997|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
126232590|NCT02270736|454144998|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
126232591|NCT02270736|454144999|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
126232592|NCT02270736|454145000|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
126232593|NCT02270736|454144996|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
126232594|NCT02270736|454144997|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
126232595|NCT02270736|454144998|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
126232596|NCT02270736|454144999|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
126232597|NCT02270736|454145000|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
126232598|NCT02270736|454144996|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
126232599|NCT02270736|454144997|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
126232600|NCT02270736|454144998|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
126232601|NCT02270736|454144999|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
126232602|NCT02270736|454145000|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
126232603|NCT02270736|454144996|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
126232604|NCT02270736|454144997|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
126232605|NCT02270736|454144998|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
126232606|NCT02270736|454144999|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
126232607|NCT02270736|454145000|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
126232608|NCT02270736|454144996|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
126232609|NCT02270736|454144997|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
126232610|NCT02270736|454144998|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
126232611|NCT02270736|454144999|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
126232612|NCT02270736|454145000|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
126232613|NCT02270736|454144996|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
126232614|NCT02270736|454144997|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
126232615|NCT02270736|454144998|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
126232616|NCT02270736|454144999|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
126232617|NCT02270736|454145000|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
126232618|NCT02270736|454144996|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
126232619|NCT02270736|454144997|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
126232620|NCT02270736|454144998|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
126232621|NCT02270736|454144999|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
126354048|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
126354049|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Death|1|||
126354050|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Death|0|||
126354051|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Death|0|||
126354052|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
126354053|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
126354054|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
126354055|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
126354056|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
126354057|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
126354058|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
126354059|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
126354060|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
126354061|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
126354062|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
126354063|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
126354064|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
126354065|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
126354066|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
126354067|NCT05073315|454587576|FG000|Period 2|Adverse Event|0|||
126354068|NCT05073315|454587577|FG001|Period 2|Adverse Event|3|||
126354069|NCT05073315|454587578|FG002|Period 2|Adverse Event|6|||
126354070|NCT05073315|454587576|FG000|Period 2|Lost to Follow-up|0|||
126354071|NCT05073315|454587577|FG001|Period 2|Lost to Follow-up|5|||
126023066|NCT02605837|453380599|FG001|Overall Study|Physician Decision|1|||
126232622|NCT02270736|454145000|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
126232623|NCT02270736|454144996|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
126232624|NCT02270736|454144997|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
126232625|NCT02270736|454144998|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
126232626|NCT02270736|454144999|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
126232627|NCT02270736|454145000|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
126232628|NCT02270736|454144996|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
126232629|NCT02270736|454144997|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
126232630|NCT02270736|454144998|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
126232631|NCT02270736|454144999|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
126232632|NCT02270736|454145000|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
126354072|NCT05073315|454587578|FG002|Period 2|Lost to Follow-up|5|||
126354073|NCT05073315|454587576|FG000|Period 2|Withdrawal by Subject|0|||
126354074|NCT05073315|454587577|FG001|Period 2|Withdrawal by Subject|4|||
126354075|NCT05073315|454587578|FG002|Period 2|Withdrawal by Subject|9|||
126354076|NCT05073315|454587576|FG000|Period 2|Protocol Violation|0|||
126354077|NCT05073315|454587577|FG001|Period 2|Protocol Violation|0|||
126354078|NCT05073315|454587578|FG002|Period 2|Protocol Violation|1|||
126354079|NCT01529268|454587579|FG000|Overall Study|Lost to Follow-up|9|||
126354080|NCT01529268|454587580|FG001|Overall Study|Lost to Follow-up|3|||
126354081|NCT01529268|454587579|FG000|Overall Study|Moved|3|||
126354082|NCT01529268|454587580|FG001|Overall Study|Moved|0|||
126354083|NCT02691572|454587585|FG000|Overall Study|Withdrawal by Subject|1|||
126354084|NCT02691572|454587586|FG001|Overall Study|Withdrawal by Subject|0|||
126354085|NCT02691572|454587585|FG000|Overall Study|Protocol Violation|0|||
126354086|NCT02691572|454587586|FG001|Overall Study|Protocol Violation|1|||
126354087|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
126354088|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
126354089|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Death|28|||
126354090|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Death|29|||
126354091|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
126354092|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
126354093|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Other|30|||
126354094|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Other|20|||
126354095|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
126354096|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
126354097|NCT00699751|454587587|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
126354098|NCT00699751|454587588|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
126354099|NCT00699751|454587587|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
126354100|NCT00699751|454587588|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
126354101|NCT00699751|454587587|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
126354102|NCT00699751|454587588|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
126354103|NCT00985790|454587591|FG000|Overall Study|Withdrawal by Subject|1|||
126354104|NCT00985790|454587592|FG001|Overall Study|Withdrawal by Subject|1|||
126354105|NCT00985790|454587591|FG000|Overall Study|Lost to Follow-up|6|||
126354106|NCT00985790|454587592|FG001|Overall Study|Lost to Follow-up|7|||
126354107|NCT04180696|454587593|FG000|Overall Study|Death|5|||
126354108|NCT04180696|454587594|FG001|Overall Study|Death|6|||
126354109|NCT04180696|454587593|FG000|Overall Study|Lost to Follow-up|1|||
126354110|NCT04180696|454587594|FG001|Overall Study|Lost to Follow-up|0|||
126354111|NCT04180696|454587593|FG000|Overall Study|Withdrawal by Subject|0|||
126354112|NCT04180696|454587594|FG001|Overall Study|Withdrawal by Subject|1|||
126354113|NCT04739709|454587597|FG000|Overall Study|Physician Decision|1|||
126354114|NCT04739709|454587598|FG001|Overall Study|Physician Decision|0|||
126354115|NCT04124965|454587599|FG000|Overall Study|Adverse event, non-fatal|3|||
126354116|NCT04124965|454587600|FG001|Overall Study|Adverse event, non-fatal|1|||
126354117|NCT04124965|454587599|FG000|Overall Study|Withdrawal by Subject|1|||
126354118|NCT04124965|454587600|FG001|Overall Study|Withdrawal by Subject|1|||
126354119|NCT04124965|454587599|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
126354120|NCT04124965|454587600|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
126354121|NCT04124965|454587599|FG000|Overall Study|Pregnancy|1|||
126354122|NCT04124965|454587600|FG001|Overall Study|Pregnancy|0|||
126354123|NCT04124965|454587599|FG000|Overall Study|Sponsor and participant decision|0|||
126354124|NCT04124965|454587600|FG001|Overall Study|Sponsor and participant decision|1|||
126354125|NCT04124965|454587599|FG000|Overall Study|Personal surgery|0|||
126354126|NCT04124965|454587600|FG001|Overall Study|Personal surgery|1|||
126354127|NCT04124965|454587599|FG000|Overall Study|Physician Decision|0|||
126354128|NCT04124965|454587600|FG001|Overall Study|Physician Decision|1|||
126354129|NCT02184156|454587601|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
126354130|NCT02184156|454587602|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
126354131|NCT02184156|454587601|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
126232633|NCT02153398|454145003|FG000|Overall Study|Withdrawal by Subject|1|||
126232634|NCT02153398|454145004|FG001|Overall Study|Withdrawal by Subject|0|||
126232635|NCT02153398|454145005|FG002|Overall Study|Withdrawal by Subject|0|||
126232636|NCT02153398|454145006|FG003|Overall Study|Withdrawal by Subject|0|||
126232637|NCT02153398|454145007|FG004|Overall Study|Withdrawal by Subject|0|||
126232638|NCT02153398|454145003|FG000|Overall Study|Adverse Event|0|||
126232639|NCT02153398|454145004|FG001|Overall Study|Adverse Event|0|||
126232640|NCT02153398|454145005|FG002|Overall Study|Adverse Event|1|||
126232641|NCT02153398|454145006|FG003|Overall Study|Adverse Event|1|||
126232642|NCT02153398|454145007|FG004|Overall Study|Adverse Event|0|||
126232643|NCT02402166|454145008|FG000|Overall Study|Adverse Event|2|||
126232644|NCT02402166|454145008|FG000|Overall Study|Withdrawal by Subject|2|||
126232645|NCT02402166|454145008|FG000|Overall Study|Lost to Follow-up|1|||
126232646|NCT03331042|454145012|FG000|Overall Study|Protocol Violation|1|||
126232647|NCT03331042|454145013|FG001|Overall Study|Protocol Violation|0|||
126232648|NCT03331042|454145014|FG002|Overall Study|Protocol Violation|0|||
126232649|NCT03331042|454145015|FG003|Overall Study|Protocol Violation|0|||
126232650|NCT03331042|454145012|FG000|Overall Study|Physician Decision|0|||
126232651|NCT03331042|454145013|FG001|Overall Study|Physician Decision|0|||
126232652|NCT03331042|454145014|FG002|Overall Study|Physician Decision|1|||
126232653|NCT03331042|454145015|FG003|Overall Study|Physician Decision|0|||
126232654|NCT03331042|454145012|FG000|Overall Study|Lost to Follow-up|0|||
126232655|NCT03331042|454145013|FG001|Overall Study|Lost to Follow-up|0|||
126232656|NCT03331042|454145014|FG002|Overall Study|Lost to Follow-up|0|||
126232657|NCT03331042|454145015|FG003|Overall Study|Lost to Follow-up|1|||
126232658|NCT00720096|454145019|FG000|Overall Study|Withdrawal by Subject|0|||
126232659|NCT00720096|454145020|FG001|Overall Study|Withdrawal by Subject|2|||
126232660|NCT00524459|454145021|FG000|Overall Study|Withdrawal by Subject|1|||
126232661|NCT00524459|454145021|FG000|Overall Study|Other|1|||
126354132|NCT02184156|454587602|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
126354133|NCT00002874|454587603|FG000|Overall Study|Withdrawal by Subject|1|||
126354134|NCT00002874|454587604|FG001|Overall Study|Withdrawal by Subject|1|||
126354135|NCT00002874|454587603|FG000|Overall Study|Protocol Violation|44|||
126354136|NCT00002874|454587604|FG001|Overall Study|Protocol Violation|34|||
126354137|NCT01397747|454587605|FG000|Overall Study|Multitarget DNA test excluded|689|||
126354138|NCT01397747|454587605|FG000|Overall Study|Colonoscopy excluded|304|||
126354139|NCT01397747|454587605|FG000|Overall Study|FIT excluded|34|||
126354140|NCT03828383|454587608|FG000|Overall Study|Lost to Follow-up|3|||
126354141|NCT03828383|454587609|FG001|Overall Study|Lost to Follow-up|2|||
126354142|NCT03828383|454587608|FG000|Overall Study|Withdrawal by Subject|4|||
126354143|NCT03828383|454587609|FG001|Overall Study|Withdrawal by Subject|5|||
126354144|NCT00504309|454587610|FG000|Overall Study|Death|0|||
126354145|NCT00504309|454587611|FG001|Overall Study|Death|0|||
126354146|NCT00504309|454587612|FG002|Overall Study|Death|0|||
126354147|NCT00504309|454587613|FG003|Overall Study|Death|0|||
126354148|NCT00504309|454587614|FG004|Overall Study|Death|1|||
126354149|NCT00504309|454587615|FG005|Overall Study|Death|0|||
126354150|NCT00504309|454587610|FG000|Overall Study|Withdrawal by Subject|0|||
126354151|NCT00504309|454587611|FG001|Overall Study|Withdrawal by Subject|0|||
126354152|NCT00504309|454587612|FG002|Overall Study|Withdrawal by Subject|1|||
126354153|NCT00504309|454587613|FG003|Overall Study|Withdrawal by Subject|0|||
126354154|NCT00504309|454587614|FG004|Overall Study|Withdrawal by Subject|0|||
126354155|NCT00504309|454587615|FG005|Overall Study|Withdrawal by Subject|0|||
126354156|NCT01018953|454587618|FG000|Overall Study|Adverse Event|2|||
126354157|NCT01018953|454587618|FG000|Overall Study|Withdrawal by Subject|1|||
126354158|NCT01018953|454587618|FG000|Overall Study|Study termination by sponsor|5|||
126354159|NCT01407367|454587624|FG000|Overall Study|Death|24|||
126354160|NCT01407367|454587625|FG001|Overall Study|Death|32|||
126354161|NCT01407367|454587624|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
126354162|NCT01407367|454587625|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
126354163|NCT01407367|454587624|FG000|Overall Study|Withdrawal by Subject|4|||
126354164|NCT01407367|454587625|FG001|Overall Study|Withdrawal by Subject|15|||
126354165|NCT01407367|454587624|FG000|Overall Study|Lost to Follow-up|0|||
126354166|NCT01407367|454587625|FG001|Overall Study|Lost to Follow-up|2|||
126354167|NCT01452347|454587626|FG000|Overall Study|Adverse Event|2|||
126354168|NCT01452347|454587627|FG001|Overall Study|Adverse Event|1|||
126354169|NCT01452347|454587626|FG000|Overall Study|Non compliance protocol|2|||
126354170|NCT01452347|454587627|FG001|Overall Study|Non compliance protocol|0|||
126354171|NCT01452347|454587626|FG000|Overall Study|Lost to Follow-up|2|||
126354172|NCT01452347|454587627|FG001|Overall Study|Lost to Follow-up|0|||
126354173|NCT01452347|454587626|FG000|Overall Study|Withdrawal by Subject|3|||
126354174|NCT01452347|454587627|FG001|Overall Study|Withdrawal by Subject|3|||
126354175|NCT01452347|454587626|FG000|Overall Study|Not treated|6|||
126023067|NCT05056246|453380600|FG000|Overall Study|Adverse Event|0|||
126232662|NCT02428699|454145022|FG000|Washout Period 1|Screen Failure|1|||
126232663|NCT02428699|454145023|FG001|Washout Period 1|Screen Failure|2|||
126232664|NCT01574248|454145024|FG000|Overall Study|Withdrawal by Subject|2|||
126232665|NCT01574248|454145025|FG001|Overall Study|Withdrawal by Subject|0|||
126232666|NCT01574248|454145024|FG000|Overall Study|Missing primary endpoint data|1|||
126232667|NCT01574248|454145025|FG001|Overall Study|Missing primary endpoint data|0|||
126232668|NCT01424722|454145026|FG000|Overall Study|Sponsor terminated investigation|2258|||
126232669|NCT01781286|454145029|FG000|Overall Study|Lost to Follow-up|0|||
126232670|NCT01781286|454145030|FG001|Overall Study|Lost to Follow-up|0|||
126232671|NCT01781286|454145031|FG002|Overall Study|Lost to Follow-up|0|||
126232672|NCT01781286|454145032|FG003|Overall Study|Lost to Follow-up|0|||
126232673|NCT01781286|454145033|FG004|Overall Study|Lost to Follow-up|0|||
126232674|NCT01781286|454145034|FG005|Overall Study|Lost to Follow-up|1|||
126232675|NCT01781286|454145029|FG000|Overall Study|Time Constraints|2|||
126232676|NCT01781286|454145030|FG001|Overall Study|Time Constraints|0|||
126232677|NCT01781286|454145031|FG002|Overall Study|Time Constraints|2|||
126232678|NCT01781286|454145032|FG003|Overall Study|Time Constraints|0|||
126232679|NCT01781286|454145033|FG004|Overall Study|Time Constraints|0|||
126232680|NCT01781286|454145034|FG005|Overall Study|Time Constraints|0|||
126232681|NCT01781286|454145029|FG000|Overall Study|Noncompliance|0|||
126232682|NCT01781286|454145030|FG001|Overall Study|Noncompliance|0|||
126232683|NCT01781286|454145031|FG002|Overall Study|Noncompliance|0|||
126232684|NCT01781286|454145032|FG003|Overall Study|Noncompliance|1|||
126232685|NCT01781286|454145033|FG004|Overall Study|Noncompliance|0|||
126232686|NCT01781286|454145034|FG005|Overall Study|Noncompliance|0|||
126232687|NCT00995410|454145035|FG000|Overall Study|Adverse Event|51|||
126232688|NCT00995410|454145035|FG000|Overall Study|Withdrawal by Subject|7|||
126232689|NCT00995410|454145035|FG000|Overall Study|Lost to Follow-up|2|||
126232690|NCT00995410|454145035|FG000|Overall Study|Misc|28|||
126232691|NCT03594123|454145036|FG000|Overall Study|Lost to Follow-up|0|||
126232692|NCT03594123|454145037|FG001|Overall Study|Lost to Follow-up|1|||
126232693|NCT03594123|454145036|FG000|Overall Study|Adverse Event|8|||
126232694|NCT03594123|454145037|FG001|Overall Study|Adverse Event|5|||
126232695|NCT03594123|454145036|FG000|Overall Study|Site Terminated by Sponsor|4|||
126232696|NCT03594123|454145037|FG001|Overall Study|Site Terminated by Sponsor|1|||
126232697|NCT03594123|454145036|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
126232698|NCT03594123|454145037|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
126232699|NCT03594123|454145036|FG000|Overall Study|Lack of Efficacy|1|||
126232700|NCT03594123|454145037|FG001|Overall Study|Lack of Efficacy|0|||
126232701|NCT03594123|454145036|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
126232702|NCT03594123|454145037|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
126232703|NCT02483975|454145038|FG000|Overall Study|Adverse Event|0|||
126232704|NCT02483975|454145039|FG001|Overall Study|Adverse Event|1|||
126232705|NCT02483975|454145038|FG000|Overall Study|Lost to Follow-up|0|||
126232706|NCT02483975|454145039|FG001|Overall Study|Lost to Follow-up|1|||
126232707|NCT02483975|454145038|FG000|Overall Study|Physician Decision|2|||
126232708|NCT02483975|454145039|FG001|Overall Study|Physician Decision|0|||
126232709|NCT00818883|454145040|FG000|Overall Study|Adverse Event|28|||
126232710|NCT00818883|454145041|FG001|Overall Study|Adverse Event|19|||
126232711|NCT00818883|454145040|FG000|Overall Study|Protocol Violation|2|||
126232712|NCT00818883|454145041|FG001|Overall Study|Protocol Violation|2|||
126232713|NCT00818883|454145040|FG000|Overall Study|Lost to Follow-up|3|||
126232714|NCT00818883|454145041|FG001|Overall Study|Lost to Follow-up|2|||
126232715|NCT00818883|454145040|FG000|Overall Study|Withdrawal by Subject|16|||
126354176|NCT01452347|454587627|FG001|Overall Study|Not treated|3|||
126354177|NCT01452347|454587626|FG000|Overall Study|Other reason not defined above|2|||
126354178|NCT01452347|454587627|FG001|Overall Study|Other reason not defined above|0|||
126354179|NCT02642679|454589317|FG000|Overall Study|Withdrawal by Subject|1|||
126354180|NCT02642679|454589317|FG000|Overall Study|Physician Decision|1|||
126093134|NCT00958841|453634532|FG000|Overall Study|Completed M6/did not enter extension|27|||
126093135|NCT00958841|453634532|FG000|Overall Study|Discontinued prior to M*|28|||
126093136|NCT03014011|453634534|FG000|First Intervention|Withdrawal by Subject|1|||
126093137|NCT03014011|453634535|FG001|First Intervention|Withdrawal by Subject|0|||
126093138|NCT03014011|453634534|FG000|Washout|Withdrawal by Subject|1|||
126354181|NCT02642679|454589317|FG000|Overall Study|Physician Decision|1|||
126093139|NCT03014011|453634535|FG001|Washout|Withdrawal by Subject|0|||
126093140|NCT02416453|453634536|FG000|Overall Study|Adverse Event|0|||
126232716|NCT00818883|454145041|FG001|Overall Study|Withdrawal by Subject|14|||
126232717|NCT00818883|454145040|FG000|Overall Study|Lack of Efficacy|0|||
126232718|NCT00818883|454145041|FG001|Overall Study|Lack of Efficacy|2|||
126232719|NCT00818883|454145040|FG000|Overall Study|Other|2|||
126232720|NCT00818883|454145041|FG001|Overall Study|Other|7|||
126232721|NCT03992196|454145042|FG000|Enrollment|lost to follow-up prior dosing|1|||
126232722|NCT03992196|454145043|FG001|Enrollment|lost to follow-up prior dosing|0|||
126232723|NCT03992196|454145044|FG002|Enrollment|lost to follow-up prior dosing|0|||
126232724|NCT03992196|454145042|FG000|Treatment|Protocol Violation|0|||
126232725|NCT03992196|454145043|FG001|Treatment|Protocol Violation|0|||
126232726|NCT03992196|454145044|FG002|Treatment|Protocol Violation|1|||
126232727|NCT03992196|454145042|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
126093141|NCT02416453|453634537|FG001|Overall Study|Adverse Event|0|||
126232728|NCT03992196|454145043|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
126232729|NCT03992196|454145044|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
126232730|NCT03992196|454145042|FG000|Treatment|Withdrawal due to non-compliance|0|||
126232731|NCT03992196|454145043|FG001|Treatment|Withdrawal due to non-compliance|0|||
126023068|NCT05056246|453380601|FG001|Overall Study|Adverse Event|0|||
126023069|NCT05056246|453380602|FG002|Overall Study|Adverse Event|0|||
126023070|NCT05056246|453380603|FG003|Overall Study|Adverse Event|0|||
126023071|NCT05056246|453380604|FG004|Overall Study|Adverse Event|1|||
126023072|NCT05056246|453380600|FG000|Overall Study|Lost to Follow-up|0|||
126023073|NCT05056246|453380601|FG001|Overall Study|Lost to Follow-up|0|||
126023074|NCT05056246|453380602|FG002|Overall Study|Lost to Follow-up|0|||
126232732|NCT03992196|454145044|FG002|Treatment|Withdrawal due to non-compliance|1|||
126232733|NCT03992196|454145042|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
126232734|NCT03992196|454145043|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
126232735|NCT03992196|454145044|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
126232736|NCT03992196|454145042|FG000|Treatment|Withdrawal by parent/guardian|0|||
126232737|NCT03992196|454145043|FG001|Treatment|Withdrawal by parent/guardian|0|||
126232738|NCT03992196|454145044|FG002|Treatment|Withdrawal by parent/guardian|2|||
126232739|NCT02684578|454145047|FG000|Overall Study|Withdrawal by Subject|10|||
126232740|NCT02684578|454145048|FG001|Overall Study|Withdrawal by Subject|7|||
126232741|NCT02684578|454145047|FG000|Overall Study|Lost to Follow-up|0|||
126232742|NCT02684578|454145048|FG001|Overall Study|Lost to Follow-up|3|||
126232743|NCT02684578|454145047|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
126232744|NCT02684578|454145048|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
126232745|NCT02684578|454145047|FG000|Overall Study|Missing follow-up data|0|||
126232746|NCT02684578|454145048|FG001|Overall Study|Missing follow-up data|1|||
126232747|NCT01505530|454145049|FG000|Overall Study|Progressive Disease|19|||
126232748|NCT01505530|454145050|FG001|Overall Study|Progressive Disease|17|||
126232749|NCT01505530|454145051|FG002|Overall Study|Progressive Disease|18|||
126232750|NCT01505530|454145049|FG000|Overall Study|Adverse Event|1|||
126232751|NCT01505530|454145050|FG001|Overall Study|Adverse Event|1|||
126232752|NCT01505530|454145051|FG002|Overall Study|Adverse Event|0|||
126232753|NCT01505530|454145049|FG000|Overall Study|Withdrawal by Subject|7|||
126232754|NCT01505530|454145050|FG001|Overall Study|Withdrawal by Subject|8|||
126232755|NCT01505530|454145051|FG002|Overall Study|Withdrawal by Subject|6|||
126232756|NCT01505530|454145049|FG000|Overall Study|Physician Decision|6|||
126232757|NCT01505530|454145050|FG001|Overall Study|Physician Decision|2|||
126232758|NCT01505530|454145051|FG002|Overall Study|Physician Decision|5|||
126232759|NCT01505530|454145049|FG000|Overall Study|Sponsor Decision|1|||
126232760|NCT01505530|454145050|FG001|Overall Study|Sponsor Decision|8|||
126232761|NCT01505530|454145051|FG002|Overall Study|Sponsor Decision|7|||
126232762|NCT01505530|454145049|FG000|Overall Study|Death|7|||
126232763|NCT01505530|454145050|FG001|Overall Study|Death|6|||
126232764|NCT01505530|454145051|FG002|Overall Study|Death|5|||
126232765|NCT01505530|454145049|FG000|Overall Study|entry criteria not met|0|||
126232766|NCT01505530|454145050|FG001|Overall Study|entry criteria not met|1|||
126232767|NCT01505530|454145051|FG002|Overall Study|entry criteria not met|0|||
126232768|NCT00973700|454145052|FG000|Overall Study|Withdrawal by Subject|2|||
126232769|NCT00973700|454145053|FG001|Overall Study|Withdrawal by Subject|2|||
126232770|NCT00973700|454145054|FG002|Overall Study|Withdrawal by Subject|8|||
126232771|NCT00973700|454145055|FG003|Overall Study|Withdrawal by Subject|4|||
126232772|NCT00973700|454145056|FG004|Overall Study|Withdrawal by Subject|4|||
126232773|NCT00973700|454145052|FG000|Overall Study|Lost to Follow-up|5|||
126232774|NCT00973700|454145053|FG001|Overall Study|Lost to Follow-up|0|||
126232775|NCT00973700|454145054|FG002|Overall Study|Lost to Follow-up|1|||
126232776|NCT00973700|454145055|FG003|Overall Study|Lost to Follow-up|8|||
126232777|NCT00973700|454145056|FG004|Overall Study|Lost to Follow-up|5|||
126232778|NCT00973700|454145052|FG000|Overall Study|Inappropriate enrolment|0|||
126232779|NCT00973700|454145053|FG001|Overall Study|Inappropriate enrolment|0|||
126232780|NCT00973700|454145054|FG002|Overall Study|Inappropriate enrolment|0|||
126023075|NCT05056246|453380603|FG003|Overall Study|Lost to Follow-up|2|||
126023076|NCT05056246|453380604|FG004|Overall Study|Lost to Follow-up|0|||
126023077|NCT05056246|453380600|FG000|Overall Study|Withdrawal by Subject|0|||
126023078|NCT05056246|453380601|FG001|Overall Study|Withdrawal by Subject|1|||
126023079|NCT05056246|453380602|FG002|Overall Study|Withdrawal by Subject|0|||
126023080|NCT05056246|453380603|FG003|Overall Study|Withdrawal by Subject|0|||
126023081|NCT05056246|453380604|FG004|Overall Study|Withdrawal by Subject|0|||
126232781|NCT00973700|454145055|FG003|Overall Study|Inappropriate enrolment|4|||
126232782|NCT00973700|454145056|FG004|Overall Study|Inappropriate enrolment|0|||
126232783|NCT00973700|454145052|FG000|Overall Study|Unable to Classify|0|||
126232784|NCT00973700|454145053|FG001|Overall Study|Unable to Classify|0|||
126232785|NCT00973700|454145054|FG002|Overall Study|Unable to Classify|1|||
126354182|NCT01112267|454589319|FG000|Overall Study|Adverse Event|24|||
126354183|NCT01112267|454589320|FG001|Overall Study|Adverse Event|6|||
126354184|NCT01112267|454589319|FG000|Overall Study|Withdrawal by Subject|3|||
126354185|NCT01112267|454589320|FG001|Overall Study|Withdrawal by Subject|5|||
126354186|NCT01112267|454589319|FG000|Overall Study|Protocol Violation|5|||
126354187|NCT01112267|454589320|FG001|Overall Study|Protocol Violation|3|||
126354188|NCT01112267|454589319|FG000|Overall Study|Participants not compliant|1|||
126354189|NCT01112267|454589320|FG001|Overall Study|Participants not compliant|2|||
126354190|NCT01112267|454589319|FG000|Overall Study|Participants not receive any study drug|1|||
126354191|NCT01112267|454589320|FG001|Overall Study|Participants not receive any study drug|2|||
126354192|NCT05638737|454589323|FG000|Overall Study|Withdrawal by Subject|4|||
126354193|NCT05638737|454589324|FG001|Overall Study|Withdrawal by Subject|7|||
126232786|NCT00973700|454145055|FG003|Overall Study|Unable to Classify|2|||
126232787|NCT00973700|454145056|FG004|Overall Study|Unable to Classify|1|||
126232788|NCT02492958|454145057|FG000|Overall Study|Withdrawal by Subject|0|||
126232789|NCT02492958|454145058|FG001|Overall Study|Withdrawal by Subject|0|||
126232790|NCT02492958|454145059|FG002|Overall Study|Withdrawal by Subject|1|||
126232791|NCT02492958|454145060|FG003|Overall Study|Withdrawal by Subject|0|||
126232792|NCT02492958|454145057|FG000|Overall Study|Adverse Event|1|||
126232793|NCT02492958|454145058|FG001|Overall Study|Adverse Event|0|||
126232794|NCT02492958|454145059|FG002|Overall Study|Adverse Event|1|||
126232795|NCT02492958|454145060|FG003|Overall Study|Adverse Event|0|||
126232796|NCT01193608|454145061|FG000|Overall Study|Other|0|||
126232797|NCT01193608|454145062|FG001|Overall Study|Other|1|||
126232798|NCT01193608|454145063|FG002|Overall Study|Other|0|||
126232799|NCT01193608|454145064|FG003|Overall Study|Other|0|||
126232800|NCT01193608|454145065|FG004|Overall Study|Other|0|||
126232801|NCT01193608|454145066|FG005|Overall Study|Other|0|||
126232802|NCT01193608|454145061|FG000|Overall Study|Withdrawal by Subject|0|||
126023082|NCT05656911|453380615|FG000|Treatment Phase|Physician Decision|2|||
126232803|NCT01193608|454145062|FG001|Overall Study|Withdrawal by Subject|1|||
126232804|NCT01193608|454145063|FG002|Overall Study|Withdrawal by Subject|2|||
126232805|NCT01193608|454145064|FG003|Overall Study|Withdrawal by Subject|3|||
126232806|NCT01193608|454145065|FG004|Overall Study|Withdrawal by Subject|3|||
126232807|NCT01193608|454145066|FG005|Overall Study|Withdrawal by Subject|0|||
126232808|NCT01193608|454145061|FG000|Overall Study|Lost to Follow-up|0|||
126232809|NCT01193608|454145062|FG001|Overall Study|Lost to Follow-up|0|||
126232810|NCT01193608|454145063|FG002|Overall Study|Lost to Follow-up|0|||
126232811|NCT01193608|454145064|FG003|Overall Study|Lost to Follow-up|0|||
126232812|NCT01193608|454145065|FG004|Overall Study|Lost to Follow-up|1|||
126232813|NCT01193608|454145066|FG005|Overall Study|Lost to Follow-up|2|||
126232814|NCT01193608|454145061|FG000|Overall Study|Adverse Event|0|||
126232815|NCT01193608|454145062|FG001|Overall Study|Adverse Event|0|||
126232816|NCT01193608|454145063|FG002|Overall Study|Adverse Event|0|||
126232817|NCT01193608|454145064|FG003|Overall Study|Adverse Event|0|||
126232818|NCT01193608|454145065|FG004|Overall Study|Adverse Event|1|||
126232819|NCT01193608|454145066|FG005|Overall Study|Adverse Event|0|||
126232820|NCT00712010|454145067|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
126232821|NCT01901055|454145068|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
126232822|NCT01901055|454145069|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
126232823|NCT01901055|454145068|FG000|Randomization But Not Titrated|Physician Decision|0|||
126232824|NCT01901055|454145069|FG001|Randomization But Not Titrated|Physician Decision|1|||
126232825|NCT01901055|454145068|FG000|Started Protocol to Week 6|Physician Decision|2|||
126232826|NCT01901055|454145069|FG001|Started Protocol to Week 6|Physician Decision|1|||
126232827|NCT01901055|454145068|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
126232828|NCT01901055|454145069|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
126232829|NCT01901055|454145068|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
126232830|NCT01901055|454145069|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
126232831|NCT01901055|454145068|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
126232832|NCT01901055|454145069|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
126232833|NCT01901055|454145068|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
126232834|NCT01901055|454145069|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
126232835|NCT01901055|454145068|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
126232836|NCT01901055|454145069|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
126232837|NCT01901055|454145068|FG000|Week 24|Withdrawal by Subject|13|||
126232838|NCT01901055|454145069|FG001|Week 24|Withdrawal by Subject|19|||
126232839|NCT01901055|454145068|FG000|Week 24|Physician Decision|1|||
126232840|NCT01901055|454145069|FG001|Week 24|Physician Decision|0|||
126232841|NCT01901055|454145068|FG000|Week 36|Withdrawal by Subject|0|||
126232842|NCT01901055|454145069|FG001|Week 36|Withdrawal by Subject|5|||
126232843|NCT00525590|454145075|FG000|Overall Study|Adverse Event|3|||
126232844|NCT00525590|454145075|FG000|Overall Study|Physician Decision|3|||
126232845|NCT00525590|454145075|FG000|Overall Study|Withdrawal by Subject|16|||
126232846|NCT00525590|454145075|FG000|Overall Study|Lost to Follow-up|1|||
126232847|NCT00525590|454145075|FG000|Overall Study|Death|9|||
126232848|NCT00525590|454145075|FG000|Overall Study|Other|13|||
126232849|NCT00948675|454145076|FG000|Overall Study|Lost to Follow-up|1|||
126232850|NCT00948675|454145077|FG001|Overall Study|Lost to Follow-up|0|||
126232851|NCT03830164|454145086|FG000|Overall Study|Adverse Event|0|||
126232852|NCT03830164|454145087|FG001|Overall Study|Adverse Event|2|||
126232853|NCT03830164|454145088|FG002|Overall Study|Adverse Event|0|||
126232854|NCT03830164|454145086|FG000|Overall Study|Lack of Efficacy|1|||
126232855|NCT03830164|454145087|FG001|Overall Study|Lack of Efficacy|5|||
126232856|NCT03830164|454145088|FG002|Overall Study|Lack of Efficacy|0|||
126232857|NCT03830164|454145086|FG000|Overall Study|Lost to Follow-up|0|||
126232858|NCT03830164|454145087|FG001|Overall Study|Lost to Follow-up|1|||
126232859|NCT03830164|454145088|FG002|Overall Study|Lost to Follow-up|0|||
126232860|NCT03830164|454145086|FG000|Overall Study|Withdrawal by Subject|1|||
126232861|NCT03830164|454145087|FG001|Overall Study|Withdrawal by Subject|0|||
126232862|NCT03830164|454145088|FG002|Overall Study|Withdrawal by Subject|0|||
126232863|NCT02192099|454145089|FG000|Overall Study|Adverse Event|1|||
126232864|NCT02192099|454145089|FG000|Overall Study|Lost to Follow-up|2|||
126232865|NCT02192099|454145089|FG000|Overall Study|Physician Decision|1|||
126232866|NCT02192099|454145089|FG000|Overall Study|Pregnancy|1|||
126232867|NCT02192099|454145089|FG000|Overall Study|Protocol Violation|8|||
126232868|NCT02192099|454145089|FG000|Overall Study|Study Terminated by Sponsor|32|||
126232869|NCT02192099|454145089|FG000|Overall Study|Withdrawal by Subject|11|||
126232870|NCT02192099|454145089|FG000|Overall Study|Miscellaneous Reasons|5|||
126232871|NCT02796664|454145092|FG000|Overall Study|Withdrawal by Subject|0|||
126232872|NCT02796664|454145093|FG001|Overall Study|Withdrawal by Subject|3|||
126232873|NCT02796664|454145092|FG000|Overall Study|Noncompliance|1|||
126232874|NCT02796664|454145093|FG001|Overall Study|Noncompliance|1|||
126232875|NCT02796664|454145092|FG000|Overall Study|Death|0|||
126232876|NCT02796664|454145093|FG001|Overall Study|Death|1|||
126093142|NCT02416453|453634538|FG002|Overall Study|Adverse Event|0|||
126232877|NCT02246478|454145094|FG000|Multiple-dose Phase|Protocol Violation|1|||
126232878|NCT02246478|454145095|FG001|Multiple-dose Phase|Protocol Violation|0|||
126232879|NCT02246478|454145096|FG002|Multiple-dose Phase|Protocol Violation|0|||
126232880|NCT02246478|454145097|FG003|Multiple-dose Phase|Protocol Violation|1|||
126232881|NCT01531205|454145102|FG000|Overall Study|Did not proceed to surgery|1|||
126232882|NCT02001558|454145103|FG000|Overall Study|Lost to Follow-up|8|||
126232883|NCT02001558|454145104|FG001|Overall Study|Lost to Follow-up|14|||
126232884|NCT04128007|454145105|FG000|Overall Study|Withdrawal by Subject|9|||
126232885|NCT04128007|454145106|FG001|Overall Study|Withdrawal by Subject|6|||
126232886|NCT04128007|454145105|FG000|Overall Study|Protocol Violation|1|||
126232887|NCT04128007|454145106|FG001|Overall Study|Protocol Violation|0|||
126232888|NCT04128007|454145105|FG000|Overall Study|Lost to Follow-up|8|||
126232889|NCT04128007|454145106|FG001|Overall Study|Lost to Follow-up|7|||
126232890|NCT04128007|454145105|FG000|Overall Study|Adverse Event|5|||
126232891|NCT04128007|454145106|FG001|Overall Study|Adverse Event|2|||
126232892|NCT04128007|454145105|FG000|Overall Study|Not reported|0|||
126232893|NCT04128007|454145106|FG001|Overall Study|Not reported|2|||
126232894|NCT04117607|454145107|FG000|Overall Study|Early Termination|0|||
126232895|NCT04117607|454145108|FG001|Overall Study|Early Termination|1|||
126232896|NCT04117607|454145109|FG002|Overall Study|Early Termination|0|||
126232897|NCT04117607|454145110|FG003|Overall Study|Early Termination|0|||
126232898|NCT04117607|454145111|FG004|Overall Study|Early Termination|0|||
126232899|NCT04117607|454145112|FG005|Overall Study|Early Termination|0|||
126232900|NCT04117607|454145113|FG006|Overall Study|Early Termination|1|||
126232901|NCT04117607|454145114|FG007|Overall Study|Early Termination|0|||
126232902|NCT04117607|454145115|FG008|Overall Study|Early Termination|0|||
126232903|NCT04117607|454145116|FG009|Overall Study|Early Termination|0|||
126232904|NCT04117607|454145117|FG010|Overall Study|Early Termination|0|||
126232905|NCT04117607|454145118|FG011|Overall Study|Early Termination|0|||
126232906|NCT04117607|454145119|FG012|Overall Study|Early Termination|0|||
126232907|NCT04117607|454145120|FG013|Overall Study|Early Termination|0|||
126232908|NCT00950807|454145124|FG000|Treatment Period 1|Lack of Efficacy|1|||
126232909|NCT00950807|454145125|FG001|Treatment Period 1|Lack of Efficacy|0|||
126232910|NCT00950807|454145126|FG002|Treatment Period 1|Lack of Efficacy|0|||
126232911|NCT00950807|454145127|FG003|Treatment Period 1|Lack of Efficacy|0|||
126232912|NCT00950807|454145128|FG004|Treatment Period 1|Lack of Efficacy|0|||
126232913|NCT00950807|454145129|FG005|Treatment Period 1|Lack of Efficacy|1|||
126232914|NCT00950807|454145130|FG006|Treatment Period 1|Lack of Efficacy|0|||
126232915|NCT00950807|454145131|FG007|Treatment Period 1|Lack of Efficacy|0|||
126232916|NCT00950807|454145132|FG008|Treatment Period 1|Lack of Efficacy|0|||
126232917|NCT00950807|454145133|FG009|Treatment Period 1|Lack of Efficacy|0|||
126232918|NCT00950807|454145124|FG000|Treatment Period 1|Protocol Violation|1|||
126232919|NCT00950807|454145125|FG001|Treatment Period 1|Protocol Violation|0|||
126232920|NCT00950807|454145126|FG002|Treatment Period 1|Protocol Violation|0|||
126232921|NCT00950807|454145127|FG003|Treatment Period 1|Protocol Violation|0|||
126232922|NCT00950807|454145128|FG004|Treatment Period 1|Protocol Violation|0|||
126232923|NCT00950807|454145129|FG005|Treatment Period 1|Protocol Violation|0|||
126232924|NCT00950807|454145130|FG006|Treatment Period 1|Protocol Violation|0|||
126232925|NCT00950807|454145131|FG007|Treatment Period 1|Protocol Violation|0|||
126232926|NCT00950807|454145132|FG008|Treatment Period 1|Protocol Violation|0|||
126232927|NCT00950807|454145133|FG009|Treatment Period 1|Protocol Violation|0|||
126232928|NCT00950807|454145124|FG000|Treatment Period 1|Lost to Follow-up|0|||
126232929|NCT00950807|454145125|FG001|Treatment Period 1|Lost to Follow-up|0|||
126232930|NCT00950807|454145126|FG002|Treatment Period 1|Lost to Follow-up|1|||
126232931|NCT00950807|454145127|FG003|Treatment Period 1|Lost to Follow-up|0|||
126232932|NCT00950807|454145128|FG004|Treatment Period 1|Lost to Follow-up|0|||
126232933|NCT00950807|454145129|FG005|Treatment Period 1|Lost to Follow-up|0|||
126232934|NCT00950807|454145130|FG006|Treatment Period 1|Lost to Follow-up|0|||
126232935|NCT00950807|454145131|FG007|Treatment Period 1|Lost to Follow-up|0|||
126232936|NCT00950807|454145132|FG008|Treatment Period 1|Lost to Follow-up|0|||
126232937|NCT00950807|454145133|FG009|Treatment Period 1|Lost to Follow-up|0|||
126232938|NCT00950807|454145124|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126232939|NCT00950807|454145125|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126232940|NCT00950807|454145126|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126232941|NCT00950807|454145127|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126232942|NCT00950807|454145128|FG004|Treatment Period 1|Withdrawal by Subject|1|||
126232943|NCT00950807|454145129|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126232944|NCT00950807|454145130|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126046467|NCT02467270|453468226|FG000|Overall Study|Lost to Follow-up|2|||
126232945|NCT00950807|454145131|FG007|Treatment Period 1|Withdrawal by Subject|0|||
126232946|NCT00950807|454145132|FG008|Treatment Period 1|Withdrawal by Subject|1|||
126232947|NCT00950807|454145133|FG009|Treatment Period 1|Withdrawal by Subject|0|||
126232948|NCT00950807|454145124|FG000|Treatment Period 1|Adverse Event|0|||
126232949|NCT00950807|454145125|FG001|Treatment Period 1|Adverse Event|0|||
126232950|NCT00950807|454145126|FG002|Treatment Period 1|Adverse Event|0|||
126232951|NCT00950807|454145127|FG003|Treatment Period 1|Adverse Event|0|||
126232952|NCT00950807|454145128|FG004|Treatment Period 1|Adverse Event|0|||
126093143|NCT02416453|453634539|FG003|Overall Study|Adverse Event|2|||
126093144|NCT02416453|453634540|FG004|Overall Study|Adverse Event|0|||
126093145|NCT02416453|453634541|FG005|Overall Study|Adverse Event|1|||
126093146|NCT02416453|453634542|FG006|Overall Study|Adverse Event|0|||
126093147|NCT02416453|453634543|FG007|Overall Study|Adverse Event|0|||
126093148|NCT02416453|453634544|FG008|Overall Study|Adverse Event|0|||
126093149|NCT02416453|453634545|FG009|Overall Study|Adverse Event|0|||
126093150|NCT02416453|453634546|FG010|Overall Study|Adverse Event|0|||
126093151|NCT02416453|453634536|FG000|Overall Study|Lost to Follow-up|1|||
126093152|NCT02416453|453634537|FG001|Overall Study|Lost to Follow-up|3|||
126093153|NCT02416453|453634538|FG002|Overall Study|Lost to Follow-up|0|||
126093154|NCT02416453|453634539|FG003|Overall Study|Lost to Follow-up|8|||
126093155|NCT02416453|453634540|FG004|Overall Study|Lost to Follow-up|0|||
126093156|NCT02416453|453634541|FG005|Overall Study|Lost to Follow-up|5|||
126093157|NCT02416453|453634542|FG006|Overall Study|Lost to Follow-up|1|||
126093158|NCT02416453|453634543|FG007|Overall Study|Lost to Follow-up|3|||
126093159|NCT02416453|453634544|FG008|Overall Study|Lost to Follow-up|1|||
126093160|NCT02416453|453634545|FG009|Overall Study|Lost to Follow-up|0|||
126093161|NCT02416453|453634546|FG010|Overall Study|Lost to Follow-up|0|||
126093162|NCT02416453|453634536|FG000|Overall Study|Physician Decision|0|||
126093163|NCT02416453|453634537|FG001|Overall Study|Physician Decision|0|||
126093164|NCT02416453|453634538|FG002|Overall Study|Physician Decision|0|||
126093165|NCT02416453|453634539|FG003|Overall Study|Physician Decision|0|||
126093166|NCT02416453|453634540|FG004|Overall Study|Physician Decision|0|||
126093167|NCT02416453|453634541|FG005|Overall Study|Physician Decision|1|||
126093168|NCT02416453|453634542|FG006|Overall Study|Physician Decision|1|||
126093169|NCT02416453|453634543|FG007|Overall Study|Physician Decision|1|||
126093170|NCT02416453|453634544|FG008|Overall Study|Physician Decision|0|||
126093171|NCT02416453|453634545|FG009|Overall Study|Physician Decision|0|||
126093172|NCT02416453|453634546|FG010|Overall Study|Physician Decision|0|||
126093173|NCT02416453|453634536|FG000|Overall Study|Withdrawal by Subject|2|||
126093174|NCT02416453|453634537|FG001|Overall Study|Withdrawal by Subject|0|||
126093175|NCT02416453|453634538|FG002|Overall Study|Withdrawal by Subject|0|||
126093176|NCT02416453|453634539|FG003|Overall Study|Withdrawal by Subject|5|||
126093177|NCT02416453|453634540|FG004|Overall Study|Withdrawal by Subject|1|||
126093178|NCT02416453|453634541|FG005|Overall Study|Withdrawal by Subject|8|||
126093179|NCT02416453|453634542|FG006|Overall Study|Withdrawal by Subject|0|||
126093180|NCT02416453|453634543|FG007|Overall Study|Withdrawal by Subject|8|||
126093181|NCT02416453|453634544|FG008|Overall Study|Withdrawal by Subject|4|||
126093182|NCT02416453|453634545|FG009|Overall Study|Withdrawal by Subject|0|||
126093183|NCT02416453|453634546|FG010|Overall Study|Withdrawal by Subject|0|||
126093184|NCT02416453|453634536|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093185|NCT02416453|453634537|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093186|NCT02416453|453634538|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
126093187|NCT02416453|453634539|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093188|NCT02416453|453634540|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093189|NCT02416453|453634541|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093190|NCT02416453|453634542|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093191|NCT02416453|453634543|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093192|NCT02416453|453634544|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093193|NCT02416453|453634545|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093194|NCT02416453|453634546|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126093195|NCT02416453|453634536|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126093196|NCT02416453|453634537|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126093197|NCT02416453|453634538|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126093198|NCT02416453|453634539|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125878740|NCT03175367|452853402|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
126093199|NCT02416453|453634540|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126093200|NCT02416453|453634541|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
126093201|NCT02416453|453634542|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125878741|NCT03175367|452853403|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
126232953|NCT00950807|454145129|FG005|Treatment Period 1|Adverse Event|1|||
126232954|NCT00950807|454145130|FG006|Treatment Period 1|Adverse Event|0|||
126232955|NCT00950807|454145131|FG007|Treatment Period 1|Adverse Event|0|||
126232956|NCT00950807|454145132|FG008|Treatment Period 1|Adverse Event|0|||
126232957|NCT00950807|454145133|FG009|Treatment Period 1|Adverse Event|0|||
126232958|NCT00950807|454145124|FG000|Washout Period 1|Lack of Efficacy|0|||
126232959|NCT00950807|454145125|FG001|Washout Period 1|Lack of Efficacy|0|||
126232960|NCT00950807|454145126|FG002|Washout Period 1|Lack of Efficacy|0|||
126232961|NCT00950807|454145127|FG003|Washout Period 1|Lack of Efficacy|0|||
126232962|NCT00950807|454145128|FG004|Washout Period 1|Lack of Efficacy|0|||
126232963|NCT00950807|454145129|FG005|Washout Period 1|Lack of Efficacy|0|||
126232964|NCT00950807|454145130|FG006|Washout Period 1|Lack of Efficacy|1|||
126232965|NCT00950807|454145131|FG007|Washout Period 1|Lack of Efficacy|0|||
126232966|NCT00950807|454145132|FG008|Washout Period 1|Lack of Efficacy|0|||
126232967|NCT00950807|454145133|FG009|Washout Period 1|Lack of Efficacy|0|||
126232968|NCT00950807|454145124|FG000|Washout Period 1|Withdrawal by Subject|0|||
126232969|NCT00950807|454145125|FG001|Washout Period 1|Withdrawal by Subject|0|||
126232970|NCT00950807|454145126|FG002|Washout Period 1|Withdrawal by Subject|0|||
126232971|NCT00950807|454145127|FG003|Washout Period 1|Withdrawal by Subject|0|||
126232972|NCT00950807|454145128|FG004|Washout Period 1|Withdrawal by Subject|0|||
126232973|NCT00950807|454145129|FG005|Washout Period 1|Withdrawal by Subject|0|||
126232974|NCT00950807|454145130|FG006|Washout Period 1|Withdrawal by Subject|0|||
126232975|NCT00950807|454145131|FG007|Washout Period 1|Withdrawal by Subject|0|||
126354194|NCT03641924|454589327|FG000|Overall Study|Withdrawal by Subject|26|||
126354195|NCT03641924|454589327|FG000|Overall Study|Lost to Follow-up|16|||
126354196|NCT03641924|454589327|FG000|Overall Study|Protocol Violation|10|||
126354197|NCT04333498|454589328|FG000|Overall Study|Lost to Follow-up|1|||
126354198|NCT04333498|454589329|FG001|Overall Study|Lost to Follow-up|0|||
126354199|NCT04333498|454589328|FG000|Overall Study|Lost to Follow-up|0|||
126354200|NCT04333498|454589329|FG001|Overall Study|Lost to Follow-up|1|||
126354201|NCT01565694|454589330|FG000|Dose-Titration Period|Adverse Event|4|||
126354202|NCT01565694|454589330|FG000|Dose-Titration Period|Protocol Violation|10|||
126354203|NCT01565694|454589330|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
126354204|NCT05417113|454589334|FG000|Overall Study|Lost to Follow-up|2|||
126354205|NCT05417113|454589335|FG001|Overall Study|Lost to Follow-up|2|||
126354206|NCT01022580|454589336|FG000|Overall Study|Death|18|||
126354207|NCT01022580|454589337|FG001|Overall Study|Death|22|||
126354208|NCT00541229|454589338|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
126354209|NCT00541229|454589339|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
126354210|NCT00541229|454589340|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
126354211|NCT00541229|454589341|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
126354212|NCT00541229|454589342|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
126354213|NCT00541229|454589343|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
126354214|NCT00541229|454589338|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354215|NCT00541229|454589339|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354216|NCT00541229|454589340|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354217|NCT00541229|454589341|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354218|NCT00541229|454589342|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354219|NCT00541229|454589343|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
126354220|NCT00541229|454589338|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354221|NCT00541229|454589339|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354222|NCT00541229|454589340|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354223|NCT00541229|454589341|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354224|NCT00541229|454589342|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354225|NCT00541229|454589343|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
126354226|NCT00541229|454589338|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
126354227|NCT00541229|454589339|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
126354228|NCT00541229|454589340|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
126354229|NCT00541229|454589341|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
126354230|NCT00541229|454589342|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
126354231|NCT00541229|454589343|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
126354232|NCT00541229|454589338|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
126354233|NCT00541229|454589339|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
126354234|NCT00541229|454589340|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
126354235|NCT00541229|454589341|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
126354236|NCT00541229|454589342|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
126354237|NCT00541229|454589343|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
126354238|NCT00541229|454589338|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
126354239|NCT00541229|454589339|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
126354240|NCT00541229|454589340|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
126354241|NCT00541229|454589341|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
126232976|NCT00950807|454145132|FG008|Washout Period 1|Withdrawal by Subject|1|||
126232977|NCT00950807|454145133|FG009|Washout Period 1|Withdrawal by Subject|0|||
126232978|NCT00950807|454145124|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
126354242|NCT00541229|454589342|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
126354243|NCT00541229|454589343|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
126354244|NCT00541229|454589338|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
126232979|NCT00950807|454145125|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126232980|NCT00950807|454145126|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126232981|NCT00950807|454145127|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126232982|NCT00950807|454145128|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126232983|NCT00950807|454145129|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126232984|NCT00950807|454145130|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
126232985|NCT00950807|454145131|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
126232986|NCT00950807|454145132|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126232987|NCT00950807|454145133|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126232988|NCT00950807|454145124|FG000|Washout Period 1|Adverse Event|2|||
126232989|NCT00950807|454145125|FG001|Washout Period 1|Adverse Event|0|||
126232990|NCT00950807|454145126|FG002|Washout Period 1|Adverse Event|0|||
126232991|NCT00950807|454145127|FG003|Washout Period 1|Adverse Event|1|||
126232992|NCT00950807|454145128|FG004|Washout Period 1|Adverse Event|1|||
126232993|NCT00950807|454145129|FG005|Washout Period 1|Adverse Event|0|||
126232994|NCT00950807|454145130|FG006|Washout Period 1|Adverse Event|0|||
126232995|NCT00950807|454145131|FG007|Washout Period 1|Adverse Event|0|||
126232996|NCT00950807|454145132|FG008|Washout Period 1|Adverse Event|0|||
126232997|NCT00950807|454145133|FG009|Washout Period 1|Adverse Event|0|||
126232998|NCT00950807|454145124|FG000|Treatment Period 2|Lack of Efficacy|1|||
126232999|NCT00950807|454145125|FG001|Treatment Period 2|Lack of Efficacy|0|||
126233000|NCT00950807|454145126|FG002|Treatment Period 2|Lack of Efficacy|0|||
126233001|NCT00950807|454145127|FG003|Treatment Period 2|Lack of Efficacy|0|||
126233002|NCT00950807|454145128|FG004|Treatment Period 2|Lack of Efficacy|0|||
126233003|NCT00950807|454145129|FG005|Treatment Period 2|Lack of Efficacy|0|||
126233004|NCT00950807|454145130|FG006|Treatment Period 2|Lack of Efficacy|0|||
126233005|NCT00950807|454145131|FG007|Treatment Period 2|Lack of Efficacy|0|||
126233006|NCT00950807|454145132|FG008|Treatment Period 2|Lack of Efficacy|0|||
126233007|NCT00950807|454145133|FG009|Treatment Period 2|Lack of Efficacy|0|||
126233008|NCT00950807|454145124|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126233009|NCT00950807|454145125|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126233010|NCT00950807|454145126|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126233011|NCT00950807|454145127|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126233012|NCT00950807|454145128|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126233013|NCT00950807|454145129|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126233014|NCT00950807|454145130|FG006|Treatment Period 2|Withdrawal by Subject|1|||
126233015|NCT00950807|454145131|FG007|Treatment Period 2|Withdrawal by Subject|2|||
126233016|NCT00950807|454145132|FG008|Treatment Period 2|Withdrawal by Subject|0|||
126233017|NCT00950807|454145133|FG009|Treatment Period 2|Withdrawal by Subject|0|||
126233018|NCT00950807|454145124|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
126233019|NCT00950807|454145125|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233020|NCT00950807|454145126|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233021|NCT00950807|454145127|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233022|NCT00950807|454145128|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233023|NCT00950807|454145129|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233024|NCT00950807|454145130|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233025|NCT00950807|454145131|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233026|NCT00950807|454145132|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233027|NCT00950807|454145133|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126233028|NCT00950807|454145124|FG000|Treatment Period 2|Adverse Event|0|||
126233029|NCT00950807|454145125|FG001|Treatment Period 2|Adverse Event|1|||
126233030|NCT00950807|454145126|FG002|Treatment Period 2|Adverse Event|0|||
126233031|NCT00950807|454145127|FG003|Treatment Period 2|Adverse Event|1|||
126233032|NCT00950807|454145128|FG004|Treatment Period 2|Adverse Event|0|||
126233033|NCT00950807|454145129|FG005|Treatment Period 2|Adverse Event|1|||
126233034|NCT00950807|454145130|FG006|Treatment Period 2|Adverse Event|0|||
126233035|NCT00950807|454145131|FG007|Treatment Period 2|Adverse Event|1|||
126233036|NCT00950807|454145132|FG008|Treatment Period 2|Adverse Event|0|||
126233037|NCT00950807|454145133|FG009|Treatment Period 2|Adverse Event|0|||
126233038|NCT00950807|454145124|FG000|Washout Period 2|Lack of Efficacy|1|||
126233039|NCT00950807|454145125|FG001|Washout Period 2|Lack of Efficacy|0|||
126233040|NCT00950807|454145126|FG002|Washout Period 2|Lack of Efficacy|0|||
126023083|NCT05656911|453380616|FG001|Treatment Phase|Physician Decision|0|||
126233041|NCT00950807|454145127|FG003|Washout Period 2|Lack of Efficacy|0|||
126233042|NCT00950807|454145128|FG004|Washout Period 2|Lack of Efficacy|0|||
126023084|NCT05656911|453380615|FG000|Treatment Phase|Lack of Efficacy|6|||
126233043|NCT00950807|454145129|FG005|Washout Period 2|Lack of Efficacy|0|||
126233044|NCT00950807|454145130|FG006|Washout Period 2|Lack of Efficacy|0|||
126233045|NCT00950807|454145131|FG007|Washout Period 2|Lack of Efficacy|0|||
126233046|NCT00950807|454145132|FG008|Washout Period 2|Lack of Efficacy|0|||
126233047|NCT00950807|454145133|FG009|Washout Period 2|Lack of Efficacy|0|||
126233048|NCT00950807|454145124|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126233049|NCT00950807|454145125|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
126233050|NCT00950807|454145126|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126233051|NCT00950807|454145127|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126233052|NCT00950807|454145128|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
126233053|NCT00950807|454145129|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126233054|NCT00950807|454145130|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
126233055|NCT00950807|454145131|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
126233056|NCT00950807|454145132|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126233057|NCT00950807|454145133|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126233058|NCT00950807|454145124|FG000|Washout Period 2|Adverse Event|3|||
126233059|NCT00950807|454145125|FG001|Washout Period 2|Adverse Event|0|||
126233060|NCT00950807|454145126|FG002|Washout Period 2|Adverse Event|0|||
126233061|NCT00950807|454145127|FG003|Washout Period 2|Adverse Event|1|||
126233062|NCT00950807|454145128|FG004|Washout Period 2|Adverse Event|0|||
126233063|NCT00950807|454145129|FG005|Washout Period 2|Adverse Event|0|||
126233064|NCT00950807|454145130|FG006|Washout Period 2|Adverse Event|0|||
126233065|NCT00950807|454145131|FG007|Washout Period 2|Adverse Event|0|||
126233066|NCT00950807|454145132|FG008|Washout Period 2|Adverse Event|0|||
126233067|NCT00950807|454145133|FG009|Washout Period 2|Adverse Event|0|||
126233068|NCT00950807|454145124|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126233069|NCT00950807|454145125|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126233070|NCT00950807|454145126|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126233071|NCT00950807|454145127|FG003|Treatment Period 3|Withdrawal by Subject|0|||
126233072|NCT00950807|454145128|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126233073|NCT00950807|454145129|FG005|Treatment Period 3|Withdrawal by Subject|0|||
126233074|NCT00950807|454145130|FG006|Treatment Period 3|Withdrawal by Subject|0|||
126233075|NCT00950807|454145131|FG007|Treatment Period 3|Withdrawal by Subject|0|||
126233076|NCT00950807|454145132|FG008|Treatment Period 3|Withdrawal by Subject|0|||
126233077|NCT00950807|454145133|FG009|Treatment Period 3|Withdrawal by Subject|1|||
126233078|NCT00950807|454145124|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
126233079|NCT00950807|454145125|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126233080|NCT00950807|454145126|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126233081|NCT00950807|454145127|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126233082|NCT00950807|454145128|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126233083|NCT00950807|454145129|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126233084|NCT00950807|454145130|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126233085|NCT00950807|454145131|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
126233086|NCT00950807|454145132|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126233087|NCT00950807|454145133|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126233088|NCT00950807|454145124|FG000|Treatment Period 3|Adverse Event|0|||
126233089|NCT00950807|454145125|FG001|Treatment Period 3|Adverse Event|0|||
126354245|NCT00541229|454589339|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
126354246|NCT00541229|454589340|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
126354247|NCT00541229|454589341|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
126354248|NCT00541229|454589342|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
126354249|NCT00541229|454589343|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
126354250|NCT00541229|454589338|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
126354251|NCT00541229|454589339|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
126354252|NCT00541229|454589340|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
126354253|NCT00541229|454589341|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
126354254|NCT00541229|454589342|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
126354255|NCT00541229|454589343|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
126354256|NCT00541229|454589338|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
126354257|NCT00541229|454589339|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
126354258|NCT00541229|454589340|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
126354259|NCT00541229|454589341|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
126354260|NCT00541229|454589342|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
126354261|NCT00541229|454589343|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
126354262|NCT00541229|454589338|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
126354263|NCT00541229|454589339|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
126354264|NCT00541229|454589340|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
126354265|NCT00541229|454589341|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
126354266|NCT00541229|454589342|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
126354267|NCT00541229|454589343|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
126354268|NCT00541229|454589338|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
126354269|NCT00541229|454589339|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354270|NCT00541229|454589340|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354271|NCT00541229|454589341|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354272|NCT00541229|454589342|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354273|NCT00541229|454589343|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354274|NCT00541229|454589338|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126233090|NCT00950807|454145126|FG002|Treatment Period 3|Adverse Event|0|||
126233091|NCT00950807|454145127|FG003|Treatment Period 3|Adverse Event|0|||
126233092|NCT00950807|454145128|FG004|Treatment Period 3|Adverse Event|0|||
126233093|NCT00950807|454145129|FG005|Treatment Period 3|Adverse Event|0|||
126233094|NCT00950807|454145130|FG006|Treatment Period 3|Adverse Event|1|||
126023085|NCT05656911|453380616|FG001|Treatment Phase|Lack of Efficacy|3|||
126023086|NCT05656911|453380615|FG000|Treatment Phase|Subject Decision|4|||
126233095|NCT00950807|454145131|FG007|Treatment Period 3|Adverse Event|0|||
126233096|NCT00950807|454145132|FG008|Treatment Period 3|Adverse Event|0|||
126233097|NCT00950807|454145133|FG009|Treatment Period 3|Adverse Event|0|||
126233098|NCT00337077|454145134|FG000|Overall Study|Progressive disease|25|||
126233099|NCT00337077|454145135|FG001|Overall Study|Progressive disease|37|||
126233100|NCT00337077|454145136|FG002|Overall Study|Progressive disease|19|||
126233101|NCT00337077|454145134|FG000|Overall Study|Adverse Event|7|||
126233102|NCT00337077|454145135|FG001|Overall Study|Adverse Event|7|||
126233103|NCT00337077|454145136|FG002|Overall Study|Adverse Event|1|||
126233104|NCT00337077|454145134|FG000|Overall Study|Death|0|||
126233105|NCT00337077|454145135|FG001|Overall Study|Death|1|||
126233106|NCT00337077|454145136|FG002|Overall Study|Death|0|||
126233107|NCT00337077|454145134|FG000|Overall Study|Withdrawal by Subject|7|||
126233108|NCT00337077|454145135|FG001|Overall Study|Withdrawal by Subject|2|||
126233109|NCT00337077|454145136|FG002|Overall Study|Withdrawal by Subject|2|||
126233110|NCT00337077|454145134|FG000|Overall Study|Alternative therapy|1|||
126233111|NCT00337077|454145135|FG001|Overall Study|Alternative therapy|0|||
126023087|NCT05656911|453380616|FG001|Treatment Phase|Subject Decision|2|||
126233112|NCT00337077|454145136|FG002|Overall Study|Alternative therapy|0|||
126233113|NCT00337077|454145134|FG000|Overall Study|Physician Decision|1|||
126233114|NCT00337077|454145135|FG001|Overall Study|Physician Decision|4|||
126233115|NCT00337077|454145136|FG002|Overall Study|Physician Decision|2|||
126233116|NCT00337077|454145134|FG000|Overall Study|Never started treatment|1|||
126233117|NCT00337077|454145135|FG001|Overall Study|Never started treatment|1|||
126233118|NCT00337077|454145136|FG002|Overall Study|Never started treatment|0|||
126233119|NCT00337077|454145134|FG000|Overall Study|Ineligible|1|||
126233120|NCT00337077|454145135|FG001|Overall Study|Ineligible|1|||
126233121|NCT00337077|454145136|FG002|Overall Study|Ineligible|1|||
126233122|NCT02430870|454145149|FG000|Part 2|Voluntary Withdrawal|0|||
126233123|NCT02430870|454145150|FG001|Part 2|Voluntary Withdrawal|0|||
126233124|NCT02430870|454145151|FG002|Part 2|Voluntary Withdrawal|0|||
126233125|NCT02430870|454145152|FG003|Part 2|Voluntary Withdrawal|0|||
126233126|NCT02430870|454145153|FG004|Part 2|Voluntary Withdrawal|0|||
126233127|NCT02430870|454145154|FG005|Part 2|Voluntary Withdrawal|0|||
126233128|NCT02430870|454145155|FG006|Part 2|Voluntary Withdrawal|1|||
126233129|NCT02430870|454145156|FG007|Part 2|Voluntary Withdrawal|0|||
126233130|NCT02430870|454145149|FG000|Part 2|Other Reason Not Specified|0|||
126233131|NCT02430870|454145150|FG001|Part 2|Other Reason Not Specified|0|||
126233132|NCT02430870|454145151|FG002|Part 2|Other Reason Not Specified|0|||
126233133|NCT02430870|454145152|FG003|Part 2|Other Reason Not Specified|0|||
126233134|NCT02430870|454145153|FG004|Part 2|Other Reason Not Specified|0|||
126233135|NCT02430870|454145154|FG005|Part 2|Other Reason Not Specified|0|||
126233136|NCT02430870|454145155|FG006|Part 2|Other Reason Not Specified|0|||
126233137|NCT02430870|454145156|FG007|Part 2|Other Reason Not Specified|1|||
126233138|NCT01265784|454145157|FG000|Overall Study|Lost to Follow-up|5|||
126354275|NCT00541229|454589339|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126354276|NCT00541229|454589340|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126354277|NCT00541229|454589341|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126354278|NCT00541229|454589342|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
126354279|NCT00541229|454589343|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126023088|NCT05656911|453380615|FG000|Treatment Phase|Other Reasons|1|||
126023089|NCT05656911|453380616|FG001|Treatment Phase|Other Reasons|0|||
126023090|NCT05656911|453380615|FG000|Treatment Phase|Adverse Event|3|||
126354280|NCT00541229|454589338|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
126354281|NCT00541229|454589339|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
126354282|NCT00541229|454589340|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
126233139|NCT01265784|454145158|FG001|Overall Study|Lost to Follow-up|3|||
126233140|NCT01265784|454145159|FG002|Overall Study|Lost to Follow-up|2|||
126233141|NCT01265784|454145157|FG000|Overall Study|Withdrawal by Subject|0|||
126233142|NCT01265784|454145158|FG001|Overall Study|Withdrawal by Subject|5|||
126233143|NCT01265784|454145159|FG002|Overall Study|Withdrawal by Subject|0|||
126233144|NCT01265784|454145157|FG000|Overall Study|Physician Decision|1|||
126233145|NCT01265784|454145158|FG001|Overall Study|Physician Decision|0|||
126233146|NCT01265784|454145159|FG002|Overall Study|Physician Decision|1|||
126233147|NCT01265784|454145157|FG000|Overall Study|Adverse Event|1|||
126233148|NCT01265784|454145158|FG001|Overall Study|Adverse Event|0|||
126233149|NCT01265784|454145159|FG002|Overall Study|Adverse Event|0|||
126233150|NCT01265784|454145157|FG000|Overall Study|Death|3|||
126233151|NCT01265784|454145158|FG001|Overall Study|Death|0|||
126233152|NCT01265784|454145159|FG002|Overall Study|Death|0|||
126233153|NCT01265784|454145157|FG000|Overall Study|Protocol Violation|2|||
126233154|NCT01265784|454145158|FG001|Overall Study|Protocol Violation|0|||
126233155|NCT01265784|454145159|FG002|Overall Study|Protocol Violation|0|||
126233156|NCT01265784|454145157|FG000|Overall Study|Incorrectly Randomized|0|||
126233157|NCT01265784|454145158|FG001|Overall Study|Incorrectly Randomized|0|||
126233158|NCT01265784|454145159|FG002|Overall Study|Incorrectly Randomized|1|||
126233159|NCT01867242|454145162|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
126233160|NCT01867242|454145163|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
126233161|NCT01867242|454145164|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
126233162|NCT03184441|454145169|FG000|Overall Study|Withdrawal by Subject|1|||
126233163|NCT00264810|454145170|FG000|Baseline|Withdrawal by Subject|10|||
126233164|NCT00264810|454145171|FG001|Baseline|Withdrawal by Subject|10|||
126233165|NCT00264810|454145170|FG000|Baseline|Physician Decision|7|||
126233166|NCT00264810|454145171|FG001|Baseline|Physician Decision|8|||
126233167|NCT00264810|454145170|FG000|Baseline|Subject Compliance Failure|3|||
126233168|NCT00264810|454145171|FG001|Baseline|Subject Compliance Failure|3|||
126233169|NCT00264810|454145170|FG000|Baseline|Insufficient Seizure Frequency|2|||
126233170|NCT00264810|454145171|FG001|Baseline|Insufficient Seizure Frequency|2|||
126233171|NCT00264810|454145170|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
126233172|NCT00264810|454145171|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
126233173|NCT00264810|454145170|FG000|Baseline|Other|0|||
126233174|NCT00264810|454145171|FG001|Baseline|Other|1|||
126233175|NCT00264810|454145170|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
126233176|NCT00264810|454145171|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
126233177|NCT00264810|454145170|FG000|Stimulation Optimization Period|Death|0|||
126233178|NCT00264810|454145171|FG001|Stimulation Optimization Period|Death|1|||
126233179|NCT00264810|454145170|FG000|Blinded Evaluation Period|Explant due to infection|1|||
126233180|NCT00264810|454145171|FG001|Blinded Evaluation Period|Explant due to infection|1|||
126233181|NCT00264810|454145170|FG000|Open Label Evaluation Period|Explant due to infection|1|||
126233182|NCT00264810|454145171|FG001|Open Label Evaluation Period|Explant due to infection|1|||
126233183|NCT00264810|454145170|FG000|Open Label Evaluation Period|Death|3|||
126233184|NCT00264810|454145171|FG001|Open Label Evaluation Period|Death|2|||
126233185|NCT00264810|454145170|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
126233186|NCT00264810|454145171|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
126233187|NCT02199509|454145172|FG000|Overall Study|Suicidal Ideation|0|||
126233188|NCT02199509|454145173|FG001|Overall Study|Suicidal Ideation|1|||
126233189|NCT02199509|454145172|FG000|Overall Study|Misunderstood titration schedule|1|||
126233190|NCT02199509|454145173|FG001|Overall Study|Misunderstood titration schedule|0|||
126233191|NCT02093689|454145174|FG000|Overall Study|Physician Decision|4|||
126354283|NCT00541229|454589341|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
126354284|NCT00541229|454589342|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
126354285|NCT00541229|454589343|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
126354286|NCT00541229|454589338|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
126354287|NCT00541229|454589339|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
126354288|NCT00541229|454589340|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
126354289|NCT00541229|454589341|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
126354290|NCT00541229|454589342|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
126354291|NCT00541229|454589343|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
126354292|NCT00541229|454589338|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354293|NCT00541229|454589339|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354294|NCT00541229|454589340|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354295|NCT00541229|454589341|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354296|NCT00541229|454589342|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354297|NCT00541229|454589343|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
126354298|NCT00541229|454589338|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354299|NCT00541229|454589339|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354300|NCT00541229|454589340|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
126354301|NCT00541229|454589341|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354302|NCT00541229|454589342|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354303|NCT00541229|454589343|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354304|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354305|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
126023091|NCT05656911|453380616|FG001|Treatment Phase|Adverse Event|1|||
126023092|NCT05656911|453380615|FG000|Follow-up Phase|Subject Decision|0|||
126233192|NCT02093689|454145175|FG001|Overall Study|Physician Decision|0|||
126233193|NCT02093689|454145176|FG002|Overall Study|Physician Decision|0|||
126233194|NCT03309956|454145177|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
126233195|NCT02768298|454145178|FG000|Overall Study|Adverse Event|1|||
126233196|NCT02768298|454145179|FG001|Overall Study|Adverse Event|4|||
126233197|NCT02768298|454145178|FG000|Overall Study|Death|2|||
126233198|NCT02768298|454145179|FG001|Overall Study|Death|1|||
126233199|NCT02768298|454145178|FG000|Overall Study|Non-compliance with study treatment|0|||
126023093|NCT05656911|453380616|FG001|Follow-up Phase|Subject Decision|1|||
126023094|NCT05656911|453380615|FG000|Follow-up Phase|Missing|1|||
126233200|NCT02768298|454145179|FG001|Overall Study|Non-compliance with study treatment|1|||
126233201|NCT02768298|454145178|FG000|Overall Study|Subject/guardian decision|1|||
126233202|NCT02768298|454145179|FG001|Overall Study|Subject/guardian decision|0|||
126233203|NCT02768298|454145178|FG000|Overall Study|Withdrawal of informed consent|0|||
126233204|NCT02768298|454145179|FG001|Overall Study|Withdrawal of informed consent|1|||
126233205|NCT04634409|454145180|FG000|Overall Study|Death|0|||
126233206|NCT04634409|454145181|FG001|Overall Study|Death|0|||
126233207|NCT04634409|454145182|FG002|Overall Study|Death|0|||
126233208|NCT04634409|454145183|FG003|Overall Study|Death|0|||
126233209|NCT04634409|454145184|FG004|Overall Study|Death|0|||
126233210|NCT04634409|454145185|FG005|Overall Study|Death|0|||
126233211|NCT04634409|454145186|FG006|Overall Study|Death|0|||
126233212|NCT04634409|454145187|FG007|Overall Study|Death|0|||
126233213|NCT04634409|454145188|FG008|Overall Study|Death|0|||
126233214|NCT04634409|454145189|FG009|Overall Study|Death|0|||
126233215|NCT04634409|454145190|FG010|Overall Study|Death|1|||
126233216|NCT04634409|454145191|FG011|Overall Study|Death|0|||
126233217|NCT04634409|454145192|FG012|Overall Study|Death|1|||
126233218|NCT04634409|454145193|FG013|Overall Study|Death|0|||
126233219|NCT04634409|454145194|FG014|Overall Study|Death|0|||
126233220|NCT04634409|454145195|FG015|Overall Study|Death|0|||
126233221|NCT04634409|454145196|FG016|Overall Study|Death|0|||
126233222|NCT04634409|454145197|FG017|Overall Study|Death|0|||
126233223|NCT04634409|454145198|FG018|Overall Study|Death|0|||
126233224|NCT04634409|454145199|FG019|Overall Study|Death|0|||
126233225|NCT04634409|454145200|FG020|Overall Study|Death|0|||
126233226|NCT04634409|454145201|FG021|Overall Study|Death|0|||
126233227|NCT04634409|454145202|FG022|Overall Study|Death|0|||
126354306|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
126354307|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354308|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354309|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354310|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354311|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
126354312|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354313|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
126354314|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354315|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354316|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354317|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354318|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354319|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354320|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
126354321|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354322|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354323|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354324|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354325|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
126354326|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354327|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354328|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354329|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354330|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126023095|NCT05656911|453380616|FG001|Follow-up Phase|Missing|0|||
126023096|NCT03088813|453380617|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
126023097|NCT03088813|453380618|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
126046468|NCT02467270|453468227|FG001|Overall Study|Lost to Follow-up|1|||
126233228|NCT04634409|454145203|FG023|Overall Study|Death|0|||
126233229|NCT04634409|454145204|FG024|Overall Study|Death|0|||
126233230|NCT04634409|454145205|FG025|Overall Study|Death|0|||
126233231|NCT04634409|454145206|FG026|Overall Study|Death|0|||
126233232|NCT04634409|454145180|FG000|Overall Study|Adverse Event|0|||
126233233|NCT04634409|454145181|FG001|Overall Study|Adverse Event|0|||
126233234|NCT04634409|454145182|FG002|Overall Study|Adverse Event|1|||
126233235|NCT04634409|454145183|FG003|Overall Study|Adverse Event|0|||
126233236|NCT04634409|454145184|FG004|Overall Study|Adverse Event|0|||
126233237|NCT04634409|454145185|FG005|Overall Study|Adverse Event|1|||
126233238|NCT04634409|454145186|FG006|Overall Study|Adverse Event|0|||
126233239|NCT04634409|454145187|FG007|Overall Study|Adverse Event|0|||
126233240|NCT04634409|454145188|FG008|Overall Study|Adverse Event|0|||
126233241|NCT04634409|454145189|FG009|Overall Study|Adverse Event|0|||
126233242|NCT04634409|454145190|FG010|Overall Study|Adverse Event|0|||
126233243|NCT04634409|454145191|FG011|Overall Study|Adverse Event|0|||
126233244|NCT04634409|454145192|FG012|Overall Study|Adverse Event|0|||
126233245|NCT04634409|454145193|FG013|Overall Study|Adverse Event|0|||
126233246|NCT04634409|454145194|FG014|Overall Study|Adverse Event|0|||
126233247|NCT04634409|454145195|FG015|Overall Study|Adverse Event|0|||
126233248|NCT04634409|454145196|FG016|Overall Study|Adverse Event|0|||
126233249|NCT04634409|454145197|FG017|Overall Study|Adverse Event|0|||
126233250|NCT04634409|454145198|FG018|Overall Study|Adverse Event|0|||
126233251|NCT04634409|454145199|FG019|Overall Study|Adverse Event|0|||
126233252|NCT04634409|454145200|FG020|Overall Study|Adverse Event|0|||
126233253|NCT04634409|454145201|FG021|Overall Study|Adverse Event|0|||
126233254|NCT04634409|454145202|FG022|Overall Study|Adverse Event|0|||
126233255|NCT04634409|454145203|FG023|Overall Study|Adverse Event|0|||
126233256|NCT04634409|454145204|FG024|Overall Study|Adverse Event|0|||
126233257|NCT04634409|454145205|FG025|Overall Study|Adverse Event|0|||
126233258|NCT04634409|454145206|FG026|Overall Study|Adverse Event|0|||
126233259|NCT04634409|454145180|FG000|Overall Study|Lost to Follow-up|3|||
126233260|NCT04634409|454145181|FG001|Overall Study|Lost to Follow-up|1|||
126233261|NCT04634409|454145182|FG002|Overall Study|Lost to Follow-up|1|||
126233262|NCT04634409|454145183|FG003|Overall Study|Lost to Follow-up|3|||
126233263|NCT04634409|454145184|FG004|Overall Study|Lost to Follow-up|1|||
126233264|NCT04634409|454145185|FG005|Overall Study|Lost to Follow-up|1|||
126233265|NCT04634409|454145186|FG006|Overall Study|Lost to Follow-up|1|||
126233266|NCT04634409|454145187|FG007|Overall Study|Lost to Follow-up|3|||
126233267|NCT04634409|454145188|FG008|Overall Study|Lost to Follow-up|3|||
126233268|NCT04634409|454145189|FG009|Overall Study|Lost to Follow-up|11|||
126233269|NCT04634409|454145190|FG010|Overall Study|Lost to Follow-up|8|||
126233270|NCT04634409|454145191|FG011|Overall Study|Lost to Follow-up|15|||
126233271|NCT04634409|454145192|FG012|Overall Study|Lost to Follow-up|3|||
126233272|NCT04634409|454145193|FG013|Overall Study|Lost to Follow-up|2|||
126233273|NCT04634409|454145194|FG014|Overall Study|Lost to Follow-up|7|||
126233274|NCT04634409|454145195|FG015|Overall Study|Lost to Follow-up|0|||
126233275|NCT04634409|454145196|FG016|Overall Study|Lost to Follow-up|0|||
126233276|NCT04634409|454145197|FG017|Overall Study|Lost to Follow-up|0|||
126233277|NCT04634409|454145198|FG018|Overall Study|Lost to Follow-up|0|||
126233278|NCT04634409|454145199|FG019|Overall Study|Lost to Follow-up|0|||
126233279|NCT04634409|454145200|FG020|Overall Study|Lost to Follow-up|0|||
126233280|NCT04634409|454145201|FG021|Overall Study|Lost to Follow-up|0|||
126233281|NCT04634409|454145202|FG022|Overall Study|Lost to Follow-up|0|||
126233282|NCT04634409|454145203|FG023|Overall Study|Lost to Follow-up|0|||
126233283|NCT04634409|454145204|FG024|Overall Study|Lost to Follow-up|0|||
126233284|NCT04634409|454145205|FG025|Overall Study|Lost to Follow-up|0|||
126023098|NCT03088813|453380619|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
126023099|NCT03088813|453380620|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
126023100|NCT03088813|453380617|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
126046469|NCT02467270|453468228|FG002|Overall Study|Lost to Follow-up|0|||
126233285|NCT04634409|454145206|FG026|Overall Study|Lost to Follow-up|0|||
126233286|NCT04634409|454145180|FG000|Overall Study|Withdrawal by Subject|3|||
126233287|NCT04634409|454145181|FG001|Overall Study|Withdrawal by Subject|1|||
126233288|NCT04634409|454145182|FG002|Overall Study|Withdrawal by Subject|6|||
126233289|NCT04634409|454145183|FG003|Overall Study|Withdrawal by Subject|4|||
126233290|NCT04634409|454145184|FG004|Overall Study|Withdrawal by Subject|2|||
126233291|NCT04634409|454145185|FG005|Overall Study|Withdrawal by Subject|0|||
126233292|NCT04634409|454145186|FG006|Overall Study|Withdrawal by Subject|0|||
126233293|NCT04634409|454145187|FG007|Overall Study|Withdrawal by Subject|2|||
126233294|NCT04634409|454145188|FG008|Overall Study|Withdrawal by Subject|3|||
126233295|NCT04634409|454145189|FG009|Overall Study|Withdrawal by Subject|2|||
126233296|NCT04634409|454145190|FG010|Overall Study|Withdrawal by Subject|3|||
126233297|NCT04634409|454145191|FG011|Overall Study|Withdrawal by Subject|2|||
126233298|NCT04634409|454145192|FG012|Overall Study|Withdrawal by Subject|2|||
126233299|NCT04634409|454145193|FG013|Overall Study|Withdrawal by Subject|1|||
126233300|NCT04634409|454145194|FG014|Overall Study|Withdrawal by Subject|5|||
126233301|NCT04634409|454145195|FG015|Overall Study|Withdrawal by Subject|0|||
126233302|NCT04634409|454145196|FG016|Overall Study|Withdrawal by Subject|0|||
126233303|NCT04634409|454145197|FG017|Overall Study|Withdrawal by Subject|1|||
126233304|NCT04634409|454145198|FG018|Overall Study|Withdrawal by Subject|0|||
126233305|NCT04634409|454145199|FG019|Overall Study|Withdrawal by Subject|0|||
126233306|NCT04634409|454145200|FG020|Overall Study|Withdrawal by Subject|0|||
126233307|NCT04634409|454145201|FG021|Overall Study|Withdrawal by Subject|0|||
126233308|NCT04634409|454145202|FG022|Overall Study|Withdrawal by Subject|0|||
126233309|NCT04634409|454145203|FG023|Overall Study|Withdrawal by Subject|1|||
126233310|NCT04634409|454145204|FG024|Overall Study|Withdrawal by Subject|0|||
126233311|NCT04634409|454145205|FG025|Overall Study|Withdrawal by Subject|0|||
126233312|NCT04634409|454145206|FG026|Overall Study|Withdrawal by Subject|0|||
126233313|NCT04634409|454145180|FG000|Overall Study|Other - As reported by Investigator|1|||
126233314|NCT04634409|454145181|FG001|Overall Study|Other - As reported by Investigator|0|||
126233315|NCT04634409|454145182|FG002|Overall Study|Other - As reported by Investigator|0|||
126233316|NCT04634409|454145183|FG003|Overall Study|Other - As reported by Investigator|0|||
126233317|NCT04634409|454145184|FG004|Overall Study|Other - As reported by Investigator|0|||
126233318|NCT04634409|454145185|FG005|Overall Study|Other - As reported by Investigator|0|||
126233319|NCT04634409|454145186|FG006|Overall Study|Other - As reported by Investigator|0|||
126233320|NCT04634409|454145187|FG007|Overall Study|Other - As reported by Investigator|6|||
126233321|NCT04634409|454145188|FG008|Overall Study|Other - As reported by Investigator|4|||
126233322|NCT04634409|454145189|FG009|Overall Study|Other - As reported by Investigator|0|||
126233323|NCT04634409|454145190|FG010|Overall Study|Other - As reported by Investigator|1|||
126233324|NCT04634409|454145191|FG011|Overall Study|Other - As reported by Investigator|2|||
126233325|NCT04634409|454145192|FG012|Overall Study|Other - As reported by Investigator|2|||
126233326|NCT04634409|454145193|FG013|Overall Study|Other - As reported by Investigator|1|||
126233327|NCT04634409|454145194|FG014|Overall Study|Other - As reported by Investigator|0|||
126233328|NCT04634409|454145195|FG015|Overall Study|Other - As reported by Investigator|0|||
126233329|NCT04634409|454145196|FG016|Overall Study|Other - As reported by Investigator|0|||
126233330|NCT04634409|454145197|FG017|Overall Study|Other - As reported by Investigator|0|||
126233331|NCT04634409|454145198|FG018|Overall Study|Other - As reported by Investigator|0|||
126233332|NCT04634409|454145199|FG019|Overall Study|Other - As reported by Investigator|0|||
126233333|NCT04634409|454145200|FG020|Overall Study|Other - As reported by Investigator|0|||
126233334|NCT04634409|454145201|FG021|Overall Study|Other - As reported by Investigator|0|||
126233335|NCT04634409|454145202|FG022|Overall Study|Other - As reported by Investigator|0|||
126233336|NCT04634409|454145203|FG023|Overall Study|Other - As reported by Investigator|0|||
126233337|NCT04634409|454145204|FG024|Overall Study|Other - As reported by Investigator|0|||
126233338|NCT04634409|454145205|FG025|Overall Study|Other - As reported by Investigator|0|||
126233339|NCT04634409|454145206|FG026|Overall Study|Other - As reported by Investigator|0|||
126233340|NCT00502775|454147050|FG000|Overall Study|Adverse Event|1|||
126233341|NCT00502775|454147051|FG001|Overall Study|Adverse Event|2|||
126233342|NCT00502775|454147052|FG002|Overall Study|Adverse Event|1|||
126233343|NCT00502775|454147050|FG000|Overall Study|Protocol Violation|1|||
126233344|NCT00502775|454147051|FG001|Overall Study|Protocol Violation|5|||
126233345|NCT00502775|454147052|FG002|Overall Study|Protocol Violation|2|||
126233346|NCT00502775|454147050|FG000|Overall Study|Withdrawal by Subject|1|||
126233347|NCT00502775|454147051|FG001|Overall Study|Withdrawal by Subject|1|||
126233348|NCT00502775|454147052|FG002|Overall Study|Withdrawal by Subject|2|||
126233349|NCT00502775|454147050|FG000|Overall Study|Sponsor Terminated Study|1|||
126233350|NCT00502775|454147051|FG001|Overall Study|Sponsor Terminated Study|0|||
126233351|NCT00502775|454147052|FG002|Overall Study|Sponsor Terminated Study|1|||
126233352|NCT00502775|454147050|FG000|Overall Study|Non-compliance with eDiary|4|||
126233353|NCT00502775|454147051|FG001|Overall Study|Non-compliance with eDiary|1|||
126233354|NCT00502775|454147052|FG002|Overall Study|Non-compliance with eDiary|1|||
126233355|NCT00502775|454147050|FG000|Overall Study|Subject unable to swallow capsule|1|||
126233356|NCT00502775|454147051|FG001|Overall Study|Subject unable to swallow capsule|0|||
126233357|NCT00502775|454147052|FG002|Overall Study|Subject unable to swallow capsule|1|||
126233358|NCT00502775|454147050|FG000|Overall Study|Logpad compliance <80%|1|||
126233359|NCT00502775|454147051|FG001|Overall Study|Logpad compliance <80%|0|||
126023101|NCT03088813|453380618|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
126023102|NCT03088813|453380619|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
126023103|NCT03088813|453380620|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
126023104|NCT03088813|453380617|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
126023105|NCT03088813|453380618|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
126023106|NCT03088813|453380619|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
126023107|NCT03088813|453380620|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
126023108|NCT03088813|453380617|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
126023109|NCT03088813|453380618|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
126023110|NCT03088813|453380619|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
126023111|NCT03088813|453380620|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
126023112|NCT03088813|453380617|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
126023113|NCT03088813|453380618|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
126023114|NCT03088813|453380619|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
126023115|NCT03088813|453380620|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
126023116|NCT03088813|453380617|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
126023117|NCT03088813|453380618|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
126023118|NCT03088813|453380619|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
126023119|NCT03088813|453380620|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
126023120|NCT03088813|453380617|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
126023121|NCT03088813|453380618|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
126023122|NCT03088813|453380619|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
126023123|NCT03088813|453380620|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
126023124|NCT02780388|453380621|FG000|Overall Study|Lost to Follow-up|0|||
126023125|NCT02780388|453380622|FG001|Overall Study|Lost to Follow-up|1|||
126023126|NCT02780388|453380623|FG002|Overall Study|Lost to Follow-up|0|||
126023127|NCT02780388|453380624|FG003|Overall Study|Lost to Follow-up|0|||
126023128|NCT02780388|453380625|FG004|Overall Study|Lost to Follow-up|0|||
126023129|NCT02780388|453380621|FG000|Overall Study|Withdrawal by Subject|1|||
126023130|NCT02780388|453380622|FG001|Overall Study|Withdrawal by Subject|1|||
126023131|NCT02780388|453380623|FG002|Overall Study|Withdrawal by Subject|0|||
126023132|NCT02780388|453380624|FG003|Overall Study|Withdrawal by Subject|0|||
126023133|NCT02780388|453380625|FG004|Overall Study|Withdrawal by Subject|0|||
126023134|NCT04527146|453380626|FG000|Overall Study|Withdrawal by Subject|12|||
126023135|NCT04527146|453380627|FG001|Overall Study|Withdrawal by Subject|15|||
126023136|NCT04527146|453380628|FG002|Overall Study|Withdrawal by Subject|7|||
126023137|NCT04527146|453380629|FG003|Overall Study|Withdrawal by Subject|16|||
126023138|NCT04527146|453380626|FG000|Overall Study|Lost to Follow-up|13|||
126023139|NCT04527146|453380627|FG001|Overall Study|Lost to Follow-up|9|||
126023140|NCT04527146|453380628|FG002|Overall Study|Lost to Follow-up|16|||
126023141|NCT04527146|453380629|FG003|Overall Study|Lost to Follow-up|13|||
126023142|NCT04527146|453380626|FG000|Overall Study|Death|0|||
126023143|NCT04527146|453380627|FG001|Overall Study|Death|1|||
126023144|NCT04527146|453380628|FG002|Overall Study|Death|1|||
126023145|NCT04527146|453380629|FG003|Overall Study|Death|0|||
126023146|NCT04527146|453380626|FG000|Overall Study|Adverse Event|0|||
126023147|NCT04527146|453380627|FG001|Overall Study|Adverse Event|0|||
126354331|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354332|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126354333|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126354334|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
126354335|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126023148|NCT04527146|453380628|FG002|Overall Study|Adverse Event|1|||
126023149|NCT04527146|453380629|FG003|Overall Study|Adverse Event|0|||
126023150|NCT04527146|453380626|FG000|Overall Study|Ineligible after randomization|2|||
126023151|NCT04527146|453380627|FG001|Overall Study|Ineligible after randomization|0|||
126023152|NCT04527146|453380628|FG002|Overall Study|Ineligible after randomization|2|||
126023153|NCT04527146|453380629|FG003|Overall Study|Ineligible after randomization|2|||
126023154|NCT04527146|453380626|FG000|Overall Study|Moved to a different group|6|||
126023155|NCT04527146|453380627|FG001|Overall Study|Moved to a different group|3|||
126354336|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126354337|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126354338|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126023156|NCT04527146|453380628|FG002|Overall Study|Moved to a different group|0|||
126023157|NCT04527146|453380629|FG003|Overall Study|Moved to a different group|2|||
126023158|NCT05107401|453380630|FG000|Overall Study|Lost to Follow-up|13|||
126354339|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
126354340|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126023159|NCT05107401|453380631|FG001|Overall Study|Lost to Follow-up|12|||
126023160|NCT01903811|453380643|FG000|Overall Study|No measurable disease|1|||
126023161|NCT01903811|453380644|FG001|Overall Study|No measurable disease|1|||
126046470|NCT02467270|453468226|FG000|Overall Study|Pregnancy|0|||
126233360|NCT00502775|454147052|FG002|Overall Study|Logpad compliance <80%|0|||
126233361|NCT00502775|454147050|FG000|Overall Study|Randomized in error|0|||
126233362|NCT00502775|454147051|FG001|Overall Study|Randomized in error|1|||
126233363|NCT00502775|454147052|FG002|Overall Study|Randomized in error|1|||
126233364|NCT00502775|454147050|FG000|Overall Study|Non-compliance|0|||
126233365|NCT00502775|454147051|FG001|Overall Study|Non-compliance|2|||
126233366|NCT00502775|454147052|FG002|Overall Study|Non-compliance|2|||
126233367|NCT00502775|454147050|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
126233368|NCT00502775|454147051|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
126233369|NCT00502775|454147052|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
126233370|NCT00502775|454147050|FG000|Overall Study|Declining pollen counts|0|||
126233371|NCT00502775|454147051|FG001|Overall Study|Declining pollen counts|1|||
126233372|NCT00502775|454147052|FG002|Overall Study|Declining pollen counts|1|||
126233373|NCT00502775|454147050|FG000|Overall Study|Subject in jail|0|||
126233374|NCT00502775|454147051|FG001|Overall Study|Subject in jail|1|||
126233375|NCT00502775|454147052|FG002|Overall Study|Subject in jail|0|||
126233376|NCT00502775|454147050|FG000|Overall Study|Subject took disallowed drug|0|||
126233377|NCT00502775|454147051|FG001|Overall Study|Subject took disallowed drug|0|||
126233378|NCT00502775|454147052|FG002|Overall Study|Subject took disallowed drug|1|||
126233379|NCT01545076|454147054|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
126233380|NCT01545076|454147055|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
126233381|NCT01545076|454147056|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
126233382|NCT01545076|454147057|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
126233383|NCT01545076|454147058|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
126233384|NCT01545076|454147054|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
126233385|NCT01545076|454147055|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
126233386|NCT01545076|454147056|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
126233387|NCT01545076|454147057|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
126233388|NCT01545076|454147058|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
126233389|NCT01545076|454147054|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
126233390|NCT01545076|454147055|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
126233391|NCT01545076|454147056|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
126233392|NCT01545076|454147057|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
126233393|NCT01545076|454147058|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
126233394|NCT01545076|454147054|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
126233395|NCT01545076|454147055|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
126233396|NCT01545076|454147056|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
126354341|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354342|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354343|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354344|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354345|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354346|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
126354347|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
126233397|NCT01545076|454147057|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
126233398|NCT01545076|454147058|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
126023162|NCT01903811|453380643|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
126046471|NCT02467270|453468227|FG001|Overall Study|Pregnancy|1|||
126233399|NCT01545076|454147054|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
126354348|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
126023163|NCT01903811|453380644|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
126023164|NCT01903811|453380643|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
126023165|NCT01903811|453380644|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
126023166|NCT01903811|453380643|FG000|Overall Study|Withdrawal by Subject|0|||
126023167|NCT01903811|453380644|FG001|Overall Study|Withdrawal by Subject|1|||
126023168|NCT04468776|453380645|FG000|Overall Study|Lost to Follow-up|4|||
126023169|NCT04468776|453380646|FG001|Overall Study|Lost to Follow-up|3|||
126023170|NCT04468776|453380647|FG002|Overall Study|Lost to Follow-up|4|||
126023171|NCT04468776|453380645|FG000|Overall Study|Withdrawal by Subject|1|||
126023172|NCT04468776|453380646|FG001|Overall Study|Withdrawal by Subject|10|||
126023173|NCT04468776|453380647|FG002|Overall Study|Withdrawal by Subject|4|||
126023174|NCT04468776|453380645|FG000|Overall Study|Physician Decision|0|||
126233400|NCT01545076|454147055|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
126233401|NCT01545076|454147056|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
126233402|NCT01545076|454147057|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
126233403|NCT01545076|454147058|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
126233404|NCT01545076|454147054|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
126233405|NCT01545076|454147055|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
126233406|NCT01545076|454147056|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
126233407|NCT01545076|454147057|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
126233408|NCT01545076|454147058|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
126233409|NCT01545076|454147054|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
126233410|NCT01545076|454147055|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
126233411|NCT01545076|454147056|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
126233412|NCT01545076|454147057|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
126233413|NCT01545076|454147058|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
126233414|NCT01545076|454147054|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
126233415|NCT01545076|454147055|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
126233416|NCT01545076|454147056|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
126233417|NCT01545076|454147057|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
126233418|NCT01545076|454147058|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
126023175|NCT04468776|453380646|FG001|Overall Study|Physician Decision|1|||
126023176|NCT04468776|453380647|FG002|Overall Study|Physician Decision|1|||
126023177|NCT03285763|453380651|FG000|Overall Study|Death|470|||
126023178|NCT03285763|453380651|FG000|Overall Study|Lost to Follow-up|18|||
126023179|NCT03285763|453380651|FG000|Overall Study|Physician Decision|2|||
126023180|NCT03285763|453380651|FG000|Overall Study|Study Terminated By Sponsor|79|||
126233419|NCT01545076|454147054|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
126233420|NCT01545076|454147055|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
126354349|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
126354350|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
126354351|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
126354352|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
126354353|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354354|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354355|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354356|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
126023181|NCT03285763|453380651|FG000|Overall Study|Withdrawal by Subject|33|||
126023182|NCT03624972|453380652|FG000|Overall Study|Lost to Follow-up|2|||
126233421|NCT01545076|454147056|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
126023183|NCT03624972|453380653|FG001|Overall Study|Lost to Follow-up|0|||
126023184|NCT03624972|453380654|FG002|Overall Study|Lost to Follow-up|0|||
126023185|NCT03624972|453380652|FG000|Overall Study|Withdrawal by Subject|0|||
126023186|NCT03624972|453380653|FG001|Overall Study|Withdrawal by Subject|2|||
126023187|NCT03624972|453380654|FG002|Overall Study|Withdrawal by Subject|0|||
126023188|NCT03456076|453380655|FG000|Overall Study|Withdrawal by Subject|5|||
126023189|NCT03456076|453380656|FG001|Overall Study|Withdrawal by Subject|9|||
126023190|NCT03456076|453380655|FG000|Overall Study|Protocol deviation|0|||
126023191|NCT03456076|453380656|FG001|Overall Study|Protocol deviation|1|||
126023192|NCT03456076|453380655|FG000|Overall Study|Lost to Follow-up|0|||
126023193|NCT03456076|453380656|FG001|Overall Study|Lost to Follow-up|1|||
126023194|NCT03456076|453380655|FG000|Overall Study|Death|2|||
126023195|NCT03456076|453380656|FG001|Overall Study|Death|5|||
126354357|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354358|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354359|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354360|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
126354361|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354362|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354363|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354364|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354365|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354366|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354367|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354368|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
126354369|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354370|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354371|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354372|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354373|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354374|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
126354375|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354376|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354377|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
126354378|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354379|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354380|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354381|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
126354382|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
126354383|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
126354384|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
126354385|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
126354386|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
126354387|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
126354388|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
126354389|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
126354390|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
126354391|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
126354392|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
126354393|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
126354394|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
126354395|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
126354396|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
126354397|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
126354398|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
126354399|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
126354400|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
126354401|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
126354402|NCT01807520|454589344|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354403|NCT01807520|454589345|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354404|NCT01807520|454589346|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354405|NCT01807520|454589347|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354406|NCT01807520|454589348|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354407|NCT01807520|454589349|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
126354408|NCT01807520|454589350|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354409|NCT01807520|454589344|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354410|NCT01807520|454589345|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354411|NCT01807520|454589346|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354412|NCT01807520|454589347|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354413|NCT01807520|454589348|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126023196|NCT03456076|453380655|FG000|Overall Study|Study ongoing|123|||
126023197|NCT03456076|453380656|FG001|Overall Study|Study ongoing|111|||
126023198|NCT00792636|453380657|FG000|Overall Study|Protocol Violation|17|||
126023199|NCT00792636|453380658|FG001|Overall Study|Protocol Violation|23|||
126023200|NCT00792636|453380659|FG002|Overall Study|Protocol Violation|20|||
126023201|NCT00792636|453380657|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
126023202|NCT00792636|453380658|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
126023203|NCT00792636|453380659|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
126023204|NCT00792636|453380657|FG000|Overall Study|Lost to Follow-up|13|||
126093202|NCT02416453|453634543|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126093203|NCT02416453|453634544|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126023205|NCT00792636|453380658|FG001|Overall Study|Lost to Follow-up|19|||
126093204|NCT02416453|453634545|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126023206|NCT00792636|453380659|FG002|Overall Study|Lost to Follow-up|14|||
126093205|NCT02416453|453634546|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126023207|NCT00792636|453380657|FG000|Overall Study|Withdrew Consent|10|||
126023208|NCT00792636|453380658|FG001|Overall Study|Withdrew Consent|13|||
126023209|NCT00792636|453380659|FG002|Overall Study|Withdrew Consent|9|||
126023210|NCT00792636|453380657|FG000|Overall Study|Lack of Efficacy|3|||
126023211|NCT00792636|453380658|FG001|Overall Study|Lack of Efficacy|4|||
126023212|NCT00792636|453380659|FG002|Overall Study|Lack of Efficacy|13|||
126233422|NCT01545076|454147057|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
126233423|NCT01545076|454147058|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
126233424|NCT00287118|454147059|FG000|Overall Study|Adverse Event|30|||
126233425|NCT00287118|454147059|FG000|Overall Study|Death|1|||
126233426|NCT00287118|454147059|FG000|Overall Study|Lack of Efficacy|11|||
126233427|NCT00287118|454147059|FG000|Overall Study|Lost to Follow-up|1|||
126233428|NCT00287118|454147059|FG000|Overall Study|Protocol Violation|2|||
126233429|NCT00287118|454147059|FG000|Overall Study|Other|7|||
126233430|NCT00262600|454147060|FG000|Overall Study|Lost to Follow-up|17|||
126233431|NCT00262600|454147061|FG001|Overall Study|Lost to Follow-up|31|||
126233432|NCT00262600|454147062|FG002|Overall Study|Lost to Follow-up|41|||
126233433|NCT00262600|454147060|FG000|Overall Study|Withdrawal by Subject|128|||
126233434|NCT00262600|454147061|FG001|Overall Study|Withdrawal by Subject|145|||
126233435|NCT00262600|454147062|FG002|Overall Study|Withdrawal by Subject|139|||
126233436|NCT00262600|454147060|FG000|Overall Study|Not Treated|32|||
126233437|NCT00262600|454147061|FG001|Overall Study|Not Treated|17|||
126233438|NCT00262600|454147062|FG002|Overall Study|Not Treated|24|||
126233439|NCT00262600|454147060|FG000|Overall Study|Other|58|||
126233440|NCT00262600|454147061|FG001|Overall Study|Other|59|||
126233441|NCT00262600|454147062|FG002|Overall Study|Other|62|||
126233442|NCT04471207|454147063|FG000|Overall Study|Lost to Follow-up|4|||
126233443|NCT04471207|454147064|FG001|Overall Study|Lost to Follow-up|1|||
126233444|NCT04471207|454147063|FG000|Overall Study|Medication Contraindication|0|||
126233445|NCT04471207|454147064|FG001|Overall Study|Medication Contraindication|1|||
126233446|NCT04471207|454147063|FG000|Overall Study|Loss of Interest|2|||
126233447|NCT04471207|454147064|FG001|Overall Study|Loss of Interest|1|||
126233448|NCT04471207|454147063|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
126233449|NCT04471207|454147064|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
126233450|NCT04471207|454147063|FG000|Overall Study|Scheduling Conflicts|3|||
126233451|NCT04471207|454147064|FG001|Overall Study|Scheduling Conflicts|1|||
126233452|NCT04471207|454147063|FG000|Overall Study|Physician Decision|1|||
126233453|NCT04471207|454147064|FG001|Overall Study|Physician Decision|0|||
126233454|NCT04471207|454147063|FG000|Overall Study|Unwilling to Use System|0|||
126233455|NCT04471207|454147064|FG001|Overall Study|Unwilling to Use System|1|||
126354414|NCT01807520|454589349|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
126354415|NCT01807520|454589350|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354416|NCT01807520|454589344|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354417|NCT01807520|454589345|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354418|NCT01807520|454589346|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354419|NCT01807520|454589347|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354420|NCT01807520|454589348|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354421|NCT01807520|454589349|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
126354422|NCT01807520|454589350|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
126354423|NCT01797185|454589353|FG000|Overall Study|Adverse Event|5|||
126354424|NCT01797185|454589354|FG001|Overall Study|Adverse Event|15|||
126354425|NCT01797185|454589355|FG002|Overall Study|Adverse Event|6|||
126354426|NCT01797185|454589353|FG000|Overall Study|Withdrawal by Subject|6|||
126354427|NCT01797185|454589354|FG001|Overall Study|Withdrawal by Subject|9|||
126354428|NCT01797185|454589355|FG002|Overall Study|Withdrawal by Subject|5|||
126354429|NCT01797185|454589353|FG000|Overall Study|Site terminated|8|||
126354430|NCT01797185|454589354|FG001|Overall Study|Site terminated|4|||
126354431|NCT01797185|454589355|FG002|Overall Study|Site terminated|0|||
126354432|NCT01797185|454589353|FG000|Overall Study|Lost to Follow-up|2|||
126354433|NCT01797185|454589354|FG001|Overall Study|Lost to Follow-up|6|||
126354434|NCT01797185|454589355|FG002|Overall Study|Lost to Follow-up|1|||
126354435|NCT01797185|454589353|FG000|Overall Study|Withdrawn per sponsor|5|||
126354436|NCT01797185|454589354|FG001|Overall Study|Withdrawn per sponsor|0|||
126354437|NCT01797185|454589355|FG002|Overall Study|Withdrawn per sponsor|0|||
126354438|NCT01797185|454589353|FG000|Overall Study|Physician Decision|1|||
126354439|NCT01797185|454589354|FG001|Overall Study|Physician Decision|3|||
126354440|NCT01797185|454589355|FG002|Overall Study|Physician Decision|0|||
126354441|NCT01797185|454589353|FG000|Overall Study|Protocol Violation|1|||
126354442|NCT01797185|454589354|FG001|Overall Study|Protocol Violation|1|||
126354443|NCT01797185|454589355|FG002|Overall Study|Protocol Violation|0|||
126354444|NCT03418675|454589358|FG000|Overall Study|Lost to Follow-up|13|||
126354445|NCT03418675|454589359|FG001|Overall Study|Lost to Follow-up|10|||
126354446|NCT03418675|454589358|FG000|Overall Study|Adverse Event|2|||
126354447|NCT03418675|454589359|FG001|Overall Study|Adverse Event|0|||
126354448|NCT00421733|454589362|FG000|Overall Study|Adverse Event|4|||
126354449|NCT00421733|454589363|FG001|Overall Study|Adverse Event|9|||
126354450|NCT00421733|454589364|FG002|Overall Study|Adverse Event|2|||
126354451|NCT00421733|454589362|FG000|Overall Study|Lost to Follow-up|1|||
126354452|NCT00421733|454589363|FG001|Overall Study|Lost to Follow-up|2|||
126233456|NCT00561730|454147065|FG000|Overall Study|Adverse Event|2|||
126233457|NCT00561730|454147065|FG000|Overall Study|Handling of the drug|1|||
126233458|NCT00561730|454147065|FG000|Overall Study|Lost to Follow-up|5|||
126354453|NCT00421733|454589364|FG002|Overall Study|Lost to Follow-up|4|||
126233459|NCT00561730|454147065|FG000|Overall Study|Not specified reasons|1|||
126233460|NCT00376220|454147066|FG000|Overall Study|Lost to Follow-up|7|||
126233461|NCT00376220|454147067|FG001|Overall Study|Lost to Follow-up|10|||
126233462|NCT00376220|454147066|FG000|Overall Study|Withdrawal by Subject|3|||
126233463|NCT00376220|454147067|FG001|Overall Study|Withdrawal by Subject|2|||
126233464|NCT00531206|454147072|FG000|Overall Study|Adverse Event related|5|||
126354454|NCT00421733|454589362|FG000|Overall Study|Withdrawal by Subject|1|||
126354455|NCT00421733|454589363|FG001|Overall Study|Withdrawal by Subject|2|||
126354456|NCT00421733|454589364|FG002|Overall Study|Withdrawal by Subject|7|||
126354457|NCT00421733|454589362|FG000|Overall Study|Death|0|||
126354458|NCT00421733|454589363|FG001|Overall Study|Death|3|||
126354459|NCT00421733|454589364|FG002|Overall Study|Death|0|||
126354460|NCT00421733|454589362|FG000|Overall Study|Required dialysis|1|||
126354461|NCT00421733|454589363|FG001|Overall Study|Required dialysis|0|||
126354462|NCT00421733|454589364|FG002|Overall Study|Required dialysis|0|||
126354463|NCT00421733|454589362|FG000|Overall Study|Administrative|2|||
126354464|NCT00421733|454589363|FG001|Overall Study|Administrative|0|||
126354465|NCT00421733|454589364|FG002|Overall Study|Administrative|0|||
126354466|NCT00421733|454589362|FG000|Overall Study|Did not satisfy entry criteria|1|||
126354467|NCT00421733|454589363|FG001|Overall Study|Did not satisfy entry criteria|3|||
126354468|NCT00421733|454589364|FG002|Overall Study|Did not satisfy entry criteria|2|||
126354469|NCT00421733|454589362|FG000|Overall Study|Sponsor request|1|||
126354470|NCT00421733|454589363|FG001|Overall Study|Sponsor request|0|||
126354471|NCT00421733|454589364|FG002|Overall Study|Sponsor request|3|||
126354472|NCT00421733|454589362|FG000|Overall Study|Protocol deviation|4|||
126354473|NCT00421733|454589363|FG001|Overall Study|Protocol deviation|7|||
126354474|NCT00421733|454589364|FG002|Overall Study|Protocol deviation|2|||
126354475|NCT02265744|454589365|FG000|Overall Study|Poor/Non-compliance|1|||
126354476|NCT02265744|454589366|FG001|Overall Study|Poor/Non-compliance|1|||
126354477|NCT02265744|454589367|FG002|Overall Study|Poor/Non-compliance|0|||
126354478|NCT02265744|454589368|FG003|Overall Study|Poor/Non-compliance|0|||
126354479|NCT02265744|454589369|FG004|Overall Study|Poor/Non-compliance|2|||
126354480|NCT02265744|454589365|FG000|Overall Study|Lost to Follow-up|0|||
126354481|NCT02265744|454589366|FG001|Overall Study|Lost to Follow-up|0|||
126354482|NCT02265744|454589367|FG002|Overall Study|Lost to Follow-up|0|||
126354483|NCT02265744|454589368|FG003|Overall Study|Lost to Follow-up|1|||
126354484|NCT02265744|454589369|FG004|Overall Study|Lost to Follow-up|0|||
126354485|NCT02265744|454589365|FG000|Overall Study|Death|0|||
126354486|NCT02265744|454589366|FG001|Overall Study|Death|0|||
126354487|NCT02265744|454589367|FG002|Overall Study|Death|0|||
126354488|NCT02265744|454589368|FG003|Overall Study|Death|2|||
126354489|NCT02265744|454589369|FG004|Overall Study|Death|0|||
126354490|NCT02265744|454589365|FG000|Overall Study|Withdrawal by Subject|2|||
126354491|NCT02265744|454589366|FG001|Overall Study|Withdrawal by Subject|0|||
126354492|NCT02265744|454589367|FG002|Overall Study|Withdrawal by Subject|0|||
126354493|NCT02265744|454589368|FG003|Overall Study|Withdrawal by Subject|2|||
126354494|NCT02265744|454589369|FG004|Overall Study|Withdrawal by Subject|0|||
126354495|NCT02265744|454589365|FG000|Overall Study|Participant request to discontinue|2|||
126354496|NCT02265744|454589366|FG001|Overall Study|Participant request to discontinue|2|||
126354497|NCT02265744|454589367|FG002|Overall Study|Participant request to discontinue|2|||
126354498|NCT02265744|454589368|FG003|Overall Study|Participant request to discontinue|0|||
126354499|NCT02265744|454589369|FG004|Overall Study|Participant request to discontinue|0|||
126354500|NCT02265744|454589365|FG000|Overall Study|Adverse Event|8|||
126354501|NCT02265744|454589366|FG001|Overall Study|Adverse Event|4|||
126354502|NCT02265744|454589367|FG002|Overall Study|Adverse Event|9|||
126354503|NCT02265744|454589368|FG003|Overall Study|Adverse Event|8|||
126354504|NCT02265744|454589369|FG004|Overall Study|Adverse Event|2|||
126354505|NCT02265744|454589365|FG000|Overall Study|Lack of Efficacy|2|||
126354506|NCT02265744|454589366|FG001|Overall Study|Lack of Efficacy|4|||
126354507|NCT02265744|454589367|FG002|Overall Study|Lack of Efficacy|3|||
126354508|NCT02265744|454589368|FG003|Overall Study|Lack of Efficacy|4|||
126354509|NCT02265744|454589369|FG004|Overall Study|Lack of Efficacy|5|||
126354510|NCT02265744|454589365|FG000|Overall Study|Reason not provided by Investigator|1|||
126354511|NCT02265744|454589366|FG001|Overall Study|Reason not provided by Investigator|0|||
126354512|NCT02265744|454589367|FG002|Overall Study|Reason not provided by Investigator|0|||
126354513|NCT02265744|454589368|FG003|Overall Study|Reason not provided by Investigator|2|||
126354514|NCT02265744|454589369|FG004|Overall Study|Reason not provided by Investigator|0|||
126354515|NCT02265744|454589365|FG000|Overall Study|Administrative reason by sponsor|3|||
126354516|NCT02265744|454589366|FG001|Overall Study|Administrative reason by sponsor|2|||
126354517|NCT02265744|454589367|FG002|Overall Study|Administrative reason by sponsor|2|||
126354518|NCT02265744|454589368|FG003|Overall Study|Administrative reason by sponsor|3|||
126354519|NCT02265744|454589369|FG004|Overall Study|Administrative reason by sponsor|3|||
126354520|NCT02265744|454589365|FG000|Overall Study|Subject no longer meets study criteria|0|||
126354521|NCT02265744|454589366|FG001|Overall Study|Subject no longer meets study criteria|0|||
126354522|NCT02265744|454589367|FG002|Overall Study|Subject no longer meets study criteria|0|||
126354523|NCT02265744|454589368|FG003|Overall Study|Subject no longer meets study criteria|0|||
126354524|NCT02265744|454589369|FG004|Overall Study|Subject no longer meets study criteria|1|||
126354525|NCT02265744|454589365|FG000|Overall Study|Pregnancy|1|||
126233465|NCT00531206|454147072|FG000|Overall Study|Lack of Efficacy|2|||
126233466|NCT00531206|454147072|FG000|Overall Study|Lost to Follow-up|5|||
126354526|NCT02265744|454589366|FG001|Overall Study|Pregnancy|2|||
126354527|NCT02265744|454589367|FG002|Overall Study|Pregnancy|1|||
126354528|NCT02265744|454589368|FG003|Overall Study|Pregnancy|1|||
126354529|NCT02265744|454589369|FG004|Overall Study|Pregnancy|0|||
126354530|NCT05161936|454589372|FG000|Overall Study|Study terminated by Sponsor|1|||
126354531|NCT05161936|454589373|FG001|Overall Study|Study terminated by Sponsor|0|||
126354532|NCT05161936|454589374|FG002|Overall Study|Study terminated by Sponsor|0|||
126354533|NCT05161936|454589372|FG000|Overall Study|Withdrawal by Subject|0|||
126354534|NCT05161936|454589373|FG001|Overall Study|Withdrawal by Subject|0|||
126354535|NCT05161936|454589374|FG002|Overall Study|Withdrawal by Subject|1|||
126354536|NCT04999020|454589382|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
126354537|NCT04999020|454589383|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
126354538|NCT04999020|454589384|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
126354539|NCT04999020|454589385|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
126354540|NCT04999020|454589382|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
126354541|NCT04999020|454589383|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
126354542|NCT04999020|454589384|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
126354543|NCT04999020|454589385|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
126354544|NCT04999020|454589382|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
126354545|NCT04999020|454589383|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
126354546|NCT04999020|454589384|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
126354547|NCT04999020|454589385|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
126354548|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126354549|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126354550|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
126354551|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
126354552|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
126354553|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
126354554|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
126354555|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
126354556|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
126354557|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
126354558|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
126354559|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
126354560|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
126354561|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
126354562|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
126354563|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
126354564|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
126354565|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
126354566|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
126354567|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
126354568|NCT02448043|454589386|FG000|Overall Study|Withdrawal by Subject|2|||
126354569|NCT02448043|454589387|FG001|Overall Study|Withdrawal by Subject|2|||
126354570|NCT02448043|454589386|FG000|Overall Study|Protocol Violation|1|||
126354571|NCT02448043|454589387|FG001|Overall Study|Protocol Violation|2|||
126354572|NCT00933166|454589392|FG000|Overall Study|Lost to Follow-up|4|||
126354573|NCT00933166|454589392|FG000|Overall Study|Lack of Efficacy|9|||
126354574|NCT00933166|454589392|FG000|Overall Study|Unavailable|4|||
126354575|NCT00933166|454589392|FG000|Overall Study|Withdrawal by Subject|1|||
126354576|NCT02112552|454589401|FG000|Overall Study|Withdrawal by Subject|1|||
126354577|NCT02112552|454589401|FG000|Overall Study|Adverse Event|1|||
126354578|NCT03501277|454589402|FG000|Intervention Period 1 (4 Days)|Other|0|||
126354579|NCT03501277|454589403|FG001|Intervention Period 1 (4 Days)|Other|0|||
126354580|NCT03501277|454589404|FG002|Intervention Period 1 (4 Days)|Other|1|||
126354581|NCT03501277|454589405|FG003|Intervention Period 1 (4 Days)|Other|0|||
126023213|NCT00792636|453380657|FG000|Overall Study|Adverse Event|4|||
126023214|NCT00792636|453380658|FG001|Overall Study|Adverse Event|2|||
126023215|NCT00792636|453380659|FG002|Overall Study|Adverse Event|3|||
126023216|NCT00792636|453380657|FG000|Overall Study|Investigator Discretion|2|||
126023217|NCT00792636|453380658|FG001|Overall Study|Investigator Discretion|0|||
126023218|NCT00792636|453380659|FG002|Overall Study|Investigator Discretion|2|||
126023219|NCT04711135|453380661|FG000|Overall Study|Physician Decision|0|||
126233467|NCT00531206|454147072|FG000|Overall Study|including non-related adverse events|8|||
126354582|NCT03501277|454589402|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
126354583|NCT03501277|454589403|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
126354584|NCT03501277|454589404|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
126023220|NCT04711135|453380662|FG001|Overall Study|Physician Decision|1|||
126354585|NCT03501277|454589405|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
126354586|NCT03501277|454589402|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
126233468|NCT02906709|454147079|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
126233469|NCT02906709|454147080|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
126233470|NCT02906709|454147079|FG000|Phase A (Week 0 to Week 16)|Death|0|||
126233471|NCT02906709|454147080|FG001|Phase A (Week 0 to Week 16)|Death|1|||
126233472|NCT02906709|454147079|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
126233473|NCT02906709|454147080|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
126233474|NCT02906709|454147079|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
126233475|NCT02906709|454147080|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
126233476|NCT00920140|454147082|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
126233477|NCT00920140|454147083|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
126233478|NCT00920140|454147084|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
126233479|NCT00920140|454147085|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
126023221|NCT04711135|453380661|FG000|Overall Study|Ongoing treatment|0|||
126233480|NCT00920140|454147086|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
126233481|NCT00920140|454147082|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
126233482|NCT00920140|454147083|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
126233483|NCT00920140|454147084|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
126233484|NCT00920140|454147085|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
126233485|NCT00920140|454147086|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
126233486|NCT00920140|454147082|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126233487|NCT00920140|454147083|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
126233488|NCT00920140|454147084|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126233489|NCT00920140|454147085|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126233490|NCT00920140|454147086|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126233491|NCT00920140|454147082|FG000|Phase 2|Adverse Event|0|||
126233492|NCT00920140|454147083|FG001|Phase 2|Adverse Event|0|||
126233493|NCT00920140|454147084|FG002|Phase 2|Adverse Event|14|||
126233494|NCT00920140|454147085|FG003|Phase 2|Adverse Event|2|||
126233495|NCT00920140|454147086|FG004|Phase 2|Adverse Event|3|||
126233496|NCT00920140|454147082|FG000|Phase 2|Lack of Efficacy|0|||
126233497|NCT00920140|454147083|FG001|Phase 2|Lack of Efficacy|0|||
126233498|NCT00920140|454147084|FG002|Phase 2|Lack of Efficacy|29|||
126233499|NCT00920140|454147085|FG003|Phase 2|Lack of Efficacy|14|||
126233500|NCT00920140|454147086|FG004|Phase 2|Lack of Efficacy|5|||
126233501|NCT00920140|454147082|FG000|Phase 2|Lost to Follow-up|0|||
126233502|NCT00920140|454147083|FG001|Phase 2|Lost to Follow-up|0|||
126233503|NCT00920140|454147084|FG002|Phase 2|Lost to Follow-up|0|||
126233504|NCT00920140|454147085|FG003|Phase 2|Lost to Follow-up|1|||
126233505|NCT00920140|454147086|FG004|Phase 2|Lost to Follow-up|0|||
126233506|NCT00920140|454147082|FG000|Phase 2|Physician Decision|0|||
126233507|NCT00920140|454147083|FG001|Phase 2|Physician Decision|0|||
126233508|NCT00920140|454147084|FG002|Phase 2|Physician Decision|3|||
126233509|NCT00920140|454147085|FG003|Phase 2|Physician Decision|3|||
126233510|NCT00920140|454147086|FG004|Phase 2|Physician Decision|2|||
126233511|NCT00920140|454147082|FG000|Phase 2|Withdrawal by Subject|0|||
126233512|NCT00920140|454147083|FG001|Phase 2|Withdrawal by Subject|0|||
126233513|NCT00920140|454147084|FG002|Phase 2|Withdrawal by Subject|4|||
126233514|NCT00920140|454147085|FG003|Phase 2|Withdrawal by Subject|2|||
126233515|NCT00920140|454147086|FG004|Phase 2|Withdrawal by Subject|1|||
126233516|NCT00977106|454147087|FG000|Overall Study|Adverse Event|5|||
126233517|NCT00977106|454147088|FG001|Overall Study|Adverse Event|6|||
126233518|NCT00977106|454147087|FG000|Overall Study|Withdrawal by Subject|2|||
126233519|NCT00977106|454147088|FG001|Overall Study|Withdrawal by Subject|2|||
126233520|NCT00977106|454147087|FG000|Overall Study|Lack of Efficacy|2|||
126233521|NCT00977106|454147088|FG001|Overall Study|Lack of Efficacy|2|||
126233522|NCT00977106|454147087|FG000|Overall Study|Protocol Violation|0|||
126233523|NCT00977106|454147088|FG001|Overall Study|Protocol Violation|1|||
126233524|NCT00977106|454147087|FG000|Overall Study|Other|1|||
126233525|NCT00977106|454147088|FG001|Overall Study|Other|0|||
126233526|NCT01124149|454147089|FG000|Acute Phase|Withdrawal by Subject|22|||
126233527|NCT01124149|454147089|FG000|Acute Phase|Adverse Event|21|||
126233528|NCT01124149|454147089|FG000|Acute Phase|Lack of Efficacy|17|||
126233529|NCT01124149|454147089|FG000|Acute Phase|Protocol Violation|14|||
126233530|NCT01124149|454147089|FG000|Acute Phase|Lost to Follow-up|2|||
126233531|NCT01124149|454147089|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
126233532|NCT01124149|454147089|FG000|Acute Phase|Sponsor request|1|||
126233533|NCT01124149|454147089|FG000|Acute Phase|UC symptoms not ameliorated|1|||
126233534|NCT01124149|454147089|FG000|Acute Phase|Non-compliance|1|||
126233535|NCT01124149|454147089|FG000|Acute Phase|Low hemoglobin|1|||
126233536|NCT01124149|454147089|FG000|Acute Phase|Travelling to another country|1|||
126233537|NCT01124149|454147089|FG000|Acute Phase|Sponsor decision|1|||
126233538|NCT01124149|454147089|FG000|Maintenance Phase|Lack of Efficacy|40|||
126233539|NCT01124149|454147089|FG000|Maintenance Phase|Adverse Event|24|||
126233540|NCT01124149|454147089|FG000|Maintenance Phase|Lost to Follow-up|15|||
126233541|NCT01124149|454147089|FG000|Maintenance Phase|Withdrawal by Subject|10|||
126233542|NCT01124149|454147089|FG000|Maintenance Phase|Protocol Violation|5|||
126233543|NCT01124149|454147089|FG000|Maintenance Phase|Coordinator error|1|||
126233544|NCT01124149|454147089|FG000|Maintenance Phase|Non-compliance|1|||
126233545|NCT01644500|454147090|FG000|Overall Study|Adverse Event|6|||
126233546|NCT01644500|454147091|FG001|Overall Study|Adverse Event|1|||
126233547|NCT01644500|454147092|FG002|Overall Study|Adverse Event|2|||
126023222|NCT04711135|453380662|FG001|Overall Study|Ongoing treatment|1|||
126233548|NCT01644500|454147090|FG000|Overall Study|Death|0|||
126233549|NCT01644500|454147091|FG001|Overall Study|Death|1|||
126233550|NCT01644500|454147092|FG002|Overall Study|Death|0|||
126233551|NCT01644500|454147090|FG000|Overall Study|Lost to Follow-up|3|||
126233552|NCT01644500|454147091|FG001|Overall Study|Lost to Follow-up|8|||
126233553|NCT01644500|454147092|FG002|Overall Study|Lost to Follow-up|0|||
126233554|NCT01644500|454147090|FG000|Overall Study|Protocol Violation|1|||
126233555|NCT01644500|454147091|FG001|Overall Study|Protocol Violation|1|||
126233556|NCT01644500|454147092|FG002|Overall Study|Protocol Violation|0|||
126233557|NCT01644500|454147090|FG000|Overall Study|Withdrawal by Subject|11|||
126233558|NCT01644500|454147091|FG001|Overall Study|Withdrawal by Subject|12|||
126233559|NCT01644500|454147092|FG002|Overall Study|Withdrawal by Subject|12|||
126233560|NCT01644500|454147090|FG000|Overall Study|Physician Decision|1|||
126233561|NCT01644500|454147091|FG001|Overall Study|Physician Decision|1|||
126233562|NCT01644500|454147092|FG002|Overall Study|Physician Decision|1|||
126233563|NCT00721409|454147099|FG000|Overall Study|Global deterioration of health status|2|||
126233564|NCT00721409|454147100|FG001|Overall Study|Global deterioration of health status|6|||
126233565|NCT00721409|454147101|FG002|Overall Study|Global deterioration of health status|3|||
126233566|NCT00721409|454147099|FG000|Overall Study|Death|0|||
126233567|NCT00721409|454147100|FG001|Overall Study|Death|1|||
126233568|NCT00721409|454147101|FG002|Overall Study|Death|0|||
126233569|NCT00721409|454147099|FG000|Overall Study|Randomized not Treated|0|||
126233570|NCT00721409|454147100|FG001|Overall Study|Randomized not Treated|1|||
126233571|NCT00721409|454147101|FG002|Overall Study|Randomized not Treated|4|||
126233572|NCT00721409|454147099|FG000|Overall Study|Reason not specified|1|||
126233573|NCT00721409|454147100|FG001|Overall Study|Reason not specified|0|||
126233574|NCT00721409|454147101|FG002|Overall Study|Reason not specified|2|||
126233575|NCT00721409|454147099|FG000|Overall Study|Adverse Event|0|||
126233576|NCT00721409|454147100|FG001|Overall Study|Adverse Event|13|||
126233577|NCT00721409|454147101|FG002|Overall Study|Adverse Event|2|||
126233578|NCT00721409|454147099|FG000|Overall Study|Lost to Follow-up|0|||
126233579|NCT00721409|454147100|FG001|Overall Study|Lost to Follow-up|0|||
126233580|NCT00721409|454147101|FG002|Overall Study|Lost to Follow-up|1|||
126093206|NCT00831129|453634554|FG000|Overall Study|Adverse Event|0|||
126233581|NCT00721409|454147099|FG000|Overall Study|Withdrawal by Subject|1|||
126233582|NCT00721409|454147100|FG001|Overall Study|Withdrawal by Subject|6|||
126233583|NCT00721409|454147101|FG002|Overall Study|Withdrawal by Subject|5|||
126233584|NCT00721409|454147099|FG000|Overall Study|Objective progression or relapse|8|||
126233585|NCT00721409|454147100|FG001|Overall Study|Objective progression or relapse|55|||
126233586|NCT00721409|454147101|FG002|Overall Study|Objective progression or relapse|62|||
126233587|NCT00322491|454147103|FG000|Overall Study|Adverse Event|1|||
126233588|NCT00322491|454147104|FG001|Overall Study|Adverse Event|0|||
126233589|NCT00322491|454147103|FG000|Overall Study|Death|1|||
126233590|NCT00322491|454147104|FG001|Overall Study|Death|2|||
126233591|NCT01400425|454147105|FG000|Overall Study|Withdrawal by Subject|10|||
126233592|NCT00048048|454147106|FG000|Core Treatment|Withdrawal by Subject|0|||
126233593|NCT00048048|454147107|FG001|Core Treatment|Withdrawal by Subject|0|||
126233594|NCT00048048|454147108|FG002|Core Treatment|Withdrawal by Subject|1|||
126233595|NCT00048048|454147109|FG003|Core Treatment|Withdrawal by Subject|0|||
126233596|NCT00048048|454147110|FG004|Core Treatment|Withdrawal by Subject|0|||
126233597|NCT00048048|454147111|FG005|Core Treatment|Withdrawal by Subject|0|||
126233598|NCT00048048|454147112|FG006|Core Treatment|Withdrawal by Subject|0|||
126233599|NCT00048048|454147113|FG007|Core Treatment|Withdrawal by Subject|0|||
126233600|NCT00048048|454147114|FG008|Core Treatment|Withdrawal by Subject|0|||
126233601|NCT00048048|454147115|FG009|Core Treatment|Withdrawal by Subject|0|||
126233602|NCT00048048|454147116|FG010|Core Treatment|Withdrawal by Subject|0|||
126233603|NCT00048048|454147117|FG011|Core Treatment|Withdrawal by Subject|0|||
126233604|NCT00048048|454147106|FG000|Core Treatment|Adverse Event|0|||
126233605|NCT00048048|454147107|FG001|Core Treatment|Adverse Event|0|||
126233606|NCT00048048|454147108|FG002|Core Treatment|Adverse Event|0|||
126233607|NCT00048048|454147109|FG003|Core Treatment|Adverse Event|0|||
126233608|NCT00048048|454147110|FG004|Core Treatment|Adverse Event|0|||
126093207|NCT00831129|453634555|FG001|Overall Study|Adverse Event|1|||
126093208|NCT00831129|453634554|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
126233609|NCT00048048|454147111|FG005|Core Treatment|Adverse Event|0|||
126233610|NCT00048048|454147112|FG006|Core Treatment|Adverse Event|0|||
126233611|NCT00048048|454147113|FG007|Core Treatment|Adverse Event|1|||
126233612|NCT00048048|454147114|FG008|Core Treatment|Adverse Event|0|||
126233613|NCT00048048|454147115|FG009|Core Treatment|Adverse Event|0|||
126233614|NCT00048048|454147116|FG010|Core Treatment|Adverse Event|0|||
126233615|NCT00048048|454147117|FG011|Core Treatment|Adverse Event|0|||
126233616|NCT00048048|454147106|FG000|Extension Year 1|Early withdrawals|0|||
126233617|NCT00048048|454147107|FG001|Extension Year 1|Early withdrawals|0|||
126233618|NCT00048048|454147108|FG002|Extension Year 1|Early withdrawals|0|||
126233619|NCT00048048|454147109|FG003|Extension Year 1|Early withdrawals|0|||
126233620|NCT00048048|454147110|FG004|Extension Year 1|Early withdrawals|0|||
126233621|NCT00048048|454147111|FG005|Extension Year 1|Early withdrawals|0|||
126233622|NCT00048048|454147112|FG006|Extension Year 1|Early withdrawals|0|||
126233623|NCT00048048|454147113|FG007|Extension Year 1|Early withdrawals|0|||
126233624|NCT00048048|454147114|FG008|Extension Year 1|Early withdrawals|0|||
126233625|NCT00048048|454147115|FG009|Extension Year 1|Early withdrawals|2|||
126233626|NCT00048048|454147116|FG010|Extension Year 1|Early withdrawals|2|||
126233627|NCT00048048|454147117|FG011|Extension Year 1|Early withdrawals|4|||
126233628|NCT00048048|454147106|FG000|Extension Year 2|Early withdrawals|0|||
126233629|NCT00048048|454147107|FG001|Extension Year 2|Early withdrawals|0|||
126233630|NCT00048048|454147108|FG002|Extension Year 2|Early withdrawals|0|||
126233631|NCT00048048|454147109|FG003|Extension Year 2|Early withdrawals|0|||
126233632|NCT00048048|454147110|FG004|Extension Year 2|Early withdrawals|0|||
126233633|NCT00048048|454147111|FG005|Extension Year 2|Early withdrawals|0|||
126233634|NCT00048048|454147112|FG006|Extension Year 2|Early withdrawals|0|||
126233635|NCT00048048|454147113|FG007|Extension Year 2|Early withdrawals|0|||
126233636|NCT00048048|454147114|FG008|Extension Year 2|Early withdrawals|0|||
126233637|NCT00048048|454147115|FG009|Extension Year 2|Early withdrawals|0|||
126233638|NCT00048048|454147116|FG010|Extension Year 2|Early withdrawals|4|||
126233639|NCT00048048|454147117|FG011|Extension Year 2|Early withdrawals|2|||
126233640|NCT05518487|454147118|FG000|Overall Study|Withdrawal by Subject|3|||
126233641|NCT02752776|454147122|FG000|Overall Study|Adverse Event|15|||
126233642|NCT02752776|454147123|FG001|Overall Study|Adverse Event|23|||
126233643|NCT02752776|454147124|FG002|Overall Study|Adverse Event|11|||
126233644|NCT02752776|454147122|FG000|Overall Study|Lack of Efficacy|2|||
126233645|NCT02752776|454147123|FG001|Overall Study|Lack of Efficacy|6|||
126023223|NCT00998881|453380663|FG000|Overall Study|Adverse Event|2|||
126023224|NCT00998881|453380664|FG001|Overall Study|Adverse Event|2|||
126023225|NCT00998881|453380663|FG000|Overall Study|Lack of Efficacy|1|||
126023226|NCT00998881|453380664|FG001|Overall Study|Lack of Efficacy|0|||
126023227|NCT00998881|453380663|FG000|Overall Study|Physician Decision|3|||
126023228|NCT00998881|453380664|FG001|Overall Study|Physician Decision|0|||
126023229|NCT00998881|453380663|FG000|Overall Study|Withdrawal by Subject|1|||
126023230|NCT00998881|453380664|FG001|Overall Study|Withdrawal by Subject|0|||
126023231|NCT00998881|453380663|FG000|Overall Study|Personal matter|1|||
126023232|NCT00998881|453380664|FG001|Overall Study|Personal matter|0|||
126023233|NCT01610297|453380666|FG000|Overall Study|Lost to Follow-up|1|||
126023234|NCT01007396|453380670|FG000|Overall Study|Lost to Follow-up|47|||
126023235|NCT02590432|453380674|FG000|Open-label Treatment Period|Adverse Event|97|||
126023236|NCT02590432|453380675|FG001|Open-label Treatment Period|Adverse Event|79|||
126023237|NCT02590432|453380676|FG002|Open-label Treatment Period|Adverse Event|0|||
126023238|NCT02590432|453380677|FG003|Open-label Treatment Period|Adverse Event|0|||
126023239|NCT02590432|453380678|FG004|Open-label Treatment Period|Adverse Event|0|||
126023240|NCT02590432|453380679|FG005|Open-label Treatment Period|Adverse Event|0|||
126023241|NCT02590432|453380680|FG006|Open-label Treatment Period|Adverse Event|0|||
126023242|NCT02590432|453380681|FG007|Open-label Treatment Period|Adverse Event|0|||
126023243|NCT02590432|453380682|FG008|Open-label Treatment Period|Adverse Event|0|||
126023244|NCT02590432|453380674|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
126023245|NCT02590432|453380675|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
126023246|NCT02590432|453380676|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
126023247|NCT02590432|453380677|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
126023248|NCT02590432|453380678|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
126023249|NCT02590432|453380679|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
126023250|NCT02590432|453380680|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
126023251|NCT02590432|453380681|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
126023252|NCT02590432|453380682|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
126023253|NCT02590432|453380674|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
126023254|NCT02590432|453380675|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
126023255|NCT02590432|453380676|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
126023256|NCT02590432|453380677|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
126023257|NCT02590432|453380678|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
126023258|NCT02590432|453380679|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
126023259|NCT02590432|453380680|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
126023260|NCT02590432|453380681|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
126023261|NCT02590432|453380682|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
126023262|NCT02590432|453380674|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
126023263|NCT02590432|453380675|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
126023264|NCT02590432|453380676|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
126023265|NCT02590432|453380677|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
126023266|NCT02590432|453380678|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
126023267|NCT02590432|453380679|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
126233646|NCT02752776|454147124|FG002|Overall Study|Lack of Efficacy|14|||
126233647|NCT02752776|454147122|FG000|Overall Study|Lost to Follow-up|11|||
126233648|NCT02752776|454147123|FG001|Overall Study|Lost to Follow-up|12|||
126233649|NCT02752776|454147124|FG002|Overall Study|Lost to Follow-up|4|||
126023268|NCT02590432|453380680|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
126233650|NCT02752776|454147122|FG000|Overall Study|Non-compliance with study treatment|0|||
126023269|NCT02590432|453380681|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
126023270|NCT02590432|453380682|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
126233651|NCT02752776|454147123|FG001|Overall Study|Non-compliance with study treatment|0|||
126233652|NCT02752776|454147124|FG002|Overall Study|Non-compliance with study treatment|1|||
126233653|NCT02752776|454147122|FG000|Overall Study|Physician Decision|2|||
126023271|NCT02590432|453380674|FG000|Open-label Treatment Period|Protocol Violation|10|||
126023272|NCT02590432|453380675|FG001|Open-label Treatment Period|Protocol Violation|4|||
126046472|NCT02467270|453468228|FG002|Overall Study|Pregnancy|0|||
126233654|NCT02752776|454147123|FG001|Overall Study|Physician Decision|6|||
126233655|NCT02752776|454147124|FG002|Overall Study|Physician Decision|2|||
126233656|NCT02752776|454147122|FG000|Overall Study|Pregnancy|1|||
126233657|NCT02752776|454147123|FG001|Overall Study|Pregnancy|6|||
126233658|NCT02752776|454147124|FG002|Overall Study|Pregnancy|3|||
126233659|NCT02752776|454147122|FG000|Overall Study|Protocol Violation|10|||
126233660|NCT02752776|454147123|FG001|Overall Study|Protocol Violation|13|||
126233661|NCT02752776|454147124|FG002|Overall Study|Protocol Violation|6|||
126233662|NCT02752776|454147122|FG000|Overall Study|Subject/guardian decision|8|||
126233663|NCT02752776|454147123|FG001|Overall Study|Subject/guardian decision|6|||
126233664|NCT02752776|454147124|FG002|Overall Study|Subject/guardian decision|4|||
126233665|NCT02752776|454147122|FG000|Overall Study|Death|0|||
126233666|NCT02752776|454147123|FG001|Overall Study|Death|0|||
126233667|NCT02752776|454147124|FG002|Overall Study|Death|1|||
126233668|NCT02752776|454147122|FG000|Overall Study|Withdrawal by Subject|3|||
126233669|NCT02752776|454147123|FG001|Overall Study|Withdrawal by Subject|4|||
126233670|NCT02752776|454147124|FG002|Overall Study|Withdrawal by Subject|2|||
126233671|NCT01946165|454147125|FG000|Overall Study|Physician Decision|2|||
126233672|NCT01946165|454147126|FG001|Overall Study|Physician Decision|0|||
126233673|NCT01946165|454147125|FG000|Overall Study|Withdrawal by Subject|0|||
126233674|NCT01946165|454147126|FG001|Overall Study|Withdrawal by Subject|2|||
126233675|NCT01179919|454147127|FG000|Overall Study|Protocol Violation|1|||
126233676|NCT01179919|454147127|FG000|Overall Study|Adverse Event|1|||
126233677|NCT00806156|454147128|FG000|Overall Study|Death|35|||
126233678|NCT00806156|454147129|FG001|Overall Study|Death|95|||
126233679|NCT00806156|454147128|FG000|Overall Study|Did not meet eligibility criteria|1|||
126233680|NCT00806156|454147129|FG001|Overall Study|Did not meet eligibility criteria|0|||
126233681|NCT00806156|454147128|FG000|Overall Study|Study terminated by Sponsor|2|||
126233682|NCT00806156|454147129|FG001|Overall Study|Study terminated by Sponsor|40|||
126233683|NCT00806156|454147128|FG000|Overall Study|Consent withdrawn by subject|1|||
126233684|NCT00806156|454147129|FG001|Overall Study|Consent withdrawn by subject|3|||
126233685|NCT00806156|454147128|FG000|Overall Study|Lost to Follow-up|0|||
126233686|NCT00806156|454147129|FG001|Overall Study|Lost to Follow-up|1|||
126233687|NCT00337571|454147133|FG000|Overall Study|Lack of Efficacy|3|||
126233688|NCT00337571|454147134|FG001|Overall Study|Lack of Efficacy|0|||
126233689|NCT00337571|454147135|FG002|Overall Study|Lack of Efficacy|0|||
126233690|NCT00337571|454147136|FG003|Overall Study|Lack of Efficacy|0|||
126233691|NCT00337571|454147133|FG000|Overall Study|Adverse Event|4|||
126233692|NCT00337571|454147134|FG001|Overall Study|Adverse Event|5|||
126233693|NCT00337571|454147135|FG002|Overall Study|Adverse Event|8|||
126233694|NCT00337571|454147136|FG003|Overall Study|Adverse Event|4|||
126233695|NCT00337571|454147133|FG000|Overall Study|Withdrawal by Subject|2|||
126233696|NCT00337571|454147134|FG001|Overall Study|Withdrawal by Subject|2|||
126233697|NCT00337571|454147135|FG002|Overall Study|Withdrawal by Subject|1|||
126233698|NCT00337571|454147136|FG003|Overall Study|Withdrawal by Subject|0|||
126233699|NCT00337571|454147133|FG000|Overall Study|Lost to Follow-up|3|||
126233700|NCT00337571|454147134|FG001|Overall Study|Lost to Follow-up|1|||
126233701|NCT00337571|454147135|FG002|Overall Study|Lost to Follow-up|0|||
126233702|NCT00337571|454147136|FG003|Overall Study|Lost to Follow-up|1|||
126233703|NCT00337571|454147133|FG000|Overall Study|Poor/noncompliance|1|||
126233704|NCT00337571|454147134|FG001|Overall Study|Poor/noncompliance|1|||
126233705|NCT00337571|454147135|FG002|Overall Study|Poor/noncompliance|1|||
126233706|NCT00337571|454147136|FG003|Overall Study|Poor/noncompliance|1|||
126233707|NCT00337571|454147133|FG000|Overall Study|No longer met study criteria|1|||
126233708|NCT00337571|454147134|FG001|Overall Study|No longer met study criteria|0|||
126233709|NCT00337571|454147135|FG002|Overall Study|No longer met study criteria|0|||
126233710|NCT00337571|454147136|FG003|Overall Study|No longer met study criteria|0|||
126233711|NCT00337571|454147133|FG000|Overall Study|High Potassium level|0|||
126354587|NCT03501277|454589403|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
126354588|NCT03501277|454589404|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
126354589|NCT03501277|454589405|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
126233712|NCT00337571|454147134|FG001|Overall Study|High Potassium level|0|||
126233713|NCT00337571|454147135|FG002|Overall Study|High Potassium level|0|||
126233714|NCT00337571|454147136|FG003|Overall Study|High Potassium level|1|||
126233715|NCT03552757|454147139|FG000|Overall Study|Withdrawal by Subject|10|||
126233716|NCT03552757|454147140|FG001|Overall Study|Withdrawal by Subject|5|||
126233717|NCT03552757|454147141|FG002|Overall Study|Withdrawal by Subject|12|||
126233718|NCT03552757|454147139|FG000|Overall Study|Lost to Follow-up|2|||
126233719|NCT03552757|454147140|FG001|Overall Study|Lost to Follow-up|7|||
126233720|NCT03552757|454147141|FG002|Overall Study|Lost to Follow-up|7|||
126233721|NCT03552757|454147139|FG000|Overall Study|Death|1|||
126233722|NCT03552757|454147140|FG001|Overall Study|Death|1|||
126233723|NCT03552757|454147141|FG002|Overall Study|Death|1|||
126233724|NCT02674334|454147142|FG000|Overall Study|Lost to Follow-up|5|||
126354590|NCT03501277|454589402|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
126233725|NCT02674334|454147143|FG001|Overall Study|Lost to Follow-up|3|||
126233726|NCT02674334|454147142|FG000|Overall Study|participant difficulty breathing|1|||
126233727|NCT02674334|454147143|FG001|Overall Study|participant difficulty breathing|0|||
126233728|NCT02674334|454147142|FG000|Overall Study|NIRS not recording|1|||
126354591|NCT03501277|454589403|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
126233729|NCT02674334|454147143|FG001|Overall Study|NIRS not recording|0|||
126233730|NCT00449150|454147144|FG000|Overall Study|Adverse Event|11|||
126233731|NCT00449150|454147145|FG001|Overall Study|Adverse Event|18|||
126233732|NCT00449150|454147146|FG002|Overall Study|Adverse Event|9|||
126233733|NCT00449150|454147144|FG000|Overall Study|Lack of Efficacy|1|||
126233734|NCT00449150|454147145|FG001|Overall Study|Lack of Efficacy|2|||
126233735|NCT00449150|454147146|FG002|Overall Study|Lack of Efficacy|2|||
126233736|NCT00449150|454147144|FG000|Overall Study|Other|16|||
126233737|NCT00449150|454147145|FG001|Overall Study|Other|13|||
126233738|NCT00449150|454147146|FG002|Overall Study|Other|14|||
126233739|NCT00449150|454147144|FG000|Overall Study|Withdrawal by Subject|17|||
126233740|NCT00449150|454147145|FG001|Overall Study|Withdrawal by Subject|18|||
126233741|NCT00449150|454147146|FG002|Overall Study|Withdrawal by Subject|21|||
126233742|NCT00449150|454147144|FG000|Overall Study|Protocol Violation|1|||
126233743|NCT00449150|454147145|FG001|Overall Study|Protocol Violation|2|||
126233744|NCT00449150|454147146|FG002|Overall Study|Protocol Violation|1|||
126233745|NCT02660242|454147151|FG000|Glucose Tabs|Lost to Follow-up|1|||
126233746|NCT02660242|454147151|FG000|Glucagon Injection|Lost to Follow-up|1|||
126233747|NCT01345019|454147153|FG000|Blinded Treatment Phase|Death|147|||
126233748|NCT01345019|454147154|FG001|Blinded Treatment Phase|Death|137|||
126233749|NCT01345019|454147153|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
126233750|NCT01345019|454147154|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
126233751|NCT01345019|454147153|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
126233752|NCT01345019|454147154|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
126233753|NCT01345019|454147153|FG000|Blinded Treatment Phase|Disease Progression|12|||
126233754|NCT01345019|454147154|FG001|Blinded Treatment Phase|Disease Progression|10|||
126233755|NCT01345019|454147153|FG000|Blinded Treatment Phase|Adverse Event|6|||
126233756|NCT01345019|454147154|FG001|Blinded Treatment Phase|Adverse Event|13|||
126233757|NCT01345019|454147153|FG000|Blinded Treatment Phase|Administrative Decision|10|||
126233758|NCT01345019|454147154|FG001|Blinded Treatment Phase|Administrative Decision|8|||
126233759|NCT01345019|454147153|FG000|Blinded Treatment Phase|Noncompliance|5|||
126233760|NCT01345019|454147154|FG001|Blinded Treatment Phase|Noncompliance|3|||
126233761|NCT01345019|454147153|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
126233762|NCT01345019|454147154|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
126233763|NCT01345019|454147153|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
126233764|NCT01345019|454147154|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
126233765|NCT01345019|454147153|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
126233766|NCT01345019|454147154|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
126233767|NCT01345019|454147153|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
126233768|NCT01345019|454147154|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
126233769|NCT01345019|454147153|FG000|Open Label Treatment Phase|Death|49|||
126233770|NCT01345019|454147154|FG001|Open Label Treatment Phase|Death|48|||
126233771|NCT01345019|454147153|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
126233772|NCT01345019|454147154|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
126233773|NCT01345019|454147153|FG000|Open Label Treatment Phase|Adverse Event|30|||
126233774|NCT01345019|454147154|FG001|Open Label Treatment Phase|Adverse Event|51|||
126233775|NCT01345019|454147153|FG000|Open Label Treatment Phase|Administrative Decision|30|||
126233776|NCT01345019|454147154|FG001|Open Label Treatment Phase|Administrative Decision|15|||
126233777|NCT01345019|454147153|FG000|Open Label Treatment Phase|Disease Progression|17|||
126233778|NCT01345019|454147154|FG001|Open Label Treatment Phase|Disease Progression|18|||
126233779|NCT01345019|454147153|FG000|Open Label Treatment Phase|Noncompliance|5|||
126233780|NCT01345019|454147154|FG001|Open Label Treatment Phase|Noncompliance|4|||
126233781|NCT01345019|454147153|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
126233782|NCT01345019|454147154|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
126233783|NCT01345019|454147153|FG000|Open Label Treatment Phase|Pregnancy|1|||
126233784|NCT01345019|454147154|FG001|Open Label Treatment Phase|Pregnancy|0|||
126233785|NCT01345019|454147153|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
126233786|NCT01345019|454147154|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
126233787|NCT01345019|454147153|FG000|Open Label Treatment Phase|Protocol Violation|0|||
126233788|NCT01345019|454147154|FG001|Open Label Treatment Phase|Protocol Violation|1|||
126233789|NCT00386009|454147157|FG000|Overall Study|Adverse Event|0|||
126233790|NCT00386009|454147158|FG001|Overall Study|Adverse Event|2|||
126233791|NCT00386009|454147157|FG000|Overall Study|Death|1|||
126233792|NCT00386009|454147158|FG001|Overall Study|Death|0|||
126233793|NCT00386009|454147157|FG000|Overall Study|Entry Criteria Not Met|0|||
126233794|NCT00386009|454147158|FG001|Overall Study|Entry Criteria Not Met|2|||
126233795|NCT00386009|454147157|FG000|Overall Study|Lost to Follow-up|1|||
126233796|NCT00386009|454147158|FG001|Overall Study|Lost to Follow-up|1|||
126233797|NCT00386009|454147157|FG000|Overall Study|Protocol Violation|1|||
126233798|NCT00386009|454147158|FG001|Overall Study|Protocol Violation|0|||
126233799|NCT00386009|454147157|FG000|Overall Study|Sponsor Decision|1|||
126233800|NCT00386009|454147158|FG001|Overall Study|Sponsor Decision|1|||
126233801|NCT00386009|454147157|FG000|Overall Study|Withdrawal by Subject|5|||
126233802|NCT00386009|454147158|FG001|Overall Study|Withdrawal by Subject|4|||
126233803|NCT00604500|454147160|FG000|Overall Study|Adverse Event|2|||
126233804|NCT00604500|454147160|FG000|Overall Study|Protocol Violation|2|||
126233805|NCT00604500|454147160|FG000|Overall Study|Treatment Failure|1|||
126233806|NCT00604500|454147160|FG000|Overall Study|Withdrawal by Subject|4|||
126233807|NCT00604500|454147160|FG000|Overall Study|Administrative|1|||
126233808|NCT00604500|454147160|FG000|Overall Study|Did not meet protocol eligibility|1|||
126233809|NCT01492400|454147161|FG000|Overall Study|Miscellaneous Reasons|2|||
126233810|NCT01492400|454147162|FG001|Overall Study|Miscellaneous Reasons|3|||
126233811|NCT01492400|454147161|FG000|Overall Study|Personal Reasons|0|||
126233812|NCT01492400|454147162|FG001|Overall Study|Personal Reasons|5|||
126233813|NCT01492400|454147161|FG000|Overall Study|Lost to Follow-up|3|||
126233814|NCT01492400|454147162|FG001|Overall Study|Lost to Follow-up|1|||
126233815|NCT01492400|454147161|FG000|Overall Study|Pregnancy|0|||
126233816|NCT01492400|454147162|FG001|Overall Study|Pregnancy|1|||
126233817|NCT01492400|454147161|FG000|Overall Study|Lack of Efficacy|1|||
126233818|NCT01492400|454147162|FG001|Overall Study|Lack of Efficacy|1|||
126233819|NCT01492400|454147161|FG000|Overall Study|Adverse Event|10|||
126233820|NCT01492400|454147162|FG001|Overall Study|Adverse Event|5|||
126233821|NCT00320112|454147163|FG000|Overall Study|Lost to Follow-up|3|||
126233822|NCT00320112|454147164|FG001|Overall Study|Lost to Follow-up|4|||
126233823|NCT00320112|454147163|FG000|Overall Study|Withdrawal by Subject|3|||
126233824|NCT00320112|454147164|FG001|Overall Study|Withdrawal by Subject|0|||
126233825|NCT00320112|454147163|FG000|Overall Study|Death|2|||
126233826|NCT00320112|454147164|FG001|Overall Study|Death|1|||
126233827|NCT02899338|454147165|FG000|Overall Study|Adverse Event|1|||
126233828|NCT02899338|454147166|FG001|Overall Study|Adverse Event|2|||
126233829|NCT02899338|454147165|FG000|Overall Study|Withdrawal by Subject|2|||
126233830|NCT02899338|454147166|FG001|Overall Study|Withdrawal by Subject|0|||
126233831|NCT02353169|454147167|FG000|Overall Study|QTc > 450 msec|1|||
126233832|NCT02353169|454147168|FG001|Overall Study|QTc > 450 msec|1|||
126233833|NCT02353169|454147169|FG002|Overall Study|QTc > 450 msec|1|||
126233834|NCT02353169|454147170|FG003|Overall Study|QTc > 450 msec|1|||
126233835|NCT02353169|454147167|FG000|Overall Study|OR team declined|2|||
126233836|NCT02353169|454147168|FG001|Overall Study|OR team declined|0|||
126233837|NCT02353169|454147169|FG002|Overall Study|OR team declined|0|||
126233838|NCT02353169|454147170|FG003|Overall Study|OR team declined|0|||
126233839|NCT02353169|454147167|FG000|Overall Study|Inhalational induction|0|||
126233840|NCT02353169|454147168|FG001|Overall Study|Inhalational induction|2|||
126233841|NCT02353169|454147169|FG002|Overall Study|Inhalational induction|0|||
126233842|NCT02353169|454147170|FG003|Overall Study|Inhalational induction|0|||
126233843|NCT02353169|454147167|FG000|Overall Study|ECG data error|0|||
126233844|NCT02353169|454147168|FG001|Overall Study|ECG data error|3|||
126233845|NCT02353169|454147169|FG002|Overall Study|ECG data error|2|||
126233846|NCT02353169|454147170|FG003|Overall Study|ECG data error|2|||
126233847|NCT02353169|454147167|FG000|Overall Study|Pre-op medication|0|||
126233848|NCT02353169|454147168|FG001|Overall Study|Pre-op medication|0|||
126233849|NCT02353169|454147169|FG002|Overall Study|Pre-op medication|1|||
126233850|NCT02353169|454147170|FG003|Overall Study|Pre-op medication|0|||
126233851|NCT00796822|454147171|FG000|Overall Study|Lost to Follow-up|2|||
126233852|NCT00796822|454147172|FG001|Overall Study|Lost to Follow-up|0|||
126233853|NCT00796822|454147171|FG000|Overall Study|Adverse Event|1|||
126233854|NCT00796822|454147172|FG001|Overall Study|Adverse Event|0|||
126233855|NCT02603952|454147175|FG000|Overall Study|Withdrawal by Subject|1|||
126233856|NCT02603952|454147176|FG001|Overall Study|Withdrawal by Subject|0|||
126233857|NCT02603952|454147177|FG002|Overall Study|Withdrawal by Subject|0|||
126233858|NCT02603952|454147178|FG003|Overall Study|Withdrawal by Subject|0|||
126233859|NCT02603952|454147175|FG000|Overall Study|Received oseltamivir by error|0|||
126233860|NCT02603952|454147176|FG001|Overall Study|Received oseltamivir by error|0|||
126233861|NCT02603952|454147177|FG002|Overall Study|Received oseltamivir by error|0|||
126233862|NCT02603952|454147178|FG003|Overall Study|Received oseltamivir by error|1|||
126233863|NCT04646109|454147181|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
126233864|NCT04646109|454147182|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
126233865|NCT00577460|454147183|FG000|Overall Study|Adverse Event|11|||
126233866|NCT00577460|454147184|FG001|Overall Study|Adverse Event|7|||
126233867|NCT00577460|454147185|FG002|Overall Study|Adverse Event|14|||
126233868|NCT00577460|454147183|FG000|Overall Study|Protocol Violation|0|||
126233869|NCT00577460|454147184|FG001|Overall Study|Protocol Violation|1|||
126233870|NCT00577460|454147185|FG002|Overall Study|Protocol Violation|1|||
126233871|NCT00577460|454147183|FG000|Overall Study|Lost to Follow-up|0|||
126233872|NCT00577460|454147184|FG001|Overall Study|Lost to Follow-up|3|||
126233873|NCT00577460|454147185|FG002|Overall Study|Lost to Follow-up|4|||
126233874|NCT00577460|454147183|FG000|Overall Study|Withdrawal by Subject|5|||
126233875|NCT00577460|454147184|FG001|Overall Study|Withdrawal by Subject|5|||
126233876|NCT00577460|454147185|FG002|Overall Study|Withdrawal by Subject|6|||
126233877|NCT00577460|454147183|FG000|Overall Study|Other|0|||
126233878|NCT00577460|454147184|FG001|Overall Study|Other|3|||
126233879|NCT00577460|454147185|FG002|Overall Study|Other|2|||
126233880|NCT00182091|454147191|FG000|Overall Study|Withdrawal by Subject|1|||
126233881|NCT00182091|454147192|FG001|Overall Study|Withdrawal by Subject|0|||
126233882|NCT00182091|454147193|FG002|Overall Study|Withdrawal by Subject|0|||
126233883|NCT00182091|454147194|FG003|Overall Study|Withdrawal by Subject|0|||
126233884|NCT00993616|454147198|FG000|Overall Study|No tumor at entry|1|||
126233885|NCT00993616|454147198|FG000|Overall Study|Never treated|1|||
126233886|NCT03815942|454148567|FG000|Overall Study|Withdrawal by Subject|0|||
126233887|NCT03815942|454148568|FG001|Overall Study|Withdrawal by Subject|17|||
126233888|NCT03717064|454148569|FG000|Period 2|Adverse Event|1|||
126233889|NCT01298570|454148570|FG000|Overall Study|Disease progression, relapse during acti|64|||
126233890|NCT01298570|454148571|FG001|Overall Study|Disease progression, relapse during acti|40|||
126233891|NCT01298570|454148570|FG000|Overall Study|Adverse Event|20|||
126233892|NCT01298570|454148571|FG001|Overall Study|Adverse Event|2|||
126233893|NCT01298570|454148570|FG000|Overall Study|Withdrawal by Subject|21|||
126233894|NCT01298570|454148571|FG001|Overall Study|Withdrawal by Subject|6|||
126233895|NCT01298570|454148570|FG000|Overall Study|Treatment delay > 4 weeks|4|||
126233896|NCT01298570|454148571|FG001|Overall Study|Treatment delay > 4 weeks|5|||
126233897|NCT01298570|454148570|FG000|Overall Study|Physician Decision|4|||
126233898|NCT01298570|454148571|FG001|Overall Study|Physician Decision|2|||
126233899|NCT01298570|454148570|FG000|Overall Study|Other complicating disease|2|||
126233900|NCT01298570|454148571|FG001|Overall Study|Other complicating disease|1|||
126233901|NCT01298570|454148570|FG000|Overall Study|Surgery|2|||
126233902|NCT01298570|454148571|FG001|Overall Study|Surgery|1|||
126233903|NCT01298570|454148570|FG000|Overall Study|Symptomatic progression/deterioration|3|||
126233904|NCT01298570|454148571|FG001|Overall Study|Symptomatic progression/deterioration|2|||
126233905|NCT01298570|454148570|FG000|Overall Study|Death|0|||
126233906|NCT01298570|454148571|FG001|Overall Study|Death|1|||
126233907|NCT01298570|454148570|FG000|Overall Study|Ineligibility|0|||
126233908|NCT01298570|454148571|FG001|Overall Study|Ineligibility|1|||
126233909|NCT02841709|454148572|FG000|5th Intervention|Adverse Event|2|||
126233910|NCT02841709|454148573|FG001|5th Intervention|Adverse Event|0|||
126233911|NCT02841709|454148574|FG002|5th Intervention|Adverse Event|0|||
126233912|NCT02841709|454148575|FG003|5th Intervention|Adverse Event|0|||
126233913|NCT02841709|454148576|FG004|5th Intervention|Adverse Event|2|||
126233914|NCT01929109|454148577|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
126233915|NCT01929109|454148578|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
126233916|NCT01929109|454148579|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
126233917|NCT01929109|454148580|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
126233918|NCT01929109|454148581|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
126233919|NCT00076102|454148582|FG000|Overall Study|Clinical progression|1|||
126233920|NCT00076102|454148582|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
126233921|NCT00076102|454148582|FG000|Overall Study|plexiform neurofibroma surgery|1|||
126233922|NCT00076102|454148582|FG000|Overall Study|refusal of further therapy|2|||
126233923|NCT01210001|454148583|FG000|Overall Study|Not treated|1|||
126233924|NCT01210001|454148584|FG001|Overall Study|Not treated|0|||
126233925|NCT01210001|454148585|FG002|Overall Study|Not treated|0|||
126233926|NCT01210001|454148583|FG000|Overall Study|Adverse Event|4|||
126233927|NCT01210001|454148584|FG001|Overall Study|Adverse Event|2|||
126233928|NCT01210001|454148585|FG002|Overall Study|Adverse Event|5|||
126233929|NCT01210001|454148583|FG000|Overall Study|Non compliant with protocol|2|||
126233930|NCT01210001|454148584|FG001|Overall Study|Non compliant with protocol|2|||
126233931|NCT01210001|454148585|FG002|Overall Study|Non compliant with protocol|3|||
126233932|NCT01210001|454148583|FG000|Overall Study|Lost to Follow-up|4|||
126233933|NCT01210001|454148584|FG001|Overall Study|Lost to Follow-up|3|||
126233934|NCT01210001|454148585|FG002|Overall Study|Lost to Follow-up|2|||
126233935|NCT01210001|454148583|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
126233936|NCT01210001|454148584|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
126233937|NCT01210001|454148585|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
126233938|NCT01210001|454148583|FG000|Overall Study|Other reason not defined above|2|||
126233939|NCT01210001|454148584|FG001|Overall Study|Other reason not defined above|2|||
126233940|NCT01210001|454148585|FG002|Overall Study|Other reason not defined above|1|||
126233941|NCT01402908|454148586|FG000|Overall Study|Withdrawal by Subject|30|||
126233942|NCT01402908|454148587|FG001|Overall Study|Withdrawal by Subject|17|||
126233943|NCT01402908|454148586|FG000|Overall Study|Lost to Follow-up|3|||
126233944|NCT01402908|454148587|FG001|Overall Study|Lost to Follow-up|1|||
126233945|NCT01402908|454148586|FG000|Overall Study|Physician Decision|1|||
126233946|NCT01402908|454148587|FG001|Overall Study|Physician Decision|0|||
126233947|NCT01739790|454148589|FG000|Overall Study|Early Trial Termination|2|||
126233948|NCT01739790|454148590|FG001|Overall Study|Early Trial Termination|4|||
126233949|NCT02581345|454148591|FG000|Part 1: up to Week 16|Adverse Event|3|||
126354592|NCT03501277|454589404|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
126354593|NCT03501277|454589405|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
126233950|NCT02581345|454148592|FG001|Part 1: up to Week 16|Adverse Event|8|||
126233951|NCT02581345|454148593|FG002|Part 1: up to Week 16|Adverse Event|0|||
126233952|NCT02581345|454148594|FG003|Part 1: up to Week 16|Adverse Event|0|||
126233953|NCT02581345|454148591|FG000|Part 1: up to Week 16|Physician Decision|2|||
126233954|NCT02581345|454148592|FG001|Part 1: up to Week 16|Physician Decision|4|||
126233955|NCT02581345|454148593|FG002|Part 1: up to Week 16|Physician Decision|0|||
126233956|NCT02581345|454148594|FG003|Part 1: up to Week 16|Physician Decision|0|||
126233957|NCT02581345|454148591|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
126233958|NCT02581345|454148592|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
126233959|NCT02581345|454148593|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
126233960|NCT02581345|454148594|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
126233961|NCT02581345|454148591|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
126233962|NCT02581345|454148592|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
126233963|NCT02581345|454148593|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
126233964|NCT02581345|454148594|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
126233965|NCT02581345|454148591|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
126233966|NCT02581345|454148592|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
126233967|NCT02581345|454148593|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
126233968|NCT02581345|454148594|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
126233969|NCT02581345|454148591|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
126233970|NCT02581345|454148592|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
126233971|NCT02581345|454148593|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
126233972|NCT02581345|454148594|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
126233973|NCT02581345|454148591|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
126233974|NCT02581345|454148592|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
126233975|NCT02581345|454148593|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
126233976|NCT02581345|454148594|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
126233977|NCT02581345|454148591|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
126233978|NCT02581345|454148592|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
126233979|NCT02581345|454148593|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
126233980|NCT02581345|454148594|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
126233981|NCT02581345|454148591|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
126233982|NCT02581345|454148592|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
126233983|NCT02581345|454148593|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
126233984|NCT02581345|454148594|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
126233985|NCT02581345|454148591|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
126233986|NCT02581345|454148592|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
126233987|NCT02581345|454148593|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
126233988|NCT02581345|454148594|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
126233989|NCT02581345|454148591|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
126233990|NCT02581345|454148592|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
126233991|NCT02581345|454148593|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
126233992|NCT02581345|454148594|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
126233993|NCT02581345|454148591|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
126233994|NCT02581345|454148592|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
126233995|NCT02581345|454148593|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
126233996|NCT02581345|454148594|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
126233997|NCT01244126|454148600|FG000|Overall Study|Protocol Violation|3|||
126233998|NCT01244126|454148601|FG001|Overall Study|Protocol Violation|3|||
126233999|NCT01244126|454148602|FG002|Overall Study|Protocol Violation|9|||
126234000|NCT01451762|454148603|FG000|Overall Study|Lost to Follow-up|3|||
126234001|NCT01451762|454148604|FG001|Overall Study|Lost to Follow-up|6|||
126234002|NCT01451762|454148605|FG002|Overall Study|Lost to Follow-up|6|||
126234003|NCT00863746|454148610|FG000|Treatment|Not treated|4|||
126234004|NCT00863746|454148611|FG001|Treatment|Not treated|2|||
126234005|NCT00863746|454148610|FG000|Treatment|Adverse Event|41|||
126234006|NCT00863746|454148611|FG001|Treatment|Adverse Event|16|||
126234007|NCT00863746|454148610|FG000|Treatment|non-compliant with study medication|4|||
126234008|NCT00863746|454148611|FG001|Treatment|non-compliant with study medication|0|||
126234009|NCT00863746|454148610|FG000|Treatment|Consent withdrawn|15|||
126234010|NCT00863746|454148611|FG001|Treatment|Consent withdrawn|14|||
126234011|NCT00863746|454148610|FG000|Treatment|Lost to Follow-up|1|||
126234012|NCT00863746|454148611|FG001|Treatment|Lost to Follow-up|0|||
126234013|NCT00863746|454148610|FG000|Treatment|Protocol Violation|5|||
126234014|NCT00863746|454148611|FG001|Treatment|Protocol Violation|3|||
126234015|NCT00863746|454148610|FG000|Treatment|Other|1|||
126234016|NCT00863746|454148611|FG001|Treatment|Other|0|||
126234017|NCT00863746|454148610|FG000|Survival Follow up|Death|244|||
126234018|NCT00863746|454148611|FG001|Survival Follow up|Death|271|||
126234019|NCT00863746|454148610|FG000|Survival Follow up|Lost to Follow-up|2|||
126234020|NCT00863746|454148611|FG001|Survival Follow up|Lost to Follow-up|1|||
126234021|NCT00863746|454148610|FG000|Survival Follow up|Consent Withdrawn|7|||
126234022|NCT00863746|454148611|FG001|Survival Follow up|Consent Withdrawn|8|||
126234023|NCT00862979|454148617|FG000|Overall Study|Adverse Event|6|||
126234024|NCT00862979|454148618|FG001|Overall Study|Adverse Event|3|||
126234025|NCT00862979|454148617|FG000|Overall Study|Protocol Violation|0|||
126234026|NCT00862979|454148618|FG001|Overall Study|Protocol Violation|1|||
126234027|NCT00862979|454148617|FG000|Overall Study|Patient withdrew consent|2|||
126234028|NCT00862979|454148618|FG001|Overall Study|Patient withdrew consent|1|||
126234029|NCT00862979|454148617|FG000|Overall Study|Administrative problems|0|||
126234030|NCT00862979|454148618|FG001|Overall Study|Administrative problems|1|||
126234031|NCT00862979|454148617|FG000|Overall Study|Death|0|||
126234032|NCT00862979|454148618|FG001|Overall Study|Death|1|||
126234033|NCT01367275|454148621|FG000|Overall Study|Ineligible|1|||
126234034|NCT01367275|454148621|FG000|Overall Study|Disease Progression|2|||
126234035|NCT02388763|454148633|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
126234036|NCT02388763|454148634|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
126234037|NCT02388763|454148633|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
126234038|NCT02388763|454148634|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
126234039|NCT01153984|454148635|FG000|Overall Study|Withdrawal by Subject|1|||
126234040|NCT01153984|454148635|FG000|Overall Study|Adverse Event|1|||
126234041|NCT02460159|454148636|FG000|Overall Study|Adverse Event|4|||
126234042|NCT02460159|454148637|FG001|Overall Study|Adverse Event|1|||
126234043|NCT02460159|454148636|FG000|Overall Study|Withdrawal by Subject|2|||
126234044|NCT02460159|454148637|FG001|Overall Study|Withdrawal by Subject|0|||
126234045|NCT02194998|454148646|FG000|On-HCV Treatment|Did not pick up study medication|0|||
126234046|NCT02194998|454148647|FG001|On-HCV Treatment|Did not pick up study medication|1|||
126234047|NCT02194998|454148648|FG002|On-HCV Treatment|Did not pick up study medication|0|||
126234048|NCT02194998|454148649|FG003|On-HCV Treatment|Did not pick up study medication|0|||
126234049|NCT02194998|454148646|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
126234050|NCT02194998|454148647|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
126234051|NCT02194998|454148648|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
126234052|NCT02194998|454148649|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
126234053|NCT01458405|454148650|FG000|Phase 1 (up to 12 Months)|Other|0|||
126234054|NCT01458405|454148651|FG001|Phase 1 (up to 12 Months)|Other|1|||
126234055|NCT01458405|454148652|FG002|Phase 1 (up to 12 Months)|Other|0|||
126234056|NCT01458405|454148653|FG003|Phase 1 (up to 12 Months)|Other|0|||
126234057|NCT01458405|454148650|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
126234058|NCT01458405|454148651|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
126234059|NCT01458405|454148652|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
126234060|NCT01458405|454148653|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
126234061|NCT01458405|454148650|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
126234062|NCT01458405|454148651|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
126234063|NCT01458405|454148652|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
126234064|NCT01458405|454148653|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
126234065|NCT01458405|454148650|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
126234066|NCT01458405|454148651|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
126234067|NCT01458405|454148652|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
126234068|NCT01458405|454148653|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
126234069|NCT02497781|454148654|FG000|Overall Study|Withdrawal by Subject|2|||
126234070|NCT02497781|454148655|FG001|Overall Study|Withdrawal by Subject|0|||
126234071|NCT02497781|454148654|FG000|Overall Study|Lack of Efficacy|0|||
126234072|NCT02497781|454148655|FG001|Overall Study|Lack of Efficacy|1|||
126234073|NCT02497781|454148654|FG000|Overall Study|Randomised but not treated|1|||
126234074|NCT02497781|454148655|FG001|Overall Study|Randomised but not treated|1|||
126234075|NCT02497781|454148654|FG000|Overall Study|Lost to Follow-up|1|||
126234076|NCT02497781|454148655|FG001|Overall Study|Lost to Follow-up|1|||
126234077|NCT02236130|454148656|FG000|Overall Study|Lost to Follow-up|7|||
126234078|NCT02236130|454148657|FG001|Overall Study|Lost to Follow-up|12|||
126234079|NCT00454636|454148658|FG000|Overall Study|Adverse Event|10|||
126234080|NCT00454636|454148659|FG001|Overall Study|Adverse Event|6|||
126234081|NCT00454636|454148660|FG002|Overall Study|Adverse Event|9|||
126234082|NCT00454636|454148661|FG003|Overall Study|Adverse Event|15|||
126234083|NCT00454636|454148658|FG000|Overall Study|Disease Progression|11|||
126234084|NCT00454636|454148659|FG001|Overall Study|Disease Progression|12|||
126234085|NCT00454636|454148660|FG002|Overall Study|Disease Progression|4|||
126234086|NCT00454636|454148661|FG003|Overall Study|Disease Progression|11|||
126234087|NCT00454636|454148658|FG000|Overall Study|Protocol Violation|3|||
126234088|NCT00454636|454148659|FG001|Overall Study|Protocol Violation|2|||
126234089|NCT00454636|454148660|FG002|Overall Study|Protocol Violation|3|||
126234090|NCT00454636|454148661|FG003|Overall Study|Protocol Violation|3|||
126234091|NCT00454636|454148658|FG000|Overall Study|Death|6|||
126234092|NCT00454636|454148659|FG001|Overall Study|Death|1|||
126234093|NCT00454636|454148660|FG002|Overall Study|Death|1|||
126234094|NCT00454636|454148661|FG003|Overall Study|Death|1|||
126234095|NCT00454636|454148658|FG000|Overall Study|Patient refusal|1|||
126234096|NCT00454636|454148659|FG001|Overall Study|Patient refusal|1|||
126234097|NCT00454636|454148660|FG002|Overall Study|Patient refusal|3|||
126234098|NCT00454636|454148661|FG003|Overall Study|Patient refusal|2|||
126234099|NCT00454636|454148658|FG000|Overall Study|Lost to Follow-up|0|||
126234100|NCT00454636|454148659|FG001|Overall Study|Lost to Follow-up|1|||
126234101|NCT00454636|454148660|FG002|Overall Study|Lost to Follow-up|0|||
126234102|NCT00454636|454148661|FG003|Overall Study|Lost to Follow-up|0|||
126234103|NCT01400113|454148662|FG000|Overall Study|Withdrawal by Subject|1|||
126234104|NCT01400113|454148663|FG001|Overall Study|Withdrawal by Subject|1|||
126234105|NCT01025037|454148668|FG000|Overall Study|Adverse Event|3|||
126234106|NCT01025037|454148668|FG000|Overall Study|Lost to Follow-up|7|||
126234107|NCT01025037|454148668|FG000|Overall Study|Withdrawal by Subject|1|||
126234108|NCT01890915|454148670|FG000|Overall Study|Adverse Event|1|||
126234109|NCT01890915|454148671|FG001|Overall Study|Adverse Event|0|||
126234110|NCT01890915|454148670|FG000|Overall Study|Protocol Violation|2|||
126234111|NCT01890915|454148671|FG001|Overall Study|Protocol Violation|0|||
126234112|NCT01890915|454148670|FG000|Overall Study|Equipment Malfunction|0|||
126234113|NCT01890915|454148671|FG001|Overall Study|Equipment Malfunction|1|||
126234114|NCT02114697|454148672|FG000|Overall Study|Study terminated|5|||
126234115|NCT02114697|454148673|FG001|Overall Study|Study terminated|4|||
126234116|NCT00424489|454148674|FG000|Overall Study|Death|3|||
126234117|NCT00860405|454148687|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
126234118|NCT00860405|454148688|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
126234119|NCT02465567|454148689|FG000|Overall Study|Adverse Event|118|||
126234120|NCT02465567|454148690|FG001|Overall Study|Adverse Event|113|||
126234121|NCT02465567|454148691|FG002|Overall Study|Adverse Event|147|||
126234122|NCT02465567|454148692|FG003|Overall Study|Adverse Event|138|||
126234123|NCT02465567|454148689|FG000|Overall Study|Lack of Efficacy|103|||
126234124|NCT02465567|454148690|FG001|Overall Study|Lack of Efficacy|102|||
126234125|NCT02465567|454148691|FG002|Overall Study|Lack of Efficacy|171|||
126234126|NCT02465567|454148692|FG003|Overall Study|Lack of Efficacy|135|||
126234127|NCT02465567|454148689|FG000|Overall Study|Withdrawal by Subject|104|||
126234128|NCT02465567|454148690|FG001|Overall Study|Withdrawal by Subject|94|||
126234129|NCT02465567|454148691|FG002|Overall Study|Withdrawal by Subject|123|||
126234130|NCT02465567|454148692|FG003|Overall Study|Withdrawal by Subject|130|||
126234131|NCT02465567|454148689|FG000|Overall Study|Physician Decision|23|||
126234132|NCT02465567|454148690|FG001|Overall Study|Physician Decision|33|||
126234133|NCT02465567|454148691|FG002|Overall Study|Physician Decision|38|||
126234134|NCT02465567|454148692|FG003|Overall Study|Physician Decision|28|||
126234135|NCT02465567|454148689|FG000|Overall Study|Major Protocol Deviation|24|||
126234136|NCT02465567|454148690|FG001|Overall Study|Major Protocol Deviation|26|||
126234137|NCT02465567|454148691|FG002|Overall Study|Major Protocol Deviation|22|||
126234138|NCT02465567|454148692|FG003|Overall Study|Major Protocol Deviation|25|||
126234139|NCT02465567|454148689|FG000|Overall Study|Lost to Follow-up|25|||
126234140|NCT02465567|454148690|FG001|Overall Study|Lost to Follow-up|21|||
126234141|NCT02465567|454148691|FG002|Overall Study|Lost to Follow-up|19|||
126234142|NCT02465567|454148692|FG003|Overall Study|Lost to Follow-up|15|||
126234143|NCT02465567|454148689|FG000|Overall Study|Protocol Specified Criteria|20|||
126234144|NCT02465567|454148690|FG001|Overall Study|Protocol Specified Criteria|10|||
126234145|NCT02465567|454148691|FG002|Overall Study|Protocol Specified Criteria|9|||
126234146|NCT02465567|454148692|FG003|Overall Study|Protocol Specified Criteria|12|||
126234147|NCT02465567|454148689|FG000|Overall Study|Administrative Reasons|12|||
126234148|NCT02465567|454148690|FG001|Overall Study|Administrative Reasons|9|||
126234149|NCT02465567|454148691|FG002|Overall Study|Administrative Reasons|11|||
126234150|NCT02465567|454148692|FG003|Overall Study|Administrative Reasons|5|||
126234151|NCT02465567|454148689|FG000|Overall Study|Randomized but not treated|1|||
126234152|NCT02465567|454148690|FG001|Overall Study|Randomized but not treated|5|||
126234153|NCT02465567|454148691|FG002|Overall Study|Randomized but not treated|4|||
126234154|NCT02465567|454148692|FG003|Overall Study|Randomized but not treated|5|||
126234155|NCT02465567|454148689|FG000|Overall Study|enrolled in >1 studies|18|||
126234156|NCT02465567|454148690|FG001|Overall Study|enrolled in >1 studies|11|||
126234157|NCT02465567|454148691|FG002|Overall Study|enrolled in >1 studies|19|||
126234158|NCT02465567|454148692|FG003|Overall Study|enrolled in >1 studies|15|||
126234159|NCT02465567|454148689|FG000|Overall Study|missing PI Signature|1|||
126234160|NCT02465567|454148690|FG001|Overall Study|missing PI Signature|0|||
126234161|NCT02465567|454148691|FG002|Overall Study|missing PI Signature|0|||
126234162|NCT02465567|454148692|FG003|Overall Study|missing PI Signature|0|||
126234163|NCT02780687|454148699|FG000|Overall Study|Adverse Event|1|||
126234164|NCT02780687|454148700|FG001|Overall Study|Adverse Event|1|||
126234165|NCT02780687|454148699|FG000|Overall Study|Withdrawal by Subject|2|||
126023273|NCT02590432|453380676|FG002|Open-label Treatment Period|Protocol Violation|0|||
126023274|NCT02590432|453380677|FG003|Open-label Treatment Period|Protocol Violation|0|||
126023275|NCT02590432|453380678|FG004|Open-label Treatment Period|Protocol Violation|0|||
126234166|NCT02780687|454148700|FG001|Overall Study|Withdrawal by Subject|1|||
126234167|NCT02780687|454148699|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
126234168|NCT02780687|454148700|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
126234169|NCT02780687|454148699|FG000|Overall Study|progressive disease|29|||
126234170|NCT02780687|454148700|FG001|Overall Study|progressive disease|6|||
126234171|NCT01448057|454148701|FG000|Overall Study|Protocol Violation|3|||
126234172|NCT01448057|454148702|FG001|Overall Study|Protocol Violation|2|||
126234173|NCT01448057|454148701|FG000|Overall Study|Lost to Follow-up|3|||
126234174|NCT01448057|454148702|FG001|Overall Study|Lost to Follow-up|0|||
126234175|NCT01448057|454148701|FG000|Overall Study|Adverse Event|0|||
126234176|NCT01448057|454148702|FG001|Overall Study|Adverse Event|2|||
126234177|NCT01448057|454148701|FG000|Overall Study|Withdrawal by Subject|2|||
126234178|NCT01448057|454148702|FG001|Overall Study|Withdrawal by Subject|0|||
126234179|NCT00906347|454148704|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
126234180|NCT00906347|454148705|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
126234181|NCT00906347|454148704|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
126234182|NCT00906347|454148705|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
126234183|NCT00906347|454148704|FG000|Received Study Drug|Refused study drug|1|||
126234184|NCT00906347|454148705|FG001|Received Study Drug|Refused study drug|0|||
126234185|NCT00906347|454148704|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
126234186|NCT00906347|454148705|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
126234187|NCT04591626|454148707|FG000|Overall Study|Adverse Event|4|||
126234188|NCT04591626|454148708|FG001|Overall Study|Adverse Event|0|||
126234189|NCT04591626|454148707|FG000|Overall Study|Withdrawal by Subject|5|||
126234190|NCT04591626|454148708|FG001|Overall Study|Withdrawal by Subject|3|||
126234191|NCT04591626|454148707|FG000|Overall Study|Physician Decision|0|||
126234192|NCT04591626|454148708|FG001|Overall Study|Physician Decision|1|||
126234193|NCT04591626|454148707|FG000|Overall Study|Death|0|||
126234194|NCT04591626|454148708|FG001|Overall Study|Death|1|||
126234195|NCT04591626|454148707|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126234196|NCT04591626|454148708|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126234197|NCT02672553|454148709|FG000|Overall Study|Death|3|||
126234198|NCT02672553|454148710|FG001|Overall Study|Death|5|||
126234199|NCT02672553|454148709|FG000|Overall Study|Valve Explant|1|||
126234200|NCT02672553|454148710|FG001|Overall Study|Valve Explant|0|||
126234201|NCT02672553|454148709|FG000|Overall Study|Conversion to Commercial Valve|3|||
126234202|NCT02672553|454148710|FG001|Overall Study|Conversion to Commercial Valve|0|||
126234203|NCT02672553|454148709|FG000|Overall Study|Withdrawal by Subject|3|||
126234204|NCT02672553|454148710|FG001|Overall Study|Withdrawal by Subject|3|||
126234205|NCT02672553|454148709|FG000|Overall Study|Intraoperative screen failure|2|||
126234206|NCT02672553|454148710|FG001|Overall Study|Intraoperative screen failure|0|||
126234207|NCT02507375|454148714|FG000|Overall Study|Progressive Disease|4|||
126234208|NCT02507375|454148715|FG001|Overall Study|Progressive Disease|5|||
126234209|NCT02507375|454148714|FG000|Overall Study|Death|0|||
126234210|NCT02507375|454148715|FG001|Overall Study|Death|1|||
126234211|NCT02507375|454148714|FG000|Overall Study|Refused treatment|0|||
126234212|NCT02507375|454148715|FG001|Overall Study|Refused treatment|1|||
126234213|NCT02507375|454148714|FG000|Overall Study|Adverse Event|0|||
126234214|NCT02507375|454148715|FG001|Overall Study|Adverse Event|1|||
126234215|NCT00522457|454148716|FG000|Overall Study|Due to disease progression|16|||
126234216|NCT00522457|454148716|FG000|Overall Study|Adverse Event|2|||
126234217|NCT01691248|454148717|FG000|Overall Study|Protocol Violation|43|||
126234218|NCT01691248|454148718|FG001|Overall Study|Protocol Violation|27|||
126234219|NCT01691248|454148717|FG000|Overall Study|Adverse Event|24|||
126234220|NCT01691248|454148718|FG001|Overall Study|Adverse Event|22|||
126234221|NCT01691248|454148717|FG000|Overall Study|Withdrawal by Subject|20|||
126234222|NCT01691248|454148718|FG001|Overall Study|Withdrawal by Subject|18|||
126234223|NCT01691248|454148717|FG000|Overall Study|Confirmed CDAD|14|||
126234224|NCT01691248|454148718|FG001|Overall Study|Confirmed CDAD|31|||
126093209|NCT00831129|453634555|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
126234225|NCT01691248|454148717|FG000|Overall Study|Lost to Follow-up|2|||
126234226|NCT01691248|454148718|FG001|Overall Study|Lost to Follow-up|5|||
126234227|NCT01691248|454148717|FG000|Overall Study|Reason not provided|4|||
126234228|NCT01691248|454148718|FG001|Overall Study|Reason not provided|4|||
126234229|NCT01691248|454148717|FG000|Overall Study|Not Treated|4|||
126234230|NCT01691248|454148718|FG001|Overall Study|Not Treated|7|||
126234231|NCT02863575|454148719|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
126234232|NCT02863575|454148720|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
126234233|NCT02863575|454148721|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
126234234|NCT02863575|454148719|FG000|Overall Study|Withdrawal by Subject|0|||
126234235|NCT02863575|454148720|FG001|Overall Study|Withdrawal by Subject|1|||
126234236|NCT02863575|454148721|FG002|Overall Study|Withdrawal by Subject|1|||
126354594|NCT01327703|454589406|FG000|Second Treatment Period|Adverse Event|1|||
126354595|NCT01327703|454589407|FG001|Second Treatment Period|Adverse Event|1|||
126234237|NCT02863575|454148719|FG000|Overall Study|Adverse Event|0|||
126354596|NCT01327703|454589406|FG000|Second Treatment Period|Protocol Violation|0|||
126354597|NCT01327703|454589407|FG001|Second Treatment Period|Protocol Violation|1|||
126354598|NCT01131585|454589408|FG000|Overall Study|Adverse Event|0|||
126354599|NCT01131585|454589409|FG001|Overall Study|Adverse Event|2|||
126354600|NCT01131585|454589408|FG000|Overall Study|Abnormal laboratory value|1|||
126354601|NCT01131585|454589409|FG001|Overall Study|Abnormal laboratory value|0|||
126234238|NCT02863575|454148720|FG001|Overall Study|Adverse Event|1|||
126234239|NCT02863575|454148721|FG002|Overall Study|Adverse Event|0|||
126234240|NCT02785913|454149825|FG000|Overall Study|Adverse Event|5|||
126234241|NCT02785913|454149825|FG000|Overall Study|Death|2|||
126234242|NCT02785913|454149825|FG000|Overall Study|Progression|18|||
126354602|NCT01131585|454589408|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126354603|NCT01131585|454589409|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126354604|NCT01131585|454589408|FG000|Overall Study|Protocol Violation|2|||
126354605|NCT01131585|454589409|FG001|Overall Study|Protocol Violation|1|||
126354606|NCT01131585|454589408|FG000|Overall Study|Withdrawal by Subject|3|||
126354607|NCT01131585|454589409|FG001|Overall Study|Withdrawal by Subject|3|||
126354608|NCT01131585|454589408|FG000|Overall Study|Lost to Follow-up|0|||
126354609|NCT01131585|454589409|FG001|Overall Study|Lost to Follow-up|1|||
126354610|NCT01131585|454589408|FG000|Overall Study|Administrative problems|1|||
126354611|NCT01131585|454589409|FG001|Overall Study|Administrative problems|1|||
126354612|NCT01131585|454589408|FG000|Overall Study|Study termination|78|||
126354613|NCT01131585|454589409|FG001|Overall Study|Study termination|32|||
126354614|NCT00812097|454589410|FG000|Overall Study|Death|3|||
126354615|NCT00812097|454589411|FG001|Overall Study|Death|10|||
126354616|NCT00812097|454589412|FG002|Overall Study|Death|3|||
126354617|NCT00812097|454589413|FG003|Overall Study|Death|3|||
126354618|NCT00812097|454589410|FG000|Overall Study|Withdrawal by Subject|14|||
126354619|NCT00812097|454589411|FG001|Overall Study|Withdrawal by Subject|12|||
126354620|NCT00812097|454589412|FG002|Overall Study|Withdrawal by Subject|8|||
126354621|NCT00812097|454589413|FG003|Overall Study|Withdrawal by Subject|2|||
126354622|NCT00812097|454589410|FG000|Overall Study|Lost to Follow-up|90|||
126354623|NCT00812097|454589411|FG001|Overall Study|Lost to Follow-up|14|||
126354624|NCT00812097|454589412|FG002|Overall Study|Lost to Follow-up|17|||
126354625|NCT00812097|454589413|FG003|Overall Study|Lost to Follow-up|5|||
126234243|NCT02785913|454149825|FG000|Overall Study|Not protocol specified|1|||
126234244|NCT00788125|454149826|FG000|Overall Study|Death|6|||
126354626|NCT00812097|454589410|FG000|Overall Study|Explantation of study device(s)|27|||
126354627|NCT00812097|454589411|FG001|Overall Study|Explantation of study device(s)|29|||
126354628|NCT00812097|454589412|FG002|Overall Study|Explantation of study device(s)|14|||
126354629|NCT00812097|454589413|FG003|Overall Study|Explantation of study device(s)|20|||
126354630|NCT00812097|454589410|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
126354631|NCT00812097|454589411|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
126354632|NCT00812097|454589412|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
126354633|NCT00812097|454589413|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
126234245|NCT02777528|454149834|FG000|Overall Study|Still in study|24|||
126234246|NCT02777528|454149835|FG001|Overall Study|Still in study|10|||
126234247|NCT02777528|454149836|FG002|Overall Study|Still in study|1|||
126234248|NCT02777528|454149834|FG000|Overall Study|Study Device Explanted|1|||
126234249|NCT02777528|454149835|FG001|Overall Study|Study Device Explanted|0|||
126234250|NCT02777528|454149836|FG002|Overall Study|Study Device Explanted|0|||
126234251|NCT02777528|454149834|FG000|Overall Study|Death|14|||
126234252|NCT02777528|454149835|FG001|Overall Study|Death|7|||
126234253|NCT02777528|454149836|FG002|Overall Study|Death|1|||
126234254|NCT02777528|454149834|FG000|Overall Study|Withdrawal by Subject|2|||
126234255|NCT02777528|454149835|FG001|Overall Study|Withdrawal by Subject|2|||
126234256|NCT02777528|454149836|FG002|Overall Study|Withdrawal by Subject|1|||
126234257|NCT02777528|454149834|FG000|Overall Study|Physician Decision|2|||
126234258|NCT02777528|454149835|FG001|Overall Study|Physician Decision|1|||
126234259|NCT02777528|454149836|FG002|Overall Study|Physician Decision|0|||
126234260|NCT02777528|454149834|FG000|Overall Study|Lost to Follow-up|2|||
126354634|NCT00927082|454589414|FG000|Overall Study|Lost to Follow-up|9|||
126354635|NCT00927082|454589415|FG001|Overall Study|Lost to Follow-up|8|||
126354636|NCT00927082|454589416|FG002|Overall Study|Lost to Follow-up|12|||
126354637|NCT00927082|454589417|FG003|Overall Study|Lost to Follow-up|16|||
126093210|NCT01877239|453634556|FG000|Overall Study|Adverse Event|4|||
126093211|NCT01877239|453634556|FG000|Overall Study|Disease Remission|1|||
126093212|NCT01877239|453634556|FG000|Overall Study|Withdrawal by Subject|4|||
126093213|NCT01877239|453634556|FG000|Overall Study|Other|2|||
126093214|NCT01877239|453634556|FG000|Overall Study|Lack of Efficacy|4|||
126093215|NCT01877239|453634556|FG000|Overall Study|Data not available|35|||
126093216|NCT00743431|453634562|FG000|Overall Study|Toxicity|6|||
126093217|NCT00743431|453634562|FG000|Overall Study|Tumor progression|56|||
126093218|NCT00743431|453634562|FG000|Overall Study|Withdrawal by Subject|13|||
126354638|NCT00927082|454589414|FG000|Overall Study|Withdrawal by Subject|3|||
126093219|NCT00743431|453634562|FG000|Overall Study|Death|9|||
126093220|NCT00743431|453634562|FG000|Overall Study|Reason for discontinuation not specified|29|||
126093221|NCT00743431|453634562|FG000|Overall Study|No documentation available|13|||
126093222|NCT03291288|453634563|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
126093223|NCT03291288|453634564|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
126093224|NCT03291288|453634563|FG000|Drug-drug Interaction Phase|Disease progression|1|||
126234261|NCT02777528|454149835|FG001|Overall Study|Lost to Follow-up|0|||
126234262|NCT02777528|454149836|FG002|Overall Study|Lost to Follow-up|0|||
126234263|NCT02777528|454149834|FG000|Overall Study|Discontinued due to Other|1|||
126234264|NCT02777528|454149835|FG001|Overall Study|Discontinued due to Other|0|||
126234265|NCT02777528|454149836|FG002|Overall Study|Discontinued due to Other|0|||
126354639|NCT00927082|454589415|FG001|Overall Study|Withdrawal by Subject|2|||
126354640|NCT00927082|454589416|FG002|Overall Study|Withdrawal by Subject|7|||
126354641|NCT00927082|454589417|FG003|Overall Study|Withdrawal by Subject|2|||
126354642|NCT00927082|454589414|FG000|Overall Study|Death|0|||
126234266|NCT00453362|454149839|FG000|Overall Study|Adverse Event|5|||
126234267|NCT00453362|454149839|FG000|Overall Study|Death|7|||
126234268|NCT00453362|454149839|FG000|Overall Study|Physician Decision|2|||
126234269|NCT00453362|454149839|FG000|Overall Study|Withdrawal by Subject|3|||
126234270|NCT00453362|454149839|FG000|Overall Study|Progression of disease|56|||
126234271|NCT00453362|454149839|FG000|Overall Study|Screening Failure|14|||
126234272|NCT04885296|454149840|FG000|Period 1|Covid-19 Related|1|||
126234273|NCT04885296|454149841|FG001|Period 1|Covid-19 Related|0|||
126234274|NCT04885296|454149840|FG000|Period 1|Adverse Event|0|||
126234275|NCT04885296|454149841|FG001|Period 1|Adverse Event|1|||
126234276|NCT04885296|454149840|FG000|Period 1|Withdrawal by Subject|1|||
126093225|NCT03291288|453634564|FG001|Drug-drug Interaction Phase|Disease progression|0|||
126093226|NCT03291288|453634563|FG000|Drug-drug Interaction Phase|Other|3|||
126093227|NCT03291288|453634564|FG001|Drug-drug Interaction Phase|Other|0|||
126093228|NCT03291288|453634563|FG000|Pexidartinib Only|Ongoing|0|||
126093229|NCT03291288|453634564|FG001|Pexidartinib Only|Ongoing|2|||
126093230|NCT04276415|453634565|FG000|Overall Study|Adverse Event|0|||
126093231|NCT04276415|453634566|FG001|Overall Study|Adverse Event|0|||
126093232|NCT04276415|453634567|FG002|Overall Study|Adverse Event|0|||
126234277|NCT04885296|454149841|FG001|Period 1|Withdrawal by Subject|1|||
126093233|NCT04276415|453634568|FG003|Overall Study|Adverse Event|3|||
126093234|NCT04276415|453634569|FG004|Overall Study|Adverse Event|0|||
126093235|NCT04276415|453634570|FG005|Overall Study|Adverse Event|0|||
126093236|NCT04276415|453634565|FG000|Overall Study|Clinical progression|1|||
126093237|NCT04276415|453634566|FG001|Overall Study|Clinical progression|1|||
126093238|NCT04276415|453634567|FG002|Overall Study|Clinical progression|0|||
126093239|NCT04276415|453634568|FG003|Overall Study|Clinical progression|0|||
126093240|NCT04276415|453634569|FG004|Overall Study|Clinical progression|1|||
126093241|NCT04276415|453634570|FG005|Overall Study|Clinical progression|0|||
126093242|NCT04276415|453634565|FG000|Overall Study|Other|0|||
126093243|NCT04276415|453634566|FG001|Overall Study|Other|0|||
126093244|NCT04276415|453634567|FG002|Overall Study|Other|0|||
126093245|NCT04276415|453634568|FG003|Overall Study|Other|1|||
126093246|NCT04276415|453634569|FG004|Overall Study|Other|0|||
126093247|NCT04276415|453634570|FG005|Overall Study|Other|0|||
126093248|NCT04276415|453634565|FG000|Overall Study|Physician Decision|0|||
126093249|NCT04276415|453634566|FG001|Overall Study|Physician Decision|0|||
126093250|NCT04276415|453634567|FG002|Overall Study|Physician Decision|1|||
126093251|NCT04276415|453634568|FG003|Overall Study|Physician Decision|3|||
126093252|NCT04276415|453634569|FG004|Overall Study|Physician Decision|2|||
126093253|NCT04276415|453634570|FG005|Overall Study|Physician Decision|0|||
126093254|NCT04276415|453634565|FG000|Overall Study|Progressive disease|3|||
126093255|NCT04276415|453634566|FG001|Overall Study|Progressive disease|3|||
126093256|NCT04276415|453634567|FG002|Overall Study|Progressive disease|4|||
126234278|NCT04885296|454149840|FG000|Period 1|Test Article No Longer Available|1|||
126023276|NCT02590432|453380679|FG005|Open-label Treatment Period|Protocol Violation|0|||
126023277|NCT02590432|453380680|FG006|Open-label Treatment Period|Protocol Violation|0|||
126023278|NCT02590432|453380681|FG007|Open-label Treatment Period|Protocol Violation|0|||
126023279|NCT02590432|453380682|FG008|Open-label Treatment Period|Protocol Violation|0|||
126023280|NCT02590432|453380674|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
126023281|NCT02590432|453380675|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
126023282|NCT02590432|453380676|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126023283|NCT02590432|453380677|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126023284|NCT02590432|453380678|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126023285|NCT02590432|453380679|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126023286|NCT02590432|453380680|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126023287|NCT02590432|453380681|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126023288|NCT02590432|453380682|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126023289|NCT02590432|453380674|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
126023290|NCT02590432|453380675|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
126093257|NCT04276415|453634568|FG003|Overall Study|Progressive disease|5|||
126093258|NCT04276415|453634569|FG004|Overall Study|Progressive disease|1|||
126093259|NCT04276415|453634570|FG005|Overall Study|Progressive disease|2|||
126093260|NCT04276415|453634565|FG000|Overall Study|Withdrawal by patient|0|||
126093261|NCT04276415|453634566|FG001|Overall Study|Withdrawal by patient|0|||
126093262|NCT04276415|453634567|FG002|Overall Study|Withdrawal by patient|0|||
126093263|NCT04276415|453634568|FG003|Overall Study|Withdrawal by patient|1|||
126234279|NCT04885296|454149841|FG001|Period 1|Test Article No Longer Available|0|||
126234280|NCT04885296|454149840|FG000|Period 1|Dispensed Study lens in Error|1|||
126234281|NCT04885296|454149841|FG001|Period 1|Dispensed Study lens in Error|0|||
126234282|NCT04885296|454149840|FG000|Period 1|Lost to Follow-up|1|||
126234283|NCT04885296|454149841|FG001|Period 1|Lost to Follow-up|0|||
126234284|NCT04885296|454149840|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
126234285|NCT04885296|454149841|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
126234286|NCT01027143|454149843|FG000|Overall Study|Lost to Follow-up|9|||
126234287|NCT01027143|454149844|FG001|Overall Study|Lost to Follow-up|4|||
126234288|NCT05346055|454149845|FG000|Overall Study|Withdrawal by Subject|1|||
126234289|NCT05346055|454149845|FG000|Overall Study|Protocol Violation|1|||
126234290|NCT05346055|454149845|FG000|Overall Study|Therapist decision|1|||
126234291|NCT02564263|454149846|FG000|Overall Study|Adverse Event|31|||
126234292|NCT02564263|454149847|FG001|Overall Study|Adverse Event|29|||
126234293|NCT02564263|454149846|FG000|Overall Study|Death|270|||
126234294|NCT02564263|454149847|FG001|Overall Study|Death|262|||
126023291|NCT02590432|453380676|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126234295|NCT02564263|454149846|FG000|Overall Study|Withdrawal by Subject|4|||
126234296|NCT02564263|454149847|FG001|Overall Study|Withdrawal by Subject|19|||
126234297|NCT02564263|454149846|FG000|Overall Study|Sponsor's decision|9|||
126234298|NCT02564263|454149847|FG001|Overall Study|Sponsor's decision|4|||
126234299|NCT02319148|454149848|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
126234300|NCT02319148|454149849|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
126234301|NCT02319148|454149850|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
126234302|NCT02319148|454149851|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
126234303|NCT02319148|454149848|FG000|Second Intervention Period|No longer willing to participate|0|||
126234304|NCT02319148|454149849|FG001|Second Intervention Period|No longer willing to participate|1|||
126234305|NCT02319148|454149850|FG002|Second Intervention Period|No longer willing to participate|0|||
126234306|NCT02319148|454149851|FG003|Second Intervention Period|No longer willing to participate|0|||
126234307|NCT02319148|454149848|FG000|Second Intervention Period|Other|0|||
126234308|NCT02319148|454149849|FG001|Second Intervention Period|Other|0|||
126234309|NCT02319148|454149850|FG002|Second Intervention Period|Other|0|||
126234310|NCT02319148|454149851|FG003|Second Intervention Period|Other|1|||
126234311|NCT01087970|454149853|FG000|Overall Study|Protocol Violation|2|||
126234312|NCT00264797|454149854|FG000|Overall Study|Withdrawal by Subject|11|||
126234313|NCT00264797|454149855|FG001|Overall Study|Withdrawal by Subject|11|||
126234314|NCT00264797|454149854|FG000|Overall Study|Lost to Follow-up|9|||
126234315|NCT00264797|454149855|FG001|Overall Study|Lost to Follow-up|17|||
126234316|NCT00264797|454149854|FG000|Overall Study|Moved from area|3|||
126234317|NCT00264797|454149855|FG001|Overall Study|Moved from area|1|||
126234318|NCT00264797|454149854|FG000|Overall Study|Practical Problems|2|||
126234319|NCT00264797|454149855|FG001|Overall Study|Practical Problems|3|||
126234320|NCT00264797|454149854|FG000|Overall Study|Incarceration|4|||
126234321|NCT00264797|454149855|FG001|Overall Study|Incarceration|5|||
126234322|NCT00264797|454149854|FG000|Overall Study|Pressure/advice from Outsiders|1|||
126234323|NCT00264797|454149855|FG001|Overall Study|Pressure/advice from Outsiders|1|||
126234324|NCT00264797|454149854|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
126234325|NCT00264797|454149855|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
126234326|NCT00264797|454149854|FG000|Overall Study|Other|3|||
126234327|NCT00264797|454149855|FG001|Overall Study|Other|4|||
126234328|NCT02636907|454149858|FG000|Autoinjector Assessment Period|Adverse Event|2|||
126234329|NCT02636907|454149858|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
126234330|NCT02636907|454149858|FG000|Extension Phase|Adverse Event|2|||
126234331|NCT02636907|454149858|FG000|Extension Phase|Withdrawal by Subject|4|||
126234332|NCT02636907|454149858|FG000|Extension Phase|Physician Decision|1|||
126234333|NCT02636907|454149858|FG000|Extension Phase|Lost to Follow-up|2|||
126234334|NCT02636907|454149858|FG000|Extension Phase|Lack of Efficacy|1|||
126234335|NCT00762086|454149859|FG000|Overall Study|Adverse Event|2|||
126354643|NCT00927082|454589415|FG001|Overall Study|Death|0|||
126234336|NCT00762086|454149860|FG001|Overall Study|Adverse Event|0|||
126234337|NCT00762086|454149859|FG000|Overall Study|Lost to Follow-up|0|||
126234338|NCT00762086|454149860|FG001|Overall Study|Lost to Follow-up|2|||
126234339|NCT00762086|454149859|FG000|Overall Study|Non compliance|1|||
126354644|NCT00927082|454589416|FG002|Overall Study|Death|1|||
126354645|NCT00927082|454589417|FG003|Overall Study|Death|0|||
126354646|NCT00927082|454589414|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
126354647|NCT00927082|454589415|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
126354648|NCT00927082|454589416|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
126354649|NCT00927082|454589417|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
126354650|NCT00317369|454589418|FG000|Overall Study|Adverse Event|2|||
126234340|NCT00762086|454149860|FG001|Overall Study|Non compliance|0|||
126234341|NCT00762086|454149859|FG000|Overall Study|Withdrawal by Subject|2|||
126234342|NCT00762086|454149860|FG001|Overall Study|Withdrawal by Subject|2|||
126234343|NCT00762086|454149859|FG000|Overall Study|Ineligible to participate in the study|1|||
126234344|NCT00762086|454149860|FG001|Overall Study|Ineligible to participate in the study|0|||
126234345|NCT00497796|454149865|FG000|Overall Study|Adverse event (not related)|9|||
126354651|NCT00317369|454589419|FG001|Overall Study|Adverse Event|1|||
126234346|NCT00497796|454149866|FG001|Overall Study|Adverse event (not related)|9|||
126234347|NCT00497796|454149865|FG000|Overall Study|Adverse event (related)|5|||
126234348|NCT00497796|454149866|FG001|Overall Study|Adverse event (related)|4|||
126234349|NCT00497796|454149865|FG000|Overall Study|CMV infection or disease treatment|30|||
126234350|NCT00497796|454149866|FG001|Overall Study|CMV infection or disease treatment|4|||
126234351|NCT00497796|454149865|FG000|Overall Study|Consent withdrawn|10|||
126234352|NCT00497796|454149866|FG001|Overall Study|Consent withdrawn|3|||
126234353|NCT00497796|454149865|FG000|Overall Study|Investigator/sponsor discretion|31|||
126234354|NCT00497796|454149866|FG001|Overall Study|Investigator/sponsor discretion|34|||
126234355|NCT00497796|454149865|FG000|Overall Study|Lost to Follow-up|0|||
126023292|NCT02590432|453380677|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126023293|NCT02590432|453380678|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126234356|NCT00497796|454149866|FG001|Overall Study|Lost to Follow-up|1|||
126234357|NCT00497796|454149865|FG000|Overall Study|Not applicable (randomized not treated)|0|||
126234358|NCT00497796|454149866|FG001|Overall Study|Not applicable (randomized not treated)|4|||
126234359|NCT01074554|454149867|FG000|Overall Study|Adverse Event|3|||
126234360|NCT01074554|454149868|FG001|Overall Study|Adverse Event|3|||
126234361|NCT01074554|454149867|FG000|Overall Study|Lost to Follow-up|0|||
126234362|NCT01074554|454149868|FG001|Overall Study|Lost to Follow-up|1|||
126234363|NCT04276883|454149869|FG000|Overall Study|Withdrawal by Subject|2|||
126234364|NCT04276883|454149870|FG001|Overall Study|Withdrawal by Subject|3|||
126234365|NCT04276883|454149871|FG002|Overall Study|Withdrawal by Subject|6|||
126234366|NCT04276883|454149869|FG000|Overall Study|Lost to Follow-up|1|||
126234367|NCT04276883|454149870|FG001|Overall Study|Lost to Follow-up|3|||
126234368|NCT04276883|454149871|FG002|Overall Study|Lost to Follow-up|0|||
126234369|NCT04276883|454149869|FG000|Overall Study|Adverse Event|0|||
126234370|NCT04276883|454149870|FG001|Overall Study|Adverse Event|1|||
126234371|NCT04276883|454149871|FG002|Overall Study|Adverse Event|0|||
126234372|NCT04276883|454149869|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
126234373|NCT04276883|454149870|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
126234374|NCT04276883|454149871|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
126234375|NCT01876706|454149872|FG000|Overall Study|BPH Intervention|9|||
126234376|NCT01876706|454149872|FG000|Overall Study|Lost to Follow-up|7|||
126234377|NCT01876706|454149872|FG000|Overall Study|Withdrawals|6|||
126234378|NCT01876706|454149872|FG000|Overall Study|Death|3|||
126234379|NCT01370408|454149876|FG000|Overall Study|treatment failure|9|||
126234380|NCT02073643|454149878|FG000|Overall Study|Lost to Follow-up|24|||
126234381|NCT01062256|454149881|FG000|Overall Study|Adverse Event|1|||
126234382|NCT01062256|454149882|FG001|Overall Study|Adverse Event|0|||
126234383|NCT01062256|454149883|FG002|Overall Study|Adverse Event|0|||
126234384|NCT01062256|454149881|FG000|Overall Study|Withdrawal by Subject|1|||
126234385|NCT01062256|454149882|FG001|Overall Study|Withdrawal by Subject|1|||
126234386|NCT01062256|454149883|FG002|Overall Study|Withdrawal by Subject|1|||
126234387|NCT01062256|454149881|FG000|Overall Study|Ineligible|1|||
126234388|NCT01062256|454149882|FG001|Overall Study|Ineligible|4|||
126234389|NCT01062256|454149883|FG002|Overall Study|Ineligible|3|||
126234390|NCT01062256|454149881|FG000|Overall Study|Administrative|0|||
126234391|NCT01062256|454149882|FG001|Overall Study|Administrative|2|||
126234392|NCT01062256|454149883|FG002|Overall Study|Administrative|0|||
126234393|NCT03049488|454149884|FG000|Overall Study|Lost to Follow-up|1|||
126234394|NCT03049488|454149885|FG001|Overall Study|Lost to Follow-up|1|||
126234395|NCT03049488|454149886|FG002|Overall Study|Lost to Follow-up|0|||
126234396|NCT03049488|454149887|FG003|Overall Study|Lost to Follow-up|0|||
126046473|NCT02467270|453468226|FG000|Overall Study|Physician Decision|0|||
126234397|NCT03049488|454149888|FG004|Overall Study|Lost to Follow-up|0|||
126234398|NCT03049488|454149889|FG005|Overall Study|Lost to Follow-up|0|||
126234399|NCT03049488|454149884|FG000|Overall Study|Moved from Area|1|||
126234400|NCT03049488|454149885|FG001|Overall Study|Moved from Area|0|||
126234401|NCT03049488|454149886|FG002|Overall Study|Moved from Area|0|||
126234402|NCT03049488|454149887|FG003|Overall Study|Moved from Area|1|||
126234403|NCT03049488|454149888|FG004|Overall Study|Moved from Area|1|||
126234404|NCT03049488|454149889|FG005|Overall Study|Moved from Area|0|||
126234405|NCT03049488|454149884|FG000|Overall Study|Physician Decision|0|||
126234406|NCT03049488|454149885|FG001|Overall Study|Physician Decision|1|||
126234407|NCT03049488|454149886|FG002|Overall Study|Physician Decision|0|||
126234408|NCT03049488|454149887|FG003|Overall Study|Physician Decision|0|||
126234409|NCT03049488|454149888|FG004|Overall Study|Physician Decision|0|||
126234410|NCT03049488|454149889|FG005|Overall Study|Physician Decision|0|||
126234411|NCT03049488|454149884|FG000|Overall Study|Withdrawal by Subject|0|||
126234412|NCT03049488|454149885|FG001|Overall Study|Withdrawal by Subject|0|||
126234413|NCT03049488|454149886|FG002|Overall Study|Withdrawal by Subject|0|||
126234414|NCT03049488|454149887|FG003|Overall Study|Withdrawal by Subject|1|||
126234415|NCT03049488|454149888|FG004|Overall Study|Withdrawal by Subject|1|||
126234416|NCT03049488|454149889|FG005|Overall Study|Withdrawal by Subject|0|||
126234417|NCT00891293|454149892|FG000|Overall Study|Adverse Event|2|||
126234418|NCT00891293|454149892|FG000|Overall Study|Protocol Violation|2|||
126234419|NCT00891293|454149892|FG000|Overall Study|Laboratory abnormality|4|||
126234420|NCT00891293|454149892|FG000|Overall Study|Lost to Follow-up|7|||
126234421|NCT00891293|454149892|FG000|Overall Study|Subject withdrew consent|7|||
126234422|NCT00891293|454149892|FG000|Overall Study|Sponsor termination|62|||
126234423|NCT03883906|454149896|FG000|Overall Study|Withdrawal by Subject|2|||
126234424|NCT03883906|454149896|FG000|Overall Study|Physician Decision|5|||
126234425|NCT00117949|454149913|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
126234426|NCT00117949|454149914|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
126234427|NCT00117949|454149915|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
126234428|NCT00117949|454149916|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
126234429|NCT00117949|454149913|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
126234430|NCT00117949|454149914|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
126234431|NCT00117949|454149915|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
126234432|NCT00117949|454149916|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
126234433|NCT00117949|454149913|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
126234434|NCT00117949|454149914|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
126234435|NCT00117949|454149915|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
126234436|NCT00117949|454149916|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
126234437|NCT00117949|454149913|FG000|Overall Study|PSA increase >=10ng/mL|0|||
126234438|NCT00117949|454149914|FG001|Overall Study|PSA increase >=10ng/mL|1|||
126234439|NCT00117949|454149915|FG002|Overall Study|PSA increase >=10ng/mL|1|||
126234440|NCT00117949|454149916|FG003|Overall Study|PSA increase >=10ng/mL|0|||
126234441|NCT00117949|454149913|FG000|Overall Study|PSA reduction <=50%|0|||
126234442|NCT00117949|454149914|FG001|Overall Study|PSA reduction <=50%|2|||
126234443|NCT00117949|454149915|FG002|Overall Study|PSA reduction <=50%|2|||
126234444|NCT00117949|454149916|FG003|Overall Study|PSA reduction <=50%|4|||
126234445|NCT00117949|454149913|FG000|Overall Study|Hepatic abnormalities|0|||
126234446|NCT00117949|454149914|FG001|Overall Study|Hepatic abnormalities|1|||
126234447|NCT00117949|454149915|FG002|Overall Study|Hepatic abnormalities|0|||
126234448|NCT00117949|454149916|FG003|Overall Study|Hepatic abnormalities|1|||
126234449|NCT00841100|454149920|FG000|Phase 1 (28 Days)|Adverse Event|1|||
126234450|NCT00841100|454149920|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
126234451|NCT01355081|454149921|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
126234452|NCT01355081|454149922|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
126234453|NCT01355081|454149923|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
126234454|NCT01355081|454149921|FG000|Overall Study|Major Protocol Deviation|0|||
126234455|NCT01355081|454149922|FG001|Overall Study|Major Protocol Deviation|1|||
126234456|NCT01355081|454149923|FG002|Overall Study|Major Protocol Deviation|0|||
126234457|NCT01355081|454149921|FG000|Overall Study|Lost to Follow-up|0|||
126234458|NCT01355081|454149922|FG001|Overall Study|Lost to Follow-up|0|||
126234459|NCT01355081|454149923|FG002|Overall Study|Lost to Follow-up|1|||
126234460|NCT01355081|454149921|FG000|Overall Study|Withdrawal of Consent|2|||
126234461|NCT01355081|454149922|FG001|Overall Study|Withdrawal of Consent|3|||
126234462|NCT01355081|454149923|FG002|Overall Study|Withdrawal of Consent|3|||
126234463|NCT01355081|454149921|FG000|Overall Study|Lack of Efficacy|2|||
126234464|NCT01355081|454149922|FG001|Overall Study|Lack of Efficacy|1|||
126234465|NCT01355081|454149923|FG002|Overall Study|Lack of Efficacy|1|||
126234466|NCT01355081|454149921|FG000|Overall Study|Non Compliance with Study Medication|0|||
126234467|NCT01355081|454149922|FG001|Overall Study|Non Compliance with Study Medication|1|||
126234468|NCT01355081|454149923|FG002|Overall Study|Non Compliance with Study Medication|0|||
126234469|NCT01475474|454149924|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
126234470|NCT01475474|454149924|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
126234471|NCT01868009|454149927|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
126234472|NCT01868009|454149928|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
126234473|NCT01868009|454149927|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
126234474|NCT01868009|454149928|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
126234475|NCT01868009|454149927|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
126234476|NCT01868009|454149928|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
126234477|NCT04803357|454149931|FG000|Overall Study|Withdrawal by Subject|31|||
126354652|NCT00317369|454589420|FG002|Overall Study|Adverse Event|0|||
126354653|NCT00317369|454589418|FG000|Overall Study|Lack of Efficacy|0|||
126354654|NCT00317369|454589419|FG001|Overall Study|Lack of Efficacy|1|||
126234478|NCT04803357|454149932|FG001|Overall Study|Withdrawal by Subject|5|||
126234479|NCT01046253|454149935|FG000|Second Intervention|Adverse Event|0|||
126234480|NCT01046253|454149936|FG001|Second Intervention|Adverse Event|1|||
126234481|NCT01046253|454149935|FG000|Second Intervention|Protocol Violation|0|||
126354655|NCT00317369|454589420|FG002|Overall Study|Lack of Efficacy|1|||
126354656|NCT00317369|454589418|FG000|Overall Study|Withdrawal by Subject|0|||
126354657|NCT00317369|454589419|FG001|Overall Study|Withdrawal by Subject|0|||
126234482|NCT01046253|454149936|FG001|Second Intervention|Protocol Violation|1|||
126234483|NCT02339909|454149937|FG000|Overall Study|Became ineligible after randomisation|89|||
126234484|NCT02339909|454149938|FG001|Overall Study|Became ineligible after randomisation|63|||
126234485|NCT02339909|454149939|FG002|Overall Study|Became ineligible after randomisation|71|||
126354658|NCT00317369|454589420|FG002|Overall Study|Withdrawal by Subject|1|||
126354659|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
126354660|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
126234486|NCT00860028|454149942|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
126234487|NCT00860028|454149943|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
126234488|NCT01658943|454149945|FG000|Overall Study|Adverse Event|6|||
126234489|NCT01658943|454149946|FG001|Overall Study|Adverse Event|13|||
126234490|NCT01658943|454149945|FG000|Overall Study|Withdrawal by Subject|9|||
126234491|NCT01658943|454149946|FG001|Overall Study|Withdrawal by Subject|2|||
126234492|NCT01658943|454149945|FG000|Overall Study|Progression/Relapse|39|||
126234493|NCT01658943|454149946|FG001|Overall Study|Progression/Relapse|40|||
126234494|NCT01658943|454149945|FG000|Overall Study|Death|4|||
126234495|NCT01658943|454149946|FG001|Overall Study|Death|2|||
126234496|NCT01658943|454149945|FG000|Overall Study|not protocol specified|4|||
126234497|NCT01658943|454149946|FG001|Overall Study|not protocol specified|1|||
126234498|NCT01658943|454149945|FG000|Overall Study|Not eligible|7|||
126234499|NCT01658943|454149946|FG001|Overall Study|Not eligible|9|||
126234500|NCT01658943|454149945|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
126234501|NCT01658943|454149946|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
126234502|NCT03144687|454149948|FG000|Overall Study|Death|0|||
126234503|NCT03144687|454149949|FG001|Overall Study|Death|2|||
126234504|NCT03144687|454149948|FG000|Overall Study|Lost to Follow-up|0|||
126234505|NCT03144687|454149949|FG001|Overall Study|Lost to Follow-up|1|||
126234506|NCT03144687|454149948|FG000|Overall Study|Physician Decision|0|||
126234507|NCT03144687|454149949|FG001|Overall Study|Physician Decision|1|||
126234508|NCT03144687|454149948|FG000|Overall Study|Withdrawal by Subject|1|||
126234509|NCT03144687|454149949|FG001|Overall Study|Withdrawal by Subject|3|||
126234510|NCT03144687|454149948|FG000|Overall Study|Not Reported|2|||
126234511|NCT03144687|454149949|FG001|Overall Study|Not Reported|0|||
126234512|NCT01494506|454152086|FG000|Overall Study|Lack of Efficacy|77|||
126234513|NCT01494506|454152087|FG001|Overall Study|Lack of Efficacy|83|||
126234514|NCT01494506|454152088|FG002|Overall Study|Lack of Efficacy|57|||
126234515|NCT01494506|454152086|FG000|Overall Study|Adverse Event|17|||
126234516|NCT01494506|454152087|FG001|Overall Study|Adverse Event|10|||
126234517|NCT01494506|454152088|FG002|Overall Study|Adverse Event|11|||
126234518|NCT01494506|454152086|FG000|Overall Study|Death|9|||
126234519|NCT01494506|454152087|FG001|Overall Study|Death|5|||
126234520|NCT01494506|454152088|FG002|Overall Study|Death|2|||
126234521|NCT01494506|454152086|FG000|Overall Study|Physician Decision|7|||
126234522|NCT01494506|454152087|FG001|Overall Study|Physician Decision|5|||
126234523|NCT01494506|454152088|FG002|Overall Study|Physician Decision|4|||
126234524|NCT01494506|454152086|FG000|Overall Study|Withdrawal by Subject|17|||
126234525|NCT01494506|454152087|FG001|Overall Study|Withdrawal by Subject|20|||
126234526|NCT01494506|454152088|FG002|Overall Study|Withdrawal by Subject|14|||
126234527|NCT01494506|454152086|FG000|Overall Study|Clinical Deterioration|21|||
126234528|NCT01494506|454152087|FG001|Overall Study|Clinical Deterioration|17|||
126234529|NCT01494506|454152088|FG002|Overall Study|Clinical Deterioration|13|||
126234530|NCT01494506|454152086|FG000|Overall Study|Sponsor Decision|0|||
126234531|NCT01494506|454152087|FG001|Overall Study|Sponsor Decision|0|||
126234532|NCT01494506|454152088|FG002|Overall Study|Sponsor Decision|1|||
126234533|NCT01494506|454152086|FG000|Overall Study|Other|0|||
126234534|NCT01494506|454152087|FG001|Overall Study|Other|3|||
126234535|NCT01494506|454152088|FG002|Overall Study|Other|1|||
126234536|NCT01492361|454152089|FG000|Overall Study|Withdrawal by Subject|281|||
126234537|NCT01492361|454152090|FG001|Overall Study|Withdrawal by Subject|297|||
126234538|NCT01492361|454152089|FG000|Overall Study|Physician Decision|12|||
126234539|NCT01492361|454152090|FG001|Overall Study|Physician Decision|12|||
126234540|NCT01492361|454152089|FG000|Overall Study|Lost to Follow-up|6|||
126234541|NCT01492361|454152090|FG001|Overall Study|Lost to Follow-up|13|||
126234542|NCT01492361|454152089|FG000|Overall Study|Other than specified above|106|||
126234543|NCT01492361|454152090|FG001|Overall Study|Other than specified above|138|||
126234544|NCT03444038|454152091|FG000|Overall Study|Adverse Event|12|||
126234545|NCT03444038|454152091|FG000|Overall Study|Withdrawal by Subject|7|||
126234546|NCT03444038|454152091|FG000|Overall Study|Lost to Follow-up|1|||
126234547|NCT03444038|454152091|FG000|Overall Study|Physician Decision|2|||
126234548|NCT03444038|454152091|FG000|Overall Study|Lack of Efficacy|7|||
126234549|NCT00543309|454152092|FG000|Overall Study|Physician Decision|0|||
126234550|NCT00543309|454152093|FG001|Overall Study|Physician Decision|1|||
126234551|NCT00543309|454152094|FG002|Overall Study|Physician Decision|0|||
126234552|NCT02143102|454152097|FG000|Overall Study|Lost to Follow-up|11|||
126234553|NCT02143102|454152098|FG001|Overall Study|Lost to Follow-up|0|||
126234554|NCT03247556|454152103|FG000|Overall Study|Adverse Event|1|||
126234555|NCT03247556|454152104|FG001|Overall Study|Adverse Event|4|||
126234556|NCT03247556|454152105|FG002|Overall Study|Adverse Event|5|||
126234557|NCT03247556|454152103|FG000|Overall Study|Lost to Follow-up|5|||
126234558|NCT03247556|454152104|FG001|Overall Study|Lost to Follow-up|5|||
126234559|NCT03247556|454152105|FG002|Overall Study|Lost to Follow-up|4|||
126234560|NCT03247556|454152103|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
126234561|NCT03247556|454152104|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
126234562|NCT03247556|454152105|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
126234563|NCT03247556|454152103|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
126234564|NCT03247556|454152104|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
126234565|NCT03247556|454152105|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
126234566|NCT03247556|454152103|FG000|Overall Study|Protocol Violation|2|||
126234567|NCT03247556|454152104|FG001|Overall Study|Protocol Violation|0|||
126234568|NCT03247556|454152105|FG002|Overall Study|Protocol Violation|1|||
126234569|NCT03247556|454152103|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
126234570|NCT03247556|454152104|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
126046474|NCT02467270|453468227|FG001|Overall Study|Physician Decision|4|||
126234571|NCT03247556|454152105|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
126234572|NCT01203878|454152106|FG000|Overall Study|Withdrawal by Subject|0|||
126234573|NCT01203878|454152107|FG001|Overall Study|Withdrawal by Subject|0|||
126234574|NCT01203878|454152108|FG002|Overall Study|Withdrawal by Subject|1|||
126234575|NCT01203878|454152106|FG000|Overall Study|Adverse Event|0|||
126234576|NCT01203878|454152107|FG001|Overall Study|Adverse Event|0|||
126234577|NCT01203878|454152108|FG002|Overall Study|Adverse Event|2|||
126234578|NCT01682083|454152109|FG000|Overall Study|Lost to Follow-up|11|||
126234579|NCT01682083|454152110|FG001|Overall Study|Lost to Follow-up|18|||
126234580|NCT01682083|454152109|FG000|Overall Study|Withdrawal by Subject|31|||
126234581|NCT01682083|454152110|FG001|Overall Study|Withdrawal by Subject|40|||
126234582|NCT01682083|454152109|FG000|Overall Study|Death|60|||
126234583|NCT01682083|454152110|FG001|Overall Study|Death|93|||
126234584|NCT01682083|454152109|FG000|Overall Study|Physician Decision|5|||
126234585|NCT01682083|454152110|FG001|Overall Study|Physician Decision|4|||
126234586|NCT03952143|454152111|FG000|Lead-In Period|Adverse Event|2|||
126234587|NCT03952143|454152112|FG001|Lead-In Period|Adverse Event|0|||
126234588|NCT03952143|454152113|FG002|Lead-In Period|Adverse Event|0|||
126234589|NCT03952143|454152111|FG000|Lead-In Period|Lack of Efficacy|2|||
126234590|NCT03952143|454152112|FG001|Lead-In Period|Lack of Efficacy|0|||
126234591|NCT03952143|454152113|FG002|Lead-In Period|Lack of Efficacy|0|||
126234592|NCT03952143|454152111|FG000|Lead-In Period|Physician Decision|5|||
126234593|NCT03952143|454152112|FG001|Lead-In Period|Physician Decision|0|||
126234594|NCT03952143|454152113|FG002|Lead-In Period|Physician Decision|0|||
126234595|NCT03952143|454152111|FG000|Lead-In Period|Protocol Violation|5|||
126234596|NCT03952143|454152112|FG001|Lead-In Period|Protocol Violation|0|||
126234597|NCT03952143|454152113|FG002|Lead-In Period|Protocol Violation|0|||
126234598|NCT03952143|454152111|FG000|Lead-In Period|Withdrawal by Subject|19|||
126234599|NCT03952143|454152112|FG001|Lead-In Period|Withdrawal by Subject|0|||
126234600|NCT03952143|454152113|FG002|Lead-In Period|Withdrawal by Subject|0|||
126234601|NCT03952143|454152111|FG000|Treatment Period|Adverse Event|0|||
126234602|NCT03952143|454152112|FG001|Treatment Period|Adverse Event|0|||
126234603|NCT03952143|454152113|FG002|Treatment Period|Adverse Event|1|||
126234604|NCT03952143|454152111|FG000|Treatment Period|Lost to Follow-up|0|||
126234605|NCT03952143|454152112|FG001|Treatment Period|Lost to Follow-up|2|||
126234606|NCT03952143|454152113|FG002|Treatment Period|Lost to Follow-up|0|||
126234607|NCT03952143|454152111|FG000|Treatment Period|Physician Decision|0|||
126234608|NCT03952143|454152112|FG001|Treatment Period|Physician Decision|0|||
126234609|NCT03952143|454152113|FG002|Treatment Period|Physician Decision|2|||
126234610|NCT03952143|454152111|FG000|Treatment Period|Protocol Violation|0|||
126234611|NCT03952143|454152112|FG001|Treatment Period|Protocol Violation|0|||
126234612|NCT03952143|454152113|FG002|Treatment Period|Protocol Violation|1|||
126234613|NCT03952143|454152111|FG000|Treatment Period|Withdrawal by Subject|0|||
126234614|NCT03952143|454152112|FG001|Treatment Period|Withdrawal by Subject|5|||
126234615|NCT03952143|454152113|FG002|Treatment Period|Withdrawal by Subject|26|||
126234616|NCT03952143|454152111|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
126234617|NCT03952143|454152112|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
126234618|NCT03952143|454152113|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
126234619|NCT03952143|454152111|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
126234620|NCT03952143|454152112|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
126234621|NCT03952143|454152113|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
126234622|NCT01866319|454152114|FG000|Overall Study|Adverse Event|12|||
126234623|NCT01866319|454152115|FG001|Overall Study|Adverse Event|5|||
126234624|NCT01866319|454152116|FG002|Overall Study|Adverse Event|9|||
126234625|NCT01866319|454152114|FG000|Overall Study|Clinical progression|3|||
126234626|NCT01866319|454152115|FG001|Overall Study|Clinical progression|2|||
126234627|NCT01866319|454152116|FG002|Overall Study|Clinical progression|2|||
126234628|NCT01866319|454152114|FG000|Overall Study|Death|153|||
126234629|NCT01866319|454152115|FG001|Overall Study|Death|154|||
126234630|NCT01866319|454152116|FG002|Overall Study|Death|147|||
126234631|NCT01866319|454152114|FG000|Overall Study|Lost to Follow-up|6|||
126234632|NCT01866319|454152115|FG001|Overall Study|Lost to Follow-up|3|||
126234633|NCT01866319|454152116|FG002|Overall Study|Lost to Follow-up|8|||
126234634|NCT01866319|454152114|FG000|Overall Study|Physician Decision|1|||
126234635|NCT01866319|454152115|FG001|Overall Study|Physician Decision|0|||
126234636|NCT01866319|454152116|FG002|Overall Study|Physician Decision|1|||
126234637|NCT01866319|454152114|FG000|Overall Study|Protocol Violation|0|||
126234638|NCT01866319|454152115|FG001|Overall Study|Protocol Violation|0|||
126234639|NCT01866319|454152116|FG002|Overall Study|Protocol Violation|1|||
126234640|NCT01866319|454152114|FG000|Overall Study|Withdrawal by Subject|32|||
126234641|NCT01866319|454152115|FG001|Overall Study|Withdrawal by Subject|14|||
126234642|NCT01866319|454152116|FG002|Overall Study|Withdrawal by Subject|12|||
126234643|NCT03980483|454152120|FG000|Overall Study|Adverse Event|13|||
126234644|NCT03980483|454152121|FG001|Overall Study|Adverse Event|29|||
126234645|NCT03980483|454152122|FG002|Overall Study|Adverse Event|11|||
126234646|NCT03980483|454152123|FG003|Overall Study|Adverse Event|2|||
126234647|NCT03980483|454152124|FG004|Overall Study|Adverse Event|2|||
126234648|NCT03980483|454152125|FG005|Overall Study|Adverse Event|2|||
126234649|NCT03980483|454152120|FG000|Overall Study|Lack of Efficacy|7|||
126234650|NCT03980483|454152121|FG001|Overall Study|Lack of Efficacy|6|||
126234651|NCT03980483|454152122|FG002|Overall Study|Lack of Efficacy|0|||
126234652|NCT03980483|454152123|FG003|Overall Study|Lack of Efficacy|3|||
126234653|NCT03980483|454152124|FG004|Overall Study|Lack of Efficacy|1|||
126234654|NCT03980483|454152125|FG005|Overall Study|Lack of Efficacy|1|||
126234655|NCT03980483|454152120|FG000|Overall Study|Lost to Follow-up|2|||
126234656|NCT03980483|454152121|FG001|Overall Study|Lost to Follow-up|4|||
126234657|NCT03980483|454152122|FG002|Overall Study|Lost to Follow-up|2|||
126234658|NCT03980483|454152123|FG003|Overall Study|Lost to Follow-up|1|||
126234659|NCT03980483|454152124|FG004|Overall Study|Lost to Follow-up|2|||
126234660|NCT03980483|454152125|FG005|Overall Study|Lost to Follow-up|0|||
126234661|NCT03980483|454152120|FG000|Overall Study|Protocol Violation|4|||
126234662|NCT03980483|454152121|FG001|Overall Study|Protocol Violation|2|||
126234663|NCT03980483|454152122|FG002|Overall Study|Protocol Violation|1|||
126234664|NCT03980483|454152123|FG003|Overall Study|Protocol Violation|1|||
126234665|NCT03980483|454152124|FG004|Overall Study|Protocol Violation|0|||
126234666|NCT03980483|454152125|FG005|Overall Study|Protocol Violation|0|||
126234667|NCT03980483|454152120|FG000|Overall Study|Physician Decision|14|||
126234668|NCT03980483|454152121|FG001|Overall Study|Physician Decision|10|||
126234669|NCT03980483|454152122|FG002|Overall Study|Physician Decision|7|||
126234670|NCT03980483|454152123|FG003|Overall Study|Physician Decision|4|||
126234671|NCT03980483|454152124|FG004|Overall Study|Physician Decision|4|||
126234672|NCT03980483|454152125|FG005|Overall Study|Physician Decision|2|||
126234673|NCT03980483|454152120|FG000|Overall Study|Withdrawal by Subject|38|||
126234674|NCT03980483|454152121|FG001|Overall Study|Withdrawal by Subject|21|||
126234675|NCT03980483|454152122|FG002|Overall Study|Withdrawal by Subject|15|||
126234676|NCT03980483|454152123|FG003|Overall Study|Withdrawal by Subject|5|||
126234677|NCT03980483|454152124|FG004|Overall Study|Withdrawal by Subject|3|||
126234678|NCT03980483|454152125|FG005|Overall Study|Withdrawal by Subject|4|||
126234679|NCT03980483|454152120|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
126234680|NCT03980483|454152121|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126234681|NCT03980483|454152122|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126234682|NCT03980483|454152123|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126234683|NCT03980483|454152124|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126234684|NCT03980483|454152125|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126234685|NCT03980483|454152120|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126234686|NCT03980483|454152121|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
126234687|NCT03980483|454152122|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126234688|NCT03980483|454152123|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126234689|NCT03980483|454152124|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126234690|NCT03980483|454152125|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126234691|NCT03980483|454152120|FG000|Overall Study|Other|0|||
126234692|NCT03980483|454152121|FG001|Overall Study|Other|1|||
126234693|NCT03980483|454152122|FG002|Overall Study|Other|0|||
126234694|NCT03980483|454152123|FG003|Overall Study|Other|0|||
126234695|NCT03980483|454152124|FG004|Overall Study|Other|0|||
126234696|NCT03980483|454152125|FG005|Overall Study|Other|0|||
126234697|NCT00760266|454152128|FG000|Overall Study|Adverse Event|13|||
126234698|NCT00760266|454152129|FG001|Overall Study|Adverse Event|7|||
126234699|NCT00760266|454152128|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126234700|NCT00760266|454152129|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126234701|NCT00760266|454152128|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126234702|NCT00760266|454152129|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126234703|NCT00760266|454152128|FG000|Overall Study|Lack of Efficacy|2|||
126234704|NCT00760266|454152129|FG001|Overall Study|Lack of Efficacy|2|||
126234705|NCT00760266|454152128|FG000|Overall Study|Protocol deviation|2|||
126234706|NCT00760266|454152129|FG001|Overall Study|Protocol deviation|4|||
126234707|NCT00760266|454152128|FG000|Overall Study|Patient withdrew consent|3|||
126234708|NCT00760266|454152129|FG001|Overall Study|Patient withdrew consent|3|||
126234709|NCT00760266|454152128|FG000|Overall Study|Lost to Follow-up|2|||
126234710|NCT00760266|454152129|FG001|Overall Study|Lost to Follow-up|1|||
126234711|NCT00760266|454152128|FG000|Overall Study|Administrative Problems|0|||
126023294|NCT02590432|453380679|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126234712|NCT00760266|454152129|FG001|Overall Study|Administrative Problems|1|||
126234713|NCT01225146|454152130|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
126023295|NCT02590432|453380680|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126234714|NCT01225146|454152131|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
126234715|NCT00659607|454152134|FG000|Overall Study|No blood pressure recorded|147|||
126234716|NCT00659607|454152134|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
126234717|NCT00659607|454152134|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
126354661|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
126023296|NCT02590432|453380681|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126234718|NCT00659607|454152134|FG000|Overall Study|No recorded efficacy data|15|||
126234719|NCT00659607|454152134|FG000|Overall Study|Inconsistent BP measuring date|2|||
126234720|NCT02191891|454152135|FG000|Overall Study|Withdrawal by Subject|0|||
126234721|NCT02191891|454152136|FG001|Overall Study|Withdrawal by Subject|1|||
126234722|NCT02191891|454152137|FG002|Overall Study|Withdrawal by Subject|0|||
126234723|NCT02191891|454152138|FG003|Overall Study|Withdrawal by Subject|0|||
126234724|NCT02191891|454152139|FG004|Overall Study|Withdrawal by Subject|1|||
126234725|NCT02191891|454152135|FG000|Overall Study|Adverse Event|0|||
126234726|NCT02191891|454152136|FG001|Overall Study|Adverse Event|1|||
126234727|NCT02191891|454152137|FG002|Overall Study|Adverse Event|0|||
126234728|NCT02191891|454152138|FG003|Overall Study|Adverse Event|0|||
126234729|NCT02191891|454152139|FG004|Overall Study|Adverse Event|2|||
126234730|NCT02191891|454152135|FG000|Overall Study|Disease Progression|4|||
126234731|NCT02191891|454152136|FG001|Overall Study|Disease Progression|10|||
126234732|NCT02191891|454152137|FG002|Overall Study|Disease Progression|4|||
126234733|NCT02191891|454152138|FG003|Overall Study|Disease Progression|2|||
126234734|NCT02191891|454152139|FG004|Overall Study|Disease Progression|7|||
126234735|NCT00486837|454152140|FG000|Overall Study|Withdrawal by Subject|1|||
126234736|NCT00486837|454152141|FG001|Overall Study|Withdrawal by Subject|0|||
126234737|NCT00486837|454152140|FG000|Overall Study|Adverse Event|1|||
126234738|NCT00486837|454152141|FG001|Overall Study|Adverse Event|1|||
126234739|NCT00486837|454152140|FG000|Overall Study|Protocol Violation|4|||
126234740|NCT00486837|454152141|FG001|Overall Study|Protocol Violation|2|||
126234741|NCT00486837|454152140|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
126234742|NCT00486837|454152141|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
126234743|NCT02468778|454152142|FG000|Overall Study|Death|2|||
126234744|NCT02468778|454152143|FG001|Overall Study|Death|1|||
126234745|NCT02468778|454152144|FG002|Overall Study|Death|0|||
126234746|NCT02468778|454152142|FG000|Overall Study|Lost to Follow-up|1|||
126234747|NCT02468778|454152143|FG001|Overall Study|Lost to Follow-up|2|||
126234748|NCT02468778|454152144|FG002|Overall Study|Lost to Follow-up|2|||
126234749|NCT02468778|454152142|FG000|Overall Study|Withdrawal by Subject|0|||
126234750|NCT02468778|454152143|FG001|Overall Study|Withdrawal by Subject|1|||
126234751|NCT02468778|454152144|FG002|Overall Study|Withdrawal by Subject|1|||
126234752|NCT03130699|454152152|FG000|Overall Study|Lost to Follow-up|34|||
126234753|NCT03130699|454152153|FG001|Overall Study|Lost to Follow-up|37|||
126234754|NCT03130699|454152154|FG002|Overall Study|Lost to Follow-up|26|||
126234755|NCT03130699|454152152|FG000|Overall Study|Withdrawal by Subject|5|||
126234756|NCT03130699|454152153|FG001|Overall Study|Withdrawal by Subject|1|||
126234757|NCT03130699|454152154|FG002|Overall Study|Withdrawal by Subject|0|||
126234758|NCT03130699|454152152|FG000|Overall Study|Withdrawal by PI|1|||
126234759|NCT03130699|454152153|FG001|Overall Study|Withdrawal by PI|2|||
126234760|NCT03130699|454152154|FG002|Overall Study|Withdrawal by PI|5|||
126234761|NCT03130699|454152152|FG000|Overall Study|Death|0|||
126234762|NCT03130699|454152153|FG001|Overall Study|Death|0|||
126234763|NCT03130699|454152154|FG002|Overall Study|Death|1|||
126234764|NCT01199861|454152155|FG000|Overall Study|Administrative problems|1|||
126234765|NCT01199861|454152156|FG001|Overall Study|Administrative problems|0|||
126234766|NCT01199861|454152155|FG000|Overall Study|Adverse Event|1|||
126234767|NCT01199861|454152156|FG001|Overall Study|Adverse Event|0|||
126234768|NCT00669864|454152159|FG000|Overall Study|Lost to Follow-up|2|||
126234769|NCT00669864|454152159|FG000|Overall Study|Protocol Violation|2|||
126234770|NCT00669864|454152159|FG000|Overall Study|Withdrawal by Subject|3|||
126234771|NCT00669864|454152159|FG000|Overall Study|Other|2|||
126234772|NCT00680121|454152165|FG000|Overall Study|Lost to Follow-up|27|||
126234773|NCT00680121|454152166|FG001|Overall Study|Lost to Follow-up|23|||
126234774|NCT02545998|454152175|FG000|Overall Study|Lost to Follow-up|12|||
126234775|NCT02545998|454152176|FG001|Overall Study|Lost to Follow-up|3|||
126234776|NCT02545998|454152175|FG000|Overall Study|Withdrawal by Subject|3|||
126234777|NCT02545998|454152176|FG001|Overall Study|Withdrawal by Subject|2|||
126234778|NCT01226797|454152182|FG000|Overall Study|Adverse Event|1|||
126234779|NCT01226797|454152183|FG001|Overall Study|Adverse Event|0|||
126234780|NCT01226797|454152182|FG000|Overall Study|No longer willing to participate|1|||
126234781|NCT01226797|454152183|FG001|Overall Study|No longer willing to participate|0|||
126234782|NCT01226797|454152182|FG000|Overall Study|Protocol Violation|0|||
126234783|NCT01226797|454152183|FG001|Overall Study|Protocol Violation|1|||
126234784|NCT01318499|454152184|FG000|Overall Study|Adverse Event|16|||
126234785|NCT01318499|454152185|FG001|Overall Study|Adverse Event|11|||
126234786|NCT01318499|454152186|FG002|Overall Study|Adverse Event|6|||
126234787|NCT01318499|454152184|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
126234788|NCT01318499|454152185|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
126234789|NCT01318499|454152186|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
126234790|NCT01318499|454152184|FG000|Overall Study|Noncompliance|2|||
126234791|NCT01318499|454152185|FG001|Overall Study|Noncompliance|3|||
126234792|NCT01318499|454152186|FG002|Overall Study|Noncompliance|0|||
126234793|NCT01318499|454152184|FG000|Overall Study|Treatment Failure|19|||
126234794|NCT01318499|454152185|FG001|Overall Study|Treatment Failure|19|||
126234795|NCT01318499|454152186|FG002|Overall Study|Treatment Failure|101|||
126234796|NCT01318499|454152184|FG000|Overall Study|Protocol Violation|2|||
126234797|NCT01318499|454152185|FG001|Overall Study|Protocol Violation|4|||
126234798|NCT01318499|454152186|FG002|Overall Study|Protocol Violation|2|||
126234799|NCT01318499|454152184|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
126234800|NCT01318499|454152185|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
126234801|NCT01318499|454152186|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
126234802|NCT01318499|454152184|FG000|Overall Study|Other|7|||
126234803|NCT01318499|454152185|FG001|Overall Study|Other|10|||
126234804|NCT01318499|454152186|FG002|Overall Study|Other|22|||
126234805|NCT04977336|454152190|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
126234806|NCT04977336|454152191|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126234807|NCT04977336|454152192|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126234808|NCT04977336|454152193|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
126234809|NCT04977336|454152194|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
126234810|NCT04977336|454152190|FG000|Overall Study|Lost to Follow-up|0|||
126234811|NCT04977336|454152191|FG001|Overall Study|Lost to Follow-up|0|||
126234812|NCT04977336|454152192|FG002|Overall Study|Lost to Follow-up|1|||
126234813|NCT04977336|454152193|FG003|Overall Study|Lost to Follow-up|0|||
126234814|NCT04977336|454152194|FG004|Overall Study|Lost to Follow-up|0|||
126234815|NCT01347710|454152195|FG000|Overall Study|Withdrawal by Subject|2|||
126234816|NCT01347710|454152195|FG000|Overall Study|Adverse Event|4|||
126234817|NCT01347710|454152195|FG000|Overall Study|Angio or SPECT not completed|18|||
126234818|NCT01347710|454152195|FG000|Overall Study|issue with vitals prior to dosing|1|||
126234819|NCT01347710|454152195|FG000|Overall Study|Lost to Follow-up|1|||
126234820|NCT01347710|454152195|FG000|Overall Study|Physician Decision|2|||
126234821|NCT01347710|454152195|FG000|Overall Study|Other|3|||
126234822|NCT01004172|454152196|FG000|Overall Study|Progressive Disease in CNS Only|16|||
126234823|NCT01004172|454152196|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
126234824|NCT01004172|454152196|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
126234825|NCT01004172|454152196|FG000|Overall Study|Adverse Event|1|||
126234826|NCT01004172|454152196|FG000|Overall Study|Physician Decision|1|||
126234827|NCT01004172|454152196|FG000|Overall Study|Symptomatic Deterioration|2|||
126234828|NCT01606306|454152197|FG000|Overall Study|Lack of Efficacy|2|||
126234829|NCT01606306|454152198|FG001|Overall Study|Lack of Efficacy|1|||
126234830|NCT01606306|454152199|FG002|Overall Study|Lack of Efficacy|4|||
126234831|NCT01606306|454152200|FG003|Overall Study|Lack of Efficacy|4|||
126234832|NCT01606306|454152201|FG004|Overall Study|Lack of Efficacy|1|||
126234833|NCT01606306|454152202|FG005|Overall Study|Lack of Efficacy|2|||
126234834|NCT01606306|454152197|FG000|Overall Study|Adverse Event|1|||
126234835|NCT01606306|454152198|FG001|Overall Study|Adverse Event|0|||
126234836|NCT01606306|454152199|FG002|Overall Study|Adverse Event|1|||
126234837|NCT01606306|454152200|FG003|Overall Study|Adverse Event|1|||
126234838|NCT01606306|454152201|FG004|Overall Study|Adverse Event|2|||
126234839|NCT01606306|454152202|FG005|Overall Study|Adverse Event|0|||
126234840|NCT01606306|454152197|FG000|Overall Study|Lost to Follow-up|7|||
126234841|NCT01606306|454152198|FG001|Overall Study|Lost to Follow-up|4|||
126234842|NCT01606306|454152199|FG002|Overall Study|Lost to Follow-up|5|||
126234843|NCT01606306|454152200|FG003|Overall Study|Lost to Follow-up|4|||
126234844|NCT01606306|454152201|FG004|Overall Study|Lost to Follow-up|3|||
126234845|NCT01606306|454152202|FG005|Overall Study|Lost to Follow-up|5|||
126234846|NCT01606306|454152197|FG000|Overall Study|Withdrawal by Subject|4|||
126234847|NCT01606306|454152198|FG001|Overall Study|Withdrawal by Subject|3|||
126234848|NCT01606306|454152199|FG002|Overall Study|Withdrawal by Subject|4|||
126234849|NCT01606306|454152200|FG003|Overall Study|Withdrawal by Subject|4|||
126234850|NCT01606306|454152201|FG004|Overall Study|Withdrawal by Subject|5|||
126234851|NCT01606306|454152202|FG005|Overall Study|Withdrawal by Subject|4|||
126234852|NCT01606306|454152197|FG000|Overall Study|Physician Decision|1|||
126023297|NCT02590432|453380682|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126023298|NCT02590432|453380674|FG000|Double-blind Treatment Period|Adverse Event|0|||
126023299|NCT02590432|453380675|FG001|Double-blind Treatment Period|Adverse Event|0|||
126023300|NCT02590432|453380676|FG002|Double-blind Treatment Period|Adverse Event|14|||
126023301|NCT02590432|453380677|FG003|Double-blind Treatment Period|Adverse Event|12|||
126023302|NCT02590432|453380678|FG004|Double-blind Treatment Period|Adverse Event|6|||
126023303|NCT02590432|453380679|FG005|Double-blind Treatment Period|Adverse Event|22|||
126046475|NCT02467270|453468228|FG002|Overall Study|Physician Decision|1|||
126234853|NCT01606306|454152198|FG001|Overall Study|Physician Decision|2|||
126234854|NCT01606306|454152199|FG002|Overall Study|Physician Decision|0|||
126234855|NCT01606306|454152200|FG003|Overall Study|Physician Decision|0|||
126234856|NCT01606306|454152201|FG004|Overall Study|Physician Decision|0|||
126234857|NCT01606306|454152202|FG005|Overall Study|Physician Decision|0|||
126234858|NCT00408902|454152205|FG000|Overall Study|Lack of Efficacy|7|||
126234859|NCT00408902|454152205|FG000|Overall Study|Adverse Event|3|||
126234860|NCT00970281|454152206|FG000|Overall Study|Lack of Efficacy|1|||
126234861|NCT00970281|454152207|FG001|Overall Study|Lack of Efficacy|14|||
126234862|NCT00970281|454152206|FG000|Overall Study|Withdrawal by Subject|0|||
126234863|NCT00970281|454152207|FG001|Overall Study|Withdrawal by Subject|1|||
126234864|NCT00970281|454152206|FG000|Overall Study|Physician Decision|1|||
126234865|NCT00970281|454152207|FG001|Overall Study|Physician Decision|1|||
126234866|NCT01139164|454152209|FG000|Overall Study|Withdrawn prior to study start|0|||
126234867|NCT01139164|454152210|FG001|Overall Study|Withdrawn prior to study start|2|||
126234868|NCT01139164|454152211|FG002|Overall Study|Withdrawn prior to study start|0|||
126234869|NCT02003183|454152212|FG000|Overall Study|Lost to Follow-up|0|||
126234870|NCT02003183|454152213|FG001|Overall Study|Lost to Follow-up|2|||
126234871|NCT00878995|454152216|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
126234872|NCT00878995|454152217|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
126234873|NCT01759290|454152218|FG000|Overall Study|Subjects withdrawn consent|5|||
126234874|NCT01759290|454152218|FG000|Overall Study|Physician Decision|2|||
126234875|NCT01759290|454152218|FG000|Overall Study|Death|17|||
126234876|NCT01759290|454152218|FG000|Overall Study|Lost to Follow-up|53|||
126234877|NCT01759290|454152218|FG000|Overall Study|Unknown reason|4|||
126234878|NCT03338972|454152221|FG000|Overall Study|Death|1|||
126234879|NCT03338972|454152222|FG001|Overall Study|Death|1|||
126234880|NCT03338972|454152223|FG002|Overall Study|Death|0|||
126234881|NCT03338972|454152224|FG003|Overall Study|Death|0|||
126234882|NCT03338972|454152221|FG000|Overall Study|Withdrawal by Subject|1|||
126234883|NCT03338972|454152222|FG001|Overall Study|Withdrawal by Subject|0|||
126234884|NCT03338972|454152223|FG002|Overall Study|Withdrawal by Subject|0|||
126234885|NCT03338972|454152224|FG003|Overall Study|Withdrawal by Subject|0|||
126234886|NCT02480764|454152225|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
126234887|NCT02480764|454152226|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
126234888|NCT02480764|454152227|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
126234889|NCT02480764|454152225|FG000|Overall Study|Major Protocol Deviation|1|||
126234890|NCT02480764|454152226|FG001|Overall Study|Major Protocol Deviation|4|||
126234891|NCT02480764|454152227|FG002|Overall Study|Major Protocol Deviation|3|||
126234892|NCT02480764|454152225|FG000|Overall Study|Lost to Follow-up|0|||
126234893|NCT02480764|454152226|FG001|Overall Study|Lost to Follow-up|1|||
126234894|NCT02480764|454152227|FG002|Overall Study|Lost to Follow-up|2|||
126234895|NCT02480764|454152225|FG000|Overall Study|Voluntary Withdrawal|6|||
126234896|NCT02480764|454152226|FG001|Overall Study|Voluntary Withdrawal|5|||
126234897|NCT02480764|454152227|FG002|Overall Study|Voluntary Withdrawal|10|||
126234898|NCT02480764|454152225|FG000|Overall Study|Lack of Efficacy|0|||
126234899|NCT02480764|454152226|FG001|Overall Study|Lack of Efficacy|3|||
126234900|NCT02480764|454152227|FG002|Overall Study|Lack of Efficacy|3|||
126234901|NCT02480764|454152225|FG000|Overall Study|Reason not Specified|0|||
126234902|NCT02480764|454152226|FG001|Overall Study|Reason not Specified|1|||
126234903|NCT02480764|454152227|FG002|Overall Study|Reason not Specified|0|||
126234904|NCT03629249|454152228|FG000|Overall Study|Study terminated by sponsor|197|||
126234905|NCT03629249|454152229|FG001|Overall Study|Study terminated by sponsor|197|||
126234906|NCT03629249|454152230|FG002|Overall Study|Study terminated by sponsor|194|||
126234907|NCT03629249|454152228|FG000|Overall Study|Protocol deviation|0|||
126234908|NCT03629249|454152229|FG001|Overall Study|Protocol deviation|2|||
126234909|NCT03629249|454152230|FG002|Overall Study|Protocol deviation|5|||
126234910|NCT03629249|454152228|FG000|Overall Study|Subject decision|1|||
126234911|NCT03629249|454152229|FG001|Overall Study|Subject decision|1|||
126234912|NCT03629249|454152230|FG002|Overall Study|Subject decision|3|||
126234913|NCT03629249|454152228|FG000|Overall Study|Adverse Event|1|||
126234914|NCT03629249|454152229|FG001|Overall Study|Adverse Event|1|||
126234915|NCT03629249|454152230|FG002|Overall Study|Adverse Event|0|||
126234916|NCT03629249|454152228|FG000|Overall Study|Death|1|||
126234917|NCT03629249|454152229|FG001|Overall Study|Death|0|||
126234918|NCT03629249|454152230|FG002|Overall Study|Death|0|||
126234919|NCT03629249|454152228|FG000|Overall Study|Physician Decision|1|||
126234920|NCT03629249|454152229|FG001|Overall Study|Physician Decision|0|||
126234921|NCT03629249|454152230|FG002|Overall Study|Physician Decision|0|||
126234922|NCT01030965|454152233|FG000|Overall Study|Lack of Efficacy|3|||
126234923|NCT01030965|454152234|FG001|Overall Study|Lack of Efficacy|2|||
126234924|NCT01030965|454152235|FG002|Overall Study|Lack of Efficacy|0|||
126234925|NCT01030965|454152236|FG003|Overall Study|Lack of Efficacy|3|||
126234926|NCT01030965|454152233|FG000|Overall Study|Protocol Violation|1|||
126234927|NCT01030965|454152234|FG001|Overall Study|Protocol Violation|1|||
126234928|NCT01030965|454152235|FG002|Overall Study|Protocol Violation|1|||
126234929|NCT01030965|454152236|FG003|Overall Study|Protocol Violation|1|||
126234930|NCT01030965|454152233|FG000|Overall Study|Adverse Event|0|||
126234931|NCT01030965|454152234|FG001|Overall Study|Adverse Event|1|||
126234932|NCT01030965|454152235|FG002|Overall Study|Adverse Event|2|||
126234933|NCT01030965|454152236|FG003|Overall Study|Adverse Event|1|||
126234934|NCT01030965|454152233|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
126234935|NCT01030965|454152234|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
126234936|NCT01030965|454152235|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
126234937|NCT01030965|454152236|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
126234938|NCT01030965|454152233|FG000|Overall Study|Withdrawal by Subject|0|||
126234939|NCT01030965|454152234|FG001|Overall Study|Withdrawal by Subject|1|||
126234940|NCT01030965|454152235|FG002|Overall Study|Withdrawal by Subject|0|||
126234941|NCT01030965|454152236|FG003|Overall Study|Withdrawal by Subject|2|||
126234942|NCT02097290|454152237|FG000|Overall Study|Death|6|||
126234943|NCT02097290|454152237|FG000|Overall Study|Total Withdrawals|3|||
126234944|NCT02097290|454152237|FG000|Overall Study|Attempt|8|||
126234945|NCT06096168|454152238|FG000|Overall Study|Death|30|||
126234946|NCT06096168|454152238|FG000|Overall Study|Revision|2|||
126234947|NCT01054599|454152241|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
126234948|NCT01054599|454152242|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
126234949|NCT01054599|454152241|FG000|Overall Study|Protocol Violation|1|||
126234950|NCT01054599|454152242|FG001|Overall Study|Protocol Violation|0|||
126234951|NCT01054599|454152241|FG000|Overall Study|Spells/seizure-like episodes|1|||
126234952|NCT01054599|454152242|FG001|Overall Study|Spells/seizure-like episodes|1|||
126234953|NCT01054599|454152241|FG000|Overall Study|Timing/scheduling difficulties|1|||
126234954|NCT01054599|454152242|FG001|Overall Study|Timing/scheduling difficulties|1|||
126234955|NCT01054599|454152241|FG000|Overall Study|Visual impairment, WTAR <80|0|||
126234956|NCT01054599|454152242|FG001|Overall Study|Visual impairment, WTAR <80|1|||
126234957|NCT01054599|454152241|FG000|Overall Study|Lost to Follow-up|0|||
126234958|NCT01054599|454152242|FG001|Overall Study|Lost to Follow-up|2|||
126234959|NCT01054599|454152241|FG000|Overall Study|Adverse Event|0|||
126234960|NCT01054599|454152242|FG001|Overall Study|Adverse Event|1|||
126234961|NCT01054599|454152241|FG000|Overall Study|Withdrawal by Subject|0|||
126234962|NCT01054599|454152242|FG001|Overall Study|Withdrawal by Subject|1|||
126234963|NCT00743197|454152243|FG000|Overall Study|Study terminated due to departure of PI.|1|||
126234964|NCT00743197|454152244|FG001|Overall Study|Study terminated due to departure of PI.|2|||
126234965|NCT01478620|454152245|FG000|Overall Study|Lost to Follow-up|6|||
126234966|NCT00475020|454152246|FG000|Overall Study|Physician Decision|3|||
126234967|NCT00475020|454152246|FG000|Overall Study|Insurance Denial|1|||
126234968|NCT00475020|454152246|FG000|Overall Study|Donor not able to donate the last minute|1|||
126234969|NCT02514174|454152250|FG000|Overall Study|Patient refused to continue medication|1|||
126234970|NCT02514174|454152250|FG000|Overall Study|Adverse Event|2|||
125878742|NCT03175367|452853404|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
126093264|NCT04276415|453634569|FG004|Overall Study|Withdrawal by patient|2|||
126093265|NCT04276415|453634570|FG005|Overall Study|Withdrawal by patient|0|||
126234971|NCT02514174|454152250|FG000|Overall Study|Study closed by sponsor|9|||
126234972|NCT02514174|454152250|FG000|Overall Study|Progressive disease|11|||
126234973|NCT02514174|454152250|FG000|Overall Study|Treatment change|1|||
126234974|NCT02514174|454152250|FG000|Overall Study|Treated off study with Afatinib.|1|||
126234975|NCT02130466|454152253|FG000|Overall Study|Death|4|||
126234976|NCT02130466|454152254|FG001|Overall Study|Death|1|||
126234977|NCT02130466|454152255|FG002|Overall Study|Death|1|||
126234978|NCT02130466|454152256|FG003|Overall Study|Death|3|||
126234979|NCT02130466|454152257|FG004|Overall Study|Death|2|||
126234980|NCT02130466|454152258|FG005|Overall Study|Death|30|||
126234981|NCT02130466|454152259|FG006|Overall Study|Death|45|||
126234982|NCT02130466|454152260|FG007|Overall Study|Death|2|||
126234983|NCT02130466|454152261|FG008|Overall Study|Death|3|||
126234984|NCT02130466|454152262|FG009|Overall Study|Death|4|||
126234985|NCT02130466|454152263|FG010|Overall Study|Death|5|||
126234986|NCT02130466|454152264|FG011|Overall Study|Death|3|||
126234987|NCT02130466|454152265|FG012|Overall Study|Death|11|||
126234988|NCT02130466|454152266|FG013|Overall Study|Death|7|||
126234989|NCT02130466|454152253|FG000|Overall Study|Lost to Follow-up|1|||
126234990|NCT02130466|454152254|FG001|Overall Study|Lost to Follow-up|0|||
126234991|NCT02130466|454152255|FG002|Overall Study|Lost to Follow-up|0|||
126234992|NCT02130466|454152256|FG003|Overall Study|Lost to Follow-up|0|||
126234993|NCT02130466|454152257|FG004|Overall Study|Lost to Follow-up|0|||
126234994|NCT02130466|454152258|FG005|Overall Study|Lost to Follow-up|1|||
126234995|NCT02130466|454152259|FG006|Overall Study|Lost to Follow-up|0|||
126234996|NCT02130466|454152260|FG007|Overall Study|Lost to Follow-up|0|||
126234997|NCT02130466|454152261|FG008|Overall Study|Lost to Follow-up|0|||
126234998|NCT02130466|454152262|FG009|Overall Study|Lost to Follow-up|0|||
126234999|NCT02130466|454152263|FG010|Overall Study|Lost to Follow-up|0|||
126235000|NCT02130466|454152264|FG011|Overall Study|Lost to Follow-up|0|||
126235001|NCT02130466|454152265|FG012|Overall Study|Lost to Follow-up|1|||
126235002|NCT02130466|454152266|FG013|Overall Study|Lost to Follow-up|0|||
126235003|NCT02130466|454152253|FG000|Overall Study|Physician Decision|0|||
126235004|NCT02130466|454152254|FG001|Overall Study|Physician Decision|0|||
126235005|NCT02130466|454152255|FG002|Overall Study|Physician Decision|0|||
126235006|NCT02130466|454152256|FG003|Overall Study|Physician Decision|0|||
126235007|NCT02130466|454152257|FG004|Overall Study|Physician Decision|0|||
126235008|NCT02130466|454152258|FG005|Overall Study|Physician Decision|1|||
126235009|NCT02130466|454152259|FG006|Overall Study|Physician Decision|1|||
126235010|NCT02130466|454152260|FG007|Overall Study|Physician Decision|0|||
126235011|NCT02130466|454152261|FG008|Overall Study|Physician Decision|0|||
126235012|NCT02130466|454152262|FG009|Overall Study|Physician Decision|0|||
126235013|NCT02130466|454152263|FG010|Overall Study|Physician Decision|0|||
126235014|NCT02130466|454152264|FG011|Overall Study|Physician Decision|0|||
126235015|NCT02130466|454152265|FG012|Overall Study|Physician Decision|0|||
126023304|NCT02590432|453380680|FG006|Double-blind Treatment Period|Adverse Event|20|||
126235016|NCT02130466|454152266|FG013|Overall Study|Physician Decision|0|||
126235017|NCT02130466|454152253|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126235018|NCT02130466|454152254|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
126235019|NCT02130466|454152255|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126235020|NCT02130466|454152256|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
126235021|NCT02130466|454152257|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
126235022|NCT02130466|454152258|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
126235023|NCT02130466|454152259|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
126235024|NCT02130466|454152260|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126235025|NCT02130466|454152261|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
126235026|NCT02130466|454152262|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126235027|NCT02130466|454152263|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126235028|NCT02130466|454152264|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
126235029|NCT02130466|454152265|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
126235030|NCT02130466|454152266|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
126235031|NCT02130466|454152253|FG000|Overall Study|Withdrawal by Subject|1|||
126235032|NCT02130466|454152254|FG001|Overall Study|Withdrawal by Subject|0|||
126235033|NCT02130466|454152255|FG002|Overall Study|Withdrawal by Subject|0|||
126235034|NCT02130466|454152256|FG003|Overall Study|Withdrawal by Subject|0|||
126235035|NCT02130466|454152257|FG004|Overall Study|Withdrawal by Subject|0|||
126235036|NCT02130466|454152258|FG005|Overall Study|Withdrawal by Subject|1|||
126354662|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
126354663|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
126354664|NCT00849472|454589421|FG000|Weekly Paclitaxel|Disease Progression|1|||
126354665|NCT00849472|454589421|FG000|Weekly Paclitaxel|Adverse Event|11|||
126354666|NCT00849472|454589421|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
126354667|NCT00849472|454589421|FG000|Weekly Paclitaxel|Physician Decision|3|||
126023305|NCT02590432|453380681|FG007|Double-blind Treatment Period|Adverse Event|0|||
126354668|NCT00849472|454589421|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
126354669|NCT00849472|454589421|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
126023306|NCT02590432|453380682|FG008|Double-blind Treatment Period|Adverse Event|0|||
126235037|NCT02130466|454152259|FG006|Overall Study|Withdrawal by Subject|0|||
126235038|NCT02130466|454152260|FG007|Overall Study|Withdrawal by Subject|0|||
126235039|NCT02130466|454152261|FG008|Overall Study|Withdrawal by Subject|1|||
126235040|NCT02130466|454152262|FG009|Overall Study|Withdrawal by Subject|0|||
126235041|NCT02130466|454152263|FG010|Overall Study|Withdrawal by Subject|0|||
126023307|NCT02590432|453380674|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126235042|NCT02130466|454152264|FG011|Overall Study|Withdrawal by Subject|0|||
126235043|NCT02130466|454152265|FG012|Overall Study|Withdrawal by Subject|0|||
126235044|NCT02130466|454152266|FG013|Overall Study|Withdrawal by Subject|0|||
126235045|NCT04529109|454152267|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
126235046|NCT04529109|454152268|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
126235047|NCT02170688|454152269|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
126235048|NCT02170688|454152270|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
126235049|NCT02170688|454152271|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
126235050|NCT02170688|454152272|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
126235051|NCT02170688|454152273|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
126235052|NCT02170688|454152269|FG000|Overall Study|Full dose not received|0|||
126235053|NCT02170688|454152270|FG001|Overall Study|Full dose not received|1|||
126235054|NCT02170688|454152271|FG002|Overall Study|Full dose not received|0|||
126235055|NCT02170688|454152272|FG003|Overall Study|Full dose not received|0|||
126235056|NCT02170688|454152273|FG004|Overall Study|Full dose not received|0|||
126235057|NCT02170688|454152269|FG000|Overall Study|Physician Decision|0|||
126235058|NCT02170688|454152270|FG001|Overall Study|Physician Decision|0|||
126235059|NCT02170688|454152271|FG002|Overall Study|Physician Decision|1|||
126235060|NCT02170688|454152272|FG003|Overall Study|Physician Decision|0|||
126235061|NCT02170688|454152273|FG004|Overall Study|Physician Decision|0|||
126235062|NCT00444145|454153764|FG000|Overall Study|Withdrawal by Subject|2|||
126235063|NCT00444145|454153764|FG000|Overall Study|Lost to Follow-up|1|||
126235064|NCT00444145|454153764|FG000|Overall Study|non-compliant|11|||
126235065|NCT00444145|454153764|FG000|Overall Study|Screen Failures|5|||
126023308|NCT02590432|453380675|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
126235066|NCT01374919|454153765|FG000|Overall Study|Withdrawal by Subject|2|||
126235067|NCT03100903|454153771|FG000|Overall Study|Withdrawal by Subject|0|||
126235068|NCT03100903|454153772|FG001|Overall Study|Withdrawal by Subject|0|||
126235069|NCT03100903|454153773|FG002|Overall Study|Withdrawal by Subject|1|||
126235070|NCT00433147|454153774|FG000|Overall Study|Adverse Event|0|||
126235071|NCT00433147|454153775|FG001|Overall Study|Adverse Event|1|||
126235072|NCT00433147|454153776|FG002|Overall Study|Adverse Event|0|||
126235073|NCT00433147|454153777|FG003|Overall Study|Adverse Event|0|||
126235074|NCT01882647|454153778|FG000|Overall Study|Lost to Follow-up|2|||
126235075|NCT01882647|454153779|FG001|Overall Study|Lost to Follow-up|2|||
126235076|NCT01882647|454153778|FG000|Overall Study|Withdrawal by Subject|0|||
126235077|NCT01882647|454153779|FG001|Overall Study|Withdrawal by Subject|4|||
126235078|NCT03311646|454153782|FG000|Overall Study|Physician Decision|1|||
126235079|NCT03311646|454153782|FG000|Overall Study|Withdrawal by Subject|5|||
126235080|NCT03311646|454153782|FG000|Overall Study|Lost to Follow-up|5|||
126235081|NCT03311646|454153782|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
126235082|NCT00728949|454153793|FG000|Overall Study|Adverse Event|8|||
126235083|NCT00728949|454153794|FG001|Overall Study|Adverse Event|0|||
126235084|NCT00728949|454153793|FG000|Overall Study|Withdrawal by Subject|2|||
126235085|NCT00728949|454153794|FG001|Overall Study|Withdrawal by Subject|2|||
126235086|NCT00728949|454153793|FG000|Overall Study|Abnormal Lab Results|0|||
126235087|NCT00728949|454153794|FG001|Overall Study|Abnormal Lab Results|2|||
126235088|NCT00728949|454153793|FG000|Overall Study|On treatment at cutoff date|1|||
126235089|NCT00728949|454153794|FG001|Overall Study|On treatment at cutoff date|0|||
126235090|NCT03127137|454153796|FG000|Overall Study|Requested sedation after consent|1|||
126235091|NCT03127137|454153797|FG001|Overall Study|Requested sedation after consent|0|||
126235092|NCT03127137|454153796|FG000|Overall Study|Malfunction in electronic data collection|1|||
126023309|NCT02590432|453380676|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
126235093|NCT03127137|454153797|FG001|Overall Study|Malfunction in electronic data collection|0|||
126235094|NCT03127137|454153796|FG000|Overall Study|Post procedure testing could not be obtained|0|||
126235095|NCT03127137|454153797|FG001|Overall Study|Post procedure testing could not be obtained|1|||
126235096|NCT01996033|454153798|FG000|Overall Study|Death|1|||
126235097|NCT01996033|454153798|FG000|Overall Study|Physician Decision|1|||
126235098|NCT01996033|454153798|FG000|Overall Study|Withdrawal by Subject|4|||
126235099|NCT01996033|454153798|FG000|Overall Study|Lost to Follow-up|3|||
126235100|NCT01249664|454153799|FG000|Overall Study|Withdrawal by Subject|5|||
126235101|NCT01249664|454153800|FG001|Overall Study|Withdrawal by Subject|0|||
126235102|NCT01249664|454153799|FG000|Overall Study|Adverse Event|1|||
126235103|NCT01249664|454153800|FG001|Overall Study|Adverse Event|0|||
126235104|NCT01239121|454153802|FG000|Overall Study|Withdrawal by Subject|2|||
126235105|NCT01239121|454153803|FG001|Overall Study|Withdrawal by Subject|4|||
126235106|NCT01239121|454153804|FG002|Overall Study|Withdrawal by Subject|0|||
126235107|NCT00220337|454153805|FG000|Overall Study|Adverse Event|70|||
126235108|NCT00220337|454153805|FG000|Overall Study|Lack of Efficacy|17|||
126235109|NCT00220337|454153805|FG000|Overall Study|Withdrawal by Subject|68|||
126235110|NCT00220337|454153805|FG000|Overall Study|Protocol Violation|2|||
126235111|NCT00220337|454153805|FG000|Overall Study|Lost to Follow-up|5|||
126235112|NCT00220337|454153805|FG000|Overall Study|Other|12|||
126235113|NCT00220337|454153805|FG000|Overall Study|Unsatisfactory compliance|5|||
126235114|NCT00944697|454153808|FG000|Overall Study|Withdrawal by Subject|1|||
126235115|NCT00944697|454153809|FG001|Overall Study|Withdrawal by Subject|1|||
126235116|NCT00944697|454153808|FG000|Overall Study|Adverse Event|0|||
126235117|NCT00944697|454153809|FG001|Overall Study|Adverse Event|3|||
126235118|NCT00944697|454153808|FG000|Overall Study|Administrative|1|||
126235119|NCT00944697|454153809|FG001|Overall Study|Administrative|1|||
126235120|NCT01273181|454153810|FG000|Phase I, Dose 1|Study termination|1|||
126235121|NCT01273181|454153811|FG001|Phase I, Dose 1|Study termination|0|||
126235122|NCT01273181|454153812|FG002|Phase I, Dose 1|Study termination|0|||
126235123|NCT01273181|454153813|FG003|Phase I, Dose 1|Study termination|0|||
126235124|NCT01273181|454153810|FG000|Phase I, Dose 2|Death during treatment|0|||
126235125|NCT01273181|454153811|FG001|Phase I, Dose 2|Death during treatment|1|||
126235126|NCT01273181|454153812|FG002|Phase I, Dose 2|Death during treatment|0|||
126235127|NCT01273181|454153813|FG003|Phase I, Dose 2|Death during treatment|0|||
126235128|NCT01273181|454153810|FG000|Phase 2, Dose 1|Study termination|0|||
126235129|NCT01273181|454153811|FG001|Phase 2, Dose 1|Study termination|0|||
126235130|NCT01273181|454153812|FG002|Phase 2, Dose 1|Study termination|1|||
126235131|NCT01273181|454153813|FG003|Phase 2, Dose 1|Study termination|0|||
126235132|NCT01273181|454153810|FG000|Phase 2, Dose 2|Death during treatment|0|||
126235133|NCT01273181|454153811|FG001|Phase 2, Dose 2|Death during treatment|0|||
126235134|NCT01273181|454153812|FG002|Phase 2, Dose 2|Death during treatment|0|||
126235135|NCT01273181|454153813|FG003|Phase 2, Dose 2|Death during treatment|1|||
126235136|NCT04638153|454153814|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126235137|NCT04638153|454153815|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126235138|NCT04638153|454153816|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126235139|NCT04638153|454153814|FG000|Overall Study|Study terminated by sponsor|4|||
126235140|NCT04638153|454153815|FG001|Overall Study|Study terminated by sponsor|2|||
126235141|NCT04638153|454153816|FG002|Overall Study|Study terminated by sponsor|14|||
126235142|NCT04006171|454153817|FG000|Overall Study|Withdrawal by Subject|8|||
126235143|NCT04006171|454153818|FG001|Overall Study|Withdrawal by Subject|7|||
126235144|NCT04006171|454153817|FG000|Overall Study|missing serum samples|2|||
126235145|NCT04006171|454153818|FG001|Overall Study|missing serum samples|2|||
126235146|NCT04006171|454153817|FG000|Overall Study|insufficient sample volume|2|||
126235147|NCT04006171|454153818|FG001|Overall Study|insufficient sample volume|3|||
126235148|NCT00874237|454153824|FG000|Overall Study|Physician Decision|0|||
126235149|NCT00874237|454153825|FG001|Overall Study|Physician Decision|1|||
126235150|NCT00874237|454153826|FG002|Overall Study|Physician Decision|0|||
126235151|NCT00874237|454153827|FG003|Overall Study|Physician Decision|0|||
126235152|NCT00874237|454153828|FG004|Overall Study|Physician Decision|0|||
126235153|NCT00874237|454153829|FG005|Overall Study|Physician Decision|0|||
126235154|NCT00874237|454153824|FG000|Overall Study|Withdrawal by Subject|0|||
126235155|NCT00874237|454153825|FG001|Overall Study|Withdrawal by Subject|0|||
126235156|NCT00874237|454153826|FG002|Overall Study|Withdrawal by Subject|1|||
126235157|NCT00874237|454153827|FG003|Overall Study|Withdrawal by Subject|0|||
126235158|NCT00874237|454153828|FG004|Overall Study|Withdrawal by Subject|0|||
126235159|NCT00874237|454153829|FG005|Overall Study|Withdrawal by Subject|0|||
126235160|NCT03912337|454153832|FG000|Overall Study|Withdrawal of Consent From Study|1|||
126235161|NCT03912337|454153833|FG001|Overall Study|Withdrawal of Consent From Study|0|||
126235162|NCT03912337|454153832|FG000|Overall Study|Lost to Follow-up|1|||
126235163|NCT03912337|454153833|FG001|Overall Study|Lost to Follow-up|1|||
126235164|NCT03752528|454153834|FG000|Part A|Lost to Follow-up|1|||
126235165|NCT03752528|454153834|FG000|Part A|Protocol Violation|1|||
126235166|NCT03752528|454153834|FG000|Part B|Protocol Violation|1|||
126235167|NCT03752528|454153834|FG000|Part B|Study terminated by sponsor|3|||
126235168|NCT00537030|454153835|FG000|Overall Study|Physician Decision|2|||
126235169|NCT00537030|454153835|FG000|Overall Study|Withdrawal by Subject|2|||
126235170|NCT00537030|454153835|FG000|Overall Study|≥ Grade 2 allergy|7|||
126235171|NCT00537030|454153835|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
126235172|NCT00537030|454153835|FG000|Overall Study|Ineligible|2|||
126235173|NCT00537030|454153835|FG000|Overall Study|Inevaluable|2|||
126235174|NCT00414765|454153836|FG000|Overall Study|Adverse Event|5|||
126235175|NCT00414765|454153837|FG001|Overall Study|Adverse Event|9|||
126235176|NCT00414765|454153836|FG000|Overall Study|Withdrawal by Subject|1|||
126235177|NCT00414765|454153837|FG001|Overall Study|Withdrawal by Subject|1|||
126235178|NCT00414765|454153836|FG000|Overall Study|Disease Progression|0|||
126235179|NCT00414765|454153837|FG001|Overall Study|Disease Progression|1|||
126235180|NCT02458469|454153838|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126235181|NCT02458469|454153839|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126235182|NCT02458469|454153840|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
126235183|NCT02458469|454153841|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126235184|NCT02458469|454153842|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126235185|NCT02458469|454153843|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126235186|NCT02458469|454153838|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
126235187|NCT02458469|454153839|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
126235188|NCT02458469|454153840|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
126235189|NCT02458469|454153841|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
126235190|NCT02458469|454153842|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
126235191|NCT02458469|454153843|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
126235192|NCT02458469|454153838|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126235193|NCT02458469|454153839|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126235194|NCT02458469|454153840|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126235195|NCT02458469|454153841|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126235196|NCT02458469|454153842|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126235197|NCT02458469|454153843|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
126235198|NCT04534283|454153844|FG000|Overall Study|Physician Decision|2|||
126235199|NCT04534283|454153844|FG000|Overall Study|Withdrawal by Subject|1|||
126235200|NCT04534283|454153844|FG000|Overall Study|Disease Progression|12|||
126235201|NCT04534283|454153844|FG000|Overall Study|Adverse Event|1|||
126235202|NCT00661505|454153845|FG000|Overall Study|Adverse Event|3|||
126235203|NCT00661505|454153845|FG000|Overall Study|Protocol Violation|14|||
126235204|NCT00661505|454153845|FG000|Overall Study|Withdrawal by Subject|8|||
126235205|NCT00661505|454153845|FG000|Overall Study|Lost to Follow-up|3|||
126235206|NCT00661505|454153845|FG000|Overall Study|Other|2|||
126235207|NCT03561883|454153846|FG000|Overall Study|Adverse Event|10|||
126235208|NCT03561883|454153847|FG001|Overall Study|Adverse Event|13|||
126235209|NCT03561883|454153846|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126235210|NCT03561883|454153847|FG001|Overall Study|Non-Compliance With Study Drug|2|||
126235211|NCT03561883|454153846|FG000|Overall Study|Protocol Violation|2|||
126235212|NCT03561883|454153847|FG001|Overall Study|Protocol Violation|3|||
126235213|NCT03561883|454153846|FG000|Overall Study|Withdrawal by Subject|14|||
126235214|NCT03561883|454153847|FG001|Overall Study|Withdrawal by Subject|6|||
126235215|NCT03561883|454153846|FG000|Overall Study|Lost to Follow-up|2|||
126235216|NCT03561883|454153847|FG001|Overall Study|Lost to Follow-up|6|||
126235217|NCT03561883|454153846|FG000|Overall Study|Study Terminated by Sponsor|12|||
126235218|NCT03561883|454153847|FG001|Overall Study|Study Terminated by Sponsor|11|||
126235219|NCT03561883|454153846|FG000|Overall Study|Physician Decision|1|||
126235220|NCT03561883|454153847|FG001|Overall Study|Physician Decision|0|||
126235221|NCT03561883|454153846|FG000|Overall Study|Randomized by Mistake|1|||
126235222|NCT03561883|454153847|FG001|Overall Study|Randomized by Mistake|0|||
126235223|NCT03561883|454153846|FG000|Overall Study|Other, Not Specified|3|||
126235224|NCT03561883|454153847|FG001|Overall Study|Other, Not Specified|2|||
126235225|NCT06354270|454153848|FG000|Overall Study|Withdrawal by Subject|1|||
126235226|NCT06354270|454153849|FG001|Overall Study|Withdrawal by Subject|0|||
126235227|NCT01939197|454153850|FG000|Overall Study|Withdrawal by Subject|1|||
126235228|NCT01939197|454153851|FG001|Overall Study|Withdrawal by Subject|0|||
126235229|NCT01939197|454153852|FG002|Overall Study|Withdrawal by Subject|0|||
126235230|NCT01939197|454153853|FG003|Overall Study|Withdrawal by Subject|0|||
126235231|NCT01939197|454153854|FG004|Overall Study|Withdrawal by Subject|1|||
126235232|NCT01939197|454153855|FG005|Overall Study|Withdrawal by Subject|0|||
126235233|NCT01939197|454153856|FG006|Overall Study|Withdrawal by Subject|0|||
126235234|NCT01939197|454153850|FG000|Overall Study|Lost to Follow-up|0|||
126235235|NCT01939197|454153851|FG001|Overall Study|Lost to Follow-up|1|||
126235236|NCT01939197|454153852|FG002|Overall Study|Lost to Follow-up|0|||
126235237|NCT01939197|454153853|FG003|Overall Study|Lost to Follow-up|1|||
126235238|NCT01939197|454153854|FG004|Overall Study|Lost to Follow-up|3|||
126235239|NCT01939197|454153855|FG005|Overall Study|Lost to Follow-up|1|||
126235240|NCT01939197|454153856|FG006|Overall Study|Lost to Follow-up|2|||
126235241|NCT00745095|454153857|FG000|Overall Study|Declined to participate|1|||
126354670|NCT00849472|454589421|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
126354671|NCT00849472|454589421|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
126354672|NCT00849472|454589421|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
126235242|NCT00745095|454153858|FG001|Overall Study|Declined to participate|0|||
126235243|NCT00745095|454153859|FG002|Overall Study|Declined to participate|0|||
126235244|NCT00745095|454153860|FG003|Overall Study|Declined to participate|0|||
126235245|NCT00745095|454153861|FG004|Overall Study|Declined to participate|92|||
126235246|NCT00745095|454153862|FG005|Overall Study|Declined to participate|95|||
126235247|NCT00745095|454153857|FG000|Overall Study|Ineligible due to GFR criteria|0|||
126235248|NCT00745095|454153858|FG001|Overall Study|Ineligible due to GFR criteria|2|||
126235249|NCT00745095|454153859|FG002|Overall Study|Ineligible due to GFR criteria|3|||
126235250|NCT00745095|454153860|FG003|Overall Study|Ineligible due to GFR criteria|3|||
126235251|NCT00745095|454153861|FG004|Overall Study|Ineligible due to GFR criteria|30|||
126235252|NCT00745095|454153862|FG005|Overall Study|Ineligible due to GFR criteria|28|||
126235253|NCT00958243|454153863|FG000|Overall Study|Withdrawal by Subject|0|||
126235254|NCT00958243|454153864|FG001|Overall Study|Withdrawal by Subject|1|||
126235255|NCT00958243|454153865|FG002|Overall Study|Withdrawal by Subject|3|||
126235256|NCT00958243|454153866|FG003|Overall Study|Withdrawal by Subject|1|||
126235257|NCT00958243|454153867|FG004|Overall Study|Withdrawal by Subject|1|||
126235258|NCT00958243|454153868|FG005|Overall Study|Withdrawal by Subject|5|||
126235259|NCT00958243|454153863|FG000|Overall Study|Lost to Follow-up|2|||
126235260|NCT00958243|454153864|FG001|Overall Study|Lost to Follow-up|5|||
126235261|NCT00958243|454153865|FG002|Overall Study|Lost to Follow-up|11|||
126235262|NCT00958243|454153866|FG003|Overall Study|Lost to Follow-up|2|||
126235263|NCT00958243|454153867|FG004|Overall Study|Lost to Follow-up|8|||
126235264|NCT00958243|454153868|FG005|Overall Study|Lost to Follow-up|5|||
126235265|NCT01974141|454153876|FG000|Overall Study|Other Reasons|28|||
126235266|NCT01974141|454153877|FG001|Overall Study|Other Reasons|18|||
126235267|NCT01974141|454153876|FG000|Overall Study|Protocol Violation|2|||
126235268|NCT01974141|454153877|FG001|Overall Study|Protocol Violation|6|||
126235269|NCT01974141|454153876|FG000|Overall Study|Personal Reasons|21|||
126235270|NCT01974141|454153877|FG001|Overall Study|Personal Reasons|20|||
126235271|NCT01974141|454153876|FG000|Overall Study|Lost to Follow-up|38|||
126235272|NCT01974141|454153877|FG001|Overall Study|Lost to Follow-up|29|||
126235273|NCT01974141|454153876|FG000|Overall Study|Pregnancy|3|||
126235274|NCT01974141|454153877|FG001|Overall Study|Pregnancy|3|||
126235275|NCT01974141|454153876|FG000|Overall Study|Lack of Efficacy|0|||
126235276|NCT01974141|454153877|FG001|Overall Study|Lack of Efficacy|1|||
126235277|NCT01974141|454153876|FG000|Overall Study|Adverse Event|4|||
126235278|NCT01974141|454153877|FG001|Overall Study|Adverse Event|5|||
126235279|NCT02781727|454153878|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
126235280|NCT02781727|454153879|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
126235281|NCT02781727|454153878|FG000|Treatment Period|Withdrawal by Subject|1|||
126235282|NCT02781727|454153879|FG001|Treatment Period|Withdrawal by Subject|0|||
126235283|NCT02781727|454153878|FG000|Treatment Period|Lost to Follow-up|0|||
126354673|NCT00849472|454589421|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
126354674|NCT00849472|454589421|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
126023310|NCT02590432|453380677|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
126023311|NCT02590432|453380678|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
126023312|NCT02590432|453380679|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
126023313|NCT02590432|453380680|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
126023314|NCT02590432|453380681|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
126023315|NCT02590432|453380682|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
126023316|NCT02590432|453380674|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
126023317|NCT02590432|453380675|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
126023318|NCT02590432|453380676|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
126023319|NCT02590432|453380677|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
126023320|NCT02590432|453380678|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
126354675|NCT00849472|454589421|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
126354676|NCT00825175|454589422|FG000|Overall Study|Withdrawal by Subject|0|||
126354677|NCT00825175|454589423|FG001|Overall Study|Withdrawal by Subject|5|||
126354678|NCT03370302|454589428|FG000|Dose Escalation Phase|Other|0|||
126354679|NCT03370302|454589429|FG001|Dose Escalation Phase|Other|1|||
126354680|NCT03370302|454589430|FG002|Dose Escalation Phase|Other|1|||
126354681|NCT03370302|454589431|FG003|Dose Escalation Phase|Other|0|||
126354682|NCT03370302|454589432|FG004|Dose Escalation Phase|Other|0|||
126354683|NCT03370302|454589433|FG005|Dose Escalation Phase|Other|0|||
126354684|NCT03370302|454589428|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126354685|NCT03370302|454589429|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
126354686|NCT03370302|454589430|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
126354687|NCT03370302|454589431|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126354688|NCT03370302|454589432|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
126354689|NCT03370302|454589433|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
126354690|NCT03370302|454589428|FG000|Dose Escalation Phase|Adverse Event|1|||
126354691|NCT03370302|454589429|FG001|Dose Escalation Phase|Adverse Event|0|||
126354692|NCT03370302|454589430|FG002|Dose Escalation Phase|Adverse Event|2|||
126354693|NCT03370302|454589431|FG003|Dose Escalation Phase|Adverse Event|0|||
126354694|NCT03370302|454589432|FG004|Dose Escalation Phase|Adverse Event|0|||
126354695|NCT03370302|454589433|FG005|Dose Escalation Phase|Adverse Event|0|||
126235284|NCT02781727|454153879|FG001|Treatment Period|Lost to Follow-up|1|||
126235285|NCT00950872|454153883|FG000|Overall Study|Withdrawal by Subject|1|||
126235286|NCT00950872|454153883|FG000|Overall Study|Did not have surgery|2|||
126235287|NCT00406848|454153884|FG000|Overall Study|Withdrawal by Subject|27|||
126235288|NCT00406848|454153885|FG001|Overall Study|Withdrawal by Subject|22|||
126354696|NCT03370302|454589428|FG000|Dose Escalation Phase|Progressive Disease|2|||
126235289|NCT00406848|454153884|FG000|Overall Study|Adverse Event|38|||
126235290|NCT00406848|454153885|FG001|Overall Study|Adverse Event|7|||
126235291|NCT00406848|454153884|FG000|Overall Study|Lack of Efficacy|9|||
126235292|NCT00406848|454153885|FG001|Overall Study|Lack of Efficacy|14|||
126235293|NCT00406848|454153884|FG000|Overall Study|Protocol Violation|10|||
126235294|NCT00406848|454153885|FG001|Overall Study|Protocol Violation|6|||
126235295|NCT00406848|454153884|FG000|Overall Study|Lost to Follow-up|6|||
126235296|NCT00406848|454153885|FG001|Overall Study|Lost to Follow-up|2|||
126235297|NCT00406848|454153884|FG000|Overall Study|Physician Decision|2|||
126235298|NCT00406848|454153885|FG001|Overall Study|Physician Decision|2|||
126235299|NCT00406848|454153884|FG000|Overall Study|Sponsor Decision|1|||
126235300|NCT00406848|454153885|FG001|Overall Study|Sponsor Decision|1|||
126235301|NCT00352690|454153886|FG000|Overall Study|Determined to be ineligible|2|||
126235302|NCT00352690|454153887|FG001|Overall Study|Determined to be ineligible|0|||
126235303|NCT02719522|454153892|FG000|Overall Study|Implant Failure|4|||
126235304|NCT02719522|454153892|FG000|Overall Study|Death|2|||
126235305|NCT02719522|454153892|FG000|Overall Study|Lost to Follow-up|5|||
126235306|NCT05277389|454153894|FG000|Overall Study|Lost to Follow-up|1|||
126235307|NCT05277389|454153895|FG001|Overall Study|Lost to Follow-up|4|||
126235308|NCT04025879|454153898|FG000|Randomization|Participant withdrew consent|0|||
126235309|NCT04025879|454153899|FG001|Randomization|Participant withdrew consent|1|||
126235310|NCT04025879|454153898|FG000|Randomization|Participant no longer met study criteria|1|||
126235311|NCT04025879|454153899|FG001|Randomization|Participant no longer met study criteria|1|||
126235312|NCT04025879|454153898|FG000|Treatment|Ongoing treatment|10|||
126235313|NCT04025879|454153899|FG001|Treatment|Ongoing treatment|8|||
126235314|NCT04025879|454153898|FG000|Treatment|Disease progression/recurrence|36|||
126235315|NCT04025879|454153899|FG001|Treatment|Disease progression/recurrence|72|||
126235316|NCT04025879|454153898|FG000|Treatment|Study drug toxicity|36|||
126235317|NCT04025879|454153899|FG001|Treatment|Study drug toxicity|13|||
126235318|NCT04025879|454153898|FG000|Treatment|Death|2|||
126235319|NCT04025879|454153899|FG001|Treatment|Death|0|||
126235320|NCT04025879|454153898|FG000|Treatment|Adverse event unrelated to study drug|21|||
126235321|NCT04025879|454153899|FG001|Treatment|Adverse event unrelated to study drug|14|||
126354697|NCT03370302|454589429|FG001|Dose Escalation Phase|Progressive Disease|4|||
126354698|NCT03370302|454589430|FG002|Dose Escalation Phase|Progressive Disease|2|||
126354699|NCT03370302|454589431|FG003|Dose Escalation Phase|Progressive Disease|0|||
126354700|NCT03370302|454589432|FG004|Dose Escalation Phase|Progressive Disease|3|||
126354701|NCT03370302|454589433|FG005|Dose Escalation Phase|Progressive Disease|1|||
126354702|NCT03370302|454589428|FG000|Dose Expansion Phase|Progressive Disease|0|||
126354703|NCT03370302|454589429|FG001|Dose Expansion Phase|Progressive Disease|0|||
126354704|NCT03370302|454589430|FG002|Dose Expansion Phase|Progressive Disease|0|||
126354705|NCT03370302|454589431|FG003|Dose Expansion Phase|Progressive Disease|6|||
126354706|NCT03370302|454589432|FG004|Dose Expansion Phase|Progressive Disease|0|||
126354707|NCT03370302|454589433|FG005|Dose Expansion Phase|Progressive Disease|0|||
126354708|NCT01428128|454589434|FG000|Overall Study|Withdrawal by Subject|4|||
126354709|NCT01428128|454589434|FG000|Overall Study|Screen failure by p53|10|||
126354710|NCT01428128|454589434|FG000|Overall Study|Received Neulasta in one cycle|2|||
126354711|NCT01428128|454589434|FG000|Overall Study|Adverse Event|1|||
126354712|NCT00424008|454589436|FG000|Overall Study|Adverse Event|8|||
126354713|NCT00424008|454589437|FG001|Overall Study|Adverse Event|6|||
126354714|NCT00424008|454589436|FG000|Overall Study|Lack of Efficacy|40|||
126354715|NCT00424008|454589437|FG001|Overall Study|Lack of Efficacy|34|||
126354716|NCT00424008|454589436|FG000|Overall Study|Lost to Follow-up|1|||
126354717|NCT00424008|454589437|FG001|Overall Study|Lost to Follow-up|2|||
126354718|NCT00424008|454589436|FG000|Overall Study|Withdrawal by Subject|5|||
126354719|NCT00424008|454589437|FG001|Overall Study|Withdrawal by Subject|8|||
126354720|NCT00424008|454589436|FG000|Overall Study|Noncompliance with protocol|13|||
126354721|NCT00424008|454589437|FG001|Overall Study|Noncompliance with protocol|7|||
126354722|NCT00424008|454589436|FG000|Overall Study|Did not meet protocol eligibility|16|||
126354723|NCT00424008|454589437|FG001|Overall Study|Did not meet protocol eligibility|21|||
126354724|NCT00424008|454589436|FG000|Overall Study|Administrative|266|||
126354725|NCT00424008|454589437|FG001|Overall Study|Administrative|257|||
126354726|NCT02593864|454589440|FG000|Overall Study|Withdrawal by Subject|3|||
126354727|NCT02593864|454589440|FG000|Overall Study|Lost to Follow-up|3|||
126235322|NCT04025879|454153898|FG000|Treatment|Participant request to discontinue study treatment|16|||
126235323|NCT04025879|454153899|FG001|Treatment|Participant request to discontinue study treatment|8|||
126235324|NCT04025879|454153898|FG000|Treatment|Participant withdrew consent|1|||
126235325|NCT04025879|454153899|FG001|Treatment|Participant withdrew consent|3|||
126235326|NCT04025879|454153898|FG000|Treatment|Participant no longer meets study criteria|3|||
126235327|NCT04025879|454153899|FG001|Treatment|Participant no longer meets study criteria|2|||
126235328|NCT04025879|454153898|FG000|Treatment|Lost to Follow-up|1|||
126235329|NCT04025879|454153899|FG001|Treatment|Lost to Follow-up|0|||
126354728|NCT02530242|454589455|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
126354729|NCT02530242|454589456|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
126354730|NCT00283959|454589457|FG000|Extension Period|Low Compliance|1|||
126354731|NCT05591755|454589458|FG000|Overall Study|Screen Failure|1|||
126354732|NCT05591755|454589459|FG001|Overall Study|Screen Failure|0|||
126354733|NCT05591755|454589460|FG002|Overall Study|Screen Failure|0|||
126235330|NCT04025879|454153898|FG000|Treatment|Other reasons|15|||
126235331|NCT04025879|454153899|FG001|Treatment|Other reasons|17|||
126235332|NCT04025879|454153898|FG000|Treatment|Administrative reason by sponsor|0|||
126235333|NCT04025879|454153899|FG001|Treatment|Administrative reason by sponsor|1|||
126235334|NCT04025879|454153898|FG000|Treatment|Not reported|2|||
126235335|NCT04025879|454153899|FG001|Treatment|Not reported|0|||
126235336|NCT02888171|454153902|FG000|Overall Study|Lost to Follow-up|2|||
126235337|NCT02888171|454153903|FG001|Overall Study|Lost to Follow-up|1|||
126235338|NCT02888171|454153902|FG000|Overall Study|Withdrawal by Subject|3|||
126235339|NCT02888171|454153903|FG001|Overall Study|Withdrawal by Subject|2|||
126235340|NCT02888171|454153902|FG000|Overall Study|Adverse Event|0|||
126235341|NCT02888171|454153903|FG001|Overall Study|Adverse Event|1|||
126235342|NCT01411332|454153904|FG000|Enrollment|Protocol Violation|0|||
126235343|NCT01411332|454153905|FG001|Enrollment|Protocol Violation|1|||
126235344|NCT01411332|454153904|FG000|Enrollment|Withdrawal by Subject|0|||
126235345|NCT01411332|454153905|FG001|Enrollment|Withdrawal by Subject|1|||
126235346|NCT01411332|454153904|FG000|Treatment|Lost to Follow-up|1|||
126235347|NCT01411332|454153905|FG001|Treatment|Lost to Follow-up|0|||
126235348|NCT01471522|454153909|FG000|Overall Study|Withdrawal by Subject|28|||
126235349|NCT01471522|454153910|FG001|Overall Study|Withdrawal by Subject|22|||
126235350|NCT01471522|454153909|FG000|Overall Study|Lost to Follow-up|36|||
126235351|NCT01471522|454153910|FG001|Overall Study|Lost to Follow-up|26|||
126235352|NCT03805438|454155126|FG000|Overall Study|Lack of Efficacy|1|||
126235353|NCT03805438|454155126|FG000|Overall Study|Protocol Violation|1|||
126235354|NCT00366899|454155127|FG000|Infant Series|Withdrawal by Subject|4|||
126235355|NCT00366899|454155128|FG001|Infant Series|Withdrawal by Subject|7|||
126235356|NCT00366899|454155127|FG000|Infant Series|Protocol Violation|2|||
126235357|NCT00366899|454155128|FG001|Infant Series|Protocol Violation|1|||
126235358|NCT00366899|454155127|FG000|Infant Series|Failed to return|1|||
126235359|NCT00366899|454155128|FG001|Infant Series|Failed to return|1|||
126235360|NCT00366899|454155127|FG000|Infant Series|Lost to Follow-up|0|||
126235361|NCT00366899|454155128|FG001|Infant Series|Lost to Follow-up|2|||
126235362|NCT00366899|454155127|FG000|Infant Series|Adverse Event|0|||
126235363|NCT00366899|454155128|FG001|Infant Series|Adverse Event|1|||
126235364|NCT00366899|454155127|FG000|Infant Series|Physician Decision|1|||
126235365|NCT00366899|454155128|FG001|Infant Series|Physician Decision|0|||
126235366|NCT00366899|454155127|FG000|Infant Series|Randomized but not consented|1|||
126235367|NCT00366899|454155128|FG001|Infant Series|Randomized but not consented|0|||
126235368|NCT00366899|454155127|FG000|After Infant Series|Lost to Follow-up|4|||
126235369|NCT00366899|454155128|FG001|After Infant Series|Lost to Follow-up|3|||
126235370|NCT00366899|454155127|FG000|After Infant Series|Withdrawal by Subject|1|||
126235371|NCT00366899|454155128|FG001|After Infant Series|Withdrawal by Subject|4|||
126235372|NCT00366899|454155127|FG000|After Infant Series|Adverse Event|1|||
126235373|NCT00366899|454155128|FG001|After Infant Series|Adverse Event|2|||
126235374|NCT00366899|454155127|FG000|After Infant Series|Protocol Violation|1|||
126235375|NCT00366899|454155128|FG001|After Infant Series|Protocol Violation|0|||
126235376|NCT00366899|454155127|FG000|Toddler Dose|Withdrawal by Subject|1|||
126235377|NCT00366899|454155128|FG001|Toddler Dose|Withdrawal by Subject|1|||
126235378|NCT00366899|454155127|FG000|Toddler Dose|Protocol Violation|1|||
126235379|NCT00366899|454155128|FG001|Toddler Dose|Protocol Violation|0|||
126235380|NCT01619800|454155129|FG000|Overall Study|study terminated|2|||
126235381|NCT01619800|454155130|FG001|Overall Study|study terminated|0|||
126235382|NCT00419770|454155132|FG000|Overall Study|Withdrawal by Subject|5|||
126235383|NCT00419770|454155133|FG001|Overall Study|Withdrawal by Subject|1|||
126235384|NCT02848326|454155134|FG000|Treatment Period|Adverse Event|5|||
126235385|NCT02848326|454155135|FG001|Treatment Period|Adverse Event|4|||
126235386|NCT02848326|454155136|FG002|Treatment Period|Adverse Event|11|||
126354734|NCT05591755|454589461|FG003|Overall Study|Screen Failure|0|||
126354735|NCT05591755|454589458|FG000|Overall Study|Protocol Violation|0|||
126354736|NCT05591755|454589459|FG001|Overall Study|Protocol Violation|0|||
126354737|NCT05591755|454589460|FG002|Overall Study|Protocol Violation|2|||
126354738|NCT05591755|454589461|FG003|Overall Study|Protocol Violation|0|||
126354739|NCT05591755|454589458|FG000|Overall Study|Withdrawal by Subject|0|||
126354740|NCT05591755|454589459|FG001|Overall Study|Withdrawal by Subject|1|||
126354741|NCT05591755|454589460|FG002|Overall Study|Withdrawal by Subject|0|||
126235387|NCT02848326|454155137|FG003|Treatment Period|Adverse Event|6|||
126235388|NCT02848326|454155138|FG004|Treatment Period|Adverse Event|5|||
126235389|NCT02848326|454155139|FG005|Treatment Period|Adverse Event|7|||
126235390|NCT02848326|454155134|FG000|Treatment Period|Withdrawal of Consent|20|||
126235391|NCT02848326|454155135|FG001|Treatment Period|Withdrawal of Consent|6|||
126235392|NCT02848326|454155136|FG002|Treatment Period|Withdrawal of Consent|9|||
126235393|NCT02848326|454155137|FG003|Treatment Period|Withdrawal of Consent|6|||
126235394|NCT02848326|454155138|FG004|Treatment Period|Withdrawal of Consent|9|||
126235395|NCT02848326|454155139|FG005|Treatment Period|Withdrawal of Consent|6|||
126235396|NCT02848326|454155134|FG000|Treatment Period|Lost to Follow-up|5|||
126235397|NCT02848326|454155135|FG001|Treatment Period|Lost to Follow-up|1|||
126354742|NCT05591755|454589461|FG003|Overall Study|Withdrawal by Subject|0|||
126354743|NCT00433290|454589462|FG000|Overall Study|Adverse Event|24|||
126354744|NCT00433290|454589463|FG001|Overall Study|Adverse Event|7|||
126354745|NCT00433290|454589462|FG000|Overall Study|Lack of Efficacy|1|||
126354746|NCT00433290|454589463|FG001|Overall Study|Lack of Efficacy|5|||
126354747|NCT00433290|454589462|FG000|Overall Study|Withdrawal by Subject|4|||
126354748|NCT00433290|454589463|FG001|Overall Study|Withdrawal by Subject|2|||
126354749|NCT00433290|454589462|FG000|Overall Study|Protocol Violation|3|||
126354750|NCT00433290|454589463|FG001|Overall Study|Protocol Violation|2|||
126354751|NCT00433290|454589462|FG000|Overall Study|Physician Decision|2|||
126354752|NCT00433290|454589463|FG001|Overall Study|Physician Decision|0|||
126354753|NCT00433290|454589462|FG000|Overall Study|Entry Criteria Not Met|0|||
126354754|NCT00433290|454589463|FG001|Overall Study|Entry Criteria Not Met|1|||
126354755|NCT00433290|454589462|FG000|Overall Study|Lost to Follow-up|1|||
126354756|NCT00433290|454589463|FG001|Overall Study|Lost to Follow-up|0|||
126354757|NCT01483651|454589464|FG000|Overall Study|Withdrawal by Subject|0|||
126354758|NCT01483651|454589465|FG001|Overall Study|Withdrawal by Subject|1|||
126354759|NCT01483651|454589466|FG002|Overall Study|Withdrawal by Subject|1|||
126354760|NCT01483651|454589467|FG003|Overall Study|Withdrawal by Subject|0|||
126354761|NCT01483651|454589468|FG004|Overall Study|Withdrawal by Subject|0|||
126354762|NCT01483651|454589469|FG005|Overall Study|Withdrawal by Subject|1|||
126354763|NCT00308685|454589478|FG000|Overall Study|Lost to Follow-up|1|||
126354764|NCT00308685|454589479|FG001|Overall Study|Lost to Follow-up|0|||
126354765|NCT00308685|454589478|FG000|Overall Study|Need to administer prohibited medication|1|||
126354766|NCT00308685|454589479|FG001|Overall Study|Need to administer prohibited medication|2|||
126354767|NCT00308685|454589478|FG000|Overall Study|Other than specified|1|||
126354768|NCT00308685|454589479|FG001|Overall Study|Other than specified|3|||
126354769|NCT03345095|454589480|FG000|Overall Study|Lack of Efficacy|184|||
126354770|NCT03345095|454589481|FG001|Overall Study|Lack of Efficacy|156|||
126354771|NCT03345095|454589480|FG000|Overall Study|Adverse Event|36|||
126354772|NCT03345095|454589481|FG001|Overall Study|Adverse Event|118|||
126235398|NCT02848326|454155136|FG002|Treatment Period|Lost to Follow-up|11|||
126235399|NCT02848326|454155137|FG003|Treatment Period|Lost to Follow-up|7|||
126235400|NCT02848326|454155138|FG004|Treatment Period|Lost to Follow-up|2|||
126235401|NCT02848326|454155139|FG005|Treatment Period|Lost to Follow-up|3|||
126235402|NCT02848326|454155134|FG000|Treatment Period|Pregnancy|0|||
126235403|NCT02848326|454155135|FG001|Treatment Period|Pregnancy|0|||
126235404|NCT02848326|454155136|FG002|Treatment Period|Pregnancy|1|||
126235405|NCT02848326|454155137|FG003|Treatment Period|Pregnancy|1|||
126235406|NCT02848326|454155138|FG004|Treatment Period|Pregnancy|0|||
126235407|NCT02848326|454155139|FG005|Treatment Period|Pregnancy|1|||
126235408|NCT02848326|454155134|FG000|Treatment Period|Protocol Violation|4|||
126235409|NCT02848326|454155135|FG001|Treatment Period|Protocol Violation|3|||
126235410|NCT02848326|454155136|FG002|Treatment Period|Protocol Violation|4|||
126235411|NCT02848326|454155137|FG003|Treatment Period|Protocol Violation|2|||
126235412|NCT02848326|454155138|FG004|Treatment Period|Protocol Violation|3|||
126235413|NCT02848326|454155139|FG005|Treatment Period|Protocol Violation|3|||
126235414|NCT02848326|454155134|FG000|Treatment Period|Non-compliance with Study Drug|4|||
126235415|NCT02848326|454155135|FG001|Treatment Period|Non-compliance with Study Drug|0|||
126235416|NCT02848326|454155136|FG002|Treatment Period|Non-compliance with Study Drug|0|||
126235417|NCT02848326|454155137|FG003|Treatment Period|Non-compliance with Study Drug|1|||
126235418|NCT02848326|454155138|FG004|Treatment Period|Non-compliance with Study Drug|0|||
126235419|NCT02848326|454155139|FG005|Treatment Period|Non-compliance with Study Drug|0|||
126235420|NCT02848326|454155134|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
126235421|NCT02848326|454155135|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
126235422|NCT02848326|454155136|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
126235423|NCT02848326|454155137|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
126235424|NCT02848326|454155138|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
126235425|NCT02848326|454155139|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
126235426|NCT02848326|454155134|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
126235427|NCT02848326|454155135|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
126235428|NCT02848326|454155136|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
126235429|NCT02848326|454155137|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
126235430|NCT02848326|454155138|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
126235431|NCT02848326|454155139|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
126235432|NCT00414466|454155146|FG000|Overall Study|Adverse Event|0|||
126235433|NCT00414466|454155147|FG001|Overall Study|Adverse Event|0|||
126235434|NCT00414466|454155148|FG002|Overall Study|Adverse Event|1|||
126235435|NCT00414466|454155149|FG003|Overall Study|Adverse Event|1|||
126235436|NCT00414466|454155146|FG000|Overall Study|Lack of Efficacy|1|||
126235437|NCT00414466|454155147|FG001|Overall Study|Lack of Efficacy|0|||
126235438|NCT00414466|454155148|FG002|Overall Study|Lack of Efficacy|0|||
126235439|NCT00414466|454155149|FG003|Overall Study|Lack of Efficacy|0|||
126235440|NCT00414466|454155146|FG000|Overall Study|Withdrawn by Sponsor|1|||
126235441|NCT00414466|454155147|FG001|Overall Study|Withdrawn by Sponsor|0|||
126235442|NCT00414466|454155148|FG002|Overall Study|Withdrawn by Sponsor|0|||
126235443|NCT00414466|454155149|FG003|Overall Study|Withdrawn by Sponsor|0|||
126235444|NCT04526210|454155150|FG000|Overall Study|Sponsor decision|7|||
126235445|NCT04526210|454155151|FG001|Overall Study|Sponsor decision|5|||
126235446|NCT04526210|454155150|FG000|Overall Study|Withdrawal by Subject|3|||
126235447|NCT04526210|454155151|FG001|Overall Study|Withdrawal by Subject|2|||
126235448|NCT02637232|454155152|FG000|Overall Study|Lost to Follow-up|42|||
126235449|NCT02637232|454155152|FG000|Overall Study|Adverse Event|11|||
126235450|NCT02637232|454155152|FG000|Overall Study|patient 's decision|2|||
126235451|NCT02999178|454155153|FG000|Overall Study|Adverse Event|85|||
126235452|NCT02999178|454155154|FG001|Overall Study|Adverse Event|62|||
126235453|NCT02999178|454155153|FG000|Overall Study|Protocol Violation|1|||
126235454|NCT02999178|454155154|FG001|Overall Study|Protocol Violation|2|||
126235455|NCT02999178|454155153|FG000|Overall Study|Lost to Follow-up|0|||
126235456|NCT02999178|454155154|FG001|Overall Study|Lost to Follow-up|2|||
126235457|NCT02999178|454155153|FG000|Overall Study|Withdrawal by Subject|21|||
126235458|NCT02999178|454155154|FG001|Overall Study|Withdrawal by Subject|21|||
126235459|NCT02999178|454155153|FG000|Overall Study|Other reason not defined above|7|||
126235460|NCT02999178|454155154|FG001|Overall Study|Other reason not defined above|13|||
126235461|NCT00090857|454155155|FG000|Overall Study|Lost to Follow-up|0|||
126235462|NCT00090857|454155156|FG001|Overall Study|Lost to Follow-up|1|||
126235463|NCT00090857|454155155|FG000|Overall Study|Withdrawal by Subject|2|||
126235464|NCT00090857|454155156|FG001|Overall Study|Withdrawal by Subject|0|||
126235465|NCT00090857|454155155|FG000|Overall Study|Adverse Event|2|||
126235466|NCT00090857|454155156|FG001|Overall Study|Adverse Event|2|||
126235467|NCT05097326|454155157|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
126235468|NCT05097326|454155158|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
126235469|NCT02684344|454155159|FG000|Overall Study|Withdrawal by Subject|0|||
126235470|NCT02684344|454155160|FG001|Overall Study|Withdrawal by Subject|1|||
126235471|NCT03480425|454155161|FG000|Overall Study|Force transducer technical failure|1|||
126235472|NCT02424188|454155163|FG000|Overall Study|Death|2|||
126235473|NCT02424188|454155164|FG001|Overall Study|Death|2|||
126235474|NCT02424188|454155163|FG000|Overall Study|Lost to Follow-up|1|||
126235475|NCT02424188|454155164|FG001|Overall Study|Lost to Follow-up|3|||
126235476|NCT02424188|454155163|FG000|Overall Study|Incarceration|1|||
126235477|NCT02424188|454155164|FG001|Overall Study|Incarceration|0|||
126235478|NCT00630305|454155165|FG000|Overall Study|Withdrawal by Subject|1|||
126235479|NCT00630305|454155165|FG000|Overall Study|Inability to insert contact lens|1|||
126235480|NCT03471078|454155176|FG000|Overall Study|Withdrawal by Subject|9|||
126235481|NCT03471078|454155177|FG001|Overall Study|Withdrawal by Subject|1|||
126235482|NCT03471078|454155176|FG000|Overall Study|Adverse Event|4|||
126235483|NCT03471078|454155177|FG001|Overall Study|Adverse Event|1|||
126235484|NCT03471078|454155176|FG000|Overall Study|Physician Decision|3|||
126235485|NCT03471078|454155177|FG001|Overall Study|Physician Decision|2|||
126235486|NCT03471078|454155176|FG000|Overall Study|Death|2|||
126235487|NCT03471078|454155177|FG001|Overall Study|Death|0|||
126235488|NCT03471078|454155176|FG000|Overall Study|Other|3|||
126235489|NCT03471078|454155177|FG001|Overall Study|Other|2|||
126235490|NCT02473640|454155181|FG000|Treatment Period 1|Adverse Event|1|||
126235491|NCT02395822|454155182|FG000|Overall Study|Withdrawal by Subject|1|||
126235492|NCT02395822|454155182|FG000|Overall Study|Death|1|||
126235493|NCT02937701|454155185|FG000|Day 1 to Week 22|Adverse Event|11|||
126235494|NCT02937701|454155186|FG001|Day 1 to Week 22|Adverse Event|14|||
126235495|NCT02937701|454155187|FG002|Day 1 to Week 22|Adverse Event|0|||
126235496|NCT02937701|454155188|FG003|Day 1 to Week 22|Adverse Event|0|||
126235497|NCT02937701|454155189|FG004|Day 1 to Week 22|Adverse Event|0|||
126235498|NCT02937701|454155185|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
126235499|NCT02937701|454155186|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
126235500|NCT02937701|454155187|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
126235501|NCT02937701|454155188|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
126235502|NCT02937701|454155189|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
126235503|NCT02937701|454155185|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
126235504|NCT02937701|454155186|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
126235505|NCT02937701|454155187|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
126235506|NCT02937701|454155188|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
126235507|NCT02937701|454155189|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
126235508|NCT02937701|454155185|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
126235509|NCT02937701|454155186|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
126235510|NCT02937701|454155187|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
126235511|NCT02937701|454155188|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
126235512|NCT02937701|454155189|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
126235513|NCT02937701|454155185|FG000|Day 1 to Week 22|Death|1|||
126235514|NCT02937701|454155186|FG001|Day 1 to Week 22|Death|1|||
126235515|NCT02937701|454155187|FG002|Day 1 to Week 22|Death|0|||
126235516|NCT02937701|454155188|FG003|Day 1 to Week 22|Death|0|||
126235517|NCT02937701|454155189|FG004|Day 1 to Week 22|Death|0|||
126235518|NCT02937701|454155185|FG000|Day 1 to Week 22|Protocol Violation|1|||
126235519|NCT02937701|454155186|FG001|Day 1 to Week 22|Protocol Violation|1|||
126235520|NCT02937701|454155187|FG002|Day 1 to Week 22|Protocol Violation|0|||
126235521|NCT02937701|454155188|FG003|Day 1 to Week 22|Protocol Violation|0|||
126235522|NCT02937701|454155189|FG004|Day 1 to Week 22|Protocol Violation|0|||
126235523|NCT02937701|454155185|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
126235524|NCT02937701|454155186|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
126235525|NCT02937701|454155187|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
126235526|NCT02937701|454155188|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
126235527|NCT02937701|454155189|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
126235528|NCT02937701|454155185|FG000|Day 1 to Week 22|Physician Decision|2|||
126235529|NCT02937701|454155186|FG001|Day 1 to Week 22|Physician Decision|0|||
126235530|NCT02937701|454155187|FG002|Day 1 to Week 22|Physician Decision|0|||
126235531|NCT02937701|454155188|FG003|Day 1 to Week 22|Physician Decision|0|||
126235532|NCT02937701|454155189|FG004|Day 1 to Week 22|Physician Decision|0|||
126235533|NCT02937701|454155185|FG000|Day 1 to Week 22|Other|1|||
126235534|NCT02937701|454155186|FG001|Day 1 to Week 22|Other|0|||
126235535|NCT02937701|454155187|FG002|Day 1 to Week 22|Other|0|||
126235536|NCT02937701|454155188|FG003|Day 1 to Week 22|Other|0|||
126235537|NCT02937701|454155189|FG004|Day 1 to Week 22|Other|0|||
126235538|NCT02937701|454155185|FG000|Week 22 to Week 50|Adverse Event|0|||
126235539|NCT02937701|454155186|FG001|Week 22 to Week 50|Adverse Event|0|||
126235540|NCT02937701|454155187|FG002|Week 22 to Week 50|Adverse Event|10|||
126235541|NCT02937701|454155188|FG003|Week 22 to Week 50|Adverse Event|3|||
126235542|NCT02937701|454155189|FG004|Week 22 to Week 50|Adverse Event|3|||
126235543|NCT02937701|454155185|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
126235544|NCT02937701|454155186|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
126235545|NCT02937701|454155187|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
126235546|NCT02937701|454155188|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
126235547|NCT02937701|454155189|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
126235548|NCT02937701|454155185|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
126235549|NCT02937701|454155186|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
126235550|NCT02937701|454155187|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
126235551|NCT02937701|454155188|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
126235552|NCT02937701|454155189|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
126235553|NCT02937701|454155185|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
126235554|NCT02937701|454155186|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
126235555|NCT02937701|454155187|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
126235556|NCT02937701|454155188|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
126235557|NCT02937701|454155189|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
126235558|NCT02937701|454155185|FG000|Week 22 to Week 50|Physician Decision|0|||
126235559|NCT02937701|454155186|FG001|Week 22 to Week 50|Physician Decision|0|||
126235560|NCT02937701|454155187|FG002|Week 22 to Week 50|Physician Decision|2|||
126235561|NCT02937701|454155188|FG003|Week 22 to Week 50|Physician Decision|0|||
126235562|NCT02937701|454155189|FG004|Week 22 to Week 50|Physician Decision|1|||
126235563|NCT02937701|454155185|FG000|Week 22 to Week 50|Other|0|||
126235564|NCT02937701|454155186|FG001|Week 22 to Week 50|Other|0|||
126235565|NCT02937701|454155187|FG002|Week 22 to Week 50|Other|0|||
126235566|NCT02937701|454155188|FG003|Week 22 to Week 50|Other|0|||
126235567|NCT02937701|454155189|FG004|Week 22 to Week 50|Other|1|||
126235568|NCT03292653|454155191|FG000|Overall Study|Adverse Event|0|||
126235569|NCT03292653|454155192|FG001|Overall Study|Adverse Event|0|||
126235570|NCT03292653|454155193|FG002|Overall Study|Adverse Event|1|||
126235571|NCT03292653|454155191|FG000|Overall Study|Did not Receive Treatment|1|||
126235572|NCT03292653|454155192|FG001|Overall Study|Did not Receive Treatment|0|||
126235573|NCT03292653|454155193|FG002|Overall Study|Did not Receive Treatment|0|||
126235574|NCT04720664|454155194|FG000|Overall Study|Adverse Event|2|||
126235575|NCT04720664|454155194|FG000|Overall Study|Lack of Efficacy|9|||
126235576|NCT00623779|454155198|FG000|Overall Study|Adverse Event|1|||
126235577|NCT00623779|454155199|FG001|Overall Study|Adverse Event|3|||
126023321|NCT02590432|453380679|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
126023322|NCT02590432|453380680|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
126023323|NCT02590432|453380681|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
126023324|NCT02590432|453380682|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
126023325|NCT02590432|453380674|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126023326|NCT02590432|453380675|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126235578|NCT00623779|454155200|FG002|Overall Study|Adverse Event|0|||
126235579|NCT00623779|454155198|FG000|Overall Study|Criteria from CSR|2|||
126235580|NCT00623779|454155199|FG001|Overall Study|Criteria from CSR|0|||
126235581|NCT00623779|454155200|FG002|Overall Study|Criteria from CSR|1|||
126023327|NCT02590432|453380676|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
126023328|NCT02590432|453380677|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126023329|NCT02590432|453380678|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
126023330|NCT02590432|453380679|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
126235582|NCT01856309|454155201|FG000|Overall Study|Death|4|||
126235583|NCT01856309|454155202|FG001|Overall Study|Death|6|||
126235584|NCT01856309|454155203|FG002|Overall Study|Death|11|||
126235585|NCT01856309|454155204|FG003|Overall Study|Death|6|||
126235586|NCT01856309|454155201|FG000|Overall Study|Lost to Follow-up|6|||
126235587|NCT01856309|454155202|FG001|Overall Study|Lost to Follow-up|2|||
126235588|NCT01856309|454155203|FG002|Overall Study|Lost to Follow-up|4|||
126235589|NCT01856309|454155204|FG003|Overall Study|Lost to Follow-up|8|||
126235590|NCT01856309|454155201|FG000|Overall Study|Withdrawal by Subject|11|||
126235591|NCT01856309|454155202|FG001|Overall Study|Withdrawal by Subject|13|||
126235592|NCT01856309|454155203|FG002|Overall Study|Withdrawal by Subject|28|||
126235593|NCT01856309|454155204|FG003|Overall Study|Withdrawal by Subject|26|||
126235594|NCT01856309|454155201|FG000|Overall Study|Other|227|||
126235595|NCT01856309|454155202|FG001|Overall Study|Other|225|||
126235596|NCT01856309|454155203|FG002|Overall Study|Other|447|||
126235597|NCT01856309|454155204|FG003|Overall Study|Other|469|||
126235598|NCT01856309|454155201|FG000|Overall Study|Lack of Efficacy|14|||
126235599|NCT01856309|454155202|FG001|Overall Study|Lack of Efficacy|9|||
126235600|NCT01856309|454155203|FG002|Overall Study|Lack of Efficacy|40|||
126235601|NCT01856309|454155204|FG003|Overall Study|Lack of Efficacy|25|||
126235602|NCT01856309|454155201|FG000|Overall Study|Adverse Event|31|||
126023331|NCT02590432|453380680|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
126023332|NCT02590432|453380681|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
126023333|NCT02590432|453380682|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
126023334|NCT02590432|453380674|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126023335|NCT02590432|453380675|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126023336|NCT02590432|453380676|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126023337|NCT02590432|453380677|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126023338|NCT02590432|453380678|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126023339|NCT02590432|453380679|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
126023340|NCT02590432|453380680|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126023341|NCT02590432|453380681|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126023342|NCT02590432|453380682|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126023343|NCT02590432|453380674|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126023344|NCT02590432|453380675|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126023345|NCT02590432|453380676|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126023346|NCT02590432|453380677|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126023347|NCT02590432|453380678|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126235603|NCT01856309|454155202|FG001|Overall Study|Adverse Event|31|||
126235604|NCT01856309|454155203|FG002|Overall Study|Adverse Event|55|||
126235605|NCT01856309|454155204|FG003|Overall Study|Adverse Event|65|||
126235606|NCT01856309|454155201|FG000|Overall Study|Pregnancy|0|||
126235607|NCT01856309|454155202|FG001|Overall Study|Pregnancy|0|||
126235608|NCT01856309|454155203|FG002|Overall Study|Pregnancy|0|||
126235609|NCT01856309|454155204|FG003|Overall Study|Pregnancy|1|||
126235610|NCT01856309|454155201|FG000|Overall Study|Physician Decision|6|||
126235611|NCT01856309|454155202|FG001|Overall Study|Physician Decision|1|||
126235612|NCT01856309|454155203|FG002|Overall Study|Physician Decision|6|||
126235613|NCT01856309|454155204|FG003|Overall Study|Physician Decision|8|||
126235614|NCT01856309|454155201|FG000|Overall Study|Noncompliance With Study Drug|0|||
126023348|NCT02590432|453380679|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126235615|NCT01856309|454155202|FG001|Overall Study|Noncompliance With Study Drug|1|||
126235616|NCT01856309|454155203|FG002|Overall Study|Noncompliance With Study Drug|4|||
126235617|NCT01856309|454155204|FG003|Overall Study|Noncompliance With Study Drug|1|||
126235618|NCT03657160|454155205|FG000|Overall Study|Adverse Event|5|||
126235619|NCT03657160|454155206|FG001|Overall Study|Adverse Event|6|||
126235620|NCT03657160|454155205|FG000|Overall Study|Protocol Deviation|3|||
126235621|NCT03657160|454155206|FG001|Overall Study|Protocol Deviation|0|||
126235622|NCT03657160|454155205|FG000|Overall Study|Withdrawal by Subject|18|||
126235623|NCT03657160|454155206|FG001|Overall Study|Withdrawal by Subject|16|||
126235624|NCT03657160|454155205|FG000|Overall Study|Site Termination|1|||
126235625|NCT03657160|454155206|FG001|Overall Study|Site Termination|0|||
126235626|NCT03657160|454155205|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
126235627|NCT03657160|454155206|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
126235628|NCT03657160|454155205|FG000|Overall Study|Death|33|||
126235629|NCT03657160|454155206|FG001|Overall Study|Death|26|||
126235630|NCT03657160|454155205|FG000|Overall Study|Death (COVID-19-Related)|1|||
126235631|NCT03657160|454155206|FG001|Overall Study|Death (COVID-19-Related)|0|||
126235632|NCT03657160|454155205|FG000|Overall Study|Reason Not Specified|5|||
126235633|NCT03657160|454155206|FG001|Overall Study|Reason Not Specified|5|||
126235634|NCT03657160|454155205|FG000|Overall Study|Other (COVID-19-Related)|0|||
126235635|NCT03657160|454155206|FG001|Overall Study|Other (COVID-19-Related)|1|||
126235636|NCT02732210|454155208|FG000|Overall Study|Site Closed|0|||
126235637|NCT02732210|454155209|FG001|Overall Study|Site Closed|11|||
126235638|NCT02732210|454155208|FG000|Overall Study|Study Ended|13|||
126235639|NCT02732210|454155209|FG001|Overall Study|Study Ended|13|||
126235640|NCT02732210|454155208|FG000|Overall Study|Withdrawal by Subject|28|||
126235641|NCT02732210|454155209|FG001|Overall Study|Withdrawal by Subject|87|||
126235642|NCT02732210|454155208|FG000|Overall Study|Lost to Follow-up|5|||
126235643|NCT02732210|454155209|FG001|Overall Study|Lost to Follow-up|57|||
126235644|NCT02732210|454155208|FG000|Overall Study|Death|4|||
126235645|NCT02732210|454155209|FG001|Overall Study|Death|15|||
126235646|NCT02732210|454155208|FG000|Overall Study|Other|35|||
126235647|NCT02732210|454155209|FG001|Overall Study|Other|103|||
126235648|NCT02732210|454155208|FG000|Overall Study|Missing|0|||
126235649|NCT02732210|454155209|FG001|Overall Study|Missing|8|||
126235650|NCT01434693|454155212|FG000|Overall Study|Adverse Event|1|||
126235651|NCT01434693|454155213|FG001|Overall Study|Adverse Event|0|||
126235652|NCT01434693|454155214|FG002|Overall Study|Adverse Event|0|||
126235653|NCT01434693|454155215|FG003|Overall Study|Adverse Event|0|||
126235654|NCT01434693|454155212|FG000|Overall Study|Withdrawal by Subject|1|||
126235655|NCT01434693|454155213|FG001|Overall Study|Withdrawal by Subject|0|||
126235656|NCT01434693|454155214|FG002|Overall Study|Withdrawal by Subject|1|||
126235657|NCT01434693|454155215|FG003|Overall Study|Withdrawal by Subject|1|||
126235658|NCT01434693|454155212|FG000|Overall Study|Lost to Follow-up|1|||
126235659|NCT01434693|454155213|FG001|Overall Study|Lost to Follow-up|0|||
126093266|NCT03309813|453634571|FG000|Main Randomized Study|Withdrawal by Subject|1|||
126093267|NCT03309813|453634572|FG001|Main Randomized Study|Withdrawal by Subject|0|||
126093268|NCT01989169|453634575|FG000|Period 2|Adverse Event|0|||
126093269|NCT01989169|453634576|FG001|Period 2|Adverse Event|1|||
126093270|NCT02406677|453634577|FG000|Overall Study|Death|16|||
126093271|NCT02406677|453634578|FG001|Overall Study|Death|8|||
126093272|NCT02406677|453634577|FG000|Overall Study|Discharged without P2Y12|1|||
126093273|NCT02406677|453634578|FG001|Overall Study|Discharged without P2Y12|3|||
126093274|NCT02406677|453634577|FG000|Overall Study|Discharged on prasugrel|283|||
126093275|NCT02406677|453634578|FG001|Overall Study|Discharged on prasugrel|587|||
126235660|NCT01434693|454155214|FG002|Overall Study|Lost to Follow-up|0|||
126235661|NCT01434693|454155215|FG003|Overall Study|Lost to Follow-up|0|||
126235662|NCT01440283|454155216|FG000|Overall Study|Death|3|||
126093276|NCT02406677|453634577|FG000|Overall Study|Withdrawal by Subject|1|||
126093277|NCT02406677|453634578|FG001|Overall Study|Withdrawal by Subject|0|||
126093278|NCT04531904|453634579|FG000|Overall Study|Lost to Follow-up|1|||
126093279|NCT04531904|453634579|FG000|Overall Study|Death|14|||
126093280|NCT00283244|453634580|FG000|Overall Study|Adverse Event|0|||
126093281|NCT00283244|453634581|FG001|Overall Study|Adverse Event|8|||
126093282|NCT00283244|453634582|FG002|Overall Study|Adverse Event|11|||
126093283|NCT00283244|453634580|FG000|Overall Study|Death|4|||
126093284|NCT00283244|453634581|FG001|Overall Study|Death|3|||
126093285|NCT00283244|453634582|FG002|Overall Study|Death|2|||
126093286|NCT00283244|453634580|FG000|Overall Study|Lack of Efficacy|8|||
126093287|NCT00283244|453634581|FG001|Overall Study|Lack of Efficacy|32|||
126093288|NCT00283244|453634582|FG002|Overall Study|Lack of Efficacy|26|||
126093289|NCT00283244|453634580|FG000|Overall Study|Withdrawal by Subject|1|||
126093290|NCT00283244|453634581|FG001|Overall Study|Withdrawal by Subject|2|||
126093291|NCT00283244|453634582|FG002|Overall Study|Withdrawal by Subject|2|||
126235663|NCT01440283|454155216|FG000|Overall Study|Withdrawal by Subject|4|||
126235664|NCT01440283|454155216|FG000|Overall Study|Physician Decision|3|||
126354773|NCT03345095|454589480|FG000|Overall Study|Withdrawal by Subject|22|||
126354774|NCT03345095|454589481|FG001|Overall Study|Withdrawal by Subject|59|||
126354775|NCT03345095|454589480|FG000|Overall Study|Physician Decision|3|||
126354776|NCT03345095|454589481|FG001|Overall Study|Physician Decision|18|||
126354777|NCT03345095|454589480|FG000|Overall Study|Death|2|||
126354778|NCT03345095|454589481|FG001|Overall Study|Death|4|||
126354779|NCT03345095|454589480|FG000|Overall Study|Other reasons|2|||
126354780|NCT03345095|454589481|FG001|Overall Study|Other reasons|11|||
126354781|NCT03345095|454589480|FG000|Overall Study|Protocol Violation|0|||
126354782|NCT03345095|454589481|FG001|Overall Study|Protocol Violation|1|||
126354783|NCT01121575|454589482|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
126354784|NCT01121575|454589483|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
126354785|NCT01121575|454589484|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
126354786|NCT01121575|454589485|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
126354787|NCT01121575|454589486|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
126354788|NCT01121575|454589487|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
126354789|NCT01121575|454589482|FG000|Overall Study|Unspecified Reasons|8|||
126354790|NCT01121575|454589483|FG001|Overall Study|Unspecified Reasons|6|||
126354791|NCT01121575|454589484|FG002|Overall Study|Unspecified Reasons|7|||
126354792|NCT01121575|454589485|FG003|Overall Study|Unspecified Reasons|5|||
126354793|NCT01121575|454589486|FG004|Overall Study|Unspecified Reasons|13|||
126354794|NCT01121575|454589487|FG005|Overall Study|Unspecified Reasons|10|||
126354795|NCT01121575|454589482|FG000|Overall Study|Death|6|||
126354796|NCT01121575|454589483|FG001|Overall Study|Death|0|||
126354797|NCT01121575|454589484|FG002|Overall Study|Death|0|||
126354798|NCT01121575|454589485|FG003|Overall Study|Death|1|||
126354799|NCT01121575|454589486|FG004|Overall Study|Death|7|||
126354800|NCT01121575|454589487|FG005|Overall Study|Death|1|||
126354801|NCT03158311|454589488|FG000|Overall Study|Subject/Guardian Decision|10|||
126354802|NCT03158311|454589489|FG001|Overall Study|Subject/Guardian Decision|6|||
126354803|NCT03158311|454589490|FG002|Overall Study|Subject/Guardian Decision|11|||
126354804|NCT03158311|454589488|FG000|Overall Study|Adverse Event|5|||
126354805|NCT03158311|454589489|FG001|Overall Study|Adverse Event|3|||
126354806|NCT03158311|454589490|FG002|Overall Study|Adverse Event|3|||
126354807|NCT03158311|454589488|FG000|Overall Study|Techinical Problems|3|||
126354808|NCT03158311|454589489|FG001|Overall Study|Techinical Problems|1|||
126354809|NCT03158311|454589490|FG002|Overall Study|Techinical Problems|5|||
126354810|NCT03158311|454589488|FG000|Overall Study|Physician Decision|2|||
126354811|NCT03158311|454589489|FG001|Overall Study|Physician Decision|3|||
126093292|NCT00283244|453634580|FG000|Overall Study|Physician Decision|0|||
126354812|NCT03158311|454589490|FG002|Overall Study|Physician Decision|7|||
126354813|NCT03158311|454589488|FG000|Overall Study|Lost to Follow-up|1|||
126354814|NCT03158311|454589489|FG001|Overall Study|Lost to Follow-up|1|||
126354815|NCT03158311|454589490|FG002|Overall Study|Lost to Follow-up|1|||
126354816|NCT03158311|454589488|FG000|Overall Study|Sponsor decision|1|||
126354817|NCT03158311|454589489|FG001|Overall Study|Sponsor decision|0|||
126354818|NCT03158311|454589490|FG002|Overall Study|Sponsor decision|0|||
126354819|NCT03158311|454589488|FG000|Overall Study|Pregnancy|0|||
126354820|NCT03158311|454589489|FG001|Overall Study|Pregnancy|2|||
126354821|NCT03158311|454589490|FG002|Overall Study|Pregnancy|0|||
126354822|NCT03158311|454589488|FG000|Overall Study|Randomized in error|0|||
126354823|NCT03158311|454589489|FG001|Overall Study|Randomized in error|0|||
126354824|NCT03158311|454589490|FG002|Overall Study|Randomized in error|1|||
126354825|NCT02665455|454589492|FG000|Overall Study|Withdrawal by Subject|6|||
126354826|NCT02665455|454589492|FG000|Overall Study|Lost to Follow-up|1|||
126354827|NCT02665455|454589492|FG000|Overall Study|Adverse Event|1|||
126354828|NCT02665455|454589492|FG000|Overall Study|Protocol Violation|1|||
126354829|NCT00724503|454589493|FG000|Overall Study|Lost to Follow-up|4|||
126354830|NCT00724503|454589494|FG001|Overall Study|Lost to Follow-up|8|||
126354831|NCT00724503|454589493|FG000|Overall Study|Withdrawal by Subject|11|||
126354832|NCT00724503|454589494|FG001|Overall Study|Withdrawal by Subject|23|||
126354833|NCT00724503|454589493|FG000|Overall Study|Death|190|||
126354834|NCT00724503|454589494|FG001|Overall Study|Death|182|||
126354835|NCT00724503|454589493|FG000|Overall Study|Adverse Event|1|||
126354836|NCT00724503|454589494|FG001|Overall Study|Adverse Event|0|||
126354837|NCT00724503|454589493|FG000|Overall Study|Not otherwise specified|4|||
126354838|NCT00724503|454589494|FG001|Overall Study|Not otherwise specified|7|||
126354839|NCT01186419|454589495|FG000|Overall Study|Withdrawal by Subject|5|||
126093293|NCT00283244|453634581|FG001|Overall Study|Physician Decision|0|||
126093294|NCT00283244|453634582|FG002|Overall Study|Physician Decision|1|||
126093295|NCT00283244|453634580|FG000|Overall Study|Medical illness (other complicating dz)|4|||
126093296|NCT00283244|453634581|FG001|Overall Study|Medical illness (other complicating dz)|3|||
126093297|NCT00283244|453634582|FG002|Overall Study|Medical illness (other complicating dz)|6|||
126093298|NCT00283244|453634580|FG000|Overall Study|Clinical deterioration|1|||
126093299|NCT00283244|453634581|FG001|Overall Study|Clinical deterioration|3|||
126093300|NCT00283244|453634582|FG002|Overall Study|Clinical deterioration|3|||
126093301|NCT00658788|453634583|FG000|Overall Study|Adverse Event|11|||
126093302|NCT00658788|453634583|FG000|Overall Study|Withdrawal by Subject|13|||
126093303|NCT00658788|453634583|FG000|Overall Study|Lost to Follow-up|18|||
126093304|NCT00658788|453634583|FG000|Overall Study|Treatment Discontinuation|32|||
126093305|NCT00653523|453634584|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
126093306|NCT00653523|453634584|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
126093307|NCT00653523|453634584|FG000|Overall Study|Adverse Event|7|||
126093308|NCT00653523|453634584|FG000|Overall Study|Withdrawal by Subject|6|||
126093309|NCT00653523|453634584|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
126093310|NCT00653523|453634584|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
126093311|NCT05384938|453634585|FG000|Overall Study|Withdrawal by Subject|8|||
126093312|NCT05384938|453634585|FG000|Overall Study|Lost to Follow-up|6|||
126093313|NCT05384938|453634585|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
126093314|NCT03843554|453636011|FG000|Overall Study|Physician Decision|0|||
126093315|NCT03843554|453636012|FG001|Overall Study|Physician Decision|2|||
126093316|NCT04396366|453636013|FG000|Overall Study|Adverse Event|1|||
126093317|NCT04396366|453636014|FG001|Overall Study|Adverse Event|0|||
126093318|NCT00166712|453636016|FG000|Overall Study|Death|0|||
126093319|NCT00166712|453636017|FG001|Overall Study|Death|1|||
126093320|NCT00166712|453636016|FG000|Overall Study|Adverse Event|1|||
126093321|NCT00166712|453636017|FG001|Overall Study|Adverse Event|0|||
126093322|NCT00166712|453636016|FG000|Overall Study|Withdrawal by Subject|1|||
126093323|NCT00166712|453636017|FG001|Overall Study|Withdrawal by Subject|2|||
126093324|NCT00166712|453636016|FG000|Overall Study|Physician Decision|0|||
126093325|NCT00166712|453636017|FG001|Overall Study|Physician Decision|2|||
126354840|NCT01186419|454589496|FG001|Overall Study|Withdrawal by Subject|3|||
126354841|NCT01186419|454589495|FG000|Overall Study|Adverse Event|1|||
126354842|NCT01186419|454589496|FG001|Overall Study|Adverse Event|2|||
126093326|NCT03986944|453636018|FG000|Overall Study|Adverse Event|1|||
126093327|NCT03986944|453636019|FG001|Overall Study|Adverse Event|2|||
126093328|NCT03986944|453636020|FG002|Overall Study|Adverse Event|3|||
126093329|NCT03986944|453636018|FG000|Overall Study|Protocol Violation|0|||
126354843|NCT01186419|454589495|FG000|Overall Study|Physician Decision|0|||
126093330|NCT03986944|453636019|FG001|Overall Study|Protocol Violation|1|||
126093331|NCT03986944|453636020|FG002|Overall Study|Protocol Violation|1|||
126354844|NCT01186419|454589496|FG001|Overall Study|Physician Decision|3|||
126354845|NCT01186419|454589495|FG000|Overall Study|Other|1|||
126354846|NCT01186419|454589496|FG001|Overall Study|Other|1|||
126354847|NCT01928771|454589500|FG000|Overall Study|Adverse Event|6|||
126354848|NCT01928771|454589501|FG001|Overall Study|Adverse Event|5|||
126023349|NCT02590432|453380680|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126023350|NCT02590432|453380681|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
126023351|NCT02590432|453380682|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
126023352|NCT02590432|453380674|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126023353|NCT02590432|453380675|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126023354|NCT02590432|453380676|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126023355|NCT02590432|453380677|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126023356|NCT02590432|453380678|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126023357|NCT02590432|453380679|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126023358|NCT02590432|453380680|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126023359|NCT02590432|453380681|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
126023360|NCT02590432|453380682|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126023361|NCT02590432|453380674|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126023362|NCT02590432|453380675|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126023363|NCT02590432|453380676|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126023364|NCT02590432|453380677|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126023365|NCT02590432|453380678|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126023366|NCT02590432|453380679|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126023367|NCT02590432|453380680|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126023368|NCT02590432|453380681|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
126023369|NCT02590432|453380682|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
126023370|NCT02590432|453380674|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126023371|NCT02590432|453380675|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126023372|NCT02590432|453380676|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126023373|NCT02590432|453380677|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126023374|NCT02590432|453380678|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126023375|NCT02590432|453380679|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126023376|NCT02590432|453380680|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126023377|NCT02590432|453380681|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126023378|NCT02590432|453380682|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
126023379|NCT02590432|453380674|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126023380|NCT02590432|453380675|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126023381|NCT02590432|453380676|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126023382|NCT02590432|453380677|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126023383|NCT02590432|453380678|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126023384|NCT02590432|453380679|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126023385|NCT02590432|453380680|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126023386|NCT02590432|453380681|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126023387|NCT02590432|453380682|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
126023388|NCT02590432|453380674|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126023389|NCT02590432|453380675|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126023390|NCT02590432|453380676|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126023391|NCT02590432|453380677|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126354849|NCT01928771|454589502|FG002|Overall Study|Adverse Event|1|||
126354850|NCT01928771|454589500|FG000|Overall Study|Death|2|||
126354851|NCT01928771|454589501|FG001|Overall Study|Death|2|||
126354852|NCT01928771|454589502|FG002|Overall Study|Death|2|||
126354853|NCT01928771|454589500|FG000|Overall Study|Lost to Follow-up|5|||
126354854|NCT01928771|454589501|FG001|Overall Study|Lost to Follow-up|6|||
126354855|NCT01928771|454589502|FG002|Overall Study|Lost to Follow-up|3|||
126354856|NCT01928771|454589500|FG000|Overall Study|Withdrawal by Subject|20|||
126354857|NCT01928771|454589501|FG001|Overall Study|Withdrawal by Subject|15|||
126354858|NCT01928771|454589502|FG002|Overall Study|Withdrawal by Subject|17|||
126354859|NCT01928771|454589500|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
126354860|NCT01928771|454589501|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
126354861|NCT01928771|454589502|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
126354862|NCT01928771|454589500|FG000|Overall Study|Other Reasons|9|||
126354863|NCT01928771|454589501|FG001|Overall Study|Other Reasons|9|||
126354864|NCT01928771|454589502|FG002|Overall Study|Other Reasons|14|||
126354865|NCT01928771|454589500|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
126354866|NCT01928771|454589501|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
126354867|NCT01928771|454589502|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
126354868|NCT03932331|454589503|FG000|Overall Study|Death|0|||
126354869|NCT03932331|454589504|FG001|Overall Study|Death|7|||
126354870|NCT03932331|454589505|FG002|Overall Study|Death|2|||
126354871|NCT03932331|454589503|FG000|Overall Study|Withdrawal by Subject|0|||
126023392|NCT02590432|453380678|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126023393|NCT02590432|453380679|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126023394|NCT02590432|453380680|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126023395|NCT02590432|453380681|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
126023396|NCT02590432|453380682|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126046476|NCT02467270|453468226|FG000|Overall Study|Withdrawal by Subject|4|||
125878743|NCT03175367|452853405|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
126354872|NCT03932331|454589504|FG001|Overall Study|Withdrawal by Subject|3|||
126354873|NCT03932331|454589505|FG002|Overall Study|Withdrawal by Subject|0|||
126354874|NCT03932331|454589503|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
126354875|NCT03932331|454589504|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
126354876|NCT03932331|454589505|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
126354877|NCT03932331|454589503|FG000|Overall Study|Progressive disease|3|||
126354878|NCT03932331|454589504|FG001|Overall Study|Progressive disease|0|||
126354879|NCT03932331|454589505|FG002|Overall Study|Progressive disease|0|||
126354880|NCT03932331|454589503|FG000|Overall Study|Lung infection|1|||
126354881|NCT03932331|454589504|FG001|Overall Study|Lung infection|0|||
126354882|NCT03932331|454589505|FG002|Overall Study|Lung infection|0|||
126354883|NCT03932331|454589503|FG000|Overall Study|Other|0|||
126354884|NCT03932331|454589504|FG001|Overall Study|Other|0|||
126354885|NCT03932331|454589505|FG002|Overall Study|Other|58|||
126354886|NCT01937117|454589506|FG000|Overall Study|Disease Progression|7|||
126354887|NCT01937117|454589506|FG000|Overall Study|Physician Decision|4|||
126354888|NCT01937117|454589506|FG000|Overall Study|Adverse Event|2|||
126354889|NCT04633447|454591159|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
126354890|NCT04633447|454591160|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
126354891|NCT04633447|454591159|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
126354892|NCT04633447|454591160|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
126354893|NCT04633447|454591159|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
126354894|NCT04633447|454591160|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
126354895|NCT04633447|454591159|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
126354896|NCT04633447|454591160|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
126354897|NCT04633447|454591159|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
126354898|NCT04633447|454591160|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
126354899|NCT04633447|454591159|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
126354900|NCT04633447|454591160|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
126354901|NCT01500096|454591162|FG000|Overall Study|Lost to Follow-up|1|||
126354902|NCT01500096|454591163|FG001|Overall Study|Lost to Follow-up|0|||
126354903|NCT01500096|454591164|FG002|Overall Study|Lost to Follow-up|0|||
126354904|NCT01500096|454591165|FG003|Overall Study|Lost to Follow-up|2|||
126354905|NCT01734928|454591166|FG000|Randomization|Physician Decision|0|||
126354906|NCT01734928|454591167|FG001|Randomization|Physician Decision|1|||
126354907|NCT01734928|454591166|FG000|Randomization|clinical progression|0|||
126354908|NCT01734928|454591167|FG001|Randomization|clinical progression|1|||
126354909|NCT01734928|454591166|FG000|Randomization|progressive disease|0|||
126354910|NCT01734928|454591167|FG001|Randomization|progressive disease|2|||
126354911|NCT01734928|454591166|FG000|Randomization|Withdrew informed consent|0|||
126354912|NCT01734928|454591167|FG001|Randomization|Withdrew informed consent|4|||
126354913|NCT01734928|454591166|FG000|Randomization|Death|1|||
126354914|NCT01734928|454591167|FG001|Randomization|Death|0|||
126354915|NCT01734928|454591166|FG000|Randomization|Randomization error|1|||
126354916|NCT01734928|454591167|FG001|Randomization|Randomization error|0|||
126354917|NCT01734928|454591166|FG000|Randomization|Lost to Follow-up|1|||
126354918|NCT01734928|454591167|FG001|Randomization|Lost to Follow-up|0|||
126354919|NCT01734928|454591166|FG000|Treatment Period|Lost to Follow-up|0|||
126354920|NCT01734928|454591167|FG001|Treatment Period|Lost to Follow-up|2|||
126354921|NCT01734928|454591166|FG000|Treatment Period|Progressive Disease|167|||
126354922|NCT01734928|454591167|FG001|Treatment Period|Progressive Disease|165|||
126354923|NCT01734928|454591166|FG000|Treatment Period|Adverse Event|39|||
126354924|NCT01734928|454591167|FG001|Treatment Period|Adverse Event|52|||
126354925|NCT01734928|454591166|FG000|Treatment Period|Withdrawal of Consent|25|||
126354926|NCT01734928|454591167|FG001|Treatment Period|Withdrawal of Consent|22|||
126354927|NCT01734928|454591166|FG000|Treatment Period|Death|20|||
126354928|NCT01734928|454591167|FG001|Treatment Period|Death|9|||
126354929|NCT01734928|454591166|FG000|Treatment Period|Other Reasons|27|||
126354930|NCT01734928|454591167|FG001|Treatment Period|Other Reasons|19|||
126354931|NCT01734928|454591166|FG000|Treatment Period|Pregnancy|0|||
126354932|NCT01734928|454591167|FG001|Treatment Period|Pregnancy|1|||
126354933|NCT03600350|454591168|FG000|Overall Study|Death|1|||
126354934|NCT03600350|454591168|FG000|Overall Study|On Follow Up|18|||
126354935|NCT01105130|454591169|FG000|Overall Study|Withdrawal by Subject|4|||
126354936|NCT01105130|454591170|FG001|Overall Study|Withdrawal by Subject|6|||
126354937|NCT01105130|454591171|FG002|Overall Study|Withdrawal by Subject|2|||
126354938|NCT01105130|454591169|FG000|Overall Study|Never Started|2|||
126354939|NCT01105130|454591170|FG001|Overall Study|Never Started|2|||
126354940|NCT01105130|454591171|FG002|Overall Study|Never Started|4|||
126354941|NCT01105130|454591169|FG000|Overall Study|Toxicity|1|||
126354942|NCT01105130|454591170|FG001|Overall Study|Toxicity|3|||
126354943|NCT01105130|454591171|FG002|Overall Study|Toxicity|2|||
126354944|NCT01105130|454591169|FG000|Overall Study|Multiple Reasons|3|||
126354945|NCT01105130|454591170|FG001|Overall Study|Multiple Reasons|0|||
126354946|NCT01105130|454591171|FG002|Overall Study|Multiple Reasons|2|||
126354947|NCT01363440|454591174|FG000|Overall Study|Adverse Event|5|||
126354948|NCT01363440|454591175|FG001|Overall Study|Adverse Event|4|||
126023397|NCT02590432|453380674|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126023398|NCT02590432|453380675|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126354949|NCT01363440|454591176|FG002|Overall Study|Adverse Event|4|||
126354950|NCT01363440|454591174|FG000|Overall Study|Death|3|||
126354951|NCT01363440|454591175|FG001|Overall Study|Death|7|||
126354952|NCT01363440|454591176|FG002|Overall Study|Death|5|||
126354953|NCT01363440|454591174|FG000|Overall Study|Withdrawal by Subject|9|||
126354954|NCT01363440|454591175|FG001|Overall Study|Withdrawal by Subject|11|||
126354955|NCT01363440|454591176|FG002|Overall Study|Withdrawal by Subject|11|||
126354956|NCT01363440|454591174|FG000|Overall Study|Lost to Follow-up|2|||
126354957|NCT01363440|454591175|FG001|Overall Study|Lost to Follow-up|4|||
126354958|NCT01363440|454591176|FG002|Overall Study|Lost to Follow-up|5|||
126354959|NCT01363440|454591174|FG000|Overall Study|Other|4|||
126354960|NCT01363440|454591175|FG001|Overall Study|Other|5|||
126354961|NCT01363440|454591176|FG002|Overall Study|Other|2|||
126354962|NCT02323334|454591177|FG000|Period 3|Lost to Follow-up|0|||
126354963|NCT02323334|454591178|FG001|Period 3|Lost to Follow-up|0|||
126354964|NCT02323334|454591179|FG002|Period 3|Lost to Follow-up|1|||
126354965|NCT02323334|454591180|FG003|Period 3|Lost to Follow-up|0|||
126354966|NCT02323334|454591181|FG004|Period 3|Lost to Follow-up|0|||
126354967|NCT02323334|454591182|FG005|Period 3|Lost to Follow-up|0|||
126354968|NCT02323334|454591183|FG006|Period 3|Lost to Follow-up|0|||
126354969|NCT02323334|454591184|FG007|Period 3|Lost to Follow-up|0|||
126354970|NCT02323334|454591185|FG008|Period 3|Lost to Follow-up|0|||
126354971|NCT02323334|454591186|FG009|Period 3|Lost to Follow-up|0|||
126354972|NCT02323334|454591187|FG010|Period 3|Lost to Follow-up|0|||
126354973|NCT02323334|454591188|FG011|Period 3|Lost to Follow-up|0|||
126354974|NCT02323334|454591189|FG012|Period 3|Lost to Follow-up|0|||
126354975|NCT02323334|454591190|FG013|Period 3|Lost to Follow-up|0|||
126354976|NCT02323334|454591191|FG014|Period 3|Lost to Follow-up|0|||
126354977|NCT02323334|454591192|FG015|Period 3|Lost to Follow-up|0|||
126354978|NCT02323334|454591193|FG016|Period 3|Lost to Follow-up|0|||
126354979|NCT02323334|454591177|FG000|Period 3|Withdrawal by Subject|1|||
126354980|NCT02323334|454591178|FG001|Period 3|Withdrawal by Subject|0|||
126354981|NCT02323334|454591179|FG002|Period 3|Withdrawal by Subject|0|||
126354982|NCT02323334|454591180|FG003|Period 3|Withdrawal by Subject|0|||
126354983|NCT02323334|454591181|FG004|Period 3|Withdrawal by Subject|0|||
126354984|NCT02323334|454591182|FG005|Period 3|Withdrawal by Subject|0|||
126354985|NCT02323334|454591183|FG006|Period 3|Withdrawal by Subject|0|||
126354986|NCT02323334|454591184|FG007|Period 3|Withdrawal by Subject|0|||
126354987|NCT02323334|454591185|FG008|Period 3|Withdrawal by Subject|0|||
126354988|NCT02323334|454591186|FG009|Period 3|Withdrawal by Subject|0|||
126354989|NCT02323334|454591187|FG010|Period 3|Withdrawal by Subject|0|||
126354990|NCT02323334|454591188|FG011|Period 3|Withdrawal by Subject|0|||
126354991|NCT02323334|454591189|FG012|Period 3|Withdrawal by Subject|0|||
126354992|NCT02323334|454591190|FG013|Period 3|Withdrawal by Subject|0|||
126354993|NCT02323334|454591191|FG014|Period 3|Withdrawal by Subject|0|||
126354994|NCT02323334|454591192|FG015|Period 3|Withdrawal by Subject|0|||
126354995|NCT02323334|454591193|FG016|Period 3|Withdrawal by Subject|0|||
126354996|NCT03520569|454591195|FG000|Overall Study|Withdrawal by Subject|1|||
126354997|NCT03422718|454591196|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
126354998|NCT03422718|454591197|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
126354999|NCT03422718|454591198|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
126355000|NCT03422718|454591199|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
126355001|NCT03422718|454591200|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
126355002|NCT03422718|454591201|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
126355003|NCT03422718|454591202|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
126355004|NCT03422718|454591203|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
126355005|NCT03422718|454591196|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
126355006|NCT03422718|454591197|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
126355007|NCT03422718|454591198|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
126355008|NCT03422718|454591199|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
126355009|NCT03422718|454591200|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
126355010|NCT03422718|454591201|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
126355011|NCT03422718|454591202|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
126355012|NCT03422718|454591203|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
126355013|NCT03422718|454591196|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
126355014|NCT03422718|454591197|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
126355015|NCT03422718|454591198|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
126355016|NCT03422718|454591199|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
126355017|NCT03422718|454591200|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
126355018|NCT03422718|454591201|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
126355019|NCT03422718|454591202|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
126023399|NCT02590432|453380676|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126023400|NCT02590432|453380677|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126023401|NCT02590432|453380678|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126023402|NCT02590432|453380679|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126235665|NCT00440557|454155218|FG000|Overall Study|Withdrawal by Subject|10|||
126235666|NCT00440557|454155219|FG001|Overall Study|Withdrawal by Subject|5|||
126235667|NCT00440557|454155220|FG002|Overall Study|Withdrawal by Subject|11|||
126093332|NCT03986944|453636018|FG000|Overall Study|Withdrawal by Subject|3|||
126235668|NCT00440557|454155218|FG000|Overall Study|Lost to Follow-up|1|||
126093333|NCT03986944|453636019|FG001|Overall Study|Withdrawal by Subject|5|||
126235669|NCT00440557|454155219|FG001|Overall Study|Lost to Follow-up|2|||
126235670|NCT00440557|454155220|FG002|Overall Study|Lost to Follow-up|6|||
126355020|NCT03422718|454591203|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
126355021|NCT03422718|454591196|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355022|NCT03422718|454591197|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
126355023|NCT03422718|454591198|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355024|NCT03422718|454591199|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355025|NCT03422718|454591200|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
126355026|NCT03422718|454591201|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
126355027|NCT03422718|454591202|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355028|NCT03422718|454591203|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355029|NCT03422718|454591196|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
126355030|NCT03422718|454591197|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
126355031|NCT03422718|454591198|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
126355032|NCT03422718|454591199|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
126355033|NCT03422718|454591200|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
126355034|NCT03422718|454591201|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
126355035|NCT03422718|454591202|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
126355036|NCT03422718|454591203|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
126355037|NCT03422718|454591196|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
126355038|NCT03422718|454591197|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
126355039|NCT03422718|454591198|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
126355040|NCT03422718|454591199|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
126355041|NCT03422718|454591200|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
126355042|NCT03422718|454591201|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
126355043|NCT03422718|454591202|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
126355044|NCT03422718|454591203|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
126355045|NCT01178411|454591204|FG000|Overall Study|Adverse Event|5|||
126355046|NCT01178411|454591204|FG000|Overall Study|Withdrawal by Subject|4|||
126355047|NCT01178411|454591204|FG000|Overall Study|Protocol Violation|1|||
126355048|NCT01178411|454591204|FG000|Overall Study|Progressive disease per RECIST|32|||
126355049|NCT01178411|454591204|FG000|Overall Study|Progressive disease per clinician|9|||
126355050|NCT01178411|454591204|FG000|Overall Study|Physician Decision|6|||
126355051|NCT01178411|454591204|FG000|Overall Study|Death|1|||
126355052|NCT01178411|454591204|FG000|Overall Study|No reason provided|1|||
126355053|NCT01178411|454591204|FG000|Overall Study|Drug manufacturing ended|1|||
126355054|NCT01129284|454591205|FG000|Overall Study|Adverse Event|2|||
126355055|NCT01129284|454591206|FG001|Overall Study|Adverse Event|0|||
126355056|NCT01129284|454591207|FG002|Overall Study|Adverse Event|1|||
126355057|NCT01625182|454591215|FG000|Overall Study|Administrative problems|1|||
126355058|NCT01625182|454591216|FG001|Overall Study|Administrative problems|0|||
126355059|NCT01625182|454591215|FG000|Overall Study|Protocol deviation|0|||
126355060|NCT01625182|454591216|FG001|Overall Study|Protocol deviation|2|||
126355061|NCT01625182|454591215|FG000|Overall Study|Adverse Event|2|||
126355062|NCT01625182|454591216|FG001|Overall Study|Adverse Event|0|||
126355063|NCT01625182|454591215|FG000|Overall Study|Withdrawal by Subject|5|||
126355064|NCT01625182|454591216|FG001|Overall Study|Withdrawal by Subject|1|||
126355065|NCT01625182|454591215|FG000|Overall Study|Lack of Efficacy|12|||
126355066|NCT01625182|454591216|FG001|Overall Study|Lack of Efficacy|8|||
126355067|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
126355068|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
126355069|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
126355070|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
126355071|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
126355072|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
126355073|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
126355074|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
126355075|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
126355076|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
126355077|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
126355078|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
126355079|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
126355080|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
126355081|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
126355082|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
126355083|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
126355084|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
126355085|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
126355086|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
126355087|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
126355088|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
126355089|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
126355090|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
126355091|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
126355092|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
126355093|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
126355094|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
126355095|NCT05427916|454591222|FG000|Overall Study|Adverse Event|3|||
126355096|NCT05427916|454591223|FG001|Overall Study|Adverse Event|0|||
126355097|NCT05427916|454591222|FG000|Overall Study|Lack of Efficacy|6|||
126355098|NCT05427916|454591223|FG001|Overall Study|Lack of Efficacy|0|||
126355099|NCT05427916|454591222|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
126355100|NCT05427916|454591223|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
126355101|NCT03558672|454591224|FG000|Overall Study|Study Early Termination|10|||
126355102|NCT01158404|454591232|FG000|Overall Study|Withdrawal by Subject|0|||
126355103|NCT01158404|454591233|FG001|Overall Study|Withdrawal by Subject|1|||
126355104|NCT01158404|454591234|FG002|Overall Study|Withdrawal by Subject|0|||
126355105|NCT01158404|454591235|FG003|Overall Study|Withdrawal by Subject|0|||
126355106|NCT01158404|454591236|FG004|Overall Study|Withdrawal by Subject|3|||
126355107|NCT01158404|454591237|FG005|Overall Study|Withdrawal by Subject|1|||
126355108|NCT01158404|454591238|FG006|Overall Study|Withdrawal by Subject|0|||
126355109|NCT01158404|454591239|FG007|Overall Study|Withdrawal by Subject|1|||
126355110|NCT01158404|454591232|FG000|Overall Study|Physician Decision|0|||
126355111|NCT01158404|454591233|FG001|Overall Study|Physician Decision|0|||
126355112|NCT01158404|454591234|FG002|Overall Study|Physician Decision|0|||
126355113|NCT01158404|454591235|FG003|Overall Study|Physician Decision|0|||
126355114|NCT01158404|454591236|FG004|Overall Study|Physician Decision|0|||
126355115|NCT01158404|454591237|FG005|Overall Study|Physician Decision|0|||
126355116|NCT01158404|454591238|FG006|Overall Study|Physician Decision|0|||
126355117|NCT01158404|454591239|FG007|Overall Study|Physician Decision|1|||
126355118|NCT01158404|454591232|FG000|Overall Study|Progressive Disease|0|||
126355119|NCT01158404|454591233|FG001|Overall Study|Progressive Disease|0|||
126355120|NCT01158404|454591234|FG002|Overall Study|Progressive Disease|0|||
126355121|NCT01158404|454591235|FG003|Overall Study|Progressive Disease|0|||
126355122|NCT01158404|454591236|FG004|Overall Study|Progressive Disease|0|||
126355123|NCT01158404|454591237|FG005|Overall Study|Progressive Disease|0|||
126355124|NCT01158404|454591238|FG006|Overall Study|Progressive Disease|1|||
126355125|NCT01158404|454591239|FG007|Overall Study|Progressive Disease|0|||
126355126|NCT02384460|454591241|FG000|Overall Study|Protocol Violation|0|||
126355127|NCT02384460|454591242|FG001|Overall Study|Protocol Violation|1|||
126355128|NCT02384460|454591241|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
126355129|NCT02384460|454591242|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
126355130|NCT02384460|454591241|FG000|Overall Study|Adverse Event|5|||
126355131|NCT02384460|454591242|FG001|Overall Study|Adverse Event|2|||
126355132|NCT02384460|454591241|FG000|Overall Study|Withdrawal by Subject|0|||
126355133|NCT02384460|454591242|FG001|Overall Study|Withdrawal by Subject|3|||
126355134|NCT02384460|454591241|FG000|Overall Study|Elective medical treatment|1|||
126355135|NCT02384460|454591242|FG001|Overall Study|Elective medical treatment|0|||
126355136|NCT02384460|454591241|FG000|Overall Study|Non-compliance|1|||
126355137|NCT02384460|454591242|FG001|Overall Study|Non-compliance|0|||
126355138|NCT01060111|454591243|FG000|Overall Study|Adverse Event|9|||
126355139|NCT01060111|454591244|FG001|Overall Study|Adverse Event|5|||
126355140|NCT01060111|454591245|FG002|Overall Study|Adverse Event|18|||
126355141|NCT01060111|454591243|FG000|Overall Study|Lack of Efficacy|2|||
126355142|NCT01060111|454591244|FG001|Overall Study|Lack of Efficacy|1|||
126355143|NCT01060111|454591245|FG002|Overall Study|Lack of Efficacy|0|||
126355144|NCT01060111|454591243|FG000|Overall Study|Inappropriate participant|5|||
126355145|NCT01060111|454591244|FG001|Overall Study|Inappropriate participant|4|||
126355146|NCT01060111|454591245|FG002|Overall Study|Inappropriate participant|5|||
126355147|NCT01060111|454591243|FG000|Overall Study|Participants' evasion for hospital visit|0|||
126355148|NCT01060111|454591244|FG001|Overall Study|Participants' evasion for hospital visit|3|||
126355149|NCT01060111|454591245|FG002|Overall Study|Participants' evasion for hospital visit|2|||
126023403|NCT02590432|453380680|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126023404|NCT02590432|453380681|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
126023405|NCT02590432|453380682|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126023406|NCT04788641|453380688|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
126023407|NCT04788641|453380689|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
126023408|NCT04788641|453380690|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
126023409|NCT04788641|453380691|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
126023410|NCT04788641|453380688|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
126023411|NCT04788641|453380689|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
126023412|NCT04788641|453380690|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
126023413|NCT04788641|453380691|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
126023414|NCT04788641|453380688|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
126023415|NCT04788641|453380689|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
126023416|NCT04788641|453380690|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
126023417|NCT04788641|453380691|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
126355150|NCT01060111|454591243|FG000|Overall Study|Participants' non-cooperation|8|||
126355151|NCT01060111|454591244|FG001|Overall Study|Participants' non-cooperation|6|||
126355152|NCT01060111|454591245|FG002|Overall Study|Participants' non-cooperation|6|||
126355153|NCT01060111|454591243|FG000|Overall Study|Adverse event and insufficient effect|0|||
126355154|NCT01060111|454591244|FG001|Overall Study|Adverse event and insufficient effect|1|||
126355155|NCT01060111|454591245|FG002|Overall Study|Adverse event and insufficient effect|0|||
126355156|NCT01060111|454591243|FG000|Overall Study|Participants' non-cooperation|1|||
126355157|NCT01060111|454591244|FG001|Overall Study|Participants' non-cooperation|0|||
126355158|NCT01060111|454591245|FG002|Overall Study|Participants' non-cooperation|0|||
126355159|NCT01060111|454591243|FG000|Overall Study|Other|2|||
126355160|NCT01060111|454591244|FG001|Overall Study|Other|3|||
126355161|NCT01060111|454591245|FG002|Overall Study|Other|4|||
126355162|NCT00997126|454591247|FG000|Overall Study|Physician Decision|7|||
126355163|NCT00997126|454591248|FG001|Overall Study|Physician Decision|11|||
126355164|NCT00896233|454591256|FG000|Overall Study|Claustrophobia during MRI|1|||
126355165|NCT04280562|454591257|FG000|Study|Adverse Event|2|||
126355166|NCT04280562|454591258|FG001|Study|Adverse Event|0|||
126355167|NCT04280562|454591257|FG000|Study|Lost to Follow-up|3|||
126355168|NCT04280562|454591258|FG001|Study|Lost to Follow-up|3|||
126355169|NCT02965456|454591259|FG000|Overall Study|Lost to Follow-up|40|||
126355170|NCT02965456|454591260|FG001|Overall Study|Lost to Follow-up|18|||
126355171|NCT02965456|454591259|FG000|Overall Study|Subject Request|22|||
126355172|NCT02965456|454591260|FG001|Overall Study|Subject Request|13|||
126355173|NCT02965456|454591259|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
126355174|NCT02965456|454591260|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
126355175|NCT02965456|454591259|FG000|Overall Study|Adverse Event|3|||
126355176|NCT02965456|454591260|FG001|Overall Study|Adverse Event|0|||
126355177|NCT02965456|454591259|FG000|Overall Study|Noncompliance with Study Drug|1|||
126355178|NCT02965456|454591260|FG001|Overall Study|Noncompliance with Study Drug|1|||
126355179|NCT02965456|454591259|FG000|Overall Study|Worsening Condition|0|||
126355180|NCT02965456|454591260|FG001|Overall Study|Worsening Condition|2|||
126355181|NCT02965456|454591259|FG000|Overall Study|Lack of Efficacy|1|||
126355182|NCT02965456|454591260|FG001|Overall Study|Lack of Efficacy|0|||
126355183|NCT02965456|454591259|FG000|Overall Study|Physician Decision|0|||
126355184|NCT02965456|454591260|FG001|Overall Study|Physician Decision|1|||
126355185|NCT02965456|454591259|FG000|Overall Study|Pregnancy|1|||
126355186|NCT02965456|454591260|FG001|Overall Study|Pregnancy|0|||
126355187|NCT02965456|454591259|FG000|Overall Study|Protocol Violation|0|||
126355188|NCT02965456|454591260|FG001|Overall Study|Protocol Violation|1|||
126355189|NCT02965456|454591259|FG000|Overall Study|Participant ran out of study drug|0|||
126355190|NCT02965456|454591260|FG001|Overall Study|Participant ran out of study drug|1|||
126355191|NCT02583477|454591261|FG000|Overall Study|Adverse Event|0|||
126355192|NCT02583477|454591262|FG001|Overall Study|Adverse Event|2|||
126355193|NCT02583477|454591261|FG000|Overall Study|Death|1|||
126355194|NCT02583477|454591262|FG001|Overall Study|Death|16|||
126355195|NCT02583477|454591261|FG000|Overall Study|Study terminated|2|||
126355196|NCT02583477|454591262|FG001|Overall Study|Study terminated|2|||
126355197|NCT04465955|454591263|FG000|Overall Study|Withdrew consent|6|||
126355198|NCT04465955|454591264|FG001|Overall Study|Withdrew consent|10|||
126355199|NCT04465955|454591265|FG002|Overall Study|Withdrew consent|7|||
126355200|NCT04465955|454591263|FG000|Overall Study|Adverse Event|6|||
126355201|NCT04465955|454591264|FG001|Overall Study|Adverse Event|5|||
126355202|NCT04465955|454591265|FG002|Overall Study|Adverse Event|1|||
126355203|NCT04465955|454591263|FG000|Overall Study|Lost to Follow-up|2|||
126355204|NCT04465955|454591264|FG001|Overall Study|Lost to Follow-up|0|||
126355205|NCT04465955|454591265|FG002|Overall Study|Lost to Follow-up|3|||
126355206|NCT04465955|454591263|FG000|Overall Study|Other|1|||
126355207|NCT04465955|454591264|FG001|Overall Study|Other|1|||
126355208|NCT04465955|454591265|FG002|Overall Study|Other|3|||
126355209|NCT01860404|454591272|FG000|Overall Study|Lost to Follow-up|3|||
126355210|NCT01860404|454591273|FG001|Overall Study|Lost to Follow-up|4|||
126355211|NCT01860404|454591274|FG002|Overall Study|Lost to Follow-up|1|||
126355212|NCT01860404|454591275|FG003|Overall Study|Lost to Follow-up|6|||
126355213|NCT01860404|454591276|FG004|Overall Study|Lost to Follow-up|4|||
126355214|NCT01860404|454591272|FG000|Overall Study|Withdrawal by Subject|0|||
126355215|NCT01860404|454591273|FG001|Overall Study|Withdrawal by Subject|0|||
126355216|NCT01860404|454591274|FG002|Overall Study|Withdrawal by Subject|4|||
126355217|NCT01860404|454591275|FG003|Overall Study|Withdrawal by Subject|0|||
126355218|NCT01860404|454591276|FG004|Overall Study|Withdrawal by Subject|0|||
126355219|NCT02762604|454591277|FG000|Overall Study|Lost to Follow-up|2|||
126355220|NCT02762604|454591278|FG001|Overall Study|Lost to Follow-up|7|||
126355221|NCT02762604|454591277|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
126355222|NCT02762604|454591278|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
126355223|NCT06038643|454591279|FG000|Overall Study|Withdrawal by Subject|9|||
126355224|NCT06038643|454591280|FG001|Overall Study|Withdrawal by Subject|4|||
126355225|NCT06038643|454591279|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
126355226|NCT06038643|454591280|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
126355227|NCT05259033|454591290|FG000|Overall Study|Withdrawal by Subject|10|||
126355228|NCT05259033|454591291|FG001|Overall Study|Withdrawal by Subject|5|||
126355229|NCT05259033|454591290|FG000|Overall Study|Lost to Follow-up|1|||
126355230|NCT05259033|454591291|FG001|Overall Study|Lost to Follow-up|0|||
126355231|NCT05259033|454591290|FG000|Overall Study|Death|2|||
126355232|NCT05259033|454591291|FG001|Overall Study|Death|0|||
126355233|NCT04210375|454591292|FG000|Overall Study|Death|0|||
126355234|NCT04210375|454591293|FG001|Overall Study|Death|1|||
126355235|NCT04210375|454591294|FG002|Overall Study|Death|0|||
126355236|NCT04210375|454591295|FG003|Overall Study|Death|0|||
126355237|NCT01405911|454591296|FG000|Overall Study|Pre-treatment lab AE|0|||
126355238|NCT01405911|454591297|FG001|Overall Study|Pre-treatment lab AE|1|||
126355239|NCT01405911|454591298|FG002|Overall Study|Pre-treatment lab AE|0|||
126355240|NCT01405911|454591296|FG000|Overall Study|Lost to Follow-up|0|||
126355241|NCT01405911|454591297|FG001|Overall Study|Lost to Follow-up|1|||
126355242|NCT01405911|454591298|FG002|Overall Study|Lost to Follow-up|0|||
126355243|NCT01405911|454591296|FG000|Overall Study|Protocol Violation|1|||
126355244|NCT01405911|454591297|FG001|Overall Study|Protocol Violation|0|||
126355245|NCT01405911|454591298|FG002|Overall Study|Protocol Violation|0|||
126355246|NCT01405911|454591296|FG000|Overall Study|Withdrawal by Subject|3|||
126355247|NCT01405911|454591297|FG001|Overall Study|Withdrawal by Subject|1|||
126355248|NCT01405911|454591298|FG002|Overall Study|Withdrawal by Subject|1|||
126355249|NCT01980888|454591301|FG000|Overall Study|Study Terminated by Sponsor|116|||
126355250|NCT01980888|454591302|FG001|Overall Study|Study Terminated by Sponsor|122|||
126355251|NCT01980888|454591301|FG000|Overall Study|Withdrew Consent|17|||
126355252|NCT01980888|454591302|FG001|Overall Study|Withdrew Consent|6|||
126355253|NCT01980888|454591301|FG000|Overall Study|Investigator's Discretion|8|||
126355254|NCT01980888|454591302|FG001|Overall Study|Investigator's Discretion|3|||
126355255|NCT01980888|454591301|FG000|Overall Study|Non-Compliance with Study Drug|3|||
126355256|NCT01980888|454591302|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126355257|NCT05762744|454591304|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
126355258|NCT05762744|454591305|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
126355259|NCT05762744|454591304|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
126355260|NCT05762744|454591305|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
126355261|NCT01671059|454591306|FG000|Overall Study|Adverse Event|4|||
126355262|NCT01671059|454591306|FG000|Overall Study|Lack of Efficacy|1|||
126355263|NCT01560416|454591307|FG000|Randomized Phase|Crossover Participants|7|||
126355264|NCT01560416|454591308|FG001|Randomized Phase|Crossover Participants|0|||
126355265|NCT01179399|454591309|FG000|Overall Study|Adverse Event|1|||
126355266|NCT01179399|454591309|FG000|Overall Study|Lack of Efficacy|30|||
126355267|NCT01179399|454591309|FG000|Overall Study|Withdrawal by Subject|1|||
126355268|NCT03334175|454591310|FG000|Overall Study|Lost to Follow-up|0|||
126355269|NCT03334175|454591311|FG001|Overall Study|Lost to Follow-up|1|||
126355270|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
126355271|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
126355272|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
126355273|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
126355274|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
126355275|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126355276|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
126355277|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
126355278|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
126355279|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
126235671|NCT00440557|454155218|FG000|Overall Study|Adverse Event|3|||
126235672|NCT00440557|454155219|FG001|Overall Study|Adverse Event|3|||
126235673|NCT00440557|454155220|FG002|Overall Study|Adverse Event|5|||
126235674|NCT00440557|454155218|FG000|Overall Study|Death|2|||
126235675|NCT00440557|454155219|FG001|Overall Study|Death|6|||
126235676|NCT00440557|454155220|FG002|Overall Study|Death|3|||
126235677|NCT00440557|454155218|FG000|Overall Study|Began Dialysis|4|||
126235678|NCT00440557|454155219|FG001|Overall Study|Began Dialysis|1|||
126235679|NCT00440557|454155220|FG002|Overall Study|Began Dialysis|4|||
126235680|NCT00440557|454155218|FG000|Overall Study|Principal Investigator decision|0|||
126235681|NCT00440557|454155219|FG001|Overall Study|Principal Investigator decision|3|||
126235682|NCT00440557|454155220|FG002|Overall Study|Principal Investigator decision|1|||
126235683|NCT00440557|454155218|FG000|Overall Study|Patient moved|1|||
126235684|NCT00440557|454155219|FG001|Overall Study|Patient moved|2|||
126235685|NCT00440557|454155220|FG002|Overall Study|Patient moved|1|||
126235686|NCT00440557|454155218|FG000|Overall Study|Principal Investigator's office closed|3|||
126235687|NCT00440557|454155219|FG001|Overall Study|Principal Investigator's office closed|6|||
126235688|NCT00440557|454155220|FG002|Overall Study|Principal Investigator's office closed|4|||
126235689|NCT00440557|454155218|FG000|Overall Study|Patient transferred to nursing home|0|||
126235690|NCT00440557|454155219|FG001|Overall Study|Patient transferred to nursing home|1|||
126235691|NCT00440557|454155220|FG002|Overall Study|Patient transferred to nursing home|0|||
126235692|NCT00440557|454155218|FG000|Overall Study|Patient had surgery|1|||
126235693|NCT00440557|454155219|FG001|Overall Study|Patient had surgery|0|||
126235694|NCT00440557|454155220|FG002|Overall Study|Patient had surgery|0|||
126235695|NCT00162123|454155221|FG000|Overall Study|Disease progression|27|||
126235696|NCT00162123|454155222|FG001|Overall Study|Disease progression|19|||
126235697|NCT00162123|454155223|FG002|Overall Study|Disease progression|10|||
126235698|NCT00162123|454155224|FG003|Overall Study|Disease progression|4|||
126235699|NCT00162123|454155225|FG004|Overall Study|Disease progression|8|||
126235700|NCT00162123|454155226|FG005|Overall Study|Disease progression|3|||
126235701|NCT00162123|454155227|FG006|Overall Study|Disease progression|1|||
126235702|NCT00162123|454155228|FG007|Overall Study|Disease progression|0|||
126235703|NCT00162123|454155221|FG000|Overall Study|Study drug toxicity|6|||
126235704|NCT00162123|454155222|FG001|Overall Study|Study drug toxicity|1|||
126235705|NCT00162123|454155223|FG002|Overall Study|Study drug toxicity|5|||
126235706|NCT00162123|454155224|FG003|Overall Study|Study drug toxicity|0|||
126235707|NCT00162123|454155225|FG004|Overall Study|Study drug toxicity|4|||
126235708|NCT00162123|454155226|FG005|Overall Study|Study drug toxicity|1|||
126235709|NCT00162123|454155227|FG006|Overall Study|Study drug toxicity|1|||
126235710|NCT00162123|454155228|FG007|Overall Study|Study drug toxicity|0|||
126235711|NCT00162123|454155221|FG000|Overall Study|Death|3|||
126235712|NCT00162123|454155222|FG001|Overall Study|Death|3|||
126235713|NCT00162123|454155223|FG002|Overall Study|Death|1|||
126235714|NCT00162123|454155224|FG003|Overall Study|Death|1|||
126235715|NCT00162123|454155225|FG004|Overall Study|Death|1|||
126235716|NCT00162123|454155226|FG005|Overall Study|Death|1|||
126235717|NCT00162123|454155227|FG006|Overall Study|Death|0|||
126235718|NCT00162123|454155228|FG007|Overall Study|Death|0|||
126235719|NCT00162123|454155221|FG000|Overall Study|Withdrawal by Subject|2|||
126235720|NCT00162123|454155222|FG001|Overall Study|Withdrawal by Subject|0|||
126235721|NCT00162123|454155223|FG002|Overall Study|Withdrawal by Subject|2|||
126235722|NCT00162123|454155224|FG003|Overall Study|Withdrawal by Subject|1|||
126235723|NCT00162123|454155225|FG004|Overall Study|Withdrawal by Subject|1|||
126235724|NCT00162123|454155226|FG005|Overall Study|Withdrawal by Subject|2|||
126235725|NCT00162123|454155227|FG006|Overall Study|Withdrawal by Subject|1|||
126235726|NCT00162123|454155228|FG007|Overall Study|Withdrawal by Subject|0|||
126355280|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
126355281|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
126355282|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
126355283|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
126355284|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
126355285|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
126355286|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
126093334|NCT03986944|453636020|FG002|Overall Study|Withdrawal by Subject|5|||
126235727|NCT00162123|454155221|FG000|Overall Study|Deterioration without progression|2|||
126235728|NCT00162123|454155222|FG001|Overall Study|Deterioration without progression|2|||
126235729|NCT00162123|454155223|FG002|Overall Study|Deterioration without progression|3|||
126235730|NCT00162123|454155224|FG003|Overall Study|Deterioration without progression|0|||
126235731|NCT00162123|454155225|FG004|Overall Study|Deterioration without progression|1|||
126235732|NCT00162123|454155226|FG005|Overall Study|Deterioration without progression|0|||
126235733|NCT00162123|454155227|FG006|Overall Study|Deterioration without progression|0|||
126235734|NCT00162123|454155228|FG007|Overall Study|Deterioration without progression|0|||
126235735|NCT00162123|454155221|FG000|Overall Study|Adverse Event|1|||
126235736|NCT00162123|454155222|FG001|Overall Study|Adverse Event|2|||
126235737|NCT00162123|454155223|FG002|Overall Study|Adverse Event|0|||
126235738|NCT00162123|454155224|FG003|Overall Study|Adverse Event|2|||
126235739|NCT00162123|454155225|FG004|Overall Study|Adverse Event|1|||
126235740|NCT00162123|454155226|FG005|Overall Study|Adverse Event|0|||
126235741|NCT00162123|454155227|FG006|Overall Study|Adverse Event|0|||
126235742|NCT00162123|454155228|FG007|Overall Study|Adverse Event|0|||
126235743|NCT00162123|454155221|FG000|Overall Study|Not specified (before treatment)|2|||
126235744|NCT00162123|454155222|FG001|Overall Study|Not specified (before treatment)|0|||
126235745|NCT00162123|454155223|FG002|Overall Study|Not specified (before treatment)|0|||
126235746|NCT00162123|454155224|FG003|Overall Study|Not specified (before treatment)|0|||
126235747|NCT00162123|454155225|FG004|Overall Study|Not specified (before treatment)|12|||
126235748|NCT00162123|454155226|FG005|Overall Study|Not specified (before treatment)|1|||
126235749|NCT00162123|454155227|FG006|Overall Study|Not specified (before treatment)|0|||
126235750|NCT00162123|454155228|FG007|Overall Study|Not specified (before treatment)|0|||
126235751|NCT00162123|454155221|FG000|Overall Study|Not specified (after start of treatment)|0|||
126235752|NCT00162123|454155222|FG001|Overall Study|Not specified (after start of treatment)|0|||
126235753|NCT00162123|454155223|FG002|Overall Study|Not specified (after start of treatment)|0|||
126235754|NCT00162123|454155224|FG003|Overall Study|Not specified (after start of treatment)|0|||
126235755|NCT00162123|454155225|FG004|Overall Study|Not specified (after start of treatment)|3|||
126235756|NCT00162123|454155226|FG005|Overall Study|Not specified (after start of treatment)|0|||
126235757|NCT00162123|454155227|FG006|Overall Study|Not specified (after start of treatment)|0|||
126235758|NCT00162123|454155228|FG007|Overall Study|Not specified (after start of treatment)|0|||
126235759|NCT00162123|454155221|FG000|Overall Study|Physician Decision|1|||
126235760|NCT00162123|454155222|FG001|Overall Study|Physician Decision|2|||
126235761|NCT00162123|454155223|FG002|Overall Study|Physician Decision|0|||
126235762|NCT00162123|454155224|FG003|Overall Study|Physician Decision|0|||
126235763|NCT00162123|454155225|FG004|Overall Study|Physician Decision|0|||
126235764|NCT00162123|454155226|FG005|Overall Study|Physician Decision|1|||
126235765|NCT00162123|454155227|FG006|Overall Study|Physician Decision|1|||
126235766|NCT00162123|454155228|FG007|Overall Study|Physician Decision|0|||
126235767|NCT00162123|454155221|FG000|Overall Study|Tumor assessment only (not treated)|0|||
126235768|NCT00162123|454155222|FG001|Overall Study|Tumor assessment only (not treated)|0|||
126235769|NCT00162123|454155223|FG002|Overall Study|Tumor assessment only (not treated)|0|||
126235770|NCT00162123|454155224|FG003|Overall Study|Tumor assessment only (not treated)|0|||
126235771|NCT00162123|454155225|FG004|Overall Study|Tumor assessment only (not treated)|0|||
126355287|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
126355288|NCT03738215|454591312|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
126355289|NCT03738215|454591313|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
126355290|NCT03738215|454591314|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
126355291|NCT03738215|454591312|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
126355292|NCT03738215|454591313|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
126355293|NCT03738215|454591314|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
126355294|NCT03738215|454591312|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
126355295|NCT03738215|454591313|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
126355296|NCT03738215|454591314|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
126355297|NCT03738215|454591312|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
126355298|NCT03738215|454591313|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
126355299|NCT03738215|454591314|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
126355300|NCT01695772|454591316|FG000|Overall Study|Withdrawal by Subject|18|||
126355301|NCT01695772|454591316|FG000|Overall Study|Progressive Disease|8|||
126355302|NCT01695772|454591316|FG000|Overall Study|Investigator Decision|5|||
126355303|NCT01695772|454591316|FG000|Overall Study|Lost to Follow-up|4|||
126355304|NCT01695772|454591316|FG000|Overall Study|Protocol Violation|2|||
126355305|NCT01695772|454591316|FG000|Overall Study|Unspecified Reason|1|||
126355306|NCT03921541|454592973|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
126355307|NCT03921541|454592974|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
126355308|NCT01653262|454592975|FG000|Overall Study|Lack of Efficacy|1|||
126355309|NCT01653262|454592975|FG000|Overall Study|SAE, non-fatal|1|||
126355310|NCT01653262|454592975|FG000|Overall Study|AE, non-serious non-fatal|1|||
126355311|NCT00420407|454592977|FG000|Overall Study|Lost to Follow-up|0|||
126355312|NCT00420407|454592978|FG001|Overall Study|Lost to Follow-up|3|||
126355313|NCT00420407|454592977|FG000|Overall Study|Physician Decision|2|||
126093335|NCT03986944|453636018|FG000|Overall Study|Study termination|10|||
126235772|NCT00162123|454155226|FG005|Overall Study|Tumor assessment only (not treated)|0|||
126235773|NCT00162123|454155227|FG006|Overall Study|Tumor assessment only (not treated)|0|||
126235774|NCT00162123|454155228|FG007|Overall Study|Tumor assessment only (not treated)|1|||
126093336|NCT03986944|453636019|FG001|Overall Study|Study termination|10|||
126235775|NCT00162123|454155221|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
126235776|NCT00162123|454155222|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
126235777|NCT00162123|454155223|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
126235778|NCT00162123|454155224|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
126235779|NCT00162123|454155225|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
126235780|NCT00162123|454155226|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
126235781|NCT00162123|454155227|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
126235782|NCT00162123|454155228|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
126235783|NCT01936948|454155229|FG000|Overall Study|no 30-day follow-up data|0|||
126235784|NCT01936948|454155230|FG001|Overall Study|no 30-day follow-up data|3|||
126235785|NCT01936948|454155231|FG002|Overall Study|no 30-day follow-up data|3|||
126235786|NCT01936948|454155232|FG003|Overall Study|no 30-day follow-up data|3|||
126235787|NCT02327130|454155233|FG000|Overall Study|Discharged in less than 5 days|5|||
126235788|NCT02327130|454155233|FG000|Overall Study|Physician Decision|2|||
126235789|NCT02327130|454155233|FG000|Overall Study|Unable to provide breath sample|1|||
126235790|NCT02327130|454155233|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
126235791|NCT02327130|454155233|FG000|Overall Study|Met exclusion criteria|3|||
126235792|NCT01378975|454155236|FG000|Overall Study|Death|77|||
126235793|NCT01378975|454155237|FG001|Overall Study|Death|46|||
126235794|NCT01378975|454155236|FG000|Overall Study|Investigator Request|1|||
126235795|NCT01378975|454155237|FG001|Overall Study|Investigator Request|0|||
126235796|NCT01378975|454155236|FG000|Overall Study|Lost to Follow-up|4|||
126235797|NCT01378975|454155237|FG001|Overall Study|Lost to Follow-up|1|||
126235798|NCT01378975|454155236|FG000|Overall Study|Withdrew Consent|4|||
126235799|NCT01378975|454155237|FG001|Overall Study|Withdrew Consent|3|||
126355314|NCT00420407|454592978|FG001|Overall Study|Physician Decision|1|||
126355315|NCT00420407|454592977|FG000|Overall Study|subject identified as detainee|1|||
126355316|NCT00420407|454592978|FG001|Overall Study|subject identified as detainee|0|||
126355317|NCT00420407|454592977|FG000|Overall Study|subject identified as Jehovah's witness|1|||
126355318|NCT00420407|454592978|FG001|Overall Study|subject identified as Jehovah's witness|0|||
126355319|NCT00420407|454592977|FG000|Overall Study|Withdrawal by Subject|0|||
126355320|NCT00420407|454592978|FG001|Overall Study|Withdrawal by Subject|2|||
126355321|NCT02724644|454592979|FG000|Overall Study|Adverse Event|7|||
126355322|NCT02724644|454592980|FG001|Overall Study|Adverse Event|1|||
126355323|NCT02724644|454592979|FG000|Overall Study|Lost to Follow-up|6|||
126355324|NCT02724644|454592980|FG001|Overall Study|Lost to Follow-up|2|||
126355325|NCT02724644|454592979|FG000|Overall Study|Withdrawal by Subject|7|||
126355326|NCT02724644|454592980|FG001|Overall Study|Withdrawal by Subject|1|||
126355327|NCT02724644|454592979|FG000|Overall Study|Administrative|1|||
126355328|NCT02724644|454592980|FG001|Overall Study|Administrative|0|||
126355329|NCT01778985|454592981|FG000|Overall Study|Lost to Follow-up|1|||
126355330|NCT01778985|454592982|FG001|Overall Study|Lost to Follow-up|0|||
126355331|NCT01778985|454592981|FG000|Overall Study|Physician Decision|2|||
126355332|NCT01778985|454592982|FG001|Overall Study|Physician Decision|2|||
126355333|NCT01778985|454592981|FG000|Overall Study|Protocol Violation|4|||
126355334|NCT01778985|454592982|FG001|Overall Study|Protocol Violation|1|||
126355335|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
126355336|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Adverse Event|1|||
126355337|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
126355338|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Physician Decision|1|||
126355339|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
126355340|NCT00088881|454592983|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
126355341|NCT00088881|454592983|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
126355342|NCT01631188|454592989|FG000|Overall Study|Physician Decision|75|||
126355343|NCT00835978|454592990|FG000|Overall Study|Death|33|||
126355344|NCT00835978|454592991|FG001|Overall Study|Death|40|||
126355345|NCT00835978|454592992|FG002|Overall Study|Death|49|||
126355346|NCT00835978|454592993|FG003|Overall Study|Death|4|||
126355347|NCT00835978|454592990|FG000|Overall Study|Lost to Follow-up|3|||
126355348|NCT00835978|454592991|FG001|Overall Study|Lost to Follow-up|4|||
126355349|NCT00835978|454592992|FG002|Overall Study|Lost to Follow-up|2|||
126355350|NCT00835978|454592993|FG003|Overall Study|Lost to Follow-up|1|||
126355351|NCT00835978|454592990|FG000|Overall Study|Other|5|||
126355352|NCT00835978|454592991|FG001|Overall Study|Other|1|||
126355353|NCT00835978|454592992|FG002|Overall Study|Other|8|||
126355354|NCT00835978|454592993|FG003|Overall Study|Other|0|||
126355355|NCT00835978|454592990|FG000|Overall Study|Objective progression or relapse|2|||
126355356|NCT00835978|454592991|FG001|Overall Study|Objective progression or relapse|0|||
126355357|NCT00835978|454592992|FG002|Overall Study|Objective progression or relapse|1|||
126355358|NCT00835978|454592993|FG003|Overall Study|Objective progression or relapse|0|||
126355359|NCT00835978|454592990|FG000|Overall Study|Adverse Event|1|||
126355360|NCT00835978|454592991|FG001|Overall Study|Adverse Event|0|||
126355361|NCT00835978|454592992|FG002|Overall Study|Adverse Event|1|||
126355362|NCT00835978|454592993|FG003|Overall Study|Adverse Event|0|||
126355363|NCT00835978|454592990|FG000|Overall Study|Withdrawal by Subject|0|||
126355364|NCT00835978|454592991|FG001|Overall Study|Withdrawal by Subject|3|||
126355365|NCT00835978|454592992|FG002|Overall Study|Withdrawal by Subject|0|||
126235800|NCT02343120|454155241|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
126235801|NCT02343120|454155242|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
126235802|NCT02343120|454155243|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
126235803|NCT02343120|454155244|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
126235804|NCT02343120|454155245|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
126235805|NCT02343120|454155241|FG000|Part 1: Dose Escalation|Death|1|||
126235806|NCT02343120|454155242|FG001|Part 1: Dose Escalation|Death|2|||
126235807|NCT02343120|454155243|FG002|Part 1: Dose Escalation|Death|2|||
126355366|NCT00835978|454592993|FG003|Overall Study|Withdrawal by Subject|5|||
126355367|NCT00835978|454592990|FG000|Overall Study|Study terminated by sponsor|12|||
126355368|NCT00835978|454592991|FG001|Overall Study|Study terminated by sponsor|8|||
126355369|NCT00835978|454592992|FG002|Overall Study|Study terminated by sponsor|30|||
126355370|NCT00835978|454592993|FG003|Overall Study|Study terminated by sponsor|0|||
126355371|NCT03684057|454592994|FG000|Overall Study|Withdrawal by Subject|4|||
126355372|NCT03684057|454592995|FG001|Overall Study|Withdrawal by Subject|5|||
126355373|NCT02927145|454592996|FG000|Initial Recruitment|Withdrawal by Subject|0|||
126355374|NCT02927145|454592997|FG001|Initial Recruitment|Withdrawal by Subject|1|||
126355375|NCT02927145|454592998|FG002|Initial Recruitment|Withdrawal by Subject|1|||
126355376|NCT02927145|454592999|FG003|Initial Recruitment|Withdrawal by Subject|4|||
126355377|NCT02927145|454593000|FG004|Initial Recruitment|Withdrawal by Subject|1|||
126355378|NCT02927145|454593001|FG005|Initial Recruitment|Withdrawal by Subject|1|||
126355379|NCT02927145|454593002|FG006|Initial Recruitment|Withdrawal by Subject|0|||
126355380|NCT02927145|454593003|FG007|Initial Recruitment|Withdrawal by Subject|0|||
126355381|NCT02927145|454593004|FG008|Initial Recruitment|Withdrawal by Subject|2|||
126355382|NCT02927145|454592996|FG000|Initial Recruitment|Adverse Event|0|||
126355383|NCT02927145|454592997|FG001|Initial Recruitment|Adverse Event|0|||
126355384|NCT02927145|454592998|FG002|Initial Recruitment|Adverse Event|0|||
126355385|NCT02927145|454592999|FG003|Initial Recruitment|Adverse Event|0|||
126355386|NCT02927145|454593000|FG004|Initial Recruitment|Adverse Event|2|||
126355387|NCT02927145|454593001|FG005|Initial Recruitment|Adverse Event|0|||
126235808|NCT02343120|454155244|FG003|Part 1: Dose Escalation|Death|2|||
126235809|NCT02343120|454155245|FG004|Part 1: Dose Escalation|Death|1|||
126235810|NCT02343120|454155241|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
126235811|NCT02343120|454155242|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
126235812|NCT02343120|454155243|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
126235813|NCT02343120|454155244|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
126235814|NCT02343120|454155245|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
126235815|NCT02343120|454155241|FG000|Part 2: Expansion|Sponsor decision|0|||
126235816|NCT02343120|454155242|FG001|Part 2: Expansion|Sponsor decision|0|||
126235817|NCT02343120|454155243|FG002|Part 2: Expansion|Sponsor decision|0|||
126235818|NCT02343120|454155244|FG003|Part 2: Expansion|Sponsor decision|165|||
126235819|NCT02343120|454155245|FG004|Part 2: Expansion|Sponsor decision|67|||
126235820|NCT02343120|454155241|FG000|Part 2: Expansion|Death|0|||
126235821|NCT02343120|454155242|FG001|Part 2: Expansion|Death|0|||
126235822|NCT02343120|454155243|FG002|Part 2: Expansion|Death|0|||
126235823|NCT02343120|454155244|FG003|Part 2: Expansion|Death|74|||
126235824|NCT02343120|454155245|FG004|Part 2: Expansion|Death|17|||
126235825|NCT02343120|454155241|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
126235826|NCT02343120|454155242|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
126235827|NCT02343120|454155243|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
126235828|NCT02343120|454155244|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
126235829|NCT02343120|454155245|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
126235830|NCT02343120|454155241|FG000|Part 2: Expansion|Lost to Follow-up|0|||
126235831|NCT02343120|454155242|FG001|Part 2: Expansion|Lost to Follow-up|0|||
126235832|NCT02343120|454155243|FG002|Part 2: Expansion|Lost to Follow-up|0|||
126235833|NCT02343120|454155244|FG003|Part 2: Expansion|Lost to Follow-up|5|||
126235834|NCT02343120|454155245|FG004|Part 2: Expansion|Lost to Follow-up|2|||
126235835|NCT02343120|454155241|FG000|Part 2: Expansion|Other|0|||
126235836|NCT02343120|454155242|FG001|Part 2: Expansion|Other|0|||
126235837|NCT02343120|454155243|FG002|Part 2: Expansion|Other|0|||
126235838|NCT02343120|454155244|FG003|Part 2: Expansion|Other|1|||
126235839|NCT02343120|454155245|FG004|Part 2: Expansion|Other|5|||
126235840|NCT02343120|454155241|FG000|Part 2: Expansion|Adverse Event|0|||
126235841|NCT02343120|454155242|FG001|Part 2: Expansion|Adverse Event|0|||
126235842|NCT02343120|454155243|FG002|Part 2: Expansion|Adverse Event|0|||
126235843|NCT02343120|454155244|FG003|Part 2: Expansion|Adverse Event|1|||
126235844|NCT02343120|454155245|FG004|Part 2: Expansion|Adverse Event|1|||
126235845|NCT03544138|454155246|FG000|Overall Study|Lost to Follow-up|29|||
126235846|NCT01766778|454155247|FG000|Overall Study|Adverse Event|4|||
126235847|NCT01766778|454155248|FG001|Overall Study|Adverse Event|4|||
126235848|NCT01766778|454155247|FG000|Overall Study|Withdrawal by Subject|1|||
126235849|NCT01766778|454155248|FG001|Overall Study|Withdrawal by Subject|0|||
126235850|NCT01104662|454155249|FG000|Overall Study|Adverse Event|2|||
126235851|NCT01104662|454155250|FG001|Overall Study|Adverse Event|2|||
126235852|NCT01104662|454155251|FG002|Overall Study|Adverse Event|0|||
126235853|NCT01104662|454155252|FG003|Overall Study|Adverse Event|1|||
126235854|NCT01104662|454155253|FG004|Overall Study|Adverse Event|1|||
126235855|NCT01104662|454155254|FG005|Overall Study|Adverse Event|1|||
126235856|NCT01104662|454155255|FG006|Overall Study|Adverse Event|0|||
126235857|NCT01104662|454155256|FG007|Overall Study|Adverse Event|0|||
126023418|NCT03283371|453380692|FG000|Placebo-controlled|Adverse Event|1|||
126023419|NCT03283371|453380693|FG001|Placebo-controlled|Adverse Event|1|||
126023420|NCT03283371|453380694|FG002|Placebo-controlled|Adverse Event|0|||
126235858|NCT01104662|454155249|FG000|Overall Study|Clinical Failure|1|||
126235859|NCT01104662|454155250|FG001|Overall Study|Clinical Failure|0|||
126235860|NCT01104662|454155251|FG002|Overall Study|Clinical Failure|0|||
126235861|NCT01104662|454155252|FG003|Overall Study|Clinical Failure|0|||
126235862|NCT01104662|454155253|FG004|Overall Study|Clinical Failure|0|||
126235863|NCT01104662|454155254|FG005|Overall Study|Clinical Failure|1|||
126235864|NCT01104662|454155255|FG006|Overall Study|Clinical Failure|0|||
126235865|NCT01104662|454155256|FG007|Overall Study|Clinical Failure|0|||
126235866|NCT01104662|454155249|FG000|Overall Study|Participant left investigator's care|1|||
126235867|NCT01104662|454155250|FG001|Overall Study|Participant left investigator's care|1|||
126235868|NCT01104662|454155251|FG002|Overall Study|Participant left investigator's care|0|||
126235869|NCT01104662|454155252|FG003|Overall Study|Participant left investigator's care|0|||
126235870|NCT01104662|454155253|FG004|Overall Study|Participant left investigator's care|0|||
126235871|NCT01104662|454155254|FG005|Overall Study|Participant left investigator's care|0|||
126235872|NCT01104662|454155255|FG006|Overall Study|Participant left investigator's care|0|||
126235873|NCT01104662|454155256|FG007|Overall Study|Participant left investigator's care|0|||
126235874|NCT01104662|454155249|FG000|Overall Study|Reason not specified|3|||
126235875|NCT01104662|454155250|FG001|Overall Study|Reason not specified|3|||
126235876|NCT01104662|454155251|FG002|Overall Study|Reason not specified|0|||
126235877|NCT01104662|454155252|FG003|Overall Study|Reason not specified|0|||
126235878|NCT01104662|454155253|FG004|Overall Study|Reason not specified|0|||
126235879|NCT01104662|454155254|FG005|Overall Study|Reason not specified|1|||
126235880|NCT01104662|454155255|FG006|Overall Study|Reason not specified|0|||
126235881|NCT01104662|454155256|FG007|Overall Study|Reason not specified|0|||
126235882|NCT01104662|454155249|FG000|Overall Study|Randomized but not treated|3|||
126093337|NCT03986944|453636020|FG002|Overall Study|Study termination|10|||
126093338|NCT03986944|453636018|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
126355388|NCT02927145|454593002|FG006|Initial Recruitment|Adverse Event|0|||
126355389|NCT02927145|454593003|FG007|Initial Recruitment|Adverse Event|0|||
126355390|NCT02927145|454593004|FG008|Initial Recruitment|Adverse Event|0|||
126355391|NCT02927145|454592996|FG000|Invitation for Additional Challenge|Pregnancy|0|||
126355392|NCT02927145|454592997|FG001|Invitation for Additional Challenge|Pregnancy|0|||
126355393|NCT02927145|454592998|FG002|Invitation for Additional Challenge|Pregnancy|0|||
126355394|NCT02927145|454592999|FG003|Invitation for Additional Challenge|Pregnancy|0|||
126355395|NCT02927145|454593000|FG004|Invitation for Additional Challenge|Pregnancy|0|||
126355396|NCT02927145|454593001|FG005|Invitation for Additional Challenge|Pregnancy|0|||
126355397|NCT02927145|454593002|FG006|Invitation for Additional Challenge|Pregnancy|1|||
126355398|NCT02927145|454593003|FG007|Invitation for Additional Challenge|Pregnancy|0|||
126355399|NCT02927145|454593004|FG008|Invitation for Additional Challenge|Pregnancy|0|||
126355400|NCT00327171|454593005|FG000|Overall Study|Did not receive study medication|3|||
126355401|NCT00327171|454593006|FG001|Overall Study|Did not receive study medication|0|||
126355402|NCT00327171|454593005|FG000|Overall Study|Adverse Event|23|||
126355403|NCT00327171|454593006|FG001|Overall Study|Adverse Event|23|||
126355404|NCT00327171|454593005|FG000|Overall Study|Disease progression/lack of efficacy|68|||
126355405|NCT00327171|454593006|FG001|Overall Study|Disease progression/lack of efficacy|69|||
126355406|NCT00327171|454593005|FG000|Overall Study|Investigator/participant request|1|||
126355407|NCT00327171|454593006|FG001|Overall Study|Investigator/participant request|8|||
126355408|NCT00327171|454593005|FG000|Overall Study|Clinical progression|12|||
126355409|NCT00327171|454593006|FG001|Overall Study|Clinical progression|8|||
126355410|NCT00327171|454593005|FG000|Overall Study|Undisclosed history of ischemia|0|||
126355411|NCT00327171|454593006|FG001|Overall Study|Undisclosed history of ischemia|1|||
126355412|NCT00327171|454593005|FG000|Overall Study|Other|1|||
126355413|NCT00327171|454593006|FG001|Overall Study|Other|0|||
126355414|NCT02506036|454593009|FG000|First Intervention (4-6 Weeks)|Death|1|||
126355415|NCT02506036|454593010|FG001|First Intervention (4-6 Weeks)|Death|0|||
126355416|NCT02506036|454593009|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
126355417|NCT02506036|454593010|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
126355418|NCT02506036|454593009|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
126355419|NCT02506036|454593010|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
126355420|NCT00530075|454593011|FG000|Overall Study|Adverse Event|1|||
126355421|NCT00530075|454593011|FG000|Overall Study|Death|1|||
126355422|NCT00530075|454593011|FG000|Overall Study|Lack of Efficacy|3|||
126355423|NCT00530075|454593011|FG000|Overall Study|Protocol Violation|1|||
126355424|NCT00530075|454593011|FG000|Overall Study|Withdrawal by Subject|1|||
126355425|NCT00758043|454593015|FG000|Overall Study|Adverse Event|1|||
126355426|NCT00758043|454593016|FG001|Overall Study|Adverse Event|20|||
126355427|NCT00758043|454593017|FG002|Overall Study|Adverse Event|12|||
126355428|NCT00758043|454593018|FG003|Overall Study|Adverse Event|62|||
126355429|NCT00758043|454593015|FG000|Overall Study|Lack of Efficacy|0|||
126355430|NCT00758043|454593016|FG001|Overall Study|Lack of Efficacy|6|||
126355431|NCT00758043|454593017|FG002|Overall Study|Lack of Efficacy|18|||
126355432|NCT00758043|454593018|FG003|Overall Study|Lack of Efficacy|12|||
126355433|NCT00758043|454593015|FG000|Overall Study|Refused Further Treatment|0|||
126355434|NCT00758043|454593016|FG001|Overall Study|Refused Further Treatment|11|||
126355435|NCT00758043|454593017|FG002|Overall Study|Refused Further Treatment|5|||
126355436|NCT00758043|454593018|FG003|Overall Study|Refused Further Treatment|8|||
126355437|NCT00758043|454593015|FG000|Overall Study|Lost to Follow-up|0|||
126355438|NCT00758043|454593016|FG001|Overall Study|Lost to Follow-up|2|||
126355439|NCT00758043|454593017|FG002|Overall Study|Lost to Follow-up|2|||
126355440|NCT00758043|454593018|FG003|Overall Study|Lost to Follow-up|5|||
126355441|NCT00758043|454593015|FG000|Overall Study|Withdrawal by Subject|0|||
126355442|NCT00758043|454593016|FG001|Overall Study|Withdrawal by Subject|1|||
126355443|NCT00758043|454593017|FG002|Overall Study|Withdrawal by Subject|1|||
126355444|NCT00758043|454593018|FG003|Overall Study|Withdrawal by Subject|4|||
126093339|NCT03986944|453636019|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
126355445|NCT00758043|454593015|FG000|Overall Study|Required Prohibited Medication|0|||
126355446|NCT00758043|454593016|FG001|Overall Study|Required Prohibited Medication|0|||
126355447|NCT00758043|454593017|FG002|Overall Study|Required Prohibited Medication|1|||
126355448|NCT00758043|454593018|FG003|Overall Study|Required Prohibited Medication|3|||
126355449|NCT00758043|454593015|FG000|Overall Study|Non-Compliant With study Drug|0|||
126355450|NCT00758043|454593016|FG001|Overall Study|Non-Compliant With study Drug|0|||
126355451|NCT00758043|454593017|FG002|Overall Study|Non-Compliant With study Drug|0|||
126355452|NCT00758043|454593018|FG003|Overall Study|Non-Compliant With study Drug|1|||
126355453|NCT00758043|454593015|FG000|Overall Study|Other Reasons|0|||
126355454|NCT00758043|454593016|FG001|Overall Study|Other Reasons|1|||
126355455|NCT00758043|454593017|FG002|Overall Study|Other Reasons|0|||
126355456|NCT00758043|454593018|FG003|Overall Study|Other Reasons|5|||
126355457|NCT00552058|454593021|FG000|Overall Study|Adverse Event|8|||
126355458|NCT00552058|454593022|FG001|Overall Study|Adverse Event|7|||
126235883|NCT01104662|454155250|FG001|Overall Study|Randomized but not treated|4|||
126235884|NCT01104662|454155251|FG002|Overall Study|Randomized but not treated|1|||
126235885|NCT01104662|454155252|FG003|Overall Study|Randomized but not treated|0|||
126235886|NCT01104662|454155253|FG004|Overall Study|Randomized but not treated|0|||
126235887|NCT01104662|454155254|FG005|Overall Study|Randomized but not treated|1|||
126235888|NCT01104662|454155255|FG006|Overall Study|Randomized but not treated|0|||
126235889|NCT01104662|454155256|FG007|Overall Study|Randomized but not treated|0|||
126235890|NCT01706926|454155257|FG000|Overall Study|Lost to Follow-up|0|||
126235891|NCT01706926|454155258|FG001|Overall Study|Lost to Follow-up|0|||
126235892|NCT01706926|454155259|FG002|Overall Study|Lost to Follow-up|1|||
126235893|NCT01706926|454155260|FG003|Overall Study|Lost to Follow-up|0|||
126235894|NCT01706926|454155257|FG000|Overall Study|Withdrawal by Subject|2|||
126235895|NCT01706926|454155258|FG001|Overall Study|Withdrawal by Subject|0|||
126235896|NCT01706926|454155259|FG002|Overall Study|Withdrawal by Subject|1|||
126235897|NCT01706926|454155260|FG003|Overall Study|Withdrawal by Subject|2|||
126235898|NCT01706926|454155257|FG000|Overall Study|Other|4|||
126235899|NCT01706926|454155258|FG001|Overall Study|Other|4|||
126235900|NCT01706926|454155259|FG002|Overall Study|Other|4|||
126235901|NCT01706926|454155260|FG003|Overall Study|Other|3|||
126235902|NCT01781637|454156634|FG000|Overall Study|Adverse Event|1|||
126235903|NCT01781637|454156635|FG001|Overall Study|Adverse Event|0|||
126235904|NCT01781637|454156634|FG000|Overall Study|Lack of Efficacy|2|||
126235905|NCT01781637|454156635|FG001|Overall Study|Lack of Efficacy|6|||
126235906|NCT01781637|454156634|FG000|Overall Study|Withdrawal by Subject|1|||
126235907|NCT01781637|454156635|FG001|Overall Study|Withdrawal by Subject|0|||
126235908|NCT02127281|454156638|FG000|Overall Study|Lost to Follow-up|1|||
126355459|NCT00552058|454593021|FG000|Overall Study|Lack of Efficacy|1|||
126355460|NCT00552058|454593022|FG001|Overall Study|Lack of Efficacy|5|||
126355461|NCT00552058|454593021|FG000|Overall Study|Lost to Follow-up|1|||
126355462|NCT00552058|454593022|FG001|Overall Study|Lost to Follow-up|0|||
126355463|NCT00552058|454593021|FG000|Overall Study|Withdrawal by Subject|4|||
126355464|NCT00552058|454593022|FG001|Overall Study|Withdrawal by Subject|4|||
126355465|NCT00552058|454593021|FG000|Overall Study|Other: Protocol Violation|0|||
126355466|NCT00552058|454593022|FG001|Overall Study|Other: Protocol Violation|1|||
126355467|NCT00552058|454593021|FG000|Overall Study|Other: Non Compliance|1|||
126355468|NCT00552058|454593022|FG001|Overall Study|Other: Non Compliance|2|||
126355469|NCT00552058|454593021|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
126355470|NCT00552058|454593022|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
126355471|NCT00552058|454593021|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
126355472|NCT00552058|454593022|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
126355473|NCT00552058|454593021|FG000|Overall Study|Other: Positive Stool Result|0|||
126355474|NCT00552058|454593022|FG001|Overall Study|Other: Positive Stool Result|1|||
126355475|NCT00552058|454593021|FG000|Overall Study|Other: Randomized in error|0|||
126355476|NCT00552058|454593022|FG001|Overall Study|Other: Randomized in error|1|||
126355477|NCT00552058|454593021|FG000|Overall Study|Other: Sponsors Decision|0|||
126355478|NCT00552058|454593022|FG001|Overall Study|Other: Sponsors Decision|1|||
126355479|NCT00552058|454593021|FG000|Overall Study|Other: Early Roll Over|1|||
126355480|NCT00552058|454593022|FG001|Overall Study|Other: Early Roll Over|0|||
126355481|NCT00845182|454593023|FG000|Overall Study|Lost to Follow-up|3|||
126355482|NCT00845182|454593024|FG001|Overall Study|Lost to Follow-up|3|||
126355483|NCT00845182|454593025|FG002|Overall Study|Lost to Follow-up|4|||
126355484|NCT00845182|454593023|FG000|Overall Study|Adverse Event|0|||
126355485|NCT00845182|454593024|FG001|Overall Study|Adverse Event|1|||
126355486|NCT00845182|454593025|FG002|Overall Study|Adverse Event|1|||
126355487|NCT00845182|454593023|FG000|Overall Study|Physician Decision|0|||
126355488|NCT00845182|454593024|FG001|Overall Study|Physician Decision|0|||
126355489|NCT00845182|454593025|FG002|Overall Study|Physician Decision|1|||
126355490|NCT01348698|454593026|FG000|Overall Study|Does not meet lesion size criteria|1|||
126355491|NCT01348698|454593026|FG000|Overall Study|Death|3|||
126355492|NCT01348698|454593026|FG000|Overall Study|PI decision to close study|68|||
126355493|NCT02595749|454593027|FG000|Overall Study|Withdrawal by Subject|12|||
126355494|NCT02595749|454593028|FG001|Overall Study|Withdrawal by Subject|7|||
126355495|NCT00263562|454593029|FG000|Overall Study|Protocol Violation|3|||
126355496|NCT00263562|454593030|FG001|Overall Study|Protocol Violation|0|||
126235909|NCT02127281|454156639|FG001|Overall Study|Lost to Follow-up|0|||
126235910|NCT05628675|454156641|FG000|Overall Study|Lost to Follow-up|2|||
126235911|NCT05628675|454156641|FG000|Overall Study|Withdrawal by Subject|1|||
126235912|NCT05818137|454156645|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
126235913|NCT05818137|454156645|FG000|Extension Treatment Period|Ongoing participants|44|||
126235914|NCT01648166|454156648|FG000|Overall Study|inadequate toenail samples|53|||
126235915|NCT01648166|454156649|FG001|Overall Study|inadequate toenail samples|100|||
126355497|NCT00986232|454593033|FG000|Overall Study|Adverse Event|1|||
126355498|NCT00986232|454593034|FG001|Overall Study|Adverse Event|2|||
126355499|NCT00986232|454593035|FG002|Overall Study|Adverse Event|3|||
126355500|NCT00986232|454593036|FG003|Overall Study|Adverse Event|0|||
126355501|NCT00986232|454593033|FG000|Overall Study|Lost to Follow-up|19|||
126355502|NCT00986232|454593034|FG001|Overall Study|Lost to Follow-up|12|||
126235916|NCT00883090|454156650|FG000|Overall Study|Sponsor's decision|1|||
126235917|NCT00883090|454156650|FG000|Overall Study|Withdrawal by Subject|1|||
126235918|NCT01475838|454156653|FG000|Randomized Phase|Randomized but Not Treated|0|||
126235919|NCT01475838|454156654|FG001|Randomized Phase|Randomized but Not Treated|5|||
126235920|NCT01475838|454156653|FG000|Randomized Phase|Adverse Event|6|||
126235921|NCT01475838|454156654|FG001|Randomized Phase|Adverse Event|1|||
126235922|NCT01475838|454156653|FG000|Randomized Phase|Pregnancy|0|||
126235923|NCT01475838|454156654|FG001|Randomized Phase|Pregnancy|1|||
126235924|NCT01475838|454156653|FG000|Randomized Phase|Investigators Discretion|1|||
126235925|NCT01475838|454156654|FG001|Randomized Phase|Investigators Discretion|2|||
126235926|NCT01475838|454156653|FG000|Randomized Phase|Withdrew Consent|10|||
126235927|NCT01475838|454156654|FG001|Randomized Phase|Withdrew Consent|14|||
126235928|NCT01475838|454156653|FG000|Randomized Phase|Lost to Follow-up|3|||
126235929|NCT01475838|454156654|FG001|Randomized Phase|Lost to Follow-up|4|||
126235930|NCT01475838|454156653|FG000|Randomized Phase|Participant Noncompliance|1|||
126235931|NCT01475838|454156654|FG001|Randomized Phase|Participant Noncompliance|5|||
126235932|NCT01475838|454156653|FG000|Randomized Phase|Protocol Violation|9|||
126235933|NCT01475838|454156654|FG001|Randomized Phase|Protocol Violation|4|||
126235934|NCT01475838|454156653|FG000|Extension Phase|Participant Noncompliance|1|||
126235935|NCT01475838|454156654|FG001|Extension Phase|Participant Noncompliance|0|||
126235936|NCT00048568|454156655|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
126235937|NCT00048568|454156656|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
126235938|NCT00048568|454156657|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
126235939|NCT00048568|454156655|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
126235940|NCT00048568|454156656|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
126235941|NCT00048568|454156657|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
126235942|NCT00048568|454156655|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
126235943|NCT00048568|454156656|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
126235944|NCT00048568|454156657|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
126235945|NCT00048568|454156655|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
126235946|NCT00048568|454156656|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
126235947|NCT00048568|454156657|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
126235948|NCT00048568|454156655|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
126235949|NCT00048568|454156656|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
126235950|NCT00048568|454156657|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
126235951|NCT00048568|454156655|FG000|Double-Blind Period Days 170 to 365|Death|1|||
126235952|NCT00048568|454156656|FG001|Double-Blind Period Days 170 to 365|Death|1|||
126235953|NCT00048568|454156657|FG002|Double-Blind Period Days 170 to 365|Death|0|||
126235954|NCT00048568|454156655|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
126235955|NCT00048568|454156656|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
126235956|NCT00048568|454156657|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
126235957|NCT00048568|454156655|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
126235958|NCT00048568|454156656|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
126235959|NCT00048568|454156657|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
126235960|NCT00048568|454156655|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
126235961|NCT00048568|454156656|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
126235962|NCT00048568|454156657|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
126235963|NCT00048568|454156655|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
126235964|NCT00048568|454156656|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
126235965|NCT00048568|454156657|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
126235966|NCT00048568|454156655|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
126235967|NCT00048568|454156656|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
126235968|NCT00048568|454156657|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
126235969|NCT00048568|454156655|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
126235970|NCT00048568|454156656|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
126235971|NCT00048568|454156657|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
126235972|NCT00048568|454156655|FG000|Open-Label Period|Death|0|||
126235973|NCT00048568|454156656|FG001|Open-Label Period|Death|0|||
126235974|NCT00048568|454156657|FG002|Open-Label Period|Death|13|||
126235975|NCT00048568|454156655|FG000|Open-Label Period|Adverse Event|0|||
126235976|NCT00048568|454156656|FG001|Open-Label Period|Adverse Event|0|||
126235977|NCT00048568|454156657|FG002|Open-Label Period|Adverse Event|49|||
126235978|NCT00048568|454156655|FG000|Open-Label Period|Lack of Efficacy|0|||
126235979|NCT00048568|454156656|FG001|Open-Label Period|Lack of Efficacy|0|||
126235980|NCT00048568|454156657|FG002|Open-Label Period|Lack of Efficacy|32|||
126235981|NCT00048568|454156655|FG000|Open-Label Period|Withdrawal by Subject|0|||
126235982|NCT00048568|454156656|FG001|Open-Label Period|Withdrawal by Subject|0|||
126235983|NCT00048568|454156657|FG002|Open-Label Period|Withdrawal by Subject|26|||
126235984|NCT00048568|454156655|FG000|Open-Label Period|Pregnancy|0|||
126235985|NCT00048568|454156656|FG001|Open-Label Period|Pregnancy|0|||
126235986|NCT00048568|454156657|FG002|Open-Label Period|Pregnancy|5|||
126235987|NCT00048568|454156655|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
126235988|NCT00048568|454156656|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
126235989|NCT00048568|454156657|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
126235990|NCT00048568|454156655|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
126235991|NCT00048568|454156656|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
126235992|NCT00048568|454156657|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
126235993|NCT00048568|454156655|FG000|Open-Label Period|Unknown Reasons|0|||
126235994|NCT00048568|454156656|FG001|Open-Label Period|Unknown Reasons|0|||
126235995|NCT00048568|454156657|FG002|Open-Label Period|Unknown Reasons|25|||
126235996|NCT00048568|454156655|FG000|Open-Label Period|Lost to Follow-up|0|||
126235997|NCT00048568|454156656|FG001|Open-Label Period|Lost to Follow-up|0|||
126235998|NCT00048568|454156657|FG002|Open-Label Period|Lost to Follow-up|7|||
126235999|NCT03831048|454156658|FG000|Overall Study|Protocol Violation|9|||
126236000|NCT03831048|454156659|FG001|Overall Study|Protocol Violation|3|||
126236001|NCT03831048|454156658|FG000|Overall Study|Death|4|||
126236002|NCT03831048|454156659|FG001|Overall Study|Death|9|||
126236003|NCT03831048|454156658|FG000|Overall Study|Re-transplant|0|||
126236004|NCT03831048|454156659|FG001|Overall Study|Re-transplant|2|||
126236005|NCT03831048|454156658|FG000|Overall Study|Protocol violation and death|1|||
126236006|NCT03831048|454156659|FG001|Overall Study|Protocol violation and death|1|||
126236007|NCT00560235|454156663|FG000|Phase 1|Discontinued|8|||
126236008|NCT00560235|454156664|FG001|Phase 1|Discontinued|0|||
126236009|NCT00560235|454156665|FG002|Phase 1|Discontinued|0|||
126236010|NCT00560235|454156663|FG000|Phase 1B|Discontinued|0|||
126236011|NCT00560235|454156664|FG001|Phase 1B|Discontinued|19|||
126236012|NCT00560235|454156665|FG002|Phase 1B|Discontinued|0|||
126236013|NCT00560235|454156663|FG000|Phase 2|Discontinued|0|||
126236014|NCT00560235|454156664|FG001|Phase 2|Discontinued|0|||
126236015|NCT00560235|454156665|FG002|Phase 2|Discontinued|96|||
126236016|NCT00560235|454156663|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
126236017|NCT00560235|454156664|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
126236018|NCT00560235|454156665|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
126236019|NCT01315249|454156668|FG000|Overall Study|Adverse Event|22|||
126236020|NCT01315249|454156669|FG001|Overall Study|Adverse Event|26|||
126236021|NCT01315249|454156668|FG000|Overall Study|Withdrawal by Subject|11|||
126236022|NCT01315249|454156669|FG001|Overall Study|Withdrawal by Subject|10|||
126236023|NCT01315249|454156668|FG000|Overall Study|Protocol Violation|8|||
126236024|NCT01315249|454156669|FG001|Overall Study|Protocol Violation|5|||
126236025|NCT01315249|454156668|FG000|Overall Study|Abnormal test results|1|||
126236026|NCT01315249|454156669|FG001|Overall Study|Abnormal test results|2|||
126236027|NCT01315249|454156668|FG000|Overall Study|Administrative problems|1|||
126236028|NCT01315249|454156669|FG001|Overall Study|Administrative problems|0|||
126236029|NCT01315249|454156668|FG000|Overall Study|inability to use device|1|||
126236030|NCT01315249|454156669|FG001|Overall Study|inability to use device|0|||
126236031|NCT01315249|454156668|FG000|Overall Study|Lack of Efficacy|0|||
126236032|NCT01315249|454156669|FG001|Overall Study|Lack of Efficacy|1|||
126236033|NCT01315249|454156668|FG000|Overall Study|Lost to Follow-up|0|||
126236034|NCT01315249|454156669|FG001|Overall Study|Lost to Follow-up|2|||
126236035|NCT01315249|454156668|FG000|Overall Study|Death|0|||
126236036|NCT01315249|454156669|FG001|Overall Study|Death|1|||
126236037|NCT03227445|454156674|FG000|Period 1 (28 Days)|Adverse Event|1|||
126236038|NCT03227445|454156675|FG001|Period 1 (28 Days)|Adverse Event|2|||
126236039|NCT03227445|454156676|FG002|Period 1 (28 Days)|Adverse Event|0|||
126236040|NCT03227445|454156677|FG003|Period 1 (28 Days)|Adverse Event|1|||
126236041|NCT03227445|454156674|FG000|Period 1 (28 Days)|Protocol Violation|1|||
126236042|NCT03227445|454156675|FG001|Period 1 (28 Days)|Protocol Violation|0|||
126236043|NCT03227445|454156676|FG002|Period 1 (28 Days)|Protocol Violation|0|||
126236044|NCT03227445|454156677|FG003|Period 1 (28 Days)|Protocol Violation|0|||
126355503|NCT00986232|454593035|FG002|Overall Study|Lost to Follow-up|12|||
126355504|NCT00986232|454593036|FG003|Overall Study|Lost to Follow-up|7|||
126355505|NCT00986232|454593033|FG000|Overall Study|Protocol Violation|2|||
126355506|NCT00986232|454593034|FG001|Overall Study|Protocol Violation|3|||
126355507|NCT00986232|454593035|FG002|Overall Study|Protocol Violation|0|||
126355508|NCT00986232|454593036|FG003|Overall Study|Protocol Violation|1|||
126355509|NCT00986232|454593033|FG000|Overall Study|Withdrawal by Subject|13|||
126355510|NCT00986232|454593034|FG001|Overall Study|Withdrawal by Subject|16|||
126355511|NCT00986232|454593035|FG002|Overall Study|Withdrawal by Subject|12|||
126355512|NCT00986232|454593036|FG003|Overall Study|Withdrawal by Subject|3|||
126355513|NCT00986232|454593033|FG000|Overall Study|Missed one or more bleeds|13|||
126355514|NCT00986232|454593034|FG001|Overall Study|Missed one or more bleeds|10|||
126355515|NCT00986232|454593035|FG002|Overall Study|Missed one or more bleeds|6|||
126355516|NCT00986232|454593036|FG003|Overall Study|Missed one or more bleeds|7|||
126355517|NCT00986232|454593033|FG000|Overall Study|Incomplete safety follow-up|3|||
126355518|NCT00986232|454593034|FG001|Overall Study|Incomplete safety follow-up|7|||
126355519|NCT00986232|454593035|FG002|Overall Study|Incomplete safety follow-up|2|||
126355520|NCT00986232|454593036|FG003|Overall Study|Incomplete safety follow-up|2|||
126355521|NCT05558410|454593037|FG000|Overall Study|Adverse Event|1|||
126355522|NCT05558410|454593038|FG001|Overall Study|Adverse Event|2|||
126236045|NCT03227445|454156674|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
126236046|NCT03227445|454156675|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
126236047|NCT03227445|454156676|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
126236048|NCT03227445|454156677|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
126236049|NCT03227445|454156674|FG000|Period 2 (28 Days)|Adverse Event|1|||
126236050|NCT03227445|454156675|FG001|Period 2 (28 Days)|Adverse Event|0|||
126236051|NCT03227445|454156676|FG002|Period 2 (28 Days)|Adverse Event|2|||
126236052|NCT03227445|454156677|FG003|Period 2 (28 Days)|Adverse Event|1|||
126236053|NCT03227445|454156674|FG000|Period 2 (28 Days)|Protocol Violation|0|||
126236054|NCT03227445|454156675|FG001|Period 2 (28 Days)|Protocol Violation|0|||
126236055|NCT03227445|454156676|FG002|Period 2 (28 Days)|Protocol Violation|0|||
126236056|NCT03227445|454156677|FG003|Period 2 (28 Days)|Protocol Violation|1|||
126236057|NCT03227445|454156674|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
126236058|NCT03227445|454156675|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
126236059|NCT03227445|454156676|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
126236060|NCT03227445|454156677|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
126236061|NCT00755196|454156679|FG000|Overall Study|Lost to Follow-up|1|||
126236062|NCT00755196|454156679|FG000|Overall Study|Lack of Efficiency|1|||
126236063|NCT01703832|454156680|FG000|Overall Study|Withdrawal by Subject|1|||
126236064|NCT01703832|454156681|FG001|Overall Study|Withdrawal by Subject|0|||
126236065|NCT01991470|454156682|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
126236066|NCT01991470|454156682|FG000|Enlite 1 Period|Adverse Event|1|||
126236067|NCT01991470|454156682|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
126236068|NCT01991470|454156682|FG000|Enlite 3 Period|Lost to Follow-up|1|||
126236069|NCT01991470|454156682|FG000|Enlite 3 Period|Physician Decision|2|||
126236070|NCT01991470|454156682|FG000|Enlite 3 Period|Physician Decision|8|||
126236071|NCT01991470|454156682|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
126023421|NCT03283371|453380695|FG003|Placebo-controlled|Adverse Event|0|||
126023422|NCT03283371|453380692|FG000|Placebo-controlled|Lack of Efficacy|1|||
126023423|NCT03283371|453380693|FG001|Placebo-controlled|Lack of Efficacy|0|||
126023424|NCT03283371|453380694|FG002|Placebo-controlled|Lack of Efficacy|0|||
126023425|NCT03283371|453380695|FG003|Placebo-controlled|Lack of Efficacy|0|||
126023426|NCT03283371|453380692|FG000|Placebo-controlled|Withdrawal by Subject|1|||
126023427|NCT03283371|453380693|FG001|Placebo-controlled|Withdrawal by Subject|1|||
126023428|NCT03283371|453380694|FG002|Placebo-controlled|Withdrawal by Subject|0|||
126023429|NCT03283371|453380695|FG003|Placebo-controlled|Withdrawal by Subject|0|||
126023430|NCT03283371|453380692|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
126023431|NCT03283371|453380693|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
126023432|NCT03283371|453380694|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
126023433|NCT03283371|453380695|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
126023434|NCT03283371|453380692|FG000|Open-label Phase|Adverse Event|0|||
126023435|NCT03283371|453380693|FG001|Open-label Phase|Adverse Event|0|||
126023436|NCT03283371|453380694|FG002|Open-label Phase|Adverse Event|2|||
126023437|NCT03283371|453380695|FG003|Open-label Phase|Adverse Event|0|||
126023438|NCT03283371|453380692|FG000|Open-label Phase|Withdrawal by Subject|0|||
126023439|NCT03283371|453380693|FG001|Open-label Phase|Withdrawal by Subject|0|||
126023440|NCT03283371|453380694|FG002|Open-label Phase|Withdrawal by Subject|1|||
126023441|NCT03283371|453380695|FG003|Open-label Phase|Withdrawal by Subject|0|||
126023442|NCT03283371|453380692|FG000|Open-label Phase|Other|0|||
126023443|NCT03283371|453380693|FG001|Open-label Phase|Other|0|||
126023444|NCT03283371|453380694|FG002|Open-label Phase|Other|1|||
126236072|NCT00243932|454156699|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
126236073|NCT00243932|454156700|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
126236074|NCT00243932|454156701|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
126236075|NCT00880568|454156703|FG000|Overall Study|Disease progression|3|||
126236076|NCT00880568|454156704|FG001|Overall Study|Disease progression|3|||
126023445|NCT03283371|453380695|FG003|Open-label Phase|Other|1|||
126023446|NCT02462759|453380696|FG000|Part 1: Double Blind|Death|1|||
126023447|NCT02462759|453380697|FG001|Part 1: Double Blind|Death|0|||
126023448|NCT02462759|453380698|FG002|Part 1: Double Blind|Death|0|||
126023449|NCT02740231|453380699|FG000|Overall Study|Withdrawal by Subject|1|||
126023450|NCT02740231|453380700|FG001|Overall Study|Withdrawal by Subject|1|||
126023451|NCT02740231|453380701|FG002|Overall Study|Withdrawal by Subject|1|||
126023452|NCT02740231|453380702|FG003|Overall Study|Withdrawal by Subject|0|||
126023453|NCT02740231|453380699|FG000|Overall Study|Lack of Efficacy|0|||
126023454|NCT02740231|453380700|FG001|Overall Study|Lack of Efficacy|1|||
126023455|NCT02740231|453380701|FG002|Overall Study|Lack of Efficacy|0|||
126023456|NCT02740231|453380702|FG003|Overall Study|Lack of Efficacy|4|||
126023457|NCT02740231|453380699|FG000|Overall Study|Lost to Follow-up|1|||
126023458|NCT02740231|453380700|FG001|Overall Study|Lost to Follow-up|3|||
126023459|NCT02740231|453380701|FG002|Overall Study|Lost to Follow-up|0|||
126023460|NCT02740231|453380702|FG003|Overall Study|Lost to Follow-up|3|||
126023461|NCT02740231|453380699|FG000|Overall Study|Adverse Event|0|||
126023462|NCT02740231|453380700|FG001|Overall Study|Adverse Event|1|||
126023463|NCT02740231|453380701|FG002|Overall Study|Adverse Event|0|||
126023464|NCT02740231|453380702|FG003|Overall Study|Adverse Event|1|||
126023465|NCT00243503|453380705|FG000|Overall Study|Adverse Event|11|||
126023466|NCT00243503|453380705|FG000|Overall Study|Withdrawal by Subject|1|||
126023467|NCT00243503|453380705|FG000|Overall Study|Lack of Efficacy|44|||
126023468|NCT00243503|453380705|FG000|Overall Study|Death|1|||
126023469|NCT00243503|453380705|FG000|Overall Study|Other|1|||
126023470|NCT04600752|453380710|FG000|Overall Study|Physician Decision|0|||
126023471|NCT04600752|453380711|FG001|Overall Study|Physician Decision|0|||
126023472|NCT04600752|453380712|FG002|Overall Study|Physician Decision|1|||
125878744|NCT03175367|452853406|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
126023473|NCT04600752|453380710|FG000|Overall Study|Adverse Event|0|||
126023474|NCT04600752|453380711|FG001|Overall Study|Adverse Event|1|||
126023475|NCT04600752|453380712|FG002|Overall Study|Adverse Event|0|||
126023476|NCT04600752|453380710|FG000|Overall Study|Withdrawal by Subject|2|||
126023477|NCT04600752|453380711|FG001|Overall Study|Withdrawal by Subject|1|||
126023478|NCT04600752|453380712|FG002|Overall Study|Withdrawal by Subject|0|||
126023479|NCT04600752|453380710|FG000|Overall Study|Lack of Efficacy|1|||
126023480|NCT04600752|453380711|FG001|Overall Study|Lack of Efficacy|0|||
126023481|NCT04600752|453380712|FG002|Overall Study|Lack of Efficacy|0|||
126023482|NCT03076515|453380713|FG000|Overall Study|DMC decision based on interim analysis|25|||
126023483|NCT03076515|453380714|FG001|Overall Study|DMC decision based on interim analysis|29|||
126023484|NCT02374307|453380715|FG000|3-months Follow-up|Lost to Follow-up|1|||
126023485|NCT02374307|453380716|FG001|3-months Follow-up|Lost to Follow-up|2|||
126023486|NCT02374307|453380715|FG000|3-months Follow-up|Withdrawal by Subject|1|||
126023487|NCT02374307|453380716|FG001|3-months Follow-up|Withdrawal by Subject|4|||
126023488|NCT02374307|453380715|FG000|3-months Follow-up|Death|1|||
126023489|NCT02374307|453380716|FG001|3-months Follow-up|Death|2|||
126023490|NCT02374307|453380715|FG000|3-months Follow-up|Missed first follow-up|5|||
126023491|NCT02374307|453380716|FG001|3-months Follow-up|Missed first follow-up|1|||
126023492|NCT02374307|453380715|FG000|6-months Follow-up|Lost to Follow-up|1|||
126023493|NCT02374307|453380716|FG001|6-months Follow-up|Lost to Follow-up|2|||
126023494|NCT02374307|453380715|FG000|6-months Follow-up|Death|2|||
126023495|NCT02374307|453380716|FG001|6-months Follow-up|Death|1|||
126023496|NCT02374307|453380715|FG000|6-months Follow-up|Withdrawal by Subject|0|||
126236077|NCT00880568|454156705|FG002|Overall Study|Disease progression|3|||
126023497|NCT02374307|453380716|FG001|6-months Follow-up|Withdrawal by Subject|3|||
126023498|NCT00999167|453380717|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
126023499|NCT00999167|453380718|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
126023500|NCT00999167|453380719|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
126023501|NCT00999167|453380717|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
126023502|NCT00999167|453380718|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
126023503|NCT00999167|453380719|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
126023504|NCT00999167|453380717|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
126023505|NCT00999167|453380718|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
126023506|NCT00999167|453380719|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
126023507|NCT00999167|453380717|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
126023508|NCT00999167|453380718|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
126023509|NCT00999167|453380719|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
126023510|NCT00999167|453380717|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
126023511|NCT00999167|453380718|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
126023512|NCT00999167|453380719|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
126023513|NCT00999167|453380717|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
126023514|NCT00999167|453380718|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
126023515|NCT00999167|453380719|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
126023516|NCT00999167|453380717|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
126023517|NCT00999167|453380718|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
126023518|NCT00999167|453380719|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
126023519|NCT00999167|453380717|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
126023520|NCT00999167|453380718|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
126023521|NCT00999167|453380719|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
126023522|NCT02554786|453380720|FG000|Overall Study|Subject/guardian decision|29|||
126023523|NCT02554786|453380721|FG001|Overall Study|Subject/guardian decision|17|||
126023524|NCT02554786|453380722|FG002|Overall Study|Subject/guardian decision|18|||
126023525|NCT02554786|453380723|FG003|Overall Study|Subject/guardian decision|30|||
126023526|NCT02554786|453380724|FG004|Overall Study|Subject/guardian decision|20|||
126023527|NCT02554786|453380720|FG000|Overall Study|Lost to Follow-up|4|||
126023528|NCT02554786|453380721|FG001|Overall Study|Lost to Follow-up|3|||
126023529|NCT02554786|453380722|FG002|Overall Study|Lost to Follow-up|4|||
126023530|NCT02554786|453380723|FG003|Overall Study|Lost to Follow-up|2|||
126023531|NCT02554786|453380724|FG004|Overall Study|Lost to Follow-up|2|||
126023532|NCT02554786|453380720|FG000|Overall Study|Protocol deviation|1|||
126023533|NCT02554786|453380721|FG001|Overall Study|Protocol deviation|3|||
126023534|NCT02554786|453380722|FG002|Overall Study|Protocol deviation|3|||
126023535|NCT02554786|453380723|FG003|Overall Study|Protocol deviation|4|||
126236078|NCT00880568|454156706|FG003|Overall Study|Disease progression|1|||
126236079|NCT00880568|454156707|FG004|Overall Study|Disease progression|3|||
126236080|NCT00880568|454156708|FG005|Overall Study|Disease progression|3|||
126236081|NCT00880568|454156709|FG006|Overall Study|Disease progression|5|||
126236082|NCT00880568|454156710|FG007|Overall Study|Disease progression|0|||
126023536|NCT02554786|453380724|FG004|Overall Study|Protocol deviation|2|||
126023537|NCT02554786|453380720|FG000|Overall Study|Technical problems|1|||
126023538|NCT02554786|453380721|FG001|Overall Study|Technical problems|1|||
126023539|NCT02554786|453380722|FG002|Overall Study|Technical problems|0|||
126023540|NCT02554786|453380723|FG003|Overall Study|Technical problems|2|||
126023541|NCT02554786|453380724|FG004|Overall Study|Technical problems|1|||
126236083|NCT00880568|454156711|FG008|Overall Study|Disease progression|3|||
126236084|NCT00880568|454156703|FG000|Overall Study|Adverse Event|0|||
126236085|NCT00880568|454156704|FG001|Overall Study|Adverse Event|0|||
126236086|NCT00880568|454156705|FG002|Overall Study|Adverse Event|0|||
126236087|NCT00880568|454156706|FG003|Overall Study|Adverse Event|0|||
126236088|NCT00880568|454156707|FG004|Overall Study|Adverse Event|0|||
126355523|NCT05558410|454593039|FG002|Overall Study|Adverse Event|0|||
126355524|NCT05558410|454593037|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
126355525|NCT05558410|454593038|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
126355526|NCT05558410|454593039|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
126355527|NCT05558410|454593037|FG000|Overall Study|Lost to Follow-up|10|||
126355528|NCT05558410|454593038|FG001|Overall Study|Lost to Follow-up|17|||
126355529|NCT05558410|454593039|FG002|Overall Study|Lost to Follow-up|19|||
126355530|NCT05558410|454593037|FG000|Overall Study|Death|1|||
126355531|NCT05558410|454593038|FG001|Overall Study|Death|0|||
126355532|NCT05558410|454593039|FG002|Overall Study|Death|0|||
126023542|NCT02554786|453380720|FG000|Overall Study|Adverse Event|0|||
126023543|NCT02554786|453380721|FG001|Overall Study|Adverse Event|0|||
126023544|NCT02554786|453380722|FG002|Overall Study|Adverse Event|0|||
126236089|NCT00880568|454156708|FG005|Overall Study|Adverse Event|0|||
126236090|NCT00880568|454156709|FG006|Overall Study|Adverse Event|1|||
126355533|NCT05558410|454593037|FG000|Overall Study|Other non-compliance|0|||
126355534|NCT05558410|454593038|FG001|Overall Study|Other non-compliance|1|||
126236091|NCT00880568|454156710|FG007|Overall Study|Adverse Event|1|||
126236092|NCT00880568|454156711|FG008|Overall Study|Adverse Event|0|||
126236093|NCT00880568|454156703|FG000|Overall Study|Withdrawal by Subject|0|||
126236094|NCT00880568|454156704|FG001|Overall Study|Withdrawal by Subject|0|||
126236095|NCT00880568|454156705|FG002|Overall Study|Withdrawal by Subject|0|||
126236096|NCT00880568|454156706|FG003|Overall Study|Withdrawal by Subject|0|||
126236097|NCT00880568|454156707|FG004|Overall Study|Withdrawal by Subject|0|||
126236098|NCT00880568|454156708|FG005|Overall Study|Withdrawal by Subject|0|||
126236099|NCT00880568|454156709|FG006|Overall Study|Withdrawal by Subject|0|||
126236100|NCT00880568|454156710|FG007|Overall Study|Withdrawal by Subject|1|||
126236101|NCT00880568|454156711|FG008|Overall Study|Withdrawal by Subject|0|||
126236102|NCT00849901|454156712|FG000|Acute Treatment Phase|Adverse Event|9|||
126236103|NCT00849901|454156713|FG001|Acute Treatment Phase|Adverse Event|1|||
126236104|NCT00849901|454156714|FG002|Acute Treatment Phase|Adverse Event|3|||
126236105|NCT00849901|454156712|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
126236106|NCT00849901|454156713|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
126236107|NCT00849901|454156714|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
126236108|NCT00849901|454156712|FG000|Acute Treatment Phase|Protocol Violation|0|||
126236109|NCT00849901|454156713|FG001|Acute Treatment Phase|Protocol Violation|2|||
126236110|NCT00849901|454156714|FG002|Acute Treatment Phase|Protocol Violation|1|||
126236111|NCT00849901|454156712|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
126236112|NCT00849901|454156713|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
126236113|NCT00849901|454156714|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
126236114|NCT00849901|454156712|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
126236115|NCT00849901|454156713|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
126236116|NCT00849901|454156714|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
126236117|NCT00849901|454156712|FG000|Acute Treatment Phase|Physician Decision|1|||
126236118|NCT00849901|454156713|FG001|Acute Treatment Phase|Physician Decision|1|||
126236119|NCT00849901|454156714|FG002|Acute Treatment Phase|Physician Decision|1|||
126236120|NCT00849901|454156712|FG000|Acute Treatment Phase|Sponsor Decision|1|||
126236121|NCT00849901|454156713|FG001|Acute Treatment Phase|Sponsor Decision|0|||
126236122|NCT00849901|454156714|FG002|Acute Treatment Phase|Sponsor Decision|0|||
126236123|NCT00849901|454156712|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
126023545|NCT02554786|453380723|FG003|Overall Study|Adverse Event|0|||
126023546|NCT02554786|453380724|FG004|Overall Study|Adverse Event|2|||
126023547|NCT02554786|453380720|FG000|Overall Study|Death|0|||
126023548|NCT02554786|453380721|FG001|Overall Study|Death|0|||
126023549|NCT02554786|453380722|FG002|Overall Study|Death|0|||
126023550|NCT02554786|453380723|FG003|Overall Study|Death|1|||
126023551|NCT02554786|453380724|FG004|Overall Study|Death|0|||
126023552|NCT02554786|453380720|FG000|Overall Study|Non-compliance with study treatment|0|||
126023553|NCT02554786|453380721|FG001|Overall Study|Non-compliance with study treatment|1|||
126236124|NCT00849901|454156713|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
126023554|NCT02554786|453380722|FG002|Overall Study|Non-compliance with study treatment|1|||
126023555|NCT02554786|453380723|FG003|Overall Study|Non-compliance with study treatment|0|||
126023556|NCT02554786|453380724|FG004|Overall Study|Non-compliance with study treatment|1|||
126023557|NCT02554786|453380720|FG000|Overall Study|Physician Decision|0|||
126023558|NCT02554786|453380721|FG001|Overall Study|Physician Decision|1|||
126023559|NCT02554786|453380722|FG002|Overall Study|Physician Decision|4|||
126023560|NCT02554786|453380723|FG003|Overall Study|Physician Decision|1|||
126023561|NCT02554786|453380724|FG004|Overall Study|Physician Decision|1|||
126023562|NCT02554786|453380720|FG000|Overall Study|Pregnancy|0|||
126023563|NCT02554786|453380721|FG001|Overall Study|Pregnancy|0|||
126023564|NCT02554786|453380722|FG002|Overall Study|Pregnancy|0|||
126023565|NCT02554786|453380723|FG003|Overall Study|Pregnancy|1|||
126023566|NCT02554786|453380724|FG004|Overall Study|Pregnancy|1|||
126023567|NCT00522951|453380725|FG000|Period 1|body motion|0|||
126236125|NCT00849901|454156714|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
126236126|NCT00849901|454156712|FG000|Extension Phase|Adverse Event|2|||
126023568|NCT00522951|453380726|FG001|Period 1|body motion|1|||
126236127|NCT00849901|454156713|FG001|Extension Phase|Adverse Event|8|||
126236128|NCT00849901|454156714|FG002|Extension Phase|Adverse Event|4|||
126023569|NCT00522951|453380725|FG000|Washout Period|Adverse Event|0|||
126023570|NCT00522951|453380726|FG001|Washout Period|Adverse Event|1|||
126023571|NCT00522951|453380725|FG000|Washout Period|Death|0|||
126023572|NCT00522951|453380726|FG001|Washout Period|Death|1|||
126093340|NCT03986944|453636020|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
126023573|NCT00522951|453380725|FG000|Period 2|Withdrawal by Subject|1|||
126023574|NCT00522951|453380726|FG001|Period 2|Withdrawal by Subject|0|||
126023575|NCT00522951|453380725|FG000|Period 2|residual contrast medium|1|||
126023576|NCT00522951|453380726|FG001|Period 2|residual contrast medium|1|||
126023577|NCT01747486|453380727|FG000|Stage 1|Physician Decision|3|||
126023578|NCT01747486|453380728|FG001|Stage 1|Physician Decision|0|||
126023579|NCT01747486|453380727|FG000|Stage 1|Withdrawal by Subject|4|||
126023580|NCT01747486|453380728|FG001|Stage 1|Withdrawal by Subject|3|||
126023581|NCT01747486|453380727|FG000|Stage 1|Disease progression|4|||
126023582|NCT01747486|453380728|FG001|Stage 1|Disease progression|9|||
126023583|NCT01747486|453380727|FG000|Stage 1|Death|1|||
126023584|NCT01747486|453380728|FG001|Stage 1|Death|1|||
126093341|NCT03986944|453636018|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
126093342|NCT03986944|453636019|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
126023585|NCT01747486|453380727|FG000|Stage 2|Physician Decision|2|||
126023586|NCT01747486|453380728|FG001|Stage 2|Physician Decision|0|||
126023587|NCT01747486|453380727|FG000|Stage 2|Withdrawal by Subject|1|||
126023588|NCT01747486|453380728|FG001|Stage 2|Withdrawal by Subject|0|||
126023589|NCT01747486|453380727|FG000|Stage 2|New Cancer Therapy|3|||
126023590|NCT01747486|453380728|FG001|Stage 2|New Cancer Therapy|0|||
126023591|NCT01747486|453380727|FG000|Stage 2|Disease Progression|3|||
126023592|NCT01747486|453380728|FG001|Stage 2|Disease Progression|0|||
126023593|NCT01771731|453380729|FG000|Overall Study|Physician Decision|1|||
126023594|NCT01771731|453380730|FG001|Overall Study|Physician Decision|0|||
126023595|NCT01771731|453380729|FG000|Overall Study|Protocol Violation|0|||
126023596|NCT01771731|453380730|FG001|Overall Study|Protocol Violation|1|||
126023597|NCT01771731|453380729|FG000|Overall Study|Adverse event: Pain Crisis|1|||
126023598|NCT01771731|453380730|FG001|Overall Study|Adverse event: Pain Crisis|1|||
126023599|NCT02321514|453380731|FG000|Overall Study|Death|15|||
126023600|NCT02321514|453380731|FG000|Overall Study|Missed Visit|7|||
126023601|NCT02321514|453380731|FG000|Overall Study|Study Exit|3|||
126023602|NCT01216176|453382753|FG000|Overall Study|Adverse Event|0|||
126023603|NCT01216176|453382754|FG001|Overall Study|Adverse Event|8|||
126023604|NCT01216176|453382755|FG002|Overall Study|Adverse Event|0|||
126023605|NCT01216176|453382753|FG000|Overall Study|Physician Decision|0|||
126023606|NCT01216176|453382754|FG001|Overall Study|Physician Decision|0|||
126093343|NCT03986944|453636020|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
126093344|NCT03339245|453636024|FG000|Overall Study|Adverse Event|1|||
126093345|NCT03339245|453636025|FG001|Overall Study|Adverse Event|1|||
126093346|NCT03339245|453636024|FG000|Overall Study|Withdrawal by Subject|1|||
126093347|NCT03339245|453636025|FG001|Overall Study|Withdrawal by Subject|0|||
126093348|NCT00837694|453636026|FG000|Overall Study|Lost to Follow-up|2|||
126093349|NCT00837694|453636027|FG001|Overall Study|Lost to Follow-up|0|||
126093350|NCT00837694|453636028|FG002|Overall Study|Lost to Follow-up|2|||
126093351|NCT00837694|453636029|FG003|Overall Study|Lost to Follow-up|1|||
126093352|NCT00837694|453636030|FG004|Overall Study|Lost to Follow-up|1|||
126023607|NCT01216176|453382755|FG002|Overall Study|Physician Decision|1|||
126023608|NCT03725722|453382758|FG000|Overall Study|Lack of Efficacy|2|||
126023609|NCT03725722|453382759|FG001|Overall Study|Lack of Efficacy|1|||
126023610|NCT03725722|453382760|FG002|Overall Study|Lack of Efficacy|2|||
126023611|NCT03725722|453382761|FG003|Overall Study|Lack of Efficacy|0|||
126023612|NCT03725722|453382762|FG004|Overall Study|Lack of Efficacy|2|||
126023613|NCT03725722|453382758|FG000|Overall Study|Adverse Event|2|||
126023614|NCT03725722|453382759|FG001|Overall Study|Adverse Event|2|||
126023615|NCT03725722|453382760|FG002|Overall Study|Adverse Event|1|||
126023616|NCT03725722|453382761|FG003|Overall Study|Adverse Event|0|||
126023617|NCT03725722|453382762|FG004|Overall Study|Adverse Event|6|||
126023618|NCT03725722|453382758|FG000|Overall Study|Withdrawal by Subject|4|||
126023619|NCT03725722|453382759|FG001|Overall Study|Withdrawal by Subject|1|||
126023620|NCT03725722|453382760|FG002|Overall Study|Withdrawal by Subject|0|||
126023621|NCT03725722|453382761|FG003|Overall Study|Withdrawal by Subject|4|||
126023622|NCT03725722|453382762|FG004|Overall Study|Withdrawal by Subject|4|||
126023623|NCT03725722|453382758|FG000|Overall Study|Lost to Follow-up|3|||
126023624|NCT03725722|453382759|FG001|Overall Study|Lost to Follow-up|1|||
126023625|NCT03725722|453382760|FG002|Overall Study|Lost to Follow-up|2|||
126023626|NCT03725722|453382761|FG003|Overall Study|Lost to Follow-up|2|||
126023627|NCT03725722|453382762|FG004|Overall Study|Lost to Follow-up|1|||
126023628|NCT03725722|453382758|FG000|Overall Study|Personal reasons|0|||
126023629|NCT03725722|453382759|FG001|Overall Study|Personal reasons|0|||
126023630|NCT03725722|453382760|FG002|Overall Study|Personal reasons|1|||
126236129|NCT00849901|454156712|FG000|Extension Phase|Lost to Follow-up|3|||
126023631|NCT03725722|453382761|FG003|Overall Study|Personal reasons|0|||
126023632|NCT03725722|453382762|FG004|Overall Study|Personal reasons|1|||
126023633|NCT03725722|453382758|FG000|Overall Study|COVID-19 situation|0|||
126236130|NCT00849901|454156713|FG001|Extension Phase|Lost to Follow-up|0|||
126236131|NCT00849901|454156714|FG002|Extension Phase|Lost to Follow-up|1|||
126236132|NCT00849901|454156712|FG000|Extension Phase|Protocol Violation|2|||
126023634|NCT03725722|453382759|FG001|Overall Study|COVID-19 situation|1|||
126023635|NCT03725722|453382760|FG002|Overall Study|COVID-19 situation|0|||
126023636|NCT03725722|453382761|FG003|Overall Study|COVID-19 situation|0|||
126023637|NCT03725722|453382762|FG004|Overall Study|COVID-19 situation|0|||
126023638|NCT01600014|453382763|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
126023639|NCT01600014|453382764|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
126023640|NCT01600014|453382763|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
126023641|NCT01600014|453382764|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
126023642|NCT01600014|453382763|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
126023643|NCT01600014|453382764|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
126023644|NCT01600014|453382763|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
126023645|NCT01600014|453382764|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
126023646|NCT01600014|453382763|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
126023647|NCT01600014|453382764|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
126023648|NCT01600014|453382763|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
126023649|NCT01600014|453382764|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
126023650|NCT01600014|453382763|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
126023651|NCT01600014|453382764|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
126023652|NCT01600014|453382763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
126023653|NCT01600014|453382764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
126023654|NCT01600014|453382763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
126023655|NCT01600014|453382764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
126023656|NCT01600014|453382763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
126023657|NCT01600014|453382764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
126023658|NCT01600014|453382763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
126023659|NCT01600014|453382764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
126023660|NCT01600014|453382763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
126023661|NCT01600014|453382764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
126023662|NCT01600014|453382763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
126023663|NCT01600014|453382764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
126023664|NCT01600014|453382763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
126023665|NCT01600014|453382764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
126023666|NCT01600014|453382763|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
126023667|NCT01600014|453382764|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
126023668|NCT01600014|453382763|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
126023669|NCT01600014|453382764|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
126023670|NCT01600014|453382763|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
126023671|NCT01600014|453382764|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
126023672|NCT04104321|453382772|FG000|Overall Study|didn't take the study drug|3|||
126023673|NCT05696080|453382773|FG000|Overall Study|Lost to Follow-up|2|||
126023674|NCT05696080|453382774|FG001|Overall Study|Lost to Follow-up|1|||
126236133|NCT00849901|454156713|FG001|Extension Phase|Protocol Violation|2|||
126236134|NCT00849901|454156714|FG002|Extension Phase|Protocol Violation|4|||
126023675|NCT05696080|453382773|FG000|Overall Study|Physician Decision|1|||
126023676|NCT05696080|453382774|FG001|Overall Study|Physician Decision|0|||
126023677|NCT05696080|453382773|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126023678|NCT05696080|453382774|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126023679|NCT05696080|453382773|FG000|Overall Study|Withdrawal by Subject|12|||
126023680|NCT05696080|453382774|FG001|Overall Study|Withdrawal by Subject|0|||
126023681|NCT02652260|453382783|FG000|Base Study|Pregnancy|0|||
126023682|NCT02652260|453382784|FG001|Base Study|Pregnancy|1|||
126023683|NCT02652260|453382783|FG000|Base Study|Withdrawal by Subject|0|||
126023684|NCT02652260|453382784|FG001|Base Study|Withdrawal by Subject|1|||
126023685|NCT02652260|453382783|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
126023686|NCT02652260|453382784|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
126023687|NCT02652260|453382783|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
126023688|NCT02652260|453382784|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
126023689|NCT02652260|453382783|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
126023690|NCT02652260|453382784|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
126023691|NCT02652260|453382783|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
126023692|NCT02652260|453382784|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
126023693|NCT02652260|453382783|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
126023694|NCT02652260|453382784|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
126023695|NCT02652260|453382783|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
126023696|NCT02652260|453382784|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
126023697|NCT02652260|453382783|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
126023698|NCT02652260|453382784|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
126023699|NCT02652260|453382783|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
126023700|NCT02652260|453382784|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
126023701|NCT02652260|453382783|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
126023702|NCT02652260|453382784|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
126355535|NCT05558410|454593039|FG002|Overall Study|Other non-compliance|2|||
126355536|NCT05558410|454593037|FG000|Overall Study|Sponsor Decision|1|||
126355537|NCT05558410|454593038|FG001|Overall Study|Sponsor Decision|0|||
126355538|NCT05558410|454593039|FG002|Overall Study|Sponsor Decision|0|||
126355539|NCT05558410|454593037|FG000|Overall Study|Other|1|||
126355540|NCT05558410|454593038|FG001|Overall Study|Other|0|||
126355541|NCT05558410|454593039|FG002|Overall Study|Other|1|||
126355542|NCT02400580|454593040|FG000|Overall Study|Withdrawal by Subject|1|||
126355543|NCT02400580|454593041|FG001|Overall Study|Withdrawal by Subject|1|||
126355544|NCT02400580|454593040|FG000|Overall Study|Adverse Event|1|||
126355545|NCT02400580|454593041|FG001|Overall Study|Adverse Event|0|||
126355546|NCT00965094|454593042|FG000|Overall Study|Adverse Event|5|||
126355547|NCT00965094|454593043|FG001|Overall Study|Adverse Event|0|||
126355548|NCT00965094|454593042|FG000|Overall Study|Lost to Follow-up|0|||
126355549|NCT00965094|454593043|FG001|Overall Study|Lost to Follow-up|1|||
126355550|NCT01336972|454593044|FG000|Overall Study|Adverse Event|1|||
126355551|NCT01336972|454593045|FG001|Overall Study|Adverse Event|1|||
126355552|NCT01336972|454593046|FG002|Overall Study|Adverse Event|0|||
126355553|NCT04433975|454593052|FG000|1-month Follow Up|Withdrawal by Subject|1|||
126355554|NCT04433975|454593053|FG001|1-month Follow Up|Withdrawal by Subject|1|||
126355555|NCT04433975|454593052|FG000|1-month Follow Up|Lost to Follow-up|21|||
126355556|NCT04433975|454593053|FG001|1-month Follow Up|Lost to Follow-up|25|||
126355557|NCT04433975|454593052|FG000|3-month Follow Up|Lost to Follow-up|20|||
126355558|NCT04433975|454593053|FG001|3-month Follow Up|Lost to Follow-up|24|||
126355559|NCT04433975|454593052|FG000|3-month Follow Up|Death|1|||
126355560|NCT04433975|454593053|FG001|3-month Follow Up|Death|0|||
126355561|NCT04433975|454593052|FG000|3-month Follow Up|Withdrawal by Subject|2|||
126355562|NCT04433975|454593053|FG001|3-month Follow Up|Withdrawal by Subject|0|||
126355563|NCT04433975|454593052|FG000|6-month Follow Up|Lost to Follow-up|23|||
126355564|NCT04433975|454593053|FG001|6-month Follow Up|Lost to Follow-up|28|||
126355565|NCT04433975|454593052|FG000|6-month Follow Up|Withdrawal by Subject|1|||
126355566|NCT04433975|454593053|FG001|6-month Follow Up|Withdrawal by Subject|1|||
126355567|NCT04433975|454593052|FG000|9-month Follow Up|Lost to Follow-up|27|||
126355568|NCT04433975|454593053|FG001|9-month Follow Up|Lost to Follow-up|36|||
126355569|NCT04433975|454593052|FG000|9-month Follow Up|Death|0|||
126355570|NCT04433975|454593053|FG001|9-month Follow Up|Death|1|||
126355571|NCT04433975|454593052|FG000|12-month Follow Up|Lost to Follow-up|27|||
126355572|NCT04433975|454593053|FG001|12-month Follow Up|Lost to Follow-up|31|||
126355573|NCT04606771|454593054|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
126355574|NCT04606771|454593055|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
126355575|NCT04606771|454593054|FG000|Overall Study|Death|5|||
126355576|NCT04606771|454593055|FG001|Overall Study|Death|6|||
126355577|NCT04606771|454593054|FG000|Overall Study|Wrong randomisation|0|||
126355578|NCT04606771|454593055|FG001|Overall Study|Wrong randomisation|1|||
126355579|NCT04392635|454593058|FG000|Overall Study|Lost to Follow-up|0|||
126355580|NCT04392635|454593059|FG001|Overall Study|Lost to Follow-up|1|||
126355581|NCT02030418|454593060|FG000|Overall Study|Death|78|||
126355582|NCT02030418|454593060|FG000|Overall Study|Missed 12-Month Visit|9|||
126023703|NCT02652260|453382783|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
126023704|NCT02652260|453382784|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
126023705|NCT02652260|453382783|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
126093353|NCT00837694|453636031|FG005|Overall Study|Lost to Follow-up|1|||
126355583|NCT02030418|454593060|FG000|Overall Study|Withdrawn|57|||
126355584|NCT04149353|454593064|FG000|Overall Study|Study terminated|1|||
126355585|NCT00887588|454593066|FG000|Core Period|Death|1|||
126355586|NCT00887588|454593067|FG001|Core Period|Death|1|||
126355587|NCT00887588|454593066|FG000|Core Period|Lost to Follow-up|3|||
126355588|NCT00887588|454593067|FG001|Core Period|Lost to Follow-up|1|||
126355589|NCT00887588|454593066|FG000|Core Period|Withdrawal by Subject|6|||
126355590|NCT00887588|454593067|FG001|Core Period|Withdrawal by Subject|8|||
126355591|NCT00887588|454593066|FG000|Core Period|Adverse Event|9|||
126023706|NCT02652260|453382784|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
126023707|NCT02652260|453382783|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
126023708|NCT02652260|453382784|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
126023709|NCT03899961|453382785|FG000|Overall Study|-delivery prior to|2|||
126023710|NCT03899961|453382786|FG001|Overall Study|-delivery prior to|7|||
126023711|NCT03899961|453382785|FG000|Overall Study|req general anesth|1|||
126023712|NCT03899961|453382786|FG001|Overall Study|req general anesth|2|||
126023713|NCT03899961|453382785|FG000|Overall Study|capacity|5|||
126023714|NCT03899961|453382786|FG001|Overall Study|capacity|6|||
126023715|NCT03899961|453382785|FG000|Overall Study|Withdrawal by Subject|1|||
126023716|NCT03899961|453382786|FG001|Overall Study|Withdrawal by Subject|1|||
126023717|NCT02837510|453382787|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
126023718|NCT02837510|453382788|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
126023719|NCT02837510|453382787|FG000|Washout (2 Weeks)|Adverse Event|0|||
126023720|NCT02837510|453382788|FG001|Washout (2 Weeks)|Adverse Event|1|||
126023721|NCT02837510|453382787|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
126023722|NCT02837510|453382788|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
126023723|NCT02837510|453382787|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
126023724|NCT02837510|453382788|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
126236135|NCT00849901|454156712|FG000|Extension Phase|Withdrawal by Subject|7|||
126236136|NCT00849901|454156713|FG001|Extension Phase|Withdrawal by Subject|6|||
126023725|NCT02837510|453382787|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
126023726|NCT02837510|453382788|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
126023727|NCT02837510|453382787|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
126023728|NCT02837510|453382788|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
126023729|NCT04440176|453382793|FG000|Overall Study|Withdrawal by Subject|5|||
126023730|NCT04440176|453382794|FG001|Overall Study|Withdrawal by Subject|3|||
126023731|NCT04440176|453382793|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126023732|NCT04440176|453382794|FG001|Overall Study|Withdrawal by parent/guardian|5|||
126023733|NCT04440176|453382793|FG000|Overall Study|Adverse Event|2|||
126023734|NCT04440176|453382794|FG001|Overall Study|Adverse Event|6|||
126023735|NCT04440176|453382793|FG000|Overall Study|Lost to Follow-up|22|||
126023736|NCT04440176|453382794|FG001|Overall Study|Lost to Follow-up|23|||
126023737|NCT04440176|453382793|FG000|Overall Study|Medication error without associated adverse event|0|||
126023738|NCT04440176|453382794|FG001|Overall Study|Medication error without associated adverse event|1|||
126023739|NCT04440176|453382793|FG000|Overall Study|No longer met eligibility criteria|7|||
126023740|NCT04440176|453382794|FG001|Overall Study|No longer met eligibility criteria|1|||
126236137|NCT00849901|454156714|FG002|Extension Phase|Withdrawal by Subject|3|||
126236138|NCT00849901|454156712|FG000|Extension Phase|Parent or Caregiver Decision|10|||
126236139|NCT00849901|454156713|FG001|Extension Phase|Parent or Caregiver Decision|4|||
126236140|NCT00849901|454156714|FG002|Extension Phase|Parent or Caregiver Decision|4|||
126236141|NCT00849901|454156712|FG000|Extension Phase|Physician Decision|1|||
126236142|NCT00849901|454156713|FG001|Extension Phase|Physician Decision|2|||
126236143|NCT00849901|454156714|FG002|Extension Phase|Physician Decision|0|||
126236144|NCT00849901|454156712|FG000|Extension Phase|Lack of Efficacy|2|||
126023741|NCT04440176|453382793|FG000|Overall Study|Other|1|||
126023742|NCT04440176|453382794|FG001|Overall Study|Other|2|||
126023743|NCT04440176|453382793|FG000|Overall Study|Protocol deviation|6|||
126023744|NCT04440176|453382794|FG001|Overall Study|Protocol deviation|8|||
126023745|NCT04440176|453382793|FG000|Overall Study|Randomized but not vaccinated|6|||
126023746|NCT04440176|453382794|FG001|Overall Study|Randomized but not vaccinated|3|||
126023747|NCT04608045|453382795|FG000|Overall Study|Physician Decision|1|||
126023748|NCT03517553|453382796|FG000|Overall Study|Withdrawal by Subject|2|||
126023749|NCT03575052|453382797|FG000|Overall Study|Adverse Event|6|||
126023750|NCT03575052|453382798|FG001|Overall Study|Adverse Event|10|||
126023751|NCT03575052|453382797|FG000|Overall Study|Not further specified|5|||
126023752|NCT03575052|453382798|FG001|Overall Study|Not further specified|7|||
126023753|NCT03575052|453382797|FG000|Overall Study|Withdrawal by Subject|5|||
126023754|NCT03575052|453382798|FG001|Overall Study|Withdrawal by Subject|6|||
126023755|NCT03575052|453382797|FG000|Overall Study|Lost to Follow-up|3|||
126023756|NCT03575052|453382798|FG001|Overall Study|Lost to Follow-up|0|||
126236145|NCT00849901|454156713|FG001|Extension Phase|Lack of Efficacy|4|||
126236146|NCT00849901|454156714|FG002|Extension Phase|Lack of Efficacy|1|||
126236147|NCT00437658|454156715|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
126236148|NCT00437658|454156716|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
126236149|NCT00437658|454156717|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
126236150|NCT00437658|454156715|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
126023757|NCT03575052|453382797|FG000|Overall Study|Death|2|||
126023758|NCT03575052|453382798|FG001|Overall Study|Death|1|||
126236151|NCT00437658|454156716|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
126236152|NCT00437658|454156717|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
126236153|NCT00437658|454156715|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
126236154|NCT00437658|454156716|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
126236155|NCT00437658|454156717|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
126236156|NCT00437658|454156715|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
126236157|NCT00437658|454156716|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
126236158|NCT00437658|454156717|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
126236159|NCT00437658|454156715|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
126236160|NCT00437658|454156716|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
126236161|NCT00437658|454156717|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
126236162|NCT00437658|454156715|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
126236163|NCT00437658|454156716|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
126355592|NCT00887588|454593067|FG001|Core Period|Adverse Event|11|||
126355593|NCT00887588|454593066|FG000|Extension Period|Adverse Event|4|||
126023759|NCT03575052|453382797|FG000|Overall Study|Lack of Efficacy|2|||
126355594|NCT00887588|454593067|FG001|Extension Period|Adverse Event|4|||
126355595|NCT00887588|454593066|FG000|Extension Period|Death|0|||
126355596|NCT00887588|454593067|FG001|Extension Period|Death|1|||
126355597|NCT00887588|454593066|FG000|Extension Period|Protocol deviation|1|||
126355598|NCT00887588|454593067|FG001|Extension Period|Protocol deviation|0|||
126355599|NCT00887588|454593066|FG000|Extension Period|Lost to Follow-up|1|||
126355600|NCT00887588|454593067|FG001|Extension Period|Lost to Follow-up|0|||
126023760|NCT03575052|453382798|FG001|Overall Study|Lack of Efficacy|1|||
126023761|NCT03575052|453382797|FG000|Overall Study|Study drug noncompliance|1|||
126023762|NCT03575052|453382798|FG001|Overall Study|Study drug noncompliance|2|||
126023763|NCT03575052|453382797|FG000|Overall Study|Protocol Violation|0|||
126023764|NCT03575052|453382798|FG001|Overall Study|Protocol Violation|2|||
126236164|NCT00437658|454156717|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
126355601|NCT03753542|454593070|FG000|Overall Study|Lost to Follow-up|9|||
126355602|NCT03753542|454593071|FG001|Overall Study|Lost to Follow-up|14|||
126355603|NCT06100250|454593072|FG000|Overall Study|Lost to Follow-up|5|||
126023765|NCT03575052|453382797|FG000|Overall Study|Physician Decision|1|||
126236165|NCT00437658|454156715|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
126236166|NCT00437658|454156716|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
126236167|NCT00437658|454156717|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
126023766|NCT03575052|453382798|FG001|Overall Study|Physician Decision|0|||
126023767|NCT03271151|453382799|FG000|Overall Study|Lost to Follow-up|1|||
126023768|NCT03271151|453382800|FG001|Overall Study|Lost to Follow-up|3|||
126023769|NCT03271151|453382799|FG000|Overall Study|Withdrawal by Subject|1|||
126023770|NCT03271151|453382800|FG001|Overall Study|Withdrawal by Subject|0|||
126023771|NCT03103321|453382801|FG000|Overall Study|Protocol Violation|1|||
126023772|NCT03103321|453382802|FG001|Overall Study|Protocol Violation|1|||
126023773|NCT03103321|453382803|FG002|Overall Study|Protocol Violation|1|||
126023774|NCT03103321|453382804|FG003|Overall Study|Protocol Violation|0|||
126023775|NCT04247542|453382805|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
126236168|NCT00437658|454156715|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
126236169|NCT00437658|454156716|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
126236170|NCT00437658|454156717|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
126236171|NCT00437658|454156715|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
126236172|NCT00437658|454156716|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
126236173|NCT00437658|454156717|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
126236174|NCT00437658|454156715|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
126236175|NCT00437658|454156716|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
126236176|NCT00437658|454156717|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
126236177|NCT00437658|454156715|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
126023776|NCT04247542|453382806|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
126023777|NCT04247542|453382807|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
126023778|NCT04247542|453382805|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
126023779|NCT04247542|453382806|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
126023780|NCT04247542|453382807|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
126023781|NCT04118452|453382808|FG000|Overall Study|Lost to Follow-up|5|||
126093354|NCT00306670|453636038|FG000|Overall Study|patients recruited; Genentech, the st|0|||
126093355|NCT00306670|453636039|FG001|Overall Study|patients recruited; Genentech, the st|2|||
126093356|NCT00503139|453636040|FG000|Overall Study|Case Report Forms were not collected|4|||
126093357|NCT00503139|453636040|FG000|Overall Study|Protocol Violation|4|||
126093358|NCT02735577|453636041|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
126093359|NCT02735577|453636041|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
126093360|NCT02731690|453636042|FG000|Overall Study|Adverse Event|1|||
126093361|NCT02731690|453636042|FG000|Overall Study|Withdrawal by Subject|3|||
126093362|NCT02731690|453636042|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
126093363|NCT00833833|453636043|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
126093364|NCT00833833|453636044|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
126093365|NCT00833833|453636045|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
126093366|NCT00833833|453636046|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
126093367|NCT00833833|453636047|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
126093368|NCT00833833|453636048|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
126236178|NCT00437658|454156716|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
126236179|NCT00437658|454156717|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
126236180|NCT00437658|454156715|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
126355604|NCT02021318|454593073|FG000|Overall Study|Adverse Event|2|||
126355605|NCT02021318|454593074|FG001|Overall Study|Adverse Event|1|||
126355606|NCT02021318|454593073|FG000|Overall Study|Death|33|||
126355607|NCT02021318|454593074|FG001|Overall Study|Death|34|||
126355608|NCT02021318|454593073|FG000|Overall Study|Lost to Follow-up|3|||
126355609|NCT02021318|454593074|FG001|Overall Study|Lost to Follow-up|3|||
126355610|NCT02021318|454593073|FG000|Overall Study|Progressive Disease|0|||
126355611|NCT02021318|454593074|FG001|Overall Study|Progressive Disease|1|||
126355612|NCT02021318|454593073|FG000|Overall Study|Withdrawal by Subject|30|||
126355613|NCT02021318|454593074|FG001|Overall Study|Withdrawal by Subject|18|||
126355614|NCT02021318|454593073|FG000|Overall Study|Physician Decision|3|||
126355615|NCT02021318|454593074|FG001|Overall Study|Physician Decision|3|||
126355616|NCT02021318|454593073|FG000|Overall Study|Miscellaneous|2|||
126023782|NCT04118452|453382809|FG001|Overall Study|Lost to Follow-up|5|||
126023783|NCT04118452|453382808|FG000|Overall Study|Withdrawal by Subject|17|||
126023784|NCT04118452|453382809|FG001|Overall Study|Withdrawal by Subject|17|||
126023785|NCT05086744|453382810|FG000|Part A|Adverse Event|0|||
126023786|NCT05086744|453382811|FG001|Part A|Adverse Event|1|||
126023787|NCT05086744|453382810|FG000|Part A|Lack of Efficacy|3|||
126093369|NCT00833833|453636043|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
126355617|NCT02021318|454593074|FG001|Overall Study|Miscellaneous|3|||
126355618|NCT00421993|454593076|FG000|Overall Study|Withdrawal by Subject|22|||
126355619|NCT00421993|454593077|FG001|Overall Study|Withdrawal by Subject|23|||
126355620|NCT00421993|454593078|FG002|Overall Study|Withdrawal by Subject|23|||
126236181|NCT00437658|454156716|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
126236182|NCT00437658|454156717|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
126236183|NCT04407806|454156719|FG000|Overall Study|Withdrawal by Subject|1|||
126236184|NCT04407806|454156720|FG001|Overall Study|Withdrawal by Subject|2|||
126236185|NCT02731157|454156721|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
126236186|NCT00832377|454156722|FG000|Overall Study|Protocol Violation|1|||
126236187|NCT01449630|454156723|FG000|Period 1|Physician Decision|1|||
126236188|NCT01449630|454156724|FG001|Period 1|Physician Decision|0|||
126236189|NCT01449630|454156725|FG002|Period 1|Physician Decision|0|||
126236190|NCT01449630|454156726|FG003|Period 1|Physician Decision|1|||
126093370|NCT00833833|453636044|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
126093371|NCT00833833|453636045|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
126236191|NCT01449630|454156727|FG004|Period 1|Physician Decision|0|||
126236192|NCT01449630|454156728|FG005|Period 1|Physician Decision|0|||
126236193|NCT01449630|454156729|FG006|Period 1|Physician Decision|0|||
126355621|NCT00421993|454593079|FG003|Overall Study|Withdrawal by Subject|24|||
126093372|NCT00833833|453636046|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
126093373|NCT00833833|453636047|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
126093374|NCT00833833|453636048|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
126236194|NCT01449630|454156730|FG007|Period 1|Physician Decision|0|||
126355622|NCT00421993|454593076|FG000|Overall Study|Lost to Follow-up|18|||
126023788|NCT05086744|453382811|FG001|Part A|Lack of Efficacy|0|||
126023789|NCT05086744|453382810|FG000|Part A|Protocol deviation|1|||
126023790|NCT05086744|453382811|FG001|Part A|Protocol deviation|0|||
126023791|NCT05086744|453382810|FG000|Part A|Subject decision|1|||
126023792|NCT05086744|453382811|FG001|Part A|Subject decision|0|||
126023793|NCT05086744|453382810|FG000|Part B|Adverse Event|0|||
126023794|NCT05086744|453382811|FG001|Part B|Adverse Event|1|||
126023795|NCT05086744|453382810|FG000|Part B|Lack of Efficacy|0|||
126023796|NCT05086744|453382811|FG001|Part B|Lack of Efficacy|1|||
126023797|NCT05086744|453382810|FG000|Part B|Study terminated by sponsor|1|||
126023798|NCT05086744|453382811|FG001|Part B|Study terminated by sponsor|6|||
126023799|NCT01704079|453382812|FG000|Overall Study|Withdrawal by Subject|5|||
126023800|NCT01704079|453382813|FG001|Overall Study|Withdrawal by Subject|7|||
126023801|NCT01704079|453382812|FG000|Overall Study|Lost to Follow-up|2|||
126023802|NCT01704079|453382813|FG001|Overall Study|Lost to Follow-up|5|||
126023803|NCT01704079|453382812|FG000|Overall Study|Adverse Event|4|||
126355623|NCT00421993|454593077|FG001|Overall Study|Lost to Follow-up|19|||
126355624|NCT00421993|454593078|FG002|Overall Study|Lost to Follow-up|22|||
126355625|NCT00421993|454593079|FG003|Overall Study|Lost to Follow-up|20|||
126355626|NCT00421993|454593076|FG000|Overall Study|Adverse Event|11|||
126355627|NCT00421993|454593077|FG001|Overall Study|Adverse Event|1|||
126355628|NCT00421993|454593078|FG002|Overall Study|Adverse Event|6|||
126355629|NCT00421993|454593079|FG003|Overall Study|Adverse Event|4|||
126355630|NCT00421993|454593076|FG000|Overall Study|Protocol Violation|2|||
126355631|NCT00421993|454593077|FG001|Overall Study|Protocol Violation|2|||
126355632|NCT00421993|454593078|FG002|Overall Study|Protocol Violation|0|||
126355633|NCT00421993|454593079|FG003|Overall Study|Protocol Violation|1|||
126355634|NCT00421993|454593076|FG000|Overall Study|Lack of Efficacy|0|||
126355635|NCT00421993|454593077|FG001|Overall Study|Lack of Efficacy|3|||
126355636|NCT00421993|454593078|FG002|Overall Study|Lack of Efficacy|0|||
126355637|NCT00421993|454593079|FG003|Overall Study|Lack of Efficacy|5|||
126355638|NCT00421993|454593076|FG000|Overall Study|Pregnancy|0|||
126355639|NCT00421993|454593077|FG001|Overall Study|Pregnancy|1|||
126355640|NCT00421993|454593078|FG002|Overall Study|Pregnancy|1|||
126355641|NCT00421993|454593079|FG003|Overall Study|Pregnancy|2|||
126355642|NCT00421993|454593076|FG000|Overall Study|Subject transportation issues|0|||
126355643|NCT00421993|454593077|FG001|Overall Study|Subject transportation issues|0|||
126355644|NCT00421993|454593078|FG002|Overall Study|Subject transportation issues|0|||
126355645|NCT00421993|454593079|FG003|Overall Study|Subject transportation issues|1|||
126023804|NCT01704079|453382813|FG001|Overall Study|Adverse Event|7|||
126023805|NCT01704079|453382812|FG000|Overall Study|Protocol Violation|1|||
126023806|NCT01704079|453382813|FG001|Overall Study|Protocol Violation|0|||
126023807|NCT01704079|453382812|FG000|Overall Study|Subject noncompliance|2|||
126023808|NCT01704079|453382813|FG001|Overall Study|Subject noncompliance|3|||
126023809|NCT01704079|453382812|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
126023810|NCT01704079|453382813|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
126355646|NCT02015104|454593084|FG000|Overall Study|Withdrew consent after first dose drug|1|||
126355647|NCT02015104|454593085|FG001|Overall Study|Withdrew consent after first dose drug|0|||
126355648|NCT02015104|454593084|FG000|Overall Study|Withdrew consent prior to treatment|0|||
126355649|NCT02015104|454593085|FG001|Overall Study|Withdrew consent prior to treatment|1|||
126023811|NCT04300231|453382814|FG000|Overall Study|Protocol Violation|4|||
126355650|NCT01030900|454593092|FG000|Overall Study|Not treated due to congestive heart failure|1|||
126355651|NCT01030900|454593092|FG000|Overall Study|Not treated due to rapid disease|1|||
126355652|NCT00441896|454593093|FG000|Overall Study|Withdrawal by Subject|0|||
126355653|NCT00441896|454593094|FG001|Overall Study|Withdrawal by Subject|0|||
126023812|NCT04300231|453382815|FG001|Overall Study|Protocol Violation|3|||
126023813|NCT04300231|453382816|FG002|Overall Study|Protocol Violation|0|||
126023814|NCT04300231|453382817|FG003|Overall Study|Protocol Violation|2|||
126023815|NCT05986565|453382823|FG000|Overall Study|Lost to Follow-up|8|||
126023816|NCT05986565|453382824|FG001|Overall Study|Lost to Follow-up|3|||
126023817|NCT05986565|453382823|FG000|Overall Study|Withdrawal by Subject|0|||
126023818|NCT05986565|453382824|FG001|Overall Study|Withdrawal by Subject|1|||
126023819|NCT02991807|453382827|FG000|Overall Study|Withdrawal by Subject|2|||
126023820|NCT02991807|453382828|FG001|Overall Study|Withdrawal by Subject|1|||
126023821|NCT02991807|453382827|FG000|Overall Study|Physician Decision|0|||
126023822|NCT02991807|453382828|FG001|Overall Study|Physician Decision|1|||
126023823|NCT02991807|453382827|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
126023824|NCT02991807|453382828|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
126023825|NCT02300298|453382831|FG000|Disposition for Nintedanib|Progressive disease|10|||
126023826|NCT02300298|453382832|FG001|Disposition for Nintedanib|Progressive disease|0|||
126023827|NCT02300298|453382831|FG000|Disposition for Docetaxel|Progressive disease|0|||
126023828|NCT02300298|453382832|FG001|Disposition for Docetaxel|Progressive disease|6|||
126023829|NCT02300298|453382831|FG000|Disposition for Docetaxel|other adverse event|0|||
126023830|NCT02300298|453382832|FG001|Disposition for Docetaxel|other adverse event|4|||
126023831|NCT04579250|453382836|FG000|Overall Study|Withdrawal by Subject|1|||
126023832|NCT04579250|453382837|FG001|Overall Study|Withdrawal by Subject|1|||
126023833|NCT04579250|453382838|FG002|Overall Study|Withdrawal by Subject|0|||
126023834|NCT04579250|453382836|FG000|Overall Study|Lost to Follow-up|1|||
126023835|NCT04579250|453382837|FG001|Overall Study|Lost to Follow-up|1|||
126355654|NCT00441896|454593095|FG002|Overall Study|Withdrawal by Subject|0|||
126355655|NCT00441896|454593096|FG003|Overall Study|Withdrawal by Subject|1|||
126355656|NCT00441896|454593097|FG004|Overall Study|Withdrawal by Subject|0|||
126355657|NCT00441896|454593098|FG005|Overall Study|Withdrawal by Subject|0|||
126355658|NCT00441896|454593099|FG006|Overall Study|Withdrawal by Subject|0|||
126355659|NCT00441896|454593100|FG007|Overall Study|Withdrawal by Subject|0|||
126355660|NCT00441896|454593101|FG008|Overall Study|Withdrawal by Subject|0|||
126355661|NCT00441896|454593102|FG009|Overall Study|Withdrawal by Subject|0|||
126355662|NCT00441896|454593093|FG000|Overall Study|Other|0|||
126355663|NCT00441896|454593094|FG001|Overall Study|Other|0|||
126355664|NCT00441896|454593095|FG002|Overall Study|Other|0|||
126355665|NCT00441896|454593096|FG003|Overall Study|Other|0|||
126355666|NCT00441896|454593097|FG004|Overall Study|Other|1|||
126355667|NCT00441896|454593098|FG005|Overall Study|Other|0|||
126355668|NCT00441896|454593099|FG006|Overall Study|Other|0|||
126355669|NCT00441896|454593100|FG007|Overall Study|Other|0|||
126355670|NCT00441896|454593101|FG008|Overall Study|Other|0|||
126355671|NCT00441896|454593102|FG009|Overall Study|Other|0|||
126355672|NCT01350973|454593103|FG000|Overall Study|Adverse Event|4|||
126355673|NCT01350973|454593104|FG001|Overall Study|Adverse Event|7|||
126355674|NCT01350973|454593105|FG002|Overall Study|Adverse Event|7|||
126355675|NCT01350973|454593103|FG000|Overall Study|Voluntary Withdrawal|2|||
126355676|NCT01350973|454593104|FG001|Overall Study|Voluntary Withdrawal|1|||
126355677|NCT01350973|454593105|FG002|Overall Study|Voluntary Withdrawal|1|||
126355678|NCT02638493|454593109|FG000|Overall Study|Inability to provide semen samples|2|||
126355679|NCT02638493|454593110|FG001|Overall Study|Inability to provide semen samples|0|||
126355680|NCT02638493|454593111|FG002|Overall Study|Inability to provide semen samples|0|||
126355681|NCT01033071|454593112|FG000|Overall Study|Adverse Event|28|||
126355682|NCT01033071|454593113|FG001|Overall Study|Adverse Event|51|||
126355683|NCT01033071|454593114|FG002|Overall Study|Adverse Event|26|||
126355684|NCT01033071|454593112|FG000|Overall Study|Protocol Violation|0|||
126355685|NCT01033071|454593113|FG001|Overall Study|Protocol Violation|2|||
126355686|NCT01033071|454593114|FG002|Overall Study|Protocol Violation|1|||
126355687|NCT01033071|454593112|FG000|Overall Study|Lost to Follow-up|4|||
126355688|NCT01033071|454593113|FG001|Overall Study|Lost to Follow-up|5|||
126355689|NCT01033071|454593114|FG002|Overall Study|Lost to Follow-up|5|||
126355690|NCT01033071|454593112|FG000|Overall Study|Withdrawal by Subject|17|||
126355691|NCT01033071|454593113|FG001|Overall Study|Withdrawal by Subject|14|||
126355692|NCT01033071|454593114|FG002|Overall Study|Withdrawal by Subject|11|||
126355693|NCT01033071|454593112|FG000|Overall Study|Lack of Efficacy|0|||
126355694|NCT01033071|454593113|FG001|Overall Study|Lack of Efficacy|1|||
126355695|NCT01033071|454593114|FG002|Overall Study|Lack of Efficacy|1|||
126355696|NCT01033071|454593112|FG000|Overall Study|Other|6|||
126355697|NCT01033071|454593113|FG001|Overall Study|Other|4|||
126355698|NCT01033071|454593114|FG002|Overall Study|Other|3|||
126355699|NCT00004859|454593117|FG000|Overall Study|Lack of Efficacy|43|||
126355700|NCT00004859|454593118|FG001|Overall Study|Lack of Efficacy|113|||
126355701|NCT00004859|454593117|FG000|Overall Study|Adverse Event|31|||
126355702|NCT00004859|454593118|FG001|Overall Study|Adverse Event|93|||
126023836|NCT04579250|453382838|FG002|Overall Study|Lost to Follow-up|0|||
126023837|NCT04579250|453382836|FG000|Overall Study|Moved from area|0|||
126023838|NCT04579250|453382837|FG001|Overall Study|Moved from area|1|||
126023839|NCT04579250|453382838|FG002|Overall Study|Moved from area|2|||
126023840|NCT02058108|453382839|FG000|Overall Study|Abnormal Laboratory Values|0|||
126023841|NCT02058108|453382840|FG001|Overall Study|Abnormal Laboratory Values|1|||
126023842|NCT02058108|453382839|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
126023843|NCT02058108|453382840|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126023844|NCT02058108|453382839|FG000|Overall Study|No longer requires study drug|0|||
126236195|NCT01449630|454156731|FG008|Period 1|Physician Decision|0|||
126355703|NCT00004859|454593117|FG000|Overall Study|Death|5|||
126355704|NCT00004859|454593118|FG001|Overall Study|Death|5|||
126355705|NCT00004859|454593117|FG000|Overall Study|Withdrawal by Subject|7|||
126355706|NCT00004859|454593118|FG001|Overall Study|Withdrawal by Subject|33|||
126355707|NCT00004859|454593117|FG000|Overall Study|Protocol Violation|2|||
126355708|NCT00004859|454593118|FG001|Overall Study|Protocol Violation|2|||
126355709|NCT00004859|454593117|FG000|Overall Study|other disease|0|||
126355710|NCT00004859|454593118|FG001|Overall Study|other disease|3|||
126355711|NCT00004859|454593117|FG000|Overall Study|error|3|||
126355712|NCT00004859|454593118|FG001|Overall Study|error|1|||
126355713|NCT00004859|454593117|FG000|Overall Study|missing data|14|||
126355714|NCT00004859|454593118|FG001|Overall Study|missing data|11|||
126355715|NCT00004859|454593117|FG000|Overall Study|Other|13|||
126355716|NCT00004859|454593118|FG001|Overall Study|Other|21|||
126093375|NCT00833833|453636043|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
126093376|NCT00833833|453636044|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
126093377|NCT00833833|453636045|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
126093378|NCT00833833|453636046|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
126093379|NCT00833833|453636047|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
126093380|NCT00833833|453636048|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
126093381|NCT00833833|453636043|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
126093382|NCT00833833|453636044|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
126093383|NCT00833833|453636045|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
126093384|NCT00833833|453636046|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
126093385|NCT00833833|453636047|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
126093386|NCT00833833|453636048|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
126093387|NCT00833833|453636043|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
126236196|NCT01449630|454156723|FG000|Period 1|Sponsor Decision|0|||
125878745|NCT03175367|452853407|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
126023845|NCT02058108|453382840|FG001|Overall Study|No longer requires study drug|1|||
126023846|NCT02058108|453382839|FG000|Overall Study|Withdrawal by Subject|1|||
126023847|NCT02058108|453382840|FG001|Overall Study|Withdrawal by Subject|0|||
126023848|NCT02058108|453382839|FG000|Overall Study|Administrative problems|3|||
126023849|NCT02058108|453382840|FG001|Overall Study|Administrative problems|3|||
126023850|NCT02058108|453382839|FG000|Overall Study|Protocol Violation|0|||
126023851|NCT02058108|453382840|FG001|Overall Study|Protocol Violation|1|||
126023852|NCT00818246|453382845|FG000|Overall Study|Impossible to match pictures|5|||
126023853|NCT01121991|453382846|FG000|Overall Study|Lack of Ovarian Response|2|||
126023854|NCT01121991|453382846|FG000|Overall Study|No Oocytes Retrieved|3|||
126023855|NCT01121991|453382846|FG000|Overall Study|No Fertilization|1|||
126023856|NCT02006758|453382847|FG000|Overall Study|Protocol Violation|1|||
126023857|NCT02006758|453382847|FG000|Overall Study|Death|1|||
126023858|NCT02006758|453382847|FG000|Overall Study|Lost to Follow-up|4|||
126023859|NCT02006758|453382847|FG000|Overall Study|Withdrawal by Subject|4|||
126023860|NCT02006758|453382847|FG000|Overall Study|Procedurally excluded|1|||
126023861|NCT02006758|453382847|FG000|Overall Study|Other|2|||
126023862|NCT00093015|453382848|FG000|Overall Study|Withdrawal by Subject|194|||
126023863|NCT00093015|453382849|FG001|Overall Study|Withdrawal by Subject|171|||
126023864|NCT00093015|453382848|FG000|Overall Study|Lost to Follow-up|96|||
126023865|NCT00093015|453382849|FG001|Overall Study|Lost to Follow-up|108|||
126023866|NCT00093015|453382848|FG000|Overall Study|Death|375|||
126023867|NCT00093015|453382849|FG001|Overall Study|Death|385|||
126023868|NCT02794480|453382859|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
126023869|NCT02794480|453382860|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
126023870|NCT02794480|453382861|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
126023871|NCT02794480|453382862|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
126023872|NCT02794480|453382859|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
126023873|NCT02794480|453382860|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
126023874|NCT02794480|453382861|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
126023875|NCT02794480|453382862|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
126023876|NCT02794480|453382859|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126023877|NCT02794480|453382860|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126023878|NCT02794480|453382861|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126023879|NCT02794480|453382862|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
126023880|NCT02794480|453382859|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126023881|NCT02794480|453382860|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
126023882|NCT02794480|453382861|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126023883|NCT02794480|453382862|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126023884|NCT02794480|453382859|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
126023885|NCT02794480|453382860|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126023886|NCT02794480|453382861|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126023887|NCT02794480|453382862|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
126023888|NCT01017146|453382863|FG000|Overall Study|Adverse Event|11|||
126023889|NCT01017146|453382864|FG001|Overall Study|Adverse Event|1|||
126023890|NCT01017146|453382863|FG000|Overall Study|Lost to Follow-up|14|||
126023891|NCT01017146|453382864|FG001|Overall Study|Lost to Follow-up|14|||
126023892|NCT01017146|453382863|FG000|Overall Study|Noncompliance with Study Product|1|||
126023893|NCT01017146|453382864|FG001|Overall Study|Noncompliance with Study Product|1|||
126023894|NCT01017146|453382863|FG000|Overall Study|Withdrawal by Subject|32|||
126023895|NCT01017146|453382864|FG001|Overall Study|Withdrawal by Subject|16|||
126023896|NCT01017146|453382863|FG000|Overall Study|Relocation|0|||
126023897|NCT01017146|453382864|FG001|Overall Study|Relocation|4|||
126023898|NCT01017146|453382863|FG000|Overall Study|Pregnancy|2|||
126023899|NCT01017146|453382864|FG001|Overall Study|Pregnancy|1|||
126023900|NCT01017146|453382863|FG000|Overall Study|Protocol Violation|2|||
126023901|NCT01017146|453382864|FG001|Overall Study|Protocol Violation|0|||
126023902|NCT01017146|453382863|FG000|Overall Study|Took Excluded Medication|2|||
126023903|NCT01017146|453382864|FG001|Overall Study|Took Excluded Medication|0|||
126023904|NCT01017146|453382863|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
126093388|NCT00833833|453636044|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126236197|NCT01449630|454156724|FG001|Period 1|Sponsor Decision|0|||
126236198|NCT01449630|454156725|FG002|Period 1|Sponsor Decision|0|||
126236199|NCT01449630|454156726|FG003|Period 1|Sponsor Decision|0|||
126236200|NCT01449630|454156727|FG004|Period 1|Sponsor Decision|0|||
126023905|NCT01017146|453382864|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
126023906|NCT01017146|453382863|FG000|Overall Study|Change in Work Situation|1|||
126023907|NCT01017146|453382864|FG001|Overall Study|Change in Work Situation|0|||
126023908|NCT05171777|453382870|FG000|Treatment Crossover Period|Adverse Event|9|||
126023909|NCT05171777|453382871|FG001|Treatment Crossover Period|Adverse Event|6|||
126023910|NCT05171777|453382872|FG002|Treatment Crossover Period|Adverse Event|0|||
126023911|NCT05171777|453382873|FG003|Treatment Crossover Period|Adverse Event|0|||
126236201|NCT01449630|454156728|FG005|Period 1|Sponsor Decision|1|||
126236202|NCT01449630|454156729|FG006|Period 1|Sponsor Decision|0|||
126023912|NCT05171777|453382870|FG000|Treatment Crossover Period|Death|5|||
126023913|NCT05171777|453382871|FG001|Treatment Crossover Period|Death|5|||
126023914|NCT05171777|453382872|FG002|Treatment Crossover Period|Death|0|||
126023915|NCT05171777|453382873|FG003|Treatment Crossover Period|Death|0|||
126023916|NCT05171777|453382870|FG000|Treatment Crossover Period|Disease Relapse|0|||
126023917|NCT05171777|453382871|FG001|Treatment Crossover Period|Disease Relapse|1|||
126023918|NCT05171777|453382872|FG002|Treatment Crossover Period|Disease Relapse|0|||
126023919|NCT05171777|453382873|FG003|Treatment Crossover Period|Disease Relapse|0|||
126023920|NCT05171777|453382870|FG000|Treatment Crossover Period|Reason not Specified|2|||
126023921|NCT05171777|453382871|FG001|Treatment Crossover Period|Reason not Specified|1|||
126023922|NCT05171777|453382872|FG002|Treatment Crossover Period|Reason not Specified|0|||
126023923|NCT05171777|453382873|FG003|Treatment Crossover Period|Reason not Specified|0|||
126023924|NCT05171777|453382870|FG000|Treatment Crossover Period|Physician Decision|0|||
126023925|NCT05171777|453382871|FG001|Treatment Crossover Period|Physician Decision|1|||
126023926|NCT05171777|453382872|FG002|Treatment Crossover Period|Physician Decision|0|||
126023927|NCT05171777|453382873|FG003|Treatment Crossover Period|Physician Decision|0|||
126023928|NCT05171777|453382870|FG000|Treatment Crossover Period|Progressive Disease|13|||
126023929|NCT05171777|453382871|FG001|Treatment Crossover Period|Progressive Disease|9|||
126023930|NCT05171777|453382872|FG002|Treatment Crossover Period|Progressive Disease|0|||
126023931|NCT05171777|453382873|FG003|Treatment Crossover Period|Progressive Disease|0|||
126023932|NCT05171777|453382870|FG000|Treatment Crossover Period|Protocol Violation|0|||
126023933|NCT05171777|453382871|FG001|Treatment Crossover Period|Protocol Violation|2|||
126023934|NCT05171777|453382872|FG002|Treatment Crossover Period|Protocol Violation|0|||
126023935|NCT05171777|453382873|FG003|Treatment Crossover Period|Protocol Violation|0|||
126023936|NCT05171777|453382870|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
126236203|NCT01449630|454156730|FG007|Period 1|Sponsor Decision|0|||
126236204|NCT01449630|454156731|FG008|Period 1|Sponsor Decision|0|||
126236205|NCT01449630|454156723|FG000|Period 2|Sponsor Decision|0|||
126236206|NCT01449630|454156724|FG001|Period 2|Sponsor Decision|0|||
126236207|NCT01449630|454156725|FG002|Period 2|Sponsor Decision|0|||
126236208|NCT01449630|454156726|FG003|Period 2|Sponsor Decision|0|||
126236209|NCT01449630|454156727|FG004|Period 2|Sponsor Decision|0|||
126236210|NCT01449630|454156728|FG005|Period 2|Sponsor Decision|0|||
126236211|NCT01449630|454156729|FG006|Period 2|Sponsor Decision|1|||
126236212|NCT01449630|454156730|FG007|Period 2|Sponsor Decision|0|||
126236213|NCT01449630|454156731|FG008|Period 2|Sponsor Decision|0|||
126236214|NCT01735630|454156736|FG000|Overall Study|Adverse Event|8|||
126236215|NCT01735630|454156737|FG001|Overall Study|Adverse Event|7|||
126236216|NCT01735630|454156736|FG000|Overall Study|Lost to Follow-up|1|||
126236217|NCT01735630|454156737|FG001|Overall Study|Lost to Follow-up|0|||
126236218|NCT01735630|454156736|FG000|Overall Study|Physician Decision|0|||
126236219|NCT01735630|454156737|FG001|Overall Study|Physician Decision|1|||
126236220|NCT01735630|454156736|FG000|Overall Study|Sponsor Decision|2|||
126236221|NCT01735630|454156737|FG001|Overall Study|Sponsor Decision|1|||
126236222|NCT01735630|454156736|FG000|Overall Study|Withdrawal by Subject|7|||
126236223|NCT01735630|454156737|FG001|Overall Study|Withdrawal by Subject|9|||
126236224|NCT03099538|454156738|FG000|Overall Study|Lack of Efficacy|3|||
126236225|NCT01941030|454156749|FG000|Overall Study|Death|3|||
126236226|NCT01941030|454156750|FG001|Overall Study|Death|2|||
126236227|NCT01941030|454156749|FG000|Overall Study|Lost to Follow-up|6|||
126236228|NCT01941030|454156750|FG001|Overall Study|Lost to Follow-up|5|||
126236229|NCT01941030|454156749|FG000|Overall Study|Withdrawal by Subject|4|||
126236230|NCT01941030|454156750|FG001|Overall Study|Withdrawal by Subject|6|||
126236231|NCT02930005|454156751|FG000|Overall Study|Lost to Follow-up|1|||
126236232|NCT02930005|454156752|FG001|Overall Study|Lost to Follow-up|5|||
126236233|NCT00822926|454156755|FG000|Second Injection Visit|Lost to Follow-up|1|||
126236234|NCT00822926|454156756|FG001|Second Injection Visit|Lost to Follow-up|0|||
126236235|NCT00822926|454156755|FG000|Second Injection Visit|Withdrawal by Subject|0|||
126236236|NCT00822926|454156756|FG001|Second Injection Visit|Withdrawal by Subject|1|||
126236237|NCT02534493|454156759|FG000|Overall Study|Lost to Follow-up|1|||
126236238|NCT02534493|454156759|FG000|Overall Study|Withdrawal by Subject|1|||
126236239|NCT03262012|454156762|FG000|Overall Study|Withdrawal by Subject|15|||
126236240|NCT03262012|454156763|FG001|Overall Study|Withdrawal by Subject|13|||
126355717|NCT04073407|454593119|FG000|Part 1|Withdrawal by Subject|1|||
126355718|NCT04073407|454593120|FG001|Part 1|Withdrawal by Subject|0|||
126355719|NCT04073407|454593119|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
126023937|NCT05171777|453382871|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
126023938|NCT05171777|453382872|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
126023939|NCT05171777|453382873|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
126236241|NCT03262012|454156764|FG002|Overall Study|Withdrawal by Subject|8|||
126236242|NCT03262012|454156765|FG003|Overall Study|Withdrawal by Subject|7|||
126236243|NCT03262012|454156762|FG000|Overall Study|Adverse Event|10|||
126236244|NCT03262012|454156763|FG001|Overall Study|Adverse Event|12|||
126236245|NCT03262012|454156764|FG002|Overall Study|Adverse Event|4|||
126236246|NCT03262012|454156765|FG003|Overall Study|Adverse Event|6|||
126236247|NCT03262012|454156762|FG000|Overall Study|Physician Decision|2|||
126236248|NCT03262012|454156763|FG001|Overall Study|Physician Decision|5|||
126236249|NCT03262012|454156764|FG002|Overall Study|Physician Decision|1|||
126236250|NCT03262012|454156765|FG003|Overall Study|Physician Decision|0|||
126236251|NCT03262012|454156762|FG000|Overall Study|Lack of Efficacy|0|||
126236252|NCT03262012|454156763|FG001|Overall Study|Lack of Efficacy|5|||
126236253|NCT03262012|454156764|FG002|Overall Study|Lack of Efficacy|1|||
126236254|NCT03262012|454156765|FG003|Overall Study|Lack of Efficacy|2|||
126236255|NCT03262012|454156762|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
126236256|NCT03262012|454156763|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
126236257|NCT03262012|454156764|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
126236258|NCT03262012|454156765|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
126236259|NCT01469546|454156766|FG000|Received 5 mg Dose|Adverse Event|13|||
126236260|NCT01469546|454156766|FG000|Received 5 mg Dose|Death|2|||
126236261|NCT01469546|454156766|FG000|Received 5 mg Dose|Protocol Violation|2|||
126236262|NCT01469546|454156766|FG000|Received 5 mg Dose|Progressive Disease|3|||
126236263|NCT01469546|454156766|FG000|Received 5 mg Dose|Physician Decision|3|||
126236264|NCT02079532|454156769|FG000|Overall Study|Adverse Event|7|||
126236265|NCT02079532|454156769|FG000|Overall Study|Additional or changed therapy|2|||
126236266|NCT02079532|454156769|FG000|Overall Study|Lack of Efficacy|9|||
126236267|NCT02079532|454156769|FG000|Overall Study|Protocol Violation|3|||
126236268|NCT02079532|454156769|FG000|Overall Study|Withdrawal by Subject|1|||
126236269|NCT02079532|454156769|FG000|Overall Study|Administrative problems|1|||
126236270|NCT02079532|454156769|FG000|Overall Study|Inclusion into ReFIRST|3|||
126236271|NCT02079532|454156769|FG000|Overall Study|Other|3|||
126236272|NCT02158936|454156770|FG000|Overall Study|Study closed/ terminated|57|||
126236273|NCT02158936|454156771|FG001|Overall Study|Study closed/ terminated|77|||
126236274|NCT02158936|454156770|FG000|Overall Study|Azacitidine tx discontinued|53|||
126236275|NCT02158936|454156771|FG001|Overall Study|Azacitidine tx discontinued|46|||
126236276|NCT02158936|454156770|FG000|Overall Study|Adverse Event|39|||
126236277|NCT02158936|454156771|FG001|Overall Study|Adverse Event|24|||
126236278|NCT02158936|454156770|FG000|Overall Study|Withdrawal by Subject|15|||
126236279|NCT02158936|454156771|FG001|Overall Study|Withdrawal by Subject|16|||
126236280|NCT02158936|454156770|FG000|Overall Study|Physician Decision|15|||
126236281|NCT02158936|454156771|FG001|Overall Study|Physician Decision|13|||
126236282|NCT02158936|454156770|FG000|Overall Study|Lost to Follow-up|0|||
126236283|NCT02158936|454156771|FG001|Overall Study|Lost to Follow-up|1|||
126236284|NCT01432171|454156772|FG000|Overall Study|Death|1|||
126236285|NCT01432171|454156773|FG001|Overall Study|Death|2|||
126236286|NCT01432171|454156772|FG000|Overall Study|Lost to Follow-up|6|||
126236287|NCT01432171|454156773|FG001|Overall Study|Lost to Follow-up|5|||
126236288|NCT01432171|454156772|FG000|Overall Study|Withdrawal by Subject|3|||
126236289|NCT01432171|454156773|FG001|Overall Study|Withdrawal by Subject|1|||
126236290|NCT01432171|454156772|FG000|Overall Study|Noncompliance|2|||
126236291|NCT01432171|454156773|FG001|Overall Study|Noncompliance|3|||
126236292|NCT01432171|454156772|FG000|Overall Study|Insurance denial trial coverage|1|||
126236293|NCT01432171|454156773|FG001|Overall Study|Insurance denial trial coverage|0|||
126355720|NCT04073407|454593120|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
126355721|NCT04073407|454593119|FG000|Part 2|Withdrawal by Subject|0|||
126355722|NCT04073407|454593120|FG001|Part 2|Withdrawal by Subject|1|||
126355723|NCT04941898|454595536|FG000|Overall Study|Protocol Violation|1|||
126355724|NCT00884949|454595537|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
126355725|NCT00884949|454595537|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
126355726|NCT03022630|454595538|FG000|Overall Study|Death|9|||
126236294|NCT01432171|454156772|FG000|Overall Study|Patient moved to palliative care|1|||
126236295|NCT01432171|454156773|FG001|Overall Study|Patient moved to palliative care|0|||
126236296|NCT01085045|454158499|FG000|Part A|Withdrawal by Subject|4|||
126236297|NCT01085045|454158499|FG000|Part A|Adverse Event|6|||
126236298|NCT01085045|454158499|FG000|Part A|Protocol Violation|1|||
126355727|NCT03022630|454595539|FG001|Overall Study|Death|7|||
126236299|NCT01085045|454158499|FG000|Part A|Protocol Specified Criteria|7|||
126355728|NCT03022630|454595538|FG000|Overall Study|Withdrawal by Subject|0|||
126355729|NCT03022630|454595539|FG001|Overall Study|Withdrawal by Subject|5|||
126236300|NCT01085045|454158499|FG000|Part B|Withdrawal by Subject|2|||
126236301|NCT01085045|454158499|FG000|Part B|Protocol Specified Criteria|6|||
126236302|NCT01085045|454158499|FG000|Part B|Lost to Follow-up|1|||
126236303|NCT01085045|454158499|FG000|Part B|Adverse Event|6|||
126236304|NCT00416520|454158504|FG000|Open-label Period|Adverse Event|28|||
126236305|NCT00416520|454158505|FG001|Open-label Period|Adverse Event|10|||
126355730|NCT01567085|454595542|FG000|Overall Study|Death|6|||
126236306|NCT00416520|454158506|FG002|Open-label Period|Adverse Event|0|||
126236307|NCT00416520|454158507|FG003|Open-label Period|Adverse Event|0|||
126236308|NCT00416520|454158504|FG000|Open-label Period|Death|2|||
126236309|NCT00416520|454158505|FG001|Open-label Period|Death|1|||
126236310|NCT00416520|454158506|FG002|Open-label Period|Death|0|||
126236311|NCT00416520|454158507|FG003|Open-label Period|Death|0|||
126236312|NCT00416520|454158504|FG000|Open-label Period|Lack of Efficacy|8|||
126236313|NCT00416520|454158505|FG001|Open-label Period|Lack of Efficacy|1|||
126236314|NCT00416520|454158506|FG002|Open-label Period|Lack of Efficacy|0|||
126236315|NCT00416520|454158507|FG003|Open-label Period|Lack of Efficacy|0|||
126236316|NCT00416520|454158504|FG000|Open-label Period|Protocol Violation|3|||
126236317|NCT00416520|454158505|FG001|Open-label Period|Protocol Violation|3|||
126236318|NCT00416520|454158506|FG002|Open-label Period|Protocol Violation|0|||
126236319|NCT00416520|454158507|FG003|Open-label Period|Protocol Violation|0|||
126236320|NCT00416520|454158504|FG000|Open-label Period|Withdrawal by Subject|16|||
126236321|NCT00416520|454158505|FG001|Open-label Period|Withdrawal by Subject|5|||
126236322|NCT00416520|454158506|FG002|Open-label Period|Withdrawal by Subject|0|||
126236323|NCT00416520|454158507|FG003|Open-label Period|Withdrawal by Subject|0|||
126355731|NCT01567085|454595542|FG000|Overall Study|Adverse Event|6|||
126355732|NCT01567085|454595542|FG000|Overall Study|Lost to Follow-up|3|||
126355733|NCT01567085|454595542|FG000|Overall Study|Graft loss|2|||
126355734|NCT01567085|454595542|FG000|Overall Study|Renal transplantectomy|1|||
126355735|NCT01567085|454595542|FG000|Overall Study|Returned to chronic dialysis|1|||
126355736|NCT01567085|454595542|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
126355737|NCT00504231|454595546|FG000|Overall Study|Discrepant chart documentation re route|0|||
126355738|NCT00504231|454595547|FG001|Overall Study|Discrepant chart documentation re route|0|||
126355739|NCT00504231|454595548|FG002|Overall Study|Discrepant chart documentation re route|1|||
126355740|NCT00504231|454595549|FG003|Overall Study|Discrepant chart documentation re route|0|||
126355741|NCT03928704|454595551|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355742|NCT03928704|454595552|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
126355743|NCT03928704|454595553|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355744|NCT03928704|454595554|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355745|NCT03928704|454595555|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355746|NCT03928704|454595556|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355747|NCT03928704|454595551|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
126355748|NCT03928704|454595552|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126355749|NCT03928704|454595553|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126236324|NCT00416520|454158504|FG000|Open-label Period|Other Reasons|3|||
126236325|NCT00416520|454158505|FG001|Open-label Period|Other Reasons|12|||
126236326|NCT00416520|454158506|FG002|Open-label Period|Other Reasons|0|||
126236327|NCT00416520|454158507|FG003|Open-label Period|Other Reasons|0|||
126236328|NCT00416520|454158504|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
126236329|NCT00416520|454158505|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
126236330|NCT00416520|454158506|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
126236331|NCT00416520|454158507|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
126236332|NCT00416520|454158504|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
126236333|NCT00416520|454158505|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
126236334|NCT00416520|454158506|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
126236335|NCT00416520|454158507|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
126236336|NCT00416520|454158504|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
126236337|NCT00416520|454158505|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
126236338|NCT00416520|454158506|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
126023940|NCT05171777|453382870|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
126023941|NCT05171777|453382871|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
126023942|NCT05171777|453382872|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
126023943|NCT05171777|453382873|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
126023944|NCT05171777|453382870|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
126023945|NCT05171777|453382871|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
126023946|NCT05171777|453382872|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
126023947|NCT05171777|453382873|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
126023948|NCT05171777|453382870|FG000|Treatment Continuation Period|Death|0|||
126023949|NCT05171777|453382871|FG001|Treatment Continuation Period|Death|0|||
126023950|NCT05171777|453382872|FG002|Treatment Continuation Period|Death|1|||
126023951|NCT05171777|453382873|FG003|Treatment Continuation Period|Death|6|||
126023952|NCT05171777|453382870|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
126023953|NCT05171777|453382871|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
126023954|NCT05171777|453382872|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
126023955|NCT05171777|453382873|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
126236339|NCT00416520|454158507|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
126236340|NCT01101022|454158519|FG000|Overall Study|Adverse Event|6|||
126236341|NCT01101022|454158520|FG001|Overall Study|Adverse Event|2|||
126236342|NCT01101022|454158519|FG000|Overall Study|Protocol Violation|4|||
126236343|NCT01101022|454158520|FG001|Overall Study|Protocol Violation|3|||
126236344|NCT01101022|454158519|FG000|Overall Study|Withdrawal by Subject|3|||
126023956|NCT02538341|453382874|FG000|Overall Study|Lost to Follow-up|51|||
126023957|NCT02538341|453382875|FG001|Overall Study|Lost to Follow-up|46|||
126023958|NCT02538341|453382874|FG000|Overall Study|Withdrawal by Subject|3|||
126023959|NCT02538341|453382875|FG001|Overall Study|Withdrawal by Subject|1|||
126023960|NCT02538341|453382874|FG000|Overall Study|Death|2|||
126023961|NCT02538341|453382875|FG001|Overall Study|Death|0|||
126023962|NCT00632749|453382876|FG000|Overall Study|Progressive disease|3|||
126023963|NCT00632749|453382877|FG001|Overall Study|Progressive disease|2|||
126023964|NCT00632749|453382878|FG002|Overall Study|Progressive disease|2|||
126023965|NCT00632749|453382879|FG003|Overall Study|Progressive disease|2|||
126023966|NCT00632749|453382880|FG004|Overall Study|Progressive disease|4|||
126023967|NCT00632749|453382881|FG005|Overall Study|Progressive disease|4|||
126023968|NCT00632749|453382882|FG006|Overall Study|Progressive disease|3|||
126023969|NCT00632749|453382883|FG007|Overall Study|Progressive disease|2|||
126023970|NCT00632749|453382884|FG008|Overall Study|Progressive disease|3|||
126023971|NCT00632749|453382885|FG009|Overall Study|Progressive disease|2|||
126023972|NCT00632749|453382886|FG010|Overall Study|Progressive disease|4|||
126023973|NCT00632749|453382887|FG011|Overall Study|Progressive disease|3|||
126023974|NCT00632749|453382888|FG012|Overall Study|Progressive disease|2|||
126023975|NCT00632749|453382889|FG013|Overall Study|Progressive disease|4|||
126023976|NCT00632749|453382876|FG000|Overall Study|Other Adverse event|1|||
126023977|NCT00632749|453382877|FG001|Overall Study|Other Adverse event|1|||
126023978|NCT00632749|453382878|FG002|Overall Study|Other Adverse event|1|||
126023979|NCT00632749|453382879|FG003|Overall Study|Other Adverse event|1|||
126023980|NCT00632749|453382880|FG004|Overall Study|Other Adverse event|2|||
126236345|NCT01101022|454158520|FG001|Overall Study|Withdrawal by Subject|8|||
126236346|NCT01101022|454158519|FG000|Overall Study|Lost to Follow-up|1|||
126023981|NCT00632749|453382881|FG005|Overall Study|Other Adverse event|4|||
126023982|NCT00632749|453382882|FG006|Overall Study|Other Adverse event|1|||
126023983|NCT00632749|453382883|FG007|Overall Study|Other Adverse event|2|||
126023984|NCT00632749|453382884|FG008|Overall Study|Other Adverse event|2|||
126023985|NCT00632749|453382885|FG009|Overall Study|Other Adverse event|0|||
126023986|NCT00632749|453382886|FG010|Overall Study|Other Adverse event|1|||
126023987|NCT00632749|453382887|FG011|Overall Study|Other Adverse event|0|||
126023988|NCT00632749|453382888|FG012|Overall Study|Other Adverse event|1|||
126023989|NCT00632749|453382889|FG013|Overall Study|Other Adverse event|0|||
126023990|NCT00632749|453382876|FG000|Overall Study|Refuse to continue medication|0|||
126023991|NCT00632749|453382877|FG001|Overall Study|Refuse to continue medication|0|||
126023992|NCT00632749|453382878|FG002|Overall Study|Refuse to continue medication|0|||
126023993|NCT00632749|453382879|FG003|Overall Study|Refuse to continue medication|1|||
126023994|NCT00632749|453382880|FG004|Overall Study|Refuse to continue medication|0|||
126023995|NCT00632749|453382881|FG005|Overall Study|Refuse to continue medication|0|||
126023996|NCT00632749|453382882|FG006|Overall Study|Refuse to continue medication|0|||
126023997|NCT00632749|453382883|FG007|Overall Study|Refuse to continue medication|0|||
126023998|NCT00632749|453382884|FG008|Overall Study|Refuse to continue medication|0|||
126023999|NCT00632749|453382885|FG009|Overall Study|Refuse to continue medication|1|||
126024000|NCT00632749|453382886|FG010|Overall Study|Refuse to continue medication|0|||
126024001|NCT00632749|453382887|FG011|Overall Study|Refuse to continue medication|0|||
126236347|NCT01101022|454158520|FG001|Overall Study|Lost to Follow-up|4|||
126236348|NCT01101022|454158519|FG000|Overall Study|Lack of Efficacy|0|||
126236349|NCT01101022|454158520|FG001|Overall Study|Lack of Efficacy|7|||
126355750|NCT03928704|454595554|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126355751|NCT03928704|454595555|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126024002|NCT00632749|453382888|FG012|Overall Study|Refuse to continue medication|0|||
126024003|NCT00632749|453382889|FG013|Overall Study|Refuse to continue medication|0|||
126024004|NCT00632749|453382876|FG000|Overall Study|Reason other than those specified above|0|||
126024005|NCT00632749|453382877|FG001|Overall Study|Reason other than those specified above|2|||
126024006|NCT00632749|453382878|FG002|Overall Study|Reason other than those specified above|0|||
126024007|NCT00632749|453382879|FG003|Overall Study|Reason other than those specified above|0|||
126024008|NCT00632749|453382880|FG004|Overall Study|Reason other than those specified above|1|||
126024009|NCT00632749|453382881|FG005|Overall Study|Reason other than those specified above|0|||
126024010|NCT00632749|453382882|FG006|Overall Study|Reason other than those specified above|1|||
126024011|NCT00632749|453382883|FG007|Overall Study|Reason other than those specified above|0|||
126024012|NCT00632749|453382884|FG008|Overall Study|Reason other than those specified above|0|||
126024013|NCT00632749|453382885|FG009|Overall Study|Reason other than those specified above|0|||
126024014|NCT00632749|453382886|FG010|Overall Study|Reason other than those specified above|2|||
126024015|NCT00632749|453382887|FG011|Overall Study|Reason other than those specified above|1|||
126024016|NCT00632749|453382888|FG012|Overall Study|Reason other than those specified above|0|||
126024017|NCT00632749|453382889|FG013|Overall Study|Reason other than those specified above|2|||
126024018|NCT04128319|453382890|FG000|Overall Study|Death|3|||
126024019|NCT04484935|453382893|FG000|Overall Study|Other|0|||
126024020|NCT04484935|453382894|FG001|Overall Study|Other|1|||
126024021|NCT04484935|453382893|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126024022|NCT04484935|453382894|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126024023|NCT04484935|453382893|FG000|Overall Study|Lost to Follow-up|1|||
126024024|NCT04484935|453382894|FG001|Overall Study|Lost to Follow-up|0|||
126024025|NCT04484935|453382893|FG000|Overall Study|Death|2|||
126024026|NCT04484935|453382894|FG001|Overall Study|Death|1|||
126024027|NCT01094184|453382895|FG000|Overall Study|Death|35|||
126024028|NCT01094184|453382896|FG001|Overall Study|Death|11|||
126236350|NCT01101022|454158519|FG000|Overall Study|Sponsor decision|1|||
126355752|NCT03928704|454595556|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126355753|NCT03928704|454595551|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
126355754|NCT03928704|454595552|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355755|NCT03928704|454595553|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355756|NCT03928704|454595554|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355757|NCT03928704|454595555|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355758|NCT03928704|454595556|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355759|NCT03928704|454595551|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
126355760|NCT03928704|454595552|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
126355761|NCT03928704|454595553|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
126355762|NCT03928704|454595554|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
126355763|NCT03928704|454595555|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
126355764|NCT03928704|454595556|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
126355765|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355766|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355767|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
126024029|NCT03892564|453382897|FG000|Overall Study|Withdrawal by Subject|2|||
126024030|NCT01959698|453382899|FG000|Overall Study|Adverse Event|0|||
126024031|NCT01959698|453382900|FG001|Overall Study|Adverse Event|0|||
126024032|NCT01959698|453382901|FG002|Overall Study|Adverse Event|0|||
126024033|NCT01959698|453382902|FG003|Overall Study|Adverse Event|0|||
126024034|NCT01959698|453382903|FG004|Overall Study|Adverse Event|0|||
126236351|NCT01101022|454158520|FG001|Overall Study|Sponsor decision|1|||
126236352|NCT01101022|454158519|FG000|Overall Study|Non-compliance|1|||
126024035|NCT01959698|453382904|FG005|Overall Study|Adverse Event|0|||
126024036|NCT01959698|453382905|FG006|Overall Study|Adverse Event|1|||
126024037|NCT01959698|453382899|FG000|Overall Study|Physician Decision|1|||
126024038|NCT01959698|453382900|FG001|Overall Study|Physician Decision|0|||
126024039|NCT01959698|453382901|FG002|Overall Study|Physician Decision|1|||
126024040|NCT01959698|453382902|FG003|Overall Study|Physician Decision|2|||
126024041|NCT01959698|453382903|FG004|Overall Study|Physician Decision|0|||
126024042|NCT01959698|453382904|FG005|Overall Study|Physician Decision|3|||
126024043|NCT01959698|453382905|FG006|Overall Study|Physician Decision|3|||
126024044|NCT04402294|453382906|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
126024045|NCT04402294|453382907|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
126024046|NCT04402294|453382906|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
126024047|NCT04402294|453382907|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
126024048|NCT03398148|453384767|FG000|Substudy 1 Period 1|Adverse Event|5|||
126024049|NCT03398148|453384768|FG001|Substudy 1 Period 1|Adverse Event|2|||
126024050|NCT03398148|453384769|FG002|Substudy 1 Period 1|Adverse Event|2|||
126024051|NCT03398148|453384770|FG003|Substudy 1 Period 1|Adverse Event|0|||
126024052|NCT03398148|453384771|FG004|Substudy 1 Period 1|Adverse Event|8|||
126024053|NCT03398148|453384772|FG005|Substudy 1 Period 1|Adverse Event|0|||
126024054|NCT03398148|453384773|FG006|Substudy 1 Period 1|Adverse Event|0|||
126024055|NCT03398148|453384774|FG007|Substudy 1 Period 1|Adverse Event|0|||
126024056|NCT03398148|453384775|FG008|Substudy 1 Period 1|Adverse Event|0|||
126024057|NCT03398148|453384776|FG009|Substudy 1 Period 1|Adverse Event|0|||
126024058|NCT03398148|453384777|FG010|Substudy 1 Period 1|Adverse Event|0|||
126024059|NCT03398148|453384778|FG011|Substudy 1 Period 1|Adverse Event|0|||
126024060|NCT03398148|453384779|FG012|Substudy 1 Period 1|Adverse Event|0|||
126024061|NCT03398148|453384780|FG013|Substudy 1 Period 1|Adverse Event|0|||
126024062|NCT03398148|453384781|FG014|Substudy 1 Period 1|Adverse Event|0|||
126024063|NCT03398148|453384767|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
126024064|NCT03398148|453384768|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
126024065|NCT03398148|453384769|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024066|NCT03398148|453384770|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
126024067|NCT03398148|453384771|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
126024068|NCT03398148|453384772|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024069|NCT03398148|453384773|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024070|NCT03398148|453384774|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024071|NCT03398148|453384775|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024072|NCT03398148|453384776|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024073|NCT03398148|453384777|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024074|NCT03398148|453384778|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024075|NCT03398148|453384779|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024076|NCT03398148|453384780|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024077|NCT03398148|453384781|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126024078|NCT03398148|453384767|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
126024079|NCT03398148|453384768|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
126024080|NCT03398148|453384769|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
126024081|NCT03398148|453384770|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
126024082|NCT03398148|453384771|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
126024083|NCT03398148|453384772|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
126024084|NCT03398148|453384773|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
126024085|NCT03398148|453384774|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
126024086|NCT03398148|453384775|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
126024087|NCT03398148|453384776|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
126024088|NCT03398148|453384777|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
126024089|NCT03398148|453384778|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
126024090|NCT03398148|453384779|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
126024091|NCT03398148|453384780|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
126024092|NCT03398148|453384781|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
126024093|NCT03398148|453384767|FG000|Substudy 1 Period 1|Other|0|||
126024094|NCT03398148|453384768|FG001|Substudy 1 Period 1|Other|1|||
126024095|NCT03398148|453384769|FG002|Substudy 1 Period 1|Other|0|||
126024096|NCT03398148|453384770|FG003|Substudy 1 Period 1|Other|0|||
126024097|NCT03398148|453384771|FG004|Substudy 1 Period 1|Other|3|||
126024098|NCT03398148|453384772|FG005|Substudy 1 Period 1|Other|0|||
126024099|NCT03398148|453384773|FG006|Substudy 1 Period 1|Other|0|||
126024100|NCT03398148|453384774|FG007|Substudy 1 Period 1|Other|0|||
126024101|NCT03398148|453384775|FG008|Substudy 1 Period 1|Other|0|||
126024102|NCT03398148|453384776|FG009|Substudy 1 Period 1|Other|0|||
126024103|NCT03398148|453384777|FG010|Substudy 1 Period 1|Other|0|||
126024104|NCT03398148|453384778|FG011|Substudy 1 Period 1|Other|0|||
126024105|NCT03398148|453384779|FG012|Substudy 1 Period 1|Other|0|||
126024106|NCT03398148|453384780|FG013|Substudy 1 Period 1|Other|0|||
126024107|NCT03398148|453384781|FG014|Substudy 1 Period 1|Other|0|||
126024108|NCT03398148|453384767|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024109|NCT03398148|453384768|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024110|NCT03398148|453384769|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024111|NCT03398148|453384770|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024112|NCT03398148|453384771|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
126024113|NCT03398148|453384772|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024114|NCT03398148|453384773|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024115|NCT03398148|453384774|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024116|NCT03398148|453384775|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024117|NCT03398148|453384776|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024118|NCT03398148|453384777|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024119|NCT03398148|453384778|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024120|NCT03398148|453384779|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024121|NCT03398148|453384780|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024122|NCT03398148|453384781|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
126024123|NCT03398148|453384767|FG000|Substudy 1 Period 2|Adverse Event|0|||
126024124|NCT03398148|453384768|FG001|Substudy 1 Period 2|Adverse Event|0|||
126024125|NCT03398148|453384769|FG002|Substudy 1 Period 2|Adverse Event|0|||
126024126|NCT03398148|453384770|FG003|Substudy 1 Period 2|Adverse Event|0|||
126024127|NCT03398148|453384771|FG004|Substudy 1 Period 2|Adverse Event|0|||
126024128|NCT03398148|453384772|FG005|Substudy 1 Period 2|Adverse Event|2|||
126024129|NCT03398148|453384773|FG006|Substudy 1 Period 2|Adverse Event|4|||
126024130|NCT03398148|453384774|FG007|Substudy 1 Period 2|Adverse Event|0|||
126024131|NCT03398148|453384775|FG008|Substudy 1 Period 2|Adverse Event|0|||
126355768|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355769|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355770|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355771|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355772|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355773|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
126355774|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355775|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355776|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355777|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
126355778|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
126355779|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
126355780|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
126355781|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
126355782|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
126355783|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355784|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355785|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
126355786|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355787|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355788|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355789|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355790|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355791|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355792|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355793|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355794|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
126355795|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
126355796|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
126024132|NCT03398148|453384776|FG009|Substudy 1 Period 2|Adverse Event|0|||
126024133|NCT03398148|453384777|FG010|Substudy 1 Period 2|Adverse Event|0|||
126024134|NCT03398148|453384778|FG011|Substudy 1 Period 2|Adverse Event|0|||
126024135|NCT03398148|453384779|FG012|Substudy 1 Period 2|Adverse Event|0|||
126024136|NCT03398148|453384780|FG013|Substudy 1 Period 2|Adverse Event|0|||
126024137|NCT03398148|453384781|FG014|Substudy 1 Period 2|Adverse Event|0|||
126024138|NCT03398148|453384767|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024139|NCT03398148|453384768|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024140|NCT03398148|453384769|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024141|NCT03398148|453384770|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024142|NCT03398148|453384771|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024143|NCT03398148|453384772|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024144|NCT03398148|453384773|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
126024145|NCT03398148|453384774|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
126024146|NCT03398148|453384775|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024147|NCT03398148|453384776|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024148|NCT03398148|453384777|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024149|NCT03398148|453384778|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024150|NCT03398148|453384779|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024151|NCT03398148|453384780|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024152|NCT03398148|453384781|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126024153|NCT03398148|453384767|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
126024154|NCT03398148|453384768|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
126024155|NCT03398148|453384769|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
126024156|NCT03398148|453384770|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
126024157|NCT03398148|453384771|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
126024158|NCT03398148|453384772|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
126024159|NCT03398148|453384773|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
126024160|NCT03398148|453384774|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
126024161|NCT03398148|453384775|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
126024162|NCT03398148|453384776|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
126024163|NCT03398148|453384777|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
126024164|NCT03398148|453384778|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
126024165|NCT03398148|453384779|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
126024166|NCT03398148|453384780|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
126024167|NCT03398148|453384781|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
126024168|NCT03398148|453384767|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024169|NCT03398148|453384768|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024170|NCT03398148|453384769|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024171|NCT03398148|453384770|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024172|NCT03398148|453384771|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024173|NCT03398148|453384772|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024174|NCT03398148|453384773|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
126024175|NCT03398148|453384774|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024176|NCT03398148|453384775|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024177|NCT03398148|453384776|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024178|NCT03398148|453384777|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024179|NCT03398148|453384778|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024180|NCT03398148|453384779|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126236353|NCT01101022|454158520|FG001|Overall Study|Non-compliance|0|||
126236354|NCT01101022|454158519|FG000|Overall Study|Work schedule|1|||
126236355|NCT01101022|454158520|FG001|Overall Study|Work schedule|1|||
126236356|NCT01101022|454158519|FG000|Overall Study|Vacation|0|||
126236357|NCT01101022|454158520|FG001|Overall Study|Vacation|1|||
126236358|NCT01519661|454158521|FG000|Overall Study|Protocol deviation|6|||
126236359|NCT01519661|454158521|FG000|Overall Study|Lost to Follow-up|3|||
126236360|NCT01519661|454158521|FG000|Overall Study|Withdrawal by Subject|17|||
126236361|NCT01519661|454158521|FG000|Overall Study|Lack of Efficacy|6|||
126236362|NCT01519661|454158521|FG000|Overall Study|Adverse Event|29|||
126024181|NCT03398148|453384780|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024182|NCT03398148|453384781|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024183|NCT03398148|453384767|FG000|Substudy 1 Period 2|Other|0|||
126024184|NCT03398148|453384768|FG001|Substudy 1 Period 2|Other|0|||
126024185|NCT03398148|453384769|FG002|Substudy 1 Period 2|Other|0|||
126024186|NCT03398148|453384770|FG003|Substudy 1 Period 2|Other|0|||
126024187|NCT03398148|453384771|FG004|Substudy 1 Period 2|Other|0|||
126024188|NCT03398148|453384772|FG005|Substudy 1 Period 2|Other|0|||
126024189|NCT03398148|453384773|FG006|Substudy 1 Period 2|Other|1|||
126024190|NCT03398148|453384774|FG007|Substudy 1 Period 2|Other|0|||
126024191|NCT03398148|453384775|FG008|Substudy 1 Period 2|Other|0|||
126236363|NCT01139047|454158522|FG000|Overall Study|Withdrawal by Subject|1|||
126024192|NCT03398148|453384776|FG009|Substudy 1 Period 2|Other|0|||
126024193|NCT03398148|453384777|FG010|Substudy 1 Period 2|Other|0|||
126024194|NCT03398148|453384778|FG011|Substudy 1 Period 2|Other|0|||
126236364|NCT01941095|454158523|FG000|Overall Study|Insufficient therapeutic response|13|||
126024195|NCT03398148|453384779|FG012|Substudy 1 Period 2|Other|0|||
126024196|NCT03398148|453384780|FG013|Substudy 1 Period 2|Other|0|||
126024197|NCT03398148|453384781|FG014|Substudy 1 Period 2|Other|0|||
126024198|NCT03398148|453384767|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024199|NCT03398148|453384768|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024200|NCT03398148|453384769|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024201|NCT03398148|453384770|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024202|NCT03398148|453384771|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024203|NCT03398148|453384772|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024204|NCT03398148|453384773|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
126024205|NCT03398148|453384774|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024206|NCT03398148|453384775|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024207|NCT03398148|453384776|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024208|NCT03398148|453384777|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024209|NCT03398148|453384778|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024210|NCT03398148|453384779|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024211|NCT03398148|453384780|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024212|NCT03398148|453384781|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
126024213|NCT03398148|453384767|FG000|Substudy 2 Period 1|Adverse Event|0|||
126024214|NCT03398148|453384768|FG001|Substudy 2 Period 1|Adverse Event|0|||
126024215|NCT03398148|453384769|FG002|Substudy 2 Period 1|Adverse Event|0|||
126024216|NCT03398148|453384770|FG003|Substudy 2 Period 1|Adverse Event|0|||
126024217|NCT03398148|453384771|FG004|Substudy 2 Period 1|Adverse Event|0|||
126024218|NCT03398148|453384772|FG005|Substudy 2 Period 1|Adverse Event|0|||
126024219|NCT03398148|453384773|FG006|Substudy 2 Period 1|Adverse Event|0|||
126024220|NCT03398148|453384774|FG007|Substudy 2 Period 1|Adverse Event|0|||
126024221|NCT03398148|453384775|FG008|Substudy 2 Period 1|Adverse Event|0|||
126024222|NCT03398148|453384776|FG009|Substudy 2 Period 1|Adverse Event|12|||
126024223|NCT03398148|453384777|FG010|Substudy 2 Period 1|Adverse Event|2|||
126024224|NCT03398148|453384778|FG011|Substudy 2 Period 1|Adverse Event|0|||
126024225|NCT03398148|453384779|FG012|Substudy 2 Period 1|Adverse Event|0|||
126024226|NCT03398148|453384780|FG013|Substudy 2 Period 1|Adverse Event|0|||
126024227|NCT03398148|453384781|FG014|Substudy 2 Period 1|Adverse Event|0|||
126236365|NCT01941095|454158523|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
126236366|NCT01941095|454158523|FG000|Overall Study|Adverse Event|11|||
126236367|NCT01941095|454158523|FG000|Overall Study|Physician Decision|3|||
126355797|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
126355798|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
126024228|NCT03398148|453384767|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024229|NCT03398148|453384768|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024230|NCT03398148|453384769|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024231|NCT03398148|453384770|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024232|NCT03398148|453384771|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024233|NCT03398148|453384772|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024234|NCT03398148|453384773|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024235|NCT03398148|453384774|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024236|NCT03398148|453384775|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024237|NCT03398148|453384776|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
126024238|NCT03398148|453384777|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
126024239|NCT03398148|453384778|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024240|NCT03398148|453384779|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024241|NCT03398148|453384780|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126093389|NCT00833833|453636045|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
126355799|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
126355800|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
126355801|NCT04575324|454595559|FG000|Overall Study|Lost to Follow-up|29|||
126355802|NCT04575324|454595560|FG001|Overall Study|Lost to Follow-up|25|||
126355803|NCT04575324|454595559|FG000|Overall Study|Death|1|||
126355804|NCT04575324|454595560|FG001|Overall Study|Death|2|||
126355805|NCT04575324|454595559|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
126355806|NCT04575324|454595560|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
126355807|NCT00456612|454595566|FG000|Overall Study|Withdrawal by Subject|3|||
126024242|NCT03398148|453384781|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126024243|NCT03398148|453384767|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
126024244|NCT03398148|453384768|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
126024245|NCT03398148|453384769|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
126024246|NCT03398148|453384770|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
126024247|NCT03398148|453384771|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
126024248|NCT03398148|453384772|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
126024249|NCT03398148|453384773|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
126024250|NCT03398148|453384774|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
126093390|NCT00833833|453636046|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126236368|NCT01941095|454158523|FG000|Overall Study|Withdrawal by Subject|17|||
126355808|NCT00266812|454595567|FG000|Overall Study|Disease Progression|9|||
126355809|NCT00266812|454595568|FG001|Overall Study|Disease Progression|3|||
126024251|NCT03398148|453384775|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
126024252|NCT03398148|453384776|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
126024253|NCT03398148|453384777|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
126024254|NCT03398148|453384778|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
126024255|NCT03398148|453384779|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
126236369|NCT01941095|454158523|FG000|Overall Study|Lost to Follow-up|10|||
126236370|NCT02918877|454158526|FG000|Overall Study|Withdrawal by Subject|2|||
126236371|NCT02918877|454158527|FG001|Overall Study|Withdrawal by Subject|2|||
126236372|NCT02918877|454158526|FG000|Overall Study|Surgery cancelled|1|||
126236373|NCT02918877|454158527|FG001|Overall Study|Surgery cancelled|0|||
126236374|NCT02918877|454158526|FG000|Overall Study|Physician Decision|1|||
126236375|NCT02918877|454158527|FG001|Overall Study|Physician Decision|0|||
126236376|NCT02918877|454158526|FG000|Overall Study|Received intraoperative steroids|1|||
126236377|NCT02918877|454158527|FG001|Overall Study|Received intraoperative steroids|0|||
126236378|NCT02918877|454158526|FG000|Overall Study|Unable to obtain lab samples|1|||
126236379|NCT02918877|454158527|FG001|Overall Study|Unable to obtain lab samples|0|||
126236380|NCT02918877|454158526|FG000|Overall Study|Unsafe to perform BAL|0|||
126236381|NCT02918877|454158527|FG001|Overall Study|Unsafe to perform BAL|1|||
126236382|NCT02532764|454158528|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126236383|NCT02532764|454158529|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126236384|NCT02532764|454158530|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126236385|NCT02532764|454158531|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126236386|NCT02532764|454158532|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126236387|NCT02532764|454158533|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126236388|NCT02532764|454158534|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126236389|NCT02532764|454158535|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
126236390|NCT02532764|454158536|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
126236391|NCT02532764|454158537|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
126236392|NCT03527745|454158538|FG000|Overall Study|Lost to Follow-up|3|||
126024256|NCT03398148|453384780|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
126024257|NCT03398148|453384781|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
126024258|NCT03398148|453384767|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024259|NCT03398148|453384768|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024260|NCT03398148|453384769|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024261|NCT03398148|453384770|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024262|NCT03398148|453384771|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024263|NCT03398148|453384772|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024264|NCT03398148|453384773|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024265|NCT03398148|453384774|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024266|NCT03398148|453384775|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024267|NCT03398148|453384776|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024268|NCT03398148|453384777|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
126024269|NCT03398148|453384778|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024270|NCT03398148|453384779|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024271|NCT03398148|453384780|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024272|NCT03398148|453384781|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126024273|NCT03398148|453384767|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126236393|NCT03527745|454158539|FG001|Overall Study|Lost to Follow-up|6|||
126236394|NCT03527745|454158540|FG002|Overall Study|Lost to Follow-up|7|||
126236395|NCT03527745|454158541|FG003|Overall Study|Lost to Follow-up|9|||
126236396|NCT03527745|454158542|FG004|Overall Study|Lost to Follow-up|0|||
126236397|NCT03527745|454158543|FG005|Overall Study|Lost to Follow-up|2|||
126236398|NCT03527745|454158544|FG006|Overall Study|Lost to Follow-up|3|||
126236399|NCT03527745|454158545|FG007|Overall Study|Lost to Follow-up|2|||
126236400|NCT03527745|454158546|FG008|Overall Study|Lost to Follow-up|3|||
126236401|NCT03527745|454158547|FG009|Overall Study|Lost to Follow-up|2|||
126236402|NCT03527745|454158548|FG010|Overall Study|Lost to Follow-up|1|||
126236403|NCT03527745|454158549|FG011|Overall Study|Lost to Follow-up|1|||
126236404|NCT03527745|454158550|FG012|Overall Study|Lost to Follow-up|0|||
126236405|NCT03527745|454158551|FG013|Overall Study|Lost to Follow-up|0|||
126236406|NCT03527745|454158552|FG014|Overall Study|Lost to Follow-up|0|||
126236407|NCT03527745|454158553|FG015|Overall Study|Lost to Follow-up|0|||
126236408|NCT03527745|454158554|FG016|Overall Study|Lost to Follow-up|1|||
126236409|NCT03527745|454158555|FG017|Overall Study|Lost to Follow-up|0|||
126236410|NCT03527745|454158556|FG018|Overall Study|Lost to Follow-up|0|||
126236411|NCT03527745|454158557|FG019|Overall Study|Lost to Follow-up|1|||
126024274|NCT03398148|453384768|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024275|NCT03398148|453384769|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024276|NCT03398148|453384770|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024277|NCT03398148|453384771|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126236412|NCT03527745|454158558|FG020|Overall Study|Lost to Follow-up|1|||
126236413|NCT03527745|454158559|FG021|Overall Study|Lost to Follow-up|5|||
126236414|NCT03527745|454158560|FG022|Overall Study|Lost to Follow-up|6|||
126355810|NCT00266812|454595567|FG000|Overall Study|Death|5|||
126355811|NCT00266812|454595568|FG001|Overall Study|Death|4|||
126355812|NCT00266812|454595567|FG000|Overall Study|Adverse Event|3|||
126355813|NCT00266812|454595568|FG001|Overall Study|Adverse Event|1|||
126093391|NCT00833833|453636047|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126093392|NCT00833833|453636048|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126093393|NCT00833833|453636043|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
126093394|NCT00833833|453636044|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
126093395|NCT00833833|453636045|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
126093396|NCT00833833|453636046|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
126093397|NCT00833833|453636047|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
126093398|NCT00833833|453636048|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
126093399|NCT00833833|453636043|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
126093400|NCT00833833|453636044|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
126093401|NCT00833833|453636045|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
126093402|NCT00833833|453636046|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
126093403|NCT00833833|453636047|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
126093404|NCT00833833|453636048|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
126093405|NCT00833833|453636043|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
126093406|NCT00833833|453636044|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
126093407|NCT00833833|453636045|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
126093408|NCT00833833|453636046|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
126093409|NCT00833833|453636047|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
126093410|NCT00833833|453636048|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
126093411|NCT00833833|453636043|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
126093412|NCT00833833|453636044|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
126093413|NCT00833833|453636045|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
126093414|NCT00833833|453636046|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
126093415|NCT00833833|453636047|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
126093416|NCT00833833|453636048|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
126093417|NCT00833833|453636043|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126093418|NCT00833833|453636044|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126093419|NCT00833833|453636045|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126093420|NCT00833833|453636046|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126093421|NCT00833833|453636047|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
126093422|NCT00833833|453636048|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
126093423|NCT00833833|453636043|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
126093424|NCT00833833|453636044|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
126093425|NCT00833833|453636045|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
126093426|NCT00833833|453636046|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
126093427|NCT00833833|453636047|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
126093428|NCT00833833|453636048|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
126093429|NCT00833833|453636043|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
126093430|NCT00833833|453636044|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
126093431|NCT00833833|453636045|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
126093432|NCT00833833|453636046|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
126093433|NCT00833833|453636047|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
126093434|NCT00833833|453636048|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
126093435|NCT00833833|453636043|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126093436|NCT00833833|453636044|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126093437|NCT00833833|453636045|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126093438|NCT00833833|453636046|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126093439|NCT00833833|453636047|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126093440|NCT00833833|453636048|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
126093441|NCT01994837|453636049|FG000|Overall Study|Progressive disease per protocol|23|||
126093442|NCT01994837|453636049|FG000|Overall Study|Adv event related to progressive disease|3|||
126093443|NCT01994837|453636049|FG000|Overall Study|Fatal progressive disease|2|||
126093444|NCT01994837|453636049|FG000|Overall Study|Adverse event not related to progression|1|||
126093445|NCT01994837|453636049|FG000|Overall Study|Chose palliative care|1|||
126093446|NCT01994837|453636049|FG000|Overall Study|Proceeded to transplant|1|||
126093447|NCT01994837|453636049|FG000|Overall Study|Removed from study due to no response|1|||
126093448|NCT01127893|453636050|FG000|Overall Study|Study Termination by the Sponsor|1|||
126236415|NCT03527745|454158561|FG023|Overall Study|Lost to Follow-up|8|||
126355814|NCT00266812|454595567|FG000|Overall Study|Protocol Violation|0|||
126355815|NCT00266812|454595568|FG001|Overall Study|Protocol Violation|1|||
126355816|NCT00266812|454595567|FG000|Overall Study|Withdrawal by Subject|0|||
126093449|NCT01262677|453636051|FG000|Overall Study|Does not meet entrance criteria|0|||
126093450|NCT01262677|453636052|FG001|Overall Study|Does not meet entrance criteria|2|||
126093451|NCT01262677|453636053|FG002|Overall Study|Does not meet entrance criteria|0|||
126355817|NCT00266812|454595568|FG001|Overall Study|Withdrawal by Subject|2|||
126236416|NCT03527745|454158562|FG024|Overall Study|Lost to Follow-up|1|||
126236417|NCT03527745|454158563|FG025|Overall Study|Lost to Follow-up|3|||
126236418|NCT01717976|454158564|FG000|Overall Study|Protocol Violation|0|||
126236419|NCT01717976|454158565|FG001|Overall Study|Protocol Violation|1|||
126236420|NCT01604850|454158566|FG000|Overall Study|Enrolled but never treated|0|||
126236421|NCT01604850|454158567|FG001|Overall Study|Enrolled but never treated|1|||
126024278|NCT03398148|453384772|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024279|NCT03398148|453384773|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024280|NCT03398148|453384774|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024281|NCT03398148|453384775|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024282|NCT03398148|453384776|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024283|NCT03398148|453384777|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
126024284|NCT03398148|453384778|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024285|NCT03398148|453384779|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024286|NCT03398148|453384780|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024287|NCT03398148|453384781|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126024288|NCT03398148|453384767|FG000|Substudy 2 Period 1|Other|0|||
126024289|NCT03398148|453384768|FG001|Substudy 2 Period 1|Other|0|||
126024290|NCT03398148|453384769|FG002|Substudy 2 Period 1|Other|0|||
126024291|NCT03398148|453384770|FG003|Substudy 2 Period 1|Other|0|||
126024292|NCT03398148|453384771|FG004|Substudy 2 Period 1|Other|0|||
126024293|NCT03398148|453384772|FG005|Substudy 2 Period 1|Other|0|||
126024294|NCT03398148|453384773|FG006|Substudy 2 Period 1|Other|0|||
126024295|NCT03398148|453384774|FG007|Substudy 2 Period 1|Other|0|||
126024296|NCT03398148|453384775|FG008|Substudy 2 Period 1|Other|0|||
126024297|NCT03398148|453384776|FG009|Substudy 2 Period 1|Other|4|||
126024298|NCT03398148|453384777|FG010|Substudy 2 Period 1|Other|4|||
126024299|NCT03398148|453384778|FG011|Substudy 2 Period 1|Other|0|||
126024300|NCT03398148|453384779|FG012|Substudy 2 Period 1|Other|0|||
126236422|NCT01604850|454158566|FG000|Overall Study|Efficacy Failure|50|||
126236423|NCT01604850|454158567|FG001|Overall Study|Efficacy Failure|29|||
126024301|NCT03398148|453384780|FG013|Substudy 2 Period 1|Other|0|||
126024302|NCT03398148|453384781|FG014|Substudy 2 Period 1|Other|0|||
126024303|NCT03398148|453384767|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024304|NCT03398148|453384768|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024305|NCT03398148|453384769|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024306|NCT03398148|453384770|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
126236424|NCT01604850|454158566|FG000|Overall Study|Lost to Follow-up|1|||
126024307|NCT03398148|453384771|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024308|NCT03398148|453384772|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024309|NCT03398148|453384773|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024310|NCT03398148|453384774|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024311|NCT03398148|453384775|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024312|NCT03398148|453384776|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024313|NCT03398148|453384777|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
126024314|NCT03398148|453384778|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024315|NCT03398148|453384779|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024316|NCT03398148|453384780|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024317|NCT03398148|453384781|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
126024318|NCT03398148|453384767|FG000|Substudy 2 Period 2|Adverse Event|0|||
126024319|NCT03398148|453384768|FG001|Substudy 2 Period 2|Adverse Event|0|||
126024320|NCT03398148|453384769|FG002|Substudy 2 Period 2|Adverse Event|0|||
126236425|NCT01604850|454158567|FG001|Overall Study|Lost to Follow-up|0|||
126024321|NCT03398148|453384770|FG003|Substudy 2 Period 2|Adverse Event|0|||
126236426|NCT01604850|454158566|FG000|Overall Study|Subject withdrew consent|1|||
126024322|NCT03398148|453384771|FG004|Substudy 2 Period 2|Adverse Event|0|||
126024323|NCT03398148|453384772|FG005|Substudy 2 Period 2|Adverse Event|0|||
126024324|NCT03398148|453384773|FG006|Substudy 2 Period 2|Adverse Event|0|||
126024325|NCT03398148|453384774|FG007|Substudy 2 Period 2|Adverse Event|0|||
126024326|NCT03398148|453384775|FG008|Substudy 2 Period 2|Adverse Event|0|||
126024327|NCT03398148|453384776|FG009|Substudy 2 Period 2|Adverse Event|0|||
126236427|NCT01604850|454158567|FG001|Overall Study|Subject withdrew consent|0|||
126236428|NCT00051025|454158575|FG000|Overall Study|Progressive Disease|1|||
126236429|NCT00051025|454158576|FG001|Overall Study|Progressive Disease|1|||
126024328|NCT03398148|453384777|FG010|Substudy 2 Period 2|Adverse Event|0|||
126024329|NCT03398148|453384778|FG011|Substudy 2 Period 2|Adverse Event|0|||
126236430|NCT00051025|454158575|FG000|Overall Study|Adverse Event|1|||
126024330|NCT03398148|453384779|FG012|Substudy 2 Period 2|Adverse Event|0|||
126236431|NCT00051025|454158576|FG001|Overall Study|Adverse Event|1|||
126236432|NCT00051025|454158575|FG000|Overall Study|Withdrawal by Subject|0|||
126236433|NCT00051025|454158576|FG001|Overall Study|Withdrawal by Subject|1|||
126236434|NCT00051025|454158575|FG000|Overall Study|Death|0|||
126236435|NCT00051025|454158576|FG001|Overall Study|Death|1|||
126236436|NCT00274937|454158577|FG000|Overall Study|Physician Decision|10|||
126236437|NCT00274937|454158577|FG000|Overall Study|Withdrawal by Subject|6|||
126236438|NCT00274937|454158577|FG000|Overall Study|Progressive Disease|4|||
126236439|NCT02189941|454158578|FG000|Overall Study|Non-compliance|0|||
126236440|NCT02189941|454158579|FG001|Overall Study|Non-compliance|0|||
126236441|NCT02189941|454158580|FG002|Overall Study|Non-compliance|1|||
126236442|NCT00445003|454158581|FG000|Overall Study|Death|1|||
126024331|NCT03398148|453384780|FG013|Substudy 2 Period 2|Adverse Event|1|||
126024332|NCT03398148|453384781|FG014|Substudy 2 Period 2|Adverse Event|3|||
126024333|NCT03398148|453384767|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
126024334|NCT03398148|453384768|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
126024335|NCT03398148|453384769|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
126024336|NCT03398148|453384770|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
126024337|NCT03398148|453384771|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
126024338|NCT03398148|453384772|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
126024339|NCT03398148|453384773|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
126024340|NCT03398148|453384774|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
126024341|NCT03398148|453384775|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
126024342|NCT03398148|453384776|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
126024343|NCT03398148|453384777|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
126024344|NCT03398148|453384778|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
126024345|NCT03398148|453384779|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
126024346|NCT03398148|453384780|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
126024347|NCT03398148|453384781|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
126024348|NCT03398148|453384767|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024349|NCT03398148|453384768|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024350|NCT03398148|453384769|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024351|NCT03398148|453384770|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024352|NCT03398148|453384771|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024353|NCT03398148|453384772|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024354|NCT03398148|453384773|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024355|NCT03398148|453384774|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024356|NCT03398148|453384775|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126236443|NCT00445003|454158582|FG001|Overall Study|Death|2|||
126024357|NCT03398148|453384776|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024358|NCT03398148|453384777|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126024359|NCT03398148|453384778|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
126024360|NCT03398148|453384779|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126236444|NCT00445003|454158583|FG002|Overall Study|Death|1|||
126236445|NCT00445003|454158581|FG000|Overall Study|Missed Visit|3|||
126236446|NCT00445003|454158582|FG001|Overall Study|Missed Visit|5|||
126024361|NCT03398148|453384780|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
126024362|NCT03398148|453384781|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
126024363|NCT03398148|453384767|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
126024364|NCT03398148|453384768|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
126024365|NCT03398148|453384769|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
126024366|NCT03398148|453384770|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
126024367|NCT03398148|453384771|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
126024368|NCT03398148|453384772|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
126024369|NCT03398148|453384773|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
126024370|NCT03398148|453384774|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
126024371|NCT03398148|453384775|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
126024372|NCT03398148|453384776|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
126024373|NCT03398148|453384777|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
126024374|NCT03398148|453384778|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
126024375|NCT03398148|453384779|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
126024376|NCT03398148|453384780|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
126024377|NCT03398148|453384781|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
126024378|NCT03398148|453384767|FG000|Substudy 2 Period 2|Other|0|||
126024379|NCT03398148|453384768|FG001|Substudy 2 Period 2|Other|0|||
126024380|NCT03398148|453384769|FG002|Substudy 2 Period 2|Other|0|||
126024381|NCT03398148|453384770|FG003|Substudy 2 Period 2|Other|0|||
126024382|NCT03398148|453384771|FG004|Substudy 2 Period 2|Other|0|||
126024383|NCT03398148|453384772|FG005|Substudy 2 Period 2|Other|0|||
126024384|NCT03398148|453384773|FG006|Substudy 2 Period 2|Other|0|||
126024385|NCT03398148|453384774|FG007|Substudy 2 Period 2|Other|0|||
126024386|NCT03398148|453384775|FG008|Substudy 2 Period 2|Other|0|||
126355818|NCT00266812|454595567|FG000|Overall Study|Discontinued before starting study drug|4|||
126355819|NCT00266812|454595568|FG001|Overall Study|Discontinued before starting study drug|0|||
126355820|NCT03695094|454595569|FG000|Overall Study|Adverse Event|1|||
126355821|NCT03695094|454595570|FG001|Overall Study|Adverse Event|1|||
126355822|NCT03695094|454595569|FG000|Overall Study|Withdrawal by Subject|1|||
126355823|NCT03695094|454595570|FG001|Overall Study|Withdrawal by Subject|0|||
126355824|NCT00784927|454595573|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
126355825|NCT00784927|454595573|FG000|Overall Study|Protocol Violation|1|||
126355826|NCT00784927|454595573|FG000|Overall Study|Ineligible|1|||
126355827|NCT01795937|454595578|FG000|Overall Study|Withdrawal by Subject|1|||
126355828|NCT01795937|454595579|FG001|Overall Study|Withdrawal by Subject|0|||
126355829|NCT01795937|454595580|FG002|Overall Study|Withdrawal by Subject|0|||
126355830|NCT01795937|454595578|FG000|Overall Study|Physician Decision|0|||
126355831|NCT01795937|454595579|FG001|Overall Study|Physician Decision|1|||
126355832|NCT01795937|454595580|FG002|Overall Study|Physician Decision|0|||
126355833|NCT01028053|454595581|FG000|Overall Study|Screen Failure|113|||
126355834|NCT01028053|454595581|FG000|Overall Study|Patient Request|11|||
126355835|NCT01028053|454595581|FG000|Overall Study|Protocol Violation|1|||
126355836|NCT01028053|454595581|FG000|Overall Study|Physician Decision|2|||
126355837|NCT01028053|454595581|FG000|Overall Study|Technical Problem|1|||
126355838|NCT01028053|454595581|FG000|Overall Study|Terminated by Sponsor|1|||
126355839|NCT01028053|454595581|FG000|Overall Study|Various reasons|4|||
126355840|NCT04027946|454595582|FG000|Overall Study|Screen failures|3|||
126355841|NCT00983957|454595583|FG000|Overall Study|Adverse Event|1|||
126355842|NCT00983957|454595583|FG000|Overall Study|Personal Reasons|1|||
126355843|NCT00790933|454595584|FG000|Overall Study|Adverse Event|94|||
126355844|NCT00790933|454595585|FG001|Overall Study|Adverse Event|119|||
126355845|NCT00790933|454595586|FG002|Overall Study|Adverse Event|65|||
126355846|NCT00790933|454595587|FG003|Overall Study|Adverse Event|5|||
126355847|NCT00790933|454595588|FG004|Overall Study|Adverse Event|69|||
126355848|NCT00790933|454595584|FG000|Overall Study|Protocol Violation(s)|8|||
126355849|NCT00790933|454595585|FG001|Overall Study|Protocol Violation(s)|18|||
126355850|NCT00790933|454595586|FG002|Overall Study|Protocol Violation(s)|7|||
126355851|NCT00790933|454595587|FG003|Overall Study|Protocol Violation(s)|0|||
126355852|NCT00790933|454595588|FG004|Overall Study|Protocol Violation(s)|12|||
126355853|NCT00790933|454595584|FG000|Overall Study|Lack of Efficacy|192|||
126355854|NCT00790933|454595585|FG001|Overall Study|Lack of Efficacy|176|||
126355855|NCT00790933|454595586|FG002|Overall Study|Lack of Efficacy|130|||
126355856|NCT00790933|454595587|FG003|Overall Study|Lack of Efficacy|1|||
126355857|NCT00790933|454595588|FG004|Overall Study|Lack of Efficacy|121|||
126355858|NCT00790933|454595584|FG000|Overall Study|Study Terminated by Sponsor|0|||
126355859|NCT00790933|454595585|FG001|Overall Study|Study Terminated by Sponsor|0|||
126024387|NCT03398148|453384776|FG009|Substudy 2 Period 2|Other|0|||
126355860|NCT00790933|454595586|FG002|Overall Study|Study Terminated by Sponsor|1|||
126355861|NCT00790933|454595587|FG003|Overall Study|Study Terminated by Sponsor|0|||
126355862|NCT00790933|454595588|FG004|Overall Study|Study Terminated by Sponsor|0|||
126355863|NCT00790933|454595584|FG000|Overall Study|Withdrawal by Subject|123|||
126355864|NCT00790933|454595585|FG001|Overall Study|Withdrawal by Subject|120|||
126355865|NCT00790933|454595586|FG002|Overall Study|Withdrawal by Subject|52|||
126355866|NCT00790933|454595587|FG003|Overall Study|Withdrawal by Subject|6|||
126355867|NCT00790933|454595588|FG004|Overall Study|Withdrawal by Subject|50|||
126024388|NCT03398148|453384777|FG010|Substudy 2 Period 2|Other|0|||
126024389|NCT03398148|453384778|FG011|Substudy 2 Period 2|Other|0|||
126024390|NCT03398148|453384779|FG012|Substudy 2 Period 2|Other|0|||
126024391|NCT03398148|453384780|FG013|Substudy 2 Period 2|Other|1|||
126024392|NCT03398148|453384781|FG014|Substudy 2 Period 2|Other|1|||
126024393|NCT03398148|453384767|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024394|NCT03398148|453384768|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024395|NCT03398148|453384769|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024396|NCT03398148|453384770|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024397|NCT03398148|453384771|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024398|NCT03398148|453384772|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024399|NCT03398148|453384773|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024400|NCT03398148|453384774|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024401|NCT03398148|453384775|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024402|NCT03398148|453384776|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024403|NCT03398148|453384777|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024404|NCT03398148|453384778|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024405|NCT03398148|453384779|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
126024406|NCT03398148|453384780|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
126024407|NCT03398148|453384781|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
126024408|NCT02791230|453384782|FG000|Overall Study|Adverse Event|10|||
126024409|NCT02791230|453384783|FG001|Overall Study|Adverse Event|9|||
126024410|NCT02791230|453384784|FG002|Overall Study|Adverse Event|66|||
126024411|NCT02791230|453384782|FG000|Overall Study|Death|38|||
126024412|NCT02791230|453384783|FG001|Overall Study|Death|25|||
126024413|NCT02791230|453384784|FG002|Overall Study|Death|184|||
126024414|NCT02791230|453384782|FG000|Overall Study|Lack of Efficacy|1|||
126024415|NCT02791230|453384783|FG001|Overall Study|Lack of Efficacy|0|||
126024416|NCT02791230|453384784|FG002|Overall Study|Lack of Efficacy|3|||
126024417|NCT02791230|453384782|FG000|Overall Study|Lost to Follow-up|0|||
126024418|NCT02791230|453384783|FG001|Overall Study|Lost to Follow-up|0|||
126024419|NCT02791230|453384784|FG002|Overall Study|Lost to Follow-up|10|||
126024420|NCT02791230|453384782|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
126024421|NCT02791230|453384783|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
126024422|NCT02791230|453384784|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
126024423|NCT02791230|453384782|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
126024424|NCT02791230|453384783|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
126024425|NCT02791230|453384784|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
126024426|NCT02791230|453384782|FG000|Overall Study|Study sites terminated by sponsor|1|||
126024427|NCT02791230|453384783|FG001|Overall Study|Study sites terminated by sponsor|0|||
126024428|NCT02791230|453384784|FG002|Overall Study|Study sites terminated by sponsor|5|||
126024429|NCT02791230|453384782|FG000|Overall Study|Other|9|||
126024430|NCT02791230|453384783|FG001|Overall Study|Other|1|||
126024431|NCT02791230|453384784|FG002|Overall Study|Other|28|||
126024432|NCT02791230|453384782|FG000|Overall Study|Protocol Violation|0|||
126024433|NCT02791230|453384783|FG001|Overall Study|Protocol Violation|0|||
126024434|NCT02791230|453384784|FG002|Overall Study|Protocol Violation|4|||
126024435|NCT02791230|453384782|FG000|Overall Study|Withdrawal by Subject|24|||
126024436|NCT02791230|453384783|FG001|Overall Study|Withdrawal by Subject|13|||
126024437|NCT02791230|453384784|FG002|Overall Study|Withdrawal by Subject|172|||
126024438|NCT02791230|453384782|FG000|Overall Study|Enrolled but not treated|0|||
126024439|NCT02791230|453384783|FG001|Overall Study|Enrolled but not treated|0|||
126024440|NCT02791230|453384784|FG002|Overall Study|Enrolled but not treated|5|||
126024441|NCT01259401|453384785|FG000|4-month Follow-up|Death|0|||
126024442|NCT01259401|453384786|FG001|4-month Follow-up|Death|1|||
126024443|NCT01259401|453384785|FG000|4-month Follow-up|Lost to Follow-up|0|||
126024444|NCT01259401|453384786|FG001|4-month Follow-up|Lost to Follow-up|1|||
126024445|NCT04201834|453384788|FG000|Overall Study|Screen fail|1|||
126024446|NCT00212355|453384789|FG000|Overall Study|Adverse Event|1|||
126024447|NCT00212355|453384789|FG000|Overall Study|Withdrawal by Subject|1|||
126024448|NCT00212355|453384789|FG000|Overall Study|A change of address|1|||
126024449|NCT04310735|453384794|FG000|Overall Study|Withdrawal by Subject|1|||
126024450|NCT04310735|453384795|FG001|Overall Study|Withdrawal by Subject|3|||
126024451|NCT04310735|453384796|FG002|Overall Study|Withdrawal by Subject|8|||
126024452|NCT04310735|453384794|FG000|Overall Study|Equipment malfunction|0|||
126024453|NCT04310735|453384795|FG001|Overall Study|Equipment malfunction|1|||
126024454|NCT04310735|453384796|FG002|Overall Study|Equipment malfunction|0|||
126024455|NCT03954184|453384797|FG000|Overall Study|Lost to Follow-up|500|||
126024456|NCT03954184|453384798|FG001|Overall Study|Lost to Follow-up|0|||
126024457|NCT03398200|453384799|FG000|Overall Study|Withdrawal by Subject|0|||
126024458|NCT03398200|453384800|FG001|Overall Study|Withdrawal by Subject|1|||
126024459|NCT05478525|453384801|FG000|Overall Study|Withdrawal by Subject|0|||
126024460|NCT05478525|453384802|FG001|Overall Study|Withdrawal by Subject|1|||
126024461|NCT05478525|453384803|FG002|Overall Study|Withdrawal by Subject|2|||
126024462|NCT05478525|453384804|FG003|Overall Study|Withdrawal by Subject|0|||
126024463|NCT05478525|453384801|FG000|Overall Study|COVID-19 Infection|2|||
126024464|NCT05478525|453384802|FG001|Overall Study|COVID-19 Infection|0|||
126024465|NCT05478525|453384803|FG002|Overall Study|COVID-19 Infection|1|||
126024466|NCT05478525|453384804|FG003|Overall Study|COVID-19 Infection|1|||
126024467|NCT01649271|453384805|FG000|Overall Study|Progressive disease|4|||
126024468|NCT01649271|453384806|FG001|Overall Study|Progressive disease|5|||
126024469|NCT01649271|453384805|FG000|Overall Study|Other Adverse Event|0|||
126024470|NCT01649271|453384806|FG001|Overall Study|Other Adverse Event|2|||
126024471|NCT01649271|453384805|FG000|Overall Study|Withdrawal by Subject|1|||
126024472|NCT01649271|453384806|FG001|Overall Study|Withdrawal by Subject|0|||
126024473|NCT01649271|453384805|FG000|Overall Study|Other than stated above|1|||
126024474|NCT01649271|453384806|FG001|Overall Study|Other than stated above|0|||
126024475|NCT05644002|453384809|FG000|Overall Study|Lost to Follow-up|1|||
126024476|NCT05644002|453384810|FG001|Overall Study|Lost to Follow-up|2|||
126024477|NCT05644002|453384809|FG000|Overall Study|Withdrawal by Subject|0|||
126024478|NCT05644002|453384810|FG001|Overall Study|Withdrawal by Subject|1|||
126024479|NCT04842500|453384811|FG000|Overall Study|Withdrawal by Subject|4|||
126024480|NCT04842500|453384812|FG001|Overall Study|Withdrawal by Subject|1|||
126024481|NCT04842500|453384813|FG002|Overall Study|Withdrawal by Subject|2|||
126024482|NCT04842500|453384814|FG003|Overall Study|Withdrawal by Subject|3|||
126024483|NCT04842500|453384811|FG000|Overall Study|Protocol Violation|1|||
126024484|NCT04842500|453384812|FG001|Overall Study|Protocol Violation|0|||
126024485|NCT04842500|453384813|FG002|Overall Study|Protocol Violation|0|||
126024486|NCT04842500|453384814|FG003|Overall Study|Protocol Violation|1|||
126024487|NCT05756075|453384815|FG000|Overall Study|Withdrawal by Subject|16|||
126024488|NCT05756075|453384816|FG001|Overall Study|Withdrawal by Subject|9|||
126024489|NCT05104697|453384818|FG000|Overall Study|Withdrawal by Subject|0|||
126024490|NCT05104697|453384819|FG001|Overall Study|Withdrawal by Subject|1|||
126024491|NCT03845465|453384820|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
126024492|NCT03845465|453384821|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
126024493|NCT03845465|453384820|FG000|6-month Data Collection|Withdrawal by Subject|0|||
126024494|NCT03845465|453384821|FG001|6-month Data Collection|Withdrawal by Subject|2|||
126024495|NCT03845465|453384820|FG000|12-month Data Collection|Withdrawal by Subject|0|||
126024496|NCT03845465|453384821|FG001|12-month Data Collection|Withdrawal by Subject|2|||
126024497|NCT03547908|453384822|FG000|Blinded Phase|Lost to Follow-up|3|||
126024498|NCT03547908|453384823|FG001|Blinded Phase|Lost to Follow-up|3|||
126024499|NCT03547908|453384824|FG002|Blinded Phase|Lost to Follow-up|0|||
126024500|NCT03547908|453384825|FG003|Blinded Phase|Lost to Follow-up|0|||
126024501|NCT03547908|453384822|FG000|Blinded Phase|Withdrew Consent|2|||
126024502|NCT03547908|453384823|FG001|Blinded Phase|Withdrew Consent|3|||
126024503|NCT03547908|453384824|FG002|Blinded Phase|Withdrew Consent|0|||
126024504|NCT03547908|453384825|FG003|Blinded Phase|Withdrew Consent|0|||
126024505|NCT03547908|453384822|FG000|Blinded Phase|Investigator's Discretion|2|||
126024506|NCT03547908|453384823|FG001|Blinded Phase|Investigator's Discretion|1|||
126024507|NCT03547908|453384824|FG002|Blinded Phase|Investigator's Discretion|0|||
126024508|NCT03547908|453384825|FG003|Blinded Phase|Investigator's Discretion|0|||
126024509|NCT03547908|453384822|FG000|Blinded Phase|Death|2|||
126024510|NCT03547908|453384823|FG001|Blinded Phase|Death|0|||
126024511|NCT03547908|453384824|FG002|Blinded Phase|Death|0|||
126024512|NCT03547908|453384825|FG003|Blinded Phase|Death|0|||
126024513|NCT03547908|453384822|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
126024514|NCT03547908|453384823|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
126024515|NCT03547908|453384824|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
126024516|NCT03547908|453384825|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
126024517|NCT03547908|453384822|FG000|Blinded Phase|Adverse Event|1|||
126024518|NCT03547908|453384823|FG001|Blinded Phase|Adverse Event|0|||
126024519|NCT03547908|453384824|FG002|Blinded Phase|Adverse Event|0|||
126024520|NCT03547908|453384825|FG003|Blinded Phase|Adverse Event|0|||
126024521|NCT03547908|453384822|FG000|Blinded Phase|Randomized But Never Treated|1|||
126024522|NCT03547908|453384823|FG001|Blinded Phase|Randomized But Never Treated|0|||
126024523|NCT03547908|453384824|FG002|Blinded Phase|Randomized But Never Treated|0|||
126024524|NCT03547908|453384825|FG003|Blinded Phase|Randomized But Never Treated|0|||
126024525|NCT03547908|453384822|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
126024526|NCT03547908|453384823|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
126024527|NCT03547908|453384824|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
126024528|NCT03547908|453384825|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
126024529|NCT03547908|453384822|FG000|Open-label Extension Phase|Death|0|||
126024530|NCT03547908|453384823|FG001|Open-label Extension Phase|Death|0|||
126024531|NCT03547908|453384824|FG002|Open-label Extension Phase|Death|1|||
126024532|NCT03547908|453384825|FG003|Open-label Extension Phase|Death|0|||
126024533|NCT03416023|453384828|FG000|Overall Study|Exclusion criteria failure|1|||
126024534|NCT03416023|453384828|FG000|Overall Study|Withdrawal by Subject|6|||
126024535|NCT03416023|453384828|FG000|Overall Study|Explanted|7|||
126024536|NCT03416023|453384828|FG000|Overall Study|Physician Decision|1|||
126024537|NCT03416023|453384828|FG000|Overall Study|Lost to Follow-up|1|||
126024538|NCT03416023|453384828|FG000|Overall Study|Death|1|||
126024539|NCT05419505|453384829|FG000|Overall Study|Adverse Event|0|||
126024540|NCT05419505|453384830|FG001|Overall Study|Adverse Event|0|||
126024541|NCT05419505|453384831|FG002|Overall Study|Adverse Event|0|||
126024542|NCT05419505|453384832|FG003|Overall Study|Adverse Event|1|||
126024543|NCT05419505|453384833|FG004|Overall Study|Adverse Event|0|||
126024544|NCT05419505|453384834|FG005|Overall Study|Adverse Event|0|||
126024545|NCT05419505|453384835|FG006|Overall Study|Adverse Event|0|||
126024546|NCT05419505|453384836|FG007|Overall Study|Adverse Event|0|||
126024547|NCT05419505|453384829|FG000|Overall Study|Withdrawal by Subject|1|||
126024548|NCT05419505|453384830|FG001|Overall Study|Withdrawal by Subject|2|||
126024549|NCT05419505|453384831|FG002|Overall Study|Withdrawal by Subject|0|||
126024550|NCT05419505|453384832|FG003|Overall Study|Withdrawal by Subject|0|||
126024551|NCT05419505|453384833|FG004|Overall Study|Withdrawal by Subject|0|||
126024552|NCT05419505|453384834|FG005|Overall Study|Withdrawal by Subject|0|||
126024553|NCT05419505|453384835|FG006|Overall Study|Withdrawal by Subject|1|||
126024554|NCT05419505|453384836|FG007|Overall Study|Withdrawal by Subject|0|||
126024555|NCT05419505|453384829|FG000|Overall Study|Lost to Follow-up|2|||
126024556|NCT05419505|453384830|FG001|Overall Study|Lost to Follow-up|1|||
126024557|NCT05419505|453384831|FG002|Overall Study|Lost to Follow-up|0|||
126024558|NCT05419505|453384832|FG003|Overall Study|Lost to Follow-up|0|||
126024559|NCT05419505|453384833|FG004|Overall Study|Lost to Follow-up|1|||
126024560|NCT05419505|453384834|FG005|Overall Study|Lost to Follow-up|2|||
126024561|NCT05419505|453384835|FG006|Overall Study|Lost to Follow-up|0|||
126024562|NCT05419505|453384836|FG007|Overall Study|Lost to Follow-up|1|||
126024563|NCT03358875|453384837|FG000|Overall Study|Death|409|||
126024564|NCT03358875|453384838|FG001|Overall Study|Death|223|||
126024565|NCT03358875|453384837|FG000|Overall Study|Study Closed by Sponsor|66|||
126024566|NCT03358875|453384838|FG001|Overall Study|Study Closed by Sponsor|29|||
126024567|NCT03358875|453384837|FG000|Overall Study|Withdrawal by Subject|13|||
126024568|NCT03358875|453384838|FG001|Overall Study|Withdrawal by Subject|16|||
126024569|NCT03358875|453384837|FG000|Overall Study|Lost to Follow-up|13|||
126024570|NCT03358875|453384838|FG001|Overall Study|Lost to Follow-up|2|||
126024571|NCT03358875|453384837|FG000|Overall Study|Miscellaneous|33|||
126024572|NCT03358875|453384838|FG001|Overall Study|Miscellaneous|0|||
126024573|NCT03358875|453384837|FG000|Overall Study|Remained on Study|1|||
126024574|NCT03358875|453384838|FG001|Overall Study|Remained on Study|0|||
126024575|NCT01064440|453384843|FG000|Overall Study|Lost to Follow-up|1|||
126024576|NCT01064440|453384844|FG001|Overall Study|Lost to Follow-up|1|||
126024577|NCT01064440|453384845|FG002|Overall Study|Lost to Follow-up|1|||
126024578|NCT01064440|453384843|FG000|Overall Study|Non-compliance|0|||
126024579|NCT01064440|453384844|FG001|Overall Study|Non-compliance|1|||
126024580|NCT01064440|453384845|FG002|Overall Study|Non-compliance|0|||
126024581|NCT01064440|453384843|FG000|Overall Study|Death|1|||
126024582|NCT01064440|453384844|FG001|Overall Study|Death|0|||
126024583|NCT01064440|453384845|FG002|Overall Study|Death|1|||
126024584|NCT01064440|453384843|FG000|Overall Study|Withdrawal by Subject|0|||
126024585|NCT01064440|453384844|FG001|Overall Study|Withdrawal by Subject|1|||
126024586|NCT01064440|453384845|FG002|Overall Study|Withdrawal by Subject|1|||
126024587|NCT01064440|453384843|FG000|Overall Study|Other: amputation|1|||
126024588|NCT01064440|453384844|FG001|Overall Study|Other: amputation|0|||
126024589|NCT01064440|453384845|FG002|Overall Study|Other: amputation|0|||
126024590|NCT06194214|453384847|FG000|Overall Study|Adverse Event|1|||
126024591|NCT05288283|453384853|FG000|Overall Study|Study Terminated Early|1|||
126024592|NCT05288283|453384854|FG001|Overall Study|Study Terminated Early|1|||
126024593|NCT01046136|453384855|FG000|Overall Study|Withdrawal by Subject|0|||
126024594|NCT01046136|453384856|FG001|Overall Study|Withdrawal by Subject|4|||
126024595|NCT01046136|453384855|FG000|Overall Study|Physician Decision|1|||
126024596|NCT01046136|453384856|FG001|Overall Study|Physician Decision|1|||
126024597|NCT01046136|453384855|FG000|Overall Study|Lost to Follow-up|3|||
126024598|NCT01046136|453384856|FG001|Overall Study|Lost to Follow-up|3|||
126024599|NCT04759833|453384860|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
126024600|NCT04759833|453384861|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
126024601|NCT04759833|453384862|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
126024602|NCT04759833|453384863|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
126024603|NCT04759833|453384864|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
126024604|NCT04759833|453384860|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
126024605|NCT04759833|453384861|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
126024606|NCT04759833|453384862|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
126024607|NCT04759833|453384863|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
126024608|NCT04759833|453384864|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
126024609|NCT04759833|453384860|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
126024610|NCT04759833|453384861|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
126024611|NCT04759833|453384862|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
126024612|NCT04759833|453384863|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
126024613|NCT04759833|453384864|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
126024614|NCT04759833|453384860|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
126024615|NCT04759833|453384861|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
126024616|NCT04759833|453384862|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
126024617|NCT04759833|453384863|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
126024618|NCT04759833|453384864|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
126024619|NCT04759833|453384860|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
126024620|NCT04759833|453384861|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
126024621|NCT04759833|453384862|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
126024622|NCT04759833|453384863|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
126093452|NCT01262677|453636051|FG000|Overall Study|Insufficient clinical response|0|||
126093453|NCT01262677|453636052|FG001|Overall Study|Insufficient clinical response|0|||
126093454|NCT01262677|453636053|FG002|Overall Study|Insufficient clinical response|1|||
126093455|NCT01262677|453636051|FG000|Overall Study|Lost to Follow-up|1|||
126093456|NCT01262677|453636052|FG001|Overall Study|Lost to Follow-up|0|||
126093457|NCT01262677|453636053|FG002|Overall Study|Lost to Follow-up|2|||
126093458|NCT01262677|453636051|FG000|Overall Study|No longer willing to participate|3|||
126093459|NCT01262677|453636052|FG001|Overall Study|No longer willing to participate|3|||
126093460|NCT01262677|453636053|FG002|Overall Study|No longer willing to participate|2|||
126093461|NCT01262677|453636051|FG000|Overall Study|Reason not provided|2|||
126093462|NCT01262677|453636052|FG001|Overall Study|Reason not provided|1|||
126093463|NCT01262677|453636053|FG002|Overall Study|Reason not provided|3|||
126093464|NCT01262677|453636051|FG000|Overall Study|Protocol Violation|0|||
126093465|NCT01262677|453636052|FG001|Overall Study|Protocol Violation|1|||
126093466|NCT01262677|453636053|FG002|Overall Study|Protocol Violation|1|||
126093467|NCT01262677|453636051|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
126093468|NCT01262677|453636052|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
126093469|NCT01262677|453636053|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
126093470|NCT03446781|453636063|FG000|Overall Study|Lost to Follow-up|11|||
126093471|NCT03446781|453636064|FG001|Overall Study|Lost to Follow-up|5|||
126024623|NCT04759833|453384864|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
126024624|NCT04759833|453384860|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
126093472|NCT03446781|453636063|FG000|Overall Study|Withdrawal by Subject|9|||
126093473|NCT03446781|453636064|FG001|Overall Study|Withdrawal by Subject|7|||
126093474|NCT03446781|453636063|FG000|Overall Study|Adverse Event|8|||
126024625|NCT04759833|453384861|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
126024626|NCT04759833|453384862|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
126024627|NCT04759833|453384863|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
126024628|NCT04759833|453384864|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
126024629|NCT04759833|453384860|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
126024630|NCT04759833|453384861|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
126024631|NCT04759833|453384862|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
126024632|NCT04759833|453384863|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
126024633|NCT04759833|453384864|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
126024634|NCT04759833|453384860|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
126024635|NCT04759833|453384861|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
126024636|NCT04759833|453384862|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
126024637|NCT04759833|453384863|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
126024638|NCT04759833|453384864|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
126024639|NCT04759833|453384860|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
126024640|NCT04759833|453384861|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
126024641|NCT04759833|453384862|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
126024642|NCT04759833|453384863|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
126024643|NCT04759833|453384864|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
126024644|NCT04759833|453384860|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
126024645|NCT04759833|453384861|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
126024646|NCT04759833|453384862|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
126024647|NCT04759833|453384863|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
126024648|NCT04759833|453384864|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
126024649|NCT04759833|453384860|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
126024650|NCT04759833|453384861|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
126024651|NCT04759833|453384862|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
126024652|NCT04759833|453384863|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
126024653|NCT04759833|453384864|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
126024654|NCT04759833|453384860|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
126024655|NCT04759833|453384861|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
126024656|NCT04759833|453384862|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
126024657|NCT04759833|453384863|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
126024658|NCT04759833|453384864|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
126024659|NCT04759833|453384860|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
126024660|NCT04759833|453384861|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
126024661|NCT04759833|453384862|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
126024662|NCT04759833|453384863|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
126024663|NCT04759833|453384864|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
126024664|NCT03446157|453384865|FG000|Overall Study|Death|11|||
126024665|NCT03446157|453384866|FG001|Overall Study|Death|9|||
126024666|NCT03446157|453384865|FG000|Overall Study|Lost to Follow-up|0|||
126024667|NCT03446157|453384866|FG001|Overall Study|Lost to Follow-up|1|||
126024668|NCT03446157|453384865|FG000|Overall Study|Withdrawal by Subject|2|||
126024669|NCT03446157|453384866|FG001|Overall Study|Withdrawal by Subject|1|||
126024670|NCT00411151|453384867|FG000|Overall Study|Death|38|||
126024671|NCT00411151|453384867|FG000|Overall Study|Withdrawal by Subject|2|||
126024672|NCT00411151|453384867|FG000|Overall Study|Lost to Follow-up|2|||
126024673|NCT00411151|453384867|FG000|Overall Study|Protocol Violation|1|||
126024674|NCT00411151|453384867|FG000|Overall Study|Trial prematurely closed|4|||
126024675|NCT00409838|453384870|FG000|Short-term Period|Adverse Event|0|||
126024676|NCT00409838|453384871|FG001|Short-term Period|Adverse Event|1|||
126024677|NCT00409838|453384870|FG000|Short-term Period|Lost to Follow-up|0|||
126024678|NCT00409838|453384871|FG001|Short-term Period|Lost to Follow-up|1|||
126024679|NCT00409838|453384870|FG000|Short-term Period|Withdrawal by Subject|2|||
126024680|NCT00409838|453384871|FG001|Short-term Period|Withdrawal by Subject|3|||
126024681|NCT00409838|453384870|FG000|Short-term Period|Never Treated|1|||
126024682|NCT00409838|453384871|FG001|Short-term Period|Never Treated|0|||
126024683|NCT00409838|453384870|FG000|Long-term Extension Period|Adverse Event|10|||
126355868|NCT00790933|454595584|FG000|Overall Study|Lost to Follow-up|13|||
126355869|NCT00790933|454595585|FG001|Overall Study|Lost to Follow-up|31|||
126355870|NCT00790933|454595586|FG002|Overall Study|Lost to Follow-up|10|||
126355871|NCT00790933|454595587|FG003|Overall Study|Lost to Follow-up|1|||
126024684|NCT00409838|453384871|FG001|Long-term Extension Period|Adverse Event|0|||
126093475|NCT03446781|453636064|FG001|Overall Study|Adverse Event|2|||
126355872|NCT00790933|454595588|FG004|Overall Study|Lost to Follow-up|15|||
126093476|NCT03446781|453636063|FG000|Overall Study|Protocol Violation|0|||
126355873|NCT00790933|454595584|FG000|Overall Study|Reason Not Specified|8|||
126355874|NCT00790933|454595585|FG001|Overall Study|Reason Not Specified|16|||
126355875|NCT00790933|454595586|FG002|Overall Study|Reason Not Specified|4|||
126355876|NCT00790933|454595587|FG003|Overall Study|Reason Not Specified|1|||
126355877|NCT00790933|454595588|FG004|Overall Study|Reason Not Specified|9|||
126355878|NCT00245570|454595589|FG000|Washout Between Periods III and IV|Adverse Event|0|||
126355879|NCT00245570|454595590|FG001|Washout Between Periods III and IV|Adverse Event|1|||
126355880|NCT00245570|454595591|FG002|Washout Between Periods III and IV|Adverse Event|0|||
126355881|NCT00245570|454595592|FG003|Washout Between Periods III and IV|Adverse Event|0|||
126355882|NCT00245570|454595593|FG004|Washout Between Periods III and IV|Adverse Event|0|||
126355883|NCT00245570|454595594|FG005|Washout Between Periods III and IV|Adverse Event|0|||
126355884|NCT01829165|454595595|FG000|Overall Study|Did not complete intervention|2|||
126355885|NCT01829165|454595596|FG001|Overall Study|Did not complete intervention|0|||
126355886|NCT04233580|454595615|FG000|Overall Study|Adverse Event|3|||
126355887|NCT04233580|454595616|FG001|Overall Study|Adverse Event|3|||
126355888|NCT04233580|454595615|FG000|Overall Study|Withdrawal by Subject|2|||
126355889|NCT04233580|454595616|FG001|Overall Study|Withdrawal by Subject|1|||
126355890|NCT02441114|454595618|FG000|Washout2|Withdrawal by Subject|4|||
126355891|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
126355892|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
126355893|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
126355894|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
126355895|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
126355896|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
126355897|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
126355898|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
126024685|NCT00409838|453384870|FG000|Long-term Extension Period|Death|1|||
126024686|NCT00409838|453384871|FG001|Long-term Extension Period|Death|0|||
126024687|NCT00409838|453384870|FG000|Long-term Extension Period|Lack of Efficacy|2|||
126024688|NCT00409838|453384871|FG001|Long-term Extension Period|Lack of Efficacy|0|||
126024689|NCT00409838|453384870|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
126024690|NCT00409838|453384871|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
126355899|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
126355900|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
126355901|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
126355902|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
126355903|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
126355904|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
126355905|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
126355906|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
126355907|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
126024691|NCT00409838|453384870|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
126024692|NCT00409838|453384871|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
126024693|NCT00409838|453384870|FG000|Long-term Extension Period|Pregnancy|1|||
126024694|NCT00409838|453384871|FG001|Long-term Extension Period|Pregnancy|0|||
126024695|NCT01619410|453384872|FG000|Overall Study|Lost to Follow-up|7|||
126024696|NCT01619410|453384873|FG001|Overall Study|Lost to Follow-up|4|||
126024697|NCT01250769|453384874|FG000|Overall Study|Withdrawal by Subject|0|||
126024698|NCT01250769|453384875|FG001|Overall Study|Withdrawal by Subject|1|||
126024699|NCT01250769|453384876|FG002|Overall Study|Withdrawal by Subject|1|||
126024700|NCT01250769|453384877|FG003|Overall Study|Withdrawal by Subject|0|||
126024701|NCT01250769|453384874|FG000|Overall Study|Adverse Event|0|||
126024702|NCT01250769|453384875|FG001|Overall Study|Adverse Event|0|||
126024703|NCT01250769|453384876|FG002|Overall Study|Adverse Event|1|||
126024704|NCT01250769|453384877|FG003|Overall Study|Adverse Event|0|||
126024705|NCT02538900|453384878|FG000|Overall Study|Death|2|||
126024706|NCT02538900|453384879|FG001|Overall Study|Death|2|||
126024707|NCT02538900|453384880|FG002|Overall Study|Death|2|||
126024708|NCT02538900|453384878|FG000|Overall Study|Withdrawal by Subject|18|||
126024709|NCT02538900|453384879|FG001|Overall Study|Withdrawal by Subject|16|||
126024710|NCT02538900|453384880|FG002|Overall Study|Withdrawal by Subject|15|||
126024711|NCT04110054|453384881|FG000|Overall Study|COVID-19 reason other than AE|0|||
126024712|NCT04110054|453384882|FG001|Overall Study|COVID-19 reason other than AE|0|||
126024713|NCT04110054|453384883|FG002|Overall Study|COVID-19 reason other than AE|2|||
126024714|NCT04110054|453384884|FG003|Overall Study|COVID-19 reason other than AE|0|||
126024715|NCT04110054|453384881|FG000|Overall Study|Withdrawal by Subject|0|||
126024716|NCT04110054|453384882|FG001|Overall Study|Withdrawal by Subject|3|||
126024717|NCT04110054|453384883|FG002|Overall Study|Withdrawal by Subject|2|||
126024718|NCT04110054|453384884|FG003|Overall Study|Withdrawal by Subject|0|||
126355908|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
126355909|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
126024719|NCT04110054|453384881|FG000|Overall Study|Adverse Event|1|||
126024720|NCT04110054|453384882|FG001|Overall Study|Adverse Event|1|||
126024721|NCT04110054|453384883|FG002|Overall Study|Adverse Event|4|||
126024722|NCT04110054|453384884|FG003|Overall Study|Adverse Event|3|||
126024723|NCT02874534|453384885|FG000|Overall Study|Withdrawal by Subject|5|||
126024724|NCT02874534|453384886|FG001|Overall Study|Withdrawal by Subject|8|||
126024725|NCT02874534|453384885|FG000|Overall Study|Lost to Follow-up|2|||
126024726|NCT02874534|453384886|FG001|Overall Study|Lost to Follow-up|2|||
126024727|NCT02874534|453384885|FG000|Overall Study|Ongoing in study|1|||
126024728|NCT02874534|453384886|FG001|Overall Study|Ongoing in study|1|||
126024729|NCT02923180|453384888|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
126024730|NCT02923180|453384888|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
126024731|NCT01989455|453384889|FG000|Overall Study|Adverse Event|0|||
126024732|NCT01989455|453384890|FG001|Overall Study|Adverse Event|1|||
126024733|NCT01989455|453384891|FG002|Overall Study|Adverse Event|0|||
126024734|NCT01989455|453384892|FG003|Overall Study|Adverse Event|0|||
126024735|NCT01989455|453384893|FG004|Overall Study|Adverse Event|0|||
126024736|NCT01989455|453384889|FG000|Overall Study|Withdrawal by Subject|0|||
126024737|NCT01989455|453384890|FG001|Overall Study|Withdrawal by Subject|1|||
126024738|NCT01989455|453384891|FG002|Overall Study|Withdrawal by Subject|0|||
126024739|NCT01989455|453384892|FG003|Overall Study|Withdrawal by Subject|0|||
126024740|NCT01989455|453384893|FG004|Overall Study|Withdrawal by Subject|0|||
126024741|NCT01989455|453384889|FG000|Overall Study|Technical problems with infusion|0|||
126024742|NCT01989455|453384890|FG001|Overall Study|Technical problems with infusion|0|||
126024743|NCT01989455|453384891|FG002|Overall Study|Technical problems with infusion|1|||
126024744|NCT01989455|453384892|FG003|Overall Study|Technical problems with infusion|0|||
126024745|NCT01989455|453384893|FG004|Overall Study|Technical problems with infusion|1|||
126024746|NCT00632203|453384894|FG000|Overall Study|Did not start study treatment|1|||
126024747|NCT00632203|453384895|FG001|Overall Study|Did not start study treatment|0|||
126024748|NCT04287985|453384898|FG000|Overall Study|Adverse Event|1|||
126024749|NCT04287985|453384899|FG001|Overall Study|Adverse Event|0|||
126024750|NCT04287985|453384900|FG002|Overall Study|Adverse Event|0|||
126024751|NCT04287985|453384901|FG003|Overall Study|Adverse Event|0|||
126024752|NCT04287985|453384898|FG000|Overall Study|Protocol Violation|0|||
126024753|NCT04287985|453384899|FG001|Overall Study|Protocol Violation|1|||
126024754|NCT04287985|453384900|FG002|Overall Study|Protocol Violation|0|||
126024755|NCT04287985|453384901|FG003|Overall Study|Protocol Violation|0|||
126024756|NCT04287985|453384898|FG000|Overall Study|Physician Decision|0|||
126236447|NCT00445003|454158583|FG002|Overall Study|Missed Visit|1|||
126236448|NCT00445003|454158581|FG000|Overall Study|Dropped|1|||
126236449|NCT00445003|454158582|FG001|Overall Study|Dropped|3|||
126236450|NCT00445003|454158583|FG002|Overall Study|Dropped|2|||
126236451|NCT01471093|454158584|FG000|Overall Study|Adverse Event|1|||
126024757|NCT04287985|453384899|FG001|Overall Study|Physician Decision|0|||
126024758|NCT04287985|453384900|FG002|Overall Study|Physician Decision|0|||
126024759|NCT04287985|453384901|FG003|Overall Study|Physician Decision|1|||
126024760|NCT04287985|453384898|FG000|Overall Study|Withdrawal by Subject|2|||
126024761|NCT04287985|453384899|FG001|Overall Study|Withdrawal by Subject|1|||
126024762|NCT04287985|453384900|FG002|Overall Study|Withdrawal by Subject|1|||
126236452|NCT01471093|454158585|FG001|Overall Study|Adverse Event|0|||
126236453|NCT01471093|454158586|FG002|Overall Study|Adverse Event|0|||
126236454|NCT01471093|454158587|FG003|Overall Study|Adverse Event|0|||
126236455|NCT02475954|454158588|FG000|Overall Study|Withdrawal by Subject|2|||
126236456|NCT02475954|454158589|FG001|Overall Study|Withdrawal by Subject|2|||
126236457|NCT02475954|454158588|FG000|Overall Study|Lost to Follow-up|11|||
126236458|NCT02475954|454158589|FG001|Overall Study|Lost to Follow-up|9|||
126236459|NCT02475954|454158588|FG000|Overall Study|Death|1|||
126355910|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
126355911|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
126355912|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
126355913|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
126355914|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
126355915|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
126355916|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
126355917|NCT01371565|454595621|FG000|Overall Study|Withdrawal by Subject|1|||
126355918|NCT01371565|454595621|FG000|Overall Study|Death|1|||
126355919|NCT01371565|454595621|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
126355920|NCT02070991|454595622|FG000|Overall Study|Death|2|||
126355921|NCT02070991|454595623|FG001|Overall Study|Death|0|||
126355922|NCT02070991|454595622|FG000|Overall Study|Withdrawal by Subject|1|||
126355923|NCT02070991|454595623|FG001|Overall Study|Withdrawal by Subject|0|||
126355924|NCT00827242|454595624|FG000|Overall Study|Withdrawal by Subject|2|||
126355925|NCT00827242|454595625|FG001|Overall Study|Withdrawal by Subject|4|||
126355926|NCT00827242|454595624|FG000|Overall Study|Protocol Violation|1|||
126355927|NCT00827242|454595625|FG001|Overall Study|Protocol Violation|3|||
126355928|NCT00827242|454595624|FG000|Overall Study|Lost to Follow-up|0|||
126355929|NCT00827242|454595625|FG001|Overall Study|Lost to Follow-up|3|||
126355930|NCT00827242|454595624|FG000|Overall Study|Adverse Event Excluding Death|2|||
126355931|NCT00827242|454595625|FG001|Overall Study|Adverse Event Excluding Death|1|||
126355932|NCT00827242|454595624|FG000|Overall Study|Entry Criteria Not Met|4|||
126355933|NCT00827242|454595625|FG001|Overall Study|Entry Criteria Not Met|1|||
126355934|NCT00827242|454595624|FG000|Overall Study|Physician Decision|2|||
126355935|NCT00827242|454595625|FG001|Overall Study|Physician Decision|0|||
126355936|NCT00827242|454595624|FG000|Overall Study|Death|1|||
126355937|NCT00827242|454595625|FG001|Overall Study|Death|0|||
126355938|NCT00827242|454595624|FG000|Overall Study|Lack of Efficacy|1|||
126355939|NCT00827242|454595625|FG001|Overall Study|Lack of Efficacy|0|||
126355940|NCT00899847|454595626|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
126355941|NCT05987540|454595627|FG000|Overall Study|Withdrawal by Subject|2|||
126355942|NCT05987540|454595627|FG000|Overall Study|Death|1|||
126355943|NCT05987540|454595627|FG000|Overall Study|Study Termination|1|||
126355944|NCT05987540|454595627|FG000|Overall Study|Adverse Event|2|||
126355945|NCT00471107|454595628|FG000|Overall Study|Technical problems/data loss|3|||
126355946|NCT00471107|454595629|FG001|Overall Study|Technical problems/data loss|1|||
126355947|NCT00471107|454595630|FG002|Overall Study|Technical problems/data loss|3|||
126355948|NCT01769443|454595631|FG000|Overall Study|Study closure|1|||
126355949|NCT01769443|454595632|FG001|Overall Study|Study closure|0|||
126024763|NCT04287985|453384901|FG003|Overall Study|Withdrawal by Subject|2|||
126024764|NCT01340066|453384906|FG000|Placebo Run in Period|Screen Failures|27|||
126024765|NCT01340066|453384907|FG001|Placebo Run in Period|Screen Failures|0|||
126024766|NCT01340066|453384908|FG002|Placebo Run in Period|Screen Failures|0|||
126024767|NCT01340066|453384906|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
126024768|NCT01340066|453384907|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
126024769|NCT01340066|453384908|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
126024770|NCT01340066|453384906|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
126024771|NCT01340066|453384907|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
126024772|NCT01340066|453384908|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
126024773|NCT01340066|453384906|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
126024774|NCT01340066|453384907|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
126024775|NCT01340066|453384908|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
126024776|NCT02789020|453384909|FG000|Overall Study|Withdrawal by Subject|6|||
126024777|NCT02789020|453384910|FG001|Overall Study|Withdrawal by Subject|5|||
126024778|NCT03771352|453384921|FG000|Overall Study|Screen failure|2|||
126024779|NCT03771352|453384921|FG000|Overall Study|Withdrawal by Subject|2|||
126024780|NCT04238247|453384922|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
126024781|NCT04238247|453384923|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
126024782|NCT04238247|453384924|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
126024783|NCT04238247|453384925|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
126236460|NCT02475954|454158589|FG001|Overall Study|Death|1|||
126355950|NCT04996264|454595633|FG000|Overall Study|Lost to Follow-up|0|||
126355951|NCT04996264|454595634|FG001|Overall Study|Lost to Follow-up|1|||
126355952|NCT04996264|454595633|FG000|Overall Study|Withdrawal by Subject|4|||
126355953|NCT04996264|454595634|FG001|Overall Study|Withdrawal by Subject|3|||
126355954|NCT04996264|454595633|FG000|Overall Study|1 left AMA|0|||
126355955|NCT04996264|454595634|FG001|Overall Study|1 left AMA|1|||
126236461|NCT02932878|454158590|FG000|Overall Study|Due to Lab Results|2|||
126236462|NCT02932878|454158591|FG001|Overall Study|Due to Lab Results|1|||
126236463|NCT01918397|454158594|FG000|Overall Study|Never started treatment|2|||
126236464|NCT01918397|454158595|FG001|Overall Study|Never started treatment|1|||
126236465|NCT01918397|454158596|FG002|Overall Study|Never started treatment|0|||
126236466|NCT01918397|454158597|FG003|Overall Study|Never started treatment|0|||
126236467|NCT01918397|454158594|FG000|Overall Study|Adverse Event|1|||
126236468|NCT01918397|454158595|FG001|Overall Study|Adverse Event|1|||
126236469|NCT01918397|454158596|FG002|Overall Study|Adverse Event|1|||
126236470|NCT01918397|454158597|FG003|Overall Study|Adverse Event|0|||
126236471|NCT01918397|454158594|FG000|Overall Study|Lack of compliance|2|||
126236472|NCT01918397|454158595|FG001|Overall Study|Lack of compliance|2|||
126024784|NCT04238247|453384922|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
126024785|NCT04238247|453384923|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
126024786|NCT04238247|453384924|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
126024787|NCT04238247|453384925|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
126024788|NCT04238247|453384922|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
126024789|NCT04238247|453384923|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
126024790|NCT04238247|453384924|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
126024791|NCT04238247|453384925|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
126024792|NCT04238247|453384922|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
126024793|NCT04238247|453384923|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
126024794|NCT04238247|453384924|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
126024795|NCT04238247|453384925|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
126024796|NCT03988842|453384926|FG000|Overall Study|Death|1|||
126024797|NCT01227265|453384928|FG000|Overall Study|Did Not Receive Treatment|1|||
126024798|NCT01227265|453384929|FG001|Overall Study|Did Not Receive Treatment|2|||
126024799|NCT01227265|453384930|FG002|Overall Study|Did Not Receive Treatment|0|||
126024800|NCT01227265|453384928|FG000|Overall Study|Administrative|1|||
126024801|NCT01227265|453384929|FG001|Overall Study|Administrative|0|||
126024802|NCT01227265|453384930|FG002|Overall Study|Administrative|2|||
126024803|NCT01227265|453384928|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
126024804|NCT01227265|453384929|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
126024805|NCT01227265|453384930|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
126024806|NCT01227265|453384928|FG000|Overall Study|Protocol Violation|2|||
126024807|NCT01227265|453384929|FG001|Overall Study|Protocol Violation|1|||
126024808|NCT01227265|453384930|FG002|Overall Study|Protocol Violation|0|||
126024809|NCT01227265|453384928|FG000|Overall Study|Withdrawal by Subject|7|||
126024810|NCT01227265|453384929|FG001|Overall Study|Withdrawal by Subject|7|||
126024811|NCT01227265|453384930|FG002|Overall Study|Withdrawal by Subject|3|||
126024812|NCT01227265|453384928|FG000|Overall Study|Lost to Follow-up|2|||
126024813|NCT01227265|453384929|FG001|Overall Study|Lost to Follow-up|0|||
126024814|NCT01227265|453384930|FG002|Overall Study|Lost to Follow-up|3|||
126024815|NCT01227265|453384928|FG000|Overall Study|Adverse Event|6|||
126024816|NCT01227265|453384929|FG001|Overall Study|Adverse Event|10|||
126024817|NCT01227265|453384930|FG002|Overall Study|Adverse Event|5|||
126024818|NCT03690206|453384931|FG000|Overall Study|Withdrawal by Subject|2|||
126024819|NCT03690206|453384932|FG001|Overall Study|Withdrawal by Subject|0|||
126024820|NCT03690206|453384933|FG002|Overall Study|Withdrawal by Subject|0|||
126024821|NCT03690206|453384931|FG000|Overall Study|ICF withdrawal|2|||
126024822|NCT03690206|453384932|FG001|Overall Study|ICF withdrawal|0|||
126024823|NCT03690206|453384933|FG002|Overall Study|ICF withdrawal|0|||
126024824|NCT05028582|453384934|FG000|Overall Study|Lost to Follow-up|11|||
126024825|NCT05028582|453384935|FG001|Overall Study|Lost to Follow-up|9|||
126024826|NCT05028582|453384934|FG000|Overall Study|Withdrawal by Subject|9|||
126024827|NCT05028582|453384935|FG001|Overall Study|Withdrawal by Subject|10|||
126024828|NCT05028582|453384934|FG000|Overall Study|Adverse Event|5|||
126024829|NCT05028582|453384935|FG001|Overall Study|Adverse Event|2|||
126024830|NCT05028582|453384934|FG000|Overall Study|Miscellaneous|3|||
126024831|NCT05028582|453384935|FG001|Overall Study|Miscellaneous|2|||
126024832|NCT05028582|453384934|FG000|Overall Study|Lack of Efficacy|3|||
126024833|NCT05028582|453384935|FG001|Overall Study|Lack of Efficacy|1|||
126024834|NCT05028582|453384934|FG000|Overall Study|Physician Decision|0|||
126024835|NCT05028582|453384935|FG001|Overall Study|Physician Decision|1|||
126024836|NCT03481660|453386872|FG000|Overall Study|Adverse Event|5|||
126024837|NCT03481660|453386873|FG001|Overall Study|Adverse Event|4|||
126024838|NCT03481660|453386872|FG000|Overall Study|Death|13|||
126024839|NCT03481660|453386873|FG001|Overall Study|Death|9|||
126024840|NCT03481660|453386872|FG000|Overall Study|Lost to Follow-up|2|||
126024841|NCT03481660|453386873|FG001|Overall Study|Lost to Follow-up|2|||
126024842|NCT03481660|453386872|FG000|Overall Study|Physician Decision|2|||
126024843|NCT03481660|453386873|FG001|Overall Study|Physician Decision|3|||
126024844|NCT03481660|453386872|FG000|Overall Study|Withdrawal by Subject|14|||
126024845|NCT03481660|453386873|FG001|Overall Study|Withdrawal by Subject|7|||
126236473|NCT01918397|454158596|FG002|Overall Study|Lack of compliance|3|||
126236474|NCT01918397|454158597|FG003|Overall Study|Lack of compliance|0|||
126236475|NCT01918397|454158594|FG000|Overall Study|Pregnancy|0|||
126024846|NCT03012841|453386874|FG000|Overall Study|Protocol Violation|0|||
126024847|NCT03012841|453386875|FG001|Overall Study|Protocol Violation|10|||
126024848|NCT03012841|453386874|FG000|Overall Study|Lost to Follow-up|6|||
126024849|NCT03012841|453386875|FG001|Overall Study|Lost to Follow-up|1|||
126024850|NCT03012841|453386874|FG000|Overall Study|Withdrawal by Subject|6|||
126024851|NCT03012841|453386875|FG001|Overall Study|Withdrawal by Subject|0|||
126024852|NCT03012841|453386874|FG000|Overall Study|Unable to complete 12 month visit|6|||
126024853|NCT03012841|453386875|FG001|Overall Study|Unable to complete 12 month visit|0|||
126024854|NCT03012841|453386874|FG000|Overall Study|Subject relocation|1|||
126024855|NCT03012841|453386875|FG001|Overall Study|Subject relocation|0|||
126024856|NCT03012841|453386874|FG000|Overall Study|Seasonal winter travel|1|||
126024857|NCT03012841|453386875|FG001|Overall Study|Seasonal winter travel|0|||
126024858|NCT03012841|453386874|FG000|Overall Study|Physician Decision|0|||
126024859|NCT03012841|453386875|FG001|Overall Study|Physician Decision|2|||
126024860|NCT03012841|453386874|FG000|Overall Study|No ablation performed|0|||
126024861|NCT03012841|453386875|FG001|Overall Study|No ablation performed|2|||
126024862|NCT03012841|453386874|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
126024863|NCT03012841|453386875|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
126024864|NCT03012841|453386874|FG000|Overall Study|Insurance change|0|||
126024865|NCT03012841|453386875|FG001|Overall Study|Insurance change|1|||
126024866|NCT00186992|453386876|FG000|Overall Study|Withdrawal by Subject|5|||
126024867|NCT00186992|453386876|FG000|Overall Study|Physician's discretion|13|||
126024868|NCT00186992|453386876|FG000|Overall Study|PI Discretion|4|||
126024869|NCT00186992|453386876|FG000|Overall Study|Ineligible|2|||
126024870|NCT00186992|453386876|FG000|Overall Study|Lost to Follow-up|2|||
126024871|NCT00186992|453386876|FG000|Overall Study|Still on Study|9|||
126024872|NCT03683069|453386877|FG000|Overall Study|see limitations|12|||
126024873|NCT03683069|453386878|FG001|Overall Study|see limitations|13|||
126024874|NCT03769168|453386879|FG000|Overall Study|Adverse Event|0|||
126024875|NCT03769168|453386880|FG001|Overall Study|Adverse Event|1|||
126024876|NCT03769168|453386879|FG000|Overall Study|Lack of Efficacy|2|||
126024877|NCT03769168|453386880|FG001|Overall Study|Lack of Efficacy|4|||
126024878|NCT03769168|453386879|FG000|Overall Study|Post study access to treatment|3|||
126024879|NCT03769168|453386880|FG001|Overall Study|Post study access to treatment|11|||
126024880|NCT03769168|453386879|FG000|Overall Study|Physician Decision|1|||
126024881|NCT03769168|453386880|FG001|Overall Study|Physician Decision|4|||
126024882|NCT03769168|453386879|FG000|Overall Study|Subject Decision|2|||
126024883|NCT03769168|453386880|FG001|Overall Study|Subject Decision|4|||
126024884|NCT03769168|453386879|FG000|Overall Study|Guardian decision|1|||
126024885|NCT03769168|453386880|FG001|Overall Study|Guardian decision|0|||
126024886|NCT04941287|453386881|FG000|Overall Study|Rapid decline before starting treatment|3|||
126024887|NCT04941287|453386882|FG001|Overall Study|Rapid decline before starting treatment|1|||
126024888|NCT04065048|453386883|FG000|Overall Study|Withdrawal by Subject|1|||
126024889|NCT04065048|453386884|FG001|Overall Study|Withdrawal by Subject|2|||
126024890|NCT04065048|453386885|FG002|Overall Study|Withdrawal by Subject|1|||
126024891|NCT04065048|453386886|FG003|Overall Study|Withdrawal by Subject|1|||
126024892|NCT04065048|453386883|FG000|Overall Study|Adverse Event|1|||
126024893|NCT04065048|453386884|FG001|Overall Study|Adverse Event|0|||
126024894|NCT04065048|453386885|FG002|Overall Study|Adverse Event|1|||
126024895|NCT04065048|453386886|FG003|Overall Study|Adverse Event|0|||
126024896|NCT05096819|453386895|FG000|Overall Study|Withdrawal by Subject|3|||
126024897|NCT05096819|453386896|FG001|Overall Study|Withdrawal by Subject|0|||
126024898|NCT05307978|453386897|FG000|Overall Study|Lost to Follow-up|0|||
126024899|NCT05307978|453386898|FG001|Overall Study|Lost to Follow-up|1|||
126024900|NCT05307978|453386899|FG002|Overall Study|Lost to Follow-up|0|||
126024901|NCT05307978|453386900|FG003|Overall Study|Lost to Follow-up|4|||
126024902|NCT05307978|453386901|FG004|Overall Study|Lost to Follow-up|0|||
126024903|NCT05307978|453386902|FG005|Overall Study|Lost to Follow-up|0|||
126024904|NCT05307978|453386903|FG006|Overall Study|Lost to Follow-up|1|||
126024905|NCT03324984|453386904|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
126024906|NCT03324984|453386905|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
126355956|NCT04996264|454595633|FG000|Overall Study|Subject changed hospitals|0|||
126355957|NCT04996264|454595634|FG001|Overall Study|Subject changed hospitals|1|||
126355958|NCT04996264|454595633|FG000|Overall Study|unable to complete due to work|0|||
126355959|NCT04996264|454595634|FG001|Overall Study|unable to complete due to work|1|||
126355960|NCT01279200|454595635|FG000|Overall Study|Withdrawal by Subject|1|||
126355961|NCT01279200|454595636|FG001|Overall Study|Withdrawal by Subject|3|||
126355962|NCT01279200|454595635|FG000|Overall Study|Patient withdrawal due to high cost|0|||
126355963|NCT01279200|454595636|FG001|Overall Study|Patient withdrawal due to high cost|1|||
126355964|NCT01279200|454595635|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
126355965|NCT01279200|454595636|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
126355966|NCT01279200|454595635|FG000|Overall Study|ultrasound screening failure|0|||
126355967|NCT01279200|454595636|FG001|Overall Study|ultrasound screening failure|1|||
126355968|NCT01279200|454595635|FG000|Overall Study|Lost to Follow-up|0|||
126355969|NCT01279200|454595636|FG001|Overall Study|Lost to Follow-up|1|||
126355970|NCT01279200|454595635|FG000|Overall Study|Adverse Event|1|||
126355971|NCT01279200|454595636|FG001|Overall Study|Adverse Event|0|||
126024907|NCT04607044|453386910|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
126024908|NCT04607044|453386910|FG000|Overall Study|Adverse Event|1|||
126024909|NCT04607044|453386910|FG000|Overall Study|Did not receive study device|3|||
126024910|NCT04607044|453386910|FG000|Overall Study|Death|1|||
126024911|NCT05075408|453386911|FG000|Overall Study|Withdrawal by Subject|5|||
126355972|NCT01149538|454595639|FG000|Overall Study|Lost to Follow-up|0|||
126355973|NCT01149538|454595640|FG001|Overall Study|Lost to Follow-up|1|||
126355974|NCT01149538|454595639|FG000|Overall Study|Withdrawal by Subject|5|||
126024912|NCT05075408|453386912|FG001|Overall Study|Withdrawal by Subject|3|||
126024913|NCT05075408|453386913|FG002|Overall Study|Withdrawal by Subject|4|||
126024914|NCT05075408|453386911|FG000|Overall Study|Adverse Event|5|||
126024915|NCT05075408|453386912|FG001|Overall Study|Adverse Event|7|||
126024916|NCT05075408|453386913|FG002|Overall Study|Adverse Event|8|||
126024917|NCT05075408|453386911|FG000|Overall Study|Protocol Violation|0|||
126024918|NCT05075408|453386912|FG001|Overall Study|Protocol Violation|1|||
126024919|NCT05075408|453386913|FG002|Overall Study|Protocol Violation|0|||
126024920|NCT05075408|453386911|FG000|Overall Study|Lost to Follow-up|2|||
126024921|NCT05075408|453386912|FG001|Overall Study|Lost to Follow-up|1|||
126024922|NCT05075408|453386913|FG002|Overall Study|Lost to Follow-up|1|||
126024923|NCT05075408|453386911|FG000|Overall Study|Physician Decision|1|||
126024924|NCT05075408|453386912|FG001|Overall Study|Physician Decision|0|||
126024925|NCT05075408|453386913|FG002|Overall Study|Physician Decision|0|||
126024926|NCT05075408|453386911|FG000|Overall Study|Other-unspecified|3|||
126024927|NCT05075408|453386912|FG001|Overall Study|Other-unspecified|2|||
126024928|NCT05075408|453386913|FG002|Overall Study|Other-unspecified|0|||
126024929|NCT04878354|453386917|FG000|Overall Study|Adverse Event|4|||
126024930|NCT04878354|453386918|FG001|Overall Study|Adverse Event|13|||
126024931|NCT04878354|453386917|FG000|Overall Study|Withdrawal by Subject|14|||
126024932|NCT04878354|453386918|FG001|Overall Study|Withdrawal by Subject|12|||
126024933|NCT04878354|453386917|FG000|Overall Study|Lost to Follow-up|4|||
126024934|NCT04878354|453386918|FG001|Overall Study|Lost to Follow-up|1|||
126024935|NCT04878354|453386917|FG000|Overall Study|Lack of Efficacy|1|||
126024936|NCT04878354|453386918|FG001|Overall Study|Lack of Efficacy|0|||
126024937|NCT04878354|453386917|FG000|Overall Study|Protocol Violation|0|||
126024938|NCT04878354|453386918|FG001|Overall Study|Protocol Violation|1|||
126024939|NCT04878354|453386917|FG000|Overall Study|"Reason stated as other in CRF"|2|||
126024940|NCT04878354|453386918|FG001|Overall Study|"Reason stated as other in CRF"|3|||
126024941|NCT01631214|453386924|FG000|Overall Study|Withdrawal by Subject|276|||
126024942|NCT01631214|453386925|FG001|Overall Study|Withdrawal by Subject|290|||
126024943|NCT01631214|453386924|FG000|Overall Study|Death|113|||
126024944|NCT01631214|453386925|FG001|Overall Study|Death|106|||
126024945|NCT01631214|453386924|FG000|Overall Study|Lost to Follow-up|54|||
126024946|NCT01631214|453386925|FG001|Overall Study|Lost to Follow-up|40|||
126024947|NCT01631214|453386924|FG000|Overall Study|Adverse Event|45|||
126024948|NCT01631214|453386925|FG001|Overall Study|Adverse Event|45|||
126024949|NCT01631214|453386924|FG000|Overall Study|Other|22|||
126024950|NCT01631214|453386925|FG001|Overall Study|Other|19|||
126024951|NCT01631214|453386924|FG000|Overall Study|Noncompliance|16|||
126024952|NCT01631214|453386925|FG001|Overall Study|Noncompliance|15|||
126024953|NCT01631214|453386924|FG000|Overall Study|Requirement for Alternative Therapy|8|||
126024954|NCT01631214|453386925|FG001|Overall Study|Requirement for Alternative Therapy|3|||
126024955|NCT01631214|453386924|FG000|Overall Study|Protocol Deviation|4|||
126024956|NCT01631214|453386925|FG001|Overall Study|Protocol Deviation|3|||
126024957|NCT01631214|453386924|FG000|Overall Study|Ineligibility determined|5|||
126024958|NCT01631214|453386925|FG001|Overall Study|Ineligibility determined|2|||
126024959|NCT01631214|453386924|FG000|Overall Study|Administrative Decision|1|||
126024960|NCT01631214|453386925|FG001|Overall Study|Administrative Decision|0|||
126024961|NCT04093362|453386932|FG000|Overall Study|Study Termination|1|||
126024962|NCT04093362|453386933|FG001|Overall Study|Study Termination|1|||
126024963|NCT04093362|453386932|FG000|Overall Study|Withdrawal of Consent|1|||
126024964|NCT04093362|453386933|FG001|Overall Study|Withdrawal of Consent|0|||
126024965|NCT04093362|453386932|FG000|Overall Study|Death|1|||
126024966|NCT04093362|453386933|FG001|Overall Study|Death|3|||
126024967|NCT04093362|453386932|FG000|Overall Study|Reason not Specified|1|||
126024968|NCT04093362|453386933|FG001|Overall Study|Reason not Specified|2|||
126024969|NCT04847999|453386934|FG000|Overall Study|Lost to Follow-up|0|||
126024970|NCT04847999|453386935|FG001|Overall Study|Lost to Follow-up|1|||
126024971|NCT02879448|453386936|FG000|Overall Study|Death|251|||
126024972|NCT02879448|453386937|FG001|Overall Study|Death|263|||
126024973|NCT02879448|453386936|FG000|Overall Study|Lost to Follow-up|23|||
126024974|NCT02879448|453386937|FG001|Overall Study|Lost to Follow-up|28|||
126024975|NCT02879448|453386936|FG000|Overall Study|Withdrawal by Subject|42|||
126024976|NCT02879448|453386937|FG001|Overall Study|Withdrawal by Subject|79|||
126024977|NCT02879448|453386936|FG000|Overall Study|Other Reasons|8|||
126024978|NCT02879448|453386937|FG001|Overall Study|Other Reasons|12|||
126024979|NCT03433339|453386938|FG000|Overall Study|Lost to Follow-up|2|||
126024980|NCT03433339|453386939|FG001|Overall Study|Lost to Follow-up|0|||
126024981|NCT03433339|453386938|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
126024982|NCT03433339|453386939|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
126024983|NCT03433339|453386938|FG000|Overall Study|Withdrawal by Subject|0|||
126024984|NCT03433339|453386939|FG001|Overall Study|Withdrawal by Subject|2|||
126024985|NCT05952076|453386940|FG000|Overall Study|Death|1|||
126024986|NCT05952076|453386941|FG001|Overall Study|Death|1|||
126024987|NCT05952076|453386940|FG000|Overall Study|Lost to Follow-up|0|||
126024988|NCT05952076|453386941|FG001|Overall Study|Lost to Follow-up|1|||
126024989|NCT02919449|453386942|FG000|Overall Study|Withdrawal by Subject|1|||
126024990|NCT02919449|453386942|FG000|Overall Study|Investigator decision|1|||
126024991|NCT00727909|453386943|FG000|Overall Study|Withdrawal by Subject|5|||
126024992|NCT00727909|453386944|FG001|Overall Study|Withdrawal by Subject|11|||
126024993|NCT00727909|453386945|FG002|Overall Study|Withdrawal by Subject|8|||
126024994|NCT00727909|453386946|FG003|Overall Study|Withdrawal by Subject|5|||
126024995|NCT00727909|453386943|FG000|Overall Study|Death|0|||
126024996|NCT00727909|453386944|FG001|Overall Study|Death|0|||
126024997|NCT00727909|453386945|FG002|Overall Study|Death|1|||
126024998|NCT00727909|453386946|FG003|Overall Study|Death|0|||
126024999|NCT00448669|453386949|FG000|Overall Study|Lost to Follow-up|52|||
126025000|NCT00448669|453386950|FG001|Overall Study|Lost to Follow-up|63|||
126025001|NCT00448669|453386949|FG000|Overall Study|Withdrawal by Subject|90|||
126025002|NCT00448669|453386950|FG001|Overall Study|Withdrawal by Subject|74|||
126025003|NCT00448669|453386949|FG000|Overall Study|Relocated|49|||
126025004|NCT00448669|453386950|FG001|Overall Study|Relocated|36|||
126025005|NCT00448669|453386949|FG000|Overall Study|Were withdrawn by investigator|10|||
126025006|NCT00448669|453386950|FG001|Overall Study|Were withdrawn by investigator|6|||
126025007|NCT00448669|453386949|FG000|Overall Study|Death|2|||
126025008|NCT00448669|453386950|FG001|Overall Study|Death|4|||
126025009|NCT00448669|453386949|FG000|Overall Study|Had other reasons|5|||
126025010|NCT00448669|453386950|FG001|Overall Study|Had other reasons|6|||
126025011|NCT00448669|453386949|FG000|Overall Study|HIV-infected at enrollment|1|||
126025012|NCT00448669|453386950|FG001|Overall Study|HIV-infected at enrollment|2|||
126025013|NCT00448669|453386949|FG000|Overall Study|Never started drug|9|||
126025014|NCT00448669|453386950|FG001|Overall Study|Never started drug|7|||
126025015|NCT02638337|453386951|FG000|Overall Study|Adverse Event|6|||
126025016|NCT02638337|453386952|FG001|Overall Study|Adverse Event|10|||
126025017|NCT02638337|453386951|FG000|Overall Study|Protocol Violation|3|||
126025018|NCT02638337|453386952|FG001|Overall Study|Protocol Violation|0|||
126025019|NCT02638337|453386951|FG000|Overall Study|Withdrawal by Subject|13|||
126025020|NCT02638337|453386952|FG001|Overall Study|Withdrawal by Subject|16|||
126025021|NCT02638337|453386951|FG000|Overall Study|Lost to Follow-up|7|||
126025022|NCT02638337|453386952|FG001|Overall Study|Lost to Follow-up|7|||
126025023|NCT02638337|453386951|FG000|Overall Study|Other - Miscellaneous|4|||
126025024|NCT02638337|453386952|FG001|Overall Study|Other - Miscellaneous|3|||
126025025|NCT03338816|453386962|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
126025026|NCT03338816|453386963|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
126025027|NCT03338816|453386964|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
126025028|NCT03338816|453386965|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
126025029|NCT03338816|453386962|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
126025030|NCT03338816|453386963|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
126025031|NCT03338816|453386964|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
126025032|NCT03338816|453386965|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
126025033|NCT03338816|453386962|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
126025034|NCT03338816|453386963|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
126025035|NCT03338816|453386964|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
126025036|NCT03338816|453386965|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
126025037|NCT03338816|453386962|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
126025038|NCT03338816|453386963|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
126025039|NCT03338816|453386964|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
126025040|NCT03338816|453386965|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
126025041|NCT03338816|453386962|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
126025042|NCT03338816|453386963|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
126025043|NCT03338816|453386964|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
126025044|NCT03338816|453386965|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
126025045|NCT03338816|453386962|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
126025046|NCT03338816|453386963|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
126025047|NCT03338816|453386964|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
126025048|NCT03338816|453386965|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
126025049|NCT03338816|453386962|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
126025050|NCT03338816|453386963|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
126025051|NCT03338816|453386964|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
126025052|NCT03338816|453386965|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
126025053|NCT03092726|453386970|FG000|Overall Study|Adverse Event|3|||
126025054|NCT03092726|453386971|FG001|Overall Study|Adverse Event|10|||
126025055|NCT03092726|453386970|FG000|Overall Study|Lack of Efficacy|0|||
126025056|NCT03092726|453386971|FG001|Overall Study|Lack of Efficacy|1|||
126025057|NCT03092726|453386970|FG000|Overall Study|Lost to Follow-up|1|||
126025058|NCT03092726|453386971|FG001|Overall Study|Lost to Follow-up|0|||
126025059|NCT03092726|453386970|FG000|Overall Study|Withdrawal by Subject|5|||
126025060|NCT03092726|453386971|FG001|Overall Study|Withdrawal by Subject|3|||
126025061|NCT04950127|453386972|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
126025062|NCT04950127|453386973|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
126025063|NCT04950127|453386974|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
126025064|NCT04950127|453386975|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
126025065|NCT04950127|453386976|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
126025066|NCT04950127|453386977|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
126025067|NCT04950127|453386972|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
126025068|NCT04950127|453386973|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
126025069|NCT04950127|453386974|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
126025070|NCT04950127|453386975|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
126025071|NCT04950127|453386976|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
126025072|NCT04950127|453386977|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
126025073|NCT04950127|453386972|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
126025074|NCT04950127|453386973|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
126025075|NCT04950127|453386974|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
126025076|NCT04950127|453386975|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
126025077|NCT04950127|453386976|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
126025078|NCT04950127|453386977|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
126025079|NCT04950127|453386972|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126025080|NCT04950127|453386973|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126025081|NCT04950127|453386974|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126025082|NCT04950127|453386975|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126025083|NCT04950127|453386976|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126025084|NCT04950127|453386977|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
126025085|NCT04950127|453386972|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
126025086|NCT04950127|453386973|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
126025087|NCT04950127|453386974|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
126025088|NCT04950127|453386975|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
126025089|NCT04950127|453386976|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
126025090|NCT04950127|453386977|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
126025091|NCT03833167|453386982|FG000|Overall Study|Withdrawal by Subject|4|||
126025092|NCT03833167|453386983|FG001|Overall Study|Withdrawal by Subject|6|||
126025093|NCT03833167|453386982|FG000|Overall Study|Ongoing|186|||
126025094|NCT03833167|453386983|FG001|Overall Study|Ongoing|194|||
126025095|NCT03833167|453386982|FG000|Overall Study|Lost to Follow-up|1|||
126025096|NCT03833167|453386983|FG001|Overall Study|Lost to Follow-up|1|||
126025097|NCT03833167|453386982|FG000|Overall Study|Physician Decision|0|||
126025098|NCT03833167|453386983|FG001|Overall Study|Physician Decision|2|||
126025099|NCT03833167|453386982|FG000|Overall Study|Death|34|||
126025100|NCT03833167|453386983|FG001|Overall Study|Death|22|||
126025101|NCT01948661|453386985|FG000|Overall Study|Withdrawal by Subject|2|||
126025102|NCT01948661|453386986|FG001|Overall Study|Withdrawal by Subject|4|||
126025103|NCT03271489|453386987|FG000|Double-Blind (DB) Period|Adverse Event|4|||
126025104|NCT03271489|453386988|FG001|Double-Blind (DB) Period|Adverse Event|1|||
126025105|NCT03271489|453386987|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
126025106|NCT03271489|453386988|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
126025107|NCT03271489|453386987|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
126025108|NCT03271489|453386988|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
126025109|NCT03271489|453386987|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
126025110|NCT03271489|453386988|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
126025111|NCT03271489|453386987|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
126025112|NCT03271489|453386988|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
126025113|NCT03271489|453386987|FG000|Double-Blind (DB) Period|Other|6|||
126025114|NCT03271489|453386988|FG001|Double-Blind (DB) Period|Other|1|||
126025115|NCT03271489|453386987|FG000|Double-Blind (DB) Period|Missing|1|||
126025116|NCT03271489|453386988|FG001|Double-Blind (DB) Period|Missing|0|||
126025117|NCT03271489|453386987|FG000|Open-Label (OL) Period|Adverse Event|2|||
126025118|NCT03271489|453386988|FG001|Open-Label (OL) Period|Adverse Event|0|||
126025119|NCT03271489|453386987|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
126025120|NCT03271489|453386988|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
126355975|NCT01149538|454595640|FG001|Overall Study|Withdrawal by Subject|3|||
126355976|NCT00888849|454595643|FG000|Overall Study|Death|4|||
126355977|NCT00888849|454595644|FG001|Overall Study|Death|7|||
126025121|NCT03271489|453386987|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
126025122|NCT03271489|453386988|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
126355978|NCT00888849|454595643|FG000|Overall Study|Lost to Follow-up|1|||
126025123|NCT03271489|453386987|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
126025124|NCT03271489|453386988|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
126025125|NCT03271489|453386987|FG000|Open-Label (OL) Period|No Specified|2|||
126355979|NCT00888849|454595644|FG001|Overall Study|Lost to Follow-up|2|||
126025126|NCT03271489|453386988|FG001|Open-Label (OL) Period|No Specified|2|||
126025127|NCT03271489|453386987|FG000|Open-Label (OL) Period|Missing|2|||
126025128|NCT03271489|453386988|FG001|Open-Label (OL) Period|Missing|0|||
126025129|NCT03271489|453386987|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
126025130|NCT03271489|453386988|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
126025131|NCT03271489|453386987|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
126025132|NCT03271489|453386988|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
126025133|NCT03271489|453386987|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
126025134|NCT03271489|453386988|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
126025135|NCT03271489|453386987|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
126025136|NCT03271489|453386988|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
126025137|NCT03271489|453386987|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
126025138|NCT03271489|453386988|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
126025139|NCT03271489|453386987|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
126025140|NCT03271489|453386988|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
126025141|NCT03271489|453386987|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
126025142|NCT03271489|453386988|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
126025143|NCT03271489|453386987|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
126025144|NCT03271489|453386988|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
126025145|NCT02860130|453386989|FG000|Overall Study|Adverse Event|2|||
126025146|NCT02860130|453386990|FG001|Overall Study|Adverse Event|3|||
126025147|NCT02860130|453386989|FG000|Overall Study|Protocol Violation|1|||
126025148|NCT02860130|453386990|FG001|Overall Study|Protocol Violation|1|||
126025149|NCT02860130|453386989|FG000|Overall Study|Withdrawal by Subject|0|||
126025150|NCT02860130|453386990|FG001|Overall Study|Withdrawal by Subject|2|||
126025151|NCT02860130|453386989|FG000|Overall Study|Physician Decision|2|||
126025152|NCT02860130|453386990|FG001|Overall Study|Physician Decision|2|||
126025153|NCT02860130|453386989|FG000|Overall Study|Other|2|||
126025154|NCT02860130|453386990|FG001|Overall Study|Other|1|||
126025155|NCT03330795|453386991|FG000|Overall Study|Death|3|||
126025156|NCT03330795|453386991|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
126025157|NCT05064735|453386992|FG000|Overall Study|Withdrawal by Subject|7|||
126025158|NCT05064735|453386993|FG001|Overall Study|Withdrawal by Subject|8|||
126025159|NCT05064735|453386992|FG000|Overall Study|Lost to Follow-up|7|||
126025160|NCT05064735|453386993|FG001|Overall Study|Lost to Follow-up|2|||
126025161|NCT05064735|453386992|FG000|Overall Study|Physician Decision|2|||
126025162|NCT05064735|453386993|FG001|Overall Study|Physician Decision|1|||
126025163|NCT05064735|453386992|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
126025164|NCT05064735|453386993|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
126025165|NCT05064735|453386992|FG000|Overall Study|Site Closure|7|||
126025166|NCT05064735|453386993|FG001|Overall Study|Site Closure|2|||
126025167|NCT03380390|453386994|FG000|Overall Study|Adverse Event|3|||
126025168|NCT02886286|453386995|FG000|Overall Study|pump motor stall|0|||
126093477|NCT03446781|453636064|FG001|Overall Study|Protocol Violation|3|||
126093478|NCT03339583|453636073|FG000|First Intervention (14 Days)|Adverse Event|1|||
126093479|NCT03339583|453636074|FG001|First Intervention (14 Days)|Adverse Event|0|||
126093480|NCT03339583|453636073|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
126093481|NCT03339583|453636074|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
126093482|NCT03339583|453636073|FG000|Second Intervention (14 Days)|Adverse Event|0|||
126093483|NCT03339583|453636074|FG001|Second Intervention (14 Days)|Adverse Event|1|||
126093484|NCT03339583|453636073|FG000|Follow-up (14 Days)|Physician Decision|6|||
126093485|NCT03339583|453636074|FG001|Follow-up (14 Days)|Physician Decision|3|||
126093486|NCT00734591|453636075|FG000|Screening for Prospective Period|Site did not participate|1604|||
126093487|NCT00734591|453636076|FG001|Screening for Prospective Period|Site did not participate|1488|||
126093488|NCT00734591|453636075|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
126093489|NCT00734591|453636076|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
126236476|NCT01918397|454158595|FG001|Overall Study|Pregnancy|1|||
126236477|NCT01918397|454158596|FG002|Overall Study|Pregnancy|0|||
126355980|NCT05507450|454595650|FG000|Overall Study|Death|0|||
126355981|NCT05507450|454595651|FG001|Overall Study|Death|0|||
126355982|NCT05507450|454595652|FG002|Overall Study|Death|1|||
126355983|NCT05507450|454595653|FG003|Overall Study|Death|0|||
126355984|NCT05507450|454595650|FG000|Overall Study|Lost to Follow-up|22|||
126355985|NCT05507450|454595651|FG001|Overall Study|Lost to Follow-up|20|||
126355986|NCT05507450|454595652|FG002|Overall Study|Lost to Follow-up|20|||
126025169|NCT02886286|453386996|FG001|Overall Study|pump motor stall|1|||
126025170|NCT02376790|453386997|FG000|Overall Study|Withdrawal by Subject|43|||
126025171|NCT02376790|453386998|FG001|Overall Study|Withdrawal by Subject|36|||
126025172|NCT02376790|453386999|FG002|Overall Study|Withdrawal by Subject|37|||
126025173|NCT02376790|453386997|FG000|Overall Study|Decision by Sponsor|2|||
126025174|NCT02376790|453386998|FG001|Overall Study|Decision by Sponsor|1|||
126025175|NCT02376790|453386999|FG002|Overall Study|Decision by Sponsor|4|||
126025176|NCT02376790|453386997|FG000|Overall Study|Lost to Follow-up|15|||
126025177|NCT02376790|453386998|FG001|Overall Study|Lost to Follow-up|10|||
126025178|NCT02376790|453386999|FG002|Overall Study|Lost to Follow-up|12|||
126025179|NCT03014453|453387000|FG000|Overall Study|Lost to Follow-up|12|||
126025180|NCT03014453|453387000|FG000|Overall Study|Discontinued GER|3|||
126025181|NCT03014453|453387000|FG000|Overall Study|Excluded|19|||
126025182|NCT03014453|453387000|FG000|Overall Study|Refused to take part in|37|||
126025183|NCT05450458|453387001|FG000|Overall Study|Lost to Follow-up|4|||
126025184|NCT00262301|453387002|FG000|Double-blind Phase|Lost to Follow-up|1|||
126025185|NCT00262301|453387003|FG001|Double-blind Phase|Lost to Follow-up|0|||
126025186|NCT00262301|453387004|FG002|Double-blind Phase|Lost to Follow-up|0|||
126025187|NCT00262301|453387002|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
126025188|NCT00262301|453387003|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
126025189|NCT00262301|453387004|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
126025190|NCT00901901|453387005|FG000|Treatment Period|Adverse Event|120|||
126025191|NCT00901901|453387006|FG001|Treatment Period|Adverse Event|128|||
126025192|NCT00901901|453387005|FG000|Treatment Period|Withdrawal by Subject|26|||
126025193|NCT00901901|453387006|FG001|Treatment Period|Withdrawal by Subject|24|||
126025194|NCT00901901|453387005|FG000|Treatment Period|Physician Decision|2|||
126025195|NCT00901901|453387006|FG001|Treatment Period|Physician Decision|2|||
126025196|NCT00901901|453387005|FG000|Treatment Period|Lost to Follow-up|3|||
126025197|NCT00901901|453387006|FG001|Treatment Period|Lost to Follow-up|5|||
126025198|NCT00901901|453387005|FG000|Treatment Period|Noncompliance with study medication|4|||
126025199|NCT00901901|453387006|FG001|Treatment Period|Noncompliance with study medication|1|||
126025200|NCT00901901|453387005|FG000|Treatment Period|Missing|1|||
126025201|NCT00901901|453387006|FG001|Treatment Period|Missing|0|||
126025202|NCT00901901|453387005|FG000|Treatment Period|Never treated|0|||
126025203|NCT00901901|453387006|FG001|Treatment Period|Never treated|3|||
126025204|NCT00901901|453387005|FG000|Treatment Period|Protocol driven decision point|0|||
126025205|NCT00901901|453387006|FG001|Treatment Period|Protocol driven decision point|2|||
126025206|NCT00901901|453387005|FG000|Treatment Period|Study terminated by sponsor|2|||
126025207|NCT00901901|453387006|FG001|Treatment Period|Study terminated by sponsor|0|||
126025208|NCT00901901|453387005|FG000|Treatment Period|Protocol Violation|5|||
126025209|NCT00901901|453387006|FG001|Treatment Period|Protocol Violation|9|||
126025210|NCT00901901|453387005|FG000|Treatment Period|Switch to commercial drug|1|||
126355987|NCT05507450|454595653|FG003|Overall Study|Lost to Follow-up|7|||
126355988|NCT05507450|454595650|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126355989|NCT05507450|454595651|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
126355990|NCT05507450|454595652|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126355991|NCT05507450|454595653|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126355992|NCT05507450|454595650|FG000|Overall Study|Withdrawal by Subject|4|||
126355993|NCT05507450|454595651|FG001|Overall Study|Withdrawal by Subject|11|||
126355994|NCT05507450|454595652|FG002|Overall Study|Withdrawal by Subject|7|||
126025211|NCT00901901|453387006|FG001|Treatment Period|Switch to commercial drug|1|||
126025212|NCT00901901|453387005|FG000|Treatment Period|Transfer to treatment continuation study|5|||
126025213|NCT00901901|453387006|FG001|Treatment Period|Transfer to treatment continuation study|2|||
126025214|NCT00901901|453387005|FG000|Follow-up Period|Death|181|||
126355995|NCT05507450|454595653|FG003|Overall Study|Withdrawal by Subject|3|||
126355996|NCT05507450|454595650|FG000|Overall Study|Participant left the country|0|||
126355997|NCT05507450|454595651|FG001|Overall Study|Participant left the country|0|||
126355998|NCT05507450|454595652|FG002|Overall Study|Participant left the country|1|||
126355999|NCT05507450|454595653|FG003|Overall Study|Participant left the country|0|||
126356000|NCT00514917|454595657|FG000|Overall Study|Death|4|||
126356001|NCT00514917|454595658|FG001|Overall Study|Death|10|||
126356002|NCT00514917|454595657|FG000|Overall Study|Protocol Violation|1|||
126356003|NCT00514917|454595658|FG001|Overall Study|Protocol Violation|0|||
126356004|NCT00514917|454595657|FG000|Overall Study|Lost to Follow-up|4|||
126356005|NCT00514917|454595658|FG001|Overall Study|Lost to Follow-up|3|||
126025215|NCT00901901|453387006|FG001|Follow-up Period|Death|208|||
126025216|NCT00901901|453387005|FG000|Follow-up Period|Protocol driven decision point|47|||
126025217|NCT00901901|453387006|FG001|Follow-up Period|Protocol driven decision point|36|||
126025218|NCT00901901|453387005|FG000|Follow-up Period|Withdrawal by Subject|6|||
126025219|NCT00901901|453387006|FG001|Follow-up Period|Withdrawal by Subject|9|||
126025220|NCT00901901|453387005|FG000|Follow-up Period|Lost to Follow-up|12|||
126025221|NCT00901901|453387006|FG001|Follow-up Period|Lost to Follow-up|8|||
126025222|NCT00901901|453387005|FG000|Follow-up Period|Missing|94|||
126025223|NCT00901901|453387006|FG001|Follow-up Period|Missing|80|||
126025224|NCT02272816|453387007|FG000|Overall Study|Adverse Event|1|||
126025225|NCT01136876|453387008|FG000|Overall Study|Lost to Follow-up|0|||
126025226|NCT01136876|453387009|FG001|Overall Study|Lost to Follow-up|1|||
126025227|NCT01136876|453387008|FG000|Overall Study|Physician Decision|3|||
126025228|NCT01136876|453387009|FG001|Overall Study|Physician Decision|5|||
126025229|NCT01136876|453387008|FG000|Overall Study|Missing NGAL measurement|2|||
126025230|NCT01136876|453387009|FG001|Overall Study|Missing NGAL measurement|5|||
126025231|NCT00976937|453387012|FG000|Overall Study|Adverse Event|4|||
126025232|NCT00976937|453387013|FG001|Overall Study|Adverse Event|5|||
126025233|NCT00976937|453387012|FG000|Overall Study|Lost to Follow-up|2|||
126025234|NCT00976937|453387013|FG001|Overall Study|Lost to Follow-up|1|||
126025235|NCT00976937|453387012|FG000|Overall Study|Withdrawal by Subject|5|||
126025236|NCT00976937|453387013|FG001|Overall Study|Withdrawal by Subject|3|||
126025237|NCT00976937|453387012|FG000|Overall Study|Poor compliance to protocol|3|||
126025238|NCT00976937|453387013|FG001|Overall Study|Poor compliance to protocol|0|||
126025239|NCT00976937|453387012|FG000|Overall Study|Personal and Familial Reason|2|||
126025240|NCT00976937|453387013|FG001|Overall Study|Personal and Familial Reason|2|||
126025241|NCT01011946|453387014|FG000|Overall Study|Transferred to another hospital|2|||
126025242|NCT01011946|453387014|FG000|Overall Study|No pathological lab value|1|||
126025243|NCT04820686|453387015|FG000|Overall Study|Withdrawal by Subject|5|||
126025244|NCT04820686|453387016|FG001|Overall Study|Withdrawal by Subject|2|||
126025245|NCT04820686|453387017|FG002|Overall Study|Withdrawal by Subject|3|||
126025246|NCT04820686|453387015|FG000|Overall Study|Study Termination|25|||
126025247|NCT04820686|453387016|FG001|Overall Study|Study Termination|13|||
126025248|NCT04820686|453387017|FG002|Overall Study|Study Termination|14|||
126025249|NCT04820686|453387015|FG000|Overall Study|Adverse Event|0|||
126025250|NCT04820686|453387016|FG001|Overall Study|Adverse Event|1|||
126025251|NCT04820686|453387017|FG002|Overall Study|Adverse Event|0|||
126025252|NCT01424670|453387018|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
126025253|NCT01424670|453387019|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
126025254|NCT01424670|453387018|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
126025255|NCT01424670|453387019|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
126025256|NCT01424670|453387018|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
126025257|NCT01424670|453387019|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
126025258|NCT01424670|453387018|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
126025259|NCT01424670|453387019|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
126025260|NCT01424670|453387018|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
126025261|NCT01424670|453387019|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
126025262|NCT01424670|453387018|FG000|Continuation Period|Adverse Event|13|||
126025263|NCT01424670|453387019|FG001|Continuation Period|Adverse Event|5|||
126093490|NCT00734591|453636075|FG000|Prospective Period|Withdrawal by Subject|11|||
126025264|NCT01424670|453387018|FG000|Continuation Period|Lost to Follow-up|2|||
126093491|NCT00734591|453636076|FG001|Prospective Period|Withdrawal by Subject|9|||
126356006|NCT00514917|454595657|FG000|Overall Study|Withdrawal by Subject|18|||
126356007|NCT00514917|454595658|FG001|Overall Study|Withdrawal by Subject|16|||
126025265|NCT01424670|453387019|FG001|Continuation Period|Lost to Follow-up|0|||
126025266|NCT01424670|453387018|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
126025267|NCT01424670|453387019|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
126025268|NCT01424670|453387018|FG000|Continuation Period|Physician Decision|5|||
126025269|NCT01424670|453387019|FG001|Continuation Period|Physician Decision|4|||
126025270|NCT01424670|453387018|FG000|Continuation Period|Withdrawal by Subject|13|||
126025271|NCT01424670|453387019|FG001|Continuation Period|Withdrawal by Subject|4|||
126025272|NCT02891915|453387024|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
126025273|NCT02891915|453387025|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
126025274|NCT02891915|453387024|FG000|Overall Study|Withdrawal by Subject|3|||
126025275|NCT02891915|453387025|FG001|Overall Study|Withdrawal by Subject|3|||
126025276|NCT02891915|453387024|FG000|Overall Study|Became Ineligible After Enrollment|2|||
126025277|NCT02891915|453387025|FG001|Overall Study|Became Ineligible After Enrollment|1|||
126025278|NCT02891915|453387024|FG000|Overall Study|Lost to Follow-up|1|||
126025279|NCT02891915|453387025|FG001|Overall Study|Lost to Follow-up|4|||
126025280|NCT02891915|453387024|FG000|Overall Study|Physician Decision|1|||
126025281|NCT02891915|453387025|FG001|Overall Study|Physician Decision|0|||
126025282|NCT00709098|453387026|FG000|Double-blind Period|Withdrawal of consent|3|||
126025283|NCT00709098|453387027|FG001|Double-blind Period|Withdrawal of consent|3|||
126025284|NCT00709098|453387028|FG002|Double-blind Period|Withdrawal of consent|0|||
126025285|NCT00709098|453387026|FG000|Double-blind Period|Administrative reason|1|||
126025286|NCT00709098|453387027|FG001|Double-blind Period|Administrative reason|3|||
126025287|NCT00709098|453387028|FG002|Double-blind Period|Administrative reason|0|||
126025288|NCT00709098|453387026|FG000|Double-blind Period|Death|1|||
126025289|NCT00709098|453387027|FG001|Double-blind Period|Death|1|||
126025290|NCT00709098|453387028|FG002|Double-blind Period|Death|0|||
126025291|NCT00709098|453387026|FG000|Double-blind Period|Lost to Follow-up|1|||
126025292|NCT00709098|453387027|FG001|Double-blind Period|Lost to Follow-up|1|||
126025293|NCT00709098|453387028|FG002|Double-blind Period|Lost to Follow-up|0|||
126025294|NCT00709098|453387026|FG000|Open-label Period|Withdrawal of consent|0|||
126025295|NCT00709098|453387027|FG001|Open-label Period|Withdrawal of consent|0|||
126025296|NCT00709098|453387028|FG002|Open-label Period|Withdrawal of consent|7|||
126025297|NCT00709098|453387026|FG000|Open-label Period|Administrative reason|0|||
126025298|NCT00709098|453387027|FG001|Open-label Period|Administrative reason|0|||
126025299|NCT00709098|453387028|FG002|Open-label Period|Administrative reason|5|||
126025300|NCT00709098|453387026|FG000|Open-label Period|Death|0|||
126025301|NCT00709098|453387027|FG001|Open-label Period|Death|0|||
126025302|NCT00709098|453387028|FG002|Open-label Period|Death|1|||
126025303|NCT00709098|453387026|FG000|Open-label Period|Lost to Follow-up|0|||
126025304|NCT00709098|453387027|FG001|Open-label Period|Lost to Follow-up|0|||
126025305|NCT00709098|453387028|FG002|Open-label Period|Lost to Follow-up|1|||
126025306|NCT03481816|453387030|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
126025307|NCT03481816|453387031|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
126025308|NCT03481816|453387030|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
126025309|NCT03481816|453387031|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
126025310|NCT03481816|453387030|FG000|Dose Expansion|Withdrawal by Subject|0|||
126025311|NCT03481816|453387031|FG001|Dose Expansion|Withdrawal by Subject|2|||
126025312|NCT03481816|453387030|FG000|Dose Expansion|Physician Decision|0|||
126025313|NCT03481816|453387031|FG001|Dose Expansion|Physician Decision|5|||
126025314|NCT01091168|453387034|FG000|Overall Study|Progressive disease|250|||
126025315|NCT01091168|453387035|FG001|Overall Study|Progressive disease|234|||
126025316|NCT01091168|453387034|FG000|Overall Study|Adverse Event|21|||
126025317|NCT01091168|453387035|FG001|Overall Study|Adverse Event|24|||
126025318|NCT01091168|453387034|FG000|Overall Study|Lost to Follow-up|0|||
126025319|NCT01091168|453387035|FG001|Overall Study|Lost to Follow-up|1|||
126025320|NCT01091168|453387034|FG000|Overall Study|Physician, patient's decision, other|27|||
126025321|NCT01091168|453387035|FG001|Overall Study|Physician, patient's decision, other|37|||
126025322|NCT03582722|453387038|FG000|Overall Study|Lost to Follow-up|1|||
126025323|NCT03582722|453387039|FG001|Overall Study|Lost to Follow-up|4|||
126025324|NCT03582722|453387038|FG000|Overall Study|Withdrawal by Subject|3|||
126025325|NCT03582722|453387039|FG001|Overall Study|Withdrawal by Subject|3|||
126025326|NCT06024174|453387040|FG000|Overall Study|Other Reasons|1|||
126025327|NCT06024174|453387040|FG000|Overall Study|Study terminated by Sponsor|4|||
126025328|NCT04567615|453387041|FG000|Randomization|Participant withdrew consent|1|||
126025329|NCT04567615|453387042|FG001|Randomization|Participant withdrew consent|0|||
126025330|NCT04567615|453387043|FG002|Randomization|Participant withdrew consent|0|||
126025331|NCT04567615|453387041|FG000|Randomization|Adverse event unrelated to study drug|0|||
126025332|NCT04567615|453387042|FG001|Randomization|Adverse event unrelated to study drug|1|||
126025333|NCT04567615|453387043|FG002|Randomization|Adverse event unrelated to study drug|0|||
126025334|NCT04567615|453387041|FG000|Treatment Period|Participant Withdrew Consent|2|||
126025335|NCT04567615|453387042|FG001|Treatment Period|Participant Withdrew Consent|5|||
126025336|NCT04567615|453387043|FG002|Treatment Period|Participant Withdrew Consent|1|||
126025337|NCT04567615|453387041|FG000|Treatment Period|Death|1|||
126025338|NCT04567615|453387042|FG001|Treatment Period|Death|2|||
126025339|NCT04567615|453387043|FG002|Treatment Period|Death|0|||
126025340|NCT04567615|453387041|FG000|Treatment Period|Lost to Follow-up|0|||
126025341|NCT04567615|453387042|FG001|Treatment Period|Lost to Follow-up|1|||
126025342|NCT04567615|453387043|FG002|Treatment Period|Lost to Follow-up|0|||
126025343|NCT04567615|453387041|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
126025344|NCT04567615|453387042|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
126025345|NCT04567615|453387043|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
126025346|NCT04567615|453387041|FG000|Treatment Period|Disease Progression|85|||
126025347|NCT04567615|453387042|FG001|Treatment Period|Disease Progression|63|||
126025348|NCT04567615|453387043|FG002|Treatment Period|Disease Progression|16|||
126025349|NCT04567615|453387041|FG000|Treatment Period|Study Drug Toxicity|3|||
126025350|NCT04567615|453387042|FG001|Treatment Period|Study Drug Toxicity|10|||
126025351|NCT04567615|453387043|FG002|Treatment Period|Study Drug Toxicity|4|||
126025352|NCT04567615|453387041|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
126025353|NCT04567615|453387042|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
126025354|NCT04567615|453387043|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
126025355|NCT04567615|453387041|FG000|Treatment Period|Other Reasons|1|||
126025356|NCT04567615|453387042|FG001|Treatment Period|Other Reasons|2|||
126025357|NCT04567615|453387043|FG002|Treatment Period|Other Reasons|0|||
126025358|NCT04567615|453387041|FG000|Treatment Period|Still On-going Treatment|21|||
126025359|NCT04567615|453387042|FG001|Treatment Period|Still On-going Treatment|22|||
126025360|NCT04567615|453387043|FG002|Treatment Period|Still On-going Treatment|2|||
126025361|NCT02152137|453389129|FG000|Overall Study|Withdrawal by Subject|1|||
126025362|NCT02152137|453389129|FG000|Overall Study|Originally assigned to Arm B|3|||
126025363|NCT05510232|453389130|FG000|Overall Study|Withdrawal by Subject|2|||
126025364|NCT05510232|453389131|FG001|Overall Study|Withdrawal by Subject|7|||
126025365|NCT05510232|453389132|FG002|Overall Study|Withdrawal by Subject|6|||
126025366|NCT05307783|453389139|FG000|Overall Study|Death|7|||
126025367|NCT05307783|453389139|FG000|Overall Study|Lost to Follow-up|4|||
126025368|NCT04883645|453389140|FG000|Overall Study|Death|1|||
126025369|NCT05687903|453389141|FG000|Overall Study|Protocol Deviation|1|||
126025370|NCT05687903|453389142|FG001|Overall Study|Protocol Deviation|1|||
126025371|NCT05687903|453389143|FG002|Overall Study|Protocol Deviation|0|||
126025372|NCT05687903|453389144|FG003|Overall Study|Protocol Deviation|1|||
126025373|NCT05687903|453389145|FG004|Overall Study|Protocol Deviation|0|||
126025374|NCT04855760|453389146|FG000|Overall Study|Adverse Event|21|||
126025375|NCT04855760|453389146|FG000|Overall Study|Withdrawal by Subject|116|||
126025376|NCT04855760|453389146|FG000|Overall Study|Lack of Efficacy|21|||
126025377|NCT04855760|453389146|FG000|Overall Study|Lost to Follow-up|49|||
126025378|NCT04855760|453389146|FG000|Overall Study|Protocol Violation|2|||
126025379|NCT04855760|453389146|FG000|Overall Study|Physician Decision|5|||
126025380|NCT04855760|453389146|FG000|Overall Study|Pregnancy|1|||
126025381|NCT04855760|453389146|FG000|Overall Study|Non-Compliance with Study Drug|11|||
126025382|NCT04855760|453389146|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
126025383|NCT04855760|453389146|FG000|Overall Study|Study Completed by Sponsor|202|||
126025384|NCT04855760|453389146|FG000|Overall Study|Other|13|||
126025385|NCT05613205|453389147|FG000|Overall Study|Lost to Follow-up|0|||
126025386|NCT05613205|453389148|FG001|Overall Study|Lost to Follow-up|0|||
126025387|NCT05613205|453389149|FG002|Overall Study|Lost to Follow-up|1|||
126025388|NCT05613205|453389150|FG003|Overall Study|Lost to Follow-up|1|||
126025389|NCT05613205|453389151|FG004|Overall Study|Lost to Follow-up|0|||
126025390|NCT05613205|453389147|FG000|Overall Study|Withdrawal by Subject|0|||
126025391|NCT05613205|453389148|FG001|Overall Study|Withdrawal by Subject|0|||
126025392|NCT05613205|453389149|FG002|Overall Study|Withdrawal by Subject|1|||
126025393|NCT05613205|453389150|FG003|Overall Study|Withdrawal by Subject|1|||
126025394|NCT05613205|453389151|FG004|Overall Study|Withdrawal by Subject|0|||
126025395|NCT04869982|453389154|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
126025396|NCT04869982|453389155|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
126025397|NCT04869982|453389154|FG000|Overall Study|Migrated / moved from the study area|1|||
126025398|NCT04869982|453389155|FG001|Overall Study|Migrated / moved from the study area|1|||
126025399|NCT04869982|453389154|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
126025400|NCT04869982|453389155|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
126025401|NCT04869982|453389154|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
126025402|NCT04869982|453389155|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
126025403|NCT04869982|453389154|FG000|Overall Study|Solicited adverse event|2|||
126356008|NCT00514917|454595657|FG000|Overall Study|Discontinued due to study closure|88|||
126356009|NCT00514917|454595658|FG001|Overall Study|Discontinued due to study closure|81|||
126356010|NCT00514917|454595657|FG000|Overall Study|Undefined|11|||
126356011|NCT00514917|454595658|FG001|Overall Study|Undefined|5|||
126356012|NCT02697422|454595659|FG000|Overall Study|Declined exit survey|9|||
126356013|NCT02697422|454595660|FG001|Overall Study|Declined exit survey|2|||
126356014|NCT02697422|454595659|FG000|Overall Study|Lost to Follow-up|13|||
126356015|NCT02697422|454595660|FG001|Overall Study|Lost to Follow-up|8|||
126356016|NCT02697422|454595659|FG000|Overall Study|Death|2|||
126356017|NCT02697422|454595660|FG001|Overall Study|Death|1|||
126356018|NCT02697422|454595659|FG000|Overall Study|Withdrawal by Subject|0|||
126356019|NCT02697422|454595660|FG001|Overall Study|Withdrawal by Subject|1|||
126356020|NCT02697422|454595659|FG000|Overall Study|Physician Decision|1|||
126356021|NCT02697422|454595660|FG001|Overall Study|Physician Decision|1|||
126356022|NCT02697422|454595659|FG000|Overall Study|Exit survey data lost|1|||
126356023|NCT02697422|454595660|FG001|Overall Study|Exit survey data lost|0|||
126356024|NCT01873833|454595664|FG000|Overall Study|Withdrawal by Subject|1|||
126356025|NCT03983109|454595667|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
126356026|NCT03983109|454595668|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
126356027|NCT02068599|454595669|FG000|Overall Study|Adverse Event|4|||
126356028|NCT02068599|454595670|FG001|Overall Study|Adverse Event|1|||
126356029|NCT02068599|454595671|FG002|Overall Study|Adverse Event|1|||
126356030|NCT02068599|454595669|FG000|Overall Study|Withdrawal by Subject|2|||
126356031|NCT02068599|454595670|FG001|Overall Study|Withdrawal by Subject|7|||
126356032|NCT02068599|454595671|FG002|Overall Study|Withdrawal by Subject|5|||
126356033|NCT02068599|454595669|FG000|Overall Study|Protocol Violation|4|||
126356034|NCT02068599|454595670|FG001|Overall Study|Protocol Violation|2|||
126356035|NCT02068599|454595671|FG002|Overall Study|Protocol Violation|3|||
126356036|NCT02068599|454595669|FG000|Overall Study|Lost to Follow-up|1|||
126356037|NCT02068599|454595670|FG001|Overall Study|Lost to Follow-up|0|||
126356038|NCT02068599|454595671|FG002|Overall Study|Lost to Follow-up|0|||
126356039|NCT02068599|454595669|FG000|Overall Study|Lack of Efficacy|0|||
126356040|NCT02068599|454595670|FG001|Overall Study|Lack of Efficacy|0|||
126356041|NCT02068599|454595671|FG002|Overall Study|Lack of Efficacy|3|||
126356042|NCT02068599|454595669|FG000|Overall Study|Noncompliance|0|||
126356043|NCT02068599|454595670|FG001|Overall Study|Noncompliance|0|||
126356044|NCT02068599|454595671|FG002|Overall Study|Noncompliance|1|||
126356045|NCT01871727|454595674|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
126356046|NCT01871727|454595675|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
126356047|NCT01871727|454595676|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
126025404|NCT04869982|453389155|FG001|Overall Study|Solicited adverse event|1|||
126025405|NCT04112316|453389157|FG000|First Period (8 Weeks)|Protocol Violation|1|||
126025406|NCT04112316|453389158|FG001|First Period (8 Weeks)|Protocol Violation|0|||
126025407|NCT04112316|453389157|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
126025408|NCT04112316|453389158|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
126356048|NCT01871727|454595677|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
126356049|NCT01871727|454595678|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
126356050|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
126356051|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
126356052|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
126356053|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
126356054|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
126356055|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
126093492|NCT00734591|453636075|FG000|Prospective Period|Lost to Follow-up|37|||
126093493|NCT00734591|453636076|FG001|Prospective Period|Lost to Follow-up|33|||
126093494|NCT00734591|453636075|FG000|Prospective Period|Study Terminated|1|||
126093495|NCT00734591|453636076|FG001|Prospective Period|Study Terminated|0|||
126093496|NCT00734591|453636075|FG000|Prospective Period|Other|2|||
126093497|NCT00734591|453636076|FG001|Prospective Period|Other|2|||
126093498|NCT01072630|453636085|FG000|Overall Study|Adverse Event|11|||
126093499|NCT01072630|453636086|FG001|Overall Study|Adverse Event|19|||
126093500|NCT01072630|453636087|FG002|Overall Study|Adverse Event|2|||
126093501|NCT01072630|453636085|FG000|Overall Study|Lack of Efficacy|10|||
126093502|NCT01072630|453636086|FG001|Overall Study|Lack of Efficacy|10|||
126093503|NCT01072630|453636087|FG002|Overall Study|Lack of Efficacy|1|||
126093504|NCT01072630|453636085|FG000|Overall Study|Withdrawal by Subject|8|||
126093505|NCT01072630|453636086|FG001|Overall Study|Withdrawal by Subject|7|||
126093506|NCT01072630|453636087|FG002|Overall Study|Withdrawal by Subject|2|||
126093507|NCT01072630|453636085|FG000|Overall Study|Protocol Violation|10|||
126093508|NCT01072630|453636086|FG001|Overall Study|Protocol Violation|8|||
126093509|NCT01072630|453636087|FG002|Overall Study|Protocol Violation|4|||
126093510|NCT01072630|453636085|FG000|Overall Study|Lost to Follow-up|11|||
126093511|NCT01072630|453636086|FG001|Overall Study|Lost to Follow-up|11|||
126093512|NCT01072630|453636087|FG002|Overall Study|Lost to Follow-up|1|||
126093513|NCT01072630|453636085|FG000|Overall Study|Noncompliance with study medication|1|||
126093514|NCT01072630|453636086|FG001|Overall Study|Noncompliance with study medication|1|||
126093515|NCT01072630|453636087|FG002|Overall Study|Noncompliance with study medication|1|||
126093516|NCT01072630|453636085|FG000|Overall Study|Noncompliance with study procedures|1|||
126093517|NCT01072630|453636086|FG001|Overall Study|Noncompliance with study procedures|2|||
126093518|NCT01072630|453636087|FG002|Overall Study|Noncompliance with study procedures|1|||
126093519|NCT01072630|453636085|FG000|Overall Study|Other|3|||
126236478|NCT01918397|454158597|FG003|Overall Study|Pregnancy|0|||
126025409|NCT03857620|453389159|FG000|Overall Study|Death|4|||
126356056|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
126025410|NCT03857620|453389160|FG001|Overall Study|Death|5|||
126025411|NCT03857620|453389161|FG002|Overall Study|Death|7|||
126025412|NCT03857620|453389159|FG000|Overall Study|Lost to Follow-up|2|||
126025413|NCT03857620|453389160|FG001|Overall Study|Lost to Follow-up|5|||
126025414|NCT03857620|453389161|FG002|Overall Study|Lost to Follow-up|3|||
126025415|NCT03857620|453389159|FG000|Overall Study|Disease progression or relapse after study registration|1|||
126025416|NCT03857620|453389160|FG001|Overall Study|Disease progression or relapse after study registration|5|||
126356057|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
126356058|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
126356059|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
126356060|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
126356061|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
126356062|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
126356063|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
126356064|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
126356065|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
126356066|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
126356067|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
126356068|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
126356069|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
126356070|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
126356071|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
126356072|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
126356073|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
126356074|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
126356075|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
126356076|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
126356077|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
126356078|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
126356079|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
126025417|NCT03857620|453389161|FG002|Overall Study|Disease progression or relapse after study registration|1|||
126025418|NCT03857620|453389159|FG000|Overall Study|Ineligible|5|||
126025419|NCT03857620|453389160|FG001|Overall Study|Ineligible|0|||
126025420|NCT03857620|453389161|FG002|Overall Study|Ineligible|2|||
126093520|NCT01072630|453636086|FG001|Overall Study|Other|2|||
126093521|NCT01072630|453636087|FG002|Overall Study|Other|1|||
126093522|NCT00338962|453636088|FG000|Overall Study|Lost to Follow-up|3|||
126093523|NCT00338962|453636089|FG001|Overall Study|Lost to Follow-up|3|||
126093524|NCT00338962|453636090|FG002|Overall Study|Lost to Follow-up|2|||
126236479|NCT01918397|454158594|FG000|Overall Study|Rifampin susceptible|0|||
126356080|NCT00309244|454595679|FG000|Overall Study|Adverse Event|29|||
126356081|NCT00309244|454595680|FG001|Overall Study|Adverse Event|12|||
126025421|NCT03857620|453389159|FG000|Overall Study|No malignancy|1|||
126025422|NCT03857620|453389160|FG001|Overall Study|No malignancy|0|||
126025423|NCT03857620|453389161|FG002|Overall Study|No malignancy|1|||
126025424|NCT03857620|453389159|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
126025425|NCT03857620|453389160|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
126025426|NCT03857620|453389161|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
126025427|NCT03857620|453389159|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
126025428|NCT03857620|453389160|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
126025429|NCT03857620|453389161|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
126025430|NCT03857620|453389159|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
126025431|NCT03857620|453389160|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
126025432|NCT03857620|453389161|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
126025433|NCT03857620|453389159|FG000|Overall Study|Surgery not performed, patient decision|0|||
126025434|NCT03857620|453389160|FG001|Overall Study|Surgery not performed, patient decision|3|||
126025435|NCT03857620|453389161|FG002|Overall Study|Surgery not performed, patient decision|1|||
126236480|NCT01918397|454158595|FG001|Overall Study|Rifampin susceptible|0|||
126236481|NCT01918397|454158596|FG002|Overall Study|Rifampin susceptible|0|||
126236482|NCT01918397|454158597|FG003|Overall Study|Rifampin susceptible|2|||
126236483|NCT01918397|454158594|FG000|Overall Study|Treatment failure|0|||
126025436|NCT03857620|453389159|FG000|Overall Study|Surgery not performed, other reason|3|||
126025437|NCT03857620|453389160|FG001|Overall Study|Surgery not performed, other reason|1|||
126025438|NCT03857620|453389161|FG002|Overall Study|Surgery not performed, other reason|4|||
126025439|NCT03857620|453389159|FG000|Overall Study|Worsening performance status after surgery performed|0|||
126025440|NCT03857620|453389160|FG001|Overall Study|Worsening performance status after surgery performed|1|||
126025441|NCT03857620|453389161|FG002|Overall Study|Worsening performance status after surgery performed|1|||
126025442|NCT02473250|453389162|FG000|Overall Study|Lost to Follow-up|10|||
126025443|NCT02473250|453389162|FG000|Overall Study|Physician Decision|5|||
126025444|NCT02473250|453389162|FG000|Overall Study|Did not tolerate medication washout|3|||
126025445|NCT02473250|453389162|FG000|Overall Study|Antidepressant effect of divalproex|2|||
126236484|NCT01918397|454158595|FG001|Overall Study|Treatment failure|0|||
126236485|NCT01918397|454158596|FG002|Overall Study|Treatment failure|0|||
126236486|NCT01918397|454158597|FG003|Overall Study|Treatment failure|1|||
126236487|NCT01918397|454158594|FG000|Overall Study|Withdrawal by Subject|3|||
126236488|NCT01918397|454158595|FG001|Overall Study|Withdrawal by Subject|2|||
126236489|NCT01918397|454158596|FG002|Overall Study|Withdrawal by Subject|1|||
126236490|NCT01918397|454158597|FG003|Overall Study|Withdrawal by Subject|1|||
126236491|NCT01918397|454158594|FG000|Overall Study|XDR at baseline|0|||
126236492|NCT01918397|454158595|FG001|Overall Study|XDR at baseline|0|||
126356082|NCT00309244|454595679|FG000|Overall Study|Lost to Follow-up|6|||
126356083|NCT00309244|454595680|FG001|Overall Study|Lost to Follow-up|22|||
126356084|NCT00309244|454595679|FG000|Overall Study|Physician Decision|5|||
126356085|NCT00309244|454595680|FG001|Overall Study|Physician Decision|8|||
126356086|NCT00309244|454595679|FG000|Overall Study|Protocol Violation|6|||
126356087|NCT00309244|454595680|FG001|Overall Study|Protocol Violation|3|||
126356088|NCT00309244|454595679|FG000|Overall Study|Withdrawal by Subject|50|||
126356089|NCT00309244|454595680|FG001|Overall Study|Withdrawal by Subject|32|||
126356090|NCT00309244|454595679|FG000|Overall Study|Various|7|||
126356091|NCT00309244|454595680|FG001|Overall Study|Various|7|||
126356092|NCT00309244|454595679|FG000|Overall Study|Randomized but not dosed|11|||
126356093|NCT00309244|454595680|FG001|Overall Study|Randomized but not dosed|12|||
126356094|NCT00309244|454595679|FG000|Overall Study|Death|4|||
126356095|NCT00309244|454595680|FG001|Overall Study|Death|1|||
126356096|NCT01263028|454595681|FG000|Overall Study|Withdrawal by Subject|1|||
126356097|NCT01263028|454595681|FG000|Overall Study|Adverse Event|1|||
126356098|NCT01263028|454595681|FG000|Overall Study|Study terminated due to low enrollment.|4|||
126356099|NCT00356421|454595682|FG000|Overall Study|Lack of Efficacy|3|||
126356100|NCT00356421|454595683|FG001|Overall Study|Lack of Efficacy|0|||
126356101|NCT00356421|454595682|FG000|Overall Study|Withdrawal by Subject|9|||
126356102|NCT00356421|454595683|FG001|Overall Study|Withdrawal by Subject|2|||
126356103|NCT00356421|454595682|FG000|Overall Study|Related to study drug|15|||
126356104|NCT00356421|454595683|FG001|Overall Study|Related to study drug|12|||
126356105|NCT00356421|454595682|FG000|Overall Study|Not related to study drug|5|||
126236493|NCT01918397|454158596|FG002|Overall Study|XDR at baseline|1|||
126236494|NCT01918397|454158597|FG003|Overall Study|XDR at baseline|0|||
126356106|NCT00356421|454595683|FG001|Overall Study|Not related to study drug|3|||
126356107|NCT03019588|454595684|FG000|Overall Study|Death|44|||
126356108|NCT03019588|454595685|FG001|Overall Study|Death|46|||
126356109|NCT03019588|454595684|FG000|Overall Study|Study terminated by Sponsor|3|||
126356110|NCT03019588|454595685|FG001|Overall Study|Study terminated by Sponsor|1|||
126356111|NCT00501085|454595686|FG000|Overall Study|Lost to Follow-up|195|||
126356112|NCT00501085|454595686|FG000|Overall Study|Withdrawal by Subject|34|||
126093525|NCT00338962|453636091|FG003|Overall Study|Lost to Follow-up|3|||
126093526|NCT00338962|453636088|FG000|Overall Study|Withdrawal by Subject|1|||
126093527|NCT00338962|453636089|FG001|Overall Study|Withdrawal by Subject|0|||
126093528|NCT00338962|453636090|FG002|Overall Study|Withdrawal by Subject|0|||
126093529|NCT00338962|453636091|FG003|Overall Study|Withdrawal by Subject|0|||
126093530|NCT00338962|453636088|FG000|Overall Study|No Transportation|2|||
126093531|NCT00338962|453636089|FG001|Overall Study|No Transportation|0|||
126093532|NCT00338962|453636090|FG002|Overall Study|No Transportation|0|||
126093533|NCT00338962|453636091|FG003|Overall Study|No Transportation|0|||
126093534|NCT00338962|453636088|FG000|Overall Study|Time Constraint|2|||
126093535|NCT00338962|453636089|FG001|Overall Study|Time Constraint|0|||
126093536|NCT00338962|453636090|FG002|Overall Study|Time Constraint|0|||
126093537|NCT00338962|453636091|FG003|Overall Study|Time Constraint|0|||
126093538|NCT00338962|453636088|FG000|Overall Study|Moved|0|||
126093539|NCT00338962|453636089|FG001|Overall Study|Moved|1|||
126093540|NCT00338962|453636090|FG002|Overall Study|Moved|0|||
126093541|NCT00338962|453636091|FG003|Overall Study|Moved|0|||
126093542|NCT00338962|453636088|FG000|Overall Study|Adverse Event|0|||
126093543|NCT00338962|453636089|FG001|Overall Study|Adverse Event|0|||
126093544|NCT00338962|453636090|FG002|Overall Study|Adverse Event|2|||
126093545|NCT00338962|453636091|FG003|Overall Study|Adverse Event|0|||
126093546|NCT00338962|453636088|FG000|Overall Study|Poor Compliance|0|||
126093547|NCT00338962|453636089|FG001|Overall Study|Poor Compliance|0|||
126093548|NCT00338962|453636090|FG002|Overall Study|Poor Compliance|2|||
126093549|NCT00338962|453636091|FG003|Overall Study|Poor Compliance|0|||
126093550|NCT03214640|453636092|FG000|Overall Study|Protocol Violation|1|||
126093551|NCT03214640|453636093|FG001|Overall Study|Protocol Violation|2|||
126093552|NCT03214640|453636094|FG002|Overall Study|Protocol Violation|1|||
126093553|NCT03214640|453636095|FG003|Overall Study|Protocol Violation|4|||
126093554|NCT00910039|453636096|FG000|Overall Study|Physician Decision|1|||
126093555|NCT03547739|453636104|FG000|Overall Study|Death|0|||
126093556|NCT03547739|453636105|FG001|Overall Study|Death|1|||
126093557|NCT03547739|453636106|FG002|Overall Study|Death|5|||
126093558|NCT03547739|453636104|FG000|Overall Study|Adverse Event|24|||
126093559|NCT03547739|453636105|FG001|Overall Study|Adverse Event|11|||
126093560|NCT03547739|453636106|FG002|Overall Study|Adverse Event|13|||
126093561|NCT03547739|453636104|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
126093562|NCT03547739|453636105|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
126093563|NCT03547739|453636106|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
126093564|NCT03547739|453636104|FG000|Overall Study|Lost to Follow-up|80|||
126093565|NCT03547739|453636105|FG001|Overall Study|Lost to Follow-up|84|||
126093566|NCT03547739|453636106|FG002|Overall Study|Lost to Follow-up|116|||
126093567|NCT04035499|453636109|FG000|Overall Study|Death|2|||
126093568|NCT04035499|453636109|FG000|Overall Study|Withdrawal by Subject|1|||
126093569|NCT02003222|453636110|FG000|Induction|Never started treatment|0|||
126093570|NCT02003222|453636111|FG001|Induction|Never started treatment|0|||
126093571|NCT02003222|453636112|FG002|Induction|Never started treatment|0|||
126093572|NCT02003222|453636113|FG003|Induction|Never started treatment|0|||
126093573|NCT02003222|453636114|FG004|Induction|Never started treatment|8|||
126093574|NCT02003222|453636110|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
126093575|NCT02003222|453636111|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
126093576|NCT02003222|453636112|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
126093577|NCT02003222|453636113|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
126093578|NCT02003222|453636114|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
126093579|NCT02003222|453636110|FG000|Induction|Adverse Event|0|||
126093580|NCT02003222|453636111|FG001|Induction|Adverse Event|0|||
126093581|NCT02003222|453636112|FG002|Induction|Adverse Event|0|||
126093582|NCT02003222|453636113|FG003|Induction|Adverse Event|0|||
126093583|NCT02003222|453636114|FG004|Induction|Adverse Event|13|||
126093584|NCT02003222|453636110|FG000|Induction|Alternative therapy|0|||
126093585|NCT02003222|453636111|FG001|Induction|Alternative therapy|0|||
126236495|NCT01918397|454158594|FG000|Overall Study|Lost to Follow-up|2|||
126236496|NCT01918397|454158595|FG001|Overall Study|Lost to Follow-up|1|||
126236497|NCT01918397|454158596|FG002|Overall Study|Lost to Follow-up|1|||
126236498|NCT01918397|454158597|FG003|Overall Study|Lost to Follow-up|1|||
126236499|NCT01918397|454158594|FG000|Overall Study|Increased QTc|1|||
126236500|NCT01918397|454158595|FG001|Overall Study|Increased QTc|0|||
126236501|NCT01918397|454158596|FG002|Overall Study|Increased QTc|0|||
126236502|NCT01918397|454158597|FG003|Overall Study|Increased QTc|1|||
126236503|NCT01918397|454158594|FG000|Overall Study|Death|0|||
126236504|NCT01918397|454158595|FG001|Overall Study|Death|0|||
126236505|NCT01918397|454158596|FG002|Overall Study|Death|1|||
126236506|NCT01918397|454158597|FG003|Overall Study|Death|0|||
126236507|NCT01918397|454158594|FG000|Overall Study|Involved in another investigative trial|0|||
126236508|NCT01918397|454158595|FG001|Overall Study|Involved in another investigative trial|0|||
126236509|NCT01918397|454158596|FG002|Overall Study|Involved in another investigative trial|0|||
126236510|NCT01918397|454158597|FG003|Overall Study|Involved in another investigative trial|1|||
126236511|NCT00864097|454158598|FG000|Overall Study|Death|0|||
126236512|NCT00864097|454158599|FG001|Overall Study|Death|1|||
126236513|NCT00864097|454158600|FG002|Overall Study|Death|0|||
126236514|NCT00864097|454158601|FG003|Overall Study|Death|0|||
126236515|NCT00864097|454158598|FG000|Overall Study|Adverse Event|6|||
126236516|NCT00864097|454158599|FG001|Overall Study|Adverse Event|8|||
126236517|NCT00864097|454158600|FG002|Overall Study|Adverse Event|11|||
126236518|NCT00864097|454158601|FG003|Overall Study|Adverse Event|9|||
126236519|NCT00864097|454158598|FG000|Overall Study|Lack of Efficacy|9|||
126236520|NCT00864097|454158599|FG001|Overall Study|Lack of Efficacy|3|||
126236521|NCT00864097|454158600|FG002|Overall Study|Lack of Efficacy|7|||
126236522|NCT00864097|454158601|FG003|Overall Study|Lack of Efficacy|2|||
126236523|NCT00864097|454158598|FG000|Overall Study|Lost to Follow-up|0|||
126236524|NCT00864097|454158599|FG001|Overall Study|Lost to Follow-up|1|||
126236525|NCT00864097|454158600|FG002|Overall Study|Lost to Follow-up|0|||
126236526|NCT00864097|454158601|FG003|Overall Study|Lost to Follow-up|1|||
126236527|NCT00864097|454158598|FG000|Overall Study|Withdrawal by Subject|15|||
126236528|NCT00864097|454158599|FG001|Overall Study|Withdrawal by Subject|11|||
126236529|NCT00864097|454158600|FG002|Overall Study|Withdrawal by Subject|11|||
126236530|NCT00864097|454158601|FG003|Overall Study|Withdrawal by Subject|12|||
126236531|NCT00864097|454158598|FG000|Overall Study|Protocol Violation|2|||
126236532|NCT00864097|454158599|FG001|Overall Study|Protocol Violation|1|||
126236533|NCT00864097|454158600|FG002|Overall Study|Protocol Violation|0|||
126236534|NCT00864097|454158601|FG003|Overall Study|Protocol Violation|1|||
126236535|NCT00864097|454158598|FG000|Overall Study|Terminated by sponsor|105|||
126236536|NCT00864097|454158599|FG001|Overall Study|Terminated by sponsor|112|||
126236537|NCT00864097|454158600|FG002|Overall Study|Terminated by sponsor|102|||
126236538|NCT00864097|454158601|FG003|Overall Study|Terminated by sponsor|99|||
126236539|NCT00864097|454158598|FG000|Overall Study|Randomized but not treated|2|||
126236540|NCT00864097|454158599|FG001|Overall Study|Randomized but not treated|0|||
126236541|NCT00864097|454158600|FG002|Overall Study|Randomized but not treated|1|||
126236542|NCT00864097|454158601|FG003|Overall Study|Randomized but not treated|0|||
126236543|NCT00864097|454158598|FG000|Overall Study|Other|0|||
126236544|NCT00864097|454158599|FG001|Overall Study|Other|0|||
126236545|NCT00864097|454158600|FG002|Overall Study|Other|0|||
126236546|NCT00864097|454158601|FG003|Overall Study|Other|1|||
126236547|NCT00620022|454158602|FG000|Treatment Period 1|Adverse Event|4|||
126236548|NCT00620022|454158603|FG001|Treatment Period 1|Adverse Event|6|||
126236549|NCT00620022|454158602|FG000|Treatment Period 1|Subject withdrew consent|1|||
126236550|NCT00620022|454158603|FG001|Treatment Period 1|Subject withdrew consent|0|||
126236551|NCT00620022|454158602|FG000|Treatment Period 2|Adverse Event|2|||
126236552|NCT00620022|454158603|FG001|Treatment Period 2|Adverse Event|2|||
126236553|NCT00262223|454158607|FG000|Treatment Phase|Withdrawal by Subject|3|||
126236554|NCT00262223|454158608|FG001|Treatment Phase|Withdrawal by Subject|6|||
126236555|NCT00262223|454158607|FG000|Treatment Phase|Adverse Event|1|||
126236556|NCT00262223|454158608|FG001|Treatment Phase|Adverse Event|2|||
126236557|NCT00262223|454158607|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
126236558|NCT00262223|454158608|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
126236559|NCT00262223|454158607|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
126236560|NCT00262223|454158608|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
126236561|NCT00262223|454158607|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
126236562|NCT00262223|454158608|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
126236563|NCT01804270|454158611|FG000|Overall Study|Withdrawal by Subject|1|||
126236564|NCT01804270|454158612|FG001|Overall Study|Withdrawal by Subject|1|||
126236565|NCT01328093|454158616|FG000|Double-Blind Phase|Adverse Event|78|||
126236566|NCT01328093|454158617|FG001|Double-Blind Phase|Adverse Event|15|||
126236567|NCT01328093|454158616|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
126236568|NCT01328093|454158617|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
126236569|NCT01328093|454158616|FG000|Double-Blind Phase|Lost to Follow-up|39|||
126236570|NCT01328093|454158617|FG001|Double-Blind Phase|Lost to Follow-up|14|||
126236571|NCT01328093|454158616|FG000|Double-Blind Phase|Protocol Violation|30|||
126236572|NCT01328093|454158617|FG001|Double-Blind Phase|Protocol Violation|10|||
126236573|NCT01328093|454158616|FG000|Double-Blind Phase|Lack of Efficacy|55|||
126236574|NCT01328093|454158617|FG001|Double-Blind Phase|Lack of Efficacy|13|||
126236575|NCT01328093|454158616|FG000|Double-Blind Phase|Sponsor Decision|17|||
126236576|NCT01328093|454158617|FG001|Double-Blind Phase|Sponsor Decision|3|||
126236577|NCT01328093|454158616|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
126236578|NCT01328093|454158617|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
126236579|NCT01328093|454158616|FG000|Double-Blind Phase|Scheduling conflict|8|||
126236580|NCT01328093|454158617|FG001|Double-Blind Phase|Scheduling conflict|3|||
126236581|NCT01328093|454158616|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
126236582|NCT01328093|454158617|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
126236583|NCT01328093|454158616|FG000|Double-Blind Phase|Death|1|||
126236584|NCT01328093|454158617|FG001|Double-Blind Phase|Death|0|||
126236585|NCT01328093|454158616|FG000|Open-Label Phase|Sponsor Decision|98|||
126236586|NCT01328093|454158617|FG001|Open-Label Phase|Sponsor Decision|34|||
126236587|NCT01328093|454158616|FG000|Open-Label Phase|Protocol Violation|8|||
126236588|NCT01328093|454158617|FG001|Open-Label Phase|Protocol Violation|3|||
126236589|NCT01328093|454158616|FG000|Open-Label Phase|Lost to Follow-up|10|||
126236590|NCT01328093|454158617|FG001|Open-Label Phase|Lost to Follow-up|1|||
126236591|NCT01328093|454158616|FG000|Open-Label Phase|Adverse Event|10|||
126236592|NCT01328093|454158617|FG001|Open-Label Phase|Adverse Event|4|||
126236593|NCT01328093|454158616|FG000|Open-Label Phase|Lack of Efficacy|5|||
126236594|NCT01328093|454158617|FG001|Open-Label Phase|Lack of Efficacy|6|||
126236595|NCT01328093|454158616|FG000|Open-Label Phase|Withdrawal by Subject|4|||
126236596|NCT01328093|454158617|FG001|Open-Label Phase|Withdrawal by Subject|1|||
126236597|NCT01328093|454158616|FG000|Open-Label Phase|Scheduling conflict|2|||
126236598|NCT01328093|454158617|FG001|Open-Label Phase|Scheduling conflict|1|||
126236599|NCT01328093|454158616|FG000|Open-Label Phase|Subject is moving or has moved|2|||
126236600|NCT01328093|454158617|FG001|Open-Label Phase|Subject is moving or has moved|0|||
126236601|NCT01328093|454158616|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
126236602|NCT01328093|454158617|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
126236603|NCT05150964|454158620|FG000|Overall Study|Lost to Follow-up|2|||
126236604|NCT03661528|454158621|FG000|Overall Study|Death|1|||
126236605|NCT03661528|454158622|FG001|Overall Study|Death|0|||
126236606|NCT03661528|454158621|FG000|Overall Study|Physician Decision|3|||
126236607|NCT03661528|454158622|FG001|Overall Study|Physician Decision|1|||
126236608|NCT03661528|454158621|FG000|Overall Study|Other than Specified|5|||
126236609|NCT03661528|454158622|FG001|Overall Study|Other than Specified|2|||
126236610|NCT03661528|454158621|FG000|Overall Study|Withdrawal by Subject|5|||
126236611|NCT03661528|454158622|FG001|Overall Study|Withdrawal by Subject|3|||
126236612|NCT03661528|454158621|FG000|Overall Study|Disease Progression|8|||
126236613|NCT03661528|454158622|FG001|Overall Study|Disease Progression|13|||
126236614|NCT03661528|454158621|FG000|Overall Study|Adverse Event|61|||
126236615|NCT03661528|454158622|FG001|Overall Study|Adverse Event|55|||
126236616|NCT02178722|454158623|FG000|Overall Study|Withdrawal by Subject|0|||
126236617|NCT02178722|454158624|FG001|Overall Study|Withdrawal by Subject|0|||
126236618|NCT02178722|454158625|FG002|Overall Study|Withdrawal by Subject|0|||
126236619|NCT02178722|454158626|FG003|Overall Study|Withdrawal by Subject|2|||
126236620|NCT02178722|454158627|FG004|Overall Study|Withdrawal by Subject|33|||
126236621|NCT02178722|454158623|FG000|Overall Study|Death|2|||
126025446|NCT01898494|453389180|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
126025447|NCT01898494|453389181|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
126025448|NCT01898494|453389182|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
126025449|NCT01898494|453389183|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
126025450|NCT01898494|453389184|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
126025451|NCT01898494|453389180|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
126025452|NCT01898494|453389181|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
126025453|NCT01898494|453389182|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
126025454|NCT01898494|453389183|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
126025455|NCT01898494|453389184|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
126025456|NCT01898494|453389180|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
126025457|NCT01898494|453389181|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
126025458|NCT01898494|453389182|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
126025459|NCT01898494|453389183|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
126025460|NCT01898494|453389184|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
126025461|NCT01898494|453389180|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
126025462|NCT01898494|453389181|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
126025463|NCT01898494|453389182|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
126025464|NCT01898494|453389183|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
126025465|NCT01898494|453389184|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
126025466|NCT01898494|453389180|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
126025467|NCT01898494|453389181|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
126025468|NCT01898494|453389182|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
126025469|NCT01898494|453389183|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
126025470|NCT01898494|453389184|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
126025471|NCT01898494|453389180|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
126025472|NCT01898494|453389181|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
126025473|NCT01898494|453389182|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
126025474|NCT01898494|453389183|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
126025475|NCT01898494|453389184|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
126025476|NCT01898494|453389180|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
126025477|NCT01898494|453389181|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
126025478|NCT01898494|453389182|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
126025479|NCT01898494|453389183|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
126025480|NCT01898494|453389184|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
126025481|NCT01898494|453389180|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
126025482|NCT01898494|453389181|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
126025483|NCT01898494|453389182|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
126025484|NCT01898494|453389183|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
126025485|NCT01898494|453389184|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
126025486|NCT01898494|453389180|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
126025487|NCT01898494|453389181|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
126025488|NCT01898494|453389182|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
126025489|NCT01898494|453389183|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
126025490|NCT01898494|453389184|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
126025491|NCT01898494|453389180|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
126025492|NCT01898494|453389181|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
126025493|NCT01898494|453389182|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
126025494|NCT01898494|453389183|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
126025495|NCT01898494|453389184|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
126025496|NCT01898494|453389180|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
126025497|NCT01898494|453389181|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
126025498|NCT01898494|453389182|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
126025499|NCT01898494|453389183|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
126025500|NCT01898494|453389184|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
126025501|NCT01898494|453389180|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
126025502|NCT01898494|453389181|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
126025503|NCT01898494|453389182|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
126025504|NCT01898494|453389183|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
126025505|NCT01898494|453389184|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
126025506|NCT01898494|453389180|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
126025507|NCT01898494|453389181|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
126025508|NCT01898494|453389182|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
126093586|NCT02003222|453636112|FG002|Induction|Alternative therapy|0|||
126236622|NCT02178722|454158624|FG001|Overall Study|Death|13|||
126236623|NCT02178722|454158625|FG002|Overall Study|Death|12|||
126236624|NCT02178722|454158626|FG003|Overall Study|Death|12|||
126236625|NCT02178722|454158627|FG004|Overall Study|Death|205|||
126236626|NCT02178722|454158623|FG000|Overall Study|Lost to Follow-up|0|||
126236627|NCT02178722|454158624|FG001|Overall Study|Lost to Follow-up|0|||
126236628|NCT02178722|454158625|FG002|Overall Study|Lost to Follow-up|0|||
126236629|NCT02178722|454158626|FG003|Overall Study|Lost to Follow-up|2|||
126236630|NCT02178722|454158627|FG004|Overall Study|Lost to Follow-up|11|||
126236631|NCT02178722|454158623|FG000|Overall Study|Study terminated by Sponsor|2|||
126236632|NCT02178722|454158624|FG001|Overall Study|Study terminated by Sponsor|7|||
126236633|NCT02178722|454158625|FG002|Overall Study|Study terminated by Sponsor|6|||
126236634|NCT02178722|454158626|FG003|Overall Study|Study terminated by Sponsor|4|||
126236635|NCT02178722|454158627|FG004|Overall Study|Study terminated by Sponsor|128|||
126236636|NCT02178722|454158623|FG000|Overall Study|Physician Decision|0|||
126236637|NCT02178722|454158624|FG001|Overall Study|Physician Decision|0|||
126236638|NCT02178722|454158625|FG002|Overall Study|Physician Decision|0|||
126236639|NCT02178722|454158626|FG003|Overall Study|Physician Decision|0|||
126236640|NCT02178722|454158627|FG004|Overall Study|Physician Decision|3|||
126236641|NCT02178722|454158623|FG000|Overall Study|Other|0|||
126236642|NCT02178722|454158624|FG001|Overall Study|Other|0|||
126236643|NCT02178722|454158625|FG002|Overall Study|Other|0|||
126236644|NCT02178722|454158626|FG003|Overall Study|Other|0|||
126236645|NCT02178722|454158627|FG004|Overall Study|Other|2|||
126236646|NCT03553823|454158628|FG000|Overall Study|Physician Decision|0|||
126236647|NCT03553823|454158629|FG001|Overall Study|Physician Decision|1|||
126236648|NCT03340727|454158630|FG000|Overall Study|Death|1|||
126236649|NCT03340727|454158631|FG001|Overall Study|Death|0|||
126236650|NCT03340727|454158630|FG000|Overall Study|Lost to Follow-up|31|||
126236651|NCT03340727|454158631|FG001|Overall Study|Lost to Follow-up|35|||
126236652|NCT03340727|454158630|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
126236653|NCT03340727|454158631|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
126236654|NCT03340727|454158630|FG000|Overall Study|Transferred to another facility|10|||
126236655|NCT03340727|454158631|FG001|Overall Study|Transferred to another facility|7|||
126236656|NCT03340727|454158630|FG000|Overall Study|Withdrawal by Subject|28|||
126236657|NCT03340727|454158631|FG001|Overall Study|Withdrawal by Subject|17|||
126236658|NCT03991494|454158646|FG000|Overall Study|Progressive Disease|4|||
126236659|NCT03125200|454158652|FG000|Overall Study|Study Termination|0|||
126236660|NCT03125200|454158653|FG001|Overall Study|Study Termination|0|||
126236661|NCT03125200|454158654|FG002|Overall Study|Study Termination|0|||
126236662|NCT03125200|454158655|FG003|Overall Study|Study Termination|1|||
126236663|NCT03125200|454158656|FG004|Overall Study|Study Termination|1|||
126236664|NCT03125200|454158657|FG005|Overall Study|Study Termination|2|||
126236665|NCT03125200|454158658|FG006|Overall Study|Study Termination|1|||
126236666|NCT03125200|454158652|FG000|Overall Study|Clinical Progression|0|||
126236667|NCT03125200|454158653|FG001|Overall Study|Clinical Progression|0|||
126236668|NCT03125200|454158654|FG002|Overall Study|Clinical Progression|0|||
126236669|NCT03125200|454158655|FG003|Overall Study|Clinical Progression|1|||
126236670|NCT03125200|454158656|FG004|Overall Study|Clinical Progression|0|||
126236671|NCT03125200|454158657|FG005|Overall Study|Clinical Progression|1|||
126236672|NCT03125200|454158658|FG006|Overall Study|Clinical Progression|0|||
126236673|NCT03125200|454158652|FG000|Overall Study|Progressive Disease|2|||
126236674|NCT03125200|454158653|FG001|Overall Study|Progressive Disease|1|||
126236675|NCT03125200|454158654|FG002|Overall Study|Progressive Disease|2|||
126236676|NCT03125200|454158655|FG003|Overall Study|Progressive Disease|1|||
126236677|NCT03125200|454158656|FG004|Overall Study|Progressive Disease|2|||
126236678|NCT03125200|454158657|FG005|Overall Study|Progressive Disease|0|||
126236679|NCT03125200|454158658|FG006|Overall Study|Progressive Disease|1|||
126236680|NCT03125200|454158652|FG000|Overall Study|Lack of Efficacy|0|||
126236681|NCT03125200|454158653|FG001|Overall Study|Lack of Efficacy|0|||
126236682|NCT03125200|454158654|FG002|Overall Study|Lack of Efficacy|0|||
126236683|NCT03125200|454158655|FG003|Overall Study|Lack of Efficacy|1|||
126236684|NCT03125200|454158656|FG004|Overall Study|Lack of Efficacy|0|||
126236685|NCT03125200|454158657|FG005|Overall Study|Lack of Efficacy|0|||
126236686|NCT03125200|454158658|FG006|Overall Study|Lack of Efficacy|0|||
126236687|NCT03125200|454158652|FG000|Overall Study|Toxicity|0|||
126236688|NCT03125200|454158653|FG001|Overall Study|Toxicity|0|||
126236689|NCT03125200|454158654|FG002|Overall Study|Toxicity|0|||
126236690|NCT03125200|454158655|FG003|Overall Study|Toxicity|1|||
126236691|NCT03125200|454158656|FG004|Overall Study|Toxicity|0|||
126236692|NCT03125200|454158657|FG005|Overall Study|Toxicity|0|||
126236693|NCT03125200|454158658|FG006|Overall Study|Toxicity|0|||
126236694|NCT03125200|454158652|FG000|Overall Study|Consent Withdrawn by Subject|0|||
126236695|NCT03125200|454158653|FG001|Overall Study|Consent Withdrawn by Subject|1|||
126236696|NCT03125200|454158654|FG002|Overall Study|Consent Withdrawn by Subject|0|||
126236697|NCT03125200|454158655|FG003|Overall Study|Consent Withdrawn by Subject|0|||
126236698|NCT03125200|454158656|FG004|Overall Study|Consent Withdrawn by Subject|1|||
126236699|NCT03125200|454158657|FG005|Overall Study|Consent Withdrawn by Subject|0|||
126236700|NCT03125200|454158658|FG006|Overall Study|Consent Withdrawn by Subject|1|||
126236701|NCT00119379|454158662|FG000|Overall Study|Adverse Event|4|||
126236702|NCT00119379|454158663|FG001|Overall Study|Adverse Event|1|||
126236703|NCT01937390|454158671|FG000|Overall Study|Death|2|||
126236704|NCT01937390|454158671|FG000|Overall Study|Lost to Follow-up|7|||
126236705|NCT01937390|454158671|FG000|Overall Study|Withdrawal by Subject|5|||
126236706|NCT01937390|454158671|FG000|Overall Study|Fail to return|21|||
126236707|NCT01706536|454158672|FG000|Overall Study|Withdrawal by Subject|1|||
126236708|NCT01706536|454158673|FG001|Overall Study|Withdrawal by Subject|0|||
126236709|NCT01706536|454158674|FG002|Overall Study|Withdrawal by Subject|1|||
126236710|NCT01706536|454158675|FG003|Overall Study|Withdrawal by Subject|0|||
126236711|NCT01706536|454158676|FG004|Overall Study|Withdrawal by Subject|0|||
126236712|NCT01706536|454158672|FG000|Overall Study|Adverse Event|2|||
126236713|NCT01706536|454158673|FG001|Overall Study|Adverse Event|3|||
126236714|NCT01706536|454158674|FG002|Overall Study|Adverse Event|4|||
126236715|NCT01706536|454158675|FG003|Overall Study|Adverse Event|3|||
126236716|NCT01706536|454158676|FG004|Overall Study|Adverse Event|2|||
126236717|NCT01706536|454158672|FG000|Overall Study|Lack of Efficacy|1|||
126236718|NCT01706536|454158673|FG001|Overall Study|Lack of Efficacy|0|||
126236719|NCT01706536|454158674|FG002|Overall Study|Lack of Efficacy|0|||
126236720|NCT01706536|454158675|FG003|Overall Study|Lack of Efficacy|1|||
126236721|NCT01706536|454158676|FG004|Overall Study|Lack of Efficacy|0|||
126236722|NCT01706536|454158672|FG000|Overall Study|non compliance|0|||
126236723|NCT01706536|454158673|FG001|Overall Study|non compliance|1|||
126236724|NCT01706536|454158674|FG002|Overall Study|non compliance|0|||
126236725|NCT01706536|454158675|FG003|Overall Study|non compliance|0|||
126236726|NCT01706536|454158676|FG004|Overall Study|non compliance|0|||
126236727|NCT00683293|454158688|FG000|Overall Study|Withdrawal by Subject|2|||
126236728|NCT00683293|454158689|FG001|Overall Study|Withdrawal by Subject|3|||
126236729|NCT04455633|454160120|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
126236730|NCT04455633|454160121|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
126236731|NCT04455633|454160122|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
126236732|NCT04455633|454160120|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
126236733|NCT04455633|454160121|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
126236734|NCT04455633|454160122|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
126236735|NCT04455633|454160120|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
126236736|NCT04455633|454160121|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
126236737|NCT04455633|454160122|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
126236738|NCT04455633|454160120|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
126236739|NCT04455633|454160121|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
126236740|NCT04455633|454160122|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
126236741|NCT00727571|454160125|FG000|Overall Study|Ineligibility determined|1|||
126236742|NCT00727571|454160126|FG001|Overall Study|Ineligibility determined|1|||
126236743|NCT00727571|454160127|FG002|Overall Study|Ineligibility determined|1|||
126236744|NCT00727571|454160128|FG003|Overall Study|Ineligibility determined|0|||
126236745|NCT00727571|454160125|FG000|Overall Study|Death|0|||
126236746|NCT00727571|454160126|FG001|Overall Study|Death|19|||
126236747|NCT00727571|454160127|FG002|Overall Study|Death|5|||
126236748|NCT00727571|454160128|FG003|Overall Study|Death|1|||
126236749|NCT00727571|454160125|FG000|Overall Study|Physician Decision|0|||
126236750|NCT00727571|454160126|FG001|Overall Study|Physician Decision|5|||
126236751|NCT00727571|454160127|FG002|Overall Study|Physician Decision|0|||
126236752|NCT00727571|454160128|FG003|Overall Study|Physician Decision|0|||
126236753|NCT00727571|454160125|FG000|Overall Study|Withdrawal by Subject|0|||
126356113|NCT00501085|454595686|FG000|Overall Study|Subject Decision|1|||
126356114|NCT00501085|454595686|FG000|Overall Study|Revision Surgery|7|||
126356115|NCT00501085|454595686|FG000|Overall Study|Explantation Surgery|26|||
126356116|NCT00501085|454595686|FG000|Overall Study|Adverse Event|4|||
126356117|NCT00501085|454595686|FG000|Overall Study|Non-Compliance|24|||
126356118|NCT00501085|454595686|FG000|Overall Study|Study closed by sponsor|109|||
126356119|NCT00501085|454595686|FG000|Overall Study|Other loss to follow-up|32|||
126356120|NCT00366535|454595687|FG000|First Phase: 12 Weeks|Adverse Event|1|||
126356121|NCT00366535|454595688|FG001|First Phase: 12 Weeks|Adverse Event|3|||
126356122|NCT00366535|454595687|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
126236754|NCT00727571|454160126|FG001|Overall Study|Withdrawal by Subject|10|||
126236755|NCT00727571|454160127|FG002|Overall Study|Withdrawal by Subject|11|||
126236756|NCT00727571|454160128|FG003|Overall Study|Withdrawal by Subject|0|||
126236757|NCT00727571|454160125|FG000|Overall Study|Subject Non Compliance|0|||
126236758|NCT00727571|454160126|FG001|Overall Study|Subject Non Compliance|6|||
126236759|NCT00727571|454160127|FG002|Overall Study|Subject Non Compliance|0|||
126236760|NCT00727571|454160128|FG003|Overall Study|Subject Non Compliance|4|||
126236761|NCT00727571|454160125|FG000|Overall Study|Dismissed from nursing home|0|||
126236762|NCT00727571|454160126|FG001|Overall Study|Dismissed from nursing home|9|||
126356123|NCT00366535|454595688|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
126356124|NCT00366535|454595687|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
126356125|NCT00366535|454595688|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
126236763|NCT00727571|454160127|FG002|Overall Study|Dismissed from nursing home|5|||
126236764|NCT00727571|454160128|FG003|Overall Study|Dismissed from nursing home|0|||
126236765|NCT00727571|454160125|FG000|Overall Study|Hospitalization|0|||
126236766|NCT00727571|454160126|FG001|Overall Study|Hospitalization|1|||
126236767|NCT00727571|454160127|FG002|Overall Study|Hospitalization|0|||
126236768|NCT00727571|454160128|FG003|Overall Study|Hospitalization|1|||
126236769|NCT00727571|454160125|FG000|Overall Study|AE not leading to hospitalization|0|||
126236770|NCT00727571|454160126|FG001|Overall Study|AE not leading to hospitalization|0|||
126236771|NCT00727571|454160127|FG002|Overall Study|AE not leading to hospitalization|2|||
126236772|NCT00727571|454160128|FG003|Overall Study|AE not leading to hospitalization|0|||
126093587|NCT02003222|453636113|FG003|Induction|Alternative therapy|0|||
126236773|NCT00727571|454160125|FG000|Overall Study|Other|0|||
126236774|NCT00727571|454160126|FG001|Overall Study|Other|4|||
126236775|NCT00727571|454160127|FG002|Overall Study|Other|6|||
126236776|NCT00727571|454160128|FG003|Overall Study|Other|0|||
126236777|NCT03164772|454160129|FG000|Overall Study|Death|4|||
126236778|NCT03164772|454160130|FG001|Overall Study|Death|2|||
126236779|NCT03164772|454160129|FG000|Overall Study|Adverse Event|1|||
126236780|NCT03164772|454160130|FG001|Overall Study|Adverse Event|4|||
126236781|NCT03164772|454160129|FG000|Overall Study|Progressive Disease|11|||
126236782|NCT03164772|454160130|FG001|Overall Study|Progressive Disease|21|||
126236783|NCT03164772|454160129|FG000|Overall Study|Physician Decision|2|||
126236784|NCT03164772|454160130|FG001|Overall Study|Physician Decision|0|||
126236785|NCT03164772|454160129|FG000|Overall Study|Withdrawal by Subject|0|||
126236786|NCT03164772|454160130|FG001|Overall Study|Withdrawal by Subject|4|||
126236787|NCT04099888|454160132|FG000|Overall Study|Study terminated by sponsor|9|||
126236788|NCT04099888|454160133|FG001|Overall Study|Study terminated by sponsor|11|||
126236789|NCT04099888|454160132|FG000|Overall Study|Lost to Follow-up|1|||
126236790|NCT04099888|454160133|FG001|Overall Study|Lost to Follow-up|1|||
126236791|NCT04099888|454160132|FG000|Overall Study|Withdrawal by Subject|5|||
126236792|NCT04099888|454160133|FG001|Overall Study|Withdrawal by Subject|6|||
126236793|NCT04099888|454160132|FG000|Overall Study|Death|5|||
126236794|NCT04099888|454160133|FG001|Overall Study|Death|2|||
126236795|NCT04099888|454160132|FG000|Overall Study|Other|1|||
126236796|NCT04099888|454160133|FG001|Overall Study|Other|0|||
126236797|NCT04538170|454160134|FG000|Overall Study|Withdrawal by Subject|104|||
126236798|NCT04538170|454160135|FG001|Overall Study|Withdrawal by Subject|210|||
126236799|NCT02334722|454160136|FG000|Overall Study|Lost to Follow-up|4|||
126236800|NCT02334722|454160137|FG001|Overall Study|Lost to Follow-up|0|||
126236801|NCT02334722|454160136|FG000|Overall Study|6 week questionnaire not completed|2|||
126236802|NCT02334722|454160137|FG001|Overall Study|6 week questionnaire not completed|0|||
126236803|NCT02334722|454160136|FG000|Overall Study|Unable to obtain medication|1|||
126236804|NCT02334722|454160137|FG001|Overall Study|Unable to obtain medication|1|||
126236805|NCT02334722|454160136|FG000|Overall Study|Withdrawal by Subject|0|||
126236806|NCT02334722|454160137|FG001|Overall Study|Withdrawal by Subject|3|||
126236807|NCT02334722|454160136|FG000|Overall Study|Adverse Event|0|||
126236808|NCT02334722|454160137|FG001|Overall Study|Adverse Event|2|||
126236809|NCT02334722|454160136|FG000|Overall Study|Physician Decision|0|||
126236810|NCT02334722|454160137|FG001|Overall Study|Physician Decision|1|||
126236811|NCT00856388|454160138|FG000|Overall Study|Other|1|||
126236812|NCT01617668|454160141|FG000|Overall Study|Adverse Event|7|||
126236813|NCT01617668|454160142|FG001|Overall Study|Adverse Event|0|||
126236814|NCT01617668|454160143|FG002|Overall Study|Adverse Event|12|||
126236815|NCT01617668|454160144|FG003|Overall Study|Adverse Event|5|||
126236816|NCT01617668|454160141|FG000|Overall Study|Physician Decision|1|||
126236817|NCT01617668|454160142|FG001|Overall Study|Physician Decision|2|||
126236818|NCT01617668|454160143|FG002|Overall Study|Physician Decision|3|||
126236819|NCT01617668|454160144|FG003|Overall Study|Physician Decision|0|||
126236820|NCT01617668|454160141|FG000|Overall Study|Progressive Disease|4|||
126236821|NCT01617668|454160142|FG001|Overall Study|Progressive Disease|4|||
126236822|NCT01617668|454160143|FG002|Overall Study|Progressive Disease|6|||
126236823|NCT01617668|454160144|FG003|Overall Study|Progressive Disease|9|||
126236824|NCT01617668|454160141|FG000|Overall Study|Subject/guardian decision|1|||
126356126|NCT00366535|454595687|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
126356127|NCT00366535|454595688|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
126356128|NCT02958527|454595693|FG000|Overall Study|Not collected CRFs|12|||
126356129|NCT00250718|454595696|FG000|Overall Study|Death|1|||
126236825|NCT01617668|454160142|FG001|Overall Study|Subject/guardian decision|3|||
126236826|NCT01617668|454160143|FG002|Overall Study|Subject/guardian decision|2|||
126236827|NCT01617668|454160144|FG003|Overall Study|Subject/guardian decision|1|||
126236828|NCT00925769|454160145|FG000|Overall Study|Major toxicity|1|||
126236829|NCT00925769|454160146|FG001|Overall Study|Major toxicity|0|||
126236830|NCT00925769|454160147|FG002|Overall Study|Major toxicity|1|||
126236831|NCT00925769|454160148|FG003|Overall Study|Major toxicity|1|||
126236832|NCT00925769|454160149|FG004|Overall Study|Major toxicity|0|||
126236833|NCT00925769|454160150|FG005|Overall Study|Major toxicity|0|||
126236834|NCT00925769|454160145|FG000|Overall Study|Disease progression|4|||
126236835|NCT00925769|454160146|FG001|Overall Study|Disease progression|5|||
126356130|NCT00250718|454595696|FG000|Overall Study|Adverse Event|1|||
126236836|NCT00925769|454160147|FG002|Overall Study|Disease progression|3|||
126236837|NCT00925769|454160148|FG003|Overall Study|Disease progression|4|||
126236838|NCT00925769|454160149|FG004|Overall Study|Disease progression|2|||
126236839|NCT00925769|454160150|FG005|Overall Study|Disease progression|3|||
126236840|NCT00925769|454160145|FG000|Overall Study|Death|0|||
126236841|NCT00925769|454160146|FG001|Overall Study|Death|0|||
126236842|NCT00925769|454160147|FG002|Overall Study|Death|1|||
126236843|NCT00925769|454160148|FG003|Overall Study|Death|0|||
126236844|NCT00925769|454160149|FG004|Overall Study|Death|0|||
126236845|NCT00925769|454160150|FG005|Overall Study|Death|0|||
126236846|NCT00925769|454160145|FG000|Overall Study|Physician Decision|1|||
126236847|NCT00925769|454160146|FG001|Overall Study|Physician Decision|0|||
126236848|NCT00925769|454160147|FG002|Overall Study|Physician Decision|0|||
126236849|NCT00925769|454160148|FG003|Overall Study|Physician Decision|0|||
126236850|NCT00925769|454160149|FG004|Overall Study|Physician Decision|0|||
126236851|NCT00925769|454160150|FG005|Overall Study|Physician Decision|0|||
126236852|NCT00925769|454160145|FG000|Overall Study|Missing documentation|0|||
126236853|NCT00925769|454160146|FG001|Overall Study|Missing documentation|1|||
126236854|NCT00925769|454160147|FG002|Overall Study|Missing documentation|0|||
126236855|NCT00925769|454160148|FG003|Overall Study|Missing documentation|0|||
126236856|NCT00925769|454160149|FG004|Overall Study|Missing documentation|0|||
126236857|NCT00925769|454160150|FG005|Overall Study|Missing documentation|0|||
126236858|NCT00925769|454160145|FG000|Overall Study|End of study visit not done|0|||
126236859|NCT00925769|454160146|FG001|Overall Study|End of study visit not done|0|||
126236860|NCT00925769|454160147|FG002|Overall Study|End of study visit not done|1|||
126236861|NCT00925769|454160148|FG003|Overall Study|End of study visit not done|0|||
126236862|NCT00925769|454160149|FG004|Overall Study|End of study visit not done|0|||
126236863|NCT00925769|454160150|FG005|Overall Study|End of study visit not done|0|||
126236864|NCT00925769|454160145|FG000|Overall Study|Participant is unable to swallow drug|0|||
126236865|NCT00925769|454160146|FG001|Overall Study|Participant is unable to swallow drug|0|||
126236866|NCT00925769|454160147|FG002|Overall Study|Participant is unable to swallow drug|0|||
126236867|NCT00925769|454160148|FG003|Overall Study|Participant is unable to swallow drug|1|||
126236868|NCT00925769|454160149|FG004|Overall Study|Participant is unable to swallow drug|0|||
126236869|NCT00925769|454160150|FG005|Overall Study|Participant is unable to swallow drug|0|||
126236870|NCT00925769|454160145|FG000|Overall Study|Adverse Event|0|||
126236871|NCT00925769|454160146|FG001|Overall Study|Adverse Event|0|||
126236872|NCT00925769|454160147|FG002|Overall Study|Adverse Event|0|||
126236873|NCT00925769|454160148|FG003|Overall Study|Adverse Event|0|||
126236874|NCT00925769|454160149|FG004|Overall Study|Adverse Event|1|||
126236875|NCT00925769|454160150|FG005|Overall Study|Adverse Event|0|||
126025509|NCT01898494|453389183|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
126025510|NCT01898494|453389184|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
126236876|NCT02017964|454160151|FG000|Overall Study|Patient deemed ineligible|1|||
126236877|NCT00686959|454160153|FG000|Overall Study|Participants censored (no death events)|124|||
126236878|NCT00686959|454160154|FG001|Overall Study|Participants censored (no death events)|117|||
126236879|NCT00150462|454160155|FG000|Overall Study|Disease Progression or Relapse|3|||
126236880|NCT00150462|454160156|FG001|Overall Study|Disease Progression or Relapse|1|||
126236881|NCT00150462|454160157|FG002|Overall Study|Disease Progression or Relapse|2|||
126236882|NCT00150462|454160158|FG003|Overall Study|Disease Progression or Relapse|1|||
126236883|NCT00150462|454160159|FG004|Overall Study|Disease Progression or Relapse|2|||
126236884|NCT00150462|454160160|FG005|Overall Study|Disease Progression or Relapse|2|||
126236885|NCT00150462|454160161|FG006|Overall Study|Disease Progression or Relapse|3|||
126356131|NCT00250718|454595696|FG000|Overall Study|Withdrawal by Subject|1|||
126356132|NCT01666314|454595697|FG000|Overall Study|Adverse Event|3|||
126356133|NCT01666314|454595698|FG001|Overall Study|Adverse Event|13|||
126356134|NCT01666314|454595699|FG002|Overall Study|Adverse Event|7|||
126356135|NCT01666314|454595700|FG003|Overall Study|Adverse Event|7|||
126356136|NCT01666314|454595697|FG000|Overall Study|Progressive Disease|11|||
126356137|NCT01666314|454595698|FG001|Overall Study|Progressive Disease|9|||
126356138|NCT01666314|454595699|FG002|Overall Study|Progressive Disease|19|||
126356139|NCT01666314|454595700|FG003|Overall Study|Progressive Disease|20|||
126356140|NCT01666314|454595697|FG000|Overall Study|Symptomatic Deterioration|1|||
126356141|NCT01666314|454595698|FG001|Overall Study|Symptomatic Deterioration|0|||
126356142|NCT01666314|454595699|FG002|Overall Study|Symptomatic Deterioration|2|||
126356143|NCT01666314|454595700|FG003|Overall Study|Symptomatic Deterioration|0|||
126356144|NCT01666314|454595697|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
126356145|NCT01666314|454595698|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
126356146|NCT01666314|454595699|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
126356147|NCT01666314|454595700|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
126025511|NCT01898494|453389180|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
126236886|NCT00150462|454160162|FG007|Overall Study|Disease Progression or Relapse|5|||
126356148|NCT01666314|454595697|FG000|Overall Study|Withdrawal by Subject|1|||
126356149|NCT01666314|454595698|FG001|Overall Study|Withdrawal by Subject|1|||
126356150|NCT01666314|454595699|FG002|Overall Study|Withdrawal by Subject|2|||
126356151|NCT01666314|454595700|FG003|Overall Study|Withdrawal by Subject|3|||
126236887|NCT00150462|454160163|FG008|Overall Study|Disease Progression or Relapse|5|||
126236888|NCT00150462|454160164|FG009|Overall Study|Disease Progression or Relapse|3|||
126236889|NCT00150462|454160165|FG010|Overall Study|Disease Progression or Relapse|2|||
126236890|NCT00150462|454160155|FG000|Overall Study|Withdrawal by Subject|0|||
126236891|NCT00150462|454160156|FG001|Overall Study|Withdrawal by Subject|1|||
126236892|NCT00150462|454160157|FG002|Overall Study|Withdrawal by Subject|1|||
126236893|NCT00150462|454160158|FG003|Overall Study|Withdrawal by Subject|0|||
126236894|NCT00150462|454160159|FG004|Overall Study|Withdrawal by Subject|1|||
126236895|NCT00150462|454160160|FG005|Overall Study|Withdrawal by Subject|2|||
126236896|NCT00150462|454160161|FG006|Overall Study|Withdrawal by Subject|0|||
126236897|NCT00150462|454160162|FG007|Overall Study|Withdrawal by Subject|1|||
126236898|NCT00150462|454160163|FG008|Overall Study|Withdrawal by Subject|0|||
126236899|NCT00150462|454160164|FG009|Overall Study|Withdrawal by Subject|1|||
126236900|NCT00150462|454160165|FG010|Overall Study|Withdrawal by Subject|0|||
126236901|NCT00150462|454160155|FG000|Overall Study|Death|0|||
126236902|NCT00150462|454160156|FG001|Overall Study|Death|1|||
126236903|NCT00150462|454160157|FG002|Overall Study|Death|0|||
126236904|NCT00150462|454160158|FG003|Overall Study|Death|0|||
126236905|NCT00150462|454160159|FG004|Overall Study|Death|0|||
126236906|NCT00150462|454160160|FG005|Overall Study|Death|0|||
126236907|NCT00150462|454160161|FG006|Overall Study|Death|0|||
126236908|NCT00150462|454160162|FG007|Overall Study|Death|0|||
126236909|NCT00150462|454160163|FG008|Overall Study|Death|1|||
126236910|NCT00150462|454160164|FG009|Overall Study|Death|0|||
126236911|NCT00150462|454160165|FG010|Overall Study|Death|0|||
126236912|NCT00150462|454160155|FG000|Overall Study|Adverse Event|0|||
126236913|NCT00150462|454160156|FG001|Overall Study|Adverse Event|0|||
126236914|NCT00150462|454160157|FG002|Overall Study|Adverse Event|0|||
126236915|NCT00150462|454160158|FG003|Overall Study|Adverse Event|1|||
126236916|NCT00150462|454160159|FG004|Overall Study|Adverse Event|0|||
126236917|NCT00150462|454160160|FG005|Overall Study|Adverse Event|0|||
126236918|NCT00150462|454160161|FG006|Overall Study|Adverse Event|0|||
126236919|NCT00150462|454160162|FG007|Overall Study|Adverse Event|2|||
126236920|NCT00150462|454160163|FG008|Overall Study|Adverse Event|0|||
126236921|NCT00150462|454160164|FG009|Overall Study|Adverse Event|1|||
126236922|NCT00150462|454160165|FG010|Overall Study|Adverse Event|0|||
126236923|NCT00150462|454160155|FG000|Overall Study|Physician Decision|0|||
126236924|NCT00150462|454160156|FG001|Overall Study|Physician Decision|0|||
126236925|NCT00150462|454160157|FG002|Overall Study|Physician Decision|1|||
126236926|NCT00150462|454160158|FG003|Overall Study|Physician Decision|1|||
126236927|NCT00150462|454160159|FG004|Overall Study|Physician Decision|0|||
126236928|NCT00150462|454160160|FG005|Overall Study|Physician Decision|0|||
126236929|NCT00150462|454160161|FG006|Overall Study|Physician Decision|0|||
126236930|NCT00150462|454160162|FG007|Overall Study|Physician Decision|0|||
126236931|NCT00150462|454160163|FG008|Overall Study|Physician Decision|0|||
126236932|NCT00150462|454160164|FG009|Overall Study|Physician Decision|0|||
126236933|NCT00150462|454160165|FG010|Overall Study|Physician Decision|0|||
126236934|NCT00150462|454160155|FG000|Overall Study|Other|0|||
126236935|NCT00150462|454160156|FG001|Overall Study|Other|0|||
126236936|NCT00150462|454160157|FG002|Overall Study|Other|0|||
126236937|NCT00150462|454160158|FG003|Overall Study|Other|0|||
126236938|NCT00150462|454160159|FG004|Overall Study|Other|0|||
126236939|NCT00150462|454160160|FG005|Overall Study|Other|0|||
126236940|NCT00150462|454160161|FG006|Overall Study|Other|0|||
126236941|NCT00150462|454160162|FG007|Overall Study|Other|0|||
126236942|NCT00150462|454160163|FG008|Overall Study|Other|0|||
126236943|NCT00150462|454160164|FG009|Overall Study|Other|1|||
126236944|NCT00150462|454160165|FG010|Overall Study|Other|1|||
126236945|NCT01196052|454160168|FG000|Overall Study|Adverse Event|9|||
126236946|NCT01196052|454160168|FG000|Overall Study|Lost to Follow-up|1|||
126236947|NCT01196052|454160168|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
126236948|NCT01196052|454160168|FG000|Overall Study|Reason not Specified|5|||
126236949|NCT01196052|454160168|FG000|Overall Study|Withdrawal by Subject|6|||
126236950|NCT01572948|454160169|FG000|Overall Study|Lost to Follow-up|1|||
126236951|NCT01572948|454160170|FG001|Overall Study|Lost to Follow-up|0|||
126236952|NCT01572948|454160169|FG000|Overall Study|unable to contact|0|||
126093588|NCT02003222|453636114|FG004|Induction|Alternative therapy|12|||
126236953|NCT01572948|454160170|FG001|Overall Study|unable to contact|1|||
126236954|NCT03603314|454160171|FG000|Overall Study|Lost to Follow-up|0|||
126236955|NCT03603314|454160172|FG001|Overall Study|Lost to Follow-up|3|||
126236956|NCT03603314|454160173|FG002|Overall Study|Lost to Follow-up|0|||
126236957|NCT03603314|454160171|FG000|Overall Study|Protocol Violation|0|||
126236958|NCT03603314|454160172|FG001|Overall Study|Protocol Violation|1|||
126236959|NCT03603314|454160173|FG002|Overall Study|Protocol Violation|0|||
126236960|NCT03603314|454160171|FG000|Overall Study|Adverse Event|2|||
126236961|NCT03603314|454160172|FG001|Overall Study|Adverse Event|0|||
126025512|NCT01898494|453389181|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
126025513|NCT01898494|453389182|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
126025514|NCT01898494|453389183|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
126093589|NCT02003222|453636110|FG000|Induction|Disease progression|0|||
126025515|NCT01898494|453389184|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
126025516|NCT01718743|453389185|FG000|Overall Study|Physician Decision|7|||
126236962|NCT03603314|454160173|FG002|Overall Study|Adverse Event|0|||
126236963|NCT03603314|454160171|FG000|Overall Study|Physician Decision|1|||
126236964|NCT03603314|454160172|FG001|Overall Study|Physician Decision|1|||
126236965|NCT03603314|454160173|FG002|Overall Study|Physician Decision|0|||
126236966|NCT03603314|454160171|FG000|Overall Study|Withdrawal by Subject|4|||
126236967|NCT03603314|454160172|FG001|Overall Study|Withdrawal by Subject|5|||
126236968|NCT03603314|454160173|FG002|Overall Study|Withdrawal by Subject|3|||
126236969|NCT03603314|454160171|FG000|Overall Study|Other|0|||
126236970|NCT03603314|454160172|FG001|Overall Study|Other|1|||
126236971|NCT03603314|454160173|FG002|Overall Study|Other|0|||
126236972|NCT03450070|454160174|FG000|Overall Study|Withdrawal by Subject|8|||
126236973|NCT01720264|454160177|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
126236974|NCT01720264|454160177|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
126236975|NCT01720264|454160177|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
126236976|NCT00877032|454160178|FG000|Overall Study|Did not meet entrance criteria|0|||
126236977|NCT00877032|454160179|FG001|Overall Study|Did not meet entrance criteria|0|||
126236978|NCT00877032|454160180|FG002|Overall Study|Did not meet entrance criteria|0|||
126236979|NCT00877032|454160181|FG003|Overall Study|Did not meet entrance criteria|1|||
126236980|NCT00877032|454160182|FG004|Overall Study|Did not meet entrance criteria|0|||
126236981|NCT00877032|454160183|FG005|Overall Study|Did not meet entrance criteria|0|||
126236982|NCT00877032|454160184|FG006|Overall Study|Did not meet entrance criteria|2|||
126236983|NCT00615069|454160194|FG000|Overall Study|Death|10|||
126236984|NCT00615069|454160194|FG000|Overall Study|Physician Decision|2|||
126236985|NCT00615069|454160194|FG000|Overall Study|Withdrawal by Subject|4|||
126236986|NCT00669942|454160196|FG000|Parts 2 and 3|Adverse Event|0|||
126236987|NCT00669942|454160197|FG001|Parts 2 and 3|Adverse Event|0|||
126236988|NCT00669942|454160198|FG002|Parts 2 and 3|Adverse Event|0|||
126236989|NCT00669942|454160199|FG003|Parts 2 and 3|Adverse Event|0|||
126236990|NCT00669942|454160200|FG004|Parts 2 and 3|Adverse Event|0|||
126236991|NCT00669942|454160201|FG005|Parts 2 and 3|Adverse Event|0|||
126236992|NCT00669942|454160202|FG006|Parts 2 and 3|Adverse Event|0|||
126236993|NCT00669942|454160203|FG007|Parts 2 and 3|Adverse Event|2|||
126236994|NCT00669942|454160204|FG008|Parts 2 and 3|Adverse Event|1|||
126236995|NCT00669942|454160205|FG009|Parts 2 and 3|Adverse Event|0|||
126236996|NCT00669942|454160206|FG010|Parts 2 and 3|Adverse Event|0|||
126236997|NCT00669942|454160207|FG011|Parts 2 and 3|Adverse Event|0|||
126236998|NCT00669942|454160196|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
126236999|NCT00669942|454160197|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
126237000|NCT00669942|454160198|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
126237001|NCT00669942|454160199|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
126237002|NCT00669942|454160200|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
126237003|NCT00669942|454160201|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
126237004|NCT00669942|454160202|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
126237005|NCT00669942|454160203|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
126237006|NCT00669942|454160204|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
126237007|NCT00669942|454160205|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
126237008|NCT00669942|454160206|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
126237009|NCT00669942|454160207|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
126237010|NCT00669942|454160196|FG000|Parts 2 and 3|Protocol Violation|0|||
126356152|NCT01666314|454595697|FG000|Overall Study|Reason not Specified|10|||
126356153|NCT01666314|454595698|FG001|Overall Study|Reason not Specified|7|||
126356154|NCT01666314|454595699|FG002|Overall Study|Reason not Specified|5|||
126356155|NCT01666314|454595700|FG003|Overall Study|Reason not Specified|5|||
126356156|NCT01301092|454595701|FG000|Overall Study|Lost to Follow-up|0|||
126356157|NCT01301092|454595702|FG001|Overall Study|Lost to Follow-up|0|||
126356158|NCT01301092|454595703|FG002|Overall Study|Lost to Follow-up|1|||
126356159|NCT01002105|454597742|FG000|Overall Study|Lost to Follow-up|10|||
126356160|NCT01002105|454597743|FG001|Overall Study|Lost to Follow-up|16|||
126356161|NCT01002105|454597742|FG000|Overall Study|non compliance|5|||
126356162|NCT01002105|454597743|FG001|Overall Study|non compliance|3|||
126356163|NCT01002105|454597742|FG000|Overall Study|condition worsened|4|||
126356164|NCT01002105|454597743|FG001|Overall Study|condition worsened|2|||
126356165|NCT02316613|454597744|FG000|Overall Study|Death|63|||
126356166|NCT02316613|454597744|FG000|Overall Study|Lost to Follow-up|9|||
126356167|NCT02316613|454597744|FG000|Overall Study|Lymphoma transformation|2|||
126356168|NCT02316613|454597744|FG000|Overall Study|Participant moved/changed medical team|11|||
126356169|NCT02316613|454597744|FG000|Overall Study|No data and duplicate cases|5|||
126356170|NCT02316613|454597744|FG000|Overall Study|Did not met selection criteria|14|||
126356171|NCT01166945|454597745|FG000|Randomized|diagnosed with Group A strep|4|||
126356172|NCT01166945|454597746|FG001|Randomized|diagnosed with Group A strep|4|||
126356173|NCT01166945|454597745|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
126356174|NCT01166945|454597746|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
126356175|NCT01166945|454597745|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
126356176|NCT01166945|454597746|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
126356177|NCT01166945|454597745|FG000|Day 30|Lost to Follow-up|4|||
126237011|NCT00669942|454160197|FG001|Parts 2 and 3|Protocol Violation|0|||
126237012|NCT00669942|454160198|FG002|Parts 2 and 3|Protocol Violation|0|||
126237013|NCT00669942|454160199|FG003|Parts 2 and 3|Protocol Violation|0|||
126237014|NCT00669942|454160200|FG004|Parts 2 and 3|Protocol Violation|0|||
126237015|NCT00669942|454160201|FG005|Parts 2 and 3|Protocol Violation|1|||
126237016|NCT00669942|454160202|FG006|Parts 2 and 3|Protocol Violation|0|||
126237017|NCT00669942|454160203|FG007|Parts 2 and 3|Protocol Violation|0|||
126237018|NCT00669942|454160204|FG008|Parts 2 and 3|Protocol Violation|0|||
126237019|NCT00669942|454160205|FG009|Parts 2 and 3|Protocol Violation|0|||
126237020|NCT00669942|454160206|FG010|Parts 2 and 3|Protocol Violation|0|||
126237021|NCT00669942|454160207|FG011|Parts 2 and 3|Protocol Violation|0|||
126237022|NCT00259012|454160209|FG000|Overall Study|Adverse Event|0|||
126237023|NCT00259012|454160210|FG001|Overall Study|Adverse Event|1|||
126237024|NCT00259012|454160209|FG000|Overall Study|Withdrawal by Subject|1|||
126237025|NCT00259012|454160210|FG001|Overall Study|Withdrawal by Subject|0|||
126237026|NCT00259012|454160209|FG000|Overall Study|Physician Decision|0|||
126237027|NCT00259012|454160210|FG001|Overall Study|Physician Decision|1|||
126237028|NCT00259012|454160209|FG000|Overall Study|Lost to Follow-up|0|||
126237029|NCT00259012|454160210|FG001|Overall Study|Lost to Follow-up|1|||
126237030|NCT00259012|454160209|FG000|Overall Study|Protocol Violation|1|||
126237031|NCT00259012|454160210|FG001|Overall Study|Protocol Violation|1|||
126237032|NCT01496183|454160217|FG000|Overall Study|Physician Decision|3|||
126237033|NCT01496183|454160218|FG001|Overall Study|Physician Decision|1|||
126237034|NCT01496183|454160217|FG000|Overall Study|Withdrawal by Subject|0|||
126237035|NCT01496183|454160218|FG001|Overall Study|Withdrawal by Subject|1|||
126237036|NCT03002077|454160219|FG000|Overall Study|Non-compliance with Study Drug|4|||
126237037|NCT03002077|454160219|FG000|Overall Study|Non-compliance w/Background ADT|1|||
126237038|NCT03002077|454160219|FG000|Overall Study|Study Terminated by Sponsor|257|||
126237039|NCT03002077|454160219|FG000|Overall Study|Site Terminated by Sponsor|5|||
126237040|NCT03002077|454160219|FG000|Overall Study|Miscellaneous Reasons|10|||
126237041|NCT03002077|454160219|FG000|Overall Study|Adverse Event|23|||
126237042|NCT03002077|454160219|FG000|Overall Study|Lack of Efficacy|20|||
126237043|NCT03002077|454160219|FG000|Overall Study|Withdrawal by Subject|72|||
126237044|NCT03002077|454160219|FG000|Overall Study|Lost to Follow-up|21|||
126237045|NCT03002077|454160219|FG000|Overall Study|Pregnancy|4|||
126237046|NCT03002077|454160219|FG000|Overall Study|Protocol Violation|21|||
126356178|NCT01166945|454597746|FG001|Day 30|Lost to Follow-up|3|||
126356179|NCT03309605|454597749|FG000|Overall Study|Adverse Event|0|||
126356180|NCT03309605|454597750|FG001|Overall Study|Adverse Event|0|||
126356181|NCT03309605|454597751|FG002|Overall Study|Adverse Event|0|||
126356182|NCT03309605|454597752|FG003|Overall Study|Adverse Event|1|||
126356183|NCT03309605|454597753|FG004|Overall Study|Adverse Event|0|||
126093590|NCT02003222|453636111|FG001|Induction|Disease progression|0|||
126356184|NCT03309605|454597754|FG005|Overall Study|Adverse Event|0|||
126237047|NCT04625114|454160220|FG000|Overall Study|Adverse Event|3|||
126237048|NCT04625114|454160221|FG001|Overall Study|Adverse Event|1|||
126237049|NCT04625114|454160220|FG000|Overall Study|Withdrawal by Subject|2|||
126356185|NCT03309605|454597755|FG006|Overall Study|Adverse Event|2|||
126237050|NCT04625114|454160221|FG001|Overall Study|Withdrawal by Subject|0|||
126237051|NCT00472290|454160222|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
126237052|NCT00472290|454160222|FG000|Overall Study|Protocol Specified Criteria|7|||
126237053|NCT00472290|454160222|FG000|Overall Study|Administrative Decision|37|||
126237054|NCT00472290|454160222|FG000|Overall Study|Death|3|||
126237055|NCT00472290|454160222|FG000|Overall Study|Lost to Follow-up|1|||
126356186|NCT03309605|454597756|FG007|Overall Study|Adverse Event|1|||
126356187|NCT03309605|454597749|FG000|Overall Study|Withdrawal by Subject|0|||
126093591|NCT02003222|453636112|FG002|Induction|Disease progression|0|||
126093592|NCT02003222|453636113|FG003|Induction|Disease progression|0|||
126093593|NCT02003222|453636114|FG004|Induction|Disease progression|22|||
126093594|NCT02003222|453636110|FG000|Induction|Death|0|||
126093595|NCT02003222|453636111|FG001|Induction|Death|0|||
126093596|NCT02003222|453636112|FG002|Induction|Death|0|||
126093597|NCT02003222|453636113|FG003|Induction|Death|0|||
126093598|NCT02003222|453636114|FG004|Induction|Death|3|||
126093599|NCT02003222|453636110|FG000|Induction|Withdrawal by Subject|0|||
126093600|NCT02003222|453636111|FG001|Induction|Withdrawal by Subject|0|||
126093601|NCT02003222|453636112|FG002|Induction|Withdrawal by Subject|0|||
126093602|NCT02003222|453636113|FG003|Induction|Withdrawal by Subject|0|||
126093603|NCT02003222|453636114|FG004|Induction|Withdrawal by Subject|8|||
126093604|NCT02003222|453636110|FG000|Induction|Other reasons|0|||
126093605|NCT02003222|453636111|FG001|Induction|Other reasons|0|||
126093606|NCT02003222|453636112|FG002|Induction|Other reasons|0|||
126093607|NCT02003222|453636113|FG003|Induction|Other reasons|0|||
126093608|NCT02003222|453636114|FG004|Induction|Other reasons|22|||
126093609|NCT02003222|453636110|FG000|Intensification|Never started treatment|0|||
126093610|NCT02003222|453636111|FG001|Intensification|Never started treatment|0|||
126093611|NCT02003222|453636112|FG002|Intensification|Never started treatment|0|||
126093612|NCT02003222|453636113|FG003|Intensification|Never started treatment|0|||
126093613|NCT02003222|453636114|FG004|Intensification|Never started treatment|2|||
126093614|NCT02003222|453636110|FG000|Intensification|Adverse Event|0|||
126093615|NCT02003222|453636111|FG001|Intensification|Adverse Event|0|||
126237056|NCT00472290|454160222|FG000|Overall Study|Lack of Efficacy|1|||
126237057|NCT00472290|454160222|FG000|Overall Study|Disease Progression|4|||
126237058|NCT00472290|454160222|FG000|Overall Study|Withdrawal by Subject|5|||
126237059|NCT00472290|454160222|FG000|Overall Study|Adverse Event|6|||
126237060|NCT00472290|454160222|FG000|Overall Study|Requirement for alternative therapy|7|||
126237061|NCT00777829|454160223|FG000|Overall Study|Withdrawal by Subject|0|||
126093616|NCT02003222|453636112|FG002|Intensification|Adverse Event|0|||
126093617|NCT02003222|453636113|FG003|Intensification|Adverse Event|0|||
126093618|NCT02003222|453636114|FG004|Intensification|Adverse Event|6|||
126093619|NCT02003222|453636110|FG000|Intensification|Alternative therapy|0|||
126093620|NCT02003222|453636111|FG001|Intensification|Alternative therapy|0|||
126237062|NCT00777829|454160224|FG001|Overall Study|Withdrawal by Subject|2|||
126237063|NCT02016170|454160237|FG000|Overall Study|Adverse Event|1|||
126237064|NCT02016170|454160238|FG001|Overall Study|Adverse Event|1|||
126093621|NCT02003222|453636112|FG002|Intensification|Alternative therapy|0|||
126093622|NCT02003222|453636113|FG003|Intensification|Alternative therapy|0|||
126093623|NCT02003222|453636114|FG004|Intensification|Alternative therapy|8|||
126093624|NCT02003222|453636110|FG000|Intensification|Disease progression|0|||
126237065|NCT02016170|454160239|FG002|Overall Study|Adverse Event|0|||
126237066|NCT02016170|454160237|FG000|Overall Study|Protocol Violation|1|||
126237067|NCT02016170|454160238|FG001|Overall Study|Protocol Violation|0|||
126237068|NCT02016170|454160239|FG002|Overall Study|Protocol Violation|0|||
126237069|NCT00336479|454160240|FG000|Overall Study|Adverse Event|8|||
126237070|NCT00336479|454160241|FG001|Overall Study|Adverse Event|11|||
126237071|NCT00336479|454160242|FG002|Overall Study|Adverse Event|18|||
126237072|NCT00336479|454160243|FG003|Overall Study|Adverse Event|4|||
126237073|NCT00336479|454160240|FG000|Overall Study|Noncompliant|1|||
126237074|NCT00336479|454160241|FG001|Overall Study|Noncompliant|7|||
126237075|NCT00336479|454160242|FG002|Overall Study|Noncompliant|3|||
126237076|NCT00336479|454160243|FG003|Overall Study|Noncompliant|0|||
126237077|NCT00336479|454160240|FG000|Overall Study|Physician Decision|2|||
126237078|NCT00336479|454160241|FG001|Overall Study|Physician Decision|3|||
126237079|NCT00336479|454160242|FG002|Overall Study|Physician Decision|1|||
126237080|NCT00336479|454160243|FG003|Overall Study|Physician Decision|0|||
126237081|NCT00336479|454160240|FG000|Overall Study|Lost to Follow-up|3|||
126237082|NCT00336479|454160241|FG001|Overall Study|Lost to Follow-up|2|||
126237083|NCT00336479|454160242|FG002|Overall Study|Lost to Follow-up|0|||
126237084|NCT00336479|454160243|FG003|Overall Study|Lost to Follow-up|0|||
126237085|NCT00336479|454160240|FG000|Overall Study|Withdrawal by Subject|3|||
126237086|NCT00336479|454160241|FG001|Overall Study|Withdrawal by Subject|2|||
126237087|NCT00336479|454160242|FG002|Overall Study|Withdrawal by Subject|3|||
126237088|NCT00336479|454160243|FG003|Overall Study|Withdrawal by Subject|0|||
126237089|NCT00336479|454160240|FG000|Overall Study|Other|0|||
126237090|NCT00336479|454160241|FG001|Overall Study|Other|0|||
126237091|NCT00336479|454160242|FG002|Overall Study|Other|1|||
126237092|NCT00336479|454160243|FG003|Overall Study|Other|0|||
126237093|NCT00336479|454160240|FG000|Overall Study|Virologic Stopping Rule|20|||
126237094|NCT00336479|454160241|FG001|Overall Study|Virologic Stopping Rule|0|||
126237095|NCT00336479|454160242|FG002|Overall Study|Virologic Stopping Rule|0|||
126237096|NCT00336479|454160243|FG003|Overall Study|Virologic Stopping Rule|0|||
126237097|NCT01479439|454160244|FG000|Overall Study|Adverse Event|1|||
126237098|NCT01479439|454160245|FG001|Overall Study|Adverse Event|0|||
126237099|NCT01479439|454160246|FG002|Overall Study|Adverse Event|0|||
126237100|NCT01479439|454160244|FG000|Overall Study|Lost to Follow-up|0|||
126237101|NCT01479439|454160245|FG001|Overall Study|Lost to Follow-up|1|||
126237102|NCT01479439|454160246|FG002|Overall Study|Lost to Follow-up|0|||
126237103|NCT01479439|454160244|FG000|Overall Study|Protocol Violation|0|||
126237104|NCT01479439|454160245|FG001|Overall Study|Protocol Violation|0|||
126237105|NCT01479439|454160246|FG002|Overall Study|Protocol Violation|2|||
126237106|NCT02365207|454160247|FG000|Overall Study|Withdrawal by Subject|1|||
126237107|NCT02365207|454160247|FG000|Overall Study|Physician Decision|1|||
126237108|NCT01722877|454160248|FG000|Overall Study|Death|1|||
126237109|NCT01722877|454160248|FG000|Overall Study|Lost to Follow-up|1|||
126237110|NCT01395030|454160249|FG000|Overall Study|Did not complete FCH PET/CT|7|||
126237111|NCT02079766|454160250|FG000|Overall Study|Physician Decision|1|||
126237112|NCT02079766|454160251|FG001|Overall Study|Physician Decision|0|||
126237113|NCT02079766|454160250|FG000|Overall Study|Withdrawal by Subject|1|||
126237114|NCT02079766|454160251|FG001|Overall Study|Withdrawal by Subject|0|||
126237115|NCT05067647|454160255|FG000|Overall Study|Lost to Follow-up|1|||
126237116|NCT00857623|454160258|FG000|Overall Study|Adverse Event|5|||
126237117|NCT00857623|454160259|FG001|Overall Study|Adverse Event|2|||
126237118|NCT00857623|454160258|FG000|Overall Study|Study-specific discontinuation criteria|5|||
126237119|NCT00857623|454160259|FG001|Overall Study|Study-specific discontinuation criteria|3|||
126237120|NCT00857623|454160258|FG000|Overall Study|Withdrawal by Subject|2|||
126237121|NCT00857623|454160259|FG001|Overall Study|Withdrawal by Subject|1|||
126237122|NCT00857623|454160258|FG000|Overall Study|Lack of Efficacy|1|||
126237123|NCT00857623|454160259|FG001|Overall Study|Lack of Efficacy|1|||
126237124|NCT00857623|454160258|FG000|Overall Study|Severe non-compliance to protocol|1|||
126237125|NCT00857623|454160259|FG001|Overall Study|Severe non-compliance to protocol|1|||
126237126|NCT00857623|454160258|FG000|Overall Study|Intake of prohibited medication|0|||
126237127|NCT00857623|454160259|FG001|Overall Study|Intake of prohibited medication|1|||
126237128|NCT00857623|454160258|FG000|Overall Study|Positive for HEP C|0|||
126237129|NCT00857623|454160259|FG001|Overall Study|Positive for HEP C|1|||
126237130|NCT00870870|454160262|FG000|Overall Study|Withdrawal by Subject|0|||
126237131|NCT00870870|454160263|FG001|Overall Study|Withdrawal by Subject|1|||
126237132|NCT00870870|454160264|FG002|Overall Study|Withdrawal by Subject|1|||
126237133|NCT00870870|454160265|FG003|Overall Study|Withdrawal by Subject|3|||
126237134|NCT00870870|454160262|FG000|Overall Study|Adverse Event|0|||
126237135|NCT00870870|454160263|FG001|Overall Study|Adverse Event|0|||
126237136|NCT00870870|454160264|FG002|Overall Study|Adverse Event|2|||
126237137|NCT00870870|454160265|FG003|Overall Study|Adverse Event|2|||
126237138|NCT00694551|454160268|FG000|Overall Study|Disease Progression|1|||
126237139|NCT00694551|454160269|FG001|Overall Study|Disease Progression|0|||
126237140|NCT00694551|454160270|FG002|Overall Study|Disease Progression|1|||
126237141|NCT01569152|454160271|FG000|Phase IIa, Period 1|Early Escape|5|||
126237142|NCT01569152|454160272|FG001|Phase IIa, Period 1|Early Escape|22|||
126237143|NCT01569152|454160273|FG002|Phase IIa, Period 1|Early Escape|0|||
126237144|NCT01569152|454160271|FG000|Phase IIa, Period 1|Adverse Event|4|||
126237145|NCT01569152|454160272|FG001|Phase IIa, Period 1|Adverse Event|0|||
126237146|NCT01569152|454160273|FG002|Phase IIa, Period 1|Adverse Event|0|||
126237147|NCT01569152|454160271|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
126237148|NCT01569152|454160272|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
126237149|NCT01569152|454160273|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
126237150|NCT01569152|454160271|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
126237151|NCT01569152|454160272|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
126237152|NCT01569152|454160273|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
126237153|NCT01569152|454160271|FG000|Phase IIa, Period 1|Protocol Violation|0|||
126237154|NCT01569152|454160272|FG001|Phase IIa, Period 1|Protocol Violation|1|||
126237155|NCT01569152|454160273|FG002|Phase IIa, Period 1|Protocol Violation|0|||
126237156|NCT01569152|454160271|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
126237157|NCT01569152|454160272|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
126237158|NCT01569152|454160273|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
126237159|NCT01569152|454160271|FG000|Safety Extension, Period 3|Adverse Event|0|||
126237160|NCT01569152|454160272|FG001|Safety Extension, Period 3|Adverse Event|0|||
126237161|NCT01569152|454160273|FG002|Safety Extension, Period 3|Adverse Event|4|||
126237162|NCT01569152|454160271|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
126237163|NCT01569152|454160272|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
126237164|NCT01569152|454160273|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
126237165|NCT01569152|454160271|FG000|Safety Extension, Period 3|Physician Decision|0|||
126356188|NCT03309605|454597750|FG001|Overall Study|Withdrawal by Subject|0|||
126356189|NCT03309605|454597751|FG002|Overall Study|Withdrawal by Subject|0|||
126356190|NCT03309605|454597752|FG003|Overall Study|Withdrawal by Subject|0|||
126356191|NCT03309605|454597753|FG004|Overall Study|Withdrawal by Subject|1|||
126356192|NCT03309605|454597754|FG005|Overall Study|Withdrawal by Subject|0|||
126356193|NCT03309605|454597755|FG006|Overall Study|Withdrawal by Subject|1|||
126025517|NCT01718743|453389185|FG000|Overall Study|Withdrawal by Subject|14|||
126025518|NCT01718743|453389185|FG000|Overall Study|Progressive Disease|22|||
126025519|NCT01718743|453389185|FG000|Overall Study|Toxicity|1|||
126025520|NCT01718743|453389185|FG000|Overall Study|Malignancy|1|||
126025521|NCT04905407|453389189|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
126025522|NCT04905407|453389190|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
126237166|NCT01569152|454160272|FG001|Safety Extension, Period 3|Physician Decision|0|||
126237167|NCT01569152|454160273|FG002|Safety Extension, Period 3|Physician Decision|2|||
126237168|NCT01569152|454160271|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
126237169|NCT01569152|454160272|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
126237170|NCT01569152|454160273|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
126237171|NCT02920996|454160280|FG000|Overall Study|Adverse Event|8|||
126237172|NCT02920996|454160281|FG001|Overall Study|Adverse Event|0|||
126237173|NCT02920996|454160280|FG000|Overall Study|Physician Decision|1|||
126237174|NCT02920996|454160281|FG001|Overall Study|Physician Decision|0|||
126237175|NCT02920996|454160280|FG000|Overall Study|Death|1|||
126237176|NCT02920996|454160281|FG001|Overall Study|Death|0|||
126237177|NCT02920996|454160280|FG000|Overall Study|Missing|1|||
126237178|NCT02920996|454160281|FG001|Overall Study|Missing|0|||
126237179|NCT02920996|454160280|FG000|Overall Study|Subject Non-Compliance|1|||
126237180|NCT02920996|454160281|FG001|Overall Study|Subject Non-Compliance|0|||
126237181|NCT00154102|454160282|FG000|Overall Study|investigational study phase ongoing|7|||
126025523|NCT04905407|453389191|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
126356194|NCT03309605|454597756|FG007|Overall Study|Withdrawal by Subject|1|||
126237182|NCT00154102|454160283|FG001|Overall Study|investigational study phase ongoing|2|||
126237183|NCT00463606|454160284|FG000|Overall Study|Adverse Event|21|||
126237184|NCT00463606|454160285|FG001|Overall Study|Adverse Event|18|||
126237185|NCT00463606|454160286|FG002|Overall Study|Adverse Event|11|||
126237186|NCT00463606|454160284|FG000|Overall Study|Withdrawal by Subject|11|||
126237187|NCT00463606|454160285|FG001|Overall Study|Withdrawal by Subject|11|||
126237188|NCT00463606|454160286|FG002|Overall Study|Withdrawal by Subject|5|||
126237189|NCT00463606|454160284|FG000|Overall Study|Lost to Follow-up|2|||
126237190|NCT00463606|454160285|FG001|Overall Study|Lost to Follow-up|2|||
126237191|NCT00463606|454160286|FG002|Overall Study|Lost to Follow-up|3|||
126237192|NCT00463606|454160284|FG000|Overall Study|Subject noncompliance|1|||
126237193|NCT00463606|454160285|FG001|Overall Study|Subject noncompliance|1|||
126093625|NCT02003222|453636111|FG001|Intensification|Disease progression|0|||
126093626|NCT02003222|453636112|FG002|Intensification|Disease progression|0|||
126093627|NCT02003222|453636113|FG003|Intensification|Disease progression|0|||
126237194|NCT00463606|454160286|FG002|Overall Study|Subject noncompliance|0|||
126237195|NCT00463606|454160284|FG000|Overall Study|Subject moved out of town|1|||
126237196|NCT00463606|454160285|FG001|Overall Study|Subject moved out of town|0|||
126237197|NCT00463606|454160286|FG002|Overall Study|Subject moved out of town|0|||
126237198|NCT00463606|454160284|FG000|Overall Study|Physician Decision|0|||
126237199|NCT00463606|454160285|FG001|Overall Study|Physician Decision|1|||
126237200|NCT00463606|454160286|FG002|Overall Study|Physician Decision|0|||
126025524|NCT04905407|453389192|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
126025525|NCT04905407|453389189|FG000|Part 1 and Part 2|Death|7|||
126237201|NCT00463606|454160284|FG000|Overall Study|Sponsor request|0|||
126237202|NCT00463606|454160285|FG001|Overall Study|Sponsor request|1|||
126237203|NCT00463606|454160286|FG002|Overall Study|Sponsor request|0|||
126237204|NCT00463606|454160284|FG000|Overall Study|Exclusion criteria violation|2|||
126237205|NCT00463606|454160285|FG001|Overall Study|Exclusion criteria violation|0|||
126237206|NCT00463606|454160286|FG002|Overall Study|Exclusion criteria violation|0|||
126237207|NCT00463606|454160284|FG000|Overall Study|Coordinator error|1|||
126237208|NCT00463606|454160285|FG001|Overall Study|Coordinator error|0|||
126237209|NCT00463606|454160286|FG002|Overall Study|Coordinator error|0|||
126237210|NCT00463606|454160284|FG000|Overall Study|Patient randomized in error|1|||
126237211|NCT00463606|454160285|FG001|Overall Study|Patient randomized in error|0|||
126237212|NCT00463606|454160286|FG002|Overall Study|Patient randomized in error|0|||
126356195|NCT00422461|454597759|FG000|Overall Study|Adverse Event|1|||
126356196|NCT00422461|454597760|FG001|Overall Study|Adverse Event|2|||
126356197|NCT00422461|454597761|FG002|Overall Study|Adverse Event|1|||
126356198|NCT00422461|454597762|FG003|Overall Study|Adverse Event|1|||
126356199|NCT00422461|454597759|FG000|Overall Study|Other|0|||
126356200|NCT00422461|454597760|FG001|Overall Study|Other|0|||
126356201|NCT00422461|454597761|FG002|Overall Study|Other|0|||
126356202|NCT00422461|454597762|FG003|Overall Study|Other|2|||
126356203|NCT00422461|454597759|FG000|Overall Study|Participants no longer willing to participate in study|1|||
126356204|NCT00422461|454597760|FG001|Overall Study|Participants no longer willing to participate in study|0|||
126356205|NCT00422461|454597761|FG002|Overall Study|Participants no longer willing to participate in study|0|||
126356206|NCT00422461|454597762|FG003|Overall Study|Participants no longer willing to participate in study|0|||
126356207|NCT00422461|454597759|FG000|Overall Study|Randomized but not treated|1|||
126356208|NCT00422461|454597760|FG001|Overall Study|Randomized but not treated|1|||
126356209|NCT00422461|454597761|FG002|Overall Study|Randomized but not treated|0|||
126356210|NCT00422461|454597762|FG003|Overall Study|Randomized but not treated|0|||
126356211|NCT01471574|454597763|FG000|Treatment Period|Lack of Efficacy|12|||
126356212|NCT01471574|454597764|FG001|Treatment Period|Lack of Efficacy|4|||
126356213|NCT01471574|454597765|FG002|Treatment Period|Lack of Efficacy|14|||
126356214|NCT01471574|454597766|FG003|Treatment Period|Lack of Efficacy|1|||
126356215|NCT01471574|454597763|FG000|Treatment Period|Adverse Event|7|||
126356216|NCT01471574|454597764|FG001|Treatment Period|Adverse Event|3|||
126356217|NCT01471574|454597765|FG002|Treatment Period|Adverse Event|6|||
126356218|NCT01471574|454597766|FG003|Treatment Period|Adverse Event|1|||
126356219|NCT01471574|454597763|FG000|Treatment Period|Withdrawal by Subject|5|||
126356220|NCT01471574|454597764|FG001|Treatment Period|Withdrawal by Subject|1|||
126237213|NCT00463606|454160284|FG000|Overall Study|Participation in another ABT-335 trial|1|||
126356221|NCT01471574|454597765|FG002|Treatment Period|Withdrawal by Subject|1|||
126025526|NCT04905407|453389190|FG001|Part 1 and Part 2|Death|7|||
126237214|NCT00463606|454160285|FG001|Overall Study|Participation in another ABT-335 trial|0|||
126237215|NCT00463606|454160286|FG002|Overall Study|Participation in another ABT-335 trial|0|||
126237216|NCT00463606|454160284|FG000|Overall Study|Protocol Violation|0|||
126237217|NCT00463606|454160285|FG001|Overall Study|Protocol Violation|0|||
126237218|NCT00463606|454160286|FG002|Overall Study|Protocol Violation|1|||
126237219|NCT02682602|454160288|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
126237220|NCT02682602|454160289|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
126237221|NCT02682602|454160288|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
126237222|NCT02682602|454160289|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
126237223|NCT02924038|454161677|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
126237224|NCT02924038|454161678|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
126237225|NCT03601637|454161679|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
126237226|NCT03601637|454161680|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
126237227|NCT03601637|454161679|FG000|Overall Study|Adverse Event|1|||
126025527|NCT04905407|453389191|FG002|Part 1 and Part 2|Death|7|||
126025528|NCT04905407|453389192|FG003|Part 1 and Part 2|Death|0|||
126237228|NCT03601637|454161680|FG001|Overall Study|Adverse Event|1|||
126237229|NCT03601637|454161679|FG000|Overall Study|Other|0|||
126237230|NCT03601637|454161680|FG001|Overall Study|Other|1|||
126237231|NCT01248247|454161681|FG000|Overall Study|Adverse Event|2|||
126237232|NCT01248247|454161682|FG001|Overall Study|Adverse Event|4|||
126237233|NCT01248247|454161683|FG002|Overall Study|Adverse Event|4|||
126237234|NCT01248247|454161684|FG003|Overall Study|Adverse Event|2|||
126237235|NCT01248247|454161681|FG000|Overall Study|Death|0|||
126237236|NCT01248247|454161682|FG001|Overall Study|Death|1|||
126237237|NCT01248247|454161683|FG002|Overall Study|Death|4|||
126237238|NCT01248247|454161684|FG003|Overall Study|Death|7|||
126237239|NCT01248247|454161681|FG000|Overall Study|Lost to Follow-up|0|||
126237240|NCT01248247|454161682|FG001|Overall Study|Lost to Follow-up|1|||
126237241|NCT01248247|454161683|FG002|Overall Study|Lost to Follow-up|1|||
126237242|NCT01248247|454161684|FG003|Overall Study|Lost to Follow-up|0|||
126237243|NCT01248247|454161681|FG000|Overall Study|Alternative treatment|0|||
126237244|NCT01248247|454161682|FG001|Overall Study|Alternative treatment|1|||
126237245|NCT01248247|454161683|FG002|Overall Study|Alternative treatment|0|||
126237246|NCT01248247|454161684|FG003|Overall Study|Alternative treatment|0|||
126237247|NCT01248247|454161681|FG000|Overall Study|Other|2|||
126237248|NCT01248247|454161682|FG001|Overall Study|Other|8|||
126237249|NCT01248247|454161683|FG002|Overall Study|Other|8|||
126237250|NCT01248247|454161684|FG003|Overall Study|Other|5|||
126237251|NCT01248247|454161681|FG000|Overall Study|Progression|18|||
126237252|NCT01248247|454161682|FG001|Overall Study|Progression|27|||
126237253|NCT01248247|454161683|FG002|Overall Study|Progression|56|||
126237254|NCT01248247|454161684|FG003|Overall Study|Progression|44|||
126237255|NCT01248247|454161681|FG000|Overall Study|Refuse further treatment|0|||
126237256|NCT01248247|454161682|FG001|Overall Study|Refuse further treatment|0|||
126356222|NCT01471574|454597766|FG003|Treatment Period|Withdrawal by Subject|0|||
126356223|NCT01471574|454597763|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
126356224|NCT01471574|454597764|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
126356225|NCT01471574|454597765|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
126356226|NCT01471574|454597766|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
126356227|NCT01471574|454597763|FG000|Treatment Period|Lost to Follow-up|1|||
126356228|NCT01471574|454597764|FG001|Treatment Period|Lost to Follow-up|2|||
126356229|NCT01471574|454597765|FG002|Treatment Period|Lost to Follow-up|2|||
126356230|NCT01471574|454597766|FG003|Treatment Period|Lost to Follow-up|0|||
126356231|NCT01471574|454597763|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
126356232|NCT01471574|454597764|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
126356233|NCT01471574|454597765|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
126356234|NCT01471574|454597766|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
126356235|NCT01471574|454597763|FG000|Treatment Period|Other|1|||
126356236|NCT01471574|454597764|FG001|Treatment Period|Other|0|||
126356237|NCT01471574|454597765|FG002|Treatment Period|Other|0|||
126356238|NCT01471574|454597766|FG003|Treatment Period|Other|0|||
126356239|NCT01471574|454597763|FG000|Follow-up Period|Withdrawal by Subject|3|||
126356240|NCT01471574|454597764|FG001|Follow-up Period|Withdrawal by Subject|0|||
126356241|NCT01471574|454597765|FG002|Follow-up Period|Withdrawal by Subject|3|||
126356242|NCT01471574|454597766|FG003|Follow-up Period|Withdrawal by Subject|1|||
126356243|NCT01471574|454597763|FG000|Follow-up Period|Lost to Follow-up|4|||
126356244|NCT01471574|454597764|FG001|Follow-up Period|Lost to Follow-up|1|||
126356245|NCT01471574|454597765|FG002|Follow-up Period|Lost to Follow-up|3|||
126356246|NCT01471574|454597766|FG003|Follow-up Period|Lost to Follow-up|2|||
126356247|NCT01471574|454597763|FG000|Follow-up Period|Death|0|||
126356248|NCT01471574|454597764|FG001|Follow-up Period|Death|0|||
126356249|NCT01471574|454597765|FG002|Follow-up Period|Death|1|||
126356250|NCT01471574|454597766|FG003|Follow-up Period|Death|0|||
126025529|NCT04905407|453389189|FG000|Part 1 and Part 2|Other than specified|0|||
126237257|NCT01248247|454161683|FG002|Overall Study|Refuse further treatment|1|||
126237258|NCT01248247|454161684|FG003|Overall Study|Refuse further treatment|2|||
126237259|NCT01248247|454161681|FG000|Overall Study|Complicating disease|0|||
126025530|NCT04905407|453389190|FG001|Part 1 and Part 2|Other than specified|0|||
126237260|NCT01248247|454161682|FG001|Overall Study|Complicating disease|0|||
126237261|NCT01248247|454161683|FG002|Overall Study|Complicating disease|1|||
126237262|NCT01248247|454161684|FG003|Overall Study|Complicating disease|1|||
126237263|NCT01108094|454161689|FG000|Overall Study|Adverse Event|2|||
126237264|NCT01108094|454161690|FG001|Overall Study|Adverse Event|0|||
126237265|NCT01108094|454161691|FG002|Overall Study|Adverse Event|0|||
126237266|NCT01108094|454161692|FG003|Overall Study|Adverse Event|0|||
126237267|NCT01108094|454161689|FG000|Overall Study|Withdrawal by Subject|1|||
126237268|NCT01108094|454161690|FG001|Overall Study|Withdrawal by Subject|0|||
126237269|NCT01108094|454161691|FG002|Overall Study|Withdrawal by Subject|0|||
126237270|NCT01108094|454161692|FG003|Overall Study|Withdrawal by Subject|0|||
126237271|NCT00420303|454161695|FG000|Overall Study|Serious Adverse Event|1|||
126237272|NCT00420303|454161696|FG001|Overall Study|Serious Adverse Event|0|||
126237273|NCT00420303|454161695|FG000|Overall Study|Lack of Efficacy|0|||
126237274|NCT00420303|454161696|FG001|Overall Study|Lack of Efficacy|3|||
126237275|NCT00420303|454161695|FG000|Overall Study|Physician Decision|0|||
126237276|NCT00420303|454161696|FG001|Overall Study|Physician Decision|1|||
126237277|NCT04015232|454161701|FG000|Overall Study|Withdrawal by Subject|7|||
126237278|NCT04015232|454161702|FG001|Overall Study|Withdrawal by Subject|4|||
126237279|NCT04015232|454161701|FG000|Overall Study|Protocol Violation|1|||
126237280|NCT04015232|454161702|FG001|Overall Study|Protocol Violation|0|||
126237281|NCT04015232|454161701|FG000|Overall Study|Medical Grounds|3|||
126237282|NCT04015232|454161702|FG001|Overall Study|Medical Grounds|3|||
126237283|NCT01029353|454161703|FG000|Overall Study|Lost to Follow-up|4|||
126237284|NCT01029353|454161704|FG001|Overall Study|Lost to Follow-up|5|||
126237285|NCT01029353|454161705|FG002|Overall Study|Lost to Follow-up|5|||
126237286|NCT01029353|454161706|FG003|Overall Study|Lost to Follow-up|4|||
126237287|NCT01029353|454161703|FG000|Overall Study|Consent Withdrawn|2|||
126237288|NCT01029353|454161704|FG001|Overall Study|Consent Withdrawn|0|||
126237289|NCT01029353|454161705|FG002|Overall Study|Consent Withdrawn|0|||
126237290|NCT01029353|454161706|FG003|Overall Study|Consent Withdrawn|0|||
126237291|NCT01029353|454161703|FG000|Overall Study|Primary Outcome Indeterminate|1|||
126237292|NCT01029353|454161704|FG001|Overall Study|Primary Outcome Indeterminate|3|||
126237293|NCT01029353|454161705|FG002|Overall Study|Primary Outcome Indeterminate|2|||
126237294|NCT01029353|454161706|FG003|Overall Study|Primary Outcome Indeterminate|0|||
126237295|NCT01900730|454161707|FG000|Overall Study|Withdrawal by Subject|1|||
126025531|NCT04905407|453389191|FG002|Part 1 and Part 2|Other than specified|1|||
126025532|NCT04905407|453389192|FG003|Part 1 and Part 2|Other than specified|0|||
126237296|NCT01900730|454161708|FG001|Overall Study|Withdrawal by Subject|0|||
126237297|NCT01900730|454161707|FG000|Overall Study|Screen Failure|1|||
126356251|NCT01471574|454597763|FG000|Follow-up Period|Follow-up no longer required|0|||
126356252|NCT01471574|454597764|FG001|Follow-up Period|Follow-up no longer required|1|||
126356253|NCT01471574|454597765|FG002|Follow-up Period|Follow-up no longer required|0|||
126356254|NCT01471574|454597766|FG003|Follow-up Period|Follow-up no longer required|0|||
126356255|NCT00574951|454597774|FG000|Overall Study|Ineligible - improper prior treatment|1|||
126356256|NCT01160744|454597789|FG000|Overall Study|Withdrawal by Subject|11|||
126356257|NCT01160744|454597790|FG001|Overall Study|Withdrawal by Subject|5|||
126356258|NCT01160744|454597791|FG002|Overall Study|Withdrawal by Subject|6|||
126356259|NCT01160744|454597792|FG003|Overall Study|Withdrawal by Subject|4|||
126356260|NCT01160744|454597789|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
126356261|NCT01160744|454597790|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
126356262|NCT01160744|454597791|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
126356263|NCT01160744|454597792|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
126356264|NCT02056288|454597793|FG000|In-Hospital Data|Surgery cancelled|1|||
126356265|NCT02056288|454597794|FG001|In-Hospital Data|Surgery cancelled|0|||
126356266|NCT02056288|454597793|FG000|In-Hospital Data|Protocol Violation|3|||
126356267|NCT02056288|454597794|FG001|In-Hospital Data|Protocol Violation|0|||
126356268|NCT02056288|454597793|FG000|In-Hospital Data|Physician Decision|1|||
126356269|NCT02056288|454597794|FG001|In-Hospital Data|Physician Decision|0|||
126356270|NCT02056288|454597793|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
126356271|NCT02056288|454597794|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
126356272|NCT02301429|454597795|FG000|Overall Study|not acceptable vascular anatomy|3|||
126356273|NCT00500110|454597796|FG000|Overall Study|Withdrawal by Subject|3|||
126356274|NCT01502072|454597797|FG000|Overall Study|Withdrawal by Subject|1|||
126356275|NCT01502072|454597798|FG001|Overall Study|Withdrawal by Subject|0|||
126025533|NCT04905407|453389189|FG000|Part 3|Death|0|||
126237298|NCT01900730|454161708|FG001|Overall Study|Screen Failure|0|||
126237299|NCT02152566|454161711|FG000|Overall Study|Lost to Follow-up|1|||
126237300|NCT02152566|454161711|FG000|Overall Study|Withdrawal by Subject|2|||
126237301|NCT01520909|454161712|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
126237302|NCT01520909|454161713|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
126237303|NCT01520909|454161714|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
126237304|NCT01520909|454161712|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
126237305|NCT01520909|454161713|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
126237306|NCT01520909|454161714|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
126237307|NCT01520909|454161712|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
126237308|NCT01520909|454161713|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
126237309|NCT01520909|454161714|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
126237310|NCT01520909|454161712|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
126237311|NCT01520909|454161713|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
126237312|NCT01520909|454161714|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
126237313|NCT02107092|454161717|FG000|Overall Study|Miscellaneous|3|||
126237314|NCT02107092|454161717|FG000|Overall Study|Subject compliance|3|||
126237315|NCT02107092|454161717|FG000|Overall Study|Hypo-or hyperkalemia|2|||
126237316|NCT02107092|454161717|FG000|Overall Study|Met ECG withdrawal criteria|3|||
126237317|NCT02107092|454161717|FG000|Overall Study|Physician Decision|3|||
126237318|NCT02107092|454161717|FG000|Overall Study|Lost to Follow-up|2|||
126237319|NCT02107092|454161717|FG000|Overall Study|Withdrawal by Subject|9|||
126356276|NCT01502072|454597799|FG002|Overall Study|Withdrawal by Subject|0|||
126356277|NCT01502072|454597797|FG000|Overall Study|Death|0|||
126356278|NCT01502072|454597798|FG001|Overall Study|Death|1|||
126356279|NCT01502072|454597799|FG002|Overall Study|Death|0|||
126356280|NCT03954938|454597800|FG000|Overall Study|Withdrawal by Subject|2|||
126237320|NCT02107092|454161717|FG000|Overall Study|Adverse Event|7|||
126237321|NCT02107092|454161717|FG000|Overall Study|Expected progression of CKD|12|||
126356281|NCT03954938|454597800|FG000|Overall Study|Adverse Event|1|||
126356282|NCT02217982|454597801|FG000|Overall Study|Trial discontinued|1|||
126356283|NCT02217982|454597802|FG001|Overall Study|Trial discontinued|0|||
126356284|NCT02217982|454597801|FG000|Overall Study|Adverse Event|0|||
126356285|NCT02217982|454597802|FG001|Overall Study|Adverse Event|1|||
126356286|NCT04676646|454597803|FG000|Open-label Run-in Phase|Adverse Event|3|||
126356287|NCT04676646|454597804|FG001|Open-label Run-in Phase|Adverse Event|0|||
126356288|NCT04676646|454597805|FG002|Open-label Run-in Phase|Adverse Event|0|||
126356289|NCT04676646|454597803|FG000|Open-label Run-in Phase|Death|3|||
126356290|NCT04676646|454597804|FG001|Open-label Run-in Phase|Death|0|||
126356291|NCT04676646|454597805|FG002|Open-label Run-in Phase|Death|0|||
126356292|NCT04676646|454597803|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
126356293|NCT04676646|454597804|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
126356294|NCT04676646|454597805|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
126356295|NCT04676646|454597803|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
126356296|NCT04676646|454597804|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
126356297|NCT04676646|454597805|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
126356298|NCT04676646|454597803|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
126356299|NCT04676646|454597804|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
126356300|NCT04676646|454597805|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
126356301|NCT04676646|454597803|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
126356302|NCT04676646|454597804|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
126356303|NCT04676646|454597805|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
126356304|NCT04676646|454597803|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
126356305|NCT04676646|454597804|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
126356306|NCT04676646|454597805|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
126356307|NCT04676646|454597803|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
126356308|NCT04676646|454597804|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
126356309|NCT04676646|454597805|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
126356310|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
126356311|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
126356312|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
126356313|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Death|0|||
126356314|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Death|1|||
126237322|NCT00707161|454161718|FG000|Overall Study|Physician Decision|6|||
126356315|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Death|2|||
126356316|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
126237323|NCT02076022|454161719|FG000|Overall Study|Withdrawal by Subject|2|||
126237324|NCT02076022|454161720|FG001|Overall Study|Withdrawal by Subject|0|||
126237325|NCT02661295|454161725|FG000|Overall Study|Death|1|||
126237326|NCT02661295|454161725|FG000|Overall Study|Transferred Out|1|||
126237327|NCT02661295|454161725|FG000|Overall Study|Kidney Transplant|1|||
126237328|NCT02661295|454161725|FG000|Overall Study|Withdrawn due to side effects|8|||
126356317|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
126356318|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
126356319|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
126356320|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
126356321|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
126356322|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
126356323|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
126356324|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
126356325|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
126356326|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
126356327|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
126356328|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
126356329|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
126356330|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
126356331|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
126356332|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
126356333|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
126356334|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
126356335|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
126356336|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
126356337|NCT04270760|454597806|FG000|Overall Study|Withdrawal by Subject|0|||
126356338|NCT04270760|454597807|FG001|Overall Study|Withdrawal by Subject|1|||
126356339|NCT04270760|454597808|FG002|Overall Study|Withdrawal by Subject|3|||
126356340|NCT04270760|454597809|FG003|Overall Study|Withdrawal by Subject|0|||
126356341|NCT04270760|454597810|FG004|Overall Study|Withdrawal by Subject|0|||
126356342|NCT04270760|454597806|FG000|Overall Study|Lost to Follow-up|1|||
126356343|NCT04270760|454597807|FG001|Overall Study|Lost to Follow-up|2|||
126356344|NCT04270760|454597808|FG002|Overall Study|Lost to Follow-up|1|||
126356345|NCT04270760|454597809|FG003|Overall Study|Lost to Follow-up|0|||
126356346|NCT04270760|454597810|FG004|Overall Study|Lost to Follow-up|0|||
126356347|NCT04270760|454597806|FG000|Overall Study|Death|0|||
126356348|NCT04270760|454597807|FG001|Overall Study|Death|0|||
126356349|NCT04270760|454597808|FG002|Overall Study|Death|0|||
126356350|NCT04270760|454597809|FG003|Overall Study|Death|0|||
126356351|NCT04270760|454597810|FG004|Overall Study|Death|1|||
126356352|NCT02421510|454597811|FG000|Overall Study|Other|4|||
126356353|NCT02421510|454597812|FG001|Overall Study|Other|2|||
126356354|NCT02421510|454597813|FG002|Overall Study|Other|3|||
126356355|NCT02421510|454597811|FG000|Overall Study|Protocol Violation|1|||
126356356|NCT02421510|454597812|FG001|Overall Study|Protocol Violation|2|||
126356357|NCT02421510|454597813|FG002|Overall Study|Protocol Violation|0|||
126356358|NCT02421510|454597811|FG000|Overall Study|Death|1|||
126356359|NCT02421510|454597812|FG001|Overall Study|Death|0|||
126356360|NCT02421510|454597813|FG002|Overall Study|Death|0|||
126356361|NCT02421510|454597811|FG000|Overall Study|Noncompliance with study drug|1|||
126356362|NCT02421510|454597812|FG001|Overall Study|Noncompliance with study drug|0|||
126356363|NCT02421510|454597813|FG002|Overall Study|Noncompliance with study drug|0|||
126356364|NCT02421510|454597811|FG000|Overall Study|Physician Decision|1|||
126356365|NCT02421510|454597812|FG001|Overall Study|Physician Decision|1|||
126356366|NCT02421510|454597813|FG002|Overall Study|Physician Decision|3|||
126356367|NCT02421510|454597811|FG000|Overall Study|Adverse Event|9|||
126356368|NCT02421510|454597812|FG001|Overall Study|Adverse Event|10|||
126356369|NCT02421510|454597813|FG002|Overall Study|Adverse Event|18|||
126356370|NCT02421510|454597811|FG000|Overall Study|Pregnancy|1|||
126356371|NCT02421510|454597812|FG001|Overall Study|Pregnancy|1|||
126356372|NCT02421510|454597813|FG002|Overall Study|Pregnancy|0|||
126356373|NCT02421510|454597811|FG000|Overall Study|Withdrawal by Subject|14|||
126356374|NCT02421510|454597812|FG001|Overall Study|Withdrawal by Subject|18|||
126356375|NCT02421510|454597813|FG002|Overall Study|Withdrawal by Subject|12|||
126356376|NCT02421510|454597811|FG000|Overall Study|Lost to Follow-up|1|||
126356377|NCT02421510|454597812|FG001|Overall Study|Lost to Follow-up|1|||
126356378|NCT02421510|454597813|FG002|Overall Study|Lost to Follow-up|0|||
126237329|NCT02661295|454161725|FG000|Overall Study|Withdrawn due to access type|1|||
126025534|NCT04905407|453389190|FG001|Part 3|Death|0|||
126025535|NCT04905407|453389191|FG002|Part 3|Death|0|||
126025536|NCT04905407|453389192|FG003|Part 3|Death|2|||
126025537|NCT03263026|453389195|FG000|Overall Study|Withdrawal by Subject|1|||
126025538|NCT03263026|453389196|FG001|Overall Study|Withdrawal by Subject|0|||
126025539|NCT03263026|453389195|FG000|Overall Study|Death|1|||
126025540|NCT03263026|453389196|FG001|Overall Study|Death|0|||
126025541|NCT03263026|453389195|FG000|Overall Study|Other/ Various|41|||
126025542|NCT03263026|453389196|FG001|Overall Study|Other/ Various|29|||
126237330|NCT02661295|454161725|FG000|Overall Study|Withdrawn due to allergies|1|||
126237331|NCT02661295|454161725|FG000|Overall Study|Withdrawn due to non-compliance|1|||
126237332|NCT02661295|454161725|FG000|Overall Study|Withdrawal by Subject|3|||
126237333|NCT02661295|454161725|FG000|Overall Study|Failed screening|2|||
126237334|NCT00565448|454161736|FG000|Overall Study|Adverse Event|1|||
126237335|NCT00565448|454161737|FG001|Overall Study|Adverse Event|2|||
126237336|NCT00565448|454161736|FG000|Overall Study|Disease progression|1|||
126237337|NCT00565448|454161737|FG001|Overall Study|Disease progression|0|||
126237338|NCT00565448|454161736|FG000|Overall Study|Withdrawal by Subject|1|||
126237339|NCT00565448|454161737|FG001|Overall Study|Withdrawal by Subject|0|||
126237340|NCT00302952|454161739|FG000|Overall Study|Physician Decision|1|||
126237341|NCT00302952|454161740|FG001|Overall Study|Physician Decision|1|||
126237342|NCT00302952|454161739|FG000|Overall Study|Withdrawal by Subject|2|||
126237343|NCT00302952|454161740|FG001|Overall Study|Withdrawal by Subject|3|||
126237344|NCT00302952|454161739|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
126237345|NCT00302952|454161740|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
126237346|NCT02373098|454161744|FG000|Overall Study|Lost to Follow-up|1|||
126237347|NCT02373098|454161745|FG001|Overall Study|Lost to Follow-up|0|||
126237348|NCT02373098|454161744|FG000|Overall Study|Protocol Violation|3|||
126237349|NCT02373098|454161745|FG001|Overall Study|Protocol Violation|0|||
126237350|NCT02373098|454161744|FG000|Overall Study|Withdrawal by Subject|5|||
126237351|NCT02373098|454161745|FG001|Overall Study|Withdrawal by Subject|0|||
126237352|NCT02373098|454161744|FG000|Overall Study|Adverse Event|3|||
126237353|NCT02373098|454161745|FG001|Overall Study|Adverse Event|0|||
126237354|NCT02008565|454161746|FG000|Overall Study|Protocol Violation|1|||
126237355|NCT02008565|454161747|FG001|Overall Study|Protocol Violation|1|||
126237356|NCT02008565|454161748|FG002|Overall Study|Protocol Violation|2|||
126237357|NCT02008565|454161749|FG003|Overall Study|Protocol Violation|0|||
126237358|NCT02193178|454161750|FG000|Overall Study|Lost to Follow-up|1|||
126237359|NCT02193178|454161750|FG000|Overall Study|Dry eyes|1|||
126237360|NCT03435081|454161751|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
126237361|NCT03435081|454161752|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
126237362|NCT03435081|454161753|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
126237363|NCT03435081|454161751|FG000|Week 0 to Week 16|Adverse Event|2|||
126237364|NCT03435081|454161752|FG001|Week 0 to Week 16|Adverse Event|2|||
126237365|NCT03435081|454161753|FG002|Week 0 to Week 16|Adverse Event|2|||
126237366|NCT03435081|454161751|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
126237367|NCT03435081|454161752|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
126237368|NCT03435081|454161753|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
126237369|NCT03435081|454161751|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
126237370|NCT03435081|454161752|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
126237371|NCT03435081|454161753|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
126237372|NCT03435081|454161751|FG000|Week 0 to Week 16|Pregnancy|1|||
126237373|NCT03435081|454161752|FG001|Week 0 to Week 16|Pregnancy|0|||
126237374|NCT03435081|454161753|FG002|Week 0 to Week 16|Pregnancy|0|||
126237375|NCT03435081|454161751|FG000|Week 0 to Week 16|Non-compliance|1|||
126237376|NCT03435081|454161752|FG001|Week 0 to Week 16|Non-compliance|0|||
126237377|NCT03435081|454161753|FG002|Week 0 to Week 16|Non-compliance|2|||
126237378|NCT03435081|454161751|FG000|Week 0 to Week 16|Inadequate Response|0|||
126237379|NCT03435081|454161752|FG001|Week 0 to Week 16|Inadequate Response|1|||
126237380|NCT03435081|454161753|FG002|Week 0 to Week 16|Inadequate Response|0|||
126237381|NCT03435081|454161751|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
126237382|NCT03435081|454161752|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
126237383|NCT03435081|454161753|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
126237384|NCT03435081|454161751|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
126237385|NCT03435081|454161752|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
126237386|NCT03435081|454161753|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
126237387|NCT03435081|454161751|FG000|Week 16 to Week 104|Adverse Event|1|||
126237388|NCT03435081|454161752|FG001|Week 16 to Week 104|Adverse Event|0|||
126237389|NCT03435081|454161753|FG002|Week 16 to Week 104|Adverse Event|2|||
126237390|NCT03435081|454161751|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
126237391|NCT03435081|454161752|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
126237392|NCT03435081|454161753|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
126237393|NCT03435081|454161751|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
126237394|NCT03435081|454161752|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
126237395|NCT03435081|454161753|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
126237396|NCT03435081|454161751|FG000|Week 16 to Week 104|Non--Compliance|0|||
126237397|NCT03435081|454161752|FG001|Week 16 to Week 104|Non--Compliance|0|||
126237398|NCT03435081|454161753|FG002|Week 16 to Week 104|Non--Compliance|1|||
126237399|NCT00420238|454161754|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
126237400|NCT00420238|454161755|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
126237401|NCT00420238|454161754|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
126237402|NCT00420238|454161755|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
126237403|NCT00420238|454161754|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
126237404|NCT00420238|454161755|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
126237405|NCT00420238|454161754|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
126237406|NCT00420238|454161755|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
126237407|NCT00420238|454161754|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
126237408|NCT00420238|454161755|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
126237409|NCT00420238|454161754|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
126237410|NCT00420238|454161755|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
126237411|NCT05214560|454161756|FG000|Overall Study|Screening Failure|1|||
126237412|NCT05214560|454161756|FG000|Overall Study|Physician Decision|4|||
126237413|NCT05214560|454161756|FG000|Overall Study|Withdrawal by Subject|1|||
126237414|NCT05214560|454161756|FG000|Overall Study|Lost to Follow-up|2|||
126237415|NCT05214560|454161756|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
126237416|NCT05214560|454161756|FG000|Overall Study|Study physician not available for the anesthesia|3|||
126237417|NCT05214560|454161756|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
126237418|NCT05214560|454161756|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
126237419|NCT05214560|454161756|FG000|Overall Study|Surgery not performed|3|||
126237420|NCT03639311|454161757|FG000|Maintenance Phase|Lost to Follow-up|1|||
126237421|NCT03639311|454161758|FG001|Maintenance Phase|Lost to Follow-up|0|||
126237422|NCT03639311|454161759|FG002|Maintenance Phase|Lost to Follow-up|0|||
126237423|NCT03639311|454161757|FG000|Maintenance Phase|Adverse Event|1|||
126237424|NCT03639311|454161758|FG001|Maintenance Phase|Adverse Event|0|||
126237425|NCT03639311|454161759|FG002|Maintenance Phase|Adverse Event|0|||
126237426|NCT03639311|454161757|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
126237427|NCT03639311|454161758|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
126025543|NCT03739996|453389199|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
126025544|NCT03739996|453389199|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
126025545|NCT03739996|453389199|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
126025546|NCT03739996|453389199|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
126025547|NCT03739996|453389199|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
126025548|NCT03739996|453389199|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
126025549|NCT03739996|453389199|FG000|Step 3 (SOC ART)|Death|1|||
126025550|NCT03739996|453389199|FG000|Step 3 (SOC ART)|Participant moved|1|||
126025551|NCT01673984|453389200|FG000|Overall Study|Adverse Event|1|||
126025552|NCT01673984|453389201|FG001|Overall Study|Adverse Event|0|||
126025553|NCT01673984|453389200|FG000|Overall Study|Study termination|9|||
126025554|NCT01673984|453389201|FG001|Overall Study|Study termination|6|||
126025555|NCT02553642|453389202|FG000|Overall Study|Withdrawal by Subject|0|||
126025556|NCT02553642|453389203|FG001|Overall Study|Withdrawal by Subject|3|||
126025557|NCT02553642|453389202|FG000|Overall Study|Physician Decision|0|||
126025558|NCT02553642|453389203|FG001|Overall Study|Physician Decision|1|||
126237428|NCT03639311|454161759|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
126237429|NCT03639311|454161757|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
126237430|NCT03639311|454161758|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
126237431|NCT03639311|454161759|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
126237432|NCT03639311|454161757|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
126237433|NCT03639311|454161758|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
126237434|NCT03639311|454161759|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
126237435|NCT03639311|454161757|FG000|Maintenance Phase|Lack of Efficacy|1|||
126237436|NCT03639311|454161758|FG001|Maintenance Phase|Lack of Efficacy|0|||
126237437|NCT03639311|454161759|FG002|Maintenance Phase|Lack of Efficacy|0|||
126237438|NCT03018249|454161762|FG000|Overall Study|Withdrawal by Subject|2|||
126237439|NCT03018249|454161763|FG001|Overall Study|Withdrawal by Subject|2|||
126237440|NCT04320849|454161764|FG000|Overall Study|Withdrawal by Subject|4|||
126237441|NCT04320849|454161764|FG000|Overall Study|Imaging data unavailable|2|||
126237442|NCT04320849|454161764|FG000|Overall Study|Incomplete imaging|2|||
126237443|NCT00304083|454161772|FG000|Overall Study|Withdrawal by Subject|4|||
126237444|NCT00304083|454161773|FG001|Overall Study|Withdrawal by Subject|2|||
126237445|NCT00304083|454161772|FG000|Overall Study|Physician Decision|8|||
126237446|NCT00304083|454161773|FG001|Overall Study|Physician Decision|3|||
126237447|NCT00304083|454161772|FG000|Overall Study|Disease Progression|5|||
126237448|NCT00304083|454161773|FG001|Overall Study|Disease Progression|1|||
126237449|NCT00304083|454161772|FG000|Overall Study|Other|5|||
126237450|NCT00304083|454161773|FG001|Overall Study|Other|2|||
126237451|NCT03966365|454161776|FG000|Overall Study|Protocol Violation|1|||
126237452|NCT03966365|454161777|FG001|Overall Study|Protocol Violation|0|||
126237453|NCT01044732|454161778|FG000|Overall Study|Lost to Follow-up|2|||
126237454|NCT01044732|454161779|FG001|Overall Study|Lost to Follow-up|1|||
126237455|NCT01044732|454161778|FG000|Overall Study|Physician Decision|5|||
126237456|NCT01044732|454161779|FG001|Overall Study|Physician Decision|3|||
126237457|NCT01044732|454161778|FG000|Overall Study|Protocol Violation|11|||
126237458|NCT01044732|454161779|FG001|Overall Study|Protocol Violation|12|||
126237459|NCT01044732|454161778|FG000|Overall Study|Withdrawal by Subject|0|||
126237460|NCT01044732|454161779|FG001|Overall Study|Withdrawal by Subject|1|||
126237461|NCT01044732|454161778|FG000|Overall Study|Inadequate bowel preparation|11|||
126237462|NCT01044732|454161779|FG001|Overall Study|Inadequate bowel preparation|17|||
126237463|NCT01044732|454161778|FG000|Overall Study|Inability to reach cecum|5|||
126237464|NCT01044732|454161779|FG001|Overall Study|Inability to reach cecum|2|||
126237465|NCT01044732|454161778|FG000|Overall Study|Technical error or malfunction|15|||
126237466|NCT01044732|454161779|FG001|Overall Study|Technical error or malfunction|14|||
126237467|NCT00824265|454161782|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
126237468|NCT00824265|454161783|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
126237469|NCT00824265|454161782|FG000|Treatment Phase|Protocol Violation|1|||
126237470|NCT00824265|454161783|FG001|Treatment Phase|Protocol Violation|0|||
126237471|NCT00824265|454161782|FG000|Treatment Phase|Lost to Follow-up|1|||
126237472|NCT00824265|454161783|FG001|Treatment Phase|Lost to Follow-up|1|||
126237473|NCT00824265|454161782|FG000|Treatment Phase|Physician Decision|6|||
126237474|NCT00824265|454161783|FG001|Treatment Phase|Physician Decision|12|||
126237475|NCT00824265|454161782|FG000|Treatment Phase|Withdrawal by Subject|6|||
126237476|NCT00824265|454161783|FG001|Treatment Phase|Withdrawal by Subject|15|||
126025559|NCT02553642|453389202|FG000|Overall Study|Additional cancer dx|0|||
126237477|NCT00824265|454161782|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
126237478|NCT00824265|454161783|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
126237479|NCT00824265|454161782|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
126356379|NCT02609633|454597818|FG000|Overall Study|Consent Withdrawn|0|||
126025560|NCT02553642|453389203|FG001|Overall Study|Additional cancer dx|1|||
126025561|NCT02553642|453389202|FG000|Overall Study|Never started treatment|0|||
126025562|NCT02553642|453389203|FG001|Overall Study|Never started treatment|1|||
126237480|NCT00824265|454161783|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
126237481|NCT01402947|454161786|FG000|First Intervention|Adverse Event|0|||
126237482|NCT01402947|454161787|FG001|First Intervention|Adverse Event|1|||
126237483|NCT00385684|454161788|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
126237484|NCT00385684|454161789|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
126237485|NCT00385684|454161788|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
126237486|NCT00385684|454161789|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
126237487|NCT00385684|454161788|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
126237488|NCT00385684|454161789|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
126237489|NCT02801877|454161790|FG000|Overall Study|Lost to Follow-up|1|||
126237490|NCT02801877|454161791|FG001|Overall Study|Lost to Follow-up|1|||
126237491|NCT02801877|454161792|FG002|Overall Study|Lost to Follow-up|2|||
126237492|NCT02801877|454161793|FG003|Overall Study|Lost to Follow-up|0|||
126237493|NCT02801877|454161790|FG000|Overall Study|Never Started Treatment|2|||
126237494|NCT02801877|454161791|FG001|Overall Study|Never Started Treatment|0|||
126237495|NCT02801877|454161792|FG002|Overall Study|Never Started Treatment|4|||
126237496|NCT02801877|454161793|FG003|Overall Study|Never Started Treatment|0|||
126237497|NCT00591630|454161794|FG000|Overall Study|Death|0|||
126237498|NCT00591630|454161795|FG001|Overall Study|Death|0|||
126237499|NCT00591630|454161796|FG002|Overall Study|Death|1|||
126237500|NCT00591630|454161797|FG003|Overall Study|Death|0|||
126237501|NCT04349917|454163323|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
126237502|NCT04349917|454163324|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
126237503|NCT04349917|454163323|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
126237504|NCT04349917|454163324|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
126237505|NCT04188106|454163325|FG000|Overall Study|Lost to Follow-up|5|||
126237506|NCT04188106|454163325|FG000|Overall Study|Non-Compliance|1|||
126237507|NCT01042522|454163327|FG000|Overall Study|Adverse Event|1|||
126237508|NCT01042522|454163328|FG001|Overall Study|Adverse Event|2|||
126237509|NCT01042522|454163327|FG000|Overall Study|Disease Progression|5|||
126237510|NCT01042522|454163328|FG001|Overall Study|Disease Progression|0|||
126237511|NCT01042522|454163327|FG000|Overall Study|Death|1|||
126237512|NCT01042522|454163328|FG001|Overall Study|Death|0|||
126237513|NCT01042522|454163327|FG000|Overall Study|Patient Refused|0|||
126237514|NCT01042522|454163328|FG001|Overall Study|Patient Refused|3|||
126237515|NCT01042522|454163327|FG000|Overall Study|Withdrawal by Subject|1|||
126237516|NCT01042522|454163328|FG001|Overall Study|Withdrawal by Subject|1|||
126237517|NCT02424097|454163329|FG000|Overall Study|Lost to Follow-up|1|||
126237518|NCT02424097|454163330|FG001|Overall Study|Lost to Follow-up|2|||
126237519|NCT01507051|454163331|FG000|Overall Study|Withdrawal by Subject|1|||
126237520|NCT01507051|454163332|FG001|Overall Study|Withdrawal by Subject|3|||
126237521|NCT01507051|454163333|FG002|Overall Study|Withdrawal by Subject|1|||
126237522|NCT01507051|454163334|FG003|Overall Study|Withdrawal by Subject|6|||
126237523|NCT01507051|454163331|FG000|Overall Study|Physician Decision|0|||
126237524|NCT01507051|454163332|FG001|Overall Study|Physician Decision|0|||
126237525|NCT01507051|454163333|FG002|Overall Study|Physician Decision|0|||
126237526|NCT01507051|454163334|FG003|Overall Study|Physician Decision|1|||
126237527|NCT01507051|454163331|FG000|Overall Study|Adverse Event|1|||
126237528|NCT01507051|454163332|FG001|Overall Study|Adverse Event|0|||
126237529|NCT01507051|454163333|FG002|Overall Study|Adverse Event|0|||
126237530|NCT01507051|454163334|FG003|Overall Study|Adverse Event|0|||
126237531|NCT02311361|454163335|FG000|Overall Study|Did not receive treatment|0|||
126237532|NCT02311361|454163336|FG001|Overall Study|Did not receive treatment|1|||
126237533|NCT02311361|454163337|FG002|Overall Study|Did not receive treatment|0|||
126237534|NCT02311361|454163338|FG003|Overall Study|Did not receive treatment|1|||
126237535|NCT00745420|454163340|FG000|Overall Study|Ineligible|1|||
126237536|NCT02653664|454163341|FG000|Post-Treatment|Withdrawal by Subject|6|||
126237537|NCT02653664|454163342|FG001|Post-Treatment|Withdrawal by Subject|5|||
126237538|NCT02653664|454163343|FG002|Post-Treatment|Withdrawal by Subject|7|||
126237539|NCT02653664|454163341|FG000|Post-Treatment|Lost to Follow-up|8|||
126237540|NCT02653664|454163342|FG001|Post-Treatment|Lost to Follow-up|1|||
126237541|NCT02653664|454163343|FG002|Post-Treatment|Lost to Follow-up|7|||
126237542|NCT02653664|454163341|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
126237543|NCT02653664|454163342|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
126237544|NCT02653664|454163343|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
126237545|NCT02653664|454163341|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
126356380|NCT02609633|454597819|FG001|Overall Study|Consent Withdrawn|1|||
126025563|NCT04437433|453389204|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
126025564|NCT04437433|453389205|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
126237546|NCT02653664|454163342|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
126237547|NCT02653664|454163343|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
126237548|NCT02653664|454163341|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
126237549|NCT02653664|454163342|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
126237550|NCT02653664|454163343|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
126237551|NCT02653664|454163341|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
126237552|NCT02653664|454163342|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
126237553|NCT02653664|454163343|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
126237554|NCT02653664|454163341|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
126237555|NCT02653664|454163342|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
126237556|NCT02653664|454163343|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
126237557|NCT02653664|454163341|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
126237558|NCT02653664|454163342|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
126237559|NCT02653664|454163343|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
126237560|NCT02653664|454163341|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
126237561|NCT02653664|454163342|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
126237562|NCT02653664|454163343|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
126237563|NCT02653664|454163341|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
126237564|NCT02653664|454163342|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
126237565|NCT02653664|454163343|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
126237566|NCT00485472|454163344|FG000|Overall Study|Adverse Event|8|||
126237567|NCT00485472|454163345|FG001|Overall Study|Adverse Event|5|||
126237568|NCT00485472|454163344|FG000|Overall Study|Lack of Efficacy|5|||
126237569|NCT00485472|454163345|FG001|Overall Study|Lack of Efficacy|4|||
126356381|NCT02609633|454597818|FG000|Overall Study|Protocol Deviation|1|||
126356382|NCT02609633|454597819|FG001|Overall Study|Protocol Deviation|0|||
126356383|NCT02609633|454597818|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
126356384|NCT02609633|454597819|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
126356385|NCT02609633|454597818|FG000|Overall Study|Reason not Specified|2|||
126356386|NCT02609633|454597819|FG001|Overall Study|Reason not Specified|1|||
126356387|NCT01096186|454597822|FG000|Overall Study|Adverse Event|16|||
126356388|NCT01096186|454597822|FG000|Overall Study|Death|4|||
126356389|NCT01096186|454597822|FG000|Overall Study|Lack of Efficacy|4|||
126356390|NCT01096186|454597822|FG000|Overall Study|Lost to Follow-up|2|||
126356391|NCT01096186|454597822|FG000|Overall Study|Withdrawal by Subject|22|||
126356392|NCT01096186|454597822|FG000|Overall Study|Physician Decision|1|||
126356393|NCT01096186|454597822|FG000|Overall Study|Noncompliance with study drug|1|||
126356394|NCT00122187|454597823|FG000|Overall Study|Withdrew because of resource limitations|2|||
126356395|NCT00122187|454597824|FG001|Overall Study|Withdrew because of resource limitations|2|||
126356396|NCT02061592|454597825|FG000|Period 1|Withdrawal by Subject|1|||
126356397|NCT02061592|454597826|FG001|Period 1|Withdrawal by Subject|0|||
126356398|NCT02061592|454597825|FG000|Period 1|Protocol Violation|1|||
126356399|NCT02061592|454597826|FG001|Period 1|Protocol Violation|0|||
126356400|NCT02061592|454597825|FG000|Period 2|Lost to Follow-up|0|||
126356401|NCT02061592|454597826|FG001|Period 2|Lost to Follow-up|1|||
126356402|NCT03338023|454597827|FG000|Overall Study|Withdrawal by Subject|3|||
126356403|NCT03338023|454597828|FG001|Overall Study|Withdrawal by Subject|4|||
126356404|NCT03338023|454597827|FG000|Overall Study|Protocol Violation|3|||
126356405|NCT03338023|454597828|FG001|Overall Study|Protocol Violation|3|||
126356406|NCT03338023|454597827|FG000|Overall Study|Lost to Follow-up|2|||
126356407|NCT03338023|454597828|FG001|Overall Study|Lost to Follow-up|1|||
126356408|NCT03338023|454597827|FG000|Overall Study|Physician Decision|1|||
126356409|NCT03338023|454597828|FG001|Overall Study|Physician Decision|2|||
126356410|NCT00685698|454597829|FG000|Overall Study|Withdrawal by Subject|1|||
126356411|NCT00685698|454597829|FG000|Overall Study|Protocol Violation|6|||
126356412|NCT00685698|454597829|FG000|Overall Study|Adverse Event|3|||
126356413|NCT00685698|454597829|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
126356414|NCT00685698|454597829|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
126356415|NCT00685698|454597829|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
126356416|NCT05061706|454597831|FG000|Overall Study|Adverse Event|29|||
126356417|NCT05061706|454597832|FG001|Overall Study|Adverse Event|1|||
126356418|NCT05061706|454597831|FG000|Overall Study|Lack of Efficacy|0|||
126356419|NCT05061706|454597832|FG001|Overall Study|Lack of Efficacy|1|||
126356420|NCT05061706|454597831|FG000|Overall Study|Lost to Follow-up|2|||
126356421|NCT05061706|454597832|FG001|Overall Study|Lost to Follow-up|2|||
126356422|NCT05061706|454597831|FG000|Overall Study|Protocol Violation|3|||
126356423|NCT05061706|454597832|FG001|Overall Study|Protocol Violation|1|||
126237570|NCT00485472|454163344|FG000|Overall Study|Withdrawal by Subject|1|||
126356424|NCT05061706|454597831|FG000|Overall Study|Withdrawal by Subject|3|||
126356425|NCT05061706|454597832|FG001|Overall Study|Withdrawal by Subject|9|||
126356426|NCT00724893|454597833|FG000|Overall Study|Adverse Event|76|||
126356427|NCT00724893|454597834|FG001|Overall Study|Adverse Event|142|||
126356428|NCT00724893|454597833|FG000|Overall Study|Withdrawal by Subject|0|||
126356429|NCT00724893|454597834|FG001|Overall Study|Withdrawal by Subject|1|||
126356430|NCT00724893|454597833|FG000|Overall Study|Lack of virologic response|94|||
126356431|NCT00724893|454597834|FG001|Overall Study|Lack of virologic response|202|||
126356432|NCT00724893|454597833|FG000|Overall Study|Reason not specified|193|||
126356433|NCT00724893|454597834|FG001|Overall Study|Reason not specified|7|||
126356434|NCT00724893|454597833|FG000|Overall Study|Patient choice|0|||
126356435|NCT00724893|454597834|FG001|Overall Study|Patient choice|26|||
126356436|NCT00724893|454597833|FG000|Overall Study|Geographic reasons|0|||
126237571|NCT00485472|454163345|FG001|Overall Study|Withdrawal by Subject|0|||
126237572|NCT00485472|454163344|FG000|Overall Study|Protocol Violation|0|||
126237573|NCT00485472|454163345|FG001|Overall Study|Protocol Violation|1|||
126237574|NCT00485472|454163344|FG000|Overall Study|Other|2|||
126237575|NCT00485472|454163345|FG001|Overall Study|Other|1|||
126237576|NCT00485472|454163344|FG000|Overall Study|Lost to Follow-up|0|||
126237577|NCT00485472|454163345|FG001|Overall Study|Lost to Follow-up|1|||
126237578|NCT00088829|454163347|FG000|Overall Study|PI left institution and study was close|22|||
126237579|NCT00633594|454163348|FG000|Overall Study|Adverse Event|0|||
126237580|NCT00633594|454163349|FG001|Overall Study|Adverse Event|4|||
126237581|NCT00633594|454163350|FG002|Overall Study|Adverse Event|7|||
126237582|NCT00633594|454163348|FG000|Overall Study|Death|0|||
126237583|NCT00633594|454163349|FG001|Overall Study|Death|1|||
126237584|NCT00633594|454163350|FG002|Overall Study|Death|2|||
126237585|NCT00633594|454163348|FG000|Overall Study|Disease Progression|0|||
126237586|NCT00633594|454163349|FG001|Overall Study|Disease Progression|0|||
126237587|NCT00633594|454163350|FG002|Overall Study|Disease Progression|1|||
126237588|NCT00365300|454163355|FG000|Open-label Phase|Adverse Event|4|||
126237589|NCT00365300|454163356|FG001|Open-label Phase|Adverse Event|0|||
126237590|NCT00365300|454163355|FG000|Open-label Phase|Failed to Return|1|||
126237591|NCT00365300|454163356|FG001|Open-label Phase|Failed to Return|0|||
126237592|NCT00365300|454163355|FG000|Open-label Phase|Physician Decision|1|||
126237593|NCT00365300|454163356|FG001|Open-label Phase|Physician Decision|0|||
126237594|NCT00365300|454163355|FG000|Open-label Phase|Noncompliance|9|||
126237595|NCT00365300|454163356|FG001|Open-label Phase|Noncompliance|0|||
126237596|NCT00365300|454163355|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
126237597|NCT00365300|454163356|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
126237598|NCT00365300|454163355|FG000|Open-label Phase|Protocol Violation|1|||
126237599|NCT00365300|454163356|FG001|Open-label Phase|Protocol Violation|0|||
126237600|NCT00365300|454163355|FG000|Open-label Phase|Lack of Efficacy|1|||
126237601|NCT00365300|454163356|FG001|Open-label Phase|Lack of Efficacy|0|||
126237602|NCT00365300|454163355|FG000|Open-label Phase|Patient skipped open label phase|1|||
126237603|NCT00365300|454163356|FG001|Open-label Phase|Patient skipped open label phase|0|||
126237604|NCT00365300|454163355|FG000|Double-blind Phase|Failed to return|1|||
126237605|NCT00365300|454163356|FG001|Double-blind Phase|Failed to return|0|||
126237606|NCT00365300|454163355|FG000|Double-blind Phase|Noncompliance|1|||
126237607|NCT00365300|454163356|FG001|Double-blind Phase|Noncompliance|1|||
126237608|NCT00365300|454163355|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126237609|NCT00365300|454163356|FG001|Double-blind Phase|Withdrawal by Subject|1|||
126237610|NCT00365300|454163355|FG000|Double-blind Phase|Protocol Violation|3|||
126237611|NCT00365300|454163356|FG001|Double-blind Phase|Protocol Violation|1|||
126237612|NCT00365300|454163355|FG000|Double-blind Phase|Lack of Efficacy|6|||
126237613|NCT00365300|454163356|FG001|Double-blind Phase|Lack of Efficacy|6|||
126237614|NCT01287013|454163358|FG000|Overall Study|Non-evaluable|3|||
126237615|NCT01287013|454163359|FG001|Overall Study|Non-evaluable|5|||
126237616|NCT01287013|454163360|FG002|Overall Study|Non-evaluable|21|||
126237617|NCT01179048|454163361|FG000|Overall Study|Withdrawn - does not allow contact|4|||
126237618|NCT01179048|454163362|FG001|Overall Study|Withdrawn - does not allow contact|8|||
126237619|NCT01179048|454163361|FG000|Overall Study|Lost to Follow-up|8|||
126237620|NCT01179048|454163362|FG001|Overall Study|Lost to Follow-up|9|||
126237621|NCT01179048|454163361|FG000|Overall Study|Alive|127|||
126237622|NCT01179048|454163362|FG001|Overall Study|Alive|142|||
126237623|NCT02109042|454163363|FG000|Overall Study|Sponsor Decision|15|||
126237624|NCT03203447|454163364|FG000|Overall Study|Withdrawal by Subject|2|||
126237625|NCT03203447|454163365|FG001|Overall Study|Withdrawal by Subject|1|||
126237626|NCT03203447|454163364|FG000|Overall Study|Lost to Follow-up|1|||
126237627|NCT03203447|454163365|FG001|Overall Study|Lost to Follow-up|10|||
126237628|NCT03203447|454163364|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
126237629|NCT03203447|454163365|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
126237630|NCT00528606|454163367|FG000|Overall Study|Withdrew consent|4|||
126237631|NCT00528606|454163368|FG001|Overall Study|Withdrew consent|3|||
126237632|NCT00528606|454163367|FG000|Overall Study|Lost to Follow-up|4|||
126237633|NCT00528606|454163368|FG001|Overall Study|Lost to Follow-up|1|||
126237634|NCT00528606|454163367|FG000|Overall Study|Adverse Event|3|||
126237635|NCT00528606|454163368|FG001|Overall Study|Adverse Event|0|||
126237636|NCT00528606|454163367|FG000|Overall Study|Other|2|||
126237637|NCT00528606|454163368|FG001|Overall Study|Other|0|||
126237638|NCT03478397|454163375|FG000|Overall Study|Refused to participate|31|||
126237639|NCT03478397|454163376|FG001|Overall Study|Refused to participate|7|||
126237640|NCT02942264|454163377|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126237641|NCT02942264|454163378|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
126237642|NCT02942264|454163379|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126237643|NCT02942264|454163380|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126237644|NCT02942264|454163381|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126237645|NCT02942264|454163382|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126237646|NCT02942264|454163383|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
126237647|NCT02942264|454163384|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126237648|NCT02942264|454163385|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126237649|NCT02942264|454163377|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126237650|NCT02942264|454163378|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126237651|NCT02942264|454163379|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126237652|NCT02942264|454163380|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126237653|NCT02942264|454163381|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126237654|NCT02942264|454163382|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126237655|NCT02942264|454163383|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126237656|NCT02942264|454163384|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126237657|NCT02942264|454163385|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
126237658|NCT02188303|454163386|FG000|Overall Study|Adverse Event|0|||
126237659|NCT02188303|454163387|FG001|Overall Study|Adverse Event|0|||
126237660|NCT02188303|454163388|FG002|Overall Study|Adverse Event|0|||
126237661|NCT02188303|454163389|FG003|Overall Study|Adverse Event|0|||
126237662|NCT02188303|454163390|FG004|Overall Study|Adverse Event|0|||
126237663|NCT02188303|454163391|FG005|Overall Study|Adverse Event|2|||
126237664|NCT02188303|454163392|FG006|Overall Study|Adverse Event|0|||
126237665|NCT02188303|454163393|FG007|Overall Study|Adverse Event|2|||
126237666|NCT02188303|454163386|FG000|Overall Study|Dose Termination Criteria Met|0|||
126237667|NCT02188303|454163387|FG001|Overall Study|Dose Termination Criteria Met|0|||
126237668|NCT02188303|454163388|FG002|Overall Study|Dose Termination Criteria Met|0|||
126237669|NCT02188303|454163389|FG003|Overall Study|Dose Termination Criteria Met|0|||
126237670|NCT02188303|454163390|FG004|Overall Study|Dose Termination Criteria Met|0|||
126237671|NCT02188303|454163391|FG005|Overall Study|Dose Termination Criteria Met|0|||
126237672|NCT02188303|454163392|FG006|Overall Study|Dose Termination Criteria Met|2|||
126237673|NCT02188303|454163393|FG007|Overall Study|Dose Termination Criteria Met|4|||
126237674|NCT04206332|454163394|FG000|Part A|Lost to Follow-up|0|||
126237675|NCT04206332|454163395|FG001|Part A|Lost to Follow-up|1|||
126237676|NCT04206332|454163396|FG002|Part A|Lost to Follow-up|0|||
126237677|NCT04206332|454163397|FG003|Part A|Lost to Follow-up|0|||
126237678|NCT04206332|454163398|FG004|Part A|Lost to Follow-up|0|||
126237679|NCT04206332|454163399|FG005|Part A|Lost to Follow-up|0|||
126237680|NCT04206332|454163400|FG006|Part A|Lost to Follow-up|0|||
126237681|NCT04206332|454163401|FG007|Part A|Lost to Follow-up|0|||
126237682|NCT04206332|454163402|FG008|Part A|Lost to Follow-up|0|||
126237683|NCT04206332|454163403|FG009|Part A|Lost to Follow-up|0|||
126237684|NCT04206332|454163404|FG010|Part A|Lost to Follow-up|0|||
126237685|NCT04206332|454163405|FG011|Part A|Lost to Follow-up|0|||
126237686|NCT04206332|454163406|FG012|Part A|Lost to Follow-up|0|||
126237687|NCT04206332|454163407|FG013|Part A|Lost to Follow-up|0|||
126237688|NCT04206332|454163408|FG014|Part A|Lost to Follow-up|0|||
126237689|NCT04206332|454163409|FG015|Part A|Lost to Follow-up|0|||
126237690|NCT04206332|454163410|FG016|Part A|Lost to Follow-up|0|||
126237691|NCT04206332|454163394|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237692|NCT04206332|454163395|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237693|NCT04206332|454163396|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237694|NCT04206332|454163397|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237695|NCT04206332|454163398|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237696|NCT04206332|454163399|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
126237697|NCT04206332|454163400|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237698|NCT04206332|454163401|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126025565|NCT04437433|453389204|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
126025566|NCT04437433|453389205|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
126025567|NCT04437433|453389204|FG000|Overall Study|Adverse Event|9|||
126237699|NCT04206332|454163402|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237700|NCT04206332|454163403|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237701|NCT04206332|454163404|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237702|NCT04206332|454163405|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237703|NCT04206332|454163406|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237704|NCT04206332|454163407|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237705|NCT04206332|454163408|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237706|NCT04206332|454163409|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237707|NCT04206332|454163410|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126237708|NCT04206332|454163394|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237709|NCT04206332|454163395|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237710|NCT04206332|454163396|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237711|NCT04206332|454163397|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237712|NCT04206332|454163398|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237713|NCT04206332|454163399|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237714|NCT04206332|454163400|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237715|NCT04206332|454163401|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
126237716|NCT04206332|454163402|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237717|NCT04206332|454163403|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237718|NCT04206332|454163404|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
126237719|NCT04206332|454163405|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237720|NCT04206332|454163406|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237721|NCT04206332|454163407|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237722|NCT04206332|454163408|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237723|NCT04206332|454163409|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237724|NCT04206332|454163410|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237725|NCT04206332|454163394|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237726|NCT04206332|454163395|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237727|NCT04206332|454163396|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237728|NCT04206332|454163397|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237729|NCT04206332|454163398|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237730|NCT04206332|454163399|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237731|NCT04206332|454163400|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126306193|NCT03260244|454410221|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
126025568|NCT04437433|453389205|FG001|Overall Study|Adverse Event|0|||
126025569|NCT04437433|453389204|FG000|Overall Study|Lack of Efficacy|4|||
126025570|NCT04437433|453389205|FG001|Overall Study|Lack of Efficacy|0|||
126025571|NCT04437433|453389204|FG000|Overall Study|Withdrawal by Subject|4|||
126025572|NCT04437433|453389205|FG001|Overall Study|Withdrawal by Subject|1|||
126025573|NCT04437433|453389204|FG000|Overall Study|Protocol Deviation|0|||
126025574|NCT04437433|453389205|FG001|Overall Study|Protocol Deviation|1|||
126025575|NCT04437433|453389204|FG000|Overall Study|Other, not specified|0|||
126025576|NCT04437433|453389205|FG001|Overall Study|Other, not specified|1|||
126237732|NCT04206332|454163401|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237733|NCT04206332|454163402|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237734|NCT04206332|454163403|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237735|NCT04206332|454163404|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237736|NCT04206332|454163405|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237737|NCT04206332|454163406|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237738|NCT04206332|454163407|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237739|NCT04206332|454163408|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237740|NCT04206332|454163409|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126237741|NCT04206332|454163410|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
126237742|NCT04206332|454163394|FG000|Part C|Withdrawal by Subject|0|||
126237743|NCT04206332|454163395|FG001|Part C|Withdrawal by Subject|0|||
126237744|NCT04206332|454163396|FG002|Part C|Withdrawal by Subject|0|||
126237745|NCT04206332|454163397|FG003|Part C|Withdrawal by Subject|0|||
126237746|NCT04206332|454163398|FG004|Part C|Withdrawal by Subject|0|||
126237747|NCT04206332|454163399|FG005|Part C|Withdrawal by Subject|0|||
126237748|NCT04206332|454163400|FG006|Part C|Withdrawal by Subject|0|||
126237749|NCT04206332|454163401|FG007|Part C|Withdrawal by Subject|0|||
126237750|NCT04206332|454163402|FG008|Part C|Withdrawal by Subject|0|||
126237751|NCT04206332|454163403|FG009|Part C|Withdrawal by Subject|0|||
126237752|NCT04206332|454163404|FG010|Part C|Withdrawal by Subject|0|||
126237753|NCT04206332|454163405|FG011|Part C|Withdrawal by Subject|0|||
126237754|NCT04206332|454163406|FG012|Part C|Withdrawal by Subject|0|||
126237755|NCT04206332|454163407|FG013|Part C|Withdrawal by Subject|0|||
126237756|NCT04206332|454163408|FG014|Part C|Withdrawal by Subject|2|||
126237757|NCT04206332|454163409|FG015|Part C|Withdrawal by Subject|0|||
126237758|NCT04206332|454163410|FG016|Part C|Withdrawal by Subject|0|||
126237759|NCT00569374|454163415|FG000|Overall Study|Withdrawal by Subject|4|||
126237760|NCT00912288|454163416|FG000|Overall Study|Death|0|||
126237761|NCT00912288|454163417|FG001|Overall Study|Death|1|||
126237762|NCT00912288|454163416|FG000|Overall Study|Adverse Event|1|||
126237763|NCT00912288|454163417|FG001|Overall Study|Adverse Event|1|||
126237764|NCT00912288|454163416|FG000|Overall Study|Lost to Follow-up|1|||
126237765|NCT00912288|454163417|FG001|Overall Study|Lost to Follow-up|0|||
126237766|NCT00912288|454163416|FG000|Overall Study|Protocol Violation|1|||
126237767|NCT00912288|454163417|FG001|Overall Study|Protocol Violation|0|||
126237768|NCT00912288|454163416|FG000|Overall Study|Withdrawal by Subject|3|||
126237769|NCT00912288|454163417|FG001|Overall Study|Withdrawal by Subject|3|||
126237770|NCT00912288|454163416|FG000|Overall Study|Study terminated by sponsor|34|||
126093628|NCT02003222|453636114|FG004|Intensification|Disease progression|18|||
126093629|NCT02003222|453636110|FG000|Intensification|Withdrawal by Subject|0|||
126093630|NCT02003222|453636111|FG001|Intensification|Withdrawal by Subject|0|||
126093631|NCT02003222|453636112|FG002|Intensification|Withdrawal by Subject|0|||
126093632|NCT02003222|453636113|FG003|Intensification|Withdrawal by Subject|0|||
126093633|NCT02003222|453636114|FG004|Intensification|Withdrawal by Subject|5|||
126093634|NCT02003222|453636110|FG000|Intensification|Other reasons|0|||
126237771|NCT00912288|454163417|FG001|Overall Study|Study terminated by sponsor|35|||
126237772|NCT00912288|454163416|FG000|Overall Study|Other|1|||
126237773|NCT00912288|454163417|FG001|Overall Study|Other|0|||
126237774|NCT00050778|454163420|FG000|Overall Study|Adverse Event|13|||
126237775|NCT00050778|454163421|FG001|Overall Study|Adverse Event|3|||
126237776|NCT00050778|454163422|FG002|Overall Study|Adverse Event|2|||
126237777|NCT00050778|454163420|FG000|Overall Study|Death|0|||
126237778|NCT00050778|454163421|FG001|Overall Study|Death|1|||
126237779|NCT00050778|454163422|FG002|Overall Study|Death|1|||
126237780|NCT00050778|454163420|FG000|Overall Study|Lack of Efficacy|16|||
126237781|NCT00050778|454163421|FG001|Overall Study|Lack of Efficacy|2|||
126237782|NCT00050778|454163422|FG002|Overall Study|Lack of Efficacy|2|||
126237783|NCT00050778|454163420|FG000|Overall Study|Lost to Follow-up|0|||
126237784|NCT00050778|454163421|FG001|Overall Study|Lost to Follow-up|2|||
126237785|NCT00050778|454163422|FG002|Overall Study|Lost to Follow-up|4|||
126237786|NCT00050778|454163420|FG000|Overall Study|Physician Decision|3|||
126237787|NCT00050778|454163421|FG001|Overall Study|Physician Decision|0|||
126237788|NCT00050778|454163422|FG002|Overall Study|Physician Decision|2|||
126237789|NCT00050778|454163420|FG000|Overall Study|Protocol Violation|2|||
126237790|NCT00050778|454163421|FG001|Overall Study|Protocol Violation|0|||
126237791|NCT00050778|454163422|FG002|Overall Study|Protocol Violation|1|||
126237792|NCT00050778|454163420|FG000|Overall Study|Withdrawal by Subject|6|||
126237793|NCT00050778|454163421|FG001|Overall Study|Withdrawal by Subject|8|||
126237794|NCT00050778|454163422|FG002|Overall Study|Withdrawal by Subject|4|||
126237795|NCT00050778|454163420|FG000|Overall Study|Randomized but not treated|4|||
126237796|NCT00050778|454163421|FG001|Overall Study|Randomized but not treated|5|||
126237797|NCT00050778|454163422|FG002|Overall Study|Randomized but not treated|2|||
126237798|NCT00050778|454163420|FG000|Overall Study|Familial and personal reasons|1|||
126237799|NCT00050778|454163421|FG001|Overall Study|Familial and personal reasons|0|||
126237800|NCT00050778|454163422|FG002|Overall Study|Familial and personal reasons|0|||
126237801|NCT01126736|454163425|FG000|Overall Study|Death|2|||
126237802|NCT01126736|454163426|FG001|Overall Study|Death|2|||
126237803|NCT01126736|454163427|FG002|Overall Study|Death|1|||
126237804|NCT01126736|454163428|FG003|Overall Study|Death|19|||
126237805|NCT01126736|454163429|FG004|Overall Study|Death|19|||
126237806|NCT01126736|454163425|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
126237807|NCT01126736|454163426|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
126237808|NCT01126736|454163427|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
126237809|NCT01126736|454163428|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
126237810|NCT01126736|454163429|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
126237811|NCT01126736|454163425|FG000|Overall Study|Lost to Follow-up|0|||
126237812|NCT01126736|454163426|FG001|Overall Study|Lost to Follow-up|0|||
126237813|NCT01126736|454163427|FG002|Overall Study|Lost to Follow-up|0|||
126237814|NCT01126736|454163428|FG003|Overall Study|Lost to Follow-up|1|||
126237815|NCT01126736|454163429|FG004|Overall Study|Lost to Follow-up|1|||
126237816|NCT01126736|454163425|FG000|Overall Study|Administrative reasons|0|||
126237817|NCT01126736|454163426|FG001|Overall Study|Administrative reasons|0|||
126237818|NCT01126736|454163427|FG002|Overall Study|Administrative reasons|0|||
126237819|NCT01126736|454163428|FG003|Overall Study|Administrative reasons|0|||
126237820|NCT01126736|454163429|FG004|Overall Study|Administrative reasons|1|||
126237821|NCT01126736|454163425|FG000|Overall Study|Progressive disease|0|||
126237822|NCT01126736|454163426|FG001|Overall Study|Progressive disease|0|||
126237823|NCT01126736|454163427|FG002|Overall Study|Progressive disease|0|||
126237824|NCT01126736|454163428|FG003|Overall Study|Progressive disease|2|||
126237825|NCT01126736|454163429|FG004|Overall Study|Progressive disease|1|||
126237826|NCT01126736|454163425|FG000|Overall Study|Withdrawal by Subject|0|||
126237827|NCT01126736|454163426|FG001|Overall Study|Withdrawal by Subject|0|||
126237828|NCT01126736|454163427|FG002|Overall Study|Withdrawal by Subject|0|||
126237829|NCT01126736|454163428|FG003|Overall Study|Withdrawal by Subject|1|||
126237830|NCT01126736|454163429|FG004|Overall Study|Withdrawal by Subject|1|||
126237831|NCT01126736|454163425|FG000|Overall Study|Other|2|||
126237832|NCT01126736|454163426|FG001|Overall Study|Other|4|||
126237833|NCT01126736|454163427|FG002|Overall Study|Other|4|||
126237834|NCT01126736|454163428|FG003|Overall Study|Other|16|||
126237835|NCT01126736|454163429|FG004|Overall Study|Other|15|||
126237836|NCT00064753|454163430|FG000|Overall Study|Death|251|||
126237837|NCT00064753|454163431|FG001|Overall Study|Death|242|||
126237838|NCT00064753|454163430|FG000|Overall Study|Withdrawal by Subject|198|||
126237839|NCT00064753|454163431|FG001|Overall Study|Withdrawal by Subject|171|||
126237840|NCT00064753|454163430|FG000|Overall Study|Lost to Follow-up|225|||
126237841|NCT00064753|454163431|FG001|Overall Study|Lost to Follow-up|235|||
126237842|NCT00813293|454163437|FG000|Overall Study|Intercurrent illness|1|||
126237843|NCT00813293|454163438|FG001|Overall Study|Intercurrent illness|0|||
126237844|NCT00813293|454163437|FG000|Overall Study|Adverse Event|0|||
126237845|NCT00813293|454163438|FG001|Overall Study|Adverse Event|1|||
126237846|NCT01544127|454163439|FG000|Overall Study|Lost to Follow-up|4|||
126237847|NCT01544127|454163440|FG001|Overall Study|Lost to Follow-up|2|||
126237848|NCT01544127|454163441|FG002|Overall Study|Lost to Follow-up|9|||
126237849|NCT01544127|454163439|FG000|Overall Study|Withdrawal by Subject|2|||
126237850|NCT01544127|454163440|FG001|Overall Study|Withdrawal by Subject|2|||
126237851|NCT01544127|454163441|FG002|Overall Study|Withdrawal by Subject|1|||
126237852|NCT01544127|454163439|FG000|Overall Study|Discharged out of catchment area|1|||
126237853|NCT01544127|454163440|FG001|Overall Study|Discharged out of catchment area|1|||
126237854|NCT01544127|454163441|FG002|Overall Study|Discharged out of catchment area|1|||
126237855|NCT01544127|454163439|FG000|Overall Study|Death|1|||
126237856|NCT01544127|454163440|FG001|Overall Study|Death|0|||
126237857|NCT01544127|454163441|FG002|Overall Study|Death|0|||
126237858|NCT01544127|454163439|FG000|Overall Study|Jail or Prison|1|||
126237859|NCT01544127|454163440|FG001|Overall Study|Jail or Prison|1|||
126237860|NCT01544127|454163441|FG002|Overall Study|Jail or Prison|2|||
126237861|NCT01544127|454163439|FG000|Overall Study|Became Psychotic|1|||
126237862|NCT01544127|454163440|FG001|Overall Study|Became Psychotic|0|||
126237863|NCT01544127|454163441|FG002|Overall Study|Became Psychotic|0|||
126237864|NCT01544127|454163439|FG000|Overall Study|Researcher withdrew|1|||
126237865|NCT01544127|454163440|FG001|Overall Study|Researcher withdrew|0|||
126237866|NCT01544127|454163441|FG002|Overall Study|Researcher withdrew|0|||
126237867|NCT01544127|454163439|FG000|Overall Study|Went active duty|0|||
126237868|NCT01544127|454163440|FG001|Overall Study|Went active duty|0|||
126237869|NCT01544127|454163441|FG002|Overall Study|Went active duty|1|||
126237870|NCT00533273|454163442|FG000|Double-blind|Withdrew consent|0|||
126237871|NCT00533273|454163443|FG001|Double-blind|Withdrew consent|2|||
126237872|NCT00533273|454163442|FG000|Open-label|Withdrawal by Subject|6|||
126237873|NCT00533273|454163443|FG001|Open-label|Withdrawal by Subject|0|||
126237874|NCT02914600|454163447|FG000|Overall Study|Adverse Event|298|||
126237875|NCT02914600|454163448|FG001|Overall Study|Adverse Event|35|||
126237876|NCT02914600|454163449|FG002|Overall Study|Adverse Event|25|||
126237877|NCT02914600|454163447|FG000|Overall Study|Sponsors decision|287|||
126237878|NCT02914600|454163448|FG001|Overall Study|Sponsors decision|41|||
126237879|NCT02914600|454163449|FG002|Overall Study|Sponsors decision|12|||
126237880|NCT02914600|454163447|FG000|Overall Study|Withdrawal by Subject|158|||
126237881|NCT02914600|454163448|FG001|Overall Study|Withdrawal by Subject|20|||
126237882|NCT02914600|454163449|FG002|Overall Study|Withdrawal by Subject|18|||
126237883|NCT02914600|454163447|FG000|Overall Study|Investigators discretion|169|||
126237884|NCT02914600|454163448|FG001|Overall Study|Investigators discretion|14|||
126237885|NCT02914600|454163449|FG002|Overall Study|Investigators discretion|13|||
126237886|NCT02914600|454163447|FG000|Overall Study|Lost to Follow-up|10|||
126237887|NCT02914600|454163448|FG001|Overall Study|Lost to Follow-up|4|||
126237888|NCT02914600|454163449|FG002|Overall Study|Lost to Follow-up|0|||
126237889|NCT02914600|454163447|FG000|Overall Study|Pregnancy|8|||
126237890|NCT02914600|454163448|FG001|Overall Study|Pregnancy|0|||
126237891|NCT02914600|454163449|FG002|Overall Study|Pregnancy|0|||
126237892|NCT02914600|454163447|FG000|Overall Study|Protocol Violation|5|||
126237893|NCT02914600|454163448|FG001|Overall Study|Protocol Violation|3|||
126237894|NCT02914600|454163449|FG002|Overall Study|Protocol Violation|0|||
126356437|NCT00724893|454597834|FG001|Overall Study|Geographic reasons|11|||
126356438|NCT00724893|454597833|FG000|Overall Study|Incarceration|0|||
126356439|NCT00724893|454597834|FG001|Overall Study|Incarceration|9|||
126356440|NCT00724893|454597833|FG000|Overall Study|Substance abuse|0|||
126356441|NCT00724893|454597834|FG001|Overall Study|Substance abuse|3|||
126356442|NCT00724893|454597833|FG000|Overall Study|Financial reasons|0|||
126356443|NCT00724893|454597834|FG001|Overall Study|Financial reasons|2|||
126237895|NCT02914600|454163447|FG000|Overall Study|Non-compliance with study drug|6|||
126237896|NCT02914600|454163448|FG001|Overall Study|Non-compliance with study drug|1|||
126237897|NCT02914600|454163449|FG002|Overall Study|Non-compliance with study drug|0|||
126237898|NCT02914600|454163447|FG000|Overall Study|Death|3|||
126237899|NCT02914600|454163448|FG001|Overall Study|Death|1|||
126237900|NCT02914600|454163449|FG002|Overall Study|Death|1|||
126356444|NCT00724893|454597833|FG000|Overall Study|Assigned shorter treatment|0|||
126237901|NCT02914600|454163447|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
126237902|NCT02914600|454163448|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
126356445|NCT00724893|454597834|FG001|Overall Study|Assigned shorter treatment|2|||
126237903|NCT02914600|454163449|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
126237904|NCT02914600|454163447|FG000|Overall Study|Enrolled but not treated|1|||
126237905|NCT02914600|454163448|FG001|Overall Study|Enrolled but not treated|0|||
126237906|NCT02914600|454163449|FG002|Overall Study|Enrolled but not treated|0|||
126237907|NCT00454909|454163450|FG000|Overall Study|Withdrawal by Subject|1|||
126237908|NCT00454909|454163451|FG001|Overall Study|Withdrawal by Subject|0|||
126237909|NCT00454909|454163452|FG002|Overall Study|Withdrawal by Subject|0|||
126237910|NCT00454909|454163450|FG000|Overall Study|Migrated/moved from study area|0|||
126237911|NCT00454909|454163451|FG001|Overall Study|Migrated/moved from study area|0|||
126237912|NCT00454909|454163452|FG002|Overall Study|Migrated/moved from study area|1|||
126237913|NCT00454909|454163450|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
126237914|NCT00454909|454163451|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
126237915|NCT00454909|454163452|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
126237916|NCT00454909|454163450|FG000|Overall Study|Others|1|||
126237917|NCT00454909|454163451|FG001|Overall Study|Others|0|||
126237918|NCT00454909|454163452|FG002|Overall Study|Others|0|||
126237919|NCT02457520|454163453|FG000|Active Treatment Phase|Adverse Event|10|||
126237920|NCT02457520|454163453|FG000|Active Treatment Phase|Lost to Follow-up|8|||
126237921|NCT02457520|454163453|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
126237922|NCT02457520|454163453|FG000|Active Treatment Phase|other|4|||
126237923|NCT02457520|454163453|FG000|Active Treatment Phase|Physician Decision|1|||
126237924|NCT02457520|454163453|FG000|Active Treatment Phase|Protocol Violation|1|||
126237925|NCT02457520|454163453|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
126237926|NCT02457520|454163453|FG000|Post-treatment Period|Other: Retreatment Required|7|||
126237927|NCT02457520|454163453|FG000|Post-treatment Period|Lost to Follow-up|23|||
126237928|NCT02457520|454163453|FG000|Post-treatment Period|Other|3|||
126237929|NCT02457520|454163453|FG000|Post-treatment Period|Physician Decision|1|||
126237930|NCT02457520|454163453|FG000|Post-treatment Period|Withdrawal by Subject|14|||
126237931|NCT00282048|454163454|FG000|Overall Study|Lack of Efficacy|30|||
126237932|NCT00282048|454163454|FG000|Overall Study|Adverse Event|22|||
126237933|NCT00282048|454163454|FG000|Overall Study|Withdrawal by Subject|1|||
126237934|NCT00282048|454163454|FG000|Overall Study|Other|8|||
126237935|NCT00282048|454163454|FG000|Overall Study|Ongoing|1|||
126237936|NCT03522675|454163456|FG000|Overall Study|Screen fail|1|||
126237937|NCT03522675|454163456|FG000|Overall Study|Non-reactive to histamine|1|||
126237938|NCT00312663|454163459|FG000|Immunization Phase|Adverse Event|0|||
126237939|NCT00312663|454163460|FG001|Immunization Phase|Adverse Event|1|||
126237940|NCT00312663|454163461|FG002|Immunization Phase|Adverse Event|0|||
126237941|NCT01536405|454163462|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
126237942|NCT01536405|454163463|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
126237943|NCT01536405|454163462|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
126237944|NCT01536405|454163463|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
126237945|NCT01536405|454163462|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
126237946|NCT01536405|454163463|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
126237947|NCT01536405|454163462|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
126237948|NCT01536405|454163463|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
126237949|NCT01536405|454163462|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
126237950|NCT01536405|454163463|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
126237951|NCT01536405|454163462|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
126237952|NCT01536405|454163463|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
126237953|NCT01536405|454163462|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
126237954|NCT01536405|454163463|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
126237955|NCT01536405|454163462|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
126237956|NCT01536405|454163463|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
126237957|NCT01536405|454163462|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
126237958|NCT01536405|454163463|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
126237959|NCT01536405|454163462|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
126237960|NCT01536405|454163463|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
126237961|NCT01536405|454163462|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
126237962|NCT01536405|454163463|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
126237963|NCT01536405|454163462|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
126237964|NCT01536405|454163463|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
126237965|NCT01536405|454163462|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
126237966|NCT01536405|454163463|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
126237967|NCT00301366|454163464|FG000|Overall Study|Adverse Event|1|||
126237968|NCT04213326|454163465|FG000|Overall Study|Consent withdrawn|51|||
126237969|NCT04213326|454163466|FG001|Overall Study|Consent withdrawn|241|||
126237970|NCT04213326|454163465|FG000|Overall Study|Lost to Follow-up|50|||
126237971|NCT04213326|454163466|FG001|Overall Study|Lost to Follow-up|902|||
126237972|NCT04213326|454163465|FG000|Overall Study|Protocol Violation|3|||
126237973|NCT04213326|454163466|FG001|Overall Study|Protocol Violation|25|||
126237974|NCT04213326|454163465|FG000|Overall Study|Participant eligibility changed|106|||
126237975|NCT04213326|454163466|FG001|Overall Study|Participant eligibility changed|19|||
126237976|NCT04213326|454163465|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
126237977|NCT04213326|454163466|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
126237978|NCT04213326|454163465|FG000|Overall Study|Incomplete study visit|0|||
126237979|NCT04213326|454163466|FG001|Overall Study|Incomplete study visit|367|||
126237980|NCT02549092|454163469|FG000|Treatment Period|Adverse Event|2|||
126237981|NCT02549092|454163470|FG001|Treatment Period|Adverse Event|2|||
126237982|NCT02549092|454163469|FG000|Treatment Period|Withdrawal by Subject|1|||
126237983|NCT02549092|454163470|FG001|Treatment Period|Withdrawal by Subject|3|||
126237984|NCT02549092|454163469|FG000|Treatment Period|Lack of Efficacy|0|||
126237985|NCT02549092|454163470|FG001|Treatment Period|Lack of Efficacy|2|||
126237986|NCT02549092|454163469|FG000|Extension/Transition Period|Adverse Event|1|||
126237987|NCT02549092|454163470|FG001|Extension/Transition Period|Adverse Event|1|||
126237988|NCT02549092|454163469|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
126237989|NCT02549092|454163470|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
126237990|NCT02549092|454163469|FG000|Extension/Transition Period|Other, Not Specified|4|||
126237991|NCT02549092|454163470|FG001|Extension/Transition Period|Other, Not Specified|2|||
126237992|NCT02511782|454163471|FG000|Overall Study|Withdrawal by Subject|1|||
126237993|NCT02511782|454163472|FG001|Overall Study|Withdrawal by Subject|0|||
126237994|NCT02511782|454163473|FG002|Overall Study|Withdrawal by Subject|0|||
126237995|NCT03627091|454163474|FG000|Overall Study|Adverse Event|0|||
126237996|NCT03627091|454163475|FG001|Overall Study|Adverse Event|0|||
126237997|NCT03627091|454163476|FG002|Overall Study|Adverse Event|2|||
126237998|NCT03627091|454163474|FG000|Overall Study|Withdrawal by Subject|2|||
126237999|NCT03627091|454163475|FG001|Overall Study|Withdrawal by Subject|0|||
126238000|NCT03627091|454163476|FG002|Overall Study|Withdrawal by Subject|2|||
126238001|NCT03627091|454163474|FG000|Overall Study|Physician Decision|2|||
126238002|NCT03627091|454163475|FG001|Overall Study|Physician Decision|0|||
126238003|NCT03627091|454163476|FG002|Overall Study|Physician Decision|0|||
126238004|NCT03627091|454163474|FG000|Overall Study|Site terminated by sponsor|0|||
126238005|NCT03627091|454163475|FG001|Overall Study|Site terminated by sponsor|1|||
126238006|NCT03627091|454163476|FG002|Overall Study|Site terminated by sponsor|0|||
126238007|NCT03627091|454163474|FG000|Overall Study|Disease relapse|7|||
126238008|NCT03627091|454163475|FG001|Overall Study|Disease relapse|5|||
126238009|NCT03627091|454163476|FG002|Overall Study|Disease relapse|1|||
126238010|NCT03627091|454163474|FG000|Overall Study|Other|1|||
126238011|NCT03627091|454163475|FG001|Overall Study|Other|0|||
126238012|NCT03627091|454163476|FG002|Overall Study|Other|0|||
126238013|NCT00450190|454163477|FG000|Overall Study|Withdrawal by Subject|2|||
126238014|NCT01376167|454163478|FG000|Overall Study|Lost to Follow-up|2|||
126238015|NCT01376167|454163479|FG001|Overall Study|Lost to Follow-up|4|||
126238016|NCT01376167|454163480|FG002|Overall Study|Lost to Follow-up|2|||
126238017|NCT01376167|454163478|FG000|Overall Study|Physician Decision|1|||
126238018|NCT01376167|454163479|FG001|Overall Study|Physician Decision|1|||
126238019|NCT01376167|454163480|FG002|Overall Study|Physician Decision|0|||
126238020|NCT01376167|454163478|FG000|Overall Study|Withdrawal by Subject|1|||
126238021|NCT01376167|454163479|FG001|Overall Study|Withdrawal by Subject|5|||
126238022|NCT01376167|454163480|FG002|Overall Study|Withdrawal by Subject|4|||
126025577|NCT00894543|453389208|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
126238023|NCT02849652|454163485|FG000|Overall Study|Lost to Follow-up|104|||
126025578|NCT00894543|453389209|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
126025579|NCT00894543|453389208|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
126025580|NCT00894543|453389209|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
126025581|NCT04048681|453389210|FG000|Overall Study|family emergency|0|||
126025582|NCT04048681|453389211|FG001|Overall Study|family emergency|0|||
126025583|NCT04048681|453389212|FG002|Overall Study|family emergency|0|||
126238024|NCT02849652|454163486|FG001|Overall Study|Lost to Follow-up|35|||
126238025|NCT02849652|454163487|FG002|Overall Study|Lost to Follow-up|116|||
126238026|NCT02849652|454163488|FG003|Overall Study|Lost to Follow-up|22|||
126238027|NCT02849652|454163485|FG000|Overall Study|Withdrawal by Subject|10|||
126025584|NCT04048681|453389213|FG003|Overall Study|family emergency|1|||
126356446|NCT00724893|454597833|FG000|Overall Study|Lost to Follow-up|0|||
126356447|NCT00724893|454597834|FG001|Overall Study|Lost to Follow-up|52|||
126025585|NCT04048681|453389214|FG004|Overall Study|family emergency|0|||
126025586|NCT01532388|453389215|FG000|3-month Follow-up|Lost to Follow-up|68|||
126025587|NCT01532388|453389216|FG001|3-month Follow-up|Lost to Follow-up|68|||
126025588|NCT01532388|453389215|FG000|6-month Follow-up|Lost to Follow-up|74|||
126025589|NCT01532388|453389216|FG001|6-month Follow-up|Lost to Follow-up|66|||
126025590|NCT01532388|453389215|FG000|12-month Follow-up|Lost to Follow-up|69|||
126025591|NCT01532388|453389216|FG001|12-month Follow-up|Lost to Follow-up|67|||
126238028|NCT02849652|454163486|FG001|Overall Study|Withdrawal by Subject|2|||
126238029|NCT02849652|454163487|FG002|Overall Study|Withdrawal by Subject|8|||
126238030|NCT02849652|454163488|FG003|Overall Study|Withdrawal by Subject|4|||
126238031|NCT04149964|454163494|FG000|Overall Study|Lost to Follow-up|19|||
126025592|NCT02697136|453389220|FG000|Overall Study|Adverse Event|3|||
126238032|NCT04149964|454163495|FG001|Overall Study|Lost to Follow-up|18|||
126238033|NCT00705536|454165514|FG000|Start Period 1|Withdrawal by Subject|0|||
126238034|NCT00705536|454165515|FG001|Start Period 1|Withdrawal by Subject|0|||
126238035|NCT00705536|454165516|FG002|Start Period 1|Withdrawal by Subject|0|||
126238036|NCT00705536|454165517|FG003|Start Period 1|Withdrawal by Subject|1|||
126238037|NCT00441467|454165518|FG000|Overall Study|Adverse Event|6|||
126238038|NCT00441467|454165518|FG000|Overall Study|Withdrawal by Subject|3|||
126238039|NCT00441467|454165518|FG000|Overall Study|Progressive disease|9|||
126238040|NCT02289963|454165519|FG000|Overall Study|Adverse Event|1|||
126093635|NCT02003222|453636111|FG001|Intensification|Other reasons|0|||
126093636|NCT02003222|453636112|FG002|Intensification|Other reasons|0|||
126093637|NCT02003222|453636113|FG003|Intensification|Other reasons|0|||
126093638|NCT02003222|453636114|FG004|Intensification|Other reasons|8|||
126093639|NCT01280357|453636115|FG000|Overall Study|Excluded no internal monitoring|14|||
126093640|NCT01280357|453636115|FG000|Overall Study|IInsufficient data/No data supplied|12|||
126093641|NCT00886795|453636120|FG000|Overall Study|Lack of Efficacy|1|||
126238041|NCT02289963|454165520|FG001|Overall Study|Adverse Event|2|||
126238042|NCT02289963|454165519|FG000|Overall Study|Poor compliance to protocol|1|||
126025593|NCT02697136|453389221|FG001|Overall Study|Adverse Event|0|||
126025594|NCT03578536|453389224|FG000|Overall Study|Lost to Follow-up|1|||
126025595|NCT05198310|453389225|FG000|Overall Study|Lost to Follow-up|0|||
126025596|NCT05198310|453389226|FG001|Overall Study|Lost to Follow-up|1|||
126025597|NCT05198310|453389227|FG002|Overall Study|Lost to Follow-up|0|||
126025598|NCT05198310|453389228|FG003|Overall Study|Lost to Follow-up|0|||
126025599|NCT05198310|453389229|FG004|Overall Study|Lost to Follow-up|0|||
126025600|NCT05198310|453389230|FG005|Overall Study|Lost to Follow-up|0|||
126025601|NCT05198310|453389231|FG006|Overall Study|Lost to Follow-up|0|||
126025602|NCT05198310|453389232|FG007|Overall Study|Lost to Follow-up|0|||
126025603|NCT05198310|453389225|FG000|Overall Study|Withdrawal by Subject|0|||
126025604|NCT05198310|453389226|FG001|Overall Study|Withdrawal by Subject|0|||
126025605|NCT05198310|453389227|FG002|Overall Study|Withdrawal by Subject|0|||
126025606|NCT05198310|453389228|FG003|Overall Study|Withdrawal by Subject|2|||
126025607|NCT05198310|453389229|FG004|Overall Study|Withdrawal by Subject|0|||
126025608|NCT05198310|453389230|FG005|Overall Study|Withdrawal by Subject|2|||
126025609|NCT05198310|453389231|FG006|Overall Study|Withdrawal by Subject|1|||
126025610|NCT05198310|453389232|FG007|Overall Study|Withdrawal by Subject|3|||
126025611|NCT04436107|453389233|FG000|Overall Study|Sponsor Ended Study|2|||
126025612|NCT04436107|453389234|FG001|Overall Study|Sponsor Ended Study|4|||
126025613|NCT04436107|453389235|FG002|Overall Study|Sponsor Ended Study|8|||
126025614|NCT04436107|453389236|FG003|Overall Study|Sponsor Ended Study|20|||
126025615|NCT04436107|453389233|FG000|Overall Study|Death|3|||
126025616|NCT04436107|453389234|FG001|Overall Study|Death|5|||
126025617|NCT04436107|453389235|FG002|Overall Study|Death|3|||
126025618|NCT04436107|453389236|FG003|Overall Study|Death|18|||
126025619|NCT04436107|453389233|FG000|Overall Study|Withdrawal by Subject|1|||
126025620|NCT04436107|453389234|FG001|Overall Study|Withdrawal by Subject|1|||
126025621|NCT04436107|453389235|FG002|Overall Study|Withdrawal by Subject|0|||
126025622|NCT04436107|453389236|FG003|Overall Study|Withdrawal by Subject|1|||
126025623|NCT01095796|453389237|FG000|Overall Study|Randomized but Not Treated|5|||
126025624|NCT01095796|453389238|FG001|Overall Study|Randomized but Not Treated|2|||
126025625|NCT01095796|453389237|FG000|Overall Study|Adverse Event|9|||
126025626|NCT01095796|453389238|FG001|Overall Study|Adverse Event|19|||
126025627|NCT01095796|453389237|FG000|Overall Study|Death|3|||
126025628|NCT01095796|453389238|FG001|Overall Study|Death|2|||
126025629|NCT01095796|453389237|FG000|Overall Study|Pregnancy|2|||
126025630|NCT01095796|453389238|FG001|Overall Study|Pregnancy|0|||
126025631|NCT01095796|453389237|FG000|Overall Study|Lack of Efficacy|5|||
126025632|NCT01095796|453389238|FG001|Overall Study|Lack of Efficacy|3|||
126025633|NCT01095796|453389237|FG000|Overall Study|Investigator's Discretion|7|||
126025634|NCT01095796|453389238|FG001|Overall Study|Investigator's Discretion|2|||
126025635|NCT01095796|453389237|FG000|Overall Study|Withdrew Consent|16|||
126025636|NCT01095796|453389238|FG001|Overall Study|Withdrew Consent|22|||
126025637|NCT01095796|453389237|FG000|Overall Study|Lost to Follow-up|27|||
126025638|NCT01095796|453389238|FG001|Overall Study|Lost to Follow-up|29|||
126025639|NCT01095796|453389237|FG000|Overall Study|Participant Noncompliance|5|||
126025640|NCT01095796|453389238|FG001|Overall Study|Participant Noncompliance|10|||
126093642|NCT01259089|453636121|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126238043|NCT02289963|454165520|FG001|Overall Study|Poor compliance to protocol|0|||
126238044|NCT02289963|454165519|FG000|Overall Study|Withdrawal by Subject|1|||
126238045|NCT02289963|454165520|FG001|Overall Study|Withdrawal by Subject|0|||
126025641|NCT01095796|453389237|FG000|Overall Study|Protocol Violation|1|||
126025642|NCT01095796|453389238|FG001|Overall Study|Protocol Violation|0|||
126025643|NCT01095796|453389237|FG000|Overall Study|Participant Transferred to Another Study|215|||
126025644|NCT01095796|453389238|FG001|Overall Study|Participant Transferred to Another Study|200|||
126025645|NCT04116736|453389241|FG000|Overall Study|Withdrew consent during study|3|||
126025646|NCT04116736|453389242|FG001|Overall Study|Withdrew consent during study|1|||
126025647|NCT04116736|453389241|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
126025648|NCT04116736|453389242|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
126238046|NCT02289963|454165519|FG000|Overall Study|Last injection missed|2|||
126238047|NCT02289963|454165520|FG001|Overall Study|Last injection missed|2|||
126238048|NCT02289963|454165519|FG000|Overall Study|End treatment visit outside visit window|0|||
126238049|NCT02289963|454165520|FG001|Overall Study|End treatment visit outside visit window|4|||
126238050|NCT02289963|454165519|FG000|Overall Study|Other than specified above|0|||
126238051|NCT02289963|454165520|FG001|Overall Study|Other than specified above|2|||
126238052|NCT00549718|454165523|FG000|Overall Study|Insufficient clinical response|20|||
126238053|NCT00549718|454165524|FG001|Overall Study|Insufficient clinical response|7|||
126238054|NCT00549718|454165525|FG002|Overall Study|Insufficient clinical response|18|||
126238055|NCT00549718|454165526|FG003|Overall Study|Insufficient clinical response|32|||
126238056|NCT00549718|454165523|FG000|Overall Study|Adverse Event|6|||
126238057|NCT00549718|454165524|FG001|Overall Study|Adverse Event|8|||
126238058|NCT00549718|454165525|FG002|Overall Study|Adverse Event|7|||
126238059|NCT00549718|454165526|FG003|Overall Study|Adverse Event|3|||
126238060|NCT00549718|454165523|FG000|Overall Study|Lost to Follow-up|4|||
126238061|NCT00549718|454165524|FG001|Overall Study|Lost to Follow-up|2|||
126238062|NCT00549718|454165525|FG002|Overall Study|Lost to Follow-up|0|||
126238063|NCT00549718|454165526|FG003|Overall Study|Lost to Follow-up|6|||
126238064|NCT00549718|454165523|FG000|Overall Study|Withdrawal by Subject|9|||
126238065|NCT00549718|454165524|FG001|Overall Study|Withdrawal by Subject|18|||
126238066|NCT00549718|454165525|FG002|Overall Study|Withdrawal by Subject|12|||
126238067|NCT00549718|454165526|FG003|Overall Study|Withdrawal by Subject|13|||
126238068|NCT00549718|454165523|FG000|Overall Study|Administrative|2|||
126238069|NCT00549718|454165524|FG001|Overall Study|Administrative|2|||
126238070|NCT00549718|454165525|FG002|Overall Study|Administrative|2|||
126238071|NCT00549718|454165526|FG003|Overall Study|Administrative|1|||
126238072|NCT01675622|454165529|FG000|Overall Study|Withdrawal by Subject|2|||
126238073|NCT01675622|454165530|FG001|Overall Study|Withdrawal by Subject|2|||
126238074|NCT01675622|454165529|FG000|Overall Study|Adverse Event|12|||
126238075|NCT01675622|454165530|FG001|Overall Study|Adverse Event|10|||
126238076|NCT01675622|454165529|FG000|Overall Study|Protocol Violation|4|||
126238077|NCT01675622|454165530|FG001|Overall Study|Protocol Violation|1|||
126238078|NCT01675622|454165529|FG000|Overall Study|Lack of Efficacy|2|||
126238079|NCT01675622|454165530|FG001|Overall Study|Lack of Efficacy|4|||
126238080|NCT01675622|454165529|FG000|Overall Study|Lost to Follow-up|1|||
126238081|NCT01675622|454165530|FG001|Overall Study|Lost to Follow-up|3|||
126238082|NCT01675622|454165529|FG000|Overall Study|Other|5|||
126238083|NCT01675622|454165530|FG001|Overall Study|Other|4|||
126238084|NCT04032977|454165531|FG000|Overall Study|Withdrawal by Subject|6|||
126238085|NCT04032977|454165532|FG001|Overall Study|Withdrawal by Subject|1|||
126238086|NCT04032977|454165531|FG000|Overall Study|Lost to Follow-up|2|||
126238087|NCT04032977|454165532|FG001|Overall Study|Lost to Follow-up|7|||
126238088|NCT04032977|454165531|FG000|Overall Study|Pregnancy|1|||
126238089|NCT04032977|454165532|FG001|Overall Study|Pregnancy|0|||
126238090|NCT02880761|454165533|FG000|Overall Study|Death|6|||
126238091|NCT02880761|454165534|FG001|Overall Study|Death|8|||
126238092|NCT02880761|454165533|FG000|Overall Study|Withdrawal by Subject|3|||
126238093|NCT02880761|454165534|FG001|Overall Study|Withdrawal by Subject|6|||
126238094|NCT02880761|454165533|FG000|Overall Study|Protocol Violation|4|||
126238095|NCT02880761|454165534|FG001|Overall Study|Protocol Violation|3|||
126238096|NCT02880761|454165533|FG000|Overall Study|Lost to Follow-up|3|||
126238097|NCT02880761|454165534|FG001|Overall Study|Lost to Follow-up|4|||
126238098|NCT03597256|454165535|FG000|Overall Study|Lost to Follow-up|3|||
126238099|NCT03597256|454165536|FG001|Overall Study|Lost to Follow-up|1|||
126025649|NCT04116736|453389241|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
126025650|NCT04116736|453389242|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
126238100|NCT03597256|454165535|FG000|Overall Study|Withdrawal by Subject|0|||
126238101|NCT03597256|454165536|FG001|Overall Study|Withdrawal by Subject|1|||
126238102|NCT03597256|454165535|FG000|Overall Study|Could not return for treatment|0|||
126238103|NCT03597256|454165536|FG001|Overall Study|Could not return for treatment|1|||
126238104|NCT03597256|454165535|FG000|Overall Study|Moved from location|0|||
126238105|NCT03597256|454165536|FG001|Overall Study|Moved from location|1|||
126238106|NCT03597256|454165535|FG000|Overall Study|Not accepted the treatment|0|||
126238107|NCT03597256|454165536|FG001|Overall Study|Not accepted the treatment|1|||
126238108|NCT02943447|454165537|FG000|Blinded Study Phase|Withdrew Consent|1|||
126238109|NCT02943447|454165538|FG001|Blinded Study Phase|Withdrew Consent|2|||
126025651|NCT04116736|453389241|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
126046477|NCT02467270|453468227|FG001|Overall Study|Withdrawal by Subject|3|||
126238110|NCT02943447|454165539|FG002|Blinded Study Phase|Withdrew Consent|1|||
126238111|NCT02943447|454165537|FG000|Blinded Study Phase|Adverse Event|3|||
126238112|NCT02943447|454165538|FG001|Blinded Study Phase|Adverse Event|0|||
126238113|NCT02943447|454165539|FG002|Blinded Study Phase|Adverse Event|0|||
126238114|NCT02943447|454165537|FG000|Blinded Study Phase|Investigator's discretion|1|||
126238115|NCT02943447|454165538|FG001|Blinded Study Phase|Investigator's discretion|0|||
126238116|NCT02943447|454165539|FG002|Blinded Study Phase|Investigator's discretion|0|||
126238117|NCT02943447|454165537|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
126238118|NCT02943447|454165538|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
126025652|NCT04116736|453389242|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
126025653|NCT04116736|453389241|FG000|Overall Study|Subject was enrolled in error|2|||
126025654|NCT04116736|453389242|FG001|Overall Study|Subject was enrolled in error|0|||
126025655|NCT04116736|453389241|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
126025656|NCT04116736|453389242|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
126238119|NCT02943447|454165539|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
126238120|NCT02943447|454165537|FG000|Open-Label Extension Phase|Adverse Event|4|||
126238121|NCT02943447|454165538|FG001|Open-Label Extension Phase|Adverse Event|7|||
126238122|NCT02943447|454165539|FG002|Open-Label Extension Phase|Adverse Event|3|||
126238123|NCT02943447|454165537|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
126238124|NCT02943447|454165538|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
126238125|NCT02943447|454165539|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
126238126|NCT02943447|454165537|FG000|Open-Label Extension Phase|Withdrew consent|1|||
126238127|NCT02943447|454165538|FG001|Open-Label Extension Phase|Withdrew consent|1|||
126238128|NCT02943447|454165539|FG002|Open-Label Extension Phase|Withdrew consent|1|||
126238129|NCT02943447|454165537|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
126238130|NCT02943447|454165538|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
126238131|NCT02943447|454165539|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
126238132|NCT02106156|454165540|FG000|Overall Study|Patient Died|19|||
126238133|NCT02106156|454165541|FG001|Overall Study|Patient Died|0|||
126238134|NCT02106156|454165542|FG002|Overall Study|Patient Died|0|||
126238135|NCT02106156|454165540|FG000|Overall Study|Lack of Tolerability|305|||
126238136|NCT02106156|454165541|FG001|Overall Study|Lack of Tolerability|3|||
126238137|NCT02106156|454165542|FG002|Overall Study|Lack of Tolerability|0|||
126238138|NCT02106156|454165540|FG000|Overall Study|Lack of Virological Response|1044|||
126238139|NCT02106156|454165541|FG001|Overall Study|Lack of Virological Response|8|||
126238140|NCT02106156|454165542|FG002|Overall Study|Lack of Virological Response|0|||
126238141|NCT02106156|454165540|FG000|Overall Study|Concomitant Disease|74|||
126238142|NCT02106156|454165541|FG001|Overall Study|Concomitant Disease|2|||
126238143|NCT02106156|454165542|FG002|Overall Study|Concomitant Disease|0|||
126025657|NCT04116736|453389241|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
126025658|NCT04116736|453389242|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
126025659|NCT04116736|453389241|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
126093643|NCT01259089|453636122|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126356448|NCT00724893|454597833|FG000|Overall Study|Unknown, missing data|1|||
126356449|NCT00724893|454597834|FG001|Overall Study|Unknown, missing data|1|||
126356450|NCT01078545|454597837|FG000|Overall Study|Lost to Follow-up|13|||
126238144|NCT02106156|454165540|FG000|Overall Study|Lack of Compliance|211|||
126238145|NCT02106156|454165541|FG001|Overall Study|Lack of Compliance|7|||
126238146|NCT02106156|454165542|FG002|Overall Study|Lack of Compliance|0|||
126238147|NCT02106156|454165540|FG000|Overall Study|Patients Request|307|||
126238148|NCT02106156|454165541|FG001|Overall Study|Patients Request|9|||
126238149|NCT02106156|454165542|FG002|Overall Study|Patients Request|0|||
126238150|NCT02106156|454165540|FG000|Overall Study|Lost to Follow-up|451|||
126356451|NCT01078545|454597837|FG000|Overall Study|Physician Decision|6|||
126356452|NCT01078545|454597837|FG000|Overall Study|Withdrawal by Subject|3|||
126093644|NCT01259089|453636123|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126238151|NCT02106156|454165541|FG001|Overall Study|Lost to Follow-up|8|||
126238152|NCT02106156|454165542|FG002|Overall Study|Lost to Follow-up|0|||
126238153|NCT02106156|454165540|FG000|Overall Study|Unplanned Event|82|||
126238154|NCT02106156|454165541|FG001|Overall Study|Unplanned Event|2|||
126238155|NCT02106156|454165542|FG002|Overall Study|Unplanned Event|0|||
126238156|NCT02106156|454165540|FG000|Overall Study|Change of Laboratory Parameter|10|||
126238157|NCT02106156|454165541|FG001|Overall Study|Change of Laboratory Parameter|0|||
126238158|NCT02106156|454165542|FG002|Overall Study|Change of Laboratory Parameter|0|||
126238159|NCT02106156|454165540|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
126238160|NCT02106156|454165541|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
126238161|NCT02106156|454165542|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
126238162|NCT02106156|454165540|FG000|Overall Study|Relocation/Change of Physician|40|||
126238163|NCT02106156|454165541|FG001|Overall Study|Relocation/Change of Physician|1|||
126238164|NCT02106156|454165542|FG002|Overall Study|Relocation/Change of Physician|0|||
126238165|NCT05017480|454165549|FG000|Stage 1 Study|Withdrawal by Subject|8|||
126238166|NCT05017480|454165550|FG001|Stage 1 Study|Withdrawal by Subject|6|||
126356453|NCT01078545|454597837|FG000|Overall Study|Death|3|||
126238167|NCT05017480|454165551|FG002|Stage 1 Study|Withdrawal by Subject|0|||
126238168|NCT05017480|454165552|FG003|Stage 1 Study|Withdrawal by Subject|0|||
126093645|NCT01259089|453636124|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126238169|NCT05017480|454165553|FG004|Stage 1 Study|Withdrawal by Subject|0|||
126238170|NCT05017480|454165549|FG000|Stage 1 Study|Adverse Event|1|||
126356454|NCT01078545|454597837|FG000|Overall Study|Participant moved to another physician|1|||
126356455|NCT01774370|454597840|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
126238171|NCT05017480|454165550|FG001|Stage 1 Study|Adverse Event|1|||
126238172|NCT05017480|454165551|FG002|Stage 1 Study|Adverse Event|0|||
126238173|NCT05017480|454165552|FG003|Stage 1 Study|Adverse Event|0|||
126238174|NCT05017480|454165553|FG004|Stage 1 Study|Adverse Event|0|||
126238175|NCT05017480|454165549|FG000|Stage 1 Study|Poor Compliance|1|||
126238176|NCT05017480|454165550|FG001|Stage 1 Study|Poor Compliance|1|||
126238177|NCT05017480|454165551|FG002|Stage 1 Study|Poor Compliance|0|||
126238178|NCT05017480|454165552|FG003|Stage 1 Study|Poor Compliance|0|||
126238179|NCT05017480|454165553|FG004|Stage 1 Study|Poor Compliance|0|||
126238180|NCT05017480|454165549|FG000|Stage 1 Study|Physician Decision|0|||
126238181|NCT05017480|454165550|FG001|Stage 1 Study|Physician Decision|1|||
126238182|NCT05017480|454165551|FG002|Stage 1 Study|Physician Decision|0|||
126238183|NCT05017480|454165552|FG003|Stage 1 Study|Physician Decision|0|||
126238184|NCT05017480|454165553|FG004|Stage 1 Study|Physician Decision|0|||
126238185|NCT05017480|454165549|FG000|Stage 2 Study|Withdrawal by Subject|0|||
126238186|NCT05017480|454165550|FG001|Stage 2 Study|Withdrawal by Subject|0|||
126238187|NCT05017480|454165551|FG002|Stage 2 Study|Withdrawal by Subject|6|||
126238188|NCT05017480|454165552|FG003|Stage 2 Study|Withdrawal by Subject|9|||
126238189|NCT05017480|454165553|FG004|Stage 2 Study|Withdrawal by Subject|11|||
126238190|NCT05017480|454165549|FG000|Stage 2 Study|Lost to Follow-up|0|||
126238191|NCT05017480|454165550|FG001|Stage 2 Study|Lost to Follow-up|0|||
126025660|NCT04116736|453389242|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
126025661|NCT05512962|453389246|FG000|Overall Study|Withdrawal by Subject|1|||
126025662|NCT05512962|453389247|FG001|Overall Study|Withdrawal by Subject|0|||
126025663|NCT05575076|453389249|FG000|Overall Study|Adverse Event|24|||
126025664|NCT05575076|453389249|FG000|Overall Study|Death|7|||
126025665|NCT05575076|453389249|FG000|Overall Study|Lost to Follow-up|16|||
126238192|NCT05017480|454165551|FG002|Stage 2 Study|Lost to Follow-up|0|||
126238193|NCT05017480|454165552|FG003|Stage 2 Study|Lost to Follow-up|2|||
126238194|NCT05017480|454165553|FG004|Stage 2 Study|Lost to Follow-up|1|||
126238195|NCT05017480|454165549|FG000|Stage 2 Study|Adverse Event|0|||
126238196|NCT05017480|454165550|FG001|Stage 2 Study|Adverse Event|0|||
126238197|NCT05017480|454165551|FG002|Stage 2 Study|Adverse Event|0|||
126238198|NCT05017480|454165552|FG003|Stage 2 Study|Adverse Event|1|||
126238199|NCT05017480|454165553|FG004|Stage 2 Study|Adverse Event|0|||
126238200|NCT05017480|454165549|FG000|Stage 2 Study|COVID-19|0|||
126025666|NCT05575076|453389249|FG000|Overall Study|Non-Compliance|3|||
126238201|NCT05017480|454165550|FG001|Stage 2 Study|COVID-19|0|||
126238202|NCT05017480|454165551|FG002|Stage 2 Study|COVID-19|0|||
126238203|NCT05017480|454165552|FG003|Stage 2 Study|COVID-19|1|||
126238204|NCT05017480|454165553|FG004|Stage 2 Study|COVID-19|0|||
126238205|NCT05017480|454165549|FG000|Stage 2 Study|Pregnancy|0|||
126238206|NCT05017480|454165550|FG001|Stage 2 Study|Pregnancy|0|||
126238207|NCT05017480|454165551|FG002|Stage 2 Study|Pregnancy|0|||
126238208|NCT05017480|454165552|FG003|Stage 2 Study|Pregnancy|0|||
126238209|NCT05017480|454165553|FG004|Stage 2 Study|Pregnancy|1|||
126025667|NCT05575076|453389249|FG000|Overall Study|Physician Decision|6|||
126025668|NCT05575076|453389249|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
126025669|NCT05575076|453389249|FG000|Overall Study|Withdrawal by Subject|71|||
126025670|NCT05575076|453389249|FG000|Overall Study|Study Terminated by Sponsor|630|||
126025671|NCT05575076|453389249|FG000|Overall Study|Other|17|||
126238210|NCT01136382|454165554|FG000|Overall Study|Other|8|||
126238211|NCT01136382|454165555|FG001|Overall Study|Other|3|||
126238212|NCT01136382|454165554|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
126238213|NCT01136382|454165555|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
126238214|NCT01136382|454165554|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
126238215|NCT01136382|454165555|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
126238216|NCT01136382|454165554|FG000|Overall Study|Withdrawal by Subject|4|||
126238217|NCT01136382|454165555|FG001|Overall Study|Withdrawal by Subject|1|||
126238218|NCT00746798|454165560|FG000|Overall Study|Protocol Violation|0|||
126238219|NCT00746798|454165561|FG001|Overall Study|Protocol Violation|1|||
126238220|NCT00746798|454165562|FG002|Overall Study|Protocol Violation|0|||
126238221|NCT00746798|454165563|FG003|Overall Study|Protocol Violation|0|||
126238222|NCT00746798|454165560|FG000|Overall Study|Withdrawal by Subject|0|||
126238223|NCT00746798|454165561|FG001|Overall Study|Withdrawal by Subject|1|||
126238224|NCT00746798|454165562|FG002|Overall Study|Withdrawal by Subject|1|||
126238225|NCT00746798|454165563|FG003|Overall Study|Withdrawal by Subject|0|||
126238226|NCT00746798|454165560|FG000|Overall Study|Death|0|||
126238227|NCT00746798|454165561|FG001|Overall Study|Death|0|||
126238228|NCT00746798|454165562|FG002|Overall Study|Death|2|||
126238229|NCT00746798|454165563|FG003|Overall Study|Death|0|||
126238230|NCT00746798|454165560|FG000|Overall Study|Participant unable to return for visit|1|||
126238231|NCT00746798|454165561|FG001|Overall Study|Participant unable to return for visit|0|||
126238232|NCT00746798|454165562|FG002|Overall Study|Participant unable to return for visit|0|||
126238233|NCT00746798|454165563|FG003|Overall Study|Participant unable to return for visit|0|||
126356456|NCT01774370|454597840|FG000|Overall Study|Administered prior to the contract date|4|||
126356457|NCT01774370|454597840|FG000|Overall Study|Subjects of contraindications|34|||
126356458|NCT01774370|454597840|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
126356459|NCT01774370|454597840|FG000|Overall Study|Follow-up failure|34|||
126356460|NCT05436288|454597841|FG000|Overall Study|Lost to Follow-up|1|||
126356461|NCT05436288|454597841|FG000|Overall Study|Adverse Event|1|||
126356462|NCT01436500|454597845|FG000|Overall Study|Death|1|||
126356463|NCT01436500|454597846|FG001|Overall Study|Death|0|||
126356464|NCT01436500|454597847|FG002|Overall Study|Death|0|||
126356465|NCT01436500|454597848|FG003|Overall Study|Death|0|||
126356466|NCT01436500|454597849|FG004|Overall Study|Death|0|||
126356467|NCT01436500|454597845|FG000|Overall Study|Adverse Event|0|||
126356468|NCT01436500|454597846|FG001|Overall Study|Adverse Event|2|||
126356469|NCT01436500|454597847|FG002|Overall Study|Adverse Event|2|||
126356470|NCT01436500|454597848|FG003|Overall Study|Adverse Event|0|||
126356471|NCT01436500|454597849|FG004|Overall Study|Adverse Event|1|||
126356472|NCT01436500|454597845|FG000|Overall Study|Withdrawal by Subject|0|||
126356473|NCT01436500|454597846|FG001|Overall Study|Withdrawal by Subject|0|||
126356474|NCT01436500|454597847|FG002|Overall Study|Withdrawal by Subject|2|||
126356475|NCT01436500|454597848|FG003|Overall Study|Withdrawal by Subject|0|||
126356476|NCT01436500|454597849|FG004|Overall Study|Withdrawal by Subject|2|||
126356477|NCT01436500|454597845|FG000|Overall Study|Physician Decision|0|||
126356478|NCT01436500|454597846|FG001|Overall Study|Physician Decision|0|||
126356479|NCT01436500|454597847|FG002|Overall Study|Physician Decision|1|||
126356480|NCT01436500|454597848|FG003|Overall Study|Physician Decision|0|||
126356481|NCT01436500|454597849|FG004|Overall Study|Physician Decision|0|||
126356482|NCT01436500|454597845|FG000|Overall Study|liver transplant|1|||
126356483|NCT01436500|454597846|FG001|Overall Study|liver transplant|0|||
126356484|NCT01436500|454597847|FG002|Overall Study|liver transplant|0|||
126025672|NCT01127373|453389250|FG000|Overall Study|Not Treated|3|||
126238234|NCT02896361|454165564|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
126238235|NCT02896361|454165565|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
126238236|NCT02896361|454165566|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
126356485|NCT01436500|454597848|FG003|Overall Study|liver transplant|0|||
126356486|NCT01436500|454597849|FG004|Overall Study|liver transplant|0|||
126356487|NCT01436500|454597845|FG000|Overall Study|initiation of dialysis|0|||
126356488|NCT01436500|454597846|FG001|Overall Study|initiation of dialysis|0|||
126356489|NCT01436500|454597847|FG002|Overall Study|initiation of dialysis|0|||
126356490|NCT01436500|454597848|FG003|Overall Study|initiation of dialysis|0|||
126025673|NCT01127373|453389250|FG000|Overall Study|Lost to Follow-up|7|||
126025674|NCT01127373|453389250|FG000|Overall Study|Withdrawal by Subject|1|||
126025675|NCT01127373|453389250|FG000|Overall Study|Disease progression|1|||
126025676|NCT01426412|453389257|FG000|Overall Study|Withdrawal by Subject|1|||
126238237|NCT02896361|454165564|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
126238238|NCT02896361|454165565|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
126238239|NCT02896361|454165566|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
126238240|NCT01045096|454165568|FG000|Overall Study|Withdrawal by Subject|2|||
126238241|NCT01045096|454165569|FG001|Overall Study|Withdrawal by Subject|0|||
126238242|NCT01045096|454165570|FG002|Overall Study|Withdrawal by Subject|0|||
126238243|NCT01045096|454165568|FG000|Overall Study|Other|1|||
126238244|NCT01045096|454165569|FG001|Overall Study|Other|0|||
126238245|NCT01045096|454165570|FG002|Overall Study|Other|0|||
126238246|NCT01511939|454165571|FG000|Overall Study|Withdrawal by Subject|2|||
126238247|NCT01511939|454165572|FG001|Overall Study|Withdrawal by Subject|1|||
126238248|NCT01511939|454165573|FG002|Overall Study|Withdrawal by Subject|0|||
126238249|NCT00324168|454165574|FG000|Overall Study|Lost to Follow-up|19|||
126238250|NCT00324168|454165575|FG001|Overall Study|Lost to Follow-up|18|||
126238251|NCT00324168|454165574|FG000|Overall Study|Death|3|||
126238252|NCT00324168|454165575|FG001|Overall Study|Death|3|||
126238253|NCT00324168|454165574|FG000|Overall Study|Patient did not visit in f/u window|6|||
126238254|NCT00324168|454165575|FG001|Overall Study|Patient did not visit in f/u window|9|||
126238255|NCT03497897|454165578|FG000|Overall Study|Adverse Event|1|||
126238256|NCT03497897|454165579|FG001|Overall Study|Adverse Event|1|||
126238257|NCT03497897|454165580|FG002|Overall Study|Adverse Event|1|||
126238258|NCT03497897|454165578|FG000|Overall Study|Lost to Follow-up|2|||
126238259|NCT03497897|454165579|FG001|Overall Study|Lost to Follow-up|0|||
126238260|NCT03497897|454165580|FG002|Overall Study|Lost to Follow-up|2|||
126238261|NCT03497897|454165578|FG000|Overall Study|Physician Decision|1|||
126238262|NCT03497897|454165579|FG001|Overall Study|Physician Decision|0|||
126238263|NCT03497897|454165580|FG002|Overall Study|Physician Decision|0|||
126238264|NCT03497897|454165578|FG000|Overall Study|Subject/Guardian Decision|2|||
126238265|NCT03497897|454165579|FG001|Overall Study|Subject/Guardian Decision|1|||
126238266|NCT03497897|454165580|FG002|Overall Study|Subject/Guardian Decision|3|||
126238267|NCT01391793|454165588|FG000|Overall Study|Ineligible|3|||
126238268|NCT01391793|454165589|FG001|Overall Study|Ineligible|0|||
126238269|NCT01391793|454165588|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
126025677|NCT01426412|453389258|FG001|Overall Study|Withdrawal by Subject|0|||
126025678|NCT01426412|453389259|FG002|Overall Study|Withdrawal by Subject|0|||
126025679|NCT01426412|453389260|FG003|Overall Study|Withdrawal by Subject|0|||
126025680|NCT01426412|453389261|FG004|Overall Study|Withdrawal by Subject|1|||
126025681|NCT01426412|453389262|FG005|Overall Study|Withdrawal by Subject|0|||
126025682|NCT01426412|453389263|FG006|Overall Study|Withdrawal by Subject|0|||
126025683|NCT01426412|453389264|FG007|Overall Study|Withdrawal by Subject|3|||
126025684|NCT01426412|453389265|FG008|Overall Study|Withdrawal by Subject|1|||
126025685|NCT04157348|453389267|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
126025686|NCT04157348|453389268|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
126025687|NCT04157348|453389267|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126025688|NCT04157348|453389268|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126025689|NCT04157348|453389267|FG000|Double-blind Treatment Period|Adverse Event|0|||
126025690|NCT04157348|453389268|FG001|Double-blind Treatment Period|Adverse Event|1|||
126025691|NCT04157348|453389267|FG000|Open-label Extension Period|Adverse Event|1|||
126025692|NCT04157348|453389268|FG001|Open-label Extension Period|Adverse Event|1|||
126025693|NCT04157348|453389267|FG000|Open-label Extension Period|Death|0|||
126025694|NCT04157348|453389268|FG001|Open-label Extension Period|Death|1|||
126025695|NCT04157348|453389267|FG000|Open-label Extension Period|Lack of Efficacy|2|||
126025696|NCT04157348|453389268|FG001|Open-label Extension Period|Lack of Efficacy|2|||
126025697|NCT04157348|453389267|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
126025698|NCT04157348|453389268|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
126025699|NCT04157348|453389267|FG000|Open-label Extension Period|Ongoing|60|||
126025700|NCT04157348|453389268|FG001|Open-label Extension Period|Ongoing|57|||
126025701|NCT04157348|453389267|FG000|Open-label Extension Period|other reasons|1|||
126025702|NCT04157348|453389268|FG001|Open-label Extension Period|other reasons|1|||
126025703|NCT02965846|453389269|FG000|Overall Study|Lost to Follow-up|1|||
126025704|NCT02965846|453389270|FG001|Overall Study|Lost to Follow-up|0|||
126025705|NCT02965846|453389271|FG002|Overall Study|Lost to Follow-up|0|||
126025706|NCT02965846|453389269|FG000|Overall Study|Withdrawal by Subject|0|||
126025707|NCT02965846|453389270|FG001|Overall Study|Withdrawal by Subject|1|||
126025708|NCT02965846|453389271|FG002|Overall Study|Withdrawal by Subject|0|||
126025709|NCT02965846|453389269|FG000|Overall Study|Study Terminated By Sponsor|4|||
126025710|NCT02965846|453389270|FG001|Overall Study|Study Terminated By Sponsor|4|||
126025711|NCT02965846|453389271|FG002|Overall Study|Study Terminated By Sponsor|0|||
126025712|NCT02965846|453389269|FG000|Overall Study|Participants not randomized|0|||
126025713|NCT02965846|453389270|FG001|Overall Study|Participants not randomized|0|||
126025714|NCT02965846|453389271|FG002|Overall Study|Participants not randomized|33|||
126025715|NCT01084707|453389272|FG000|Overall Study|Withdrawal by Subject|6|||
126025716|NCT00879333|453389275|FG000|Overall Study|Adverse Event|94|||
126025717|NCT00879333|453389276|FG001|Overall Study|Adverse Event|34|||
126025718|NCT00879333|453389275|FG000|Overall Study|Abnormal Laboratory Value|1|||
126238270|NCT01391793|454165589|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
126238271|NCT01391793|454165588|FG000|Overall Study|No DMSA|73|||
126238272|NCT01391793|454165589|FG001|Overall Study|No DMSA|57|||
126238273|NCT01666730|454165590|FG000|Overall Study|Adverse Event|16|||
126238274|NCT01666730|454165590|FG000|Overall Study|Death|2|||
126238275|NCT01666730|454165590|FG000|Overall Study|Physician Decision|5|||
126238276|NCT01666730|454165590|FG000|Overall Study|Withdrawal by Subject|9|||
126238277|NCT01666730|454165590|FG000|Overall Study|Disease progression/relapse|18|||
126238278|NCT02087904|454165593|FG000|Overall Study|Did Not Receive Study Drug|0|||
126238279|NCT02087904|454165594|FG001|Overall Study|Did Not Receive Study Drug|0|||
126238280|NCT02087904|454165595|FG002|Overall Study|Did Not Receive Study Drug|2|||
126238281|NCT02087904|454165596|FG003|Overall Study|Did Not Receive Study Drug|1|||
126238282|NCT02087904|454165593|FG000|Overall Study|Adverse Event|8|||
126238283|NCT02087904|454165594|FG001|Overall Study|Adverse Event|4|||
126238284|NCT02087904|454165595|FG002|Overall Study|Adverse Event|4|||
126238285|NCT02087904|454165596|FG003|Overall Study|Adverse Event|12|||
126238286|NCT02087904|454165593|FG000|Overall Study|Lack of Efficacy|3|||
126238287|NCT02087904|454165594|FG001|Overall Study|Lack of Efficacy|6|||
126238288|NCT02087904|454165595|FG002|Overall Study|Lack of Efficacy|3|||
126238289|NCT02087904|454165596|FG003|Overall Study|Lack of Efficacy|2|||
126238290|NCT02087904|454165593|FG000|Overall Study|Other|6|||
126238291|NCT02087904|454165594|FG001|Overall Study|Other|2|||
126238292|NCT02087904|454165595|FG002|Overall Study|Other|4|||
126238293|NCT02087904|454165596|FG003|Overall Study|Other|4|||
126238294|NCT02087904|454165593|FG000|Overall Study|Withdrawal by Subject|8|||
126238295|NCT02087904|454165594|FG001|Overall Study|Withdrawal by Subject|3|||
126238296|NCT02087904|454165595|FG002|Overall Study|Withdrawal by Subject|7|||
126238297|NCT02087904|454165596|FG003|Overall Study|Withdrawal by Subject|4|||
126238298|NCT02087904|454165593|FG000|Overall Study|Lost to Follow-up|0|||
126238299|NCT02087904|454165594|FG001|Overall Study|Lost to Follow-up|4|||
126238300|NCT02087904|454165595|FG002|Overall Study|Lost to Follow-up|2|||
126238301|NCT02087904|454165596|FG003|Overall Study|Lost to Follow-up|2|||
126238302|NCT01389102|454165598|FG000|Overall Study|Adverse Event|1|||
126238303|NCT01389102|454165599|FG001|Overall Study|Adverse Event|3|||
126238304|NCT01389102|454165600|FG002|Overall Study|Adverse Event|2|||
126238305|NCT01389102|454165601|FG003|Overall Study|Adverse Event|2|||
126238306|NCT01389102|454165602|FG004|Overall Study|Adverse Event|2|||
126238307|NCT01389102|454165603|FG005|Overall Study|Adverse Event|2|||
126238308|NCT01389102|454165598|FG000|Overall Study|Hurricane Katrina|4|||
126238309|NCT01389102|454165599|FG001|Overall Study|Hurricane Katrina|2|||
126238310|NCT01389102|454165600|FG002|Overall Study|Hurricane Katrina|3|||
126238311|NCT01389102|454165601|FG003|Overall Study|Hurricane Katrina|0|||
126238312|NCT01389102|454165602|FG004|Overall Study|Hurricane Katrina|3|||
126238313|NCT01389102|454165603|FG005|Overall Study|Hurricane Katrina|1|||
126238314|NCT01389102|454165598|FG000|Overall Study|Lost to Follow-up|4|||
126238315|NCT01389102|454165599|FG001|Overall Study|Lost to Follow-up|1|||
126238316|NCT01389102|454165600|FG002|Overall Study|Lost to Follow-up|1|||
126238317|NCT01389102|454165601|FG003|Overall Study|Lost to Follow-up|2|||
126238318|NCT01389102|454165602|FG004|Overall Study|Lost to Follow-up|4|||
126238319|NCT01389102|454165603|FG005|Overall Study|Lost to Follow-up|1|||
126238320|NCT01389102|454165598|FG000|Overall Study|Protocol Violation|0|||
126238321|NCT01389102|454165599|FG001|Overall Study|Protocol Violation|0|||
126238322|NCT01389102|454165600|FG002|Overall Study|Protocol Violation|3|||
126238323|NCT01389102|454165601|FG003|Overall Study|Protocol Violation|0|||
126238324|NCT01389102|454165602|FG004|Overall Study|Protocol Violation|1|||
126238325|NCT01389102|454165603|FG005|Overall Study|Protocol Violation|1|||
126238326|NCT01389102|454165598|FG000|Overall Study|Withdrawal by Subject|7|||
126238327|NCT01389102|454165599|FG001|Overall Study|Withdrawal by Subject|4|||
126238328|NCT01389102|454165600|FG002|Overall Study|Withdrawal by Subject|9|||
126238329|NCT01389102|454165601|FG003|Overall Study|Withdrawal by Subject|2|||
126238330|NCT01389102|454165602|FG004|Overall Study|Withdrawal by Subject|3|||
126238331|NCT01389102|454165603|FG005|Overall Study|Withdrawal by Subject|3|||
126238332|NCT01389102|454165598|FG000|Overall Study|Subject Traveling Out of Country|0|||
126238333|NCT01389102|454165599|FG001|Overall Study|Subject Traveling Out of Country|0|||
126238334|NCT01389102|454165600|FG002|Overall Study|Subject Traveling Out of Country|0|||
126238335|NCT01389102|454165601|FG003|Overall Study|Subject Traveling Out of Country|1|||
126238336|NCT01389102|454165602|FG004|Overall Study|Subject Traveling Out of Country|0|||
126238337|NCT01389102|454165603|FG005|Overall Study|Subject Traveling Out of Country|0|||
126238338|NCT01389102|454165598|FG000|Overall Study|Subject Moved|2|||
126238339|NCT01389102|454165599|FG001|Overall Study|Subject Moved|0|||
126238340|NCT01389102|454165600|FG002|Overall Study|Subject Moved|1|||
126238341|NCT01389102|454165601|FG003|Overall Study|Subject Moved|0|||
126238342|NCT01389102|454165602|FG004|Overall Study|Subject Moved|0|||
126238343|NCT01389102|454165603|FG005|Overall Study|Subject Moved|0|||
126238344|NCT01389102|454165598|FG000|Overall Study|Unavailable due to husband's illness|0|||
126238345|NCT01389102|454165599|FG001|Overall Study|Unavailable due to husband's illness|1|||
126238346|NCT01389102|454165600|FG002|Overall Study|Unavailable due to husband's illness|0|||
126238347|NCT01389102|454165601|FG003|Overall Study|Unavailable due to husband's illness|0|||
126238348|NCT01389102|454165602|FG004|Overall Study|Unavailable due to husband's illness|0|||
126238349|NCT01389102|454165603|FG005|Overall Study|Unavailable due to husband's illness|0|||
126238350|NCT01389102|454165598|FG000|Overall Study|Investigator Judgement|0|||
126238351|NCT01389102|454165599|FG001|Overall Study|Investigator Judgement|1|||
126238352|NCT01389102|454165600|FG002|Overall Study|Investigator Judgement|0|||
126238353|NCT01389102|454165601|FG003|Overall Study|Investigator Judgement|0|||
126238354|NCT01389102|454165602|FG004|Overall Study|Investigator Judgement|0|||
126238355|NCT01389102|454165603|FG005|Overall Study|Investigator Judgement|0|||
126238356|NCT00893464|454165604|FG000|Overall Study|Did not complete therapy/experience PD|0|||
126238357|NCT00893464|454165605|FG001|Overall Study|Did not complete therapy/experience PD|0|||
126238358|NCT00893464|454165606|FG002|Overall Study|Did not complete therapy/experience PD|0|||
126238359|NCT00893464|454165607|FG003|Overall Study|Did not complete therapy/experience PD|0|||
126238360|NCT00893464|454165608|FG004|Overall Study|Did not complete therapy/experience PD|0|||
126238361|NCT00893464|454165609|FG005|Overall Study|Did not complete therapy/experience PD|0|||
126238362|NCT00893464|454165610|FG006|Overall Study|Did not complete therapy/experience PD|2|||
126238363|NCT00893464|454165611|FG007|Overall Study|Did not complete therapy/experience PD|2|||
126238364|NCT02910037|454165612|FG000|Overall Study|Withdrawal by Subject|4|||
126238365|NCT02910037|454165612|FG000|Overall Study|Lost to Follow-up|6|||
126238366|NCT00436553|454165613|FG000|Overall Study|Adverse Event|4|||
126238367|NCT00436553|454165614|FG001|Overall Study|Adverse Event|3|||
126238368|NCT00436553|454165615|FG002|Overall Study|Adverse Event|4|||
126238369|NCT00436553|454165613|FG000|Overall Study|Death|3|||
126238370|NCT00436553|454165614|FG001|Overall Study|Death|1|||
126238371|NCT00436553|454165615|FG002|Overall Study|Death|3|||
126238372|NCT00436553|454165613|FG000|Overall Study|Lost to Follow-up|0|||
126238373|NCT00436553|454165614|FG001|Overall Study|Lost to Follow-up|2|||
126238374|NCT00436553|454165615|FG002|Overall Study|Lost to Follow-up|0|||
126238375|NCT00436553|454165613|FG000|Overall Study|Protocol Violation|1|||
126238376|NCT00436553|454165614|FG001|Overall Study|Protocol Violation|0|||
126238377|NCT00436553|454165615|FG002|Overall Study|Protocol Violation|0|||
126238378|NCT00436553|454165613|FG000|Overall Study|Withdrawal by Subject|5|||
126238379|NCT00436553|454165614|FG001|Overall Study|Withdrawal by Subject|6|||
126238380|NCT00436553|454165615|FG002|Overall Study|Withdrawal by Subject|3|||
126238381|NCT01661686|454165626|FG000|Overall Study|Lost to Follow-up|2|||
126238382|NCT01661686|454165627|FG001|Overall Study|Lost to Follow-up|1|||
126238383|NCT01661686|454165626|FG000|Overall Study|did not receive allocated intervention|0|||
126238384|NCT01661686|454165627|FG001|Overall Study|did not receive allocated intervention|1|||
126238385|NCT04869787|454165628|FG000|Screening|Physician Decision|1|||
126238386|NCT04869787|454165628|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
126238387|NCT01873586|454165629|FG000|Overall Study|Lost to Follow-up|3|||
126238388|NCT00696020|454165630|FG000|Overall Study|Adverse Event|3|||
126238389|NCT00696020|454165631|FG001|Overall Study|Adverse Event|1|||
126238390|NCT00696020|454165632|FG002|Overall Study|Adverse Event|2|||
126238391|NCT00696020|454165633|FG003|Overall Study|Adverse Event|1|||
126238392|NCT00696020|454165630|FG000|Overall Study|Lack of Efficacy|1|||
126238393|NCT00696020|454165631|FG001|Overall Study|Lack of Efficacy|0|||
126238394|NCT00696020|454165632|FG002|Overall Study|Lack of Efficacy|0|||
126238395|NCT00696020|454165633|FG003|Overall Study|Lack of Efficacy|0|||
126238396|NCT00696020|454165630|FG000|Overall Study|Protocol Violation|0|||
126238397|NCT00696020|454165631|FG001|Overall Study|Protocol Violation|0|||
126238398|NCT00696020|454165632|FG002|Overall Study|Protocol Violation|0|||
126238399|NCT00696020|454165633|FG003|Overall Study|Protocol Violation|1|||
126238400|NCT00696020|454165630|FG000|Overall Study|Withdrawal by Subject|0|||
126238401|NCT00696020|454165631|FG001|Overall Study|Withdrawal by Subject|1|||
126238402|NCT00696020|454165632|FG002|Overall Study|Withdrawal by Subject|0|||
126238403|NCT00696020|454165633|FG003|Overall Study|Withdrawal by Subject|1|||
126238404|NCT00696020|454165630|FG000|Overall Study|Other not stated above|0|||
126238405|NCT00696020|454165631|FG001|Overall Study|Other not stated above|0|||
126238406|NCT00696020|454165632|FG002|Overall Study|Other not stated above|1|||
126238407|NCT00696020|454165633|FG003|Overall Study|Other not stated above|1|||
126238408|NCT00624065|454165634|FG000|Overall Study|Adverse Event|5|||
126238409|NCT00624065|454165635|FG001|Overall Study|Adverse Event|6|||
126238410|NCT00624065|454165634|FG000|Overall Study|Lost to Follow-up|4|||
126238411|NCT00624065|454165635|FG001|Overall Study|Lost to Follow-up|1|||
126238412|NCT00624065|454165634|FG000|Overall Study|Consent withdrawn|6|||
126238413|NCT00624065|454165635|FG001|Overall Study|Consent withdrawn|5|||
126238414|NCT00624065|454165634|FG000|Overall Study|Lack of Efficacy|0|||
126238415|NCT00624065|454165635|FG001|Overall Study|Lack of Efficacy|3|||
126238416|NCT00624065|454165634|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
126238417|NCT00624065|454165635|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
126238418|NCT01387022|454165636|FG000|Overall Study|Death|1|||
126238419|NCT01387022|454165637|FG001|Overall Study|Death|1|||
126238420|NCT01387022|454165636|FG000|Overall Study|Lost to Follow-up|0|||
126238421|NCT01387022|454165637|FG001|Overall Study|Lost to Follow-up|3|||
126238422|NCT01536574|454165647|FG000|Overall Study|Adverse Event|4|||
126238423|NCT01536574|454165648|FG001|Overall Study|Adverse Event|5|||
126238424|NCT01536574|454165647|FG000|Overall Study|Withdrawal by Subject|1|||
126238425|NCT01536574|454165648|FG001|Overall Study|Withdrawal by Subject|2|||
126238426|NCT01536574|454165647|FG000|Overall Study|Lack of Efficacy|1|||
126238427|NCT01536574|454165648|FG001|Overall Study|Lack of Efficacy|0|||
126238428|NCT02193165|454165651|FG000|4 Week Product Use|Lost to Follow-up|1|||
126238429|NCT02193165|454165652|FG001|4 Week Product Use|Lost to Follow-up|1|||
126238430|NCT02193165|454165653|FG002|4 Week Product Use|Lost to Follow-up|1|||
126238431|NCT02193165|454165651|FG000|6 Week Product Use|Lost to Follow-up|0|||
126238432|NCT02193165|454165652|FG001|6 Week Product Use|Lost to Follow-up|1|||
126238433|NCT02193165|454165653|FG002|6 Week Product Use|Lost to Follow-up|0|||
126238434|NCT01498120|454165654|FG000|Overall Study|Lost to Follow-up|1|||
126238435|NCT01498120|454165654|FG000|Overall Study|Withdrawal by Subject|5|||
126238436|NCT01498120|454165654|FG000|Overall Study|AE, non-serious non-fatal|3|||
126238437|NCT01498120|454165654|FG000|Overall Study|Other|4|||
126238438|NCT01173692|454165655|FG000|Overall Study|Adverse Event|1|||
126238439|NCT01173692|454165656|FG001|Overall Study|Adverse Event|2|||
126238440|NCT01173692|454165655|FG000|Overall Study|Withdrawal by Subject|1|||
126238441|NCT01173692|454165656|FG001|Overall Study|Withdrawal by Subject|3|||
126238442|NCT00678639|454165657|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
126238443|NCT00678639|454165658|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
126238444|NCT00986245|454165659|FG000|First Intervention|Poor compliance|8|||
126238445|NCT00986245|454165660|FG001|First Intervention|Poor compliance|4|||
126356491|NCT01436500|454597849|FG004|Overall Study|initiation of dialysis|1|||
126356492|NCT01436500|454597845|FG000|Overall Study|discontinued study drug|1|||
126356493|NCT01436500|454597846|FG001|Overall Study|discontinued study drug|0|||
126356494|NCT01436500|454597847|FG002|Overall Study|discontinued study drug|0|||
126356495|NCT01436500|454597848|FG003|Overall Study|discontinued study drug|0|||
126356496|NCT01436500|454597849|FG004|Overall Study|discontinued study drug|0|||
126356497|NCT01436500|454597845|FG000|Overall Study|Other|0|||
126356498|NCT01436500|454597846|FG001|Overall Study|Other|1|||
126356499|NCT01436500|454597847|FG002|Overall Study|Other|0|||
126356500|NCT01436500|454597848|FG003|Overall Study|Other|1|||
126356501|NCT01436500|454597849|FG004|Overall Study|Other|0|||
126356502|NCT01487161|454597853|FG000|Overall Study|Adverse Event|1|||
126356503|NCT01487161|454597854|FG001|Overall Study|Adverse Event|0|||
126356504|NCT01487161|454597855|FG002|Overall Study|Adverse Event|0|||
126356505|NCT01487161|454597856|FG003|Overall Study|Adverse Event|0|||
126356506|NCT01487161|454597853|FG000|Overall Study|Withdrawal by Subject|1|||
126356507|NCT01487161|454597854|FG001|Overall Study|Withdrawal by Subject|1|||
126356508|NCT01487161|454597855|FG002|Overall Study|Withdrawal by Subject|1|||
126356509|NCT01487161|454597856|FG003|Overall Study|Withdrawal by Subject|2|||
126356510|NCT01487161|454597853|FG000|Overall Study|missing data|0|||
126356511|NCT01487161|454597854|FG001|Overall Study|missing data|1|||
126356512|NCT01487161|454597855|FG002|Overall Study|missing data|0|||
126356513|NCT01487161|454597856|FG003|Overall Study|missing data|0|||
126356514|NCT02945046|454597857|FG000|Overall Study|Adverse Event|1|||
126356515|NCT02945046|454597858|FG001|Overall Study|Adverse Event|0|||
126356516|NCT02945046|454597859|FG002|Overall Study|Adverse Event|2|||
126356517|NCT02945046|454597857|FG000|Overall Study|Withdrawal by Subject|3|||
126356518|NCT02945046|454597858|FG001|Overall Study|Withdrawal by Subject|3|||
126356519|NCT02945046|454597859|FG002|Overall Study|Withdrawal by Subject|3|||
126356520|NCT02945046|454597857|FG000|Overall Study|Protocol Violation|2|||
126356521|NCT02945046|454597858|FG001|Overall Study|Protocol Violation|3|||
126356522|NCT02945046|454597859|FG002|Overall Study|Protocol Violation|2|||
126356523|NCT02945046|454597857|FG000|Overall Study|Lost to Follow-up|1|||
126356524|NCT02945046|454597858|FG001|Overall Study|Lost to Follow-up|1|||
126356525|NCT02945046|454597859|FG002|Overall Study|Lost to Follow-up|0|||
126356526|NCT02945046|454597857|FG000|Overall Study|Lack of Efficacy|1|||
126356527|NCT02945046|454597858|FG001|Overall Study|Lack of Efficacy|2|||
126356528|NCT02945046|454597859|FG002|Overall Study|Lack of Efficacy|1|||
126356529|NCT02945046|454597857|FG000|Overall Study|Other than specified|5|||
126356530|NCT02945046|454597858|FG001|Overall Study|Other than specified|4|||
126356531|NCT02945046|454597859|FG002|Overall Study|Other than specified|7|||
126356532|NCT03113136|454597860|FG000|Overall Study|Lost to Follow-up|22|||
126356533|NCT03113136|454597861|FG001|Overall Study|Lost to Follow-up|47|||
126356534|NCT03113136|454597862|FG002|Overall Study|Lost to Follow-up|54|||
126356535|NCT03113136|454597860|FG000|Overall Study|Withdrawal by Subject|4|||
126356536|NCT03113136|454597861|FG001|Overall Study|Withdrawal by Subject|13|||
126238446|NCT00986245|454165659|FG000|First Intervention|Lack of Efficacy|1|||
126356537|NCT03113136|454597862|FG002|Overall Study|Withdrawal by Subject|14|||
126356538|NCT03113136|454597860|FG000|Overall Study|Ineligible|0|||
126238447|NCT00986245|454165660|FG001|First Intervention|Lack of Efficacy|2|||
126238448|NCT00986245|454165659|FG000|First Intervention|Withdrawal by Subject|0|||
126356539|NCT03113136|454597861|FG001|Overall Study|Ineligible|2|||
126356540|NCT03113136|454597862|FG002|Overall Study|Ineligible|1|||
126356541|NCT03113136|454597860|FG000|Overall Study|Study Team Decision|1|||
126356542|NCT03113136|454597861|FG001|Overall Study|Study Team Decision|4|||
126238449|NCT00986245|454165660|FG001|First Intervention|Withdrawal by Subject|1|||
126238450|NCT00986245|454165659|FG000|First Intervention|Protocol Violation|0|||
126238451|NCT00986245|454165660|FG001|First Intervention|Protocol Violation|1|||
126238452|NCT00986245|454165659|FG000|First Intervention|Out of indication|1|||
126238453|NCT00986245|454165660|FG001|First Intervention|Out of indication|0|||
126238454|NCT00986245|454165659|FG000|Second Intervention|Poor compliance|1|||
126238455|NCT00986245|454165660|FG001|Second Intervention|Poor compliance|0|||
126238456|NCT00986245|454165659|FG000|Second Intervention|Lost to Follow-up|1|||
126238457|NCT00986245|454165660|FG001|Second Intervention|Lost to Follow-up|0|||
126238458|NCT00986245|454165659|FG000|Second Intervention|Protocol Violation|0|||
126238459|NCT00986245|454165660|FG001|Second Intervention|Protocol Violation|1|||
126238460|NCT01629381|454165661|FG000|Overall Study|Withdrawal by Subject|2|||
126238461|NCT01629381|454165662|FG001|Overall Study|Withdrawal by Subject|5|||
126238462|NCT01214850|454165663|FG000|Overall Study|Withdrawal by Subject|38|||
126238463|NCT01214850|454165664|FG001|Overall Study|Withdrawal by Subject|31|||
126238464|NCT01214850|454165665|FG002|Overall Study|Withdrawal by Subject|28|||
126238465|NCT01214850|454165663|FG000|Overall Study|Lost to Follow-up|124|||
126238466|NCT01214850|454165664|FG001|Overall Study|Lost to Follow-up|98|||
126238467|NCT01214850|454165665|FG002|Overall Study|Lost to Follow-up|123|||
126238468|NCT01214850|454165663|FG000|Overall Study|Protocol Violation|5|||
126238469|NCT01214850|454165664|FG001|Overall Study|Protocol Violation|5|||
126238470|NCT01214850|454165665|FG002|Overall Study|Protocol Violation|6|||
126238471|NCT01214850|454165663|FG000|Overall Study|Adverse event or death|11|||
126238472|NCT01214850|454165664|FG001|Overall Study|Adverse event or death|8|||
126238473|NCT01214850|454165665|FG002|Overall Study|Adverse event or death|3|||
126238474|NCT01214850|454165663|FG000|Overall Study|Inappropriate enrollment|2|||
126238475|NCT01214850|454165664|FG001|Overall Study|Inappropriate enrollment|1|||
126238476|NCT01214850|454165665|FG002|Overall Study|Inappropriate enrollment|0|||
126238477|NCT01214850|454165663|FG000|Overall Study|Administrative reason|1|||
126238478|NCT01214850|454165664|FG001|Overall Study|Administrative reason|0|||
126238479|NCT01214850|454165665|FG002|Overall Study|Administrative reason|0|||
126238480|NCT01214850|454165663|FG000|Overall Study|Unable to classify|2|||
126238481|NCT01214850|454165664|FG001|Overall Study|Unable to classify|1|||
126238482|NCT01214850|454165665|FG002|Overall Study|Unable to classify|1|||
126238483|NCT01863745|454165666|FG000|Overall Study|Disease Progression|9|||
126238484|NCT01863745|454165666|FG000|Overall Study|Adverse Event|2|||
126238485|NCT01863745|454165666|FG000|Overall Study|Death|1|||
126238486|NCT01863745|454165666|FG000|Overall Study|Withdrawal by Subject|1|||
126238487|NCT00193609|454165667|FG000|Overall Study|Lack of Efficacy|2|||
126238488|NCT00193609|454165667|FG000|Overall Study|Adverse Event|2|||
126238489|NCT00854308|454165668|FG000|Overall Study|Disease progression|42|||
126238490|NCT00854308|454165669|FG001|Overall Study|Disease progression|50|||
126238491|NCT00854308|454165668|FG000|Overall Study|Adverse Event|8|||
126238492|NCT00854308|454165669|FG001|Overall Study|Adverse Event|3|||
126238493|NCT00854308|454165668|FG000|Overall Study|Death|2|||
126238494|NCT00854308|454165669|FG001|Overall Study|Death|5|||
126238495|NCT00854308|454165668|FG000|Overall Study|Physician Decision|6|||
126238496|NCT00854308|454165669|FG001|Overall Study|Physician Decision|6|||
126238497|NCT00854308|454165668|FG000|Overall Study|Withdrawal by Subject|4|||
126238498|NCT00854308|454165669|FG001|Overall Study|Withdrawal by Subject|2|||
126238499|NCT00854308|454165668|FG000|Overall Study|Sponsor's decision to terminate study|0|||
126238500|NCT00854308|454165669|FG001|Overall Study|Sponsor's decision to terminate study|1|||
126238501|NCT00610363|454165672|FG000|Overall Study|Non-compliance with protocol|0|||
126238502|NCT00610363|454165673|FG001|Overall Study|Non-compliance with protocol|1|||
126238503|NCT00610363|454165672|FG000|Overall Study|Adverse Event|3|||
126238504|NCT00610363|454165673|FG001|Overall Study|Adverse Event|1|||
126238505|NCT00610363|454165672|FG000|Overall Study|Lack of Efficacy|2|||
126238506|NCT00610363|454165673|FG001|Overall Study|Lack of Efficacy|0|||
126238507|NCT00610363|454165672|FG000|Overall Study|Lost to Follow-up|4|||
126238508|NCT00610363|454165673|FG001|Overall Study|Lost to Follow-up|0|||
126238509|NCT00610363|454165672|FG000|Overall Study|Withdrawal by Subject|1|||
126238510|NCT00610363|454165673|FG001|Overall Study|Withdrawal by Subject|0|||
126238511|NCT00610363|454165672|FG000|Overall Study|Other than specified above|1|||
126238512|NCT00610363|454165673|FG001|Overall Study|Other than specified above|1|||
126238513|NCT03048500|454165674|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
126238514|NCT03048500|454165674|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
126238515|NCT03048500|454165674|FG000|Reached 1st Response/Continued Treatment|Death|1|||
126025719|NCT00879333|453389276|FG001|Overall Study|Abnormal Laboratory Value|0|||
126238516|NCT03048500|454165674|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
126238517|NCT03048500|454165674|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
126238518|NCT03048500|454165674|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
126238519|NCT03048500|454165674|FG000|Follow up for 3 Years|Death|12|||
126238520|NCT01171963|454165675|FG000|Overall Study|Adverse Event|10|||
126238521|NCT01171963|454165676|FG001|Overall Study|Adverse Event|15|||
126238522|NCT01171963|454165675|FG000|Overall Study|Lost to Follow-up|23|||
126238523|NCT01171963|454165676|FG001|Overall Study|Lost to Follow-up|24|||
126238524|NCT01171963|454165675|FG000|Overall Study|Other - diarrhoea|1|||
126238525|NCT01171963|454165676|FG001|Overall Study|Other - diarrhoea|0|||
126238526|NCT01171963|454165675|FG000|Overall Study|Withdrawal by Subject|114|||
126238527|NCT01171963|454165676|FG001|Overall Study|Withdrawal by Subject|129|||
126238528|NCT00626548|454165686|FG000|Overall Study|Adverse Event|164|||
126238529|NCT00626548|454165687|FG001|Overall Study|Adverse Event|44|||
126238530|NCT00626548|454165686|FG000|Overall Study|Withdrawal by Subject|42|||
126238531|NCT00626548|454165687|FG001|Overall Study|Withdrawal by Subject|46|||
126238532|NCT00626548|454165686|FG000|Overall Study|Protocol Violation|4|||
126238533|NCT00626548|454165687|FG001|Overall Study|Protocol Violation|11|||
126238534|NCT00626548|454165686|FG000|Overall Study|Lost to Follow-up|2|||
126238535|NCT00626548|454165687|FG001|Overall Study|Lost to Follow-up|2|||
126238536|NCT00626548|454165686|FG000|Overall Study|Other termination reason|493|||
126238537|NCT00626548|454165687|FG001|Overall Study|Other termination reason|613|||
126238538|NCT00048581|454165688|FG000|Double-Blind Period|Adverse Event|9|||
126238539|NCT00048581|454165689|FG001|Double-Blind Period|Adverse Event|5|||
126238540|NCT00048581|454165690|FG002|Double-Blind Period|Adverse Event|0|||
126238541|NCT00048581|454165688|FG000|Double-Blind Period|Lack of Efficacy|14|||
126238542|NCT00048581|454165689|FG001|Double-Blind Period|Lack of Efficacy|27|||
126238543|NCT00048581|454165690|FG002|Double-Blind Period|Lack of Efficacy|0|||
126238544|NCT00048581|454165688|FG000|Double-Blind Period|Lost to Follow-up|5|||
126238545|NCT00048581|454165689|FG001|Double-Blind Period|Lost to Follow-up|0|||
126238546|NCT00048581|454165690|FG002|Double-Blind Period|Lost to Follow-up|0|||
126238547|NCT00048581|454165688|FG000|Double-Blind Period|Withdrawal by Subject|5|||
126238548|NCT00048581|454165689|FG001|Double-Blind Period|Withdrawal by Subject|2|||
126238549|NCT00048581|454165690|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126238550|NCT00048581|454165688|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
126238551|NCT00048581|454165689|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
126238552|NCT00048581|454165690|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
126238553|NCT00048581|454165688|FG000|Double-Blind Period|Investigator Decision|1|||
126238554|NCT00048581|454165689|FG001|Double-Blind Period|Investigator Decision|0|||
126238555|NCT00048581|454165690|FG002|Double-Blind Period|Investigator Decision|0|||
126238556|NCT00048581|454165688|FG000|Open-Label Period|Death|0|||
126238557|NCT00048581|454165689|FG001|Open-Label Period|Death|0|||
126238558|NCT00048581|454165690|FG002|Open-Label Period|Death|4|||
126238559|NCT00048581|454165688|FG000|Open-Label Period|Adverse Event|0|||
126238560|NCT00048581|454165689|FG001|Open-Label Period|Adverse Event|0|||
126238561|NCT00048581|454165690|FG002|Open-Label Period|Adverse Event|37|||
126238562|NCT00048581|454165688|FG000|Open-Label Period|Lack of Efficacy|0|||
126238563|NCT00048581|454165689|FG001|Open-Label Period|Lack of Efficacy|0|||
126238564|NCT00048581|454165690|FG002|Open-Label Period|Lack of Efficacy|69|||
126238565|NCT00048581|454165688|FG000|Open-Label Period|Lost to Follow-up|0|||
126238566|NCT00048581|454165689|FG001|Open-Label Period|Lost to Follow-up|0|||
126238567|NCT00048581|454165690|FG002|Open-Label Period|Lost to Follow-up|14|||
126238568|NCT00048581|454165688|FG000|Open-Label Period|Withdrawal by Subject|0|||
126238569|NCT00048581|454165689|FG001|Open-Label Period|Withdrawal by Subject|0|||
126238570|NCT00048581|454165690|FG002|Open-Label Period|Withdrawal by Subject|20|||
126238571|NCT00048581|454165688|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
126238572|NCT00048581|454165689|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
126238573|NCT00048581|454165690|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
126238574|NCT00048581|454165688|FG000|Open-Label Period|Poor/Non-compliance|0|||
126238575|NCT00048581|454165689|FG001|Open-Label Period|Poor/Non-compliance|0|||
126238576|NCT00048581|454165690|FG002|Open-Label Period|Poor/Non-compliance|5|||
126238577|NCT00048581|454165688|FG000|Open-Label Period|Pregnancy|0|||
126238578|NCT00048581|454165689|FG001|Open-Label Period|Pregnancy|0|||
126238579|NCT00048581|454165690|FG002|Open-Label Period|Pregnancy|7|||
126238580|NCT00048581|454165688|FG000|Open-Label Period|Study Site Closure|0|||
126238581|NCT00048581|454165689|FG001|Open-Label Period|Study Site Closure|0|||
126238582|NCT00048581|454165690|FG002|Open-Label Period|Study Site Closure|2|||
126238583|NCT00048581|454165688|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
126356543|NCT03113136|454597862|FG002|Overall Study|Study Team Decision|0|||
126356544|NCT02675452|454597863|FG000|Overall Study|Sponsor decision|0|||
126356545|NCT02675452|454597864|FG001|Overall Study|Sponsor decision|0|||
126238584|NCT00048581|454165689|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
126238585|NCT00048581|454165690|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
126238586|NCT00048581|454165688|FG000|Open-Label Period|Problem With Transportation To Site|0|||
126238587|NCT00048581|454165689|FG001|Open-Label Period|Problem With Transportation To Site|0|||
126238588|NCT00048581|454165690|FG002|Open-Label Period|Problem With Transportation To Site|1|||
126356546|NCT02675452|454597865|FG002|Overall Study|Sponsor decision|0|||
126356547|NCT02675452|454597866|FG003|Overall Study|Sponsor decision|0|||
126238589|NCT00048581|454165688|FG000|Open-Label Period|Primary Investigator Retired|0|||
126238590|NCT00048581|454165689|FG001|Open-Label Period|Primary Investigator Retired|0|||
126238591|NCT00048581|454165690|FG002|Open-Label Period|Primary Investigator Retired|2|||
126238592|NCT00048581|454165688|FG000|Open-Label Period|Study Ended By Sponsor|0|||
126238593|NCT00048581|454165689|FG001|Open-Label Period|Study Ended By Sponsor|0|||
126238594|NCT00048581|454165690|FG002|Open-Label Period|Study Ended By Sponsor|1|||
126238595|NCT01059903|454165691|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
126238596|NCT01059903|454165692|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
126238597|NCT00385593|454165693|FG000|Overall Study|Adverse Event|3|||
126238598|NCT00385593|454165694|FG001|Overall Study|Adverse Event|2|||
126238599|NCT00385593|454165693|FG000|Overall Study|Withdrawal by Subject|17|||
126238600|NCT00385593|454165694|FG001|Overall Study|Withdrawal by Subject|7|||
126238601|NCT00385593|454165693|FG000|Overall Study|Lost to Follow-up|12|||
126238602|NCT00385593|454165694|FG001|Overall Study|Lost to Follow-up|8|||
126238603|NCT00385593|454165693|FG000|Overall Study|Protocol Violation|7|||
126238604|NCT00385593|454165694|FG001|Overall Study|Protocol Violation|4|||
126238605|NCT00385593|454165693|FG000|Overall Study|Several reasons|17|||
126238606|NCT00385593|454165694|FG001|Overall Study|Several reasons|15|||
126238607|NCT00385593|454165693|FG000|Overall Study|Incorrect inclusion|2|||
126238608|NCT00385593|454165694|FG001|Overall Study|Incorrect inclusion|0|||
126238609|NCT00385593|454165693|FG000|Overall Study|Incorrect randomization|0|||
126238610|NCT00385593|454165694|FG001|Overall Study|Incorrect randomization|1|||
126238611|NCT00214422|454165695|FG000|Overall Study|Physician Decision|2|||
126238612|NCT00214422|454165696|FG001|Overall Study|Physician Decision|0|||
126238613|NCT00214422|454165697|FG002|Overall Study|Physician Decision|0|||
126238614|NCT00214422|454165695|FG000|Overall Study|Developed esophageal ca|1|||
126238615|NCT00214422|454165696|FG001|Overall Study|Developed esophageal ca|0|||
126238616|NCT00214422|454165697|FG002|Overall Study|Developed esophageal ca|0|||
126238617|NCT00214422|454165695|FG000|Overall Study|Pt taken off study|1|||
126238618|NCT00214422|454165696|FG001|Overall Study|Pt taken off study|1|||
126238619|NCT00214422|454165697|FG002|Overall Study|Pt taken off study|0|||
126238620|NCT00214422|454165695|FG000|Overall Study|Disease progression on study|1|||
126238621|NCT00214422|454165696|FG001|Overall Study|Disease progression on study|0|||
126238622|NCT00214422|454165697|FG002|Overall Study|Disease progression on study|0|||
126238623|NCT00214422|454165695|FG000|Overall Study|Unable to make a radiation treatment|0|||
126238624|NCT00214422|454165696|FG001|Overall Study|Unable to make a radiation treatment|0|||
126238625|NCT00214422|454165697|FG002|Overall Study|Unable to make a radiation treatment|1|||
126238626|NCT00319735|454165698|FG000|Overall Study|Death|2|||
126238627|NCT03929393|454165699|FG000|Overall Study|Death|1|||
126238628|NCT03929393|454165700|FG001|Overall Study|Death|0|||
126238629|NCT03929393|454165699|FG000|Overall Study|Time Commitment|2|||
126238630|NCT03929393|454165700|FG001|Overall Study|Time Commitment|5|||
126238631|NCT03929393|454165699|FG000|Overall Study|Motor Vehicle Accident|0|||
126238632|NCT03929393|454165700|FG001|Overall Study|Motor Vehicle Accident|1|||
126238633|NCT03929393|454165699|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
126238634|NCT03929393|454165700|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
126238635|NCT03929393|454165699|FG000|Overall Study|Other|1|||
126238636|NCT03929393|454165700|FG001|Overall Study|Other|3|||
126238637|NCT04753437|454165703|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126238638|NCT04753437|454165704|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
126238639|NCT04753437|454165703|FG000|Overall Study|Liver Function Test Abnormalities|2|||
126238640|NCT04753437|454165704|FG001|Overall Study|Liver Function Test Abnormalities|4|||
126238641|NCT03075761|454167088|FG000|Overall Study|Lost to Follow-up|1|||
126238642|NCT03075761|454167089|FG001|Overall Study|Lost to Follow-up|6|||
126238643|NCT04657770|454167092|FG000|Overall Study|Withdrawal by Subject|3|||
126238644|NCT04657770|454167092|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
126238645|NCT03655106|454167093|FG000|Overall Study|Withdrawal by Subject|3|||
126238646|NCT03655106|454167094|FG001|Overall Study|Withdrawal by Subject|2|||
126238647|NCT03655106|454167093|FG000|Overall Study|Lost to Follow-up|2|||
126238648|NCT03655106|454167094|FG001|Overall Study|Lost to Follow-up|1|||
126238649|NCT03655106|454167093|FG000|Overall Study|Duplicate Enrollment|1|||
126238650|NCT03655106|454167094|FG001|Overall Study|Duplicate Enrollment|1|||
126238651|NCT03655106|454167093|FG000|Overall Study|Protocol Violation|3|||
126238652|NCT03655106|454167094|FG001|Overall Study|Protocol Violation|0|||
126238653|NCT00358449|454167104|FG000|Overall Study|Adverse Event|1|||
126238654|NCT00358449|454167105|FG001|Overall Study|Adverse Event|0|||
126238655|NCT00358449|454167106|FG002|Overall Study|Adverse Event|1|||
126238656|NCT00358449|454167104|FG000|Overall Study|Lost to Follow-up|1|||
126238657|NCT00358449|454167105|FG001|Overall Study|Lost to Follow-up|0|||
126238658|NCT00358449|454167106|FG002|Overall Study|Lost to Follow-up|0|||
126238659|NCT00358449|454167104|FG000|Overall Study|Withdrawal by Subject|2|||
126238660|NCT00358449|454167105|FG001|Overall Study|Withdrawal by Subject|0|||
126238661|NCT00358449|454167106|FG002|Overall Study|Withdrawal by Subject|0|||
126238662|NCT00358449|454167104|FG000|Overall Study|Lack of Efficacy|0|||
126238663|NCT00358449|454167105|FG001|Overall Study|Lack of Efficacy|1|||
126238664|NCT00358449|454167106|FG002|Overall Study|Lack of Efficacy|0|||
126238665|NCT00358449|454167104|FG000|Overall Study|Steriod Inhaler was Increased|0|||
126238666|NCT00358449|454167105|FG001|Overall Study|Steriod Inhaler was Increased|0|||
126238667|NCT00358449|454167106|FG002|Overall Study|Steriod Inhaler was Increased|1|||
126238668|NCT01367457|454167107|FG000|Overall Study|Death|2|||
126238669|NCT01367457|454167108|FG001|Overall Study|Death|0|||
126238670|NCT01367457|454167109|FG002|Overall Study|Death|0|||
126238671|NCT01367457|454167107|FG000|Overall Study|Investigator's decision|2|||
126238672|NCT01367457|454167108|FG001|Overall Study|Investigator's decision|0|||
126238673|NCT01367457|454167109|FG002|Overall Study|Investigator's decision|0|||
126238674|NCT01367457|454167107|FG000|Overall Study|Clinical decline (CD)|2|||
126238675|NCT01367457|454167108|FG001|Overall Study|Clinical decline (CD)|0|||
126238676|NCT01367457|454167109|FG002|Overall Study|Clinical decline (CD)|0|||
126238677|NCT01367457|454167107|FG000|Overall Study|Progression and death|8|||
126238678|NCT01367457|454167108|FG001|Overall Study|Progression and death|0|||
126238679|NCT01367457|454167109|FG002|Overall Study|Progression and death|0|||
126238680|NCT01367457|454167107|FG000|Overall Study|Toxicity|16|||
126238681|NCT01367457|454167108|FG001|Overall Study|Toxicity|0|||
126238682|NCT01367457|454167109|FG002|Overall Study|Toxicity|0|||
126238683|NCT01367457|454167107|FG000|Overall Study|Progression|137|||
126238684|NCT01367457|454167108|FG001|Overall Study|Progression|0|||
126238685|NCT01367457|454167109|FG002|Overall Study|Progression|0|||
126238686|NCT01367457|454167107|FG000|Overall Study|Patient asks for rest + slow progression|1|||
126238687|NCT01367457|454167108|FG001|Overall Study|Patient asks for rest + slow progression|0|||
126238688|NCT01367457|454167109|FG002|Overall Study|Patient asks for rest + slow progression|0|||
126238689|NCT01367457|454167107|FG000|Overall Study|Investigator's opinion, stable disease|1|||
126238690|NCT01367457|454167108|FG001|Overall Study|Investigator's opinion, stable disease|0|||
126238691|NCT01367457|454167109|FG002|Overall Study|Investigator's opinion, stable disease|0|||
126238692|NCT01367457|454167107|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
126238693|NCT01367457|454167108|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
126238694|NCT01367457|454167109|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
126238695|NCT01367457|454167107|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
126356548|NCT02675452|454597867|FG004|Overall Study|Sponsor decision|0|||
126356549|NCT02675452|454597868|FG005|Overall Study|Sponsor decision|0|||
126356550|NCT02675452|454597869|FG006|Overall Study|Sponsor decision|0|||
126356551|NCT02675452|454597870|FG007|Overall Study|Sponsor decision|0|||
126356552|NCT02675452|454597871|FG008|Overall Study|Sponsor decision|0|||
126356553|NCT02675452|454597872|FG009|Overall Study|Sponsor decision|1|||
126356554|NCT02675452|454597873|FG010|Overall Study|Sponsor decision|0|||
126356555|NCT02675452|454597874|FG011|Overall Study|Sponsor decision|0|||
126356556|NCT02675452|454597875|FG012|Overall Study|Sponsor decision|0|||
126238696|NCT01367457|454167108|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
126238697|NCT01367457|454167109|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
126238698|NCT01367457|454167107|FG000|Overall Study|low grade toxicities + stable disease|1|||
126238699|NCT01367457|454167108|FG001|Overall Study|low grade toxicities + stable disease|0|||
126238700|NCT01367457|454167109|FG002|Overall Study|low grade toxicities + stable disease|0|||
126238701|NCT01367457|454167107|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
126238702|NCT01367457|454167108|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
126356557|NCT02675452|454597876|FG013|Overall Study|Sponsor decision|2|||
126356558|NCT02675452|454597877|FG014|Overall Study|Sponsor decision|1|||
126238703|NCT01367457|454167109|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
126238704|NCT01367457|454167107|FG000|Overall Study|Withdrawal by Subject|1|||
126238705|NCT01367457|454167108|FG001|Overall Study|Withdrawal by Subject|0|||
126238706|NCT01367457|454167109|FG002|Overall Study|Withdrawal by Subject|0|||
126238707|NCT01367457|454167107|FG000|Overall Study|CD, associated leukaemia|1|||
126238708|NCT01367457|454167108|FG001|Overall Study|CD, associated leukaemia|0|||
126238709|NCT01367457|454167109|FG002|Overall Study|CD, associated leukaemia|0|||
126238710|NCT01367457|454167107|FG000|Overall Study|Uncontrolled pain|1|||
126238711|NCT01367457|454167108|FG001|Overall Study|Uncontrolled pain|0|||
126238712|NCT01367457|454167109|FG002|Overall Study|Uncontrolled pain|0|||
126238713|NCT01367457|454167107|FG000|Overall Study|Overall status worsens to grade 4|1|||
126238714|NCT01367457|454167108|FG001|Overall Study|Overall status worsens to grade 4|0|||
126238715|NCT01367457|454167109|FG002|Overall Study|Overall status worsens to grade 4|0|||
126238716|NCT01367457|454167107|FG000|Overall Study|Stabilisation + frequent infections|1|||
126238717|NCT01367457|454167108|FG001|Overall Study|Stabilisation + frequent infections|0|||
126238718|NCT01367457|454167109|FG002|Overall Study|Stabilisation + frequent infections|0|||
126238719|NCT01367457|454167107|FG000|Overall Study|No clinical benefit|1|||
126238720|NCT01367457|454167108|FG001|Overall Study|No clinical benefit|0|||
126238721|NCT01367457|454167109|FG002|Overall Study|No clinical benefit|0|||
126238722|NCT01367457|454167107|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
126238723|NCT01367457|454167108|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
126238724|NCT01367457|454167109|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
126238725|NCT01367457|454167107|FG000|Overall Study|Overall decline|1|||
126238726|NCT01367457|454167108|FG001|Overall Study|Overall decline|0|||
126356559|NCT02675452|454597878|FG015|Overall Study|Sponsor decision|0|||
126356560|NCT02675452|454597879|FG016|Overall Study|Sponsor decision|1|||
126356561|NCT02675452|454597880|FG017|Overall Study|Sponsor decision|0|||
126356562|NCT02675452|454597881|FG018|Overall Study|Sponsor decision|0|||
126356563|NCT02675452|454597882|FG019|Overall Study|Sponsor decision|0|||
126356564|NCT02675452|454597883|FG020|Overall Study|Sponsor decision|0|||
126356565|NCT02675452|454597884|FG021|Overall Study|Sponsor decision|0|||
126356566|NCT02675452|454597885|FG022|Overall Study|Sponsor decision|0|||
126356567|NCT02675452|454597886|FG023|Overall Study|Sponsor decision|0|||
126356568|NCT02675452|454597887|FG024|Overall Study|Sponsor decision|0|||
126238727|NCT01367457|454167109|FG002|Overall Study|Overall decline|0|||
126238728|NCT01367457|454167107|FG000|Overall Study|Rejection of treatment|1|||
126238729|NCT01367457|454167108|FG001|Overall Study|Rejection of treatment|0|||
126238730|NCT01367457|454167109|FG002|Overall Study|Rejection of treatment|0|||
126238731|NCT01367457|454167107|FG000|Overall Study|Lost to Follow-up|1|||
126238732|NCT01367457|454167108|FG001|Overall Study|Lost to Follow-up|0|||
126238733|NCT01367457|454167109|FG002|Overall Study|Lost to Follow-up|0|||
126238734|NCT01367457|454167107|FG000|Overall Study|Death from septic shock|1|||
126238735|NCT01367457|454167108|FG001|Overall Study|Death from septic shock|0|||
126238736|NCT01367457|454167109|FG002|Overall Study|Death from septic shock|0|||
126238737|NCT01367457|454167107|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
126238738|NCT01367457|454167108|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
126238739|NCT01367457|454167109|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
126238740|NCT01367457|454167107|FG000|Overall Study|Patient's Wish|1|||
126356569|NCT02675452|454597888|FG025|Overall Study|Sponsor decision|0|||
126356570|NCT02675452|454597889|FG026|Overall Study|Sponsor decision|2|||
126356571|NCT02675452|454597890|FG027|Overall Study|Sponsor decision|0|||
126356572|NCT02675452|454597891|FG028|Overall Study|Sponsor decision|0|||
126238741|NCT01367457|454167108|FG001|Overall Study|Patient's Wish|0|||
126238742|NCT01367457|454167109|FG002|Overall Study|Patient's Wish|0|||
126238743|NCT01367457|454167107|FG000|Overall Study|Palliative. Overall decline|1|||
126238744|NCT01367457|454167108|FG001|Overall Study|Palliative. Overall decline|0|||
126238745|NCT01367457|454167109|FG002|Overall Study|Palliative. Overall decline|0|||
126356573|NCT02675452|454597863|FG000|Overall Study|Withdrawal by Subject|0|||
126356574|NCT02675452|454597864|FG001|Overall Study|Withdrawal by Subject|0|||
126356575|NCT02675452|454597865|FG002|Overall Study|Withdrawal by Subject|0|||
126238746|NCT01367457|454167107|FG000|Overall Study|Suspected DP/suspected active infection|1|||
126356576|NCT02675452|454597866|FG003|Overall Study|Withdrawal by Subject|0|||
126356577|NCT02675452|454597867|FG004|Overall Study|Withdrawal by Subject|0|||
126025720|NCT00879333|453389275|FG000|Overall Study|Withdrawal by Subject|20|||
126025721|NCT00879333|453389276|FG001|Overall Study|Withdrawal by Subject|7|||
126238747|NCT01367457|454167108|FG001|Overall Study|Suspected DP/suspected active infection|0|||
126356578|NCT02675452|454597868|FG005|Overall Study|Withdrawal by Subject|0|||
126238748|NCT01367457|454167109|FG002|Overall Study|Suspected DP/suspected active infection|0|||
126238749|NCT01882257|454167112|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
126238750|NCT01882257|454167113|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
126238751|NCT01882257|454167114|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
126238752|NCT01882257|454167112|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
126238753|NCT01882257|454167113|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
126238754|NCT01882257|454167114|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
126238755|NCT02058498|454167115|FG000|Overall Study|Withdrawal by Subject|4|||
126356579|NCT02675452|454597869|FG006|Overall Study|Withdrawal by Subject|0|||
126238756|NCT01038856|454167124|FG000|Overall Study|Adverse Event|2|||
126238757|NCT04466111|454167126|FG000|Prior to Trial Phase|Physician Decision|1|||
126238758|NCT00105196|454167127|FG000|Overall Study|Lack of Efficacy|2|||
126238759|NCT00105196|454167128|FG001|Overall Study|Lack of Efficacy|3|||
126238760|NCT00105196|454167127|FG000|Overall Study|Adverse Event|11|||
126238761|NCT00105196|454167128|FG001|Overall Study|Adverse Event|3|||
126238762|NCT00105196|454167127|FG000|Overall Study|Withdrawal by Subject|6|||
126238763|NCT00105196|454167128|FG001|Overall Study|Withdrawal by Subject|6|||
126238764|NCT00105196|454167127|FG000|Overall Study|Lost to Follow-up|3|||
126238765|NCT00105196|454167128|FG001|Overall Study|Lost to Follow-up|2|||
126238766|NCT00105196|454167127|FG000|Overall Study|Poor/noncompliance|3|||
126238767|NCT00105196|454167128|FG001|Overall Study|Poor/noncompliance|4|||
126238768|NCT00105196|454167127|FG000|Overall Study|Protocol Violation|5|||
126238769|NCT00105196|454167128|FG001|Overall Study|Protocol Violation|2|||
126238770|NCT00105196|454167127|FG000|Overall Study|pending surgery|0|||
126238771|NCT00105196|454167128|FG001|Overall Study|pending surgery|1|||
126238772|NCT00105196|454167127|FG000|Overall Study|marijuana use|0|||
126238773|NCT00105196|454167128|FG001|Overall Study|marijuana use|1|||
126238774|NCT00105196|454167127|FG000|Overall Study|Subject became unblinded|0|||
126238775|NCT00105196|454167128|FG001|Overall Study|Subject became unblinded|1|||
126238776|NCT03025880|454167129|FG000|Overall Study|Adverse Event|1|||
126238777|NCT03025880|454167130|FG001|Overall Study|Adverse Event|0|||
126238778|NCT03025880|454167129|FG000|Overall Study|Death|1|||
126238779|NCT03025880|454167130|FG001|Overall Study|Death|1|||
126238780|NCT03025880|454167129|FG000|Overall Study|Withdrawal by Subject|0|||
126238781|NCT03025880|454167130|FG001|Overall Study|Withdrawal by Subject|1|||
126238782|NCT03025880|454167129|FG000|Overall Study|Physician Decision|0|||
126238783|NCT03025880|454167130|FG001|Overall Study|Physician Decision|1|||
126238784|NCT03025880|454167129|FG000|Overall Study|Progressive Disease|12|||
126238785|NCT03025880|454167130|FG001|Overall Study|Progressive Disease|19|||
126238786|NCT01035060|454167131|FG000|Overall Study|Lost to Follow-up|0|||
126238787|NCT01035060|454167132|FG001|Overall Study|Lost to Follow-up|7|||
126238788|NCT01035060|454167131|FG000|Overall Study|Did not quality after 2nd screening|14|||
126238789|NCT01035060|454167132|FG001|Overall Study|Did not quality after 2nd screening|1|||
126238790|NCT01035060|454167131|FG000|Overall Study|Withdrawal by Subject|8|||
126238791|NCT01035060|454167132|FG001|Overall Study|Withdrawal by Subject|6|||
126238792|NCT01035060|454167131|FG000|Overall Study|Physician Decision|2|||
126238793|NCT01035060|454167132|FG001|Overall Study|Physician Decision|0|||
126238794|NCT02015390|454167137|FG000|Overall Study|Lost to Follow-up|1|||
126238795|NCT02015390|454167138|FG001|Overall Study|Lost to Follow-up|0|||
126238796|NCT02015390|454167137|FG000|Overall Study|Adverse Event|0|||
126238797|NCT02015390|454167138|FG001|Overall Study|Adverse Event|3|||
126238798|NCT02015390|454167137|FG000|Overall Study|Physician Decision|0|||
126238799|NCT02015390|454167138|FG001|Overall Study|Physician Decision|1|||
126238800|NCT02193880|454167139|FG000|Overall Study|patients did not collect enough HPC|3|||
126238801|NCT03136380|454167140|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126238802|NCT03136380|454167141|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
126238803|NCT03136380|454167142|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126238804|NCT03136380|454167143|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126238805|NCT03136380|454167144|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126238806|NCT00553280|454167148|FG000|Overall Study|Adverse Event|19|||
126238807|NCT00553280|454167148|FG000|Overall Study|Lack of Efficacy|3|||
126238808|NCT00553280|454167148|FG000|Overall Study|Withdrawal by Subject|3|||
126238809|NCT00553280|454167148|FG000|Overall Study|Physician Decision|1|||
126238810|NCT02794974|454167149|FG000|Overall Study|Physician Decision|0|||
126238811|NCT02794974|454167150|FG001|Overall Study|Physician Decision|1|||
126238812|NCT02202850|454167151|FG000|Overall Study|Other|2|||
126238813|NCT02202850|454167152|FG001|Overall Study|Other|2|||
126238814|NCT02202850|454167151|FG000|Overall Study|Enbrel treatment discontinued|15|||
126356580|NCT02675452|454597870|FG007|Overall Study|Withdrawal by Subject|0|||
126238815|NCT02202850|454167152|FG001|Overall Study|Enbrel treatment discontinued|3|||
126238816|NCT02202850|454167151|FG000|Overall Study|Lost to Follow-up|7|||
126356581|NCT02675452|454597871|FG008|Overall Study|Withdrawal by Subject|0|||
126356582|NCT02675452|454597872|FG009|Overall Study|Withdrawal by Subject|1|||
126238817|NCT02202850|454167152|FG001|Overall Study|Lost to Follow-up|1|||
126356583|NCT02675452|454597873|FG010|Overall Study|Withdrawal by Subject|0|||
126238818|NCT02996682|454167153|FG000|Overall Study|Death|0|||
126238819|NCT02996682|454167154|FG001|Overall Study|Death|3|||
126238820|NCT00735904|454167155|FG000|Overall Study|Adverse Event|3|||
126238821|NCT00735904|454167155|FG000|Overall Study|Death|20|||
126238822|NCT00735904|454167155|FG000|Overall Study|Protocol Violation|1|||
126238823|NCT00735904|454167155|FG000|Overall Study|Withdrawal by Subject|1|||
126238824|NCT00735904|454167155|FG000|Overall Study|Study Terminated by Sponsor|5|||
126238825|NCT00735904|454167155|FG000|Overall Study|Other|8|||
126238826|NCT01390844|454167158|FG000|Treatment Phase|Adverse Event|12|||
126356584|NCT02675452|454597874|FG011|Overall Study|Withdrawal by Subject|1|||
126356585|NCT02675452|454597875|FG012|Overall Study|Withdrawal by Subject|0|||
126238827|NCT01390844|454167159|FG001|Treatment Phase|Adverse Event|2|||
126238828|NCT01390844|454167160|FG002|Treatment Phase|Adverse Event|3|||
126238829|NCT01390844|454167161|FG003|Treatment Phase|Adverse Event|2|||
126093646|NCT01259089|453636125|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126093647|NCT01259089|453636126|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
126093648|NCT01259089|453636121|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
126093649|NCT01259089|453636122|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
126093650|NCT01259089|453636123|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
126093651|NCT01259089|453636124|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
126093652|NCT01259089|453636125|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
126093653|NCT01259089|453636126|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
126093654|NCT01259089|453636121|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126093655|NCT01259089|453636122|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126093656|NCT01259089|453636123|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126093657|NCT01259089|453636124|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126093658|NCT01259089|453636125|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126093659|NCT01259089|453636126|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
126093660|NCT01259089|453636121|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
126093661|NCT01259089|453636122|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
126093662|NCT01259089|453636123|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
126093663|NCT01259089|453636124|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
126093664|NCT01259089|453636125|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
126093665|NCT01259089|453636126|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
126238830|NCT01390844|454167158|FG000|Treatment Phase|Treatment Failure|23|||
126238831|NCT01390844|454167159|FG001|Treatment Phase|Treatment Failure|25|||
126238832|NCT01390844|454167160|FG002|Treatment Phase|Treatment Failure|10|||
126238833|NCT01390844|454167161|FG003|Treatment Phase|Treatment Failure|13|||
126238834|NCT01390844|454167158|FG000|Treatment Phase|Non-Medical Reasons|5|||
126238835|NCT01390844|454167159|FG001|Treatment Phase|Non-Medical Reasons|1|||
126238836|NCT01390844|454167160|FG002|Treatment Phase|Non-Medical Reasons|8|||
126238837|NCT01390844|454167161|FG003|Treatment Phase|Non-Medical Reasons|1|||
126238838|NCT01390844|454167158|FG000|Treatment Phase|Non-GCP Compliant|0|||
126238839|NCT01390844|454167159|FG001|Treatment Phase|Non-GCP Compliant|0|||
126238840|NCT01390844|454167160|FG002|Treatment Phase|Non-GCP Compliant|10|||
126238841|NCT01390844|454167161|FG003|Treatment Phase|Non-GCP Compliant|3|||
126238842|NCT01390844|454167158|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
126238843|NCT01390844|454167159|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
126238844|NCT01390844|454167160|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
126238845|NCT01390844|454167161|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
126238846|NCT03204539|454167162|FG000|Overall Study|Loss of funding|0|||
126238847|NCT03204539|454167163|FG001|Overall Study|Loss of funding|1|||
126238848|NCT05093205|454167164|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
126238849|NCT05093205|454167165|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
126238850|NCT05093205|454167166|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
126238851|NCT05093205|454167167|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
126238852|NCT05093205|454167168|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
126238853|NCT05093205|454167169|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
126238854|NCT05093205|454167170|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
126238855|NCT05093205|454167171|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
126238856|NCT05093205|454167172|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
126238857|NCT05093205|454167173|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
126238858|NCT05093205|454167174|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
126238859|NCT05093205|454167175|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
126238860|NCT05093205|454167176|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
126238861|NCT05093205|454167164|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238862|NCT05093205|454167165|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238863|NCT05093205|454167166|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
126238864|NCT05093205|454167167|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238865|NCT05093205|454167168|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238866|NCT05093205|454167169|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238867|NCT05093205|454167170|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238868|NCT05093205|454167171|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238869|NCT05093205|454167172|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238870|NCT05093205|454167173|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238871|NCT05093205|454167174|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238872|NCT05093205|454167175|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238873|NCT05093205|454167176|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126238874|NCT05093205|454167164|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
126238875|NCT05093205|454167165|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
126238876|NCT05093205|454167166|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
126093666|NCT01259089|453636121|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
126238877|NCT05093205|454167167|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
126238878|NCT05093205|454167168|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
126238879|NCT05093205|454167169|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
126238880|NCT05093205|454167170|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
126238881|NCT05093205|454167171|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
126238882|NCT05093205|454167172|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
126238883|NCT05093205|454167173|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
126238884|NCT05093205|454167174|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
126238885|NCT05093205|454167175|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
126238886|NCT05093205|454167176|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
126238887|NCT05093205|454167164|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
126238888|NCT05093205|454167165|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
126238889|NCT05093205|454167166|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
126238890|NCT05093205|454167167|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
126238891|NCT05093205|454167168|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
126238892|NCT05093205|454167169|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
126238893|NCT05093205|454167170|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
126238894|NCT05093205|454167171|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
126238895|NCT05093205|454167172|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
126238896|NCT05093205|454167173|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
126238897|NCT05093205|454167174|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
126238898|NCT05093205|454167175|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
126238899|NCT05093205|454167176|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
126238900|NCT05093205|454167164|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
126238901|NCT05093205|454167165|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
126238902|NCT05093205|454167166|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
126238903|NCT05093205|454167167|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
126238904|NCT05093205|454167168|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
126238905|NCT05093205|454167169|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
126238906|NCT05093205|454167170|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
126238907|NCT05093205|454167171|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
126238908|NCT05093205|454167172|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
126238909|NCT05093205|454167173|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
126238910|NCT05093205|454167174|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
126238911|NCT05093205|454167175|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
126238912|NCT05093205|454167176|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
126238913|NCT05093205|454167164|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
126238914|NCT05093205|454167165|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
126238915|NCT05093205|454167166|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
126238916|NCT05093205|454167167|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
126238917|NCT05093205|454167168|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
126238918|NCT05093205|454167169|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
126238919|NCT05093205|454167170|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
126238920|NCT05093205|454167171|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
126238921|NCT05093205|454167172|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
126238922|NCT05093205|454167173|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
126238923|NCT05093205|454167174|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
126238924|NCT05093205|454167175|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
126238925|NCT05093205|454167176|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
126238926|NCT05093205|454167164|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
126238927|NCT05093205|454167165|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
126238928|NCT05093205|454167166|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
126238929|NCT05093205|454167167|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
126238930|NCT05093205|454167168|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
126238931|NCT05093205|454167169|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
126238932|NCT05093205|454167170|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
126238933|NCT05093205|454167171|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
126238934|NCT05093205|454167172|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
126238935|NCT05093205|454167173|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
126238936|NCT05093205|454167174|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
126238937|NCT05093205|454167175|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
126238938|NCT05093205|454167176|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
126238939|NCT05093205|454167164|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
126238940|NCT05093205|454167165|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
126238941|NCT05093205|454167166|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
126238942|NCT05093205|454167167|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
126238943|NCT05093205|454167168|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
126238944|NCT05093205|454167169|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
126025722|NCT00879333|453389275|FG000|Overall Study|Lost to Follow-up|2|||
126238945|NCT05093205|454167170|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
126238946|NCT05093205|454167171|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
126238947|NCT05093205|454167172|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
126238948|NCT05093205|454167173|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
126238949|NCT05093205|454167174|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
126238950|NCT05093205|454167175|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
126238951|NCT05093205|454167176|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
126238952|NCT05093205|454167164|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238953|NCT05093205|454167165|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238954|NCT05093205|454167166|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238955|NCT05093205|454167167|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238956|NCT05093205|454167168|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238957|NCT05093205|454167169|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238958|NCT05093205|454167170|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238959|NCT05093205|454167171|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238960|NCT05093205|454167172|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238961|NCT05093205|454167173|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
126238962|NCT05093205|454167174|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238963|NCT05093205|454167175|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238964|NCT05093205|454167176|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126238965|NCT05093205|454167164|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
126238966|NCT05093205|454167165|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
126238967|NCT05093205|454167166|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
126238968|NCT05093205|454167167|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
126238969|NCT05093205|454167168|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
126238970|NCT05093205|454167169|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
126238971|NCT05093205|454167170|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
126238972|NCT05093205|454167171|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
126238973|NCT05093205|454167172|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
126238974|NCT05093205|454167173|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
126238975|NCT05093205|454167174|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
126238976|NCT05093205|454167175|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
126238977|NCT05093205|454167176|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
126238978|NCT05093205|454167164|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238979|NCT05093205|454167165|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238980|NCT05093205|454167166|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238981|NCT05093205|454167167|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238982|NCT05093205|454167168|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238983|NCT05093205|454167169|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238984|NCT05093205|454167170|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238985|NCT05093205|454167171|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238986|NCT05093205|454167172|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238987|NCT05093205|454167173|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238988|NCT05093205|454167174|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
126238989|NCT05093205|454167175|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238990|NCT05093205|454167176|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126238991|NCT05093205|454167164|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126025723|NCT00879333|453389276|FG001|Overall Study|Lost to Follow-up|1|||
126025724|NCT00879333|453389275|FG000|Overall Study|Administrative Problems|2|||
126025725|NCT00879333|453389276|FG001|Overall Study|Administrative Problems|0|||
126025726|NCT00879333|453389275|FG000|Overall Study|Death|16|||
126025727|NCT00879333|453389276|FG001|Overall Study|Death|5|||
126093667|NCT01259089|453636122|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
126238992|NCT05093205|454167165|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126238993|NCT05093205|454167166|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126238994|NCT05093205|454167167|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126238995|NCT05093205|454167168|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126238996|NCT05093205|454167169|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126238997|NCT05093205|454167170|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126238998|NCT05093205|454167171|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126238999|NCT05093205|454167172|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126025728|NCT00879333|453389275|FG000|Overall Study|Disease Progression|292|||
126025729|NCT00879333|453389276|FG001|Overall Study|Disease Progression|169|||
126239000|NCT05093205|454167173|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126239001|NCT05093205|454167174|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126239002|NCT05093205|454167175|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
126239003|NCT05093205|454167176|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126239004|NCT05093205|454167164|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
126239005|NCT05093205|454167165|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
126239006|NCT05093205|454167166|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
126239007|NCT05093205|454167167|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
126239008|NCT05093205|454167168|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
126239009|NCT05093205|454167169|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
126239010|NCT05093205|454167170|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
126239011|NCT05093205|454167171|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
126239012|NCT05093205|454167172|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
126239013|NCT05093205|454167173|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
126239014|NCT05093205|454167174|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
126239015|NCT05093205|454167175|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
126239016|NCT05093205|454167176|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
126239017|NCT05093205|454167164|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239018|NCT05093205|454167165|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239019|NCT05093205|454167166|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239020|NCT05093205|454167167|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239021|NCT05093205|454167168|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239022|NCT05093205|454167169|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239023|NCT05093205|454167170|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239024|NCT05093205|454167171|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239025|NCT05093205|454167172|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239026|NCT05093205|454167173|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239027|NCT05093205|454167174|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239028|NCT05093205|454167175|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
126239029|NCT05093205|454167176|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126239030|NCT03361228|454167178|FG000|Overall Study|Other|1|||
126239031|NCT03361228|454167179|FG001|Overall Study|Other|1|||
126239032|NCT03361228|454167178|FG000|Overall Study|Death|3|||
126239033|NCT03361228|454167179|FG001|Overall Study|Death|0|||
126239034|NCT03693430|454167180|FG000|Overall Study|Lost to Follow-up|3|||
126239035|NCT03693430|454167181|FG001|Overall Study|Lost to Follow-up|14|||
126239036|NCT03693430|454167180|FG000|Overall Study|Death|1|||
126239037|NCT03693430|454167181|FG001|Overall Study|Death|0|||
126239038|NCT03693430|454167180|FG000|Overall Study|Withdrawal by Subject|0|||
126239039|NCT03693430|454167181|FG001|Overall Study|Withdrawal by Subject|4|||
126239040|NCT04185909|454167182|FG000|Overall Study|Lost to Follow-up|1|||
126239041|NCT01417078|454167183|FG000|Overall Study|Withdrawal by Subject|1|||
126239042|NCT03420300|454167192|FG000|Overall Study|Death|2|||
126239043|NCT02421952|454167193|FG000|Overall Study|Diary Not Returned|93|||
126239044|NCT02421952|454167193|FG000|Overall Study|Failed seriation task|13|||
126239045|NCT02421952|454167193|FG000|Overall Study|Subject uncooperative for baseline test|2|||
126239046|NCT02421952|454167193|FG000|Overall Study|Surgery cancelled|1|||
126239047|NCT01223365|454167194|FG000|Open-label Titration Period|Enrolled but not treated|1|||
126239048|NCT01223365|454167194|FG000|Open-label Titration Period|Adverse Event|23|||
126239049|NCT01223365|454167194|FG000|Open-label Titration Period|Lack of Efficacy|3|||
126239050|NCT01223365|454167194|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
126239051|NCT01223365|454167194|FG000|Open-label Titration Period|Protocol Violation|1|||
126239052|NCT01223365|454167194|FG000|Open-label Titration Period|Lost to Follow-up|2|||
126239053|NCT01223365|454167194|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
126239054|NCT01223365|454167194|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
126239055|NCT01223365|454167194|FG000|Open-label Titration Period|Starting physical therapy|1|||
126239056|NCT01223365|454167194|FG000|Open-label Treatment Period|Adverse Event|39|||
126239057|NCT01223365|454167194|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
126239058|NCT01223365|454167194|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
126239059|NCT01223365|454167194|FG000|Open-label Treatment Period|Protocol Violation|15|||
126239060|NCT01223365|454167194|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
126239061|NCT01223365|454167194|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
126239062|NCT01223365|454167194|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
126239063|NCT01223365|454167194|FG000|Open-label Treatment Period|Moved out of area|2|||
126239064|NCT01223365|454167194|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
126239065|NCT01223365|454167194|FG000|Open-label Treatment Period|"Out of window"|1|||
126239066|NCT01223365|454167194|FG000|Open-label Treatment Period|Starting physical therapy|1|||
126239067|NCT01223365|454167194|FG000|Open-label Treatment Period|Physician Decision|2|||
126239068|NCT03567174|454167195|FG000|Overall Study|Death|24|||
126239069|NCT03567174|454167196|FG001|Overall Study|Death|31|||
126239070|NCT03567174|454167195|FG000|Overall Study|Lost to Follow-up|165|||
126239071|NCT03567174|454167196|FG001|Overall Study|Lost to Follow-up|174|||
126239072|NCT03243630|454167197|FG000|Overall Study|Protocol Violation|1|||
126025730|NCT00879333|453389275|FG000|Overall Study|Protocol Violation|1|||
126025731|NCT00879333|453389276|FG001|Overall Study|Protocol Violation|1|||
126025732|NCT02671435|453389279|FG000|Overall Study|Death|1|||
126025733|NCT02671435|453389280|FG001|Overall Study|Death|3|||
126025734|NCT02671435|453389281|FG002|Overall Study|Death|0|||
126239073|NCT03243630|454167197|FG000|Overall Study|Physician Decision|1|||
126025735|NCT02671435|453389282|FG003|Overall Study|Death|16|||
126025736|NCT02671435|453389283|FG004|Overall Study|Death|14|||
126239074|NCT02140060|454167198|FG000|Overall Study|Adverse Event|0|||
126239075|NCT02140060|454167199|FG001|Overall Study|Adverse Event|0|||
126239076|NCT02140060|454167200|FG002|Overall Study|Adverse Event|0|||
126239077|NCT02140060|454167201|FG003|Overall Study|Adverse Event|1|||
126239078|NCT02140060|454167202|FG004|Overall Study|Adverse Event|1|||
126239079|NCT02140060|454167203|FG005|Overall Study|Adverse Event|1|||
126239080|NCT02140060|454167198|FG000|Overall Study|Lack of Efficacy|0|||
126239081|NCT02140060|454167199|FG001|Overall Study|Lack of Efficacy|0|||
126239082|NCT02140060|454167200|FG002|Overall Study|Lack of Efficacy|0|||
126239083|NCT02140060|454167201|FG003|Overall Study|Lack of Efficacy|1|||
126239084|NCT02140060|454167202|FG004|Overall Study|Lack of Efficacy|0|||
126239085|NCT02140060|454167203|FG005|Overall Study|Lack of Efficacy|0|||
126239086|NCT02817841|454168942|FG000|Overall Study|Lost to Follow-up|287|||
126239087|NCT02817841|454168942|FG000|Overall Study|Withdrawal by Subject|183|||
126239088|NCT02817841|454168942|FG000|Overall Study|Adverse event not related to bleeding|131|||
126239089|NCT02817841|454168942|FG000|Overall Study|Adverse event related to bleeding|51|||
126239090|NCT02817841|454168942|FG000|Overall Study|Pregnancy|32|||
126239091|NCT02817841|454168942|FG000|Overall Study|Pregnancy wish|17|||
126239092|NCT02817841|454168942|FG000|Overall Study|Other reasons|53|||
126239093|NCT02817841|454168942|FG000|Overall Study|Protocol Violation|94|||
126239094|NCT01746017|454168949|FG000|Period 1|Withdrawal by Subject|0|||
126239095|NCT01746017|454168950|FG001|Period 1|Withdrawal by Subject|0|||
126239096|NCT01746017|454168951|FG002|Period 1|Withdrawal by Subject|0|||
126239097|NCT01746017|454168952|FG003|Period 1|Withdrawal by Subject|0|||
126239098|NCT01746017|454168953|FG004|Period 1|Withdrawal by Subject|0|||
126239099|NCT01746017|454168954|FG005|Period 1|Withdrawal by Subject|0|||
126239100|NCT01746017|454168955|FG006|Period 1|Withdrawal by Subject|1|||
126239101|NCT01746017|454168956|FG007|Period 1|Withdrawal by Subject|0|||
126239102|NCT01746017|454168957|FG008|Period 1|Withdrawal by Subject|0|||
126239103|NCT01746017|454168958|FG009|Period 1|Withdrawal by Subject|0|||
126239104|NCT01746017|454168959|FG010|Period 1|Withdrawal by Subject|0|||
126239105|NCT01746017|454168949|FG000|Period 3|Withdrawal by Subject|0|||
126239106|NCT01746017|454168950|FG001|Period 3|Withdrawal by Subject|0|||
126239107|NCT01746017|454168951|FG002|Period 3|Withdrawal by Subject|0|||
126239108|NCT01746017|454168952|FG003|Period 3|Withdrawal by Subject|0|||
126239109|NCT01746017|454168953|FG004|Period 3|Withdrawal by Subject|0|||
126239110|NCT01746017|454168954|FG005|Period 3|Withdrawal by Subject|1|||
126239111|NCT01746017|454168955|FG006|Period 3|Withdrawal by Subject|0|||
126239112|NCT01746017|454168956|FG007|Period 3|Withdrawal by Subject|0|||
126239113|NCT01746017|454168957|FG008|Period 3|Withdrawal by Subject|0|||
126239114|NCT01746017|454168958|FG009|Period 3|Withdrawal by Subject|0|||
126239115|NCT01746017|454168959|FG010|Period 3|Withdrawal by Subject|0|||
126239116|NCT00397488|454168960|FG000|Overall Study|Withdrawal by Subject|3|||
126239117|NCT00397488|454168960|FG000|Overall Study|Adverse Event|3|||
126239118|NCT00397488|454168960|FG000|Overall Study|Death|1|||
126239119|NCT01215981|454168963|FG000|Overall Study|Physician Decision|0|||
126239120|NCT01215981|454168964|FG001|Overall Study|Physician Decision|1|||
126239121|NCT01215981|454168963|FG000|Overall Study|Protocol Violation|1|||
126239122|NCT01215981|454168964|FG001|Overall Study|Protocol Violation|0|||
126239123|NCT01215981|454168963|FG000|Overall Study|Withdrawal by Subject|1|||
126239124|NCT01215981|454168964|FG001|Overall Study|Withdrawal by Subject|0|||
126239125|NCT00840632|454168968|FG000|First Intervention|Withdrawal by Subject|0|||
126239126|NCT00840632|454168969|FG001|First Intervention|Withdrawal by Subject|1|||
126239127|NCT00840632|454168968|FG000|Washout|Withdrawal by Subject|1|||
126239128|NCT00840632|454168969|FG001|Washout|Withdrawal by Subject|1|||
126239129|NCT01294787|454168970|FG000|Period 1|Adverse Event|0|||
126239130|NCT01294787|454168971|FG001|Period 1|Adverse Event|0|||
126239131|NCT01294787|454168972|FG002|Period 1|Adverse Event|0|||
126239132|NCT01294787|454168973|FG003|Period 1|Adverse Event|0|||
126356586|NCT02675452|454597876|FG013|Overall Study|Withdrawal by Subject|1|||
126356587|NCT02675452|454597877|FG014|Overall Study|Withdrawal by Subject|1|||
126356588|NCT02675452|454597878|FG015|Overall Study|Withdrawal by Subject|0|||
126356589|NCT02675452|454597879|FG016|Overall Study|Withdrawal by Subject|2|||
126356590|NCT02675452|454597880|FG017|Overall Study|Withdrawal by Subject|0|||
126239133|NCT01294787|454168974|FG004|Period 1|Adverse Event|1|||
126239134|NCT01294787|454168975|FG005|Period 1|Adverse Event|0|||
126239135|NCT01294787|454168970|FG000|Period 1|Withdrawal by Subject|0|||
126239136|NCT01294787|454168971|FG001|Period 1|Withdrawal by Subject|0|||
126239137|NCT01294787|454168972|FG002|Period 1|Withdrawal by Subject|0|||
126239138|NCT01294787|454168973|FG003|Period 1|Withdrawal by Subject|1|||
126239139|NCT01294787|454168974|FG004|Period 1|Withdrawal by Subject|1|||
126239140|NCT01294787|454168975|FG005|Period 1|Withdrawal by Subject|1|||
126239141|NCT01294787|454168970|FG000|Period 1|Administrative problem|0|||
126239142|NCT01294787|454168971|FG001|Period 1|Administrative problem|0|||
126239143|NCT01294787|454168972|FG002|Period 1|Administrative problem|1|||
126356591|NCT02675452|454597881|FG018|Overall Study|Withdrawal by Subject|0|||
126239144|NCT01294787|454168973|FG003|Period 1|Administrative problem|0|||
126239145|NCT01294787|454168974|FG004|Period 1|Administrative problem|0|||
126239146|NCT01294787|454168975|FG005|Period 1|Administrative problem|1|||
126239147|NCT01294787|454168970|FG000|Period 2|Adverse Event|0|||
126239148|NCT01294787|454168971|FG001|Period 2|Adverse Event|3|||
126239149|NCT01294787|454168972|FG002|Period 2|Adverse Event|0|||
126239150|NCT01294787|454168973|FG003|Period 2|Adverse Event|1|||
126239151|NCT01294787|454168974|FG004|Period 2|Adverse Event|0|||
126239152|NCT01294787|454168975|FG005|Period 2|Adverse Event|0|||
126239153|NCT01294787|454168970|FG000|Period 2|No longer needs study drug|0|||
126239154|NCT01294787|454168971|FG001|Period 2|No longer needs study drug|0|||
126239155|NCT01294787|454168972|FG002|Period 2|No longer needs study drug|0|||
126239156|NCT01294787|454168973|FG003|Period 2|No longer needs study drug|1|||
126239157|NCT01294787|454168974|FG004|Period 2|No longer needs study drug|0|||
126239158|NCT01294787|454168975|FG005|Period 2|No longer needs study drug|0|||
126239159|NCT01294787|454168970|FG000|Period 3|Adverse Event|0|||
126239160|NCT01294787|454168971|FG001|Period 3|Adverse Event|0|||
126239161|NCT01294787|454168972|FG002|Period 3|Adverse Event|0|||
126239162|NCT01294787|454168973|FG003|Period 3|Adverse Event|0|||
126239163|NCT01294787|454168974|FG004|Period 3|Adverse Event|1|||
126239164|NCT01294787|454168975|FG005|Period 3|Adverse Event|0|||
126239165|NCT03785548|454168978|FG000|Overall Study|age > 80|1|||
126239166|NCT03785548|454168979|FG001|Overall Study|age > 80|0|||
126239167|NCT03785548|454168978|FG000|Overall Study|no Postop queries|1|||
126239168|NCT03785548|454168979|FG001|Overall Study|no Postop queries|0|||
126239169|NCT05327491|454168984|FG000|Periods 1 & 2|Miscellaneous|0|||
126239170|NCT05327491|454168985|FG001|Periods 1 & 2|Miscellaneous|1|||
126239171|NCT05327491|454168986|FG002|Periods 1 & 2|Miscellaneous|0|||
126239172|NCT05327491|454168987|FG003|Periods 1 & 2|Miscellaneous|0|||
126239173|NCT05327491|454168984|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
126239174|NCT05327491|454168985|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
126239175|NCT05327491|454168986|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
126239176|NCT05327491|454168987|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
126239177|NCT05038293|454168988|FG000|Overall Study|device was not operating properly for one subject.|1|||
126239178|NCT05038293|454168989|FG001|Overall Study|device was not operating properly for one subject.|0|||
126239179|NCT05038293|454168988|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
126239180|NCT05038293|454168989|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
126239181|NCT01171989|454168990|FG000|Overall Study|Lost to Follow-up|0|||
126239182|NCT01171989|454168991|FG001|Overall Study|Lost to Follow-up|0|||
126239183|NCT01171989|454168992|FG002|Overall Study|Lost to Follow-up|1|||
126239184|NCT01247701|454168995|FG000|Overall Study|Death|2|||
126239185|NCT01247701|454168995|FG000|Overall Study|Relapsed|8|||
126239186|NCT04166630|454168996|FG000|Overall Study|Withdrawal by Subject|0|||
126239187|NCT04166630|454168997|FG001|Overall Study|Withdrawal by Subject|1|||
126239188|NCT00096447|454168998|FG000|Overall Study|Never treated|1|||
126239189|NCT00834743|454168999|FG000|Second Intervention|Withdrawal by Subject|1|||
126239190|NCT00834743|454169000|FG001|Second Intervention|Withdrawal by Subject|0|||
126239191|NCT04088760|454169001|FG000|Overall Study|Physician Decision|1|||
126239192|NCT02300103|454169002|FG000|Overall Study|Lack of Efficacy|3|||
126239193|NCT02300103|454169002|FG000|Overall Study|Protocol Violation|1|||
126239194|NCT02300103|454169002|FG000|Overall Study|Withdrew Consent|2|||
126239195|NCT04091971|454169003|FG000|Overall Study|Withdrawal by Subject|1|||
126239196|NCT04091971|454169003|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
126239197|NCT04091971|454169003|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
126239198|NCT02419937|454169009|FG000|Overall Study|Lost to Follow-up|1|||
126239199|NCT02419937|454169010|FG001|Overall Study|Lost to Follow-up|0|||
126239200|NCT02587962|454169011|FG000|Overall Study|Adverse Event|0|||
126239201|NCT02587962|454169012|FG001|Overall Study|Adverse Event|0|||
126239202|NCT02587962|454169013|FG002|Overall Study|Adverse Event|1|||
126239203|NCT02587962|454169014|FG003|Overall Study|Adverse Event|0|||
126239204|NCT02587962|454169015|FG004|Overall Study|Adverse Event|0|||
126239205|NCT02587962|454169011|FG000|Overall Study|Withdrawal by Subject|0|||
126239206|NCT02587962|454169012|FG001|Overall Study|Withdrawal by Subject|0|||
126239207|NCT02587962|454169013|FG002|Overall Study|Withdrawal by Subject|1|||
126239208|NCT02587962|454169014|FG003|Overall Study|Withdrawal by Subject|1|||
126025737|NCT02671435|453389284|FG005|Overall Study|Death|29|||
126025738|NCT02671435|453389285|FG006|Overall Study|Death|34|||
126025739|NCT02671435|453389286|FG007|Overall Study|Death|28|||
126239209|NCT02587962|454169015|FG004|Overall Study|Withdrawal by Subject|4|||
126239210|NCT02587962|454169011|FG000|Overall Study|Radiological progression|2|||
126025740|NCT02671435|453389287|FG008|Overall Study|Death|19|||
126025741|NCT02671435|453389288|FG009|Overall Study|Death|10|||
126025742|NCT02671435|453389289|FG010|Overall Study|Death|8|||
126025743|NCT02671435|453389290|FG011|Overall Study|Death|29|||
126356592|NCT02675452|454597882|FG019|Overall Study|Withdrawal by Subject|0|||
126356593|NCT02675452|454597883|FG020|Overall Study|Withdrawal by Subject|0|||
126239211|NCT02587962|454169012|FG001|Overall Study|Radiological progression|2|||
126239212|NCT02587962|454169013|FG002|Overall Study|Radiological progression|2|||
126239213|NCT02587962|454169014|FG003|Overall Study|Radiological progression|5|||
126239214|NCT02587962|454169015|FG004|Overall Study|Radiological progression|10|||
126239215|NCT02587962|454169011|FG000|Overall Study|Clinical progression|0|||
126025744|NCT02671435|453389291|FG012|Overall Study|Death|29|||
126025745|NCT02671435|453389292|FG013|Overall Study|Death|29|||
126239216|NCT02587962|454169012|FG001|Overall Study|Clinical progression|1|||
126239217|NCT02587962|454169013|FG002|Overall Study|Clinical progression|2|||
126239218|NCT02587962|454169014|FG003|Overall Study|Clinical progression|0|||
126239219|NCT02587962|454169015|FG004|Overall Study|Clinical progression|1|||
126239220|NCT01981720|454169016|FG000|Overall Study|Adverse Event|1|||
126239221|NCT01981720|454169016|FG000|Overall Study|Withdrawal by Subject|3|||
126239222|NCT01981720|454169016|FG000|Overall Study|Pregnancy|1|||
126239223|NCT00086996|454169018|FG000|Overall Study|Adverse Event|29|||
126239224|NCT00086996|454169018|FG000|Overall Study|Death|4|||
126239225|NCT00086996|454169018|FG000|Overall Study|progression/relapse|7|||
126239226|NCT00086996|454169018|FG000|Overall Study|Withdrawal by Subject|13|||
126239227|NCT00086996|454169018|FG000|Overall Study|Other|6|||
126239228|NCT00086996|454169018|FG000|Overall Study|not eligible|5|||
126239229|NCT00184600|454169019|FG000|Overall Study|Adverse Event|9|||
126239230|NCT00184600|454169020|FG001|Overall Study|Adverse Event|0|||
126239231|NCT00184600|454169021|FG002|Overall Study|Adverse Event|5|||
126239232|NCT00184600|454169019|FG000|Overall Study|Death|3|||
126239233|NCT00184600|454169020|FG001|Overall Study|Death|9|||
126239234|NCT00184600|454169021|FG002|Overall Study|Death|7|||
126239235|NCT00184600|454169019|FG000|Overall Study|Lack of Efficacy|3|||
126239236|NCT00184600|454169020|FG001|Overall Study|Lack of Efficacy|1|||
126239237|NCT00184600|454169021|FG002|Overall Study|Lack of Efficacy|3|||
126239238|NCT00184600|454169019|FG000|Overall Study|Lost to Follow-up|4|||
126239239|NCT00184600|454169020|FG001|Overall Study|Lost to Follow-up|6|||
126025746|NCT02671435|453389293|FG014|Overall Study|Death|27|||
126025747|NCT02671435|453389279|FG000|Overall Study|Lost to Follow-up|0|||
126025748|NCT02671435|453389280|FG001|Overall Study|Lost to Follow-up|0|||
126025749|NCT02671435|453389281|FG002|Overall Study|Lost to Follow-up|1|||
126025750|NCT02671435|453389282|FG003|Overall Study|Lost to Follow-up|0|||
126025751|NCT02671435|453389283|FG004|Overall Study|Lost to Follow-up|1|||
126239240|NCT00184600|454169021|FG002|Overall Study|Lost to Follow-up|1|||
126239241|NCT00184600|454169019|FG000|Overall Study|Protocol Violation|2|||
126239242|NCT00184600|454169020|FG001|Overall Study|Protocol Violation|2|||
126239243|NCT00184600|454169021|FG002|Overall Study|Protocol Violation|3|||
126239244|NCT00184600|454169019|FG000|Overall Study|Withdrawal by Subject|20|||
126239245|NCT00184600|454169020|FG001|Overall Study|Withdrawal by Subject|28|||
126239246|NCT00184600|454169021|FG002|Overall Study|Withdrawal by Subject|12|||
126239247|NCT00184600|454169019|FG000|Overall Study|Unclassified|4|||
126239248|NCT00184600|454169020|FG001|Overall Study|Unclassified|5|||
126239249|NCT00184600|454169021|FG002|Overall Study|Unclassified|3|||
126239250|NCT02674477|454169022|FG000|Overall Study|Protocol Violation|8|||
126239251|NCT02674477|454169023|FG001|Overall Study|Protocol Violation|2|||
126239252|NCT00004562|454169024|FG000|Overall Study|Lost to Follow-up|102|||
126239253|NCT00004562|454169025|FG001|Overall Study|Lost to Follow-up|91|||
126239254|NCT04274686|454169027|FG000|Overall Study|Physician Decision|1|||
126239255|NCT04274686|454169028|FG001|Overall Study|Physician Decision|0|||
126239256|NCT00376623|454169029|FG000|Overall Study|Progressive disease|35|||
126239257|NCT00376623|454169030|FG001|Overall Study|Progressive disease|22|||
126239258|NCT00376623|454169031|FG002|Overall Study|Progressive disease|17|||
126239259|NCT00376623|454169029|FG000|Overall Study|Lost to Follow-up|0|||
126239260|NCT00376623|454169030|FG001|Overall Study|Lost to Follow-up|1|||
126239261|NCT00376623|454169031|FG002|Overall Study|Lost to Follow-up|0|||
126239262|NCT00376623|454169029|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
126239263|NCT00376623|454169030|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
126239264|NCT00376623|454169031|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
126239265|NCT00376623|454169029|FG000|Overall Study|Not treated with BI 2536|1|||
126239266|NCT00376623|454169030|FG001|Overall Study|Not treated with BI 2536|0|||
126239267|NCT00376623|454169031|FG002|Overall Study|Not treated with BI 2536|0|||
126239268|NCT00376623|454169029|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
126239269|NCT00376623|454169030|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
126239270|NCT00376623|454169031|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
126239271|NCT00376623|454169029|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
126239272|NCT00376623|454169030|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
126239273|NCT00376623|454169031|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
126239274|NCT00376623|454169029|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
126239275|NCT00376623|454169030|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
126239276|NCT00376623|454169031|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
126239277|NCT00376623|454169029|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
126239278|NCT00376623|454169030|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
126239279|NCT00376623|454169031|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
126239280|NCT00376623|454169029|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
126239281|NCT00376623|454169030|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
126239282|NCT00376623|454169031|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
126239283|NCT00376623|454169029|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
126239284|NCT00376623|454169030|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
126239285|NCT00376623|454169031|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
126239286|NCT00376623|454169029|FG000|Overall Study|Increase of tumour markers|0|||
126239287|NCT00376623|454169030|FG001|Overall Study|Increase of tumour markers|1|||
126239288|NCT00376623|454169031|FG002|Overall Study|Increase of tumour markers|0|||
126239289|NCT00376623|454169029|FG000|Overall Study|Bone metastasis|1|||
126239290|NCT00376623|454169030|FG001|Overall Study|Bone metastasis|0|||
126239291|NCT00376623|454169031|FG002|Overall Study|Bone metastasis|0|||
126239292|NCT00286754|454169032|FG000|Overall Study|Adverse Event|2|||
126239293|NCT00286754|454169033|FG001|Overall Study|Adverse Event|2|||
126239294|NCT00286754|454169034|FG002|Overall Study|Adverse Event|3|||
126239295|NCT00286754|454169032|FG000|Overall Study|Withdrawal by Subject|6|||
126025752|NCT02671435|453389284|FG005|Overall Study|Lost to Follow-up|1|||
126025753|NCT02671435|453389285|FG006|Overall Study|Lost to Follow-up|2|||
126239296|NCT00286754|454169033|FG001|Overall Study|Withdrawal by Subject|2|||
126239297|NCT00286754|454169034|FG002|Overall Study|Withdrawal by Subject|0|||
126239298|NCT00286754|454169032|FG000|Overall Study|Lost to Follow-up|12|||
126239299|NCT00286754|454169033|FG001|Overall Study|Lost to Follow-up|14|||
126239300|NCT00286754|454169034|FG002|Overall Study|Lost to Follow-up|6|||
126239301|NCT00286754|454169032|FG000|Overall Study|Moved out of state|0|||
126239302|NCT00286754|454169033|FG001|Overall Study|Moved out of state|0|||
126239303|NCT00286754|454169034|FG002|Overall Study|Moved out of state|1|||
126239304|NCT02336165|454169035|FG000|Overall Study|Death|3|||
126239305|NCT02336165|454169036|FG001|Overall Study|Death|0|||
126239306|NCT02336165|454169037|FG002|Overall Study|Death|0|||
126239307|NCT02336165|454169038|FG003|Overall Study|Death|0|||
126239308|NCT02336165|454169039|FG004|Overall Study|Death|1|||
126239309|NCT02336165|454169035|FG000|Overall Study|Physician Decision|2|||
126239310|NCT02336165|454169036|FG001|Overall Study|Physician Decision|2|||
126239311|NCT02336165|454169037|FG002|Overall Study|Physician Decision|1|||
126239312|NCT02336165|454169038|FG003|Overall Study|Physician Decision|1|||
126239313|NCT02336165|454169039|FG004|Overall Study|Physician Decision|0|||
126239314|NCT02336165|454169035|FG000|Overall Study|Withdrawal by Subject|0|||
126239315|NCT02336165|454169036|FG001|Overall Study|Withdrawal by Subject|0|||
126239316|NCT02336165|454169037|FG002|Overall Study|Withdrawal by Subject|1|||
126239317|NCT02336165|454169038|FG003|Overall Study|Withdrawal by Subject|0|||
126239318|NCT02336165|454169039|FG004|Overall Study|Withdrawal by Subject|1|||
126239319|NCT02336165|454169035|FG000|Overall Study|Adverse Event|4|||
126239320|NCT02336165|454169036|FG001|Overall Study|Adverse Event|1|||
126239321|NCT02336165|454169037|FG002|Overall Study|Adverse Event|2|||
126239322|NCT02336165|454169038|FG003|Overall Study|Adverse Event|4|||
126239323|NCT02336165|454169039|FG004|Overall Study|Adverse Event|1|||
126239324|NCT02336165|454169035|FG000|Overall Study|Progressive disease|23|||
126239325|NCT02336165|454169036|FG001|Overall Study|Progressive disease|22|||
126239326|NCT02336165|454169037|FG002|Overall Study|Progressive disease|27|||
126239327|NCT02336165|454169038|FG003|Overall Study|Progressive disease|24|||
126239328|NCT02336165|454169039|FG004|Overall Study|Progressive disease|19|||
126239329|NCT02336165|454169035|FG000|Overall Study|Non-compliance|1|||
126239330|NCT02336165|454169036|FG001|Overall Study|Non-compliance|0|||
126239331|NCT02336165|454169037|FG002|Overall Study|Non-compliance|0|||
126239332|NCT02336165|454169038|FG003|Overall Study|Non-compliance|1|||
126239333|NCT02336165|454169039|FG004|Overall Study|Non-compliance|0|||
126239334|NCT02336165|454169035|FG000|Overall Study|Other|1|||
126239335|NCT02336165|454169036|FG001|Overall Study|Other|0|||
126239336|NCT02336165|454169037|FG002|Overall Study|Other|0|||
126239337|NCT02336165|454169038|FG003|Overall Study|Other|1|||
126239338|NCT02336165|454169039|FG004|Overall Study|Other|0|||
126239339|NCT00910663|454169046|FG000|Period 1|Withdrawal by Subject|0|||
126239340|NCT00910663|454169047|FG001|Period 1|Withdrawal by Subject|1|||
126239341|NCT02865850|454169048|FG000|Overall Study|Death|15|||
126239342|NCT02865850|454169049|FG001|Overall Study|Death|19|||
126239343|NCT02865850|454169048|FG000|Overall Study|Withdrawal by Subject|3|||
126239344|NCT02865850|454169049|FG001|Overall Study|Withdrawal by Subject|2|||
126239345|NCT02865850|454169048|FG000|Overall Study|Lost to Follow-up|3|||
126239346|NCT02865850|454169049|FG001|Overall Study|Lost to Follow-up|2|||
126239347|NCT02726581|454169050|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
126239348|NCT02726581|454169051|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
126239349|NCT02726581|454169052|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
126239350|NCT02726581|454169050|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
126239351|NCT02726581|454169051|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
126239352|NCT02726581|454169052|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
126239353|NCT02726581|454169050|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126239354|NCT02726581|454169051|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126239355|NCT02726581|454169052|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126239356|NCT02726581|454169050|FG000|Treatment Period|Disease progression|47|||
126239357|NCT02726581|454169051|FG001|Treatment Period|Disease progression|50|||
126239358|NCT02726581|454169052|FG002|Treatment Period|Disease progression|16|||
126239359|NCT02726581|454169050|FG000|Treatment Period|Other reasons|9|||
126239360|NCT02726581|454169051|FG001|Treatment Period|Other reasons|8|||
126239361|NCT02726581|454169052|FG002|Treatment Period|Other reasons|2|||
126239362|NCT02726581|454169050|FG000|Treatment Period|Study drug toxicity|6|||
126239363|NCT02726581|454169051|FG001|Treatment Period|Study drug toxicity|3|||
126239364|NCT02726581|454169052|FG002|Treatment Period|Study drug toxicity|2|||
126239365|NCT02726581|454169050|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
126239366|NCT02726581|454169051|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
126239367|NCT02726581|454169052|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
126239368|NCT02726581|454169050|FG000|Treatment Period|Participant withdrew consent|3|||
126239369|NCT02726581|454169051|FG001|Treatment Period|Participant withdrew consent|1|||
126239370|NCT02726581|454169052|FG002|Treatment Period|Participant withdrew consent|1|||
126239371|NCT02726581|454169050|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
126239372|NCT02726581|454169051|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
126239373|NCT02726581|454169052|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
126239374|NCT02726581|454169050|FG000|Treatment Period|Maximum clinical benefit|0|||
126239375|NCT02726581|454169051|FG001|Treatment Period|Maximum clinical benefit|2|||
126239376|NCT02726581|454169052|FG002|Treatment Period|Maximum clinical benefit|0|||
126239377|NCT02726581|454169050|FG000|Treatment Period|Death|1|||
126239378|NCT02726581|454169051|FG001|Treatment Period|Death|0|||
126239379|NCT02726581|454169052|FG002|Treatment Period|Death|0|||
126239380|NCT02726581|454169050|FG000|Treatment Period|Poor/non-compliance|1|||
126239381|NCT02726581|454169051|FG001|Treatment Period|Poor/non-compliance|0|||
126239382|NCT02726581|454169052|FG002|Treatment Period|Poor/non-compliance|0|||
126239383|NCT02726581|454169050|FG000|Treatment Period|Participant no longer meets study criteria|0|||
126239384|NCT02726581|454169051|FG001|Treatment Period|Participant no longer meets study criteria|1|||
126239385|NCT02726581|454169052|FG002|Treatment Period|Participant no longer meets study criteria|0|||
126239386|NCT00552669|454169053|FG000|Overall Study|Death|3|||
126239387|NCT00552669|454169054|FG001|Overall Study|Death|7|||
126239388|NCT01844375|454169058|FG000|Overall Study|Protocol Violation|1|||
126239389|NCT01844375|454169059|FG001|Overall Study|Protocol Violation|1|||
126239390|NCT01772537|454169061|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
126239391|NCT01772537|454169062|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
126239392|NCT01772537|454169063|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
126239393|NCT03195491|454169064|FG000|Overall Study|Study drug toxicity|25|||
126239394|NCT03195491|454169065|FG001|Overall Study|Study drug toxicity|3|||
126239395|NCT03195491|454169064|FG000|Overall Study|Maximum clinical benefit|5|||
126239396|NCT03195491|454169065|FG001|Overall Study|Maximum clinical benefit|0|||
126239397|NCT03195491|454169064|FG000|Overall Study|Lost to Follow-up|1|||
126239398|NCT03195491|454169065|FG001|Overall Study|Lost to Follow-up|0|||
126239399|NCT03195491|454169064|FG000|Overall Study|Death|3|||
126239400|NCT03195491|454169065|FG001|Overall Study|Death|0|||
126239401|NCT03195491|454169064|FG000|Overall Study|Adverse event unrelated to study drug|19|||
126239402|NCT03195491|454169065|FG001|Overall Study|Adverse event unrelated to study drug|2|||
126239403|NCT03195491|454169064|FG000|Overall Study|Disease progression|266|||
126239404|NCT03195491|454169065|FG001|Overall Study|Disease progression|8|||
126239405|NCT03195491|454169064|FG000|Overall Study|Other reasons|10|||
126239406|NCT03195491|454169065|FG001|Overall Study|Other reasons|0|||
126239407|NCT03195491|454169064|FG000|Overall Study|Participant withdrew consent|8|||
126239408|NCT03195491|454169065|FG001|Overall Study|Participant withdrew consent|1|||
126239409|NCT03195491|454169064|FG000|Overall Study|Participant no longer meets study criteria|0|||
126239410|NCT03195491|454169065|FG001|Overall Study|Participant no longer meets study criteria|1|||
126239411|NCT03195491|454169064|FG000|Overall Study|Participant request to discontinue study treatment|10|||
126239412|NCT03195491|454169065|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126239413|NCT01263704|454169066|FG000|Overall Study|Progressive disease|18|||
126239414|NCT01263704|454169066|FG000|Overall Study|Adverse Event|3|||
126239415|NCT01263704|454169066|FG000|Overall Study|Death|2|||
126239416|NCT01263704|454169066|FG000|Overall Study|Patient withdrew consent|2|||
126239417|NCT01263704|454169066|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
126239418|NCT01263704|454169066|FG000|Overall Study|Lost to Follow-up|1|||
126239419|NCT01263704|454169066|FG000|Overall Study|Colon metastases|1|||
126239420|NCT01263704|454169066|FG000|Overall Study|Principal Investigator (PI) decision|1|||
126239421|NCT03020615|454169067|FG000|Overall Study|Physician Decision|3|||
126239422|NCT03020615|454169068|FG001|Overall Study|Physician Decision|1|||
126239423|NCT03020615|454169069|FG002|Overall Study|Physician Decision|2|||
126239424|NCT03020615|454169067|FG000|Overall Study|Parent/guardian/patient choice|3|||
126239425|NCT03020615|454169068|FG001|Overall Study|Parent/guardian/patient choice|0|||
126239426|NCT03020615|454169069|FG002|Overall Study|Parent/guardian/patient choice|4|||
126239427|NCT03020615|454169067|FG000|Overall Study|Screen failure|0|||
126239428|NCT03020615|454169068|FG001|Overall Study|Screen failure|0|||
126239429|NCT03020615|454169069|FG002|Overall Study|Screen failure|1|||
126239430|NCT03020615|454169067|FG000|Overall Study|Death|1|||
126239431|NCT03020615|454169068|FG001|Overall Study|Death|0|||
126239432|NCT03020615|454169069|FG002|Overall Study|Death|0|||
126239433|NCT03020615|454169067|FG000|Overall Study|Lost to Follow-up|0|||
126239434|NCT03020615|454169068|FG001|Overall Study|Lost to Follow-up|1|||
126239435|NCT03020615|454169069|FG002|Overall Study|Lost to Follow-up|0|||
126239436|NCT00252720|454169071|FG000|Overall Study|Withdrawal by Subject|95|||
126239437|NCT00252720|454169072|FG001|Overall Study|Withdrawal by Subject|97|||
126239438|NCT00252720|454169071|FG000|Overall Study|Death|7|||
126239439|NCT00252720|454169072|FG001|Overall Study|Death|8|||
126239440|NCT00252720|454169071|FG000|Overall Study|Moving|23|||
126239441|NCT00252720|454169072|FG001|Overall Study|Moving|42|||
126239442|NCT00252720|454169071|FG000|Overall Study|Mainly patients lost to follow-up|7|||
126239443|NCT00252720|454169072|FG001|Overall Study|Mainly patients lost to follow-up|18|||
126239444|NCT02514122|454169078|FG000|Overall Study|Withdrawal by Subject|2|||
126239445|NCT02514122|454169079|FG001|Overall Study|Withdrawal by Subject|0|||
126239446|NCT04239872|454169080|FG000|Overall Study|Lost to Follow-up|0|||
126239447|NCT04239872|454169081|FG001|Overall Study|Lost to Follow-up|1|||
126239448|NCT00112463|454169084|FG000|Overall Study|Physician Decision|1|||
126239449|NCT00112463|454169084|FG000|Overall Study|Progression|30|||
126239450|NCT00112463|454169084|FG000|Overall Study|Second Primary|1|||
126093668|NCT01259089|453636123|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
126093669|NCT01259089|453636124|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
126093670|NCT01259089|453636125|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
126093671|NCT01259089|453636126|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
126093672|NCT01259089|453636121|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
126093673|NCT01259089|453636122|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126093674|NCT01259089|453636123|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126093675|NCT01259089|453636124|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126093676|NCT01259089|453636125|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126093677|NCT01259089|453636126|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126093678|NCT01259089|453636121|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
126093679|NCT01259089|453636122|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
126093680|NCT01259089|453636123|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
126093681|NCT01259089|453636124|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
126093682|NCT01259089|453636125|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
126093683|NCT01259089|453636126|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
126093684|NCT01259089|453636121|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
126093685|NCT01259089|453636122|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
126093686|NCT01259089|453636123|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
126093687|NCT01259089|453636124|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
126093688|NCT01259089|453636125|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
126093689|NCT01259089|453636126|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
126093690|NCT01259089|453636121|FG000|Survival Follow up for Two Years|Death|3|||
126093691|NCT01259089|453636122|FG001|Survival Follow up for Two Years|Death|2|||
126093692|NCT01259089|453636123|FG002|Survival Follow up for Two Years|Death|2|||
126093693|NCT01259089|453636124|FG003|Survival Follow up for Two Years|Death|3|||
126093694|NCT01259089|453636125|FG004|Survival Follow up for Two Years|Death|6|||
126093695|NCT01259089|453636126|FG005|Survival Follow up for Two Years|Death|13|||
126093696|NCT01259089|453636121|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
126093697|NCT01259089|453636122|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
126093698|NCT01259089|453636123|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
126093699|NCT01259089|453636124|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
126239451|NCT00112463|454169084|FG000|Overall Study|Toxicity|3|||
126239452|NCT00112463|454169084|FG000|Overall Study|Withdrawal by Subject|2|||
126239453|NCT00112463|454169084|FG000|Overall Study|Never started treatment|2|||
126025754|NCT02671435|453389286|FG007|Overall Study|Lost to Follow-up|2|||
126025755|NCT02671435|453389287|FG008|Overall Study|Lost to Follow-up|0|||
126025756|NCT02671435|453389288|FG009|Overall Study|Lost to Follow-up|2|||
126025757|NCT02671435|453389289|FG010|Overall Study|Lost to Follow-up|0|||
126025758|NCT02671435|453389290|FG011|Overall Study|Lost to Follow-up|3|||
126025759|NCT02671435|453389291|FG012|Overall Study|Lost to Follow-up|3|||
126025760|NCT02671435|453389292|FG013|Overall Study|Lost to Follow-up|2|||
126025761|NCT02671435|453389293|FG014|Overall Study|Lost to Follow-up|0|||
126025762|NCT02671435|453389279|FG000|Overall Study|Withdrawal by Subject|2|||
126025763|NCT02671435|453389280|FG001|Overall Study|Withdrawal by Subject|0|||
126025764|NCT02671435|453389281|FG002|Overall Study|Withdrawal by Subject|2|||
126025765|NCT02671435|453389282|FG003|Overall Study|Withdrawal by Subject|2|||
126025766|NCT02671435|453389283|FG004|Overall Study|Withdrawal by Subject|2|||
126025767|NCT02671435|453389284|FG005|Overall Study|Withdrawal by Subject|7|||
126025768|NCT02671435|453389285|FG006|Overall Study|Withdrawal by Subject|2|||
126025769|NCT02671435|453389286|FG007|Overall Study|Withdrawal by Subject|7|||
126025770|NCT02671435|453389287|FG008|Overall Study|Withdrawal by Subject|1|||
126025771|NCT02671435|453389288|FG009|Overall Study|Withdrawal by Subject|1|||
126025772|NCT02671435|453389289|FG010|Overall Study|Withdrawal by Subject|2|||
126025773|NCT02671435|453389290|FG011|Overall Study|Withdrawal by Subject|4|||
126025774|NCT02671435|453389291|FG012|Overall Study|Withdrawal by Subject|4|||
126025775|NCT02671435|453389292|FG013|Overall Study|Withdrawal by Subject|4|||
126025776|NCT02671435|453389293|FG014|Overall Study|Withdrawal by Subject|2|||
126025777|NCT02671435|453389279|FG000|Overall Study|Un-specified|0|||
126025778|NCT02671435|453389280|FG001|Overall Study|Un-specified|0|||
126025779|NCT02671435|453389281|FG002|Overall Study|Un-specified|0|||
126025780|NCT02671435|453389282|FG003|Overall Study|Un-specified|0|||
126025781|NCT02671435|453389283|FG004|Overall Study|Un-specified|1|||
126239454|NCT01118312|454169091|FG000|Overall Study|Lost to Follow-up|33|||
126239455|NCT01118312|454169092|FG001|Overall Study|Lost to Follow-up|32|||
126239456|NCT01118312|454169091|FG000|Overall Study|Withdrawal by Subject|1|||
126025782|NCT02671435|453389284|FG005|Overall Study|Un-specified|3|||
126025783|NCT02671435|453389285|FG006|Overall Study|Un-specified|2|||
126025784|NCT02671435|453389286|FG007|Overall Study|Un-specified|3|||
126025785|NCT02671435|453389287|FG008|Overall Study|Un-specified|0|||
126025786|NCT02671435|453389288|FG009|Overall Study|Un-specified|5|||
126239457|NCT01118312|454169092|FG001|Overall Study|Withdrawal by Subject|3|||
126239458|NCT01185821|454169097|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126239459|NCT01185821|454169098|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126239460|NCT01185821|454169099|FG002|Overall Study|Abnormal laboratory value(s)|1|||
126239461|NCT01185821|454169100|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126239462|NCT01185821|454169101|FG004|Overall Study|Abnormal laboratory value(s)|0|||
126239463|NCT01185821|454169097|FG000|Overall Study|Protocol Violation|0|||
126239464|NCT01185821|454169098|FG001|Overall Study|Protocol Violation|0|||
126239465|NCT01185821|454169099|FG002|Overall Study|Protocol Violation|0|||
126239466|NCT01185821|454169100|FG003|Overall Study|Protocol Violation|1|||
126239467|NCT01185821|454169101|FG004|Overall Study|Protocol Violation|1|||
126239468|NCT01185821|454169097|FG000|Overall Study|Abnormal test procedure result|0|||
126239469|NCT01185821|454169098|FG001|Overall Study|Abnormal test procedure result|0|||
126239470|NCT01185821|454169099|FG002|Overall Study|Abnormal test procedure result|0|||
126239471|NCT01185821|454169100|FG003|Overall Study|Abnormal test procedure result|0|||
126239472|NCT01185821|454169101|FG004|Overall Study|Abnormal test procedure result|1|||
126239473|NCT01185821|454169097|FG000|Overall Study|Death|0|||
126239474|NCT01185821|454169098|FG001|Overall Study|Death|1|||
126239475|NCT01185821|454169099|FG002|Overall Study|Death|0|||
126239476|NCT01185821|454169100|FG003|Overall Study|Death|0|||
126239477|NCT01185821|454169101|FG004|Overall Study|Death|0|||
126239478|NCT01185821|454169097|FG000|Overall Study|Condition no longer required study drug|0|||
126239479|NCT01185821|454169098|FG001|Overall Study|Condition no longer required study drug|0|||
126239480|NCT01185821|454169099|FG002|Overall Study|Condition no longer required study drug|0|||
126239481|NCT01185821|454169100|FG003|Overall Study|Condition no longer required study drug|0|||
126239482|NCT01185821|454169101|FG004|Overall Study|Condition no longer required study drug|1|||
126239483|NCT01185821|454169097|FG000|Overall Study|Adverse Event|2|||
126239484|NCT01185821|454169098|FG001|Overall Study|Adverse Event|3|||
126239485|NCT01185821|454169099|FG002|Overall Study|Adverse Event|1|||
126239486|NCT01185821|454169100|FG003|Overall Study|Adverse Event|2|||
126239487|NCT01185821|454169101|FG004|Overall Study|Adverse Event|5|||
126239488|NCT01185821|454169097|FG000|Overall Study|Lack of Efficacy|0|||
126239489|NCT01185821|454169098|FG001|Overall Study|Lack of Efficacy|0|||
126239490|NCT01185821|454169099|FG002|Overall Study|Lack of Efficacy|3|||
126239491|NCT01185821|454169100|FG003|Overall Study|Lack of Efficacy|0|||
126239492|NCT01185821|454169101|FG004|Overall Study|Lack of Efficacy|9|||
126239493|NCT01185821|454169097|FG000|Overall Study|Withdrawal by Subject|3|||
126239494|NCT01185821|454169098|FG001|Overall Study|Withdrawal by Subject|2|||
126239495|NCT01185821|454169099|FG002|Overall Study|Withdrawal by Subject|2|||
126239496|NCT01185821|454169100|FG003|Overall Study|Withdrawal by Subject|1|||
126239497|NCT01185821|454169101|FG004|Overall Study|Withdrawal by Subject|3|||
126239498|NCT01185821|454169097|FG000|Overall Study|Lost to Follow-up|1|||
126239499|NCT01185821|454169098|FG001|Overall Study|Lost to Follow-up|1|||
126239500|NCT01185821|454169099|FG002|Overall Study|Lost to Follow-up|2|||
126239501|NCT01185821|454169100|FG003|Overall Study|Lost to Follow-up|1|||
126239502|NCT01185821|454169101|FG004|Overall Study|Lost to Follow-up|2|||
126239503|NCT01185821|454169097|FG000|Overall Study|Administrative problems|0|||
126239504|NCT01185821|454169098|FG001|Overall Study|Administrative problems|0|||
126239505|NCT01185821|454169099|FG002|Overall Study|Administrative problems|1|||
126239506|NCT01185821|454169100|FG003|Overall Study|Administrative problems|1|||
126239507|NCT01185821|454169101|FG004|Overall Study|Administrative problems|2|||
126239508|NCT01546545|454169102|FG000|Overall Study|Withdrawal by Subject|1|||
126239509|NCT00296647|454169103|FG000|Overall Study|Death|4|||
126239510|NCT00296647|454169104|FG001|Overall Study|Death|1|||
126239511|NCT00296647|454169105|FG002|Overall Study|Death|2|||
126239512|NCT00296647|454169106|FG003|Overall Study|Death|1|||
126239513|NCT00296647|454169107|FG004|Overall Study|Death|1|||
126239514|NCT00296647|454169103|FG000|Overall Study|Withdrawal by Subject|28|||
126239515|NCT00296647|454169104|FG001|Overall Study|Withdrawal by Subject|27|||
126239516|NCT00296647|454169105|FG002|Overall Study|Withdrawal by Subject|32|||
126239517|NCT00296647|454169106|FG003|Overall Study|Withdrawal by Subject|16|||
126239518|NCT00296647|454169107|FG004|Overall Study|Withdrawal by Subject|19|||
126356594|NCT02675452|454597884|FG021|Overall Study|Withdrawal by Subject|0|||
126356595|NCT02675452|454597885|FG022|Overall Study|Withdrawal by Subject|3|||
126239519|NCT00854100|454169112|FG000|Overall Study|Inability to complete the study visits|0|||
126356596|NCT02675452|454597886|FG023|Overall Study|Withdrawal by Subject|0|||
126356597|NCT02675452|454597887|FG024|Overall Study|Withdrawal by Subject|1|||
126239520|NCT00854100|454169113|FG001|Overall Study|Inability to complete the study visits|0|||
126239521|NCT00854100|454169114|FG002|Overall Study|Inability to complete the study visits|1|||
126239522|NCT00854100|454169112|FG000|Overall Study|Lost to Follow-up|2|||
126239523|NCT00854100|454169113|FG001|Overall Study|Lost to Follow-up|0|||
126239524|NCT00854100|454169114|FG002|Overall Study|Lost to Follow-up|3|||
126239525|NCT00854100|454169112|FG000|Overall Study|Withdrawal by Subject|3|||
126239526|NCT00854100|454169113|FG001|Overall Study|Withdrawal by Subject|1|||
126239527|NCT00854100|454169114|FG002|Overall Study|Withdrawal by Subject|2|||
126239528|NCT00854100|454169112|FG000|Overall Study|Protocol Violation|2|||
126239529|NCT00854100|454169113|FG001|Overall Study|Protocol Violation|4|||
126239530|NCT00854100|454169114|FG002|Overall Study|Protocol Violation|3|||
126239531|NCT00854100|454169112|FG000|Overall Study|Adverse Event|2|||
126239532|NCT00854100|454169113|FG001|Overall Study|Adverse Event|1|||
126239533|NCT00854100|454169114|FG002|Overall Study|Adverse Event|2|||
126239534|NCT01387737|454170674|FG000|Overall Study|Adverse Event|20|||
126239535|NCT01387737|454170675|FG001|Overall Study|Adverse Event|30|||
126239536|NCT01387737|454170674|FG000|Overall Study|Lack of Efficacy|1|||
126239537|NCT01387737|454170675|FG001|Overall Study|Lack of Efficacy|0|||
126239538|NCT01387737|454170674|FG000|Overall Study|Physician Decision|3|||
126239539|NCT01387737|454170675|FG001|Overall Study|Physician Decision|10|||
126239540|NCT01387737|454170674|FG000|Overall Study|Withdrawal by Subject|27|||
126239541|NCT01387737|454170675|FG001|Overall Study|Withdrawal by Subject|31|||
126239542|NCT01387737|454170674|FG000|Overall Study|Clearly not eligible for the study|1|||
126239543|NCT01387737|454170675|FG001|Overall Study|Clearly not eligible for the study|3|||
126239544|NCT01725529|454170676|FG000|Overall Study|Adverse Event|1|||
126239545|NCT01725529|454170677|FG001|Overall Study|Adverse Event|0|||
126239546|NCT01725529|454170678|FG002|Overall Study|Adverse Event|0|||
126239547|NCT01725529|454170676|FG000|Overall Study|Lost to Follow-up|2|||
126239548|NCT01725529|454170677|FG001|Overall Study|Lost to Follow-up|1|||
126239549|NCT01725529|454170678|FG002|Overall Study|Lost to Follow-up|1|||
126239550|NCT01725529|454170676|FG000|Overall Study|Protocol Violation|0|||
126239551|NCT01725529|454170677|FG001|Overall Study|Protocol Violation|1|||
126239552|NCT01725529|454170678|FG002|Overall Study|Protocol Violation|1|||
126239553|NCT01725529|454170676|FG000|Overall Study|Withdrawal by Subject|12|||
126239554|NCT01725529|454170677|FG001|Overall Study|Withdrawal by Subject|14|||
126239555|NCT01725529|454170678|FG002|Overall Study|Withdrawal by Subject|8|||
126239556|NCT01948258|454170683|FG000|Overall Study|Pregnancy|41|||
126239557|NCT01948258|454170683|FG000|Overall Study|Did not complete by cut-off date|35|||
126239558|NCT01948258|454170683|FG000|Overall Study|Lost to Follow-up|27|||
126239559|NCT01948258|454170683|FG000|Overall Study|Withdrawal by SPD|8|||
126239560|NCT01948258|454170683|FG000|Overall Study|Withdrawal by Subject|6|||
126239561|NCT01948258|454170683|FG000|Overall Study|Health Care Professional|43|||
126239562|NCT01948258|454170683|FG000|Overall Study|Removed from statistical analysis|2|||
126239563|NCT02262377|454170684|FG000|Overall Study|Lost to Follow-up|5|||
126239564|NCT02262377|454170685|FG001|Overall Study|Lost to Follow-up|6|||
126239565|NCT02262377|454170684|FG000|Overall Study|Found ineligible after enrollment|3|||
126239566|NCT02262377|454170685|FG001|Overall Study|Found ineligible after enrollment|0|||
126239567|NCT02262377|454170684|FG000|Overall Study|Withdrawal by Subject|4|||
126239568|NCT02262377|454170685|FG001|Overall Study|Withdrawal by Subject|0|||
126239569|NCT00723528|454170687|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
126239570|NCT00723528|454170688|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
126239571|NCT00723528|454170689|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
126239572|NCT00723528|454170690|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
126239573|NCT00723528|454170691|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
126239574|NCT00723528|454170692|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
126239575|NCT00723528|454170693|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
126239576|NCT00723528|454170687|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
126239577|NCT00723528|454170688|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126239578|NCT00723528|454170689|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126239579|NCT00723528|454170690|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126239580|NCT00723528|454170691|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126239581|NCT00723528|454170692|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126239582|NCT00723528|454170693|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126239583|NCT00723528|454170687|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
126239584|NCT00723528|454170688|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
126239585|NCT00723528|454170689|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
126356598|NCT02675452|454597888|FG025|Overall Study|Withdrawal by Subject|0|||
126356599|NCT02675452|454597889|FG026|Overall Study|Withdrawal by Subject|1|||
126025787|NCT02671435|453389289|FG010|Overall Study|Un-specified|8|||
126025788|NCT02671435|453389290|FG011|Overall Study|Un-specified|4|||
126356600|NCT02675452|454597890|FG027|Overall Study|Withdrawal by Subject|3|||
126239586|NCT00723528|454170690|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
126239587|NCT00723528|454170691|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
126239588|NCT00723528|454170692|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
126239589|NCT00723528|454170693|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
126356601|NCT02675452|454597891|FG028|Overall Study|Withdrawal by Subject|4|||
126025789|NCT02671435|453389291|FG012|Overall Study|Un-specified|5|||
126239590|NCT00723528|454170687|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126239591|NCT00723528|454170688|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126239592|NCT00723528|454170689|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
126239593|NCT00723528|454170690|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126239594|NCT00723528|454170691|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126239595|NCT00723528|454170692|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126239596|NCT00723528|454170693|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126239597|NCT00723528|454170687|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
126239598|NCT00723528|454170688|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126239599|NCT00723528|454170689|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
126239600|NCT00723528|454170690|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126239601|NCT00723528|454170691|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126239602|NCT00723528|454170692|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126025790|NCT02671435|453389292|FG013|Overall Study|Un-specified|9|||
126025791|NCT02671435|453389293|FG014|Overall Study|Un-specified|8|||
126025792|NCT02412748|453389296|FG000|Overall Study|Lost to Follow-up|38|||
126025793|NCT02412748|453389297|FG001|Overall Study|Lost to Follow-up|39|||
126025794|NCT03069313|453389298|FG000|Overall Study|Adverse Event|5|||
126025795|NCT01872078|453389302|FG000|Overall Study|Adverse Event|0|||
126025796|NCT01872078|453389303|FG001|Overall Study|Adverse Event|0|||
126025797|NCT01872078|453389304|FG002|Overall Study|Adverse Event|1|||
126025798|NCT01872078|453389305|FG003|Overall Study|Adverse Event|0|||
126025799|NCT01872078|453389302|FG000|Overall Study|Dose administration non-compliance|0|||
126025800|NCT01872078|453389303|FG001|Overall Study|Dose administration non-compliance|0|||
126025801|NCT01872078|453389304|FG002|Overall Study|Dose administration non-compliance|0|||
126025802|NCT01872078|453389305|FG003|Overall Study|Dose administration non-compliance|1|||
126025803|NCT01872078|453389302|FG000|Overall Study|Protocol Violation|0|||
126025804|NCT01872078|453389303|FG001|Overall Study|Protocol Violation|0|||
126025805|NCT01872078|453389304|FG002|Overall Study|Protocol Violation|1|||
126093700|NCT01259089|453636125|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
126239603|NCT00723528|454170693|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126239604|NCT00723528|454170687|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
126093701|NCT01259089|453636126|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
126093702|NCT01259089|453636121|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126093703|NCT01259089|453636122|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126093704|NCT01259089|453636123|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126093705|NCT01259089|453636124|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126093706|NCT01259089|453636125|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126093707|NCT01259089|453636126|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
126093708|NCT02310100|453636127|FG000|Overall Study|Physician Decision|3|||
126093709|NCT02310100|453636127|FG000|Overall Study|Withdrawal by Subject|10|||
126093710|NCT02310100|453636127|FG000|Overall Study|Enrollment closure|1|||
126093711|NCT02310100|453636127|FG000|Overall Study|Unapproved ablation operator|1|||
126093712|NCT02310100|453636127|FG000|Overall Study|Visit compliance|1|||
126093713|NCT02310100|453636127|FG000|Overall Study|Lost to Follow-up|2|||
126093714|NCT00688870|453636130|FG000|Infant Series|Parent or legal guardian request|4|||
126093715|NCT00688870|453636131|FG001|Infant Series|Parent or legal guardian request|0|||
126093716|NCT01253018|453636142|FG000|Overall Study|Lost to Follow-up|1|||
126093717|NCT01253018|453636143|FG001|Overall Study|Lost to Follow-up|1|||
126093718|NCT01253018|453636142|FG000|Overall Study|Robot Repair Issues|2|||
126093719|NCT01253018|453636143|FG001|Overall Study|Robot Repair Issues|0|||
126093720|NCT01253018|453636142|FG000|Overall Study|Withdrawal by Subject|1|||
126093721|NCT01253018|453636143|FG001|Overall Study|Withdrawal by Subject|1|||
126093722|NCT03449901|453636144|FG000|Overall Study|Progression|57|||
126093723|NCT03449901|453636145|FG001|Overall Study|Progression|12|||
126093724|NCT03449901|453636144|FG000|Overall Study|Adverse Event|3|||
126239605|NCT00723528|454170688|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
126025806|NCT01872078|453389305|FG003|Overall Study|Protocol Violation|0|||
126093725|NCT03449901|453636145|FG001|Overall Study|Adverse Event|0|||
126093726|NCT03449901|453636144|FG000|Overall Study|Death|6|||
126093727|NCT03449901|453636145|FG001|Overall Study|Death|2|||
126025807|NCT01872078|453389302|FG000|Overall Study|Withdrawal by Subject|0|||
126025808|NCT01872078|453389303|FG001|Overall Study|Withdrawal by Subject|0|||
126025809|NCT01872078|453389304|FG002|Overall Study|Withdrawal by Subject|1|||
126025810|NCT01872078|453389305|FG003|Overall Study|Withdrawal by Subject|0|||
126356602|NCT02675452|454597863|FG000|Overall Study|Death|0|||
126356603|NCT02675452|454597864|FG001|Overall Study|Death|0|||
126356604|NCT02675452|454597865|FG002|Overall Study|Death|1|||
126356605|NCT02675452|454597866|FG003|Overall Study|Death|0|||
126356606|NCT02675452|454597867|FG004|Overall Study|Death|0|||
126356607|NCT02675452|454597868|FG005|Overall Study|Death|1|||
126356608|NCT02675452|454597869|FG006|Overall Study|Death|0|||
126356609|NCT02675452|454597870|FG007|Overall Study|Death|0|||
126356610|NCT02675452|454597871|FG008|Overall Study|Death|1|||
126356611|NCT02675452|454597872|FG009|Overall Study|Death|0|||
126356612|NCT02675452|454597873|FG010|Overall Study|Death|0|||
126356613|NCT02675452|454597874|FG011|Overall Study|Death|0|||
126356614|NCT02675452|454597875|FG012|Overall Study|Death|1|||
126356615|NCT02675452|454597876|FG013|Overall Study|Death|0|||
126356616|NCT02675452|454597877|FG014|Overall Study|Death|0|||
126356617|NCT02675452|454597878|FG015|Overall Study|Death|2|||
126356618|NCT02675452|454597879|FG016|Overall Study|Death|0|||
126356619|NCT02675452|454597880|FG017|Overall Study|Death|0|||
126356620|NCT02675452|454597881|FG018|Overall Study|Death|4|||
126356621|NCT02675452|454597882|FG019|Overall Study|Death|3|||
126356622|NCT02675452|454597883|FG020|Overall Study|Death|3|||
126356623|NCT02675452|454597884|FG021|Overall Study|Death|3|||
126356624|NCT02675452|454597885|FG022|Overall Study|Death|7|||
126356625|NCT02675452|454597886|FG023|Overall Study|Death|5|||
126356626|NCT02675452|454597887|FG024|Overall Study|Death|3|||
126239606|NCT00723528|454170689|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
126239607|NCT00723528|454170690|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
126239608|NCT00723528|454170691|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
126239609|NCT00723528|454170692|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
126239610|NCT00723528|454170693|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
126239611|NCT00723528|454170687|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126239612|NCT00723528|454170688|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126239613|NCT00723528|454170689|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126239614|NCT00723528|454170690|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126239615|NCT00723528|454170691|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126239616|NCT00723528|454170692|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
126239617|NCT00723528|454170693|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126239618|NCT00723528|454170687|FG000|Period 2: After Controlled Period|Other|0|||
126239619|NCT00723528|454170688|FG001|Period 2: After Controlled Period|Other|0|||
126239620|NCT00723528|454170689|FG002|Period 2: After Controlled Period|Other|0|||
126239621|NCT00723528|454170690|FG003|Period 2: After Controlled Period|Other|0|||
126239622|NCT00723528|454170691|FG004|Period 2: After Controlled Period|Other|1|||
126239623|NCT00723528|454170692|FG005|Period 2: After Controlled Period|Other|4|||
126239624|NCT00723528|454170693|FG006|Period 2: After Controlled Period|Other|0|||
126239625|NCT00723528|454170687|FG000|Period 2: After Controlled Period|Adverse Event|0|||
126239626|NCT00723528|454170688|FG001|Period 2: After Controlled Period|Adverse Event|0|||
126239627|NCT00723528|454170689|FG002|Period 2: After Controlled Period|Adverse Event|0|||
126239628|NCT00723528|454170690|FG003|Period 2: After Controlled Period|Adverse Event|0|||
126239629|NCT00723528|454170691|FG004|Period 2: After Controlled Period|Adverse Event|1|||
126239630|NCT00723528|454170692|FG005|Period 2: After Controlled Period|Adverse Event|0|||
126239631|NCT00723528|454170693|FG006|Period 2: After Controlled Period|Adverse Event|1|||
126239632|NCT00723528|454170687|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126239633|NCT00723528|454170688|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126239634|NCT00723528|454170689|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126239635|NCT00723528|454170690|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126239636|NCT00723528|454170691|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126239637|NCT00723528|454170692|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126356627|NCT02675452|454597888|FG025|Overall Study|Death|4|||
126025811|NCT01872078|453389302|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
126025812|NCT01872078|453389303|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
126025813|NCT01872078|453389304|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
126025814|NCT01872078|453389305|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
126239638|NCT00723528|454170693|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
126239639|NCT00723528|454170687|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126356628|NCT02675452|454597889|FG026|Overall Study|Death|7|||
126356629|NCT02675452|454597890|FG027|Overall Study|Death|6|||
126025815|NCT00761189|453389306|FG000|Overall Study|Adverse Event|42|||
126025816|NCT00761189|453389306|FG000|Overall Study|Lack of Efficacy|45|||
126356630|NCT02675452|454597891|FG028|Overall Study|Death|9|||
126356631|NCT02675452|454597863|FG000|Overall Study|Lost to Follow-up|0|||
126356632|NCT02675452|454597864|FG001|Overall Study|Lost to Follow-up|1|||
126356633|NCT02675452|454597865|FG002|Overall Study|Lost to Follow-up|0|||
126356634|NCT02675452|454597866|FG003|Overall Study|Lost to Follow-up|0|||
126356635|NCT02675452|454597867|FG004|Overall Study|Lost to Follow-up|0|||
126239640|NCT00723528|454170688|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126239641|NCT00723528|454170689|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126239642|NCT00723528|454170690|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126239643|NCT00723528|454170691|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126239644|NCT00723528|454170692|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126239645|NCT00723528|454170693|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
126239646|NCT01993030|454170694|FG000|Overall Study|Adverse Event|0|||
126239647|NCT01993030|454170695|FG001|Overall Study|Adverse Event|4|||
126239648|NCT01710657|454170696|FG000|Overall Study|Lost to Follow-up|2|||
126239649|NCT01710657|454170697|FG001|Overall Study|Lost to Follow-up|0|||
126239650|NCT01710657|454170698|FG002|Overall Study|Lost to Follow-up|1|||
126239651|NCT01710657|454170696|FG000|Overall Study|Protocol Violation|2|||
126239652|NCT01710657|454170697|FG001|Overall Study|Protocol Violation|2|||
126239653|NCT01710657|454170698|FG002|Overall Study|Protocol Violation|0|||
126239654|NCT01710657|454170696|FG000|Overall Study|Adverse Event|14|||
126239655|NCT01710657|454170697|FG001|Overall Study|Adverse Event|8|||
126239656|NCT01710657|454170698|FG002|Overall Study|Adverse Event|28|||
126239657|NCT01710657|454170696|FG000|Overall Study|Withdrawal by Subject|0|||
126239658|NCT01710657|454170697|FG001|Overall Study|Withdrawal by Subject|1|||
126239659|NCT01710657|454170698|FG002|Overall Study|Withdrawal by Subject|2|||
126239660|NCT01710657|454170696|FG000|Overall Study|Lack of Efficacy|0|||
126239661|NCT01710657|454170697|FG001|Overall Study|Lack of Efficacy|1|||
126239662|NCT01710657|454170698|FG002|Overall Study|Lack of Efficacy|1|||
126239663|NCT01591785|454170701|FG000|Overall Study|worsening condition|1|||
126239664|NCT01591785|454170702|FG001|Overall Study|worsening condition|2|||
126239665|NCT01591785|454170701|FG000|Overall Study|Protocol Violation|2|||
126093728|NCT03449901|453636144|FG000|Overall Study|Withdrawal by Subject|12|||
126093729|NCT03449901|453636145|FG001|Overall Study|Withdrawal by Subject|1|||
126093730|NCT03449901|453636144|FG000|Overall Study|Physician Decision|1|||
126093731|NCT03449901|453636145|FG001|Overall Study|Physician Decision|0|||
126093732|NCT03449901|453636144|FG000|Overall Study|Patient elected for surgical intervention|1|||
126093733|NCT03449901|453636145|FG001|Overall Study|Patient elected for surgical intervention|0|||
126093734|NCT03449901|453636144|FG000|Overall Study|Patient off for other complicating disease|1|||
126093735|NCT03449901|453636145|FG001|Overall Study|Patient off for other complicating disease|0|||
126093736|NCT03466073|453636146|FG000|Overall Study|Death|1|||
126093737|NCT03466073|453636147|FG001|Overall Study|Death|0|||
126093738|NCT03466073|453636148|FG002|Overall Study|Death|0|||
126093739|NCT03466073|453636149|FG003|Overall Study|Death|0|||
126093740|NCT03466073|453636150|FG004|Overall Study|Death|0|||
126093741|NCT03466073|453636151|FG005|Overall Study|Death|1|||
126093742|NCT00744757|453636152|FG000|Overall Study|Objective disease progression|7|||
126093743|NCT00744757|453636152|FG000|Overall Study|Physician Decision|5|||
126093744|NCT00744757|453636152|FG000|Overall Study|Withdrawal by Subject|1|||
126093745|NCT00744757|453636152|FG000|Overall Study|Death|6|||
126093746|NCT00744757|453636152|FG000|Overall Study|Adverse Event|2|||
126093747|NCT03682302|453636153|FG000|Overall Study|Lost to Follow-up|1|||
126093748|NCT03682302|453636154|FG001|Overall Study|Lost to Follow-up|2|||
126239666|NCT01591785|454170702|FG001|Overall Study|Protocol Violation|0|||
126239667|NCT01591785|454170701|FG000|Overall Study|Lost to Follow-up|1|||
126239668|NCT01591785|454170702|FG001|Overall Study|Lost to Follow-up|0|||
126239669|NCT00496964|454170709|FG000|Overall Study|Withdrawal by Subject|0|||
126239670|NCT00496964|454170710|FG001|Overall Study|Withdrawal by Subject|1|||
126093749|NCT03682302|453636155|FG002|Overall Study|Lost to Follow-up|0|||
126239671|NCT00469417|454170711|FG000|Overall Study|Treatment failure all lesions|18|||
126239672|NCT00469417|454170712|FG001|Overall Study|Treatment failure all lesions|11|||
126239673|NCT00469417|454170711|FG000|Overall Study|Consent withdrawn|1|||
126239674|NCT00469417|454170712|FG001|Overall Study|Consent withdrawn|1|||
126239675|NCT00469417|454170711|FG000|Overall Study|Adverse Event|8|||
126239676|NCT00469417|454170712|FG001|Overall Study|Adverse Event|2|||
126239677|NCT00469417|454170711|FG000|Overall Study|Lost to Follow-up|1|||
126239678|NCT00469417|454170712|FG001|Overall Study|Lost to Follow-up|2|||
126239679|NCT00469417|454170711|FG000|Overall Study|Intercurrent disease|0|||
126239680|NCT00469417|454170712|FG001|Overall Study|Intercurrent disease|1|||
126093750|NCT03682302|453636156|FG003|Overall Study|Lost to Follow-up|1|||
126239681|NCT00469417|454170711|FG000|Overall Study|Randomized but not treated|2|||
126239682|NCT00469417|454170712|FG001|Overall Study|Randomized but not treated|0|||
126239683|NCT00909610|454170713|FG000|Period: First Intervention|Adverse Event|0|||
126239684|NCT00909610|454170714|FG001|Period: First Intervention|Adverse Event|1|||
126093751|NCT03682302|453636153|FG000|Overall Study|Study drug was not administered|0|||
126093752|NCT03682302|453636154|FG001|Overall Study|Study drug was not administered|0|||
126239685|NCT00909610|454170713|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
126239686|NCT00909610|454170714|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
126239687|NCT00909610|454170713|FG000|Period: Second Intervention|Adverse Event|1|||
126239688|NCT00909610|454170714|FG001|Period: Second Intervention|Adverse Event|0|||
126239689|NCT04123548|454170717|FG000|Overall Study|Withdrawal by Subject|1|||
126239690|NCT04123548|454170717|FG000|Overall Study|Lost to Follow-up|8|||
126239691|NCT04123548|454170717|FG000|Overall Study|Death|4|||
126239692|NCT04123548|454170717|FG000|Overall Study|Reason Not Specified|1|||
126239693|NCT00418184|454170718|FG000|Double-blind Phase|Withdrawal by Subject|22|||
126239694|NCT00418184|454170719|FG001|Double-blind Phase|Withdrawal by Subject|9|||
126239695|NCT00418184|454170718|FG000|Double-blind Phase|Adverse Event|2|||
126239696|NCT00418184|454170719|FG001|Double-blind Phase|Adverse Event|1|||
126239697|NCT00418184|454170718|FG000|Double-blind Phase|Poor compliance|3|||
126239698|NCT00418184|454170719|FG001|Double-blind Phase|Poor compliance|1|||
126239699|NCT01015625|454170720|FG000|Overall Study|Lost to Follow-up|3|||
126239700|NCT01015625|454170721|FG001|Overall Study|Lost to Follow-up|1|||
126239701|NCT01015625|454170720|FG000|Overall Study|Withdrawal by Subject|2|||
126239702|NCT01015625|454170721|FG001|Overall Study|Withdrawal by Subject|3|||
126239703|NCT01015625|454170720|FG000|Overall Study|Physician Decision|2|||
126239704|NCT01015625|454170721|FG001|Overall Study|Physician Decision|0|||
126239705|NCT01015625|454170720|FG000|Overall Study|Death|30|||
126239706|NCT01015625|454170721|FG001|Overall Study|Death|22|||
126239707|NCT02728102|454170722|FG000|Overall Study|Death|3|||
126239708|NCT02728102|454170723|FG001|Overall Study|Death|0|||
126239709|NCT02728102|454170724|FG002|Overall Study|Death|1|||
126239710|NCT02728102|454170722|FG000|Overall Study|Withdrawal by Subject|0|||
126239711|NCT02728102|454170723|FG001|Overall Study|Withdrawal by Subject|2|||
126239712|NCT02728102|454170724|FG002|Overall Study|Withdrawal by Subject|3|||
126239713|NCT02728102|454170722|FG000|Overall Study|Physician Decision|1|||
126239714|NCT02728102|454170723|FG001|Overall Study|Physician Decision|1|||
126239715|NCT02728102|454170724|FG002|Overall Study|Physician Decision|0|||
126239716|NCT02728102|454170722|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
126239717|NCT02728102|454170723|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
126239718|NCT02728102|454170724|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
126239719|NCT02728102|454170722|FG000|Overall Study|Covid|0|||
126239720|NCT02728102|454170723|FG001|Overall Study|Covid|0|||
126239721|NCT02728102|454170724|FG002|Overall Study|Covid|1|||
126239722|NCT02472366|454170725|FG000|Overall Study|Lost to Follow-up|1|||
126239723|NCT02472366|454170726|FG001|Overall Study|Lost to Follow-up|0|||
126239724|NCT02924883|454170727|FG000|Overall Study|Death|39|||
126239725|NCT02924883|454170728|FG001|Overall Study|Death|20|||
126239726|NCT02924883|454170727|FG000|Overall Study|Lost to Follow-up|1|||
126239727|NCT02924883|454170728|FG001|Overall Study|Lost to Follow-up|0|||
126239728|NCT02924883|454170727|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
126239729|NCT02924883|454170728|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
126239730|NCT02924883|454170727|FG000|Overall Study|Protocol Violation|1|||
126239731|NCT02924883|454170728|FG001|Overall Study|Protocol Violation|0|||
126239732|NCT02924883|454170727|FG000|Overall Study|Withdrawal by Subject|22|||
126239733|NCT02924883|454170728|FG001|Overall Study|Withdrawal by Subject|16|||
126356636|NCT02675452|454597868|FG005|Overall Study|Lost to Follow-up|0|||
126356637|NCT02675452|454597869|FG006|Overall Study|Lost to Follow-up|0|||
126356638|NCT02675452|454597870|FG007|Overall Study|Lost to Follow-up|0|||
126356639|NCT02675452|454597871|FG008|Overall Study|Lost to Follow-up|0|||
126356640|NCT02675452|454597872|FG009|Overall Study|Lost to Follow-up|0|||
126356641|NCT02675452|454597873|FG010|Overall Study|Lost to Follow-up|0|||
126356642|NCT02675452|454597874|FG011|Overall Study|Lost to Follow-up|0|||
126356643|NCT02675452|454597875|FG012|Overall Study|Lost to Follow-up|1|||
126356644|NCT02675452|454597876|FG013|Overall Study|Lost to Follow-up|0|||
126356645|NCT02675452|454597877|FG014|Overall Study|Lost to Follow-up|0|||
126356646|NCT02675452|454597878|FG015|Overall Study|Lost to Follow-up|0|||
126356647|NCT02675452|454597879|FG016|Overall Study|Lost to Follow-up|0|||
126356648|NCT02675452|454597880|FG017|Overall Study|Lost to Follow-up|0|||
126356649|NCT02675452|454597881|FG018|Overall Study|Lost to Follow-up|0|||
126356650|NCT02675452|454597882|FG019|Overall Study|Lost to Follow-up|0|||
126239734|NCT02924883|454170727|FG000|Overall Study|Progressive Disease|1|||
126239735|NCT02924883|454170728|FG001|Overall Study|Progressive Disease|0|||
126239736|NCT02924883|454170727|FG000|Overall Study|Study Terminated by Sponsor|69|||
126239737|NCT02924883|454170728|FG001|Overall Study|Study Terminated by Sponsor|32|||
126239738|NCT01182415|454170729|FG000|Overall Study|Lost to Follow-up|1|||
126239739|NCT02770820|454170734|FG000|Overall Study|Death|1|||
126239740|NCT02770820|454170734|FG000|Overall Study|Physician Decision|2|||
126239741|NCT02098876|454170737|FG000|Overall Study|Withdrawal by Subject|5|||
126239742|NCT02098876|454170738|FG001|Overall Study|Withdrawal by Subject|5|||
126239743|NCT01061866|454170739|FG000|Overall Study|Adverse Event|2|||
126239744|NCT00772941|454170740|FG000|Overall Study|CRFs not available|195|||
126239745|NCT00772941|454170740|FG000|Overall Study|Study not completed|16|||
126239746|NCT00772941|454170740|FG000|Overall Study|Missed Visits|374|||
126356651|NCT02675452|454597883|FG020|Overall Study|Lost to Follow-up|0|||
126356652|NCT02675452|454597884|FG021|Overall Study|Lost to Follow-up|0|||
126239747|NCT00772941|454170740|FG000|Overall Study|Poor Compliance|7|||
126239748|NCT00772941|454170740|FG000|Overall Study|GPSP Violation|90|||
126239749|NCT04786184|454170741|FG000|Overall Study|Adverse Event|4|||
126239750|NCT04786184|454170742|FG001|Overall Study|Adverse Event|0|||
126239751|NCT04786184|454170741|FG000|Overall Study|Withdrawal by Subject|3|||
126239752|NCT04786184|454170742|FG001|Overall Study|Withdrawal by Subject|1|||
126239753|NCT04786184|454170741|FG000|Overall Study|Lost to Follow-up|4|||
126239754|NCT04786184|454170742|FG001|Overall Study|Lost to Follow-up|2|||
126239755|NCT00834756|454170743|FG000|First Intervention|Adverse Event|1|||
126239756|NCT00834756|454170744|FG001|First Intervention|Adverse Event|0|||
126239757|NCT00834756|454170743|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
126239758|NCT00834756|454170744|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
126239759|NCT01472341|454170747|FG000|Overall Study|Started insulin therapy|55|||
126239760|NCT01472341|454170747|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
126239761|NCT01472341|454170747|FG000|Overall Study|Withdrawal by Subject|39|||
126239762|NCT01472341|454170747|FG000|Overall Study|Lost to Follow-up|52|||
126239763|NCT01472341|454170747|FG000|Overall Study|Laboratory parameters unavailable|25|||
126239764|NCT01472341|454170747|FG000|Overall Study|Death|9|||
126239765|NCT04060147|454170759|FG000|Overall Study|Withdrew consent|1|||
126239766|NCT02057458|454170763|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
126239767|NCT02057458|454170764|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
126239768|NCT02057458|454170765|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
126239769|NCT02057458|454170763|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
126239770|NCT02057458|454170764|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
126239771|NCT02057458|454170765|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
126239772|NCT02057458|454170763|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
126239773|NCT02057458|454170764|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
126239774|NCT02057458|454170765|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
126239775|NCT01534520|454170766|FG000|Overall Study|Adverse Event|0|||
126239776|NCT01534520|454170767|FG001|Overall Study|Adverse Event|1|||
126239777|NCT02979353|454170770|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
126239778|NCT02979353|454170771|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
126239779|NCT02979353|454170770|FG000|Overall Study|Withdrawal by Subject|16|||
126239780|NCT02979353|454170771|FG001|Overall Study|Withdrawal by Subject|12|||
126239781|NCT02979353|454170770|FG000|Overall Study|Death|10|||
126239782|NCT02979353|454170771|FG001|Overall Study|Death|11|||
126239783|NCT02979353|454170770|FG000|Overall Study|Transfer to Hospice Care|19|||
126239784|NCT02979353|454170771|FG001|Overall Study|Transfer to Hospice Care|14|||
126239785|NCT02979353|454170770|FG000|Overall Study|Lost to Follow-up|1|||
126239786|NCT02979353|454170771|FG001|Overall Study|Lost to Follow-up|5|||
126239787|NCT00585689|454170772|FG000|Overall Study|Received different ABI-007 schedule|3|||
126239788|NCT00585689|454170772|FG000|Overall Study|Adverse Event|1|||
126239789|NCT00585689|454170772|FG000|Overall Study|Patient Declined Surgery|1|||
126239790|NCT00585689|454170772|FG000|Overall Study|Patient had unresectable disease|1|||
126239791|NCT00585689|454170772|FG000|Overall Study|Death|1|||
126239792|NCT01079988|454170773|FG000|Overall Study|Lost to Follow-up|0|||
126239793|NCT01079988|454170774|FG001|Overall Study|Lost to Follow-up|0|||
126239794|NCT01079988|454170775|FG002|Overall Study|Lost to Follow-up|0|||
126239795|NCT01079988|454170776|FG003|Overall Study|Lost to Follow-up|1|||
126239796|NCT01079988|454170777|FG004|Overall Study|Lost to Follow-up|0|||
126239797|NCT01079988|454170773|FG000|Overall Study|Lack of Efficacy|1|||
126239798|NCT01079988|454170774|FG001|Overall Study|Lack of Efficacy|0|||
126239799|NCT01079988|454170775|FG002|Overall Study|Lack of Efficacy|0|||
126239800|NCT01079988|454170776|FG003|Overall Study|Lack of Efficacy|0|||
126239801|NCT01079988|454170777|FG004|Overall Study|Lack of Efficacy|0|||
126239802|NCT01079988|454170773|FG000|Overall Study|Other|0|||
126239803|NCT01079988|454170774|FG001|Overall Study|Other|0|||
126239804|NCT01079988|454170775|FG002|Overall Study|Other|0|||
126239805|NCT01079988|454170776|FG003|Overall Study|Other|2|||
126239806|NCT01079988|454170777|FG004|Overall Study|Other|1|||
126239807|NCT00550537|454170778|FG000|Overall Study|Death|18|||
126239808|NCT00550537|454170778|FG000|Overall Study|Adverse Event|20|||
126239809|NCT00550537|454170778|FG000|Overall Study|Disease progression before|46|||
126239810|NCT00550537|454170778|FG000|Overall Study|Withdrawal by Subject|7|||
126239811|NCT00550537|454170778|FG000|Overall Study|Change in treatment plan|4|||
126239812|NCT00550537|454170778|FG000|Overall Study|Other complicating ilness|3|||
126239813|NCT00550537|454170778|FG000|Overall Study|Declining performance status|2|||
126239814|NCT00550537|454170778|FG000|Overall Study|Treated closer to home|4|||
126239815|NCT00268905|454170779|FG000|Overall Study|Adverse Event|3|||
126239816|NCT00268905|454170780|FG001|Overall Study|Adverse Event|0|||
126239817|NCT00268905|454170781|FG002|Overall Study|Adverse Event|4|||
126239818|NCT00268905|454170779|FG000|Overall Study|Lost to Follow-up|0|||
126239819|NCT00268905|454170780|FG001|Overall Study|Lost to Follow-up|1|||
126239820|NCT00268905|454170781|FG002|Overall Study|Lost to Follow-up|0|||
126239821|NCT00268905|454170779|FG000|Overall Study|Withdrawal by Subject|0|||
126239822|NCT00268905|454170780|FG001|Overall Study|Withdrawal by Subject|0|||
126239823|NCT00268905|454170781|FG002|Overall Study|Withdrawal by Subject|3|||
126239824|NCT00268905|454170779|FG000|Overall Study|Progressive Disease|28|||
126239825|NCT00268905|454170780|FG001|Overall Study|Progressive Disease|4|||
126239826|NCT00268905|454170781|FG002|Overall Study|Progressive Disease|3|||
126239827|NCT00268905|454170779|FG000|Overall Study|Physician Decision|3|||
126239828|NCT00268905|454170780|FG001|Overall Study|Physician Decision|0|||
126239829|NCT00268905|454170781|FG002|Overall Study|Physician Decision|1|||
126239830|NCT00268905|454170779|FG000|Overall Study|Clinical Progression|9|||
126239831|NCT00268905|454170780|FG001|Overall Study|Clinical Progression|4|||
126239832|NCT00268905|454170781|FG002|Overall Study|Clinical Progression|1|||
126239833|NCT00617305|454170782|FG000|Overall Study|Adverse Event|4|||
126025817|NCT00761189|453389306|FG000|Overall Study|Lost to Follow-up|36|||
126025818|NCT00761189|453389306|FG000|Overall Study|Withdrawal by Subject|49|||
126025819|NCT00761189|453389306|FG000|Overall Study|Other|13|||
126025820|NCT01494922|453389307|FG000|Overall Study|Adverse Event|1|||
126025821|NCT02759016|453389308|FG000|Overall Study|Not treated with BI 836826|1|||
126025822|NCT02759016|453389309|FG001|Overall Study|Not treated with BI 836826|0|||
126025823|NCT02759016|453389308|FG000|Overall Study|Progressive disease|1|||
126025824|NCT02759016|453389309|FG001|Overall Study|Progressive disease|0|||
126025825|NCT02759016|453389308|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
126025826|NCT02759016|453389309|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
126025827|NCT02759016|453389308|FG000|Overall Study|Other not defined above|2|||
126025828|NCT02759016|453389309|FG001|Overall Study|Other not defined above|1|||
126025829|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
126025830|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
126025831|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
126025832|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
126025833|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
126025834|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
126025835|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
126025836|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
126025837|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
126025838|NCT03939312|453389310|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
126025839|NCT03939312|453389310|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
126025840|NCT03939312|453389310|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
126025841|NCT02119650|453389311|FG000|Overall Study|Adverse Event|3|||
126025842|NCT02119650|453389312|FG001|Overall Study|Adverse Event|4|||
126025843|NCT02119650|453389311|FG000|Overall Study|Subject decision|2|||
126025844|NCT02119650|453389312|FG001|Overall Study|Subject decision|3|||
126025845|NCT02119650|453389311|FG000|Overall Study|Disease progression|11|||
126025846|NCT02119650|453389312|FG001|Overall Study|Disease progression|14|||
126025847|NCT02119650|453389311|FG000|Overall Study|Death|5|||
126025848|NCT02119650|453389312|FG001|Overall Study|Death|1|||
126025849|NCT02119650|453389311|FG000|Overall Study|Noncompliance with study treatment|1|||
126025850|NCT02119650|453389312|FG001|Overall Study|Noncompliance with study treatment|1|||
126025851|NCT02119650|453389311|FG000|Overall Study|Study terminated by the sponsor|1|||
126025852|NCT02119650|453389312|FG001|Overall Study|Study terminated by the sponsor|0|||
126025853|NCT02119650|453389311|FG000|Overall Study|Physician Decision|0|||
126025854|NCT02119650|453389312|FG001|Overall Study|Physician Decision|2|||
126025855|NCT02119650|453389311|FG000|Overall Study|Multiple reasons for termination|2|||
126025856|NCT02119650|453389312|FG001|Overall Study|Multiple reasons for termination|1|||
126025857|NCT01721291|453389313|FG000|Overall Study|Withdrawal by Subject|1|||
126025858|NCT01721291|453389314|FG001|Overall Study|Withdrawal by Subject|0|||
126025859|NCT01721291|453389313|FG000|Overall Study|did not like the treatment|1|||
126025860|NCT01721291|453389314|FG001|Overall Study|did not like the treatment|0|||
126025861|NCT04059354|453390581|FG000|Overall Study|COVID-19 pandemic|3|||
126025862|NCT05403801|453390582|FG000|Overall Study|Withdrawal by Subject|2|||
126025863|NCT03651895|453390584|FG000|First Drug Assignment|Adverse Event|4|||
126025864|NCT03651895|453390585|FG001|First Drug Assignment|Adverse Event|5|||
126025865|NCT03651895|453390584|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
126025866|NCT03651895|453390585|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
126025867|NCT02525692|453390586|FG000|Overall Study|Withdrawal by Subject|1|||
126025868|NCT02525692|453390587|FG001|Overall Study|Withdrawal by Subject|1|||
126239834|NCT00617305|454170783|FG001|Overall Study|Adverse Event|0|||
126239835|NCT00617305|454170784|FG002|Overall Study|Adverse Event|0|||
126239836|NCT00617305|454170782|FG000|Overall Study|Death|1|||
126025869|NCT02525692|453390588|FG002|Overall Study|Withdrawal by Subject|0|||
126025870|NCT02525692|453390589|FG003|Overall Study|Withdrawal by Subject|5|||
126025871|NCT02525692|453390590|FG004|Overall Study|Withdrawal by Subject|0|||
126025872|NCT02525692|453390591|FG005|Overall Study|Withdrawal by Subject|1|||
126239837|NCT00617305|454170783|FG001|Overall Study|Death|0|||
126239838|NCT00617305|454170784|FG002|Overall Study|Death|0|||
126239839|NCT00617305|454170782|FG000|Overall Study|Physician Decision|1|||
126239840|NCT00617305|454170783|FG001|Overall Study|Physician Decision|0|||
126239841|NCT00617305|454170784|FG002|Overall Study|Physician Decision|0|||
126239842|NCT00617305|454170782|FG000|Overall Study|Protocol Violation|1|||
126239843|NCT00617305|454170783|FG001|Overall Study|Protocol Violation|0|||
126239844|NCT00617305|454170784|FG002|Overall Study|Protocol Violation|1|||
126239845|NCT00617305|454170782|FG000|Overall Study|Withdrawal by Subject|1|||
126239846|NCT00617305|454170783|FG001|Overall Study|Withdrawal by Subject|0|||
126239847|NCT00617305|454170784|FG002|Overall Study|Withdrawal by Subject|0|||
126239848|NCT04510285|454170785|FG000|Overall Study|Death|1|||
126239849|NCT03897088|454170786|FG000|Overall Study|Withdrawal by Subject|12|||
126239850|NCT03897088|454170787|FG001|Overall Study|Withdrawal by Subject|12|||
126239851|NCT03897088|454170786|FG000|Overall Study|Lost to Follow-up|7|||
126239852|NCT03897088|454170787|FG001|Overall Study|Lost to Follow-up|15|||
126239853|NCT03897088|454170786|FG000|Overall Study|Sponsor Decision|1|||
126239854|NCT03897088|454170787|FG001|Overall Study|Sponsor Decision|2|||
126239855|NCT03897088|454170786|FG000|Overall Study|COVID-19|2|||
126239856|NCT03897088|454170787|FG001|Overall Study|COVID-19|0|||
126239857|NCT03897088|454170786|FG000|Overall Study|Other|3|||
126239858|NCT03897088|454170787|FG001|Overall Study|Other|0|||
126239859|NCT03897088|454170786|FG000|Overall Study|Non-compliance with Study Drug|1|||
126239860|NCT03897088|454170787|FG001|Overall Study|Non-compliance with Study Drug|1|||
126239861|NCT03897088|454170786|FG000|Overall Study|Pregnancy|0|||
126239862|NCT03897088|454170787|FG001|Overall Study|Pregnancy|1|||
126239863|NCT02392000|454170790|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
126239864|NCT02392000|454170790|FG000|Overall Study|Withdrawal by Subject|1|||
126239865|NCT02392000|454170790|FG000|Overall Study|Lost to Follow-up|8|||
126239866|NCT04384978|454170791|FG000|Overall Study|Withdrawal by Subject|4|||
126239867|NCT04384978|454170792|FG001|Overall Study|Withdrawal by Subject|0|||
126239868|NCT03555305|454170793|FG000|Period 1|Physician Decision|0|||
126239869|NCT03555305|454170794|FG001|Period 1|Physician Decision|1|||
126239870|NCT03555305|454170793|FG000|Period 1|Adverse Event|0|||
126239871|NCT03555305|454170794|FG001|Period 1|Adverse Event|1|||
126239872|NCT03586726|454170800|FG000|Overall Study|Withdrawal by Subject|1|||
126239873|NCT02100228|454170803|FG000|Overall Study|Other|19|||
126239874|NCT02100228|454170804|FG001|Overall Study|Other|19|||
126239875|NCT02100228|454170803|FG000|Overall Study|Administrative reason|0|||
126239876|NCT02100228|454170804|FG001|Overall Study|Administrative reason|1|||
126239877|NCT02100228|454170803|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
126239878|NCT02100228|454170804|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
126239879|NCT02100228|454170803|FG000|Overall Study|Non-compliance|0|||
126239880|NCT02100228|454170804|FG001|Overall Study|Non-compliance|3|||
126239881|NCT02100228|454170803|FG000|Overall Study|Lost to Follow-up|0|||
126239882|NCT02100228|454170804|FG001|Overall Study|Lost to Follow-up|1|||
126239883|NCT02100228|454170803|FG000|Overall Study|Withdrawal by Subject|27|||
126239884|NCT02100228|454170804|FG001|Overall Study|Withdrawal by Subject|37|||
126239885|NCT02100228|454170803|FG000|Overall Study|Adverse Event|16|||
126239886|NCT02100228|454170804|FG001|Overall Study|Adverse Event|12|||
126025873|NCT02525692|453390586|FG000|Overall Study|Death|16|||
126025874|NCT02525692|453390587|FG001|Overall Study|Death|18|||
126025875|NCT02525692|453390588|FG002|Overall Study|Death|7|||
126239887|NCT02100228|454170803|FG000|Overall Study|Death|1|||
126239888|NCT02100228|454170804|FG001|Overall Study|Death|1|||
126239889|NCT02216071|454170829|FG000|Overall Study|Withdrawal by Subject|7|||
126239890|NCT02216071|454170830|FG001|Overall Study|Withdrawal by Subject|2|||
126239891|NCT02216071|454170829|FG000|Overall Study|Lost to Follow-up|3|||
126239892|NCT02216071|454170830|FG001|Overall Study|Lost to Follow-up|3|||
126239893|NCT02216071|454170829|FG000|Overall Study|Protocol Violation|3|||
126239894|NCT02216071|454170830|FG001|Overall Study|Protocol Violation|5|||
126239895|NCT02216071|454170829|FG000|Overall Study|Other|2|||
126239896|NCT02216071|454170830|FG001|Overall Study|Other|2|||
126239897|NCT00389064|454170831|FG000|Overall Study|Adverse Event|11|||
126239898|NCT00389064|454170832|FG001|Overall Study|Adverse Event|3|||
126239899|NCT00389064|454170831|FG000|Overall Study|Lack of Efficacy|3|||
126239900|NCT00389064|454170832|FG001|Overall Study|Lack of Efficacy|14|||
126239901|NCT00389064|454170831|FG000|Overall Study|Withdrawal by Subject|17|||
126356653|NCT02675452|454597885|FG022|Overall Study|Lost to Follow-up|0|||
126356654|NCT02675452|454597886|FG023|Overall Study|Lost to Follow-up|0|||
126356655|NCT02675452|454597887|FG024|Overall Study|Lost to Follow-up|0|||
126356656|NCT02675452|454597888|FG025|Overall Study|Lost to Follow-up|0|||
126356657|NCT02675452|454597889|FG026|Overall Study|Lost to Follow-up|1|||
126356658|NCT02675452|454597890|FG027|Overall Study|Lost to Follow-up|0|||
126356659|NCT02675452|454597891|FG028|Overall Study|Lost to Follow-up|0|||
126356660|NCT02675452|454597863|FG000|Overall Study|Other|0|||
126356661|NCT02675452|454597864|FG001|Overall Study|Other|0|||
126356662|NCT02675452|454597865|FG002|Overall Study|Other|0|||
126356663|NCT02675452|454597866|FG003|Overall Study|Other|0|||
126356664|NCT02675452|454597867|FG004|Overall Study|Other|0|||
126356665|NCT02675452|454597868|FG005|Overall Study|Other|0|||
126239902|NCT00389064|454170832|FG001|Overall Study|Withdrawal by Subject|27|||
126239903|NCT00389064|454170831|FG000|Overall Study|Physician Decision|2|||
126239904|NCT00389064|454170832|FG001|Overall Study|Physician Decision|2|||
126239905|NCT00389064|454170831|FG000|Overall Study|Lost to Follow-up|1|||
126239906|NCT00389064|454170832|FG001|Overall Study|Lost to Follow-up|2|||
126239907|NCT00389064|454170831|FG000|Overall Study|Protocol Violation|2|||
126239908|NCT00389064|454170832|FG001|Overall Study|Protocol Violation|0|||
126239909|NCT00389064|454170831|FG000|Overall Study|Multiple Reasons|9|||
126239910|NCT00389064|454170832|FG001|Overall Study|Multiple Reasons|11|||
126239911|NCT01811953|454172227|FG000|Overall Study|Adverse Event|0|||
126239912|NCT01811953|454172228|FG001|Overall Study|Adverse Event|0|||
126239913|NCT01811953|454172229|FG002|Overall Study|Adverse Event|0|||
126239914|NCT01811953|454172230|FG003|Overall Study|Adverse Event|1|||
126239915|NCT01811953|454172231|FG004|Overall Study|Adverse Event|0|||
126239916|NCT01811953|454172232|FG005|Overall Study|Adverse Event|1|||
126239917|NCT01811953|454172227|FG000|Overall Study|Protocol Violation|0|||
126239918|NCT01811953|454172228|FG001|Overall Study|Protocol Violation|0|||
126239919|NCT01811953|454172229|FG002|Overall Study|Protocol Violation|0|||
126239920|NCT01811953|454172230|FG003|Overall Study|Protocol Violation|0|||
126239921|NCT01811953|454172231|FG004|Overall Study|Protocol Violation|1|||
126239922|NCT01811953|454172232|FG005|Overall Study|Protocol Violation|0|||
126239923|NCT00371839|454172234|FG000|Overall Study|Death|4|||
126239924|NCT00371839|454172235|FG001|Overall Study|Death|0|||
126239925|NCT00371839|454172236|FG002|Overall Study|Death|0|||
126239926|NCT00371839|454172234|FG000|Overall Study|Withdrawal by Subject|7|||
126239927|NCT00371839|454172235|FG001|Overall Study|Withdrawal by Subject|4|||
126239928|NCT00371839|454172236|FG002|Overall Study|Withdrawal by Subject|0|||
126239929|NCT00371839|454172234|FG000|Overall Study|Lost to Follow-up|6|||
126239930|NCT00371839|454172235|FG001|Overall Study|Lost to Follow-up|3|||
126239931|NCT00371839|454172236|FG002|Overall Study|Lost to Follow-up|2|||
126239932|NCT01049334|454172238|FG000|Overall Study|Withdrawal by Subject|5|||
126239933|NCT01049334|454172239|FG001|Overall Study|Withdrawal by Subject|3|||
126239934|NCT01049334|454172238|FG000|Overall Study|Adverse Event|2|||
126239935|NCT01049334|454172239|FG001|Overall Study|Adverse Event|3|||
126239936|NCT01049334|454172238|FG000|Overall Study|Physician Decision|2|||
126239937|NCT01049334|454172239|FG001|Overall Study|Physician Decision|0|||
126239938|NCT01049334|454172238|FG000|Overall Study|Protocol Violation|0|||
126239939|NCT01049334|454172239|FG001|Overall Study|Protocol Violation|1|||
126239940|NCT00396279|454172240|FG000|Overall Study|Ongoing in study|26|||
126239941|NCT00396279|454172240|FG000|Overall Study|Disease progression|2|||
126239942|NCT00396279|454172240|FG000|Overall Study|Withdrawal by Subject|1|||
126239943|NCT00396279|454172240|FG000|Overall Study|Physician Decision|1|||
126239944|NCT02883452|454172241|FG000|Overall Study|Withdrawal by Subject|1|||
126239945|NCT02883452|454172242|FG001|Overall Study|Withdrawal by Subject|1|||
126239946|NCT02883452|454172243|FG002|Overall Study|Withdrawal by Subject|3|||
126239947|NCT02883452|454172244|FG003|Overall Study|Withdrawal by Subject|0|||
126025876|NCT02525692|453390589|FG003|Overall Study|Death|20|||
126025877|NCT02525692|453390590|FG004|Overall Study|Death|3|||
126025878|NCT02525692|453390591|FG005|Overall Study|Death|6|||
126025879|NCT02525692|453390586|FG000|Overall Study|Lost to Follow-up|0|||
126025880|NCT02525692|453390587|FG001|Overall Study|Lost to Follow-up|0|||
126025881|NCT02525692|453390588|FG002|Overall Study|Lost to Follow-up|1|||
126025882|NCT02525692|453390589|FG003|Overall Study|Lost to Follow-up|5|||
126239948|NCT02883452|454172245|FG004|Overall Study|Withdrawal by Subject|2|||
126239949|NCT02883452|454172246|FG005|Overall Study|Withdrawal by Subject|5|||
126239950|NCT02883452|454172241|FG000|Overall Study|Disease progression|1|||
126239951|NCT02883452|454172242|FG001|Overall Study|Disease progression|0|||
126239952|NCT02883452|454172243|FG002|Overall Study|Disease progression|0|||
126239953|NCT02883452|454172244|FG003|Overall Study|Disease progression|1|||
126239954|NCT02883452|454172245|FG004|Overall Study|Disease progression|4|||
126239955|NCT02883452|454172246|FG005|Overall Study|Disease progression|5|||
126239956|NCT02883452|454172241|FG000|Overall Study|Adverse Event|2|||
126239957|NCT02883452|454172242|FG001|Overall Study|Adverse Event|1|||
126239958|NCT02883452|454172243|FG002|Overall Study|Adverse Event|1|||
126239959|NCT02883452|454172244|FG003|Overall Study|Adverse Event|1|||
126239960|NCT02883452|454172245|FG004|Overall Study|Adverse Event|1|||
126239961|NCT02883452|454172246|FG005|Overall Study|Adverse Event|3|||
126239962|NCT02883452|454172241|FG000|Overall Study|Physician Decision|0|||
126239963|NCT02883452|454172242|FG001|Overall Study|Physician Decision|0|||
126239964|NCT02883452|454172243|FG002|Overall Study|Physician Decision|0|||
126239965|NCT02883452|454172244|FG003|Overall Study|Physician Decision|0|||
126025883|NCT02525692|453390590|FG004|Overall Study|Lost to Follow-up|0|||
126025884|NCT02525692|453390591|FG005|Overall Study|Lost to Follow-up|0|||
126239966|NCT02883452|454172245|FG004|Overall Study|Physician Decision|4|||
126239967|NCT02883452|454172246|FG005|Overall Study|Physician Decision|1|||
126239968|NCT02883452|454172241|FG000|Overall Study|Death|1|||
126239969|NCT02883452|454172242|FG001|Overall Study|Death|0|||
126239970|NCT02883452|454172243|FG002|Overall Study|Death|1|||
126239971|NCT02883452|454172244|FG003|Overall Study|Death|0|||
126239972|NCT02883452|454172245|FG004|Overall Study|Death|0|||
126239973|NCT02883452|454172246|FG005|Overall Study|Death|0|||
126239974|NCT02883452|454172241|FG000|Overall Study|Other|0|||
126239975|NCT02883452|454172242|FG001|Overall Study|Other|0|||
126239976|NCT02883452|454172243|FG002|Overall Study|Other|0|||
126239977|NCT02883452|454172244|FG003|Overall Study|Other|0|||
126239978|NCT02883452|454172245|FG004|Overall Study|Other|0|||
126239979|NCT02883452|454172246|FG005|Overall Study|Other|1|||
126239980|NCT00667095|454172254|FG000|Overall Study|Withdrawal by Subject|0|||
126239981|NCT00667095|454172255|FG001|Overall Study|Withdrawal by Subject|1|||
126239982|NCT03447262|454172256|FG000|Overall Study|Adverse Event|7|||
126239983|NCT03447262|454172256|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
126239984|NCT03447262|454172256|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
126239985|NCT03447262|454172256|FG000|Overall Study|Death|2|||
126239986|NCT03447262|454172256|FG000|Overall Study|Study Termination by Sponsor|455|||
126239987|NCT03447262|454172256|FG000|Overall Study|Other|4|||
126239988|NCT00830206|454172258|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
126239989|NCT00830206|454172259|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
126239990|NCT00905346|454172262|FG000|Period 1|Withdrawal by Subject|1|||
126239991|NCT00905346|454172263|FG001|Period 1|Withdrawal by Subject|0|||
126239992|NCT03351335|454172264|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
126239993|NCT03351335|454172265|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
126239994|NCT03351335|454172266|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
126239995|NCT05612724|454172271|FG000|Overall Study|Lost to Follow-up|4|||
126239996|NCT04000815|454172274|FG000|Overall Study|Lost to Follow-up|9|||
126239997|NCT04000815|454172275|FG001|Overall Study|Lost to Follow-up|2|||
126239998|NCT04000815|454172276|FG002|Overall Study|Lost to Follow-up|3|||
126239999|NCT04000815|454172274|FG000|Overall Study|Withdrawal by Subject|4|||
126240000|NCT04000815|454172275|FG001|Overall Study|Withdrawal by Subject|3|||
126240001|NCT04000815|454172276|FG002|Overall Study|Withdrawal by Subject|2|||
126240002|NCT04000815|454172274|FG000|Overall Study|Right ovarian cyst occured|1|||
126240003|NCT04000815|454172275|FG001|Overall Study|Right ovarian cyst occured|0|||
126240004|NCT04000815|454172276|FG002|Overall Study|Right ovarian cyst occured|0|||
126240005|NCT04000815|454172274|FG000|Overall Study|Hypertension occured on follow up|0|||
126240006|NCT04000815|454172275|FG001|Overall Study|Hypertension occured on follow up|0|||
126240007|NCT04000815|454172276|FG002|Overall Study|Hypertension occured on follow up|2|||
126240008|NCT00239577|454172277|FG000|Primary Phase|Adverse Event|0|||
126240009|NCT00239577|454172278|FG001|Primary Phase|Adverse Event|0|||
126240010|NCT00239577|454172279|FG002|Primary Phase|Adverse Event|1|||
126240011|NCT00239577|454172280|FG003|Primary Phase|Adverse Event|0|||
126240012|NCT00239577|454172277|FG000|Primary Phase|Other|5|||
126240013|NCT00239577|454172278|FG001|Primary Phase|Other|3|||
126240014|NCT00239577|454172279|FG002|Primary Phase|Other|2|||
126240015|NCT00239577|454172280|FG003|Primary Phase|Other|0|||
126240016|NCT02736721|454172283|FG000|Overall Study|Adverse Event|8|||
126240017|NCT02736721|454172283|FG000|Overall Study|Lost to Follow-up|3|||
126240018|NCT02736721|454172283|FG000|Overall Study|Other|5|||
126240019|NCT03988803|454172284|FG000|Period 2|Prematurely discontinued from medication|2|||
126240020|NCT03988803|454172284|FG000|Period 2|Adverse Event|1|||
126240021|NCT03021018|454172285|FG000|Overall Study|Adverse Event|1|||
126240022|NCT03021018|454172286|FG001|Overall Study|Adverse Event|0|||
126240023|NCT03021018|454172287|FG002|Overall Study|Adverse Event|0|||
126240024|NCT03021018|454172285|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
126240025|NCT03021018|454172286|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
126240026|NCT03021018|454172287|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
126240027|NCT00328926|454172298|FG000|Overall Study|Pregnancy|2|||
126240028|NCT00328926|454172299|FG001|Overall Study|Pregnancy|1|||
126240029|NCT00328926|454172300|FG002|Overall Study|Pregnancy|0|||
126240030|NCT00328926|454172298|FG000|Overall Study|Lost to Follow-up|0|||
126240031|NCT00328926|454172299|FG001|Overall Study|Lost to Follow-up|1|||
126240032|NCT00328926|454172300|FG002|Overall Study|Lost to Follow-up|0|||
126240033|NCT00328926|454172298|FG000|Overall Study|Death|0|||
126240034|NCT00328926|454172299|FG001|Overall Study|Death|0|||
126240035|NCT00328926|454172300|FG002|Overall Study|Death|1|||
126240036|NCT00328926|454172298|FG000|Overall Study|In vitro fertilization treatment|0|||
126240037|NCT00328926|454172299|FG001|Overall Study|In vitro fertilization treatment|0|||
126240038|NCT00328926|454172300|FG002|Overall Study|In vitro fertilization treatment|1|||
126240039|NCT00328926|454172298|FG000|Overall Study|Lack of ovarian response|0|||
126240040|NCT00328926|454172299|FG001|Overall Study|Lack of ovarian response|1|||
126240041|NCT00328926|454172300|FG002|Overall Study|Lack of ovarian response|0|||
126240042|NCT02269657|454172301|FG000|Overall Study|Protocol Violation|3|||
126240043|NCT00620074|454172306|FG000|Overall Study|Adverse Event|1|||
126240044|NCT00829673|454172307|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126240045|NCT00829673|454172308|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126240046|NCT00573066|454172309|FG000|Overall Study|Exclusion criteria|18|||
126240047|NCT00573066|454172309|FG000|Overall Study|IV malfunction|1|||
126240048|NCT00573066|454172309|FG000|Overall Study|Postoperative bleeding|1|||
126240049|NCT01838941|454172310|FG000|Overall Study|Adverse Event|1|||
126240050|NCT01838941|454172310|FG000|Overall Study|Withdrawal by Subject|1|||
126240051|NCT02822235|454172311|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
126240052|NCT02822235|454172312|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
126240053|NCT02822235|454172311|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
126240054|NCT02822235|454172312|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
126240055|NCT02822235|454172311|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
126240056|NCT02822235|454172312|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
126240057|NCT02822235|454172311|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
126240058|NCT02822235|454172312|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
126240059|NCT02822235|454172311|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
126240060|NCT02822235|454172312|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
126240061|NCT02822235|454172311|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
126240062|NCT02822235|454172312|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
126240063|NCT03214952|454172313|FG000|Overall Study|Protocol Deviation|45|||
126356666|NCT02675452|454597869|FG006|Overall Study|Other|0|||
126356667|NCT02675452|454597870|FG007|Overall Study|Other|0|||
126356668|NCT02675452|454597871|FG008|Overall Study|Other|0|||
126356669|NCT02675452|454597872|FG009|Overall Study|Other|0|||
126356670|NCT02675452|454597873|FG010|Overall Study|Other|0|||
126356671|NCT02675452|454597874|FG011|Overall Study|Other|0|||
126356672|NCT02675452|454597875|FG012|Overall Study|Other|0|||
126240064|NCT03214952|454172313|FG000|Overall Study|Case Report Forms Uncollected|13|||
126240065|NCT03769896|454172316|FG000|Open-label Phase|Lack of Efficacy|5|||
126240066|NCT03769896|454172317|FG001|Open-label Phase|Lack of Efficacy|0|||
126240067|NCT03769896|454172316|FG000|Open-label Phase|Adverse Event|3|||
126240068|NCT03769896|454172317|FG001|Open-label Phase|Adverse Event|0|||
126240069|NCT03769896|454172316|FG000|Open-label Phase|Withdrawal by Subject|1|||
126240070|NCT03769896|454172317|FG001|Open-label Phase|Withdrawal by Subject|0|||
126240071|NCT00377260|454172318|FG000|Overall Study|Lost to Follow-up|0|||
126240072|NCT00377260|454172319|FG001|Overall Study|Lost to Follow-up|1|||
126240073|NCT00377260|454172318|FG000|Overall Study|Withdrawal by Subject|2|||
126240074|NCT00377260|454172319|FG001|Overall Study|Withdrawal by Subject|4|||
126356673|NCT02675452|454597876|FG013|Overall Study|Other|0|||
126356674|NCT02675452|454597877|FG014|Overall Study|Other|0|||
126240075|NCT00829530|454172320|FG000|First Intervention|Adverse Event|0|||
126356675|NCT02675452|454597878|FG015|Overall Study|Other|0|||
126356676|NCT02675452|454597879|FG016|Overall Study|Other|0|||
126240076|NCT00829530|454172321|FG001|First Intervention|Adverse Event|1|||
126240077|NCT00829530|454172320|FG000|First Intervention|Intolerance to Venopuncture|0|||
126240078|NCT00829530|454172321|FG001|First Intervention|Intolerance to Venopuncture|1|||
126240079|NCT00829530|454172320|FG000|Second Intervention|Intolerance to Venopuncture|1|||
126240080|NCT00829530|454172321|FG001|Second Intervention|Intolerance to Venopuncture|0|||
126240081|NCT04112823|454172324|FG000|Overall Study|Lost to Follow-up|2|||
126240082|NCT04112823|454172325|FG001|Overall Study|Lost to Follow-up|3|||
126240083|NCT00625443|454172326|FG000|Overall Study|Adverse Event|1|||
126240084|NCT00625443|454172327|FG001|Overall Study|Adverse Event|4|||
126240085|NCT00625443|454172328|FG002|Overall Study|Adverse Event|0|||
126240086|NCT00625443|454172326|FG000|Overall Study|Non-compliance with protocol|0|||
126240087|NCT00625443|454172327|FG001|Overall Study|Non-compliance with protocol|1|||
126240088|NCT00625443|454172328|FG002|Overall Study|Non-compliance with protocol|0|||
126240089|NCT00625443|454172326|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
126240090|NCT00625443|454172327|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
126240091|NCT00625443|454172328|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
126240092|NCT00625443|454172326|FG000|Overall Study|Withdrawal by Subject|0|||
126240093|NCT00625443|454172327|FG001|Overall Study|Withdrawal by Subject|1|||
126240094|NCT00625443|454172328|FG002|Overall Study|Withdrawal by Subject|2|||
126240095|NCT00625443|454172326|FG000|Overall Study|Physician Decision|0|||
126240096|NCT00625443|454172327|FG001|Overall Study|Physician Decision|4|||
126240097|NCT00625443|454172328|FG002|Overall Study|Physician Decision|2|||
126240098|NCT00625443|454172326|FG000|Overall Study|Other|0|||
126240099|NCT00625443|454172327|FG001|Overall Study|Other|1|||
126240100|NCT00625443|454172328|FG002|Overall Study|Other|1|||
126240101|NCT01256684|454172329|FG000|Overall Study|Adverse Event|1|||
126240102|NCT01256684|454172330|FG001|Overall Study|Adverse Event|4|||
126240103|NCT01256684|454172331|FG002|Overall Study|Adverse Event|2|||
126240104|NCT01256684|454172329|FG000|Overall Study|Withdrawal by Subject|4|||
126240105|NCT01256684|454172330|FG001|Overall Study|Withdrawal by Subject|0|||
126240106|NCT01256684|454172331|FG002|Overall Study|Withdrawal by Subject|2|||
126240107|NCT01256684|454172329|FG000|Overall Study|Physician Decision|0|||
126240108|NCT01256684|454172330|FG001|Overall Study|Physician Decision|1|||
126240109|NCT01256684|454172331|FG002|Overall Study|Physician Decision|0|||
126240110|NCT01256684|454172329|FG000|Overall Study|Lack of Efficacy|0|||
126240111|NCT01256684|454172330|FG001|Overall Study|Lack of Efficacy|1|||
126240112|NCT01256684|454172331|FG002|Overall Study|Lack of Efficacy|1|||
126240113|NCT01256684|454172329|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
126240114|NCT01256684|454172330|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
126240115|NCT01256684|454172331|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
126240116|NCT01422538|454172335|FG000|Overall Study|Lost to Follow-up|0|||
126240117|NCT01422538|454172336|FG001|Overall Study|Lost to Follow-up|1|||
126240118|NCT01422538|454172337|FG002|Overall Study|Lost to Follow-up|1|||
126240119|NCT01422538|454172335|FG000|Overall Study|Missed visit|0|||
126240120|NCT01422538|454172336|FG001|Overall Study|Missed visit|1|||
126240121|NCT01422538|454172337|FG002|Overall Study|Missed visit|1|||
126240122|NCT03459807|454172339|FG000|Overall Study|Withdrawal due to transplant|0|||
126240123|NCT03459807|454172340|FG001|Overall Study|Withdrawal due to transplant|1|||
126240124|NCT01406795|454172341|FG000|Overall Study|Withdrawal by Subject|1|||
126240125|NCT00855738|454172344|FG000|Overall Study|Lost to Follow-up|2|||
126240126|NCT00855738|454172344|FG000|Overall Study|Adverse Event|1|||
126240127|NCT00855738|454172344|FG000|Overall Study|Subject Defaulted|1|||
126240128|NCT00855738|454172344|FG000|Overall Study|Death|1|||
126240129|NCT03725605|454172345|FG000|Overall Study|Unsuccessful TIL expansion|2|||
126240130|NCT00965185|454172348|FG000|Overall Study|Lost to Follow-up|2|||
126240131|NCT00965185|454172349|FG001|Overall Study|Lost to Follow-up|0|||
126240132|NCT00965185|454172348|FG000|Overall Study|Withdrawal by Subject|0|||
126240133|NCT00965185|454172349|FG001|Overall Study|Withdrawal by Subject|1|||
126240134|NCT03707912|454172353|FG000|Overall Study|Violation of inclusion criteria|1|||
126240135|NCT03707912|454172354|FG001|Overall Study|Violation of inclusion criteria|0|||
126240136|NCT01802320|454172355|FG000|Overall Study|Death|1|||
126240137|NCT01802320|454172355|FG000|Overall Study|Withdrawal by Subject|1|||
126240138|NCT01066143|454173882|FG000|Overall Study|ineligible for the study|8|||
126240139|NCT05376319|454173883|FG000|Overall Study|Funding termination|2|||
126240140|NCT05376319|454173884|FG001|Overall Study|Funding termination|4|||
126240141|NCT00942968|454173885|FG000|Overall Study|Adverse Event|60|||
126240142|NCT00942968|454173885|FG000|Overall Study|Death|76|||
126240143|NCT00942968|454173885|FG000|Overall Study|Protocol Violation|9|||
126240144|NCT00942968|454173885|FG000|Overall Study|Lost to Follow-up|4|||
126356677|NCT02675452|454597880|FG017|Overall Study|Other|0|||
126240145|NCT00942968|454173885|FG000|Overall Study|Withdrawal by Subject|44|||
126240146|NCT00942968|454173885|FG000|Overall Study|Sponsor request|5|||
126240147|NCT00942968|454173885|FG000|Overall Study|Physician Decision|11|||
126240148|NCT00942968|454173885|FG000|Overall Study|Progression of disease|12|||
126240149|NCT00942968|454173885|FG000|Overall Study|Inferior vena cava filter placement|4|||
126240150|NCT00942968|454173885|FG000|Overall Study|Pulmonary embolism (PE)|1|||
126356678|NCT02675452|454597881|FG018|Overall Study|Other|0|||
126025885|NCT02396199|453390592|FG000|Overall Study|Lost to Follow-up|1|||
126025886|NCT02396199|453390592|FG000|Overall Study|Death|4|||
126025887|NCT00567398|453390596|FG000|Overall Study|Adverse Event|6|||
126025888|NCT00567398|453390597|FG001|Overall Study|Adverse Event|14|||
126025889|NCT00567398|453390596|FG000|Overall Study|Physician Decision|0|||
126025890|NCT00567398|453390597|FG001|Overall Study|Physician Decision|4|||
126025891|NCT00567398|453390596|FG000|Overall Study|Withdrawal by Subject|0|||
126025892|NCT00567398|453390597|FG001|Overall Study|Withdrawal by Subject|2|||
126025893|NCT00567398|453390596|FG000|Overall Study|Renal Transplantation|0|||
126025894|NCT00567398|453390597|FG001|Overall Study|Renal Transplantation|3|||
126240151|NCT00942968|454173885|FG000|Overall Study|Participant required pancreatic biopsy|1|||
126240152|NCT00942968|454173885|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
126240153|NCT01466166|454173888|FG000|Overall Study|Death|1|||
126025895|NCT00567398|453390596|FG000|Overall Study|Other|1|||
126025896|NCT00567398|453390597|FG001|Overall Study|Other|0|||
126240154|NCT01466166|454173888|FG000|Overall Study|Lost to Follow-up|7|||
126025897|NCT02201108|453390598|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
126025898|NCT02201108|453390599|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
126025899|NCT02201108|453390600|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
126240155|NCT01466166|454173888|FG000|Overall Study|Infusion Reaction (IR)|27|||
126240156|NCT01466166|454173888|FG000|Overall Study|Adverse Event (Other than IR)|11|||
126240157|NCT01466166|454173888|FG000|Overall Study|Elevated Serum Uric Acid|78|||
126240158|NCT01466166|454173888|FG000|Overall Study|Withdrawal by Subject|13|||
126240159|NCT01466166|454173888|FG000|Overall Study|Sponsor Decision|4|||
126240160|NCT01466166|454173888|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
126240161|NCT01466166|454173888|FG000|Overall Study|Other|20|||
126240162|NCT01340495|454173891|FG000|Overall Study|Withdrawal by Subject|1|||
126240163|NCT00667862|454173894|FG000|Overall Study|Adverse Event|9|||
126240164|NCT00667862|454173894|FG000|Overall Study|Death|1|||
126240165|NCT00667862|454173894|FG000|Overall Study|Disease Progression|22|||
126356679|NCT02675452|454597882|FG019|Overall Study|Other|0|||
126356680|NCT02675452|454597883|FG020|Overall Study|Other|0|||
126356681|NCT02675452|454597884|FG021|Overall Study|Other|0|||
126356682|NCT02675452|454597885|FG022|Overall Study|Other|0|||
126356683|NCT02675452|454597886|FG023|Overall Study|Other|0|||
126356684|NCT02675452|454597887|FG024|Overall Study|Other|0|||
126356685|NCT02675452|454597888|FG025|Overall Study|Other|0|||
126356686|NCT02675452|454597889|FG026|Overall Study|Other|1|||
126356687|NCT02675452|454597890|FG027|Overall Study|Other|0|||
126356688|NCT02675452|454597891|FG028|Overall Study|Other|0|||
126356689|NCT02939781|454597892|FG000|Overall Study|Protocol Violation|8|||
126356690|NCT02939781|454597892|FG000|Overall Study|Withdrawal by Subject|1|||
126356691|NCT00689052|454597896|FG000|Overall Study|Adverse Event|4|||
126356692|NCT00689052|454597897|FG001|Overall Study|Adverse Event|6|||
126356693|NCT00689052|454597896|FG000|Overall Study|Protocol Violation|1|||
126356694|NCT00689052|454597897|FG001|Overall Study|Protocol Violation|0|||
126356695|NCT00689052|454597896|FG000|Overall Study|Lost to Follow-up|2|||
126356696|NCT00689052|454597897|FG001|Overall Study|Lost to Follow-up|0|||
126356697|NCT00689052|454597896|FG000|Overall Study|Withdrawal by Subject|2|||
126356698|NCT00689052|454597897|FG001|Overall Study|Withdrawal by Subject|0|||
126356699|NCT00689052|454597896|FG000|Overall Study|Early termination of the trial|22|||
126356700|NCT00689052|454597897|FG001|Overall Study|Early termination of the trial|24|||
126356701|NCT02569242|454597898|FG000|Overall Study|Death|1|||
126356702|NCT02569242|454597899|FG001|Overall Study|Death|0|||
126356703|NCT02569242|454597898|FG000|Overall Study|Withdrawal by Subject|0|||
126356704|NCT02569242|454597899|FG001|Overall Study|Withdrawal by Subject|1|||
126356705|NCT03003468|454597900|FG000|Overall Study|Withdrawal by Subject|0|||
126356706|NCT03003468|454597901|FG001|Overall Study|Withdrawal by Subject|0|||
126356707|NCT03003468|454597902|FG002|Overall Study|Withdrawal by Subject|1|||
126356708|NCT03003468|454597900|FG000|Overall Study|No measurable lesions|0|||
126356709|NCT03003468|454597901|FG001|Overall Study|No measurable lesions|0|||
126356710|NCT03003468|454597902|FG002|Overall Study|No measurable lesions|1|||
126356711|NCT02114684|454597903|FG000|Overall Study|Death|6|||
126356712|NCT02114684|454597904|FG001|Overall Study|Death|4|||
126356713|NCT02114684|454597903|FG000|Overall Study|Lost to Follow-up|1|||
126356714|NCT02114684|454597904|FG001|Overall Study|Lost to Follow-up|2|||
126356715|NCT02114684|454597903|FG000|Overall Study|Withdrawal by Subject|1|||
126356716|NCT02114684|454597904|FG001|Overall Study|Withdrawal by Subject|2|||
126356717|NCT02114684|454597903|FG000|Overall Study|Relocation|3|||
126356718|NCT02114684|454597904|FG001|Overall Study|Relocation|1|||
126356719|NCT02114684|454597903|FG000|Overall Study|Rifampicin resistant on culture|0|||
126356720|NCT02114684|454597904|FG001|Overall Study|Rifampicin resistant on culture|1|||
126356721|NCT02114684|454597903|FG000|Overall Study|Patient Incarcerated|1|||
126356722|NCT02114684|454597904|FG001|Overall Study|Patient Incarcerated|0|||
126356723|NCT04625972|454597907|FG000|Overall Study|Death|3|||
126356724|NCT04625972|454597908|FG001|Overall Study|Death|2|||
126356725|NCT04625972|454597907|FG000|Overall Study|Lost to Follow-up|82|||
126356726|NCT04625972|454597908|FG001|Overall Study|Lost to Follow-up|38|||
126356727|NCT04625972|454597907|FG000|Overall Study|Physician Decision|2|||
126356728|NCT04625972|454597908|FG001|Overall Study|Physician Decision|0|||
126356729|NCT04625972|454597907|FG000|Overall Study|Protocol Violation|0|||
126356730|NCT04625972|454597908|FG001|Overall Study|Protocol Violation|1|||
126356731|NCT04625972|454597907|FG000|Overall Study|Withdrawal by Subject|37|||
126356732|NCT04625972|454597908|FG001|Overall Study|Withdrawal by Subject|24|||
126356733|NCT04625972|454597907|FG000|Overall Study|Not specified elsewhere|8|||
126356734|NCT04625972|454597908|FG001|Overall Study|Not specified elsewhere|6|||
126356735|NCT03259308|454597915|FG000|Overall Study|Adverse Event|5|||
126356736|NCT03259308|454597916|FG001|Overall Study|Adverse Event|4|||
126356737|NCT03259308|454597917|FG002|Overall Study|Adverse Event|1|||
126025900|NCT02201108|453390598|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
126025901|NCT02201108|453390599|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
126025902|NCT02201108|453390600|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
126025903|NCT02201108|453390598|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
126025904|NCT02201108|453390599|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
126025905|NCT02201108|453390600|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
126025906|NCT02201108|453390598|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
126025907|NCT02201108|453390599|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
126025908|NCT02201108|453390600|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
126025909|NCT02201108|453390598|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
126025910|NCT02201108|453390599|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
126025911|NCT02201108|453390600|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
126025912|NCT02201108|453390598|FG000|Open Label Period (up to Week 192)|Other reason|4|||
126025913|NCT02201108|453390599|FG001|Open Label Period (up to Week 192)|Other reason|7|||
126025914|NCT02201108|453390600|FG002|Open Label Period (up to Week 192)|Other reason|0|||
126025915|NCT02201108|453390598|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
126025916|NCT02201108|453390599|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
126025917|NCT02201108|453390600|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
126025918|NCT02201108|453390598|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
126025919|NCT02201108|453390599|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
126025920|NCT02201108|453390600|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
126093753|NCT03682302|453636155|FG002|Overall Study|Study drug was not administered|1|||
126093754|NCT03682302|453636156|FG003|Overall Study|Study drug was not administered|1|||
126240166|NCT00667862|454173894|FG000|Overall Study|Withdrawal by Subject|3|||
126240167|NCT02495857|454173896|FG000|Overall Study|Adverse Event|5|||
126240168|NCT02495857|454173897|FG001|Overall Study|Adverse Event|0|||
126240169|NCT02495857|454173898|FG002|Overall Study|Adverse Event|1|||
126240170|NCT02495857|454173896|FG000|Overall Study|Withdrawal by Subject|9|||
126240171|NCT02495857|454173897|FG001|Overall Study|Withdrawal by Subject|6|||
126240172|NCT02495857|454173898|FG002|Overall Study|Withdrawal by Subject|10|||
126240173|NCT02495857|454173896|FG000|Overall Study|Physician Decision|0|||
126240174|NCT02495857|454173897|FG001|Overall Study|Physician Decision|1|||
126240175|NCT02495857|454173898|FG002|Overall Study|Physician Decision|0|||
126240176|NCT02495857|454173896|FG000|Overall Study|Protocol Violation|1|||
126240177|NCT02495857|454173897|FG001|Overall Study|Protocol Violation|1|||
126240178|NCT02495857|454173898|FG002|Overall Study|Protocol Violation|2|||
126240179|NCT02495857|454173896|FG000|Overall Study|Lost to Follow-up|4|||
126240180|NCT02495857|454173897|FG001|Overall Study|Lost to Follow-up|5|||
126240181|NCT02495857|454173898|FG002|Overall Study|Lost to Follow-up|3|||
126240182|NCT02495857|454173896|FG000|Overall Study|Other|3|||
126240183|NCT02495857|454173897|FG001|Overall Study|Other|3|||
126240184|NCT02495857|454173898|FG002|Overall Study|Other|2|||
126240185|NCT01435265|454173900|FG000|Overall Study|Lost to Follow-up|0|||
126240186|NCT01435265|454173901|FG001|Overall Study|Lost to Follow-up|1|||
126240187|NCT04605094|454173902|FG000|Overall Study|Adverse Event|2|||
126240188|NCT04605094|454173903|FG001|Overall Study|Adverse Event|2|||
126240189|NCT04605094|454173902|FG000|Overall Study|Lost to Follow-up|1|||
126240190|NCT04605094|454173903|FG001|Overall Study|Lost to Follow-up|4|||
126240191|NCT04605094|454173902|FG000|Overall Study|Physician Decision|2|||
126240192|NCT04605094|454173903|FG001|Overall Study|Physician Decision|2|||
126240193|NCT04605094|454173902|FG000|Overall Study|Study terminated by Sponsor|31|||
126240194|NCT04605094|454173903|FG001|Overall Study|Study terminated by Sponsor|33|||
126240195|NCT04605094|454173902|FG000|Overall Study|Withdrawal by Subject|22|||
125878746|NCT03175367|452853401|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125878747|NCT03175367|452853402|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125878748|NCT03175367|452853403|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
125878749|NCT03175367|452853404|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
125878750|NCT03175367|452853405|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
125878751|NCT03175367|452853406|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125878752|NCT03175367|452853407|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125878753|NCT03175367|452853401|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125878754|NCT03175367|452853402|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125878755|NCT03175367|452853403|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
125878756|NCT03175367|452853404|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
125878757|NCT03175367|452853405|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125878758|NCT03175367|452853406|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125878759|NCT03175367|452853407|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125878760|NCT03175367|452853401|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
125878761|NCT03175367|452853402|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
125878762|NCT03175367|452853403|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
125878763|NCT03175367|452853404|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
125878764|NCT03175367|452853405|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125878765|NCT03175367|452853406|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125878766|NCT03175367|452853407|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125878767|NCT03175367|452853401|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125878768|NCT03175367|452853402|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125878769|NCT03175367|452853403|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
125878770|NCT03175367|452853404|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125878771|NCT03175367|452853405|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
125878772|NCT03175367|452853406|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125878773|NCT03175367|452853407|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125878774|NCT03175367|452853401|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125878775|NCT03175367|452853402|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125878776|NCT03175367|452853403|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125878777|NCT03175367|452853404|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125878778|NCT03175367|452853405|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125878779|NCT03175367|452853406|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125878780|NCT03175367|452853407|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
125878781|NCT03175367|452853401|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878782|NCT03175367|452853402|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878783|NCT03175367|452853403|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878784|NCT03175367|452853404|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878785|NCT03175367|452853405|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125878786|NCT03175367|452853406|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
125878787|NCT03175367|452853407|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
125878788|NCT02151058|452853408|FG000|Overall Study|Withdrawal by Subject|1|||
125878789|NCT02151058|452853409|FG001|Overall Study|Withdrawal by Subject|1|||
125878790|NCT02151058|452853410|FG002|Overall Study|Withdrawal by Subject|3|||
125878791|NCT02151058|452853408|FG000|Overall Study|Lost to Follow-up|1|||
125878792|NCT02151058|452853409|FG001|Overall Study|Lost to Follow-up|0|||
125878793|NCT02151058|452853410|FG002|Overall Study|Lost to Follow-up|2|||
125878794|NCT03181932|452853412|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
125878795|NCT03181932|452853413|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
125878796|NCT03181932|452853412|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
126025921|NCT02201108|453390598|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
126025922|NCT02201108|453390599|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
126025923|NCT02201108|453390600|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
126025924|NCT03055377|453390610|FG000|Treatment Phase|Lost to Follow-up|28|||
126240196|NCT04605094|454173903|FG001|Overall Study|Withdrawal by Subject|19|||
126356738|NCT03259308|454597915|FG000|Overall Study|Withdrawal by Subject|2|||
126240197|NCT04605094|454173902|FG000|Overall Study|Other|1|||
126240198|NCT04605094|454173903|FG001|Overall Study|Other|1|||
126240199|NCT02724462|454173904|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
126240200|NCT02724462|454173905|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
126240201|NCT02724462|454173904|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
126240202|NCT02724462|454173905|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
126240203|NCT02724462|454173904|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
126240204|NCT02724462|454173905|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
126356739|NCT03259308|454597916|FG001|Overall Study|Withdrawal by Subject|1|||
126356740|NCT03259308|454597917|FG002|Overall Study|Withdrawal by Subject|3|||
126240205|NCT02724462|454173904|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
126240206|NCT02724462|454173905|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
126240207|NCT02724462|454173904|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
126240208|NCT02724462|454173905|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
126240209|NCT02724462|454173904|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
126240210|NCT02724462|454173905|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
126240211|NCT01900691|454173906|FG000|Overall Study|Death|7|||
126240212|NCT01900691|454173906|FG000|Overall Study|Lost to Follow-up|4|||
126240213|NCT01900691|454173906|FG000|Overall Study|Study Device Not Placed|3|||
126240214|NCT01900691|454173906|FG000|Overall Study|Non study stent placed|2|||
126240215|NCT01900691|454173906|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
126240216|NCT01900691|454173906|FG000|Overall Study|Complete stent migration through digestive tract|1|||
126240217|NCT02128997|454173914|FG000|Overall Study|Lost to Follow-up|6|||
126240218|NCT02128997|454173915|FG001|Overall Study|Lost to Follow-up|11|||
126240219|NCT00851877|454173921|FG000|Phase I-1|Death|1|||
126240220|NCT00851877|454173922|FG001|Phase I-1|Death|0|||
126240221|NCT00851877|454173923|FG002|Phase I-1|Death|0|||
126240222|NCT00851877|454173921|FG000|Phase II|Withdrawal by Subject|0|||
126240223|NCT00851877|454173922|FG001|Phase II|Withdrawal by Subject|0|||
126240224|NCT00851877|454173923|FG002|Phase II|Withdrawal by Subject|3|||
126240225|NCT03450057|454173924|FG000|Overall Study|Death|17|||
126240226|NCT03450057|454173924|FG000|Overall Study|ICF withdrawal|4|||
126240227|NCT03450057|454173924|FG000|Overall Study|Lost to Follow-up|2|||
126240228|NCT02246166|454173925|FG000|Overall Study|Protocol Violation|1|||
126240229|NCT02246166|454173926|FG001|Overall Study|Protocol Violation|0|||
126240230|NCT01185548|454173929|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
126240231|NCT02678286|454173930|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
126240232|NCT02678286|454173931|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
126240233|NCT02678286|454173930|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
126240234|NCT02678286|454173931|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
126240235|NCT02678286|454173930|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
126240236|NCT02678286|454173931|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
126240237|NCT02678286|454173930|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
126240238|NCT02678286|454173931|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
126240239|NCT02678286|454173930|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
126240240|NCT02678286|454173931|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
126240241|NCT02331394|454173932|FG000|Overall Study|Disease progression|1|||
126240242|NCT01313273|454173933|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
126240243|NCT01313273|454173934|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
126240244|NCT01313273|454173933|FG000|Overall Study|Withdrawal by Subject|1|||
126240245|NCT01313273|454173934|FG001|Overall Study|Withdrawal by Subject|0|||
126240246|NCT01313273|454173933|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
126240247|NCT01313273|454173934|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
126240248|NCT03687736|454173935|FG000|Overall Study|Lost to Follow-up|7|||
126240249|NCT03687736|454173935|FG000|Overall Study|Withdrawal by Subject|3|||
126240250|NCT01270503|454173936|FG000|Overall Study|Lost to Follow-up|1|||
126240251|NCT02459951|454173937|FG000|Overall Study|Unable to meet holding requirement|1|||
126240252|NCT02481830|454173941|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
126240253|NCT02481830|454173942|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
126240254|NCT02481830|454173941|FG000|Pre-treatment|Withdrawal by Subject|0|||
126240255|NCT02481830|454173942|FG001|Pre-treatment|Withdrawal by Subject|10|||
126240256|NCT02481830|454173941|FG000|Pre-treatment|Disease Progression|1|||
126240257|NCT02481830|454173942|FG001|Pre-treatment|Disease Progression|1|||
126240258|NCT02481830|454173941|FG000|Pre-treatment|Other reasons|0|||
126240259|NCT02481830|454173942|FG001|Pre-treatment|Other reasons|1|||
126240260|NCT02481830|454173941|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
126240261|NCT02481830|454173942|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
126240262|NCT02481830|454173941|FG000|Treatment|Disease Progression|233|||
126240263|NCT02481830|454173942|FG001|Treatment|Disease Progression|171|||
126240264|NCT02481830|454173941|FG000|Treatment|Study drug toxicity|18|||
126240265|NCT02481830|454173942|FG001|Treatment|Study drug toxicity|38|||
126240266|NCT02481830|454173941|FG000|Treatment|Death|1|||
126240267|NCT02481830|454173942|FG001|Treatment|Death|1|||
126240268|NCT02481830|454173941|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
126240269|NCT02481830|454173942|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
126025925|NCT03055377|453390611|FG001|Treatment Phase|Lost to Follow-up|24|||
126240270|NCT02481830|454173941|FG000|Treatment|Participants request to discontinue Study treatment|6|||
126240271|NCT02481830|454173942|FG001|Treatment|Participants request to discontinue Study treatment|34|||
126240272|NCT02481830|454173941|FG000|Treatment|Withdrawal by Subject|2|||
126240273|NCT02481830|454173942|FG001|Treatment|Withdrawal by Subject|3|||
126240274|NCT02481830|454173941|FG000|Treatment|Lost to Follow-up|1|||
126240275|NCT02481830|454173942|FG001|Treatment|Lost to Follow-up|0|||
126356741|NCT03259308|454597915|FG000|Overall Study|Lost to Follow-up|0|||
126240276|NCT02481830|454173941|FG000|Treatment|Maximum Clinical Benefit|0|||
126240277|NCT02481830|454173942|FG001|Treatment|Maximum Clinical Benefit|5|||
126240278|NCT02481830|454173941|FG000|Treatment|Administrative reason by sponsor|1|||
126240279|NCT02481830|454173942|FG001|Treatment|Administrative reason by sponsor|1|||
126240280|NCT02481830|454173941|FG000|Treatment|Other reasons|6|||
126240281|NCT02481830|454173942|FG001|Treatment|Other reasons|1|||
126240282|NCT00102440|454173943|FG000|Overall Study|Lost to Follow-up|25|||
126240283|NCT00102440|454173944|FG001|Overall Study|Lost to Follow-up|18|||
126240284|NCT00102440|454173945|FG002|Overall Study|Lost to Follow-up|21|||
126240285|NCT00102440|454173943|FG000|Overall Study|Adverse Event|16|||
126240286|NCT00102440|454173944|FG001|Overall Study|Adverse Event|23|||
126240287|NCT00102440|454173945|FG002|Overall Study|Adverse Event|8|||
126240288|NCT00102440|454173943|FG000|Overall Study|Gout Flare|10|||
126240289|NCT00102440|454173944|FG001|Overall Study|Gout Flare|28|||
126240290|NCT00102440|454173945|FG002|Overall Study|Gout Flare|9|||
126240291|NCT00102440|454173943|FG000|Overall Study|Personal Reason(s)|19|||
126240292|NCT00102440|454173944|FG001|Overall Study|Personal Reason(s)|13|||
126240293|NCT00102440|454173945|FG002|Overall Study|Personal Reason(s)|13|||
126240294|NCT00102440|454173943|FG000|Overall Study|Other|11|||
126240295|NCT00102440|454173944|FG001|Overall Study|Other|14|||
126240296|NCT00102440|454173945|FG002|Overall Study|Other|14|||
126240297|NCT00102440|454173943|FG000|Overall Study|Protocol Violation|7|||
126240298|NCT00102440|454173944|FG001|Overall Study|Protocol Violation|2|||
126240299|NCT00102440|454173945|FG002|Overall Study|Protocol Violation|1|||
126240300|NCT04627038|454173946|FG000|Overall Study|Adverse Event|36|||
126240301|NCT04627038|454173947|FG001|Overall Study|Adverse Event|8|||
126240302|NCT04627038|454173946|FG000|Overall Study|Lost to Follow-up|1|||
126240303|NCT04627038|454173947|FG001|Overall Study|Lost to Follow-up|0|||
126240304|NCT04627038|454173946|FG000|Overall Study|Physician Decision|0|||
126240305|NCT04627038|454173947|FG001|Overall Study|Physician Decision|1|||
126240306|NCT04627038|454173946|FG000|Overall Study|Protocol Violation|3|||
126240307|NCT04627038|454173947|FG001|Overall Study|Protocol Violation|1|||
126240308|NCT04627038|454173946|FG000|Overall Study|Withdrawal by Subject|13|||
126240309|NCT04627038|454173947|FG001|Overall Study|Withdrawal by Subject|3|||
126240310|NCT04627038|454173946|FG000|Overall Study|Non-compliance with study drug|0|||
126240311|NCT04627038|454173947|FG001|Overall Study|Non-compliance with study drug|1|||
126240312|NCT04627038|454173946|FG000|Overall Study|Prohibited Concomitant Medication|1|||
126240313|NCT04627038|454173947|FG001|Overall Study|Prohibited Concomitant Medication|0|||
126240314|NCT02255097|454173948|FG000|Overall Study|Death|151|||
126240315|NCT02255097|454173948|FG000|Overall Study|Lost to Follow-up|5|||
126240316|NCT02255097|454173948|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
126240317|NCT02255097|454173948|FG000|Overall Study|Withdrawal by Subject|7|||
126240318|NCT02255097|454173948|FG000|Overall Study|Allocated but not treated|1|||
126240319|NCT01010542|454173950|FG000|Overall Study|Adverse Event|0|||
126240320|NCT01010542|454173951|FG001|Overall Study|Adverse Event|1|||
126240321|NCT01010542|454173952|FG002|Overall Study|Adverse Event|0|||
126240322|NCT01010542|454173950|FG000|Overall Study|Lost to Follow-up|0|||
126240323|NCT01010542|454173951|FG001|Overall Study|Lost to Follow-up|1|||
126240324|NCT01010542|454173952|FG002|Overall Study|Lost to Follow-up|0|||
126240325|NCT01010542|454173950|FG000|Overall Study|Withdrawal by Subject|0|||
126240326|NCT01010542|454173951|FG001|Overall Study|Withdrawal by Subject|3|||
126240327|NCT01010542|454173952|FG002|Overall Study|Withdrawal by Subject|2|||
126240328|NCT01745120|454173957|FG000|Overall Study|Investigator decision|1|||
126240329|NCT01745120|454173958|FG001|Overall Study|Investigator decision|0|||
126240330|NCT03956862|454173959|FG000|Overall Study|Lost to Follow-up|1|||
126240331|NCT03956862|454173960|FG001|Overall Study|Lost to Follow-up|1|||
126240332|NCT03956862|454173959|FG000|Overall Study|Withdrawal by Subject|1|||
126240333|NCT03956862|454173960|FG001|Overall Study|Withdrawal by Subject|1|||
126240334|NCT00579670|454173963|FG000|Overall Study|Death|1|||
126240335|NCT00579670|454173964|FG001|Overall Study|Death|0|||
126240336|NCT00579670|454173965|FG002|Overall Study|Death|0|||
126240337|NCT00579670|454173966|FG003|Overall Study|Death|0|||
126240338|NCT00579670|454173967|FG004|Overall Study|Death|0|||
126240339|NCT00579670|454173963|FG000|Overall Study|Adverse Event|1|||
126240340|NCT00579670|454173964|FG001|Overall Study|Adverse Event|0|||
126240341|NCT00579670|454173965|FG002|Overall Study|Adverse Event|1|||
126240342|NCT00579670|454173966|FG003|Overall Study|Adverse Event|2|||
126240343|NCT00579670|454173967|FG004|Overall Study|Adverse Event|0|||
126240344|NCT00579670|454173963|FG000|Overall Study|Lack of Efficacy|0|||
126240345|NCT00579670|454173964|FG001|Overall Study|Lack of Efficacy|0|||
126240346|NCT00579670|454173965|FG002|Overall Study|Lack of Efficacy|1|||
126240347|NCT00579670|454173966|FG003|Overall Study|Lack of Efficacy|14|||
126240348|NCT00579670|454173967|FG004|Overall Study|Lack of Efficacy|0|||
126240349|NCT00579670|454173963|FG000|Overall Study|Lost to Follow-up|0|||
126240350|NCT00579670|454173964|FG001|Overall Study|Lost to Follow-up|1|||
126240351|NCT00579670|454173965|FG002|Overall Study|Lost to Follow-up|0|||
126240352|NCT00579670|454173966|FG003|Overall Study|Lost to Follow-up|4|||
126240353|NCT00579670|454173967|FG004|Overall Study|Lost to Follow-up|0|||
126240354|NCT00579670|454173963|FG000|Overall Study|Other|0|||
126240355|NCT00579670|454173964|FG001|Overall Study|Other|0|||
126240356|NCT00579670|454173965|FG002|Overall Study|Other|1|||
126240357|NCT00579670|454173966|FG003|Overall Study|Other|2|||
126240358|NCT00579670|454173967|FG004|Overall Study|Other|0|||
126240359|NCT00579670|454173963|FG000|Overall Study|Withdrawal by Subject|0|||
126240360|NCT00579670|454173964|FG001|Overall Study|Withdrawal by Subject|0|||
126240361|NCT00579670|454173965|FG002|Overall Study|Withdrawal by Subject|1|||
126240362|NCT00579670|454173966|FG003|Overall Study|Withdrawal by Subject|0|||
126240363|NCT00579670|454173967|FG004|Overall Study|Withdrawal by Subject|0|||
126240364|NCT00850174|454173971|FG000|Washout: One Week|Withdrawal by Subject|0|||
126240365|NCT00850174|454173972|FG001|Washout: One Week|Withdrawal by Subject|2|||
126240366|NCT00850174|454173971|FG000|Second Intervention|Withdrawal by Subject|1|||
126240367|NCT00850174|454173972|FG001|Second Intervention|Withdrawal by Subject|0|||
126240368|NCT01363765|454173973|FG000|Overall Study|non-diagnostic|2621|||
126240369|NCT01363765|454173974|FG001|Overall Study|non-diagnostic|1124|||
126240370|NCT01363765|454173973|FG000|Overall Study|duplicate records|736|||
125878797|NCT03181932|452853413|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
125878798|NCT03181932|452853412|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
125878799|NCT03181932|452853413|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
125878800|NCT03181932|452853412|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
125878801|NCT03181932|452853413|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
125878802|NCT03181932|452853412|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
125878803|NCT03181932|452853413|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
125878804|NCT03181932|452853412|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
125878805|NCT03181932|452853413|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
125878806|NCT03181932|452853412|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
125878807|NCT03181932|452853413|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
125878808|NCT03181932|452853412|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
125878809|NCT03181932|452853413|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
125878810|NCT03181932|452853412|FG000|Period 2 (Open-label Period)|Reason missing|2|||
125878811|NCT03181932|452853413|FG001|Period 2 (Open-label Period)|Reason missing|0|||
125878812|NCT00853307|452853414|FG000|Overall Study|Adverse Event|1|||
125878813|NCT00853307|452853415|FG001|Overall Study|Adverse Event|2|||
125878814|NCT00853307|452853414|FG000|Overall Study|Withdrawal by Subject|1|||
125878815|NCT00853307|452853415|FG001|Overall Study|Withdrawal by Subject|2|||
125878816|NCT00853307|452853414|FG000|Overall Study|Reason Not Specified|0|||
125878817|NCT00853307|452853415|FG001|Overall Study|Reason Not Specified|1|||
125878818|NCT00674817|452853416|FG000|Period 1|Withdrawal by Subject|2|||
125878819|NCT00674817|452853416|FG000|Period 1|Protocol Violation|1|||
125878820|NCT00674817|452853416|FG000|Period 3|Adverse Event|1|||
125878821|NCT00674817|452853416|FG000|Period 3|Protocol Violation|1|||
125878822|NCT00674817|452853416|FG000|Period 4|Adverse Event|1|||
125878823|NCT01112917|452853417|FG000|Overall Study|Death|2|||
125878824|NCT01112917|452853418|FG001|Overall Study|Death|11|||
125878825|NCT01112917|452853417|FG000|Overall Study|Lost to Follow-up|1|||
125878826|NCT01112917|452853418|FG001|Overall Study|Lost to Follow-up|1|||
125878827|NCT01112917|452853417|FG000|Overall Study|Withdrawal by Subject|1|||
125878828|NCT01112917|452853418|FG001|Overall Study|Withdrawal by Subject|3|||
125878829|NCT01112917|452853417|FG000|Overall Study|Unable to Convert Filter|3|||
125878830|NCT01112917|452853418|FG001|Overall Study|Unable to Convert Filter|0|||
125878831|NCT02177123|452853419|FG000|Overall Study|Lost to Follow-up|6|||
125878832|NCT02177123|452853419|FG000|Overall Study|Withdrawal by Subject|4|||
126025926|NCT03055377|453390610|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
126240371|NCT01363765|454173974|FG001|Overall Study|duplicate records|3177|||
126240372|NCT01363765|454173973|FG000|Overall Study|non-resident|156|||
126240373|NCT01363765|454173974|FG001|Overall Study|non-resident|76|||
126240374|NCT01363765|454173973|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
126240375|NCT01363765|454173974|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
126240376|NCT01363765|454173973|FG000|Overall Study|smear during intervention|2170|||
126240377|NCT01363765|454173974|FG001|Overall Study|smear during intervention|0|||
126240378|NCT01900626|454173975|FG000|Overall Study|study was closed due to low enrollment|1|||
126240379|NCT01900626|454173976|FG001|Overall Study|study was closed due to low enrollment|1|||
126240380|NCT00635492|454173977|FG000|Overall Study|Death|12|||
126240381|NCT00635492|454173978|FG001|Overall Study|Death|40|||
126240382|NCT00635492|454173977|FG000|Overall Study|Lost to Follow-up|151|||
126240383|NCT00635492|454173978|FG001|Overall Study|Lost to Follow-up|172|||
126240384|NCT00635492|454173977|FG000|Overall Study|Physician Decision|32|||
126240385|NCT00635492|454173978|FG001|Overall Study|Physician Decision|22|||
126240386|NCT00635492|454173977|FG000|Overall Study|Sponsor decision|2|||
126240387|NCT00635492|454173978|FG001|Overall Study|Sponsor decision|3|||
126240388|NCT00635492|454173977|FG000|Overall Study|Withdrawal by Subject|82|||
126240389|NCT00635492|454173978|FG001|Overall Study|Withdrawal by Subject|45|||
126240390|NCT01702987|454173979|FG000|Overall Study|Withdrawal by Subject|1|||
126240391|NCT01702987|454173980|FG001|Overall Study|Withdrawal by Subject|0|||
126240392|NCT02017223|454173981|FG000|Overall Study|Algorithm problems|2|||
126240393|NCT04263649|454173983|FG000|Overall Study|Adverse Event|53|||
126240394|NCT04263649|454173983|FG000|Overall Study|Lost to Follow-up|3|||
126240395|NCT04263649|454173983|FG000|Overall Study|Death|29|||
126240396|NCT04263649|454173983|FG000|Overall Study|Device deficiency|19|||
126240397|NCT04263649|454173983|FG000|Overall Study|other reasons|11|||
126240398|NCT05169710|454173984|FG000|Overall Study|Adverse Event|1|||
126240399|NCT05169710|454173985|FG001|Overall Study|Adverse Event|2|||
125878833|NCT02177123|452853419|FG000|Overall Study|Adverse Event|4|||
125878834|NCT02177123|452853419|FG000|Overall Study|Physician Decision|3|||
125878835|NCT02177123|452853419|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
125878836|NCT02177123|452853419|FG000|Overall Study|Excluded for medical reasons|2|||
125878837|NCT02177123|452853419|FG000|Overall Study|Death|1|||
125878838|NCT02177123|452853419|FG000|Overall Study|Other|1|||
126025927|NCT03055377|453390611|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
126240400|NCT05169710|454173986|FG002|Overall Study|Adverse Event|2|||
126240401|NCT05169710|454173984|FG000|Overall Study|Lost to Follow-up|0|||
126240402|NCT05169710|454173985|FG001|Overall Study|Lost to Follow-up|0|||
126025928|NCT05215847|453390612|FG000|Overall Study|Lost to Follow-up|1|||
126025929|NCT04143061|453390614|FG000|Overall Study|Protocol Deviation|0|||
126025930|NCT04143061|453390615|FG001|Overall Study|Protocol Deviation|0|||
126025931|NCT04143061|453390616|FG002|Overall Study|Protocol Deviation|0|||
126025932|NCT04143061|453390617|FG003|Overall Study|Protocol Deviation|0|||
126240403|NCT05169710|454173986|FG002|Overall Study|Lost to Follow-up|1|||
126240404|NCT05169710|454173984|FG000|Overall Study|Withdrawal by Subject|2|||
126240405|NCT05169710|454173985|FG001|Overall Study|Withdrawal by Subject|1|||
126240406|NCT05169710|454173986|FG002|Overall Study|Withdrawal by Subject|0|||
126240407|NCT05169710|454173984|FG000|Overall Study|Other Study Discontinuation Reason|0|||
126240408|NCT05169710|454173985|FG001|Overall Study|Other Study Discontinuation Reason|2|||
126240409|NCT05169710|454173986|FG002|Overall Study|Other Study Discontinuation Reason|0|||
126240410|NCT00846495|454173991|FG000|Overall Study|Lost to Follow-up|1|||
126240411|NCT00846495|454173992|FG001|Overall Study|Lost to Follow-up|0|||
126240412|NCT00846495|454173991|FG000|Overall Study|Adverse Event|5|||
126240413|NCT00846495|454173992|FG001|Overall Study|Adverse Event|1|||
126240414|NCT00846495|454173991|FG000|Overall Study|Lack of Efficacy|1|||
126240415|NCT00846495|454173992|FG001|Overall Study|Lack of Efficacy|2|||
126240416|NCT00846495|454173991|FG000|Overall Study|Physician Decision|1|||
126240417|NCT00846495|454173992|FG001|Overall Study|Physician Decision|0|||
126240418|NCT01686438|454173993|FG000|Overall Study|Lost to Follow-up|8|||
126240419|NCT01686438|454173994|FG001|Overall Study|Lost to Follow-up|9|||
126240420|NCT01686438|454173995|FG002|Overall Study|Lost to Follow-up|10|||
126240421|NCT01686438|454173993|FG000|Overall Study|Adverse Event|0|||
126240422|NCT01686438|454173994|FG001|Overall Study|Adverse Event|0|||
126240423|NCT01686438|454173995|FG002|Overall Study|Adverse Event|1|||
126240424|NCT01686438|454173993|FG000|Overall Study|Protocol Violation|0|||
126240425|NCT01686438|454173994|FG001|Overall Study|Protocol Violation|0|||
126240426|NCT01686438|454173995|FG002|Overall Study|Protocol Violation|1|||
126240427|NCT01686438|454173993|FG000|Overall Study|Withdrawal by Subject|0|||
126240428|NCT01686438|454173994|FG001|Overall Study|Withdrawal by Subject|0|||
126240429|NCT01686438|454173995|FG002|Overall Study|Withdrawal by Subject|1|||
126240430|NCT01265056|454173998|FG000|Initial Study Period|Withdrawal by Subject|1|||
126240431|NCT01265056|454173999|FG001|Initial Study Period|Withdrawal by Subject|1|||
126240432|NCT01265056|454173998|FG000|Initial Study Period|Withdrawal by Subject|1|||
126240433|NCT01265056|454173999|FG001|Initial Study Period|Withdrawal by Subject|1|||
126240434|NCT01265056|454173998|FG000|Follow up|Lost to Follow-up|7|||
126240435|NCT01265056|454173999|FG001|Follow up|Lost to Follow-up|3|||
126240436|NCT02601560|454174000|FG000|Overall Study|Other|0|||
126240437|NCT02601560|454174001|FG001|Overall Study|Other|0|||
126240438|NCT02601560|454174002|FG002|Overall Study|Other|0|||
126240439|NCT02601560|454174003|FG003|Overall Study|Other|0|||
126240440|NCT02601560|454174004|FG004|Overall Study|Other|0|||
126240441|NCT02601560|454174005|FG005|Overall Study|Other|0|||
126240442|NCT02601560|454174006|FG006|Overall Study|Other|1|||
126240443|NCT02601560|454174007|FG007|Overall Study|Other|0|||
126240444|NCT03500692|454174011|FG000|Overall Study|Death|163|||
126240445|NCT03500692|454174011|FG000|Overall Study|Lost to Follow-up|75|||
126240446|NCT03500692|454174011|FG000|Overall Study|Termination Reasons|3|||
126240447|NCT01880593|454174012|FG000|Overall Study|Adverse Event|1|||
126240448|NCT01880593|454174013|FG001|Overall Study|Adverse Event|0|||
126240449|NCT01880593|454174012|FG000|Overall Study|Lack of Efficacy|1|||
126240450|NCT01880593|454174013|FG001|Overall Study|Lack of Efficacy|5|||
126240451|NCT01880593|454174012|FG000|Overall Study|Withdrawal by Subject|6|||
126240452|NCT01880593|454174013|FG001|Overall Study|Withdrawal by Subject|1|||
126240453|NCT02272777|454174014|FG000|Overall Study|Adverse Event|0|||
126240454|NCT02272777|454174015|FG001|Overall Study|Adverse Event|1|||
126240455|NCT02272777|454174014|FG000|Overall Study|Withdrawal by Subject|0|||
126240456|NCT02272777|454174015|FG001|Overall Study|Withdrawal by Subject|3|||
126240457|NCT02272777|454174014|FG000|Overall Study|Lost to Follow-up|2|||
126025933|NCT04143061|453390618|FG004|Overall Study|Protocol Deviation|0|||
126025934|NCT04143061|453390619|FG005|Overall Study|Protocol Deviation|0|||
126093755|NCT05051462|453636157|FG000|Overall Study|Lost to Follow-up|1|||
126093756|NCT05051462|453636158|FG001|Overall Study|Lost to Follow-up|8|||
126025935|NCT04143061|453390620|FG006|Overall Study|Protocol Deviation|5|||
126025936|NCT04143061|453390621|FG007|Overall Study|Protocol Deviation|5|||
126093757|NCT05051462|453636157|FG000|Overall Study|Withdrawal by Subject|1|||
126093758|NCT05051462|453636158|FG001|Overall Study|Withdrawal by Subject|0|||
126240458|NCT02272777|454174015|FG001|Overall Study|Lost to Follow-up|0|||
126240459|NCT02272777|454174014|FG000|Overall Study|Other|2|||
126240460|NCT02272777|454174015|FG001|Overall Study|Other|0|||
126240461|NCT05275205|454174016|FG000|Overall Study|Adverse Event|1|||
126240462|NCT05275205|454174017|FG001|Overall Study|Adverse Event|2|||
126240463|NCT05275205|454174016|FG000|Overall Study|Physician Decision|1|||
126240464|NCT05275205|454174017|FG001|Overall Study|Physician Decision|1|||
126240465|NCT05275205|454174016|FG000|Overall Study|Withdrawal by Subject|2|||
126240466|NCT05275205|454174017|FG001|Overall Study|Withdrawal by Subject|3|||
126240467|NCT05275205|454174016|FG000|Overall Study|Death|1|||
126240468|NCT05275205|454174017|FG001|Overall Study|Death|0|||
126240469|NCT05275205|454174016|FG000|Overall Study|Patient unable to attend visits|1|||
126240470|NCT05275205|454174017|FG001|Overall Study|Patient unable to attend visits|0|||
126240471|NCT02066922|454174018|FG000|Overall Study|Adverse Event|1|||
126240472|NCT00440297|454174019|FG000|Overall Study|Adverse Event|8|||
126240473|NCT00440297|454174020|FG001|Overall Study|Adverse Event|5|||
126240474|NCT00440297|454174019|FG000|Overall Study|Lost to Follow-up|1|||
126240475|NCT00440297|454174020|FG001|Overall Study|Lost to Follow-up|0|||
126240476|NCT00440297|454174019|FG000|Overall Study|Physician Decision|1|||
126240477|NCT00440297|454174020|FG001|Overall Study|Physician Decision|0|||
126240478|NCT00440297|454174019|FG000|Overall Study|Protocol Violation|11|||
126240479|NCT00440297|454174020|FG001|Overall Study|Protocol Violation|7|||
126240480|NCT00440297|454174019|FG000|Overall Study|Withdrawal by Subject|1|||
126240481|NCT00440297|454174020|FG001|Overall Study|Withdrawal by Subject|6|||
126356742|NCT03259308|454597916|FG001|Overall Study|Lost to Follow-up|0|||
126356743|NCT03259308|454597917|FG002|Overall Study|Lost to Follow-up|1|||
126356744|NCT03259308|454597915|FG000|Overall Study|Pregnancy|0|||
126356745|NCT03259308|454597916|FG001|Overall Study|Pregnancy|0|||
126356746|NCT03259308|454597917|FG002|Overall Study|Pregnancy|1|||
126356747|NCT03259308|454597915|FG000|Overall Study|Protocol Deviation|0|||
126356748|NCT03259308|454597916|FG001|Overall Study|Protocol Deviation|3|||
126356749|NCT03259308|454597917|FG002|Overall Study|Protocol Deviation|0|||
126356750|NCT03259308|454597915|FG000|Overall Study|Lack of Efficacy|0|||
126356751|NCT03259308|454597916|FG001|Overall Study|Lack of Efficacy|0|||
126356752|NCT03259308|454597917|FG002|Overall Study|Lack of Efficacy|1|||
126356753|NCT00694122|454597918|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
126356754|NCT00694122|454597919|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
126356755|NCT00694122|454597918|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
126356756|NCT00694122|454597919|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
126356757|NCT00694122|454597918|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
126356758|NCT00694122|454597919|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
126356759|NCT01727154|454597922|FG000|Overall Study|Death|17|||
126356760|NCT01727154|454597922|FG000|Overall Study|Withdrawal by Subject|14|||
126356761|NCT01727154|454597922|FG000|Overall Study|Subject Withdrew Consent|18|||
126356762|NCT01727154|454597922|FG000|Overall Study|Study Terminated|6|||
126356763|NCT01727154|454597922|FG000|Overall Study|No Discontinuation Documentation|4|||
126356764|NCT00003474|454597923|FG000|Overall Study|Not Evaluable|14|||
126356765|NCT03020888|454597926|FG000|Overall Study|Physician Decision|4|||
126356766|NCT03020888|454597926|FG000|Overall Study|Withdrawal by Subject|6|||
126356767|NCT03020888|454597926|FG000|Overall Study|Insurance coverage|2|||
126356768|NCT03020888|454597926|FG000|Overall Study|Lost to Follow-up|1|||
126356769|NCT01198548|454597933|FG000|Overall Study|Disease Progression|9|||
126356770|NCT01198548|454597933|FG000|Overall Study|Administrative Decision|1|||
126356771|NCT01245062|454597935|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
126356772|NCT01245062|454597936|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
126356773|NCT01245062|454597937|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
126356774|NCT01245062|454597935|FG000|Randomization and Crossover Phase|Physician Decision|2|||
126356775|NCT01245062|454597936|FG001|Randomization and Crossover Phase|Physician Decision|4|||
126356776|NCT01245062|454597937|FG002|Randomization and Crossover Phase|Physician Decision|0|||
126356777|NCT01245062|454597935|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
126356778|NCT01245062|454597936|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
126356779|NCT01245062|454597937|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
126356780|NCT01245062|454597935|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
126356781|NCT01245062|454597936|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
126356782|NCT01245062|454597937|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
126356783|NCT01245062|454597935|FG000|Cross-over Phase|Lost to Follow-up|0|||
126356784|NCT01245062|454597936|FG001|Cross-over Phase|Lost to Follow-up|0|||
126356785|NCT01245062|454597937|FG002|Cross-over Phase|Lost to Follow-up|1|||
126356786|NCT01245062|454597935|FG000|Cross-over Phase|Physician Decision|0|||
126356787|NCT01245062|454597936|FG001|Cross-over Phase|Physician Decision|0|||
126356788|NCT01245062|454597937|FG002|Cross-over Phase|Physician Decision|1|||
126356789|NCT01245062|454597935|FG000|Cross-over Phase|Withdrew Consent|0|||
126356790|NCT01245062|454597936|FG001|Cross-over Phase|Withdrew Consent|0|||
126356791|NCT01245062|454597937|FG002|Cross-over Phase|Withdrew Consent|4|||
126356792|NCT01245062|454597935|FG000|Cross-over Phase|Study closed/ terminated|0|||
126356793|NCT01245062|454597936|FG001|Cross-over Phase|Study closed/ terminated|0|||
126240482|NCT00440297|454174019|FG000|Overall Study|Randomized by mistake|1|||
126025937|NCT04143061|453390614|FG000|Overall Study|Withdrawal by Subject|2|||
126240483|NCT00440297|454174020|FG001|Overall Study|Randomized by mistake|0|||
126240484|NCT02039908|454174023|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
126240485|NCT02039908|454174024|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
126240486|NCT02039908|454174025|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
126240487|NCT02039908|454174026|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
126240488|NCT02039908|454174023|FG000|Phase 1-Summer|Protocol Violation|6|||
126240489|NCT02039908|454174024|FG001|Phase 1-Summer|Protocol Violation|0|||
126240490|NCT02039908|454174025|FG002|Phase 1-Summer|Protocol Violation|0|||
126240491|NCT02039908|454174026|FG003|Phase 1-Summer|Protocol Violation|0|||
126240492|NCT02039908|454174023|FG000|Phase 2-School Year|Lost to Follow-up|0|||
126240493|NCT02039908|454174024|FG001|Phase 2-School Year|Lost to Follow-up|0|||
126240494|NCT02039908|454174025|FG002|Phase 2-School Year|Lost to Follow-up|1|||
126240495|NCT02039908|454174026|FG003|Phase 2-School Year|Lost to Follow-up|3|||
126240496|NCT02039908|454174023|FG000|Phase 2-School Year|Protocol Violation|0|||
126240497|NCT02039908|454174024|FG001|Phase 2-School Year|Protocol Violation|0|||
126240498|NCT02039908|454174025|FG002|Phase 2-School Year|Protocol Violation|3|||
126240499|NCT02039908|454174026|FG003|Phase 2-School Year|Protocol Violation|0|||
126240500|NCT02039908|454174023|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
126240501|NCT02039908|454174024|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
126240502|NCT02039908|454174025|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
126240503|NCT02039908|454174026|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
126240504|NCT06358820|454175625|FG000|Overall Study|Adverse Event|11|||
126240505|NCT06358820|454175625|FG000|Overall Study|kidney transplantation|3|||
126240506|NCT06358820|454175625|FG000|Overall Study|patient voluntary withdrawal|6|||
126240507|NCT06358820|454175625|FG000|Overall Study|Physician Decision|1|||
126240508|NCT01124175|454175626|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
126240509|NCT01124175|454175627|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
126240510|NCT00218257|454175633|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
126240511|NCT00218257|454175634|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
126240512|NCT00462345|454175637|FG000|Overall Study|Withdrawal by Subject|2|||
126240513|NCT00462345|454175637|FG000|Overall Study|Did not complete second course|1|||
126240514|NCT00070291|454175640|FG000|Step 1|Withdrawal by Subject|1|||
126240515|NCT00070291|454175640|FG000|Step 1|Adverse Event|1|||
126240516|NCT00070291|454175640|FG000|Step 2|Adverse Event|1|||
126240517|NCT02028715|454175641|FG000|Overall Study|Adverse Event|2|||
126240518|NCT02028715|454175642|FG001|Overall Study|Adverse Event|2|||
126240519|NCT02028715|454175641|FG000|Overall Study|Physician Decision|1|||
126240520|NCT02028715|454175642|FG001|Overall Study|Physician Decision|0|||
126240521|NCT02028715|454175641|FG000|Overall Study|Did not complete satisfaction surveys|2|||
126240522|NCT02028715|454175642|FG001|Overall Study|Did not complete satisfaction surveys|2|||
126240523|NCT00520130|454175643|FG000|Overall Study|Disease progression on study|4|||
126240524|NCT00520130|454175644|FG001|Overall Study|Disease progression on study|0|||
126240525|NCT00520130|454175643|FG000|Overall Study|Physician Decision|1|||
126240526|NCT00520130|454175644|FG001|Overall Study|Physician Decision|1|||
126240527|NCT01954394|454175647|FG000|Overall Study|Enrolled but not treated|1|||
126240528|NCT01954394|454175648|FG001|Overall Study|Enrolled but not treated|0|||
126240529|NCT01954394|454175647|FG000|Overall Study|Adverse Event|10|||
126240530|NCT01954394|454175648|FG001|Overall Study|Adverse Event|23|||
126240531|NCT01954394|454175647|FG000|Overall Study|Poor compliance to protocol|7|||
126240532|NCT01954394|454175648|FG001|Overall Study|Poor compliance to protocol|7|||
126240533|NCT01954394|454175647|FG000|Overall Study|Participant Moved|0|||
126240534|NCT01954394|454175648|FG001|Overall Study|Participant Moved|4|||
126240535|NCT01954394|454175647|FG000|Overall Study|Related to Study Drug administration|2|||
126240536|NCT01954394|454175648|FG001|Overall Study|Related to Study Drug administration|2|||
126240537|NCT01954394|454175647|FG000|Overall Study|Other than specified above|10|||
126240538|NCT01954394|454175648|FG001|Overall Study|Other than specified above|21|||
126240539|NCT02422264|454175653|FG000|Overall Study|Serious Adverse Event|1|||
126356794|NCT01245062|454597937|FG002|Cross-over Phase|Study closed/ terminated|11|||
126356795|NCT06025695|454597938|FG000|Overall Study|Adverse Event|5|||
126356796|NCT06025695|454597939|FG001|Overall Study|Adverse Event|6|||
126356797|NCT06025695|454597938|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
126356798|NCT06025695|454597939|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
126356799|NCT06025695|454597938|FG000|Overall Study|Other|23|||
126025938|NCT04143061|453390615|FG001|Overall Study|Withdrawal by Subject|0|||
126240540|NCT02422264|454175654|FG001|Overall Study|Serious Adverse Event|0|||
126240541|NCT02422264|454175653|FG000|Overall Study|Withdrawal by Subject|1|||
126356800|NCT06025695|454597939|FG001|Overall Study|Other|19|||
126356801|NCT06025695|454597938|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
126240542|NCT02422264|454175654|FG001|Overall Study|Withdrawal by Subject|2|||
126240543|NCT02422264|454175653|FG000|Overall Study|Migrated/moved from study area|3|||
126240544|NCT02422264|454175654|FG001|Overall Study|Migrated/moved from study area|1|||
126240545|NCT02422264|454175653|FG000|Overall Study|Subject vaccinated outside of the study|0|||
126240546|NCT02422264|454175654|FG001|Overall Study|Subject vaccinated outside of the study|1|||
126240547|NCT03874715|454175655|FG000|Overall Study|Adverse Event|2|||
126240548|NCT03874715|454175656|FG001|Overall Study|Adverse Event|0|||
126025939|NCT04143061|453390616|FG002|Overall Study|Withdrawal by Subject|0|||
126025940|NCT04143061|453390617|FG003|Overall Study|Withdrawal by Subject|0|||
126025941|NCT04143061|453390618|FG004|Overall Study|Withdrawal by Subject|0|||
126240549|NCT03874715|454175655|FG000|Overall Study|Poor compliance to protocol|5|||
126240550|NCT03874715|454175656|FG001|Overall Study|Poor compliance to protocol|1|||
126240551|NCT03874715|454175655|FG000|Overall Study|Withdrawal by Subject|1|||
126240552|NCT03874715|454175656|FG001|Overall Study|Withdrawal by Subject|0|||
126240553|NCT03874715|454175655|FG000|Overall Study|Other-unspecified|1|||
126240554|NCT03874715|454175656|FG001|Overall Study|Other-unspecified|0|||
126240555|NCT01034358|454175659|FG000|Overall Study|Withdrawal by Subject|1|||
126240556|NCT01034358|454175659|FG000|Overall Study|Protocol Violation|1|||
126240557|NCT00829790|454175662|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
126240558|NCT00829790|454175663|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
126240559|NCT01534663|454175664|FG000|Overall Study|Lost to Follow-up|0|||
126240560|NCT01534663|454175665|FG001|Overall Study|Lost to Follow-up|2|||
126240561|NCT01534663|454175664|FG000|Overall Study|Adverse Event|2|||
126240562|NCT01534663|454175665|FG001|Overall Study|Adverse Event|1|||
126240563|NCT00627016|454175666|FG000|Overall Study|Adverse Event|1|||
126240564|NCT00627016|454175667|FG001|Overall Study|Adverse Event|1|||
126240565|NCT00627016|454175666|FG000|Overall Study|Protocol Violation|0|||
126240566|NCT00627016|454175667|FG001|Overall Study|Protocol Violation|2|||
126240567|NCT00627016|454175666|FG000|Overall Study|Lost to Follow-up|0|||
126240568|NCT00627016|454175667|FG001|Overall Study|Lost to Follow-up|1|||
126240569|NCT00627016|454175666|FG000|Overall Study|Withdrawal by Subject|2|||
126240570|NCT00627016|454175667|FG001|Overall Study|Withdrawal by Subject|1|||
126240571|NCT00627016|454175666|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
126240572|NCT00627016|454175667|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
126240573|NCT00627016|454175666|FG000|Overall Study|Lack of Efficacy|1|||
126240574|NCT00627016|454175667|FG001|Overall Study|Lack of Efficacy|0|||
126240575|NCT00627016|454175666|FG000|Overall Study|Placed on Excluded Drugs|1|||
126240576|NCT00627016|454175667|FG001|Overall Study|Placed on Excluded Drugs|0|||
126240577|NCT00627016|454175666|FG000|Overall Study|Pregnancy|1|||
126240578|NCT00627016|454175667|FG001|Overall Study|Pregnancy|0|||
126240579|NCT03107091|454175668|FG000|Overall Study|Physician Decision|1|||
126240580|NCT04567186|454175673|FG000|Period 1|COVID-19 related|1|||
126240581|NCT04567186|454175674|FG001|Period 1|COVID-19 related|0|||
126240582|NCT04567186|454175673|FG000|Period 1|Protocol Violation|0|||
126240583|NCT04567186|454175674|FG001|Period 1|Protocol Violation|1|||
126240584|NCT04567186|454175673|FG000|Period 1|Adverse Event|0|||
126240585|NCT04567186|454175674|FG001|Period 1|Adverse Event|2|||
126240586|NCT04567186|454175673|FG000|Period 2|COVID-19 Related|0|||
126240587|NCT04567186|454175674|FG001|Period 2|COVID-19 Related|1|||
126240588|NCT04567186|454175673|FG000|Period 2|Protocol Violation|0|||
126240589|NCT04567186|454175674|FG001|Period 2|Protocol Violation|1|||
126240590|NCT04567186|454175673|FG000|Period 2|Lost to Follow-up|0|||
126240591|NCT04567186|454175674|FG001|Period 2|Lost to Follow-up|1|||
126240592|NCT04567186|454175673|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
126240593|NCT04567186|454175674|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
126240594|NCT03375463|454175677|FG000|Period 1|Lost to Follow-up|0|||
126240595|NCT03375463|454175678|FG001|Period 1|Lost to Follow-up|0|||
126240596|NCT03375463|454175679|FG002|Period 1|Lost to Follow-up|1|||
126240597|NCT03375463|454175680|FG003|Period 1|Lost to Follow-up|0|||
126240598|NCT03375463|454175681|FG004|Period 1|Lost to Follow-up|0|||
126240599|NCT03375463|454175682|FG005|Period 1|Lost to Follow-up|0|||
126240600|NCT03375463|454175677|FG000|Period 1|Adverse Event|0|||
126240601|NCT03375463|454175678|FG001|Period 1|Adverse Event|0|||
126240602|NCT03375463|454175679|FG002|Period 1|Adverse Event|0|||
126240603|NCT03375463|454175680|FG003|Period 1|Adverse Event|0|||
126240604|NCT03375463|454175681|FG004|Period 1|Adverse Event|1|||
126240605|NCT03375463|454175682|FG005|Period 1|Adverse Event|0|||
126025942|NCT04143061|453390619|FG005|Overall Study|Withdrawal by Subject|1|||
126025943|NCT04143061|453390620|FG006|Overall Study|Withdrawal by Subject|0|||
126025944|NCT04143061|453390621|FG007|Overall Study|Withdrawal by Subject|0|||
126240606|NCT03375463|454175677|FG000|Period 2|Lost to Follow-up|1|||
126240607|NCT03375463|454175678|FG001|Period 2|Lost to Follow-up|1|||
126240608|NCT03375463|454175679|FG002|Period 2|Lost to Follow-up|0|||
126025945|NCT04143061|453390614|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126240609|NCT03375463|454175680|FG003|Period 2|Lost to Follow-up|0|||
126240610|NCT03375463|454175681|FG004|Period 2|Lost to Follow-up|0|||
126240611|NCT03375463|454175682|FG005|Period 2|Lost to Follow-up|0|||
126240612|NCT04533594|454175685|FG000|Overall Study|Death|26|||
126240613|NCT00836056|454175695|FG000|First Intervention|Adverse Event|1|||
126240614|NCT00836056|454175696|FG001|First Intervention|Adverse Event|0|||
126240615|NCT01029340|454175698|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
126240616|NCT01029340|454175699|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
126240617|NCT01029340|454175700|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
126240618|NCT01029340|454175701|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
126240619|NCT01029340|454175702|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
126240620|NCT01029340|454175703|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
126240621|NCT01029340|454175698|FG000|Part B Treatment Period|Protocol Violation|0|||
126240622|NCT01029340|454175699|FG001|Part B Treatment Period|Protocol Violation|0|||
126240623|NCT01029340|454175700|FG002|Part B Treatment Period|Protocol Violation|1|||
126240624|NCT01029340|454175701|FG003|Part B Treatment Period|Protocol Violation|0|||
126240625|NCT01029340|454175702|FG004|Part B Treatment Period|Protocol Violation|0|||
126240626|NCT01029340|454175703|FG005|Part B Treatment Period|Protocol Violation|0|||
126240627|NCT01029340|454175698|FG000|Extension Period|Adverse Event|0|||
126240628|NCT01029340|454175699|FG001|Extension Period|Adverse Event|0|||
126240629|NCT01029340|454175700|FG002|Extension Period|Adverse Event|0|||
126240630|NCT01029340|454175701|FG003|Extension Period|Adverse Event|0|||
126240631|NCT01029340|454175702|FG004|Extension Period|Adverse Event|0|||
126240632|NCT01029340|454175703|FG005|Extension Period|Adverse Event|1|||
126240633|NCT01029340|454175698|FG000|Extension Period|starting another study|0|||
126240634|NCT01029340|454175699|FG001|Extension Period|starting another study|0|||
126240635|NCT01029340|454175700|FG002|Extension Period|starting another study|0|||
126240636|NCT01029340|454175701|FG003|Extension Period|starting another study|0|||
126240637|NCT01029340|454175702|FG004|Extension Period|starting another study|0|||
126240638|NCT01029340|454175703|FG005|Extension Period|starting another study|8|||
126240639|NCT01029340|454175698|FG000|Extension Period|non-compliance|0|||
126240640|NCT01029340|454175699|FG001|Extension Period|non-compliance|0|||
126240641|NCT01029340|454175700|FG002|Extension Period|non-compliance|0|||
126240642|NCT01029340|454175701|FG003|Extension Period|non-compliance|0|||
126240643|NCT01029340|454175702|FG004|Extension Period|non-compliance|0|||
126240644|NCT01029340|454175703|FG005|Extension Period|non-compliance|1|||
126240645|NCT01029340|454175698|FG000|Extension Period|Withdrawal by Subject|0|||
126240646|NCT01029340|454175699|FG001|Extension Period|Withdrawal by Subject|0|||
126240647|NCT01029340|454175700|FG002|Extension Period|Withdrawal by Subject|0|||
126240648|NCT01029340|454175701|FG003|Extension Period|Withdrawal by Subject|0|||
126240649|NCT01029340|454175702|FG004|Extension Period|Withdrawal by Subject|0|||
126240650|NCT01029340|454175703|FG005|Extension Period|Withdrawal by Subject|1|||
126240651|NCT01029340|454175698|FG000|Extension Period|Physician Decision|0|||
126240652|NCT01029340|454175699|FG001|Extension Period|Physician Decision|0|||
126240653|NCT01029340|454175700|FG002|Extension Period|Physician Decision|0|||
126240654|NCT01029340|454175701|FG003|Extension Period|Physician Decision|0|||
126240655|NCT01029340|454175702|FG004|Extension Period|Physician Decision|0|||
126240656|NCT01029340|454175703|FG005|Extension Period|Physician Decision|1|||
126240657|NCT02648347|454175704|FG000|Overall Study|Death|174|||
126240658|NCT02648347|454175705|FG001|Overall Study|Death|167|||
126240659|NCT02648347|454175704|FG000|Overall Study|Withdrawal by Subject|16|||
126240660|NCT02648347|454175705|FG001|Overall Study|Withdrawal by Subject|9|||
126240661|NCT02648347|454175704|FG000|Overall Study|Lost to Follow-up|18|||
126240662|NCT02648347|454175705|FG001|Overall Study|Lost to Follow-up|21|||
126240663|NCT02648347|454175704|FG000|Overall Study|Missing|1|||
126240664|NCT02648347|454175705|FG001|Overall Study|Missing|0|||
126240665|NCT03546842|454175707|FG000|Overall Study|Protocol Violation|1|||
126240666|NCT03546842|454175707|FG000|Overall Study|Withdrawal by Subject|2|||
126240667|NCT00833937|454175721|FG000|Washout|Withdrawal by Subject|1|||
126356802|NCT06025695|454597939|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
126356803|NCT03834883|454597940|FG000|Second Treatment|Withdrawal by Subject|1|||
126356804|NCT03834883|454597941|FG001|Second Treatment|Withdrawal by Subject|0|||
126356805|NCT03834883|454597942|FG002|Second Treatment|Withdrawal by Subject|0|||
126240668|NCT00833937|454175722|FG001|Washout|Withdrawal by Subject|0|||
126240669|NCT04419311|454175723|FG000|Overall Study|Lost to Follow-up|1|||
126240670|NCT04419311|454175724|FG001|Overall Study|Lost to Follow-up|0|||
126240671|NCT03135834|454175725|FG000|Stage 1|Adverse Event|1|||
126240672|NCT03135834|454175726|FG001|Stage 1|Adverse Event|2|||
126356806|NCT03834883|454597943|FG003|Second Treatment|Withdrawal by Subject|0|||
126356807|NCT03834883|454597940|FG000|Second Treatment|COVID-19 pandemic|1|||
126356808|NCT03834883|454597941|FG001|Second Treatment|COVID-19 pandemic|0|||
126356809|NCT03834883|454597942|FG002|Second Treatment|COVID-19 pandemic|1|||
126356810|NCT03834883|454597943|FG003|Second Treatment|COVID-19 pandemic|1|||
126356811|NCT00853047|454597946|FG000|Core Phase|Participant Request|0|||
126356812|NCT00853047|454597947|FG001|Core Phase|Participant Request|0|||
126356813|NCT00853047|454597948|FG002|Core Phase|Participant Request|0|||
125878839|NCT02177123|452853419|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
126240673|NCT03135834|454175727|FG002|Stage 1|Adverse Event|2|||
126093759|NCT05051462|453636157|FG000|Overall Study|Protocol Violation|0|||
126240674|NCT03135834|454175728|FG003|Stage 1|Adverse Event|1|||
126240675|NCT03135834|454175725|FG000|Stage 1|Death|1|||
126240676|NCT03135834|454175726|FG001|Stage 1|Death|0|||
126240677|NCT03135834|454175727|FG002|Stage 1|Death|0|||
126356814|NCT00853047|454597949|FG003|Core Phase|Participant Request|1|||
126356815|NCT00853047|454597950|FG004|Core Phase|Participant Request|0|||
126356816|NCT00853047|454597951|FG005|Core Phase|Participant Request|0|||
126240678|NCT03135834|454175728|FG003|Stage 1|Death|0|||
126240679|NCT03135834|454175725|FG000|Stage 1|Lost to Follow-up|17|||
126240680|NCT03135834|454175726|FG001|Stage 1|Lost to Follow-up|24|||
126240681|NCT03135834|454175727|FG002|Stage 1|Lost to Follow-up|21|||
126240682|NCT03135834|454175728|FG003|Stage 1|Lost to Follow-up|38|||
126240683|NCT03135834|454175725|FG000|Stage 1|No longer met eligibility criteria|1|||
126240684|NCT03135834|454175726|FG001|Stage 1|No longer met eligibility criteria|6|||
126240685|NCT03135834|454175727|FG002|Stage 1|No longer met eligibility criteria|2|||
126240686|NCT03135834|454175728|FG003|Stage 1|No longer met eligibility criteria|5|||
126240687|NCT03135834|454175725|FG000|Stage 1|Other|0|||
126240688|NCT03135834|454175726|FG001|Stage 1|Other|2|||
126240689|NCT03135834|454175727|FG002|Stage 1|Other|1|||
126240690|NCT03135834|454175728|FG003|Stage 1|Other|0|||
126240691|NCT03135834|454175725|FG000|Stage 1|Physician Decision|0|||
126240692|NCT03135834|454175726|FG001|Stage 1|Physician Decision|1|||
126240693|NCT03135834|454175727|FG002|Stage 1|Physician Decision|0|||
126240694|NCT03135834|454175728|FG003|Stage 1|Physician Decision|0|||
126240695|NCT03135834|454175725|FG000|Stage 1|Pregnancy|0|||
126240696|NCT03135834|454175726|FG001|Stage 1|Pregnancy|4|||
126240697|NCT03135834|454175727|FG002|Stage 1|Pregnancy|2|||
126240698|NCT03135834|454175728|FG003|Stage 1|Pregnancy|4|||
126240699|NCT03135834|454175725|FG000|Stage 1|Protocol Violation|1|||
126240700|NCT03135834|454175726|FG001|Stage 1|Protocol Violation|1|||
126240701|NCT03135834|454175727|FG002|Stage 1|Protocol Violation|2|||
126240702|NCT03135834|454175728|FG003|Stage 1|Protocol Violation|1|||
126240703|NCT03135834|454175725|FG000|Stage 1|Withdrawal by parent/guardian|2|||
126240704|NCT03135834|454175726|FG001|Stage 1|Withdrawal by parent/guardian|10|||
126240705|NCT03135834|454175727|FG002|Stage 1|Withdrawal by parent/guardian|2|||
126240706|NCT03135834|454175728|FG003|Stage 1|Withdrawal by parent/guardian|1|||
126240707|NCT03135834|454175725|FG000|Stage 1|Withdrawal by Subject|16|||
126240708|NCT03135834|454175726|FG001|Stage 1|Withdrawal by Subject|22|||
126240709|NCT03135834|454175727|FG002|Stage 1|Withdrawal by Subject|7|||
126240710|NCT03135834|454175728|FG003|Stage 1|Withdrawal by Subject|10|||
126240711|NCT03135834|454175725|FG000|Stage 1|Randomized but not Vaccinated|0|||
126240712|NCT03135834|454175726|FG001|Stage 1|Randomized but not Vaccinated|3|||
126240713|NCT03135834|454175727|FG002|Stage 1|Randomized but not Vaccinated|1|||
126240714|NCT03135834|454175728|FG003|Stage 1|Randomized but not Vaccinated|6|||
126240715|NCT03135834|454175725|FG000|Stage 2|Lost to Follow-up|0|||
126240716|NCT03135834|454175726|FG001|Stage 2|Lost to Follow-up|1|||
126240717|NCT03135834|454175727|FG002|Stage 2|Lost to Follow-up|0|||
126240718|NCT03135834|454175728|FG003|Stage 2|Lost to Follow-up|0|||
126240719|NCT03135834|454175725|FG000|Stage 2|Withdrawal by Subject|0|||
126240720|NCT03135834|454175726|FG001|Stage 2|Withdrawal by Subject|1|||
126240721|NCT03135834|454175727|FG002|Stage 2|Withdrawal by Subject|0|||
126240722|NCT03135834|454175728|FG003|Stage 2|Withdrawal by Subject|0|||
126240723|NCT03135834|454175725|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
126240724|NCT03135834|454175726|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
126240725|NCT03135834|454175727|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
126240726|NCT03135834|454175728|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
126240727|NCT03135834|454175725|FG000|Stage 2|Did not receive Booster Vaccination|1|||
126240728|NCT03135834|454175726|FG001|Stage 2|Did not receive Booster Vaccination|1|||
126240729|NCT03135834|454175727|FG002|Stage 2|Did not receive Booster Vaccination|0|||
126240730|NCT03135834|454175728|FG003|Stage 2|Did not receive Booster Vaccination|0|||
126240731|NCT02612337|454175731|FG000|Overall Study|Lack of Efficacy|1|||
126240732|NCT02612337|454175732|FG001|Overall Study|Lack of Efficacy|0|||
126240733|NCT02612337|454175731|FG000|Overall Study|Withdrawal by Subject|2|||
126240734|NCT02612337|454175732|FG001|Overall Study|Withdrawal by Subject|2|||
126240735|NCT02612337|454175731|FG000|Overall Study|Did not receive study drug|0|||
126240736|NCT02612337|454175732|FG001|Overall Study|Did not receive study drug|1|||
126240737|NCT02242201|454175735|FG000|Overall Study|preoperative identified neuropathy|2|||
126240738|NCT02242201|454175736|FG001|Overall Study|preoperative identified neuropathy|0|||
126240739|NCT02242201|454175737|FG002|Overall Study|preoperative identified neuropathy|0|||
126240740|NCT02242201|454175735|FG000|Overall Study|planned post-op anticoagulation|1|||
126240741|NCT02242201|454175736|FG001|Overall Study|planned post-op anticoagulation|0|||
126240742|NCT02242201|454175737|FG002|Overall Study|planned post-op anticoagulation|0|||
126240743|NCT02242201|454175735|FG000|Overall Study|changed surgical procedure|1|||
126240744|NCT02242201|454175736|FG001|Overall Study|changed surgical procedure|0|||
126240745|NCT02242201|454175737|FG002|Overall Study|changed surgical procedure|0|||
126240746|NCT02242201|454175735|FG000|Overall Study|postponed surgery|0|||
126240747|NCT02242201|454175736|FG001|Overall Study|postponed surgery|0|||
126240748|NCT02242201|454175737|FG002|Overall Study|postponed surgery|1|||
126240749|NCT02242201|454175735|FG000|Overall Study|preoperative opioid consumption|0|||
126240750|NCT02242201|454175736|FG001|Overall Study|preoperative opioid consumption|1|||
126240751|NCT02242201|454175737|FG002|Overall Study|preoperative opioid consumption|0|||
126240752|NCT02374853|454175740|FG000|Overall Study|Surgery Cancelled|5|||
126240753|NCT02374853|454175741|FG001|Overall Study|Surgery Cancelled|11|||
126240754|NCT02281084|454175744|FG000|Overall Study|Death|21|||
126240755|NCT02281084|454175745|FG001|Overall Study|Death|18|||
126240756|NCT02281084|454175746|FG002|Overall Study|Death|3|||
126240757|NCT02281084|454175747|FG003|Overall Study|Death|5|||
126240758|NCT02281084|454175744|FG000|Overall Study|Adverse Event|1|||
126240759|NCT02281084|454175745|FG001|Overall Study|Adverse Event|0|||
126240760|NCT02281084|454175746|FG002|Overall Study|Adverse Event|0|||
126240761|NCT02281084|454175747|FG003|Overall Study|Adverse Event|0|||
126240762|NCT02281084|454175744|FG000|Overall Study|Withdrawal by Subject|2|||
126240763|NCT02281084|454175745|FG001|Overall Study|Withdrawal by Subject|2|||
126240764|NCT02281084|454175746|FG002|Overall Study|Withdrawal by Subject|0|||
126240765|NCT02281084|454175747|FG003|Overall Study|Withdrawal by Subject|0|||
126240766|NCT02281084|454175744|FG000|Overall Study|Site Closure by Sponsor|5|||
126240767|NCT02281084|454175745|FG001|Overall Study|Site Closure by Sponsor|1|||
126240768|NCT02281084|454175746|FG002|Overall Study|Site Closure by Sponsor|2|||
126240769|NCT02281084|454175747|FG003|Overall Study|Site Closure by Sponsor|0|||
126240770|NCT01697696|454175748|FG000|Overall Study|Study terminated by sponsor|0|||
126240771|NCT01697696|454175749|FG001|Overall Study|Study terminated by sponsor|3|||
126240772|NCT01697696|454175748|FG000|Overall Study|Protocol deviation|1|||
126240773|NCT01697696|454175749|FG001|Overall Study|Protocol deviation|0|||
126240774|NCT01697696|454175748|FG000|Overall Study|Physician Decision|1|||
126240775|NCT01697696|454175749|FG001|Overall Study|Physician Decision|0|||
126240776|NCT01697696|454175748|FG000|Overall Study|Death|4|||
126240777|NCT01697696|454175749|FG001|Overall Study|Death|2|||
126240778|NCT01697696|454175748|FG000|Overall Study|Lost to Follow-up|10|||
126240779|NCT01697696|454175749|FG001|Overall Study|Lost to Follow-up|7|||
126240780|NCT01697696|454175748|FG000|Overall Study|Subject/guardian decision|31|||
126240781|NCT01697696|454175749|FG001|Overall Study|Subject/guardian decision|35|||
126240782|NCT01424644|454175750|FG000|Overall Study|Adverse Event|2|||
126240783|NCT01424644|454175751|FG001|Overall Study|Adverse Event|0|||
126240784|NCT01424644|454175750|FG000|Overall Study|Withdrawal by Subject|9|||
126240785|NCT01424644|454175751|FG001|Overall Study|Withdrawal by Subject|12|||
126240786|NCT01424644|454175750|FG000|Overall Study|Lost to Follow-up|16|||
126240787|NCT01424644|454175751|FG001|Overall Study|Lost to Follow-up|12|||
126240788|NCT01424644|454175750|FG000|Overall Study|Protocol Violation|4|||
126240789|NCT01424644|454175751|FG001|Overall Study|Protocol Violation|3|||
126240790|NCT01424644|454175750|FG000|Overall Study|Administrative Reason|1|||
126240791|NCT01424644|454175751|FG001|Overall Study|Administrative Reason|0|||
126240792|NCT01424644|454175750|FG000|Overall Study|Unable to Classify|1|||
126240793|NCT01424644|454175751|FG001|Overall Study|Unable to Classify|0|||
126240794|NCT05593965|454175752|FG000|1st Intervention (1 Day)|Technical error|1|||
126240795|NCT05593965|454175753|FG001|1st Intervention (1 Day)|Technical error|0|||
126240796|NCT02024932|454175772|FG000|Overall Study|Adverse Event|2|||
126240797|NCT02024932|454175773|FG001|Overall Study|Adverse Event|3|||
126240798|NCT02024932|454175774|FG002|Overall Study|Adverse Event|0|||
126240799|NCT02024932|454175775|FG003|Overall Study|Adverse Event|0|||
126240800|NCT02024932|454175776|FG004|Overall Study|Adverse Event|2|||
126240801|NCT02024932|454175777|FG005|Overall Study|Adverse Event|0|||
126240802|NCT02024932|454175772|FG000|Overall Study|Abnormal laboratory value|0|||
126240803|NCT02024932|454175773|FG001|Overall Study|Abnormal laboratory value|0|||
126240804|NCT02024932|454175774|FG002|Overall Study|Abnormal laboratory value|0|||
126240805|NCT02024932|454175775|FG003|Overall Study|Abnormal laboratory value|2|||
126240806|NCT02024932|454175776|FG004|Overall Study|Abnormal laboratory value|0|||
126240807|NCT02024932|454175777|FG005|Overall Study|Abnormal laboratory value|0|||
126240808|NCT03020641|454175778|FG000|Overall Study|Lost to Follow-up|0|||
126240809|NCT03020641|454175779|FG001|Overall Study|Lost to Follow-up|1|||
126240810|NCT03020641|454175778|FG000|Overall Study|Converted to open surgery|2|||
126240811|NCT03020641|454175779|FG001|Overall Study|Converted to open surgery|1|||
126240812|NCT03020641|454175778|FG000|Overall Study|for surgery not performed|0|||
126240813|NCT03020641|454175779|FG001|Overall Study|for surgery not performed|1|||
126356817|NCT00853047|454597946|FG000|Open-Label Extension Phase|Participant Request|0|||
126240814|NCT00939003|454175781|FG000|Double-blind Treatment Period|Adverse Event|1|||
126240815|NCT00939003|454175782|FG001|Double-blind Treatment Period|Adverse Event|1|||
126240816|NCT00939003|454175781|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126240817|NCT00939003|454175782|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
126240818|NCT00939003|454175781|FG000|Double-blind Treatment Period|Pregnancy|0|||
126240819|NCT00939003|454175782|FG001|Double-blind Treatment Period|Pregnancy|1|||
126240820|NCT00939003|454175781|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
126240821|NCT00939003|454175782|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
126240822|NCT00939003|454175781|FG000|Open-label Treatment Period|Adverse Event|4|||
126240823|NCT00939003|454175782|FG001|Open-label Treatment Period|Adverse Event|8|||
126240824|NCT00939003|454175781|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
126240825|NCT00939003|454175782|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
126240826|NCT00939003|454175781|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
126240827|NCT00939003|454175782|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
126240828|NCT00939003|454175781|FG000|Open-label Treatment Period|Pregnancy|1|||
126240829|NCT00939003|454175782|FG001|Open-label Treatment Period|Pregnancy|1|||
126240830|NCT00939003|454175781|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
126240831|NCT00939003|454175782|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
126240832|NCT00939003|454175781|FG000|Open-label Treatment Period|Site Closure|3|||
126240833|NCT00939003|454175782|FG001|Open-label Treatment Period|Site Closure|4|||
126240834|NCT04915755|454177311|FG000|Overall Study|Physician Decision|3|||
126240835|NCT04915755|454177312|FG001|Overall Study|Physician Decision|2|||
126240836|NCT04915755|454177311|FG000|Overall Study|Withdrawal by Subject|1|||
126240837|NCT04915755|454177312|FG001|Overall Study|Withdrawal by Subject|1|||
126240838|NCT04915755|454177311|FG000|Overall Study|Ongoing for PACT|3|||
126240839|NCT04915755|454177312|FG001|Overall Study|Ongoing for PACT|2|||
126240840|NCT04915755|454177311|FG000|Overall Study|Other|7|||
126240841|NCT04915755|454177312|FG001|Overall Study|Other|11|||
126240842|NCT02533258|454177313|FG000|Overall Study|Adverse Event|1|||
126240843|NCT02533258|454177313|FG000|Overall Study|Death|2|||
126240844|NCT02533258|454177313|FG000|Overall Study|Other|1|||
126240845|NCT02533258|454177313|FG000|Overall Study|Economic factor|1|||
126240846|NCT02533258|454177313|FG000|Overall Study|Progression of pleural effusion|1|||
126240847|NCT02533258|454177313|FG000|Overall Study|Lack of Efficacy|2|||
126240848|NCT01149473|454177314|FG000|First Intervention|Adverse Event|1|||
126240849|NCT01149473|454177315|FG001|First Intervention|Adverse Event|1|||
126240850|NCT01149473|454177314|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126240851|NCT01149473|454177315|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126240852|NCT04089735|454177316|FG000|Overall Study|Adverse Event|1|||
126240853|NCT04089735|454177317|FG001|Overall Study|Adverse Event|0|||
126240854|NCT04089735|454177318|FG002|Overall Study|Adverse Event|1|||
126240855|NCT04089735|454177319|FG003|Overall Study|Adverse Event|1|||
126240856|NCT04089735|454177320|FG004|Overall Study|Adverse Event|0|||
126240857|NCT04089735|454177321|FG005|Overall Study|Adverse Event|0|||
126240858|NCT04089735|454177316|FG000|Overall Study|Physician Decision|0|||
126240859|NCT04089735|454177317|FG001|Overall Study|Physician Decision|3|||
126240860|NCT04089735|454177318|FG002|Overall Study|Physician Decision|0|||
126240861|NCT04089735|454177319|FG003|Overall Study|Physician Decision|0|||
126240862|NCT04089735|454177320|FG004|Overall Study|Physician Decision|0|||
126240863|NCT04089735|454177321|FG005|Overall Study|Physician Decision|0|||
126240864|NCT04089735|454177316|FG000|Overall Study|Withdrawal by Subject|0|||
126240865|NCT04089735|454177317|FG001|Overall Study|Withdrawal by Subject|0|||
126240866|NCT04089735|454177318|FG002|Overall Study|Withdrawal by Subject|1|||
126240867|NCT04089735|454177319|FG003|Overall Study|Withdrawal by Subject|0|||
126240868|NCT04089735|454177320|FG004|Overall Study|Withdrawal by Subject|0|||
126240869|NCT04089735|454177321|FG005|Overall Study|Withdrawal by Subject|0|||
126240870|NCT04089735|454177316|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
126240871|NCT04089735|454177317|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
126240872|NCT04089735|454177318|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
126240873|NCT04089735|454177319|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
126240874|NCT04089735|454177320|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
126240875|NCT04089735|454177321|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
126240876|NCT01439880|454177323|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
126240877|NCT01439880|454177324|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
126240878|NCT01439880|454177323|FG000|SOC-controlled Period (Year 1)|Death|2|||
126240879|NCT01439880|454177324|FG001|SOC-controlled Period (Year 1)|Death|1|||
126240880|NCT01439880|454177323|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
126240881|NCT01439880|454177324|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
126240882|NCT01439880|454177323|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
126240883|NCT01439880|454177324|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
126240884|NCT01439880|454177323|FG000|SOC-controlled Period (Year 1)|Other|8|||
126240885|NCT01439880|454177324|FG001|SOC-controlled Period (Year 1)|Other|13|||
126240886|NCT01439880|454177323|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
126240887|NCT01439880|454177324|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
126240888|NCT01439880|454177323|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
126240889|NCT01439880|454177324|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
126240890|NCT01439880|454177323|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
126240891|NCT01439880|454177324|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
126240892|NCT01439880|454177323|FG000|All-IP Period (Years 2 to 5)|Death|3|||
126240893|NCT01439880|454177324|FG001|All-IP Period (Years 2 to 5)|Death|13|||
126240894|NCT01439880|454177323|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
126240895|NCT01439880|454177324|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
126240896|NCT01439880|454177323|FG000|All-IP Period (Years 2 to 5)|Other|14|||
126240897|NCT01439880|454177324|FG001|All-IP Period (Years 2 to 5)|Other|31|||
126240898|NCT01439880|454177323|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
126240899|NCT01439880|454177324|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
126240900|NCT02956460|454177326|FG000|Lens 1|Lost to Follow-up|1|||
126240901|NCT02956460|454177327|FG001|Lens 1|Lost to Follow-up|0|||
126240902|NCT00834067|454177330|FG000|Washout of 21 Days|Protocol Violation|0|||
126240903|NCT00834067|454177331|FG001|Washout of 21 Days|Protocol Violation|1|||
126240904|NCT04129346|454177332|FG000|Overall Study|Death|1|||
126240905|NCT04129346|454177333|FG001|Overall Study|Death|0|||
126240906|NCT01083693|454177334|FG000|Overall Study|Adverse Event|1|||
126240907|NCT01083693|454177335|FG001|Overall Study|Adverse Event|1|||
126240908|NCT01083693|454177336|FG002|Overall Study|Adverse Event|0|||
126240909|NCT01083693|454177334|FG000|Overall Study|Lost to Follow-up|2|||
126240910|NCT01083693|454177335|FG001|Overall Study|Lost to Follow-up|0|||
126240911|NCT01083693|454177336|FG002|Overall Study|Lost to Follow-up|2|||
126240912|NCT01083693|454177334|FG000|Overall Study|Lack of effectiveness|13|||
126240913|NCT01083693|454177335|FG001|Overall Study|Lack of effectiveness|2|||
126240914|NCT01083693|454177336|FG002|Overall Study|Lack of effectiveness|2|||
126240915|NCT01083693|454177334|FG000|Overall Study|Patient Moved|0|||
126240916|NCT01083693|454177335|FG001|Overall Study|Patient Moved|1|||
126240917|NCT01083693|454177336|FG002|Overall Study|Patient Moved|0|||
126240918|NCT01083693|454177334|FG000|Overall Study|Complete remission|0|||
126240919|NCT01083693|454177335|FG001|Overall Study|Complete remission|1|||
126240920|NCT01083693|454177336|FG002|Overall Study|Complete remission|0|||
126240921|NCT01083693|454177334|FG000|Overall Study|Other medical condition/surgery|1|||
126240922|NCT01083693|454177335|FG001|Overall Study|Other medical condition/surgery|1|||
126240923|NCT01083693|454177336|FG002|Overall Study|Other medical condition/surgery|0|||
126240924|NCT01083693|454177334|FG000|Overall Study|Withdrawal by Subject|3|||
126240925|NCT01083693|454177335|FG001|Overall Study|Withdrawal by Subject|0|||
126240926|NCT01083693|454177336|FG002|Overall Study|Withdrawal by Subject|2|||
126240927|NCT01083693|454177334|FG000|Overall Study|Reason unknown|0|||
126240928|NCT01083693|454177335|FG001|Overall Study|Reason unknown|0|||
126240929|NCT01083693|454177336|FG002|Overall Study|Reason unknown|1|||
126240930|NCT00089661|454177339|FG000|Overall Study|Adverse Event|0|||
126240931|NCT00089661|454177340|FG001|Overall Study|Adverse Event|2|||
126240932|NCT00089661|454177339|FG000|Overall Study|Death|1|||
126240933|NCT00089661|454177340|FG001|Overall Study|Death|0|||
126240934|NCT00089661|454177339|FG000|Overall Study|Lost to Follow-up|0|||
126240935|NCT00089661|454177340|FG001|Overall Study|Lost to Follow-up|3|||
126240936|NCT00089661|454177339|FG000|Overall Study|Withdrawal by Subject|11|||
126240937|NCT00089661|454177340|FG001|Overall Study|Withdrawal by Subject|9|||
126240938|NCT00089661|454177339|FG000|Overall Study|Disease progression|1|||
126240939|NCT00089661|454177340|FG001|Overall Study|Disease progression|3|||
126240940|NCT00089661|454177339|FG000|Overall Study|Ineligibility determined|4|||
126240941|NCT00089661|454177340|FG001|Overall Study|Ineligibility determined|4|||
126240942|NCT00089661|454177339|FG000|Overall Study|Noncompliance|2|||
126240943|NCT00089661|454177340|FG001|Overall Study|Noncompliance|4|||
126240944|NCT00089661|454177339|FG000|Overall Study|Other|2|||
126240945|NCT00089661|454177340|FG001|Overall Study|Other|1|||
126240946|NCT01602419|454177341|FG000|Overall Study|Not treated with Wilate|9|||
126240947|NCT01602419|454177341|FG000|Overall Study|Adverse Drug Reaction|4|||
126240948|NCT01602419|454177341|FG000|Overall Study|Insurance issues|3|||
126240949|NCT01602419|454177341|FG000|Overall Study|Changed treatment centre|1|||
126240950|NCT01602419|454177341|FG000|Overall Study|Treatment centre closed|1|||
126240951|NCT01602419|454177341|FG000|Overall Study|Withdrawal by Subject|5|||
126240952|NCT01602419|454177341|FG000|Overall Study|Lost to Follow-up|6|||
126240953|NCT01792635|454177342|FG000|Part B|Adverse Event|0|||
126240954|NCT01792635|454177343|FG001|Part B|Adverse Event|0|||
126240955|NCT01792635|454177344|FG002|Part B|Adverse Event|1|||
126240956|NCT01792635|454177342|FG000|Part B|Study terminated|0|||
126240957|NCT01792635|454177343|FG001|Part B|Study terminated|4|||
126240958|NCT01792635|454177344|FG002|Part B|Study terminated|3|||
126240959|NCT02902211|454177346|FG000|First Three Months|Withdrawal by Subject|7|||
126240960|NCT02902211|454177347|FG001|First Three Months|Withdrawal by Subject|3|||
126240961|NCT01513174|454177348|FG000|Overall Study|Inclusion Error|1|||
126240962|NCT01513174|454177349|FG001|Overall Study|Inclusion Error|7|||
126240963|NCT01513174|454177348|FG000|Overall Study|Not receive study treatment|3|||
126240964|NCT01513174|454177349|FG001|Overall Study|Not receive study treatment|1|||
126356818|NCT00853047|454597947|FG001|Open-Label Extension Phase|Participant Request|0|||
126356819|NCT00853047|454597948|FG002|Open-Label Extension Phase|Participant Request|0|||
126356820|NCT00853047|454597949|FG003|Open-Label Extension Phase|Participant Request|0|||
126356821|NCT00853047|454597950|FG004|Open-Label Extension Phase|Participant Request|0|||
126356822|NCT00853047|454597951|FG005|Open-Label Extension Phase|Participant Request|7|||
126356823|NCT00853047|454597946|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
126240965|NCT02682784|454177357|FG000|Overall Study|Withdrawal by Subject|0|||
126240966|NCT02682784|454177358|FG001|Overall Study|Withdrawal by Subject|2|||
126240967|NCT02682784|454177359|FG002|Overall Study|Withdrawal by Subject|1|||
126240968|NCT02682784|454177360|FG003|Overall Study|Withdrawal by Subject|2|||
126240969|NCT02682784|454177357|FG000|Overall Study|Physician Decision|1|||
126240970|NCT02682784|454177358|FG001|Overall Study|Physician Decision|0|||
126240971|NCT02682784|454177359|FG002|Overall Study|Physician Decision|1|||
126240972|NCT02682784|454177360|FG003|Overall Study|Physician Decision|1|||
126025946|NCT04143061|453390615|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126025947|NCT04143061|453390616|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126240973|NCT00467363|454177361|FG000|Overall Study|Lost to Follow-up|80|||
126240974|NCT00467363|454177362|FG001|Overall Study|Lost to Follow-up|70|||
126240975|NCT03138967|454177366|FG000|Overall Study|Death|0|||
126240976|NCT03138967|454177367|FG001|Overall Study|Death|1|||
126240977|NCT03138967|454177366|FG000|Overall Study|Physician Decision|1|||
126240978|NCT03138967|454177367|FG001|Overall Study|Physician Decision|3|||
126240979|NCT02711852|454177372|FG000|Overall Study|Death|5|||
126240980|NCT02711852|454177372|FG000|Overall Study|Lost to Follow-up|1|||
126240981|NCT02711852|454177372|FG000|Overall Study|Completed follow-up|3|||
126240982|NCT02711852|454177372|FG000|Overall Study|Withdrawal by Subject|1|||
126240983|NCT02453386|454177377|FG000|Overall Study|Adverse Event|22|||
126240984|NCT02453386|454177378|FG001|Overall Study|Adverse Event|30|||
126240985|NCT02453386|454177379|FG002|Overall Study|Adverse Event|15|||
126240986|NCT02453386|454177377|FG000|Overall Study|Protocol Violation|1|||
126240987|NCT02453386|454177378|FG001|Overall Study|Protocol Violation|0|||
126240988|NCT02453386|454177379|FG002|Overall Study|Protocol Violation|1|||
126240989|NCT02453386|454177377|FG000|Overall Study|Withdrawal by Subject|10|||
126240990|NCT02453386|454177378|FG001|Overall Study|Withdrawal by Subject|9|||
126240991|NCT02453386|454177379|FG002|Overall Study|Withdrawal by Subject|9|||
126240992|NCT02453386|454177377|FG000|Overall Study|Sponsor Terminated Study|14|||
126240993|NCT02453386|454177378|FG001|Overall Study|Sponsor Terminated Study|8|||
126025948|NCT04143061|453390617|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126025949|NCT04143061|453390618|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
126240994|NCT02453386|454177379|FG002|Overall Study|Sponsor Terminated Study|11|||
126240995|NCT02453386|454177377|FG000|Overall Study|Subject Terminated by Sponsor|1|||
126240996|NCT02453386|454177378|FG001|Overall Study|Subject Terminated by Sponsor|1|||
126240997|NCT02453386|454177379|FG002|Overall Study|Subject Terminated by Sponsor|1|||
126240998|NCT02453386|454177377|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
126240999|NCT02453386|454177378|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
126241000|NCT02453386|454177379|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
126241001|NCT02453386|454177377|FG000|Overall Study|Lost to Follow-up|0|||
126241002|NCT02453386|454177378|FG001|Overall Study|Lost to Follow-up|0|||
126241003|NCT02453386|454177379|FG002|Overall Study|Lost to Follow-up|1|||
126241004|NCT02453386|454177377|FG000|Overall Study|Other|1|||
126025950|NCT04143061|453390619|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
126025951|NCT04143061|453390620|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
126241005|NCT02453386|454177378|FG001|Overall Study|Other|0|||
126241006|NCT02453386|454177379|FG002|Overall Study|Other|1|||
126241007|NCT00465270|454177393|FG000|Overall Study|Death|7|||
126241008|NCT00465270|454177394|FG001|Overall Study|Death|11|||
126241009|NCT00465270|454177393|FG000|Overall Study|Withdrawal by Subject|34|||
126241010|NCT00465270|454177394|FG001|Overall Study|Withdrawal by Subject|78|||
126241011|NCT00465270|454177393|FG000|Overall Study|Lost to Follow-up|60|||
126241012|NCT00465270|454177394|FG001|Overall Study|Lost to Follow-up|67|||
126241013|NCT00465270|454177393|FG000|Overall Study|Investigator request|3|||
126241014|NCT00465270|454177394|FG001|Overall Study|Investigator request|4|||
126241015|NCT03233724|454177406|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
126241016|NCT03233724|454177407|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
126241017|NCT03233724|454177408|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
126241018|NCT03233724|454177409|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
126241019|NCT03233724|454177410|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
126241020|NCT03233724|454177406|FG000|Phase I Dose Escalation|Best interest of participant|1|||
126241021|NCT03233724|454177407|FG001|Phase I Dose Escalation|Best interest of participant|1|||
126241022|NCT03233724|454177408|FG002|Phase I Dose Escalation|Best interest of participant|1|||
126241023|NCT03233724|454177409|FG003|Phase I Dose Escalation|Best interest of participant|0|||
126241024|NCT03233724|454177410|FG004|Phase I Dose Escalation|Best interest of participant|0|||
126241025|NCT03233724|454177406|FG000|Phase I Dose Escalation|Physician Decision|0|||
126241026|NCT03233724|454177407|FG001|Phase I Dose Escalation|Physician Decision|0|||
126241027|NCT03233724|454177408|FG002|Phase I Dose Escalation|Physician Decision|1|||
126241028|NCT03233724|454177409|FG003|Phase I Dose Escalation|Physician Decision|0|||
126241029|NCT03233724|454177410|FG004|Phase I Dose Escalation|Physician Decision|0|||
126241030|NCT03233724|454177406|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
126241031|NCT03233724|454177407|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
126241032|NCT03233724|454177408|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
126025952|NCT04143061|453390621|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
126025953|NCT03602014|453390622|FG000|Overall Study|Lost to Follow-up|2|||
126241033|NCT03233724|454177409|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
126241034|NCT03233724|454177410|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
126241035|NCT02388191|454177412|FG000|Overall Study|Patient did not receive IUD|1|||
126241036|NCT02388191|454177413|FG001|Overall Study|Patient did not receive IUD|0|||
126241037|NCT03197883|454177414|FG000|Overall Study|Adverse Event|1|||
126241038|NCT03197883|454177415|FG001|Overall Study|Adverse Event|1|||
126241039|NCT03197883|454177414|FG000|Overall Study|Lost to Follow-up|1|||
126241040|NCT03197883|454177415|FG001|Overall Study|Lost to Follow-up|0|||
126241041|NCT03197883|454177414|FG000|Overall Study|Protocol Violation|1|||
126241042|NCT03197883|454177415|FG001|Overall Study|Protocol Violation|0|||
126241043|NCT03197883|454177414|FG000|Overall Study|Other (Not Specified)|0|||
126241044|NCT03197883|454177415|FG001|Overall Study|Other (Not Specified)|5|||
126241045|NCT01045161|454177416|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
126241046|NCT01045161|454177417|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
126025954|NCT03602014|453390623|FG001|Overall Study|Lost to Follow-up|0|||
126025955|NCT03602014|453390624|FG002|Overall Study|Lost to Follow-up|0|||
126025956|NCT03289039|453390627|FG000|Overall Study|Withdrawal by Subject|0|||
126025957|NCT03289039|453390628|FG001|Overall Study|Withdrawal by Subject|1|||
126025958|NCT03289039|453390627|FG000|Overall Study|Became ineligible prior to treatment start|0|||
126025959|NCT03289039|453390628|FG001|Overall Study|Became ineligible prior to treatment start|1|||
126025960|NCT03289039|453390627|FG000|Overall Study|progressed before treatment start|1|||
126025961|NCT03289039|453390628|FG001|Overall Study|progressed before treatment start|0|||
126025962|NCT04732494|453390629|FG000|Overall Study|Death|39|||
126025963|NCT04732494|453390630|FG001|Overall Study|Death|36|||
126025964|NCT04732494|453390629|FG000|Overall Study|Study Closed by Sponsor|20|||
126025965|NCT04732494|453390630|FG001|Overall Study|Study Closed by Sponsor|15|||
126025966|NCT04732494|453390629|FG000|Overall Study|Withdrawal by Subject|2|||
126025967|NCT04732494|453390630|FG001|Overall Study|Withdrawal by Subject|7|||
126025968|NCT04732494|453390629|FG000|Overall Study|Lost to Follow-up|1|||
126025969|NCT04732494|453390630|FG001|Overall Study|Lost to Follow-up|5|||
126025970|NCT03897686|453390631|FG000|Overall Study|Protocol Violation|1|||
126025971|NCT03897686|453390632|FG001|Overall Study|Protocol Violation|1|||
126025972|NCT03897686|453390631|FG000|Overall Study|Withdrawal by Subject|1|||
126025973|NCT03897686|453390632|FG001|Overall Study|Withdrawal by Subject|1|||
126025974|NCT03157167|453390633|FG000|Overall Study|Withdrawal by Subject|1|||
126025975|NCT03157167|453390634|FG001|Overall Study|Withdrawal by Subject|0|||
126025976|NCT03157167|453390635|FG002|Overall Study|Withdrawal by Subject|0|||
126025977|NCT06023082|453390638|FG000|Overall Study|Withdrawal by Subject|2|||
126025978|NCT06023082|453390638|FG000|Overall Study|Lost to Follow-up|15|||
126025979|NCT06023082|453390638|FG000|Overall Study|Side effects|5|||
126025980|NCT04823611|453390639|FG000|Overall Study|Adverse Event|2|||
126025981|NCT04823611|453390640|FG001|Overall Study|Adverse Event|0|||
126025982|NCT04823611|453390641|FG002|Overall Study|Adverse Event|1|||
126025983|NCT04823611|453390642|FG003|Overall Study|Adverse Event|0|||
126025984|NCT04823611|453390643|FG004|Overall Study|Adverse Event|0|||
126025985|NCT04823611|453390644|FG005|Overall Study|Adverse Event|0|||
126025986|NCT04823611|453390645|FG006|Overall Study|Adverse Event|0|||
126025987|NCT05444192|453390646|FG000|Overall Study|Lost to Follow-up|1|||
126025988|NCT05444192|453390647|FG001|Overall Study|Lost to Follow-up|0|||
126025989|NCT05623345|453390649|FG000|Overall Study|Withdrawal by Subject|14|||
126025990|NCT05623345|453390650|FG001|Overall Study|Withdrawal by Subject|0|||
126025991|NCT05623345|453390651|FG002|Overall Study|Withdrawal by Subject|9|||
126025992|NCT05623345|453390652|FG003|Overall Study|Withdrawal by Subject|20|||
126025993|NCT05623345|453390649|FG000|Overall Study|Lost to Follow-up|3|||
126025994|NCT05623345|453390650|FG001|Overall Study|Lost to Follow-up|0|||
126025995|NCT05623345|453390651|FG002|Overall Study|Lost to Follow-up|7|||
126025996|NCT05623345|453390652|FG003|Overall Study|Lost to Follow-up|2|||
126025997|NCT05623345|453390649|FG000|Overall Study|Termination of Study By Sponsor|37|||
126025998|NCT05623345|453390650|FG001|Overall Study|Termination of Study By Sponsor|4|||
126025999|NCT05623345|453390651|FG002|Overall Study|Termination of Study By Sponsor|40|||
126026000|NCT05623345|453390652|FG003|Overall Study|Termination of Study By Sponsor|38|||
126026001|NCT01385176|453390653|FG000|Randomization Phase|Death|1|||
126241047|NCT01045161|454177418|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
126241048|NCT01045161|454177416|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
126241049|NCT01045161|454177417|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
126026002|NCT01385176|453390654|FG001|Randomization Phase|Death|2|||
126026003|NCT01385176|453390653|FG000|6-18 Month All VNS Active|Death|1|||
126026004|NCT01385176|453390654|FG001|6-18 Month All VNS Active|Death|2|||
126026005|NCT01385176|453390653|FG000|6-18 Month All VNS Active|Physician Decision|0|||
126026006|NCT01385176|453390654|FG001|6-18 Month All VNS Active|Physician Decision|1|||
126026007|NCT01385176|453390653|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
126026008|NCT01385176|453390654|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
126026009|NCT01385176|453390653|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
126026010|NCT01385176|453390654|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
126026011|NCT05384730|453390655|FG000|Overall Study|Adverse Event|1|||
126026012|NCT05384730|453390656|FG001|Overall Study|Adverse Event|0|||
126241050|NCT01045161|454177418|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
126241051|NCT01045161|454177416|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
126241052|NCT01045161|454177417|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
126241053|NCT01045161|454177418|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
126241054|NCT01045161|454177416|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
126241055|NCT01045161|454177417|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
126241056|NCT01045161|454177418|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
126241057|NCT01045161|454177416|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
126241058|NCT01045161|454177417|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
126241059|NCT01045161|454177418|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
126241060|NCT01045161|454177416|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
126241061|NCT01045161|454177417|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
126241062|NCT01045161|454177418|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
126241063|NCT01045161|454177416|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
126241064|NCT01045161|454177417|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
126241065|NCT01045161|454177418|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
126241066|NCT01045161|454177416|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
126241067|NCT01045161|454177417|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
126241068|NCT01045161|454177418|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
126241069|NCT01045161|454177416|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
126241070|NCT01045161|454177417|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
126241071|NCT01045161|454177418|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
126241072|NCT01045161|454177416|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
126241073|NCT01045161|454177417|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
126241074|NCT01045161|454177418|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
126241075|NCT01045161|454177416|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
126241076|NCT01045161|454177417|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
126241077|NCT01045161|454177418|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
126241078|NCT01045161|454177416|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
126241079|NCT01045161|454177417|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
126241080|NCT01045161|454177418|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
126241081|NCT01045161|454177416|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
126241082|NCT01045161|454177417|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
126241083|NCT01045161|454177418|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
126241084|NCT01045161|454177416|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
126241085|NCT01045161|454177417|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
126241086|NCT01045161|454177418|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
126241087|NCT03686033|454177419|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
126241088|NCT03686033|454177420|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
126241089|NCT03686033|454177421|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
126241090|NCT03686033|454177422|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
126241091|NCT03686033|454177423|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
126241092|NCT03686033|454177424|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
126241093|NCT00858845|454177426|FG000|Overall Study|Patient underwent heart transplant.|0|||
126241094|NCT00858845|454177427|FG001|Overall Study|Patient underwent heart transplant.|1|||
126241095|NCT03031847|454177428|FG000|Overall Study|Death|1|||
126241096|NCT03031847|454177429|FG001|Overall Study|Death|1|||
126241097|NCT03031847|454177430|FG002|Overall Study|Death|2|||
126241098|NCT03031847|454177431|FG003|Overall Study|Death|3|||
126093760|NCT05051462|453636158|FG001|Overall Study|Protocol Violation|2|||
126241099|NCT03031847|454177428|FG000|Overall Study|Lost to Follow-up|1|||
125878840|NCT03199976|452853420|FG000|Overall Study|Lack of Efficacy|3|||
126241100|NCT03031847|454177429|FG001|Overall Study|Lost to Follow-up|1|||
126241101|NCT03031847|454177430|FG002|Overall Study|Lost to Follow-up|2|||
126241102|NCT03031847|454177431|FG003|Overall Study|Lost to Follow-up|3|||
126241103|NCT01353664|454177433|FG000|Overall Study|Other|3|||
126241104|NCT01353664|454177433|FG000|Overall Study|Disease Progression|16|||
126241105|NCT02605928|454177436|FG000|Overall Study|Model tuning phase|28|||
126241106|NCT02605928|454177436|FG000|Overall Study|Lack of Efficacy|5|||
126241107|NCT02089997|454177444|FG000|Overall Study|Case report forms uncollected|99|||
126241108|NCT02089997|454177444|FG000|Overall Study|Protocol Violation|147|||
126241109|NCT02441309|454177445|FG000|Overall Study|Disease progression|2|||
126241110|NCT02441309|454177446|FG001|Overall Study|Disease progression|1|||
126241111|NCT02441309|454177447|FG002|Overall Study|Disease progression|2|||
126241112|NCT02441309|454177445|FG000|Overall Study|Adverse Event|0|||
126241113|NCT02441309|454177446|FG001|Overall Study|Adverse Event|1|||
126241114|NCT02441309|454177447|FG002|Overall Study|Adverse Event|0|||
126241115|NCT02441309|454177445|FG000|Overall Study|Withdrawal by Subject|1|||
126241116|NCT02441309|454177446|FG001|Overall Study|Withdrawal by Subject|0|||
126241117|NCT02441309|454177447|FG002|Overall Study|Withdrawal by Subject|1|||
126241118|NCT02335658|454177452|FG000|Overall Study|Adverse Event|18|||
126241119|NCT02335658|454177453|FG001|Overall Study|Adverse Event|12|||
126356824|NCT00853047|454597947|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126356825|NCT00853047|454597948|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
126356826|NCT00853047|454597949|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
126356827|NCT00853047|454597950|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
126356828|NCT00853047|454597951|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
126356829|NCT00853047|454597946|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356830|NCT00853047|454597947|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356831|NCT00853047|454597948|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356832|NCT00853047|454597949|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356833|NCT00853047|454597950|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356834|NCT00853047|454597951|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
126356835|NCT00853047|454597946|FG000|Open-Label Extension Phase|Investigator Decision|0|||
126356836|NCT00853047|454597947|FG001|Open-Label Extension Phase|Investigator Decision|0|||
126356837|NCT00853047|454597948|FG002|Open-Label Extension Phase|Investigator Decision|0|||
126356838|NCT00853047|454597949|FG003|Open-Label Extension Phase|Investigator Decision|0|||
126356839|NCT00853047|454597950|FG004|Open-Label Extension Phase|Investigator Decision|0|||
126356840|NCT00853047|454597951|FG005|Open-Label Extension Phase|Investigator Decision|1|||
126356841|NCT00853047|454597946|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
126356842|NCT00853047|454597947|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
126356843|NCT00853047|454597948|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
126356844|NCT00853047|454597949|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
126356845|NCT00853047|454597950|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
126356846|NCT00853047|454597951|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
126356847|NCT00160615|454599600|FG000|Overall Study|Adverse Event|5|||
126356848|NCT00160615|454599601|FG001|Overall Study|Adverse Event|12|||
126356849|NCT00160615|454599600|FG000|Overall Study|Withdrawal by Subject|0|||
126356850|NCT00160615|454599601|FG001|Overall Study|Withdrawal by Subject|2|||
126356851|NCT00160615|454599600|FG000|Overall Study|Lack of Efficacy|11|||
126356852|NCT00160615|454599601|FG001|Overall Study|Lack of Efficacy|23|||
126356853|NCT00160615|454599600|FG000|Overall Study|Patient decision|1|||
126356854|NCT00160615|454599601|FG001|Overall Study|Patient decision|2|||
126356855|NCT00160615|454599600|FG000|Overall Study|Investigator decision|1|||
126356856|NCT00160615|454599601|FG001|Overall Study|Investigator decision|1|||
126356857|NCT00160615|454599600|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
126356858|NCT00160615|454599601|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
126356859|NCT00160615|454599600|FG000|Overall Study|Switch to surgical treatment|0|||
126356860|NCT00160615|454599601|FG001|Overall Study|Switch to surgical treatment|2|||
126356861|NCT00160615|454599600|FG000|Overall Study|Non-compliance was suspected|0|||
126356862|NCT00160615|454599601|FG001|Overall Study|Non-compliance was suspected|1|||
126356863|NCT00160615|454599600|FG000|Overall Study|Poor compliance|0|||
126356864|NCT00160615|454599601|FG001|Overall Study|Poor compliance|1|||
126356865|NCT03166631|454599602|FG000|Overall Study|Progressive disease|2|||
126356866|NCT03166631|454599603|FG001|Overall Study|Progressive disease|1|||
126241120|NCT02335658|454177452|FG000|Overall Study|Lack of Efficacy|4|||
126093761|NCT02425904|453636159|FG000|Overall Study|Lost to Follow-up|1|||
126241121|NCT02335658|454177453|FG001|Overall Study|Lack of Efficacy|5|||
126241122|NCT02335658|454177452|FG000|Overall Study|Pregnancy|1|||
126241123|NCT02335658|454177453|FG001|Overall Study|Pregnancy|0|||
126241124|NCT02335658|454177452|FG000|Overall Study|Withdrawal by Subject|13|||
126356867|NCT03166631|454599604|FG002|Overall Study|Progressive disease|3|||
126356868|NCT03166631|454599605|FG003|Overall Study|Progressive disease|4|||
126356869|NCT03166631|454599606|FG004|Overall Study|Progressive disease|2|||
126356870|NCT03166631|454599607|FG005|Overall Study|Progressive disease|2|||
126356871|NCT03166631|454599608|FG006|Overall Study|Progressive disease|5|||
126026013|NCT05384730|453390655|FG000|Overall Study|Lack of social support|2|||
126026014|NCT05384730|453390656|FG001|Overall Study|Lack of social support|0|||
126026015|NCT05384730|453390655|FG000|Overall Study|Hospital readmission|2|||
126026016|NCT05384730|453390656|FG001|Overall Study|Hospital readmission|0|||
126026017|NCT05384730|453390655|FG000|Overall Study|Disease progression|5|||
126026018|NCT05384730|453390656|FG001|Overall Study|Disease progression|0|||
126026019|NCT05384730|453390655|FG000|Overall Study|Overwhelmed with College commitments|0|||
126241125|NCT02335658|454177453|FG001|Overall Study|Withdrawal by Subject|21|||
126241126|NCT02335658|454177452|FG000|Overall Study|non-compliance|2|||
126241127|NCT02335658|454177453|FG001|Overall Study|non-compliance|3|||
126241128|NCT02335658|454177452|FG000|Overall Study|other reason|2|||
126241129|NCT02335658|454177453|FG001|Overall Study|other reason|3|||
126241130|NCT02305758|454177454|FG000|Overall Study|Death|27|||
126241131|NCT02305758|454177455|FG001|Overall Study|Death|27|||
126241132|NCT02305758|454177454|FG000|Overall Study|Withdrew consent|9|||
126241133|NCT02305758|454177455|FG001|Overall Study|Withdrew consent|2|||
126241134|NCT02305758|454177454|FG000|Overall Study|Lost to Follow-up|6|||
126241135|NCT02305758|454177455|FG001|Overall Study|Lost to Follow-up|1|||
126241136|NCT02305758|454177454|FG000|Overall Study|Study Terminated by Sponsor|21|||
126241137|NCT02305758|454177455|FG001|Overall Study|Study Terminated by Sponsor|34|||
126241138|NCT02305758|454177454|FG000|Overall Study|Other, not specified|2|||
126241139|NCT02305758|454177455|FG001|Overall Study|Other, not specified|1|||
126241140|NCT02032888|454177456|FG000|Treatment Period|Poor compliance/noncompliance|1|||
126241141|NCT02032888|454177457|FG001|Treatment Period|Poor compliance/noncompliance|1|||
126241142|NCT02032888|454177458|FG002|Treatment Period|Poor compliance/noncompliance|0|||
126241143|NCT02032888|454177456|FG000|Treatment Period|Other|1|||
126241144|NCT02032888|454177457|FG001|Treatment Period|Other|1|||
126241145|NCT02032888|454177458|FG002|Treatment Period|Other|0|||
126241146|NCT02032888|454177456|FG000|Follow-up Period|Lost to Follow-up|1|||
126241147|NCT02032888|454177457|FG001|Follow-up Period|Lost to Follow-up|1|||
126241148|NCT02032888|454177458|FG002|Follow-up Period|Lost to Follow-up|0|||
126241149|NCT02032888|454177456|FG000|Follow-up Period|Death|1|||
126241150|NCT02032888|454177457|FG001|Follow-up Period|Death|1|||
126241151|NCT02032888|454177458|FG002|Follow-up Period|Death|0|||
126241152|NCT02032888|454177456|FG000|Follow-up Period|Other|1|||
126241153|NCT02032888|454177457|FG001|Follow-up Period|Other|0|||
126241154|NCT02032888|454177458|FG002|Follow-up Period|Other|0|||
126241155|NCT03616106|454177461|FG000|Overall Study|Removed by PI|6|||
126241156|NCT03616106|454177462|FG001|Overall Study|Removed by PI|0|||
126026020|NCT05384730|453390656|FG001|Overall Study|Overwhelmed with College commitments|2|||
126093762|NCT02425904|453636160|FG001|Overall Study|Lost to Follow-up|0|||
126241157|NCT03616106|454177461|FG000|Overall Study|Withdrawal by Subject|1|||
126241158|NCT03616106|454177462|FG001|Overall Study|Withdrawal by Subject|1|||
126241159|NCT03616106|454177461|FG000|Overall Study|Lost to Follow-up|7|||
126241160|NCT03616106|454177462|FG001|Overall Study|Lost to Follow-up|0|||
126241161|NCT02445339|454177464|FG000|Overall Study|Physician Decision|1|||
126026021|NCT01772472|453390657|FG000|Overall Study|Death|126|||
126093763|NCT02425904|453636159|FG000|Overall Study|Withdrawal by Subject|2|||
126093764|NCT02425904|453636160|FG001|Overall Study|Withdrawal by Subject|0|||
126241162|NCT02445339|454177465|FG001|Overall Study|Physician Decision|0|||
126241163|NCT02445339|454177464|FG000|Overall Study|Lost to Follow-up|11|||
126241164|NCT02445339|454177465|FG001|Overall Study|Lost to Follow-up|15|||
125878841|NCT03199976|452853421|FG001|Overall Study|Lack of Efficacy|6|||
126093765|NCT02425904|453636159|FG000|Overall Study|Death|0|||
126093766|NCT02425904|453636160|FG001|Overall Study|Death|3|||
126093767|NCT05260021|453636165|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
126093768|NCT05260021|453636166|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
126093769|NCT05260021|453636167|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
126093770|NCT05260021|453636165|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
126093771|NCT05260021|453636166|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
126093772|NCT05260021|453636167|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
126093773|NCT05260021|453636165|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
126093774|NCT05260021|453636166|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
126093775|NCT05260021|453636167|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
126093776|NCT05260021|453636165|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
126093777|NCT05260021|453636166|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
126093778|NCT05260021|453636167|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
126093779|NCT05260021|453636165|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
126241165|NCT03206177|454177466|FG000|Overall Study|Withdrawal by Subject|1|||
126241166|NCT03041025|454177467|FG000|Overall Study|Adverse Event|0|||
126241167|NCT03041025|454177468|FG001|Overall Study|Adverse Event|0|||
126241168|NCT03041025|454177469|FG002|Overall Study|Adverse Event|1|||
126241169|NCT03041025|454177467|FG000|Overall Study|Lost to Follow-up|1|||
125878842|NCT03199976|452853422|FG002|Overall Study|Lack of Efficacy|13|||
125878843|NCT03199976|452853420|FG000|Overall Study|Withdrawal by Subject|1|||
125878844|NCT03199976|452853421|FG001|Overall Study|Withdrawal by Subject|0|||
125878845|NCT03199976|452853422|FG002|Overall Study|Withdrawal by Subject|0|||
125878846|NCT03199976|452853420|FG000|Overall Study|Lost to Follow-up|0|||
125878847|NCT03199976|452853421|FG001|Overall Study|Lost to Follow-up|1|||
125878848|NCT03199976|452853422|FG002|Overall Study|Lost to Follow-up|1|||
125878849|NCT01780506|452853429|FG000|Double-Blind Phase|Randomized but not Treated|3|||
125878850|NCT01780506|452853430|FG001|Double-Blind Phase|Randomized but not Treated|2|||
125878851|NCT01780506|452853429|FG000|Double-Blind Phase|Adverse Event|4|||
125878852|NCT01780506|452853430|FG001|Double-Blind Phase|Adverse Event|14|||
125878853|NCT01780506|452853429|FG000|Double-Blind Phase|Death|1|||
125878854|NCT01780506|452853430|FG001|Double-Blind Phase|Death|2|||
125878855|NCT01780506|452853429|FG000|Double-Blind Phase|Pregnancy|2|||
125878856|NCT01780506|452853430|FG001|Double-Blind Phase|Pregnancy|1|||
125878857|NCT01780506|452853429|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125878858|NCT01780506|452853430|FG001|Double-Blind Phase|Lack of Efficacy|1|||
125878859|NCT01780506|452853429|FG000|Double-Blind Phase|Investigator's Discretion|5|||
126241170|NCT03041025|454177468|FG001|Overall Study|Lost to Follow-up|0|||
126241171|NCT03041025|454177469|FG002|Overall Study|Lost to Follow-up|0|||
126241172|NCT03041025|454177467|FG000|Overall Study|Withdrawal by Subject|0|||
126241173|NCT03041025|454177468|FG001|Overall Study|Withdrawal by Subject|0|||
126241174|NCT03041025|454177469|FG002|Overall Study|Withdrawal by Subject|1|||
126241175|NCT02963259|454177470|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
126241176|NCT02963259|454177470|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
126241177|NCT02963259|454177470|FG000|Overall Study|Death|1|||
126241178|NCT02963259|454177470|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
126241179|NCT04611789|454177472|FG000|Overall Study|Lost to Follow-up|1|||
126241180|NCT04611789|454177473|FG001|Overall Study|Lost to Follow-up|0|||
126241181|NCT04611789|454177474|FG002|Overall Study|Lost to Follow-up|0|||
125878860|NCT01780506|452853430|FG001|Double-Blind Phase|Investigator's Discretion|2|||
125878861|NCT01780506|452853429|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
125878862|NCT01780506|452853430|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
126093780|NCT05260021|453636166|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
126093781|NCT05260021|453636167|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
126093782|NCT03842358|453636169|FG000|Overall Study|Poor DOT probe contact with breast|2|||
126093783|NCT03842358|453636169|FG000|Overall Study|DOT system problem|1|||
126093784|NCT03842358|453636169|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
126093785|NCT03842358|453636169|FG000|Overall Study|No biopsy after physician review|4|||
126093786|NCT03842358|453636169|FG000|Overall Study|Patient withdrew|2|||
126241182|NCT02131129|454177475|FG000|Overall Study|Withdrawal by Subject|1|||
126241183|NCT02131129|454177476|FG001|Overall Study|Withdrawal by Subject|0|||
126241184|NCT00727961|454177477|FG000|Overall Study|Lost to Follow-up|1|||
126241185|NCT00727961|454177477|FG000|Overall Study|Adverse Event|4|||
126241186|NCT00727961|454177477|FG000|Overall Study|Patient's refusal|2|||
126241187|NCT00727961|454177477|FG000|Overall Study|Progression|30|||
125878863|NCT01780506|452853429|FG000|Double-Blind Phase|Protocol Violation|4|||
125878864|NCT01780506|452853430|FG001|Double-Blind Phase|Protocol Violation|3|||
125878865|NCT01780506|452853429|FG000|Double-Blind Phase|Withdrew Consent|23|||
125878866|NCT01780506|452853430|FG001|Double-Blind Phase|Withdrew Consent|24|||
125878867|NCT01780506|452853429|FG000|Double-Blind Phase|Lost to Follow-up|23|||
126241188|NCT02865122|454177478|FG000|Overall Study|Adverse Event|1|||
126241189|NCT02865122|454177479|FG001|Overall Study|Adverse Event|0|||
126026022|NCT01772472|453390658|FG001|Overall Study|Death|94|||
126026023|NCT01772472|453390657|FG000|Overall Study|Lost to Follow-up|51|||
126026024|NCT01772472|453390658|FG001|Overall Study|Lost to Follow-up|50|||
126026025|NCT01772472|453390657|FG000|Overall Study|Other|9|||
126026026|NCT01772472|453390658|FG001|Overall Study|Other|7|||
126026027|NCT01772472|453390657|FG000|Overall Study|Physician Decision|1|||
126026028|NCT01772472|453390658|FG001|Overall Study|Physician Decision|7|||
126241190|NCT02865122|454177480|FG002|Overall Study|Adverse Event|0|||
126241191|NCT03880266|454177481|FG000|Overall Study|Withdrawal by Subject|0|||
126241192|NCT03880266|454177482|FG001|Overall Study|Withdrawal by Subject|1|||
126241193|NCT03880266|454177483|FG002|Overall Study|Withdrawal by Subject|1|||
126241194|NCT03880266|454177484|FG003|Overall Study|Withdrawal by Subject|0|||
126241195|NCT03880266|454177485|FG004|Overall Study|Withdrawal by Subject|0|||
126241196|NCT03880266|454177486|FG005|Overall Study|Withdrawal by Subject|0|||
126241197|NCT03880266|454177487|FG006|Overall Study|Withdrawal by Subject|0|||
126241198|NCT03880266|454177488|FG007|Overall Study|Withdrawal by Subject|0|||
126241199|NCT03161405|454177489|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
126241200|NCT00837486|454177490|FG000|Blinded-treatment Phase|Physician Decision|1|||
126241201|NCT00837486|454177491|FG001|Blinded-treatment Phase|Physician Decision|0|||
126241202|NCT00837486|454177490|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
126241203|NCT00837486|454177491|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
126241204|NCT00837486|454177490|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
126241205|NCT00837486|454177491|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
126241206|NCT00837486|454177490|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
126241207|NCT00837486|454177491|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
126241208|NCT01421277|454177493|FG000|Overall Study|Lack of qualifying event|0|||
126241209|NCT01421277|454177494|FG001|Overall Study|Lack of qualifying event|61|||
126241210|NCT01421277|454177493|FG000|Overall Study|Incomplete baseline data|0|||
126241211|NCT01421277|454177494|FG001|Overall Study|Incomplete baseline data|31|||
126356872|NCT03166631|454599609|FG007|Overall Study|Progressive disease|6|||
126356873|NCT03166631|454599610|FG008|Overall Study|Progressive disease|11|||
126356874|NCT03166631|454599611|FG009|Overall Study|Progressive disease|5|||
126356875|NCT03166631|454599612|FG010|Overall Study|Progressive disease|7|||
126356876|NCT03166631|454599602|FG000|Overall Study|Physician Decision|0|||
126356877|NCT03166631|454599603|FG001|Overall Study|Physician Decision|0|||
126356878|NCT03166631|454599604|FG002|Overall Study|Physician Decision|0|||
126356879|NCT03166631|454599605|FG003|Overall Study|Physician Decision|0|||
126356880|NCT03166631|454599606|FG004|Overall Study|Physician Decision|0|||
126356881|NCT03166631|454599607|FG005|Overall Study|Physician Decision|0|||
126356882|NCT03166631|454599608|FG006|Overall Study|Physician Decision|1|||
126356883|NCT03166631|454599609|FG007|Overall Study|Physician Decision|0|||
126356884|NCT03166631|454599610|FG008|Overall Study|Physician Decision|1|||
126356885|NCT03166631|454599611|FG009|Overall Study|Physician Decision|0|||
126356886|NCT03166631|454599612|FG010|Overall Study|Physician Decision|1|||
126356887|NCT03166631|454599602|FG000|Overall Study|Death|0|||
126356888|NCT03166631|454599603|FG001|Overall Study|Death|0|||
126356889|NCT03166631|454599604|FG002|Overall Study|Death|0|||
126356890|NCT03166631|454599605|FG003|Overall Study|Death|0|||
126356891|NCT03166631|454599606|FG004|Overall Study|Death|1|||
126356892|NCT03166631|454599607|FG005|Overall Study|Death|0|||
126356893|NCT03166631|454599608|FG006|Overall Study|Death|1|||
126356894|NCT03166631|454599609|FG007|Overall Study|Death|0|||
126356895|NCT03166631|454599610|FG008|Overall Study|Death|0|||
126356896|NCT03166631|454599611|FG009|Overall Study|Death|0|||
126356897|NCT03166631|454599612|FG010|Overall Study|Death|0|||
126356898|NCT03166631|454599602|FG000|Overall Study|Adverse Event|1|||
126356899|NCT03166631|454599603|FG001|Overall Study|Adverse Event|0|||
126356900|NCT03166631|454599604|FG002|Overall Study|Adverse Event|0|||
126356901|NCT03166631|454599605|FG003|Overall Study|Adverse Event|0|||
126356902|NCT03166631|454599606|FG004|Overall Study|Adverse Event|0|||
126356903|NCT03166631|454599607|FG005|Overall Study|Adverse Event|1|||
126356904|NCT03166631|454599608|FG006|Overall Study|Adverse Event|1|||
126356905|NCT03166631|454599609|FG007|Overall Study|Adverse Event|0|||
126356906|NCT03166631|454599610|FG008|Overall Study|Adverse Event|1|||
126356907|NCT03166631|454599611|FG009|Overall Study|Adverse Event|2|||
126356908|NCT03166631|454599612|FG010|Overall Study|Adverse Event|1|||
125878868|NCT01780506|452853430|FG001|Double-Blind Phase|Lost to Follow-up|26|||
126241212|NCT00834249|454179227|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126356909|NCT03166631|454599602|FG000|Overall Study|Withdrawal by Subject|0|||
126356910|NCT03166631|454599603|FG001|Overall Study|Withdrawal by Subject|0|||
126356911|NCT03166631|454599604|FG002|Overall Study|Withdrawal by Subject|0|||
126356912|NCT03166631|454599605|FG003|Overall Study|Withdrawal by Subject|0|||
126026029|NCT01772472|453390657|FG000|Overall Study|Withdrawal by Subject|115|||
126026030|NCT01772472|453390658|FG001|Overall Study|Withdrawal by Subject|90|||
126026031|NCT01772472|453390657|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
126356913|NCT03166631|454599606|FG004|Overall Study|Withdrawal by Subject|0|||
126356914|NCT03166631|454599607|FG005|Overall Study|Withdrawal by Subject|0|||
126356915|NCT03166631|454599608|FG006|Overall Study|Withdrawal by Subject|0|||
126026032|NCT01772472|453390658|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
126026033|NCT04431726|453390667|FG000|Overall Study|Ongoing in the Study|55|||
126026034|NCT04093752|453390669|FG000|Overall Study|Adverse Event|7|||
126026035|NCT04093752|453390670|FG001|Overall Study|Adverse Event|19|||
126026036|NCT04093752|453390671|FG002|Overall Study|Adverse Event|18|||
126026037|NCT04093752|453390672|FG003|Overall Study|Adverse Event|4|||
126026038|NCT04093752|453390669|FG000|Overall Study|Withdrawal by Subject|6|||
126026039|NCT04093752|453390670|FG001|Overall Study|Withdrawal by Subject|6|||
126241213|NCT00834249|454179228|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
126241214|NCT00834249|454179227|FG000|Second Intervention|Adverse Event|1|||
126026040|NCT04093752|453390671|FG002|Overall Study|Withdrawal by Subject|8|||
126241215|NCT00834249|454179228|FG001|Second Intervention|Adverse Event|0|||
126241216|NCT02146105|454179229|FG000|Overall Study|Adverse Event|1|||
126241217|NCT02146105|454179229|FG000|Overall Study|Withdrawal by Subject|5|||
126241218|NCT05755282|454179232|FG000|Overall Study|Protocol Violation|0|||
126241219|NCT05755282|454179233|FG001|Overall Study|Protocol Violation|1|||
126241220|NCT03935880|454179235|FG000|Overall Study|Lost to Follow-up|0|||
126241221|NCT03935880|454179236|FG001|Overall Study|Lost to Follow-up|1|||
126241222|NCT02476994|454179237|FG000|Overall Study|Based on feedback from FDA|1|||
126241223|NCT02476994|454179238|FG001|Overall Study|Based on feedback from FDA|0|||
126241224|NCT01015703|454179239|FG000|Overall Study|Withdrawal by Subject|0|||
126241225|NCT01015703|454179240|FG001|Overall Study|Withdrawal by Subject|1|||
126241226|NCT01015703|454179241|FG002|Overall Study|Withdrawal by Subject|0|||
126241227|NCT01015703|454179242|FG003|Overall Study|Withdrawal by Subject|0|||
126241228|NCT01015703|454179243|FG004|Overall Study|Withdrawal by Subject|0|||
126241229|NCT01015703|454179239|FG000|Overall Study|Adverse Event|1|||
126241230|NCT01015703|454179240|FG001|Overall Study|Adverse Event|0|||
126241231|NCT01015703|454179241|FG002|Overall Study|Adverse Event|0|||
126241232|NCT01015703|454179242|FG003|Overall Study|Adverse Event|0|||
126241233|NCT01015703|454179243|FG004|Overall Study|Adverse Event|0|||
126241234|NCT01015703|454179239|FG000|Overall Study|Protocol Violation|1|||
126241235|NCT01015703|454179240|FG001|Overall Study|Protocol Violation|0|||
126241236|NCT01015703|454179241|FG002|Overall Study|Protocol Violation|0|||
126241237|NCT01015703|454179242|FG003|Overall Study|Protocol Violation|0|||
126241238|NCT01015703|454179243|FG004|Overall Study|Protocol Violation|0|||
126241239|NCT02718326|454179244|FG000|Overall Study|Adverse Event|4|||
126241240|NCT02718326|454179245|FG001|Overall Study|Adverse Event|9|||
126241241|NCT02718326|454179246|FG002|Overall Study|Adverse Event|0|||
126241242|NCT02718326|454179244|FG000|Overall Study|Death|8|||
126241243|NCT02718326|454179245|FG001|Overall Study|Death|1|||
126241244|NCT02718326|454179246|FG002|Overall Study|Death|2|||
126241245|NCT02718326|454179244|FG000|Overall Study|Withdrawal by Subject|4|||
126241246|NCT02718326|454179245|FG001|Overall Study|Withdrawal by Subject|9|||
126241247|NCT02718326|454179246|FG002|Overall Study|Withdrawal by Subject|6|||
126241248|NCT02718326|454179244|FG000|Overall Study|Lost to Follow-up|18|||
126241249|NCT02718326|454179245|FG001|Overall Study|Lost to Follow-up|5|||
126241250|NCT02718326|454179246|FG002|Overall Study|Lost to Follow-up|14|||
126241251|NCT02718326|454179244|FG000|Overall Study|Protocol Deviation|1|||
126241252|NCT02718326|454179245|FG001|Overall Study|Protocol Deviation|0|||
126241253|NCT02718326|454179246|FG002|Overall Study|Protocol Deviation|0|||
126241254|NCT02718326|454179244|FG000|Overall Study|Pregnancy|1|||
126241255|NCT02718326|454179245|FG001|Overall Study|Pregnancy|0|||
126026041|NCT04093752|453390672|FG003|Overall Study|Withdrawal by Subject|20|||
126241256|NCT02718326|454179246|FG002|Overall Study|Pregnancy|0|||
126241257|NCT03122535|454179247|FG000|Overall Study|Lost to Follow-up|68|||
126241258|NCT03122535|454179248|FG001|Overall Study|Lost to Follow-up|68|||
126241259|NCT03122535|454179247|FG000|Overall Study|Physician Decision|3|||
126241260|NCT03122535|454179248|FG001|Overall Study|Physician Decision|3|||
126241261|NCT03122535|454179247|FG000|Overall Study|Withdrawal by Subject|2|||
126026042|NCT04093752|453390669|FG000|Overall Study|Lost to Follow-up|2|||
126026043|NCT04093752|453390670|FG001|Overall Study|Lost to Follow-up|1|||
126241262|NCT03122535|454179248|FG001|Overall Study|Withdrawal by Subject|2|||
126241263|NCT01558635|454179252|FG000|Overall Study|Death|1|||
126241264|NCT01558635|454179252|FG000|Overall Study|Withdrawal by Subject|2|||
126241265|NCT01558635|454179252|FG000|Overall Study|Physician Decision|1|||
126241266|NCT01558635|454179252|FG000|Overall Study|Subject received other treatment|1|||
126241267|NCT01558635|454179252|FG000|Overall Study|Reveal XT was explanted|1|||
126241268|NCT00834418|454179255|FG000|Overall Study|Adverse Event|0|||
126241269|NCT00834418|454179256|FG001|Overall Study|Adverse Event|2|||
126241270|NCT01705574|454179257|FG000|Double-Blind Phase|Lost to Follow-up|12|||
126241271|NCT01705574|454179258|FG001|Double-Blind Phase|Lost to Follow-up|16|||
126241272|NCT01705574|454179259|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126241273|NCT01705574|454179260|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126241274|NCT01705574|454179257|FG000|Double-Blind Phase|Adverse Event|3|||
126241275|NCT01705574|454179258|FG001|Double-Blind Phase|Adverse Event|10|||
126241276|NCT01705574|454179259|FG002|Double-Blind Phase|Adverse Event|0|||
126241277|NCT01705574|454179260|FG003|Double-Blind Phase|Adverse Event|0|||
126241278|NCT01705574|454179257|FG000|Double-Blind Phase|Withdrew Consent|8|||
126241279|NCT01705574|454179258|FG001|Double-Blind Phase|Withdrew Consent|5|||
126241280|NCT01705574|454179259|FG002|Double-Blind Phase|Withdrew Consent|0|||
126241281|NCT01705574|454179260|FG003|Double-Blind Phase|Withdrew Consent|0|||
126241282|NCT01705574|454179257|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
126241283|NCT01705574|454179258|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
126241284|NCT01705574|454179259|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
126241285|NCT01705574|454179260|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
126241286|NCT01705574|454179257|FG000|Double-Blind Phase|Pregnancy|1|||
126241287|NCT01705574|454179258|FG001|Double-Blind Phase|Pregnancy|1|||
126026044|NCT04093752|453390671|FG002|Overall Study|Lost to Follow-up|1|||
126241288|NCT01705574|454179259|FG002|Double-Blind Phase|Pregnancy|0|||
126241289|NCT01705574|454179260|FG003|Double-Blind Phase|Pregnancy|0|||
126241290|NCT01705574|454179257|FG000|Double-Blind Phase|Protocol Violation|1|||
126241291|NCT01705574|454179258|FG001|Double-Blind Phase|Protocol Violation|0|||
126241292|NCT01705574|454179259|FG002|Double-Blind Phase|Protocol Violation|0|||
126241293|NCT01705574|454179260|FG003|Double-Blind Phase|Protocol Violation|0|||
126241294|NCT01705574|454179257|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
126241295|NCT01705574|454179258|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
126241296|NCT01705574|454179259|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
126241297|NCT01705574|454179260|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
126241298|NCT01705574|454179257|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
126241299|NCT01705574|454179258|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126241300|NCT01705574|454179259|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
126241301|NCT01705574|454179260|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
126241302|NCT01705574|454179257|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
126241303|NCT01705574|454179258|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
126241304|NCT01705574|454179259|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
126241305|NCT01705574|454179260|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
126241306|NCT01705574|454179257|FG000|Open-Label Extension Phase|Adverse Event|3|||
126241307|NCT01705574|454179258|FG001|Open-Label Extension Phase|Adverse Event|0|||
126241308|NCT01705574|454179259|FG002|Open-Label Extension Phase|Adverse Event|0|||
126241309|NCT01705574|454179260|FG003|Open-Label Extension Phase|Adverse Event|1|||
126241310|NCT01705574|454179257|FG000|Open-Label Extension Phase|Death|2|||
126241311|NCT01705574|454179258|FG001|Open-Label Extension Phase|Death|0|||
126241312|NCT01705574|454179259|FG002|Open-Label Extension Phase|Death|1|||
126241313|NCT01705574|454179260|FG003|Open-Label Extension Phase|Death|0|||
126241314|NCT01705574|454179257|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
126241315|NCT01705574|454179258|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
126241316|NCT01705574|454179259|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
126241317|NCT01705574|454179260|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
126241318|NCT01705574|454179257|FG000|Open-Label Extension Phase|Physician Decision|0|||
126241319|NCT01705574|454179258|FG001|Open-Label Extension Phase|Physician Decision|0|||
126241320|NCT01705574|454179259|FG002|Open-Label Extension Phase|Physician Decision|2|||
126241321|NCT01705574|454179260|FG003|Open-Label Extension Phase|Physician Decision|0|||
126241322|NCT01705574|454179257|FG000|Open-Label Extension Phase|Pregnancy|0|||
126356916|NCT03166631|454599609|FG007|Overall Study|Withdrawal by Subject|0|||
126356917|NCT03166631|454599610|FG008|Overall Study|Withdrawal by Subject|1|||
126356918|NCT03166631|454599611|FG009|Overall Study|Withdrawal by Subject|1|||
126356919|NCT03166631|454599612|FG010|Overall Study|Withdrawal by Subject|0|||
126356920|NCT00567580|454599615|FG000|Overall Study|Protocol Violation|28|||
126356921|NCT00567580|454599616|FG001|Overall Study|Protocol Violation|24|||
126356922|NCT00567580|454599617|FG002|Overall Study|Protocol Violation|24|||
126356923|NCT03197935|454599620|FG000|Overall Study|Death due to any cause|26|||
126356924|NCT03197935|454599621|FG001|Overall Study|Death due to any cause|15|||
126356925|NCT03197935|454599620|FG000|Overall Study|Lost to Follow-up|3|||
126356926|NCT03197935|454599621|FG001|Overall Study|Lost to Follow-up|5|||
126356927|NCT03197935|454599620|FG000|Overall Study|Physician Decision|2|||
126356928|NCT03197935|454599621|FG001|Overall Study|Physician Decision|1|||
126356929|NCT03197935|454599620|FG000|Overall Study|Withdrawal by Subject|16|||
126356930|NCT03197935|454599621|FG001|Overall Study|Withdrawal by Subject|8|||
126356931|NCT00864513|454599622|FG000|Overall Study|Withdrawal by Subject|3|||
126356932|NCT00762788|454599623|FG000|Overall Study|Lost to Follow-up|26|||
126356933|NCT00762788|454599624|FG001|Overall Study|Lost to Follow-up|37|||
126356934|NCT00762788|454599625|FG002|Overall Study|Lost to Follow-up|21|||
126356935|NCT00762788|454599626|FG003|Overall Study|Lost to Follow-up|26|||
126356936|NCT00762788|454599627|FG004|Overall Study|Lost to Follow-up|13|||
126356937|NCT00762788|454599628|FG005|Overall Study|Lost to Follow-up|21|||
126356938|NCT03073109|454599629|FG000|Overall Study|Adverse Event|0|||
126356939|NCT03073109|454599630|FG001|Overall Study|Adverse Event|1|||
126356940|NCT03073109|454599629|FG000|Overall Study|Other|2|||
126356941|NCT03073109|454599630|FG001|Overall Study|Other|0|||
126356942|NCT03073109|454599629|FG000|Overall Study|Lost to Follow-up|8|||
126356943|NCT03073109|454599630|FG001|Overall Study|Lost to Follow-up|1|||
126241323|NCT01705574|454179258|FG001|Open-Label Extension Phase|Pregnancy|0|||
126241324|NCT01705574|454179259|FG002|Open-Label Extension Phase|Pregnancy|1|||
126241325|NCT01705574|454179260|FG003|Open-Label Extension Phase|Pregnancy|1|||
126356944|NCT05938010|454599631|FG000|Overall Study|Lost to Follow-up|2|||
126241326|NCT02543203|454179261|FG000|Overall Study|Unpalatable Fragrance|2|||
126241327|NCT02543203|454179262|FG001|Overall Study|Unpalatable Fragrance|2|||
126356945|NCT01562444|454599636|FG000|Overall Study|Did not meet entry criteria|2|||
126356946|NCT01562444|454599637|FG001|Overall Study|Did not meet entry criteria|0|||
126356947|NCT01562444|454599638|FG002|Overall Study|Did not meet entry criteria|3|||
126356948|NCT01562444|454599636|FG000|Overall Study|Did not comply with blood draw schedule|1|||
126026045|NCT04093752|453390672|FG003|Overall Study|Lost to Follow-up|1|||
126241328|NCT02543203|454179261|FG000|Overall Study|Lost to Follow-up|1|||
126241329|NCT02543203|454179262|FG001|Overall Study|Lost to Follow-up|0|||
126241330|NCT02543203|454179261|FG000|Overall Study|Increased Irritability|1|||
126241331|NCT02543203|454179262|FG001|Overall Study|Increased Irritability|0|||
126241332|NCT02543203|454179261|FG000|Overall Study|Family|1|||
126241333|NCT02543203|454179262|FG001|Overall Study|Family|2|||
126241334|NCT02543203|454179261|FG000|Overall Study|Negative Behavior|1|||
126241335|NCT02543203|454179262|FG001|Overall Study|Negative Behavior|0|||
126241336|NCT02543203|454179261|FG000|Overall Study|Withdrawal by Subject|0|||
126241337|NCT02543203|454179262|FG001|Overall Study|Withdrawal by Subject|1|||
126241338|NCT01273805|454179263|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
126241339|NCT01273805|454179264|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
126241340|NCT02647944|454179265|FG000|Overall Study|Withdrawal by Subject|0|||
126241341|NCT02647944|454179266|FG001|Overall Study|Withdrawal by Subject|3|||
126241342|NCT02647944|454179265|FG000|Overall Study|Adverse Event|2|||
126241343|NCT02647944|454179266|FG001|Overall Study|Adverse Event|0|||
126241344|NCT02077465|454179267|FG000|Overall Study|Withdrew Consent|0|||
126241345|NCT02077465|454179268|FG001|Overall Study|Withdrew Consent|1|||
126241346|NCT02077465|454179267|FG000|Overall Study|Lost to Follow-up|1|||
126241347|NCT02077465|454179268|FG001|Overall Study|Lost to Follow-up|0|||
126241348|NCT02760368|454179270|FG000|Overall Study|Withdrawal by Subject|8|||
126241349|NCT02760368|454179271|FG001|Overall Study|Withdrawal by Subject|12|||
126241350|NCT02760368|454179272|FG002|Overall Study|Withdrawal by Subject|9|||
126241351|NCT02760368|454179270|FG000|Overall Study|Screen Failure|0|||
126241352|NCT02760368|454179271|FG001|Overall Study|Screen Failure|0|||
126241353|NCT02760368|454179272|FG002|Overall Study|Screen Failure|1|||
126241354|NCT02760368|454179270|FG000|Overall Study|Death|0|||
126241355|NCT02760368|454179271|FG001|Overall Study|Death|1|||
126241356|NCT02760368|454179272|FG002|Overall Study|Death|0|||
126241357|NCT02760368|454179270|FG000|Overall Study|Withdrawal by Sponsor|0|||
126241358|NCT02760368|454179271|FG001|Overall Study|Withdrawal by Sponsor|0|||
126241359|NCT02760368|454179272|FG002|Overall Study|Withdrawal by Sponsor|1|||
126241360|NCT01827163|454179273|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
126241361|NCT01827163|454179273|FG000|Overall Study|Adverse Event|9|||
126241362|NCT03620747|454179275|FG000|Overall Study|Participant decision|7|||
126241363|NCT03620747|454179275|FG000|Overall Study|Adverse Event|6|||
126241364|NCT03620747|454179275|FG000|Overall Study|Lack of Efficacy|1|||
126241365|NCT03620747|454179275|FG000|Overall Study|Poor compliance to protocol|2|||
126241366|NCT03620747|454179275|FG000|Overall Study|Other-unspecified|3|||
126241367|NCT02714062|454179276|FG000|Overall Study|Adverse Event|0|||
126241368|NCT02714062|454179277|FG001|Overall Study|Adverse Event|0|||
126241369|NCT02714062|454179278|FG002|Overall Study|Adverse Event|2|||
126241370|NCT02714062|454179276|FG000|Overall Study|Withdrawal by Subject|1|||
126241371|NCT02714062|454179277|FG001|Overall Study|Withdrawal by Subject|0|||
126241372|NCT02714062|454179278|FG002|Overall Study|Withdrawal by Subject|1|||
126241373|NCT02714062|454179276|FG000|Overall Study|Protocol Violation|0|||
126241374|NCT02714062|454179277|FG001|Overall Study|Protocol Violation|1|||
126356949|NCT01562444|454599637|FG001|Overall Study|Did not comply with blood draw schedule|0|||
126356950|NCT01562444|454599638|FG002|Overall Study|Did not comply with blood draw schedule|1|||
126356951|NCT01562444|454599636|FG000|Overall Study|Unavailable serological results|0|||
126356952|NCT01562444|454599637|FG001|Overall Study|Unavailable serological results|2|||
126356953|NCT01562444|454599638|FG002|Overall Study|Unavailable serological results|2|||
126356954|NCT01562444|454599636|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
126356955|NCT01562444|454599637|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
126356956|NCT01562444|454599638|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
126356957|NCT01562444|454599636|FG000|Overall Study|Protocol forbidden medication|1|||
126356958|NCT01562444|454599637|FG001|Overall Study|Protocol forbidden medication|0|||
126356959|NCT01562444|454599638|FG002|Overall Study|Protocol forbidden medication|0|||
126356960|NCT02568423|454599646|FG000|Overall Study|Lost to Follow-up|0|||
126356961|NCT02568423|454599647|FG001|Overall Study|Lost to Follow-up|2|||
126356962|NCT02568423|454599648|FG002|Overall Study|Lost to Follow-up|0|||
126356963|NCT02568423|454599649|FG003|Overall Study|Lost to Follow-up|0|||
126356964|NCT02568423|454599650|FG004|Overall Study|Lost to Follow-up|0|||
126356965|NCT02568423|454599651|FG005|Overall Study|Lost to Follow-up|0|||
126356966|NCT02568423|454599652|FG006|Overall Study|Lost to Follow-up|0|||
126356967|NCT02568423|454599653|FG007|Overall Study|Lost to Follow-up|0|||
126356968|NCT02568423|454599646|FG000|Overall Study|Physician Decision|0|||
126026046|NCT04093752|453390669|FG000|Overall Study|Death|0|||
126241375|NCT02714062|454179278|FG002|Overall Study|Protocol Violation|0|||
126241376|NCT02294604|454179279|FG000|Overall Study|Did not provide samples for culture|0|||
126241377|NCT02294604|454179280|FG001|Overall Study|Did not provide samples for culture|1|||
126241378|NCT02294604|454179281|FG002|Overall Study|Did not provide samples for culture|0|||
126241379|NCT02294604|454179279|FG000|Overall Study|Culture contamination|1|||
126241380|NCT02294604|454179280|FG001|Overall Study|Culture contamination|2|||
126241381|NCT02294604|454179281|FG002|Overall Study|Culture contamination|0|||
126241382|NCT01401647|454179288|FG000|Overall Study|Withdrawal by Subject|1|||
125878869|NCT01780506|452853429|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
125878870|NCT01780506|452853430|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
125878871|NCT05236270|452853431|FG000|Overall Study|Lost to Follow-up|3|||
125878872|NCT05236270|452853432|FG001|Overall Study|Lost to Follow-up|2|||
125878873|NCT05236270|452853433|FG002|Overall Study|Lost to Follow-up|0|||
125878874|NCT05236270|452853434|FG003|Overall Study|Lost to Follow-up|0|||
125878875|NCT05236270|452853435|FG004|Overall Study|Lost to Follow-up|2|||
125878876|NCT05236270|452853436|FG005|Overall Study|Lost to Follow-up|0|||
125878877|NCT05236270|452853437|FG006|Overall Study|Lost to Follow-up|1|||
125878878|NCT05236270|452853438|FG007|Overall Study|Lost to Follow-up|3|||
125878879|NCT04030143|452853439|FG000|Overall Study|Adverse Event|5|||
125878880|NCT04030143|452853440|FG001|Overall Study|Adverse Event|10|||
125878881|NCT04030143|452853439|FG000|Overall Study|Lost to Follow-up|3|||
125878882|NCT04030143|452853440|FG001|Overall Study|Lost to Follow-up|7|||
125878883|NCT04030143|452853439|FG000|Overall Study|Protocol Deviation|2|||
125878884|NCT04030143|452853440|FG001|Overall Study|Protocol Deviation|2|||
125878885|NCT04030143|452853439|FG000|Overall Study|Withdrawal by Subject|16|||
125878886|NCT04030143|452853440|FG001|Overall Study|Withdrawal by Subject|18|||
125878887|NCT04030143|452853439|FG000|Overall Study|Physician Decision|1|||
125878888|NCT04030143|452853440|FG001|Overall Study|Physician Decision|1|||
125878889|NCT04030143|452853439|FG000|Overall Study|Due to Covid-19|2|||
125878890|NCT04030143|452853440|FG001|Overall Study|Due to Covid-19|3|||
125878891|NCT04030143|452853439|FG000|Overall Study|Not Due to Covid-19|1|||
125878892|NCT04030143|452853440|FG001|Overall Study|Not Due to Covid-19|1|||
125878893|NCT00412984|452853441|FG000|Overall Study|Death|331|||
125878894|NCT00412984|452853442|FG001|Overall Study|Death|349|||
125878895|NCT00412984|452853441|FG000|Overall Study|Adverse Event|679|||
125878896|NCT00412984|452853442|FG001|Overall Study|Adverse Event|738|||
125878897|NCT00412984|452853441|FG000|Overall Study|Withdrawal by Subject|921|||
125878898|NCT00412984|452853442|FG001|Overall Study|Withdrawal by Subject|989|||
125878899|NCT00412984|452853441|FG000|Overall Study|Lost to Follow-up|51|||
125878900|NCT00412984|452853442|FG001|Overall Study|Lost to Follow-up|39|||
125878901|NCT00412984|452853441|FG000|Overall Study|Poor/Noncompliance|57|||
125878902|NCT00412984|452853442|FG001|Overall Study|Poor/Noncompliance|77|||
125878903|NCT00412984|452853441|FG000|Overall Study|Pregnancy|1|||
125878904|NCT00412984|452853442|FG001|Overall Study|Pregnancy|0|||
125878905|NCT00412984|452853441|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
125878906|NCT00412984|452853442|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
125878907|NCT00412984|452853441|FG000|Overall Study|Administrative Reason by Sponsor|11|||
125878908|NCT00412984|452853442|FG001|Overall Study|Administrative Reason by Sponsor|8|||
125878909|NCT00412984|452853441|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
125878910|NCT00412984|452853442|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
125878911|NCT00412984|452853441|FG000|Overall Study|Other Reason|80|||
125878912|NCT00412984|452853442|FG001|Overall Study|Other Reason|92|||
125878913|NCT00412984|452853441|FG000|Overall Study|Not Reported|11|||
125878914|NCT00412984|452853442|FG001|Overall Study|Not Reported|12|||
125878915|NCT01499940|452853443|FG000|Overall Study|Study was withdrawn before completion.|9|||
125878916|NCT04218240|452853444|FG000|Overall Study|Withdrawal by Subject|6|||
125878917|NCT04218240|452853445|FG001|Overall Study|Withdrawal by Subject|0|||
125878918|NCT04218240|452853444|FG000|Overall Study|Lack of Efficacy|24|||
125878919|NCT04218240|452853445|FG001|Overall Study|Lack of Efficacy|19|||
125878920|NCT04218240|452853444|FG000|Overall Study|Physician Decision|0|||
125878921|NCT04218240|452853445|FG001|Overall Study|Physician Decision|1|||
125878922|NCT04218240|452853444|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
125878923|NCT04218240|452853445|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
125878924|NCT04914364|452853446|FG000|Overall Study|No longer eligible for study|1|||
125878925|NCT04914364|452853446|FG000|Overall Study|Lost to Follow-up|2|||
125878926|NCT04097678|452853447|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
125878927|NCT04097678|452853448|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
125878928|NCT03694678|452853449|FG000|Overall Study|Withdrawal by Subject|2|||
125878929|NCT03694678|452853450|FG001|Overall Study|Withdrawal by Subject|0|||
125878930|NCT03694678|452853449|FG000|Overall Study|Lost to Follow-up|2|||
125878931|NCT03694678|452853450|FG001|Overall Study|Lost to Follow-up|3|||
125878932|NCT02435212|452853451|FG000|Core Phase|Adverse Event|8|||
125878933|NCT02435212|452853452|FG001|Core Phase|Adverse Event|5|||
125878934|NCT02435212|452853451|FG000|Core Phase|Withdrawal by Subject|3|||
125878935|NCT02435212|452853452|FG001|Core Phase|Withdrawal by Subject|0|||
125878936|NCT02435212|452853451|FG000|Core Phase|Withdrawal by parent/guardian|9|||
125878937|NCT02435212|452853452|FG001|Core Phase|Withdrawal by parent/guardian|4|||
125878938|NCT02435212|452853451|FG000|Core Phase|Protocol Violation|1|||
125878939|NCT02435212|452853452|FG001|Core Phase|Protocol Violation|2|||
125878940|NCT02435212|452853451|FG000|Core Phase|Physician Decision|3|||
125878941|NCT02435212|452853452|FG001|Core Phase|Physician Decision|0|||
125878942|NCT02435212|452853451|FG000|Core Phase|Lost to Follow-up|0|||
125878943|NCT02435212|452853452|FG001|Core Phase|Lost to Follow-up|1|||
125878944|NCT02435212|452853451|FG000|Core Phase|Lack of Efficacy|0|||
125878945|NCT02435212|452853452|FG001|Core Phase|Lack of Efficacy|1|||
125878946|NCT02435212|452853451|FG000|Core Phase|Recovery|1|||
125878947|NCT02435212|452853452|FG001|Core Phase|Recovery|0|||
125878948|NCT02435212|452853451|FG000|Optional Extension Phase|Adverse Event|3|||
125878949|NCT02435212|452853452|FG001|Optional Extension Phase|Adverse Event|9|||
125878950|NCT02435212|452853451|FG000|Optional Extension Phase|Physician Decision|6|||
125878951|NCT02435212|452853452|FG001|Optional Extension Phase|Physician Decision|8|||
125878952|NCT02435212|452853451|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
125878953|NCT02435212|452853452|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
125878954|NCT02435212|452853451|FG000|Optional Extension Phase|Lack of Efficacy|2|||
125878955|NCT02435212|452853452|FG001|Optional Extension Phase|Lack of Efficacy|3|||
125878956|NCT02435212|452853451|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
125878957|NCT02435212|452853452|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
125878958|NCT02435212|452853451|FG000|Optional Extension Phase|Protocol Violation|0|||
125878959|NCT02435212|452853452|FG001|Optional Extension Phase|Protocol Violation|1|||
125878960|NCT02435212|452853451|FG000|Optional Extension Phase|Recovery|1|||
125878961|NCT02435212|452853452|FG001|Optional Extension Phase|Recovery|1|||
125878962|NCT02435212|452853451|FG000|Optional Extension Phase|Death|1|||
125878963|NCT02435212|452853452|FG001|Optional Extension Phase|Death|0|||
125878964|NCT02435212|452853451|FG000|Optional Extension Phase|Technical problems|2|||
125878965|NCT02435212|452853452|FG001|Optional Extension Phase|Technical problems|0|||
125878966|NCT05966142|452853462|FG000|Overall Study|Death|3|||
125878967|NCT05966142|452853463|FG001|Overall Study|Death|3|||
125878968|NCT05966142|452853462|FG000|Overall Study|Lost to Follow-up|55|||
125878969|NCT05966142|452853463|FG001|Overall Study|Lost to Follow-up|52|||
125878970|NCT05966142|452853462|FG000|Overall Study|Physician Decision|1|||
125878971|NCT05966142|452853463|FG001|Overall Study|Physician Decision|0|||
125878972|NCT05966142|452853462|FG000|Overall Study|Withdrawal by Subject|9|||
125878973|NCT05966142|452853463|FG001|Overall Study|Withdrawal by Subject|8|||
126241383|NCT01401647|454179289|FG001|Overall Study|Withdrawal by Subject|5|||
126241384|NCT01401647|454179290|FG002|Overall Study|Withdrawal by Subject|2|||
126241385|NCT01401647|454179288|FG000|Overall Study|Lost to Follow-up|3|||
126241386|NCT01401647|454179289|FG001|Overall Study|Lost to Follow-up|3|||
126241387|NCT01401647|454179290|FG002|Overall Study|Lost to Follow-up|1|||
126241388|NCT00473330|454179294|FG000|Core Study|Adverse Event|4|||
126241389|NCT00473330|454179295|FG001|Core Study|Adverse Event|4|||
126241390|NCT00473330|454179296|FG002|Core Study|Adverse Event|1|||
126241391|NCT00473330|454179294|FG000|Core Study|Death|6|||
126241392|NCT00473330|454179295|FG001|Core Study|Death|4|||
126241393|NCT00473330|454179296|FG002|Core Study|Death|4|||
126241394|NCT00473330|454179294|FG000|Core Study|Lost to Follow-up|5|||
126241395|NCT00473330|454179295|FG001|Core Study|Lost to Follow-up|5|||
126241396|NCT00473330|454179296|FG002|Core Study|Lost to Follow-up|10|||
126241397|NCT00473330|454179294|FG000|Core Study|Physician Decision|2|||
126241398|NCT00473330|454179295|FG001|Core Study|Physician Decision|1|||
126241399|NCT00473330|454179296|FG002|Core Study|Physician Decision|3|||
126241400|NCT00473330|454179294|FG000|Core Study|Subject Non-compliance|1|||
126241401|NCT00473330|454179295|FG001|Core Study|Subject Non-compliance|2|||
126241402|NCT00473330|454179296|FG002|Core Study|Subject Non-compliance|1|||
126241403|NCT00473330|454179294|FG000|Core Study|Subject Required Other Therapy|0|||
125878974|NCT05966142|452853462|FG000|Overall Study|Duplicate Enrollment|1|||
125878975|NCT05966142|452853463|FG001|Overall Study|Duplicate Enrollment|0|||
126241404|NCT00473330|454179295|FG001|Core Study|Subject Required Other Therapy|1|||
125878976|NCT05966142|452853462|FG000|Overall Study|Study Logistical Reason|1|||
125878977|NCT05966142|452853463|FG001|Overall Study|Study Logistical Reason|0|||
125878978|NCT05966142|452853462|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
125878979|NCT05966142|452853463|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
125878980|NCT04852302|452853469|FG000|Overall Study|Withdrawal by Subject|2|||
125878981|NCT04852302|452853469|FG000|Overall Study|Did not complete CALM therapy.|2|||
125878982|NCT03267277|452853470|FG000|Overall Study|Withdrawal by Subject|1|||
126026047|NCT04093752|453390670|FG001|Overall Study|Death|0|||
126241405|NCT00473330|454179296|FG002|Core Study|Subject Required Other Therapy|3|||
126241406|NCT00473330|454179294|FG000|Core Study|Subject's Decision|9|||
126241407|NCT00473330|454179295|FG001|Core Study|Subject's Decision|8|||
126241408|NCT00473330|454179296|FG002|Core Study|Subject's Decision|19|||
126241409|NCT00473330|454179294|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
126026048|NCT04093752|453390671|FG002|Overall Study|Death|1|||
126026049|NCT04093752|453390672|FG003|Overall Study|Death|2|||
126026050|NCT04093752|453390669|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
126241410|NCT00473330|454179295|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
126241411|NCT00473330|454179296|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
126241412|NCT00473330|454179294|FG000|Open-label Extension Through Month 48|Death|2|||
126241413|NCT00473330|454179295|FG001|Open-label Extension Through Month 48|Death|0|||
126241414|NCT00473330|454179296|FG002|Open-label Extension Through Month 48|Death|0|||
126241415|NCT00473330|454179294|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
126241416|NCT00473330|454179295|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
126241417|NCT00473330|454179296|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
126241418|NCT00473330|454179294|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
126241419|NCT00473330|454179295|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
126241420|NCT00473330|454179296|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
126241421|NCT00473330|454179294|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
126241422|NCT00473330|454179295|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
126241423|NCT00473330|454179296|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
126241424|NCT00473330|454179294|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
125878983|NCT04849364|452853471|FG000|Overall Study|Eligibility criteria not meet|0|||
125878984|NCT04849364|452853472|FG001|Overall Study|Eligibility criteria not meet|1|||
126093787|NCT03568318|453637104|FG000|Overall Study|Adverse Event|3|||
126241425|NCT00473330|454179295|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
126241426|NCT00473330|454179296|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
126241427|NCT00473330|454179294|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
126241428|NCT00473330|454179295|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
126241429|NCT00473330|454179296|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
126241430|NCT00473330|454179294|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
126241431|NCT00473330|454179295|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
126241432|NCT00473330|454179296|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
126241433|NCT00473330|454179294|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
126241434|NCT00473330|454179295|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
126241435|NCT00473330|454179296|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
126241436|NCT00473330|454179294|FG000|Open-label Extension Through Month 60|Death|2|||
126241437|NCT00473330|454179295|FG001|Open-label Extension Through Month 60|Death|2|||
126241438|NCT00473330|454179296|FG002|Open-label Extension Through Month 60|Death|1|||
126241439|NCT00473330|454179294|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
126241440|NCT00473330|454179295|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
126241441|NCT00473330|454179296|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
126241442|NCT00473330|454179294|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
126241443|NCT00473330|454179295|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
126241444|NCT00473330|454179296|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
126026051|NCT04093752|453390670|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
126241445|NCT00473330|454179294|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
126241446|NCT00473330|454179295|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
126241447|NCT00473330|454179296|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
126241448|NCT00473330|454179294|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
126241449|NCT00473330|454179295|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
126241450|NCT00473330|454179296|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
126241451|NCT00473330|454179294|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
126241452|NCT00473330|454179295|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
126241453|NCT00473330|454179296|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
126241454|NCT00473330|454179294|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
126241455|NCT00473330|454179295|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
126241456|NCT00473330|454179296|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
126241457|NCT01975948|454179298|FG000|Overall Study|Withdrawal by Subject|17|||
126241458|NCT01975948|454179299|FG001|Overall Study|Withdrawal by Subject|21|||
126241459|NCT01975948|454179300|FG002|Overall Study|Withdrawal by Subject|7|||
126241460|NCT01975948|454179301|FG003|Overall Study|Withdrawal by Subject|6|||
126241461|NCT01675765|454179302|FG000|Overall Study|Progressive disease|4|||
126241462|NCT01675765|454179303|FG001|Overall Study|Progressive disease|4|||
126241463|NCT01675765|454179302|FG000|Overall Study|Adverse Event|1|||
126241464|NCT01675765|454179303|FG001|Overall Study|Adverse Event|2|||
126241465|NCT01675765|454179302|FG000|Overall Study|Withdrawal by Subject|2|||
126241466|NCT01675765|454179303|FG001|Overall Study|Withdrawal by Subject|0|||
126241467|NCT01675765|454179302|FG000|Overall Study|Death|1|||
126241468|NCT01675765|454179303|FG001|Overall Study|Death|0|||
126241469|NCT01675765|454179302|FG000|Overall Study|Clinical progression|3|||
126241470|NCT01675765|454179303|FG001|Overall Study|Clinical progression|2|||
126241471|NCT00365846|454179307|FG000|Overall Study|Lost to Follow-up|1|||
126241472|NCT01200810|454179308|FG000|Overall Study|Physician Decision|1|||
126241473|NCT01200810|454179309|FG001|Overall Study|Physician Decision|0|||
126241474|NCT01200810|454179308|FG000|Overall Study|Withdrawal by Subject|1|||
126241475|NCT01200810|454179309|FG001|Overall Study|Withdrawal by Subject|2|||
126241476|NCT01200810|454179308|FG000|Overall Study|Sponsor stopped making study drug|3|||
126241477|NCT01200810|454179309|FG001|Overall Study|Sponsor stopped making study drug|3|||
126241478|NCT00904215|454179311|FG000|Overall Study|Adverse Event|25|||
126356969|NCT02568423|454599647|FG001|Overall Study|Physician Decision|0|||
126356970|NCT02568423|454599648|FG002|Overall Study|Physician Decision|0|||
126356971|NCT02568423|454599649|FG003|Overall Study|Physician Decision|0|||
126356972|NCT02568423|454599650|FG004|Overall Study|Physician Decision|0|||
126356973|NCT02568423|454599651|FG005|Overall Study|Physician Decision|1|||
126356974|NCT02568423|454599652|FG006|Overall Study|Physician Decision|0|||
126356975|NCT02568423|454599653|FG007|Overall Study|Physician Decision|0|||
126356976|NCT01027416|454599657|FG000|Overall Study|Withdrawal by Subject|0|||
126356977|NCT01027416|454599658|FG001|Overall Study|Withdrawal by Subject|1|||
126356978|NCT01027416|454599657|FG000|Overall Study|Physician Decision|1|||
126356979|NCT01027416|454599658|FG001|Overall Study|Physician Decision|4|||
126356980|NCT00676052|454599660|FG000|Overall Study|Adverse Event|0|||
126241479|NCT00904215|454179311|FG000|Overall Study|Protocol Violation|10|||
126241480|NCT00904215|454179311|FG000|Overall Study|Lost to Follow-up|63|||
126241481|NCT00904215|454179311|FG000|Overall Study|Withdrawal by Subject|9|||
126241482|NCT00904215|454179311|FG000|Overall Study|Other|28|||
126241483|NCT00960297|454179312|FG000|Overall Study|Physician Decision|1|||
126241484|NCT00960297|454179312|FG000|Overall Study|Venous port infection|1|||
126241485|NCT00960297|454179312|FG000|Overall Study|Disease progression|1|||
126241486|NCT03965091|454179320|FG000|Overall Study|Adverse Event|0|||
126241487|NCT03965091|454179321|FG001|Overall Study|Adverse Event|2|||
126241488|NCT03965091|454179322|FG002|Overall Study|Adverse Event|3|||
126241489|NCT03965091|454179320|FG000|Overall Study|Withdrawal by Subject|11|||
126241490|NCT03965091|454179321|FG001|Overall Study|Withdrawal by Subject|3|||
126241491|NCT03965091|454179322|FG002|Overall Study|Withdrawal by Subject|5|||
126241492|NCT03965091|454179320|FG000|Overall Study|Non-compliance with study drug|0|||
126241493|NCT03965091|454179321|FG001|Overall Study|Non-compliance with study drug|0|||
126241494|NCT03965091|454179322|FG002|Overall Study|Non-compliance with study drug|1|||
126241495|NCT03965091|454179320|FG000|Overall Study|Lost to Follow-up|1|||
126241496|NCT03965091|454179321|FG001|Overall Study|Lost to Follow-up|1|||
126241497|NCT03965091|454179322|FG002|Overall Study|Lost to Follow-up|1|||
126241498|NCT03965091|454179320|FG000|Overall Study|Lack of Efficacy|2|||
126241499|NCT03965091|454179321|FG001|Overall Study|Lack of Efficacy|0|||
126241500|NCT03965091|454179322|FG002|Overall Study|Lack of Efficacy|0|||
126241501|NCT03965091|454179320|FG000|Overall Study|Other than specified|9|||
126241502|NCT03965091|454179321|FG001|Overall Study|Other than specified|11|||
126241503|NCT03965091|454179322|FG002|Overall Study|Other than specified|8|||
126241504|NCT02159950|454179329|FG000|Overall Study|Adverse Event|0|||
126241505|NCT02159950|454179330|FG001|Overall Study|Adverse Event|1|||
126241506|NCT02159950|454179329|FG000|Overall Study|Progression|0|||
126241507|NCT02159950|454179330|FG001|Overall Study|Progression|1|||
126241508|NCT00003659|454179331|FG000|Overall Study|Withdrawal by Subject|3|||
126241509|NCT04400890|454179334|FG000|Overall Study|Withdrawal by Subject|3|||
126241510|NCT04400890|454179335|FG001|Overall Study|Withdrawal by Subject|2|||
126241511|NCT03925532|454179336|FG000|Overall Study|Lost to Follow-up|1|||
126241512|NCT02258074|454179337|FG000|Overall Study|Withdrawal by Subject|1|||
126241513|NCT02258074|454179338|FG001|Overall Study|Withdrawal by Subject|0|||
126241514|NCT02258074|454179339|FG002|Overall Study|Withdrawal by Subject|0|||
126241515|NCT02258074|454179340|FG003|Overall Study|Withdrawal by Subject|0|||
126241516|NCT04405570|454179341|FG000|Overall Study|Adverse Event|0|||
126241517|NCT04405570|454179342|FG001|Overall Study|Adverse Event|1|||
126241518|NCT04405570|454179343|FG002|Overall Study|Adverse Event|1|||
126241519|NCT04405570|454179344|FG003|Overall Study|Adverse Event|1|||
126241520|NCT04405570|454179341|FG000|Overall Study|Lost to Follow-up|0|||
126241521|NCT04405570|454179342|FG001|Overall Study|Lost to Follow-up|1|||
126241522|NCT04405570|454179343|FG002|Overall Study|Lost to Follow-up|0|||
126241523|NCT04405570|454179344|FG003|Overall Study|Lost to Follow-up|0|||
126241524|NCT04405570|454179341|FG000|Overall Study|Physician Decision|0|||
126241525|NCT04405570|454179342|FG001|Overall Study|Physician Decision|0|||
126241526|NCT04405570|454179343|FG002|Overall Study|Physician Decision|1|||
126241527|NCT04405570|454179344|FG003|Overall Study|Physician Decision|0|||
126241528|NCT04405570|454179341|FG000|Overall Study|Withdrawal by Subject|0|||
126241529|NCT04405570|454179342|FG001|Overall Study|Withdrawal by Subject|1|||
126026052|NCT04093752|453390671|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
126241530|NCT04405570|454179343|FG002|Overall Study|Withdrawal by Subject|1|||
126241531|NCT04405570|454179344|FG003|Overall Study|Withdrawal by Subject|0|||
126241532|NCT04405570|454179341|FG000|Overall Study|Randomized not dosed|0|||
126026053|NCT04093752|453390672|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
126241533|NCT04405570|454179342|FG001|Overall Study|Randomized not dosed|2|||
126241534|NCT04405570|454179343|FG002|Overall Study|Randomized not dosed|0|||
126241535|NCT04405570|454179344|FG003|Overall Study|Randomized not dosed|0|||
126241536|NCT00723710|454179345|FG000|Overall Study|Disease progression|48|||
126241537|NCT00723710|454179345|FG000|Overall Study|Adverse Event|88|||
126241538|NCT00723710|454179345|FG000|Overall Study|Withdrawal by Subject|36|||
126241539|NCT00723710|454179345|FG000|Overall Study|Physician Decision|2|||
126241540|NCT04499963|454179346|FG000|Overall Study|Adverse Event|3|||
126241541|NCT04499963|454179347|FG001|Overall Study|Adverse Event|0|||
126241542|NCT04499963|454179346|FG000|Overall Study|Death|3|||
126241543|NCT04499963|454179347|FG001|Overall Study|Death|0|||
126241544|NCT04499963|454179346|FG000|Overall Study|Lack of Efficacy|7|||
126241545|NCT04499963|454179347|FG001|Overall Study|Lack of Efficacy|0|||
126241546|NCT04499963|454179346|FG000|Overall Study|Lost to Follow-up|2|||
126241547|NCT04499963|454179347|FG001|Overall Study|Lost to Follow-up|0|||
126241548|NCT01208337|454179350|FG000|Overall Study|Death|3|||
126241549|NCT03663179|454179353|FG000|Overall Study|Withdrawal by Subject|2|||
126241550|NCT03663179|454179354|FG001|Overall Study|Withdrawal by Subject|0|||
126241551|NCT03663179|454179353|FG000|Overall Study|Lost to Follow-up|1|||
126241552|NCT03663179|454179354|FG001|Overall Study|Lost to Follow-up|1|||
126241553|NCT03663179|454179353|FG000|Overall Study|Revealed exclusionary condition|1|||
126026054|NCT04093752|453390669|FG000|Overall Study|Covid 19|0|||
126026055|NCT04093752|453390670|FG001|Overall Study|Covid 19|0|||
126026056|NCT04093752|453390671|FG002|Overall Study|Covid 19|0|||
126026057|NCT04093752|453390672|FG003|Overall Study|Covid 19|1|||
126026058|NCT04093752|453390669|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
126241554|NCT03663179|454179354|FG001|Overall Study|Revealed exclusionary condition|0|||
126241555|NCT00984126|454179358|FG000|Overall Study|Protocol Violation|0|||
126241556|NCT00984126|454179359|FG001|Overall Study|Protocol Violation|0|||
126026059|NCT04093752|453390670|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
126241557|NCT00984126|454179360|FG002|Overall Study|Protocol Violation|1|||
126241558|NCT00984126|454179361|FG003|Overall Study|Protocol Violation|2|||
126241559|NCT00984126|454179358|FG000|Overall Study|Adverse Event|0|||
126241560|NCT00984126|454179359|FG001|Overall Study|Adverse Event|0|||
126241561|NCT00984126|454179360|FG002|Overall Study|Adverse Event|0|||
126241562|NCT00984126|454179361|FG003|Overall Study|Adverse Event|2|||
126241563|NCT00984126|454179358|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
126241564|NCT00984126|454179359|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
126241565|NCT00984126|454179360|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
126241566|NCT00984126|454179361|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
126241567|NCT00984126|454179358|FG000|Overall Study|Withdrawal criteria|0|||
126241568|NCT00984126|454179359|FG001|Overall Study|Withdrawal criteria|1|||
126241569|NCT00984126|454179360|FG002|Overall Study|Withdrawal criteria|3|||
126241570|NCT00984126|454179361|FG003|Overall Study|Withdrawal criteria|9|||
126241571|NCT01001208|454179362|FG000|Overall Study|Adverse Event|10|||
126241572|NCT01001208|454179363|FG001|Overall Study|Adverse Event|5|||
126241573|NCT01001208|454179362|FG000|Overall Study|Lost to Follow-up|5|||
126241574|NCT01001208|454179363|FG001|Overall Study|Lost to Follow-up|9|||
126241575|NCT01001208|454179362|FG000|Overall Study|Physician Decision|1|||
126241576|NCT01001208|454179363|FG001|Overall Study|Physician Decision|0|||
126241577|NCT01001208|454179362|FG000|Overall Study|Withdrawal by Subject|4|||
126241578|NCT01001208|454179363|FG001|Overall Study|Withdrawal by Subject|5|||
126241579|NCT01001208|454179362|FG000|Overall Study|Ineligibility Determined|4|||
126241580|NCT01001208|454179363|FG001|Overall Study|Ineligibility Determined|2|||
126241581|NCT01001208|454179362|FG000|Overall Study|Noncompliance|4|||
126241582|NCT01001208|454179363|FG001|Overall Study|Noncompliance|7|||
126241583|NCT01001208|454179362|FG000|Overall Study|Disease Progression|0|||
126241584|NCT01001208|454179363|FG001|Overall Study|Disease Progression|3|||
126241585|NCT01001208|454179362|FG000|Overall Study|Other|0|||
126241586|NCT01001208|454179363|FG001|Overall Study|Other|2|||
126241587|NCT01864174|454179364|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
126241588|NCT01864174|454179365|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
126241589|NCT01864174|454179364|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
126241590|NCT01864174|454179365|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
126241591|NCT01864174|454179364|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
126241592|NCT01864174|454179365|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
126241593|NCT01864174|454179364|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
126241594|NCT01864174|454179365|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
126241595|NCT01864174|454179364|FG000|Double Blind - Compliant Randomized|Death|1|||
126241596|NCT01864174|454179365|FG001|Double Blind - Compliant Randomized|Death|0|||
126241597|NCT01864174|454179364|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
126241598|NCT01864174|454179365|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
126241599|NCT01864174|454179364|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
126241600|NCT01864174|454179365|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
126241601|NCT01864174|454179364|FG000|Double Blind - Compliant Randomized|Other|6|||
126241602|NCT01864174|454179365|FG001|Double Blind - Compliant Randomized|Other|10|||
126241603|NCT01864174|454179364|FG000|Off Treatment Follow-Up|Other|2|||
126241604|NCT01864174|454179365|FG001|Off Treatment Follow-Up|Other|0|||
126241605|NCT01864174|454179364|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
126241606|NCT01864174|454179365|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
126241607|NCT01723397|454179369|FG000|Study Period 1|Protocol Violation|0|||
126241608|NCT01723397|454179370|FG001|Study Period 1|Protocol Violation|1|||
126241609|NCT01723397|454179369|FG000|Study Period 2|Protocol Violation|0|||
126241610|NCT01723397|454179370|FG001|Study Period 2|Protocol Violation|1|||
126241611|NCT00468286|454179371|FG000|Overall Study|Adverse Event|1|||
126241612|NCT00468286|454179372|FG001|Overall Study|Adverse Event|6|||
126241613|NCT00468286|454179371|FG000|Overall Study|Protocol Violation|2|||
126241614|NCT00468286|454179372|FG001|Overall Study|Protocol Violation|2|||
126241615|NCT00468286|454179371|FG000|Overall Study|Withdrawal by Subject|4|||
126241616|NCT00468286|454179372|FG001|Overall Study|Withdrawal by Subject|3|||
126241617|NCT00468286|454179371|FG000|Overall Study|Physician Decision|0|||
126241618|NCT00468286|454179372|FG001|Overall Study|Physician Decision|1|||
126241619|NCT02196675|454179373|FG000|Overall Study|Withdrawal by Subject|1|||
126241620|NCT02196675|454179374|FG001|Overall Study|Withdrawal by Subject|0|||
126241621|NCT02196675|454179375|FG002|Overall Study|Withdrawal by Subject|0|||
126241622|NCT02196675|454179373|FG000|Overall Study|Intra-operative surgical exclusion|1|||
126241623|NCT02196675|454179374|FG001|Overall Study|Intra-operative surgical exclusion|1|||
126241624|NCT02196675|454179375|FG002|Overall Study|Intra-operative surgical exclusion|0|||
126241625|NCT02196675|454179373|FG000|Overall Study|Protocol Violation|0|||
126241626|NCT02196675|454179374|FG001|Overall Study|Protocol Violation|1|||
126241627|NCT02196675|454179375|FG002|Overall Study|Protocol Violation|0|||
126241628|NCT02196675|454179373|FG000|Overall Study|Death|0|||
126241629|NCT02196675|454179374|FG001|Overall Study|Death|0|||
126241630|NCT02196675|454179375|FG002|Overall Study|Death|1|||
126241631|NCT02158663|454179376|FG000|Overall Study|Withdrawal by Subject|5|||
126241632|NCT02158663|454179377|FG001|Overall Study|Withdrawal by Subject|4|||
126241633|NCT00537979|454179378|FG000|Overall Study|Adverse Event|2|||
126241634|NCT00537979|454179379|FG001|Overall Study|Adverse Event|2|||
126241635|NCT00537979|454179378|FG000|Overall Study|Withdrawal by Subject|1|||
126241636|NCT00537979|454179379|FG001|Overall Study|Withdrawal by Subject|4|||
126241637|NCT00537979|454179378|FG000|Overall Study|Lost to Follow-up|1|||
126241638|NCT00537979|454179379|FG001|Overall Study|Lost to Follow-up|4|||
126241639|NCT00537979|454179378|FG000|Overall Study|Lack of Efficacy|0|||
126241640|NCT00537979|454179379|FG001|Overall Study|Lack of Efficacy|1|||
126241641|NCT00537979|454179378|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
126241642|NCT00537979|454179379|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
126241643|NCT00537979|454179378|FG000|Overall Study|Death|0|||
126241644|NCT00537979|454179379|FG001|Overall Study|Death|3|||
126241645|NCT00537979|454179378|FG000|Overall Study|Kidney transplant|0|||
126241646|NCT00537979|454179379|FG001|Overall Study|Kidney transplant|3|||
126241647|NCT00537979|454179378|FG000|Overall Study|Heart failure|0|||
126241648|NCT00537979|454179379|FG001|Overall Study|Heart failure|1|||
126241649|NCT02009163|454179380|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
126241650|NCT02009163|454179381|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
126241651|NCT02009163|454179382|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
126241652|NCT02009163|454179380|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
126241653|NCT02009163|454179381|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
126241654|NCT02009163|454179382|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
126241655|NCT02009163|454179380|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
126241656|NCT02009163|454179381|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
126241657|NCT02009163|454179382|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
126241658|NCT02009163|454179380|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
126241659|NCT02009163|454179381|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
126241660|NCT02009163|454179382|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
126241661|NCT02009163|454179380|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
126241662|NCT02009163|454179381|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
126241663|NCT02009163|454179382|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
126241664|NCT02009163|454179380|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
126241665|NCT02009163|454179381|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
126241666|NCT02009163|454179382|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
126241667|NCT02009163|454179380|FG000|Open-label Period (Non-randomized)|Other|13|||
126356981|NCT00676052|454599661|FG001|Overall Study|Adverse Event|1|||
126356982|NCT00676052|454599662|FG002|Overall Study|Adverse Event|1|||
126241668|NCT02009163|454179381|FG001|Open-label Period (Non-randomized)|Other|0|||
126241669|NCT02009163|454179382|FG002|Open-label Period (Non-randomized)|Other|0|||
126241670|NCT02009163|454179380|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
126241671|NCT02009163|454179381|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
126241672|NCT02009163|454179382|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
126356983|NCT00676052|454599663|FG003|Overall Study|Adverse Event|2|||
126356984|NCT00676052|454599664|FG004|Overall Study|Adverse Event|2|||
126241673|NCT02009163|454179380|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
126356985|NCT00676052|454599665|FG005|Overall Study|Adverse Event|2|||
126241674|NCT02009163|454179381|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
126241675|NCT02009163|454179382|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
126241676|NCT02009163|454179380|FG000|Randomized-withdrawal Period|Adverse Event|0|||
126241677|NCT02009163|454179381|FG001|Randomized-withdrawal Period|Adverse Event|0|||
126241678|NCT02009163|454179382|FG002|Randomized-withdrawal Period|Adverse Event|6|||
126241679|NCT02009163|454179380|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
126241680|NCT02009163|454179381|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
126241681|NCT02009163|454179382|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
126241682|NCT02009163|454179380|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
126241683|NCT02009163|454179381|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
126241684|NCT02009163|454179382|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
126241685|NCT02009163|454179380|FG000|Randomized-withdrawal Period|Pregnancy|0|||
126241686|NCT02009163|454179381|FG001|Randomized-withdrawal Period|Pregnancy|0|||
126241687|NCT02009163|454179382|FG002|Randomized-withdrawal Period|Pregnancy|2|||
126241688|NCT02009163|454179380|FG000|Randomized-withdrawal Period|Other|0|||
126241689|NCT02009163|454179381|FG001|Randomized-withdrawal Period|Other|9|||
126241690|NCT02009163|454179382|FG002|Randomized-withdrawal Period|Other|5|||
126241691|NCT00415363|454179383|FG000|Overall Study|Withdrawal by Subject|4|||
126241692|NCT00415363|454179384|FG001|Overall Study|Withdrawal by Subject|4|||
126241693|NCT00415363|454179383|FG000|Overall Study|Adverse Event|4|||
126241694|NCT00415363|454179384|FG001|Overall Study|Adverse Event|4|||
126241695|NCT00415363|454179383|FG000|Overall Study|Lost to Follow-up|2|||
126241696|NCT00415363|454179384|FG001|Overall Study|Lost to Follow-up|1|||
126241697|NCT00415363|454179383|FG000|Overall Study|Physician Decision|3|||
126241698|NCT00415363|454179384|FG001|Overall Study|Physician Decision|1|||
126241699|NCT00415363|454179383|FG000|Overall Study|Death|16|||
126241700|NCT00415363|454179384|FG001|Overall Study|Death|12|||
126241701|NCT00415363|454179383|FG000|Overall Study|Progressive disease|26|||
126241702|NCT00415363|454179384|FG001|Overall Study|Progressive disease|32|||
126241703|NCT00095212|454179385|FG000|Overall Study|Withdrawal by Subject|1|||
126241704|NCT00095212|454179386|FG001|Overall Study|Withdrawal by Subject|3|||
126241705|NCT05341622|454179387|FG000|Overall Study|Death|0|||
126241706|NCT05341622|454179388|FG001|Overall Study|Death|0|||
126241707|NCT05341622|454179389|FG002|Overall Study|Death|0|||
126241708|NCT05341622|454179390|FG003|Overall Study|Death|0|||
126241709|NCT05341622|454179391|FG004|Overall Study|Death|1|||
126241710|NCT05341622|454179392|FG005|Overall Study|Death|0|||
126241711|NCT05341622|454179393|FG006|Overall Study|Death|0|||
126241712|NCT05341622|454179394|FG007|Overall Study|Death|1|||
126241713|NCT05341622|454179387|FG000|Overall Study|Invalid Address|0|||
126241714|NCT05341622|454179388|FG001|Overall Study|Invalid Address|1|||
126241715|NCT05341622|454179389|FG002|Overall Study|Invalid Address|0|||
126241716|NCT05341622|454179390|FG003|Overall Study|Invalid Address|0|||
126241717|NCT05341622|454179391|FG004|Overall Study|Invalid Address|0|||
126241718|NCT05341622|454179392|FG005|Overall Study|Invalid Address|0|||
126241719|NCT05341622|454179393|FG006|Overall Study|Invalid Address|0|||
126241720|NCT05341622|454179394|FG007|Overall Study|Invalid Address|0|||
126241721|NCT05341622|454179387|FG000|Overall Study|Ineligible|26|||
126241722|NCT05341622|454179388|FG001|Overall Study|Ineligible|21|||
126241723|NCT05341622|454179389|FG002|Overall Study|Ineligible|28|||
126241724|NCT05341622|454179390|FG003|Overall Study|Ineligible|24|||
126241725|NCT05341622|454179391|FG004|Overall Study|Ineligible|29|||
126241726|NCT05341622|454179392|FG005|Overall Study|Ineligible|31|||
126241727|NCT05341622|454179393|FG006|Overall Study|Ineligible|28|||
126241728|NCT05341622|454179394|FG007|Overall Study|Ineligible|26|||
126241729|NCT02658084|454179395|FG000|Overall Study|Withdrawal by Subject|1|||
126241730|NCT02658084|454179396|FG001|Overall Study|Withdrawal by Subject|0|||
126241731|NCT02658084|454179395|FG000|Overall Study|Study Termination|1|||
126241732|NCT02658084|454179396|FG001|Overall Study|Study Termination|0|||
126241733|NCT02655679|454179399|FG000|Overall Study|Adverse Event|0|||
126241734|NCT02655679|454179400|FG001|Overall Study|Adverse Event|1|||
126241735|NCT02655679|454179401|FG002|Overall Study|Adverse Event|0|||
126241736|NCT02655679|454179402|FG003|Overall Study|Adverse Event|0|||
126241737|NCT02655679|454179403|FG004|Overall Study|Adverse Event|0|||
126241738|NCT02655679|454179399|FG000|Overall Study|Withdrawal by Subject|1|||
126241739|NCT02655679|454179400|FG001|Overall Study|Withdrawal by Subject|1|||
126241740|NCT02655679|454179401|FG002|Overall Study|Withdrawal by Subject|0|||
126241741|NCT02655679|454179402|FG003|Overall Study|Withdrawal by Subject|3|||
126241742|NCT02655679|454179403|FG004|Overall Study|Withdrawal by Subject|1|||
126241743|NCT02655679|454179399|FG000|Overall Study|Inability to Comply with the Protocol|1|||
126241744|NCT02655679|454179400|FG001|Overall Study|Inability to Comply with the Protocol|0|||
126241745|NCT02655679|454179401|FG002|Overall Study|Inability to Comply with the Protocol|0|||
126241746|NCT02655679|454179402|FG003|Overall Study|Inability to Comply with the Protocol|0|||
126241747|NCT02655679|454179403|FG004|Overall Study|Inability to Comply with the Protocol|0|||
126241748|NCT02655679|454179399|FG000|Overall Study|Lost to Follow-up|0|||
126241749|NCT02655679|454179400|FG001|Overall Study|Lost to Follow-up|1|||
126241750|NCT02655679|454179401|FG002|Overall Study|Lost to Follow-up|1|||
126241751|NCT02655679|454179402|FG003|Overall Study|Lost to Follow-up|1|||
126241752|NCT02655679|454179403|FG004|Overall Study|Lost to Follow-up|0|||
126241753|NCT02655679|454179399|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126241754|NCT02655679|454179400|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126241755|NCT02655679|454179401|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126241756|NCT02655679|454179402|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126241757|NCT02655679|454179403|FG004|Overall Study|Other Miscellaneous Reasons|0|||
126241758|NCT01577381|454179404|FG000|Overall Study|Discontinued|2|||
126241759|NCT01577381|454179405|FG001|Overall Study|Discontinued|1|||
126241760|NCT01577381|454179406|FG002|Overall Study|Discontinued|2|||
126241761|NCT01577381|454179407|FG003|Overall Study|Discontinued|2|||
126241762|NCT01577381|454179404|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
126241763|NCT01577381|454179405|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
126241764|NCT01577381|454179406|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
126241765|NCT01577381|454179407|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
126241766|NCT02186821|454179408|FG000|Overall Study|Adverse Event|9|||
126241767|NCT02186821|454179408|FG000|Overall Study|Death|2|||
126241768|NCT02186821|454179408|FG000|Overall Study|Disease progression|32|||
126241769|NCT02186821|454179408|FG000|Overall Study|Protocol Violation|1|||
126093788|NCT03568318|453637105|FG001|Overall Study|Adverse Event|1|||
126093789|NCT03568318|453637106|FG002|Overall Study|Adverse Event|1|||
126093790|NCT03568318|453637107|FG003|Overall Study|Adverse Event|0|||
126093791|NCT03568318|453637108|FG004|Overall Study|Adverse Event|1|||
126241770|NCT02186821|454179408|FG000|Overall Study|Physician Decision|1|||
126356986|NCT00676052|454599660|FG000|Overall Study|Lack of Efficacy|2|||
126093792|NCT03568318|453637109|FG005|Overall Study|Adverse Event|0|||
126093793|NCT03568318|453637104|FG000|Overall Study|Withdrawal by Subject|6|||
126093794|NCT03568318|453637105|FG001|Overall Study|Withdrawal by Subject|5|||
126356987|NCT00676052|454599661|FG001|Overall Study|Lack of Efficacy|2|||
126356988|NCT00676052|454599662|FG002|Overall Study|Lack of Efficacy|1|||
126356989|NCT00676052|454599663|FG003|Overall Study|Lack of Efficacy|1|||
126356990|NCT00676052|454599664|FG004|Overall Study|Lack of Efficacy|2|||
126356991|NCT00676052|454599665|FG005|Overall Study|Lack of Efficacy|1|||
126356992|NCT00676052|454599660|FG000|Overall Study|Protocol Violation|5|||
126356993|NCT00676052|454599661|FG001|Overall Study|Protocol Violation|3|||
126356994|NCT00676052|454599662|FG002|Overall Study|Protocol Violation|2|||
126356995|NCT00676052|454599663|FG003|Overall Study|Protocol Violation|2|||
126356996|NCT00676052|454599664|FG004|Overall Study|Protocol Violation|1|||
126356997|NCT00676052|454599665|FG005|Overall Study|Protocol Violation|2|||
126356998|NCT00676052|454599660|FG000|Overall Study|Lost to Follow-up|0|||
126356999|NCT00676052|454599661|FG001|Overall Study|Lost to Follow-up|0|||
126357000|NCT00676052|454599662|FG002|Overall Study|Lost to Follow-up|0|||
126357001|NCT00676052|454599663|FG003|Overall Study|Lost to Follow-up|0|||
126357002|NCT00676052|454599664|FG004|Overall Study|Lost to Follow-up|1|||
126357003|NCT00676052|454599665|FG005|Overall Study|Lost to Follow-up|0|||
126357004|NCT00676052|454599660|FG000|Overall Study|Physician Decision|1|||
126357005|NCT00676052|454599661|FG001|Overall Study|Physician Decision|1|||
126357006|NCT00676052|454599662|FG002|Overall Study|Physician Decision|1|||
126357007|NCT00676052|454599663|FG003|Overall Study|Physician Decision|0|||
126357008|NCT00676052|454599664|FG004|Overall Study|Physician Decision|0|||
126357009|NCT00676052|454599665|FG005|Overall Study|Physician Decision|1|||
126357010|NCT00676052|454599660|FG000|Overall Study|Withdrawal by Subject|1|||
126357011|NCT00676052|454599661|FG001|Overall Study|Withdrawal by Subject|0|||
126357012|NCT00676052|454599662|FG002|Overall Study|Withdrawal by Subject|1|||
126357013|NCT00676052|454599663|FG003|Overall Study|Withdrawal by Subject|0|||
125878985|NCT04849364|452853473|FG002|Overall Study|Eligibility criteria not meet|0|||
126093795|NCT03568318|453637106|FG002|Overall Study|Withdrawal by Subject|2|||
126093796|NCT03568318|453637107|FG003|Overall Study|Withdrawal by Subject|1|||
126093797|NCT03568318|453637108|FG004|Overall Study|Withdrawal by Subject|0|||
126093798|NCT03568318|453637109|FG005|Overall Study|Withdrawal by Subject|0|||
126241771|NCT02186821|454179408|FG000|Overall Study|Study terminated by sponsor|2|||
126241772|NCT00819741|454179413|FG000|Overall Study|Adverse Event|5|||
126241773|NCT00819741|454179414|FG001|Overall Study|Adverse Event|2|||
126241774|NCT00819741|454179413|FG000|Overall Study|Lack of Efficacy|0|||
126357014|NCT00676052|454599664|FG004|Overall Study|Withdrawal by Subject|0|||
126357015|NCT00676052|454599665|FG005|Overall Study|Withdrawal by Subject|0|||
126357016|NCT02930941|454599666|FG000|Overall Study|Lost to Follow-up|1|||
126357017|NCT02930941|454599667|FG001|Overall Study|Lost to Follow-up|2|||
126357018|NCT00289978|454599670|FG000|Overall Study|Withdrawal by Subject|31|||
126241775|NCT00819741|454179414|FG001|Overall Study|Lack of Efficacy|2|||
126241776|NCT00819741|454179413|FG000|Overall Study|Lost to Follow-up|3|||
126241777|NCT00819741|454179414|FG001|Overall Study|Lost to Follow-up|1|||
126241778|NCT00819741|454179413|FG000|Overall Study|Protocol Violation|3|||
126241779|NCT00819741|454179414|FG001|Overall Study|Protocol Violation|4|||
126241780|NCT00819741|454179413|FG000|Overall Study|Withdrawal by Subject|2|||
126241781|NCT00819741|454179414|FG001|Overall Study|Withdrawal by Subject|2|||
126241782|NCT00819741|454179413|FG000|Overall Study|Unclassified|6|||
126241783|NCT00819741|454179414|FG001|Overall Study|Unclassified|0|||
126357019|NCT00289978|454599671|FG001|Overall Study|Withdrawal by Subject|17|||
126357020|NCT00289978|454599672|FG002|Overall Study|Withdrawal by Subject|28|||
126357021|NCT00289978|454599670|FG000|Overall Study|Adverse Event|22|||
126357022|NCT00289978|454599671|FG001|Overall Study|Adverse Event|13|||
126357023|NCT00289978|454599672|FG002|Overall Study|Adverse Event|18|||
126357024|NCT00289978|454599670|FG000|Overall Study|Lack of Efficacy|13|||
126357025|NCT00289978|454599671|FG001|Overall Study|Lack of Efficacy|6|||
126357026|NCT00289978|454599672|FG002|Overall Study|Lack of Efficacy|25|||
126357027|NCT00289978|454599670|FG000|Overall Study|Abnormal laboratory value(s)|20|||
126357028|NCT00289978|454599671|FG001|Overall Study|Abnormal laboratory value(s)|9|||
126357029|NCT00289978|454599672|FG002|Overall Study|Abnormal laboratory value(s)|1|||
126357030|NCT00289978|454599670|FG000|Overall Study|Lost to Follow-up|3|||
126357031|NCT00289978|454599671|FG001|Overall Study|Lost to Follow-up|5|||
126357032|NCT00289978|454599672|FG002|Overall Study|Lost to Follow-up|7|||
126357033|NCT00289978|454599670|FG000|Overall Study|Protocol Violation|5|||
126357034|NCT00289978|454599671|FG001|Overall Study|Protocol Violation|5|||
126357035|NCT00289978|454599672|FG002|Overall Study|Protocol Violation|4|||
126357036|NCT00289978|454599670|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126357037|NCT00289978|454599671|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126357038|NCT00289978|454599672|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126357039|NCT00289978|454599670|FG000|Overall Study|Death|1|||
126357040|NCT00289978|454599671|FG001|Overall Study|Death|0|||
126357041|NCT00289978|454599672|FG002|Overall Study|Death|2|||
126357042|NCT01967277|454599674|FG000|Overall Study|Lost to Follow-up|1|||
126357043|NCT01967277|454599675|FG001|Overall Study|Lost to Follow-up|2|||
126357044|NCT01967277|454599674|FG000|Overall Study|Unrelated illness|0|||
126357045|NCT01967277|454599675|FG001|Overall Study|Unrelated illness|1|||
126357046|NCT00103506|454599682|FG000|Overall Study|Study closed by sponsor|34|||
126357047|NCT00103506|454599683|FG001|Overall Study|Study closed by sponsor|37|||
126357048|NCT00103506|454599682|FG000|Overall Study|Death|257|||
126357049|NCT00103506|454599683|FG001|Overall Study|Death|253|||
126357050|NCT00103506|454599682|FG000|Overall Study|Lost to Follow-up|13|||
126357051|NCT00103506|454599683|FG001|Overall Study|Lost to Follow-up|13|||
126357052|NCT00103506|454599682|FG000|Overall Study|Withdrawal by Subject|18|||
126357053|NCT00103506|454599683|FG001|Overall Study|Withdrawal by Subject|21|||
126357054|NCT00585585|454599684|FG000|Overall Study|Adverse Event|1|||
126357055|NCT00585169|454599685|FG000|Overall Study|Withdrawal by Subject|1|||
126357056|NCT00710970|454599686|FG000|Overall Study|Never took drug|3|||
126357057|NCT01028560|454599687|FG000|Overall Study|Lack of Efficacy|3|||
126357058|NCT01028560|454599688|FG001|Overall Study|Lack of Efficacy|6|||
126357059|NCT01028560|454599687|FG000|Overall Study|Withdrawal by Subject|7|||
126357060|NCT01028560|454599688|FG001|Overall Study|Withdrawal by Subject|12|||
126357061|NCT03055221|454599689|FG000|Overall Study|Adverse Event|2|||
126357062|NCT03055221|454599689|FG000|Overall Study|Withdrawal by Subject|4|||
126357063|NCT03055221|454599689|FG000|Overall Study|Death|6|||
126357064|NCT03055221|454599689|FG000|Overall Study|Physician Decision|1|||
126357065|NCT03055221|454599689|FG000|Overall Study|Study terminated by Sponsor|3|||
126357066|NCT03055221|454599689|FG000|Overall Study|Lost to Follow-up|4|||
126357067|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
126357068|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
126357069|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
126357070|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
126357071|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
126357072|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
126241784|NCT00819741|454179413|FG000|Overall Study|Reasons unknown|3|||
126241785|NCT00819741|454179414|FG001|Overall Study|Reasons unknown|3|||
126241786|NCT00119015|454179415|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
126357073|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
126357074|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
126357075|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
126357076|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
126357077|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
126357078|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
126357079|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
126357080|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
125878986|NCT03521570|452853475|FG000|Overall Study|Not eligible|11|||
125878987|NCT04531176|452853478|FG000|Overall Study|Study was stopped early|24|||
125878988|NCT04531176|452853479|FG001|Overall Study|Study was stopped early|26|||
125878989|NCT04531176|452853480|FG002|Overall Study|Study was stopped early|24|||
126357081|NCT01243424|454599690|FG000|Discontinuation From Treatment|Not treated|5|||
126357082|NCT01243424|454599691|FG001|Discontinuation From Treatment|Not treated|4|||
126357083|NCT01243424|454599690|FG000|Discontinuation From Treatment|Adverse Event|457|||
126357084|NCT01243424|454599691|FG001|Discontinuation From Treatment|Adverse Event|523|||
126357085|NCT01243424|454599690|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
126357086|NCT01243424|454599691|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
126357087|NCT01243424|454599690|FG000|Discontinuation From Treatment|Protocol Violation|46|||
126357088|NCT01243424|454599691|FG001|Discontinuation From Treatment|Protocol Violation|47|||
126357089|NCT01243424|454599690|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
126357090|NCT01243424|454599691|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
126357091|NCT01243424|454599690|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
126357092|NCT01243424|454599691|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
126357093|NCT01243424|454599690|FG000|Discontinuation From Treatment|Other than listed above|230|||
126357094|NCT01243424|454599691|FG001|Discontinuation From Treatment|Other than listed above|211|||
126357095|NCT00397930|454599694|FG000|Overall Study|Personal reasons|14|||
126357096|NCT00397930|454599695|FG001|Overall Study|Personal reasons|8|||
126357097|NCT00397930|454599694|FG000|Overall Study|Other medical|9|||
126357098|NCT00397930|454599695|FG001|Overall Study|Other medical|4|||
126357099|NCT00397930|454599694|FG000|Overall Study|Unknown reasons|9|||
126357100|NCT00397930|454599695|FG001|Overall Study|Unknown reasons|14|||
126357101|NCT00397930|454599694|FG000|Overall Study|Noncompliant|3|||
126357102|NCT00397930|454599695|FG001|Overall Study|Noncompliant|2|||
126357103|NCT00397930|454599694|FG000|Overall Study|Too time-consuming|2|||
126357104|NCT00397930|454599695|FG001|Overall Study|Too time-consuming|9|||
126357105|NCT00397930|454599694|FG000|Overall Study|Started own yoga program|1|||
126357106|NCT00397930|454599695|FG001|Overall Study|Started own yoga program|1|||
126357107|NCT00397930|454599694|FG000|Overall Study|Did not want to be in control group|0|||
126357108|NCT00397930|454599695|FG001|Overall Study|Did not want to be in control group|1|||
126357109|NCT00397930|454599694|FG000|Overall Study|Withdrawal by Subject|0|||
126357110|NCT00397930|454599695|FG001|Overall Study|Withdrawal by Subject|8|||
126357111|NCT00397930|454599694|FG000|Overall Study|Missing data|0|||
126357112|NCT00397930|454599695|FG001|Overall Study|Missing data|4|||
126357113|NCT00617903|454599703|FG000|Overall Study|Withdrawal by Subject|2|||
126357114|NCT00617903|454599704|FG001|Overall Study|Withdrawal by Subject|3|||
126357115|NCT00617903|454599703|FG000|Overall Study|Lost to Follow-up|1|||
126357116|NCT00617903|454599704|FG001|Overall Study|Lost to Follow-up|1|||
126357117|NCT00617903|454599703|FG000|Overall Study|Lack of Efficacy|0|||
126357118|NCT00617903|454599704|FG001|Overall Study|Lack of Efficacy|1|||
126357119|NCT00617903|454599703|FG000|Overall Study|Adverse Event|0|||
126357120|NCT00617903|454599704|FG001|Overall Study|Adverse Event|1|||
126357121|NCT00617903|454599703|FG000|Overall Study|noncompliance|0|||
126357122|NCT00617903|454599704|FG001|Overall Study|noncompliance|1|||
126357123|NCT05156125|454599705|FG000|Overall Study|Lack of Efficacy|1|||
126357124|NCT05156125|454599706|FG001|Overall Study|Lack of Efficacy|1|||
126357125|NCT05156125|454599707|FG002|Overall Study|Lack of Efficacy|1|||
126357126|NCT05156125|454599705|FG000|Overall Study|Physician Decision|0|||
126357127|NCT05156125|454599706|FG001|Overall Study|Physician Decision|0|||
126357128|NCT05156125|454599707|FG002|Overall Study|Physician Decision|1|||
126357129|NCT05156125|454599705|FG000|Overall Study|Non-compliance|0|||
126357130|NCT05156125|454599706|FG001|Overall Study|Non-compliance|1|||
126357131|NCT05156125|454599707|FG002|Overall Study|Non-compliance|1|||
126357132|NCT05156125|454599705|FG000|Overall Study|Withdrawal by Subject|0|||
126357133|NCT05156125|454599706|FG001|Overall Study|Withdrawal by Subject|0|||
126357134|NCT05156125|454599707|FG002|Overall Study|Withdrawal by Subject|1|||
126357135|NCT05156125|454599705|FG000|Overall Study|Adverse Event|2|||
126357136|NCT05156125|454599706|FG001|Overall Study|Adverse Event|1|||
126357137|NCT05156125|454599707|FG002|Overall Study|Adverse Event|0|||
126357138|NCT03123588|454599713|FG000|Overall Study|Study Terminated by Sponsor|2|||
126357139|NCT03123588|454599714|FG001|Overall Study|Study Terminated by Sponsor|5|||
126357140|NCT03123588|454599713|FG000|Overall Study|Withdrawal by Subject|1|||
126357141|NCT03123588|454599714|FG001|Overall Study|Withdrawal by Subject|0|||
126357142|NCT03123588|454599713|FG000|Overall Study|Adverse Event|1|||
126357143|NCT03123588|454599714|FG001|Overall Study|Adverse Event|0|||
126357144|NCT03123588|454599713|FG000|Overall Study|Physician Decision|2|||
126357145|NCT03123588|454599714|FG001|Overall Study|Physician Decision|1|||
126357146|NCT01698008|454599717|FG000|Overall Study|Withdrawal by Subject|1|||
126357147|NCT01698008|454599718|FG001|Overall Study|Withdrawal by Subject|2|||
126357148|NCT01814332|454599722|FG000|Overall Study|Adverse Event|8|||
126357149|NCT01814332|454599723|FG001|Overall Study|Adverse Event|3|||
126357150|NCT01814332|454599722|FG000|Overall Study|Withdrawal by Subject|3|||
126357151|NCT01814332|454599723|FG001|Overall Study|Withdrawal by Subject|8|||
126357152|NCT01814332|454599722|FG000|Overall Study|Protocol Violation|0|||
125878990|NCT01345240|452853493|FG000|Overall Study|Adverse Event|3|||
126241787|NCT00119015|454179416|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
126241788|NCT00119015|454179417|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
126241789|NCT01313780|454179418|FG000|Overall Study|Lack of Efficacy|4|||
126241790|NCT01313780|454179419|FG001|Overall Study|Lack of Efficacy|2|||
126241791|NCT01313780|454179418|FG000|Overall Study|Adverse Event|6|||
126241792|NCT01313780|454179419|FG001|Overall Study|Adverse Event|11|||
126241793|NCT01313780|454179418|FG000|Overall Study|Withdrawal by Subject|2|||
126241794|NCT01313780|454179419|FG001|Overall Study|Withdrawal by Subject|8|||
126241795|NCT01313780|454179418|FG000|Overall Study|Protocol Violation|10|||
126241796|NCT01313780|454179419|FG001|Overall Study|Protocol Violation|4|||
126241797|NCT01313780|454179418|FG000|Overall Study|missing data|3|||
126241798|NCT01313780|454179419|FG001|Overall Study|missing data|3|||
126241799|NCT03235739|454180914|FG000|Overall Study|Withdrawal by Subject|2|||
126241800|NCT03235739|454180915|FG001|Overall Study|Withdrawal by Subject|2|||
126241801|NCT03235739|454180914|FG000|Overall Study|Physician Decision|0|||
126241802|NCT03235739|454180915|FG001|Overall Study|Physician Decision|1|||
126241803|NCT02847650|454180916|FG000|Overall Study|Adverse Event|2|||
126241804|NCT02847650|454180917|FG001|Overall Study|Adverse Event|4|||
126241805|NCT02847650|454180916|FG000|Overall Study|Lost to Follow-up|1|||
126241806|NCT02847650|454180917|FG001|Overall Study|Lost to Follow-up|0|||
126241807|NCT02847650|454180916|FG000|Overall Study|Protocol Violation|0|||
126241808|NCT02847650|454180917|FG001|Overall Study|Protocol Violation|1|||
126241809|NCT02847650|454180916|FG000|Overall Study|Withdrawal by Subject|1|||
126241810|NCT02847650|454180917|FG001|Overall Study|Withdrawal by Subject|1|||
126241811|NCT03818581|454180920|FG000|Overall Study|Adverse Event|1|||
126241812|NCT03818581|454180921|FG001|Overall Study|Adverse Event|0|||
126241813|NCT03818581|454180922|FG002|Overall Study|Adverse Event|0|||
126241814|NCT03818581|454180923|FG003|Overall Study|Adverse Event|0|||
126241815|NCT03818581|454180924|FG004|Overall Study|Adverse Event|0|||
126241816|NCT03818581|454180920|FG000|Overall Study|Covid-19|2|||
126241817|NCT03818581|454180921|FG001|Overall Study|Covid-19|0|||
126241818|NCT03818581|454180922|FG002|Overall Study|Covid-19|0|||
126241819|NCT03818581|454180923|FG003|Overall Study|Covid-19|0|||
126241820|NCT03818581|454180924|FG004|Overall Study|Covid-19|1|||
126241821|NCT03818581|454180920|FG000|Overall Study|Withdrawal by Subject|0|||
126241822|NCT03818581|454180921|FG001|Overall Study|Withdrawal by Subject|0|||
126241823|NCT03818581|454180922|FG002|Overall Study|Withdrawal by Subject|0|||
126241824|NCT03818581|454180923|FG003|Overall Study|Withdrawal by Subject|0|||
126241825|NCT03818581|454180924|FG004|Overall Study|Withdrawal by Subject|1|||
126241826|NCT03818581|454180920|FG000|Overall Study|No longer met study criteria|0|||
126241827|NCT03818581|454180921|FG001|Overall Study|No longer met study criteria|0|||
126241828|NCT03818581|454180922|FG002|Overall Study|No longer met study criteria|0|||
126241829|NCT03818581|454180923|FG003|Overall Study|No longer met study criteria|0|||
126241830|NCT03818581|454180924|FG004|Overall Study|No longer met study criteria|1|||
126241831|NCT02096211|454180927|FG000|Overall Study|Death|2|||
126241832|NCT02096211|454180927|FG000|Overall Study|Withdrawal by Subject|8|||
126241833|NCT02096211|454180927|FG000|Overall Study|Revision of implant|7|||
126241834|NCT02096211|454180927|FG000|Overall Study|Lost to Follow-up|43|||
126241835|NCT00834522|454180930|FG000|Washout|Adverse Event|1|||
126241836|NCT00834522|454180931|FG001|Washout|Adverse Event|0|||
126241837|NCT00834522|454180930|FG000|Washout|Withdrawal by Subject|2|||
126241838|NCT00834522|454180931|FG001|Washout|Withdrawal by Subject|1|||
126241839|NCT00519194|454180932|FG000|Overall Study|Withdrawal by Subject|9|||
125878991|NCT01345240|452853494|FG001|Overall Study|Adverse Event|5|||
125878992|NCT01345240|452853495|FG002|Overall Study|Adverse Event|4|||
126241840|NCT00519194|454180932|FG000|Overall Study|Death|9|||
126241841|NCT00519194|454180932|FG000|Overall Study|Lost to Follow-up|3|||
125878993|NCT01345240|452853496|FG003|Overall Study|Adverse Event|2|||
125878994|NCT01345240|452853497|FG004|Overall Study|Adverse Event|1|||
125878995|NCT01345240|452853493|FG000|Overall Study|Lost to Follow-up|8|||
126241842|NCT03165994|454180933|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
126241843|NCT03165994|454180933|FG000|Overall Study|Death|2|||
126357153|NCT01814332|454599723|FG001|Overall Study|Protocol Violation|4|||
126357154|NCT01814332|454599722|FG000|Overall Study|Lost to Follow-up|5|||
126357155|NCT01814332|454599723|FG001|Overall Study|Lost to Follow-up|1|||
126357156|NCT01755637|454599724|FG000|Period 1|Adverse Event|0|||
126357157|NCT01755637|454599725|FG001|Period 1|Adverse Event|1|||
126357158|NCT02287025|454599726|FG000|Overall Study|Not treated|2|||
126357159|NCT02287025|454599727|FG001|Overall Study|Not treated|0|||
126357160|NCT02287025|454599726|FG000|Overall Study|Progression of disease|3|||
126357161|NCT02287025|454599727|FG001|Overall Study|Progression of disease|2|||
126357162|NCT02287025|454599726|FG000|Overall Study|Adverse Event|2|||
126357163|NCT02287025|454599727|FG001|Overall Study|Adverse Event|4|||
126357164|NCT02287025|454599726|FG000|Overall Study|Withdrawal by Subject|2|||
126357165|NCT02287025|454599727|FG001|Overall Study|Withdrawal by Subject|2|||
126357166|NCT02287025|454599726|FG000|Overall Study|Screening failed|1|||
126357167|NCT02287025|454599727|FG001|Overall Study|Screening failed|1|||
126357168|NCT04053452|454599728|FG000|Overall Study|Withdrawal by Subject|1|||
126357169|NCT04053452|454599729|FG001|Overall Study|Withdrawal by Subject|0|||
126357170|NCT04053452|454599728|FG000|Overall Study|Time restraint due to inpatient needs|1|||
126357171|NCT04053452|454599729|FG001|Overall Study|Time restraint due to inpatient needs|2|||
126357172|NCT02959892|454599734|FG000|Overall Study|PET tracer synthesis failure|1|||
126357173|NCT02959892|454599735|FG001|Overall Study|PET tracer synthesis failure|0|||
126357174|NCT02959892|454599734|FG000|Overall Study|Study termination|0|||
126357175|NCT02959892|454599735|FG001|Overall Study|Study termination|1|||
126357176|NCT00799864|454599738|FG000|Overall Study|Participant reached a virologic endpoint|9|||
126357177|NCT00799864|454599739|FG001|Overall Study|Participant reached a virologic endpoint|2|||
126357178|NCT00799864|454599740|FG002|Overall Study|Participant reached a virologic endpoint|2|||
126357179|NCT00799864|454599741|FG003|Overall Study|Participant reached a virologic endpoint|0|||
126357180|NCT00799864|454599742|FG004|Overall Study|Participant reached a virologic endpoint|0|||
126357181|NCT00799864|454599738|FG000|Overall Study|Other|2|||
126357182|NCT00799864|454599739|FG001|Overall Study|Other|1|||
126357183|NCT00799864|454599740|FG002|Overall Study|Other|0|||
126357184|NCT00799864|454599741|FG003|Overall Study|Other|0|||
126357185|NCT00799864|454599742|FG004|Overall Study|Other|0|||
126357186|NCT02346370|454599743|FG000|Overall Study|Not treated|1|||
126357187|NCT02346370|454599744|FG001|Overall Study|Not treated|0|||
126357188|NCT02346370|454599745|FG002|Overall Study|Not treated|0|||
126241844|NCT03165994|454180933|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
126241845|NCT03165994|454180933|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
126241846|NCT03165994|454180933|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
126241847|NCT03165994|454180933|FG000|Overall Study|Miscellaneous|1|||
126241848|NCT00934050|454180940|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
126241849|NCT00934050|454180941|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
126241850|NCT00934050|454180942|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
126241851|NCT00934050|454180943|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
126241852|NCT00934050|454180944|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
126241853|NCT00934050|454180945|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
126241854|NCT00934050|454180940|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
126241855|NCT00934050|454180941|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
126241856|NCT00934050|454180942|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
126241857|NCT00934050|454180943|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
126241858|NCT00934050|454180944|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
126241859|NCT00934050|454180945|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
126241860|NCT00934050|454180940|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126241861|NCT00934050|454180941|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126241862|NCT00934050|454180942|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
126241863|NCT00934050|454180943|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125878996|NCT01345240|452853494|FG001|Overall Study|Lost to Follow-up|9|||
125878997|NCT01345240|452853495|FG002|Overall Study|Lost to Follow-up|14|||
125878998|NCT01345240|452853496|FG003|Overall Study|Lost to Follow-up|7|||
125878999|NCT01345240|452853497|FG004|Overall Study|Lost to Follow-up|9|||
126241864|NCT00934050|454180944|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126241865|NCT00934050|454180945|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126241866|NCT00934050|454180940|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
126241867|NCT00934050|454180941|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
126241868|NCT00934050|454180942|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
126241869|NCT00934050|454180943|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
125879000|NCT04298697|452853498|FG000|Overall Study|Lost to Follow-up|5|||
125879001|NCT04298697|452853499|FG001|Overall Study|Lost to Follow-up|5|||
125879002|NCT04298697|452853500|FG002|Overall Study|Lost to Follow-up|1|||
125879003|NCT04298697|452853501|FG003|Overall Study|Lost to Follow-up|0|||
125879004|NCT04298697|452853498|FG000|Overall Study|Withdrawal by Subject|0|||
125879005|NCT04298697|452853499|FG001|Overall Study|Withdrawal by Subject|3|||
125879006|NCT04298697|452853500|FG002|Overall Study|Withdrawal by Subject|2|||
125879007|NCT04298697|452853501|FG003|Overall Study|Withdrawal by Subject|3|||
125879008|NCT00449696|452853502|FG000|Overall Study|Other Treatment Required|6|||
125879009|NCT00449696|452853503|FG001|Overall Study|Other Treatment Required|1|||
125879010|NCT00449696|452853502|FG000|Overall Study|Withdrawal by Subject|5|||
125879011|NCT00449696|452853503|FG001|Overall Study|Withdrawal by Subject|5|||
125879012|NCT00449696|452853502|FG000|Overall Study|Lost to Follow-up|2|||
125879013|NCT00449696|452853503|FG001|Overall Study|Lost to Follow-up|3|||
125879014|NCT00449696|452853502|FG000|Overall Study|Others|7|||
125879015|NCT00449696|452853503|FG001|Overall Study|Others|0|||
125879016|NCT01903460|452853508|FG000|Overall Study|Adverse Event|0|||
125879017|NCT01903460|452853509|FG001|Overall Study|Adverse Event|0|||
125879018|NCT01903460|452853510|FG002|Overall Study|Adverse Event|0|||
125879019|NCT01903460|452853511|FG003|Overall Study|Adverse Event|1|||
125879020|NCT02246530|452853512|FG000|Overall Study|Lost to Follow-up|4|||
125879021|NCT02246530|452853513|FG001|Overall Study|Lost to Follow-up|0|||
125879022|NCT00888173|452853514|FG000|Overall Study|Wrong Primary|1|||
125879023|NCT00888173|452853514|FG000|Overall Study|Ineligible: required test not done|1|||
125879024|NCT01488890|452853515|FG000|Overall Study|Serious adverse event|2|||
125879025|NCT01488890|452853516|FG001|Overall Study|Serious adverse event|0|||
125879026|NCT01488890|452853517|FG002|Overall Study|Serious adverse event|0|||
125879027|NCT01488890|452853518|FG003|Overall Study|Serious adverse event|0|||
125879028|NCT01488890|452853515|FG000|Overall Study|Protocol Violation|3|||
125879029|NCT01488890|452853516|FG001|Overall Study|Protocol Violation|0|||
125879030|NCT01488890|452853517|FG002|Overall Study|Protocol Violation|4|||
125879031|NCT01488890|452853518|FG003|Overall Study|Protocol Violation|0|||
125879032|NCT01488890|452853515|FG000|Overall Study|Lost to Follow-up|13|||
125879033|NCT01488890|452853516|FG001|Overall Study|Lost to Follow-up|10|||
125879034|NCT01488890|452853517|FG002|Overall Study|Lost to Follow-up|20|||
125879035|NCT01488890|452853518|FG003|Overall Study|Lost to Follow-up|3|||
125879036|NCT01488890|452853515|FG000|Overall Study|Withdrawal by Subject|14|||
125879037|NCT01488890|452853516|FG001|Overall Study|Withdrawal by Subject|10|||
125879038|NCT01488890|452853517|FG002|Overall Study|Withdrawal by Subject|11|||
125879039|NCT01488890|452853518|FG003|Overall Study|Withdrawal by Subject|2|||
126241870|NCT00934050|454180944|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
126241871|NCT00934050|454180945|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
126241872|NCT00934050|454180940|FG000|Enrolled After 15 Dec 2009|Death|0|||
126241873|NCT00934050|454180941|FG001|Enrolled After 15 Dec 2009|Death|0|||
126241874|NCT00934050|454180942|FG002|Enrolled After 15 Dec 2009|Death|0|||
126241875|NCT00934050|454180943|FG003|Enrolled After 15 Dec 2009|Death|0|||
125879040|NCT05712460|452853519|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879041|NCT05712460|452853520|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879042|NCT05712460|452853521|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879043|NCT05712460|452853522|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126241876|NCT00934050|454180944|FG004|Enrolled After 15 Dec 2009|Death|0|||
126241877|NCT00934050|454180945|FG005|Enrolled After 15 Dec 2009|Death|1|||
126241878|NCT00934050|454180940|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125879044|NCT05712460|452853523|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126241879|NCT00934050|454180941|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125879045|NCT05712460|452853524|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879046|NCT05712460|452853525|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879047|NCT05712460|452853526|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
125879048|NCT05712460|452853527|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879049|NCT05712460|452853528|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879050|NCT05712460|452853529|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879051|NCT05712460|452853530|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125879052|NCT00829426|452853534|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125879053|NCT00829426|452853535|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125879054|NCT05135767|452853538|FG000|Baseline|Lost to Follow-up|1|||
126093799|NCT03568318|453637104|FG000|Overall Study|Lost to Follow-up|3|||
126241880|NCT00934050|454180942|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
126241881|NCT00934050|454180943|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
126241882|NCT00934050|454180944|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
126241883|NCT00934050|454180945|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
126241884|NCT00934050|454180940|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
126241885|NCT00934050|454180941|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
126241886|NCT00934050|454180942|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
126241887|NCT00934050|454180943|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
126241888|NCT00934050|454180944|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
126241889|NCT00934050|454180945|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
126241890|NCT00461786|454180946|FG000|Overall Study|Entry Criteria Not Met|2|||
126241891|NCT00461786|454180946|FG000|Overall Study|Inevaluable (Never Treated)|1|||
126241892|NCT00835991|454180947|FG000|First Intervention|Adverse Event|0|||
126241893|NCT00835991|454180948|FG001|First Intervention|Adverse Event|1|||
126241894|NCT00835991|454180947|FG000|Washout|Protocol Violation|0|||
126241895|NCT00835991|454180948|FG001|Washout|Protocol Violation|2|||
126241896|NCT00835991|454180947|FG000|Washout|Withdrawal by Subject|3|||
126241897|NCT00835991|454180948|FG001|Washout|Withdrawal by Subject|1|||
126241898|NCT02149420|454180949|FG000|Core Study|Administrative problems|0|||
126241899|NCT02149420|454180950|FG001|Core Study|Administrative problems|1|||
126241900|NCT02149420|454180951|FG002|Core Study|Administrative problems|2|||
126241901|NCT02149420|454180949|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
126241902|NCT02149420|454180950|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
126241903|NCT02149420|454180951|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
126241904|NCT02378935|454180952|FG000|Overall Study|Lack of Efficacy|10|||
126241905|NCT02378935|454180953|FG001|Overall Study|Lack of Efficacy|0|||
126241906|NCT02378935|454180954|FG002|Overall Study|Lack of Efficacy|2|||
126241907|NCT02378935|454180955|FG003|Overall Study|Lack of Efficacy|6|||
126241908|NCT02378935|454180956|FG004|Overall Study|Lack of Efficacy|0|||
126241909|NCT02378935|454180957|FG005|Overall Study|Lack of Efficacy|0|||
126241910|NCT02378935|454180958|FG006|Overall Study|Lack of Efficacy|0|||
126241911|NCT02378935|454180952|FG000|Overall Study|Death|0|||
126241912|NCT02378935|454180953|FG001|Overall Study|Death|0|||
126241913|NCT02378935|454180954|FG002|Overall Study|Death|1|||
126241914|NCT02378935|454180955|FG003|Overall Study|Death|0|||
126241915|NCT02378935|454180956|FG004|Overall Study|Death|0|||
126241916|NCT02378935|454180957|FG005|Overall Study|Death|0|||
126241917|NCT02378935|454180958|FG006|Overall Study|Death|0|||
126241918|NCT03616535|454180959|FG000|Overall Study|Death|2|||
126241919|NCT03616535|454180960|FG001|Overall Study|Death|0|||
126241920|NCT03616535|454180961|FG002|Overall Study|Death|0|||
126241921|NCT03616535|454180962|FG003|Overall Study|Death|1|||
126241922|NCT03616535|454180959|FG000|Overall Study|Lost to Follow-up|2|||
126241923|NCT03616535|454180960|FG001|Overall Study|Lost to Follow-up|1|||
126241924|NCT03616535|454180961|FG002|Overall Study|Lost to Follow-up|0|||
126241925|NCT03616535|454180962|FG003|Overall Study|Lost to Follow-up|2|||
126241926|NCT03616535|454180959|FG000|Overall Study|Withdrawal by Subject|1|||
126241927|NCT03616535|454180960|FG001|Overall Study|Withdrawal by Subject|2|||
126241928|NCT03616535|454180961|FG002|Overall Study|Withdrawal by Subject|5|||
126241929|NCT03616535|454180962|FG003|Overall Study|Withdrawal by Subject|1|||
126241930|NCT03616535|454180959|FG000|Overall Study|Not specified or change in eligibility|2|||
126241931|NCT03616535|454180960|FG001|Overall Study|Not specified or change in eligibility|3|||
126241932|NCT03616535|454180961|FG002|Overall Study|Not specified or change in eligibility|3|||
126241933|NCT03616535|454180962|FG003|Overall Study|Not specified or change in eligibility|1|||
126241934|NCT02563561|454180965|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
126241935|NCT02563561|454180966|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
126241936|NCT02563561|454180967|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
126241937|NCT02563561|454180965|FG000|Overall Study|Withdrew of Consent|1|||
126241938|NCT02563561|454180966|FG001|Overall Study|Withdrew of Consent|1|||
126241939|NCT02563561|454180967|FG002|Overall Study|Withdrew of Consent|2|||
126241940|NCT02563561|454180965|FG000|Overall Study|Lost to Follow-up|1|||
126241941|NCT02563561|454180966|FG001|Overall Study|Lost to Follow-up|1|||
126241942|NCT02563561|454180967|FG002|Overall Study|Lost to Follow-up|0|||
126241943|NCT02563561|454180965|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
126357189|NCT02346370|454599743|FG000|Overall Study|Withdrawal of consent|1|||
126357190|NCT02346370|454599744|FG001|Overall Study|Withdrawal of consent|0|||
126357191|NCT02346370|454599745|FG002|Overall Study|Withdrawal of consent|0|||
126357192|NCT02346370|454599743|FG000|Overall Study|Death|1|||
126357193|NCT02346370|454599744|FG001|Overall Study|Death|3|||
126241944|NCT02563561|454180966|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
126241945|NCT02563561|454180967|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
126241946|NCT02563561|454180965|FG000|Overall Study|Investigator Decision|3|||
126241947|NCT02563561|454180966|FG001|Overall Study|Investigator Decision|4|||
126241948|NCT02563561|454180967|FG002|Overall Study|Investigator Decision|2|||
126241949|NCT02563561|454180965|FG000|Overall Study|Sponsor Decision|5|||
126357194|NCT02346370|454599745|FG002|Overall Study|Death|1|||
126241950|NCT02563561|454180966|FG001|Overall Study|Sponsor Decision|2|||
126241951|NCT02563561|454180967|FG002|Overall Study|Sponsor Decision|4|||
126241952|NCT02563561|454180965|FG000|Overall Study|Other|1|||
126241953|NCT02563561|454180966|FG001|Overall Study|Other|5|||
126241954|NCT02563561|454180967|FG002|Overall Study|Other|2|||
126241955|NCT03154047|454180970|FG000|Overall Study|Death|1|||
126241956|NCT03154047|454180970|FG000|Overall Study|Study terminated by sponsor|76|||
126241957|NCT03154047|454180970|FG000|Overall Study|Withdrawal by Subject|3|||
126241958|NCT00857454|454180971|FG000|Overall Study|Withdrawal by Subject|2|||
126241959|NCT00857454|454180971|FG000|Overall Study|Lost to Follow-up|1|||
126241960|NCT00857454|454180971|FG000|Overall Study|Adverse Event|2|||
126241961|NCT00857454|454180971|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
126241962|NCT00857454|454180971|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
126241963|NCT00857454|454180971|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
126241964|NCT00455312|454180972|FG000|Overall Study|Death|0|||
126241965|NCT00455312|454180973|FG001|Overall Study|Death|1|||
126241966|NCT01693523|454180974|FG000|Overall Study|Adverse Event|2|||
126241967|NCT01693523|454180975|FG001|Overall Study|Adverse Event|1|||
126241968|NCT01693523|454180976|FG002|Overall Study|Adverse Event|0|||
126241969|NCT01693523|454180974|FG000|Overall Study|Death|0|||
126241970|NCT01693523|454180975|FG001|Overall Study|Death|1|||
126241971|NCT01693523|454180976|FG002|Overall Study|Death|1|||
126241972|NCT01693523|454180974|FG000|Overall Study|Lost to Follow-up|0|||
126241973|NCT01693523|454180975|FG001|Overall Study|Lost to Follow-up|0|||
126241974|NCT01693523|454180976|FG002|Overall Study|Lost to Follow-up|4|||
126241975|NCT01693523|454180974|FG000|Overall Study|Physician Decision|0|||
126241976|NCT01693523|454180975|FG001|Overall Study|Physician Decision|0|||
126241977|NCT01693523|454180976|FG002|Overall Study|Physician Decision|1|||
126241978|NCT01693523|454180974|FG000|Overall Study|Withdrawal by Subject|1|||
126241979|NCT01693523|454180975|FG001|Overall Study|Withdrawal by Subject|2|||
126241980|NCT01693523|454180976|FG002|Overall Study|Withdrawal by Subject|2|||
126241981|NCT01693523|454180974|FG000|Overall Study|Lack of compliance study medication|1|||
126241982|NCT01693523|454180975|FG001|Overall Study|Lack of compliance study medication|2|||
126241983|NCT01693523|454180976|FG002|Overall Study|Lack of compliance study medication|0|||
126241984|NCT01693523|454180974|FG000|Overall Study|Chemotherapy was held|1|||
126241985|NCT01693523|454180975|FG001|Overall Study|Chemotherapy was held|2|||
126241986|NCT01693523|454180976|FG002|Overall Study|Chemotherapy was held|0|||
126241987|NCT03699020|454180977|FG000|Overall Study|Withdrawal by Subject|3|||
126241988|NCT03699020|454180978|FG001|Overall Study|Withdrawal by Subject|2|||
126241989|NCT02246920|454180979|FG000|Overall Study|Adverse Event|3|||
126241990|NCT02246920|454180980|FG001|Overall Study|Adverse Event|1|||
126241991|NCT02246920|454180981|FG002|Overall Study|Adverse Event|1|||
126241992|NCT02246920|454180979|FG000|Overall Study|Lost to Follow-up|2|||
126241993|NCT02246920|454180980|FG001|Overall Study|Lost to Follow-up|1|||
126241994|NCT02246920|454180981|FG002|Overall Study|Lost to Follow-up|0|||
126241995|NCT02246920|454180979|FG000|Overall Study|Protocol Violation|2|||
126241996|NCT02246920|454180980|FG001|Overall Study|Protocol Violation|5|||
126241997|NCT02246920|454180981|FG002|Overall Study|Protocol Violation|1|||
126241998|NCT02246920|454180979|FG000|Overall Study|Withdrawal by Subject|0|||
126241999|NCT02246920|454180980|FG001|Overall Study|Withdrawal by Subject|0|||
126242000|NCT02246920|454180981|FG002|Overall Study|Withdrawal by Subject|1|||
126242001|NCT00448019|454180984|FG000|Overall Study|Withdrawal by Subject|3|||
126242002|NCT00448019|454180984|FG000|Overall Study|Disease progression|1|||
126242003|NCT00448019|454180984|FG000|Overall Study|Death|2|||
126242004|NCT00448019|454180984|FG000|Overall Study|Insurance Issues|1|||
126242005|NCT03500341|454180986|FG000|Overall Study|Withdrawn prior to Completion|2|||
126242006|NCT02576938|454180987|FG000|Overall Study|Adverse Event|5|||
126242007|NCT02576938|454180988|FG001|Overall Study|Adverse Event|3|||
126242008|NCT02576938|454180989|FG002|Overall Study|Adverse Event|6|||
126242009|NCT02576938|454180987|FG000|Overall Study|Protocol Violation|1|||
126242010|NCT02576938|454180988|FG001|Overall Study|Protocol Violation|1|||
126242011|NCT02576938|454180989|FG002|Overall Study|Protocol Violation|1|||
126242012|NCT02576938|454180987|FG000|Overall Study|Withdrawal by Subject|3|||
126242013|NCT02576938|454180988|FG001|Overall Study|Withdrawal by Subject|2|||
126242014|NCT02576938|454180989|FG002|Overall Study|Withdrawal by Subject|4|||
126242015|NCT02576938|454180987|FG000|Overall Study|Lack of Efficacy|9|||
126242016|NCT02576938|454180988|FG001|Overall Study|Lack of Efficacy|4|||
126242017|NCT02576938|454180989|FG002|Overall Study|Lack of Efficacy|0|||
126242018|NCT02576938|454180987|FG000|Overall Study|Lost to Follow-up|2|||
126242019|NCT02576938|454180988|FG001|Overall Study|Lost to Follow-up|0|||
126242020|NCT02576938|454180989|FG002|Overall Study|Lost to Follow-up|1|||
126242021|NCT02576938|454180987|FG000|Overall Study|Physician Decision|0|||
126242022|NCT02576938|454180988|FG001|Overall Study|Physician Decision|1|||
126242023|NCT02576938|454180989|FG002|Overall Study|Physician Decision|0|||
126242024|NCT02576938|454180987|FG000|Overall Study|Met Exclusion Criteria|0|||
126242025|NCT02576938|454180988|FG001|Overall Study|Met Exclusion Criteria|1|||
126242026|NCT02576938|454180989|FG002|Overall Study|Met Exclusion Criteria|0|||
126242027|NCT00838630|454180991|FG000|First Intervention|Adverse Event|1|||
126242028|NCT00838630|454180992|FG001|First Intervention|Adverse Event|0|||
126242029|NCT00838630|454180991|FG000|Washout: 7 Days|Protocol Violation|1|||
126242030|NCT00838630|454180992|FG001|Washout: 7 Days|Protocol Violation|0|||
126242031|NCT03017885|454180993|FG000|Overall Study|Adverse Event|2|||
126242032|NCT03017885|454180994|FG001|Overall Study|Adverse Event|0|||
126242033|NCT03017885|454180995|FG002|Overall Study|Adverse Event|0|||
126242034|NCT03017885|454180996|FG003|Overall Study|Adverse Event|0|||
126242035|NCT03017885|454180997|FG004|Overall Study|Adverse Event|0|||
126242036|NCT03017885|454180998|FG005|Overall Study|Adverse Event|0|||
126242037|NCT03017885|454180993|FG000|Overall Study|Progression of disease|4|||
126242038|NCT03017885|454180994|FG001|Overall Study|Progression of disease|3|||
126242039|NCT03017885|454180995|FG002|Overall Study|Progression of disease|4|||
126242040|NCT03017885|454180996|FG003|Overall Study|Progression of disease|0|||
126242041|NCT03017885|454180997|FG004|Overall Study|Progression of disease|0|||
126242042|NCT03017885|454180998|FG005|Overall Study|Progression of disease|0|||
126242043|NCT03017885|454180993|FG000|Overall Study|Other than listed|1|||
126242044|NCT03017885|454180994|FG001|Overall Study|Other than listed|2|||
126242045|NCT03017885|454180995|FG002|Overall Study|Other than listed|1|||
126242046|NCT03017885|454180996|FG003|Overall Study|Other than listed|0|||
126242047|NCT03017885|454180997|FG004|Overall Study|Other than listed|0|||
126242048|NCT03017885|454180998|FG005|Overall Study|Other than listed|0|||
126242049|NCT03017885|454180993|FG000|Overall Study|Lost to Follow-up|2|||
126242050|NCT03017885|454180994|FG001|Overall Study|Lost to Follow-up|0|||
126242051|NCT03017885|454180995|FG002|Overall Study|Lost to Follow-up|3|||
126357195|NCT02346370|454599743|FG000|Overall Study|Sponsor discontinued study|5|||
126357196|NCT02346370|454599744|FG001|Overall Study|Sponsor discontinued study|0|||
126357197|NCT02346370|454599745|FG002|Overall Study|Sponsor discontinued study|2|||
126357198|NCT02346370|454599743|FG000|Overall Study|Radiologic progression|0|||
126357199|NCT02346370|454599744|FG001|Overall Study|Radiologic progression|0|||
126357200|NCT02346370|454599745|FG002|Overall Study|Radiologic progression|1|||
126357201|NCT02346370|454599743|FG000|Overall Study|Physician Decision|0|||
126357202|NCT02346370|454599744|FG001|Overall Study|Physician Decision|1|||
126357203|NCT02346370|454599745|FG002|Overall Study|Physician Decision|0|||
126357204|NCT03528577|454599748|FG000|Sequence 1|Failed Spirometry|1|||
126357205|NCT03528577|454599748|FG000|Sequence 1|Restricted medication|1|||
126357206|NCT03528577|454599748|FG000|Sequence 2|Adverse Event|1|||
126357207|NCT03528577|454599748|FG000|Sequence 2|Withdrawal by Subject|1|||
126357208|NCT03528577|454599748|FG000|Sequence 2|Failed Spirometry|1|||
126357209|NCT03528577|454599748|FG000|Sequence 3|Failed Spirometry|1|||
126357210|NCT03528577|454599748|FG000|Sequence 4|Failed Spirometry|2|||
126357211|NCT03528577|454599748|FG000|Sequence 4|Adverse Event|1|||
126357212|NCT04882215|454599749|FG000|Overall Study|Withdrawal by Subject|5|||
126357213|NCT04882215|454599750|FG001|Overall Study|Withdrawal by Subject|0|||
126357214|NCT04263532|454599751|FG000|Overall Study|Withdrawal by Subject|2|||
126357215|NCT04263532|454599752|FG001|Overall Study|Withdrawal by Subject|0|||
126357216|NCT04098302|454599753|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
126242052|NCT03017885|454180996|FG003|Overall Study|Lost to Follow-up|0|||
126242053|NCT03017885|454180997|FG004|Overall Study|Lost to Follow-up|0|||
126242054|NCT03017885|454180998|FG005|Overall Study|Lost to Follow-up|0|||
126242055|NCT03017885|454180993|FG000|Overall Study|Change to other anti-cancer therapy|0|||
126242056|NCT03017885|454180994|FG001|Overall Study|Change to other anti-cancer therapy|0|||
126242057|NCT03017885|454180995|FG002|Overall Study|Change to other anti-cancer therapy|1|||
126242058|NCT03017885|454180996|FG003|Overall Study|Change to other anti-cancer therapy|0|||
126026060|NCT04093752|453390671|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
126026061|NCT04093752|453390672|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
126026062|NCT04093752|453390669|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
126242059|NCT03017885|454180997|FG004|Overall Study|Change to other anti-cancer therapy|0|||
126242060|NCT03017885|454180998|FG005|Overall Study|Change to other anti-cancer therapy|0|||
126242061|NCT03285594|454180999|FG000|Overall Study|At the Participant's Own Request|10|||
126242062|NCT03285594|454181000|FG001|Overall Study|At the Participant's Own Request|5|||
126242063|NCT03285594|454181001|FG002|Overall Study|At the Participant's Own Request|21|||
126242064|NCT03285594|454180999|FG000|Overall Study|Adverse Event|2|||
126242065|NCT03285594|454181000|FG001|Overall Study|Adverse Event|2|||
126242066|NCT03285594|454181001|FG002|Overall Study|Adverse Event|6|||
126242067|NCT03285594|454180999|FG000|Overall Study|Poor Compliance to Protocol|0|||
126242068|NCT03285594|454181000|FG001|Overall Study|Poor Compliance to Protocol|0|||
126242069|NCT03285594|454181001|FG002|Overall Study|Poor Compliance to Protocol|1|||
126242070|NCT03285594|454180999|FG000|Overall Study|Lost to Follow-up|0|||
126242071|NCT03285594|454181000|FG001|Overall Study|Lost to Follow-up|0|||
126242072|NCT03285594|454181001|FG002|Overall Study|Lost to Follow-up|1|||
126242073|NCT03285594|454180999|FG000|Overall Study|Reason Not Specified|3|||
126242074|NCT03285594|454181000|FG001|Overall Study|Reason Not Specified|4|||
126242075|NCT03285594|454181001|FG002|Overall Study|Reason Not Specified|8|||
126242076|NCT02648438|454181003|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126242077|NCT02648438|454181004|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
126242078|NCT02648438|454181005|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126242079|NCT02648438|454181003|FG000|Overall Study|Protocol Violation|2|||
126242080|NCT02648438|454181004|FG001|Overall Study|Protocol Violation|0|||
126242081|NCT02648438|454181005|FG002|Overall Study|Protocol Violation|0|||
126242082|NCT02648438|454181003|FG000|Overall Study|Withdrawal by Subject|1|||
126242083|NCT02648438|454181004|FG001|Overall Study|Withdrawal by Subject|1|||
126242084|NCT02648438|454181005|FG002|Overall Study|Withdrawal by Subject|0|||
126242085|NCT01615198|454181006|FG000|Overall Study|Withdrawal by Subject|5|||
126242086|NCT01615198|454181007|FG001|Overall Study|Withdrawal by Subject|5|||
126242087|NCT01615198|454181006|FG000|Overall Study|Protocol deviation|1|||
126242088|NCT01615198|454181007|FG001|Overall Study|Protocol deviation|1|||
126242089|NCT01615198|454181006|FG000|Overall Study|Physician Decision|5|||
126242090|NCT01615198|454181007|FG001|Overall Study|Physician Decision|1|||
126242091|NCT01615198|454181006|FG000|Overall Study|Lost to Follow-up|1|||
126242092|NCT01615198|454181007|FG001|Overall Study|Lost to Follow-up|1|||
126242093|NCT01615198|454181006|FG000|Overall Study|Lack of Efficacy|1|||
126242094|NCT01615198|454181007|FG001|Overall Study|Lack of Efficacy|6|||
126242095|NCT01615198|454181006|FG000|Overall Study|Adverse Event|11|||
126242096|NCT01615198|454181007|FG001|Overall Study|Adverse Event|5|||
126242097|NCT02739997|454181008|FG000|Overall Study|Death|1|||
126242098|NCT02739997|454181008|FG000|Overall Study|Withdrawal by Subject|1|||
126242099|NCT03552393|454181011|FG000|Core Period|Kidney Transplant|1|||
126242100|NCT03552393|454181011|FG000|Core Period|Prohibited Medication|1|||
126242101|NCT03552393|454181011|FG000|Safety Extension Period|Kidney Transplant|4|||
126242102|NCT02414152|454181013|FG000|Overall Study|Withdrawal by Subject|1|||
126242103|NCT02414152|454181013|FG000|Overall Study|Lack of Efficacy|1|||
126242104|NCT02601625|454181014|FG000|Overall Study|Lost to Follow-up|0|||
126242105|NCT02601625|454181015|FG001|Overall Study|Lost to Follow-up|0|||
126242106|NCT02601625|454181016|FG002|Overall Study|Lost to Follow-up|1|||
126242107|NCT02601625|454181017|FG003|Overall Study|Lost to Follow-up|1|||
126242108|NCT00359281|454181018|FG000|Overall Study|Adverse Event|1|||
126242109|NCT00359281|454181019|FG001|Overall Study|Adverse Event|0|||
126242110|NCT00359281|454181020|FG002|Overall Study|Adverse Event|0|||
126242111|NCT00359281|454181021|FG003|Overall Study|Adverse Event|0|||
126242112|NCT00359281|454181022|FG004|Overall Study|Adverse Event|0|||
126242113|NCT00359281|454181023|FG005|Overall Study|Adverse Event|0|||
126242114|NCT00359281|454181024|FG006|Overall Study|Adverse Event|1|||
126242115|NCT00359281|454181025|FG007|Overall Study|Adverse Event|0|||
126242116|NCT00359281|454181026|FG008|Overall Study|Adverse Event|0|||
126242117|NCT00359281|454181018|FG000|Overall Study|Withdrawal by Subject|0|||
126242118|NCT00359281|454181019|FG001|Overall Study|Withdrawal by Subject|0|||
126242119|NCT00359281|454181020|FG002|Overall Study|Withdrawal by Subject|0|||
126242120|NCT00359281|454181021|FG003|Overall Study|Withdrawal by Subject|0|||
126026063|NCT04093752|453390670|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
126242121|NCT00359281|454181022|FG004|Overall Study|Withdrawal by Subject|0|||
126242122|NCT00359281|454181023|FG005|Overall Study|Withdrawal by Subject|0|||
126242123|NCT00359281|454181024|FG006|Overall Study|Withdrawal by Subject|1|||
126242124|NCT00359281|454181025|FG007|Overall Study|Withdrawal by Subject|0|||
126242125|NCT00359281|454181026|FG008|Overall Study|Withdrawal by Subject|0|||
126242126|NCT01289262|454181027|FG000|Overall Study|Lost to Follow-up|29|||
126242127|NCT01289262|454181028|FG001|Overall Study|Lost to Follow-up|16|||
126242128|NCT01289262|454181027|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
126242129|NCT01289262|454181028|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
126242130|NCT04887415|454181029|FG000|Overall Study|Lost to Follow-up|2|||
126242131|NCT00838279|454181030|FG000|Washout|Protocol Violation|1|||
126242132|NCT00838279|454181031|FG001|Washout|Protocol Violation|0|||
126242133|NCT00838279|454181030|FG000|Washout|Withdrawal by Subject|0|||
126242134|NCT00838279|454181031|FG001|Washout|Withdrawal by Subject|1|||
126242135|NCT04608188|454181032|FG000|Overall Study|Withdrawal by Subject|4|||
126242136|NCT04608188|454181033|FG001|Overall Study|Withdrawal by Subject|8|||
126242137|NCT01415986|454181036|FG000|Overall Study|Lost to Follow-up|1|||
126242138|NCT01250912|454181038|FG000|Overall Study|Lost to Follow-up|1|||
126242139|NCT01218867|454181041|FG000|Overall Study|Death during treatment|0|||
126242140|NCT01218867|454181042|FG001|Overall Study|Death during treatment|0|||
126242141|NCT01218867|454181043|FG002|Overall Study|Death during treatment|0|||
126242142|NCT01218867|454181044|FG003|Overall Study|Death during treatment|0|||
126242143|NCT01218867|454181045|FG004|Overall Study|Death during treatment|0|||
126242144|NCT01218867|454181046|FG005|Overall Study|Death during treatment|0|||
126242145|NCT01218867|454181047|FG006|Overall Study|Death during treatment|1|||
126242146|NCT01218867|454181048|FG007|Overall Study|Death during treatment|0|||
126242147|NCT01218867|454181049|FG008|Overall Study|Death during treatment|0|||
126242148|NCT01218867|454181050|FG009|Overall Study|Death during treatment|0|||
126242149|NCT01218867|454181051|FG010|Overall Study|Death during treatment|0|||
126242150|NCT03792477|454181052|FG000|Overall Study|Adverse Event|0|||
126242151|NCT03792477|454181053|FG001|Overall Study|Adverse Event|0|||
126242152|NCT03792477|454181054|FG002|Overall Study|Adverse Event|0|||
126242153|NCT03792477|454181055|FG003|Overall Study|Adverse Event|1|||
126242154|NCT03792477|454181056|FG004|Overall Study|Adverse Event|0|||
126242155|NCT03792477|454181052|FG000|Overall Study|Lost to Follow-up|0|||
126242156|NCT03792477|454181053|FG001|Overall Study|Lost to Follow-up|0|||
126242157|NCT03792477|454181054|FG002|Overall Study|Lost to Follow-up|2|||
126242158|NCT03792477|454181055|FG003|Overall Study|Lost to Follow-up|0|||
126242159|NCT03792477|454181056|FG004|Overall Study|Lost to Follow-up|0|||
126242160|NCT03792477|454181052|FG000|Overall Study|Other|0|||
126242161|NCT03792477|454181053|FG001|Overall Study|Other|0|||
126242162|NCT03792477|454181054|FG002|Overall Study|Other|0|||
126242163|NCT03792477|454181055|FG003|Overall Study|Other|0|||
126242164|NCT03792477|454181056|FG004|Overall Study|Other|1|||
126242165|NCT01474551|454181057|FG000|Overall Study|Death|1|||
126242166|NCT00840411|454181058|FG000|First Intervention|Adverse Event|1|||
126242167|NCT00840411|454181059|FG001|First Intervention|Adverse Event|0|||
126242168|NCT00840411|454181058|FG000|Washout|Withdrawal by Subject|1|||
126242169|NCT00840411|454181059|FG001|Washout|Withdrawal by Subject|0|||
126242170|NCT01921062|454181062|FG000|Overall Study|Withdrawal by Subject|0|||
126242171|NCT01921062|454181063|FG001|Overall Study|Withdrawal by Subject|7|||
126242172|NCT01921062|454181062|FG000|Overall Study|Adverse Event|5|||
126242173|NCT01921062|454181063|FG001|Overall Study|Adverse Event|6|||
126242174|NCT01921062|454181062|FG000|Overall Study|Protocol Violation|0|||
126242175|NCT01921062|454181063|FG001|Overall Study|Protocol Violation|1|||
126242176|NCT01921062|454181062|FG000|Overall Study|VMIQ score > 72|4|||
126242177|NCT01921062|454181063|FG001|Overall Study|VMIQ score > 72|1|||
126242178|NCT01921062|454181062|FG000|Overall Study|Logistic error|0|||
126242179|NCT01921062|454181063|FG001|Overall Study|Logistic error|1|||
126242180|NCT01854047|454181064|FG000|Overall Study|Lack of Efficacy|1|||
126242181|NCT01854047|454181065|FG001|Overall Study|Lack of Efficacy|0|||
126242182|NCT01854047|454181066|FG002|Overall Study|Lack of Efficacy|0|||
126242183|NCT01854047|454181067|FG003|Overall Study|Lack of Efficacy|0|||
126242184|NCT01854047|454181068|FG004|Overall Study|Lack of Efficacy|0|||
126242185|NCT01854047|454181064|FG000|Overall Study|Poor compliance to protocol|3|||
126242186|NCT01854047|454181065|FG001|Overall Study|Poor compliance to protocol|0|||
126242187|NCT01854047|454181066|FG002|Overall Study|Poor compliance to protocol|2|||
126242188|NCT01854047|454181067|FG003|Overall Study|Poor compliance to protocol|0|||
126242189|NCT01854047|454181068|FG004|Overall Study|Poor compliance to protocol|0|||
126242190|NCT01854047|454181064|FG000|Overall Study|Adverse Event|5|||
126242191|NCT01854047|454181065|FG001|Overall Study|Adverse Event|4|||
126242192|NCT01854047|454181066|FG002|Overall Study|Adverse Event|6|||
126242193|NCT01854047|454181067|FG003|Overall Study|Adverse Event|10|||
126357217|NCT04098302|454599754|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
126357218|NCT04098302|454599755|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
126242194|NCT01854047|454181068|FG004|Overall Study|Adverse Event|7|||
126242195|NCT01854047|454181064|FG000|Overall Study|Randomized but not treated|0|||
126242196|NCT01854047|454181065|FG001|Overall Study|Randomized but not treated|1|||
126242197|NCT01854047|454181066|FG002|Overall Study|Randomized but not treated|2|||
126242198|NCT01854047|454181067|FG003|Overall Study|Randomized but not treated|0|||
126242199|NCT01854047|454181068|FG004|Overall Study|Randomized but not treated|4|||
126242200|NCT01854047|454181064|FG000|Overall Study|Other than specified above|3|||
126242201|NCT01854047|454181065|FG001|Overall Study|Other than specified above|3|||
126242202|NCT01854047|454181066|FG002|Overall Study|Other than specified above|3|||
126242203|NCT01854047|454181067|FG003|Overall Study|Other than specified above|5|||
126357219|NCT04098302|454599756|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
126357220|NCT04098302|454599753|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
126357221|NCT04098302|454599754|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
126357222|NCT04098302|454599755|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
126357223|NCT04098302|454599756|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
126357224|NCT04098302|454599753|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
126357225|NCT04098302|454599754|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
126357226|NCT04098302|454599755|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
126357227|NCT04098302|454599756|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
126242204|NCT01854047|454181068|FG004|Overall Study|Other than specified above|8|||
126242205|NCT00576056|454181069|FG000|Overall Study|Adverse Event|1|||
126357228|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
126242206|NCT00576056|454181069|FG000|Overall Study|Death|1|||
126242207|NCT00576056|454181069|FG000|Overall Study|Lack of Efficacy|1|||
126242208|NCT00576056|454181069|FG000|Overall Study|Withdrawal by Subject|2|||
126242209|NCT00576056|454181069|FG000|Overall Study|did not meet eligibility criteria|8|||
126242210|NCT00576056|454181069|FG000|Overall Study|Physician Decision|1|||
126242211|NCT03273153|454181070|FG000|Overall Study|Adverse Event|1|||
126242212|NCT03273153|454181071|FG001|Overall Study|Adverse Event|2|||
126242213|NCT03273153|454181070|FG000|Overall Study|Missing|0|||
126242214|NCT03273153|454181071|FG001|Overall Study|Missing|2|||
126242215|NCT03273153|454181070|FG000|Overall Study|Other|3|||
126357229|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
126357230|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
126357231|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
126357232|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
126357233|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
126357234|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
126242216|NCT03273153|454181071|FG001|Overall Study|Other|2|||
126242217|NCT03273153|454181070|FG000|Overall Study|Symptomatic Deterioration|0|||
126242218|NCT03273153|454181071|FG001|Overall Study|Symptomatic Deterioration|1|||
126242219|NCT03273153|454181070|FG000|Overall Study|Progressive Disease|6|||
126357235|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
126357236|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
126357237|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
126357238|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
126357239|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
126357240|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
126357241|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
126357242|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
126357243|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
126357244|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
126357245|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
126357246|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
126357247|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
126357248|NCT01290731|454599759|FG000|Overall Study|Withdrawal by Subject|1|||
126357249|NCT01399099|454599760|FG000|Overall Study|Lost to Follow-up|14|||
126357250|NCT01399099|454599760|FG000|Overall Study|Physician Decision|1|||
126357251|NCT01399099|454599760|FG000|Overall Study|Protocol Violation|1|||
126357252|NCT01399099|454599760|FG000|Overall Study|Skin Irritation|13|||
126357253|NCT01399099|454599760|FG000|Overall Study|Infection|1|||
126357254|NCT01399099|454599760|FG000|Overall Study|Miscellaneous|4|||
126357255|NCT01668537|454599761|FG000|Overall Study|Request to Discontinue Prematurely|1|||
126357256|NCT01668537|454599762|FG001|Overall Study|Request to Discontinue Prematurely|1|||
126357257|NCT01668537|454599761|FG000|Overall Study|Subject unwilling/unable to comply|5|||
126357258|NCT01668537|454599762|FG001|Overall Study|Subject unwilling/unable to comply|0|||
126357259|NCT01668537|454599761|FG000|Overall Study|Reason Precludes Participation|1|||
126357260|NCT01668537|454599762|FG001|Overall Study|Reason Precludes Participation|0|||
126357261|NCT01668537|454599761|FG000|Overall Study|Lost to Follow-up|13|||
126357262|NCT01668537|454599762|FG001|Overall Study|Lost to Follow-up|6|||
126357263|NCT01668537|454599761|FG000|Overall Study|Other|2|||
126357264|NCT01668537|454599762|FG001|Overall Study|Other|3|||
126357265|NCT05064800|454599763|FG000|Period 3|Withdrawal by Subject|0|||
126357266|NCT05064800|454599764|FG001|Period 3|Withdrawal by Subject|0|||
126357267|NCT05064800|454599765|FG002|Period 3|Withdrawal by Subject|0|||
126357268|NCT05064800|454599766|FG003|Period 3|Withdrawal by Subject|0|||
126357269|NCT05064800|454599767|FG004|Period 3|Withdrawal by Subject|1|||
126357270|NCT05064800|454599768|FG005|Period 3|Withdrawal by Subject|0|||
126357271|NCT04477486|454599769|FG000|Overall Study|Death|2|||
126357272|NCT04477486|454599769|FG000|Overall Study|Ongoing at Time of Analysis|11|||
126357273|NCT02497755|454599770|FG000|Overall Study|Protocol Violation|1|||
126357274|NCT02497755|454599771|FG001|Overall Study|Protocol Violation|0|||
126357275|NCT02487199|454599778|FG000|Overall Study|Withdrew Consent|0|||
126357276|NCT02487199|454599779|FG001|Overall Study|Withdrew Consent|1|||
126357277|NCT03554473|454602029|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
126357278|NCT03554473|454602030|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
126357279|NCT03554473|454602031|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
126357280|NCT03554473|454602029|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
126357281|NCT03554473|454602030|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
126357282|NCT03554473|454602031|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
126357283|NCT03554473|454602029|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
126357284|NCT03554473|454602030|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
126357285|NCT03554473|454602031|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
125879055|NCT05135767|452853539|FG001|Baseline|Lost to Follow-up|1|||
126357286|NCT04971837|454602035|FG000|Overall Study|Long Term Illness|1|||
126357287|NCT04971837|454602035|FG000|Overall Study|BMI too low|9|||
126357288|NCT04971837|454602035|FG000|Overall Study|geographic location|1|||
126093800|NCT03568318|453637105|FG001|Overall Study|Lost to Follow-up|2|||
126093801|NCT03568318|453637106|FG002|Overall Study|Lost to Follow-up|2|||
126357289|NCT04971837|454602035|FG000|Overall Study|Discontinued scheduling conflict|1|||
126093802|NCT03568318|453637107|FG003|Overall Study|Lost to Follow-up|2|||
126242220|NCT03273153|454181071|FG001|Overall Study|Progressive Disease|5|||
126242221|NCT03273153|454181070|FG000|Overall Study|Physician Decision|1|||
126242222|NCT03273153|454181071|FG001|Overall Study|Physician Decision|3|||
126242223|NCT03273153|454181070|FG000|Overall Study|Study Terminated by Sponsor|112|||
126242224|NCT03273153|454181071|FG001|Overall Study|Study Terminated by Sponsor|102|||
126242225|NCT03273153|454181070|FG000|Overall Study|Withdrawal by Subject|26|||
126242226|NCT03273153|454181071|FG001|Overall Study|Withdrawal by Subject|25|||
126242227|NCT03273153|454181070|FG000|Overall Study|Protocol Deviation|3|||
126242228|NCT03273153|454181071|FG001|Overall Study|Protocol Deviation|0|||
126242229|NCT03273153|454181070|FG000|Overall Study|Lost to Follow-up|6|||
126242230|NCT03273153|454181071|FG001|Overall Study|Lost to Follow-up|11|||
126242231|NCT03273153|454181070|FG000|Overall Study|Death|66|||
126242232|NCT03273153|454181071|FG001|Overall Study|Death|69|||
126242233|NCT05323396|454181072|FG000|Overall Study|Lost to Follow-up|1|||
126242234|NCT05323396|454181073|FG001|Overall Study|Lost to Follow-up|35|||
126242235|NCT05323396|454181072|FG000|Overall Study|Pregnancy|1|||
126242236|NCT05323396|454181073|FG001|Overall Study|Pregnancy|0|||
126242237|NCT04646213|454181074|FG000|Overall Study|Physician Decision|3|||
126242238|NCT04646213|454181074|FG000|Overall Study|Withdrawal by Subject|2|||
126242239|NCT01597245|454181085|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
126242240|NCT01597245|454181086|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
126242241|NCT01597245|454181087|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
126242242|NCT01597245|454181088|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
126242243|NCT01597245|454181089|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242244|NCT01597245|454181090|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242245|NCT01597245|454181091|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242246|NCT01597245|454181092|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242247|NCT01597245|454181093|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242248|NCT01597245|454181094|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242249|NCT01597245|454181095|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242250|NCT01597245|454181096|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242251|NCT01597245|454181097|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242252|NCT01597245|454181098|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242253|NCT01597245|454181099|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242254|NCT01597245|454181100|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242255|NCT01597245|454181101|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242256|NCT01597245|454181102|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242257|NCT01597245|454181103|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242258|NCT01597245|454181104|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242259|NCT01597245|454181105|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126242260|NCT01597245|454181085|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
126242261|NCT01597245|454181086|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
126242262|NCT01597245|454181087|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
126242263|NCT01597245|454181088|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
126242264|NCT01597245|454181089|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242265|NCT01597245|454181090|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242266|NCT01597245|454181091|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242267|NCT01597245|454181092|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242268|NCT01597245|454181093|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242269|NCT01597245|454181094|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242270|NCT01597245|454181095|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242271|NCT01597245|454181096|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242272|NCT01597245|454181097|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242273|NCT01597245|454181098|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242274|NCT01597245|454181099|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242275|NCT01597245|454181100|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242276|NCT01597245|454181101|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242277|NCT01597245|454181102|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242278|NCT01597245|454181103|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242279|NCT01597245|454181104|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242280|NCT01597245|454181105|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126242281|NCT01597245|454181085|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
126242282|NCT01597245|454181086|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
126242283|NCT01597245|454181087|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
126242284|NCT01597245|454181088|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
126242285|NCT01597245|454181089|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126357290|NCT00382070|454602036|FG000|Overall Study|No follow up data mapped to Other|17|||
126357291|NCT00382070|454602037|FG001|Overall Study|No follow up data mapped to Other|19|||
126357292|NCT00382070|454602036|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
126357293|NCT00382070|454602037|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
126357294|NCT00382070|454602036|FG000|Overall Study|No clinical assessment|9|||
126357295|NCT00382070|454602037|FG001|Overall Study|No clinical assessment|11|||
126357296|NCT00284934|454602043|FG000|Overall Study|Adverse Event|1|||
126357297|NCT00284934|454602044|FG001|Overall Study|Adverse Event|2|||
126357298|NCT00284934|454602043|FG000|Overall Study|Other reasons|3|||
126357299|NCT00284934|454602044|FG001|Overall Study|Other reasons|1|||
126357300|NCT01245751|454602045|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
126357301|NCT01245751|454602046|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
126357302|NCT01245751|454602047|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
126357303|NCT01245751|454602048|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
126357304|NCT01245751|454602045|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
126357305|NCT01245751|454602046|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
126357306|NCT01245751|454602047|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
126357307|NCT01245751|454602048|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
126357308|NCT01245751|454602045|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
126357309|NCT01245751|454602046|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
126357310|NCT01245751|454602047|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
126357311|NCT01245751|454602048|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
126357312|NCT05788328|454602049|FG000|Treatment Period 4 (5 Days)|Other|1|||
126357313|NCT05788328|454602049|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
126357314|NCT02082483|454602050|FG000|Overall Study|Lost to Follow-up|1|||
126357315|NCT02082483|454602051|FG001|Overall Study|Lost to Follow-up|1|||
126357316|NCT02082483|454602050|FG000|Overall Study|Withdrawal by Subject|2|||
126357317|NCT02082483|454602051|FG001|Overall Study|Withdrawal by Subject|1|||
126357318|NCT02082483|454602050|FG000|Overall Study|Physician Decision|1|||
126357319|NCT02082483|454602051|FG001|Overall Study|Physician Decision|1|||
126357320|NCT02082483|454602050|FG000|Overall Study|Death|2|||
126357321|NCT02082483|454602051|FG001|Overall Study|Death|3|||
126357322|NCT00145327|454602053|FG000|Overall Study|Withdrawal by Subject|77|||
126357323|NCT00145327|454602054|FG001|Overall Study|Withdrawal by Subject|72|||
126357324|NCT00145327|454602055|FG002|Overall Study|Withdrawal by Subject|164|||
126357325|NCT00145327|454602053|FG000|Overall Study|Death|26|||
126357326|NCT00145327|454602054|FG001|Overall Study|Death|18|||
126357327|NCT00145327|454602055|FG002|Overall Study|Death|30|||
126357328|NCT00145327|454602053|FG000|Overall Study|Adverse Event|14|||
126357329|NCT00145327|454602054|FG001|Overall Study|Adverse Event|11|||
126357330|NCT00145327|454602055|FG002|Overall Study|Adverse Event|22|||
126357331|NCT00145327|454602053|FG000|Overall Study|Lost to Follow-up|9|||
126357332|NCT00145327|454602054|FG001|Overall Study|Lost to Follow-up|14|||
126357333|NCT00145327|454602055|FG002|Overall Study|Lost to Follow-up|14|||
126357334|NCT00145327|454602053|FG000|Overall Study|Administrative problems|12|||
126357335|NCT00145327|454602054|FG001|Overall Study|Administrative problems|9|||
126357336|NCT00145327|454602055|FG002|Overall Study|Administrative problems|13|||
126357337|NCT00145327|454602053|FG000|Overall Study|Protocol Violation|2|||
126357338|NCT00145327|454602054|FG001|Overall Study|Protocol Violation|0|||
126357339|NCT00145327|454602055|FG002|Overall Study|Protocol Violation|2|||
126026064|NCT04093752|453390671|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
126026065|NCT04093752|453390672|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
126026066|NCT04093752|453390669|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
126026067|NCT04093752|453390670|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
126026068|NCT04093752|453390671|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
126026069|NCT04093752|453390672|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
126026070|NCT01101451|453390673|FG000|Overall Study|Eligible and never treated|0|||
126026071|NCT01101451|453390674|FG001|Overall Study|Eligible and never treated|5|||
126026072|NCT01101451|453390673|FG000|Overall Study|Ineligible and treated|12|||
126026073|NCT01101451|453390674|FG001|Overall Study|Ineligible and treated|8|||
126026074|NCT01101451|453390673|FG000|Overall Study|Ineligible and never treated|2|||
126026075|NCT01101451|453390674|FG001|Overall Study|Ineligible and never treated|2|||
126026076|NCT04854096|453390675|FG000|Overall Study|Adverse Event|1|||
126026077|NCT04854096|453390676|FG001|Overall Study|Adverse Event|0|||
126026078|NCT04854096|453390675|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
126357340|NCT00145327|454602053|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126357341|NCT00145327|454602054|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126357342|NCT00145327|454602055|FG002|Overall Study|Abnormal laboratory value(s)|2|||
126357343|NCT00145327|454602053|FG000|Overall Study|Missing - not stated|1|||
126026079|NCT04854096|453390676|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
126026080|NCT04854096|453390675|FG000|Overall Study|Withdrawal by Subject|1|||
126242286|NCT01597245|454181090|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242287|NCT01597245|454181091|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242288|NCT01597245|454181092|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242289|NCT01597245|454181093|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242290|NCT01597245|454181094|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242291|NCT01597245|454181095|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242292|NCT01597245|454181096|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242293|NCT01597245|454181097|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126026081|NCT04854096|453390676|FG001|Overall Study|Withdrawal by Subject|0|||
126026082|NCT04854096|453390675|FG000|Overall Study|Other reasons|1|||
126026083|NCT04854096|453390676|FG001|Overall Study|Other reasons|0|||
126242294|NCT01597245|454181098|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242295|NCT01597245|454181099|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242296|NCT01597245|454181100|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242297|NCT01597245|454181101|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242298|NCT01597245|454181102|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242299|NCT01597245|454181103|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242300|NCT01597245|454181104|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242301|NCT01597245|454181105|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126242302|NCT01597245|454181085|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
126242303|NCT01597245|454181086|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
126242304|NCT01597245|454181087|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
126242305|NCT01597245|454181088|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242306|NCT01597245|454181089|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242307|NCT01597245|454181090|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242308|NCT01597245|454181091|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242309|NCT01597245|454181092|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126026084|NCT04757610|453390677|FG000|Overall Study|Adverse Event|13|||
126242310|NCT01597245|454181093|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242311|NCT01597245|454181094|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126026085|NCT04757610|453390678|FG001|Overall Study|Adverse Event|10|||
126026086|NCT04757610|453390679|FG002|Overall Study|Adverse Event|5|||
126026087|NCT04757610|453390677|FG000|Overall Study|Death|5|||
126026088|NCT04757610|453390678|FG001|Overall Study|Death|13|||
126026089|NCT04757610|453390679|FG002|Overall Study|Death|8|||
126026090|NCT04757610|453390677|FG000|Overall Study|Lack of Efficacy|1|||
126026091|NCT04757610|453390678|FG001|Overall Study|Lack of Efficacy|2|||
126026092|NCT04757610|453390679|FG002|Overall Study|Lack of Efficacy|3|||
126026093|NCT04757610|453390677|FG000|Overall Study|Lost to Follow-up|7|||
126026094|NCT04757610|453390678|FG001|Overall Study|Lost to Follow-up|2|||
126242312|NCT01597245|454181095|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242313|NCT01597245|454181096|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242314|NCT01597245|454181097|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242315|NCT01597245|454181098|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242316|NCT01597245|454181099|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242317|NCT01597245|454181100|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242318|NCT01597245|454181101|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242319|NCT01597245|454181102|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242320|NCT01597245|454181103|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242321|NCT01597245|454181104|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242322|NCT01597245|454181105|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126242323|NCT01597245|454181085|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
126242324|NCT01597245|454181086|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242325|NCT01597245|454181087|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242326|NCT01597245|454181088|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
126242327|NCT01597245|454181089|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242328|NCT01597245|454181090|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242329|NCT01597245|454181091|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242330|NCT01597245|454181092|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242331|NCT01597245|454181093|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242332|NCT01597245|454181094|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242333|NCT01597245|454181095|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126026095|NCT04757610|453390679|FG002|Overall Study|Lost to Follow-up|7|||
126026096|NCT04757610|453390677|FG000|Overall Study|Physician Decision|4|||
126357344|NCT00145327|454602054|FG001|Overall Study|Missing - not stated|0|||
126357345|NCT00145327|454602055|FG002|Overall Study|Missing - not stated|1|||
126357346|NCT02802865|454602056|FG000|Overall Study|Pregnancy|1|||
126026097|NCT04757610|453390678|FG001|Overall Study|Physician Decision|1|||
126026098|NCT04757610|453390679|FG002|Overall Study|Physician Decision|2|||
126026099|NCT04757610|453390677|FG000|Overall Study|Withdrawal by Subject|26|||
126242334|NCT01597245|454181096|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242335|NCT01597245|454181097|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242336|NCT01597245|454181098|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242337|NCT01597245|454181099|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242338|NCT01597245|454181100|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242339|NCT01597245|454181101|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242340|NCT01597245|454181102|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242341|NCT01597245|454181103|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242342|NCT01597245|454181104|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242343|NCT01597245|454181105|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126242344|NCT01597245|454181085|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
126242345|NCT01597245|454181086|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
126242346|NCT01597245|454181087|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
126242347|NCT01597245|454181088|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242348|NCT01597245|454181089|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242349|NCT01597245|454181090|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242350|NCT01597245|454181091|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242351|NCT01597245|454181092|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242352|NCT01597245|454181093|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242353|NCT01597245|454181094|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242354|NCT01597245|454181095|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242355|NCT01597245|454181096|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242356|NCT01597245|454181097|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242357|NCT01597245|454181098|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242358|NCT01597245|454181099|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242359|NCT01597245|454181100|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242360|NCT01597245|454181101|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242361|NCT01597245|454181102|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242362|NCT01597245|454181103|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242363|NCT01597245|454181104|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242364|NCT01597245|454181105|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126242365|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242366|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242367|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242368|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242369|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242370|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
126242371|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
126242372|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242373|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242374|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242375|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242376|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242377|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242378|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242379|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242380|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242381|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242382|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242383|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242384|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242385|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126242386|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242387|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242388|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242389|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126026100|NCT04757610|453390678|FG001|Overall Study|Withdrawal by Subject|25|||
126026101|NCT04757610|453390679|FG002|Overall Study|Withdrawal by Subject|25|||
126026102|NCT04757610|453390677|FG000|Overall Study|Study Terminated by Sponsor|105|||
126026103|NCT04757610|453390678|FG001|Overall Study|Study Terminated by Sponsor|105|||
126026104|NCT04757610|453390679|FG002|Overall Study|Study Terminated by Sponsor|110|||
126026105|NCT04757610|453390677|FG000|Overall Study|Randomized in Error|1|||
126026106|NCT04757610|453390678|FG001|Overall Study|Randomized in Error|0|||
126026107|NCT04757610|453390679|FG002|Overall Study|Randomized in Error|0|||
126026108|NCT00073749|453390680|FG000|Overall Study|Disease Progression|2|||
126026109|NCT00073749|453390681|FG001|Overall Study|Disease Progression|0|||
126026110|NCT00073749|453390682|FG002|Overall Study|Disease Progression|3|||
126026111|NCT00073749|453390683|FG003|Overall Study|Disease Progression|2|||
126026112|NCT00073749|453390684|FG004|Overall Study|Disease Progression|3|||
126242390|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
126242391|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
126242392|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
126242393|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
126242394|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242395|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
126242396|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242397|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242398|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242399|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242400|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242401|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242402|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242403|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242404|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242405|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242406|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126242407|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242408|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242409|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242410|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242411|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242412|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
126242413|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242414|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242415|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
126242416|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242417|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
126242418|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
126242419|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
126242420|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242421|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242422|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242423|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242424|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242425|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242426|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126357347|NCT02802865|454602057|FG001|Overall Study|Pregnancy|1|||
126026113|NCT00073749|453390685|FG005|Overall Study|Disease Progression|1|||
126026114|NCT00073749|453390686|FG006|Overall Study|Disease Progression|3|||
126026115|NCT00073749|453390680|FG000|Overall Study|Death|0|||
126357348|NCT02802865|454602056|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
126357349|NCT02802865|454602057|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
126357350|NCT00985192|454602059|FG000|Overall Study|Withdrawal by Subject|1|||
126357351|NCT00985192|454602059|FG000|Overall Study|Disease Progression|1|||
126357352|NCT00985192|454602059|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
126357353|NCT01454063|454602060|FG000|Randomized|Adverse Event|1|||
126357354|NCT01454063|454602061|FG001|Randomized|Adverse Event|1|||
126026116|NCT00073749|453390681|FG001|Overall Study|Death|1|||
126242427|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126242428|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242429|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242430|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242431|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242432|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
126242433|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
126242434|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
126242435|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
126242436|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
126242437|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
126242438|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
126242439|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
126242440|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
126242441|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242442|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242443|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126357355|NCT01454063|454602060|FG000|Randomized|Protocol Violation|0|||
126357356|NCT01454063|454602061|FG001|Randomized|Protocol Violation|1|||
126357357|NCT00509600|454602065|FG000|Overall Study|Adverse Event|1|||
126357358|NCT03055195|454602066|FG000|Overall Study|Lack of Efficacy|1|||
126357359|NCT03055195|454602067|FG001|Overall Study|Lack of Efficacy|0|||
126357360|NCT03055195|454602066|FG000|Overall Study|Withdrawal by Subject|6|||
126357361|NCT03055195|454602067|FG001|Overall Study|Withdrawal by Subject|7|||
126357362|NCT03055195|454602066|FG000|Overall Study|Study Terminated by Sponsor|2|||
126357363|NCT03055195|454602067|FG001|Overall Study|Study Terminated by Sponsor|6|||
126357364|NCT03055195|454602066|FG000|Overall Study|Protocol Violation|2|||
126357365|NCT03055195|454602067|FG001|Overall Study|Protocol Violation|1|||
126357366|NCT03055195|454602066|FG000|Overall Study|Physician Decision|1|||
126357367|NCT03055195|454602067|FG001|Overall Study|Physician Decision|0|||
126357368|NCT00720083|454602068|FG000|Overall Study|Ineligible|1|||
126357369|NCT00720083|454602069|FG001|Overall Study|Ineligible|2|||
126357370|NCT01960842|454602070|FG000|Overall Study|Adverse Event|1|||
126357371|NCT01960842|454602070|FG000|Overall Study|Withdrawal by Subject|2|||
126357372|NCT02391584|454602071|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
126357373|NCT02391584|454602072|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
126357374|NCT02391584|454602071|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
126357375|NCT02391584|454602072|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
126357376|NCT02391584|454602071|FG000|3 Month|Lost to Follow-up|1|||
126357377|NCT02391584|454602072|FG001|3 Month|Lost to Follow-up|0|||
126357378|NCT02391584|454602071|FG000|6 Month|Withdrawal by Subject|1|||
126357379|NCT02391584|454602072|FG001|6 Month|Withdrawal by Subject|0|||
125879056|NCT05135767|452853538|FG000|Baseline|Withdrawal by Subject|0|||
126026117|NCT00073749|453390682|FG002|Overall Study|Death|1|||
126026118|NCT00073749|453390683|FG003|Overall Study|Death|0|||
126026119|NCT00073749|453390684|FG004|Overall Study|Death|0|||
126026120|NCT00073749|453390685|FG005|Overall Study|Death|0|||
126026121|NCT00073749|453390686|FG006|Overall Study|Death|29|||
126026122|NCT00073749|453390680|FG000|Overall Study|Adverse Event|0|||
126026123|NCT00073749|453390681|FG001|Overall Study|Adverse Event|3|||
126026124|NCT00073749|453390682|FG002|Overall Study|Adverse Event|6|||
126026125|NCT00073749|453390683|FG003|Overall Study|Adverse Event|4|||
126026126|NCT00073749|453390684|FG004|Overall Study|Adverse Event|2|||
126026127|NCT00073749|453390685|FG005|Overall Study|Adverse Event|1|||
126026128|NCT00073749|453390686|FG006|Overall Study|Adverse Event|0|||
126026129|NCT00073749|453390680|FG000|Overall Study|Physician Decision|0|||
126026130|NCT00073749|453390681|FG001|Overall Study|Physician Decision|0|||
126026131|NCT00073749|453390682|FG002|Overall Study|Physician Decision|1|||
126026132|NCT00073749|453390683|FG003|Overall Study|Physician Decision|0|||
126026133|NCT00073749|453390684|FG004|Overall Study|Physician Decision|0|||
126026134|NCT00073749|453390685|FG005|Overall Study|Physician Decision|2|||
126026135|NCT00073749|453390686|FG006|Overall Study|Physician Decision|0|||
126026136|NCT00073749|453390680|FG000|Overall Study|Withdrawal by Subject|0|||
126026137|NCT00073749|453390681|FG001|Overall Study|Withdrawal by Subject|1|||
126026138|NCT00073749|453390682|FG002|Overall Study|Withdrawal by Subject|0|||
126026139|NCT00073749|453390683|FG003|Overall Study|Withdrawal by Subject|0|||
126026140|NCT00073749|453390684|FG004|Overall Study|Withdrawal by Subject|1|||
126026141|NCT00073749|453390685|FG005|Overall Study|Withdrawal by Subject|0|||
126026142|NCT00073749|453390686|FG006|Overall Study|Withdrawal by Subject|2|||
126026143|NCT00073749|453390680|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
126026144|NCT00073749|453390681|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126026145|NCT00073749|453390682|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
126026146|NCT00073749|453390683|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
126242444|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242445|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242446|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242447|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242448|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126242449|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242450|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242451|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242452|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242453|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
126242454|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
126242455|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
126242456|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242457|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
126242458|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
126242459|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
126242460|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
126242461|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
126242462|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242463|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242464|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242465|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242466|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242467|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242468|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242469|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126242470|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242471|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242472|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242473|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242474|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
126242475|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242476|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242477|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242478|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
126242479|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
126242480|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
126242481|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242482|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
126242483|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242484|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242485|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242486|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242487|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242488|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242489|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242490|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126242491|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242492|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242493|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242494|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242495|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
126242496|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
126242497|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
126242498|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242499|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
125879057|NCT05135767|452853539|FG001|Baseline|Withdrawal by Subject|2|||
125879058|NCT05135767|452853538|FG000|Active Study Phase|Lost to Follow-up|2|||
125879059|NCT05135767|452853539|FG001|Active Study Phase|Lost to Follow-up|0|||
125879060|NCT02260934|452853540|FG000|Overall Study|Lost to Follow-up|2|||
125879061|NCT02260934|452853541|FG001|Overall Study|Lost to Follow-up|1|||
125879062|NCT02260934|452853540|FG000|Overall Study|Withdrawal by Subject|0|||
126026147|NCT00073749|453390684|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
125879063|NCT02260934|452853541|FG001|Overall Study|Withdrawal by Subject|2|||
125879064|NCT02260934|452853540|FG000|Overall Study|Participant Relocated|1|||
126026148|NCT00073749|453390685|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
126242500|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
126242501|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
126242502|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
126242503|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
126242504|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242505|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242506|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242507|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242508|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242509|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242510|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242511|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126242512|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242513|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242514|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242515|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242516|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242517|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126242518|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242519|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242520|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126242521|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126242522|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126242523|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126242524|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242525|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242526|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242527|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242528|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242529|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242530|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242531|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242532|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126242533|NCT01597245|454181085|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242534|NCT01597245|454181086|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242535|NCT01597245|454181087|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242536|NCT01597245|454181088|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242537|NCT01597245|454181089|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242538|NCT01597245|454181090|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242539|NCT01597245|454181091|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242540|NCT01597245|454181092|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242541|NCT01597245|454181093|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242542|NCT01597245|454181094|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242543|NCT01597245|454181095|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
126242544|NCT01597245|454181096|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242545|NCT01597245|454181097|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242546|NCT01597245|454181098|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242547|NCT01597245|454181099|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242548|NCT01597245|454181100|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242549|NCT01597245|454181101|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242550|NCT01597245|454181102|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242551|NCT01597245|454181103|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242552|NCT01597245|454181104|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242553|NCT01597245|454181105|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126242554|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242555|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242556|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242557|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242558|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242559|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242560|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242561|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126026149|NCT00073749|453390686|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
126026150|NCT00073749|453390680|FG000|Overall Study|Lost to Follow-up|0|||
126242562|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242563|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242564|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242565|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242566|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242567|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
126242568|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
126242569|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
126242570|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242571|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242572|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242573|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242574|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126242575|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242576|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242577|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242578|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242579|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242580|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242581|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242582|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242583|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242584|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242585|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242586|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242587|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242588|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
126242589|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
126242590|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
126242591|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242592|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242593|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242594|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242595|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126242596|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242597|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242598|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242599|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242600|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242601|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242602|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242603|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242604|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242605|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242606|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242607|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242608|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242609|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242610|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
126242611|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
126242612|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242613|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242614|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242615|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242616|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126242617|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242618|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242619|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242620|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242621|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242622|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126357380|NCT02391584|454602071|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
126357381|NCT02391584|454602072|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
126357382|NCT01441414|454602080|FG000|Overall Study|Participant died|9|||
126093803|NCT03568318|453637108|FG004|Overall Study|Lost to Follow-up|1|||
126093804|NCT03568318|453637109|FG005|Overall Study|Lost to Follow-up|0|||
126093805|NCT03568318|453637104|FG000|Overall Study|Other|3|||
126093806|NCT03568318|453637105|FG001|Overall Study|Other|1|||
126093807|NCT03568318|453637106|FG002|Overall Study|Other|3|||
126093808|NCT03568318|453637107|FG003|Overall Study|Other|0|||
126093809|NCT03568318|453637108|FG004|Overall Study|Other|0|||
126093810|NCT03568318|453637109|FG005|Overall Study|Other|0|||
126242623|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242624|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242625|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242626|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242627|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242628|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242629|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242630|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242631|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
126242632|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
126242633|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242634|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242635|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126093811|NCT03568318|453637104|FG000|Overall Study|Ongoing at Time of Analysis|5|||
126093812|NCT03568318|453637105|FG001|Overall Study|Ongoing at Time of Analysis|3|||
126242636|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242637|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126242638|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242639|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242640|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242641|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126093813|NCT03568318|453637106|FG002|Overall Study|Ongoing at Time of Analysis|2|||
126093814|NCT03568318|453637107|FG003|Overall Study|Ongoing at Time of Analysis|1|||
126093815|NCT03568318|453637108|FG004|Overall Study|Ongoing at Time of Analysis|0|||
126242642|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126093816|NCT03568318|453637109|FG005|Overall Study|Ongoing at Time of Analysis|0|||
126093817|NCT05870228|453637114|FG000|Overall Study|Lost to Follow-up|2|||
126093818|NCT05870228|453637115|FG001|Overall Study|Lost to Follow-up|0|||
126093819|NCT05870228|453637114|FG000|Overall Study|Withdrawal by Subject|1|||
126242643|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242644|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242645|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242646|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242647|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242648|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242649|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126357383|NCT01441414|454602080|FG000|Overall Study|Other reasons|3|||
126357384|NCT01441414|454602080|FG000|Overall Study|Study terminated by sponsor|2|||
126093820|NCT05870228|453637115|FG001|Overall Study|Withdrawal by Subject|0|||
126093821|NCT04662931|453637116|FG000|Overall Study|Withdrawal by Subject|17|||
126093822|NCT04662931|453637116|FG000|Overall Study|Death|3|||
126093823|NCT04662931|453637116|FG000|Overall Study|Lost to Follow-up|3|||
126093824|NCT04662931|453637116|FG000|Overall Study|Guardian Decision|1|||
126093825|NCT06665919|453637118|FG000|Overall Study|Withdrawal by Subject|4|||
126093826|NCT06665919|453637119|FG001|Overall Study|Withdrawal by Subject|4|||
126093827|NCT06665919|453637120|FG002|Overall Study|Withdrawal by Subject|4|||
126093828|NCT06665919|453637118|FG000|Overall Study|Non-compliance to Treatment|4|||
126093829|NCT06665919|453637119|FG001|Overall Study|Non-compliance to Treatment|1|||
126093830|NCT06665919|453637120|FG002|Overall Study|Non-compliance to Treatment|6|||
126093831|NCT06665919|453637118|FG000|Overall Study|Lost to Follow-up|3|||
126093832|NCT06665919|453637119|FG001|Overall Study|Lost to Follow-up|0|||
126093833|NCT06665919|453637120|FG002|Overall Study|Lost to Follow-up|2|||
126093834|NCT06665919|453637118|FG000|Overall Study|Physician Decision|4|||
126093835|NCT06665919|453637119|FG001|Overall Study|Physician Decision|0|||
126357385|NCT01441414|454602080|FG000|Overall Study|Subject refused further follow-up|1|||
126093836|NCT06665919|453637120|FG002|Overall Study|Physician Decision|1|||
126093837|NCT04150068|453637121|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
126093838|NCT04150068|453637122|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
126093839|NCT04150068|453637123|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
126093840|NCT04150068|453637121|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
126093841|NCT04150068|453637122|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
126093842|NCT04150068|453637123|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
126093843|NCT05316701|453637124|FG000|Overall Study|Adverse Event|0|||
126242650|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242651|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
126242652|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
126242653|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
126242654|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242655|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242656|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126026151|NCT00073749|453390681|FG001|Overall Study|Lost to Follow-up|0|||
126242657|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126026152|NCT00073749|453390682|FG002|Overall Study|Lost to Follow-up|0|||
126242658|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126242659|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242660|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242661|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242662|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242663|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242664|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242665|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242666|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242667|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242668|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242669|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242670|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242671|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242672|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242673|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
126242674|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
126242675|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242676|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242677|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242678|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242679|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
126242680|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242681|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242682|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242683|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242684|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126357386|NCT01773889|454602087|FG000|Overall Study|lack of funding|2|||
126357387|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
126357388|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
126357389|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
126357390|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
126357391|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
126357392|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
126357393|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
126357394|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
126357395|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
126357396|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
126357397|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
126357398|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
126357399|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
126357400|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
126357401|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
126357402|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
126357403|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
126357404|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
126357405|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
126357406|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
126357407|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
126357408|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
126357409|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
126357410|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
126357411|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
126357412|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
126357413|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
126357414|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
126357415|NCT02018887|454602090|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
126357416|NCT02018887|454602091|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126242685|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242686|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242687|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242688|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242689|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242690|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242691|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242692|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242693|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242694|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
126242695|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
126242696|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242697|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242698|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242699|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242700|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126242701|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242702|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242703|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242704|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242705|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242706|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242707|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242708|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242709|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242710|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242711|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242712|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242713|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242714|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242715|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
126242716|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
126242717|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242718|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242719|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242720|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242721|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126242722|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242723|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242724|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242725|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242726|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242727|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242728|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242729|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242730|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242731|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242732|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242733|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126026153|NCT00073749|453390683|FG003|Overall Study|Lost to Follow-up|0|||
126242734|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242735|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242736|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
126242737|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
126242738|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242739|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242740|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242741|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242742|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126242743|NCT01597245|454181085|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242744|NCT01597245|454181086|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242745|NCT01597245|454181087|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242746|NCT01597245|454181088|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242747|NCT01597245|454181089|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242748|NCT01597245|454181090|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242749|NCT01597245|454181091|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242750|NCT01597245|454181092|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242751|NCT01597245|454181093|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242752|NCT01597245|454181094|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242753|NCT01597245|454181095|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242754|NCT01597245|454181096|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242755|NCT01597245|454181097|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242756|NCT01597245|454181098|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
126242757|NCT01597245|454181099|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242758|NCT01597245|454181100|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242759|NCT01597245|454181101|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242760|NCT01597245|454181102|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242761|NCT01597245|454181103|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242762|NCT01597245|454181104|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242763|NCT01597245|454181105|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126242764|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242765|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242766|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242767|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242768|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242769|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242770|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242771|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242772|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242773|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242774|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242775|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242776|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242777|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242778|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242779|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126242780|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
126242781|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
126242782|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
126242783|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
126242784|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
126242785|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242786|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126026154|NCT00073749|453390684|FG004|Overall Study|Lost to Follow-up|0|||
126026155|NCT00073749|453390685|FG005|Overall Study|Lost to Follow-up|0|||
126242787|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242788|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242789|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242790|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242791|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242792|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242793|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242794|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242795|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242796|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242797|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242798|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242799|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242800|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242801|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126242802|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
126242803|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
126242804|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
126242805|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
126242806|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242807|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242808|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242809|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242810|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242811|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242812|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242813|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242814|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242815|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242816|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242817|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242818|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242819|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242820|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242821|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242822|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
126242823|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242824|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126242825|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
126242826|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
126242827|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242828|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242829|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242830|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242831|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242832|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242833|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242834|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242835|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126357417|NCT02018887|454602092|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357418|NCT02018887|454602093|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357419|NCT02018887|454602094|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357420|NCT02018887|454602095|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357421|NCT02018887|454602096|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357422|NCT02018887|454602097|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357423|NCT02018887|454602098|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357424|NCT02018887|454602099|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357425|NCT02018887|454602100|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357426|NCT02018887|454602090|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357427|NCT02018887|454602091|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357428|NCT02018887|454602092|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357429|NCT02018887|454602093|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357430|NCT02018887|454602094|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
126357431|NCT02018887|454602095|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357432|NCT02018887|454602096|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
126026156|NCT00073749|453390686|FG006|Overall Study|Lost to Follow-up|2|||
126026157|NCT00073749|453390680|FG000|Overall Study|Other|0|||
126026158|NCT00073749|453390681|FG001|Overall Study|Other|0|||
126026159|NCT00073749|453390682|FG002|Overall Study|Other|0|||
126026160|NCT00073749|453390683|FG003|Overall Study|Other|0|||
126242836|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242837|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242838|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242839|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242840|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242841|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242842|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242843|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242844|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126242845|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
126242846|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
126242847|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
126242848|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242849|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242850|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242851|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242852|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242853|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242854|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242855|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242856|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242857|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242858|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242859|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242860|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126026161|NCT00073749|453390684|FG004|Overall Study|Other|0|||
126026162|NCT00073749|453390685|FG005|Overall Study|Other|2|||
126026163|NCT00073749|453390686|FG006|Overall Study|Other|0|||
126026164|NCT04154384|453390687|FG000|Overall Study|Lost to Follow-up|24|||
126093844|NCT05316701|453637125|FG001|Overall Study|Adverse Event|1|||
126093845|NCT05316701|453637124|FG000|Overall Study|Death|3|||
126093846|NCT05316701|453637125|FG001|Overall Study|Death|9|||
126093847|NCT05316701|453637124|FG000|Overall Study|Lost to Follow-up|1|||
126093848|NCT05316701|453637125|FG001|Overall Study|Lost to Follow-up|0|||
126093849|NCT05316701|453637124|FG000|Overall Study|Physician Decision|1|||
126093850|NCT05316701|453637125|FG001|Overall Study|Physician Decision|4|||
126093851|NCT05316701|453637124|FG000|Overall Study|Withdrawal by Subject|3|||
126093852|NCT05316701|453637125|FG001|Overall Study|Withdrawal by Subject|5|||
126093853|NCT05316701|453637124|FG000|Overall Study|Progression/Relapse|14|||
126093854|NCT05316701|453637125|FG001|Overall Study|Progression/Relapse|9|||
126093855|NCT05316701|453637124|FG000|Overall Study|Received Standard of Care|1|||
126093856|NCT05316701|453637125|FG001|Overall Study|Received Standard of Care|0|||
126093857|NCT05316701|453637124|FG000|Overall Study|Ongoing|70|||
126093858|NCT05316701|453637125|FG001|Overall Study|Ongoing|64|||
126093859|NCT04696653|453637126|FG000|Overall Study|left organization|18|||
126093860|NCT04696653|453637126|FG000|Overall Study|Lost to Follow-up|3|||
126093861|NCT04625413|453637127|FG000|Overall Study|Hospice|2|||
126093862|NCT04625413|453637127|FG000|Overall Study|Distress|1|||
126093863|NCT04625413|453637127|FG000|Overall Study|Not feeling well|1|||
126093864|NCT04679935|453637128|FG000|Overall Study|Death|0|||
126093865|NCT04679935|453637129|FG001|Overall Study|Death|1|||
126093866|NCT02993146|453637130|FG000|Overall Study|Withdrawal by Subject|0|||
126093867|NCT02993146|453637131|FG001|Overall Study|Withdrawal by Subject|0|||
126093868|NCT02993146|453637132|FG002|Overall Study|Withdrawal by Subject|1|||
126093869|NCT02993146|453637133|FG003|Overall Study|Withdrawal by Subject|1|||
126093870|NCT04362189|453637134|FG000|Overall Study|Lost to Follow-up|0|||
126093871|NCT04362189|453637135|FG001|Overall Study|Lost to Follow-up|1|||
126093872|NCT04362189|453637134|FG000|Overall Study|Withdrawal by Subject|1|||
126093873|NCT04362189|453637135|FG001|Overall Study|Withdrawal by Subject|0|||
126093874|NCT04362189|453637134|FG000|Overall Study|FDA Clinical Hold|7|||
126093875|NCT04362189|453637135|FG001|Overall Study|FDA Clinical Hold|2|||
126093876|NCT04362189|453637134|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
126093877|NCT04362189|453637135|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
126093878|NCT04362189|453637134|FG000|Overall Study|Adverse Event|0|||
126093879|NCT04362189|453637135|FG001|Overall Study|Adverse Event|2|||
126093880|NCT04362189|453637134|FG000|Overall Study|Death|4|||
126093881|NCT04362189|453637135|FG001|Overall Study|Death|1|||
126093882|NCT02111681|453637136|FG000|Overall Study|Death|5|||
126093883|NCT02111681|453637136|FG000|Overall Study|Lack of Efficacy|2|||
126093884|NCT02111681|453637136|FG000|Overall Study|Progression of disease|4|||
126093885|NCT04349631|453637143|FG000|Overall Study|Lost to Follow-up|3|||
126093886|NCT04349631|453637143|FG000|Overall Study|Withdrawal by Subject|7|||
126093887|NCT01982448|453637144|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
126093888|NCT01982448|453637145|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
126093889|NCT01982448|453637144|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
126093890|NCT01982448|453637145|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
126093891|NCT01982448|453637144|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
126093892|NCT01982448|453637145|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
126093893|NCT01982448|453637144|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
126093894|NCT01982448|453637145|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
126242861|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242862|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242863|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242864|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
126242865|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126242866|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125879065|NCT02260934|452853541|FG001|Overall Study|Participant Relocated|0|||
126093895|NCT02898077|453639061|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
126093896|NCT02898077|453639062|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
126093897|NCT02898077|453639061|FG000|Overall Study|Lost to Follow-up|4|||
126093898|NCT02898077|453639062|FG001|Overall Study|Lost to Follow-up|3|||
126093899|NCT02898077|453639061|FG000|Overall Study|Physician Decision|0|||
126093900|NCT02898077|453639062|FG001|Overall Study|Physician Decision|2|||
126093901|NCT02898077|453639061|FG000|Overall Study|Sponsor Decision|32|||
126093902|NCT02898077|453639062|FG001|Overall Study|Sponsor Decision|13|||
126093903|NCT02898077|453639061|FG000|Overall Study|Withdrawal by Subject|6|||
126093904|NCT02898077|453639062|FG001|Overall Study|Withdrawal by Subject|3|||
126242867|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
126093905|NCT02898077|453639061|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
126093906|NCT02898077|453639062|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
126093907|NCT02898077|453639061|FG000|Overall Study|Ended extension period|3|||
126093908|NCT02898077|453639062|FG001|Overall Study|Ended extension period|0|||
125879066|NCT02260934|452853540|FG000|Overall Study|Site error|0|||
126242868|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
126242869|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242870|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242871|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242872|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242873|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242874|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242875|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242876|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242877|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242878|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242879|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242880|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242881|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242882|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242883|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242884|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242885|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
126242886|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242887|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126242888|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
126242889|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
126242890|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242891|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242892|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242893|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242894|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242895|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242896|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242897|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242898|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242899|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242900|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242901|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242902|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242903|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242904|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242905|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242906|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
126242907|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242908|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126093909|NCT00621777|453639063|FG000|Open Phase|Adverse Event|20|||
126242909|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
126242910|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126242911|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242912|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242913|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242914|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242915|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242916|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242917|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242918|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242919|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242920|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242921|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242922|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242923|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242924|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126093910|NCT00621777|453639064|FG001|Open Phase|Adverse Event|0|||
126093911|NCT00621777|453639063|FG000|Open Phase|Did not abstain during open phase|56|||
126093912|NCT00621777|453639064|FG001|Open Phase|Did not abstain during open phase|0|||
126093913|NCT00621777|453639063|FG000|Open Phase|Withdrawal by Subject|17|||
126093914|NCT00621777|453639064|FG001|Open Phase|Withdrawal by Subject|0|||
126242925|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242926|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242927|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
126242928|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242929|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242930|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
126242931|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126242932|NCT01597245|454181085|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242933|NCT01597245|454181086|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242934|NCT01597245|454181087|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242935|NCT01597245|454181088|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242936|NCT01597245|454181089|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242937|NCT01597245|454181090|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242938|NCT01597245|454181091|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242939|NCT01597245|454181092|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242940|NCT01597245|454181093|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242941|NCT01597245|454181094|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242942|NCT01597245|454181095|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242943|NCT01597245|454181096|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242944|NCT01597245|454181097|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242945|NCT01597245|454181098|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242946|NCT01597245|454181099|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242947|NCT01597245|454181100|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242948|NCT01597245|454181101|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242949|NCT01597245|454181102|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242950|NCT01597245|454181103|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242951|NCT01597245|454181104|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
126242952|NCT01597245|454181105|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126242953|NCT00731783|454181106|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
126242954|NCT00731783|454181107|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
126242955|NCT00731783|454181106|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
126242956|NCT00731783|454181107|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
126242957|NCT00731783|454181106|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
126242958|NCT00731783|454181107|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
126242959|NCT00731783|454181106|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
126242960|NCT00731783|454181107|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
126242961|NCT00467896|454183111|FG000|Overall Study|Consent Withdrawal|18|||
126242962|NCT00467896|454183111|FG000|Overall Study|Adverse Event|7|||
126242963|NCT00467896|454183111|FG000|Overall Study|Serious Adverse Event|13|||
126242964|NCT00467896|454183111|FG000|Overall Study|Non-compliance|3|||
126242965|NCT00467896|454183111|FG000|Overall Study|Changed therapy|2|||
126242966|NCT00467896|454183111|FG000|Overall Study|Patient received transplant|2|||
126242967|NCT00467896|454183111|FG000|Overall Study|Patient had atrial septostomy|1|||
126242968|NCT00467896|454183111|FG000|Overall Study|Patient weaned off iloprost|1|||
126242969|NCT00467896|454183111|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
126242970|NCT00467896|454183111|FG000|Overall Study|Started intravenous prostacyclin|1|||
126242971|NCT00467896|454183111|FG000|Overall Study|Started inhaled Remodulin|1|||
126242972|NCT00467896|454183111|FG000|Overall Study|Patient had no improvement|1|||
126242973|NCT03772522|454183112|FG000|Pre-intervention|Withdrawal by Subject|3|||
126242974|NCT03772522|454183113|FG001|Pre-intervention|Withdrawal by Subject|4|||
126242975|NCT03772522|454183112|FG000|Intervention|Withdrawal by Subject|1|||
126242976|NCT03772522|454183113|FG001|Intervention|Withdrawal by Subject|0|||
126242977|NCT03772522|454183112|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
126242978|NCT03772522|454183113|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
126242979|NCT02175095|454183114|FG000|Overall Study|Withdrawal by Subject|3|||
126242980|NCT03697109|454183115|FG000|Open-label (OL) Phase|Adverse Event|24|||
126242981|NCT03697109|454183116|FG001|Open-label (OL) Phase|Adverse Event|0|||
126242982|NCT03697109|454183117|FG002|Open-label (OL) Phase|Adverse Event|0|||
126093915|NCT00621777|453639063|FG000|Open Phase|administrative|13|||
126093916|NCT00621777|453639064|FG001|Open Phase|administrative|0|||
126093917|NCT00621777|453639063|FG000|Open Phase|Lost to Follow-up|10|||
126093918|NCT00621777|453639064|FG001|Open Phase|Lost to Follow-up|0|||
126093919|NCT00621777|453639063|FG000|Randomized Phase|Adverse Event|3|||
126093920|NCT00621777|453639064|FG001|Randomized Phase|Adverse Event|3|||
126093921|NCT00621777|453639063|FG000|Randomized Phase|Lost to Follow-up|3|||
126242983|NCT03697109|454183115|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
126242984|NCT03697109|454183116|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
126242985|NCT03697109|454183117|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
126242986|NCT03697109|454183115|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
126026165|NCT04154384|453390688|FG001|Overall Study|Lost to Follow-up|33|||
126026166|NCT04154384|453390689|FG002|Overall Study|Lost to Follow-up|0|||
126026167|NCT04154384|453390687|FG000|Overall Study|Withdrawal by Subject|7|||
126026168|NCT04154384|453390688|FG001|Overall Study|Withdrawal by Subject|18|||
126026169|NCT04154384|453390689|FG002|Overall Study|Withdrawal by Subject|0|||
126242987|NCT03697109|454183116|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
126242988|NCT03697109|454183117|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
126242989|NCT03697109|454183115|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
126242990|NCT03697109|454183116|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
126242991|NCT03697109|454183117|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
126242992|NCT03697109|454183115|FG000|Open-label (OL) Phase|Physician Decision|2|||
126242993|NCT03697109|454183116|FG001|Open-label (OL) Phase|Physician Decision|0|||
126242994|NCT03697109|454183117|FG002|Open-label (OL) Phase|Physician Decision|0|||
126242995|NCT03697109|454183115|FG000|Open-label (OL) Phase|Death|2|||
126242996|NCT03697109|454183116|FG001|Open-label (OL) Phase|Death|0|||
126242997|NCT03697109|454183117|FG002|Open-label (OL) Phase|Death|0|||
126242998|NCT03697109|454183115|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
126242999|NCT03697109|454183116|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
126243000|NCT03697109|454183117|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
126243001|NCT03697109|454183115|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
126243002|NCT03697109|454183116|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
126243003|NCT03697109|454183117|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
126243004|NCT03697109|454183115|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
126243005|NCT03697109|454183116|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
126243006|NCT03697109|454183117|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
126243007|NCT01111461|454183120|FG000|Overall Study|Adverse Event|32|||
126243008|NCT01111461|454183120|FG000|Overall Study|Participant choice|11|||
126243009|NCT01111461|454183120|FG000|Overall Study|Lost to Follow-up|1|||
126243010|NCT01111461|454183120|FG000|Overall Study|Withdrawal by Subject|1|||
126243011|NCT01111461|454183120|FG000|Overall Study|Other|6|||
126243012|NCT00440518|454183122|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
126243013|NCT00440518|454183123|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
126243014|NCT00440518|454183124|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
126243015|NCT00440518|454183122|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
126243016|NCT00440518|454183123|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
126243017|NCT00440518|454183124|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
126243018|NCT00440518|454183122|FG000|Randomized /Titration Period|Protocol Deviation|1|||
126243019|NCT00440518|454183123|FG001|Randomized /Titration Period|Protocol Deviation|0|||
126243020|NCT00440518|454183124|FG002|Randomized /Titration Period|Protocol Deviation|0|||
126243021|NCT00440518|454183122|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
126243022|NCT00440518|454183123|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
126243023|NCT00440518|454183124|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
126243024|NCT00440518|454183122|FG000|Randomized /Titration Period|Other|1|||
126243025|NCT00440518|454183123|FG001|Randomized /Titration Period|Other|0|||
126243026|NCT00440518|454183124|FG002|Randomized /Titration Period|Other|0|||
126243027|NCT00440518|454183122|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
126243028|NCT00440518|454183123|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
126243029|NCT00440518|454183124|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
126243030|NCT00440518|454183122|FG000|Randomized /Titration Period|Adverse Event|2|||
126243031|NCT00440518|454183123|FG001|Randomized /Titration Period|Adverse Event|3|||
126026170|NCT04154384|453390687|FG000|Overall Study|Missing outcome data|1|||
126026171|NCT04154384|453390688|FG001|Overall Study|Missing outcome data|0|||
126026172|NCT04154384|453390689|FG002|Overall Study|Missing outcome data|0|||
126026173|NCT05048186|453390690|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
126026174|NCT05048186|453390691|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
126026175|NCT05048186|453390690|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
126026176|NCT05048186|453390691|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
126026177|NCT00951379|453390692|FG000|Overall Study|Adverse Event|4|||
126026178|NCT00951379|453390693|FG001|Overall Study|Adverse Event|1|||
126026179|NCT00951379|453390692|FG000|Overall Study|Withdrawal by Subject|1|||
126026180|NCT00951379|453390693|FG001|Overall Study|Withdrawal by Subject|0|||
126026181|NCT00951379|453390692|FG000|Overall Study|Noncompliance|1|||
126026182|NCT00951379|453390693|FG001|Overall Study|Noncompliance|0|||
126026183|NCT00951379|453390692|FG000|Overall Study|Disease Progression|0|||
126026184|NCT00951379|453390693|FG001|Overall Study|Disease Progression|1|||
126026185|NCT04218266|453390694|FG000|Overall Study|Death|1|||
126026186|NCT04218266|453390695|FG001|Overall Study|Death|2|||
126026187|NCT04218266|453390696|FG002|Overall Study|Death|3|||
126243032|NCT00440518|454183124|FG002|Randomized /Titration Period|Adverse Event|0|||
126026188|NCT04218266|453390694|FG000|Overall Study|Adverse Event|13|||
126093922|NCT00621777|453639064|FG001|Randomized Phase|Lost to Follow-up|3|||
126093923|NCT00621777|453639063|FG000|Randomized Phase|Withdrawal by Subject|1|||
126093924|NCT00621777|453639064|FG001|Randomized Phase|Withdrawal by Subject|9|||
126093925|NCT00621777|453639063|FG000|Randomized Phase|administrative|0|||
126093926|NCT00621777|453639064|FG001|Randomized Phase|administrative|3|||
126093927|NCT00621777|453639063|FG000|Randomized Phase|Death|0|||
126093928|NCT00621777|453639064|FG001|Randomized Phase|Death|1|||
126093929|NCT04410523|453639065|FG000|Overall Study|Study terminated by sponsor|1|||
126093930|NCT04410523|453639066|FG001|Overall Study|Study terminated by sponsor|3|||
126093931|NCT04410523|453639067|FG002|Overall Study|Study terminated by sponsor|2|||
126093932|NCT04410523|453639068|FG003|Overall Study|Study terminated by sponsor|6|||
126093933|NCT04410523|453639069|FG004|Overall Study|Study terminated by sponsor|3|||
126093934|NCT04410523|453639070|FG005|Overall Study|Study terminated by sponsor|4|||
126093935|NCT04410523|453639065|FG000|Overall Study|Adverse Event|1|||
126093936|NCT04410523|453639066|FG001|Overall Study|Adverse Event|0|||
126093937|NCT04410523|453639067|FG002|Overall Study|Adverse Event|0|||
126093938|NCT04410523|453639068|FG003|Overall Study|Adverse Event|0|||
126093939|NCT04410523|453639069|FG004|Overall Study|Adverse Event|0|||
126093940|NCT04410523|453639070|FG005|Overall Study|Adverse Event|2|||
126093941|NCT04410523|453639065|FG000|Overall Study|Lost to Follow-up|0|||
126093942|NCT04410523|453639066|FG001|Overall Study|Lost to Follow-up|1|||
126093943|NCT04410523|453639067|FG002|Overall Study|Lost to Follow-up|0|||
126026189|NCT04218266|453390695|FG001|Overall Study|Adverse Event|14|||
126026190|NCT04218266|453390696|FG002|Overall Study|Adverse Event|11|||
126026191|NCT04218266|453390694|FG000|Overall Study|Other|7|||
126026192|NCT04218266|453390695|FG001|Overall Study|Other|5|||
126026193|NCT04218266|453390696|FG002|Overall Study|Other|14|||
126026194|NCT04218266|453390694|FG000|Overall Study|Physician Decision|1|||
126026195|NCT04218266|453390695|FG001|Overall Study|Physician Decision|3|||
126026196|NCT04218266|453390696|FG002|Overall Study|Physician Decision|2|||
126026197|NCT04218266|453390694|FG000|Overall Study|Non-compliance with study drug|0|||
126026198|NCT04218266|453390695|FG001|Overall Study|Non-compliance with study drug|0|||
126026199|NCT04218266|453390696|FG002|Overall Study|Non-compliance with study drug|1|||
126093944|NCT04410523|453639068|FG003|Overall Study|Lost to Follow-up|0|||
126093945|NCT04410523|453639069|FG004|Overall Study|Lost to Follow-up|0|||
126093946|NCT04410523|453639070|FG005|Overall Study|Lost to Follow-up|0|||
126093947|NCT04410523|453639065|FG000|Overall Study|Physician Decision|0|||
126093948|NCT04410523|453639066|FG001|Overall Study|Physician Decision|1|||
126093949|NCT04410523|453639067|FG002|Overall Study|Physician Decision|0|||
126093950|NCT04410523|453639068|FG003|Overall Study|Physician Decision|0|||
126093951|NCT04410523|453639069|FG004|Overall Study|Physician Decision|0|||
126093952|NCT04410523|453639070|FG005|Overall Study|Physician Decision|0|||
126093953|NCT04410523|453639065|FG000|Overall Study|Pregnancy|0|||
126093954|NCT04410523|453639066|FG001|Overall Study|Pregnancy|0|||
126093955|NCT04410523|453639067|FG002|Overall Study|Pregnancy|0|||
126093956|NCT04410523|453639068|FG003|Overall Study|Pregnancy|0|||
126093957|NCT04410523|453639069|FG004|Overall Study|Pregnancy|0|||
126093958|NCT04410523|453639070|FG005|Overall Study|Pregnancy|1|||
126093959|NCT04410523|453639065|FG000|Overall Study|Protocol deviation|0|||
126093960|NCT04410523|453639066|FG001|Overall Study|Protocol deviation|0|||
126093961|NCT04410523|453639067|FG002|Overall Study|Protocol deviation|0|||
126093962|NCT04410523|453639068|FG003|Overall Study|Protocol deviation|0|||
126093963|NCT04410523|453639069|FG004|Overall Study|Protocol deviation|0|||
126093964|NCT04410523|453639070|FG005|Overall Study|Protocol deviation|2|||
126093965|NCT04410523|453639065|FG000|Overall Study|Subject decision|2|||
126093966|NCT04410523|453639066|FG001|Overall Study|Subject decision|0|||
126093967|NCT04410523|453639067|FG002|Overall Study|Subject decision|0|||
126093968|NCT04410523|453639068|FG003|Overall Study|Subject decision|1|||
126093969|NCT04410523|453639069|FG004|Overall Study|Subject decision|0|||
126093970|NCT04410523|453639070|FG005|Overall Study|Subject decision|1|||
125879067|NCT02260934|452853541|FG001|Overall Study|Site error|1|||
126026200|NCT04218266|453390694|FG000|Overall Study|Withdrawal by Subject|1|||
126026201|NCT04218266|453390695|FG001|Overall Study|Withdrawal by Subject|3|||
126026202|NCT04218266|453390696|FG002|Overall Study|Withdrawal by Subject|1|||
126093971|NCT01239043|453639071|FG000|Overall Study|Protocol Violation|2|||
126093972|NCT01239043|453639072|FG001|Overall Study|Protocol Violation|1|||
126093973|NCT00436852|453639078|FG000|Overall Study|Death|23|||
126093974|NCT00436852|453639079|FG001|Overall Study|Death|34|||
126093975|NCT00436852|453639078|FG000|Overall Study|Lack of Efficacy|9|||
126093976|NCT00436852|453639079|FG001|Overall Study|Lack of Efficacy|7|||
125879068|NCT03597347|452853542|FG000|Overall Study|Withdrawal by Subject|1|||
125879069|NCT03597347|452853543|FG001|Overall Study|Withdrawal by Subject|1|||
126093977|NCT00436852|453639078|FG000|Overall Study|Withdrawal by Subject|2|||
126093978|NCT00436852|453639079|FG001|Overall Study|Withdrawal by Subject|4|||
126093979|NCT00436852|453639078|FG000|Overall Study|Ineligible|1|||
126093980|NCT00436852|453639079|FG001|Overall Study|Ineligible|0|||
126093981|NCT00370682|453639080|FG000|Overall Study|Moved from area|0|||
126093982|NCT00370682|453639081|FG001|Overall Study|Moved from area|2|||
126093983|NCT00370682|453639082|FG002|Overall Study|Moved from area|0|||
126093984|NCT00370682|453639080|FG000|Overall Study|Lost to Follow-up|0|||
126093985|NCT00370682|453639081|FG001|Overall Study|Lost to Follow-up|1|||
126026203|NCT04218266|453390694|FG000|Overall Study|Study drug never administered|2|||
126026204|NCT04218266|453390695|FG001|Overall Study|Study drug never administered|0|||
126026205|NCT04218266|453390696|FG002|Overall Study|Study drug never administered|0|||
126026206|NCT02742519|453390698|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
126026207|NCT02742519|453390699|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
126026208|NCT02742519|453390700|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
126026209|NCT02742519|453390698|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
126026210|NCT02742519|453390699|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
126026211|NCT02742519|453390700|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
126026212|NCT02742519|453390698|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
126026213|NCT02742519|453390699|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
126026214|NCT02742519|453390700|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
126026215|NCT04377308|453390701|FG000|Overall Study|Withdrawal by Subject|0|||
126026216|NCT04377308|453390702|FG001|Overall Study|Withdrawal by Subject|1|||
126026217|NCT04774237|453390713|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
126026218|NCT04774237|453390714|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
126026219|NCT04774237|453390715|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
126026220|NCT04774237|453390716|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
126026221|NCT04774237|453390717|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
126026222|NCT04774237|453390718|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
126026223|NCT03744312|453391613|FG000|Overall Study|Withdrawal by Subject|0|||
126026224|NCT03744312|453391614|FG001|Overall Study|Withdrawal by Subject|1|||
126026225|NCT03744312|453391613|FG000|Overall Study|Screen fail|0|||
126026226|NCT03744312|453391614|FG001|Overall Study|Screen fail|1|||
126026227|NCT05134337|453391615|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
126026228|NCT05134337|453391616|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
126026229|NCT04924062|453391617|FG000|Overall Study|Death|49|||
126026230|NCT04924062|453391618|FG001|Overall Study|Death|63|||
126026231|NCT04924062|453391617|FG000|Overall Study|Participant On-going|26|||
126026232|NCT04924062|453391618|FG001|Overall Study|Participant On-going|20|||
126026233|NCT02349412|453391623|FG000|Overall Study|Withdrawal by Subject|7|||
126026234|NCT02349412|453391624|FG001|Overall Study|Withdrawal by Subject|7|||
126026235|NCT04337372|453391625|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
126026236|NCT04337372|453391626|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
126026237|NCT04337372|453391627|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
126243033|NCT00440518|454183122|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
126243034|NCT00440518|454183123|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
126243035|NCT00440518|454183124|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
126243036|NCT00440518|454183122|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
126243037|NCT00440518|454183123|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
126243038|NCT00440518|454183124|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
126243039|NCT00440518|454183122|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
126243040|NCT00440518|454183123|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
126243041|NCT00440518|454183124|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
126243042|NCT00440518|454183122|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
126243043|NCT00440518|454183123|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
126243044|NCT00440518|454183124|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
126243045|NCT00440518|454183122|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
126243046|NCT00440518|454183123|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
126243047|NCT00440518|454183124|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
126243048|NCT00440518|454183122|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
126243049|NCT00440518|454183123|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
126243050|NCT00440518|454183124|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
126243051|NCT00272779|454183125|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
126243052|NCT00272779|454183126|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
126243053|NCT00272779|454183125|FG000|Baseline Through Week 48|Death before Week 48|4|||
126243054|NCT00272779|454183126|FG001|Baseline Through Week 48|Death before Week 48|4|||
126243055|NCT00272779|454183125|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
126243056|NCT00272779|454183126|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
126243057|NCT00272779|454183125|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
126243058|NCT00272779|454183126|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
126243059|NCT00272779|454183125|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
126243060|NCT00272779|454183126|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
126243061|NCT00272779|454183125|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
126026238|NCT04337372|453391628|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
126026239|NCT04337372|453391625|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
126026240|NCT04337372|453391626|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
126026241|NCT04337372|453391627|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
126026242|NCT04337372|453391628|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
126026243|NCT04337372|453391625|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
126026244|NCT04337372|453391626|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
126026245|NCT04337372|453391627|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
126243062|NCT00272779|454183126|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
126243063|NCT00272779|454183125|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
126243064|NCT00272779|454183126|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
126243065|NCT00272779|454183125|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
126243066|NCT00272779|454183126|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
126243067|NCT00272779|454183125|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
126243068|NCT00272779|454183126|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
126243069|NCT00272779|454183125|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
126243070|NCT00272779|454183126|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
126243071|NCT00272779|454183125|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
126243072|NCT00272779|454183126|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
126243073|NCT00272779|454183125|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
126243074|NCT00272779|454183126|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
126243075|NCT00272779|454183125|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
126243076|NCT00272779|454183126|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
126243077|NCT00272779|454183125|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
126243078|NCT00272779|454183126|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
126243079|NCT00272779|454183125|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
126243080|NCT00272779|454183126|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
126243081|NCT00272779|454183125|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
126243082|NCT00272779|454183126|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
126243083|NCT00272779|454183125|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
126243084|NCT00272779|454183126|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
126243085|NCT00272779|454183125|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
126243086|NCT00272779|454183126|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
126243087|NCT00272779|454183125|FG000|Baseline Through Week 48|Continuing treatment|385|||
126243088|NCT00272779|454183126|FG001|Baseline Through Week 48|Continuing treatment|368|||
126243089|NCT00272779|454183125|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
126243090|NCT00272779|454183126|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
126243091|NCT00272779|454183125|FG000|Baseline Through Week 48|Never treated|2|||
126243092|NCT00272779|454183126|FG001|Baseline Through Week 48|Never treated|3|||
126243093|NCT00272779|454183125|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
126243094|NCT00272779|454183126|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
126243095|NCT00272779|454183125|FG000|Baseline Through Week 96|Death before Week 96|6|||
126243096|NCT00272779|454183126|FG001|Baseline Through Week 96|Death before Week 96|5|||
126243097|NCT00272779|454183125|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
126243098|NCT00272779|454183126|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
126243099|NCT00272779|454183125|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
126243100|NCT00272779|454183126|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
126243101|NCT00272779|454183125|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
126243102|NCT00272779|454183126|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
126243103|NCT00272779|454183125|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
126243104|NCT00272779|454183126|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
126243105|NCT00272779|454183125|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
126243106|NCT00272779|454183126|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
126243107|NCT00272779|454183125|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
126243108|NCT00272779|454183126|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
126243109|NCT00272779|454183125|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
126243110|NCT00272779|454183126|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
126243111|NCT00272779|454183125|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
126026246|NCT04337372|453391628|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
126026247|NCT04337372|453391625|FG000|Day 2: EEG Measures|Protocol Violation|6|||
126026248|NCT04337372|453391626|FG001|Day 2: EEG Measures|Protocol Violation|6|||
126026249|NCT04337372|453391627|FG002|Day 2: EEG Measures|Protocol Violation|5|||
126026250|NCT04337372|453391628|FG003|Day 2: EEG Measures|Protocol Violation|17|||
126026251|NCT03460236|453391629|FG000|Overall Study|failed radiographic screening|16|||
126026252|NCT03460236|453391629|FG000|Overall Study|Withdrawal by Subject|11|||
126026253|NCT00979576|453391632|FG000|Combination Treatment Phase|Progressive disease|3|||
126026254|NCT00979576|453391633|FG001|Combination Treatment Phase|Progressive disease|1|||
126243112|NCT00272779|454183126|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
126026255|NCT00979576|453391634|FG002|Combination Treatment Phase|Progressive disease|5|||
126243113|NCT00272779|454183125|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
126243114|NCT00272779|454183126|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
126243115|NCT00272779|454183125|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
126243116|NCT00272779|454183126|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
126243117|NCT00272779|454183125|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
126243118|NCT00272779|454183126|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
126243119|NCT00272779|454183125|FG000|Baseline Through Week 96|Never treated|2|||
126243120|NCT00272779|454183126|FG001|Baseline Through Week 96|Never treated|3|||
126243121|NCT00272779|454183125|FG000|Baseline Through Week 96|Continuing on treatment|61|||
126243122|NCT00272779|454183126|FG001|Baseline Through Week 96|Continuing on treatment|38|||
126243123|NCT00561015|454183127|FG000|Overall Study|Adverse Event|0|||
126243124|NCT00561015|454183128|FG001|Overall Study|Adverse Event|0|||
126243125|NCT00561015|454183129|FG002|Overall Study|Adverse Event|0|||
126243126|NCT00561015|454183130|FG003|Overall Study|Adverse Event|0|||
126243127|NCT00561015|454183131|FG004|Overall Study|Adverse Event|1|||
126243128|NCT00561015|454183132|FG005|Overall Study|Adverse Event|0|||
126243129|NCT00561015|454183127|FG000|Overall Study|Lost to Follow-up|2|||
126243130|NCT00561015|454183128|FG001|Overall Study|Lost to Follow-up|0|||
126243131|NCT00561015|454183129|FG002|Overall Study|Lost to Follow-up|0|||
126243132|NCT00561015|454183130|FG003|Overall Study|Lost to Follow-up|1|||
126243133|NCT00561015|454183131|FG004|Overall Study|Lost to Follow-up|0|||
126243134|NCT00561015|454183132|FG005|Overall Study|Lost to Follow-up|3|||
126243135|NCT00561015|454183127|FG000|Overall Study|Participant non-compliance|2|||
126243136|NCT00561015|454183128|FG001|Overall Study|Participant non-compliance|0|||
126243137|NCT00561015|454183129|FG002|Overall Study|Participant non-compliance|0|||
126243138|NCT00561015|454183130|FG003|Overall Study|Participant non-compliance|0|||
126243139|NCT00561015|454183131|FG004|Overall Study|Participant non-compliance|0|||
126243140|NCT00561015|454183132|FG005|Overall Study|Participant non-compliance|0|||
126243141|NCT02440711|454183133|FG000|Second Intervention|Lost to Follow-up|1|||
126243142|NCT02440711|454183134|FG001|Second Intervention|Lost to Follow-up|0|||
126243143|NCT00163657|454183137|FG000|Overall Study|Death|12|||
126243144|NCT00163657|454183138|FG001|Overall Study|Death|14|||
126243145|NCT00163657|454183139|FG002|Overall Study|Death|19|||
126243146|NCT00163657|454183137|FG000|Overall Study|graft loss|4|||
126243147|NCT00163657|454183138|FG001|Overall Study|graft loss|1|||
126243148|NCT00163657|454183139|FG002|Overall Study|graft loss|2|||
126243149|NCT00163657|454183137|FG000|Overall Study|Withdrawal by Subject|2|||
126243150|NCT00163657|454183138|FG001|Overall Study|Withdrawal by Subject|3|||
126243151|NCT00163657|454183139|FG002|Overall Study|Withdrawal by Subject|2|||
126243152|NCT00163657|454183137|FG000|Overall Study|Physician Decision|0|||
126243153|NCT00163657|454183138|FG001|Overall Study|Physician Decision|1|||
126243154|NCT00163657|454183139|FG002|Overall Study|Physician Decision|1|||
126243155|NCT00163657|454183137|FG000|Overall Study|Non Compliance|1|||
126243156|NCT00163657|454183138|FG001|Overall Study|Non Compliance|0|||
126243157|NCT00163657|454183139|FG002|Overall Study|Non Compliance|0|||
126243158|NCT00163657|454183137|FG000|Overall Study|Lost to Follow-up|1|||
126243159|NCT00163657|454183138|FG001|Overall Study|Lost to Follow-up|3|||
126243160|NCT00163657|454183139|FG002|Overall Study|Lost to Follow-up|10|||
126243161|NCT00163657|454183137|FG000|Overall Study|Other reason|0|||
126243162|NCT00163657|454183138|FG001|Overall Study|Other reason|1|||
126243163|NCT00163657|454183139|FG002|Overall Study|Other reason|3|||
126243164|NCT02646124|454183140|FG000|Overall Study|Lost to Follow-up|0|||
126243165|NCT02646124|454183141|FG001|Overall Study|Lost to Follow-up|2|||
126243166|NCT02436005|454183142|FG000|Second Intervention|Adverse Event|0|||
126243167|NCT02436005|454183143|FG001|Second Intervention|Adverse Event|1|||
126243168|NCT00365365|454183144|FG000|Overall Study|Randomized but not treated|0|||
126243169|NCT00365365|454183145|FG001|Overall Study|Randomized but not treated|2|||
126026256|NCT00979576|453391632|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
126026257|NCT00979576|453391633|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
126026258|NCT00979576|453391634|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
126026259|NCT00979576|453391632|FG000|Combination Treatment Phase|Adverse Event|0|||
126026260|NCT00979576|453391633|FG001|Combination Treatment Phase|Adverse Event|2|||
126026261|NCT00979576|453391634|FG002|Combination Treatment Phase|Adverse Event|2|||
126026262|NCT00979576|453391632|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
126026263|NCT00979576|453391633|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
126026264|NCT00979576|453391634|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
126243170|NCT00365365|454183146|FG002|Overall Study|Randomized but not treated|0|||
126243171|NCT00365365|454183144|FG000|Overall Study|Poor compliance to protocol|0|||
126243172|NCT00365365|454183145|FG001|Overall Study|Poor compliance to protocol|1|||
126243173|NCT00365365|454183146|FG002|Overall Study|Poor compliance to protocol|0|||
126243174|NCT00365365|454183144|FG000|Overall Study|Lost to Follow-up|3|||
126243175|NCT00365365|454183145|FG001|Overall Study|Lost to Follow-up|3|||
126243176|NCT00365365|454183146|FG002|Overall Study|Lost to Follow-up|3|||
126243177|NCT00365365|454183144|FG000|Overall Study|Death|1|||
126026265|NCT04840199|453391635|FG000|Overall Study|Study Terminated by Sponsor|8|||
126243178|NCT00365365|454183145|FG001|Overall Study|Death|3|||
126243179|NCT00365365|454183146|FG002|Overall Study|Death|0|||
126243180|NCT00365365|454183144|FG000|Overall Study|Subject's request|11|||
126243181|NCT00365365|454183145|FG001|Overall Study|Subject's request|13|||
126243182|NCT00365365|454183146|FG002|Overall Study|Subject's request|1|||
126243183|NCT00365365|454183144|FG000|Overall Study|Disease progression/relapse|9|||
126243184|NCT00365365|454183145|FG001|Overall Study|Disease progression/relapse|6|||
126243185|NCT00365365|454183146|FG002|Overall Study|Disease progression/relapse|7|||
126243186|NCT00365365|454183144|FG000|Overall Study|Adverse Event|6|||
126243187|NCT00365365|454183145|FG001|Overall Study|Adverse Event|6|||
126243188|NCT00365365|454183146|FG002|Overall Study|Adverse Event|3|||
126243189|NCT00365365|454183144|FG000|Overall Study|Moved|2|||
126243190|NCT00365365|454183145|FG001|Overall Study|Moved|0|||
126243191|NCT00365365|454183146|FG002|Overall Study|Moved|0|||
126243192|NCT00365365|454183144|FG000|Overall Study|New cancer|1|||
126243193|NCT00365365|454183145|FG001|Overall Study|New cancer|0|||
126243194|NCT00365365|454183146|FG002|Overall Study|New cancer|0|||
126243195|NCT00365365|454183144|FG000|Overall Study|Withdrew consent|1|||
126243196|NCT00365365|454183145|FG001|Overall Study|Withdrew consent|1|||
126243197|NCT00365365|454183146|FG002|Overall Study|Withdrew consent|0|||
126243198|NCT00365365|454183144|FG000|Overall Study|Second malignancy|0|||
126243199|NCT00365365|454183145|FG001|Overall Study|Second malignancy|1|||
126243200|NCT00365365|454183146|FG002|Overall Study|Second malignancy|0|||
126243201|NCT00365365|454183144|FG000|Overall Study|Patient/physician decision|0|||
126243202|NCT00365365|454183145|FG001|Overall Study|Patient/physician decision|0|||
126243203|NCT00365365|454183146|FG002|Overall Study|Patient/physician decision|1|||
126243204|NCT00984022|454183147|FG000|Overall Study|Lost to Follow-up|10|||
126243205|NCT00984022|454183148|FG001|Overall Study|Lost to Follow-up|14|||
126243206|NCT00573443|454183152|FG000|Double-Blind Phase|Lost to Follow-up|1|||
126243207|NCT00573443|454183153|FG001|Double-Blind Phase|Lost to Follow-up|3|||
126243208|NCT00573443|454183154|FG002|Double-Blind Phase|Lost to Follow-up|2|||
126243209|NCT00573443|454183152|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
126243210|NCT00573443|454183153|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
126243211|NCT00573443|454183154|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
126243212|NCT00573443|454183152|FG000|Double-Blind Phase|Adverse Event|1|||
126243213|NCT00573443|454183153|FG001|Double-Blind Phase|Adverse Event|5|||
126243214|NCT00573443|454183154|FG002|Double-Blind Phase|Adverse Event|0|||
126243215|NCT00573443|454183152|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
126243216|NCT00573443|454183153|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
126243217|NCT00573443|454183154|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
126243218|NCT00573443|454183152|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
126243219|NCT00573443|454183153|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
126243220|NCT00573443|454183154|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
126243221|NCT00573443|454183152|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
126243222|NCT00573443|454183153|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
126243223|NCT00573443|454183154|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
126243224|NCT00573443|454183152|FG000|Double-Blind Phase|Protocol Violation|0|||
126243225|NCT00573443|454183153|FG001|Double-Blind Phase|Protocol Violation|2|||
126243226|NCT00573443|454183154|FG002|Double-Blind Phase|Protocol Violation|1|||
126243227|NCT00573443|454183152|FG000|Double-Blind Phase|Other|0|||
126243228|NCT00573443|454183153|FG001|Double-Blind Phase|Other|2|||
126243229|NCT00573443|454183154|FG002|Double-Blind Phase|Other|3|||
126243230|NCT00573443|454183152|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
126243231|NCT00573443|454183153|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126243232|NCT00573443|454183154|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
126243233|NCT00573443|454183152|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
126243234|NCT00573443|454183153|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
126243235|NCT00573443|454183154|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
126243236|NCT00573443|454183152|FG000|Open-Label Extension Phase|Adverse Event|3|||
126243237|NCT00573443|454183153|FG001|Open-Label Extension Phase|Adverse Event|0|||
126243238|NCT00573443|454183154|FG002|Open-Label Extension Phase|Adverse Event|0|||
126243239|NCT00573443|454183152|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
126093986|NCT00370682|453639082|FG002|Overall Study|Lost to Follow-up|1|||
126243240|NCT00573443|454183153|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
126243241|NCT00573443|454183154|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
126243242|NCT00573443|454183152|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
126243243|NCT00573443|454183153|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
126243244|NCT00573443|454183154|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
126243245|NCT00573443|454183152|FG000|Open-Label Extension Phase|Protocol Violation|2|||
126243246|NCT00573443|454183153|FG001|Open-Label Extension Phase|Protocol Violation|0|||
126243247|NCT00573443|454183154|FG002|Open-Label Extension Phase|Protocol Violation|0|||
126243248|NCT00573443|454183152|FG000|Open-Label Extension Phase|Other|2|||
126243249|NCT00573443|454183153|FG001|Open-Label Extension Phase|Other|0|||
126243250|NCT00573443|454183154|FG002|Open-Label Extension Phase|Other|0|||
126243251|NCT00905606|454183155|FG000|Period 1|Adverse Event|0|||
126243252|NCT00905606|454183156|FG001|Period 1|Adverse Event|1|||
126243253|NCT00905606|454183155|FG000|Washout|Withdrawal by Subject|1|||
126243254|NCT00905606|454183156|FG001|Washout|Withdrawal by Subject|0|||
126026266|NCT04840199|453391636|FG001|Overall Study|Study Terminated by Sponsor|9|||
126243255|NCT00804856|454183159|FG000|Overall Study|Progressive Disease|3|||
126243256|NCT00804856|454183160|FG001|Overall Study|Progressive Disease|2|||
126243257|NCT00804856|454183161|FG002|Overall Study|Progressive Disease|4|||
126243258|NCT00804856|454183162|FG003|Overall Study|Progressive Disease|6|||
126243259|NCT00804856|454183163|FG004|Overall Study|Progressive Disease|4|||
126243260|NCT00804856|454183164|FG005|Overall Study|Progressive Disease|1|||
126243261|NCT00804856|454183165|FG006|Overall Study|Progressive Disease|8|||
126243262|NCT00804856|454183166|FG007|Overall Study|Progressive Disease|2|||
126243263|NCT00804856|454183167|FG008|Overall Study|Progressive Disease|4|||
126243264|NCT00804856|454183168|FG009|Overall Study|Progressive Disease|5|||
126243265|NCT00804856|454183169|FG010|Overall Study|Progressive Disease|12|||
126243266|NCT00804856|454183170|FG011|Overall Study|Progressive Disease|2|||
126243267|NCT00804856|454183171|FG012|Overall Study|Progressive Disease|2|||
126243268|NCT00804856|454183172|FG013|Overall Study|Progressive Disease|26|||
126243269|NCT00804856|454183173|FG014|Overall Study|Progressive Disease|20|||
126243270|NCT00804856|454183159|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243271|NCT00804856|454183160|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243272|NCT00804856|454183161|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243273|NCT00804856|454183162|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243274|NCT00804856|454183163|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126243275|NCT00804856|454183164|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243276|NCT00804856|454183165|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243277|NCT00804856|454183166|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243278|NCT00804856|454183167|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243279|NCT00804856|454183168|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243280|NCT00804856|454183169|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243281|NCT00804856|454183170|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243282|NCT00804856|454183171|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243283|NCT00804856|454183172|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126243284|NCT00804856|454183173|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126243285|NCT00804856|454183159|FG000|Overall Study|Other Adverse Event|1|||
126243286|NCT00804856|454183160|FG001|Overall Study|Other Adverse Event|1|||
126243287|NCT00804856|454183161|FG002|Overall Study|Other Adverse Event|1|||
126243288|NCT00804856|454183162|FG003|Overall Study|Other Adverse Event|2|||
126243289|NCT00804856|454183163|FG004|Overall Study|Other Adverse Event|2|||
126243290|NCT00804856|454183164|FG005|Overall Study|Other Adverse Event|1|||
126243291|NCT00804856|454183165|FG006|Overall Study|Other Adverse Event|3|||
126243292|NCT00804856|454183166|FG007|Overall Study|Other Adverse Event|0|||
126243293|NCT00804856|454183167|FG008|Overall Study|Other Adverse Event|0|||
126243294|NCT00804856|454183168|FG009|Overall Study|Other Adverse Event|1|||
126243295|NCT00804856|454183169|FG010|Overall Study|Other Adverse Event|5|||
126243296|NCT00804856|454183170|FG011|Overall Study|Other Adverse Event|2|||
126243297|NCT00804856|454183171|FG012|Overall Study|Other Adverse Event|0|||
126243298|NCT00804856|454183172|FG013|Overall Study|Other Adverse Event|6|||
126243299|NCT00804856|454183173|FG014|Overall Study|Other Adverse Event|13|||
126243300|NCT00804856|454183159|FG000|Overall Study|Non compliance with protocol|0|||
126243301|NCT00804856|454183160|FG001|Overall Study|Non compliance with protocol|0|||
126243302|NCT00804856|454183161|FG002|Overall Study|Non compliance with protocol|0|||
126243303|NCT00804856|454183162|FG003|Overall Study|Non compliance with protocol|0|||
126243304|NCT00804856|454183163|FG004|Overall Study|Non compliance with protocol|0|||
126243305|NCT00804856|454183164|FG005|Overall Study|Non compliance with protocol|0|||
126243306|NCT00804856|454183165|FG006|Overall Study|Non compliance with protocol|0|||
126243307|NCT00804856|454183166|FG007|Overall Study|Non compliance with protocol|0|||
126243308|NCT00804856|454183167|FG008|Overall Study|Non compliance with protocol|0|||
126243309|NCT00804856|454183168|FG009|Overall Study|Non compliance with protocol|0|||
126243310|NCT00804856|454183169|FG010|Overall Study|Non compliance with protocol|0|||
126243311|NCT00804856|454183170|FG011|Overall Study|Non compliance with protocol|0|||
126243312|NCT00804856|454183171|FG012|Overall Study|Non compliance with protocol|0|||
126243313|NCT00804856|454183172|FG013|Overall Study|Non compliance with protocol|2|||
126243314|NCT00804856|454183173|FG014|Overall Study|Non compliance with protocol|0|||
126243315|NCT00804856|454183159|FG000|Overall Study|Refused to continue medication|0|||
126243316|NCT00804856|454183160|FG001|Overall Study|Refused to continue medication|0|||
126243317|NCT00804856|454183161|FG002|Overall Study|Refused to continue medication|0|||
126243318|NCT00804856|454183162|FG003|Overall Study|Refused to continue medication|1|||
126243319|NCT00804856|454183163|FG004|Overall Study|Refused to continue medication|1|||
126243320|NCT00804856|454183164|FG005|Overall Study|Refused to continue medication|0|||
126243321|NCT00804856|454183165|FG006|Overall Study|Refused to continue medication|0|||
126243322|NCT00804856|454183166|FG007|Overall Study|Refused to continue medication|0|||
126243323|NCT00804856|454183167|FG008|Overall Study|Refused to continue medication|0|||
126243324|NCT00804856|454183168|FG009|Overall Study|Refused to continue medication|0|||
126026267|NCT04840199|453391635|FG000|Overall Study|Lost to Follow-up|0|||
126243325|NCT00804856|454183169|FG010|Overall Study|Refused to continue medication|3|||
126243326|NCT00804856|454183170|FG011|Overall Study|Refused to continue medication|0|||
126243327|NCT00804856|454183171|FG012|Overall Study|Refused to continue medication|1|||
126243328|NCT00804856|454183172|FG013|Overall Study|Refused to continue medication|1|||
126243329|NCT00804856|454183173|FG014|Overall Study|Refused to continue medication|5|||
126243330|NCT00804856|454183159|FG000|Overall Study|Other reason than listed above|0|||
126243331|NCT00804856|454183160|FG001|Overall Study|Other reason than listed above|0|||
126243332|NCT00804856|454183161|FG002|Overall Study|Other reason than listed above|0|||
126243333|NCT00804856|454183162|FG003|Overall Study|Other reason than listed above|0|||
126243334|NCT00804856|454183163|FG004|Overall Study|Other reason than listed above|0|||
126243335|NCT00804856|454183164|FG005|Overall Study|Other reason than listed above|1|||
126243336|NCT00804856|454183165|FG006|Overall Study|Other reason than listed above|0|||
126243337|NCT00804856|454183166|FG007|Overall Study|Other reason than listed above|0|||
126243338|NCT00804856|454183167|FG008|Overall Study|Other reason than listed above|1|||
126243339|NCT00804856|454183168|FG009|Overall Study|Other reason than listed above|0|||
126243340|NCT00804856|454183169|FG010|Overall Study|Other reason than listed above|3|||
126243341|NCT00804856|454183170|FG011|Overall Study|Other reason than listed above|1|||
126243342|NCT00804856|454183171|FG012|Overall Study|Other reason than listed above|1|||
126243343|NCT00804856|454183172|FG013|Overall Study|Other reason than listed above|10|||
126243344|NCT00804856|454183173|FG014|Overall Study|Other reason than listed above|3|||
126243345|NCT00418561|454183174|FG000|Overall Study|Participant's (guardian's) decision|0|||
126243346|NCT00418561|454183175|FG001|Overall Study|Participant's (guardian's) decision|1|||
126243347|NCT00418561|454183176|FG002|Overall Study|Participant's (guardian's) decision|0|||
126243348|NCT01796171|454183177|FG000|Enrolled|Death|0|||
126243349|NCT01796171|454183178|FG001|Enrolled|Death|0|||
126243350|NCT01796171|454183179|FG002|Enrolled|Death|0|||
126243351|NCT01796171|454183180|FG003|Enrolled|Death|0|||
126243352|NCT01796171|454183181|FG004|Enrolled|Death|0|||
126243353|NCT01796171|454183182|FG005|Enrolled|Death|0|||
126243354|NCT01796171|454183183|FG006|Enrolled|Death|0|||
126243355|NCT01796171|454183184|FG007|Enrolled|Death|0|||
126243356|NCT01796171|454183185|FG008|Enrolled|Death|0|||
126243357|NCT01796171|454183186|FG009|Enrolled|Death|0|||
126243358|NCT01796171|454183187|FG010|Enrolled|Death|0|||
126243359|NCT01796171|454183188|FG011|Enrolled|Death|0|||
126243360|NCT01796171|454183189|FG012|Enrolled|Death|0|||
126243361|NCT01796171|454183190|FG013|Enrolled|Death|0|||
126243362|NCT01796171|454183191|FG014|Enrolled|Death|1|||
126243363|NCT01796171|454183177|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
126243364|NCT01796171|454183178|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
126243365|NCT01796171|454183179|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
126243366|NCT01796171|454183180|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
126243367|NCT01796171|454183181|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
126243368|NCT01796171|454183182|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
126243369|NCT01796171|454183183|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
126243370|NCT01796171|454183184|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
126243371|NCT01796171|454183185|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
126243372|NCT01796171|454183186|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
126243373|NCT01796171|454183187|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
126243374|NCT01796171|454183188|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
126243375|NCT01796171|454183189|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
126243376|NCT01796171|454183190|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
126243377|NCT01796171|454183191|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
126243378|NCT01796171|454183177|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243379|NCT01796171|454183178|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243380|NCT01796171|454183179|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243381|NCT01796171|454183180|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243382|NCT01796171|454183181|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243383|NCT01796171|454183182|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243384|NCT01796171|454183183|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243385|NCT01796171|454183184|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243386|NCT01796171|454183185|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243387|NCT01796171|454183186|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243388|NCT01796171|454183187|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243389|NCT01796171|454183188|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243390|NCT01796171|454183189|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243391|NCT01796171|454183190|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
126026268|NCT04840199|453391636|FG001|Overall Study|Lost to Follow-up|2|||
126243392|NCT01796171|454183191|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126243393|NCT01796171|454183177|FG000|Treatment Period With Betalutin|Progressive disease|0|||
126243394|NCT01796171|454183178|FG001|Treatment Period With Betalutin|Progressive disease|1|||
126243395|NCT01796171|454183179|FG002|Treatment Period With Betalutin|Progressive disease|0|||
126243396|NCT01796171|454183180|FG003|Treatment Period With Betalutin|Progressive disease|0|||
126243397|NCT01796171|454183181|FG004|Treatment Period With Betalutin|Progressive disease|0|||
126243398|NCT01796171|454183182|FG005|Treatment Period With Betalutin|Progressive disease|0|||
126243399|NCT01796171|454183183|FG006|Treatment Period With Betalutin|Progressive disease|0|||
126243400|NCT01796171|454183184|FG007|Treatment Period With Betalutin|Progressive disease|0|||
126243401|NCT01796171|454183185|FG008|Treatment Period With Betalutin|Progressive disease|0|||
126243402|NCT01796171|454183186|FG009|Treatment Period With Betalutin|Progressive disease|0|||
126243403|NCT01796171|454183187|FG010|Treatment Period With Betalutin|Progressive disease|0|||
126243404|NCT01796171|454183188|FG011|Treatment Period With Betalutin|Progressive disease|0|||
126243405|NCT01796171|454183189|FG012|Treatment Period With Betalutin|Progressive disease|0|||
126243406|NCT01796171|454183190|FG013|Treatment Period With Betalutin|Progressive disease|0|||
126243407|NCT01796171|454183191|FG014|Treatment Period With Betalutin|Progressive disease|0|||
126243408|NCT01796171|454183177|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243409|NCT01796171|454183178|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243410|NCT01796171|454183179|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243411|NCT01796171|454183180|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243412|NCT01796171|454183181|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243413|NCT01796171|454183182|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243414|NCT01796171|454183183|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243415|NCT01796171|454183184|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243416|NCT01796171|454183185|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
126243417|NCT01796171|454183186|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243418|NCT01796171|454183187|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
126243419|NCT01796171|454183188|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
126243420|NCT01796171|454183189|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243421|NCT01796171|454183190|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243422|NCT01796171|454183191|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126243423|NCT01796171|454183177|FG000|Treatment Period With Betalutin|Physician Decision|0|||
126243424|NCT01796171|454183178|FG001|Treatment Period With Betalutin|Physician Decision|0|||
126243425|NCT01796171|454183179|FG002|Treatment Period With Betalutin|Physician Decision|0|||
126243426|NCT01796171|454183180|FG003|Treatment Period With Betalutin|Physician Decision|0|||
126243427|NCT01796171|454183181|FG004|Treatment Period With Betalutin|Physician Decision|0|||
126243428|NCT01796171|454183182|FG005|Treatment Period With Betalutin|Physician Decision|0|||
126243429|NCT01796171|454183183|FG006|Treatment Period With Betalutin|Physician Decision|0|||
126243430|NCT01796171|454183184|FG007|Treatment Period With Betalutin|Physician Decision|0|||
126243431|NCT01796171|454183185|FG008|Treatment Period With Betalutin|Physician Decision|0|||
126243432|NCT01796171|454183186|FG009|Treatment Period With Betalutin|Physician Decision|0|||
126243433|NCT01796171|454183187|FG010|Treatment Period With Betalutin|Physician Decision|5|||
126243434|NCT01796171|454183188|FG011|Treatment Period With Betalutin|Physician Decision|1|||
126243435|NCT01796171|454183189|FG012|Treatment Period With Betalutin|Physician Decision|1|||
126243436|NCT01796171|454183190|FG013|Treatment Period With Betalutin|Physician Decision|0|||
126243437|NCT01796171|454183191|FG014|Treatment Period With Betalutin|Physician Decision|0|||
126243438|NCT01796171|454183177|FG000|Treatment Period With Betalutin|Death|0|||
126243439|NCT01796171|454183178|FG001|Treatment Period With Betalutin|Death|0|||
126243440|NCT01796171|454183179|FG002|Treatment Period With Betalutin|Death|0|||
126243441|NCT01796171|454183180|FG003|Treatment Period With Betalutin|Death|0|||
126243442|NCT01796171|454183181|FG004|Treatment Period With Betalutin|Death|0|||
126243443|NCT01796171|454183182|FG005|Treatment Period With Betalutin|Death|0|||
126243444|NCT01796171|454183183|FG006|Treatment Period With Betalutin|Death|0|||
126243445|NCT01796171|454183184|FG007|Treatment Period With Betalutin|Death|0|||
126243446|NCT01796171|454183185|FG008|Treatment Period With Betalutin|Death|0|||
126243447|NCT01796171|454183186|FG009|Treatment Period With Betalutin|Death|0|||
126243448|NCT01796171|454183187|FG010|Treatment Period With Betalutin|Death|2|||
126243449|NCT01796171|454183188|FG011|Treatment Period With Betalutin|Death|0|||
126243450|NCT01796171|454183189|FG012|Treatment Period With Betalutin|Death|0|||
126243451|NCT01796171|454183190|FG013|Treatment Period With Betalutin|Death|0|||
126243452|NCT01796171|454183191|FG014|Treatment Period With Betalutin|Death|0|||
126026269|NCT04840199|453391635|FG000|Overall Study|Withdrawal by Subject|2|||
126026270|NCT04840199|453391636|FG001|Overall Study|Withdrawal by Subject|0|||
126026271|NCT04840199|453391635|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
126243453|NCT01796171|454183177|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
126243454|NCT01796171|454183178|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
126243455|NCT01796171|454183179|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
126243456|NCT01796171|454183180|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
126243457|NCT01796171|454183181|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
126243458|NCT01796171|454183182|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
126243459|NCT01796171|454183183|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
126243460|NCT01796171|454183184|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
126243461|NCT01796171|454183185|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
126243462|NCT01796171|454183186|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
126243463|NCT01796171|454183187|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
126243464|NCT01796171|454183188|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
126243465|NCT01796171|454183189|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
126243466|NCT01796171|454183190|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
126243467|NCT01796171|454183191|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
126243468|NCT01796171|454183177|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243469|NCT01796171|454183178|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243470|NCT01796171|454183179|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243471|NCT01796171|454183180|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243472|NCT01796171|454183181|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243473|NCT01796171|454183182|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243474|NCT01796171|454183183|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243475|NCT01796171|454183184|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243476|NCT01796171|454183185|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243477|NCT01796171|454183186|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243478|NCT01796171|454183187|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
126243479|NCT01796171|454183188|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
126243480|NCT01796171|454183189|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243481|NCT01796171|454183190|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243482|NCT01796171|454183191|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126243483|NCT01796171|454183177|FG000|Follow-up Period|Start of further anticancer therapy|4|||
126243484|NCT01796171|454183178|FG001|Follow-up Period|Start of further anticancer therapy|25|||
126243485|NCT01796171|454183179|FG002|Follow-up Period|Start of further anticancer therapy|2|||
126243486|NCT01796171|454183180|FG003|Follow-up Period|Start of further anticancer therapy|1|||
126243487|NCT01796171|454183181|FG004|Follow-up Period|Start of further anticancer therapy|2|||
126243488|NCT01796171|454183182|FG005|Follow-up Period|Start of further anticancer therapy|2|||
126243489|NCT01796171|454183183|FG006|Follow-up Period|Start of further anticancer therapy|1|||
126243490|NCT01796171|454183184|FG007|Follow-up Period|Start of further anticancer therapy|15|||
126243491|NCT01796171|454183185|FG008|Follow-up Period|Start of further anticancer therapy|2|||
126243492|NCT01796171|454183186|FG009|Follow-up Period|Start of further anticancer therapy|0|||
126243493|NCT01796171|454183187|FG010|Follow-up Period|Start of further anticancer therapy|0|||
126243494|NCT01796171|454183188|FG011|Follow-up Period|Start of further anticancer therapy|0|||
126243495|NCT01796171|454183189|FG012|Follow-up Period|Start of further anticancer therapy|0|||
126243496|NCT01796171|454183190|FG013|Follow-up Period|Start of further anticancer therapy|0|||
126243497|NCT01796171|454183191|FG014|Follow-up Period|Start of further anticancer therapy|0|||
126243498|NCT01796171|454183177|FG000|Follow-up Period|Progressive disease|0|||
126243499|NCT01796171|454183178|FG001|Follow-up Period|Progressive disease|1|||
126243500|NCT01796171|454183179|FG002|Follow-up Period|Progressive disease|0|||
126243501|NCT01796171|454183180|FG003|Follow-up Period|Progressive disease|0|||
126243502|NCT01796171|454183181|FG004|Follow-up Period|Progressive disease|0|||
126243503|NCT01796171|454183182|FG005|Follow-up Period|Progressive disease|0|||
126243504|NCT01796171|454183183|FG006|Follow-up Period|Progressive disease|0|||
126243505|NCT01796171|454183184|FG007|Follow-up Period|Progressive disease|3|||
126243506|NCT01796171|454183185|FG008|Follow-up Period|Progressive disease|0|||
126243507|NCT01796171|454183186|FG009|Follow-up Period|Progressive disease|0|||
126243508|NCT01796171|454183187|FG010|Follow-up Period|Progressive disease|0|||
126243509|NCT01796171|454183188|FG011|Follow-up Period|Progressive disease|0|||
126243510|NCT01796171|454183189|FG012|Follow-up Period|Progressive disease|0|||
126243511|NCT01796171|454183190|FG013|Follow-up Period|Progressive disease|0|||
126243512|NCT01796171|454183191|FG014|Follow-up Period|Progressive disease|0|||
126243513|NCT01796171|454183177|FG000|Follow-up Period|Physician Decision|0|||
126243514|NCT01796171|454183178|FG001|Follow-up Period|Physician Decision|2|||
126243515|NCT01796171|454183179|FG002|Follow-up Period|Physician Decision|0|||
126026272|NCT04840199|453391636|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
126026273|NCT05136404|453391641|FG000|Period 1|Adverse Event|0|||
126026274|NCT05136404|453391642|FG001|Period 1|Adverse Event|1|||
126026275|NCT05136404|453391643|FG002|Period 1|Adverse Event|1|||
126026276|NCT05136404|453391641|FG000|Period 2|Inappropriate Behavior|0|||
126026277|NCT05136404|453391642|FG001|Period 2|Inappropriate Behavior|0|||
126026278|NCT05136404|453391643|FG002|Period 2|Inappropriate Behavior|1|||
126026279|NCT05136404|453391641|FG000|Period 3|Adverse Event|0|||
126026280|NCT05136404|453391642|FG001|Period 3|Adverse Event|0|||
126026281|NCT05136404|453391643|FG002|Period 3|Adverse Event|1|||
126026282|NCT03584516|453391644|FG000|Part 1|Death|2|||
126026283|NCT03584516|453391645|FG001|Part 1|Death|3|||
126026284|NCT03584516|453391646|FG002|Part 1|Death|0|||
126026285|NCT03584516|453391647|FG003|Part 1|Death|0|||
126026286|NCT03584516|453391648|FG004|Part 1|Death|0|||
126243516|NCT01796171|454183180|FG003|Follow-up Period|Physician Decision|0|||
126243517|NCT01796171|454183181|FG004|Follow-up Period|Physician Decision|0|||
126243518|NCT01796171|454183182|FG005|Follow-up Period|Physician Decision|0|||
126243519|NCT01796171|454183183|FG006|Follow-up Period|Physician Decision|0|||
126243520|NCT01796171|454183184|FG007|Follow-up Period|Physician Decision|0|||
126243521|NCT01796171|454183185|FG008|Follow-up Period|Physician Decision|0|||
126243522|NCT01796171|454183186|FG009|Follow-up Period|Physician Decision|0|||
126243523|NCT01796171|454183187|FG010|Follow-up Period|Physician Decision|5|||
126243524|NCT01796171|454183188|FG011|Follow-up Period|Physician Decision|0|||
126243525|NCT01796171|454183189|FG012|Follow-up Period|Physician Decision|0|||
126243526|NCT01796171|454183190|FG013|Follow-up Period|Physician Decision|0|||
126243527|NCT01796171|454183191|FG014|Follow-up Period|Physician Decision|0|||
126243528|NCT01796171|454183177|FG000|Follow-up Period|Withdrawal by Subject|0|||
126243529|NCT01796171|454183178|FG001|Follow-up Period|Withdrawal by Subject|1|||
126243530|NCT01796171|454183179|FG002|Follow-up Period|Withdrawal by Subject|0|||
126243531|NCT01796171|454183180|FG003|Follow-up Period|Withdrawal by Subject|0|||
126243532|NCT01796171|454183181|FG004|Follow-up Period|Withdrawal by Subject|0|||
126243533|NCT01796171|454183182|FG005|Follow-up Period|Withdrawal by Subject|1|||
126243534|NCT01796171|454183183|FG006|Follow-up Period|Withdrawal by Subject|0|||
126243535|NCT01796171|454183184|FG007|Follow-up Period|Withdrawal by Subject|0|||
126243536|NCT01796171|454183185|FG008|Follow-up Period|Withdrawal by Subject|0|||
126243537|NCT01796171|454183186|FG009|Follow-up Period|Withdrawal by Subject|0|||
126243538|NCT01796171|454183187|FG010|Follow-up Period|Withdrawal by Subject|3|||
126243539|NCT01796171|454183188|FG011|Follow-up Period|Withdrawal by Subject|1|||
126243540|NCT01796171|454183189|FG012|Follow-up Period|Withdrawal by Subject|0|||
126243541|NCT01796171|454183190|FG013|Follow-up Period|Withdrawal by Subject|0|||
126243542|NCT01796171|454183191|FG014|Follow-up Period|Withdrawal by Subject|0|||
126243543|NCT01796171|454183177|FG000|Follow-up Period|Death|0|||
126243544|NCT01796171|454183178|FG001|Follow-up Period|Death|0|||
126243545|NCT01796171|454183179|FG002|Follow-up Period|Death|0|||
126026287|NCT03584516|453391649|FG005|Part 1|Death|0|||
126243546|NCT01796171|454183180|FG003|Follow-up Period|Death|0|||
126243547|NCT01796171|454183181|FG004|Follow-up Period|Death|0|||
126243548|NCT01796171|454183182|FG005|Follow-up Period|Death|0|||
126243549|NCT01796171|454183183|FG006|Follow-up Period|Death|1|||
126243550|NCT01796171|454183184|FG007|Follow-up Period|Death|0|||
126243551|NCT01796171|454183185|FG008|Follow-up Period|Death|0|||
126243552|NCT01796171|454183186|FG009|Follow-up Period|Death|0|||
126026288|NCT03584516|453391644|FG000|Part 1|Withdrawal by Subject|2|||
126026289|NCT03584516|453391645|FG001|Part 1|Withdrawal by Subject|0|||
126026290|NCT03584516|453391646|FG002|Part 1|Withdrawal by Subject|0|||
126026291|NCT03584516|453391647|FG003|Part 1|Withdrawal by Subject|0|||
126026292|NCT03584516|453391648|FG004|Part 1|Withdrawal by Subject|0|||
126026293|NCT03584516|453391649|FG005|Part 1|Withdrawal by Subject|0|||
126026294|NCT03584516|453391644|FG000|Part 1|Lost to Follow-up|1|||
126243553|NCT01796171|454183187|FG010|Follow-up Period|Death|17|||
126243554|NCT01796171|454183188|FG011|Follow-up Period|Death|9|||
126243555|NCT01796171|454183189|FG012|Follow-up Period|Death|1|||
126243556|NCT01796171|454183190|FG013|Follow-up Period|Death|0|||
126243557|NCT01796171|454183191|FG014|Follow-up Period|Death|0|||
126243558|NCT01796171|454183177|FG000|Follow-up Period|Patient transferred to other hospital|0|||
126243559|NCT01796171|454183178|FG001|Follow-up Period|Patient transferred to other hospital|1|||
126243560|NCT01796171|454183179|FG002|Follow-up Period|Patient transferred to other hospital|0|||
126243561|NCT01796171|454183180|FG003|Follow-up Period|Patient transferred to other hospital|0|||
126243562|NCT01796171|454183181|FG004|Follow-up Period|Patient transferred to other hospital|0|||
126243563|NCT01796171|454183182|FG005|Follow-up Period|Patient transferred to other hospital|0|||
126243564|NCT01796171|454183183|FG006|Follow-up Period|Patient transferred to other hospital|0|||
126243565|NCT01796171|454183184|FG007|Follow-up Period|Patient transferred to other hospital|0|||
126243566|NCT01796171|454183185|FG008|Follow-up Period|Patient transferred to other hospital|0|||
126243567|NCT01796171|454183186|FG009|Follow-up Period|Patient transferred to other hospital|0|||
126243568|NCT01796171|454183187|FG010|Follow-up Period|Patient transferred to other hospital|0|||
126243569|NCT01796171|454183188|FG011|Follow-up Period|Patient transferred to other hospital|0|||
126243570|NCT01796171|454183189|FG012|Follow-up Period|Patient transferred to other hospital|0|||
126243571|NCT01796171|454183190|FG013|Follow-up Period|Patient transferred to other hospital|0|||
126243572|NCT01796171|454183191|FG014|Follow-up Period|Patient transferred to other hospital|0|||
126243573|NCT01796171|454183177|FG000|Follow-up Period|Sponsor Decision|0|||
126243574|NCT01796171|454183178|FG001|Follow-up Period|Sponsor Decision|0|||
126243575|NCT01796171|454183179|FG002|Follow-up Period|Sponsor Decision|0|||
126243576|NCT01796171|454183180|FG003|Follow-up Period|Sponsor Decision|0|||
126243577|NCT01796171|454183181|FG004|Follow-up Period|Sponsor Decision|0|||
126243578|NCT01796171|454183182|FG005|Follow-up Period|Sponsor Decision|0|||
126243579|NCT01796171|454183183|FG006|Follow-up Period|Sponsor Decision|0|||
126243580|NCT01796171|454183184|FG007|Follow-up Period|Sponsor Decision|0|||
126243581|NCT01796171|454183185|FG008|Follow-up Period|Sponsor Decision|0|||
126243582|NCT01796171|454183186|FG009|Follow-up Period|Sponsor Decision|0|||
126243583|NCT01796171|454183187|FG010|Follow-up Period|Sponsor Decision|40|||
126243584|NCT01796171|454183188|FG011|Follow-up Period|Sponsor Decision|15|||
126243585|NCT01796171|454183189|FG012|Follow-up Period|Sponsor Decision|7|||
126243586|NCT01796171|454183190|FG013|Follow-up Period|Sponsor Decision|0|||
126243587|NCT01796171|454183191|FG014|Follow-up Period|Sponsor Decision|0|||
126243588|NCT00829309|454183192|FG000|Washout: 7 Days|Protocol Violation|1|||
126243589|NCT00829309|454183193|FG001|Washout: 7 Days|Protocol Violation|0|||
126243590|NCT03343535|454183196|FG000|Overall Study|Lost to Follow-up|1|||
126243591|NCT03343535|454183196|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
126243592|NCT03343535|454183196|FG000|Overall Study|Death|12|||
126243593|NCT00777023|454183198|FG000|Overall Study|Adverse Event|15|||
126243594|NCT00777023|454183199|FG001|Overall Study|Adverse Event|21|||
126243595|NCT00777023|454183200|FG002|Overall Study|Adverse Event|8|||
126243596|NCT00777023|454183198|FG000|Overall Study|Lack of Efficacy|1|||
126243597|NCT00777023|454183199|FG001|Overall Study|Lack of Efficacy|0|||
126243598|NCT00777023|454183200|FG002|Overall Study|Lack of Efficacy|14|||
126243599|NCT00777023|454183198|FG000|Overall Study|Protocol Violation|2|||
126243600|NCT00777023|454183199|FG001|Overall Study|Protocol Violation|1|||
126243601|NCT00777023|454183200|FG002|Overall Study|Protocol Violation|1|||
126243602|NCT00777023|454183198|FG000|Overall Study|Lost to Follow-up|2|||
126243603|NCT00777023|454183199|FG001|Overall Study|Lost to Follow-up|3|||
126243604|NCT00777023|454183200|FG002|Overall Study|Lost to Follow-up|3|||
126243605|NCT00777023|454183198|FG000|Overall Study|Death|0|||
126243606|NCT00777023|454183199|FG001|Overall Study|Death|1|||
126243607|NCT00777023|454183200|FG002|Overall Study|Death|0|||
126243608|NCT00777023|454183198|FG000|Overall Study|Withdrawal by Subject|7|||
126026295|NCT03584516|453391645|FG001|Part 1|Lost to Follow-up|0|||
126026296|NCT03584516|453391646|FG002|Part 1|Lost to Follow-up|0|||
126026297|NCT03584516|453391647|FG003|Part 1|Lost to Follow-up|0|||
126026298|NCT03584516|453391648|FG004|Part 1|Lost to Follow-up|0|||
126243609|NCT00777023|454183199|FG001|Overall Study|Withdrawal by Subject|7|||
126243610|NCT00777023|454183200|FG002|Overall Study|Withdrawal by Subject|8|||
126243611|NCT00777023|454183198|FG000|Overall Study|Missing data|1|||
126243612|NCT00777023|454183199|FG001|Overall Study|Missing data|1|||
126243613|NCT00777023|454183200|FG002|Overall Study|Missing data|0|||
126243614|NCT00777023|454183198|FG000|Overall Study|Reasons not specified|4|||
126243615|NCT00777023|454183199|FG001|Overall Study|Reasons not specified|4|||
126243616|NCT00777023|454183200|FG002|Overall Study|Reasons not specified|2|||
126243617|NCT00777023|454183198|FG000|Overall Study|Last dose date unknown|3|||
126243618|NCT00777023|454183199|FG001|Overall Study|Last dose date unknown|3|||
126243619|NCT00777023|454183200|FG002|Overall Study|Last dose date unknown|1|||
126243620|NCT02659150|454183201|FG000|Subject Enrollment|Physician Decision|3|||
126243621|NCT02659150|454183201|FG000|Subject Enrollment|Withdrawal by Subject|2|||
126026299|NCT03584516|453391649|FG005|Part 1|Lost to Follow-up|0|||
126026300|NCT03584516|453391644|FG000|Part 1|Study Terminated by Sponsor|0|||
126243622|NCT02659150|454183201|FG000|Baseline Imaging|Withdrawal by Subject|1|||
126243623|NCT02659150|454183201|FG000|Baseline Imaging|Physician Decision|1|||
126243624|NCT02659150|454183201|FG000|Study Drug Dosing|Adverse Event|1|||
126243625|NCT04247282|454183205|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
126243626|NCT04247282|454183206|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
126243627|NCT04247282|454183207|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
126243628|NCT04247282|454183208|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
126243629|NCT04247282|454183205|FG000|Overall Study|Refused further treatment|0|||
126243630|NCT04247282|454183206|FG001|Overall Study|Refused further treatment|1|||
126243631|NCT04247282|454183207|FG002|Overall Study|Refused further treatment|0|||
126243632|NCT04247282|454183208|FG003|Overall Study|Refused further treatment|0|||
126243633|NCT01037114|454183215|FG000|Year 20|Others|1|||
126243634|NCT00968812|454183223|FG000|Overall Study|Adverse Event|30|||
126243635|NCT00968812|454183224|FG001|Overall Study|Adverse Event|46|||
126243636|NCT00968812|454183225|FG002|Overall Study|Adverse Event|33|||
126243637|NCT00968812|454183223|FG000|Overall Study|Death|2|||
126243638|NCT00968812|454183224|FG001|Overall Study|Death|2|||
126243639|NCT00968812|454183225|FG002|Overall Study|Death|1|||
126243640|NCT00968812|454183223|FG000|Overall Study|Lack of Efficacy|9|||
126243641|NCT00968812|454183224|FG001|Overall Study|Lack of Efficacy|7|||
126243642|NCT00968812|454183225|FG002|Overall Study|Lack of Efficacy|16|||
126243643|NCT00968812|454183223|FG000|Overall Study|Lost to Follow-up|17|||
126243644|NCT00968812|454183224|FG001|Overall Study|Lost to Follow-up|12|||
126243645|NCT00968812|454183225|FG002|Overall Study|Lost to Follow-up|11|||
126243646|NCT00968812|454183223|FG000|Overall Study|Physician Decision|8|||
126243647|NCT00968812|454183224|FG001|Overall Study|Physician Decision|5|||
126243648|NCT00968812|454183225|FG002|Overall Study|Physician Decision|9|||
126243649|NCT00968812|454183223|FG000|Overall Study|Protocol Violation|7|||
126243650|NCT00968812|454183224|FG001|Overall Study|Protocol Violation|4|||
126243651|NCT00968812|454183225|FG002|Overall Study|Protocol Violation|3|||
126243652|NCT00968812|454183223|FG000|Overall Study|Withdrawal by Subject|17|||
126243653|NCT00968812|454183224|FG001|Overall Study|Withdrawal by Subject|23|||
126243654|NCT00968812|454183225|FG002|Overall Study|Withdrawal by Subject|25|||
126243655|NCT00968812|454183223|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
126243656|NCT00968812|454183224|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
126243657|NCT00968812|454183225|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
126243658|NCT00968812|454183223|FG000|Overall Study|Noncompliance with study drug|4|||
126243659|NCT00968812|454183224|FG001|Overall Study|Noncompliance with study drug|1|||
126243660|NCT00968812|454183225|FG002|Overall Study|Noncompliance with study drug|6|||
126243661|NCT00968812|454183223|FG000|Overall Study|Unable to take rescue therapy|12|||
126243662|NCT00968812|454183224|FG001|Overall Study|Unable to take rescue therapy|12|||
126243663|NCT00968812|454183225|FG002|Overall Study|Unable to take rescue therapy|17|||
126243664|NCT00968812|454183223|FG000|Overall Study|Other|25|||
126243665|NCT00968812|454183224|FG001|Overall Study|Other|37|||
126243666|NCT00968812|454183225|FG002|Overall Study|Other|40|||
126243667|NCT00448591|454183228|FG000|Overall Study|Withdrawal by Subject|178|||
126243668|NCT00448591|454183228|FG000|Overall Study|Progressive Disease|1382|||
126243669|NCT00448591|454183228|FG000|Overall Study|Adverse Event|382|||
126243670|NCT00448591|454183228|FG000|Overall Study|Protocol Violation|41|||
126243671|NCT00448591|454183228|FG000|Overall Study|Lost to Follow-up|19|||
126243672|NCT00448591|454183228|FG000|Overall Study|Treatment Regimen Completed|70|||
126243673|NCT00448591|454183228|FG000|Overall Study|Other|154|||
126243674|NCT00448591|454183228|FG000|Overall Study|Termination of Study|70|||
126243675|NCT00640562|454183229|FG000|Overall Study|Adverse Event|8|||
126243676|NCT00640562|454183230|FG001|Overall Study|Adverse Event|5|||
126243677|NCT00640562|454183229|FG000|Overall Study|Lack of Efficacy|1|||
126243678|NCT00640562|454183230|FG001|Overall Study|Lack of Efficacy|4|||
126243679|NCT00640562|454183229|FG000|Overall Study|Protocol Violation|2|||
126243680|NCT00640562|454183230|FG001|Overall Study|Protocol Violation|4|||
126243681|NCT00640562|454183229|FG000|Overall Study|Withdrawal by Subject|6|||
126243682|NCT00640562|454183230|FG001|Overall Study|Withdrawal by Subject|10|||
126243683|NCT00640562|454183229|FG000|Overall Study|Known risperidone intolerance|0|||
126243684|NCT00640562|454183230|FG001|Overall Study|Known risperidone intolerance|1|||
126243685|NCT00640562|454183229|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
126243686|NCT00640562|454183230|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
126243687|NCT00640562|454183229|FG000|Overall Study|Low study drug dose|0|||
126243688|NCT00640562|454183230|FG001|Overall Study|Low study drug dose|1|||
126243689|NCT00640562|454183229|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
126243690|NCT00640562|454183230|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
126243691|NCT02937870|454183231|FG000|Overall Study|Adverse Event|1|||
126243692|NCT02937870|454183231|FG000|Overall Study|Protocol Deviation|2|||
126243693|NCT03098394|454183235|FG000|Overall Study|Pregnancy|0|||
126243694|NCT03098394|454183236|FG001|Overall Study|Pregnancy|1|||
126243695|NCT00609674|454183237|FG000|Overall Study|Adverse Event|1|||
126243696|NCT00609674|454183238|FG001|Overall Study|Adverse Event|1|||
126243697|NCT00609674|454183237|FG000|Overall Study|Protocol Violation|3|||
126243698|NCT00609674|454183238|FG001|Overall Study|Protocol Violation|5|||
126243699|NCT00609674|454183237|FG000|Overall Study|Lost to Follow-up|1|||
126243700|NCT00609674|454183238|FG001|Overall Study|Lost to Follow-up|0|||
126243701|NCT00609674|454183237|FG000|Overall Study|Withdrew consent|2|||
126243702|NCT00609674|454183238|FG001|Overall Study|Withdrew consent|1|||
126243703|NCT00571064|454183240|FG000|Overall Study|Adverse Event|13|||
126243704|NCT00571064|454183240|FG000|Overall Study|Protocol Violation|4|||
126243705|NCT00571064|454183240|FG000|Overall Study|Withdrawal by Subject|2|||
126243706|NCT00571064|454183240|FG000|Overall Study|Other|2|||
126243707|NCT00244764|454183241|FG000|Overall Study|Adverse Event|37|||
126243708|NCT00244764|454183241|FG000|Overall Study|Lost to Follow-up|23|||
126243709|NCT00244764|454183241|FG000|Overall Study|Withdrawal by Subject|12|||
126243710|NCT00244764|454183241|FG000|Overall Study|Disease Progression|13|||
126243711|NCT00244764|454183241|FG000|Overall Study|Protocol Violation|2|||
126243712|NCT00244764|454183241|FG000|Overall Study|Death|1|||
126243713|NCT00244764|454183241|FG000|Overall Study|Off Study Medication for >21 Days|1|||
126243714|NCT00244764|454183241|FG000|Overall Study|Declining Performance Status|1|||
126243715|NCT00244764|454183241|FG000|Overall Study|Participant was Hospitalized until Death|1|||
126243716|NCT00244764|454183241|FG000|Overall Study|Primary Investigator Discretion|2|||
126243717|NCT00244764|454183241|FG000|Overall Study|Sponsor Terminated Study|2|||
126243718|NCT00244764|454183241|FG000|Overall Study|Developed Secondary Malignancy|1|||
126243719|NCT04022954|454183251|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
126243720|NCT04022954|454183251|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
126243721|NCT04022954|454183251|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
126243722|NCT03872128|454183254|FG000|Overall Study|Dropped out before treatment|1|||
126243723|NCT03872128|454183255|FG001|Overall Study|Dropped out before treatment|0|||
126243724|NCT03872128|454183256|FG002|Overall Study|Dropped out before treatment|4|||
126243725|NCT03872128|454183254|FG000|Overall Study|Lost to Follow-up|2|||
126243726|NCT03872128|454183255|FG001|Overall Study|Lost to Follow-up|5|||
126243727|NCT03872128|454183256|FG002|Overall Study|Lost to Follow-up|8|||
126243728|NCT03122457|454183259|FG000|Overall Study|Withdrawal by Subject|6|||
126243729|NCT02409355|454183263|FG000|Overall Study|Withdrawal by Subject|1|||
126243730|NCT02409355|454183264|FG001|Overall Study|Withdrawal by Subject|0|||
126243731|NCT02409355|454183263|FG000|Overall Study|Death|1|||
126243732|NCT02409355|454183264|FG001|Overall Study|Death|1|||
126243733|NCT02409355|454183263|FG000|Overall Study|Study terminated by Sponsor|2|||
126243734|NCT02409355|454183264|FG001|Overall Study|Study terminated by Sponsor|3|||
126243735|NCT01908205|454183265|FG000|Overall Study|Lost to Follow-up|2|||
126357433|NCT02018887|454602097|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
126026301|NCT03584516|453391645|FG001|Part 1|Study Terminated by Sponsor|2|||
126026302|NCT03584516|453391646|FG002|Part 1|Study Terminated by Sponsor|0|||
126026303|NCT03584516|453391647|FG003|Part 1|Study Terminated by Sponsor|0|||
126026304|NCT03584516|453391648|FG004|Part 1|Study Terminated by Sponsor|0|||
126026305|NCT03584516|453391649|FG005|Part 1|Study Terminated by Sponsor|0|||
126026306|NCT03584516|453391644|FG000|Part 1 Expansion|Death|0|||
126026307|NCT03584516|453391645|FG001|Part 1 Expansion|Death|0|||
126026308|NCT03584516|453391646|FG002|Part 1 Expansion|Death|9|||
126026309|NCT03584516|453391647|FG003|Part 1 Expansion|Death|8|||
126026310|NCT03584516|453391648|FG004|Part 1 Expansion|Death|4|||
126026311|NCT03584516|453391649|FG005|Part 1 Expansion|Death|5|||
126243736|NCT01908205|454183266|FG001|Overall Study|Lost to Follow-up|0|||
126243737|NCT01908205|454183265|FG000|Overall Study|Withdrawal by Subject|3|||
126243738|NCT01908205|454183266|FG001|Overall Study|Withdrawal by Subject|1|||
126243739|NCT03134222|454183271|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
126243740|NCT03134222|454183272|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
126243741|NCT03134222|454183273|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
126243742|NCT03134222|454183274|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
126243743|NCT03134222|454183275|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
126243744|NCT03134222|454183271|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
126243745|NCT03134222|454183272|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
126243746|NCT03134222|454183273|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
126243747|NCT03134222|454183274|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
126026312|NCT03584516|453391644|FG000|Part 1 Expansion|Lost to Follow-up|0|||
126026313|NCT03584516|453391645|FG001|Part 1 Expansion|Lost to Follow-up|0|||
126026314|NCT03584516|453391646|FG002|Part 1 Expansion|Lost to Follow-up|0|||
126026315|NCT03584516|453391647|FG003|Part 1 Expansion|Lost to Follow-up|1|||
126243748|NCT03134222|454183275|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
126243749|NCT03134222|454183271|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
126243750|NCT03134222|454183272|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
126243751|NCT03134222|454183273|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
126243752|NCT03134222|454183274|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
126243753|NCT03134222|454183275|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
126243754|NCT03134222|454183271|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
126243755|NCT03134222|454183272|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
126243756|NCT03134222|454183273|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
126243757|NCT03134222|454183274|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
126243758|NCT03134222|454183275|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
126243759|NCT03134222|454183271|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
126243760|NCT03134222|454183272|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
126243761|NCT03134222|454183273|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
126243762|NCT03134222|454183274|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
126243763|NCT03134222|454183275|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
126243764|NCT03134222|454183271|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
126243765|NCT03134222|454183272|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
126243766|NCT03134222|454183273|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
126243767|NCT03134222|454183274|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
126243768|NCT03134222|454183275|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
126243769|NCT03134222|454183271|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
126243770|NCT03134222|454183272|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
126243771|NCT03134222|454183273|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
126243772|NCT03134222|454183274|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
126243773|NCT03134222|454183275|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
126243774|NCT03134222|454183271|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
126243775|NCT03134222|454183272|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
126243776|NCT03134222|454183273|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
126243777|NCT03134222|454183274|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
126243778|NCT03134222|454183275|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
126243779|NCT03482882|454183278|FG000|Overall Study|Adverse Event|3|||
126243780|NCT03482882|454183278|FG000|Overall Study|Lost to Follow-up|1|||
126243781|NCT03482882|454183278|FG000|Overall Study|Protocol Violation|2|||
126243782|NCT03482882|454183278|FG000|Overall Study|Not further specified|1|||
126243783|NCT01110005|454183283|FG000|Overall Study|ineligible|1|||
126243784|NCT01110005|454183284|FG001|Overall Study|ineligible|2|||
126243785|NCT01110005|454183283|FG000|Overall Study|missing consent|3|||
126243786|NCT01110005|454183284|FG001|Overall Study|missing consent|2|||
126243787|NCT01110005|454183283|FG000|Overall Study|Withdrawal by Subject|0|||
126243788|NCT01110005|454183284|FG001|Overall Study|Withdrawal by Subject|1|||
126243789|NCT03681470|454183285|FG000|Overall Study|Lack of Efficacy|3|||
126243790|NCT03681470|454183285|FG000|Overall Study|Lost to Follow-up|1|||
126243791|NCT03681470|454183285|FG000|Overall Study|Protocol Violation|3|||
126243792|NCT03681470|454183285|FG000|Overall Study|Withdrawal by Subject|1|||
126243793|NCT01686477|454183286|FG000|Feeding Intervention|Death|1|||
126243794|NCT01686477|454183287|FG001|Feeding Intervention|Death|0|||
126243795|NCT01686477|454183288|FG002|Feeding Intervention|Death|1|||
126243796|NCT01686477|454183286|FG000|Feeding Intervention|Withdrawal by Subject|0|||
126243797|NCT01686477|454183287|FG001|Feeding Intervention|Withdrawal by Subject|6|||
126243798|NCT01686477|454183288|FG002|Feeding Intervention|Withdrawal by Subject|0|||
126243799|NCT01686477|454183286|FG000|Feeding Intervention|Physician Decision|1|||
126243800|NCT01686477|454183287|FG001|Feeding Intervention|Physician Decision|2|||
126243801|NCT01686477|454183288|FG002|Feeding Intervention|Physician Decision|0|||
126243802|NCT01686477|454183286|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
126243803|NCT01686477|454183287|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
126243804|NCT01686477|454183288|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
126026316|NCT03584516|453391648|FG004|Part 1 Expansion|Lost to Follow-up|0|||
126026317|NCT03584516|453391649|FG005|Part 1 Expansion|Lost to Follow-up|0|||
126243805|NCT01686477|454183286|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
126243806|NCT01686477|454183287|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
126243807|NCT01686477|454183288|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
126243808|NCT01686477|454183286|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
126243809|NCT01686477|454183287|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
126243810|NCT01686477|454183288|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
126243811|NCT01686477|454183286|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
126243812|NCT01686477|454183287|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
126243813|NCT01686477|454183288|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
126243814|NCT01686477|454183286|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
126243815|NCT01686477|454183287|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
126243816|NCT01686477|454183288|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
126243817|NCT01686477|454183286|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
126243818|NCT01686477|454183287|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
126243819|NCT01686477|454183288|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
126243820|NCT01686477|454183286|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
126243821|NCT01686477|454183287|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
126243822|NCT01686477|454183288|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
126243823|NCT03290781|454183290|FG000|Overall Study|Adverse Event|5|||
126243824|NCT03290781|454183291|FG001|Overall Study|Adverse Event|7|||
126243825|NCT03290781|454183292|FG002|Overall Study|Adverse Event|4|||
126243826|NCT03290781|454183293|FG003|Overall Study|Adverse Event|1|||
126243827|NCT03290781|454183294|FG004|Overall Study|Adverse Event|0|||
126243828|NCT03290781|454183295|FG005|Overall Study|Adverse Event|0|||
126243829|NCT03290781|454183296|FG006|Overall Study|Adverse Event|0|||
126243830|NCT03290781|454183290|FG000|Overall Study|Death|0|||
126243831|NCT03290781|454183291|FG001|Overall Study|Death|0|||
126243832|NCT03290781|454183292|FG002|Overall Study|Death|1|||
126243833|NCT03290781|454183293|FG003|Overall Study|Death|0|||
126243834|NCT03290781|454183294|FG004|Overall Study|Death|1|||
126243835|NCT03290781|454183295|FG005|Overall Study|Death|0|||
126243836|NCT03290781|454183296|FG006|Overall Study|Death|0|||
126243837|NCT03290781|454183290|FG000|Overall Study|Withdrawal by Subject|6|||
126243838|NCT03290781|454183291|FG001|Overall Study|Withdrawal by Subject|5|||
126243839|NCT03290781|454183292|FG002|Overall Study|Withdrawal by Subject|9|||
126243840|NCT03290781|454183293|FG003|Overall Study|Withdrawal by Subject|10|||
126243841|NCT03290781|454183294|FG004|Overall Study|Withdrawal by Subject|1|||
126243842|NCT03290781|454183295|FG005|Overall Study|Withdrawal by Subject|2|||
126243843|NCT03290781|454183296|FG006|Overall Study|Withdrawal by Subject|0|||
126243844|NCT03290781|454183290|FG000|Overall Study|Physician Decision|0|||
126243845|NCT03290781|454183291|FG001|Overall Study|Physician Decision|1|||
126243846|NCT03290781|454183292|FG002|Overall Study|Physician Decision|0|||
126243847|NCT03290781|454183293|FG003|Overall Study|Physician Decision|0|||
126243848|NCT03290781|454183294|FG004|Overall Study|Physician Decision|0|||
126243849|NCT03290781|454183295|FG005|Overall Study|Physician Decision|0|||
126243850|NCT03290781|454183296|FG006|Overall Study|Physician Decision|0|||
126243851|NCT03290781|454183290|FG000|Overall Study|Site Terminated by Sponsor|1|||
126243852|NCT03290781|454183291|FG001|Overall Study|Site Terminated by Sponsor|0|||
126243853|NCT03290781|454183292|FG002|Overall Study|Site Terminated by Sponsor|2|||
126243854|NCT03290781|454183293|FG003|Overall Study|Site Terminated by Sponsor|1|||
126243855|NCT03290781|454183294|FG004|Overall Study|Site Terminated by Sponsor|0|||
126243856|NCT03290781|454183295|FG005|Overall Study|Site Terminated by Sponsor|0|||
126243857|NCT03290781|454183296|FG006|Overall Study|Site Terminated by Sponsor|0|||
126243858|NCT03290781|454183290|FG000|Overall Study|Lost to Follow-up|0|||
126243859|NCT03290781|454183291|FG001|Overall Study|Lost to Follow-up|0|||
126243860|NCT03290781|454183292|FG002|Overall Study|Lost to Follow-up|0|||
126243861|NCT03290781|454183293|FG003|Overall Study|Lost to Follow-up|1|||
126243862|NCT03290781|454183294|FG004|Overall Study|Lost to Follow-up|0|||
126243863|NCT03290781|454183295|FG005|Overall Study|Lost to Follow-up|0|||
126243864|NCT03290781|454183296|FG006|Overall Study|Lost to Follow-up|0|||
126243865|NCT03290781|454183290|FG000|Overall Study|Protocol Deviation|2|||
126243866|NCT03290781|454183291|FG001|Overall Study|Protocol Deviation|0|||
126243867|NCT03290781|454183292|FG002|Overall Study|Protocol Deviation|0|||
126243868|NCT03290781|454183293|FG003|Overall Study|Protocol Deviation|1|||
126243869|NCT03290781|454183294|FG004|Overall Study|Protocol Deviation|0|||
126243870|NCT03290781|454183295|FG005|Overall Study|Protocol Deviation|0|||
126243871|NCT03290781|454183296|FG006|Overall Study|Protocol Deviation|0|||
126243872|NCT03290781|454183290|FG000|Overall Study|Disease Relapse|32|||
126243873|NCT03290781|454183291|FG001|Overall Study|Disease Relapse|5|||
126243874|NCT03290781|454183292|FG002|Overall Study|Disease Relapse|38|||
126243875|NCT03290781|454183293|FG003|Overall Study|Disease Relapse|7|||
126243876|NCT03290781|454183294|FG004|Overall Study|Disease Relapse|3|||
126243877|NCT03290781|454183295|FG005|Overall Study|Disease Relapse|1|||
126243878|NCT03290781|454183296|FG006|Overall Study|Disease Relapse|4|||
126243879|NCT03290781|454183290|FG000|Overall Study|Other|3|||
126243880|NCT03290781|454183291|FG001|Overall Study|Other|0|||
126243881|NCT03290781|454183292|FG002|Overall Study|Other|2|||
126243882|NCT03290781|454183293|FG003|Overall Study|Other|2|||
126243883|NCT03290781|454183294|FG004|Overall Study|Other|0|||
126243884|NCT03290781|454183295|FG005|Overall Study|Other|0|||
126243885|NCT03290781|454183296|FG006|Overall Study|Other|0|||
126243886|NCT01136174|454183297|FG000|Overall Study|Adverse Event|0|||
126243887|NCT01136174|454183298|FG001|Overall Study|Adverse Event|0|||
126243888|NCT01136174|454183299|FG002|Overall Study|Adverse Event|0|||
126243889|NCT01136174|454183300|FG003|Overall Study|Adverse Event|4|||
126243890|NCT03071575|454184797|FG000|Overall Study|Death|0|||
126243891|NCT03071575|454184798|FG001|Overall Study|Death|1|||
126243892|NCT03071575|454184797|FG000|Overall Study|Lost to Follow-up|5|||
126243893|NCT03071575|454184798|FG001|Overall Study|Lost to Follow-up|11|||
126243894|NCT03071575|454184797|FG000|Overall Study|Withdrawal by Subject|4|||
126243895|NCT03071575|454184798|FG001|Overall Study|Withdrawal by Subject|2|||
126243896|NCT00834795|454184799|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
126243897|NCT00834795|454184800|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
126243898|NCT00834795|454184799|FG000|Second Intervention|Adverse Event|1|||
126243899|NCT00834795|454184800|FG001|Second Intervention|Adverse Event|0|||
126243900|NCT00579345|454184801|FG000|Overall Study|Withdrawal by Subject|2|||
126243901|NCT00579345|454184802|FG001|Overall Study|Withdrawal by Subject|0|||
126243902|NCT00579345|454184803|FG002|Overall Study|Withdrawal by Subject|0|||
126243903|NCT00579345|454184804|FG003|Overall Study|Withdrawal by Subject|0|||
126243904|NCT00579345|454184805|FG004|Overall Study|Withdrawal by Subject|0|||
126243905|NCT00579345|454184806|FG005|Overall Study|Withdrawal by Subject|0|||
126243906|NCT00579345|454184807|FG006|Overall Study|Withdrawal by Subject|0|||
126243907|NCT00579345|454184808|FG007|Overall Study|Withdrawal by Subject|1|||
126093987|NCT02141620|453639083|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
126093988|NCT02141620|453639084|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
126093989|NCT03651622|453639085|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
126093990|NCT03651622|453639086|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
126093991|NCT03651622|453639087|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
126093992|NCT03651622|453639085|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
126357434|NCT02018887|454602098|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357435|NCT02018887|454602099|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357436|NCT02018887|454602100|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357437|NCT02018887|454602090|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
126357438|NCT02018887|454602091|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
126357439|NCT02018887|454602092|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
126357440|NCT02018887|454602093|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
126357441|NCT02018887|454602094|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
126357442|NCT02018887|454602095|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
126093993|NCT03651622|453639086|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
126093994|NCT03651622|453639087|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
126093995|NCT03651622|453639085|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
126093996|NCT03651622|453639086|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
126093997|NCT03651622|453639087|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
126093998|NCT03651622|453639085|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
126357443|NCT02018887|454602096|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
126357444|NCT02018887|454602097|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
126357445|NCT02018887|454602098|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
126357446|NCT02018887|454602099|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
126357447|NCT02018887|454602100|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
126357448|NCT02018887|454602090|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
126093999|NCT03651622|453639086|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
126094000|NCT03651622|453639087|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
126094001|NCT03651622|453639085|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
126243908|NCT00579345|454184801|FG000|Overall Study|Lost to Follow-up|1|||
126094002|NCT03651622|453639086|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
126243909|NCT00579345|454184802|FG001|Overall Study|Lost to Follow-up|0|||
126243910|NCT00579345|454184803|FG002|Overall Study|Lost to Follow-up|0|||
126243911|NCT00579345|454184804|FG003|Overall Study|Lost to Follow-up|0|||
126243912|NCT00579345|454184805|FG004|Overall Study|Lost to Follow-up|0|||
126243913|NCT00579345|454184806|FG005|Overall Study|Lost to Follow-up|0|||
126243914|NCT00579345|454184807|FG006|Overall Study|Lost to Follow-up|0|||
126243915|NCT00579345|454184808|FG007|Overall Study|Lost to Follow-up|0|||
126357449|NCT02018887|454602091|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
126357450|NCT02018887|454602092|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
126243916|NCT00579345|454184801|FG000|Overall Study|Adverse Event|0|||
126243917|NCT00579345|454184802|FG001|Overall Study|Adverse Event|0|||
126243918|NCT00579345|454184803|FG002|Overall Study|Adverse Event|1|||
126243919|NCT00579345|454184804|FG003|Overall Study|Adverse Event|0|||
126243920|NCT00579345|454184805|FG004|Overall Study|Adverse Event|0|||
126243921|NCT00579345|454184806|FG005|Overall Study|Adverse Event|0|||
126243922|NCT00579345|454184807|FG006|Overall Study|Adverse Event|0|||
126243923|NCT00579345|454184808|FG007|Overall Study|Adverse Event|0|||
126243924|NCT00579345|454184801|FG000|Overall Study|Protocol Violation|1|||
126243925|NCT00579345|454184802|FG001|Overall Study|Protocol Violation|0|||
126243926|NCT00579345|454184803|FG002|Overall Study|Protocol Violation|0|||
126243927|NCT00579345|454184804|FG003|Overall Study|Protocol Violation|0|||
126243928|NCT00579345|454184805|FG004|Overall Study|Protocol Violation|0|||
126243929|NCT00579345|454184806|FG005|Overall Study|Protocol Violation|0|||
126243930|NCT00579345|454184807|FG006|Overall Study|Protocol Violation|0|||
126243931|NCT00579345|454184808|FG007|Overall Study|Protocol Violation|1|||
126243932|NCT00579345|454184801|FG000|Overall Study|Death|1|||
126243933|NCT00579345|454184802|FG001|Overall Study|Death|1|||
126243934|NCT00579345|454184803|FG002|Overall Study|Death|1|||
126243935|NCT00579345|454184804|FG003|Overall Study|Death|1|||
126243936|NCT00579345|454184805|FG004|Overall Study|Death|0|||
126243937|NCT00579345|454184806|FG005|Overall Study|Death|0|||
126243938|NCT00579345|454184807|FG006|Overall Study|Death|0|||
126243939|NCT00579345|454184808|FG007|Overall Study|Death|0|||
126243940|NCT03255733|454184812|FG000|Overall Study|Lost to Follow-up|4|||
126243941|NCT04299087|454184813|FG000|Overall Study|Lost to Follow-up|2|||
126243942|NCT04299087|454184814|FG001|Overall Study|Lost to Follow-up|1|||
126243943|NCT00594035|454184815|FG000|Overall Study|Lost to Follow-up|1|||
126243944|NCT00594035|454184816|FG001|Overall Study|Lost to Follow-up|1|||
126243945|NCT00594035|454184815|FG000|Overall Study|Withdrawal by Subject|1|||
126243946|NCT00594035|454184816|FG001|Overall Study|Withdrawal by Subject|0|||
126243947|NCT00594035|454184815|FG000|Overall Study|Subject transferred to nursing home|0|||
126243948|NCT00594035|454184816|FG001|Overall Study|Subject transferred to nursing home|1|||
126243949|NCT00594035|454184815|FG000|Overall Study|Subject couldn't return due to job|0|||
126243950|NCT00594035|454184816|FG001|Overall Study|Subject couldn't return due to job|1|||
126243951|NCT00795821|454184817|FG000|Acute Treatment Phase|Adverse Event|23|||
126243952|NCT00795821|454184818|FG001|Acute Treatment Phase|Adverse Event|4|||
126243953|NCT00795821|454184817|FG000|Acute Treatment Phase|Death|1|||
126243954|NCT00795821|454184818|FG001|Acute Treatment Phase|Death|0|||
126243955|NCT00795821|454184817|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
126357451|NCT02018887|454602093|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
126357452|NCT02018887|454602094|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
126357453|NCT02018887|454602095|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
126357454|NCT02018887|454602096|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
126357455|NCT02018887|454602097|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
126357456|NCT02018887|454602098|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
126357457|NCT02018887|454602099|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
126026318|NCT03584516|453391644|FG000|Part 1 Expansion|Physician Decision|0|||
126026319|NCT03584516|453391645|FG001|Part 1 Expansion|Physician Decision|0|||
126026320|NCT03584516|453391646|FG002|Part 1 Expansion|Physician Decision|4|||
126026321|NCT03584516|453391647|FG003|Part 1 Expansion|Physician Decision|3|||
126026322|NCT03584516|453391648|FG004|Part 1 Expansion|Physician Decision|2|||
126026323|NCT03584516|453391649|FG005|Part 1 Expansion|Physician Decision|3|||
126026324|NCT03584516|453391644|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
126026325|NCT03584516|453391645|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
126026326|NCT03584516|453391646|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
126026327|NCT03584516|453391647|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
126026328|NCT03584516|453391648|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
126026329|NCT03584516|453391649|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
126026330|NCT03584516|453391644|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
126026331|NCT03584516|453391645|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
126026332|NCT03584516|453391646|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
126026333|NCT03584516|453391647|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
126026334|NCT03584516|453391648|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
126026335|NCT03584516|453391649|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
126243956|NCT00795821|454184818|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
126243957|NCT00795821|454184817|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
126243958|NCT00795821|454184818|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
126243959|NCT00795821|454184817|FG000|Acute Treatment Phase|Physician Decision|1|||
126243960|NCT00795821|454184818|FG001|Acute Treatment Phase|Physician Decision|1|||
126243961|NCT00795821|454184817|FG000|Acute Treatment Phase|Protocol Violation|1|||
126243962|NCT00795821|454184818|FG001|Acute Treatment Phase|Protocol Violation|2|||
126243963|NCT00795821|454184817|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
126243964|NCT00795821|454184818|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
126243965|NCT00795821|454184817|FG000|Long-term Extension Phase|Adverse Event|25|||
126243966|NCT00795821|454184818|FG001|Long-term Extension Phase|Adverse Event|32|||
126243967|NCT00795821|454184817|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
126243968|NCT00795821|454184818|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
126243969|NCT00795821|454184817|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
126243970|NCT00795821|454184818|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
126243971|NCT00795821|454184817|FG000|Long-term Extension Phase|Physician Decision|1|||
126243972|NCT00795821|454184818|FG001|Long-term Extension Phase|Physician Decision|2|||
126243973|NCT00795821|454184817|FG000|Long-term Extension Phase|Protocol Violation|3|||
126243974|NCT00795821|454184818|FG001|Long-term Extension Phase|Protocol Violation|5|||
126243975|NCT00795821|454184817|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
126243976|NCT00795821|454184818|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
126243977|NCT00795821|454184817|FG000|Taper Phase|Adverse Event|2|||
126243978|NCT00795821|454184818|FG001|Taper Phase|Adverse Event|0|||
126243979|NCT00795821|454184817|FG000|Taper Phase|Lost to Follow-up|1|||
126243980|NCT00795821|454184818|FG001|Taper Phase|Lost to Follow-up|0|||
126243981|NCT00795821|454184817|FG000|Taper Phase|Physician Decision|2|||
126243982|NCT00795821|454184818|FG001|Taper Phase|Physician Decision|0|||
126243983|NCT00795821|454184817|FG000|Taper Phase|Withdrawal by Subject|4|||
126243984|NCT00795821|454184818|FG001|Taper Phase|Withdrawal by Subject|0|||
126243985|NCT00583453|454184827|FG000|Overall Study|discontinued intervention|0|||
126243986|NCT00583453|454184828|FG001|Overall Study|discontinued intervention|2|||
126243987|NCT03868891|454184833|FG000|Overall Study|Adverse Event|1|||
126243988|NCT03868891|454184834|FG001|Overall Study|Adverse Event|0|||
126243989|NCT03868891|454184833|FG000|Overall Study|Lost to Follow-up|2|||
126243990|NCT03868891|454184834|FG001|Overall Study|Lost to Follow-up|1|||
126243991|NCT03868891|454184833|FG000|Overall Study|COVID-19 Restrictions|1|||
126243992|NCT03868891|454184834|FG001|Overall Study|COVID-19 Restrictions|2|||
126243993|NCT03123094|454184835|FG000|Overall Study|Withdrawal by Subject|0|||
126243994|NCT03123094|454184836|FG001|Overall Study|Withdrawal by Subject|2|||
126243995|NCT03123094|454184837|FG002|Overall Study|Withdrawal by Subject|1|||
126243996|NCT03123094|454184838|FG003|Overall Study|Withdrawal by Subject|0|||
126243997|NCT03123094|454184839|FG004|Overall Study|Withdrawal by Subject|1|||
126243998|NCT03496623|454184842|FG000|Run-In Period (2 Weeks)|Death|1|||
126243999|NCT03496623|454184843|FG001|Run-In Period (2 Weeks)|Death|0|||
126244000|NCT03496623|454184844|FG002|Run-In Period (2 Weeks)|Death|0|||
126244001|NCT03496623|454184845|FG003|Run-In Period (2 Weeks)|Death|0|||
126244002|NCT03496623|454184846|FG004|Run-In Period (2 Weeks)|Death|0|||
126244003|NCT03496623|454184842|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
126244004|NCT03496623|454184843|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
126244005|NCT03496623|454184844|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
126244006|NCT03496623|454184845|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
126244007|NCT03496623|454184846|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
126244008|NCT03496623|454184842|FG000|Period 1 (12 Weeks)|Death|0|||
126244009|NCT03496623|454184843|FG001|Period 1 (12 Weeks)|Death|3|||
126244010|NCT03496623|454184844|FG002|Period 1 (12 Weeks)|Death|0|||
126244011|NCT03496623|454184845|FG003|Period 1 (12 Weeks)|Death|0|||
126244012|NCT03496623|454184846|FG004|Period 1 (12 Weeks)|Death|0|||
126244013|NCT03496623|454184842|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
126244014|NCT03496623|454184843|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
126244015|NCT03496623|454184844|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
126244016|NCT03496623|454184845|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
126244017|NCT03496623|454184846|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
126244018|NCT03496623|454184842|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126244019|NCT03496623|454184843|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
126244020|NCT03496623|454184844|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
126244021|NCT03496623|454184845|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126244022|NCT03496623|454184846|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126244023|NCT03496623|454184842|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
126244024|NCT03496623|454184843|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
126244025|NCT03496623|454184844|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
126244026|NCT03496623|454184845|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
126244027|NCT03496623|454184846|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
126244028|NCT03496623|454184842|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126244029|NCT03496623|454184843|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126244030|NCT03496623|454184844|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
126244031|NCT03496623|454184845|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126244032|NCT03496623|454184846|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126094003|NCT03651622|453639087|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
126094004|NCT01519089|453639088|FG000|Overall Study|Adverse Event|4|||
126094005|NCT01519089|453639089|FG001|Overall Study|Adverse Event|4|||
126094006|NCT01519089|453639088|FG000|Overall Study|Lack of Efficacy|0|||
126094007|NCT01519089|453639089|FG001|Overall Study|Lack of Efficacy|2|||
126094008|NCT01519089|453639088|FG000|Overall Study|Lost to Follow-up|1|||
126094009|NCT01519089|453639089|FG001|Overall Study|Lost to Follow-up|0|||
126094010|NCT01519089|453639088|FG000|Overall Study|Withdrawal by Subject|0|||
125879070|NCT03597347|452853544|FG002|Overall Study|Withdrawal by Subject|0|||
125879071|NCT03597347|452853542|FG000|Overall Study|Withdrawal due to Covid-19|3|||
126244033|NCT03496623|454184842|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
126244034|NCT03496623|454184843|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
126244035|NCT03496623|454184844|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
126244036|NCT03496623|454184845|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
126244037|NCT03496623|454184846|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
126244038|NCT03496623|454184842|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126094011|NCT01519089|453639089|FG001|Overall Study|Withdrawal by Subject|2|||
126244039|NCT03496623|454184843|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
126244040|NCT03496623|454184844|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126244041|NCT03496623|454184845|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126244042|NCT03496623|454184846|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126244043|NCT00794963|454184847|FG000|Overall Study|Withdrawal by Subject|1|||
126244044|NCT00794963|454184848|FG001|Overall Study|Withdrawal by Subject|4|||
126244045|NCT03181594|454184857|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
126244046|NCT03181594|454184857|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
126244047|NCT03181594|454184857|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
126244048|NCT03181594|454184857|FG000|Initial Study Protocol (12-month FU)|Death|1|||
126094012|NCT01519089|453639088|FG000|Overall Study|Other|2|||
126094013|NCT01519089|453639089|FG001|Overall Study|Other|6|||
126094014|NCT01519089|453639088|FG000|Overall Study|Not received study drug|0|||
126094015|NCT01519089|453639089|FG001|Overall Study|Not received study drug|1|||
126094016|NCT00127205|453639090|FG000|Overall Study|Adverse Event|228|||
126094017|NCT00127205|453639091|FG001|Overall Study|Adverse Event|387|||
126094018|NCT00127205|453639092|FG002|Overall Study|Adverse Event|273|||
126094019|NCT00127205|453639090|FG000|Overall Study|Death|8|||
126094020|NCT00127205|453639091|FG001|Overall Study|Death|6|||
126094021|NCT00127205|453639092|FG002|Overall Study|Death|5|||
126094022|NCT00127205|453639090|FG000|Overall Study|Withdrawal by Subject|318|||
126094023|NCT00127205|453639091|FG001|Overall Study|Withdrawal by Subject|310|||
126094024|NCT00127205|453639092|FG002|Overall Study|Withdrawal by Subject|172|||
126094025|NCT00127205|453639090|FG000|Overall Study|Other-non protocol specified|142|||
126094026|NCT00127205|453639091|FG001|Overall Study|Other-non protocol specified|129|||
126094027|NCT00127205|453639092|FG002|Overall Study|Other-non protocol specified|77|||
126094028|NCT00127205|453639090|FG000|Overall Study|Data not reported|6|||
126094029|NCT00127205|453639091|FG001|Overall Study|Data not reported|10|||
126094030|NCT00127205|453639092|FG002|Overall Study|Data not reported|1|||
126094031|NCT00127205|453639090|FG000|Overall Study|Progression|127|||
126094032|NCT00127205|453639091|FG001|Overall Study|Progression|131|||
126094033|NCT00127205|453639092|FG002|Overall Study|Progression|84|||
126094034|NCT00307684|453639096|FG000|Open Label Phase|Lack of Efficacy|0|||
126094035|NCT00307684|453639097|FG001|Open Label Phase|Lack of Efficacy|0|||
126094036|NCT00307684|453639098|FG002|Open Label Phase|Lack of Efficacy|3|||
126094037|NCT00307684|453639096|FG000|Open Label Phase|Adverse Event|0|||
126094038|NCT00307684|453639097|FG001|Open Label Phase|Adverse Event|0|||
126094039|NCT00307684|453639098|FG002|Open Label Phase|Adverse Event|16|||
126094040|NCT00307684|453639096|FG000|Open Label Phase|Withdrawal by Subject|0|||
126094041|NCT00307684|453639097|FG001|Open Label Phase|Withdrawal by Subject|0|||
126094042|NCT00307684|453639098|FG002|Open Label Phase|Withdrawal by Subject|15|||
126094043|NCT00307684|453639096|FG000|Open Label Phase|Lost to Follow-up|0|||
126094044|NCT00307684|453639097|FG001|Open Label Phase|Lost to Follow-up|0|||
126094045|NCT00307684|453639098|FG002|Open Label Phase|Lost to Follow-up|11|||
126094046|NCT00307684|453639096|FG000|Open Label Phase|non compliance|0|||
126094047|NCT00307684|453639097|FG001|Open Label Phase|non compliance|0|||
126094048|NCT00307684|453639098|FG002|Open Label Phase|non compliance|5|||
126094049|NCT00307684|453639096|FG000|Open Label Phase|other|0|||
126094050|NCT00307684|453639097|FG001|Open Label Phase|other|0|||
126094051|NCT00307684|453639098|FG002|Open Label Phase|other|6|||
126094052|NCT00307684|453639096|FG000|Double Blind Phase|Lack of Efficacy|2|||
126094053|NCT00307684|453639097|FG001|Double Blind Phase|Lack of Efficacy|5|||
126094054|NCT00307684|453639098|FG002|Double Blind Phase|Lack of Efficacy|0|||
126094055|NCT03377699|453639099|FG000|Overall Study|Withdrawal by Subject|2|||
126094056|NCT03377699|453639100|FG001|Overall Study|Withdrawal by Subject|9|||
126094057|NCT03377699|453639099|FG000|Overall Study|Lost to Follow-up|1|||
126094058|NCT03377699|453639100|FG001|Overall Study|Lost to Follow-up|1|||
126094059|NCT03377699|453639099|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
126094060|NCT03377699|453639100|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
126094061|NCT03377699|453639099|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
126094062|NCT03377699|453639100|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
126094063|NCT03377699|453639099|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
126094064|NCT03377699|453639100|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
126094065|NCT03377699|453639099|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
126094066|NCT03377699|453639100|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
126094067|NCT02580305|453639101|FG000|Overall Study|Adverse Event|15|||
126094068|NCT02580305|453639102|FG001|Overall Study|Adverse Event|19|||
126094069|NCT02580305|453639103|FG002|Overall Study|Adverse Event|10|||
126094070|NCT02580305|453639101|FG000|Overall Study|Lack of Efficacy|5|||
126094071|NCT02580305|453639102|FG001|Overall Study|Lack of Efficacy|0|||
126094072|NCT02580305|453639103|FG002|Overall Study|Lack of Efficacy|2|||
126094073|NCT02580305|453639101|FG000|Overall Study|Protocol Violation|4|||
126094074|NCT02580305|453639102|FG001|Overall Study|Protocol Violation|9|||
126094075|NCT02580305|453639103|FG002|Overall Study|Protocol Violation|6|||
126094076|NCT02580305|453639101|FG000|Overall Study|Lost to Follow-up|4|||
126094077|NCT02580305|453639102|FG001|Overall Study|Lost to Follow-up|4|||
126094078|NCT02580305|453639103|FG002|Overall Study|Lost to Follow-up|2|||
126094079|NCT02580305|453639101|FG000|Overall Study|Withdrawal by Subject|11|||
126094080|NCT02580305|453639102|FG001|Overall Study|Withdrawal by Subject|9|||
126094081|NCT02580305|453639103|FG002|Overall Study|Withdrawal by Subject|7|||
126094082|NCT02580305|453639101|FG000|Overall Study|Randomized in error and never treated|4|||
126094083|NCT02580305|453639102|FG001|Overall Study|Randomized in error and never treated|8|||
126094084|NCT02580305|453639103|FG002|Overall Study|Randomized in error and never treated|5|||
126094085|NCT00224887|453639104|FG000|Overall Study|Pregnancy|6|||
126094086|NCT00224887|453639105|FG001|Overall Study|Pregnancy|6|||
126094087|NCT03582943|453639110|FG000|Allocated to Groups|Withdrawal by Subject|1|||
126094088|NCT03582943|453639111|FG001|Allocated to Groups|Withdrawal by Subject|1|||
126094089|NCT03582943|453639110|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
126094090|NCT03582943|453639111|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
126094091|NCT03582943|453639110|FG000|Analyzed|Protocol Violation|4|||
126094092|NCT03582943|453639111|FG001|Analyzed|Protocol Violation|1|||
126094093|NCT05032872|453639112|FG000|Overall Study|Adverse Event|1|||
126094094|NCT05032872|453639113|FG001|Overall Study|Adverse Event|0|||
126094095|NCT05032872|453639112|FG000|Overall Study|Lost to Follow-up|2|||
126094096|NCT05032872|453639113|FG001|Overall Study|Lost to Follow-up|4|||
126094097|NCT05032872|453639112|FG000|Overall Study|Withdrawal by Subject|4|||
126094098|NCT05032872|453639113|FG001|Overall Study|Withdrawal by Subject|3|||
126094099|NCT00488475|453639114|FG000|Overall Study|Other|1754|||
126094100|NCT00798590|453639135|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
126094101|NCT00798590|453639136|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
126094102|NCT01163292|453639142|FG000|Overall Study|Lack of Efficacy|9|||
126094103|NCT01163292|453639143|FG001|Overall Study|Lack of Efficacy|0|||
126094104|NCT01163292|453639142|FG000|Overall Study|Adverse Event|6|||
126094105|NCT01163292|453639143|FG001|Overall Study|Adverse Event|0|||
126094106|NCT01163292|453639142|FG000|Overall Study|Initiation of biological therapy|0|||
126094107|NCT01163292|453639143|FG001|Overall Study|Initiation of biological therapy|15|||
126094108|NCT01163292|453639142|FG000|Overall Study|Sufficient response to adalimumab|8|||
126094109|NCT01163292|453639143|FG001|Overall Study|Sufficient response to adalimumab|0|||
126094110|NCT01163292|453639142|FG000|Overall Study|Refusal to receive adalimumab|7|||
126094111|NCT01163292|453639143|FG001|Overall Study|Refusal to receive adalimumab|0|||
126094112|NCT01163292|453639142|FG000|Overall Study|Economic reasons|6|||
126094113|NCT01163292|453639143|FG001|Overall Study|Economic reasons|0|||
126094114|NCT01163292|453639142|FG000|Overall Study|No further visits|5|||
126094115|NCT01163292|453639143|FG001|Overall Study|No further visits|7|||
126094116|NCT03223662|453639144|FG000|Overall Study|Physician Decision|1|||
126094117|NCT03223662|453639144|FG000|Overall Study|Study closure|1|||
126094118|NCT02217475|453639145|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
126094119|NCT02217475|453639146|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
126094120|NCT02217475|453639147|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
126094121|NCT02217475|453639145|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
126094122|NCT02217475|453639146|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
126094123|NCT02217475|453639147|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
126094124|NCT02217475|453639145|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
125879072|NCT03597347|452853543|FG001|Overall Study|Withdrawal due to Covid-19|0|||
125879073|NCT03597347|452853544|FG002|Overall Study|Withdrawal due to Covid-19|0|||
126026336|NCT03584516|453391644|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126026337|NCT03584516|453391645|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126026338|NCT03584516|453391646|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126026339|NCT03584516|453391647|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
126094125|NCT02217475|453639146|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
126094126|NCT02217475|453639147|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
126094127|NCT02217475|453639145|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
126094128|NCT02217475|453639146|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
126094129|NCT02217475|453639147|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
126094130|NCT02217475|453639145|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
126094131|NCT02217475|453639146|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
126094132|NCT02217475|453639147|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
126094133|NCT02217475|453639145|FG000|Discontinued After Period 1|Adverse Event|1|||
126094134|NCT02217475|453639146|FG001|Discontinued After Period 1|Adverse Event|2|||
126094135|NCT02217475|453639147|FG002|Discontinued After Period 1|Adverse Event|0|||
126094136|NCT02217475|453639145|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
126094137|NCT02217475|453639146|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
126094138|NCT02217475|453639147|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
126094139|NCT02217475|453639145|FG000|Discontinued After Period 1|Physician Decision|0|||
126094140|NCT02217475|453639146|FG001|Discontinued After Period 1|Physician Decision|0|||
126094141|NCT02217475|453639147|FG002|Discontinued After Period 1|Physician Decision|1|||
126094142|NCT02217475|453639145|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
126094143|NCT02217475|453639146|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
126094144|NCT02217475|453639147|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
126094145|NCT02217475|453639145|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
126094146|NCT02217475|453639146|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
126094147|NCT02217475|453639147|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
126094148|NCT02217475|453639145|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
126094149|NCT02217475|453639146|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
126094150|NCT02217475|453639147|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
126094151|NCT02217475|453639145|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
126094152|NCT02217475|453639146|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
126094153|NCT02217475|453639147|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
126094154|NCT02217475|453639145|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
126094155|NCT02217475|453639146|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
126094156|NCT02217475|453639147|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
126094157|NCT02643472|453639148|FG000|Overall Study|Death|2|||
126094158|NCT02643472|453639149|FG001|Overall Study|Death|5|||
126094159|NCT02643472|453639148|FG000|Overall Study|Withdrawal by Subject|3|||
126094160|NCT02643472|453639149|FG001|Overall Study|Withdrawal by Subject|2|||
126094161|NCT02643472|453639148|FG000|Overall Study|Protocol Violation|0|||
126094162|NCT02643472|453639149|FG001|Overall Study|Protocol Violation|1|||
126094163|NCT02643472|453639148|FG000|Overall Study|Lost to Follow-up|22|||
126094164|NCT02643472|453639149|FG001|Overall Study|Lost to Follow-up|26|||
126094165|NCT01012414|453639150|FG000|Overall Study|Withdrawal by Subject|2|||
126094166|NCT01012414|453639150|FG000|Overall Study|Lost to Follow-up|1|||
126094167|NCT01012414|453639150|FG000|Overall Study|Trial was stopped before completed|7|||
126094168|NCT00506441|453639151|FG000|Period 1; Open-label Period|Adverse Event|21|||
126094169|NCT00506441|453639152|FG001|Period 1; Open-label Period|Adverse Event|0|||
126094170|NCT00506441|453639151|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
126094171|NCT00506441|453639152|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
126094172|NCT00506441|453639151|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
126094173|NCT00506441|453639152|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
126244049|NCT03181594|454184857|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
126244050|NCT03181594|454184857|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
126244051|NCT01527006|454184860|FG000|Core Study|Adverse Event|0|||
126244052|NCT01527006|454184861|FG001|Core Study|Adverse Event|2|||
126244053|NCT01527006|454184860|FG000|Core Study|Lost to Follow-up|0|||
126244054|NCT01527006|454184861|FG001|Core Study|Lost to Follow-up|1|||
126244055|NCT01527006|454184860|FG000|Core Study|Subject Choice|1|||
126244056|NCT01527006|454184861|FG001|Core Study|Subject Choice|0|||
126244057|NCT01527006|454184860|FG000|Core Study|Inadequate Therapeutic Effect|1|||
126244058|NCT01527006|454184861|FG001|Core Study|Inadequate Therapeutic Effect|0|||
126244059|NCT01527006|454184860|FG000|Core Study|Withdrawal by Subject|0|||
126244060|NCT01527006|454184861|FG001|Core Study|Withdrawal by Subject|1|||
126244061|NCT01527006|454184860|FG000|Core Study|Other|0|||
126244062|NCT01527006|454184861|FG001|Core Study|Other|2|||
126244063|NCT01527006|454184860|FG000|Extension Phase|Adverse Event|4|||
126244064|NCT01527006|454184861|FG001|Extension Phase|Adverse Event|2|||
126244065|NCT01527006|454184860|FG000|Extension Phase|Lost to Follow-up|0|||
126244066|NCT01527006|454184861|FG001|Extension Phase|Lost to Follow-up|1|||
126244067|NCT01527006|454184860|FG000|Extension Phase|Subject Choice|1|||
126244068|NCT01527006|454184861|FG001|Extension Phase|Subject Choice|1|||
126244069|NCT01527006|454184860|FG000|Extension Phase|Inadequate therapeutic effect|1|||
126357458|NCT02018887|454602100|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
126094174|NCT00506441|453639151|FG000|Period 1; Open-label Period|Physician Decision|5|||
126094175|NCT00506441|453639152|FG001|Period 1; Open-label Period|Physician Decision|0|||
126094176|NCT00506441|453639151|FG000|Period 1; Open-label Period|Protocol Violation|9|||
126094177|NCT00506441|453639152|FG001|Period 1; Open-label Period|Protocol Violation|0|||
126094178|NCT00506441|453639151|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
126094179|NCT00506441|453639152|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
126094180|NCT00506441|453639151|FG000|Period 1; Open-label Period|Other Reasons|13|||
126094181|NCT00506441|453639152|FG001|Period 1; Open-label Period|Other Reasons|0|||
126094182|NCT00506441|453639151|FG000|Period 2; Double-blind Period|Adverse Event|0|||
126244070|NCT01527006|454184861|FG001|Extension Phase|Inadequate therapeutic effect|1|||
126244071|NCT01527006|454184860|FG000|Extension Phase|Other|0|||
126244072|NCT01527006|454184861|FG001|Extension Phase|Other|3|||
126244073|NCT03247972|454184862|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
126026340|NCT03584516|453391648|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126244074|NCT03247972|454184862|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
126244075|NCT00123734|454184864|FG000|Overall Study|Death|3|||
126244076|NCT00123734|454184864|FG000|Overall Study|Lost to Follow-up|3|||
126244077|NCT00123734|454184864|FG000|Overall Study|Dropout|1|||
126244078|NCT00123734|454184864|FG000|Overall Study|Withdrawal by Subject|1|||
126244079|NCT00113386|454184865|FG000|Overall Study|Withdrawal by Subject|1|||
126244080|NCT00113386|454184866|FG001|Overall Study|Withdrawal by Subject|0|||
126244081|NCT00113386|454184865|FG000|Overall Study|Physician Decision|0|||
126244082|NCT00113386|454184866|FG001|Overall Study|Physician Decision|1|||
126244083|NCT00113386|454184865|FG000|Overall Study|Toxicity|3|||
126244084|NCT00113386|454184866|FG001|Overall Study|Toxicity|0|||
126244085|NCT00113386|454184865|FG000|Overall Study|Ineligible|1|||
126244086|NCT00113386|454184866|FG001|Overall Study|Ineligible|2|||
126244087|NCT00113386|454184865|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
126244088|NCT00113386|454184866|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
126244089|NCT00834340|454184867|FG000|Washout|Adverse Event|1|||
126244090|NCT00834340|454184868|FG001|Washout|Adverse Event|0|||
126244091|NCT00834340|454184867|FG000|Washout|Withdrawal by Subject|1|||
126244092|NCT00834340|454184868|FG001|Washout|Withdrawal by Subject|0|||
126244093|NCT01175018|454184870|FG000|Overall Study|Adverse Event|3|||
126244094|NCT01175018|454184871|FG001|Overall Study|Adverse Event|1|||
126244095|NCT00840073|454184875|FG000|Second Intervention|Missed 72 hour blood draw|1|||
126244096|NCT00840073|454184876|FG001|Second Intervention|Missed 72 hour blood draw|1|||
126244097|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
126244098|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
126244099|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
126244100|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
126244101|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
126244102|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
126244103|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126244104|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126244105|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
126244106|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
126244107|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
126244108|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
126244109|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
126244110|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
126244111|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
126244112|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
126244113|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
126244114|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
126244115|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
126244116|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
126244117|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Death|0|||
126244118|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Death|1|||
126244119|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Death|0|||
126244120|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Death|0|||
126244121|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
126244122|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
126244123|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
126244124|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
126244125|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
126244126|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
126244127|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
126244128|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
126244129|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126244130|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
126244131|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126244132|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126244133|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
126244134|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
126026341|NCT03584516|453391649|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126026342|NCT03584516|453391644|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126244135|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
126244136|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
126244137|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
126244138|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
126244139|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
126244140|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
126244141|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126244142|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126244143|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
126244144|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126244145|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
126244146|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
126244147|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
126244148|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
126244149|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126244150|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126244151|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
126244152|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126244153|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
126244154|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
126244155|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
126244156|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
126244157|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126244158|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126244159|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
126244160|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126244161|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126244162|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126244163|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126244164|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
126244165|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126244166|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126244167|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126244168|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
126244169|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
126244170|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
126244171|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
126244172|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
126244173|NCT00841698|454184888|FG000|First Intervention|Withdrawal by Subject|1|||
126244174|NCT00841698|454184889|FG001|First Intervention|Withdrawal by Subject|0|||
126244175|NCT00185458|454184890|FG000|Contraception Phase|Adverse Event|37|||
126244176|NCT00185458|454184890|FG000|Contraception Phase|Lost to Follow-up|10|||
126244177|NCT00185458|454184890|FG000|Contraception Phase|Protocol Violation|2|||
126244178|NCT00185458|454184890|FG000|Contraception Phase|Physician Decision|2|||
126244179|NCT00185458|454184890|FG000|Contraception Phase|Withdrawal by Subject|7|||
126244180|NCT00185458|454184890|FG000|HRT Phase|Adverse Event|18|||
126244181|NCT00185458|454184890|FG000|HRT Phase|Lost to Follow-up|4|||
126244182|NCT00185458|454184890|FG000|HRT Phase|Protocol Violation|2|||
126244183|NCT00185458|454184890|FG000|HRT Phase|Withdrawal by Subject|3|||
126244184|NCT00251979|454184891|FG000|Overall Study|Protocol Violation|3|||
126244185|NCT00251979|454184892|FG001|Overall Study|Protocol Violation|5|||
126244186|NCT00251979|454184891|FG000|Overall Study|Adverse Event|11|||
126244187|NCT00251979|454184892|FG001|Overall Study|Adverse Event|17|||
126244188|NCT00251979|454184891|FG000|Overall Study|Withdrawal by Subject|13|||
126244189|NCT00251979|454184892|FG001|Overall Study|Withdrawal by Subject|7|||
126244190|NCT00251979|454184891|FG000|Overall Study|Lost to Follow-up|8|||
126244191|NCT00251979|454184892|FG001|Overall Study|Lost to Follow-up|6|||
126244192|NCT00251979|454184891|FG000|Overall Study|Death|3|||
126244193|NCT00251979|454184892|FG001|Overall Study|Death|5|||
126244194|NCT01576042|454184893|FG000|Overall Study|Physician Decision|2|||
126244195|NCT01576042|454184894|FG001|Overall Study|Physician Decision|0|||
126244196|NCT00835536|454184901|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
126244197|NCT00835536|454184902|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
126244198|NCT00657553|454184903|FG000|Overall Study|low accrual, no analysis run|5|||
126244199|NCT00657553|454184904|FG001|Overall Study|low accrual, no analysis run|5|||
126244200|NCT03173547|454184905|FG000|Overall Study|Adverse Event|2|||
126244201|NCT03173547|454184906|FG001|Overall Study|Adverse Event|0|||
126244202|NCT03173547|454184905|FG000|Overall Study|Withdrawal by Subject|2|||
126244203|NCT03173547|454184906|FG001|Overall Study|Withdrawal by Subject|2|||
126244204|NCT00446563|454184907|FG000|Overall Study|Adverse Event|4|||
126244205|NCT00446563|454184908|FG001|Overall Study|Adverse Event|3|||
126244206|NCT00446563|454184907|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126244207|NCT00446563|454184908|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126244208|NCT00446563|454184907|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126357459|NCT01058005|454602101|FG000|Overall Study|Adverse Event|0|||
126244209|NCT00446563|454184908|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126244210|NCT00446563|454184907|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126244211|NCT00446563|454184908|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126244212|NCT00446563|454184907|FG000|Overall Study|Withdrawal by Subject|2|||
126244213|NCT00446563|454184908|FG001|Overall Study|Withdrawal by Subject|1|||
126244214|NCT00446563|454184907|FG000|Overall Study|Administrative problems|0|||
126244215|NCT00446563|454184908|FG001|Overall Study|Administrative problems|1|||
126244216|NCT03769025|454184909|FG000|Overall Study|Withdrawal by Subject|1|||
126244217|NCT03769025|454184910|FG001|Overall Study|Withdrawal by Subject|1|||
126244218|NCT03769025|454184909|FG000|Overall Study|Lost to Follow-up|4|||
126244219|NCT03769025|454184910|FG001|Overall Study|Lost to Follow-up|3|||
126244220|NCT01169558|454184911|FG000|Overall Study|Disease progression|98|||
126244221|NCT01169558|454184911|FG000|Overall Study|Adverse Event|25|||
126244222|NCT01169558|454184911|FG000|Overall Study|Withdrawal of Consent|8|||
126244223|NCT01169558|454184911|FG000|Overall Study|Medical Decision|7|||
126244224|NCT01169558|454184911|FG000|Overall Study|Stable Disease|4|||
126244225|NCT01169558|454184911|FG000|Overall Study|Lost to Follow-up|4|||
126244226|NCT01169558|454184911|FG000|Overall Study|Need for Surgery|4|||
126244227|NCT01169558|454184911|FG000|Overall Study|Non-compliance|2|||
126244228|NCT01169558|454184911|FG000|Overall Study|Protocol Violation|2|||
126244229|NCT01169558|454184911|FG000|Overall Study|Partial response|2|||
126244230|NCT00838539|454184917|FG000|Overall Study|Disease Progression|2|||
126244231|NCT00838539|454184918|FG001|Overall Study|Disease Progression|4|||
126244232|NCT00838539|454184919|FG002|Overall Study|Disease Progression|3|||
126244233|NCT00838539|454184920|FG003|Overall Study|Disease Progression|2|||
126244234|NCT00838539|454184921|FG004|Overall Study|Disease Progression|4|||
126244235|NCT00838539|454184922|FG005|Overall Study|Disease Progression|2|||
126244236|NCT00838539|454184923|FG006|Overall Study|Disease Progression|3|||
126244237|NCT00838539|454184924|FG007|Overall Study|Disease Progression|4|||
126244238|NCT00838539|454184925|FG008|Overall Study|Disease Progression|4|||
126244239|NCT00838539|454184926|FG009|Overall Study|Disease Progression|5|||
126244240|NCT00838539|454184927|FG010|Overall Study|Disease Progression|1|||
126244241|NCT00838539|454184928|FG011|Overall Study|Disease Progression|4|||
126244242|NCT00838539|454184917|FG000|Overall Study|Adverse Event|1|||
126244243|NCT00838539|454184918|FG001|Overall Study|Adverse Event|1|||
126244244|NCT00838539|454184919|FG002|Overall Study|Adverse Event|1|||
126244245|NCT00838539|454184920|FG003|Overall Study|Adverse Event|1|||
126244246|NCT00838539|454184921|FG004|Overall Study|Adverse Event|2|||
126244247|NCT00838539|454184922|FG005|Overall Study|Adverse Event|1|||
126244248|NCT00838539|454184923|FG006|Overall Study|Adverse Event|0|||
126244249|NCT00838539|454184924|FG007|Overall Study|Adverse Event|2|||
126244250|NCT00838539|454184925|FG008|Overall Study|Adverse Event|0|||
126244251|NCT00838539|454184926|FG009|Overall Study|Adverse Event|1|||
126244252|NCT00838539|454184927|FG010|Overall Study|Adverse Event|2|||
126244253|NCT00838539|454184928|FG011|Overall Study|Adverse Event|0|||
126244254|NCT00838539|454184917|FG000|Overall Study|Withdrawal by Subject|0|||
126244255|NCT00838539|454184918|FG001|Overall Study|Withdrawal by Subject|1|||
126244256|NCT00838539|454184919|FG002|Overall Study|Withdrawal by Subject|0|||
126244257|NCT00838539|454184920|FG003|Overall Study|Withdrawal by Subject|0|||
126244258|NCT00838539|454184921|FG004|Overall Study|Withdrawal by Subject|0|||
126244259|NCT00838539|454184922|FG005|Overall Study|Withdrawal by Subject|0|||
126244260|NCT00838539|454184923|FG006|Overall Study|Withdrawal by Subject|0|||
125879074|NCT03597347|452853542|FG000|Overall Study|Sponsor decision to terminate study|3|||
125879075|NCT03597347|452853543|FG001|Overall Study|Sponsor decision to terminate study|2|||
125879076|NCT03597347|452853544|FG002|Overall Study|Sponsor decision to terminate study|4|||
126026343|NCT03584516|453391645|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126026344|NCT03584516|453391646|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
125879077|NCT02532517|452853545|FG000|Overall Study|Did not complete 24-Month visit|4|||
126244261|NCT00838539|454184924|FG007|Overall Study|Withdrawal by Subject|0|||
126244262|NCT00838539|454184925|FG008|Overall Study|Withdrawal by Subject|0|||
126244263|NCT00838539|454184926|FG009|Overall Study|Withdrawal by Subject|1|||
126244264|NCT00838539|454184927|FG010|Overall Study|Withdrawal by Subject|2|||
126244265|NCT00838539|454184928|FG011|Overall Study|Withdrawal by Subject|0|||
126244266|NCT00838539|454184917|FG000|Overall Study|Death|0|||
126244267|NCT00838539|454184918|FG001|Overall Study|Death|0|||
126244268|NCT00838539|454184919|FG002|Overall Study|Death|0|||
126244269|NCT00838539|454184920|FG003|Overall Study|Death|0|||
126244270|NCT00838539|454184921|FG004|Overall Study|Death|0|||
126244271|NCT00838539|454184922|FG005|Overall Study|Death|0|||
126244272|NCT00838539|454184923|FG006|Overall Study|Death|1|||
126244273|NCT00838539|454184924|FG007|Overall Study|Death|0|||
126244274|NCT00838539|454184925|FG008|Overall Study|Death|0|||
126244275|NCT00838539|454184926|FG009|Overall Study|Death|0|||
126244276|NCT00838539|454184927|FG010|Overall Study|Death|0|||
126244277|NCT00838539|454184928|FG011|Overall Study|Death|0|||
126244278|NCT00838539|454184917|FG000|Overall Study|Physician Decision|0|||
126244279|NCT00838539|454184918|FG001|Overall Study|Physician Decision|0|||
126244280|NCT00838539|454184919|FG002|Overall Study|Physician Decision|0|||
126244281|NCT00838539|454184920|FG003|Overall Study|Physician Decision|0|||
126244282|NCT00838539|454184921|FG004|Overall Study|Physician Decision|0|||
126244283|NCT00838539|454184922|FG005|Overall Study|Physician Decision|0|||
126244284|NCT00838539|454184923|FG006|Overall Study|Physician Decision|0|||
126244285|NCT00838539|454184924|FG007|Overall Study|Physician Decision|0|||
126244286|NCT00838539|454184925|FG008|Overall Study|Physician Decision|1|||
126244287|NCT00838539|454184926|FG009|Overall Study|Physician Decision|0|||
126244288|NCT00838539|454184927|FG010|Overall Study|Physician Decision|0|||
126244289|NCT00838539|454184928|FG011|Overall Study|Physician Decision|0|||
126244290|NCT00838539|454184917|FG000|Overall Study|Clinical Progression|0|||
126244291|NCT00838539|454184918|FG001|Overall Study|Clinical Progression|0|||
126244292|NCT00838539|454184919|FG002|Overall Study|Clinical Progression|0|||
126244293|NCT00838539|454184920|FG003|Overall Study|Clinical Progression|0|||
126244294|NCT00838539|454184921|FG004|Overall Study|Clinical Progression|0|||
126244295|NCT00838539|454184922|FG005|Overall Study|Clinical Progression|0|||
126244296|NCT00838539|454184923|FG006|Overall Study|Clinical Progression|1|||
126244297|NCT00838539|454184924|FG007|Overall Study|Clinical Progression|0|||
126244298|NCT00838539|454184925|FG008|Overall Study|Clinical Progression|0|||
126244299|NCT00838539|454184926|FG009|Overall Study|Clinical Progression|0|||
126244300|NCT00838539|454184927|FG010|Overall Study|Clinical Progression|0|||
126244301|NCT00838539|454184928|FG011|Overall Study|Clinical Progression|0|||
126244302|NCT00838539|454184917|FG000|Overall Study|Symptomatic Deterioration|0|||
126244303|NCT00838539|454184918|FG001|Overall Study|Symptomatic Deterioration|0|||
126244304|NCT00838539|454184919|FG002|Overall Study|Symptomatic Deterioration|1|||
126244305|NCT00838539|454184920|FG003|Overall Study|Symptomatic Deterioration|1|||
126244306|NCT00838539|454184921|FG004|Overall Study|Symptomatic Deterioration|0|||
126244307|NCT00838539|454184922|FG005|Overall Study|Symptomatic Deterioration|1|||
126244308|NCT00838539|454184923|FG006|Overall Study|Symptomatic Deterioration|0|||
126244309|NCT00838539|454184924|FG007|Overall Study|Symptomatic Deterioration|0|||
126244310|NCT00838539|454184925|FG008|Overall Study|Symptomatic Deterioration|0|||
126244311|NCT00838539|454184926|FG009|Overall Study|Symptomatic Deterioration|1|||
126244312|NCT00838539|454184927|FG010|Overall Study|Symptomatic Deterioration|0|||
126244313|NCT00838539|454184928|FG011|Overall Study|Symptomatic Deterioration|0|||
126244314|NCT03123471|454184929|FG000|Placebo-controlled Phase|Adverse Event|3|||
126244315|NCT03123471|454184930|FG001|Placebo-controlled Phase|Adverse Event|8|||
126244316|NCT03123471|454184929|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
126244317|NCT03123471|454184930|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
126244318|NCT03123471|454184929|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
126244319|NCT03123471|454184930|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
126244320|NCT03123471|454184929|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
126244321|NCT03123471|454184930|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
126244322|NCT03123471|454184929|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
126026345|NCT03584516|453391647|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126026346|NCT03584516|453391648|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126244323|NCT03123471|454184930|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
126244324|NCT03123471|454184929|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
126244325|NCT03123471|454184930|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
126244326|NCT03123471|454184929|FG000|Placebo-controlled Phase|Miscellaneous|0|||
126244327|NCT03123471|454184930|FG001|Placebo-controlled Phase|Miscellaneous|1|||
126244328|NCT03123471|454184929|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
126244329|NCT03123471|454184930|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
126244330|NCT03123471|454184929|FG000|Apremilast Extension Phase|Adverse Event|1|||
126244331|NCT03123471|454184930|FG001|Apremilast Extension Phase|Adverse Event|5|||
126244332|NCT03123471|454184929|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
126244333|NCT03123471|454184930|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
126244334|NCT03123471|454184929|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
126244335|NCT03123471|454184930|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
126244336|NCT02957942|454184933|FG000|Overall Study|Withdrawal by Subject|0|||
126244337|NCT02957942|454184934|FG001|Overall Study|Withdrawal by Subject|1|||
126244338|NCT02957942|454184933|FG000|Overall Study|Practicing experiment protocol|0|||
126244339|NCT02957942|454184934|FG001|Overall Study|Practicing experiment protocol|6|||
126244340|NCT03238781|454184935|FG000|Overall Study|Adverse Event|1|||
126244341|NCT03238781|454184936|FG001|Overall Study|Adverse Event|1|||
126244342|NCT03238781|454184937|FG002|Overall Study|Adverse Event|2|||
126244343|NCT03238781|454184935|FG000|Overall Study|Lost to Follow-up|2|||
126244344|NCT03238781|454184936|FG001|Overall Study|Lost to Follow-up|1|||
126244345|NCT03238781|454184937|FG002|Overall Study|Lost to Follow-up|2|||
126244346|NCT03238781|454184935|FG000|Overall Study|Withdrawal by Subject|23|||
126244347|NCT03238781|454184936|FG001|Overall Study|Withdrawal by Subject|14|||
126244348|NCT03238781|454184937|FG002|Overall Study|Withdrawal by Subject|16|||
126244349|NCT03238781|454184935|FG000|Overall Study|Decision by sponsor|0|||
126244350|NCT03238781|454184936|FG001|Overall Study|Decision by sponsor|1|||
126244351|NCT03238781|454184937|FG002|Overall Study|Decision by sponsor|0|||
126244352|NCT01249651|454184941|FG000|Overall Study|Withdrawal by Subject|4|||
126244353|NCT01249651|454184941|FG000|Overall Study|Adverse Event|1|||
126244354|NCT01249651|454184941|FG000|Overall Study|Protocol Violation|1|||
126244355|NCT01249651|454184941|FG000|Overall Study|Sponsor Decision|1|||
126244356|NCT02820350|454184948|FG000|Overall Study|Withdrawal by Subject|3|||
126244357|NCT02820350|454184948|FG000|Overall Study|Death|4|||
126244358|NCT00787254|454184949|FG000|Overall Study|Adverse Event|24|||
126244359|NCT00787254|454184950|FG001|Overall Study|Adverse Event|23|||
126244360|NCT00787254|454184949|FG000|Overall Study|Protocol Violation|26|||
126244361|NCT00787254|454184950|FG001|Overall Study|Protocol Violation|23|||
126244362|NCT00787254|454184949|FG000|Overall Study|Withdrawal by Subject|16|||
126244363|NCT00787254|454184950|FG001|Overall Study|Withdrawal by Subject|11|||
126244364|NCT00787254|454184949|FG000|Overall Study|Lack of Efficacy|4|||
126244365|NCT00787254|454184950|FG001|Overall Study|Lack of Efficacy|15|||
126244366|NCT00787254|454184949|FG000|Overall Study|NSAIDs discontinuation|1|||
126244367|NCT00787254|454184950|FG001|Overall Study|NSAIDs discontinuation|2|||
126244368|NCT00787254|454184949|FG000|Overall Study|Institution closed|1|||
126244369|NCT00787254|454184950|FG001|Overall Study|Institution closed|0|||
126244370|NCT00787254|454184949|FG000|Overall Study|Physician Decision|4|||
126244371|NCT00787254|454184950|FG001|Overall Study|Physician Decision|8|||
126244372|NCT00316186|454184961|FG000|Overall Study|Adverse Event|6|||
126244373|NCT00316186|454184961|FG000|Overall Study|Disease Progression|4|||
126244374|NCT00316186|454184961|FG000|Overall Study|Lost to Follow-up|1|||
126244375|NCT00316186|454184961|FG000|Overall Study|Other|1|||
126244376|NCT02301975|454186887|FG000|Overall Study|Adverse Event|8|||
126244377|NCT02301975|454186888|FG001|Overall Study|Adverse Event|3|||
126244378|NCT02301975|454186889|FG002|Overall Study|Adverse Event|2|||
126244379|NCT02301975|454186887|FG000|Overall Study|Lack of Efficacy|1|||
126244380|NCT02301975|454186888|FG001|Overall Study|Lack of Efficacy|1|||
126244381|NCT02301975|454186889|FG002|Overall Study|Lack of Efficacy|1|||
126244382|NCT02301975|454186887|FG000|Overall Study|Protocol Violation|3|||
126244383|NCT02301975|454186888|FG001|Overall Study|Protocol Violation|5|||
126244384|NCT02301975|454186889|FG002|Overall Study|Protocol Violation|3|||
126244385|NCT02301975|454186887|FG000|Overall Study|Lost to Follow-up|0|||
126244386|NCT02301975|454186888|FG001|Overall Study|Lost to Follow-up|2|||
126244387|NCT02301975|454186889|FG002|Overall Study|Lost to Follow-up|2|||
126244388|NCT02301975|454186887|FG000|Overall Study|Physician Decision|4|||
126244389|NCT02301975|454186888|FG001|Overall Study|Physician Decision|2|||
126244390|NCT02301975|454186889|FG002|Overall Study|Physician Decision|3|||
126244391|NCT02301975|454186887|FG000|Overall Study|Withdrawal by Subject|15|||
126244392|NCT02301975|454186888|FG001|Overall Study|Withdrawal by Subject|12|||
126244393|NCT02301975|454186889|FG002|Overall Study|Withdrawal by Subject|11|||
126244394|NCT03733730|454186890|FG000|Overall Study|Lost to Follow-up|1|||
126244395|NCT03733730|454186891|FG001|Overall Study|Lost to Follow-up|32|||
126244396|NCT03733730|454186890|FG000|Overall Study|Other|1|||
126244397|NCT03733730|454186891|FG001|Overall Study|Other|0|||
126244398|NCT03733730|454186890|FG000|Overall Study|Adverse Event|0|||
126244399|NCT03733730|454186891|FG001|Overall Study|Adverse Event|4|||
126244400|NCT03733730|454186890|FG000|Overall Study|Death|0|||
126244401|NCT03733730|454186891|FG001|Overall Study|Death|5|||
126244402|NCT03733730|454186890|FG000|Overall Study|Withdrawal by Subject|0|||
126244403|NCT03733730|454186891|FG001|Overall Study|Withdrawal by Subject|8|||
126244404|NCT03635320|454186892|FG000|Overall Study|not implanted the device|1|||
126244405|NCT03635320|454186893|FG001|Overall Study|not implanted the device|2|||
126244406|NCT03635320|454186892|FG000|Overall Study|Withdrawal by Subject|11|||
126244407|NCT03635320|454186893|FG001|Overall Study|Withdrawal by Subject|6|||
126244408|NCT00835575|454186896|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
126244409|NCT00835575|454186897|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
126244410|NCT03606174|454186898|FG000|Overall Study|Death|37|||
126244411|NCT03606174|454186899|FG001|Overall Study|Death|15|||
126244412|NCT03606174|454186900|FG002|Overall Study|Death|15|||
126244413|NCT03606174|454186901|FG003|Overall Study|Death|7|||
126244414|NCT03606174|454186902|FG004|Overall Study|Death|35|||
126244415|NCT03606174|454186903|FG005|Overall Study|Death|12|||
126244416|NCT03606174|454186904|FG006|Overall Study|Death|35|||
126244417|NCT03606174|454186905|FG007|Overall Study|Death|8|||
126244418|NCT03606174|454186906|FG008|Overall Study|Death|5|||
126244419|NCT03606174|454186907|FG009|Overall Study|Death|3|||
126244420|NCT03606174|454186908|FG010|Overall Study|Death|0|||
126244421|NCT03606174|454186898|FG000|Overall Study|Lost to Follow-up|0|||
126244422|NCT03606174|454186899|FG001|Overall Study|Lost to Follow-up|0|||
126244423|NCT03606174|454186900|FG002|Overall Study|Lost to Follow-up|0|||
126244424|NCT03606174|454186901|FG003|Overall Study|Lost to Follow-up|0|||
126244425|NCT03606174|454186902|FG004|Overall Study|Lost to Follow-up|1|||
126244426|NCT03606174|454186903|FG005|Overall Study|Lost to Follow-up|1|||
126244427|NCT03606174|454186904|FG006|Overall Study|Lost to Follow-up|0|||
126244428|NCT03606174|454186905|FG007|Overall Study|Lost to Follow-up|0|||
126244429|NCT03606174|454186906|FG008|Overall Study|Lost to Follow-up|0|||
126244430|NCT03606174|454186907|FG009|Overall Study|Lost to Follow-up|0|||
126244431|NCT03606174|454186908|FG010|Overall Study|Lost to Follow-up|0|||
126244432|NCT03606174|454186898|FG000|Overall Study|Withdrawal by Subject|6|||
126244433|NCT03606174|454186899|FG001|Overall Study|Withdrawal by Subject|0|||
126244434|NCT03606174|454186900|FG002|Overall Study|Withdrawal by Subject|0|||
126244435|NCT03606174|454186901|FG003|Overall Study|Withdrawal by Subject|1|||
126244436|NCT03606174|454186902|FG004|Overall Study|Withdrawal by Subject|2|||
126244437|NCT03606174|454186903|FG005|Overall Study|Withdrawal by Subject|1|||
126244438|NCT03606174|454186904|FG006|Overall Study|Withdrawal by Subject|4|||
126244439|NCT03606174|454186905|FG007|Overall Study|Withdrawal by Subject|0|||
126244440|NCT03606174|454186906|FG008|Overall Study|Withdrawal by Subject|0|||
126244441|NCT03606174|454186907|FG009|Overall Study|Withdrawal by Subject|0|||
126244442|NCT03606174|454186908|FG010|Overall Study|Withdrawal by Subject|1|||
126244443|NCT03606174|454186898|FG000|Overall Study|Study Terminated by Sponsor|5|||
126244444|NCT03606174|454186899|FG001|Overall Study|Study Terminated by Sponsor|7|||
126244445|NCT03606174|454186900|FG002|Overall Study|Study Terminated by Sponsor|3|||
126244446|NCT03606174|454186901|FG003|Overall Study|Study Terminated by Sponsor|0|||
126244447|NCT03606174|454186902|FG004|Overall Study|Study Terminated by Sponsor|11|||
126244448|NCT03606174|454186903|FG005|Overall Study|Study Terminated by Sponsor|6|||
126026347|NCT03584516|453391649|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
126026348|NCT04868110|453391651|FG000|Overall Study|Withdrawal by Subject|3|||
126026349|NCT04868110|453391652|FG001|Overall Study|Withdrawal by Subject|4|||
126026350|NCT04511702|453391658|FG000|Overall Study|Lost to Follow-up|3|||
126026351|NCT04511702|453391659|FG001|Overall Study|Lost to Follow-up|0|||
126026352|NCT04511702|453391660|FG002|Overall Study|Lost to Follow-up|4|||
126026353|NCT04511702|453391658|FG000|Overall Study|Withdrawal by Subject|17|||
126026354|NCT04511702|453391659|FG001|Overall Study|Withdrawal by Subject|1|||
126026355|NCT04511702|453391660|FG002|Overall Study|Withdrawal by Subject|8|||
126026356|NCT01894061|453391661|FG000|Overall Study|Screen failure|1|||
126026357|NCT01894061|453391661|FG000|Overall Study|Withdrawal by Subject|1|||
126026358|NCT02840474|453391664|FG000|Overall Study|Lost to Follow-up|1|||
126026359|NCT02840474|453391665|FG001|Overall Study|Lost to Follow-up|0|||
126026360|NCT03192891|453391666|FG000|Overall Study|Lost to Follow-up|55|||
126026361|NCT05141903|453391667|FG000|Overall Study|Withdrawal by Subject|0|||
126026362|NCT05141903|453391668|FG001|Overall Study|Withdrawal by Subject|1|||
126026363|NCT05141903|453391669|FG002|Overall Study|Withdrawal by Subject|1|||
126026364|NCT05141903|453391670|FG003|Overall Study|Withdrawal by Subject|0|||
126026365|NCT05141903|453391671|FG004|Overall Study|Withdrawal by Subject|0|||
126026366|NCT05141903|453391667|FG000|Overall Study|Other|1|||
126026367|NCT05141903|453391668|FG001|Overall Study|Other|1|||
126026368|NCT05141903|453391669|FG002|Overall Study|Other|0|||
126026369|NCT05141903|453391670|FG003|Overall Study|Other|0|||
126026370|NCT05141903|453391671|FG004|Overall Study|Other|0|||
126026371|NCT03089398|453391674|FG000|Overall Study|Death|4|||
126026372|NCT03089398|453391675|FG001|Overall Study|Death|9|||
126026373|NCT03089398|453391674|FG000|Overall Study|Lost to Follow-up|21|||
126026374|NCT03089398|453391675|FG001|Overall Study|Lost to Follow-up|30|||
126026375|NCT03089398|453391674|FG000|Overall Study|Withdrawal by Subject|2|||
126026376|NCT03089398|453391675|FG001|Overall Study|Withdrawal by Subject|2|||
126026377|NCT05062265|453391676|FG000|Overall Study|Withdrawal by Subject|1|||
126244449|NCT03606174|454186904|FG006|Overall Study|Study Terminated by Sponsor|12|||
126244450|NCT03606174|454186905|FG007|Overall Study|Study Terminated by Sponsor|1|||
126244451|NCT03606174|454186906|FG008|Overall Study|Study Terminated by Sponsor|3|||
126244452|NCT03606174|454186907|FG009|Overall Study|Study Terminated by Sponsor|1|||
126244453|NCT03606174|454186908|FG010|Overall Study|Study Terminated by Sponsor|2|||
126244454|NCT03606174|454186898|FG000|Overall Study|Miscellaneous|1|||
126244455|NCT03606174|454186899|FG001|Overall Study|Miscellaneous|1|||
126244456|NCT03606174|454186900|FG002|Overall Study|Miscellaneous|0|||
126244457|NCT03606174|454186901|FG003|Overall Study|Miscellaneous|1|||
126244458|NCT03606174|454186902|FG004|Overall Study|Miscellaneous|4|||
126244459|NCT03606174|454186903|FG005|Overall Study|Miscellaneous|7|||
126244460|NCT03606174|454186904|FG006|Overall Study|Miscellaneous|5|||
126244461|NCT03606174|454186905|FG007|Overall Study|Miscellaneous|0|||
126244462|NCT03606174|454186906|FG008|Overall Study|Miscellaneous|0|||
126244463|NCT03606174|454186907|FG009|Overall Study|Miscellaneous|0|||
126244464|NCT03606174|454186908|FG010|Overall Study|Miscellaneous|1|||
126244465|NCT01609257|454186909|FG000|Overall Study|Lost to Follow-up|2|||
126244466|NCT01609257|454186910|FG001|Overall Study|Lost to Follow-up|1|||
126244467|NCT01609257|454186909|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
126244468|NCT01609257|454186910|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
126244469|NCT01609257|454186909|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
126244470|NCT01609257|454186910|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
126244471|NCT03049748|454186911|FG000|Overall Study|Lost to Follow-up|1|||
126244472|NCT03049748|454186912|FG001|Overall Study|Lost to Follow-up|0|||
126244473|NCT03049748|454186911|FG000|Overall Study|Death|3|||
126244474|NCT03049748|454186912|FG001|Overall Study|Death|0|||
126244475|NCT03049748|454186911|FG000|Overall Study|Withdrawal by Subject|0|||
126244476|NCT03049748|454186912|FG001|Overall Study|Withdrawal by Subject|3|||
126026378|NCT05062265|453391677|FG001|Overall Study|Withdrawal by Subject|0|||
126026379|NCT05439603|453391678|FG000|Overall Study|met withdrawal criteria|2|||
126244477|NCT03049748|454186911|FG000|Overall Study|Protocol Violation|0|||
126026380|NCT02682316|453391681|FG000|Overall Study|Benign Final Pathology|27|||
126244478|NCT03049748|454186912|FG001|Overall Study|Protocol Violation|2|||
126244479|NCT03049748|454186911|FG000|Overall Study|Moved out of state (relocation)|0|||
126357460|NCT01058005|454602102|FG001|Overall Study|Adverse Event|2|||
126357461|NCT01058005|454602103|FG002|Overall Study|Adverse Event|1|||
126357462|NCT01058005|454602101|FG000|Overall Study|Physician Decision|2|||
126357463|NCT01058005|454602102|FG001|Overall Study|Physician Decision|2|||
126357464|NCT01058005|454602103|FG002|Overall Study|Physician Decision|0|||
126357465|NCT01058005|454602101|FG000|Overall Study|Withdrawal by Subject|4|||
126357466|NCT01058005|454602102|FG001|Overall Study|Withdrawal by Subject|5|||
126357467|NCT01058005|454602103|FG002|Overall Study|Withdrawal by Subject|11|||
126357468|NCT01058005|454602101|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
126357469|NCT01058005|454602102|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
126357470|NCT01058005|454602103|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
126357471|NCT01058005|454602101|FG000|Overall Study|Reason Missing|5|||
126357472|NCT01058005|454602102|FG001|Overall Study|Reason Missing|3|||
126357473|NCT01058005|454602103|FG002|Overall Study|Reason Missing|1|||
126357474|NCT00927186|454602104|FG000|12 Months Primary Study|Adverse Event|5|||
126357475|NCT00927186|454602105|FG001|12 Months Primary Study|Adverse Event|2|||
126357476|NCT00927186|454602104|FG000|12 Months Primary Study|Lost to Follow-up|1|||
126357477|NCT00927186|454602105|FG001|12 Months Primary Study|Lost to Follow-up|0|||
126357478|NCT00927186|454602104|FG000|12 Months Primary Study|Protocol Violation|0|||
126357479|NCT00927186|454602105|FG001|12 Months Primary Study|Protocol Violation|1|||
126357480|NCT00927186|454602104|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
126357481|NCT00927186|454602105|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
126357482|NCT01145222|454602106|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
126357483|NCT01145222|454602107|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
126357484|NCT01145222|454602108|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
126357485|NCT01145222|454602109|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
126357486|NCT01145222|454602106|FG000|Overall Study|Poor bowel preparation|0|||
126357487|NCT01145222|454602107|FG001|Overall Study|Poor bowel preparation|0|||
126357488|NCT01145222|454602108|FG002|Overall Study|Poor bowel preparation|0|||
126357489|NCT01145222|454602109|FG003|Overall Study|Poor bowel preparation|1|||
126357490|NCT01421134|454602110|FG000|Overall Study|Adverse Event|3|||
126357491|NCT01421134|454602111|FG001|Overall Study|Adverse Event|5|||
126357492|NCT01421134|454602110|FG000|Overall Study|Lack of Efficacy|2|||
126357493|NCT01421134|454602111|FG001|Overall Study|Lack of Efficacy|4|||
126357494|NCT01421134|454602110|FG000|Overall Study|Protocol Violation|0|||
126357495|NCT01421134|454602111|FG001|Overall Study|Protocol Violation|3|||
126357496|NCT01421134|454602110|FG000|Overall Study|Withdrawal by Subject|1|||
126357497|NCT01421134|454602111|FG001|Overall Study|Withdrawal by Subject|1|||
126357498|NCT01421134|454602110|FG000|Overall Study|Administrative|0|||
126357499|NCT01421134|454602111|FG001|Overall Study|Administrative|1|||
126357500|NCT01421134|454602110|FG000|Overall Study|Lost to Follow-up|1|||
126357501|NCT01421134|454602111|FG001|Overall Study|Lost to Follow-up|1|||
126357502|NCT01851369|454602116|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357503|NCT01851369|454602117|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126244480|NCT03049748|454186912|FG001|Overall Study|Moved out of state (relocation)|1|||
126244481|NCT04994535|454186916|FG000|Overall Study|Lost to Follow-up|7|||
126244482|NCT04994535|454186917|FG001|Overall Study|Lost to Follow-up|7|||
126244483|NCT04994535|454186916|FG000|Overall Study|Withdrawal by Subject|10|||
126244484|NCT04994535|454186917|FG001|Overall Study|Withdrawal by Subject|7|||
126244485|NCT04994535|454186916|FG000|Overall Study|Other|1|||
126244486|NCT04994535|454186917|FG001|Overall Study|Other|1|||
126244487|NCT01158118|454186918|FG000|Overall Study|Screen failure|1|||
126244488|NCT01158118|454186919|FG001|Overall Study|Screen failure|0|||
126244489|NCT01158118|454186918|FG000|Overall Study|Donor match was a screen failure|0|||
126244490|NCT01158118|454186919|FG001|Overall Study|Donor match was a screen failure|1|||
126244491|NCT01158118|454186918|FG000|Overall Study|Suffered stroke prior to transplant|0|||
126244492|NCT01158118|454186919|FG001|Overall Study|Suffered stroke prior to transplant|1|||
126244493|NCT01158118|454186918|FG000|Overall Study|Death|0|||
126244494|NCT01158118|454186919|FG001|Overall Study|Death|1|||
126244495|NCT00604162|454186920|FG000|Overall Study|Physician Decision|3|||
126244496|NCT00604162|454186920|FG000|Overall Study|Withdrawal by Subject|1|||
126244497|NCT01015287|454186921|FG000|Overall Study|Death|21|||
126244498|NCT01015287|454186922|FG001|Overall Study|Death|16|||
126244499|NCT01015287|454186921|FG000|Overall Study|Adverse Event|1|||
126244500|NCT01015287|454186922|FG001|Overall Study|Adverse Event|0|||
126244501|NCT01015287|454186921|FG000|Overall Study|Sponsor Decision|3|||
126244502|NCT01015287|454186922|FG001|Overall Study|Sponsor Decision|7|||
126244503|NCT01015287|454186921|FG000|Overall Study|Physician Decision|19|||
126244504|NCT01015287|454186922|FG001|Overall Study|Physician Decision|21|||
126244505|NCT01015287|454186921|FG000|Overall Study|Withdrawal by Subject|14|||
126244506|NCT01015287|454186922|FG001|Overall Study|Withdrawal by Subject|19|||
126244507|NCT01015287|454186921|FG000|Overall Study|Entry Criteria not Met|11|||
126244508|NCT01015287|454186922|FG001|Overall Study|Entry Criteria not Met|14|||
126244509|NCT01015287|454186921|FG000|Overall Study|Lost to Follow-up|2|||
126244510|NCT01015287|454186922|FG001|Overall Study|Lost to Follow-up|1|||
126244511|NCT01015287|454186921|FG000|Overall Study|Protocol Violation|1|||
126244512|NCT01015287|454186922|FG001|Overall Study|Protocol Violation|1|||
126244513|NCT00905840|454186923|FG000|Overall Study|Lost to Follow-up|11|||
126244514|NCT00905840|454186923|FG000|Overall Study|Death|3|||
126244515|NCT00905840|454186923|FG000|Overall Study|Withdrawal by Subject|1|||
126244516|NCT00905840|454186923|FG000|Overall Study|Adverse Event|1|||
126244517|NCT01370317|454186924|FG000|Overall Study|Participant withdrew consent|1|||
126244518|NCT01370317|454186925|FG001|Overall Study|Participant withdrew consent|0|||
126244519|NCT01370317|454186924|FG000|Overall Study|Protocol deviation|0|||
126244520|NCT01370317|454186925|FG001|Overall Study|Protocol deviation|1|||
126244521|NCT02849457|454186931|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
126244522|NCT02849457|454186932|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
126244523|NCT02849457|454186933|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
126026381|NCT02682316|453391682|FG001|Overall Study|Benign Final Pathology|26|||
126026382|NCT02682316|453391681|FG000|Overall Study|Reoperation before 30 days|7|||
126244524|NCT02849457|454186934|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
126244525|NCT03673670|454186937|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
126244526|NCT03673670|454186938|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244527|NCT03673670|454186939|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244528|NCT03673670|454186940|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244529|NCT03673670|454186941|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244530|NCT03673670|454186942|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244531|NCT03673670|454186937|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
126357504|NCT01851369|454602118|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126026383|NCT02682316|453391682|FG001|Overall Study|Reoperation before 30 days|6|||
126026384|NCT02682316|453391681|FG000|Overall Study|Ineligible|1|||
126026385|NCT02682316|453391682|FG001|Overall Study|Ineligible|0|||
126026386|NCT02682316|453391681|FG000|Overall Study|Death|1|||
126026387|NCT02682316|453391682|FG001|Overall Study|Death|0|||
126026388|NCT02682316|453391681|FG000|Overall Study|Lost to Follow-up|7|||
126026389|NCT02682316|453391682|FG001|Overall Study|Lost to Follow-up|3|||
126026390|NCT00150813|453391684|FG000|Overall Study|Adverse Event|1|||
126026391|NCT00150813|453391684|FG000|Overall Study|Lack of Efficacy|1|||
126026392|NCT00150813|453391684|FG000|Overall Study|Lost to Follow-up|5|||
126026393|NCT00150813|453391684|FG000|Overall Study|Withdrawal by Subject|5|||
126026394|NCT00150813|453391684|FG000|Overall Study|Remission|3|||
126026395|NCT00150813|453391684|FG000|Overall Study|Planned pregancy|1|||
126094183|NCT00506441|453639152|FG001|Period 2; Double-blind Period|Adverse Event|1|||
126026396|NCT00150813|453391684|FG000|Overall Study|Switch to commercially available LEV|2|||
126026397|NCT03052608|453391686|FG000|Treatment Phase|Adverse Event|10|||
126026398|NCT03052608|453391687|FG001|Treatment Phase|Adverse Event|12|||
126026399|NCT03052608|453391686|FG000|Treatment Phase|Death|6|||
126026400|NCT03052608|453391687|FG001|Treatment Phase|Death|4|||
126244532|NCT03673670|454186938|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
126244533|NCT03673670|454186939|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
126244534|NCT03673670|454186940|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
126244535|NCT03673670|454186941|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
126244536|NCT03673670|454186942|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
126244537|NCT03673670|454186937|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244538|NCT03673670|454186938|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244539|NCT03673670|454186939|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244540|NCT03673670|454186940|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244541|NCT03673670|454186941|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244542|NCT03673670|454186942|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
126244543|NCT03673670|454186937|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126244544|NCT03673670|454186938|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126244545|NCT03673670|454186939|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126094184|NCT00506441|453639151|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
126244546|NCT03673670|454186940|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126244547|NCT03673670|454186941|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126244548|NCT03673670|454186942|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
126244549|NCT03673670|454186937|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
126244550|NCT03673670|454186938|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
126244551|NCT03673670|454186939|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
126244552|NCT03673670|454186940|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
126244553|NCT03673670|454186941|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
126244554|NCT03673670|454186942|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
126244555|NCT03673670|454186937|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244556|NCT03673670|454186938|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244557|NCT03673670|454186939|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244558|NCT03673670|454186940|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244559|NCT03673670|454186941|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
126244560|NCT03673670|454186942|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244561|NCT03673670|454186937|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244562|NCT03673670|454186938|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244563|NCT03673670|454186939|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244564|NCT03673670|454186940|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244565|NCT03673670|454186941|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
126244566|NCT03673670|454186942|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244567|NCT04408794|454186943|FG000|Overall Study|Adverse Event|43|||
126244568|NCT04408794|454186943|FG000|Overall Study|Infrequent study drug usage|43|||
126244569|NCT04408794|454186943|FG000|Overall Study|Lack of Efficacy|61|||
126244570|NCT04408794|454186943|FG000|Overall Study|Lost to Follow-up|33|||
126244571|NCT04408794|454186943|FG000|Overall Study|Non-compliance|6|||
126244572|NCT04408794|454186943|FG000|Overall Study|Physician Decision|1|||
126244573|NCT04408794|454186943|FG000|Overall Study|Pregnancy|6|||
126244574|NCT04408794|454186943|FG000|Overall Study|Protocol Deviation|9|||
126244575|NCT04408794|454186943|FG000|Overall Study|Sheehan-STS Result|1|||
126244576|NCT04408794|454186943|FG000|Overall Study|Withdrawal by Subject|57|||
126244577|NCT04408794|454186943|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
126244578|NCT04408794|454186943|FG000|Overall Study|Never Treated Migraine|5|||
126244579|NCT04238754|454186948|FG000|Washout - 1 Week|Lost to Follow-up|1|||
126244580|NCT04238754|454186949|FG001|Washout - 1 Week|Lost to Follow-up|0|||
126244581|NCT01518972|454186953|FG000|Overall Study|Lost to Follow-up|2|||
126244582|NCT01518972|454186954|FG001|Overall Study|Lost to Follow-up|1|||
126244583|NCT01518972|454186953|FG000|Overall Study|Withdrawal by Subject|1|||
126244584|NCT01518972|454186954|FG001|Overall Study|Withdrawal by Subject|0|||
126244585|NCT01518972|454186953|FG000|Overall Study|Moved from area|1|||
126244586|NCT01518972|454186954|FG001|Overall Study|Moved from area|0|||
126244587|NCT01518972|454186953|FG000|Overall Study|Transportation problems|1|||
126244588|NCT01518972|454186954|FG001|Overall Study|Transportation problems|0|||
126094185|NCT00506441|453639152|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
126094186|NCT00506441|453639151|FG000|Period 2; Double-blind Period|Physician Decision|1|||
126244589|NCT01518972|454186953|FG000|Overall Study|Exclusionary medical condition|1|||
126244590|NCT01518972|454186954|FG001|Overall Study|Exclusionary medical condition|0|||
126244591|NCT01518972|454186953|FG000|Overall Study|Missed safety visits|0|||
126244592|NCT01518972|454186954|FG001|Overall Study|Missed safety visits|1|||
126244593|NCT01518972|454186953|FG000|Overall Study|Exclusionary medication|0|||
126244594|NCT01518972|454186954|FG001|Overall Study|Exclusionary medication|1|||
126244595|NCT01518972|454186953|FG000|Overall Study|Declined medication starting on day 12|0|||
126244596|NCT01518972|454186954|FG001|Overall Study|Declined medication starting on day 12|1|||
126244597|NCT00556322|454186956|FG000|Overall Study|Insufficient therapeutic response|158|||
126244598|NCT00556322|454186957|FG001|Overall Study|Insufficient therapeutic response|168|||
126244599|NCT00556322|454186956|FG000|Overall Study|Adverse Event|7|||
126244600|NCT00556322|454186957|FG001|Overall Study|Adverse Event|4|||
126244601|NCT00556322|454186956|FG000|Overall Study|Other|4|||
126244602|NCT00556322|454186957|FG001|Overall Study|Other|1|||
126244603|NCT00556322|454186956|FG000|Overall Study|Lost to Follow-up|5|||
126244604|NCT00556322|454186957|FG001|Overall Study|Lost to Follow-up|3|||
126244605|NCT00556322|454186956|FG000|Overall Study|Withdrawal by Subject|19|||
126244606|NCT00556322|454186957|FG001|Overall Study|Withdrawal by Subject|7|||
126244607|NCT00556322|454186956|FG000|Overall Study|Protocol Violation|5|||
126244608|NCT00556322|454186957|FG001|Overall Study|Protocol Violation|1|||
126244609|NCT00556322|454186956|FG000|Overall Study|Ongoing at data cutoff|3|||
126244610|NCT00556322|454186957|FG001|Overall Study|Ongoing at data cutoff|5|||
126244611|NCT00556322|454186956|FG000|Overall Study|Death|20|||
126244612|NCT00556322|454186957|FG001|Overall Study|Death|14|||
126244613|NCT03733444|454186958|FG000|Overall Study|Adverse Event|8|||
126244614|NCT03733444|454186959|FG001|Overall Study|Adverse Event|10|||
126026401|NCT03052608|453391686|FG000|Treatment Phase|Withdrawal by Subject|4|||
126244615|NCT03733444|454186960|FG002|Overall Study|Adverse Event|5|||
126244616|NCT03733444|454186958|FG000|Overall Study|Death|20|||
126244617|NCT03733444|454186959|FG001|Overall Study|Death|19|||
126026402|NCT03052608|453391687|FG001|Treatment Phase|Withdrawal by Subject|12|||
126026403|NCT03052608|453391686|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
126026404|NCT03052608|453391687|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
126026405|NCT03052608|453391686|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
126026406|NCT03052608|453391687|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
126026407|NCT03052608|453391686|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
126026408|NCT03052608|453391687|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
126026409|NCT03052608|453391686|FG000|Treatment Phase|Ongoing|103|||
126026410|NCT03052608|453391687|FG001|Treatment Phase|Ongoing|31|||
126026411|NCT03052608|453391686|FG000|Long-Term Follow-up Phase|Death|23|||
126026412|NCT03052608|453391687|FG001|Long-Term Follow-up Phase|Death|28|||
126026413|NCT03052608|453391686|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
126026414|NCT03052608|453391687|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
126026415|NCT03052608|453391686|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
126026416|NCT03052608|453391687|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
126026417|NCT03052608|453391686|FG000|Long-Term Follow-up Phase|Ongoing|122|||
126244618|NCT03733444|454186960|FG002|Overall Study|Death|11|||
126244619|NCT03733444|454186958|FG000|Overall Study|Lost to Follow-up|3|||
126244620|NCT03733444|454186959|FG001|Overall Study|Lost to Follow-up|0|||
126244621|NCT03733444|454186960|FG002|Overall Study|Lost to Follow-up|1|||
126244622|NCT03733444|454186958|FG000|Overall Study|Lack of Efficacy|0|||
126244623|NCT03733444|454186959|FG001|Overall Study|Lack of Efficacy|1|||
126244624|NCT03733444|454186960|FG002|Overall Study|Lack of Efficacy|1|||
126244625|NCT03733444|454186958|FG000|Overall Study|Physician Decision|2|||
126026418|NCT03052608|453391687|FG001|Long-Term Follow-up Phase|Ongoing|99|||
126026419|NCT03113500|453391688|FG000|Overall Study|Withdrawal by Subject|1|||
126026420|NCT03580369|453391692|FG000|Overall Study|No treatment due to mis-randomization|1|||
126026421|NCT03580369|453391693|FG001|Overall Study|No treatment due to mis-randomization|0|||
126026422|NCT03580369|453391694|FG002|Overall Study|No treatment due to mis-randomization|0|||
126026423|NCT03580369|453391695|FG003|Overall Study|No treatment due to mis-randomization|0|||
126026424|NCT03580369|453391696|FG004|Overall Study|No treatment due to mis-randomization|3|||
126026425|NCT03580369|453391697|FG005|Overall Study|No treatment due to mis-randomization|0|||
126026426|NCT03580369|453391698|FG006|Overall Study|No treatment due to mis-randomization|0|||
126026427|NCT03580369|453391699|FG007|Overall Study|No treatment due to mis-randomization|0|||
126026428|NCT03580369|453391692|FG000|Overall Study|Reason unknown|0|||
126026429|NCT03580369|453391693|FG001|Overall Study|Reason unknown|0|||
126026430|NCT03580369|453391694|FG002|Overall Study|Reason unknown|1|||
126026431|NCT03580369|453391695|FG003|Overall Study|Reason unknown|0|||
126026432|NCT03580369|453391696|FG004|Overall Study|Reason unknown|0|||
126026433|NCT03580369|453391697|FG005|Overall Study|Reason unknown|0|||
126026434|NCT03580369|453391698|FG006|Overall Study|Reason unknown|0|||
126026435|NCT03580369|453391699|FG007|Overall Study|Reason unknown|0|||
126026436|NCT03580369|453391692|FG000|Overall Study|Technical problems|0|||
126026437|NCT03580369|453391693|FG001|Overall Study|Technical problems|0|||
126026438|NCT03580369|453391694|FG002|Overall Study|Technical problems|0|||
126026439|NCT03580369|453391695|FG003|Overall Study|Technical problems|0|||
126026440|NCT03580369|453391696|FG004|Overall Study|Technical problems|1|||
126026441|NCT03580369|453391697|FG005|Overall Study|Technical problems|0|||
126026442|NCT03580369|453391698|FG006|Overall Study|Technical problems|2|||
126026443|NCT03580369|453391699|FG007|Overall Study|Technical problems|0|||
126026444|NCT03580369|453391692|FG000|Overall Study|Pregnancy|2|||
126026445|NCT03580369|453391693|FG001|Overall Study|Pregnancy|0|||
126026446|NCT03580369|453391694|FG002|Overall Study|Pregnancy|3|||
126026447|NCT03580369|453391695|FG003|Overall Study|Pregnancy|0|||
126026448|NCT03580369|453391696|FG004|Overall Study|Pregnancy|2|||
126026449|NCT03580369|453391697|FG005|Overall Study|Pregnancy|0|||
126026450|NCT03580369|453391698|FG006|Overall Study|Pregnancy|0|||
126244626|NCT03733444|454186959|FG001|Overall Study|Physician Decision|1|||
126244627|NCT03733444|454186960|FG002|Overall Study|Physician Decision|0|||
126244628|NCT03733444|454186958|FG000|Overall Study|Protocol Violation|2|||
126244629|NCT03733444|454186959|FG001|Overall Study|Protocol Violation|1|||
126244630|NCT03733444|454186960|FG002|Overall Study|Protocol Violation|0|||
126244631|NCT03733444|454186958|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
126026451|NCT03580369|453391699|FG007|Overall Study|Pregnancy|0|||
126026452|NCT03580369|453391692|FG000|Overall Study|Lost to Follow-up|2|||
126357505|NCT01851369|454602119|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126026453|NCT03580369|453391693|FG001|Overall Study|Lost to Follow-up|0|||
126026454|NCT03580369|453391694|FG002|Overall Study|Lost to Follow-up|2|||
126026455|NCT03580369|453391695|FG003|Overall Study|Lost to Follow-up|0|||
126026456|NCT03580369|453391696|FG004|Overall Study|Lost to Follow-up|3|||
126026457|NCT03580369|453391697|FG005|Overall Study|Lost to Follow-up|0|||
126026458|NCT03580369|453391698|FG006|Overall Study|Lost to Follow-up|1|||
126026459|NCT03580369|453391699|FG007|Overall Study|Lost to Follow-up|0|||
126244632|NCT03733444|454186959|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
126244633|NCT03733444|454186960|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
126244634|NCT03733444|454186958|FG000|Overall Study|Study Terminated by Sponsor|203|||
126244635|NCT03733444|454186959|FG001|Overall Study|Study Terminated by Sponsor|209|||
126244636|NCT03733444|454186960|FG002|Overall Study|Study Terminated by Sponsor|221|||
126244637|NCT03733444|454186958|FG000|Overall Study|Withdrawal by Subject|19|||
126244638|NCT03733444|454186959|FG001|Overall Study|Withdrawal by Subject|18|||
126244639|NCT03733444|454186960|FG002|Overall Study|Withdrawal by Subject|16|||
126244640|NCT03733444|454186958|FG000|Overall Study|Miscellaneous|1|||
126244641|NCT03733444|454186959|FG001|Overall Study|Miscellaneous|0|||
126244642|NCT03733444|454186960|FG002|Overall Study|Miscellaneous|1|||
126244643|NCT03733444|454186958|FG000|Overall Study|Not Treated|1|||
126244644|NCT03733444|454186959|FG001|Overall Study|Not Treated|2|||
126244645|NCT03733444|454186960|FG002|Overall Study|Not Treated|1|||
126244646|NCT01788423|454186961|FG000|Overall Study|See Comments in Completed (above)|0|||
126244647|NCT01788423|454186962|FG001|Overall Study|See Comments in Completed (above)|4|||
126244648|NCT01788423|454186963|FG002|Overall Study|See Comments in Completed (above)|5|||
126244649|NCT03637764|454186964|FG000|Overall Study|Adverse Event|2|||
126244650|NCT03637764|454186965|FG001|Overall Study|Adverse Event|0|||
126244651|NCT03637764|454186966|FG002|Overall Study|Adverse Event|0|||
126244652|NCT03637764|454186967|FG003|Overall Study|Adverse Event|1|||
126244653|NCT03637764|454186964|FG000|Overall Study|Progressive Disease|23|||
126244654|NCT03637764|454186965|FG001|Overall Study|Progressive Disease|23|||
126244655|NCT03637764|454186966|FG002|Overall Study|Progressive Disease|18|||
126244656|NCT03637764|454186967|FG003|Overall Study|Progressive Disease|31|||
126244657|NCT03637764|454186964|FG000|Overall Study|Withdrawal by Subject|1|||
126244658|NCT03637764|454186965|FG001|Overall Study|Withdrawal by Subject|3|||
126244659|NCT03637764|454186966|FG002|Overall Study|Withdrawal by Subject|0|||
126244660|NCT03637764|454186967|FG003|Overall Study|Withdrawal by Subject|1|||
126244661|NCT02760927|454186972|FG000|Overall Study|Tube Slippage from Device|1|||
126244662|NCT02105272|454186973|FG000|Overall Study|Adverse Event|1|||
126244663|NCT02105272|454186974|FG001|Overall Study|Adverse Event|2|||
126244664|NCT02105272|454186973|FG000|Overall Study|Physician Decision|0|||
126244665|NCT02105272|454186974|FG001|Overall Study|Physician Decision|1|||
126244666|NCT02105272|454186973|FG000|Overall Study|Protocol Violation|2|||
126244667|NCT02105272|454186974|FG001|Overall Study|Protocol Violation|0|||
126244668|NCT02105272|454186973|FG000|Overall Study|Withdrawal by Subject|2|||
126244669|NCT02105272|454186974|FG001|Overall Study|Withdrawal by Subject|0|||
126244670|NCT03190915|454186976|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
126244671|NCT03190915|454186976|FG000|Overall Study|Progressive Disease|3|||
126244672|NCT02964039|454186977|FG000|Overall Study|Medical reason unrelated to study participation|1|||
126244673|NCT02964039|454186978|FG001|Overall Study|Medical reason unrelated to study participation|0|||
126244674|NCT02964039|454186979|FG002|Overall Study|Medical reason unrelated to study participation|3|||
126244675|NCT02964039|454186977|FG000|Overall Study|Research shutdown due to pandemic|2|||
126244676|NCT02964039|454186978|FG001|Overall Study|Research shutdown due to pandemic|0|||
126244677|NCT02964039|454186979|FG002|Overall Study|Research shutdown due to pandemic|1|||
126244678|NCT02964039|454186977|FG000|Overall Study|Withdrawal by Subject|0|||
126244679|NCT02964039|454186978|FG001|Overall Study|Withdrawal by Subject|1|||
126244680|NCT02964039|454186979|FG002|Overall Study|Withdrawal by Subject|0|||
126244681|NCT02964039|454186977|FG000|Overall Study|Lost to Follow-up|1|||
126244682|NCT02964039|454186978|FG001|Overall Study|Lost to Follow-up|0|||
126244683|NCT02964039|454186979|FG002|Overall Study|Lost to Follow-up|1|||
126244684|NCT01103713|454186983|FG000|Overall Study|Lost to Follow-up|2|||
126244685|NCT01103713|454186983|FG000|Overall Study|Withdrawal by Subject|8|||
126244686|NCT01103713|454186983|FG000|Overall Study|Study terminated by sponsor|2|||
126244687|NCT01103713|454186983|FG000|Overall Study|Other|1|||
126244688|NCT03084471|454186988|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
126244689|NCT03084471|454186988|FG000|Overall Study|Condition under investigation worsened|84|||
126244690|NCT03084471|454186988|FG000|Overall Study|Lack of therapeutic response|2|||
126244691|NCT03084471|454186988|FG000|Overall Study|Protocol Violation|1|||
126244692|NCT03084471|454186988|FG000|Overall Study|Adverse Event|73|||
126244693|NCT03084471|454186988|FG000|Overall Study|Withdrawal by Subject|12|||
126244694|NCT03084471|454186988|FG000|Overall Study|Disease relapse|181|||
126244695|NCT03084471|454186988|FG000|Overall Study|Subjective disease progression|359|||
126244696|NCT03084471|454186988|FG000|Overall Study|Other (as recorded)|33|||
126357506|NCT01851369|454602120|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357507|NCT01851369|454602121|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
126357508|NCT01851369|454602122|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357509|NCT01851369|454602123|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357510|NCT01851369|454602124|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126369556|NCT01497197|454650596|FG000|Overall Study|Excessive/lack of response to treatment|1|||
126026460|NCT03580369|453391692|FG000|Overall Study|Physician Decision|4|||
126244697|NCT03084471|454186988|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
126244698|NCT00505622|454186989|FG000|Overall Study|Adverse Event|5|||
126244699|NCT00505622|454186990|FG001|Overall Study|Adverse Event|6|||
126244700|NCT00505622|454186991|FG002|Overall Study|Adverse Event|4|||
125879078|NCT02532517|452853545|FG000|Overall Study|Failed Angiographic eligibility|1|||
125879079|NCT02532517|452853545|FG000|Overall Study|Lost to Follow-up|4|||
125879080|NCT02532517|452853545|FG000|Overall Study|Withdrawal by Subject|4|||
125879081|NCT02532517|452853545|FG000|Overall Study|Death|4|||
125879082|NCT05720897|452853546|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
125879083|NCT05720897|452853547|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
125879084|NCT04780061|452853548|FG000|Overall Study|Withdrawal by Subject|5|||
125879085|NCT04780061|452853549|FG001|Overall Study|Withdrawal by Subject|8|||
125879086|NCT04780061|452853548|FG000|Overall Study|Adverse Event|2|||
125879087|NCT04780061|452853549|FG001|Overall Study|Adverse Event|2|||
125879088|NCT04780061|452853548|FG000|Overall Study|Lost to Follow-up|1|||
125879089|NCT04780061|452853549|FG001|Overall Study|Lost to Follow-up|5|||
125879090|NCT01456039|452855236|FG000|Phase 1 (First Step)|Disease Progression|1|||
125879091|NCT01456039|452855237|FG001|Phase 1 (First Step)|Disease Progression|1|||
125879092|NCT01456039|452855238|FG002|Phase 1 (First Step)|Disease Progression|0|||
125879093|NCT01456039|452855236|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
125879094|NCT01456039|452855237|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
125879095|NCT01456039|452855238|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
125879096|NCT01456039|452855236|FG000|Phase 1 (First Step)|Adverse Event|0|||
125879097|NCT01456039|452855237|FG001|Phase 1 (First Step)|Adverse Event|3|||
125879098|NCT01456039|452855238|FG002|Phase 1 (First Step)|Adverse Event|0|||
125879099|NCT01456039|452855236|FG000|Phase 1 (First Step)|Other|0|||
125879100|NCT01456039|452855237|FG001|Phase 1 (First Step)|Other|1|||
125879101|NCT01456039|452855238|FG002|Phase 1 (First Step)|Other|0|||
125879102|NCT01456039|452855236|FG000|Phase 2 (Second Step)|Disease Progression|0|||
125879103|NCT01456039|452855237|FG001|Phase 2 (Second Step)|Disease Progression|0|||
125879104|NCT01456039|452855238|FG002|Phase 2 (Second Step)|Disease Progression|17|||
125879105|NCT01456039|452855236|FG000|Phase 2 (Second Step)|Adverse Event|0|||
125879106|NCT01456039|452855237|FG001|Phase 2 (Second Step)|Adverse Event|0|||
125879107|NCT01456039|452855238|FG002|Phase 2 (Second Step)|Adverse Event|10|||
125879108|NCT01456039|452855236|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
125879109|NCT01456039|452855237|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
125879110|NCT01456039|452855238|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
125879111|NCT01456039|452855236|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
125879112|NCT01456039|452855237|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
125879113|NCT01456039|452855238|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
125879114|NCT01456039|452855236|FG000|Phase 2 (Second Step)|Other|0|||
125879115|NCT01456039|452855237|FG001|Phase 2 (Second Step)|Other|0|||
125879116|NCT01456039|452855238|FG002|Phase 2 (Second Step)|Other|1|||
125879117|NCT00755183|452855239|FG000|Overall Study|Adverse Event|5|||
125879118|NCT00755183|452855240|FG001|Overall Study|Adverse Event|2|||
125879119|NCT00755183|452855239|FG000|Overall Study|Protocol Violation|0|||
125879120|NCT00755183|452855240|FG001|Overall Study|Protocol Violation|1|||
125879121|NCT00755183|452855239|FG000|Overall Study|Withdrawal by Subject|0|||
125879122|NCT00755183|452855240|FG001|Overall Study|Withdrawal by Subject|2|||
125879123|NCT00755183|452855239|FG000|Overall Study|Administrative|2|||
125879124|NCT00755183|452855240|FG001|Overall Study|Administrative|1|||
125879125|NCT00335777|452855241|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
125879126|NCT00335777|452855241|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
125879127|NCT00335777|452855241|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
125879128|NCT00335777|452855241|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
125879129|NCT00335777|452855241|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
125879130|NCT04639245|452855242|FG000|Overall Study|Death|1|||
125879131|NCT03337477|452855245|FG000|Overall Study|not categorized into the listed ones|11|||
125879132|NCT03337477|452855246|FG001|Overall Study|not categorized into the listed ones|9|||
125879133|NCT03337477|452855245|FG000|Overall Study|Withdrawal by Subject|0|||
125879134|NCT03337477|452855246|FG001|Overall Study|Withdrawal by Subject|1|||
125879135|NCT03337477|452855245|FG000|Overall Study|Death|0|||
125879136|NCT03337477|452855246|FG001|Overall Study|Death|1|||
125879137|NCT03337477|452855245|FG000|Overall Study|Lost to Follow-up|0|||
126244701|NCT00505622|454186989|FG000|Overall Study|Protocol Violation|1|||
126244702|NCT00505622|454186990|FG001|Overall Study|Protocol Violation|1|||
125879138|NCT03337477|452855246|FG001|Overall Study|Lost to Follow-up|2|||
125879139|NCT02220920|452855247|FG000|Overall Study|Adverse Event|1|||
125879140|NCT02220920|452855248|FG001|Overall Study|Adverse Event|0|||
125879141|NCT02220920|452855247|FG000|Overall Study|Lack of Efficacy|0|||
125879142|NCT02220920|452855248|FG001|Overall Study|Lack of Efficacy|1|||
126244703|NCT00505622|454186991|FG002|Overall Study|Protocol Violation|0|||
126244704|NCT00505622|454186989|FG000|Overall Study|Withdrawal by Subject|0|||
125879143|NCT02220920|452855247|FG000|Overall Study|Withdrawal by Subject|1|||
125879144|NCT02220920|452855248|FG001|Overall Study|Withdrawal by Subject|0|||
126244705|NCT00505622|454186990|FG001|Overall Study|Withdrawal by Subject|3|||
125879145|NCT02220920|452855247|FG000|Overall Study|Conflict with the stopping criteria|1|||
125879146|NCT02220920|452855248|FG001|Overall Study|Conflict with the stopping criteria|2|||
126026461|NCT03580369|453391693|FG001|Overall Study|Physician Decision|0|||
126026462|NCT03580369|453391694|FG002|Overall Study|Physician Decision|4|||
126244706|NCT00505622|454186991|FG002|Overall Study|Withdrawal by Subject|2|||
126244707|NCT00505622|454186989|FG000|Overall Study|Study termination by sponsor|115|||
126244708|NCT00505622|454186990|FG001|Overall Study|Study termination by sponsor|98|||
126244709|NCT00505622|454186991|FG002|Overall Study|Study termination by sponsor|90|||
126244710|NCT01757392|454186994|FG000|Overall Study|Withdrawal by Subject|1|||
126244711|NCT01757392|454186994|FG000|Overall Study|Screen Fail|3|||
125879147|NCT00473564|452855249|FG000|Overall Study|robot surgery aborted in OR|23|||
125879148|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
125879149|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
125879150|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
125879151|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Death|9|||
125879152|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Death|0|||
125879153|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Death|0|||
125879154|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
125879155|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
125879156|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
125879157|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
125879158|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
125879159|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
125879160|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Other|135|||
125879161|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Other|0|||
125879162|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Other|0|||
125879163|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
125879164|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
125879165|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
125879166|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
125879167|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
125879168|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
125879169|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
125879170|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
125879171|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
125879172|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Other|3|||
125879173|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Other|0|||
125879174|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Other|0|||
125879175|NCT02118584|452855253|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
125879176|NCT02118584|452855254|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
125879177|NCT02118584|452855255|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
125879178|NCT02118584|452855253|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
125879179|NCT02118584|452855254|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
125879180|NCT02118584|452855255|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
125879181|NCT02118584|452855253|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
125879182|NCT02118584|452855254|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
125879183|NCT02118584|452855255|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
125879184|NCT02118584|452855253|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
125879185|NCT02118584|452855254|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
125879186|NCT02118584|452855255|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
125879187|NCT02118584|452855253|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
125879188|NCT02118584|452855254|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
125879189|NCT02118584|452855255|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
125879190|NCT02118584|452855253|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
125879191|NCT02118584|452855254|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
125879192|NCT02118584|452855255|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
125879193|NCT02118584|452855253|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
126026463|NCT03580369|453391695|FG003|Overall Study|Physician Decision|1|||
126026464|NCT03580369|453391696|FG004|Overall Study|Physician Decision|1|||
126026465|NCT03580369|453391697|FG005|Overall Study|Physician Decision|0|||
126026466|NCT03580369|453391698|FG006|Overall Study|Physician Decision|0|||
126026467|NCT03580369|453391699|FG007|Overall Study|Physician Decision|0|||
126026468|NCT03580369|453391692|FG000|Overall Study|Lack of Efficacy|3|||
126244712|NCT00811655|454187000|FG000|Overall Study|Physician Decision|1|||
126244713|NCT00813592|454187001|FG000|Overall Study|Disease assessment was not completed per|2|||
126244714|NCT03801707|454187006|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
126026469|NCT03580369|453391693|FG001|Overall Study|Lack of Efficacy|0|||
126244715|NCT03873272|454187007|FG000|Overall Study|Withdrawal by Subject|2|||
125879194|NCT02118584|452855254|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
126026470|NCT03580369|453391694|FG002|Overall Study|Lack of Efficacy|7|||
126026471|NCT03580369|453391695|FG003|Overall Study|Lack of Efficacy|0|||
126244716|NCT03873272|454187008|FG001|Overall Study|Withdrawal by Subject|0|||
126244717|NCT03873272|454187009|FG002|Overall Study|Withdrawal by Subject|1|||
126244718|NCT03873272|454187007|FG000|Overall Study|Death|0|||
126244719|NCT03873272|454187008|FG001|Overall Study|Death|2|||
126244720|NCT03873272|454187009|FG002|Overall Study|Death|1|||
126244721|NCT04852978|454187015|FG000|Overall Study|Physician Decision|0|||
126244722|NCT04852978|454187016|FG001|Overall Study|Physician Decision|1|||
126244723|NCT04852978|454187017|FG002|Overall Study|Physician Decision|0|||
126244724|NCT04852978|454187018|FG003|Overall Study|Physician Decision|0|||
126244725|NCT04852978|454187019|FG004|Overall Study|Physician Decision|0|||
126244726|NCT04852978|454187020|FG005|Overall Study|Physician Decision|0|||
126244727|NCT04852978|454187021|FG006|Overall Study|Physician Decision|0|||
126244728|NCT04852978|454187022|FG007|Overall Study|Physician Decision|2|||
126244729|NCT04852978|454187023|FG008|Overall Study|Physician Decision|0|||
126244730|NCT04852978|454187015|FG000|Overall Study|Sponsor request|0|||
126244731|NCT04852978|454187016|FG001|Overall Study|Sponsor request|0|||
126244732|NCT04852978|454187017|FG002|Overall Study|Sponsor request|1|||
126244733|NCT04852978|454187018|FG003|Overall Study|Sponsor request|0|||
126244734|NCT04852978|454187019|FG004|Overall Study|Sponsor request|0|||
126244735|NCT04852978|454187020|FG005|Overall Study|Sponsor request|0|||
126244736|NCT04852978|454187021|FG006|Overall Study|Sponsor request|0|||
126244737|NCT04852978|454187022|FG007|Overall Study|Sponsor request|0|||
126244738|NCT04852978|454187023|FG008|Overall Study|Sponsor request|0|||
126244739|NCT04852978|454187015|FG000|Overall Study|Death|0|||
126244740|NCT04852978|454187016|FG001|Overall Study|Death|0|||
126026472|NCT03580369|453391696|FG004|Overall Study|Lack of Efficacy|2|||
126026473|NCT03580369|453391697|FG005|Overall Study|Lack of Efficacy|0|||
126026474|NCT03580369|453391698|FG006|Overall Study|Lack of Efficacy|3|||
126026475|NCT03580369|453391699|FG007|Overall Study|Lack of Efficacy|0|||
126026476|NCT03580369|453391692|FG000|Overall Study|Protocol Violation|6|||
126026477|NCT03580369|453391693|FG001|Overall Study|Protocol Violation|0|||
126026478|NCT03580369|453391694|FG002|Overall Study|Protocol Violation|6|||
126244741|NCT04852978|454187017|FG002|Overall Study|Death|0|||
126244742|NCT04852978|454187018|FG003|Overall Study|Death|0|||
126244743|NCT04852978|454187019|FG004|Overall Study|Death|0|||
126244744|NCT04852978|454187020|FG005|Overall Study|Death|0|||
126244745|NCT04852978|454187021|FG006|Overall Study|Death|1|||
126244746|NCT04852978|454187022|FG007|Overall Study|Death|0|||
126244747|NCT04852978|454187023|FG008|Overall Study|Death|0|||
126244748|NCT04852978|454187015|FG000|Overall Study|Lost to Follow-up|3|||
126244749|NCT04852978|454187016|FG001|Overall Study|Lost to Follow-up|2|||
126244750|NCT04852978|454187017|FG002|Overall Study|Lost to Follow-up|2|||
126244751|NCT04852978|454187018|FG003|Overall Study|Lost to Follow-up|0|||
126244752|NCT04852978|454187019|FG004|Overall Study|Lost to Follow-up|2|||
126244753|NCT04852978|454187020|FG005|Overall Study|Lost to Follow-up|4|||
126244754|NCT04852978|454187021|FG006|Overall Study|Lost to Follow-up|1|||
126244755|NCT04852978|454187022|FG007|Overall Study|Lost to Follow-up|2|||
126244756|NCT04852978|454187023|FG008|Overall Study|Lost to Follow-up|2|||
126244757|NCT04852978|454187015|FG000|Overall Study|Withdrawal by Subject|4|||
126244758|NCT04852978|454187016|FG001|Overall Study|Withdrawal by Subject|2|||
126244759|NCT04852978|454187017|FG002|Overall Study|Withdrawal by Subject|2|||
126244760|NCT04852978|454187018|FG003|Overall Study|Withdrawal by Subject|1|||
126244761|NCT04852978|454187019|FG004|Overall Study|Withdrawal by Subject|5|||
126244762|NCT04852978|454187020|FG005|Overall Study|Withdrawal by Subject|3|||
126244763|NCT04852978|454187021|FG006|Overall Study|Withdrawal by Subject|2|||
126244764|NCT04852978|454187022|FG007|Overall Study|Withdrawal by Subject|2|||
126244765|NCT04852978|454187023|FG008|Overall Study|Withdrawal by Subject|1|||
126244766|NCT00859430|454187024|FG000|First Intervention|Withdrawal by Subject|0|||
126244767|NCT00859430|454187025|FG001|First Intervention|Withdrawal by Subject|1|||
126244768|NCT04115293|454189267|FG000|Overall Study|Adverse Event|0|||
126026479|NCT03580369|453391695|FG003|Overall Study|Protocol Violation|1|||
126026480|NCT03580369|453391696|FG004|Overall Study|Protocol Violation|8|||
126244769|NCT04115293|454189268|FG001|Overall Study|Adverse Event|2|||
126244770|NCT04115293|454189267|FG000|Overall Study|Withdrawal by Subject|2|||
126244771|NCT04115293|454189268|FG001|Overall Study|Withdrawal by Subject|1|||
126244772|NCT04115293|454189267|FG000|Overall Study|Physician Decision|1|||
126244773|NCT04115293|454189268|FG001|Overall Study|Physician Decision|0|||
126244774|NCT04115293|454189267|FG000|Overall Study|Death|1|||
126244775|NCT04115293|454189268|FG001|Overall Study|Death|1|||
126244776|NCT00001703|454189269|FG000|Overall Study|progressed disease|2|||
126244777|NCT00001703|454189269|FG000|Overall Study|No evidence of disease|1|||
126026481|NCT03580369|453391697|FG005|Overall Study|Protocol Violation|2|||
126244778|NCT00001703|454189269|FG000|Overall Study|recurrent disease|2|||
126244779|NCT02057835|454189270|FG000|Overall Study|Withdrawal by Subject|0|||
126244780|NCT02057835|454189271|FG001|Overall Study|Withdrawal by Subject|2|||
126244781|NCT02057835|454189272|FG002|Overall Study|Withdrawal by Subject|0|||
126244782|NCT02057835|454189273|FG003|Overall Study|Withdrawal by Subject|0|||
126026482|NCT03580369|453391698|FG006|Overall Study|Protocol Violation|1|||
126026483|NCT03580369|453391699|FG007|Overall Study|Protocol Violation|0|||
126244783|NCT02057835|454189274|FG004|Overall Study|Withdrawal by Subject|0|||
126244784|NCT02057835|454189275|FG005|Overall Study|Withdrawal by Subject|0|||
126244785|NCT02057835|454189276|FG006|Overall Study|Withdrawal by Subject|0|||
126026484|NCT03580369|453391692|FG000|Overall Study|Adverse Event|7|||
126244786|NCT02057835|454189277|FG007|Overall Study|Withdrawal by Subject|0|||
126244787|NCT02057835|454189278|FG008|Overall Study|Withdrawal by Subject|0|||
126244788|NCT02057835|454189279|FG009|Overall Study|Withdrawal by Subject|0|||
126244789|NCT00712959|454189283|FG000|Overall Study|Protocol Violation|3|||
126244790|NCT00712959|454189284|FG001|Overall Study|Protocol Violation|1|||
126244791|NCT00712959|454189283|FG000|Overall Study|Lost to Follow-up|13|||
126244792|NCT00712959|454189284|FG001|Overall Study|Lost to Follow-up|2|||
126244793|NCT00712959|454189283|FG000|Overall Study|Withdrawal by Subject|3|||
126244794|NCT00712959|454189284|FG001|Overall Study|Withdrawal by Subject|0|||
126244795|NCT01531894|454189289|FG000|Overall Study|Physician Decision|8|||
126244796|NCT01531894|454189289|FG000|Overall Study|Death|1|||
126244797|NCT01440803|454189290|FG000|Overall Study|Met study stopping rule|2|||
126244798|NCT01440803|454189291|FG001|Overall Study|Met study stopping rule|1|||
126244799|NCT01440803|454189290|FG000|Overall Study|Lost to Follow-up|0|||
126244800|NCT01440803|454189291|FG001|Overall Study|Lost to Follow-up|2|||
126244801|NCT01440803|454189290|FG000|Overall Study|Withdrawal by Subject|0|||
126244802|NCT01440803|454189291|FG001|Overall Study|Withdrawal by Subject|1|||
126244803|NCT02125461|454189296|FG000|Overall Study|Withdrawal by Subject|30|||
126244804|NCT02125461|454189297|FG001|Overall Study|Withdrawal by Subject|16|||
126244805|NCT02125461|454189296|FG000|Overall Study|Lost to Follow-up|8|||
126244806|NCT02125461|454189297|FG001|Overall Study|Lost to Follow-up|3|||
126244807|NCT02125461|454189296|FG000|Overall Study|Death|260|||
126244808|NCT02125461|454189297|FG001|Overall Study|Death|149|||
126244809|NCT02125461|454189296|FG000|Overall Study|Missing Termination Reason|0|||
126244810|NCT02125461|454189297|FG001|Overall Study|Missing Termination Reason|1|||
126244811|NCT01244620|454189301|FG000|Overall Study|Study terminated|4|||
126244812|NCT01244620|454189302|FG001|Overall Study|Study terminated|4|||
126244813|NCT01244620|454189303|FG002|Overall Study|Study terminated|4|||
126244814|NCT01244620|454189304|FG003|Overall Study|Study terminated|4|||
126244815|NCT01663233|454189306|FG000|Overall Study|Withdrawal by Subject|3|||
126244816|NCT01663233|454189307|FG001|Overall Study|Withdrawal by Subject|2|||
126244817|NCT01663233|454189306|FG000|Overall Study|Protocol Deviation|1|||
126244818|NCT01663233|454189307|FG001|Overall Study|Protocol Deviation|4|||
126244819|NCT01663233|454189306|FG000|Overall Study|Lost to Follow-up|0|||
126244820|NCT01663233|454189307|FG001|Overall Study|Lost to Follow-up|1|||
126244821|NCT02321098|454189308|FG000|12 Weeks Treament|Lost to Follow-up|1|||
126244822|NCT02321098|454189309|FG001|12 Weeks Treament|Lost to Follow-up|1|||
126244823|NCT02321098|454189310|FG002|12 Weeks Treament|Lost to Follow-up|0|||
126244824|NCT02321098|454189308|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
126244825|NCT02321098|454189309|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
126244826|NCT02321098|454189310|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
126244827|NCT02321098|454189308|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
126244828|NCT02321098|454189309|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
126244829|NCT02321098|454189310|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
126244830|NCT02321098|454189308|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
126244831|NCT02321098|454189309|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
126244832|NCT02321098|454189310|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
126244833|NCT05630885|454189313|FG000|Study Completion|Took prohibited medications|2|||
126244834|NCT05630885|454189314|FG001|Study Completion|Took prohibited medications|0|||
126244835|NCT05630885|454189313|FG000|Study Completion|Non-compliance with study drug|1|||
126244836|NCT05630885|454189314|FG001|Study Completion|Non-compliance with study drug|0|||
126244837|NCT05630885|454189313|FG000|Study Completion|Adverse Event|1|||
126244838|NCT05630885|454189314|FG001|Study Completion|Adverse Event|0|||
126244839|NCT05630885|454189313|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
126244840|NCT05630885|454189314|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
126244841|NCT05630885|454189313|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
126244842|NCT05630885|454189314|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
126244843|NCT01370733|454189315|FG000|Overall Study|Withdrawal by Subject|8|||
126244844|NCT01370733|454189316|FG001|Overall Study|Withdrawal by Subject|8|||
126244845|NCT01370733|454189315|FG000|Overall Study|Lost to Follow-up|3|||
126244846|NCT01370733|454189316|FG001|Overall Study|Lost to Follow-up|0|||
126244847|NCT01370733|454189315|FG000|Overall Study|Adverse Event|2|||
126244848|NCT01370733|454189316|FG001|Overall Study|Adverse Event|4|||
126244849|NCT01370733|454189315|FG000|Overall Study|Lack of Efficacy|3|||
126244850|NCT01370733|454189316|FG001|Overall Study|Lack of Efficacy|5|||
126244851|NCT01370733|454189315|FG000|Overall Study|Physician Decision|0|||
126244852|NCT01370733|454189316|FG001|Overall Study|Physician Decision|2|||
126244853|NCT01370733|454189315|FG000|Overall Study|Protocol Violation|1|||
126244854|NCT01370733|454189316|FG001|Overall Study|Protocol Violation|3|||
126244855|NCT06539676|454189317|FG000|Overall Study|Early study termination|1|||
125879195|NCT02118584|452855255|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
125879196|NCT02118584|452855253|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125879197|NCT02118584|452855254|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
125879198|NCT02118584|452855255|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125879199|NCT02118584|452855253|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
125879200|NCT02118584|452855254|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
125879201|NCT02118584|452855255|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
125879202|NCT03103542|452855258|FG000|Overall Study|Physician Decision|2|||
125879203|NCT03103542|452855258|FG000|Overall Study|Adverse Event|2|||
125879204|NCT03103542|452855258|FG000|Overall Study|Other|2|||
125879205|NCT03103542|452855258|FG000|Overall Study|Withdrawal by Subject|1|||
125879206|NCT02939287|452855259|FG000|Overall Study|met exclusion criteria|1|||
125879207|NCT02939287|452855260|FG001|Overall Study|met exclusion criteria|1|||
125879208|NCT02939287|452855261|FG002|Overall Study|met exclusion criteria|1|||
125879209|NCT02939287|452855259|FG000|Overall Study|Did not complete survey|2|||
125879210|NCT02939287|452855260|FG001|Overall Study|Did not complete survey|2|||
125879211|NCT02939287|452855261|FG002|Overall Study|Did not complete survey|0|||
125879212|NCT02939287|452855259|FG000|Overall Study|Withdrawal by Subject|1|||
125879213|NCT02939287|452855260|FG001|Overall Study|Withdrawal by Subject|1|||
125879214|NCT02939287|452855261|FG002|Overall Study|Withdrawal by Subject|0|||
125879215|NCT03406780|452855262|FG000|Overall Study|Withdrawal by Subject|1|||
125879216|NCT03406780|452855263|FG001|Overall Study|Withdrawal by Subject|1|||
125879217|NCT03406780|452855262|FG000|Overall Study|Other|0|||
125879218|NCT03406780|452855263|FG001|Overall Study|Other|2|||
125879219|NCT00837434|452855267|FG000|Overall Study|Physician Decision|3|||
125879220|NCT00837434|452855268|FG001|Overall Study|Physician Decision|0|||
125879221|NCT00837434|452855267|FG000|Overall Study|Lost to Follow-up|1|||
125879222|NCT00837434|452855268|FG001|Overall Study|Lost to Follow-up|1|||
125879223|NCT00837434|452855267|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
126244856|NCT06539676|454189318|FG001|Overall Study|Early study termination|0|||
126244857|NCT06539676|454189319|FG002|Overall Study|Early study termination|6|||
126244858|NCT02645409|454189320|FG000|Overall Study|Withdrawal by Subject|3|||
126244859|NCT02645409|454189321|FG001|Overall Study|Withdrawal by Subject|0|||
126244860|NCT02645409|454189320|FG000|Overall Study|Physician Decision|1|||
126244861|NCT02645409|454189321|FG001|Overall Study|Physician Decision|0|||
126244862|NCT03419403|454189322|FG000|Overall Study|Withdrawal by Subject|5|||
126244863|NCT03419403|454189323|FG001|Overall Study|Withdrawal by Subject|2|||
126244864|NCT03419403|454189324|FG002|Overall Study|Withdrawal by Subject|5|||
126244865|NCT03419403|454189325|FG003|Overall Study|Withdrawal by Subject|1|||
126244866|NCT03419403|454189322|FG000|Overall Study|Progressive disease (per protocol)|0|||
126244867|NCT03419403|454189323|FG001|Overall Study|Progressive disease (per protocol)|2|||
126244868|NCT03419403|454189324|FG002|Overall Study|Progressive disease (per protocol)|2|||
126244869|NCT03419403|454189325|FG003|Overall Study|Progressive disease (per protocol)|0|||
126244870|NCT03419403|454189322|FG000|Overall Study|Other, not specified|6|||
126244871|NCT03419403|454189323|FG001|Overall Study|Other, not specified|4|||
126244872|NCT03419403|454189324|FG002|Overall Study|Other, not specified|5|||
126244873|NCT03419403|454189325|FG003|Overall Study|Other, not specified|1|||
126244874|NCT03419403|454189322|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
126244875|NCT03419403|454189323|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
126244876|NCT03419403|454189324|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
126244877|NCT03419403|454189325|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
126244878|NCT02089685|454189330|FG000|Overall Study|Adverse Event|1|||
126244879|NCT02089685|454189331|FG001|Overall Study|Adverse Event|0|||
126244880|NCT02089685|454189332|FG002|Overall Study|Adverse Event|0|||
126244881|NCT02089685|454189333|FG003|Overall Study|Adverse Event|0|||
126244882|NCT02089685|454189334|FG004|Overall Study|Adverse Event|1|||
126244883|NCT02089685|454189335|FG005|Overall Study|Adverse Event|0|||
126244884|NCT02089685|454189330|FG000|Overall Study|Clinical Progression|4|||
126244885|NCT02089685|454189331|FG001|Overall Study|Clinical Progression|0|||
126244886|NCT02089685|454189332|FG002|Overall Study|Clinical Progression|0|||
126244887|NCT02089685|454189333|FG003|Overall Study|Clinical Progression|5|||
126244888|NCT02089685|454189334|FG004|Overall Study|Clinical Progression|1|||
126244889|NCT02089685|454189335|FG005|Overall Study|Clinical Progression|2|||
126244890|NCT02089685|454189330|FG000|Overall Study|Excluded Medication|1|||
126244891|NCT02089685|454189331|FG001|Overall Study|Excluded Medication|0|||
125879224|NCT00837434|452855268|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
126094187|NCT00506441|453639152|FG001|Period 2; Double-blind Period|Physician Decision|1|||
125879225|NCT00837434|452855267|FG000|Overall Study|Noncompliant|2|||
125879226|NCT00837434|452855268|FG001|Overall Study|Noncompliant|0|||
125879227|NCT00837434|452855267|FG000|Overall Study|Baseline assessments not done in time|1|||
125879228|NCT00837434|452855268|FG001|Overall Study|Baseline assessments not done in time|0|||
126244892|NCT02089685|454189332|FG002|Overall Study|Excluded Medication|0|||
125879229|NCT00837434|452855267|FG000|Overall Study|Unable to obtain study drug|1|||
125879230|NCT00837434|452855268|FG001|Overall Study|Unable to obtain study drug|0|||
126244893|NCT02089685|454189333|FG003|Overall Study|Excluded Medication|11|||
126244894|NCT02089685|454189334|FG004|Overall Study|Excluded Medication|2|||
126244895|NCT02089685|454189335|FG005|Overall Study|Excluded Medication|1|||
126244896|NCT02089685|454189330|FG000|Overall Study|Progressive disease|13|||
126244897|NCT02089685|454189331|FG001|Overall Study|Progressive disease|10|||
126244898|NCT02089685|454189332|FG002|Overall Study|Progressive disease|3|||
126244899|NCT02089685|454189333|FG003|Overall Study|Progressive disease|51|||
126244900|NCT02089685|454189334|FG004|Overall Study|Progressive disease|17|||
126244901|NCT02089685|454189335|FG005|Overall Study|Progressive disease|12|||
126244902|NCT02089685|454189330|FG000|Overall Study|Follow up ended by sponsor|2|||
126244903|NCT02089685|454189331|FG001|Overall Study|Follow up ended by sponsor|2|||
126244904|NCT02089685|454189332|FG002|Overall Study|Follow up ended by sponsor|0|||
126244905|NCT02089685|454189333|FG003|Overall Study|Follow up ended by sponsor|70|||
126244906|NCT02089685|454189334|FG004|Overall Study|Follow up ended by sponsor|26|||
126244907|NCT02089685|454189335|FG005|Overall Study|Follow up ended by sponsor|26|||
126244908|NCT02089685|454189330|FG000|Overall Study|Withdrawal by Subject|0|||
126244909|NCT02089685|454189331|FG001|Overall Study|Withdrawal by Subject|2|||
126244910|NCT02089685|454189332|FG002|Overall Study|Withdrawal by Subject|0|||
126244911|NCT02089685|454189333|FG003|Overall Study|Withdrawal by Subject|8|||
126244912|NCT02089685|454189334|FG004|Overall Study|Withdrawal by Subject|1|||
126244913|NCT02089685|454189335|FG005|Overall Study|Withdrawal by Subject|1|||
126244914|NCT02089685|454189330|FG000|Overall Study|Status not recorded|1|||
126244915|NCT02089685|454189331|FG001|Overall Study|Status not recorded|0|||
126244916|NCT02089685|454189332|FG002|Overall Study|Status not recorded|0|||
126244917|NCT02089685|454189333|FG003|Overall Study|Status not recorded|0|||
126244918|NCT02089685|454189334|FG004|Overall Study|Status not recorded|1|||
126244919|NCT02089685|454189335|FG005|Overall Study|Status not recorded|0|||
126094188|NCT00506441|453639151|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
126094189|NCT00506441|453639152|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
126094190|NCT00506441|453639151|FG000|Period 2; Double-blind Period|Other Reason|1|||
126094191|NCT00506441|453639152|FG001|Period 2; Double-blind Period|Other Reason|1|||
126094192|NCT01215188|453639153|FG000|Overall Study|Lost to Follow-up|22|||
126094193|NCT01215188|453639154|FG001|Overall Study|Lost to Follow-up|22|||
126094194|NCT01215188|453639155|FG002|Overall Study|Lost to Follow-up|16|||
126094195|NCT01215188|453639153|FG000|Overall Study|Adverse Event|1|||
126094196|NCT01215188|453639154|FG001|Overall Study|Adverse Event|1|||
126094197|NCT01215188|453639155|FG002|Overall Study|Adverse Event|3|||
126094198|NCT01215188|453639153|FG000|Overall Study|Physician Decision|2|||
126094199|NCT01215188|453639154|FG001|Overall Study|Physician Decision|1|||
126094200|NCT01215188|453639155|FG002|Overall Study|Physician Decision|0|||
126094201|NCT01215188|453639153|FG000|Overall Study|Lack of Efficacy|0|||
126094202|NCT01215188|453639154|FG001|Overall Study|Lack of Efficacy|0|||
126094203|NCT01215188|453639155|FG002|Overall Study|Lack of Efficacy|1|||
126094204|NCT01215188|453639153|FG000|Overall Study|Protocol Violation|1|||
126094205|NCT01215188|453639154|FG001|Overall Study|Protocol Violation|1|||
126094206|NCT01215188|453639155|FG002|Overall Study|Protocol Violation|1|||
126094207|NCT01215188|453639153|FG000|Overall Study|Withdrawal by Subject|32|||
126094208|NCT01215188|453639154|FG001|Overall Study|Withdrawal by Subject|34|||
126094209|NCT01215188|453639155|FG002|Overall Study|Withdrawal by Subject|31|||
126094210|NCT02601300|453639156|FG000|Induction Phase|Lack of Efficacy|2|||
126094211|NCT02601300|453639156|FG000|Induction Phase|Protocol Violation|1|||
126094212|NCT02601300|453639156|FG000|Extension Phase|Withdrawal by Subject|3|||
126094213|NCT02601300|453639156|FG000|Extension Phase|Adverse Event|4|||
126094214|NCT02601300|453639156|FG000|Extension Phase|Lack of Efficacy|10|||
126094215|NCT00528931|453639160|FG000|Overall Study|Lost to Follow-up|1|||
126094216|NCT00992225|453639161|FG000|Overall Study|Entry Criteria Not Met|8|||
126094217|NCT00992225|453639161|FG000|Overall Study|Adverse Event|2|||
126094218|NCT00291642|453639164|FG000|Overall Study|Adverse Event|1|||
126094219|NCT00291642|453639165|FG001|Overall Study|Adverse Event|0|||
126094220|NCT00291642|453639166|FG002|Overall Study|Adverse Event|1|||
126094221|NCT00291642|453639167|FG003|Overall Study|Adverse Event|0|||
126244920|NCT02089685|454189330|FG000|Overall Study|Death|0|||
126244921|NCT02089685|454189331|FG001|Overall Study|Death|0|||
126244922|NCT02089685|454189332|FG002|Overall Study|Death|0|||
126244923|NCT02089685|454189333|FG003|Overall Study|Death|7|||
126244924|NCT02089685|454189334|FG004|Overall Study|Death|2|||
126244925|NCT02089685|454189335|FG005|Overall Study|Death|5|||
126094222|NCT00291642|453639168|FG004|Overall Study|Adverse Event|1|||
126094223|NCT00291642|453639164|FG000|Overall Study|Patient missed visit|0|||
126094224|NCT00291642|453639165|FG001|Overall Study|Patient missed visit|0|||
126094225|NCT00291642|453639166|FG002|Overall Study|Patient missed visit|1|||
126094226|NCT00291642|453639167|FG003|Overall Study|Patient missed visit|0|||
126094227|NCT00291642|453639168|FG004|Overall Study|Patient missed visit|0|||
126094228|NCT00291642|453639164|FG000|Overall Study|Intake of prohibited medication|1|||
126094229|NCT00291642|453639165|FG001|Overall Study|Intake of prohibited medication|0|||
126244926|NCT02089685|454189330|FG000|Overall Study|Lost to Follow-up|0|||
126244927|NCT02089685|454189331|FG001|Overall Study|Lost to Follow-up|0|||
126244928|NCT02089685|454189332|FG002|Overall Study|Lost to Follow-up|0|||
126244929|NCT02089685|454189333|FG003|Overall Study|Lost to Follow-up|1|||
126244930|NCT02089685|454189334|FG004|Overall Study|Lost to Follow-up|0|||
126244931|NCT02089685|454189335|FG005|Overall Study|Lost to Follow-up|0|||
126244932|NCT02089685|454189330|FG000|Overall Study|Physician Decision|0|||
126244933|NCT02089685|454189331|FG001|Overall Study|Physician Decision|0|||
126244934|NCT02089685|454189332|FG002|Overall Study|Physician Decision|0|||
126244935|NCT02089685|454189333|FG003|Overall Study|Physician Decision|0|||
126244936|NCT02089685|454189334|FG004|Overall Study|Physician Decision|0|||
126244937|NCT02089685|454189335|FG005|Overall Study|Physician Decision|4|||
126244938|NCT02089685|454189330|FG000|Overall Study|Screen failure|1|||
126244939|NCT02089685|454189331|FG001|Overall Study|Screen failure|0|||
126244940|NCT02089685|454189332|FG002|Overall Study|Screen failure|0|||
126244941|NCT02089685|454189333|FG003|Overall Study|Screen failure|0|||
126244942|NCT02089685|454189334|FG004|Overall Study|Screen failure|0|||
126244943|NCT02089685|454189335|FG005|Overall Study|Screen failure|0|||
126244944|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Adverse Event|11|||
126244945|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Adverse Event|23|||
126244946|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Adverse Event|29|||
126244947|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Adverse Event|2|||
126244948|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Adverse Event|8|||
126244949|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
126244950|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
126244951|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
126244952|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
126244953|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
126244954|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
126244955|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
126244956|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
126244957|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
126244958|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
126244959|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
126244960|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
126244961|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
126244962|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
126244963|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
126244964|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
126244965|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
126244966|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
126244967|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
126244968|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
126244969|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
126244970|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
126244971|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
126244972|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
126244973|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
126244974|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
126244975|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
126244976|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
126244977|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
126244978|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
126244979|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Move|0|||
126244980|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Move|1|||
126244981|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Move|0|||
126244982|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Move|0|||
126244983|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Move|0|||
126244984|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
126244985|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
126244986|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
126244987|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125879231|NCT03041038|452855285|FG000|Overall Study|Withdrawal by Subject|4|||
126244988|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
126244989|NCT00318461|454189336|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
126244990|NCT00318461|454189337|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
126244991|NCT00318461|454189338|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
126244992|NCT00318461|454189339|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
126244993|NCT00318461|454189340|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
126244994|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Work commitment|0|||
126244995|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Work commitment|0|||
126244996|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Work commitment|0|||
126244997|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Work commitment|0|||
126244998|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Work commitment|1|||
126244999|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Investigator decision|0|||
126245000|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Investigator decision|0|||
126245001|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Investigator decision|0|||
126245002|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Investigator decision|0|||
126245003|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Investigator decision|1|||
126245004|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Lack of time|1|||
126245005|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Lack of time|0|||
126245006|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Lack of time|0|||
126245007|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Lack of time|0|||
126245008|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Lack of time|0|||
126245009|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
126245010|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
126245011|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
126245012|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
126245013|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
126245014|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
126245015|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
126245016|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
126245017|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
126245018|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
126245019|NCT00318461|454189336|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
126245020|NCT00318461|454189337|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
126245021|NCT00318461|454189338|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
126245022|NCT00318461|454189339|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
126245023|NCT00318461|454189340|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
126245024|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
126245025|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
126245026|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
126245027|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
126245028|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
126245029|NCT00318461|454189336|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
126245030|NCT00318461|454189337|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
126245031|NCT00318461|454189338|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
126245032|NCT00318461|454189339|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
126245033|NCT00318461|454189340|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
126245034|NCT00318461|454189336|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
125879232|NCT03041038|452855286|FG001|Overall Study|Withdrawal by Subject|0|||
125879233|NCT03041038|452855285|FG000|Overall Study|Lost to Follow-up|1|||
126245035|NCT00318461|454189337|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
126245036|NCT00318461|454189338|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
126245037|NCT00318461|454189339|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
126245038|NCT00318461|454189340|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
126245039|NCT00318461|454189336|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
126357511|NCT01851369|454602125|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357512|NCT01851369|454602126|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357513|NCT01851369|454602127|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357514|NCT01851369|454602128|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357515|NCT02453191|454602129|FG000|Overall Study|Withdrawal by Subject|1|||
126357516|NCT03364686|454602130|FG000|Overall Study|Physician Decision|2|||
126357517|NCT02336503|454602133|FG000|Overall Study|Lost to Follow-up|0|||
126357518|NCT02336503|454602134|FG001|Overall Study|Lost to Follow-up|3|||
126357519|NCT02336503|454602135|FG002|Overall Study|Lost to Follow-up|0|||
126357520|NCT02336503|454602136|FG003|Overall Study|Lost to Follow-up|2|||
126357521|NCT02336503|454602133|FG000|Overall Study|Withdrawal by Subject|2|||
126357522|NCT02336503|454602134|FG001|Overall Study|Withdrawal by Subject|0|||
126357523|NCT02336503|454602135|FG002|Overall Study|Withdrawal by Subject|0|||
125879234|NCT03041038|452855286|FG001|Overall Study|Lost to Follow-up|1|||
126026485|NCT03580369|453391693|FG001|Overall Study|Adverse Event|0|||
126026486|NCT03580369|453391694|FG002|Overall Study|Adverse Event|14|||
126026487|NCT03580369|453391695|FG003|Overall Study|Adverse Event|1|||
126026488|NCT03580369|453391696|FG004|Overall Study|Adverse Event|6|||
126026489|NCT03580369|453391697|FG005|Overall Study|Adverse Event|0|||
126026490|NCT03580369|453391698|FG006|Overall Study|Adverse Event|1|||
126026491|NCT03580369|453391699|FG007|Overall Study|Adverse Event|0|||
126026492|NCT03580369|453391692|FG000|Overall Study|Withdrawal by Subject|19|||
126026493|NCT03580369|453391693|FG001|Overall Study|Withdrawal by Subject|0|||
126026494|NCT03580369|453391694|FG002|Overall Study|Withdrawal by Subject|17|||
126026495|NCT03580369|453391695|FG003|Overall Study|Withdrawal by Subject|0|||
126026496|NCT03580369|453391696|FG004|Overall Study|Withdrawal by Subject|16|||
126026497|NCT03580369|453391697|FG005|Overall Study|Withdrawal by Subject|1|||
126026498|NCT03580369|453391698|FG006|Overall Study|Withdrawal by Subject|7|||
126026499|NCT03580369|453391699|FG007|Overall Study|Withdrawal by Subject|0|||
126026500|NCT03152786|453393528|FG000|Overall Study|Withdrawal by Subject|2|||
126026501|NCT03152786|453393529|FG001|Overall Study|Withdrawal by Subject|1|||
126026502|NCT04923347|453393530|FG000|Overall Study|Withdrawal by Subject|14|||
126026503|NCT00753090|453393542|FG000|Overall Study|Withdrawal by Subject|10|||
126026504|NCT00753090|453393543|FG001|Overall Study|Withdrawal by Subject|10|||
126026505|NCT00753090|453393542|FG000|Overall Study|Death|17|||
126026506|NCT00753090|453393543|FG001|Overall Study|Death|6|||
126026507|NCT00753090|453393542|FG000|Overall Study|Study Prosthesis Removed|12|||
126026508|NCT00753090|453393543|FG001|Overall Study|Study Prosthesis Removed|3|||
126026509|NCT00753090|453393542|FG000|Overall Study|Lost to Follow-up|2|||
126026510|NCT00753090|453393543|FG001|Overall Study|Lost to Follow-up|2|||
126026511|NCT00753090|453393542|FG000|Overall Study|Other|127|||
126026512|NCT00753090|453393543|FG001|Overall Study|Other|75|||
126026513|NCT06066541|453393550|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
126026514|NCT06066541|453393551|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
126026515|NCT06066541|453393552|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
126026516|NCT06066541|453393553|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
126026517|NCT06066541|453393554|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
126026518|NCT06066541|453393555|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
126026519|NCT06066541|453393556|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
126026520|NCT06066541|453393550|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
126026521|NCT06066541|453393551|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
126026522|NCT06066541|453393552|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
126026523|NCT06066541|453393553|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
126026524|NCT06066541|453393554|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
126026525|NCT06066541|453393555|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
126026526|NCT06066541|453393556|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
126026527|NCT02819843|453393557|FG000|Overall Study|Disease progression before RT|0|||
126026528|NCT02819843|453393558|FG001|Overall Study|Disease progression before RT|1|||
126026529|NCT03055858|453393560|FG000|Overall Study|Death|9|||
126026530|NCT03055858|453393560|FG000|Overall Study|Withdrawal by Subject|11|||
126094230|NCT00291642|453639166|FG002|Overall Study|Intake of prohibited medication|0|||
126094231|NCT00291642|453639167|FG003|Overall Study|Intake of prohibited medication|0|||
126245040|NCT00318461|454189337|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
126245041|NCT00318461|454189338|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
126245042|NCT00318461|454189339|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
126245043|NCT00318461|454189340|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
126245044|NCT00318461|454189336|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
126245045|NCT00318461|454189337|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
126245046|NCT00318461|454189338|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
126245047|NCT00318461|454189339|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
126245048|NCT00318461|454189340|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
126245049|NCT00796653|454189344|FG000|Overall Study|Adverse Event|19|||
126245050|NCT00796653|454189345|FG001|Overall Study|Adverse Event|16|||
126245051|NCT00796653|454189346|FG002|Overall Study|Adverse Event|16|||
126245052|NCT00796653|454189347|FG003|Overall Study|Adverse Event|16|||
126245053|NCT00796653|454189344|FG000|Overall Study|Lost to Follow-up|2|||
126245054|NCT00796653|454189345|FG001|Overall Study|Lost to Follow-up|1|||
126026531|NCT03055858|453393560|FG000|Overall Study|Lost to Follow-up|6|||
126245055|NCT00796653|454189346|FG002|Overall Study|Lost to Follow-up|2|||
126245056|NCT00796653|454189347|FG003|Overall Study|Lost to Follow-up|3|||
126245057|NCT00796653|454189344|FG000|Overall Study|Withdrawal by Subject|16|||
126245058|NCT00796653|454189345|FG001|Overall Study|Withdrawal by Subject|8|||
126245059|NCT00796653|454189346|FG002|Overall Study|Withdrawal by Subject|8|||
126245060|NCT00796653|454189347|FG003|Overall Study|Withdrawal by Subject|13|||
126245061|NCT00796653|454189344|FG000|Overall Study|Lack of Efficacy|8|||
126245062|NCT00796653|454189345|FG001|Overall Study|Lack of Efficacy|1|||
126245063|NCT00796653|454189346|FG002|Overall Study|Lack of Efficacy|3|||
126245064|NCT00796653|454189347|FG003|Overall Study|Lack of Efficacy|2|||
126245065|NCT00796653|454189344|FG000|Overall Study|Non compliance with protocol|2|||
126245066|NCT00796653|454189345|FG001|Overall Study|Non compliance with protocol|2|||
126245067|NCT00796653|454189346|FG002|Overall Study|Non compliance with protocol|0|||
126245068|NCT00796653|454189347|FG003|Overall Study|Non compliance with protocol|2|||
126245069|NCT00796653|454189344|FG000|Overall Study|Other reason not described above|4|||
126245070|NCT00796653|454189345|FG001|Overall Study|Other reason not described above|9|||
126245071|NCT00796653|454189346|FG002|Overall Study|Other reason not described above|7|||
126245072|NCT00796653|454189347|FG003|Overall Study|Other reason not described above|4|||
126245073|NCT01848938|454189356|FG000|Overall Study|Lost to Follow-up|1|||
126245074|NCT01848938|454189357|FG001|Overall Study|Lost to Follow-up|1|||
126245075|NCT00207090|454189360|FG000|Overall Study|Study drug toxicity|3|||
126245076|NCT00207090|454189360|FG000|Overall Study|Chest wall mass larger|1|||
126245077|NCT00207090|454189360|FG000|Overall Study|Disease progression/relapse|2|||
126245078|NCT00207090|454189360|FG000|Overall Study|Physician Decision|1|||
126245079|NCT00651820|454189371|FG000|Overall Study|Lost to Follow-up|2|||
126245080|NCT01911676|454189372|FG000|Period 1 of Study|Withdrawal by Subject|4|||
126245081|NCT01911676|454189373|FG001|Period 1 of Study|Withdrawal by Subject|2|||
126245082|NCT01911676|454189374|FG002|Period 1 of Study|Withdrawal by Subject|1|||
126245083|NCT01911676|454189375|FG003|Period 1 of Study|Withdrawal by Subject|2|||
126245084|NCT01911676|454189372|FG000|Period 1 of Study|Physician Decision|2|||
126245085|NCT01911676|454189373|FG001|Period 1 of Study|Physician Decision|0|||
126245086|NCT01911676|454189374|FG002|Period 1 of Study|Physician Decision|0|||
126357524|NCT02336503|454602136|FG003|Overall Study|Withdrawal by Subject|4|||
126245087|NCT01911676|454189375|FG003|Period 1 of Study|Physician Decision|1|||
126357525|NCT02336503|454602133|FG000|Overall Study|Adverse Event|0|||
126357526|NCT02336503|454602134|FG001|Overall Study|Adverse Event|0|||
126357527|NCT02336503|454602135|FG002|Overall Study|Adverse Event|1|||
126357528|NCT02336503|454602136|FG003|Overall Study|Adverse Event|0|||
126357529|NCT01543503|454602137|FG000|Overall Study|Lost to Follow-up|32|||
126357530|NCT01543503|454602138|FG001|Overall Study|Lost to Follow-up|36|||
126357531|NCT01543503|454602137|FG000|Overall Study|Adverse Event|9|||
126357532|NCT01543503|454602138|FG001|Overall Study|Adverse Event|13|||
126357533|NCT01543503|454602137|FG000|Overall Study|Lack of Efficacy|4|||
126357534|NCT01543503|454602138|FG001|Overall Study|Lack of Efficacy|16|||
126245088|NCT01911676|454189372|FG000|Period 2 of Study|Physician Decision|2|||
126245089|NCT01911676|454189373|FG001|Period 2 of Study|Physician Decision|0|||
126245090|NCT01911676|454189374|FG002|Period 2 of Study|Physician Decision|0|||
126245091|NCT01911676|454189375|FG003|Period 2 of Study|Physician Decision|1|||
126245092|NCT01911676|454189372|FG000|Period 2 of Study|Lost to Follow-up|0|||
126245093|NCT01911676|454189373|FG001|Period 2 of Study|Lost to Follow-up|0|||
126245094|NCT01911676|454189374|FG002|Period 2 of Study|Lost to Follow-up|0|||
126245095|NCT01911676|454189375|FG003|Period 2 of Study|Lost to Follow-up|1|||
126245096|NCT01878292|454189376|FG000|Randomized|Protocol Violation|1|||
126245097|NCT01878292|454189377|FG001|Randomized|Protocol Violation|0|||
126245098|NCT01878292|454189378|FG002|Randomized|Protocol Violation|0|||
126245099|NCT01878292|454189376|FG000|Randomized|Lost to Follow-up|1|||
126245100|NCT01878292|454189377|FG001|Randomized|Lost to Follow-up|0|||
126245101|NCT01878292|454189378|FG002|Randomized|Lost to Follow-up|0|||
126245102|NCT01878292|454189376|FG000|Randomized|Adverse Event|1|||
126245103|NCT01878292|454189377|FG001|Randomized|Adverse Event|0|||
126245104|NCT01878292|454189378|FG002|Randomized|Adverse Event|0|||
126245105|NCT01878292|454189376|FG000|Double-blind Treatment Period|Other Reasons|2|||
126245106|NCT01878292|454189377|FG001|Double-blind Treatment Period|Other Reasons|0|||
126245107|NCT01878292|454189378|FG002|Double-blind Treatment Period|Other Reasons|0|||
126245108|NCT01878292|454189376|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
126245109|NCT01878292|454189377|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
126245110|NCT01878292|454189378|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
126245111|NCT01878292|454189376|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
126245112|NCT01878292|454189377|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
126245113|NCT01878292|454189378|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
126245114|NCT01878292|454189376|FG000|Double-blind Treatment Period|Protocol Violation|3|||
126245115|NCT01878292|454189377|FG001|Double-blind Treatment Period|Protocol Violation|4|||
126245116|NCT01878292|454189378|FG002|Double-blind Treatment Period|Protocol Violation|2|||
126245117|NCT01878292|454189376|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
126245118|NCT01878292|454189377|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
126245119|NCT01878292|454189378|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
126245120|NCT01878292|454189376|FG000|Double-blind Treatment Period|Adverse Event|4|||
126245121|NCT01878292|454189377|FG001|Double-blind Treatment Period|Adverse Event|9|||
126245122|NCT01878292|454189378|FG002|Double-blind Treatment Period|Adverse Event|8|||
126245123|NCT01878292|454189376|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
126357535|NCT01543503|454602137|FG000|Overall Study|Participant withdrew informed consent|8|||
126357536|NCT01543503|454602138|FG001|Overall Study|Participant withdrew informed consent|10|||
126357537|NCT01543503|454602137|FG000|Overall Study|Change of jobs|0|||
126357538|NCT01543503|454602138|FG001|Overall Study|Change of jobs|1|||
126357539|NCT01543503|454602137|FG000|Overall Study|Intolerance to the biologic treatment|0|||
126357540|NCT01543503|454602138|FG001|Overall Study|Intolerance to the biologic treatment|1|||
126357541|NCT01543503|454602137|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
126357542|NCT01543503|454602138|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
126357543|NCT01543503|454602137|FG000|Overall Study|Participant did not complete last visit|0|||
126357544|NCT01543503|454602138|FG001|Overall Study|Participant did not complete last visit|2|||
126357545|NCT01543503|454602137|FG000|Overall Study|Refused to continue treatment|7|||
126357546|NCT01543503|454602138|FG001|Overall Study|Refused to continue treatment|0|||
126357547|NCT01543503|454602137|FG000|Overall Study|Incorrect medication received|1|||
126357548|NCT01543503|454602138|FG001|Overall Study|Incorrect medication received|0|||
126357549|NCT01543503|454602137|FG000|Overall Study|Participant moved to another city|2|||
126357550|NCT01543503|454602138|FG001|Overall Study|Participant moved to another city|0|||
126357551|NCT01543503|454602137|FG000|Overall Study|Participant will not return for visits|0|||
126357552|NCT01543503|454602138|FG001|Overall Study|Participant will not return for visits|2|||
126357553|NCT01543503|454602137|FG000|Overall Study|Participant transferred to another city|1|||
126357554|NCT01543503|454602138|FG001|Overall Study|Participant transferred to another city|0|||
126357555|NCT01543503|454602137|FG000|Overall Study|Participant moved to Scotland|1|||
126357556|NCT01543503|454602138|FG001|Overall Study|Participant moved to Scotland|0|||
126357557|NCT01543503|454602137|FG000|Overall Study|Participant decision to stop treatment|1|||
126357558|NCT01543503|454602138|FG001|Overall Study|Participant decision to stop treatment|0|||
126357559|NCT01543503|454602137|FG000|Overall Study|Investigator did not wish to participate|1|||
126357560|NCT01543503|454602138|FG001|Overall Study|Investigator did not wish to participate|1|||
126357561|NCT01543503|454602137|FG000|Overall Study|Participant recruited after closing date|0|||
126357562|NCT01543503|454602138|FG001|Overall Study|Participant recruited after closing date|1|||
126357563|NCT01543503|454602137|FG000|Overall Study|Site stopped participation|5|||
126357564|NCT01543503|454602138|FG001|Overall Study|Site stopped participation|1|||
126357565|NCT01543503|454602137|FG000|Overall Study|Participant did not attend a visit|1|||
126357566|NCT01543503|454602138|FG001|Overall Study|Participant did not attend a visit|0|||
126357567|NCT01543503|454602137|FG000|Overall Study|Moved to other rheumatologic site|0|||
126357568|NCT01543503|454602138|FG001|Overall Study|Moved to other rheumatologic site|1|||
126357569|NCT01543503|454602137|FG000|Overall Study|Participant consented to another study|0|||
126357570|NCT01543503|454602138|FG001|Overall Study|Participant consented to another study|2|||
126357571|NCT01543503|454602137|FG000|Overall Study|Participant went to United States|1|||
126245124|NCT01878292|454189377|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
126245125|NCT01878292|454189378|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
126245126|NCT00773253|454189379|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
126245127|NCT00773253|454189380|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
126245128|NCT01566721|454189381|FG000|Treatment Period|Withdrawal by Subject|35|||
126245129|NCT01566721|454189382|FG001|Treatment Period|Withdrawal by Subject|9|||
126245130|NCT01566721|454189381|FG000|Treatment Period|Disease Progression/Recurrence|37|||
126245131|NCT01566721|454189382|FG001|Treatment Period|Disease Progression/Recurrence|13|||
126245132|NCT01566721|454189381|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
126245133|NCT01566721|454189382|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
126245134|NCT01566721|454189381|FG000|Treatment Period|Other|13|||
126245135|NCT01566721|454189382|FG001|Treatment Period|Other|2|||
126245136|NCT01566721|454189381|FG000|Treatment Period|Lack of Compliance|5|||
126245137|NCT01566721|454189382|FG001|Treatment Period|Lack of Compliance|1|||
126245138|NCT01566721|454189381|FG000|Treatment Period|Adverse Event|100|||
126245139|NCT01566721|454189382|FG001|Treatment Period|Adverse Event|30|||
126245140|NCT01566721|454189381|FG000|Treatment Period|Pregnancy|1|||
126245141|NCT01566721|454189382|FG001|Treatment Period|Pregnancy|0|||
126245142|NCT01566721|454189381|FG000|Safety Follow-up|Physician Decision|6|||
126245143|NCT01566721|454189382|FG001|Safety Follow-up|Physician Decision|4|||
126245144|NCT01566721|454189381|FG000|Safety Follow-up|Lost to Follow-up|101|||
126245145|NCT01566721|454189382|FG001|Safety Follow-up|Lost to Follow-up|48|||
126245146|NCT01566721|454189381|FG000|Safety Follow-up|Withdrawal by Subject|155|||
126245147|NCT01566721|454189382|FG001|Safety Follow-up|Withdrawal by Subject|49|||
126245148|NCT01566721|454189381|FG000|Safety Follow-up|Death|28|||
126245149|NCT01566721|454189382|FG001|Safety Follow-up|Death|4|||
126245150|NCT01566721|454189381|FG000|Safety Follow-up|Non-compliance|7|||
126245151|NCT01566721|454189382|FG001|Safety Follow-up|Non-compliance|3|||
126245152|NCT01566721|454189381|FG000|Safety Follow-up|Protocol Violation|7|||
126245153|NCT01566721|454189382|FG001|Safety Follow-up|Protocol Violation|0|||
126026532|NCT03055858|453393560|FG000|Overall Study|Missed Follow-Up Visits|18|||
126245154|NCT01566721|454189381|FG000|Safety Follow-up|Site closure|2|||
126245155|NCT01566721|454189382|FG001|Safety Follow-up|Site closure|3|||
126245156|NCT01566721|454189381|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
126245157|NCT01566721|454189382|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
126245158|NCT01566721|454189381|FG000|Safety Follow-up|Missing|7|||
126245159|NCT01566721|454189382|FG001|Safety Follow-up|Missing|2|||
126245160|NCT01566721|454189381|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
126245161|NCT01566721|454189382|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
126245162|NCT01566721|454189381|FG000|Safety Follow-up|Sponsor decision|1|||
126245163|NCT01566721|454189382|FG001|Safety Follow-up|Sponsor decision|0|||
126245164|NCT01566721|454189381|FG000|Safety Follow-up|Adverse Event|8|||
126245165|NCT01566721|454189382|FG001|Safety Follow-up|Adverse Event|4|||
126245166|NCT01302548|454189387|FG000|Overall Study|Lost to Follow-up|2|||
126245167|NCT01302548|454189388|FG001|Overall Study|Lost to Follow-up|1|||
126245168|NCT01237054|454189389|FG000|Overall Study|imaging 10C0096|1|||
126245169|NCT02619682|454189390|FG000|Overall Study|Withdrawal by Subject|3|||
126245170|NCT02619682|454189390|FG000|Overall Study|Lack of Efficacy|8|||
126245171|NCT02619682|454189390|FG000|Overall Study|new secondary cancer|1|||
126245172|NCT02619682|454189390|FG000|Overall Study|post surgery complications|2|||
126245173|NCT00268203|454189393|FG000|Overall Study|Lost to Follow-up|92|||
126245174|NCT00268203|454189393|FG000|Overall Study|Withdrawal by Subject|9|||
126245175|NCT00268203|454189393|FG000|Overall Study|Received Other NHL Therapy|7|||
126245176|NCT00268203|454189393|FG000|Overall Study|Progressive Disease|359|||
126245177|NCT00268203|454189393|FG000|Overall Study|Death|84|||
126245178|NCT00268203|454189393|FG000|Overall Study|Reason Not Specified|34|||
126245179|NCT00268203|454189393|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
126245180|NCT00950989|454189394|FG000|Overall Study|Death|0|||
126245181|NCT00950989|454189395|FG001|Overall Study|Death|0|||
126245182|NCT00950989|454189396|FG002|Overall Study|Death|1|||
126357572|NCT01543503|454602138|FG001|Overall Study|Participant went to United States|0|||
126357573|NCT01543503|454602137|FG000|Overall Study|Screen failure|1|||
126357574|NCT01543503|454602138|FG001|Overall Study|Screen failure|0|||
126357575|NCT01936974|454602141|FG000|Overall Study|Physician Decision|2|||
126357576|NCT01936974|454602142|FG001|Overall Study|Physician Decision|5|||
126357577|NCT04584554|454602145|FG000|Overall Study|Withdrawal by Subject|2|||
126357578|NCT04584554|454602146|FG001|Overall Study|Withdrawal by Subject|2|||
126357579|NCT00063999|454602147|FG000|Overall Study|Withdrawal by Subject|1|||
126357580|NCT00063999|454602148|FG001|Overall Study|Withdrawal by Subject|0|||
126357581|NCT00063999|454602147|FG000|Overall Study|Ineligible|44|||
126357582|NCT00063999|454602148|FG001|Overall Study|Ineligible|24|||
126357583|NCT03767894|454602149|FG000|Overall Study|Withdrawal by Subject|1|||
126245183|NCT00950989|454189397|FG003|Overall Study|Death|0|||
126245184|NCT00950989|454189394|FG000|Overall Study|Administrative Decision|0|||
126245185|NCT00950989|454189395|FG001|Overall Study|Administrative Decision|1|||
126245186|NCT00950989|454189396|FG002|Overall Study|Administrative Decision|0|||
126245187|NCT00950989|454189397|FG003|Overall Study|Administrative Decision|0|||
126245188|NCT00950989|454189394|FG000|Overall Study|Disease Progression|0|||
126245189|NCT00950989|454189395|FG001|Overall Study|Disease Progression|0|||
126245190|NCT00950989|454189396|FG002|Overall Study|Disease Progression|1|||
126245191|NCT00950989|454189397|FG003|Overall Study|Disease Progression|0|||
126245192|NCT00950989|454189394|FG000|Overall Study|Withdrawal by Subject|2|||
126245193|NCT00950989|454189395|FG001|Overall Study|Withdrawal by Subject|1|||
126245194|NCT00950989|454189396|FG002|Overall Study|Withdrawal by Subject|0|||
126245195|NCT00950989|454189397|FG003|Overall Study|Withdrawal by Subject|0|||
126245196|NCT00950989|454189394|FG000|Overall Study|Adverse Event|2|||
126245197|NCT00950989|454189395|FG001|Overall Study|Adverse Event|1|||
126245198|NCT00950989|454189396|FG002|Overall Study|Adverse Event|1|||
126245199|NCT00950989|454189397|FG003|Overall Study|Adverse Event|0|||
126245200|NCT02152163|454189398|FG000|Overall Study|Physician Decision|12|||
126245201|NCT02152163|454189399|FG001|Overall Study|Physician Decision|13|||
126245202|NCT00796562|454189403|FG000|Overall Study|Death|49|||
126245203|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
126245204|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
126245205|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
126245206|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
126245207|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
126245208|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
126245209|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
126245210|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
126245211|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
126245212|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
126245213|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
126245214|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
126245215|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Adverse Event|22|||
126245216|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Adverse Event|12|||
126245217|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Progression of disease|92|||
126245218|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Progression of disease|128|||
126245219|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
126245220|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
126245221|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
126245222|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
126245223|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Death|11|||
126245224|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Death|11|||
126245225|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Other|5|||
126245226|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Other|4|||
126245227|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
126245228|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
126245229|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
126245230|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
126245231|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
126245232|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
126245233|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
126245234|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
126245235|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
126245236|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
126245237|NCT00730691|454189409|FG000|Overall Study|Adverse Event|4|||
126245238|NCT00730691|454189410|FG001|Overall Study|Adverse Event|8|||
126245239|NCT00730691|454189411|FG002|Overall Study|Adverse Event|11|||
126245240|NCT00730691|454189412|FG003|Overall Study|Adverse Event|11|||
126026533|NCT04586920|453393561|FG000|Overall Study|Lost to Follow-up|0|||
126026534|NCT04586920|453393562|FG001|Overall Study|Lost to Follow-up|0|||
126026535|NCT04586920|453393563|FG002|Overall Study|Lost to Follow-up|0|||
126026536|NCT04586920|453393564|FG003|Overall Study|Lost to Follow-up|0|||
126026537|NCT04586920|453393565|FG004|Overall Study|Lost to Follow-up|0|||
126026538|NCT04586920|453393566|FG005|Overall Study|Lost to Follow-up|0|||
126026539|NCT04586920|453393567|FG006|Overall Study|Lost to Follow-up|1|||
126026540|NCT04586920|453393568|FG007|Overall Study|Lost to Follow-up|1|||
126026541|NCT04586920|453393569|FG008|Overall Study|Lost to Follow-up|0|||
126026542|NCT04586920|453393570|FG009|Overall Study|Lost to Follow-up|1|||
126026543|NCT04586920|453393571|FG010|Overall Study|Lost to Follow-up|0|||
126026544|NCT04586920|453393572|FG011|Overall Study|Lost to Follow-up|0|||
126026545|NCT04586920|453393573|FG012|Overall Study|Lost to Follow-up|0|||
126026546|NCT04586920|453393574|FG013|Overall Study|Lost to Follow-up|1|||
126026547|NCT04586920|453393575|FG014|Overall Study|Lost to Follow-up|0|||
126026548|NCT04586920|453393576|FG015|Overall Study|Lost to Follow-up|0|||
126026549|NCT04586920|453393577|FG016|Overall Study|Lost to Follow-up|0|||
126026550|NCT04586920|453393578|FG017|Overall Study|Lost to Follow-up|0|||
126026551|NCT04586920|453393561|FG000|Overall Study|Withdrawal by Subject|0|||
126026552|NCT04586920|453393562|FG001|Overall Study|Withdrawal by Subject|0|||
126026553|NCT04586920|453393563|FG002|Overall Study|Withdrawal by Subject|0|||
126026554|NCT04586920|453393564|FG003|Overall Study|Withdrawal by Subject|0|||
126026555|NCT04586920|453393565|FG004|Overall Study|Withdrawal by Subject|0|||
126026556|NCT04586920|453393566|FG005|Overall Study|Withdrawal by Subject|0|||
126026557|NCT04586920|453393567|FG006|Overall Study|Withdrawal by Subject|0|||
126026558|NCT04586920|453393568|FG007|Overall Study|Withdrawal by Subject|1|||
126026559|NCT04586920|453393569|FG008|Overall Study|Withdrawal by Subject|0|||
126026560|NCT04586920|453393570|FG009|Overall Study|Withdrawal by Subject|1|||
126026561|NCT04586920|453393571|FG010|Overall Study|Withdrawal by Subject|0|||
126026562|NCT04586920|453393572|FG011|Overall Study|Withdrawal by Subject|1|||
126026563|NCT04586920|453393573|FG012|Overall Study|Withdrawal by Subject|0|||
126026564|NCT04586920|453393574|FG013|Overall Study|Withdrawal by Subject|0|||
126026565|NCT04586920|453393575|FG014|Overall Study|Withdrawal by Subject|0|||
126026566|NCT04586920|453393576|FG015|Overall Study|Withdrawal by Subject|0|||
126026567|NCT04586920|453393577|FG016|Overall Study|Withdrawal by Subject|0|||
126026568|NCT04586920|453393578|FG017|Overall Study|Withdrawal by Subject|0|||
126026569|NCT02728557|453393579|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
126026570|NCT02728557|453393580|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
126026571|NCT02728557|453393579|FG000|Overall Study|Dissatisfaction with research tasks|0|||
126026572|NCT02728557|453393580|FG001|Overall Study|Dissatisfaction with research tasks|1|||
126026573|NCT02728557|453393579|FG000|Overall Study|Scheduling or change in availability|1|||
126026574|NCT02728557|453393580|FG001|Overall Study|Scheduling or change in availability|1|||
126026575|NCT04052516|453393581|FG000|Overall Study|Withdrawal by Subject|4|||
126026576|NCT04052516|453393582|FG001|Overall Study|Withdrawal by Subject|5|||
126026577|NCT04052516|453393583|FG002|Overall Study|Withdrawal by Subject|6|||
126026578|NCT04052516|453393581|FG000|Overall Study|Adverse Event|3|||
126026579|NCT04052516|453393582|FG001|Overall Study|Adverse Event|2|||
126026580|NCT04052516|453393583|FG002|Overall Study|Adverse Event|8|||
126026581|NCT04052516|453393581|FG000|Overall Study|Lost to Follow-up|2|||
126026582|NCT04052516|453393582|FG001|Overall Study|Lost to Follow-up|5|||
126026583|NCT04052516|453393583|FG002|Overall Study|Lost to Follow-up|3|||
126026584|NCT04052516|453393581|FG000|Overall Study|Protocol Violation|1|||
126026585|NCT04052516|453393582|FG001|Overall Study|Protocol Violation|1|||
126026586|NCT04052516|453393583|FG002|Overall Study|Protocol Violation|0|||
126026587|NCT04052516|453393581|FG000|Overall Study|Death|1|||
126026588|NCT04052516|453393582|FG001|Overall Study|Death|0|||
126026589|NCT04052516|453393583|FG002|Overall Study|Death|0|||
126026590|NCT04052516|453393581|FG000|Overall Study|Physician Decision|0|||
126026591|NCT04052516|453393582|FG001|Overall Study|Physician Decision|1|||
126026592|NCT04052516|453393583|FG002|Overall Study|Physician Decision|0|||
126026593|NCT04052516|453393581|FG000|Overall Study|Pregnancy|1|||
126026594|NCT04052516|453393582|FG001|Overall Study|Pregnancy|0|||
126026595|NCT04052516|453393583|FG002|Overall Study|Pregnancy|0|||
126026596|NCT04052516|453393581|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
126026597|NCT04052516|453393582|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
126026598|NCT04052516|453393583|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
126026599|NCT04052516|453393581|FG000|Overall Study|Reason not recorded|0|||
126026600|NCT04052516|453393582|FG001|Overall Study|Reason not recorded|1|||
126026601|NCT04052516|453393583|FG002|Overall Study|Reason not recorded|0|||
126026602|NCT03416010|453393584|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
126026603|NCT03416010|453393585|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
126026604|NCT03416010|453393584|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
126026605|NCT03416010|453393585|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
126026606|NCT03416010|453393584|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
126026607|NCT03416010|453393585|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
126245241|NCT00730691|454189413|FG004|Overall Study|Adverse Event|23|||
126245242|NCT00730691|454189409|FG000|Overall Study|Lack of Efficacy|4|||
126245243|NCT00730691|454189410|FG001|Overall Study|Lack of Efficacy|4|||
126245244|NCT00730691|454189411|FG002|Overall Study|Lack of Efficacy|2|||
126245245|NCT00730691|454189412|FG003|Overall Study|Lack of Efficacy|1|||
126245246|NCT00730691|454189413|FG004|Overall Study|Lack of Efficacy|1|||
126245247|NCT00730691|454189409|FG000|Overall Study|Non-compliance with Study Drug|6|||
126245248|NCT00730691|454189410|FG001|Overall Study|Non-compliance with Study Drug|1|||
126245249|NCT00730691|454189411|FG002|Overall Study|Non-compliance with Study Drug|6|||
126245250|NCT00730691|454189412|FG003|Overall Study|Non-compliance with Study Drug|3|||
126245251|NCT00730691|454189413|FG004|Overall Study|Non-compliance with Study Drug|3|||
126245252|NCT00730691|454189409|FG000|Overall Study|Protocol Deviations|3|||
126245253|NCT00730691|454189410|FG001|Overall Study|Protocol Deviations|5|||
126245254|NCT00730691|454189411|FG002|Overall Study|Protocol Deviations|3|||
126245255|NCT00730691|454189412|FG003|Overall Study|Protocol Deviations|7|||
126245256|NCT00730691|454189413|FG004|Overall Study|Protocol Deviations|5|||
126245257|NCT00730691|454189409|FG000|Overall Study|Withdrawal of Consent|7|||
126245258|NCT00730691|454189410|FG001|Overall Study|Withdrawal of Consent|9|||
126245259|NCT00730691|454189411|FG002|Overall Study|Withdrawal of Consent|3|||
126245260|NCT00730691|454189412|FG003|Overall Study|Withdrawal of Consent|6|||
126245261|NCT00730691|454189413|FG004|Overall Study|Withdrawal of Consent|3|||
126245262|NCT00730691|454189409|FG000|Overall Study|Lost to Follow-up|11|||
126245263|NCT00730691|454189410|FG001|Overall Study|Lost to Follow-up|8|||
126245264|NCT00730691|454189411|FG002|Overall Study|Lost to Follow-up|13|||
126245265|NCT00730691|454189412|FG003|Overall Study|Lost to Follow-up|15|||
126245266|NCT00730691|454189413|FG004|Overall Study|Lost to Follow-up|13|||
126245267|NCT00730691|454189409|FG000|Overall Study|Other|1|||
126245268|NCT00730691|454189410|FG001|Overall Study|Other|1|||
126245269|NCT00730691|454189411|FG002|Overall Study|Other|1|||
126245270|NCT00730691|454189412|FG003|Overall Study|Other|2|||
126245271|NCT00730691|454189413|FG004|Overall Study|Other|2|||
126245272|NCT02178787|454189414|FG000|Overall Study|Lost to Follow-up|1|||
126245273|NCT02178787|454189415|FG001|Overall Study|Lost to Follow-up|0|||
126245274|NCT02178787|454189414|FG000|Overall Study|Withdrawal by Subject|0|||
126245275|NCT02178787|454189415|FG001|Overall Study|Withdrawal by Subject|2|||
126245276|NCT02178787|454189414|FG000|Overall Study|No TCD window|3|||
126245277|NCT02178787|454189415|FG001|Overall Study|No TCD window|7|||
126245278|NCT02178787|454189414|FG000|Overall Study|Physician Decision|1|||
126245279|NCT02178787|454189415|FG001|Overall Study|Physician Decision|0|||
126245280|NCT02554890|454189416|FG000|Double-blind|Adverse Event|45|||
126245281|NCT02554890|454189417|FG001|Double-blind|Adverse Event|51|||
126245282|NCT02554890|454189416|FG000|Double-blind|Death|6|||
126245283|NCT02554890|454189417|FG001|Double-blind|Death|4|||
126245284|NCT02554890|454189416|FG000|Double-blind|Protocol Violation|1|||
126245285|NCT02554890|454189417|FG001|Double-blind|Protocol Violation|1|||
126245286|NCT02554890|454189416|FG000|Double-blind|Physician Decision|4|||
126245287|NCT02554890|454189417|FG001|Double-blind|Physician Decision|3|||
126245288|NCT02554890|454189416|FG000|Double-blind|Subject/Guardian decision|21|||
126245289|NCT02554890|454189417|FG001|Double-blind|Subject/Guardian decision|16|||
126245290|NCT02554890|454189416|FG000|Double-blind|Lost to Follow-up|7|||
126245291|NCT02554890|454189417|FG001|Double-blind|Lost to Follow-up|5|||
126245292|NCT02554890|454189416|FG000|Double-blind|Technical problems|1|||
126245293|NCT02554890|454189417|FG001|Double-blind|Technical problems|0|||
126245294|NCT02554890|454189416|FG000|Double-blind|Withdrawal by Subject|5|||
126245295|NCT02554890|454189417|FG001|Double-blind|Withdrawal by Subject|6|||
126245296|NCT02554890|454189416|FG000|Double-blind|Noncompliance with study treatment|6|||
126245297|NCT02554890|454189417|FG001|Double-blind|Noncompliance with study treatment|5|||
126245298|NCT02554890|454189416|FG000|Open-label|Adverse Event|0|||
126245299|NCT02554890|454189417|FG001|Open-label|Adverse Event|30|||
126245300|NCT02554890|454189416|FG000|Open-label|Death|0|||
126245301|NCT02554890|454189417|FG001|Open-label|Death|1|||
126245302|NCT02554890|454189416|FG000|Open-label|Physician Decision|0|||
126245303|NCT02554890|454189417|FG001|Open-label|Physician Decision|1|||
126245304|NCT02554890|454189416|FG000|Open-label|Subject/Guardian decision|0|||
126245305|NCT02554890|454189417|FG001|Open-label|Subject/Guardian decision|11|||
126245306|NCT02554890|454189416|FG000|Open-label|Lost to Follow-up|0|||
126245307|NCT02554890|454189417|FG001|Open-label|Lost to Follow-up|7|||
126245308|NCT02554890|454189416|FG000|Open-label|Technical problems|0|||
126245309|NCT02554890|454189417|FG001|Open-label|Technical problems|1|||
126245310|NCT02554890|454189416|FG000|Open-label|Withdrawal by Subject|0|||
126245311|NCT02554890|454189417|FG001|Open-label|Withdrawal by Subject|1|||
126245312|NCT03043872|454189421|FG000|Overall Study|Withdrawal by Subject|6|||
126245313|NCT03043872|454189422|FG001|Overall Study|Withdrawal by Subject|6|||
126245314|NCT03043872|454189423|FG002|Overall Study|Withdrawal by Subject|15|||
126245315|NCT03043872|454189421|FG000|Overall Study|Lost to Follow-up|2|||
126245316|NCT03043872|454189422|FG001|Overall Study|Lost to Follow-up|1|||
126026608|NCT03416010|453393584|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
126026609|NCT03416010|453393585|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
126026610|NCT03416010|453393584|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
126026611|NCT03416010|453393585|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
126026612|NCT03416010|453393584|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
126026613|NCT03416010|453393585|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
126245317|NCT03043872|454189423|FG002|Overall Study|Lost to Follow-up|1|||
126245318|NCT03043872|454189421|FG000|Overall Study|Death|270|||
126245319|NCT03043872|454189422|FG001|Overall Study|Death|269|||
126245320|NCT03043872|454189423|FG002|Overall Study|Death|296|||
126026614|NCT03416010|453393584|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
126245321|NCT03649477|454189424|FG000|Overall Study|Adverse Event|2|||
126245322|NCT03649477|454189425|FG001|Overall Study|Adverse Event|0|||
126245323|NCT03649477|454189426|FG002|Overall Study|Adverse Event|0|||
126245324|NCT02430480|454189427|FG000|Overall Study|Death|1|||
126245325|NCT02430480|454189427|FG000|Overall Study|Anesthesia concerns|1|||
126245326|NCT02430480|454189427|FG000|Overall Study|Progressed on treatment|1|||
126245327|NCT01154231|454189428|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
126245328|NCT01154231|454189428|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
126245329|NCT01097577|454189429|FG000|Overall Study|Adverse Event|0|||
126245330|NCT01097577|454189430|FG001|Overall Study|Adverse Event|1|||
126026615|NCT03416010|453393585|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
126094232|NCT00291642|453639168|FG004|Overall Study|Intake of prohibited medication|0|||
126094233|NCT02576587|453639173|FG000|Baseline|Equipment failure|0|||
126094234|NCT02576587|453639174|FG001|Baseline|Equipment failure|1|||
126094235|NCT02576587|453639173|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
126094236|NCT02576587|453639174|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
126094237|NCT02576587|453639173|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
126094238|NCT02576587|453639174|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
126094239|NCT02576587|453639173|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
126094240|NCT02576587|453639174|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
126094241|NCT00532493|453639175|FG000|Overall Study|Death|1|||
126094242|NCT00532493|453639176|FG001|Overall Study|Death|1|||
126094243|NCT00532493|453639175|FG000|Overall Study|Lost to Follow-up|10|||
126094244|NCT00532493|453639176|FG001|Overall Study|Lost to Follow-up|7|||
126094245|NCT00532493|453639175|FG000|Overall Study|Withdrawal by Subject|7|||
126094246|NCT00532493|453639176|FG001|Overall Study|Withdrawal by Subject|9|||
126094247|NCT00532493|453639175|FG000|Overall Study|Physician Decision|1|||
126094248|NCT00532493|453639176|FG001|Overall Study|Physician Decision|6|||
126094249|NCT00532493|453639175|FG000|Overall Study|Adverse Event|6|||
126094250|NCT00532493|453639176|FG001|Overall Study|Adverse Event|5|||
126094251|NCT00532493|453639175|FG000|Overall Study|Protocol Deviation|1|||
126094252|NCT00532493|453639176|FG001|Overall Study|Protocol Deviation|0|||
126094253|NCT00532493|453639175|FG000|Overall Study|Subject Moved Away|3|||
126094254|NCT00532493|453639176|FG001|Overall Study|Subject Moved Away|1|||
126094255|NCT00532493|453639175|FG000|Overall Study|Contraindicative Medication|1|||
126094256|NCT00532493|453639176|FG001|Overall Study|Contraindicative Medication|0|||
126094257|NCT00738894|453639179|FG000|Overall Study|Lost to Follow-up|23|||
126094258|NCT00738894|453639180|FG001|Overall Study|Lost to Follow-up|13|||
126094259|NCT00738894|453639179|FG000|Overall Study|Withdrawal by Subject|10|||
126094260|NCT00738894|453639180|FG001|Overall Study|Withdrawal by Subject|15|||
126094261|NCT00738894|453639179|FG000|Overall Study|Physician Decision|4|||
126094262|NCT00738894|453639180|FG001|Overall Study|Physician Decision|5|||
126094263|NCT00738894|453639179|FG000|Overall Study|Death|2|||
126094264|NCT00738894|453639180|FG001|Overall Study|Death|0|||
126094265|NCT02546921|453639187|FG000|Overall Study|Adverse Event|0|||
126094266|NCT02546921|453639188|FG001|Overall Study|Adverse Event|5|||
126094267|NCT02546921|453639189|FG002|Overall Study|Adverse Event|2|||
126094268|NCT02546921|453639190|FG003|Overall Study|Adverse Event|0|||
126094269|NCT02546921|453639191|FG004|Overall Study|Adverse Event|0|||
126094270|NCT02546921|453639192|FG005|Overall Study|Adverse Event|0|||
126094271|NCT02546921|453639193|FG006|Overall Study|Adverse Event|0|||
126094272|NCT02546921|453639187|FG000|Overall Study|Evidence of Disease Progression|1|||
126094273|NCT02546921|453639188|FG001|Overall Study|Evidence of Disease Progression|0|||
126094274|NCT02546921|453639189|FG002|Overall Study|Evidence of Disease Progression|0|||
126094275|NCT02546921|453639190|FG003|Overall Study|Evidence of Disease Progression|0|||
126245331|NCT04493684|454189433|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
126245332|NCT04493684|454189434|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245333|NCT04493684|454189435|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
126026616|NCT05415436|453393586|FG000|Overall Study|Surgeon cancelled procedure|1|||
126094276|NCT02546921|453639191|FG004|Overall Study|Evidence of Disease Progression|1|||
126094277|NCT02546921|453639192|FG005|Overall Study|Evidence of Disease Progression|0|||
126094278|NCT02546921|453639193|FG006|Overall Study|Evidence of Disease Progression|0|||
126094279|NCT02546921|453639187|FG000|Overall Study|Patient Choice|0|||
126094280|NCT02546921|453639188|FG001|Overall Study|Patient Choice|1|||
126245334|NCT04493684|454189436|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245335|NCT04493684|454189437|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245336|NCT04493684|454189438|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
126245337|NCT04493684|454189439|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245338|NCT04493684|454189440|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245339|NCT04493684|454189441|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245340|NCT04493684|454189442|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245341|NCT04493684|454189443|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245342|NCT04493684|454189444|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245343|NCT04493684|454189445|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245344|NCT04493684|454189446|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245345|NCT04493684|454189447|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245346|NCT04493684|454189448|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245347|NCT04493684|454189449|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245348|NCT04493684|454189433|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
126245349|NCT04493684|454189434|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245350|NCT04493684|454189435|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245351|NCT04493684|454189436|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245352|NCT04493684|454189437|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245353|NCT04493684|454189438|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245354|NCT04493684|454189439|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245355|NCT04493684|454189440|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245356|NCT04493684|454189441|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245357|NCT04493684|454189442|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245358|NCT04493684|454189443|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126357584|NCT04243837|454602150|FG000|Overall Study|Adverse Event|2|||
126357585|NCT04243837|454602151|FG001|Overall Study|Adverse Event|1|||
126357586|NCT04243837|454602150|FG000|Overall Study|Withdrawal by Subject|4|||
126357587|NCT04243837|454602151|FG001|Overall Study|Withdrawal by Subject|2|||
126357588|NCT04243837|454602150|FG000|Overall Study|Covid-19 lock down|1|||
126357589|NCT04243837|454602151|FG001|Overall Study|Covid-19 lock down|0|||
126357590|NCT04243837|454602150|FG000|Overall Study|Study Terminated by Sponsor|11|||
126357591|NCT04243837|454602151|FG001|Overall Study|Study Terminated by Sponsor|12|||
126357592|NCT02280499|454602152|FG000|Overall Study|Death|14|||
126357593|NCT02280499|454602152|FG000|Overall Study|Lost to Follow-up|42|||
126094281|NCT02546921|453639189|FG002|Overall Study|Patient Choice|0|||
126094282|NCT02546921|453639190|FG003|Overall Study|Patient Choice|0|||
126094283|NCT02546921|453639191|FG004|Overall Study|Patient Choice|0|||
126357594|NCT02280499|454602152|FG000|Overall Study|Adverse Event|5|||
126094284|NCT02546921|453639192|FG005|Overall Study|Patient Choice|1|||
126094285|NCT02546921|453639193|FG006|Overall Study|Patient Choice|0|||
126094286|NCT00680992|453639197|FG000|Overall Study|Complete Resection (as per protocol)|25|||
126094287|NCT00680992|453639198|FG001|Overall Study|Complete Resection (as per protocol)|121|||
126094288|NCT00680992|453639199|FG002|Overall Study|Complete Resection (as per protocol)|0|||
126094289|NCT00680992|453639197|FG000|Overall Study|Administrative Decision|83|||
126094290|NCT00680992|453639198|FG001|Overall Study|Administrative Decision|42|||
126094291|NCT00680992|453639199|FG002|Overall Study|Administrative Decision|5|||
126245359|NCT04493684|454189444|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245360|NCT04493684|454189445|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245361|NCT04493684|454189446|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245362|NCT04493684|454189447|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126357595|NCT00977561|454602155|FG000|Overall Study|Death|3|||
126357596|NCT00977561|454602156|FG001|Overall Study|Death|2|||
126357597|NCT00977561|454602155|FG000|Overall Study|Study terminated|0|||
126357598|NCT00977561|454602156|FG001|Overall Study|Study terminated|2|||
126094292|NCT00680992|453639197|FG000|Overall Study|End of Trial|32|||
126245363|NCT04493684|454189448|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245364|NCT04493684|454189449|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245365|NCT04493684|454189433|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245366|NCT04493684|454189434|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245367|NCT04493684|454189435|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245368|NCT04493684|454189436|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245369|NCT04493684|454189437|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245370|NCT04493684|454189438|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245371|NCT04493684|454189439|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
126245372|NCT04493684|454189440|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245373|NCT04493684|454189441|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245374|NCT04493684|454189442|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245375|NCT04493684|454189443|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245376|NCT04493684|454189444|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245377|NCT04493684|454189445|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245378|NCT04493684|454189446|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245379|NCT04493684|454189447|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245380|NCT04493684|454189448|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245381|NCT04493684|454189449|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245382|NCT04493684|454189433|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
126245383|NCT04493684|454189434|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245384|NCT04493684|454189435|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245385|NCT04493684|454189436|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245386|NCT04493684|454189437|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245387|NCT04493684|454189438|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245388|NCT04493684|454189439|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245389|NCT04493684|454189440|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245390|NCT04493684|454189441|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245391|NCT04493684|454189442|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245392|NCT04493684|454189443|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245393|NCT04493684|454189444|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245394|NCT04493684|454189445|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245395|NCT04493684|454189446|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245396|NCT04493684|454189447|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245397|NCT04493684|454189448|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245398|NCT04493684|454189449|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245399|NCT04493684|454189433|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245400|NCT04493684|454189434|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245401|NCT04493684|454189435|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245402|NCT04493684|454189436|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245403|NCT04493684|454189437|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245404|NCT04493684|454189438|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
126245405|NCT04493684|454189439|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245406|NCT04493684|454189440|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245407|NCT04493684|454189441|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245408|NCT04493684|454189442|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245409|NCT04493684|454189443|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245410|NCT04493684|454189444|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245411|NCT04493684|454189445|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245412|NCT04493684|454189446|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245413|NCT04493684|454189447|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245414|NCT04493684|454189448|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245415|NCT04493684|454189449|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245416|NCT04493684|454189433|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245417|NCT04493684|454189434|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245418|NCT04493684|454189435|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245419|NCT04493684|454189436|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245420|NCT04493684|454189437|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245421|NCT04493684|454189438|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245422|NCT04493684|454189439|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245423|NCT04493684|454189440|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126357599|NCT00977561|454602155|FG000|Overall Study|Other|2|||
126357600|NCT00977561|454602156|FG001|Overall Study|Other|0|||
126245424|NCT04493684|454189441|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245425|NCT04493684|454189442|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245426|NCT04493684|454189443|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245427|NCT04493684|454189444|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
126245428|NCT04493684|454189445|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245429|NCT04493684|454189446|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245430|NCT04493684|454189447|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245431|NCT04493684|454189448|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245432|NCT04493684|454189449|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245433|NCT04493684|454189433|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245434|NCT04493684|454189434|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245435|NCT04493684|454189435|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245436|NCT04493684|454189436|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245437|NCT04493684|454189437|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245438|NCT04493684|454189438|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245439|NCT04493684|454189439|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245440|NCT04493684|454189440|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245441|NCT04493684|454189441|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245442|NCT04493684|454189442|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245443|NCT04493684|454189443|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245444|NCT04493684|454189444|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245445|NCT04493684|454189445|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245446|NCT04493684|454189446|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245447|NCT04493684|454189447|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245448|NCT04493684|454189448|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
126245449|NCT04493684|454189449|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245450|NCT04493684|454189433|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245451|NCT04493684|454189434|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245452|NCT04493684|454189435|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245453|NCT04493684|454189436|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245454|NCT04493684|454189437|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245455|NCT04493684|454189438|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245456|NCT04493684|454189439|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245457|NCT04493684|454189440|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245458|NCT04493684|454189441|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245459|NCT04493684|454189442|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245460|NCT04493684|454189443|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245461|NCT04493684|454189444|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245462|NCT04493684|454189445|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245463|NCT04493684|454189446|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245464|NCT04493684|454189447|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245465|NCT04493684|454189448|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
126245466|NCT04493684|454189449|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245467|NCT01963728|454189450|FG000|Overall Study|Study terminated early|0|||
126245468|NCT01963728|454189451|FG001|Overall Study|Study terminated early|1|||
126245469|NCT05152576|454189452|FG000|Overall Study|Lost to Follow-up|3|||
126245470|NCT05152576|454189453|FG001|Overall Study|Lost to Follow-up|0|||
126245471|NCT05152576|454189454|FG002|Overall Study|Lost to Follow-up|0|||
126245472|NCT05152576|454189455|FG003|Overall Study|Lost to Follow-up|1|||
126245473|NCT05152576|454189452|FG000|Overall Study|Withdrawal by Subject|0|||
126245474|NCT05152576|454189453|FG001|Overall Study|Withdrawal by Subject|1|||
126245475|NCT05152576|454189454|FG002|Overall Study|Withdrawal by Subject|0|||
126245476|NCT05152576|454189455|FG003|Overall Study|Withdrawal by Subject|1|||
126245477|NCT05152576|454189452|FG000|Overall Study|Other|2|||
126245478|NCT05152576|454189453|FG001|Overall Study|Other|0|||
126245479|NCT05152576|454189454|FG002|Overall Study|Other|0|||
126026617|NCT05415436|453393587|FG001|Overall Study|Surgeon cancelled procedure|0|||
126026618|NCT05415436|453393586|FG000|Overall Study|Death|1|||
126245480|NCT05152576|454189455|FG003|Overall Study|Other|0|||
126245481|NCT01376037|454191414|FG000|Overall Study|Lost to Follow-up|0|||
126245482|NCT01376037|454191415|FG001|Overall Study|Lost to Follow-up|2|||
126245483|NCT02328040|454191416|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
126245484|NCT02328040|454191417|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
126245485|NCT04278560|454191422|FG000|Overall Study|Adverse Event|1|||
126245486|NCT04278560|454191423|FG001|Overall Study|Adverse Event|2|||
126026619|NCT05415436|453393587|FG001|Overall Study|Death|0|||
126026620|NCT03948763|453393591|FG000|Overall Study|Sponsor's decision|0|||
126245487|NCT04278560|454191422|FG000|Overall Study|Withdrawal by Subject|0|||
126245488|NCT04278560|454191423|FG001|Overall Study|Withdrawal by Subject|1|||
126245489|NCT02832063|454191424|FG000|Overall Study|Adverse Event|2|||
126245490|NCT02832063|454191425|FG001|Overall Study|Adverse Event|1|||
126245491|NCT02832063|454191424|FG000|Overall Study|Physician Decision|5|||
126245492|NCT02832063|454191425|FG001|Overall Study|Physician Decision|7|||
126245493|NCT02832063|454191424|FG000|Overall Study|Lost to Follow-up|15|||
126245494|NCT02832063|454191425|FG001|Overall Study|Lost to Follow-up|8|||
126245495|NCT02832063|454191424|FG000|Overall Study|Withdrawal by Subject|10|||
126245496|NCT02832063|454191425|FG001|Overall Study|Withdrawal by Subject|21|||
126245497|NCT02832063|454191424|FG000|Overall Study|Other|2|||
126245498|NCT02832063|454191425|FG001|Overall Study|Other|1|||
126245499|NCT03086460|454191430|FG000|Study Participants|Lost to Follow-up|2|||
126245500|NCT03086460|454191430|FG000|Study Participants|Protocol Violation|1|||
126245501|NCT03086460|454191430|FG000|Study Participants|Withdrawal by Subject|6|||
126245502|NCT03086460|454191430|FG000|Treatment A|Lost to Follow-up|1|||
126245503|NCT03086460|454191430|FG000|Treatment A|Protocol Violation|1|||
126245504|NCT03086460|454191430|FG000|Treatment A|Withdrawal by Subject|2|||
126245505|NCT03086460|454191430|FG000|Treatment C|Withdrawal by Subject|2|||
126245506|NCT03086460|454191430|FG000|Treatment E|Lost to Follow-up|1|||
125879235|NCT03041038|452855285|FG000|Overall Study|Protocol Violation|1|||
125879236|NCT03041038|452855286|FG001|Overall Study|Protocol Violation|1|||
125879237|NCT00360230|452855287|FG000|Overall Study|Withdrawal by Subject|1|||
125879238|NCT00360230|452855288|FG001|Overall Study|Withdrawal by Subject|1|||
125879239|NCT00360230|452855289|FG002|Overall Study|Withdrawal by Subject|0|||
125879240|NCT00360230|452855290|FG003|Overall Study|Withdrawal by Subject|1|||
125879241|NCT00360230|452855291|FG004|Overall Study|Withdrawal by Subject|1|||
125879242|NCT00360230|452855292|FG005|Overall Study|Withdrawal by Subject|1|||
125879243|NCT00360230|452855293|FG006|Overall Study|Withdrawal by Subject|0|||
125879244|NCT00360230|452855287|FG000|Overall Study|Migrated|4|||
125879245|NCT00360230|452855288|FG001|Overall Study|Migrated|1|||
125879246|NCT00360230|452855289|FG002|Overall Study|Migrated|3|||
125879247|NCT00360230|452855290|FG003|Overall Study|Migrated|1|||
125879248|NCT00360230|452855291|FG004|Overall Study|Migrated|4|||
125879249|NCT00360230|452855292|FG005|Overall Study|Migrated|1|||
125879250|NCT00360230|452855293|FG006|Overall Study|Migrated|1|||
126026621|NCT03948763|453393592|FG001|Overall Study|Sponsor's decision|2|||
126026622|NCT03948763|453393593|FG002|Overall Study|Sponsor's decision|6|||
126026623|NCT03948763|453393594|FG003|Overall Study|Sponsor's decision|4|||
126026624|NCT03948763|453393595|FG004|Overall Study|Sponsor's decision|0|||
126026625|NCT03948763|453393591|FG000|Overall Study|Physician Decision|0|||
126026626|NCT03948763|453393592|FG001|Overall Study|Physician Decision|0|||
126026627|NCT03948763|453393593|FG002|Overall Study|Physician Decision|1|||
126026628|NCT03948763|453393594|FG003|Overall Study|Physician Decision|0|||
126026629|NCT03948763|453393595|FG004|Overall Study|Physician Decision|0|||
126026630|NCT03948763|453393591|FG000|Overall Study|Lost to Follow-up|0|||
126026631|NCT03948763|453393592|FG001|Overall Study|Lost to Follow-up|0|||
126026632|NCT03948763|453393593|FG002|Overall Study|Lost to Follow-up|0|||
126026633|NCT03948763|453393594|FG003|Overall Study|Lost to Follow-up|0|||
126026634|NCT03948763|453393595|FG004|Overall Study|Lost to Follow-up|1|||
126026635|NCT03948763|453393591|FG000|Overall Study|Death|2|||
126026636|NCT03948763|453393592|FG001|Overall Study|Death|12|||
126026637|NCT03948763|453393593|FG002|Overall Study|Death|13|||
126026638|NCT03948763|453393594|FG003|Overall Study|Death|10|||
126026639|NCT03948763|453393595|FG004|Overall Study|Death|11|||
126245507|NCT03086460|454191430|FG000|Treatment E|Withdrawal by Subject|3|||
126245508|NCT03600805|454191431|FG000|Overall Study|Adverse Event|2|||
126245509|NCT03600805|454191432|FG001|Overall Study|Adverse Event|1|||
126245510|NCT03600805|454191433|FG002|Overall Study|Adverse Event|1|||
126245511|NCT03600805|454191434|FG003|Overall Study|Adverse Event|7|||
126245512|NCT03600805|454191431|FG000|Overall Study|Lack of Efficacy|2|||
126245513|NCT03600805|454191432|FG001|Overall Study|Lack of Efficacy|1|||
126245514|NCT03600805|454191433|FG002|Overall Study|Lack of Efficacy|0|||
125879251|NCT00360230|452855287|FG000|Overall Study|Other|1|||
125879252|NCT00360230|452855288|FG001|Overall Study|Other|0|||
125879253|NCT00360230|452855289|FG002|Overall Study|Other|0|||
125879254|NCT00360230|452855290|FG003|Overall Study|Other|0|||
125879255|NCT00360230|452855291|FG004|Overall Study|Other|0|||
126026640|NCT03948763|453393591|FG000|Overall Study|Withdrawal by Subject|1|||
126026641|NCT03948763|453393592|FG001|Overall Study|Withdrawal by Subject|1|||
126026642|NCT03948763|453393593|FG002|Overall Study|Withdrawal by Subject|0|||
126026643|NCT03948763|453393594|FG003|Overall Study|Withdrawal by Subject|2|||
126026644|NCT03948763|453393595|FG004|Overall Study|Withdrawal by Subject|4|||
126026645|NCT03819686|453393600|FG000|Overall Study|Lost to Follow-up|2|||
125879256|NCT00360230|452855292|FG005|Overall Study|Other|0|||
125879257|NCT00360230|452855293|FG006|Overall Study|Other|0|||
126026646|NCT03819686|453393601|FG001|Overall Study|Lost to Follow-up|3|||
126026647|NCT02597946|453393617|FG000|Overall Study|Withdrawal by Subject|1|||
126026648|NCT02597946|453393617|FG000|Overall Study|Progressive disease|16|||
126026649|NCT02597946|453393617|FG000|Overall Study|Other than above|1|||
126026650|NCT05058391|453393625|FG000|Overall Study|Adverse Event|1|||
126026651|NCT05387447|453393631|FG000|Overall Study|Participants changed their minds about study participation.|3|||
126026652|NCT05387447|453393632|FG001|Overall Study|Participants changed their minds about study participation.|5|||
126026653|NCT03391466|453393635|FG000|Overall Study|Death|82|||
126026654|NCT03391466|453393636|FG001|Overall Study|Death|85|||
126026655|NCT03391466|453393635|FG000|Overall Study|Still on study|93|||
126026656|NCT03391466|453393636|FG001|Overall Study|Still on study|74|||
126245515|NCT03600805|454191434|FG003|Overall Study|Lack of Efficacy|0|||
126026657|NCT03391466|453393635|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
126026658|NCT03391466|453393636|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
126026659|NCT03391466|453393635|FG000|Overall Study|Lost to Follow-up|5|||
126026660|NCT03391466|453393636|FG001|Overall Study|Lost to Follow-up|5|||
126026661|NCT03391466|453393635|FG000|Overall Study|Investigator decision|0|||
126026662|NCT03391466|453393636|FG001|Overall Study|Investigator decision|1|||
126026663|NCT03391466|453393635|FG000|Overall Study|Other|0|||
126245516|NCT03600805|454191431|FG000|Overall Study|Withdrawal by Subject|1|||
126245517|NCT03600805|454191432|FG001|Overall Study|Withdrawal by Subject|0|||
126245518|NCT03600805|454191433|FG002|Overall Study|Withdrawal by Subject|0|||
125879258|NCT00360230|452855287|FG000|Overall Study|Protocol Violation|0|||
125879259|NCT00360230|452855288|FG001|Overall Study|Protocol Violation|0|||
125879260|NCT00360230|452855289|FG002|Overall Study|Protocol Violation|0|||
126026664|NCT03391466|453393636|FG001|Overall Study|Other|1|||
126245519|NCT03600805|454191434|FG003|Overall Study|Withdrawal by Subject|1|||
126245520|NCT03600805|454191431|FG000|Overall Study|Other unspecified|14|||
126245521|NCT03600805|454191432|FG001|Overall Study|Other unspecified|6|||
126245522|NCT03600805|454191433|FG002|Overall Study|Other unspecified|7|||
126245523|NCT03600805|454191434|FG003|Overall Study|Other unspecified|11|||
126245524|NCT06195579|454191435|FG000|Overall Study|Withdrawal by Subject|1|||
126245525|NCT02545283|454191436|FG000|Overall Study|Lost to Follow-up|2|||
126245526|NCT02545283|454191437|FG001|Overall Study|Lost to Follow-up|4|||
126245527|NCT02545283|454191436|FG000|Overall Study|Withdrawal by Subject|5|||
126245528|NCT02545283|454191437|FG001|Overall Study|Withdrawal by Subject|9|||
126245529|NCT02545283|454191436|FG000|Overall Study|Death|109|||
126245530|NCT02545283|454191437|FG001|Overall Study|Death|211|||
126245531|NCT02545283|454191436|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
126245532|NCT02545283|454191437|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
126245533|NCT02545283|454191436|FG000|Overall Study|Study Terminated By Sponsor|33|||
126245534|NCT02545283|454191437|FG001|Overall Study|Study Terminated By Sponsor|71|||
126245535|NCT00443651|454191439|FG000|Overall Study|Death|1|||
126245536|NCT00443651|454191440|FG001|Overall Study|Death|5|||
126245537|NCT00443651|454191439|FG000|Overall Study|Adverse Event|5|||
126245538|NCT00443651|454191440|FG001|Overall Study|Adverse Event|6|||
126245539|NCT00443651|454191439|FG000|Overall Study|Lost to Follow-up|18|||
126245540|NCT00443651|454191440|FG001|Overall Study|Lost to Follow-up|12|||
126245541|NCT00443651|454191439|FG000|Overall Study|Patient's/Guardian's Decision|58|||
126245542|NCT00443651|454191440|FG001|Overall Study|Patient's/Guardian's Decision|30|||
126026665|NCT03655132|453393637|FG000|Overall Study|Lost to Follow-up|2|||
126026666|NCT03655132|453393638|FG001|Overall Study|Lost to Follow-up|1|||
126026667|NCT03655132|453393637|FG000|Overall Study|Withdrawal by Subject|0|||
126026668|NCT03655132|453393638|FG001|Overall Study|Withdrawal by Subject|1|||
126026669|NCT03655132|453393637|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
126026670|NCT03655132|453393638|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
126026671|NCT05919082|453393642|FG000|Overall Study|Adverse Event|3|||
126026672|NCT05919082|453393643|FG001|Overall Study|Adverse Event|0|||
126026673|NCT05919082|453393642|FG000|Overall Study|Lost to Follow-up|0|||
126026674|NCT05919082|453393643|FG001|Overall Study|Lost to Follow-up|1|||
126026675|NCT05919082|453393642|FG000|Overall Study|Withdrawal by Subject|8|||
126026676|NCT05919082|453393643|FG001|Overall Study|Withdrawal by Subject|9|||
126245543|NCT00443651|454191439|FG000|Overall Study|Physician Decision|13|||
126245544|NCT00443651|454191440|FG001|Overall Study|Physician Decision|4|||
126245545|NCT00443651|454191439|FG000|Overall Study|Pregnancy|0|||
126245546|NCT00443651|454191440|FG001|Overall Study|Pregnancy|1|||
126026677|NCT05919082|453393642|FG000|Overall Study|Lack of Efficacy|0|||
126026678|NCT05919082|453393643|FG001|Overall Study|Lack of Efficacy|1|||
126026679|NCT05919082|453393642|FG000|Overall Study|Investigator Decision|1|||
126026680|NCT05919082|453393643|FG001|Overall Study|Investigator Decision|0|||
126026681|NCT05249439|453393649|FG000|Overall Study|Withdrawal by Subject|2|||
126026682|NCT05249439|453393650|FG001|Overall Study|Withdrawal by Subject|5|||
126026683|NCT05249439|453393649|FG000|Overall Study|Physician Decision|3|||
126026684|NCT05249439|453393650|FG001|Overall Study|Physician Decision|1|||
126026685|NCT01707030|453393651|FG000|Overall Study|Death|1|||
126026686|NCT01707030|453393652|FG001|Overall Study|Death|1|||
126026687|NCT01707030|453393651|FG000|Overall Study|Withdrawal by Subject|2|||
126026688|NCT01707030|453393652|FG001|Overall Study|Withdrawal by Subject|3|||
126026689|NCT01707030|453393651|FG000|Overall Study|Lost to Follow-up|8|||
126026690|NCT01707030|453393652|FG001|Overall Study|Lost to Follow-up|13|||
126245547|NCT01547286|454191445|FG000|Overall Study|Did not meet all eligibility criteria|1|||
126245548|NCT01547286|454191445|FG000|Overall Study|Physician Decision|1|||
126245549|NCT03415308|454191446|FG000|Overall Study|Lost to Follow-up|0|||
126245550|NCT03415308|454191447|FG001|Overall Study|Lost to Follow-up|0|||
126245551|NCT03415308|454191448|FG002|Overall Study|Lost to Follow-up|1|||
126245552|NCT03415308|454191446|FG000|Overall Study|Scheduling Conflicts|0|||
126245553|NCT03415308|454191447|FG001|Overall Study|Scheduling Conflicts|0|||
126245554|NCT03415308|454191448|FG002|Overall Study|Scheduling Conflicts|7|||
126245555|NCT01471353|454191450|FG000|Overall Study|remain on study|3|||
126245556|NCT00836472|454191451|FG000|Washout|Adverse Event|1|||
126245557|NCT00836472|454191452|FG001|Washout|Adverse Event|2|||
126245558|NCT00836472|454191451|FG000|Washout|Withdrawal by Subject|1|||
126245559|NCT00836472|454191452|FG001|Washout|Withdrawal by Subject|1|||
126245560|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
126245561|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
126245562|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
126245563|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
126245564|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245565|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245566|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245567|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245568|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245569|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245570|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245571|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126026691|NCT04820855|453393653|FG000|Overall Study|Lost to Follow-up|6|||
126245572|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245573|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245574|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
126245575|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
126026692|NCT04820855|453393654|FG001|Overall Study|Lost to Follow-up|9|||
126026693|NCT02140645|453393667|FG000|Overall Study|Not linked|5489|||
126026694|NCT02140645|453393668|FG001|Overall Study|Not linked|61654|||
126026695|NCT02140645|453393669|FG002|Overall Study|Not linked|4236|||
126026696|NCT02140645|453393670|FG003|Overall Study|Not linked|13833|||
126026697|NCT02140645|453393671|FG004|Overall Study|Not linked|3286|||
126026698|NCT02140645|453393672|FG005|Overall Study|Not linked|70896|||
126026699|NCT00593489|453393679|FG000|Allocation|did not attend workshop; allocation not|2|||
126026700|NCT00593489|453393680|FG001|Allocation|did not attend workshop; allocation not|1|||
126026701|NCT00611559|453393681|FG000|Overall Study|Lost to Follow-up|0|||
126026702|NCT00611559|453393682|FG001|Overall Study|Lost to Follow-up|1|||
126026703|NCT00611559|453393683|FG002|Overall Study|Lost to Follow-up|0|||
126026704|NCT00611559|453393681|FG000|Overall Study|Protocol Violation|1|||
126026705|NCT00611559|453393682|FG001|Overall Study|Protocol Violation|0|||
126026706|NCT00611559|453393683|FG002|Overall Study|Protocol Violation|1|||
126026707|NCT04095104|453393684|FG000|Overall Study|Withdrawal by Subject|0|||
126026708|NCT04095104|453393685|FG001|Overall Study|Withdrawal by Subject|1|||
126026709|NCT03912831|453393687|FG000|Overall Study|Death|1|||
126026710|NCT03912831|453393688|FG001|Overall Study|Death|1|||
126026711|NCT03912831|453393689|FG002|Overall Study|Death|1|||
126026712|NCT03912831|453393690|FG003|Overall Study|Death|1|||
126026713|NCT03912831|453393691|FG004|Overall Study|Death|1|||
126026714|NCT03912831|453393692|FG005|Overall Study|Death|1|||
126026715|NCT03912831|453393687|FG000|Overall Study|Reason not Specified|0|||
126026716|NCT03912831|453393688|FG001|Overall Study|Reason not Specified|0|||
126026717|NCT03912831|453393689|FG002|Overall Study|Reason not Specified|0|||
126026718|NCT03912831|453393690|FG003|Overall Study|Reason not Specified|0|||
126026719|NCT03912831|453393691|FG004|Overall Study|Reason not Specified|1|||
126026720|NCT03912831|453393692|FG005|Overall Study|Reason not Specified|0|||
126026721|NCT03912831|453393687|FG000|Overall Study|Withdrawal by Participant|0|||
126026722|NCT03912831|453393688|FG001|Overall Study|Withdrawal by Participant|0|||
126026723|NCT03912831|453393689|FG002|Overall Study|Withdrawal by Participant|0|||
126026724|NCT03912831|453393690|FG003|Overall Study|Withdrawal by Participant|0|||
126026725|NCT03912831|453393691|FG004|Overall Study|Withdrawal by Participant|1|||
126026726|NCT03912831|453393692|FG005|Overall Study|Withdrawal by Participant|0|||
126026727|NCT02910713|453393695|FG000|Overall Study|Protocol Violation|2|||
126026728|NCT02910713|453393695|FG000|Overall Study|Subject Choice|4|||
126026729|NCT02910713|453393695|FG000|Overall Study|Received One Application|10|||
126026730|NCT02910713|453393695|FG000|Overall Study|Received Neither Application|18|||
126026731|NCT02910713|453393695|FG000|Overall Study|Enrollment cap|7|||
126026732|NCT02910713|453393695|FG000|Overall Study|Investigator Discretion|1|||
126026733|NCT04442126|453393697|FG000|Overall Study|Withdrawal by Subject|0|||
126026734|NCT04442126|453393698|FG001|Overall Study|Withdrawal by Subject|0|||
126245576|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
126245577|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
126026735|NCT04442126|453393699|FG002|Overall Study|Withdrawal by Subject|0|||
126026736|NCT04442126|453393700|FG003|Overall Study|Withdrawal by Subject|2|||
126026737|NCT04442126|453393701|FG004|Overall Study|Withdrawal by Subject|1|||
126026738|NCT04442126|453393702|FG005|Overall Study|Withdrawal by Subject|0|||
126026739|NCT04442126|453393703|FG006|Overall Study|Withdrawal by Subject|1|||
126026740|NCT04442126|453393704|FG007|Overall Study|Withdrawal by Subject|1|||
126026741|NCT04442126|453393705|FG008|Overall Study|Withdrawal by Subject|3|||
126026742|NCT04442126|453393697|FG000|Overall Study|Death|1|||
126026743|NCT04442126|453393698|FG001|Overall Study|Death|0|||
126245578|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126026744|NCT04442126|453393699|FG002|Overall Study|Death|0|||
126245579|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245580|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245581|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245582|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245583|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245584|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245585|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245586|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245587|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245588|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
126245589|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245590|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
126245591|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245592|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245593|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245594|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245595|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245596|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245597|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245598|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245599|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245600|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245601|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245602|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
126245603|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
126245604|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
126245605|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245606|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245607|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245608|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245609|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245610|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245611|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245612|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245613|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245614|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245615|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245616|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
126245617|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245618|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
126245619|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245620|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245621|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245622|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245623|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245624|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245625|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245626|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245627|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245628|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245629|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245630|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
126245631|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245632|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
126245633|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245634|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245635|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245636|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245637|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245638|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245639|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245640|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245641|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245642|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245643|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245644|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
126245645|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245646|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245647|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245648|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245649|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245650|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245651|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245652|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245653|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245654|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245655|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245656|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245657|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245658|NCT01695239|454191453|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245659|NCT01695239|454191454|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245660|NCT01695239|454191455|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245661|NCT01695239|454191456|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245662|NCT01695239|454191457|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245663|NCT01695239|454191458|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245664|NCT01695239|454191459|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245665|NCT01695239|454191460|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
126245666|NCT01695239|454191461|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245667|NCT01695239|454191462|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245668|NCT01695239|454191463|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245669|NCT01695239|454191464|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245670|NCT01695239|454191465|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245671|NCT01695239|454191466|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245672|NCT01695239|454191453|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245673|NCT01695239|454191454|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245674|NCT01695239|454191455|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245675|NCT01695239|454191456|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245676|NCT01695239|454191457|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245677|NCT01695239|454191458|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245678|NCT01695239|454191459|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245679|NCT01695239|454191460|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
126245680|NCT01695239|454191461|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245681|NCT01695239|454191462|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245682|NCT01695239|454191463|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245683|NCT01695239|454191464|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245684|NCT01695239|454191465|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245685|NCT01695239|454191466|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245686|NCT01695239|454191453|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245687|NCT01695239|454191454|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245688|NCT01695239|454191455|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245689|NCT01695239|454191456|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245690|NCT01695239|454191457|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245691|NCT01695239|454191458|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245692|NCT01695239|454191459|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245693|NCT01695239|454191460|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
126245694|NCT01695239|454191461|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245695|NCT01695239|454191462|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245696|NCT01695239|454191463|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245697|NCT01695239|454191464|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245698|NCT01695239|454191465|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245699|NCT01695239|454191466|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245700|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126026745|NCT04442126|453393700|FG003|Overall Study|Death|1|||
126026746|NCT04442126|453393701|FG004|Overall Study|Death|2|||
126026747|NCT04442126|453393702|FG005|Overall Study|Death|2|||
126026748|NCT04442126|453393703|FG006|Overall Study|Death|4|||
126026749|NCT04442126|453393704|FG007|Overall Study|Death|1|||
126026750|NCT04442126|453393705|FG008|Overall Study|Death|5|||
126026751|NCT04442126|453393697|FG000|Overall Study|Study Terminated by Sponsor|0|||
126026752|NCT04442126|453393698|FG001|Overall Study|Study Terminated by Sponsor|0|||
126245701|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245702|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245703|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245704|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245705|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245706|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245707|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245708|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
126245709|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
126245710|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245711|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245712|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245713|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245714|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
126245715|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
126245716|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
126245717|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
126245718|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
126245719|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
126245720|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
126245721|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
126245722|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
126245723|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
126245724|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
126245725|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
126245726|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
126245727|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
126245728|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245729|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245730|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245731|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245732|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245733|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245734|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245735|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245736|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
126245737|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
126245738|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245739|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245740|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245741|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245742|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
126245743|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
126245744|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
126245745|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
126245746|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
126245747|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
126245748|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
126245749|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
126245750|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
126245751|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
126245752|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
126245753|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
126245754|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
126245755|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
126245756|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245757|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245758|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245759|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245760|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126094293|NCT00680992|453639198|FG001|Overall Study|End of Trial|12|||
126094294|NCT00680992|453639199|FG002|Overall Study|End of Trial|3|||
126094295|NCT00680992|453639197|FG000|Overall Study|Withdrawal by Subject|33|||
126094296|NCT00680992|453639198|FG001|Overall Study|Withdrawal by Subject|11|||
126094297|NCT00680992|453639199|FG002|Overall Study|Withdrawal by Subject|1|||
126245761|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245762|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245763|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245764|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
126245765|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
126245766|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245767|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245768|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245769|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245770|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245771|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245772|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245773|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245774|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245775|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245776|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245777|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245778|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
126245779|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
126245780|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245781|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245782|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245783|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245784|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Death|0|||
126245785|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Death|0|||
126245786|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Death|0|||
126245787|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Death|0|||
126245788|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Death|0|||
126245789|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Death|0|||
126245790|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Death|0|||
126245791|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Death|0|||
126245792|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Death|1|||
126245793|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Death|0|||
126245794|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Death|0|||
126245795|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Death|0|||
126245796|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Death|0|||
126245797|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Death|0|||
126245798|NCT01695239|454191453|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245799|NCT01695239|454191454|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245800|NCT01695239|454191455|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245801|NCT01695239|454191456|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126357601|NCT01968785|454602164|FG000|Overall Study|Withdrawal by Subject|1|||
126357602|NCT01968785|454602165|FG001|Overall Study|Withdrawal by Subject|0|||
126357603|NCT04000724|454602172|FG000|Overall Study|Withdrawal by Subject|5|||
126357604|NCT04000724|454602173|FG001|Overall Study|Withdrawal by Subject|3|||
126357605|NCT04000724|454602174|FG002|Overall Study|Withdrawal by Subject|4|||
126357606|NCT04000724|454602172|FG000|Overall Study|Lost to Follow-up|11|||
126357607|NCT04000724|454602173|FG001|Overall Study|Lost to Follow-up|7|||
126357608|NCT04000724|454602174|FG002|Overall Study|Lost to Follow-up|13|||
126357609|NCT00455455|454602175|FG000|Washout|Withdrawal by Subject|0|||
126357610|NCT00455455|454602176|FG001|Washout|Withdrawal by Subject|1|||
126357611|NCT00455455|454602175|FG000|Washout|Withdrawal by Subject|1|||
126357612|NCT00455455|454602176|FG001|Washout|Withdrawal by Subject|0|||
126357613|NCT01827943|454602177|FG000|Overall Study|Protocol Violation|8|||
126357614|NCT01827943|454602177|FG000|Overall Study|Never treated because of an rapid progression|1|||
126357615|NCT04689009|454602182|FG000|Overall Study|Adverse Event|1|||
126357616|NCT04689009|454602183|FG001|Overall Study|Adverse Event|0|||
126357617|NCT04689009|454602182|FG000|Overall Study|Lost to Follow-up|1|||
126357618|NCT04689009|454602183|FG001|Overall Study|Lost to Follow-up|2|||
126357619|NCT04689009|454602182|FG000|Overall Study|Withdrawal by Subject|4|||
126357620|NCT04689009|454602183|FG001|Overall Study|Withdrawal by Subject|3|||
126357621|NCT04689009|454602182|FG000|Overall Study|Protocol Violation|1|||
126357622|NCT04689009|454602183|FG001|Overall Study|Protocol Violation|0|||
126357623|NCT00545948|454602185|FG000|Overall Study|Not Treated|1|||
126357624|NCT00545948|454602186|FG001|Overall Study|Not Treated|1|||
126357625|NCT00545948|454602187|FG002|Overall Study|Not Treated|7|||
126357626|NCT02187055|454602190|FG000|Overall Study|Lack of Efficacy|10|||
126357627|NCT02187055|454602191|FG001|Overall Study|Lack of Efficacy|3|||
126357628|NCT02187055|454602192|FG002|Overall Study|Lack of Efficacy|7|||
126357629|NCT02187055|454602190|FG000|Overall Study|Lost to Follow-up|2|||
126026753|NCT04442126|453393699|FG002|Overall Study|Study Terminated by Sponsor|0|||
126026754|NCT04442126|453393700|FG003|Overall Study|Study Terminated by Sponsor|0|||
126026755|NCT04442126|453393701|FG004|Overall Study|Study Terminated by Sponsor|0|||
126026756|NCT04442126|453393702|FG005|Overall Study|Study Terminated by Sponsor|1|||
126026757|NCT04442126|453393703|FG006|Overall Study|Study Terminated by Sponsor|4|||
126026758|NCT04442126|453393704|FG007|Overall Study|Study Terminated by Sponsor|2|||
126026759|NCT04442126|453393705|FG008|Overall Study|Study Terminated by Sponsor|10|||
126026760|NCT04442126|453393697|FG000|Overall Study|Lost to Follow-up|0|||
126026761|NCT04442126|453393698|FG001|Overall Study|Lost to Follow-up|0|||
126026762|NCT04442126|453393699|FG002|Overall Study|Lost to Follow-up|0|||
126026763|NCT04442126|453393700|FG003|Overall Study|Lost to Follow-up|0|||
126026764|NCT04442126|453393701|FG004|Overall Study|Lost to Follow-up|0|||
126026765|NCT04442126|453393702|FG005|Overall Study|Lost to Follow-up|0|||
126026766|NCT04442126|453393703|FG006|Overall Study|Lost to Follow-up|0|||
126026767|NCT04442126|453393704|FG007|Overall Study|Lost to Follow-up|1|||
126026768|NCT04442126|453393705|FG008|Overall Study|Lost to Follow-up|2|||
126026769|NCT04442126|453393697|FG000|Overall Study|Progressive Disease|0|||
126094298|NCT00680992|453639197|FG000|Overall Study|Adverse Event|21|||
126094299|NCT00680992|453639198|FG001|Overall Study|Adverse Event|19|||
126094300|NCT00680992|453639199|FG002|Overall Study|Adverse Event|1|||
126094301|NCT00680992|453639197|FG000|Overall Study|Other|19|||
126245802|NCT01695239|454191457|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245803|NCT01695239|454191458|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245804|NCT01695239|454191459|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245805|NCT01695239|454191460|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245806|NCT01695239|454191461|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245807|NCT01695239|454191462|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245808|NCT01695239|454191463|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245809|NCT01695239|454191464|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
126245810|NCT01695239|454191465|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
126245811|NCT01695239|454191466|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
126245812|NCT01695239|454191453|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245813|NCT01695239|454191454|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245814|NCT01695239|454191455|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245815|NCT01695239|454191456|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245816|NCT01695239|454191457|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245817|NCT01695239|454191458|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245818|NCT01695239|454191459|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245819|NCT01695239|454191460|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245820|NCT01695239|454191461|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245821|NCT01695239|454191462|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245822|NCT01695239|454191463|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245823|NCT01695239|454191464|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245824|NCT01695239|454191465|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
126245825|NCT01695239|454191466|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
126245826|NCT01695239|454191453|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245827|NCT01695239|454191454|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245828|NCT01695239|454191455|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245829|NCT01695239|454191456|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245830|NCT01695239|454191457|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245831|NCT01695239|454191458|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245832|NCT01695239|454191459|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245833|NCT01695239|454191460|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245834|NCT01695239|454191461|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245835|NCT01695239|454191462|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245836|NCT01695239|454191463|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245837|NCT01695239|454191464|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245838|NCT01695239|454191465|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
126245839|NCT01695239|454191466|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245840|NCT01695239|454191453|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126094302|NCT00680992|453639198|FG001|Overall Study|Other|14|||
126245841|NCT01695239|454191454|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245842|NCT01695239|454191455|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245843|NCT01695239|454191456|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126357630|NCT02187055|454602191|FG001|Overall Study|Lost to Follow-up|7|||
126026770|NCT04442126|453393698|FG001|Overall Study|Progressive Disease|1|||
126026771|NCT04442126|453393699|FG002|Overall Study|Progressive Disease|3|||
126026772|NCT04442126|453393700|FG003|Overall Study|Progressive Disease|0|||
126026773|NCT04442126|453393701|FG004|Overall Study|Progressive Disease|3|||
126094303|NCT00680992|453639199|FG002|Overall Study|Other|1|||
126094304|NCT00680992|453639197|FG000|Overall Study|Disease Progression|21|||
126094305|NCT00680992|453639198|FG001|Overall Study|Disease Progression|9|||
126245844|NCT01695239|454191457|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245845|NCT01695239|454191458|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245846|NCT01695239|454191459|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245847|NCT01695239|454191460|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245848|NCT01695239|454191461|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245849|NCT01695239|454191462|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245850|NCT01695239|454191463|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245851|NCT01695239|454191464|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245852|NCT01695239|454191465|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245853|NCT01695239|454191466|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
126245854|NCT03502811|454191468|FG000|Overall Study|Death|157|||
126245855|NCT03502811|454191468|FG000|Overall Study|Withdrawal by Subject|105|||
126245856|NCT03502811|454191468|FG000|Overall Study|Lost to Follow-up|26|||
126245857|NCT03502811|454191468|FG000|Overall Study|No Visits (Missed)|31|||
126245858|NCT01735994|454191469|FG000|Overall Study|Withdrawal by Subject|6|||
126245859|NCT01735994|454191470|FG001|Overall Study|Withdrawal by Subject|4|||
126245860|NCT01735994|454191469|FG000|Overall Study|Injury|2|||
126245861|NCT01735994|454191470|FG001|Overall Study|Injury|0|||
126245862|NCT01735994|454191469|FG000|Overall Study|Kicked off team|5|||
126245863|NCT01735994|454191470|FG001|Overall Study|Kicked off team|0|||
126245864|NCT01735994|454191469|FG000|Overall Study|Lost to Follow-up|50|||
126245865|NCT01735994|454191470|FG001|Overall Study|Lost to Follow-up|62|||
126245866|NCT02241551|454191473|FG000|Overall Study|Adverse Event|1|||
126245867|NCT02241551|454191474|FG001|Overall Study|Adverse Event|0|||
126245868|NCT00469898|454191478|FG000|Overall Study|Adverse Event|7|||
126245869|NCT00469898|454191478|FG000|Overall Study|Withdrawal by Subject|4|||
126245870|NCT00469898|454191478|FG000|Overall Study|Death|4|||
126245871|NCT00469898|454191478|FG000|Overall Study|Disease progression|9|||
126245872|NCT00469898|454191478|FG000|Overall Study|Decreased performance status|1|||
126245873|NCT01205035|454191479|FG000|Overall Study|Withdrawal by Subject|1|||
126245874|NCT01205035|454191480|FG001|Overall Study|Withdrawal by Subject|0|||
126245875|NCT01205035|454191479|FG000|Overall Study|Physician Decision|1|||
126245876|NCT01205035|454191480|FG001|Overall Study|Physician Decision|0|||
126245877|NCT00392665|454191482|FG000|Overall Study|Death|16|||
126245878|NCT00392665|454191483|FG001|Overall Study|Death|14|||
126245879|NCT00392665|454191482|FG000|Overall Study|Lost to Follow-up|1|||
126245880|NCT00392665|454191483|FG001|Overall Study|Lost to Follow-up|1|||
126245881|NCT02294786|454191486|FG000|Overall Study|Withdrawal by Subject|0|||
126245882|NCT02294786|454191487|FG001|Overall Study|Withdrawal by Subject|1|||
126245883|NCT02294786|454191486|FG000|Overall Study|Physician Decision|6|||
126245884|NCT02294786|454191487|FG001|Overall Study|Physician Decision|7|||
126245885|NCT02294786|454191486|FG000|Overall Study|Lost to Follow-up|1|||
126245886|NCT02294786|454191487|FG001|Overall Study|Lost to Follow-up|2|||
126245887|NCT02294786|454191486|FG000|Overall Study|Protocol Violation|1|||
126245888|NCT02294786|454191487|FG001|Overall Study|Protocol Violation|0|||
126245889|NCT02294786|454191486|FG000|Overall Study|Adverse Event|1|||
126245890|NCT02294786|454191487|FG001|Overall Study|Adverse Event|1|||
126245891|NCT02294786|454191486|FG000|Overall Study|Death|2|||
126245892|NCT02294786|454191487|FG001|Overall Study|Death|3|||
126245893|NCT01778010|454191488|FG000|Overall Study|Withdrawal by Subject|2|||
126245894|NCT01778010|454191488|FG000|Overall Study|abnormal ECG before meds|1|||
126245895|NCT01778010|454191488|FG000|Overall Study|Arrested|1|||
126245896|NCT01778010|454191488|FG000|Overall Study|rash while on placebo|1|||
126245897|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
126245898|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
126245899|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
126245900|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
126245901|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
126245902|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
126245903|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
126245904|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
126245905|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
126245906|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
126245907|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
126245908|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
126245909|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
126245910|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
126245911|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
126245912|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
126245913|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
126245914|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
126357631|NCT02187055|454602192|FG002|Overall Study|Lost to Follow-up|3|||
126357632|NCT02187055|454602190|FG000|Overall Study|No longer meets eligibility criteria|0|||
126357633|NCT02187055|454602191|FG001|Overall Study|No longer meets eligibility criteria|2|||
126245915|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
126245916|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
126245917|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
126245918|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
126245919|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
126245920|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
126245921|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
126245922|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
126245923|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
126245924|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
126245925|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
126245926|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
126245927|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
126245928|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
126245929|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
126245930|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
126245931|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
126245932|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
126245933|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
126245934|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
126245935|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
126245936|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
126245937|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
126245938|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
126245939|NCT02159183|454191491|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
126245940|NCT02159183|454191492|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
126245941|NCT02159183|454191491|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
126245942|NCT02159183|454191492|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
126245943|NCT02159183|454191491|FG000|Analysis After the 36 Months Follow-up|Death|0|||
126245944|NCT02159183|454191492|FG001|Analysis After the 36 Months Follow-up|Death|1|||
126245945|NCT02159183|454191491|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
126245946|NCT02159183|454191492|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
126245947|NCT02159183|454191491|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
126245948|NCT02159183|454191492|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
126245949|NCT01294917|454191496|FG000|Overall Study|Relocation|5|||
126245950|NCT01294917|454191496|FG000|Overall Study|Inconvenience|1|||
126245951|NCT02519348|454191497|FG000|Overall Study|Death|31|||
126245952|NCT02519348|454191498|FG001|Overall Study|Death|74|||
126245953|NCT02519348|454191499|FG002|Overall Study|Death|47|||
126245954|NCT02519348|454191500|FG003|Overall Study|Death|54|||
126245955|NCT02519348|454191501|FG004|Overall Study|Death|63|||
126245956|NCT02519348|454191502|FG005|Overall Study|Death|18|||
126245957|NCT02519348|454191503|FG006|Overall Study|Death|2|||
126245958|NCT02519348|454191504|FG007|Overall Study|Death|5|||
126245959|NCT02519348|454191505|FG008|Overall Study|Death|5|||
126245960|NCT02519348|454191497|FG000|Overall Study|Withdrawal by Subject|4|||
126245961|NCT02519348|454191498|FG001|Overall Study|Withdrawal by Subject|7|||
126245962|NCT02519348|454191499|FG002|Overall Study|Withdrawal by Subject|4|||
126245963|NCT02519348|454191500|FG003|Overall Study|Withdrawal by Subject|3|||
126245964|NCT02519348|454191501|FG004|Overall Study|Withdrawal by Subject|3|||
126245965|NCT02519348|454191502|FG005|Overall Study|Withdrawal by Subject|2|||
126245966|NCT02519348|454191503|FG006|Overall Study|Withdrawal by Subject|0|||
126245967|NCT02519348|454191504|FG007|Overall Study|Withdrawal by Subject|0|||
126245968|NCT02519348|454191505|FG008|Overall Study|Withdrawal by Subject|1|||
126245969|NCT02519348|454191497|FG000|Overall Study|Lost to Follow-up|0|||
126245970|NCT02519348|454191498|FG001|Overall Study|Lost to Follow-up|0|||
126245971|NCT02519348|454191499|FG002|Overall Study|Lost to Follow-up|1|||
126245972|NCT02519348|454191500|FG003|Overall Study|Lost to Follow-up|0|||
126245973|NCT02519348|454191501|FG004|Overall Study|Lost to Follow-up|2|||
126245974|NCT02519348|454191502|FG005|Overall Study|Lost to Follow-up|1|||
126245975|NCT02519348|454191503|FG006|Overall Study|Lost to Follow-up|1|||
126245976|NCT02519348|454191504|FG007|Overall Study|Lost to Follow-up|0|||
126245977|NCT02519348|454191505|FG008|Overall Study|Lost to Follow-up|0|||
126245978|NCT02519348|454191497|FG000|Overall Study|Other|0|||
126245979|NCT02519348|454191498|FG001|Overall Study|Other|3|||
126245980|NCT02519348|454191499|FG002|Overall Study|Other|0|||
126245981|NCT02519348|454191500|FG003|Overall Study|Other|0|||
126245982|NCT02519348|454191501|FG004|Overall Study|Other|1|||
126245983|NCT02519348|454191502|FG005|Overall Study|Other|0|||
126245984|NCT02519348|454191503|FG006|Overall Study|Other|0|||
126245985|NCT02519348|454191504|FG007|Overall Study|Other|0|||
126245986|NCT02519348|454191505|FG008|Overall Study|Other|0|||
126245987|NCT02519348|454191497|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
126026774|NCT04442126|453393702|FG005|Overall Study|Progressive Disease|0|||
126245988|NCT02519348|454191498|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
126245989|NCT02519348|454191499|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
126245990|NCT02519348|454191500|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
126245991|NCT02519348|454191501|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
126245992|NCT02519348|454191502|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
126245993|NCT02519348|454191503|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
126245994|NCT02519348|454191504|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
126245995|NCT02519348|454191505|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
126245996|NCT01444378|454191506|FG000|Overall Study|Lost to Follow-up|1|||
126245997|NCT01444378|454191506|FG000|Overall Study|Withdrawal by Subject|1|||
126245998|NCT01444378|454191506|FG000|Overall Study|Death|3|||
126245999|NCT01444378|454191506|FG000|Overall Study|Administrative Closure Of The Study|2|||
126246000|NCT01444378|454191506|FG000|Overall Study|Missed Visits|10|||
126246001|NCT02911792|454191507|FG000|Overall Study|Lost to Follow-up|3|||
126246002|NCT02911792|454191508|FG001|Overall Study|Lost to Follow-up|3|||
126246003|NCT02911792|454191509|FG002|Overall Study|Lost to Follow-up|3|||
126246004|NCT02911792|454191510|FG003|Overall Study|Lost to Follow-up|3|||
126246005|NCT01929863|454191520|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
126246006|NCT01929863|454191521|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
126246007|NCT01929863|454191520|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
126246008|NCT01929863|454191521|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
126246009|NCT01929863|454191520|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
126246010|NCT01929863|454191521|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
126246011|NCT00323882|454191522|FG000|Overall Study|Adverse Event|2|||
126246012|NCT00323882|454191523|FG001|Overall Study|Adverse Event|1|||
126246013|NCT00323882|454191524|FG002|Overall Study|Adverse Event|1|||
126246014|NCT00323882|454191525|FG003|Overall Study|Adverse Event|1|||
126246015|NCT00323882|454191526|FG004|Overall Study|Adverse Event|3|||
126246016|NCT00323882|454191522|FG000|Overall Study|Disease Progression|6|||
126246017|NCT00323882|454191523|FG001|Overall Study|Disease Progression|4|||
126246018|NCT00323882|454191524|FG002|Overall Study|Disease Progression|10|||
126246019|NCT00323882|454191525|FG003|Overall Study|Disease Progression|5|||
126246020|NCT00323882|454191526|FG004|Overall Study|Disease Progression|22|||
126246021|NCT00323882|454191522|FG000|Overall Study|Death|0|||
126246022|NCT00323882|454191523|FG001|Overall Study|Death|1|||
126246023|NCT00323882|454191524|FG002|Overall Study|Death|1|||
126246024|NCT00323882|454191525|FG003|Overall Study|Death|0|||
126246025|NCT00323882|454191526|FG004|Overall Study|Death|5|||
126246026|NCT00323882|454191522|FG000|Overall Study|Lost to Follow-up|0|||
126246027|NCT00323882|454191523|FG001|Overall Study|Lost to Follow-up|0|||
126246028|NCT00323882|454191524|FG002|Overall Study|Lost to Follow-up|1|||
126246029|NCT00323882|454191525|FG003|Overall Study|Lost to Follow-up|0|||
126246030|NCT00323882|454191526|FG004|Overall Study|Lost to Follow-up|1|||
126246031|NCT00323882|454191522|FG000|Overall Study|Other|0|||
126246032|NCT00323882|454191523|FG001|Overall Study|Other|0|||
126246033|NCT00323882|454191524|FG002|Overall Study|Other|0|||
126246034|NCT00323882|454191525|FG003|Overall Study|Other|1|||
126246035|NCT00323882|454191526|FG004|Overall Study|Other|1|||
126246036|NCT02911701|454191527|FG000|Overall Study|Withdrawal by Subject|2|||
126246037|NCT02911701|454191528|FG001|Overall Study|Withdrawal by Subject|4|||
126246038|NCT02911701|454191527|FG000|Overall Study|Adverse Event|1|||
126246039|NCT02911701|454191528|FG001|Overall Study|Adverse Event|0|||
126246040|NCT00830024|454191529|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126246041|NCT00830024|454191530|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
126246042|NCT01983969|454191531|FG000|Overall Study|Disease Progression|0|||
126246043|NCT01983969|454191532|FG001|Overall Study|Disease Progression|1|||
126246044|NCT01983969|454191533|FG002|Overall Study|Disease Progression|0|||
126246045|NCT00436163|454191534|FG000|Overall Study|Lost to Follow-up|2|||
126246046|NCT00436163|454191534|FG000|Overall Study|Adverse Event|1|||
126246047|NCT02530905|454191535|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
126246048|NCT02530905|454191536|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
126246049|NCT02530905|454191537|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
126246050|NCT01841554|454191539|FG000|Overall Study|Death|7|||
126246051|NCT01841554|454191539|FG000|Overall Study|No Implantation|1|||
126246052|NCT01841554|454191539|FG000|Overall Study|Discontinued Follow Up|5|||
126246053|NCT01841554|454191539|FG000|Overall Study|Study exit due to secondary intervention|6|||
126026775|NCT04442126|453393703|FG006|Overall Study|Progressive Disease|0|||
126246054|NCT03804983|454191543|FG000|Overall Study|Adverse Event|0|||
126246055|NCT03804983|454191544|FG001|Overall Study|Adverse Event|1|||
126026776|NCT04442126|453393704|FG007|Overall Study|Progressive Disease|0|||
126026777|NCT04442126|453393705|FG008|Overall Study|Progressive Disease|0|||
126246056|NCT03804983|454191543|FG000|Overall Study|Family Obligation|1|||
126246057|NCT03804983|454191544|FG001|Overall Study|Family Obligation|0|||
126246058|NCT03600376|454191545|FG000|Overall Study|Adverse Event|1|||
126026778|NCT04442126|453393697|FG000|Overall Study|Other|0|||
126246059|NCT03600376|454191546|FG001|Overall Study|Adverse Event|1|||
126246060|NCT03600376|454191545|FG000|Overall Study|Transferred to other facility|1|||
126246061|NCT03600376|454191546|FG001|Overall Study|Transferred to other facility|0|||
126246062|NCT03600376|454191545|FG000|Overall Study|Investigator Decision|0|||
126246063|NCT03600376|454191546|FG001|Overall Study|Investigator Decision|4|||
126246064|NCT03600376|454191545|FG000|Overall Study|Determined to be ineligible for study|0|||
126246065|NCT03600376|454191546|FG001|Overall Study|Determined to be ineligible for study|1|||
126246066|NCT00312897|454191549|FG000|Overall Study|Adverse Event|1|||
126246067|NCT00312897|454191550|FG001|Overall Study|Adverse Event|0|||
126246068|NCT00312897|454191549|FG000|Overall Study|Lost to Follow-up|2|||
126246069|NCT00312897|454191550|FG001|Overall Study|Lost to Follow-up|0|||
126246070|NCT00312897|454191549|FG000|Overall Study|Physician Decision|1|||
126246071|NCT00312897|454191550|FG001|Overall Study|Physician Decision|0|||
126246072|NCT00312897|454191549|FG000|Overall Study|Withdrawal by Subject|1|||
126246073|NCT00312897|454191550|FG001|Overall Study|Withdrawal by Subject|3|||
126246074|NCT00312897|454191549|FG000|Overall Study|Pregnancy|1|||
126246075|NCT00312897|454191550|FG001|Overall Study|Pregnancy|0|||
126246076|NCT00312897|454191549|FG000|Overall Study|discontinued prior to getting treatment|0|||
126246077|NCT00312897|454191550|FG001|Overall Study|discontinued prior to getting treatment|3|||
126246078|NCT03100344|454191551|FG000|Overall Study|Adverse Event|0|||
126246079|NCT03100344|454191552|FG001|Overall Study|Adverse Event|3|||
126246080|NCT03100344|454191553|FG002|Overall Study|Adverse Event|2|||
126246081|NCT03100344|454191554|FG003|Overall Study|Adverse Event|3|||
126246082|NCT03100344|454191551|FG000|Overall Study|Lack of Efficacy|2|||
126246083|NCT03100344|454191552|FG001|Overall Study|Lack of Efficacy|0|||
126246084|NCT03100344|454191553|FG002|Overall Study|Lack of Efficacy|0|||
126246085|NCT03100344|454191554|FG003|Overall Study|Lack of Efficacy|0|||
126246086|NCT03100344|454191551|FG000|Overall Study|Protocol Violation|1|||
126246087|NCT03100344|454191552|FG001|Overall Study|Protocol Violation|0|||
126246088|NCT03100344|454191553|FG002|Overall Study|Protocol Violation|0|||
126246089|NCT03100344|454191554|FG003|Overall Study|Protocol Violation|0|||
126246090|NCT03100344|454191551|FG000|Overall Study|Withdrawal by Subject|10|||
126246091|NCT03100344|454191552|FG001|Overall Study|Withdrawal by Subject|7|||
126246092|NCT03100344|454191553|FG002|Overall Study|Withdrawal by Subject|4|||
126246093|NCT03100344|454191554|FG003|Overall Study|Withdrawal by Subject|8|||
126246094|NCT03100344|454191551|FG000|Overall Study|Lost to Follow-up|1|||
126246095|NCT03100344|454191552|FG001|Overall Study|Lost to Follow-up|1|||
126246096|NCT03100344|454191553|FG002|Overall Study|Lost to Follow-up|1|||
126246097|NCT03100344|454191554|FG003|Overall Study|Lost to Follow-up|1|||
126246098|NCT01010503|454191555|FG000|Overall Study|Adverse Event|1|||
126246099|NCT01010503|454191555|FG000|Overall Study|Death|1|||
126246100|NCT04633564|454191556|FG000|Period 1|Adverse Event|28|||
126246101|NCT04633564|454191557|FG001|Period 1|Adverse Event|19|||
126246102|NCT04633564|454191556|FG000|Period 1|Death|8|||
126246103|NCT04633564|454191557|FG001|Period 1|Death|7|||
126246104|NCT04633564|454191556|FG000|Period 1|Lost to Follow-up|3|||
126246105|NCT04633564|454191557|FG001|Period 1|Lost to Follow-up|5|||
126246106|NCT04633564|454191556|FG000|Period 1|Physician Decision|4|||
126246107|NCT04633564|454191557|FG001|Period 1|Physician Decision|12|||
126246108|NCT04633564|454191556|FG000|Period 1|Protocol Violation|0|||
126246109|NCT04633564|454191557|FG001|Period 1|Protocol Violation|1|||
126246110|NCT04633564|454191556|FG000|Period 1|Withdrawal by Subject|10|||
126246111|NCT04633564|454191557|FG001|Period 1|Withdrawal by Subject|8|||
126246112|NCT04633564|454191556|FG000|Period 1|Progressive disease|47|||
126246113|NCT04633564|454191557|FG001|Period 1|Progressive disease|51|||
126246114|NCT04633564|454191556|FG000|Period 1|Terminated by Sponsor|8|||
126246115|NCT04633564|454191557|FG001|Period 1|Terminated by Sponsor|6|||
126246116|NCT04633564|454191556|FG000|Period 2|Adverse Event|3|||
126246117|NCT04633564|454191557|FG001|Period 2|Adverse Event|4|||
126246118|NCT04633564|454191556|FG000|Period 2|Death|0|||
126246119|NCT04633564|454191557|FG001|Period 2|Death|2|||
126246120|NCT04633564|454191556|FG000|Period 2|Lost to Follow-up|0|||
126246121|NCT04633564|454191557|FG001|Period 2|Lost to Follow-up|1|||
126246122|NCT04633564|454191556|FG000|Period 2|Physician Decision|2|||
126246123|NCT04633564|454191557|FG001|Period 2|Physician Decision|4|||
126246124|NCT04633564|454191556|FG000|Period 2|Withdrawal by Subject|5|||
126246125|NCT04633564|454191557|FG001|Period 2|Withdrawal by Subject|1|||
126246126|NCT04633564|454191556|FG000|Period 2|Progressive Disease|74|||
126246127|NCT04633564|454191557|FG001|Period 2|Progressive Disease|82|||
126094306|NCT00680992|453639199|FG002|Overall Study|Disease Progression|0|||
126094307|NCT00680992|453639197|FG000|Overall Study|Lost to Follow-up|12|||
126246128|NCT04633564|454191556|FG000|Period 2|Terminated by Sponsor|9|||
126094308|NCT00680992|453639198|FG001|Overall Study|Lost to Follow-up|14|||
126246129|NCT04633564|454191557|FG001|Period 2|Terminated by Sponsor|3|||
126246130|NCT02267187|454192905|FG000|Overall Study|Physician Decision|2|||
126246131|NCT02267187|454192905|FG000|Overall Study|Screen fail|3|||
126246132|NCT02222818|454192908|FG000|Period 1|Eligibility criteria not met|0|||
126094309|NCT00680992|453639199|FG002|Overall Study|Lost to Follow-up|0|||
126246133|NCT02222818|454192909|FG001|Period 1|Eligibility criteria not met|3|||
126246134|NCT00834717|454192910|FG000|First Intervention|Adverse Event|1|||
126246135|NCT00834717|454192911|FG001|First Intervention|Adverse Event|0|||
126246136|NCT00834717|454192910|FG000|First Intervention|Withdrawal by Subject|0|||
126246137|NCT00834717|454192911|FG001|First Intervention|Withdrawal by Subject|1|||
126246138|NCT01660243|454192912|FG000|Overall Study|Adverse Event|1|||
126246139|NCT01660243|454192913|FG001|Overall Study|Adverse Event|0|||
126246140|NCT01660243|454192914|FG002|Overall Study|Adverse Event|1|||
126246141|NCT01660243|454192915|FG003|Overall Study|Adverse Event|0|||
126246142|NCT01660243|454192912|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
126246143|NCT01660243|454192913|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
126246144|NCT01660243|454192914|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
126246145|NCT01660243|454192915|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
126246146|NCT01660243|454192912|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
126246147|NCT01660243|454192913|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
126246148|NCT01660243|454192914|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
126246149|NCT01660243|454192915|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
126246150|NCT01660243|454192912|FG000|Overall Study|Randomization error|0|||
126246151|NCT01660243|454192913|FG001|Overall Study|Randomization error|0|||
126246152|NCT01660243|454192914|FG002|Overall Study|Randomization error|0|||
126246153|NCT01660243|454192915|FG003|Overall Study|Randomization error|1|||
126246154|NCT03025087|454192916|FG000|Overall Study|Physician Decision|3|||
126246155|NCT03025087|454192917|FG001|Overall Study|Physician Decision|3|||
126246156|NCT03025087|454192918|FG002|Overall Study|Physician Decision|0|||
126246157|NCT03025087|454192919|FG003|Overall Study|Physician Decision|0|||
126246158|NCT03025087|454192920|FG004|Overall Study|Physician Decision|0|||
126246159|NCT03025087|454192916|FG000|Overall Study|Withdrawal by Subject|1|||
126246160|NCT03025087|454192917|FG001|Overall Study|Withdrawal by Subject|1|||
126246161|NCT03025087|454192918|FG002|Overall Study|Withdrawal by Subject|0|||
126246162|NCT03025087|454192919|FG003|Overall Study|Withdrawal by Subject|0|||
126246163|NCT03025087|454192920|FG004|Overall Study|Withdrawal by Subject|0|||
126246164|NCT03025087|454192916|FG000|Overall Study|Unable to complete MRI|2|||
126246165|NCT03025087|454192917|FG001|Overall Study|Unable to complete MRI|2|||
126246166|NCT03025087|454192918|FG002|Overall Study|Unable to complete MRI|0|||
126246167|NCT03025087|454192919|FG003|Overall Study|Unable to complete MRI|0|||
126246168|NCT03025087|454192920|FG004|Overall Study|Unable to complete MRI|0|||
126246169|NCT00508651|454192927|FG000|Overall Study|Lost to Follow-up|3|||
126246170|NCT00508651|454192928|FG001|Overall Study|Lost to Follow-up|1|||
126246171|NCT00508651|454192927|FG000|Overall Study|Withdrawal by Subject|1|||
126246172|NCT00508651|454192928|FG001|Overall Study|Withdrawal by Subject|1|||
126246173|NCT02255149|454192937|FG000|Overall Study|Lost to Follow-up|2|||
126246174|NCT02255149|454192937|FG000|Overall Study|Withdrawal by Subject|1|||
126246175|NCT02255149|454192937|FG000|Overall Study|Withdrawal by PI|1|||
126246176|NCT02255149|454192937|FG000|Overall Study|Implant Failure|1|||
126246177|NCT05710718|454192944|FG000|Overall Study|Withdrawal by Subject|5|||
126246178|NCT05710718|454192945|FG001|Overall Study|Withdrawal by Subject|1|||
126246179|NCT05710718|454192944|FG000|Overall Study|Lost to Follow-up|0|||
126246180|NCT05710718|454192945|FG001|Overall Study|Lost to Follow-up|1|||
126246181|NCT05710718|454192944|FG000|Overall Study|Death|0|||
126246182|NCT05710718|454192945|FG001|Overall Study|Death|1|||
126246183|NCT03121586|454192946|FG000|Overall Study|Study terminated by sponsor|0|||
126246184|NCT03121586|454192947|FG001|Overall Study|Study terminated by sponsor|0|||
126246185|NCT03121586|454192948|FG002|Overall Study|Study terminated by sponsor|99|||
126246186|NCT03121586|454192946|FG000|Overall Study|Withdrawal by Subject|37|||
126026779|NCT04442126|453393698|FG001|Overall Study|Other|0|||
126026780|NCT04442126|453393699|FG002|Overall Study|Other|0|||
126026781|NCT04442126|453393700|FG003|Overall Study|Other|0|||
126246187|NCT03121586|454192947|FG001|Overall Study|Withdrawal by Subject|14|||
126246188|NCT03121586|454192948|FG002|Overall Study|Withdrawal by Subject|9|||
126246189|NCT03121586|454192946|FG000|Overall Study|Not further specified|6|||
126246190|NCT03121586|454192947|FG001|Overall Study|Not further specified|11|||
126246191|NCT03121586|454192948|FG002|Overall Study|Not further specified|10|||
126246192|NCT03121586|454192946|FG000|Overall Study|Adverse Event|16|||
126246193|NCT03121586|454192947|FG001|Overall Study|Adverse Event|5|||
126246194|NCT03121586|454192948|FG002|Overall Study|Adverse Event|6|||
126246195|NCT03121586|454192946|FG000|Overall Study|Protocol Violation|0|||
126246196|NCT03121586|454192947|FG001|Overall Study|Protocol Violation|5|||
126246197|NCT03121586|454192948|FG002|Overall Study|Protocol Violation|0|||
126026782|NCT04442126|453393701|FG004|Overall Study|Other|0|||
126246198|NCT03121586|454192946|FG000|Overall Study|Lack of Efficacy|3|||
126246199|NCT03121586|454192947|FG001|Overall Study|Lack of Efficacy|3|||
126246200|NCT03121586|454192948|FG002|Overall Study|Lack of Efficacy|1|||
126246201|NCT03121586|454192946|FG000|Overall Study|Physician Decision|2|||
126246202|NCT03121586|454192947|FG001|Overall Study|Physician Decision|2|||
126246203|NCT03121586|454192948|FG002|Overall Study|Physician Decision|0|||
126246204|NCT03121586|454192946|FG000|Overall Study|Noncompliance with study drug|5|||
126026783|NCT04442126|453393702|FG005|Overall Study|Other|0|||
126246205|NCT03121586|454192947|FG001|Overall Study|Noncompliance with study drug|3|||
126246206|NCT03121586|454192948|FG002|Overall Study|Noncompliance with study drug|5|||
126246207|NCT03121586|454192946|FG000|Overall Study|Lost to Follow-up|4|||
126246208|NCT03121586|454192947|FG001|Overall Study|Lost to Follow-up|2|||
126246209|NCT03121586|454192948|FG002|Overall Study|Lost to Follow-up|0|||
126246210|NCT03121586|454192946|FG000|Overall Study|Death|2|||
126246211|NCT03121586|454192947|FG001|Overall Study|Death|0|||
126246212|NCT03121586|454192948|FG002|Overall Study|Death|0|||
126246213|NCT06381102|454192949|FG000|Washout 5 Days|Withdrawal by Subject|0|||
126246214|NCT06381102|454192950|FG001|Washout 5 Days|Withdrawal by Subject|2|||
126246215|NCT01987765|454192951|FG000|Overall Study|Protocol Violation|65|||
126246216|NCT01987765|454192951|FG000|Overall Study|Lost to Follow-up|37|||
126246217|NCT01528696|454192954|FG000|Overall Study|See detailed description|18|||
126246218|NCT01528696|454192955|FG001|Overall Study|See detailed description|19|||
126246219|NCT00859521|454192956|FG000|Washout|Withdrawal by Subject|0|||
126246220|NCT00859521|454192957|FG001|Washout|Withdrawal by Subject|1|||
126246221|NCT05239195|454192964|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
126246222|NCT05239195|454192965|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
126246223|NCT03552484|454192966|FG000|Overall Study|Death|6|||
126246224|NCT03552484|454192967|FG001|Overall Study|Death|4|||
126246225|NCT03552484|454192966|FG000|Overall Study|Lost to Follow-up|0|||
126246226|NCT03552484|454192967|FG001|Overall Study|Lost to Follow-up|16|||
126246227|NCT02663349|454192973|FG000|Overall Study|Withdrawal by Subject|6|||
126246228|NCT01204294|454192974|FG000|Overall Study|Adverse Event|2|||
126246229|NCT01204294|454192975|FG001|Overall Study|Adverse Event|6|||
126246230|NCT01204294|454192976|FG002|Overall Study|Adverse Event|0|||
126246231|NCT01204294|454192977|FG003|Overall Study|Adverse Event|7|||
126246232|NCT01204294|454192978|FG004|Overall Study|Adverse Event|1|||
126246233|NCT01204294|454192979|FG005|Overall Study|Adverse Event|4|||
126246234|NCT01204294|454192980|FG006|Overall Study|Adverse Event|0|||
126246235|NCT01204294|454192974|FG000|Overall Study|Protocol Violation|1|||
126246236|NCT01204294|454192975|FG001|Overall Study|Protocol Violation|0|||
126246237|NCT01204294|454192976|FG002|Overall Study|Protocol Violation|2|||
126246238|NCT01204294|454192977|FG003|Overall Study|Protocol Violation|1|||
126246239|NCT01204294|454192978|FG004|Overall Study|Protocol Violation|0|||
126246240|NCT01204294|454192979|FG005|Overall Study|Protocol Violation|0|||
126246241|NCT01204294|454192980|FG006|Overall Study|Protocol Violation|0|||
126246242|NCT01204294|454192974|FG000|Overall Study|Withdrawal by Subject|0|||
126246243|NCT01204294|454192975|FG001|Overall Study|Withdrawal by Subject|2|||
126246244|NCT01204294|454192976|FG002|Overall Study|Withdrawal by Subject|2|||
126246245|NCT01204294|454192977|FG003|Overall Study|Withdrawal by Subject|1|||
126246246|NCT01204294|454192978|FG004|Overall Study|Withdrawal by Subject|1|||
126246247|NCT01204294|454192979|FG005|Overall Study|Withdrawal by Subject|1|||
126246248|NCT01204294|454192980|FG006|Overall Study|Withdrawal by Subject|2|||
126246249|NCT01204294|454192974|FG000|Overall Study|Lack of Efficacy|0|||
126246250|NCT01204294|454192975|FG001|Overall Study|Lack of Efficacy|0|||
126246251|NCT01204294|454192976|FG002|Overall Study|Lack of Efficacy|0|||
126246252|NCT01204294|454192977|FG003|Overall Study|Lack of Efficacy|2|||
126246253|NCT01204294|454192978|FG004|Overall Study|Lack of Efficacy|0|||
126246254|NCT01204294|454192979|FG005|Overall Study|Lack of Efficacy|0|||
126246255|NCT01204294|454192980|FG006|Overall Study|Lack of Efficacy|0|||
126246256|NCT01204294|454192974|FG000|Overall Study|Other (house moving)|0|||
126246257|NCT01204294|454192975|FG001|Overall Study|Other (house moving)|0|||
126246258|NCT01204294|454192976|FG002|Overall Study|Other (house moving)|1|||
126246259|NCT01204294|454192977|FG003|Overall Study|Other (house moving)|0|||
126246260|NCT01204294|454192978|FG004|Overall Study|Other (house moving)|0|||
126246261|NCT01204294|454192979|FG005|Overall Study|Other (house moving)|0|||
126246262|NCT01204294|454192980|FG006|Overall Study|Other (house moving)|0|||
126246263|NCT03128723|454192983|FG000|Overall Study|Withdrawal by Subject|2|||
126246264|NCT00673660|454192984|FG000|Overall Study|Lost to Follow-up|107|||
126246265|NCT01383486|454192985|FG000|Overall Study|Lost to Follow-up|10|||
126246266|NCT01383486|454192985|FG000|Overall Study|Incomplete information for analysis|2|||
126246267|NCT01383486|454192985|FG000|Overall Study|Did not take any product|6|||
126026784|NCT04442126|453393703|FG006|Overall Study|Other|0|||
126246268|NCT00245063|454192986|FG000|Overall Study|Adverse Event|6|||
126246269|NCT00245063|454192987|FG001|Overall Study|Adverse Event|5|||
126246270|NCT00245063|454192986|FG000|Overall Study|Death|1|||
126026785|NCT04442126|453393704|FG007|Overall Study|Other|0|||
126026786|NCT04442126|453393705|FG008|Overall Study|Other|1|||
126246271|NCT00245063|454192987|FG001|Overall Study|Death|0|||
126246272|NCT05099380|454192989|FG000|Overall Study|Subject enrolled in error|1|||
126246273|NCT05099380|454192990|FG001|Overall Study|Subject enrolled in error|0|||
126246274|NCT05099380|454192989|FG000|Overall Study|Study Procedure|1|||
126246275|NCT05099380|454192990|FG001|Overall Study|Study Procedure|0|||
126246276|NCT05099380|454192989|FG000|Overall Study|Protocol Violation|1|||
126246277|NCT05099380|454192990|FG001|Overall Study|Protocol Violation|0|||
126246278|NCT05099380|454192989|FG000|Overall Study|Adverse Event|1|||
126246279|NCT05099380|454192990|FG001|Overall Study|Adverse Event|1|||
126246280|NCT05099380|454192989|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
126246281|NCT05099380|454192990|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
126246282|NCT03276754|454192991|FG000|Overall Study|Withdrawal of informed consent|4|||
126246283|NCT03276754|454192991|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
126246284|NCT03276754|454192991|FG000|Overall Study|Lost to Follow-up|27|||
126246285|NCT03276754|454192991|FG000|Overall Study|No data reported at Month 24|31|||
126246286|NCT03276754|454192991|FG000|Overall Study|Death|39|||
126246287|NCT00927069|454192993|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
126246288|NCT00927069|454192994|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
126246289|NCT00927069|454192995|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
126246290|NCT00927069|454192996|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
126246291|NCT00927069|454192993|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
126246292|NCT00927069|454192994|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
126246293|NCT00927069|454192995|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
126246294|NCT00927069|454192996|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
126246295|NCT00927069|454192993|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
126246296|NCT00927069|454192994|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
126246297|NCT00927069|454192995|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
126246298|NCT00927069|454192996|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
126246299|NCT00927069|454192993|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
126246300|NCT00927069|454192994|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
126246301|NCT00927069|454192995|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
126246302|NCT00927069|454192996|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
126246303|NCT00927069|454192993|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
126246304|NCT00927069|454192994|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
126246305|NCT00927069|454192995|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
126246306|NCT00927069|454192996|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
126246307|NCT02558491|454192997|FG000|First Invention|Withdrawal by Subject|3|||
126246308|NCT02558491|454192998|FG001|First Invention|Withdrawal by Subject|1|||
126246309|NCT02558491|454192997|FG000|First Invention|Data collection issues|1|||
126246310|NCT02558491|454192998|FG001|First Invention|Data collection issues|0|||
126246311|NCT02558491|454192997|FG000|First Invention|Stopping criteria|0|||
126246312|NCT02558491|454192998|FG001|First Invention|Stopping criteria|1|||
126246313|NCT02558491|454192997|FG000|First Invention|Changed parameters during trial|1|||
126246314|NCT02558491|454192998|FG001|First Invention|Changed parameters during trial|0|||
126246315|NCT02558491|454192997|FG000|Second Intervention|Withdrawal by Subject|1|||
126246316|NCT02558491|454192998|FG001|Second Intervention|Withdrawal by Subject|0|||
126246317|NCT02558491|454192997|FG000|Second Intervention|Stopping Criteria|1|||
126246318|NCT02558491|454192998|FG001|Second Intervention|Stopping Criteria|0|||
126246319|NCT00834431|454193001|FG000|First Intervention|Adverse Event|0|||
126246320|NCT00834431|454193002|FG001|First Intervention|Adverse Event|1|||
126246321|NCT00834431|454193001|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
126246322|NCT00834431|454193002|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126246323|NCT03249454|454193003|FG000|Overall Study|Withdrawal by Subject|0|||
126246324|NCT03249454|454193004|FG001|Overall Study|Withdrawal by Subject|0|||
126246325|NCT03249454|454193005|FG002|Overall Study|Withdrawal by Subject|0|||
126246326|NCT03249454|454193006|FG003|Overall Study|Withdrawal by Subject|0|||
126246327|NCT03249454|454193007|FG004|Overall Study|Withdrawal by Subject|0|||
126246328|NCT03249454|454193008|FG005|Overall Study|Withdrawal by Subject|0|||
126246329|NCT03249454|454193009|FG006|Overall Study|Withdrawal by Subject|0|||
126246330|NCT03249454|454193010|FG007|Overall Study|Withdrawal by Subject|0|||
126246331|NCT03249454|454193011|FG008|Overall Study|Withdrawal by Subject|0|||
126246332|NCT03249454|454193012|FG009|Overall Study|Withdrawal by Subject|1|||
126246333|NCT03249454|454193013|FG010|Overall Study|Withdrawal by Subject|1|||
126246334|NCT01913405|454193014|FG000|Overall Study|Withdrawal by Subject|1|||
126246335|NCT01913405|454193014|FG000|Overall Study|Adverse Event|1|||
126246336|NCT01020474|454193017|FG000|Overall Study|Adverse Event|4|||
126246337|NCT01020474|454193018|FG001|Overall Study|Adverse Event|4|||
126246338|NCT01020474|454193017|FG000|Overall Study|Protocol Violation|0|||
126246339|NCT01020474|454193018|FG001|Overall Study|Protocol Violation|2|||
126246340|NCT01020474|454193017|FG000|Overall Study|Withdrawal by Subject|5|||
126246341|NCT01020474|454193018|FG001|Overall Study|Withdrawal by Subject|7|||
126246342|NCT01020474|454193017|FG000|Overall Study|Other Reasons|1|||
126246343|NCT01020474|454193018|FG001|Overall Study|Other Reasons|1|||
126246344|NCT01020474|454193017|FG000|Overall Study|Insufficient Clinical Response|0|||
126246345|NCT01020474|454193018|FG001|Overall Study|Insufficient Clinical Response|3|||
126246346|NCT03199963|454193021|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
126246347|NCT03199963|454193022|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
126246348|NCT03199963|454193021|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
126246349|NCT03199963|454193022|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
126246350|NCT03199963|454193021|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
126246351|NCT03199963|454193022|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
126306194|NCT03260244|454410221|FG000|Overall Study|Subject Noncompliance|6|||
126246352|NCT03199963|454193021|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
126246353|NCT03199963|454193022|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
126246354|NCT03199963|454193021|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
126246355|NCT03199963|454193022|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
126246356|NCT03199963|454193021|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
126246357|NCT03199963|454193022|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
126246358|NCT00466167|454193023|FG000|Overall Study|Adverse Event|8|||
126246359|NCT00466167|454193024|FG001|Overall Study|Adverse Event|8|||
126246360|NCT00466167|454193025|FG002|Overall Study|Adverse Event|7|||
126246361|NCT00466167|454193023|FG000|Overall Study|Lack of Efficacy|2|||
126246362|NCT00466167|454193024|FG001|Overall Study|Lack of Efficacy|0|||
126246363|NCT00466167|454193025|FG002|Overall Study|Lack of Efficacy|3|||
126246364|NCT00466167|454193023|FG000|Overall Study|Protocol Violation|1|||
126246365|NCT00466167|454193024|FG001|Overall Study|Protocol Violation|1|||
126246366|NCT00466167|454193025|FG002|Overall Study|Protocol Violation|2|||
126246367|NCT00466167|454193023|FG000|Overall Study|Lost to Follow-up|3|||
126246368|NCT00466167|454193024|FG001|Overall Study|Lost to Follow-up|2|||
126246369|NCT00466167|454193025|FG002|Overall Study|Lost to Follow-up|2|||
126246370|NCT00466167|454193023|FG000|Overall Study|Withdrawal by Subject|4|||
126246371|NCT00466167|454193024|FG001|Overall Study|Withdrawal by Subject|1|||
126246372|NCT00466167|454193025|FG002|Overall Study|Withdrawal by Subject|6|||
126246373|NCT00466167|454193023|FG000|Overall Study|patient did not meet inclusion criteria|1|||
126246374|NCT00466167|454193024|FG001|Overall Study|patient did not meet inclusion criteria|0|||
126246375|NCT00466167|454193025|FG002|Overall Study|patient did not meet inclusion criteria|1|||
126246376|NCT00466167|454193023|FG000|Overall Study|Not treated|1|||
126246377|NCT00466167|454193024|FG001|Overall Study|Not treated|0|||
126246378|NCT00466167|454193025|FG002|Overall Study|Not treated|0|||
126246379|NCT01075282|454193034|FG000|Overall Study|Withdrawal by Subject|11|||
126246380|NCT01075282|454193035|FG001|Overall Study|Withdrawal by Subject|7|||
126246381|NCT01075282|454193036|FG002|Overall Study|Withdrawal by Subject|11|||
126246382|NCT01075282|454193034|FG000|Overall Study|Adverse Event|9|||
126246383|NCT01075282|454193035|FG001|Overall Study|Adverse Event|8|||
126246384|NCT01075282|454193036|FG002|Overall Study|Adverse Event|5|||
126246385|NCT01075282|454193034|FG000|Overall Study|Entry Criteria Not Met|3|||
126246386|NCT01075282|454193035|FG001|Overall Study|Entry Criteria Not Met|2|||
126246387|NCT01075282|454193036|FG002|Overall Study|Entry Criteria Not Met|0|||
126246388|NCT01075282|454193034|FG000|Overall Study|Lost to Follow-up|3|||
126246389|NCT01075282|454193035|FG001|Overall Study|Lost to Follow-up|3|||
126246390|NCT01075282|454193036|FG002|Overall Study|Lost to Follow-up|3|||
126246391|NCT01075282|454193034|FG000|Overall Study|Physician Decision|3|||
126246392|NCT01075282|454193035|FG001|Overall Study|Physician Decision|3|||
126246393|NCT01075282|454193036|FG002|Overall Study|Physician Decision|3|||
126246394|NCT01075282|454193034|FG000|Overall Study|Lack of Efficacy|1|||
126246395|NCT01075282|454193035|FG001|Overall Study|Lack of Efficacy|1|||
126246396|NCT01075282|454193036|FG002|Overall Study|Lack of Efficacy|0|||
126246397|NCT01075282|454193034|FG000|Overall Study|Treatment Non-compliance|1|||
126246398|NCT01075282|454193035|FG001|Overall Study|Treatment Non-compliance|2|||
126246399|NCT01075282|454193036|FG002|Overall Study|Treatment Non-compliance|2|||
126246400|NCT01075282|454193034|FG000|Overall Study|Protocol Violation|0|||
126246401|NCT01075282|454193035|FG001|Overall Study|Protocol Violation|2|||
126246402|NCT01075282|454193036|FG002|Overall Study|Protocol Violation|1|||
126246403|NCT01075282|454193034|FG000|Overall Study|Death|0|||
126246404|NCT01075282|454193035|FG001|Overall Study|Death|1|||
126246405|NCT01075282|454193036|FG002|Overall Study|Death|2|||
126246406|NCT01794845|454193038|FG000|Overall Study|Withdrawal by Subject|1|||
126246407|NCT02139826|454193039|FG000|Overall Study|Adverse Event|1|||
126246408|NCT00429416|454193040|FG000|Overall Study|Death|1|||
126246409|NCT01456221|454193041|FG000|Overall Study|Withdrawal by Subject|56|||
126246410|NCT01456221|454193042|FG001|Overall Study|Withdrawal by Subject|49|||
126246411|NCT01456221|454193041|FG000|Overall Study|Lost to Follow-up|1|||
126246412|NCT01456221|454193042|FG001|Overall Study|Lost to Follow-up|4|||
126246413|NCT01456221|454193041|FG000|Overall Study|Received medication|3|||
126246414|NCT01456221|454193042|FG001|Overall Study|Received medication|2|||
126246415|NCT01456221|454193041|FG000|Overall Study|Incomplete data|4|||
126246416|NCT01456221|454193042|FG001|Overall Study|Incomplete data|2|||
126246417|NCT06647173|454193045|FG000|Overall Study|Lost to Follow-up|24|||
126246418|NCT01473953|454193046|FG000|Overall Study|Other|1|||
126246419|NCT01473953|454193047|FG001|Overall Study|Other|0|||
126246420|NCT01473953|454193048|FG002|Overall Study|Other|0|||
126246421|NCT01473953|454193049|FG003|Overall Study|Other|0|||
126246422|NCT01473953|454193050|FG004|Overall Study|Other|0|||
126246423|NCT02358538|454193051|FG000|Through Week 26|Adverse Event|0|||
126246424|NCT02358538|454193052|FG001|Through Week 26|Adverse Event|1|||
126246425|NCT02358538|454193053|FG002|Through Week 26|Adverse Event|1|||
126246426|NCT02358538|454193054|FG003|Through Week 26|Adverse Event|2|||
126246427|NCT02358538|454193051|FG000|Through Week 26|Lack of Efficacy|1|||
126026787|NCT06450405|453393706|FG000|Overall Study|Study funding terminated.|0|||
126026788|NCT06450405|453393707|FG001|Overall Study|Study funding terminated.|2|||
126026789|NCT03424811|453394638|FG000|Overall Study|Lost to Follow-up|9|||
126026790|NCT03424811|453394639|FG001|Overall Study|Lost to Follow-up|0|||
126026791|NCT06143670|453394640|FG000|Overall Study|Lost to Follow-up|0|||
126026792|NCT06143670|453394641|FG001|Overall Study|Lost to Follow-up|1|||
126026793|NCT06143670|453394640|FG000|Overall Study|Withdrawal by Subject|3|||
126026794|NCT06143670|453394641|FG001|Overall Study|Withdrawal by Subject|0|||
126026795|NCT01938547|453394648|FG000|Overall Study|Physician Decision|1|||
126026796|NCT05038566|453394651|FG000|Overall Study|Technical Difficulties with the Device|0|||
126026797|NCT05038566|453394652|FG001|Overall Study|Technical Difficulties with the Device|1|||
126026798|NCT04842643|453394653|FG000|Overall Study|Physician Decision|1|||
126026799|NCT04842643|453394653|FG000|Overall Study|Other|1|||
126026800|NCT00739648|453394656|FG000|Overall Study|Adverse Event|3|||
126026801|NCT00739648|453394657|FG001|Overall Study|Adverse Event|15|||
126026802|NCT00739648|453394656|FG000|Overall Study|Withdrawal by Subject|13|||
126026803|NCT00739648|453394657|FG001|Overall Study|Withdrawal by Subject|25|||
126026804|NCT00739648|453394656|FG000|Overall Study|Lost to Follow-up|4|||
126026805|NCT00739648|453394657|FG001|Overall Study|Lost to Follow-up|7|||
126026806|NCT00739648|453394656|FG000|Overall Study|Death|2|||
126026807|NCT00739648|453394657|FG001|Overall Study|Death|0|||
126026808|NCT00739648|453394656|FG000|Overall Study|Do not know|4|||
126026809|NCT00739648|453394657|FG001|Overall Study|Do not know|6|||
126026810|NCT05110495|453394658|FG000|Overall Study|Lost to Follow-up|1|||
126026811|NCT05110495|453394658|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
126026812|NCT04716634|453394662|FG000|Overall Study|Death|24|||
126026813|NCT04716634|453394663|FG001|Overall Study|Death|24|||
126026814|NCT04716634|453394664|FG002|Overall Study|Death|8|||
126026815|NCT04716634|453394662|FG000|Overall Study|Closed by Sponsor|4|||
126026816|NCT04716634|453394663|FG001|Overall Study|Closed by Sponsor|4|||
126026817|NCT04716634|453394664|FG002|Overall Study|Closed by Sponsor|5|||
126026818|NCT04716634|453394662|FG000|Overall Study|Lost to Follow-up|1|||
126026819|NCT04716634|453394663|FG001|Overall Study|Lost to Follow-up|0|||
126026820|NCT04716634|453394664|FG002|Overall Study|Lost to Follow-up|1|||
126026821|NCT04716634|453394662|FG000|Overall Study|Withdrawal by Subject|0|||
126026822|NCT04716634|453394663|FG001|Overall Study|Withdrawal by Subject|0|||
126026823|NCT04716634|453394664|FG002|Overall Study|Withdrawal by Subject|1|||
126026824|NCT06311084|453394668|FG000|Overall Study|Lost to Follow-up|14|||
126026825|NCT03526861|453394677|FG000|Initial Treatment Period|Not dosed|1|||
126026826|NCT03526861|453394678|FG001|Initial Treatment Period|Not dosed|1|||
126026827|NCT03526861|453394679|FG002|Initial Treatment Period|Not dosed|1|||
126026828|NCT03526861|453394680|FG003|Initial Treatment Period|Not dosed|0|||
126026829|NCT03526861|453394681|FG004|Initial Treatment Period|Not dosed|0|||
126026830|NCT03526861|453394682|FG005|Initial Treatment Period|Not dosed|0|||
126026831|NCT03526861|453394683|FG006|Initial Treatment Period|Not dosed|0|||
126026832|NCT03526861|453394684|FG007|Initial Treatment Period|Not dosed|0|||
126026833|NCT03526861|453394685|FG008|Initial Treatment Period|Not dosed|0|||
126026834|NCT03526861|453394677|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
126026835|NCT03526861|453394678|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
126026836|NCT03526861|453394679|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
126026837|NCT03526861|453394680|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026838|NCT03526861|453394681|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026839|NCT03526861|453394682|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026840|NCT03526861|453394683|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026841|NCT03526861|453394684|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026842|NCT03526861|453394685|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026843|NCT03526861|453394677|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
126026844|NCT03526861|453394678|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
126026845|NCT03526861|453394679|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
126026846|NCT03526861|453394680|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126246428|NCT02358538|454193052|FG001|Through Week 26|Lack of Efficacy|1|||
126246429|NCT02358538|454193053|FG002|Through Week 26|Lack of Efficacy|3|||
126246430|NCT02358538|454193054|FG003|Through Week 26|Lack of Efficacy|3|||
126246431|NCT02358538|454193051|FG000|Through Week 26|Withdrawal by Subject|1|||
126026847|NCT03526861|453394681|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126026848|NCT03526861|453394682|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126026849|NCT03526861|453394683|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126246432|NCT02358538|454193052|FG001|Through Week 26|Withdrawal by Subject|0|||
126094310|NCT00680992|453639197|FG000|Overall Study|Noncompliance|4|||
126246433|NCT02358538|454193053|FG002|Through Week 26|Withdrawal by Subject|0|||
126246434|NCT02358538|454193054|FG003|Through Week 26|Withdrawal by Subject|0|||
126246435|NCT02358538|454193051|FG000|Through Week 26|Non-Compliance|0|||
126246436|NCT02358538|454193052|FG001|Through Week 26|Non-Compliance|0|||
126246437|NCT02358538|454193053|FG002|Through Week 26|Non-Compliance|1|||
126246438|NCT02358538|454193054|FG003|Through Week 26|Non-Compliance|0|||
126246439|NCT02358538|454193051|FG000|Through Week 26|Family did not see benefit from IP|1|||
126246440|NCT02358538|454193052|FG001|Through Week 26|Family did not see benefit from IP|0|||
126246441|NCT02358538|454193053|FG002|Through Week 26|Family did not see benefit from IP|0|||
126026850|NCT03526861|453394684|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126246442|NCT02358538|454193054|FG003|Through Week 26|Family did not see benefit from IP|0|||
126246443|NCT02358538|454193051|FG000|52 Week Extension Period|Lack of Efficacy|0|||
126246444|NCT02358538|454193052|FG001|52 Week Extension Period|Lack of Efficacy|0|||
126246445|NCT02358538|454193053|FG002|52 Week Extension Period|Lack of Efficacy|2|||
126246446|NCT02358538|454193054|FG003|52 Week Extension Period|Lack of Efficacy|4|||
126246447|NCT01494532|454193055|FG000|Overall Study|Adverse Event|4|||
126246448|NCT01494532|454193056|FG001|Overall Study|Adverse Event|1|||
126246449|NCT01494532|454193057|FG002|Overall Study|Adverse Event|8|||
126246450|NCT01494532|454193058|FG003|Overall Study|Adverse Event|6|||
126246451|NCT01494532|454193059|FG004|Overall Study|Adverse Event|5|||
126246452|NCT01494532|454193060|FG005|Overall Study|Adverse Event|0|||
126246453|NCT01494532|454193055|FG000|Overall Study|Lack of Efficacy|0|||
126246454|NCT01494532|454193056|FG001|Overall Study|Lack of Efficacy|0|||
126246455|NCT01494532|454193057|FG002|Overall Study|Lack of Efficacy|0|||
126246456|NCT01494532|454193058|FG003|Overall Study|Lack of Efficacy|0|||
126246457|NCT01494532|454193059|FG004|Overall Study|Lack of Efficacy|2|||
126246458|NCT01494532|454193060|FG005|Overall Study|Lack of Efficacy|0|||
126246459|NCT01494532|454193055|FG000|Overall Study|Protocol deviation|2|||
126246460|NCT01494532|454193056|FG001|Overall Study|Protocol deviation|1|||
126246461|NCT01494532|454193057|FG002|Overall Study|Protocol deviation|3|||
126246462|NCT01494532|454193058|FG003|Overall Study|Protocol deviation|2|||
126246463|NCT01494532|454193059|FG004|Overall Study|Protocol deviation|3|||
126246464|NCT01494532|454193060|FG005|Overall Study|Protocol deviation|0|||
126246465|NCT01494532|454193055|FG000|Overall Study|Protocol-defined stopping criteria|0|||
126246466|NCT01494532|454193056|FG001|Overall Study|Protocol-defined stopping criteria|0|||
126246467|NCT01494532|454193057|FG002|Overall Study|Protocol-defined stopping criteria|1|||
126246468|NCT01494532|454193058|FG003|Overall Study|Protocol-defined stopping criteria|0|||
126246469|NCT01494532|454193059|FG004|Overall Study|Protocol-defined stopping criteria|0|||
126246470|NCT01494532|454193060|FG005|Overall Study|Protocol-defined stopping criteria|0|||
126246471|NCT01494532|454193055|FG000|Overall Study|Lost to Follow-up|1|||
126246472|NCT01494532|454193056|FG001|Overall Study|Lost to Follow-up|0|||
126246473|NCT01494532|454193057|FG002|Overall Study|Lost to Follow-up|0|||
126246474|NCT01494532|454193058|FG003|Overall Study|Lost to Follow-up|2|||
126246475|NCT01494532|454193059|FG004|Overall Study|Lost to Follow-up|0|||
126246476|NCT01494532|454193060|FG005|Overall Study|Lost to Follow-up|0|||
126246477|NCT01494532|454193055|FG000|Overall Study|Physician Decision|0|||
126246478|NCT01494532|454193056|FG001|Overall Study|Physician Decision|1|||
126246479|NCT01494532|454193057|FG002|Overall Study|Physician Decision|1|||
126246480|NCT01494532|454193058|FG003|Overall Study|Physician Decision|2|||
126246481|NCT01494532|454193059|FG004|Overall Study|Physician Decision|0|||
126246482|NCT01494532|454193060|FG005|Overall Study|Physician Decision|0|||
126246483|NCT01494532|454193055|FG000|Overall Study|Withdrawal by Subject|3|||
126246484|NCT01494532|454193056|FG001|Overall Study|Withdrawal by Subject|1|||
126246485|NCT01494532|454193057|FG002|Overall Study|Withdrawal by Subject|4|||
126246486|NCT01494532|454193058|FG003|Overall Study|Withdrawal by Subject|3|||
126246487|NCT01494532|454193059|FG004|Overall Study|Withdrawal by Subject|2|||
126246488|NCT01494532|454193060|FG005|Overall Study|Withdrawal by Subject|0|||
126246489|NCT06999265|454193061|FG000|Overall Study|Lost to Follow-up|1|||
126246490|NCT06999265|454193062|FG001|Overall Study|Lost to Follow-up|1|||
126246491|NCT04025229|454194089|FG000|Overall Study|Adverse Event|1|||
126246492|NCT04025229|454194090|FG001|Overall Study|Adverse Event|0|||
126246493|NCT04025229|454194089|FG000|Overall Study|Withdrawal by Subject|0|||
126246494|NCT04025229|454194090|FG001|Overall Study|Withdrawal by Subject|2|||
126246495|NCT04025229|454194089|FG000|Overall Study|Death|0|||
126246496|NCT04025229|454194090|FG001|Overall Study|Death|1|||
126246497|NCT04025229|454194089|FG000|Overall Study|Physician Decision|0|||
126026851|NCT03526861|453394685|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126026852|NCT03526861|453394677|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126246498|NCT04025229|454194090|FG001|Overall Study|Physician Decision|1|||
126246499|NCT02571907|454194091|FG000|Overall Study|Death|4|||
126246500|NCT02571907|454194091|FG000|Overall Study|Lost to Follow-up|3|||
126246501|NCT02571907|454194091|FG000|Overall Study|Withdrawal by Subject|3|||
126246502|NCT02286739|454194096|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
126246503|NCT02286739|454194097|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
126246504|NCT02286739|454194096|FG000|Overall Study|No Verasense type documented|0|||
126246505|NCT02286739|454194097|FG001|Overall Study|No Verasense type documented|23|||
126246506|NCT02286739|454194096|FG000|Overall Study|Adverse Event|1|||
126094311|NCT00680992|453639198|FG001|Overall Study|Noncompliance|6|||
126094312|NCT00680992|453639199|FG002|Overall Study|Noncompliance|0|||
126094313|NCT00680992|453639197|FG000|Overall Study|Requirement for Alternative Therapy|8|||
126094314|NCT00680992|453639198|FG001|Overall Study|Requirement for Alternative Therapy|2|||
126094315|NCT00680992|453639199|FG002|Overall Study|Requirement for Alternative Therapy|0|||
126094316|NCT00680992|453639197|FG000|Overall Study|Pregnancy|5|||
126094317|NCT00680992|453639198|FG001|Overall Study|Pregnancy|0|||
126094318|NCT00680992|453639199|FG002|Overall Study|Pregnancy|1|||
126094319|NCT00680992|453639197|FG000|Overall Study|Death|5|||
126094320|NCT00680992|453639198|FG001|Overall Study|Death|1|||
126094321|NCT00680992|453639199|FG002|Overall Study|Death|0|||
126094322|NCT00680992|453639197|FG000|Overall Study|Ineligibility Determined|0|||
126094323|NCT00680992|453639198|FG001|Overall Study|Ineligibility Determined|1|||
126094324|NCT00680992|453639199|FG002|Overall Study|Ineligibility Determined|0|||
126094325|NCT01585155|453639200|FG000|Overall Study|Adverse Event|1|||
126094326|NCT01585155|453639200|FG000|Overall Study|Lack of Efficacy|2|||
126094327|NCT01585155|453639200|FG000|Overall Study|Worsening ulcerative colitis|2|||
126094328|NCT01397422|453639205|FG000|Overall Study|Adverse Event|0|||
126094329|NCT01397422|453639206|FG001|Overall Study|Adverse Event|3|||
126094330|NCT01397422|453639207|FG002|Overall Study|Adverse Event|3|||
126094331|NCT01397422|453639208|FG003|Overall Study|Adverse Event|8|||
126094332|NCT01397422|453639205|FG000|Overall Study|Withdrawal by Subject|1|||
126094333|NCT01397422|453639206|FG001|Overall Study|Withdrawal by Subject|0|||
126094334|NCT01397422|453639207|FG002|Overall Study|Withdrawal by Subject|0|||
126094335|NCT01397422|453639208|FG003|Overall Study|Withdrawal by Subject|0|||
126094336|NCT01397422|453639205|FG000|Overall Study|Increased bradykinesia related to PD|1|||
126094337|NCT01397422|453639206|FG001|Overall Study|Increased bradykinesia related to PD|0|||
126094338|NCT01397422|453639207|FG002|Overall Study|Increased bradykinesia related to PD|0|||
126094339|NCT01397422|453639208|FG003|Overall Study|Increased bradykinesia related to PD|0|||
126094340|NCT03772587|453639209|FG000|Overall Study|COVID-19|0|||
126094341|NCT03772587|453639210|FG001|Overall Study|COVID-19|0|||
126094342|NCT03772587|453639211|FG002|Overall Study|COVID-19|1|||
126246507|NCT02286739|454194097|FG001|Overall Study|Adverse Event|2|||
126246508|NCT02286739|454194096|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
126246509|NCT02286739|454194097|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
126246510|NCT03447353|454194101|FG000|Overall Study|Failure at Screening Visit|2|||
126246511|NCT03447353|454194101|FG000|Overall Study|Lost to Follow-up|4|||
126246512|NCT03447353|454194101|FG000|Overall Study|Scheduling Conflicts|3|||
126246513|NCT03447353|454194101|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
125879261|NCT00360230|452855290|FG003|Overall Study|Protocol Violation|0|||
126094343|NCT03772587|453639212|FG003|Overall Study|COVID-19|1|||
126094344|NCT03772587|453639213|FG004|Overall Study|COVID-19|0|||
126094345|NCT03772587|453639209|FG000|Overall Study|Withdrawal by Subject|1|||
126094346|NCT03772587|453639210|FG001|Overall Study|Withdrawal by Subject|0|||
126094347|NCT03772587|453639211|FG002|Overall Study|Withdrawal by Subject|0|||
126094348|NCT03772587|453639212|FG003|Overall Study|Withdrawal by Subject|0|||
126026853|NCT03526861|453394678|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026854|NCT03526861|453394679|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026855|NCT03526861|453394680|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
126026856|NCT03526861|453394681|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
126026857|NCT03526861|453394682|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026858|NCT03526861|453394683|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
126026859|NCT03526861|453394684|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026860|NCT03526861|453394685|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026861|NCT03526861|453394677|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
126026862|NCT03526861|453394678|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
126026863|NCT03526861|453394679|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
126026864|NCT03526861|453394680|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
126026865|NCT03526861|453394681|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
126026866|NCT03526861|453394682|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
126026867|NCT03526861|453394683|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
126026868|NCT03526861|453394684|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
126026869|NCT03526861|453394685|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
126026870|NCT03526861|453394677|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026871|NCT03526861|453394678|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026872|NCT03526861|453394679|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026873|NCT03526861|453394680|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
126026874|NCT03526861|453394681|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026875|NCT03526861|453394682|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026876|NCT03526861|453394683|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026877|NCT03526861|453394684|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026878|NCT03526861|453394685|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026879|NCT03526861|453394677|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026880|NCT03526861|453394678|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026881|NCT03526861|453394679|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026882|NCT03526861|453394680|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026883|NCT03526861|453394681|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026884|NCT03526861|453394682|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026885|NCT03526861|453394683|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026886|NCT03526861|453394684|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126026887|NCT03526861|453394685|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
126026888|NCT03526861|453394677|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126026889|NCT03526861|453394678|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126026890|NCT03526861|453394679|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126026891|NCT03526861|453394680|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126026892|NCT03526861|453394681|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126026893|NCT03526861|453394682|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126026894|NCT03526861|453394683|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126026895|NCT03526861|453394684|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126026896|NCT03526861|453394685|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
126094349|NCT03772587|453639213|FG004|Overall Study|Withdrawal by Subject|0|||
126094350|NCT00513305|453639214|FG000|Overall Study|Adverse Event|6|||
126246514|NCT02642653|454194104|FG000|Overall Study|Adverse Event|2|||
126246515|NCT02642653|454194105|FG001|Overall Study|Adverse Event|0|||
126246516|NCT01319383|454194106|FG000|Overall Study|No ex vivo or in vivo response|4|||
126246517|NCT01319383|454194107|FG001|Overall Study|No ex vivo or in vivo response|0|||
126246518|NCT01319383|454194106|FG000|Overall Study|Physician Decision|3|||
126246519|NCT01319383|454194107|FG001|Overall Study|Physician Decision|0|||
126246520|NCT01319383|454194106|FG000|Overall Study|Lack of Efficacy|5|||
126246521|NCT01319383|454194107|FG001|Overall Study|Lack of Efficacy|9|||
126246522|NCT01319383|454194106|FG000|Overall Study|No in vivo response to interval doses|0|||
126246523|NCT01319383|454194107|FG001|Overall Study|No in vivo response to interval doses|1|||
126246524|NCT00772603|454194108|FG000|Overall Study|Withdrawal by Subject|11|||
126246525|NCT00772603|454194109|FG001|Overall Study|Withdrawal by Subject|10|||
126246526|NCT00772603|454194110|FG002|Overall Study|Withdrawal by Subject|6|||
126246527|NCT00772603|454194108|FG000|Overall Study|Adverse Event|37|||
126246528|NCT00772603|454194109|FG001|Overall Study|Adverse Event|18|||
126246529|NCT00772603|454194110|FG002|Overall Study|Adverse Event|10|||
126246530|NCT00772603|454194108|FG000|Overall Study|Subject Non-compliance|1|||
126246531|NCT00772603|454194109|FG001|Overall Study|Subject Non-compliance|6|||
126246532|NCT00772603|454194110|FG002|Overall Study|Subject Non-compliance|4|||
126246533|NCT00772603|454194108|FG000|Overall Study|Protocol Violation|0|||
126246534|NCT00772603|454194109|FG001|Overall Study|Protocol Violation|1|||
126246535|NCT00772603|454194110|FG002|Overall Study|Protocol Violation|1|||
126246536|NCT00772603|454194108|FG000|Overall Study|Lost to Follow-up|1|||
126246537|NCT00772603|454194109|FG001|Overall Study|Lost to Follow-up|5|||
126246538|NCT00772603|454194110|FG002|Overall Study|Lost to Follow-up|2|||
126246539|NCT00772603|454194108|FG000|Overall Study|Physician Decision|0|||
126246540|NCT00772603|454194109|FG001|Overall Study|Physician Decision|0|||
126246541|NCT00772603|454194110|FG002|Overall Study|Physician Decision|1|||
126246542|NCT00772603|454194108|FG000|Overall Study|Other|2|||
126246543|NCT00772603|454194109|FG001|Overall Study|Other|0|||
126246544|NCT00772603|454194110|FG002|Overall Study|Other|2|||
126246545|NCT01056484|454194119|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
126246546|NCT01056484|454194120|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
126094351|NCT00513305|453639215|FG001|Overall Study|Adverse Event|2|||
126094352|NCT00513305|453639214|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
126094353|NCT00513305|453639215|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
126094354|NCT00513305|453639214|FG000|Overall Study|Lack of Efficacy|8|||
126094355|NCT00513305|453639215|FG001|Overall Study|Lack of Efficacy|13|||
126094356|NCT00513305|453639214|FG000|Overall Study|Withdrawal by Subject|1|||
126094357|NCT00513305|453639215|FG001|Overall Study|Withdrawal by Subject|2|||
126094358|NCT00513305|453639214|FG000|Overall Study|Disease progression|8|||
126094359|NCT00513305|453639215|FG001|Overall Study|Disease progression|5|||
126094360|NCT00513305|453639214|FG000|Overall Study|Eligible for stem cell transplant|1|||
126094361|NCT00513305|453639215|FG001|Overall Study|Eligible for stem cell transplant|0|||
126094362|NCT00513305|453639214|FG000|Overall Study|Hematologic counts did not recover|1|||
126094363|NCT00513305|453639215|FG001|Overall Study|Hematologic counts did not recover|0|||
126094364|NCT00513305|453639214|FG000|Overall Study|Physician Decision|1|||
126094365|NCT00513305|453639215|FG001|Overall Study|Physician Decision|0|||
126094366|NCT00513305|453639214|FG000|Overall Study|Persistent hypocellularity|0|||
126094367|NCT00513305|453639215|FG001|Overall Study|Persistent hypocellularity|1|||
126094368|NCT00513305|453639214|FG000|Overall Study|Sponsor Decision|0|||
126094369|NCT00513305|453639215|FG001|Overall Study|Sponsor Decision|2|||
126094370|NCT03798691|453639216|FG000|Overall Study|Lost to Follow-up|2|||
126094371|NCT03798691|453639217|FG001|Overall Study|Lost to Follow-up|2|||
126094372|NCT05148962|453639218|FG000|Overall Study|Withdrawal by Subject|1|||
126094373|NCT05148962|453639219|FG001|Overall Study|Withdrawal by Subject|1|||
126094374|NCT05148962|453639220|FG002|Overall Study|Withdrawal by Subject|0|||
126094375|NCT05148962|453639221|FG003|Overall Study|Withdrawal by Subject|1|||
126094376|NCT05148962|453639222|FG004|Overall Study|Withdrawal by Subject|0|||
126094377|NCT05148962|453639218|FG000|Overall Study|Participant was early terminated per protocol|0|||
126094378|NCT05148962|453639219|FG001|Overall Study|Participant was early terminated per protocol|0|||
126094379|NCT05148962|453639220|FG002|Overall Study|Participant was early terminated per protocol|3|||
126094380|NCT05148962|453639221|FG003|Overall Study|Participant was early terminated per protocol|5|||
126094381|NCT05148962|453639222|FG004|Overall Study|Participant was early terminated per protocol|2|||
126094382|NCT05148962|453639218|FG000|Overall Study|Miscellaneous|0|||
126094383|NCT05148962|453639219|FG001|Overall Study|Miscellaneous|0|||
126094384|NCT05148962|453639220|FG002|Overall Study|Miscellaneous|0|||
126094385|NCT05148962|453639221|FG003|Overall Study|Miscellaneous|1|||
126094386|NCT05148962|453639222|FG004|Overall Study|Miscellaneous|0|||
126094387|NCT01525238|453639225|FG000|Overall Study|Withdrawal by Subject|1|||
126094388|NCT01525238|453639226|FG001|Overall Study|Withdrawal by Subject|0|||
126094389|NCT01525238|453639227|FG002|Overall Study|Withdrawal by Subject|0|||
126094390|NCT00151281|453639228|FG000|Overall Study|Not evaluable|3|||
126094391|NCT01133418|453639229|FG000|Overall Study|Lost to Follow-up|5|||
126094392|NCT01133418|453639230|FG001|Overall Study|Lost to Follow-up|6|||
126094393|NCT01077271|453641378|FG000|Overall Study|Parental desire|8|||
126094394|NCT01077271|453641378|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
126094395|NCT01077271|453641378|FG000|Overall Study|Noncompliance|2|||
126094396|NCT01077271|453641378|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
126246547|NCT01056484|454194119|FG000|Randomized Controlled Trial|Physician Decision|1|||
126246548|NCT01056484|454194120|FG001|Randomized Controlled Trial|Physician Decision|0|||
126246549|NCT01056484|454194119|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
126246550|NCT01056484|454194120|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
126246551|NCT00446966|454194123|FG000|Overall Study|Lost to Follow-up|10|||
126246552|NCT00446966|454194124|FG001|Overall Study|Lost to Follow-up|7|||
126246553|NCT01564394|454194125|FG000|Overall Study|Withdrawal by Subject|6|||
126246554|NCT01564394|454194126|FG001|Overall Study|Withdrawal by Subject|10|||
126246555|NCT02888756|454194130|FG000|Analytical Treatment Interruption|Physician Decision|10|||
126246556|NCT02888756|454194131|FG001|Analytical Treatment Interruption|Physician Decision|6|||
126246557|NCT02888756|454194132|FG002|Analytical Treatment Interruption|Physician Decision|5|||
126246558|NCT00488774|454194133|FG000|Overall Study|Withdrawal of consent|2|||
126246559|NCT00488774|454194134|FG001|Overall Study|Withdrawal of consent|2|||
126246560|NCT00488774|454194135|FG002|Overall Study|Withdrawal of consent|2|||
126246561|NCT00488774|454194136|FG003|Overall Study|Withdrawal of consent|0|||
126246562|NCT00488774|454194133|FG000|Overall Study|Other|6|||
126246563|NCT00488774|454194134|FG001|Overall Study|Other|3|||
126246564|NCT00488774|454194135|FG002|Overall Study|Other|2|||
126246565|NCT00488774|454194136|FG003|Overall Study|Other|2|||
126246566|NCT00488774|454194133|FG000|Overall Study|Lost to Follow-up|0|||
126246567|NCT00488774|454194134|FG001|Overall Study|Lost to Follow-up|0|||
126246568|NCT00488774|454194135|FG002|Overall Study|Lost to Follow-up|1|||
126246569|NCT00488774|454194136|FG003|Overall Study|Lost to Follow-up|1|||
125879262|NCT00360230|452855291|FG004|Overall Study|Protocol Violation|0|||
126246570|NCT04590027|454194137|FG000|Overall Study|Lost to Follow-up|17|||
126094397|NCT01077271|453641378|FG000|Overall Study|Changed doctors|2|||
126094398|NCT01077271|453641378|FG000|Overall Study|Parents thought too many injections|2|||
126094399|NCT01077271|453641378|FG000|Overall Study|End of RSV season nearly reached|1|||
126094400|NCT01077271|453641378|FG000|Overall Study|Mother unconvinced of the necessity|1|||
126094401|NCT03333876|453641379|FG000|Screening Period|Screen Failure|4|||
126094402|NCT03333876|453641379|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
126094403|NCT03333876|453641379|FG000|Mandibular Advancement|Adverse Event|2|||
126094404|NCT03333876|453641379|FG000|Mandibular Advancement|Product Damage|2|||
126094405|NCT00095498|453641380|FG000|Overall Study|Physician Decision|9|||
126094406|NCT00095498|453641381|FG001|Overall Study|Physician Decision|10|||
126094407|NCT00095498|453641382|FG002|Overall Study|Physician Decision|8|||
126094408|NCT00095498|453641380|FG000|Overall Study|Adverse Event|1|||
126094409|NCT00095498|453641381|FG001|Overall Study|Adverse Event|0|||
126094410|NCT00095498|453641382|FG002|Overall Study|Adverse Event|1|||
126094411|NCT00095498|453641380|FG000|Overall Study|Withdrawal by Subject|15|||
126094412|NCT00095498|453641381|FG001|Overall Study|Withdrawal by Subject|16|||
126246571|NCT04590027|454194138|FG001|Overall Study|Lost to Follow-up|14|||
126246572|NCT04590027|454194137|FG000|Overall Study|Protocol Violation|0|||
126246573|NCT04590027|454194138|FG001|Overall Study|Protocol Violation|3|||
126246574|NCT02682238|454194139|FG000|Overall Study|Lost to Follow-up|0|||
126246575|NCT02682238|454194140|FG001|Overall Study|Lost to Follow-up|2|||
126246576|NCT02682238|454194139|FG000|Overall Study|Withdrawal by Subject|1|||
126246577|NCT02682238|454194140|FG001|Overall Study|Withdrawal by Subject|0|||
126246578|NCT02682238|454194139|FG000|Overall Study|Adverse Event|1|||
126246579|NCT02682238|454194140|FG001|Overall Study|Adverse Event|0|||
126246580|NCT02682238|454194139|FG000|Overall Study|Non-compliance with Study Drug|1|||
126246581|NCT02682238|454194140|FG001|Overall Study|Non-compliance with Study Drug|0|||
126246582|NCT02682238|454194139|FG000|Overall Study|Non-compliance with Protocol|0|||
126246583|NCT02682238|454194140|FG001|Overall Study|Non-compliance with Protocol|2|||
126246584|NCT02909907|454194141|FG000|Overall Study|Withdrawal by Subject|0|||
126246585|NCT02909907|454194142|FG001|Overall Study|Withdrawal by Subject|1|||
126246586|NCT00075478|454194143|FG000|Overall Study|not eligible|1|||
126246587|NCT00075478|454194144|FG001|Overall Study|not eligible|0|||
126246588|NCT00075478|454194143|FG000|Overall Study|Physician Decision|0|||
126246589|NCT00075478|454194144|FG001|Overall Study|Physician Decision|1|||
126246590|NCT02075463|454194147|FG000|Overall Study|Adverse Event|3|||
126246591|NCT02075463|454194147|FG000|Overall Study|Par. reached stopping criteria|4|||
126246592|NCT02075463|454194147|FG000|Overall Study|Withdrawal by Subject|1|||
126246593|NCT01839279|454194149|FG000|Overall Study|Adverse Event|4|||
126246594|NCT01839279|454194150|FG001|Overall Study|Adverse Event|1|||
126246595|NCT01839279|454194151|FG002|Overall Study|Adverse Event|1|||
126246596|NCT01839279|454194149|FG000|Overall Study|Withdrawal by Subject|4|||
126246597|NCT01839279|454194150|FG001|Overall Study|Withdrawal by Subject|1|||
126246598|NCT01839279|454194151|FG002|Overall Study|Withdrawal by Subject|1|||
126246599|NCT01839279|454194149|FG000|Overall Study|Classified as 'Other'|5|||
126246600|NCT01839279|454194150|FG001|Overall Study|Classified as 'Other'|0|||
126246601|NCT01839279|454194151|FG002|Overall Study|Classified as 'Other'|0|||
126246602|NCT03437265|454194152|FG000|Overall Study|Protocol Violation|6|||
126246603|NCT00316277|454194153|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
126246604|NCT00316277|454194154|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
126246605|NCT00316277|454194153|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
126246606|NCT00316277|454194154|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
126246607|NCT00316277|454194153|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
126094413|NCT00095498|453641382|FG002|Overall Study|Withdrawal by Subject|15|||
126094414|NCT00095498|453641380|FG000|Overall Study|Disease progression|0|||
126094415|NCT00095498|453641381|FG001|Overall Study|Disease progression|1|||
126094416|NCT00095498|453641382|FG002|Overall Study|Disease progression|1|||
126094417|NCT00095498|453641380|FG000|Overall Study|Ineligibility determined|3|||
126094418|NCT00095498|453641381|FG001|Overall Study|Ineligibility determined|0|||
126094419|NCT00095498|453641382|FG002|Overall Study|Ineligibility determined|2|||
126094420|NCT00095498|453641380|FG000|Overall Study|Lost to Follow-up|1|||
126094421|NCT00095498|453641381|FG001|Overall Study|Lost to Follow-up|1|||
126094422|NCT00095498|453641382|FG002|Overall Study|Lost to Follow-up|2|||
126094423|NCT00095498|453641380|FG000|Overall Study|Noncompliance|1|||
126094424|NCT00095498|453641381|FG001|Overall Study|Noncompliance|0|||
126094425|NCT00095498|453641382|FG002|Overall Study|Noncompliance|1|||
126094426|NCT00095498|453641380|FG000|Overall Study|Other|6|||
126094427|NCT00095498|453641381|FG001|Overall Study|Other|7|||
126094428|NCT00095498|453641382|FG002|Overall Study|Other|6|||
126094429|NCT00095498|453641380|FG000|Overall Study|Protocol Violation|0|||
126246608|NCT00316277|454194154|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
126246609|NCT00316277|454194153|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
125879263|NCT00360230|452855292|FG005|Overall Study|Protocol Violation|1|||
126094430|NCT00095498|453641381|FG001|Overall Study|Protocol Violation|0|||
126246610|NCT00316277|454194154|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
126246611|NCT00316277|454194153|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
126246612|NCT00316277|454194154|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
126246613|NCT00835263|454194161|FG000|Second Intervention|Adverse Event|1|||
126246614|NCT00835263|454194162|FG001|Second Intervention|Adverse Event|0|||
126246615|NCT00848536|454194163|FG000|Overall Study|Adverse Event|2|||
126246616|NCT00848536|454194164|FG001|Overall Study|Adverse Event|2|||
126246617|NCT00848536|454194163|FG000|Overall Study|Withdrawal by Subject|0|||
126246618|NCT00848536|454194164|FG001|Overall Study|Withdrawal by Subject|1|||
126246619|NCT00848536|454194163|FG000|Overall Study|Protocol Violation|0|||
126246620|NCT00848536|454194164|FG001|Overall Study|Protocol Violation|1|||
126246621|NCT00848536|454194163|FG000|Overall Study|Noncompliance|1|||
126246622|NCT00848536|454194164|FG001|Overall Study|Noncompliance|0|||
126246623|NCT00848536|454194163|FG000|Overall Study|Inadequate Control of IOP|1|||
126246624|NCT00848536|454194164|FG001|Overall Study|Inadequate Control of IOP|1|||
126246625|NCT00848536|454194163|FG000|Overall Study|Patient Moved|0|||
126246626|NCT00848536|454194164|FG001|Overall Study|Patient Moved|2|||
126246627|NCT03987191|454194165|FG000|Overall Study|COVID-19 related research disruption|0|||
126246628|NCT03987191|454194166|FG001|Overall Study|COVID-19 related research disruption|2|||
126246629|NCT03261167|454194167|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
126246630|NCT03261167|454194168|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
126246631|NCT03261167|454194167|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
126246632|NCT03261167|454194168|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
126246633|NCT03261167|454194167|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
126246634|NCT03261167|454194168|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
126246635|NCT03261167|454194167|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
126246636|NCT03261167|454194168|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
126246637|NCT03261167|454194167|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
126246638|NCT03261167|454194168|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
126246639|NCT00918645|454194169|FG000|Overall Study|Withdrawal by Subject|1|||
126246640|NCT01442155|454194170|FG000|Overall Study|Complete remission|35|||
126246641|NCT01442155|454194170|FG000|Overall Study|Recurrence|26|||
126246642|NCT01442155|454194170|FG000|Overall Study|Adverse Event|2|||
126246643|NCT01442155|454194170|FG000|Overall Study|Lost to Follow-up|2|||
126246644|NCT03669861|454194171|FG000|Overall Study|Disease Flare|5|||
126246645|NCT03669861|454194171|FG000|Overall Study|Lack of Efficacy|2|||
126246646|NCT00705666|454194173|FG000|Overall Study|No post-treatment questionnaire|279|||
126246647|NCT00705666|454194173|FG000|Overall Study|Withdrawal by Subject|21|||
126246648|NCT00705666|454194173|FG000|Overall Study|Physician Decision|7|||
126246649|NCT00705666|454194173|FG000|Overall Study|Lost to Follow-up|5|||
126246650|NCT00705666|454194173|FG000|Overall Study|Death|1|||
126246651|NCT00705666|454194173|FG000|Overall Study|Adverse Event|4|||
126246652|NCT00705666|454194173|FG000|Overall Study|Other|12|||
126246653|NCT00705666|454194173|FG000|Overall Study|Other|2|||
126246654|NCT00705666|454194173|FG000|Overall Study|Lack of data|3|||
126246655|NCT00705666|454194173|FG000|Overall Study|Untreated|5|||
126246656|NCT01590563|454194183|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
126246657|NCT01604941|454194184|FG000|Overall Study|Adverse Event|1|||
126246658|NCT01604941|454194185|FG001|Overall Study|Adverse Event|2|||
126246659|NCT01604941|454194186|FG002|Overall Study|Adverse Event|0|||
126246660|NCT01604941|454194187|FG003|Overall Study|Adverse Event|0|||
126246661|NCT01604941|454194188|FG004|Overall Study|Adverse Event|1|||
126094431|NCT00095498|453641382|FG002|Overall Study|Protocol Violation|1|||
126094432|NCT00095498|453641380|FG000|Overall Study|Requirement for alternative therapy|1|||
126094433|NCT00095498|453641381|FG001|Overall Study|Requirement for alternative therapy|0|||
126094434|NCT00095498|453641382|FG002|Overall Study|Requirement for alternative therapy|2|||
126094435|NCT05020327|453641383|FG000|Overall Study|Physician Decision|3|||
126094436|NCT05020327|453641384|FG001|Overall Study|Physician Decision|0|||
126094437|NCT05020327|453641385|FG002|Overall Study|Physician Decision|0|||
126094438|NCT05020327|453641383|FG000|Overall Study|Withdrawal by Subject|1|||
126094439|NCT05020327|453641384|FG001|Overall Study|Withdrawal by Subject|1|||
126094440|NCT05020327|453641385|FG002|Overall Study|Withdrawal by Subject|0|||
126094441|NCT05020327|453641383|FG000|Overall Study|personal/cultural, ineligible|12|||
126094442|NCT05020327|453641384|FG001|Overall Study|personal/cultural, ineligible|0|||
126246662|NCT01604941|454194189|FG005|Overall Study|Adverse Event|5|||
126246663|NCT01604941|454194184|FG000|Overall Study|Non-compliance|1|||
126094443|NCT05020327|453641385|FG002|Overall Study|personal/cultural, ineligible|0|||
126094444|NCT04684394|453641386|FG000|Overall Study|Death|1|||
126094445|NCT04684394|453641387|FG001|Overall Study|Death|2|||
126246664|NCT01604941|454194185|FG001|Overall Study|Non-compliance|0|||
126246665|NCT01604941|454194186|FG002|Overall Study|Non-compliance|0|||
126246666|NCT01604941|454194187|FG003|Overall Study|Non-compliance|0|||
126094446|NCT04684394|453641386|FG000|Overall Study|Lost to Follow-up|1|||
126094447|NCT04684394|453641387|FG001|Overall Study|Lost to Follow-up|0|||
126094448|NCT04684394|453641386|FG000|Overall Study|Withdrawal by Subject|2|||
126246667|NCT01604941|454194188|FG004|Overall Study|Non-compliance|0|||
126246668|NCT01604941|454194189|FG005|Overall Study|Non-compliance|0|||
126246669|NCT01604941|454194184|FG000|Overall Study|Participant Decision|0|||
126246670|NCT01604941|454194185|FG001|Overall Study|Participant Decision|0|||
126246671|NCT01604941|454194186|FG002|Overall Study|Participant Decision|0|||
126246672|NCT01604941|454194187|FG003|Overall Study|Participant Decision|0|||
126246673|NCT01604941|454194188|FG004|Overall Study|Participant Decision|0|||
126246674|NCT01604941|454194189|FG005|Overall Study|Participant Decision|2|||
126246675|NCT01604941|454194184|FG000|Overall Study|Early Study Termination|9|||
126246676|NCT01604941|454194185|FG001|Overall Study|Early Study Termination|2|||
126246677|NCT01604941|454194186|FG002|Overall Study|Early Study Termination|3|||
126246678|NCT01604941|454194187|FG003|Overall Study|Early Study Termination|3|||
126246679|NCT01604941|454194188|FG004|Overall Study|Early Study Termination|0|||
126246680|NCT01604941|454194189|FG005|Overall Study|Early Study Termination|0|||
126246681|NCT03256695|454194190|FG000|Overall Study|Adverse Event|8|||
126246682|NCT03256695|454194190|FG000|Overall Study|Death|2|||
126246683|NCT03256695|454194190|FG000|Overall Study|Withdrawal by Subject|14|||
126246684|NCT03256695|454194190|FG000|Overall Study|Non-compliance with study drug|1|||
126246685|NCT03256695|454194190|FG000|Overall Study|Lost to Follow-up|3|||
126246686|NCT03256695|454194190|FG000|Overall Study|Lack of Efficacy|3|||
126246687|NCT03256695|454194190|FG000|Overall Study|Protocol Violation|5|||
126246688|NCT03256695|454194190|FG000|Overall Study|Other than specified|3|||
126246689|NCT03366792|454194191|FG000|Overall Study|Withdrawal by Subject|7|||
126246690|NCT03366792|454194191|FG000|Overall Study|Lost to Follow-up|2|||
126246691|NCT03366792|454194191|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
126246692|NCT03366792|454194191|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
126246693|NCT02450539|454194192|FG000|Overall Study|Withdrawal by Subject|12|||
126246694|NCT02450539|454194193|FG001|Overall Study|Withdrawal by Subject|6|||
126246695|NCT02450539|454194192|FG000|Overall Study|Lost to Follow-up|4|||
126246696|NCT02450539|454194193|FG001|Overall Study|Lost to Follow-up|1|||
126246697|NCT00585286|454194194|FG000|Overall Study|Lost to Follow-up|1|||
126246698|NCT05479058|454194195|FG000|Overall Study|Withdrawal by Subject|1|||
126246699|NCT05479058|454194196|FG001|Overall Study|Withdrawal by Subject|1|||
126246700|NCT05479058|454194195|FG000|Overall Study|Study terminated by sponsor|10|||
126246701|NCT05479058|454194196|FG001|Overall Study|Study terminated by sponsor|10|||
126246702|NCT00402103|454194201|FG000|Overall Study|Adverse Event|60|||
126026897|NCT03526861|453394677|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026898|NCT03526861|453394678|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026899|NCT03526861|453394679|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026900|NCT03526861|453394680|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026901|NCT03526861|453394681|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126046478|NCT02467270|453468228|FG002|Overall Study|Withdrawal by Subject|5|||
126246703|NCT00402103|454194202|FG001|Overall Study|Adverse Event|7|||
126246704|NCT00402103|454194201|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126246705|NCT00402103|454194202|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126246706|NCT00402103|454194201|FG000|Overall Study|Condition no longer requires study drug|2|||
126246707|NCT00402103|454194202|FG001|Overall Study|Condition no longer requires study drug|0|||
126246708|NCT00402103|454194201|FG000|Overall Study|Protocol Deviation|8|||
126246709|NCT00402103|454194202|FG001|Overall Study|Protocol Deviation|0|||
126246710|NCT00402103|454194201|FG000|Overall Study|Patient withdrew consent|12|||
126246711|NCT00402103|454194202|FG001|Overall Study|Patient withdrew consent|1|||
126246712|NCT00402103|454194201|FG000|Overall Study|Lost to Follow-up|6|||
126246713|NCT00402103|454194202|FG001|Overall Study|Lost to Follow-up|3|||
126246714|NCT00402103|454194201|FG000|Overall Study|Administrative problems|2|||
126246715|NCT00402103|454194202|FG001|Overall Study|Administrative problems|0|||
126246716|NCT04078022|454194203|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
126246717|NCT04078022|454194204|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
126246718|NCT01895335|454194209|FG000|Overall Study|Adverse Event|106|||
126246719|NCT01895335|454194209|FG000|Overall Study|Lack of Efficacy|53|||
126246720|NCT01895335|454194209|FG000|Overall Study|Poor Compliance to Protocol|11|||
126246721|NCT01895335|454194209|FG000|Overall Study|Included But Not treated|1|||
126246722|NCT01895335|454194209|FG000|Overall Study|Other than Specified Above|44|||
126246723|NCT00418938|454194210|FG000|Overall Study|Reimbursement|1|||
126246724|NCT00418938|454194211|FG001|Overall Study|Reimbursement|0|||
126246725|NCT00418938|454194210|FG000|Overall Study|Administrative decision|3|||
126246726|NCT00418938|454194211|FG001|Overall Study|Administrative decision|3|||
126246727|NCT00418938|454194210|FG000|Overall Study|Withdrawal by Subject|16|||
126246728|NCT00418938|454194211|FG001|Overall Study|Withdrawal by Subject|15|||
126246729|NCT00418938|454194210|FG000|Overall Study|Lost to Follow-up|1|||
126246730|NCT00418938|454194211|FG001|Overall Study|Lost to Follow-up|3|||
126246731|NCT00418938|454194210|FG000|Overall Study|Adverse Event|1|||
126246732|NCT00418938|454194211|FG001|Overall Study|Adverse Event|1|||
126246733|NCT00418938|454194210|FG000|Overall Study|On-going|1|||
126246734|NCT00418938|454194211|FG001|Overall Study|On-going|1|||
126246735|NCT00418938|454194210|FG000|Overall Study|Ineligibility Determined|1|||
126246736|NCT00418938|454194211|FG001|Overall Study|Ineligibility Determined|0|||
125879264|NCT00360230|452855293|FG006|Overall Study|Protocol Violation|0|||
125879265|NCT00360230|452855287|FG000|Overall Study|Death|0|||
126026902|NCT03526861|453394682|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026903|NCT03526861|453394683|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026904|NCT03526861|453394684|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126026905|NCT03526861|453394685|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
126026906|NCT05862870|453394686|FG000|Overall Study|Lost to Follow-up|3|||
126026907|NCT00650104|453394694|FG000|Overall Study|Adverse Event|17|||
126026908|NCT00650104|453394694|FG000|Overall Study|Death|2|||
126026909|NCT00650104|453394694|FG000|Overall Study|Withdrawal by Subject|11|||
126026910|NCT00650104|453394694|FG000|Overall Study|Physician Decision|7|||
126026911|NCT00650104|453394694|FG000|Overall Study|Lost to Follow-up|1|||
126026912|NCT00650104|453394694|FG000|Overall Study|Non-compliance|2|||
126026913|NCT00650104|453394694|FG000|Overall Study|Sponsor Terminated Dosing|1|||
126026914|NCT00931710|453394695|FG000|Overall Study|Adverse Event|16|||
126026915|NCT00931710|453394696|FG001|Overall Study|Adverse Event|10|||
126026916|NCT00931710|453394695|FG000|Overall Study|Abnormal test procedure results|2|||
126026917|NCT00931710|453394696|FG001|Overall Study|Abnormal test procedure results|0|||
126026918|NCT00931710|453394695|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
126026919|NCT00931710|453394696|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
126026920|NCT00931710|453394695|FG000|Overall Study|Patient withdrew consent|4|||
126026921|NCT00931710|453394696|FG001|Overall Study|Patient withdrew consent|9|||
126026922|NCT00931710|453394695|FG000|Overall Study|Lost to Follow-up|6|||
126026923|NCT00931710|453394696|FG001|Overall Study|Lost to Follow-up|5|||
126026924|NCT00931710|453394695|FG000|Overall Study|Protocol deviation|1|||
126026925|NCT00931710|453394696|FG001|Overall Study|Protocol deviation|2|||
126026926|NCT01376700|453394697|FG000|Overall Study|Sponsor terminated study early|8|||
126026927|NCT01376700|453394697|FG000|Overall Study|Low or high titer inhibitor|8|||
126026928|NCT00601900|453394701|FG000|Overall Study|Withdrawal by Subject|0|||
126026929|NCT00601900|453394702|FG001|Overall Study|Withdrawal by Subject|3|||
126026930|NCT02500758|453394704|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
126026931|NCT02500758|453394705|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
126026932|NCT02500758|453394704|FG000|Washout (1 Week)|Lost to Follow-up|2|||
126026933|NCT02500758|453394705|FG001|Washout (1 Week)|Lost to Follow-up|2|||
126026934|NCT02500758|453394704|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
126026935|NCT02500758|453394705|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
126026936|NCT02500758|453394704|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
126026937|NCT02500758|453394705|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
126026938|NCT02500758|453394704|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
126246737|NCT00463684|454194212|FG000|Overall Study|Withdrawal by Subject|1|||
126246738|NCT00463684|454194212|FG000|Overall Study|Lost to Follow-up|3|||
126246739|NCT00115063|454194213|FG000|Overall Study|Lost to Follow-up|98|||
126246740|NCT00115063|454194214|FG001|Overall Study|Lost to Follow-up|104|||
126246741|NCT00115063|454194213|FG000|Overall Study|Death|1|||
126246742|NCT00115063|454194214|FG001|Overall Study|Death|0|||
126246743|NCT00191815|454194215|FG000|Overall Study|Adverse Event|2|||
126246744|NCT00191815|454194215|FG000|Overall Study|Disease progression or relapse|24|||
126246745|NCT00191815|454194215|FG000|Overall Study|Death|2|||
125879266|NCT00360230|452855288|FG001|Overall Study|Death|1|||
126246746|NCT00191815|454194215|FG000|Overall Study|Protocol Violation|3|||
126246747|NCT00191815|454194215|FG000|Overall Study|Physician Decision|2|||
126246748|NCT00191815|454194215|FG000|Overall Study|Withdrawal by Subject|7|||
126246749|NCT01316055|454194221|FG000|Overall Study|Lost to Follow-up|1|||
126246750|NCT01316055|454194222|FG001|Overall Study|Lost to Follow-up|0|||
126246751|NCT01316055|454194223|FG002|Overall Study|Lost to Follow-up|0|||
126246752|NCT00003470|454194224|FG000|Overall Study|Not evaluable|6|||
126246753|NCT01825798|454194225|FG000|Overall Study|Adverse Event|1|||
126246754|NCT01825798|454194226|FG001|Overall Study|Adverse Event|5|||
126246755|NCT01825798|454194225|FG000|Overall Study|Lost to Follow-up|1|||
126246756|NCT01825798|454194226|FG001|Overall Study|Lost to Follow-up|0|||
126246757|NCT03500094|454194229|FG000|Overall Study|Withdrawal by Subject|1|||
126246758|NCT03500094|454194229|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
126246759|NCT03500094|454194229|FG000|Overall Study|Lost to Follow-up|1|||
126246760|NCT01030133|454194230|FG000|Overall Study|failed to experience pain at level 7/10|2|||
126246761|NCT01030133|454194231|FG001|Overall Study|failed to experience pain at level 7/10|2|||
126246762|NCT02068794|454195697|FG000|Overall Study|Withdrawal by Subject|0|||
126246763|NCT02068794|454195698|FG001|Overall Study|Withdrawal by Subject|1|||
126246764|NCT02068794|454195699|FG002|Overall Study|Withdrawal by Subject|2|||
126246765|NCT02068794|454195697|FG000|Overall Study|Early Progression|1|||
126246766|NCT02068794|454195698|FG001|Overall Study|Early Progression|0|||
126246767|NCT02068794|454195699|FG002|Overall Study|Early Progression|1|||
126246768|NCT02068794|454195697|FG000|Overall Study|Ineligible|0|||
126026939|NCT02500758|453394705|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
126246769|NCT02068794|454195698|FG001|Overall Study|Ineligible|0|||
126246770|NCT02068794|454195699|FG002|Overall Study|Ineligible|1|||
126246771|NCT02316548|454195701|FG000|Overall Study|Protocol Violation|0|||
126246772|NCT02316548|454195702|FG001|Overall Study|Protocol Violation|1|||
126246773|NCT01958294|454195703|FG000|Overall Study|Clinical Circumstances|2|||
126246774|NCT02566850|454195705|FG000|Overall Study|Protocol Violation|1|||
126026940|NCT00274469|453394707|FG000|Overall Study|Death|63|||
126026941|NCT00274469|453394708|FG001|Overall Study|Death|74|||
126026942|NCT00274469|453394707|FG000|Overall Study|Did not consent to OS follow-up|16|||
126026943|NCT00274469|453394708|FG001|Overall Study|Did not consent to OS follow-up|19|||
126246775|NCT02635750|454195706|FG000|Part 1, Period 2|Adverse Event|1|||
126246776|NCT02635750|454195707|FG001|Part 1, Period 2|Adverse Event|0|||
126246777|NCT02635750|454195708|FG002|Part 1, Period 2|Adverse Event|0|||
126246778|NCT00830258|454195711|FG000|First Intervention|Adverse Event|1|||
126246779|NCT00830258|454195712|FG001|First Intervention|Adverse Event|0|||
126246780|NCT00830258|454195711|FG000|Washout: 7 Days|Protocol Violation|1|||
126246781|NCT00830258|454195712|FG001|Washout: 7 Days|Protocol Violation|0|||
126246782|NCT00682461|454195716|FG000|Overall Study|Adverse Event|5|||
126246783|NCT00682461|454195717|FG001|Overall Study|Adverse Event|7|||
126246784|NCT00682461|454195716|FG000|Overall Study|Lost to Follow-up|8|||
126246785|NCT00682461|454195717|FG001|Overall Study|Lost to Follow-up|5|||
126026944|NCT04999592|453394714|FG000|Overall Study|Withdrawal by Subject|1|||
126026945|NCT04999592|453394715|FG001|Overall Study|Withdrawal by Subject|0|||
126026946|NCT03527160|453394717|FG000|Overall Study|No urine collected|13|||
126026947|NCT03527160|453394717|FG000|Overall Study|No clinical serum creatinine collected|6|||
126026948|NCT03527160|453394717|FG000|Overall Study|Did not meet inclusion|2|||
126026949|NCT05179395|453394718|FG000|Overall Study|Lack of Efficacy|1|||
126026950|NCT03767517|453394722|FG000|Overall Study|Lost to Follow-up|16|||
126026951|NCT03767517|453394723|FG001|Overall Study|Lost to Follow-up|10|||
126026952|NCT03767517|453394722|FG000|Overall Study|Death|2|||
126026953|NCT03767517|453394723|FG001|Overall Study|Death|3|||
126026954|NCT05792423|453394724|FG000|Overall Study|Withdrawal by Subject|2|||
126026955|NCT02471638|453394725|FG000|Overall Study|Early Term Withdrawal|10|||
126026956|NCT05338086|453396069|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
126026957|NCT05338086|453396070|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
126026958|NCT05338086|453396071|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
126026959|NCT05338086|453396072|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
126026960|NCT05338086|453396073|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
126026961|NCT05338086|453396069|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
126026962|NCT05338086|453396070|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
126026963|NCT05338086|453396071|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
126026964|NCT05338086|453396072|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
126094449|NCT04684394|453641387|FG001|Overall Study|Withdrawal by Subject|0|||
126094450|NCT04684394|453641386|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
125879267|NCT00360230|452855289|FG002|Overall Study|Death|0|||
125879268|NCT00360230|452855290|FG003|Overall Study|Death|0|||
125879269|NCT00360230|452855291|FG004|Overall Study|Death|0|||
125879270|NCT00360230|452855292|FG005|Overall Study|Death|1|||
125879271|NCT00360230|452855293|FG006|Overall Study|Death|1|||
125879272|NCT00581308|452855294|FG000|Pre Discharge|Lost to Follow-up|1|||
125879273|NCT00581308|452855294|FG000|Pre Discharge|Device Removed|1|||
125879274|NCT00581308|452855294|FG000|Month 1|Lost to Follow-up|3|||
125879275|NCT00581308|452855294|FG000|Month 1|Withdrawal by Subject|2|||
125879276|NCT00581308|452855294|FG000|Month 1|Device Removed|2|||
125879277|NCT00581308|452855294|FG000|Month 1|Uknown|1|||
125879278|NCT00581308|452855294|FG000|Month 6|Lost to Follow-up|1|||
125879279|NCT00581308|452855294|FG000|Month 6|Withdrawal by Subject|2|||
125879280|NCT00581308|452855294|FG000|Month 12|Death|1|||
125879281|NCT00581308|452855294|FG000|Month 12|Lost to Follow-up|14|||
125879282|NCT00581308|452855294|FG000|Month 12|Withdrawal by Subject|3|||
125879283|NCT00581308|452855294|FG000|Month 12|Device Removed|1|||
125879284|NCT00581308|452855294|FG000|Month 12|Other|1|||
125879285|NCT00886379|452855295|FG000|Overall Study|Transferred Schools|0|||
125879286|NCT00886379|452855296|FG001|Overall Study|Transferred Schools|0|||
125879287|NCT00886379|452855297|FG002|Overall Study|Transferred Schools|2|||
125879288|NCT00886379|452855298|FG003|Overall Study|Transferred Schools|1|||
125879289|NCT00886379|452855299|FG004|Overall Study|Transferred Schools|1|||
125879290|NCT00886379|452855295|FG000|Overall Study|Final blood draw not obtained|3|||
125879291|NCT00886379|452855296|FG001|Overall Study|Final blood draw not obtained|3|||
125879292|NCT00886379|452855297|FG002|Overall Study|Final blood draw not obtained|4|||
125879293|NCT00886379|452855298|FG003|Overall Study|Final blood draw not obtained|2|||
125879294|NCT00886379|452855299|FG004|Overall Study|Final blood draw not obtained|2|||
125879295|NCT04558125|452855300|FG000|Overall Study|Death|1|||
125879296|NCT01614886|452855301|FG000|Overall Study|Adverse Event|15|||
125879297|NCT01614886|452855302|FG001|Overall Study|Adverse Event|20|||
125879298|NCT01614886|452855301|FG000|Overall Study|Withdrawal by Subject|4|||
125879299|NCT01614886|452855302|FG001|Overall Study|Withdrawal by Subject|4|||
125879300|NCT01614886|452855301|FG000|Overall Study|Death|1|||
125879301|NCT01614886|452855302|FG001|Overall Study|Death|0|||
125879302|NCT01614886|452855301|FG000|Overall Study|Protocol deviation|0|||
125879303|NCT01614886|452855302|FG001|Overall Study|Protocol deviation|2|||
125879304|NCT01207414|452855304|FG000|Overall Study|Adverse Event|25|||
125879305|NCT01207414|452855305|FG001|Overall Study|Adverse Event|39|||
125879306|NCT01207414|452855304|FG000|Overall Study|Abnormal test procedure results|0|||
125879307|NCT01207414|452855305|FG001|Overall Study|Abnormal test procedure results|1|||
125879308|NCT01207414|452855304|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125879309|NCT01207414|452855305|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125879310|NCT01207414|452855304|FG000|Overall Study|Patient withdrew consent|14|||
125879311|NCT01207414|452855305|FG001|Overall Study|Patient withdrew consent|11|||
125879312|NCT01207414|452855304|FG000|Overall Study|Lost to Follow-up|15|||
125879313|NCT01207414|452855305|FG001|Overall Study|Lost to Follow-up|17|||
125879314|NCT01207414|452855304|FG000|Overall Study|Administrative problems|1|||
125879315|NCT01207414|452855305|FG001|Overall Study|Administrative problems|1|||
125879316|NCT01207414|452855304|FG000|Overall Study|Protocol deviation|12|||
125879317|NCT01207414|452855305|FG001|Overall Study|Protocol deviation|9|||
125879318|NCT01207414|452855304|FG000|Overall Study|Randomized in error|1|||
125879319|NCT01207414|452855305|FG001|Overall Study|Randomized in error|0|||
125879320|NCT01748292|452855306|FG000|Overall Study|Adverse Event|2|||
125879321|NCT01748292|452855307|FG001|Overall Study|Adverse Event|4|||
125879322|NCT01748292|452855306|FG000|Overall Study|Lost to Follow-up|0|||
125879323|NCT01748292|452855307|FG001|Overall Study|Lost to Follow-up|3|||
126246786|NCT00682461|454195716|FG000|Overall Study|Withdrawal by Subject|12|||
126246787|NCT00682461|454195717|FG001|Overall Study|Withdrawal by Subject|19|||
126246788|NCT04035187|454195720|FG000|Overall Study|Withdrawal by Subject|2|||
126246789|NCT04035187|454195721|FG001|Overall Study|Withdrawal by Subject|1|||
125879324|NCT01748292|452855306|FG000|Overall Study|Death|0|||
126026965|NCT05338086|453396073|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
126246790|NCT04035187|454195722|FG002|Overall Study|Withdrawal by Subject|0|||
126246791|NCT04035187|454195723|FG003|Overall Study|Withdrawal by Subject|0|||
126246792|NCT04035187|454195720|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
125879325|NCT01748292|452855307|FG001|Overall Study|Death|3|||
125879326|NCT01748292|452855306|FG000|Overall Study|Withdrawal by Subject|0|||
125879327|NCT01748292|452855307|FG001|Overall Study|Withdrawal by Subject|2|||
125879328|NCT01527370|452855308|FG000|Overall Study|Withdrawal by Subject|4|||
125879329|NCT01527370|452855308|FG000|Overall Study|Physician Decision|1|||
125879330|NCT01527370|452855308|FG000|Overall Study|Death|1|||
125879331|NCT01435382|452855311|FG000|Overall Study|Lost to Follow-up|1|||
125879332|NCT01435382|452855312|FG001|Overall Study|Lost to Follow-up|0|||
125879333|NCT01435382|452855313|FG002|Overall Study|Lost to Follow-up|1|||
125879334|NCT01435382|452855314|FG003|Overall Study|Lost to Follow-up|0|||
125879335|NCT01435382|452855311|FG000|Overall Study|Withdrawal by Subject|0|||
125879336|NCT01435382|452855312|FG001|Overall Study|Withdrawal by Subject|2|||
125879337|NCT01435382|452855313|FG002|Overall Study|Withdrawal by Subject|0|||
126246793|NCT04035187|454195721|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
126246794|NCT04035187|454195722|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
126246795|NCT04035187|454195723|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
126246796|NCT01116739|454195724|FG000|Overall Study|Child had 2 years of HS|110|||
126246797|NCT01116739|454195725|FG001|Overall Study|Child had 2 years of HS|128|||
126246798|NCT01116739|454195724|FG000|Overall Study|Withdrawal by Subject|6|||
126246799|NCT01116739|454195725|FG001|Overall Study|Withdrawal by Subject|0|||
126246800|NCT01116739|454195724|FG000|Overall Study|child too young|2|||
126246801|NCT01116739|454195725|FG001|Overall Study|child too young|6|||
126246802|NCT01116739|454195724|FG000|Overall Study|child not enrolled in head start|10|||
126246803|NCT01116739|454195725|FG001|Overall Study|child not enrolled in head start|2|||
126246804|NCT01116739|454195724|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
126246805|NCT01116739|454195725|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
126246806|NCT05511935|454195726|FG000|Overall Study|Lost to Follow-up|9|||
126246807|NCT05511935|454195727|FG001|Overall Study|Lost to Follow-up|27|||
126246808|NCT05090839|454195730|FG000|Overall Study|Lost to Follow-up|2|||
126246809|NCT05090839|454195731|FG001|Overall Study|Lost to Follow-up|3|||
126246810|NCT05090839|454195732|FG002|Overall Study|Lost to Follow-up|1|||
126246811|NCT05090839|454195733|FG003|Overall Study|Lost to Follow-up|1|||
126246812|NCT03913377|454195734|FG000|Period 1|Test Article no longer available|0|||
126246813|NCT03913377|454195735|FG001|Period 1|Test Article no longer available|1|||
126246814|NCT03913377|454195736|FG002|Period 1|Test Article no longer available|0|||
126246815|NCT03913377|454195734|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
126246816|NCT03913377|454195735|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
126246817|NCT03913377|454195736|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
126246818|NCT03499353|454195737|FG000|Treatment|Adverse Event|3|||
126246819|NCT03499353|454195737|FG000|Treatment|Progressive Disease|10|||
126246820|NCT03499353|454195737|FG000|Treatment|Other|1|||
126246821|NCT03499353|454195737|FG000|Treatment|Withdrawal by Subject|2|||
126246822|NCT03499353|454195737|FG000|Long-Term Follow-up|Death|2|||
126246823|NCT03499353|454195737|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
126246824|NCT03499353|454195737|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
126246825|NCT01117623|454195738|FG000|Overall Study|Adverse Event|0|||
126246826|NCT01117623|454195739|FG001|Overall Study|Adverse Event|2|||
126246827|NCT01117623|454195740|FG002|Overall Study|Adverse Event|4|||
126246828|NCT01117623|454195741|FG003|Overall Study|Adverse Event|0|||
126246829|NCT01117623|454195742|FG004|Overall Study|Adverse Event|2|||
126246830|NCT01117623|454195743|FG005|Overall Study|Adverse Event|0|||
126246831|NCT01117623|454195744|FG006|Overall Study|Adverse Event|0|||
126246832|NCT01117623|454195745|FG007|Overall Study|Adverse Event|2|||
126246833|NCT01117623|454195738|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
126246834|NCT01117623|454195739|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
126246835|NCT01117623|454195740|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
126246836|NCT01117623|454195741|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
126246837|NCT01117623|454195742|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
126246838|NCT01117623|454195743|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
126246839|NCT01117623|454195744|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
126246840|NCT01117623|454195745|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
126246841|NCT01117623|454195738|FG000|Overall Study|Withdrawal by Subject|0|||
126246842|NCT01117623|454195739|FG001|Overall Study|Withdrawal by Subject|0|||
126246843|NCT01117623|454195740|FG002|Overall Study|Withdrawal by Subject|2|||
126094451|NCT04684394|453641387|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
126094452|NCT00591370|453641389|FG000|Overall Study|Not Treated|2|||
126246844|NCT01117623|454195741|FG003|Overall Study|Withdrawal by Subject|0|||
126246845|NCT01117623|454195742|FG004|Overall Study|Withdrawal by Subject|0|||
126246846|NCT01117623|454195743|FG005|Overall Study|Withdrawal by Subject|1|||
126246847|NCT01117623|454195744|FG006|Overall Study|Withdrawal by Subject|1|||
126246848|NCT01117623|454195745|FG007|Overall Study|Withdrawal by Subject|1|||
126246849|NCT01117623|454195738|FG000|Overall Study|Non-compliance with study medication|0|||
126246850|NCT01117623|454195739|FG001|Overall Study|Non-compliance with study medication|0|||
126246851|NCT01117623|454195740|FG002|Overall Study|Non-compliance with study medication|0|||
126246852|NCT01117623|454195741|FG003|Overall Study|Non-compliance with study medication|0|||
126094453|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
126094454|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
126246853|NCT01117623|454195742|FG004|Overall Study|Non-compliance with study medication|0|||
126246854|NCT01117623|454195743|FG005|Overall Study|Non-compliance with study medication|0|||
126246855|NCT01117623|454195744|FG006|Overall Study|Non-compliance with study medication|0|||
126246856|NCT01117623|454195745|FG007|Overall Study|Non-compliance with study medication|1|||
126246857|NCT01117623|454195738|FG000|Overall Study|Invest. text: completed all planned txs|0|||
126246858|NCT01117623|454195739|FG001|Overall Study|Invest. text: completed all planned txs|0|||
126094455|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
126246859|NCT01117623|454195740|FG002|Overall Study|Invest. text: completed all planned txs|0|||
126246860|NCT01117623|454195741|FG003|Overall Study|Invest. text: completed all planned txs|0|||
126246861|NCT01117623|454195742|FG004|Overall Study|Invest. text: completed all planned txs|0|||
126246862|NCT01117623|454195743|FG005|Overall Study|Invest. text: completed all planned txs|1|||
126246863|NCT01117623|454195744|FG006|Overall Study|Invest. text: completed all planned txs|0|||
126246864|NCT01117623|454195745|FG007|Overall Study|Invest. text: completed all planned txs|0|||
126246865|NCT00736190|454195750|FG000|Overall Study|Pregnancy|1|||
126246866|NCT00736190|454195750|FG000|Overall Study|Withdrawal by Subject|1|||
126246867|NCT00736190|454195750|FG000|Overall Study|Adverse Event|1|||
126246868|NCT01896934|454195752|FG000|Overall Study|Adverse Event|1|||
126246869|NCT01896934|454195752|FG000|Overall Study|Withdrawal by Subject|1|||
126246870|NCT00824291|454195753|FG000|Overall Study|Adverse Event|15|||
126246871|NCT00824291|454195754|FG001|Overall Study|Adverse Event|6|||
126246872|NCT00824291|454195753|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
126246873|NCT00824291|454195754|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
126246874|NCT00824291|454195753|FG000|Overall Study|Lost to Follow-up|11|||
126246875|NCT00824291|454195754|FG001|Overall Study|Lost to Follow-up|9|||
126246876|NCT00824291|454195753|FG000|Overall Study|Non-compliance|1|||
126246877|NCT00824291|454195754|FG001|Overall Study|Non-compliance|1|||
126246878|NCT00824291|454195753|FG000|Overall Study|Protocol Violation|4|||
126246879|NCT00824291|454195754|FG001|Overall Study|Protocol Violation|1|||
126246880|NCT00824291|454195753|FG000|Overall Study|Withdrawal by Subject|14|||
126246881|NCT00824291|454195754|FG001|Overall Study|Withdrawal by Subject|8|||
126246882|NCT00824291|454195753|FG000|Overall Study|Lack of Efficacy|7|||
126246883|NCT00824291|454195754|FG001|Overall Study|Lack of Efficacy|8|||
126246884|NCT00824291|454195753|FG000|Overall Study|Participant on prohibited medication|1|||
126246885|NCT00824291|454195754|FG001|Overall Study|Participant on prohibited medication|0|||
126246886|NCT00933686|454195755|FG000|Overall Study|Protocol Violation|0|||
126246887|NCT00933686|454195756|FG001|Overall Study|Protocol Violation|1|||
126246888|NCT00933686|454195755|FG000|Overall Study|Lost to Follow-up|2|||
126246889|NCT00933686|454195756|FG001|Overall Study|Lost to Follow-up|2|||
126246890|NCT00933686|454195755|FG000|Overall Study|Withdrawal by Subject|6|||
126246891|NCT00933686|454195756|FG001|Overall Study|Withdrawal by Subject|5|||
126246892|NCT00933686|454195755|FG000|Overall Study|Adverse Event|1|||
126246893|NCT00933686|454195756|FG001|Overall Study|Adverse Event|1|||
126246894|NCT00933686|454195755|FG000|Overall Study|Physician Decision|1|||
126246895|NCT00933686|454195756|FG001|Overall Study|Physician Decision|0|||
126246896|NCT00933686|454195755|FG000|Overall Study|Failure to show up at endpoint visits|0|||
126246897|NCT00933686|454195756|FG001|Overall Study|Failure to show up at endpoint visits|2|||
126246898|NCT00840216|454195762|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126246899|NCT00840216|454195763|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
126246900|NCT05041361|454195764|FG000|Overall Study|Lost to Follow-up|1|||
126246901|NCT05041361|454195765|FG001|Overall Study|Lost to Follow-up|3|||
126246902|NCT01642277|454195766|FG000|Overall Study|Adverse Event|10|||
126246903|NCT01642277|454195767|FG001|Overall Study|Adverse Event|0|||
126246904|NCT01642277|454195766|FG000|Overall Study|Physician Decision|2|||
126246905|NCT01642277|454195767|FG001|Overall Study|Physician Decision|0|||
126246906|NCT01642277|454195766|FG000|Overall Study|Protocol Violation|1|||
126246907|NCT01642277|454195767|FG001|Overall Study|Protocol Violation|0|||
126246908|NCT01642277|454195766|FG000|Overall Study|Withdrawal by Subject|11|||
126246909|NCT01642277|454195767|FG001|Overall Study|Withdrawal by Subject|0|||
126246910|NCT03605342|454195770|FG000|Overall Study|Withdrawal by Subject|9|||
126246911|NCT03605342|454195771|FG001|Overall Study|Withdrawal by Subject|7|||
126246912|NCT03605342|454195770|FG000|Overall Study|Lost to Follow-up|1|||
126246913|NCT03605342|454195771|FG001|Overall Study|Lost to Follow-up|1|||
126246914|NCT00796328|454195772|FG000|Overall Study|experienced hypotension requiring tx|6|||
126246915|NCT01572662|454195780|FG000|Overall Study|Withdrawal by Subject|1|||
126246916|NCT01572662|454195781|FG001|Overall Study|Withdrawal by Subject|0|||
126246917|NCT01572662|454195780|FG000|Overall Study|Physician Decision|0|||
126246918|NCT01572662|454195781|FG001|Overall Study|Physician Decision|1|||
126246919|NCT03364192|454195782|FG000|Overall Study|Ineligible|10|||
126246920|NCT03364192|454195782|FG000|Overall Study|Withdrawal by Subject|5|||
126246921|NCT03364192|454195782|FG000|Overall Study|Lost to Follow-up|1|||
126246922|NCT03446768|454195787|FG000|Overall Study|Withdrawal by Subject|0|||
126246923|NCT03446768|454195788|FG001|Overall Study|Withdrawal by Subject|1|||
126246924|NCT05133180|454195789|FG000|Overall Study|Withdrawal of consent|1|||
126246925|NCT05133180|454195790|FG001|Overall Study|Withdrawal of consent|1|||
126246926|NCT05133180|454195789|FG000|Overall Study|Lost to Follow-up|1|||
126246927|NCT05133180|454195790|FG001|Overall Study|Lost to Follow-up|1|||
126246928|NCT05133180|454195789|FG000|Overall Study|Documented disease progression|0|||
126246929|NCT05133180|454195790|FG001|Overall Study|Documented disease progression|1|||
126246930|NCT00107991|454195791|FG000|Eligibility Assessment|Disease not severe enough|7|||
126246931|NCT00107991|454195791|FG000|Eligibility Assessment|Unwilling to participate|7|||
126246932|NCT00107991|454195791|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
126246933|NCT00107991|454195791|FG000|Eligibility Assessment|Abnormal labs|2|||
126246934|NCT00107991|454195791|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
125879338|NCT01435382|452855314|FG003|Overall Study|Withdrawal by Subject|1|||
125879339|NCT00910650|452855315|FG000|Overall Study|Death|2|||
125879340|NCT03367793|452855316|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125879341|NCT03367793|452855317|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
126246935|NCT00107991|454195791|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
125879342|NCT03367793|452855318|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
126246936|NCT00107991|454195791|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
126246937|NCT00107991|454195791|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
126246938|NCT00107991|454195791|FG000|12 Week Treatment Period|Adverse Event|1|||
126246939|NCT00107991|454195791|FG000|12 Week Treatment Period|Protocol Violation|1|||
126246940|NCT00107991|454195791|FG000|12 Week Treatment Period|Incarcerated|1|||
126246941|NCT00107991|454195791|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
126246942|NCT01535222|454195792|FG000|Overall Study|Inclusion/exclusion|0|||
126246943|NCT01535222|454195793|FG001|Overall Study|Inclusion/exclusion|0|||
126246944|NCT01535222|454195794|FG002|Overall Study|Inclusion/exclusion|1|||
126246945|NCT01535222|454195795|FG003|Overall Study|Inclusion/exclusion|0|||
125879343|NCT03367793|452855319|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125879344|NCT03367793|452855320|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125879345|NCT03367793|452855321|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125879346|NCT00260533|452855322|FG000|Overall Study|Other|3|||
125879347|NCT00260533|452855323|FG001|Overall Study|Other|3|||
125879348|NCT01310777|452855325|FG000|Overall Study|Adverse Event|23|||
125879349|NCT01310777|452855326|FG001|Overall Study|Adverse Event|1|||
125879350|NCT01310777|452855327|FG002|Overall Study|Adverse Event|15|||
125879351|NCT01310777|452855325|FG000|Overall Study|Lost to Follow-up|0|||
125879352|NCT01310777|452855326|FG001|Overall Study|Lost to Follow-up|4|||
125879353|NCT01310777|452855327|FG002|Overall Study|Lost to Follow-up|1|||
125879354|NCT01310777|452855325|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
125879355|NCT01310777|452855326|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
125879356|NCT01310777|452855327|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
125879357|NCT01310777|452855325|FG000|Overall Study|Inadequate Control of IOP|5|||
125879358|NCT01310777|452855326|FG001|Overall Study|Inadequate Control of IOP|7|||
125879359|NCT01310777|452855327|FG002|Overall Study|Inadequate Control of IOP|10|||
125879360|NCT01310777|452855325|FG000|Overall Study|Other|4|||
125879361|NCT01310777|452855326|FG001|Overall Study|Other|1|||
125879362|NCT01310777|452855327|FG002|Overall Study|Other|2|||
125879363|NCT03697252|452855328|FG000|Overall Study|Adverse Event|3|||
125879364|NCT03697252|452855329|FG001|Overall Study|Adverse Event|2|||
125879365|NCT03697252|452855328|FG000|Overall Study|Withdrawal by Subject|14|||
126026966|NCT05338086|453396069|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
126246946|NCT01535222|454195796|FG004|Overall Study|Inclusion/exclusion|0|||
126246947|NCT01535222|454195797|FG005|Overall Study|Inclusion/exclusion|0|||
126246948|NCT00935012|454195798|FG000|Overall Study|Death|19|||
126246949|NCT00935012|454195798|FG000|Overall Study|Withdrawal by Subject|3|||
126246950|NCT00935012|454195798|FG000|Overall Study|Other|5|||
126246951|NCT00935012|454195798|FG000|Overall Study|Adverse Event|2|||
126246952|NCT03930732|454195799|FG000|Overall Study|Adverse Event|9|||
126246953|NCT03930732|454195800|FG001|Overall Study|Adverse Event|7|||
126246954|NCT03930732|454195799|FG000|Overall Study|Poor compliance to protocol|0|||
125879366|NCT03697252|452855329|FG001|Overall Study|Withdrawal by Subject|14|||
125879367|NCT03697252|452855328|FG000|Overall Study|Lost to Follow-up|0|||
126026967|NCT05338086|453396070|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
126026968|NCT05338086|453396071|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
126026969|NCT05338086|453396072|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
126026970|NCT05338086|453396073|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
126026971|NCT05338086|453396069|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
126246955|NCT03930732|454195800|FG001|Overall Study|Poor compliance to protocol|1|||
126246956|NCT03930732|454195799|FG000|Overall Study|Withdrawal by Subject|23|||
125879368|NCT03697252|452855329|FG001|Overall Study|Lost to Follow-up|1|||
125879369|NCT03697252|452855328|FG000|Overall Study|Physician Decision|1|||
125879370|NCT03697252|452855329|FG001|Overall Study|Physician Decision|1|||
125879371|NCT03697252|452855328|FG000|Overall Study|Other|0|||
125879372|NCT03697252|452855329|FG001|Overall Study|Other|1|||
126026972|NCT05338086|453396070|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
126246957|NCT03930732|454195800|FG001|Overall Study|Withdrawal by Subject|11|||
126246958|NCT03930732|454195799|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
126246959|NCT03930732|454195800|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
126246960|NCT03930732|454195799|FG000|Overall Study|Other reason not related to COVID-19|5|||
125879373|NCT02224560|452855330|FG000|Overall Study|Protocol Deviation|1|||
125879374|NCT02224560|452855331|FG001|Overall Study|Protocol Deviation|0|||
125879375|NCT02224560|452855332|FG002|Overall Study|Protocol Deviation|0|||
125879376|NCT02224560|452855330|FG000|Overall Study|Withdrawal by Subject|2|||
125879377|NCT02224560|452855331|FG001|Overall Study|Withdrawal by Subject|0|||
125879378|NCT02224560|452855332|FG002|Overall Study|Withdrawal by Subject|1|||
126246961|NCT03930732|454195800|FG001|Overall Study|Other reason not related to COVID-19|8|||
126246962|NCT03406156|454195801|FG000|Overall Study|Death|9|||
126246963|NCT03406156|454195802|FG001|Overall Study|Death|3|||
126246964|NCT03406156|454195801|FG000|Overall Study|Withdrawal by Subject|1|||
126246965|NCT03406156|454195802|FG001|Overall Study|Withdrawal by Subject|2|||
126246966|NCT03406156|454195801|FG000|Overall Study|COVID-19 infection|1|||
126246967|NCT03406156|454195802|FG001|Overall Study|COVID-19 infection|0|||
126246968|NCT03406156|454195801|FG000|Overall Study|Non-compliance with study procedures|1|||
126246969|NCT03406156|454195802|FG001|Overall Study|Non-compliance with study procedures|1|||
126246970|NCT03406156|454195801|FG000|Overall Study|Lost to Follow-up|0|||
126246971|NCT03406156|454195802|FG001|Overall Study|Lost to Follow-up|2|||
126246972|NCT03406156|454195801|FG000|Overall Study|Other, not specified|72|||
126246973|NCT03406156|454195802|FG001|Overall Study|Other, not specified|28|||
126246974|NCT02699463|454195805|FG000|Overall Study|Lost to Follow-up|11|||
126246975|NCT02699463|454195806|FG001|Overall Study|Lost to Follow-up|8|||
126246976|NCT02699463|454195805|FG000|Overall Study|Withdrawal by Subject|4|||
126246977|NCT02699463|454195806|FG001|Overall Study|Withdrawal by Subject|1|||
126246978|NCT00918684|454195812|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
126246979|NCT00918684|454195812|FG000|Treatment Phase|Lack of Efficacy|6|||
126246980|NCT00918684|454195812|FG000|Treatment Phase|Lost to Follow-up|2|||
126246981|NCT00918684|454195812|FG000|Treatment Phase|Physician Decision|8|||
126246982|NCT00918684|454195812|FG000|Treatment Phase|Protocol Violation|1|||
126246983|NCT00918684|454195812|FG000|Treatment Phase|Withdrawal by Subject|8|||
126246984|NCT00909038|454195813|FG000|Overall Study|Protocol Violation|187|||
126246985|NCT00909038|454195813|FG000|Overall Study|Non-evaluable Subjects|230|||
126246986|NCT00484679|454195814|FG000|Overall Study|Withdrawal by Subject|3|||
126246987|NCT00835692|454195815|FG000|First Intervention|Withdrawal by Subject|1|||
126246988|NCT00835692|454195816|FG001|First Intervention|Withdrawal by Subject|0|||
126246989|NCT04345653|454195819|FG000|Overall Study|Withdrawal by Subject|2|||
126246990|NCT03808376|454195820|FG000|Overall Study|Withdrawal by Subject|10|||
126246991|NCT03644550|454195821|FG000|Overall Study|Withdrawal by Subject|3|||
126246992|NCT03644550|454195821|FG000|Overall Study|Progressive disease|15|||
126246993|NCT01348789|454195824|FG000|Overall Study|Protocol Violation|2|||
126246994|NCT01348789|454195824|FG000|Overall Study|Withdrawal by Subject|2|||
126246995|NCT03503318|454195827|FG000|Overall Study|Death|1|||
126246996|NCT03503318|454195828|FG001|Overall Study|Death|0|||
126246997|NCT03503318|454195829|FG002|Overall Study|Death|4|||
126246998|NCT03503318|454195827|FG000|Overall Study|Adverse Event|3|||
126246999|NCT03503318|454195828|FG001|Overall Study|Adverse Event|4|||
126247000|NCT03503318|454195829|FG002|Overall Study|Adverse Event|2|||
126247001|NCT03503318|454195827|FG000|Overall Study|Withdrawal by Subject|12|||
126247002|NCT03503318|454195828|FG001|Overall Study|Withdrawal by Subject|17|||
126247003|NCT03503318|454195829|FG002|Overall Study|Withdrawal by Subject|16|||
126247004|NCT03503318|454195827|FG000|Overall Study|Protocol Violation|5|||
126247005|NCT03503318|454195828|FG001|Overall Study|Protocol Violation|0|||
126247006|NCT03503318|454195829|FG002|Overall Study|Protocol Violation|3|||
126247007|NCT03503318|454195827|FG000|Overall Study|Lost to Follow-up|17|||
126247008|NCT03503318|454195828|FG001|Overall Study|Lost to Follow-up|15|||
126247009|NCT03503318|454195829|FG002|Overall Study|Lost to Follow-up|12|||
126247010|NCT03503318|454195827|FG000|Overall Study|Other than specified|1|||
126247011|NCT03503318|454195828|FG001|Overall Study|Other than specified|3|||
126247012|NCT03503318|454195829|FG002|Overall Study|Other than specified|3|||
126247013|NCT00834873|454195836|FG000|First Intervention|Adverse Event|0|||
126247014|NCT00834873|454195837|FG001|First Intervention|Adverse Event|1|||
126247015|NCT00477594|454195844|FG000|Year 1 and Year 2|Adverse Event|4|||
126247016|NCT00477594|454195845|FG001|Year 1 and Year 2|Adverse Event|2|||
126247017|NCT00477594|454195844|FG000|Year 1 and Year 2|Physician Decision|2|||
126247018|NCT00477594|454195845|FG001|Year 1 and Year 2|Physician Decision|1|||
126247019|NCT00477594|454195844|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
126247020|NCT00477594|454195845|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
126247021|NCT00477594|454195844|FG000|Year 1 and Year 2|Other|1|||
126247022|NCT00477594|454195845|FG001|Year 1 and Year 2|Other|0|||
126247023|NCT00477594|454195844|FG000|Year 3|Adverse Event|1|||
126094456|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
126247024|NCT00477594|454195845|FG001|Year 3|Adverse Event|0|||
126247025|NCT00477594|454195844|FG000|Year 3|Withdrawal by Subject|1|||
126247026|NCT00477594|454195845|FG001|Year 3|Withdrawal by Subject|0|||
126247027|NCT00477594|454195844|FG000|Follow-up Period|Withdrawal by Subject|2|||
126247028|NCT00477594|454195845|FG001|Follow-up Period|Withdrawal by Subject|1|||
126247029|NCT00477594|454195844|FG000|Follow-up Period|Other|1|||
126247030|NCT00477594|454195845|FG001|Follow-up Period|Other|0|||
126247031|NCT03114891|454195846|FG000|First Treatment Round|Lost to Follow-up|0|||
126247032|NCT03114891|454195847|FG001|First Treatment Round|Lost to Follow-up|1|||
126247033|NCT03114891|454195848|FG002|First Treatment Round|Lost to Follow-up|1|||
126247034|NCT03114891|454195849|FG003|First Treatment Round|Lost to Follow-up|0|||
126247035|NCT03114891|454195846|FG000|First Treatment Round|Withdrawal by Subject|0|||
126247036|NCT03114891|454195847|FG001|First Treatment Round|Withdrawal by Subject|2|||
126247037|NCT03114891|454195848|FG002|First Treatment Round|Withdrawal by Subject|0|||
126247038|NCT03114891|454195849|FG003|First Treatment Round|Withdrawal by Subject|1|||
126247039|NCT03114891|454195846|FG000|3 Week Break|Lost to Follow-up|1|||
126247040|NCT03114891|454195847|FG001|3 Week Break|Lost to Follow-up|0|||
126247041|NCT03114891|454195848|FG002|3 Week Break|Lost to Follow-up|0|||
126247042|NCT03114891|454195849|FG003|3 Week Break|Lost to Follow-up|1|||
126247043|NCT03114891|454195846|FG000|3 Week Break|Withdrawal by Subject|0|||
126247044|NCT03114891|454195847|FG001|3 Week Break|Withdrawal by Subject|1|||
126247045|NCT03114891|454195848|FG002|3 Week Break|Withdrawal by Subject|0|||
126247046|NCT03114891|454195849|FG003|3 Week Break|Withdrawal by Subject|0|||
126247047|NCT03114891|454195846|FG000|Second Treatment Round|Lost to Follow-up|1|||
126247048|NCT03114891|454195847|FG001|Second Treatment Round|Lost to Follow-up|0|||
126247049|NCT03114891|454195848|FG002|Second Treatment Round|Lost to Follow-up|0|||
126247050|NCT03114891|454195849|FG003|Second Treatment Round|Lost to Follow-up|0|||
126247051|NCT03114891|454195846|FG000|Second Treatment Round|Physician Decision|1|||
126247052|NCT03114891|454195847|FG001|Second Treatment Round|Physician Decision|0|||
126247053|NCT03114891|454195848|FG002|Second Treatment Round|Physician Decision|0|||
126247054|NCT03114891|454195849|FG003|Second Treatment Round|Physician Decision|0|||
126247055|NCT02875392|454198003|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
126247056|NCT02875392|454198004|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
126247057|NCT03599193|454198005|FG000|Overall Study|Adverse Event|0|||
126247058|NCT03599193|454198006|FG001|Overall Study|Adverse Event|2|||
126247059|NCT03599193|454198005|FG000|Overall Study|Withdrawal by Subject|1|||
126247060|NCT03599193|454198006|FG001|Overall Study|Withdrawal by Subject|0|||
126247061|NCT03599193|454198005|FG000|Overall Study|Protocol Violation|1|||
126247062|NCT03599193|454198006|FG001|Overall Study|Protocol Violation|0|||
126247063|NCT03599193|454198005|FG000|Overall Study|Lost to Follow-up|0|||
126247064|NCT03599193|454198006|FG001|Overall Study|Lost to Follow-up|1|||
126247065|NCT00835705|454198007|FG000|First Intervention|Difficulty with vein|1|||
126247066|NCT00835705|454198008|FG001|First Intervention|Difficulty with vein|0|||
126247067|NCT00835705|454198007|FG000|Second Intervention|Difficulty with vein|1|||
126247068|NCT00835705|454198008|FG001|Second Intervention|Difficulty with vein|0|||
126247069|NCT01750294|454198009|FG000|Overall Study|Withdrawal by Subject|1|||
126247070|NCT01750294|454198009|FG000|Overall Study|Safety Endpoint|1|||
126247071|NCT00665925|454198010|FG000|Overall Study|Lack of Efficacy|10|||
126247072|NCT00665925|454198011|FG001|Overall Study|Lack of Efficacy|8|||
126247073|NCT00665925|454198012|FG002|Overall Study|Lack of Efficacy|9|||
126247074|NCT00665925|454198013|FG003|Overall Study|Lack of Efficacy|8|||
126247075|NCT00665925|454198010|FG000|Overall Study|Lost to Follow-up|1|||
126247076|NCT00665925|454198011|FG001|Overall Study|Lost to Follow-up|2|||
126247077|NCT00665925|454198012|FG002|Overall Study|Lost to Follow-up|2|||
126247078|NCT00665925|454198013|FG003|Overall Study|Lost to Follow-up|2|||
126247079|NCT00665925|454198010|FG000|Overall Study|Withdrawal by Subject|2|||
126247080|NCT00665925|454198011|FG001|Overall Study|Withdrawal by Subject|2|||
126247081|NCT00665925|454198012|FG002|Overall Study|Withdrawal by Subject|3|||
126247082|NCT00665925|454198013|FG003|Overall Study|Withdrawal by Subject|2|||
126247083|NCT00665925|454198010|FG000|Overall Study|Physician Decision|0|||
126247084|NCT00665925|454198011|FG001|Overall Study|Physician Decision|0|||
126247085|NCT00665925|454198012|FG002|Overall Study|Physician Decision|1|||
126247086|NCT00665925|454198013|FG003|Overall Study|Physician Decision|2|||
126247087|NCT00665925|454198010|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
126247088|NCT00665925|454198011|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
126247089|NCT00665925|454198012|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
126247090|NCT00665925|454198013|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
126247091|NCT00665925|454198010|FG000|Overall Study|Adverse Event|1|||
126247092|NCT00665925|454198011|FG001|Overall Study|Adverse Event|5|||
126247093|NCT00665925|454198012|FG002|Overall Study|Adverse Event|10|||
126247094|NCT00665925|454198013|FG003|Overall Study|Adverse Event|5|||
126247095|NCT00665925|454198010|FG000|Overall Study|Enrolled by mistake|0|||
126247096|NCT00665925|454198011|FG001|Overall Study|Enrolled by mistake|0|||
126247097|NCT00665925|454198012|FG002|Overall Study|Enrolled by mistake|0|||
126247098|NCT00665925|454198013|FG003|Overall Study|Enrolled by mistake|1|||
126247099|NCT00665925|454198010|FG000|Overall Study|Due to exclusion criteria|1|||
126046479|NCT02467270|453468226|FG000|Overall Study|Reason not Specified|1|||
126247100|NCT00665925|454198011|FG001|Overall Study|Due to exclusion criteria|0|||
126247101|NCT00665925|454198012|FG002|Overall Study|Due to exclusion criteria|0|||
126247102|NCT00665925|454198013|FG003|Overall Study|Due to exclusion criteria|0|||
126247103|NCT01592240|454198014|FG000|Overall Study|Adverse Event|1|||
126247104|NCT01592240|454198015|FG001|Overall Study|Adverse Event|0|||
126247105|NCT01592240|454198016|FG002|Overall Study|Adverse Event|0|||
126247106|NCT01592240|454198017|FG003|Overall Study|Adverse Event|1|||
126247107|NCT01592240|454198018|FG004|Overall Study|Adverse Event|1|||
126247108|NCT01592240|454198019|FG005|Overall Study|Adverse Event|0|||
126247109|NCT01592240|454198020|FG006|Overall Study|Adverse Event|0|||
126247110|NCT01592240|454198014|FG000|Overall Study|Death|0|||
126247111|NCT01592240|454198015|FG001|Overall Study|Death|1|||
126247112|NCT01592240|454198016|FG002|Overall Study|Death|0|||
126247113|NCT01592240|454198017|FG003|Overall Study|Death|0|||
126247114|NCT01592240|454198018|FG004|Overall Study|Death|0|||
126247115|NCT01592240|454198019|FG005|Overall Study|Death|0|||
126247116|NCT01592240|454198020|FG006|Overall Study|Death|0|||
126247117|NCT01592240|454198014|FG000|Overall Study|Lost to Follow-up|1|||
126247118|NCT01592240|454198015|FG001|Overall Study|Lost to Follow-up|3|||
126247119|NCT01592240|454198016|FG002|Overall Study|Lost to Follow-up|1|||
126247120|NCT01592240|454198017|FG003|Overall Study|Lost to Follow-up|0|||
126247121|NCT01592240|454198018|FG004|Overall Study|Lost to Follow-up|3|||
126247122|NCT01592240|454198019|FG005|Overall Study|Lost to Follow-up|2|||
126247123|NCT01592240|454198020|FG006|Overall Study|Lost to Follow-up|0|||
126247124|NCT01592240|454198014|FG000|Overall Study|Protocol Violation|0|||
126247125|NCT01592240|454198015|FG001|Overall Study|Protocol Violation|0|||
126247126|NCT01592240|454198016|FG002|Overall Study|Protocol Violation|0|||
126247127|NCT01592240|454198017|FG003|Overall Study|Protocol Violation|0|||
126247128|NCT01592240|454198018|FG004|Overall Study|Protocol Violation|0|||
126247129|NCT01592240|454198019|FG005|Overall Study|Protocol Violation|1|||
126247130|NCT01592240|454198020|FG006|Overall Study|Protocol Violation|0|||
126247131|NCT01592240|454198014|FG000|Overall Study|Withdrawal by Subject|0|||
126247132|NCT01592240|454198015|FG001|Overall Study|Withdrawal by Subject|4|||
126247133|NCT01592240|454198016|FG002|Overall Study|Withdrawal by Subject|4|||
126247134|NCT01592240|454198017|FG003|Overall Study|Withdrawal by Subject|1|||
126247135|NCT01592240|454198018|FG004|Overall Study|Withdrawal by Subject|3|||
126247136|NCT01592240|454198019|FG005|Overall Study|Withdrawal by Subject|0|||
126247137|NCT01592240|454198020|FG006|Overall Study|Withdrawal by Subject|2|||
126247138|NCT01592240|454198014|FG000|Overall Study|Other|0|||
126247139|NCT01592240|454198015|FG001|Overall Study|Other|3|||
126247140|NCT01592240|454198016|FG002|Overall Study|Other|1|||
126247141|NCT01592240|454198017|FG003|Overall Study|Other|1|||
126247142|NCT01592240|454198018|FG004|Overall Study|Other|0|||
126247143|NCT01592240|454198019|FG005|Overall Study|Other|0|||
126247144|NCT01592240|454198020|FG006|Overall Study|Other|1|||
126247145|NCT01592240|454198014|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126247146|NCT01592240|454198015|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
126247147|NCT01592240|454198016|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
126247148|NCT01592240|454198017|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
126247149|NCT01592240|454198018|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
126247150|NCT01592240|454198019|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
126247151|NCT01592240|454198020|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
126247152|NCT03246503|454198024|FG000|Overall Study|Lost to Follow-up|23|||
126247153|NCT03246503|454198024|FG000|Overall Study|Withdrawal by Subject|20|||
126247154|NCT03246503|454198024|FG000|Overall Study|Physician Decision|5|||
126247155|NCT03246503|454198024|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
126094457|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
126094458|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
126094459|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
126094460|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126094461|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126094462|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126094463|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126094464|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126094465|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Death|1|||
126094466|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Death|2|||
126094467|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Death|2|||
126094468|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Death|0|||
126094469|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Death|0|||
126094470|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Death|0|||
126094471|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
126094472|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
126094473|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
126247156|NCT02751424|454198025|FG000|Part 2|Adverse Event|0|||
126247157|NCT02751424|454198026|FG001|Part 2|Adverse Event|0|||
126247158|NCT02751424|454198027|FG002|Part 2|Adverse Event|0|||
126247159|NCT02751424|454198028|FG003|Part 2|Adverse Event|0|||
126247160|NCT02751424|454198029|FG004|Part 2|Adverse Event|0|||
126247161|NCT02751424|454198030|FG005|Part 2|Adverse Event|0|||
126247162|NCT02751424|454198031|FG006|Part 2|Adverse Event|0|||
126247163|NCT02751424|454198032|FG007|Part 2|Adverse Event|5|||
126247164|NCT02751424|454198033|FG008|Part 2|Adverse Event|0|||
126247165|NCT03206749|454198034|FG000|Overall Study|Withdrawal of consent|5|||
126247166|NCT03206749|454198035|FG001|Overall Study|Withdrawal of consent|3|||
126247167|NCT03206749|454198036|FG002|Overall Study|Withdrawal of consent|6|||
126247168|NCT03206749|454198034|FG000|Overall Study|Lost to Follow-up|0|||
126247169|NCT03206749|454198035|FG001|Overall Study|Lost to Follow-up|0|||
126247170|NCT03206749|454198036|FG002|Overall Study|Lost to Follow-up|1|||
126247171|NCT01492439|454198037|FG000|Overall Study|Withdrew from RTE|4|||
126247172|NCT01492439|454198038|FG001|Overall Study|Withdrew from RTE|9|||
126247173|NCT00716625|454198039|FG000|Overall Study|Safety was not Assessable|1|||
126247174|NCT00395694|454198041|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
126247175|NCT00395694|454198042|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
126247176|NCT00395694|454198041|FG000|Continuation Phase|Adverse Event|1|||
126247177|NCT00395694|454198042|FG001|Continuation Phase|Adverse Event|0|||
126247178|NCT00395694|454198041|FG000|Continuation Phase|Lack of Efficacy|12|||
126247179|NCT00395694|454198042|FG001|Continuation Phase|Lack of Efficacy|11|||
126247180|NCT00395694|454198041|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
126247181|NCT00395694|454198042|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
126247182|NCT00395694|454198041|FG000|Continuation Phase|Poor Compliance|1|||
126247183|NCT00395694|454198042|FG001|Continuation Phase|Poor Compliance|0|||
126247184|NCT00395694|454198041|FG000|Continuation Phase|Withdrawal by Subject|0|||
126247185|NCT00395694|454198042|FG001|Continuation Phase|Withdrawal by Subject|2|||
126247186|NCT01648582|454198043|FG000|Overall Study|Adverse Event|6|||
126247187|NCT01648582|454198044|FG001|Overall Study|Adverse Event|11|||
126247188|NCT01648582|454198045|FG002|Overall Study|Adverse Event|2|||
126247189|NCT01648582|454198043|FG000|Overall Study|Lost to Follow-up|9|||
126247190|NCT01648582|454198044|FG001|Overall Study|Lost to Follow-up|6|||
126247191|NCT01648582|454198045|FG002|Overall Study|Lost to Follow-up|8|||
126247192|NCT01648582|454198043|FG000|Overall Study|Protocol Violation|1|||
126247193|NCT01648582|454198044|FG001|Overall Study|Protocol Violation|2|||
126247194|NCT01648582|454198045|FG002|Overall Study|Protocol Violation|1|||
126247195|NCT01648582|454198043|FG000|Overall Study|Withdrawal by Subject|15|||
126094474|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
126094475|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
126094476|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
126094477|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
126094478|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126094479|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126094480|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126094481|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126094482|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126094483|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
126094484|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126094485|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126094486|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126094487|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126094488|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126094489|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
126094490|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126094491|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126094492|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126094493|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126094494|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126094495|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126094496|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
126094497|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126247196|NCT01648582|454198044|FG001|Overall Study|Withdrawal by Subject|17|||
126247197|NCT01648582|454198045|FG002|Overall Study|Withdrawal by Subject|17|||
126247198|NCT01648582|454198043|FG000|Overall Study|Physician Decision|0|||
126247199|NCT01648582|454198044|FG001|Overall Study|Physician Decision|1|||
126247200|NCT01648582|454198045|FG002|Overall Study|Physician Decision|3|||
126247201|NCT01648582|454198043|FG000|Overall Study|Death|1|||
126247202|NCT01648582|454198044|FG001|Overall Study|Death|0|||
126247203|NCT01648582|454198045|FG002|Overall Study|Death|0|||
126247204|NCT01648582|454198043|FG000|Overall Study|Sponsor Decision|0|||
126247205|NCT01648582|454198044|FG001|Overall Study|Sponsor Decision|1|||
126247206|NCT01648582|454198045|FG002|Overall Study|Sponsor Decision|1|||
126357634|NCT02187055|454602192|FG002|Overall Study|No longer meets eligibility criteria|0|||
126357635|NCT02187055|454602190|FG000|Overall Study|No longer willing to participate|6|||
126247207|NCT02699866|454198046|FG000|Overall Study|Withdrawal by Subject|3|||
126247208|NCT02699866|454198046|FG000|Overall Study|Physician Decision|2|||
126247209|NCT02699866|454198046|FG000|Overall Study|Adverse Event|3|||
126247210|NCT01959672|454198047|FG000|Overall Study|Death|1|||
126247211|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Adverse Event|8|||
126247212|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Adverse Event|15|||
126247213|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Adverse Event|25|||
126247214|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
126247215|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
126247216|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
126247217|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
126247218|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
126247219|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
126247220|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
126247221|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
126247222|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
126247223|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126247224|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
126247225|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
126247226|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
126247227|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
126247228|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
126247229|NCT02842853|454198059|FG000|Overall Study|Non-compliance with the protocol|3|||
126247230|NCT02842853|454198060|FG001|Overall Study|Non-compliance with the protocol|7|||
126247231|NCT02842853|454198061|FG002|Overall Study|Non-compliance with the protocol|2|||
126247232|NCT02842853|454198062|FG003|Overall Study|Non-compliance with the protocol|5|||
126247233|NCT02842853|454198059|FG000|Overall Study|Subject met exclusion criteria|0|||
126247234|NCT02842853|454198060|FG001|Overall Study|Subject met exclusion criteria|1|||
126247235|NCT02842853|454198061|FG002|Overall Study|Subject met exclusion criteria|0|||
126247236|NCT02842853|454198062|FG003|Overall Study|Subject met exclusion criteria|0|||
126247237|NCT02842853|454198059|FG000|Overall Study|Withdrawal by Subject|11|||
126247238|NCT02842853|454198060|FG001|Overall Study|Withdrawal by Subject|13|||
126247239|NCT02842853|454198061|FG002|Overall Study|Withdrawal by Subject|9|||
126247240|NCT02842853|454198062|FG003|Overall Study|Withdrawal by Subject|8|||
126247241|NCT02842853|454198059|FG000|Overall Study|Lost to Follow-up|9|||
126247242|NCT02842853|454198060|FG001|Overall Study|Lost to Follow-up|13|||
126247243|NCT02842853|454198061|FG002|Overall Study|Lost to Follow-up|10|||
126247244|NCT02842853|454198062|FG003|Overall Study|Lost to Follow-up|11|||
126247245|NCT04089553|454198063|FG000|Overall Study|Death|1|||
126247246|NCT04089553|454198064|FG001|Overall Study|Death|1|||
126247247|NCT04089553|454198063|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
126247248|NCT04089553|454198064|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
126247249|NCT04089553|454198063|FG000|Overall Study|Withdrawal by Subject|3|||
126247250|NCT04089553|454198064|FG001|Overall Study|Withdrawal by Subject|3|||
126247251|NCT04089553|454198063|FG000|Overall Study|Physician Decision|1|||
126247252|NCT04089553|454198064|FG001|Overall Study|Physician Decision|0|||
126247253|NCT04089553|454198063|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
126247254|NCT04089553|454198064|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
126247255|NCT04089553|454198063|FG000|Overall Study|Other|1|||
126247256|NCT04089553|454198064|FG001|Overall Study|Other|0|||
126247257|NCT04089553|454198063|FG000|Overall Study|Adverse Event|1|||
126247258|NCT04089553|454198064|FG001|Overall Study|Adverse Event|1|||
126247259|NCT01403194|454198065|FG000|Overall Study|Screen Failure|2|||
126247260|NCT01403194|454198065|FG000|Overall Study|Lost to Follow-up|8|||
126247261|NCT00506831|454198072|FG000|Overall Study|Death|1|||
126247262|NCT00506831|454198072|FG000|Overall Study|Withdrawal by Subject|1|||
126247263|NCT01808651|454198076|FG000|Study Period 1|Lost to Follow-up|1|||
126247264|NCT01808651|454198077|FG001|Study Period 1|Lost to Follow-up|3|||
126247265|NCT01808651|454198078|FG002|Study Period 1|Lost to Follow-up|0|||
126247266|NCT01808651|454198076|FG000|Study Period 1|Protocol Violation|1|||
126247267|NCT01808651|454198077|FG001|Study Period 1|Protocol Violation|0|||
126247268|NCT01808651|454198078|FG002|Study Period 1|Protocol Violation|1|||
126357636|NCT02187055|454602191|FG001|Overall Study|No longer willing to participate|8|||
126357637|NCT02187055|454602192|FG002|Overall Study|No longer willing to participate|10|||
126357638|NCT02187055|454602190|FG000|Overall Study|Other|5|||
126357639|NCT02187055|454602191|FG001|Overall Study|Other|6|||
126357640|NCT02187055|454602192|FG002|Overall Study|Other|3|||
126357641|NCT02187055|454602190|FG000|Overall Study|Protocol Violation|9|||
126357642|NCT02187055|454602191|FG001|Overall Study|Protocol Violation|9|||
126357643|NCT02187055|454602192|FG002|Overall Study|Protocol Violation|4|||
126357644|NCT02187055|454602190|FG000|Overall Study|Pregnancy|3|||
126357645|NCT02187055|454602191|FG001|Overall Study|Pregnancy|1|||
126357646|NCT02187055|454602192|FG002|Overall Study|Pregnancy|0|||
126357647|NCT02187055|454602190|FG000|Overall Study|Withdrawal by Subject|11|||
126357648|NCT02187055|454602191|FG001|Overall Study|Withdrawal by Subject|11|||
126247269|NCT01808651|454198076|FG000|Study Period 1|Physician Decision|3|||
126247270|NCT01808651|454198077|FG001|Study Period 1|Physician Decision|2|||
126247271|NCT01808651|454198078|FG002|Study Period 1|Physician Decision|0|||
126247272|NCT01808651|454198076|FG000|Study Period 1|Lack of Efficacy|2|||
126247273|NCT01808651|454198077|FG001|Study Period 1|Lack of Efficacy|1|||
126247274|NCT01808651|454198078|FG002|Study Period 1|Lack of Efficacy|0|||
126247275|NCT01808651|454198076|FG000|Study Period 1|Adverse Event|10|||
126247276|NCT01808651|454198077|FG001|Study Period 1|Adverse Event|4|||
126247277|NCT01808651|454198078|FG002|Study Period 1|Adverse Event|1|||
126247278|NCT01808651|454198076|FG000|Study Period 1|Participant Decision|9|||
126247279|NCT01808651|454198077|FG001|Study Period 1|Participant Decision|7|||
126247280|NCT01808651|454198078|FG002|Study Period 1|Participant Decision|3|||
126247281|NCT02488239|454198080|FG000|Overall Study|Death|3|||
126247282|NCT02488239|454198080|FG000|Overall Study|Withdrawal by Subject|3|||
126247283|NCT02488239|454198080|FG000|Overall Study|Physician Decision|2|||
126247284|NCT02488239|454198080|FG000|Overall Study|Consent ineligible|1|||
126247285|NCT02488239|454198080|FG000|Overall Study|Did not undergo implant procedure|1|||
126247286|NCT00608322|454198084|FG000|Overall Study|Death|2|||
126247287|NCT00608322|454198085|FG001|Overall Study|Death|1|||
126247288|NCT00834444|454198086|FG000|First Intervention|Adverse Event|1|||
126247289|NCT00834444|454198087|FG001|First Intervention|Adverse Event|0|||
126247290|NCT00834444|454198086|FG000|First Intervention|Intolerance to Venopuncture|0|||
126247291|NCT00834444|454198087|FG001|First Intervention|Intolerance to Venopuncture|1|||
126247292|NCT00834444|454198086|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
126247293|NCT00834444|454198087|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126247294|NCT00834444|454198086|FG000|Second Intervention|Adverse Event|1|||
126247295|NCT00834444|454198087|FG001|Second Intervention|Adverse Event|0|||
126247296|NCT00606281|454198090|FG000|Overall Study|Adverse Event|11|||
126247297|NCT00606281|454198091|FG001|Overall Study|Adverse Event|12|||
126247298|NCT00606281|454198090|FG000|Overall Study|Death|1|||
126247299|NCT00606281|454198091|FG001|Overall Study|Death|0|||
126247300|NCT00606281|454198090|FG000|Overall Study|Lack of Efficacy|28|||
126247301|NCT00606281|454198091|FG001|Overall Study|Lack of Efficacy|35|||
126247302|NCT00606281|454198090|FG000|Overall Study|Physician Decision|0|||
126247303|NCT00606281|454198091|FG001|Overall Study|Physician Decision|1|||
126247304|NCT00606281|454198090|FG000|Overall Study|Protocol Violation|3|||
126247305|NCT00606281|454198091|FG001|Overall Study|Protocol Violation|3|||
126247306|NCT00606281|454198090|FG000|Overall Study|Withdrawal by Subject|11|||
126247307|NCT00606281|454198091|FG001|Overall Study|Withdrawal by Subject|13|||
126247308|NCT00606281|454198090|FG000|Overall Study|Progression to depressive phase|1|||
126247309|NCT00606281|454198091|FG001|Overall Study|Progression to depressive phase|1|||
126247310|NCT00606281|454198090|FG000|Overall Study|Change of residence or other commitments|1|||
126247311|NCT00606281|454198091|FG001|Overall Study|Change of residence or other commitments|1|||
126247312|NCT02294981|454198092|FG000|Overall Study|Lost to Follow-up|1|||
126247313|NCT00829712|454198093|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
126247314|NCT00829712|454198094|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126247315|NCT02213263|454198098|FG000|Overall Study|Insufficient clinical response|4|||
126247316|NCT02213263|454198099|FG001|Overall Study|Insufficient clinical response|3|||
126247317|NCT02213263|454198098|FG000|Overall Study|Lost to Follow-up|0|||
126247318|NCT02213263|454198099|FG001|Overall Study|Lost to Follow-up|1|||
126247319|NCT02213263|454198098|FG000|Overall Study|No longer willing to participate|3|||
126247320|NCT02213263|454198099|FG001|Overall Study|No longer willing to participate|4|||
126247321|NCT02213263|454198098|FG000|Overall Study|Progressive disease|20|||
126247322|NCT02213263|454198099|FG001|Overall Study|Progressive disease|14|||
126247323|NCT02213263|454198098|FG000|Overall Study|Protocol Violation|0|||
126247324|NCT02213263|454198099|FG001|Overall Study|Protocol Violation|1|||
126247325|NCT02213263|454198098|FG000|Overall Study|Adverse Event|1|||
126247326|NCT02213263|454198099|FG001|Overall Study|Adverse Event|3|||
126247327|NCT01188681|454198100|FG000|Overall Study|bladder cancer|0|||
126247328|NCT01188681|454198101|FG001|Overall Study|bladder cancer|0|||
126247329|NCT01188681|454198102|FG002|Overall Study|bladder cancer|1|||
126247330|NCT01188681|454198103|FG003|Overall Study|bladder cancer|0|||
126247331|NCT01188681|454198100|FG000|Overall Study|Withdrawal by Subject|0|||
126247332|NCT01188681|454198101|FG001|Overall Study|Withdrawal by Subject|0|||
126247333|NCT01188681|454198102|FG002|Overall Study|Withdrawal by Subject|0|||
126247334|NCT01188681|454198103|FG003|Overall Study|Withdrawal by Subject|1|||
126247335|NCT05752721|454198104|FG000|Overall Study|Lost to Follow-up|22|||
126247336|NCT05752721|454198105|FG001|Overall Study|Lost to Follow-up|20|||
126247337|NCT05752721|454198104|FG000|Overall Study|Withdrawal by Subject|15|||
126247338|NCT05752721|454198105|FG001|Overall Study|Withdrawal by Subject|12|||
126247339|NCT02280863|454198106|FG000|Integrated Platform|Met stopping criteria|0|||
126247340|NCT02280863|454198107|FG001|Integrated Platform|Met stopping criteria|1|||
126247341|NCT00263588|454198108|FG000|Overall Study|Death|54|||
126247342|NCT00263588|454198109|FG001|Overall Study|Death|90|||
126247343|NCT00263588|454198108|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
126247344|NCT00263588|454198109|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
126247345|NCT00263588|454198108|FG000|Overall Study|Lost to Follow-up|7|||
126247346|NCT00263588|454198109|FG001|Overall Study|Lost to Follow-up|10|||
126247347|NCT00263588|454198108|FG000|Overall Study|Withdrawal by Subject|3|||
126247348|NCT00263588|454198109|FG001|Overall Study|Withdrawal by Subject|4|||
126247349|NCT00263588|454198108|FG000|Overall Study|Protocol Violation|0|||
126247350|NCT00263588|454198109|FG001|Overall Study|Protocol Violation|1|||
126247351|NCT00263588|454198108|FG000|Overall Study|Investigator decision|7|||
126247352|NCT00263588|454198109|FG001|Overall Study|Investigator decision|15|||
126247353|NCT00263588|454198108|FG000|Overall Study|Sponsor terminated study|0|||
126247354|NCT00263588|454198109|FG001|Overall Study|Sponsor terminated study|1|||
126247355|NCT03236311|454198110|FG000|Overall Study|Study terminated by sponsor|0|||
126247356|NCT03236311|454198111|FG001|Overall Study|Study terminated by sponsor|2|||
126247357|NCT03236311|454198110|FG000|Overall Study|Adverse Event|0|||
126247358|NCT03236311|454198111|FG001|Overall Study|Adverse Event|1|||
126247359|NCT00700739|454198112|FG000|Overall Study|Lost to Follow-up|4|||
126247360|NCT00700739|454198113|FG001|Overall Study|Lost to Follow-up|4|||
126247361|NCT02336074|454198114|FG000|Overall Study|Adverse Event|0|||
126247362|NCT02336074|454198115|FG001|Overall Study|Adverse Event|2|||
126247363|NCT02679729|454198116|FG000|Overall Study|Lost to Follow-up|0|||
126247364|NCT02679729|454198117|FG001|Overall Study|Lost to Follow-up|1|||
126247365|NCT02679729|454198118|FG002|Overall Study|Lost to Follow-up|0|||
126247366|NCT02679729|454198119|FG003|Overall Study|Lost to Follow-up|0|||
126247367|NCT02679729|454198120|FG004|Overall Study|Lost to Follow-up|1|||
126247368|NCT02679729|454198121|FG005|Overall Study|Lost to Follow-up|0|||
126247369|NCT02679729|454198122|FG006|Overall Study|Lost to Follow-up|0|||
126247370|NCT02679729|454198123|FG007|Overall Study|Lost to Follow-up|0|||
126247371|NCT02679729|454198124|FG008|Overall Study|Lost to Follow-up|0|||
126247372|NCT02679729|454198116|FG000|Overall Study|Participant decision|0|||
126247373|NCT02679729|454198117|FG001|Overall Study|Participant decision|1|||
126247374|NCT02679729|454198118|FG002|Overall Study|Participant decision|0|||
126247375|NCT02679729|454198119|FG003|Overall Study|Participant decision|0|||
126247376|NCT02679729|454198120|FG004|Overall Study|Participant decision|0|||
126247377|NCT02679729|454198121|FG005|Overall Study|Participant decision|0|||
126247378|NCT02679729|454198122|FG006|Overall Study|Participant decision|1|||
126247379|NCT02679729|454198123|FG007|Overall Study|Participant decision|0|||
126247380|NCT02679729|454198124|FG008|Overall Study|Participant decision|0|||
126247381|NCT03488108|454198131|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
126247382|NCT03488108|454198132|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126247383|NCT03488108|454198131|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
126247384|NCT03488108|454198132|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
126247385|NCT03602339|454198137|FG000|Overall Study|Withdrawal by Subject|9|||
126247386|NCT03602339|454198137|FG000|Overall Study|Physician Decision|2|||
126247387|NCT03602339|454198137|FG000|Overall Study|Other reason|4|||
126247388|NCT01297504|454198138|FG000|Overall Study|Invalid Consent|1|||
126247389|NCT01297504|454198138|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
126247390|NCT01297504|454198138|FG000|Overall Study|No Study Visits|4|||
126247391|NCT01297504|454198138|FG000|Overall Study|Death|3|||
126247392|NCT01297504|454198138|FG000|Overall Study|Lost to Follow-up|43|||
126247393|NCT01297504|454198138|FG000|Overall Study|Withdrawal by Subject|9|||
126247394|NCT01297504|454198138|FG000|Overall Study|Site Closure|3|||
126247395|NCT01297504|454198138|FG000|Overall Study|Protocol Violation|3|||
126247396|NCT04827394|454198140|FG000|Overall Study|Physician Decision|0|||
126247397|NCT04827394|454198141|FG001|Overall Study|Physician Decision|2|||
126247398|NCT00829764|454198144|FG000|First Intervention|Adverse Event|1|||
126247399|NCT00829764|454198145|FG001|First Intervention|Adverse Event|0|||
126247400|NCT00829764|454198144|FG000|First Intervention|Withdrawal by Subject|1|||
126247401|NCT00829764|454198145|FG001|First Intervention|Withdrawal by Subject|1|||
126247402|NCT04594252|454198146|FG000|Overall Study|Adverse Event|0|||
126046480|NCT02467270|453468227|FG001|Overall Study|Reason not Specified|2|||
126247403|NCT04594252|454198147|FG001|Overall Study|Adverse Event|2|||
126247404|NCT01624233|454200254|FG000|Period 2 - Induction|Adverse Event|1|||
126247405|NCT01624233|454200254|FG000|Period 3 - Maintenance|Adverse Event|2|||
126247406|NCT01624233|454200254|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
126247407|NCT01624233|454200254|FG000|Period 3 - Maintenance|Physician Decision|2|||
126247408|NCT01624233|454200254|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
126247409|NCT01624233|454200254|FG000|Period 4 - Drug Free Period|Relapsed|61|||
126247410|NCT01624233|454200254|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
126247411|NCT01624233|454200254|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
126247412|NCT01624233|454200254|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
126247413|NCT01624233|454200254|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
126247414|NCT01624233|454200254|FG000|Period 6: Follow-up|Adverse Event|3|||
126247415|NCT01624233|454200254|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
126247416|NCT01624233|454200254|FG000|Period 6: Follow-up|Physician Decision|1|||
126247417|NCT01624233|454200254|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
126247418|NCT00334815|454200255|FG000|Overall Study|Adverse Event|3|||
126247419|NCT00334815|454200256|FG001|Overall Study|Adverse Event|2|||
126247420|NCT00334815|454200255|FG000|Overall Study|Death|0|||
126247421|NCT00334815|454200256|FG001|Overall Study|Death|2|||
126247422|NCT00334815|454200255|FG000|Overall Study|Progression|1|||
126247423|NCT00334815|454200256|FG001|Overall Study|Progression|0|||
126247424|NCT00334815|454200255|FG000|Overall Study|ineligible|1|||
126247425|NCT00334815|454200256|FG001|Overall Study|ineligible|1|||
126247426|NCT00334815|454200255|FG000|Overall Study|patient refused treatment|0|||
126247427|NCT00334815|454200256|FG001|Overall Study|patient refused treatment|1|||
126247428|NCT00334815|454200255|FG000|Overall Study|Physician Decision|2|||
126247429|NCT00334815|454200256|FG001|Overall Study|Physician Decision|4|||
126247430|NCT02197416|454200257|FG000|Overall Study|Other reasons|0|||
126247431|NCT02197416|454200258|FG001|Overall Study|Other reasons|2|||
126247432|NCT02197416|454200259|FG002|Overall Study|Other reasons|5|||
126247433|NCT02197416|454200257|FG000|Overall Study|Withdrawal by Subject|0|||
126247434|NCT02197416|454200258|FG001|Overall Study|Withdrawal by Subject|2|||
126247435|NCT02197416|454200259|FG002|Overall Study|Withdrawal by Subject|1|||
126247436|NCT02197416|454200257|FG000|Overall Study|Protocol Violation|1|||
126247437|NCT02197416|454200258|FG001|Overall Study|Protocol Violation|0|||
126247438|NCT02197416|454200259|FG002|Overall Study|Protocol Violation|1|||
126247439|NCT02197416|454200257|FG000|Overall Study|Adverse Event|0|||
126247440|NCT02197416|454200258|FG001|Overall Study|Adverse Event|0|||
126247441|NCT02197416|454200259|FG002|Overall Study|Adverse Event|1|||
126247442|NCT02451696|454200260|FG000|Overall Study|Surgery postponed|1|||
126247443|NCT02451696|454200261|FG001|Overall Study|Surgery postponed|0|||
126247444|NCT05014828|454200262|FG000|Overall Study|Study Completed by Sponsor|16|||
126247445|NCT05014828|454200263|FG001|Overall Study|Study Completed by Sponsor|16|||
126247446|NCT05014828|454200264|FG002|Overall Study|Study Completed by Sponsor|3|||
126247447|NCT05014828|454200265|FG003|Overall Study|Study Completed by Sponsor|3|||
126247448|NCT05014828|454200262|FG000|Overall Study|Death|11|||
126247449|NCT05014828|454200263|FG001|Overall Study|Death|6|||
126247450|NCT05014828|454200264|FG002|Overall Study|Death|0|||
126247451|NCT05014828|454200265|FG003|Overall Study|Death|0|||
126247452|NCT05014828|454200262|FG000|Overall Study|Lost to Follow-up|0|||
126247453|NCT05014828|454200263|FG001|Overall Study|Lost to Follow-up|0|||
126247454|NCT05014828|454200264|FG002|Overall Study|Lost to Follow-up|2|||
126247455|NCT05014828|454200265|FG003|Overall Study|Lost to Follow-up|0|||
126247456|NCT05014828|454200262|FG000|Overall Study|Miscellaneous.|0|||
126247457|NCT05014828|454200263|FG001|Overall Study|Miscellaneous.|1|||
126247458|NCT05014828|454200264|FG002|Overall Study|Miscellaneous.|0|||
126247459|NCT05014828|454200265|FG003|Overall Study|Miscellaneous.|0|||
126247460|NCT05523895|454200266|FG000|Overall Study|Adverse Event|2|||
126247461|NCT05523895|454200267|FG001|Overall Study|Adverse Event|1|||
126247462|NCT05523895|454200268|FG002|Overall Study|Adverse Event|1|||
126247463|NCT05523895|454200266|FG000|Overall Study|Lost to Follow-up|0|||
126247464|NCT05523895|454200267|FG001|Overall Study|Lost to Follow-up|1|||
126247465|NCT05523895|454200268|FG002|Overall Study|Lost to Follow-up|2|||
126247466|NCT05523895|454200266|FG000|Overall Study|Noncompliance with study drug|1|||
126247467|NCT05523895|454200267|FG001|Overall Study|Noncompliance with study drug|1|||
126247468|NCT05523895|454200268|FG002|Overall Study|Noncompliance with study drug|1|||
126247469|NCT05523895|454200266|FG000|Overall Study|Protocol Violation|0|||
126247470|NCT05523895|454200267|FG001|Overall Study|Protocol Violation|2|||
126247471|NCT05523895|454200268|FG002|Overall Study|Protocol Violation|0|||
126247472|NCT05523895|454200266|FG000|Overall Study|Withdrawal by Subject|1|||
126247473|NCT05523895|454200267|FG001|Overall Study|Withdrawal by Subject|3|||
126247474|NCT05523895|454200268|FG002|Overall Study|Withdrawal by Subject|1|||
126247475|NCT05523895|454200266|FG000|Overall Study|Not further specified|0|||
126247476|NCT05523895|454200267|FG001|Overall Study|Not further specified|3|||
126247477|NCT05523895|454200268|FG002|Overall Study|Not further specified|1|||
126247478|NCT03674892|454200269|FG000|Overall Study|Lack of Efficacy|5|||
126247479|NCT03674892|454200269|FG000|Overall Study|Lost to Follow-up|3|||
126247480|NCT03674892|454200269|FG000|Overall Study|Migraine|2|||
126247481|NCT03674892|454200269|FG000|Overall Study|Excessive Tearing|1|||
126247482|NCT03674892|454200269|FG000|Overall Study|Increased Eye Pain|1|||
126247483|NCT03674892|454200269|FG000|Overall Study|Increased Facial Pain|1|||
126247484|NCT03674892|454200269|FG000|Overall Study|Sinus Irritation|1|||
126247485|NCT03674892|454200269|FG000|Overall Study|Sinus Infection|1|||
126247486|NCT03779334|454200273|FG000|Overall Study|Withdrawal by Subject|3|||
126247487|NCT03779334|454200274|FG001|Overall Study|Withdrawal by Subject|0|||
126247488|NCT03779334|454200275|FG002|Overall Study|Withdrawal by Subject|0|||
126247489|NCT03779334|454200273|FG000|Overall Study|Ongoing in Study|5|||
126247490|NCT03779334|454200274|FG001|Overall Study|Ongoing in Study|13|||
126247491|NCT03779334|454200275|FG002|Overall Study|Ongoing in Study|5|||
126247492|NCT01175135|454200276|FG000|Overall Study|Adverse Event|2|||
126247493|NCT01175135|454200277|FG001|Overall Study|Adverse Event|5|||
126247494|NCT01175135|454200278|FG002|Overall Study|Adverse Event|3|||
126247495|NCT01175135|454200279|FG003|Overall Study|Adverse Event|4|||
126247496|NCT01175135|454200276|FG000|Overall Study|Death|1|||
126247497|NCT01175135|454200277|FG001|Overall Study|Death|0|||
126247498|NCT01175135|454200278|FG002|Overall Study|Death|0|||
126247499|NCT01175135|454200279|FG003|Overall Study|Death|0|||
126247500|NCT01175135|454200276|FG000|Overall Study|Lack of Efficacy|4|||
126247501|NCT01175135|454200277|FG001|Overall Study|Lack of Efficacy|5|||
126247502|NCT01175135|454200278|FG002|Overall Study|Lack of Efficacy|0|||
126247503|NCT01175135|454200279|FG003|Overall Study|Lack of Efficacy|5|||
126247504|NCT01175135|454200276|FG000|Overall Study|Lost to Follow-up|1|||
126247505|NCT01175135|454200277|FG001|Overall Study|Lost to Follow-up|2|||
126247506|NCT01175135|454200278|FG002|Overall Study|Lost to Follow-up|0|||
126247507|NCT01175135|454200279|FG003|Overall Study|Lost to Follow-up|0|||
126247508|NCT01175135|454200276|FG000|Overall Study|Protocol Violation|1|||
126247509|NCT01175135|454200277|FG001|Overall Study|Protocol Violation|1|||
126247510|NCT01175135|454200278|FG002|Overall Study|Protocol Violation|0|||
126247511|NCT01175135|454200279|FG003|Overall Study|Protocol Violation|0|||
126247512|NCT01175135|454200276|FG000|Overall Study|Withdrawal by Subject|4|||
126247513|NCT01175135|454200277|FG001|Overall Study|Withdrawal by Subject|8|||
126247514|NCT01175135|454200278|FG002|Overall Study|Withdrawal by Subject|5|||
126247515|NCT01175135|454200279|FG003|Overall Study|Withdrawal by Subject|5|||
126247516|NCT01175135|454200276|FG000|Overall Study|Other|3|||
126247517|NCT01175135|454200277|FG001|Overall Study|Other|1|||
126247518|NCT01175135|454200278|FG002|Overall Study|Other|3|||
126247519|NCT01175135|454200279|FG003|Overall Study|Other|0|||
126247520|NCT01175135|454200276|FG000|Overall Study|Randomized But Not Treated|0|||
126247521|NCT01175135|454200277|FG001|Overall Study|Randomized But Not Treated|0|||
126247522|NCT01175135|454200278|FG002|Overall Study|Randomized But Not Treated|1|||
126247523|NCT01175135|454200279|FG003|Overall Study|Randomized But Not Treated|0|||
126247524|NCT04692155|454200283|FG000|Overall Study|Death|1|||
126247525|NCT03957551|454200284|FG000|Overall Study|Adverse Event|2|||
126247526|NCT03957551|454200285|FG001|Overall Study|Adverse Event|2|||
126247527|NCT03957551|454200286|FG002|Overall Study|Adverse Event|6|||
126247528|NCT03957551|454200284|FG000|Overall Study|Physician Decision|1|||
126247529|NCT03957551|454200285|FG001|Overall Study|Physician Decision|0|||
126247530|NCT03957551|454200286|FG002|Overall Study|Physician Decision|2|||
126247531|NCT03957551|454200284|FG000|Overall Study|Withdrawal by Subject|1|||
126247532|NCT03957551|454200285|FG001|Overall Study|Withdrawal by Subject|0|||
126247533|NCT03957551|454200286|FG002|Overall Study|Withdrawal by Subject|2|||
126247534|NCT03957551|454200284|FG000|Overall Study|Disease progression|1|||
126247535|NCT03957551|454200285|FG001|Overall Study|Disease progression|0|||
126247536|NCT03957551|454200286|FG002|Overall Study|Disease progression|8|||
126247537|NCT03325881|454200291|FG000|Overall Study|Protocol Violation|0|||
126247538|NCT03325881|454200292|FG001|Overall Study|Protocol Violation|1|||
126247539|NCT03325881|454200291|FG000|Overall Study|Withdrawal by Subject|0|||
126247540|NCT03325881|454200292|FG001|Overall Study|Withdrawal by Subject|2|||
126247541|NCT03325881|454200291|FG000|Overall Study|Lack of Efficacy|2|||
126247542|NCT03325881|454200292|FG001|Overall Study|Lack of Efficacy|0|||
126247543|NCT03325881|454200291|FG000|Overall Study|Not treated|1|||
126247544|NCT03325881|454200292|FG001|Overall Study|Not treated|0|||
126247545|NCT03676634|454200293|FG000|Overall Study|Red blood cell loss|1|||
126247546|NCT03676634|454200293|FG000|Overall Study|Out-of-limit pulse|2|||
126247547|NCT00540423|454200301|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126247548|NCT00540423|454200302|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126247549|NCT00540423|454200303|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126247550|NCT00540423|454200301|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
126247551|NCT00540423|454200302|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
126247552|NCT00540423|454200303|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
126026973|NCT05338086|453396071|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
126026974|NCT05338086|453396072|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
126026975|NCT05338086|453396073|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
126026976|NCT05338086|453396069|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
126247553|NCT03131895|454200304|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
126247554|NCT03131895|454200305|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
126247555|NCT03131895|454200306|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
126247556|NCT03131895|454200307|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
126247557|NCT03131895|454200304|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
126247558|NCT03131895|454200305|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
126247559|NCT03131895|454200306|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
126247560|NCT03131895|454200307|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
126247561|NCT03131895|454200304|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126247562|NCT03131895|454200305|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
126247563|NCT03131895|454200306|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126247564|NCT03131895|454200307|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
126247565|NCT03131895|454200304|FG000|Washout Period (at Least 5 Days)|Other|0|||
126247566|NCT03131895|454200305|FG001|Washout Period (at Least 5 Days)|Other|0|||
126247567|NCT03131895|454200306|FG002|Washout Period (at Least 5 Days)|Other|2|||
126247568|NCT03131895|454200307|FG003|Washout Period (at Least 5 Days)|Other|0|||
126247569|NCT03131895|454200304|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
126247570|NCT03131895|454200305|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
126247571|NCT03131895|454200306|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
126247572|NCT03131895|454200307|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
126247573|NCT03131895|454200304|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
126247574|NCT03131895|454200305|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
126247575|NCT03131895|454200306|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
126247576|NCT03131895|454200307|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
126247577|NCT00216736|454200316|FG000|Overall Study|Lost to Follow-up|1|||
126247578|NCT00216736|454200317|FG001|Overall Study|Lost to Follow-up|1|||
126247579|NCT02622386|454200318|FG000|First Assignment|Withdrawal by Subject|3|||
126247580|NCT02622386|454200319|FG001|First Assignment|Withdrawal by Subject|2|||
126247581|NCT02622386|454200318|FG000|Washout|Withdrawal by Subject|4|||
126247582|NCT02622386|454200319|FG001|Washout|Withdrawal by Subject|4|||
126247583|NCT02622386|454200318|FG000|Second Assignment|Withdrawal by Subject|0|||
126247584|NCT02622386|454200319|FG001|Second Assignment|Withdrawal by Subject|2|||
126247585|NCT00909753|454200320|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
126247586|NCT00909753|454200321|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
126247587|NCT00909753|454200320|FG000|Period: Second Intervention|Protocol Violation|1|||
126247588|NCT00909753|454200321|FG001|Period: Second Intervention|Protocol Violation|0|||
126247589|NCT00418145|454200324|FG000|Overall Study|study terminated|6|||
126247590|NCT03214588|454200325|FG000|Overall Study|Adverse Event|1|||
126247591|NCT03214588|454200326|FG001|Overall Study|Adverse Event|0|||
126247592|NCT03214588|454200327|FG002|Overall Study|Adverse Event|2|||
126247593|NCT03214588|454200325|FG000|Overall Study|Reason Not Specified|0|||
126247594|NCT03214588|454200326|FG001|Overall Study|Reason Not Specified|1|||
126247595|NCT03214588|454200327|FG002|Overall Study|Reason Not Specified|0|||
126247596|NCT03480763|454200328|FG000|Overall Study|Withdrawal by Subject|18|||
126247597|NCT03480763|454200329|FG001|Overall Study|Withdrawal by Subject|10|||
126247598|NCT03480763|454200328|FG000|Overall Study|Lost to Follow-up|4|||
126247599|NCT03480763|454200329|FG001|Overall Study|Lost to Follow-up|7|||
126247600|NCT03480763|454200328|FG000|Overall Study|non-study pneumococcal vaccine|1|||
126247601|NCT03480763|454200329|FG001|Overall Study|non-study pneumococcal vaccine|0|||
126247602|NCT03480763|454200328|FG000|Overall Study|oncological treatment|0|||
126247603|NCT03480763|454200329|FG001|Overall Study|oncological treatment|2|||
126247604|NCT03480763|454200328|FG000|Overall Study|pain with vaccination|1|||
126247605|NCT03480763|454200329|FG001|Overall Study|pain with vaccination|0|||
126247606|NCT03629054|454200337|FG000|Period 2 (4 Days)|Not treated|0|||
126247607|NCT03629054|454200338|FG001|Period 2 (4 Days)|Not treated|1|||
126247608|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
126247609|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
126247610|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
126247611|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
126247612|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
126247613|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
126247614|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Death|9|||
126247615|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Death|7|||
126247616|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Death|14|||
126247617|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Death|7|||
126247618|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Death|0|||
126247619|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Death|0|||
126247620|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
126247621|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
126247622|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
126247623|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
126247624|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
126247625|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
126247626|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Other Event|49|||
126247627|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Other Event|52|||
126247628|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Other Event|41|||
126247629|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Other Event|58|||
126247630|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Other Event|0|||
126247631|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Other Event|0|||
126247632|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
126247633|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
126247634|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
126247635|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
126247636|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
126247637|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
126247638|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
126247639|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
126247640|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
126247641|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
126247642|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
126247643|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
126247644|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
126247645|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
126247646|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
126247647|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
125879379|NCT02224560|452855330|FG000|Overall Study|Met Withdrawal Criteria|1|||
125879380|NCT02224560|452855331|FG001|Overall Study|Met Withdrawal Criteria|0|||
125879381|NCT02224560|452855332|FG002|Overall Study|Met Withdrawal Criteria|0|||
125879382|NCT02224560|452855330|FG000|Overall Study|Adverse Event|4|||
126247648|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
126247649|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
126247650|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
126247651|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
126247652|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
126247653|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
126247654|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
126247655|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
125879383|NCT02224560|452855331|FG001|Overall Study|Adverse Event|1|||
125879384|NCT02224560|452855332|FG002|Overall Study|Adverse Event|1|||
125879385|NCT02224560|452855330|FG000|Overall Study|Withdrawn by Investigator|1|||
125879386|NCT02224560|452855331|FG001|Overall Study|Withdrawn by Investigator|1|||
125879387|NCT02224560|452855332|FG002|Overall Study|Withdrawn by Investigator|0|||
125879388|NCT02383576|452855335|FG000|Overall Study|Death|53|||
126247656|NCT00205777|454200339|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
126247657|NCT00205777|454200340|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
125879389|NCT02383576|452855336|FG001|Overall Study|Death|33|||
126247658|NCT00205777|454200341|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
126247659|NCT00205777|454200342|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
126247660|NCT00205777|454200343|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
126247661|NCT00205777|454200344|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
126247662|NCT00205777|454200339|FG000|Completed Core Study, Entered SE I|Other Event|52|||
126247663|NCT00205777|454200340|FG001|Completed Core Study, Entered SE I|Other Event|46|||
126247664|NCT00205777|454200341|FG002|Completed Core Study, Entered SE I|Other Event|47|||
126247665|NCT00205777|454200342|FG003|Completed Core Study, Entered SE I|Other Event|50|||
126247666|NCT00205777|454200343|FG004|Completed Core Study, Entered SE I|Other Event|0|||
126247667|NCT00205777|454200344|FG005|Completed Core Study, Entered SE I|Other Event|0|||
126247668|NCT00205777|454200339|FG000|Study Extension I|Adverse Event|57|||
126247669|NCT00205777|454200340|FG001|Study Extension I|Adverse Event|0|||
126247670|NCT00205777|454200341|FG002|Study Extension I|Adverse Event|0|||
126247671|NCT00205777|454200342|FG003|Study Extension I|Adverse Event|61|||
126247672|NCT00205777|454200343|FG004|Study Extension I|Adverse Event|58|||
126247673|NCT00205777|454200344|FG005|Study Extension I|Adverse Event|0|||
126247674|NCT00205777|454200339|FG000|Study Extension I|Death|5|||
126247675|NCT00205777|454200340|FG001|Study Extension I|Death|0|||
126247676|NCT00205777|454200341|FG002|Study Extension I|Death|0|||
126026977|NCT05338086|453396070|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
126026978|NCT05338086|453396071|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
126026979|NCT05338086|453396072|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
126026980|NCT05338086|453396073|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
126026981|NCT05338086|453396069|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
126247677|NCT00205777|454200342|FG003|Study Extension I|Death|1|||
126247678|NCT00205777|454200343|FG004|Study Extension I|Death|2|||
126247679|NCT00205777|454200344|FG005|Study Extension I|Death|0|||
126026982|NCT05338086|453396070|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
126026983|NCT05338086|453396071|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
126026984|NCT05338086|453396072|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
126026985|NCT05338086|453396073|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
126026986|NCT05338086|453396069|FG000|Transition Period (M12 to M18)|Death|0|||
126026987|NCT05338086|453396070|FG001|Transition Period (M12 to M18)|Death|0|||
126026988|NCT05338086|453396071|FG002|Transition Period (M12 to M18)|Death|1|||
126026989|NCT05338086|453396072|FG003|Transition Period (M12 to M18)|Death|0|||
126026990|NCT05338086|453396073|FG004|Transition Period (M12 to M18)|Death|0|||
126026991|NCT05338086|453396069|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
126026992|NCT05338086|453396070|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
126026993|NCT05338086|453396071|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
126026994|NCT05338086|453396072|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
126026995|NCT05338086|453396073|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
126026996|NCT05338086|453396069|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
126026997|NCT05338086|453396070|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
126026998|NCT05338086|453396071|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
126026999|NCT05338086|453396072|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
126027000|NCT05338086|453396073|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
126027001|NCT05338086|453396069|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
126027002|NCT05338086|453396070|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
126027003|NCT05338086|453396071|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
126027004|NCT05338086|453396072|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
126027005|NCT05338086|453396073|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
126027006|NCT03940703|453396074|FG000|Overall Study|Still under treatment|31|||
126027007|NCT03940703|453396075|FG001|Overall Study|Still under treatment|0|||
126027008|NCT04533022|453396076|FG000|Overall Study|Withdrawal by Subject|15|||
126027009|NCT04533022|453396076|FG000|Overall Study|Adverse Event|6|||
126027010|NCT04533022|453396076|FG000|Overall Study|Death|1|||
126027011|NCT04533022|453396076|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
126027012|NCT04533022|453396076|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
126027013|NCT02163447|453396077|FG000|Overall Study|Withdrawal by Subject|2|||
126027014|NCT02163447|453396078|FG001|Overall Study|Withdrawal by Subject|0|||
126027015|NCT02163447|453396079|FG002|Overall Study|Withdrawal by Subject|1|||
126027016|NCT02163447|453396077|FG000|Overall Study|Lost to Follow-up|1|||
126027017|NCT02163447|453396078|FG001|Overall Study|Lost to Follow-up|3|||
126027018|NCT02163447|453396079|FG002|Overall Study|Lost to Follow-up|0|||
126027019|NCT02163447|453396077|FG000|Overall Study|Moved out of study area|2|||
126247680|NCT00205777|454200339|FG000|Study Extension I|Withdrawal by Subject|99|||
126247681|NCT00205777|454200340|FG001|Study Extension I|Withdrawal by Subject|0|||
126247682|NCT00205777|454200341|FG002|Study Extension I|Withdrawal by Subject|0|||
126027020|NCT02163447|453396078|FG001|Overall Study|Moved out of study area|3|||
125879390|NCT02383576|452855335|FG000|Overall Study|Lost to Follow-up|7|||
125879391|NCT02383576|452855336|FG001|Overall Study|Lost to Follow-up|1|||
125879392|NCT02383576|452855335|FG000|Overall Study|Withdrew Consent|1|||
125879393|NCT02383576|452855336|FG001|Overall Study|Withdrew Consent|6|||
125879394|NCT02383576|452855335|FG000|Overall Study|Investigator's Decision|0|||
125879395|NCT02383576|452855336|FG001|Overall Study|Investigator's Decision|1|||
125879396|NCT02383576|452855335|FG000|Overall Study|Administrative/Other|2|||
125879397|NCT02383576|452855336|FG001|Overall Study|Administrative/Other|4|||
125879398|NCT04711850|452855337|FG000|Overall Study|Graft loss|2|||
125879399|NCT04711850|452855338|FG001|Overall Study|Graft loss|1|||
125879400|NCT04711850|452855337|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
125879401|NCT04711850|452855338|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
125879402|NCT04711850|452855337|FG000|Overall Study|Study terminated by sponsor|5|||
125879403|NCT04711850|452855338|FG001|Overall Study|Study terminated by sponsor|3|||
125879404|NCT04711850|452855337|FG000|Overall Study|Sponsor decision|0|||
125879405|NCT04711850|452855338|FG001|Overall Study|Sponsor decision|2|||
125879406|NCT02340026|452855339|FG000|Treatment Phase|Withdrawal by Subject|2|||
125879407|NCT02340026|452855340|FG001|Treatment Phase|Withdrawal by Subject|2|||
125879408|NCT02340026|452855339|FG000|Follow-up Phase|Lost to Follow-up|1|||
125879409|NCT02340026|452855340|FG001|Follow-up Phase|Lost to Follow-up|0|||
125879410|NCT02738801|452855353|FG000|Overall Study|Adverse Event|1|||
125879411|NCT02738801|452855354|FG001|Overall Study|Adverse Event|1|||
125879412|NCT02738801|452855353|FG000|Overall Study|Withdrawal by Subject|0|||
125879413|NCT02738801|452855354|FG001|Overall Study|Withdrawal by Subject|1|||
126094498|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126094499|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126103470|NCT04620811|453672167|FG000|Overall Study|Elevation of ALT or AST|1|||
126247683|NCT00205777|454200342|FG003|Study Extension I|Withdrawal by Subject|106|||
126247684|NCT00205777|454200343|FG004|Study Extension I|Withdrawal by Subject|89|||
126247685|NCT00205777|454200344|FG005|Study Extension I|Withdrawal by Subject|0|||
126247686|NCT00205777|454200339|FG000|Study Extension I|Protocol Violation|4|||
126247687|NCT00205777|454200340|FG001|Study Extension I|Protocol Violation|0|||
126247688|NCT00205777|454200341|FG002|Study Extension I|Protocol Violation|0|||
126247689|NCT00205777|454200342|FG003|Study Extension I|Protocol Violation|8|||
126247690|NCT00205777|454200343|FG004|Study Extension I|Protocol Violation|8|||
126247691|NCT00205777|454200344|FG005|Study Extension I|Protocol Violation|0|||
126247692|NCT00205777|454200339|FG000|Study Extension I|Lack of Efficacy|0|||
126247693|NCT00205777|454200340|FG001|Study Extension I|Lack of Efficacy|0|||
126247694|NCT00205777|454200341|FG002|Study Extension I|Lack of Efficacy|0|||
126247695|NCT00205777|454200342|FG003|Study Extension I|Lack of Efficacy|1|||
126247696|NCT00205777|454200343|FG004|Study Extension I|Lack of Efficacy|2|||
126247697|NCT00205777|454200344|FG005|Study Extension I|Lack of Efficacy|0|||
126247698|NCT00205777|454200339|FG000|Study Extension I|Failed to return|15|||
126247699|NCT00205777|454200340|FG001|Study Extension I|Failed to return|0|||
126247700|NCT00205777|454200341|FG002|Study Extension I|Failed to return|0|||
126247701|NCT00205777|454200342|FG003|Study Extension I|Failed to return|17|||
126247702|NCT00205777|454200343|FG004|Study Extension I|Failed to return|13|||
126247703|NCT00205777|454200344|FG005|Study Extension I|Failed to return|0|||
126247704|NCT00205777|454200339|FG000|Study Extension I|Other Event|34|||
126247705|NCT00205777|454200340|FG001|Study Extension I|Other Event|0|||
126247706|NCT00205777|454200341|FG002|Study Extension I|Other Event|0|||
126247707|NCT00205777|454200342|FG003|Study Extension I|Other Event|34|||
126247708|NCT00205777|454200343|FG004|Study Extension I|Other Event|29|||
126247709|NCT00205777|454200344|FG005|Study Extension I|Other Event|0|||
126247710|NCT00205777|454200339|FG000|Study Extension I|Withdrawn as per protocol|0|||
126247711|NCT00205777|454200340|FG001|Study Extension I|Withdrawn as per protocol|0|||
126247712|NCT00205777|454200341|FG002|Study Extension I|Withdrawn as per protocol|1070|||
126247713|NCT00205777|454200342|FG003|Study Extension I|Withdrawn as per protocol|0|||
126247714|NCT00205777|454200343|FG004|Study Extension I|Withdrawn as per protocol|0|||
126247715|NCT00205777|454200344|FG005|Study Extension I|Withdrawn as per protocol|0|||
125879414|NCT03279081|452855355|FG000|Overall Study|Withdrawal by Subject|12|||
125879415|NCT03279081|452855356|FG001|Overall Study|Withdrawal by Subject|20|||
125879416|NCT03279081|452855355|FG000|Overall Study|Physician Decision|4|||
125879417|NCT03279081|452855356|FG001|Overall Study|Physician Decision|1|||
125879418|NCT03279081|452855355|FG000|Overall Study|Lost to Follow-up|8|||
125879419|NCT03279081|452855356|FG001|Overall Study|Lost to Follow-up|8|||
125879420|NCT03279081|452855355|FG000|Overall Study|Death|0|||
125879421|NCT03279081|452855356|FG001|Overall Study|Death|1|||
125879422|NCT03279081|452855355|FG000|Overall Study|Adverse Event|1|||
125879423|NCT03279081|452855356|FG001|Overall Study|Adverse Event|0|||
125879424|NCT03279081|452855355|FG000|Overall Study|Reason not Specified|14|||
126247716|NCT00205777|454200339|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
126247717|NCT00205777|454200340|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
126306195|NCT03260244|454410221|FG000|Overall Study|No inducible Arrhythmia|2|||
126094500|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126094501|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
126094502|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
126094503|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
126094504|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
126094505|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
126094506|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
126094507|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126094508|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126247718|NCT00205777|454200341|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
126247719|NCT00205777|454200342|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
126247720|NCT00205777|454200343|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
126247721|NCT00205777|454200344|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
126247722|NCT00205777|454200339|FG000|Study Extension II|Adverse Event|0|||
126247723|NCT00205777|454200340|FG001|Study Extension II|Adverse Event|0|||
126247724|NCT00205777|454200341|FG002|Study Extension II|Adverse Event|0|||
126247725|NCT00205777|454200342|FG003|Study Extension II|Adverse Event|14|||
126247726|NCT00205777|454200343|FG004|Study Extension II|Adverse Event|0|||
126247727|NCT00205777|454200344|FG005|Study Extension II|Adverse Event|30|||
126247728|NCT00205777|454200339|FG000|Study Extension II|Death|0|||
126247729|NCT00205777|454200340|FG001|Study Extension II|Death|0|||
126247730|NCT00205777|454200341|FG002|Study Extension II|Death|0|||
126247731|NCT00205777|454200342|FG003|Study Extension II|Death|2|||
126247732|NCT00205777|454200343|FG004|Study Extension II|Death|0|||
126247733|NCT00205777|454200344|FG005|Study Extension II|Death|5|||
126247734|NCT00205777|454200339|FG000|Study Extension II|Withdrawal by Subject|0|||
126247735|NCT00205777|454200340|FG001|Study Extension II|Withdrawal by Subject|0|||
126247736|NCT00205777|454200341|FG002|Study Extension II|Withdrawal by Subject|0|||
126247737|NCT00205777|454200342|FG003|Study Extension II|Withdrawal by Subject|35|||
126247738|NCT00205777|454200343|FG004|Study Extension II|Withdrawal by Subject|0|||
126247739|NCT00205777|454200344|FG005|Study Extension II|Withdrawal by Subject|59|||
126247740|NCT00205777|454200339|FG000|Study Extension II|Protocol Violation|0|||
126247741|NCT00205777|454200340|FG001|Study Extension II|Protocol Violation|0|||
126247742|NCT00205777|454200341|FG002|Study Extension II|Protocol Violation|0|||
126247743|NCT00205777|454200342|FG003|Study Extension II|Protocol Violation|1|||
126247744|NCT00205777|454200343|FG004|Study Extension II|Protocol Violation|0|||
126247745|NCT00205777|454200344|FG005|Study Extension II|Protocol Violation|10|||
126247746|NCT00205777|454200339|FG000|Study Extension II|Lack of Efficacy|0|||
126247747|NCT00205777|454200340|FG001|Study Extension II|Lack of Efficacy|0|||
126247748|NCT00205777|454200341|FG002|Study Extension II|Lack of Efficacy|0|||
126247749|NCT00205777|454200342|FG003|Study Extension II|Lack of Efficacy|0|||
125879425|NCT03279081|452855356|FG001|Overall Study|Reason not Specified|4|||
125879426|NCT01210313|452855365|FG000|Overall Study|Withdrawal by Subject|3|||
125879427|NCT01210313|452855365|FG000|Overall Study|Adverse Event|2|||
125879428|NCT01210313|452855365|FG000|Overall Study|Distant recurrence|4|||
125879429|NCT01210313|452855365|FG000|Overall Study|Non-compliance|7|||
125879430|NCT01710345|452855366|FG000|Overall Study|Adverse Event|0|||
125879431|NCT01710345|452855367|FG001|Overall Study|Adverse Event|2|||
125879432|NCT01710345|452855368|FG002|Overall Study|Adverse Event|0|||
125879433|NCT01710345|452855366|FG000|Overall Study|Lack of Efficacy|2|||
125879434|NCT01710345|452855367|FG001|Overall Study|Lack of Efficacy|3|||
125879435|NCT01710345|452855368|FG002|Overall Study|Lack of Efficacy|1|||
125879436|NCT01710345|452855366|FG000|Overall Study|Drug Dosing Error|1|||
125879437|NCT01710345|452855367|FG001|Overall Study|Drug Dosing Error|0|||
125879438|NCT01710345|452855368|FG002|Overall Study|Drug Dosing Error|0|||
125879439|NCT01502293|452855371|FG000|Overall Study|Progressive Disease|20|||
125879440|NCT01502293|452855372|FG001|Overall Study|Progressive Disease|12|||
125879441|NCT01502293|452855373|FG002|Overall Study|Progressive Disease|2|||
125879442|NCT01502293|452855371|FG000|Overall Study|Withdrawal by Subject|3|||
125879443|NCT01502293|452855372|FG001|Overall Study|Withdrawal by Subject|3|||
125879444|NCT01502293|452855373|FG002|Overall Study|Withdrawal by Subject|1|||
125879445|NCT01502293|452855371|FG000|Overall Study|Adverse Event|0|||
125879446|NCT01502293|452855372|FG001|Overall Study|Adverse Event|2|||
126027021|NCT02163447|453396079|FG002|Overall Study|Moved out of study area|2|||
126027022|NCT02163447|453396077|FG000|Overall Study|Became HIV infected at time of delivery|1|||
126027023|NCT02163447|453396078|FG001|Overall Study|Became HIV infected at time of delivery|0|||
126027024|NCT02163447|453396079|FG002|Overall Study|Became HIV infected at time of delivery|0|||
126027025|NCT05113966|453396081|FG000|Overall Study|Death|21|||
126027026|NCT05113966|453396081|FG000|Overall Study|Study Terminated by Sponsor|9|||
126027027|NCT05386355|453396082|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
126027028|NCT05386355|453396083|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
126027029|NCT05386355|453396084|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
126027030|NCT05386355|453396085|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
126027031|NCT03747484|453396086|FG000|Overall Study|Lack of Efficacy|0|||
126027032|NCT03747484|453396087|FG001|Overall Study|Lack of Efficacy|1|||
126027033|NCT03747484|453396088|FG002|Overall Study|Lack of Efficacy|1|||
126027034|NCT03747484|453396089|FG003|Overall Study|Lack of Efficacy|2|||
126027035|NCT03747484|453396090|FG004|Overall Study|Lack of Efficacy|2|||
126027036|NCT04521478|453396091|FG000|Overall Study|Protocol Violation|2|||
126027037|NCT04521478|453396092|FG001|Overall Study|Protocol Violation|0|||
126027038|NCT04521478|453396093|FG002|Overall Study|Protocol Violation|1|||
126027039|NCT04521478|453396094|FG003|Overall Study|Protocol Violation|0|||
126027040|NCT04521478|453396095|FG004|Overall Study|Protocol Violation|0|||
126027041|NCT04521478|453396096|FG005|Overall Study|Protocol Violation|0|||
126027042|NCT04521478|453396091|FG000|Overall Study|Technical Problems|0|||
126247750|NCT00205777|454200343|FG004|Study Extension II|Lack of Efficacy|0|||
126027043|NCT04521478|453396092|FG001|Overall Study|Technical Problems|0|||
125879447|NCT01502293|452855373|FG002|Overall Study|Adverse Event|0|||
125879448|NCT01502293|452855371|FG000|Overall Study|Reason Not Specified|2|||
125879449|NCT01502293|452855372|FG001|Overall Study|Reason Not Specified|0|||
126357649|NCT02187055|454602192|FG002|Overall Study|Withdrawal by Subject|11|||
126357650|NCT02187055|454602190|FG000|Overall Study|Adverse Event|21|||
126357651|NCT02187055|454602191|FG001|Overall Study|Adverse Event|26|||
126357652|NCT02187055|454602192|FG002|Overall Study|Adverse Event|36|||
126357653|NCT02187055|454602190|FG000|Overall Study|Death|2|||
126357654|NCT02187055|454602191|FG001|Overall Study|Death|0|||
126357655|NCT02187055|454602192|FG002|Overall Study|Death|0|||
126357656|NCT03520387|454602195|FG000|Pre-Randomization|Withdrawal by Subject|1|||
126357657|NCT03520387|454602196|FG001|Pre-Randomization|Withdrawal by Subject|0|||
126357658|NCT03520387|454602197|FG002|Pre-Randomization|Withdrawal by Subject|0|||
126357659|NCT03520387|454602198|FG003|Pre-Randomization|Withdrawal by Subject|0|||
126357660|NCT03520387|454602199|FG004|Pre-Randomization|Withdrawal by Subject|0|||
126357661|NCT03520387|454602195|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
126357662|NCT03520387|454602196|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
126357663|NCT03520387|454602197|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
126357664|NCT03520387|454602198|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
126027044|NCT04521478|453396093|FG002|Overall Study|Technical Problems|0|||
126027045|NCT04521478|453396094|FG003|Overall Study|Technical Problems|1|||
126027046|NCT04521478|453396095|FG004|Overall Study|Technical Problems|0|||
126027047|NCT04521478|453396096|FG005|Overall Study|Technical Problems|0|||
126027048|NCT04521478|453396091|FG000|Overall Study|Burden of Study Procedures|1|||
126027049|NCT04521478|453396092|FG001|Overall Study|Burden of Study Procedures|0|||
126027050|NCT04521478|453396093|FG002|Overall Study|Burden of Study Procedures|0|||
126027051|NCT04521478|453396094|FG003|Overall Study|Burden of Study Procedures|1|||
126027052|NCT04521478|453396095|FG004|Overall Study|Burden of Study Procedures|0|||
126027053|NCT04521478|453396096|FG005|Overall Study|Burden of Study Procedures|1|||
126027054|NCT04521478|453396091|FG000|Overall Study|Lack of Efficacy|0|||
126027055|NCT04521478|453396092|FG001|Overall Study|Lack of Efficacy|0|||
126027056|NCT04521478|453396093|FG002|Overall Study|Lack of Efficacy|0|||
126027057|NCT04521478|453396094|FG003|Overall Study|Lack of Efficacy|0|||
126027058|NCT04521478|453396095|FG004|Overall Study|Lack of Efficacy|1|||
126027059|NCT04521478|453396096|FG005|Overall Study|Lack of Efficacy|1|||
126027060|NCT04521478|453396091|FG000|Overall Study|Adverse Event|7|||
126027061|NCT04521478|453396092|FG001|Overall Study|Adverse Event|0|||
126027062|NCT04521478|453396093|FG002|Overall Study|Adverse Event|2|||
126027063|NCT04521478|453396094|FG003|Overall Study|Adverse Event|1|||
126027064|NCT04521478|453396095|FG004|Overall Study|Adverse Event|2|||
126027065|NCT04521478|453396096|FG005|Overall Study|Adverse Event|7|||
126027066|NCT04521478|453396091|FG000|Overall Study|No Reason Available|0|||
126027067|NCT04521478|453396092|FG001|Overall Study|No Reason Available|2|||
126027068|NCT04521478|453396093|FG002|Overall Study|No Reason Available|0|||
126027069|NCT04521478|453396094|FG003|Overall Study|No Reason Available|0|||
126027070|NCT04521478|453396095|FG004|Overall Study|No Reason Available|1|||
126027071|NCT04521478|453396096|FG005|Overall Study|No Reason Available|0|||
126027072|NCT04521478|453396091|FG000|Overall Study|Other than listed|3|||
126027073|NCT04521478|453396092|FG001|Overall Study|Other than listed|3|||
126027074|NCT04521478|453396093|FG002|Overall Study|Other than listed|3|||
126027075|NCT04521478|453396094|FG003|Overall Study|Other than listed|2|||
126027076|NCT04521478|453396095|FG004|Overall Study|Other than listed|3|||
126027077|NCT04521478|453396096|FG005|Overall Study|Other than listed|3|||
126027078|NCT04521478|453396091|FG000|Overall Study|Not treated|0|||
126027079|NCT04521478|453396092|FG001|Overall Study|Not treated|0|||
126027080|NCT04521478|453396093|FG002|Overall Study|Not treated|0|||
126027081|NCT04521478|453396094|FG003|Overall Study|Not treated|0|||
126027082|NCT04521478|453396095|FG004|Overall Study|Not treated|0|||
126027083|NCT04521478|453396096|FG005|Overall Study|Not treated|1|||
126027084|NCT03833245|453396100|FG000|Overall Study|Death|0|||
126027085|NCT03833245|453396101|FG001|Overall Study|Death|1|||
126027086|NCT03775109|453396102|FG000|Overall Study|Adverse Event|1|||
126027087|NCT03775109|453396103|FG001|Overall Study|Adverse Event|0|||
126027088|NCT03775109|453396102|FG000|Overall Study|COVID-19 outbreak|2|||
126027089|NCT03775109|453396103|FG001|Overall Study|COVID-19 outbreak|0|||
126027090|NCT03775109|453396102|FG000|Overall Study|Lost to Follow-up|0|||
126027091|NCT03775109|453396103|FG001|Overall Study|Lost to Follow-up|2|||
126027092|NCT03775109|453396102|FG000|Overall Study|Withdrawal by Subject|1|||
126027093|NCT03775109|453396103|FG001|Overall Study|Withdrawal by Subject|1|||
126027094|NCT03775109|453396102|FG000|Overall Study|Death|0|||
126027095|NCT03775109|453396103|FG001|Overall Study|Death|1|||
126027096|NCT03775109|453396102|FG000|Overall Study|Lack of Efficacy|1|||
126357665|NCT03520387|454602199|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
126357666|NCT03336866|454602200|FG000|Overall Study|Lost to Follow-up|2|||
126027097|NCT03775109|453396103|FG001|Overall Study|Lack of Efficacy|0|||
126027098|NCT03347383|453396104|FG000|Overall Study|Death|39|||
126027099|NCT03347383|453396104|FG000|Overall Study|Withdrawal by Subject|3|||
126094509|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
126357667|NCT03336866|454602201|FG001|Overall Study|Lost to Follow-up|0|||
126357668|NCT03336866|454602202|FG002|Overall Study|Lost to Follow-up|3|||
126027100|NCT03347383|453396104|FG000|Overall Study|Lost to Follow-up|9|||
126027101|NCT05691452|453396106|FG000|Overall Study|Withdrawal by Subject|1|||
126027102|NCT05691452|453396107|FG001|Overall Study|Withdrawal by Subject|1|||
126027103|NCT05691452|453396108|FG002|Overall Study|Withdrawal by Subject|0|||
126027104|NCT05691452|453396106|FG000|Overall Study|Physician Decision|1|||
126027105|NCT05691452|453396107|FG001|Overall Study|Physician Decision|0|||
126027106|NCT05691452|453396108|FG002|Overall Study|Physician Decision|0|||
126027107|NCT05691452|453396106|FG000|Overall Study|Lost to Follow-up|0|||
126027108|NCT05691452|453396107|FG001|Overall Study|Lost to Follow-up|0|||
126027109|NCT05691452|453396108|FG002|Overall Study|Lost to Follow-up|1|||
126027110|NCT05691452|453396106|FG000|Overall Study|Adverse Event|0|||
126027111|NCT05691452|453396107|FG001|Overall Study|Adverse Event|0|||
126027112|NCT05691452|453396108|FG002|Overall Study|Adverse Event|1|||
126027113|NCT05320432|453396113|FG000|Overall Study|Withdrawal by Subject|0|||
126027114|NCT05320432|453396114|FG001|Overall Study|Withdrawal by Subject|2|||
126027115|NCT04173663|453396121|FG000|Overall Study|Withdrawal by Subject|1|||
126027116|NCT04173663|453396122|FG001|Overall Study|Withdrawal by Subject|6|||
126027117|NCT04173663|453396121|FG000|Overall Study|Lost to Follow-up|17|||
125879450|NCT01502293|452855373|FG002|Overall Study|Reason Not Specified|0|||
125879451|NCT01502293|452855371|FG000|Overall Study|Physician Decision|0|||
125879452|NCT01502293|452855372|FG001|Overall Study|Physician Decision|0|||
125879453|NCT01502293|452855373|FG002|Overall Study|Physician Decision|1|||
126027118|NCT04173663|453396122|FG001|Overall Study|Lost to Follow-up|24|||
126027119|NCT01757665|453396123|FG000|Overall Study|Still on Study - Visit Completed|240|||
126027120|NCT01757665|453396124|FG001|Overall Study|Still on Study - Visit Completed|30|||
126027121|NCT01757665|453396123|FG000|Overall Study|Still on Study - Visit Pending|398|||
126027122|NCT01757665|453396124|FG001|Overall Study|Still on Study - Visit Pending|40|||
126027123|NCT01757665|453396123|FG000|Overall Study|Still on Study - Missed Visit|14|||
126027124|NCT01757665|453396124|FG001|Overall Study|Still on Study - Missed Visit|1|||
126027125|NCT01757665|453396123|FG000|Overall Study|Death|25|||
126027126|NCT01757665|453396124|FG001|Overall Study|Death|8|||
126027127|NCT01757665|453396123|FG000|Overall Study|Explant|1|||
126027128|NCT01757665|453396124|FG001|Overall Study|Explant|2|||
126027129|NCT01757665|453396123|FG000|Overall Study|Withdrawal by Subject|10|||
126027130|NCT01757665|453396124|FG001|Overall Study|Withdrawal by Subject|0|||
126027131|NCT01757665|453396123|FG000|Overall Study|Lost to Follow-up|1|||
126027132|NCT01757665|453396124|FG001|Overall Study|Lost to Follow-up|1|||
126027133|NCT01757665|453396123|FG000|Overall Study|Not Implanted with Device|5|||
126027134|NCT01757665|453396124|FG001|Overall Study|Not Implanted with Device|1|||
126027135|NCT02187003|453396128|FG000|Overall Study|Adverse Event|2|||
126027136|NCT02187003|453396129|FG001|Overall Study|Adverse Event|0|||
126027137|NCT02187003|453396128|FG000|Overall Study|Lost to Follow-up|14|||
126027138|NCT02187003|453396129|FG001|Overall Study|Lost to Follow-up|10|||
126027139|NCT02187003|453396128|FG000|Overall Study|Withdrawal by Subject|3|||
126027140|NCT02187003|453396129|FG001|Overall Study|Withdrawal by Subject|7|||
126027141|NCT02187003|453396128|FG000|Overall Study|Protocol Violation|2|||
126027142|NCT02187003|453396129|FG001|Overall Study|Protocol Violation|4|||
126027143|NCT02187003|453396128|FG000|Overall Study|Other|5|||
126027144|NCT02187003|453396129|FG001|Overall Study|Other|5|||
126027145|NCT02187003|453396128|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126027146|NCT02187003|453396129|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
126027147|NCT05816551|453396130|FG000|Overall Study|Withdrawal by Subject|0|||
126027148|NCT05816551|453396131|FG001|Overall Study|Withdrawal by Subject|1|||
126027149|NCT05816551|453396130|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
126027150|NCT05816551|453396131|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
126027151|NCT02630823|453396138|FG000|Overall Study|Withdrawal by Subject|1|||
126027152|NCT02630823|453396138|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
126027153|NCT05461131|453396151|FG000|Overall Study|Lost to Follow-up|0|||
126027154|NCT05461131|453396152|FG001|Overall Study|Lost to Follow-up|2|||
126027155|NCT03101904|453396154|FG000|Wash Out (10 Days)|Adverse Event|1|||
126027156|NCT03101904|453396155|FG001|Wash Out (10 Days)|Adverse Event|0|||
126027157|NCT03101904|453396154|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
125879454|NCT00774046|452855376|FG000|Screening|Not eligible|56|||
126027158|NCT03101904|453396155|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
126027159|NCT04538417|453396156|FG000|Overall Study|Withdrawal by Subject|2|||
126027160|NCT04703322|453396160|FG000|Overall Study|Ongoing|8|||
126027161|NCT04703322|453396160|FG000|Overall Study|Withdrawal by Subject|1|||
126027162|NCT04549168|453396161|FG000|Randomization Phase|Adverse Event|0|||
126027163|NCT04549168|453396162|FG001|Randomization Phase|Adverse Event|0|||
126027164|NCT04549168|453396163|FG002|Randomization Phase|Adverse Event|1|||
126027165|NCT04549168|453396161|FG000|Randomization Phase|Other|0|||
126027166|NCT04549168|453396162|FG001|Randomization Phase|Other|2|||
126027167|NCT04549168|453396163|FG002|Randomization Phase|Other|0|||
126027168|NCT04549168|453396161|FG000|Randomization Phase|Withdrawal by Subject|0|||
126027169|NCT04549168|453396162|FG001|Randomization Phase|Withdrawal by Subject|2|||
126027170|NCT04549168|453396163|FG002|Randomization Phase|Withdrawal by Subject|1|||
126027171|NCT03988634|453396166|FG000|Double-Blind|Adverse Event|4|||
126094510|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126094511|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126094512|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126094513|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Site closure|0|||
126094514|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Site closure|0|||
126094515|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Site closure|1|||
126094516|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Site closure|0|||
126094517|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Site closure|0|||
126094518|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Site closure|0|||
126094519|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
126094520|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
126094521|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
126094522|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
126094523|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
126094524|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
126094525|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
126094526|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
126094527|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
126094528|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
126094529|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
126094530|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
126094531|NCT03439254|453641390|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
126094532|NCT03439254|453641391|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
126094533|NCT03439254|453641392|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
126094534|NCT03439254|453641393|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
126094535|NCT03439254|453641394|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
126094536|NCT03439254|453641395|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
126094537|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
126094538|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
126094539|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
126094540|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
126094541|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
126094542|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
126094543|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
126094544|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
126094545|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
126094546|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
126094547|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
126094548|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
126094549|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126094550|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126094551|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126094552|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126094553|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126094554|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
126094555|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126094556|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126094557|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126094558|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126094559|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
126094560|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126357669|NCT03336866|454602200|FG000|Overall Study|Withdrawal by Subject|1|||
126357670|NCT03336866|454602201|FG001|Overall Study|Withdrawal by Subject|1|||
126027172|NCT03988634|453396167|FG001|Double-Blind|Adverse Event|0|||
126094561|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126247751|NCT00205777|454200344|FG005|Study Extension II|Lack of Efficacy|1|||
126247752|NCT00205777|454200339|FG000|Study Extension II|Failed to return|0|||
126247753|NCT00205777|454200340|FG001|Study Extension II|Failed to return|0|||
126247754|NCT00205777|454200341|FG002|Study Extension II|Failed to return|0|||
126247755|NCT00205777|454200342|FG003|Study Extension II|Failed to return|14|||
126247756|NCT00205777|454200343|FG004|Study Extension II|Failed to return|0|||
126247757|NCT00205777|454200344|FG005|Study Extension II|Failed to return|26|||
126247758|NCT00205777|454200339|FG000|Study Extension II|Other Event|0|||
126247759|NCT00205777|454200340|FG001|Study Extension II|Other Event|0|||
126357671|NCT03336866|454602202|FG002|Overall Study|Withdrawal by Subject|0|||
126357672|NCT03336866|454602200|FG000|Overall Study|Noncompliance with clinic house rules|0|||
126357673|NCT03336866|454602201|FG001|Overall Study|Noncompliance with clinic house rules|0|||
126357674|NCT03336866|454602202|FG002|Overall Study|Noncompliance with clinic house rules|1|||
126357675|NCT00541775|454602203|FG000|Overall Study|Adverse Event|3|||
126357676|NCT00541775|454602204|FG001|Overall Study|Adverse Event|2|||
126357677|NCT00541775|454602205|FG002|Overall Study|Adverse Event|1|||
126357678|NCT00541775|454602203|FG000|Overall Study|Lack of Efficacy|0|||
126357679|NCT00541775|454602204|FG001|Overall Study|Lack of Efficacy|0|||
126357680|NCT00541775|454602205|FG002|Overall Study|Lack of Efficacy|3|||
126357681|NCT00541775|454602203|FG000|Overall Study|Lost to Follow-up|0|||
126357682|NCT00541775|454602204|FG001|Overall Study|Lost to Follow-up|0|||
126357683|NCT00541775|454602205|FG002|Overall Study|Lost to Follow-up|2|||
126357684|NCT00541775|454602203|FG000|Overall Study|Protocol Violation|1|||
126357685|NCT00541775|454602204|FG001|Overall Study|Protocol Violation|0|||
126357686|NCT00541775|454602205|FG002|Overall Study|Protocol Violation|0|||
126357687|NCT00541775|454602203|FG000|Overall Study|Withdrawal by Subject and Other|5|||
126357688|NCT00541775|454602204|FG001|Overall Study|Withdrawal by Subject and Other|0|||
126357689|NCT00541775|454602205|FG002|Overall Study|Withdrawal by Subject and Other|2|||
126357690|NCT00032487|454602206|FG000|Overall Study|Withdrawal by Subject|67|||
126357691|NCT00032487|454602207|FG001|Overall Study|Withdrawal by Subject|43|||
126357692|NCT00032487|454602206|FG000|Overall Study|Adverse Event|3|||
126357693|NCT00032487|454602207|FG001|Overall Study|Adverse Event|7|||
126357694|NCT00032487|454602206|FG000|Overall Study|Lost to Follow-up|57|||
126357695|NCT00032487|454602207|FG001|Overall Study|Lost to Follow-up|58|||
126357696|NCT00032487|454602206|FG000|Overall Study|Had other reason|12|||
126357697|NCT00032487|454602207|FG001|Overall Study|Had other reason|12|||
126357698|NCT04518410|454602209|FG000|Overall Study|Lost to Follow-up|1|||
126357699|NCT04518410|454602210|FG001|Overall Study|Lost to Follow-up|1|||
126357700|NCT04518410|454602211|FG002|Overall Study|Lost to Follow-up|8|||
126357701|NCT04518410|454602212|FG003|Overall Study|Lost to Follow-up|5|||
126357702|NCT04518410|454602213|FG004|Overall Study|Lost to Follow-up|92|||
126357703|NCT04518410|454602214|FG005|Overall Study|Lost to Follow-up|25|||
126357704|NCT04518410|454602215|FG006|Overall Study|Lost to Follow-up|25|||
126357705|NCT04518410|454602216|FG007|Overall Study|Lost to Follow-up|3|||
126357706|NCT04518410|454602217|FG008|Overall Study|Lost to Follow-up|2|||
126357707|NCT04518410|454602218|FG009|Overall Study|Lost to Follow-up|13|||
126357708|NCT04518410|454602219|FG010|Overall Study|Lost to Follow-up|9|||
126357709|NCT04518410|454602220|FG011|Overall Study|Lost to Follow-up|13|||
126357710|NCT04518410|454602221|FG012|Overall Study|Lost to Follow-up|9|||
126357711|NCT04518410|454602222|FG013|Overall Study|Lost to Follow-up|13|||
126357712|NCT04518410|454602223|FG014|Overall Study|Lost to Follow-up|8|||
126357713|NCT04518410|454602224|FG015|Overall Study|Lost to Follow-up|10|||
126357714|NCT04518410|454602225|FG016|Overall Study|Lost to Follow-up|6|||
126357715|NCT04518410|454602226|FG017|Overall Study|Lost to Follow-up|13|||
126357716|NCT04518410|454602227|FG018|Overall Study|Lost to Follow-up|21|||
126357717|NCT04518410|454602228|FG019|Overall Study|Lost to Follow-up|6|||
126357718|NCT04518410|454602229|FG020|Overall Study|Lost to Follow-up|7|||
126357719|NCT04518410|454602230|FG021|Overall Study|Lost to Follow-up|21|||
126357720|NCT04518410|454602231|FG022|Overall Study|Lost to Follow-up|1|||
126357721|NCT04518410|454602232|FG023|Overall Study|Lost to Follow-up|7|||
126357722|NCT04518410|454602233|FG024|Overall Study|Lost to Follow-up|6|||
126357723|NCT04518410|454602209|FG000|Overall Study|Withdrawal by Subject|1|||
126357724|NCT04518410|454602210|FG001|Overall Study|Withdrawal by Subject|2|||
126357725|NCT04518410|454602211|FG002|Overall Study|Withdrawal by Subject|2|||
126357726|NCT04518410|454602212|FG003|Overall Study|Withdrawal by Subject|3|||
126357727|NCT04518410|454602213|FG004|Overall Study|Withdrawal by Subject|20|||
126357728|NCT04518410|454602214|FG005|Overall Study|Withdrawal by Subject|20|||
126357729|NCT04518410|454602215|FG006|Overall Study|Withdrawal by Subject|25|||
126357730|NCT04518410|454602216|FG007|Overall Study|Withdrawal by Subject|6|||
126357731|NCT04518410|454602217|FG008|Overall Study|Withdrawal by Subject|1|||
126357732|NCT04518410|454602218|FG009|Overall Study|Withdrawal by Subject|12|||
126357733|NCT04518410|454602219|FG010|Overall Study|Withdrawal by Subject|5|||
126357734|NCT04518410|454602220|FG011|Overall Study|Withdrawal by Subject|7|||
126357735|NCT04518410|454602221|FG012|Overall Study|Withdrawal by Subject|2|||
126357736|NCT04518410|454602222|FG013|Overall Study|Withdrawal by Subject|13|||
126357737|NCT04518410|454602223|FG014|Overall Study|Withdrawal by Subject|4|||
126357738|NCT04518410|454602224|FG015|Overall Study|Withdrawal by Subject|9|||
126094562|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126094563|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126094564|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126094565|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
126094566|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126094567|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126094568|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126094569|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126094570|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126094571|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126094572|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
126094573|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126094574|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126094575|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126094576|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
126094577|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126094578|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126094579|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
126094580|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
126094581|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
126094582|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
126094583|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
126094584|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
126094585|NCT03439254|453641390|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
126094586|NCT03439254|453641391|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
126094587|NCT03439254|453641392|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
126094588|NCT03439254|453641393|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
126094589|NCT03439254|453641394|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
126094590|NCT03439254|453641395|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
126094591|NCT02075476|453641397|FG000|Overall Study|Death|2|||
126094592|NCT02075476|453641398|FG001|Overall Study|Death|2|||
126094593|NCT02075476|453641397|FG000|Overall Study|Lost to Follow-up|1|||
126094594|NCT02075476|453641398|FG001|Overall Study|Lost to Follow-up|3|||
126094595|NCT00095056|453641399|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
126094596|NCT00095056|453641400|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
126094597|NCT00095056|453641399|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
126094598|NCT00095056|453641400|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
126094599|NCT00095056|453641399|FG000|Phase A (Weeks 0-12)|Death|1|||
126094600|NCT00095056|453641400|FG001|Phase A (Weeks 0-12)|Death|0|||
126094601|NCT00095056|453641399|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
126094602|NCT00095056|453641400|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
126094603|NCT00095056|453641399|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
126094604|NCT00095056|453641400|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
126094605|NCT00095056|453641399|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
126094606|NCT00095056|453641400|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
126094607|NCT00095056|453641399|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
126094608|NCT00095056|453641400|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
126094609|NCT00095056|453641399|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
126094610|NCT00095056|453641400|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
126094611|NCT00095056|453641399|FG000|Phase B (Weeks 12-54)|Death|3|||
126094612|NCT00095056|453641400|FG001|Phase B (Weeks 12-54)|Death|1|||
126094613|NCT00095056|453641399|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
126094614|NCT00095056|453641400|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
126094615|NCT00095056|453641399|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
126094616|NCT00095056|453641400|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
126247760|NCT00205777|454200341|FG002|Study Extension II|Other Event|0|||
126247761|NCT00205777|454200342|FG003|Study Extension II|Other Event|12|||
126247762|NCT00205777|454200343|FG004|Study Extension II|Other Event|0|||
126247763|NCT00205777|454200344|FG005|Study Extension II|Other Event|20|||
126247764|NCT00205777|454200339|FG000|Study Extension II|Enrolled but not treated|0|||
126247765|NCT00205777|454200340|FG001|Study Extension II|Enrolled but not treated|0|||
126247766|NCT00205777|454200341|FG002|Study Extension II|Enrolled but not treated|0|||
126247767|NCT00205777|454200342|FG003|Study Extension II|Enrolled but not treated|71|||
126094617|NCT00923260|453641406|FG000|Overall Study|Lost to Follow-up|1|||
126094618|NCT00923260|453641407|FG001|Overall Study|Lost to Follow-up|1|||
126094619|NCT00836745|453641411|FG000|Overall Study|Death|2|||
126247768|NCT00205777|454200343|FG004|Study Extension II|Enrolled but not treated|0|||
126094620|NCT00836745|453641411|FG000|Overall Study|Lost to Follow-up|10|||
126247769|NCT00205777|454200344|FG005|Study Extension II|Enrolled but not treated|131|||
126247770|NCT00367133|454200347|FG000|2 Years|Death|20|||
126247771|NCT00367133|454200348|FG001|2 Years|Death|12|||
126247772|NCT00367133|454200349|FG002|2 Years|Death|12|||
126247773|NCT00367133|454200347|FG000|2 Years|Dropped|34|||
126247774|NCT00367133|454200348|FG001|2 Years|Dropped|19|||
126247775|NCT00367133|454200349|FG002|2 Years|Dropped|33|||
126247776|NCT00367133|454200347|FG000|2 Years|Missed visit|4|||
126247777|NCT00367133|454200348|FG001|2 Years|Missed visit|5|||
126247778|NCT00367133|454200349|FG002|2 Years|Missed visit|4|||
126247779|NCT00906399|454200351|FG000|Year 1|Randomized But Not Treated|0|||
126247780|NCT00906399|454200352|FG001|Year 1|Randomized But Not Treated|1|||
126247781|NCT00906399|454200353|FG002|Year 1|Randomized But Not Treated|3|||
126247782|NCT00906399|454200354|FG003|Year 1|Randomized But Not Treated|0|||
126247783|NCT00906399|454200355|FG004|Year 1|Randomized But Not Treated|0|||
126247784|NCT00906399|454200356|FG005|Year 1|Randomized But Not Treated|0|||
126247785|NCT00906399|454200357|FG006|Year 1|Randomized But Not Treated|0|||
126247786|NCT00906399|454200351|FG000|Year 1|Adverse Event|4|||
126247787|NCT00906399|454200352|FG001|Year 1|Adverse Event|22|||
126247788|NCT00906399|454200353|FG002|Year 1|Adverse Event|24|||
126247789|NCT00906399|454200354|FG003|Year 1|Adverse Event|0|||
126247790|NCT00906399|454200355|FG004|Year 1|Adverse Event|0|||
126247791|NCT00906399|454200356|FG005|Year 1|Adverse Event|0|||
126247792|NCT00906399|454200357|FG006|Year 1|Adverse Event|0|||
126247793|NCT00906399|454200351|FG000|Year 1|Lost to Follow-up|4|||
126247794|NCT00906399|454200352|FG001|Year 1|Lost to Follow-up|4|||
126247795|NCT00906399|454200353|FG002|Year 1|Lost to Follow-up|2|||
126247796|NCT00906399|454200354|FG003|Year 1|Lost to Follow-up|0|||
126247797|NCT00906399|454200355|FG004|Year 1|Lost to Follow-up|0|||
126247798|NCT00906399|454200356|FG005|Year 1|Lost to Follow-up|0|||
126247799|NCT00906399|454200357|FG006|Year 1|Lost to Follow-up|0|||
126247800|NCT00906399|454200351|FG000|Year 1|Withdrawal by Subject|30|||
126247801|NCT00906399|454200352|FG001|Year 1|Withdrawal by Subject|32|||
126247802|NCT00906399|454200353|FG002|Year 1|Withdrawal by Subject|36|||
126247803|NCT00906399|454200354|FG003|Year 1|Withdrawal by Subject|0|||
126247804|NCT00906399|454200355|FG004|Year 1|Withdrawal by Subject|0|||
126247805|NCT00906399|454200356|FG005|Year 1|Withdrawal by Subject|0|||
126247806|NCT00906399|454200357|FG006|Year 1|Withdrawal by Subject|0|||
126247807|NCT00906399|454200351|FG000|Year 1|Physician Decision|0|||
126247808|NCT00906399|454200352|FG001|Year 1|Physician Decision|1|||
126247809|NCT00906399|454200353|FG002|Year 1|Physician Decision|3|||
126027173|NCT03988634|453396168|FG002|Double-Blind|Adverse Event|0|||
126027174|NCT03988634|453396166|FG000|Double-Blind|Death|18|||
126247810|NCT00906399|454200354|FG003|Year 1|Physician Decision|0|||
126247811|NCT00906399|454200355|FG004|Year 1|Physician Decision|0|||
126247812|NCT00906399|454200356|FG005|Year 1|Physician Decision|0|||
126247813|NCT00906399|454200357|FG006|Year 1|Physician Decision|0|||
126247814|NCT00906399|454200351|FG000|Year 1|Death|2|||
126247815|NCT00906399|454200352|FG001|Year 1|Death|1|||
126247816|NCT00906399|454200353|FG002|Year 1|Death|1|||
126247817|NCT00906399|454200354|FG003|Year 1|Death|0|||
126247818|NCT00906399|454200355|FG004|Year 1|Death|0|||
126247819|NCT00906399|454200356|FG005|Year 1|Death|0|||
126247820|NCT00906399|454200357|FG006|Year 1|Death|0|||
126247821|NCT00906399|454200351|FG000|Year 1|Other|4|||
126247822|NCT00906399|454200352|FG001|Year 1|Other|2|||
126247823|NCT00906399|454200353|FG002|Year 1|Other|7|||
126247824|NCT00906399|454200354|FG003|Year 1|Other|0|||
126247825|NCT00906399|454200355|FG004|Year 1|Other|0|||
126247826|NCT00906399|454200356|FG005|Year 1|Other|0|||
126247827|NCT00906399|454200357|FG006|Year 1|Other|0|||
126247828|NCT00906399|454200351|FG000|Year 2|Adverse Event|0|||
126247829|NCT00906399|454200352|FG001|Year 2|Adverse Event|0|||
126247830|NCT00906399|454200353|FG002|Year 2|Adverse Event|0|||
126027175|NCT03988634|453396167|FG001|Double-Blind|Death|26|||
126027176|NCT03988634|453396168|FG002|Double-Blind|Death|0|||
126247831|NCT00906399|454200354|FG003|Year 2|Adverse Event|9|||
126247832|NCT00906399|454200355|FG004|Year 2|Adverse Event|8|||
126027177|NCT03988634|453396166|FG000|Double-Blind|Lost to Follow-up|6|||
126247833|NCT00906399|454200356|FG005|Year 2|Adverse Event|11|||
126247834|NCT00906399|454200357|FG006|Year 2|Adverse Event|6|||
126247835|NCT00906399|454200351|FG000|Year 2|Lost to Follow-up|0|||
126247836|NCT00906399|454200352|FG001|Year 2|Lost to Follow-up|0|||
126247837|NCT00906399|454200353|FG002|Year 2|Lost to Follow-up|0|||
126247838|NCT00906399|454200354|FG003|Year 2|Lost to Follow-up|1|||
126247839|NCT00906399|454200355|FG004|Year 2|Lost to Follow-up|4|||
126247840|NCT00906399|454200356|FG005|Year 2|Lost to Follow-up|2|||
126247841|NCT00906399|454200357|FG006|Year 2|Lost to Follow-up|4|||
126247842|NCT00906399|454200351|FG000|Year 2|Withdrawal by Subject|0|||
126247843|NCT00906399|454200352|FG001|Year 2|Withdrawal by Subject|0|||
126247844|NCT00906399|454200353|FG002|Year 2|Withdrawal by Subject|0|||
126247845|NCT00906399|454200354|FG003|Year 2|Withdrawal by Subject|17|||
126247846|NCT00906399|454200355|FG004|Year 2|Withdrawal by Subject|18|||
126247847|NCT00906399|454200356|FG005|Year 2|Withdrawal by Subject|27|||
126247848|NCT00906399|454200357|FG006|Year 2|Withdrawal by Subject|13|||
126247849|NCT00906399|454200351|FG000|Year 2|Physician Decision|0|||
126247850|NCT00906399|454200352|FG001|Year 2|Physician Decision|0|||
126247851|NCT00906399|454200353|FG002|Year 2|Physician Decision|0|||
126247852|NCT00906399|454200354|FG003|Year 2|Physician Decision|0|||
126247853|NCT00906399|454200355|FG004|Year 2|Physician Decision|2|||
126247854|NCT00906399|454200356|FG005|Year 2|Physician Decision|6|||
126247855|NCT00906399|454200357|FG006|Year 2|Physician Decision|3|||
126247856|NCT00906399|454200351|FG000|Year 2|Death|0|||
126247857|NCT00906399|454200352|FG001|Year 2|Death|0|||
126247858|NCT00906399|454200353|FG002|Year 2|Death|0|||
126247859|NCT00906399|454200354|FG003|Year 2|Death|1|||
126027178|NCT03988634|453396167|FG001|Double-Blind|Lost to Follow-up|7|||
126027179|NCT03988634|453396168|FG002|Double-Blind|Lost to Follow-up|0|||
126027180|NCT03988634|453396166|FG000|Double-Blind|Physician Decision|9|||
126027181|NCT03988634|453396167|FG001|Double-Blind|Physician Decision|5|||
126027182|NCT03988634|453396168|FG002|Double-Blind|Physician Decision|0|||
126027183|NCT03988634|453396166|FG000|Double-Blind|Subject decision|24|||
126027184|NCT03988634|453396167|FG001|Double-Blind|Subject decision|13|||
126027185|NCT03988634|453396168|FG002|Double-Blind|Subject decision|0|||
126027186|NCT03988634|453396166|FG000|Open-Label|Adverse Event|0|||
126027187|NCT03988634|453396167|FG001|Open-Label|Adverse Event|0|||
126027188|NCT03988634|453396168|FG002|Open-Label|Adverse Event|7|||
126027189|NCT03988634|453396166|FG000|Open-Label|Physician Decision|0|||
126027190|NCT03988634|453396167|FG001|Open-Label|Physician Decision|0|||
126027191|NCT03988634|453396168|FG002|Open-Label|Physician Decision|1|||
126027192|NCT03988634|453396166|FG000|Open-Label|Technical problems|0|||
126027193|NCT03988634|453396167|FG001|Open-Label|Technical problems|0|||
126027194|NCT03988634|453396168|FG002|Open-Label|Technical problems|1|||
126027195|NCT04725240|453396169|FG000|Overall Study|Adverse Event|2|||
126027196|NCT02249949|453396175|FG000|Overall Study|Cancelled prior to treatment|2|||
126027197|NCT02867384|453396176|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
126027198|NCT02867384|453396177|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
126027199|NCT02867384|453396178|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
126027200|NCT02867384|453396176|FG000|Overall Study|Progression/ Relapse|15|||
126027201|NCT02867384|453396177|FG001|Overall Study|Progression/ Relapse|19|||
126027202|NCT02867384|453396178|FG002|Overall Study|Progression/ Relapse|0|||
126027203|NCT02867384|453396176|FG000|Overall Study|Adverse Event|13|||
126027204|NCT02867384|453396177|FG001|Overall Study|Adverse Event|1|||
126027205|NCT02867384|453396178|FG002|Overall Study|Adverse Event|0|||
126027206|NCT02867384|453396176|FG000|Overall Study|Withdrawal by Subject|6|||
126027207|NCT02867384|453396177|FG001|Overall Study|Withdrawal by Subject|5|||
126027208|NCT02867384|453396178|FG002|Overall Study|Withdrawal by Subject|0|||
126027209|NCT02867384|453396176|FG000|Overall Study|Physician Decision|1|||
126027210|NCT02867384|453396177|FG001|Overall Study|Physician Decision|2|||
126027211|NCT02867384|453396178|FG002|Overall Study|Physician Decision|0|||
126027212|NCT02867384|453396176|FG000|Overall Study|Patient compliance|1|||
126027213|NCT02867384|453396177|FG001|Overall Study|Patient compliance|0|||
126027214|NCT02867384|453396178|FG002|Overall Study|Patient compliance|0|||
126027215|NCT02867384|453396176|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
126027216|NCT02867384|453396177|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
126027217|NCT02867384|453396178|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
126027218|NCT02867384|453396176|FG000|Overall Study|Never start treatment|0|||
126027219|NCT02867384|453396177|FG001|Overall Study|Never start treatment|0|||
126027220|NCT02867384|453396178|FG002|Overall Study|Never start treatment|3|||
126027221|NCT05054374|453396181|FG000|Overall Study|Withdrawal by Subject|1|||
126027222|NCT05054374|453396182|FG001|Overall Study|Withdrawal by Subject|0|||
126027223|NCT05054374|453396183|FG002|Overall Study|Withdrawal by Subject|0|||
126027224|NCT05054374|453396184|FG003|Overall Study|Withdrawal by Subject|0|||
126027225|NCT05054374|453396181|FG000|Overall Study|Progressive Disease|5|||
126027226|NCT05054374|453396182|FG001|Overall Study|Progressive Disease|0|||
126027227|NCT05054374|453396183|FG002|Overall Study|Progressive Disease|0|||
126027228|NCT05054374|453396184|FG003|Overall Study|Progressive Disease|0|||
126027229|NCT03453619|453396185|FG000|Core Study (Part A)|Physician Decision|0|||
126027230|NCT03453619|453396186|FG001|Core Study (Part A)|Physician Decision|0|||
126027231|NCT03453619|453396187|FG002|Core Study (Part A)|Physician Decision|2|||
126247860|NCT00906399|454200355|FG004|Year 2|Death|0|||
126027232|NCT03453619|453396188|FG003|Core Study (Part A)|Physician Decision|0|||
126027233|NCT03453619|453396185|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
126027234|NCT03453619|453396186|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
126027235|NCT03453619|453396187|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
126027236|NCT03453619|453396188|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
126027237|NCT03453619|453396185|FG000|Core Study (Part A)|Other|0|||
126027238|NCT03453619|453396186|FG001|Core Study (Part A)|Other|1|||
126027239|NCT03453619|453396187|FG002|Core Study (Part A)|Other|0|||
126027240|NCT03453619|453396188|FG003|Core Study (Part A)|Other|0|||
126027241|NCT03453619|453396185|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
126027242|NCT03453619|453396186|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
126247861|NCT00906399|454200356|FG005|Year 2|Death|0|||
126247862|NCT00906399|454200357|FG006|Year 2|Death|3|||
126247863|NCT00906399|454200351|FG000|Year 2|Other|0|||
126247864|NCT00906399|454200352|FG001|Year 2|Other|0|||
126027243|NCT03453619|453396187|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
126027244|NCT03453619|453396188|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
126027245|NCT03453619|453396185|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
126027246|NCT03453619|453396186|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
126027247|NCT03453619|453396187|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
126027248|NCT03453619|453396188|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
126027249|NCT03453619|453396185|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
126027250|NCT03453619|453396186|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
126027251|NCT03453619|453396187|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
126027252|NCT03453619|453396188|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
126027253|NCT03453619|453396185|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
126027254|NCT03453619|453396186|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
126027255|NCT03453619|453396187|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
126027256|NCT03453619|453396188|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
126027257|NCT05633407|453396189|FG000|Overall Study|Physician Decision|2|||
126027258|NCT05633407|453396190|FG001|Overall Study|Physician Decision|0|||
126027259|NCT05633407|453396189|FG000|Overall Study|Adverse Event|1|||
126027260|NCT05633407|453396190|FG001|Overall Study|Adverse Event|0|||
126027261|NCT05633407|453396189|FG000|Overall Study|Withdrawal by Subject|1|||
126027262|NCT05633407|453396190|FG001|Overall Study|Withdrawal by Subject|0|||
126027263|NCT05633407|453396189|FG000|Overall Study|Other|1|||
126027264|NCT05633407|453396190|FG001|Overall Study|Other|1|||
126027265|NCT03625882|453397105|FG000|Overall Study|Protocol Violation|3|||
126027266|NCT03484702|453397111|FG000|Treatment Period|Death|3|||
126027267|NCT03484702|453397112|FG001|Treatment Period|Death|1|||
126027268|NCT03484702|453397113|FG002|Treatment Period|Death|0|||
126027269|NCT03484702|453397114|FG003|Treatment Period|Death|0|||
126027270|NCT03484702|453397115|FG004|Treatment Period|Death|0|||
126027271|NCT03484702|453397116|FG005|Treatment Period|Death|0|||
126027272|NCT03484702|453397111|FG000|Treatment Period|Adverse Event|1|||
126027273|NCT03484702|453397112|FG001|Treatment Period|Adverse Event|0|||
126027274|NCT03484702|453397113|FG002|Treatment Period|Adverse Event|0|||
126027275|NCT03484702|453397114|FG003|Treatment Period|Adverse Event|0|||
126027276|NCT03484702|453397115|FG004|Treatment Period|Adverse Event|0|||
126027277|NCT03484702|453397116|FG005|Treatment Period|Adverse Event|0|||
126027278|NCT03484702|453397111|FG000|Treatment Period|Participant Withdrew from Study|0|||
126027279|NCT03484702|453397112|FG001|Treatment Period|Participant Withdrew from Study|1|||
126027280|NCT03484702|453397113|FG002|Treatment Period|Participant Withdrew from Study|0|||
126027281|NCT03484702|453397114|FG003|Treatment Period|Participant Withdrew from Study|0|||
126027282|NCT03484702|453397115|FG004|Treatment Period|Participant Withdrew from Study|0|||
126027283|NCT03484702|453397116|FG005|Treatment Period|Participant Withdrew from Study|0|||
126027284|NCT03484702|453397111|FG000|Treatment Period|Physician Decision|0|||
126027285|NCT03484702|453397112|FG001|Treatment Period|Physician Decision|1|||
126027286|NCT03484702|453397113|FG002|Treatment Period|Physician Decision|0|||
126027287|NCT03484702|453397114|FG003|Treatment Period|Physician Decision|0|||
126027288|NCT03484702|453397115|FG004|Treatment Period|Physician Decision|0|||
126027289|NCT03484702|453397116|FG005|Treatment Period|Physician Decision|1|||
126027290|NCT04850807|453397120|FG000|Overall Study|Death|50|||
126027291|NCT04850807|453397121|FG001|Overall Study|Death|55|||
126027292|NCT04850807|453397120|FG000|Overall Study|Discharged|17|||
126027293|NCT04850807|453397121|FG001|Overall Study|Discharged|13|||
126027294|NCT04850807|453397120|FG000|Overall Study|Incomplete baseline data|3|||
126027295|NCT04850807|453397121|FG001|Overall Study|Incomplete baseline data|2|||
126027296|NCT04593472|453397122|FG000|Overall Study|Death|31|||
126027297|NCT04593472|453397123|FG001|Overall Study|Death|27|||
126027298|NCT04593472|453397122|FG000|Overall Study|Withdrawal by Subject|12|||
126027299|NCT04593472|453397123|FG001|Overall Study|Withdrawal by Subject|12|||
126027300|NCT04593472|453397122|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
126027301|NCT04593472|453397123|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
126027302|NCT04593472|453397122|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
126094621|NCT00836745|453641411|FG000|Overall Study|Adverse Event|3|||
126027303|NCT04593472|453397123|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
126247865|NCT00906399|454200353|FG002|Year 2|Other|0|||
126247866|NCT00906399|454200354|FG003|Year 2|Other|2|||
126247867|NCT00906399|454200355|FG004|Year 2|Other|3|||
126247868|NCT00906399|454200356|FG005|Year 2|Other|1|||
126247869|NCT00906399|454200357|FG006|Year 2|Other|0|||
126247870|NCT00858780|454200365|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
126247871|NCT00858780|454200366|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
126027304|NCT04593472|453397122|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
126027305|NCT04593472|453397123|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
126027306|NCT04593472|453397122|FG000|Overall Study|Lost to Follow-up|0|||
126027307|NCT04593472|453397123|FG001|Overall Study|Lost to Follow-up|2|||
126027308|NCT04593472|453397122|FG000|Overall Study|Still collecting 24-month assessment|17|||
126027309|NCT04593472|453397123|FG001|Overall Study|Still collecting 24-month assessment|10|||
126027310|NCT04178733|453397124|FG000|Overall Study|Investigator Decision|0|||
126027311|NCT04178733|453397125|FG001|Overall Study|Investigator Decision|0|||
126027312|NCT04178733|453397126|FG002|Overall Study|Investigator Decision|0|||
126027313|NCT04178733|453397127|FG003|Overall Study|Investigator Decision|1|||
126027314|NCT04178733|453397128|FG004|Overall Study|Investigator Decision|2|||
126027315|NCT02651324|453397129|FG000|Overall Study|drug not administered, due dispensing issue|1|||
126027316|NCT02651324|453397130|FG001|Overall Study|drug not administered, due dispensing issue|0|||
126027317|NCT03896516|453397135|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
126027318|NCT03896516|453397136|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
126027319|NCT03896516|453397135|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
126027320|NCT03896516|453397136|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
126027321|NCT03896516|453397135|FG000|Washout Period|Physician Decision|3|||
126247872|NCT00858780|454200367|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
126247873|NCT00858780|454200368|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
126247874|NCT00858780|454200369|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
126247875|NCT00858780|454200365|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
126247876|NCT00858780|454200366|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
126247877|NCT00858780|454200367|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
126247878|NCT00858780|454200368|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
126247879|NCT00858780|454200369|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
126247880|NCT00858780|454200365|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
126247881|NCT00858780|454200366|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
126247882|NCT00858780|454200367|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
126247883|NCT00858780|454200368|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
126247884|NCT00858780|454200369|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
126247885|NCT00858780|454200365|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
126247886|NCT00858780|454200366|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
126247887|NCT00858780|454200367|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
126247888|NCT00858780|454200368|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
126247889|NCT00858780|454200369|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
126247890|NCT00858780|454200365|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
126247891|NCT00858780|454200366|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
126247892|NCT00858780|454200367|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
126247893|NCT00858780|454200368|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
126247894|NCT00858780|454200369|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
126247895|NCT00858780|454200365|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
126247896|NCT00858780|454200366|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
126247897|NCT00858780|454200367|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
126247898|NCT00858780|454200368|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
126247899|NCT00858780|454200369|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
126247900|NCT00863330|454200370|FG000|Overall Study|study terminated early due to administra|6|||
126247901|NCT02615249|454200371|FG000|Overall Study|Withdrawal by Subject|1|||
126247902|NCT00574847|454200372|FG000|Overall Study|Adverse Event|2|||
126247903|NCT00574847|454200373|FG001|Overall Study|Adverse Event|0|||
126247904|NCT00574847|454200372|FG000|Overall Study|Death|1|||
126247905|NCT00574847|454200373|FG001|Overall Study|Death|0|||
126247906|NCT00574847|454200372|FG000|Overall Study|Withdrawal by Subject|2|||
126247907|NCT00574847|454200373|FG001|Overall Study|Withdrawal by Subject|2|||
126247908|NCT00574847|454200372|FG000|Overall Study|Physician Decision|1|||
126027322|NCT03896516|453397136|FG001|Washout Period|Physician Decision|1|||
126027323|NCT03896516|453397135|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
126027324|NCT03896516|453397136|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
126027325|NCT03648840|453397139|FG000|First IV Infusion Session|Adverse Event|0|||
126027326|NCT03648840|453397140|FG001|First IV Infusion Session|Adverse Event|2|||
126027327|NCT03648840|453397139|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
126027328|NCT03648840|453397140|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
126027329|NCT03648840|453397139|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
126027330|NCT03648840|453397140|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
126027331|NCT03648840|453397139|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
126027332|NCT03648840|453397140|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
126027333|NCT05382936|453397143|FG000|Overall Study|Progressive Disease|3|||
126027334|NCT05382936|453397144|FG001|Overall Study|Progressive Disease|5|||
126247909|NCT00574847|454200373|FG001|Overall Study|Physician Decision|0|||
125879455|NCT00774046|452855376|FG000|Enrollment|Desired other therapy/refused|28|||
125879456|NCT00774046|452855376|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
125879457|NCT00107653|452855395|FG000|Overall Study|Adverse Event|24|||
125879458|NCT00107653|452855396|FG001|Overall Study|Adverse Event|43|||
125879459|NCT00107653|452855395|FG000|Overall Study|Insufficient Therapeutic Response|25|||
125879460|NCT00107653|452855396|FG001|Overall Study|Insufficient Therapeutic Response|11|||
125879461|NCT00107653|452855395|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125879462|NCT00107653|452855396|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125879463|NCT00107653|452855395|FG000|Overall Study|Protocol Violation|1|||
125879464|NCT00107653|452855396|FG001|Overall Study|Protocol Violation|0|||
125879465|NCT00107653|452855395|FG000|Overall Study|Withdrawal by Subject|12|||
125879466|NCT00107653|452855396|FG001|Overall Study|Withdrawal by Subject|13|||
125879467|NCT00107653|452855395|FG000|Overall Study|Lost to Follow-up|13|||
125879468|NCT00107653|452855396|FG001|Overall Study|Lost to Follow-up|5|||
126027335|NCT05382936|453397145|FG002|Overall Study|Progressive Disease|2|||
126027336|NCT05382936|453397146|FG003|Overall Study|Progressive Disease|5|||
126027337|NCT05382936|453397143|FG000|Overall Study|Adverse Event|0|||
126027338|NCT05382936|453397144|FG001|Overall Study|Adverse Event|1|||
126027339|NCT05382936|453397145|FG002|Overall Study|Adverse Event|1|||
126027340|NCT05382936|453397146|FG003|Overall Study|Adverse Event|0|||
126027341|NCT05382936|453397143|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
126027342|NCT05382936|453397144|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
126027343|NCT05382936|453397145|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
126027344|NCT05382936|453397146|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
126027345|NCT05382936|453397143|FG000|Overall Study|Withdrawal by Subject|0|||
126027346|NCT05382936|453397144|FG001|Overall Study|Withdrawal by Subject|0|||
126027347|NCT05382936|453397145|FG002|Overall Study|Withdrawal by Subject|1|||
126027348|NCT05382936|453397146|FG003|Overall Study|Withdrawal by Subject|1|||
126027349|NCT01195831|453397150|FG000|Overall Study|Lost to Follow-up|2|||
126027350|NCT01195831|453397151|FG001|Overall Study|Lost to Follow-up|4|||
126027351|NCT01195831|453397150|FG000|Overall Study|Withdrawal by Subject|2|||
126027352|NCT01195831|453397151|FG001|Overall Study|Withdrawal by Subject|2|||
126027353|NCT01195831|453397150|FG000|Overall Study|Adverse Event|4|||
126027354|NCT01195831|453397151|FG001|Overall Study|Adverse Event|2|||
126027355|NCT01195831|453397150|FG000|Overall Study|Protocol Violation|0|||
126027356|NCT01195831|453397151|FG001|Overall Study|Protocol Violation|2|||
126027357|NCT02662062|453397157|FG000|Overall Study|Withdrawal by Subject|1|||
126027358|NCT00676715|453397159|FG000|Treatment Period (TP)|Adverse Event|0|||
126027359|NCT00676715|453397160|FG001|Treatment Period (TP)|Adverse Event|3|||
126027360|NCT00676715|453397161|FG002|Treatment Period (TP)|Adverse Event|2|||
126027361|NCT00676715|453397162|FG003|Treatment Period (TP)|Adverse Event|2|||
126027362|NCT00676715|453397159|FG000|Treatment Period (TP)|Death|0|||
126027363|NCT00676715|453397160|FG001|Treatment Period (TP)|Death|0|||
126027364|NCT00676715|453397161|FG002|Treatment Period (TP)|Death|1|||
126027365|NCT00676715|453397162|FG003|Treatment Period (TP)|Death|0|||
126027366|NCT00676715|453397159|FG000|Treatment Period (TP)|Failure to return|1|||
126027367|NCT00676715|453397160|FG001|Treatment Period (TP)|Failure to return|0|||
126027368|NCT00676715|453397161|FG002|Treatment Period (TP)|Failure to return|0|||
126027369|NCT00676715|453397162|FG003|Treatment Period (TP)|Failure to return|0|||
126027370|NCT00676715|453397159|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
126027371|NCT00676715|453397160|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
126027372|NCT00676715|453397161|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
126027373|NCT00676715|453397162|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
126094622|NCT00836745|453641411|FG000|Overall Study|Objective progression or relapse|4|||
126094623|NCT00836745|453641411|FG000|Overall Study|Other|2|||
126247910|NCT00574847|454200372|FG000|Overall Study|Did not receive medication (declined)|2|||
126247911|NCT00574847|454200373|FG001|Overall Study|Did not receive medication (declined)|5|||
126247912|NCT02055547|454200375|FG000|Overall Study|Protocol Violation|0|||
126247913|NCT02055547|454200376|FG001|Overall Study|Protocol Violation|0|||
126247914|NCT02055547|454200377|FG002|Overall Study|Protocol Violation|1|||
126247915|NCT02055547|454200378|FG003|Overall Study|Protocol Violation|0|||
126247916|NCT02055547|454200379|FG004|Overall Study|Protocol Violation|0|||
126247917|NCT02055547|454200380|FG005|Overall Study|Protocol Violation|0|||
126247918|NCT02055547|454200381|FG006|Overall Study|Protocol Violation|1|||
126247919|NCT02055547|454200382|FG007|Overall Study|Protocol Violation|0|||
126247920|NCT02055547|454200383|FG008|Overall Study|Protocol Violation|0|||
126247921|NCT02055547|454200384|FG009|Overall Study|Protocol Violation|0|||
126247922|NCT02055547|454200385|FG010|Overall Study|Protocol Violation|0|||
126247923|NCT02055547|454200386|FG011|Overall Study|Protocol Violation|0|||
126247924|NCT02055547|454200387|FG012|Overall Study|Protocol Violation|0|||
126247925|NCT02055547|454200388|FG013|Overall Study|Protocol Violation|0|||
126247926|NCT02055547|454200389|FG014|Overall Study|Protocol Violation|0|||
126247927|NCT02055547|454200390|FG015|Overall Study|Protocol Violation|0|||
126247928|NCT02055547|454200391|FG016|Overall Study|Protocol Violation|0|||
125879469|NCT00107653|452855395|FG000|Overall Study|Administrative Reasons|3|||
126027374|NCT00676715|453397159|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
126027375|NCT00676715|453397160|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
126027376|NCT00676715|453397161|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
126027377|NCT00676715|453397162|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
126027378|NCT00676715|453397159|FG000|Treatment Period (TP)|Withdrew consent|3|||
126027379|NCT00676715|453397160|FG001|Treatment Period (TP)|Withdrew consent|3|||
126027380|NCT00676715|453397161|FG002|Treatment Period (TP)|Withdrew consent|3|||
126027381|NCT00676715|453397162|FG003|Treatment Period (TP)|Withdrew consent|3|||
126027382|NCT00676715|453397159|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
126027383|NCT00676715|453397160|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
126027384|NCT00676715|453397161|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
126027385|NCT00676715|453397162|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
126027386|NCT00676715|453397159|FG000|Treatment Period (TP)|Administrative|0|||
126027387|NCT00676715|453397160|FG001|Treatment Period (TP)|Administrative|0|||
126027388|NCT00676715|453397161|FG002|Treatment Period (TP)|Administrative|0|||
126027389|NCT00676715|453397162|FG003|Treatment Period (TP)|Administrative|1|||
126027390|NCT00676715|453397159|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
126027391|NCT00676715|453397160|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
126027392|NCT00676715|453397161|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
126027393|NCT00676715|453397162|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
126027394|NCT00676715|453397159|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
126027395|NCT00676715|453397160|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
126027396|NCT00676715|453397161|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
126027397|NCT00676715|453397162|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
126027398|NCT00676715|453397159|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
126027399|NCT00676715|453397160|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
126027400|NCT00676715|453397161|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
126027401|NCT00676715|453397162|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
126027402|NCT00676715|453397159|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
126027403|NCT00676715|453397160|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
126027404|NCT00676715|453397161|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
126027405|NCT00676715|453397162|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
126027406|NCT00676715|453397159|FG000|Treatment-free Period (TFP)|Death|1|||
126027407|NCT00676715|453397160|FG001|Treatment-free Period (TFP)|Death|1|||
126027408|NCT00676715|453397161|FG002|Treatment-free Period (TFP)|Death|1|||
126027409|NCT00676715|453397162|FG003|Treatment-free Period (TFP)|Death|0|||
126027410|NCT00676715|453397159|FG000|Open Label Extension (OLE)|Reason not provided|3|||
126027411|NCT00676715|453397160|FG001|Open Label Extension (OLE)|Reason not provided|4|||
126027412|NCT00676715|453397161|FG002|Open Label Extension (OLE)|Reason not provided|1|||
126027413|NCT00676715|453397162|FG003|Open Label Extension (OLE)|Reason not provided|4|||
126027414|NCT00676715|453397159|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
126027415|NCT00676715|453397160|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
126027416|NCT00676715|453397161|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
126027417|NCT00676715|453397162|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
126027418|NCT00676715|453397159|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
126027419|NCT00676715|453397160|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
126027420|NCT00676715|453397161|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
126027421|NCT00676715|453397162|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
126027422|NCT00676715|453397159|FG000|Open Label Extension (OLE)|Adverse Event|0|||
126027423|NCT00676715|453397160|FG001|Open Label Extension (OLE)|Adverse Event|3|||
126027424|NCT00676715|453397161|FG002|Open Label Extension (OLE)|Adverse Event|1|||
126027425|NCT00676715|453397162|FG003|Open Label Extension (OLE)|Adverse Event|0|||
126027426|NCT00676715|453397159|FG000|Open Label Extension (OLE)|Death|2|||
126027427|NCT00676715|453397160|FG001|Open Label Extension (OLE)|Death|0|||
126027428|NCT00676715|453397161|FG002|Open Label Extension (OLE)|Death|2|||
126027429|NCT00676715|453397162|FG003|Open Label Extension (OLE)|Death|2|||
126027430|NCT01820260|453397163|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027431|NCT01820260|453397164|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126094624|NCT02121301|453641413|FG000|Overall Study|Protocol Violation|1|||
126027432|NCT01820260|453397165|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027433|NCT01820260|453397166|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027434|NCT01820260|453397167|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027435|NCT01820260|453397168|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027436|NCT01820260|453397169|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
126027437|NCT01820260|453397170|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027438|NCT01820260|453397171|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027439|NCT01820260|453397172|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027440|NCT01820260|453397173|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027441|NCT01820260|453397174|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027442|NCT01820260|453397175|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027443|NCT01820260|453397176|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126027444|NCT01820260|453397163|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027445|NCT01820260|453397164|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027446|NCT01820260|453397165|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027447|NCT01820260|453397166|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027448|NCT01820260|453397167|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027449|NCT01820260|453397168|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027450|NCT01820260|453397169|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027451|NCT01820260|453397170|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027452|NCT01820260|453397171|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027453|NCT01820260|453397172|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
126027454|NCT01820260|453397173|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027455|NCT01820260|453397174|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027456|NCT01820260|453397175|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027457|NCT01820260|453397176|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126027458|NCT04831281|453397178|FG000|Overall Study|Adverse Event|1|||
126027459|NCT04831281|453397179|FG001|Overall Study|Adverse Event|0|||
126027460|NCT04831281|453397180|FG002|Overall Study|Adverse Event|3|||
126094625|NCT02121301|453641414|FG001|Overall Study|Protocol Violation|4|||
126094626|NCT02121301|453641415|FG002|Overall Study|Protocol Violation|1|||
126027461|NCT04831281|453397178|FG000|Overall Study|Withdrawal by Subject|0|||
126027462|NCT04831281|453397179|FG001|Overall Study|Withdrawal by Subject|1|||
126027463|NCT04831281|453397180|FG002|Overall Study|Withdrawal by Subject|2|||
126027464|NCT04831281|453397178|FG000|Overall Study|Undetermined|1|||
126027465|NCT04831281|453397179|FG001|Overall Study|Undetermined|1|||
126027466|NCT04831281|453397180|FG002|Overall Study|Undetermined|0|||
126027467|NCT02097420|453397181|FG000|Overall Study|Death|6|||
126027468|NCT02097420|453397181|FG000|Overall Study|Valve explanted|13|||
126027469|NCT02097420|453397181|FG000|Overall Study|Other Reason|1|||
126027470|NCT03161379|453397182|FG000|Overall Study|Withdrawal by Subject|4|||
126027471|NCT03161379|453397182|FG000|Overall Study|disease progression during chemotherapy|5|||
126027472|NCT03161379|453397182|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
126027473|NCT03161379|453397182|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
126027474|NCT02728076|453397183|FG000|Overall Study|Physician Decision|4|||
126027475|NCT04089371|453397184|FG000|Overall Study|Withdrawal by Subject|0|||
126027476|NCT04089371|453397185|FG001|Overall Study|Withdrawal by Subject|1|||
126027477|NCT04089371|453397184|FG000|Overall Study|Study terminated early|0|||
126027478|NCT04089371|453397185|FG001|Overall Study|Study terminated early|9|||
126027479|NCT04936035|453397189|FG000|Overall Study|Adverse Event|0|||
126027480|NCT04936035|453397190|FG001|Overall Study|Adverse Event|1|||
126027481|NCT04936035|453397191|FG002|Overall Study|Adverse Event|0|||
126027482|NCT04936035|453397192|FG003|Overall Study|Adverse Event|0|||
126027483|NCT04936035|453397193|FG004|Overall Study|Adverse Event|0|||
126027484|NCT04936035|453397189|FG000|Overall Study|Death|0|||
126027485|NCT04936035|453397190|FG001|Overall Study|Death|0|||
126027486|NCT04936035|453397191|FG002|Overall Study|Death|0|||
126027487|NCT04936035|453397192|FG003|Overall Study|Death|1|||
126027488|NCT04936035|453397193|FG004|Overall Study|Death|0|||
126027489|NCT04936035|453397189|FG000|Overall Study|Lost to Follow-up|0|||
126027490|NCT04936035|453397190|FG001|Overall Study|Lost to Follow-up|1|||
126027491|NCT04936035|453397191|FG002|Overall Study|Lost to Follow-up|1|||
126027492|NCT04936035|453397192|FG003|Overall Study|Lost to Follow-up|2|||
126027493|NCT04936035|453397193|FG004|Overall Study|Lost to Follow-up|1|||
126027494|NCT04936035|453397189|FG000|Overall Study|Physician Decision|0|||
126027495|NCT04936035|453397190|FG001|Overall Study|Physician Decision|1|||
126027496|NCT04936035|453397191|FG002|Overall Study|Physician Decision|0|||
126027497|NCT04936035|453397192|FG003|Overall Study|Physician Decision|0|||
126247929|NCT02055547|454200392|FG017|Overall Study|Protocol Violation|0|||
126247930|NCT02055547|454200393|FG018|Overall Study|Protocol Violation|0|||
126247931|NCT02055547|454200375|FG000|Overall Study|Physician Decision|0|||
126247932|NCT02055547|454200376|FG001|Overall Study|Physician Decision|1|||
126247933|NCT02055547|454200377|FG002|Overall Study|Physician Decision|1|||
126247934|NCT02055547|454200378|FG003|Overall Study|Physician Decision|0|||
126247935|NCT02055547|454200379|FG004|Overall Study|Physician Decision|1|||
126247936|NCT02055547|454200380|FG005|Overall Study|Physician Decision|0|||
126247937|NCT02055547|454200381|FG006|Overall Study|Physician Decision|0|||
126247938|NCT02055547|454200382|FG007|Overall Study|Physician Decision|0|||
126247939|NCT02055547|454200383|FG008|Overall Study|Physician Decision|0|||
126247940|NCT02055547|454200384|FG009|Overall Study|Physician Decision|1|||
126247941|NCT02055547|454200385|FG010|Overall Study|Physician Decision|1|||
126247942|NCT02055547|454200386|FG011|Overall Study|Physician Decision|0|||
126247943|NCT02055547|454200387|FG012|Overall Study|Physician Decision|0|||
126247944|NCT02055547|454200388|FG013|Overall Study|Physician Decision|0|||
126247945|NCT02055547|454200389|FG014|Overall Study|Physician Decision|0|||
126247946|NCT02055547|454200390|FG015|Overall Study|Physician Decision|0|||
126247947|NCT02055547|454200391|FG016|Overall Study|Physician Decision|0|||
126247948|NCT02055547|454200392|FG017|Overall Study|Physician Decision|0|||
126247949|NCT02055547|454200393|FG018|Overall Study|Physician Decision|0|||
126247950|NCT02055547|454200375|FG000|Overall Study|Adverse Event|0|||
126247951|NCT02055547|454200376|FG001|Overall Study|Adverse Event|0|||
126247952|NCT02055547|454200377|FG002|Overall Study|Adverse Event|0|||
126027498|NCT04936035|453397193|FG004|Overall Study|Physician Decision|0|||
126027499|NCT04936035|453397189|FG000|Overall Study|Protocol Deviation|0|||
126027500|NCT04936035|453397190|FG001|Overall Study|Protocol Deviation|0|||
126027501|NCT04936035|453397191|FG002|Overall Study|Protocol Deviation|1|||
126027502|NCT04936035|453397192|FG003|Overall Study|Protocol Deviation|0|||
126027503|NCT04936035|453397193|FG004|Overall Study|Protocol Deviation|0|||
126027504|NCT04936035|453397189|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
126027505|NCT04936035|453397190|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
126027506|NCT04936035|453397191|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
126247953|NCT02055547|454200378|FG003|Overall Study|Adverse Event|0|||
125879470|NCT00107653|452855396|FG001|Overall Study|Administrative Reasons|3|||
125879471|NCT01838395|452855397|FG000|Overall Study|Withdrawal by Subject|0|||
125879472|NCT01838395|452855398|FG001|Overall Study|Withdrawal by Subject|0|||
125879473|NCT01838395|452855399|FG002|Overall Study|Withdrawal by Subject|0|||
125879474|NCT01838395|452855400|FG003|Overall Study|Withdrawal by Subject|0|||
125879475|NCT01838395|452855401|FG004|Overall Study|Withdrawal by Subject|1|||
125879476|NCT01838395|452855402|FG005|Overall Study|Withdrawal by Subject|0|||
125879477|NCT01838395|452855397|FG000|Overall Study|Death|0|||
125879478|NCT01838395|452855398|FG001|Overall Study|Death|0|||
125879479|NCT01838395|452855399|FG002|Overall Study|Death|1|||
125879480|NCT01838395|452855400|FG003|Overall Study|Death|0|||
125879481|NCT01838395|452855401|FG004|Overall Study|Death|0|||
125879482|NCT01838395|452855402|FG005|Overall Study|Death|0|||
125879483|NCT01838395|452855397|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125879484|NCT01838395|452855398|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
125879485|NCT01838395|452855399|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125879486|NCT01838395|452855400|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125879487|NCT01838395|452855401|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125879488|NCT01838395|452855402|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125879489|NCT03694353|452855404|FG000|Overall Study|Withdrawal by Subject|1|||
125879490|NCT03694353|452855404|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
125879491|NCT00651742|452855405|FG000|Overall Study|Objective Disease Progression|22|||
125879492|NCT00651742|452855405|FG000|Overall Study|Toxicity|3|||
125879493|NCT00651742|452855405|FG000|Overall Study|Investigator Judgment|1|||
125879494|NCT00651742|452855405|FG000|Overall Study|Withdrawal of Consent|1|||
125879495|NCT00651742|452855405|FG000|Overall Study|Enrolled but not treated|1|||
125879496|NCT01535040|452855406|FG000|Overall Study|Physician Decision|0|||
125879497|NCT01535040|452855407|FG001|Overall Study|Physician Decision|1|||
125879498|NCT01535040|452855406|FG000|Overall Study|Withdrawal by Subject|13|||
125879499|NCT01535040|452855407|FG001|Overall Study|Withdrawal by Subject|10|||
125879500|NCT01535040|452855406|FG000|Overall Study|Never Started|9|||
125879501|NCT01535040|452855407|FG001|Overall Study|Never Started|4|||
125879502|NCT01535040|452855406|FG000|Overall Study|Toxicity|7|||
125879503|NCT01535040|452855407|FG001|Overall Study|Toxicity|5|||
125879504|NCT01535040|452855406|FG000|Overall Study|Multiple Reasons|1|||
125879505|NCT01535040|452855407|FG001|Overall Study|Multiple Reasons|1|||
125879506|NCT05430854|452855408|FG000|Overall Study|Trial terminated by Sponsor|39|||
125879507|NCT05430854|452855409|FG001|Overall Study|Trial terminated by Sponsor|50|||
125879508|NCT05430854|452855410|FG002|Overall Study|Trial terminated by Sponsor|46|||
125879509|NCT05430854|452855408|FG000|Overall Study|Withdrawal by Subject|0|||
125879510|NCT05430854|452855409|FG001|Overall Study|Withdrawal by Subject|3|||
125879511|NCT05430854|452855410|FG002|Overall Study|Withdrawal by Subject|0|||
125879512|NCT04314284|452855411|FG000|Overall Study|Withdrawal by Subject|4|||
125879513|NCT04314284|452855412|FG001|Overall Study|Withdrawal by Subject|7|||
125879514|NCT04314284|452855411|FG000|Overall Study|Consented but did not complete survey|0|||
125879515|NCT04314284|452855412|FG001|Overall Study|Consented but did not complete survey|6|||
125879516|NCT01652235|452855413|FG000|Overall Study|Death|9|||
125879517|NCT01652235|452855413|FG000|Overall Study|Lost to Follow-up|5|||
125879518|NCT01652235|452855413|FG000|Overall Study|Withdrawal by Subject|2|||
125879519|NCT02023086|452855414|FG000|Overall Study|Withdrawal by Subject|2|||
125879520|NCT02023086|452855415|FG001|Overall Study|Withdrawal by Subject|0|||
125879521|NCT02608684|452857277|FG000|Overall Study|Physician Decision|2|||
125879522|NCT02608684|452857277|FG000|Overall Study|Withdrawal by Subject|1|||
125879523|NCT00148317|452857278|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
125879524|NCT00148317|452857278|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
125879525|NCT00148317|452857278|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
125879526|NCT00124943|452857279|FG000|Phase II|Adverse Event|0|||
125879527|NCT00124943|452857280|FG001|Phase II|Adverse Event|2|||
125879528|NCT00124943|452857281|FG002|Phase II|Adverse Event|0|||
125879529|NCT00124943|452857282|FG003|Phase II|Adverse Event|1|||
125879530|NCT00124943|452857279|FG000|Phase II|Protocol Violation|0|||
125879531|NCT00124943|452857280|FG001|Phase II|Protocol Violation|0|||
126027507|NCT04936035|453397192|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
126027508|NCT04936035|453397193|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
126027509|NCT04936035|453397189|FG000|Overall Study|Reason Unknown|0|||
126027510|NCT04936035|453397190|FG001|Overall Study|Reason Unknown|0|||
126027511|NCT04936035|453397191|FG002|Overall Study|Reason Unknown|0|||
125879532|NCT00124943|452857281|FG002|Phase II|Protocol Violation|0|||
125879533|NCT00124943|452857282|FG003|Phase II|Protocol Violation|1|||
125879534|NCT00124943|452857279|FG000|Phase II|Lost to Follow-up|0|||
125879535|NCT00124943|452857280|FG001|Phase II|Lost to Follow-up|0|||
125879536|NCT00124943|452857281|FG002|Phase II|Lost to Follow-up|0|||
125879537|NCT00124943|452857282|FG003|Phase II|Lost to Follow-up|1|||
125879538|NCT00124943|452857279|FG000|Phase II|Withdrawal by Subject|0|||
125879539|NCT00124943|452857280|FG001|Phase II|Withdrawal by Subject|0|||
126027512|NCT04936035|453397192|FG003|Overall Study|Reason Unknown|0|||
126027513|NCT04936035|453397193|FG004|Overall Study|Reason Unknown|1|||
126027514|NCT04936035|453397189|FG000|Overall Study|Withdrawal by Subject|1|||
126027515|NCT04936035|453397190|FG001|Overall Study|Withdrawal by Subject|0|||
126027516|NCT04936035|453397191|FG002|Overall Study|Withdrawal by Subject|0|||
126027517|NCT04936035|453397192|FG003|Overall Study|Withdrawal by Subject|0|||
126027518|NCT04936035|453397193|FG004|Overall Study|Withdrawal by Subject|0|||
126027519|NCT04936035|453397189|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
126027520|NCT04936035|453397190|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
126027521|NCT04936035|453397191|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
126027522|NCT04936035|453397192|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
126027523|NCT04936035|453397193|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
126027524|NCT04936035|453397189|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
126247954|NCT02055547|454200379|FG004|Overall Study|Adverse Event|0|||
126247955|NCT02055547|454200380|FG005|Overall Study|Adverse Event|0|||
126247956|NCT02055547|454200381|FG006|Overall Study|Adverse Event|1|||
126247957|NCT02055547|454200382|FG007|Overall Study|Adverse Event|0|||
126247958|NCT02055547|454200383|FG008|Overall Study|Adverse Event|1|||
126247959|NCT02055547|454200384|FG009|Overall Study|Adverse Event|0|||
126247960|NCT02055547|454200385|FG010|Overall Study|Adverse Event|0|||
126247961|NCT02055547|454200386|FG011|Overall Study|Adverse Event|0|||
126247962|NCT02055547|454200387|FG012|Overall Study|Adverse Event|0|||
126247963|NCT02055547|454200388|FG013|Overall Study|Adverse Event|0|||
126247964|NCT02055547|454200389|FG014|Overall Study|Adverse Event|0|||
126247965|NCT02055547|454200390|FG015|Overall Study|Adverse Event|0|||
126247966|NCT02055547|454200391|FG016|Overall Study|Adverse Event|0|||
126247967|NCT02055547|454200392|FG017|Overall Study|Adverse Event|0|||
126247968|NCT02055547|454200393|FG018|Overall Study|Adverse Event|0|||
126247969|NCT02055547|454200375|FG000|Overall Study|Withdrawal by Subject|0|||
126247970|NCT02055547|454200376|FG001|Overall Study|Withdrawal by Subject|0|||
126247971|NCT02055547|454200377|FG002|Overall Study|Withdrawal by Subject|0|||
126247972|NCT02055547|454200378|FG003|Overall Study|Withdrawal by Subject|0|||
126247973|NCT02055547|454200379|FG004|Overall Study|Withdrawal by Subject|0|||
126247974|NCT02055547|454200380|FG005|Overall Study|Withdrawal by Subject|1|||
126247975|NCT02055547|454200381|FG006|Overall Study|Withdrawal by Subject|0|||
126247976|NCT02055547|454200382|FG007|Overall Study|Withdrawal by Subject|0|||
126247977|NCT02055547|454200383|FG008|Overall Study|Withdrawal by Subject|1|||
126247978|NCT02055547|454200384|FG009|Overall Study|Withdrawal by Subject|0|||
126247979|NCT02055547|454200385|FG010|Overall Study|Withdrawal by Subject|0|||
126247980|NCT02055547|454200386|FG011|Overall Study|Withdrawal by Subject|0|||
126247981|NCT02055547|454200387|FG012|Overall Study|Withdrawal by Subject|0|||
126247982|NCT02055547|454200388|FG013|Overall Study|Withdrawal by Subject|1|||
126247983|NCT02055547|454200389|FG014|Overall Study|Withdrawal by Subject|0|||
126247984|NCT02055547|454200390|FG015|Overall Study|Withdrawal by Subject|1|||
126247985|NCT02055547|454200391|FG016|Overall Study|Withdrawal by Subject|0|||
126247986|NCT02055547|454200392|FG017|Overall Study|Withdrawal by Subject|0|||
126247987|NCT02055547|454200393|FG018|Overall Study|Withdrawal by Subject|0|||
126247988|NCT02055547|454200375|FG000|Overall Study|Lost to Follow-up|0|||
126247989|NCT02055547|454200376|FG001|Overall Study|Lost to Follow-up|0|||
126247990|NCT02055547|454200377|FG002|Overall Study|Lost to Follow-up|1|||
126247991|NCT02055547|454200378|FG003|Overall Study|Lost to Follow-up|0|||
126247992|NCT02055547|454200379|FG004|Overall Study|Lost to Follow-up|0|||
126247993|NCT02055547|454200380|FG005|Overall Study|Lost to Follow-up|0|||
126247994|NCT02055547|454200381|FG006|Overall Study|Lost to Follow-up|0|||
126247995|NCT02055547|454200382|FG007|Overall Study|Lost to Follow-up|0|||
126247996|NCT02055547|454200383|FG008|Overall Study|Lost to Follow-up|0|||
126247997|NCT02055547|454200384|FG009|Overall Study|Lost to Follow-up|0|||
126247998|NCT02055547|454200385|FG010|Overall Study|Lost to Follow-up|0|||
126247999|NCT02055547|454200386|FG011|Overall Study|Lost to Follow-up|0|||
126248000|NCT02055547|454200387|FG012|Overall Study|Lost to Follow-up|0|||
126248001|NCT02055547|454200388|FG013|Overall Study|Lost to Follow-up|0|||
126248002|NCT02055547|454200389|FG014|Overall Study|Lost to Follow-up|0|||
126248003|NCT02055547|454200390|FG015|Overall Study|Lost to Follow-up|0|||
126248004|NCT02055547|454200391|FG016|Overall Study|Lost to Follow-up|0|||
125879540|NCT00124943|452857281|FG002|Phase II|Withdrawal by Subject|0|||
126248005|NCT02055547|454200392|FG017|Overall Study|Lost to Follow-up|0|||
125879541|NCT00124943|452857282|FG003|Phase II|Withdrawal by Subject|2|||
126248006|NCT02055547|454200393|FG018|Overall Study|Lost to Follow-up|0|||
126248007|NCT05098743|454200394|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
126248008|NCT05098743|454200395|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
126248009|NCT05098743|454200394|FG000|Overall Study|Lost to Follow-up|1|||
126248010|NCT05098743|454200395|FG001|Overall Study|Lost to Follow-up|2|||
126248011|NCT03719040|454200396|FG000|Overall Study|Withdrawal by Subject|177|||
126248012|NCT03719040|454200396|FG000|Overall Study|Lost to Follow-up|26|||
126248013|NCT02923349|454200398|FG000|Overall Study|Other|1|||
126248014|NCT02923349|454200399|FG001|Overall Study|Other|2|||
126248015|NCT02923349|454200400|FG002|Overall Study|Other|4|||
126248016|NCT02923349|454200401|FG003|Overall Study|Other|1|||
126248017|NCT02923349|454200402|FG004|Overall Study|Other|3|||
126248018|NCT02923349|454200403|FG005|Overall Study|Other|0|||
126094627|NCT00943852|453641416|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094628|NCT00943852|453641417|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094629|NCT00943852|453641418|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094630|NCT00943852|453641419|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
126094631|NCT00943852|453641420|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094632|NCT00943852|453641421|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094633|NCT00943852|453641422|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094634|NCT00943852|453641423|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094635|NCT00943852|453641424|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094636|NCT00943852|453641425|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126094637|NCT00943852|453641416|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094638|NCT00943852|453641417|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094639|NCT00943852|453641418|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094640|NCT00943852|453641419|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094641|NCT00943852|453641420|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094642|NCT00943852|453641421|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
126094643|NCT00943852|453641422|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094644|NCT00943852|453641423|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094645|NCT00943852|453641424|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094646|NCT00943852|453641425|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126094647|NCT00943852|453641416|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094648|NCT00943852|453641417|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094649|NCT00943852|453641418|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094650|NCT00943852|453641419|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094651|NCT00943852|453641420|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094652|NCT00943852|453641421|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094653|NCT00943852|453641422|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
126094654|NCT00943852|453641423|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094655|NCT00943852|453641424|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094656|NCT00943852|453641425|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126094657|NCT00943852|453641416|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094658|NCT00943852|453641417|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094659|NCT00943852|453641418|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094660|NCT00943852|453641419|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094661|NCT00943852|453641420|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094662|NCT00943852|453641421|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094663|NCT00943852|453641422|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094664|NCT00943852|453641423|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
126094665|NCT00943852|453641424|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094666|NCT00943852|453641425|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126094667|NCT00943852|453641416|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
126094668|NCT00943852|453641417|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126094669|NCT00943852|453641418|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
126094670|NCT00943852|453641419|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
126094671|NCT00943852|453641420|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126094672|NCT00943852|453641421|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126094673|NCT00943852|453641422|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
126094674|NCT00943852|453641423|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126094675|NCT00943852|453641424|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126094676|NCT00943852|453641425|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126248019|NCT02923349|454200404|FG006|Overall Study|Other|1|||
126248020|NCT02923349|454200398|FG000|Overall Study|Withdrawal by Subject|2|||
126248021|NCT02923349|454200399|FG001|Overall Study|Withdrawal by Subject|2|||
126248022|NCT02923349|454200400|FG002|Overall Study|Withdrawal by Subject|8|||
126027525|NCT04936035|453397190|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
126027526|NCT04936035|453397191|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
126027527|NCT04936035|453397192|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
126027528|NCT04936035|453397193|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
126027529|NCT04936035|453397189|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
126027530|NCT04936035|453397190|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
126027531|NCT04936035|453397191|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
126027532|NCT04936035|453397192|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
126027533|NCT04936035|453397193|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
126027534|NCT04402489|453398932|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
126027535|NCT04402489|453398933|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
126027536|NCT04402489|453398934|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
126027537|NCT04402489|453398935|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
126027538|NCT04402489|453398936|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
126027539|NCT04402489|453398932|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
126027540|NCT04402489|453398933|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
126027541|NCT04402489|453398934|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
126027542|NCT04402489|453398935|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
126027543|NCT04402489|453398936|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
126027544|NCT04402489|453398932|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
126027545|NCT04402489|453398933|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
126027546|NCT04402489|453398934|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
126027547|NCT04402489|453398935|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
126027548|NCT04402489|453398936|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
126027549|NCT04402489|453398932|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
126027550|NCT04402489|453398933|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
126027551|NCT04402489|453398934|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
126027552|NCT04402489|453398935|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
126027553|NCT04402489|453398936|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
126027554|NCT04402489|453398932|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
126248023|NCT02923349|454200401|FG003|Overall Study|Withdrawal by Subject|10|||
126248024|NCT02923349|454200402|FG004|Overall Study|Withdrawal by Subject|12|||
126248025|NCT02923349|454200403|FG005|Overall Study|Withdrawal by Subject|3|||
126248026|NCT02923349|454200404|FG006|Overall Study|Withdrawal by Subject|0|||
126248027|NCT02923349|454200398|FG000|Overall Study|Physician Decision|0|||
126248028|NCT02923349|454200399|FG001|Overall Study|Physician Decision|0|||
126248029|NCT02923349|454200400|FG002|Overall Study|Physician Decision|0|||
126248030|NCT02923349|454200401|FG003|Overall Study|Physician Decision|1|||
126248031|NCT02923349|454200402|FG004|Overall Study|Physician Decision|1|||
126248032|NCT02923349|454200403|FG005|Overall Study|Physician Decision|0|||
126248033|NCT02923349|454200404|FG006|Overall Study|Physician Decision|2|||
126248034|NCT02923349|454200398|FG000|Overall Study|Lost to Follow-up|0|||
126248035|NCT02923349|454200399|FG001|Overall Study|Lost to Follow-up|0|||
126248036|NCT02923349|454200400|FG002|Overall Study|Lost to Follow-up|3|||
126248037|NCT02923349|454200401|FG003|Overall Study|Lost to Follow-up|0|||
126248038|NCT02923349|454200402|FG004|Overall Study|Lost to Follow-up|1|||
126027555|NCT04402489|453398933|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
126027556|NCT04402489|453398934|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
126027557|NCT04402489|453398935|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
126248039|NCT02923349|454200403|FG005|Overall Study|Lost to Follow-up|1|||
126248040|NCT02923349|454200404|FG006|Overall Study|Lost to Follow-up|0|||
126248041|NCT02923349|454200398|FG000|Overall Study|Death|1|||
126027558|NCT04402489|453398936|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
126027559|NCT04402489|453398932|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
126027560|NCT04402489|453398933|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
126027561|NCT04402489|453398934|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
126027562|NCT04402489|453398935|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
126027563|NCT04402489|453398936|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
126027564|NCT04833777|453398943|FG000|Overall Study|Lost to Follow-up|1|||
126248042|NCT02923349|454200399|FG001|Overall Study|Death|0|||
126248043|NCT02923349|454200400|FG002|Overall Study|Death|2|||
126248044|NCT02923349|454200401|FG003|Overall Study|Death|4|||
126248045|NCT02923349|454200402|FG004|Overall Study|Death|2|||
126248046|NCT02923349|454200403|FG005|Overall Study|Death|3|||
126248047|NCT02923349|454200404|FG006|Overall Study|Death|0|||
126248048|NCT04063878|454200407|FG000|Overall Study|Withdrawal by Subject|2|||
126248049|NCT04063878|454200407|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
126248050|NCT02751827|454200408|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
126248051|NCT02751827|454200409|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
126248052|NCT02751827|454200410|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
126248053|NCT01248728|454200411|FG000|Overall Study|Adverse Event|1|||
126248054|NCT01248728|454200412|FG001|Overall Study|Adverse Event|1|||
126357739|NCT04518410|454602225|FG016|Overall Study|Withdrawal by Subject|0|||
126357740|NCT04518410|454602226|FG017|Overall Study|Withdrawal by Subject|15|||
126357741|NCT04518410|454602227|FG018|Overall Study|Withdrawal by Subject|12|||
126357742|NCT04518410|454602228|FG019|Overall Study|Withdrawal by Subject|9|||
126357743|NCT04518410|454602229|FG020|Overall Study|Withdrawal by Subject|14|||
126357744|NCT04518410|454602230|FG021|Overall Study|Withdrawal by Subject|3|||
126357745|NCT04518410|454602231|FG022|Overall Study|Withdrawal by Subject|2|||
126357746|NCT04518410|454602232|FG023|Overall Study|Withdrawal by Subject|9|||
126027565|NCT04833777|453398944|FG001|Overall Study|Lost to Follow-up|0|||
126027566|NCT01857934|453398947|FG000|Overall Study|Relapse or progression|2|||
126027567|NCT01857934|453398947|FG000|Overall Study|Unacceptable toxicity|3|||
126027568|NCT01857934|453398947|FG000|Overall Study|Unwillingness or inability to comply|2|||
126027569|NCT01857934|453398947|FG000|Overall Study|Physician Decision|3|||
126027570|NCT03713086|453398950|FG000|Overall Study|Withdrawal by Subject|0|||
126027571|NCT03713086|453398951|FG001|Overall Study|Withdrawal by Subject|2|||
126027572|NCT03713086|453398952|FG002|Overall Study|Withdrawal by Subject|1|||
126027573|NCT03713086|453398953|FG003|Overall Study|Withdrawal by Subject|0|||
126027574|NCT03713086|453398950|FG000|Overall Study|Lost to Follow-up|0|||
126027575|NCT03713086|453398951|FG001|Overall Study|Lost to Follow-up|1|||
126027576|NCT03713086|453398952|FG002|Overall Study|Lost to Follow-up|0|||
126027577|NCT03713086|453398953|FG003|Overall Study|Lost to Follow-up|1|||
126027578|NCT05059262|453398960|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
126027579|NCT05059262|453398961|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
126027580|NCT05059262|453398960|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
126027581|NCT05059262|453398961|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
126027582|NCT05059262|453398960|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
126027583|NCT05059262|453398961|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
126027584|NCT05059262|453398960|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
126027585|NCT05059262|453398961|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
126027586|NCT05059262|453398960|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
126027587|NCT05059262|453398961|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
126027588|NCT05059262|453398960|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
126027589|NCT05059262|453398961|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
126027590|NCT05059262|453398960|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
126027591|NCT05059262|453398961|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
126027592|NCT05059262|453398960|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
126027593|NCT05059262|453398961|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
126027594|NCT05059262|453398960|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
126027595|NCT05059262|453398961|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
126027596|NCT02312960|453398980|FG000|Overall Study|Death|24|||
126027597|NCT02312960|453398981|FG001|Overall Study|Death|32|||
126248055|NCT01248728|454200411|FG000|Overall Study|Withdrawal by Subject|2|||
126357747|NCT04518410|454602233|FG024|Overall Study|Withdrawal by Subject|8|||
126357748|NCT04518410|454602209|FG000|Overall Study|Other|1|||
126027598|NCT02312960|453398982|FG002|Overall Study|Death|25|||
126027599|NCT02312960|453398983|FG003|Overall Study|Death|11|||
126248056|NCT01248728|454200412|FG001|Overall Study|Withdrawal by Subject|1|||
126248057|NCT01248728|454200411|FG000|Overall Study|Lack of Efficacy|1|||
126248058|NCT01248728|454200412|FG001|Overall Study|Lack of Efficacy|0|||
126248059|NCT00147498|454200413|FG000|Overall Study|Adverse Event|1|||
126248060|NCT00147498|454200414|FG001|Overall Study|Adverse Event|6|||
126248061|NCT00147498|454200415|FG002|Overall Study|Adverse Event|7|||
126248062|NCT00147498|454200416|FG003|Overall Study|Adverse Event|3|||
126248063|NCT00147498|454200413|FG000|Overall Study|Lack of Efficacy|1|||
126248064|NCT00147498|454200414|FG001|Overall Study|Lack of Efficacy|1|||
126248065|NCT00147498|454200415|FG002|Overall Study|Lack of Efficacy|1|||
126248066|NCT00147498|454200416|FG003|Overall Study|Lack of Efficacy|8|||
126248067|NCT00147498|454200413|FG000|Overall Study|Laboratory abnormality|0|||
126248068|NCT00147498|454200414|FG001|Overall Study|Laboratory abnormality|0|||
126248069|NCT00147498|454200415|FG002|Overall Study|Laboratory abnormality|2|||
126248070|NCT00147498|454200416|FG003|Overall Study|Laboratory abnormality|0|||
126248071|NCT00147498|454200413|FG000|Overall Study|Participant defaulted|0|||
126248072|NCT00147498|454200414|FG001|Overall Study|Participant defaulted|1|||
126248073|NCT00147498|454200415|FG002|Overall Study|Participant defaulted|4|||
126248074|NCT00147498|454200416|FG003|Overall Study|Participant defaulted|3|||
126248075|NCT00147498|454200413|FG000|Overall Study|Other|1|||
126248076|NCT00147498|454200414|FG001|Overall Study|Other|1|||
126248077|NCT00147498|454200415|FG002|Overall Study|Other|3|||
126248078|NCT00147498|454200416|FG003|Overall Study|Other|3|||
126248079|NCT01838681|454200417|FG000|Period A|Adverse Event|39|||
126248080|NCT01838681|454200418|FG001|Period A|Adverse Event|0|||
126248081|NCT01838681|454200419|FG002|Period A|Adverse Event|0|||
126248082|NCT01838681|454200420|FG003|Period A|Adverse Event|0|||
126248083|NCT01838681|454200417|FG000|Period A|Lack of Efficacy|21|||
126248084|NCT01838681|454200418|FG001|Period A|Lack of Efficacy|0|||
126248085|NCT01838681|454200419|FG002|Period A|Lack of Efficacy|0|||
126248086|NCT01838681|454200420|FG003|Period A|Lack of Efficacy|0|||
126248087|NCT01838681|454200417|FG000|Period A|Early response|148|||
126248088|NCT01838681|454200418|FG001|Period A|Early response|0|||
126248089|NCT01838681|454200419|FG002|Period A|Early response|0|||
126248090|NCT01838681|454200420|FG003|Period A|Early response|0|||
126248091|NCT01838681|454200417|FG000|Period A|Withdrawal by Subject|70|||
126248092|NCT01838681|454200418|FG001|Period A|Withdrawal by Subject|0|||
126248093|NCT01838681|454200419|FG002|Period A|Withdrawal by Subject|0|||
126248094|NCT01838681|454200420|FG003|Period A|Withdrawal by Subject|0|||
126248095|NCT01838681|454200417|FG000|Period A|Protocol Violation|16|||
126248096|NCT01838681|454200418|FG001|Period A|Protocol Violation|0|||
126248097|NCT01838681|454200419|FG002|Period A|Protocol Violation|0|||
126248098|NCT01838681|454200420|FG003|Period A|Protocol Violation|0|||
126248099|NCT01838681|454200417|FG000|Period A|Non-compliance with IMP|6|||
126248100|NCT01838681|454200418|FG001|Period A|Non-compliance with IMP|0|||
126248101|NCT01838681|454200419|FG002|Period A|Non-compliance with IMP|0|||
126248102|NCT01838681|454200420|FG003|Period A|Non-compliance with IMP|0|||
126248103|NCT01838681|454200417|FG000|Period A|Lost to Follow-up|4|||
126248104|NCT01838681|454200418|FG001|Period A|Lost to Follow-up|0|||
126248105|NCT01838681|454200419|FG002|Period A|Lost to Follow-up|0|||
126248106|NCT01838681|454200420|FG003|Period A|Lost to Follow-up|0|||
126248107|NCT01838681|454200417|FG000|Period A|Withdrawal before treatment|4|||
126248108|NCT01838681|454200418|FG001|Period A|Withdrawal before treatment|0|||
126248109|NCT01838681|454200419|FG002|Period A|Withdrawal before treatment|0|||
126248110|NCT01838681|454200420|FG003|Period A|Withdrawal before treatment|0|||
126248111|NCT01838681|454200417|FG000|Period A|Administrative or other reasons|17|||
126248112|NCT01838681|454200418|FG001|Period A|Administrative or other reasons|0|||
126248113|NCT01838681|454200419|FG002|Period A|Administrative or other reasons|0|||
126248114|NCT01838681|454200420|FG003|Period A|Administrative or other reasons|0|||
126248115|NCT01838681|454200417|FG000|Period B/A+|Adverse Event|0|||
126248116|NCT01838681|454200418|FG001|Period B/A+|Adverse Event|13|||
126248117|NCT01838681|454200419|FG002|Period B/A+|Adverse Event|27|||
126248118|NCT01838681|454200420|FG003|Period B/A+|Adverse Event|16|||
126248119|NCT01838681|454200417|FG000|Period B/A+|Lack of Efficacy|0|||
126248120|NCT01838681|454200418|FG001|Period B/A+|Lack of Efficacy|9|||
126248121|NCT01838681|454200419|FG002|Period B/A+|Lack of Efficacy|11|||
126248122|NCT01838681|454200420|FG003|Period B/A+|Lack of Efficacy|6|||
126248123|NCT01838681|454200417|FG000|Period B/A+|Withdrawal by Subject|0|||
126248124|NCT01838681|454200418|FG001|Period B/A+|Withdrawal by Subject|28|||
126248125|NCT01838681|454200419|FG002|Period B/A+|Withdrawal by Subject|35|||
126248126|NCT01838681|454200420|FG003|Period B/A+|Withdrawal by Subject|47|||
126248127|NCT01838681|454200417|FG000|Period B/A+|Protocol Violation|0|||
126248128|NCT01838681|454200418|FG001|Period B/A+|Protocol Violation|1|||
126248129|NCT01838681|454200419|FG002|Period B/A+|Protocol Violation|4|||
126248130|NCT01838681|454200420|FG003|Period B/A+|Protocol Violation|6|||
126248131|NCT01838681|454200417|FG000|Period B/A+|Non-compliance with IMP|0|||
126248132|NCT01838681|454200418|FG001|Period B/A+|Non-compliance with IMP|2|||
126248133|NCT01838681|454200419|FG002|Period B/A+|Non-compliance with IMP|3|||
126248134|NCT01838681|454200420|FG003|Period B/A+|Non-compliance with IMP|3|||
126248135|NCT01838681|454200417|FG000|Period B/A+|Lost to Follow-up|0|||
126248136|NCT01838681|454200418|FG001|Period B/A+|Lost to Follow-up|2|||
126248137|NCT01838681|454200419|FG002|Period B/A+|Lost to Follow-up|5|||
126248138|NCT01838681|454200420|FG003|Period B/A+|Lost to Follow-up|11|||
126248139|NCT01838681|454200417|FG000|Period B/A+|Withdrawal before treatment|0|||
126248140|NCT01838681|454200418|FG001|Period B/A+|Withdrawal before treatment|1|||
126248141|NCT01838681|454200419|FG002|Period B/A+|Withdrawal before treatment|0|||
126248142|NCT01838681|454200420|FG003|Period B/A+|Withdrawal before treatment|0|||
126248143|NCT01838681|454200417|FG000|Period B/A+|Administrative or other reasons|0|||
126248144|NCT01838681|454200418|FG001|Period B/A+|Administrative or other reasons|6|||
126248145|NCT01838681|454200419|FG002|Period B/A+|Administrative or other reasons|10|||
126248146|NCT01838681|454200420|FG003|Period B/A+|Administrative or other reasons|28|||
126248147|NCT01279486|454200421|FG000|Overall Study|Lost to Follow-up|1|||
126248148|NCT04198363|454200423|FG000|Overall Study|Adverse Event|1|||
126248149|NCT04198363|454200424|FG001|Overall Study|Adverse Event|1|||
126248150|NCT04198363|454200423|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
126248151|NCT04198363|454200424|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
126248152|NCT04198363|454200423|FG000|Overall Study|Reason not Specified|1|||
126248153|NCT04198363|454200424|FG001|Overall Study|Reason not Specified|0|||
126248154|NCT03067987|454200426|FG000|Overall Study|Lost to Follow-up|7|||
126248155|NCT03067987|454200427|FG001|Overall Study|Lost to Follow-up|10|||
126248156|NCT03067987|454200426|FG000|Overall Study|Protocol Violation|1|||
126248157|NCT03067987|454200427|FG001|Overall Study|Protocol Violation|2|||
126248158|NCT03067987|454200426|FG000|Overall Study|Withdrawal by Subject|2|||
126248159|NCT03067987|454200427|FG001|Overall Study|Withdrawal by Subject|1|||
126248160|NCT01404988|454200430|FG000|Overall Study|Death|2|||
126248161|NCT01404988|454200431|FG001|Overall Study|Death|0|||
126248162|NCT01404988|454200432|FG002|Overall Study|Death|2|||
126248163|NCT01404988|454200430|FG000|Overall Study|Adverse Event|1|||
126248164|NCT01404988|454200431|FG001|Overall Study|Adverse Event|0|||
125879542|NCT03829228|452857283|FG000|Overall Study|Protocol Violation|1|||
126248165|NCT01404988|454200432|FG002|Overall Study|Adverse Event|0|||
126248166|NCT01404988|454200430|FG000|Overall Study|Withdrawal by Subject|2|||
126248167|NCT01404988|454200431|FG001|Overall Study|Withdrawal by Subject|2|||
126248168|NCT01404988|454200432|FG002|Overall Study|Withdrawal by Subject|0|||
126248169|NCT01404988|454200430|FG000|Overall Study|Lost to Follow-up|1|||
126027600|NCT02312960|453398984|FG004|Overall Study|Death|5|||
126027601|NCT02312960|453398985|FG005|Overall Study|Death|5|||
126027602|NCT02312960|453398986|FG006|Overall Study|Death|8|||
126027603|NCT02312960|453398987|FG007|Overall Study|Death|5|||
126027604|NCT02312960|453398988|FG008|Overall Study|Death|7|||
126027605|NCT02312960|453398989|FG009|Overall Study|Death|3|||
126027606|NCT02312960|453398990|FG010|Overall Study|Death|3|||
126027607|NCT02312960|453398991|FG011|Overall Study|Death|1|||
126027608|NCT02312960|453398992|FG012|Overall Study|Death|25|||
126027609|NCT02312960|453398993|FG013|Overall Study|Death|19|||
126027610|NCT02312960|453398980|FG000|Overall Study|Missing|0|||
126027611|NCT02312960|453398981|FG001|Overall Study|Missing|0|||
126027612|NCT02312960|453398982|FG002|Overall Study|Missing|2|||
126027613|NCT02312960|453398983|FG003|Overall Study|Missing|0|||
126027614|NCT02312960|453398984|FG004|Overall Study|Missing|0|||
126027615|NCT02312960|453398985|FG005|Overall Study|Missing|0|||
126027616|NCT02312960|453398986|FG006|Overall Study|Missing|0|||
126027617|NCT02312960|453398987|FG007|Overall Study|Missing|0|||
126027618|NCT02312960|453398988|FG008|Overall Study|Missing|0|||
126027619|NCT02312960|453398989|FG009|Overall Study|Missing|0|||
126027620|NCT02312960|453398990|FG010|Overall Study|Missing|0|||
126027621|NCT02312960|453398991|FG011|Overall Study|Missing|0|||
126027622|NCT02312960|453398992|FG012|Overall Study|Missing|0|||
126027623|NCT02312960|453398993|FG013|Overall Study|Missing|0|||
126027624|NCT02312960|453398980|FG000|Overall Study|Lost to Follow-up|0|||
126027625|NCT02312960|453398981|FG001|Overall Study|Lost to Follow-up|0|||
126027626|NCT02312960|453398982|FG002|Overall Study|Lost to Follow-up|1|||
126027627|NCT02312960|453398983|FG003|Overall Study|Lost to Follow-up|0|||
126027628|NCT02312960|453398984|FG004|Overall Study|Lost to Follow-up|0|||
126027629|NCT02312960|453398985|FG005|Overall Study|Lost to Follow-up|0|||
126027630|NCT02312960|453398986|FG006|Overall Study|Lost to Follow-up|1|||
126027631|NCT02312960|453398987|FG007|Overall Study|Lost to Follow-up|1|||
126027632|NCT02312960|453398988|FG008|Overall Study|Lost to Follow-up|0|||
126027633|NCT02312960|453398989|FG009|Overall Study|Lost to Follow-up|1|||
126027634|NCT02312960|453398990|FG010|Overall Study|Lost to Follow-up|0|||
126248170|NCT01404988|454200431|FG001|Overall Study|Lost to Follow-up|2|||
126248171|NCT01404988|454200432|FG002|Overall Study|Lost to Follow-up|1|||
126248172|NCT02588339|454200433|FG000|Overall Study|Withdrawal by Subject|1|||
126248173|NCT02588339|454200433|FG000|Overall Study|GVHD Progression prior to treatment|2|||
126094677|NCT00941070|453641427|FG000|Overall Study|Patient non-compliant|1|||
126094678|NCT01416389|453641430|FG000|Overall Study|Lost to Follow-up|1|||
126094679|NCT01416389|453641431|FG001|Overall Study|Lost to Follow-up|0|||
126094680|NCT01416389|453641430|FG000|Overall Study|Started New Therapy|2|||
126094681|NCT01416389|453641431|FG001|Overall Study|Started New Therapy|0|||
126094682|NCT01125514|453641432|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
126094683|NCT01125514|453641432|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
126094684|NCT01125514|453641432|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
126094685|NCT01125514|453641432|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
126094686|NCT01125514|453641432|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
126094687|NCT01125514|453641432|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
126094688|NCT00858364|453641435|FG000|Overall Study|Administrative Decision|3|||
126248174|NCT00373256|454202156|FG000|Overall Study|Adverse Event (AE)|1|||
126248175|NCT00373256|454202157|FG001|Overall Study|Adverse Event (AE)|5|||
126248176|NCT00373256|454202156|FG000|Overall Study|Lost to Follow-up|2|||
126357749|NCT04518410|454602210|FG001|Overall Study|Other|0|||
126027635|NCT02312960|453398991|FG011|Overall Study|Lost to Follow-up|0|||
126027636|NCT02312960|453398992|FG012|Overall Study|Lost to Follow-up|1|||
126027637|NCT02312960|453398993|FG013|Overall Study|Lost to Follow-up|0|||
126027638|NCT02312960|453398980|FG000|Overall Study|Withdrawal by Subject|1|||
126027639|NCT02312960|453398981|FG001|Overall Study|Withdrawal by Subject|2|||
126094689|NCT00858364|453641436|FG001|Overall Study|Administrative Decision|2|||
126094690|NCT00858364|453641435|FG000|Overall Study|Adverse Event|5|||
126094691|NCT00858364|453641436|FG001|Overall Study|Adverse Event|2|||
126248177|NCT00373256|454202157|FG001|Overall Study|Lost to Follow-up|1|||
126248178|NCT00373256|454202156|FG000|Overall Study|Death|9|||
126027640|NCT02312960|453398982|FG002|Overall Study|Withdrawal by Subject|0|||
126027641|NCT02312960|453398983|FG003|Overall Study|Withdrawal by Subject|0|||
126027642|NCT02312960|453398984|FG004|Overall Study|Withdrawal by Subject|1|||
126027643|NCT02312960|453398985|FG005|Overall Study|Withdrawal by Subject|0|||
126027644|NCT02312960|453398986|FG006|Overall Study|Withdrawal by Subject|1|||
126027645|NCT02312960|453398987|FG007|Overall Study|Withdrawal by Subject|2|||
126027646|NCT02312960|453398988|FG008|Overall Study|Withdrawal by Subject|2|||
126248179|NCT00373256|454202157|FG001|Overall Study|Death|8|||
126248180|NCT00373256|454202156|FG000|Overall Study|Objective Progression or Relapse|111|||
126248181|NCT00373256|454202157|FG001|Overall Study|Objective Progression or Relapse|104|||
126248182|NCT00373256|454202156|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
126094692|NCT00858364|453641435|FG000|Overall Study|Withdrawal by Subject|44|||
126094693|NCT00858364|453641436|FG001|Overall Study|Withdrawal by Subject|118|||
126094694|NCT00858364|453641435|FG000|Overall Study|Ineligibility Determined|1|||
126094695|NCT00858364|453641436|FG001|Overall Study|Ineligibility Determined|10|||
126094696|NCT00858364|453641435|FG000|Overall Study|Lost to Follow-up|24|||
126094697|NCT00858364|453641436|FG001|Overall Study|Lost to Follow-up|54|||
126094698|NCT00858364|453641435|FG000|Overall Study|Noncompliance|3|||
126094699|NCT00858364|453641436|FG001|Overall Study|Noncompliance|4|||
126094700|NCT00858364|453641435|FG000|Overall Study|Protocol Deviation|0|||
126094701|NCT00858364|453641436|FG001|Overall Study|Protocol Deviation|2|||
126094702|NCT00858364|453641435|FG000|Overall Study|Other|9|||
126094703|NCT00858364|453641436|FG001|Overall Study|Other|17|||
126094704|NCT00858364|453641435|FG000|Overall Study|Missing|1|||
126094705|NCT00858364|453641436|FG001|Overall Study|Missing|1|||
126094706|NCT00858364|453641435|FG000|Overall Study|Still on-study|114|||
126094707|NCT00858364|453641436|FG001|Overall Study|Still on-study|247|||
126094708|NCT02755818|453641437|FG000|Overall Study|Withdrawal by Subject|0|||
126094709|NCT02755818|453641438|FG001|Overall Study|Withdrawal by Subject|0|||
126094710|NCT02755818|453641439|FG002|Overall Study|Withdrawal by Subject|0|||
126248183|NCT00373256|454202157|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
126248184|NCT00373256|454202156|FG000|Overall Study|Other|73|||
126094711|NCT02755818|453641440|FG003|Overall Study|Withdrawal by Subject|2|||
126094712|NCT02755818|453641437|FG000|Overall Study|withdrawal by PI|0|||
126094713|NCT02755818|453641438|FG001|Overall Study|withdrawal by PI|0|||
126248185|NCT00373256|454202157|FG001|Overall Study|Other|107|||
126248186|NCT00373256|454202156|FG000|Overall Study|Protocol Violation|0|||
126248187|NCT00373256|454202157|FG001|Overall Study|Protocol Violation|2|||
126248188|NCT00373256|454202156|FG000|Overall Study|Study Terminated by Sponsor|41|||
126248189|NCT00373256|454202157|FG001|Overall Study|Study Terminated by Sponsor|13|||
126248190|NCT04372238|454202158|FG000|Overall Study|Duplicate|3|||
126248191|NCT04372238|454202159|FG001|Overall Study|Duplicate|3|||
126248192|NCT04372238|454202158|FG000|Overall Study|Did not consent for data linkage|6|||
126248193|NCT04372238|454202159|FG001|Overall Study|Did not consent for data linkage|10|||
126248194|NCT05497557|454202171|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
126248195|NCT05497557|454202172|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
126248196|NCT05497557|454202173|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
126248197|NCT02752074|454202174|FG000|Overall Study|Lost to Follow-up|1|||
126248198|NCT02752074|454202175|FG001|Overall Study|Lost to Follow-up|4|||
126248199|NCT02752074|454202174|FG000|Overall Study|Death|146|||
126248200|NCT02752074|454202175|FG001|Overall Study|Death|129|||
126248201|NCT02752074|454202174|FG000|Overall Study|Withdrawal by Subject|9|||
126248202|NCT02752074|454202175|FG001|Overall Study|Withdrawal by Subject|10|||
126248203|NCT02392195|454202178|FG000|Overall Study|Lost to Follow-up|4|||
126248204|NCT02392195|454202178|FG000|Overall Study|Withdrawal by Subject|4|||
126248205|NCT00545792|454202181|FG000|Overall Study|Withdrawal by Subject|1|||
126248206|NCT03679598|454202183|FG000|Overall Study|Adverse Event|2|||
126248207|NCT03679598|454202184|FG001|Overall Study|Adverse Event|0|||
126248208|NCT01701063|454202189|FG000|Overall Study|Lost to Follow-up|0|||
126248209|NCT01701063|454202190|FG001|Overall Study|Lost to Follow-up|1|||
126248210|NCT01701063|454202191|FG002|Overall Study|Lost to Follow-up|0|||
126248211|NCT01701063|454202189|FG000|Overall Study|Withdrawal by Subject|0|||
126248212|NCT01701063|454202190|FG001|Overall Study|Withdrawal by Subject|0|||
126248213|NCT01701063|454202191|FG002|Overall Study|Withdrawal by Subject|1|||
126248214|NCT01701063|454202189|FG000|Overall Study|Other|0|||
126248215|NCT01701063|454202190|FG001|Overall Study|Other|0|||
126248216|NCT01701063|454202191|FG002|Overall Study|Other|1|||
126248217|NCT04474405|454202192|FG000|Overall Study|Withdrawal by Subject|0|||
126248218|NCT04474405|454202193|FG001|Overall Study|Withdrawal by Subject|0|||
126248219|NCT04474405|454202194|FG002|Overall Study|Withdrawal by Subject|1|||
126248220|NCT04474405|454202195|FG003|Overall Study|Withdrawal by Subject|0|||
126248221|NCT04474405|454202196|FG004|Overall Study|Withdrawal by Subject|1|||
126248222|NCT04474405|454202197|FG005|Overall Study|Withdrawal by Subject|0|||
126248223|NCT04474405|454202192|FG000|Overall Study|Other|0|||
126248224|NCT04474405|454202193|FG001|Overall Study|Other|0|||
126357750|NCT04518410|454602211|FG002|Overall Study|Other|0|||
126357751|NCT04518410|454602212|FG003|Overall Study|Other|1|||
126357752|NCT04518410|454602213|FG004|Overall Study|Other|6|||
126357753|NCT04518410|454602214|FG005|Overall Study|Other|6|||
126357754|NCT04518410|454602215|FG006|Overall Study|Other|5|||
126357755|NCT04518410|454602216|FG007|Overall Study|Other|2|||
126357756|NCT04518410|454602217|FG008|Overall Study|Other|0|||
126094714|NCT02755818|453641439|FG002|Overall Study|withdrawal by PI|1|||
126094715|NCT02755818|453641440|FG003|Overall Study|withdrawal by PI|1|||
126094716|NCT02535091|453641443|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
126248225|NCT04474405|454202194|FG002|Overall Study|Other|0|||
126248226|NCT04474405|454202195|FG003|Overall Study|Other|0|||
126094717|NCT02535091|453641444|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
126248227|NCT04474405|454202196|FG004|Overall Study|Other|3|||
126248228|NCT04474405|454202197|FG005|Overall Study|Other|0|||
126357757|NCT04518410|454602218|FG009|Overall Study|Other|1|||
126094718|NCT02535091|453641445|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
126094719|NCT02535091|453641443|FG000|Overall Study|Withdrawal by Subject|14|||
126094720|NCT02535091|453641444|FG001|Overall Study|Withdrawal by Subject|5|||
126094721|NCT02535091|453641445|FG002|Overall Study|Withdrawal by Subject|121|||
126094722|NCT02535091|453641443|FG000|Overall Study|Adverse Event|9|||
126094723|NCT02535091|453641444|FG001|Overall Study|Adverse Event|4|||
126094724|NCT02535091|453641445|FG002|Overall Study|Adverse Event|170|||
126094725|NCT02535091|453641443|FG000|Overall Study|Other|4|||
126094726|NCT02535091|453641444|FG001|Overall Study|Other|3|||
126094727|NCT02535091|453641445|FG002|Overall Study|Other|81|||
126094728|NCT02535091|453641443|FG000|Overall Study|Lost to Follow-up|0|||
126094729|NCT02535091|453641444|FG001|Overall Study|Lost to Follow-up|1|||
126094730|NCT02535091|453641445|FG002|Overall Study|Lost to Follow-up|19|||
126094731|NCT02535091|453641443|FG000|Overall Study|Protocol Violation|0|||
126094732|NCT02535091|453641444|FG001|Overall Study|Protocol Violation|1|||
126094733|NCT02535091|453641445|FG002|Overall Study|Protocol Violation|11|||
126094734|NCT02535091|453641443|FG000|Overall Study|Pregnancy|0|||
126094735|NCT02535091|453641444|FG001|Overall Study|Pregnancy|0|||
126094736|NCT02535091|453641445|FG002|Overall Study|Pregnancy|7|||
126094737|NCT01127763|453641446|FG000|Overall Study|Adverse Event|2|||
126094738|NCT01127763|453641446|FG000|Overall Study|Withdrawal by Subject|1|||
126094739|NCT01127763|453641446|FG000|Overall Study|Physician Decision|2|||
126094740|NCT01769326|453641447|FG000|Overall Study|Lost to Follow-up|1|||
126248229|NCT04723693|454202198|FG000|Overall Study|Withdrawal by Subject|2|||
126248230|NCT01410227|454202199|FG000|Overall Study|Adverse Event|1|||
126248231|NCT01410227|454202200|FG001|Overall Study|Adverse Event|0|||
126248232|NCT01410227|454202201|FG002|Overall Study|Adverse Event|0|||
126248233|NCT01410227|454202202|FG003|Overall Study|Adverse Event|0|||
126248234|NCT01410227|454202199|FG000|Overall Study|Withdrawal by Subject|3|||
126248235|NCT01410227|454202200|FG001|Overall Study|Withdrawal by Subject|0|||
126248236|NCT01410227|454202201|FG002|Overall Study|Withdrawal by Subject|1|||
125879543|NCT01462370|452857290|FG000|Overall Study|Lack of Qualifying Event|1|||
126094741|NCT01769326|453641448|FG001|Overall Study|Lost to Follow-up|2|||
126248237|NCT01410227|454202202|FG003|Overall Study|Withdrawal by Subject|0|||
126248238|NCT01410227|454202199|FG000|Overall Study|Pregnancy|0|||
126248239|NCT01410227|454202200|FG001|Overall Study|Pregnancy|0|||
126248240|NCT01410227|454202201|FG002|Overall Study|Pregnancy|0|||
126248241|NCT01410227|454202202|FG003|Overall Study|Pregnancy|1|||
126248242|NCT01410227|454202199|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
126248243|NCT01410227|454202200|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
126248244|NCT01410227|454202201|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
126248245|NCT01410227|454202202|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
126248246|NCT02890992|454202203|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248247|NCT02890992|454202204|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
126248248|NCT02890992|454202205|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248249|NCT02890992|454202206|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248250|NCT02890992|454202207|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248251|NCT02890992|454202208|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248252|NCT02890992|454202209|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248253|NCT02890992|454202210|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248254|NCT02890992|454202203|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248255|NCT02890992|454202204|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248256|NCT02890992|454202205|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248257|NCT02890992|454202206|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248258|NCT02890992|454202207|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248259|NCT02890992|454202208|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248260|NCT02890992|454202209|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
126248261|NCT02890992|454202210|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
126248262|NCT02890992|454202203|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248263|NCT02890992|454202204|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
126248264|NCT02890992|454202205|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248265|NCT02890992|454202206|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248266|NCT02890992|454202207|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248267|NCT02890992|454202208|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248268|NCT02890992|454202209|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248269|NCT02890992|454202210|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248270|NCT00669162|454202211|FG000|Overall Study|Withdrawal by Subject|1|||
126248271|NCT00807495|454202212|FG000|Overall Study|Adverse Event|6|||
126094742|NCT01769326|453641449|FG002|Overall Study|Lost to Follow-up|0|||
126094743|NCT01769326|453641450|FG003|Overall Study|Lost to Follow-up|0|||
126094744|NCT01769326|453641447|FG000|Overall Study|unrelated injry|1|||
126094745|NCT01769326|453641448|FG001|Overall Study|unrelated injry|1|||
126094746|NCT01769326|453641449|FG002|Overall Study|unrelated injry|0|||
126248272|NCT00807495|454202213|FG001|Overall Study|Adverse Event|3|||
126248273|NCT00807495|454202214|FG002|Overall Study|Adverse Event|1|||
126248274|NCT00807495|454202215|FG003|Overall Study|Adverse Event|1|||
126248275|NCT00807495|454202216|FG004|Overall Study|Adverse Event|2|||
126248276|NCT00807495|454202212|FG000|Overall Study|Withdrawal by Patient|2|||
126248277|NCT00807495|454202213|FG001|Overall Study|Withdrawal by Patient|0|||
126248278|NCT00807495|454202214|FG002|Overall Study|Withdrawal by Patient|1|||
126027647|NCT02312960|453398989|FG009|Overall Study|Withdrawal by Subject|3|||
126027648|NCT02312960|453398990|FG010|Overall Study|Withdrawal by Subject|0|||
126027649|NCT02312960|453398991|FG011|Overall Study|Withdrawal by Subject|0|||
126027650|NCT02312960|453398992|FG012|Overall Study|Withdrawal by Subject|2|||
126027651|NCT02312960|453398993|FG013|Overall Study|Withdrawal by Subject|0|||
126027652|NCT02900924|453399000|FG000|Overall Study|Death|52|||
126027653|NCT02900924|453399000|FG000|Overall Study|Lost to Follow-up|4|||
126027654|NCT02900924|453399000|FG000|Overall Study|Withdrawal by Subject|20|||
126027655|NCT02900924|453399000|FG000|Overall Study|Missed Visit|33|||
126027656|NCT02365766|453399020|FG000|Overall Study|Withdrawal by Subject|0|||
126027657|NCT02365766|453399021|FG001|Overall Study|Withdrawal by Subject|0|||
126027658|NCT02365766|453399022|FG002|Overall Study|Withdrawal by Subject|1|||
126027659|NCT02365766|453399020|FG000|Overall Study|Eligibility Criteria Not Met|0|||
126027660|NCT02365766|453399021|FG001|Overall Study|Eligibility Criteria Not Met|0|||
126027661|NCT02365766|453399022|FG002|Overall Study|Eligibility Criteria Not Met|1|||
126027662|NCT05956002|453399024|FG000|Treatment Period 3|Adverse Event|0|||
126027663|NCT05956002|453399025|FG001|Treatment Period 3|Adverse Event|0|||
126027664|NCT05956002|453399026|FG002|Treatment Period 3|Adverse Event|1|||
126027665|NCT05956002|453399027|FG003|Treatment Period 3|Adverse Event|0|||
126027666|NCT02307565|453399030|FG000|Overall Study|Adverse Event|3|||
126027667|NCT02307565|453399031|FG001|Overall Study|Adverse Event|2|||
126027668|NCT02307565|453399030|FG000|Overall Study|Withdrawal by Subject|2|||
126027669|NCT02307565|453399031|FG001|Overall Study|Withdrawal by Subject|2|||
126027670|NCT03385629|453399032|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
126027671|NCT03385629|453399033|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
126027672|NCT03385629|453399032|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
126027673|NCT03385629|453399033|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
126027674|NCT03385629|453399032|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
126027675|NCT03385629|453399033|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
126027676|NCT02913872|453399038|FG000|Overall Study|Withdrawal by Subject|1|||
126027677|NCT03978871|453399039|FG000|Overall Study|Lost to Follow-up|11|||
126027678|NCT03978871|453399040|FG001|Overall Study|Lost to Follow-up|12|||
126027679|NCT04072822|453399041|FG000|Treatment|Adverse Event|9|||
126027680|NCT04072822|453399042|FG001|Treatment|Adverse Event|5|||
126248279|NCT00807495|454202215|FG003|Overall Study|Withdrawal by Patient|0|||
126248280|NCT00807495|454202216|FG004|Overall Study|Withdrawal by Patient|0|||
126248281|NCT00807495|454202212|FG000|Overall Study|Reason Not Specified|0|||
126248282|NCT00807495|454202213|FG001|Overall Study|Reason Not Specified|3|||
126248283|NCT00807495|454202214|FG002|Overall Study|Reason Not Specified|2|||
126248284|NCT00807495|454202215|FG003|Overall Study|Reason Not Specified|0|||
126248285|NCT00807495|454202216|FG004|Overall Study|Reason Not Specified|3|||
126248286|NCT02412852|454202220|FG000|Overall Study|Withdrawal by Subject|0|||
126248287|NCT02412852|454202221|FG001|Overall Study|Withdrawal by Subject|1|||
126248288|NCT02412852|454202222|FG002|Overall Study|Withdrawal by Subject|0|||
126248289|NCT02412852|454202223|FG003|Overall Study|Withdrawal by Subject|0|||
126248290|NCT02412852|454202220|FG000|Overall Study|Physician Decision|0|||
126248291|NCT02412852|454202221|FG001|Overall Study|Physician Decision|0|||
125879544|NCT01462370|452857291|FG001|Overall Study|Lack of Qualifying Event|1|||
126027681|NCT04072822|453399041|FG000|Treatment|Met Stopping Criteria|13|||
126248292|NCT02412852|454202222|FG002|Overall Study|Physician Decision|0|||
126248293|NCT02412852|454202223|FG003|Overall Study|Physician Decision|1|||
126027682|NCT04072822|453399042|FG001|Treatment|Met Stopping Criteria|24|||
126027683|NCT04072822|453399041|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
126248294|NCT05274763|454202224|FG000|Overall Study|Lost to Follow-up|1|||
126248295|NCT01174186|454202225|FG000|Overall Study|Lost to Follow-up|0|||
126248296|NCT01174186|454202226|FG001|Overall Study|Lost to Follow-up|1|||
126027684|NCT04072822|453399042|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
126027685|NCT04072822|453399041|FG000|Treatment|Withdrawal by Subject|0|||
126027686|NCT04072822|453399042|FG001|Treatment|Withdrawal by Subject|2|||
126027687|NCT04072822|453399041|FG000|Treatment|Death|0|||
126094747|NCT01769326|453641450|FG003|Overall Study|unrelated injry|0|||
126094748|NCT01769326|453641447|FG000|Overall Study|got a job|0|||
126094749|NCT01769326|453641448|FG001|Overall Study|got a job|1|||
126094750|NCT01769326|453641449|FG002|Overall Study|got a job|0|||
126094751|NCT01769326|453641450|FG003|Overall Study|got a job|0|||
126094752|NCT01769326|453641447|FG000|Overall Study|Got sick and could not complete study|0|||
126094753|NCT01769326|453641448|FG001|Overall Study|Got sick and could not complete study|0|||
126094754|NCT01769326|453641449|FG002|Overall Study|Got sick and could not complete study|1|||
126094755|NCT01769326|453641450|FG003|Overall Study|Got sick and could not complete study|0|||
126094756|NCT01036438|453641451|FG000|Overall Study|Adverse Event|7|||
126094757|NCT01036438|453641452|FG001|Overall Study|Adverse Event|8|||
126094758|NCT01036438|453641451|FG000|Overall Study|Death|0|||
126094759|NCT01036438|453641452|FG001|Overall Study|Death|1|||
126094760|NCT01036438|453641451|FG000|Overall Study|No effect of study treatment|3|||
126094761|NCT01036438|453641452|FG001|Overall Study|No effect of study treatment|1|||
126094762|NCT02153073|453641453|FG000|Overall Study|Case Report Forms Uncollected|230|||
126094763|NCT02153073|453641453|FG000|Overall Study|Protocol Deviation|68|||
126094764|NCT03702231|453641454|FG000|Overall Study|Withdrawal by Subject|1|||
126094765|NCT03702231|453641455|FG001|Overall Study|Withdrawal by Subject|0|||
126094766|NCT03702231|453641456|FG002|Overall Study|Withdrawal by Subject|0|||
126094767|NCT03702231|453641454|FG000|Overall Study|Protocol Violation|0|||
126094768|NCT03702231|453641455|FG001|Overall Study|Protocol Violation|0|||
126094769|NCT03702231|453641456|FG002|Overall Study|Protocol Violation|1|||
126094770|NCT03702231|453641454|FG000|Overall Study|Change in CLL Treatment|0|||
126094771|NCT03702231|453641455|FG001|Overall Study|Change in CLL Treatment|0|||
126094772|NCT03702231|453641456|FG002|Overall Study|Change in CLL Treatment|1|||
126027688|NCT04072822|453399042|FG001|Treatment|Death|2|||
126027689|NCT04072822|453399041|FG000|Treatment|Lost to Follow-up|11|||
126027690|NCT04072822|453399042|FG001|Treatment|Lost to Follow-up|3|||
126027691|NCT04072822|453399041|FG000|Treatment|Physician Decision|1|||
126027692|NCT04072822|453399042|FG001|Treatment|Physician Decision|0|||
126027693|NCT04072822|453399041|FG000|Treatment|Other|7|||
126027694|NCT04072822|453399042|FG001|Treatment|Other|9|||
126027695|NCT04072822|453399041|FG000|Follow-up|Withdrawal by Subject|1|||
126027696|NCT04072822|453399042|FG001|Follow-up|Withdrawal by Subject|0|||
126027697|NCT04072822|453399041|FG000|Follow-up|Lost to Follow-up|5|||
126027698|NCT04072822|453399042|FG001|Follow-up|Lost to Follow-up|4|||
126027699|NCT02323321|453399047|FG000|Overall Study|Re-Transplant|1|||
126027700|NCT02323321|453399047|FG000|Overall Study|Death|12|||
126027701|NCT00446225|453399048|FG000|Overall Study|Protocol Violation|1|||
126027702|NCT00446225|453399049|FG001|Overall Study|Protocol Violation|0|||
126027703|NCT04450342|453399050|FG000|Overall Study|Adverse Event|1|||
126027704|NCT04450342|453399051|FG001|Overall Study|Adverse Event|1|||
126027705|NCT04450342|453399052|FG002|Overall Study|Adverse Event|0|||
126027706|NCT04450342|453399050|FG000|Overall Study|Device not used|1|||
126027707|NCT04450342|453399051|FG001|Overall Study|Device not used|0|||
126027708|NCT04450342|453399052|FG002|Overall Study|Device not used|0|||
126027709|NCT04450342|453399050|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
126027710|NCT04450342|453399051|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
126027711|NCT04450342|453399052|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
126027712|NCT04450342|453399050|FG000|Overall Study|Physician Decision|1|||
126094773|NCT03702231|453641454|FG000|Overall Study|COVID Pandemic|1|||
126027713|NCT04450342|453399051|FG001|Overall Study|Physician Decision|0|||
126027714|NCT04450342|453399052|FG002|Overall Study|Physician Decision|1|||
126094774|NCT03702231|453641455|FG001|Overall Study|COVID Pandemic|4|||
126094775|NCT03702231|453641456|FG002|Overall Study|COVID Pandemic|1|||
126094776|NCT03702231|453641454|FG000|Overall Study|Non-compliance|0|||
126094777|NCT03702231|453641455|FG001|Overall Study|Non-compliance|0|||
126094778|NCT03702231|453641456|FG002|Overall Study|Non-compliance|1|||
126094779|NCT01278173|453641457|FG000|Overall Study|Lack of Efficacy|13|||
126027715|NCT04450342|453399050|FG000|Overall Study|Protocol Deviation|0|||
126027716|NCT04450342|453399051|FG001|Overall Study|Protocol Deviation|1|||
126027717|NCT04450342|453399052|FG002|Overall Study|Protocol Deviation|0|||
126027718|NCT04450342|453399050|FG000|Overall Study|Reoperation|1|||
126094780|NCT01278173|453641457|FG000|Overall Study|Adverse Event|8|||
126094781|NCT01278173|453641457|FG000|Overall Study|Administrative or other reason|4|||
126094782|NCT01278173|453641457|FG000|Overall Study|Protocol Violation|1|||
126094783|NCT01278173|453641457|FG000|Overall Study|Withdrawal by Subject|1|||
126094784|NCT03590366|453641458|FG000|Overall Study|Adverse Event|0|||
126094785|NCT03590366|453641459|FG001|Overall Study|Adverse Event|3|||
126094786|NCT03590366|453641458|FG000|Overall Study|Lost to Follow-up|3|||
126094787|NCT03590366|453641459|FG001|Overall Study|Lost to Follow-up|3|||
126094788|NCT03590366|453641458|FG000|Overall Study|Withdrawal by Subject|0|||
126094789|NCT03590366|453641459|FG001|Overall Study|Withdrawal by Subject|2|||
126094790|NCT01373151|453641460|FG000|Period 1|Lack of Efficacy|3|||
126248297|NCT01174186|454202225|FG000|Overall Study|Withdrawal by Subject|0|||
126248298|NCT01174186|454202226|FG001|Overall Study|Withdrawal by Subject|2|||
126248299|NCT00841542|454202228|FG000|Period 1|Adverse Event|1|||
126248300|NCT00841542|454202229|FG001|Period 1|Adverse Event|0|||
126248301|NCT01647828|454202230|FG000|Overall Study|Death|3|||
126248302|NCT01647828|454202231|FG001|Overall Study|Death|4|||
126248303|NCT01647828|454202232|FG002|Overall Study|Death|4|||
126248304|NCT01647828|454202233|FG003|Overall Study|Death|5|||
126248305|NCT01647828|454202234|FG004|Overall Study|Death|6|||
125879545|NCT01462370|452857290|FG000|Overall Study|Physician Decision|0|||
125879546|NCT01462370|452857291|FG001|Overall Study|Physician Decision|1|||
125879547|NCT01462370|452857290|FG000|Overall Study|Withdrawal by Subject|0|||
125879548|NCT01462370|452857291|FG001|Overall Study|Withdrawal by Subject|3|||
125879549|NCT04385277|452857294|FG000|Overall Study|Physician Decision|2|||
125879550|NCT04385277|452857294|FG000|Overall Study|Ineligible|1|||
125879551|NCT04385277|452857294|FG000|Overall Study|Patient/Parent Refusal|2|||
125879552|NCT03566511|452857295|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
125879553|NCT03566511|452857296|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
125879554|NCT00981656|452857306|FG000|Overall Study|Protocol Violation|1|||
125879555|NCT00981656|452857306|FG000|Overall Study|Did not start protocol treatment|2|||
125879556|NCT00687596|452857307|FG000|Overall Study|Adverse Event (AE)|10|||
125879557|NCT00687596|452857308|FG001|Overall Study|Adverse Event (AE)|3|||
125879558|NCT00687596|452857307|FG000|Overall Study|Radiological Disease Progression|6|||
125879559|NCT00687596|452857308|FG001|Overall Study|Radiological Disease Progression|2|||
125879560|NCT00687596|452857307|FG000|Overall Study|Clinical Disease Progression|1|||
125879561|NCT00687596|452857308|FG001|Overall Study|Clinical Disease Progression|3|||
126094791|NCT01373151|453641461|FG001|Period 1|Lack of Efficacy|0|||
126094792|NCT01373151|453641462|FG002|Period 1|Lack of Efficacy|0|||
126094793|NCT01373151|453641463|FG003|Period 1|Lack of Efficacy|0|||
126094794|NCT01373151|453641464|FG004|Period 1|Lack of Efficacy|1|||
126094795|NCT01373151|453641465|FG005|Period 1|Lack of Efficacy|0|||
126094796|NCT01373151|453641466|FG006|Period 1|Lack of Efficacy|0|||
126094797|NCT01373151|453641460|FG000|Period 1|Adverse Event|0|||
126094798|NCT01373151|453641461|FG001|Period 1|Adverse Event|0|||
126094799|NCT01373151|453641462|FG002|Period 1|Adverse Event|1|||
126094800|NCT01373151|453641463|FG003|Period 1|Adverse Event|0|||
126248306|NCT01647828|454202235|FG005|Overall Study|Death|3|||
126248307|NCT01647828|454202236|FG006|Overall Study|Death|10|||
126248308|NCT01647828|454202237|FG007|Overall Study|Death|60|||
126248309|NCT01647828|454202238|FG008|Overall Study|Death|71|||
126248310|NCT01647828|454202230|FG000|Overall Study|Withdrawal by Subject|2|||
126248311|NCT01647828|454202231|FG001|Overall Study|Withdrawal by Subject|0|||
126094801|NCT01373151|453641464|FG004|Period 1|Adverse Event|4|||
125879562|NCT00687596|452857307|FG000|Overall Study|Investigator Discretion|3|||
125879563|NCT00687596|452857308|FG001|Overall Study|Investigator Discretion|1|||
125879564|NCT00687596|452857307|FG000|Overall Study|Sponsor Terminated Study|6|||
125879565|NCT00687596|452857308|FG001|Overall Study|Sponsor Terminated Study|17|||
126094802|NCT01373151|453641465|FG005|Period 1|Adverse Event|3|||
126094803|NCT01373151|453641466|FG006|Period 1|Adverse Event|0|||
126094804|NCT01373151|453641460|FG000|Period 1|Withdrawal by Subject|2|||
126094805|NCT01373151|453641461|FG001|Period 1|Withdrawal by Subject|0|||
126094806|NCT01373151|453641462|FG002|Period 1|Withdrawal by Subject|3|||
126094807|NCT01373151|453641463|FG003|Period 1|Withdrawal by Subject|1|||
126248312|NCT01647828|454202232|FG002|Overall Study|Withdrawal by Subject|0|||
126248313|NCT01647828|454202233|FG003|Overall Study|Withdrawal by Subject|1|||
126248314|NCT01647828|454202234|FG004|Overall Study|Withdrawal by Subject|0|||
126248315|NCT01647828|454202235|FG005|Overall Study|Withdrawal by Subject|0|||
126248316|NCT01647828|454202236|FG006|Overall Study|Withdrawal by Subject|1|||
126248317|NCT01647828|454202237|FG007|Overall Study|Withdrawal by Subject|0|||
126248318|NCT01647828|454202238|FG008|Overall Study|Withdrawal by Subject|2|||
126248319|NCT01647828|454202230|FG000|Overall Study|Study terminated by Sponsor|0|||
126248320|NCT01647828|454202231|FG001|Overall Study|Study terminated by Sponsor|0|||
126248321|NCT01647828|454202232|FG002|Overall Study|Study terminated by Sponsor|0|||
126248322|NCT01647828|454202233|FG003|Overall Study|Study terminated by Sponsor|0|||
126248323|NCT01647828|454202234|FG004|Overall Study|Study terminated by Sponsor|0|||
126248324|NCT01647828|454202235|FG005|Overall Study|Study terminated by Sponsor|0|||
126248325|NCT01647828|454202236|FG006|Overall Study|Study terminated by Sponsor|1|||
126248326|NCT01647828|454202237|FG007|Overall Study|Study terminated by Sponsor|26|||
126248327|NCT01647828|454202238|FG008|Overall Study|Study terminated by Sponsor|16|||
126248328|NCT01647828|454202230|FG000|Overall Study|Lost to Follow-up|0|||
126248329|NCT01647828|454202231|FG001|Overall Study|Lost to Follow-up|0|||
126248330|NCT01647828|454202232|FG002|Overall Study|Lost to Follow-up|0|||
126027719|NCT04450342|453399051|FG001|Overall Study|Reoperation|1|||
126027720|NCT04450342|453399052|FG002|Overall Study|Reoperation|0|||
126027721|NCT04450342|453399050|FG000|Overall Study|Screen Failures|0|||
126027722|NCT04450342|453399051|FG001|Overall Study|Screen Failures|0|||
126027723|NCT04450342|453399052|FG002|Overall Study|Screen Failures|2|||
126027724|NCT04450342|453399050|FG000|Overall Study|Site Terminated by Sponsor|1|||
126027725|NCT04450342|453399051|FG001|Overall Study|Site Terminated by Sponsor|1|||
126027726|NCT04450342|453399052|FG002|Overall Study|Site Terminated by Sponsor|1|||
126027727|NCT04450342|453399050|FG000|Overall Study|Study Terminated by Sponsor|31|||
126027728|NCT04450342|453399051|FG001|Overall Study|Study Terminated by Sponsor|29|||
126248331|NCT01647828|454202233|FG003|Overall Study|Lost to Follow-up|0|||
126248332|NCT01647828|454202234|FG004|Overall Study|Lost to Follow-up|0|||
126248333|NCT01647828|454202235|FG005|Overall Study|Lost to Follow-up|0|||
126248334|NCT01647828|454202236|FG006|Overall Study|Lost to Follow-up|0|||
126248335|NCT01647828|454202237|FG007|Overall Study|Lost to Follow-up|2|||
126248336|NCT01647828|454202238|FG008|Overall Study|Lost to Follow-up|0|||
126248337|NCT01906372|454202239|FG000|Overall Study|Withdrawal by Subject|2|||
126248338|NCT01252953|454202243|FG000|Overall Study|Withdrawal by Subject|16|||
126248339|NCT01252953|454202244|FG001|Overall Study|Withdrawal by Subject|17|||
126248340|NCT01252953|454202243|FG000|Overall Study|Lost to Follow-up|22|||
126248341|NCT01252953|454202244|FG001|Overall Study|Lost to Follow-up|21|||
126248342|NCT00624286|454202245|FG000|Overall Study|Protocol Deviation|7|||
126027729|NCT04450342|453399052|FG002|Overall Study|Study Terminated by Sponsor|6|||
126248343|NCT00624286|454202246|FG001|Overall Study|Protocol Deviation|9|||
126248344|NCT00624286|454202245|FG000|Overall Study|Adverse Event|6|||
126248345|NCT00624286|454202246|FG001|Overall Study|Adverse Event|3|||
126248346|NCT00624286|454202245|FG000|Overall Study|Withdrawal by Subject|5|||
126248347|NCT00624286|454202246|FG001|Overall Study|Withdrawal by Subject|4|||
126248348|NCT00624286|454202245|FG000|Overall Study|Lost to Follow-up|3|||
126027730|NCT04450342|453399050|FG000|Overall Study|Withdrawal by Subject|0|||
126027731|NCT04450342|453399051|FG001|Overall Study|Withdrawal by Subject|1|||
126027732|NCT04450342|453399052|FG002|Overall Study|Withdrawal by Subject|2|||
126094808|NCT01373151|453641464|FG004|Period 1|Withdrawal by Subject|0|||
126027733|NCT00220740|453399053|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
126027734|NCT00220740|453399054|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
126027735|NCT00220740|453399053|FG000|Efficacy Period|Adverse Event|1|||
126027736|NCT00220740|453399054|FG001|Efficacy Period|Adverse Event|1|||
126027737|NCT00220740|453399053|FG000|Efficacy Period|Withdrawal by Subject|1|||
126248349|NCT00624286|454202246|FG001|Overall Study|Lost to Follow-up|2|||
126248350|NCT00624286|454202245|FG000|Overall Study|Administrative problems|3|||
126248351|NCT00624286|454202246|FG001|Overall Study|Administrative problems|0|||
126248352|NCT00624286|454202245|FG000|Overall Study|Lack of Efficacy|1|||
126248353|NCT00624286|454202246|FG001|Overall Study|Lack of Efficacy|6|||
126248354|NCT00624286|454202245|FG000|Overall Study|Not stated|0|||
126248355|NCT00624286|454202246|FG001|Overall Study|Not stated|1|||
126248356|NCT00624286|454202245|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126248357|NCT00624286|454202246|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126248358|NCT00624286|454202245|FG000|Overall Study|Death|0|||
126248359|NCT00624286|454202246|FG001|Overall Study|Death|1|||
126027738|NCT00220740|453399054|FG001|Efficacy Period|Withdrawal by Subject|0|||
126027739|NCT00220740|453399053|FG000|Efficacy Period|Protocol Violation|1|||
126027740|NCT00220740|453399054|FG001|Efficacy Period|Protocol Violation|0|||
126027741|NCT00220740|453399053|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
126248360|NCT00841659|454202247|FG000|Washout: 2 Weeks|Protocol Violation|1|||
126248361|NCT00841659|454202248|FG001|Washout: 2 Weeks|Protocol Violation|0|||
126248362|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
126248363|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
126248364|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
126248365|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
126248366|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
126027742|NCT00220740|453399054|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
126248367|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
126248368|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
126248369|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
126248370|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
126248371|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
126248372|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
126248373|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
126248374|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
126248375|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
126248376|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
126248377|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
126248378|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
126248379|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
126248380|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
126248381|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
126248382|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
126248383|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
126248384|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
126248385|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
126248386|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
126248387|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
126248388|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
126248389|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
126027743|NCT02811679|453399055|FG000|Overall Study|Adverse Event|1|||
126027744|NCT02811679|453399055|FG000|Overall Study|Lack of Efficacy|6|||
126027745|NCT02811679|453399055|FG000|Overall Study|Early study closure due to slow accrual|3|||
126027746|NCT04314895|453399058|FG000|Overall Study|Lost to Follow-up|1|||
126027747|NCT04314895|453399058|FG000|Overall Study|Death|10|||
126027748|NCT04314895|453399058|FG000|Overall Study|Physician Decision|2|||
126094809|NCT01373151|453641465|FG005|Period 1|Withdrawal by Subject|1|||
126094810|NCT01373151|453641466|FG006|Period 1|Withdrawal by Subject|0|||
126248390|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
126248391|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
126357758|NCT04518410|454602219|FG010|Overall Study|Other|0|||
126357759|NCT04518410|454602220|FG011|Overall Study|Other|2|||
126357760|NCT04518410|454602221|FG012|Overall Study|Other|0|||
126357761|NCT04518410|454602222|FG013|Overall Study|Other|0|||
126027749|NCT03941860|453399059|FG000|Overall Study|Withdrawal by Subject|0|||
126027750|NCT03941860|453399060|FG001|Overall Study|Withdrawal by Subject|1|||
126027751|NCT03361748|453399061|FG000|Overall Study|Death|77|||
126027752|NCT03361748|453399061|FG000|Overall Study|Lost to Follow-up|4|||
126248392|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
126248393|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
126248394|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
126248395|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
126248396|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
126248397|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
126248398|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
126248399|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
126248400|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
126248401|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
126248402|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
126248403|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
126248404|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
126248405|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
126248406|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
126248407|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
126248408|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
126248409|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
126248410|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
126248411|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
126248412|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
126248413|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
126248414|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
126248415|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
126248416|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
126248417|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
126248418|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
126248419|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
126357762|NCT04518410|454602223|FG014|Overall Study|Other|0|||
126357763|NCT04518410|454602224|FG015|Overall Study|Other|3|||
126357764|NCT04518410|454602225|FG016|Overall Study|Other|1|||
126357765|NCT04518410|454602226|FG017|Overall Study|Other|1|||
126357766|NCT04518410|454602227|FG018|Overall Study|Other|1|||
126357767|NCT04518410|454602228|FG019|Overall Study|Other|0|||
126357768|NCT04518410|454602229|FG020|Overall Study|Other|1|||
125879566|NCT02903771|452857309|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
126027753|NCT03361748|453399061|FG000|Overall Study|Withdrawal by Subject|20|||
126248420|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
126357769|NCT04518410|454602230|FG021|Overall Study|Other|0|||
126357770|NCT04518410|454602231|FG022|Overall Study|Other|1|||
126357771|NCT04518410|454602232|FG023|Overall Study|Other|2|||
126357772|NCT04518410|454602233|FG024|Overall Study|Other|2|||
126357773|NCT04518410|454602209|FG000|Overall Study|Protocol Violation|0|||
126357774|NCT04518410|454602210|FG001|Overall Study|Protocol Violation|0|||
126357775|NCT04518410|454602211|FG002|Overall Study|Protocol Violation|0|||
126357776|NCT04518410|454602212|FG003|Overall Study|Protocol Violation|2|||
126357777|NCT04518410|454602213|FG004|Overall Study|Protocol Violation|17|||
126357778|NCT04518410|454602214|FG005|Overall Study|Protocol Violation|1|||
126357779|NCT04518410|454602215|FG006|Overall Study|Protocol Violation|2|||
126357780|NCT04518410|454602216|FG007|Overall Study|Protocol Violation|1|||
126357781|NCT04518410|454602217|FG008|Overall Study|Protocol Violation|0|||
126357782|NCT04518410|454602218|FG009|Overall Study|Protocol Violation|0|||
126357783|NCT04518410|454602219|FG010|Overall Study|Protocol Violation|0|||
126357784|NCT04518410|454602220|FG011|Overall Study|Protocol Violation|0|||
126357785|NCT04518410|454602221|FG012|Overall Study|Protocol Violation|0|||
126357786|NCT04518410|454602222|FG013|Overall Study|Protocol Violation|0|||
126357787|NCT04518410|454602223|FG014|Overall Study|Protocol Violation|0|||
126357788|NCT04518410|454602224|FG015|Overall Study|Protocol Violation|0|||
126357789|NCT04518410|454602225|FG016|Overall Study|Protocol Violation|1|||
126357790|NCT04518410|454602226|FG017|Overall Study|Protocol Violation|1|||
126357791|NCT04518410|454602227|FG018|Overall Study|Protocol Violation|0|||
126357792|NCT04518410|454602228|FG019|Overall Study|Protocol Violation|0|||
126357793|NCT04518410|454602229|FG020|Overall Study|Protocol Violation|1|||
126357794|NCT04518410|454602230|FG021|Overall Study|Protocol Violation|2|||
126357795|NCT04518410|454602231|FG022|Overall Study|Protocol Violation|0|||
126357796|NCT04518410|454602232|FG023|Overall Study|Protocol Violation|3|||
126357797|NCT04518410|454602233|FG024|Overall Study|Protocol Violation|0|||
126357798|NCT04518410|454602209|FG000|Overall Study|Death|0|||
126357799|NCT04518410|454602210|FG001|Overall Study|Death|0|||
126357800|NCT04518410|454602211|FG002|Overall Study|Death|0|||
126357801|NCT04518410|454602212|FG003|Overall Study|Death|0|||
126357802|NCT04518410|454602213|FG004|Overall Study|Death|12|||
126248421|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
126248422|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
126248423|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
126248424|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
126248425|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
126248426|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
126248427|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
126248428|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
126248429|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
126248430|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
126248431|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
126248432|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
126248433|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
126248434|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
126248435|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
126248436|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
126248437|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
126248438|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
126248439|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
126248440|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
126248441|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
126248442|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
126248443|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
126248444|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
126248445|NCT01438060|454202259|FG000|On Study Beyond Week 140|Adverse Event|0|||
126248446|NCT01438060|454202260|FG001|On Study Beyond Week 140|Adverse Event|2|||
126248447|NCT01438060|454202259|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
126248448|NCT01438060|454202260|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
126248449|NCT01438060|454202259|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
126248450|NCT01438060|454202260|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
126248451|NCT01438060|454202259|FG000|On Study Beyond Week 140|Death|0|||
126248452|NCT01438060|454202260|FG001|On Study Beyond Week 140|Death|1|||
126248453|NCT01438060|454202259|FG000|On Study Beyond Week 140|Other Reason|0|||
126248454|NCT01438060|454202260|FG001|On Study Beyond Week 140|Other Reason|3|||
126248455|NCT02436200|454202263|FG000|Overall Study|Significant outlier|1|||
126248456|NCT01483820|454202264|FG000|Overall Study|Lack of Efficacy|6|||
126248457|NCT01483820|454202264|FG000|Overall Study|Adverse Event|1|||
126248458|NCT01483820|454202264|FG000|Overall Study|Death|1|||
126248459|NCT00867360|454202265|FG000|Overall Study|Withdrawal by Subject|1|||
126248460|NCT00867360|454202266|FG001|Overall Study|Withdrawal by Subject|0|||
126248461|NCT00867360|454202265|FG000|Overall Study|Physician Decision|0|||
126248462|NCT00867360|454202266|FG001|Overall Study|Physician Decision|1|||
126248463|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
126357803|NCT04518410|454602214|FG005|Overall Study|Death|2|||
126027754|NCT02814838|453399064|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
126027755|NCT02814838|453399065|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
126027756|NCT02814838|453399064|FG000|Overall Study|Consent withdrawal|1|||
126027757|NCT02814838|453399065|FG001|Overall Study|Consent withdrawal|1|||
126027758|NCT01361711|453399067|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
126027759|NCT01361711|453399067|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
126027760|NCT01361711|453399067|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
126027761|NCT01361711|453399067|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
126027762|NCT01361711|453399067|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
126027763|NCT01361711|453399067|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
126027764|NCT01361711|453399067|FG000|Completed Week 18 of Treatment|Other|9|||
126248464|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
126248465|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
126248466|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
126248467|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
126248468|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248469|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248470|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248471|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248472|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248473|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248474|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248475|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248476|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
126357804|NCT04518410|454602215|FG006|Overall Study|Death|11|||
126357805|NCT04518410|454602216|FG007|Overall Study|Death|0|||
126357806|NCT04518410|454602217|FG008|Overall Study|Death|1|||
125879567|NCT02903771|452857310|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
125879568|NCT02903771|452857311|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
125879569|NCT02903771|452857312|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
125879570|NCT02903771|452857313|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
126248477|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248478|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248479|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
125879571|NCT02903771|452857314|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
125879572|NCT02903771|452857315|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
125879573|NCT02903771|452857309|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
125879574|NCT02903771|452857310|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
125879575|NCT02903771|452857311|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
125879576|NCT02903771|452857312|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
125879577|NCT02903771|452857313|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
125879578|NCT02903771|452857314|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
125879579|NCT02903771|452857315|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
125879580|NCT02903771|452857309|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125879581|NCT02903771|452857310|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125879582|NCT02903771|452857311|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
125879583|NCT02903771|452857312|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125879584|NCT02903771|452857313|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125879585|NCT02903771|452857314|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
125879586|NCT02903771|452857315|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125879587|NCT02903771|452857309|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126027765|NCT01361711|453399067|FG000|10 Year Follow-up|Still in follow-up|22|||
126027766|NCT01361711|453399067|FG000|10 Year Follow-up|Death|7|||
126027767|NCT01361711|453399067|FG000|10 Year Follow-up|Developed new cancer|1|||
126027768|NCT01361711|453399067|FG000|10 Year Follow-up|Lost to Follow-up|2|||
126027769|NCT01361711|453399067|FG000|10 Year Follow-up|New treatment started|6|||
126027770|NCT01361711|453399067|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
126027771|NCT01361711|453399067|FG000|10 Year Follow-up|Progressive Disease|1|||
126027772|NCT02596126|453399068|FG000|Overall Study|Lost to Follow-up|12|||
126027773|NCT02596126|453399069|FG001|Overall Study|Lost to Follow-up|21|||
126027774|NCT02596126|453399068|FG000|Overall Study|Protocol Violation|7|||
126027775|NCT02596126|453399069|FG001|Overall Study|Protocol Violation|9|||
126027776|NCT03396588|453399070|FG000|Overall Study|Physician Decision|2|||
126027777|NCT03396588|453399071|FG001|Overall Study|Physician Decision|3|||
126027778|NCT00812461|453399072|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
126027779|NCT00812461|453399073|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
126027780|NCT00812461|453399072|FG000|All Treated Patients|Adverse Event|8|||
126027781|NCT00812461|453399073|FG001|All Treated Patients|Adverse Event|15|||
126027782|NCT00812461|453399072|FG000|All Treated Patients|Lack of Efficacy|13|||
126027783|NCT00812461|453399073|FG001|All Treated Patients|Lack of Efficacy|7|||
126027784|NCT00812461|453399072|FG000|All Treated Patients|Non-compliance|6|||
126027785|NCT00812461|453399073|FG001|All Treated Patients|Non-compliance|9|||
126027786|NCT00812461|453399072|FG000|All Treated Patients|Protocol Violation|36|||
126027787|NCT00812461|453399073|FG001|All Treated Patients|Protocol Violation|27|||
126027788|NCT00812461|453399072|FG000|All Treated Patients|Withdrawal by Subject|45|||
126027789|NCT00812461|453399073|FG001|All Treated Patients|Withdrawal by Subject|54|||
126027790|NCT00812461|453399072|FG000|All Treated Patients|Lost to Follow-up|11|||
126027791|NCT00812461|453399073|FG001|All Treated Patients|Lost to Follow-up|14|||
126027792|NCT00812461|453399072|FG000|All Treated Patients|Other Reason|13|||
126027793|NCT00812461|453399073|FG001|All Treated Patients|Other Reason|21|||
126027794|NCT02287311|453400800|FG000|Cohort 1: Dose Level 1|Death|2|||
126027795|NCT02287311|453400801|FG001|Cohort 1: Dose Level 1|Death|0|||
126027796|NCT02287311|453400802|FG002|Cohort 1: Dose Level 1|Death|0|||
126027797|NCT02287311|453400803|FG003|Cohort 1: Dose Level 1|Death|3|||
126027798|NCT02287311|453400804|FG004|Cohort 1: Dose Level 1|Death|0|||
126027799|NCT02287311|453400805|FG005|Cohort 1: Dose Level 1|Death|0|||
126027800|NCT02287311|453400806|FG006|Cohort 1: Dose Level 1|Death|1|||
126027801|NCT02287311|453400807|FG007|Cohort 1: Dose Level 1|Death|0|||
126094811|NCT01373151|453641460|FG000|Period 2|Lack of Efficacy|9|||
126094812|NCT01373151|453641461|FG001|Period 2|Lack of Efficacy|0|||
126248480|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
125879588|NCT02903771|452857310|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125879589|NCT02903771|452857311|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126027802|NCT02287311|453400808|FG008|Cohort 1: Dose Level 1|Death|0|||
126027803|NCT02287311|453400800|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126027804|NCT02287311|453400801|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126027805|NCT02287311|453400802|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126027806|NCT02287311|453400803|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
126094813|NCT01373151|453641462|FG002|Period 2|Lack of Efficacy|0|||
126248481|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
126094814|NCT01373151|453641463|FG003|Period 2|Lack of Efficacy|1|||
126094815|NCT01373151|453641464|FG004|Period 2|Lack of Efficacy|2|||
126094816|NCT01373151|453641465|FG005|Period 2|Lack of Efficacy|0|||
126094817|NCT01373151|453641466|FG006|Period 2|Lack of Efficacy|3|||
126094818|NCT01373151|453641460|FG000|Period 2|Adverse Event|0|||
126094819|NCT01373151|453641461|FG001|Period 2|Adverse Event|0|||
126094820|NCT01373151|453641462|FG002|Period 2|Adverse Event|3|||
126094821|NCT01373151|453641463|FG003|Period 2|Adverse Event|3|||
126094822|NCT01373151|453641464|FG004|Period 2|Adverse Event|0|||
126094823|NCT01373151|453641465|FG005|Period 2|Adverse Event|0|||
126094824|NCT01373151|453641466|FG006|Period 2|Adverse Event|1|||
126094825|NCT01373151|453641460|FG000|Period 2|subject request to discontinue|0|||
126094826|NCT01373151|453641461|FG001|Period 2|subject request to discontinue|1|||
126094827|NCT01373151|453641462|FG002|Period 2|subject request to discontinue|0|||
126094828|NCT01373151|453641463|FG003|Period 2|subject request to discontinue|0|||
126094829|NCT01373151|453641464|FG004|Period 2|subject request to discontinue|0|||
126094830|NCT01373151|453641465|FG005|Period 2|subject request to discontinue|0|||
126094831|NCT01373151|453641466|FG006|Period 2|subject request to discontinue|0|||
126094832|NCT01373151|453641460|FG000|Period 2|Withdrawal by Subject|0|||
126094833|NCT01373151|453641461|FG001|Period 2|Withdrawal by Subject|0|||
126094834|NCT01373151|453641462|FG002|Period 2|Withdrawal by Subject|0|||
126094835|NCT01373151|453641463|FG003|Period 2|Withdrawal by Subject|1|||
126094836|NCT01373151|453641464|FG004|Period 2|Withdrawal by Subject|0|||
126094837|NCT01373151|453641465|FG005|Period 2|Withdrawal by Subject|0|||
126094838|NCT01373151|453641466|FG006|Period 2|Withdrawal by Subject|0|||
126094839|NCT01373151|453641460|FG000|Period 2|Other|0|||
126094840|NCT01373151|453641461|FG001|Period 2|Other|0|||
126094841|NCT01373151|453641462|FG002|Period 2|Other|1|||
126094842|NCT01373151|453641463|FG003|Period 2|Other|0|||
126094843|NCT01373151|453641464|FG004|Period 2|Other|0|||
126094844|NCT01373151|453641465|FG005|Period 2|Other|0|||
126094845|NCT01373151|453641466|FG006|Period 2|Other|1|||
126094846|NCT03026075|453641470|FG000|Overall Study|Physician Decision|1|||
126094847|NCT01468181|453641471|FG000|Overall Study|Adverse Event|8|||
126094848|NCT01468181|453641472|FG001|Overall Study|Adverse Event|1|||
126094849|NCT01468181|453641473|FG002|Overall Study|Adverse Event|6|||
126094850|NCT01468181|453641474|FG003|Overall Study|Adverse Event|2|||
126094851|NCT01468181|453641475|FG004|Overall Study|Adverse Event|2|||
126094852|NCT01468181|453641471|FG000|Overall Study|Protocol Violation|2|||
126094853|NCT01468181|453641472|FG001|Overall Study|Protocol Violation|0|||
126094854|NCT01468181|453641473|FG002|Overall Study|Protocol Violation|1|||
126094855|NCT01468181|453641474|FG003|Overall Study|Protocol Violation|0|||
126094856|NCT01468181|453641475|FG004|Overall Study|Protocol Violation|1|||
126094857|NCT01468181|453641471|FG000|Overall Study|Physician Decision|0|||
126094858|NCT01468181|453641472|FG001|Overall Study|Physician Decision|0|||
126094859|NCT01468181|453641473|FG002|Overall Study|Physician Decision|0|||
126094860|NCT01468181|453641474|FG003|Overall Study|Physician Decision|1|||
126094861|NCT01468181|453641475|FG004|Overall Study|Physician Decision|1|||
126094862|NCT01468181|453641471|FG000|Overall Study|Lost to Follow-up|0|||
126094863|NCT01468181|453641472|FG001|Overall Study|Lost to Follow-up|0|||
126094864|NCT01468181|453641473|FG002|Overall Study|Lost to Follow-up|1|||
126248482|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248483|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248484|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248485|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248486|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248487|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248488|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
126357807|NCT04518410|454602218|FG009|Overall Study|Death|0|||
126357808|NCT04518410|454602219|FG010|Overall Study|Death|0|||
125879590|NCT02903771|452857312|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125879591|NCT02903771|452857313|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
125879592|NCT02903771|452857314|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125879593|NCT02903771|452857315|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126094865|NCT01468181|453641474|FG003|Overall Study|Lost to Follow-up|0|||
126094866|NCT01468181|453641475|FG004|Overall Study|Lost to Follow-up|1|||
126094867|NCT01468181|453641471|FG000|Overall Study|Withdrawal by Subject|0|||
126094868|NCT01468181|453641472|FG001|Overall Study|Withdrawal by Subject|1|||
126094869|NCT01468181|453641473|FG002|Overall Study|Withdrawal by Subject|0|||
126094870|NCT01468181|453641474|FG003|Overall Study|Withdrawal by Subject|0|||
126094871|NCT01468181|453641475|FG004|Overall Study|Withdrawal by Subject|0|||
126094872|NCT02297139|453641484|FG000|Overall Study|Disease progression|0|||
126094873|NCT02297139|453641485|FG001|Overall Study|Disease progression|1|||
126094874|NCT02297139|453641484|FG000|Overall Study|Study drug toxicity|0|||
126094875|NCT02297139|453641485|FG001|Overall Study|Study drug toxicity|4|||
126094876|NCT02297139|453641484|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126094877|NCT02297139|453641485|FG001|Overall Study|Participant request to discontinue study treatment|1|||
126094878|NCT02297139|453641484|FG000|Overall Study|Maximum clinical benefit|1|||
126094879|NCT02297139|453641485|FG001|Overall Study|Maximum clinical benefit|0|||
126094880|NCT02297139|453641484|FG000|Overall Study|Administrative reason by sponsor|0|||
126248489|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248490|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
126248491|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248492|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248493|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248494|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248495|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248496|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248497|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248498|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248499|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248500|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248501|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248502|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248503|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248504|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248505|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248506|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248507|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248508|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248509|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125879594|NCT02903771|452857309|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
125879595|NCT02903771|452857310|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
125879596|NCT02903771|452857311|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
125879597|NCT02903771|452857312|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
126248510|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248511|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248512|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248513|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248514|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248515|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248516|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
126248517|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248518|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248519|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248520|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248521|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248522|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248523|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248524|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126027807|NCT02287311|453400804|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126027808|NCT02287311|453400805|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126027809|NCT02287311|453400806|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
126027810|NCT02287311|453400807|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126027811|NCT02287311|453400808|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126248525|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248526|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248527|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248528|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248529|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248530|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248531|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248532|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248533|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248534|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126027812|NCT02287311|453400800|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
126027813|NCT02287311|453400801|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
126027814|NCT02287311|453400802|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
126027815|NCT02287311|453400803|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
126027816|NCT02287311|453400804|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
126027817|NCT02287311|453400805|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
126248535|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248536|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126027818|NCT02287311|453400806|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
126248537|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248538|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248539|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248540|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248541|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
126027819|NCT02287311|453400807|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
126027820|NCT02287311|453400808|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
126248542|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248543|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
126248544|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
126248545|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
126027821|NCT02287311|453400800|FG000|Cohort 2: Dose Level 2|Death|0|||
126027822|NCT02287311|453400801|FG001|Cohort 2: Dose Level 2|Death|2|||
126027823|NCT02287311|453400802|FG002|Cohort 2: Dose Level 2|Death|0|||
126027824|NCT02287311|453400803|FG003|Cohort 2: Dose Level 2|Death|0|||
126027825|NCT02287311|453400804|FG004|Cohort 2: Dose Level 2|Death|2|||
126027826|NCT02287311|453400805|FG005|Cohort 2: Dose Level 2|Death|0|||
126027827|NCT02287311|453400806|FG006|Cohort 2: Dose Level 2|Death|0|||
126027828|NCT02287311|453400807|FG007|Cohort 2: Dose Level 2|Death|2|||
126027829|NCT02287311|453400808|FG008|Cohort 2: Dose Level 2|Death|0|||
126027830|NCT02287311|453400800|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126027831|NCT02287311|453400801|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126027832|NCT02287311|453400802|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126027833|NCT02287311|453400803|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126027834|NCT02287311|453400804|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
126027835|NCT02287311|453400805|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126027836|NCT02287311|453400806|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126027837|NCT02287311|453400807|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126027838|NCT02287311|453400808|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126027839|NCT02287311|453400800|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
126027840|NCT02287311|453400801|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
126027841|NCT02287311|453400802|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
126027842|NCT02287311|453400803|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
126027843|NCT02287311|453400804|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
126027844|NCT02287311|453400805|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
126027845|NCT02287311|453400806|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
126027846|NCT02287311|453400807|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
126027847|NCT02287311|453400808|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
126027848|NCT02287311|453400800|FG000|Cohort 3: Dose Level 3|Death|0|||
126027849|NCT02287311|453400801|FG001|Cohort 3: Dose Level 3|Death|0|||
126027850|NCT02287311|453400802|FG002|Cohort 3: Dose Level 3|Death|4|||
126027851|NCT02287311|453400803|FG003|Cohort 3: Dose Level 3|Death|0|||
126027852|NCT02287311|453400804|FG004|Cohort 3: Dose Level 3|Death|0|||
126027853|NCT02287311|453400805|FG005|Cohort 3: Dose Level 3|Death|4|||
126027854|NCT02287311|453400806|FG006|Cohort 3: Dose Level 3|Death|0|||
126027855|NCT02287311|453400807|FG007|Cohort 3: Dose Level 3|Death|0|||
126027856|NCT02287311|453400808|FG008|Cohort 3: Dose Level 3|Death|2|||
126027857|NCT02287311|453400800|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126027858|NCT02287311|453400801|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126027859|NCT02287311|453400802|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
126027860|NCT02287311|453400803|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126027861|NCT02287311|453400804|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126027862|NCT02287311|453400805|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
126027863|NCT02287311|453400806|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126027864|NCT02287311|453400807|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126027865|NCT02287311|453400808|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126027866|NCT02287311|453400800|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126027867|NCT02287311|453400801|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126027868|NCT02287311|453400802|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126027869|NCT02287311|453400803|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126027870|NCT02287311|453400804|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126027871|NCT02287311|453400805|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
126027872|NCT02287311|453400806|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126027873|NCT02287311|453400807|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126027874|NCT02287311|453400808|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
126027875|NCT05418296|453400811|FG000|Overall Study|Withdrawal by Subject|4|||
126027876|NCT05418296|453400812|FG001|Overall Study|Withdrawal by Subject|1|||
126027877|NCT04630262|453400814|FG000|Overall Study|Intraoperative Screen Failure|5|||
126248546|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126027878|NCT04630262|453400814|FG000|Overall Study|Study terminated prematurely|71|||
126027879|NCT04630262|453400814|FG000|Overall Study|Withdrawal by Subject|2|||
126027880|NCT04630262|453400814|FG000|Overall Study|Physician Decision|2|||
126027881|NCT03692676|453400820|FG000|Overall Study|exclude patients with prior use|4424|||
126027882|NCT03692676|453400821|FG001|Overall Study|exclude patients with prior use|24726|||
126248547|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126027883|NCT03692676|453400822|FG002|Overall Study|exclude patients with prior use|0|||
126027884|NCT03692676|453400823|FG003|Overall Study|exclude patients with prior use|0|||
126027885|NCT03692676|453400820|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
126027886|NCT03692676|453400821|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
126027887|NCT03692676|453400822|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
126094881|NCT02297139|453641485|FG001|Overall Study|Administrative reason by sponsor|2|||
126094882|NCT02297139|453641484|FG000|Overall Study|Other reasons|0|||
126094883|NCT02297139|453641485|FG001|Overall Study|Other reasons|8|||
126094884|NCT05597787|453641488|FG000|Overall Study|Withdrawal by Subject|0|||
126094885|NCT05597787|453641489|FG001|Overall Study|Withdrawal by Subject|0|||
126094886|NCT05597787|453641490|FG002|Overall Study|Withdrawal by Subject|1|||
126094887|NCT01934790|453641491|FG000|Treatment|Adverse Event|3|||
126094888|NCT01934790|453641491|FG000|Treatment|Clinical progression|6|||
126094889|NCT01934790|453641491|FG000|Treatment|Radiological progression|4|||
126094890|NCT01934790|453641491|FG000|Treatment|Withdrawal by Subject|2|||
126094891|NCT01934790|453641491|FG000|Treatment|Study drug never administered|1|||
126094892|NCT01934790|453641491|FG000|Active Follow up|Death|20|||
126094893|NCT01934790|453641491|FG000|Active Follow up|Physician Decision|2|||
126094894|NCT01934790|453641491|FG000|Active Follow up|Progressive disease|1|||
126094895|NCT01934790|453641491|FG000|Active Follow up|Other reason|1|||
126248548|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248549|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248550|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248551|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248552|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248553|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248554|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248555|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248556|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248557|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248558|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248559|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248560|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248561|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248562|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248563|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248564|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248565|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126094896|NCT01144377|453641496|FG000|52 Week Treatment Period|Adverse Event|0|||
126094897|NCT01144377|453641497|FG001|52 Week Treatment Period|Adverse Event|0|||
126094898|NCT01144377|453641498|FG002|52 Week Treatment Period|Adverse Event|3|||
126094899|NCT01144377|453641499|FG003|52 Week Treatment Period|Adverse Event|2|||
126094900|NCT01144377|453641500|FG004|52 Week Treatment Period|Adverse Event|1|||
126094901|NCT01144377|453641496|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
126094902|NCT01144377|453641497|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
126094903|NCT01144377|453641498|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
126094904|NCT01144377|453641499|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
126357809|NCT04518410|454602220|FG011|Overall Study|Death|0|||
126357810|NCT04518410|454602221|FG012|Overall Study|Death|0|||
126094905|NCT01144377|453641500|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
126094906|NCT01144377|453641496|FG000|52 Week Treatment Period|Protocol Violation|0|||
126248566|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248567|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
126357811|NCT04518410|454602222|FG013|Overall Study|Death|1|||
126357812|NCT04518410|454602223|FG014|Overall Study|Death|1|||
126357813|NCT04518410|454602224|FG015|Overall Study|Death|0|||
126357814|NCT04518410|454602225|FG016|Overall Study|Death|0|||
126357815|NCT04518410|454602226|FG017|Overall Study|Death|1|||
126357816|NCT04518410|454602227|FG018|Overall Study|Death|4|||
126357817|NCT04518410|454602228|FG019|Overall Study|Death|4|||
126357818|NCT04518410|454602229|FG020|Overall Study|Death|1|||
126357819|NCT04518410|454602230|FG021|Overall Study|Death|0|||
126357820|NCT04518410|454602231|FG022|Overall Study|Death|0|||
126357821|NCT04518410|454602232|FG023|Overall Study|Death|0|||
126357822|NCT04518410|454602233|FG024|Overall Study|Death|0|||
126357823|NCT04518410|454602209|FG000|Overall Study|Requirement to start alternative therapy|0|||
126357824|NCT04518410|454602210|FG001|Overall Study|Requirement to start alternative therapy|0|||
126357825|NCT04518410|454602211|FG002|Overall Study|Requirement to start alternative therapy|1|||
126357826|NCT04518410|454602212|FG003|Overall Study|Requirement to start alternative therapy|0|||
126357827|NCT04518410|454602213|FG004|Overall Study|Requirement to start alternative therapy|0|||
126357828|NCT04518410|454602214|FG005|Overall Study|Requirement to start alternative therapy|0|||
126357829|NCT04518410|454602215|FG006|Overall Study|Requirement to start alternative therapy|0|||
126357830|NCT04518410|454602216|FG007|Overall Study|Requirement to start alternative therapy|0|||
126094907|NCT01144377|453641497|FG001|52 Week Treatment Period|Protocol Violation|0|||
126094908|NCT01144377|453641498|FG002|52 Week Treatment Period|Protocol Violation|0|||
126357831|NCT04518410|454602217|FG008|Overall Study|Requirement to start alternative therapy|0|||
126094909|NCT01144377|453641499|FG003|52 Week Treatment Period|Protocol Violation|0|||
126357832|NCT04518410|454602218|FG009|Overall Study|Requirement to start alternative therapy|0|||
126248568|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
126248569|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
126248570|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
126248571|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
126248572|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248573|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248574|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248575|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248576|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248577|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248578|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248579|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248580|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248581|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248582|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248583|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248584|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248585|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248586|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248587|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248588|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248589|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248590|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248591|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248592|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248593|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|moved|0|||
126248594|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|moved|1|||
126248595|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|moved|1|||
126248596|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|moved|0|||
126248597|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|moved|0|||
126248598|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|moved|0|||
126248599|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|moved|0|||
126248600|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|moved|0|||
126248601|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|moved|0|||
126248602|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|moved|0|||
126248603|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|moved|0|||
126248604|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|moved|0|||
126248605|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|moved|0|||
126248606|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|moved|0|||
126248607|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|moved|0|||
126248608|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|moved|0|||
126248609|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|moved|0|||
126248610|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|moved|0|||
126248611|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|moved|0|||
126248612|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|moved|0|||
126248613|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|moved|0|||
126248614|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|moved|0|||
126094910|NCT01144377|453641500|FG004|52 Week Treatment Period|Protocol Violation|1|||
126094911|NCT01144377|453641496|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
126094912|NCT01144377|453641497|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
126094913|NCT01144377|453641498|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
126094914|NCT01144377|453641499|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
126094915|NCT01144377|453641500|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
126094916|NCT01144377|453641496|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
126094917|NCT01144377|453641497|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
126094918|NCT01144377|453641498|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
126094919|NCT01144377|453641499|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
126094920|NCT01144377|453641500|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
126094921|NCT01144377|453641496|FG000|52 Week Treatment Period|Sponsor Decision|0|||
126094922|NCT01144377|453641497|FG001|52 Week Treatment Period|Sponsor Decision|0|||
126094923|NCT01144377|453641498|FG002|52 Week Treatment Period|Sponsor Decision|0|||
126094924|NCT01144377|453641499|FG003|52 Week Treatment Period|Sponsor Decision|0|||
126094925|NCT01144377|453641500|FG004|52 Week Treatment Period|Sponsor Decision|1|||
126094926|NCT01144377|453641496|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
126094927|NCT01144377|453641497|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
126094928|NCT01144377|453641498|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
126248615|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|moved|0|||
126094929|NCT01144377|453641499|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
126248616|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|moved|0|||
126094930|NCT01144377|453641500|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
126094931|NCT01144377|453641496|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
126094932|NCT01144377|453641497|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
126094933|NCT01144377|453641498|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
126094934|NCT01144377|453641499|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
126094935|NCT01144377|453641500|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
126094936|NCT01144377|453641496|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
126094937|NCT01144377|453641497|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
126094938|NCT01144377|453641498|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
126094939|NCT01144377|453641499|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
126094940|NCT01144377|453641500|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
126094941|NCT00607724|453641504|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
126094942|NCT00607724|453641505|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
126094943|NCT00607724|453641506|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
126094944|NCT00607724|453641507|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
126094945|NCT00607724|453641508|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
126094946|NCT00607724|453641509|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
126094947|NCT00607724|453641510|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
126094948|NCT00607724|453641504|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
126094949|NCT00607724|453641505|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
126094950|NCT00607724|453641506|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
126094951|NCT00607724|453641507|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
126094952|NCT00607724|453641508|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
126094953|NCT00607724|453641509|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
126094954|NCT00607724|453641510|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
126094955|NCT00607724|453641504|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
126094956|NCT00607724|453641505|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
126094957|NCT00607724|453641506|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
126094958|NCT00607724|453641507|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
126094959|NCT00607724|453641508|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
126094960|NCT00607724|453641509|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
126094961|NCT00607724|453641510|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
126094962|NCT00607724|453641504|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
126094963|NCT00607724|453641505|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
126094964|NCT00607724|453641506|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
126094965|NCT00607724|453641507|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
126094966|NCT00607724|453641508|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
126094967|NCT00607724|453641509|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
126094968|NCT00607724|453641510|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
126094969|NCT00607724|453641504|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126094970|NCT00607724|453641505|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126094971|NCT00607724|453641506|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126094972|NCT00607724|453641507|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
126094973|NCT00607724|453641508|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126094974|NCT00607724|453641509|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126094975|NCT00607724|453641510|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126094976|NCT03738423|453641511|FG000|Overall Study|Withdrawal by Subject|9|||
126094977|NCT03738423|453641512|FG001|Overall Study|Withdrawal by Subject|12|||
126094978|NCT03738423|453641513|FG002|Overall Study|Withdrawal by Subject|9|||
126094979|NCT03738423|453641514|FG003|Overall Study|Withdrawal by Subject|12|||
126094980|NCT03738423|453641515|FG004|Overall Study|Withdrawal by Subject|10|||
126094981|NCT03738423|453641511|FG000|Overall Study|Lack of Efficacy|3|||
126094982|NCT03738423|453641512|FG001|Overall Study|Lack of Efficacy|1|||
126094983|NCT03738423|453641513|FG002|Overall Study|Lack of Efficacy|1|||
126094984|NCT03738423|453641514|FG003|Overall Study|Lack of Efficacy|1|||
126094985|NCT03738423|453641515|FG004|Overall Study|Lack of Efficacy|2|||
126094986|NCT03738423|453641511|FG000|Overall Study|Lost to Follow-up|1|||
126094987|NCT03738423|453641512|FG001|Overall Study|Lost to Follow-up|0|||
126094988|NCT03738423|453641513|FG002|Overall Study|Lost to Follow-up|1|||
126094989|NCT03738423|453641514|FG003|Overall Study|Lost to Follow-up|1|||
126357833|NCT04518410|454602219|FG010|Overall Study|Requirement to start alternative therapy|0|||
126094990|NCT03738423|453641515|FG004|Overall Study|Lost to Follow-up|0|||
126357834|NCT04518410|454602220|FG011|Overall Study|Requirement to start alternative therapy|0|||
126357835|NCT04518410|454602221|FG012|Overall Study|Requirement to start alternative therapy|0|||
126357836|NCT04518410|454602222|FG013|Overall Study|Requirement to start alternative therapy|0|||
126357837|NCT04518410|454602223|FG014|Overall Study|Requirement to start alternative therapy|0|||
126357838|NCT04518410|454602224|FG015|Overall Study|Requirement to start alternative therapy|0|||
126357839|NCT04518410|454602225|FG016|Overall Study|Requirement to start alternative therapy|0|||
126357840|NCT04518410|454602226|FG017|Overall Study|Requirement to start alternative therapy|0|||
126094991|NCT03738423|453641511|FG000|Overall Study|Protocol Violation|1|||
126248617|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|moved|0|||
126248618|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|moved|0|||
126248619|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248620|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248621|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248622|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
126027888|NCT03692676|453400823|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
126027889|NCT03692676|453400820|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
126027890|NCT03692676|453400821|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
126027891|NCT03692676|453400822|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
126027892|NCT03692676|453400823|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
126027893|NCT03692676|453400820|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
126027894|NCT03692676|453400821|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
126027895|NCT03692676|453400822|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
126027896|NCT03692676|453400823|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
126027897|NCT03692676|453400820|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
126027898|NCT03692676|453400821|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
126027899|NCT03692676|453400822|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
126027900|NCT03692676|453400823|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
126027901|NCT03692676|453400820|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
126027902|NCT03692676|453400821|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
126027903|NCT03692676|453400822|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
126027904|NCT03692676|453400823|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
126027905|NCT03692676|453400820|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
126027906|NCT03692676|453400821|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
126027907|NCT03692676|453400822|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
126027908|NCT03692676|453400823|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
126027909|NCT03692676|453400820|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
126027910|NCT03692676|453400821|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
126027911|NCT03692676|453400822|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
126027912|NCT03692676|453400823|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
126027913|NCT03692676|453400820|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
126027914|NCT03692676|453400821|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
126027915|NCT03692676|453400822|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
126027916|NCT03692676|453400823|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
126027917|NCT03692676|453400820|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
126027918|NCT03692676|453400821|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
126027919|NCT03692676|453400822|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
126027920|NCT03692676|453400823|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
126027921|NCT03692676|453400820|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
126027922|NCT03692676|453400821|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
126027923|NCT03692676|453400822|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
126027924|NCT03692676|453400823|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
126027925|NCT03692676|453400820|FG000|Overall Study|Other|0|||
126027926|NCT03692676|453400821|FG001|Overall Study|Other|805|||
126027927|NCT03692676|453400822|FG002|Overall Study|Other|758|||
126027928|NCT03692676|453400823|FG003|Overall Study|Other|277|||
126027929|NCT03692676|453400820|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
126027930|NCT03692676|453400821|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
126027931|NCT03692676|453400822|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
126027932|NCT03692676|453400823|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
126027933|NCT04638998|453400824|FG000|Overall Study|Withdrawal by Subject|1|||
126248623|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248624|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248625|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248626|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248627|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248628|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248629|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248630|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248631|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248632|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248633|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248634|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248635|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248636|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248637|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248638|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125879598|NCT02903771|452857313|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
125879599|NCT02903771|452857314|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
125879600|NCT02903771|452857315|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
125879601|NCT02903771|452857309|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125879602|NCT02903771|452857310|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125879603|NCT02903771|452857311|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125879604|NCT02903771|452857312|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125879605|NCT02903771|452857313|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
125879606|NCT02903771|452857314|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125879607|NCT02903771|452857315|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125879608|NCT02903771|452857309|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125879609|NCT02903771|452857310|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125879610|NCT02903771|452857311|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125879611|NCT02903771|452857312|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125879612|NCT02903771|452857313|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
125879613|NCT02903771|452857314|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125879614|NCT02903771|452857315|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125879615|NCT02903771|452857309|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125879616|NCT02903771|452857310|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125879617|NCT02903771|452857311|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125879618|NCT02903771|452857312|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125879619|NCT02903771|452857313|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
125879620|NCT02903771|452857314|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125879621|NCT02903771|452857315|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125879622|NCT02903771|452857309|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125879623|NCT02903771|452857310|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125879624|NCT02903771|452857311|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
126027934|NCT04638998|453400825|FG001|Overall Study|Withdrawal by Subject|3|||
126027935|NCT01180634|453400826|FG000|Overall Study|Adverse Event|4|||
126027936|NCT01180634|453400827|FG001|Overall Study|Adverse Event|1|||
126027937|NCT01180634|453400826|FG000|Overall Study|Miscellaneous|2|||
126027938|NCT01180634|453400827|FG001|Overall Study|Miscellaneous|0|||
126027939|NCT01180634|453400826|FG000|Overall Study|Withdrawal by Subject|4|||
126027940|NCT01180634|453400827|FG001|Overall Study|Withdrawal by Subject|0|||
126027941|NCT03692611|453400829|FG000|Overall Study|Found to be ineligible postrandomization|3|||
126027942|NCT03692611|453400830|FG001|Overall Study|Found to be ineligible postrandomization|0|||
126027943|NCT04419168|453400831|FG000|Overall Study|Protocol Violation|1|||
126027944|NCT04419168|453400832|FG001|Overall Study|Protocol Violation|1|||
126027945|NCT04419168|453400831|FG000|Overall Study|Lost to Follow-up|7|||
126027946|NCT04419168|453400832|FG001|Overall Study|Lost to Follow-up|7|||
126027947|NCT04419168|453400831|FG000|Overall Study|Missed 6-month Visit|48|||
126027948|NCT04419168|453400832|FG001|Overall Study|Missed 6-month Visit|45|||
126027949|NCT04490915|453400833|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
126027950|NCT04490915|453400834|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
126248639|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248640|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248641|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248642|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126357841|NCT04518410|454602227|FG018|Overall Study|Requirement to start alternative therapy|0|||
125879625|NCT02903771|452857312|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125879626|NCT02903771|452857313|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
126027951|NCT04490915|453400833|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126027952|NCT04490915|453400834|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126027953|NCT04490915|453400833|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126248643|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248644|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248645|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248646|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248647|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248648|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248649|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
126248650|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248651|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248652|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248653|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248654|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248655|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248656|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248657|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248658|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248659|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248660|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248661|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248662|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248663|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248664|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248665|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248666|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248667|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248668|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248669|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248670|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248671|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
126248672|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
126248673|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
126248674|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
126248675|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
126248676|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
126248677|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
126248678|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
126248679|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
126248680|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
126248681|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
126248682|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
126248683|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
126248684|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
126248685|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
126248686|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
126248687|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
126248688|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
126248689|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
126248690|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
126248691|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
126248692|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
126248693|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
126248694|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
126248695|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
126248696|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
126248697|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248698|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248699|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248700|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248701|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248702|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
126248703|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
126248704|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248705|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248706|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
126248707|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248708|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248709|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248710|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248711|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126027954|NCT04490915|453400834|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
126027955|NCT04490915|453400833|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
126027956|NCT04490915|453400834|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
126027957|NCT04490915|453400833|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
126027958|NCT04490915|453400834|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
126027959|NCT04490915|453400833|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
126027960|NCT04490915|453400834|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
126027961|NCT04490915|453400833|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
126027962|NCT04490915|453400834|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
126027963|NCT05009251|453400835|FG000|Overall Study|Protocol Violation|100|||
126027964|NCT05009251|453400836|FG001|Overall Study|Protocol Violation|105|||
126027965|NCT05009251|453400837|FG002|Overall Study|Protocol Violation|119|||
126027966|NCT05009251|453400838|FG003|Overall Study|Protocol Violation|120|||
126027967|NCT05009251|453400839|FG004|Overall Study|Protocol Violation|119|||
126027968|NCT05009251|453400835|FG000|Overall Study|Death|25|||
126027969|NCT05009251|453400836|FG001|Overall Study|Death|22|||
126027970|NCT05009251|453400837|FG002|Overall Study|Death|24|||
126027971|NCT05009251|453400838|FG003|Overall Study|Death|19|||
126027972|NCT05009251|453400839|FG004|Overall Study|Death|15|||
126027973|NCT05374837|453400840|FG000|Overall Study|Lost to Follow-up|17|||
126027974|NCT05374837|453400841|FG001|Overall Study|Lost to Follow-up|18|||
126027975|NCT05406921|453400843|FG000|Overall Study|Withdrawal by Subject|25|||
126027976|NCT05406921|453400844|FG001|Overall Study|Withdrawal by Subject|0|||
126027977|NCT05406921|453400845|FG002|Overall Study|Withdrawal by Subject|25|||
126027978|NCT05406921|453400843|FG000|Overall Study|Protocol Violation|0|||
125879627|NCT02903771|452857314|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125879628|NCT02903771|452857315|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125879629|NCT02903771|452857309|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125879630|NCT02903771|452857310|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125879631|NCT02903771|452857311|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126027979|NCT05406921|453400844|FG001|Overall Study|Protocol Violation|12|||
126094992|NCT03738423|453641512|FG001|Overall Study|Protocol Violation|0|||
126094993|NCT03738423|453641513|FG002|Overall Study|Protocol Violation|0|||
126094994|NCT03738423|453641514|FG003|Overall Study|Protocol Violation|0|||
126094995|NCT03738423|453641515|FG004|Overall Study|Protocol Violation|1|||
126094996|NCT03738423|453641511|FG000|Overall Study|Physician Decision|0|||
126094997|NCT03738423|453641512|FG001|Overall Study|Physician Decision|0|||
126248712|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248713|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248714|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248715|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248716|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248717|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248718|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248719|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248720|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248721|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248722|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248723|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248724|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248725|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248726|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248727|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248728|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248729|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248730|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248731|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
125879632|NCT02903771|452857312|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126248732|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248733|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248734|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125879633|NCT02903771|452857313|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
125879634|NCT02903771|452857314|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126027980|NCT05406921|453400845|FG002|Overall Study|Protocol Violation|0|||
126027981|NCT03786783|453400850|FG000|Overall Study|Death|1|||
126027982|NCT03786783|453400850|FG000|Overall Study|Physician Decision|6|||
126027983|NCT03786783|453400850|FG000|Overall Study|Withdrawal by Subject|2|||
126027984|NCT03786783|453400850|FG000|Overall Study|Disease Progression|7|||
126248735|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248736|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248737|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248738|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248739|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126027985|NCT03786783|453400850|FG000|Overall Study|Patient/Parent Refusal|4|||
126027986|NCT00616967|453400851|FG000|Overall Study|Withdrawal by Subject|0|||
126027987|NCT00616967|453400852|FG001|Overall Study|Withdrawal by Subject|0|||
126248740|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248741|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248742|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248743|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248744|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248745|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248746|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248747|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248748|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248749|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248750|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248751|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248752|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248753|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248754|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
126357842|NCT04518410|454602228|FG019|Overall Study|Requirement to start alternative therapy|0|||
126248755|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248756|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248757|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
126248758|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248759|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248760|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248761|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248762|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248763|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248764|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248765|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248766|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248767|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248768|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248769|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248770|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248771|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248772|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248773|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248774|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248775|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248776|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248777|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248778|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126357843|NCT04518410|454602229|FG020|Overall Study|Requirement to start alternative therapy|0|||
126027988|NCT00616967|453400853|FG002|Overall Study|Withdrawal by Subject|1|||
126027989|NCT02910583|453400854|FG000|Overall Study|Death|7|||
126027990|NCT02910583|453400855|FG001|Overall Study|Death|3|||
126027991|NCT02910583|453400854|FG000|Overall Study|Lost to Follow-up|1|||
126027992|NCT02910583|453400855|FG001|Overall Study|Lost to Follow-up|0|||
126027993|NCT02910583|453400854|FG000|Overall Study|Withdrawal by Subject|12|||
126027994|NCT02910583|453400855|FG001|Overall Study|Withdrawal by Subject|8|||
126027995|NCT02910583|453400854|FG000|Overall Study|Other, Not Specified|6|||
126027996|NCT02910583|453400855|FG001|Overall Study|Other, Not Specified|3|||
126027997|NCT01331005|453400857|FG000|Overall Study|Lost to Follow-up|2|||
126027998|NCT01331005|453400858|FG001|Overall Study|Lost to Follow-up|1|||
126027999|NCT01331005|453400857|FG000|Overall Study|Withdrawal by Subject|2|||
126028000|NCT01331005|453400858|FG001|Overall Study|Withdrawal by Subject|3|||
126028001|NCT03393975|453400865|FG000|Urgent Treatment Period|Physician Decision|0|||
126028002|NCT03393975|453400866|FG001|Urgent Treatment Period|Physician Decision|0|||
126028003|NCT03393975|453400867|FG002|Urgent Treatment Period|Physician Decision|0|||
126028004|NCT03393975|453400868|FG003|Urgent Treatment Period|Physician Decision|1|||
126028005|NCT03393975|453400865|FG000|Prophylaxis Period 1|Reason not Specified|0|||
126028006|NCT03393975|453400866|FG001|Prophylaxis Period 1|Reason not Specified|1|||
126028007|NCT03393975|453400867|FG002|Prophylaxis Period 1|Reason not Specified|0|||
126028008|NCT03393975|453400868|FG003|Prophylaxis Period 1|Reason not Specified|0|||
126028009|NCT03393975|453400865|FG000|Prophylaxis Period 2|Reason not Specified|0|||
126028010|NCT03393975|453400866|FG001|Prophylaxis Period 2|Reason not Specified|1|||
126248779|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248780|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
126248781|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
126248782|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
126248783|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
126028011|NCT03393975|453400867|FG002|Prophylaxis Period 2|Reason not Specified|0|||
126028012|NCT03393975|453400868|FG003|Prophylaxis Period 2|Reason not Specified|0|||
126028013|NCT05458011|453400869|FG000|DB Period (12 Weeks)|Adverse Event|2|||
126028014|NCT05458011|453400870|FG001|DB Period (12 Weeks)|Adverse Event|1|||
126028015|NCT05458011|453400871|FG002|DB Period (12 Weeks)|Adverse Event|1|||
126028016|NCT05458011|453400869|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
126028017|NCT05458011|453400870|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
126028018|NCT05458011|453400871|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
126028019|NCT05458011|453400869|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
126028020|NCT05458011|453400870|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
126248784|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
126248785|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248786|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248787|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248788|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248789|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248790|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248791|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248792|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248793|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248794|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248795|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248796|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248797|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248798|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248799|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248800|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248801|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248802|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248803|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248804|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248805|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248806|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248807|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248808|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248809|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248810|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
126248811|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248812|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248813|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248814|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248815|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248816|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248817|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248818|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126028021|NCT05458011|453400871|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
126028022|NCT05458011|453400869|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
126028023|NCT05458011|453400870|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
126028024|NCT05458011|453400871|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
126028025|NCT05458011|453400869|FG000|OL Period (12 Weeks)|Adverse Event|1|||
126248819|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248820|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248821|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248822|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248823|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126028026|NCT05458011|453400870|FG001|OL Period (12 Weeks)|Adverse Event|2|||
126028027|NCT05458011|453400871|FG002|OL Period (12 Weeks)|Adverse Event|1|||
126248824|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248825|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248826|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248827|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248828|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248829|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248830|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
126028028|NCT05458011|453400869|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
126094998|NCT03738423|453641513|FG002|Overall Study|Physician Decision|1|||
126028029|NCT05458011|453400870|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
126028030|NCT05458011|453400871|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
126248831|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248832|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248833|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248834|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248835|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248836|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
126248837|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248838|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248839|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248840|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248841|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248842|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248843|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248844|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248845|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248846|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248847|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248848|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248849|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248850|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248851|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248852|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248853|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Moved|0|||
126248854|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Moved|0|||
126248855|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Moved|0|||
126248856|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Moved|0|||
126248857|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Moved|0|||
126248858|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Moved|0|||
126248859|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Moved|0|||
126248860|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Moved|0|||
126248861|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Moved|0|||
126248862|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Moved|1|||
126248863|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Moved|0|||
126248864|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Moved|0|||
126248865|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Moved|0|||
126248866|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Moved|0|||
126248867|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Moved|0|||
126248868|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Moved|0|||
126248869|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Moved|0|||
126248870|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Moved|0|||
126248871|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Moved|0|||
126248872|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Moved|0|||
126248873|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Moved|0|||
126248874|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Moved|0|||
126248875|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Moved|0|||
126248876|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Moved|0|||
126248877|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Moved|0|||
126248878|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Moved|0|||
126248879|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
126248880|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
126248881|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
126248882|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
126248883|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
126028031|NCT02724878|453400888|FG000|Overall Study|Still on Active Therapy|15|||
126028032|NCT02724878|453400888|FG000|Overall Study|Disease Progression|31|||
126028033|NCT02724878|453400888|FG000|Overall Study|Toxicity|5|||
126028034|NCT02724878|453400888|FG000|Overall Study|Death|1|||
126028035|NCT02724878|453400888|FG000|Overall Study|Withdrawal by Subject|4|||
126248884|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
126028036|NCT02724878|453400888|FG000|Overall Study|Lost to Follow-up|2|||
126248885|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
126248886|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
126028037|NCT02724878|453400888|FG000|Overall Study|Protocol Violation|1|||
126028038|NCT02724878|453400888|FG000|Overall Study|Ineligible for Study Drug|5|||
126028039|NCT02724878|453400888|FG000|Overall Study|not started|1|||
126028040|NCT04838262|453400890|FG000|Overall Study|Withdrawal by Subject|9|||
126248887|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
126248888|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
126248889|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
126248890|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
126248891|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
126248892|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
126028041|NCT04838262|453400891|FG001|Overall Study|Withdrawal by Subject|4|||
126028042|NCT03175029|453400894|FG000|Overall Study|Withdrawal by Subject|2|||
126028043|NCT03175029|453400895|FG001|Overall Study|Withdrawal by Subject|1|||
126028044|NCT03175029|453400894|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
126028045|NCT03175029|453400895|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
126028046|NCT05227209|453400900|FG000|Overall Study|Adverse Event|11|||
126028047|NCT05227209|453400900|FG000|Overall Study|Lost to Follow-up|1|||
126028048|NCT05227209|453400900|FG000|Overall Study|Withdrawal by Subject|7|||
126028049|NCT05227209|453400900|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
126028050|NCT03281291|453400903|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
126028051|NCT03281291|453400904|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
126028052|NCT03281291|453400905|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
126028053|NCT03281291|453400906|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
126028054|NCT03281291|453400907|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
126028055|NCT03281291|453400903|FG000|Overall Study|Protocol Deviation|2|||
126028056|NCT03281291|453400904|FG001|Overall Study|Protocol Deviation|0|||
126028057|NCT03281291|453400905|FG002|Overall Study|Protocol Deviation|1|||
126028058|NCT03281291|453400906|FG003|Overall Study|Protocol Deviation|2|||
126028059|NCT03281291|453400907|FG004|Overall Study|Protocol Deviation|1|||
126248893|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
126248894|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
126248895|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
126248896|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
126248897|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
126248898|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
126248899|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
126248900|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
126248901|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
126248902|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
126248903|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
126248904|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
126248905|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248906|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248907|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248908|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248909|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248910|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248911|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248912|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248913|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248914|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248915|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248916|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
126248917|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248918|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
126248919|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248920|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
126248921|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248922|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248923|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
126248924|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126028060|NCT03281291|453400903|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
126028061|NCT03281291|453400904|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
126028062|NCT03281291|453400905|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
126028063|NCT03281291|453400906|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
126248925|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248926|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248927|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248928|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248929|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248930|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125879635|NCT02903771|452857315|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126028064|NCT03281291|453400907|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
126028065|NCT03281291|453400903|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
126094999|NCT03738423|453641514|FG003|Overall Study|Physician Decision|0|||
126248931|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248932|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248933|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248934|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248935|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248936|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248937|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248938|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248939|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248940|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248941|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248942|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248943|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248944|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248945|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248946|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
126248947|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248948|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248949|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248950|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248951|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248952|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248953|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248954|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248955|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248956|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248957|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248958|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248959|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248960|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248961|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248962|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248963|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248964|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248965|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248966|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248967|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248968|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248969|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248970|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248971|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248972|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
126248973|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248974|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248975|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248976|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248977|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248978|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248979|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248980|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248981|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
126357844|NCT04518410|454602230|FG021|Overall Study|Requirement to start alternative therapy|0|||
126357845|NCT04518410|454602231|FG022|Overall Study|Requirement to start alternative therapy|0|||
126357846|NCT04518410|454602232|FG023|Overall Study|Requirement to start alternative therapy|0|||
126357847|NCT04518410|454602233|FG024|Overall Study|Requirement to start alternative therapy|0|||
126357848|NCT04518410|454602209|FG000|Overall Study|Randomized but not treated|0|||
126357849|NCT04518410|454602210|FG001|Overall Study|Randomized but not treated|0|||
126357850|NCT04518410|454602211|FG002|Overall Study|Randomized but not treated|0|||
126357851|NCT04518410|454602212|FG003|Overall Study|Randomized but not treated|2|||
126357852|NCT04518410|454602213|FG004|Overall Study|Randomized but not treated|6|||
126357853|NCT04518410|454602214|FG005|Overall Study|Randomized but not treated|4|||
126357854|NCT04518410|454602215|FG006|Overall Study|Randomized but not treated|3|||
126357855|NCT04518410|454602216|FG007|Overall Study|Randomized but not treated|3|||
126357856|NCT04518410|454602217|FG008|Overall Study|Randomized but not treated|0|||
126357857|NCT04518410|454602218|FG009|Overall Study|Randomized but not treated|4|||
126357858|NCT04518410|454602219|FG010|Overall Study|Randomized but not treated|0|||
126357859|NCT04518410|454602220|FG011|Overall Study|Randomized but not treated|0|||
126357860|NCT04518410|454602221|FG012|Overall Study|Randomized but not treated|1|||
126357861|NCT04518410|454602222|FG013|Overall Study|Randomized but not treated|3|||
126357862|NCT04518410|454602223|FG014|Overall Study|Randomized but not treated|3|||
126357863|NCT04518410|454602224|FG015|Overall Study|Randomized but not treated|3|||
126357864|NCT04518410|454602225|FG016|Overall Study|Randomized but not treated|4|||
126357865|NCT04518410|454602226|FG017|Overall Study|Randomized but not treated|5|||
126357866|NCT04518410|454602227|FG018|Overall Study|Randomized but not treated|4|||
126357867|NCT04518410|454602228|FG019|Overall Study|Randomized but not treated|0|||
126248982|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248983|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248984|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248985|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248986|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248987|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248988|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248989|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248990|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248991|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248992|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248993|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248994|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
126248995|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248996|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248997|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
126248998|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248999|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249000|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249001|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249002|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249003|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249004|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249005|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249006|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249007|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249008|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249009|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126357868|NCT04518410|454602229|FG020|Overall Study|Randomized but not treated|0|||
126249010|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249011|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126357869|NCT04518410|454602230|FG021|Overall Study|Randomized but not treated|5|||
126357870|NCT04518410|454602231|FG022|Overall Study|Randomized but not treated|0|||
126357871|NCT04518410|454602232|FG023|Overall Study|Randomized but not treated|3|||
126357872|NCT04518410|454602233|FG024|Overall Study|Randomized but not treated|1|||
126357873|NCT04518410|454602209|FG000|Overall Study|Screen Fail but Randomized|0|||
126357874|NCT04518410|454602210|FG001|Overall Study|Screen Fail but Randomized|0|||
126357875|NCT04518410|454602211|FG002|Overall Study|Screen Fail but Randomized|0|||
126357876|NCT04518410|454602212|FG003|Overall Study|Screen Fail but Randomized|0|||
126357877|NCT04518410|454602213|FG004|Overall Study|Screen Fail but Randomized|2|||
126357878|NCT04518410|454602214|FG005|Overall Study|Screen Fail but Randomized|0|||
126357879|NCT04518410|454602215|FG006|Overall Study|Screen Fail but Randomized|0|||
126357880|NCT04518410|454602216|FG007|Overall Study|Screen Fail but Randomized|0|||
126357881|NCT04518410|454602217|FG008|Overall Study|Screen Fail but Randomized|0|||
126357882|NCT04518410|454602218|FG009|Overall Study|Screen Fail but Randomized|0|||
126357883|NCT04518410|454602219|FG010|Overall Study|Screen Fail but Randomized|0|||
126357884|NCT04518410|454602220|FG011|Overall Study|Screen Fail but Randomized|0|||
126357885|NCT04518410|454602221|FG012|Overall Study|Screen Fail but Randomized|0|||
126357886|NCT04518410|454602222|FG013|Overall Study|Screen Fail but Randomized|0|||
126357887|NCT04518410|454602223|FG014|Overall Study|Screen Fail but Randomized|0|||
126357888|NCT04518410|454602224|FG015|Overall Study|Screen Fail but Randomized|0|||
126357889|NCT04518410|454602225|FG016|Overall Study|Screen Fail but Randomized|0|||
126357890|NCT04518410|454602226|FG017|Overall Study|Screen Fail but Randomized|0|||
126357891|NCT04518410|454602227|FG018|Overall Study|Screen Fail but Randomized|0|||
126357892|NCT04518410|454602228|FG019|Overall Study|Screen Fail but Randomized|0|||
126357893|NCT04518410|454602229|FG020|Overall Study|Screen Fail but Randomized|0|||
126357894|NCT04518410|454602230|FG021|Overall Study|Screen Fail but Randomized|0|||
126357895|NCT04518410|454602231|FG022|Overall Study|Screen Fail but Randomized|0|||
126357896|NCT04518410|454602232|FG023|Overall Study|Screen Fail but Randomized|0|||
126357897|NCT04518410|454602233|FG024|Overall Study|Screen Fail but Randomized|0|||
126357898|NCT04518410|454602209|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357899|NCT04518410|454602210|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357900|NCT04518410|454602211|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357901|NCT04518410|454602212|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357902|NCT04518410|454602213|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
126249012|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249013|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249014|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249015|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249016|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249017|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249018|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249019|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
126249020|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
126249021|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249022|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249023|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249024|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249025|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249026|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249027|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249028|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249029|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249030|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249031|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249032|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249033|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249034|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249035|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249036|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249037|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249038|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249039|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249040|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249041|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249042|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249043|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126028066|NCT03281291|453400904|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
126028067|NCT03281291|453400905|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
126028068|NCT03281291|453400906|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
126028069|NCT03281291|453400907|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
126028070|NCT03281291|453400903|FG000|Overall Study|Lost to Follow-up|10|||
126028071|NCT03281291|453400904|FG001|Overall Study|Lost to Follow-up|10|||
126028072|NCT03281291|453400905|FG002|Overall Study|Lost to Follow-up|4|||
126028073|NCT03281291|453400906|FG003|Overall Study|Lost to Follow-up|6|||
126028074|NCT03281291|453400907|FG004|Overall Study|Lost to Follow-up|10|||
126028075|NCT03281291|453400903|FG000|Overall Study|Other|0|||
126028076|NCT03281291|453400904|FG001|Overall Study|Other|2|||
126028077|NCT03281291|453400905|FG002|Overall Study|Other|0|||
126028078|NCT03281291|453400906|FG003|Overall Study|Other|2|||
126028079|NCT03281291|453400907|FG004|Overall Study|Other|1|||
126028080|NCT05524233|453400908|FG000|Overall Study|Lost to Follow-up|2|||
126028081|NCT05524233|453400908|FG000|Overall Study|Adverse Event|2|||
126028082|NCT05524233|453400908|FG000|Overall Study|Withdrawal by Subject|1|||
126028083|NCT04382898|453400909|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
126028084|NCT04382898|453400910|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
126028085|NCT04382898|453400911|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
126028086|NCT04382898|453400912|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
126028087|NCT04382898|453400913|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
126028088|NCT04382898|453400909|FG000|Part 1: Dose Titration|Death|6|||
126028089|NCT04382898|453400910|FG001|Part 1: Dose Titration|Death|0|||
126028090|NCT04382898|453400911|FG002|Part 1: Dose Titration|Death|0|||
126028091|NCT04382898|453400912|FG003|Part 1: Dose Titration|Death|0|||
126028092|NCT04382898|453400913|FG004|Part 1: Dose Titration|Death|0|||
126028093|NCT04382898|453400909|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126028094|NCT04382898|453400910|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126028095|NCT04382898|453400911|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
126028096|NCT04382898|453400912|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126028097|NCT04382898|453400913|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126028098|NCT04382898|453400909|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
126028099|NCT04382898|453400910|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
126028100|NCT04382898|453400911|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
126028101|NCT04382898|453400912|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
126028102|NCT04382898|453400913|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
126028103|NCT04382898|453400909|FG000|Part 2: Dose Expansion|Death|0|||
126028104|NCT04382898|453400910|FG001|Part 2: Dose Expansion|Death|17|||
126028105|NCT04382898|453400911|FG002|Part 2: Dose Expansion|Death|13|||
126028106|NCT04382898|453400912|FG003|Part 2: Dose Expansion|Death|1|||
126095000|NCT03738423|453641515|FG004|Overall Study|Physician Decision|1|||
126249044|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249045|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249046|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249047|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249048|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249049|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249050|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249051|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249052|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249053|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249054|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249055|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
126249056|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
126249057|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249058|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249059|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249060|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249061|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249062|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249063|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249064|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249065|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126028107|NCT04382898|453400913|FG004|Part 2: Dose Expansion|Death|0|||
126095001|NCT03738423|453641511|FG000|Overall Study|Death|0|||
125879636|NCT02903771|452857309|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125879637|NCT02903771|452857310|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125879638|NCT02903771|452857311|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125879639|NCT02903771|452857312|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125879640|NCT02903771|452857313|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
125879641|NCT02903771|452857314|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125879642|NCT02903771|452857315|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125879643|NCT03331315|452857322|FG000|Overall Study|Physician Decision|18|||
125879644|NCT03331315|452857323|FG001|Overall Study|Physician Decision|14|||
125879645|NCT02435992|452857328|FG000|Overall Study|non compliance with protocol|2|||
125879646|NCT02435992|452857329|FG001|Overall Study|non compliance with protocol|0|||
125879647|NCT02435992|452857330|FG002|Overall Study|non compliance with protocol|1|||
125879648|NCT02435992|452857331|FG003|Overall Study|non compliance with protocol|0|||
125879649|NCT02435992|452857332|FG004|Overall Study|non compliance with protocol|0|||
125879650|NCT02435992|452857328|FG000|Overall Study|Adverse Event|11|||
125879651|NCT02435992|452857329|FG001|Overall Study|Adverse Event|6|||
125879652|NCT02435992|452857330|FG002|Overall Study|Adverse Event|12|||
125879653|NCT02435992|452857331|FG003|Overall Study|Adverse Event|0|||
125879654|NCT02435992|452857332|FG004|Overall Study|Adverse Event|0|||
125879655|NCT02435992|452857328|FG000|Overall Study|Lack of Efficacy|4|||
125879656|NCT02435992|452857329|FG001|Overall Study|Lack of Efficacy|10|||
125879657|NCT02435992|452857330|FG002|Overall Study|Lack of Efficacy|9|||
125879658|NCT02435992|452857331|FG003|Overall Study|Lack of Efficacy|0|||
125879659|NCT02435992|452857332|FG004|Overall Study|Lack of Efficacy|0|||
125879660|NCT02435992|452857328|FG000|Overall Study|Withdrawal by Subject|10|||
125879661|NCT02435992|452857329|FG001|Overall Study|Withdrawal by Subject|8|||
125879662|NCT02435992|452857330|FG002|Overall Study|Withdrawal by Subject|20|||
125879663|NCT02435992|452857331|FG003|Overall Study|Withdrawal by Subject|0|||
125879664|NCT02435992|452857332|FG004|Overall Study|Withdrawal by Subject|0|||
125879665|NCT02435992|452857328|FG000|Overall Study|Other Reason|1|||
125879666|NCT02435992|452857329|FG001|Overall Study|Other Reason|0|||
125879667|NCT02435992|452857330|FG002|Overall Study|Other Reason|0|||
125879668|NCT02435992|452857331|FG003|Overall Study|Other Reason|0|||
125879669|NCT02435992|452857332|FG004|Overall Study|Other Reason|0|||
125879670|NCT02435992|452857328|FG000|Overall Study|Physician Decision|0|||
125879671|NCT02435992|452857329|FG001|Overall Study|Physician Decision|0|||
125879672|NCT02435992|452857330|FG002|Overall Study|Physician Decision|1|||
125879673|NCT02435992|452857331|FG003|Overall Study|Physician Decision|0|||
125879674|NCT02435992|452857332|FG004|Overall Study|Physician Decision|0|||
125879675|NCT01761877|452857333|FG000|Overall Study|Adverse Event|7|||
125879676|NCT01761877|452857334|FG001|Overall Study|Adverse Event|0|||
125879677|NCT01761877|452857333|FG000|Overall Study|Withdrawal by Subject|6|||
125879678|NCT01761877|452857334|FG001|Overall Study|Withdrawal by Subject|4|||
125879679|NCT01761877|452857333|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
125879680|NCT01761877|452857334|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
125879681|NCT01761877|452857333|FG000|Overall Study|Death|0|||
125879682|NCT01761877|452857334|FG001|Overall Study|Death|1|||
125879683|NCT01761877|452857333|FG000|Overall Study|MRI intolerant|1|||
125879684|NCT01761877|452857334|FG001|Overall Study|MRI intolerant|6|||
125879685|NCT02461758|452857336|FG000|Overall Study|Lost to Follow-up|0|||
125879686|NCT02461758|452857337|FG001|Overall Study|Lost to Follow-up|1|||
125879687|NCT02461758|452857338|FG002|Overall Study|Lost to Follow-up|1|||
125879688|NCT02461758|452857339|FG003|Overall Study|Lost to Follow-up|0|||
125879689|NCT01353898|452857349|FG000|Overall Study|Study site terminated|0|||
125879690|NCT01353898|452857350|FG001|Overall Study|Study site terminated|0|||
125879691|NCT01353898|452857351|FG002|Overall Study|Study site terminated|0|||
125879692|NCT01353898|452857352|FG003|Overall Study|Study site terminated|0|||
125879693|NCT01353898|452857353|FG004|Overall Study|Study site terminated|0|||
125879694|NCT01353898|452857354|FG005|Overall Study|Study site terminated|1|||
125879695|NCT03558737|452857355|FG000|Overall Study|Death|1|||
125879696|NCT03558737|452857356|FG001|Overall Study|Death|1|||
126028108|NCT04382898|453400909|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
126028109|NCT04382898|453400910|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
126028110|NCT04382898|453400911|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
125879697|NCT00888134|452857357|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
125879698|NCT00888134|452857357|FG000|Follow-up|being followed for long-term survival|1|||
125879699|NCT03041181|452857361|FG000|Overall Study|Disease Progression|1|||
125879700|NCT03041181|452857362|FG001|Overall Study|Disease Progression|2|||
125879701|NCT03224819|452857363|FG000|Overall Study|Withdrawal by Subject|0|||
125879702|NCT03224819|452857364|FG001|Overall Study|Withdrawal by Subject|0|||
125879703|NCT03224819|452857365|FG002|Overall Study|Withdrawal by Subject|0|||
125879704|NCT03224819|452857366|FG003|Overall Study|Withdrawal by Subject|0|||
125879705|NCT03224819|452857367|FG004|Overall Study|Withdrawal by Subject|0|||
125879706|NCT03224819|452857368|FG005|Overall Study|Withdrawal by Subject|0|||
125879707|NCT03224819|452857369|FG006|Overall Study|Withdrawal by Subject|0|||
126249066|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249067|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249068|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249069|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249070|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249071|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249072|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126028111|NCT04382898|453400912|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
126249073|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249074|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126028112|NCT04382898|453400913|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
126028113|NCT04382898|453400909|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
126095002|NCT03738423|453641512|FG001|Overall Study|Death|0|||
126028114|NCT04382898|453400910|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
126028115|NCT04382898|453400911|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
126028116|NCT04382898|453400912|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
126028117|NCT04382898|453400913|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
126028118|NCT04382898|453400909|FG000|Part 2: Dose Expansion|Other|0|||
126028119|NCT04382898|453400910|FG001|Part 2: Dose Expansion|Other|0|||
126028120|NCT04382898|453400911|FG002|Part 2: Dose Expansion|Other|1|||
126028121|NCT04382898|453400912|FG003|Part 2: Dose Expansion|Other|0|||
126028122|NCT04382898|453400913|FG004|Part 2: Dose Expansion|Other|0|||
126028123|NCT05229120|453400914|FG000|Overall Study|Withdrawal by Subject|8|||
126249075|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249076|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126028124|NCT02530671|453400917|FG000|Overall Study|Lost to Follow-up|2|||
126028125|NCT02530671|453400918|FG001|Overall Study|Lost to Follow-up|0|||
126028126|NCT02530671|453400917|FG000|Overall Study|Withdrawal by Subject|1|||
126249077|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249078|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249079|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249080|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249081|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
126249082|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249083|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249084|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249085|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125879708|NCT03224819|452857370|FG007|Overall Study|Withdrawal by Subject|0|||
125879709|NCT03224819|452857371|FG008|Overall Study|Withdrawal by Subject|0|||
125879710|NCT03224819|452857372|FG009|Overall Study|Withdrawal by Subject|0|||
125879711|NCT03224819|452857373|FG010|Overall Study|Withdrawal by Subject|0|||
125879712|NCT03224819|452857374|FG011|Overall Study|Withdrawal by Subject|0|||
125879713|NCT03224819|452857375|FG012|Overall Study|Withdrawal by Subject|1|||
125879714|NCT03224819|452857376|FG013|Overall Study|Withdrawal by Subject|0|||
125879715|NCT03224819|452857363|FG000|Overall Study|Sponsor Decision|0|||
125879716|NCT03224819|452857364|FG001|Overall Study|Sponsor Decision|0|||
125879717|NCT03224819|452857365|FG002|Overall Study|Sponsor Decision|0|||
125879718|NCT03224819|452857366|FG003|Overall Study|Sponsor Decision|1|||
125879719|NCT03224819|452857367|FG004|Overall Study|Sponsor Decision|1|||
125879720|NCT03224819|452857368|FG005|Overall Study|Sponsor Decision|2|||
125879721|NCT03224819|452857369|FG006|Overall Study|Sponsor Decision|1|||
125879722|NCT03224819|452857370|FG007|Overall Study|Sponsor Decision|1|||
125879723|NCT03224819|452857371|FG008|Overall Study|Sponsor Decision|1|||
125879724|NCT03224819|452857372|FG009|Overall Study|Sponsor Decision|2|||
125879725|NCT03224819|452857373|FG010|Overall Study|Sponsor Decision|1|||
125879726|NCT03224819|452857374|FG011|Overall Study|Sponsor Decision|1|||
125879727|NCT03224819|452857375|FG012|Overall Study|Sponsor Decision|1|||
125879728|NCT03224819|452857376|FG013|Overall Study|Sponsor Decision|0|||
125879729|NCT03224819|452857363|FG000|Overall Study|Lost to Follow-up|0|||
125879730|NCT03224819|452857364|FG001|Overall Study|Lost to Follow-up|0|||
125879731|NCT03224819|452857365|FG002|Overall Study|Lost to Follow-up|0|||
125879732|NCT03224819|452857366|FG003|Overall Study|Lost to Follow-up|0|||
125879733|NCT03224819|452857367|FG004|Overall Study|Lost to Follow-up|0|||
125879734|NCT03224819|452857368|FG005|Overall Study|Lost to Follow-up|0|||
125879735|NCT03224819|452857369|FG006|Overall Study|Lost to Follow-up|0|||
125879736|NCT03224819|452857370|FG007|Overall Study|Lost to Follow-up|0|||
125879737|NCT03224819|452857371|FG008|Overall Study|Lost to Follow-up|1|||
125879738|NCT03224819|452857372|FG009|Overall Study|Lost to Follow-up|0|||
126028127|NCT02530671|453400918|FG001|Overall Study|Withdrawal by Subject|0|||
126028128|NCT04390048|453400919|FG000|Overall Study|Withdrawal by Subject|1|||
126028129|NCT04390048|453400920|FG001|Overall Study|Withdrawal by Subject|3|||
126028130|NCT01566695|453400921|FG000|Overall Study|Lack of Efficacy|1|||
126249086|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125879739|NCT03224819|452857373|FG010|Overall Study|Lost to Follow-up|0|||
126249087|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249088|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249089|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125879740|NCT03224819|452857374|FG011|Overall Study|Lost to Follow-up|0|||
125879741|NCT03224819|452857375|FG012|Overall Study|Lost to Follow-up|0|||
125879742|NCT03224819|452857376|FG013|Overall Study|Lost to Follow-up|0|||
125879743|NCT03224819|452857363|FG000|Overall Study|Death|0|||
125879744|NCT03224819|452857364|FG001|Overall Study|Death|1|||
126028131|NCT01566695|453400922|FG001|Overall Study|Lack of Efficacy|0|||
126028132|NCT01566695|453400921|FG000|Overall Study|Adverse Event|3|||
126028133|NCT01566695|453400922|FG001|Overall Study|Adverse Event|0|||
125879745|NCT03224819|452857365|FG002|Overall Study|Death|0|||
125879746|NCT03224819|452857366|FG003|Overall Study|Death|0|||
125879747|NCT03224819|452857367|FG004|Overall Study|Death|0|||
126249090|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249091|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249092|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249093|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249094|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249095|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249096|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249097|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249098|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249099|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249100|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249101|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249102|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249103|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249104|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249105|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249106|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249107|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249108|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
126249109|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249110|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249111|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249112|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249113|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249114|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249115|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249116|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249117|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249118|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249119|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249120|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249121|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249122|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249123|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249124|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249125|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249126|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249127|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249128|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249129|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249130|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249131|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249132|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249133|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249134|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
126249135|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249136|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249137|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249138|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
126028134|NCT01566695|453400921|FG000|Overall Study|Death|79|||
126028135|NCT01566695|453400922|FG001|Overall Study|Death|86|||
126028136|NCT01566695|453400921|FG000|Overall Study|Withdrawal by Subject|13|||
126028137|NCT01566695|453400922|FG001|Overall Study|Withdrawal by Subject|12|||
126249139|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249140|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249141|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249142|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249143|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249144|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249145|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249146|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249147|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249148|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249149|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249150|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249151|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249152|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249153|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249154|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249155|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249156|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126028138|NCT01566695|453400921|FG000|Overall Study|Lost to Follow-up|0|||
126028139|NCT01566695|453400922|FG001|Overall Study|Lost to Follow-up|3|||
126028140|NCT01566695|453400921|FG000|Overall Study|Other reasons|11|||
126028141|NCT01566695|453400922|FG001|Overall Study|Other reasons|8|||
126028142|NCT03763708|453400923|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
126028143|NCT03763708|453400924|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126028144|NCT03763708|453400925|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126028145|NCT03763708|453400926|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126028146|NCT03763708|453400927|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126028147|NCT03763708|453400928|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126028148|NCT03763708|453400929|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126028149|NCT03763708|453400930|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126028150|NCT03763708|453400931|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126028151|NCT03763708|453400923|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126357903|NCT04518410|454602214|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
126357904|NCT04518410|454602215|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
126357905|NCT04518410|454602216|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
126357906|NCT04518410|454602217|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
126357907|NCT04518410|454602218|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
126357908|NCT04518410|454602219|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
126357909|NCT04518410|454602220|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357910|NCT04518410|454602221|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357911|NCT04518410|454602222|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
126357912|NCT04518410|454602223|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357913|NCT04518410|454602224|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
126357914|NCT04518410|454602225|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
126357915|NCT04518410|454602226|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
126357916|NCT04518410|454602227|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
126357917|NCT04518410|454602228|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
126357918|NCT04518410|454602229|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
126357919|NCT04518410|454602230|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
126357920|NCT04518410|454602231|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
126357921|NCT04518410|454602232|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
126357922|NCT04518410|454602233|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
126357923|NCT04518410|454602209|FG000|Overall Study|Dual Enrolled Subject|0|||
126357924|NCT04518410|454602210|FG001|Overall Study|Dual Enrolled Subject|0|||
126357925|NCT04518410|454602211|FG002|Overall Study|Dual Enrolled Subject|0|||
126357926|NCT04518410|454602212|FG003|Overall Study|Dual Enrolled Subject|0|||
126357927|NCT04518410|454602213|FG004|Overall Study|Dual Enrolled Subject|0|||
126357928|NCT04518410|454602214|FG005|Overall Study|Dual Enrolled Subject|0|||
126357929|NCT04518410|454602215|FG006|Overall Study|Dual Enrolled Subject|0|||
126357930|NCT04518410|454602216|FG007|Overall Study|Dual Enrolled Subject|0|||
126357931|NCT04518410|454602217|FG008|Overall Study|Dual Enrolled Subject|0|||
126357932|NCT04518410|454602218|FG009|Overall Study|Dual Enrolled Subject|0|||
126357933|NCT04518410|454602219|FG010|Overall Study|Dual Enrolled Subject|0|||
126357934|NCT04518410|454602220|FG011|Overall Study|Dual Enrolled Subject|0|||
126357935|NCT04518410|454602221|FG012|Overall Study|Dual Enrolled Subject|0|||
126357936|NCT04518410|454602222|FG013|Overall Study|Dual Enrolled Subject|0|||
126357937|NCT04518410|454602223|FG014|Overall Study|Dual Enrolled Subject|0|||
126357938|NCT04518410|454602224|FG015|Overall Study|Dual Enrolled Subject|0|||
126357939|NCT04518410|454602225|FG016|Overall Study|Dual Enrolled Subject|0|||
126357940|NCT04518410|454602226|FG017|Overall Study|Dual Enrolled Subject|1|||
126357941|NCT04518410|454602227|FG018|Overall Study|Dual Enrolled Subject|0|||
126357942|NCT04518410|454602228|FG019|Overall Study|Dual Enrolled Subject|0|||
126357943|NCT04518410|454602229|FG020|Overall Study|Dual Enrolled Subject|0|||
126357944|NCT04518410|454602230|FG021|Overall Study|Dual Enrolled Subject|0|||
126028152|NCT03763708|453400924|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126028153|NCT03763708|453400925|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
126028154|NCT03763708|453400926|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126028155|NCT03763708|453400927|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126028156|NCT03763708|453400928|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126028157|NCT03763708|453400929|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126249157|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249158|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126028158|NCT03763708|453400930|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126028159|NCT03763708|453400931|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126028160|NCT03763708|453400923|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126028161|NCT03763708|453400924|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126028162|NCT03763708|453400925|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126028163|NCT03763708|453400926|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
126028164|NCT03763708|453400927|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126249159|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
126249160|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
126249161|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249162|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249163|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249164|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249165|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249166|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249167|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249168|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249169|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249170|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249171|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249172|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249173|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249174|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249175|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249176|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249177|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249178|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249179|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249180|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249181|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249182|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249183|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249184|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249185|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249186|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249187|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
126249188|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
126249189|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249190|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
126249191|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Death|0|||
126249192|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Death|0|||
126249193|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Death|0|||
126249194|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Death|0|||
126357945|NCT04518410|454602231|FG022|Overall Study|Dual Enrolled Subject|0|||
126357946|NCT04518410|454602232|FG023|Overall Study|Dual Enrolled Subject|0|||
126357947|NCT04518410|454602233|FG024|Overall Study|Dual Enrolled Subject|0|||
126357948|NCT05737745|454602234|FG000|Overall Study|Withdrawal by Subject|0|||
126357949|NCT05737745|454602235|FG001|Overall Study|Withdrawal by Subject|6|||
126357950|NCT05737745|454602236|FG002|Overall Study|Withdrawal by Subject|1|||
126357951|NCT02547935|454602237|FG000|Overall Study|Other|0|||
126357952|NCT02547935|454602238|FG001|Overall Study|Other|1|||
126357953|NCT02547935|454602239|FG002|Overall Study|Other|0|||
126357954|NCT02547935|454602237|FG000|Overall Study|Withdrawal by Subject|2|||
126357955|NCT02547935|454602238|FG001|Overall Study|Withdrawal by Subject|3|||
126357956|NCT02547935|454602239|FG002|Overall Study|Withdrawal by Subject|4|||
126028165|NCT03763708|453400928|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126249195|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Death|0|||
126357957|NCT02547935|454602237|FG000|Overall Study|Screen Failure|2|||
126357958|NCT02547935|454602238|FG001|Overall Study|Screen Failure|0|||
126357959|NCT02547935|454602239|FG002|Overall Study|Screen Failure|0|||
126357960|NCT02547935|454602237|FG000|Overall Study|Physician Decision|0|||
126357961|NCT02547935|454602238|FG001|Overall Study|Physician Decision|1|||
126028166|NCT03763708|453400929|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126028167|NCT03763708|453400930|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126249196|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Death|0|||
126249197|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Death|0|||
126357962|NCT02547935|454602239|FG002|Overall Study|Physician Decision|0|||
126357963|NCT02547935|454602237|FG000|Overall Study|Lost to Follow-up|0|||
126357964|NCT02547935|454602238|FG001|Overall Study|Lost to Follow-up|2|||
126357965|NCT02547935|454602239|FG002|Overall Study|Lost to Follow-up|1|||
126249198|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Death|0|||
126249199|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Death|0|||
126249200|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Death|0|||
126249201|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Death|0|||
126249202|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Death|0|||
126249203|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Death|0|||
126249204|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Death|0|||
126028168|NCT03763708|453400931|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126028169|NCT03763708|453400923|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126028170|NCT03763708|453400924|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126028171|NCT03763708|453400925|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126028172|NCT03763708|453400926|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126028173|NCT03763708|453400927|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
126028174|NCT03763708|453400928|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126028175|NCT03763708|453400929|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126028176|NCT03763708|453400930|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126028177|NCT03763708|453400931|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126028178|NCT03763708|453400923|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126028179|NCT03763708|453400924|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126028180|NCT03763708|453400925|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126028181|NCT03763708|453400926|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126028182|NCT03763708|453400927|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126028183|NCT03763708|453400928|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
126028184|NCT03763708|453400929|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126028185|NCT03763708|453400930|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126028186|NCT03763708|453400931|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126028187|NCT03763708|453400923|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126028188|NCT03763708|453400924|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126028189|NCT03763708|453400925|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126028190|NCT03763708|453400926|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126028191|NCT03763708|453400927|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126028192|NCT03763708|453400928|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126028193|NCT03763708|453400929|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
126028194|NCT03763708|453400930|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126028195|NCT03763708|453400931|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126028196|NCT03763708|453400923|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
126028197|NCT03763708|453400924|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
126249205|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Death|0|||
126249206|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Death|0|||
126249207|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Death|0|||
126249208|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Death|0|||
126249209|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Death|0|||
126249210|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Death|0|||
126249211|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Death|0|||
126249212|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Death|0|||
126249213|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Death|0|||
126249214|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Death|2|||
126249215|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Death|0|||
126249216|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Death|0|||
126249217|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249218|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249219|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249220|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249221|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249222|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249223|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249224|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249225|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249226|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126028198|NCT03763708|453400925|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
126028199|NCT03763708|453400926|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
126028200|NCT03763708|453400927|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
126028201|NCT03763708|453400928|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
126249227|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249228|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249229|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249230|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249231|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249232|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249233|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249234|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126028202|NCT03763708|453400929|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
126028203|NCT03763708|453400930|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
126028204|NCT03763708|453400931|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
126028205|NCT03763708|453400923|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
126028206|NCT03763708|453400924|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
126249235|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249236|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249237|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125879748|NCT03224819|452857368|FG005|Overall Study|Death|0|||
125879749|NCT03224819|452857369|FG006|Overall Study|Death|0|||
126028207|NCT03763708|453400925|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
126249238|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249239|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249240|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249241|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249242|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
126249243|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Other|0|||
126249244|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Other|0|||
126249245|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Other|0|||
126249246|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Other|0|||
126249247|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Other|0|||
126249248|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Other|0|||
126249249|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Other|0|||
126249250|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Other|0|||
126249251|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Other|0|||
126249252|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Other|0|||
126249253|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Other|0|||
126249254|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Other|0|||
126249255|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Other|0|||
126249256|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Other|0|||
126249257|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Other|0|||
126249258|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Other|0|||
126249259|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Other|0|||
126249260|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Other|0|||
126249261|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Other|0|||
126249262|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Other|0|||
126249263|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Other|0|||
126249264|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Other|0|||
126249265|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Other|0|||
126249266|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Other|0|||
126249267|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Other|1|||
126249268|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Other|0|||
126249269|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249270|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249271|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249272|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249273|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249274|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249275|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249276|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249277|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249278|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126028208|NCT03763708|453400926|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
126249279|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249280|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125879750|NCT03224819|452857370|FG007|Overall Study|Death|1|||
126028209|NCT03763708|453400927|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
126357966|NCT02547935|454602237|FG000|Overall Study|Death|1|||
126357967|NCT02547935|454602238|FG001|Overall Study|Death|1|||
126249281|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249282|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249283|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249284|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249285|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249286|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249287|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249288|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249289|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249290|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249291|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249292|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
126249293|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249294|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249295|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249296|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249297|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249298|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249299|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249300|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249301|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249302|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249303|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249304|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249305|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249306|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249307|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249308|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249309|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126357968|NCT02547935|454602239|FG002|Overall Study|Death|0|||
126357969|NCT04289298|454603838|FG000|Overall Study|Lost to Follow-up|5|||
126357970|NCT04289298|454603839|FG001|Overall Study|Lost to Follow-up|0|||
126357971|NCT04289298|454603838|FG000|Overall Study|Withdrawal by Subject|2|||
126357972|NCT04289298|454603839|FG001|Overall Study|Withdrawal by Subject|0|||
126357973|NCT01108796|454603840|FG000|Overall Study|Adverse Event|0|||
126357974|NCT01108796|454603841|FG001|Overall Study|Adverse Event|1|||
126357975|NCT01108796|454603840|FG000|Overall Study|Lost to Follow-up|7|||
126357976|NCT01108796|454603841|FG001|Overall Study|Lost to Follow-up|6|||
126357977|NCT00454142|454603842|FG000|Overall Study|Withdrawal by Subject|1|||
126357978|NCT02545127|454603849|FG000|Overall Study|Lost to Follow-up|1|||
126357979|NCT02545127|454603850|FG001|Overall Study|Lost to Follow-up|0|||
126357980|NCT03315689|454603851|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
126357981|NCT03315689|454603852|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
126028210|NCT03763708|453400928|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
126028211|NCT03763708|453400929|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
126028212|NCT03763708|453400930|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
126028213|NCT03763708|453400931|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
126028214|NCT03763708|453400923|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
126028215|NCT03763708|453400924|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
126028216|NCT03763708|453400925|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
126028217|NCT03763708|453400926|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
126028218|NCT03763708|453400927|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
126028219|NCT03763708|453400928|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
126028220|NCT03763708|453400929|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
126028221|NCT03763708|453400930|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
126028222|NCT03763708|453400931|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
126028223|NCT05470400|453400934|FG000|Overall Study|Lost to Follow-up|0|||
126028224|NCT05470400|453400935|FG001|Overall Study|Lost to Follow-up|0|||
126028225|NCT05470400|453400936|FG002|Overall Study|Lost to Follow-up|0|||
126028226|NCT05470400|453400937|FG003|Overall Study|Lost to Follow-up|0|||
126028227|NCT05470400|453400938|FG004|Overall Study|Lost to Follow-up|0|||
126028228|NCT05470400|453400939|FG005|Overall Study|Lost to Follow-up|0|||
126028229|NCT05470400|453400940|FG006|Overall Study|Lost to Follow-up|0|||
126028230|NCT05470400|453400941|FG007|Overall Study|Lost to Follow-up|1|||
126028231|NCT05470400|453400934|FG000|Overall Study|Withdrawal by Subject|1|||
126028232|NCT05470400|453400935|FG001|Overall Study|Withdrawal by Subject|0|||
126028233|NCT05470400|453400936|FG002|Overall Study|Withdrawal by Subject|0|||
126028234|NCT05470400|453400937|FG003|Overall Study|Withdrawal by Subject|0|||
126028235|NCT05470400|453400938|FG004|Overall Study|Withdrawal by Subject|0|||
126028236|NCT05470400|453400939|FG005|Overall Study|Withdrawal by Subject|1|||
126028237|NCT05470400|453400940|FG006|Overall Study|Withdrawal by Subject|0|||
126249310|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249311|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249312|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249313|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249314|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249315|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249316|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249317|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
126249318|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
126249319|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249320|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
126249321|NCT00842309|454202305|FG000|Overall Study|Withdrawal by Subject|3|||
126249322|NCT00842309|454202306|FG001|Overall Study|Withdrawal by Subject|1|||
126249323|NCT02911025|454202307|FG000|Overall Study|Lost to Follow-up|3|||
126249324|NCT03218787|454202308|FG000|Overall Study|Lost to Follow-up|12|||
126249325|NCT03218787|454202308|FG000|Overall Study|Withdrawal by Subject|72|||
126249326|NCT03218787|454202308|FG000|Overall Study|Physician Decision|11|||
126249327|NCT03218787|454202308|FG000|Overall Study|Death|111|||
126249328|NCT02264977|454202309|FG000|Overall Study|Death|3|||
126249329|NCT02264977|454202309|FG000|Overall Study|Physician Decision|1|||
126249330|NCT02264977|454202309|FG000|Overall Study|Refuse to return|1|||
126249331|NCT03573544|454202310|FG000|Overall Study|Adverse Event|0|||
126249332|NCT03573544|454202311|FG001|Overall Study|Adverse Event|0|||
126249333|NCT03573544|454202312|FG002|Overall Study|Adverse Event|0|||
126249334|NCT03573544|454202313|FG003|Overall Study|Adverse Event|3|||
126249335|NCT03573544|454202314|FG004|Overall Study|Adverse Event|1|||
126249336|NCT03573544|454202315|FG005|Overall Study|Adverse Event|0|||
126357982|NCT03315689|454603851|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
126357983|NCT03315689|454603852|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
126357984|NCT03315689|454603851|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
126028238|NCT05470400|453400941|FG007|Overall Study|Withdrawal by Subject|2|||
126028239|NCT01809691|453400942|FG000|Overall Study|Currently on Treatment|192|||
126028240|NCT01809691|453400943|FG001|Overall Study|Currently on Treatment|100|||
126028241|NCT01809691|453400942|FG000|Overall Study|No Protocol Treatment|10|||
126028242|NCT01809691|453400943|FG001|Overall Study|No Protocol Treatment|11|||
126028243|NCT01809691|453400942|FG000|Overall Study|Adverse Event|80|||
126028244|NCT01809691|453400943|FG001|Overall Study|Adverse Event|21|||
126028245|NCT01809691|453400942|FG000|Overall Study|Disease Progression|226|||
126028246|NCT01809691|453400943|FG001|Overall Study|Disease Progression|372|||
126028247|NCT01809691|453400942|FG000|Overall Study|Death|26|||
126028248|NCT01809691|453400943|FG001|Overall Study|Death|13|||
126028249|NCT01809691|453400942|FG000|Overall Study|Participant Refusal|70|||
126028250|NCT01809691|453400943|FG001|Overall Study|Participant Refusal|72|||
126028251|NCT01809691|453400942|FG000|Overall Study|Other, Not Specified|34|||
126028252|NCT01809691|453400943|FG001|Overall Study|Other, Not Specified|52|||
126028253|NCT02281955|453400948|FG000|Overall Study|Death|1|||
126028254|NCT04391894|453400955|FG000|Overall Study|Adverse Event|1|||
126028255|NCT04391894|453400956|FG001|Overall Study|Adverse Event|1|||
126028256|NCT04391894|453400957|FG002|Overall Study|Adverse Event|1|||
126028257|NCT04391894|453400958|FG003|Overall Study|Adverse Event|1|||
126028258|NCT04391894|453400959|FG004|Overall Study|Adverse Event|1|||
126028259|NCT04391894|453400955|FG000|Overall Study|Lost to Follow-up|1|||
126028260|NCT04391894|453400956|FG001|Overall Study|Lost to Follow-up|0|||
126028261|NCT04391894|453400957|FG002|Overall Study|Lost to Follow-up|0|||
126028262|NCT04391894|453400958|FG003|Overall Study|Lost to Follow-up|0|||
126028263|NCT04391894|453400959|FG004|Overall Study|Lost to Follow-up|0|||
126028264|NCT04391894|453400955|FG000|Overall Study|Protocol Violation|0|||
126028265|NCT04391894|453400956|FG001|Overall Study|Protocol Violation|0|||
126028266|NCT04391894|453400957|FG002|Overall Study|Protocol Violation|0|||
126028267|NCT04391894|453400958|FG003|Overall Study|Protocol Violation|1|||
126028268|NCT04391894|453400959|FG004|Overall Study|Protocol Violation|0|||
126028269|NCT04391894|453400955|FG000|Overall Study|Withdrawal by Subject|2|||
126028270|NCT04391894|453400956|FG001|Overall Study|Withdrawal by Subject|0|||
126028271|NCT04391894|453400957|FG002|Overall Study|Withdrawal by Subject|3|||
126028272|NCT04391894|453400958|FG003|Overall Study|Withdrawal by Subject|0|||
126028273|NCT04391894|453400959|FG004|Overall Study|Withdrawal by Subject|1|||
126028274|NCT04391894|453400955|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
126028275|NCT04391894|453400956|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
126028276|NCT04391894|453400957|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
126028277|NCT04391894|453400958|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
126028278|NCT04391894|453400959|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
126028279|NCT01057433|453400964|FG000|Overall Study|Adverse Event|1|||
126028280|NCT05268302|453400965|FG000|Overall Study|Death|0|||
126028281|NCT05268302|453400966|FG001|Overall Study|Death|1|||
126028282|NCT04285567|453400967|FG000|Overall Study|Death|3|||
126028283|NCT04285567|453400968|FG001|Overall Study|Death|3|||
126028284|NCT04285567|453400967|FG000|Overall Study|Lost to Follow-up|1|||
126028285|NCT04285567|453400968|FG001|Overall Study|Lost to Follow-up|1|||
126028286|NCT04285567|453400967|FG000|Overall Study|Reason Not Specified|1|||
126028287|NCT04285567|453400968|FG001|Overall Study|Reason Not Specified|1|||
126028288|NCT04285567|453400967|FG000|Overall Study|Physician Decision|2|||
126028289|NCT04285567|453400968|FG001|Overall Study|Physician Decision|1|||
126028290|NCT04285567|453400967|FG000|Overall Study|Withdrawal by Subject|2|||
126028291|NCT04285567|453400968|FG001|Overall Study|Withdrawal by Subject|6|||
126028292|NCT04285567|453400967|FG000|Overall Study|Adverse Event|1|||
126028293|NCT04285567|453400968|FG001|Overall Study|Adverse Event|0|||
126028294|NCT04285567|453400967|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
126028295|NCT04285567|453400968|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
126028296|NCT05319860|453400970|FG000|Overall Study|Death|1|||
126028297|NCT05319860|453400971|FG001|Overall Study|Death|1|||
126028298|NCT05319860|453400970|FG000|Overall Study|Lost to Follow-up|3|||
126028299|NCT05319860|453400971|FG001|Overall Study|Lost to Follow-up|1|||
126028300|NCT05319860|453400970|FG000|Overall Study|Withdrawal by Subject|1|||
126028301|NCT05319860|453400971|FG001|Overall Study|Withdrawal by Subject|7|||
126028302|NCT05063994|453402711|FG000|Cortef Run-In|Withdrawal of Consent|1|||
126249337|NCT03573544|454202316|FG006|Overall Study|Adverse Event|2|||
126249338|NCT03573544|454202317|FG007|Overall Study|Adverse Event|0|||
126028303|NCT05063994|453402712|FG001|Cortef Run-In|Withdrawal of Consent|0|||
126028304|NCT05063994|453402713|FG002|Cortef Run-In|Withdrawal of Consent|0|||
126028305|NCT05063994|453402711|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
126028306|NCT05063994|453402712|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
126028307|NCT05063994|453402713|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
126249339|NCT03573544|454202310|FG000|Overall Study|Physician Decision|0|||
126249340|NCT03573544|454202311|FG001|Overall Study|Physician Decision|0|||
126249341|NCT03573544|454202312|FG002|Overall Study|Physician Decision|0|||
126249342|NCT03573544|454202313|FG003|Overall Study|Physician Decision|0|||
126249343|NCT03573544|454202314|FG004|Overall Study|Physician Decision|0|||
126249344|NCT03573544|454202315|FG005|Overall Study|Physician Decision|0|||
126249345|NCT03573544|454202316|FG006|Overall Study|Physician Decision|1|||
126249346|NCT03573544|454202317|FG007|Overall Study|Physician Decision|0|||
126249347|NCT03573544|454202310|FG000|Overall Study|Withdrawal by Subject|2|||
126249348|NCT03573544|454202311|FG001|Overall Study|Withdrawal by Subject|0|||
126249349|NCT03573544|454202312|FG002|Overall Study|Withdrawal by Subject|0|||
126249350|NCT03573544|454202313|FG003|Overall Study|Withdrawal by Subject|1|||
126095003|NCT03738423|453641513|FG002|Overall Study|Death|0|||
126249351|NCT03573544|454202314|FG004|Overall Study|Withdrawal by Subject|1|||
126249352|NCT03573544|454202315|FG005|Overall Study|Withdrawal by Subject|1|||
126249353|NCT03573544|454202316|FG006|Overall Study|Withdrawal by Subject|0|||
126249354|NCT03573544|454202317|FG007|Overall Study|Withdrawal by Subject|1|||
126249355|NCT03573544|454202310|FG000|Overall Study|Disease progression|3|||
126249356|NCT03573544|454202311|FG001|Overall Study|Disease progression|3|||
126249357|NCT03573544|454202312|FG002|Overall Study|Disease progression|6|||
126249358|NCT03573544|454202313|FG003|Overall Study|Disease progression|4|||
126249359|NCT03573544|454202314|FG004|Overall Study|Disease progression|5|||
126249360|NCT03573544|454202315|FG005|Overall Study|Disease progression|7|||
126249361|NCT03573544|454202316|FG006|Overall Study|Disease progression|6|||
126249362|NCT03573544|454202317|FG007|Overall Study|Disease progression|7|||
126249363|NCT00227370|454202318|FG000|Overall Study|Withdrawal by Subject|1|||
126249364|NCT00227370|454202319|FG001|Overall Study|Withdrawal by Subject|2|||
126249365|NCT00227370|454202318|FG000|Overall Study|Death|3|||
126249366|NCT00227370|454202319|FG001|Overall Study|Death|4|||
126249367|NCT00227370|454202318|FG000|Overall Study|Adverse Event|6|||
126249368|NCT00227370|454202319|FG001|Overall Study|Adverse Event|11|||
126249369|NCT00227370|454202318|FG000|Overall Study|Physician Decision|9|||
126249370|NCT00227370|454202319|FG001|Overall Study|Physician Decision|6|||
126249371|NCT00227370|454202318|FG000|Overall Study|Other reasons|2|||
126249372|NCT00227370|454202319|FG001|Overall Study|Other reasons|1|||
126249373|NCT03846193|454202320|FG000|Overall Study|Physician Decision|0|||
126249374|NCT03846193|454202321|FG001|Overall Study|Physician Decision|0|||
126249375|NCT03846193|454202322|FG002|Overall Study|Physician Decision|1|||
126249376|NCT03846193|454202323|FG003|Overall Study|Physician Decision|0|||
126249377|NCT03846193|454202324|FG004|Overall Study|Physician Decision|0|||
126249378|NCT03846193|454202320|FG000|Overall Study|Lost to Follow-up|0|||
126249379|NCT03846193|454202321|FG001|Overall Study|Lost to Follow-up|0|||
126249380|NCT03846193|454202322|FG002|Overall Study|Lost to Follow-up|0|||
126249381|NCT03846193|454202323|FG003|Overall Study|Lost to Follow-up|0|||
126249382|NCT03846193|454202324|FG004|Overall Study|Lost to Follow-up|1|||
126249383|NCT03846193|454202320|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
126249384|NCT03846193|454202321|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
126249385|NCT03846193|454202322|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
126249386|NCT03846193|454202323|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
126249387|NCT03846193|454202324|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
126249388|NCT01229150|454202328|FG000|Overall Study|Toxicity|2|||
126357985|NCT03315689|454603852|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
126357986|NCT01783015|454603853|FG000|Blinded Treatment|Adverse Event|0|||
126357987|NCT01783015|454603854|FG001|Blinded Treatment|Adverse Event|1|||
126357988|NCT01783015|454603855|FG002|Blinded Treatment|Adverse Event|0|||
126028308|NCT05063994|453402711|FG000|Treatment|Physician Decision|0|||
126028309|NCT05063994|453402712|FG001|Treatment|Physician Decision|0|||
126028310|NCT05063994|453402713|FG002|Treatment|Physician Decision|1|||
126028311|NCT05063994|453402711|FG000|Treatment|Withdrawal by Subject|0|||
126028312|NCT05063994|453402712|FG001|Treatment|Withdrawal by Subject|0|||
126028313|NCT05063994|453402713|FG002|Treatment|Withdrawal by Subject|1|||
126028314|NCT05063994|453402711|FG000|Treatment|Withdrawal of Consent|0|||
126028315|NCT05063994|453402712|FG001|Treatment|Withdrawal of Consent|0|||
126028316|NCT05063994|453402713|FG002|Treatment|Withdrawal of Consent|1|||
126028317|NCT02029443|453402714|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
126028318|NCT02029443|453402715|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
126095004|NCT03738423|453641514|FG003|Overall Study|Death|0|||
126249389|NCT01229150|454202329|FG001|Overall Study|Toxicity|2|||
126249390|NCT01229150|454202330|FG002|Overall Study|Toxicity|0|||
126249391|NCT01229150|454202331|FG003|Overall Study|Toxicity|0|||
126249392|NCT02011945|454202332|FG000|Overall Study|Participant requested to Discontinue|0|||
126028319|NCT02029443|453402716|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
126028320|NCT02029443|453402717|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
126028321|NCT02029443|453402718|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
126028322|NCT02029443|453402714|FG000|Overall Study|Death|13|||
126028323|NCT02029443|453402715|FG001|Overall Study|Death|2|||
126028324|NCT02029443|453402716|FG002|Overall Study|Death|2|||
126028325|NCT02029443|453402717|FG003|Overall Study|Death|11|||
126028326|NCT02029443|453402718|FG004|Overall Study|Death|2|||
126028327|NCT02029443|453402714|FG000|Overall Study|Lost to Follow-up|1|||
126028328|NCT02029443|453402715|FG001|Overall Study|Lost to Follow-up|0|||
126028329|NCT02029443|453402716|FG002|Overall Study|Lost to Follow-up|1|||
126028330|NCT02029443|453402717|FG003|Overall Study|Lost to Follow-up|1|||
126028331|NCT02029443|453402718|FG004|Overall Study|Lost to Follow-up|0|||
126028332|NCT02029443|453402714|FG000|Overall Study|Started other anti-cancer therapy|17|||
126028333|NCT02029443|453402715|FG001|Overall Study|Started other anti-cancer therapy|4|||
126028334|NCT02029443|453402716|FG002|Overall Study|Started other anti-cancer therapy|7|||
126028335|NCT02029443|453402717|FG003|Overall Study|Started other anti-cancer therapy|9|||
126095005|NCT03738423|453641515|FG004|Overall Study|Death|1|||
126249393|NCT02011945|454202333|FG001|Overall Study|Participant requested to Discontinue|1|||
126249394|NCT02011945|454202334|FG002|Overall Study|Participant requested to Discontinue|1|||
126249395|NCT02011945|454202332|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
126249396|NCT02011945|454202333|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
126249397|NCT02011945|454202334|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
126249398|NCT02011945|454202332|FG000|Overall Study|Study Drug Toxicity|0|||
126249399|NCT02011945|454202333|FG001|Overall Study|Study Drug Toxicity|0|||
126249400|NCT02011945|454202334|FG002|Overall Study|Study Drug Toxicity|1|||
126249401|NCT02011945|454202332|FG000|Overall Study|Treatment Failure|0|||
126249402|NCT02011945|454202333|FG001|Overall Study|Treatment Failure|7|||
126249403|NCT02011945|454202334|FG002|Overall Study|Treatment Failure|6|||
126249404|NCT02011945|454202332|FG000|Overall Study|No Longer Meets Study Criteria|1|||
126249405|NCT02011945|454202333|FG001|Overall Study|No Longer Meets Study Criteria|0|||
126249406|NCT02011945|454202334|FG002|Overall Study|No Longer Meets Study Criteria|0|||
126249407|NCT02011945|454202332|FG000|Overall Study|Proceeded to stem cell transplant|0|||
126249408|NCT02011945|454202333|FG001|Overall Study|Proceeded to stem cell transplant|0|||
126249409|NCT02011945|454202334|FG002|Overall Study|Proceeded to stem cell transplant|1|||
126249410|NCT02011945|454202332|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
126249411|NCT02011945|454202333|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
126249412|NCT02011945|454202334|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
126249413|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
126249414|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249415|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249416|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249417|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249418|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249419|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
126249420|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126249421|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126249422|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126249423|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126357989|NCT01783015|454603853|FG000|Blinded Treatment|Protocol Violation|0|||
126357990|NCT01783015|454603854|FG001|Blinded Treatment|Protocol Violation|1|||
126357991|NCT01783015|454603855|FG002|Blinded Treatment|Protocol Violation|0|||
126357992|NCT01783015|454603853|FG000|Blinded Treatment|Withdrawal by Subject|0|||
126357993|NCT01783015|454603854|FG001|Blinded Treatment|Withdrawal by Subject|1|||
126357994|NCT01783015|454603855|FG002|Blinded Treatment|Withdrawal by Subject|0|||
126357995|NCT01783015|454603853|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
126357996|NCT01783015|454603854|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
126357997|NCT01783015|454603855|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
126357998|NCT01783015|454603853|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
126357999|NCT01783015|454603854|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
126358000|NCT01783015|454603855|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
126095006|NCT03738423|453641511|FG000|Overall Study|Randomized but never treated|0|||
126095007|NCT03738423|453641512|FG001|Overall Study|Randomized but never treated|0|||
126095008|NCT03738423|453641513|FG002|Overall Study|Randomized but never treated|1|||
126095009|NCT03738423|453641514|FG003|Overall Study|Randomized but never treated|1|||
126358001|NCT00669331|454603856|FG000|Randomisation to First Dose|Adverse Event|1|||
126095010|NCT03738423|453641515|FG004|Overall Study|Randomized but never treated|0|||
126028336|NCT02029443|453402718|FG004|Overall Study|Started other anti-cancer therapy|3|||
126028337|NCT02029443|453402714|FG000|Overall Study|Withdrawal by Subject|3|||
126028338|NCT02029443|453402715|FG001|Overall Study|Withdrawal by Subject|1|||
126249424|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126028339|NCT02029443|453402716|FG002|Overall Study|Withdrawal by Subject|1|||
126028340|NCT02029443|453402717|FG003|Overall Study|Withdrawal by Subject|1|||
126028341|NCT02029443|453402718|FG004|Overall Study|Withdrawal by Subject|0|||
126028342|NCT02029443|453402714|FG000|Overall Study|Other|6|||
126249425|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
126249426|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126028343|NCT02029443|453402715|FG001|Overall Study|Other|6|||
126028344|NCT02029443|453402716|FG002|Overall Study|Other|4|||
126028345|NCT02029443|453402717|FG003|Overall Study|Other|2|||
126249427|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126249428|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126249429|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126249430|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126249431|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
126249432|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249433|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249434|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249435|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249436|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249437|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
126249438|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249439|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249440|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249441|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249442|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249443|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
126249444|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
126249445|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
126249446|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
126249447|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
126249448|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
126249449|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
126249450|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
126249451|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
126249452|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
126249453|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
126249454|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
126249455|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
126249456|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
126249457|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
126249458|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
126249459|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
126249460|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
126249461|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
126249462|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
125879751|NCT03224819|452857371|FG008|Overall Study|Death|0|||
126028346|NCT02029443|453402718|FG004|Overall Study|Other|0|||
126028347|NCT04083235|453402721|FG000|Overall Study|Death|252|||
126249463|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
126249464|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
126249465|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
126249466|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
126249467|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
126249468|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
126249469|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
126249470|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
126249471|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
126028348|NCT04083235|453402722|FG001|Overall Study|Death|277|||
126249472|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
126249473|NCT00902538|454202335|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
126249474|NCT00902538|454202336|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
126249475|NCT00902538|454202337|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
126249476|NCT00902538|454202338|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
126249477|NCT00902538|454202339|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
126249478|NCT00902538|454202340|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
126249479|NCT00902538|454202335|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
126249480|NCT00902538|454202336|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
126249481|NCT00902538|454202337|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
126249482|NCT00902538|454202338|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
126249483|NCT00902538|454202339|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
126358002|NCT00669331|454603857|FG001|Randomisation to First Dose|Adverse Event|0|||
126028349|NCT04083235|453402721|FG000|Overall Study|Withdrawal by Subject|13|||
126095011|NCT01241604|453641516|FG000|Screening Period|Screen Failure|3|||
126095012|NCT01241604|453641517|FG001|Screening Period|Screen Failure|0|||
126095013|NCT01241604|453641518|FG002|Screening Period|Screen Failure|0|||
126095014|NCT01593787|453641519|FG000|Overall Study|Adverse Event|1|||
126095015|NCT01593787|453641520|FG001|Overall Study|Adverse Event|0|||
126095016|NCT01593787|453641521|FG002|Overall Study|Adverse Event|0|||
126095017|NCT02592876|453641522|FG000|Overall Study|Withdrawal by Subject|3|||
126095018|NCT02592876|453641523|FG001|Overall Study|Withdrawal by Subject|3|||
126095019|NCT02592876|453641522|FG000|Overall Study|Study Termination by Sponsor|32|||
126095020|NCT02592876|453641523|FG001|Overall Study|Study Termination by Sponsor|27|||
126095021|NCT02592876|453641522|FG000|Overall Study|Lost to Follow-up|0|||
126095022|NCT02592876|453641523|FG001|Overall Study|Lost to Follow-up|1|||
126095023|NCT02592876|453641522|FG000|Overall Study|Death|6|||
126095024|NCT02592876|453641523|FG001|Overall Study|Death|9|||
126095025|NCT01865747|453641524|FG000|Overall Study (ITT)|Adverse Event|32|||
126095026|NCT01865747|453641525|FG001|Overall Study (ITT)|Adverse Event|31|||
126095027|NCT01865747|453641524|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
126095028|NCT01865747|453641525|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
126095029|NCT01865747|453641524|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
126095030|NCT01865747|453641525|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
126095031|NCT01865747|453641524|FG000|Overall Study (ITT)|Protocol Violation|1|||
126095032|NCT01865747|453641525|FG001|Overall Study (ITT)|Protocol Violation|1|||
126095033|NCT01865747|453641524|FG000|Overall Study (ITT)|Physician Decision|5|||
126095034|NCT01865747|453641525|FG001|Overall Study (ITT)|Physician Decision|2|||
126095035|NCT01865747|453641524|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
126095036|NCT01865747|453641525|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
126095037|NCT01865747|453641524|FG000|Overall Study (ITT)|Sponsor Decision|0|||
126095038|NCT01865747|453641525|FG001|Overall Study (ITT)|Sponsor Decision|1|||
126095039|NCT01865747|453641524|FG000|Overall Study (ITT)|Progressive Disease|122|||
126095040|NCT01865747|453641525|FG001|Overall Study (ITT)|Progressive Disease|158|||
126095041|NCT01865747|453641524|FG000|Overall Study (ITT)|Reason Not Provided|0|||
126095042|NCT01865747|453641525|FG001|Overall Study (ITT)|Reason Not Provided|1|||
126095043|NCT01865747|453641524|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
126095044|NCT01865747|453641525|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
126095045|NCT01865747|453641524|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
126095046|NCT01865747|453641525|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
126028350|NCT04083235|453402722|FG001|Overall Study|Withdrawal by Subject|17|||
126028351|NCT04083235|453402721|FG000|Overall Study|Lost to Follow-up|1|||
126028352|NCT04083235|453402722|FG001|Overall Study|Lost to Follow-up|1|||
126028353|NCT04083235|453402721|FG000|Overall Study|Does not meet entry criteria|1|||
126028354|NCT04083235|453402722|FG001|Overall Study|Does not meet entry criteria|0|||
126095047|NCT01865747|453641524|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
126095048|NCT01865747|453641525|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
126095049|NCT01865747|453641524|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
126095050|NCT01865747|453641525|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
126095051|NCT01865747|453641524|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
126249484|NCT00902538|454202340|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
126028355|NCT04083235|453402721|FG000|Overall Study|Did not receive treatment|13|||
126095052|NCT01865747|453641525|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
126095053|NCT01865747|453641524|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
126095054|NCT01865747|453641525|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
126095055|NCT01865747|453641524|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
126095056|NCT01865747|453641525|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
126095057|NCT01865747|453641524|FG000|Primary Intent to Treat (PITT)|Other|0|||
126095058|NCT01865747|453641525|FG001|Primary Intent to Treat (PITT)|Other|1|||
126095059|NCT00611975|453641528|FG000|Overall Study|Withdrawal by Subject|3|||
126095060|NCT00611975|453641529|FG001|Overall Study|Withdrawal by Subject|7|||
126095061|NCT00611975|453641528|FG000|Overall Study|Pregnancy|2|||
126095062|NCT00611975|453641529|FG001|Overall Study|Pregnancy|1|||
126095063|NCT01305200|453641531|FG000|Overall Study|Physician Decision|4|||
126095064|NCT01305200|453641532|FG001|Overall Study|Physician Decision|6|||
126095065|NCT01305200|453641533|FG002|Overall Study|Physician Decision|1|||
126095066|NCT01305200|453641531|FG000|Overall Study|Withdrawal by Subject|24|||
126095067|NCT01305200|453641532|FG001|Overall Study|Withdrawal by Subject|21|||
126095068|NCT01305200|453641533|FG002|Overall Study|Withdrawal by Subject|1|||
126095069|NCT01305200|453641531|FG000|Overall Study|Ineligible|1|||
126095070|NCT01305200|453641532|FG001|Overall Study|Ineligible|2|||
126095071|NCT01305200|453641533|FG002|Overall Study|Ineligible|1|||
126095072|NCT01305200|453641531|FG000|Overall Study|Death|0|||
126095073|NCT01305200|453641532|FG001|Overall Study|Death|2|||
126095074|NCT01305200|453641533|FG002|Overall Study|Death|0|||
126095075|NCT02663518|453643011|FG000|Part 1: Phase 1a Escalation|Death|0|||
126095076|NCT02663518|453643012|FG001|Part 1: Phase 1a Escalation|Death|0|||
126095077|NCT02663518|453643013|FG002|Part 1: Phase 1a Escalation|Death|1|||
126095078|NCT02663518|453643014|FG003|Part 1: Phase 1a Escalation|Death|0|||
126095079|NCT02663518|453643015|FG004|Part 1: Phase 1a Escalation|Death|0|||
126095080|NCT02663518|453643016|FG005|Part 1: Phase 1a Escalation|Death|0|||
126095081|NCT02663518|453643017|FG006|Part 1: Phase 1a Escalation|Death|0|||
126095082|NCT02663518|453643018|FG007|Part 1: Phase 1a Escalation|Death|0|||
126095083|NCT02663518|453643019|FG008|Part 1: Phase 1a Escalation|Death|0|||
126095084|NCT02663518|453643020|FG009|Part 1: Phase 1a Escalation|Death|0|||
126095085|NCT02663518|453643021|FG010|Part 1: Phase 1a Escalation|Death|0|||
126095086|NCT02663518|453643022|FG011|Part 1: Phase 1a Escalation|Death|0|||
126095087|NCT02663518|453643023|FG012|Part 1: Phase 1a Escalation|Death|0|||
126095088|NCT02663518|453643024|FG013|Part 1: Phase 1a Escalation|Death|0|||
126095089|NCT02663518|453643011|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095090|NCT02663518|453643012|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095091|NCT02663518|453643013|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
126095092|NCT02663518|453643014|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095093|NCT02663518|453643015|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095094|NCT02663518|453643016|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095095|NCT02663518|453643017|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095096|NCT02663518|453643018|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095097|NCT02663518|453643019|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095098|NCT02663518|453643020|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095099|NCT02663518|453643021|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095100|NCT02663518|453643022|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095101|NCT02663518|453643023|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095102|NCT02663518|453643024|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126095103|NCT02663518|453643011|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
126095104|NCT02663518|453643012|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
126095105|NCT02663518|453643013|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
126095106|NCT02663518|453643014|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
126095107|NCT02663518|453643015|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095108|NCT02663518|453643016|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095109|NCT02663518|453643017|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095110|NCT02663518|453643018|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095111|NCT02663518|453643019|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095112|NCT02663518|453643020|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095113|NCT02663518|453643021|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095114|NCT02663518|453643022|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095115|NCT02663518|453643023|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095116|NCT02663518|453643024|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126095117|NCT02663518|453643011|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
126095118|NCT02663518|453643012|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095119|NCT02663518|453643013|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
126095120|NCT02663518|453643014|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
126095121|NCT02663518|453643015|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095122|NCT02663518|453643016|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095123|NCT02663518|453643017|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095124|NCT02663518|453643018|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095125|NCT02663518|453643019|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095126|NCT02663518|453643020|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095127|NCT02663518|453643021|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095128|NCT02663518|453643022|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095129|NCT02663518|453643023|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095130|NCT02663518|453643024|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126095131|NCT02663518|453643011|FG000|Part 1: Phase 1a Escalation|Other|0|||
126095132|NCT02663518|453643012|FG001|Part 1: Phase 1a Escalation|Other|0|||
126095133|NCT02663518|453643013|FG002|Part 1: Phase 1a Escalation|Other|2|||
126095134|NCT02663518|453643014|FG003|Part 1: Phase 1a Escalation|Other|0|||
126095135|NCT02663518|453643015|FG004|Part 1: Phase 1a Escalation|Other|0|||
126095136|NCT02663518|453643016|FG005|Part 1: Phase 1a Escalation|Other|0|||
126095137|NCT02663518|453643017|FG006|Part 1: Phase 1a Escalation|Other|0|||
126095138|NCT02663518|453643018|FG007|Part 1: Phase 1a Escalation|Other|0|||
126095139|NCT02663518|453643019|FG008|Part 1: Phase 1a Escalation|Other|0|||
126095140|NCT02663518|453643020|FG009|Part 1: Phase 1a Escalation|Other|0|||
126095141|NCT02663518|453643021|FG010|Part 1: Phase 1a Escalation|Other|0|||
126095142|NCT02663518|453643022|FG011|Part 1: Phase 1a Escalation|Other|0|||
126095143|NCT02663518|453643023|FG012|Part 1: Phase 1a Escalation|Other|0|||
126095144|NCT02663518|453643024|FG013|Part 1: Phase 1a Escalation|Other|0|||
126095145|NCT02663518|453643011|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095146|NCT02663518|453643012|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095147|NCT02663518|453643013|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095148|NCT02663518|453643014|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095149|NCT02663518|453643015|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
126095150|NCT02663518|453643016|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095151|NCT02663518|453643017|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
126095152|NCT02663518|453643018|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
126095153|NCT02663518|453643019|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095154|NCT02663518|453643020|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095155|NCT02663518|453643021|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095156|NCT02663518|453643022|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095157|NCT02663518|453643023|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095158|NCT02663518|453643024|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
126095159|NCT02663518|453643011|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095160|NCT02663518|453643012|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095161|NCT02663518|453643013|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095162|NCT02663518|453643014|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095163|NCT02663518|453643015|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
126095164|NCT02663518|453643016|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095165|NCT02663518|453643017|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
126095166|NCT02663518|453643018|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
126095167|NCT02663518|453643019|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095168|NCT02663518|453643020|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095169|NCT02663518|453643021|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095170|NCT02663518|453643022|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095171|NCT02663518|453643023|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095172|NCT02663518|453643024|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126095173|NCT02663518|453643011|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095174|NCT02663518|453643012|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095175|NCT02663518|453643013|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095176|NCT02663518|453643014|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095177|NCT02663518|453643015|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
126095178|NCT02663518|453643016|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095179|NCT02663518|453643017|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095180|NCT02663518|453643018|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095181|NCT02663518|453643019|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095182|NCT02663518|453643020|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095183|NCT02663518|453643021|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095184|NCT02663518|453643022|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095185|NCT02663518|453643023|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095186|NCT02663518|453643024|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126095187|NCT02663518|453643011|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126095188|NCT02663518|453643012|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126095189|NCT02663518|453643013|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126095190|NCT02663518|453643014|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126095191|NCT02663518|453643015|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
126095192|NCT02663518|453643016|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
126095193|NCT02663518|453643017|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
126249485|NCT00902538|454202335|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126249486|NCT00902538|454202336|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
126249487|NCT00902538|454202337|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126028356|NCT04083235|453402722|FG001|Overall Study|Did not receive treatment|8|||
126028357|NCT04083235|453402721|FG000|Overall Study|Ongoing at the time of DCO|44|||
126028358|NCT04083235|453402722|FG001|Overall Study|Ongoing at the time of DCO|7|||
126028359|NCT02549339|453402723|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
126028360|NCT02549339|453402724|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
126028361|NCT02549339|453402723|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
126028362|NCT02549339|453402724|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
126028363|NCT02549339|453402723|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
126028364|NCT02549339|453402724|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
126028365|NCT02549339|453402723|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
126028366|NCT02549339|453402724|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
126028367|NCT02549339|453402723|FG000|12-month Follow-up|Lack of Efficacy|0|||
126028368|NCT02549339|453402724|FG001|12-month Follow-up|Lack of Efficacy|2|||
126028369|NCT02549339|453402723|FG000|12-month Follow-up|Withdrawal by Subject|8|||
126028370|NCT02549339|453402724|FG001|12-month Follow-up|Withdrawal by Subject|3|||
126028371|NCT02549339|453402723|FG000|12-month Follow-up|Lost to Follow-up|1|||
126028372|NCT02549339|453402724|FG001|12-month Follow-up|Lost to Follow-up|3|||
126028373|NCT02549339|453402723|FG000|12-month Follow-up|Other|0|||
126028374|NCT02549339|453402724|FG001|12-month Follow-up|Other|3|||
126028375|NCT03016169|453402725|FG000|Overall Study|Lost to Follow-up|4|||
126028376|NCT03016169|453402725|FG000|Overall Study|Death|54|||
126028377|NCT03016169|453402725|FG000|Overall Study|Device Explant|11|||
126028378|NCT03016169|453402725|FG000|Overall Study|Withdrawal by Subject|19|||
126028379|NCT03016169|453402725|FG000|Overall Study|Other Reasons|1|||
126028380|NCT05082909|453402728|FG000|Overall Study|Protocol Violation|0|||
126028381|NCT05082909|453402729|FG001|Overall Study|Protocol Violation|0|||
126028382|NCT05082909|453402730|FG002|Overall Study|Protocol Violation|1|||
126028383|NCT05082909|453402731|FG003|Overall Study|Protocol Violation|0|||
126028384|NCT05082909|453402732|FG004|Overall Study|Protocol Violation|0|||
126028385|NCT05082909|453402733|FG005|Overall Study|Protocol Violation|0|||
126028386|NCT02954341|453402734|FG000|Overall Study|Attempted Implant unsuccessful|5|||
126028387|NCT02954341|453402734|FG000|Overall Study|Death|90|||
126028388|NCT02954341|453402734|FG000|Overall Study|Withdrawal by Subject|4|||
126028389|NCT02954341|453402734|FG000|Overall Study|Physician Decision|13|||
126028390|NCT02954341|453402734|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
126028391|NCT02954341|453402734|FG000|Overall Study|Not implanted due to physician's decision|1|||
126028392|NCT02954341|453402734|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
126028393|NCT04950660|453402736|FG000|Overall Study|Protocol Violation|4|||
126028394|NCT04950660|453402737|FG001|Overall Study|Protocol Violation|2|||
126028395|NCT04950660|453402736|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
126028396|NCT04950660|453402737|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
126028397|NCT04950660|453402736|FG000|Overall Study|Withdrawal by Subject|0|||
126028398|NCT04950660|453402737|FG001|Overall Study|Withdrawal by Subject|1|||
126028399|NCT04950660|453402736|FG000|Overall Study|Hypotension|1|||
126028400|NCT04950660|453402737|FG001|Overall Study|Hypotension|0|||
126028401|NCT01426425|453402739|FG000|Overall Study|Exited prior to EP study|22|||
126028402|NCT01426425|453402739|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
126028403|NCT01426425|453402739|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
126028404|NCT00512070|453402747|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
126028405|NCT00512070|453402748|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
126028406|NCT00512070|453402749|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
126028407|NCT00512070|453402747|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
126028408|NCT00512070|453402748|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
126028409|NCT00512070|453402749|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
126028410|NCT02506959|453402750|FG000|Overall Study|Physician Decision|2|||
126028411|NCT02506959|453402751|FG001|Overall Study|Physician Decision|1|||
126028412|NCT03932682|453402753|FG000|Overall Study|Death|1|||
126028413|NCT03932682|453402754|FG001|Overall Study|Death|2|||
126028414|NCT03932682|453402753|FG000|Overall Study|Withdrawal by Subject|37|||
126028415|NCT03932682|453402754|FG001|Overall Study|Withdrawal by Subject|45|||
126028416|NCT03932682|453402753|FG000|Overall Study|Lost to Follow-up|19|||
126028417|NCT03932682|453402754|FG001|Overall Study|Lost to Follow-up|25|||
126028418|NCT03932682|453402753|FG000|Overall Study|Protocol Violation|0|||
126028419|NCT03932682|453402754|FG001|Overall Study|Protocol Violation|2|||
126028420|NCT03932682|453402753|FG000|Overall Study|Other|9|||
126028421|NCT03932682|453402754|FG001|Overall Study|Other|23|||
126028422|NCT03126019|453402757|FG000|Overall Study|Death|5|||
126028423|NCT03126019|453402758|FG001|Overall Study|Death|27|||
126028424|NCT03126019|453402757|FG000|Overall Study|Lost to Follow-up|2|||
126028425|NCT03126019|453402758|FG001|Overall Study|Lost to Follow-up|4|||
126028426|NCT03126019|453402757|FG000|Overall Study|Withdrawal by Subject|1|||
126028427|NCT03126019|453402758|FG001|Overall Study|Withdrawal by Subject|9|||
126028428|NCT03126019|453402757|FG000|Overall Study|Physician Decision|1|||
125879752|NCT03224819|452857372|FG009|Overall Study|Death|0|||
126249488|NCT00902538|454202338|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126249489|NCT00902538|454202339|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126249490|NCT00902538|454202340|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126249491|NCT00902538|454202335|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249492|NCT00902538|454202336|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
126249493|NCT00902538|454202337|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249494|NCT00902538|454202338|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249495|NCT00902538|454202339|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249496|NCT00902538|454202340|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249497|NCT00902538|454202335|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
126249498|NCT00902538|454202336|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
126249499|NCT00902538|454202337|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
126249500|NCT00902538|454202338|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
126249501|NCT00902538|454202339|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
126249502|NCT00902538|454202340|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
126249503|NCT00902538|454202335|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
126249504|NCT00902538|454202336|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
126249505|NCT00902538|454202337|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
126249506|NCT00902538|454202338|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
126249507|NCT00902538|454202339|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
126249508|NCT00902538|454202340|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
126249509|NCT00902538|454202335|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249510|NCT00902538|454202336|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249511|NCT00902538|454202337|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249512|NCT00902538|454202338|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
126249513|NCT00902538|454202339|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249514|NCT00902538|454202340|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249515|NCT03531827|454202341|FG000|Overall Study|Adverse Event|2|||
126249516|NCT03531827|454202342|FG001|Overall Study|Adverse Event|0|||
126249517|NCT03531827|454202341|FG000|Overall Study|Progressive disease|1|||
126249518|NCT03531827|454202342|FG001|Overall Study|Progressive disease|0|||
125879753|NCT03224819|452857373|FG010|Overall Study|Death|0|||
126028429|NCT03126019|453402758|FG001|Overall Study|Physician Decision|0|||
126028430|NCT03126019|453402757|FG000|Overall Study|Transitioned to Rollover Study|0|||
126028431|NCT03126019|453402758|FG001|Overall Study|Transitioned to Rollover Study|11|||
126028432|NCT03126019|453402757|FG000|Overall Study|Did Not Return to Site for Care|0|||
126028433|NCT03126019|453402758|FG001|Overall Study|Did Not Return to Site for Care|1|||
126028434|NCT03126019|453402757|FG000|Overall Study|Site Closed|0|||
126028435|NCT03126019|453402758|FG001|Overall Study|Site Closed|1|||
126028436|NCT05323084|453402762|FG000|Period 2 - Washout|Lost to Follow-up|0|||
126028437|NCT05323084|453402763|FG001|Period 2 - Washout|Lost to Follow-up|1|||
126028438|NCT04382404|453402764|FG000|Overall Study|Adverse Event|1|||
126028439|NCT04382404|453402764|FG000|Overall Study|Lost to Follow-up|2|||
126028440|NCT02960893|453402766|FG000|Randomization Phase (8-week)|Adverse Event|5|||
126028441|NCT02960893|453402767|FG001|Randomization Phase (8-week)|Adverse Event|0|||
126028442|NCT02960893|453402766|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
126028443|NCT02960893|453402767|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
126028444|NCT02960893|453402766|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
126028445|NCT02960893|453402767|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
126028446|NCT02960893|453402766|FG000|Extension Phase (48-week)|Adverse Event|2|||
126028447|NCT02960893|453402767|FG001|Extension Phase (48-week)|Adverse Event|3|||
126028448|NCT02960893|453402766|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
126028449|NCT02960893|453402767|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
126028450|NCT02960893|453402766|FG000|Extension Phase (48-week)|Other Reason|2|||
126028451|NCT02960893|453402767|FG001|Extension Phase (48-week)|Other Reason|1|||
126028452|NCT02960893|453402766|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
126028453|NCT02960893|453402767|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
126028454|NCT02960893|453402766|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
126249519|NCT00849797|454202343|FG000|First Intervention|bad veins|1|||
126028455|NCT02960893|453402767|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
126028456|NCT05687916|453402769|FG000|Overall Study|Adverse Event|1|||
126028457|NCT05687916|453402770|FG001|Overall Study|Adverse Event|2|||
126028458|NCT05687916|453402771|FG002|Overall Study|Adverse Event|0|||
126028459|NCT05687916|453402769|FG000|Overall Study|Withdrawal by Subject|1|||
126028460|NCT05687916|453402770|FG001|Overall Study|Withdrawal by Subject|0|||
126028461|NCT05687916|453402771|FG002|Overall Study|Withdrawal by Subject|1|||
126028462|NCT05687916|453402769|FG000|Overall Study|Protocol Violation|0|||
126028463|NCT05687916|453402770|FG001|Overall Study|Protocol Violation|2|||
126028464|NCT05687916|453402771|FG002|Overall Study|Protocol Violation|1|||
126028465|NCT05687916|453402769|FG000|Overall Study|Reason not Specified|1|||
126028466|NCT05687916|453402770|FG001|Overall Study|Reason not Specified|0|||
126028467|NCT05687916|453402771|FG002|Overall Study|Reason not Specified|0|||
126028468|NCT04401800|453402776|FG000|Overall Study|Death|17|||
126028469|NCT04401800|453402776|FG000|Overall Study|Lost to Follow-up|5|||
126028470|NCT04401800|453402776|FG000|Overall Study|Withdrawal by Subject|4|||
126028471|NCT02783300|453402786|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028472|NCT02783300|453402787|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028473|NCT02783300|453402788|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028474|NCT02783300|453402789|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028475|NCT02783300|453402790|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028476|NCT02783300|453402791|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028477|NCT02783300|453402792|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
126028478|NCT02783300|453402793|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028479|NCT02783300|453402794|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028480|NCT02783300|453402795|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028481|NCT02783300|453402796|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028482|NCT02783300|453402797|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028483|NCT02783300|453402798|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028484|NCT02783300|453402799|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028485|NCT02783300|453402800|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028486|NCT02783300|453402801|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126249520|NCT00849797|454202344|FG001|First Intervention|bad veins|0|||
126249521|NCT00849797|454202343|FG000|First Intervention|Adverse Event|0|||
126249522|NCT00849797|454202344|FG001|First Intervention|Adverse Event|1|||
126249523|NCT00849797|454202343|FG000|Washout: One Week|Withdrawal by Subject|0|||
126249524|NCT00849797|454202344|FG001|Washout: One Week|Withdrawal by Subject|2|||
126249525|NCT00679081|454202345|FG000|Overall Study|Lost to Follow-up|1|||
126249526|NCT00725322|454202346|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
126249527|NCT00725322|454202347|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
126249528|NCT00725322|454202346|FG000|Washout (28 Days)|Protocol Violation|0|||
126249529|NCT00725322|454202347|FG001|Washout (28 Days)|Protocol Violation|1|||
126249530|NCT03578809|454204454|FG000|Overall Study|Death|0|||
126249531|NCT03578809|454204455|FG001|Overall Study|Death|2|||
126249532|NCT03578809|454204456|FG002|Overall Study|Death|0|||
126249533|NCT03578809|454204457|FG003|Overall Study|Death|1|||
126249534|NCT03578809|454204454|FG000|Overall Study|Lost to Follow-up|0|||
126249535|NCT03578809|454204455|FG001|Overall Study|Lost to Follow-up|1|||
126028487|NCT02783300|453402802|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028488|NCT02783300|453402803|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028489|NCT02783300|453402804|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028490|NCT02783300|453402805|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028491|NCT02783300|453402806|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028492|NCT02783300|453402807|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028493|NCT02783300|453402808|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028494|NCT02783300|453402809|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028495|NCT02783300|453402810|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028496|NCT02783300|453402811|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028497|NCT02783300|453402812|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126028498|NCT02783300|453402786|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028499|NCT02783300|453402787|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028500|NCT02783300|453402788|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028501|NCT02783300|453402789|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
126028502|NCT02783300|453402790|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028503|NCT02783300|453402791|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028504|NCT02783300|453402792|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126095194|NCT02663518|453643018|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
126095195|NCT02663518|453643019|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126095196|NCT02663518|453643020|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126249536|NCT03578809|454204456|FG002|Overall Study|Lost to Follow-up|0|||
126249537|NCT03578809|454204457|FG003|Overall Study|Lost to Follow-up|0|||
126249538|NCT03578809|454204454|FG000|Overall Study|Withdrawal by Subject|3|||
126249539|NCT03578809|454204455|FG001|Overall Study|Withdrawal by Subject|5|||
126249540|NCT03578809|454204456|FG002|Overall Study|Withdrawal by Subject|2|||
126249541|NCT03578809|454204457|FG003|Overall Study|Withdrawal by Subject|0|||
126249542|NCT03578809|454204454|FG000|Overall Study|Other|3|||
126249543|NCT03578809|454204455|FG001|Overall Study|Other|6|||
126249544|NCT03578809|454204456|FG002|Overall Study|Other|2|||
126249545|NCT03578809|454204457|FG003|Overall Study|Other|8|||
126249546|NCT02302716|454204460|FG000|Overall Study|Adverse Event|1|||
126249547|NCT02302716|454204461|FG001|Overall Study|Adverse Event|1|||
126249548|NCT02302716|454204460|FG000|Overall Study|Death|0|||
126249549|NCT02302716|454204461|FG001|Overall Study|Death|1|||
126249550|NCT02302716|454204460|FG000|Overall Study|Lack of Efficacy|0|||
126249551|NCT02302716|454204461|FG001|Overall Study|Lack of Efficacy|1|||
126249552|NCT02302716|454204460|FG000|Overall Study|Lost to Follow-up|2|||
126249553|NCT02302716|454204461|FG001|Overall Study|Lost to Follow-up|4|||
126249554|NCT02302716|454204460|FG000|Overall Study|Physician Decision|3|||
126249555|NCT02302716|454204461|FG001|Overall Study|Physician Decision|4|||
126249556|NCT02302716|454204460|FG000|Overall Study|Withdrawal by Subject|13|||
126249557|NCT02302716|454204461|FG001|Overall Study|Withdrawal by Subject|7|||
126249558|NCT02302716|454204460|FG000|Overall Study|Protocol Violation|0|||
126249559|NCT02302716|454204461|FG001|Overall Study|Protocol Violation|1|||
126249560|NCT02997176|454204464|FG000|Overall Study|Adverse Event|0|||
126249561|NCT02997176|454204465|FG001|Overall Study|Adverse Event|0|||
126249562|NCT02997176|454204466|FG002|Overall Study|Adverse Event|0|||
126249563|NCT02997176|454204467|FG003|Overall Study|Adverse Event|8|||
126249564|NCT02997176|454204464|FG000|Overall Study|Progressive Disease|1|||
126249565|NCT02997176|454204465|FG001|Overall Study|Progressive Disease|0|||
126249566|NCT02997176|454204466|FG002|Overall Study|Progressive Disease|1|||
126249567|NCT02997176|454204467|FG003|Overall Study|Progressive Disease|1|||
126249568|NCT02997176|454204464|FG000|Overall Study|Death|0|||
126249569|NCT02997176|454204465|FG001|Overall Study|Death|0|||
126249570|NCT02997176|454204466|FG002|Overall Study|Death|1|||
126249571|NCT02997176|454204467|FG003|Overall Study|Death|1|||
126249572|NCT02997176|454204464|FG000|Overall Study|Withdrawal by Subject|0|||
126249573|NCT02997176|454204465|FG001|Overall Study|Withdrawal by Subject|2|||
126249574|NCT02997176|454204466|FG002|Overall Study|Withdrawal by Subject|0|||
126249575|NCT02997176|454204467|FG003|Overall Study|Withdrawal by Subject|1|||
126249576|NCT04241458|454204468|FG000|Overall Study|Withdrawal by Subject|0|||
126249577|NCT04241458|454204469|FG001|Overall Study|Withdrawal by Subject|0|||
126249578|NCT04241458|454204470|FG002|Overall Study|Withdrawal by Subject|0|||
126249579|NCT04241458|454204471|FG003|Overall Study|Withdrawal by Subject|0|||
126249580|NCT04241458|454204472|FG004|Overall Study|Withdrawal by Subject|1|||
126249581|NCT06144424|454204473|FG000|Overall Study|Withdrawal by Subject|2|||
126249582|NCT06144424|454204474|FG001|Overall Study|Withdrawal by Subject|0|||
126249583|NCT06144424|454204473|FG000|Overall Study|Incarceration|1|||
126249584|NCT06144424|454204474|FG001|Overall Study|Incarceration|0|||
126249585|NCT02727192|454204475|FG000|Overall Study|Lost to Follow-up|1|||
126249586|NCT02727192|454204476|FG001|Overall Study|Lost to Follow-up|0|||
126249587|NCT02727192|454204477|FG002|Overall Study|Lost to Follow-up|0|||
126249588|NCT00928057|454204478|FG000|Overall Study|Adverse Event|1|||
126249589|NCT00928057|454204479|FG001|Overall Study|Adverse Event|2|||
126249590|NCT00928057|454204478|FG000|Overall Study|Withdrawal by Subject|1|||
126249591|NCT00928057|454204479|FG001|Overall Study|Withdrawal by Subject|0|||
126249592|NCT00928057|454204478|FG000|Overall Study|Lost to Follow-up|0|||
126249593|NCT00928057|454204479|FG001|Overall Study|Lost to Follow-up|1|||
126249594|NCT00928057|454204478|FG000|Overall Study|Protocol Violation|0|||
126249595|NCT00928057|454204479|FG001|Overall Study|Protocol Violation|1|||
126249596|NCT01380782|454204484|FG000|Overall Study|Adverse Event|0|||
126249597|NCT01380782|454204485|FG001|Overall Study|Adverse Event|1|||
126249598|NCT01380782|454204486|FG002|Overall Study|Adverse Event|0|||
126249599|NCT01380782|454204487|FG003|Overall Study|Adverse Event|0|||
126249600|NCT01380782|454204484|FG000|Overall Study|Death|1|||
126249601|NCT01380782|454204485|FG001|Overall Study|Death|0|||
126249602|NCT01380782|454204486|FG002|Overall Study|Death|0|||
126249603|NCT01380782|454204487|FG003|Overall Study|Death|0|||
126249604|NCT01380782|454204484|FG000|Overall Study|Lack of Efficacy|10|||
126249605|NCT01380782|454204485|FG001|Overall Study|Lack of Efficacy|9|||
126249606|NCT01380782|454204486|FG002|Overall Study|Lack of Efficacy|10|||
126249607|NCT01380782|454204487|FG003|Overall Study|Lack of Efficacy|3|||
126249608|NCT01380782|454204484|FG000|Overall Study|Physician Decision|1|||
126249609|NCT01380782|454204485|FG001|Overall Study|Physician Decision|0|||
126249610|NCT01380782|454204486|FG002|Overall Study|Physician Decision|0|||
126249611|NCT01380782|454204487|FG003|Overall Study|Physician Decision|0|||
126249612|NCT01380782|454204484|FG000|Overall Study|Withdrawal by Subject|0|||
126249613|NCT01380782|454204485|FG001|Overall Study|Withdrawal by Subject|0|||
126249614|NCT01380782|454204486|FG002|Overall Study|Withdrawal by Subject|1|||
126249615|NCT01380782|454204487|FG003|Overall Study|Withdrawal by Subject|1|||
126249616|NCT05387408|454204488|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
126249617|NCT03428750|454204489|FG000|Overall Study|Withdrawal by Subject|11|||
126249618|NCT03428750|454204490|FG001|Overall Study|Withdrawal by Subject|10|||
126249619|NCT03428750|454204489|FG000|Overall Study|Lost to Follow-up|3|||
126249620|NCT03428750|454204490|FG001|Overall Study|Lost to Follow-up|9|||
126249621|NCT03428750|454204489|FG000|Overall Study|Adverse Event|9|||
126249622|NCT03428750|454204490|FG001|Overall Study|Adverse Event|1|||
126249623|NCT03428750|454204489|FG000|Overall Study|Protocol Violation|1|||
126249624|NCT03428750|454204490|FG001|Overall Study|Protocol Violation|0|||
126249625|NCT03428750|454204489|FG000|Overall Study|Administrative|0|||
126249626|NCT03428750|454204490|FG001|Overall Study|Administrative|1|||
126249627|NCT01919112|454204491|FG000|Secondary Analysis-day 30|Death|1|||
126249628|NCT01919112|454204492|FG001|Secondary Analysis-day 30|Death|1|||
126249629|NCT01919112|454204493|FG002|Secondary Analysis-day 30|Death|1|||
126249630|NCT01919112|454204491|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
126249631|NCT01919112|454204492|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
126249632|NCT01919112|454204493|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
126249633|NCT02554877|454204494|FG000|Overall Study|Adverse Event|2|||
126249634|NCT02554877|454204495|FG001|Overall Study|Adverse Event|0|||
126249635|NCT02554877|454204496|FG002|Overall Study|Adverse Event|0|||
126249636|NCT02554877|454204497|FG003|Overall Study|Adverse Event|1|||
126249637|NCT02554877|454204494|FG000|Overall Study|Lost to Follow-up|1|||
126249638|NCT02554877|454204495|FG001|Overall Study|Lost to Follow-up|1|||
126249639|NCT02554877|454204496|FG002|Overall Study|Lost to Follow-up|1|||
126249640|NCT02554877|454204497|FG003|Overall Study|Lost to Follow-up|2|||
126249641|NCT02554877|454204494|FG000|Overall Study|Did not meet entrance criteria|0|||
126249642|NCT02554877|454204495|FG001|Overall Study|Did not meet entrance criteria|0|||
126249643|NCT02554877|454204496|FG002|Overall Study|Did not meet entrance criteria|1|||
126249644|NCT02554877|454204497|FG003|Overall Study|Did not meet entrance criteria|0|||
126249645|NCT02554877|454204494|FG000|Overall Study|No longer met eligibility criteria|1|||
126249646|NCT02554877|454204495|FG001|Overall Study|No longer met eligibility criteria|0|||
126249647|NCT02554877|454204496|FG002|Overall Study|No longer met eligibility criteria|1|||
126249648|NCT02554877|454204497|FG003|Overall Study|No longer met eligibility criteria|1|||
126249649|NCT02554877|454204494|FG000|Overall Study|Protocol Violation|3|||
126249650|NCT02554877|454204495|FG001|Overall Study|Protocol Violation|1|||
126249651|NCT02554877|454204496|FG002|Overall Study|Protocol Violation|1|||
126249652|NCT02554877|454204497|FG003|Overall Study|Protocol Violation|0|||
126249653|NCT02554877|454204494|FG000|Overall Study|Other|1|||
126249654|NCT02554877|454204495|FG001|Overall Study|Other|3|||
126249655|NCT02554877|454204496|FG002|Overall Study|Other|0|||
126249656|NCT02554877|454204497|FG003|Overall Study|Other|3|||
126249657|NCT02554877|454204494|FG000|Overall Study|Insufficient clinical response|4|||
126249658|NCT02554877|454204495|FG001|Overall Study|Insufficient clinical response|0|||
126249659|NCT02554877|454204496|FG002|Overall Study|Insufficient clinical response|0|||
126249660|NCT02554877|454204497|FG003|Overall Study|Insufficient clinical response|0|||
126249661|NCT02554877|454204494|FG000|Overall Study|No longer willing to participate|0|||
126249662|NCT02554877|454204495|FG001|Overall Study|No longer willing to participate|2|||
126249663|NCT02554877|454204496|FG002|Overall Study|No longer willing to participate|2|||
126249664|NCT02554877|454204497|FG003|Overall Study|No longer willing to participate|0|||
126249665|NCT00274651|454204498|FG000|Overall Study|Adverse Event|6|||
126249666|NCT00274651|454204499|FG001|Overall Study|Adverse Event|3|||
126028505|NCT02783300|453402793|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028506|NCT02783300|453402794|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028507|NCT02783300|453402795|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028508|NCT02783300|453402796|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028509|NCT02783300|453402797|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028510|NCT02783300|453402798|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028511|NCT02783300|453402799|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028512|NCT02783300|453402800|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028513|NCT02783300|453402801|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028514|NCT02783300|453402802|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028515|NCT02783300|453402803|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028516|NCT02783300|453402804|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028517|NCT02783300|453402805|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028518|NCT02783300|453402806|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028519|NCT02783300|453402807|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028520|NCT02783300|453402808|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028521|NCT02783300|453402809|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028522|NCT02783300|453402810|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028523|NCT02783300|453402811|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028524|NCT02783300|453402812|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126028525|NCT02783300|453402786|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
126028526|NCT02783300|453402787|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
126028527|NCT02783300|453402788|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
126028528|NCT02783300|453402789|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
126028529|NCT02783300|453402790|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
126028530|NCT02783300|453402791|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
126028531|NCT02783300|453402792|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
126028532|NCT02783300|453402793|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
126028533|NCT02783300|453402794|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
126028534|NCT02783300|453402795|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
126028535|NCT02783300|453402796|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
126028536|NCT02783300|453402797|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
126028537|NCT02783300|453402798|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
126028538|NCT02783300|453402799|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
126028539|NCT02783300|453402800|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
126028540|NCT02783300|453402801|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
126028541|NCT02783300|453402802|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
126028542|NCT02783300|453402803|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
126028543|NCT02783300|453402804|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
126028544|NCT02783300|453402805|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
126028545|NCT02783300|453402806|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
126028546|NCT02783300|453402807|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
126028547|NCT02783300|453402808|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
125879754|NCT03224819|452857374|FG011|Overall Study|Death|1|||
125879755|NCT03224819|452857375|FG012|Overall Study|Death|0|||
126028548|NCT02783300|453402809|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
126028549|NCT02783300|453402810|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
126028550|NCT02783300|453402811|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
126028551|NCT02783300|453402812|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
126249667|NCT00274651|454204498|FG000|Overall Study|Lack of Efficacy|13|||
126249668|NCT00274651|454204499|FG001|Overall Study|Lack of Efficacy|6|||
126028552|NCT02783300|453402786|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028553|NCT02783300|453402787|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028554|NCT02783300|453402788|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028555|NCT02783300|453402789|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028556|NCT02783300|453402790|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028557|NCT02783300|453402791|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028558|NCT02783300|453402792|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
126028559|NCT02783300|453402793|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028560|NCT02783300|453402794|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028561|NCT02783300|453402795|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028562|NCT02783300|453402796|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028563|NCT02783300|453402797|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028564|NCT02783300|453402798|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
126028565|NCT02783300|453402799|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028566|NCT02783300|453402800|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028567|NCT02783300|453402801|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028568|NCT02783300|453402802|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125879756|NCT03224819|452857376|FG013|Overall Study|Death|0|||
126028569|NCT02783300|453402803|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028570|NCT02783300|453402804|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028571|NCT02783300|453402805|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126249669|NCT00274651|454204498|FG000|Overall Study|Death|1|||
126249670|NCT00274651|454204499|FG001|Overall Study|Death|3|||
126249671|NCT00274651|454204498|FG000|Overall Study|Withdrawal by Subject|0|||
126249672|NCT00274651|454204499|FG001|Overall Study|Withdrawal by Subject|1|||
126249673|NCT00274651|454204498|FG000|Overall Study|Physician Decision|8|||
126249674|NCT00274651|454204499|FG001|Overall Study|Physician Decision|7|||
126249675|NCT00635648|454204500|FG000|Overall Study|Adverse Event|12|||
126249676|NCT00635648|454204500|FG000|Overall Study|Withdrawal by Subject|9|||
126249677|NCT00635648|454204500|FG000|Overall Study|Physician Decision|4|||
126249678|NCT00635648|454204500|FG000|Overall Study|Rapid progression of baseline disease|4|||
126249679|NCT00635648|454204500|FG000|Overall Study|Use of other antifungal agent needed|1|||
126249680|NCT00635648|454204500|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
126249681|NCT00635648|454204500|FG000|Overall Study|Noncompliance with protocol|1|||
126249682|NCT00635648|454204500|FG000|Overall Study|Other reason|2|||
126249683|NCT04547192|454204501|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
126249684|NCT04547192|454204502|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
126249685|NCT04547192|454204503|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
126249686|NCT04547192|454204504|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
126249687|NCT04547192|454204501|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
126249688|NCT04547192|454204502|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
126249689|NCT04547192|454204503|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
126249690|NCT04547192|454204504|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
126249691|NCT04547192|454204501|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
126249692|NCT04547192|454204502|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
126249693|NCT04547192|454204503|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
126249694|NCT04547192|454204504|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
126249695|NCT04547192|454204501|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
126249696|NCT04547192|454204502|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
126249697|NCT04547192|454204503|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
126249698|NCT04547192|454204504|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
126249699|NCT04547192|454204501|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
126249700|NCT04547192|454204502|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
126249701|NCT04547192|454204503|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
126249702|NCT04547192|454204504|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
126249703|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
126249704|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
126249705|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
126249706|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
126249707|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
126249708|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
126249709|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
126249710|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
126249711|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
126249712|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
126249713|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
126249714|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
126249715|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
126249716|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
126249717|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
126249718|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
126249719|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
126249720|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
126249721|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
126028572|NCT02783300|453402806|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028573|NCT02783300|453402807|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028574|NCT02783300|453402808|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028575|NCT02783300|453402809|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028576|NCT02783300|453402810|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028577|NCT02783300|453402811|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028578|NCT02783300|453402812|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126028579|NCT02783300|453402786|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028580|NCT02783300|453402787|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028581|NCT02783300|453402788|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028582|NCT02783300|453402789|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126095197|NCT02663518|453643021|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126095198|NCT02663518|453643022|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126249722|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
126249723|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
126249724|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
126249725|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
126249726|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
126249727|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
126249728|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
126249729|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
126249730|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
126249731|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
126249732|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
126249733|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
126249734|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
126249735|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
126249736|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
126249737|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
126249738|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
126249739|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
126249740|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
126249741|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
126249742|NCT04194801|454204505|FG000|Part Ib/II End of Study|Death|2|||
126249743|NCT04194801|454204506|FG001|Part Ib/II End of Study|Death|3|||
126249744|NCT04194801|454204507|FG002|Part Ib/II End of Study|Death|3|||
126249745|NCT04194801|454204505|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
126249746|NCT04194801|454204506|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
126249747|NCT04194801|454204507|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
126249748|NCT04194801|454204505|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
126249749|NCT04194801|454204506|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
126249750|NCT04194801|454204507|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
126249751|NCT04194801|454204505|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
126249752|NCT04194801|454204506|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
126249753|NCT04194801|454204507|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
126249754|NCT04194801|454204505|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
126249755|NCT04194801|454204506|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
126249756|NCT04194801|454204507|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
126249757|NCT01923740|454204508|FG000|Overall Study|Lost to Follow-up|4|||
126249758|NCT01923740|454204509|FG001|Overall Study|Lost to Follow-up|9|||
126249759|NCT01923740|454204508|FG000|Overall Study|Withdrawal by Subject|2|||
126249760|NCT01923740|454204509|FG001|Overall Study|Withdrawal by Subject|0|||
126249761|NCT00294047|454204510|FG000|Month 48|Adverse Event|28|||
126249762|NCT00294047|454204511|FG001|Month 48|Adverse Event|13|||
126249763|NCT00294047|454204510|FG000|Month 48|Protocol Violation|4|||
126249764|NCT00294047|454204511|FG001|Month 48|Protocol Violation|4|||
126249765|NCT00294047|454204510|FG000|Month 48|Withdrawal by Subject|111|||
126249766|NCT00294047|454204511|FG001|Month 48|Withdrawal by Subject|115|||
126249767|NCT00294047|454204510|FG000|Month 48|Lost to Follow-up|272|||
126249768|NCT00294047|454204511|FG001|Month 48|Lost to Follow-up|287|||
126249769|NCT00294047|454204510|FG000|Month 48|Other|10|||
126249770|NCT00294047|454204511|FG001|Month 48|Other|14|||
126249771|NCT00294047|454204510|FG000|Month 84|Adverse Event|4|||
126249772|NCT00294047|454204511|FG001|Month 84|Adverse Event|2|||
126249773|NCT00294047|454204510|FG000|Month 84|Protocol Violation|1|||
126249774|NCT00294047|454204511|FG001|Month 84|Protocol Violation|1|||
126249775|NCT00294047|454204510|FG000|Month 84|Withdrawal by Subject|33|||
126028583|NCT02783300|453402790|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
126249776|NCT00294047|454204511|FG001|Month 84|Withdrawal by Subject|31|||
126249777|NCT00294047|454204510|FG000|Month 84|Lost to Follow-up|187|||
126249778|NCT00294047|454204511|FG001|Month 84|Lost to Follow-up|190|||
126249779|NCT00294047|454204510|FG000|Month 84|Absent Cervix|2|||
126249780|NCT00294047|454204511|FG001|Month 84|Absent Cervix|0|||
126249781|NCT00294047|454204510|FG000|Month 84|Work related reasons|4|||
126249782|NCT00294047|454204511|FG001|Month 84|Work related reasons|2|||
126249783|NCT00294047|454204510|FG000|Month 84|Center closed, subject did not transfer|1|||
126249784|NCT00294047|454204511|FG001|Month 84|Center closed, subject did not transfer|0|||
126249785|NCT00294047|454204510|FG000|Month 84|Family problems|2|||
126249786|NCT00294047|454204511|FG001|Month 84|Family problems|2|||
126249787|NCT00294047|454204510|FG000|Month 84|Lack of time|3|||
126249788|NCT00294047|454204511|FG001|Month 84|Lack of time|1|||
126249789|NCT00294047|454204510|FG000|Month 84|Personal reason|2|||
126249790|NCT00294047|454204511|FG001|Month 84|Personal reason|4|||
126249791|NCT00294047|454204510|FG000|Month 84|Subject does not want male physician|1|||
126249792|NCT00294047|454204511|FG001|Month 84|Subject does not want male physician|0|||
126249793|NCT00294047|454204510|FG000|Month 84|Transport reimbursement delayed|0|||
126249794|NCT00294047|454204511|FG001|Month 84|Transport reimbursement delayed|1|||
126249795|NCT00294047|454204510|FG000|Month 84|Unable to reach study site|1|||
126249796|NCT00294047|454204511|FG001|Month 84|Unable to reach study site|0|||
126249797|NCT00294047|454204510|FG000|Month 84|Under investigation locally|1|||
126249798|NCT00294047|454204511|FG001|Month 84|Under investigation locally|0|||
126249799|NCT00294047|454204510|FG000|Month 84|Visit missed|0|||
126249800|NCT00294047|454204511|FG001|Month 84|Visit missed|1|||
126249801|NCT00294047|454204510|FG000|Month 84|No consent for Month 84 Follow-up|731|||
126249802|NCT00294047|454204511|FG001|Month 84|No consent for Month 84 Follow-up|754|||
126249803|NCT02157974|454204512|FG000|Overall Study|Withdrawal by Subject|0|||
126249804|NCT02157974|454204513|FG001|Overall Study|Withdrawal by Subject|1|||
126249805|NCT02157974|454204514|FG002|Overall Study|Withdrawal by Subject|0|||
126249806|NCT02157974|454204515|FG003|Overall Study|Withdrawal by Subject|0|||
126249807|NCT02157974|454204516|FG004|Overall Study|Withdrawal by Subject|0|||
126249808|NCT02157974|454204512|FG000|Overall Study|Screen Failure|0|||
126249809|NCT02157974|454204513|FG001|Overall Study|Screen Failure|1|||
126249810|NCT02157974|454204514|FG002|Overall Study|Screen Failure|0|||
126249811|NCT02157974|454204515|FG003|Overall Study|Screen Failure|0|||
126249812|NCT02157974|454204516|FG004|Overall Study|Screen Failure|0|||
126249813|NCT02157974|454204512|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
126249814|NCT02157974|454204513|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
126249815|NCT02157974|454204514|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
126249816|NCT02157974|454204515|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
126249817|NCT02157974|454204516|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
126249818|NCT03497130|454204519|FG000|Overall Study|Lost to Follow-up|1|||
126249819|NCT03497130|454204520|FG001|Overall Study|Lost to Follow-up|1|||
126249820|NCT04002648|454204521|FG000|Overall Study|Lost to Follow-up|2|||
126249821|NCT04002648|454204522|FG001|Overall Study|Lost to Follow-up|0|||
126249822|NCT01484912|454204523|FG000|Overall Study|Withdrawal by Subject|1|||
126249823|NCT01484912|454204524|FG001|Overall Study|Withdrawal by Subject|0|||
126249824|NCT01484912|454204523|FG000|Overall Study|Physician Decision|0|||
126249825|NCT01484912|454204524|FG001|Overall Study|Physician Decision|1|||
126249826|NCT03158727|454204527|FG000|Overall Study|Withdrawal by Subject|2|||
126249827|NCT03158727|454204528|FG001|Overall Study|Withdrawal by Subject|6|||
126249828|NCT03158727|454204527|FG000|Overall Study|Death|11|||
126249829|NCT03158727|454204528|FG001|Overall Study|Death|12|||
126249830|NCT03158727|454204527|FG000|Overall Study|Lost to Follow-up|1|||
126249831|NCT03158727|454204528|FG001|Overall Study|Lost to Follow-up|0|||
126249832|NCT03158727|454204527|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
126249833|NCT03158727|454204528|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
126249834|NCT03158727|454204527|FG000|Overall Study|Visit 11 not done by mistake|0|||
126249835|NCT03158727|454204528|FG001|Overall Study|Visit 11 not done by mistake|1|||
126249836|NCT03158727|454204527|FG000|Overall Study|Enrolled, not treated|1|||
126249837|NCT03158727|454204528|FG001|Overall Study|Enrolled, not treated|0|||
126249838|NCT00985439|454204529|FG000|Overall Study|Adverse Event|0|||
126028584|NCT02783300|453402791|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028585|NCT02783300|453402792|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
126028586|NCT02783300|453402793|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126249839|NCT00985439|454204530|FG001|Overall Study|Adverse Event|0|||
126249840|NCT00985439|454204531|FG002|Overall Study|Adverse Event|1|||
126249841|NCT00985439|454204532|FG003|Overall Study|Adverse Event|0|||
126249842|NCT01051349|454204533|FG000|Overall Study|Adverse Event|88|||
126249843|NCT01051349|454204533|FG000|Overall Study|Consent Withdrawn|54|||
126028587|NCT02783300|453402794|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028588|NCT02783300|453402795|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
126249844|NCT01051349|454204533|FG000|Overall Study|Investigator Decision|6|||
126249845|NCT01051349|454204533|FG000|Overall Study|Lost to Follow-up|6|||
126249846|NCT01051349|454204533|FG000|Overall Study|Subject non-compliance|7|||
126249847|NCT01051349|454204533|FG000|Overall Study|Reason not Specified|12|||
126249848|NCT00924638|454204540|FG000|Overall Study|Death|3|||
126249849|NCT00924638|454204541|FG001|Overall Study|Death|2|||
126249850|NCT00924638|454204540|FG000|Overall Study|Lost to Follow-up|1|||
126249851|NCT00924638|454204541|FG001|Overall Study|Lost to Follow-up|1|||
126249852|NCT00924638|454204540|FG000|Overall Study|Withdrawal by Subject|5|||
126249853|NCT00924638|454204541|FG001|Overall Study|Withdrawal by Subject|7|||
126249854|NCT00924638|454204540|FG000|Overall Study|Physician Decision|3|||
126249855|NCT00924638|454204541|FG001|Overall Study|Physician Decision|3|||
126249856|NCT00847535|454204542|FG000|Overall Study|Withdrawal by Subject|2|||
126249857|NCT00847535|454204543|FG001|Overall Study|Withdrawal by Subject|1|||
126249858|NCT00847535|454204544|FG002|Overall Study|Withdrawal by Subject|1|||
126249859|NCT00847535|454204542|FG000|Overall Study|Lost to Follow-up|0|||
126249860|NCT00847535|454204543|FG001|Overall Study|Lost to Follow-up|1|||
126249861|NCT00847535|454204544|FG002|Overall Study|Lost to Follow-up|0|||
126249862|NCT05604014|454204548|FG000|Overall Study|Lost to Follow-up|13|||
126249863|NCT04411680|454204557|FG000|Treatment Period|Adverse Event|3|||
126249864|NCT04411680|454204558|FG001|Treatment Period|Adverse Event|0|||
126249865|NCT04411680|454204557|FG000|Treatment Period|Discharged from hospital|18|||
126249866|NCT04411680|454204558|FG001|Treatment Period|Discharged from hospital|7|||
126249867|NCT04411680|454204557|FG000|Treatment Period|Missed 1 or more doses|8|||
126249868|NCT04411680|454204558|FG001|Treatment Period|Missed 1 or more doses|0|||
126249869|NCT04411680|454204557|FG000|Treatment Period|Transferred to another hospital|0|||
126249870|NCT04411680|454204558|FG001|Treatment Period|Transferred to another hospital|1|||
126249871|NCT04411680|454204557|FG000|Follow up Period|Withdrawal by Subject|2|||
126249872|NCT04411680|454204558|FG001|Follow up Period|Withdrawal by Subject|0|||
126249873|NCT04411680|454204557|FG000|Follow up Period|Lost to Follow-up|5|||
126249874|NCT04411680|454204558|FG001|Follow up Period|Lost to Follow-up|6|||
126249875|NCT04411680|454204557|FG000|Follow up Period|Death|11|||
126249876|NCT04411680|454204558|FG001|Follow up Period|Death|8|||
126249877|NCT00748566|454204559|FG000|Overall Study|Adverse Event|49|||
126249878|NCT00748566|454204559|FG000|Overall Study|Death|1|||
126249879|NCT00748566|454204559|FG000|Overall Study|Lack of Efficacy|12|||
126249880|NCT00748566|454204559|FG000|Overall Study|Lost to Follow-up|1|||
126249881|NCT00748566|454204559|FG000|Overall Study|Protocol Violation|13|||
126249882|NCT00748566|454204559|FG000|Overall Study|Withdrawal by Subject|22|||
126249883|NCT00748566|454204559|FG000|Overall Study|Study terminated by sponsor|5|||
126249884|NCT00748566|454204559|FG000|Overall Study|Other|9|||
126249885|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Refused|1|||
126249886|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Refused|3|||
126249887|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Medical|0|||
126249888|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Medical|1|||
126249889|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
126249890|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
126249891|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
126249892|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
126249893|NCT02054715|454204563|FG000|Baseline/Follow-up 1|No Reason|0|||
126249894|NCT02054715|454204564|FG001|Baseline/Follow-up 1|No Reason|1|||
126249895|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
126249896|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
126249897|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Ineligible|3|||
126249898|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Ineligible|0|||
126249899|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Hospitalization|1|||
126249900|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Hospitalization|0|||
126249901|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Changed Mind|1|||
126249902|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Changed Mind|0|||
126249903|NCT02054715|454204563|FG000|Follow-up 2|Lost to Followup|3|||
126249904|NCT02054715|454204564|FG001|Follow-up 2|Lost to Followup|1|||
126249905|NCT02054715|454204563|FG000|Follow-up 2|Refused|3|||
126249906|NCT02054715|454204564|FG001|Follow-up 2|Refused|2|||
126249907|NCT02054715|454204563|FG000|Follow-up 2|Followup Not Completed|3|||
126249908|NCT02054715|454204564|FG001|Follow-up 2|Followup Not Completed|4|||
126249909|NCT02054715|454204563|FG000|Follow-up 2|Ineligible|4|||
126249910|NCT02054715|454204564|FG001|Follow-up 2|Ineligible|5|||
126249911|NCT02054715|454204563|FG000|Follow-up 2|Death|3|||
126249912|NCT02054715|454204564|FG001|Follow-up 2|Death|3|||
126249913|NCT02054715|454204563|FG000|Follow-up 2|Hospitalization|0|||
126249914|NCT02054715|454204564|FG001|Follow-up 2|Hospitalization|2|||
126249915|NCT02054715|454204563|FG000|Follow-up 2|Changed MD/Facility|0|||
126249916|NCT02054715|454204564|FG001|Follow-up 2|Changed MD/Facility|1|||
126249917|NCT02054715|454204563|FG000|Follow-up 2|Changed Mind|0|||
126249918|NCT02054715|454204564|FG001|Follow-up 2|Changed Mind|1|||
126249919|NCT02054715|454204563|FG000|Follow-up 2|No Reason|2|||
126249920|NCT02054715|454204564|FG001|Follow-up 2|No Reason|0|||
126249921|NCT02054715|454204563|FG000|Follow-up 2|Treatment Change or Delay|1|||
126249922|NCT02054715|454204564|FG001|Follow-up 2|Treatment Change or Delay|0|||
126249923|NCT01442376|454204566|FG000|Overall Study|Adverse Event|0|||
126249924|NCT01442376|454204567|FG001|Overall Study|Adverse Event|3|||
126249925|NCT01442376|454204568|FG002|Overall Study|Adverse Event|2|||
126249926|NCT01442376|454204566|FG000|Overall Study|Death|0|||
126249927|NCT01442376|454204567|FG001|Overall Study|Death|1|||
126249928|NCT01442376|454204568|FG002|Overall Study|Death|1|||
126028589|NCT02783300|453402796|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028590|NCT02783300|453402797|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028591|NCT02783300|453402798|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
126028592|NCT02783300|453402799|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126249929|NCT01442376|454204566|FG000|Overall Study|Withdrawal of consent|0|||
126249930|NCT01442376|454204567|FG001|Overall Study|Withdrawal of consent|0|||
126249931|NCT01442376|454204568|FG002|Overall Study|Withdrawal of consent|1|||
126249932|NCT01442376|454204566|FG000|Overall Study|Patients not treated|2|||
126249933|NCT01442376|454204567|FG001|Overall Study|Patients not treated|3|||
126249934|NCT01442376|454204568|FG002|Overall Study|Patients not treated|1|||
126249935|NCT01442376|454204566|FG000|Overall Study|Not eligible for subsequent cycles|1|||
126249936|NCT01442376|454204567|FG001|Overall Study|Not eligible for subsequent cycles|2|||
126249937|NCT01442376|454204568|FG002|Overall Study|Not eligible for subsequent cycles|0|||
126028593|NCT02783300|453402800|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028594|NCT02783300|453402801|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126095199|NCT02663518|453643023|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126249938|NCT03499873|454204569|FG000|Overall Study|Withdrawal by Subject|4|||
126249939|NCT03499873|454204570|FG001|Overall Study|Withdrawal by Subject|6|||
126249940|NCT03499873|454204571|FG002|Overall Study|Withdrawal by Subject|1|||
126249941|NCT03499873|454204569|FG000|Overall Study|Subjects condition worsened|0|||
126249942|NCT03499873|454204570|FG001|Overall Study|Subjects condition worsened|3|||
126249943|NCT03499873|454204571|FG002|Overall Study|Subjects condition worsened|11|||
126249944|NCT03499873|454204569|FG000|Overall Study|Adverse Event|8|||
126249945|NCT03499873|454204570|FG001|Overall Study|Adverse Event|3|||
126249946|NCT03499873|454204571|FG002|Overall Study|Adverse Event|6|||
126249947|NCT03499873|454204569|FG000|Overall Study|Physician Decision|1|||
126249948|NCT03499873|454204570|FG001|Overall Study|Physician Decision|0|||
126249949|NCT03499873|454204571|FG002|Overall Study|Physician Decision|0|||
126249950|NCT03499873|454204569|FG000|Overall Study|Administrative reasons|0|||
126249951|NCT03499873|454204570|FG001|Overall Study|Administrative reasons|1|||
126249952|NCT03499873|454204571|FG002|Overall Study|Administrative reasons|0|||
126249953|NCT03499873|454204569|FG000|Overall Study|Concomitant therapy|5|||
126249954|NCT03499873|454204570|FG001|Overall Study|Concomitant therapy|4|||
126249955|NCT03499873|454204571|FG002|Overall Study|Concomitant therapy|7|||
126249956|NCT03499873|454204569|FG000|Overall Study|Miscellaneous|1|||
126249957|NCT03499873|454204570|FG001|Overall Study|Miscellaneous|2|||
126249958|NCT03499873|454204571|FG002|Overall Study|Miscellaneous|2|||
126249959|NCT03499873|454204569|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
126249960|NCT03499873|454204570|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
126249961|NCT03499873|454204571|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
126249962|NCT01964950|454204572|FG000|Overall Study|Protocol Violation|25|||
126249963|NCT04404725|454204573|FG000|First Intervention|Withdrawal by Subject|0|||
126249964|NCT04404725|454204574|FG001|First Intervention|Withdrawal by Subject|2|||
126249965|NCT04404725|454204573|FG000|Second Intervention|Adverse Event|1|||
126249966|NCT04404725|454204574|FG001|Second Intervention|Adverse Event|1|||
126249967|NCT04404725|454204573|FG000|Second Intervention|Withdrawal by Subject|0|||
126249968|NCT04404725|454204574|FG001|Second Intervention|Withdrawal by Subject|1|||
126249969|NCT01075516|454204575|FG000|Overall Study|Death|5|||
126249970|NCT01075516|454204576|FG001|Overall Study|Death|9|||
126249971|NCT01075516|454204575|FG000|Overall Study|Lost to Follow-up|10|||
126249972|NCT01075516|454204576|FG001|Overall Study|Lost to Follow-up|2|||
126249973|NCT01075516|454204575|FG000|Overall Study|Withdrawal by Subject|3|||
126249974|NCT01075516|454204576|FG001|Overall Study|Withdrawal by Subject|5|||
126249975|NCT02252016|454204579|FG000|Overall Study|Lost to Follow-up|2|||
126249976|NCT02252016|454204580|FG001|Overall Study|Lost to Follow-up|1|||
126249977|NCT02252016|454204579|FG000|Overall Study|Physician Decision|1|||
126249978|NCT02252016|454204580|FG001|Overall Study|Physician Decision|0|||
126249979|NCT02252016|454204579|FG000|Overall Study|Withdrawal by Subject|0|||
126249980|NCT02252016|454204580|FG001|Overall Study|Withdrawal by Subject|2|||
126249981|NCT04631562|454204589|FG000|Overall Study|Withdrawal by Subject|0|||
126249982|NCT04631562|454204590|FG001|Overall Study|Withdrawal by Subject|0|||
126249983|NCT04631562|454204591|FG002|Overall Study|Withdrawal by Subject|0|||
126249984|NCT04631562|454204592|FG003|Overall Study|Withdrawal by Subject|0|||
126249985|NCT04631562|454204593|FG004|Overall Study|Withdrawal by Subject|0|||
126249986|NCT04631562|454204594|FG005|Overall Study|Withdrawal by Subject|0|||
126249987|NCT04631562|454204595|FG006|Overall Study|Withdrawal by Subject|0|||
126249988|NCT04631562|454204596|FG007|Overall Study|Withdrawal by Subject|1|||
126028595|NCT02783300|453402802|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028596|NCT02783300|453402803|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028597|NCT02783300|453402804|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126249989|NCT04631562|454204597|FG008|Overall Study|Withdrawal by Subject|0|||
126249990|NCT04631562|454204589|FG000|Overall Study|Other|0|||
126249991|NCT04631562|454204590|FG001|Overall Study|Other|0|||
126249992|NCT04631562|454204591|FG002|Overall Study|Other|0|||
126249993|NCT04631562|454204592|FG003|Overall Study|Other|0|||
126028598|NCT02783300|453402805|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028599|NCT02783300|453402806|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028600|NCT02783300|453402807|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126249994|NCT04631562|454204593|FG004|Overall Study|Other|0|||
126249995|NCT04631562|454204594|FG005|Overall Study|Other|0|||
126249996|NCT04631562|454204595|FG006|Overall Study|Other|0|||
126249997|NCT04631562|454204596|FG007|Overall Study|Other|0|||
126249998|NCT04631562|454204597|FG008|Overall Study|Other|1|||
126249999|NCT04631562|454204589|FG000|Overall Study|Lost to Follow-up|0|||
126250000|NCT04631562|454204590|FG001|Overall Study|Lost to Follow-up|0|||
126250001|NCT04631562|454204591|FG002|Overall Study|Lost to Follow-up|0|||
126250002|NCT04631562|454204592|FG003|Overall Study|Lost to Follow-up|1|||
126250003|NCT04631562|454204593|FG004|Overall Study|Lost to Follow-up|0|||
126250004|NCT04631562|454204594|FG005|Overall Study|Lost to Follow-up|0|||
126250005|NCT04631562|454204595|FG006|Overall Study|Lost to Follow-up|0|||
126250006|NCT04631562|454204596|FG007|Overall Study|Lost to Follow-up|0|||
126250007|NCT04631562|454204597|FG008|Overall Study|Lost to Follow-up|0|||
126250008|NCT04631562|454204589|FG000|Overall Study|Adverse Event|0|||
126250009|NCT04631562|454204590|FG001|Overall Study|Adverse Event|0|||
126250010|NCT04631562|454204591|FG002|Overall Study|Adverse Event|0|||
126250011|NCT04631562|454204592|FG003|Overall Study|Adverse Event|0|||
126250012|NCT04631562|454204593|FG004|Overall Study|Adverse Event|0|||
126250013|NCT04631562|454204594|FG005|Overall Study|Adverse Event|0|||
126250014|NCT04631562|454204595|FG006|Overall Study|Adverse Event|1|||
126250015|NCT04631562|454204596|FG007|Overall Study|Adverse Event|0|||
126250016|NCT04631562|454204597|FG008|Overall Study|Adverse Event|0|||
126250017|NCT01190865|454204603|FG000|Overall Study|Withdrawal by Subject|1|||
126250018|NCT01190865|454204603|FG000|Overall Study|Non-compliance|2|||
126250019|NCT02471807|454204610|FG000|Overall Study|Death|14|||
126250020|NCT02471807|454204610|FG000|Overall Study|Withdrawal by Subject|2|||
126250021|NCT02471807|454204610|FG000|Overall Study|Explant|5|||
126250022|NCT02471807|454204610|FG000|Overall Study|Lost to Follow-up|1|||
126250023|NCT00957021|454204613|FG000|Overall Study|Death|5|||
126250024|NCT00957021|454204613|FG000|Overall Study|Lost to Follow-up|8|||
126250025|NCT00957021|454204613|FG000|Overall Study|Withdrawal by Subject|34|||
126250026|NCT00957021|454204613|FG000|Overall Study|No 2 yr ROM data|35|||
126250027|NCT00957021|454204613|FG000|Overall Study|Revised study component by 2 yr visit|8|||
126250028|NCT00957021|454204613|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
126250029|NCT00957021|454204613|FG000|Overall Study|Surgery Cancelled|9|||
126250030|NCT00957021|454204613|FG000|Overall Study|Termination due to language issue|2|||
126028601|NCT02783300|453402808|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126250031|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
126250032|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
126250033|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
126250034|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
126028602|NCT02783300|453402809|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126028603|NCT02783300|453402810|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126250035|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
126250036|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
126250037|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
126250038|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
126250039|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
126250040|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
126250041|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
126250042|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
126250043|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
126250044|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
126250045|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
126250046|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
126250047|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
126250048|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
126028604|NCT02783300|453402811|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126250049|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
126250050|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
126250051|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
126250052|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
126250053|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
126306333|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126250054|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
126250055|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
126250056|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
126250057|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
126250058|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
126250059|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
126250060|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
126250061|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
126250062|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
126250063|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
126250064|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
126250065|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
126250066|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
126250067|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
126250068|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
126250069|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
126250070|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
126250071|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
126250072|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
126250073|NCT04025021|454204629|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
126250074|NCT04025021|454204630|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
126250075|NCT03966911|454204631|FG000|Overall Study|Adverse Event|1|||
126250076|NCT03966911|454204632|FG001|Overall Study|Adverse Event|1|||
126250077|NCT03966911|454204631|FG000|Overall Study|Withdrawal by Subject|8|||
126250078|NCT03966911|454204632|FG001|Overall Study|Withdrawal by Subject|2|||
126250079|NCT03966911|454204631|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
126250080|NCT03966911|454204632|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
126250081|NCT00868998|454204633|FG000|Overall Study|Screen Failure|1|||
126250082|NCT00868998|454204633|FG000|Overall Study|Withdrawal by Subject|1|||
126250083|NCT00868998|454204633|FG000|Overall Study|Progression of disease|2|||
126250084|NCT00868998|454204633|FG000|Overall Study|Death|1|||
126250085|NCT01986647|454204634|FG000|Overall Study|Lost to Follow-up|4|||
126250086|NCT01986647|454204635|FG001|Overall Study|Lost to Follow-up|1|||
126250087|NCT01986647|454204636|FG002|Overall Study|Lost to Follow-up|4|||
126250088|NCT01986647|454204637|FG003|Overall Study|Lost to Follow-up|4|||
126250089|NCT01986647|454204634|FG000|Overall Study|Withdrawal by Subject|1|||
126250090|NCT01986647|454204635|FG001|Overall Study|Withdrawal by Subject|3|||
126250091|NCT01986647|454204636|FG002|Overall Study|Withdrawal by Subject|2|||
126250092|NCT01986647|454204637|FG003|Overall Study|Withdrawal by Subject|3|||
126250093|NCT01986647|454204634|FG000|Overall Study|Health|5|||
126250094|NCT01986647|454204635|FG001|Overall Study|Health|3|||
126250095|NCT01986647|454204636|FG002|Overall Study|Health|6|||
126250096|NCT01986647|454204637|FG003|Overall Study|Health|4|||
126250097|NCT03498560|454204641|FG000|Overall Study|Found Ineligible|2|||
126250098|NCT03498560|454204641|FG000|Overall Study|Withdrawal by Subject|14|||
126250099|NCT03498560|454204641|FG000|Overall Study|Lost to Follow-up|4|||
126250100|NCT03498560|454204641|FG000|Overall Study|Death|1|||
126250101|NCT01004510|454204644|FG000|Overall Study|Adverse Event|1|||
126250102|NCT03541252|454204647|FG000|Overall Study|Withdrawal by Subject|1|||
126250103|NCT01960296|454204648|FG000|Overall Study|Postponed surgery|1|||
126250104|NCT01960296|454204649|FG001|Overall Study|Postponed surgery|0|||
126250105|NCT01960296|454204648|FG000|Overall Study|Received different procedure|1|||
126250106|NCT01960296|454204649|FG001|Overall Study|Received different procedure|3|||
126250107|NCT02003391|454204650|FG000|Overall Study|Withdrawal by Subject|2|||
126250108|NCT02003391|454204651|FG001|Overall Study|Withdrawal by Subject|1|||
126250109|NCT02003391|454204650|FG000|Overall Study|Protocol Violation|0|||
126250110|NCT02003391|454204651|FG001|Overall Study|Protocol Violation|1|||
126250111|NCT02003391|454204650|FG000|Overall Study|Adverse Event|1|||
126250112|NCT02003391|454204651|FG001|Overall Study|Adverse Event|0|||
126250113|NCT02272803|454204652|FG000|Overall Study|Disease progression|16|||
126250114|NCT02272803|454204653|FG001|Overall Study|Disease progression|8|||
126250115|NCT02272803|454204652|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
126358003|NCT00669331|454603856|FG000|Randomisation to First Dose|Protocol Violation|1|||
126358004|NCT00669331|454603857|FG001|Randomisation to First Dose|Protocol Violation|0|||
126358005|NCT00669331|454603856|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
126250116|NCT02272803|454204653|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
126250117|NCT02272803|454204652|FG000|Overall Study|Study drug toxicity|4|||
126250118|NCT02272803|454204653|FG001|Overall Study|Study drug toxicity|9|||
126250119|NCT02272803|454204652|FG000|Overall Study|Participant request to discontinue study treatment|3|||
126250120|NCT02272803|454204653|FG001|Overall Study|Participant request to discontinue study treatment|7|||
126250121|NCT02272803|454204652|FG000|Overall Study|Maximum clinical benefit|4|||
126250122|NCT02272803|454204653|FG001|Overall Study|Maximum clinical benefit|2|||
126250123|NCT02272803|454204652|FG000|Overall Study|Poor/non-compliance|2|||
126250124|NCT02272803|454204653|FG001|Overall Study|Poor/non-compliance|2|||
126250125|NCT02272803|454204652|FG000|Overall Study|Withdrawal by Subject|2|||
126250126|NCT02272803|454204653|FG001|Overall Study|Withdrawal by Subject|1|||
126250127|NCT02272803|454204652|FG000|Overall Study|Death|0|||
126250128|NCT02272803|454204653|FG001|Overall Study|Death|1|||
126250129|NCT02272803|454204652|FG000|Overall Study|Other reasons|1|||
126250130|NCT02272803|454204653|FG001|Overall Study|Other reasons|3|||
126250131|NCT02272803|454204652|FG000|Overall Study|Administrative reason by sponsor|5|||
126250132|NCT02272803|454204653|FG001|Overall Study|Administrative reason by sponsor|4|||
126250133|NCT03733145|454204657|FG000|Overall Study|screenfail|3|||
126250134|NCT03733145|454204658|FG001|Overall Study|screenfail|3|||
126250135|NCT03733145|454204659|FG002|Overall Study|screenfail|2|||
126250136|NCT01952691|454205823|FG000|Overall Study|Lost to Follow-up|2|||
126250137|NCT00199901|454205824|FG000|Overall Study|Protocol Violation|2|||
126250138|NCT00199901|454205825|FG001|Overall Study|Protocol Violation|0|||
126250139|NCT00199901|454205824|FG000|Overall Study|Withdrawal by Subject|1|||
126250140|NCT00199901|454205825|FG001|Overall Study|Withdrawal by Subject|0|||
126250141|NCT00199901|454205824|FG000|Overall Study|Progressive Disease|24|||
126250142|NCT00199901|454205825|FG001|Overall Study|Progressive Disease|24|||
126250143|NCT05776901|454205826|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
126250144|NCT00660660|454205830|FG000|Overall Study|Adverse Event|1|||
126250145|NCT00660660|454205831|FG001|Overall Study|Adverse Event|0|||
126250146|NCT00660660|454205830|FG000|Overall Study|Lost to Follow-up|0|||
126250147|NCT00660660|454205831|FG001|Overall Study|Lost to Follow-up|6|||
126250148|NCT00660660|454205830|FG000|Overall Study|Lack of Efficacy|0|||
126250149|NCT00660660|454205831|FG001|Overall Study|Lack of Efficacy|2|||
126250150|NCT00660660|454205830|FG000|Overall Study|Withdrawal by Subject|3|||
126250151|NCT00660660|454205831|FG001|Overall Study|Withdrawal by Subject|0|||
126250152|NCT00660660|454205830|FG000|Overall Study|Incorrect enrollment and other|0|||
126250153|NCT00660660|454205831|FG001|Overall Study|Incorrect enrollment and other|1|||
126250154|NCT00660660|454205830|FG000|Overall Study|New medication after randomization|1|||
126250155|NCT00660660|454205831|FG001|Overall Study|New medication after randomization|0|||
126250156|NCT04523480|454205836|FG000|Overall Study|Lost to Follow-up|30|||
126250157|NCT04523480|454205837|FG001|Overall Study|Lost to Follow-up|35|||
126250158|NCT04523480|454205838|FG002|Overall Study|Lost to Follow-up|0|||
126250159|NCT00081653|454205844|FG000|Overall Study|Adverse Event|23|||
126250160|NCT00081653|454205845|FG001|Overall Study|Adverse Event|17|||
126250161|NCT00081653|454205844|FG000|Overall Study|Lost to Follow-up|2|||
126250162|NCT00081653|454205845|FG001|Overall Study|Lost to Follow-up|4|||
126250163|NCT00081653|454205844|FG000|Overall Study|Refused Treatment|18|||
126028605|NCT02783300|453402812|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126250164|NCT00081653|454205845|FG001|Overall Study|Refused Treatment|14|||
126250165|NCT00081653|454205844|FG000|Overall Study|Low bone mineral density|1|||
126250166|NCT00081653|454205845|FG001|Overall Study|Low bone mineral density|0|||
126250167|NCT00081653|454205844|FG000|Overall Study|Bone loss|2|||
126250168|NCT00081653|454205845|FG001|Overall Study|Bone loss|0|||
126250169|NCT00081653|454205844|FG000|Overall Study|Participant leaving country|1|||
126250170|NCT00081653|454205845|FG001|Overall Study|Participant leaving country|0|||
126250171|NCT00081653|454205844|FG000|Overall Study|Loss of bone mass|0|||
126250172|NCT00081653|454205845|FG001|Overall Study|Loss of bone mass|2|||
126250173|NCT02694536|454205853|FG000|Overall Study|Progressive Disease|40|||
126250174|NCT02694536|454205853|FG000|Overall Study|Lost to Follow-up|1|||
126250175|NCT02694536|454205853|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
126250176|NCT02694536|454205853|FG000|Overall Study|Withdrawal by Subject|8|||
126250177|NCT02694536|454205853|FG000|Overall Study|Death|8|||
126250178|NCT02694536|454205853|FG000|Overall Study|Other|22|||
126250179|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
126250180|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
126250181|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
126250182|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
126250183|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
126028606|NCT02783300|453402786|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028607|NCT02783300|453402787|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028608|NCT02783300|453402788|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028609|NCT02783300|453402789|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028610|NCT02783300|453402790|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126250184|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
126250185|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
126250186|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
126250187|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
126250188|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
126250189|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
126250190|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
126250191|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
126250192|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
126250193|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
126250194|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Other|0|||
126250195|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Other|0|||
126250196|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Other|1|||
126250197|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
126250198|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
126250199|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
126250200|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
126250201|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
126250202|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
126250203|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
126250204|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
126250205|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
126250206|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
126250207|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
126250208|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
126250209|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
126250210|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
126250211|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
126250212|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
126250213|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
126250214|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
126250215|NCT00385736|454205854|FG000|Safety Analysis Set|Adverse Event|23|||
126250216|NCT00385736|454205855|FG001|Safety Analysis Set|Adverse Event|15|||
126250217|NCT00385736|454205856|FG002|Safety Analysis Set|Adverse Event|23|||
126250218|NCT00385736|454205854|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
126250219|NCT00385736|454205855|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
126250220|NCT00385736|454205856|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
126250221|NCT00385736|454205854|FG000|Safety Analysis Set|Lost to Follow-up|0|||
126250222|NCT00385736|454205855|FG001|Safety Analysis Set|Lost to Follow-up|2|||
126250223|NCT00385736|454205856|FG002|Safety Analysis Set|Lost to Follow-up|2|||
126250224|NCT00385736|454205854|FG000|Safety Analysis Set|Lack of Efficacy|38|||
126250225|NCT00385736|454205855|FG001|Safety Analysis Set|Lack of Efficacy|16|||
126250226|NCT00385736|454205856|FG002|Safety Analysis Set|Lack of Efficacy|31|||
126250227|NCT00385736|454205854|FG000|Safety Analysis Set|Protocol Violation|2|||
126250228|NCT00385736|454205855|FG001|Safety Analysis Set|Protocol Violation|1|||
126250229|NCT00385736|454205856|FG002|Safety Analysis Set|Protocol Violation|6|||
126250230|NCT00385736|454205854|FG000|Safety Analysis Set|Other|1|||
126250231|NCT00385736|454205855|FG001|Safety Analysis Set|Other|4|||
126250232|NCT00385736|454205856|FG002|Safety Analysis Set|Other|4|||
126250233|NCT01911429|454205861|FG000|Overall Study|Adverse Event|5|||
126250234|NCT01911429|454205862|FG001|Overall Study|Adverse Event|3|||
126250235|NCT01911429|454205863|FG002|Overall Study|Adverse Event|9|||
126250236|NCT01911429|454205861|FG000|Overall Study|Lack of Efficacy|1|||
126250237|NCT01911429|454205862|FG001|Overall Study|Lack of Efficacy|2|||
126250238|NCT01911429|454205863|FG002|Overall Study|Lack of Efficacy|4|||
126250239|NCT01911429|454205861|FG000|Overall Study|Lost to Follow-up|0|||
126250240|NCT01911429|454205862|FG001|Overall Study|Lost to Follow-up|0|||
126250241|NCT01911429|454205863|FG002|Overall Study|Lost to Follow-up|1|||
126250242|NCT01911429|454205861|FG000|Overall Study|Protocol Violation|0|||
126250243|NCT01911429|454205862|FG001|Overall Study|Protocol Violation|0|||
126250244|NCT01911429|454205863|FG002|Overall Study|Protocol Violation|1|||
126250245|NCT01911429|454205861|FG000|Overall Study|Withdrawal by Subject|5|||
126250246|NCT01911429|454205862|FG001|Overall Study|Withdrawal by Subject|5|||
126250247|NCT01911429|454205863|FG002|Overall Study|Withdrawal by Subject|4|||
126250248|NCT01911429|454205861|FG000|Overall Study|Accidental randomization|0|||
126250249|NCT01911429|454205862|FG001|Overall Study|Accidental randomization|0|||
126250250|NCT01911429|454205863|FG002|Overall Study|Accidental randomization|1|||
126250251|NCT01911429|454205861|FG000|Overall Study|subject left study|1|||
126250252|NCT01911429|454205862|FG001|Overall Study|subject left study|0|||
126250253|NCT01911429|454205863|FG002|Overall Study|subject left study|0|||
126250254|NCT01557751|454205869|FG000|Overall Study|Physician Decision|3|||
126250255|NCT02043132|454205870|FG000|Overall Study|Lost to Follow-up|1|||
126250256|NCT02043132|454205871|FG001|Overall Study|Lost to Follow-up|1|||
126250257|NCT02043132|454205870|FG000|Overall Study|screen failures|4|||
126250258|NCT02043132|454205871|FG001|Overall Study|screen failures|8|||
126250259|NCT00472212|454205873|FG000|Overall Study|Lost to Follow-up|6|||
126358006|NCT00669331|454603857|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
126028611|NCT02783300|453402791|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126250260|NCT00472212|454205874|FG001|Overall Study|Lost to Follow-up|4|||
126250261|NCT02462837|454205875|FG000|Overall Study|pt developed hives|1|||
126250262|NCT02462837|454205876|FG001|Overall Study|pt developed hives|0|||
126358007|NCT00669331|454603856|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
126250263|NCT02462837|454205875|FG000|Overall Study|Withdrawal by Subject|1|||
126250264|NCT02462837|454205876|FG001|Overall Study|Withdrawal by Subject|0|||
126250265|NCT00958724|454205877|FG000|Overall Study|Disease Progression|6|||
126250266|NCT00840203|454205895|FG000|First Intervention|Protocol Violation|1|||
126250267|NCT00840203|454205896|FG001|First Intervention|Protocol Violation|1|||
126250268|NCT00840203|454205895|FG000|Washout|Protocol Violation|1|||
126250269|NCT00840203|454205896|FG001|Washout|Protocol Violation|0|||
126250270|NCT02121184|454205900|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
126250271|NCT02121184|454205901|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
126250272|NCT02121184|454205900|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
126250273|NCT02121184|454205901|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
126250274|NCT02121184|454205900|FG000|Overall Study|Emergency cesarean section required|0|||
126250275|NCT02121184|454205901|FG001|Overall Study|Emergency cesarean section required|2|||
126250276|NCT02121184|454205900|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
126250277|NCT02121184|454205901|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
126250278|NCT05562011|454205902|FG000|Overall Study|Withdrawal by Subject|3|||
126250279|NCT05562011|454205902|FG000|Overall Study|Lost to Follow-up|1|||
126250280|NCT05562011|454205902|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
126250281|NCT05562011|454205902|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
126250282|NCT05562011|454205902|FG000|Overall Study|Device malfunction|13|||
126250283|NCT02905435|454205907|FG000|Overall Study|Death|2|||
126250284|NCT02905435|454205907|FG000|Overall Study|Physician Decision|1|||
126250285|NCT02905435|454205907|FG000|Overall Study|Lost to Follow-up|4|||
126250286|NCT01507662|454205908|FG000|Overall Study|Death|26|||
126250287|NCT01507662|454205909|FG001|Overall Study|Death|18|||
126250288|NCT01507662|454205908|FG000|Overall Study|Withdrawal by Subject|290|||
126250289|NCT01507662|454205909|FG001|Overall Study|Withdrawal by Subject|287|||
126250290|NCT01507662|454205908|FG000|Overall Study|Lost to Follow-up|498|||
126250291|NCT01507662|454205909|FG001|Overall Study|Lost to Follow-up|523|||
126250292|NCT01507662|454205908|FG000|Overall Study|Proxy interview done|2|||
126250293|NCT01507662|454205909|FG001|Overall Study|Proxy interview done|3|||
126250294|NCT01395017|454205912|FG000|Overall Study|Lost to Follow-up|1|||
126250295|NCT01395017|454205913|FG001|Overall Study|Lost to Follow-up|0|||
126250296|NCT01395017|454205912|FG000|Overall Study|Adverse Event|26|||
126250297|NCT01395017|454205913|FG001|Overall Study|Adverse Event|12|||
126250298|NCT01395017|454205912|FG000|Overall Study|Physician Decision|11|||
126250299|NCT01395017|454205913|FG001|Overall Study|Physician Decision|15|||
126250300|NCT01395017|454205912|FG000|Overall Study|Withdrawal by Subject|14|||
126250301|NCT01395017|454205913|FG001|Overall Study|Withdrawal by Subject|8|||
126250302|NCT01395017|454205912|FG000|Overall Study|Protocol deviation|1|||
126250303|NCT01395017|454205913|FG001|Overall Study|Protocol deviation|2|||
126250304|NCT01395017|454205912|FG000|Overall Study|Death|4|||
126250305|NCT01395017|454205913|FG001|Overall Study|Death|3|||
126250306|NCT01395017|454205912|FG000|Overall Study|Disease progression|42|||
126250307|NCT01395017|454205913|FG001|Overall Study|Disease progression|58|||
126250308|NCT01395017|454205912|FG000|Overall Study|Sponsor discontinued study|1|||
126250309|NCT01395017|454205913|FG001|Overall Study|Sponsor discontinued study|4|||
126250310|NCT00999687|454205915|FG000|First Intervention|Withdrawal by Subject|1|||
126250311|NCT00999687|454205915|FG000|Second Intervention|Withdrawal by Subject|2|||
126250312|NCT00999687|454205915|FG000|Second Intervention|Lack of Efficacy|1|||
126250313|NCT00474188|454205916|FG000|Overall Study|Withdrawal by Subject|1|||
126250314|NCT00474188|454205916|FG000|Overall Study|Study discontinued by sponsor|5|||
126250315|NCT03684928|454205920|FG000|First Intervention|Lost to Follow-up|0|||
126250316|NCT03684928|454205921|FG001|First Intervention|Lost to Follow-up|1|||
126250317|NCT03684928|454205920|FG000|First Intervention|Withdrawal by Subject|0|||
126250318|NCT03684928|454205921|FG001|First Intervention|Withdrawal by Subject|2|||
126250319|NCT03684928|454205920|FG000|Second Intervention|Soft Tissue Injury|1|||
126250320|NCT03684928|454205921|FG001|Second Intervention|Soft Tissue Injury|0|||
126250321|NCT00557245|454206894|FG000|Overall Study|Lost to Follow-up|7|||
126250322|NCT00557245|454206895|FG001|Overall Study|Lost to Follow-up|8|||
126250323|NCT00557245|454206896|FG002|Overall Study|Lost to Follow-up|10|||
126250324|NCT00557245|454206894|FG000|Overall Study|Ineligible|5|||
126250325|NCT00557245|454206895|FG001|Overall Study|Ineligible|4|||
126250326|NCT00557245|454206896|FG002|Overall Study|Ineligible|2|||
126250327|NCT00798603|454206899|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
126250328|NCT00798603|454206899|FG000|Overall Study|Withdrawal by Subject|10|||
126250329|NCT00798603|454206899|FG000|Overall Study|Adverse Event|22|||
126250330|NCT00798603|454206899|FG000|Overall Study|Physician Decision|1|||
126250331|NCT00798603|454206899|FG000|Overall Study|Lack of insurance coverage|1|||
126250332|NCT02316223|454206902|FG000|Overall Study|Lack of Efficacy|0|||
126250333|NCT02316223|454206903|FG001|Overall Study|Lack of Efficacy|1|||
126250334|NCT02316223|454206904|FG002|Overall Study|Lack of Efficacy|1|||
126250335|NCT02316223|454206902|FG000|Overall Study|Lost to Follow-up|27|||
126250336|NCT02316223|454206903|FG001|Overall Study|Lost to Follow-up|34|||
126250337|NCT02316223|454206904|FG002|Overall Study|Lost to Follow-up|36|||
126250338|NCT02316223|454206902|FG000|Overall Study|COPD Diagnosis|3|||
126250339|NCT02316223|454206903|FG001|Overall Study|COPD Diagnosis|2|||
126250340|NCT02316223|454206904|FG002|Overall Study|COPD Diagnosis|3|||
126250341|NCT02316223|454206902|FG000|Overall Study|Reside outside study area|1|||
126250342|NCT02316223|454206903|FG001|Overall Study|Reside outside study area|1|||
126250343|NCT02316223|454206904|FG002|Overall Study|Reside outside study area|1|||
126250344|NCT02316223|454206902|FG000|Overall Study|No asthma|2|||
126250345|NCT02316223|454206903|FG001|Overall Study|No asthma|0|||
126250346|NCT02316223|454206904|FG002|Overall Study|No asthma|0|||
126250347|NCT02316223|454206902|FG000|Overall Study|Discontinued by PI|11|||
126250348|NCT02316223|454206903|FG001|Overall Study|Discontinued by PI|19|||
126250349|NCT02316223|454206904|FG002|Overall Study|Discontinued by PI|3|||
126250350|NCT00529763|454206906|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
126250351|NCT00529763|454206907|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
126250352|NCT00529763|454206908|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126250353|NCT00529763|454206906|FG000|Overall Study|Death|1|||
126250354|NCT00529763|454206907|FG001|Overall Study|Death|1|||
126250355|NCT00529763|454206908|FG002|Overall Study|Death|1|||
126250356|NCT00529763|454206906|FG000|Overall Study|Disease Progression|10|||
126250357|NCT00529763|454206907|FG001|Overall Study|Disease Progression|16|||
126250358|NCT00529763|454206908|FG002|Overall Study|Disease Progression|11|||
126250359|NCT00529763|454206906|FG000|Overall Study|Lost to Follow-up|1|||
126250360|NCT00529763|454206907|FG001|Overall Study|Lost to Follow-up|2|||
126250361|NCT00529763|454206908|FG002|Overall Study|Lost to Follow-up|3|||
126250362|NCT00529763|454206906|FG000|Overall Study|Stem Cell Transplant|0|||
126250363|NCT00529763|454206907|FG001|Overall Study|Stem Cell Transplant|3|||
126250364|NCT00529763|454206908|FG002|Overall Study|Stem Cell Transplant|1|||
126250365|NCT00529763|454206906|FG000|Overall Study|Study Drug Toxicity|3|||
126250366|NCT00529763|454206907|FG001|Overall Study|Study Drug Toxicity|6|||
126250367|NCT00529763|454206908|FG002|Overall Study|Study Drug Toxicity|4|||
126250368|NCT00529763|454206906|FG000|Overall Study|Participant Withdrew Consent|2|||
126250369|NCT00529763|454206907|FG001|Overall Study|Participant Withdrew Consent|3|||
126250370|NCT00529763|454206908|FG002|Overall Study|Participant Withdrew Consent|4|||
126250371|NCT00529763|454206906|FG000|Overall Study|Other reasons|2|||
126250372|NCT00529763|454206907|FG001|Overall Study|Other reasons|0|||
126250373|NCT00529763|454206908|FG002|Overall Study|Other reasons|2|||
126250374|NCT00529763|454206906|FG000|Overall Study|Participant request to discontinue treatment|1|||
126250375|NCT00529763|454206907|FG001|Overall Study|Participant request to discontinue treatment|1|||
126250376|NCT00529763|454206908|FG002|Overall Study|Participant request to discontinue treatment|3|||
126250377|NCT03669250|454206909|FG000|Overall Study|Adverse Event|0|||
126250378|NCT03669250|454206910|FG001|Overall Study|Adverse Event|0|||
126250379|NCT03669250|454206911|FG002|Overall Study|Adverse Event|0|||
126250380|NCT03669250|454206912|FG003|Overall Study|Adverse Event|0|||
126250381|NCT03669250|454206913|FG004|Overall Study|Adverse Event|1|||
126250382|NCT03669250|454206914|FG005|Overall Study|Adverse Event|0|||
126250383|NCT03669250|454206909|FG000|Overall Study|Withdrawal by Subject|0|||
126250384|NCT03669250|454206910|FG001|Overall Study|Withdrawal by Subject|1|||
126250385|NCT03669250|454206911|FG002|Overall Study|Withdrawal by Subject|0|||
126250386|NCT03669250|454206912|FG003|Overall Study|Withdrawal by Subject|1|||
126250387|NCT03669250|454206913|FG004|Overall Study|Withdrawal by Subject|0|||
126250388|NCT03669250|454206914|FG005|Overall Study|Withdrawal by Subject|0|||
126250389|NCT00828321|454206915|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
126250390|NCT00828321|454206916|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
126250391|NCT00828321|454206915|FG000|Second Intervention|Protocol Violation|0|||
126250392|NCT00828321|454206916|FG001|Second Intervention|Protocol Violation|1|||
126250393|NCT03234907|454206917|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
126250394|NCT03234907|454206918|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
126250395|NCT03234907|454206919|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
126250396|NCT03234907|454206920|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
126250397|NCT03234907|454206921|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
126250398|NCT03234907|454206922|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
126250399|NCT03234907|454206917|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
126250400|NCT03234907|454206918|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
126250401|NCT03234907|454206919|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
126250402|NCT03234907|454206920|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
126250403|NCT03234907|454206921|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
126250404|NCT03234907|454206922|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
126250405|NCT03234907|454206917|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
126250406|NCT03234907|454206918|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250407|NCT03234907|454206919|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250408|NCT03234907|454206920|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250409|NCT03234907|454206921|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250410|NCT03234907|454206922|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250411|NCT03234907|454206917|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
126250412|NCT03234907|454206918|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
126250413|NCT03234907|454206919|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
126250414|NCT03234907|454206920|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
126250415|NCT03234907|454206921|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
126250416|NCT03234907|454206922|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
126250417|NCT03234907|454206917|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
126250418|NCT03234907|454206918|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
126250419|NCT03234907|454206919|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
126250420|NCT03234907|454206920|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
126250421|NCT03234907|454206921|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
126250422|NCT03234907|454206922|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
126250423|NCT03234907|454206917|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
126250424|NCT03234907|454206918|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
126250425|NCT03234907|454206919|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
126250426|NCT03234907|454206920|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
126250427|NCT03234907|454206921|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
126250428|NCT03234907|454206922|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
126250429|NCT03234907|454206917|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
126250430|NCT03234907|454206918|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
126250431|NCT03234907|454206919|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
126250432|NCT03234907|454206920|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
126250433|NCT03234907|454206921|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
126250434|NCT03234907|454206922|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
126250435|NCT00642993|454206923|FG000|Overall Study|Adverse Event|85|||
126250436|NCT00642993|454206924|FG001|Overall Study|Adverse Event|4|||
126250437|NCT00642993|454206923|FG000|Overall Study|Lost to Follow-up|8|||
126250438|NCT00642993|454206924|FG001|Overall Study|Lost to Follow-up|4|||
126250439|NCT00642993|454206923|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
126250440|NCT00642993|454206924|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
126250441|NCT00642993|454206923|FG000|Overall Study|Protocol Violation|1|||
126250442|NCT00642993|454206924|FG001|Overall Study|Protocol Violation|4|||
126250443|NCT00642993|454206923|FG000|Overall Study|Did not meet protocol eligibility|0|||
126250444|NCT00642993|454206924|FG001|Overall Study|Did not meet protocol eligibility|1|||
126250445|NCT00642993|454206923|FG000|Overall Study|Administrative|1|||
126250446|NCT00642993|454206924|FG001|Overall Study|Administrative|0|||
126250447|NCT02664415|454206925|FG000|Overall Study|Adverse Event|1|||
126250448|NCT02664415|454206926|FG001|Overall Study|Adverse Event|0|||
126250449|NCT02986139|454206928|FG000|Overall Study|Sponsor Decision|1|||
126250450|NCT02986139|454206929|FG001|Overall Study|Sponsor Decision|2|||
126250451|NCT02986139|454206928|FG000|Overall Study|Withdrawal by Subject|0|||
126250452|NCT02986139|454206929|FG001|Overall Study|Withdrawal by Subject|1|||
126250453|NCT02986139|454206928|FG000|Overall Study|Lost to Follow-up|0|||
126250454|NCT02986139|454206929|FG001|Overall Study|Lost to Follow-up|1|||
126250455|NCT00414726|454206933|FG000|Overall Study|Withdrawal by Subject|0|||
126250456|NCT00414726|454206934|FG001|Overall Study|Withdrawal by Subject|1|||
126250457|NCT02107196|454206935|FG000|12-week Treatment Period|Adverse Event|6|||
126250458|NCT02107196|454206936|FG001|12-week Treatment Period|Adverse Event|3|||
126250459|NCT02107196|454206935|FG000|12-week Treatment Period|Lack of Efficacy|2|||
126250460|NCT02107196|454206936|FG001|12-week Treatment Period|Lack of Efficacy|1|||
126250461|NCT02107196|454206935|FG000|12-week Treatment Period|Lost to Follow-up|3|||
126250462|NCT02107196|454206936|FG001|12-week Treatment Period|Lost to Follow-up|6|||
126250463|NCT02107196|454206935|FG000|12-week Treatment Period|Physician Decision|0|||
126250464|NCT02107196|454206936|FG001|12-week Treatment Period|Physician Decision|1|||
126250465|NCT02107196|454206935|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
126250466|NCT02107196|454206936|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
126250467|NCT02107196|454206935|FG000|12-week Treatment Period|Protocol Violation|7|||
126250468|NCT02107196|454206936|FG001|12-week Treatment Period|Protocol Violation|8|||
126250469|NCT02107196|454206935|FG000|12-week Treatment Period|Reason Missing|11|||
126250470|NCT02107196|454206936|FG001|12-week Treatment Period|Reason Missing|8|||
126250471|NCT02107196|454206935|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
126250472|NCT02107196|454206936|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
126250473|NCT02107196|454206935|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
126250474|NCT02107196|454206936|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126250475|NCT02107196|454206935|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
126250476|NCT02107196|454206936|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
126250477|NCT02107196|454206935|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
126250478|NCT02107196|454206936|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
126250479|NCT00516295|454206937|FG000|Overall Study|Lack of Efficacy|2|||
126250480|NCT00516295|454206938|FG001|Overall Study|Lack of Efficacy|0|||
126250481|NCT00516295|454206939|FG002|Overall Study|Lack of Efficacy|0|||
126250482|NCT00516295|454206937|FG000|Overall Study|Ineligible|1|||
126250483|NCT00516295|454206938|FG001|Overall Study|Ineligible|0|||
126250484|NCT00516295|454206939|FG002|Overall Study|Ineligible|0|||
126250485|NCT01630616|454206942|FG000|Overall Study|Adverse Event|0|||
126250486|NCT01630616|454206943|FG001|Overall Study|Adverse Event|0|||
126250487|NCT01630616|454206944|FG002|Overall Study|Adverse Event|0|||
126250488|NCT01630616|454206945|FG003|Overall Study|Adverse Event|1|||
126250489|NCT01630616|454206946|FG004|Overall Study|Adverse Event|0|||
126250490|NCT01630616|454206947|FG005|Overall Study|Adverse Event|0|||
126250491|NCT01630616|454206942|FG000|Overall Study|Withdrawal by Subject|0|||
126250492|NCT01630616|454206943|FG001|Overall Study|Withdrawal by Subject|0|||
126250493|NCT01630616|454206944|FG002|Overall Study|Withdrawal by Subject|0|||
126250494|NCT01630616|454206945|FG003|Overall Study|Withdrawal by Subject|2|||
126250495|NCT01630616|454206946|FG004|Overall Study|Withdrawal by Subject|0|||
126250496|NCT01630616|454206947|FG005|Overall Study|Withdrawal by Subject|0|||
126250497|NCT02218541|454206948|FG000|Overall Study|Lost to Follow-up|2|||
126250498|NCT02218541|454206949|FG001|Overall Study|Lost to Follow-up|1|||
126250499|NCT02218541|454206948|FG000|Overall Study|Implant Failure|4|||
126250500|NCT02218541|454206949|FG001|Overall Study|Implant Failure|1|||
126250501|NCT01993186|454206950|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
126250502|NCT01993186|454206951|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
126250503|NCT01993186|454206950|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
126250504|NCT01993186|454206951|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
126250505|NCT01993186|454206950|FG000|Open-Label Extension Period|Other, Not Specified|0|||
126250506|NCT01993186|454206951|FG001|Open-Label Extension Period|Other, Not Specified|1|||
126250507|NCT01993186|454206950|FG000|Open-Label Extension Period|Adverse Event|1|||
126250508|NCT01993186|454206951|FG001|Open-Label Extension Period|Adverse Event|0|||
126250509|NCT01993186|454206950|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
126250510|NCT01993186|454206951|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
126250511|NCT01993186|454206950|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
126250512|NCT01993186|454206951|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
126250513|NCT01993186|454206950|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
126250514|NCT01993186|454206951|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
126250515|NCT03827395|454206952|FG000|Overall Study|Lost to Follow-up|1|||
126028612|NCT02783300|453402792|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028613|NCT02783300|453402793|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028614|NCT02783300|453402794|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028615|NCT02783300|453402795|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028616|NCT02783300|453402796|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126250516|NCT03827395|454206953|FG001|Overall Study|Lost to Follow-up|0|||
126250517|NCT03827395|454206952|FG000|Overall Study|Protocol Violation|1|||
126250518|NCT03827395|454206953|FG001|Overall Study|Protocol Violation|0|||
126250519|NCT03827395|454206952|FG000|Overall Study|Became ineligible after enrollment|1|||
126250520|NCT03827395|454206953|FG001|Overall Study|Became ineligible after enrollment|2|||
126250521|NCT00731939|454206954|FG000|Overall Study|Adverse Event|6|||
126250522|NCT00731939|454206954|FG000|Overall Study|Lost to Follow-up|15|||
126250523|NCT00731939|454206954|FG000|Overall Study|Not implanted with study device|9|||
126250524|NCT00731939|454206954|FG000|Overall Study|Withdrawal by Subject|2|||
126250525|NCT00731939|454206954|FG000|Overall Study|Did not meet enrollment criteria|2|||
126250526|NCT02072096|454206961|FG000|Overall Study|Lack of Efficacy|18|||
126250527|NCT02072096|454206962|FG001|Overall Study|Lack of Efficacy|29|||
126250528|NCT02072096|454206961|FG000|Overall Study|Protocol Violation|7|||
126250529|NCT02072096|454206962|FG001|Overall Study|Protocol Violation|7|||
126250530|NCT02072096|454206961|FG000|Overall Study|Withdrawal by Subject|5|||
126250531|NCT02072096|454206962|FG001|Overall Study|Withdrawal by Subject|7|||
126250532|NCT02072096|454206961|FG000|Overall Study|Adverse Event|5|||
126250533|NCT02072096|454206962|FG001|Overall Study|Adverse Event|2|||
126250534|NCT02072096|454206961|FG000|Overall Study|No Reason Provided|4|||
126250535|NCT02072096|454206962|FG001|Overall Study|No Reason Provided|2|||
126250536|NCT02072096|454206961|FG000|Overall Study|Death|2|||
126250537|NCT02072096|454206962|FG001|Overall Study|Death|0|||
126250538|NCT02072096|454206961|FG000|Overall Study|Physician Decision|0|||
126250539|NCT02072096|454206962|FG001|Overall Study|Physician Decision|1|||
126250540|NCT02072096|454206961|FG000|Overall Study|Study Terminated by Sponsor|43|||
126250541|NCT02072096|454206962|FG001|Overall Study|Study Terminated by Sponsor|30|||
126250542|NCT02072096|454206961|FG000|Overall Study|Lost to Follow-up|1|||
126028617|NCT02783300|453402797|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028618|NCT02783300|453402798|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028619|NCT02783300|453402799|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126250543|NCT02072096|454206962|FG001|Overall Study|Lost to Follow-up|0|||
126250544|NCT01168856|454206966|FG000|Overall Study|Lost to Follow-up|4|||
126250545|NCT01168856|454206967|FG001|Overall Study|Lost to Follow-up|34|||
126250546|NCT01168856|454206966|FG000|Overall Study|Withdrawal by Subject|6|||
126250547|NCT01168856|454206967|FG001|Overall Study|Withdrawal by Subject|8|||
126250548|NCT01168856|454206966|FG000|Overall Study|Physician Decision|2|||
126250549|NCT01168856|454206967|FG001|Overall Study|Physician Decision|1|||
126250550|NCT01168856|454206966|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
126250551|NCT01168856|454206967|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
126250552|NCT01168856|454206966|FG000|Overall Study|Participant received anti-HCV treatment|1|||
126250553|NCT01168856|454206967|FG001|Overall Study|Participant received anti-HCV treatment|0|||
126250554|NCT01168856|454206966|FG000|Overall Study|Death|0|||
126250555|NCT01168856|454206967|FG001|Overall Study|Death|2|||
126250556|NCT01168856|454206966|FG000|Overall Study|Other|1|||
126028620|NCT02783300|453402800|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028621|NCT02783300|453402801|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
126028622|NCT02783300|453402802|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028623|NCT02783300|453402803|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
126028624|NCT02783300|453402804|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
126028625|NCT02783300|453402805|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
126028626|NCT02783300|453402806|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028627|NCT02783300|453402807|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028628|NCT02783300|453402808|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028629|NCT02783300|453402809|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028630|NCT02783300|453402810|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
126028631|NCT02783300|453402811|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028632|NCT02783300|453402812|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126028633|NCT02783300|453402786|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028634|NCT02783300|453402787|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028635|NCT02783300|453402788|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028636|NCT02783300|453402789|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028637|NCT02783300|453402790|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028638|NCT02783300|453402791|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028639|NCT02783300|453402792|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028640|NCT02783300|453402793|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028641|NCT02783300|453402794|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028642|NCT02783300|453402795|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028643|NCT02783300|453402796|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028644|NCT02783300|453402797|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028645|NCT02783300|453402798|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028646|NCT02783300|453402799|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028647|NCT02783300|453402800|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028648|NCT02783300|453402801|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028649|NCT02783300|453402802|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
126028650|NCT02783300|453402803|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028651|NCT02783300|453402804|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
126028652|NCT02783300|453402805|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
126028653|NCT02783300|453402806|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028654|NCT02783300|453402807|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028655|NCT02783300|453402808|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028656|NCT02783300|453402809|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028657|NCT02783300|453402810|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028658|NCT02783300|453402811|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028659|NCT02783300|453402812|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126028660|NCT02783300|453402786|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028661|NCT02783300|453402787|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028662|NCT02783300|453402788|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028663|NCT02783300|453402789|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028664|NCT02783300|453402790|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028665|NCT02783300|453402791|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126250557|NCT01168856|454206967|FG001|Overall Study|Other|291|||
126250558|NCT01168856|454206966|FG000|Overall Study|Protocol Violation|4|||
126250559|NCT01168856|454206967|FG001|Overall Study|Protocol Violation|6|||
126250560|NCT04567329|454206972|FG000|Overall Study|Withdrawal by Subject|5|||
126250561|NCT04567329|454206973|FG001|Overall Study|Withdrawal by Subject|6|||
126250562|NCT04567329|454206972|FG000|Overall Study|Protocol Violation|2|||
126250563|NCT04567329|454206973|FG001|Overall Study|Protocol Violation|3|||
126250564|NCT04567329|454206972|FG000|Overall Study|Discontinued|2|||
126250565|NCT04567329|454206973|FG001|Overall Study|Discontinued|2|||
126250566|NCT04567329|454206972|FG000|Overall Study|Lost to Follow-up|0|||
126250567|NCT04567329|454206973|FG001|Overall Study|Lost to Follow-up|1|||
126250568|NCT04567329|454206972|FG000|Overall Study|Lack of Efficacy|0|||
126028666|NCT02783300|453402792|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126250569|NCT04567329|454206973|FG001|Overall Study|Lack of Efficacy|1|||
126250570|NCT00674128|454206975|FG000|Overall Study|Withdrawal by Subject|25|||
126250571|NCT00674128|454206976|FG001|Overall Study|Withdrawal by Subject|23|||
126250572|NCT00829452|454206980|FG000|First Intervention|Withdrawal by Subject|0|||
126250573|NCT00829452|454206981|FG001|First Intervention|Withdrawal by Subject|1|||
126250574|NCT00829452|454206980|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
126250575|NCT00829452|454206981|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
126250576|NCT00829452|454206980|FG000|Second Intervention|Physician Decision|0|||
126250577|NCT00829452|454206981|FG001|Second Intervention|Physician Decision|1|||
126250578|NCT00487435|454206990|FG000|Overall Study|Adverse Event|146|||
126250579|NCT00487435|454206990|FG000|Overall Study|Death|2|||
126250580|NCT00487435|454206990|FG000|Overall Study|Lack of Efficacy|33|||
126250581|NCT00487435|454206990|FG000|Overall Study|Lost to Follow-up|54|||
126250582|NCT00487435|454206990|FG000|Overall Study|Pregnancy|2|||
126250583|NCT00487435|454206990|FG000|Overall Study|Withdrawal by Subject|132|||
126250584|NCT00487435|454206990|FG000|Overall Study|Resolution Of Pain|1|||
126250585|NCT00487435|454206990|FG000|Overall Study|Study Medication Non-Compliant|32|||
126250586|NCT00487435|454206990|FG000|Overall Study|Other|83|||
126250587|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
126250588|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
126250589|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
126250590|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
126028667|NCT02783300|453402793|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028668|NCT02783300|453402794|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028669|NCT02783300|453402795|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126250591|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
126250592|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
126250593|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
126250594|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
126250595|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
126250596|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
126250597|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
126250598|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
126250599|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
126250600|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
126250601|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
126250602|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
126250603|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
126250604|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
126250605|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
126250606|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
126250607|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
126250608|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
126250609|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
126028670|NCT02783300|453402796|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028671|NCT02783300|453402797|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028672|NCT02783300|453402798|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028673|NCT02783300|453402799|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028674|NCT02783300|453402800|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028675|NCT02783300|453402801|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028676|NCT02783300|453402802|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
126028677|NCT02783300|453402803|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028678|NCT02783300|453402804|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
126028679|NCT02783300|453402805|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
126028680|NCT02783300|453402806|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
126028681|NCT02783300|453402807|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028682|NCT02783300|453402808|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028683|NCT02783300|453402809|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028684|NCT02783300|453402810|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028685|NCT02783300|453402811|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126028686|NCT02783300|453402812|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126250610|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
126250611|NCT02705716|454206993|FG000|Overall Study|Adverse Event|0|||
126250612|NCT02705716|454206994|FG001|Overall Study|Adverse Event|1|||
126250613|NCT02705716|454206993|FG000|Overall Study|Protocol Violation|3|||
126250614|NCT02705716|454206994|FG001|Overall Study|Protocol Violation|0|||
126028687|NCT02783300|453402786|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028688|NCT02783300|453402787|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028689|NCT02783300|453402788|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028690|NCT02783300|453402789|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028691|NCT02783300|453402790|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028692|NCT02783300|453402791|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028693|NCT02783300|453402792|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028694|NCT02783300|453402793|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028695|NCT02783300|453402794|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028696|NCT02783300|453402795|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028697|NCT02783300|453402796|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028698|NCT02783300|453402797|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028699|NCT02783300|453402798|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028700|NCT02783300|453402799|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028701|NCT02783300|453402800|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028702|NCT02783300|453402801|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
126028703|NCT02783300|453402802|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028704|NCT02783300|453402803|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028705|NCT02783300|453402804|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028706|NCT02783300|453402805|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126095200|NCT02663518|453643024|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126095201|NCT02663518|453643011|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095202|NCT02663518|453643012|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095203|NCT02663518|453643013|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
126250615|NCT02705716|454206993|FG000|Overall Study|Withdrawal of Consent|1|||
126250616|NCT02705716|454206994|FG001|Overall Study|Withdrawal of Consent|1|||
126250617|NCT00562718|454206996|FG000|Overall Study|Death|1|||
126250618|NCT00562718|454206996|FG000|Overall Study|Withdrawal by Subject|3|||
126250619|NCT00562718|454206996|FG000|Overall Study|Adverse Event|4|||
126250620|NCT00562718|454206996|FG000|Overall Study|Lack of Efficacy|2|||
126250621|NCT00562718|454206996|FG000|Overall Study|not stated|1|||
126250622|NCT01868243|454206997|FG000|Overall Study|Death|0|||
126250623|NCT01868243|454206998|FG001|Overall Study|Death|1|||
126250624|NCT01451541|454206999|FG000|Overall Study|Adverse Event|4|||
126250625|NCT01451541|454207000|FG001|Overall Study|Adverse Event|3|||
126250626|NCT01451541|454207001|FG002|Overall Study|Adverse Event|6|||
126250627|NCT01451541|454206999|FG000|Overall Study|Lack of Efficacy|2|||
126250628|NCT01451541|454207000|FG001|Overall Study|Lack of Efficacy|0|||
126250629|NCT01451541|454207001|FG002|Overall Study|Lack of Efficacy|0|||
126250630|NCT01451541|454206999|FG000|Overall Study|Lost to Follow-up|4|||
126250631|NCT01451541|454207000|FG001|Overall Study|Lost to Follow-up|4|||
126250632|NCT01451541|454207001|FG002|Overall Study|Lost to Follow-up|7|||
126250633|NCT01451541|454206999|FG000|Overall Study|Withdrawal by Subject|15|||
126250634|NCT01451541|454207000|FG001|Overall Study|Withdrawal by Subject|8|||
126250635|NCT01451541|454207001|FG002|Overall Study|Withdrawal by Subject|6|||
126250636|NCT01451541|454206999|FG000|Overall Study|randomization error, noncompliance|11|||
126250637|NCT01451541|454207000|FG001|Overall Study|randomization error, noncompliance|10|||
126250638|NCT01451541|454207001|FG002|Overall Study|randomization error, noncompliance|8|||
126250639|NCT03961204|454207007|FG000|Overall Study|Withdrawal by Subject|2|||
126250640|NCT03961204|454207007|FG000|Overall Study|Lost to Follow-up|3|||
126250641|NCT03961204|454207007|FG000|Overall Study|Other|1|||
126250642|NCT03961204|454207007|FG000|Overall Study|Missing|1|||
126250643|NCT01566435|454207008|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
126250644|NCT04236596|454207011|FG000|Overall Study|Withdrawal by Subject|1|||
126095204|NCT02663518|453643014|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095205|NCT02663518|453643015|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
126095206|NCT02663518|453643016|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095207|NCT02663518|453643017|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
126095208|NCT02663518|453643018|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095209|NCT02663518|453643019|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095210|NCT02663518|453643020|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095211|NCT02663518|453643021|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095212|NCT02663518|453643022|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
126095213|NCT02663518|453643023|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
126250645|NCT04236596|454207011|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
126250646|NCT04236596|454207011|FG000|Overall Study|Participants did not receive implant at all|4|||
126250647|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Subject request|8|||
126250648|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Subject request|11|||
126250649|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
126250650|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
126028707|NCT02783300|453402806|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028708|NCT02783300|453402807|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028709|NCT02783300|453402808|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
126028710|NCT02783300|453402809|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028711|NCT02783300|453402810|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028712|NCT02783300|453402811|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028713|NCT02783300|453402812|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126028714|NCT02783300|453402786|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028715|NCT02783300|453402787|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028716|NCT02783300|453402788|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028717|NCT02783300|453402789|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028718|NCT02783300|453402790|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028719|NCT02783300|453402791|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028720|NCT02783300|453402792|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028721|NCT02783300|453402793|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028722|NCT02783300|453402794|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028723|NCT02783300|453402795|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028724|NCT02783300|453402796|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028725|NCT02783300|453402797|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028726|NCT02783300|453402798|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028727|NCT02783300|453402799|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
126028728|NCT02783300|453402800|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
126028729|NCT02783300|453402801|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
126028730|NCT02783300|453402802|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
126028731|NCT02783300|453402803|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028732|NCT02783300|453402804|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
126028733|NCT02783300|453402805|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
126028734|NCT02783300|453402806|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028735|NCT02783300|453402807|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028736|NCT02783300|453402808|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028737|NCT02783300|453402809|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028738|NCT02783300|453402810|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028739|NCT02783300|453402811|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126095214|NCT02663518|453643024|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
126250651|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
126250652|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
126250653|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
126250654|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
126250655|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
126250656|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
126250657|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
126250658|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
126250659|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Death|1|||
126250660|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Death|0|||
126250661|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
126358008|NCT00669331|454603857|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
126358009|NCT00669331|454603856|FG000|Randomisation to First Dose|Death|1|||
126358010|NCT00669331|454603857|FG001|Randomisation to First Dose|Death|0|||
126358011|NCT00669331|454603856|FG000|Randomisation to First Dose|Sponsor decision|0|||
126358012|NCT00669331|454603857|FG001|Randomisation to First Dose|Sponsor decision|1|||
126358013|NCT00669331|454603856|FG000|Randomisation to First Dose|Randomised in error|3|||
126358014|NCT00669331|454603857|FG001|Randomisation to First Dose|Randomised in error|10|||
126358015|NCT00669331|454603856|FG000|Blinded Treatment Period|Adverse Event|16|||
126358016|NCT00669331|454603857|FG001|Blinded Treatment Period|Adverse Event|10|||
126358017|NCT00669331|454603856|FG000|Blinded Treatment Period|Protocol Violation|1|||
126358018|NCT00669331|454603857|FG001|Blinded Treatment Period|Protocol Violation|1|||
126358019|NCT00669331|454603856|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
126358020|NCT00669331|454603857|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
126358021|NCT00669331|454603856|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
126358022|NCT00669331|454603857|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
126358023|NCT00669331|454603856|FG000|Blinded Treatment Period|Death|0|||
126358024|NCT00669331|454603857|FG001|Blinded Treatment Period|Death|2|||
126358025|NCT00669331|454603856|FG000|Blinded Treatment Period|Physician Decision|3|||
126358026|NCT00669331|454603857|FG001|Blinded Treatment Period|Physician Decision|3|||
126358027|NCT00669331|454603856|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
126358028|NCT00669331|454603857|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
126250662|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
126250663|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
126250664|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
126250665|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
126250666|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
126250667|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
126250668|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
126250669|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
126250670|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
126250671|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
126250672|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
126028740|NCT02783300|453402812|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126028741|NCT02783300|453402786|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028742|NCT02783300|453402787|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028743|NCT02783300|453402788|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028744|NCT02783300|453402789|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028745|NCT02783300|453402790|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126250673|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
126250674|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
126358029|NCT03794544|454603858|FG000|Overall Study|Withdrawal by Subject|1|||
126358030|NCT03794544|454603859|FG001|Overall Study|Withdrawal by Subject|1|||
126358031|NCT03794544|454603860|FG002|Overall Study|Withdrawal by Subject|0|||
126358032|NCT03794544|454603861|FG003|Overall Study|Withdrawal by Subject|0|||
126358033|NCT03794544|454603858|FG000|Overall Study|Death|0|||
126358034|NCT03794544|454603859|FG001|Overall Study|Death|0|||
126358035|NCT03794544|454603860|FG002|Overall Study|Death|0|||
126358036|NCT03794544|454603861|FG003|Overall Study|Death|1|||
126358037|NCT03794544|454603858|FG000|Overall Study|Lost to Follow-up|0|||
126358038|NCT03794544|454603859|FG001|Overall Study|Lost to Follow-up|1|||
126358039|NCT03794544|454603860|FG002|Overall Study|Lost to Follow-up|1|||
126358040|NCT03794544|454603861|FG003|Overall Study|Lost to Follow-up|0|||
126358041|NCT03794544|454603858|FG000|Overall Study|Other|0|||
126358042|NCT03794544|454603859|FG001|Overall Study|Other|1|||
126358043|NCT03794544|454603860|FG002|Overall Study|Other|0|||
126358044|NCT03794544|454603861|FG003|Overall Study|Other|0|||
126358045|NCT00120250|454603865|FG000|Overall Study|Lost to Follow-up|1|||
126358046|NCT00120250|454603866|FG001|Overall Study|Lost to Follow-up|1|||
126358047|NCT00120250|454603865|FG000|Overall Study|Protocol Violation|0|||
126358048|NCT00120250|454603866|FG001|Overall Study|Protocol Violation|1|||
126358049|NCT00710554|454603873|FG000|Overall Study|Adverse Event|24|||
126358050|NCT00710554|454603874|FG001|Overall Study|Adverse Event|7|||
126358051|NCT00710554|454603873|FG000|Overall Study|Withdrawal by Subject|7|||
126358052|NCT00710554|454603874|FG001|Overall Study|Withdrawal by Subject|3|||
126358053|NCT00710554|454603873|FG000|Overall Study|Lost to Follow-up|7|||
126358054|NCT00710554|454603874|FG001|Overall Study|Lost to Follow-up|1|||
126358055|NCT00710554|454603873|FG000|Overall Study|Lack of Efficacy|11|||
126358056|NCT00710554|454603874|FG001|Overall Study|Lack of Efficacy|12|||
126358057|NCT00710554|454603873|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
126358058|NCT00710554|454603874|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
126358059|NCT01433978|454603875|FG000|Core Study|Adverse Event, Non-Fatal|0|||
126358060|NCT01433978|454603876|FG001|Core Study|Adverse Event, Non-Fatal|1|||
126358061|NCT01433978|454603877|FG002|Core Study|Adverse Event, Non-Fatal|0|||
126358062|NCT01433978|454603875|FG000|Core Study|Lack of Efficacy|5|||
126358063|NCT01433978|454603876|FG001|Core Study|Lack of Efficacy|1|||
126358064|NCT01433978|454603877|FG002|Core Study|Lack of Efficacy|0|||
126358065|NCT01433978|454603875|FG000|Core Study|Study Terminated by Sponsor|6|||
126358066|NCT01433978|454603876|FG001|Core Study|Study Terminated by Sponsor|9|||
126358067|NCT01433978|454603877|FG002|Core Study|Study Terminated by Sponsor|0|||
126358068|NCT01433978|454603875|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
126358069|NCT01433978|454603876|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
126358070|NCT01433978|454603877|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
126358071|NCT01433978|454603875|FG000|Extension Phase|Lack of Efficacy|0|||
126358072|NCT01433978|454603876|FG001|Extension Phase|Lack of Efficacy|0|||
126358073|NCT01433978|454603877|FG002|Extension Phase|Lack of Efficacy|1|||
126358074|NCT01433978|454603875|FG000|Extension Phase|Study Terminated by Sponsor|0|||
126358075|NCT01433978|454603876|FG001|Extension Phase|Study Terminated by Sponsor|0|||
126358076|NCT01433978|454603877|FG002|Extension Phase|Study Terminated by Sponsor|4|||
126358077|NCT00378560|454603878|FG000|Overall Study|Adverse Event|1|||
126358078|NCT00378560|454603879|FG001|Overall Study|Adverse Event|0|||
126358079|NCT00378560|454603878|FG000|Overall Study|Lost to Follow-up|24|||
126358080|NCT00378560|454603879|FG001|Overall Study|Lost to Follow-up|29|||
126358081|NCT00378560|454603878|FG000|Overall Study|Protocol Violation|2|||
126358082|NCT00378560|454603879|FG001|Overall Study|Protocol Violation|0|||
126358083|NCT00378560|454603878|FG000|Overall Study|Withdrawal by Subject|17|||
126250675|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
126250676|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
126250677|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
126250678|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
126250679|NCT00521586|454208910|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
126250680|NCT00521586|454208911|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
126250681|NCT00521586|454208910|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
126250682|NCT00521586|454208911|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
126250683|NCT00521586|454208910|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
126250684|NCT00521586|454208911|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
126250685|NCT02034513|454208914|FG000|Overall Study|Adverse Event|11|||
126250686|NCT02034513|454208915|FG001|Overall Study|Adverse Event|10|||
126250687|NCT02034513|454208914|FG000|Overall Study|Lack of Efficacy|0|||
126250688|NCT02034513|454208915|FG001|Overall Study|Lack of Efficacy|1|||
126250689|NCT02034513|454208914|FG000|Overall Study|Lost to Follow-up|6|||
126250690|NCT02034513|454208915|FG001|Overall Study|Lost to Follow-up|7|||
126250691|NCT02034513|454208914|FG000|Overall Study|Pregnancy|0|||
126250692|NCT02034513|454208915|FG001|Overall Study|Pregnancy|3|||
126250693|NCT02034513|454208914|FG000|Overall Study|Protocol Violation|7|||
126250694|NCT02034513|454208915|FG001|Overall Study|Protocol Violation|10|||
126250695|NCT02034513|454208914|FG000|Overall Study|Withdrawal by Subject|25|||
126250696|NCT02034513|454208915|FG001|Overall Study|Withdrawal by Subject|25|||
126250697|NCT02034513|454208914|FG000|Overall Study|Unclassified|0|||
126250698|NCT02034513|454208915|FG001|Overall Study|Unclassified|1|||
126250699|NCT01243151|454208916|FG000|Overall Study|Adverse Event|0|||
126250700|NCT01243151|454208917|FG001|Overall Study|Adverse Event|1|||
126250701|NCT01243151|454208918|FG002|Overall Study|Adverse Event|0|||
126250702|NCT01243151|454208919|FG003|Overall Study|Adverse Event|0|||
126250703|NCT01243151|454208920|FG004|Overall Study|Adverse Event|0|||
126250704|NCT01243151|454208916|FG000|Overall Study|Protocol Violation|0|||
126250705|NCT01243151|454208917|FG001|Overall Study|Protocol Violation|0|||
126250706|NCT01243151|454208918|FG002|Overall Study|Protocol Violation|1|||
126250707|NCT01243151|454208919|FG003|Overall Study|Protocol Violation|0|||
126250708|NCT01243151|454208920|FG004|Overall Study|Protocol Violation|0|||
126250709|NCT01243151|454208916|FG000|Overall Study|Other|0|||
126250710|NCT01243151|454208917|FG001|Overall Study|Other|0|||
126250711|NCT01243151|454208918|FG002|Overall Study|Other|0|||
126250712|NCT01243151|454208919|FG003|Overall Study|Other|1|||
126250713|NCT01243151|454208920|FG004|Overall Study|Other|0|||
126250714|NCT01243151|454208916|FG000|Overall Study|Randomized but not treated|0|||
126250715|NCT01243151|454208917|FG001|Overall Study|Randomized but not treated|0|||
126250716|NCT01243151|454208918|FG002|Overall Study|Randomized but not treated|0|||
126250717|NCT01243151|454208919|FG003|Overall Study|Randomized but not treated|1|||
126250718|NCT01243151|454208920|FG004|Overall Study|Randomized but not treated|0|||
126250719|NCT03119662|454208921|FG000|Overall Study|Withdrawal by Subject|0|||
126250720|NCT03119662|454208922|FG001|Overall Study|Withdrawal by Subject|1|||
126250721|NCT02308241|454208926|FG000|Overall Study|Withdrawal by Subject|3|||
126250722|NCT04661202|454208928|FG000|Overall Study|Withdrawal by Subject|1|||
126250723|NCT04661202|454208929|FG001|Overall Study|Withdrawal by Subject|1|||
126250724|NCT04661202|454208928|FG000|Overall Study|Lack of Efficacy|2|||
126250725|NCT04661202|454208929|FG001|Overall Study|Lack of Efficacy|0|||
126250726|NCT04158687|454208930|FG000|Overall Study|Adverse Event|2|||
126250727|NCT04158687|454208931|FG001|Overall Study|Adverse Event|3|||
126250728|NCT04158687|454208932|FG002|Overall Study|Adverse Event|0|||
126250729|NCT04158687|454208933|FG003|Overall Study|Adverse Event|3|||
126250730|NCT04158687|454208930|FG000|Overall Study|Lost to Follow-up|5|||
126250731|NCT04158687|454208931|FG001|Overall Study|Lost to Follow-up|12|||
126250732|NCT04158687|454208932|FG002|Overall Study|Lost to Follow-up|4|||
126250733|NCT04158687|454208933|FG003|Overall Study|Lost to Follow-up|5|||
126250734|NCT04158687|454208930|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
126250735|NCT04158687|454208931|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
126250736|NCT04158687|454208932|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
126250737|NCT04158687|454208933|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
126250738|NCT04158687|454208930|FG000|Overall Study|Non-Compliance with Study Medication|2|||
126250739|NCT04158687|454208931|FG001|Overall Study|Non-Compliance with Study Medication|2|||
126250740|NCT04158687|454208932|FG002|Overall Study|Non-Compliance with Study Medication|3|||
126250741|NCT04158687|454208933|FG003|Overall Study|Non-Compliance with Study Medication|0|||
126250742|NCT04158687|454208930|FG000|Overall Study|Investigator Decision|0|||
126250743|NCT04158687|454208931|FG001|Overall Study|Investigator Decision|0|||
126250744|NCT04158687|454208932|FG002|Overall Study|Investigator Decision|2|||
126250745|NCT04158687|454208933|FG003|Overall Study|Investigator Decision|0|||
126250746|NCT04158687|454208930|FG000|Overall Study|Protocol Violation|0|||
126250747|NCT04158687|454208931|FG001|Overall Study|Protocol Violation|2|||
126250748|NCT04158687|454208932|FG002|Overall Study|Protocol Violation|1|||
126250749|NCT04158687|454208933|FG003|Overall Study|Protocol Violation|0|||
126250750|NCT04158687|454208930|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
126250751|NCT04158687|454208931|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
126250752|NCT04158687|454208932|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
126250753|NCT04158687|454208933|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
126250754|NCT04158687|454208930|FG000|Overall Study|Reason not Specified|3|||
126250755|NCT04158687|454208931|FG001|Overall Study|Reason not Specified|2|||
126250756|NCT04158687|454208932|FG002|Overall Study|Reason not Specified|4|||
126250757|NCT04158687|454208933|FG003|Overall Study|Reason not Specified|4|||
126250758|NCT04102345|454208936|FG000|Overall Study|Withdrawal by Subject|1|||
126250759|NCT04102345|454208937|FG001|Overall Study|Withdrawal by Subject|0|||
126250760|NCT01853176|454208938|FG000|Overall Study|Study terminated|4|||
126250761|NCT01853176|454208939|FG001|Overall Study|Study terminated|0|||
126250762|NCT00198133|454208940|FG000|Overall Study|Disease progression|2|||
126250763|NCT00198133|454208941|FG001|Overall Study|Disease progression|5|||
126250764|NCT00198133|454208940|FG000|Overall Study|Adverse Event|1|||
126250765|NCT00198133|454208941|FG001|Overall Study|Adverse Event|3|||
126250766|NCT00198133|454208940|FG000|Overall Study|Withdrawal by Subject|1|||
126250767|NCT00198133|454208941|FG001|Overall Study|Withdrawal by Subject|0|||
126250768|NCT00198133|454208940|FG000|Overall Study|Physician Decision|1|||
126250769|NCT00198133|454208941|FG001|Overall Study|Physician Decision|0|||
126250770|NCT00835666|454208947|FG000|Washout|Protocol Violation|1|||
126250771|NCT00835666|454208948|FG001|Washout|Protocol Violation|0|||
126250772|NCT00835666|454208947|FG000|Washout|Withdrawal by Subject|1|||
126250773|NCT00835666|454208948|FG001|Washout|Withdrawal by Subject|0|||
126250774|NCT03599362|454208949|FG000|Overall Study|Screen Failure|3|||
126250775|NCT03707587|454208950|FG000|Overall Study|Death|0|||
126250776|NCT03707587|454208951|FG001|Overall Study|Death|1|||
126028746|NCT02783300|453402791|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126250777|NCT01537887|454208952|FG000|Period 1|Physician Decision|0|||
126250778|NCT01537887|454208953|FG001|Period 1|Physician Decision|0|||
126250779|NCT01537887|454208954|FG002|Period 1|Physician Decision|0|||
126250780|NCT01537887|454208955|FG003|Period 1|Physician Decision|0|||
126250781|NCT01537887|454208956|FG004|Period 1|Physician Decision|1|||
126250782|NCT01537887|454208957|FG005|Period 1|Physician Decision|1|||
126250783|NCT01537887|454208952|FG000|Period 1|Did not receive treatment|0|||
126250784|NCT01537887|454208953|FG001|Period 1|Did not receive treatment|0|||
126250785|NCT01537887|454208954|FG002|Period 1|Did not receive treatment|1|||
126250786|NCT01537887|454208955|FG003|Period 1|Did not receive treatment|0|||
126250787|NCT01537887|454208956|FG004|Period 1|Did not receive treatment|0|||
126250788|NCT01537887|454208957|FG005|Period 1|Did not receive treatment|0|||
126250789|NCT01537887|454208952|FG000|Period 2|Withdrawal by Subject|0|||
126250790|NCT01537887|454208953|FG001|Period 2|Withdrawal by Subject|1|||
126250791|NCT01537887|454208954|FG002|Period 2|Withdrawal by Subject|0|||
126250792|NCT01537887|454208955|FG003|Period 2|Withdrawal by Subject|0|||
126250793|NCT01537887|454208956|FG004|Period 2|Withdrawal by Subject|0|||
126250794|NCT01537887|454208957|FG005|Period 2|Withdrawal by Subject|0|||
126250795|NCT01537887|454208952|FG000|Period 3|Adverse Event|0|||
126250796|NCT01537887|454208953|FG001|Period 3|Adverse Event|0|||
126250797|NCT01537887|454208954|FG002|Period 3|Adverse Event|1|||
126250798|NCT01537887|454208955|FG003|Period 3|Adverse Event|0|||
126250799|NCT01537887|454208956|FG004|Period 3|Adverse Event|0|||
126250800|NCT01537887|454208957|FG005|Period 3|Adverse Event|0|||
126250801|NCT01537887|454208952|FG000|Period 3|Withdrawal by Subject|0|||
126250802|NCT01537887|454208953|FG001|Period 3|Withdrawal by Subject|1|||
126250803|NCT01537887|454208954|FG002|Period 3|Withdrawal by Subject|0|||
126250804|NCT01537887|454208955|FG003|Period 3|Withdrawal by Subject|0|||
126250805|NCT01537887|454208956|FG004|Period 3|Withdrawal by Subject|0|||
126250806|NCT01537887|454208957|FG005|Period 3|Withdrawal by Subject|0|||
126250807|NCT01370083|454208959|FG000|Overall Study|Lost to Follow-up|2|||
126250808|NCT01370083|454208960|FG001|Overall Study|Lost to Follow-up|0|||
126250809|NCT01370083|454208959|FG000|Overall Study|Adverse Event|0|||
126250810|NCT01370083|454208960|FG001|Overall Study|Adverse Event|1|||
126250811|NCT01634139|454208961|FG000|Overall Study|Non compliant with protocol|1|||
126250812|NCT01634139|454208962|FG001|Overall Study|Non compliant with protocol|0|||
126250813|NCT01634139|454208963|FG002|Overall Study|Non compliant with protocol|0|||
126250814|NCT01634139|454208961|FG000|Overall Study|Consent withdrawn not due to AE|4|||
126250815|NCT01634139|454208962|FG001|Overall Study|Consent withdrawn not due to AE|3|||
126250816|NCT01634139|454208963|FG002|Overall Study|Consent withdrawn not due to AE|2|||
126250817|NCT01634139|454208961|FG000|Overall Study|Other|4|||
126250818|NCT01634139|454208962|FG001|Overall Study|Other|0|||
126250819|NCT01634139|454208963|FG002|Overall Study|Other|3|||
126250820|NCT01634139|454208961|FG000|Overall Study|Lost to Follow-up|0|||
126250821|NCT01634139|454208962|FG001|Overall Study|Lost to Follow-up|2|||
126250822|NCT01634139|454208963|FG002|Overall Study|Lost to Follow-up|0|||
126250823|NCT01634139|454208961|FG000|Overall Study|Not treated|1|||
126250824|NCT01634139|454208962|FG001|Overall Study|Not treated|1|||
126250825|NCT01634139|454208963|FG002|Overall Study|Not treated|0|||
126250826|NCT00425308|454208971|FG000|Overall Study|Adverse Event|2|||
126250827|NCT00425308|454208972|FG001|Overall Study|Adverse Event|1|||
126250828|NCT00425308|454208971|FG000|Overall Study|Withdrawal by Subject|1|||
126250829|NCT00425308|454208972|FG001|Overall Study|Withdrawal by Subject|0|||
126250830|NCT00425308|454208971|FG000|Overall Study|Death|1|||
126250831|NCT00425308|454208972|FG001|Overall Study|Death|0|||
126250832|NCT01266902|454208973|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
126250833|NCT01266902|454208974|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
126250834|NCT01266902|454208975|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
126250835|NCT01266902|454208973|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
126250836|NCT01266902|454208974|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
126250837|NCT01266902|454208975|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
126250838|NCT01266902|454208973|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
126250839|NCT01266902|454208974|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
126250840|NCT01266902|454208975|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
126250841|NCT01266902|454208973|FG000|Period 1 (Main Study)|Adverse Event|3|||
126250842|NCT01266902|454208974|FG001|Period 1 (Main Study)|Adverse Event|11|||
126250843|NCT01266902|454208975|FG002|Period 1 (Main Study)|Adverse Event|0|||
126250844|NCT01266902|454208973|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
126250845|NCT01266902|454208974|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
126250846|NCT01266902|454208975|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
126250847|NCT01266902|454208973|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
126250848|NCT01266902|454208974|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
126250849|NCT01266902|454208975|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
126250850|NCT01266902|454208973|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
126250851|NCT01266902|454208974|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
126250852|NCT01266902|454208975|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
126250853|NCT01266902|454208973|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
126250854|NCT01266902|454208974|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
126250855|NCT01266902|454208975|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
126250856|NCT01266902|454208973|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
126250857|NCT01266902|454208974|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
126250858|NCT01266902|454208975|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
126028747|NCT02783300|453402792|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028748|NCT02783300|453402793|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028749|NCT02783300|453402794|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028750|NCT02783300|453402795|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028751|NCT02783300|453402796|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028752|NCT02783300|453402797|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028753|NCT02783300|453402798|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028754|NCT02783300|453402799|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
126028755|NCT02783300|453402800|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126028756|NCT02783300|453402801|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126028757|NCT02783300|453402802|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126028758|NCT02783300|453402803|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
126028759|NCT02783300|453402804|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126028760|NCT02783300|453402805|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
126028761|NCT02783300|453402806|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
126028762|NCT02783300|453402807|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
126028763|NCT02783300|453402808|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
126028764|NCT02783300|453402809|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
126028765|NCT02783300|453402810|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126028766|NCT02783300|453402811|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
126028767|NCT02783300|453402812|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126028768|NCT02783300|453402786|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028769|NCT02783300|453402787|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028770|NCT02783300|453402788|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028771|NCT02783300|453402789|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028772|NCT02783300|453402790|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028773|NCT02783300|453402791|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028774|NCT02783300|453402792|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028775|NCT02783300|453402793|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028776|NCT02783300|453402794|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028777|NCT02783300|453402795|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028778|NCT02783300|453402796|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028779|NCT02783300|453402797|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028780|NCT02783300|453402798|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028781|NCT02783300|453402799|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028782|NCT02783300|453402800|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028783|NCT02783300|453402801|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028784|NCT02783300|453402802|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028785|NCT02783300|453402803|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028786|NCT02783300|453402804|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028787|NCT02783300|453402805|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028788|NCT02783300|453402806|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028789|NCT02783300|453402807|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028790|NCT02783300|453402808|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028791|NCT02783300|453402809|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028792|NCT02783300|453402810|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028793|NCT02783300|453402811|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126028794|NCT02783300|453402812|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
126028795|NCT02783300|453402786|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028796|NCT02783300|453402787|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028797|NCT02783300|453402788|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028798|NCT02783300|453402789|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028799|NCT02783300|453402790|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028800|NCT02783300|453402791|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028801|NCT02783300|453402792|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028802|NCT02783300|453402793|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028803|NCT02783300|453402794|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028804|NCT02783300|453402795|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028805|NCT02783300|453402796|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028806|NCT02783300|453402797|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028807|NCT02783300|453402798|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028808|NCT02783300|453402799|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028809|NCT02783300|453402800|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028810|NCT02783300|453402801|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028811|NCT02783300|453402802|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028812|NCT02783300|453402803|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028813|NCT02783300|453402804|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028814|NCT02783300|453402805|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028815|NCT02783300|453402806|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028816|NCT02783300|453402807|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028817|NCT02783300|453402808|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028818|NCT02783300|453402809|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028819|NCT02783300|453402810|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028820|NCT02783300|453402811|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
126028821|NCT02783300|453402812|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
126028822|NCT03535272|453402813|FG000|Overall Study|Lost to Follow-up|71|||
126028823|NCT03535272|453402814|FG001|Overall Study|Lost to Follow-up|73|||
126028824|NCT03892616|453402817|FG000|Washout Period 2|Met discontinuation criterion|0|||
126028825|NCT03892616|453402818|FG001|Washout Period 2|Met discontinuation criterion|0|||
126028826|NCT03892616|453402819|FG002|Washout Period 2|Met discontinuation criterion|0|||
126028827|NCT03892616|453402820|FG003|Washout Period 2|Met discontinuation criterion|0|||
126028828|NCT03892616|453402821|FG004|Washout Period 2|Met discontinuation criterion|0|||
126028829|NCT03892616|453402822|FG005|Washout Period 2|Met discontinuation criterion|0|||
126028830|NCT03892616|453402823|FG006|Washout Period 2|Met discontinuation criterion|0|||
126028831|NCT03892616|453402824|FG007|Washout Period 2|Met discontinuation criterion|0|||
126028832|NCT03892616|453402825|FG008|Washout Period 2|Met discontinuation criterion|1|||
126028833|NCT03892616|453402826|FG009|Washout Period 2|Met discontinuation criterion|0|||
126095215|NCT02663518|453643011|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095216|NCT02663518|453643012|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095217|NCT02663518|453643013|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095218|NCT02663518|453643014|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095219|NCT02663518|453643015|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126250859|NCT01266902|454208973|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
126250860|NCT01266902|454208974|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
126250861|NCT01266902|454208975|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
126250862|NCT04442503|454208976|FG000|Overall Study|Adverse Event|1|||
126250863|NCT04442503|454208977|FG001|Overall Study|Adverse Event|1|||
126250864|NCT04442503|454208976|FG000|Overall Study|Lost to Follow-up|8|||
126250865|NCT04442503|454208977|FG001|Overall Study|Lost to Follow-up|6|||
126250866|NCT04442503|454208976|FG000|Overall Study|Physician Decision|0|||
126250867|NCT04442503|454208977|FG001|Overall Study|Physician Decision|2|||
126250868|NCT04442503|454208976|FG000|Overall Study|Withdrawal by Subject|3|||
126250869|NCT04442503|454208977|FG001|Overall Study|Withdrawal by Subject|4|||
126250870|NCT04442503|454208976|FG000|Overall Study|Reason not Specified|0|||
126250871|NCT04442503|454208977|FG001|Overall Study|Reason not Specified|1|||
126250872|NCT04442503|454208976|FG000|Overall Study|Randomized but not Treated|3|||
126250873|NCT04442503|454208977|FG001|Overall Study|Randomized but not Treated|1|||
126250874|NCT00387153|454208978|FG000|Overall Study|Adverse Event|1|||
126250875|NCT00387153|454208978|FG000|Overall Study|Disease Progression|3|||
126250876|NCT00387153|454208978|FG000|Overall Study|Lack of Response|4|||
126250877|NCT02933060|454208979|FG000|Overall Study|Withdrawal by Subject|0|||
126250878|NCT02933060|454208980|FG001|Overall Study|Withdrawal by Subject|1|||
126250879|NCT01945580|454208981|FG000|Overall Study|Withdrawal by Subject|13|||
126250880|NCT01945580|454208982|FG001|Overall Study|Withdrawal by Subject|35|||
126250881|NCT01945580|454208981|FG000|Overall Study|Physician Decision|3|||
126250882|NCT01945580|454208982|FG001|Overall Study|Physician Decision|2|||
126250883|NCT01945580|454208981|FG000|Overall Study|Lost to Follow-up|26|||
126250884|NCT01945580|454208982|FG001|Overall Study|Lost to Follow-up|39|||
126250885|NCT01945580|454208981|FG000|Overall Study|Death|7|||
126250886|NCT01945580|454208982|FG001|Overall Study|Death|2|||
126028834|NCT03892616|453402827|FG010|Washout Period 2|Met discontinuation criterion|0|||
126028835|NCT03892616|453402828|FG011|Washout Period 2|Met discontinuation criterion|0|||
126095220|NCT02663518|453643016|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095221|NCT02663518|453643017|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
126095222|NCT02663518|453643018|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095223|NCT02663518|453643019|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126250887|NCT01945580|454208981|FG000|Overall Study|Patient moved out of state|0|||
126028836|NCT00378105|453402829|FG000|Overall Study|Adverse Event|3|||
126028837|NCT00378105|453402830|FG001|Overall Study|Adverse Event|1|||
126028838|NCT00378105|453402829|FG000|Overall Study|Withdrawal by Subject|3|||
126028839|NCT00378105|453402830|FG001|Overall Study|Withdrawal by Subject|3|||
126250888|NCT01945580|454208982|FG001|Overall Study|Patient moved out of state|1|||
126250889|NCT01945580|454208981|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
126250890|NCT01945580|454208982|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
126250891|NCT01945580|454208981|FG000|Overall Study|Family illness - unable to return|0|||
126250892|NCT01945580|454208982|FG001|Overall Study|Family illness - unable to return|1|||
126250893|NCT01945580|454208981|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
126250894|NCT01945580|454208982|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
126250895|NCT01945580|454208981|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
126250896|NCT01945580|454208982|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
126250897|NCT01945580|454208981|FG000|Overall Study|Noncompliance with 36 month visit|1|||
126250898|NCT01945580|454208982|FG001|Overall Study|Noncompliance with 36 month visit|0|||
126250899|NCT01945580|454208981|FG000|Overall Study|The patient moved.|1|||
126250900|NCT01945580|454208982|FG001|Overall Study|The patient moved.|0|||
126250901|NCT01945580|454208981|FG000|Overall Study|No data available|0|||
126250902|NCT01945580|454208982|FG001|Overall Study|No data available|2|||
126250903|NCT05034874|454208985|FG000|Overall Study|Withdrawal by Subject|6|||
126250904|NCT05034874|454208986|FG001|Overall Study|Withdrawal by Subject|6|||
126250905|NCT05034874|454208985|FG000|Overall Study|Lost to Follow-up|18|||
126250906|NCT05034874|454208986|FG001|Overall Study|Lost to Follow-up|8|||
126250907|NCT05034874|454208985|FG000|Overall Study|Physician Decision|0|||
126250908|NCT05034874|454208986|FG001|Overall Study|Physician Decision|1|||
126250909|NCT05034874|454208985|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
126250910|NCT05034874|454208986|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
126250911|NCT00989950|454208987|FG000|Randomized Phase|Protocol Violation|1|||
126250912|NCT00989950|454208988|FG001|Randomized Phase|Protocol Violation|0|||
126250913|NCT00989950|454208989|FG002|Randomized Phase|Protocol Violation|0|||
126250914|NCT00989950|454208990|FG003|Randomized Phase|Protocol Violation|0|||
126250915|NCT00989950|454208987|FG000|Randomized Phase|Adverse Event|0|||
126250916|NCT00989950|454208988|FG001|Randomized Phase|Adverse Event|1|||
126028840|NCT00378105|453402829|FG000|Overall Study|Death|1|||
126028841|NCT00378105|453402830|FG001|Overall Study|Death|0|||
126028842|NCT00378105|453402829|FG000|Overall Study|Going to transplant|7|||
126028843|NCT00378105|453402830|FG001|Overall Study|Going to transplant|8|||
126028844|NCT00378105|453402829|FG000|Overall Study|Progressive disease|3|||
126250917|NCT00989950|454208989|FG002|Randomized Phase|Adverse Event|0|||
126250918|NCT00989950|454208990|FG003|Randomized Phase|Adverse Event|0|||
126250919|NCT00101439|454208991|FG000|Period 2|Withdrawal by Subject|0|||
126250920|NCT00101439|454208992|FG001|Period 2|Withdrawal by Subject|2|||
126250921|NCT01867658|454208994|FG000|Overall Study|Withdrawal by Subject|6|||
126250922|NCT01867658|454208994|FG000|Overall Study|Death|2|||
126250923|NCT01867658|454208994|FG000|Overall Study|Subject could not be contacted|1|||
126250924|NCT00840658|454208995|FG000|Overall Study|Death|2|||
126250925|NCT00840658|454208996|FG001|Overall Study|Death|2|||
126250926|NCT00840658|454208997|FG002|Overall Study|Death|3|||
126250927|NCT00840658|454208998|FG003|Overall Study|Death|3|||
126250928|NCT00840658|454208995|FG000|Overall Study|Lost to Follow-up|3|||
126250929|NCT00840658|454208996|FG001|Overall Study|Lost to Follow-up|1|||
126250930|NCT00840658|454208997|FG002|Overall Study|Lost to Follow-up|2|||
126250931|NCT00840658|454208998|FG003|Overall Study|Lost to Follow-up|1|||
126250932|NCT00474058|454208999|FG000|Overall Study|Adverse Event|11|||
126250933|NCT00474058|454209000|FG001|Overall Study|Adverse Event|6|||
126250934|NCT00474058|454208999|FG000|Overall Study|Lack of Efficacy|0|||
126250935|NCT00474058|454209000|FG001|Overall Study|Lack of Efficacy|4|||
126250936|NCT00474058|454208999|FG000|Overall Study|Withdrawal by Subject|11|||
126250937|NCT00474058|454209000|FG001|Overall Study|Withdrawal by Subject|7|||
126250938|NCT00474058|454208999|FG000|Overall Study|Other|2|||
126250939|NCT00474058|454209000|FG001|Overall Study|Other|0|||
126250940|NCT03101358|454209001|FG000|Overall Study|Non-compliance with study schedule|1|||
126250941|NCT03101358|454209002|FG001|Overall Study|Non-compliance with study schedule|0|||
126250942|NCT03101358|454209003|FG002|Overall Study|Non-compliance with study schedule|0|||
126250943|NCT03101358|454209004|FG003|Overall Study|Non-compliance with study schedule|1|||
126250944|NCT03101358|454209001|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
126250945|NCT03101358|454209002|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
126250946|NCT03101358|454209003|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
126250947|NCT03101358|454209004|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
126250948|NCT03101358|454209001|FG000|Overall Study|Physician Decision|1|||
126250949|NCT03101358|454209002|FG001|Overall Study|Physician Decision|0|||
126250950|NCT03101358|454209003|FG002|Overall Study|Physician Decision|0|||
126250951|NCT03101358|454209004|FG003|Overall Study|Physician Decision|3|||
126250952|NCT03101358|454209001|FG000|Overall Study|Adverse Event|0|||
126250953|NCT03101358|454209002|FG001|Overall Study|Adverse Event|0|||
126250954|NCT03101358|454209003|FG002|Overall Study|Adverse Event|1|||
126250955|NCT03101358|454209004|FG003|Overall Study|Adverse Event|0|||
126250956|NCT03101358|454209001|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
126250957|NCT03101358|454209002|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
126250958|NCT03101358|454209003|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
126250959|NCT03101358|454209004|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
126250960|NCT03101358|454209001|FG000|Overall Study|Lost to Follow-up|1|||
126250961|NCT03101358|454209002|FG001|Overall Study|Lost to Follow-up|0|||
126250962|NCT03101358|454209003|FG002|Overall Study|Lost to Follow-up|0|||
126250963|NCT03101358|454209004|FG003|Overall Study|Lost to Follow-up|1|||
126250964|NCT05616728|454209005|FG000|Overall Study|Lost to Follow-up|0|||
126250965|NCT05616728|454209006|FG001|Overall Study|Lost to Follow-up|0|||
126250966|NCT05616728|454209007|FG002|Overall Study|Lost to Follow-up|1|||
126250967|NCT05616728|454209005|FG000|Overall Study|Withdrawal by Subject|1|||
126250968|NCT05616728|454209006|FG001|Overall Study|Withdrawal by Subject|1|||
126250969|NCT05616728|454209007|FG002|Overall Study|Withdrawal by Subject|0|||
126250970|NCT05616728|454209005|FG000|Overall Study|Physician Decision|1|||
126250971|NCT05616728|454209006|FG001|Overall Study|Physician Decision|1|||
126250972|NCT05616728|454209007|FG002|Overall Study|Physician Decision|1|||
126250973|NCT05616728|454209005|FG000|Overall Study|Other|0|||
126250974|NCT05616728|454209006|FG001|Overall Study|Other|2|||
126250975|NCT05616728|454209007|FG002|Overall Study|Other|0|||
126250976|NCT01024855|454209010|FG000|Overall Study|Inclusion/exclusion criteria|1|||
126250977|NCT03306277|454209015|FG000|Overall Study|Death|1|||
126250978|NCT03306277|454209015|FG000|Overall Study|Adverse Event|1|||
126250979|NCT03306277|454209015|FG000|Overall Study|Withdrawal by Subject|1|||
126095224|NCT02663518|453643020|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126250980|NCT00881751|454209024|FG000|Overall Study|Physician Decision|0|||
126250981|NCT00881751|454209025|FG001|Overall Study|Physician Decision|1|||
126250982|NCT00881751|454209024|FG000|Overall Study|Adverse Event|0|||
126250983|NCT00881751|454209025|FG001|Overall Study|Adverse Event|2|||
126250984|NCT00881751|454209024|FG000|Overall Study|Withdrawal by Subject|0|||
126250985|NCT00881751|454209025|FG001|Overall Study|Withdrawal by Subject|2|||
126250986|NCT02385708|454209026|FG000|Overall Study|Withdrawal by Subject|0|||
126250987|NCT02385708|454209027|FG001|Overall Study|Withdrawal by Subject|2|||
126250988|NCT02385708|454209026|FG000|Overall Study|Withdrawn - surgery canceled|2|||
126250989|NCT02385708|454209027|FG001|Overall Study|Withdrawn - surgery canceled|5|||
126250990|NCT02385708|454209026|FG000|Overall Study|Investigator decision|5|||
126250991|NCT02385708|454209027|FG001|Overall Study|Investigator decision|7|||
126250992|NCT02385708|454209026|FG000|Overall Study|Protocol Violation|1|||
126250993|NCT02385708|454209027|FG001|Overall Study|Protocol Violation|1|||
126028845|NCT00378105|453402830|FG001|Overall Study|Progressive disease|3|||
126028846|NCT00378105|453402829|FG000|Overall Study|remain on study|3|||
126028847|NCT00378105|453402830|FG001|Overall Study|remain on study|11|||
126028848|NCT00378105|453402829|FG000|Overall Study|Physician Decision|0|||
126028849|NCT00378105|453402830|FG001|Overall Study|Physician Decision|2|||
126028850|NCT00378105|453402829|FG000|Overall Study|Going non-protocol therapy|0|||
126028851|NCT00378105|453402830|FG001|Overall Study|Going non-protocol therapy|1|||
126028852|NCT00378105|453402829|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
126028853|NCT00378105|453402830|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
126028854|NCT05192200|453402831|FG000|Treatment Period|Other|1|||
126028855|NCT05192200|453402831|FG000|Treatment Period|Lack of Efficacy|1|||
126028856|NCT05192200|453402831|FG000|Treatment Period|Withdrawal by Subject|1|||
126028857|NCT05192200|453402831|FG000|Follow-up|Withdrawal by Subject|1|||
126028858|NCT04533347|453402835|FG000|Overall Study|Adverse Event|1|||
126028859|NCT04533347|453402836|FG001|Overall Study|Adverse Event|2|||
126028860|NCT04533347|453402835|FG000|Overall Study|Lost to Follow-up|2|||
126028861|NCT04533347|453402836|FG001|Overall Study|Lost to Follow-up|0|||
126028862|NCT04533347|453402835|FG000|Overall Study|Withdrawal by Subject|1|||
126028863|NCT04533347|453402836|FG001|Overall Study|Withdrawal by Subject|0|||
126028864|NCT03907397|453402837|FG000|Overall Study|Lost to Follow-up|0|||
126028865|NCT03907397|453402838|FG001|Overall Study|Lost to Follow-up|1|||
126028866|NCT03907397|453402837|FG000|Overall Study|Physician Decision|2|||
126028867|NCT03907397|453402838|FG001|Overall Study|Physician Decision|1|||
126028868|NCT03907397|453402837|FG000|Overall Study|Withdrawal by Subject|5|||
126250994|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
126250995|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
126250996|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
126250997|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
126250998|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
126250999|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
126251000|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
126251001|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251002|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251003|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251004|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251005|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251006|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
126251007|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
126251008|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
126251009|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
126251010|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
126251011|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
126251012|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
126251013|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
126251014|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
126251015|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
126251016|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
126251017|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
126251018|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126251019|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
126251020|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126251021|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126028869|NCT03907397|453402838|FG001|Overall Study|Withdrawal by Subject|4|||
126028870|NCT03907397|453402837|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
126028871|NCT03907397|453402838|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
126028872|NCT04831216|453402844|FG000|Overall Study|Lost to Follow-up|32|||
126028873|NCT03930342|453402849|FG000|Overall Study|Lost to Follow-up|70|||
126028874|NCT03930342|453402850|FG001|Overall Study|Lost to Follow-up|77|||
126028875|NCT05021640|453404964|FG000|Overall Study|Lost to Follow-up|0|||
126028876|NCT05021640|453404965|FG001|Overall Study|Lost to Follow-up|0|||
126028877|NCT05021640|453404966|FG002|Overall Study|Lost to Follow-up|0|||
126028878|NCT05021640|453404967|FG003|Overall Study|Lost to Follow-up|0|||
126028879|NCT05021640|453404968|FG004|Overall Study|Lost to Follow-up|1|||
126028880|NCT04737772|453404969|FG000|Phase 2 Study|Lost to Follow-up|15|||
126028881|NCT04737772|453404970|FG001|Phase 2 Study|Lost to Follow-up|15|||
126028882|NCT04737772|453404969|FG000|Phase 2 Study|Withdrawal by Subject|0|||
126251022|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126251023|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126251024|NCT01559363|454209029|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
126251025|NCT01559363|454209030|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
126251026|NCT01559363|454209031|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
126251027|NCT01559363|454209032|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
126251028|NCT01559363|454209033|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
126251029|NCT01559363|454209034|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
126251030|NCT01559363|454209029|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251031|NCT01559363|454209030|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251032|NCT01559363|454209031|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251033|NCT01559363|454209032|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
126251034|NCT01559363|454209033|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251035|NCT01559363|454209034|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251036|NCT00672984|454209035|FG000|First Intervention|Adverse Event|5|||
126251037|NCT00672984|454209036|FG001|First Intervention|Adverse Event|0|||
126251038|NCT00672984|454209037|FG002|First Intervention|Adverse Event|0|||
126251039|NCT00672984|454209035|FG000|First Intervention|Withdrawal by Subject|1|||
126251040|NCT00672984|454209036|FG001|First Intervention|Withdrawal by Subject|2|||
126251041|NCT00672984|454209037|FG002|First Intervention|Withdrawal by Subject|2|||
126251042|NCT00672984|454209035|FG000|First Intervention|Sponsor decision|3|||
126251043|NCT00672984|454209036|FG001|First Intervention|Sponsor decision|0|||
126251044|NCT00672984|454209037|FG002|First Intervention|Sponsor decision|0|||
126251045|NCT00672984|454209035|FG000|Second Intervention|Non-compliance with facility policies|0|||
126251046|NCT00672984|454209036|FG001|Second Intervention|Non-compliance with facility policies|2|||
126251047|NCT00672984|454209037|FG002|Second Intervention|Non-compliance with facility policies|0|||
126251048|NCT00672984|454209035|FG000|Second Intervention|Withdrawal by Subject|0|||
126251049|NCT00672984|454209036|FG001|Second Intervention|Withdrawal by Subject|3|||
126251050|NCT00672984|454209037|FG002|Second Intervention|Withdrawal by Subject|0|||
126251051|NCT00672984|454209035|FG000|Second Intervention|Protocol Violation|0|||
126251052|NCT00672984|454209036|FG001|Second Intervention|Protocol Violation|1|||
126251053|NCT00672984|454209037|FG002|Second Intervention|Protocol Violation|1|||
126251054|NCT00672984|454209035|FG000|Third Intervention|Adverse Event|1|||
126251055|NCT00672984|454209036|FG001|Third Intervention|Adverse Event|0|||
126251056|NCT00672984|454209037|FG002|Third Intervention|Adverse Event|1|||
126251057|NCT00645853|454209038|FG000|Overall Study|Adverse Event|18|||
126251058|NCT00645853|454209039|FG001|Overall Study|Adverse Event|7|||
126251059|NCT00645853|454209038|FG000|Overall Study|AZ study closure in Hungary|60|||
126251060|NCT00645853|454209039|FG001|Overall Study|AZ study closure in Hungary|40|||
126251061|NCT00645853|454209038|FG000|Overall Study|Withdrawal by Subject|5|||
126251062|NCT00645853|454209039|FG001|Overall Study|Withdrawal by Subject|2|||
126251063|NCT00645853|454209038|FG000|Overall Study|Protocol Violation|0|||
126251064|NCT00645853|454209039|FG001|Overall Study|Protocol Violation|2|||
126251065|NCT00645853|454209038|FG000|Overall Study|Discontinuation criteria|2|||
126251066|NCT00645853|454209039|FG001|Overall Study|Discontinuation criteria|2|||
126251067|NCT00645853|454209038|FG000|Overall Study|recall of ICF, planned operation, death|7|||
126251068|NCT00645853|454209039|FG001|Overall Study|recall of ICF, planned operation, death|4|||
126251069|NCT04060251|454209040|FG000|Overall Study|Study terminated due to low enrollment.|7|||
126251070|NCT04060251|454209041|FG001|Overall Study|Study terminated due to low enrollment.|5|||
126251071|NCT04060251|454209042|FG002|Overall Study|Study terminated due to low enrollment.|7|||
126251072|NCT04060251|454209040|FG000|Overall Study|Adverse Event|1|||
126095225|NCT02663518|453643021|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095226|NCT02663518|453643022|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095227|NCT02663518|453643023|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095228|NCT02663518|453643024|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126095229|NCT02663518|453643011|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
126095230|NCT02663518|453643012|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
126095231|NCT02663518|453643013|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
126095232|NCT02663518|453643014|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
126095233|NCT02663518|453643015|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
126095234|NCT02663518|453643016|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
126095235|NCT02663518|453643017|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
126095236|NCT02663518|453643018|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
126095237|NCT02663518|453643019|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
126251073|NCT04060251|454209041|FG001|Overall Study|Adverse Event|1|||
126251074|NCT04060251|454209042|FG002|Overall Study|Adverse Event|0|||
126251075|NCT01632306|454209043|FG000|Overall Study|Protocol Violation|1|||
126251076|NCT01632306|454209044|FG001|Overall Study|Protocol Violation|0|||
126095238|NCT02663518|453643020|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
126095239|NCT02663518|453643021|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
126095240|NCT02663518|453643022|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
126095241|NCT02663518|453643023|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
126251077|NCT01632306|454209045|FG002|Overall Study|Protocol Violation|0|||
126251078|NCT00985751|454209048|FG000|Overall Study|Adverse Event|0|||
126251079|NCT00985751|454209049|FG001|Overall Study|Adverse Event|0|||
126251080|NCT00985751|454209050|FG002|Overall Study|Adverse Event|0|||
126251081|NCT00985751|454209051|FG003|Overall Study|Adverse Event|0|||
126251082|NCT00985751|454209052|FG004|Overall Study|Adverse Event|1|||
126251083|NCT00380588|454209053|FG000|Overall Study|Unequivocal Disease Progression|25|||
126251084|NCT00380588|454209054|FG001|Overall Study|Unequivocal Disease Progression|34|||
126251085|NCT00380588|454209053|FG000|Overall Study|Next Cycle Not Started|4|||
126251086|NCT00380588|454209054|FG001|Overall Study|Next Cycle Not Started|0|||
126251087|NCT00380588|454209053|FG000|Overall Study|Adverse Event|7|||
126251088|NCT00380588|454209054|FG001|Overall Study|Adverse Event|3|||
126251089|NCT00380588|454209053|FG000|Overall Study|Withdrawal by Subject|1|||
126028883|NCT04737772|453404970|FG001|Phase 2 Study|Withdrawal by Subject|1|||
126028884|NCT04737772|453404969|FG000|Phase 2 Study|Did not take any coaching calls|4|||
126028885|NCT04737772|453404970|FG001|Phase 2 Study|Did not take any coaching calls|0|||
126028886|NCT04737772|453404969|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
126028887|NCT04737772|453404970|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
126028888|NCT04737772|453404969|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
126028889|NCT04737772|453404970|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
126028890|NCT05691309|453404972|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
126028891|NCT05691309|453404972|FG000|Overall Study|vancomycin levels not evaluable|2|||
126028892|NCT03376321|453404974|FG000|Overall Study|Other|5|||
126028893|NCT03376321|453404975|FG001|Overall Study|Other|1|||
126028894|NCT03376321|453404974|FG000|Overall Study|Withdrawal by Subject|8|||
126028895|NCT03376321|453404975|FG001|Overall Study|Withdrawal by Subject|14|||
126028896|NCT03376321|453404974|FG000|Overall Study|Lost to Follow-up|1|||
126028897|NCT03376321|453404975|FG001|Overall Study|Lost to Follow-up|7|||
126028898|NCT03376321|453404974|FG000|Overall Study|Death|4|||
126028899|NCT03376321|453404975|FG001|Overall Study|Death|0|||
126028900|NCT03376321|453404974|FG000|Overall Study|Randomized, not treated|5|||
126028901|NCT03376321|453404975|FG001|Overall Study|Randomized, not treated|3|||
126251090|NCT00380588|454209054|FG001|Overall Study|Withdrawal by Subject|3|||
126251091|NCT00380588|454209053|FG000|Overall Study|Physician Decision|2|||
126251092|NCT00380588|454209054|FG001|Overall Study|Physician Decision|0|||
126251093|NCT03366428|454209059|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
126251094|NCT03366428|454209059|FG000|Overall Study|Adverse Event|12|||
126251095|NCT03366428|454209059|FG000|Overall Study|Clinical progression|2|||
126251096|NCT03366428|454209059|FG000|Overall Study|Withdrawal by Subject|4|||
126251097|NCT01120028|454209064|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
126251098|NCT01120028|454209065|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
126251099|NCT01120028|454209066|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
126251100|NCT01120028|454209067|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
126251101|NCT01120028|454209064|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
126251102|NCT01120028|454209065|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
126251103|NCT01120028|454209066|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
126251104|NCT01120028|454209067|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
126251105|NCT03867760|454209068|FG000|Overall Study|Lost to Follow-up|2|||
126251106|NCT03867760|454209069|FG001|Overall Study|Lost to Follow-up|3|||
126251107|NCT03867760|454209068|FG000|Overall Study|Withdrawal by Subject|1|||
126251108|NCT03867760|454209069|FG001|Overall Study|Withdrawal by Subject|2|||
126251109|NCT03867760|454209068|FG000|Overall Study|subject could not meet study logistics|3|||
126251110|NCT03867760|454209069|FG001|Overall Study|subject could not meet study logistics|3|||
126251111|NCT02286466|454209071|FG000|Overall Study|Death|1|||
126251112|NCT02286466|454209072|FG001|Overall Study|Death|3|||
126251113|NCT02286466|454209071|FG000|Overall Study|Withdrawal by Subject|5|||
126251114|NCT02286466|454209072|FG001|Overall Study|Withdrawal by Subject|2|||
126251115|NCT02286466|454209071|FG000|Overall Study|Lost to Follow-up|1|||
126251116|NCT02286466|454209072|FG001|Overall Study|Lost to Follow-up|4|||
126251117|NCT02286466|454209071|FG000|Overall Study|Declined Clinician Assessment|0|||
126251118|NCT02286466|454209072|FG001|Overall Study|Declined Clinician Assessment|1|||
126251119|NCT01018862|454209081|FG000|Overall Study|Adverse Event|2|||
126251120|NCT01018862|454209082|FG001|Overall Study|Adverse Event|0|||
126251121|NCT01018862|454209083|FG002|Overall Study|Adverse Event|6|||
126251122|NCT01018862|454209081|FG000|Overall Study|Lack of Efficacy|1|||
126251123|NCT01018862|454209082|FG001|Overall Study|Lack of Efficacy|0|||
126251124|NCT01018862|454209083|FG002|Overall Study|Lack of Efficacy|2|||
126251125|NCT01018862|454209081|FG000|Overall Study|Lost to Follow-up|3|||
126028902|NCT02992925|453404980|FG000|Cohort 2|Physician Decision|0|||
126028903|NCT02992925|453404981|FG001|Cohort 2|Physician Decision|0|||
126028904|NCT02992925|453404982|FG002|Cohort 2|Physician Decision|1|||
126028905|NCT02992925|453404983|FG003|Cohort 2|Physician Decision|0|||
126028906|NCT02992925|453404980|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
126028907|NCT02992925|453404981|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
126028908|NCT02992925|453404982|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
126251126|NCT01018862|454209082|FG001|Overall Study|Lost to Follow-up|1|||
126251127|NCT01018862|454209083|FG002|Overall Study|Lost to Follow-up|0|||
126251128|NCT01018862|454209081|FG000|Overall Study|Protocol Violation|1|||
126251129|NCT01018862|454209082|FG001|Overall Study|Protocol Violation|3|||
126251130|NCT01018862|454209083|FG002|Overall Study|Protocol Violation|3|||
126251131|NCT01018862|454209081|FG000|Overall Study|Withdrawal by Subject|1|||
126251132|NCT01018862|454209082|FG001|Overall Study|Withdrawal by Subject|2|||
126028909|NCT02992925|453404983|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
126028910|NCT01804816|453404984|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
126251133|NCT01018862|454209083|FG002|Overall Study|Withdrawal by Subject|1|||
126028911|NCT01804816|453404984|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
126028912|NCT04421378|453404990|FG000|Overall Study|Adverse Event|2|||
126028913|NCT04421378|453404991|FG001|Overall Study|Adverse Event|7|||
126028914|NCT04421378|453404992|FG002|Overall Study|Adverse Event|0|||
126028915|NCT04421378|453404993|FG003|Overall Study|Adverse Event|1|||
126028916|NCT04421378|453404994|FG004|Overall Study|Adverse Event|0|||
126028917|NCT04421378|453404990|FG000|Overall Study|Physician Decision|1|||
126028918|NCT04421378|453404991|FG001|Overall Study|Physician Decision|2|||
126028919|NCT04421378|453404992|FG002|Overall Study|Physician Decision|0|||
126028920|NCT04421378|453404993|FG003|Overall Study|Physician Decision|0|||
126251134|NCT01018862|454209081|FG000|Overall Study|administrative problems|5|||
126251135|NCT01018862|454209082|FG001|Overall Study|administrative problems|4|||
126251136|NCT01018862|454209083|FG002|Overall Study|administrative problems|4|||
126251137|NCT01968031|454209084|FG000|Overall Study|Adverse Event|13|||
126251138|NCT01968031|454209085|FG001|Overall Study|Adverse Event|10|||
126251139|NCT01968031|454209086|FG002|Overall Study|Adverse Event|22|||
126251140|NCT01968031|454209084|FG000|Overall Study|Withdrawal by Subject|3|||
126251141|NCT01968031|454209085|FG001|Overall Study|Withdrawal by Subject|7|||
126251142|NCT01968031|454209086|FG002|Overall Study|Withdrawal by Subject|3|||
126251143|NCT01968031|454209084|FG000|Overall Study|Did not meet entry criteria|1|||
126251144|NCT01968031|454209085|FG001|Overall Study|Did not meet entry criteria|1|||
126251145|NCT01968031|454209086|FG002|Overall Study|Did not meet entry criteria|1|||
126251146|NCT01968031|454209084|FG000|Overall Study|Noncompliance|0|||
126251147|NCT01968031|454209085|FG001|Overall Study|Noncompliance|0|||
126251148|NCT01968031|454209086|FG002|Overall Study|Noncompliance|2|||
126251149|NCT01968031|454209084|FG000|Overall Study|Failed inclusion criteria|0|||
126028921|NCT04421378|453404994|FG004|Overall Study|Physician Decision|0|||
126028922|NCT04421378|453404990|FG000|Overall Study|Progressive Disease|16|||
126095242|NCT02663518|453643024|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
126095243|NCT02663518|453643011|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095244|NCT02663518|453643012|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095245|NCT02663518|453643013|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095246|NCT02663518|453643014|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095247|NCT02663518|453643015|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095248|NCT02663518|453643016|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095249|NCT02663518|453643017|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095250|NCT02663518|453643018|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095251|NCT02663518|453643019|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095252|NCT02663518|453643020|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095253|NCT02663518|453643021|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095254|NCT02663518|453643022|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095255|NCT02663518|453643023|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
126095256|NCT02663518|453643024|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126095257|NCT02663518|453643011|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095258|NCT02663518|453643012|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095259|NCT02663518|453643013|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095260|NCT02663518|453643014|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095261|NCT02663518|453643015|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095262|NCT02663518|453643016|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095263|NCT02663518|453643017|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095264|NCT02663518|453643018|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126251150|NCT01968031|454209085|FG001|Overall Study|Failed inclusion criteria|2|||
126251151|NCT01968031|454209086|FG002|Overall Study|Failed inclusion criteria|0|||
126251152|NCT01968031|454209084|FG000|Overall Study|Death|0|||
126251153|NCT01968031|454209085|FG001|Overall Study|Death|0|||
126251154|NCT01968031|454209086|FG002|Overall Study|Death|1|||
126251155|NCT01968031|454209084|FG000|Overall Study|Prohibited concomitant medication|1|||
126251156|NCT01968031|454209085|FG001|Overall Study|Prohibited concomitant medication|0|||
126251157|NCT01968031|454209086|FG002|Overall Study|Prohibited concomitant medication|0|||
126028923|NCT04421378|453404991|FG001|Overall Study|Progressive Disease|4|||
126028924|NCT04421378|453404992|FG002|Overall Study|Progressive Disease|18|||
126028925|NCT04421378|453404993|FG003|Overall Study|Progressive Disease|11|||
126095265|NCT02663518|453643019|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095266|NCT02663518|453643020|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126251158|NCT00840879|454209092|FG000|Second Intervention|Withdrawal by Subject|1|||
126251159|NCT00840879|454209093|FG001|Second Intervention|Withdrawal by Subject|0|||
126251160|NCT01253564|454209096|FG000|Overall Study|Disease Progression|22|||
126251161|NCT01253564|454209096|FG000|Overall Study|Withdrawal by Subject|1|||
126251162|NCT01253564|454209096|FG000|Overall Study|Serious Adverse Event|1|||
126251163|NCT02957331|454209101|FG000|Overall Study|Protocol Violation|1|||
126251164|NCT02957331|454209102|FG001|Overall Study|Protocol Violation|0|||
126251165|NCT03247686|454210634|FG000|Overall Study|Withdrawal by Subject|1|||
126251166|NCT03247686|454210635|FG001|Overall Study|Withdrawal by Subject|2|||
126251167|NCT02583048|454210640|FG000|Overall Study|Withdrawal by Subject|0|||
126251168|NCT02583048|454210641|FG001|Overall Study|Withdrawal by Subject|1|||
126251169|NCT02583048|454210642|FG002|Overall Study|Withdrawal by Subject|0|||
126095267|NCT02663518|453643021|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095268|NCT02663518|453643022|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
126095269|NCT02663518|453643023|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095270|NCT02663518|453643024|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126095271|NCT02663518|453643011|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095272|NCT02663518|453643012|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095273|NCT02663518|453643013|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095274|NCT02663518|453643014|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095275|NCT02663518|453643015|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095276|NCT02663518|453643016|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095277|NCT02663518|453643017|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095278|NCT02663518|453643018|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095279|NCT02663518|453643019|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095280|NCT02663518|453643020|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
126095281|NCT02663518|453643021|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126095282|NCT02663518|453643022|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
126095283|NCT02663518|453643023|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
126095284|NCT02663518|453643024|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
126095285|NCT02663518|453643011|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
126095286|NCT02663518|453643012|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
126095287|NCT02663518|453643013|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
126095288|NCT02663518|453643014|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
126095289|NCT02663518|453643015|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
126095290|NCT02663518|453643016|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
126095291|NCT02663518|453643017|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
126095292|NCT02663518|453643018|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
126095293|NCT02663518|453643019|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
126095294|NCT02663518|453643020|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
126095295|NCT02663518|453643021|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
126095296|NCT02663518|453643022|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
126095297|NCT02663518|453643023|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
126095298|NCT02663518|453643024|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
126095299|NCT02663518|453643011|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095300|NCT02663518|453643012|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095301|NCT02663518|453643013|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095302|NCT02663518|453643014|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095303|NCT02663518|453643015|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095304|NCT02663518|453643016|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095305|NCT02663518|453643017|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095306|NCT02663518|453643018|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095307|NCT02663518|453643019|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095308|NCT02663518|453643020|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095309|NCT02663518|453643021|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095310|NCT02663518|453643022|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126251170|NCT02583048|454210640|FG000|Overall Study|Failed to meet eligibility criterion|0|||
126251171|NCT02583048|454210641|FG001|Overall Study|Failed to meet eligibility criterion|0|||
126251172|NCT02583048|454210642|FG002|Overall Study|Failed to meet eligibility criterion|1|||
126251173|NCT01151280|454210645|FG000|Overall Study|Adverse Event|1|||
126251174|NCT01151280|454210645|FG000|Overall Study|Lack of Efficacy|3|||
126095311|NCT02663518|453643023|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
126095312|NCT02663518|453643024|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126095313|NCT03896152|453643025|FG000|Overall Study|Patient/guardian decision|1|||
126095314|NCT03896152|453643026|FG001|Overall Study|Patient/guardian decision|1|||
126095315|NCT03896152|453643025|FG000|Overall Study|Adverse Event|0|||
126095316|NCT03896152|453643026|FG001|Overall Study|Adverse Event|1|||
126095317|NCT03896152|453643025|FG000|Overall Study|Physician Decision|1|||
126095318|NCT03896152|453643026|FG001|Overall Study|Physician Decision|0|||
126095319|NCT03896152|453643025|FG000|Overall Study|Technical problems|1|||
126095320|NCT03896152|453643026|FG001|Overall Study|Technical problems|0|||
126095321|NCT04075994|453643027|FG000|Overall Study|Withdrawal by Subject|8|||
126095322|NCT04075994|453643028|FG001|Overall Study|Withdrawal by Subject|9|||
126095323|NCT04075994|453643027|FG000|Overall Study|Adverse Event|2|||
126095324|NCT04075994|453643028|FG001|Overall Study|Adverse Event|2|||
126095325|NCT04075994|453643027|FG000|Overall Study|Investigator withdrew|3|||
126095326|NCT04075994|453643028|FG001|Overall Study|Investigator withdrew|1|||
126095327|NCT01941719|453643032|FG000|Overall Study|Lost to Follow-up|20|||
126095328|NCT01941719|453643033|FG001|Overall Study|Lost to Follow-up|19|||
126095329|NCT01744392|453643036|FG000|Overall Study|Physician Decision|1|||
126095330|NCT03980808|453643043|FG000|Overall Study|Lost to Follow-up|2|||
126095331|NCT03980808|453643044|FG001|Overall Study|Lost to Follow-up|2|||
126095332|NCT01655693|453643045|FG000|Overall Study|Progression of Disease|92|||
126095333|NCT01655693|453643046|FG001|Overall Study|Progression of Disease|76|||
126095334|NCT01655693|453643047|FG002|Overall Study|Progression of Disease|58|||
126095335|NCT01655693|453643045|FG000|Overall Study|Death|8|||
126095336|NCT01655693|453643046|FG001|Overall Study|Death|9|||
126095337|NCT01655693|453643047|FG002|Overall Study|Death|12|||
126095338|NCT01655693|453643045|FG000|Overall Study|Serious Adverse Event|3|||
126095339|NCT01655693|453643046|FG001|Overall Study|Serious Adverse Event|15|||
126095340|NCT01655693|453643047|FG002|Overall Study|Serious Adverse Event|11|||
126095341|NCT01655693|453643045|FG000|Overall Study|Withdrawal by Subject|3|||
126095342|NCT01655693|453643046|FG001|Overall Study|Withdrawal by Subject|2|||
126095343|NCT01655693|453643047|FG002|Overall Study|Withdrawal by Subject|20|||
126095344|NCT01655693|453643045|FG000|Overall Study|Adverse Event|3|||
126095345|NCT01655693|453643046|FG001|Overall Study|Adverse Event|11|||
126095346|NCT01655693|453643047|FG002|Overall Study|Adverse Event|3|||
126095347|NCT01655693|453643045|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
126095348|NCT01655693|453643046|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
126095349|NCT01655693|453643047|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
126095350|NCT01655693|453643045|FG000|Overall Study|Non-Compliance|0|||
126095351|NCT01655693|453643046|FG001|Overall Study|Non-Compliance|0|||
126095352|NCT01655693|453643047|FG002|Overall Study|Non-Compliance|7|||
126095353|NCT01655693|453643045|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
126095354|NCT01655693|453643046|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
126095355|NCT01655693|453643047|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
126095356|NCT01655693|453643045|FG000|Overall Study|Protocol Violation|1|||
126095357|NCT01655693|453643046|FG001|Overall Study|Protocol Violation|0|||
126251175|NCT04408924|454210649|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
126251176|NCT04408924|454210649|FG000|Overall Study|Lost to Follow-up|3|||
126251177|NCT04408924|454210649|FG000|Overall Study|Withdrawal by Subject|5|||
126251178|NCT04408924|454210649|FG000|Overall Study|Sponsor Decision|2|||
126251179|NCT00691704|454210650|FG000|Induction Therapy|Disease Progression|1|||
126251180|NCT00691704|454210650|FG000|Induction Therapy|Active Hepatitis|1|||
126251181|NCT00691704|454210650|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
126251182|NCT00691704|454210650|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
126251183|NCT00691704|454210650|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
126251184|NCT02578641|454210651|FG000|Overall Study|Adverse Event|5|||
126251185|NCT02578641|454210652|FG001|Overall Study|Adverse Event|15|||
126251186|NCT02578641|454210651|FG000|Overall Study|Death|16|||
126251187|NCT02578641|454210652|FG001|Overall Study|Death|8|||
126251188|NCT02578641|454210651|FG000|Overall Study|Lost to Follow-up|0|||
126251189|NCT02578641|454210652|FG001|Overall Study|Lost to Follow-up|1|||
126251190|NCT02578641|454210651|FG000|Overall Study|Withdrawal by Subject|14|||
126251191|NCT02578641|454210652|FG001|Overall Study|Withdrawal by Subject|7|||
126251192|NCT02578641|454210651|FG000|Overall Study|Progressive Disease|69|||
126251193|NCT02578641|454210652|FG001|Overall Study|Progressive Disease|21|||
126251194|NCT02578641|454210651|FG000|Overall Study|No Study Drug|2|||
126095358|NCT01655693|453643047|FG002|Overall Study|Protocol Violation|3|||
126095359|NCT01655693|453643045|FG000|Overall Study|Lost to Follow-up|1|||
126095360|NCT01655693|453643046|FG001|Overall Study|Lost to Follow-up|0|||
126095361|NCT01655693|453643047|FG002|Overall Study|Lost to Follow-up|1|||
126095362|NCT01655693|453643045|FG000|Overall Study|Screening Failure|1|||
126095363|NCT01655693|453643046|FG001|Overall Study|Screening Failure|0|||
126095364|NCT01655693|453643047|FG002|Overall Study|Screening Failure|0|||
126095365|NCT01655693|453643045|FG000|Overall Study|Other|8|||
126095366|NCT01655693|453643046|FG001|Overall Study|Other|6|||
126095367|NCT01655693|453643047|FG002|Overall Study|Other|15|||
126095368|NCT00929110|453643050|FG000|Overall Study|Adverse Event|40|||
126095369|NCT00929110|453643051|FG001|Overall Study|Adverse Event|29|||
126251195|NCT02578641|454210652|FG001|Overall Study|No Study Drug|0|||
126028926|NCT04421378|453404994|FG004|Overall Study|Progressive Disease|3|||
126028927|NCT04421378|453404990|FG000|Overall Study|Study Terminated by Sponsor|0|||
126028928|NCT04421378|453404991|FG001|Overall Study|Study Terminated by Sponsor|1|||
126028929|NCT04421378|453404992|FG002|Overall Study|Study Terminated by Sponsor|1|||
126028930|NCT04421378|453404993|FG003|Overall Study|Study Terminated by Sponsor|0|||
126028931|NCT04421378|453404994|FG004|Overall Study|Study Terminated by Sponsor|0|||
126028932|NCT04421378|453404990|FG000|Overall Study|Withdrawal by Subject|3|||
126028933|NCT04421378|453404991|FG001|Overall Study|Withdrawal by Subject|1|||
126028934|NCT04421378|453404992|FG002|Overall Study|Withdrawal by Subject|0|||
126028935|NCT04421378|453404993|FG003|Overall Study|Withdrawal by Subject|2|||
126028936|NCT04421378|453404994|FG004|Overall Study|Withdrawal by Subject|0|||
126028937|NCT04421378|453404990|FG000|Overall Study|Other|1|||
126028938|NCT04421378|453404991|FG001|Overall Study|Other|0|||
126028939|NCT04421378|453404992|FG002|Overall Study|Other|0|||
126028940|NCT04421378|453404993|FG003|Overall Study|Other|0|||
126028941|NCT04421378|453404994|FG004|Overall Study|Other|0|||
126028942|NCT04263311|453404995|FG000|Overall Study|Lost to Follow-up|1|||
126028943|NCT04263311|453404996|FG001|Overall Study|Lost to Follow-up|2|||
126028944|NCT04263311|453404997|FG002|Overall Study|Lost to Follow-up|0|||
126028945|NCT04263311|453404995|FG000|Overall Study|Health Issues|1|||
126028946|NCT04263311|453404996|FG001|Overall Study|Health Issues|0|||
126028947|NCT04263311|453404997|FG002|Overall Study|Health Issues|0|||
126028948|NCT04263311|453404995|FG000|Overall Study|Left the country|1|||
126028949|NCT04263311|453404996|FG001|Overall Study|Left the country|0|||
126028950|NCT04263311|453404997|FG002|Overall Study|Left the country|0|||
126028951|NCT04263311|453404995|FG000|Overall Study|Unable to maintain time commitment|1|||
126028952|NCT04263311|453404996|FG001|Overall Study|Unable to maintain time commitment|0|||
126028953|NCT04263311|453404997|FG002|Overall Study|Unable to maintain time commitment|0|||
126028954|NCT04263311|453404995|FG000|Overall Study|No longer interested|1|||
126028955|NCT04263311|453404996|FG001|Overall Study|No longer interested|0|||
126028956|NCT04263311|453404997|FG002|Overall Study|No longer interested|0|||
126028957|NCT04263311|453404995|FG000|Overall Study|Ineligible post consent|0|||
126028958|NCT04263311|453404996|FG001|Overall Study|Ineligible post consent|0|||
126028959|NCT04263311|453404997|FG002|Overall Study|Ineligible post consent|5|||
126028960|NCT02592330|453404998|FG000|Overall Study|Withdrawal by Subject|1|||
126028961|NCT02592330|453404999|FG001|Overall Study|Withdrawal by Subject|0|||
126095370|NCT00929110|453643052|FG002|Overall Study|Adverse Event|18|||
126251196|NCT02578641|454210651|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
126251197|NCT02578641|454210652|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
126251198|NCT02578641|454210651|FG000|Overall Study|Non-compliance with Study Schedule|1|||
126251199|NCT02578641|454210652|FG001|Overall Study|Non-compliance with Study Schedule|0|||
126251200|NCT02578641|454210651|FG000|Overall Study|Other|1|||
126251201|NCT02578641|454210652|FG001|Overall Study|Other|10|||
126251202|NCT02578641|454210651|FG000|Overall Study|Not treated|1|||
126251203|NCT02578641|454210652|FG001|Overall Study|Not treated|4|||
126251204|NCT02313558|454210653|FG000|Overall Study|Withdrawal by Subject|2|||
126251205|NCT02313558|454210654|FG001|Overall Study|Withdrawal by Subject|0|||
126251206|NCT02313558|454210653|FG000|Overall Study|Lost to Follow-up|4|||
126251207|NCT02313558|454210654|FG001|Overall Study|Lost to Follow-up|4|||
126251208|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
126251209|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
126251210|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
126251211|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
126251212|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
126251213|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
126251214|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
126251215|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
126251216|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
126251217|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
126251218|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
126251219|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
126251220|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
126251221|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
126251222|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
126028962|NCT02592330|453404998|FG000|Overall Study|Failed Biopsy|1|||
126028963|NCT02592330|453404999|FG001|Overall Study|Failed Biopsy|0|||
126028964|NCT03958955|453405000|FG000|Overall Study|Adverse Event|1|||
126095371|NCT00929110|453643050|FG000|Overall Study|Subject withdrew consent|40|||
125879757|NCT03104868|452857381|FG000|6 Week Follow up|Lost to Follow-up|5|||
126095372|NCT00929110|453643051|FG001|Overall Study|Subject withdrew consent|23|||
125879758|NCT03104868|452857382|FG001|6 Week Follow up|Lost to Follow-up|8|||
126028965|NCT02927769|453405002|FG000|Induction Phase|Study drug toxicity|1|||
126028966|NCT02927769|453405003|FG001|Induction Phase|Study drug toxicity|1|||
126028967|NCT02927769|453405002|FG000|Induction Phase|Disease progression|0|||
126028968|NCT02927769|453405003|FG001|Induction Phase|Disease progression|1|||
126251223|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
126251224|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
126251225|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
126251226|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
126251227|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
126251228|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
126251229|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
126251230|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
126028969|NCT02927769|453405002|FG000|Intensification Phase|Study drug toxicity|1|||
126028970|NCT02927769|453405003|FG001|Intensification Phase|Study drug toxicity|0|||
126028971|NCT02807636|453405004|FG000|Overall Study|Lost to Follow-up|10|||
126028972|NCT02807636|453405005|FG001|Overall Study|Lost to Follow-up|13|||
126028973|NCT02807636|453405006|FG002|Overall Study|Lost to Follow-up|6|||
126028974|NCT02807636|453405004|FG000|Overall Study|Protocol Deviation|1|||
126028975|NCT02807636|453405005|FG001|Overall Study|Protocol Deviation|0|||
126028976|NCT02807636|453405006|FG002|Overall Study|Protocol Deviation|0|||
126028977|NCT02807636|453405004|FG000|Overall Study|Symptomatic Deterioration|0|||
126028978|NCT02807636|453405005|FG001|Overall Study|Symptomatic Deterioration|1|||
126028979|NCT02807636|453405006|FG002|Overall Study|Symptomatic Deterioration|0|||
126028980|NCT02807636|453405004|FG000|Overall Study|Withdrawal by Subject|39|||
126028981|NCT02807636|453405005|FG001|Overall Study|Withdrawal by Subject|28|||
126028982|NCT02807636|453405006|FG002|Overall Study|Withdrawal by Subject|24|||
126028983|NCT02807636|453405004|FG000|Overall Study|Death|303|||
126028984|NCT02807636|453405005|FG001|Overall Study|Death|332|||
126028985|NCT02807636|453405006|FG002|Overall Study|Death|272|||
126028986|NCT02807636|453405004|FG000|Overall Study|Study Terminated By Sponsor|47|||
126028987|NCT02807636|453405005|FG001|Overall Study|Study Terminated By Sponsor|76|||
126028988|NCT02807636|453405006|FG002|Overall Study|Study Terminated By Sponsor|60|||
126028989|NCT02807636|453405004|FG000|Overall Study|Physician Decision|0|||
126028990|NCT02807636|453405005|FG001|Overall Study|Physician Decision|1|||
126028991|NCT02807636|453405006|FG002|Overall Study|Physician Decision|0|||
126028992|NCT04088630|453405007|FG000|Overall Study|Lost to Follow-up|3|||
126028993|NCT04088630|453405008|FG001|Overall Study|Lost to Follow-up|2|||
126028994|NCT04088630|453405009|FG002|Overall Study|Lost to Follow-up|6|||
126028995|NCT04088630|453405007|FG000|Overall Study|Death|3|||
126028996|NCT04088630|453405008|FG001|Overall Study|Death|1|||
126028997|NCT04088630|453405009|FG002|Overall Study|Death|1|||
126251231|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
126251232|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
126251233|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
126251234|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
126251235|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
126251236|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
126251237|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
126251238|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
126251239|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
126251240|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
126251241|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
126251242|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
126251243|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
126251244|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
126251245|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
126251246|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
126251247|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
126251248|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
126251249|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
126251250|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
126251251|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
126028998|NCT04088630|453405007|FG000|Overall Study|Physician Decision|0|||
126028999|NCT04088630|453405008|FG001|Overall Study|Physician Decision|1|||
126029000|NCT04088630|453405009|FG002|Overall Study|Physician Decision|1|||
126029001|NCT03315754|453405010|FG000|Overall Study|COVID-19 complications leading to death|1|||
126029002|NCT03315754|453405010|FG000|Overall Study|insurance coverage issue|1|||
126029003|NCT04024813|453405011|FG000|Overall Study|Study terminated by Sponsor|1|||
126029004|NCT05034952|453405012|FG000|Overall Study|Adverse Event|1|||
126029005|NCT05034952|453405013|FG001|Overall Study|Adverse Event|0|||
126251252|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
126251253|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
126251254|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
126251255|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
126251256|NCT01710358|454210656|FG000|Rescue Period|Adverse Event|0|||
126251257|NCT01710358|454210657|FG001|Rescue Period|Adverse Event|15|||
126251258|NCT01710358|454210658|FG002|Rescue Period|Adverse Event|0|||
126251259|NCT01710358|454210656|FG000|Rescue Period|Death|0|||
126251260|NCT01710358|454210657|FG001|Rescue Period|Death|1|||
126251261|NCT01710358|454210658|FG002|Rescue Period|Death|0|||
126251262|NCT01710358|454210656|FG000|Rescue Period|Lack of Efficacy|0|||
126251263|NCT01710358|454210657|FG001|Rescue Period|Lack of Efficacy|7|||
126251264|NCT01710358|454210658|FG002|Rescue Period|Lack of Efficacy|0|||
126251265|NCT01710358|454210656|FG000|Rescue Period|Withdrawal by Subject|0|||
126251266|NCT01710358|454210657|FG001|Rescue Period|Withdrawal by Subject|8|||
126251267|NCT01710358|454210658|FG002|Rescue Period|Withdrawal by Subject|0|||
126251268|NCT00084864|454210661|FG000|Overall Study|Adverse Event|1|||
126251269|NCT00084864|454210662|FG001|Overall Study|Adverse Event|0|||
126251270|NCT00084864|454210663|FG002|Overall Study|Adverse Event|0|||
126251271|NCT00084864|454210664|FG003|Overall Study|Adverse Event|0|||
126251272|NCT01741545|454210665|FG000|Treatment Period|Lack of Efficacy|0|||
126251273|NCT01741545|454210666|FG001|Treatment Period|Lack of Efficacy|1|||
126251274|NCT01741545|454210665|FG000|Treatment Period|Adverse event, non-fatal|1|||
126251275|NCT01741545|454210666|FG001|Treatment Period|Adverse event, non-fatal|3|||
126251276|NCT01741545|454210665|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
126251277|NCT01741545|454210666|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
126251278|NCT01741545|454210665|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
126251279|NCT01741545|454210666|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
126251280|NCT01456962|454210667|FG000|Overall Study|Lost to Follow-up|2|||
126251281|NCT01456962|454210668|FG001|Overall Study|Lost to Follow-up|1|||
126251282|NCT03358147|454210677|FG000|Overall Study|Withdrawal by Subject|13|||
126251283|NCT03358147|454210678|FG001|Overall Study|Withdrawal by Subject|19|||
126251284|NCT03358147|454210679|FG002|Overall Study|Withdrawal by Subject|16|||
126251285|NCT03358147|454210680|FG003|Overall Study|Withdrawal by Subject|10|||
126251286|NCT03358147|454210681|FG004|Overall Study|Withdrawal by Subject|5|||
126251287|NCT03358147|454210677|FG000|Overall Study|Adverse Event|3|||
126251288|NCT03358147|454210678|FG001|Overall Study|Adverse Event|9|||
126251289|NCT03358147|454210679|FG002|Overall Study|Adverse Event|7|||
126251290|NCT03358147|454210680|FG003|Overall Study|Adverse Event|5|||
126251291|NCT03358147|454210681|FG004|Overall Study|Adverse Event|2|||
126251292|NCT03358147|454210677|FG000|Overall Study|Lost to Follow-up|4|||
126251293|NCT03358147|454210678|FG001|Overall Study|Lost to Follow-up|3|||
126251294|NCT03358147|454210679|FG002|Overall Study|Lost to Follow-up|7|||
126251295|NCT03358147|454210680|FG003|Overall Study|Lost to Follow-up|6|||
126251296|NCT03358147|454210681|FG004|Overall Study|Lost to Follow-up|4|||
126251297|NCT03358147|454210677|FG000|Overall Study|Major Protocol Deviation|11|||
126251298|NCT03358147|454210678|FG001|Overall Study|Major Protocol Deviation|3|||
126251299|NCT03358147|454210679|FG002|Overall Study|Major Protocol Deviation|2|||
126251300|NCT03358147|454210680|FG003|Overall Study|Major Protocol Deviation|3|||
126251301|NCT03358147|454210681|FG004|Overall Study|Major Protocol Deviation|1|||
126251302|NCT03358147|454210677|FG000|Overall Study|Protocol specified criteria|2|||
126251303|NCT03358147|454210678|FG001|Overall Study|Protocol specified criteria|3|||
126251304|NCT03358147|454210679|FG002|Overall Study|Protocol specified criteria|0|||
126251305|NCT03358147|454210680|FG003|Overall Study|Protocol specified criteria|3|||
126251306|NCT03358147|454210681|FG004|Overall Study|Protocol specified criteria|1|||
126251307|NCT03358147|454210677|FG000|Overall Study|Physician Decision|1|||
126251308|NCT03358147|454210678|FG001|Overall Study|Physician Decision|0|||
126251309|NCT03358147|454210679|FG002|Overall Study|Physician Decision|1|||
126251310|NCT03358147|454210680|FG003|Overall Study|Physician Decision|6|||
126251311|NCT03358147|454210681|FG004|Overall Study|Physician Decision|1|||
126251312|NCT03358147|454210677|FG000|Overall Study|Administrative reasons|0|||
126251313|NCT03358147|454210678|FG001|Overall Study|Administrative reasons|1|||
126251314|NCT03358147|454210679|FG002|Overall Study|Administrative reasons|0|||
126251315|NCT03358147|454210680|FG003|Overall Study|Administrative reasons|3|||
126251316|NCT03358147|454210681|FG004|Overall Study|Administrative reasons|0|||
126251317|NCT03358147|454210677|FG000|Overall Study|Lack of Efficacy|0|||
126251318|NCT03358147|454210678|FG001|Overall Study|Lack of Efficacy|1|||
126251319|NCT03358147|454210679|FG002|Overall Study|Lack of Efficacy|1|||
126251320|NCT03358147|454210680|FG003|Overall Study|Lack of Efficacy|0|||
126251321|NCT03358147|454210681|FG004|Overall Study|Lack of Efficacy|0|||
126251322|NCT02704091|454210682|FG000|Overall Study|Adverse Event|4|||
126251323|NCT02704091|454210683|FG001|Overall Study|Adverse Event|3|||
126251324|NCT02704091|454210682|FG000|Overall Study|Protocol Violation|5|||
126251325|NCT02704091|454210683|FG001|Overall Study|Protocol Violation|3|||
126251326|NCT02704091|454210682|FG000|Overall Study|Consent withdrawn|4|||
126251327|NCT02704091|454210683|FG001|Overall Study|Consent withdrawn|4|||
126251328|NCT02704091|454210682|FG000|Overall Study|Lost to Follow-up|13|||
126029006|NCT05034952|453405014|FG002|Overall Study|Adverse Event|0|||
126029007|NCT05034952|453405015|FG003|Overall Study|Adverse Event|0|||
126029008|NCT05034952|453405012|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
126029009|NCT05034952|453405013|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
126251329|NCT02704091|454210683|FG001|Overall Study|Lost to Follow-up|5|||
126251330|NCT02704091|454210682|FG000|Overall Study|Other|2|||
126251331|NCT02704091|454210683|FG001|Overall Study|Other|8|||
126251332|NCT03073798|454210684|FG000|Overall Study|Adverse Event|1|||
126251333|NCT03073798|454210684|FG000|Overall Study|Withdrawal by Subject|1|||
126251334|NCT01186458|454210688|FG000|Overall Study|Adverse Event|1|||
126029010|NCT05034952|453405014|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
126029011|NCT05034952|453405015|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
126029012|NCT05034952|453405012|FG000|Overall Study|Lost to Follow-up|1|||
126029013|NCT05034952|453405013|FG001|Overall Study|Lost to Follow-up|4|||
126029014|NCT05034952|453405014|FG002|Overall Study|Lost to Follow-up|3|||
126029015|NCT05034952|453405015|FG003|Overall Study|Lost to Follow-up|3|||
126029016|NCT05034952|453405012|FG000|Overall Study|Other|0|||
126029017|NCT05034952|453405013|FG001|Overall Study|Other|0|||
126029018|NCT05034952|453405014|FG002|Overall Study|Other|0|||
126029019|NCT05034952|453405015|FG003|Overall Study|Other|1|||
126029020|NCT04783935|453405032|FG000|Overall Study|Withdrawal by Subject|6|||
126029021|NCT04783935|453405032|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
126029022|NCT04783935|453405032|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
126029023|NCT04783935|453405032|FG000|Overall Study|Lost to Follow-up|3|||
126029024|NCT04783935|453405032|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
126029025|NCT02437318|453405034|FG000|Overall Study|Progressive disease|207|||
126095373|NCT00929110|453643052|FG002|Overall Study|Subject withdrew consent|26|||
126029026|NCT02437318|453405035|FG001|Overall Study|Progressive disease|240|||
126029027|NCT02437318|453405034|FG000|Overall Study|Subject/guardian decision|24|||
126029028|NCT02437318|453405035|FG001|Overall Study|Subject/guardian decision|11|||
126251335|NCT02426918|454210695|FG000|Overall Study|Adverse Event|2|||
126251336|NCT02426918|454210696|FG001|Overall Study|Adverse Event|2|||
126251337|NCT02426918|454210697|FG002|Overall Study|Adverse Event|0|||
126251338|NCT02426918|454210695|FG000|Overall Study|Physician Decision|1|||
126029029|NCT02437318|453405034|FG000|Overall Study|Physician Decision|29|||
126029030|NCT02437318|453405035|FG001|Overall Study|Physician Decision|22|||
126251339|NCT02426918|454210696|FG001|Overall Study|Physician Decision|1|||
126251340|NCT02426918|454210697|FG002|Overall Study|Physician Decision|1|||
126251341|NCT02426918|454210695|FG000|Overall Study|Withdrawal by Subject|5|||
125879759|NCT03104868|452857381|FG000|6 Week Follow up|Death|1|||
126029031|NCT02437318|453405034|FG000|Overall Study|Adverse Event|14|||
126251342|NCT02426918|454210696|FG001|Overall Study|Withdrawal by Subject|5|||
126251343|NCT02426918|454210697|FG002|Overall Study|Withdrawal by Subject|4|||
126251344|NCT02426918|454210695|FG000|Overall Study|Other|9|||
126251345|NCT02426918|454210696|FG001|Overall Study|Other|11|||
126251346|NCT02426918|454210697|FG002|Overall Study|Other|9|||
126251347|NCT01496118|454210698|FG000|Overall Study|Disease progression|3|||
126251348|NCT01496118|454210699|FG001|Overall Study|Disease progression|2|||
126251349|NCT01496118|454210700|FG002|Overall Study|Disease progression|3|||
126251350|NCT01496118|454210701|FG003|Overall Study|Disease progression|1|||
126095374|NCT00929110|453643050|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
126095375|NCT00929110|453643051|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
126095376|NCT00929110|453643052|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
126095377|NCT00929110|453643050|FG000|Overall Study|Lost to Follow-up|7|||
126095378|NCT00929110|453643051|FG001|Overall Study|Lost to Follow-up|7|||
126095379|NCT00929110|453643052|FG002|Overall Study|Lost to Follow-up|3|||
126095380|NCT00929110|453643050|FG000|Overall Study|Protocol deviation|5|||
126095381|NCT00929110|453643051|FG001|Overall Study|Protocol deviation|2|||
126095382|NCT00929110|453643052|FG002|Overall Study|Protocol deviation|4|||
126095383|NCT00929110|453643050|FG000|Overall Study|Administrative problems|4|||
126095384|NCT00929110|453643051|FG001|Overall Study|Administrative problems|1|||
126095385|NCT00929110|453643052|FG002|Overall Study|Administrative problems|2|||
126095386|NCT00929110|453643050|FG000|Overall Study|Death|2|||
126095387|NCT00929110|453643051|FG001|Overall Study|Death|2|||
126095388|NCT00929110|453643052|FG002|Overall Study|Death|2|||
126095389|NCT00929110|453643050|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126095390|NCT00929110|453643051|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126095391|NCT00929110|453643052|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126095392|NCT00929110|453643050|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126095393|NCT00929110|453643051|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126095394|NCT00929110|453643052|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126095395|NCT00929110|453643050|FG000|Overall Study|Patient inability to use the device|0|||
126095396|NCT00929110|453643051|FG001|Overall Study|Patient inability to use the device|1|||
126095397|NCT00929110|453643052|FG002|Overall Study|Patient inability to use the device|0|||
126095398|NCT02703259|453643053|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
126095399|NCT02703259|453643054|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
126095400|NCT02703259|453643053|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
126095401|NCT02703259|453643054|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
126095402|NCT02703259|453643053|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
126095403|NCT02703259|453643054|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
126095404|NCT02285153|453643060|FG000|Overall Study|Adverse Event|1|||
126095405|NCT02285153|453643061|FG001|Overall Study|Adverse Event|0|||
126095406|NCT02544451|453643063|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
126095407|NCT02544451|453643064|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
126095408|NCT02544451|453643065|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
126095409|NCT02544451|453643066|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
126095410|NCT02544451|453643063|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
126095411|NCT02544451|453643064|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
126095412|NCT02544451|453643065|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
126095413|NCT02544451|453643066|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
126095414|NCT02544451|453643063|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
126095415|NCT02544451|453643064|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
126095416|NCT02544451|453643065|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
126095417|NCT02544451|453643066|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
126095418|NCT02544451|453643063|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
126095419|NCT02544451|453643064|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
126095420|NCT02544451|453643065|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
126095421|NCT02544451|453643066|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
126095422|NCT02544451|453643063|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
126095423|NCT02544451|453643064|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
126095424|NCT02544451|453643065|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
126095425|NCT02544451|453643066|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
126095426|NCT02544451|453643063|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
126095427|NCT02544451|453643064|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
126095428|NCT02544451|453643065|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
126095429|NCT02544451|453643066|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
126095430|NCT01489891|453643069|FG000|Overall Study|Endoscopy failure|1|||
126095431|NCT01489891|453643070|FG001|Overall Study|Endoscopy failure|0|||
126095432|NCT00998790|453643071|FG000|Overall Study|Withdrawal by Subject|21|||
126251351|NCT01496118|454210702|FG004|Overall Study|Disease progression|2|||
126251352|NCT01496118|454210703|FG005|Overall Study|Disease progression|2|||
126251353|NCT01496118|454210704|FG006|Overall Study|Disease progression|14|||
126095433|NCT03001076|453643072|FG000|Overall Study|Withdrawal by patient|2|||
126095434|NCT03001076|453643073|FG001|Overall Study|Withdrawal by patient|0|||
126251354|NCT01496118|454210705|FG007|Overall Study|Disease progression|10|||
126251355|NCT01496118|454210698|FG000|Overall Study|Physician Decision|0|||
126251356|NCT01496118|454210699|FG001|Overall Study|Physician Decision|0|||
126251357|NCT01496118|454210700|FG002|Overall Study|Physician Decision|0|||
126251358|NCT01496118|454210701|FG003|Overall Study|Physician Decision|0|||
126251359|NCT01496118|454210702|FG004|Overall Study|Physician Decision|1|||
126251360|NCT01496118|454210703|FG005|Overall Study|Physician Decision|0|||
126029032|NCT02437318|453405035|FG001|Overall Study|Adverse Event|4|||
126029033|NCT02437318|453405034|FG000|Overall Study|Death|4|||
126029034|NCT02437318|453405035|FG001|Overall Study|Death|4|||
126029035|NCT02437318|453405034|FG000|Overall Study|Protocol deviation|5|||
126029036|NCT02437318|453405035|FG001|Overall Study|Protocol deviation|7|||
126029037|NCT02437318|453405034|FG000|Overall Study|Sponsor decision|1|||
126029038|NCT02437318|453405035|FG001|Overall Study|Sponsor decision|0|||
126029039|NCT00920621|453405039|FG000|Overall Study|Lost to Follow-up|16|||
126029040|NCT00920621|453405040|FG001|Overall Study|Lost to Follow-up|17|||
126029041|NCT00920621|453405041|FG002|Overall Study|Lost to Follow-up|19|||
126029042|NCT00920621|453405042|FG003|Overall Study|Lost to Follow-up|21|||
126029043|NCT00920621|453405039|FG000|Overall Study|Fetal/neonatal deaths|16|||
126029044|NCT00920621|453405040|FG001|Overall Study|Fetal/neonatal deaths|14|||
126029045|NCT00920621|453405041|FG002|Overall Study|Fetal/neonatal deaths|16|||
126029046|NCT00920621|453405042|FG003|Overall Study|Fetal/neonatal deaths|14|||
126029047|NCT00920621|453405039|FG000|Overall Study|Blood sample not collected|22|||
126029048|NCT00920621|453405040|FG001|Overall Study|Blood sample not collected|14|||
126029049|NCT00920621|453405041|FG002|Overall Study|Blood sample not collected|0|||
126029050|NCT00920621|453405042|FG003|Overall Study|Blood sample not collected|0|||
126029051|NCT06074523|453405043|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
126029052|NCT06074523|453405043|FG000|Overall Study|Withdrawal by Subject|1|||
126029053|NCT04245501|453405044|FG000|Overall Study|Adverse Event|2|||
126029054|NCT04245501|453405045|FG001|Overall Study|Adverse Event|0|||
126029055|NCT04245501|453405044|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
126029056|NCT04245501|453405045|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
126029057|NCT00961571|453405046|FG000|Overall Study|Physician Decision|39|||
126029058|NCT05337748|453405050|FG000|Overall Study|Withdrawal by Subject|1|||
126029059|NCT05337748|453405051|FG001|Overall Study|Withdrawal by Subject|0|||
126029060|NCT05337748|453405050|FG000|Overall Study|Death|1|||
126029061|NCT05337748|453405051|FG001|Overall Study|Death|0|||
126029062|NCT04321031|453405057|FG000|Overall Study|Adverse Event|0|||
126029063|NCT04321031|453405058|FG001|Overall Study|Adverse Event|2|||
126029064|NCT04321031|453405059|FG002|Overall Study|Adverse Event|2|||
126029065|NCT04321031|453405060|FG003|Overall Study|Adverse Event|2|||
126029066|NCT04321031|453405061|FG004|Overall Study|Adverse Event|2|||
126029067|NCT04321031|453405062|FG005|Overall Study|Adverse Event|2|||
126251361|NCT01496118|454210704|FG006|Overall Study|Physician Decision|3|||
126251362|NCT01496118|454210705|FG007|Overall Study|Physician Decision|6|||
126029068|NCT04321031|453405063|FG006|Overall Study|Adverse Event|0|||
126029069|NCT04321031|453405057|FG000|Overall Study|Lost to Follow-up|0|||
126029070|NCT04321031|453405058|FG001|Overall Study|Lost to Follow-up|0|||
126029071|NCT04321031|453405059|FG002|Overall Study|Lost to Follow-up|0|||
126029072|NCT04321031|453405060|FG003|Overall Study|Lost to Follow-up|1|||
126029073|NCT04321031|453405061|FG004|Overall Study|Lost to Follow-up|0|||
126029074|NCT04321031|453405062|FG005|Overall Study|Lost to Follow-up|2|||
126029075|NCT04321031|453405063|FG006|Overall Study|Lost to Follow-up|1|||
126029076|NCT04321031|453405057|FG000|Overall Study|Withdrawal by Subject|2|||
126029077|NCT04321031|453405058|FG001|Overall Study|Withdrawal by Subject|2|||
126029078|NCT04321031|453405059|FG002|Overall Study|Withdrawal by Subject|1|||
126029079|NCT04321031|453405060|FG003|Overall Study|Withdrawal by Subject|3|||
126029080|NCT04321031|453405061|FG004|Overall Study|Withdrawal by Subject|1|||
126029081|NCT04321031|453405062|FG005|Overall Study|Withdrawal by Subject|0|||
126251363|NCT01496118|454210698|FG000|Overall Study|Adverse Event|1|||
126251364|NCT01496118|454210699|FG001|Overall Study|Adverse Event|1|||
126251365|NCT01496118|454210700|FG002|Overall Study|Adverse Event|0|||
126251366|NCT01496118|454210701|FG003|Overall Study|Adverse Event|0|||
126251367|NCT01496118|454210702|FG004|Overall Study|Adverse Event|0|||
126251368|NCT01496118|454210703|FG005|Overall Study|Adverse Event|0|||
126251369|NCT01496118|454210704|FG006|Overall Study|Adverse Event|6|||
126251370|NCT01496118|454210705|FG007|Overall Study|Adverse Event|10|||
126251371|NCT01496118|454210698|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251372|NCT01496118|454210699|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251373|NCT01496118|454210700|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251374|NCT01496118|454210701|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251375|NCT01496118|454210702|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251376|NCT01496118|454210703|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251377|NCT01496118|454210704|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
126251378|NCT01496118|454210705|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251379|NCT01496118|454210698|FG000|Overall Study|Death|0|||
126251380|NCT01496118|454210699|FG001|Overall Study|Death|0|||
126251381|NCT01496118|454210700|FG002|Overall Study|Death|0|||
126251382|NCT01496118|454210701|FG003|Overall Study|Death|0|||
126251383|NCT01496118|454210702|FG004|Overall Study|Death|0|||
126251384|NCT01496118|454210703|FG005|Overall Study|Death|0|||
126251385|NCT01496118|454210704|FG006|Overall Study|Death|1|||
126251386|NCT01496118|454210705|FG007|Overall Study|Death|1|||
126251387|NCT01496118|454210698|FG000|Overall Study|Withdrawal by Subject|0|||
126251388|NCT01496118|454210699|FG001|Overall Study|Withdrawal by Subject|0|||
126251389|NCT01496118|454210700|FG002|Overall Study|Withdrawal by Subject|0|||
126251390|NCT01496118|454210701|FG003|Overall Study|Withdrawal by Subject|2|||
126251391|NCT01496118|454210702|FG004|Overall Study|Withdrawal by Subject|0|||
126251392|NCT01496118|454210703|FG005|Overall Study|Withdrawal by Subject|1|||
126251393|NCT01496118|454210704|FG006|Overall Study|Withdrawal by Subject|6|||
126251394|NCT01496118|454210705|FG007|Overall Study|Withdrawal by Subject|3|||
126251395|NCT02845336|454210706|FG000|Overall Study|Lost to Follow-up|3|||
126251396|NCT02845336|454210707|FG001|Overall Study|Lost to Follow-up|1|||
126251397|NCT02845336|454210706|FG000|Overall Study|Inability to get medication|2|||
126251398|NCT02845336|454210707|FG001|Overall Study|Inability to get medication|0|||
126251399|NCT02420353|454210714|FG000|Overall Study|Withdrawal by Subject|0|||
126251400|NCT02420353|454210715|FG001|Overall Study|Withdrawal by Subject|1|||
126251401|NCT04608448|454210716|FG000|Overall Study|Withdrawal by Subject|1|||
126251402|NCT04608448|454210716|FG000|Overall Study|Adverse Event|1|||
126251403|NCT01149057|454210717|FG000|Overall Study|Lack of Efficacy|16|||
126251404|NCT01149057|454210717|FG000|Overall Study|Adverse Event|13|||
126251405|NCT01149057|454210717|FG000|Overall Study|Withdrawal by Subject|9|||
126251406|NCT01149057|454210717|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
126251407|NCT01149057|454210717|FG000|Overall Study|B Cell Depletion|4|||
126095435|NCT03001076|453643072|FG000|Overall Study|Other|1|||
126029082|NCT04321031|453405063|FG006|Overall Study|Withdrawal by Subject|1|||
126029083|NCT04321031|453405057|FG000|Overall Study|Non-compliance with study drug|0|||
126029084|NCT04321031|453405058|FG001|Overall Study|Non-compliance with study drug|0|||
126029085|NCT04321031|453405059|FG002|Overall Study|Non-compliance with study drug|0|||
126029086|NCT04321031|453405060|FG003|Overall Study|Non-compliance with study drug|0|||
126029087|NCT04321031|453405061|FG004|Overall Study|Non-compliance with study drug|0|||
126029088|NCT04321031|453405062|FG005|Overall Study|Non-compliance with study drug|1|||
126029089|NCT04321031|453405063|FG006|Overall Study|Non-compliance with study drug|0|||
126029090|NCT04321031|453405057|FG000|Overall Study|Other|0|||
126029091|NCT04321031|453405058|FG001|Overall Study|Other|0|||
126095436|NCT03001076|453643073|FG001|Overall Study|Other|0|||
126095437|NCT03001076|453643072|FG000|Overall Study|Adverse Event|3|||
126251408|NCT01149057|454210717|FG000|Overall Study|Participant Non-Compliance|2|||
126251409|NCT01149057|454210717|FG000|Overall Study|Lost to Follow-up|1|||
126251410|NCT01149057|454210717|FG000|Overall Study|High Parathyroid Hormone Value|1|||
126251411|NCT01149057|454210717|FG000|Overall Study|Other|6|||
126251412|NCT00654186|454210718|FG000|Overall Study|Withdrawal by Subject|5|||
126251413|NCT00577655|454210719|FG000|Overall Study|Patient Request|0|||
126251414|NCT00577655|454210720|FG001|Overall Study|Patient Request|2|||
126251415|NCT00577655|454210719|FG000|Overall Study|Protocol Violation|0|||
126251416|NCT00577655|454210720|FG001|Overall Study|Protocol Violation|1|||
126251417|NCT00577655|454210719|FG000|Overall Study|Lost to Follow-up|1|||
126251418|NCT00577655|454210720|FG001|Overall Study|Lost to Follow-up|1|||
126251419|NCT00875524|454210722|FG000|Overall Study|Serious adverse event|0|||
126251420|NCT00875524|454210723|FG001|Overall Study|Serious adverse event|1|||
126251421|NCT00875524|454210722|FG000|Overall Study|Protocol Violation|4|||
126251422|NCT00875524|454210723|FG001|Overall Study|Protocol Violation|0|||
126251423|NCT00875524|454210722|FG000|Overall Study|Lost to Follow-up|1|||
126251424|NCT00875524|454210723|FG001|Overall Study|Lost to Follow-up|0|||
126251425|NCT00875524|454210722|FG000|Overall Study|Withdrawal by Subject|3|||
126251426|NCT00875524|454210723|FG001|Overall Study|Withdrawal by Subject|5|||
126251427|NCT01370863|454210724|FG000|Overall Study|Adverse Event|1|||
126251428|NCT01370863|454210725|FG001|Overall Study|Adverse Event|1|||
126251429|NCT01370863|454210724|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
126251430|NCT01370863|454210725|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
126251431|NCT01370863|454210724|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126251432|NCT01370863|454210725|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126029092|NCT04321031|453405059|FG002|Overall Study|Other|0|||
126029093|NCT04321031|453405060|FG003|Overall Study|Other|1|||
126029094|NCT04321031|453405061|FG004|Overall Study|Other|0|||
126029095|NCT04321031|453405062|FG005|Overall Study|Other|0|||
126029096|NCT04321031|453405063|FG006|Overall Study|Other|0|||
126029097|NCT04806594|453405064|FG000|Overall Study|Withdrawal by Subject|2|||
126029098|NCT04806594|453405064|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
126029099|NCT02543281|453405065|FG000|Overall Study|Lost to Follow-up|0|||
126029100|NCT02543281|453405066|FG001|Overall Study|Lost to Follow-up|0|||
126029101|NCT02543281|453405067|FG002|Overall Study|Lost to Follow-up|1|||
126029102|NCT03143153|453405068|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
126029103|NCT03143153|453405069|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
126029104|NCT03143153|453405070|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
126029105|NCT03143153|453405068|FG000|Pre-Treatment|Participant withdrew consent|0|||
126029106|NCT03143153|453405069|FG001|Pre-Treatment|Participant withdrew consent|1|||
126029107|NCT03143153|453405070|FG002|Pre-Treatment|Participant withdrew consent|12|||
126029108|NCT03143153|453405068|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
126029109|NCT03143153|453405069|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
126029110|NCT03143153|453405070|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
126029111|NCT03143153|453405068|FG000|Pre-Treatment|Other Reasons|1|||
126029112|NCT03143153|453405069|FG001|Pre-Treatment|Other Reasons|2|||
126029113|NCT03143153|453405070|FG002|Pre-Treatment|Other Reasons|1|||
126029114|NCT03143153|453405068|FG000|Pre-Treatment|Disease Progression|1|||
126029115|NCT03143153|453405069|FG001|Pre-Treatment|Disease Progression|1|||
126029116|NCT03143153|453405070|FG002|Pre-Treatment|Disease Progression|2|||
126029117|NCT03143153|453405068|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
126029118|NCT03143153|453405069|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
126029119|NCT03143153|453405070|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
126029120|NCT03143153|453405068|FG000|Treatment|Disease progression|174|||
126029121|NCT03143153|453405069|FG001|Treatment|Disease progression|184|||
126029122|NCT03143153|453405070|FG002|Treatment|Disease progression|193|||
126029123|NCT03143153|453405068|FG000|Treatment|Study drug toxicity|59|||
126029124|NCT03143153|453405069|FG001|Treatment|Study drug toxicity|33|||
126029125|NCT03143153|453405070|FG002|Treatment|Study drug toxicity|40|||
126029126|NCT03143153|453405068|FG000|Treatment|Death|5|||
126029127|NCT03143153|453405069|FG001|Treatment|Death|3|||
126029128|NCT03143153|453405070|FG002|Treatment|Death|4|||
126029129|NCT03143153|453405068|FG000|Treatment|Adverse event unrelated to study drug|19|||
126251433|NCT00301964|454210726|FG000|Overall Study|Second primary|2|||
126251434|NCT00301964|454210726|FG000|Overall Study|Wrong primary|1|||
126029130|NCT03143153|453405069|FG001|Treatment|Adverse event unrelated to study drug|28|||
126029131|NCT03143153|453405070|FG002|Treatment|Adverse event unrelated to study drug|12|||
126029132|NCT03143153|453405068|FG000|Treatment|Participant request to discontinue study treatment|13|||
126029133|NCT03143153|453405069|FG001|Treatment|Participant request to discontinue study treatment|15|||
126251435|NCT00301964|454210726|FG000|Overall Study|Inadequate pathology|1|||
126251436|NCT01143337|454210727|FG000|Overall Study|Adverse Event|3|||
126251437|NCT01143337|454210728|FG001|Overall Study|Adverse Event|9|||
126251438|NCT01143337|454210729|FG002|Overall Study|Adverse Event|5|||
126251439|NCT01143337|454210727|FG000|Overall Study|Lack of Efficacy|6|||
126251440|NCT01143337|454210728|FG001|Overall Study|Lack of Efficacy|2|||
126251441|NCT01143337|454210729|FG002|Overall Study|Lack of Efficacy|1|||
126251442|NCT01143337|454210727|FG000|Overall Study|Protocol Violation|1|||
126251443|NCT01143337|454210728|FG001|Overall Study|Protocol Violation|0|||
126251444|NCT01143337|454210729|FG002|Overall Study|Protocol Violation|0|||
126251445|NCT01143337|454210727|FG000|Overall Study|Withdrawal by Subject|0|||
126251446|NCT01143337|454210728|FG001|Overall Study|Withdrawal by Subject|0|||
126251447|NCT01143337|454210729|FG002|Overall Study|Withdrawal by Subject|1|||
126251448|NCT01143337|454210727|FG000|Overall Study|Other reason|0|||
126251449|NCT01143337|454210728|FG001|Overall Study|Other reason|0|||
126251450|NCT01143337|454210729|FG002|Overall Study|Other reason|5|||
126251451|NCT02761915|454210730|FG000|Overall Study|Death|3|||
126251452|NCT02761915|454210731|FG001|Overall Study|Death|1|||
126251453|NCT02761915|454210732|FG002|Overall Study|Death|1|||
126251454|NCT02761915|454210733|FG003|Overall Study|Death|1|||
126251455|NCT02761915|454210734|FG004|Overall Study|Death|0|||
126251456|NCT02761915|454210735|FG005|Overall Study|Death|1|||
126251457|NCT02761915|454210730|FG000|Overall Study|Withdrawal by Subject|1|||
126251458|NCT02761915|454210731|FG001|Overall Study|Withdrawal by Subject|0|||
126251459|NCT02761915|454210732|FG002|Overall Study|Withdrawal by Subject|0|||
126251460|NCT02761915|454210733|FG003|Overall Study|Withdrawal by Subject|0|||
126251461|NCT02761915|454210734|FG004|Overall Study|Withdrawal by Subject|1|||
126251462|NCT02761915|454210735|FG005|Overall Study|Withdrawal by Subject|2|||
126251463|NCT02761915|454210730|FG000|Overall Study|Disease Progression|0|||
126251464|NCT02761915|454210731|FG001|Overall Study|Disease Progression|0|||
126251465|NCT02761915|454210732|FG002|Overall Study|Disease Progression|0|||
126251466|NCT02761915|454210733|FG003|Overall Study|Disease Progression|2|||
126029134|NCT03143153|453405070|FG002|Treatment|Participant request to discontinue study treatment|20|||
126029135|NCT03143153|453405068|FG000|Treatment|Participant withdrew consent|3|||
126029136|NCT03143153|453405069|FG001|Treatment|Participant withdrew consent|4|||
126029137|NCT03143153|453405070|FG002|Treatment|Participant withdrew consent|12|||
126029138|NCT03143153|453405068|FG000|Treatment|Pregnancy|1|||
126029139|NCT03143153|453405069|FG001|Treatment|Pregnancy|0|||
126029140|NCT03143153|453405070|FG002|Treatment|Pregnancy|0|||
126029141|NCT03143153|453405068|FG000|Treatment|Maximum clinical benefit|1|||
126029142|NCT03143153|453405069|FG001|Treatment|Maximum clinical benefit|3|||
126029143|NCT03143153|453405070|FG002|Treatment|Maximum clinical benefit|4|||
126029144|NCT03143153|453405068|FG000|Treatment|Completed treatment as per Protocol|13|||
126029145|NCT03143153|453405069|FG001|Treatment|Completed treatment as per Protocol|8|||
126029146|NCT03143153|453405070|FG002|Treatment|Completed treatment as per Protocol|0|||
126029147|NCT03143153|453405068|FG000|Treatment|Other reasons|12|||
126029148|NCT03143153|453405069|FG001|Treatment|Other reasons|7|||
126029149|NCT03143153|453405070|FG002|Treatment|Other reasons|15|||
126029150|NCT03143153|453405068|FG000|Treatment|Not reported|1|||
126029151|NCT03143153|453405069|FG001|Treatment|Not reported|0|||
126029152|NCT03143153|453405070|FG002|Treatment|Not reported|0|||
126029153|NCT02312557|453405071|FG000|Overall Study|Survival follow-up|4|||
126029154|NCT04237298|453405072|FG000|Overall Study|Lost to Follow-up|4|||
126029155|NCT04237298|453405073|FG001|Overall Study|Lost to Follow-up|5|||
126251467|NCT02761915|454210734|FG004|Overall Study|Disease Progression|2|||
126251468|NCT02761915|454210735|FG005|Overall Study|Disease Progression|2|||
126251469|NCT01151618|454210746|FG000|Overall Study|Adverse Event|2|||
126251470|NCT01151618|454210746|FG000|Overall Study|Withdrawal by Subject|7|||
126251471|NCT03277248|454210747|FG000|Overall Study|Adverse Event|3|||
126251472|NCT03277248|454210748|FG001|Overall Study|Adverse Event|1|||
126251473|NCT03277248|454210747|FG000|Overall Study|Subject Withdrawal of Consent|6|||
126251474|NCT03277248|454210748|FG001|Overall Study|Subject Withdrawal of Consent|23|||
126251475|NCT03277248|454210747|FG000|Overall Study|Investigator/Sponsor Decision|2|||
126251476|NCT03277248|454210748|FG001|Overall Study|Investigator/Sponsor Decision|2|||
126251477|NCT03277248|454210747|FG000|Overall Study|Pregnancy|4|||
126095438|NCT03001076|453643073|FG001|Overall Study|Adverse Event|3|||
126251478|NCT03277248|454210748|FG001|Overall Study|Pregnancy|1|||
126029156|NCT02736409|453405079|FG000|Overall Study|Withdrawal by Subject|4|||
126029157|NCT02736409|453405080|FG001|Overall Study|Withdrawal by Subject|2|||
126029158|NCT02736409|453405081|FG002|Overall Study|Withdrawal by Subject|17|||
126029159|NCT02736409|453405082|FG003|Overall Study|Withdrawal by Subject|3|||
126029160|NCT02736409|453405079|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126095439|NCT03001076|453643072|FG000|Overall Study|Sponsor decision|1|||
126251479|NCT03277248|454210747|FG000|Overall Study|Lost to Follow-up|0|||
126251480|NCT03277248|454210748|FG001|Overall Study|Lost to Follow-up|2|||
126251481|NCT03277248|454210747|FG000|Overall Study|Lack of Efficacy|0|||
126251482|NCT03277248|454210748|FG001|Overall Study|Lack of Efficacy|2|||
126251483|NCT03277248|454210747|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
126251484|NCT03277248|454210748|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
126251485|NCT01663896|454210749|FG000|Overall Study|Various reasons|43|||
126251486|NCT01824576|454210753|FG000|Overall Study|Device deficiency|2|||
126251487|NCT01691612|454210754|FG000|Overall Study|deemed ineligible after 1st visit|6|||
126251488|NCT01691612|454210754|FG000|Overall Study|Adverse Event|1|||
126251489|NCT03727139|454210755|FG000|Overall Study|Protocol Violation|60|||
126251490|NCT00566722|454210756|FG000|Overall Study|Adverse Event|0|||
126251491|NCT00566722|454210757|FG001|Overall Study|Adverse Event|1|||
126251492|NCT00566722|454210758|FG002|Overall Study|Adverse Event|0|||
126251493|NCT00566722|454210756|FG000|Overall Study|Withdrawal by Subject|0|||
126251494|NCT00566722|454210757|FG001|Overall Study|Withdrawal by Subject|0|||
126251495|NCT00566722|454210758|FG002|Overall Study|Withdrawal by Subject|1|||
126251496|NCT00566722|454210756|FG000|Overall Study|Lost to Follow-up|1|||
126251497|NCT00566722|454210757|FG001|Overall Study|Lost to Follow-up|1|||
126251498|NCT00566722|454210758|FG002|Overall Study|Lost to Follow-up|1|||
126251499|NCT00566722|454210756|FG000|Overall Study|Lack of Efficacy|1|||
126251500|NCT00566722|454210757|FG001|Overall Study|Lack of Efficacy|2|||
126251501|NCT00566722|454210758|FG002|Overall Study|Lack of Efficacy|4|||
126251502|NCT00566722|454210756|FG000|Overall Study|Did not meet exclusion criteria|0|||
126251503|NCT00566722|454210757|FG001|Overall Study|Did not meet exclusion criteria|0|||
126251504|NCT00566722|454210758|FG002|Overall Study|Did not meet exclusion criteria|2|||
126251505|NCT00566722|454210756|FG000|Overall Study|Serious adverse event|0|||
126251506|NCT00566722|454210757|FG001|Overall Study|Serious adverse event|1|||
126251507|NCT00566722|454210758|FG002|Overall Study|Serious adverse event|0|||
126251508|NCT00566722|454210756|FG000|Overall Study|Noncompliant with drug administration|0|||
126251509|NCT00566722|454210757|FG001|Overall Study|Noncompliant with drug administration|0|||
126251510|NCT00566722|454210758|FG002|Overall Study|Noncompliant with drug administration|1|||
126251511|NCT00858403|454210759|FG000|Overall Study|Withdrawal by Subject|1|||
126251512|NCT00858403|454210759|FG000|Overall Study|Death|3|||
126251513|NCT00858403|454210759|FG000|Overall Study|Disease Progression|1|||
126251514|NCT05315713|454210762|FG000|Overall Study|Death|5|||
126251515|NCT05315713|454210762|FG000|Overall Study|Progressive disease|1|||
126251516|NCT05315713|454210762|FG000|Overall Study|Withdrawal by Subject|1|||
126251517|NCT05315713|454210762|FG000|Overall Study|Study terminated by sponsor|1|||
126251518|NCT00556673|454210763|FG000|Overall Study|Protocol deviation|3|||
126251519|NCT00556673|454210764|FG001|Overall Study|Protocol deviation|2|||
126251520|NCT01131260|454210765|FG000|Overall Study|Randomization error|5|||
126251521|NCT01131260|454210766|FG001|Overall Study|Randomization error|1|||
126251522|NCT01131260|454210765|FG000|Overall Study|Declined to continue participation|8|||
126251523|NCT01131260|454210766|FG001|Overall Study|Declined to continue participation|13|||
126251524|NCT01131260|454210765|FG000|Overall Study|Physician Decision|22|||
126251525|NCT01131260|454210766|FG001|Overall Study|Physician Decision|24|||
126251526|NCT01131260|454210765|FG000|Overall Study|Technical problems|7|||
126251527|NCT01131260|454210766|FG001|Overall Study|Technical problems|6|||
126251528|NCT01131260|454210765|FG000|Overall Study|Staff error|2|||
126251529|NCT01131260|454210766|FG001|Overall Study|Staff error|1|||
126251530|NCT01131260|454210765|FG000|Overall Study|Ineligible|0|||
126251531|NCT01131260|454210766|FG001|Overall Study|Ineligible|2|||
126251532|NCT00874276|454210769|FG000|Overall Study|Withdrawal by Subject|1|||
126251533|NCT00874276|454210770|FG001|Overall Study|Withdrawal by Subject|1|||
126251534|NCT03694197|454210771|FG000|Overall Study|Adverse Event|9|||
126251535|NCT03694197|454210771|FG000|Overall Study|Protocol became inconvenient to participate|1|||
126251536|NCT03694197|454210771|FG000|Overall Study|Physician Decision|4|||
126251537|NCT03694197|454210771|FG000|Overall Study|Study terminated by sponsor|1350|||
126251538|NCT03694197|454210771|FG000|Overall Study|Participant moved|5|||
126251539|NCT03694197|454210771|FG000|Overall Study|Participant withdrew consent|10|||
126251540|NCT03694197|454210771|FG000|Overall Study|Related to IMP administration|1|||
126251541|NCT03694197|454210771|FG000|Overall Study|Not disclosed|5|||
126251542|NCT03506633|454212213|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
126251543|NCT03506633|454212214|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
126251544|NCT01894230|454212215|FG000|Overall Study|Lost to Follow-up|2|||
126251545|NCT01894230|454212216|FG001|Overall Study|Lost to Follow-up|2|||
126251546|NCT01894230|454212215|FG000|Overall Study|Withdrawal by Subject|4|||
126095440|NCT03001076|453643073|FG001|Overall Study|Sponsor decision|0|||
126251547|NCT01894230|454212216|FG001|Overall Study|Withdrawal by Subject|4|||
126251548|NCT01894230|454212215|FG000|Overall Study|Non-adherent|0|||
126251549|NCT01894230|454212216|FG001|Overall Study|Non-adherent|1|||
126251550|NCT01894230|454212215|FG000|Overall Study|Death|1|||
126251551|NCT01894230|454212216|FG001|Overall Study|Death|0|||
126251552|NCT01109849|454212219|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
126251553|NCT01109849|454212220|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
126251554|NCT01109849|454212221|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
126251555|NCT01109849|454212222|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
126251556|NCT01109849|454212223|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
126251557|NCT01109849|454212219|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
126251558|NCT01109849|454212220|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
126251559|NCT01109849|454212221|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
126251560|NCT01109849|454212222|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
126251561|NCT01109849|454212223|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
126251562|NCT01109849|454212219|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
126251563|NCT01109849|454212220|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
126251564|NCT01109849|454212221|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
126251565|NCT01109849|454212222|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
126251566|NCT01109849|454212223|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
126251567|NCT01109849|454212219|FG000|Initial Randomization: ADHD Treatment|move away|2|||
126251568|NCT01109849|454212220|FG001|Initial Randomization: ADHD Treatment|move away|7|||
126251569|NCT01109849|454212221|FG002|Initial Randomization: ADHD Treatment|move away|0|||
126251570|NCT01109849|454212222|FG003|Initial Randomization: ADHD Treatment|move away|0|||
126251571|NCT01109849|454212223|FG004|Initial Randomization: ADHD Treatment|move away|0|||
126251572|NCT01109849|454212219|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
126029161|NCT02736409|453405080|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126029162|NCT02736409|453405081|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126029163|NCT02736409|453405082|FG003|Overall Study|Non-Compliance with Study Drug|1|||
126029164|NCT02736409|453405079|FG000|Overall Study|Adverse Event|0|||
126029165|NCT02736409|453405080|FG001|Overall Study|Adverse Event|1|||
126029166|NCT02736409|453405081|FG002|Overall Study|Adverse Event|5|||
126029167|NCT02736409|453405082|FG003|Overall Study|Adverse Event|4|||
126029168|NCT02736409|453405079|FG000|Overall Study|Other|0|||
126029169|NCT02736409|453405080|FG001|Overall Study|Other|0|||
126029170|NCT02736409|453405081|FG002|Overall Study|Other|1|||
126029171|NCT02736409|453405082|FG003|Overall Study|Other|1|||
126029172|NCT02736409|453405079|FG000|Overall Study|Pregnancy|0|||
126029173|NCT02736409|453405080|FG001|Overall Study|Pregnancy|0|||
126029174|NCT02736409|453405081|FG002|Overall Study|Pregnancy|1|||
126029175|NCT02736409|453405082|FG003|Overall Study|Pregnancy|0|||
126029176|NCT02736409|453405079|FG000|Overall Study|Lost to Follow-up|0|||
126029177|NCT02736409|453405080|FG001|Overall Study|Lost to Follow-up|0|||
126029178|NCT02736409|453405081|FG002|Overall Study|Lost to Follow-up|2|||
126029179|NCT02736409|453405082|FG003|Overall Study|Lost to Follow-up|1|||
126029180|NCT02736409|453405079|FG000|Overall Study|Physician Decision|0|||
126251573|NCT01109849|454212220|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
126251574|NCT01109849|454212221|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
126251575|NCT01109849|454212222|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
126251576|NCT01109849|454212223|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
126251577|NCT01109849|454212219|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
126251578|NCT01109849|454212220|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
126029181|NCT02736409|453405080|FG001|Overall Study|Physician Decision|0|||
126029182|NCT02736409|453405081|FG002|Overall Study|Physician Decision|0|||
126029183|NCT02736409|453405082|FG003|Overall Study|Physician Decision|2|||
126251579|NCT01109849|454212221|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
126251580|NCT01109849|454212222|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
126251581|NCT01109849|454212223|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
126029184|NCT01415154|453405083|FG000|Overall Study|Lack of Efficacy|4|||
126029185|NCT01415154|453405084|FG001|Overall Study|Lack of Efficacy|5|||
126029186|NCT01415154|453405083|FG000|Overall Study|Withdrawal by Subject|7|||
126029187|NCT01415154|453405084|FG001|Overall Study|Withdrawal by Subject|8|||
126029188|NCT01415154|453405083|FG000|Overall Study|Lost to Follow-up|1|||
126029189|NCT01415154|453405084|FG001|Overall Study|Lost to Follow-up|4|||
126029190|NCT01415154|453405083|FG000|Overall Study|Protocol Violation|0|||
126029191|NCT01415154|453405084|FG001|Overall Study|Protocol Violation|1|||
126029192|NCT01415154|453405083|FG000|Overall Study|Satisfactory Response|0|||
126251582|NCT04364854|454212230|FG000|Overall Study|Withdrawal by Subject|1|||
126251583|NCT04364854|454212231|FG001|Overall Study|Withdrawal by Subject|0|||
126251584|NCT04364854|454212232|FG002|Overall Study|Withdrawal by Subject|1|||
126251585|NCT04364854|454212233|FG003|Overall Study|Withdrawal by Subject|3|||
126029193|NCT01415154|453405084|FG001|Overall Study|Satisfactory Response|1|||
126029194|NCT01415154|453405083|FG000|Overall Study|Adverse Event|1|||
126029195|NCT01415154|453405084|FG001|Overall Study|Adverse Event|1|||
126029196|NCT00170573|453405090|FG000|Overall Study|Violation of inclusion criteria|13|||
126029197|NCT04556656|453405092|FG000|Overall Study|Withdrawal by Subject|14|||
126029198|NCT04556656|453405093|FG001|Overall Study|Withdrawal by Subject|12|||
126029199|NCT04556656|453405092|FG000|Overall Study|Physician Decision|1|||
126029200|NCT04556656|453405093|FG001|Overall Study|Physician Decision|0|||
126029201|NCT04556656|453405092|FG000|Overall Study|Adverse Event|4|||
126029202|NCT04556656|453405093|FG001|Overall Study|Adverse Event|7|||
126029203|NCT04556656|453405092|FG000|Overall Study|Death|4|||
126029204|NCT04556656|453405093|FG001|Overall Study|Death|0|||
126029205|NCT04556656|453405092|FG000|Overall Study|Lost to Follow-up|3|||
126029206|NCT04556656|453405093|FG001|Overall Study|Lost to Follow-up|2|||
126029207|NCT04556656|453405092|FG000|Overall Study|Not further specified|2|||
126029208|NCT04556656|453405093|FG001|Overall Study|Not further specified|1|||
126029209|NCT05536440|453405108|FG000|Overall Study|Adverse Event|0|||
126029210|NCT05536440|453405109|FG001|Overall Study|Adverse Event|0|||
126029211|NCT05536440|453405110|FG002|Overall Study|Adverse Event|0|||
126029212|NCT05536440|453405111|FG003|Overall Study|Adverse Event|0|||
126029213|NCT05536440|453405112|FG004|Overall Study|Adverse Event|0|||
126029214|NCT05536440|453405113|FG005|Overall Study|Adverse Event|0|||
126029215|NCT05536440|453405114|FG006|Overall Study|Adverse Event|0|||
126029216|NCT05536440|453405115|FG007|Overall Study|Adverse Event|0|||
126029217|NCT05536440|453405116|FG008|Overall Study|Adverse Event|1|||
126029218|NCT06283173|453405117|FG000|Overall Study|Did not show for first visit|10|||
126029219|NCT06283173|453405117|FG000|Overall Study|Lost to Follow-up|12|||
126029220|NCT06283173|453405117|FG000|Overall Study|Physician Decision|7|||
126029221|NCT04784559|453405127|FG000|Overall Study|Withdrawal by Subject|3|||
126029222|NCT04784559|453405128|FG001|Overall Study|Withdrawal by Subject|2|||
126029223|NCT04784559|453405129|FG002|Overall Study|Withdrawal by Subject|1|||
126251586|NCT04364854|454212230|FG000|Overall Study|Death|1|||
126029224|NCT04784559|453405127|FG000|Overall Study|Death|2|||
126029225|NCT04784559|453405128|FG001|Overall Study|Death|1|||
126029226|NCT04784559|453405129|FG002|Overall Study|Death|2|||
126029227|NCT04784559|453405127|FG000|Overall Study|Lost to Follow-up|0|||
126029228|NCT04784559|453405128|FG001|Overall Study|Lost to Follow-up|0|||
126029229|NCT04784559|453405129|FG002|Overall Study|Lost to Follow-up|2|||
126029230|NCT04784559|453405127|FG000|Overall Study|Participant worsened, PI decision|1|||
126029231|NCT04784559|453405128|FG001|Overall Study|Participant worsened, PI decision|0|||
126029232|NCT04784559|453405129|FG002|Overall Study|Participant worsened, PI decision|0|||
126029233|NCT04784559|453405127|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
126029234|NCT04784559|453405128|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
126251587|NCT04364854|454212231|FG001|Overall Study|Death|0|||
126251588|NCT04364854|454212232|FG002|Overall Study|Death|0|||
126251589|NCT04364854|454212233|FG003|Overall Study|Death|0|||
126251590|NCT04364854|454212230|FG000|Overall Study|Lost to Follow-up|0|||
126251591|NCT04364854|454212231|FG001|Overall Study|Lost to Follow-up|0|||
126251592|NCT04364854|454212232|FG002|Overall Study|Lost to Follow-up|0|||
126251593|NCT04364854|454212233|FG003|Overall Study|Lost to Follow-up|1|||
126029235|NCT04784559|453405129|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
126029236|NCT04784559|453405127|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
126251594|NCT02435433|454212238|FG000|Overall Study|Withdrawal by Subject|2|||
126251595|NCT02435433|454212239|FG001|Overall Study|Withdrawal by Subject|3|||
126251596|NCT02435433|454212240|FG002|Overall Study|Withdrawal by Subject|1|||
126251597|NCT02435433|454212241|FG003|Overall Study|Withdrawal by Subject|0|||
126251598|NCT02435433|454212242|FG004|Overall Study|Withdrawal by Subject|0|||
126251599|NCT02435433|454212238|FG000|Overall Study|Lost to Follow-up|2|||
126251600|NCT02435433|454212239|FG001|Overall Study|Lost to Follow-up|2|||
126251601|NCT02435433|454212240|FG002|Overall Study|Lost to Follow-up|4|||
126251602|NCT02435433|454212241|FG003|Overall Study|Lost to Follow-up|1|||
126251603|NCT02435433|454212242|FG004|Overall Study|Lost to Follow-up|0|||
126251604|NCT00757705|454212243|FG000|Overall Study|Adverse Event|19|||
126251605|NCT00757705|454212243|FG000|Overall Study|Lost to Follow-up|16|||
126251606|NCT00757705|454212243|FG000|Overall Study|Withdrawal by Subject|25|||
126251607|NCT00757705|454212243|FG000|Overall Study|Insufficient Response|26|||
126251608|NCT00757705|454212243|FG000|Overall Study|Ineligible to continue|8|||
126251609|NCT00757705|454212243|FG000|Overall Study|Non-compliant|9|||
126251610|NCT00757705|454212243|FG000|Overall Study|Other|18|||
126251611|NCT00659815|454212244|FG000|Overall Study|Study related symptoms and complaints|2|||
126251612|NCT00659815|454212245|FG001|Overall Study|Study related symptoms and complaints|1|||
126251613|NCT00659815|454212244|FG000|Overall Study|Inability to maintain wearing schedule|1|||
126251614|NCT00659815|454212245|FG001|Overall Study|Inability to maintain wearing schedule|2|||
126251615|NCT00659815|454212244|FG000|Overall Study|Withdrawal by Subject|1|||
126251616|NCT00659815|454212245|FG001|Overall Study|Withdrawal by Subject|1|||
126251617|NCT00735696|454212250|FG000|Overall Study|Withdrawal by Subject|1|||
126251618|NCT00735696|454212250|FG000|Overall Study|Enrolled but never Treated|1|||
126251619|NCT00640393|454212252|FG000|Part 1|Lost to Follow-up|2|||
126251620|NCT00640393|454212253|FG001|Part 1|Lost to Follow-up|0|||
126251621|NCT00640393|454212254|FG002|Part 1|Lost to Follow-up|0|||
126251622|NCT00640393|454212252|FG000|Part 1|Withdrawal by Subject|3|||
126251623|NCT00640393|454212253|FG001|Part 1|Withdrawal by Subject|0|||
126251624|NCT00640393|454212254|FG002|Part 1|Withdrawal by Subject|0|||
126251625|NCT00640393|454212252|FG000|Randomization|Withdrawn per protocol|17|||
126251626|NCT00640393|454212253|FG001|Randomization|Withdrawn per protocol|0|||
126251627|NCT00640393|454212254|FG002|Randomization|Withdrawn per protocol|0|||
126251628|NCT00640393|454212252|FG000|Randomization|Never randomized by site|2|||
126251629|NCT00640393|454212253|FG001|Randomization|Never randomized by site|0|||
126251630|NCT00640393|454212254|FG002|Randomization|Never randomized by site|0|||
126251631|NCT00640393|454212252|FG000|Part 2|Lost to Follow-up|0|||
126251632|NCT00640393|454212253|FG001|Part 2|Lost to Follow-up|2|||
126251633|NCT00640393|454212254|FG002|Part 2|Lost to Follow-up|2|||
126251634|NCT00640393|454212252|FG000|Part 2|Withdrawal by Subject|0|||
126251635|NCT00640393|454212253|FG001|Part 2|Withdrawal by Subject|6|||
126251636|NCT00640393|454212254|FG002|Part 2|Withdrawal by Subject|1|||
126251637|NCT00640393|454212252|FG000|Part 2|Non-adherence|0|||
126251638|NCT00640393|454212253|FG001|Part 2|Non-adherence|1|||
126251639|NCT00640393|454212254|FG002|Part 2|Non-adherence|0|||
126251640|NCT00640393|454212252|FG000|Part 2|Adverse Event|0|||
126251641|NCT00640393|454212253|FG001|Part 2|Adverse Event|1|||
126251642|NCT00640393|454212254|FG002|Part 2|Adverse Event|0|||
126251643|NCT04406194|454212255|FG000|Period 1|Withdrawal by Subject|0|||
126251644|NCT04406194|454212256|FG001|Period 1|Withdrawal by Subject|1|||
126251645|NCT03540160|454212257|FG000|Overall Study|Protocol Violation|1|||
126251646|NCT03540160|454212257|FG000|Overall Study|Physician Decision|8|||
126029237|NCT04784559|453405128|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
126029238|NCT04784559|453405129|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
126029239|NCT04784559|453405127|FG000|Overall Study|Did not meet all inclusion criteria|0|||
126029240|NCT04784559|453405128|FG001|Overall Study|Did not meet all inclusion criteria|1|||
126029241|NCT04784559|453405129|FG002|Overall Study|Did not meet all inclusion criteria|0|||
126251647|NCT03540160|454212257|FG000|Overall Study|Lack of Efficacy|60|||
126251648|NCT03540160|454212257|FG000|Overall Study|Pregnancy|1|||
126251649|NCT03540160|454212257|FG000|Overall Study|Adverse Event|20|||
126251650|NCT03540160|454212257|FG000|Overall Study|Withdrawal by Subject|68|||
126251651|NCT03540160|454212257|FG000|Overall Study|COVID-19|2|||
126251652|NCT03540160|454212257|FG000|Overall Study|Study Closure|10|||
126251653|NCT03540160|454212257|FG000|Overall Study|Lost to Follow-up|18|||
126251654|NCT03540160|454212257|FG000|Overall Study|Sponsor decision|191|||
126251655|NCT01664039|454212258|FG000|Overall Study|Adverse Event|3|||
126251656|NCT01664039|454212259|FG001|Overall Study|Adverse Event|4|||
126251657|NCT01664039|454212258|FG000|Overall Study|Lost to Follow-up|1|||
126251658|NCT01664039|454212259|FG001|Overall Study|Lost to Follow-up|1|||
126251659|NCT01664039|454212258|FG000|Overall Study|Withdrawal by Subject|1|||
126251660|NCT01664039|454212259|FG001|Overall Study|Withdrawal by Subject|3|||
126251661|NCT01664039|454212258|FG000|Overall Study|Noncompliance|1|||
126251662|NCT01664039|454212259|FG001|Overall Study|Noncompliance|1|||
126251663|NCT02640235|454212263|FG000|Overall Study|Withdrawal by Subject|7|||
126251664|NCT02640235|454212264|FG001|Overall Study|Withdrawal by Subject|6|||
126251665|NCT02640235|454212263|FG000|Overall Study|Lost to Follow-up|4|||
126251666|NCT02640235|454212264|FG001|Overall Study|Lost to Follow-up|3|||
126251667|NCT02640235|454212263|FG000|Overall Study|Death|2|||
126251668|NCT02640235|454212264|FG001|Overall Study|Death|3|||
126251669|NCT02640235|454212263|FG000|Overall Study|Other|1|||
126251670|NCT02640235|454212264|FG001|Overall Study|Other|2|||
126251671|NCT00819169|454212269|FG000|Overall Study|Withdrawal by Subject|2|||
126251672|NCT00819169|454212270|FG001|Overall Study|Withdrawal by Subject|0|||
126251673|NCT00819169|454212271|FG002|Overall Study|Withdrawal by Subject|0|||
126251674|NCT00819169|454212272|FG003|Overall Study|Withdrawal by Subject|1|||
126251675|NCT00819169|454212273|FG004|Overall Study|Withdrawal by Subject|1|||
126251676|NCT00819169|454212274|FG005|Overall Study|Withdrawal by Subject|1|||
126251677|NCT00819169|454212275|FG006|Overall Study|Withdrawal by Subject|5|||
126251678|NCT00819169|454212276|FG007|Overall Study|Withdrawal by Subject|1|||
126251679|NCT00819169|454212277|FG008|Overall Study|Withdrawal by Subject|4|||
126251680|NCT00819169|454212269|FG000|Overall Study|Lost to Follow-up|0|||
126251681|NCT00819169|454212270|FG001|Overall Study|Lost to Follow-up|2|||
126251682|NCT00819169|454212271|FG002|Overall Study|Lost to Follow-up|0|||
126251683|NCT00819169|454212272|FG003|Overall Study|Lost to Follow-up|1|||
126251684|NCT00819169|454212273|FG004|Overall Study|Lost to Follow-up|0|||
126251685|NCT00819169|454212274|FG005|Overall Study|Lost to Follow-up|6|||
126251686|NCT00819169|454212275|FG006|Overall Study|Lost to Follow-up|2|||
126251687|NCT00819169|454212276|FG007|Overall Study|Lost to Follow-up|2|||
126251688|NCT00819169|454212277|FG008|Overall Study|Lost to Follow-up|1|||
126251689|NCT00819169|454212269|FG000|Overall Study|Death|1|||
126251690|NCT00819169|454212270|FG001|Overall Study|Death|1|||
126251691|NCT00819169|454212271|FG002|Overall Study|Death|3|||
126251692|NCT00819169|454212272|FG003|Overall Study|Death|8|||
126251693|NCT00819169|454212273|FG004|Overall Study|Death|5|||
126251694|NCT00819169|454212274|FG005|Overall Study|Death|7|||
126251695|NCT00819169|454212275|FG006|Overall Study|Death|9|||
126251696|NCT00819169|454212276|FG007|Overall Study|Death|4|||
126251697|NCT00819169|454212277|FG008|Overall Study|Death|7|||
126251698|NCT00819169|454212269|FG000|Overall Study|Ineligibility determined|0|||
126251699|NCT00819169|454212270|FG001|Overall Study|Ineligibility determined|0|||
126251700|NCT00819169|454212271|FG002|Overall Study|Ineligibility determined|0|||
126251701|NCT00819169|454212272|FG003|Overall Study|Ineligibility determined|2|||
126251702|NCT00819169|454212273|FG004|Overall Study|Ineligibility determined|0|||
126251703|NCT00819169|454212274|FG005|Overall Study|Ineligibility determined|0|||
126251704|NCT00819169|454212275|FG006|Overall Study|Ineligibility determined|0|||
126251705|NCT00819169|454212276|FG007|Overall Study|Ineligibility determined|0|||
126251706|NCT00819169|454212277|FG008|Overall Study|Ineligibility determined|1|||
126251707|NCT00819169|454212269|FG000|Overall Study|Adverse Event|0|||
126251708|NCT00819169|454212270|FG001|Overall Study|Adverse Event|0|||
126251709|NCT00819169|454212271|FG002|Overall Study|Adverse Event|0|||
126251710|NCT00819169|454212272|FG003|Overall Study|Adverse Event|0|||
126251711|NCT00819169|454212273|FG004|Overall Study|Adverse Event|1|||
126251712|NCT00819169|454212274|FG005|Overall Study|Adverse Event|0|||
126251713|NCT00819169|454212275|FG006|Overall Study|Adverse Event|0|||
126251714|NCT00819169|454212276|FG007|Overall Study|Adverse Event|0|||
126251715|NCT00819169|454212277|FG008|Overall Study|Adverse Event|0|||
126251716|NCT00819169|454212269|FG000|Overall Study|Administrative Decision|0|||
126251717|NCT00819169|454212270|FG001|Overall Study|Administrative Decision|0|||
126251718|NCT00819169|454212271|FG002|Overall Study|Administrative Decision|0|||
126251719|NCT00819169|454212272|FG003|Overall Study|Administrative Decision|0|||
126029242|NCT04784559|453405127|FG000|Overall Study|The participant was transferred to IRCU|0|||
126251720|NCT00819169|454212273|FG004|Overall Study|Administrative Decision|1|||
126251721|NCT00819169|454212274|FG005|Overall Study|Administrative Decision|2|||
126029243|NCT04784559|453405128|FG001|Overall Study|The participant was transferred to IRCU|1|||
126029244|NCT04784559|453405129|FG002|Overall Study|The participant was transferred to IRCU|0|||
126029245|NCT04784559|453405127|FG000|Overall Study|SAE|0|||
126251722|NCT00819169|454212275|FG006|Overall Study|Administrative Decision|0|||
126029246|NCT04784559|453405128|FG001|Overall Study|SAE|1|||
126029247|NCT04784559|453405129|FG002|Overall Study|SAE|0|||
126029248|NCT04784559|453405127|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
126029249|NCT04784559|453405128|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
126251723|NCT00819169|454212276|FG007|Overall Study|Administrative Decision|2|||
126251724|NCT00819169|454212277|FG008|Overall Study|Administrative Decision|0|||
126251725|NCT00406393|454212278|FG000|Overall Study|Did not undergo transplantation|2|||
126251726|NCT00406393|454212279|FG001|Overall Study|Did not undergo transplantation|1|||
126251727|NCT01046084|454212284|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
126029250|NCT04784559|453405129|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
126029251|NCT03138512|453405130|FG000|Randomization|Participants withdrew consent|0|||
126029252|NCT03138512|453405131|FG001|Randomization|Participants withdrew consent|1|||
126029253|NCT03138512|453405132|FG002|Randomization|Participants withdrew consent|1|||
126029254|NCT03138512|453405133|FG003|Randomization|Participants withdrew consent|0|||
126029255|NCT03138512|453405134|FG004|Randomization|Participants withdrew consent|0|||
126029256|NCT03138512|453405130|FG000|Randomization|Participant no longer meets study criteria|0|||
126029257|NCT03138512|453405131|FG001|Randomization|Participant no longer meets study criteria|3|||
126029258|NCT03138512|453405132|FG002|Randomization|Participant no longer meets study criteria|1|||
126029259|NCT03138512|453405133|FG003|Randomization|Participant no longer meets study criteria|1|||
126029260|NCT03138512|453405134|FG004|Randomization|Participant no longer meets study criteria|3|||
126029261|NCT03138512|453405130|FG000|Randomization|Other reasons|1|||
126029262|NCT03138512|453405131|FG001|Randomization|Other reasons|0|||
126029263|NCT03138512|453405132|FG002|Randomization|Other reasons|0|||
126029264|NCT03138512|453405133|FG003|Randomization|Other reasons|0|||
126029265|NCT03138512|453405134|FG004|Randomization|Other reasons|0|||
126029266|NCT03138512|453405130|FG000|Treatment Part A|Disease recurrence|10|||
126029267|NCT03138512|453405131|FG001|Treatment Part A|Disease recurrence|20|||
126029268|NCT03138512|453405132|FG002|Treatment Part A|Disease recurrence|0|||
126029269|NCT03138512|453405133|FG003|Treatment Part A|Disease recurrence|0|||
126029270|NCT03138512|453405134|FG004|Treatment Part A|Disease recurrence|0|||
126029271|NCT03138512|453405130|FG000|Treatment Part A|Study Drug Toxicity|132|||
126029272|NCT03138512|453405131|FG001|Treatment Part A|Study Drug Toxicity|5|||
126029273|NCT03138512|453405132|FG002|Treatment Part A|Study Drug Toxicity|0|||
126029274|NCT03138512|453405133|FG003|Treatment Part A|Study Drug Toxicity|0|||
126029275|NCT03138512|453405134|FG004|Treatment Part A|Study Drug Toxicity|0|||
126029276|NCT03138512|453405130|FG000|Treatment Part A|Death|1|||
126029277|NCT03138512|453405131|FG001|Treatment Part A|Death|0|||
126029278|NCT03138512|453405132|FG002|Treatment Part A|Death|0|||
126029279|NCT03138512|453405133|FG003|Treatment Part A|Death|0|||
126029280|NCT03138512|453405134|FG004|Treatment Part A|Death|0|||
126029281|NCT03138512|453405130|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
126029282|NCT03138512|453405131|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
126029283|NCT03138512|453405132|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
126029284|NCT03138512|453405133|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
126251728|NCT01046084|454212285|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
126251729|NCT02166606|454212286|FG000|Overall Study|Adverse Event|3|||
126251730|NCT02166606|454212286|FG000|Overall Study|Death|31|||
126251731|NCT02166606|454212286|FG000|Overall Study|Protocol Violation|7|||
126251732|NCT02166606|454212286|FG000|Overall Study|Lost to Follow-up|30|||
126251733|NCT02166606|454212286|FG000|Overall Study|Withdrawal by Subject|1|||
126251734|NCT02166606|454212286|FG000|Overall Study|Physician Decision|1|||
126251735|NCT02166606|454212286|FG000|Overall Study|Device upgrade|1|||
126251736|NCT02166606|454212286|FG000|Overall Study|Enrolled after End of Enrollment|4|||
126251737|NCT00379353|454212289|FG000|Overall Study|Hospitalization|3|||
126251738|NCT00379353|454212290|FG001|Overall Study|Hospitalization|3|||
126251739|NCT00379353|454212289|FG000|Overall Study|Withdrawal by Subject|5|||
126251740|NCT00379353|454212290|FG001|Overall Study|Withdrawal by Subject|2|||
126251741|NCT00379353|454212289|FG000|Overall Study|Death|1|||
126251742|NCT00379353|454212290|FG001|Overall Study|Death|0|||
126251743|NCT00379353|454212289|FG000|Overall Study|Cardiac Tamponade|1|||
126251744|NCT00379353|454212290|FG001|Overall Study|Cardiac Tamponade|0|||
126251745|NCT00379353|454212289|FG000|Overall Study|Non-compliance|1|||
126251746|NCT00379353|454212290|FG001|Overall Study|Non-compliance|0|||
126251747|NCT00379353|454212289|FG000|Overall Study|Conflicting drug treatment|0|||
126251748|NCT00379353|454212290|FG001|Overall Study|Conflicting drug treatment|1|||
126251749|NCT03614728|454212291|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
126251750|NCT03614728|454212292|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
126251751|NCT03614728|454212293|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
126251752|NCT03614728|454212294|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
126251753|NCT03614728|454212291|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
126029285|NCT03138512|453405134|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
126251754|NCT03614728|454212292|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
126251755|NCT03614728|454212293|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
126251756|NCT03614728|454212294|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
126251757|NCT01958476|454212295|FG000|Overall Study|Parent requested exclusion from analysis|1|||
126251758|NCT01958476|454212296|FG001|Overall Study|Parent requested exclusion from analysis|0|||
126251759|NCT05412121|454212301|FG000|Overall Study|Withdrawal by Subject|4|||
126251760|NCT05412121|454212301|FG000|Overall Study|Physician Decision|1|||
126029286|NCT03138512|453405130|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
126095441|NCT03001076|453643072|FG000|Overall Study|Lost to Follow-up|0|||
126251761|NCT05412121|454212301|FG000|Overall Study|Lost to Follow-up|5|||
126251762|NCT02670551|454212302|FG000|Overall Study|Adverse Event|4|||
126251763|NCT02670551|454212303|FG001|Overall Study|Adverse Event|7|||
126251764|NCT02670551|454212304|FG002|Overall Study|Adverse Event|9|||
126251765|NCT02670551|454212302|FG000|Overall Study|Lack of Efficacy|2|||
126251766|NCT02670551|454212303|FG001|Overall Study|Lack of Efficacy|0|||
126251767|NCT02670551|454212304|FG002|Overall Study|Lack of Efficacy|3|||
126251768|NCT02670551|454212302|FG000|Overall Study|Withdrawal of Consent|6|||
126251769|NCT02670551|454212303|FG001|Overall Study|Withdrawal of Consent|3|||
126251770|NCT02670551|454212304|FG002|Overall Study|Withdrawal of Consent|8|||
126251771|NCT02670551|454212302|FG000|Overall Study|Lost to Follow-up|5|||
126251772|NCT02670551|454212303|FG001|Overall Study|Lost to Follow-up|7|||
126251773|NCT02670551|454212304|FG002|Overall Study|Lost to Follow-up|6|||
126251774|NCT02670551|454212302|FG000|Overall Study|Protocol Violation|1|||
126251775|NCT02670551|454212303|FG001|Overall Study|Protocol Violation|0|||
126251776|NCT02670551|454212304|FG002|Overall Study|Protocol Violation|0|||
126251777|NCT02670551|454212302|FG000|Overall Study|Noncompliance with study drug|3|||
126251778|NCT02670551|454212303|FG001|Overall Study|Noncompliance with study drug|3|||
126251779|NCT02670551|454212304|FG002|Overall Study|Noncompliance with study drug|2|||
126251780|NCT02670551|454212302|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126251781|NCT02670551|454212303|FG001|Overall Study|Other Miscellaneous Reasons|3|||
126251782|NCT02670551|454212304|FG002|Overall Study|Other Miscellaneous Reasons|3|||
126251783|NCT02670551|454212302|FG000|Overall Study|Did Not Receive Treatment|5|||
126251784|NCT02670551|454212303|FG001|Overall Study|Did Not Receive Treatment|3|||
126251785|NCT02670551|454212304|FG002|Overall Study|Did Not Receive Treatment|0|||
126251786|NCT04476277|454212305|FG000|Overall Study|Withdrawal by Subject|0|||
126251787|NCT04476277|454212306|FG001|Overall Study|Withdrawal by Subject|0|||
126251788|NCT04476277|454212307|FG002|Overall Study|Withdrawal by Subject|1|||
126251789|NCT04476277|454212308|FG003|Overall Study|Withdrawal by Subject|0|||
126251790|NCT01971645|454212309|FG000|Overall Study|Adverse Event|1|||
126251791|NCT01971645|454212310|FG001|Overall Study|Adverse Event|0|||
126251792|NCT01971645|454212311|FG002|Overall Study|Adverse Event|0|||
126251793|NCT01971645|454212309|FG000|Overall Study|Lost to Follow-up|1|||
126251794|NCT01971645|454212310|FG001|Overall Study|Lost to Follow-up|0|||
126251795|NCT01971645|454212311|FG002|Overall Study|Lost to Follow-up|1|||
126251796|NCT01971645|454212309|FG000|Overall Study|Protocol Violation|0|||
126095442|NCT03001076|453643073|FG001|Overall Study|Lost to Follow-up|2|||
126251797|NCT01971645|454212310|FG001|Overall Study|Protocol Violation|0|||
126251798|NCT01971645|454212311|FG002|Overall Study|Protocol Violation|1|||
126251799|NCT01962298|454212312|FG000|Overall Study|Protocol Violation|1|||
126251800|NCT01962298|454212313|FG001|Overall Study|Protocol Violation|0|||
126251801|NCT01962298|454212314|FG002|Overall Study|Protocol Violation|1|||
126251802|NCT01962298|454212315|FG003|Overall Study|Protocol Violation|1|||
126251803|NCT01962298|454212316|FG004|Overall Study|Protocol Violation|0|||
126251804|NCT01962298|454212312|FG000|Overall Study|Data quality insufficient|2|||
126251805|NCT01962298|454212313|FG001|Overall Study|Data quality insufficient|0|||
126251806|NCT01962298|454212314|FG002|Overall Study|Data quality insufficient|3|||
126251807|NCT01962298|454212315|FG003|Overall Study|Data quality insufficient|1|||
126251808|NCT01962298|454212316|FG004|Overall Study|Data quality insufficient|4|||
126251809|NCT01962298|454212312|FG000|Overall Study|Insufficient data|0|||
126251810|NCT01962298|454212313|FG001|Overall Study|Insufficient data|2|||
126251811|NCT01962298|454212314|FG002|Overall Study|Insufficient data|1|||
126251812|NCT01962298|454212315|FG003|Overall Study|Insufficient data|0|||
126251813|NCT01962298|454212316|FG004|Overall Study|Insufficient data|1|||
126251814|NCT01962298|454212312|FG000|Overall Study|Incorrect data recorded|0|||
126251815|NCT01962298|454212313|FG001|Overall Study|Incorrect data recorded|1|||
126251816|NCT01962298|454212314|FG002|Overall Study|Incorrect data recorded|0|||
126251817|NCT01962298|454212315|FG003|Overall Study|Incorrect data recorded|0|||
126251818|NCT01962298|454212316|FG004|Overall Study|Incorrect data recorded|0|||
126251819|NCT01962298|454212312|FG000|Overall Study|Physician Decision|0|||
126251820|NCT01962298|454212313|FG001|Overall Study|Physician Decision|1|||
126251821|NCT01962298|454212314|FG002|Overall Study|Physician Decision|0|||
126251822|NCT01962298|454212315|FG003|Overall Study|Physician Decision|0|||
126251823|NCT01962298|454212316|FG004|Overall Study|Physician Decision|1|||
126251824|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
126251825|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
126251826|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
126251827|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
126251828|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Death|3|||
126251829|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Death|1|||
126251830|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
126251831|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
126251832|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
126251833|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
126251834|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
126251835|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
126251836|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Adverse Event|2|||
126251837|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Adverse Event|11|||
126251838|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
125879760|NCT03104868|452857382|FG001|6 Week Follow up|Death|1|||
126251839|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
125879761|NCT03104868|452857381|FG000|6 Week Follow up|Withdrawal by Subject|7|||
125879762|NCT03104868|452857382|FG001|6 Week Follow up|Withdrawal by Subject|6|||
126251840|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Death|2|||
126251841|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Death|2|||
126251842|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
126251843|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
126251844|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
126251845|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
126251846|NCT00533507|454212319|FG000|Overall Study|Withdrawal by Subject|1|||
126251847|NCT01576705|454212320|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
126251848|NCT01576705|454212321|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
126251849|NCT01576705|454212322|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
126251850|NCT01576705|454212323|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
126251851|NCT01576705|454212320|FG000|Overall Study|invalid ICF|0|||
126251852|NCT01576705|454212321|FG001|Overall Study|invalid ICF|1|||
126029287|NCT03138512|453405131|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
126029288|NCT03138512|453405132|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
126029289|NCT03138512|453405133|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
126029290|NCT03138512|453405134|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
126251853|NCT01576705|454212322|FG002|Overall Study|invalid ICF|0|||
126251854|NCT01576705|454212323|FG003|Overall Study|invalid ICF|0|||
126251855|NCT02597049|454212324|FG000|Overall Study|Lost to Follow-up|0|||
126251856|NCT02597049|454212325|FG001|Overall Study|Lost to Follow-up|3|||
126251857|NCT02597049|454212326|FG002|Overall Study|Lost to Follow-up|2|||
126251858|NCT02597049|454212324|FG000|Overall Study|Withdrawal by Subject|2|||
126251859|NCT02597049|454212325|FG001|Overall Study|Withdrawal by Subject|2|||
126251860|NCT02597049|454212326|FG002|Overall Study|Withdrawal by Subject|1|||
126251861|NCT02597049|454212324|FG000|Overall Study|Adverse Event|2|||
126251862|NCT02597049|454212325|FG001|Overall Study|Adverse Event|0|||
126029291|NCT03138512|453405130|FG000|Treatment Part A|Participant withdrew consent|2|||
126029292|NCT03138512|453405131|FG001|Treatment Part A|Participant withdrew consent|4|||
126029293|NCT03138512|453405132|FG002|Treatment Part A|Participant withdrew consent|0|||
126029294|NCT03138512|453405133|FG003|Treatment Part A|Participant withdrew consent|0|||
126029295|NCT03138512|453405134|FG004|Treatment Part A|Participant withdrew consent|0|||
126029296|NCT03138512|453405130|FG000|Treatment Part A|Lost to Follow-up|0|||
126251863|NCT02597049|454212326|FG002|Overall Study|Adverse Event|0|||
126251864|NCT02597049|454212324|FG000|Overall Study|Death|2|||
126029297|NCT03138512|453405131|FG001|Treatment Part A|Lost to Follow-up|1|||
126029298|NCT03138512|453405132|FG002|Treatment Part A|Lost to Follow-up|0|||
126029299|NCT03138512|453405133|FG003|Treatment Part A|Lost to Follow-up|0|||
126029300|NCT03138512|453405134|FG004|Treatment Part A|Lost to Follow-up|0|||
126029301|NCT03138512|453405130|FG000|Treatment Part A|Poor/non-compliance|1|||
126029302|NCT03138512|453405131|FG001|Treatment Part A|Poor/non-compliance|0|||
126029303|NCT03138512|453405132|FG002|Treatment Part A|Poor/non-compliance|0|||
126029304|NCT03138512|453405133|FG003|Treatment Part A|Poor/non-compliance|0|||
126029305|NCT03138512|453405134|FG004|Treatment Part A|Poor/non-compliance|0|||
126029306|NCT03138512|453405130|FG000|Treatment Part A|Pregnancy|0|||
126029307|NCT03138512|453405131|FG001|Treatment Part A|Pregnancy|1|||
126029308|NCT03138512|453405132|FG002|Treatment Part A|Pregnancy|0|||
126029309|NCT03138512|453405133|FG003|Treatment Part A|Pregnancy|0|||
126029310|NCT03138512|453405134|FG004|Treatment Part A|Pregnancy|0|||
126029311|NCT03138512|453405130|FG000|Treatment Part A|Other reasons|11|||
126029312|NCT03138512|453405131|FG001|Treatment Part A|Other reasons|8|||
126029313|NCT03138512|453405132|FG002|Treatment Part A|Other reasons|0|||
126029314|NCT03138512|453405133|FG003|Treatment Part A|Other reasons|0|||
126029315|NCT03138512|453405134|FG004|Treatment Part A|Other reasons|0|||
126029316|NCT03138512|453405130|FG000|Treatment Part B|Disease recurrence|0|||
126029317|NCT03138512|453405131|FG001|Treatment Part B|Disease recurrence|0|||
126029318|NCT03138512|453405132|FG002|Treatment Part B|Disease recurrence|6|||
126251865|NCT02597049|454212325|FG001|Overall Study|Death|0|||
126251866|NCT02597049|454212326|FG002|Overall Study|Death|0|||
126029319|NCT03138512|453405133|FG003|Treatment Part B|Disease recurrence|12|||
126029320|NCT03138512|453405134|FG004|Treatment Part B|Disease recurrence|10|||
126029321|NCT03138512|453405130|FG000|Treatment Part B|Study drug toxicity|0|||
126029322|NCT03138512|453405131|FG001|Treatment Part B|Study drug toxicity|0|||
126029323|NCT03138512|453405132|FG002|Treatment Part B|Study drug toxicity|63|||
126029324|NCT03138512|453405133|FG003|Treatment Part B|Study drug toxicity|3|||
126029325|NCT03138512|453405134|FG004|Treatment Part B|Study drug toxicity|45|||
126029326|NCT03138512|453405130|FG000|Treatment Part B|Death|0|||
126029327|NCT03138512|453405131|FG001|Treatment Part B|Death|0|||
126029328|NCT03138512|453405132|FG002|Treatment Part B|Death|1|||
126029329|NCT03138512|453405133|FG003|Treatment Part B|Death|0|||
126251867|NCT02597049|454212324|FG000|Overall Study|Noncompliant with Study Visits|1|||
126251868|NCT02597049|454212325|FG001|Overall Study|Noncompliant with Study Visits|0|||
126251869|NCT02597049|454212326|FG002|Overall Study|Noncompliant with Study Visits|0|||
126251870|NCT00243347|454212329|FG000|Overall Study|Lack of Efficacy|4|||
126251871|NCT00243347|454212329|FG000|Overall Study|Adverse Event|2|||
126251872|NCT00243347|454212329|FG000|Overall Study|Death|1|||
126251873|NCT00243347|454212329|FG000|Overall Study|Withdrawal by Subject|5|||
126251874|NCT00243347|454212329|FG000|Overall Study|Condition worsened|7|||
126251875|NCT01390948|454212331|FG000|Overall Study|End of Study|1|||
126251876|NCT01390948|454212332|FG001|Overall Study|End of Study|0|||
126251877|NCT01390948|454212333|FG002|Overall Study|End of Study|0|||
126251878|NCT01390948|454212331|FG000|Overall Study|Withdrew consent|2|||
126251879|NCT01390948|454212332|FG001|Overall Study|Withdrew consent|2|||
126251880|NCT01390948|454212333|FG002|Overall Study|Withdrew consent|0|||
126251881|NCT01390948|454212331|FG000|Overall Study|Progressive Disease|2|||
126251882|NCT01390948|454212332|FG001|Overall Study|Progressive Disease|5|||
126251883|NCT01390948|454212333|FG002|Overall Study|Progressive Disease|0|||
126251884|NCT01390948|454212331|FG000|Overall Study|Death during follow-up|10|||
126251885|NCT01390948|454212332|FG001|Overall Study|Death during follow-up|11|||
126251886|NCT01390948|454212333|FG002|Overall Study|Death during follow-up|1|||
126251887|NCT01401062|454212336|FG000|Overall Study|Death|9|||
126251888|NCT01401062|454212337|FG001|Overall Study|Death|7|||
126251889|NCT01401062|454212336|FG000|Overall Study|Physician Decision|1|||
126251890|NCT01401062|454212337|FG001|Overall Study|Physician Decision|0|||
126251891|NCT01401062|454212336|FG000|Overall Study|Withdrawal by Subject|1|||
126251892|NCT01401062|454212337|FG001|Overall Study|Withdrawal by Subject|1|||
126251893|NCT00757172|454212340|FG000|Overall Study|Withdrawal by Subject|4|||
126251894|NCT00757172|454212340|FG000|Overall Study|Physician Decision|3|||
126251895|NCT00757172|454212340|FG000|Overall Study|Progression|4|||
126251896|NCT03555695|454212341|FG000|Overall Study|Withdrawal by Subject|1|||
126251897|NCT03555695|454212341|FG000|Overall Study|Lost to Follow-up|1|||
126251898|NCT03555695|454212341|FG000|Overall Study|appendicitis (unrelated)|1|||
126251899|NCT03555695|454212341|FG000|Overall Study|pre-existing sciatica|1|||
126251900|NCT04194151|454212342|FG000|Overall Study|Physician Decision|1|||
126251901|NCT04194151|454212343|FG001|Overall Study|Physician Decision|1|||
126251902|NCT04194151|454212344|FG002|Overall Study|Physician Decision|1|||
126251903|NCT04194151|454212345|FG003|Overall Study|Physician Decision|1|||
126251904|NCT04194151|454212346|FG004|Overall Study|Physician Decision|0|||
126251905|NCT04194151|454212347|FG005|Overall Study|Physician Decision|1|||
126251906|NCT04194151|454212342|FG000|Overall Study|Monitorization problem|0|||
126251907|NCT04194151|454212343|FG001|Overall Study|Monitorization problem|1|||
126251908|NCT04194151|454212344|FG002|Overall Study|Monitorization problem|0|||
126251909|NCT04194151|454212345|FG003|Overall Study|Monitorization problem|0|||
126251910|NCT04194151|454212346|FG004|Overall Study|Monitorization problem|0|||
126251911|NCT04194151|454212347|FG005|Overall Study|Monitorization problem|0|||
126251912|NCT01499043|454212348|FG000|Overall Study|Progressive disease (radiographic)|2|||
126251913|NCT01499043|454212348|FG000|Overall Study|Progressive disease (clinical)|1|||
126251914|NCT01499043|454212348|FG000|Overall Study|Withdrawal by Subject|2|||
126251915|NCT01499043|454212348|FG000|Overall Study|Adverse Event|1|||
126251916|NCT04203823|454212350|FG000|Overall Study|Withdrawal by Subject|2|||
126251917|NCT04203823|454212351|FG001|Overall Study|Withdrawal by Subject|2|||
126251918|NCT04203823|454212350|FG000|Overall Study|Adverse Event|1|||
126251919|NCT04203823|454212351|FG001|Overall Study|Adverse Event|1|||
126251920|NCT04203823|454212350|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126251921|NCT04203823|454212351|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
126251922|NCT00438633|454212352|FG000|Overall Study|Withdrawal by Subject|1|||
126251923|NCT00438633|454212353|FG001|Overall Study|Withdrawal by Subject|0|||
126251924|NCT00438633|454212352|FG000|Overall Study|Lost to Follow-up|15|||
126251925|NCT00438633|454212353|FG001|Overall Study|Lost to Follow-up|17|||
126251926|NCT00835081|454212354|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126251927|NCT00835081|454212355|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126251928|NCT00421304|454212356|FG000|Overall Study|Lost to Follow-up|5|||
126251929|NCT00421304|454212357|FG001|Overall Study|Lost to Follow-up|2|||
126251930|NCT00421304|454212358|FG002|Overall Study|Lost to Follow-up|5|||
126251931|NCT00421304|454212356|FG000|Overall Study|Withdrawal by Subject|2|||
126251932|NCT00421304|454212357|FG001|Overall Study|Withdrawal by Subject|2|||
126251933|NCT00421304|454212358|FG002|Overall Study|Withdrawal by Subject|2|||
126251934|NCT00421304|454212356|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
126251935|NCT00421304|454212357|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
126251936|NCT00421304|454212358|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
126251937|NCT00421304|454212356|FG000|Overall Study|Did not attend Day 360 visit|0|||
126251938|NCT00421304|454212357|FG001|Overall Study|Did not attend Day 360 visit|0|||
126251939|NCT00421304|454212358|FG002|Overall Study|Did not attend Day 360 visit|1|||
126251940|NCT03196284|454212359|FG000|Main Part|Withdrawal by Subject|0|||
126251941|NCT03196284|454212360|FG001|Main Part|Withdrawal by Subject|1|||
126251942|NCT03196284|454212361|FG002|Main Part|Withdrawal by Subject|0|||
126251943|NCT03196284|454212359|FG000|Extension Part|Lack of Efficacy|0|||
126251944|NCT03196284|454212360|FG001|Extension Part|Lack of Efficacy|0|||
126251945|NCT03196284|454212361|FG002|Extension Part|Lack of Efficacy|1|||
126251946|NCT03196284|454212359|FG000|Extension Part|Withdrawal by Subject|0|||
126251947|NCT03196284|454212360|FG001|Extension Part|Withdrawal by Subject|0|||
126251948|NCT03196284|454212361|FG002|Extension Part|Withdrawal by Subject|1|||
126251949|NCT03196284|454212359|FG000|Extension Part|Physician Decision|0|||
126251950|NCT03196284|454212360|FG001|Extension Part|Physician Decision|0|||
126251951|NCT03196284|454212361|FG002|Extension Part|Physician Decision|1|||
126251952|NCT01912807|454212362|FG000|Overall Study|Did not meet elegibility criteria|6|||
126251953|NCT01912807|454212363|FG001|Overall Study|Did not meet elegibility criteria|4|||
126251954|NCT01912807|454212362|FG000|Overall Study|Lost to Follow-up|36|||
126251955|NCT01912807|454212363|FG001|Overall Study|Lost to Follow-up|37|||
126251956|NCT02535923|454212364|FG000|Overall Study|Lost to Follow-up|5|||
126251957|NCT02535923|454212365|FG001|Overall Study|Lost to Follow-up|5|||
126251958|NCT02535923|454212364|FG000|Overall Study|Withdrawal by Subject|4|||
126251959|NCT02535923|454212365|FG001|Overall Study|Withdrawal by Subject|3|||
126251960|NCT00754052|454213998|FG000|Overall Study|Study terminated by Sponsor|5|||
126251961|NCT00754052|454213999|FG001|Overall Study|Study terminated by Sponsor|3|||
126251962|NCT02651987|454214000|FG000|Overall Study|Adverse Event|2|||
126251963|NCT02651987|454214001|FG001|Overall Study|Adverse Event|2|||
126251964|NCT02651987|454214000|FG000|Overall Study|Consent Withdrawn|2|||
126251965|NCT02651987|454214001|FG001|Overall Study|Consent Withdrawn|0|||
126251966|NCT02651987|454214000|FG000|Overall Study|Local PD|0|||
126251967|NCT02651987|454214001|FG001|Overall Study|Local PD|2|||
126251968|NCT02651987|454214000|FG000|Overall Study|Investigator Decision|1|||
126251969|NCT02651987|454214001|FG001|Overall Study|Investigator Decision|1|||
126251970|NCT00522041|454214002|FG000|Overall Study|Adverse Event|9|||
126251971|NCT00522041|454214003|FG001|Overall Study|Adverse Event|3|||
126251972|NCT00522041|454214002|FG000|Overall Study|Protocol Violation|2|||
126251973|NCT00522041|454214003|FG001|Overall Study|Protocol Violation|0|||
126251974|NCT00522041|454214002|FG000|Overall Study|Lost to Follow-up|1|||
126251975|NCT00522041|454214003|FG001|Overall Study|Lost to Follow-up|4|||
126251976|NCT00522041|454214002|FG000|Overall Study|Voluntary withdrawal|5|||
126251977|NCT00522041|454214003|FG001|Overall Study|Voluntary withdrawal|4|||
126251978|NCT00522041|454214002|FG000|Overall Study|Did not receive treatment|0|||
126251979|NCT00522041|454214003|FG001|Overall Study|Did not receive treatment|1|||
126251980|NCT00396162|454214004|FG000|Overall Study|Withdrawal by Subject|2|||
126251981|NCT00396162|454214005|FG001|Overall Study|Withdrawal by Subject|3|||
126251982|NCT01944722|454214009|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
126251983|NCT01944722|454214009|FG000|Overall Study|Specimen Shipping Issues|34|||
126251984|NCT01944722|454214009|FG000|Overall Study|Improper Storage/Transport|5|||
126251985|NCT01944722|454214009|FG000|Overall Study|Insufficient Volume for Test|1|||
126251986|NCT01944722|454214009|FG000|Overall Study|Missing Specimens|3|||
126251987|NCT01944722|454214009|FG000|Overall Study|Specimens Mislabeled|2|||
126251988|NCT01944722|454214009|FG000|Overall Study|Withdrawal by Subject|8|||
126251989|NCT01944722|454214009|FG000|Overall Study|NILM Subjects <30 years old|8106|||
126251990|NCT01944722|454214009|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
126251991|NCT01944722|454214009|FG000|Overall Study|>ASCUS Cytology|1122|||
126251992|NCT02854800|454214010|FG000|Overall Study|Protocol Violation|16|||
126251993|NCT02854800|454214011|FG001|Overall Study|Protocol Violation|11|||
126251994|NCT02854800|454214012|FG002|Overall Study|Protocol Violation|3|||
126251995|NCT02854800|454214010|FG000|Overall Study|Withdrawal by Subject|4|||
126251996|NCT02854800|454214011|FG001|Overall Study|Withdrawal by Subject|2|||
126251997|NCT02854800|454214012|FG002|Overall Study|Withdrawal by Subject|3|||
126251998|NCT02627963|454214018|FG000|Overall Study|Randomized but not treated|2|||
126251999|NCT02627963|454214019|FG001|Overall Study|Randomized but not treated|6|||
126252000|NCT00503867|454214023|FG000|Overall Study|Lost to Follow-up|1|||
126252001|NCT00503867|454214023|FG000|Overall Study|Adverse Event|1|||
126252002|NCT00323258|454214024|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
126252003|NCT00323258|454214025|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
126252004|NCT00323258|454214024|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
126252005|NCT00323258|454214025|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
126252006|NCT00323258|454214024|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
126252007|NCT00323258|454214025|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
126252008|NCT00323258|454214024|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
126252009|NCT00323258|454214025|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
126252010|NCT00323258|454214024|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
126252011|NCT00323258|454214025|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
126252012|NCT00323258|454214024|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
126095443|NCT00948766|453643074|FG000|Core Study|Adverse Event|73|||
126095444|NCT00948766|453643075|FG001|Core Study|Adverse Event|51|||
126252013|NCT00323258|454214025|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
126252014|NCT00323258|454214024|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
126252015|NCT00323258|454214025|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
126252016|NCT02372006|454214035|FG000|Overall Study|Progressive disease|8|||
126252017|NCT02372006|454214036|FG001|Overall Study|Progressive disease|7|||
126252018|NCT02372006|454214037|FG002|Overall Study|Progressive disease|34|||
126252019|NCT02372006|454214035|FG000|Overall Study|Dose limiting toxicity|0|||
126252020|NCT02372006|454214036|FG001|Overall Study|Dose limiting toxicity|1|||
126252021|NCT02372006|454214037|FG002|Overall Study|Dose limiting toxicity|0|||
126252022|NCT02372006|454214035|FG000|Overall Study|Adverse Event|0|||
126252023|NCT02372006|454214036|FG001|Overall Study|Adverse Event|0|||
126252024|NCT02372006|454214037|FG002|Overall Study|Adverse Event|3|||
126252025|NCT02372006|454214035|FG000|Overall Study|Withdrawal by Subject|0|||
126252026|NCT02372006|454214036|FG001|Overall Study|Withdrawal by Subject|1|||
126252027|NCT02372006|454214037|FG002|Overall Study|Withdrawal by Subject|1|||
126252028|NCT02372006|454214035|FG000|Overall Study|Other reason for not completing|0|||
126252029|NCT02372006|454214036|FG001|Overall Study|Other reason for not completing|0|||
126252030|NCT02372006|454214037|FG002|Overall Study|Other reason for not completing|1|||
126252031|NCT01859598|454214041|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
126252032|NCT00354835|454214042|FG000|Overall Study|Death|1|||
126252033|NCT00354835|454214043|FG001|Overall Study|Death|1|||
126252034|NCT00354835|454214042|FG000|Overall Study|Physician Decision|8|||
126252035|NCT00354835|454214043|FG001|Overall Study|Physician Decision|13|||
126252036|NCT00354835|454214042|FG000|Overall Study|Withdrawal by Subject|2|||
126252037|NCT00354835|454214043|FG001|Overall Study|Withdrawal by Subject|1|||
126252038|NCT00354835|454214042|FG000|Overall Study|Ineligible|17|||
126252039|NCT00354835|454214043|FG001|Overall Study|Ineligible|16|||
126252040|NCT00354835|454214042|FG000|Overall Study|Disease progression or relapse|15|||
126252041|NCT00354835|454214043|FG001|Overall Study|Disease progression or relapse|22|||
126252042|NCT00354835|454214042|FG000|Overall Study|Adverse Event|6|||
126252043|NCT00354835|454214043|FG001|Overall Study|Adverse Event|0|||
126252044|NCT00354835|454214042|FG000|Overall Study|Refusal of further therapy|3|||
126252045|NCT00354835|454214043|FG001|Overall Study|Refusal of further therapy|8|||
126252046|NCT01968551|454214044|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
126252047|NCT01968551|454214045|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
126252048|NCT01968551|454214046|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
126252049|NCT01968551|454214044|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
126252050|NCT01968551|454214045|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
126252051|NCT01968551|454214046|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
126252052|NCT01968551|454214044|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
126252053|NCT01968551|454214045|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
126252054|NCT01968551|454214046|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
126252055|NCT01968551|454214044|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
126252056|NCT01968551|454214045|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
126252057|NCT01968551|454214046|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
126252058|NCT01968551|454214044|FG000|Extension Phase|Adverse Event|0|||
126252059|NCT01968551|454214045|FG001|Extension Phase|Adverse Event|0|||
126252060|NCT01968551|454214046|FG002|Extension Phase|Adverse Event|2|||
126252061|NCT01968551|454214044|FG000|Extension Phase|Death|0|||
126252062|NCT01968551|454214045|FG001|Extension Phase|Death|1|||
126252063|NCT01968551|454214046|FG002|Extension Phase|Death|0|||
126252064|NCT01968551|454214044|FG000|Extension Phase|Withdrew Consent|0|||
126252065|NCT01968551|454214045|FG001|Extension Phase|Withdrew Consent|0|||
126252066|NCT01968551|454214046|FG002|Extension Phase|Withdrew Consent|1|||
126252067|NCT01968551|454214044|FG000|Extension Phase|Lost to Follow-up|1|||
126252068|NCT01968551|454214045|FG001|Extension Phase|Lost to Follow-up|0|||
126252069|NCT01968551|454214046|FG002|Extension Phase|Lost to Follow-up|1|||
126252070|NCT00573313|454214049|FG000|Overall Study|Protocol Violation|5|||
126252071|NCT00573313|454214050|FG001|Overall Study|Protocol Violation|0|||
126252072|NCT00573313|454214051|FG002|Overall Study|Protocol Violation|6|||
126252073|NCT00573313|454214052|FG003|Overall Study|Protocol Violation|0|||
126252074|NCT03255980|454214053|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
126252075|NCT03255980|454214054|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
126252076|NCT03255980|454214055|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
126252077|NCT03255980|454214056|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
126252078|NCT03255980|454214053|FG000|Overall Study|Adverse Event|1|||
126252079|NCT03255980|454214054|FG001|Overall Study|Adverse Event|1|||
126252080|NCT03255980|454214055|FG002|Overall Study|Adverse Event|0|||
126252081|NCT03255980|454214056|FG003|Overall Study|Adverse Event|1|||
125879763|NCT03104868|452857381|FG000|6 Week Follow up|Completed Later Timepoint|24|||
126252082|NCT03255980|454214053|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
126252083|NCT03255980|454214054|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
126252084|NCT03255980|454214055|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
126252085|NCT03255980|454214056|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
126252086|NCT03255980|454214053|FG000|Overall Study|Lost to Follow-up|1|||
126252087|NCT03255980|454214054|FG001|Overall Study|Lost to Follow-up|1|||
126252088|NCT03255980|454214055|FG002|Overall Study|Lost to Follow-up|0|||
126252089|NCT03255980|454214056|FG003|Overall Study|Lost to Follow-up|3|||
126252090|NCT03255980|454214053|FG000|Overall Study|Withdrawal by Subject|0|||
126252091|NCT03255980|454214054|FG001|Overall Study|Withdrawal by Subject|1|||
126252092|NCT03255980|454214055|FG002|Overall Study|Withdrawal by Subject|0|||
126252093|NCT03255980|454214056|FG003|Overall Study|Withdrawal by Subject|3|||
126252094|NCT01597791|454214063|FG000|Overall Study|Physician Decision|2|||
125879764|NCT03104868|452857382|FG001|6 Week Follow up|Completed Later Timepoint|22|||
126252095|NCT01597791|454214064|FG001|Overall Study|Physician Decision|1|||
126252096|NCT01597791|454214063|FG000|Overall Study|Cesarean Section|6|||
126252097|NCT01597791|454214064|FG001|Overall Study|Cesarean Section|7|||
126252098|NCT01597791|454214063|FG000|Overall Study|Subject withdrawal|0|||
126252099|NCT01597791|454214064|FG001|Overall Study|Subject withdrawal|1|||
126252100|NCT01597791|454214063|FG000|Overall Study|Protocol Violation|0|||
126252101|NCT01597791|454214064|FG001|Overall Study|Protocol Violation|1|||
126252102|NCT00467597|454214066|FG000|Overall Study|Withdrawal by Subject|2|||
126252103|NCT00467597|454214067|FG001|Overall Study|Withdrawal by Subject|0|||
126252104|NCT02096705|454214068|FG000|Treatment|Adverse Event|6|||
126252105|NCT02096705|454214069|FG001|Treatment|Adverse Event|3|||
126252106|NCT02096705|454214068|FG000|Treatment|Subject request to discontinue treatment|1|||
126252107|NCT02096705|454214069|FG001|Treatment|Subject request to discontinue treatment|1|||
126252108|NCT02096705|454214068|FG000|Treatment|Withdrawal by Subject|1|||
126252109|NCT02096705|454214069|FG001|Treatment|Withdrawal by Subject|0|||
126252110|NCT02096705|454214068|FG000|Treatment|Other|1|||
126252111|NCT02096705|454214069|FG001|Treatment|Other|1|||
126252112|NCT02096705|454214068|FG000|Follow-up|Withdrawal by Subject|1|||
126252113|NCT02096705|454214069|FG001|Follow-up|Withdrawal by Subject|0|||
126252114|NCT02096705|454214068|FG000|Follow-up|Adverse Event|2|||
126252115|NCT02096705|454214069|FG001|Follow-up|Adverse Event|2|||
126252116|NCT02096705|454214068|FG000|Follow-up|Subjects not reporting status|1|||
126252117|NCT02096705|454214069|FG001|Follow-up|Subjects not reporting status|2|||
126252118|NCT00884390|454214070|FG000|Overall Study|Adverse Event|0|||
126252119|NCT00884390|454214071|FG001|Overall Study|Adverse Event|1|||
126252120|NCT00884390|454214070|FG000|Overall Study|Lost to Follow-up|0|||
126252121|NCT00884390|454214071|FG001|Overall Study|Lost to Follow-up|1|||
126252122|NCT00884390|454214070|FG000|Overall Study|Physician Decision|2|||
126252123|NCT00884390|454214071|FG001|Overall Study|Physician Decision|1|||
126252124|NCT00884390|454214070|FG000|Overall Study|Protocol Violation|4|||
126252125|NCT00884390|454214071|FG001|Overall Study|Protocol Violation|1|||
126252126|NCT00884390|454214070|FG000|Overall Study|Withdrawal by Subject|4|||
126252127|NCT00884390|454214071|FG001|Overall Study|Withdrawal by Subject|1|||
126252128|NCT00884390|454214070|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
126252129|NCT00884390|454214071|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
126252130|NCT00884390|454214070|FG000|Overall Study|Other|11|||
126252131|NCT00884390|454214071|FG001|Overall Study|Other|1|||
126252132|NCT02896296|454214075|FG000|Overall Study|Adverse Event|1|||
126252133|NCT02896296|454214075|FG000|Overall Study|Lost to Follow-up|19|||
126252134|NCT02896296|454214075|FG000|Overall Study|Pregnancy|1|||
126252135|NCT02896296|454214075|FG000|Overall Study|Physician Decision|2|||
126252136|NCT02896296|454214075|FG000|Overall Study|Withdrawal by Subject|10|||
126252137|NCT02896296|454214075|FG000|Overall Study|Site closing|7|||
126252138|NCT02896296|454214075|FG000|Overall Study|Incarceration|1|||
126252139|NCT02896296|454214075|FG000|Overall Study|Relocation|1|||
126252140|NCT01874535|454214076|FG000|Overall Study|Lost to Follow-up|10|||
126252141|NCT01874535|454214077|FG001|Overall Study|Lost to Follow-up|9|||
126252142|NCT01874535|454214076|FG000|Overall Study|incomplete symptom resolution|45|||
126252143|NCT01874535|454214077|FG001|Overall Study|incomplete symptom resolution|35|||
126252144|NCT02611323|454214078|FG000|Overall Study|Death|3|||
126252145|NCT02611323|454214079|FG001|Overall Study|Death|1|||
126252146|NCT02611323|454214080|FG002|Overall Study|Death|0|||
126029330|NCT03138512|453405134|FG004|Treatment Part B|Death|0|||
126029331|NCT03138512|453405130|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
126029332|NCT03138512|453405131|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
126029333|NCT03138512|453405132|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
126029334|NCT03138512|453405133|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
126029335|NCT03138512|453405134|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
126029336|NCT03138512|453405130|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
126029337|NCT03138512|453405131|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
126029338|NCT03138512|453405132|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
126029339|NCT03138512|453405133|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
126029340|NCT03138512|453405134|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
126029341|NCT03138512|453405130|FG000|Treatment Part B|Participant withdrew consent|0|||
126029342|NCT03138512|453405131|FG001|Treatment Part B|Participant withdrew consent|0|||
126029343|NCT03138512|453405132|FG002|Treatment Part B|Participant withdrew consent|1|||
126029344|NCT03138512|453405133|FG003|Treatment Part B|Participant withdrew consent|1|||
126029345|NCT03138512|453405134|FG004|Treatment Part B|Participant withdrew consent|2|||
126029346|NCT03138512|453405130|FG000|Treatment Part B|Lost to Follow-up|0|||
126029347|NCT03138512|453405131|FG001|Treatment Part B|Lost to Follow-up|0|||
126029348|NCT03138512|453405132|FG002|Treatment Part B|Lost to Follow-up|0|||
126029349|NCT03138512|453405133|FG003|Treatment Part B|Lost to Follow-up|1|||
126029350|NCT03138512|453405134|FG004|Treatment Part B|Lost to Follow-up|0|||
126029351|NCT03138512|453405130|FG000|Treatment Part B|Poor/non-compliance|0|||
126029352|NCT03138512|453405131|FG001|Treatment Part B|Poor/non-compliance|0|||
126029353|NCT03138512|453405132|FG002|Treatment Part B|Poor/non-compliance|1|||
126095445|NCT00948766|453643074|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
126095446|NCT00948766|453643075|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
126095447|NCT00948766|453643074|FG000|Core Study|Patient Withdrew Consent|27|||
126095448|NCT00948766|453643075|FG001|Core Study|Patient Withdrew Consent|46|||
126095449|NCT00948766|453643074|FG000|Core Study|Lost to Follow-up|3|||
126095450|NCT00948766|453643075|FG001|Core Study|Lost to Follow-up|2|||
126095451|NCT00948766|453643074|FG000|Core Study|Administrative Problems|2|||
126095452|NCT00948766|453643075|FG001|Core Study|Administrative Problems|2|||
126095453|NCT00948766|453643074|FG000|Core Study|Death|1|||
126095454|NCT00948766|453643075|FG001|Core Study|Death|1|||
126095455|NCT00948766|453643074|FG000|Core Study|Protocol Deviation|8|||
126095456|NCT00948766|453643075|FG001|Core Study|Protocol Deviation|10|||
126095457|NCT00948766|453643074|FG000|Extension Study|Adverse Event|43|||
126095458|NCT00948766|453643075|FG001|Extension Study|Adverse Event|0|||
126095459|NCT00948766|453643074|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
126095460|NCT00948766|453643075|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
126095461|NCT00948766|453643074|FG000|Extension Study|Study Drug No Longer Required|1|||
126095462|NCT00948766|453643075|FG001|Extension Study|Study Drug No Longer Required|0|||
126095463|NCT00948766|453643074|FG000|Extension Study|Patient Withdrew Consent|32|||
126095464|NCT00948766|453643075|FG001|Extension Study|Patient Withdrew Consent|0|||
126095465|NCT00948766|453643074|FG000|Extension Study|Lost to Follow-up|8|||
126095466|NCT00948766|453643075|FG001|Extension Study|Lost to Follow-up|0|||
126095467|NCT00948766|453643074|FG000|Extension Study|Administrative Problems|1|||
126095468|NCT00948766|453643075|FG001|Extension Study|Administrative Problems|0|||
126095469|NCT00948766|453643074|FG000|Extension Study|Death|4|||
126095470|NCT00948766|453643075|FG001|Extension Study|Death|0|||
126095471|NCT03459443|453643079|FG000|Overall Study|Lack of Efficacy|3|||
126095472|NCT03459443|453643079|FG000|Overall Study|Adverse Event|1|||
126095473|NCT03459443|453643079|FG000|Overall Study|Sponsor's decision to close the study|18|||
126095474|NCT01081665|453643080|FG000|Overall Study|Death|41|||
126095475|NCT01081665|453643080|FG000|Overall Study|Lost to Follow-up|18|||
126095476|NCT01081665|453643080|FG000|Overall Study|Withdrawal by Subject|17|||
126095477|NCT01081665|453643080|FG000|Overall Study|Change of dialysis unit|10|||
126029354|NCT03138512|453405133|FG003|Treatment Part B|Poor/non-compliance|1|||
126252147|NCT02611323|454214081|FG003|Overall Study|Death|0|||
126252148|NCT02611323|454214082|FG004|Overall Study|Death|1|||
126252149|NCT02611323|454214083|FG005|Overall Study|Death|1|||
126252150|NCT02611323|454214084|FG006|Overall Study|Death|8|||
126252151|NCT02611323|454214085|FG007|Overall Study|Death|0|||
126252152|NCT02611323|454214086|FG008|Overall Study|Death|4|||
126252153|NCT02611323|454214087|FG009|Overall Study|Death|6|||
126252154|NCT02611323|454214088|FG010|Overall Study|Death|26|||
126252155|NCT02611323|454214078|FG000|Overall Study|Lost to Follow-up|1|||
126252156|NCT02611323|454214079|FG001|Overall Study|Lost to Follow-up|0|||
126252157|NCT02611323|454214080|FG002|Overall Study|Lost to Follow-up|0|||
126252158|NCT02611323|454214081|FG003|Overall Study|Lost to Follow-up|0|||
126029355|NCT03138512|453405134|FG004|Treatment Part B|Poor/non-compliance|1|||
126029356|NCT03138512|453405130|FG000|Treatment Part B|Other reasons|0|||
126029357|NCT03138512|453405131|FG001|Treatment Part B|Other reasons|0|||
126029358|NCT03138512|453405132|FG002|Treatment Part B|Other reasons|3|||
126029359|NCT03138512|453405133|FG003|Treatment Part B|Other reasons|1|||
126029360|NCT03138512|453405134|FG004|Treatment Part B|Other reasons|5|||
126029361|NCT03332017|453405135|FG000|Overall Study|Lost to Follow-up|1|||
126029362|NCT03332017|453405136|FG001|Overall Study|Lost to Follow-up|2|||
126029363|NCT03332017|453405135|FG000|Overall Study|Death|17|||
126029364|NCT03332017|453405136|FG001|Overall Study|Death|16|||
126029365|NCT03332017|453405135|FG000|Overall Study|Withdrawal by Subject|6|||
126029366|NCT03332017|453405136|FG001|Overall Study|Withdrawal by Subject|14|||
126029367|NCT03332017|453405135|FG000|Overall Study|Other|1|||
126029368|NCT03332017|453405136|FG001|Overall Study|Other|3|||
126095478|NCT01081665|453643080|FG000|Overall Study|Regulation of iPTH|5|||
126095479|NCT01081665|453643080|FG000|Overall Study|Change in renal replacement therapy|2|||
126095480|NCT01081665|453643080|FG000|Overall Study|Adverse Event|1|||
126095481|NCT01081665|453643080|FG000|Overall Study|Lack of Efficacy|1|||
126095482|NCT03406078|453643085|FG000|Overall Study|Death|1|||
126095483|NCT03406078|453643086|FG001|Overall Study|Death|0|||
126095484|NCT03406078|453643085|FG000|Overall Study|Lost to Follow-up|0|||
126095485|NCT03406078|453643086|FG001|Overall Study|Lost to Follow-up|1|||
126095486|NCT03406078|453643085|FG000|Overall Study|Withdrawal by Subject|5|||
126095487|NCT03406078|453643086|FG001|Overall Study|Withdrawal by Subject|2|||
126252159|NCT02611323|454214082|FG004|Overall Study|Lost to Follow-up|0|||
126029369|NCT03332017|453405135|FG000|Overall Study|Remained in Study (Ongoing)|47|||
126252160|NCT02611323|454214083|FG005|Overall Study|Lost to Follow-up|0|||
126029370|NCT03332017|453405136|FG001|Overall Study|Remained in Study (Ongoing)|110|||
126029371|NCT01261312|453405137|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
126029372|NCT01261312|453405138|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
126252161|NCT02611323|454214084|FG006|Overall Study|Lost to Follow-up|3|||
126252162|NCT02611323|454214085|FG007|Overall Study|Lost to Follow-up|0|||
126358084|NCT00378560|454603879|FG001|Overall Study|Withdrawal by Subject|21|||
126358085|NCT00378560|454603878|FG000|Overall Study|Moved|4|||
126358086|NCT00378560|454603879|FG001|Overall Study|Moved|3|||
126358087|NCT00378560|454603878|FG000|Overall Study|Pregnancy|7|||
126358088|NCT00378560|454603879|FG001|Overall Study|Pregnancy|5|||
126358089|NCT00378560|454603878|FG000|Overall Study|Laboratory test values abnormal|1|||
126029373|NCT01261312|453405139|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
126029374|NCT01261312|453405140|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029375|NCT01261312|453405141|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029376|NCT01261312|453405142|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029377|NCT01261312|453405143|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029378|NCT01261312|453405144|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029379|NCT01261312|453405145|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029380|NCT01261312|453405146|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029381|NCT01261312|453405147|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029382|NCT01261312|453405148|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029383|NCT01261312|453405149|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126029384|NCT01261312|453405137|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
126029385|NCT01261312|453405138|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
126029386|NCT01261312|453405139|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029387|NCT01261312|453405140|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029388|NCT01261312|453405141|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029389|NCT01261312|453405142|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029390|NCT01261312|453405143|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029391|NCT01261312|453405144|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029392|NCT01261312|453405145|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029393|NCT01261312|453405146|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029394|NCT01261312|453405147|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029395|NCT01261312|453405148|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029396|NCT01261312|453405149|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126029397|NCT01261312|453405137|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
126029398|NCT01261312|453405138|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
126029399|NCT01261312|453405139|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029400|NCT01261312|453405140|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029401|NCT01261312|453405141|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029402|NCT01261312|453405142|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029403|NCT01261312|453405143|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029404|NCT01261312|453405144|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029405|NCT01261312|453405145|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029406|NCT01261312|453405146|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029407|NCT01261312|453405147|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029408|NCT01261312|453405148|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029409|NCT01261312|453405149|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126029410|NCT01261312|453405137|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
126029411|NCT01261312|453405138|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
126029412|NCT01261312|453405139|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029413|NCT01261312|453405140|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029414|NCT01261312|453405141|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029415|NCT01261312|453405142|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029416|NCT01261312|453405143|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029417|NCT01261312|453405144|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029418|NCT01261312|453405145|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029419|NCT01261312|453405146|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029420|NCT01261312|453405147|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029421|NCT01261312|453405148|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029422|NCT01261312|453405149|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126029423|NCT01261312|453405137|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
126029424|NCT01261312|453405138|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
126029425|NCT01261312|453405139|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
126029426|NCT01261312|453405140|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126029427|NCT01261312|453405141|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126029428|NCT01261312|453405142|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126029429|NCT01261312|453405143|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126029430|NCT01261312|453405144|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126358090|NCT00378560|454603879|FG001|Overall Study|Laboratory test values abnormal|0|||
126358091|NCT02852434|454603880|FG000|Overall Study|Withdrawal by Subject|0|||
126252163|NCT02611323|454214086|FG008|Overall Study|Lost to Follow-up|0|||
126252164|NCT02611323|454214087|FG009|Overall Study|Lost to Follow-up|0|||
126252165|NCT02611323|454214088|FG010|Overall Study|Lost to Follow-up|2|||
126252166|NCT02611323|454214078|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252167|NCT02611323|454214079|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252168|NCT02611323|454214080|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252169|NCT02611323|454214081|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252170|NCT02611323|454214082|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252171|NCT02611323|454214083|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252172|NCT02611323|454214084|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252173|NCT02611323|454214085|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
126029431|NCT01261312|453405145|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126029432|NCT01261312|453405146|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126029433|NCT01261312|453405147|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126029434|NCT01261312|453405148|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126252174|NCT02611323|454214086|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252175|NCT02611323|454214087|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
126252176|NCT02611323|454214088|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252177|NCT02611323|454214078|FG000|Overall Study|Progressive Disease|0|||
126252178|NCT02611323|454214079|FG001|Overall Study|Progressive Disease|0|||
126252179|NCT02611323|454214080|FG002|Overall Study|Progressive Disease|0|||
126252180|NCT02611323|454214081|FG003|Overall Study|Progressive Disease|0|||
126252181|NCT02611323|454214082|FG004|Overall Study|Progressive Disease|0|||
126252182|NCT02611323|454214083|FG005|Overall Study|Progressive Disease|0|||
126252183|NCT02611323|454214084|FG006|Overall Study|Progressive Disease|0|||
126252184|NCT02611323|454214085|FG007|Overall Study|Progressive Disease|0|||
126252185|NCT02611323|454214086|FG008|Overall Study|Progressive Disease|0|||
126252186|NCT02611323|454214087|FG009|Overall Study|Progressive Disease|0|||
126252187|NCT02611323|454214088|FG010|Overall Study|Progressive Disease|1|||
126252188|NCT02611323|454214078|FG000|Overall Study|Withdrawal by Subject|1|||
126252189|NCT02611323|454214079|FG001|Overall Study|Withdrawal by Subject|0|||
126252190|NCT02611323|454214080|FG002|Overall Study|Withdrawal by Subject|0|||
126252191|NCT02611323|454214081|FG003|Overall Study|Withdrawal by Subject|0|||
126252192|NCT02611323|454214082|FG004|Overall Study|Withdrawal by Subject|0|||
126252193|NCT02611323|454214083|FG005|Overall Study|Withdrawal by Subject|0|||
126252194|NCT02611323|454214084|FG006|Overall Study|Withdrawal by Subject|0|||
126252195|NCT02611323|454214085|FG007|Overall Study|Withdrawal by Subject|1|||
126252196|NCT02611323|454214086|FG008|Overall Study|Withdrawal by Subject|0|||
126252197|NCT02611323|454214087|FG009|Overall Study|Withdrawal by Subject|1|||
126252198|NCT02611323|454214088|FG010|Overall Study|Withdrawal by Subject|0|||
126252199|NCT01215721|454214089|FG000|Overall Study|Adverse Event|2|||
126252200|NCT00045162|454214090|FG000|Overall Study|Ineligible|12|||
126252201|NCT00045162|454214091|FG001|Overall Study|Ineligible|8|||
126252202|NCT00045162|454214090|FG000|Overall Study|Not treated|7|||
126252203|NCT00045162|454214091|FG001|Overall Study|Not treated|2|||
126252204|NCT00045162|454214090|FG000|Overall Study|Adverse Event|55|||
126029435|NCT01261312|453405149|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126029436|NCT01261312|453405137|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
126252205|NCT00045162|454214091|FG001|Overall Study|Adverse Event|50|||
126252206|NCT00045162|454214090|FG000|Overall Study|Lack of Efficacy|32|||
126252207|NCT00045162|454214091|FG001|Overall Study|Lack of Efficacy|29|||
126252208|NCT00045162|454214090|FG000|Overall Study|Death|10|||
126252209|NCT00045162|454214091|FG001|Overall Study|Death|10|||
126252210|NCT00045162|454214090|FG000|Overall Study|Withdrawal by Subject|5|||
126252211|NCT00045162|454214091|FG001|Overall Study|Withdrawal by Subject|3|||
126252212|NCT00045162|454214090|FG000|Overall Study|Other|21|||
126252213|NCT00045162|454214091|FG001|Overall Study|Other|16|||
126252214|NCT01044433|454214092|FG000|Overall Study|Lost to Follow-up|3|||
126252215|NCT01044433|454214092|FG000|Overall Study|Withdrawal by Subject|3|||
126252216|NCT01899053|454214094|FG000|Overall Study|Progressive Disease|4|||
126252217|NCT01899053|454214095|FG001|Overall Study|Progressive Disease|0|||
126252218|NCT01899053|454214096|FG002|Overall Study|Progressive Disease|3|||
126252219|NCT01899053|454214097|FG003|Overall Study|Progressive Disease|0|||
126252220|NCT01899053|454214098|FG004|Overall Study|Progressive Disease|3|||
126252221|NCT01899053|454214099|FG005|Overall Study|Progressive Disease|1|||
126252222|NCT01899053|454214100|FG006|Overall Study|Progressive Disease|1|||
126252223|NCT01899053|454214101|FG007|Overall Study|Progressive Disease|1|||
126252224|NCT01899053|454214102|FG008|Overall Study|Progressive Disease|4|||
126252225|NCT01899053|454214103|FG009|Overall Study|Progressive Disease|3|||
126252226|NCT01899053|454214104|FG010|Overall Study|Progressive Disease|12|||
126252227|NCT01899053|454214105|FG011|Overall Study|Progressive Disease|5|||
126252228|NCT01899053|454214106|FG012|Overall Study|Progressive Disease|8|||
126252229|NCT01899053|454214107|FG013|Overall Study|Progressive Disease|17|||
126252230|NCT01899053|454214094|FG000|Overall Study|Adverse Event|1|||
126252231|NCT01899053|454214095|FG001|Overall Study|Adverse Event|1|||
126252232|NCT01899053|454214096|FG002|Overall Study|Adverse Event|1|||
126252233|NCT01899053|454214097|FG003|Overall Study|Adverse Event|3|||
126252234|NCT01899053|454214098|FG004|Overall Study|Adverse Event|1|||
126252235|NCT01899053|454214099|FG005|Overall Study|Adverse Event|1|||
126252236|NCT01899053|454214100|FG006|Overall Study|Adverse Event|1|||
126252237|NCT01899053|454214101|FG007|Overall Study|Adverse Event|0|||
126252238|NCT01899053|454214102|FG008|Overall Study|Adverse Event|2|||
126252239|NCT01899053|454214103|FG009|Overall Study|Adverse Event|0|||
126252240|NCT01899053|454214104|FG010|Overall Study|Adverse Event|3|||
126252241|NCT01899053|454214105|FG011|Overall Study|Adverse Event|1|||
126252242|NCT01899053|454214106|FG012|Overall Study|Adverse Event|2|||
126252243|NCT01899053|454214107|FG013|Overall Study|Adverse Event|2|||
126095488|NCT01413503|453643087|FG000|Overall Study|Lost to Follow-up|1|||
126095489|NCT00293059|453643088|FG000|Overall Study|Adverse Event|12|||
126095490|NCT00293059|453643089|FG001|Overall Study|Adverse Event|4|||
126095491|NCT00293059|453643088|FG000|Overall Study|Lack of Efficacy|2|||
126095492|NCT00293059|453643089|FG001|Overall Study|Lack of Efficacy|0|||
126095493|NCT00293059|453643088|FG000|Overall Study|Lost to Follow-up|2|||
126095494|NCT00293059|453643089|FG001|Overall Study|Lost to Follow-up|3|||
126095495|NCT00293059|453643088|FG000|Overall Study|Pregnancy|1|||
126095496|NCT00293059|453643089|FG001|Overall Study|Pregnancy|1|||
126095497|NCT00293059|453643088|FG000|Overall Study|Protocol Violation|2|||
126095498|NCT00293059|453643089|FG001|Overall Study|Protocol Violation|0|||
126095499|NCT00293059|453643088|FG000|Overall Study|Withdrawal by Subject|11|||
126095500|NCT00293059|453643089|FG001|Overall Study|Withdrawal by Subject|5|||
126095501|NCT00293059|453643088|FG000|Overall Study|Participant moved out of state|1|||
126095502|NCT00293059|453643089|FG001|Overall Study|Participant moved out of state|0|||
126095503|NCT00293059|453643088|FG000|Overall Study|Participant stopped study drug|1|||
126095504|NCT00293059|453643089|FG001|Overall Study|Participant stopped study drug|0|||
126095505|NCT00293059|453643088|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
126095506|NCT00293059|453643089|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
126095507|NCT00293059|453643088|FG000|Overall Study|missing|3|||
126095508|NCT00293059|453643089|FG001|Overall Study|missing|5|||
126095509|NCT00438672|453643091|FG000|Overall Study|Lost to Follow-up|7|||
126095510|NCT00438672|453643092|FG001|Overall Study|Lost to Follow-up|9|||
126252244|NCT01899053|454214094|FG000|Overall Study|Reason Not Specified|0|||
126095511|NCT02712905|453643096|FG000|Monotherapy|Death|2|||
126095512|NCT02712905|453643097|FG001|Monotherapy|Death|5|||
126252245|NCT01899053|454214095|FG001|Overall Study|Reason Not Specified|0|||
126252246|NCT01899053|454214096|FG002|Overall Study|Reason Not Specified|0|||
126252247|NCT01899053|454214097|FG003|Overall Study|Reason Not Specified|0|||
126252248|NCT01899053|454214098|FG004|Overall Study|Reason Not Specified|0|||
126252249|NCT01899053|454214099|FG005|Overall Study|Reason Not Specified|0|||
126252250|NCT01899053|454214100|FG006|Overall Study|Reason Not Specified|1|||
126252251|NCT01899053|454214101|FG007|Overall Study|Reason Not Specified|0|||
126252252|NCT01899053|454214102|FG008|Overall Study|Reason Not Specified|0|||
126252253|NCT01899053|454214103|FG009|Overall Study|Reason Not Specified|0|||
126252254|NCT01899053|454214104|FG010|Overall Study|Reason Not Specified|0|||
126252255|NCT01899053|454214105|FG011|Overall Study|Reason Not Specified|0|||
126252256|NCT01899053|454214106|FG012|Overall Study|Reason Not Specified|1|||
126252257|NCT01899053|454214107|FG013|Overall Study|Reason Not Specified|0|||
126252258|NCT01899053|454214094|FG000|Overall Study|Withdrawal by Subject|1|||
126252259|NCT01899053|454214095|FG001|Overall Study|Withdrawal by Subject|1|||
126252260|NCT01899053|454214096|FG002|Overall Study|Withdrawal by Subject|2|||
126252261|NCT01899053|454214097|FG003|Overall Study|Withdrawal by Subject|0|||
126252262|NCT01899053|454214098|FG004|Overall Study|Withdrawal by Subject|2|||
126252263|NCT01899053|454214099|FG005|Overall Study|Withdrawal by Subject|0|||
126252264|NCT01899053|454214100|FG006|Overall Study|Withdrawal by Subject|0|||
126252265|NCT01899053|454214101|FG007|Overall Study|Withdrawal by Subject|1|||
126252266|NCT01899053|454214102|FG008|Overall Study|Withdrawal by Subject|0|||
126252267|NCT01899053|454214103|FG009|Overall Study|Withdrawal by Subject|0|||
126252268|NCT01899053|454214104|FG010|Overall Study|Withdrawal by Subject|0|||
126252269|NCT01899053|454214105|FG011|Overall Study|Withdrawal by Subject|0|||
126252270|NCT01899053|454214106|FG012|Overall Study|Withdrawal by Subject|1|||
126252271|NCT01899053|454214107|FG013|Overall Study|Withdrawal by Subject|1|||
126252272|NCT01899053|454214094|FG000|Overall Study|Protocol Violation|0|||
126252273|NCT01899053|454214095|FG001|Overall Study|Protocol Violation|0|||
126252274|NCT01899053|454214096|FG002|Overall Study|Protocol Violation|1|||
126252275|NCT01899053|454214097|FG003|Overall Study|Protocol Violation|0|||
126252276|NCT01899053|454214098|FG004|Overall Study|Protocol Violation|0|||
126252277|NCT01899053|454214099|FG005|Overall Study|Protocol Violation|0|||
126252278|NCT01899053|454214100|FG006|Overall Study|Protocol Violation|0|||
126252279|NCT01899053|454214101|FG007|Overall Study|Protocol Violation|0|||
126252280|NCT01899053|454214102|FG008|Overall Study|Protocol Violation|0|||
126252281|NCT01899053|454214103|FG009|Overall Study|Protocol Violation|0|||
126095513|NCT02712905|453643098|FG002|Monotherapy|Death|0|||
126095514|NCT02712905|453643099|FG003|Monotherapy|Death|3|||
126095515|NCT02712905|453643100|FG004|Monotherapy|Death|15|||
126095516|NCT02712905|453643101|FG005|Monotherapy|Death|1|||
126029437|NCT01261312|453405138|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
126029438|NCT01261312|453405139|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
126029439|NCT01261312|453405140|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029440|NCT01261312|453405141|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029441|NCT01261312|453405142|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029442|NCT01261312|453405143|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029443|NCT01261312|453405144|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029444|NCT01261312|453405145|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029445|NCT01261312|453405146|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029446|NCT01261312|453405147|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029447|NCT01261312|453405148|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029448|NCT01261312|453405149|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126029449|NCT01261312|453405137|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
126029450|NCT01261312|453405138|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029451|NCT01261312|453405139|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
126029452|NCT01261312|453405140|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029453|NCT01261312|453405141|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029454|NCT01261312|453405142|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029455|NCT01261312|453405143|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029456|NCT01261312|453405144|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029457|NCT01261312|453405145|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029458|NCT01261312|453405146|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029459|NCT01261312|453405147|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029460|NCT01261312|453405148|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126029461|NCT01261312|453405149|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126252282|NCT01899053|454214104|FG010|Overall Study|Protocol Violation|0|||
126252283|NCT01899053|454214105|FG011|Overall Study|Protocol Violation|0|||
126252284|NCT01899053|454214106|FG012|Overall Study|Protocol Violation|0|||
126252285|NCT01899053|454214107|FG013|Overall Study|Protocol Violation|0|||
126252286|NCT01899053|454214094|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
126252287|NCT01899053|454214095|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
126252288|NCT01899053|454214096|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252289|NCT01899053|454214097|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252290|NCT01899053|454214098|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252291|NCT01899053|454214099|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
126358092|NCT02852434|454603881|FG001|Overall Study|Withdrawal by Subject|1|||
126252292|NCT01899053|454214100|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252293|NCT01899053|454214101|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252294|NCT01899053|454214102|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252295|NCT01899053|454214103|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252296|NCT01899053|454214104|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
126252297|NCT01899053|454214105|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252298|NCT01899053|454214106|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252299|NCT01899053|454214107|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252300|NCT01899053|454214094|FG000|Overall Study|Symptomatic Deterioration|0|||
126252301|NCT01899053|454214095|FG001|Overall Study|Symptomatic Deterioration|0|||
126252302|NCT01899053|454214096|FG002|Overall Study|Symptomatic Deterioration|0|||
126252303|NCT01899053|454214097|FG003|Overall Study|Symptomatic Deterioration|0|||
126252304|NCT01899053|454214098|FG004|Overall Study|Symptomatic Deterioration|0|||
126252305|NCT01899053|454214099|FG005|Overall Study|Symptomatic Deterioration|1|||
126252306|NCT01899053|454214100|FG006|Overall Study|Symptomatic Deterioration|0|||
126252307|NCT01899053|454214101|FG007|Overall Study|Symptomatic Deterioration|1|||
126252308|NCT01899053|454214102|FG008|Overall Study|Symptomatic Deterioration|0|||
126252309|NCT01899053|454214103|FG009|Overall Study|Symptomatic Deterioration|0|||
126252310|NCT01899053|454214104|FG010|Overall Study|Symptomatic Deterioration|0|||
126252311|NCT01899053|454214105|FG011|Overall Study|Symptomatic Deterioration|1|||
126252312|NCT01899053|454214106|FG012|Overall Study|Symptomatic Deterioration|2|||
126358093|NCT02852434|454603880|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
126029462|NCT01261312|453405137|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029463|NCT01261312|453405138|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029464|NCT01261312|453405139|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029465|NCT01261312|453405140|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
126029466|NCT01261312|453405141|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
126029467|NCT01261312|453405142|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
126252313|NCT01899053|454214107|FG013|Overall Study|Symptomatic Deterioration|0|||
126252314|NCT03105297|454214108|FG000|Baseline Phase (Day 1)|Other|21|||
126095517|NCT02712905|453643102|FG006|Monotherapy|Death|3|||
126095518|NCT02712905|453643103|FG007|Monotherapy|Death|3|||
126095519|NCT02712905|453643104|FG008|Monotherapy|Death|0|||
126358094|NCT02852434|454603881|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
126358095|NCT01011283|454603885|FG000|Overall Study|Adverse Event|4|||
126358096|NCT01011283|454603886|FG001|Overall Study|Adverse Event|2|||
126095520|NCT02712905|453643105|FG009|Monotherapy|Death|27|||
126095521|NCT02712905|453643106|FG010|Monotherapy|Death|2|||
126095522|NCT02712905|453643107|FG011|Monotherapy|Death|5|||
126095523|NCT02712905|453643108|FG012|Monotherapy|Death|0|||
126095524|NCT02712905|453643109|FG013|Monotherapy|Death|0|||
126095525|NCT02712905|453643110|FG014|Monotherapy|Death|0|||
126095526|NCT02712905|453643111|FG015|Monotherapy|Death|0|||
126095527|NCT02712905|453643112|FG016|Monotherapy|Death|0|||
126095528|NCT02712905|453643113|FG017|Monotherapy|Death|0|||
126095529|NCT02712905|453643096|FG000|Monotherapy|Lost to Follow-up|0|||
126095530|NCT02712905|453643097|FG001|Monotherapy|Lost to Follow-up|1|||
126095531|NCT02712905|453643098|FG002|Monotherapy|Lost to Follow-up|0|||
126095532|NCT02712905|453643099|FG003|Monotherapy|Lost to Follow-up|1|||
126095533|NCT02712905|453643100|FG004|Monotherapy|Lost to Follow-up|0|||
126095534|NCT02712905|453643101|FG005|Monotherapy|Lost to Follow-up|0|||
126095535|NCT02712905|453643102|FG006|Monotherapy|Lost to Follow-up|0|||
126095536|NCT02712905|453643103|FG007|Monotherapy|Lost to Follow-up|0|||
126095537|NCT02712905|453643104|FG008|Monotherapy|Lost to Follow-up|0|||
126095538|NCT02712905|453643105|FG009|Monotherapy|Lost to Follow-up|2|||
126095539|NCT02712905|453643106|FG010|Monotherapy|Lost to Follow-up|0|||
126358097|NCT01011283|454603885|FG000|Overall Study|Progressive Disease|0|||
126358098|NCT01011283|454603886|FG001|Overall Study|Progressive Disease|2|||
126358099|NCT01011283|454603885|FG000|Overall Study|Terminated by Sponsor|5|||
126358100|NCT01011283|454603886|FG001|Overall Study|Terminated by Sponsor|5|||
126358101|NCT01011283|454603885|FG000|Overall Study|Other|2|||
126358102|NCT01011283|454603886|FG001|Overall Study|Other|2|||
126358103|NCT04865978|454603890|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
126358104|NCT04865978|454603891|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
126358105|NCT03835117|454603892|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
126358106|NCT03835117|454603893|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
126358107|NCT00609973|454603897|FG000|Overall Study|Adverse Event|2|||
126358108|NCT00609973|454603898|FG001|Overall Study|Adverse Event|1|||
126358109|NCT00609973|454603897|FG000|Overall Study|Protocol Violation|4|||
126358110|NCT00609973|454603898|FG001|Overall Study|Protocol Violation|3|||
126358111|NCT00609973|454603897|FG000|Overall Study|Lost to Follow-up|2|||
126358112|NCT00609973|454603898|FG001|Overall Study|Lost to Follow-up|1|||
126358113|NCT00609973|454603897|FG000|Overall Study|Withdrawal by Subject|0|||
126358114|NCT00609973|454603898|FG001|Overall Study|Withdrawal by Subject|1|||
126358115|NCT00191152|454603900|FG000|Initial Treatment|Adverse Event|43|||
126358116|NCT00191152|454603901|FG001|Initial Treatment|Adverse Event|67|||
126358117|NCT00191152|454603900|FG000|Initial Treatment|Physician Decision|40|||
126358118|NCT00191152|454603901|FG001|Initial Treatment|Physician Decision|31|||
126358119|NCT00191152|454603900|FG000|Initial Treatment|Withdrawal by Subject|40|||
126358120|NCT00191152|454603901|FG001|Initial Treatment|Withdrawal by Subject|28|||
126358121|NCT00191152|454603900|FG000|Initial Treatment|Lost to Follow-up|0|||
126358122|NCT00191152|454603901|FG001|Initial Treatment|Lost to Follow-up|6|||
126358123|NCT00191152|454603900|FG000|Initial Treatment|Other|18|||
126358124|NCT00191152|454603901|FG001|Initial Treatment|Other|21|||
126358125|NCT00191152|454603900|FG000|Crossover Treatment|Adverse Event|8|||
126358126|NCT00191152|454603901|FG001|Crossover Treatment|Adverse Event|8|||
125879765|NCT03104868|452857381|FG000|6 Month Follow up|Lost to Follow-up|2|||
126095540|NCT02712905|453643107|FG011|Monotherapy|Lost to Follow-up|0|||
126095541|NCT02712905|453643108|FG012|Monotherapy|Lost to Follow-up|0|||
126095542|NCT02712905|453643109|FG013|Monotherapy|Lost to Follow-up|0|||
126095543|NCT02712905|453643110|FG014|Monotherapy|Lost to Follow-up|0|||
126095544|NCT02712905|453643111|FG015|Monotherapy|Lost to Follow-up|0|||
126095545|NCT02712905|453643112|FG016|Monotherapy|Lost to Follow-up|0|||
126095546|NCT02712905|453643113|FG017|Monotherapy|Lost to Follow-up|0|||
126095547|NCT02712905|453643096|FG000|Monotherapy|Physician Decision|1|||
126095548|NCT02712905|453643097|FG001|Monotherapy|Physician Decision|0|||
126358127|NCT00191152|454603900|FG000|Crossover Treatment|Physician Decision|7|||
126358128|NCT00191152|454603901|FG001|Crossover Treatment|Physician Decision|7|||
126358129|NCT00191152|454603900|FG000|Crossover Treatment|Withdrawal by Subject|6|||
126358130|NCT00191152|454603901|FG001|Crossover Treatment|Withdrawal by Subject|9|||
126358131|NCT00191152|454603900|FG000|Crossover Treatment|Lost to Follow-up|2|||
126095549|NCT02712905|453643098|FG002|Monotherapy|Physician Decision|0|||
126095550|NCT02712905|453643099|FG003|Monotherapy|Physician Decision|1|||
126095551|NCT02712905|453643100|FG004|Monotherapy|Physician Decision|0|||
126095552|NCT02712905|453643101|FG005|Monotherapy|Physician Decision|0|||
126095553|NCT02712905|453643102|FG006|Monotherapy|Physician Decision|0|||
126095554|NCT02712905|453643103|FG007|Monotherapy|Physician Decision|0|||
126095555|NCT02712905|453643104|FG008|Monotherapy|Physician Decision|0|||
126095556|NCT02712905|453643105|FG009|Monotherapy|Physician Decision|1|||
126095557|NCT02712905|453643106|FG010|Monotherapy|Physician Decision|0|||
126095558|NCT02712905|453643107|FG011|Monotherapy|Physician Decision|0|||
126095559|NCT02712905|453643108|FG012|Monotherapy|Physician Decision|0|||
126095560|NCT02712905|453643109|FG013|Monotherapy|Physician Decision|0|||
126095561|NCT02712905|453643110|FG014|Monotherapy|Physician Decision|0|||
126095562|NCT02712905|453643111|FG015|Monotherapy|Physician Decision|0|||
126095563|NCT02712905|453643112|FG016|Monotherapy|Physician Decision|0|||
126095564|NCT02712905|453643113|FG017|Monotherapy|Physician Decision|0|||
126095565|NCT02712905|453643096|FG000|Monotherapy|Study Terminated by Sponsor|0|||
126095566|NCT02712905|453643097|FG001|Monotherapy|Study Terminated by Sponsor|0|||
126095567|NCT02712905|453643098|FG002|Monotherapy|Study Terminated by Sponsor|0|||
126095568|NCT02712905|453643099|FG003|Monotherapy|Study Terminated by Sponsor|0|||
126095569|NCT02712905|453643100|FG004|Monotherapy|Study Terminated by Sponsor|1|||
126095570|NCT02712905|453643101|FG005|Monotherapy|Study Terminated by Sponsor|0|||
126095571|NCT02712905|453643102|FG006|Monotherapy|Study Terminated by Sponsor|0|||
126095572|NCT02712905|453643103|FG007|Monotherapy|Study Terminated by Sponsor|0|||
126095573|NCT02712905|453643104|FG008|Monotherapy|Study Terminated by Sponsor|0|||
126095574|NCT02712905|453643105|FG009|Monotherapy|Study Terminated by Sponsor|2|||
126095575|NCT02712905|453643106|FG010|Monotherapy|Study Terminated by Sponsor|0|||
126095576|NCT02712905|453643107|FG011|Monotherapy|Study Terminated by Sponsor|0|||
126095577|NCT02712905|453643108|FG012|Monotherapy|Study Terminated by Sponsor|0|||
126095578|NCT02712905|453643109|FG013|Monotherapy|Study Terminated by Sponsor|0|||
126095579|NCT02712905|453643110|FG014|Monotherapy|Study Terminated by Sponsor|0|||
126095580|NCT02712905|453643111|FG015|Monotherapy|Study Terminated by Sponsor|0|||
126095581|NCT02712905|453643112|FG016|Monotherapy|Study Terminated by Sponsor|0|||
126095582|NCT02712905|453643113|FG017|Monotherapy|Study Terminated by Sponsor|0|||
126095583|NCT02712905|453643096|FG000|Monotherapy|Withdrawal by Subject|0|||
126095584|NCT02712905|453643097|FG001|Monotherapy|Withdrawal by Subject|0|||
126095585|NCT02712905|453643098|FG002|Monotherapy|Withdrawal by Subject|1|||
126095586|NCT02712905|453643099|FG003|Monotherapy|Withdrawal by Subject|0|||
126095587|NCT02712905|453643100|FG004|Monotherapy|Withdrawal by Subject|2|||
126358132|NCT00191152|454603901|FG001|Crossover Treatment|Lost to Follow-up|1|||
126358133|NCT00191152|454603900|FG000|Crossover Treatment|Other|4|||
126358134|NCT00191152|454603901|FG001|Crossover Treatment|Other|3|||
126358135|NCT00114777|454603905|FG000|Randomization to Month 36|Death|10|||
126358136|NCT00114777|454603906|FG001|Randomization to Month 36|Death|4|||
126358137|NCT00114777|454603907|FG002|Randomization to Month 36|Death|3|||
126358138|NCT00114777|454603905|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
126358139|NCT00114777|454603906|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
126358140|NCT00114777|454603907|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
126358141|NCT00114777|454603905|FG000|Randomization to Month 36|Lack of Efficacy|19|||
126358142|NCT00114777|454603906|FG001|Randomization to Month 36|Lack of Efficacy|15|||
126095588|NCT02712905|453643101|FG005|Monotherapy|Withdrawal by Subject|0|||
126095589|NCT02712905|453643102|FG006|Monotherapy|Withdrawal by Subject|0|||
126095590|NCT02712905|453643103|FG007|Monotherapy|Withdrawal by Subject|0|||
126095591|NCT02712905|453643104|FG008|Monotherapy|Withdrawal by Subject|0|||
126358143|NCT00114777|454603907|FG002|Randomization to Month 36|Lack of Efficacy|17|||
126358144|NCT00114777|454603905|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
126358145|NCT00114777|454603906|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
126095592|NCT02712905|453643105|FG009|Monotherapy|Withdrawal by Subject|4|||
126095593|NCT02712905|453643106|FG010|Monotherapy|Withdrawal by Subject|1|||
126095594|NCT02712905|453643107|FG011|Monotherapy|Withdrawal by Subject|2|||
126095595|NCT02712905|453643108|FG012|Monotherapy|Withdrawal by Subject|0|||
126095596|NCT02712905|453643109|FG013|Monotherapy|Withdrawal by Subject|0|||
126095597|NCT02712905|453643110|FG014|Monotherapy|Withdrawal by Subject|0|||
126095598|NCT02712905|453643111|FG015|Monotherapy|Withdrawal by Subject|0|||
126095599|NCT02712905|453643112|FG016|Monotherapy|Withdrawal by Subject|0|||
126095600|NCT02712905|453643113|FG017|Monotherapy|Withdrawal by Subject|0|||
126095601|NCT02712905|453643096|FG000|Monotherapy|Started New Cancer Drug|0|||
126095602|NCT02712905|453643097|FG001|Monotherapy|Started New Cancer Drug|0|||
126095603|NCT02712905|453643098|FG002|Monotherapy|Started New Cancer Drug|0|||
126095604|NCT02712905|453643099|FG003|Monotherapy|Started New Cancer Drug|0|||
126095605|NCT02712905|453643100|FG004|Monotherapy|Started New Cancer Drug|0|||
126095606|NCT02712905|453643101|FG005|Monotherapy|Started New Cancer Drug|1|||
126358146|NCT00114777|454603907|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
125879766|NCT03104868|452857382|FG001|6 Month Follow up|Lost to Follow-up|2|||
126095607|NCT02712905|453643102|FG006|Monotherapy|Started New Cancer Drug|0|||
126095608|NCT02712905|453643103|FG007|Monotherapy|Started New Cancer Drug|0|||
126095609|NCT02712905|453643104|FG008|Monotherapy|Started New Cancer Drug|0|||
126358147|NCT00114777|454603905|FG000|Randomization to Month 36|Adverse Event|34|||
126358148|NCT00114777|454603906|FG001|Randomization to Month 36|Adverse Event|35|||
126358149|NCT00114777|454603907|FG002|Randomization to Month 36|Adverse Event|44|||
126358150|NCT00114777|454603905|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
126358151|NCT00114777|454603906|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
126358152|NCT00114777|454603907|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
126358153|NCT00114777|454603905|FG000|Randomization to Month 36|Other|9|||
126358154|NCT00114777|454603906|FG001|Randomization to Month 36|Other|3|||
126358155|NCT00114777|454603907|FG002|Randomization to Month 36|Other|12|||
126358156|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Death|8|||
126358157|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Death|13|||
126358158|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Death|7|||
126358159|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
126358160|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
126358161|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
126358162|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
126358163|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
126358164|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
126358165|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
126358166|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
126358167|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
126358168|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
126029468|NCT01261312|453405143|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126358169|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
126358170|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
126358171|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
126358172|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
126358173|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
126358174|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
126358175|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
126358176|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
126358177|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
126358178|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
126358179|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
126358180|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Other|2|||
126358181|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Other|0|||
126358182|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Other|2|||
126358183|NCT00629239|454603908|FG000|Overall Study|Adverse Event|7|||
126358184|NCT00629239|454603909|FG001|Overall Study|Adverse Event|4|||
126358185|NCT00629239|454603908|FG000|Overall Study|Physician Decision|1|||
126358186|NCT00629239|454603909|FG001|Overall Study|Physician Decision|0|||
126358187|NCT02460380|454603910|FG000|Overall Study|Withdrawal by Subject|10|||
126358188|NCT02460380|454603911|FG001|Overall Study|Withdrawal by Subject|5|||
126358189|NCT03566550|454603917|FG000|Overall Study|Withdrawal by Subject|0|||
126358190|NCT03566550|454603918|FG001|Overall Study|Withdrawal by Subject|1|||
126358191|NCT01210443|454603925|FG000|Overall Study|Study terminated by sponsor|2|||
126358192|NCT00052715|454603926|FG000|Overall Study|wrong histology|1|||
126358193|NCT02807181|454603927|FG000|Overall Study|Death|28|||
126029469|NCT01261312|453405144|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029470|NCT01261312|453405145|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029471|NCT01261312|453405146|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029472|NCT01261312|453405147|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029473|NCT01261312|453405148|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029474|NCT01261312|453405149|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126029475|NCT01261312|453405137|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029476|NCT01261312|453405138|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029477|NCT01261312|453405139|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029478|NCT01261312|453405140|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029479|NCT01261312|453405141|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
126029480|NCT01261312|453405142|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
126029481|NCT01261312|453405143|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126358194|NCT02807181|454603928|FG001|Overall Study|Death|24|||
126029482|NCT01261312|453405144|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029483|NCT01261312|453405145|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029484|NCT01261312|453405146|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029485|NCT01261312|453405147|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029486|NCT01261312|453405148|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029487|NCT01261312|453405149|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126029488|NCT01261312|453405137|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126029489|NCT01261312|453405138|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126252315|NCT03105297|454214108|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
126252316|NCT03105297|454214108|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
126252317|NCT05065619|454214109|FG000|Up to Day 42|Lost to Follow-up|1|||
126252318|NCT05065619|454214110|FG001|Up to Day 42|Lost to Follow-up|0|||
126252319|NCT05065619|454214109|FG000|Up to Day 42|Withdrawal by Subject|1|||
126252320|NCT05065619|454214110|FG001|Up to Day 42|Withdrawal by Subject|0|||
126252321|NCT05065619|454214109|FG000|After Day 43|Lost to Follow-up|1|||
126252322|NCT05065619|454214110|FG001|After Day 43|Lost to Follow-up|0|||
126252323|NCT05065619|454214109|FG000|After Day 43|Physician Decision|3|||
126252324|NCT05065619|454214110|FG001|After Day 43|Physician Decision|0|||
126252325|NCT05065619|454214109|FG000|After Day 43|Withdrawal by Subject|1|||
126252326|NCT05065619|454214110|FG001|After Day 43|Withdrawal by Subject|2|||
126252327|NCT05065619|454214109|FG000|After Day 43|Public vaccination|6|||
126252328|NCT05065619|454214110|FG001|After Day 43|Public vaccination|8|||
126252329|NCT05065619|454214109|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
126252330|NCT05065619|454214110|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
126252331|NCT05065619|454214109|FG000|After Day 43|Study Terminated by Sponsor|88|||
126252332|NCT05065619|454214110|FG001|After Day 43|Study Terminated by Sponsor|16|||
126252333|NCT00714051|454214115|FG000|Overall Study|Withdrawal by Subject|1|||
126252334|NCT00714051|454214116|FG001|Overall Study|Withdrawal by Subject|0|||
126252335|NCT00714051|454214115|FG000|Overall Study|Death|0|||
126252336|NCT00714051|454214116|FG001|Overall Study|Death|1|||
126252337|NCT03868631|454214117|FG000|Baseline to Week 6|Adverse Event|0|||
126252338|NCT03868631|454214118|FG001|Baseline to Week 6|Adverse Event|3|||
126252339|NCT03868631|454214117|FG000|Baseline to Week 6|Protocol Violation|1|||
126252340|NCT03868631|454214118|FG001|Baseline to Week 6|Protocol Violation|1|||
126252341|NCT03868631|454214117|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
126252342|NCT03868631|454214118|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
126252343|NCT03868631|454214117|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
126252344|NCT03868631|454214118|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
126252345|NCT03868631|454214117|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
126252346|NCT03868631|454214118|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
126252347|NCT03868631|454214117|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
126252348|NCT03868631|454214118|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
126252349|NCT01929681|454214121|FG000|Overall Study|Withdrawal by Subject|1|||
126252350|NCT01929681|454214122|FG001|Overall Study|Withdrawal by Subject|0|||
126252351|NCT01929681|454214121|FG000|Overall Study|Physician Decision|1|||
126252352|NCT01929681|454214122|FG001|Overall Study|Physician Decision|1|||
126252353|NCT03250117|454214123|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
126252354|NCT03250117|454214124|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
126252355|NCT03250117|454214125|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
126252356|NCT03250117|454214126|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
126252357|NCT02452463|454214129|FG000|Overall Study|Death|1|||
126252358|NCT02452463|454214130|FG001|Overall Study|Death|0|||
126252359|NCT02452463|454214131|FG002|Overall Study|Death|0|||
126252360|NCT02452463|454214129|FG000|Overall Study|Study Suspended|1|||
126252361|NCT02452463|454214130|FG001|Overall Study|Study Suspended|0|||
126252362|NCT02452463|454214131|FG002|Overall Study|Study Suspended|0|||
126252363|NCT02452463|454214129|FG000|Overall Study|Recommended by DSMB|0|||
126252364|NCT02452463|454214130|FG001|Overall Study|Recommended by DSMB|1|||
126252365|NCT02452463|454214131|FG002|Overall Study|Recommended by DSMB|0|||
126252366|NCT02452463|454214129|FG000|Overall Study|Withdrawal by Subject|0|||
126358195|NCT02807181|454603927|FG000|Overall Study|Withdrawal by Subject|1|||
126095610|NCT02712905|453643105|FG009|Monotherapy|Started New Cancer Drug|0|||
126095611|NCT02712905|453643106|FG010|Monotherapy|Started New Cancer Drug|0|||
126095612|NCT02712905|453643107|FG011|Monotherapy|Started New Cancer Drug|0|||
126095613|NCT02712905|453643108|FG012|Monotherapy|Started New Cancer Drug|0|||
126095614|NCT02712905|453643109|FG013|Monotherapy|Started New Cancer Drug|0|||
126095615|NCT02712905|453643110|FG014|Monotherapy|Started New Cancer Drug|0|||
126095616|NCT02712905|453643111|FG015|Monotherapy|Started New Cancer Drug|0|||
126095617|NCT02712905|453643112|FG016|Monotherapy|Started New Cancer Drug|0|||
126095618|NCT02712905|453643113|FG017|Monotherapy|Started New Cancer Drug|0|||
126095619|NCT02712905|453643096|FG000|Monotherapy|Adverse Event|0|||
126252367|NCT02452463|454214130|FG001|Overall Study|Withdrawal by Subject|1|||
126252368|NCT02452463|454214131|FG002|Overall Study|Withdrawal by Subject|0|||
126252369|NCT05740098|454214132|FG000|Overall Study|Lost to Follow-up|26|||
126252370|NCT05740098|454214133|FG001|Overall Study|Lost to Follow-up|17|||
126252371|NCT05740098|454214134|FG002|Overall Study|Lost to Follow-up|21|||
126252372|NCT01073631|454214135|FG000|Overall Study|Death|82|||
126252373|NCT01073631|454214135|FG000|Overall Study|Adverse Event|24|||
126252374|NCT01073631|454214135|FG000|Overall Study|Other|63|||
126252375|NCT01528735|454214136|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
126252376|NCT01528735|454214137|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
126358196|NCT02807181|454603928|FG001|Overall Study|Withdrawal by Subject|1|||
126252377|NCT01528735|454214136|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
126252378|NCT01528735|454214137|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
126252379|NCT01971554|454214138|FG000|Overall Study|Lost to Follow-up|1|||
126252380|NCT01971554|454214139|FG001|Overall Study|Lost to Follow-up|0|||
126252381|NCT01971554|454214140|FG002|Overall Study|Lost to Follow-up|0|||
126252382|NCT01971554|454214141|FG003|Overall Study|Lost to Follow-up|0|||
126252383|NCT01426854|454214144|FG000|Overall Study|Adverse Event|1|||
126252384|NCT01426854|454214145|FG001|Overall Study|Adverse Event|5|||
126252385|NCT01426854|454214144|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
126252386|NCT01426854|454214145|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
126252387|NCT01426854|454214144|FG000|Overall Study|Lost to Follow-up|3|||
126252388|NCT01426854|454214145|FG001|Overall Study|Lost to Follow-up|0|||
126252389|NCT01426854|454214144|FG000|Overall Study|Noncompliance|0|||
126252390|NCT01426854|454214145|FG001|Overall Study|Noncompliance|1|||
126252391|NCT01426854|454214144|FG000|Overall Study|Treatment Failure|0|||
126252392|NCT01426854|454214145|FG001|Overall Study|Treatment Failure|16|||
126252393|NCT01426854|454214144|FG000|Overall Study|Protocol Deviation|0|||
126252394|NCT01426854|454214145|FG001|Overall Study|Protocol Deviation|1|||
126252395|NCT01426854|454214144|FG000|Overall Study|Other|3|||
126252396|NCT01426854|454214145|FG001|Overall Study|Other|2|||
126252397|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
126252398|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
126252399|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
126252400|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
126252401|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
126252402|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
126252403|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
126252404|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
126252405|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
126252406|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
126252407|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
126252408|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
126252409|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
126252410|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
126252411|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
126252412|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
126252413|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
126252414|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
126252415|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
126252416|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
126252417|NCT00950300|454214147|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
126252418|NCT00950300|454214148|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
126252419|NCT00950300|454214147|FG000|TFFU Period|Death|4|||
126252420|NCT00950300|454214148|FG001|TFFU Period|Death|1|||
126252421|NCT00950300|454214147|FG000|TFFU Period|Refused Treatment|10|||
126252422|NCT00950300|454214148|FG001|TFFU Period|Refused Treatment|11|||
126252423|NCT00950300|454214147|FG000|TFFU Period|Failure to Return|16|||
126252424|NCT00950300|454214148|FG001|TFFU Period|Failure to Return|16|||
126252425|NCT00950300|454214147|FG000|TFFU Period|Recurrence of Disease|63|||
126252426|NCT00950300|454214148|FG001|TFFU Period|Recurrence of Disease|72|||
126252427|NCT00950300|454214147|FG000|TFFU Period|Other|4|||
126252428|NCT00950300|454214148|FG001|TFFU Period|Other|3|||
125879767|NCT03104868|452857381|FG000|6 Month Follow up|Death|0|||
126029490|NCT01261312|453405139|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126029491|NCT01261312|453405140|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126252429|NCT00950300|454214147|FG000|SFU Period|Death|44|||
126252430|NCT00950300|454214148|FG001|SFU Period|Death|42|||
126252431|NCT00950300|454214147|FG000|SFU Period|Lost to Follow-up|30|||
126095620|NCT02712905|453643097|FG001|Monotherapy|Adverse Event|0|||
126095621|NCT02712905|453643098|FG002|Monotherapy|Adverse Event|0|||
126095622|NCT02712905|453643099|FG003|Monotherapy|Adverse Event|0|||
126095623|NCT02712905|453643100|FG004|Monotherapy|Adverse Event|0|||
126095624|NCT02712905|453643101|FG005|Monotherapy|Adverse Event|0|||
126095625|NCT02712905|453643102|FG006|Monotherapy|Adverse Event|0|||
126095626|NCT02712905|453643103|FG007|Monotherapy|Adverse Event|0|||
126095627|NCT02712905|453643104|FG008|Monotherapy|Adverse Event|1|||
126095628|NCT02712905|453643105|FG009|Monotherapy|Adverse Event|0|||
126095629|NCT02712905|453643106|FG010|Monotherapy|Adverse Event|0|||
126095630|NCT02712905|453643107|FG011|Monotherapy|Adverse Event|0|||
126095631|NCT02712905|453643108|FG012|Monotherapy|Adverse Event|0|||
126095632|NCT02712905|453643109|FG013|Monotherapy|Adverse Event|0|||
126095633|NCT02712905|453643110|FG014|Monotherapy|Adverse Event|0|||
126095634|NCT02712905|453643111|FG015|Monotherapy|Adverse Event|0|||
126095635|NCT02712905|453643112|FG016|Monotherapy|Adverse Event|0|||
126095636|NCT02712905|453643113|FG017|Monotherapy|Adverse Event|0|||
126095637|NCT02712905|453643096|FG000|Combination Therapy|Death|0|||
126095638|NCT02712905|453643097|FG001|Combination Therapy|Death|0|||
126095639|NCT02712905|453643098|FG002|Combination Therapy|Death|0|||
126095640|NCT02712905|453643099|FG003|Combination Therapy|Death|0|||
126095641|NCT02712905|453643100|FG004|Combination Therapy|Death|0|||
126095642|NCT02712905|453643101|FG005|Combination Therapy|Death|0|||
126095643|NCT02712905|453643102|FG006|Combination Therapy|Death|0|||
126358197|NCT02807181|454603927|FG000|Overall Study|Lost to Follow-up|0|||
126358198|NCT02807181|454603928|FG001|Overall Study|Lost to Follow-up|2|||
126358199|NCT02807181|454603927|FG000|Overall Study|Subject decision|1|||
126358200|NCT02807181|454603928|FG001|Overall Study|Subject decision|0|||
126358201|NCT02807181|454603927|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
126358202|NCT02807181|454603928|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
126358203|NCT02807181|454603927|FG000|Overall Study|In Study|3|||
126358204|NCT02807181|454603928|FG001|Overall Study|In Study|3|||
126358205|NCT02807181|454603927|FG000|Overall Study|Post Progression|3|||
126358206|NCT02807181|454603928|FG001|Overall Study|Post Progression|2|||
126358207|NCT01063881|454603929|FG000|Overall Study|Adverse Event|12|||
126358208|NCT01063881|454603930|FG001|Overall Study|Adverse Event|2|||
126358209|NCT01063881|454603931|FG002|Overall Study|Adverse Event|0|||
126358210|NCT01063881|454603929|FG000|Overall Study|Lost to Follow-up|13|||
126358211|NCT01063881|454603930|FG001|Overall Study|Lost to Follow-up|7|||
126358212|NCT01063881|454603931|FG002|Overall Study|Lost to Follow-up|1|||
126358213|NCT01063881|454603929|FG000|Overall Study|Withdrawal by Subject|25|||
126358214|NCT01063881|454603930|FG001|Overall Study|Withdrawal by Subject|1|||
126358215|NCT01063881|454603931|FG002|Overall Study|Withdrawal by Subject|0|||
126358216|NCT01063881|454603929|FG000|Overall Study|Reason for not completed not specified|5|||
126358217|NCT01063881|454603930|FG001|Overall Study|Reason for not completed not specified|1|||
126358218|NCT01063881|454603931|FG002|Overall Study|Reason for not completed not specified|0|||
126358219|NCT01309100|454603932|FG000|Overall Study|Protocol Violation|1|||
126358220|NCT01309100|454603932|FG000|Overall Study|Positive Slit lamp finding|1|||
126358221|NCT03808909|454603939|FG000|Overall Study|Lost to Follow-up|3|||
126358222|NCT03808909|454603940|FG001|Overall Study|Lost to Follow-up|0|||
126358223|NCT03335566|454603941|FG000|Overall Study|Adverse Event|0|||
126358224|NCT03335566|454603942|FG001|Overall Study|Adverse Event|1|||
126358225|NCT03335566|454603941|FG000|Overall Study|Lost to Follow-up|1|||
126358226|NCT03335566|454603942|FG001|Overall Study|Lost to Follow-up|0|||
126095644|NCT02712905|453643103|FG007|Combination Therapy|Death|0|||
126095645|NCT02712905|453643104|FG008|Combination Therapy|Death|0|||
126095646|NCT02712905|453643105|FG009|Combination Therapy|Death|0|||
126095647|NCT02712905|453643106|FG010|Combination Therapy|Death|0|||
126095648|NCT02712905|453643107|FG011|Combination Therapy|Death|0|||
126358227|NCT03335566|454603941|FG000|Overall Study|Technical Problems|1|||
126358228|NCT03335566|454603942|FG001|Overall Study|Technical Problems|0|||
126358229|NCT03335566|454603941|FG000|Overall Study|Protocol Violation|1|||
126358230|NCT03335566|454603942|FG001|Overall Study|Protocol Violation|0|||
126358231|NCT03335566|454603941|FG000|Overall Study|Other than specified above|1|||
126358232|NCT03335566|454603942|FG001|Overall Study|Other than specified above|2|||
126358233|NCT01084135|454603943|FG000|20 Week|Physician Decision|0|||
126358234|NCT01084135|454603944|FG001|20 Week|Physician Decision|1|||
126358235|NCT00663351|454603945|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
126358236|NCT00663351|454603946|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
126358237|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
126358238|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
126358239|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
126358240|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
126358241|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
126095649|NCT02712905|453643108|FG012|Combination Therapy|Death|5|||
126095650|NCT02712905|453643109|FG013|Combination Therapy|Death|6|||
126095651|NCT02712905|453643110|FG014|Combination Therapy|Death|1|||
126095652|NCT02712905|453643111|FG015|Combination Therapy|Death|3|||
126095653|NCT02712905|453643112|FG016|Combination Therapy|Death|1|||
126095654|NCT02712905|453643113|FG017|Combination Therapy|Death|3|||
126029492|NCT01261312|453405141|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
126029493|NCT01261312|453405142|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
126029494|NCT01261312|453405143|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126029495|NCT01261312|453405144|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126029496|NCT01261312|453405145|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126029497|NCT01261312|453405146|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126095655|NCT02712905|453643096|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
126095656|NCT02712905|453643097|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
126095657|NCT02712905|453643098|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
126095658|NCT02712905|453643099|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
126095659|NCT02712905|453643100|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
126095660|NCT02712905|453643101|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
126095661|NCT02712905|453643102|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
126095662|NCT02712905|453643103|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
126095663|NCT02712905|453643104|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
126095664|NCT02712905|453643105|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
126095665|NCT02712905|453643106|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
126095666|NCT02712905|453643107|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
126095667|NCT02712905|453643108|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
126095668|NCT02712905|453643109|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
126095669|NCT02712905|453643110|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
126095670|NCT02712905|453643111|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
126095671|NCT02712905|453643112|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
126095672|NCT02712905|453643113|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
126095673|NCT02712905|453643096|FG000|Combination Therapy|Withdrawal by Subject|0|||
126095674|NCT02712905|453643097|FG001|Combination Therapy|Withdrawal by Subject|0|||
126095675|NCT02712905|453643098|FG002|Combination Therapy|Withdrawal by Subject|0|||
126029498|NCT01261312|453405147|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126029499|NCT01261312|453405148|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126029500|NCT01261312|453405149|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126029501|NCT01261312|453405137|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029502|NCT01261312|453405138|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029503|NCT01261312|453405139|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029504|NCT01261312|453405140|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
126029505|NCT01261312|453405141|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
126029506|NCT01261312|453405142|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
126029507|NCT01261312|453405143|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029508|NCT01261312|453405144|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029509|NCT01261312|453405145|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029510|NCT01261312|453405146|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029511|NCT01261312|453405147|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029512|NCT01261312|453405148|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029513|NCT01261312|453405149|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
126029514|NCT01261312|453405137|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029515|NCT01261312|453405138|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029516|NCT01261312|453405139|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029517|NCT01261312|453405140|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029518|NCT01261312|453405141|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029519|NCT01261312|453405142|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
126029520|NCT01261312|453405143|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029521|NCT01261312|453405144|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126095676|NCT02712905|453643099|FG003|Combination Therapy|Withdrawal by Subject|0|||
126095677|NCT02712905|453643100|FG004|Combination Therapy|Withdrawal by Subject|0|||
126095678|NCT02712905|453643101|FG005|Combination Therapy|Withdrawal by Subject|0|||
126095679|NCT02712905|453643102|FG006|Combination Therapy|Withdrawal by Subject|0|||
126095680|NCT02712905|453643103|FG007|Combination Therapy|Withdrawal by Subject|0|||
126095681|NCT02712905|453643104|FG008|Combination Therapy|Withdrawal by Subject|0|||
126029522|NCT01261312|453405145|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029523|NCT01261312|453405146|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029524|NCT01261312|453405147|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029525|NCT01261312|453405148|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126029526|NCT01261312|453405149|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126095682|NCT02712905|453643105|FG009|Combination Therapy|Withdrawal by Subject|0|||
126095683|NCT02712905|453643106|FG010|Combination Therapy|Withdrawal by Subject|0|||
126095684|NCT02712905|453643107|FG011|Combination Therapy|Withdrawal by Subject|0|||
126029527|NCT01261312|453405137|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029528|NCT01261312|453405138|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029529|NCT01261312|453405139|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029530|NCT01261312|453405140|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
126029531|NCT01261312|453405141|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
126029532|NCT01261312|453405142|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
126095685|NCT02712905|453643108|FG012|Combination Therapy|Withdrawal by Subject|0|||
126095686|NCT02712905|453643109|FG013|Combination Therapy|Withdrawal by Subject|0|||
126095687|NCT02712905|453643110|FG014|Combination Therapy|Withdrawal by Subject|0|||
126095688|NCT02712905|453643111|FG015|Combination Therapy|Withdrawal by Subject|1|||
126095689|NCT02712905|453643112|FG016|Combination Therapy|Withdrawal by Subject|0|||
126095690|NCT02712905|453643113|FG017|Combination Therapy|Withdrawal by Subject|2|||
126095691|NCT02712905|453643096|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095692|NCT02712905|453643097|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095693|NCT02712905|453643098|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095694|NCT02712905|453643099|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095695|NCT02712905|453643100|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095696|NCT02712905|453643101|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095697|NCT02712905|453643102|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095698|NCT02712905|453643103|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095699|NCT02712905|453643104|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095700|NCT02712905|453643105|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095701|NCT02712905|453643106|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095702|NCT02712905|453643107|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095703|NCT02712905|453643108|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095704|NCT02712905|453643109|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095705|NCT02712905|453643110|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095706|NCT02712905|453643111|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
126095707|NCT02712905|453643112|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095708|NCT02712905|453643113|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126095709|NCT01942785|453643117|FG000|Overall Study|Adverse Event|2|||
126095710|NCT01942785|453643117|FG000|Overall Study|Withdrawal by Subject|1|||
126095711|NCT01942785|453643117|FG000|Overall Study|Protocol Violation|1|||
126095712|NCT02227199|453643118|FG000|Overall Study|Physician Decision|0|||
126095713|NCT02227199|453643119|FG001|Overall Study|Physician Decision|0|||
126095714|NCT02227199|453643120|FG002|Overall Study|Physician Decision|1|||
126095715|NCT02227199|453643118|FG000|Overall Study|Adverse Event|0|||
126252432|NCT00950300|454214148|FG001|SFU Period|Lost to Follow-up|28|||
126252433|NCT00950300|454214147|FG000|SFU Period|Withdrawal by Subject|4|||
126252434|NCT00950300|454214148|FG001|SFU Period|Withdrawal by Subject|8|||
126252435|NCT00494013|454214149|FG000|Overall Study|Adverse Event|0|||
126252436|NCT00494013|454214150|FG001|Overall Study|Adverse Event|1|||
126252437|NCT00494013|454214149|FG000|Overall Study|Entry Criteria Not Met|1|||
126252438|NCT00494013|454214150|FG001|Overall Study|Entry Criteria Not Met|4|||
126252439|NCT00494013|454214149|FG000|Overall Study|Lost to Follow-up|5|||
126252440|NCT00494013|454214150|FG001|Overall Study|Lost to Follow-up|6|||
126252441|NCT00494013|454214149|FG000|Overall Study|Physician Decision|3|||
126252442|NCT00494013|454214150|FG001|Overall Study|Physician Decision|5|||
126252443|NCT00494013|454214149|FG000|Overall Study|Protocol Violation|8|||
126252444|NCT00494013|454214150|FG001|Overall Study|Protocol Violation|5|||
126252445|NCT00494013|454214149|FG000|Overall Study|Withdrawal by Subject|13|||
126252446|NCT00494013|454214150|FG001|Overall Study|Withdrawal by Subject|14|||
126252447|NCT00494013|454214149|FG000|Overall Study|Sponsor Decision|0|||
126252448|NCT00494013|454214150|FG001|Overall Study|Sponsor Decision|1|||
126252449|NCT04750239|454214151|FG000|Overall Study|Withdrawal by Subject|2|||
126252450|NCT04750239|454214151|FG000|Overall Study|Trial terminated by sponsor|1|||
126252451|NCT00903877|454214152|FG000|Overall Study|Did not meet study criteria|33|||
126252452|NCT00903877|454214152|FG000|Overall Study|Withdrawal by Subject|3|||
126252453|NCT00903877|454214152|FG000|Overall Study|Adverse Event|2|||
126252454|NCT00903877|454214152|FG000|Overall Study|Lost to Follow-up|1|||
126252455|NCT00903877|454214152|FG000|Overall Study|Participation put on hold|4|||
126252456|NCT00919711|454214153|FG000|Overall Study|Withdrawal by Subject|15|||
126252457|NCT00919711|454214154|FG001|Overall Study|Withdrawal by Subject|7|||
126252458|NCT00919711|454214153|FG000|Overall Study|Adverse Event|13|||
126252459|NCT00919711|454214154|FG001|Overall Study|Adverse Event|3|||
126252460|NCT00919711|454214153|FG000|Overall Study|Other|1|||
126252461|NCT00919711|454214154|FG001|Overall Study|Other|2|||
126252462|NCT00919711|454214153|FG000|Overall Study|Administrative Decision|0|||
126252463|NCT00919711|454214154|FG001|Overall Study|Administrative Decision|1|||
126252464|NCT00919711|454214153|FG000|Overall Study|Lost to Follow-up|2|||
126252465|NCT00919711|454214154|FG001|Overall Study|Lost to Follow-up|0|||
126252466|NCT00919711|454214153|FG000|Overall Study|Death|1|||
126252467|NCT00919711|454214154|FG001|Overall Study|Death|0|||
126252468|NCT00919711|454214153|FG000|Overall Study|Noncompliance|1|||
126095716|NCT02227199|453643119|FG001|Overall Study|Adverse Event|0|||
126095717|NCT02227199|453643120|FG002|Overall Study|Adverse Event|3|||
126095718|NCT05453201|453643122|FG000|Overall Study|Withdrawal by Subject|1|||
126095719|NCT00552929|453643123|FG000|Overall Study|Lost to Follow-up|0|||
126095720|NCT00552929|453643124|FG001|Overall Study|Lost to Follow-up|0|||
126095721|NCT00552929|453643125|FG002|Overall Study|Lost to Follow-up|0|||
126095722|NCT00552929|453643126|FG003|Overall Study|Lost to Follow-up|0|||
126095723|NCT00552929|453643127|FG004|Overall Study|Lost to Follow-up|0|||
126095724|NCT00552929|453643128|FG005|Overall Study|Lost to Follow-up|0|||
126252469|NCT00919711|454214154|FG001|Overall Study|Noncompliance|0|||
126252470|NCT00685334|454214157|FG000|Overall Study|Withdrawal by Subject|5|||
126252471|NCT00685334|454214158|FG001|Overall Study|Withdrawal by Subject|6|||
126252472|NCT00685334|454214157|FG000|Overall Study|Lost to Follow-up|4|||
126252473|NCT00685334|454214158|FG001|Overall Study|Lost to Follow-up|0|||
126252474|NCT00685334|454214157|FG000|Overall Study|Chose to enter hospital|1|||
126095725|NCT00552929|453643129|FG006|Overall Study|Lost to Follow-up|0|||
126095726|NCT00552929|453643130|FG007|Overall Study|Lost to Follow-up|0|||
126095727|NCT00552929|453643131|FG008|Overall Study|Lost to Follow-up|1|||
126252475|NCT00685334|454214158|FG001|Overall Study|Chose to enter hospital|1|||
126252476|NCT01891357|454214159|FG000|Overall Study|Protocol Violation|3|||
126252477|NCT04573309|454215868|FG000|Overall Study|Protocol Violation|1|||
126252478|NCT04573309|454215869|FG001|Overall Study|Protocol Violation|0|||
126252479|NCT02300987|454215870|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
126252480|NCT02300987|454215871|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
126252481|NCT02300987|454215870|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
126252482|NCT02300987|454215871|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
126252483|NCT02300987|454215870|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
126252484|NCT02300987|454215871|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
126252485|NCT02300987|454215870|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
126252486|NCT02300987|454215871|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
126252487|NCT02300987|454215870|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
126252488|NCT02300987|454215871|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
126252489|NCT02488109|454215872|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
126252490|NCT02488109|454215873|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
126252491|NCT02488109|454215872|FG000|12-month Follow-Up|Lost to Follow-up|4|||
126252492|NCT02488109|454215873|FG001|12-month Follow-Up|Lost to Follow-up|7|||
126252493|NCT03969641|454215874|FG000|Overall Study|Lost to Follow-up|5|||
126252494|NCT03969641|454215875|FG001|Overall Study|Lost to Follow-up|3|||
126252495|NCT03969641|454215874|FG000|Overall Study|Withdrawal by Subject|1|||
126252496|NCT03969641|454215875|FG001|Overall Study|Withdrawal by Subject|2|||
126252497|NCT03969641|454215874|FG000|Overall Study|Found to be ineligible|1|||
126252498|NCT03969641|454215875|FG001|Overall Study|Found to be ineligible|1|||
126252499|NCT03969641|454215874|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
126252500|NCT03969641|454215875|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
126252501|NCT03969641|454215874|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
126252502|NCT03969641|454215875|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
126252503|NCT03969641|454215874|FG000|Overall Study|Elective termination|0|||
126252504|NCT03969641|454215875|FG001|Overall Study|Elective termination|1|||
126252505|NCT01541215|454215876|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
126252506|NCT01541215|454215877|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
126252507|NCT01541215|454215876|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
126095728|NCT00552929|453643132|FG009|Overall Study|Lost to Follow-up|0|||
126095729|NCT00552929|453643123|FG000|Overall Study|Not Eligible|0|||
126095730|NCT00552929|453643124|FG001|Overall Study|Not Eligible|0|||
126095731|NCT00552929|453643125|FG002|Overall Study|Not Eligible|0|||
126095732|NCT00552929|453643126|FG003|Overall Study|Not Eligible|0|||
126095733|NCT00552929|453643127|FG004|Overall Study|Not Eligible|0|||
126095734|NCT00552929|453643128|FG005|Overall Study|Not Eligible|1|||
126095735|NCT00552929|453643129|FG006|Overall Study|Not Eligible|0|||
126252508|NCT01541215|454215877|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
126252509|NCT01541215|454215876|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
126252510|NCT01541215|454215877|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
126095736|NCT00552929|453643130|FG007|Overall Study|Not Eligible|0|||
126095737|NCT00552929|453643131|FG008|Overall Study|Not Eligible|0|||
126095738|NCT00552929|453643132|FG009|Overall Study|Not Eligible|0|||
126095739|NCT01200290|453643133|FG000|Treatment Period|Adverse Event|1|||
126095740|NCT01200290|453643133|FG000|Post-Treatment Follow-Up Period|Death|2|||
126095741|NCT02489968|453643140|FG000|Open-label Treatment Period|Adverse Event|14|||
126095742|NCT02489968|453643141|FG001|Open-label Treatment Period|Adverse Event|7|||
126252511|NCT01541215|454215876|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
126252512|NCT01541215|454215877|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
126252513|NCT01541215|454215876|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
126252514|NCT01541215|454215877|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
126252515|NCT01541215|454215876|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
126252516|NCT01541215|454215877|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
126029533|NCT01261312|453405143|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029534|NCT01261312|453405144|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029535|NCT01261312|453405145|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029536|NCT01261312|453405146|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029537|NCT01261312|453405147|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029538|NCT01261312|453405148|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029539|NCT01261312|453405149|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126029540|NCT01261312|453405137|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126029541|NCT01261312|453405138|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126029542|NCT01261312|453405139|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126029543|NCT01261312|453405140|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
126252517|NCT02658019|454215886|FG000|Overall Study|Adverse Event|1|||
126252518|NCT00820599|454215887|FG000|Overall Study|Death|129|||
126252519|NCT00820599|454215887|FG000|Overall Study|Withdrawal by Subject|2|||
126252520|NCT00960154|454215888|FG000|Overall Study|Study termination|25|||
126252521|NCT00960154|454215889|FG001|Overall Study|Study termination|25|||
126252522|NCT00486434|454215890|FG000|Overall Study|Withdrawal by Subject|34|||
126252523|NCT00486434|454215891|FG001|Overall Study|Withdrawal by Subject|39|||
126252524|NCT00486434|454215890|FG000|Overall Study|Adverse Event|118|||
126252525|NCT00486434|454215891|FG001|Overall Study|Adverse Event|44|||
126252526|NCT00486434|454215890|FG000|Overall Study|Protocol Violation|22|||
126252527|NCT00486434|454215891|FG001|Overall Study|Protocol Violation|21|||
126252528|NCT00486434|454215890|FG000|Overall Study|Lack of Efficacy|12|||
126252529|NCT00486434|454215891|FG001|Overall Study|Lack of Efficacy|19|||
126029544|NCT01261312|453405141|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
126029545|NCT01261312|453405142|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
126029546|NCT01261312|453405143|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126029547|NCT01261312|453405144|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126029548|NCT01261312|453405145|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126252530|NCT00486434|454215890|FG000|Overall Study|Lost to Follow-up|2|||
126252531|NCT00486434|454215891|FG001|Overall Study|Lost to Follow-up|3|||
126252532|NCT00486434|454215890|FG000|Overall Study|Death|1|||
126252533|NCT00486434|454215891|FG001|Overall Study|Death|2|||
126252534|NCT00486434|454215890|FG000|Overall Study|Personal reasons|5|||
126252535|NCT00486434|454215891|FG001|Overall Study|Personal reasons|6|||
126252536|NCT00544167|454215892|FG000|Overall Study|Adverse Event|21|||
126252537|NCT00544167|454215892|FG000|Overall Study|Physician Decision|8|||
126252538|NCT02725515|454215893|FG000|Overall Study|Refused infusion (no study treatment)|1|||
126252539|NCT02725515|454215894|FG001|Overall Study|Refused infusion (no study treatment)|0|||
126252540|NCT02725515|454215893|FG000|Overall Study|Loss of Improvement per Protocol|14|||
126252541|NCT02725515|454215894|FG001|Overall Study|Loss of Improvement per Protocol|25|||
126252542|NCT02725515|454215893|FG000|Overall Study|Withdrawal by Subject|2|||
126252543|NCT02725515|454215894|FG001|Overall Study|Withdrawal by Subject|1|||
126252544|NCT02725515|454215893|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126252545|NCT02725515|454215894|FG001|Overall Study|Non-Compliance With Study Drug|3|||
126252546|NCT02725515|454215893|FG000|Overall Study|Lost to Follow-up|1|||
126252547|NCT02725515|454215894|FG001|Overall Study|Lost to Follow-up|1|||
126252548|NCT02725515|454215893|FG000|Overall Study|Adverse Event|7|||
126252549|NCT02725515|454215894|FG001|Overall Study|Adverse Event|2|||
126252550|NCT02725515|454215893|FG000|Overall Study|No Documented Disease Improvement|0|||
126252551|NCT02725515|454215894|FG001|Overall Study|No Documented Disease Improvement|1|||
126252552|NCT02725515|454215893|FG000|Overall Study|Completed Study Under Original Protocol|0|||
126252553|NCT02725515|454215894|FG001|Overall Study|Completed Study Under Original Protocol|1|||
126252554|NCT02725515|454215893|FG000|Overall Study|Lack of Response|0|||
126252555|NCT02725515|454215894|FG001|Overall Study|Lack of Response|1|||
126252556|NCT00874549|454215895|FG000|Overall Study|Adverse Event|0|||
126252557|NCT00874549|454215896|FG001|Overall Study|Adverse Event|0|||
126252558|NCT00874549|454215897|FG002|Overall Study|Adverse Event|1|||
126252559|NCT00874549|454215898|FG003|Overall Study|Adverse Event|0|||
126252560|NCT00874549|454215895|FG000|Overall Study|Protocol Violation|1|||
126252561|NCT00874549|454215896|FG001|Overall Study|Protocol Violation|0|||
126252562|NCT00874549|454215897|FG002|Overall Study|Protocol Violation|2|||
126252563|NCT00874549|454215898|FG003|Overall Study|Protocol Violation|1|||
126252564|NCT00874549|454215895|FG000|Overall Study|Lost to Follow-up|0|||
126252565|NCT00874549|454215896|FG001|Overall Study|Lost to Follow-up|0|||
126029549|NCT01261312|453405146|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126252566|NCT00874549|454215897|FG002|Overall Study|Lost to Follow-up|1|||
126252567|NCT00874549|454215898|FG003|Overall Study|Lost to Follow-up|0|||
126252568|NCT00874549|454215895|FG000|Overall Study|Withdrawal by Subject|0|||
126252569|NCT00874549|454215896|FG001|Overall Study|Withdrawal by Subject|1|||
126252570|NCT00874549|454215897|FG002|Overall Study|Withdrawal by Subject|0|||
126252571|NCT00874549|454215898|FG003|Overall Study|Withdrawal by Subject|1|||
126252572|NCT02998541|454215908|FG000|Overall Study|Adverse Event|4|||
126252573|NCT02998541|454215909|FG001|Overall Study|Adverse Event|5|||
126252574|NCT02998541|454215910|FG002|Overall Study|Adverse Event|1|||
126252575|NCT02998541|454215908|FG000|Overall Study|Protocol Violation|1|||
126252576|NCT02998541|454215909|FG001|Overall Study|Protocol Violation|0|||
126252577|NCT02998541|454215910|FG002|Overall Study|Protocol Violation|0|||
126252578|NCT02998541|454215908|FG000|Overall Study|Withdrawal by Subject|3|||
126252579|NCT02998541|454215909|FG001|Overall Study|Withdrawal by Subject|1|||
126252580|NCT02998541|454215910|FG002|Overall Study|Withdrawal by Subject|0|||
126252581|NCT02998541|454215908|FG000|Overall Study|Lost to Follow-up|0|||
126252582|NCT02998541|454215909|FG001|Overall Study|Lost to Follow-up|3|||
126252583|NCT02998541|454215910|FG002|Overall Study|Lost to Follow-up|1|||
126252584|NCT02998541|454215908|FG000|Overall Study|Physician Decision|0|||
126252585|NCT02998541|454215909|FG001|Overall Study|Physician Decision|0|||
126252586|NCT02998541|454215910|FG002|Overall Study|Physician Decision|3|||
126252587|NCT02998541|454215908|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126252588|NCT02998541|454215909|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126252589|NCT02998541|454215910|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
126252590|NCT03387462|454215918|FG000|Overall Study|Lost to Follow-up|1|||
126252591|NCT01460628|454215921|FG000|Overall Study|Adverse Event|3|||
126252592|NCT01460628|454215921|FG000|Overall Study|Withdrawal by Subject|2|||
126252593|NCT02906917|454215922|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
126252594|NCT02906917|454215923|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
126252595|NCT02906917|454215922|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
126252596|NCT02906917|454215923|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
126252597|NCT02906917|454215922|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
126252598|NCT02906917|454215923|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
126252599|NCT02906917|454215922|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
126252600|NCT02906917|454215923|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
126252601|NCT02906917|454215922|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
126252602|NCT02906917|454215923|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
126252603|NCT02906917|454215922|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
126252604|NCT02906917|454215923|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
126252605|NCT02906917|454215922|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
126252606|NCT02906917|454215923|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
126252607|NCT02906917|454215922|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
126252608|NCT02906917|454215923|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
126252609|NCT00210639|454215924|FG000|Overall Study|Lost to Follow-up|37|||
126252610|NCT00210639|454215925|FG001|Overall Study|Lost to Follow-up|29|||
126252611|NCT00210639|454215924|FG000|Overall Study|Withdrawal by Subject|8|||
126252612|NCT00210639|454215925|FG001|Overall Study|Withdrawal by Subject|1|||
126252613|NCT00210639|454215924|FG000|Overall Study|Other|18|||
126252614|NCT00210639|454215925|FG001|Overall Study|Other|12|||
126252615|NCT00874822|454215927|FG000|Overall Study|excluded by criteria|8|||
126252616|NCT05278858|454215928|FG000|Overall Study|Withdrawal by Subject|1|||
126252617|NCT00152451|454215931|FG000|Overall Study|Adverse Event|4|||
126252618|NCT04697173|454215936|FG000|Overall Study|Withdrawal by Subject|34|||
126252619|NCT04697173|454215937|FG001|Overall Study|Withdrawal by Subject|38|||
126252620|NCT03807440|454215938|FG000|Overall Study|No documentation of index date 2|320|||
126252621|NCT03807440|454215938|FG000|Overall Study|No informed consent for index date 2|117|||
126252622|NCT03504085|454215941|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
126252623|NCT03504085|454215942|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
126252624|NCT03504085|454215941|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
126252625|NCT03504085|454215942|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
126252626|NCT04133311|454215943|FG000|Period 1 Double Masked Treatment Period|Death|1|||
126252627|NCT04133311|454215944|FG001|Period 1 Double Masked Treatment Period|Death|0|||
126252628|NCT04133311|454215945|FG002|Period 1 Double Masked Treatment Period|Death|0|||
126252629|NCT04133311|454215946|FG003|Period 1 Double Masked Treatment Period|Death|0|||
126029550|NCT01261312|453405147|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126029551|NCT01261312|453405148|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126029552|NCT01261312|453405149|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126029553|NCT01261312|453405137|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029554|NCT01261312|453405138|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029555|NCT01261312|453405139|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029556|NCT01261312|453405140|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029557|NCT01261312|453405141|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126252630|NCT04133311|454215943|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
126252631|NCT04133311|454215944|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
126252632|NCT04133311|454215945|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
126252633|NCT04133311|454215946|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
126252634|NCT04133311|454215943|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
126252635|NCT04133311|454215944|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
126252636|NCT04133311|454215945|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
126252637|NCT04133311|454215946|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
126029558|NCT01261312|453405142|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029559|NCT01261312|453405143|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
126029560|NCT01261312|453405144|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
126029561|NCT01261312|453405145|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
126029562|NCT01261312|453405146|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029563|NCT01261312|453405147|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029564|NCT01261312|453405148|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029565|NCT01261312|453405149|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126029566|NCT01261312|453405137|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029567|NCT01261312|453405138|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029568|NCT01261312|453405139|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029569|NCT01261312|453405140|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029570|NCT01261312|453405141|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029571|NCT01261312|453405142|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029572|NCT01261312|453405143|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029573|NCT01261312|453405144|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
126029574|NCT01261312|453405145|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
126029575|NCT01261312|453405146|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029576|NCT01261312|453405147|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029577|NCT01261312|453405148|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029578|NCT01261312|453405149|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126029579|NCT01261312|453405137|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029580|NCT01261312|453405138|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029581|NCT01261312|453405139|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029582|NCT01261312|453405140|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029583|NCT01261312|453405141|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029584|NCT01261312|453405142|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029585|NCT01261312|453405143|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
126029586|NCT01261312|453405144|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
126029587|NCT01261312|453405145|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
126029588|NCT01261312|453405146|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029589|NCT01261312|453405147|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029590|NCT01261312|453405148|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029591|NCT01261312|453405149|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126029592|NCT01261312|453405137|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
126029593|NCT01261312|453405138|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
126029594|NCT01261312|453405139|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
126029595|NCT01261312|453405140|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
126029596|NCT01261312|453405141|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
126029597|NCT01261312|453405142|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
126029598|NCT01261312|453405143|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
126029599|NCT01261312|453405144|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
126029600|NCT01261312|453405145|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
126029601|NCT01261312|453405146|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
126029602|NCT01261312|453405147|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
126095743|NCT02489968|453643142|FG002|Open-label Treatment Period|Adverse Event|0|||
126095744|NCT02489968|453643143|FG003|Open-label Treatment Period|Adverse Event|0|||
126252638|NCT04133311|454215943|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
126252639|NCT04133311|454215944|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
126252640|NCT04133311|454215945|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
126252641|NCT04133311|454215946|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
126252642|NCT04133311|454215943|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
126252643|NCT04133311|454215944|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
126252644|NCT04133311|454215945|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
126252645|NCT04133311|454215946|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
126252646|NCT04133311|454215943|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
126252647|NCT04133311|454215944|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
126252648|NCT04133311|454215945|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
126252649|NCT04133311|454215946|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
126252650|NCT04133311|454215943|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
126252651|NCT04133311|454215944|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
126252652|NCT04133311|454215945|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
126252653|NCT04133311|454215946|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
126252654|NCT04133311|454215943|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
126095745|NCT02489968|453643144|FG004|Open-label Treatment Period|Adverse Event|0|||
126029603|NCT01261312|453405148|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
126029604|NCT01261312|453405149|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
126095746|NCT02489968|453643145|FG005|Open-label Treatment Period|Adverse Event|0|||
126252655|NCT04133311|454215944|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
126252656|NCT04133311|454215945|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
126252657|NCT04133311|454215946|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
126252658|NCT00728754|454215949|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
126252659|NCT00728754|454215950|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
126252660|NCT00728754|454215949|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
126252661|NCT00728754|454215950|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
126252662|NCT00728754|454215949|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
126252663|NCT00728754|454215950|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
126252664|NCT01926119|454215951|FG000|Overall Study|Withdrawal by Subject|1|||
126252665|NCT00009945|454215954|FG000|Overall Study|no follow up data|7|||
126252666|NCT00009945|454215955|FG001|Overall Study|no follow up data|5|||
126252667|NCT00295490|454215956|FG000|Overall Study|Protocol Violation|0|||
126252668|NCT00295490|454215957|FG001|Overall Study|Protocol Violation|0|||
126252669|NCT00295490|454215958|FG002|Overall Study|Protocol Violation|3|||
126252670|NCT00295490|454215959|FG003|Overall Study|Protocol Violation|3|||
126252671|NCT00295490|454215956|FG000|Overall Study|Withdrawal by Subject|0|||
126252672|NCT00295490|454215957|FG001|Overall Study|Withdrawal by Subject|2|||
126252673|NCT00295490|454215958|FG002|Overall Study|Withdrawal by Subject|0|||
126252674|NCT00295490|454215959|FG003|Overall Study|Withdrawal by Subject|1|||
126252675|NCT00295490|454215956|FG000|Overall Study|Lost to Follow-up|0|||
126252676|NCT00295490|454215957|FG001|Overall Study|Lost to Follow-up|0|||
126252677|NCT00295490|454215958|FG002|Overall Study|Lost to Follow-up|1|||
126252678|NCT00295490|454215959|FG003|Overall Study|Lost to Follow-up|0|||
126252679|NCT00295490|454215956|FG000|Overall Study|Adverse Event|1|||
126252680|NCT00295490|454215957|FG001|Overall Study|Adverse Event|0|||
126252681|NCT00295490|454215958|FG002|Overall Study|Adverse Event|0|||
126252682|NCT00295490|454215959|FG003|Overall Study|Adverse Event|0|||
126252683|NCT00295490|454215956|FG000|Overall Study|Other|0|||
126252684|NCT00295490|454215957|FG001|Overall Study|Other|2|||
126252685|NCT00295490|454215958|FG002|Overall Study|Other|0|||
126252686|NCT00295490|454215959|FG003|Overall Study|Other|1|||
126252687|NCT01196390|454215966|FG000|Overall Study|Protocol Violation|4|||
126252688|NCT01196390|454215967|FG001|Overall Study|Protocol Violation|5|||
126252689|NCT03141151|454215974|FG000|Overall Study|Lost to Follow-up|3|||
126252690|NCT03141151|454215975|FG001|Overall Study|Lost to Follow-up|2|||
126252691|NCT03141151|454215974|FG000|Overall Study|Withdrawal by Subject|3|||
126252692|NCT03141151|454215975|FG001|Overall Study|Withdrawal by Subject|2|||
126252693|NCT01949532|454215976|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
126252694|NCT01949532|454215977|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
126252695|NCT01050764|454215978|FG000|Overall Study|Death, before HSCT|1|||
126252696|NCT01050764|454215978|FG000|Overall Study|Donor mobilization failure, death|1|||
126252697|NCT01050764|454215978|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
126252698|NCT02119936|454215980|FG000|Overall Study|Lost to Follow-up|10|||
126252699|NCT00570128|454215981|FG000|Overall Study|Adverse Event|1|||
126252700|NCT00570128|454215982|FG001|Overall Study|Adverse Event|0|||
126252701|NCT00570128|454215981|FG000|Overall Study|Lost to Follow-up|1|||
126252702|NCT00570128|454215982|FG001|Overall Study|Lost to Follow-up|0|||
126252703|NCT00570128|454215981|FG000|Overall Study|Withdrawal by Subject|2|||
126252704|NCT00570128|454215982|FG001|Overall Study|Withdrawal by Subject|0|||
126252705|NCT04194008|454215985|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
126252706|NCT04194008|454215985|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
126252707|NCT04194008|454215985|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
126252708|NCT04194008|454215985|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
126252709|NCT04194008|454215985|FG000|Treatment Phase With Nerivio|Missing data|4|||
126252710|NCT04194008|454215985|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
126252711|NCT02218216|454215986|FG000|Overall Study|Study terminated before completed|6|||
126252712|NCT02218216|454215987|FG001|Overall Study|Study terminated before completed|0|||
126252713|NCT02218216|454215988|FG002|Overall Study|Study terminated before completed|0|||
126252714|NCT01942135|454215993|FG000|Overall Study|Adverse Event|21|||
126252715|NCT01942135|454215994|FG001|Overall Study|Adverse Event|7|||
126252716|NCT01942135|454215993|FG000|Overall Study|Global Deterioration of Health Status|9|||
126252717|NCT01942135|454215994|FG001|Overall Study|Global Deterioration of Health Status|6|||
126252718|NCT01942135|454215993|FG000|Overall Study|Randomized Not Treated|2|||
126252719|NCT01942135|454215994|FG001|Overall Study|Randomized Not Treated|2|||
126252720|NCT01942135|454215993|FG000|Overall Study|Death|2|||
126252721|NCT01942135|454215994|FG001|Overall Study|Death|1|||
125879768|NCT03104868|452857382|FG001|6 Month Follow up|Death|1|||
125879769|NCT03104868|452857381|FG000|6 Month Follow up|Completed Later Timepoint|22|||
126252722|NCT01942135|454215993|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
126252723|NCT01942135|454215994|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
126252724|NCT01942135|454215993|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
126252725|NCT01942135|454215994|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
126252726|NCT01942135|454215993|FG000|Overall Study|Withdrawal by Subject|4|||
126252727|NCT01942135|454215994|FG001|Overall Study|Withdrawal by Subject|3|||
126252728|NCT01942135|454215993|FG000|Overall Study|Protocol Violation|1|||
126252729|NCT01942135|454215994|FG001|Overall Study|Protocol Violation|0|||
126252730|NCT01942135|454215993|FG000|Overall Study|Other|19|||
126252731|NCT01942135|454215994|FG001|Overall Study|Other|4|||
126252732|NCT01717040|454215995|FG000|Overall Study|Lost to Follow-up|2|||
126252733|NCT01717040|454215996|FG001|Overall Study|Lost to Follow-up|3|||
126252734|NCT01717040|454215995|FG000|Overall Study|Lack of Efficacy|1|||
126252735|NCT01717040|454215996|FG001|Overall Study|Lack of Efficacy|1|||
126252736|NCT01717040|454215995|FG000|Overall Study|Adverse Event|1|||
126252737|NCT01717040|454215996|FG001|Overall Study|Adverse Event|0|||
126252738|NCT01717040|454215995|FG000|Overall Study|Required Medication Change|0|||
126252739|NCT01717040|454215996|FG001|Overall Study|Required Medication Change|1|||
126252740|NCT01717040|454215995|FG000|Overall Study|New Substance Use Disorder|1|||
126252741|NCT01717040|454215996|FG001|Overall Study|New Substance Use Disorder|0|||
126252742|NCT00087529|454215997|FG000|Overall Study|Death|1|||
126252743|NCT00087529|454215998|FG001|Overall Study|Death|0|||
126252744|NCT00087529|454215997|FG000|Overall Study|Adverse Event|0|||
126252745|NCT00087529|454215998|FG001|Overall Study|Adverse Event|8|||
126252746|NCT00087529|454215997|FG000|Overall Study|Pregnancy|0|||
126252747|NCT00087529|454215998|FG001|Overall Study|Pregnancy|1|||
126252748|NCT00087529|454215997|FG000|Overall Study|Lost to Follow-up|2|||
126252749|NCT00087529|454215998|FG001|Overall Study|Lost to Follow-up|3|||
126252750|NCT00087529|454215997|FG000|Overall Study|Participant Decision|14|||
126252751|NCT00087529|454215998|FG001|Overall Study|Participant Decision|37|||
126252752|NCT00087529|454215997|FG000|Overall Study|Physician Decision|4|||
126252753|NCT00087529|454215998|FG001|Overall Study|Physician Decision|8|||
126252754|NCT00087529|454215997|FG000|Overall Study|Initiation of Excluded Therapy|0|||
126252755|NCT00087529|454215998|FG001|Overall Study|Initiation of Excluded Therapy|1|||
126252756|NCT00087529|454215997|FG000|Overall Study|Participant Noncompliance|0|||
126252757|NCT00087529|454215998|FG001|Overall Study|Participant Noncompliance|1|||
126252758|NCT00087529|454215997|FG000|Overall Study|Disease Progression|5|||
126252759|NCT00087529|454215998|FG001|Overall Study|Disease Progression|4|||
126252760|NCT00087529|454215997|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
126252761|NCT00087529|454215998|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
126252762|NCT01120899|454217298|FG000|Overall Study|Withdrawal by Subject|3|||
126252763|NCT03686215|454217299|FG000|Overall Study|Adverse Event|0|||
126252764|NCT03686215|454217300|FG001|Overall Study|Adverse Event|0|||
126252765|NCT03686215|454217301|FG002|Overall Study|Adverse Event|7|||
126252766|NCT03686215|454217299|FG000|Overall Study|Physician Decision|0|||
126252767|NCT03686215|454217300|FG001|Overall Study|Physician Decision|0|||
126252768|NCT03686215|454217301|FG002|Overall Study|Physician Decision|1|||
126252769|NCT03686215|454217299|FG000|Overall Study|Protocol Violation|0|||
126252770|NCT03686215|454217300|FG001|Overall Study|Protocol Violation|0|||
126252771|NCT03686215|454217301|FG002|Overall Study|Protocol Violation|4|||
126252772|NCT03686215|454217299|FG000|Overall Study|Device issue|1|||
126252773|NCT03686215|454217300|FG001|Overall Study|Device issue|0|||
126252774|NCT03686215|454217301|FG002|Overall Study|Device issue|2|||
126029605|NCT01261312|453405137|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126029606|NCT01261312|453405138|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126252775|NCT00202839|454217304|FG000|Overall Study|Adverse Event|1|||
126252776|NCT00202839|454217305|FG001|Overall Study|Adverse Event|5|||
126252777|NCT00202839|454217304|FG000|Overall Study|Physician Decision|12|||
126252778|NCT00202839|454217305|FG001|Overall Study|Physician Decision|0|||
126252779|NCT00202839|454217304|FG000|Overall Study|Withdrawal by Subject|6|||
126252780|NCT00202839|454217305|FG001|Overall Study|Withdrawal by Subject|2|||
126252781|NCT00202839|454217304|FG000|Overall Study|Protocol Violation|2|||
126252782|NCT00202839|454217305|FG001|Overall Study|Protocol Violation|1|||
126252783|NCT00202839|454217304|FG000|Overall Study|Lost to Follow-up|3|||
126252784|NCT00202839|454217305|FG001|Overall Study|Lost to Follow-up|2|||
126252785|NCT02485158|454217306|FG000|Overall Study|Withdrawal by Subject|3|||
126252786|NCT02485158|454217306|FG000|Overall Study|expected drug side effect|1|||
126252787|NCT01098851|454217309|FG000|Overall Study|Equipment failure|1|||
126252788|NCT01098851|454217310|FG001|Overall Study|Equipment failure|0|||
126252789|NCT01813435|454217316|FG000|Overall Study|did not finish experimental regimen|1902|||
126252790|NCT01813435|454217317|FG001|Overall Study|did not finish experimental regimen|770|||
126252791|NCT01813435|454217316|FG000|Overall Study|Lost to Follow-up|268|||
126252792|NCT01813435|454217317|FG001|Overall Study|Lost to Follow-up|237|||
126252793|NCT03035890|454217318|FG000|Overall Study|Death|1|||
126252794|NCT00452348|454217319|FG000|Overall Study|Adverse Event|6|||
126252795|NCT00452348|454217320|FG001|Overall Study|Adverse Event|9|||
126252796|NCT00452348|454217319|FG000|Overall Study|Lack of Efficacy|10|||
126252797|NCT00452348|454217320|FG001|Overall Study|Lack of Efficacy|9|||
126252798|NCT00452348|454217319|FG000|Overall Study|Lost to Follow-up|14|||
126252799|NCT00452348|454217320|FG001|Overall Study|Lost to Follow-up|8|||
126252800|NCT00452348|454217319|FG000|Overall Study|Protocol Violation|22|||
126252801|NCT00452348|454217320|FG001|Overall Study|Protocol Violation|28|||
126252802|NCT00452348|454217319|FG000|Overall Study|Withdrawal by Subject|18|||
126252803|NCT00452348|454217320|FG001|Overall Study|Withdrawal by Subject|21|||
126252804|NCT00452348|454217319|FG000|Overall Study|Other|9|||
126252805|NCT00452348|454217320|FG001|Overall Study|Other|9|||
126252806|NCT01490190|454217321|FG000|Overall Study|Withdrawal by Subject|9|||
126252807|NCT01490190|454217321|FG000|Overall Study|Adverse Event|17|||
126252808|NCT01490190|454217321|FG000|Overall Study|Protocol Violation|5|||
126252809|NCT01490190|454217321|FG000|Overall Study|Lost to Follow-up|13|||
126252810|NCT01490190|454217321|FG000|Overall Study|Relocation|1|||
126252811|NCT01490190|454217321|FG000|Overall Study|Inconvenience|1|||
126252812|NCT01490190|454217321|FG000|Overall Study|Ring expulsion|2|||
126252813|NCT02817828|454217327|FG000|Overall Study|Lost to Follow-up|41|||
126252814|NCT02817828|454217327|FG000|Overall Study|Adverse event not related to bleeding|104|||
126252815|NCT02817828|454217327|FG000|Overall Study|Adverse event related to bleeding|53|||
126252816|NCT02817828|454217327|FG000|Overall Study|Protocol Violation|11|||
126252817|NCT02817828|454217327|FG000|Overall Study|Pregnancy|7|||
126252818|NCT02817828|454217327|FG000|Overall Study|Pregnancy wish|15|||
126252819|NCT02817828|454217327|FG000|Overall Study|Withdrawal by Subject|78|||
126252820|NCT02817828|454217327|FG000|Overall Study|Other|26|||
126252821|NCT00377156|454217331|FG000|Overall Study|Death|23|||
126252822|NCT00377156|454217332|FG001|Overall Study|Death|19|||
126252823|NCT00377156|454217331|FG000|Overall Study|Withdrawal by Subject|16|||
126252824|NCT00377156|454217332|FG001|Overall Study|Withdrawal by Subject|24|||
126252825|NCT00377156|454217331|FG000|Overall Study|Had follow-up <90 d|3|||
126252826|NCT00377156|454217332|FG001|Overall Study|Had follow-up <90 d|6|||
126252827|NCT00377156|454217331|FG000|Overall Study|Cancellation|1|||
126252828|NCT00377156|454217332|FG001|Overall Study|Cancellation|0|||
126252829|NCT00377156|454217331|FG000|Overall Study|Refused testing|0|||
126252830|NCT00377156|454217332|FG001|Overall Study|Refused testing|1|||
126252831|NCT00377156|454217331|FG000|Overall Study|Ineligible|0|||
126252832|NCT00377156|454217332|FG001|Overall Study|Ineligible|1|||
126252833|NCT00377156|454217331|FG000|Overall Study|Disability or language problem|0|||
126252834|NCT00377156|454217332|FG001|Overall Study|Disability or language problem|1|||
126252835|NCT00377156|454217331|FG000|Overall Study|Other|5|||
126252836|NCT00377156|454217332|FG001|Overall Study|Other|2|||
126252837|NCT00856349|454217333|FG000|Overall Study|Death|418|||
126252838|NCT00856349|454217333|FG000|Overall Study|Withdrawal by Subject|116|||
126252839|NCT00856349|454217333|FG000|Overall Study|Lost to Follow-up|91|||
126252840|NCT00856349|454217333|FG000|Overall Study|Protocol Violation|38|||
126095747|NCT02489968|453643140|FG000|Open-label Treatment Period|Protocol Violation|2|||
126095748|NCT02489968|453643141|FG001|Open-label Treatment Period|Protocol Violation|2|||
126095749|NCT02489968|453643142|FG002|Open-label Treatment Period|Protocol Violation|0|||
126095750|NCT02489968|453643143|FG003|Open-label Treatment Period|Protocol Violation|0|||
126252841|NCT00856349|454217333|FG000|Overall Study|Physician Decision|13|||
126252842|NCT00856349|454217333|FG000|Overall Study|Subject relocation|104|||
126252843|NCT00856349|454217333|FG000|Overall Study|Device explant|33|||
126252844|NCT00856349|454217333|FG000|Overall Study|Site closure|78|||
126252845|NCT00856349|454217333|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
126252846|NCT05061992|454217336|FG000|Overall Study|Excess bowel movements|1|||
126252847|NCT05061992|454217337|FG001|Overall Study|Excess bowel movements|0|||
126252848|NCT05061992|454217336|FG000|Overall Study|Complications of Medical Care|1|||
126252849|NCT05061992|454217337|FG001|Overall Study|Complications of Medical Care|0|||
126252850|NCT05061992|454217336|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
126252851|NCT05061992|454217337|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
126252852|NCT05061992|454217336|FG000|Overall Study|Withdrawal by Subject|0|||
126252853|NCT05061992|454217337|FG001|Overall Study|Withdrawal by Subject|1|||
126252854|NCT02473393|454217338|FG000|Overall Study|Adverse Event|0|||
126252855|NCT02473393|454217339|FG001|Overall Study|Adverse Event|0|||
126252856|NCT02473393|454217340|FG002|Overall Study|Adverse Event|1|||
126252857|NCT02473393|454217341|FG003|Overall Study|Adverse Event|0|||
126252858|NCT02473393|454217338|FG000|Overall Study|Withdrawal by Subject|0|||
126252859|NCT02473393|454217339|FG001|Overall Study|Withdrawal by Subject|0|||
126252860|NCT02473393|454217340|FG002|Overall Study|Withdrawal by Subject|1|||
126252861|NCT02473393|454217341|FG003|Overall Study|Withdrawal by Subject|1|||
126252862|NCT01157234|454217342|FG000|Overall Study|Withdrawal by Subject|1|||
126252863|NCT01157234|454217343|FG001|Overall Study|Withdrawal by Subject|0|||
126252864|NCT01513239|454217344|FG000|Period 1: Main Phase|Adverse Event|1|||
126252865|NCT01513239|454217345|FG001|Period 1: Main Phase|Adverse Event|1|||
126095751|NCT02489968|453643144|FG004|Open-label Treatment Period|Protocol Violation|0|||
126095752|NCT02489968|453643145|FG005|Open-label Treatment Period|Protocol Violation|0|||
126252866|NCT01513239|454217346|FG002|Period 1: Main Phase|Adverse Event|2|||
126252867|NCT01513239|454217347|FG003|Period 1: Main Phase|Adverse Event|0|||
126252868|NCT01513239|454217348|FG004|Period 1: Main Phase|Adverse Event|0|||
126252869|NCT01513239|454217349|FG005|Period 1: Main Phase|Adverse Event|0|||
126252870|NCT01513239|454217344|FG000|Period 1: Main Phase|Death|29|||
126252871|NCT01513239|454217345|FG001|Period 1: Main Phase|Death|22|||
126252872|NCT01513239|454217346|FG002|Period 1: Main Phase|Death|32|||
126252873|NCT01513239|454217347|FG003|Period 1: Main Phase|Death|0|||
126252874|NCT01513239|454217348|FG004|Period 1: Main Phase|Death|0|||
126252875|NCT01513239|454217349|FG005|Period 1: Main Phase|Death|0|||
126252876|NCT01513239|454217344|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
126252877|NCT01513239|454217345|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
126252878|NCT01513239|454217346|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
126252879|NCT01513239|454217347|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
126252880|NCT01513239|454217348|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
126252881|NCT01513239|454217349|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
126252882|NCT01513239|454217344|FG000|Period 1: Main Phase|Physician Decision|4|||
126252883|NCT01513239|454217345|FG001|Period 1: Main Phase|Physician Decision|4|||
126252884|NCT01513239|454217346|FG002|Period 1: Main Phase|Physician Decision|4|||
126252885|NCT01513239|454217347|FG003|Period 1: Main Phase|Physician Decision|0|||
126252886|NCT01513239|454217348|FG004|Period 1: Main Phase|Physician Decision|0|||
126252887|NCT01513239|454217349|FG005|Period 1: Main Phase|Physician Decision|0|||
126252888|NCT01513239|454217344|FG000|Period 1: Main Phase|Protocol Violation|2|||
126252889|NCT01513239|454217345|FG001|Period 1: Main Phase|Protocol Violation|2|||
126252890|NCT01513239|454217346|FG002|Period 1: Main Phase|Protocol Violation|2|||
126252891|NCT01513239|454217347|FG003|Period 1: Main Phase|Protocol Violation|0|||
126252892|NCT01513239|454217348|FG004|Period 1: Main Phase|Protocol Violation|0|||
126252893|NCT01513239|454217349|FG005|Period 1: Main Phase|Protocol Violation|0|||
126252894|NCT01513239|454217344|FG000|Period 1: Main Phase|Technical Problems|1|||
126252895|NCT01513239|454217345|FG001|Period 1: Main Phase|Technical Problems|2|||
126252896|NCT01513239|454217346|FG002|Period 1: Main Phase|Technical Problems|0|||
126252897|NCT01513239|454217347|FG003|Period 1: Main Phase|Technical Problems|0|||
126252898|NCT01513239|454217348|FG004|Period 1: Main Phase|Technical Problems|0|||
126252899|NCT01513239|454217349|FG005|Period 1: Main Phase|Technical Problems|0|||
126252900|NCT01513239|454217344|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
126252901|NCT01513239|454217345|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
126252902|NCT01513239|454217346|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
126252903|NCT01513239|454217347|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
126252904|NCT01513239|454217348|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
126252905|NCT01513239|454217349|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
126252906|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
126252907|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
126252908|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
126252909|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
126252910|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
126252911|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
126252912|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Death|0|||
126252913|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Death|0|||
126252914|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Death|0|||
126252915|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Death|2|||
126252916|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Death|5|||
126252917|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Death|2|||
126252918|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
126252919|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
126252920|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
126252921|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
126252922|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
126252923|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
126252924|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252925|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252926|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252927|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
126252928|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252929|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252930|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
126252931|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
126252932|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
126252933|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
126252934|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
126252935|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
126252936|NCT03167606|454217352|FG000|Overall Study|Lost to Follow-up|73|||
126252937|NCT03167606|454217353|FG001|Overall Study|Lost to Follow-up|64|||
126252938|NCT03167606|454217352|FG000|Overall Study|Withdrawal by Subject|6|||
126252939|NCT03167606|454217353|FG001|Overall Study|Withdrawal by Subject|5|||
126252940|NCT03167606|454217352|FG000|Overall Study|Withdrawal by Investigator|0|||
126252941|NCT03167606|454217353|FG001|Overall Study|Withdrawal by Investigator|2|||
126252942|NCT00059332|454217354|FG000|Overall Study|Withdrawal by Subject|2|||
126358242|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
126358243|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
126358244|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
126358245|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
126252943|NCT00059332|454217355|FG001|Overall Study|Withdrawal by Subject|1|||
126252944|NCT00059332|454217354|FG000|Overall Study|Lost to Follow-up|1|||
126252945|NCT00059332|454217355|FG001|Overall Study|Lost to Follow-up|1|||
126252946|NCT00413049|454217356|FG000|Overall Study|Adverse Event|10|||
126252947|NCT00413049|454217357|FG001|Overall Study|Adverse Event|8|||
126252948|NCT00413049|454217356|FG000|Overall Study|Withdrawal by Subject|7|||
126029607|NCT01261312|453405139|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126029608|NCT01261312|453405140|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126252949|NCT00413049|454217357|FG001|Overall Study|Withdrawal by Subject|5|||
126252950|NCT00413049|454217356|FG000|Overall Study|Lost to Follow-up|2|||
126252951|NCT00413049|454217357|FG001|Overall Study|Lost to Follow-up|3|||
126252952|NCT00413049|454217356|FG000|Overall Study|Protocol Violation|3|||
126252953|NCT00413049|454217357|FG001|Overall Study|Protocol Violation|1|||
126252954|NCT00413049|454217356|FG000|Overall Study|Subject no longer requires study drug|0|||
126252955|NCT00413049|454217357|FG001|Overall Study|Subject no longer requires study drug|1|||
126252956|NCT00413049|454217356|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125879770|NCT03104868|452857382|FG001|6 Month Follow up|Completed Later Timepoint|32|||
125879771|NCT03104868|452857381|FG000|12 Month Follow up|Lost to Follow-up|1|||
125879772|NCT03104868|452857382|FG001|12 Month Follow up|Lost to Follow-up|2|||
126029609|NCT01261312|453405141|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126252957|NCT00413049|454217357|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126252958|NCT00413049|454217356|FG000|Overall Study|Lack of Efficacy|1|||
126252959|NCT00413049|454217357|FG001|Overall Study|Lack of Efficacy|0|||
126252960|NCT02587143|454217358|FG000|Overall Study|Adverse Event|1|||
126252961|NCT02587143|454217359|FG001|Overall Study|Adverse Event|0|||
126252962|NCT03314857|454217362|FG000|Overall Study|Death|4|||
126252963|NCT03314857|454217362|FG000|Overall Study|Physician Decision|1|||
126252964|NCT00397254|454217365|FG000|Overall Study|Lost to Follow-up|2|||
126252965|NCT00397254|454217366|FG001|Overall Study|Lost to Follow-up|2|||
126252966|NCT04281472|454217370|FG000|Stage A|Lack of Efficacy|8|||
126252967|NCT04281472|454217371|FG001|Stage A|Lack of Efficacy|0|||
126252968|NCT04281472|454217372|FG002|Stage A|Lack of Efficacy|0|||
126252969|NCT04281472|454217370|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
126252970|NCT04281472|454217371|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
126252971|NCT04281472|454217372|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
126252972|NCT04281472|454217370|FG000|Stage A|Adverse Event|20|||
126252973|NCT04281472|454217371|FG001|Stage A|Adverse Event|0|||
126252974|NCT04281472|454217372|FG002|Stage A|Adverse Event|0|||
126252975|NCT04281472|454217370|FG000|Stage A|Death|1|||
126252976|NCT04281472|454217371|FG001|Stage A|Death|0|||
126252977|NCT04281472|454217372|FG002|Stage A|Death|0|||
126252978|NCT04281472|454217370|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
126252979|NCT04281472|454217371|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
126252980|NCT04281472|454217372|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
126252981|NCT04281472|454217370|FG000|Stage A|Lost to Follow-up|2|||
126252982|NCT04281472|454217371|FG001|Stage A|Lost to Follow-up|0|||
126252983|NCT04281472|454217372|FG002|Stage A|Lost to Follow-up|0|||
126029610|NCT01261312|453405142|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126029611|NCT01261312|453405143|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
126029612|NCT01261312|453405144|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
126252984|NCT04281472|454217370|FG000|Stage A|Non-compliance with study drug|1|||
126252985|NCT04281472|454217371|FG001|Stage A|Non-compliance with study drug|0|||
126252986|NCT04281472|454217372|FG002|Stage A|Non-compliance with study drug|0|||
126252987|NCT04281472|454217370|FG000|Stage A|Physician Decision|1|||
126252988|NCT04281472|454217371|FG001|Stage A|Physician Decision|0|||
126252989|NCT04281472|454217372|FG002|Stage A|Physician Decision|0|||
126252990|NCT04281472|454217370|FG000|Stage A|Prohibited medications|2|||
126029613|NCT01261312|453405145|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
126029614|NCT01261312|453405146|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126029615|NCT01261312|453405147|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126029616|NCT01261312|453405148|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126029617|NCT01261312|453405149|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126029618|NCT01261312|453405137|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126029619|NCT01261312|453405138|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126095753|NCT02489968|453643140|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126252991|NCT04281472|454217371|FG001|Stage A|Prohibited medications|0|||
126252992|NCT04281472|454217372|FG002|Stage A|Prohibited medications|0|||
126252993|NCT04281472|454217370|FG000|Stage A|Withdrawal by Subject|11|||
126252994|NCT04281472|454217371|FG001|Stage A|Withdrawal by Subject|0|||
126252995|NCT04281472|454217372|FG002|Stage A|Withdrawal by Subject|0|||
126252996|NCT04281472|454217370|FG000|Stage A|Other|5|||
126252997|NCT04281472|454217371|FG001|Stage A|Other|0|||
126252998|NCT04281472|454217372|FG002|Stage A|Other|0|||
126252999|NCT04281472|454217370|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
126306334|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126253000|NCT04281472|454217371|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
126253001|NCT04281472|454217372|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
126253002|NCT04281472|454217370|FG000|Stage B|Adverse Event|0|||
126253003|NCT04281472|454217371|FG001|Stage B|Adverse Event|3|||
126253004|NCT04281472|454217372|FG002|Stage B|Adverse Event|0|||
126253005|NCT04281472|454217370|FG000|Stage B|Death|0|||
126253006|NCT04281472|454217371|FG001|Stage B|Death|0|||
126253007|NCT04281472|454217372|FG002|Stage B|Death|1|||
126253008|NCT04281472|454217370|FG000|Stage B|Lack of Efficacy|0|||
126253009|NCT04281472|454217371|FG001|Stage B|Lack of Efficacy|0|||
126253010|NCT04281472|454217372|FG002|Stage B|Lack of Efficacy|1|||
126253011|NCT04281472|454217370|FG000|Stage B|Lost to Follow-up|0|||
126253012|NCT04281472|454217371|FG001|Stage B|Lost to Follow-up|0|||
126253013|NCT04281472|454217372|FG002|Stage B|Lost to Follow-up|2|||
126253014|NCT04281472|454217370|FG000|Stage B|Prohibited medications|0|||
126253015|NCT04281472|454217371|FG001|Stage B|Prohibited medications|2|||
126253016|NCT04281472|454217372|FG002|Stage B|Prohibited medications|1|||
126253017|NCT04281472|454217370|FG000|Stage B|Protocol Violation|0|||
126253018|NCT04281472|454217371|FG001|Stage B|Protocol Violation|1|||
126253019|NCT04281472|454217372|FG002|Stage B|Protocol Violation|1|||
126253020|NCT04281472|454217370|FG000|Stage B|Sponsor decision|0|||
126253021|NCT04281472|454217371|FG001|Stage B|Sponsor decision|0|||
126253022|NCT04281472|454217372|FG002|Stage B|Sponsor decision|1|||
126253023|NCT04281472|454217370|FG000|Stage B|Withdrawal by Subject|0|||
126253024|NCT04281472|454217371|FG001|Stage B|Withdrawal by Subject|3|||
126253025|NCT04281472|454217372|FG002|Stage B|Withdrawal by Subject|3|||
126253026|NCT04281472|454217370|FG000|Stage B|Other|0|||
126253027|NCT04281472|454217371|FG001|Stage B|Other|3|||
126253028|NCT04281472|454217372|FG002|Stage B|Other|0|||
126253029|NCT01055834|454217374|FG000|Treatment Period I|Adverse Event|1|||
126253030|NCT01055834|454217375|FG001|Treatment Period I|Adverse Event|0|||
126253031|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Death|0|||
126253032|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Death|1|||
126253033|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
126253034|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
126253035|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
126253036|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
126253037|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
126253038|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
126253039|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
126253040|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
126253041|NCT01717313|454217376|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
126253042|NCT01717313|454217377|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
126253043|NCT01717313|454217376|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
126253044|NCT01717313|454217377|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
126253045|NCT01717313|454217376|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
126253046|NCT01717313|454217377|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
126253047|NCT01717313|454217376|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
126253048|NCT01717313|454217377|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
126253049|NCT01617096|454217388|FG000|Overall Study|Withdrawal by Subject|96|||
126253050|NCT01617096|454217389|FG001|Overall Study|Withdrawal by Subject|81|||
126253051|NCT01617096|454217388|FG000|Overall Study|Lost to Follow-up|37|||
126253052|NCT01617096|454217389|FG001|Overall Study|Lost to Follow-up|32|||
126253053|NCT01617096|454217388|FG000|Overall Study|Physician Decision|10|||
126253054|NCT01617096|454217389|FG001|Overall Study|Physician Decision|18|||
126253055|NCT01617096|454217388|FG000|Overall Study|Death|4|||
126253056|NCT01617096|454217389|FG001|Overall Study|Death|3|||
126029620|NCT01261312|453405139|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126253057|NCT01617096|454217388|FG000|Overall Study|Other|1|||
126029621|NCT01261312|453405140|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126029622|NCT01261312|453405141|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126029623|NCT01261312|453405142|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126029624|NCT01261312|453405143|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
126253058|NCT01617096|454217389|FG001|Overall Study|Other|3|||
126253059|NCT04473326|454217392|FG000|Overall Study|Death|0|||
126253060|NCT04473326|454217393|FG001|Overall Study|Death|1|||
126253061|NCT04473326|454217392|FG000|Overall Study|Withdrawal by Subject|1|||
126253062|NCT04473326|454217393|FG001|Overall Study|Withdrawal by Subject|2|||
126253063|NCT02611362|454217394|FG000|Overall Study|Withdrawal by Subject|7|||
126253064|NCT02611362|454217395|FG001|Overall Study|Withdrawal by Subject|2|||
126253065|NCT02611362|454217394|FG000|Overall Study|Lost to Follow-up|2|||
126253066|NCT02611362|454217395|FG001|Overall Study|Lost to Follow-up|4|||
126253067|NCT01155531|454217396|FG000|Overall Study|Adverse Event|0|||
126253068|NCT01155531|454217397|FG001|Overall Study|Adverse Event|0|||
126253069|NCT01155531|454217398|FG002|Overall Study|Adverse Event|1|||
126253070|NCT01155531|454217399|FG003|Overall Study|Adverse Event|0|||
126253071|NCT01155531|454217396|FG000|Overall Study|Lost to Follow-up|0|||
126253072|NCT01155531|454217397|FG001|Overall Study|Lost to Follow-up|0|||
126253073|NCT01155531|454217398|FG002|Overall Study|Lost to Follow-up|0|||
126253074|NCT01155531|454217399|FG003|Overall Study|Lost to Follow-up|1|||
126253075|NCT01155531|454217396|FG000|Overall Study|Withdrawal by Subject|1|||
126253076|NCT01155531|454217397|FG001|Overall Study|Withdrawal by Subject|0|||
126253077|NCT01155531|454217398|FG002|Overall Study|Withdrawal by Subject|1|||
126253078|NCT01155531|454217399|FG003|Overall Study|Withdrawal by Subject|0|||
126253079|NCT00354159|454217400|FG000|Randomized Study Period|Withdrawal by Subject|5|||
126253080|NCT00354159|454217401|FG001|Randomized Study Period|Withdrawal by Subject|3|||
126253081|NCT00354159|454217400|FG000|Randomized Study Period|Physician Decision|6|||
126253082|NCT00354159|454217401|FG001|Randomized Study Period|Physician Decision|10|||
126253083|NCT00354159|454217400|FG000|Randomized Study Period|Lost to Follow-up|4|||
126253084|NCT00354159|454217401|FG001|Randomized Study Period|Lost to Follow-up|0|||
126253085|NCT00354159|454217400|FG000|Randomized Study Period|Death|7|||
126253086|NCT00354159|454217401|FG001|Randomized Study Period|Death|9|||
126253087|NCT00354159|454217400|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
126253088|NCT00354159|454217401|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
126253089|NCT00354159|454217400|FG000|Long-term Follow-up|Physician Decision|127|||
126253090|NCT00354159|454217401|FG001|Long-term Follow-up|Physician Decision|122|||
126253091|NCT00354159|454217400|FG000|Long-term Follow-up|Lost to Follow-up|1|||
126253092|NCT00354159|454217401|FG001|Long-term Follow-up|Lost to Follow-up|0|||
126253093|NCT00354159|454217400|FG000|Long-term Follow-up|Death|14|||
126253094|NCT00354159|454217401|FG001|Long-term Follow-up|Death|11|||
126253095|NCT00354159|454217400|FG000|Long-term Follow-up|Study Closed|29|||
126253096|NCT00354159|454217401|FG001|Long-term Follow-up|Study Closed|34|||
126253097|NCT02046122|454217402|FG000|Overall Study|Physician Decision|8|||
126253098|NCT02046122|454217402|FG000|Overall Study|Withdrawal by Subject|1|||
126253099|NCT01653704|454217403|FG000|Overall Study|Technical failure during recording|1|||
126253100|NCT01653704|454217404|FG001|Overall Study|Technical failure during recording|1|||
126253101|NCT01653704|454217403|FG000|Overall Study|Performance not reflective of training|1|||
126253102|NCT01653704|454217404|FG001|Overall Study|Performance not reflective of training|0|||
126253103|NCT01728116|454217407|FG000|Overall Study|Sponsor Terminated Study|106|||
126253104|NCT01728116|454217408|FG001|Overall Study|Sponsor Terminated Study|35|||
126253105|NCT01728116|454217407|FG000|Overall Study|Withdrawal by Subject|16|||
126253106|NCT01728116|454217408|FG001|Overall Study|Withdrawal by Subject|9|||
126253107|NCT01728116|454217407|FG000|Overall Study|Adverse Event|13|||
126253108|NCT01728116|454217408|FG001|Overall Study|Adverse Event|0|||
126253109|NCT01728116|454217407|FG000|Overall Study|Procedure/device failure|7|||
126253110|NCT01728116|454217408|FG001|Overall Study|Procedure/device failure|0|||
126253111|NCT01728116|454217407|FG000|Overall Study|Lost to Follow-up|9|||
126253112|NCT01728116|454217408|FG001|Overall Study|Lost to Follow-up|2|||
126253113|NCT01728116|454217407|FG000|Overall Study|Physician Decision|2|||
126253114|NCT01728116|454217408|FG001|Overall Study|Physician Decision|0|||
126253115|NCT01728116|454217407|FG000|Overall Study|Subject Non-Compliance|2|||
126253116|NCT01728116|454217408|FG001|Overall Study|Subject Non-Compliance|0|||
126253117|NCT01728116|454217407|FG000|Overall Study|Inter-current finding at procedure|1|||
126253118|NCT01728116|454217408|FG001|Overall Study|Inter-current finding at procedure|0|||
126253119|NCT01728116|454217407|FG000|Overall Study|Incorrectly enrolled in Study|0|||
126253120|NCT01728116|454217408|FG001|Overall Study|Incorrectly enrolled in Study|1|||
126253121|NCT01728116|454217407|FG000|Overall Study|various not noted previously|5|||
126253122|NCT01728116|454217408|FG001|Overall Study|various not noted previously|0|||
126253123|NCT01532908|454217409|FG000|Overall Study|Not Transplanted|1|||
126253124|NCT01532908|454217410|FG001|Overall Study|Not Transplanted|0|||
126253125|NCT02943096|454217411|FG000|Overall Study|Lack of Efficacy|0|||
126253126|NCT02943096|454217412|FG001|Overall Study|Lack of Efficacy|1|||
126253127|NCT00939523|454217417|FG000|Overall Study|Lack of Efficacy|1|||
126253128|NCT00939523|454217417|FG000|Overall Study|Physician Decision|2|||
126253129|NCT00024258|454217418|FG000|Overall Study|Withdrawal by Subject|1|||
126253130|NCT00024258|454217418|FG000|Overall Study|Disease Progression|8|||
126253131|NCT03193021|454217427|FG000|Overall Study|Lost to Follow-up|1|||
126253132|NCT03193021|454217428|FG001|Overall Study|Lost to Follow-up|1|||
126253133|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
126253134|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
126253135|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
126253136|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
126253137|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
126253138|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
126253139|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
126253140|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
126253141|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
126253142|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
126253143|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
126253144|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
126253145|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
126253146|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
126253147|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
126253148|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
126253149|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
126253150|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
126253151|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
126253152|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
126253153|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
126253154|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Death|0|||
126253155|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Death|1|||
126253156|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Death|1|||
126253157|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
126253158|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
126253159|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
126253160|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
126253161|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
126253162|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
126253163|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
126253164|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
126253165|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
126253166|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
126253167|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
126253168|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
126253169|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
126253170|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
126253171|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
126253172|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
126253173|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
126253174|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
126253175|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
126253176|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
126253177|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
126253178|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Adverse Event|8|||
126253179|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Adverse Event|5|||
126253180|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Adverse Event|9|||
126253181|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Adverse Event|0|||
126253182|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Adverse Event|0|||
126253183|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Adverse Event|0|||
126253184|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
126253185|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
126253186|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
126253187|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
126253188|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
126253189|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
126253190|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
126253191|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
126253192|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
126253193|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
126253194|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
126253195|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
126253196|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Physician Decision|4|||
126253197|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Physician Decision|0|||
126253198|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Physician Decision|2|||
126253199|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Physician Decision|0|||
126253200|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Physician Decision|0|||
126253201|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Physician Decision|0|||
126253202|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Pregnancy|1|||
126253203|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Pregnancy|2|||
126253204|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Pregnancy|0|||
126253205|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Pregnancy|0|||
126253206|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Pregnancy|0|||
126253207|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Pregnancy|0|||
126253208|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
126253209|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
126253210|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
126253211|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
126253212|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
126253213|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
126253214|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
126253215|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253216|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253217|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253218|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253219|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253220|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
126029625|NCT01261312|453405144|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
126253221|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
126253222|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
126253223|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
126253224|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
126253225|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
126029626|NCT01261312|453405145|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
126029627|NCT01261312|453405146|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126029628|NCT01261312|453405147|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126029629|NCT01261312|453405148|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126029630|NCT01261312|453405149|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126029631|NCT01261312|453405137|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029632|NCT01261312|453405138|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029633|NCT01261312|453405139|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029634|NCT01261312|453405140|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029635|NCT01261312|453405141|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029636|NCT01261312|453405142|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029637|NCT01261312|453405143|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
126029638|NCT01261312|453405144|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
126029639|NCT01261312|453405145|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
126029640|NCT01261312|453405146|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029641|NCT01261312|453405147|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029642|NCT01261312|453405148|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029643|NCT01261312|453405149|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126029644|NCT01261312|453405137|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126029645|NCT01261312|453405138|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126029646|NCT01261312|453405139|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126029647|NCT01261312|453405140|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126029648|NCT01261312|453405141|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126029649|NCT01261312|453405142|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126253226|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
126253227|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
126253228|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
126253229|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
126253230|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
126253231|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
126253232|NCT02614196|454217432|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
126253233|NCT02614196|454217433|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
126253234|NCT02614196|454217434|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
126253235|NCT02614196|454217435|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
126253236|NCT02614196|454217436|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
126253237|NCT02614196|454217437|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
126253238|NCT02614196|454217432|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
126253239|NCT02614196|454217433|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
126253240|NCT02614196|454217434|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
126253241|NCT02614196|454217435|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
126253242|NCT02614196|454217436|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
126253243|NCT02614196|454217437|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
126253244|NCT02614196|454217432|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
126253245|NCT02614196|454217433|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
126253246|NCT02614196|454217434|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
126253247|NCT02614196|454217435|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
126253248|NCT02614196|454217436|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
126253249|NCT02614196|454217437|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
126029650|NCT01261312|453405143|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126029651|NCT01261312|453405144|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126253250|NCT02614196|454217432|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
126253251|NCT02614196|454217433|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
126095754|NCT02489968|453643141|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
126095755|NCT02489968|453643142|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
126095756|NCT02489968|453643143|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
126095757|NCT02489968|453643144|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
126095758|NCT02489968|453643145|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
126095759|NCT02489968|453643140|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
126095760|NCT02489968|453643141|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
126095761|NCT02489968|453643142|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
126095762|NCT02489968|453643143|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
126095763|NCT02489968|453643144|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
126095764|NCT02489968|453643145|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
126095765|NCT02489968|453643140|FG000|Open-label Treatment Period|Other than specified above|204|||
126095766|NCT02489968|453643141|FG001|Open-label Treatment Period|Other than specified above|189|||
126095767|NCT02489968|453643142|FG002|Open-label Treatment Period|Other than specified above|0|||
126095768|NCT02489968|453643143|FG003|Open-label Treatment Period|Other than specified above|0|||
126095769|NCT02489968|453643144|FG004|Open-label Treatment Period|Other than specified above|0|||
126095770|NCT02489968|453643145|FG005|Open-label Treatment Period|Other than specified above|0|||
126095771|NCT02489968|453643140|FG000|Double-blind Treatment Period|Adverse Event|0|||
126095772|NCT02489968|453643141|FG001|Double-blind Treatment Period|Adverse Event|0|||
126095773|NCT02489968|453643142|FG002|Double-blind Treatment Period|Adverse Event|2|||
126095774|NCT02489968|453643143|FG003|Double-blind Treatment Period|Adverse Event|6|||
126029652|NCT01261312|453405145|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126029653|NCT01261312|453405146|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
126029654|NCT01261312|453405147|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
126029655|NCT01261312|453405148|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
126029656|NCT01261312|453405149|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
126029657|NCT01261312|453405137|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029658|NCT01261312|453405138|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029659|NCT01261312|453405139|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029660|NCT01261312|453405140|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029661|NCT01261312|453405141|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029662|NCT01261312|453405142|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029663|NCT01261312|453405143|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029664|NCT01261312|453405144|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029665|NCT01261312|453405145|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029666|NCT01261312|453405146|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
126029667|NCT01261312|453405147|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126029668|NCT01261312|453405148|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
126029669|NCT01261312|453405149|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
126029670|NCT01261312|453405137|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029671|NCT01261312|453405138|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029672|NCT01261312|453405139|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029673|NCT01261312|453405140|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029674|NCT01261312|453405141|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029675|NCT01261312|453405142|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029676|NCT01261312|453405143|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029677|NCT01261312|453405144|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029678|NCT01261312|453405145|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126029679|NCT01261312|453405146|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
126029680|NCT01261312|453405147|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
126029681|NCT01261312|453405148|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
126029682|NCT01261312|453405149|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
126029683|NCT01261312|453405137|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126029684|NCT01261312|453405138|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126029685|NCT01261312|453405139|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126029686|NCT01261312|453405140|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126029687|NCT01261312|453405141|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126029688|NCT01261312|453405142|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126029689|NCT01261312|453405143|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126029690|NCT01261312|453405144|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126095775|NCT02489968|453643144|FG004|Double-blind Treatment Period|Adverse Event|4|||
126029691|NCT01261312|453405145|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126095776|NCT02489968|453643145|FG005|Double-blind Treatment Period|Adverse Event|5|||
126095777|NCT02489968|453643140|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126095778|NCT02489968|453643141|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126029692|NCT01261312|453405146|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
126029693|NCT01261312|453405147|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
126253252|NCT02614196|454217434|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
126253253|NCT02614196|454217435|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
126253254|NCT02614196|454217436|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
126253255|NCT02614196|454217437|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
126253256|NCT01539239|454217438|FG000|Overall Study|Death|5|||
126253257|NCT01539239|454217439|FG001|Overall Study|Death|5|||
126253258|NCT01539239|454217438|FG000|Overall Study|Lost to Follow-up|7|||
126253259|NCT01539239|454217439|FG001|Overall Study|Lost to Follow-up|12|||
126253260|NCT00640341|454219334|FG000|Overall Study|Adverse Event|0|||
126253261|NCT00640341|454219335|FG001|Overall Study|Adverse Event|0|||
126253262|NCT00640341|454219336|FG002|Overall Study|Adverse Event|1|||
126253263|NCT00640341|454219334|FG000|Overall Study|Positive Slit Lamp Findings|0|||
126253264|NCT00640341|454219335|FG001|Overall Study|Positive Slit Lamp Findings|0|||
126253265|NCT00640341|454219336|FG002|Overall Study|Positive Slit Lamp Findings|1|||
126253266|NCT00640341|454219334|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
126253267|NCT00640341|454219335|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
126253268|NCT00640341|454219336|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
126253269|NCT00640341|454219334|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
126253270|NCT00640341|454219335|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
126253271|NCT00640341|454219336|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
126029694|NCT01261312|453405148|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
126029695|NCT01261312|453405149|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
126029696|NCT01261312|453405137|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126029697|NCT01261312|453405138|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126029698|NCT01261312|453405139|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126253272|NCT00640341|454219334|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
126029699|NCT01261312|453405140|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126029700|NCT01261312|453405141|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126029701|NCT01261312|453405142|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126029702|NCT01261312|453405143|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126029703|NCT01261312|453405144|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126029704|NCT01261312|453405145|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126029705|NCT01261312|453405146|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
126029706|NCT01261312|453405147|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
126029707|NCT01261312|453405148|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
126029708|NCT01261312|453405149|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
126029709|NCT01261312|453405137|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029710|NCT01261312|453405138|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029711|NCT01261312|453405139|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029712|NCT01261312|453405140|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029713|NCT01261312|453405141|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029714|NCT01261312|453405142|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029715|NCT01261312|453405143|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029716|NCT01261312|453405144|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029717|NCT01261312|453405145|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126029718|NCT01261312|453405146|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
126029719|NCT01261312|453405147|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
126029720|NCT01261312|453405148|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
126029721|NCT01261312|453405149|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
126029722|NCT01261312|453405137|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126029723|NCT01261312|453405138|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126029724|NCT01261312|453405139|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126029725|NCT01261312|453405140|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126029726|NCT01261312|453405141|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126029727|NCT01261312|453405142|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126029728|NCT01261312|453405143|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126253273|NCT00640341|454219335|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
126253274|NCT00640341|454219336|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
126253275|NCT00640341|454219334|FG000|Overall Study|Lost to Follow-up|2|||
126253276|NCT00640341|454219335|FG001|Overall Study|Lost to Follow-up|0|||
126029729|NCT01261312|453405144|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126253277|NCT00640341|454219336|FG002|Overall Study|Lost to Follow-up|0|||
126029730|NCT01261312|453405145|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126029731|NCT01261312|453405146|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
126253278|NCT00640341|454219334|FG000|Overall Study|Withdrawal by Subject|4|||
126358246|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
126029732|NCT01261312|453405147|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
126029733|NCT01261312|453405148|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
126253279|NCT00640341|454219335|FG001|Overall Study|Withdrawal by Subject|0|||
126253280|NCT00640341|454219336|FG002|Overall Study|Withdrawal by Subject|1|||
126253281|NCT00640341|454219334|FG000|Overall Study|Unacceptable Lens Movement|1|||
126253282|NCT00640341|454219335|FG001|Overall Study|Unacceptable Lens Movement|0|||
126253283|NCT00640341|454219336|FG002|Overall Study|Unacceptable Lens Movement|0|||
126253284|NCT00640341|454219334|FG000|Overall Study|Poor fit/Uncomfortable|4|||
126253285|NCT00640341|454219335|FG001|Overall Study|Poor fit/Uncomfortable|0|||
126253286|NCT00640341|454219336|FG002|Overall Study|Poor fit/Uncomfortable|0|||
126253287|NCT00640341|454219334|FG000|Overall Study|Ineligable at Baseline|5|||
126253288|NCT00640341|454219335|FG001|Overall Study|Ineligable at Baseline|3|||
126253289|NCT00640341|454219336|FG002|Overall Study|Ineligable at Baseline|2|||
126253290|NCT00640341|454219334|FG000|Overall Study|Adverse event and positive slit lamp|1|||
126253291|NCT00640341|454219335|FG001|Overall Study|Adverse event and positive slit lamp|0|||
126253292|NCT00640341|454219336|FG002|Overall Study|Adverse event and positive slit lamp|0|||
126253293|NCT01520987|454219341|FG000|Overall Study|Withdrawal by Subject|1|||
126253294|NCT01520987|454219342|FG001|Overall Study|Withdrawal by Subject|0|||
126253295|NCT01520987|454219343|FG002|Overall Study|Withdrawal by Subject|0|||
126253296|NCT01520987|454219344|FG003|Overall Study|Withdrawal by Subject|0|||
126253297|NCT01520987|454219345|FG004|Overall Study|Withdrawal by Subject|0|||
126253298|NCT01520987|454219346|FG005|Overall Study|Withdrawal by Subject|1|||
126253299|NCT01520987|454219347|FG006|Overall Study|Withdrawal by Subject|0|||
126253300|NCT01520987|454219348|FG007|Overall Study|Withdrawal by Subject|0|||
126253301|NCT02005562|454219349|FG000|Overall Study|Death|2|||
126253302|NCT02005562|454219350|FG001|Overall Study|Death|2|||
126253303|NCT02005562|454219349|FG000|Overall Study|Graft loss|7|||
126253304|NCT02005562|454219350|FG001|Overall Study|Graft loss|6|||
126253305|NCT02005562|454219349|FG000|Overall Study|Withdrawal by Subject|2|||
126253306|NCT02005562|454219350|FG001|Overall Study|Withdrawal by Subject|2|||
126253307|NCT02005562|454219349|FG000|Overall Study|No transplant|1|||
126253308|NCT02005562|454219350|FG001|Overall Study|No transplant|4|||
126253309|NCT02005562|454219349|FG000|Overall Study|Physician Decision|0|||
126253310|NCT02005562|454219350|FG001|Overall Study|Physician Decision|1|||
126253311|NCT01691430|454219351|FG000|Overall Study|Death|17|||
126253312|NCT01691430|454219352|FG001|Overall Study|Death|16|||
126253313|NCT01691430|454219351|FG000|Overall Study|Withdrawal by Subject|5|||
126253314|NCT01691430|454219352|FG001|Overall Study|Withdrawal by Subject|1|||
126253315|NCT01691430|454219351|FG000|Overall Study|Lost to Follow-up|0|||
126253316|NCT01691430|454219352|FG001|Overall Study|Lost to Follow-up|3|||
126253317|NCT00660387|454219360|FG000|Overall Study|Adverse Event|1|||
126253318|NCT00660387|454219361|FG001|Overall Study|Adverse Event|2|||
126253319|NCT00660387|454219360|FG000|Overall Study|Lack of Efficacy|0|||
126253320|NCT00660387|454219361|FG001|Overall Study|Lack of Efficacy|1|||
126253321|NCT00660387|454219360|FG000|Overall Study|Protocol Violation|1|||
126253322|NCT00660387|454219361|FG001|Overall Study|Protocol Violation|0|||
126253323|NCT04729101|454219362|FG000|Overall Study|Adverse Event|1|||
126253324|NCT04729101|454219363|FG001|Overall Study|Adverse Event|0|||
126253325|NCT04729101|454219362|FG000|Overall Study|Physician Decision|1|||
126253326|NCT04729101|454219363|FG001|Overall Study|Physician Decision|0|||
126253327|NCT04729101|454219362|FG000|Overall Study|Withdrawal by Subject|1|||
126253328|NCT04729101|454219363|FG001|Overall Study|Withdrawal by Subject|0|||
126253329|NCT03086135|454219364|FG000|Overall Study|Adverse Event|1|||
126253330|NCT03086135|454219364|FG000|Overall Study|Lost to Follow-up|2|||
126253331|NCT01023061|454219367|FG000|Overall Study|Withdrawal prior to treatment|2|||
126253332|NCT00762411|454219368|FG000|Initial Treatment|Death|7|||
126253333|NCT00762411|454219369|FG001|Initial Treatment|Death|6|||
126253334|NCT00762411|454219368|FG000|Initial Treatment|Adverse Event|132|||
126253335|NCT00762411|454219369|FG001|Initial Treatment|Adverse Event|40|||
126253336|NCT00762411|454219368|FG000|Initial Treatment|Protocol Violation|4|||
126253337|NCT00762411|454219369|FG001|Initial Treatment|Protocol Violation|1|||
126253338|NCT00762411|454219368|FG000|Initial Treatment|Withdrawal by Subject|65|||
126253339|NCT00762411|454219369|FG001|Initial Treatment|Withdrawal by Subject|52|||
126029734|NCT01261312|453405149|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
126029735|NCT04485039|453405156|FG000|TPOXX Only|Adverse Event|2|||
126029736|NCT04485039|453405156|FG000|TPOXX Only|Physician Decision|1|||
126029737|NCT04485039|453405156|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
126253340|NCT00762411|454219368|FG000|Initial Treatment|Physician Decision|1|||
126253341|NCT00762411|454219369|FG001|Initial Treatment|Physician Decision|0|||
126253342|NCT00762411|454219368|FG000|Initial Treatment|Sponsor Decision|293|||
126253343|NCT00762411|454219369|FG001|Initial Treatment|Sponsor Decision|401|||
126253344|NCT00762411|454219368|FG000|Initial Treatment|Lost to Follow-up|5|||
126358247|NCT03467945|454603947|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126253345|NCT00762411|454219369|FG001|Initial Treatment|Lost to Follow-up|0|||
126253346|NCT00762411|454219368|FG000|Initial Treatment|Caregiver Decision|21|||
126253347|NCT00762411|454219369|FG001|Initial Treatment|Caregiver Decision|16|||
126253348|NCT00762411|454219368|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
126253349|NCT00762411|454219369|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
126253350|NCT00762411|454219368|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
126253351|NCT00762411|454219369|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
126253352|NCT00762411|454219368|FG000|Delayed Start|Adverse Event|0|||
126253353|NCT00762411|454219369|FG001|Delayed Start|Adverse Event|4|||
126253354|NCT00762411|454219368|FG000|Delayed Start|Protocol Violation|0|||
126253355|NCT00762411|454219369|FG001|Delayed Start|Protocol Violation|1|||
126253356|NCT00762411|454219368|FG000|Delayed Start|Sponsor Decision|16|||
126253357|NCT00762411|454219369|FG001|Delayed Start|Sponsor Decision|20|||
126253358|NCT00762411|454219368|FG000|Delayed Start|Caregiver Decision|1|||
126253359|NCT00762411|454219369|FG001|Delayed Start|Caregiver Decision|1|||
126253360|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
126253361|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
126253362|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
126253363|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
126253364|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
126253365|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
126253366|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
126253367|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
126253368|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
126253369|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
126253370|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
126253371|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
126253372|NCT02966340|454219373|FG000|Overall Study|Adverse Event|0|||
126253373|NCT02966340|454219374|FG001|Overall Study|Adverse Event|1|||
126253374|NCT02966340|454219373|FG000|Overall Study|Lost to Follow-up|0|||
126253375|NCT02966340|454219374|FG001|Overall Study|Lost to Follow-up|1|||
126253376|NCT02966340|454219373|FG000|Overall Study|Withdrawal by Subject|1|||
126253377|NCT02966340|454219374|FG001|Overall Study|Withdrawal by Subject|0|||
126253378|NCT02966340|454219373|FG000|Overall Study|data acquisition error|1|||
126253379|NCT02966340|454219374|FG001|Overall Study|data acquisition error|0|||
126253380|NCT02966340|454219373|FG000|Overall Study|startle non-responder|1|||
126253381|NCT02966340|454219374|FG001|Overall Study|startle non-responder|1|||
126253382|NCT01622660|454219375|FG000|Overall Study|Adverse Event|1|||
126253383|NCT02259348|454219376|FG000|Overall Study|Donors|6|||
126253384|NCT02259348|454219376|FG000|Overall Study|Death|4|||
126253385|NCT04812548|454219377|FG000|Overall Study|Adverse Event|2|||
126253386|NCT04812548|454219378|FG001|Overall Study|Adverse Event|7|||
126253387|NCT04812548|454219377|FG000|Overall Study|HSCT Planned|2|||
126253388|NCT04812548|454219378|FG001|Overall Study|HSCT Planned|3|||
126253389|NCT04812548|454219377|FG000|Overall Study|Progressive Disease|0|||
126253390|NCT04812548|454219378|FG001|Overall Study|Progressive Disease|2|||
126253391|NCT04812548|454219377|FG000|Overall Study|Death|0|||
126253392|NCT04812548|454219378|FG001|Overall Study|Death|1|||
126253393|NCT04812548|454219377|FG000|Overall Study|Post Study Access to Treatment|0|||
126253394|NCT04812548|454219378|FG001|Overall Study|Post Study Access to Treatment|1|||
126253395|NCT04812548|454219377|FG000|Overall Study|Withdrawal by Subject|0|||
126253396|NCT04812548|454219378|FG001|Overall Study|Withdrawal by Subject|1|||
126253397|NCT04812548|454219377|FG000|Overall Study|Physician Decision|1|||
126253398|NCT04812548|454219378|FG001|Overall Study|Physician Decision|0|||
126253399|NCT04211766|454219379|FG000|Overall Study|Withdrawal by Subject|5|||
126029738|NCT04485039|453405156|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
126029739|NCT04005716|453405157|FG000|Overall Study|Death|175|||
126029740|NCT04005716|453405158|FG001|Overall Study|Death|196|||
126029741|NCT04005716|453405157|FG000|Overall Study|Withdrawal by Subject|1|||
126029742|NCT04005716|453405158|FG001|Overall Study|Withdrawal by Subject|6|||
126029743|NCT04005716|453405157|FG000|Overall Study|Lost to Follow-up|2|||
126029744|NCT04005716|453405158|FG001|Overall Study|Lost to Follow-up|2|||
126029745|NCT04021602|453405159|FG000|Overall Study|Lost to Follow-up|3|||
126029746|NCT04021602|453405160|FG001|Overall Study|Lost to Follow-up|3|||
126029747|NCT04021602|453405161|FG002|Overall Study|Lost to Follow-up|1|||
126029748|NCT04021602|453405159|FG000|Overall Study|Adverse Event|1|||
126029749|NCT04021602|453405160|FG001|Overall Study|Adverse Event|0|||
126029750|NCT04021602|453405161|FG002|Overall Study|Adverse Event|1|||
126029751|NCT04150718|453406669|FG000|Overall Study|Withdrawal by Subject|2|||
126029752|NCT04150718|453406670|FG001|Overall Study|Withdrawal by Subject|7|||
126029753|NCT04150718|453406671|FG002|Overall Study|Withdrawal by Subject|1|||
126029754|NCT04150718|453406669|FG000|Overall Study|Lost to Follow-up|1|||
126029755|NCT04150718|453406670|FG001|Overall Study|Lost to Follow-up|2|||
126029756|NCT04150718|453406671|FG002|Overall Study|Lost to Follow-up|0|||
126253400|NCT04211766|454219380|FG001|Overall Study|Withdrawal by Subject|1|||
126253401|NCT04590781|454219381|FG000|Overall Study|Death|0|||
126253402|NCT04590781|454219382|FG001|Overall Study|Death|2|||
126253403|NCT04590781|454219381|FG000|Overall Study|Withdrawal by Subject|2|||
126253404|NCT04590781|454219382|FG001|Overall Study|Withdrawal by Subject|0|||
126253405|NCT01680016|454219383|FG000|Overall Study|Adverse Event|0|||
126029757|NCT04150718|453406669|FG000|Overall Study|Ineligible|1|||
126253406|NCT01680016|454219384|FG001|Overall Study|Adverse Event|0|||
126253407|NCT01680016|454219385|FG002|Overall Study|Adverse Event|1|||
126253408|NCT01680016|454219386|FG003|Overall Study|Adverse Event|4|||
126253409|NCT01680016|454219383|FG000|Overall Study|The Subject went out of The Trial|1|||
126253410|NCT01680016|454219384|FG001|Overall Study|The Subject went out of The Trial|0|||
126253411|NCT01680016|454219385|FG002|Overall Study|The Subject went out of The Trial|3|||
126253412|NCT01680016|454219386|FG003|Overall Study|The Subject went out of The Trial|0|||
126253413|NCT01680016|454219383|FG000|Overall Study|Protocol Violation|0|||
126253414|NCT01680016|454219384|FG001|Overall Study|Protocol Violation|1|||
126253415|NCT01680016|454219385|FG002|Overall Study|Protocol Violation|0|||
126253416|NCT01680016|454219386|FG003|Overall Study|Protocol Violation|0|||
126253417|NCT01680016|454219383|FG000|Overall Study|Withdrawal by Subject|5|||
126253418|NCT01680016|454219384|FG001|Overall Study|Withdrawal by Subject|7|||
126253419|NCT01680016|454219385|FG002|Overall Study|Withdrawal by Subject|1|||
126253420|NCT01680016|454219386|FG003|Overall Study|Withdrawal by Subject|1|||
126253421|NCT00442351|454219387|FG000|Overall Study|Administrative|6|||
126253422|NCT00442351|454219388|FG001|Overall Study|Administrative|5|||
126253423|NCT00442351|454219387|FG000|Overall Study|Did not meet protocol eligibility|1|||
126253424|NCT00442351|454219388|FG001|Overall Study|Did not meet protocol eligibility|0|||
126253425|NCT00442351|454219387|FG000|Overall Study|Other|0|||
126253426|NCT00442351|454219388|FG001|Overall Study|Other|1|||
126253427|NCT00288704|454219389|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
126253428|NCT00288704|454219390|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
126253429|NCT00288704|454219391|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
126253430|NCT00288704|454219389|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
126253431|NCT00288704|454219390|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
126253432|NCT00288704|454219391|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
126253433|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
126253434|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
126253435|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
126253436|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
126253437|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
126253438|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
126253439|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
126253440|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
126253441|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
126253442|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
126253443|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
126253444|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
126253445|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
126253446|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
126253447|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
126253448|NCT01579006|454219392|FG000|Overall Study|Lack of Efficacy|10|||
126253449|NCT01579006|454219392|FG000|Overall Study|Adverse Event|13|||
126253450|NCT01579006|454219392|FG000|Overall Study|Withdrawal by Subject|5|||
126253451|NCT01579006|454219392|FG000|Overall Study|Non-compliance|3|||
126253452|NCT01579006|454219392|FG000|Overall Study|Due to participant's health fund|1|||
126253453|NCT01579006|454219392|FG000|Overall Study|Scheduled surgery|1|||
126253454|NCT02697617|454219393|FG000|Overall Study|Withdrawal by Subject|0|||
126253455|NCT02697617|454219394|FG001|Overall Study|Withdrawal by Subject|2|||
126253456|NCT02697617|454219393|FG000|Overall Study|Pregnancy|1|||
126095779|NCT02489968|453643142|FG002|Double-blind Treatment Period|Protocol Violation|0|||
126253457|NCT02697617|454219394|FG001|Overall Study|Pregnancy|0|||
126253458|NCT02460835|454219395|FG000|Overall Study|Disease progression prior to treatment|3|||
126253459|NCT02460835|454219395|FG000|Overall Study|Unable to complete planning scans|2|||
126253460|NCT02460835|454219395|FG000|Overall Study|Decrease in performance status|1|||
126253461|NCT02460835|454219395|FG000|Overall Study|Withdrawal by Subject|3|||
126253462|NCT02460835|454219395|FG000|Overall Study|Underwent fractionated RT|10|||
126253463|NCT02460835|454219395|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
126253464|NCT00517192|454219399|FG000|Overall Study|Adverse Event|1|||
126253465|NCT00517192|454219400|FG001|Overall Study|Adverse Event|1|||
126253466|NCT00517192|454219399|FG000|Overall Study|Lost to Follow-up|1|||
126253467|NCT00517192|454219400|FG001|Overall Study|Lost to Follow-up|1|||
126253468|NCT00517192|454219399|FG000|Overall Study|Withdrawal by Subject|1|||
126253469|NCT00517192|454219400|FG001|Overall Study|Withdrawal by Subject|0|||
126253470|NCT00517192|454219399|FG000|Overall Study|Early termination of the trial|16|||
126253471|NCT00517192|454219400|FG001|Overall Study|Early termination of the trial|18|||
126253472|NCT02733627|454219402|FG000|Overall Study|Adverse Event|0|||
126253473|NCT02733627|454219403|FG001|Overall Study|Adverse Event|1|||
126253474|NCT02733627|454219404|FG002|Overall Study|Adverse Event|1|||
126253475|NCT02733627|454219405|FG003|Overall Study|Adverse Event|0|||
126253476|NCT02733627|454219402|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
126253477|NCT02733627|454219403|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
126253478|NCT02733627|454219404|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
126253479|NCT02733627|454219405|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
126253480|NCT00183196|454219406|FG000|Overall Study|Withdrawal by Subject|18|||
126253481|NCT00183196|454219407|FG001|Overall Study|Withdrawal by Subject|11|||
126253482|NCT00183196|454219408|FG002|Overall Study|Withdrawal by Subject|13|||
126253483|NCT00183196|454219406|FG000|Overall Study|Adverse Event|1|||
126253484|NCT00183196|454219407|FG001|Overall Study|Adverse Event|2|||
126253485|NCT00183196|454219408|FG002|Overall Study|Adverse Event|2|||
126253486|NCT00183196|454219406|FG000|Overall Study|Legal event|1|||
126253487|NCT00183196|454219407|FG001|Overall Study|Legal event|1|||
126253488|NCT00183196|454219408|FG002|Overall Study|Legal event|1|||
126253489|NCT00183196|454219406|FG000|Overall Study|Required more intensive care|0|||
126253490|NCT00183196|454219407|FG001|Overall Study|Required more intensive care|1|||
126253491|NCT00183196|454219408|FG002|Overall Study|Required more intensive care|2|||
126253492|NCT01119625|454219410|FG000|Overall Study|Lost to Follow-up|1|||
126253493|NCT01119625|454219411|FG001|Overall Study|Lost to Follow-up|2|||
126253494|NCT01119625|454219410|FG000|Overall Study|Withdrawal by Subject|2|||
126253495|NCT01119625|454219411|FG001|Overall Study|Withdrawal by Subject|1|||
126253496|NCT01119625|454219410|FG000|Overall Study|Other|0|||
126253497|NCT01119625|454219411|FG001|Overall Study|Other|1|||
126253498|NCT01721772|454219416|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
126253499|NCT01721772|454219417|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
126253500|NCT01721772|454219416|FG000|Pre-Treatment|Poor/non-compliance|0|||
126253501|NCT01721772|454219417|FG001|Pre-Treatment|Poor/non-compliance|1|||
126253502|NCT01721772|454219416|FG000|Pre-Treatment|Participant withdrew consent|0|||
126253503|NCT01721772|454219417|FG001|Pre-Treatment|Participant withdrew consent|1|||
126253504|NCT01721772|454219416|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
126253505|NCT01721772|454219417|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
126253506|NCT01721772|454219416|FG000|Treatment|Disease progression|119|||
126253507|NCT01721772|454219417|FG001|Treatment|Disease progression|168|||
126253508|NCT01721772|454219416|FG000|Treatment|Study drug toxicity|19|||
126253509|NCT01721772|454219417|FG001|Treatment|Study drug toxicity|10|||
126253510|NCT01721772|454219416|FG000|Treatment|Adverse event unrelated to study drug|7|||
126253511|NCT01721772|454219417|FG001|Treatment|Adverse event unrelated to study drug|7|||
126253512|NCT01721772|454219416|FG000|Treatment|Maximum clinical benefit|16|||
126253513|NCT01721772|454219417|FG001|Treatment|Maximum clinical benefit|4|||
126253514|NCT01721772|454219416|FG000|Treatment|Other|19|||
126253515|NCT01721772|454219417|FG001|Treatment|Other|2|||
126253516|NCT01721772|454219416|FG000|Treatment|Participant withdrew consent|2|||
126253517|NCT01721772|454219417|FG001|Treatment|Participant withdrew consent|5|||
126253518|NCT01721772|454219416|FG000|Treatment|Participant request to discontinue study treatment|21|||
126253519|NCT01721772|454219417|FG001|Treatment|Participant request to discontinue study treatment|8|||
126253520|NCT01721772|454219416|FG000|Treatment|Death|1|||
126253521|NCT01721772|454219417|FG001|Treatment|Death|0|||
126253522|NCT01721772|454219416|FG000|Treatment|Not reported|1|||
126253523|NCT01721772|454219417|FG001|Treatment|Not reported|0|||
126253524|NCT01721772|454219416|FG000|Treatment|Poor/non-compliance|1|||
126253525|NCT01721772|454219417|FG001|Treatment|Poor/non-compliance|0|||
126253526|NCT01721772|454219416|FG000|Treatment|Lost to Follow-up|0|||
126253527|NCT01721772|454219417|FG001|Treatment|Lost to Follow-up|1|||
126253528|NCT02340780|454219425|FG000|Overall Study|Ineligible|1|||
126253529|NCT05004649|454219432|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
126253530|NCT05004649|454219432|FG000|Overall Study|Lost to Follow-up|1|||
126253531|NCT05004649|454219432|FG000|Overall Study|Withdrawal by Subject|2|||
126253532|NCT05004649|454219432|FG000|Overall Study|COVID-19|1|||
126253533|NCT01698554|454219433|FG000|Overall Study|Adverse Event|2|||
126253534|NCT01698554|454219434|FG001|Overall Study|Adverse Event|5|||
126253535|NCT01698554|454219435|FG002|Overall Study|Adverse Event|0|||
126253536|NCT01698554|454219436|FG003|Overall Study|Adverse Event|1|||
126253537|NCT01698554|454219433|FG000|Overall Study|Lost to Follow-up|1|||
126253538|NCT01698554|454219434|FG001|Overall Study|Lost to Follow-up|0|||
126253539|NCT01698554|454219435|FG002|Overall Study|Lost to Follow-up|0|||
126358248|NCT03467945|454603948|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126358249|NCT03467945|454603949|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126253540|NCT01698554|454219436|FG003|Overall Study|Lost to Follow-up|0|||
126253541|NCT01698554|454219433|FG000|Overall Study|Personal Reasons|0|||
126253542|NCT01698554|454219434|FG001|Overall Study|Personal Reasons|5|||
126253543|NCT01698554|454219435|FG002|Overall Study|Personal Reasons|1|||
126253544|NCT01698554|454219436|FG003|Overall Study|Personal Reasons|1|||
126253545|NCT01698554|454219433|FG000|Overall Study|Protocol Violation|2|||
126253546|NCT01698554|454219434|FG001|Overall Study|Protocol Violation|0|||
126253547|NCT01698554|454219435|FG002|Overall Study|Protocol Violation|1|||
126253548|NCT01698554|454219436|FG003|Overall Study|Protocol Violation|0|||
126253549|NCT01698554|454219433|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126253550|NCT01698554|454219434|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126253551|NCT01698554|454219435|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126253552|NCT01698554|454219436|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126253553|NCT02654145|454219437|FG000|Overall Study|Lack of Efficacy|1|||
126253554|NCT02654145|454219437|FG000|Overall Study|Protocol Violation|1|||
126253555|NCT02654145|454219437|FG000|Overall Study|Withdrawal by Subject|5|||
126253556|NCT02637141|454219438|FG000|Overall Study|Adverse Event|1|||
126253557|NCT02637141|454219439|FG001|Overall Study|Adverse Event|1|||
126253558|NCT02637141|454219440|FG002|Overall Study|Adverse Event|0|||
126253559|NCT02637141|454219438|FG000|Overall Study|Withdrawal by Subject|1|||
126253560|NCT02637141|454219439|FG001|Overall Study|Withdrawal by Subject|1|||
126253561|NCT02637141|454219440|FG002|Overall Study|Withdrawal by Subject|1|||
126253562|NCT01943435|454219442|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
126253563|NCT01943435|454219443|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
126253564|NCT01943435|454219444|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
126253565|NCT01943435|454219442|FG000|Intervention Period|Withdrawal by Subject|3|||
126253566|NCT01943435|454219443|FG001|Intervention Period|Withdrawal by Subject|3|||
126253567|NCT01943435|454219444|FG002|Intervention Period|Withdrawal by Subject|4|||
126253568|NCT01943435|454219442|FG000|2 Month Follow up|Lost to Follow-up|2|||
126253569|NCT01943435|454219443|FG001|2 Month Follow up|Lost to Follow-up|3|||
126253570|NCT01943435|454219444|FG002|2 Month Follow up|Lost to Follow-up|0|||
126253571|NCT01943435|454219442|FG000|6 Month Follow up|Lost to Follow-up|12|||
126253572|NCT01943435|454219443|FG001|6 Month Follow up|Lost to Follow-up|7|||
126253573|NCT01943435|454219444|FG002|6 Month Follow up|Lost to Follow-up|15|||
126253574|NCT03885934|454219445|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
126253575|NCT03885934|454219446|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
126253576|NCT03885934|454219447|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
126253577|NCT03885934|454219448|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
126253578|NCT03885934|454219449|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
126253579|NCT03885934|454219450|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
126253580|NCT04535986|454219458|FG000|Overall Study|Death|4|||
126253581|NCT04535986|454219459|FG001|Overall Study|Death|5|||
126253582|NCT04535986|454219458|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
126253583|NCT04535986|454219459|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
126253584|NCT04535986|454219458|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
126253585|NCT04535986|454219459|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
126253586|NCT04535986|454219458|FG000|Overall Study|Adverse Event|10|||
126253587|NCT04535986|454219459|FG001|Overall Study|Adverse Event|1|||
126253588|NCT04535986|454219458|FG000|Overall Study|Lack of Efficacy|3|||
126253589|NCT04535986|454219459|FG001|Overall Study|Lack of Efficacy|2|||
126253590|NCT04535986|454219458|FG000|Overall Study|Investigator discretion|3|||
126253591|NCT04535986|454219459|FG001|Overall Study|Investigator discretion|0|||
126253592|NCT04535986|454219458|FG000|Overall Study|Withdrawal by Subject|32|||
126253593|NCT04535986|454219459|FG001|Overall Study|Withdrawal by Subject|14|||
126253594|NCT04535986|454219458|FG000|Overall Study|Lost to Follow-up|5|||
126253595|NCT04535986|454219459|FG001|Overall Study|Lost to Follow-up|3|||
126253596|NCT04535986|454219458|FG000|Overall Study|Other|7|||
126029758|NCT04150718|453406670|FG001|Overall Study|Ineligible|0|||
126029759|NCT04150718|453406671|FG002|Overall Study|Ineligible|10|||
126029760|NCT03090152|453406672|FG000|Overall Study|Withdrawal by Subject|0|||
126029761|NCT03090152|453406673|FG001|Overall Study|Withdrawal by Subject|2|||
126029762|NCT03090152|453406674|FG002|Overall Study|Withdrawal by Subject|1|||
126029763|NCT03090152|453406672|FG000|Overall Study|Surgery Canceled|1|||
126029764|NCT03090152|453406673|FG001|Overall Study|Surgery Canceled|0|||
126029765|NCT03090152|453406674|FG002|Overall Study|Surgery Canceled|0|||
126029766|NCT03090152|453406672|FG000|Overall Study|Epidural catheter could not be placed|0|||
126029767|NCT03090152|453406673|FG001|Overall Study|Epidural catheter could not be placed|2|||
126029768|NCT03090152|453406674|FG002|Overall Study|Epidural catheter could not be placed|0|||
126029769|NCT04673929|453406675|FG000|Overall Study|Death|73|||
126029770|NCT04673929|453406675|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
126029771|NCT03436745|453406678|FG000|Overall Study|Ineligible|0|||
126029772|NCT03436745|453406679|FG001|Overall Study|Ineligible|0|||
126029773|NCT03436745|453406680|FG002|Overall Study|Ineligible|1|||
126029774|NCT01580488|453406683|FG000|Overall Study|Withdrawal by Subject|1|||
126029775|NCT03738228|453406684|FG000|Overall Study|Never received study treatment|2|||
126029776|NCT03738228|453406685|FG001|Overall Study|Never received study treatment|2|||
126029777|NCT03338790|453406694|FG000|Overall Study|Disease Progression|65|||
126253597|NCT04535986|454219459|FG001|Overall Study|Other|3|||
126253598|NCT01559116|454219462|FG000|Overall Study|Adverse Event|10|||
126253599|NCT01559116|454219462|FG000|Overall Study|Lack of Efficacy|1|||
126253600|NCT01559116|454219462|FG000|Overall Study|Lost to Follow-up|1|||
126253601|NCT01559116|454219462|FG000|Overall Study|Protocol Violation|1|||
126358250|NCT03467945|454603950|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126253602|NCT01559116|454219462|FG000|Overall Study|Withdrawal by Subject|4|||
126253603|NCT01559116|454219462|FG000|Overall Study|other than stated above|9|||
126253604|NCT04610580|454219463|FG000|Two-way Crossover Period|Adverse Event|1|||
126253605|NCT04610580|454219464|FG001|Two-way Crossover Period|Adverse Event|0|||
126253606|NCT04610580|454219465|FG002|Two-way Crossover Period|Adverse Event|0|||
126253607|NCT04610580|454219466|FG003|Two-way Crossover Period|Adverse Event|0|||
126253608|NCT04610580|454219467|FG004|Two-way Crossover Period|Adverse Event|0|||
126253609|NCT04610580|454219468|FG005|Two-way Crossover Period|Adverse Event|0|||
126253610|NCT04610580|454219463|FG000|Two-way Crossover Period|Physician Decision|1|||
126253611|NCT04610580|454219464|FG001|Two-way Crossover Period|Physician Decision|0|||
126253612|NCT04610580|454219465|FG002|Two-way Crossover Period|Physician Decision|0|||
126253613|NCT04610580|454219466|FG003|Two-way Crossover Period|Physician Decision|0|||
126253614|NCT04610580|454219467|FG004|Two-way Crossover Period|Physician Decision|0|||
126253615|NCT04610580|454219468|FG005|Two-way Crossover Period|Physician Decision|0|||
126253616|NCT04610580|454219463|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
126253617|NCT04610580|454219464|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
126253618|NCT04610580|454219465|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
126253619|NCT04610580|454219466|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
126253620|NCT04610580|454219467|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
126253621|NCT04610580|454219468|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
126253622|NCT04610580|454219463|FG000|Two-way Crossover Period|Other than specified|0|||
126253623|NCT04610580|454219464|FG001|Two-way Crossover Period|Other than specified|1|||
126253624|NCT04610580|454219465|FG002|Two-way Crossover Period|Other than specified|0|||
126253625|NCT04610580|454219466|FG003|Two-way Crossover Period|Other than specified|0|||
126253626|NCT04610580|454219467|FG004|Two-way Crossover Period|Other than specified|0|||
126253627|NCT04610580|454219468|FG005|Two-way Crossover Period|Other than specified|0|||
126253628|NCT04610580|454219463|FG000|Washout Before Extension Period|Other than specified|0|||
126253629|NCT04610580|454219464|FG001|Washout Before Extension Period|Other than specified|1|||
126253630|NCT04610580|454219465|FG002|Washout Before Extension Period|Other than specified|0|||
126253631|NCT04610580|454219466|FG003|Washout Before Extension Period|Other than specified|0|||
126253632|NCT04610580|454219467|FG004|Washout Before Extension Period|Other than specified|0|||
126253633|NCT04610580|454219468|FG005|Washout Before Extension Period|Other than specified|0|||
126253634|NCT04610580|454219463|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
126253635|NCT04610580|454219464|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
126253636|NCT04610580|454219465|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
126253637|NCT04610580|454219466|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
126253638|NCT04610580|454219467|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
126253639|NCT04610580|454219468|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
126253640|NCT04610580|454219463|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253641|NCT04610580|454219464|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253642|NCT04610580|454219465|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253643|NCT04610580|454219466|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253644|NCT04610580|454219467|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
126253645|NCT04610580|454219468|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253646|NCT01097694|454219469|FG000|Overall Study|Adverse Event|5|||
126253647|NCT01097694|454219470|FG001|Overall Study|Adverse Event|0|||
126253648|NCT01097694|454219469|FG000|Overall Study|Lost to Follow-up|0|||
126253649|NCT01097694|454219470|FG001|Overall Study|Lost to Follow-up|3|||
126253650|NCT01097694|454219469|FG000|Overall Study|Withdrawal by Subject|3|||
126253651|NCT01097694|454219470|FG001|Overall Study|Withdrawal by Subject|1|||
126253652|NCT02377349|454219471|FG000|Overall Study|Serious Adverse Event|1|||
126253653|NCT02377349|454219472|FG001|Overall Study|Serious Adverse Event|0|||
126253654|NCT02377349|454219471|FG000|Overall Study|Protocol Violation|3|||
126253655|NCT02377349|454219472|FG001|Overall Study|Protocol Violation|2|||
126253656|NCT02377349|454219471|FG000|Overall Study|Withdrawal by Subject|5|||
126253657|NCT02377349|454219472|FG001|Overall Study|Withdrawal by Subject|3|||
126253658|NCT02377349|454219471|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
126253659|NCT02377349|454219472|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
126253660|NCT02377349|454219471|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
126253661|NCT02377349|454219472|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
126253662|NCT02377349|454219471|FG000|Overall Study|Other|0|||
126253663|NCT02377349|454219472|FG001|Overall Study|Other|1|||
126253664|NCT03259165|454219473|FG000|Overall Study|COVID 19 pandemic|1|||
126253665|NCT03259165|454219474|FG001|Overall Study|COVID 19 pandemic|1|||
126253666|NCT04320745|454219475|FG000|Overall Study|Adverse Event|26|||
126253667|NCT04320745|454219475|FG000|Overall Study|Withdrawal by Subject|4|||
126253668|NCT04320745|454219475|FG000|Overall Study|Lost to Follow-up|12|||
126253669|NCT04320745|454219475|FG000|Overall Study|Protocol Deviation|2|||
126253670|NCT04320745|454219475|FG000|Overall Study|Non-compliance With Study Drug|2|||
126253671|NCT04320745|454219475|FG000|Overall Study|Reason Not Specified|1|||
126253672|NCT02004691|454219476|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
126253673|NCT02004691|454219477|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
126253674|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
126253675|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
126253676|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
126253677|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
126253678|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
126253679|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
126253680|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
126253681|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
126253682|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
126253683|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
126253684|NCT01320722|454219478|FG000|Overall Study|Did not Receive Intervention|3|||
126253685|NCT01320722|454219479|FG001|Overall Study|Did not Receive Intervention|2|||
126253686|NCT01320722|454219480|FG002|Overall Study|Did not Receive Intervention|1|||
126253687|NCT01320722|454219481|FG003|Overall Study|Did not Receive Intervention|1|||
126253688|NCT01320722|454219482|FG004|Overall Study|Did not Receive Intervention|2|||
126253689|NCT01320722|454219478|FG000|Overall Study|Lost to Follow-up|0|||
126253690|NCT01320722|454219479|FG001|Overall Study|Lost to Follow-up|1|||
126253691|NCT01320722|454219480|FG002|Overall Study|Lost to Follow-up|0|||
126253692|NCT01320722|454219481|FG003|Overall Study|Lost to Follow-up|1|||
126253693|NCT01320722|454219482|FG004|Overall Study|Lost to Follow-up|3|||
126253694|NCT01320722|454219478|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
126253695|NCT01320722|454219479|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
126253696|NCT01320722|454219480|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
126253697|NCT01320722|454219481|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
126253698|NCT01320722|454219482|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
126253699|NCT01320722|454219478|FG000|Overall Study|Participant Developed a Rash|0|||
126253700|NCT01320722|454219479|FG001|Overall Study|Participant Developed a Rash|0|||
126253701|NCT01320722|454219480|FG002|Overall Study|Participant Developed a Rash|2|||
126253702|NCT01320722|454219481|FG003|Overall Study|Participant Developed a Rash|1|||
126253703|NCT01320722|454219482|FG004|Overall Study|Participant Developed a Rash|1|||
126253704|NCT01320722|454219478|FG000|Overall Study|Non-compliant with Medication|0|||
126253705|NCT01320722|454219479|FG001|Overall Study|Non-compliant with Medication|0|||
126253706|NCT01320722|454219480|FG002|Overall Study|Non-compliant with Medication|1|||
126253707|NCT01320722|454219481|FG003|Overall Study|Non-compliant with Medication|0|||
126253708|NCT01320722|454219482|FG004|Overall Study|Non-compliant with Medication|0|||
126253709|NCT01320722|454219478|FG000|Overall Study|Adverse Event|0|||
126253710|NCT01320722|454219479|FG001|Overall Study|Adverse Event|0|||
126253711|NCT01320722|454219480|FG002|Overall Study|Adverse Event|3|||
126253712|NCT01320722|454219481|FG003|Overall Study|Adverse Event|6|||
126253713|NCT01320722|454219482|FG004|Overall Study|Adverse Event|0|||
126253714|NCT01320722|454219478|FG000|Overall Study|Not Compliant with Study Procedures|0|||
126253715|NCT01320722|454219479|FG001|Overall Study|Not Compliant with Study Procedures|0|||
126253716|NCT01320722|454219480|FG002|Overall Study|Not Compliant with Study Procedures|0|||
126253717|NCT01320722|454219481|FG003|Overall Study|Not Compliant with Study Procedures|4|||
126253718|NCT01320722|454219482|FG004|Overall Study|Not Compliant with Study Procedures|0|||
126253719|NCT01320722|454219478|FG000|Overall Study|Pregnancy|0|||
126253720|NCT01320722|454219479|FG001|Overall Study|Pregnancy|0|||
126253721|NCT01320722|454219480|FG002|Overall Study|Pregnancy|0|||
126253722|NCT01320722|454219481|FG003|Overall Study|Pregnancy|1|||
126253723|NCT01320722|454219482|FG004|Overall Study|Pregnancy|0|||
126253724|NCT01320722|454219478|FG000|Overall Study|Started an Exclusionary Medication|0|||
126253725|NCT01320722|454219479|FG001|Overall Study|Started an Exclusionary Medication|0|||
126253726|NCT01320722|454219480|FG002|Overall Study|Started an Exclusionary Medication|0|||
126253727|NCT01320722|454219481|FG003|Overall Study|Started an Exclusionary Medication|0|||
126253728|NCT01320722|454219482|FG004|Overall Study|Started an Exclusionary Medication|1|||
126253729|NCT01320722|454219478|FG000|Overall Study|Withdrew due to Health Condition|0|||
126253730|NCT01320722|454219479|FG001|Overall Study|Withdrew due to Health Condition|0|||
126029778|NCT03338790|453406695|FG001|Overall Study|Disease Progression|43|||
126253731|NCT01320722|454219480|FG002|Overall Study|Withdrew due to Health Condition|0|||
126253732|NCT01320722|454219481|FG003|Overall Study|Withdrew due to Health Condition|0|||
126029779|NCT03338790|453406696|FG002|Overall Study|Disease Progression|50|||
126029780|NCT03338790|453406697|FG003|Overall Study|Disease Progression|37|||
126029781|NCT03338790|453406694|FG000|Overall Study|Study Drug Toxicity|9|||
126029782|NCT03338790|453406695|FG001|Overall Study|Study Drug Toxicity|8|||
126253733|NCT01320722|454219482|FG004|Overall Study|Withdrew due to Health Condition|1|||
126253734|NCT00021541|454219483|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
126253735|NCT00021541|454219484|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
126253736|NCT00021541|454219483|FG000|Period 1-First Treatment|Adverse Event|2|||
126253737|NCT00021541|454219484|FG001|Period 1-First Treatment|Adverse Event|1|||
126253738|NCT00021541|454219483|FG000|Period 1-First Treatment|non-adherence|3|||
126253739|NCT00021541|454219484|FG001|Period 1-First Treatment|non-adherence|0|||
126253740|NCT00021541|454219483|FG000|Period 1-First Treatment|Death|1|||
126253741|NCT00021541|454219484|FG001|Period 1-First Treatment|Death|0|||
126253742|NCT00021541|454219483|FG000|Period 1-First Treatment|Pts that did not progress|2|||
126253743|NCT00021541|454219484|FG001|Period 1-First Treatment|Pts that did not progress|2|||
126253744|NCT00021541|454219483|FG000|Period 1-First Treatment|Ineligible|0|||
126253745|NCT00021541|454219484|FG001|Period 1-First Treatment|Ineligible|2|||
126253746|NCT00021541|454219483|FG000|Period 2-crossover|refused phase B|2|||
126253747|NCT00021541|454219484|FG001|Period 2-crossover|refused phase B|2|||
126253748|NCT00021541|454219483|FG000|Period 2-crossover|Withdrawal by Subject|3|||
126253749|NCT00021541|454219484|FG001|Period 2-crossover|Withdrawal by Subject|4|||
126253750|NCT00021541|454219483|FG000|Period 2-crossover|Adverse Event|2|||
126253751|NCT00021541|454219484|FG001|Period 2-crossover|Adverse Event|2|||
126253752|NCT00021541|454219483|FG000|Period 2-crossover|non-adherence|1|||
126253753|NCT00021541|454219484|FG001|Period 2-crossover|non-adherence|0|||
126253754|NCT00021541|454219483|FG000|Period 2-crossover|Pts that did not progress|2|||
126253755|NCT00021541|454219484|FG001|Period 2-crossover|Pts that did not progress|3|||
126253756|NCT01547728|454219485|FG000|Overall Study|Change in procedure and equipment|1|||
126253757|NCT01547728|454219485|FG000|Overall Study|Drug not ready for subject|1|||
126253758|NCT01547728|454219485|FG000|Overall Study|Screen failure|39|||
126253759|NCT03828539|454219486|FG000|Overall Study|Adverse Event|3|||
126029783|NCT03338790|453406696|FG002|Overall Study|Study Drug Toxicity|15|||
126029784|NCT03338790|453406697|FG003|Overall Study|Study Drug Toxicity|0|||
126029785|NCT03338790|453406694|FG000|Overall Study|Death|1|||
126029786|NCT03338790|453406695|FG001|Overall Study|Death|1|||
126029787|NCT03338790|453406696|FG002|Overall Study|Death|1|||
126029788|NCT03338790|453406697|FG003|Overall Study|Death|0|||
126029789|NCT03338790|453406694|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
126029790|NCT03338790|453406695|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
126029791|NCT03338790|453406696|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
126029792|NCT03338790|453406697|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
126029793|NCT03338790|453406694|FG000|Overall Study|Participant request to discontinue study treatment|3|||
126029794|NCT03338790|453406695|FG001|Overall Study|Participant request to discontinue study treatment|3|||
126029795|NCT03338790|453406696|FG002|Overall Study|Participant request to discontinue study treatment|2|||
126029796|NCT03338790|453406697|FG003|Overall Study|Participant request to discontinue study treatment|1|||
126029797|NCT03338790|453406694|FG000|Overall Study|Poor/non-compliance|0|||
126029798|NCT03338790|453406695|FG001|Overall Study|Poor/non-compliance|1|||
126029799|NCT03338790|453406696|FG002|Overall Study|Poor/non-compliance|0|||
126029800|NCT03338790|453406697|FG003|Overall Study|Poor/non-compliance|0|||
126029801|NCT03338790|453406694|FG000|Overall Study|Participant withdrew consent|1|||
126029802|NCT03338790|453406695|FG001|Overall Study|Participant withdrew consent|0|||
126029803|NCT03338790|453406696|FG002|Overall Study|Participant withdrew consent|1|||
126029804|NCT03338790|453406697|FG003|Overall Study|Participant withdrew consent|1|||
126029805|NCT03338790|453406694|FG000|Overall Study|Other reasons|0|||
126029806|NCT03338790|453406695|FG001|Overall Study|Other reasons|5|||
126029807|NCT03338790|453406696|FG002|Overall Study|Other reasons|0|||
126029808|NCT03338790|453406697|FG003|Overall Study|Other reasons|2|||
126029809|NCT03338790|453406694|FG000|Overall Study|Not reported|0|||
126029810|NCT03338790|453406695|FG001|Overall Study|Not reported|0|||
126029811|NCT03338790|453406696|FG002|Overall Study|Not reported|1|||
126029812|NCT03338790|453406697|FG003|Overall Study|Not reported|0|||
126029813|NCT03338790|453406694|FG000|Overall Study|Completed treatment period|1|||
126029814|NCT03338790|453406695|FG001|Overall Study|Completed treatment period|2|||
126029815|NCT03338790|453406696|FG002|Overall Study|Completed treatment period|0|||
126029816|NCT03338790|453406697|FG003|Overall Study|Completed treatment period|0|||
126029817|NCT03406871|453406699|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
126029818|NCT03406871|453406700|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
126029819|NCT03406871|453406701|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
126029820|NCT03406871|453406699|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
126029821|NCT03406871|453406700|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
126029822|NCT03406871|453406701|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
126029823|NCT03406871|453406699|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
126029824|NCT03406871|453406700|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
126029825|NCT03406871|453406701|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
126029826|NCT03406871|453406699|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
126029827|NCT03406871|453406700|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
126253760|NCT03828539|454219487|FG001|Overall Study|Adverse Event|12|||
126253761|NCT03828539|454219486|FG000|Overall Study|Patient's/guardian's decision|3|||
126253762|NCT03828539|454219487|FG001|Overall Study|Patient's/guardian's decision|5|||
126253763|NCT03828539|454219486|FG000|Overall Study|Lost to Follow-up|4|||
126253764|NCT03828539|454219487|FG001|Overall Study|Lost to Follow-up|2|||
126253765|NCT03828539|454219486|FG000|Overall Study|Protocol Violation|3|||
126253766|NCT03828539|454219487|FG001|Overall Study|Protocol Violation|2|||
126253767|NCT03828539|454219486|FG000|Overall Study|Withdrawal of informed consent|2|||
126253768|NCT03828539|454219487|FG001|Overall Study|Withdrawal of informed consent|1|||
126253769|NCT03828539|454219486|FG000|Overall Study|New therapy for study indication|1|||
126253770|NCT03828539|454219487|FG001|Overall Study|New therapy for study indication|0|||
126253771|NCT01341405|454219488|FG000|Overall Study|Adverse Event|0|||
126253772|NCT01341405|454219489|FG001|Overall Study|Adverse Event|1|||
126253773|NCT01341405|454219490|FG002|Overall Study|Adverse Event|1|||
126253774|NCT01341405|454219488|FG000|Overall Study|Withdrawal by Subject|3|||
126253775|NCT01341405|454219489|FG001|Overall Study|Withdrawal by Subject|2|||
126253776|NCT01341405|454219490|FG002|Overall Study|Withdrawal by Subject|1|||
126253777|NCT02616380|454219491|FG000|Overall Study|Lost to Follow-up|1|||
126358251|NCT03467945|454603947|FG000|Treatment Period 3|Withdrawal by Subject|1|||
126358252|NCT03467945|454603948|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126358253|NCT03467945|454603949|FG002|Treatment Period 3|Withdrawal by Subject|2|||
126358254|NCT03467945|454603950|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125879773|NCT03104868|452857381|FG000|12 Month Follow up|Death|0|||
126253778|NCT02616380|454219491|FG000|Overall Study|Other|2|||
125879774|NCT03104868|452857382|FG001|12 Month Follow up|Death|1|||
125879775|NCT03104868|452857381|FG000|12 Month Follow up|Withdrawal by Subject|0|||
126253779|NCT00826241|454219492|FG000|Overall Study|Withdrawal from Follow-up|1|||
126253780|NCT00826241|454219492|FG000|Overall Study|Withdrew consent|2|||
126253781|NCT00826241|454219492|FG000|Overall Study|Death|4|||
126253782|NCT00826241|454219492|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
126253783|NCT00826241|454219492|FG000|Overall Study|Non-compliance|1|||
126253784|NCT00826241|454219492|FG000|Overall Study|Progression of disease|1|||
126253785|NCT00826241|454219492|FG000|Overall Study|Patient refused follow-up|3|||
126253786|NCT00826241|454219492|FG000|Overall Study|Lost to Follow-up|9|||
126253787|NCT00826241|454219492|FG000|Overall Study|Could not obtain records|1|||
126253788|NCT00826241|454219492|FG000|Overall Study|Screen failure|2|||
126253789|NCT00826241|454219492|FG000|Overall Study|Pt unable to proceed to registration|1|||
126253790|NCT00826241|454219492|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
126253791|NCT03407729|454219493|FG000|Overall Study|Lost to Follow-up|2|||
126253792|NCT03407729|454219494|FG001|Overall Study|Lost to Follow-up|0|||
126253793|NCT03407729|454219493|FG000|Overall Study|Unable to schedule|0|||
126253794|NCT03407729|454219494|FG001|Overall Study|Unable to schedule|3|||
126253795|NCT04142658|454219495|FG000|Overall Study|Death|2|||
126253796|NCT04142658|454219496|FG001|Overall Study|Death|1|||
126253797|NCT04142658|454219495|FG000|Overall Study|Lost to Follow-up|4|||
126253798|NCT04142658|454219496|FG001|Overall Study|Lost to Follow-up|13|||
126253799|NCT04142658|454219495|FG000|Overall Study|Withdrawal by Subject|9|||
126253800|NCT04142658|454219496|FG001|Overall Study|Withdrawal by Subject|16|||
125879776|NCT03104868|452857382|FG001|12 Month Follow up|Withdrawal by Subject|3|||
125879777|NCT03104868|452857381|FG000|12 Month Follow up|Completed Later Timepoint|32|||
125879778|NCT03104868|452857382|FG001|12 Month Follow up|Completed Later Timepoint|29|||
125879779|NCT03104868|452857381|FG000|18 Month Follow up|Lost to Follow-up|7|||
125879780|NCT03104868|452857382|FG001|18 Month Follow up|Lost to Follow-up|11|||
125879781|NCT03104868|452857381|FG000|18 Month Follow up|Death|2|||
125879782|NCT03104868|452857382|FG001|18 Month Follow up|Death|1|||
125879783|NCT03104868|452857381|FG000|18 Month Follow up|Withdrawal by Subject|1|||
125879784|NCT03104868|452857382|FG001|18 Month Follow up|Withdrawal by Subject|2|||
125879785|NCT03104868|452857381|FG000|18 Month Follow up|Graft Loss|1|||
125879786|NCT03104868|452857382|FG001|18 Month Follow up|Graft Loss|1|||
125879787|NCT03104868|452857381|FG000|18 Month Follow up|Completed Later Timepoint|19|||
125879788|NCT03104868|452857382|FG001|18 Month Follow up|Completed Later Timepoint|20|||
125879789|NCT03104868|452857381|FG000|24 Month Follow up|Lost to Follow-up|15|||
125879790|NCT03104868|452857382|FG001|24 Month Follow up|Lost to Follow-up|16|||
126029828|NCT03406871|453406701|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
126029829|NCT03406871|453406699|FG000|Expansion Cohort(Final Analysis)|Death|0|||
126029830|NCT03406871|453406700|FG001|Expansion Cohort(Final Analysis)|Death|1|||
126029831|NCT03406871|453406701|FG002|Expansion Cohort(Final Analysis)|Death|0|||
126029832|NCT03406871|453406699|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
126029833|NCT03406871|453406700|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
126029834|NCT03406871|453406701|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
126029835|NCT03366649|453406702|FG000|Overall Study|Failed preoperative screening|4|||
126029836|NCT03366649|453406703|FG001|Overall Study|Failed preoperative screening|0|||
126029837|NCT03366649|453406704|FG002|Overall Study|Failed preoperative screening|0|||
126029838|NCT03366649|453406702|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
126029839|NCT03366649|453406703|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
126029840|NCT03366649|453406704|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
126253801|NCT03950674|454219501|FG000|Overall Study|Death|16|||
126358255|NCT02975700|454603951|FG000|Overall Study|Adverse Event|1|||
125879791|NCT03104868|452857381|FG000|24 Month Follow up|Death|3|||
125879792|NCT03104868|452857382|FG001|24 Month Follow up|Death|2|||
126358256|NCT02975700|454603951|FG000|Overall Study|Progressive disease|3|||
126253802|NCT03950674|454219502|FG001|Overall Study|Death|15|||
126253803|NCT03950674|454219501|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
126253804|NCT03950674|454219502|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
126253805|NCT00830167|454219505|FG000|Overall Study|Lack of Efficacy|26|||
126253806|NCT00830167|454219506|FG001|Overall Study|Lack of Efficacy|10|||
126253807|NCT00830167|454219505|FG000|Overall Study|Adverse Event|8|||
126253808|NCT00830167|454219506|FG001|Overall Study|Adverse Event|24|||
126253809|NCT00830167|454219505|FG000|Overall Study|Not meeting entrance criteria|2|||
126253810|NCT00830167|454219506|FG001|Overall Study|Not meeting entrance criteria|5|||
126253811|NCT00830167|454219505|FG000|Overall Study|Withdrawal by Subject|2|||
126253812|NCT00830167|454219506|FG001|Overall Study|Withdrawal by Subject|0|||
126253813|NCT00830167|454219505|FG000|Overall Study|Lost to Follow-up|0|||
126253814|NCT00830167|454219506|FG001|Overall Study|Lost to Follow-up|1|||
126253815|NCT00830167|454219505|FG000|Overall Study|Protocol Violation|0|||
126253816|NCT00830167|454219506|FG001|Overall Study|Protocol Violation|1|||
126253817|NCT00830167|454219505|FG000|Overall Study|Other|2|||
126253818|NCT00830167|454219506|FG001|Overall Study|Other|2|||
126253819|NCT01223027|454219507|FG000|Overall Study|Adverse Event|20|||
126253820|NCT01223027|454219508|FG001|Overall Study|Adverse Event|10|||
126253821|NCT01223027|454219507|FG000|Overall Study|Death|42|||
126253822|NCT01223027|454219508|FG001|Overall Study|Death|42|||
126253823|NCT01223027|454219507|FG000|Overall Study|Lost to Follow-up|2|||
126253824|NCT01223027|454219508|FG001|Overall Study|Lost to Follow-up|1|||
126253825|NCT01223027|454219507|FG000|Overall Study|Physician Decision|4|||
126253826|NCT01223027|454219508|FG001|Overall Study|Physician Decision|8|||
126253827|NCT01223027|454219507|FG000|Overall Study|Progressive Disease|167|||
126253828|NCT01223027|454219508|FG001|Overall Study|Progressive Disease|183|||
126253829|NCT01223027|454219507|FG000|Overall Study|Protocol Violation|2|||
126253830|NCT01223027|454219508|FG001|Overall Study|Protocol Violation|1|||
126253831|NCT01223027|454219507|FG000|Overall Study|Subject/guardian decicion|18|||
126253832|NCT01223027|454219508|FG001|Overall Study|Subject/guardian decicion|16|||
126253833|NCT01223027|454219507|FG000|Overall Study|New therapy for study indication|17|||
126253834|NCT01223027|454219508|FG001|Overall Study|New therapy for study indication|8|||
126253835|NCT01223027|454219507|FG000|Overall Study|Study terminated by sponsor|2|||
126253836|NCT01223027|454219508|FG001|Overall Study|Study terminated by sponsor|8|||
126253837|NCT03201003|454219512|FG000|Overall Study|Adverse Event|14|||
126253838|NCT03201003|454219513|FG001|Overall Study|Adverse Event|1|||
126253839|NCT03201003|454219512|FG000|Overall Study|Other reasons|5|||
126253840|NCT03201003|454219513|FG001|Overall Study|Other reasons|1|||
126253841|NCT03201003|454219512|FG000|Overall Study|Withdrawal by Subject|4|||
126253842|NCT03201003|454219513|FG001|Overall Study|Withdrawal by Subject|1|||
126253843|NCT03201003|454219512|FG000|Overall Study|Lost to Follow-up|2|||
126253844|NCT03201003|454219513|FG001|Overall Study|Lost to Follow-up|0|||
126253845|NCT03201003|454219512|FG000|Overall Study|Protocol Violation|1|||
126253846|NCT03201003|454219513|FG001|Overall Study|Protocol Violation|0|||
126253847|NCT00834613|454219514|FG000|First Intervention|Protocol Violation|1|||
126253848|NCT00834613|454219515|FG001|First Intervention|Protocol Violation|0|||
126253849|NCT01751087|454219516|FG000|Overall Study|Withdrawal by Subject|1|||
126253850|NCT01751087|454219517|FG001|Overall Study|Withdrawal by Subject|0|||
126253851|NCT01751087|454219518|FG002|Overall Study|Withdrawal by Subject|0|||
126253852|NCT01751087|454219516|FG000|Overall Study|Physician Decision|0|||
126253853|NCT01751087|454219517|FG001|Overall Study|Physician Decision|0|||
126253854|NCT01751087|454219518|FG002|Overall Study|Physician Decision|1|||
126253855|NCT00697619|454219519|FG000|Overall Study|Lack of Efficacy|2|||
126253856|NCT00697619|454219520|FG001|Overall Study|Lack of Efficacy|2|||
126253857|NCT00697619|454219519|FG000|Overall Study|Adverse Event|4|||
126253858|NCT00697619|454219520|FG001|Overall Study|Adverse Event|6|||
126253859|NCT00258856|454220934|FG000|Overall Study|Lost to Follow-up|1|||
126253860|NCT00258856|454220935|FG001|Overall Study|Lost to Follow-up|0|||
126253861|NCT00258856|454220936|FG002|Overall Study|Lost to Follow-up|2|||
126253862|NCT00258856|454220937|FG003|Overall Study|Lost to Follow-up|0|||
126253863|NCT00258856|454220934|FG000|Overall Study|Non-compliance|2|||
126358257|NCT02975700|454603951|FG000|Overall Study|Failed screening criteria|2|||
126253864|NCT00258856|454220935|FG001|Overall Study|Non-compliance|0|||
126253865|NCT00258856|454220936|FG002|Overall Study|Non-compliance|0|||
126253866|NCT00258856|454220937|FG003|Overall Study|Non-compliance|1|||
126253867|NCT02219009|454220940|FG000|Overall Study|Withdrawal by Subject|5|||
126253868|NCT02219009|454220941|FG001|Overall Study|Withdrawal by Subject|1|||
126253869|NCT02219009|454220940|FG000|Overall Study|Adverse Event|2|||
126253870|NCT02219009|454220941|FG001|Overall Study|Adverse Event|4|||
126253871|NCT02219009|454220940|FG000|Overall Study|Lost to Follow-up|2|||
126253872|NCT02219009|454220941|FG001|Overall Study|Lost to Follow-up|2|||
126253873|NCT02219009|454220940|FG000|Overall Study|Protocol deviation|1|||
126253874|NCT02219009|454220941|FG001|Overall Study|Protocol deviation|0|||
126253875|NCT02219009|454220940|FG000|Overall Study|Physician Decision|0|||
126253876|NCT02219009|454220941|FG001|Overall Study|Physician Decision|1|||
126253877|NCT00274625|454220942|FG000|Overall Study|Lost to Follow-up|46|||
126253878|NCT00274625|454220943|FG001|Overall Study|Lost to Follow-up|54|||
126253879|NCT00274625|454220942|FG000|Overall Study|Excluded from analysis|14|||
126253880|NCT00274625|454220943|FG001|Overall Study|Excluded from analysis|8|||
126253881|NCT01754376|454220947|FG000|Overall Study|Adverse Event|1|||
126253882|NCT01754376|454220947|FG000|Overall Study|Lack of Efficacy|2|||
126253883|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
126253884|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126253885|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
126253886|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253887|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253888|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253889|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253890|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253891|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
126253892|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253893|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253894|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253895|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253896|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253897|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253898|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253899|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126253900|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253901|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126253902|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253903|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253904|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253905|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253906|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253907|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
126253908|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126029841|NCT04588298|453406705|FG000|Overall Study|Adverse Event|0|||
126029842|NCT04588298|453406706|FG001|Overall Study|Adverse Event|0|||
126029843|NCT04588298|453406707|FG002|Overall Study|Adverse Event|1|||
126029844|NCT04588298|453406708|FG003|Overall Study|Adverse Event|0|||
126029845|NCT04588298|453406709|FG004|Overall Study|Adverse Event|2|||
126029846|NCT04588298|453406705|FG000|Overall Study|Withdrawal by Subject|1|||
126253909|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253910|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126029847|NCT04588298|453406706|FG001|Overall Study|Withdrawal by Subject|0|||
126029848|NCT04588298|453406707|FG002|Overall Study|Withdrawal by Subject|0|||
126029849|NCT04588298|453406708|FG003|Overall Study|Withdrawal by Subject|1|||
126029850|NCT04588298|453406709|FG004|Overall Study|Withdrawal by Subject|0|||
126029851|NCT03673111|453406710|FG000|Overall Study|Protocol Violation|0|||
126029852|NCT03673111|453406711|FG001|Overall Study|Protocol Violation|0|||
126029853|NCT03673111|453406712|FG002|Overall Study|Protocol Violation|0|||
126029854|NCT03673111|453406713|FG003|Overall Study|Protocol Violation|0|||
126029855|NCT03673111|453406714|FG004|Overall Study|Protocol Violation|0|||
126029856|NCT03673111|453406715|FG005|Overall Study|Protocol Violation|0|||
126029857|NCT03673111|453406716|FG006|Overall Study|Protocol Violation|0|||
126029858|NCT03673111|453406717|FG007|Overall Study|Protocol Violation|0|||
126029859|NCT03673111|453406718|FG008|Overall Study|Protocol Violation|0|||
126029860|NCT03673111|453406719|FG009|Overall Study|Protocol Violation|0|||
126029861|NCT03673111|453406720|FG010|Overall Study|Protocol Violation|1|||
126029862|NCT03673111|453406721|FG011|Overall Study|Protocol Violation|0|||
126029863|NCT03673111|453406722|FG012|Overall Study|Protocol Violation|0|||
126029864|NCT03673111|453406723|FG013|Overall Study|Protocol Violation|0|||
126029865|NCT03673111|453406710|FG000|Overall Study|Adverse Event|1|||
126029866|NCT03673111|453406711|FG001|Overall Study|Adverse Event|0|||
126029867|NCT03673111|453406712|FG002|Overall Study|Adverse Event|0|||
126029868|NCT03673111|453406713|FG003|Overall Study|Adverse Event|0|||
126029869|NCT03673111|453406714|FG004|Overall Study|Adverse Event|0|||
126029870|NCT03673111|453406715|FG005|Overall Study|Adverse Event|0|||
126029871|NCT03673111|453406716|FG006|Overall Study|Adverse Event|0|||
126029872|NCT03673111|453406717|FG007|Overall Study|Adverse Event|0|||
126029873|NCT03673111|453406718|FG008|Overall Study|Adverse Event|0|||
126029874|NCT03673111|453406719|FG009|Overall Study|Adverse Event|0|||
126029875|NCT03673111|453406720|FG010|Overall Study|Adverse Event|0|||
126029876|NCT03673111|453406721|FG011|Overall Study|Adverse Event|0|||
126029877|NCT03673111|453406722|FG012|Overall Study|Adverse Event|0|||
126253911|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253912|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253913|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253914|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253915|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253916|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253917|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
126253918|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253919|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253920|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253921|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253922|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253923|NCT04556734|454220948|FG000|OLE Period (28 Weeks)|Not reported|0|||
126253924|NCT04556734|454220949|FG001|OLE Period (28 Weeks)|Not reported|0|||
126253925|NCT04556734|454220950|FG002|OLE Period (28 Weeks)|Not reported|0|||
126253926|NCT04556734|454220951|FG003|OLE Period (28 Weeks)|Not reported|0|||
126253927|NCT04556734|454220952|FG004|OLE Period (28 Weeks)|Not reported|0|||
126253928|NCT04556734|454220953|FG005|OLE Period (28 Weeks)|Not reported|1|||
126253929|NCT04556734|454220954|FG006|OLE Period (28 Weeks)|Not reported|0|||
126253930|NCT04556734|454220955|FG007|OLE Period (28 Weeks)|Not reported|0|||
126253931|NCT04556734|454220948|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253932|NCT04556734|454220949|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253933|NCT04556734|454220950|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253934|NCT04556734|454220951|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253935|NCT04556734|454220952|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253936|NCT04556734|454220953|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253937|NCT04556734|454220954|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253938|NCT04556734|454220955|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
126253939|NCT04556734|454220948|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
126253940|NCT04556734|454220949|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
126253941|NCT04556734|454220950|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
126253942|NCT04556734|454220951|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
126253943|NCT04556734|454220952|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
126253944|NCT04556734|454220953|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
126253945|NCT04556734|454220954|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
126253946|NCT04556734|454220955|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
126253947|NCT04556734|454220948|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126253948|NCT04556734|454220949|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126253949|NCT04556734|454220950|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126253950|NCT04556734|454220951|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
126253951|NCT04556734|454220952|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
126253952|NCT04556734|454220953|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
126253953|NCT04556734|454220954|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
126253954|NCT04556734|454220955|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126253955|NCT04264819|454220956|FG000|Overall Study|Physician Decision|19|||
126253956|NCT04264819|454220956|FG000|Overall Study|Adverse Event|12|||
126253957|NCT04264819|454220956|FG000|Overall Study|Withdrawal by Subject|11|||
126253958|NCT04264819|454220956|FG000|Overall Study|Lost to Follow-up|2|||
126253959|NCT04264819|454220956|FG000|Overall Study|Death|2|||
126253960|NCT02229084|454220959|FG000|Overall Study|Adverse Event|1|||
126253961|NCT02229084|454220960|FG001|Overall Study|Adverse Event|0|||
126253962|NCT02229084|454220961|FG002|Overall Study|Adverse Event|0|||
126253963|NCT02229084|454220962|FG003|Overall Study|Adverse Event|0|||
126253964|NCT02229084|454220963|FG004|Overall Study|Adverse Event|0|||
126253965|NCT02229084|454220964|FG005|Overall Study|Adverse Event|0|||
126253966|NCT02229084|454220965|FG006|Overall Study|Adverse Event|0|||
126253967|NCT02229084|454220959|FG000|Overall Study|Lost to Follow-up|0|||
126253968|NCT02229084|454220960|FG001|Overall Study|Lost to Follow-up|0|||
126253969|NCT02229084|454220961|FG002|Overall Study|Lost to Follow-up|1|||
126253970|NCT02229084|454220962|FG003|Overall Study|Lost to Follow-up|1|||
126253971|NCT02229084|454220963|FG004|Overall Study|Lost to Follow-up|0|||
126253972|NCT02229084|454220964|FG005|Overall Study|Lost to Follow-up|0|||
126253973|NCT02229084|454220965|FG006|Overall Study|Lost to Follow-up|1|||
126253974|NCT02229084|454220959|FG000|Overall Study|Physician Decision|0|||
126253975|NCT02229084|454220960|FG001|Overall Study|Physician Decision|0|||
126253976|NCT02229084|454220961|FG002|Overall Study|Physician Decision|0|||
126253977|NCT02229084|454220962|FG003|Overall Study|Physician Decision|1|||
126253978|NCT02229084|454220963|FG004|Overall Study|Physician Decision|3|||
126253979|NCT02229084|454220964|FG005|Overall Study|Physician Decision|0|||
126253980|NCT02229084|454220965|FG006|Overall Study|Physician Decision|1|||
126253981|NCT02229084|454220959|FG000|Overall Study|Withdrawal by Subject|0|||
126253982|NCT02229084|454220960|FG001|Overall Study|Withdrawal by Subject|0|||
126253983|NCT02229084|454220961|FG002|Overall Study|Withdrawal by Subject|1|||
126253984|NCT02229084|454220962|FG003|Overall Study|Withdrawal by Subject|0|||
126253985|NCT02229084|454220963|FG004|Overall Study|Withdrawal by Subject|1|||
126253986|NCT02229084|454220964|FG005|Overall Study|Withdrawal by Subject|1|||
126253987|NCT02229084|454220965|FG006|Overall Study|Withdrawal by Subject|1|||
126253988|NCT02229084|454220959|FG000|Overall Study|Death|0|||
126253989|NCT02229084|454220960|FG001|Overall Study|Death|0|||
126253990|NCT02229084|454220961|FG002|Overall Study|Death|0|||
126253991|NCT02229084|454220962|FG003|Overall Study|Death|0|||
126253992|NCT02229084|454220963|FG004|Overall Study|Death|0|||
126253993|NCT02229084|454220964|FG005|Overall Study|Death|0|||
126253994|NCT02229084|454220965|FG006|Overall Study|Death|1|||
126253995|NCT02179190|454220969|FG000|Enrollment|Exit Prior to Device Attempt|11|||
126253996|NCT02179190|454220969|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
126253997|NCT02179190|454220969|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
126253998|NCT02179190|454220969|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
126253999|NCT02179190|454220969|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
126254000|NCT02179190|454220969|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
126254001|NCT00881569|454220972|FG000|Overall Study|Disease progression|1|||
126254002|NCT00881569|454220973|FG001|Overall Study|Disease progression|1|||
126254003|NCT01993940|454220984|FG000|Overall Study|Adverse Event|16|||
126254004|NCT01993940|454220985|FG001|Overall Study|Adverse Event|11|||
126254005|NCT01993940|454220984|FG000|Overall Study|Withdrawal by Subject|15|||
126254006|NCT01993940|454220985|FG001|Overall Study|Withdrawal by Subject|19|||
126254007|NCT01993940|454220984|FG000|Overall Study|Lost to Follow-up|2|||
126254008|NCT01993940|454220985|FG001|Overall Study|Lost to Follow-up|5|||
126254009|NCT01993940|454220984|FG000|Overall Study|Protocol Violation|5|||
126254010|NCT01993940|454220985|FG001|Overall Study|Protocol Violation|8|||
126254011|NCT01993940|454220984|FG000|Overall Study|Death|1|||
126254012|NCT01993940|454220985|FG001|Overall Study|Death|0|||
126254013|NCT01993940|454220984|FG000|Overall Study|Other - Miscellaneous|1|||
126254014|NCT01993940|454220985|FG001|Overall Study|Other - Miscellaneous|1|||
126254015|NCT00550147|454220988|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
126254016|NCT00550147|454220988|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
126254017|NCT00550147|454220988|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
126254018|NCT00550147|454220988|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
126254019|NCT00550147|454220988|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
126254020|NCT01824498|454220989|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
126254021|NCT01824498|454220990|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
126254022|NCT01824498|454220991|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
126254023|NCT01824498|454220992|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
126254024|NCT01824498|454220993|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
126254025|NCT01824498|454220994|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
126254026|NCT01567527|454220995|FG000|Conversion Phase.|Protocol deviation|3|||
126254027|NCT01567527|454220996|FG001|Conversion Phase.|Protocol deviation|0|||
126254028|NCT01567527|454220997|FG002|Conversion Phase.|Protocol deviation|0|||
126254029|NCT01567527|454220998|FG003|Conversion Phase.|Protocol deviation|0|||
126254030|NCT01567527|454220999|FG004|Conversion Phase.|Protocol deviation|0|||
126254031|NCT01567527|454220995|FG000|Conversion Phase.|Met withdrawal criteria|10|||
126254032|NCT01567527|454220996|FG001|Conversion Phase.|Met withdrawal criteria|0|||
126254033|NCT01567527|454220997|FG002|Conversion Phase.|Met withdrawal criteria|0|||
126254034|NCT01567527|454220998|FG003|Conversion Phase.|Met withdrawal criteria|0|||
126254035|NCT01567527|454220999|FG004|Conversion Phase.|Met withdrawal criteria|0|||
126254036|NCT01567527|454220995|FG000|Conversion Phase.|Withdrawal by Subject|32|||
126254037|NCT01567527|454220996|FG001|Conversion Phase.|Withdrawal by Subject|0|||
126254038|NCT01567527|454220997|FG002|Conversion Phase.|Withdrawal by Subject|0|||
126254039|NCT01567527|454220998|FG003|Conversion Phase.|Withdrawal by Subject|0|||
126254040|NCT01567527|454220999|FG004|Conversion Phase.|Withdrawal by Subject|0|||
126254041|NCT01567527|454220995|FG000|Conversion Phase.|Lost to Follow-up|16|||
126254042|NCT01567527|454220996|FG001|Conversion Phase.|Lost to Follow-up|0|||
126254043|NCT01567527|454220997|FG002|Conversion Phase.|Lost to Follow-up|0|||
126254044|NCT01567527|454220998|FG003|Conversion Phase.|Lost to Follow-up|0|||
126254045|NCT01567527|454220999|FG004|Conversion Phase.|Lost to Follow-up|0|||
126254046|NCT01567527|454220995|FG000|Conversion Phase.|Lack of Efficacy|2|||
126254047|NCT01567527|454220996|FG001|Conversion Phase.|Lack of Efficacy|0|||
126254048|NCT01567527|454220997|FG002|Conversion Phase.|Lack of Efficacy|0|||
126254049|NCT01567527|454220998|FG003|Conversion Phase.|Lack of Efficacy|0|||
126254050|NCT01567527|454220999|FG004|Conversion Phase.|Lack of Efficacy|0|||
126254051|NCT01567527|454220995|FG000|Conversion Phase.|Adverse Event|33|||
126254052|NCT01567527|454220996|FG001|Conversion Phase.|Adverse Event|0|||
126254053|NCT01567527|454220997|FG002|Conversion Phase.|Adverse Event|0|||
126254054|NCT01567527|454220998|FG003|Conversion Phase.|Adverse Event|0|||
126254055|NCT01567527|454220999|FG004|Conversion Phase.|Adverse Event|0|||
126254056|NCT01567527|454220995|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
126254057|NCT01567527|454220996|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
126254058|NCT01567527|454220997|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
126254059|NCT01567527|454220998|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
126254060|NCT01567527|454220999|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
126254061|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
126254062|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
126254063|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
126254064|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
126254065|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
126254066|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
126254067|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
126254068|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
126254069|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
126254070|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
126254071|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
126254072|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
126254073|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
126254074|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
126254075|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
126254076|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
126254077|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
126254078|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
126254079|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
126254080|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
126254081|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
126254082|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
126254083|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
126254084|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
126254085|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
126254086|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
126254087|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
126254088|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
126254089|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
126254090|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
126254091|NCT01567527|454220995|FG000|IM Depot Stabilization.|Protocol deviation|0|||
126254092|NCT01567527|454220996|FG001|IM Depot Stabilization.|Protocol deviation|0|||
126254093|NCT01567527|454220997|FG002|IM Depot Stabilization.|Protocol deviation|5|||
126254094|NCT01567527|454220998|FG003|IM Depot Stabilization.|Protocol deviation|0|||
126254095|NCT01567527|454220999|FG004|IM Depot Stabilization.|Protocol deviation|0|||
126254096|NCT01567527|454220995|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
126254097|NCT01567527|454220996|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
126254098|NCT01567527|454220997|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
126254099|NCT01567527|454220998|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
126254100|NCT01567527|454220999|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
126254101|NCT01567527|454220995|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
126254102|NCT01567527|454220996|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
126254103|NCT01567527|454220997|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
126254104|NCT01567527|454220998|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
126254105|NCT01567527|454220999|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
126254106|NCT01567527|454220995|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
126254107|NCT01567527|454220996|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
126254108|NCT01567527|454220997|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
126254109|NCT01567527|454220998|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
126254110|NCT01567527|454220999|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
126254111|NCT01567527|454220995|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
126254112|NCT01567527|454220996|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
126254113|NCT01567527|454220997|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
126254114|NCT01567527|454220998|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
126254115|NCT01567527|454220999|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
126254116|NCT01567527|454220995|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
126254117|NCT01567527|454220996|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
126254118|NCT01567527|454220997|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
126029878|NCT03673111|453406723|FG013|Overall Study|Adverse Event|0|||
126254119|NCT01567527|454220998|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
126254120|NCT01567527|454220999|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
126254121|NCT01567527|454220995|FG000|IM Depot Stabilization.|Adverse Event|0|||
126254122|NCT01567527|454220996|FG001|IM Depot Stabilization.|Adverse Event|0|||
126254123|NCT01567527|454220997|FG002|IM Depot Stabilization.|Adverse Event|37|||
126254124|NCT01567527|454220998|FG003|IM Depot Stabilization.|Adverse Event|0|||
126254125|NCT01567527|454220999|FG004|IM Depot Stabilization.|Adverse Event|0|||
126254126|NCT01567527|454220995|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
126254127|NCT01567527|454220996|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
126254128|NCT01567527|454220997|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
126254129|NCT01567527|454220998|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
126358258|NCT01541254|454603953|FG000|Overall Study|Withdrawal by Subject|1|||
126358259|NCT01541254|454603953|FG000|Overall Study|excluded - metal allergy|1|||
126358260|NCT01541254|454603953|FG000|Overall Study|enrolled after study closed|1|||
126358261|NCT01541254|454603953|FG000|Overall Study|GI bleed prior to procedure|1|||
126254130|NCT01567527|454220999|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
126254131|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
126254132|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
126254133|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
126254134|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
126254135|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
126254136|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
126254137|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
126254138|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
126254139|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
126254140|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
126254141|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
126254142|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
126254143|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
126254144|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
126254145|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
126254146|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
126254147|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
126254148|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
126254149|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
126254150|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
126254151|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126254152|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126254153|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126254154|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
126254155|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
126254156|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
126254157|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
126254158|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
126254159|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
126254160|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
126254161|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
126254162|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
126254163|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
126254164|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
126254165|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
126254166|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126254167|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126358262|NCT01541254|454603953|FG000|Overall Study|stent not required|1|||
126358263|NCT01541254|454603953|FG000|Overall Study|alternate stent used|1|||
126358264|NCT05660538|454603954|FG000|Overall Study|Adverse Event|0|||
126358265|NCT05660538|454603955|FG001|Overall Study|Adverse Event|0|||
126358266|NCT05660538|454603956|FG002|Overall Study|Adverse Event|1|||
126254168|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126254169|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
126358267|NCT05660538|454603957|FG003|Overall Study|Adverse Event|0|||
126358268|NCT05660538|454603954|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
126358269|NCT05660538|454603955|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
126358270|NCT05660538|454603956|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
126358271|NCT05660538|454603957|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
126254170|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
126254171|NCT02623218|454221000|FG000|Overall Study|Lost to Follow-up|0|||
126254172|NCT02623218|454221001|FG001|Overall Study|Lost to Follow-up|1|||
126254173|NCT02623218|454221002|FG002|Overall Study|Lost to Follow-up|0|||
126029879|NCT03846505|453406724|FG000|Treatment Phase|Withdrawal by Subject|9|||
126029880|NCT03846505|453406725|FG001|Treatment Phase|Withdrawal by Subject|11|||
126029881|NCT03846505|453406724|FG000|Treatment Phase|Lost to Follow-up|6|||
126029882|NCT03846505|453406725|FG001|Treatment Phase|Lost to Follow-up|2|||
126029883|NCT03846505|453406724|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
126029884|NCT03846505|453406725|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
126254174|NCT02623218|454221003|FG003|Overall Study|Lost to Follow-up|0|||
126254175|NCT02623218|454221004|FG004|Overall Study|Lost to Follow-up|0|||
126254176|NCT01726803|454221005|FG000|Overall Study|Lost to Follow-up|6|||
126254177|NCT01726803|454221006|FG001|Overall Study|Lost to Follow-up|1|||
126254178|NCT01726803|454221005|FG000|Overall Study|Withdrawal by Subject|1|||
126254179|NCT01726803|454221006|FG001|Overall Study|Withdrawal by Subject|0|||
126254180|NCT01277510|454221010|FG000|Double-blind Phase|Non-compliance|0|||
126254181|NCT01277510|454221011|FG001|Double-blind Phase|Non-compliance|1|||
126254182|NCT01277510|454221010|FG000|Double-blind Phase|Adverse Event|1|||
126254183|NCT01277510|454221011|FG001|Double-blind Phase|Adverse Event|0|||
126254184|NCT01277510|454221010|FG000|Double-blind Phase|Withdrawal by Subject|2|||
126254185|NCT01277510|454221011|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126254186|NCT01277510|454221010|FG000|Double-blind Phase|Administrative decision|7|||
126254187|NCT01277510|454221011|FG001|Double-blind Phase|Administrative decision|9|||
126254188|NCT01277510|454221010|FG000|Double-blind Phase|Death|0|||
126254189|NCT01277510|454221011|FG001|Double-blind Phase|Death|1|||
126254190|NCT01277510|454221010|FG000|Double-blind Phase|Protocol-specified criteria|2|||
126254191|NCT01277510|454221011|FG001|Double-blind Phase|Protocol-specified criteria|6|||
126254192|NCT01277510|454221010|FG000|Double-blind Phase|Other|1|||
126254193|NCT01277510|454221011|FG001|Double-blind Phase|Other|1|||
126254194|NCT01277510|454221010|FG000|Open-label Phase|Administrative decision|4|||
126254195|NCT01277510|454221011|FG001|Open-label Phase|Administrative decision|3|||
126254196|NCT01277510|454221010|FG000|Open-label Phase|Protocol-specified criteria|1|||
126254197|NCT01277510|454221011|FG001|Open-label Phase|Protocol-specified criteria|0|||
126254198|NCT01277510|454221010|FG000|Open-label Phase|Never received investigational product|2|||
126254199|NCT01277510|454221011|FG001|Open-label Phase|Never received investigational product|0|||
126254200|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
126254201|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
126254202|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
126254203|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
126254204|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
126254205|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
126254206|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
126254207|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
126254208|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
126254209|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
126254210|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
126254211|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
126254212|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
126254213|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
126254214|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
126254215|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
126254216|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
126254217|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
126254218|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
126254219|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
126254220|NCT00057941|454221030|FG000|Overall Study|Death|1|||
126254221|NCT00057941|454221031|FG001|Overall Study|Death|2|||
126254222|NCT00057941|454221030|FG000|Overall Study|Adverse Event|7|||
126358272|NCT05660538|454603954|FG000|Overall Study|Lost to Follow-up|0|||
126029885|NCT03846505|453406724|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
126254223|NCT00057941|454221031|FG001|Overall Study|Adverse Event|9|||
126358273|NCT05660538|454603955|FG001|Overall Study|Lost to Follow-up|0|||
126029886|NCT03846505|453406725|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
126029887|NCT03792555|453406728|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
126254224|NCT00057941|454221030|FG000|Overall Study|Lack of Efficacy|54|||
126254225|NCT00057941|454221031|FG001|Overall Study|Lack of Efficacy|53|||
126254226|NCT00057941|454221030|FG000|Overall Study|Withdrawal by Subject|6|||
126254227|NCT00057941|454221031|FG001|Overall Study|Withdrawal by Subject|1|||
126254228|NCT00057941|454221030|FG000|Overall Study|still on treatment|3|||
126254229|NCT00057941|454221031|FG001|Overall Study|still on treatment|1|||
126254230|NCT00057941|454221030|FG000|Overall Study|insurance, symptomatic deterioration|1|||
126254231|NCT00057941|454221031|FG001|Overall Study|insurance, symptomatic deterioration|3|||
126358274|NCT05660538|454603956|FG002|Overall Study|Lost to Follow-up|1|||
126254232|NCT00057941|454221030|FG000|Overall Study|Ineligible|2|||
126254233|NCT00057941|454221031|FG001|Overall Study|Ineligible|5|||
126254234|NCT00609154|454221032|FG000|Overall Study|Protocol Violation|1|||
126254235|NCT00609154|454221033|FG001|Overall Study|Protocol Violation|2|||
126254236|NCT00609154|454221032|FG000|Overall Study|Unable to establish IV access|0|||
126254237|NCT00609154|454221033|FG001|Overall Study|Unable to establish IV access|4|||
126254238|NCT00609154|454221032|FG000|Overall Study|Adverse Event|0|||
126254239|NCT00609154|454221033|FG001|Overall Study|Adverse Event|2|||
126254240|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
126254241|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
126254242|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
126254243|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
126254244|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
126254245|NCT01898598|454221038|FG000|Overall Study|Adverse Event|1|||
126254246|NCT01898598|454221039|FG001|Overall Study|Adverse Event|0|||
126254247|NCT01898598|454221038|FG000|Overall Study|Withdrawal by Subject|3|||
126254248|NCT01898598|454221039|FG001|Overall Study|Withdrawal by Subject|0|||
126254249|NCT01898598|454221038|FG000|Overall Study|Lost to Follow-up|0|||
126254250|NCT01898598|454221039|FG001|Overall Study|Lost to Follow-up|1|||
126254251|NCT01898598|454221038|FG000|Overall Study|Other|0|||
126254252|NCT01898598|454221039|FG001|Overall Study|Other|1|||
126254253|NCT03833427|454221040|FG000|Overall Study|Death|4|||
126254254|NCT03833427|454221041|FG001|Overall Study|Death|2|||
126254255|NCT03833427|454221042|FG002|Overall Study|Death|9|||
126254256|NCT03833427|454221043|FG003|Overall Study|Death|11|||
126254257|NCT03833427|454221044|FG004|Overall Study|Death|0|||
126358275|NCT05660538|454603957|FG003|Overall Study|Lost to Follow-up|1|||
126254258|NCT03833427|454221045|FG005|Overall Study|Death|0|||
126254259|NCT03833427|454221046|FG006|Overall Study|Death|0|||
126254260|NCT03833427|454221040|FG000|Overall Study|Withdrawal by Subject|0|||
126254261|NCT03833427|454221041|FG001|Overall Study|Withdrawal by Subject|1|||
126254262|NCT03833427|454221042|FG002|Overall Study|Withdrawal by Subject|1|||
126254263|NCT03833427|454221043|FG003|Overall Study|Withdrawal by Subject|0|||
126254264|NCT03833427|454221044|FG004|Overall Study|Withdrawal by Subject|0|||
126254265|NCT03833427|454221045|FG005|Overall Study|Withdrawal by Subject|0|||
126254266|NCT03833427|454221046|FG006|Overall Study|Withdrawal by Subject|0|||
126029888|NCT03792555|453406729|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
126029889|NCT03792555|453406730|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
126029890|NCT03792555|453406728|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
126029891|NCT03792555|453406729|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
126029892|NCT03792555|453406730|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
126029893|NCT03792555|453406728|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
126029894|NCT03792555|453406729|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
126029895|NCT03792555|453406730|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
126029896|NCT01744782|453406737|FG000|Overall Study|Death|1|||
126029897|NCT02120456|453406739|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126029898|NCT02120456|453406740|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126029899|NCT02120456|453406741|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126029900|NCT02120456|453406742|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126029901|NCT02120456|453406743|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126029902|NCT02120456|453406744|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126029903|NCT02120456|453406745|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
126254267|NCT03833427|454221040|FG000|Overall Study|Sponsor Decision|0|||
126254268|NCT03833427|454221041|FG001|Overall Study|Sponsor Decision|0|||
126358276|NCT05660538|454603954|FG000|Overall Study|Death|0|||
126254269|NCT03833427|454221042|FG002|Overall Study|Sponsor Decision|1|||
126254270|NCT03833427|454221043|FG003|Overall Study|Sponsor Decision|3|||
126254271|NCT03833427|454221044|FG004|Overall Study|Sponsor Decision|0|||
126029904|NCT02120456|453406746|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126029905|NCT02120456|453406747|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126029906|NCT02120456|453406739|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126029907|NCT02120456|453406740|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126029908|NCT02120456|453406741|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126029909|NCT02120456|453406742|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126029910|NCT02120456|453406743|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126358277|NCT05660538|454603955|FG001|Overall Study|Death|0|||
126254272|NCT03833427|454221045|FG005|Overall Study|Sponsor Decision|0|||
126254273|NCT03833427|454221046|FG006|Overall Study|Sponsor Decision|0|||
126254274|NCT01499160|454221047|FG000|Overall Study|Adverse Event|1|||
126254275|NCT01499160|454221047|FG000|Overall Study|Withdrawal by Subject|1|||
126254276|NCT00860262|454221050|FG000|Overall Study|Adverse Event|9|||
126254277|NCT00860262|454221051|FG001|Overall Study|Adverse Event|6|||
126254278|NCT00860262|454221052|FG002|Overall Study|Adverse Event|7|||
126358278|NCT05660538|454603956|FG002|Overall Study|Death|1|||
126029911|NCT02120456|453406744|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126029912|NCT02120456|453406745|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
126029913|NCT02120456|453406746|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126029914|NCT02120456|453406747|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126029915|NCT02120456|453406739|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126254279|NCT00860262|454221050|FG000|Overall Study|Protocol Violation|0|||
126254280|NCT00860262|454221051|FG001|Overall Study|Protocol Violation|1|||
126029916|NCT02120456|453406740|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126029917|NCT02120456|453406741|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126029918|NCT02120456|453406742|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126029919|NCT02120456|453406743|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126029920|NCT02120456|453406744|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126029921|NCT02120456|453406745|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126029922|NCT02120456|453406746|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126029923|NCT02120456|453406747|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
126029924|NCT02243709|453406748|FG000|Phase 1|Lost to Follow-up|0|||
126029925|NCT02243709|453406749|FG001|Phase 1|Lost to Follow-up|1|||
126254281|NCT00860262|454221052|FG002|Overall Study|Protocol Violation|0|||
126254282|NCT00860262|454221050|FG000|Overall Study|Lost to Follow-up|2|||
126254283|NCT00860262|454221051|FG001|Overall Study|Lost to Follow-up|0|||
126254284|NCT00860262|454221052|FG002|Overall Study|Lost to Follow-up|1|||
126254285|NCT00860262|454221050|FG000|Overall Study|Withdrawal by Subject|4|||
126254286|NCT00860262|454221051|FG001|Overall Study|Withdrawal by Subject|8|||
126254287|NCT00860262|454221052|FG002|Overall Study|Withdrawal by Subject|6|||
126254288|NCT00860262|454221050|FG000|Overall Study|Lack of Efficacy|0|||
126254289|NCT00860262|454221051|FG001|Overall Study|Lack of Efficacy|4|||
126254290|NCT00860262|454221052|FG002|Overall Study|Lack of Efficacy|3|||
126254291|NCT00860262|454221050|FG000|Overall Study|Other|5|||
126254292|NCT00860262|454221051|FG001|Overall Study|Other|3|||
126254293|NCT00860262|454221052|FG002|Overall Study|Other|1|||
126254294|NCT00124618|454221053|FG000|Overall Study|Ineligible|1|||
126254295|NCT00593827|454221054|FG000|Overall Study|On Active Treatment/Pending|0|||
126254296|NCT00593827|454221055|FG001|Overall Study|On Active Treatment/Pending|2|||
126254297|NCT01596127|454221056|FG000|Overall Study|Patient Ineligible|1|||
126254298|NCT01675596|454221057|FG000|Overall Study|Death|6|||
126254299|NCT01675596|454221057|FG000|Overall Study|Exit with other reason|1|||
126254300|NCT01675596|454221057|FG000|Overall Study|Missed Visit|1|||
126254301|NCT00688844|454221059|FG000|Overall Study|Lost to Follow-up|10|||
126254302|NCT01374451|454221060|FG000|Overall Study|Administrative problems|1|||
126254303|NCT01374451|454221061|FG001|Overall Study|Administrative problems|0|||
126254304|NCT00663234|454221062|FG000|Overall Study|Not willing to adhere to requirements|1|||
126254305|NCT01709903|454221065|FG000|Overall Study|administrative problems|2|||
126095780|NCT02489968|453643143|FG003|Double-blind Treatment Period|Protocol Violation|0|||
126095781|NCT02489968|453643144|FG004|Double-blind Treatment Period|Protocol Violation|1|||
126095782|NCT02489968|453643145|FG005|Double-blind Treatment Period|Protocol Violation|1|||
126254306|NCT01709903|454221066|FG001|Overall Study|administrative problems|6|||
126254307|NCT01709903|454221065|FG000|Overall Study|Abnormal test procedure results|1|||
126254308|NCT01709903|454221066|FG001|Overall Study|Abnormal test procedure results|0|||
126029926|NCT02243709|453406748|FG000|Phase 1|Withdrawal by Subject|1|||
126029927|NCT02243709|453406749|FG001|Phase 1|Withdrawal by Subject|0|||
126029928|NCT02243709|453406748|FG000|Phase 1|Protocol Violation|0|||
126029929|NCT02243709|453406749|FG001|Phase 1|Protocol Violation|1|||
126095783|NCT02489968|453643140|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126095784|NCT02489968|453643141|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126254309|NCT01709903|454221065|FG000|Overall Study|In ability to use device|1|||
126254310|NCT01709903|454221066|FG001|Overall Study|In ability to use device|1|||
126254311|NCT01709903|454221065|FG000|Overall Study|no longer needed study drug|0|||
126254312|NCT01709903|454221066|FG001|Overall Study|no longer needed study drug|1|||
126254313|NCT01709903|454221065|FG000|Overall Study|Lost to Follow-up|0|||
126254314|NCT01709903|454221066|FG001|Overall Study|Lost to Follow-up|2|||
126254315|NCT01709903|454221065|FG000|Overall Study|Death|2|||
126254316|NCT01709903|454221066|FG001|Overall Study|Death|0|||
126254317|NCT01709903|454221065|FG000|Overall Study|Protocol Violation|3|||
126254318|NCT01709903|454221066|FG001|Overall Study|Protocol Violation|2|||
126254319|NCT01709903|454221065|FG000|Overall Study|Lack of Efficacy|3|||
126254320|NCT01709903|454221066|FG001|Overall Study|Lack of Efficacy|3|||
126254321|NCT01709903|454221065|FG000|Overall Study|Withdrawal by Subject|6|||
126029930|NCT02243709|453406748|FG000|Phase 1|Adverse Event|0|||
126029931|NCT02243709|453406749|FG001|Phase 1|Adverse Event|1|||
126254322|NCT01709903|454221066|FG001|Overall Study|Withdrawal by Subject|6|||
126254323|NCT01709903|454221065|FG000|Overall Study|Adverse Event|11|||
126254324|NCT01709903|454221066|FG001|Overall Study|Adverse Event|18|||
126254325|NCT02061280|454221067|FG000|Overall Study|Protocol Violation|12|||
126254326|NCT02061280|454221068|FG001|Overall Study|Protocol Violation|8|||
126254327|NCT02061280|454221067|FG000|Overall Study|moved out of state|0|||
126254328|NCT02061280|454221068|FG001|Overall Study|moved out of state|1|||
126254329|NCT02061280|454221067|FG000|Overall Study|Withdrawal by Subject|1|||
126029932|NCT03443323|453406752|FG000|Overall Study|Lost to Follow-up|2|||
126254330|NCT02061280|454221068|FG001|Overall Study|Withdrawal by Subject|2|||
126254331|NCT02061280|454221067|FG000|Overall Study|Lost to Follow-up|5|||
126254332|NCT02061280|454221068|FG001|Overall Study|Lost to Follow-up|1|||
126254333|NCT00724958|454221073|FG000|Overall Study|Adverse Event|28|||
126254334|NCT00724958|454221073|FG000|Overall Study|Loss of Response|40|||
126254335|NCT00724958|454221073|FG000|Overall Study|No Response|18|||
126254336|NCT00724958|454221073|FG000|Overall Study|Remission|7|||
126254337|NCT00724958|454221073|FG000|Overall Study|Other Reason|76|||
126254338|NCT00724958|454221073|FG000|Overall Study|No documentation for end of therapy|13|||
126254339|NCT02940522|454222713|FG000|Overall Study|Lost to Follow-up|1|||
126254340|NCT02940522|454222714|FG001|Overall Study|Lost to Follow-up|2|||
126254341|NCT02940522|454222713|FG000|Overall Study|Withdrawal by Subject|1|||
126254342|NCT02940522|454222714|FG001|Overall Study|Withdrawal by Subject|0|||
126254343|NCT02710214|454222715|FG000|Overall Study|Lost to Follow-up|1|||
126254344|NCT02710214|454222716|FG001|Overall Study|Lost to Follow-up|0|||
126254345|NCT02710214|454222715|FG000|Overall Study|Lack of Efficacy|0|||
126254346|NCT02710214|454222716|FG001|Overall Study|Lack of Efficacy|1|||
126254347|NCT02710214|454222715|FG000|Overall Study|Death|0|||
126254348|NCT02710214|454222716|FG001|Overall Study|Death|1|||
126254349|NCT01188226|454222720|FG000|Overall Study|Withdrawal by Subject|4|||
126254350|NCT02846883|454222721|FG000|Overall Study|Death|0|||
126254351|NCT02846883|454222722|FG001|Overall Study|Death|1|||
126254352|NCT02846883|454222723|FG002|Overall Study|Death|1|||
126254353|NCT02846883|454222721|FG000|Overall Study|Lost to Follow-up|0|||
126029933|NCT03443323|453406753|FG001|Overall Study|Lost to Follow-up|2|||
126029934|NCT03443323|453406752|FG000|Overall Study|PI withdrawal|1|||
126029935|NCT03443323|453406753|FG001|Overall Study|PI withdrawal|0|||
126029936|NCT04610892|453406754|FG000|Overall Study|Adverse Event|1|||
126254354|NCT02846883|454222722|FG001|Overall Study|Lost to Follow-up|0|||
126254355|NCT02846883|454222723|FG002|Overall Study|Lost to Follow-up|1|||
126254356|NCT02846883|454222721|FG000|Overall Study|Withdrawal by Subject|1|||
126254357|NCT02846883|454222722|FG001|Overall Study|Withdrawal by Subject|0|||
126254358|NCT02846883|454222723|FG002|Overall Study|Withdrawal by Subject|0|||
126254359|NCT02846883|454222721|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
126254360|NCT02846883|454222722|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
126254361|NCT02846883|454222723|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
126254362|NCT02846883|454222721|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
126254363|NCT02846883|454222722|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
126254364|NCT02846883|454222723|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
126254365|NCT00927251|454222724|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
126254366|NCT04768296|454222725|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
126254367|NCT04768296|454222726|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
126254368|NCT03087786|454222729|FG000|Overall Study|Withdrawal by Subject|2|||
126254369|NCT03087786|454222730|FG001|Overall Study|Withdrawal by Subject|0|||
126254370|NCT01453153|454222735|FG000|Overall Study|Physician Decision|0|||
126254371|NCT01453153|454222736|FG001|Overall Study|Physician Decision|0|||
126254372|NCT01453153|454222737|FG002|Overall Study|Physician Decision|1|||
126254373|NCT01453153|454222735|FG000|Overall Study|Progressive Disease|3|||
126254374|NCT01453153|454222736|FG001|Overall Study|Progressive Disease|2|||
126254375|NCT01453153|454222737|FG002|Overall Study|Progressive Disease|16|||
126254376|NCT01453153|454222735|FG000|Overall Study|Withdrawal by Subject|0|||
126254377|NCT01453153|454222736|FG001|Overall Study|Withdrawal by Subject|1|||
126254378|NCT01453153|454222737|FG002|Overall Study|Withdrawal by Subject|2|||
126254379|NCT01453153|454222735|FG000|Overall Study|Adverse Event|1|||
126254380|NCT01453153|454222736|FG001|Overall Study|Adverse Event|1|||
126254381|NCT01453153|454222737|FG002|Overall Study|Adverse Event|1|||
126254382|NCT01802216|454222742|FG000|4 Month Visit|Participant did not show to visit|3|||
126254383|NCT01802216|454222743|FG001|4 Month Visit|Participant did not show to visit|4|||
126254384|NCT01802216|454222742|FG000|8 Month Visit|Participant did not show to visit|3|||
126254385|NCT01802216|454222743|FG001|8 Month Visit|Participant did not show to visit|5|||
126254386|NCT01802216|454222742|FG000|12 Month Visit|Participant did not show to visit|3|||
126254387|NCT01802216|454222743|FG001|12 Month Visit|Participant did not show to visit|4|||
126254388|NCT00799708|454222744|FG000|Overall Study|non-compliance|1|||
126254389|NCT00799708|454222745|FG001|Overall Study|non-compliance|0|||
126254390|NCT00799708|454222746|FG002|Overall Study|non-compliance|0|||
126029937|NCT04610892|453406755|FG001|Overall Study|Adverse Event|0|||
126254391|NCT00880334|454222747|FG000|Randomized Phase|Physician Decision|1|||
126254392|NCT00880334|454222748|FG001|Randomized Phase|Physician Decision|0|||
126029938|NCT04610892|453406756|FG002|Overall Study|Adverse Event|0|||
126254393|NCT00880334|454222747|FG000|Randomized Phase|Withdrawal by Subject|2|||
126254394|NCT00880334|454222748|FG001|Randomized Phase|Withdrawal by Subject|1|||
126254395|NCT00880334|454222747|FG000|Randomized Phase|Inadequate Labs|1|||
126254396|NCT00880334|454222748|FG001|Randomized Phase|Inadequate Labs|1|||
126254397|NCT00880334|454222747|FG000|Randomized Phase|Brain Metastasis|0|||
126254398|NCT00880334|454222748|FG001|Randomized Phase|Brain Metastasis|1|||
126254399|NCT00880334|454222747|FG000|Randomized Phase|Crossover Participants|0|||
126254400|NCT00880334|454222748|FG001|Randomized Phase|Crossover Participants|37|||
126254401|NCT03343639|454222749|FG000|Overall Study|Withdrawal by Subject|10|||
126254402|NCT03343639|454222750|FG001|Overall Study|Withdrawal by Subject|6|||
126254403|NCT03343639|454222749|FG000|Overall Study|Lost to Follow-up|4|||
126254404|NCT03343639|454222750|FG001|Overall Study|Lost to Follow-up|5|||
126254405|NCT03343639|454222749|FG000|Overall Study|Protocol Violation|0|||
126254406|NCT03343639|454222750|FG001|Overall Study|Protocol Violation|1|||
126254407|NCT02274558|454222758|FG000|Overall Study|Adverse Event|2|||
126254408|NCT02274558|454222759|FG001|Overall Study|Adverse Event|4|||
126254409|NCT02274558|454222760|FG002|Overall Study|Adverse Event|2|||
126254410|NCT02274558|454222758|FG000|Overall Study|Non-compliance|2|||
126254411|NCT02274558|454222759|FG001|Overall Study|Non-compliance|1|||
126254412|NCT02274558|454222760|FG002|Overall Study|Non-compliance|0|||
126254413|NCT02274558|454222758|FG000|Overall Study|Withdrawal by Subject|1|||
126254414|NCT02274558|454222759|FG001|Overall Study|Withdrawal by Subject|5|||
126254415|NCT02274558|454222760|FG002|Overall Study|Withdrawal by Subject|4|||
126254416|NCT02274558|454222758|FG000|Overall Study|Death|0|||
126254417|NCT02274558|454222759|FG001|Overall Study|Death|0|||
126254418|NCT02274558|454222760|FG002|Overall Study|Death|1|||
126254419|NCT02274558|454222758|FG000|Overall Study|Lost to Follow-up|2|||
126254420|NCT02274558|454222759|FG001|Overall Study|Lost to Follow-up|1|||
126254421|NCT02274558|454222760|FG002|Overall Study|Lost to Follow-up|1|||
126254422|NCT02274558|454222758|FG000|Overall Study|Physician Decision|0|||
126254423|NCT02274558|454222759|FG001|Overall Study|Physician Decision|2|||
126254424|NCT02274558|454222760|FG002|Overall Study|Physician Decision|1|||
126254425|NCT02655224|454222761|FG000|Overall Study|Adverse Event|1|||
126254426|NCT02655224|454222762|FG001|Overall Study|Adverse Event|1|||
126254427|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
126254428|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
126254429|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
126254430|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
126254431|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
126254432|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
126254433|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
126254434|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
126254435|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
126254436|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
126254437|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
126254438|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
126254439|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
126254440|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
126254441|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
126254442|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
126254443|NCT04592419|454222765|FG000|Open-Label Extension Period|Adverse Event|1|||
126254444|NCT04592419|454222766|FG001|Open-Label Extension Period|Adverse Event|2|||
126254445|NCT04592419|454222765|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
126254446|NCT04592419|454222766|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
126254447|NCT04592419|454222765|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
126254448|NCT04592419|454222766|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
126254449|NCT04592419|454222765|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
126254450|NCT04592419|454222766|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
126254451|NCT04592419|454222765|FG000|Open-Label Extension Period|Sponsor Request|73|||
126254452|NCT04592419|454222766|FG001|Open-Label Extension Period|Sponsor Request|84|||
126254453|NCT02419573|454222772|FG000|Overall Study|Lost to Follow-up|3|||
126254454|NCT02419573|454222773|FG001|Overall Study|Lost to Follow-up|0|||
126254455|NCT02419573|454222772|FG000|Overall Study|Withdrawal by Subject|1|||
126254456|NCT02419573|454222773|FG001|Overall Study|Withdrawal by Subject|0|||
126254457|NCT05393271|454222774|FG000|Overall Study|Physician Decision|0|||
126254458|NCT05393271|454222775|FG001|Overall Study|Physician Decision|0|||
126254459|NCT05393271|454222776|FG002|Overall Study|Physician Decision|0|||
126254460|NCT05393271|454222777|FG003|Overall Study|Physician Decision|0|||
126254461|NCT05393271|454222778|FG004|Overall Study|Physician Decision|0|||
126254462|NCT05393271|454222779|FG005|Overall Study|Physician Decision|0|||
126254463|NCT05393271|454222780|FG006|Overall Study|Physician Decision|1|||
126254464|NCT05393271|454222781|FG007|Overall Study|Physician Decision|0|||
126254465|NCT05393271|454222782|FG008|Overall Study|Physician Decision|0|||
126095785|NCT02489968|453643142|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126254466|NCT05393271|454222783|FG009|Overall Study|Physician Decision|0|||
126254467|NCT05393271|454222784|FG010|Overall Study|Physician Decision|0|||
126095786|NCT02489968|453643143|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
126254468|NCT02483416|454222785|FG000|Overall Study|Other reason|0|||
126254469|NCT02483416|454222786|FG001|Overall Study|Other reason|1|||
126095787|NCT02489968|453643144|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
126254470|NCT02483416|454222785|FG000|Overall Study|Treatment stop|3|||
126254471|NCT02483416|454222786|FG001|Overall Study|Treatment stop|0|||
126254472|NCT04968925|454222787|FG000|Phase I- Period 1|COVID-19 related|0|||
126254473|NCT04968925|454222788|FG001|Phase I- Period 1|COVID-19 related|1|||
126254474|NCT04968925|454222789|FG002|Phase I- Period 1|COVID-19 related|0|||
126254475|NCT04968925|454222790|FG003|Phase I- Period 1|COVID-19 related|0|||
126254476|NCT04968925|454222787|FG000|Phase I- Period 1|Subject enrolled in error|1|||
126254477|NCT04968925|454222788|FG001|Phase I- Period 1|Subject enrolled in error|1|||
126254478|NCT04968925|454222789|FG002|Phase I- Period 1|Subject enrolled in error|0|||
126254479|NCT04968925|454222790|FG003|Phase I- Period 1|Subject enrolled in error|0|||
126254480|NCT04968925|454222787|FG000|Phase II- Period 1|COVID-19 Related|0|||
126254481|NCT04968925|454222788|FG001|Phase II- Period 1|COVID-19 Related|0|||
126254482|NCT04968925|454222789|FG002|Phase II- Period 1|COVID-19 Related|6|||
126254483|NCT04968925|454222790|FG003|Phase II- Period 1|COVID-19 Related|6|||
126254484|NCT04968925|454222787|FG000|Phase II- Period 1|Subject enrolled in error|0|||
126254485|NCT04968925|454222788|FG001|Phase II- Period 1|Subject enrolled in error|0|||
126254486|NCT04968925|454222789|FG002|Phase II- Period 1|Subject enrolled in error|1|||
126254487|NCT04968925|454222790|FG003|Phase II- Period 1|Subject enrolled in error|0|||
126254488|NCT04968925|454222787|FG000|Phase II -Period 2|COVID-19 related|0|||
126254489|NCT04968925|454222788|FG001|Phase II -Period 2|COVID-19 related|0|||
126254490|NCT04968925|454222789|FG002|Phase II -Period 2|COVID-19 related|4|||
126254491|NCT04968925|454222790|FG003|Phase II -Period 2|COVID-19 related|3|||
126254492|NCT04968925|454222787|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
126254493|NCT04968925|454222788|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
126254494|NCT04968925|454222789|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
126254495|NCT04968925|454222790|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
126254496|NCT00876265|454222795|FG000|Overall Study|Miscellaneous reasons|4|||
126254497|NCT00876265|454222795|FG000|Overall Study|Lost to Follow-up|6|||
126254498|NCT00876265|454222795|FG000|Overall Study|Withdrawal by Subject|2|||
126254499|NCT01408888|454222796|FG000|First Intervention|Adverse Event|0|||
126254500|NCT01408888|454222797|FG001|First Intervention|Adverse Event|1|||
126254501|NCT01408888|454222796|FG000|First Intervention|Withdrawal by Subject|0|||
126254502|NCT01408888|454222797|FG001|First Intervention|Withdrawal by Subject|2|||
126254503|NCT01408888|454222796|FG000|Second Intervention|Withdrawal by Subject|1|||
126254504|NCT01408888|454222797|FG001|Second Intervention|Withdrawal by Subject|0|||
126254505|NCT01408888|454222796|FG000|Second Intervention|Adverse Event|1|||
126254506|NCT01408888|454222797|FG001|Second Intervention|Adverse Event|0|||
126254507|NCT00695110|454222798|FG000|Treatment Period 1|Adverse Event|1|||
126254508|NCT00695110|454222798|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126254509|NCT00695110|454222798|FG000|Treatment Period 3|Withdrawal by Subject|1|||
126254510|NCT00695110|454222798|FG000|Treatment Period 4|Adverse Event|1|||
126254511|NCT00487695|454222801|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
126254512|NCT00487695|454222802|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
126254513|NCT00487695|454222801|FG000|First Procedure|active wheezing (did not have procedure)|1|||
126254514|NCT00487695|454222802|FG001|First Procedure|active wheezing (did not have procedure)|0|||
126254515|NCT00487695|454222801|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
126254516|NCT00487695|454222802|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
126254517|NCT00487695|454222801|FG000|Second Procedure|active wheezing|0|||
126254518|NCT00487695|454222802|FG001|Second Procedure|active wheezing|1|||
126254519|NCT00487695|454222801|FG000|Second Procedure|Withdrawal by Subject|1|||
126254520|NCT00487695|454222802|FG001|Second Procedure|Withdrawal by Subject|2|||
126254521|NCT04542694|454222803|FG000|Overall Study|The need for prohibited therapy|2|||
126254522|NCT04542694|454222804|FG001|Overall Study|The need for prohibited therapy|0|||
126254523|NCT04542694|454222803|FG000|Overall Study|Adverse Event|1|||
126254524|NCT04542694|454222804|FG001|Overall Study|Adverse Event|0|||
126254525|NCT04542694|454222803|FG000|Overall Study|Protocol Violation|1|||
126254526|NCT04542694|454222804|FG001|Overall Study|Protocol Violation|0|||
126254527|NCT02167594|454222805|FG000|Overall Study|Withdrawal by Subject|2|||
126254528|NCT02167594|454222806|FG001|Overall Study|Withdrawal by Subject|0|||
126254529|NCT02167594|454222807|FG002|Overall Study|Withdrawal by Subject|0|||
126254530|NCT02167594|454222805|FG000|Overall Study|Death|0|||
126254531|NCT02167594|454222806|FG001|Overall Study|Death|1|||
126254532|NCT02167594|454222807|FG002|Overall Study|Death|0|||
126254533|NCT03433703|454222808|FG000|Overall Study|Study terminated by Sponsor|2|||
126254534|NCT01957150|454222809|FG000|Overall Study|Adverse Event|23|||
126254535|NCT01957150|454222810|FG001|Overall Study|Adverse Event|20|||
126254536|NCT01957150|454222809|FG000|Overall Study|Withdrawal by Subject|13|||
125879793|NCT03104868|452857381|FG000|24 Month Follow up|Withdrawal by Subject|1|||
125879794|NCT03104868|452857382|FG001|24 Month Follow up|Withdrawal by Subject|0|||
125879795|NCT03104868|452857381|FG000|24 Month Follow up|Graft Loss|2|||
126254537|NCT01957150|454222810|FG001|Overall Study|Withdrawal by Subject|17|||
126254538|NCT01957150|454222809|FG000|Overall Study|Physician Decision|3|||
126254539|NCT01957150|454222810|FG001|Overall Study|Physician Decision|6|||
126254540|NCT01957150|454222809|FG000|Overall Study|Lost to Follow-up|4|||
126254541|NCT01957150|454222810|FG001|Overall Study|Lost to Follow-up|4|||
126254542|NCT01957150|454222809|FG000|Overall Study|Protocol Violation|1|||
126254543|NCT01957150|454222810|FG001|Overall Study|Protocol Violation|0|||
126254544|NCT01957150|454222809|FG000|Overall Study|Lack of Efficacy|11|||
126254545|NCT01957150|454222810|FG001|Overall Study|Lack of Efficacy|11|||
126254546|NCT02786953|454222815|FG000|Overall Study|Withdrawal by Subject|3|||
126254547|NCT02786953|454222816|FG001|Overall Study|Withdrawal by Subject|0|||
126254548|NCT02786953|454222815|FG000|Overall Study|Physician Decision|0|||
126254549|NCT02786953|454222816|FG001|Overall Study|Physician Decision|1|||
126254550|NCT01745094|454222819|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
126254551|NCT01745094|454222820|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
126254552|NCT01745094|454222821|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
126254553|NCT01745094|454222822|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
126254554|NCT01745094|454222819|FG000|Overall Study|Adverse Event|0|||
126254555|NCT01745094|454222820|FG001|Overall Study|Adverse Event|0|||
126254556|NCT01745094|454222821|FG002|Overall Study|Adverse Event|3|||
126254557|NCT01745094|454222822|FG003|Overall Study|Adverse Event|0|||
126254558|NCT01745094|454222819|FG000|Overall Study|Withdrawal by Subject|2|||
126254559|NCT01745094|454222820|FG001|Overall Study|Withdrawal by Subject|0|||
126254560|NCT01745094|454222821|FG002|Overall Study|Withdrawal by Subject|1|||
126254561|NCT01745094|454222822|FG003|Overall Study|Withdrawal by Subject|2|||
126254562|NCT01745094|454222819|FG000|Overall Study|Protocol Violation|1|||
126254563|NCT01745094|454222820|FG001|Overall Study|Protocol Violation|0|||
126254564|NCT01745094|454222821|FG002|Overall Study|Protocol Violation|3|||
126254565|NCT01745094|454222822|FG003|Overall Study|Protocol Violation|1|||
126254566|NCT01745094|454222819|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
126254567|NCT01745094|454222820|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
126254568|NCT01745094|454222821|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
126254569|NCT01745094|454222822|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
126254570|NCT01745094|454222819|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
126254571|NCT01745094|454222820|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
126254572|NCT01745094|454222821|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
126254573|NCT01745094|454222822|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
126254574|NCT01745094|454222819|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
126254575|NCT01745094|454222820|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
126254576|NCT01745094|454222821|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
126254577|NCT01745094|454222822|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
126254578|NCT03414034|454222823|FG000|Overall Study|Adverse Event|6|||
126254579|NCT03414034|454222824|FG001|Overall Study|Adverse Event|1|||
126254580|NCT03414034|454222825|FG002|Overall Study|Adverse Event|1|||
126254581|NCT03414034|454222823|FG000|Overall Study|Death|0|||
126254582|NCT03414034|454222824|FG001|Overall Study|Death|0|||
126254583|NCT03414034|454222825|FG002|Overall Study|Death|1|||
126254584|NCT03414034|454222823|FG000|Overall Study|Non-compliance With Study Drug|0|||
126254585|NCT03414034|454222824|FG001|Overall Study|Non-compliance With Study Drug|0|||
126254586|NCT03414034|454222825|FG002|Overall Study|Non-compliance With Study Drug|1|||
126254587|NCT03414034|454222823|FG000|Overall Study|Physician Decision|1|||
126254588|NCT03414034|454222824|FG001|Overall Study|Physician Decision|3|||
126029939|NCT04610892|453406757|FG003|Overall Study|Adverse Event|1|||
126029940|NCT04610892|453406758|FG004|Overall Study|Adverse Event|3|||
126254589|NCT03414034|454222825|FG002|Overall Study|Physician Decision|2|||
126254590|NCT03414034|454222823|FG000|Overall Study|Withdrawal of Informed Consent|2|||
126254591|NCT03414034|454222824|FG001|Overall Study|Withdrawal of Informed Consent|1|||
126254592|NCT03414034|454222825|FG002|Overall Study|Withdrawal of Informed Consent|4|||
126254593|NCT03414034|454222823|FG000|Overall Study|Progressive Disease|15|||
126254594|NCT03414034|454222824|FG001|Overall Study|Progressive Disease|15|||
126254595|NCT03414034|454222825|FG002|Overall Study|Progressive Disease|17|||
126254596|NCT03414034|454222823|FG000|Overall Study|Miscellaneous|0|||
126254597|NCT03414034|454222824|FG001|Overall Study|Miscellaneous|0|||
126029941|NCT04610892|453406754|FG000|Overall Study|Death|0|||
126254598|NCT03414034|454222825|FG002|Overall Study|Miscellaneous|2|||
126254599|NCT04010227|454222827|FG000|Overall Study|Death|1|||
126254600|NCT04010227|454222828|FG001|Overall Study|Death|2|||
126254601|NCT04010227|454222827|FG000|Overall Study|Medical Reasons|4|||
126254602|NCT04010227|454222828|FG001|Overall Study|Medical Reasons|3|||
126254603|NCT04010227|454222827|FG000|Overall Study|Withdrawal by Subject|2|||
126254604|NCT04010227|454222828|FG001|Overall Study|Withdrawal by Subject|0|||
126254605|NCT04010227|454222827|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
126254606|NCT04010227|454222828|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
126254607|NCT00640926|454222829|FG000|Overall Study|Adverse Event|2|||
126254608|NCT00640926|454222830|FG001|Overall Study|Adverse Event|3|||
126254609|NCT00640926|454222831|FG002|Overall Study|Adverse Event|2|||
126254610|NCT00640926|454222829|FG000|Overall Study|Lack of Efficacy|0|||
126254611|NCT00640926|454222830|FG001|Overall Study|Lack of Efficacy|2|||
126254612|NCT00640926|454222831|FG002|Overall Study|Lack of Efficacy|1|||
126029942|NCT04610892|453406755|FG001|Overall Study|Death|1|||
126029943|NCT04610892|453406756|FG002|Overall Study|Death|0|||
126029944|NCT04610892|453406757|FG003|Overall Study|Death|1|||
126029945|NCT04610892|453406758|FG004|Overall Study|Death|0|||
126029946|NCT04610892|453406754|FG000|Overall Study|Withdrawal by Subject|3|||
126029947|NCT04610892|453406755|FG001|Overall Study|Withdrawal by Subject|2|||
126358279|NCT05660538|454603957|FG003|Overall Study|Death|0|||
126358280|NCT05660538|454603954|FG000|Overall Study|Physician Decision|0|||
126358281|NCT05660538|454603955|FG001|Overall Study|Physician Decision|0|||
126358282|NCT05660538|454603956|FG002|Overall Study|Physician Decision|0|||
126358283|NCT05660538|454603957|FG003|Overall Study|Physician Decision|1|||
126358284|NCT05660538|454603954|FG000|Overall Study|Sponsor Decision|1|||
126358285|NCT05660538|454603955|FG001|Overall Study|Sponsor Decision|0|||
126358286|NCT05660538|454603956|FG002|Overall Study|Sponsor Decision|0|||
126358287|NCT05660538|454603957|FG003|Overall Study|Sponsor Decision|0|||
126358288|NCT05660538|454603954|FG000|Overall Study|Other|1|||
126358289|NCT05660538|454603955|FG001|Overall Study|Other|0|||
126358290|NCT05660538|454603956|FG002|Overall Study|Other|0|||
126254613|NCT00640926|454222829|FG000|Overall Study|Protocol Violation|2|||
126254614|NCT00640926|454222830|FG001|Overall Study|Protocol Violation|0|||
126254615|NCT00640926|454222831|FG002|Overall Study|Protocol Violation|2|||
126254616|NCT00640926|454222829|FG000|Overall Study|Lost to Follow-up|3|||
126254617|NCT00640926|454222830|FG001|Overall Study|Lost to Follow-up|1|||
126254618|NCT00640926|454222831|FG002|Overall Study|Lost to Follow-up|2|||
126358291|NCT05660538|454603957|FG003|Overall Study|Other|1|||
126358292|NCT05660538|454603954|FG000|Overall Study|Randomized but did not receive study drug|1|||
126358293|NCT05660538|454603955|FG001|Overall Study|Randomized but did not receive study drug|0|||
126358294|NCT05660538|454603956|FG002|Overall Study|Randomized but did not receive study drug|0|||
126358295|NCT05660538|454603957|FG003|Overall Study|Randomized but did not receive study drug|1|||
126029948|NCT04610892|453406756|FG002|Overall Study|Withdrawal by Subject|0|||
126029949|NCT04610892|453406757|FG003|Overall Study|Withdrawal by Subject|6|||
126029950|NCT04610892|453406758|FG004|Overall Study|Withdrawal by Subject|6|||
126029951|NCT04610892|453406754|FG000|Overall Study|Subjects who did not receive treatment|1|||
126029952|NCT04610892|453406755|FG001|Overall Study|Subjects who did not receive treatment|0|||
126029953|NCT04610892|453406756|FG002|Overall Study|Subjects who did not receive treatment|0|||
126029954|NCT04610892|453406757|FG003|Overall Study|Subjects who did not receive treatment|0|||
126254619|NCT00640926|454222829|FG000|Overall Study|Withdrawal by Subject|1|||
126358296|NCT05660538|454603954|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
126029955|NCT04610892|453406758|FG004|Overall Study|Subjects who did not receive treatment|2|||
126358297|NCT05660538|454603955|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
126358298|NCT05660538|454603956|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
126254620|NCT00640926|454222830|FG001|Overall Study|Withdrawal by Subject|0|||
126254621|NCT00640926|454222831|FG002|Overall Study|Withdrawal by Subject|1|||
126254622|NCT03922750|454222832|FG000|Overall Study|Unclassified|0|||
126254623|NCT03922750|454222833|FG001|Overall Study|Unclassified|0|||
126029956|NCT05520190|453406759|FG000|Overall Study|Lost to Follow-up|7|||
126029957|NCT05520190|453406759|FG000|Overall Study|Withdrawal by Subject|2|||
126029958|NCT03683719|453406760|FG000|Overall Study|Lack of Efficacy|1|||
126029959|NCT03683719|453406761|FG001|Overall Study|Lack of Efficacy|3|||
126029960|NCT03683719|453406762|FG002|Overall Study|Lack of Efficacy|4|||
126029961|NCT03683719|453406763|FG003|Overall Study|Lack of Efficacy|0|||
126029962|NCT03683719|453406764|FG004|Overall Study|Lack of Efficacy|4|||
126029963|NCT03683719|453406760|FG000|Overall Study|Adverse Event|6|||
126095788|NCT02489968|453643145|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
126254624|NCT03922750|454222834|FG002|Overall Study|Unclassified|1|||
126254625|NCT03922750|454222832|FG000|Overall Study|Adverse Event|0|||
126254626|NCT03922750|454222833|FG001|Overall Study|Adverse Event|1|||
126254627|NCT03922750|454222834|FG002|Overall Study|Adverse Event|0|||
126254628|NCT02985398|454222835|FG000|Overall Study|Adverse Event|1|||
126254629|NCT02985398|454222835|FG000|Overall Study|Lost to Follow-up|4|||
126254630|NCT02985398|454222835|FG000|Overall Study|Withdrawal by Subject|8|||
126254631|NCT02985398|454222835|FG000|Overall Study|Study Burden|9|||
126254632|NCT01841073|454222836|FG000|Overall Study|Adverse Event|1|||
126095789|NCT02489968|453643140|FG000|Double-blind Treatment Period|Other than specified above|0|||
126254633|NCT01841073|454222837|FG001|Overall Study|Adverse Event|1|||
126095790|NCT02489968|453643141|FG001|Double-blind Treatment Period|Other than specified above|0|||
126358299|NCT05660538|454603957|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
126254634|NCT01841073|454222836|FG000|Overall Study|Physician Decision|1|||
126254635|NCT01841073|454222837|FG001|Overall Study|Physician Decision|0|||
126029964|NCT03683719|453406761|FG001|Overall Study|Adverse Event|6|||
126029965|NCT03683719|453406762|FG002|Overall Study|Adverse Event|0|||
126029966|NCT03683719|453406763|FG003|Overall Study|Adverse Event|1|||
126254636|NCT01841073|454222836|FG000|Overall Study|Lost to Follow-up|0|||
126254637|NCT01841073|454222837|FG001|Overall Study|Lost to Follow-up|2|||
126254638|NCT04164758|454222842|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
126254639|NCT04164758|454222843|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
126254640|NCT04164758|454222844|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
126254641|NCT04164758|454222842|FG000|Overall Study|Adverse Event|0|||
126254642|NCT04164758|454222843|FG001|Overall Study|Adverse Event|1|||
126254643|NCT04164758|454222844|FG002|Overall Study|Adverse Event|0|||
126254644|NCT02858037|454222845|FG000|Overall Study|Death|1|||
126254645|NCT02858037|454222845|FG000|Overall Study|Withdrawal by Subject|18|||
126254646|NCT02858037|454222845|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
126254647|NCT02858037|454222845|FG000|Overall Study|Lost to Follow-up|3|||
126254648|NCT02858037|454222845|FG000|Overall Study|Other|4|||
126254649|NCT01670097|454222848|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
126254650|NCT01670097|454222849|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
126254651|NCT01670097|454222848|FG000|Overall Study|Study burden|1|||
126254652|NCT01670097|454222849|FG001|Overall Study|Study burden|0|||
126254653|NCT01670097|454222848|FG000|Overall Study|COPD exacerbation|0|||
126254654|NCT01670097|454222849|FG001|Overall Study|COPD exacerbation|1|||
126254655|NCT01670097|454222848|FG000|Overall Study|Neutropenia|0|||
126254656|NCT01670097|454222849|FG001|Overall Study|Neutropenia|1|||
126254657|NCT01670097|454222848|FG000|Overall Study|Clinical deterioration|0|||
126254658|NCT01670097|454222849|FG001|Overall Study|Clinical deterioration|1|||
126254659|NCT01670097|454222848|FG000|Overall Study|Disease progression|0|||
126254660|NCT01670097|454222849|FG001|Overall Study|Disease progression|1|||
126254661|NCT00697827|454222850|FG000|Overall Study|enrolled but not treated|2|||
126254662|NCT00697827|454222851|FG001|Overall Study|enrolled but not treated|1|||
126254663|NCT03732833|454222852|FG000|Overall Study|Adverse Event|0|||
126254664|NCT03732833|454222853|FG001|Overall Study|Adverse Event|3|||
126254665|NCT03732833|454222854|FG002|Overall Study|Adverse Event|1|||
126254666|NCT03732833|454222852|FG000|Overall Study|Withdrawal by Subject|11|||
126254667|NCT03732833|454222853|FG001|Overall Study|Withdrawal by Subject|13|||
126254668|NCT03732833|454222854|FG002|Overall Study|Withdrawal by Subject|8|||
126254669|NCT03732833|454222852|FG000|Overall Study|Lost to Follow-up|3|||
126254670|NCT03732833|454222853|FG001|Overall Study|Lost to Follow-up|5|||
126254671|NCT03732833|454222854|FG002|Overall Study|Lost to Follow-up|4|||
126254672|NCT03732833|454222852|FG000|Overall Study|Pregnancy|0|||
126254673|NCT03732833|454222853|FG001|Overall Study|Pregnancy|2|||
126254674|NCT03732833|454222854|FG002|Overall Study|Pregnancy|0|||
126254675|NCT03732833|454222852|FG000|Overall Study|Physician Decision|2|||
126254676|NCT03732833|454222853|FG001|Overall Study|Physician Decision|3|||
126254677|NCT03732833|454222854|FG002|Overall Study|Physician Decision|1|||
126254678|NCT03732833|454222852|FG000|Overall Study|Covid-19 related and other reasons|2|||
126254679|NCT03732833|454222853|FG001|Overall Study|Covid-19 related and other reasons|7|||
126254680|NCT03732833|454222854|FG002|Overall Study|Covid-19 related and other reasons|3|||
126254681|NCT02311894|454222856|FG000|Overall Study|Discontinued in error|1|||
126254682|NCT02311894|454222856|FG000|Overall Study|Lost to Follow-up|1|||
126254683|NCT02311894|454222856|FG000|Overall Study|Adverse Event|1|||
126254684|NCT02311894|454222856|FG000|Overall Study|Withdrawal by Subject|1|||
126254685|NCT00702507|454222859|FG000|Initial Treatment Phase|Adverse Event|2|||
126254686|NCT00702507|454222859|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
126254687|NCT00702507|454222859|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
126254688|NCT00702507|454222859|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
126254689|NCT00702507|454222859|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
126254690|NCT00702507|454222859|FG000|Follow-up Phase|Protocol Violation|2|||
126254691|NCT00702507|454222859|FG000|Follow-up Phase|Lost to Follow-up|23|||
126254692|NCT00702507|454222859|FG000|Follow-up Phase|Late Enrollment|1|||
126254693|NCT00160524|454222860|FG000|Overall Study|Adverse Event|119|||
126254694|NCT00160524|454222860|FG000|Overall Study|Adverse Event and Other|94|||
126254695|NCT00160524|454222860|FG000|Overall Study|Protocol Violation|16|||
126254696|NCT00160524|454222860|FG000|Overall Study|Protocol Violation and Other|2|||
126254697|NCT00160524|454222860|FG000|Overall Study|Withdrawal by Subject|141|||
126254698|NCT00160524|454222860|FG000|Overall Study|Withdrawal by Subject and Other|17|||
125879796|NCT03104868|452857382|FG001|24 Month Follow up|Graft Loss|0|||
126029967|NCT03683719|453406764|FG004|Overall Study|Adverse Event|3|||
126029968|NCT03683719|453406760|FG000|Overall Study|Withdrawal by Subject|4|||
126029969|NCT03683719|453406761|FG001|Overall Study|Withdrawal by Subject|4|||
126029970|NCT03683719|453406762|FG002|Overall Study|Withdrawal by Subject|3|||
126029971|NCT03683719|453406763|FG003|Overall Study|Withdrawal by Subject|5|||
126254699|NCT00160524|454222860|FG000|Overall Study|Physician Decision|27|||
126254700|NCT00160524|454222860|FG000|Overall Study|Physician Decision and Other|6|||
126254701|NCT00160524|454222860|FG000|Overall Study|Lost to Follow-up|13|||
126254702|NCT00160524|454222860|FG000|Overall Study|Lost to Follow-up and Other|1|||
126254703|NCT00160524|454222860|FG000|Overall Study|Lack of Efficacy|21|||
126254704|NCT00160524|454222860|FG000|Overall Study|Lack of Efficacy and Other|1|||
126254705|NCT00160524|454222860|FG000|Overall Study|Other|20|||
126254706|NCT02661022|454222861|FG000|Overall Study|Withdrawal by Subject|3|||
126254707|NCT02661022|454222862|FG001|Overall Study|Withdrawal by Subject|0|||
126254708|NCT02661022|454222861|FG000|Overall Study|Adverse Event|1|||
126254709|NCT02661022|454222862|FG001|Overall Study|Adverse Event|1|||
126254710|NCT02661022|454222861|FG000|Overall Study|Physician Decision|1|||
126254711|NCT02661022|454222862|FG001|Overall Study|Physician Decision|0|||
126254712|NCT02661022|454222861|FG000|Overall Study|Progressive Disease|2|||
126254713|NCT02661022|454222862|FG001|Overall Study|Progressive Disease|1|||
126254714|NCT02387762|454222866|FG000|Overall Study|Withdrawal by Subject|1|||
126254715|NCT02387762|454222867|FG001|Overall Study|Withdrawal by Subject|0|||
126254716|NCT04553406|454222871|FG000|Overall Study|Study Discontinuation|0|||
126254717|NCT04553406|454222872|FG001|Overall Study|Study Discontinuation|1|||
126254718|NCT00772148|454222873|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
126254719|NCT00772148|454222874|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
126254720|NCT00772148|454222873|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
126254721|NCT00772148|454222874|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
126254722|NCT00772148|454222873|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
126254723|NCT00772148|454222874|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
126254724|NCT00772148|454222873|FG000|Maintenance Phase (Week 52)|Death|2|||
126254725|NCT00772148|454222874|FG001|Maintenance Phase (Week 52)|Death|2|||
126254726|NCT00772148|454222873|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
126254727|NCT00772148|454222874|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
126254728|NCT00772148|454222873|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
126254729|NCT00772148|454222874|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
126254730|NCT00772148|454222873|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
126254731|NCT00772148|454222874|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
126254732|NCT00633022|454222877|FG000|Overall Study|Adverse Event|1|||
126254733|NCT00633022|454222878|FG001|Overall Study|Adverse Event|0|||
126254734|NCT00633022|454222879|FG002|Overall Study|Adverse Event|5|||
126254735|NCT00633022|454222877|FG000|Overall Study|Physician Decision|0|||
126254736|NCT00633022|454222878|FG001|Overall Study|Physician Decision|1|||
126254737|NCT00633022|454222879|FG002|Overall Study|Physician Decision|0|||
126254738|NCT03573336|454222880|FG000|Overall Study|Study terminated|2|||
126254739|NCT03573336|454222881|FG001|Overall Study|Study terminated|4|||
126254740|NCT03573336|454222882|FG002|Overall Study|Study terminated|2|||
126254741|NCT04388787|454222883|FG000|Blinded Period|Patient could not follow instructions|1|||
126254742|NCT04388787|454222883|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
126254743|NCT01705717|454224401|FG000|Overall Study|Adverse Event|2|||
126254744|NCT01705717|454224402|FG001|Overall Study|Adverse Event|2|||
126254745|NCT01705717|454224401|FG000|Overall Study|Lack of Efficacy|0|||
126254746|NCT01705717|454224402|FG001|Overall Study|Lack of Efficacy|1|||
126254747|NCT01705717|454224401|FG000|Overall Study|Other|0|||
126254748|NCT01705717|454224402|FG001|Overall Study|Other|2|||
126254749|NCT01662024|454224405|FG000|Overall Study|Pregnancy|2|||
126254750|NCT01662024|454224405|FG000|Overall Study|Withdrawal by Subject|3|||
126254751|NCT04980456|454224406|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
126254752|NCT04980456|454224407|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
126254753|NCT04980456|454224406|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
126254754|NCT04980456|454224407|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
126254755|NCT04980456|454224406|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
126254756|NCT04980456|454224407|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
126254757|NCT04980456|454224406|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
126254758|NCT04980456|454224407|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
126254759|NCT04832971|454224408|FG000|Overall Study|Death|1|||
126254760|NCT04832971|454224409|FG001|Overall Study|Death|0|||
126254761|NCT04832971|454224410|FG002|Overall Study|Death|0|||
126254762|NCT04832971|454224411|FG003|Overall Study|Death|0|||
126358300|NCT03462563|454603958|FG000|Overall Study|Death|1|||
126358301|NCT03462563|454603959|FG001|Overall Study|Death|1|||
126358302|NCT03462563|454603958|FG000|Overall Study|Termination of study|2|||
125879797|NCT03050801|452857385|FG000|Experiment 1|Lost to Follow-up|0|||
125879798|NCT03050801|452857386|FG001|Experiment 1|Lost to Follow-up|1|||
126029972|NCT03683719|453406764|FG004|Overall Study|Withdrawal by Subject|5|||
126029973|NCT03683719|453406760|FG000|Overall Study|Lost to Follow-up|1|||
126029974|NCT03683719|453406761|FG001|Overall Study|Lost to Follow-up|0|||
126254763|NCT04832971|454224408|FG000|Overall Study|Lost to Follow-up|1|||
126254764|NCT04832971|454224409|FG001|Overall Study|Lost to Follow-up|1|||
126254765|NCT04832971|454224410|FG002|Overall Study|Lost to Follow-up|1|||
126254766|NCT04832971|454224411|FG003|Overall Study|Lost to Follow-up|0|||
126254767|NCT04832971|454224408|FG000|Overall Study|Withdrawal by Subject|1|||
126254768|NCT04832971|454224409|FG001|Overall Study|Withdrawal by Subject|3|||
126254769|NCT04832971|454224410|FG002|Overall Study|Withdrawal by Subject|2|||
126254770|NCT04832971|454224411|FG003|Overall Study|Withdrawal by Subject|2|||
126254771|NCT04832971|454224408|FG000|Overall Study|Other, Not Specified|0|||
126254772|NCT04832971|454224409|FG001|Overall Study|Other, Not Specified|0|||
126254773|NCT04832971|454224410|FG002|Overall Study|Other, Not Specified|1|||
126254774|NCT04832971|454224411|FG003|Overall Study|Other, Not Specified|0|||
126358303|NCT03462563|454603959|FG001|Overall Study|Termination of study|1|||
126358304|NCT03462563|454603958|FG000|Overall Study|Adverse Event|1|||
126095791|NCT02489968|453643142|FG002|Double-blind Treatment Period|Other than specified above|0|||
126095792|NCT02489968|453643143|FG003|Double-blind Treatment Period|Other than specified above|0|||
126095793|NCT02489968|453643144|FG004|Double-blind Treatment Period|Other than specified above|1|||
126358305|NCT03462563|454603959|FG001|Overall Study|Adverse Event|3|||
126358306|NCT03462563|454603958|FG000|Overall Study|Unspecified reason|10|||
126358307|NCT03462563|454603959|FG001|Overall Study|Unspecified reason|12|||
126358308|NCT03462563|454603958|FG000|Overall Study|Physician Decision|1|||
126095794|NCT02489968|453643145|FG005|Double-blind Treatment Period|Other than specified above|0|||
126095795|NCT04577001|453643146|FG000|Overall Study|Subject became ineligible|0|||
126095796|NCT04577001|453643147|FG001|Overall Study|Subject became ineligible|1|||
126095797|NCT03465904|453643150|FG000|Overall Study|Withdrawal by Subject|9|||
126095798|NCT03465904|453643151|FG001|Overall Study|Withdrawal by Subject|5|||
126095799|NCT03465904|453643150|FG000|Overall Study|Lost to Follow-up|11|||
126095800|NCT03465904|453643151|FG001|Overall Study|Lost to Follow-up|9|||
126095801|NCT03465904|453643150|FG000|Overall Study|Protocol Violation|20|||
126095802|NCT03465904|453643151|FG001|Overall Study|Protocol Violation|15|||
126095803|NCT01022112|453643154|FG000|Overall Study|Adverse Event|1|||
126254775|NCT03687242|454224416|FG000|Overall Study|Adverse Event|1|||
126254776|NCT02943993|454224436|FG000|Overall Study|Withdrawal by Subject|52|||
126254777|NCT02943993|454224436|FG000|Overall Study|Transfer to another institution|6|||
126254778|NCT02943993|454224436|FG000|Overall Study|Lost to Follow-up|135|||
126254779|NCT02943993|454224436|FG000|Overall Study|Death|98|||
126254780|NCT02943993|454224436|FG000|Overall Study|Other reason for premature termination|32|||
126254781|NCT02943993|454224436|FG000|Overall Study|Missing reason for termination|7|||
126254782|NCT02754492|454224440|FG000|Overall Study|Protocol Violation|2|||
126254783|NCT02754492|454224441|FG001|Overall Study|Protocol Violation|2|||
126095804|NCT01022112|453643155|FG001|Overall Study|Adverse Event|2|||
126254784|NCT02754492|454224442|FG002|Overall Study|Protocol Violation|0|||
126254785|NCT02754492|454224443|FG003|Overall Study|Protocol Violation|1|||
126254786|NCT02754492|454224440|FG000|Overall Study|Withdrawal by Subject|2|||
126358309|NCT03462563|454603959|FG001|Overall Study|Physician Decision|0|||
126358310|NCT05103332|454603960|FG000|Overall Study|Lost to Follow-up|0|||
126358311|NCT05103332|454603961|FG001|Overall Study|Lost to Follow-up|2|||
126254787|NCT02754492|454224441|FG001|Overall Study|Withdrawal by Subject|0|||
126254788|NCT02754492|454224442|FG002|Overall Study|Withdrawal by Subject|0|||
126254789|NCT02754492|454224443|FG003|Overall Study|Withdrawal by Subject|0|||
126254790|NCT02754492|454224440|FG000|Overall Study|Equipment malfuntion|0|||
126254791|NCT02754492|454224441|FG001|Overall Study|Equipment malfuntion|0|||
126254792|NCT02754492|454224442|FG002|Overall Study|Equipment malfuntion|2|||
126254793|NCT02754492|454224443|FG003|Overall Study|Equipment malfuntion|5|||
126254794|NCT02754492|454224440|FG000|Overall Study|Adverse Event|0|||
126254795|NCT02754492|454224441|FG001|Overall Study|Adverse Event|0|||
126254796|NCT02754492|454224442|FG002|Overall Study|Adverse Event|0|||
126254797|NCT02754492|454224443|FG003|Overall Study|Adverse Event|13|||
126358312|NCT05103332|454603962|FG002|Overall Study|Lost to Follow-up|1|||
126358313|NCT05103332|454603963|FG003|Overall Study|Lost to Follow-up|0|||
126254798|NCT02754492|454224440|FG000|Overall Study|Venous access issues not resulting in AE|0|||
126254799|NCT02754492|454224441|FG001|Overall Study|Venous access issues not resulting in AE|0|||
126254800|NCT02754492|454224442|FG002|Overall Study|Venous access issues not resulting in AE|0|||
126254801|NCT02754492|454224443|FG003|Overall Study|Venous access issues not resulting in AE|4|||
126254802|NCT00969124|454224451|FG000|Overall Study|Protocol Violation|2|||
126254803|NCT00969124|454224451|FG000|Overall Study|Inadequate bowel preparation|15|||
126254804|NCT00969124|454224451|FG000|Overall Study|Inability to reach cecum|9|||
126254805|NCT00969124|454224451|FG000|Overall Study|Previously unrecognized disease|3|||
126254806|NCT00969124|454224451|FG000|Overall Study|Technical error|1|||
126254807|NCT00252564|454224452|FG000|Overall Study|Adverse Event|17|||
126254808|NCT00252564|454224453|FG001|Overall Study|Adverse Event|13|||
126254809|NCT00252564|454224452|FG000|Overall Study|Unrelated Complication|2|||
126254810|NCT00252564|454224453|FG001|Overall Study|Unrelated Complication|1|||
126254811|NCT00252564|454224452|FG000|Overall Study|Disease Progression|14|||
126254812|NCT00252564|454224453|FG001|Overall Study|Disease Progression|20|||
126254813|NCT00252564|454224452|FG000|Overall Study|Death|0|||
126254814|NCT00252564|454224453|FG001|Overall Study|Death|3|||
126254815|NCT00252564|454224452|FG000|Overall Study|Physician Decision|1|||
126254816|NCT00252564|454224453|FG001|Overall Study|Physician Decision|0|||
126254817|NCT00252564|454224452|FG000|Overall Study|Lost to Follow-up|1|||
126095805|NCT01022112|453643156|FG002|Overall Study|Adverse Event|0|||
126254818|NCT00252564|454224453|FG001|Overall Study|Lost to Follow-up|0|||
126254819|NCT00252564|454224452|FG000|Overall Study|Patient Request|4|||
126254820|NCT00252564|454224453|FG001|Overall Study|Patient Request|5|||
126254821|NCT00252564|454224452|FG000|Overall Study|Withdrawal by Subject|0|||
126254822|NCT00252564|454224453|FG001|Overall Study|Withdrawal by Subject|2|||
126254823|NCT04561115|454224455|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
126358314|NCT05103332|454603964|FG004|Overall Study|Lost to Follow-up|0|||
126358315|NCT05103332|454603965|FG005|Overall Study|Lost to Follow-up|2|||
126358316|NCT05103332|454603960|FG000|Overall Study|Physician Decision|0|||
126095806|NCT01022112|453643157|FG003|Overall Study|Adverse Event|1|||
126254824|NCT04561115|454224456|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
126254825|NCT04561115|454224455|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
126254826|NCT04561115|454224456|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
126254827|NCT04561115|454224455|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
126254828|NCT04561115|454224456|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
126254829|NCT00743145|454224457|FG000|Overall Study|Withdrawal by Subject|1|||
126254830|NCT00743145|454224457|FG000|Overall Study|Adverse Event|2|||
126254831|NCT00743145|454224457|FG000|Overall Study|Pregnancy|1|||
126254832|NCT01583530|454224458|FG000|Overall Study|Adverse Event|0|||
126254833|NCT01583530|454224459|FG001|Overall Study|Adverse Event|0|||
126254834|NCT01583530|454224460|FG002|Overall Study|Adverse Event|0|||
126254835|NCT01583530|454224461|FG003|Overall Study|Adverse Event|0|||
126254836|NCT01583530|454224462|FG004|Overall Study|Adverse Event|0|||
126254837|NCT01583530|454224463|FG005|Overall Study|Adverse Event|1|||
126254838|NCT01583530|454224458|FG000|Overall Study|Withdrawal by Subject|0|||
126254839|NCT01583530|454224459|FG001|Overall Study|Withdrawal by Subject|3|||
126254840|NCT01583530|454224460|FG002|Overall Study|Withdrawal by Subject|0|||
126254841|NCT01583530|454224461|FG003|Overall Study|Withdrawal by Subject|1|||
126254842|NCT01583530|454224462|FG004|Overall Study|Withdrawal by Subject|1|||
126254843|NCT01583530|454224463|FG005|Overall Study|Withdrawal by Subject|2|||
126254844|NCT01583530|454224458|FG000|Overall Study|Lost to Follow-up|0|||
126254845|NCT01583530|454224459|FG001|Overall Study|Lost to Follow-up|0|||
126254846|NCT01583530|454224460|FG002|Overall Study|Lost to Follow-up|0|||
126254847|NCT01583530|454224461|FG003|Overall Study|Lost to Follow-up|0|||
126254848|NCT01583530|454224462|FG004|Overall Study|Lost to Follow-up|3|||
126254849|NCT01583530|454224463|FG005|Overall Study|Lost to Follow-up|0|||
126254850|NCT01583530|454224458|FG000|Overall Study|Lack of compliance|0|||
126254851|NCT01583530|454224459|FG001|Overall Study|Lack of compliance|0|||
126254852|NCT01583530|454224460|FG002|Overall Study|Lack of compliance|0|||
126254853|NCT01583530|454224461|FG003|Overall Study|Lack of compliance|0|||
126254854|NCT01583530|454224462|FG004|Overall Study|Lack of compliance|1|||
126254855|NCT01583530|454224463|FG005|Overall Study|Lack of compliance|0|||
126254856|NCT02416180|454224464|FG000|Overall Study|Withdrawal by Subject|1|||
126254857|NCT01332968|454224469|FG000|Induction Period|Adverse Event|23|||
126254858|NCT01332968|454224470|FG001|Induction Period|Adverse Event|26|||
126254859|NCT01332968|454224471|FG002|Induction Period|Adverse Event|0|||
126254860|NCT01332968|454224472|FG003|Induction Period|Adverse Event|0|||
126254861|NCT01332968|454224473|FG004|Induction Period|Adverse Event|0|||
126254862|NCT01332968|454224474|FG005|Induction Period|Adverse Event|0|||
126254863|NCT01332968|454224475|FG006|Induction Period|Adverse Event|0|||
126254864|NCT01332968|454224476|FG007|Induction Period|Adverse Event|0|||
126254865|NCT01332968|454224469|FG000|Induction Period|Death|1|||
126254866|NCT01332968|454224470|FG001|Induction Period|Death|4|||
126254867|NCT01332968|454224471|FG002|Induction Period|Death|0|||
126254868|NCT01332968|454224472|FG003|Induction Period|Death|0|||
126254869|NCT01332968|454224473|FG004|Induction Period|Death|0|||
126254870|NCT01332968|454224474|FG005|Induction Period|Death|0|||
126254871|NCT01332968|454224475|FG006|Induction Period|Death|0|||
126254872|NCT01332968|454224476|FG007|Induction Period|Death|0|||
126254873|NCT01332968|454224469|FG000|Induction Period|Non-compliance|1|||
126254874|NCT01332968|454224470|FG001|Induction Period|Non-compliance|0|||
126254875|NCT01332968|454224471|FG002|Induction Period|Non-compliance|0|||
126254876|NCT01332968|454224472|FG003|Induction Period|Non-compliance|0|||
126254877|NCT01332968|454224473|FG004|Induction Period|Non-compliance|0|||
126254878|NCT01332968|454224474|FG005|Induction Period|Non-compliance|0|||
126254879|NCT01332968|454224475|FG006|Induction Period|Non-compliance|0|||
126254880|NCT01332968|454224476|FG007|Induction Period|Non-compliance|0|||
126254881|NCT01332968|454224469|FG000|Induction Period|Other|2|||
126254882|NCT01332968|454224470|FG001|Induction Period|Other|2|||
126254883|NCT01332968|454224471|FG002|Induction Period|Other|0|||
126254884|NCT01332968|454224472|FG003|Induction Period|Other|0|||
126254885|NCT01332968|454224473|FG004|Induction Period|Other|0|||
126254886|NCT01332968|454224474|FG005|Induction Period|Other|0|||
126254887|NCT01332968|454224475|FG006|Induction Period|Other|0|||
126254888|NCT01332968|454224476|FG007|Induction Period|Other|0|||
126254889|NCT01332968|454224469|FG000|Induction Period|Physician Decision|6|||
126254890|NCT01332968|454224470|FG001|Induction Period|Physician Decision|1|||
126254891|NCT01332968|454224471|FG002|Induction Period|Physician Decision|0|||
126254892|NCT01332968|454224472|FG003|Induction Period|Physician Decision|0|||
126254893|NCT01332968|454224473|FG004|Induction Period|Physician Decision|0|||
126254894|NCT01332968|454224474|FG005|Induction Period|Physician Decision|0|||
126254895|NCT01332968|454224475|FG006|Induction Period|Physician Decision|0|||
126254896|NCT01332968|454224476|FG007|Induction Period|Physician Decision|0|||
126254897|NCT01332968|454224469|FG000|Induction Period|Progressive Disease|15|||
126254898|NCT01332968|454224470|FG001|Induction Period|Progressive Disease|7|||
126254899|NCT01332968|454224471|FG002|Induction Period|Progressive Disease|0|||
126358317|NCT05103332|454603961|FG001|Overall Study|Physician Decision|1|||
126254900|NCT01332968|454224472|FG003|Induction Period|Progressive Disease|0|||
126254901|NCT01332968|454224473|FG004|Induction Period|Progressive Disease|0|||
126254902|NCT01332968|454224474|FG005|Induction Period|Progressive Disease|0|||
126254903|NCT01332968|454224475|FG006|Induction Period|Progressive Disease|0|||
126254904|NCT01332968|454224476|FG007|Induction Period|Progressive Disease|0|||
126254905|NCT01332968|454224469|FG000|Induction Period|Protocol Violation|3|||
126254906|NCT01332968|454224470|FG001|Induction Period|Protocol Violation|4|||
126254907|NCT01332968|454224471|FG002|Induction Period|Protocol Violation|0|||
126254908|NCT01332968|454224472|FG003|Induction Period|Protocol Violation|0|||
126254909|NCT01332968|454224473|FG004|Induction Period|Protocol Violation|0|||
126254910|NCT01332968|454224474|FG005|Induction Period|Protocol Violation|0|||
126254911|NCT01332968|454224475|FG006|Induction Period|Protocol Violation|0|||
126254912|NCT01332968|454224476|FG007|Induction Period|Protocol Violation|0|||
126254913|NCT01332968|454224469|FG000|Induction Period|Withdrawal by Subject|3|||
126254914|NCT01332968|454224470|FG001|Induction Period|Withdrawal by Subject|5|||
126254915|NCT01332968|454224471|FG002|Induction Period|Withdrawal by Subject|0|||
126254916|NCT01332968|454224472|FG003|Induction Period|Withdrawal by Subject|0|||
126254917|NCT01332968|454224473|FG004|Induction Period|Withdrawal by Subject|0|||
126254918|NCT01332968|454224474|FG005|Induction Period|Withdrawal by Subject|0|||
126254919|NCT01332968|454224475|FG006|Induction Period|Withdrawal by Subject|0|||
126254920|NCT01332968|454224476|FG007|Induction Period|Withdrawal by Subject|0|||
126254921|NCT01332968|454224469|FG000|Induction Period|Randomised but not treated|4|||
126254922|NCT01332968|454224470|FG001|Induction Period|Randomised but not treated|7|||
126254923|NCT01332968|454224471|FG002|Induction Period|Randomised but not treated|0|||
126254924|NCT01332968|454224472|FG003|Induction Period|Randomised but not treated|0|||
126254925|NCT01332968|454224473|FG004|Induction Period|Randomised but not treated|0|||
126254926|NCT01332968|454224474|FG005|Induction Period|Randomised but not treated|0|||
126254927|NCT01332968|454224475|FG006|Induction Period|Randomised but not treated|0|||
126254928|NCT01332968|454224476|FG007|Induction Period|Randomised but not treated|0|||
126254929|NCT01332968|454224469|FG000|Maintenance/Observation Period|Adverse Event|0|||
126254930|NCT01332968|454224470|FG001|Maintenance/Observation Period|Adverse Event|0|||
126254931|NCT01332968|454224471|FG002|Maintenance/Observation Period|Adverse Event|53|||
126254932|NCT01332968|454224472|FG003|Maintenance/Observation Period|Adverse Event|66|||
126254933|NCT01332968|454224473|FG004|Maintenance/Observation Period|Adverse Event|0|||
126254934|NCT01332968|454224474|FG005|Maintenance/Observation Period|Adverse Event|0|||
126254935|NCT01332968|454224475|FG006|Maintenance/Observation Period|Adverse Event|0|||
126254936|NCT01332968|454224476|FG007|Maintenance/Observation Period|Adverse Event|0|||
126254937|NCT01332968|454224469|FG000|Maintenance/Observation Period|Death|0|||
126254938|NCT01332968|454224470|FG001|Maintenance/Observation Period|Death|0|||
126254939|NCT01332968|454224471|FG002|Maintenance/Observation Period|Death|5|||
126254940|NCT01332968|454224472|FG003|Maintenance/Observation Period|Death|6|||
126254941|NCT01332968|454224473|FG004|Maintenance/Observation Period|Death|0|||
126254942|NCT01332968|454224474|FG005|Maintenance/Observation Period|Death|0|||
126254943|NCT01332968|454224475|FG006|Maintenance/Observation Period|Death|0|||
126254944|NCT01332968|454224476|FG007|Maintenance/Observation Period|Death|0|||
126254945|NCT01332968|454224469|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
126254946|NCT01332968|454224470|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
126254947|NCT01332968|454224471|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
126254948|NCT01332968|454224472|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
126254949|NCT01332968|454224473|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
126254950|NCT01332968|454224474|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
126254951|NCT01332968|454224475|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
126254952|NCT01332968|454224476|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
126254953|NCT01332968|454224469|FG000|Maintenance/Observation Period|Non-compliance|0|||
126254954|NCT01332968|454224470|FG001|Maintenance/Observation Period|Non-compliance|0|||
126254955|NCT01332968|454224471|FG002|Maintenance/Observation Period|Non-compliance|4|||
126254956|NCT01332968|454224472|FG003|Maintenance/Observation Period|Non-compliance|3|||
126254957|NCT01332968|454224473|FG004|Maintenance/Observation Period|Non-compliance|0|||
126254958|NCT01332968|454224474|FG005|Maintenance/Observation Period|Non-compliance|0|||
126254959|NCT01332968|454224475|FG006|Maintenance/Observation Period|Non-compliance|0|||
126254960|NCT01332968|454224476|FG007|Maintenance/Observation Period|Non-compliance|0|||
126254961|NCT01332968|454224469|FG000|Maintenance/Observation Period|Other|0|||
126254962|NCT01332968|454224470|FG001|Maintenance/Observation Period|Other|0|||
126254963|NCT01332968|454224471|FG002|Maintenance/Observation Period|Other|4|||
126254964|NCT01332968|454224472|FG003|Maintenance/Observation Period|Other|7|||
126254965|NCT01332968|454224473|FG004|Maintenance/Observation Period|Other|0|||
126254966|NCT01332968|454224474|FG005|Maintenance/Observation Period|Other|0|||
126254967|NCT01332968|454224475|FG006|Maintenance/Observation Period|Other|0|||
126254968|NCT01332968|454224476|FG007|Maintenance/Observation Period|Other|0|||
126254969|NCT01332968|454224469|FG000|Maintenance/Observation Period|Physician Decision|0|||
126254970|NCT01332968|454224470|FG001|Maintenance/Observation Period|Physician Decision|0|||
126254971|NCT01332968|454224471|FG002|Maintenance/Observation Period|Physician Decision|14|||
126358318|NCT05103332|454603962|FG002|Overall Study|Physician Decision|0|||
126254972|NCT01332968|454224472|FG003|Maintenance/Observation Period|Physician Decision|19|||
126254973|NCT01332968|454224473|FG004|Maintenance/Observation Period|Physician Decision|0|||
126254974|NCT01332968|454224474|FG005|Maintenance/Observation Period|Physician Decision|1|||
126254975|NCT01332968|454224475|FG006|Maintenance/Observation Period|Physician Decision|0|||
126254976|NCT01332968|454224476|FG007|Maintenance/Observation Period|Physician Decision|0|||
126254977|NCT01332968|454224469|FG000|Maintenance/Observation Period|Progressive Disease|0|||
126254978|NCT01332968|454224470|FG001|Maintenance/Observation Period|Progressive Disease|0|||
126254979|NCT01332968|454224471|FG002|Maintenance/Observation Period|Progressive Disease|72|||
126254980|NCT01332968|454224472|FG003|Maintenance/Observation Period|Progressive Disease|40|||
126254981|NCT01332968|454224473|FG004|Maintenance/Observation Period|Progressive Disease|0|||
126254982|NCT01332968|454224474|FG005|Maintenance/Observation Period|Progressive Disease|0|||
126254983|NCT01332968|454224475|FG006|Maintenance/Observation Period|Progressive Disease|0|||
126254984|NCT01332968|454224476|FG007|Maintenance/Observation Period|Progressive Disease|0|||
126254985|NCT01332968|454224469|FG000|Maintenance/Observation Period|Protocol Violation|0|||
126254986|NCT01332968|454224470|FG001|Maintenance/Observation Period|Protocol Violation|0|||
126254987|NCT01332968|454224471|FG002|Maintenance/Observation Period|Protocol Violation|1|||
126254988|NCT01332968|454224472|FG003|Maintenance/Observation Period|Protocol Violation|1|||
126254989|NCT01332968|454224473|FG004|Maintenance/Observation Period|Protocol Violation|0|||
126254990|NCT01332968|454224474|FG005|Maintenance/Observation Period|Protocol Violation|0|||
126254991|NCT01332968|454224475|FG006|Maintenance/Observation Period|Protocol Violation|0|||
126254992|NCT01332968|454224476|FG007|Maintenance/Observation Period|Protocol Violation|0|||
126254993|NCT01332968|454224469|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
126254994|NCT01332968|454224470|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
126254995|NCT01332968|454224471|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
126254996|NCT01332968|454224472|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
126254997|NCT01332968|454224473|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
126254998|NCT01332968|454224474|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
126254999|NCT01332968|454224475|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
126255000|NCT01332968|454224476|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
126255001|NCT01332968|454224469|FG000|Follow-Up Period|Adverse Event|0|||
126255002|NCT01332968|454224470|FG001|Follow-Up Period|Adverse Event|0|||
126255003|NCT01332968|454224471|FG002|Follow-Up Period|Adverse Event|0|||
126255004|NCT01332968|454224472|FG003|Follow-Up Period|Adverse Event|0|||
126255005|NCT01332968|454224473|FG004|Follow-Up Period|Adverse Event|0|||
126255006|NCT01332968|454224474|FG005|Follow-Up Period|Adverse Event|0|||
126255007|NCT01332968|454224475|FG006|Follow-Up Period|Adverse Event|0|||
126255008|NCT01332968|454224476|FG007|Follow-Up Period|Adverse Event|4|||
126255009|NCT01332968|454224469|FG000|Follow-Up Period|Death|0|||
126255010|NCT01332968|454224470|FG001|Follow-Up Period|Death|0|||
126255011|NCT01332968|454224471|FG002|Follow-Up Period|Death|0|||
126255012|NCT01332968|454224472|FG003|Follow-Up Period|Death|0|||
126255013|NCT01332968|454224473|FG004|Follow-Up Period|Death|0|||
126255014|NCT01332968|454224474|FG005|Follow-Up Period|Death|0|||
126255015|NCT01332968|454224475|FG006|Follow-Up Period|Death|27|||
126255016|NCT01332968|454224476|FG007|Follow-Up Period|Death|30|||
126255017|NCT01332968|454224469|FG000|Follow-Up Period|Lost to Follow-up|0|||
126255018|NCT01332968|454224470|FG001|Follow-Up Period|Lost to Follow-up|0|||
126255019|NCT01332968|454224471|FG002|Follow-Up Period|Lost to Follow-up|0|||
126255020|NCT01332968|454224472|FG003|Follow-Up Period|Lost to Follow-up|0|||
126255021|NCT01332968|454224473|FG004|Follow-Up Period|Lost to Follow-up|0|||
126255022|NCT01332968|454224474|FG005|Follow-Up Period|Lost to Follow-up|0|||
126255023|NCT01332968|454224475|FG006|Follow-Up Period|Lost to Follow-up|11|||
126255024|NCT01332968|454224476|FG007|Follow-Up Period|Lost to Follow-up|15|||
126255025|NCT01332968|454224469|FG000|Follow-Up Period|Non-compliance|0|||
126255026|NCT01332968|454224470|FG001|Follow-Up Period|Non-compliance|0|||
126255027|NCT01332968|454224471|FG002|Follow-Up Period|Non-compliance|0|||
126255028|NCT01332968|454224472|FG003|Follow-Up Period|Non-compliance|0|||
126255029|NCT01332968|454224473|FG004|Follow-Up Period|Non-compliance|0|||
126255030|NCT01332968|454224474|FG005|Follow-Up Period|Non-compliance|0|||
126255031|NCT01332968|454224475|FG006|Follow-Up Period|Non-compliance|4|||
126255032|NCT01332968|454224476|FG007|Follow-Up Period|Non-compliance|9|||
126255033|NCT01332968|454224469|FG000|Follow-Up Period|Other|0|||
126255034|NCT01332968|454224470|FG001|Follow-Up Period|Other|0|||
126255035|NCT01332968|454224471|FG002|Follow-Up Period|Other|0|||
126255036|NCT01332968|454224472|FG003|Follow-Up Period|Other|0|||
126255037|NCT01332968|454224473|FG004|Follow-Up Period|Other|0|||
126255038|NCT01332968|454224474|FG005|Follow-Up Period|Other|0|||
126255039|NCT01332968|454224475|FG006|Follow-Up Period|Other|18|||
126255040|NCT01332968|454224476|FG007|Follow-Up Period|Other|21|||
126255041|NCT01332968|454224469|FG000|Follow-Up Period|Physician Decision|0|||
126255042|NCT01332968|454224470|FG001|Follow-Up Period|Physician Decision|0|||
126255043|NCT01332968|454224471|FG002|Follow-Up Period|Physician Decision|0|||
126255044|NCT01332968|454224472|FG003|Follow-Up Period|Physician Decision|0|||
126255045|NCT01332968|454224473|FG004|Follow-Up Period|Physician Decision|0|||
126255046|NCT01332968|454224474|FG005|Follow-Up Period|Physician Decision|0|||
126255047|NCT01332968|454224475|FG006|Follow-Up Period|Physician Decision|12|||
126255048|NCT01332968|454224476|FG007|Follow-Up Period|Physician Decision|15|||
126255049|NCT01332968|454224469|FG000|Follow-Up Period|Progressive Disease|0|||
126255050|NCT01332968|454224470|FG001|Follow-Up Period|Progressive Disease|0|||
126255051|NCT01332968|454224471|FG002|Follow-Up Period|Progressive Disease|0|||
126255052|NCT01332968|454224472|FG003|Follow-Up Period|Progressive Disease|0|||
126255053|NCT01332968|454224473|FG004|Follow-Up Period|Progressive Disease|0|||
126255054|NCT01332968|454224474|FG005|Follow-Up Period|Progressive Disease|0|||
126255055|NCT01332968|454224475|FG006|Follow-Up Period|Progressive Disease|126|||
126255056|NCT01332968|454224476|FG007|Follow-Up Period|Progressive Disease|106|||
126255057|NCT01332968|454224469|FG000|Follow-Up Period|Protocol Violation|0|||
126255058|NCT01332968|454224470|FG001|Follow-Up Period|Protocol Violation|0|||
126255059|NCT01332968|454224471|FG002|Follow-Up Period|Protocol Violation|0|||
126255060|NCT01332968|454224472|FG003|Follow-Up Period|Protocol Violation|0|||
126255061|NCT01332968|454224473|FG004|Follow-Up Period|Protocol Violation|0|||
126255062|NCT01332968|454224474|FG005|Follow-Up Period|Protocol Violation|0|||
126255063|NCT01332968|454224475|FG006|Follow-Up Period|Protocol Violation|1|||
126255064|NCT01332968|454224476|FG007|Follow-Up Period|Protocol Violation|0|||
126255065|NCT01332968|454224469|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126255066|NCT01332968|454224470|FG001|Follow-Up Period|Withdrawal by Subject|0|||
126255067|NCT01332968|454224471|FG002|Follow-Up Period|Withdrawal by Subject|0|||
126255068|NCT01332968|454224472|FG003|Follow-Up Period|Withdrawal by Subject|0|||
126255069|NCT01332968|454224473|FG004|Follow-Up Period|Withdrawal by Subject|0|||
126255070|NCT01332968|454224474|FG005|Follow-Up Period|Withdrawal by Subject|0|||
126255071|NCT01332968|454224475|FG006|Follow-Up Period|Withdrawal by Subject|29|||
126255072|NCT01332968|454224476|FG007|Follow-Up Period|Withdrawal by Subject|32|||
126255073|NCT01332968|454224469|FG000|Follow-Up Period|No reason provided|0|||
126255074|NCT01332968|454224470|FG001|Follow-Up Period|No reason provided|0|||
126255075|NCT01332968|454224471|FG002|Follow-Up Period|No reason provided|0|||
126255076|NCT01332968|454224472|FG003|Follow-Up Period|No reason provided|0|||
126255077|NCT01332968|454224473|FG004|Follow-Up Period|No reason provided|0|||
126255078|NCT01332968|454224474|FG005|Follow-Up Period|No reason provided|0|||
126255079|NCT01332968|454224475|FG006|Follow-Up Period|No reason provided|2|||
126255080|NCT01332968|454224476|FG007|Follow-Up Period|No reason provided|3|||
126255081|NCT03480022|454224477|FG000|Overall Study|Pregnancy|2|||
126255082|NCT03480022|454224478|FG001|Overall Study|Pregnancy|0|||
126255083|NCT03480022|454224477|FG000|Overall Study|Adverse Event|6|||
126255084|NCT03480022|454224478|FG001|Overall Study|Adverse Event|0|||
126255085|NCT03480022|454224477|FG000|Overall Study|Lack of Efficacy|0|||
126255086|NCT03480022|454224478|FG001|Overall Study|Lack of Efficacy|2|||
126255087|NCT03480022|454224477|FG000|Overall Study|Physician Decision|0|||
126255088|NCT03480022|454224478|FG001|Overall Study|Physician Decision|1|||
126255089|NCT03480022|454224477|FG000|Overall Study|Withdrawal by Subject|2|||
126255090|NCT03480022|454224478|FG001|Overall Study|Withdrawal by Subject|0|||
126255091|NCT03480022|454224477|FG000|Overall Study|Medication concerns|1|||
126255092|NCT03480022|454224478|FG001|Overall Study|Medication concerns|0|||
126255093|NCT03480022|454224477|FG000|Overall Study|Family member COVID exposure|0|||
126255094|NCT03480022|454224478|FG001|Overall Study|Family member COVID exposure|1|||
126255095|NCT00668395|454224479|FG000|Overall Study|Withdrawal by Subject|4|||
126255096|NCT00668395|454224480|FG001|Overall Study|Withdrawal by Subject|4|||
126255097|NCT00668395|454224481|FG002|Overall Study|Withdrawal by Subject|1|||
126255098|NCT00668395|454224479|FG000|Overall Study|Adverse Event|1|||
126255099|NCT00668395|454224480|FG001|Overall Study|Adverse Event|1|||
126255100|NCT00668395|454224481|FG002|Overall Study|Adverse Event|0|||
126255101|NCT00668395|454224479|FG000|Overall Study|Physician Decision|1|||
126255102|NCT00668395|454224480|FG001|Overall Study|Physician Decision|1|||
126255103|NCT00668395|454224481|FG002|Overall Study|Physician Decision|0|||
126255104|NCT00283842|454224486|FG000|Overall Study|Adverse Event|8|||
126255105|NCT00283842|454224487|FG001|Overall Study|Adverse Event|7|||
126255106|NCT00283842|454224488|FG002|Overall Study|Adverse Event|21|||
126255107|NCT00283842|454224489|FG003|Overall Study|Adverse Event|21|||
126255108|NCT00283842|454224490|FG004|Overall Study|Adverse Event|5|||
126255109|NCT00283842|454224486|FG000|Overall Study|Protocol Violation|1|||
126255110|NCT00283842|454224487|FG001|Overall Study|Protocol Violation|5|||
126255111|NCT00283842|454224488|FG002|Overall Study|Protocol Violation|4|||
126255112|NCT00283842|454224489|FG003|Overall Study|Protocol Violation|0|||
126255113|NCT00283842|454224490|FG004|Overall Study|Protocol Violation|0|||
126255114|NCT00283842|454224486|FG000|Overall Study|Protocol deviation|0|||
126255115|NCT00283842|454224487|FG001|Overall Study|Protocol deviation|0|||
126255116|NCT00283842|454224488|FG002|Overall Study|Protocol deviation|0|||
126255117|NCT00283842|454224489|FG003|Overall Study|Protocol deviation|0|||
126255118|NCT00283842|454224490|FG004|Overall Study|Protocol deviation|2|||
126255119|NCT00283842|454224486|FG000|Overall Study|Withdrawal by Subject|2|||
126255120|NCT00283842|454224487|FG001|Overall Study|Withdrawal by Subject|1|||
126255121|NCT00283842|454224488|FG002|Overall Study|Withdrawal by Subject|1|||
126255122|NCT00283842|454224489|FG003|Overall Study|Withdrawal by Subject|5|||
126358319|NCT05103332|454603963|FG003|Overall Study|Physician Decision|1|||
126255123|NCT00283842|454224490|FG004|Overall Study|Withdrawal by Subject|4|||
126358320|NCT05103332|454603964|FG004|Overall Study|Physician Decision|0|||
126255124|NCT00283842|454224486|FG000|Overall Study|Lack of Efficacy|1|||
126255125|NCT00283842|454224487|FG001|Overall Study|Lack of Efficacy|3|||
126255126|NCT00283842|454224488|FG002|Overall Study|Lack of Efficacy|1|||
126255127|NCT00283842|454224489|FG003|Overall Study|Lack of Efficacy|0|||
126255128|NCT00283842|454224490|FG004|Overall Study|Lack of Efficacy|3|||
126255129|NCT00283842|454224486|FG000|Overall Study|Lost to Follow-up|0|||
126255130|NCT00283842|454224487|FG001|Overall Study|Lost to Follow-up|2|||
126255131|NCT00283842|454224488|FG002|Overall Study|Lost to Follow-up|4|||
126255132|NCT00283842|454224489|FG003|Overall Study|Lost to Follow-up|1|||
126255133|NCT00283842|454224490|FG004|Overall Study|Lost to Follow-up|1|||
126255134|NCT05665387|454224491|FG000|Overall Study|Withdrawal by Subject|1|||
126255135|NCT05665387|454224492|FG001|Overall Study|Withdrawal by Subject|0|||
126255136|NCT05665387|454224493|FG002|Overall Study|Withdrawal by Subject|1|||
126255137|NCT02472639|454224496|FG000|Overall Study|Physician Decision|4|||
126255138|NCT02472639|454224497|FG001|Overall Study|Physician Decision|3|||
126255139|NCT00751023|454224499|FG000|Overall Study|Lost to Follow-up|11|||
126255140|NCT00751023|454224500|FG001|Overall Study|Lost to Follow-up|7|||
126255141|NCT02308696|454224503|FG000|Overall Study|Lost to Follow-up|28|||
126255142|NCT02308696|454224504|FG001|Overall Study|Lost to Follow-up|21|||
126255143|NCT02308696|454224503|FG000|Overall Study|Death|8|||
126255144|NCT02308696|454224504|FG001|Overall Study|Death|4|||
126255145|NCT02308696|454224503|FG000|Overall Study|Moved to a Higher Level of Care|17|||
126255146|NCT02308696|454224504|FG001|Overall Study|Moved to a Higher Level of Care|6|||
126255147|NCT01211262|454224506|FG000|Overall Study|Progressive Disease|18|||
126255148|NCT01211262|454224507|FG001|Overall Study|Progressive Disease|9|||
126255149|NCT01211262|454224506|FG000|Overall Study|Adverse Event|4|||
126255150|NCT01211262|454224507|FG001|Overall Study|Adverse Event|0|||
126255151|NCT01211262|454224506|FG000|Overall Study|Withdrawal of Consent|1|||
126255152|NCT01211262|454224507|FG001|Overall Study|Withdrawal of Consent|0|||
126255153|NCT01211262|454224506|FG000|Overall Study|Other|0|||
126255154|NCT01211262|454224507|FG001|Overall Study|Other|1|||
126255155|NCT04768114|454224508|FG000|Overall Study|Lost to Follow-up|5|||
126255156|NCT04768114|454224509|FG001|Overall Study|Lost to Follow-up|10|||
126255157|NCT04768114|454224508|FG000|Overall Study|Withdrawal by Subject|0|||
126255158|NCT04768114|454224509|FG001|Overall Study|Withdrawal by Subject|1|||
126255159|NCT04049097|454224513|FG000|Overall Study|Adverse Event|18|||
126255160|NCT04049097|454224513|FG000|Overall Study|Death|2|||
126255161|NCT04049097|454224513|FG000|Overall Study|Lost to Follow-up|1|||
126255162|NCT04049097|454224513|FG000|Overall Study|Physician Decision|2|||
126255163|NCT04049097|454224513|FG000|Overall Study|Withdrawal by Subject|9|||
126255164|NCT04049097|454224513|FG000|Overall Study|Protocol Violation|2|||
126255165|NCT04049097|454224513|FG000|Overall Study|Other|1|||
126358321|NCT05103332|454603965|FG005|Overall Study|Physician Decision|0|||
126255166|NCT04049097|454224513|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
126255167|NCT01970592|454224519|FG000|Overall Study|Withdrawal by Subject|4|||
126255168|NCT01970592|454224519|FG000|Overall Study|Physician Decision|1|||
126255169|NCT01970592|454224519|FG000|Overall Study|Adverse Event|1|||
126255170|NCT03980522|454224520|FG000|Treatment Period|Adverse Event|1|||
126255171|NCT03980522|454224521|FG001|Treatment Period|Adverse Event|0|||
126255172|NCT03980522|454224522|FG002|Treatment Period|Adverse Event|0|||
126255173|NCT03980522|454224523|FG003|Treatment Period|Adverse Event|0|||
126255174|NCT03980522|454224524|FG004|Treatment Period|Adverse Event|0|||
126095807|NCT01022112|453643158|FG004|Overall Study|Adverse Event|0|||
126255175|NCT04892147|454224525|FG000|Overall Study|Withdrawal by Subject|2|||
126255176|NCT04892147|454224526|FG001|Overall Study|Withdrawal by Subject|0|||
126255177|NCT05263505|454224527|FG000|Overall Study|Adverse Event|0|||
126255178|NCT05263505|454224528|FG001|Overall Study|Adverse Event|1|||
126255179|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
126255180|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
126255181|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
126358322|NCT05103332|454603960|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
126358323|NCT05103332|454603961|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
126255182|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
126255183|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
126255184|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
126358324|NCT05103332|454603962|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
126255185|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
126255186|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
126255187|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
126255188|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
126255189|NCT01785615|454224541|FG000|Dietary Phase|Lost to Follow-up|0|||
126255190|NCT01785615|454224542|FG001|Dietary Phase|Lost to Follow-up|0|||
126255191|NCT01785615|454224543|FG002|Dietary Phase|Lost to Follow-up|0|||
126255192|NCT01785615|454224544|FG003|Dietary Phase|Lost to Follow-up|24|||
126255193|NCT03428945|454224545|FG000|Overall Study|Lost to Follow-up|5|||
126255194|NCT03428945|454224546|FG001|Overall Study|Lost to Follow-up|3|||
126255195|NCT03428945|454224545|FG000|Overall Study|Withdrawal by Subject|10|||
126255196|NCT03428945|454224546|FG001|Overall Study|Withdrawal by Subject|10|||
126255197|NCT00360490|454224549|FG000|Overall Study|Adverse Event|4|||
126255198|NCT00360490|454224550|FG001|Overall Study|Adverse Event|2|||
126255199|NCT00360490|454224549|FG000|Overall Study|Lost to Follow-up|2|||
126255200|NCT00360490|454224550|FG001|Overall Study|Lost to Follow-up|1|||
126255201|NCT00360490|454224549|FG000|Overall Study|Physician Decision|2|||
126255202|NCT00360490|454224550|FG001|Overall Study|Physician Decision|1|||
126255203|NCT00360490|454224549|FG000|Overall Study|Protocol Violation|0|||
126255204|NCT00360490|454224550|FG001|Overall Study|Protocol Violation|4|||
126255205|NCT00360490|454224549|FG000|Overall Study|Withdrawal by Subject|1|||
126255206|NCT00360490|454224550|FG001|Overall Study|Withdrawal by Subject|3|||
126255207|NCT01598896|454224552|FG000|Overall Study|Withdrawal by Subject|0|||
126255208|NCT01598896|454224553|FG001|Overall Study|Withdrawal by Subject|1|||
126255209|NCT01598896|454224552|FG000|Overall Study|Lack of Efficacy|0|||
126255210|NCT01598896|454224553|FG001|Overall Study|Lack of Efficacy|1|||
126255211|NCT03493919|454224557|FG000|Overall Study|Other|2|||
126255212|NCT03493919|454224558|FG001|Overall Study|Other|0|||
126255213|NCT03493919|454224559|FG002|Overall Study|Other|1|||
126255214|NCT03493919|454224560|FG003|Overall Study|Other|0|||
126255215|NCT03493919|454224557|FG000|Overall Study|Withdrawal by Subject|9|||
126255216|NCT03493919|454224558|FG001|Overall Study|Withdrawal by Subject|3|||
126255217|NCT03493919|454224559|FG002|Overall Study|Withdrawal by Subject|1|||
126255218|NCT03493919|454224560|FG003|Overall Study|Withdrawal by Subject|1|||
126255219|NCT03493919|454224557|FG000|Overall Study|Lost to Follow-up|5|||
126255220|NCT03493919|454224558|FG001|Overall Study|Lost to Follow-up|0|||
126255221|NCT03493919|454224559|FG002|Overall Study|Lost to Follow-up|0|||
126255222|NCT03493919|454224560|FG003|Overall Study|Lost to Follow-up|3|||
126255223|NCT03493919|454224557|FG000|Overall Study|Adverse Event|0|||
126255224|NCT03493919|454224558|FG001|Overall Study|Adverse Event|1|||
126255225|NCT03493919|454224559|FG002|Overall Study|Adverse Event|0|||
126255226|NCT03493919|454224560|FG003|Overall Study|Adverse Event|0|||
126255227|NCT04640194|454224561|FG000|Overall Study|Adverse Event|3|||
126255228|NCT04640194|454224562|FG001|Overall Study|Adverse Event|7|||
126255229|NCT04640194|454224563|FG002|Overall Study|Adverse Event|0|||
126255230|NCT04640194|454224564|FG003|Overall Study|Adverse Event|5|||
126255231|NCT04640194|454224565|FG004|Overall Study|Adverse Event|0|||
126255232|NCT04640194|454224566|FG005|Overall Study|Adverse Event|4|||
126255233|NCT04640194|454224567|FG006|Overall Study|Adverse Event|0|||
126255234|NCT04640194|454224561|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
126255235|NCT04640194|454224562|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
126255236|NCT04640194|454224563|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
126255237|NCT04640194|454224564|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
126255238|NCT04640194|454224565|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
126255239|NCT04640194|454224566|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
126255240|NCT04640194|454224567|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
126255241|NCT04640194|454224561|FG000|Overall Study|fibrinogen level too low|0|||
126255242|NCT04640194|454224562|FG001|Overall Study|fibrinogen level too low|0|||
126255243|NCT04640194|454224563|FG002|Overall Study|fibrinogen level too low|0|||
126255244|NCT04640194|454224564|FG003|Overall Study|fibrinogen level too low|1|||
126255245|NCT04640194|454224565|FG004|Overall Study|fibrinogen level too low|0|||
126255246|NCT04640194|454224566|FG005|Overall Study|fibrinogen level too low|0|||
126255247|NCT04640194|454224567|FG006|Overall Study|fibrinogen level too low|0|||
126255248|NCT04640194|454224561|FG000|Overall Study|mild bleeding|0|||
126255249|NCT04640194|454224562|FG001|Overall Study|mild bleeding|0|||
126358325|NCT05103332|454603963|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
126358326|NCT05103332|454603964|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
126358327|NCT05103332|454603965|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
126255250|NCT04640194|454224563|FG002|Overall Study|mild bleeding|0|||
126358328|NCT05103332|454603960|FG000|Overall Study|Unspeccified|0|||
126358329|NCT05103332|454603961|FG001|Overall Study|Unspeccified|0|||
126255251|NCT04640194|454224564|FG003|Overall Study|mild bleeding|1|||
126255252|NCT04640194|454224565|FG004|Overall Study|mild bleeding|0|||
126255253|NCT04640194|454224566|FG005|Overall Study|mild bleeding|0|||
126255254|NCT04640194|454224567|FG006|Overall Study|mild bleeding|0|||
126255255|NCT04640194|454224561|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255256|NCT04640194|454224562|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
126255257|NCT04640194|454224563|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255258|NCT04640194|454224564|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255259|NCT04640194|454224565|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255260|NCT04640194|454224566|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255261|NCT04640194|454224567|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255262|NCT04428645|454224568|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
126358330|NCT05103332|454603962|FG002|Overall Study|Unspeccified|0|||
126095808|NCT01022112|453643154|FG000|Overall Study|Lack of Efficacy|1|||
126095809|NCT01022112|453643155|FG001|Overall Study|Lack of Efficacy|0|||
126095810|NCT01022112|453643156|FG002|Overall Study|Lack of Efficacy|0|||
126095811|NCT01022112|453643157|FG003|Overall Study|Lack of Efficacy|0|||
126095812|NCT01022112|453643158|FG004|Overall Study|Lack of Efficacy|1|||
126095813|NCT01022112|453643154|FG000|Overall Study|Physician Decision|0|||
126095814|NCT01022112|453643155|FG001|Overall Study|Physician Decision|0|||
126095815|NCT01022112|453643156|FG002|Overall Study|Physician Decision|1|||
126095816|NCT01022112|453643157|FG003|Overall Study|Physician Decision|0|||
126095817|NCT01022112|453643158|FG004|Overall Study|Physician Decision|1|||
126095818|NCT01022112|453643154|FG000|Overall Study|Withdrawal by Subject|0|||
126095819|NCT01022112|453643155|FG001|Overall Study|Withdrawal by Subject|1|||
126095820|NCT01022112|453643156|FG002|Overall Study|Withdrawal by Subject|2|||
126095821|NCT01022112|453643157|FG003|Overall Study|Withdrawal by Subject|2|||
126095822|NCT01022112|453643158|FG004|Overall Study|Withdrawal by Subject|1|||
126095823|NCT01022112|453643154|FG000|Overall Study|Fasting plasma glucose level increased|1|||
126095824|NCT01022112|453643155|FG001|Overall Study|Fasting plasma glucose level increased|0|||
126095825|NCT01022112|453643156|FG002|Overall Study|Fasting plasma glucose level increased|0|||
126095826|NCT01022112|453643157|FG003|Overall Study|Fasting plasma glucose level increased|0|||
126095827|NCT01022112|453643158|FG004|Overall Study|Fasting plasma glucose level increased|7|||
126095828|NCT00925353|453643159|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
126095829|NCT01198756|453644582|FG000|Overall Study|Adverse Event|0|||
126095830|NCT01198756|453644583|FG001|Overall Study|Adverse Event|0|||
126095831|NCT01198756|453644584|FG002|Overall Study|Adverse Event|0|||
126095832|NCT01198756|453644585|FG003|Overall Study|Adverse Event|1|||
126095833|NCT01198756|453644582|FG000|Overall Study|Protocol Violation|0|||
126095834|NCT01198756|453644583|FG001|Overall Study|Protocol Violation|0|||
126095835|NCT01198756|453644584|FG002|Overall Study|Protocol Violation|0|||
126095836|NCT01198756|453644585|FG003|Overall Study|Protocol Violation|2|||
126095837|NCT01198756|453644582|FG000|Overall Study|Withdrawal by Subject|9|||
126095838|NCT01198756|453644583|FG001|Overall Study|Withdrawal by Subject|4|||
126095839|NCT01198756|453644584|FG002|Overall Study|Withdrawal by Subject|7|||
126095840|NCT01198756|453644585|FG003|Overall Study|Withdrawal by Subject|5|||
126095841|NCT01198756|453644582|FG000|Overall Study|Lost to Follow-up|29|||
126095842|NCT01198756|453644583|FG001|Overall Study|Lost to Follow-up|36|||
126095843|NCT01198756|453644584|FG002|Overall Study|Lost to Follow-up|23|||
126095844|NCT01198756|453644585|FG003|Overall Study|Lost to Follow-up|18|||
126095845|NCT01290315|453644587|FG000|Overall Study|Adverse Event|0|||
126095846|NCT01290315|453644588|FG001|Overall Study|Adverse Event|0|||
126095847|NCT01290315|453644589|FG002|Overall Study|Adverse Event|0|||
126095848|NCT01290315|453644590|FG003|Overall Study|Adverse Event|3|||
126095849|NCT01290315|453644587|FG000|Overall Study|Selection criteria/compliance|2|||
126095850|NCT01290315|453644588|FG001|Overall Study|Selection criteria/compliance|1|||
126095851|NCT01290315|453644589|FG002|Overall Study|Selection criteria/compliance|0|||
126095852|NCT01290315|453644590|FG003|Overall Study|Selection criteria/compliance|2|||
126095853|NCT01290315|453644587|FG000|Overall Study|Lost to Follow-up|0|||
126095854|NCT01290315|453644588|FG001|Overall Study|Lost to Follow-up|1|||
126255263|NCT04773600|454224573|FG000|Overall Study|Withdrawal by Subject|15|||
126255264|NCT04773600|454224574|FG001|Overall Study|Withdrawal by Subject|9|||
126255265|NCT04773600|454224573|FG000|Overall Study|Lost to Follow-up|10|||
126255266|NCT04773600|454224574|FG001|Overall Study|Lost to Follow-up|6|||
126255267|NCT04773600|454224573|FG000|Overall Study|Adverse Event|8|||
126255268|NCT04773600|454224574|FG001|Overall Study|Adverse Event|2|||
126255269|NCT04773600|454224573|FG000|Overall Study|Lack of Efficacy|2|||
126255270|NCT04773600|454224574|FG001|Overall Study|Lack of Efficacy|3|||
126255271|NCT04773600|454224573|FG000|Overall Study|Noncompliance|2|||
126255272|NCT04773600|454224574|FG001|Overall Study|Noncompliance|0|||
126255273|NCT04773600|454224573|FG000|Overall Study|Protocol Violation|2|||
126255274|NCT04773600|454224574|FG001|Overall Study|Protocol Violation|0|||
126255275|NCT04773600|454224573|FG000|Overall Study|Physician Decision|0|||
126358331|NCT05103332|454603963|FG003|Overall Study|Unspeccified|1|||
126358332|NCT05103332|454603964|FG004|Overall Study|Unspeccified|0|||
126095855|NCT01290315|453644589|FG002|Overall Study|Lost to Follow-up|0|||
126095856|NCT01290315|453644590|FG003|Overall Study|Lost to Follow-up|0|||
126095857|NCT01290315|453644587|FG000|Overall Study|Withdrawal by Subject|1|||
126095858|NCT01290315|453644588|FG001|Overall Study|Withdrawal by Subject|1|||
126255276|NCT04773600|454224574|FG001|Overall Study|Physician Decision|1|||
126095859|NCT01290315|453644589|FG002|Overall Study|Withdrawal by Subject|0|||
126095860|NCT01290315|453644590|FG003|Overall Study|Withdrawal by Subject|0|||
126095861|NCT00591721|453644591|FG000|Overall Study|Withdrawal by Subject|10|||
126095862|NCT00591721|453644592|FG001|Overall Study|Withdrawal by Subject|10|||
126095863|NCT00591721|453644591|FG000|Overall Study|Lost to Follow-up|1|||
126095864|NCT00591721|453644592|FG001|Overall Study|Lost to Follow-up|4|||
126095865|NCT00591721|453644591|FG000|Overall Study|Intervention not received|10|||
126255277|NCT04773600|454224573|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
126255278|NCT04773600|454224574|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
126255279|NCT04773600|454224573|FG000|Overall Study|Emergency Travel Out of Country|1|||
126255280|NCT04773600|454224574|FG001|Overall Study|Emergency Travel Out of Country|0|||
126255281|NCT05135273|454226318|FG000|Overall Study|Recruited into the army|0|||
126255282|NCT05135273|454226319|FG001|Overall Study|Recruited into the army|0|||
126255283|NCT05135273|454226320|FG002|Overall Study|Recruited into the army|0|||
126255284|NCT05135273|454226321|FG003|Overall Study|Recruited into the army|0|||
126255285|NCT05135273|454226322|FG004|Overall Study|Recruited into the army|1|||
126255286|NCT05135273|454226323|FG005|Overall Study|Recruited into the army|0|||
126255287|NCT05135273|454226324|FG006|Overall Study|Recruited into the army|0|||
126255288|NCT05135273|454226325|FG007|Overall Study|Recruited into the army|0|||
126255289|NCT05135273|454226318|FG000|Overall Study|Moved away from study site|0|||
126358333|NCT05103332|454603965|FG005|Overall Study|Unspeccified|0|||
126358334|NCT02218268|454603966|FG000|24 Hour Washout|Physician Decision|11|||
126358335|NCT02218268|454603967|FG001|24 Hour Washout|Physician Decision|9|||
126358336|NCT03651336|454603968|FG000|Overall Study|Withdrawal by Subject|4|||
126358337|NCT01740427|454603969|FG000|Overall Study|Objective Progression or Relapse|286|||
126358338|NCT01740427|454603970|FG001|Overall Study|Objective Progression or Relapse|172|||
126358339|NCT01740427|454603969|FG000|Overall Study|Adverse Event|32|||
126358340|NCT01740427|454603970|FG001|Overall Study|Adverse Event|9|||
126358341|NCT01740427|454603969|FG000|Overall Study|Global Deterioration of Health Status|28|||
126358342|NCT01740427|454603970|FG001|Overall Study|Global Deterioration of Health Status|12|||
126358343|NCT01740427|454603969|FG000|Overall Study|Participant Refused Continued Treatment|27|||
126358344|NCT01740427|454603970|FG001|Overall Study|Participant Refused Continued Treatment|15|||
126358345|NCT01740427|454603969|FG000|Overall Study|Unspecified reasons|52|||
126358346|NCT01740427|454603970|FG001|Overall Study|Unspecified reasons|8|||
126358347|NCT01740427|454603969|FG000|Overall Study|Death|10|||
126358348|NCT01740427|454603970|FG001|Overall Study|Death|3|||
126358349|NCT01740427|454603969|FG000|Overall Study|Protocol Violation|5|||
126358350|NCT01740427|454603970|FG001|Overall Study|Protocol Violation|3|||
126358351|NCT01740427|454603969|FG000|Overall Study|Lost to Follow-up|3|||
126358352|NCT01740427|454603970|FG001|Overall Study|Lost to Follow-up|0|||
126358353|NCT01740427|454603969|FG000|Overall Study|Site Terminated by Sponsor|1|||
126358354|NCT01740427|454603970|FG001|Overall Study|Site Terminated by Sponsor|0|||
126358355|NCT04796207|454603973|FG000|Overall Study|Lost to Follow-up|7|||
126358356|NCT04796207|454603974|FG001|Overall Study|Lost to Follow-up|2|||
126358357|NCT00362609|454603975|FG000|Overall Study|Withdrawal by Subject|0|||
126358358|NCT00362609|454603976|FG001|Overall Study|Withdrawal by Subject|1|||
126358359|NCT00362609|454603975|FG000|Overall Study|Protocol Violation|0|||
126358360|NCT00362609|454603976|FG001|Overall Study|Protocol Violation|1|||
126358361|NCT01800058|454603985|FG000|Overall Study|Lost to Follow-up|1|||
126358362|NCT02186171|454603986|FG000|Overall Study|Withdrawal by Subject|1|||
126255290|NCT05135273|454226319|FG001|Overall Study|Moved away from study site|0|||
126255291|NCT05135273|454226320|FG002|Overall Study|Moved away from study site|0|||
126255292|NCT05135273|454226321|FG003|Overall Study|Moved away from study site|0|||
126255293|NCT05135273|454226322|FG004|Overall Study|Moved away from study site|0|||
126255294|NCT05135273|454226323|FG005|Overall Study|Moved away from study site|1|||
126255295|NCT05135273|454226324|FG006|Overall Study|Moved away from study site|1|||
126255296|NCT05135273|454226325|FG007|Overall Study|Moved away from study site|0|||
126255297|NCT05135273|454226318|FG000|Overall Study|Travel|0|||
126255298|NCT05135273|454226319|FG001|Overall Study|Travel|0|||
126255299|NCT05135273|454226320|FG002|Overall Study|Travel|0|||
126255300|NCT05135273|454226321|FG003|Overall Study|Travel|0|||
126255301|NCT05135273|454226322|FG004|Overall Study|Travel|0|||
126255302|NCT05135273|454226323|FG005|Overall Study|Travel|0|||
126255303|NCT05135273|454226324|FG006|Overall Study|Travel|0|||
126255304|NCT05135273|454226325|FG007|Overall Study|Travel|1|||
126255305|NCT00500318|454226328|FG000|Overall Study|Adverse Event|3|||
126255306|NCT00500318|454226329|FG001|Overall Study|Adverse Event|8|||
126255307|NCT00500318|454226328|FG000|Overall Study|Protocol Violation|1|||
126255308|NCT00500318|454226329|FG001|Overall Study|Protocol Violation|3|||
126255309|NCT00500318|454226328|FG000|Overall Study|Withdrawal by Subject|1|||
126255310|NCT00500318|454226329|FG001|Overall Study|Withdrawal by Subject|2|||
126255311|NCT00500318|454226328|FG000|Overall Study|Lack of Efficacy|0|||
126255312|NCT00500318|454226329|FG001|Overall Study|Lack of Efficacy|3|||
126255313|NCT00500318|454226328|FG000|Overall Study|Other Reason|0|||
126255314|NCT00500318|454226329|FG001|Overall Study|Other Reason|1|||
126255315|NCT03243396|454226330|FG000|Overall Study|Lost to Follow-up|2|||
126255316|NCT03243396|454226331|FG001|Overall Study|Lost to Follow-up|3|||
126255317|NCT03243396|454226332|FG002|Overall Study|Lost to Follow-up|15|||
126255318|NCT03243396|454226333|FG003|Overall Study|Lost to Follow-up|8|||
126255319|NCT03243396|454226334|FG004|Overall Study|Lost to Follow-up|1|||
126255320|NCT03243396|454226335|FG005|Overall Study|Lost to Follow-up|4|||
126255321|NCT03243396|454226336|FG006|Overall Study|Lost to Follow-up|9|||
126358363|NCT02186171|454603987|FG001|Overall Study|Withdrawal by Subject|9|||
126358364|NCT02186171|454603986|FG000|Overall Study|Lost to Follow-up|2|||
126358365|NCT02186171|454603987|FG001|Overall Study|Lost to Follow-up|2|||
126358366|NCT02186171|454603986|FG000|Overall Study|Death|1|||
126358367|NCT02186171|454603987|FG001|Overall Study|Death|2|||
126358368|NCT02186171|454603986|FG000|Overall Study|Protocol-specified Criteria|0|||
126255322|NCT01257581|454226337|FG000|Overall Study|Early Termination|3|||
126255323|NCT01257581|454226338|FG001|Overall Study|Early Termination|1|||
126255324|NCT01257581|454226339|FG002|Overall Study|Early Termination|2|||
126255325|NCT01257581|454226337|FG000|Overall Study|Death|2|||
126255326|NCT01257581|454226338|FG001|Overall Study|Death|2|||
126255327|NCT01257581|454226339|FG002|Overall Study|Death|4|||
126358369|NCT02186171|454603987|FG001|Overall Study|Protocol-specified Criteria|2|||
126358370|NCT05206604|454605311|FG000|Overall Study|Non-compliance with study drug|0|||
126358371|NCT05206604|454605312|FG001|Overall Study|Non-compliance with study drug|0|||
126358372|NCT05206604|454605313|FG002|Overall Study|Non-compliance with study drug|0|||
126255328|NCT02246764|454226342|FG000|Overall Study|Adverse Event|15|||
126255329|NCT02246764|454226343|FG001|Overall Study|Adverse Event|29|||
126255330|NCT02246764|454226344|FG002|Overall Study|Adverse Event|1|||
126255331|NCT02246764|454226342|FG000|Overall Study|Withdrawal by Subject|0|||
126255332|NCT02246764|454226343|FG001|Overall Study|Withdrawal by Subject|0|||
126255333|NCT02246764|454226344|FG002|Overall Study|Withdrawal by Subject|1|||
126255334|NCT02246764|454226342|FG000|Overall Study|Disallowed Concomitant Medication|1|||
126255335|NCT02246764|454226343|FG001|Overall Study|Disallowed Concomitant Medication|0|||
126255336|NCT02246764|454226344|FG002|Overall Study|Disallowed Concomitant Medication|0|||
126255337|NCT02246764|454226342|FG000|Overall Study|Physician Decision|0|||
126255338|NCT02246764|454226343|FG001|Overall Study|Physician Decision|2|||
126255339|NCT02246764|454226344|FG002|Overall Study|Physician Decision|1|||
126255340|NCT02246764|454226342|FG000|Overall Study|Protocol Violation|2|||
126255341|NCT02246764|454226343|FG001|Overall Study|Protocol Violation|1|||
126255342|NCT02246764|454226344|FG002|Overall Study|Protocol Violation|1|||
126255343|NCT02104817|454226347|FG000|Overall Study|Death|363|||
126255344|NCT02104817|454226348|FG001|Overall Study|Death|330|||
126255345|NCT02104817|454226347|FG000|Overall Study|Lost to Follow-up|3|||
126255346|NCT02104817|454226348|FG001|Overall Study|Lost to Follow-up|2|||
126255347|NCT02104817|454226347|FG000|Overall Study|Protocol Violation|0|||
126255348|NCT02104817|454226348|FG001|Overall Study|Protocol Violation|1|||
126255349|NCT02104817|454226347|FG000|Overall Study|Study terminated by sponsor|5854|||
126255350|NCT02104817|454226348|FG001|Overall Study|Study terminated by sponsor|5901|||
126255351|NCT02104817|454226347|FG000|Overall Study|Withdrawal by Subject|111|||
126255352|NCT02104817|454226348|FG001|Overall Study|Withdrawal by Subject|78|||
126255353|NCT02104817|454226347|FG000|Overall Study|Other reasons|128|||
126255354|NCT02104817|454226348|FG001|Overall Study|Other reasons|135|||
126255355|NCT02575339|454226352|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
126255356|NCT02575339|454226353|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
126255357|NCT02575339|454226354|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
126255358|NCT02575339|454226352|FG000|Study Treatment|Disease Progression|5|||
126255359|NCT02575339|454226353|FG001|Study Treatment|Disease Progression|2|||
126255360|NCT02575339|454226354|FG002|Study Treatment|Disease Progression|0|||
126255361|NCT02575339|454226352|FG000|Study Treatment|Adverse Event|1|||
126255362|NCT02575339|454226353|FG001|Study Treatment|Adverse Event|2|||
126255363|NCT02575339|454226354|FG002|Study Treatment|Adverse Event|0|||
126255364|NCT02575339|454226352|FG000|Follow up|Death|6|||
126255365|NCT02575339|454226353|FG001|Follow up|Death|2|||
126255366|NCT02575339|454226354|FG002|Follow up|Death|0|||
126255367|NCT02575339|454226352|FG000|Follow up|Study Terminated|0|||
126255368|NCT02575339|454226353|FG001|Follow up|Study Terminated|2|||
126255369|NCT02575339|454226354|FG002|Follow up|Study Terminated|0|||
126255370|NCT02575339|454226352|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
126255371|NCT02575339|454226353|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
126255372|NCT02575339|454226354|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
126255373|NCT04633642|454226355|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
126255374|NCT04633642|454226356|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
126255375|NCT04675775|454226357|FG000|Overall Study|Withdrawal by Subject|7|||
126255376|NCT02161549|454226359|FG000|Overall Study|Physician Decision|6|||
126255377|NCT02161549|454226360|FG001|Overall Study|Physician Decision|2|||
126255378|NCT03223909|454226361|FG000|Overall Study|Protocol Violation|48|||
126358373|NCT05206604|454605314|FG003|Overall Study|Non-compliance with study drug|0|||
126358374|NCT05206604|454605315|FG004|Overall Study|Non-compliance with study drug|0|||
126358375|NCT05206604|454605316|FG005|Overall Study|Non-compliance with study drug|1|||
126358376|NCT05206604|454605317|FG006|Overall Study|Non-compliance with study drug|0|||
126358377|NCT05206604|454605318|FG007|Overall Study|Non-compliance with study drug|0|||
126255379|NCT03223909|454226362|FG001|Overall Study|Protocol Violation|45|||
126255380|NCT03223909|454226363|FG002|Overall Study|Protocol Violation|16|||
126255381|NCT01628549|454226368|FG000|Overall Study|Adverse Event|1|||
126255382|NCT01628549|454226369|FG001|Overall Study|Adverse Event|1|||
126255383|NCT01628549|454226370|FG002|Overall Study|Adverse Event|0|||
126255384|NCT01628549|454226371|FG003|Overall Study|Adverse Event|4|||
126255385|NCT01628549|454226368|FG000|Overall Study|Lost to Follow-up|3|||
126255386|NCT01628549|454226369|FG001|Overall Study|Lost to Follow-up|4|||
126255387|NCT01628549|454226370|FG002|Overall Study|Lost to Follow-up|3|||
126358378|NCT03735498|454605319|FG000|Overall Study|Withdrawal by Subject|3|||
126255388|NCT01628549|454226371|FG003|Overall Study|Lost to Follow-up|3|||
126255389|NCT01628549|454226368|FG000|Overall Study|Withdrawal by Subject|3|||
126255390|NCT01628549|454226369|FG001|Overall Study|Withdrawal by Subject|4|||
126255391|NCT01628549|454226370|FG002|Overall Study|Withdrawal by Subject|4|||
126255392|NCT01628549|454226371|FG003|Overall Study|Withdrawal by Subject|1|||
126255393|NCT01628549|454226368|FG000|Overall Study|Protocol Violation|2|||
126255394|NCT01628549|454226369|FG001|Overall Study|Protocol Violation|1|||
126255395|NCT01628549|454226370|FG002|Overall Study|Protocol Violation|1|||
126255396|NCT01628549|454226371|FG003|Overall Study|Protocol Violation|0|||
126255397|NCT01628549|454226368|FG000|Overall Study|withdrawn for noncompliance|0|||
126255398|NCT01628549|454226369|FG001|Overall Study|withdrawn for noncompliance|2|||
126255399|NCT01628549|454226370|FG002|Overall Study|withdrawn for noncompliance|1|||
126255400|NCT01628549|454226371|FG003|Overall Study|withdrawn for noncompliance|0|||
126255401|NCT01628549|454226368|FG000|Overall Study|abnormal laboratory test results|0|||
126255402|NCT01628549|454226369|FG001|Overall Study|abnormal laboratory test results|0|||
126255403|NCT01628549|454226370|FG002|Overall Study|abnormal laboratory test results|1|||
126255404|NCT01628549|454226371|FG003|Overall Study|abnormal laboratory test results|0|||
126255405|NCT01628549|454226368|FG000|Overall Study|positive pregnancy test|0|||
126255406|NCT01628549|454226369|FG001|Overall Study|positive pregnancy test|0|||
126255407|NCT01628549|454226370|FG002|Overall Study|positive pregnancy test|0|||
126255408|NCT01628549|454226371|FG003|Overall Study|positive pregnancy test|1|||
126255409|NCT00177164|454226373|FG000|Overall Study|Protocol Violation|0|||
126255410|NCT00177164|454226374|FG001|Overall Study|Protocol Violation|7|||
126255411|NCT00177164|454226373|FG000|Overall Study|Lost to Follow-up|4|||
126255412|NCT00177164|454226374|FG001|Overall Study|Lost to Follow-up|5|||
126255413|NCT00177164|454226373|FG000|Overall Study|increase in alcohol and drug use|1|||
126255414|NCT00177164|454226374|FG001|Overall Study|increase in alcohol and drug use|2|||
126255415|NCT00177164|454226373|FG000|Overall Study|Adverse Event|1|||
126255416|NCT00177164|454226374|FG001|Overall Study|Adverse Event|0|||
126255417|NCT00177164|454226373|FG000|Overall Study|discharge from hospital|1|||
126255418|NCT00177164|454226374|FG001|Overall Study|discharge from hospital|0|||
126255419|NCT00177164|454226373|FG000|Overall Study|Lack of Efficacy|2|||
126255420|NCT00177164|454226374|FG001|Overall Study|Lack of Efficacy|1|||
126255421|NCT00177164|454226373|FG000|Overall Study|Pregnancy|0|||
126255422|NCT00177164|454226374|FG001|Overall Study|Pregnancy|1|||
126255423|NCT00965757|454226375|FG000|Double-blind Phase|Progression of concomitant disease|1|||
126255424|NCT00965757|454226376|FG001|Double-blind Phase|Progression of concomitant disease|2|||
126255425|NCT00965757|454226377|FG002|Double-blind Phase|Progression of concomitant disease|0|||
126255426|NCT00965757|454226378|FG003|Double-blind Phase|Progression of concomitant disease|0|||
126255427|NCT00965757|454226375|FG000|Double-blind Phase|Adverse drug reaction|2|||
126255428|NCT00965757|454226376|FG001|Double-blind Phase|Adverse drug reaction|1|||
126255429|NCT00965757|454226377|FG002|Double-blind Phase|Adverse drug reaction|0|||
126255430|NCT00965757|454226378|FG003|Double-blind Phase|Adverse drug reaction|0|||
126255431|NCT00965757|454226375|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
126255432|NCT00965757|454226376|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
126255433|NCT00965757|454226377|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
126255434|NCT00965757|454226378|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
126255435|NCT00965757|454226375|FG000|Double-blind Phase|Lack of Efficacy|7|||
126255436|NCT00965757|454226376|FG001|Double-blind Phase|Lack of Efficacy|11|||
126255437|NCT00965757|454226377|FG002|Double-blind Phase|Lack of Efficacy|0|||
126255438|NCT00965757|454226378|FG003|Double-blind Phase|Lack of Efficacy|0|||
126255439|NCT00965757|454226375|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
126255440|NCT00965757|454226376|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
126255441|NCT00965757|454226377|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
126255442|NCT00965757|454226378|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
126255443|NCT00965757|454226375|FG000|Double-blind Phase|Lost to Follow-up|0|||
126255444|NCT00965757|454226376|FG001|Double-blind Phase|Lost to Follow-up|1|||
126255445|NCT00965757|454226377|FG002|Double-blind Phase|Lost to Follow-up|0|||
126255446|NCT00965757|454226378|FG003|Double-blind Phase|Lost to Follow-up|0|||
125879799|NCT03050801|452857387|FG002|Experiment 1|Lost to Follow-up|0|||
125879800|NCT03050801|452857388|FG003|Experiment 1|Lost to Follow-up|0|||
125879801|NCT03050801|452857389|FG004|Experiment 1|Lost to Follow-up|0|||
126255447|NCT00965757|454226375|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
126255448|NCT00965757|454226376|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
126255449|NCT00965757|454226377|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
126255450|NCT00965757|454226378|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
126255451|NCT00965757|454226375|FG000|Double-blind Phase|Other|1|||
126255452|NCT00965757|454226376|FG001|Double-blind Phase|Other|0|||
126255453|NCT00965757|454226377|FG002|Double-blind Phase|Other|0|||
126255454|NCT00965757|454226378|FG003|Double-blind Phase|Other|0|||
126255455|NCT00965757|454226375|FG000|Extension Phase|Progression of concomitant disease|0|||
126255456|NCT00965757|454226376|FG001|Extension Phase|Progression of concomitant disease|0|||
126255457|NCT00965757|454226377|FG002|Extension Phase|Progression of concomitant disease|4|||
126255458|NCT00965757|454226378|FG003|Extension Phase|Progression of concomitant disease|2|||
126255459|NCT00965757|454226375|FG000|Extension Phase|Adverse drug reaction|0|||
126255460|NCT00965757|454226376|FG001|Extension Phase|Adverse drug reaction|0|||
126255461|NCT00965757|454226377|FG002|Extension Phase|Adverse drug reaction|6|||
126255462|NCT00965757|454226378|FG003|Extension Phase|Adverse drug reaction|3|||
126255463|NCT00965757|454226375|FG000|Extension Phase|Abnormal Laboratory Value|0|||
126255464|NCT00965757|454226376|FG001|Extension Phase|Abnormal Laboratory Value|0|||
126255465|NCT00965757|454226377|FG002|Extension Phase|Abnormal Laboratory Value|6|||
126255466|NCT00965757|454226378|FG003|Extension Phase|Abnormal Laboratory Value|1|||
126255467|NCT00965757|454226375|FG000|Extension Phase|Lack of Efficacy|0|||
126255468|NCT00965757|454226376|FG001|Extension Phase|Lack of Efficacy|0|||
126255469|NCT00965757|454226377|FG002|Extension Phase|Lack of Efficacy|8|||
126255470|NCT00965757|454226378|FG003|Extension Phase|Lack of Efficacy|12|||
126255471|NCT00965757|454226375|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
126255472|NCT00965757|454226376|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
126255473|NCT00965757|454226377|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
126255474|NCT00965757|454226378|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
126255475|NCT00965757|454226375|FG000|Extension Phase|Lost to Follow-up|0|||
126255476|NCT00965757|454226376|FG001|Extension Phase|Lost to Follow-up|0|||
126255477|NCT00965757|454226377|FG002|Extension Phase|Lost to Follow-up|0|||
126255478|NCT00965757|454226378|FG003|Extension Phase|Lost to Follow-up|1|||
126255479|NCT00965757|454226375|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
126255480|NCT00965757|454226376|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
126255481|NCT00965757|454226377|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
126255482|NCT00965757|454226378|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
126255483|NCT00965757|454226375|FG000|Extension Phase|Protocol Violation|0|||
126255484|NCT00965757|454226376|FG001|Extension Phase|Protocol Violation|0|||
126255485|NCT00965757|454226377|FG002|Extension Phase|Protocol Violation|0|||
126255486|NCT00965757|454226378|FG003|Extension Phase|Protocol Violation|1|||
126255487|NCT00965757|454226375|FG000|Extension Phase|Other|0|||
126255488|NCT00965757|454226376|FG001|Extension Phase|Other|0|||
126255489|NCT00965757|454226377|FG002|Extension Phase|Other|2|||
126255490|NCT00965757|454226378|FG003|Extension Phase|Other|1|||
126255491|NCT02451358|454226379|FG000|Overall Study|Withdrawal by Subject|1|||
126255492|NCT02451358|454226380|FG001|Overall Study|Withdrawal by Subject|1|||
126255493|NCT02451358|454226381|FG002|Overall Study|Withdrawal by Subject|0|||
126255494|NCT02451358|454226382|FG003|Overall Study|Withdrawal by Subject|0|||
126255495|NCT02451358|454226379|FG000|Overall Study|Protocol Violation|0|||
126255496|NCT02451358|454226380|FG001|Overall Study|Protocol Violation|1|||
126255497|NCT02451358|454226381|FG002|Overall Study|Protocol Violation|1|||
126255498|NCT02451358|454226382|FG003|Overall Study|Protocol Violation|0|||
126255499|NCT01344018|454226393|FG000|Overall Study|Death|22|||
126255500|NCT01344018|454226394|FG001|Overall Study|Death|25|||
126255501|NCT01344018|454226393|FG000|Overall Study|Lost to Follow-up|4|||
126255502|NCT01344018|454226394|FG001|Overall Study|Lost to Follow-up|7|||
126255503|NCT05070754|454226395|FG000|Overall Study|Withdrawal by Subject|0|||
126255504|NCT05070754|454226396|FG001|Overall Study|Withdrawal by Subject|0|||
126255505|NCT05070754|454226397|FG002|Overall Study|Withdrawal by Subject|0|||
126255506|NCT05070754|454226398|FG003|Overall Study|Withdrawal by Subject|1|||
126255507|NCT05070754|454226395|FG000|Overall Study|Protocol Violation|0|||
126255508|NCT05070754|454226396|FG001|Overall Study|Protocol Violation|0|||
126255509|NCT05070754|454226397|FG002|Overall Study|Protocol Violation|0|||
126255510|NCT05070754|454226398|FG003|Overall Study|Protocol Violation|1|||
126255511|NCT01398787|454226399|FG000|Overall Study|Adverse Event|1|||
126255512|NCT02351167|454226400|FG000|Overall Study|Withdrawal by Subject|19|||
126255513|NCT02351167|454226401|FG001|Overall Study|Withdrawal by Subject|18|||
126255514|NCT02351167|454226402|FG002|Overall Study|Withdrawal by Subject|21|||
126255515|NCT00113919|454226405|FG000|Overall Study|Physician Decision|8|||
126255516|NCT00113919|454226405|FG000|Overall Study|Death|6|||
126255517|NCT00715676|454226409|FG000|Overall Study|Adverse Event|3|||
126255518|NCT00715676|454226410|FG001|Overall Study|Adverse Event|5|||
126255519|NCT00715676|454226411|FG002|Overall Study|Adverse Event|21|||
126255520|NCT00715676|454226409|FG000|Overall Study|Withdrawal by Subject|1|||
126255521|NCT00715676|454226410|FG001|Overall Study|Withdrawal by Subject|3|||
126255522|NCT00715676|454226411|FG002|Overall Study|Withdrawal by Subject|8|||
126255523|NCT00715676|454226409|FG000|Overall Study|Lost to Follow-up|1|||
126255524|NCT00715676|454226410|FG001|Overall Study|Lost to Follow-up|2|||
126255525|NCT00715676|454226411|FG002|Overall Study|Lost to Follow-up|1|||
126255526|NCT00715676|454226409|FG000|Overall Study|Terminated by Sponsor|1|||
126255527|NCT00715676|454226410|FG001|Overall Study|Terminated by Sponsor|0|||
126255528|NCT00715676|454226411|FG002|Overall Study|Terminated by Sponsor|0|||
126255529|NCT00715676|454226409|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
126255530|NCT00715676|454226410|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
126255531|NCT00715676|454226411|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
126255532|NCT00715676|454226409|FG000|Overall Study|Use of Exclusionary Medication|0|||
126255533|NCT00715676|454226410|FG001|Overall Study|Use of Exclusionary Medication|0|||
126255534|NCT00715676|454226411|FG002|Overall Study|Use of Exclusionary Medication|1|||
126255535|NCT00715676|454226409|FG000|Overall Study|Elevated Blood Glucose|0|||
126255536|NCT00715676|454226410|FG001|Overall Study|Elevated Blood Glucose|1|||
126255537|NCT00715676|454226411|FG002|Overall Study|Elevated Blood Glucose|0|||
126255538|NCT00372996|454226412|FG000|Overall Study|Death|11|||
126255539|NCT00372996|454226413|FG001|Overall Study|Death|4|||
126255540|NCT00372996|454226414|FG002|Overall Study|Death|8|||
126255541|NCT00372996|454226415|FG003|Overall Study|Death|7|||
126255542|NCT00372996|454226412|FG000|Overall Study|Lost to Follow-up|0|||
126255543|NCT00372996|454226413|FG001|Overall Study|Lost to Follow-up|2|||
126255544|NCT00372996|454226414|FG002|Overall Study|Lost to Follow-up|0|||
126255545|NCT00372996|454226415|FG003|Overall Study|Lost to Follow-up|1|||
126255546|NCT00372996|454226412|FG000|Overall Study|Withdrawal by Subject|12|||
126255547|NCT00372996|454226413|FG001|Overall Study|Withdrawal by Subject|6|||
126255548|NCT00372996|454226414|FG002|Overall Study|Withdrawal by Subject|9|||
126255549|NCT00372996|454226415|FG003|Overall Study|Withdrawal by Subject|5|||
126255550|NCT00372996|454226412|FG000|Overall Study|Study Terminated by Sponsor|4|||
126255551|NCT00372996|454226413|FG001|Overall Study|Study Terminated by Sponsor|0|||
126255552|NCT00372996|454226414|FG002|Overall Study|Study Terminated by Sponsor|4|||
126255553|NCT00372996|454226415|FG003|Overall Study|Study Terminated by Sponsor|0|||
126255554|NCT00372996|454226412|FG000|Overall Study|Other|10|||
126095866|NCT00591721|453644592|FG001|Overall Study|Intervention not received|8|||
126255555|NCT00372996|454226413|FG001|Overall Study|Other|2|||
126255556|NCT00372996|454226414|FG002|Overall Study|Other|7|||
126255557|NCT00372996|454226415|FG003|Overall Study|Other|7|||
126255558|NCT01091363|454226416|FG000|Overall Study|Withdrawal by Subject|11|||
126255559|NCT01091363|454226417|FG001|Overall Study|Withdrawal by Subject|15|||
126255560|NCT01091363|454226416|FG000|Overall Study|Lost to Follow-up|2|||
126255561|NCT01091363|454226417|FG001|Overall Study|Lost to Follow-up|2|||
126255562|NCT02151149|454226420|FG000|Treatment Period|Death|2|||
126255563|NCT02151149|454226421|FG001|Treatment Period|Death|3|||
126255564|NCT02151149|454226420|FG000|Treatment Period|Adverse Event|17|||
126255565|NCT02151149|454226421|FG001|Treatment Period|Adverse Event|14|||
126255566|NCT02151149|454226420|FG000|Treatment Period|Progressive Disease|25|||
126255567|NCT02151149|454226421|FG001|Treatment Period|Progressive Disease|24|||
126255568|NCT02151149|454226420|FG000|Treatment Period|Symptomatic Deterioration|2|||
126255569|NCT02151149|454226421|FG001|Treatment Period|Symptomatic Deterioration|10|||
126255570|NCT02151149|454226420|FG000|Treatment Period|Withdrawal by Subject|13|||
126255571|NCT02151149|454226421|FG001|Treatment Period|Withdrawal by Subject|11|||
126255572|NCT02151149|454226420|FG000|Treatment Period|Miscellaneous|8|||
126255573|NCT02151149|454226421|FG001|Treatment Period|Miscellaneous|7|||
126255574|NCT02151149|454226420|FG000|Treatment Period|Participants randomized but not treated|3|||
126255575|NCT02151149|454226421|FG001|Treatment Period|Participants randomized but not treated|2|||
126255576|NCT02151149|454226420|FG000|Follow-Up Period|Lost to Follow-up|2|||
126255577|NCT02151149|454226421|FG001|Follow-Up Period|Lost to Follow-up|3|||
126255578|NCT02151149|454226420|FG000|Follow-Up Period|Death|37|||
126255579|NCT02151149|454226421|FG001|Follow-Up Period|Death|34|||
126255580|NCT02760433|454226422|FG000|Overall Study|Lost to Follow-up|1|||
126255581|NCT02760433|454226423|FG001|Overall Study|Lost to Follow-up|0|||
126255582|NCT02760433|454226424|FG002|Overall Study|Lost to Follow-up|1|||
126255583|NCT02760433|454226425|FG003|Overall Study|Lost to Follow-up|0|||
126255584|NCT02760433|454226426|FG004|Overall Study|Lost to Follow-up|0|||
126255585|NCT02760433|454226422|FG000|Overall Study|Withdrawal by Subject|23|||
126255586|NCT02760433|454226423|FG001|Overall Study|Withdrawal by Subject|9|||
126255587|NCT02760433|454226424|FG002|Overall Study|Withdrawal by Subject|0|||
126255588|NCT02760433|454226425|FG003|Overall Study|Withdrawal by Subject|2|||
126255589|NCT02760433|454226426|FG004|Overall Study|Withdrawal by Subject|9|||
126255590|NCT02760433|454226422|FG000|Overall Study|Lack of Response At Week 14|0|||
126095867|NCT00901186|453644597|FG000|Overall Study|Lack of Efficacy|0|||
126095868|NCT00901186|453644598|FG001|Overall Study|Lack of Efficacy|1|||
126095869|NCT00901186|453644597|FG000|Overall Study|Abnormal laboratory values|0|||
126255591|NCT02760433|454226423|FG001|Overall Study|Lack of Response At Week 14|0|||
126095870|NCT00901186|453644598|FG001|Overall Study|Abnormal laboratory values|1|||
126095871|NCT00901186|453644597|FG000|Overall Study|Lost to Follow-up|2|||
126255592|NCT02760433|454226424|FG002|Overall Study|Lack of Response At Week 14|0|||
126255593|NCT02760433|454226425|FG003|Overall Study|Lack of Response At Week 14|0|||
126255594|NCT02760433|454226426|FG004|Overall Study|Lack of Response At Week 14|1|||
126255595|NCT02760433|454226422|FG000|Overall Study|Subject refused to continue the study|1|||
126255596|NCT02760433|454226423|FG001|Overall Study|Subject refused to continue the study|0|||
126255597|NCT02760433|454226424|FG002|Overall Study|Subject refused to continue the study|0|||
126255598|NCT02760433|454226425|FG003|Overall Study|Subject refused to continue the study|0|||
126255599|NCT02760433|454226426|FG004|Overall Study|Subject refused to continue the study|0|||
126255600|NCT02760433|454226422|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
126255601|NCT02760433|454226423|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125879802|NCT03050801|452857390|FG005|Experiment 1|Lost to Follow-up|0|||
126255602|NCT02760433|454226424|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
126255603|NCT02760433|454226425|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
126255604|NCT02760433|454226426|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
126255605|NCT02760433|454226422|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
126255606|NCT02760433|454226423|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
126255607|NCT02760433|454226424|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
126255608|NCT02760433|454226425|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
126255609|NCT02760433|454226426|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
126255610|NCT05889039|454226432|FG000|Overall Study|error in completing survey|0|||
126255611|NCT05889039|454226433|FG001|Overall Study|error in completing survey|2|||
126255612|NCT05889039|454226434|FG002|Overall Study|error in completing survey|0|||
126255613|NCT05889039|454226435|FG003|Overall Study|error in completing survey|0|||
126255614|NCT05889039|454226432|FG000|Overall Study|Lost to Follow-up|4|||
126255615|NCT05889039|454226433|FG001|Overall Study|Lost to Follow-up|0|||
126255616|NCT05889039|454226434|FG002|Overall Study|Lost to Follow-up|0|||
126255617|NCT05889039|454226435|FG003|Overall Study|Lost to Follow-up|0|||
126255618|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
126255619|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
126255620|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
126255621|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
126255622|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
126255623|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
126255624|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
126255625|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
126255626|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
126255627|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
126255628|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
126255629|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
126255630|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
126255631|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
126255632|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
126255633|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
126255634|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
126255635|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
126255636|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
126255637|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
126255638|NCT01438476|454226438|FG000|Overall Study|Protocol Violation|1|||
126255639|NCT01438476|454226439|FG001|Overall Study|Protocol Violation|0|||
126255640|NCT01438476|454226438|FG000|Overall Study|Withdrawal by Subject|1|||
126255641|NCT01438476|454226439|FG001|Overall Study|Withdrawal by Subject|0|||
126255642|NCT01438476|454226438|FG000|Overall Study|No Surgery- Disease|8|||
126255643|NCT01438476|454226439|FG001|Overall Study|No Surgery- Disease|10|||
126255644|NCT01438476|454226438|FG000|Overall Study|Communication barrier|0|||
126255645|NCT01438476|454226439|FG001|Overall Study|Communication barrier|1|||
126255646|NCT02058160|454226440|FG000|Overall Study|Randomized but not treated|2|||
126255647|NCT02058160|454226441|FG001|Overall Study|Randomized but not treated|4|||
126255648|NCT02058160|454226440|FG000|Overall Study|Poor compliance to protocol|4|||
126255649|NCT02058160|454226441|FG001|Overall Study|Poor compliance to protocol|1|||
126255650|NCT02058160|454226440|FG000|Overall Study|Adverse Event|12|||
126255651|NCT02058160|454226441|FG001|Overall Study|Adverse Event|3|||
126255652|NCT02058160|454226440|FG000|Overall Study|Lost to Follow-up|1|||
126255653|NCT02058160|454226441|FG001|Overall Study|Lost to Follow-up|0|||
126255654|NCT02058160|454226440|FG000|Overall Study|Other than specified above|12|||
126255655|NCT02058160|454226441|FG001|Overall Study|Other than specified above|6|||
126255656|NCT01517867|454226443|FG000|Overall Study|never started treatment|29|||
126255657|NCT01517867|454226444|FG001|Overall Study|never started treatment|32|||
126255658|NCT01517867|454226443|FG000|Overall Study|Withdrawal by Subject|34|||
126255659|NCT01517867|454226444|FG001|Overall Study|Withdrawal by Subject|30|||
126255660|NCT01517867|454226443|FG000|Overall Study|Still in treatment at study end|0|||
126255661|NCT01517867|454226444|FG001|Overall Study|Still in treatment at study end|3|||
126255662|NCT03294317|454226446|FG000|Overall Study|Physician Decision|1|||
126255663|NCT03294317|454226446|FG000|Overall Study|Withdrawal by Subject|6|||
126255664|NCT03294317|454226446|FG000|Overall Study|Lost to Follow-up|1|||
126255665|NCT03294317|454226446|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
126255666|NCT03294317|454226446|FG000|Overall Study|Failed HB lead implant|8|||
126095872|NCT00901186|453644598|FG001|Overall Study|Lost to Follow-up|0|||
126255667|NCT03294317|454226446|FG000|Overall Study|Received CRT instead|1|||
126255668|NCT03294317|454226446|FG000|Overall Study|Exited after lead revision|2|||
126255669|NCT01266603|454226447|FG000|Overall Study|Adverse Event|1|||
126255670|NCT01266603|454226447|FG000|Overall Study|Lack of Efficacy|14|||
126255671|NCT01266603|454226447|FG000|Overall Study|Withdrawal by Subject|1|||
126255672|NCT01266603|454226447|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
126255673|NCT01160640|454226448|FG000|Overall Study|Physician Decision|3|||
126255674|NCT01160640|454226449|FG001|Overall Study|Physician Decision|3|||
126255675|NCT01160640|454226448|FG000|Overall Study|Incarceration|1|||
126255676|NCT01160640|454226449|FG001|Overall Study|Incarceration|0|||
126255677|NCT01160640|454226448|FG000|Overall Study|Withdrawal by Subject|0|||
126255678|NCT01160640|454226449|FG001|Overall Study|Withdrawal by Subject|3|||
126255679|NCT01120691|454226454|FG000|Overall Study|Adverse Event|59|||
126255680|NCT01120691|454226455|FG001|Overall Study|Adverse Event|67|||
126255681|NCT01120691|454226456|FG002|Overall Study|Adverse Event|47|||
126255682|NCT01120691|454226454|FG000|Overall Study|Subject withdrew consent|33|||
126255683|NCT01120691|454226455|FG001|Overall Study|Subject withdrew consent|50|||
126255684|NCT01120691|454226456|FG002|Overall Study|Subject withdrew consent|44|||
126255685|NCT01120691|454226454|FG000|Overall Study|Death|21|||
126255686|NCT01120691|454226455|FG001|Overall Study|Death|22|||
126255687|NCT01120691|454226456|FG002|Overall Study|Death|24|||
126255688|NCT01120691|454226454|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
126255689|NCT01120691|454226455|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
126255690|NCT01120691|454226456|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
126255691|NCT01120691|454226454|FG000|Overall Study|Administrative problems|15|||
126255692|NCT01120691|454226455|FG001|Overall Study|Administrative problems|8|||
126255693|NCT01120691|454226456|FG002|Overall Study|Administrative problems|9|||
126255694|NCT01120691|454226454|FG000|Overall Study|Protocol deviation|13|||
126255695|NCT01120691|454226455|FG001|Overall Study|Protocol deviation|12|||
126255696|NCT01120691|454226456|FG002|Overall Study|Protocol deviation|12|||
126255697|NCT01120691|454226454|FG000|Overall Study|Lost to Follow-up|5|||
126255698|NCT01120691|454226455|FG001|Overall Study|Lost to Follow-up|6|||
126255699|NCT01120691|454226456|FG002|Overall Study|Lost to Follow-up|4|||
126255700|NCT01120691|454226454|FG000|Overall Study|Abnormal test procedure result(s)|3|||
126255701|NCT01120691|454226455|FG001|Overall Study|Abnormal test procedure result(s)|2|||
126255702|NCT01120691|454226456|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126255703|NCT01120691|454226454|FG000|Overall Study|Patient's inability to use the device|3|||
126255704|NCT01120691|454226455|FG001|Overall Study|Patient's inability to use the device|1|||
126255705|NCT01120691|454226456|FG002|Overall Study|Patient's inability to use the device|0|||
126255706|NCT01120691|454226454|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126255707|NCT01120691|454226455|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126255708|NCT01120691|454226456|FG002|Overall Study|Abnormal laboratory value(s)|4|||
126255709|NCT00642811|454226457|FG000|Overall Study|Adverse Event|2|||
126255710|NCT00642811|454226458|FG001|Overall Study|Adverse Event|3|||
126255711|NCT00642811|454226459|FG002|Overall Study|Adverse Event|0|||
126255712|NCT00642811|454226460|FG003|Overall Study|Adverse Event|0|||
126255713|NCT00642811|454226461|FG004|Overall Study|Adverse Event|0|||
126255714|NCT00642811|454226462|FG005|Overall Study|Adverse Event|1|||
126255715|NCT00642811|454226457|FG000|Overall Study|Developement of discontinuation criteria|0|||
126255716|NCT00642811|454226458|FG001|Overall Study|Developement of discontinuation criteria|0|||
126255717|NCT00642811|454226459|FG002|Overall Study|Developement of discontinuation criteria|0|||
126255718|NCT00642811|454226460|FG003|Overall Study|Developement of discontinuation criteria|0|||
126255719|NCT00642811|454226461|FG004|Overall Study|Developement of discontinuation criteria|1|||
126255720|NCT00642811|454226462|FG005|Overall Study|Developement of discontinuation criteria|0|||
126255721|NCT00642811|454226457|FG000|Overall Study|Severe Non-compliance to protocol|1|||
126255722|NCT00642811|454226458|FG001|Overall Study|Severe Non-compliance to protocol|0|||
126255723|NCT00642811|454226459|FG002|Overall Study|Severe Non-compliance to protocol|0|||
126255724|NCT00642811|454226460|FG003|Overall Study|Severe Non-compliance to protocol|0|||
126255725|NCT00642811|454226461|FG004|Overall Study|Severe Non-compliance to protocol|0|||
126255726|NCT00642811|454226462|FG005|Overall Study|Severe Non-compliance to protocol|0|||
126255727|NCT00642811|454226457|FG000|Overall Study|Other|0|||
126255728|NCT00642811|454226458|FG001|Overall Study|Other|1|||
126255729|NCT00642811|454226459|FG002|Overall Study|Other|0|||
126255730|NCT00642811|454226460|FG003|Overall Study|Other|1|||
126255731|NCT00642811|454226461|FG004|Overall Study|Other|0|||
126255732|NCT00642811|454226462|FG005|Overall Study|Other|0|||
126255733|NCT03370510|454226466|FG000|Overall Study|COVID-19|2|||
126255734|NCT03370510|454226467|FG001|Overall Study|COVID-19|0|||
126255735|NCT01562613|454226468|FG000|Overall Study|Lost to Follow-up|2|||
126255736|NCT01562613|454226468|FG000|Overall Study|Withdrawal by Subject|2|||
126255737|NCT01525628|454226473|FG000|Overall Study|Adverse Event|1|||
126255738|NCT01525628|454226474|FG001|Overall Study|Adverse Event|1|||
126255739|NCT01525628|454226475|FG002|Overall Study|Adverse Event|2|||
126358379|NCT03735498|454605319|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
126358380|NCT03787212|454605321|FG000|Period 1|Study Termination|2|||
125879803|NCT03050801|452857385|FG000|Experiment 1|Physician Decision|0|||
125879804|NCT03050801|452857386|FG001|Experiment 1|Physician Decision|3|||
126255740|NCT01525628|454226476|FG003|Overall Study|Adverse Event|0|||
126255741|NCT01525628|454226477|FG004|Overall Study|Adverse Event|1|||
126255742|NCT01525628|454226473|FG000|Overall Study|Lack of Efficacy|0|||
126255743|NCT01525628|454226474|FG001|Overall Study|Lack of Efficacy|2|||
126255744|NCT01525628|454226475|FG002|Overall Study|Lack of Efficacy|2|||
126255745|NCT01525628|454226476|FG003|Overall Study|Lack of Efficacy|1|||
126255746|NCT01525628|454226477|FG004|Overall Study|Lack of Efficacy|2|||
126255747|NCT01525628|454226473|FG000|Overall Study|Protocol Violation|0|||
126255748|NCT01525628|454226474|FG001|Overall Study|Protocol Violation|0|||
126255749|NCT01525628|454226475|FG002|Overall Study|Protocol Violation|1|||
126255750|NCT01525628|454226476|FG003|Overall Study|Protocol Violation|0|||
126255751|NCT01525628|454226477|FG004|Overall Study|Protocol Violation|0|||
126255752|NCT01525628|454226473|FG000|Overall Study|Lost to Follow-up|1|||
126255753|NCT01525628|454226474|FG001|Overall Study|Lost to Follow-up|1|||
126255754|NCT01525628|454226475|FG002|Overall Study|Lost to Follow-up|0|||
126255755|NCT01525628|454226476|FG003|Overall Study|Lost to Follow-up|0|||
126255756|NCT01525628|454226477|FG004|Overall Study|Lost to Follow-up|0|||
126255757|NCT01525628|454226473|FG000|Overall Study|Withdrawal by Subject|0|||
126255758|NCT01525628|454226474|FG001|Overall Study|Withdrawal by Subject|1|||
126255759|NCT01525628|454226475|FG002|Overall Study|Withdrawal by Subject|0|||
126255760|NCT01525628|454226476|FG003|Overall Study|Withdrawal by Subject|0|||
126255761|NCT01525628|454226477|FG004|Overall Study|Withdrawal by Subject|0|||
126255762|NCT01525628|454226473|FG000|Overall Study|Other reason not defined above|0|||
126255763|NCT01525628|454226474|FG001|Overall Study|Other reason not defined above|0|||
126255764|NCT01525628|454226475|FG002|Overall Study|Other reason not defined above|0|||
126255765|NCT01525628|454226476|FG003|Overall Study|Other reason not defined above|3|||
126255766|NCT01525628|454226477|FG004|Overall Study|Other reason not defined above|0|||
126255767|NCT00239005|454226478|FG000|Overall Study|Adverse Event|6|||
126255768|NCT00239005|454226479|FG001|Overall Study|Adverse Event|6|||
126255769|NCT00239005|454226478|FG000|Overall Study|Withdrawal by Subject|3|||
126255770|NCT00239005|454226479|FG001|Overall Study|Withdrawal by Subject|4|||
126255771|NCT00239005|454226478|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
126255772|NCT00239005|454226479|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
126255773|NCT00239005|454226478|FG000|Overall Study|Protocol Violation|1|||
126255774|NCT00239005|454226479|FG001|Overall Study|Protocol Violation|0|||
126255775|NCT00239005|454226478|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
126255776|NCT00239005|454226479|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
126255777|NCT00239005|454226478|FG000|Overall Study|Lost to Follow-up|0|||
126255778|NCT00239005|454226479|FG001|Overall Study|Lost to Follow-up|1|||
126255779|NCT02614898|454226480|FG000|Overall Study|Participated until study termination|10|||
126255780|NCT02614898|454226481|FG001|Overall Study|Participated until study termination|26|||
126255781|NCT02614898|454226480|FG000|Overall Study|Lost to Follow-up|0|||
126255782|NCT02614898|454226481|FG001|Overall Study|Lost to Follow-up|2|||
126255783|NCT02614898|454226480|FG000|Overall Study|Physician Decision|1|||
126255784|NCT02614898|454226481|FG001|Overall Study|Physician Decision|8|||
126255785|NCT02614898|454226480|FG000|Overall Study|Study Terminated by Sponsor|3|||
126255786|NCT02614898|454226481|FG001|Overall Study|Study Terminated by Sponsor|0|||
126255787|NCT02614898|454226480|FG000|Overall Study|Withdrawal by Subject|0|||
126255788|NCT02614898|454226481|FG001|Overall Study|Withdrawal by Subject|2|||
126255789|NCT02614898|454226480|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126255790|NCT02614898|454226481|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126255791|NCT02614898|454226480|FG000|Overall Study|Other-Additional Information Unavailable|0|||
126255792|NCT02614898|454226481|FG001|Overall Study|Other-Additional Information Unavailable|11|||
126255793|NCT02614898|454226480|FG000|Overall Study|Missing|0|||
126255794|NCT02614898|454226481|FG001|Overall Study|Missing|1|||
126255795|NCT03382041|454226482|FG000|Overall Study|Consent Form Lost|2|||
126255796|NCT03382041|454226483|FG001|Overall Study|Consent Form Lost|1|||
126255797|NCT03382041|454226482|FG000|Overall Study|Withdrawal by Subject|1|||
126255798|NCT03382041|454226483|FG001|Overall Study|Withdrawal by Subject|4|||
126255799|NCT03382041|454226482|FG000|Overall Study|Lost to Follow-up|1|||
126255800|NCT03382041|454226483|FG001|Overall Study|Lost to Follow-up|4|||
126255801|NCT03108820|454226484|FG000|Overall Study|Lost to Follow-up|30|||
126095873|NCT00901186|453644597|FG000|Overall Study|Adverse Event|2|||
126095874|NCT00901186|453644598|FG001|Overall Study|Adverse Event|4|||
126095875|NCT00901186|453644597|FG000|Overall Study|Administration problems|0|||
126095876|NCT00901186|453644598|FG001|Overall Study|Administration problems|1|||
126255802|NCT03108820|454226485|FG001|Overall Study|Lost to Follow-up|28|||
126255803|NCT03108820|454226484|FG000|Overall Study|Withdrawal by Subject|32|||
126255804|NCT03108820|454226485|FG001|Overall Study|Withdrawal by Subject|24|||
126255805|NCT03108820|454226484|FG000|Overall Study|Death|6|||
126255806|NCT03108820|454226485|FG001|Overall Study|Death|11|||
126255807|NCT00787605|454226486|FG000|Overall Study|Administrative Problems|3|||
126255808|NCT00787605|454226487|FG001|Overall Study|Administrative Problems|0|||
126255809|NCT00787605|454226486|FG000|Overall Study|Adverse Event|14|||
126255810|NCT00787605|454226487|FG001|Overall Study|Adverse Event|25|||
126255811|NCT00787605|454226486|FG000|Overall Study|Lost to Follow-up|3|||
126095877|NCT00901186|453644597|FG000|Overall Study|Protocol deviations|5|||
126255812|NCT00787605|454226487|FG001|Overall Study|Lost to Follow-up|6|||
126255813|NCT00787605|454226486|FG000|Overall Study|Protocol Violation|7|||
126255814|NCT00787605|454226487|FG001|Overall Study|Protocol Violation|3|||
126255815|NCT00787605|454226486|FG000|Overall Study|Withdrawal by Subject|6|||
126095878|NCT00901186|453644598|FG001|Overall Study|Protocol deviations|4|||
126095879|NCT00581555|453644601|FG000|Overall Study|Adverse Event|4|||
126095880|NCT00581555|453644602|FG001|Overall Study|Adverse Event|3|||
126095881|NCT00581555|453644601|FG000|Overall Study|Physician Decision|3|||
126095882|NCT00581555|453644602|FG001|Overall Study|Physician Decision|2|||
126095883|NCT00581555|453644601|FG000|Overall Study|Withdrawal by Subject|18|||
126095884|NCT00581555|453644602|FG001|Overall Study|Withdrawal by Subject|9|||
126095885|NCT00581555|453644601|FG000|Overall Study|Lost to Follow-up|2|||
126095886|NCT00581555|453644602|FG001|Overall Study|Lost to Follow-up|2|||
126095887|NCT00581555|453644601|FG000|Overall Study|Other reasons|16|||
126255816|NCT00787605|454226487|FG001|Overall Study|Withdrawal by Subject|13|||
126255817|NCT00787605|454226486|FG000|Overall Study|Lack of Efficacy|13|||
126255818|NCT00787605|454226487|FG001|Overall Study|Lack of Efficacy|9|||
126255819|NCT00089973|454226490|FG000|Overall Study|Adverse Event|3|||
126255820|NCT00089973|454226490|FG000|Overall Study|Withdrawal by Subject|1|||
126255821|NCT00089973|454226490|FG000|Overall Study|Disease progression|45|||
126255822|NCT00089973|454226490|FG000|Overall Study|Death|1|||
126255823|NCT01992094|454226492|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
126255824|NCT01992094|454226493|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
126255825|NCT01992094|454226494|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
126095888|NCT00581555|453644602|FG001|Overall Study|Other reasons|4|||
126095889|NCT03828747|453644603|FG000|Double-Blind Treatment Period|Adverse Event|6|||
126095890|NCT03828747|453644604|FG001|Double-Blind Treatment Period|Adverse Event|6|||
126095891|NCT03828747|453644603|FG000|Double-Blind Treatment Period|Death|1|||
126095892|NCT03828747|453644604|FG001|Double-Blind Treatment Period|Death|1|||
126095893|NCT03828747|453644603|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126095894|NCT03828747|453644604|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126095895|NCT03828747|453644603|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
126095896|NCT03828747|453644604|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
126095897|NCT03828747|453644603|FG000|Double-Blind Treatment Period|Physician Decision|1|||
126095898|NCT03828747|453644604|FG001|Double-Blind Treatment Period|Physician Decision|4|||
126095899|NCT03828747|453644603|FG000|Double-Blind Treatment Period|Various reasons|5|||
126095900|NCT03828747|453644604|FG001|Double-Blind Treatment Period|Various reasons|3|||
126095901|NCT03828747|453644603|FG000|Open-Label Extension|Adverse Event|9|||
126095902|NCT03828747|453644604|FG001|Open-Label Extension|Adverse Event|7|||
126095903|NCT03828747|453644603|FG000|Open-Label Extension|Death|0|||
126095904|NCT03828747|453644604|FG001|Open-Label Extension|Death|2|||
126358381|NCT03787212|454605322|FG001|Period 1|Study Termination|2|||
126358382|NCT02014103|454605323|FG000|Overall Study|Protocol Violation|7|||
126358383|NCT02014103|454605324|FG001|Overall Study|Protocol Violation|7|||
126255826|NCT01992094|454226492|FG000|Overall Study|Adverse Event|1|||
126255827|NCT01992094|454226493|FG001|Overall Study|Adverse Event|0|||
126255828|NCT01992094|454226494|FG002|Overall Study|Adverse Event|0|||
126255829|NCT01992094|454226492|FG000|Overall Study|Death|5|||
126255830|NCT01992094|454226493|FG001|Overall Study|Death|5|||
126358384|NCT02014103|454605323|FG000|Overall Study|Adverse Event|1|||
126358385|NCT02014103|454605324|FG001|Overall Study|Adverse Event|0|||
126358386|NCT02014103|454605323|FG000|Overall Study|Lost venous access|1|||
126358387|NCT02014103|454605324|FG001|Overall Study|Lost venous access|0|||
126358388|NCT02014103|454605323|FG000|Overall Study|Withdrawal by Subject|0|||
126095905|NCT03828747|453644603|FG000|Open-Label Extension|Lost to Follow-up|4|||
126095906|NCT03828747|453644604|FG001|Open-Label Extension|Lost to Follow-up|0|||
126095907|NCT03828747|453644603|FG000|Open-Label Extension|Withdrawal by Subject|31|||
126095908|NCT03828747|453644604|FG001|Open-Label Extension|Withdrawal by Subject|30|||
126358389|NCT02014103|454605324|FG001|Overall Study|Withdrawal by Subject|2|||
126358390|NCT00620035|454605325|FG000|Overall Study|Adverse Event|106|||
126255831|NCT01992094|454226494|FG002|Overall Study|Death|2|||
126255832|NCT01992094|454226492|FG000|Overall Study|Lost to Follow-up|26|||
126255833|NCT01992094|454226493|FG001|Overall Study|Lost to Follow-up|9|||
126095909|NCT03828747|453644603|FG000|Open-Label Extension|Various reasons|4|||
126095910|NCT03828747|453644604|FG001|Open-Label Extension|Various reasons|4|||
126255834|NCT01992094|454226494|FG002|Overall Study|Lost to Follow-up|13|||
126255835|NCT01992094|454226492|FG000|Overall Study|OTHER|4|||
126255836|NCT01992094|454226493|FG001|Overall Study|OTHER|0|||
126095911|NCT03828747|453644603|FG000|Open-Label Extension|Physician Decision|6|||
126255837|NCT01992094|454226494|FG002|Overall Study|OTHER|0|||
126255838|NCT01992094|454226492|FG000|Overall Study|Protocol Violation|1|||
126255839|NCT01992094|454226493|FG001|Overall Study|Protocol Violation|0|||
126255840|NCT01992094|454226494|FG002|Overall Study|Protocol Violation|1|||
126255841|NCT01992094|454226492|FG000|Overall Study|Withdrawal by Subject|7|||
126255842|NCT01992094|454226493|FG001|Overall Study|Withdrawal by Subject|3|||
126095912|NCT03828747|453644604|FG001|Open-Label Extension|Physician Decision|2|||
126095913|NCT05816330|453644605|FG000|Overall Study|Withdrawal by Subject|4|||
126255843|NCT01992094|454226494|FG002|Overall Study|Withdrawal by Subject|4|||
126358391|NCT00620035|454605325|FG000|Overall Study|Withdrawal of Informed Consent|1|||
126358392|NCT00620035|454605325|FG000|Overall Study|Other Reason|38|||
126358393|NCT04193176|454605327|FG000|Overall Study|Withdrawal by Subject|6|||
126255844|NCT01214239|454226495|FG000|Overall Study|Adverse Event|3|||
126255845|NCT01214239|454226496|FG001|Overall Study|Adverse Event|4|||
126255846|NCT01214239|454226495|FG000|Overall Study|Protocol Violation|2|||
126255847|NCT01214239|454226496|FG001|Overall Study|Protocol Violation|1|||
126255848|NCT01214239|454226495|FG000|Overall Study|Lost to Follow-up|1|||
126255849|NCT01214239|454226496|FG001|Overall Study|Lost to Follow-up|1|||
126255850|NCT01214239|454226495|FG000|Overall Study|Withdrawal by Subject|4|||
126255851|NCT01214239|454226496|FG001|Overall Study|Withdrawal by Subject|9|||
126255852|NCT01214239|454226495|FG000|Overall Study|Lack of Efficacy|1|||
126255853|NCT01214239|454226496|FG001|Overall Study|Lack of Efficacy|2|||
126255854|NCT01214239|454226495|FG000|Overall Study|patient's private reason|1|||
126255855|NCT01214239|454226496|FG001|Overall Study|patient's private reason|1|||
126255856|NCT01049581|454226497|FG000|Overall Study|Lost to Follow-up|2|||
126255857|NCT01049581|454226498|FG001|Overall Study|Lost to Follow-up|1|||
126255858|NCT03203642|454226499|FG000|Overall Study|Adverse Event|3|||
126255859|NCT03203642|454226500|FG001|Overall Study|Adverse Event|1|||
126255860|NCT03203642|454226499|FG000|Overall Study|Withdrawal by Subject|6|||
126255861|NCT03203642|454226500|FG001|Overall Study|Withdrawal by Subject|6|||
126255862|NCT03203642|454226499|FG000|Overall Study|Lost to Follow-up|2|||
126255863|NCT03203642|454226500|FG001|Overall Study|Lost to Follow-up|1|||
126255864|NCT03203642|454226499|FG000|Overall Study|Termination of the study by sponsor|1|||
126255865|NCT03203642|454226500|FG001|Overall Study|Termination of the study by sponsor|1|||
126255866|NCT03203642|454226499|FG000|Overall Study|Participant moved|0|||
126255867|NCT03203642|454226500|FG001|Overall Study|Participant moved|1|||
126255868|NCT03203642|454226499|FG000|Overall Study|Investigator's decision|3|||
126255869|NCT03203642|454226500|FG001|Overall Study|Investigator's decision|0|||
126255870|NCT03203642|454226499|FG000|Overall Study|Other than above specified|0|||
126255871|NCT03203642|454226500|FG001|Overall Study|Other than above specified|1|||
126255872|NCT05068284|454226513|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
126255873|NCT05068284|454226514|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
126255874|NCT05068284|454226515|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255875|NCT05068284|454226516|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255876|NCT05068284|454226517|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255877|NCT05068284|454226518|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255878|NCT05068284|454226519|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255879|NCT05068284|454226520|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255880|NCT05068284|454226513|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255881|NCT05068284|454226514|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255882|NCT05068284|454226515|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
126255883|NCT05068284|454226516|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255884|NCT05068284|454226517|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255885|NCT05068284|454226518|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255886|NCT05068284|454226519|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255887|NCT05068284|454226520|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255888|NCT05068284|454226513|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
126255889|NCT05068284|454226514|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
126255890|NCT05068284|454226515|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
126255891|NCT05068284|454226516|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
126255892|NCT05068284|454226517|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
126255893|NCT05068284|454226518|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
126255894|NCT05068284|454226519|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
126255895|NCT05068284|454226520|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
126255896|NCT05068284|454226513|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255897|NCT05068284|454226514|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255898|NCT05068284|454226515|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
126255899|NCT05068284|454226516|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255900|NCT05068284|454226517|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
126255901|NCT05068284|454226518|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255902|NCT05068284|454226519|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255903|NCT05068284|454226520|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255904|NCT05068284|454226513|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255905|NCT05068284|454226514|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255906|NCT05068284|454226515|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255907|NCT05068284|454226516|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
126255908|NCT05068284|454226517|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255909|NCT05068284|454226518|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255910|NCT05068284|454226519|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255911|NCT05068284|454226520|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255912|NCT05068284|454226513|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255913|NCT05068284|454226514|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255914|NCT05068284|454226515|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
126255915|NCT05068284|454226516|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
126255916|NCT05068284|454226517|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255917|NCT05068284|454226518|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255918|NCT05068284|454226519|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255919|NCT05068284|454226520|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255920|NCT05068284|454226513|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255921|NCT05068284|454226514|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255922|NCT05068284|454226515|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
126255923|NCT05068284|454226516|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255924|NCT05068284|454226517|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255925|NCT05068284|454226518|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255926|NCT05068284|454226519|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255927|NCT05068284|454226520|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255928|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
126255929|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255930|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255931|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255932|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255933|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255934|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255935|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255936|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
126255937|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255938|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255939|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255940|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255941|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
126255942|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
126255943|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255944|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
126255945|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255946|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255947|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126095914|NCT05816330|453644606|FG001|Overall Study|Withdrawal by Subject|1|||
126095915|NCT03900416|453644607|FG000|Six Week Follow-up|Lost to Follow-up|1|||
126095916|NCT03900416|453644608|FG001|Six Week Follow-up|Lost to Follow-up|0|||
126095917|NCT03900416|453644607|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
126255948|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255949|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255950|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
126255951|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255952|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
126255953|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255954|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255955|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255956|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255957|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255958|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255959|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255960|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
126255961|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255962|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255963|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255964|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255965|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126095918|NCT03900416|453644608|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
126095919|NCT03900416|453644607|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
126095920|NCT03900416|453644608|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
126095921|NCT03900416|453644607|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
126095922|NCT03900416|453644608|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
126095923|NCT03900416|453644607|FG000|Twelve Week Follow-up|Adverse Event|1|||
126095924|NCT03900416|453644608|FG001|Twelve Week Follow-up|Adverse Event|1|||
126095925|NCT03900416|453644607|FG000|Six Month Follow-up|Lost to Follow-up|4|||
126358394|NCT04193176|454605328|FG001|Overall Study|Withdrawal by Subject|10|||
126358395|NCT01629563|454605329|FG000|Overall Study|Adverse Event|16|||
126358396|NCT01629563|454605330|FG001|Overall Study|Adverse Event|16|||
126095926|NCT03900416|453644608|FG001|Six Month Follow-up|Lost to Follow-up|3|||
126095927|NCT03900416|453644607|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
126095928|NCT03900416|453644608|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
126095929|NCT00772330|453644609|FG000|Overall Study|Lost to Follow-up|3|||
126095930|NCT01353859|453644610|FG000|Overall Study|Adverse Event|3|||
126095931|NCT01353859|453644610|FG000|Overall Study|Lack of Efficacy|1|||
126095932|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
126095933|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
126255966|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255967|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255968|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
126255969|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
126255970|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
126255971|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
126255972|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
126255973|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
126255974|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
126255975|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
126255976|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255977|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255978|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255979|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255980|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255981|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255982|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255983|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
126255984|NCT00965731|454226521|FG000|Overall Study|Death|0|||
126255985|NCT00965731|454226522|FG001|Overall Study|Death|4|||
126255986|NCT00965731|454226521|FG000|Overall Study|Withdrawal by Subject|0|||
126255987|NCT00965731|454226522|FG001|Overall Study|Withdrawal by Subject|1|||
126255988|NCT00965731|454226521|FG000|Overall Study|Other|7|||
126255989|NCT00965731|454226522|FG001|Overall Study|Other|15|||
126255990|NCT01074008|454229146|FG000|Overall Study|Adverse Event|0|||
126255991|NCT01074008|454229147|FG001|Overall Study|Adverse Event|1|||
126255992|NCT01074008|454229148|FG002|Overall Study|Adverse Event|0|||
126095934|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
126095935|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
126095936|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
126095937|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
126095938|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
126255993|NCT01074008|454229149|FG003|Overall Study|Adverse Event|0|||
126255994|NCT01074008|454229150|FG004|Overall Study|Adverse Event|0|||
126255995|NCT01074008|454229151|FG005|Overall Study|Adverse Event|0|||
126255996|NCT01074008|454229152|FG006|Overall Study|Adverse Event|0|||
126255997|NCT01074008|454229153|FG007|Overall Study|Adverse Event|0|||
126255998|NCT01074008|454229154|FG008|Overall Study|Adverse Event|0|||
126255999|NCT01074008|454229146|FG000|Overall Study|Withdrawal by Subject|1|||
126256000|NCT01074008|454229147|FG001|Overall Study|Withdrawal by Subject|1|||
126256001|NCT01074008|454229148|FG002|Overall Study|Withdrawal by Subject|1|||
126256002|NCT01074008|454229149|FG003|Overall Study|Withdrawal by Subject|0|||
126256003|NCT01074008|454229150|FG004|Overall Study|Withdrawal by Subject|1|||
126256004|NCT01074008|454229151|FG005|Overall Study|Withdrawal by Subject|0|||
126256005|NCT01074008|454229152|FG006|Overall Study|Withdrawal by Subject|0|||
126256006|NCT01074008|454229153|FG007|Overall Study|Withdrawal by Subject|0|||
126256007|NCT01074008|454229154|FG008|Overall Study|Withdrawal by Subject|0|||
126256008|NCT01074008|454229146|FG000|Overall Study|Lost to Follow-up|0|||
126256009|NCT01074008|454229147|FG001|Overall Study|Lost to Follow-up|1|||
126256010|NCT01074008|454229148|FG002|Overall Study|Lost to Follow-up|1|||
126256011|NCT01074008|454229149|FG003|Overall Study|Lost to Follow-up|1|||
126358397|NCT01629563|454605329|FG000|Overall Study|Death|2|||
126358398|NCT01629563|454605330|FG001|Overall Study|Death|0|||
126095939|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
126095940|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
126095941|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
126095942|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
126095943|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
126095944|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
126095945|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
126095946|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
126095947|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
126095948|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
126095949|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
126095950|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
126095951|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
126095952|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
126095953|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
126095954|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
126095955|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
126095956|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
126095957|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
126095958|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
126095959|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
126095960|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
126095961|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
126095962|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
126095963|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
126095964|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
126095965|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
126095966|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
126095967|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
126256012|NCT01074008|454229150|FG004|Overall Study|Lost to Follow-up|1|||
126256013|NCT01074008|454229151|FG005|Overall Study|Lost to Follow-up|0|||
126256014|NCT01074008|454229152|FG006|Overall Study|Lost to Follow-up|1|||
126256015|NCT01074008|454229153|FG007|Overall Study|Lost to Follow-up|0|||
126256016|NCT01074008|454229154|FG008|Overall Study|Lost to Follow-up|4|||
126256017|NCT02805309|454229155|FG000|Overall Study|Lost to Follow-up|2|||
126256018|NCT02805309|454229156|FG001|Overall Study|Lost to Follow-up|2|||
126256019|NCT02805309|454229157|FG002|Overall Study|Lost to Follow-up|2|||
126256020|NCT02805309|454229155|FG000|Overall Study|Post-Randomization Exclusion|0|||
126256021|NCT02805309|454229156|FG001|Overall Study|Post-Randomization Exclusion|2|||
126256022|NCT02805309|454229157|FG002|Overall Study|Post-Randomization Exclusion|1|||
126256023|NCT01350934|454229160|FG000|Base Study|Adverse Event|6|||
126256024|NCT01350934|454229161|FG001|Base Study|Adverse Event|0|||
126256025|NCT01350934|454229160|FG000|Base Study|Lost to Follow-up|1|||
126256026|NCT01350934|454229161|FG001|Base Study|Lost to Follow-up|0|||
126256027|NCT01350934|454229160|FG000|Base Study|Protocol Violation|1|||
126256028|NCT01350934|454229161|FG001|Base Study|Protocol Violation|1|||
126256029|NCT01350934|454229160|FG000|Base Study|Withdrawal by Subject|1|||
126256030|NCT01350934|454229161|FG001|Base Study|Withdrawal by Subject|2|||
126256031|NCT01350934|454229160|FG000|Base Study|Non-Compliance With Study Drug|2|||
126256032|NCT01350934|454229161|FG001|Base Study|Non-Compliance With Study Drug|0|||
126256033|NCT01350934|454229160|FG000|Extension Study|Adverse Event|2|||
126256034|NCT01350934|454229161|FG001|Extension Study|Adverse Event|1|||
126256035|NCT01350934|454229160|FG000|Extension Study|Lost to Follow-up|2|||
126256036|NCT01350934|454229161|FG001|Extension Study|Lost to Follow-up|0|||
126256037|NCT01350934|454229160|FG000|Extension Study|Protocol Violation|1|||
126256038|NCT01350934|454229161|FG001|Extension Study|Protocol Violation|1|||
126256039|NCT01350934|454229160|FG000|Extension Study|Lack of Efficacy|0|||
126256040|NCT01350934|454229161|FG001|Extension Study|Lack of Efficacy|1|||
126256041|NCT01350934|454229160|FG000|Extension Study|Withdrawal by Subject|0|||
126256042|NCT01350934|454229161|FG001|Extension Study|Withdrawal by Subject|1|||
126256043|NCT04129944|454229164|FG000|Overall Study|Death|0|||
126256044|NCT04129944|454229165|FG001|Overall Study|Death|0|||
126256045|NCT04129944|454229166|FG002|Overall Study|Death|0|||
126256046|NCT04129944|454229167|FG003|Overall Study|Death|1|||
126256047|NCT04129944|454229164|FG000|Overall Study|Lost to Follow-up|1|||
126256048|NCT04129944|454229165|FG001|Overall Study|Lost to Follow-up|0|||
126095968|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
126256049|NCT04129944|454229166|FG002|Overall Study|Lost to Follow-up|0|||
126256050|NCT04129944|454229167|FG003|Overall Study|Lost to Follow-up|0|||
126256051|NCT04129944|454229164|FG000|Overall Study|Withdrawal by Subject|1|||
126256052|NCT04129944|454229165|FG001|Overall Study|Withdrawal by Subject|0|||
126256053|NCT04129944|454229166|FG002|Overall Study|Withdrawal by Subject|1|||
126095969|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
126095970|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
126095971|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
126095972|NCT00700427|453644611|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
126095973|NCT00700427|453644612|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
126095974|NCT00700427|453644613|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
126095975|NCT00700427|453644614|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
126095976|NCT00700427|453644615|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
126095977|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
126095978|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
126095979|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
126095980|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
126095981|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
126095982|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
126095983|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
126095984|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
126095985|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
126095986|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
126095987|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
126095988|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
126095989|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
126095990|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
126095991|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
126095992|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
126095993|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
126095994|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
126095995|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
126095996|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
126095997|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
126095998|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
126095999|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
126096000|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
126096001|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
126096002|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
126096003|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
126096004|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
126096005|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
126096006|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
126096007|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
126096008|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
126096009|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
126096010|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
126096011|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
126096012|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
126096013|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
126096014|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
126096015|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
126096016|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
126096017|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
126096018|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
126096019|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
126096020|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
126096021|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
126096022|NCT00700427|453644611|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
126096023|NCT00700427|453644612|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
126096024|NCT00700427|453644613|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
126096025|NCT00700427|453644614|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
126096026|NCT00700427|453644615|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
126096027|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
126096028|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
126096029|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
126096030|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
126096031|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
126358399|NCT01629563|454605329|FG000|Overall Study|Lack of Efficacy|2|||
126256054|NCT04129944|454229167|FG003|Overall Study|Withdrawal by Subject|2|||
126256055|NCT00493792|454229168|FG000|Overall Study|Death|55|||
126256056|NCT00493792|454229169|FG001|Overall Study|Death|50|||
126256057|NCT00493792|454229168|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
126256058|NCT00493792|454229169|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
126256059|NCT00685035|454229170|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
126256060|NCT00685035|454229171|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
126256061|NCT04241133|454229172|FG000|Overall Study|COVID19 Precautions|14|||
126256062|NCT04241133|454229173|FG001|Overall Study|COVID19 Precautions|34|||
126256063|NCT04982445|454229174|FG000|Overall Study|Protocol Violation|1|||
126256064|NCT04982445|454229174|FG000|Overall Study|Withdrawal by Subject|4|||
126256065|NCT04982445|454229174|FG000|Overall Study|Lost to Follow-up|1|||
126256066|NCT00611884|454229176|FG000|Overall Study|Adverse Event|1|||
126256067|NCT00611884|454229177|FG001|Overall Study|Adverse Event|0|||
126256068|NCT00611884|454229178|FG002|Overall Study|Adverse Event|0|||
126256069|NCT00611884|454229179|FG003|Overall Study|Adverse Event|1|||
126256070|NCT00611884|454229176|FG000|Overall Study|Non-Compliance|1|||
126256071|NCT00611884|454229177|FG001|Overall Study|Non-Compliance|4|||
126256072|NCT00611884|454229178|FG002|Overall Study|Non-Compliance|2|||
126256073|NCT00611884|454229179|FG003|Overall Study|Non-Compliance|2|||
126256074|NCT00611884|454229176|FG000|Overall Study|Lack of Efficacy|0|||
126256075|NCT00611884|454229177|FG001|Overall Study|Lack of Efficacy|1|||
126256076|NCT00611884|454229178|FG002|Overall Study|Lack of Efficacy|0|||
126256077|NCT00611884|454229179|FG003|Overall Study|Lack of Efficacy|0|||
126256078|NCT00611884|454229176|FG000|Overall Study|Unclassified|7|||
126256079|NCT00611884|454229177|FG001|Overall Study|Unclassified|4|||
126256080|NCT00611884|454229178|FG002|Overall Study|Unclassified|2|||
126256081|NCT00611884|454229179|FG003|Overall Study|Unclassified|3|||
126256082|NCT00981799|454229180|FG000|Overall Study|Adverse Event|1|||
126256083|NCT00981799|454229181|FG001|Overall Study|Adverse Event|1|||
126256084|NCT00981799|454229182|FG002|Overall Study|Adverse Event|0|||
126256085|NCT00981799|454229183|FG003|Overall Study|Adverse Event|0|||
126256086|NCT00348816|454229184|FG000|Overall Study|Noncompliance with radiation treatment|1|||
126256087|NCT00687739|454229185|FG000|Overall Study|Lost to Follow-up|2|||
126256088|NCT00687739|454229186|FG001|Overall Study|Lost to Follow-up|2|||
126256089|NCT00687739|454229187|FG002|Overall Study|Lost to Follow-up|1|||
126256090|NCT00687739|454229188|FG003|Overall Study|Lost to Follow-up|2|||
126256091|NCT00687739|454229185|FG000|Overall Study|Adverse Event|0|||
126256092|NCT00687739|454229186|FG001|Overall Study|Adverse Event|1|||
126256093|NCT00687739|454229187|FG002|Overall Study|Adverse Event|1|||
126256094|NCT00687739|454229188|FG003|Overall Study|Adverse Event|0|||
126256095|NCT01190930|454229189|FG000|Induction|Adverse Event|17|||
126256096|NCT01190930|454229190|FG001|Induction|Adverse Event|0|||
126256097|NCT01190930|454229191|FG002|Induction|Adverse Event|0|||
126256098|NCT01190930|454229192|FG003|Induction|Adverse Event|0|||
126256099|NCT01190930|454229193|FG004|Induction|Adverse Event|0|||
126256100|NCT01190930|454229194|FG005|Induction|Adverse Event|0|||
126256101|NCT01190930|454229195|FG006|Induction|Adverse Event|0|||
126256102|NCT01190930|454229196|FG007|Induction|Adverse Event|0|||
126256103|NCT01190930|454229197|FG008|Induction|Adverse Event|0|||
126256104|NCT01190930|454229198|FG009|Induction|Adverse Event|0|||
126256105|NCT01190930|454229189|FG000|Induction|Death|34|||
126256106|NCT01190930|454229190|FG001|Induction|Death|0|||
126256107|NCT01190930|454229191|FG002|Induction|Death|0|||
126256108|NCT01190930|454229192|FG003|Induction|Death|0|||
126256109|NCT01190930|454229193|FG004|Induction|Death|0|||
126256110|NCT01190930|454229194|FG005|Induction|Death|0|||
126256111|NCT01190930|454229195|FG006|Induction|Death|0|||
126256112|NCT01190930|454229196|FG007|Induction|Death|0|||
126256113|NCT01190930|454229197|FG008|Induction|Death|0|||
126256114|NCT01190930|454229198|FG009|Induction|Death|0|||
126256115|NCT01190930|454229189|FG000|Induction|Lost to Follow-up|1|||
126256116|NCT01190930|454229190|FG001|Induction|Lost to Follow-up|0|||
126256117|NCT01190930|454229191|FG002|Induction|Lost to Follow-up|0|||
126256118|NCT01190930|454229192|FG003|Induction|Lost to Follow-up|0|||
126256119|NCT01190930|454229193|FG004|Induction|Lost to Follow-up|0|||
126256120|NCT01190930|454229194|FG005|Induction|Lost to Follow-up|0|||
126029975|NCT03683719|453406762|FG002|Overall Study|Lost to Follow-up|0|||
126029976|NCT03683719|453406763|FG003|Overall Study|Lost to Follow-up|1|||
126029977|NCT03683719|453406764|FG004|Overall Study|Lost to Follow-up|1|||
126029978|NCT03683719|453406760|FG000|Overall Study|Other personal reasons|0|||
126029979|NCT03683719|453406761|FG001|Overall Study|Other personal reasons|0|||
126256121|NCT01190930|454229195|FG006|Induction|Lost to Follow-up|0|||
126256122|NCT01190930|454229196|FG007|Induction|Lost to Follow-up|0|||
126256123|NCT01190930|454229197|FG008|Induction|Lost to Follow-up|0|||
126256124|NCT01190930|454229198|FG009|Induction|Lost to Follow-up|0|||
126256125|NCT01190930|454229189|FG000|Induction|Physician Decision|125|||
126256126|NCT01190930|454229190|FG001|Induction|Physician Decision|3|||
126256127|NCT01190930|454229191|FG002|Induction|Physician Decision|0|||
126256128|NCT01190930|454229192|FG003|Induction|Physician Decision|0|||
126256129|NCT01190930|454229193|FG004|Induction|Physician Decision|0|||
126256130|NCT01190930|454229194|FG005|Induction|Physician Decision|0|||
126256131|NCT01190930|454229195|FG006|Induction|Physician Decision|0|||
126256132|NCT01190930|454229196|FG007|Induction|Physician Decision|0|||
126256133|NCT01190930|454229197|FG008|Induction|Physician Decision|0|||
126256134|NCT01190930|454229198|FG009|Induction|Physician Decision|0|||
126256135|NCT01190930|454229189|FG000|Induction|Withdrawal by Subject|9|||
126256136|NCT01190930|454229190|FG001|Induction|Withdrawal by Subject|0|||
126256137|NCT01190930|454229191|FG002|Induction|Withdrawal by Subject|0|||
126256138|NCT01190930|454229192|FG003|Induction|Withdrawal by Subject|0|||
126256139|NCT01190930|454229193|FG004|Induction|Withdrawal by Subject|0|||
126256140|NCT01190930|454229194|FG005|Induction|Withdrawal by Subject|0|||
126256141|NCT01190930|454229195|FG006|Induction|Withdrawal by Subject|0|||
126256142|NCT01190930|454229196|FG007|Induction|Withdrawal by Subject|0|||
126256143|NCT01190930|454229197|FG008|Induction|Withdrawal by Subject|0|||
126256144|NCT01190930|454229198|FG009|Induction|Withdrawal by Subject|0|||
126256145|NCT01190930|454229189|FG000|Induction|Refusal|235|||
126256146|NCT01190930|454229190|FG001|Induction|Refusal|0|||
126256147|NCT01190930|454229191|FG002|Induction|Refusal|0|||
126256148|NCT01190930|454229192|FG003|Induction|Refusal|0|||
126256149|NCT01190930|454229193|FG004|Induction|Refusal|0|||
126256150|NCT01190930|454229194|FG005|Induction|Refusal|0|||
126256151|NCT01190930|454229195|FG006|Induction|Refusal|0|||
126256152|NCT01190930|454229196|FG007|Induction|Refusal|0|||
126256153|NCT01190930|454229197|FG008|Induction|Refusal|0|||
126256154|NCT01190930|454229198|FG009|Induction|Refusal|0|||
126256155|NCT01190930|454229189|FG000|Induction|Inevaluable|23|||
126256156|NCT01190930|454229190|FG001|Induction|Inevaluable|1|||
126256157|NCT01190930|454229191|FG002|Induction|Inevaluable|0|||
126256158|NCT01190930|454229192|FG003|Induction|Inevaluable|0|||
126256159|NCT01190930|454229193|FG004|Induction|Inevaluable|0|||
126256160|NCT01190930|454229194|FG005|Induction|Inevaluable|0|||
126256161|NCT01190930|454229195|FG006|Induction|Inevaluable|0|||
126256162|NCT01190930|454229196|FG007|Induction|Inevaluable|0|||
126256163|NCT01190930|454229197|FG008|Induction|Inevaluable|0|||
126256164|NCT01190930|454229198|FG009|Induction|Inevaluable|0|||
126256165|NCT01190930|454229189|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
126256166|NCT01190930|454229190|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256167|NCT01190930|454229191|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256168|NCT01190930|454229192|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256169|NCT01190930|454229193|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256170|NCT01190930|454229194|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256171|NCT01190930|454229195|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256172|NCT01190930|454229196|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256173|NCT01190930|454229197|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256174|NCT01190930|454229198|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256175|NCT01190930|454229189|FG000|Induction|High Risk Downs|80|||
126256176|NCT01190930|454229190|FG001|Induction|High Risk Downs|0|||
126256177|NCT01190930|454229191|FG002|Induction|High Risk Downs|0|||
126029980|NCT03683719|453406762|FG002|Overall Study|Other personal reasons|1|||
126256178|NCT01190930|454229192|FG003|Induction|High Risk Downs|0|||
126256179|NCT01190930|454229193|FG004|Induction|High Risk Downs|0|||
126256180|NCT01190930|454229194|FG005|Induction|High Risk Downs|0|||
126256181|NCT01190930|454229195|FG006|Induction|High Risk Downs|0|||
126256182|NCT01190930|454229196|FG007|Induction|High Risk Downs|0|||
126256183|NCT01190930|454229197|FG008|Induction|High Risk Downs|0|||
126256184|NCT01190930|454229198|FG009|Induction|High Risk Downs|0|||
126256185|NCT01190930|454229189|FG000|Induction|Enrollment onto another COG Protocol|1|||
126256186|NCT01190930|454229190|FG001|Induction|Enrollment onto another COG Protocol|0|||
126256187|NCT01190930|454229191|FG002|Induction|Enrollment onto another COG Protocol|0|||
126256188|NCT01190930|454229192|FG003|Induction|Enrollment onto another COG Protocol|0|||
126256189|NCT01190930|454229193|FG004|Induction|Enrollment onto another COG Protocol|0|||
126256190|NCT01190930|454229194|FG005|Induction|Enrollment onto another COG Protocol|0|||
126256191|NCT01190930|454229195|FG006|Induction|Enrollment onto another COG Protocol|0|||
126256192|NCT01190930|454229196|FG007|Induction|Enrollment onto another COG Protocol|0|||
126256193|NCT01190930|454229197|FG008|Induction|Enrollment onto another COG Protocol|0|||
126256194|NCT01190930|454229198|FG009|Induction|Enrollment onto another COG Protocol|0|||
126256195|NCT01190930|454229189|FG000|Induction|Average Risk|1847|||
126256196|NCT01190930|454229190|FG001|Induction|Average Risk|0|||
126256197|NCT01190930|454229191|FG002|Induction|Average Risk|0|||
126256198|NCT01190930|454229192|FG003|Induction|Average Risk|0|||
126256199|NCT01190930|454229193|FG004|Induction|Average Risk|0|||
126256200|NCT01190930|454229194|FG005|Induction|Average Risk|0|||
126256201|NCT01190930|454229195|FG006|Induction|Average Risk|0|||
126256202|NCT01190930|454229196|FG007|Induction|Average Risk|0|||
126256203|NCT01190930|454229197|FG008|Induction|Average Risk|0|||
126256204|NCT01190930|454229198|FG009|Induction|Average Risk|0|||
126256205|NCT01190930|454229189|FG000|Induction|High Risk|1227|||
126256206|NCT01190930|454229190|FG001|Induction|High Risk|0|||
126256207|NCT01190930|454229191|FG002|Induction|High Risk|0|||
126256208|NCT01190930|454229192|FG003|Induction|High Risk|0|||
126256209|NCT01190930|454229193|FG004|Induction|High Risk|0|||
126256210|NCT01190930|454229194|FG005|Induction|High Risk|0|||
126256211|NCT01190930|454229195|FG006|Induction|High Risk|0|||
126256212|NCT01190930|454229196|FG007|Induction|High Risk|0|||
126256213|NCT01190930|454229197|FG008|Induction|High Risk|0|||
126256214|NCT01190930|454229198|FG009|Induction|High Risk|0|||
126256215|NCT01190930|454229189|FG000|Induction|Low Risk|443|||
126256216|NCT01190930|454229190|FG001|Induction|Low Risk|0|||
126256217|NCT01190930|454229191|FG002|Induction|Low Risk|0|||
126256218|NCT01190930|454229192|FG003|Induction|Low Risk|0|||
126256219|NCT01190930|454229193|FG004|Induction|Low Risk|0|||
126256220|NCT01190930|454229194|FG005|Induction|Low Risk|0|||
126256221|NCT01190930|454229195|FG006|Induction|Low Risk|0|||
126256222|NCT01190930|454229196|FG007|Induction|Low Risk|0|||
126256223|NCT01190930|454229197|FG008|Induction|Low Risk|0|||
126256224|NCT01190930|454229198|FG009|Induction|Low Risk|0|||
126256225|NCT01190930|454229189|FG000|Induction|Very High Risk|1012|||
126256226|NCT01190930|454229190|FG001|Induction|Very High Risk|0|||
126256227|NCT01190930|454229191|FG002|Induction|Very High Risk|0|||
126256228|NCT01190930|454229192|FG003|Induction|Very High Risk|0|||
126256229|NCT01190930|454229193|FG004|Induction|Very High Risk|0|||
126256230|NCT01190930|454229194|FG005|Induction|Very High Risk|0|||
126256231|NCT01190930|454229195|FG006|Induction|Very High Risk|0|||
126256232|NCT01190930|454229196|FG007|Induction|Very High Risk|0|||
126256233|NCT01190930|454229197|FG008|Induction|Very High Risk|0|||
126256234|NCT01190930|454229198|FG009|Induction|Very High Risk|0|||
126256235|NCT01190930|454229189|FG000|Induction|Philadelphia chromosome-positive|99|||
126256236|NCT01190930|454229190|FG001|Induction|Philadelphia chromosome-positive|0|||
126256237|NCT01190930|454229191|FG002|Induction|Philadelphia chromosome-positive|0|||
126256238|NCT01190930|454229192|FG003|Induction|Philadelphia chromosome-positive|0|||
126256239|NCT01190930|454229193|FG004|Induction|Philadelphia chromosome-positive|0|||
126256240|NCT01190930|454229194|FG005|Induction|Philadelphia chromosome-positive|0|||
126256241|NCT01190930|454229195|FG006|Induction|Philadelphia chromosome-positive|0|||
126256242|NCT01190930|454229196|FG007|Induction|Philadelphia chromosome-positive|0|||
126256243|NCT01190930|454229197|FG008|Induction|Philadelphia chromosome-positive|0|||
126256244|NCT01190930|454229198|FG009|Induction|Philadelphia chromosome-positive|0|||
126256245|NCT01190930|454229189|FG000|Induction|Incomplete Induction data|63|||
126256246|NCT01190930|454229190|FG001|Induction|Incomplete Induction data|0|||
126256247|NCT01190930|454229191|FG002|Induction|Incomplete Induction data|0|||
126256248|NCT01190930|454229192|FG003|Induction|Incomplete Induction data|0|||
126256249|NCT01190930|454229193|FG004|Induction|Incomplete Induction data|0|||
126256250|NCT01190930|454229194|FG005|Induction|Incomplete Induction data|0|||
126256251|NCT01190930|454229195|FG006|Induction|Incomplete Induction data|0|||
126256252|NCT01190930|454229196|FG007|Induction|Incomplete Induction data|0|||
126256253|NCT01190930|454229197|FG008|Induction|Incomplete Induction data|0|||
126256254|NCT01190930|454229198|FG009|Induction|Incomplete Induction data|0|||
126256255|NCT01190930|454229189|FG000|Induction|Progressive disease|0|||
126256256|NCT01190930|454229190|FG001|Induction|Progressive disease|1|||
126256257|NCT01190930|454229191|FG002|Induction|Progressive disease|0|||
126096032|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
126256258|NCT01190930|454229192|FG003|Induction|Progressive disease|0|||
126096033|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
126256259|NCT01190930|454229193|FG004|Induction|Progressive disease|0|||
126256260|NCT01190930|454229194|FG005|Induction|Progressive disease|0|||
126256261|NCT01190930|454229195|FG006|Induction|Progressive disease|0|||
126256262|NCT01190930|454229196|FG007|Induction|Progressive disease|0|||
126256263|NCT01190930|454229197|FG008|Induction|Progressive disease|0|||
126256264|NCT01190930|454229198|FG009|Induction|Progressive disease|0|||
126256265|NCT01190930|454229189|FG000|Induction|No treatment|3|||
126256266|NCT01190930|454229190|FG001|Induction|No treatment|0|||
126256267|NCT01190930|454229191|FG002|Induction|No treatment|0|||
126256268|NCT01190930|454229192|FG003|Induction|No treatment|0|||
126256269|NCT01190930|454229193|FG004|Induction|No treatment|0|||
126256270|NCT01190930|454229194|FG005|Induction|No treatment|0|||
126256271|NCT01190930|454229195|FG006|Induction|No treatment|0|||
126256272|NCT01190930|454229196|FG007|Induction|No treatment|0|||
126256273|NCT01190930|454229197|FG008|Induction|No treatment|0|||
126256274|NCT01190930|454229198|FG009|Induction|No treatment|0|||
126256275|NCT01190930|454229189|FG000|Induction|Ineligible|69|||
126256276|NCT01190930|454229190|FG001|Induction|Ineligible|4|||
126256277|NCT01190930|454229191|FG002|Induction|Ineligible|0|||
126256278|NCT01190930|454229192|FG003|Induction|Ineligible|0|||
126256279|NCT01190930|454229193|FG004|Induction|Ineligible|0|||
126256280|NCT01190930|454229194|FG005|Induction|Ineligible|0|||
126256281|NCT01190930|454229195|FG006|Induction|Ineligible|0|||
126256282|NCT01190930|454229196|FG007|Induction|Ineligible|0|||
126256283|NCT01190930|454229197|FG008|Induction|Ineligible|0|||
126256284|NCT01190930|454229198|FG009|Induction|Ineligible|0|||
126256285|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
126256286|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
126256287|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
126256288|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
126256289|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
126256290|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
126256291|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
126256292|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
126256293|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
126256294|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
126256295|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Death|0|||
126256296|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Death|0|||
126256297|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Death|8|||
126256298|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Death|4|||
126256299|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Death|0|||
126256300|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Death|0|||
126256301|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Death|0|||
126256302|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Death|0|||
126256303|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Death|0|||
126256304|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Death|0|||
126256305|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
126256306|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
126256307|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
126256308|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
126256309|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
126256310|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
126256311|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
126256312|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
126256313|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
126256314|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
126256315|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256316|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
126256317|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
126256318|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
126256319|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256320|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256321|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256322|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256323|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256324|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256325|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Refusal|0|||
126256326|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Refusal|2|||
126256327|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Refusal|694|||
126256328|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Refusal|4|||
126256329|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Refusal|0|||
126256330|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Refusal|3|||
126029981|NCT03683719|453406763|FG003|Overall Study|Other personal reasons|0|||
126256331|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Refusal|0|||
126256332|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Refusal|0|||
126256333|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Refusal|0|||
126256334|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Refusal|0|||
126256335|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
126029982|NCT03683719|453406764|FG004|Overall Study|Other personal reasons|1|||
126029983|NCT04896476|453406770|FG000|Overall Study|Withdrawal by Subject|1|||
126029984|NCT04896476|453406770|FG000|Overall Study|Lost to Follow-up|2|||
126256336|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
126256337|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
126256338|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
126256339|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
126029985|NCT03476187|453406771|FG000|Overall Study|Protocol Violation|7|||
126256340|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
126256341|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
126256342|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
126256343|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
126256344|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
126256345|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256346|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
126256347|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256348|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256349|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256350|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256351|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256352|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256353|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256354|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256355|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
126256356|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
126256357|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
126256358|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
126256359|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
126256360|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
126256361|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
126256362|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
126256363|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
126256364|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
126256365|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Relapse|0|||
126256366|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Relapse|0|||
126256367|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Relapse|1|||
126256368|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Relapse|0|||
126256369|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Relapse|0|||
126256370|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Relapse|0|||
126256371|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Relapse|0|||
126256372|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Relapse|0|||
126256373|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Relapse|0|||
126256374|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Relapse|0|||
126256375|NCT01190930|454229189|FG000|Maintenance|Adverse Event|0|||
126256376|NCT01190930|454229190|FG001|Maintenance|Adverse Event|0|||
126256377|NCT01190930|454229191|FG002|Maintenance|Adverse Event|0|||
126256378|NCT01190930|454229192|FG003|Maintenance|Adverse Event|0|||
126256379|NCT01190930|454229193|FG004|Maintenance|Adverse Event|0|||
126256380|NCT01190930|454229194|FG005|Maintenance|Adverse Event|1|||
126256381|NCT01190930|454229195|FG006|Maintenance|Adverse Event|1|||
126256382|NCT01190930|454229196|FG007|Maintenance|Adverse Event|3|||
126256383|NCT01190930|454229197|FG008|Maintenance|Adverse Event|3|||
126256384|NCT01190930|454229198|FG009|Maintenance|Adverse Event|0|||
126256385|NCT01190930|454229189|FG000|Maintenance|Death|0|||
126256386|NCT01190930|454229190|FG001|Maintenance|Death|0|||
126029986|NCT03476187|453406771|FG000|Overall Study|Physician Decision|5|||
126029987|NCT03135548|453406773|FG000|Overall Study|Lost to Follow-up|3|||
126029988|NCT03135548|453406774|FG001|Overall Study|Lost to Follow-up|0|||
126029989|NCT03135548|453406775|FG002|Overall Study|Lost to Follow-up|0|||
126029990|NCT03135548|453406773|FG000|Overall Study|Withdrawal by Subject|2|||
126029991|NCT03135548|453406774|FG001|Overall Study|Withdrawal by Subject|2|||
126029992|NCT03135548|453406775|FG002|Overall Study|Withdrawal by Subject|1|||
126029993|NCT03135548|453406773|FG000|Overall Study|Other than listed|0|||
126029994|NCT03135548|453406774|FG001|Overall Study|Other than listed|2|||
126029995|NCT03135548|453406775|FG002|Overall Study|Other than listed|2|||
126256387|NCT01190930|454229191|FG002|Maintenance|Death|0|||
126256388|NCT01190930|454229192|FG003|Maintenance|Death|1|||
126256389|NCT01190930|454229193|FG004|Maintenance|Death|0|||
126256390|NCT01190930|454229194|FG005|Maintenance|Death|0|||
126256391|NCT01190930|454229195|FG006|Maintenance|Death|2|||
126256392|NCT01190930|454229196|FG007|Maintenance|Death|2|||
126256393|NCT01190930|454229197|FG008|Maintenance|Death|2|||
126256394|NCT01190930|454229198|FG009|Maintenance|Death|2|||
126256395|NCT01190930|454229189|FG000|Maintenance|Lost to Follow-up|0|||
126256396|NCT01190930|454229190|FG001|Maintenance|Lost to Follow-up|0|||
126256397|NCT01190930|454229191|FG002|Maintenance|Lost to Follow-up|0|||
126029996|NCT03924986|453406776|FG000|Overall Study|Death|57|||
126029997|NCT03924986|453406777|FG001|Overall Study|Death|66|||
126029998|NCT03924986|453406776|FG000|Overall Study|Study Concluded by Sponsor|51|||
126256398|NCT01190930|454229192|FG003|Maintenance|Lost to Follow-up|0|||
126256399|NCT01190930|454229193|FG004|Maintenance|Lost to Follow-up|0|||
126256400|NCT01190930|454229194|FG005|Maintenance|Lost to Follow-up|0|||
126256401|NCT01190930|454229195|FG006|Maintenance|Lost to Follow-up|1|||
126256402|NCT01190930|454229196|FG007|Maintenance|Lost to Follow-up|1|||
126256403|NCT01190930|454229197|FG008|Maintenance|Lost to Follow-up|1|||
126256404|NCT01190930|454229198|FG009|Maintenance|Lost to Follow-up|0|||
126256405|NCT01190930|454229189|FG000|Maintenance|Physician Decision|0|||
126029999|NCT03924986|453406777|FG001|Overall Study|Study Concluded by Sponsor|41|||
126030000|NCT03924986|453406776|FG000|Overall Study|Withdrawal by Subject|15|||
126030001|NCT03924986|453406777|FG001|Overall Study|Withdrawal by Subject|20|||
126030002|NCT03924986|453406776|FG000|Overall Study|Lost to Follow-up|7|||
126030003|NCT03924986|453406777|FG001|Overall Study|Lost to Follow-up|5|||
126030004|NCT03924986|453406776|FG000|Overall Study|Miscellaneous|1|||
126030005|NCT03924986|453406777|FG001|Overall Study|Miscellaneous|0|||
126030006|NCT03445988|453406780|FG000|Overall Study|Lost to Follow-up|14|||
126030007|NCT03445988|453406781|FG001|Overall Study|Lost to Follow-up|26|||
126030008|NCT03445988|453406782|FG002|Overall Study|Lost to Follow-up|27|||
126030009|NCT03445988|453406783|FG003|Overall Study|Lost to Follow-up|66|||
126030010|NCT03445988|453406780|FG000|Overall Study|Withdrawal by Subject|7|||
126030011|NCT03445988|453406781|FG001|Overall Study|Withdrawal by Subject|4|||
126030012|NCT03445988|453406782|FG002|Overall Study|Withdrawal by Subject|3|||
126030013|NCT03445988|453406783|FG003|Overall Study|Withdrawal by Subject|5|||
126030014|NCT03445988|453406780|FG000|Overall Study|Death (unrelated to study)|5|||
126030015|NCT03445988|453406781|FG001|Overall Study|Death (unrelated to study)|1|||
126030016|NCT03445988|453406782|FG002|Overall Study|Death (unrelated to study)|2|||
126030017|NCT03445988|453406783|FG003|Overall Study|Death (unrelated to study)|4|||
126030018|NCT03988608|453406784|FG000|Overall Study|Adverse Event|1|||
126030019|NCT03988608|453406784|FG000|Overall Study|Lost to Follow-up|1|||
126030020|NCT03988608|453406784|FG000|Overall Study|Withdrawal by Subject|3|||
126030021|NCT03988608|453406784|FG000|Overall Study|Death|1|||
126030022|NCT02689284|453406791|FG000|Overall Study|Adverse Event|1|||
126030023|NCT02689284|453406792|FG001|Overall Study|Adverse Event|8|||
126256406|NCT01190930|454229190|FG001|Maintenance|Physician Decision|1|||
126256407|NCT01190930|454229191|FG002|Maintenance|Physician Decision|0|||
126256408|NCT01190930|454229192|FG003|Maintenance|Physician Decision|5|||
126256409|NCT01190930|454229193|FG004|Maintenance|Physician Decision|9|||
126256410|NCT01190930|454229194|FG005|Maintenance|Physician Decision|4|||
126256411|NCT01190930|454229195|FG006|Maintenance|Physician Decision|8|||
126256412|NCT01190930|454229196|FG007|Maintenance|Physician Decision|8|||
126256413|NCT01190930|454229197|FG008|Maintenance|Physician Decision|10|||
126256414|NCT01190930|454229198|FG009|Maintenance|Physician Decision|17|||
126256415|NCT01190930|454229189|FG000|Maintenance|Withdrawal by Subject|0|||
126256416|NCT01190930|454229190|FG001|Maintenance|Withdrawal by Subject|0|||
126256417|NCT01190930|454229191|FG002|Maintenance|Withdrawal by Subject|0|||
126256418|NCT01190930|454229192|FG003|Maintenance|Withdrawal by Subject|0|||
126256419|NCT01190930|454229193|FG004|Maintenance|Withdrawal by Subject|0|||
126256420|NCT01190930|454229194|FG005|Maintenance|Withdrawal by Subject|0|||
126256421|NCT01190930|454229195|FG006|Maintenance|Withdrawal by Subject|2|||
126256422|NCT01190930|454229196|FG007|Maintenance|Withdrawal by Subject|1|||
126256423|NCT01190930|454229197|FG008|Maintenance|Withdrawal by Subject|4|||
126256424|NCT01190930|454229198|FG009|Maintenance|Withdrawal by Subject|1|||
126256425|NCT01190930|454229189|FG000|Maintenance|Refusal|0|||
126256426|NCT01190930|454229190|FG001|Maintenance|Refusal|1|||
126256427|NCT01190930|454229191|FG002|Maintenance|Refusal|0|||
126256428|NCT01190930|454229192|FG003|Maintenance|Refusal|2|||
126256429|NCT01190930|454229193|FG004|Maintenance|Refusal|0|||
126256430|NCT01190930|454229194|FG005|Maintenance|Refusal|4|||
126256431|NCT01190930|454229195|FG006|Maintenance|Refusal|5|||
126256432|NCT01190930|454229196|FG007|Maintenance|Refusal|17|||
126256433|NCT01190930|454229197|FG008|Maintenance|Refusal|13|||
126256434|NCT01190930|454229198|FG009|Maintenance|Refusal|6|||
126256435|NCT01190930|454229189|FG000|Maintenance|second malignant neoplasm|0|||
126256436|NCT01190930|454229190|FG001|Maintenance|second malignant neoplasm|0|||
126256437|NCT01190930|454229191|FG002|Maintenance|second malignant neoplasm|0|||
126030024|NCT02689284|453406791|FG000|Overall Study|Death|0|||
126030025|NCT02689284|453406792|FG001|Overall Study|Death|1|||
126030026|NCT02689284|453406791|FG000|Overall Study|Physician Decision|1|||
126030027|NCT02689284|453406792|FG001|Overall Study|Physician Decision|2|||
126256438|NCT01190930|454229192|FG003|Maintenance|second malignant neoplasm|1|||
126256439|NCT01190930|454229193|FG004|Maintenance|second malignant neoplasm|0|||
126256440|NCT01190930|454229194|FG005|Maintenance|second malignant neoplasm|1|||
126256441|NCT01190930|454229195|FG006|Maintenance|second malignant neoplasm|0|||
126256442|NCT01190930|454229196|FG007|Maintenance|second malignant neoplasm|0|||
126256443|NCT01190930|454229197|FG008|Maintenance|second malignant neoplasm|1|||
126256444|NCT01190930|454229198|FG009|Maintenance|second malignant neoplasm|0|||
126256445|NCT01190930|454229189|FG000|Maintenance|Inevaluable|0|||
126256446|NCT01190930|454229190|FG001|Maintenance|Inevaluable|0|||
126256447|NCT01190930|454229191|FG002|Maintenance|Inevaluable|0|||
126256448|NCT01190930|454229192|FG003|Maintenance|Inevaluable|0|||
126256449|NCT01190930|454229193|FG004|Maintenance|Inevaluable|0|||
126256450|NCT01190930|454229194|FG005|Maintenance|Inevaluable|1|||
126256451|NCT01190930|454229195|FG006|Maintenance|Inevaluable|1|||
126096034|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
126256452|NCT01190930|454229196|FG007|Maintenance|Inevaluable|1|||
126256453|NCT01190930|454229197|FG008|Maintenance|Inevaluable|0|||
126256454|NCT01190930|454229198|FG009|Maintenance|Inevaluable|0|||
126256455|NCT01190930|454229189|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
126256456|NCT01190930|454229190|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
126256457|NCT01190930|454229191|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
126256458|NCT01190930|454229192|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
126256459|NCT01190930|454229193|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
126256460|NCT01190930|454229194|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
126256461|NCT01190930|454229195|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
126256462|NCT01190930|454229196|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
126256463|NCT01190930|454229197|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
126256464|NCT01190930|454229198|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
126256465|NCT01190930|454229189|FG000|Maintenance|Relapse|0|||
126256466|NCT01190930|454229190|FG001|Maintenance|Relapse|0|||
126256467|NCT01190930|454229191|FG002|Maintenance|Relapse|0|||
126256468|NCT01190930|454229192|FG003|Maintenance|Relapse|2|||
126256469|NCT01190930|454229193|FG004|Maintenance|Relapse|0|||
126256470|NCT01190930|454229194|FG005|Maintenance|Relapse|1|||
126256471|NCT01190930|454229195|FG006|Maintenance|Relapse|6|||
126256472|NCT01190930|454229196|FG007|Maintenance|Relapse|13|||
126256473|NCT01190930|454229197|FG008|Maintenance|Relapse|11|||
126256474|NCT01190930|454229198|FG009|Maintenance|Relapse|11|||
126256475|NCT01190930|454229189|FG000|Maintenance|Still on therapy|0|||
126256476|NCT01190930|454229190|FG001|Maintenance|Still on therapy|8|||
126256477|NCT01190930|454229191|FG002|Maintenance|Still on therapy|0|||
126256478|NCT01190930|454229192|FG003|Maintenance|Still on therapy|29|||
126256479|NCT01190930|454229193|FG004|Maintenance|Still on therapy|0|||
126256480|NCT01190930|454229194|FG005|Maintenance|Still on therapy|0|||
126256481|NCT01190930|454229195|FG006|Maintenance|Still on therapy|0|||
126256482|NCT01190930|454229196|FG007|Maintenance|Still on therapy|0|||
126256483|NCT01190930|454229197|FG008|Maintenance|Still on therapy|0|||
126256484|NCT01190930|454229198|FG009|Maintenance|Still on therapy|0|||
126256485|NCT00046839|454229203|FG000|Overall Study|Ineligible / No protocol treatment|0|||
126256486|NCT00046839|454229204|FG001|Overall Study|Ineligible / No protocol treatment|2|||
126256487|NCT00046839|454229203|FG000|Overall Study|Withdrawal of consent|1|||
126256488|NCT00046839|454229204|FG001|Overall Study|Withdrawal of consent|0|||
126256489|NCT01292837|454229209|FG000|Overall Study|Adverse Event|1|||
126256490|NCT01292837|454229209|FG000|Overall Study|Further treatment determined|1|||
126256491|NCT04531527|454229210|FG000|Overall Study|Found to be Ineligible|3|||
126256492|NCT01881737|454229216|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
126256493|NCT01881737|454229216|FG000|Overall Study|Withdrawal by Subject|1|||
126256494|NCT01881737|454229216|FG000|Overall Study|Worsening of baseline behavior|1|||
126256495|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
126256496|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
126256497|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
126256498|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
126256499|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
126256500|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
126256501|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
126256502|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
126256503|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
126256504|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
126256505|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
126256506|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
126256507|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
126096035|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
126096036|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
126256508|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
126256509|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
126256510|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
126256511|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
126256512|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
126256513|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
126256514|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
126256515|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
126256516|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
126256517|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
126256518|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
126256519|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
126256520|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
126256521|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
126256522|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
126256523|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
126256524|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
126256525|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
126256526|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
126256527|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
126256528|NCT02250651|454229227|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
126256529|NCT02250651|454229228|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
126256530|NCT02250651|454229229|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
126256531|NCT02250651|454229227|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
126256532|NCT02250651|454229228|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
126256533|NCT02250651|454229229|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
126256534|NCT02250651|454229227|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
126256535|NCT02250651|454229228|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
126256536|NCT02250651|454229229|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
126256537|NCT02250651|454229227|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
126256538|NCT02250651|454229228|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
126256539|NCT02250651|454229229|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
126256540|NCT03496298|454229230|FG000|Overall Study|Adverse Event|49|||
126256541|NCT03496298|454229231|FG001|Overall Study|Adverse Event|68|||
126256542|NCT03496298|454229232|FG002|Overall Study|Adverse Event|79|||
126256543|NCT03496298|454229230|FG000|Overall Study|Study terminated by Sponsor|1050|||
126256544|NCT03496298|454229231|FG001|Overall Study|Study terminated by Sponsor|1063|||
126256545|NCT03496298|454229232|FG002|Overall Study|Study terminated by Sponsor|1071|||
126256546|NCT03496298|454229230|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
126256547|NCT03496298|454229231|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
126256548|NCT03496298|454229232|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
126256549|NCT03496298|454229230|FG000|Overall Study|Withdrawal by Subject|176|||
126256550|NCT03496298|454229231|FG001|Overall Study|Withdrawal by Subject|154|||
126256551|NCT03496298|454229232|FG002|Overall Study|Withdrawal by Subject|151|||
126256552|NCT03496298|454229230|FG000|Overall Study|Other|29|||
126256553|NCT03496298|454229231|FG001|Overall Study|Other|20|||
126256554|NCT03496298|454229232|FG002|Overall Study|Other|23|||
126256555|NCT03496298|454229230|FG000|Overall Study|Randomized and not treated|1|||
126256556|NCT03496298|454229231|FG001|Overall Study|Randomized and not treated|1|||
126256557|NCT03496298|454229232|FG002|Overall Study|Randomized and not treated|1|||
126256558|NCT02522780|454229239|FG000|Overall Study|Consent withdrawn by subject|5|||
126256559|NCT02522780|454229240|FG001|Overall Study|Consent withdrawn by subject|7|||
126256560|NCT02522780|454229239|FG000|Overall Study|Protocol deviation|1|||
126256561|NCT02522780|454229240|FG001|Overall Study|Protocol deviation|3|||
126256562|NCT02522780|454229239|FG000|Overall Study|Subject refused endoscopic procedure|0|||
126256563|NCT02522780|454229240|FG001|Overall Study|Subject refused endoscopic procedure|1|||
126256564|NCT02522780|454229239|FG000|Overall Study|Adverse event, non-fatal|11|||
126256565|NCT02522780|454229240|FG001|Overall Study|Adverse event, non-fatal|16|||
126256566|NCT02260635|454229241|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
126256567|NCT02260635|454229242|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
126256568|NCT02260635|454229241|FG000|Open-Label Extension|Study Termination|25|||
126256569|NCT02260635|454229242|FG001|Open-Label Extension|Study Termination|25|||
126256570|NCT02260635|454229241|FG000|Open-Label Extension|Withdrawal by Subject|1|||
126256571|NCT02260635|454229242|FG001|Open-Label Extension|Withdrawal by Subject|0|||
126256572|NCT04106817|454229243|FG000|Overall Study|Lost to Follow-up|1|||
126256573|NCT04106817|454229244|FG001|Overall Study|Lost to Follow-up|0|||
126256574|NCT04106817|454229245|FG002|Overall Study|Lost to Follow-up|0|||
126256575|NCT03310619|454229246|FG000|Pre-Treatment Period|Death|1|||
126256576|NCT03310619|454229247|FG001|Pre-Treatment Period|Death|0|||
126256577|NCT03310619|454229248|FG002|Pre-Treatment Period|Death|0|||
126256578|NCT03310619|454229249|FG003|Pre-Treatment Period|Death|0|||
126256579|NCT03310619|454229250|FG004|Pre-Treatment Period|Death|1|||
126256580|NCT03310619|454229251|FG005|Pre-Treatment Period|Death|0|||
126256581|NCT03310619|454229252|FG006|Pre-Treatment Period|Death|0|||
125879805|NCT03050801|452857387|FG002|Experiment 1|Physician Decision|0|||
126256582|NCT03310619|454229253|FG007|Pre-Treatment Period|Death|0|||
126256583|NCT03310619|454229246|FG000|Pre-Treatment Period|Other reasons|2|||
126256584|NCT03310619|454229247|FG001|Pre-Treatment Period|Other reasons|1|||
126256585|NCT03310619|454229248|FG002|Pre-Treatment Period|Other reasons|2|||
126256586|NCT03310619|454229249|FG003|Pre-Treatment Period|Other reasons|0|||
126256587|NCT03310619|454229250|FG004|Pre-Treatment Period|Other reasons|0|||
126256588|NCT03310619|454229251|FG005|Pre-Treatment Period|Other reasons|0|||
126256589|NCT03310619|454229252|FG006|Pre-Treatment Period|Other reasons|2|||
126256590|NCT03310619|454229253|FG007|Pre-Treatment Period|Other reasons|0|||
126256591|NCT03310619|454229246|FG000|Treatment Period|Death|1|||
126256592|NCT03310619|454229247|FG001|Treatment Period|Death|2|||
126256593|NCT03310619|454229248|FG002|Treatment Period|Death|0|||
126256594|NCT03310619|454229249|FG003|Treatment Period|Death|0|||
126256595|NCT03310619|454229250|FG004|Treatment Period|Death|1|||
126256596|NCT03310619|454229251|FG005|Treatment Period|Death|0|||
126256597|NCT03310619|454229252|FG006|Treatment Period|Death|2|||
126256598|NCT03310619|454229253|FG007|Treatment Period|Death|0|||
126256599|NCT03310619|454229246|FG000|Treatment Period|Adverse Event|0|||
126256600|NCT03310619|454229247|FG001|Treatment Period|Adverse Event|1|||
126256601|NCT03310619|454229248|FG002|Treatment Period|Adverse Event|4|||
126256602|NCT03310619|454229249|FG003|Treatment Period|Adverse Event|1|||
126256603|NCT03310619|454229250|FG004|Treatment Period|Adverse Event|0|||
126256604|NCT03310619|454229251|FG005|Treatment Period|Adverse Event|0|||
126256605|NCT03310619|454229252|FG006|Treatment Period|Adverse Event|0|||
126256606|NCT03310619|454229253|FG007|Treatment Period|Adverse Event|0|||
126256607|NCT03310619|454229246|FG000|Treatment Period|Withdrawal by participant|0|||
126256608|NCT03310619|454229247|FG001|Treatment Period|Withdrawal by participant|0|||
126256609|NCT03310619|454229248|FG002|Treatment Period|Withdrawal by participant|1|||
126256610|NCT03310619|454229249|FG003|Treatment Period|Withdrawal by participant|0|||
126256611|NCT03310619|454229250|FG004|Treatment Period|Withdrawal by participant|0|||
126256612|NCT03310619|454229251|FG005|Treatment Period|Withdrawal by participant|0|||
126256613|NCT03310619|454229252|FG006|Treatment Period|Withdrawal by participant|0|||
126256614|NCT03310619|454229253|FG007|Treatment Period|Withdrawal by participant|0|||
126256615|NCT03310619|454229246|FG000|Treatment Period|Lost to Follow-up|0|||
126256616|NCT03310619|454229247|FG001|Treatment Period|Lost to Follow-up|0|||
126256617|NCT03310619|454229248|FG002|Treatment Period|Lost to Follow-up|0|||
126256618|NCT03310619|454229249|FG003|Treatment Period|Lost to Follow-up|0|||
126256619|NCT03310619|454229250|FG004|Treatment Period|Lost to Follow-up|0|||
126256620|NCT03310619|454229251|FG005|Treatment Period|Lost to Follow-up|0|||
126256621|NCT03310619|454229252|FG006|Treatment Period|Lost to Follow-up|0|||
126256622|NCT03310619|454229253|FG007|Treatment Period|Lost to Follow-up|1|||
126256623|NCT03310619|454229246|FG000|Treatment Period|Study terminated by sponsor|0|||
126256624|NCT03310619|454229247|FG001|Treatment Period|Study terminated by sponsor|0|||
126256625|NCT03310619|454229248|FG002|Treatment Period|Study terminated by sponsor|0|||
126256626|NCT03310619|454229249|FG003|Treatment Period|Study terminated by sponsor|0|||
126256627|NCT03310619|454229250|FG004|Treatment Period|Study terminated by sponsor|0|||
126256628|NCT03310619|454229251|FG005|Treatment Period|Study terminated by sponsor|0|||
126256629|NCT03310619|454229252|FG006|Treatment Period|Study terminated by sponsor|0|||
126256630|NCT03310619|454229253|FG007|Treatment Period|Study terminated by sponsor|1|||
126256631|NCT03310619|454229246|FG000|Treatment Period|Physician Decision|0|||
126256632|NCT03310619|454229247|FG001|Treatment Period|Physician Decision|0|||
126256633|NCT03310619|454229248|FG002|Treatment Period|Physician Decision|0|||
126256634|NCT03310619|454229249|FG003|Treatment Period|Physician Decision|0|||
126256635|NCT03310619|454229250|FG004|Treatment Period|Physician Decision|3|||
126256636|NCT03310619|454229251|FG005|Treatment Period|Physician Decision|0|||
126256637|NCT03310619|454229252|FG006|Treatment Period|Physician Decision|0|||
126256638|NCT03310619|454229253|FG007|Treatment Period|Physician Decision|0|||
126256639|NCT03310619|454229246|FG000|Treatment Period|Other reasons|1|||
126256640|NCT03310619|454229247|FG001|Treatment Period|Other reasons|0|||
126256641|NCT03310619|454229248|FG002|Treatment Period|Other reasons|2|||
126256642|NCT03310619|454229249|FG003|Treatment Period|Other reasons|0|||
126256643|NCT03310619|454229250|FG004|Treatment Period|Other reasons|0|||
126256644|NCT03310619|454229251|FG005|Treatment Period|Other reasons|0|||
126256645|NCT03310619|454229252|FG006|Treatment Period|Other reasons|0|||
126256646|NCT03310619|454229253|FG007|Treatment Period|Other reasons|0|||
126256647|NCT00152516|454229254|FG000|Overall Study|Adverse Event|18|||
126256648|NCT00152516|454229254|FG000|Overall Study|Lack and Loss of Efficacy|30|||
126256649|NCT00152516|454229254|FG000|Overall Study|Lost to Follow-up|5|||
126256650|NCT00152516|454229254|FG000|Overall Study|Withdrawal by Subject|8|||
126256651|NCT00152516|454229254|FG000|Overall Study|Protocol Violation|3|||
126256652|NCT00152516|454229254|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
126256653|NCT00152516|454229254|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
126256654|NCT00152516|454229254|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
126256655|NCT00152516|454229254|FG000|Overall Study|Other: Non-Compliance|2|||
126256656|NCT00152516|454229254|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
126256657|NCT00152516|454229254|FG000|Overall Study|Other: Moved Out Of State|1|||
126358400|NCT01629563|454605330|FG001|Overall Study|Lack of Efficacy|3|||
126358401|NCT01629563|454605329|FG000|Overall Study|Lost to Follow-up|1|||
126096037|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
126096038|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
126096039|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
126096040|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
126096041|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
126096042|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
126256658|NCT00152516|454229254|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
126256659|NCT00152516|454229254|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
126256660|NCT02427399|454229255|FG000|Overall Study|Protocol Violation|14|||
126358402|NCT01629563|454605330|FG001|Overall Study|Lost to Follow-up|0|||
126358403|NCT01629563|454605329|FG000|Overall Study|Pregnancy|1|||
126358404|NCT01629563|454605330|FG001|Overall Study|Pregnancy|2|||
126358405|NCT01629563|454605329|FG000|Overall Study|Protocol Violation|0|||
126358406|NCT01629563|454605330|FG001|Overall Study|Protocol Violation|1|||
126358407|NCT01629563|454605329|FG000|Overall Study|Withdrawal by Subject|27|||
126358408|NCT01629563|454605330|FG001|Overall Study|Withdrawal by Subject|20|||
126358409|NCT01629563|454605329|FG000|Overall Study|surgery|0|||
126358410|NCT01629563|454605330|FG001|Overall Study|surgery|3|||
126358411|NCT01629563|454605329|FG000|Overall Study|Lack of return of menses|12|||
126358412|NCT01629563|454605330|FG001|Overall Study|Lack of return of menses|7|||
126358413|NCT01629563|454605329|FG000|Overall Study|Protocol Violation|0|||
126358414|NCT01629563|454605330|FG001|Overall Study|Protocol Violation|1|||
126358415|NCT02370394|454605332|FG000|Overall Study|Lost to Follow-up|2|||
126358416|NCT02370394|454605333|FG001|Overall Study|Lost to Follow-up|1|||
126358417|NCT02370394|454605332|FG000|Overall Study|Withdrawal by Subject|0|||
126358418|NCT02370394|454605333|FG001|Overall Study|Withdrawal by Subject|1|||
126358419|NCT01902303|454605335|FG000|Overall Study|Adverse Event|0|||
126358420|NCT01902303|454605336|FG001|Overall Study|Adverse Event|1|||
126358421|NCT01902303|454605335|FG000|Overall Study|Lost to Follow-up|0|||
126358422|NCT01902303|454605336|FG001|Overall Study|Lost to Follow-up|1|||
126358423|NCT01902303|454605335|FG000|Overall Study|Protocol Violation|2|||
126358424|NCT01902303|454605336|FG001|Overall Study|Protocol Violation|2|||
126358425|NCT01902303|454605335|FG000|Overall Study|subject lost investigational product|0|||
126358426|NCT01902303|454605336|FG001|Overall Study|subject lost investigational product|1|||
126358427|NCT01902303|454605335|FG000|Overall Study|Did not develop a cold sore|21|||
126358428|NCT01902303|454605336|FG001|Overall Study|Did not develop a cold sore|19|||
126358429|NCT02821000|454605337|FG000|Overall Study|Death|89|||
126358430|NCT02821000|454605337|FG000|Overall Study|Sponsor Decision|12|||
126358431|NCT02821000|454605337|FG000|Overall Study|Withdrawal by Subject|2|||
126358432|NCT00394472|454605345|FG000|Overall Study|Protocol Violation|1|||
126358433|NCT00394472|454605346|FG001|Overall Study|Protocol Violation|3|||
126256661|NCT02427399|454229256|FG001|Overall Study|Protocol Violation|16|||
126256662|NCT02427399|454229257|FG002|Overall Study|Protocol Violation|12|||
126256663|NCT02427399|454229258|FG003|Overall Study|Protocol Violation|18|||
126256664|NCT02427399|454229259|FG004|Overall Study|Protocol Violation|15|||
126256665|NCT01115933|454229260|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
126256666|NCT02289820|454229261|FG000|Overall Study|Withdrawal by Subject|2|||
126256667|NCT02289820|454229262|FG001|Overall Study|Withdrawal by Subject|1|||
126256668|NCT02289820|454229263|FG002|Overall Study|Withdrawal by Subject|2|||
126256669|NCT02289820|454229264|FG003|Overall Study|Withdrawal by Subject|1|||
126256670|NCT02289820|454229265|FG004|Overall Study|Withdrawal by Subject|0|||
126256671|NCT02289820|454229266|FG005|Overall Study|Withdrawal by Subject|0|||
126256672|NCT02289820|454229267|FG006|Overall Study|Withdrawal by Subject|1|||
126256673|NCT02289820|454229261|FG000|Overall Study|Death|0|||
126256674|NCT02289820|454229262|FG001|Overall Study|Death|0|||
126358434|NCT00394472|454605345|FG000|Overall Study|incorrect enrolment|4|||
126358435|NCT00394472|454605346|FG001|Overall Study|incorrect enrolment|2|||
126358436|NCT00394472|454605345|FG000|Overall Study|Adverse Event|4|||
126096043|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
126096044|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
126096045|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
126256675|NCT02289820|454229263|FG002|Overall Study|Death|1|||
126256676|NCT02289820|454229264|FG003|Overall Study|Death|0|||
126256677|NCT02289820|454229265|FG004|Overall Study|Death|0|||
126358437|NCT00394472|454605346|FG001|Overall Study|Adverse Event|2|||
126358438|NCT00394472|454605345|FG000|Overall Study|Withdrawal by Subject|0|||
126358439|NCT00394472|454605346|FG001|Overall Study|Withdrawal by Subject|2|||
126358440|NCT00394472|454605345|FG000|Overall Study|Physician Decision|0|||
126358441|NCT00394472|454605346|FG001|Overall Study|Physician Decision|1|||
126358442|NCT00394472|454605345|FG000|Overall Study|Lost to Follow-up|0|||
126358443|NCT00394472|454605346|FG001|Overall Study|Lost to Follow-up|1|||
126358444|NCT00520572|454605347|FG000|Overall Study|Adverse Event|9|||
126358445|NCT00520572|454605348|FG001|Overall Study|Adverse Event|3|||
126358446|NCT00520572|454605349|FG002|Overall Study|Adverse Event|6|||
126358447|NCT00520572|454605350|FG003|Overall Study|Adverse Event|9|||
126358448|NCT00520572|454605351|FG004|Overall Study|Adverse Event|7|||
126358449|NCT00520572|454605352|FG005|Overall Study|Adverse Event|2|||
126358450|NCT00520572|454605347|FG000|Overall Study|Withdrawal by Subject|0|||
126358451|NCT00520572|454605348|FG001|Overall Study|Withdrawal by Subject|9|||
126358452|NCT00520572|454605349|FG002|Overall Study|Withdrawal by Subject|5|||
126358453|NCT00520572|454605350|FG003|Overall Study|Withdrawal by Subject|2|||
126358454|NCT00520572|454605351|FG004|Overall Study|Withdrawal by Subject|2|||
126358455|NCT00520572|454605352|FG005|Overall Study|Withdrawal by Subject|0|||
126358456|NCT00520572|454605347|FG000|Overall Study|Protocol Violation|0|||
126358457|NCT00520572|454605348|FG001|Overall Study|Protocol Violation|0|||
126358458|NCT00520572|454605349|FG002|Overall Study|Protocol Violation|1|||
126358459|NCT00520572|454605350|FG003|Overall Study|Protocol Violation|0|||
126358460|NCT00520572|454605351|FG004|Overall Study|Protocol Violation|0|||
126358461|NCT00520572|454605352|FG005|Overall Study|Protocol Violation|0|||
126358462|NCT00520572|454605347|FG000|Overall Study|Lack of Efficacy|1|||
126358463|NCT00520572|454605348|FG001|Overall Study|Lack of Efficacy|1|||
126358464|NCT00520572|454605349|FG002|Overall Study|Lack of Efficacy|1|||
126358465|NCT00520572|454605350|FG003|Overall Study|Lack of Efficacy|2|||
126358466|NCT00520572|454605351|FG004|Overall Study|Lack of Efficacy|1|||
126358467|NCT00520572|454605352|FG005|Overall Study|Lack of Efficacy|0|||
126358468|NCT00520572|454605347|FG000|Overall Study|Lost to Follow-up|0|||
126358469|NCT00520572|454605348|FG001|Overall Study|Lost to Follow-up|0|||
126358470|NCT00520572|454605349|FG002|Overall Study|Lost to Follow-up|0|||
126358471|NCT00520572|454605350|FG003|Overall Study|Lost to Follow-up|0|||
126358472|NCT00520572|454605351|FG004|Overall Study|Lost to Follow-up|1|||
126358473|NCT00520572|454605352|FG005|Overall Study|Lost to Follow-up|0|||
126358474|NCT00520572|454605347|FG000|Overall Study|Incorrect enrollment|1|||
126358475|NCT00520572|454605348|FG001|Overall Study|Incorrect enrollment|0|||
126358476|NCT00520572|454605349|FG002|Overall Study|Incorrect enrollment|1|||
126358477|NCT00520572|454605350|FG003|Overall Study|Incorrect enrollment|0|||
126358478|NCT00520572|454605351|FG004|Overall Study|Incorrect enrollment|1|||
126358479|NCT00520572|454605352|FG005|Overall Study|Incorrect enrollment|0|||
126358480|NCT00520572|454605347|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358481|NCT00520572|454605348|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
126358482|NCT00520572|454605349|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358483|NCT00520572|454605350|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358484|NCT00520572|454605351|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358485|NCT00520572|454605352|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358486|NCT00520572|454605347|FG000|Overall Study|Long break in taking Medication|0|||
126358487|NCT00520572|454605348|FG001|Overall Study|Long break in taking Medication|0|||
126358488|NCT00520572|454605349|FG002|Overall Study|Long break in taking Medication|0|||
126358489|NCT00520572|454605350|FG003|Overall Study|Long break in taking Medication|1|||
126358490|NCT00520572|454605351|FG004|Overall Study|Long break in taking Medication|0|||
126358491|NCT00520572|454605352|FG005|Overall Study|Long break in taking Medication|0|||
126358492|NCT00520572|454605347|FG000|Overall Study|Did not receive Treatment|1|||
126358493|NCT00520572|454605348|FG001|Overall Study|Did not receive Treatment|0|||
126358494|NCT00520572|454605349|FG002|Overall Study|Did not receive Treatment|1|||
126358495|NCT00520572|454605350|FG003|Overall Study|Did not receive Treatment|0|||
126358496|NCT00520572|454605351|FG004|Overall Study|Did not receive Treatment|0|||
126358497|NCT00520572|454605352|FG005|Overall Study|Did not receive Treatment|0|||
126358498|NCT02181621|454605353|FG000|Overall Study|Adverse Event|1|||
126358499|NCT02181621|454605354|FG001|Overall Study|Adverse Event|0|||
126358500|NCT02181621|454605353|FG000|Overall Study|Previously Enrolled|0|||
126358501|NCT02181621|454605354|FG001|Overall Study|Previously Enrolled|1|||
126358502|NCT02181621|454605353|FG000|Overall Study|Enrollment Hold|1|||
126358503|NCT02181621|454605354|FG001|Overall Study|Enrollment Hold|1|||
126358504|NCT00960856|454605355|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126358505|NCT00960856|454605356|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
126358506|NCT00960856|454605357|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
126358507|NCT00960856|454605358|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
126358508|NCT00960856|454605355|FG000|Washout Period of 7 Days|Adverse Event|0|||
125879806|NCT03050801|452857388|FG003|Experiment 1|Physician Decision|0|||
126030028|NCT02689284|453406791|FG000|Overall Study|Withdrawal by Subject|0|||
126030029|NCT02689284|453406792|FG001|Overall Study|Withdrawal by Subject|1|||
126030030|NCT02689284|453406791|FG000|Overall Study|progression of cancer|1|||
126358509|NCT00960856|454605356|FG001|Washout Period of 7 Days|Adverse Event|0|||
126358510|NCT00960856|454605357|FG002|Washout Period of 7 Days|Adverse Event|1|||
126358511|NCT00960856|454605358|FG003|Washout Period of 7 Days|Adverse Event|0|||
126358512|NCT03387046|454605360|FG000|Overall Study|Adverse Event|1|||
126358513|NCT03387046|454605361|FG001|Overall Study|Adverse Event|1|||
126358514|NCT01964560|454605373|FG000|Overall Study|Adverse Event|23|||
126358515|NCT01964560|454605373|FG000|Overall Study|Lack of Efficacy|46|||
126358516|NCT01964560|454605373|FG000|Overall Study|Protocol deviation|2|||
126358517|NCT01964560|454605373|FG000|Overall Study|Lost to Follow-up|4|||
126358518|NCT01964560|454605373|FG000|Overall Study|Withdrawal by Subject|64|||
126256678|NCT02289820|454229266|FG005|Overall Study|Death|0|||
126256679|NCT02289820|454229267|FG006|Overall Study|Death|0|||
126256680|NCT02289820|454229261|FG000|Overall Study|Lost to Follow-up|0|||
126256681|NCT02289820|454229262|FG001|Overall Study|Lost to Follow-up|0|||
126256682|NCT02289820|454229263|FG002|Overall Study|Lost to Follow-up|3|||
126256683|NCT02289820|454229264|FG003|Overall Study|Lost to Follow-up|1|||
126256684|NCT02289820|454229265|FG004|Overall Study|Lost to Follow-up|0|||
126256685|NCT02289820|454229266|FG005|Overall Study|Lost to Follow-up|1|||
126256686|NCT02289820|454229267|FG006|Overall Study|Lost to Follow-up|1|||
126256687|NCT02289820|454229261|FG000|Overall Study|withdrawal of consent|0|||
126256688|NCT02289820|454229262|FG001|Overall Study|withdrawal of consent|1|||
126256689|NCT02289820|454229263|FG002|Overall Study|withdrawal of consent|0|||
126256690|NCT02289820|454229264|FG003|Overall Study|withdrawal of consent|0|||
126256691|NCT02289820|454229265|FG004|Overall Study|withdrawal of consent|0|||
126256692|NCT02289820|454229266|FG005|Overall Study|withdrawal of consent|0|||
126256693|NCT02289820|454229267|FG006|Overall Study|withdrawal of consent|0|||
126256694|NCT00926367|454229270|FG000|Overall Study|Withdrawal by Subject|0|||
126256695|NCT00926367|454229271|FG001|Overall Study|Withdrawal by Subject|1|||
126256696|NCT00926367|454229270|FG000|Overall Study|Lost to Follow-up|1|||
126256697|NCT00926367|454229271|FG001|Overall Study|Lost to Follow-up|0|||
126256698|NCT00926367|454229270|FG000|Overall Study|Skin Irritation|1|||
126256699|NCT00926367|454229271|FG001|Overall Study|Skin Irritation|2|||
126256700|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
126256701|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
126256702|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
126256703|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
126256704|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
126256705|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
126256706|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
126256707|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
126256708|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
126256709|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Other|1|||
126256710|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Other|4|||
126256711|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Other|5|||
126256712|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
126256713|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
126256714|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
126256715|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
126256716|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
126256717|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
126256718|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
126256719|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
126256720|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
126256721|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
126256722|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
126256723|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
126256724|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
126256725|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
126256726|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
126256727|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Other|1|||
126256728|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Other|4|||
126256729|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Other|2|||
126256730|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
126256731|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
126256732|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
126256733|NCT03847974|454229281|FG000|Overall Study|relocated out of region|3|||
126256734|NCT03847974|454229281|FG000|Overall Study|Withdrawal by Subject|2|||
126256735|NCT03847974|454229281|FG000|Overall Study|Adverse Event|1|||
126256736|NCT01924364|454229282|FG000|Overall Study|Physician Decision|3|||
126256737|NCT02911935|454229283|FG000|Overall Study|Lost to Follow-up|5|||
126256738|NCT02911935|454229284|FG001|Overall Study|Lost to Follow-up|7|||
126256739|NCT01685216|454229287|FG000|Overall Study|Did not receive study drug|1|||
126030031|NCT02689284|453406792|FG001|Overall Study|progression of cancer|72|||
126256740|NCT00756717|454229288|FG000|Overall Study|Withdrawal by Subject|2|||
126256741|NCT00603512|454229289|FG000|Overall Study|Adverse Event|0|||
126256742|NCT00603512|454229290|FG001|Overall Study|Adverse Event|2|||
126256743|NCT00603512|454229291|FG002|Overall Study|Adverse Event|4|||
126256744|NCT00603512|454229292|FG003|Overall Study|Adverse Event|4|||
126256745|NCT00603512|454229293|FG004|Overall Study|Adverse Event|2|||
126256746|NCT00603512|454229289|FG000|Overall Study|Lack of Efficacy|0|||
126358519|NCT01964560|454605373|FG000|Overall Study|Surgery-hemispherotomy|1|||
126256747|NCT00603512|454229290|FG001|Overall Study|Lack of Efficacy|1|||
126256748|NCT00603512|454229291|FG002|Overall Study|Lack of Efficacy|0|||
126256749|NCT00603512|454229292|FG003|Overall Study|Lack of Efficacy|0|||
126256750|NCT00603512|454229293|FG004|Overall Study|Lack of Efficacy|1|||
126256751|NCT00603512|454229289|FG000|Overall Study|Other|2|||
126256752|NCT00603512|454229290|FG001|Overall Study|Other|1|||
126256753|NCT00603512|454229291|FG002|Overall Study|Other|0|||
126256754|NCT00603512|454229292|FG003|Overall Study|Other|1|||
126256755|NCT00603512|454229293|FG004|Overall Study|Other|1|||
126256756|NCT00603512|454229289|FG000|Overall Study|Withdrawal by Subject|0|||
126256757|NCT00603512|454229290|FG001|Overall Study|Withdrawal by Subject|0|||
126256758|NCT00603512|454229291|FG002|Overall Study|Withdrawal by Subject|0|||
126256759|NCT00603512|454229292|FG003|Overall Study|Withdrawal by Subject|0|||
126256760|NCT00603512|454229293|FG004|Overall Study|Withdrawal by Subject|1|||
126256761|NCT00603512|454229289|FG000|Overall Study|Randomized but not treated|0|||
126256762|NCT00603512|454229290|FG001|Overall Study|Randomized but not treated|1|||
126256763|NCT00603512|454229291|FG002|Overall Study|Randomized but not treated|1|||
126256764|NCT00603512|454229292|FG003|Overall Study|Randomized but not treated|2|||
126256765|NCT00603512|454229293|FG004|Overall Study|Randomized but not treated|0|||
126256766|NCT00685750|454229294|FG000|Overall Study|Tumor sampling failure|0|||
126256767|NCT00685750|454229295|FG001|Overall Study|Tumor sampling failure|0|||
126256768|NCT00685750|454229296|FG002|Overall Study|Tumor sampling failure|1|||
126256769|NCT00685750|454229297|FG003|Overall Study|Tumor sampling failure|0|||
126256770|NCT00685750|454229298|FG004|Overall Study|Tumor sampling failure|0|||
126256771|NCT00685750|454229299|FG005|Overall Study|Tumor sampling failure|0|||
126256772|NCT00685750|454229300|FG006|Overall Study|Tumor sampling failure|0|||
126256773|NCT00685750|454229294|FG000|Overall Study|Patient didn't receive the treatment|0|||
126256774|NCT00685750|454229295|FG001|Overall Study|Patient didn't receive the treatment|0|||
126256775|NCT00685750|454229296|FG002|Overall Study|Patient didn't receive the treatment|0|||
126256776|NCT00685750|454229297|FG003|Overall Study|Patient didn't receive the treatment|0|||
126256777|NCT00685750|454229298|FG004|Overall Study|Patient didn't receive the treatment|0|||
126256778|NCT00685750|454229299|FG005|Overall Study|Patient didn't receive the treatment|0|||
126256779|NCT00685750|454229300|FG006|Overall Study|Patient didn't receive the treatment|1|||
126256780|NCT00685750|454229294|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126256781|NCT00685750|454229295|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126256782|NCT00685750|454229296|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126256783|NCT00685750|454229297|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
126256784|NCT00685750|454229298|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
126256785|NCT00685750|454229299|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
126256786|NCT00685750|454229300|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
126256787|NCT04979858|454229301|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
126256788|NCT04979858|454229302|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
126256789|NCT02654015|454229303|FG000|Overall Study|Death|12|||
126256790|NCT02654015|454229303|FG000|Overall Study|Lost to Follow-up|3|||
126256791|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
126256792|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
126256793|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
126256794|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
126256795|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
126256796|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
126256797|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
126256798|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
126256799|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
126256800|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
126256801|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
126256802|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
126256803|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
126256804|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
126256805|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
126256806|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
126256807|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
126256808|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
126256809|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
126256810|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
126256811|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
126256812|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
126256813|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
126256814|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
126256815|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
126256816|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
126358520|NCT01964560|454605373|FG000|Overall Study|Surgery|1|||
126256817|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
126256818|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
126256819|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
126256820|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
126256821|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
126256822|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
126256823|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
126256824|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
126256825|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
126256826|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
126256827|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
126256828|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
126256829|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
126256830|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
126256831|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
126256832|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
126256833|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
126256834|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
126256835|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
126256836|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
126256837|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
126256838|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
126256839|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
126030032|NCT02689284|453406791|FG000|Overall Study|decreased heart function|0|||
126030033|NCT02689284|453406792|FG001|Overall Study|decreased heart function|1|||
126256840|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
126256841|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
126256842|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
126256843|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
126256844|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
126256845|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
126256846|NCT01896505|454229311|FG000|Overall Study|Adverse Event|1|||
126256847|NCT01896505|454229312|FG001|Overall Study|Adverse Event|0|||
126256848|NCT01896505|454229313|FG002|Overall Study|Adverse Event|2|||
126256849|NCT01896505|454229314|FG003|Overall Study|Adverse Event|1|||
126256850|NCT01896505|454229315|FG004|Overall Study|Adverse Event|1|||
126256851|NCT01896505|454229316|FG005|Overall Study|Adverse Event|0|||
126256852|NCT01896505|454229311|FG000|Overall Study|Physician Decision|1|||
126256853|NCT01896505|454229312|FG001|Overall Study|Physician Decision|3|||
126256854|NCT01896505|454229313|FG002|Overall Study|Physician Decision|2|||
126256855|NCT01896505|454229314|FG003|Overall Study|Physician Decision|0|||
126256856|NCT01896505|454229315|FG004|Overall Study|Physician Decision|0|||
126256857|NCT01896505|454229316|FG005|Overall Study|Physician Decision|1|||
126256858|NCT01896505|454229311|FG000|Overall Study|Withdrawal by Subject|1|||
126256859|NCT01896505|454229312|FG001|Overall Study|Withdrawal by Subject|0|||
126256860|NCT01896505|454229313|FG002|Overall Study|Withdrawal by Subject|3|||
126256861|NCT01896505|454229314|FG003|Overall Study|Withdrawal by Subject|1|||
126256862|NCT01896505|454229315|FG004|Overall Study|Withdrawal by Subject|0|||
126256863|NCT01896505|454229316|FG005|Overall Study|Withdrawal by Subject|0|||
126256864|NCT01896505|454229311|FG000|Overall Study|Disease Progression|7|||
126256865|NCT01896505|454229312|FG001|Overall Study|Disease Progression|5|||
126256866|NCT01896505|454229313|FG002|Overall Study|Disease Progression|8|||
126256867|NCT01896505|454229314|FG003|Overall Study|Disease Progression|4|||
126256868|NCT01896505|454229315|FG004|Overall Study|Disease Progression|4|||
126256869|NCT01896505|454229316|FG005|Overall Study|Disease Progression|4|||
126256870|NCT01896505|454229311|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
126256871|NCT01896505|454229312|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
126256872|NCT01896505|454229313|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
126256873|NCT01896505|454229314|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
126256874|NCT01896505|454229315|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
126256875|NCT01896505|454229316|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
126256876|NCT01896505|454229311|FG000|Overall Study|Intercurrent illness|0|||
126256877|NCT01896505|454229312|FG001|Overall Study|Intercurrent illness|1|||
126256878|NCT01896505|454229313|FG002|Overall Study|Intercurrent illness|0|||
126256879|NCT01896505|454229314|FG003|Overall Study|Intercurrent illness|0|||
126256880|NCT01896505|454229315|FG004|Overall Study|Intercurrent illness|0|||
126256881|NCT01896505|454229316|FG005|Overall Study|Intercurrent illness|0|||
126256882|NCT01896505|454229311|FG000|Overall Study|Death|0|||
126256883|NCT01896505|454229312|FG001|Overall Study|Death|0|||
126256884|NCT01896505|454229313|FG002|Overall Study|Death|1|||
126256885|NCT01896505|454229314|FG003|Overall Study|Death|1|||
126256886|NCT01896505|454229315|FG004|Overall Study|Death|0|||
126256887|NCT01896505|454229316|FG005|Overall Study|Death|1|||
126256888|NCT04974580|454229317|FG000|Overall Study|Lost to Follow-up|33|||
126256889|NCT04974580|454229318|FG001|Overall Study|Lost to Follow-up|39|||
126256890|NCT04974580|454229319|FG002|Overall Study|Lost to Follow-up|30|||
126256891|NCT04974580|454229320|FG003|Overall Study|Lost to Follow-up|29|||
126256892|NCT00250705|454229323|FG000|Overall Study|Lack of Efficacy|2|||
126256893|NCT02466386|454229334|FG000|Overall Study|Adverse Event|5|||
126256894|NCT02466386|454229334|FG000|Overall Study|Protocol Violation|2|||
126256895|NCT02466386|454229334|FG000|Overall Study|Withdrawal by Subject|14|||
126256896|NCT02466386|454229334|FG000|Overall Study|Lost to Follow-up|5|||
126256897|NCT02466386|454229334|FG000|Overall Study|Lack of Efficacy|8|||
126256898|NCT02466386|454229334|FG000|Overall Study|Other|10|||
126256899|NCT05317195|454229335|FG000|Randomization|Withdrawal by Subject|1|||
126256900|NCT05317195|454229335|FG000|Randomization|Discontinued|6|||
126256901|NCT05317195|454229335|FG000|Admission|Withdrawal by Subject|2|||
126256902|NCT03919695|454229338|FG000|3-month Follow-up|Death|1|||
126256903|NCT03919695|454229339|FG001|3-month Follow-up|Death|1|||
126256904|NCT03919695|454229338|FG000|3-month Follow-up|unable to contact|0|||
126256905|NCT03919695|454229339|FG001|3-month Follow-up|unable to contact|3|||
126256906|NCT03919695|454229338|FG000|3-month Follow-up|in prison|0|||
126256907|NCT03919695|454229339|FG001|3-month Follow-up|in prison|1|||
126256908|NCT03919695|454229338|FG000|6-month Follow-up|Death|0|||
126256909|NCT03919695|454229339|FG001|6-month Follow-up|Death|1|||
126256910|NCT03919695|454229338|FG000|6-month Follow-up|Lost to Follow-up|1|||
126256911|NCT03919695|454229339|FG001|6-month Follow-up|Lost to Follow-up|2|||
126256912|NCT03919695|454229338|FG000|6-month Follow-up|in prison|0|||
126256913|NCT03919695|454229339|FG001|6-month Follow-up|in prison|2|||
126256914|NCT03919695|454229338|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
126256915|NCT03919695|454229339|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
126256916|NCT03919695|454229338|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
126256917|NCT03919695|454229339|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
126256918|NCT01688882|454229340|FG000|Overall Study|Adverse Event|1|||
126256919|NCT01688882|454229341|FG001|Overall Study|Adverse Event|0|||
126256920|NCT01688882|454229340|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126256921|NCT01688882|454229341|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126256922|NCT01688882|454229340|FG000|Overall Study|Administrative problems|1|||
126256923|NCT01688882|454229341|FG001|Overall Study|Administrative problems|0|||
126256924|NCT03259789|454229342|FG000|Overall Study|Adverse Event|3|||
126256925|NCT03259789|454229343|FG001|Overall Study|Adverse Event|2|||
126256926|NCT03259789|454229344|FG002|Overall Study|Adverse Event|1|||
126256927|NCT03259789|454229342|FG000|Overall Study|Withdrawal by Subject|9|||
126256928|NCT03259789|454229343|FG001|Overall Study|Withdrawal by Subject|5|||
126256929|NCT03259789|454229344|FG002|Overall Study|Withdrawal by Subject|1|||
126256930|NCT03259789|454229342|FG000|Overall Study|Lost to Follow-up|5|||
126256931|NCT03259789|454229343|FG001|Overall Study|Lost to Follow-up|9|||
126256932|NCT03259789|454229344|FG002|Overall Study|Lost to Follow-up|4|||
126256933|NCT03259789|454229342|FG000|Overall Study|Physician Decision|0|||
126256934|NCT03259789|454229343|FG001|Overall Study|Physician Decision|1|||
126256935|NCT03259789|454229344|FG002|Overall Study|Physician Decision|0|||
126256936|NCT02063217|454229346|FG000|Overall Study|Withdrawal by Subject|1|||
126256937|NCT02063217|454229347|FG001|Overall Study|Withdrawal by Subject|0|||
126256938|NCT02063217|454229348|FG002|Overall Study|Withdrawal by Subject|0|||
126256939|NCT00889252|454229349|FG000|Overall Study|Adverse Event|2|||
126256940|NCT00889252|454229350|FG001|Overall Study|Adverse Event|4|||
126256941|NCT00889252|454229349|FG000|Overall Study|Withdrawal by Subject|3|||
126256942|NCT00889252|454229350|FG001|Overall Study|Withdrawal by Subject|0|||
126256943|NCT00889252|454229349|FG000|Overall Study|Protocol Violation|2|||
126256944|NCT00889252|454229350|FG001|Overall Study|Protocol Violation|0|||
126256945|NCT02416934|454229351|FG000|Overall Study|given steroids|1|||
126256946|NCT02416934|454229352|FG001|Overall Study|given steroids|2|||
126256947|NCT02416934|454229351|FG000|Overall Study|Lost to Follow-up|0|||
126256948|NCT02416934|454229352|FG001|Overall Study|Lost to Follow-up|2|||
126256949|NCT02416934|454229351|FG000|Overall Study|Withdrawal by Subject|1|||
126256950|NCT02416934|454229352|FG001|Overall Study|Withdrawal by Subject|0|||
126358521|NCT01964560|454605373|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
126358522|NCT01964560|454605373|FG000|Overall Study|Patient and Investigator choice|1|||
126256951|NCT02416934|454229351|FG000|Overall Study|recruited during continuing renewal proc|0|||
126256952|NCT02416934|454229352|FG001|Overall Study|recruited during continuing renewal proc|1|||
126358523|NCT01964560|454605373|FG000|Overall Study|Patient was prescribed CBD|1|||
126358524|NCT01964560|454605373|FG000|Overall Study|Participant moved to another country|1|||
126358525|NCT01301001|454605374|FG000|First Intervention|Lost to Follow-up|4|||
126358526|NCT01301001|454605375|FG001|First Intervention|Lost to Follow-up|4|||
126256953|NCT02416934|454229351|FG000|Overall Study|Protocol Violation|0|||
126256954|NCT02416934|454229352|FG001|Overall Study|Protocol Violation|1|||
126256955|NCT02416934|454229351|FG000|Overall Study|surgery started late|0|||
126256956|NCT02416934|454229352|FG001|Overall Study|surgery started late|1|||
126256957|NCT02416934|454229351|FG000|Overall Study|re-operation|1|||
126256958|NCT02416934|454229352|FG001|Overall Study|re-operation|0|||
126256959|NCT01020526|454229353|FG000|Overall Study|Withdrawal by Subject|5|||
126256960|NCT01020526|454229353|FG000|Overall Study|Other reasons|3|||
126256961|NCT01020526|454229353|FG000|Overall Study|Insufficient clinical response|3|||
126256962|NCT01020526|454229353|FG000|Overall Study|Lost to Follow-up|1|||
126256963|NCT01020526|454229353|FG000|Overall Study|Adverse Event|2|||
126358527|NCT01301001|454605374|FG000|First Intervention|Withdrawal by Subject|1|||
126358528|NCT01301001|454605375|FG001|First Intervention|Withdrawal by Subject|4|||
126358529|NCT01301001|454605374|FG000|First Intervention|Adverse Event|5|||
126358530|NCT01301001|454605375|FG001|First Intervention|Adverse Event|0|||
126358531|NCT01301001|454605374|FG000|First Intervention|Protocol Violation|0|||
126358532|NCT01301001|454605375|FG001|First Intervention|Protocol Violation|1|||
126358533|NCT01301001|454605374|FG000|Second Intervention|Adverse Event|2|||
126358534|NCT01301001|454605375|FG001|Second Intervention|Adverse Event|0|||
126358535|NCT01301001|454605374|FG000|Second Intervention|Withdrawal by Subject|2|||
126358536|NCT01301001|454605375|FG001|Second Intervention|Withdrawal by Subject|0|||
126358537|NCT01560988|454605376|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
126358538|NCT01560988|454605377|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
126358539|NCT01560988|454605376|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
126358540|NCT01560988|454605377|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
126358541|NCT01560988|454605376|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
126358542|NCT01560988|454605377|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
126358543|NCT01346709|454605378|FG000|Overall Study|Protocol Violation|35|||
126358544|NCT01346709|454605378|FG000|Overall Study|Lost to Follow-up|31|||
126358545|NCT01346709|454605378|FG000|Overall Study|Missing data in candidate risk factor|285|||
126358546|NCT02565186|454605379|FG000|Overall Study|Adverse Event|113|||
126358547|NCT02565186|454605380|FG001|Overall Study|Adverse Event|148|||
126358548|NCT02565186|454605379|FG000|Overall Study|Lost to Follow-up|102|||
126358549|NCT02565186|454605380|FG001|Overall Study|Lost to Follow-up|93|||
126358550|NCT02565186|454605379|FG000|Overall Study|Non-Compliance|57|||
126358551|NCT02565186|454605380|FG001|Overall Study|Non-Compliance|55|||
126358552|NCT02565186|454605379|FG000|Overall Study|Withdrawal by Subject|229|||
126256964|NCT00398073|454229359|FG000|Overall Study|Withdrawal by Subject|1|||
126256965|NCT00398073|454229360|FG001|Overall Study|Withdrawal by Subject|0|||
126256966|NCT01833169|454229366|FG000|Overall Study|Disease Progression|99|||
126256967|NCT01833169|454229366|FG000|Overall Study|Adverse Event|33|||
126256968|NCT01833169|454229366|FG000|Overall Study|Withdrawal by Subject|9|||
126256969|NCT01833169|454229366|FG000|Overall Study|Death|3|||
126256970|NCT01833169|454229366|FG000|Overall Study|Physician Decision|2|||
126256971|NCT00879684|454229367|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
126256972|NCT00879684|454229368|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
126256973|NCT00879684|454229369|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
126256974|NCT00879684|454229370|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
126256975|NCT00879684|454229371|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
126256976|NCT00879684|454229372|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
126256977|NCT00879684|454229373|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
126256978|NCT00879684|454229367|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
126256979|NCT00879684|454229368|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
126256980|NCT00879684|454229369|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
126256981|NCT00879684|454229370|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
126256982|NCT00879684|454229371|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
126256983|NCT00879684|454229372|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
126256984|NCT00879684|454229373|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
126256985|NCT00879684|454229367|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256986|NCT00879684|454229368|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256987|NCT00879684|454229369|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
126256988|NCT00879684|454229370|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
126256989|NCT00879684|454229371|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256990|NCT00879684|454229372|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256991|NCT00879684|454229373|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256992|NCT00879684|454229367|FG000|Stage 1: Dose Escalation|Death|0|||
126256993|NCT00879684|454229368|FG001|Stage 1: Dose Escalation|Death|0|||
126256994|NCT00879684|454229369|FG002|Stage 1: Dose Escalation|Death|1|||
126256995|NCT00879684|454229370|FG003|Stage 1: Dose Escalation|Death|0|||
126256996|NCT00879684|454229371|FG004|Stage 1: Dose Escalation|Death|0|||
126256997|NCT00879684|454229372|FG005|Stage 1: Dose Escalation|Death|0|||
126256998|NCT00879684|454229373|FG006|Stage 1: Dose Escalation|Death|0|||
126256999|NCT00879684|454229367|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126257000|NCT00879684|454229368|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126257001|NCT00879684|454229369|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126358553|NCT02565186|454605380|FG001|Overall Study|Withdrawal by Subject|214|||
126358554|NCT02565186|454605379|FG000|Overall Study|Physician Decision|18|||
126358555|NCT02565186|454605380|FG001|Overall Study|Physician Decision|16|||
126358556|NCT02565186|454605379|FG000|Overall Study|Sponsor Request|5|||
126358557|NCT02565186|454605380|FG001|Overall Study|Sponsor Request|9|||
126030034|NCT02689284|453406791|FG000|Overall Study|concern for anemia|0|||
126257002|NCT00879684|454229370|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126257003|NCT00879684|454229371|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126257004|NCT00879684|454229372|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126358558|NCT02565186|454605379|FG000|Overall Study|Missing|1|||
126257005|NCT00879684|454229373|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
126257006|NCT00879684|454229367|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257007|NCT00879684|454229368|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257008|NCT00879684|454229369|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257009|NCT00879684|454229370|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257010|NCT00879684|454229371|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257011|NCT00879684|454229372|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257012|NCT00879684|454229373|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
126257013|NCT00879684|454229367|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257014|NCT00879684|454229368|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257015|NCT00879684|454229369|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257016|NCT00879684|454229370|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257017|NCT00879684|454229371|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257018|NCT00879684|454229372|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257019|NCT00879684|454229373|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
126257020|NCT02169336|454229374|FG000|Overall Study|Lack of Efficacy|1|||
126257021|NCT02169336|454229375|FG001|Overall Study|Lack of Efficacy|1|||
126257022|NCT02169336|454229376|FG002|Overall Study|Lack of Efficacy|0|||
126257023|NCT02169336|454229374|FG000|Overall Study|Adverse Event|2|||
126257024|NCT02169336|454229375|FG001|Overall Study|Adverse Event|3|||
126257025|NCT02169336|454229376|FG002|Overall Study|Adverse Event|1|||
126257026|NCT02169336|454229374|FG000|Overall Study|Withdrawal by Subject|1|||
126257027|NCT02169336|454229375|FG001|Overall Study|Withdrawal by Subject|0|||
126257028|NCT02169336|454229376|FG002|Overall Study|Withdrawal by Subject|0|||
126257029|NCT02169336|454229374|FG000|Overall Study|Physician Decision|0|||
126257030|NCT02169336|454229375|FG001|Overall Study|Physician Decision|0|||
126257031|NCT02169336|454229376|FG002|Overall Study|Physician Decision|1|||
126257032|NCT02169336|454229374|FG000|Overall Study|Subject declined to continue dosing|0|||
126257033|NCT02169336|454229375|FG001|Overall Study|Subject declined to continue dosing|0|||
126257034|NCT02169336|454229376|FG002|Overall Study|Subject declined to continue dosing|1|||
126257035|NCT02212457|454229379|FG000|Overall Study|Adverse Event|1|||
126257036|NCT02212457|454229380|FG001|Overall Study|Adverse Event|2|||
126257037|NCT02212457|454229381|FG002|Overall Study|Adverse Event|2|||
126257038|NCT02212457|454229382|FG003|Overall Study|Adverse Event|2|||
126257039|NCT02212457|454229383|FG004|Overall Study|Adverse Event|0|||
126257040|NCT02212457|454229384|FG005|Overall Study|Adverse Event|1|||
126257041|NCT02212457|454229379|FG000|Overall Study|Withdrawal by Subject|8|||
126257042|NCT02212457|454229380|FG001|Overall Study|Withdrawal by Subject|10|||
126257043|NCT02212457|454229381|FG002|Overall Study|Withdrawal by Subject|8|||
126257044|NCT02212457|454229382|FG003|Overall Study|Withdrawal by Subject|6|||
126257045|NCT02212457|454229383|FG004|Overall Study|Withdrawal by Subject|5|||
126257046|NCT02212457|454229384|FG005|Overall Study|Withdrawal by Subject|4|||
126257047|NCT02212457|454229379|FG000|Overall Study|Lost to Follow-up|6|||
126257048|NCT02212457|454229380|FG001|Overall Study|Lost to Follow-up|7|||
126257049|NCT02212457|454229381|FG002|Overall Study|Lost to Follow-up|4|||
126257050|NCT02212457|454229382|FG003|Overall Study|Lost to Follow-up|1|||
126257051|NCT02212457|454229383|FG004|Overall Study|Lost to Follow-up|8|||
126257052|NCT02212457|454229384|FG005|Overall Study|Lost to Follow-up|4|||
126257053|NCT02212457|454229379|FG000|Overall Study|Protocol Violation|2|||
126257054|NCT02212457|454229380|FG001|Overall Study|Protocol Violation|1|||
126257055|NCT02212457|454229381|FG002|Overall Study|Protocol Violation|0|||
126257056|NCT02212457|454229382|FG003|Overall Study|Protocol Violation|1|||
126257057|NCT02212457|454229383|FG004|Overall Study|Protocol Violation|2|||
126257058|NCT02212457|454229384|FG005|Overall Study|Protocol Violation|3|||
126257059|NCT02212457|454229379|FG000|Overall Study|Other|2|||
126257060|NCT02212457|454229380|FG001|Overall Study|Other|1|||
126257061|NCT02212457|454229381|FG002|Overall Study|Other|2|||
126257062|NCT02212457|454229382|FG003|Overall Study|Other|1|||
126257063|NCT02212457|454229383|FG004|Overall Study|Other|0|||
126257064|NCT02212457|454229384|FG005|Overall Study|Other|1|||
126306196|NCT03260244|454410221|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
126306197|NCT03260244|454410221|FG000|Overall Study|Screen Failure|2|||
126306198|NCT03260244|454410221|FG000|Overall Study|Treated Off Label|69|||
126306199|NCT03260244|454410221|FG000|Overall Study|No Radiofrequency Ablation|14|||
126306200|NCT04292912|454410222|FG000|Overall Study|Physician Decision|1|||
126306201|NCT04292912|454410222|FG000|Overall Study|Protocol Violation|6|||
126306202|NCT05338502|454410232|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
126306203|NCT05338502|454410233|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
126306204|NCT05338502|454410234|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
126306205|NCT05338502|454410232|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
126306206|NCT05338502|454410233|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
126306207|NCT05338502|454410234|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
126306208|NCT03575793|454410237|FG000|Overall Study|Withdrawal by Subject|0|||
126306209|NCT03575793|454410238|FG001|Overall Study|Withdrawal by Subject|1|||
126306210|NCT03575793|454410237|FG000|Overall Study|Never Treated|0|||
126306211|NCT03575793|454410238|FG001|Overall Study|Never Treated|2|||
126257065|NCT02832167|454231229|FG000|Treatment Period 1|Disease progression|90|||
126257066|NCT02832167|454231229|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
126257067|NCT02832167|454231229|FG000|Treatment Period 1|Death|2|||
126257068|NCT02832167|454231229|FG000|Treatment Period 1|Study Drug Toxicity|6|||
126257069|NCT02832167|454231229|FG000|Treatment Period 1|Participant request to discontinue|9|||
126257070|NCT02832167|454231229|FG000|Treatment Period 1|No longer meet study criteria|1|||
126257071|NCT02832167|454231229|FG000|Treatment Period 1|Participant withdrew consent|3|||
126257072|NCT02832167|454231229|FG000|Treatment Period 1|Other reasons|6|||
126257073|NCT02832167|454231229|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
126257074|NCT02832167|454231229|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
126257075|NCT02832167|454231229|FG000|Transition From Period 1 to Period 2|Death|2|||
126257076|NCT02832167|454231229|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
126257077|NCT02832167|454231229|FG000|Treatment Period 2|Disease progression|69|||
126257078|NCT02832167|454231229|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
126257079|NCT02832167|454231229|FG000|Treatment Period 2|Maximum clinical benefit|1|||
126257080|NCT02832167|454231229|FG000|Treatment Period 2|Study Drug Toxicity|5|||
126257081|NCT02832167|454231229|FG000|Treatment Period 2|Participant request to discontinue|2|||
126257082|NCT02832167|454231229|FG000|Treatment Period 2|Participant withdrew consent|3|||
126257083|NCT02832167|454231229|FG000|Treatment Period 2|Other reasons|3|||
126257084|NCT02293460|454231230|FG000|Overall Study|Protocol Violation|1|||
126257085|NCT02293460|454231230|FG000|Overall Study|Lack of Efficacy|2|||
126257086|NCT02293460|454231230|FG000|Overall Study|Adverse Event|2|||
126257087|NCT02293460|454231230|FG000|Overall Study|Withdrawal by Subject|1|||
126257088|NCT00224484|454231231|FG000|Overall Study|Serious Adverse Event|1|||
126257089|NCT00224484|454231232|FG001|Overall Study|Serious Adverse Event|1|||
126257090|NCT00224484|454231233|FG002|Overall Study|Serious Adverse Event|0|||
126257091|NCT00224484|454231231|FG000|Overall Study|Non-Serious Adverse Event|5|||
126257092|NCT00224484|454231232|FG001|Overall Study|Non-Serious Adverse Event|7|||
126257093|NCT00224484|454231233|FG002|Overall Study|Non-Serious Adverse Event|3|||
126257094|NCT00224484|454231231|FG000|Overall Study|Protocol Violation|2|||
126257095|NCT00224484|454231232|FG001|Overall Study|Protocol Violation|2|||
126257096|NCT00224484|454231233|FG002|Overall Study|Protocol Violation|0|||
126257097|NCT00224484|454231231|FG000|Overall Study|Withdrawal by Subject|49|||
126257098|NCT00224484|454231232|FG001|Overall Study|Withdrawal by Subject|18|||
126257099|NCT00224484|454231233|FG002|Overall Study|Withdrawal by Subject|16|||
126257100|NCT00224484|454231231|FG000|Overall Study|Migrated/moved from study area|18|||
126257101|NCT00224484|454231232|FG001|Overall Study|Migrated/moved from study area|5|||
126257102|NCT00224484|454231233|FG002|Overall Study|Migrated/moved from study area|5|||
126257103|NCT00224484|454231231|FG000|Overall Study|Lost to Follow-up|66|||
126257104|NCT00224484|454231232|FG001|Overall Study|Lost to Follow-up|28|||
126257105|NCT00224484|454231233|FG002|Overall Study|Lost to Follow-up|36|||
126257106|NCT00224484|454231231|FG000|Overall Study|Reason not specified|5|||
126257107|NCT00224484|454231232|FG001|Overall Study|Reason not specified|4|||
126257108|NCT00224484|454231233|FG002|Overall Study|Reason not specified|2|||
126257109|NCT00108628|454231239|FG000|Overall Study|Withdrawal by Subject|17|||
126257110|NCT00108628|454231240|FG001|Overall Study|Withdrawal by Subject|9|||
126257111|NCT00108628|454231239|FG000|Overall Study|Lack of Efficacy|2|||
126257112|NCT00108628|454231240|FG001|Overall Study|Lack of Efficacy|1|||
126257113|NCT00108628|454231239|FG000|Overall Study|Death|1|||
126257114|NCT00108628|454231240|FG001|Overall Study|Death|0|||
126257115|NCT03547635|454231243|FG000|Overall Study|Adverse Event|5|||
126257116|NCT03547635|454231244|FG001|Overall Study|Adverse Event|2|||
126257117|NCT03547635|454231245|FG002|Overall Study|Adverse Event|3|||
126257118|NCT03547635|454231243|FG000|Overall Study|Lost to Follow-up|1|||
126257119|NCT03547635|454231244|FG001|Overall Study|Lost to Follow-up|3|||
126257120|NCT03547635|454231245|FG002|Overall Study|Lost to Follow-up|4|||
126257121|NCT03547635|454231243|FG000|Overall Study|Withdrawal by Subject|1|||
126257122|NCT03547635|454231244|FG001|Overall Study|Withdrawal by Subject|0|||
126257123|NCT03547635|454231245|FG002|Overall Study|Withdrawal by Subject|0|||
126257124|NCT03547635|454231243|FG000|Overall Study|Withdrawal By PI|0|||
126257125|NCT03547635|454231244|FG001|Overall Study|Withdrawal By PI|1|||
126257126|NCT03547635|454231245|FG002|Overall Study|Withdrawal By PI|0|||
126257127|NCT03547635|454231243|FG000|Overall Study|Withdrawal by Sponsor|0|||
126257128|NCT03547635|454231244|FG001|Overall Study|Withdrawal by Sponsor|0|||
126096046|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
126096047|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
126257129|NCT03547635|454231245|FG002|Overall Study|Withdrawal by Sponsor|1|||
126257130|NCT03547635|454231243|FG000|Overall Study|Errant Randomization before Treatment|0|||
126257131|NCT03547635|454231244|FG001|Overall Study|Errant Randomization before Treatment|1|||
126257132|NCT03547635|454231245|FG002|Overall Study|Errant Randomization before Treatment|0|||
126257133|NCT03547635|454231243|FG000|Overall Study|Withdrawal by Subject|1|||
126257134|NCT03547635|454231244|FG001|Overall Study|Withdrawal by Subject|0|||
126257135|NCT03547635|454231245|FG002|Overall Study|Withdrawal by Subject|0|||
126257136|NCT02415387|454231253|FG000|Overall Study|Withdrawal by Subject|6|||
126257137|NCT02415387|454231254|FG001|Overall Study|Withdrawal by Subject|1|||
126257138|NCT02415387|454231253|FG000|Overall Study|blood draw problem|0|||
126257139|NCT02415387|454231254|FG001|Overall Study|blood draw problem|1|||
126257140|NCT02415387|454231253|FG000|Overall Study|Protocol Violation|1|||
126257141|NCT02415387|454231254|FG001|Overall Study|Protocol Violation|0|||
126257142|NCT00676650|454231255|FG000|Overall Study|Death|45|||
126257143|NCT00676650|454231256|FG001|Overall Study|Death|14|||
126257144|NCT00676650|454231255|FG000|Overall Study|Adverse Event|159|||
126257145|NCT00676650|454231256|FG001|Overall Study|Adverse Event|21|||
126257146|NCT00676650|454231255|FG000|Overall Study|Global deterioration of health status|66|||
126257147|NCT00676650|454231256|FG001|Overall Study|Global deterioration of health status|31|||
126257148|NCT00676650|454231255|FG000|Overall Study|Lost to Follow-up|0|||
126257149|NCT00676650|454231256|FG001|Overall Study|Lost to Follow-up|1|||
126257150|NCT00676650|454231255|FG000|Overall Study|Objective progression or relapse|189|||
126257151|NCT00676650|454231256|FG001|Overall Study|Objective progression or relapse|140|||
126257152|NCT00676650|454231255|FG000|Overall Study|Other|14|||
126257153|NCT00676650|454231256|FG001|Overall Study|Other|10|||
126257154|NCT00676650|454231255|FG000|Overall Study|Protocol Violation|3|||
126257155|NCT00676650|454231256|FG001|Overall Study|Protocol Violation|1|||
126257156|NCT00676650|454231255|FG000|Overall Study|Study terminated by sponsor|57|||
126257157|NCT00676650|454231256|FG001|Overall Study|Study terminated by sponsor|43|||
126257158|NCT00676650|454231255|FG000|Overall Study|Withdrawal by Subject|48|||
126257159|NCT00676650|454231256|FG001|Overall Study|Withdrawal by Subject|24|||
126257160|NCT00676650|454231255|FG000|Overall Study|Randomized but not treated|3|||
126257161|NCT00676650|454231256|FG001|Overall Study|Randomized but not treated|4|||
126257162|NCT02297841|454231260|FG000|Overall Study|Withdrawal by Subject|1|||
126257163|NCT02297841|454231260|FG000|Overall Study|Protocol Violation|7|||
126257164|NCT00683592|454231261|FG000|Overall Study|Adverse Event|12|||
126257165|NCT00683592|454231262|FG001|Overall Study|Adverse Event|4|||
126257166|NCT00683592|454231261|FG000|Overall Study|Withdrawal by Subject|11|||
126257167|NCT00683592|454231262|FG001|Overall Study|Withdrawal by Subject|11|||
126257168|NCT00683592|454231261|FG000|Overall Study|Lost to Follow-up|17|||
126257169|NCT00683592|454231262|FG001|Overall Study|Lost to Follow-up|17|||
126257170|NCT00683592|454231261|FG000|Overall Study|Lack of Efficacy|3|||
126257171|NCT00683592|454231262|FG001|Overall Study|Lack of Efficacy|7|||
126257172|NCT00683592|454231261|FG000|Overall Study|Physician Decision|0|||
126257173|NCT00683592|454231262|FG001|Overall Study|Physician Decision|1|||
126257174|NCT00683592|454231261|FG000|Overall Study|Non-compliance|3|||
126257175|NCT00683592|454231262|FG001|Overall Study|Non-compliance|5|||
126257176|NCT00683592|454231261|FG000|Overall Study|Other|1|||
126257177|NCT00683592|454231262|FG001|Overall Study|Other|1|||
126257178|NCT03431337|454231265|FG000|Overall Study|Lost to Follow-up|21|||
126030035|NCT02689284|453406792|FG001|Overall Study|concern for anemia|1|||
126030036|NCT02689284|453406791|FG000|Overall Study|no measurable cancer for evaluation|0|||
126030037|NCT02689284|453406792|FG001|Overall Study|no measurable cancer for evaluation|1|||
126257179|NCT03431337|454231266|FG001|Overall Study|Lost to Follow-up|19|||
126257180|NCT03431337|454231265|FG000|Overall Study|Withdrawal by Subject|8|||
126257181|NCT03431337|454231266|FG001|Overall Study|Withdrawal by Subject|3|||
126030038|NCT05592418|453406793|FG000|Overall Study|Adverse Event|1|||
126257182|NCT04501094|454231267|FG000|Overall Study|Death (unrelated to research)|1|||
126257183|NCT04501094|454231268|FG001|Overall Study|Death (unrelated to research)|0|||
126030039|NCT05592418|453406794|FG001|Overall Study|Adverse Event|0|||
126257184|NCT02050321|454231272|FG000|Overall Study|Withdrawal by Subject|1|||
126257185|NCT02050321|454231272|FG000|Overall Study|Adverse Event|1|||
126257186|NCT02005276|454231273|FG000|Overall Study|No longer interested|5|||
126257187|NCT02005276|454231274|FG001|Overall Study|No longer interested|2|||
126257188|NCT02005276|454231275|FG002|Overall Study|No longer interested|3|||
126257189|NCT02005276|454231276|FG003|Overall Study|No longer interested|3|||
126257190|NCT01963260|454231277|FG000|Overall Study|Withdrawal by Subject|2|||
126257191|NCT01963260|454231278|FG001|Overall Study|Withdrawal by Subject|0|||
126257192|NCT01963260|454231279|FG002|Overall Study|Withdrawal by Subject|0|||
126257193|NCT01963260|454231280|FG003|Overall Study|Withdrawal by Subject|1|||
126257194|NCT01963260|454231281|FG004|Overall Study|Withdrawal by Subject|2|||
126257195|NCT01963260|454231282|FG005|Overall Study|Withdrawal by Subject|0|||
126257196|NCT01963260|454231283|FG006|Overall Study|Withdrawal by Subject|0|||
126257197|NCT01963260|454231284|FG007|Overall Study|Withdrawal by Subject|0|||
126257198|NCT01963260|454231285|FG008|Overall Study|Withdrawal by Subject|0|||
126257199|NCT01963260|454231286|FG009|Overall Study|Withdrawal by Subject|0|||
126257200|NCT04994431|454231287|FG000|Overall Study|Adverse Event|1|||
126257201|NCT04994431|454231288|FG001|Overall Study|Adverse Event|0|||
126257202|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
126257203|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
126257204|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
126257205|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
126257206|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
126257207|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
126257208|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
126257209|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
126257210|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
126257211|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
126257212|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
126257213|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
126257214|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
126257215|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
126257216|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
126257217|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
126257218|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
126257219|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
126257220|NCT01067521|454231291|FG000|Open-Label Period|Death|3|||
126257221|NCT01067521|454231292|FG001|Open-Label Period|Death|1|||
126257222|NCT01067521|454231291|FG000|Open-Label Period|Adverse Event|30|||
126257223|NCT01067521|454231292|FG001|Open-Label Period|Adverse Event|28|||
126257224|NCT01067521|454231291|FG000|Open-Label Period|Withdrawal by Subject|160|||
126257225|NCT01067521|454231292|FG001|Open-Label Period|Withdrawal by Subject|88|||
126257226|NCT01067521|454231291|FG000|Open-Label Period|Physician Decision|13|||
126257227|NCT01067521|454231292|FG001|Open-Label Period|Physician Decision|11|||
126257228|NCT01067521|454231291|FG000|Open-Label Period|Non-compliance with study drug|5|||
126257229|NCT01067521|454231292|FG001|Open-Label Period|Non-compliance with study drug|0|||
126257230|NCT01067521|454231291|FG000|Open-Label Period|Protocol Violation|3|||
126257231|NCT01067521|454231292|FG001|Open-Label Period|Protocol Violation|0|||
126257232|NCT01067521|454231291|FG000|Open-Label Period|Pregnancy|14|||
126257233|NCT01067521|454231292|FG001|Open-Label Period|Pregnancy|8|||
126257234|NCT01067521|454231291|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
126257235|NCT01067521|454231292|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
126257236|NCT01067521|454231291|FG000|Open-Label Period|Lost to Follow-up|21|||
126257237|NCT01067521|454231292|FG001|Open-Label Period|Lost to Follow-up|20|||
126257238|NCT00766493|454231293|FG000|30 Days Post-Procedure|Discontinued|7|||
126257239|NCT00766493|454231293|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
126257240|NCT00766493|454231293|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
126257241|NCT03419962|454231296|FG000|Overall Study|Change to other medication|1|||
126257242|NCT03419962|454231296|FG000|Overall Study|Refusal of continuing with trial drug|1|||
126257243|NCT03419962|454231296|FG000|Overall Study|Lost to Follow-up|3|||
126257244|NCT03419962|454231296|FG000|Overall Study|Difficulty in inhaling the doses|1|||
126257245|NCT03419962|454231296|FG000|Overall Study|Missing completion data|31|||
126257246|NCT02914457|454231297|FG000|Overall Study|Withdrawal by Subject|1|||
126257247|NCT02914457|454231297|FG000|Overall Study|Physician Decision|1|||
126257248|NCT02914457|454231297|FG000|Overall Study|No veins available for lead placement|1|||
126257249|NCT02914457|454231297|FG000|Overall Study|Electrical instability of patient|1|||
126257250|NCT02914457|454231297|FG000|Overall Study|ECG acquisition error due to sweating|1|||
126257251|NCT02914457|454231297|FG000|Overall Study|Protocol Violation|1|||
126257252|NCT01098539|454231298|FG000|Overall Study|Adverse Event|26|||
126257253|NCT01098539|454231299|FG001|Overall Study|Adverse Event|26|||
126257254|NCT01098539|454231298|FG000|Overall Study|Protocol Violation|1|||
126257255|NCT01098539|454231299|FG001|Overall Study|Protocol Violation|4|||
126358559|NCT02565186|454605380|FG001|Overall Study|Missing|0|||
126358560|NCT02565186|454605379|FG000|Overall Study|Did Not Receive Study Drug|55|||
126358561|NCT02565186|454605380|FG001|Overall Study|Did Not Receive Study Drug|86|||
126358562|NCT00337194|454605381|FG000|Overall Study|Adverse Event|5|||
126358563|NCT00337194|454605382|FG001|Overall Study|Adverse Event|1|||
126358564|NCT00337194|454605381|FG000|Overall Study|Death|2|||
126358565|NCT00337194|454605382|FG001|Overall Study|Death|0|||
126358566|NCT00337194|454605381|FG000|Overall Study|Withdrawal by Subject|1|||
126358567|NCT00337194|454605382|FG001|Overall Study|Withdrawal by Subject|0|||
126358568|NCT00337194|454605381|FG000|Overall Study|Disease progression|1|||
126358569|NCT00337194|454605382|FG001|Overall Study|Disease progression|2|||
126358570|NCT00337194|454605381|FG000|Overall Study|Subsequent non-protocol therapy|3|||
126358571|NCT00337194|454605382|FG001|Overall Study|Subsequent non-protocol therapy|1|||
126358572|NCT03188705|454605383|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
126358573|NCT03188705|454605383|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
126358574|NCT01174459|454605384|FG000|Overall Study|case report form (CRF) not collected|5|||
126358575|NCT01623752|454605385|FG000|Phase 1 (78 Weeks)|No Data|249|||
126358576|NCT01623752|454605386|FG001|Phase 1 (78 Weeks)|No Data|66|||
126358577|NCT01623752|454605387|FG002|Phase 1 (78 Weeks)|No Data|2|||
126358578|NCT01623752|454605385|FG000|Phase 1 (78 Weeks)|Other|33|||
126358579|NCT01623752|454605386|FG001|Phase 1 (78 Weeks)|Other|20|||
126358580|NCT01623752|454605387|FG002|Phase 1 (78 Weeks)|Other|0|||
126358581|NCT01623752|454605385|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
126358582|NCT01623752|454605386|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
126358583|NCT01623752|454605387|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
126358584|NCT01623752|454605385|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
126358585|NCT01623752|454605386|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
126358586|NCT01623752|454605387|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
126358587|NCT01623752|454605385|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
126358588|NCT01623752|454605386|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
126358589|NCT01623752|454605387|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
126257256|NCT01098539|454231298|FG000|Overall Study|Noncompliance|3|||
126257257|NCT01098539|454231299|FG001|Overall Study|Noncompliance|5|||
126257258|NCT01098539|454231298|FG000|Overall Study|Lost to Follow-up|4|||
126257259|NCT01098539|454231299|FG001|Overall Study|Lost to Follow-up|4|||
126257260|NCT01098539|454231298|FG000|Overall Study|Withdrawal by Subject|12|||
126257261|NCT01098539|454231299|FG001|Overall Study|Withdrawal by Subject|26|||
126257262|NCT01098539|454231298|FG000|Overall Study|Physician Decision|5|||
126257263|NCT01098539|454231299|FG001|Overall Study|Physician Decision|3|||
126257264|NCT01849458|454231302|FG000|Overall Study|Lost to Follow-up|4|||
126257265|NCT01781234|454231303|FG000|Overall Study|Adverse Event|2|||
126257266|NCT01781234|454231304|FG001|Overall Study|Adverse Event|0|||
126257267|NCT01781234|454231303|FG000|Overall Study|Protocol Violation|3|||
126257268|NCT01781234|454231304|FG001|Overall Study|Protocol Violation|0|||
126257269|NCT01781234|454231303|FG000|Overall Study|Withdrawal by Subject|4|||
126257270|NCT01781234|454231304|FG001|Overall Study|Withdrawal by Subject|3|||
126257271|NCT00721955|454231305|FG000|Overall Study|Adverse Event|0|||
126257272|NCT00721955|454231306|FG001|Overall Study|Adverse Event|0|||
126257273|NCT00721955|454231307|FG002|Overall Study|Adverse Event|2|||
126257274|NCT03439085|454231308|FG000|Overall Study|Death|2|||
126257275|NCT03439085|454231308|FG000|Overall Study|Screen Failure|20|||
126257276|NCT01863433|454231309|FG000|Overall Study|Protocol Violation|1|||
126257277|NCT02174276|454231310|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
126257278|NCT02174276|454231311|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
126257279|NCT02174276|454231312|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
126257280|NCT02174276|454231313|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
126257281|NCT02174276|454231310|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
126257282|NCT02174276|454231311|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
126257283|NCT02174276|454231312|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
126257284|NCT02174276|454231313|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
126358590|NCT01623752|454605385|FG000|Phase 2 (78 Weeks)|Other|5|||
126358591|NCT01623752|454605386|FG001|Phase 2 (78 Weeks)|Other|1|||
126358592|NCT01623752|454605387|FG002|Phase 2 (78 Weeks)|Other|0|||
126358593|NCT01623752|454605385|FG000|Phase 2 (78 Weeks)|No Data|43|||
126358594|NCT01623752|454605386|FG001|Phase 2 (78 Weeks)|No Data|11|||
126358595|NCT01623752|454605387|FG002|Phase 2 (78 Weeks)|No Data|0|||
126358596|NCT01623752|454605385|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
126358597|NCT01623752|454605386|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
126358598|NCT01623752|454605387|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
125879807|NCT03050801|452857389|FG004|Experiment 1|Physician Decision|0|||
125879808|NCT03050801|452857390|FG005|Experiment 1|Physician Decision|0|||
125879809|NCT03050801|452857385|FG000|Experiment 1|Change of experimental design|0|||
125879810|NCT03050801|452857386|FG001|Experiment 1|Change of experimental design|3|||
125879811|NCT03050801|452857387|FG002|Experiment 1|Change of experimental design|0|||
125879812|NCT03050801|452857388|FG003|Experiment 1|Change of experimental design|0|||
125879813|NCT03050801|452857389|FG004|Experiment 1|Change of experimental design|0|||
125879814|NCT03050801|452857390|FG005|Experiment 1|Change of experimental design|0|||
125879815|NCT03050801|452857385|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
125879816|NCT03050801|452857386|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
125879817|NCT03050801|452857387|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
125879818|NCT03050801|452857388|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
126257285|NCT02174276|454231310|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
126257286|NCT02174276|454231311|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
126257287|NCT02174276|454231312|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
126257288|NCT02174276|454231313|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
126257289|NCT02174276|454231310|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
126257290|NCT02174276|454231311|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
126257291|NCT02174276|454231312|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
126257292|NCT02174276|454231313|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
126257293|NCT02174276|454231310|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
126257294|NCT02174276|454231311|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
126257295|NCT02174276|454231312|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
126257296|NCT02174276|454231313|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
126257297|NCT02174276|454231310|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
126257298|NCT02174276|454231311|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
126257299|NCT02174276|454231312|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
126257300|NCT02174276|454231313|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
126257301|NCT01206439|454231314|FG000|Overall Study|subject did not meet inclusion criteria|1|||
126257302|NCT00434837|454231326|FG000|Overall Study|Lost to Follow-up|20|||
126257303|NCT00434837|454231327|FG001|Overall Study|Lost to Follow-up|23|||
126257304|NCT00434837|454231328|FG002|Overall Study|Lost to Follow-up|30|||
126257305|NCT01077258|454231329|FG000|Overall Study|Lost to Follow-up|1390|||
126257306|NCT01077258|454231329|FG000|Overall Study|Adverse drug reaction|218|||
126257307|NCT01077258|454231329|FG000|Overall Study|Lack of Efficacy|663|||
126257308|NCT01077258|454231329|FG000|Overall Study|Clinical remission|37|||
126257309|NCT01077258|454231329|FG000|Overall Study|Other reasons|260|||
126257310|NCT00515216|454231330|FG000|Overall Study|Withdrawal by Subject|1|||
126257311|NCT00726895|454231331|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126257312|NCT00726895|454231332|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126257313|NCT02786927|454231334|FG000|Overall Study|Adverse Event|1|||
126257314|NCT02786927|454231334|FG000|Overall Study|Protocol Violation|4|||
126257315|NCT01801917|454231335|FG000|Period 1 - Randomized|Adverse Event|1|||
126257316|NCT01801917|454231336|FG001|Period 1 - Randomized|Adverse Event|0|||
126257317|NCT01801917|454231337|FG002|Period 1 - Randomized|Adverse Event|1|||
126257318|NCT01801917|454231338|FG003|Period 1 - Randomized|Adverse Event|0|||
126257319|NCT04307849|454231339|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
126257320|NCT04307849|454231340|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
126257321|NCT04307849|454231341|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
126257322|NCT04307849|454231342|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
126257323|NCT04307849|454231343|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
126257324|NCT04307849|454231344|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
126257325|NCT04307849|454231339|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257326|NCT04307849|454231340|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257327|NCT04307849|454231341|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
126257328|NCT04307849|454231342|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257329|NCT04307849|454231343|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257330|NCT04307849|454231344|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257331|NCT04307849|454231339|FG000|Overall Study|Family member did not want them to continue|0|||
126257332|NCT04307849|454231340|FG001|Overall Study|Family member did not want them to continue|0|||
126257333|NCT04307849|454231341|FG002|Overall Study|Family member did not want them to continue|1|||
126257334|NCT04307849|454231342|FG003|Overall Study|Family member did not want them to continue|0|||
125879819|NCT03050801|452857389|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
125879820|NCT03050801|452857390|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
126030040|NCT05592418|453406793|FG000|Overall Study|Lost to Follow-up|1|||
126257335|NCT04307849|454231343|FG004|Overall Study|Family member did not want them to continue|0|||
126257336|NCT04307849|454231344|FG005|Overall Study|Family member did not want them to continue|0|||
125879821|NCT03050801|452857385|FG000|Experiment 2|Lost to Follow-up|0|||
125879822|NCT03050801|452857386|FG001|Experiment 2|Lost to Follow-up|0|||
126030041|NCT05592418|453406794|FG001|Overall Study|Lost to Follow-up|3|||
126030042|NCT05592418|453406793|FG000|Overall Study|Withdrawal by Subject|2|||
126030043|NCT05592418|453406794|FG001|Overall Study|Withdrawal by Subject|7|||
126030044|NCT05569252|453406797|FG000|Overall Study|Adverse event (central vision loss)|1|||
126257337|NCT04307849|454231339|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
126257338|NCT04307849|454231340|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
126257339|NCT04307849|454231341|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
126257340|NCT04307849|454231342|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
126257341|NCT04307849|454231343|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
126257342|NCT04307849|454231344|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
126257343|NCT05467982|454231345|FG000|Overall Study|Death|0|||
126257344|NCT05467982|454231346|FG001|Overall Study|Death|1|||
126257345|NCT05467982|454231345|FG000|Overall Study|Lost to Follow-up|3|||
126257346|NCT05467982|454231346|FG001|Overall Study|Lost to Follow-up|1|||
126257347|NCT00105157|454231362|FG000|Double-Blind (DB)|Never Treated|1|||
126257348|NCT00105157|454231363|FG001|Double-Blind (DB)|Never Treated|0|||
126257349|NCT00105157|454231364|FG002|Double-Blind (DB)|Never Treated|0|||
126257350|NCT00105157|454231365|FG003|Double-Blind (DB)|Never Treated|0|||
126257351|NCT00105157|454231362|FG000|Double-Blind (DB)|Adverse Event|2|||
126257352|NCT00105157|454231363|FG001|Double-Blind (DB)|Adverse Event|0|||
126257353|NCT00105157|454231364|FG002|Double-Blind (DB)|Adverse Event|1|||
126257354|NCT00105157|454231365|FG003|Double-Blind (DB)|Adverse Event|1|||
126257355|NCT00105157|454231362|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
126257356|NCT00105157|454231363|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
126257357|NCT00105157|454231364|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
126257358|NCT00105157|454231365|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
126257359|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Adverse Event|3|||
126257360|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Adverse Event|1|||
126257361|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Adverse Event|0|||
126257362|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Adverse Event|0|||
126257363|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
126257364|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
126257365|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
126257366|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
126257367|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
126257368|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
126257369|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
126257370|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
126257371|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
126257372|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
126257373|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
126257374|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
126257375|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
126257376|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
126257377|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
126257378|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
126257379|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
126257380|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
126257381|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
126257382|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
126257383|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
126257384|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
126257385|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
126257386|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
126257387|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
126257388|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
126257389|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
126257390|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
126257391|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
126030045|NCT05569252|453406798|FG001|Overall Study|Adverse event (central vision loss)|0|||
126030046|NCT05569252|453406799|FG002|Overall Study|Adverse event (central vision loss)|0|||
126030047|NCT05569252|453406800|FG003|Overall Study|Adverse event (central vision loss)|0|||
126030048|NCT03665597|453406801|FG000|Period 1|Adverse Event|1|||
126030049|NCT03665597|453406802|FG001|Period 1|Adverse Event|0|||
126257392|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
126257393|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
126257394|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
126358599|NCT03994120|454605388|FG000|Overall Study|Lost to Follow-up|3|||
126358600|NCT03994120|454605389|FG001|Overall Study|Lost to Follow-up|1|||
126030050|NCT03665597|453406803|FG002|Period 1|Adverse Event|0|||
126257395|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
126257396|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
126257397|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
126257398|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
126257399|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
126257400|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
126257401|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
126257402|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
126257403|NCT00127166|454231366|FG000|Period I|Protocol Violation|0|||
126257404|NCT00127166|454231367|FG001|Period I|Protocol Violation|2|||
126257405|NCT00127166|454231366|FG000|Period I|Withdrawal by Subject|2|||
126257406|NCT00127166|454231367|FG001|Period I|Withdrawal by Subject|0|||
126257407|NCT00127166|454231366|FG000|Period I|Patient did not meet inclusion criteria|1|||
126257408|NCT00127166|454231367|FG001|Period I|Patient did not meet inclusion criteria|0|||
126257409|NCT00127166|454231366|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
126257410|NCT00127166|454231367|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
126257411|NCT00127166|454231366|FG000|Period II|Withdrawal by Subject|2|||
126257412|NCT00127166|454231367|FG001|Period II|Withdrawal by Subject|0|||
126257413|NCT00127166|454231366|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
126257414|NCT00127166|454231367|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
126257415|NCT01148225|454231370|FG000|Overall Study|Other|185|||
126257416|NCT00393705|454231371|FG000|Overall Study|Adverse Event|0|||
126257417|NCT00393705|454231372|FG001|Overall Study|Adverse Event|2|||
126257418|NCT00393705|454231371|FG000|Overall Study|Death|0|||
126257419|NCT00393705|454231372|FG001|Overall Study|Death|1|||
126257420|NCT00393705|454231371|FG000|Overall Study|Lost to Follow-up|2|||
126257421|NCT00393705|454231372|FG001|Overall Study|Lost to Follow-up|2|||
126257422|NCT00393705|454231371|FG000|Overall Study|Entry Criteria Not Met|10|||
126257423|NCT00393705|454231372|FG001|Overall Study|Entry Criteria Not Met|10|||
126257424|NCT00393705|454231371|FG000|Overall Study|Protocol Violation|4|||
126257425|NCT00393705|454231372|FG001|Overall Study|Protocol Violation|3|||
126257426|NCT00393705|454231371|FG000|Overall Study|Withdrawal by Subject|5|||
126257427|NCT00393705|454231372|FG001|Overall Study|Withdrawal by Subject|3|||
126257428|NCT00393705|454231371|FG000|Overall Study|Physician Decision|2|||
126257429|NCT00393705|454231372|FG001|Overall Study|Physician Decision|2|||
126257430|NCT02490800|454231373|FG000|Overall Study|Adverse Event|0|||
126257431|NCT02490800|454231374|FG001|Overall Study|Adverse Event|0|||
126257432|NCT02490800|454231375|FG002|Overall Study|Adverse Event|0|||
126257433|NCT02490800|454231376|FG003|Overall Study|Adverse Event|2|||
126257434|NCT02490800|454231377|FG004|Overall Study|Adverse Event|3|||
126257435|NCT02490800|454231378|FG005|Overall Study|Adverse Event|2|||
126257436|NCT02490800|454231379|FG006|Overall Study|Adverse Event|0|||
126257437|NCT02490800|454231380|FG007|Overall Study|Adverse Event|0|||
126257438|NCT02490800|454231381|FG008|Overall Study|Adverse Event|0|||
126257439|NCT02490800|454231382|FG009|Overall Study|Adverse Event|0|||
126257440|NCT02490800|454231383|FG010|Overall Study|Adverse Event|0|||
126257441|NCT02490800|454231384|FG011|Overall Study|Adverse Event|2|||
126257442|NCT02490800|454231385|FG012|Overall Study|Adverse Event|2|||
126257443|NCT02490800|454231373|FG000|Overall Study|Withdrawal by Subject|0|||
126257444|NCT02490800|454231374|FG001|Overall Study|Withdrawal by Subject|0|||
126257445|NCT02490800|454231375|FG002|Overall Study|Withdrawal by Subject|0|||
126257446|NCT02490800|454231376|FG003|Overall Study|Withdrawal by Subject|1|||
126257447|NCT02490800|454231377|FG004|Overall Study|Withdrawal by Subject|0|||
126257448|NCT02490800|454231378|FG005|Overall Study|Withdrawal by Subject|0|||
126257449|NCT02490800|454231379|FG006|Overall Study|Withdrawal by Subject|0|||
126257450|NCT02490800|454231380|FG007|Overall Study|Withdrawal by Subject|0|||
126257451|NCT02490800|454231381|FG008|Overall Study|Withdrawal by Subject|1|||
126096048|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
126257452|NCT02490800|454231382|FG009|Overall Study|Withdrawal by Subject|0|||
126257453|NCT02490800|454231383|FG010|Overall Study|Withdrawal by Subject|0|||
126257454|NCT02490800|454231384|FG011|Overall Study|Withdrawal by Subject|0|||
126257455|NCT02490800|454231385|FG012|Overall Study|Withdrawal by Subject|0|||
126257456|NCT02490800|454231373|FG000|Overall Study|Progressive disease|3|||
126257457|NCT02490800|454231374|FG001|Overall Study|Progressive disease|3|||
126257458|NCT02490800|454231375|FG002|Overall Study|Progressive disease|3|||
126257459|NCT02490800|454231376|FG003|Overall Study|Progressive disease|4|||
126257460|NCT02490800|454231377|FG004|Overall Study|Progressive disease|4|||
126257461|NCT02490800|454231378|FG005|Overall Study|Progressive disease|1|||
126030051|NCT03665597|453406804|FG003|Period 1|Adverse Event|1|||
126030052|NCT03665597|453406805|FG004|Period 1|Adverse Event|0|||
126030053|NCT03665597|453406806|FG005|Period 1|Adverse Event|0|||
126030054|NCT03665597|453406807|FG006|Period 1|Adverse Event|0|||
126030055|NCT03665597|453406801|FG000|Period 1|Screen Failure|0|||
126030056|NCT03665597|453406802|FG001|Period 1|Screen Failure|0|||
126030057|NCT03665597|453406803|FG002|Period 1|Screen Failure|0|||
126030058|NCT03665597|453406804|FG003|Period 1|Screen Failure|1|||
126257462|NCT02490800|454231379|FG006|Overall Study|Progressive disease|4|||
126257463|NCT02490800|454231380|FG007|Overall Study|Progressive disease|3|||
126257464|NCT02490800|454231381|FG008|Overall Study|Progressive disease|6|||
126257465|NCT02490800|454231382|FG009|Overall Study|Progressive disease|2|||
126257466|NCT02490800|454231383|FG010|Overall Study|Progressive disease|7|||
126257467|NCT02490800|454231384|FG011|Overall Study|Progressive disease|1|||
126257468|NCT02490800|454231385|FG012|Overall Study|Progressive disease|10|||
126257469|NCT02490800|454231373|FG000|Overall Study|Patient enrolled in post-trial access|0|||
126257470|NCT02490800|454231374|FG001|Overall Study|Patient enrolled in post-trial access|0|||
126257471|NCT02490800|454231375|FG002|Overall Study|Patient enrolled in post-trial access|0|||
126257472|NCT02490800|454231376|FG003|Overall Study|Patient enrolled in post-trial access|0|||
126257473|NCT02490800|454231377|FG004|Overall Study|Patient enrolled in post-trial access|0|||
126257474|NCT02490800|454231378|FG005|Overall Study|Patient enrolled in post-trial access|0|||
126257475|NCT02490800|454231379|FG006|Overall Study|Patient enrolled in post-trial access|0|||
126257476|NCT02490800|454231380|FG007|Overall Study|Patient enrolled in post-trial access|0|||
126257477|NCT02490800|454231381|FG008|Overall Study|Patient enrolled in post-trial access|0|||
126257478|NCT02490800|454231382|FG009|Overall Study|Patient enrolled in post-trial access|1|||
126257479|NCT02490800|454231383|FG010|Overall Study|Patient enrolled in post-trial access|1|||
126257480|NCT02490800|454231384|FG011|Overall Study|Patient enrolled in post-trial access|0|||
126257481|NCT02490800|454231385|FG012|Overall Study|Patient enrolled in post-trial access|6|||
126257482|NCT00654641|454231386|FG000|Overall Study|Lost to Follow-up|2|||
126257483|NCT00654641|454231387|FG001|Overall Study|Lost to Follow-up|3|||
126257484|NCT01337596|454231388|FG000|Overall Study|Withdrawal by Subject|0|||
126257485|NCT01337596|454231389|FG001|Overall Study|Withdrawal by Subject|0|||
126257486|NCT01337596|454231390|FG002|Overall Study|Withdrawal by Subject|0|||
126257487|NCT01337596|454231391|FG003|Overall Study|Withdrawal by Subject|0|||
126257488|NCT01337596|454231392|FG004|Overall Study|Withdrawal by Subject|2|||
126257489|NCT01337596|454231393|FG005|Overall Study|Withdrawal by Subject|0|||
126257490|NCT01337596|454231394|FG006|Overall Study|Withdrawal by Subject|0|||
126257491|NCT01337596|454231395|FG007|Overall Study|Withdrawal by Subject|0|||
126257492|NCT01337596|454231396|FG008|Overall Study|Withdrawal by Subject|0|||
126257493|NCT03365791|454231397|FG000|Overall Study|Adverse Event|5|||
126257494|NCT03365791|454231397|FG000|Overall Study|Death|1|||
126257495|NCT03365791|454231397|FG000|Overall Study|Lost to Follow-up|1|||
126257496|NCT03365791|454231397|FG000|Overall Study|Physician Decision|9|||
126257497|NCT03365791|454231397|FG000|Overall Study|Progressive disease|51|||
126257498|NCT03365791|454231397|FG000|Overall Study|Subject/guardian decision|5|||
126257499|NCT03693950|454231398|FG000|Overall Study|Withdrawal by Subject|1|||
126257500|NCT03693950|454231399|FG001|Overall Study|Withdrawal by Subject|0|||
126257501|NCT01475487|454231400|FG000|Overall Study|had to leave early for personal reasons|2|||
126257502|NCT01475487|454231401|FG001|Overall Study|had to leave early for personal reasons|1|||
126257503|NCT00559637|454232666|FG000|Overall Study|Adverse Event|22|||
126257504|NCT00559637|454232666|FG000|Overall Study|Withdrawal by Subject|4|||
126257505|NCT00559637|454232666|FG000|Overall Study|Protocol Violation|6|||
126257506|NCT00559637|454232666|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
126257507|NCT00559637|454232666|FG000|Overall Study|Failure to return|6|||
126257508|NCT00559637|454232666|FG000|Overall Study|Insufficient response|3|||
126257509|NCT00559637|454232666|FG000|Overall Study|Started requiring dialysis after month 7|2|||
126257510|NCT00559637|454232666|FG000|Overall Study|Suspected lung cancer|1|||
126257511|NCT00559637|454232666|FG000|Overall Study|Participation in another study|1|||
126257512|NCT00559637|454232666|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
126257513|NCT00559637|454232666|FG000|Overall Study|Change of center|1|||
126257514|NCT00559637|454232666|FG000|Overall Study|Change of home|1|||
126257515|NCT00559637|454232666|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
126257516|NCT01958060|454232669|FG000|Overall Study|Not treated|2|||
126257517|NCT01958060|454232670|FG001|Overall Study|Not treated|0|||
126257518|NCT01958060|454232671|FG002|Overall Study|Not treated|0|||
126257519|NCT01958060|454232672|FG003|Overall Study|Not treated|0|||
126257520|NCT01958060|454232673|FG004|Overall Study|Not treated|1|||
126257521|NCT01958060|454232674|FG005|Overall Study|Not treated|0|||
126030059|NCT03665597|453406805|FG004|Period 1|Screen Failure|0|||
126257522|NCT01765270|454232707|FG000|Overall Study|Physician Decision|1|||
126030060|NCT03665597|453406806|FG005|Period 1|Screen Failure|0|||
126257523|NCT01765270|454232708|FG001|Overall Study|Physician Decision|0|||
126030061|NCT03665597|453406807|FG006|Period 1|Screen Failure|0|||
126030062|NCT03665597|453406801|FG000|Period 1|Death|0|||
126257524|NCT01765270|454232707|FG000|Overall Study|Withdrawal by Subject|0|||
126257525|NCT01765270|454232708|FG001|Overall Study|Withdrawal by Subject|1|||
126257526|NCT00329160|454232709|FG000|Overall Study|Adverse Event|27|||
126257527|NCT00329160|454232709|FG000|Overall Study|Withdrawal by Subject|13|||
126257528|NCT00329160|454232709|FG000|Overall Study|Protocol Violation|2|||
126257529|NCT00329160|454232709|FG000|Overall Study|Did not Receive Study Drug|1|||
126257530|NCT00329160|454232709|FG000|Overall Study|Incomplete IVUS|45|||
126257531|NCT00063258|454232710|FG000|Overall Study|Physician Decision|2|||
126257532|NCT00063258|454232711|FG001|Overall Study|Physician Decision|0|||
126257533|NCT00063258|454232710|FG000|Overall Study|Lack of Efficacy|2|||
126257534|NCT00063258|454232711|FG001|Overall Study|Lack of Efficacy|0|||
126257535|NCT00784979|454232714|FG000|Overall Study|incomplete data|6|||
126257536|NCT00894933|454232715|FG000|Overall Study|Lost to Follow-up|2|||
126257537|NCT00894933|454232715|FG000|Overall Study|Cancelled Procedure|1|||
126257538|NCT00894933|454232715|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
126257539|NCT01235715|454232720|FG000|Overall Study|Physician Decision|0|||
126257540|NCT01235715|454232721|FG001|Overall Study|Physician Decision|2|||
126257541|NCT03619876|454232722|FG000|Overall Study|Withdrawal by Subject|1|||
126257542|NCT03619876|454232723|FG001|Overall Study|Withdrawal by Subject|2|||
126257543|NCT03619876|454232722|FG000|Overall Study|Withdrawal due to incidental finding|0|||
126257544|NCT03619876|454232723|FG001|Overall Study|Withdrawal due to incidental finding|2|||
126257545|NCT00396630|454232726|FG000|Overall Study|Lost to Follow-up|1|||
126257546|NCT00396630|454232727|FG001|Overall Study|Lost to Follow-up|1|||
126257547|NCT00396630|454232726|FG000|Overall Study|Withdrawal by Subject|1|||
126257548|NCT00396630|454232727|FG001|Overall Study|Withdrawal by Subject|1|||
126257549|NCT00396630|454232726|FG000|Overall Study|Not vaccinated at Visit 3|3|||
126257550|NCT00396630|454232727|FG001|Overall Study|Not vaccinated at Visit 3|3|||
126257551|NCT00996437|454232730|FG000|Overall Study|Death|1|||
126257552|NCT00996437|454232731|FG001|Overall Study|Death|0|||
126257553|NCT00996437|454232730|FG000|Overall Study|Dropped|2|||
126257554|NCT00996437|454232731|FG001|Overall Study|Dropped|2|||
126257555|NCT00996437|454232730|FG000|Overall Study|Missed|2|||
126257556|NCT00996437|454232731|FG001|Overall Study|Missed|5|||
126257557|NCT02576717|454232734|FG000|Overall Study|Other Reasons|16|||
126257558|NCT02576717|454232735|FG001|Overall Study|Other Reasons|18|||
126257559|NCT02576717|454232736|FG002|Overall Study|Other Reasons|15|||
126257560|NCT02576717|454232734|FG000|Overall Study|Covid-19 Pandemic|0|||
126257561|NCT02576717|454232735|FG001|Overall Study|Covid-19 Pandemic|1|||
126257562|NCT02576717|454232736|FG002|Overall Study|Covid-19 Pandemic|1|||
126257563|NCT02576717|454232734|FG000|Overall Study|Sponsor Decision|0|||
126257564|NCT02576717|454232735|FG001|Overall Study|Sponsor Decision|0|||
126257565|NCT02576717|454232736|FG002|Overall Study|Sponsor Decision|1|||
126257566|NCT02576717|454232734|FG000|Overall Study|Physician Decision|3|||
126257567|NCT02576717|454232735|FG001|Overall Study|Physician Decision|8|||
126257568|NCT02576717|454232736|FG002|Overall Study|Physician Decision|9|||
126257569|NCT02576717|454232734|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
126257570|NCT02576717|454232735|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
126257571|NCT02576717|454232736|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
126257572|NCT02576717|454232734|FG000|Overall Study|Death|3|||
126257573|NCT02576717|454232735|FG001|Overall Study|Death|5|||
126257574|NCT02576717|454232736|FG002|Overall Study|Death|3|||
126257575|NCT02576717|454232734|FG000|Overall Study|Lost to Follow-up|9|||
126257576|NCT02576717|454232735|FG001|Overall Study|Lost to Follow-up|10|||
126257577|NCT02576717|454232736|FG002|Overall Study|Lost to Follow-up|19|||
126257578|NCT02576717|454232734|FG000|Overall Study|Protocol Violation|4|||
126257579|NCT02576717|454232735|FG001|Overall Study|Protocol Violation|0|||
126257580|NCT02576717|454232736|FG002|Overall Study|Protocol Violation|5|||
126257581|NCT02576717|454232734|FG000|Overall Study|Lack of Efficacy|24|||
126257582|NCT02576717|454232735|FG001|Overall Study|Lack of Efficacy|28|||
126257583|NCT02576717|454232736|FG002|Overall Study|Lack of Efficacy|20|||
126257584|NCT02576717|454232734|FG000|Overall Study|Adverse Event|26|||
126257585|NCT02576717|454232735|FG001|Overall Study|Adverse Event|32|||
126257586|NCT02576717|454232736|FG002|Overall Study|Adverse Event|26|||
125879823|NCT03050801|452857387|FG002|Experiment 2|Lost to Follow-up|0|||
126257587|NCT01755975|454232737|FG000|Overall Study|Adverse Event|0|||
126257588|NCT01755975|454232738|FG001|Overall Study|Adverse Event|0|||
126257589|NCT01755975|454232739|FG002|Overall Study|Adverse Event|1|||
126257590|NCT01755975|454232740|FG003|Overall Study|Adverse Event|0|||
126257591|NCT01755975|454232741|FG004|Overall Study|Adverse Event|2|||
126257592|NCT00399893|454232742|FG000|Overall Study|Withdrawal by Subject|1|||
126257593|NCT00399893|454232743|FG001|Overall Study|Withdrawal by Subject|0|||
126257594|NCT03653026|454232744|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
126257595|NCT03653026|454232745|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
126257596|NCT03653026|454232746|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
126257597|NCT03653026|454232747|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
126257598|NCT03653026|454232744|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
126257599|NCT03653026|454232745|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
126257600|NCT03653026|454232746|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126257601|NCT03653026|454232747|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126257602|NCT03653026|454232744|FG000|Part 1: Placebo-controlled Period|Other|0|||
126257603|NCT03653026|454232745|FG001|Part 1: Placebo-controlled Period|Other|3|||
126257604|NCT03653026|454232746|FG002|Part 1: Placebo-controlled Period|Other|0|||
126257605|NCT03653026|454232747|FG003|Part 1: Placebo-controlled Period|Other|0|||
126257606|NCT03653026|454232744|FG000|Part 2: Open-label Extension|Adverse Event|0|||
126257607|NCT03653026|454232745|FG001|Part 2: Open-label Extension|Adverse Event|0|||
126257608|NCT03653026|454232746|FG002|Part 2: Open-label Extension|Adverse Event|1|||
126257609|NCT03653026|454232747|FG003|Part 2: Open-label Extension|Adverse Event|1|||
126257610|NCT03653026|454232744|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
126257611|NCT03653026|454232745|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
126257612|NCT03653026|454232746|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
126257613|NCT03653026|454232747|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
126257614|NCT03653026|454232744|FG000|Part 2: Open-label Extension|Other|0|||
126257615|NCT03653026|454232745|FG001|Part 2: Open-label Extension|Other|0|||
126257616|NCT03653026|454232746|FG002|Part 2: Open-label Extension|Other|1|||
126257617|NCT03653026|454232747|FG003|Part 2: Open-label Extension|Other|2|||
126257618|NCT02457819|454232748|FG000|Overall Study|reason not given|8|||
126257619|NCT02457819|454232748|FG000|Overall Study|Withdrawal by Subject|24|||
126257620|NCT02457819|454232748|FG000|Overall Study|Protocol Violation|1|||
126257621|NCT02457819|454232748|FG000|Overall Study|non compliance with study drug|4|||
126257622|NCT02457819|454232748|FG000|Overall Study|Lost to Follow-up|10|||
126257623|NCT02457819|454232748|FG000|Overall Study|Lack of Efficacy|19|||
126257624|NCT02457819|454232748|FG000|Overall Study|Adverse Event|33|||
126257625|NCT03330236|454232751|FG000|Overall Study|Death|2|||
126257626|NCT03330236|454232752|FG001|Overall Study|Death|1|||
126257627|NCT03330236|454232751|FG000|Overall Study|Withdrawal by Subject|2|||
126257628|NCT03330236|454232752|FG001|Overall Study|Withdrawal by Subject|4|||
126257629|NCT03330236|454232751|FG000|Overall Study|Lost to Follow-up|0|||
126257630|NCT03330236|454232752|FG001|Overall Study|Lost to Follow-up|2|||
126257631|NCT03330236|454232751|FG000|Overall Study|Physician Decision|2|||
126257632|NCT03330236|454232752|FG001|Overall Study|Physician Decision|0|||
126257633|NCT03330236|454232751|FG000|Overall Study|Protocol Violation|4|||
126257634|NCT03330236|454232752|FG001|Overall Study|Protocol Violation|3|||
126257635|NCT03330236|454232751|FG000|Overall Study|SedLine malfunction/blinding|19|||
126257636|NCT03330236|454232752|FG001|Overall Study|SedLine malfunction/blinding|14|||
126257637|NCT03330236|454232751|FG000|Overall Study|Volatile anesthetics used|11|||
126257638|NCT03330236|454232752|FG001|Overall Study|Volatile anesthetics used|8|||
126257639|NCT03330236|454232751|FG000|Overall Study|Surgery aborted/converted to open|60|||
126257640|NCT03330236|454232752|FG001|Overall Study|Surgery aborted/converted to open|52|||
126257641|NCT01901848|454232753|FG000|Randomized and Treated|Lost to Follow-up|3|||
126257642|NCT01901848|454232754|FG001|Randomized and Treated|Lost to Follow-up|6|||
126257643|NCT01901848|454232753|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
126257644|NCT01901848|454232754|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
126257645|NCT00763555|454232755|FG000|Overall Study|Adverse Event|2|||
126257646|NCT00763555|454232756|FG001|Overall Study|Adverse Event|1|||
126257647|NCT00763555|454232755|FG000|Overall Study|Withdrawal by Subject|2|||
126257648|NCT00763555|454232756|FG001|Overall Study|Withdrawal by Subject|6|||
126257649|NCT00763555|454232755|FG000|Overall Study|Lost to Follow-up|0|||
126257650|NCT00763555|454232756|FG001|Overall Study|Lost to Follow-up|3|||
126257651|NCT01729026|454232757|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
126257652|NCT01729026|454232758|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
126257653|NCT01729026|454232757|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
126257654|NCT01729026|454232758|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
126257655|NCT03710590|454232759|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
126257656|NCT03710590|454232760|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
126257657|NCT00852917|454232761|FG000|Overall Study|Adverse Event|13|||
126257658|NCT00852917|454232762|FG001|Overall Study|Adverse Event|20|||
126257659|NCT00852917|454232763|FG002|Overall Study|Adverse Event|35|||
126257660|NCT00852917|454232764|FG003|Overall Study|Adverse Event|17|||
126257661|NCT00852917|454232761|FG000|Overall Study|Lack of Efficacy|21|||
126257662|NCT00852917|454232762|FG001|Overall Study|Lack of Efficacy|11|||
126257663|NCT00852917|454232763|FG002|Overall Study|Lack of Efficacy|11|||
126257664|NCT00852917|454232764|FG003|Overall Study|Lack of Efficacy|47|||
126257665|NCT00852917|454232761|FG000|Overall Study|Withdrawal by Subject|4|||
126257666|NCT00852917|454232762|FG001|Overall Study|Withdrawal by Subject|8|||
126257667|NCT00852917|454232763|FG002|Overall Study|Withdrawal by Subject|10|||
126257668|NCT00852917|454232764|FG003|Overall Study|Withdrawal by Subject|9|||
126257669|NCT00852917|454232761|FG000|Overall Study|Physician Decision|6|||
126257670|NCT00852917|454232762|FG001|Overall Study|Physician Decision|7|||
126257671|NCT00852917|454232763|FG002|Overall Study|Physician Decision|2|||
126257672|NCT00852917|454232764|FG003|Overall Study|Physician Decision|19|||
126257673|NCT00852917|454232761|FG000|Overall Study|Death|0|||
126257674|NCT00852917|454232762|FG001|Overall Study|Death|0|||
126257675|NCT00852917|454232763|FG002|Overall Study|Death|0|||
126257676|NCT00852917|454232764|FG003|Overall Study|Death|1|||
126257677|NCT02488824|454232765|FG000|Overall Study|Adverse Event|1|||
126257678|NCT02488824|454232766|FG001|Overall Study|Adverse Event|1|||
126257679|NCT01201759|454232768|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
126257680|NCT01201759|454232769|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
126257681|NCT01201759|454232768|FG000|Visit 3 - Washout|Adverse Event|0|||
126257682|NCT01201759|454232769|FG001|Visit 3 - Washout|Adverse Event|3|||
126257683|NCT01201759|454232768|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
126257684|NCT01201759|454232769|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
126257685|NCT01201759|454232768|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
126257686|NCT01201759|454232769|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
126257687|NCT00906373|454232770|FG000|Overall Study|Withdrawal by Subject|0|||
126257688|NCT00906373|454232771|FG001|Overall Study|Withdrawal by Subject|5|||
126257689|NCT00906373|454232770|FG000|Overall Study|Other|0|||
126257690|NCT00906373|454232771|FG001|Overall Study|Other|1|||
126257691|NCT00906373|454232770|FG000|Overall Study|Still on treatment at cutoff date|0|||
126257692|NCT00906373|454232771|FG001|Overall Study|Still on treatment at cutoff date|2|||
125879824|NCT03050801|452857388|FG003|Experiment 2|Lost to Follow-up|1|||
126030063|NCT03665597|453406802|FG001|Period 1|Death|0|||
126030064|NCT03665597|453406803|FG002|Period 1|Death|0|||
126030065|NCT03665597|453406804|FG003|Period 1|Death|0|||
126257693|NCT00979212|454232778|FG000|Overall Study|Protocol Violation|1|||
126257694|NCT00979212|454232779|FG001|Overall Study|Protocol Violation|8|||
126358601|NCT03511066|454605390|FG000|Overall Study|Withdrawal by Subject|1|||
126358602|NCT03511066|454605391|FG001|Overall Study|Withdrawal by Subject|2|||
126358603|NCT03511066|454605392|FG002|Overall Study|Withdrawal by Subject|3|||
126358604|NCT03511066|454605390|FG000|Overall Study|Lost to Follow-up|2|||
126358605|NCT03511066|454605391|FG001|Overall Study|Lost to Follow-up|3|||
126358606|NCT03511066|454605392|FG002|Overall Study|Lost to Follow-up|0|||
126358607|NCT04146909|454605395|FG000|Overall Study|Withdrawal by Subject|3|||
126358608|NCT04146909|454605395|FG000|Overall Study|Did not qualify after consented|1|||
126358609|NCT05085405|454605396|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
126358610|NCT05085405|454605397|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
126358611|NCT05085405|454605398|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
126358612|NCT05085405|454605399|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
126358613|NCT05085405|454605400|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
126358614|NCT05085405|454605401|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
126358615|NCT05085405|454605396|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358616|NCT05085405|454605397|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358617|NCT05085405|454605398|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358618|NCT05085405|454605399|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
126358619|NCT05085405|454605400|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358620|NCT05085405|454605401|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358621|NCT02362412|454605402|FG000|Treatment Period III|Lost to Follow-up|0|||
126358622|NCT02362412|454605403|FG001|Treatment Period III|Lost to Follow-up|1|||
126358623|NCT00165698|454605406|FG000|Overall Study|Adverse Event|2|||
126358624|NCT00165698|454605407|FG001|Overall Study|Adverse Event|10|||
126358625|NCT00165698|454605406|FG000|Overall Study|Lost to Follow-up|2|||
126358626|NCT00165698|454605407|FG001|Overall Study|Lost to Follow-up|2|||
126358627|NCT00165698|454605406|FG000|Overall Study|Withdrawal by Subject|2|||
126358628|NCT00165698|454605407|FG001|Overall Study|Withdrawal by Subject|1|||
126358629|NCT00165698|454605406|FG000|Overall Study|Protocol Violation|1|||
126358630|NCT00165698|454605407|FG001|Overall Study|Protocol Violation|0|||
126358631|NCT00165698|454605406|FG000|Overall Study|Not Taken/Lost the medicine|1|||
126358632|NCT00165698|454605407|FG001|Overall Study|Not Taken/Lost the medicine|2|||
126358633|NCT01107457|454605408|FG000|Part A|Adverse Event|1|||
126358634|NCT01107457|454605409|FG001|Part A|Adverse Event|2|||
126358635|NCT01107457|454605410|FG002|Part A|Adverse Event|1|||
126358636|NCT01107457|454605411|FG003|Part A|Adverse Event|0|||
126358637|NCT01107457|454605412|FG004|Part A|Adverse Event|0|||
126358638|NCT01107457|454605413|FG005|Part A|Adverse Event|0|||
126358639|NCT01107457|454605408|FG000|Part A|Withdrawal by Subject|3|||
126358640|NCT01107457|454605409|FG001|Part A|Withdrawal by Subject|3|||
126358641|NCT01107457|454605410|FG002|Part A|Withdrawal by Subject|0|||
126358642|NCT01107457|454605411|FG003|Part A|Withdrawal by Subject|3|||
126358643|NCT01107457|454605412|FG004|Part A|Withdrawal by Subject|1|||
126358644|NCT01107457|454605413|FG005|Part A|Withdrawal by Subject|0|||
126358645|NCT01107457|454605408|FG000|Part A|Lost to Follow-up|0|||
126358646|NCT01107457|454605409|FG001|Part A|Lost to Follow-up|1|||
125879825|NCT03050801|452857389|FG004|Experiment 2|Lost to Follow-up|1|||
126257695|NCT00979212|454232778|FG000|Overall Study|No protocol therapy received|1|||
126257696|NCT00979212|454232779|FG001|Overall Study|No protocol therapy received|0|||
126257697|NCT04886063|454232784|FG000|Overall Study|Adverse Event|50|||
126358647|NCT01107457|454605410|FG002|Part A|Lost to Follow-up|0|||
126358648|NCT01107457|454605411|FG003|Part A|Lost to Follow-up|0|||
126358649|NCT01107457|454605412|FG004|Part A|Lost to Follow-up|0|||
126358650|NCT01107457|454605413|FG005|Part A|Lost to Follow-up|0|||
126358651|NCT01107457|454605408|FG000|Part A|Lack of Efficacy|1|||
126358652|NCT01107457|454605409|FG001|Part A|Lack of Efficacy|0|||
126257698|NCT04886063|454232784|FG000|Overall Study|Lack of Efficacy|31|||
126257699|NCT04886063|454232784|FG000|Overall Study|Withdrawal by Subject|45|||
126257700|NCT04886063|454232784|FG000|Overall Study|Physician Decision|3|||
126257701|NCT04886063|454232784|FG000|Overall Study|Protocol Violation|3|||
126257702|NCT04886063|454232784|FG000|Overall Study|Site closure|4|||
126257703|NCT04886063|454232784|FG000|Overall Study|Nursing home replacement|3|||
126257704|NCT04886063|454232784|FG000|Overall Study|Lost to Follow-up|5|||
126257705|NCT04886063|454232784|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
126257706|NCT04886063|454232784|FG000|Overall Study|>1 reason|20|||
126257707|NCT02448563|454232789|FG000|Overall Study|Lost to Follow-up|16|||
126257708|NCT02448563|454232790|FG001|Overall Study|Lost to Follow-up|10|||
126257709|NCT02448563|454232789|FG000|Overall Study|Withdrawal by Subject|0|||
126257710|NCT02448563|454232790|FG001|Overall Study|Withdrawal by Subject|1|||
126257711|NCT02340962|454232792|FG000|Overall Study|Lost to Follow-up|1|||
126257712|NCT02340962|454232793|FG001|Overall Study|Lost to Follow-up|0|||
126257713|NCT01450800|454232794|FG000|Overall Study|Protocol Violation|1|||
126257714|NCT01450800|454232795|FG001|Overall Study|Protocol Violation|3|||
126257715|NCT00265785|454232796|FG000|Overall Study|Adverse Event|4|||
126257716|NCT00265785|454232796|FG000|Overall Study|Withdrawal by Subject|3|||
126257717|NCT00265785|454232796|FG000|Overall Study|Progression/Relapse|15|||
126257718|NCT00265785|454232796|FG000|Overall Study|Not protocol specified|2|||
126257719|NCT00265785|454232796|FG000|Overall Study|Ineligible|1|||
126257720|NCT00265785|454232796|FG000|Overall Study|Did not receive protocol treatment|2|||
126257721|NCT01294449|454232799|FG000|Overall Study|Death|11|||
126257722|NCT01294449|454232800|FG001|Overall Study|Death|12|||
126257723|NCT01294449|454232799|FG000|Overall Study|Withdrawal by Subject|1|||
126257724|NCT01294449|454232800|FG001|Overall Study|Withdrawal by Subject|3|||
126257725|NCT00708682|454232805|FG000|Infant Series|Adverse Event|1|||
126257726|NCT00708682|454232805|FG000|Infant Series|Lost to Follow-up|4|||
126257727|NCT00708682|454232805|FG000|Infant Series|Protocol Violation|1|||
126257728|NCT00708682|454232805|FG000|Infant Series|Parent/legal guardian request|6|||
126257729|NCT00708682|454232805|FG000|Infant Series|Failed to return|2|||
126257730|NCT00708682|454232805|FG000|Infant Series|Other|19|||
126257731|NCT00708682|454232805|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
126030066|NCT03665597|453406805|FG004|Period 1|Death|0|||
126030067|NCT03665597|453406806|FG005|Period 1|Death|0|||
126030068|NCT03665597|453406807|FG006|Period 1|Death|45|||
126030069|NCT03665597|453406801|FG000|Period 1|Withdrawal by Subject|0|||
126030070|NCT03665597|453406802|FG001|Period 1|Withdrawal by Subject|0|||
126030071|NCT03665597|453406803|FG002|Period 1|Withdrawal by Subject|0|||
126257732|NCT00708682|454232805|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
126257733|NCT00708682|454232805|FG000|Toddler Dose|Lost to Follow-up|3|||
126257734|NCT00708682|454232805|FG000|Toddler Dose|Failed to Return|4|||
126257735|NCT00420095|454232806|FG000|Overall Study|Adverse Event|1|||
126257736|NCT00420095|454232807|FG001|Overall Study|Adverse Event|0|||
126257737|NCT00420095|454232806|FG000|Overall Study|Protocol Violation|1|||
126257738|NCT00420095|454232807|FG001|Overall Study|Protocol Violation|1|||
126257739|NCT00420095|454232806|FG000|Overall Study|Lost to Follow-up|1|||
126257740|NCT00420095|454232807|FG001|Overall Study|Lost to Follow-up|0|||
126257741|NCT03185741|454232808|FG000|Baseline|Withdrawal by Subject|1|||
126257742|NCT03185741|454232809|FG001|Baseline|Withdrawal by Subject|3|||
126030072|NCT03665597|453406804|FG003|Period 1|Withdrawal by Subject|0|||
126257743|NCT03185741|454232810|FG002|Baseline|Withdrawal by Subject|2|||
126257744|NCT03185741|454232808|FG000|Baseline|Lost to Follow-up|1|||
126030073|NCT03665597|453406805|FG004|Period 1|Withdrawal by Subject|0|||
126030074|NCT03665597|453406806|FG005|Period 1|Withdrawal by Subject|0|||
126030075|NCT03665597|453406807|FG006|Period 1|Withdrawal by Subject|5|||
126030076|NCT03665597|453406801|FG000|Period 2|Adverse Event|0|||
126030077|NCT03665597|453406802|FG001|Period 2|Adverse Event|0|||
126030078|NCT03665597|453406803|FG002|Period 2|Adverse Event|0|||
126030079|NCT03665597|453406804|FG003|Period 2|Adverse Event|0|||
126030080|NCT03665597|453406805|FG004|Period 2|Adverse Event|0|||
126030081|NCT03665597|453406806|FG005|Period 2|Adverse Event|1|||
126096049|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
126096050|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
126096051|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
126096052|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
126096053|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
126096054|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
126096055|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
126096056|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
126096057|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
126257745|NCT03185741|454232809|FG001|Baseline|Lost to Follow-up|2|||
126030082|NCT03665597|453406807|FG006|Period 2|Adverse Event|0|||
126030083|NCT03665597|453406801|FG000|Period 3|Adverse Event|0|||
126030084|NCT03665597|453406802|FG001|Period 3|Adverse Event|1|||
126030085|NCT03665597|453406803|FG002|Period 3|Adverse Event|0|||
126096058|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
126257746|NCT03185741|454232810|FG002|Baseline|Lost to Follow-up|3|||
126257747|NCT03185741|454232808|FG000|3Month|Death|1|||
126257748|NCT03185741|454232809|FG001|3Month|Death|1|||
126257749|NCT03185741|454232810|FG002|3Month|Death|2|||
126257750|NCT03185741|454232808|FG000|3Month|Withdrawal by Subject|1|||
126257751|NCT03185741|454232809|FG001|3Month|Withdrawal by Subject|5|||
126257752|NCT03185741|454232810|FG002|3Month|Withdrawal by Subject|1|||
126257753|NCT03185741|454232808|FG000|3Month|Lost to Follow-up|7|||
126257754|NCT03185741|454232809|FG001|3Month|Lost to Follow-up|9|||
126257755|NCT03185741|454232810|FG002|3Month|Lost to Follow-up|8|||
126257756|NCT03185741|454232808|FG000|3Month|Unavailable for 3Month|11|||
126257757|NCT03185741|454232809|FG001|3Month|Unavailable for 3Month|10|||
126257758|NCT03185741|454232810|FG002|3Month|Unavailable for 3Month|11|||
126257759|NCT03185741|454232808|FG000|3Month|Protocol Violation|0|||
126257760|NCT03185741|454232809|FG001|3Month|Protocol Violation|0|||
126257761|NCT03185741|454232810|FG002|3Month|Protocol Violation|3|||
126257762|NCT03185741|454232808|FG000|6Month|Death|1|||
126257763|NCT03185741|454232809|FG001|6Month|Death|1|||
126257764|NCT03185741|454232810|FG002|6Month|Death|2|||
126257765|NCT03185741|454232808|FG000|6Month|Withdrawal by Subject|2|||
126257766|NCT03185741|454232809|FG001|6Month|Withdrawal by Subject|3|||
126257767|NCT03185741|454232810|FG002|6Month|Withdrawal by Subject|1|||
126257768|NCT03185741|454232808|FG000|6Month|Lost to Follow-up|16|||
126257769|NCT03185741|454232809|FG001|6Month|Lost to Follow-up|15|||
126257770|NCT03185741|454232810|FG002|6Month|Lost to Follow-up|16|||
126257771|NCT01634854|454232811|FG000|Overall Study|Cesarean delivery|2|||
126257772|NCT01634854|454232812|FG001|Overall Study|Cesarean delivery|7|||
126257773|NCT01977456|454232813|FG000|Overall Study|Death|5|||
126257774|NCT01142661|454232814|FG000|Overall Study|Adverse Event|2|||
126096059|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
126257775|NCT01142661|454232814|FG000|Overall Study|Withdrawal by Subject|1|||
126030086|NCT03665597|453406804|FG003|Period 3|Adverse Event|0|||
126030087|NCT03665597|453406805|FG004|Period 3|Adverse Event|0|||
126030088|NCT03665597|453406806|FG005|Period 3|Adverse Event|0|||
126030089|NCT03665597|453406807|FG006|Period 3|Adverse Event|0|||
126030090|NCT03665597|453406801|FG000|Period 3|Death|0|||
126030091|NCT03665597|453406802|FG001|Period 3|Death|0|||
126257776|NCT01142661|454232814|FG000|Overall Study|Physician Decision|1|||
126257777|NCT00434590|454232815|FG000|Overall Study|Administrative problems|5|||
126257778|NCT00434590|454232816|FG001|Overall Study|Administrative problems|5|||
126257779|NCT01011335|454234427|FG000|Overall Study|Lost to Follow-up|0|||
126257780|NCT01011335|454234428|FG001|Overall Study|Lost to Follow-up|0|||
126257781|NCT01011335|454234429|FG002|Overall Study|Lost to Follow-up|1|||
126257782|NCT01011335|454234430|FG003|Overall Study|Lost to Follow-up|1|||
126257783|NCT01011335|454234431|FG004|Overall Study|Lost to Follow-up|1|||
126257784|NCT01011335|454234432|FG005|Overall Study|Lost to Follow-up|1|||
126257785|NCT01011335|454234433|FG006|Overall Study|Lost to Follow-up|2|||
126257786|NCT01011335|454234434|FG007|Overall Study|Lost to Follow-up|2|||
126257787|NCT01011335|454234435|FG008|Overall Study|Lost to Follow-up|1|||
126257788|NCT01011335|454234436|FG009|Overall Study|Lost to Follow-up|0|||
126257789|NCT01011335|454234437|FG010|Overall Study|Lost to Follow-up|0|||
126257790|NCT01011335|454234438|FG011|Overall Study|Lost to Follow-up|1|||
126257791|NCT01011335|454234439|FG012|Overall Study|Lost to Follow-up|2|||
126257792|NCT01011335|454234427|FG000|Overall Study|Protocol Violation|0|||
126257793|NCT01011335|454234428|FG001|Overall Study|Protocol Violation|1|||
126257794|NCT01011335|454234429|FG002|Overall Study|Protocol Violation|0|||
126257795|NCT01011335|454234430|FG003|Overall Study|Protocol Violation|0|||
126257796|NCT01011335|454234431|FG004|Overall Study|Protocol Violation|0|||
126257797|NCT01011335|454234432|FG005|Overall Study|Protocol Violation|0|||
126257798|NCT01011335|454234433|FG006|Overall Study|Protocol Violation|0|||
126257799|NCT01011335|454234434|FG007|Overall Study|Protocol Violation|0|||
126257800|NCT01011335|454234435|FG008|Overall Study|Protocol Violation|0|||
126257801|NCT01011335|454234436|FG009|Overall Study|Protocol Violation|0|||
126257802|NCT01011335|454234437|FG010|Overall Study|Protocol Violation|0|||
126257803|NCT01011335|454234438|FG011|Overall Study|Protocol Violation|0|||
126257804|NCT01011335|454234439|FG012|Overall Study|Protocol Violation|0|||
126257805|NCT01011335|454234427|FG000|Overall Study|Moved/deployed or no booster|1|||
126257806|NCT01011335|454234428|FG001|Overall Study|Moved/deployed or no booster|0|||
126257807|NCT01011335|454234429|FG002|Overall Study|Moved/deployed or no booster|0|||
126030092|NCT03665597|453406803|FG002|Period 3|Death|0|||
126030093|NCT03665597|453406804|FG003|Period 3|Death|0|||
126030094|NCT03665597|453406805|FG004|Period 3|Death|1|||
126030095|NCT03665597|453406806|FG005|Period 3|Death|0|||
126030096|NCT03665597|453406807|FG006|Period 3|Death|0|||
126030097|NCT03665597|453406801|FG000|Period 4|Adverse Event|2|||
126030098|NCT03665597|453406802|FG001|Period 4|Adverse Event|2|||
126030099|NCT03665597|453406803|FG002|Period 4|Adverse Event|2|||
126030100|NCT03665597|453406804|FG003|Period 4|Adverse Event|2|||
126030101|NCT03665597|453406805|FG004|Period 4|Adverse Event|1|||
126030102|NCT03665597|453406806|FG005|Period 4|Adverse Event|0|||
126257808|NCT01011335|454234430|FG003|Overall Study|Moved/deployed or no booster|1|||
126030103|NCT03665597|453406807|FG006|Period 4|Adverse Event|0|||
126030104|NCT03665597|453406801|FG000|Period 4|Death|0|||
126030105|NCT03665597|453406802|FG001|Period 4|Death|0|||
126030106|NCT03665597|453406803|FG002|Period 4|Death|2|||
126030107|NCT03665597|453406804|FG003|Period 4|Death|0|||
126030108|NCT03665597|453406805|FG004|Period 4|Death|0|||
126030109|NCT03665597|453406806|FG005|Period 4|Death|0|||
126030110|NCT03665597|453406807|FG006|Period 4|Death|0|||
126030111|NCT03665597|453406801|FG000|Period 4|Physician Decision|1|||
126030112|NCT03665597|453406802|FG001|Period 4|Physician Decision|2|||
126030113|NCT03665597|453406803|FG002|Period 4|Physician Decision|0|||
126030114|NCT03665597|453406804|FG003|Period 4|Physician Decision|0|||
126030115|NCT03665597|453406805|FG004|Period 4|Physician Decision|0|||
126030116|NCT03665597|453406806|FG005|Period 4|Physician Decision|0|||
126030117|NCT03665597|453406807|FG006|Period 4|Physician Decision|0|||
126030118|NCT03110315|453406810|FG000|Overall Study|Withdrawal by Subject|1|||
126030119|NCT03110315|453406811|FG001|Overall Study|Withdrawal by Subject|0|||
126030120|NCT00450658|453406815|FG000|Overall Study|Adverse Event|24|||
126030121|NCT00450658|453406816|FG001|Overall Study|Adverse Event|15|||
126030122|NCT00450658|453406815|FG000|Overall Study|Withdrawal by Subject|43|||
126030123|NCT00450658|453406816|FG001|Overall Study|Withdrawal by Subject|26|||
126030124|NCT00450658|453406815|FG000|Overall Study|Lost to Follow-up|22|||
126030125|NCT00450658|453406816|FG001|Overall Study|Lost to Follow-up|5|||
126030126|NCT00450658|453406815|FG000|Overall Study|UGI ulcer|33|||
126257809|NCT01011335|454234431|FG004|Overall Study|Moved/deployed or no booster|0|||
126257810|NCT01011335|454234432|FG005|Overall Study|Moved/deployed or no booster|0|||
126030127|NCT00450658|453406816|FG001|Overall Study|UGI ulcer|34|||
126030128|NCT00450658|453406815|FG000|Overall Study|misc|21|||
126030129|NCT00450658|453406816|FG001|Overall Study|misc|10|||
126030130|NCT04727554|453406819|FG000|Overall Study|Lost to Follow-up|0|||
126030131|NCT04727554|453406820|FG001|Overall Study|Lost to Follow-up|1|||
126030132|NCT04727554|453406819|FG000|Overall Study|Death|2|||
126030133|NCT04727554|453406820|FG001|Overall Study|Death|6|||
126257811|NCT01011335|454234433|FG006|Overall Study|Moved/deployed or no booster|1|||
126257812|NCT01011335|454234434|FG007|Overall Study|Moved/deployed or no booster|0|||
126257813|NCT01011335|454234435|FG008|Overall Study|Moved/deployed or no booster|1|||
126257814|NCT01011335|454234436|FG009|Overall Study|Moved/deployed or no booster|0|||
126030134|NCT04727554|453406819|FG000|Overall Study|Withdrawal by Subject|1|||
126257815|NCT01011335|454234437|FG010|Overall Study|Moved/deployed or no booster|2|||
126257816|NCT01011335|454234438|FG011|Overall Study|Moved/deployed or no booster|0|||
126257817|NCT01011335|454234439|FG012|Overall Study|Moved/deployed or no booster|0|||
126257818|NCT01011335|454234427|FG000|Overall Study|Adverse Event|0|||
126257819|NCT01011335|454234428|FG001|Overall Study|Adverse Event|0|||
126257820|NCT01011335|454234429|FG002|Overall Study|Adverse Event|0|||
126257821|NCT01011335|454234430|FG003|Overall Study|Adverse Event|0|||
126257822|NCT01011335|454234431|FG004|Overall Study|Adverse Event|0|||
126257823|NCT01011335|454234432|FG005|Overall Study|Adverse Event|0|||
126257824|NCT01011335|454234433|FG006|Overall Study|Adverse Event|0|||
126257825|NCT01011335|454234434|FG007|Overall Study|Adverse Event|0|||
126257826|NCT01011335|454234435|FG008|Overall Study|Adverse Event|0|||
126257827|NCT01011335|454234436|FG009|Overall Study|Adverse Event|0|||
126257828|NCT01011335|454234437|FG010|Overall Study|Adverse Event|4|||
126257829|NCT01011335|454234438|FG011|Overall Study|Adverse Event|0|||
126257830|NCT01011335|454234439|FG012|Overall Study|Adverse Event|1|||
126257831|NCT01636934|454234440|FG000|Overall Study|Withdrawal by Subject|3|||
126257832|NCT01636934|454234441|FG001|Overall Study|Withdrawal by Subject|2|||
126257833|NCT01636934|454234440|FG000|Overall Study|Chemo cancel|1|||
126257834|NCT01636934|454234441|FG001|Overall Study|Chemo cancel|0|||
126257835|NCT01636934|454234440|FG000|Overall Study|Too ill to continue|1|||
126257836|NCT01636934|454234441|FG001|Overall Study|Too ill to continue|0|||
126257837|NCT01636934|454234440|FG000|Overall Study|Never started study medication|1|||
126257838|NCT01636934|454234441|FG001|Overall Study|Never started study medication|1|||
126257839|NCT01765751|454234448|FG000|Overall Study|Lost to Follow-up|0|||
126257840|NCT01765751|454234449|FG001|Overall Study|Lost to Follow-up|2|||
126257841|NCT01765751|454234450|FG002|Overall Study|Lost to Follow-up|1|||
126257842|NCT03429049|454234451|FG000|Overall Study|Adverse Event|2|||
126257843|NCT03429049|454234452|FG001|Overall Study|Adverse Event|3|||
126257844|NCT03429049|454234451|FG000|Overall Study|Death|0|||
126257845|NCT03429049|454234452|FG001|Overall Study|Death|1|||
126257846|NCT03429049|454234451|FG000|Overall Study|Lack of Efficacy|4|||
126257847|NCT03429049|454234452|FG001|Overall Study|Lack of Efficacy|2|||
126257848|NCT03429049|454234451|FG000|Overall Study|Lost to Follow-up|9|||
126257849|NCT03429049|454234452|FG001|Overall Study|Lost to Follow-up|8|||
126257850|NCT03429049|454234451|FG000|Overall Study|Physician Decision|1|||
126257851|NCT03429049|454234452|FG001|Overall Study|Physician Decision|0|||
126257852|NCT03429049|454234451|FG000|Overall Study|Protocol Violation|3|||
126030135|NCT04727554|453406820|FG001|Overall Study|Withdrawal by Subject|0|||
126257853|NCT03429049|454234452|FG001|Overall Study|Protocol Violation|0|||
126257854|NCT03429049|454234451|FG000|Overall Study|Sponsor Decision|2|||
126257855|NCT03429049|454234452|FG001|Overall Study|Sponsor Decision|0|||
126257856|NCT03429049|454234451|FG000|Overall Study|Withdrawal by Subject|4|||
126257857|NCT03429049|454234452|FG001|Overall Study|Withdrawal by Subject|20|||
126257858|NCT03429049|454234451|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
126257859|NCT03429049|454234452|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
126257860|NCT01841060|454234456|FG000|Overall Study|Protocol Violation|10|||
126257861|NCT02459418|454234460|FG000|Overall Study|Exclusion Criteria|4|||
126257862|NCT02459418|454234461|FG001|Overall Study|Exclusion Criteria|0|||
126257863|NCT02459418|454234460|FG000|Overall Study|Protocol Violation|0|||
126257864|NCT02459418|454234461|FG001|Overall Study|Protocol Violation|2|||
126257865|NCT02459418|454234460|FG000|Overall Study|Physician Decision|0|||
126257866|NCT02459418|454234461|FG001|Overall Study|Physician Decision|2|||
126257867|NCT02459418|454234460|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
126257868|NCT02459418|454234461|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
126257869|NCT02459418|454234460|FG000|Overall Study|Adverse Event|0|||
126257870|NCT02459418|454234461|FG001|Overall Study|Adverse Event|1|||
126257871|NCT02459418|454234460|FG000|Overall Study|Withdrawal by Subject|1|||
126257872|NCT02459418|454234461|FG001|Overall Study|Withdrawal by Subject|1|||
126257873|NCT02459418|454234460|FG000|Overall Study|Elevated Creatine Kinase|1|||
126257874|NCT02459418|454234461|FG001|Overall Study|Elevated Creatine Kinase|0|||
126257875|NCT02459418|454234460|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
126257876|NCT02459418|454234461|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
126257877|NCT01872715|454234462|FG000|Overall Study|Adverse Event|1|||
126257878|NCT01872715|454234462|FG000|Overall Study|Protocol Violation|1|||
126257879|NCT01872715|454234462|FG000|Overall Study|Withdrawal by Subject|2|||
126257880|NCT05258630|454234463|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
126257881|NCT05258630|454234464|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
126257882|NCT05258630|454234463|FG000|Overall Study|Lost to Follow-up|0|||
126257883|NCT05258630|454234464|FG001|Overall Study|Lost to Follow-up|2|||
126257884|NCT03303417|454234465|FG000|Overall Study|Withdrawal by Subject|1|||
126257885|NCT03303417|454234466|FG001|Overall Study|Withdrawal by Subject|1|||
126257886|NCT01848210|454234467|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
126257887|NCT01848210|454234468|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
126257888|NCT01848210|454234467|FG000|Overall Study|Lost to Follow-up|24|||
126257889|NCT01848210|454234468|FG001|Overall Study|Lost to Follow-up|12|||
126257890|NCT01848210|454234467|FG000|Overall Study|Protocol Violation|3|||
126257891|NCT01848210|454234468|FG001|Overall Study|Protocol Violation|5|||
126257892|NCT01848210|454234467|FG000|Overall Study|Use of Forbidden Drugs|9|||
126257893|NCT01848210|454234468|FG001|Overall Study|Use of Forbidden Drugs|10|||
126257894|NCT01848210|454234467|FG000|Overall Study|Impedition Condition|5|||
126257895|NCT01848210|454234468|FG001|Overall Study|Impedition Condition|9|||
126257896|NCT01848210|454234467|FG000|Overall Study|Adverse Event|7|||
126257897|NCT01848210|454234468|FG001|Overall Study|Adverse Event|9|||
126257898|NCT01848210|454234467|FG000|Overall Study|Discontinuation Criterion|5|||
126257899|NCT01848210|454234468|FG001|Overall Study|Discontinuation Criterion|7|||
126257900|NCT01848210|454234467|FG000|Overall Study|Hypesensitivity|1|||
126257901|NCT01848210|454234468|FG001|Overall Study|Hypesensitivity|0|||
126257902|NCT01848210|454234467|FG000|Overall Study|Hepatic Function Alteration|4|||
126257903|NCT01848210|454234468|FG001|Overall Study|Hepatic Function Alteration|0|||
126257904|NCT01848210|454234467|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
126096060|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
126257905|NCT01848210|454234468|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
126257906|NCT01848210|454234467|FG000|Overall Study|Administrative|1|||
126257907|NCT01848210|454234468|FG001|Overall Study|Administrative|0|||
126257908|NCT02994394|454234469|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257909|NCT02994394|454234470|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257910|NCT02994394|454234471|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
126257911|NCT02994394|454234472|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257912|NCT02994394|454234473|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257913|NCT02994394|454234474|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257914|NCT02994394|454234469|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
126257915|NCT02994394|454234470|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
126257916|NCT02994394|454234471|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
126257917|NCT02994394|454234472|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
126257918|NCT02994394|454234473|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
125879826|NCT03050801|452857390|FG005|Experiment 2|Lost to Follow-up|0|||
126257919|NCT02994394|454234474|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
126257920|NCT02327325|454234475|FG000|Overall Study|Withdrawal by Subject|1|||
126257921|NCT02327325|454234476|FG001|Overall Study|Withdrawal by Subject|4|||
126257922|NCT02327325|454234477|FG002|Overall Study|Withdrawal by Subject|4|||
126257923|NCT02327325|454234475|FG000|Overall Study|Excluded by Study Team|0|||
126257924|NCT02327325|454234476|FG001|Overall Study|Excluded by Study Team|0|||
126257925|NCT02327325|454234477|FG002|Overall Study|Excluded by Study Team|1|||
126257926|NCT01597479|454234482|FG000|Overall Study|Protocol Violation|1|||
126257927|NCT01597479|454234483|FG001|Overall Study|Protocol Violation|0|||
126257928|NCT01597479|454234482|FG000|Overall Study|Lost to Follow-up|1|||
126257929|NCT01597479|454234483|FG001|Overall Study|Lost to Follow-up|0|||
126257930|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
126257931|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
126257932|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
126257933|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
126257934|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
126257935|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
126257936|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
126257937|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
126257938|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
126257939|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
126257940|NCT01045707|454234484|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
126257941|NCT01045707|454234485|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
126257942|NCT01045707|454234484|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
126257943|NCT01045707|454234485|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
126257944|NCT01045707|454234484|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
126257945|NCT01045707|454234485|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
126257946|NCT01045707|454234484|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
126257947|NCT01045707|454234485|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
126257948|NCT00848042|454234486|FG000|Overall Study|Death|1|||
126257949|NCT00848042|454234487|FG001|Overall Study|Death|2|||
126257950|NCT00848042|454234488|FG002|Overall Study|Death|0|||
126257951|NCT00848042|454234486|FG000|Overall Study|Other Therapy|3|||
126257952|NCT00848042|454234487|FG001|Overall Study|Other Therapy|0|||
126257953|NCT00848042|454234488|FG002|Overall Study|Other Therapy|0|||
126257954|NCT04317599|454234489|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
126257955|NCT04317599|454234489|FG000|Overall Study|treatment outside standard of care|4|||
126257956|NCT00809965|454234490|FG000|Overall Study|Death|194|||
126257957|NCT00809965|454234491|FG001|Overall Study|Death|147|||
126257958|NCT00809965|454234492|FG002|Overall Study|Death|196|||
126257959|NCT00809965|454234490|FG000|Overall Study|Lost to Follow-up|17|||
126257960|NCT00809965|454234491|FG001|Overall Study|Lost to Follow-up|10|||
126257961|NCT00809965|454234492|FG002|Overall Study|Lost to Follow-up|18|||
126257962|NCT00809965|454234490|FG000|Overall Study|Withdrawal by Subject|405|||
126257963|NCT00809965|454234491|FG001|Overall Study|Withdrawal by Subject|448|||
126257964|NCT00809965|454234492|FG002|Overall Study|Withdrawal by Subject|441|||
126257965|NCT00809965|454234490|FG000|Overall Study|Other Reason|167|||
126257966|NCT00809965|454234491|FG001|Overall Study|Other Reason|170|||
126257967|NCT00809965|454234492|FG002|Overall Study|Other Reason|189|||
126257968|NCT02315066|454234493|FG000|Overall Study|Lost to Follow-up|0|||
126096061|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
126257969|NCT02315066|454234494|FG001|Overall Study|Lost to Follow-up|1|||
126257970|NCT02315066|454234495|FG002|Overall Study|Lost to Follow-up|1|||
126257971|NCT02315066|454234496|FG003|Overall Study|Lost to Follow-up|0|||
126257972|NCT02315066|454234497|FG004|Overall Study|Lost to Follow-up|1|||
126257973|NCT02315066|454234498|FG005|Overall Study|Lost to Follow-up|0|||
126257974|NCT02315066|454234499|FG006|Overall Study|Lost to Follow-up|2|||
126257975|NCT02315066|454234500|FG007|Overall Study|Lost to Follow-up|1|||
126257976|NCT02315066|454234501|FG008|Overall Study|Lost to Follow-up|0|||
126257977|NCT02315066|454234502|FG009|Overall Study|Lost to Follow-up|0|||
126257978|NCT02315066|454234503|FG010|Overall Study|Lost to Follow-up|1|||
126257979|NCT02315066|454234504|FG011|Overall Study|Lost to Follow-up|2|||
126257980|NCT02315066|454234505|FG012|Overall Study|Lost to Follow-up|0|||
126257981|NCT02315066|454234506|FG013|Overall Study|Lost to Follow-up|4|||
126257982|NCT02315066|454234493|FG000|Overall Study|Death|2|||
126257983|NCT02315066|454234494|FG001|Overall Study|Death|7|||
126257984|NCT02315066|454234495|FG002|Overall Study|Death|6|||
126257985|NCT02315066|454234496|FG003|Overall Study|Death|11|||
126257986|NCT02315066|454234497|FG004|Overall Study|Death|10|||
126257987|NCT02315066|454234498|FG005|Overall Study|Death|3|||
126257988|NCT02315066|454234499|FG006|Overall Study|Death|9|||
126257989|NCT02315066|454234500|FG007|Overall Study|Death|9|||
126257990|NCT02315066|454234501|FG008|Overall Study|Death|10|||
126257991|NCT02315066|454234502|FG009|Overall Study|Death|8|||
126257992|NCT02315066|454234503|FG010|Overall Study|Death|10|||
126257993|NCT02315066|454234504|FG011|Overall Study|Death|7|||
126257994|NCT02315066|454234505|FG012|Overall Study|Death|8|||
126257995|NCT02315066|454234506|FG013|Overall Study|Death|21|||
126257996|NCT02315066|454234493|FG000|Overall Study|Other|0|||
126257997|NCT02315066|454234494|FG001|Overall Study|Other|0|||
126257998|NCT02315066|454234495|FG002|Overall Study|Other|0|||
126257999|NCT02315066|454234496|FG003|Overall Study|Other|0|||
126258000|NCT02315066|454234497|FG004|Overall Study|Other|0|||
126258001|NCT02315066|454234498|FG005|Overall Study|Other|0|||
126258002|NCT02315066|454234499|FG006|Overall Study|Other|0|||
126258003|NCT02315066|454234500|FG007|Overall Study|Other|1|||
126258004|NCT02315066|454234501|FG008|Overall Study|Other|1|||
126258005|NCT02315066|454234502|FG009|Overall Study|Other|2|||
126258006|NCT02315066|454234503|FG010|Overall Study|Other|0|||
126258007|NCT02315066|454234504|FG011|Overall Study|Other|0|||
126258008|NCT02315066|454234505|FG012|Overall Study|Other|0|||
126258009|NCT02315066|454234506|FG013|Overall Study|Other|0|||
126258010|NCT02315066|454234493|FG000|Overall Study|Subject refused further follow-up|0|||
126258011|NCT02315066|454234494|FG001|Overall Study|Subject refused further follow-up|2|||
126258012|NCT02315066|454234495|FG002|Overall Study|Subject refused further follow-up|2|||
126258013|NCT02315066|454234496|FG003|Overall Study|Subject refused further follow-up|0|||
126258014|NCT02315066|454234497|FG004|Overall Study|Subject refused further follow-up|0|||
126258015|NCT02315066|454234498|FG005|Overall Study|Subject refused further follow-up|0|||
126258016|NCT02315066|454234499|FG006|Overall Study|Subject refused further follow-up|2|||
126258017|NCT02315066|454234500|FG007|Overall Study|Subject refused further follow-up|3|||
126258018|NCT02315066|454234501|FG008|Overall Study|Subject refused further follow-up|0|||
126258019|NCT02315066|454234502|FG009|Overall Study|Subject refused further follow-up|1|||
126258020|NCT02315066|454234503|FG010|Overall Study|Subject refused further follow-up|1|||
126258021|NCT02315066|454234504|FG011|Overall Study|Subject refused further follow-up|2|||
126258022|NCT02315066|454234505|FG012|Overall Study|Subject refused further follow-up|2|||
126258023|NCT02315066|454234506|FG013|Overall Study|Subject refused further follow-up|4|||
126258024|NCT02315066|454234493|FG000|Overall Study|Study ongoing at date of cut-off|0|||
126258025|NCT02315066|454234494|FG001|Overall Study|Study ongoing at date of cut-off|0|||
126258026|NCT02315066|454234495|FG002|Overall Study|Study ongoing at date of cut-off|0|||
126258027|NCT02315066|454234496|FG003|Overall Study|Study ongoing at date of cut-off|0|||
126258028|NCT02315066|454234497|FG004|Overall Study|Study ongoing at date of cut-off|0|||
126258029|NCT02315066|454234498|FG005|Overall Study|Study ongoing at date of cut-off|0|||
126258030|NCT02315066|454234499|FG006|Overall Study|Study ongoing at date of cut-off|0|||
126258031|NCT02315066|454234500|FG007|Overall Study|Study ongoing at date of cut-off|0|||
126258032|NCT02315066|454234501|FG008|Overall Study|Study ongoing at date of cut-off|0|||
126258033|NCT02315066|454234502|FG009|Overall Study|Study ongoing at date of cut-off|0|||
126258034|NCT02315066|454234503|FG010|Overall Study|Study ongoing at date of cut-off|0|||
126258035|NCT02315066|454234504|FG011|Overall Study|Study ongoing at date of cut-off|0|||
126258036|NCT02315066|454234505|FG012|Overall Study|Study ongoing at date of cut-off|0|||
126258037|NCT02315066|454234506|FG013|Overall Study|Study ongoing at date of cut-off|1|||
126258038|NCT00112294|454234507|FG000|Overall Study|Still on study|5|||
126258039|NCT00112294|454234508|FG001|Overall Study|Still on study|0|||
126358653|NCT01107457|454605410|FG002|Part A|Lack of Efficacy|0|||
126358654|NCT01107457|454605411|FG003|Part A|Lack of Efficacy|0|||
126258040|NCT01142908|454234509|FG000|Overall Study|Lost to Follow-up|19|||
126258041|NCT01142908|454234510|FG001|Overall Study|Lost to Follow-up|13|||
126258042|NCT01142908|454234509|FG000|Overall Study|Death|1|||
126258043|NCT01142908|454234510|FG001|Overall Study|Death|4|||
126258044|NCT01142908|454234509|FG000|Overall Study|Excluded - did not meet criteria|9|||
126258045|NCT01142908|454234510|FG001|Overall Study|Excluded - did not meet criteria|5|||
126258046|NCT01142908|454234509|FG000|Overall Study|Withdrawal by Subject|3|||
126258047|NCT01142908|454234510|FG001|Overall Study|Withdrawal by Subject|0|||
126258048|NCT00035555|454234511|FG000|Overall Study|Adverse Event|5|||
126258049|NCT00035555|454234512|FG001|Overall Study|Adverse Event|8|||
126258050|NCT00035555|454234513|FG002|Overall Study|Adverse Event|9|||
126258051|NCT00035555|454234511|FG000|Overall Study|Allograft loss|1|||
126258052|NCT00035555|454234512|FG001|Overall Study|Allograft loss|1|||
126358655|NCT01107457|454605412|FG004|Part A|Lack of Efficacy|0|||
126358656|NCT01107457|454605413|FG005|Part A|Lack of Efficacy|0|||
126358657|NCT01107457|454605408|FG000|Part A|Protocol Violation|0|||
126358658|NCT01107457|454605409|FG001|Part A|Protocol Violation|1|||
126358659|NCT01107457|454605410|FG002|Part A|Protocol Violation|0|||
126358660|NCT01107457|454605411|FG003|Part A|Protocol Violation|0|||
126358661|NCT01107457|454605412|FG004|Part A|Protocol Violation|0|||
126358662|NCT01107457|454605413|FG005|Part A|Protocol Violation|0|||
126358663|NCT01107457|454605408|FG000|Part B and C|Adverse Event|0|||
126358664|NCT01107457|454605409|FG001|Part B and C|Adverse Event|0|||
126358665|NCT01107457|454605410|FG002|Part B and C|Adverse Event|0|||
126358666|NCT01107457|454605411|FG003|Part B and C|Adverse Event|0|||
126358667|NCT01107457|454605412|FG004|Part B and C|Adverse Event|0|||
126358668|NCT01107457|454605413|FG005|Part B and C|Adverse Event|12|||
126358669|NCT01107457|454605408|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126358670|NCT01107457|454605409|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126358671|NCT01107457|454605410|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126358672|NCT01107457|454605411|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126358673|NCT01107457|454605412|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125879827|NCT03050801|452857385|FG000|Experiment 2|Physician Decision|0|||
126258053|NCT00035555|454234513|FG002|Overall Study|Allograft loss|2|||
126258054|NCT00035555|454234511|FG000|Overall Study|Death|0|||
126258055|NCT00035555|454234512|FG001|Overall Study|Death|0|||
126258056|NCT00035555|454234513|FG002|Overall Study|Death|2|||
126258057|NCT00035555|454234511|FG000|Overall Study|Lost to Follow-up|0|||
126258058|NCT00035555|454234512|FG001|Overall Study|Lost to Follow-up|0|||
126258059|NCT00035555|454234513|FG002|Overall Study|Lost to Follow-up|1|||
126258060|NCT00035555|454234511|FG000|Overall Study|Noncompliance|0|||
126258061|NCT00035555|454234512|FG001|Overall Study|Noncompliance|1|||
126258062|NCT00035555|454234513|FG002|Overall Study|Noncompliance|1|||
126258063|NCT00035555|454234511|FG000|Overall Study|Prohibited medication|1|||
126258064|NCT00035555|454234512|FG001|Overall Study|Prohibited medication|1|||
126258065|NCT00035555|454234513|FG002|Overall Study|Prohibited medication|0|||
126258066|NCT00035555|454234511|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
126258067|NCT00035555|454234512|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
126258068|NCT00035555|454234513|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
126258069|NCT00035555|454234511|FG000|Overall Study|Withdrawal by Subject|2|||
126258070|NCT00035555|454234512|FG001|Overall Study|Withdrawal by Subject|0|||
126258071|NCT00035555|454234513|FG002|Overall Study|Withdrawal by Subject|2|||
126258072|NCT00035555|454234511|FG000|Overall Study|Investigator deemed not a good candidate|0|||
126258073|NCT00035555|454234512|FG001|Overall Study|Investigator deemed not a good candidate|0|||
125879828|NCT03050801|452857386|FG001|Experiment 2|Physician Decision|0|||
125879829|NCT03050801|452857387|FG002|Experiment 2|Physician Decision|0|||
126258074|NCT00035555|454234513|FG002|Overall Study|Investigator deemed not a good candidate|1|||
126258075|NCT00035555|454234511|FG000|Overall Study|Received cyclosporin in error|0|||
126258076|NCT00035555|454234512|FG001|Overall Study|Received cyclosporin in error|0|||
126358674|NCT01107457|454605413|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
126358675|NCT01107457|454605408|FG000|Part B and C|Physician Decision|0|||
126358676|NCT01107457|454605409|FG001|Part B and C|Physician Decision|0|||
126358677|NCT01107457|454605410|FG002|Part B and C|Physician Decision|0|||
126258077|NCT00035555|454234513|FG002|Overall Study|Received cyclosporin in error|1|||
126258078|NCT00309985|454234514|FG000|Overall Study|Disease progression|12|||
126258079|NCT00309985|454234515|FG001|Overall Study|Disease progression|0|||
126258080|NCT00309985|454234514|FG000|Overall Study|Adverse Event|30|||
126258081|NCT00309985|454234515|FG001|Overall Study|Adverse Event|0|||
126258082|NCT00309985|454234514|FG000|Overall Study|Death|2|||
126258083|NCT00309985|454234515|FG001|Overall Study|Death|0|||
126258084|NCT00309985|454234514|FG000|Overall Study|Withdrawal by Subject|5|||
126258085|NCT00309985|454234515|FG001|Overall Study|Withdrawal by Subject|1|||
126258086|NCT00309985|454234514|FG000|Overall Study|Physician Decision|3|||
126258087|NCT00309985|454234515|FG001|Overall Study|Physician Decision|0|||
126258088|NCT00309985|454234514|FG000|Overall Study|Never started treatment|7|||
126258089|NCT00309985|454234515|FG001|Overall Study|Never started treatment|0|||
126258090|NCT00309985|454234514|FG000|Overall Study|Complicating disease|1|||
126258091|NCT00309985|454234515|FG001|Overall Study|Complicating disease|0|||
126258092|NCT00309985|454234514|FG000|Overall Study|Non-compliance|1|||
126258093|NCT00309985|454234515|FG001|Overall Study|Non-compliance|0|||
126258094|NCT00309985|454234514|FG000|Overall Study|Chemotherapy discontinued only|1|||
126258095|NCT00309985|454234515|FG001|Overall Study|Chemotherapy discontinued only|0|||
126258096|NCT01186016|454234518|FG000|Overall Study|Withdrawal by Subject|46|||
126258097|NCT01186016|454234519|FG001|Overall Study|Withdrawal by Subject|29|||
126258098|NCT01055886|454234521|FG000|Overall Study|Withdrawal by Subject|4|||
126258099|NCT01055886|454234522|FG001|Overall Study|Withdrawal by Subject|9|||
126258100|NCT01055886|454234521|FG000|Overall Study|Lost to Follow-up|1|||
126258101|NCT01055886|454234522|FG001|Overall Study|Lost to Follow-up|1|||
126258102|NCT01055886|454234521|FG000|Overall Study|Withdrawal by PI|0|||
126258103|NCT01055886|454234522|FG001|Overall Study|Withdrawal by PI|1|||
126258104|NCT02972515|454234525|FG000|Overall Study|Lost to Follow-up|78|||
126258105|NCT01086969|454234530|FG000|Overall Study|Withdrawal by Subject|1|||
126258106|NCT01086969|454234531|FG001|Overall Study|Withdrawal by Subject|2|||
126258107|NCT01086969|454234532|FG002|Overall Study|Withdrawal by Subject|0|||
126258108|NCT00585312|454234548|FG000|Overall Study|Adverse Event|3|||
126258109|NCT00585312|454234549|FG001|Overall Study|Adverse Event|0|||
126258110|NCT00585312|454234548|FG000|Overall Study|Lack of Efficacy|6|||
126258111|NCT00585312|454234549|FG001|Overall Study|Lack of Efficacy|11|||
126258112|NCT00585312|454234548|FG000|Overall Study|Lost to Follow-up|1|||
126258113|NCT00585312|454234549|FG001|Overall Study|Lost to Follow-up|1|||
126258114|NCT00585312|454234548|FG000|Overall Study|Reason not specified|2|||
126258115|NCT00585312|454234549|FG001|Overall Study|Reason not specified|0|||
126258116|NCT00585312|454234548|FG000|Overall Study|Withdrawal by Subject|5|||
126258117|NCT00585312|454234549|FG001|Overall Study|Withdrawal by Subject|1|||
126258118|NCT00585312|454234548|FG000|Overall Study|Study terminated by the sponsor|34|||
126258119|NCT00585312|454234549|FG001|Overall Study|Study terminated by the sponsor|31|||
126258120|NCT04291508|454234553|FG000|Overall Study|Withdrawal by Subject|1|||
126258121|NCT04291508|454234554|FG001|Overall Study|Withdrawal by Subject|0|||
126258122|NCT04291508|454234555|FG002|Overall Study|Withdrawal by Subject|1|||
126258123|NCT04291508|454234556|FG003|Overall Study|Withdrawal by Subject|0|||
126258124|NCT04291508|454234553|FG000|Overall Study|lost to follow up|4|||
126258125|NCT04291508|454234554|FG001|Overall Study|lost to follow up|0|||
126258126|NCT04291508|454234555|FG002|Overall Study|lost to follow up|1|||
126258127|NCT04291508|454234556|FG003|Overall Study|lost to follow up|0|||
126358678|NCT01107457|454605411|FG003|Part B and C|Physician Decision|0|||
126358679|NCT01107457|454605412|FG004|Part B and C|Physician Decision|0|||
126358680|NCT01107457|454605413|FG005|Part B and C|Physician Decision|3|||
126358681|NCT01107457|454605408|FG000|Part B and C|Lack of Efficacy|0|||
126358682|NCT01107457|454605409|FG001|Part B and C|Lack of Efficacy|0|||
126358683|NCT01107457|454605410|FG002|Part B and C|Lack of Efficacy|0|||
126358684|NCT01107457|454605411|FG003|Part B and C|Lack of Efficacy|0|||
126358685|NCT01107457|454605412|FG004|Part B and C|Lack of Efficacy|0|||
126358686|NCT01107457|454605413|FG005|Part B and C|Lack of Efficacy|7|||
126358687|NCT01107457|454605408|FG000|Part B and C|Lost to Follow-up|0|||
126358688|NCT01107457|454605409|FG001|Part B and C|Lost to Follow-up|0|||
126358689|NCT01107457|454605410|FG002|Part B and C|Lost to Follow-up|0|||
126358690|NCT01107457|454605411|FG003|Part B and C|Lost to Follow-up|0|||
126358691|NCT01107457|454605412|FG004|Part B and C|Lost to Follow-up|0|||
126358692|NCT01107457|454605413|FG005|Part B and C|Lost to Follow-up|10|||
126358693|NCT01107457|454605408|FG000|Part B and C|Protocol Violation|0|||
126358694|NCT01107457|454605409|FG001|Part B and C|Protocol Violation|0|||
126358695|NCT01107457|454605410|FG002|Part B and C|Protocol Violation|0|||
126358696|NCT01107457|454605411|FG003|Part B and C|Protocol Violation|0|||
126358697|NCT01107457|454605412|FG004|Part B and C|Protocol Violation|0|||
126358698|NCT01107457|454605413|FG005|Part B and C|Protocol Violation|1|||
126358699|NCT01107457|454605408|FG000|Part B and C|Sponsor Decision|0|||
126258128|NCT04203667|454234557|FG000|Overall Study|Withdrawal by Subject|1|||
126358700|NCT01107457|454605409|FG001|Part B and C|Sponsor Decision|0|||
126358701|NCT01107457|454605410|FG002|Part B and C|Sponsor Decision|0|||
126358702|NCT01107457|454605411|FG003|Part B and C|Sponsor Decision|0|||
126358703|NCT01107457|454605412|FG004|Part B and C|Sponsor Decision|0|||
126358704|NCT01107457|454605413|FG005|Part B and C|Sponsor Decision|66|||
126358705|NCT01107457|454605408|FG000|Part B and C|Withdrawal by Subject|0|||
126358706|NCT01107457|454605409|FG001|Part B and C|Withdrawal by Subject|0|||
126358707|NCT01107457|454605410|FG002|Part B and C|Withdrawal by Subject|0|||
126358708|NCT01107457|454605411|FG003|Part B and C|Withdrawal by Subject|0|||
126358709|NCT01107457|454605412|FG004|Part B and C|Withdrawal by Subject|0|||
126358710|NCT01107457|454605413|FG005|Part B and C|Withdrawal by Subject|16|||
126358711|NCT01107457|454605408|FG000|Part B and C|Clinical Relapse|0|||
126358712|NCT01107457|454605409|FG001|Part B and C|Clinical Relapse|0|||
126358713|NCT01107457|454605410|FG002|Part B and C|Clinical Relapse|0|||
126358714|NCT01107457|454605411|FG003|Part B and C|Clinical Relapse|0|||
126358715|NCT01107457|454605412|FG004|Part B and C|Clinical Relapse|0|||
126358716|NCT01107457|454605413|FG005|Part B and C|Clinical Relapse|4|||
126358717|NCT03679884|454605414|FG000|Overall Study|Other|12|||
126358718|NCT03679884|454605415|FG001|Overall Study|Other|12|||
126358719|NCT03679884|454605416|FG002|Overall Study|Other|12|||
126358720|NCT03679884|454605417|FG003|Overall Study|Other|7|||
126358721|NCT03679884|454605418|FG004|Overall Study|Other|8|||
126358722|NCT03679884|454605414|FG000|Overall Study|Lack of Efficacy|15|||
126358723|NCT03679884|454605415|FG001|Overall Study|Lack of Efficacy|29|||
126358724|NCT03679884|454605416|FG002|Overall Study|Lack of Efficacy|13|||
126358725|NCT03679884|454605417|FG003|Overall Study|Lack of Efficacy|29|||
126358726|NCT03679884|454605418|FG004|Overall Study|Lack of Efficacy|10|||
126358727|NCT03679884|454605414|FG000|Overall Study|Death|1|||
126358728|NCT03679884|454605415|FG001|Overall Study|Death|0|||
126358729|NCT03679884|454605416|FG002|Overall Study|Death|0|||
126358730|NCT03679884|454605417|FG003|Overall Study|Death|0|||
126358731|NCT03679884|454605418|FG004|Overall Study|Death|0|||
126358732|NCT03679884|454605414|FG000|Overall Study|Adverse Event|2|||
126358733|NCT03679884|454605415|FG001|Overall Study|Adverse Event|10|||
126358734|NCT03679884|454605416|FG002|Overall Study|Adverse Event|9|||
126358735|NCT03679884|454605417|FG003|Overall Study|Adverse Event|6|||
126358736|NCT03679884|454605418|FG004|Overall Study|Adverse Event|6|||
126358737|NCT03679884|454605414|FG000|Overall Study|Withdrawal by Subject|12|||
126358738|NCT03679884|454605415|FG001|Overall Study|Withdrawal by Subject|23|||
126358739|NCT03679884|454605416|FG002|Overall Study|Withdrawal by Subject|8|||
126358740|NCT03679884|454605417|FG003|Overall Study|Withdrawal by Subject|8|||
126096062|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
126358741|NCT03679884|454605418|FG004|Overall Study|Withdrawal by Subject|9|||
126358742|NCT03679884|454605414|FG000|Overall Study|Lost to Follow-up|1|||
126358743|NCT03679884|454605415|FG001|Overall Study|Lost to Follow-up|4|||
126358744|NCT03679884|454605416|FG002|Overall Study|Lost to Follow-up|2|||
126358745|NCT03679884|454605417|FG003|Overall Study|Lost to Follow-up|0|||
126358746|NCT03679884|454605418|FG004|Overall Study|Lost to Follow-up|3|||
126358747|NCT01227395|454605419|FG000|Overall Study|Protocol Violation|0|||
126358748|NCT01227395|454605420|FG001|Overall Study|Protocol Violation|1|||
126358749|NCT00105508|454605425|FG000|Overall Study|Prephase Dropout|1|||
126358750|NCT00105508|454605426|FG001|Overall Study|Prephase Dropout|0|||
126030136|NCT04060355|453408157|FG000|Overall Study|Lost to Follow-up|41|||
126030137|NCT01140880|453408162|FG000|Overall Study|Death|0|||
126030138|NCT01140880|453408163|FG001|Overall Study|Death|1|||
126030139|NCT01140880|453408162|FG000|Overall Study|Withdrawal by Subject|6|||
126030140|NCT01140880|453408163|FG001|Overall Study|Withdrawal by Subject|3|||
126030141|NCT01140880|453408162|FG000|Overall Study|Lost to Follow-up|8|||
126030142|NCT01140880|453408163|FG001|Overall Study|Lost to Follow-up|10|||
126030143|NCT01140880|453408162|FG000|Overall Study|Protocol Violation|0|||
126030144|NCT01140880|453408163|FG001|Overall Study|Protocol Violation|30|||
126030145|NCT03131648|453408165|FG000|Initial Treatment Period|Not dosed|2|||
126030146|NCT03131648|453408166|FG001|Initial Treatment Period|Not dosed|2|||
126030147|NCT03131648|453408167|FG002|Initial Treatment Period|Not dosed|0|||
126030148|NCT03131648|453408168|FG003|Initial Treatment Period|Not dosed|0|||
126030149|NCT03131648|453408169|FG004|Initial Treatment Period|Not dosed|0|||
126030150|NCT03131648|453408170|FG005|Initial Treatment Period|Not dosed|0|||
126030151|NCT03131648|453408171|FG006|Initial Treatment Period|Not dosed|0|||
126030152|NCT03131648|453408172|FG007|Initial Treatment Period|Not dosed|0|||
126030153|NCT03131648|453408165|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
126030154|NCT03131648|453408166|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
126030155|NCT03131648|453408167|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126030156|NCT03131648|453408168|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126030157|NCT03131648|453408169|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126030158|NCT03131648|453408170|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126030159|NCT03131648|453408171|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126030160|NCT03131648|453408172|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126030161|NCT03131648|453408165|FG000|Open-label Treatment|Discontinued IMP|0|||
126030162|NCT03131648|453408166|FG001|Open-label Treatment|Discontinued IMP|0|||
126030163|NCT03131648|453408167|FG002|Open-label Treatment|Discontinued IMP|0|||
126030164|NCT03131648|453408168|FG003|Open-label Treatment|Discontinued IMP|0|||
126030165|NCT03131648|453408169|FG004|Open-label Treatment|Discontinued IMP|0|||
126030166|NCT03131648|453408170|FG005|Open-label Treatment|Discontinued IMP|0|||
126030167|NCT03131648|453408171|FG006|Open-label Treatment|Discontinued IMP|112|||
126030168|NCT03131648|453408172|FG007|Open-label Treatment|Discontinued IMP|0|||
126030169|NCT03131648|453408165|FG000|Open-label Treatment|Completed Week 50|0|||
126030170|NCT03131648|453408166|FG001|Open-label Treatment|Completed Week 50|0|||
126030171|NCT03131648|453408167|FG002|Open-label Treatment|Completed Week 50|0|||
126030172|NCT03131648|453408168|FG003|Open-label Treatment|Completed Week 50|0|||
126030173|NCT03131648|453408169|FG004|Open-label Treatment|Completed Week 50|0|||
126030174|NCT03131648|453408170|FG005|Open-label Treatment|Completed Week 50|0|||
126030175|NCT03131648|453408171|FG006|Open-label Treatment|Completed Week 50|6|||
126030176|NCT03131648|453408172|FG007|Open-label Treatment|Completed Week 50|0|||
126030177|NCT03131648|453408165|FG000|Maintenance Treatment Period|Not dosed|0|||
126030178|NCT03131648|453408166|FG001|Maintenance Treatment Period|Not dosed|0|||
126030179|NCT03131648|453408167|FG002|Maintenance Treatment Period|Not dosed|3|||
126030180|NCT03131648|453408168|FG003|Maintenance Treatment Period|Not dosed|2|||
126030181|NCT03131648|453408169|FG004|Maintenance Treatment Period|Not dosed|1|||
126030182|NCT03131648|453408170|FG005|Maintenance Treatment Period|Not dosed|0|||
126258129|NCT04203667|454234557|FG000|Overall Study|Lost to Follow-up|1|||
126258130|NCT04203667|454234557|FG000|Overall Study|Death|1|||
126258131|NCT04203667|454234557|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
126258132|NCT02329431|454234558|FG000|Overall Study|Lost to Follow-up|20|||
126258133|NCT02329431|454234559|FG001|Overall Study|Lost to Follow-up|13|||
126258134|NCT01362296|454234560|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
126258135|NCT01362296|454234561|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
126258136|NCT01362296|454234562|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
126258137|NCT01362296|454234563|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
126030183|NCT03131648|453408171|FG006|Maintenance Treatment Period|Not dosed|0|||
126030184|NCT03131648|453408172|FG007|Maintenance Treatment Period|Not dosed|0|||
126030185|NCT03131648|453408165|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
126030186|NCT03131648|453408166|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
126030187|NCT03131648|453408167|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
126030188|NCT03131648|453408168|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
126030189|NCT03131648|453408169|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
126030190|NCT03131648|453408170|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
126030191|NCT03131648|453408171|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
126030192|NCT03131648|453408172|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
126030193|NCT03131648|453408165|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126030194|NCT03131648|453408166|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126030195|NCT03131648|453408167|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
126030196|NCT03131648|453408168|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
126030197|NCT03131648|453408169|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
126030198|NCT03131648|453408170|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
126030199|NCT03131648|453408171|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126258138|NCT01362296|454234560|FG000|Randomized Phase (RP)|Physician Decision|1|||
126258139|NCT01362296|454234561|FG001|Randomized Phase (RP)|Physician Decision|9|||
126258140|NCT01362296|454234562|FG002|Randomized Phase (RP)|Physician Decision|0|||
126258141|NCT01362296|454234563|FG003|Randomized Phase (RP)|Physician Decision|0|||
126258142|NCT01362296|454234560|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
126258143|NCT01362296|454234561|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
126258144|NCT01362296|454234562|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
126258145|NCT01362296|454234563|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
126258146|NCT01362296|454234560|FG000|Randomized Phase (RP)|Adverse Event|20|||
126258147|NCT01362296|454234561|FG001|Randomized Phase (RP)|Adverse Event|4|||
126030200|NCT03131648|453408172|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126030201|NCT03131648|453408165|FG000|Maintenance Treatment Period|Completed Week 50|0|||
126258148|NCT01362296|454234562|FG002|Randomized Phase (RP)|Adverse Event|0|||
126258149|NCT01362296|454234563|FG003|Randomized Phase (RP)|Adverse Event|0|||
126258150|NCT01362296|454234560|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
126258151|NCT01362296|454234561|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
126258152|NCT01362296|454234562|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
126258153|NCT01362296|454234563|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
126258154|NCT01362296|454234560|FG000|Crossover Phase|PD including Death due to PD|0|||
126258155|NCT01362296|454234561|FG001|Crossover Phase|PD including Death due to PD|0|||
126258156|NCT01362296|454234562|FG002|Crossover Phase|PD including Death due to PD|16|||
126258157|NCT01362296|454234563|FG003|Crossover Phase|PD including Death due to PD|1|||
126258158|NCT01362296|454234560|FG000|Crossover Phase|Withdrawal by Subject|0|||
126258159|NCT01362296|454234561|FG001|Crossover Phase|Withdrawal by Subject|0|||
126258160|NCT01362296|454234562|FG002|Crossover Phase|Withdrawal by Subject|2|||
126258161|NCT01362296|454234563|FG003|Crossover Phase|Withdrawal by Subject|1|||
126258162|NCT01362296|454234560|FG000|Crossover Phase|Adverse Event|0|||
126258163|NCT01362296|454234561|FG001|Crossover Phase|Adverse Event|0|||
126258164|NCT01362296|454234562|FG002|Crossover Phase|Adverse Event|4|||
126258165|NCT01362296|454234563|FG003|Crossover Phase|Adverse Event|0|||
126258166|NCT01362296|454234560|FG000|Crossover Phase|Study Closed/Terminated|0|||
126258167|NCT01362296|454234561|FG001|Crossover Phase|Study Closed/Terminated|0|||
126258168|NCT01362296|454234562|FG002|Crossover Phase|Study Closed/Terminated|1|||
126258169|NCT01362296|454234563|FG003|Crossover Phase|Study Closed/Terminated|0|||
126258170|NCT02625974|454234564|FG000|Part 1|Lost to Follow-up|9|||
126258171|NCT02625974|454234565|FG001|Part 1|Lost to Follow-up|3|||
126030202|NCT03131648|453408166|FG001|Maintenance Treatment Period|Completed Week 50|0|||
126030203|NCT03131648|453408167|FG002|Maintenance Treatment Period|Completed Week 50|0|||
126030204|NCT03131648|453408168|FG003|Maintenance Treatment Period|Completed Week 50|0|||
126258172|NCT02625974|454234564|FG000|Part 2|Lost to Follow-up|4|||
126258173|NCT02625974|454234565|FG001|Part 2|Lost to Follow-up|6|||
126258174|NCT02625974|454234564|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
126258175|NCT02625974|454234565|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
126258176|NCT02129062|454235808|FG000|Overall Study|Death|1|||
126030205|NCT03131648|453408169|FG004|Maintenance Treatment Period|Completed Week 50|1|||
126258177|NCT02129062|454235808|FG000|Overall Study|Disease Progression|2|||
126258178|NCT02722616|454235809|FG000|Overall Study|Sponsor closed study after one month|2|||
126258179|NCT02722616|454235810|FG001|Overall Study|Sponsor closed study after one month|0|||
126258180|NCT02722616|454235811|FG002|Overall Study|Sponsor closed study after one month|0|||
126258181|NCT01923311|454235812|FG000|Overall Study|Pregnancy|1|||
126258182|NCT01923311|454235813|FG001|Overall Study|Pregnancy|0|||
126258183|NCT01923311|454235812|FG000|Overall Study|Investigator's Discretion|1|||
126258184|NCT01923311|454235813|FG001|Overall Study|Investigator's Discretion|0|||
126258185|NCT01923311|454235812|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126258186|NCT01923311|454235813|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126258187|NCT01923311|454235812|FG000|Overall Study|Withdrew Consent|1|||
126258188|NCT01923311|454235813|FG001|Overall Study|Withdrew Consent|0|||
126258189|NCT01923311|454235812|FG000|Overall Study|Study Terminated by Sponsor|12|||
126258190|NCT01923311|454235813|FG001|Overall Study|Study Terminated by Sponsor|0|||
126258191|NCT02031237|454235814|FG000|Overall Study|Death|1|||
126258192|NCT02031237|454235815|FG001|Overall Study|Death|5|||
126258193|NCT02031237|454235816|FG002|Overall Study|Death|0|||
126258194|NCT02031237|454235814|FG000|Overall Study|Physician Decision|0|||
126258195|NCT02031237|454235815|FG001|Overall Study|Physician Decision|1|||
126258196|NCT02031237|454235816|FG002|Overall Study|Physician Decision|0|||
126258197|NCT02031237|454235814|FG000|Overall Study|Withdrawal by Subject|2|||
126258198|NCT02031237|454235815|FG001|Overall Study|Withdrawal by Subject|2|||
126258199|NCT02031237|454235816|FG002|Overall Study|Withdrawal by Subject|0|||
126258200|NCT02031237|454235814|FG000|Overall Study|Protocol Violation|2|||
126258201|NCT02031237|454235815|FG001|Overall Study|Protocol Violation|6|||
126258202|NCT02031237|454235816|FG002|Overall Study|Protocol Violation|0|||
126258203|NCT02031237|454235814|FG000|Overall Study|Alternate Treatment Given|0|||
126258204|NCT02031237|454235815|FG001|Overall Study|Alternate Treatment Given|0|||
126258205|NCT02031237|454235816|FG002|Overall Study|Alternate Treatment Given|3|||
126258206|NCT00381849|454235817|FG000|Wash Out|Withdrawal by Subject|0|||
126258207|NCT00381849|454235818|FG001|Wash Out|Withdrawal by Subject|1|||
126258208|NCT02426541|454235822|FG000|Overall Study|Protocol Violation|1|||
126258209|NCT02426541|454235823|FG001|Overall Study|Protocol Violation|0|||
126258210|NCT00631007|454235826|FG000|Overall Study|Adverse Event|0|||
126258211|NCT00631007|454235827|FG001|Overall Study|Adverse Event|2|||
126258212|NCT00631007|454235828|FG002|Overall Study|Adverse Event|0|||
126258213|NCT00631007|454235829|FG003|Overall Study|Adverse Event|2|||
126258214|NCT00631007|454235830|FG004|Overall Study|Adverse Event|3|||
126258215|NCT00631007|454235831|FG005|Overall Study|Adverse Event|2|||
126258216|NCT00631007|454235826|FG000|Overall Study|Lost to Follow-up|2|||
126030206|NCT03131648|453408170|FG005|Maintenance Treatment Period|Completed Week 50|0|||
126030207|NCT03131648|453408171|FG006|Maintenance Treatment Period|Completed Week 50|0|||
126258217|NCT00631007|454235827|FG001|Overall Study|Lost to Follow-up|1|||
126258218|NCT00631007|454235828|FG002|Overall Study|Lost to Follow-up|2|||
126258219|NCT00631007|454235829|FG003|Overall Study|Lost to Follow-up|4|||
126258220|NCT00631007|454235830|FG004|Overall Study|Lost to Follow-up|5|||
126258221|NCT00631007|454235831|FG005|Overall Study|Lost to Follow-up|3|||
126258222|NCT00631007|454235826|FG000|Overall Study|Physician Decision|1|||
126258223|NCT00631007|454235827|FG001|Overall Study|Physician Decision|0|||
126258224|NCT00631007|454235828|FG002|Overall Study|Physician Decision|1|||
126258225|NCT00631007|454235829|FG003|Overall Study|Physician Decision|0|||
126258226|NCT00631007|454235830|FG004|Overall Study|Physician Decision|0|||
126258227|NCT00631007|454235831|FG005|Overall Study|Physician Decision|2|||
126258228|NCT00631007|454235826|FG000|Overall Study|Persistent Hyperglycemia|2|||
126258229|NCT00631007|454235827|FG001|Overall Study|Persistent Hyperglycemia|2|||
126258230|NCT00631007|454235828|FG002|Overall Study|Persistent Hyperglycemia|5|||
126258231|NCT00631007|454235829|FG003|Overall Study|Persistent Hyperglycemia|1|||
126030208|NCT03131648|453408172|FG007|Maintenance Treatment Period|Completed Week 50|0|||
126258232|NCT00631007|454235830|FG004|Overall Study|Persistent Hyperglycemia|2|||
126258233|NCT00631007|454235831|FG005|Overall Study|Persistent Hyperglycemia|5|||
126358751|NCT00105508|454605425|FG000|Overall Study|Adverse Event|16|||
126358752|NCT00105508|454605426|FG001|Overall Study|Adverse Event|19|||
126358753|NCT00105508|454605425|FG000|Overall Study|Insufficient Efficacy|1|||
126358754|NCT00105508|454605426|FG001|Overall Study|Insufficient Efficacy|0|||
126358755|NCT00105508|454605425|FG000|Overall Study|Withdrawal by Subject|10|||
126358756|NCT00105508|454605426|FG001|Overall Study|Withdrawal by Subject|6|||
126358757|NCT00105508|454605425|FG000|Overall Study|Lost to Follow-up|3|||
126358758|NCT00105508|454605426|FG001|Overall Study|Lost to Follow-up|0|||
126358759|NCT00105508|454605425|FG000|Overall Study|Protocol Violation|1|||
126358760|NCT00105508|454605426|FG001|Overall Study|Protocol Violation|2|||
126358761|NCT00105508|454605425|FG000|Overall Study|Other|8|||
126358762|NCT00105508|454605426|FG001|Overall Study|Other|9|||
126358763|NCT00086307|454605427|FG000|Overall Study|Lack of Efficacy|1|||
126358764|NCT00086307|454605428|FG001|Overall Study|Lack of Efficacy|1|||
126358765|NCT00086307|454605429|FG002|Overall Study|Lack of Efficacy|2|||
126358766|NCT00086307|454605427|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
126358767|NCT00086307|454605428|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
126358768|NCT00086307|454605429|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
126358769|NCT00086307|454605427|FG000|Overall Study|Nausea and headaches|0|||
126358770|NCT00086307|454605428|FG001|Overall Study|Nausea and headaches|0|||
126358771|NCT00086307|454605429|FG002|Overall Study|Nausea and headaches|1|||
126358772|NCT00086307|454605427|FG000|Overall Study|Constipation and sleepiness|0|||
126358773|NCT00086307|454605428|FG001|Overall Study|Constipation and sleepiness|0|||
126358774|NCT00086307|454605429|FG002|Overall Study|Constipation and sleepiness|1|||
126358775|NCT00086307|454605427|FG000|Overall Study|Suicidal ideation|0|||
126358776|NCT00086307|454605428|FG001|Overall Study|Suicidal ideation|0|||
126358777|NCT00086307|454605429|FG002|Overall Study|Suicidal ideation|1|||
126358778|NCT00086307|454605427|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
126358779|NCT00086307|454605428|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
126358780|NCT00086307|454605429|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
126358781|NCT00086307|454605427|FG000|Overall Study|Withdrawal by Subject|0|||
126358782|NCT00086307|454605428|FG001|Overall Study|Withdrawal by Subject|0|||
126358783|NCT00086307|454605429|FG002|Overall Study|Withdrawal by Subject|2|||
126358784|NCT00683384|454605430|FG000|Overall Study|Death|1|||
126358785|NCT00683384|454605430|FG000|Overall Study|Adverse Event|1|||
126358786|NCT00120874|454605432|FG000|Overall Study|Death|0|||
126358787|NCT00120874|454605433|FG001|Overall Study|Death|1|||
126358788|NCT00300495|454605440|FG000|Overall Study|Protocol Violation|4|||
126358789|NCT00300495|454605441|FG001|Overall Study|Protocol Violation|1|||
126358790|NCT03632720|454605442|FG000|Overall Study|Adverse Event|2|||
126358791|NCT03632720|454605443|FG001|Overall Study|Adverse Event|0|||
126358792|NCT03632720|454605444|FG002|Overall Study|Adverse Event|0|||
126358793|NCT03632720|454605442|FG000|Overall Study|Lost to Follow-up|0|||
126358794|NCT03632720|454605443|FG001|Overall Study|Lost to Follow-up|1|||
126030209|NCT03131648|453408165|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
126030210|NCT03131648|453408166|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
126030211|NCT03131648|453408167|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
126358795|NCT03632720|454605444|FG002|Overall Study|Lost to Follow-up|0|||
126358796|NCT03632720|454605442|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
126358797|NCT03632720|454605443|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
126358798|NCT03632720|454605444|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
126358799|NCT03632720|454605442|FG000|Overall Study|Screen failure|0|||
126358800|NCT03632720|454605443|FG001|Overall Study|Screen failure|1|||
126358801|NCT03632720|454605444|FG002|Overall Study|Screen failure|0|||
126358802|NCT00682435|454605445|FG000|Overall Study|Insufficient data|5|||
126096063|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
126258234|NCT00631007|454235826|FG000|Overall Study|Withdrawal by Subject|4|||
126258235|NCT00631007|454235827|FG001|Overall Study|Withdrawal by Subject|5|||
126258236|NCT00631007|454235828|FG002|Overall Study|Withdrawal by Subject|2|||
126258237|NCT00631007|454235829|FG003|Overall Study|Withdrawal by Subject|2|||
126258238|NCT00631007|454235830|FG004|Overall Study|Withdrawal by Subject|1|||
126258239|NCT00631007|454235831|FG005|Overall Study|Withdrawal by Subject|3|||
126258240|NCT00631007|454235826|FG000|Overall Study|Other|2|||
126258241|NCT00631007|454235827|FG001|Overall Study|Other|1|||
126096064|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
125879830|NCT03050801|452857388|FG003|Experiment 2|Physician Decision|0|||
126258242|NCT00631007|454235828|FG002|Overall Study|Other|0|||
126258243|NCT00631007|454235829|FG003|Overall Study|Other|0|||
126258244|NCT00631007|454235830|FG004|Overall Study|Other|1|||
126258245|NCT00631007|454235831|FG005|Overall Study|Other|0|||
125879831|NCT03050801|452857389|FG004|Experiment 2|Physician Decision|1|||
125879832|NCT03050801|452857390|FG005|Experiment 2|Physician Decision|0|||
125879833|NCT03050801|452857385|FG000|Experiment 2|Pregnancy|0|||
125879834|NCT03050801|452857386|FG001|Experiment 2|Pregnancy|0|||
125879835|NCT03050801|452857387|FG002|Experiment 2|Pregnancy|0|||
125879836|NCT03050801|452857388|FG003|Experiment 2|Pregnancy|0|||
125879837|NCT03050801|452857389|FG004|Experiment 2|Pregnancy|1|||
125879838|NCT03050801|452857390|FG005|Experiment 2|Pregnancy|0|||
125879839|NCT03050801|452857385|FG000|Experiment 2|Withdrawal by Subject|0|||
125879840|NCT03050801|452857386|FG001|Experiment 2|Withdrawal by Subject|0|||
125879841|NCT03050801|452857387|FG002|Experiment 2|Withdrawal by Subject|0|||
125879842|NCT03050801|452857388|FG003|Experiment 2|Withdrawal by Subject|1|||
125879843|NCT03050801|452857389|FG004|Experiment 2|Withdrawal by Subject|0|||
125879844|NCT03050801|452857390|FG005|Experiment 2|Withdrawal by Subject|0|||
125879845|NCT03050801|452857385|FG000|Experiment 2|Poor data quality|0|||
125879846|NCT03050801|452857386|FG001|Experiment 2|Poor data quality|0|||
125879847|NCT03050801|452857387|FG002|Experiment 2|Poor data quality|0|||
125879848|NCT03050801|452857388|FG003|Experiment 2|Poor data quality|4|||
125879849|NCT03050801|452857389|FG004|Experiment 2|Poor data quality|1|||
125879850|NCT03050801|452857390|FG005|Experiment 2|Poor data quality|0|||
125879851|NCT03050801|452857385|FG000|Experiment 2|Discomfort during stimulation|0|||
125879852|NCT03050801|452857386|FG001|Experiment 2|Discomfort during stimulation|0|||
125879853|NCT03050801|452857387|FG002|Experiment 2|Discomfort during stimulation|0|||
125879854|NCT03050801|452857388|FG003|Experiment 2|Discomfort during stimulation|0|||
125879855|NCT03050801|452857389|FG004|Experiment 2|Discomfort during stimulation|0|||
125879856|NCT03050801|452857390|FG005|Experiment 2|Discomfort during stimulation|2|||
125879857|NCT00005780|452857391|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
125879858|NCT03600909|452857392|FG000|Overall Study|Not treated|0|||
125879859|NCT03600909|452857393|FG001|Overall Study|Not treated|3|||
125879860|NCT03600909|452857394|FG002|Overall Study|Not treated|0|||
125879861|NCT04973449|452857395|FG000|Overall Study|Withdrawal by Subject|3|||
125879862|NCT04973449|452857396|FG001|Overall Study|Withdrawal by Subject|3|||
125879863|NCT04973449|452857397|FG002|Overall Study|Withdrawal by Subject|2|||
125879864|NCT04973449|452857398|FG003|Overall Study|Withdrawal by Subject|5|||
125879865|NCT04973449|452857399|FG004|Overall Study|Withdrawal by Subject|5|||
125879866|NCT04973449|452857400|FG005|Overall Study|Withdrawal by Subject|4|||
125879867|NCT04973449|452857401|FG006|Overall Study|Withdrawal by Subject|7|||
125879868|NCT04973449|452857402|FG007|Overall Study|Withdrawal by Subject|5|||
125879869|NCT04973449|452857395|FG000|Overall Study|Lost to Follow-up|15|||
125879870|NCT04973449|452857396|FG001|Overall Study|Lost to Follow-up|16|||
125879871|NCT04973449|452857397|FG002|Overall Study|Lost to Follow-up|16|||
125879872|NCT04973449|452857398|FG003|Overall Study|Lost to Follow-up|13|||
125879873|NCT04973449|452857399|FG004|Overall Study|Lost to Follow-up|5|||
125879874|NCT04973449|452857400|FG005|Overall Study|Lost to Follow-up|6|||
126258246|NCT00683787|454235832|FG000|Overall Study|Progression|3|||
126258247|NCT00683787|454235833|FG001|Overall Study|Progression|3|||
126258248|NCT00683787|454235834|FG002|Overall Study|Progression|0|||
126258249|NCT00683787|454235832|FG000|Overall Study|Adverse Event|0|||
126258250|NCT00683787|454235833|FG001|Overall Study|Adverse Event|0|||
126258251|NCT00683787|454235834|FG002|Overall Study|Adverse Event|2|||
126258252|NCT02674633|454235835|FG000|Overall Study|Lost to Follow-up|3|||
126258253|NCT02674633|454235836|FG001|Overall Study|Lost to Follow-up|2|||
126258254|NCT02674633|454235835|FG000|Overall Study|Physician Decision|1|||
126258255|NCT02674633|454235836|FG001|Overall Study|Physician Decision|0|||
126258256|NCT02674633|454235835|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126258257|NCT02674633|454235836|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126258258|NCT00460109|454235837|FG000|Overall Study|Death|1|||
126258259|NCT04167618|454235838|FG000|Overall Study|Trial terminated by sponsor|1|||
126258260|NCT04167618|454235839|FG001|Overall Study|Trial terminated by sponsor|1|||
126258261|NCT05996198|454235840|FG000|Overall Study|Withdrawal by Subject|1|||
126258262|NCT05996198|454235841|FG001|Overall Study|Withdrawal by Subject|0|||
126258263|NCT00835796|454235843|FG000|First Intervention|Withdrawal by Subject|0|||
125879875|NCT04973449|452857401|FG006|Overall Study|Lost to Follow-up|10|||
125879876|NCT04973449|452857402|FG007|Overall Study|Lost to Follow-up|6|||
126258264|NCT00835796|454235844|FG001|First Intervention|Withdrawal by Subject|1|||
126258265|NCT00651183|454235845|FG000|Overall Study|Lack of Efficacy|1|||
125879877|NCT04973449|452857395|FG000|Overall Study|Death|1|||
125879878|NCT04973449|452857396|FG001|Overall Study|Death|0|||
126258266|NCT00651183|454235846|FG001|Overall Study|Lack of Efficacy|0|||
126258267|NCT00651183|454235845|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
126258268|NCT00651183|454235846|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
126258269|NCT00651183|454235845|FG000|Overall Study|Tolerability insufficient|5|||
125879879|NCT04973449|452857397|FG002|Overall Study|Death|0|||
125879880|NCT04973449|452857398|FG003|Overall Study|Death|0|||
125879881|NCT04973449|452857399|FG004|Overall Study|Death|0|||
125879882|NCT04973449|452857400|FG005|Overall Study|Death|1|||
125879883|NCT04973449|452857401|FG006|Overall Study|Death|0|||
125879884|NCT04973449|452857402|FG007|Overall Study|Death|0|||
125879885|NCT04973449|452857395|FG000|Overall Study|Other|1|||
126358803|NCT00682435|454605445|FG000|Overall Study|Erroneously enrolled twice|2|||
126358804|NCT00290238|454605446|FG000|Overall Study|Study terminated|27|||
126358805|NCT00290238|454605447|FG001|Overall Study|Study terminated|27|||
126358806|NCT00290238|454605446|FG000|Overall Study|Lost to Follow-up|0|||
126358807|NCT00290238|454605447|FG001|Overall Study|Lost to Follow-up|1|||
126358808|NCT00290238|454605446|FG000|Overall Study|Withdrawal by Subject|15|||
126358809|NCT00290238|454605447|FG001|Overall Study|Withdrawal by Subject|13|||
126358810|NCT06868667|454605448|FG000|Overall Study|Death|0|||
126358811|NCT06868667|454605449|FG001|Overall Study|Death|4|||
126358812|NCT06868667|454605448|FG000|Overall Study|Lost to Follow-up|0|||
126358813|NCT06868667|454605449|FG001|Overall Study|Lost to Follow-up|1|||
126358814|NCT06868667|454605448|FG000|Overall Study|Withdrawal by Subject|1|||
126358815|NCT06868667|454605449|FG001|Overall Study|Withdrawal by Subject|0|||
126358816|NCT06868667|454605448|FG000|Overall Study|Ongoing|9|||
126358817|NCT06868667|454605449|FG001|Overall Study|Ongoing|9|||
126358818|NCT05330429|454605450|FG000|Overall Study|Study Terminated by Sponsor|4|||
126358819|NCT05330429|454605451|FG001|Overall Study|Study Terminated by Sponsor|33|||
126358820|NCT05330429|454605452|FG002|Overall Study|Study Terminated by Sponsor|12|||
126358821|NCT05330429|454605450|FG000|Overall Study|Death|5|||
126358822|NCT05330429|454605451|FG001|Overall Study|Death|2|||
126358823|NCT05330429|454605452|FG002|Overall Study|Death|4|||
126358824|NCT05330429|454605450|FG000|Overall Study|Withdrew Consent|0|||
126358825|NCT05330429|454605451|FG001|Overall Study|Withdrew Consent|5|||
126358826|NCT05330429|454605452|FG002|Overall Study|Withdrew Consent|4|||
126358827|NCT05330429|454605450|FG000|Overall Study|Investigator's Discretion|0|||
126358828|NCT05330429|454605451|FG001|Overall Study|Investigator's Discretion|1|||
126358829|NCT05330429|454605452|FG002|Overall Study|Investigator's Discretion|3|||
126030212|NCT03131648|453408168|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
126030213|NCT03131648|453408169|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
126358830|NCT05330429|454605450|FG000|Overall Study|Subject Decision|1|||
126358831|NCT05330429|454605451|FG001|Overall Study|Subject Decision|2|||
126358832|NCT05330429|454605452|FG002|Overall Study|Subject Decision|0|||
126358833|NCT05330429|454605450|FG000|Overall Study|Lost to Follow-up|0|||
126358834|NCT05330429|454605451|FG001|Overall Study|Lost to Follow-up|1|||
126358835|NCT05330429|454605452|FG002|Overall Study|Lost to Follow-up|0|||
126358836|NCT06097273|454605454|FG000|Overall Study|Death|2|||
126358837|NCT06097273|454605455|FG001|Overall Study|Death|1|||
126358838|NCT06097273|454605456|FG002|Overall Study|Death|2|||
126358839|NCT06097273|454605457|FG003|Overall Study|Death|2|||
126358840|NCT06097273|454605454|FG000|Overall Study|Lost to Follow-up|27|||
126358841|NCT06097273|454605455|FG001|Overall Study|Lost to Follow-up|18|||
126030214|NCT03131648|453408170|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
126030215|NCT03131648|453408171|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
126030216|NCT03131648|453408172|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
126358842|NCT06097273|454605456|FG002|Overall Study|Lost to Follow-up|36|||
126358843|NCT06097273|454605457|FG003|Overall Study|Lost to Follow-up|31|||
126358844|NCT06097273|454605454|FG000|Overall Study|Physician Decision|0|||
126358845|NCT06097273|454605455|FG001|Overall Study|Physician Decision|1|||
126358846|NCT06097273|454605456|FG002|Overall Study|Physician Decision|0|||
126358847|NCT06097273|454605457|FG003|Overall Study|Physician Decision|3|||
126358848|NCT06097273|454605454|FG000|Overall Study|Protocol Violation|1|||
126358849|NCT06097273|454605455|FG001|Overall Study|Protocol Violation|1|||
126358850|NCT06097273|454605456|FG002|Overall Study|Protocol Violation|2|||
126358851|NCT06097273|454605457|FG003|Overall Study|Protocol Violation|1|||
126358852|NCT06097273|454605454|FG000|Overall Study|Withdrawal by Subject|14|||
126358853|NCT06097273|454605455|FG001|Overall Study|Withdrawal by Subject|11|||
126358854|NCT06097273|454605456|FG002|Overall Study|Withdrawal by Subject|14|||
126358855|NCT06097273|454605457|FG003|Overall Study|Withdrawal by Subject|15|||
126358856|NCT06097273|454605454|FG000|Overall Study|Other Than Specified|7|||
126358857|NCT06097273|454605455|FG001|Overall Study|Other Than Specified|3|||
126358858|NCT06097273|454605456|FG002|Overall Study|Other Than Specified|11|||
126258270|NCT00651183|454235846|FG001|Overall Study|Tolerability insufficient|2|||
126258271|NCT00651183|454235845|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
126258272|NCT00651183|454235846|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
126258273|NCT00651183|454235845|FG000|Overall Study|Withdrawal by Subject|6|||
126258274|NCT00651183|454235846|FG001|Overall Study|Withdrawal by Subject|3|||
126258275|NCT00651183|454235845|FG000|Overall Study|Lost to Follow-up|3|||
126258276|NCT00651183|454235846|FG001|Overall Study|Lost to Follow-up|1|||
126258277|NCT00651183|454235845|FG000|Overall Study|Other reasons|4|||
126258278|NCT00651183|454235846|FG001|Overall Study|Other reasons|2|||
126258279|NCT00651183|454235845|FG000|Overall Study|missing|1|||
126258280|NCT00651183|454235846|FG001|Overall Study|missing|0|||
126258281|NCT01363011|454235850|FG000|Main Study|Adverse Event|2|||
126258282|NCT01363011|454235851|FG001|Main Study|Adverse Event|3|||
126258283|NCT01363011|454235850|FG000|Main Study|Investigator's Discretion|1|||
126258284|NCT01363011|454235851|FG001|Main Study|Investigator's Discretion|1|||
126258285|NCT01363011|454235850|FG000|Main Study|Withdrew Consent|1|||
126258286|NCT01363011|454235851|FG001|Main Study|Withdrew Consent|4|||
126258287|NCT01363011|454235850|FG000|Main Study|Protocol Violation|0|||
126258288|NCT01363011|454235851|FG001|Main Study|Protocol Violation|1|||
126258289|NCT01363011|454235850|FG000|Extension Phase|Adverse Event|1|||
126258290|NCT01363011|454235851|FG001|Extension Phase|Adverse Event|1|||
126258291|NCT01363011|454235850|FG000|Extension Phase|Lack of Efficacy|0|||
126258292|NCT01363011|454235851|FG001|Extension Phase|Lack of Efficacy|1|||
126258293|NCT01363011|454235850|FG000|Extension Phase|Investigator's Discretion|2|||
126258294|NCT01363011|454235851|FG001|Extension Phase|Investigator's Discretion|2|||
126258295|NCT01363011|454235850|FG000|Extension Phase|Withdrew Consent|0|||
126258296|NCT01363011|454235851|FG001|Extension Phase|Withdrew Consent|1|||
126258297|NCT01363011|454235850|FG000|Extension Phase|Lost to Follow-up|0|||
126258298|NCT01363011|454235851|FG001|Extension Phase|Lost to Follow-up|2|||
126258299|NCT01363011|454235850|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
126258300|NCT01363011|454235851|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
126258301|NCT04412057|454235852|FG000|Overall Study|Death|3|||
126258302|NCT04412057|454235853|FG001|Overall Study|Death|7|||
126258303|NCT04412057|454235852|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
126258304|NCT04412057|454235853|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
126258305|NCT01961882|454235857|FG000|Overall Study|Adverse Event|3|||
126258306|NCT01961882|454235858|FG001|Overall Study|Adverse Event|2|||
126258307|NCT01961882|454235857|FG000|Overall Study|Physician Decision|1|||
126258308|NCT01961882|454235858|FG001|Overall Study|Physician Decision|0|||
126258309|NCT01961882|454235857|FG000|Overall Study|Withdrawal by Subject|4|||
126258310|NCT01961882|454235858|FG001|Overall Study|Withdrawal by Subject|1|||
126258311|NCT01961882|454235857|FG000|Overall Study|Relapse of AML|39|||
126258312|NCT01961882|454235858|FG001|Overall Study|Relapse of AML|37|||
126258313|NCT01961882|454235857|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
126258314|NCT01961882|454235858|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
126258315|NCT01961882|454235857|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
126258316|NCT01961882|454235858|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
126258317|NCT00407745|454235862|FG000|Overall Study|Lack of Efficacy|1|||
126258318|NCT00407745|454235863|FG001|Overall Study|Lack of Efficacy|2|||
126258319|NCT00407745|454235862|FG000|Overall Study|Withdrawal by Subject|3|||
126258320|NCT00407745|454235863|FG001|Overall Study|Withdrawal by Subject|3|||
126258321|NCT00407745|454235862|FG000|Overall Study|Protocol Violation|5|||
126258322|NCT00407745|454235863|FG001|Overall Study|Protocol Violation|3|||
126258323|NCT00407745|454235862|FG000|Overall Study|Adverse Event|8|||
126258324|NCT00407745|454235863|FG001|Overall Study|Adverse Event|8|||
126258325|NCT00407745|454235862|FG000|Overall Study|Other|2|||
126258326|NCT00407745|454235863|FG001|Overall Study|Other|0|||
126258327|NCT00407745|454235862|FG000|Overall Study|Randomized, unknown if treated|0|||
126258328|NCT00407745|454235863|FG001|Overall Study|Randomized, unknown if treated|1|||
126258329|NCT00108082|454235864|FG000|Overall Study|Adverse Event|14|||
126258330|NCT00108082|454235865|FG001|Overall Study|Adverse Event|12|||
126258331|NCT00108082|454235866|FG002|Overall Study|Adverse Event|17|||
126258332|NCT00108082|454235864|FG000|Overall Study|Lost to Follow-up|6|||
126258333|NCT00108082|454235865|FG001|Overall Study|Lost to Follow-up|3|||
126258334|NCT00108082|454235866|FG002|Overall Study|Lost to Follow-up|7|||
126258335|NCT00108082|454235864|FG000|Overall Study|Consent Withdrawn|3|||
126258336|NCT00108082|454235865|FG001|Overall Study|Consent Withdrawn|3|||
126258337|NCT00108082|454235866|FG002|Overall Study|Consent Withdrawn|5|||
126258338|NCT00108082|454235864|FG000|Overall Study|Protocol Violation|1|||
126258339|NCT00108082|454235865|FG001|Overall Study|Protocol Violation|2|||
126258340|NCT00108082|454235866|FG002|Overall Study|Protocol Violation|0|||
126258341|NCT00108082|454235864|FG000|Overall Study|Lack of Efficacy|3|||
126258342|NCT00108082|454235865|FG001|Overall Study|Lack of Efficacy|1|||
126258343|NCT00108082|454235866|FG002|Overall Study|Lack of Efficacy|2|||
126258344|NCT00108082|454235864|FG000|Overall Study|Amendment 4: > Month 12|5|||
126258345|NCT00108082|454235865|FG001|Overall Study|Amendment 4: > Month 12|7|||
126258346|NCT00108082|454235866|FG002|Overall Study|Amendment 4: > Month 12|5|||
126258347|NCT00108082|454235864|FG000|Overall Study|Woman of Child-bearing Potential|2|||
126258348|NCT00108082|454235865|FG001|Overall Study|Woman of Child-bearing Potential|0|||
126358859|NCT06097273|454605457|FG003|Overall Study|Other Than Specified|6|||
126358860|NCT03882801|454607282|FG000|Period 1|Adverse Event|0|||
126358861|NCT03882801|454607283|FG001|Period 1|Adverse Event|1|||
126358862|NCT03882801|454607282|FG000|Period 1|Non-compliance with study drug|1|||
126358863|NCT03882801|454607283|FG001|Period 1|Non-compliance with study drug|1|||
126358864|NCT03882801|454607282|FG000|Period 1|Never treated with study drug|1|||
126358865|NCT03882801|454607283|FG001|Period 1|Never treated with study drug|0|||
126358866|NCT03882801|454607282|FG000|Washout Period|Physician Decision|0|||
126358867|NCT03882801|454607283|FG001|Washout Period|Physician Decision|1|||
126358868|NCT03882801|454607282|FG000|Period 2|Non-compliance with study drug|0|||
126358869|NCT03882801|454607283|FG001|Period 2|Non-compliance with study drug|1|||
126358870|NCT03548415|454607287|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
126358871|NCT03548415|454607288|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
126358872|NCT03548415|454607289|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
126358873|NCT03548415|454607290|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
126358874|NCT03548415|454607291|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
126358875|NCT01803737|454607292|FG000|Overall Study|Lack of Time|1|||
126358876|NCT01803737|454607293|FG001|Overall Study|Lack of Time|0|||
126358877|NCT01803737|454607292|FG000|Overall Study|Medical Reason|0|||
126358878|NCT01803737|454607293|FG001|Overall Study|Medical Reason|1|||
126358879|NCT01803737|454607292|FG000|Overall Study|Lost to Follow-up|0|||
126358880|NCT01803737|454607293|FG001|Overall Study|Lost to Follow-up|2|||
126358881|NCT01748552|454607294|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
126358882|NCT01748552|454607295|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
126358883|NCT01748552|454607296|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
126358884|NCT01748552|454607297|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
126358885|NCT01748552|454607298|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
126358886|NCT01748552|454607299|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
126358887|NCT01748552|454607300|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
126358888|NCT01748552|454607301|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
126358889|NCT01748552|454607302|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
125879886|NCT04973449|452857396|FG001|Overall Study|Other|1|||
125879887|NCT04973449|452857397|FG002|Overall Study|Other|2|||
125879888|NCT04973449|452857398|FG003|Overall Study|Other|1|||
125879889|NCT04973449|452857399|FG004|Overall Study|Other|4|||
125879890|NCT04973449|452857400|FG005|Overall Study|Other|0|||
125879891|NCT04973449|452857401|FG006|Overall Study|Other|2|||
125879892|NCT04973449|452857402|FG007|Overall Study|Other|2|||
125879893|NCT00521079|452857403|FG000|Overall Study|Adverse Event|7|||
125879894|NCT00521079|452857404|FG001|Overall Study|Adverse Event|1|||
125879895|NCT00521079|452857403|FG000|Overall Study|Lost to Follow-up|2|||
125879896|NCT00521079|452857404|FG001|Overall Study|Lost to Follow-up|1|||
125879897|NCT00521079|452857403|FG000|Overall Study|Withdrawal by Subject|5|||
125879898|NCT00521079|452857404|FG001|Overall Study|Withdrawal by Subject|3|||
125879899|NCT02651675|452857405|FG000|Overall Study|Death|0|||
125879900|NCT02651675|452857406|FG001|Overall Study|Death|0|||
125879901|NCT02651675|452857407|FG002|Overall Study|Death|1|||
125879902|NCT03674411|452857408|FG000|Overall Study|Non-treatment|4|||
125879903|NCT01506596|452857410|FG000|Overall Study|ineligible pathology|1|||
125879904|NCT04408989|452857411|FG000|Overall Study|Lost to Follow-up|0|||
125879905|NCT04408989|452857412|FG001|Overall Study|Lost to Follow-up|0|||
125879906|NCT04408989|452857413|FG002|Overall Study|Lost to Follow-up|1|||
125879907|NCT04408989|452857411|FG000|Overall Study|Withdrawal by Subject|0|||
125879908|NCT04408989|452857412|FG001|Overall Study|Withdrawal by Subject|0|||
125879909|NCT04408989|452857413|FG002|Overall Study|Withdrawal by Subject|2|||
125879910|NCT05082857|452857414|FG000|Overall Study|participants relocated and could not continue|2|||
125879911|NCT05082857|452857415|FG001|Overall Study|participants relocated and could not continue|1|||
125879912|NCT05082857|452857414|FG000|Overall Study|Lost to Follow-up|1|||
125879913|NCT05082857|452857415|FG001|Overall Study|Lost to Follow-up|3|||
125879914|NCT04606134|452857422|FG000|Overall Study|Adverse Event|0|||
125879915|NCT04606134|452857423|FG001|Overall Study|Adverse Event|1|||
125879916|NCT01099267|452857424|FG000|MDS-003 Study|Adverse Event|37|||
125879917|NCT01099267|452857424|FG000|MDS-003 Study|Lack of Efficacy|52|||
125879918|NCT01099267|452857424|FG000|MDS-003 Study|Withdrawal by Subject|8|||
125879919|NCT01099267|452857424|FG000|MDS-003 Study|Lost to Follow-up|1|||
125879920|NCT01099267|452857424|FG000|MDS-003 Study|Death|11|||
126258349|NCT00108082|454235866|FG002|Overall Study|Woman of Child-bearing Potential|2|||
126258350|NCT00108082|454235864|FG000|Overall Study|Incorrectly Randomized|0|||
126258351|NCT00108082|454235865|FG001|Overall Study|Incorrectly Randomized|0|||
126258352|NCT00108082|454235866|FG002|Overall Study|Incorrectly Randomized|2|||
126258353|NCT00108082|454235864|FG000|Overall Study|Non-compliance|1|||
126258354|NCT00108082|454235865|FG001|Overall Study|Non-compliance|0|||
126258355|NCT00108082|454235866|FG002|Overall Study|Non-compliance|2|||
126258356|NCT00108082|454235864|FG000|Overall Study|Stopped Study Medication|0|||
126258357|NCT00108082|454235865|FG001|Overall Study|Stopped Study Medication|0|||
125879921|NCT01099267|452857424|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
125879922|NCT01099267|452857424|FG000|MDS-003 Study|Disease Progression|7|||
125879923|NCT01099267|452857424|FG000|MDS-003 Study|Investigator Decision|2|||
125879924|NCT01099267|452857424|FG000|MDS-003 Study|Non-Compliance|2|||
125879925|NCT01099267|452857424|FG000|MDS-003 Study|Loss of Response|1|||
125879926|NCT01099267|452857424|FG000|MDS-003 Study|Secondary Malign Disease|1|||
125879927|NCT04050553|452857435|FG000|Period 1|Physician Decision|2|||
125879928|NCT04050553|452857436|FG001|Period 1|Physician Decision|2|||
125879929|NCT04050553|452857435|FG000|Period 1|Adverse Event|1|||
125879930|NCT04050553|452857436|FG001|Period 1|Adverse Event|1|||
125879931|NCT04050553|452857435|FG000|Period 1|Withdrawal by Subject|0|||
126258358|NCT00108082|454235866|FG002|Overall Study|Stopped Study Medication|1|||
125879932|NCT04050553|452857436|FG001|Period 1|Withdrawal by Subject|1|||
125879933|NCT04050553|452857435|FG000|Wash-out|Adverse Event|0|||
125879934|NCT04050553|452857436|FG001|Wash-out|Adverse Event|1|||
125879935|NCT04050553|452857435|FG000|Wash-out|Withdrawal by Subject|0|||
125879936|NCT04050553|452857436|FG001|Wash-out|Withdrawal by Subject|1|||
125879937|NCT03472885|452857439|FG000|24-Week Treatment Period|Adverse Event|1|||
125879938|NCT02201953|452857440|FG000|Overall Study|Randomized but Never Treated|1|||
125879939|NCT02201953|452857441|FG001|Overall Study|Randomized but Never Treated|5|||
125879940|NCT02201953|452857440|FG000|Overall Study|Lack of Efficacy|9|||
125879941|NCT02201953|452857441|FG001|Overall Study|Lack of Efficacy|30|||
126258359|NCT00108082|454235864|FG000|Overall Study|Site Closed Study|0|||
126258360|NCT00108082|454235865|FG001|Overall Study|Site Closed Study|2|||
126258361|NCT00108082|454235866|FG002|Overall Study|Site Closed Study|0|||
126258362|NCT00108082|454235864|FG000|Overall Study|Protocol Amendment|0|||
126258363|NCT00108082|454235865|FG001|Overall Study|Protocol Amendment|1|||
125879942|NCT02201953|452857440|FG000|Overall Study|Lost to Follow-up|8|||
125879943|NCT02201953|452857441|FG001|Overall Study|Lost to Follow-up|8|||
125879944|NCT02201953|452857440|FG000|Overall Study|Withdrew Consent|2|||
125879945|NCT02201953|452857441|FG001|Overall Study|Withdrew Consent|5|||
125879946|NCT02201953|452857440|FG000|Overall Study|Adverse Event|0|||
125879947|NCT02201953|452857441|FG001|Overall Study|Adverse Event|5|||
125879948|NCT02201953|452857440|FG000|Overall Study|Death|0|||
125879949|NCT02201953|452857441|FG001|Overall Study|Death|3|||
125879950|NCT01615939|452858712|FG000|Overall Study|Lost to Follow-up|5|||
125879951|NCT01615939|452858713|FG001|Overall Study|Lost to Follow-up|0|||
125879952|NCT02892344|452858717|FG000|Overall Study|Protocol deviation|3|||
125879953|NCT02892344|452858718|FG001|Overall Study|Protocol deviation|4|||
125879954|NCT02892344|452858717|FG000|Overall Study|Adverse Event|1|||
126030217|NCT02671903|453408173|FG000|Period 0 (Run-In)|Death|0|||
126030218|NCT02671903|453408174|FG001|Period 0 (Run-In)|Death|0|||
126030219|NCT02671903|453408175|FG002|Period 0 (Run-In)|Death|3|||
126030220|NCT02671903|453408173|FG000|Period 0 (Run-In)|Physician Decision|0|||
126030221|NCT02671903|453408174|FG001|Period 0 (Run-In)|Physician Decision|0|||
126030222|NCT02671903|453408175|FG002|Period 0 (Run-In)|Physician Decision|4|||
125879955|NCT02892344|452858718|FG001|Overall Study|Adverse Event|8|||
126030223|NCT02671903|453408173|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
126030224|NCT02671903|453408174|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
125879956|NCT02892344|452858717|FG000|Overall Study|Lost to Follow-up|0|||
126096065|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
125879957|NCT02892344|452858718|FG001|Overall Study|Lost to Follow-up|1|||
125879958|NCT02892344|452858717|FG000|Overall Study|Non-compliance with study treatment|0|||
126096066|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
125879959|NCT02892344|452858718|FG001|Overall Study|Non-compliance with study treatment|1|||
125879960|NCT02892344|452858717|FG000|Overall Study|Physician Decision|0|||
125879961|NCT02892344|452858718|FG001|Overall Study|Physician Decision|2|||
126030225|NCT02671903|453408175|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
126030226|NCT02671903|453408173|FG000|Period 0 (Run-In)|Protocol Violation|0|||
126258364|NCT00108082|454235866|FG002|Overall Study|Protocol Amendment|0|||
126358890|NCT01748552|454607303|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
126358891|NCT01748552|454607304|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
126358892|NCT01748552|454607305|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
126358893|NCT01748552|454607294|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358894|NCT01748552|454607295|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358895|NCT01748552|454607296|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358896|NCT01748552|454607297|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358897|NCT01748552|454607298|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358898|NCT01748552|454607299|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358899|NCT01748552|454607300|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
126358900|NCT01748552|454607301|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
126358901|NCT01748552|454607302|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
126358902|NCT01748552|454607303|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358903|NCT01748552|454607304|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358904|NCT01748552|454607305|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358905|NCT00004228|454607308|FG000|Overall Study|Adverse Event|0|||
126358906|NCT00004228|454607309|FG001|Overall Study|Adverse Event|1|||
126358907|NCT00004228|454607310|FG002|Overall Study|Adverse Event|0|||
126358908|NCT00004228|454607311|FG003|Overall Study|Adverse Event|0|||
126358909|NCT00004228|454607312|FG004|Overall Study|Adverse Event|1|||
126358910|NCT00004228|454607313|FG005|Overall Study|Adverse Event|0|||
126358911|NCT00004228|454607314|FG006|Overall Study|Adverse Event|0|||
126358912|NCT00004228|454607308|FG000|Overall Study|Death|0|||
126358913|NCT00004228|454607309|FG001|Overall Study|Death|1|||
126358914|NCT00004228|454607310|FG002|Overall Study|Death|2|||
126358915|NCT00004228|454607311|FG003|Overall Study|Death|0|||
126358916|NCT00004228|454607312|FG004|Overall Study|Death|1|||
126358917|NCT00004228|454607313|FG005|Overall Study|Death|0|||
126358918|NCT00004228|454607314|FG006|Overall Study|Death|0|||
126358919|NCT00004228|454607308|FG000|Overall Study|Lack of Efficacy|1|||
126358920|NCT00004228|454607309|FG001|Overall Study|Lack of Efficacy|6|||
126358921|NCT00004228|454607310|FG002|Overall Study|Lack of Efficacy|5|||
126358922|NCT00004228|454607311|FG003|Overall Study|Lack of Efficacy|3|||
126358923|NCT00004228|454607312|FG004|Overall Study|Lack of Efficacy|9|||
126358924|NCT00004228|454607313|FG005|Overall Study|Lack of Efficacy|8|||
126358925|NCT00004228|454607314|FG006|Overall Study|Lack of Efficacy|4|||
126358926|NCT00004228|454607308|FG000|Overall Study|Lost to Follow-up|0|||
126358927|NCT00004228|454607309|FG001|Overall Study|Lost to Follow-up|0|||
126358928|NCT00004228|454607310|FG002|Overall Study|Lost to Follow-up|1|||
126358929|NCT00004228|454607311|FG003|Overall Study|Lost to Follow-up|0|||
126358930|NCT00004228|454607312|FG004|Overall Study|Lost to Follow-up|0|||
126358931|NCT00004228|454607313|FG005|Overall Study|Lost to Follow-up|0|||
126358932|NCT00004228|454607314|FG006|Overall Study|Lost to Follow-up|0|||
126358933|NCT00004228|454607308|FG000|Overall Study|Physician Decision|1|||
126358934|NCT00004228|454607309|FG001|Overall Study|Physician Decision|0|||
126358935|NCT00004228|454607310|FG002|Overall Study|Physician Decision|3|||
126358936|NCT00004228|454607311|FG003|Overall Study|Physician Decision|2|||
126358937|NCT00004228|454607312|FG004|Overall Study|Physician Decision|1|||
126358938|NCT00004228|454607313|FG005|Overall Study|Physician Decision|1|||
126358939|NCT00004228|454607314|FG006|Overall Study|Physician Decision|1|||
126358940|NCT00004228|454607308|FG000|Overall Study|Protocol Violation|0|||
126358941|NCT00004228|454607309|FG001|Overall Study|Protocol Violation|5|||
126358942|NCT00004228|454607310|FG002|Overall Study|Protocol Violation|2|||
126358943|NCT00004228|454607311|FG003|Overall Study|Protocol Violation|1|||
126358944|NCT00004228|454607312|FG004|Overall Study|Protocol Violation|1|||
126358945|NCT00004228|454607313|FG005|Overall Study|Protocol Violation|2|||
126358946|NCT00004228|454607314|FG006|Overall Study|Protocol Violation|0|||
126358947|NCT00004228|454607308|FG000|Overall Study|Withdrawal by Subject|3|||
126358948|NCT00004228|454607309|FG001|Overall Study|Withdrawal by Subject|0|||
126358949|NCT00004228|454607310|FG002|Overall Study|Withdrawal by Subject|1|||
126358950|NCT00004228|454607311|FG003|Overall Study|Withdrawal by Subject|0|||
126358951|NCT00004228|454607312|FG004|Overall Study|Withdrawal by Subject|2|||
126358952|NCT00004228|454607313|FG005|Overall Study|Withdrawal by Subject|1|||
126358953|NCT00004228|454607314|FG006|Overall Study|Withdrawal by Subject|2|||
126358954|NCT00004228|454607308|FG000|Overall Study|Other|0|||
126358955|NCT00004228|454607309|FG001|Overall Study|Other|0|||
126358956|NCT00004228|454607310|FG002|Overall Study|Other|1|||
126358957|NCT00004228|454607311|FG003|Overall Study|Other|0|||
126358958|NCT00004228|454607312|FG004|Overall Study|Other|0|||
126358959|NCT00004228|454607313|FG005|Overall Study|Other|0|||
126358960|NCT00004228|454607314|FG006|Overall Study|Other|0|||
126358961|NCT00004228|454607308|FG000|Overall Study|ineligible|4|||
126358962|NCT00004228|454607309|FG001|Overall Study|ineligible|2|||
126358963|NCT00004228|454607310|FG002|Overall Study|ineligible|4|||
126358964|NCT00004228|454607311|FG003|Overall Study|ineligible|1|||
126358965|NCT00004228|454607312|FG004|Overall Study|ineligible|1|||
126358966|NCT00004228|454607313|FG005|Overall Study|ineligible|2|||
126358967|NCT00004228|454607314|FG006|Overall Study|ineligible|5|||
126258365|NCT00108082|454235864|FG000|Overall Study|Study Medication Not Tapered|0|||
126258366|NCT00108082|454235865|FG001|Overall Study|Study Medication Not Tapered|1|||
126258367|NCT00108082|454235866|FG002|Overall Study|Study Medication Not Tapered|0|||
126258368|NCT00108082|454235864|FG000|Overall Study|Subject Left Site Location|1|||
126258369|NCT00108082|454235865|FG001|Overall Study|Subject Left Site Location|0|||
126258370|NCT00108082|454235866|FG002|Overall Study|Subject Left Site Location|0|||
126258371|NCT00108082|454235864|FG000|Overall Study|Investigator Not at Site|1|||
126258372|NCT00108082|454235865|FG001|Overall Study|Investigator Not at Site|0|||
126258373|NCT00108082|454235866|FG002|Overall Study|Investigator Not at Site|0|||
126258374|NCT00108082|454235864|FG000|Overall Study|Blood Pressure Not Controlled|1|||
126258375|NCT00108082|454235865|FG001|Overall Study|Blood Pressure Not Controlled|0|||
126258376|NCT00108082|454235866|FG002|Overall Study|Blood Pressure Not Controlled|0|||
126258377|NCT01563237|454235867|FG000|Overall Study|Lost to Follow-up|6|||
126258378|NCT01563237|454235868|FG001|Overall Study|Lost to Follow-up|0|||
126258379|NCT01563237|454235867|FG000|Overall Study|Withdrawal by Subject|1|||
126258380|NCT01563237|454235868|FG001|Overall Study|Withdrawal by Subject|0|||
126258381|NCT01563237|454235867|FG000|Overall Study|Adverse Event|1|||
126258382|NCT01563237|454235868|FG001|Overall Study|Adverse Event|0|||
126258383|NCT01563237|454235867|FG000|Overall Study|Medical Reasons|1|||
126258384|NCT01563237|454235868|FG001|Overall Study|Medical Reasons|0|||
126258385|NCT01563237|454235867|FG000|Overall Study|Death|1|||
126258386|NCT01563237|454235868|FG001|Overall Study|Death|0|||
126258387|NCT02940730|454235874|FG000|Intervention 2|Physician Decision|7|||
126258388|NCT02940730|454235875|FG001|Intervention 2|Physician Decision|0|||
126258389|NCT03036839|454235877|FG000|Overall Study|Adverse Event|0|||
126258390|NCT03036839|454235878|FG001|Overall Study|Adverse Event|0|||
126258391|NCT03036839|454235879|FG002|Overall Study|Adverse Event|1|||
126258392|NCT03036839|454235877|FG000|Overall Study|Death|3|||
126358968|NCT02533674|454607315|FG000|Dose Level I|Progressive disease|1|||
126358969|NCT02533674|454607316|FG001|Dose Level I|Progressive disease|0|||
126358970|NCT02533674|454607317|FG002|Dose Level I|Progressive disease|0|||
126358971|NCT02533674|454607318|FG003|Dose Level I|Progressive disease|0|||
126358972|NCT02533674|454607319|FG004|Dose Level I|Progressive disease|0|||
126358973|NCT02533674|454607320|FG005|Dose Level I|Progressive disease|0|||
126358974|NCT02533674|454607321|FG006|Dose Level I|Progressive disease|0|||
126258393|NCT03036839|454235878|FG001|Overall Study|Death|0|||
126258394|NCT03036839|454235879|FG002|Overall Study|Death|3|||
126258395|NCT03036839|454235877|FG000|Overall Study|Withdrew Consent|0|||
126358975|NCT02533674|454607322|FG007|Dose Level I|Progressive disease|0|||
126358976|NCT02533674|454607315|FG000|Dose Level I|Withdrawal by Subject|1|||
126358977|NCT02533674|454607316|FG001|Dose Level I|Withdrawal by Subject|0|||
126358978|NCT02533674|454607317|FG002|Dose Level I|Withdrawal by Subject|0|||
126358979|NCT02533674|454607318|FG003|Dose Level I|Withdrawal by Subject|0|||
126358980|NCT02533674|454607319|FG004|Dose Level I|Withdrawal by Subject|0|||
126358981|NCT02533674|454607320|FG005|Dose Level I|Withdrawal by Subject|0|||
126358982|NCT02533674|454607321|FG006|Dose Level I|Withdrawal by Subject|0|||
126358983|NCT02533674|454607322|FG007|Dose Level I|Withdrawal by Subject|0|||
126358984|NCT02533674|454607315|FG000|Dose Level I|Physician Decision|1|||
126358985|NCT02533674|454607316|FG001|Dose Level I|Physician Decision|0|||
126358986|NCT02533674|454607317|FG002|Dose Level I|Physician Decision|0|||
126358987|NCT02533674|454607318|FG003|Dose Level I|Physician Decision|0|||
126358988|NCT02533674|454607319|FG004|Dose Level I|Physician Decision|0|||
126358989|NCT02533674|454607320|FG005|Dose Level I|Physician Decision|0|||
126358990|NCT02533674|454607321|FG006|Dose Level I|Physician Decision|0|||
126358991|NCT02533674|454607322|FG007|Dose Level I|Physician Decision|0|||
126358992|NCT02533674|454607315|FG000|Dose Level I|Death|1|||
126358993|NCT02533674|454607316|FG001|Dose Level I|Death|0|||
126358994|NCT02533674|454607317|FG002|Dose Level I|Death|0|||
126358995|NCT02533674|454607318|FG003|Dose Level I|Death|0|||
126358996|NCT02533674|454607319|FG004|Dose Level I|Death|0|||
126358997|NCT02533674|454607320|FG005|Dose Level I|Death|0|||
126358998|NCT02533674|454607321|FG006|Dose Level I|Death|0|||
126358999|NCT02533674|454607322|FG007|Dose Level I|Death|0|||
126359000|NCT02533674|454607315|FG000|Dose Level I|Never Treated|1|||
126359001|NCT02533674|454607316|FG001|Dose Level I|Never Treated|0|||
126359002|NCT02533674|454607317|FG002|Dose Level I|Never Treated|0|||
126359003|NCT02533674|454607318|FG003|Dose Level I|Never Treated|0|||
126359004|NCT02533674|454607319|FG004|Dose Level I|Never Treated|0|||
125879962|NCT02892344|452858717|FG000|Overall Study|Subject/guardian decision|0|||
126359005|NCT02533674|454607320|FG005|Dose Level I|Never Treated|0|||
126359006|NCT02533674|454607321|FG006|Dose Level I|Never Treated|0|||
126359007|NCT02533674|454607322|FG007|Dose Level I|Never Treated|0|||
126359008|NCT02533674|454607315|FG000|Dose Level II|Progressive disease|0|||
126258396|NCT03036839|454235878|FG001|Overall Study|Withdrew Consent|0|||
126258397|NCT03036839|454235879|FG002|Overall Study|Withdrew Consent|1|||
126258398|NCT00412737|454235881|FG000|Overall Study|Death|1|||
126258399|NCT00412737|454235882|FG001|Overall Study|Death|0|||
126258400|NCT00412737|454235881|FG000|Overall Study|Adverse Event|3|||
126258401|NCT00412737|454235882|FG001|Overall Study|Adverse Event|2|||
126258402|NCT00412737|454235881|FG000|Overall Study|Refused Treatment|6|||
126030227|NCT02671903|453408174|FG001|Period 0 (Run-In)|Protocol Violation|0|||
126030228|NCT02671903|453408175|FG002|Period 0 (Run-In)|Protocol Violation|1|||
126030229|NCT02671903|453408173|FG000|Period 0 (Run-In)|Adverse Event|0|||
125879963|NCT02892344|452858718|FG001|Overall Study|Subject/guardian decision|4|||
126030230|NCT02671903|453408174|FG001|Period 0 (Run-In)|Adverse Event|0|||
126030231|NCT02671903|453408175|FG002|Period 0 (Run-In)|Adverse Event|1|||
126030232|NCT02671903|453408173|FG000|Period 0 (Run-In)|Implantation Failure|0|||
126030233|NCT02671903|453408174|FG001|Period 0 (Run-In)|Implantation Failure|0|||
126030234|NCT02671903|453408175|FG002|Period 0 (Run-In)|Implantation Failure|2|||
126030235|NCT02671903|453408173|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
126359009|NCT02533674|454607316|FG001|Dose Level II|Progressive disease|3|||
126359010|NCT02533674|454607317|FG002|Dose Level II|Progressive disease|0|||
126359011|NCT02533674|454607318|FG003|Dose Level II|Progressive disease|0|||
126359012|NCT02533674|454607319|FG004|Dose Level II|Progressive disease|0|||
126359013|NCT02533674|454607320|FG005|Dose Level II|Progressive disease|0|||
126359014|NCT02533674|454607321|FG006|Dose Level II|Progressive disease|0|||
126359015|NCT02533674|454607322|FG007|Dose Level II|Progressive disease|0|||
126359016|NCT02533674|454607315|FG000|Dose Level II|Withdrawal by Subject|0|||
126359017|NCT02533674|454607316|FG001|Dose Level II|Withdrawal by Subject|1|||
126359018|NCT02533674|454607317|FG002|Dose Level II|Withdrawal by Subject|0|||
126359019|NCT02533674|454607318|FG003|Dose Level II|Withdrawal by Subject|0|||
126359020|NCT02533674|454607319|FG004|Dose Level II|Withdrawal by Subject|0|||
126359021|NCT02533674|454607320|FG005|Dose Level II|Withdrawal by Subject|0|||
126359022|NCT02533674|454607321|FG006|Dose Level II|Withdrawal by Subject|0|||
126359023|NCT02533674|454607322|FG007|Dose Level II|Withdrawal by Subject|0|||
126030236|NCT02671903|453408174|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
126030237|NCT02671903|453408175|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
126030238|NCT04258709|453408176|FG000|Overall Study|Lost to Follow-up|10|||
126030239|NCT04258709|453408177|FG001|Overall Study|Lost to Follow-up|4|||
126030240|NCT04258709|453408176|FG000|Overall Study|Withdrawal by Subject|1|||
126030241|NCT04258709|453408177|FG001|Overall Study|Withdrawal by Subject|0|||
126030242|NCT04258709|453408176|FG000|Overall Study|Fetal demise|0|||
126030243|NCT04258709|453408177|FG001|Overall Study|Fetal demise|1|||
126030244|NCT04258709|453408176|FG000|Overall Study|Protocol Violation|1|||
126030245|NCT04258709|453408177|FG001|Overall Study|Protocol Violation|1|||
126030246|NCT05633953|453408178|FG000|Overall Study|Adverse Event|7|||
126030247|NCT05633953|453408178|FG000|Overall Study|Death|30|||
126030248|NCT05633953|453408178|FG000|Overall Study|Lost to Follow-up|1|||
126030249|NCT05633953|453408178|FG000|Overall Study|Osilodrostat discontinued|4|||
126030250|NCT05633953|453408178|FG000|Overall Study|Physician Decision|1|||
126030251|NCT05633953|453408178|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
126030252|NCT05633953|453408178|FG000|Overall Study|Progressive disease|2|||
126030253|NCT03047928|453408179|FG000|Overall Study|Adverse Event|0|||
126030254|NCT03047928|453408180|FG001|Overall Study|Adverse Event|2|||
126030255|NCT03047928|453408181|FG002|Overall Study|Adverse Event|0|||
126030256|NCT03047928|453408179|FG000|Overall Study|Protocol Violation|0|||
126030257|NCT03047928|453408180|FG001|Overall Study|Protocol Violation|1|||
126030258|NCT03047928|453408181|FG002|Overall Study|Protocol Violation|0|||
126030259|NCT03047928|453408179|FG000|Overall Study|included in another protocol|0|||
126030260|NCT03047928|453408180|FG001|Overall Study|included in another protocol|1|||
126030261|NCT03047928|453408181|FG002|Overall Study|included in another protocol|0|||
126030262|NCT02729311|453408182|FG000|Overall Study|Withdrawal by Subject|8|||
126030263|NCT02729311|453408183|FG001|Overall Study|Withdrawal by Subject|2|||
126030264|NCT05324124|453408184|FG000|Period 1|Withdrawal by Subject|1|||
126030265|NCT05324124|453408185|FG001|Period 1|Withdrawal by Subject|0|||
126030266|NCT05324124|453408184|FG000|Period 1|Physician Decision|0|||
126030267|NCT05324124|453408185|FG001|Period 1|Physician Decision|1|||
126030268|NCT04034251|453408186|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
126030269|NCT04034251|453408187|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
126030270|NCT04034251|453408188|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
126030271|NCT02287610|453408189|FG000|Overall Study|Lost to Follow-up|3|||
126030272|NCT02287610|453408189|FG000|Overall Study|Withdrawal by Subject|8|||
126030273|NCT02287610|453408189|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
126030274|NCT05273749|453408191|FG000|Overall Study|Adverse Event|14|||
126030275|NCT05273749|453408192|FG001|Overall Study|Adverse Event|8|||
126030276|NCT05273749|453408191|FG000|Overall Study|Lack of Efficacy|2|||
126030277|NCT05273749|453408192|FG001|Overall Study|Lack of Efficacy|8|||
126030278|NCT05273749|453408191|FG000|Overall Study|Physician Decision|0|||
126030279|NCT05273749|453408192|FG001|Overall Study|Physician Decision|2|||
126030280|NCT05273749|453408191|FG000|Overall Study|Withdrawal by Subject|14|||
126030281|NCT05273749|453408192|FG001|Overall Study|Withdrawal by Subject|16|||
126030282|NCT05273749|453408191|FG000|Overall Study|Lost to Follow-up|10|||
126030283|NCT05273749|453408192|FG001|Overall Study|Lost to Follow-up|10|||
126359024|NCT02533674|454607315|FG000|Dose Level II|Treatment-related AE|0|||
126359025|NCT02533674|454607316|FG001|Dose Level II|Treatment-related AE|1|||
126030284|NCT05273749|453408191|FG000|Overall Study|Pregnancy|1|||
126030285|NCT05273749|453408192|FG001|Overall Study|Pregnancy|0|||
126030286|NCT05273749|453408191|FG000|Overall Study|Non-Compliance|3|||
126030287|NCT05273749|453408192|FG001|Overall Study|Non-Compliance|2|||
126359026|NCT02533674|454607317|FG002|Dose Level II|Treatment-related AE|0|||
125879964|NCT02892344|452858717|FG000|Overall Study|Technical problems|0|||
126359027|NCT02533674|454607318|FG003|Dose Level II|Treatment-related AE|0|||
126359028|NCT02533674|454607319|FG004|Dose Level II|Treatment-related AE|0|||
126030288|NCT05273749|453408191|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
126030289|NCT05273749|453408192|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
126030290|NCT04956861|453408193|FG000|Overall Study|Withdrawal by Subject|4|||
126030291|NCT04956861|453408194|FG001|Overall Study|Withdrawal by Subject|4|||
126030292|NCT04956861|453408195|FG002|Overall Study|Withdrawal by Subject|2|||
126030293|NCT04956861|453408193|FG000|Overall Study|Physician Decision|4|||
126030294|NCT04956861|453408194|FG001|Overall Study|Physician Decision|5|||
126030295|NCT04956861|453408195|FG002|Overall Study|Physician Decision|1|||
126030296|NCT05247489|453408198|FG000|Overall Study|Lost to Follow-up|5|||
126030297|NCT05247489|453408199|FG001|Overall Study|Lost to Follow-up|1|||
126030298|NCT05247489|453408198|FG000|Overall Study|Withdrawal by Subject|6|||
126030299|NCT05247489|453408199|FG001|Overall Study|Withdrawal by Subject|7|||
126030300|NCT05247489|453408198|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
126030301|NCT05247489|453408199|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
126030302|NCT05247489|453408198|FG000|Overall Study|Left Country|1|||
126030303|NCT05247489|453408199|FG001|Overall Study|Left Country|0|||
126030304|NCT05247489|453408198|FG000|Overall Study|Noncompliance with Investigational Product|1|||
126030305|NCT05247489|453408199|FG001|Overall Study|Noncompliance with Investigational Product|0|||
126030306|NCT05247489|453408198|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
126030307|NCT05247489|453408199|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
126030308|NCT03771898|453408200|FG000|Overall Study|Adverse Event|1|||
126030309|NCT03771898|453408201|FG001|Overall Study|Adverse Event|0|||
126030310|NCT03771898|453408202|FG002|Overall Study|Adverse Event|0|||
126030311|NCT03771898|453408203|FG003|Overall Study|Adverse Event|0|||
126030312|NCT03771898|453408204|FG004|Overall Study|Adverse Event|0|||
126030313|NCT03771898|453408200|FG000|Overall Study|Lost to Follow-up|1|||
126030314|NCT03771898|453408201|FG001|Overall Study|Lost to Follow-up|1|||
126030315|NCT03771898|453408202|FG002|Overall Study|Lost to Follow-up|1|||
126030316|NCT03771898|453408203|FG003|Overall Study|Lost to Follow-up|0|||
126030317|NCT03771898|453408204|FG004|Overall Study|Lost to Follow-up|0|||
126030318|NCT03771898|453408200|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126030319|NCT03771898|453408201|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126030320|NCT03771898|453408202|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126030321|NCT03771898|453408203|FG003|Overall Study|Withdrawal by parent/guardian|0|||
126030322|NCT03771898|453408204|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126030323|NCT03771898|453408200|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
126030324|NCT03771898|453408201|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
126030325|NCT03771898|453408202|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
126030326|NCT03771898|453408203|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
126030327|NCT03771898|453408204|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
126030328|NCT04541706|453408205|FG000|Overall Study|Withdrawal by Subject|3|||
126030329|NCT04541706|453408205|FG000|Overall Study|Progressive disease|33|||
126030330|NCT04541706|453408205|FG000|Overall Study|Physician Decision|1|||
126030331|NCT04541706|453408205|FG000|Overall Study|Lost to Follow-up|2|||
126030332|NCT04541706|453408205|FG000|Overall Study|Death|5|||
126030333|NCT04541706|453408205|FG000|Overall Study|Adverse Event|1|||
126030334|NCT05563246|453408206|FG000|Overall Study|Withdrawal by Subject|1|||
126030335|NCT05563246|453408207|FG001|Overall Study|Withdrawal by Subject|2|||
126030336|NCT05563246|453408208|FG002|Overall Study|Withdrawal by Subject|0|||
126030337|NCT05563246|453408209|FG003|Overall Study|Withdrawal by Subject|0|||
126030338|NCT05563246|453408206|FG000|Overall Study|Protocol Deviation|0|||
126030339|NCT05563246|453408207|FG001|Overall Study|Protocol Deviation|1|||
126030340|NCT05563246|453408208|FG002|Overall Study|Protocol Deviation|0|||
126030341|NCT05563246|453408209|FG003|Overall Study|Protocol Deviation|0|||
126030342|NCT05563246|453408206|FG000|Overall Study|Physician Decision|0|||
126030343|NCT05563246|453408207|FG001|Overall Study|Physician Decision|1|||
126030344|NCT05563246|453408208|FG002|Overall Study|Physician Decision|0|||
126030345|NCT05563246|453408209|FG003|Overall Study|Physician Decision|0|||
126030346|NCT05563246|453408206|FG000|Overall Study|Adverse Event|0|||
126030347|NCT05563246|453408207|FG001|Overall Study|Adverse Event|0|||
126030348|NCT05563246|453408208|FG002|Overall Study|Adverse Event|2|||
126030349|NCT05563246|453408209|FG003|Overall Study|Adverse Event|0|||
126030350|NCT05563246|453408206|FG000|Overall Study|Lost to Follow-up|0|||
126030351|NCT05563246|453408207|FG001|Overall Study|Lost to Follow-up|0|||
126030352|NCT05563246|453408208|FG002|Overall Study|Lost to Follow-up|1|||
126030353|NCT05563246|453408209|FG003|Overall Study|Lost to Follow-up|0|||
126030354|NCT01416831|453408212|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
126030355|NCT01416831|453408213|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
126030356|NCT05215314|453408214|FG000|Overall Study|Lost to Follow-up|2|||
126030357|NCT05215314|453408215|FG001|Overall Study|Lost to Follow-up|2|||
126030358|NCT05215314|453408214|FG000|Overall Study|Withdrawal by Subject|2|||
126030359|NCT05215314|453408215|FG001|Overall Study|Withdrawal by Subject|0|||
126030360|NCT05215314|453408214|FG000|Overall Study|Physician Decision|1|||
126030361|NCT05215314|453408215|FG001|Overall Study|Physician Decision|0|||
126258403|NCT00412737|454235882|FG001|Overall Study|Refused Treatment|2|||
126258404|NCT00412737|454235881|FG000|Overall Study|Failure to Return|6|||
126258405|NCT00412737|454235882|FG001|Overall Study|Failure to Return|2|||
126258406|NCT01064531|454235884|FG000|Overall Study|Lost to Follow-up|0|||
126258407|NCT01064531|454235885|FG001|Overall Study|Lost to Follow-up|2|||
126258408|NCT01064531|454235884|FG000|Overall Study|Physician Decision|0|||
126258409|NCT01064531|454235885|FG001|Overall Study|Physician Decision|1|||
126258410|NCT01064531|454235884|FG000|Overall Study|Withdrawal by Subject|2|||
126258411|NCT01064531|454235885|FG001|Overall Study|Withdrawal by Subject|2|||
126258412|NCT01064531|454235884|FG000|Overall Study|Revision due to femoral stem loosening|1|||
126258413|NCT01064531|454235885|FG001|Overall Study|Revision due to femoral stem loosening|0|||
126258414|NCT01064531|454235884|FG000|Overall Study|Revision due to dislocation|0|||
126258415|NCT01064531|454235885|FG001|Overall Study|Revision due to dislocation|1|||
126258416|NCT01064531|454235884|FG000|Overall Study|Death|0|||
126258417|NCT01064531|454235885|FG001|Overall Study|Death|1|||
126258418|NCT02618382|454235891|FG000|Overall Study|Physician Decision|1|||
126258419|NCT02618382|454235891|FG000|Overall Study|Withdrawal by Subject|1|||
126258420|NCT02618382|454235891|FG000|Overall Study|Protocol Violation|1|||
126258421|NCT03843125|454235892|FG000|Overall Study|Adverse Event|17|||
126258422|NCT03843125|454235893|FG001|Overall Study|Adverse Event|13|||
126258423|NCT03843125|454235894|FG002|Overall Study|Adverse Event|5|||
126258424|NCT03843125|454235895|FG003|Overall Study|Adverse Event|9|||
126258425|NCT03843125|454235892|FG000|Overall Study|Death|0|||
126258426|NCT03843125|454235893|FG001|Overall Study|Death|6|||
126030362|NCT04294225|453408220|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
126030363|NCT04294225|453408220|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
126030364|NCT04294225|453408220|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
126030365|NCT04294225|453408220|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
126030366|NCT04294225|453408220|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
126030367|NCT04812535|453408221|FG000|Overall Study|Withdrawal by Subject|0|||
126258427|NCT03843125|454235894|FG002|Overall Study|Death|2|||
126258428|NCT03843125|454235895|FG003|Overall Study|Death|0|||
126258429|NCT03843125|454235892|FG000|Overall Study|Lack of Efficacy|14|||
126258430|NCT03843125|454235893|FG001|Overall Study|Lack of Efficacy|11|||
126258431|NCT03843125|454235894|FG002|Overall Study|Lack of Efficacy|9|||
126258432|NCT03843125|454235895|FG003|Overall Study|Lack of Efficacy|4|||
126030368|NCT04812535|453408222|FG001|Overall Study|Withdrawal by Subject|0|||
126030369|NCT04812535|453408223|FG002|Overall Study|Withdrawal by Subject|0|||
126030370|NCT04812535|453408224|FG003|Overall Study|Withdrawal by Subject|1|||
126030371|NCT04812535|453408221|FG000|Overall Study|Death|7|||
126030372|NCT04812535|453408222|FG001|Overall Study|Death|2|||
126030373|NCT04812535|453408223|FG002|Overall Study|Death|4|||
126030374|NCT04812535|453408224|FG003|Overall Study|Death|1|||
126030375|NCT04812535|453408221|FG000|Overall Study|Due to premature study termination by sponsor|2|||
126030376|NCT04812535|453408222|FG001|Overall Study|Due to premature study termination by sponsor|0|||
126030377|NCT04812535|453408223|FG002|Overall Study|Due to premature study termination by sponsor|1|||
126030378|NCT04812535|453408224|FG003|Overall Study|Due to premature study termination by sponsor|3|||
126030379|NCT03336333|453408225|FG000|Overall Study|Remained on study at time of data cut-off|202|||
126030380|NCT03336333|453408226|FG001|Overall Study|Remained on study at time of data cut-off|219|||
126030381|NCT03336333|453408227|FG002|Overall Study|Remained on study at time of data cut-off|102|||
126030382|NCT03336333|453408225|FG000|Overall Study|Death|14|||
126030383|NCT03336333|453408226|FG001|Overall Study|Death|16|||
126030384|NCT03336333|453408227|FG002|Overall Study|Death|8|||
126030385|NCT03336333|453408225|FG000|Overall Study|Withdrawal by Subject|16|||
126030386|NCT03336333|453408226|FG001|Overall Study|Withdrawal by Subject|5|||
126030387|NCT03336333|453408227|FG002|Overall Study|Withdrawal by Subject|1|||
126030388|NCT03336333|453408225|FG000|Overall Study|Physician Decision|5|||
126030389|NCT03336333|453408226|FG001|Overall Study|Physician Decision|1|||
126030390|NCT03336333|453408227|FG002|Overall Study|Physician Decision|0|||
126030391|NCT03336333|453408225|FG000|Overall Study|Lost to Follow-up|1|||
126030392|NCT03336333|453408226|FG001|Overall Study|Lost to Follow-up|0|||
126030393|NCT03336333|453408227|FG002|Overall Study|Lost to Follow-up|0|||
126030394|NCT03623321|453408234|FG000|Overall Study|Adverse Event|32|||
126030395|NCT03623321|453408234|FG000|Overall Study|Death|9|||
126030396|NCT03623321|453408234|FG000|Overall Study|Lack of Efficacy|9|||
126030397|NCT03623321|453408234|FG000|Overall Study|Lost to Follow-up|6|||
126030398|NCT03623321|453408234|FG000|Overall Study|Noncompliance with study drug|6|||
126030399|NCT03623321|453408234|FG000|Overall Study|Use of prohibited medication|3|||
126030400|NCT03623321|453408234|FG000|Overall Study|Physician Decision|5|||
126030401|NCT03623321|453408234|FG000|Overall Study|Protocol Violation|1|||
126030402|NCT03623321|453408234|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
126030403|NCT03623321|453408234|FG000|Overall Study|Not further specified|43|||
126030404|NCT01785719|453408236|FG000|4-week Baseline Evaluation|Physician Decision|1|||
126030405|NCT01785719|453408237|FG001|4-week Baseline Evaluation|Physician Decision|0|||
126030406|NCT01785719|453408236|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
126030407|NCT01785719|453408237|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
126030408|NCT01785719|453408236|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
126030409|NCT01785719|453408237|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
126030410|NCT01785719|453408236|FG000|4-week Baseline Evaluation|Pregnancy|0|||
126030411|NCT01785719|453408237|FG001|4-week Baseline Evaluation|Pregnancy|2|||
126030412|NCT01785719|453408236|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
126030413|NCT01785719|453408237|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
126030414|NCT01785719|453408236|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
126030415|NCT01785719|453408237|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
126030416|NCT01785719|453408236|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
126030417|NCT01785719|453408237|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
126030418|NCT01785719|453408236|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
126030419|NCT01785719|453408237|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
126030420|NCT01785719|453408236|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
126030421|NCT01785719|453408237|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
126030422|NCT01785719|453408236|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
126030423|NCT01785719|453408237|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
126030424|NCT01785719|453408236|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
126030425|NCT01785719|453408237|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
126030426|NCT01785719|453408236|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
125879965|NCT02892344|452858718|FG001|Overall Study|Technical problems|1|||
125879966|NCT01520506|452858719|FG000|Overall Study|Missed Visit|4|||
125879967|NCT01520506|452858719|FG000|Overall Study|Lost to Follow-up|1|||
125879968|NCT01520506|452858719|FG000|Overall Study|Withdrawal by Subject|1|||
125879969|NCT00425269|452858720|FG000|Overall Study|Pregnancy|5|||
125879970|NCT00425269|452858721|FG001|Overall Study|Pregnancy|7|||
125879971|NCT00425269|452858720|FG000|Overall Study|Lost to Follow-up|9|||
125879972|NCT00425269|452858721|FG001|Overall Study|Lost to Follow-up|9|||
125879973|NCT00425269|452858720|FG000|Overall Study|moved or medical reason|5|||
125879974|NCT00425269|452858721|FG001|Overall Study|moved or medical reason|4|||
125879975|NCT01084655|452858726|FG000|Overall Study|Radiographic disease progression|3|||
125879976|NCT01084655|452858727|FG001|Overall Study|Radiographic disease progression|2|||
125879977|NCT01084655|452858728|FG002|Overall Study|Radiographic disease progression|8|||
125879978|NCT01084655|452858726|FG000|Overall Study|Withdrawal by Subject|1|||
126030427|NCT01785719|453408237|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
126030428|NCT01785719|453408236|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
126258433|NCT03843125|454235892|FG000|Overall Study|Lost to Follow-up|3|||
126258434|NCT03843125|454235893|FG001|Overall Study|Lost to Follow-up|4|||
126258435|NCT03843125|454235894|FG002|Overall Study|Lost to Follow-up|0|||
126258436|NCT03843125|454235895|FG003|Overall Study|Lost to Follow-up|2|||
126258437|NCT03843125|454235892|FG000|Overall Study|Other|12|||
126258438|NCT03843125|454235893|FG001|Overall Study|Other|14|||
126258439|NCT03843125|454235894|FG002|Overall Study|Other|3|||
126258440|NCT03843125|454235895|FG003|Overall Study|Other|4|||
126258441|NCT03843125|454235892|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
126258442|NCT03843125|454235893|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
126258443|NCT03843125|454235894|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
126258444|NCT03843125|454235895|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
126258445|NCT03843125|454235892|FG000|Overall Study|Study Terminated by Sponsor|318|||
126258446|NCT03843125|454235893|FG001|Overall Study|Study Terminated by Sponsor|318|||
126258447|NCT03843125|454235894|FG002|Overall Study|Study Terminated by Sponsor|163|||
126258448|NCT03843125|454235895|FG003|Overall Study|Study Terminated by Sponsor|163|||
126258449|NCT03843125|454235892|FG000|Overall Study|Withdrawal by Subject|23|||
126258450|NCT03843125|454235893|FG001|Overall Study|Withdrawal by Subject|12|||
126258451|NCT03843125|454235894|FG002|Overall Study|Withdrawal by Subject|6|||
126258452|NCT03843125|454235895|FG003|Overall Study|Withdrawal by Subject|9|||
126258453|NCT03843125|454235892|FG000|Overall Study|Missing data|0|||
126258454|NCT03843125|454235893|FG001|Overall Study|Missing data|1|||
126258455|NCT03843125|454235894|FG002|Overall Study|Missing data|1|||
126258456|NCT03843125|454235895|FG003|Overall Study|Missing data|0|||
126258457|NCT03173560|454235896|FG000|Overall Study|Death|70|||
126258458|NCT03173560|454235897|FG001|Overall Study|Death|60|||
126258459|NCT03173560|454235896|FG000|Overall Study|Lost to Follow-up|1|||
126258460|NCT03173560|454235897|FG001|Overall Study|Lost to Follow-up|4|||
126258461|NCT03173560|454235896|FG000|Overall Study|Withdrawal by Subject|10|||
126258462|NCT03173560|454235897|FG001|Overall Study|Withdrawal by Subject|5|||
126258463|NCT03173560|454235896|FG000|Overall Study|Other|0|||
126258464|NCT03173560|454235897|FG001|Overall Study|Other|1|||
125879979|NCT01084655|452858727|FG001|Overall Study|Withdrawal by Subject|0|||
125879980|NCT01084655|452858728|FG002|Overall Study|Withdrawal by Subject|4|||
125879981|NCT01084655|452858726|FG000|Overall Study|Adverse Event|2|||
125879982|NCT01084655|452858727|FG001|Overall Study|Adverse Event|1|||
126030429|NCT01785719|453408237|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
126030430|NCT01785719|453408236|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
125879983|NCT01084655|452858728|FG002|Overall Study|Adverse Event|2|||
126030431|NCT01785719|453408237|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
126030432|NCT01785719|453408236|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
126030433|NCT01785719|453408237|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
126030434|NCT05368103|453408248|FG000|Overall Study|Withdrawal by Subject|4|||
126030435|NCT05368103|453408248|FG000|Overall Study|Lost to Follow-up|1|||
126030436|NCT05368103|453408248|FG000|Overall Study|Lack of Efficacy|3|||
126030437|NCT05763823|453408254|FG000|Overall Study|Death|6|||
125879984|NCT01084655|452858726|FG000|Overall Study|Other|0|||
125879985|NCT01084655|452858727|FG001|Overall Study|Other|3|||
125879986|NCT01084655|452858728|FG002|Overall Study|Other|2|||
126030438|NCT05763823|453408254|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126030439|NCT05763823|453408254|FG000|Overall Study|Withdrawal by Subject|6|||
126096067|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
126258465|NCT04254809|454235898|FG000|Overall Study|Lost to Follow-up|5|||
126258466|NCT04254809|454235899|FG001|Overall Study|Lost to Follow-up|10|||
126258467|NCT03023137|454235900|FG000|Overall Study|Multiple pregnancy|2|||
126258468|NCT03023137|454235901|FG001|Overall Study|Multiple pregnancy|4|||
126258469|NCT03023137|454235900|FG000|Overall Study|Lost to Follow-up|1|||
126258470|NCT03023137|454235901|FG001|Overall Study|Lost to Follow-up|1|||
126258471|NCT03023137|454235900|FG000|Overall Study|Protocol Violation|0|||
126258472|NCT03023137|454235901|FG001|Overall Study|Protocol Violation|4|||
126258473|NCT03023137|454235900|FG000|Overall Study|Lost the baby in a car accident|1|||
126258474|NCT03023137|454235901|FG001|Overall Study|Lost the baby in a car accident|0|||
126258475|NCT02795676|454235902|FG000|Overall Study|Adverse Event|2|||
126258476|NCT02795676|454235903|FG001|Overall Study|Adverse Event|0|||
126258477|NCT02795676|454235902|FG000|Overall Study|Withdrawal by Subject|3|||
126258478|NCT02795676|454235903|FG001|Overall Study|Withdrawal by Subject|1|||
126258479|NCT02608476|454235904|FG000|Overall Study|Withdrawal by Subject|30|||
126258480|NCT02608476|454235905|FG001|Overall Study|Withdrawal by Subject|37|||
126258481|NCT02608476|454235904|FG000|Overall Study|Lost to Follow-up|24|||
126258482|NCT02608476|454235905|FG001|Overall Study|Lost to Follow-up|24|||
126258483|NCT02608476|454235904|FG000|Overall Study|Adverse Event|2|||
126258484|NCT02608476|454235905|FG001|Overall Study|Adverse Event|8|||
126258485|NCT02608476|454235904|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
126258486|NCT02608476|454235905|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
126258487|NCT02608476|454235904|FG000|Overall Study|Noncompliance with treatment|1|||
126258488|NCT02608476|454235905|FG001|Overall Study|Noncompliance with treatment|5|||
126258489|NCT02608476|454235904|FG000|Overall Study|Lack of Efficacy|3|||
126258490|NCT02608476|454235905|FG001|Overall Study|Lack of Efficacy|1|||
126258491|NCT02608476|454235904|FG000|Overall Study|Other|0|||
126258492|NCT02608476|454235905|FG001|Overall Study|Other|1|||
126258493|NCT02608476|454235904|FG000|Overall Study|Physician Decision|1|||
126258494|NCT02608476|454235905|FG001|Overall Study|Physician Decision|0|||
126258495|NCT02608476|454235904|FG000|Overall Study|Pregnancy|0|||
126258496|NCT02608476|454235905|FG001|Overall Study|Pregnancy|1|||
126258497|NCT02608476|454235904|FG000|Overall Study|Progressive disease|1|||
126258498|NCT02608476|454235905|FG001|Overall Study|Progressive disease|0|||
126258499|NCT00605176|454235906|FG000|Overall Study|Adverse Event|2|||
126258500|NCT00605176|454235907|FG001|Overall Study|Adverse Event|1|||
126258501|NCT00605176|454235908|FG002|Overall Study|Adverse Event|3|||
126258502|NCT00605176|454235906|FG000|Overall Study|Withdrawal by Subject|4|||
126258503|NCT00605176|454235907|FG001|Overall Study|Withdrawal by Subject|2|||
126258504|NCT00605176|454235908|FG002|Overall Study|Withdrawal by Subject|4|||
126258505|NCT00605176|454235906|FG000|Overall Study|Lost to Follow-up|2|||
126258506|NCT00605176|454235907|FG001|Overall Study|Lost to Follow-up|2|||
126258507|NCT00605176|454235908|FG002|Overall Study|Lost to Follow-up|1|||
126258508|NCT00605176|454235906|FG000|Overall Study|Non-complicance with study procedures|1|||
126258509|NCT00605176|454235907|FG001|Overall Study|Non-complicance with study procedures|0|||
126258510|NCT00605176|454235908|FG002|Overall Study|Non-complicance with study procedures|0|||
126030440|NCT05371652|453408258|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
126258511|NCT00605176|454235906|FG000|Overall Study|Use of concomitant therapy|1|||
126258512|NCT00605176|454235907|FG001|Overall Study|Use of concomitant therapy|0|||
126258513|NCT00605176|454235908|FG002|Overall Study|Use of concomitant therapy|1|||
126258514|NCT00605176|454235906|FG000|Overall Study|Other (not due to AE)|1|||
126258515|NCT00605176|454235907|FG001|Overall Study|Other (not due to AE)|1|||
126258516|NCT00605176|454235908|FG002|Overall Study|Other (not due to AE)|0|||
126258517|NCT04253236|454235920|FG000|Overall Study|Adverse Event|1|||
126258518|NCT04253236|454235921|FG001|Overall Study|Adverse Event|0|||
126258519|NCT04253236|454235920|FG000|Overall Study|Safety Concerns|1|||
125879987|NCT01084655|452858726|FG000|Overall Study|Symptomatic deterioration|0|||
125879988|NCT01084655|452858727|FG001|Overall Study|Symptomatic deterioration|0|||
125879989|NCT01084655|452858728|FG002|Overall Study|Symptomatic deterioration|2|||
125879990|NCT01084655|452858726|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
125879991|NCT01084655|452858727|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
125879992|NCT01084655|452858728|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
125879993|NCT00535496|452858729|FG000|Overall Study|Lost to Follow-up|0|||
125879994|NCT00535496|452858730|FG001|Overall Study|Lost to Follow-up|1|||
125879995|NCT00535496|452858731|FG002|Overall Study|Lost to Follow-up|0|||
125879996|NCT00535496|452858732|FG003|Overall Study|Lost to Follow-up|0|||
125879997|NCT00535496|452858729|FG000|Overall Study|Not treated with sugammadex|0|||
125879998|NCT00535496|452858730|FG001|Overall Study|Not treated with sugammadex|1|||
125879999|NCT00535496|452858731|FG002|Overall Study|Not treated with sugammadex|0|||
125880000|NCT00535496|452858732|FG003|Overall Study|Not treated with sugammadex|0|||
125880001|NCT02326155|452858734|FG000|Overall Study|Adverse Event|21|||
125880002|NCT02326155|452858735|FG001|Overall Study|Adverse Event|5|||
125880003|NCT02326155|452858734|FG000|Overall Study|Death|3|||
125880004|NCT02326155|452858735|FG001|Overall Study|Death|0|||
125880005|NCT02326155|452858734|FG000|Overall Study|Lack of Efficacy|49|||
125880006|NCT02326155|452858735|FG001|Overall Study|Lack of Efficacy|5|||
125880007|NCT02326155|452858734|FG000|Overall Study|Lost to Follow-up|14|||
125880008|NCT02326155|452858735|FG001|Overall Study|Lost to Follow-up|3|||
125880009|NCT02326155|452858734|FG000|Overall Study|Protocol Violation|2|||
125880010|NCT02326155|452858735|FG001|Overall Study|Protocol Violation|0|||
125880011|NCT02326155|452858734|FG000|Overall Study|Withdrawal by Subject|34|||
126030441|NCT05371652|453408258|FG000|Overall Study|Withdrawal by Subject|12|||
126030442|NCT05371652|453408258|FG000|Overall Study|Adverse Event|1|||
126258520|NCT04253236|454235921|FG001|Overall Study|Safety Concerns|0|||
126258521|NCT04253236|454235920|FG000|Overall Study|Study Terminated by Sponsor|1|||
126258522|NCT04253236|454235921|FG001|Overall Study|Study Terminated by Sponsor|0|||
126258523|NCT00587431|454235922|FG000|Overall Study|Adverse Event|1|||
126258524|NCT00587431|454235923|FG001|Overall Study|Adverse Event|0|||
126258525|NCT00587431|454235922|FG000|Overall Study|Withdrawal by Subject|0|||
126258526|NCT00587431|454235923|FG001|Overall Study|Withdrawal by Subject|1|||
126258527|NCT02169791|454235924|FG000|Overall Study|Death|6|||
126359029|NCT02533674|454607320|FG005|Dose Level II|Treatment-related AE|0|||
126359030|NCT02533674|454607321|FG006|Dose Level II|Treatment-related AE|0|||
126359031|NCT02533674|454607322|FG007|Dose Level II|Treatment-related AE|0|||
126359032|NCT02533674|454607315|FG000|Dose Level II|Physician Decision|0|||
126359033|NCT02533674|454607316|FG001|Dose Level II|Physician Decision|1|||
126359034|NCT02533674|454607317|FG002|Dose Level II|Physician Decision|0|||
126359035|NCT02533674|454607318|FG003|Dose Level II|Physician Decision|0|||
126359036|NCT02533674|454607319|FG004|Dose Level II|Physician Decision|0|||
126359037|NCT02533674|454607320|FG005|Dose Level II|Physician Decision|0|||
126359038|NCT02533674|454607321|FG006|Dose Level II|Physician Decision|0|||
126359039|NCT02533674|454607322|FG007|Dose Level II|Physician Decision|0|||
126359040|NCT02533674|454607315|FG000|Dose Level II|Non-treatment-related AE|0|||
126359041|NCT02533674|454607316|FG001|Dose Level II|Non-treatment-related AE|1|||
126359042|NCT02533674|454607317|FG002|Dose Level II|Non-treatment-related AE|0|||
126359043|NCT02533674|454607318|FG003|Dose Level II|Non-treatment-related AE|0|||
126359044|NCT02533674|454607319|FG004|Dose Level II|Non-treatment-related AE|0|||
126359045|NCT02533674|454607320|FG005|Dose Level II|Non-treatment-related AE|0|||
126359046|NCT02533674|454607321|FG006|Dose Level II|Non-treatment-related AE|0|||
126359047|NCT02533674|454607322|FG007|Dose Level II|Non-treatment-related AE|0|||
126359048|NCT02533674|454607315|FG000|Dose Level III|Progressive disease|0|||
126359049|NCT02533674|454607316|FG001|Dose Level III|Progressive disease|0|||
126359050|NCT02533674|454607317|FG002|Dose Level III|Progressive disease|2|||
126359051|NCT02533674|454607318|FG003|Dose Level III|Progressive disease|0|||
126359052|NCT02533674|454607319|FG004|Dose Level III|Progressive disease|0|||
126359053|NCT02533674|454607320|FG005|Dose Level III|Progressive disease|0|||
126359054|NCT02533674|454607321|FG006|Dose Level III|Progressive disease|0|||
126359055|NCT02533674|454607322|FG007|Dose Level III|Progressive disease|0|||
126359056|NCT02533674|454607315|FG000|Dose Level III|Withdrawal by Subject|0|||
125880012|NCT02326155|452858735|FG001|Overall Study|Withdrawal by Subject|11|||
126359057|NCT02533674|454607316|FG001|Dose Level III|Withdrawal by Subject|0|||
125880013|NCT02326155|452858734|FG000|Overall Study|Disease progression|37|||
125880014|NCT02326155|452858735|FG001|Overall Study|Disease progression|4|||
125880015|NCT02326155|452858734|FG000|Overall Study|Study close|188|||
125880016|NCT02326155|452858735|FG001|Overall Study|Study close|21|||
125880017|NCT02326155|452858734|FG000|Overall Study|except for study close|46|||
126030443|NCT05371652|453408258|FG000|Overall Study|Other|11|||
126258528|NCT02169791|454235924|FG000|Overall Study|patient withdrew consent|1|||
126258529|NCT03566238|454235925|FG000|Overall Study|Adverse Event|0|||
126258530|NCT03566238|454235926|FG001|Overall Study|Adverse Event|1|||
126359058|NCT02533674|454607317|FG002|Dose Level III|Withdrawal by Subject|1|||
126359059|NCT02533674|454607318|FG003|Dose Level III|Withdrawal by Subject|0|||
126359060|NCT02533674|454607319|FG004|Dose Level III|Withdrawal by Subject|0|||
126359061|NCT02533674|454607320|FG005|Dose Level III|Withdrawal by Subject|0|||
126359062|NCT02533674|454607321|FG006|Dose Level III|Withdrawal by Subject|0|||
126359063|NCT02533674|454607322|FG007|Dose Level III|Withdrawal by Subject|0|||
126359064|NCT02533674|454607315|FG000|Dose Level III|Treatment-related AE|0|||
126359065|NCT02533674|454607316|FG001|Dose Level III|Treatment-related AE|0|||
126359066|NCT02533674|454607317|FG002|Dose Level III|Treatment-related AE|1|||
126359067|NCT02533674|454607318|FG003|Dose Level III|Treatment-related AE|0|||
126359068|NCT02533674|454607319|FG004|Dose Level III|Treatment-related AE|0|||
126359069|NCT02533674|454607320|FG005|Dose Level III|Treatment-related AE|0|||
126359070|NCT02533674|454607321|FG006|Dose Level III|Treatment-related AE|0|||
126359071|NCT02533674|454607322|FG007|Dose Level III|Treatment-related AE|0|||
126359072|NCT02533674|454607315|FG000|Dose Level IV|Progressive disease|0|||
126359073|NCT02533674|454607316|FG001|Dose Level IV|Progressive disease|0|||
126359074|NCT02533674|454607317|FG002|Dose Level IV|Progressive disease|0|||
126359075|NCT02533674|454607318|FG003|Dose Level IV|Progressive disease|3|||
126359076|NCT02533674|454607319|FG004|Dose Level IV|Progressive disease|0|||
126359077|NCT02533674|454607320|FG005|Dose Level IV|Progressive disease|0|||
126359078|NCT02533674|454607321|FG006|Dose Level IV|Progressive disease|0|||
126359079|NCT02533674|454607322|FG007|Dose Level IV|Progressive disease|0|||
126359080|NCT02533674|454607315|FG000|Dose Level IV|Withdrawal by Subject|0|||
126359081|NCT02533674|454607316|FG001|Dose Level IV|Withdrawal by Subject|0|||
126359082|NCT02533674|454607317|FG002|Dose Level IV|Withdrawal by Subject|0|||
126359083|NCT02533674|454607318|FG003|Dose Level IV|Withdrawal by Subject|1|||
126359084|NCT02533674|454607319|FG004|Dose Level IV|Withdrawal by Subject|0|||
126359085|NCT02533674|454607320|FG005|Dose Level IV|Withdrawal by Subject|0|||
126359086|NCT02533674|454607321|FG006|Dose Level IV|Withdrawal by Subject|0|||
126359087|NCT02533674|454607322|FG007|Dose Level IV|Withdrawal by Subject|0|||
126359088|NCT02533674|454607315|FG000|Dose Level IV|Physician Decision|0|||
126359089|NCT02533674|454607316|FG001|Dose Level IV|Physician Decision|0|||
126359090|NCT02533674|454607317|FG002|Dose Level IV|Physician Decision|0|||
126359091|NCT02533674|454607318|FG003|Dose Level IV|Physician Decision|1|||
126359092|NCT02533674|454607319|FG004|Dose Level IV|Physician Decision|0|||
126359093|NCT02533674|454607320|FG005|Dose Level IV|Physician Decision|0|||
126359094|NCT02533674|454607321|FG006|Dose Level IV|Physician Decision|0|||
126359095|NCT02533674|454607322|FG007|Dose Level IV|Physician Decision|0|||
126359096|NCT02533674|454607315|FG000|Dose Level V|Progressive disease|0|||
126359097|NCT02533674|454607316|FG001|Dose Level V|Progressive disease|0|||
126359098|NCT02533674|454607317|FG002|Dose Level V|Progressive disease|0|||
126359099|NCT02533674|454607318|FG003|Dose Level V|Progressive disease|0|||
126359100|NCT02533674|454607319|FG004|Dose Level V|Progressive disease|3|||
126359101|NCT02533674|454607320|FG005|Dose Level V|Progressive disease|0|||
126359102|NCT02533674|454607321|FG006|Dose Level V|Progressive disease|0|||
126359103|NCT02533674|454607322|FG007|Dose Level V|Progressive disease|0|||
126359104|NCT02533674|454607315|FG000|Dose Level V|Withdrawal by Subject|0|||
126359105|NCT02533674|454607316|FG001|Dose Level V|Withdrawal by Subject|0|||
126359106|NCT02533674|454607317|FG002|Dose Level V|Withdrawal by Subject|0|||
126359107|NCT02533674|454607318|FG003|Dose Level V|Withdrawal by Subject|0|||
126359108|NCT02533674|454607319|FG004|Dose Level V|Withdrawal by Subject|1|||
126359109|NCT02533674|454607320|FG005|Dose Level V|Withdrawal by Subject|0|||
126359110|NCT02533674|454607321|FG006|Dose Level V|Withdrawal by Subject|0|||
126359111|NCT02533674|454607322|FG007|Dose Level V|Withdrawal by Subject|0|||
126359112|NCT02533674|454607315|FG000|Dose Level V|Physician Decision|0|||
126359113|NCT02533674|454607316|FG001|Dose Level V|Physician Decision|0|||
126359114|NCT02533674|454607317|FG002|Dose Level V|Physician Decision|0|||
126359115|NCT02533674|454607318|FG003|Dose Level V|Physician Decision|0|||
126359116|NCT02533674|454607319|FG004|Dose Level V|Physician Decision|1|||
126359117|NCT02533674|454607320|FG005|Dose Level V|Physician Decision|0|||
126359118|NCT02533674|454607321|FG006|Dose Level V|Physician Decision|0|||
126359119|NCT02533674|454607322|FG007|Dose Level V|Physician Decision|0|||
126359120|NCT02533674|454607315|FG000|Dose Level VI|Progressive disease|0|||
126359121|NCT02533674|454607316|FG001|Dose Level VI|Progressive disease|0|||
126359122|NCT02533674|454607317|FG002|Dose Level VI|Progressive disease|0|||
126359123|NCT02533674|454607318|FG003|Dose Level VI|Progressive disease|0|||
126359124|NCT02533674|454607319|FG004|Dose Level VI|Progressive disease|0|||
126359125|NCT02533674|454607320|FG005|Dose Level VI|Progressive disease|7|||
126359126|NCT02533674|454607321|FG006|Dose Level VI|Progressive disease|0|||
126359127|NCT02533674|454607322|FG007|Dose Level VI|Progressive disease|0|||
126359128|NCT02533674|454607315|FG000|Dose Level VI|Withdrawal by Subject|0|||
126359129|NCT02533674|454607316|FG001|Dose Level VI|Withdrawal by Subject|0|||
126359130|NCT02533674|454607317|FG002|Dose Level VI|Withdrawal by Subject|0|||
126359131|NCT02533674|454607318|FG003|Dose Level VI|Withdrawal by Subject|0|||
126359132|NCT02533674|454607319|FG004|Dose Level VI|Withdrawal by Subject|0|||
126359133|NCT02533674|454607320|FG005|Dose Level VI|Withdrawal by Subject|1|||
126359134|NCT02533674|454607321|FG006|Dose Level VI|Withdrawal by Subject|0|||
126359135|NCT02533674|454607322|FG007|Dose Level VI|Withdrawal by Subject|0|||
126359136|NCT02533674|454607315|FG000|Dose Level VI|Treatment-related AE|0|||
126359137|NCT02533674|454607316|FG001|Dose Level VI|Treatment-related AE|0|||
126359138|NCT02533674|454607317|FG002|Dose Level VI|Treatment-related AE|0|||
126359139|NCT02533674|454607318|FG003|Dose Level VI|Treatment-related AE|0|||
126359140|NCT02533674|454607319|FG004|Dose Level VI|Treatment-related AE|0|||
126359141|NCT02533674|454607320|FG005|Dose Level VI|Treatment-related AE|1|||
126359142|NCT02533674|454607321|FG006|Dose Level VI|Treatment-related AE|0|||
126359143|NCT02533674|454607322|FG007|Dose Level VI|Treatment-related AE|0|||
126359144|NCT02533674|454607315|FG000|Dose Level VII|Progressive disease|0|||
126359145|NCT02533674|454607316|FG001|Dose Level VII|Progressive disease|0|||
126359146|NCT02533674|454607317|FG002|Dose Level VII|Progressive disease|0|||
126359147|NCT02533674|454607318|FG003|Dose Level VII|Progressive disease|0|||
126359148|NCT02533674|454607319|FG004|Dose Level VII|Progressive disease|0|||
126359149|NCT02533674|454607320|FG005|Dose Level VII|Progressive disease|0|||
126359150|NCT02533674|454607321|FG006|Dose Level VII|Progressive disease|10|||
126359151|NCT02533674|454607322|FG007|Dose Level VII|Progressive disease|0|||
126359152|NCT02533674|454607315|FG000|Dose Level VII|Withdrawal by Subject|0|||
126359153|NCT02533674|454607316|FG001|Dose Level VII|Withdrawal by Subject|0|||
126359154|NCT02533674|454607317|FG002|Dose Level VII|Withdrawal by Subject|0|||
126359155|NCT02533674|454607318|FG003|Dose Level VII|Withdrawal by Subject|0|||
126359156|NCT02533674|454607319|FG004|Dose Level VII|Withdrawal by Subject|0|||
126359157|NCT02533674|454607320|FG005|Dose Level VII|Withdrawal by Subject|0|||
126359158|NCT02533674|454607321|FG006|Dose Level VII|Withdrawal by Subject|3|||
126359159|NCT02533674|454607322|FG007|Dose Level VII|Withdrawal by Subject|0|||
126359160|NCT02533674|454607315|FG000|Dose Level VII|Treatment-related AE|0|||
126359161|NCT02533674|454607316|FG001|Dose Level VII|Treatment-related AE|0|||
126359162|NCT02533674|454607317|FG002|Dose Level VII|Treatment-related AE|0|||
126096068|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
126096069|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
126096070|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
126096071|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
126096072|NCT00700427|453644611|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
126096073|NCT00700427|453644612|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
126096074|NCT00700427|453644613|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
126096075|NCT00700427|453644614|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
126096076|NCT00700427|453644615|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
126096077|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
126096078|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
126096079|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
126096080|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
126096081|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
126096082|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
126096083|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
126096084|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
126096085|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
126096086|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
126096087|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
126096088|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
126096089|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
126096090|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
126096091|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
126096092|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
126096093|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
126096094|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
126096095|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
126096096|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
126096097|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
126096098|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
126096099|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
126359163|NCT02533674|454607318|FG003|Dose Level VII|Treatment-related AE|0|||
126359164|NCT02533674|454607319|FG004|Dose Level VII|Treatment-related AE|0|||
126359165|NCT02533674|454607320|FG005|Dose Level VII|Treatment-related AE|0|||
126359166|NCT02533674|454607321|FG006|Dose Level VII|Treatment-related AE|1|||
126359167|NCT02533674|454607322|FG007|Dose Level VII|Treatment-related AE|0|||
126359168|NCT02533674|454607315|FG000|Dose Level VII|Death|0|||
126359169|NCT02533674|454607316|FG001|Dose Level VII|Death|0|||
126030444|NCT04410042|453408264|FG000|Overall Study|Not Eligible|1|||
126030445|NCT04410042|453408265|FG001|Overall Study|Not Eligible|1|||
126030446|NCT03720795|453408268|FG000|Phase 1|Lost to Follow-up|4|||
126030447|NCT03720795|453408268|FG000|Phase 1|Withdrawal by Subject|6|||
126258531|NCT03566238|454235927|FG002|Overall Study|Adverse Event|0|||
126258532|NCT03566238|454235925|FG000|Overall Study|Lack of Efficacy|4|||
126258533|NCT03566238|454235926|FG001|Overall Study|Lack of Efficacy|2|||
126258534|NCT03566238|454235927|FG002|Overall Study|Lack of Efficacy|5|||
126258535|NCT03566238|454235925|FG000|Overall Study|Other|1|||
126258536|NCT03566238|454235926|FG001|Overall Study|Other|0|||
126258537|NCT03566238|454235927|FG002|Overall Study|Other|0|||
126258538|NCT01183884|454235934|FG000|Overall Study|Progressive Disease|26|||
126258539|NCT01183884|454235934|FG000|Overall Study|Adverse Event|3|||
126258540|NCT01183884|454235934|FG000|Overall Study|Withdrawal by Subject|1|||
126258541|NCT01183884|454235934|FG000|Overall Study|Other Complicating Disease|3|||
126258542|NCT01183884|454235934|FG000|Overall Study|Not Treated|1|||
126258543|NCT01183884|454235934|FG000|Overall Study|Other|4|||
126258544|NCT03689894|454235936|FG000|Overall Study|Adverse Event|1|||
126258545|NCT01169038|454235945|FG000|Overall Study|Death|1|||
126258546|NCT01169038|454235945|FG000|Overall Study|Adverse Event|5|||
126258547|NCT01169038|454235945|FG000|Overall Study|Required antibiotic administration|1|||
126258548|NCT01488448|454235946|FG000|Overall Study|Withdrawal by Subject|3|||
126258549|NCT01488448|454235947|FG001|Overall Study|Withdrawal by Subject|1|||
126258550|NCT01488448|454235946|FG000|Overall Study|Adverse Event|9|||
126258551|NCT01488448|454235947|FG001|Overall Study|Adverse Event|4|||
126258552|NCT01488448|454235946|FG000|Overall Study|Physician Decision|4|||
126258553|NCT01488448|454235947|FG001|Overall Study|Physician Decision|9|||
126258554|NCT01488448|454235946|FG000|Overall Study|Protocol Violation|4|||
126258555|NCT01488448|454235947|FG001|Overall Study|Protocol Violation|3|||
126258556|NCT00857818|454235950|FG000|Overall Study|Lack of Efficacy|1|||
126258557|NCT00857818|454235951|FG001|Overall Study|Lack of Efficacy|0|||
126258558|NCT00857818|454235950|FG000|Overall Study|Adverse Event|3|||
126258559|NCT00857818|454235951|FG001|Overall Study|Adverse Event|0|||
126258560|NCT00857818|454235950|FG000|Overall Study|Withdrawal by Subject|0|||
126258561|NCT00857818|454235951|FG001|Overall Study|Withdrawal by Subject|4|||
126258562|NCT00857818|454235950|FG000|Overall Study|Sponsor terminated study|6|||
126258563|NCT00857818|454235951|FG001|Overall Study|Sponsor terminated study|4|||
126258564|NCT00857818|454235950|FG000|Overall Study|Investigator decision|1|||
126258565|NCT00857818|454235951|FG001|Overall Study|Investigator decision|0|||
126258566|NCT02219308|454235952|FG000|Overall Study|Withdrawal by Subject|1|||
126258567|NCT02219308|454235953|FG001|Overall Study|Withdrawal by Subject|2|||
126258568|NCT04149535|454235956|FG000|Overall Study|Death|11|||
126258569|NCT04149535|454235957|FG001|Overall Study|Death|7|||
126030448|NCT03720795|453408268|FG000|Phase 1|Protocol Violation|1|||
126030449|NCT03720795|453408268|FG000|Phase 1|Other|1|||
126030450|NCT03720795|453408268|FG000|Phase 2|Lost to Follow-up|5|||
126258570|NCT04149535|454235956|FG000|Overall Study|Physician Decision|10|||
126258571|NCT04149535|454235957|FG001|Overall Study|Physician Decision|4|||
126258572|NCT04149535|454235956|FG000|Overall Study|Withdrawal by Subject|6|||
126258573|NCT04149535|454235957|FG001|Overall Study|Withdrawal by Subject|7|||
126258574|NCT04149535|454235956|FG000|Overall Study|Not described|2|||
126258575|NCT04149535|454235957|FG001|Overall Study|Not described|0|||
126258576|NCT02175368|454235958|FG000|Overall Study|Lost to Follow-up|1|||
126258577|NCT02875028|454235959|FG000|Washout Period|Withdrawal by Subject|0|||
126258578|NCT02875028|454235960|FG001|Washout Period|Withdrawal by Subject|1|||
126258579|NCT00653159|454237846|FG000|Overall Study|Adverse Event|4|||
126030451|NCT03720795|453408268|FG000|Phase 2|Withdrawal by Subject|10|||
126030452|NCT03720795|453408268|FG000|Phase 2|Protocol Violation|2|||
126030453|NCT03720795|453408268|FG000|3 Month Follow Up|Lost to Follow-up|2|||
126258580|NCT00653159|454237847|FG001|Overall Study|Adverse Event|1|||
126258581|NCT00653159|454237846|FG000|Overall Study|Lost to Follow-up|1|||
126258582|NCT00653159|454237847|FG001|Overall Study|Lost to Follow-up|2|||
126258583|NCT00109837|454237848|FG000|Overall Study|Adverse Event|2|||
126258584|NCT00109837|454237848|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
126258585|NCT00109837|454237848|FG000|Overall Study|Death|1|||
126258586|NCT00109837|454237848|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
126258587|NCT00109837|454237848|FG000|Overall Study|Not treated|1|||
126258588|NCT00109837|454237848|FG000|Overall Study|Ineligible|1|||
126258589|NCT00401245|454237849|FG000|Double Blind Titration Phase|Adverse Event|3|||
126258590|NCT00401245|454237850|FG001|Double Blind Titration Phase|Adverse Event|2|||
126258591|NCT00401245|454237851|FG002|Double Blind Titration Phase|Adverse Event|5|||
126258592|NCT00401245|454237852|FG003|Double Blind Titration Phase|Adverse Event|12|||
126258593|NCT00401245|454237853|FG004|Double Blind Titration Phase|Adverse Event|0|||
126258594|NCT00401245|454237854|FG005|Double Blind Titration Phase|Adverse Event|0|||
126258595|NCT00401245|454237855|FG006|Double Blind Titration Phase|Adverse Event|0|||
126258596|NCT00401245|454237856|FG007|Double Blind Titration Phase|Adverse Event|0|||
126258597|NCT00401245|454237849|FG000|Double Blind Titration Phase|Other|0|||
126258598|NCT00401245|454237850|FG001|Double Blind Titration Phase|Other|0|||
126258599|NCT00401245|454237851|FG002|Double Blind Titration Phase|Other|1|||
126096100|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
126258600|NCT00401245|454237852|FG003|Double Blind Titration Phase|Other|0|||
126258601|NCT00401245|454237853|FG004|Double Blind Titration Phase|Other|0|||
126258602|NCT00401245|454237854|FG005|Double Blind Titration Phase|Other|0|||
126258603|NCT00401245|454237855|FG006|Double Blind Titration Phase|Other|0|||
126258604|NCT00401245|454237856|FG007|Double Blind Titration Phase|Other|0|||
126258605|NCT00401245|454237849|FG000|Double Blind Titration Phase|Protocol Violation|0|||
126258606|NCT00401245|454237850|FG001|Double Blind Titration Phase|Protocol Violation|0|||
126258607|NCT00401245|454237851|FG002|Double Blind Titration Phase|Protocol Violation|0|||
126258608|NCT00401245|454237852|FG003|Double Blind Titration Phase|Protocol Violation|1|||
126258609|NCT00401245|454237853|FG004|Double Blind Titration Phase|Protocol Violation|0|||
126258610|NCT00401245|454237854|FG005|Double Blind Titration Phase|Protocol Violation|0|||
126258611|NCT00401245|454237855|FG006|Double Blind Titration Phase|Protocol Violation|0|||
126258612|NCT00401245|454237856|FG007|Double Blind Titration Phase|Protocol Violation|0|||
126258613|NCT00401245|454237849|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
126258614|NCT00401245|454237850|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
126258615|NCT00401245|454237851|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258616|NCT00401245|454237852|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
126258617|NCT00401245|454237853|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258618|NCT00401245|454237854|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258619|NCT00401245|454237855|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258620|NCT00401245|454237856|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258621|NCT00401245|454237849|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258622|NCT00401245|454237850|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
126258623|NCT00401245|454237851|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126096101|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
126258624|NCT00401245|454237852|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
126258625|NCT00401245|454237853|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258626|NCT00401245|454237854|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258627|NCT00401245|454237855|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258628|NCT00401245|454237856|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258629|NCT00401245|454237849|FG000|Open Label Phase|Adverse Event|5|||
126258630|NCT00401245|454237850|FG001|Open Label Phase|Adverse Event|14|||
126258631|NCT00401245|454237851|FG002|Open Label Phase|Adverse Event|6|||
126258632|NCT00401245|454237852|FG003|Open Label Phase|Adverse Event|7|||
126258633|NCT00401245|454237853|FG004|Open Label Phase|Adverse Event|0|||
126258634|NCT00401245|454237854|FG005|Open Label Phase|Adverse Event|0|||
126258635|NCT00401245|454237855|FG006|Open Label Phase|Adverse Event|0|||
126258636|NCT00401245|454237856|FG007|Open Label Phase|Adverse Event|0|||
126258637|NCT00401245|454237849|FG000|Open Label Phase|Lost to Follow-up|5|||
126258638|NCT00401245|454237850|FG001|Open Label Phase|Lost to Follow-up|7|||
126258639|NCT00401245|454237851|FG002|Open Label Phase|Lost to Follow-up|5|||
126258640|NCT00401245|454237852|FG003|Open Label Phase|Lost to Follow-up|4|||
126258641|NCT00401245|454237853|FG004|Open Label Phase|Lost to Follow-up|0|||
126258642|NCT00401245|454237854|FG005|Open Label Phase|Lost to Follow-up|0|||
126258643|NCT00401245|454237855|FG006|Open Label Phase|Lost to Follow-up|0|||
126258644|NCT00401245|454237856|FG007|Open Label Phase|Lost to Follow-up|0|||
126258645|NCT00401245|454237849|FG000|Open Label Phase|Other|4|||
126258646|NCT00401245|454237850|FG001|Open Label Phase|Other|8|||
126258647|NCT00401245|454237851|FG002|Open Label Phase|Other|7|||
126258648|NCT00401245|454237852|FG003|Open Label Phase|Other|8|||
126258649|NCT00401245|454237853|FG004|Open Label Phase|Other|0|||
126258650|NCT00401245|454237854|FG005|Open Label Phase|Other|0|||
126258651|NCT00401245|454237855|FG006|Open Label Phase|Other|0|||
126258652|NCT00401245|454237856|FG007|Open Label Phase|Other|0|||
126258653|NCT00401245|454237849|FG000|Open Label Phase|Protocol Violation|0|||
126258654|NCT00401245|454237850|FG001|Open Label Phase|Protocol Violation|1|||
126258655|NCT00401245|454237851|FG002|Open Label Phase|Protocol Violation|0|||
126258656|NCT00401245|454237852|FG003|Open Label Phase|Protocol Violation|1|||
126258657|NCT00401245|454237853|FG004|Open Label Phase|Protocol Violation|0|||
126258658|NCT00401245|454237854|FG005|Open Label Phase|Protocol Violation|0|||
126258659|NCT00401245|454237855|FG006|Open Label Phase|Protocol Violation|0|||
126258660|NCT00401245|454237856|FG007|Open Label Phase|Protocol Violation|0|||
126258661|NCT00401245|454237849|FG000|Open Label Phase|Withdrawal by Subject|3|||
126258662|NCT00401245|454237850|FG001|Open Label Phase|Withdrawal by Subject|3|||
126258663|NCT00401245|454237851|FG002|Open Label Phase|Withdrawal by Subject|2|||
126258664|NCT00401245|454237852|FG003|Open Label Phase|Withdrawal by Subject|1|||
126258665|NCT00401245|454237853|FG004|Open Label Phase|Withdrawal by Subject|0|||
126258666|NCT00401245|454237854|FG005|Open Label Phase|Withdrawal by Subject|0|||
126258667|NCT00401245|454237855|FG006|Open Label Phase|Withdrawal by Subject|0|||
126258668|NCT00401245|454237856|FG007|Open Label Phase|Withdrawal by Subject|0|||
126258669|NCT00401245|454237849|FG000|Open Label Phase|Lack of Efficacy|4|||
126258670|NCT00401245|454237850|FG001|Open Label Phase|Lack of Efficacy|2|||
126359170|NCT02533674|454607317|FG002|Dose Level VII|Death|0|||
126096102|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
126359171|NCT02533674|454607318|FG003|Dose Level VII|Death|0|||
126359172|NCT02533674|454607319|FG004|Dose Level VII|Death|0|||
126359173|NCT02533674|454607320|FG005|Dose Level VII|Death|0|||
126359174|NCT02533674|454607321|FG006|Dose Level VII|Death|2|||
126359175|NCT02533674|454607322|FG007|Dose Level VII|Death|0|||
126359176|NCT02533674|454607315|FG000|Dose Level VIII|Progressive disease|0|||
126359177|NCT02533674|454607316|FG001|Dose Level VIII|Progressive disease|0|||
126359178|NCT02533674|454607317|FG002|Dose Level VIII|Progressive disease|0|||
126359179|NCT02533674|454607318|FG003|Dose Level VIII|Progressive disease|0|||
126359180|NCT02533674|454607319|FG004|Dose Level VIII|Progressive disease|0|||
126359181|NCT02533674|454607320|FG005|Dose Level VIII|Progressive disease|0|||
126359182|NCT02533674|454607321|FG006|Dose Level VIII|Progressive disease|0|||
126359183|NCT02533674|454607322|FG007|Dose Level VIII|Progressive disease|3|||
126359184|NCT02533674|454607315|FG000|Dose Level VIII|Withdrawal by Subject|0|||
126359185|NCT02533674|454607316|FG001|Dose Level VIII|Withdrawal by Subject|0|||
126359186|NCT02533674|454607317|FG002|Dose Level VIII|Withdrawal by Subject|0|||
126359187|NCT02533674|454607318|FG003|Dose Level VIII|Withdrawal by Subject|0|||
126359188|NCT02533674|454607319|FG004|Dose Level VIII|Withdrawal by Subject|0|||
126258671|NCT00401245|454237851|FG002|Open Label Phase|Lack of Efficacy|3|||
126258672|NCT00401245|454237852|FG003|Open Label Phase|Lack of Efficacy|0|||
126359189|NCT02533674|454607320|FG005|Dose Level VIII|Withdrawal by Subject|0|||
126359190|NCT02533674|454607321|FG006|Dose Level VIII|Withdrawal by Subject|0|||
126359191|NCT02533674|454607322|FG007|Dose Level VIII|Withdrawal by Subject|1|||
126359192|NCT02533674|454607315|FG000|Dose Level VIII|Treatment-related AE|0|||
126359193|NCT02533674|454607316|FG001|Dose Level VIII|Treatment-related AE|0|||
126258673|NCT00401245|454237853|FG004|Open Label Phase|Lack of Efficacy|0|||
126258674|NCT00401245|454237854|FG005|Open Label Phase|Lack of Efficacy|0|||
126030454|NCT03302494|453408269|FG000|Overall Study|Other|7|||
126030455|NCT03302494|453408270|FG001|Overall Study|Other|4|||
126030456|NCT03302494|453408271|FG002|Overall Study|Other|6|||
126258675|NCT00401245|454237855|FG006|Open Label Phase|Lack of Efficacy|0|||
126258676|NCT00401245|454237856|FG007|Open Label Phase|Lack of Efficacy|0|||
126258677|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Adverse Event|0|||
126258678|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Adverse Event|0|||
126258679|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Adverse Event|0|||
126258680|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Adverse Event|0|||
126258681|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Adverse Event|1|||
126030457|NCT03302494|453408269|FG000|Overall Study|Withdrawal by Subject|10|||
126030458|NCT03302494|453408270|FG001|Overall Study|Withdrawal by Subject|2|||
126030459|NCT03302494|453408271|FG002|Overall Study|Withdrawal by Subject|9|||
126030460|NCT03302494|453408269|FG000|Overall Study|Study Terminated by Sponsor|32|||
126258682|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Adverse Event|1|||
126258683|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Adverse Event|2|||
126258684|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Adverse Event|4|||
126258685|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Investigator request|0|||
126258686|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Investigator request|0|||
126258687|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Investigator request|0|||
126258688|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Investigator request|0|||
126258689|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Investigator request|0|||
126258690|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Investigator request|0|||
126258691|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Investigator request|0|||
126258692|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Investigator request|1|||
126258693|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Other|0|||
126258694|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Other|0|||
126258695|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Other|0|||
126258696|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Other|0|||
126258697|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Other|1|||
126258698|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Other|0|||
126258699|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Other|2|||
126258700|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Other|2|||
126258701|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258702|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258703|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258704|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258705|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
126258706|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
126258707|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
126258708|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258709|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
126030461|NCT03302494|453408270|FG001|Overall Study|Study Terminated by Sponsor|29|||
126030462|NCT03302494|453408271|FG002|Overall Study|Study Terminated by Sponsor|30|||
126030463|NCT03302494|453408269|FG000|Overall Study|Physician Decision|1|||
126030464|NCT03302494|453408270|FG001|Overall Study|Physician Decision|0|||
126030465|NCT03302494|453408271|FG002|Overall Study|Physician Decision|1|||
126030466|NCT03302494|453408269|FG000|Overall Study|Lost to Follow-up|1|||
126030467|NCT03302494|453408270|FG001|Overall Study|Lost to Follow-up|3|||
126030468|NCT03302494|453408271|FG002|Overall Study|Lost to Follow-up|3|||
126030469|NCT03302494|453408269|FG000|Overall Study|Death|13|||
126030470|NCT03302494|453408270|FG001|Overall Study|Death|11|||
126030471|NCT03302494|453408271|FG002|Overall Study|Death|4|||
126030472|NCT03302494|453408269|FG000|Overall Study|Adverse Event|1|||
126030473|NCT03302494|453408270|FG001|Overall Study|Adverse Event|2|||
126030474|NCT03302494|453408271|FG002|Overall Study|Adverse Event|0|||
126030475|NCT03302494|453408269|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
126030476|NCT03302494|453408270|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
126030477|NCT03302494|453408271|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
126030478|NCT05134233|453408272|FG000|Overall Study|Pregnancy|1|||
126030479|NCT05134233|453408272|FG000|Overall Study|MEP value too low|2|||
126030480|NCT05134233|453408272|FG000|Overall Study|Lost to Follow-up|1|||
126030481|NCT01573442|453408273|FG000|Overall Study|Cancels|9|||
126030482|NCT01573442|453408274|FG001|Overall Study|Cancels|10|||
126030483|NCT02724631|453408277|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
126030484|NCT04763265|453408281|FG000|Overall Study|Adverse Event|1|||
126258710|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258711|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258712|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258713|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258714|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
126258715|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258716|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258717|NCT02344745|454237857|FG000|Overall Study|Data collection sheets were lost|2|||
126258718|NCT02344745|454237858|FG001|Overall Study|Data collection sheets were lost|0|||
126258719|NCT02014441|454237859|FG000|Overall Study|Withdrawal by Subject|12|||
126258720|NCT01933919|454237860|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
126258721|NCT01933919|454237861|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
126258722|NCT01933919|454237860|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
126258723|NCT01933919|454237861|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
126258724|NCT01933919|454237860|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
126258725|NCT01933919|454237861|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
126258726|NCT01933919|454237860|FG000|Open-label Long-term Phase|Adverse Event|2|||
126258727|NCT01933919|454237861|FG001|Open-label Long-term Phase|Adverse Event|0|||
126258728|NCT01933919|454237860|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
126258729|NCT01933919|454237861|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
126258730|NCT01933919|454237860|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
126258731|NCT01933919|454237861|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
126258732|NCT01933919|454237860|FG000|Open-label Long-term Phase|Other|1|||
126258733|NCT01933919|454237861|FG001|Open-label Long-term Phase|Other|2|||
126258734|NCT00991510|454237862|FG000|Period I (Days 1-14)|Adverse Event|1|||
126258735|NCT00991510|454237863|FG001|Period I (Days 1-14)|Adverse Event|0|||
126258736|NCT00991510|454237862|FG000|Period III (Days 29-112)|Adverse Event|1|||
126258737|NCT00991510|454237863|FG001|Period III (Days 29-112)|Adverse Event|1|||
126258738|NCT02510261|454237872|FG000|Overall Study|Adverse Event|5|||
126258739|NCT02510261|454237873|FG001|Overall Study|Adverse Event|8|||
126258740|NCT02510261|454237874|FG002|Overall Study|Adverse Event|0|||
126258741|NCT02510261|454237872|FG000|Overall Study|Physician Decision|1|||
126258742|NCT02510261|454237873|FG001|Overall Study|Physician Decision|5|||
126258743|NCT02510261|454237874|FG002|Overall Study|Physician Decision|0|||
126258744|NCT02510261|454237872|FG000|Overall Study|Death|19|||
126258745|NCT02510261|454237873|FG001|Overall Study|Death|19|||
126258746|NCT02510261|454237874|FG002|Overall Study|Death|0|||
126258747|NCT02510261|454237872|FG000|Overall Study|Withdrawal by Subject|3|||
126258748|NCT02510261|454237873|FG001|Overall Study|Withdrawal by Subject|10|||
126258749|NCT02510261|454237874|FG002|Overall Study|Withdrawal by Subject|3|||
126258750|NCT02443324|454237878|FG000|Overall Study|Death|4|||
126258751|NCT02443324|454237879|FG001|Overall Study|Death|1|||
126258752|NCT02443324|454237880|FG002|Overall Study|Death|0|||
126258753|NCT02443324|454237881|FG003|Overall Study|Death|3|||
126258754|NCT02443324|454237882|FG004|Overall Study|Death|1|||
126258755|NCT02443324|454237883|FG005|Overall Study|Death|3|||
126258756|NCT02443324|454237884|FG006|Overall Study|Death|2|||
126258757|NCT02443324|454237878|FG000|Overall Study|Lost to Follow-up|0|||
126258758|NCT02443324|454237879|FG001|Overall Study|Lost to Follow-up|0|||
126258759|NCT02443324|454237880|FG002|Overall Study|Lost to Follow-up|0|||
126258760|NCT02443324|454237881|FG003|Overall Study|Lost to Follow-up|1|||
126258761|NCT02443324|454237882|FG004|Overall Study|Lost to Follow-up|0|||
126258762|NCT02443324|454237883|FG005|Overall Study|Lost to Follow-up|1|||
126258763|NCT02443324|454237884|FG006|Overall Study|Lost to Follow-up|0|||
126258764|NCT02443324|454237878|FG000|Overall Study|Physician Decision|0|||
126258765|NCT02443324|454237879|FG001|Overall Study|Physician Decision|3|||
126258766|NCT02443324|454237880|FG002|Overall Study|Physician Decision|5|||
126258767|NCT02443324|454237881|FG003|Overall Study|Physician Decision|1|||
126258768|NCT02443324|454237882|FG004|Overall Study|Physician Decision|1|||
126258769|NCT02443324|454237883|FG005|Overall Study|Physician Decision|0|||
126258770|NCT02443324|454237884|FG006|Overall Study|Physician Decision|2|||
126258771|NCT02443324|454237878|FG000|Overall Study|Progressive Disease|20|||
126258772|NCT02443324|454237879|FG001|Overall Study|Progressive Disease|20|||
126258773|NCT02443324|454237880|FG002|Overall Study|Progressive Disease|13|||
126258774|NCT02443324|454237881|FG003|Overall Study|Progressive Disease|10|||
126258775|NCT02443324|454237882|FG004|Overall Study|Progressive Disease|13|||
126258776|NCT02443324|454237883|FG005|Overall Study|Progressive Disease|17|||
126258777|NCT02443324|454237884|FG006|Overall Study|Progressive Disease|10|||
126258778|NCT02443324|454237878|FG000|Overall Study|Withdrawal by Subject|0|||
126258779|NCT02443324|454237879|FG001|Overall Study|Withdrawal by Subject|0|||
126258780|NCT02443324|454237880|FG002|Overall Study|Withdrawal by Subject|3|||
126258781|NCT02443324|454237881|FG003|Overall Study|Withdrawal by Subject|1|||
126258782|NCT02443324|454237882|FG004|Overall Study|Withdrawal by Subject|1|||
126258783|NCT02443324|454237883|FG005|Overall Study|Withdrawal by Subject|0|||
126258784|NCT02443324|454237884|FG006|Overall Study|Withdrawal by Subject|1|||
126258785|NCT02443324|454237878|FG000|Overall Study|Adverse Event|0|||
126258786|NCT02443324|454237879|FG001|Overall Study|Adverse Event|1|||
126258787|NCT02443324|454237880|FG002|Overall Study|Adverse Event|3|||
126258788|NCT02443324|454237881|FG003|Overall Study|Adverse Event|0|||
126258789|NCT02443324|454237882|FG004|Overall Study|Adverse Event|4|||
126258790|NCT02443324|454237883|FG005|Overall Study|Adverse Event|3|||
126258791|NCT02443324|454237884|FG006|Overall Study|Adverse Event|3|||
126258792|NCT02443324|454237878|FG000|Overall Study|Enrolled but Never Treated|0|||
126258793|NCT02443324|454237879|FG001|Overall Study|Enrolled but Never Treated|0|||
126258794|NCT02443324|454237880|FG002|Overall Study|Enrolled but Never Treated|1|||
126258795|NCT02443324|454237881|FG003|Overall Study|Enrolled but Never Treated|0|||
126258796|NCT02443324|454237882|FG004|Overall Study|Enrolled but Never Treated|1|||
126258797|NCT02443324|454237883|FG005|Overall Study|Enrolled but Never Treated|0|||
126258798|NCT02443324|454237884|FG006|Overall Study|Enrolled but Never Treated|1|||
126258799|NCT01091103|454237888|FG000|Overall Study|Adverse Event|1|||
126258800|NCT01091103|454237888|FG000|Overall Study|Progressive Disease|3|||
126258801|NCT03449199|454237889|FG000|Overall Study|Lost to Follow-up|1|||
126258802|NCT03449199|454237890|FG001|Overall Study|Lost to Follow-up|1|||
126258803|NCT03449199|454237891|FG002|Overall Study|Lost to Follow-up|0|||
126258804|NCT03449199|454237889|FG000|Overall Study|Protocol Deviation|0|||
126258805|NCT03449199|454237890|FG001|Overall Study|Protocol Deviation|0|||
126258806|NCT03449199|454237891|FG002|Overall Study|Protocol Deviation|1|||
126258807|NCT03449199|454237889|FG000|Overall Study|Withdrawal by Subject|0|||
126258808|NCT03449199|454237890|FG001|Overall Study|Withdrawal by Subject|0|||
126258809|NCT03449199|454237891|FG002|Overall Study|Withdrawal by Subject|1|||
126258810|NCT01270620|454237892|FG000|Overall Study|Withdrawal by Subject|1|||
126258811|NCT01270620|454237893|FG001|Overall Study|Withdrawal by Subject|3|||
126258812|NCT00684567|454237894|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
126258813|NCT00684567|454237894|FG000|Monotherapy Period|Adverse Event|2|||
126258814|NCT00684567|454237894|FG000|Monotherapy Period|Death|1|||
126258815|NCT00684567|454237894|FG000|Monotherapy Period|Progression of primary disease|11|||
126258816|NCT03136406|454237900|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
126258817|NCT00988208|454237903|FG000|Overall Study|Adverse Event|71|||
126258818|NCT00988208|454237904|FG001|Overall Study|Adverse Event|122|||
126258819|NCT00988208|454237903|FG000|Overall Study|Disease Progression|103|||
126258820|NCT00988208|454237904|FG001|Overall Study|Disease Progression|89|||
126258821|NCT00988208|454237903|FG000|Overall Study|Withdrawal by Subject|50|||
126258822|NCT00988208|454237904|FG001|Overall Study|Withdrawal by Subject|57|||
126258823|NCT00988208|454237903|FG000|Overall Study|Death|9|||
126258824|NCT00988208|454237904|FG001|Overall Study|Death|15|||
126258825|NCT00988208|454237903|FG000|Overall Study|Lost to Follow-up|2|||
126258826|NCT00988208|454237904|FG001|Overall Study|Lost to Follow-up|3|||
126258827|NCT00988208|454237903|FG000|Overall Study|Protocol Violation|9|||
126258828|NCT00988208|454237904|FG001|Overall Study|Protocol Violation|2|||
126258829|NCT00988208|454237903|FG000|Overall Study|Sponsor Decision|102|||
126258830|NCT00988208|454237904|FG001|Overall Study|Sponsor Decision|78|||
126258831|NCT00988208|454237903|FG000|Overall Study|Clinical Progression|17|||
126258832|NCT00988208|454237904|FG001|Overall Study|Clinical Progression|16|||
126258833|NCT00988208|454237903|FG000|Overall Study|Biochemical Progression|21|||
126258834|NCT00988208|454237904|FG001|Overall Study|Biochemical Progression|7|||
126258835|NCT00988208|454237903|FG000|Overall Study|Clinical Deterioration|7|||
126258836|NCT00988208|454237904|FG001|Overall Study|Clinical Deterioration|14|||
126258837|NCT00988208|454237903|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
126359194|NCT02533674|454607317|FG002|Dose Level VIII|Treatment-related AE|0|||
126359195|NCT02533674|454607318|FG003|Dose Level VIII|Treatment-related AE|0|||
126359196|NCT02533674|454607319|FG004|Dose Level VIII|Treatment-related AE|0|||
126359197|NCT02533674|454607320|FG005|Dose Level VIII|Treatment-related AE|0|||
126359198|NCT02533674|454607321|FG006|Dose Level VIII|Treatment-related AE|0|||
126359199|NCT02533674|454607322|FG007|Dose Level VIII|Treatment-related AE|1|||
126359200|NCT02533674|454607315|FG000|Dose Level VIII|Never treated|0|||
126359201|NCT02533674|454607316|FG001|Dose Level VIII|Never treated|0|||
126359202|NCT02533674|454607317|FG002|Dose Level VIII|Never treated|0|||
126359203|NCT02533674|454607318|FG003|Dose Level VIII|Never treated|0|||
126359204|NCT02533674|454607319|FG004|Dose Level VIII|Never treated|0|||
126359205|NCT02533674|454607320|FG005|Dose Level VIII|Never treated|0|||
126030485|NCT04763265|453408282|FG001|Overall Study|Adverse Event|0|||
126258838|NCT00988208|454237904|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
126258839|NCT00988208|454237903|FG000|Overall Study|Other|8|||
126258840|NCT00988208|454237904|FG001|Overall Study|Other|3|||
126258841|NCT02780167|454237912|FG000|Overall Study|Adverse Event|9|||
126258842|NCT02780167|454237913|FG001|Overall Study|Adverse Event|8|||
126359206|NCT02533674|454607321|FG006|Dose Level VIII|Never treated|0|||
126030486|NCT04763265|453408281|FG000|Overall Study|Lost to Follow-up|2|||
126258843|NCT02780167|454237914|FG002|Overall Study|Adverse Event|8|||
126258844|NCT02780167|454237915|FG003|Overall Study|Adverse Event|12|||
126258845|NCT02780167|454237916|FG004|Overall Study|Adverse Event|8|||
126258846|NCT02780167|454237912|FG000|Overall Study|Lack of Efficacy|6|||
126258847|NCT02780167|454237913|FG001|Overall Study|Lack of Efficacy|5|||
126258848|NCT02780167|454237914|FG002|Overall Study|Lack of Efficacy|6|||
126258849|NCT02780167|454237915|FG003|Overall Study|Lack of Efficacy|1|||
126258850|NCT02780167|454237916|FG004|Overall Study|Lack of Efficacy|0|||
126258851|NCT02780167|454237912|FG000|Overall Study|Lost to Follow-up|2|||
126258852|NCT02780167|454237913|FG001|Overall Study|Lost to Follow-up|0|||
126258853|NCT02780167|454237914|FG002|Overall Study|Lost to Follow-up|1|||
126258854|NCT02780167|454237915|FG003|Overall Study|Lost to Follow-up|0|||
126258855|NCT02780167|454237916|FG004|Overall Study|Lost to Follow-up|0|||
126258856|NCT02780167|454237912|FG000|Overall Study|Does not meet entrance criteria|0|||
126258857|NCT02780167|454237913|FG001|Overall Study|Does not meet entrance criteria|0|||
126258858|NCT02780167|454237914|FG002|Overall Study|Does not meet entrance criteria|1|||
126258859|NCT02780167|454237915|FG003|Overall Study|Does not meet entrance criteria|0|||
126258860|NCT02780167|454237916|FG004|Overall Study|Does not meet entrance criteria|0|||
126258861|NCT02780167|454237912|FG000|Overall Study|No longer meets eligibility criteria|0|||
126258862|NCT02780167|454237913|FG001|Overall Study|No longer meets eligibility criteria|0|||
126258863|NCT02780167|454237914|FG002|Overall Study|No longer meets eligibility criteria|0|||
126258864|NCT02780167|454237915|FG003|Overall Study|No longer meets eligibility criteria|1|||
126258865|NCT02780167|454237916|FG004|Overall Study|No longer meets eligibility criteria|1|||
126096103|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
126096104|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
126096105|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
126096106|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
126258866|NCT02780167|454237912|FG000|Overall Study|Protocol Violation|5|||
126258867|NCT02780167|454237913|FG001|Overall Study|Protocol Violation|5|||
126258868|NCT02780167|454237914|FG002|Overall Study|Protocol Violation|1|||
126258869|NCT02780167|454237915|FG003|Overall Study|Protocol Violation|1|||
126258870|NCT02780167|454237916|FG004|Overall Study|Protocol Violation|2|||
126258871|NCT02780167|454237912|FG000|Overall Study|Withdrawal by Subject|6|||
126258872|NCT02780167|454237913|FG001|Overall Study|Withdrawal by Subject|4|||
126258873|NCT02780167|454237914|FG002|Overall Study|Withdrawal by Subject|4|||
126258874|NCT02780167|454237915|FG003|Overall Study|Withdrawal by Subject|3|||
126258875|NCT02780167|454237916|FG004|Overall Study|Withdrawal by Subject|4|||
126258876|NCT02780167|454237912|FG000|Overall Study|Other|0|||
126258877|NCT02780167|454237913|FG001|Overall Study|Other|0|||
126258878|NCT02780167|454237914|FG002|Overall Study|Other|3|||
126258879|NCT02780167|454237915|FG003|Overall Study|Other|1|||
126258880|NCT02780167|454237916|FG004|Overall Study|Other|2|||
126258881|NCT03180801|454237917|FG000|Overall Study|Physician Decision|3|||
126258882|NCT03180801|454237918|FG001|Overall Study|Physician Decision|3|||
126258883|NCT03180801|454237919|FG002|Overall Study|Physician Decision|1|||
126258884|NCT03180801|454237917|FG000|Overall Study|Non-compliance|1|||
126258885|NCT03180801|454237918|FG001|Overall Study|Non-compliance|4|||
126258886|NCT03180801|454237919|FG002|Overall Study|Non-compliance|0|||
126258887|NCT03180801|454237917|FG000|Overall Study|Inoculation Target Reached|1|||
126258888|NCT03180801|454237918|FG001|Overall Study|Inoculation Target Reached|1|||
126258889|NCT03180801|454237919|FG002|Overall Study|Inoculation Target Reached|3|||
126096107|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
126258890|NCT03180801|454237917|FG000|Overall Study|Adverse Event|1|||
126258891|NCT03180801|454237918|FG001|Overall Study|Adverse Event|0|||
126258892|NCT03180801|454237919|FG002|Overall Study|Adverse Event|2|||
126258893|NCT03180801|454237917|FG000|Overall Study|Withdrawal by Subject|2|||
126258894|NCT03180801|454237918|FG001|Overall Study|Withdrawal by Subject|2|||
126258895|NCT03180801|454237919|FG002|Overall Study|Withdrawal by Subject|1|||
126258896|NCT03180801|454237917|FG000|Overall Study|Lost to Follow-up|0|||
126258897|NCT03180801|454237918|FG001|Overall Study|Lost to Follow-up|2|||
126258898|NCT03180801|454237919|FG002|Overall Study|Lost to Follow-up|3|||
126258899|NCT03756883|454237920|FG000|Overall Study|Adverse Event|2|||
126258900|NCT03756883|454237921|FG001|Overall Study|Adverse Event|2|||
126258901|NCT03756883|454237922|FG002|Overall Study|Adverse Event|2|||
126030487|NCT04763265|453408282|FG001|Overall Study|Lost to Follow-up|4|||
126258902|NCT03756883|454237920|FG000|Overall Study|Lack of Efficacy|0|||
126258903|NCT03756883|454237921|FG001|Overall Study|Lack of Efficacy|1|||
126258904|NCT03756883|454237922|FG002|Overall Study|Lack of Efficacy|2|||
126258905|NCT03756883|454237920|FG000|Overall Study|Lost to Follow-up|3|||
126258906|NCT03756883|454237921|FG001|Overall Study|Lost to Follow-up|3|||
126258907|NCT03756883|454237922|FG002|Overall Study|Lost to Follow-up|0|||
126258908|NCT03756883|454237920|FG000|Overall Study|Protocol Violation|2|||
126258909|NCT03756883|454237921|FG001|Overall Study|Protocol Violation|0|||
126258910|NCT03756883|454237922|FG002|Overall Study|Protocol Violation|1|||
126258911|NCT03756883|454237920|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
126258912|NCT03756883|454237921|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
126258913|NCT03756883|454237922|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
126258914|NCT03756883|454237920|FG000|Overall Study|Withdrawal by Subject|4|||
126258915|NCT03756883|454237921|FG001|Overall Study|Withdrawal by Subject|1|||
126258916|NCT03756883|454237922|FG002|Overall Study|Withdrawal by Subject|0|||
126258917|NCT03756883|454237920|FG000|Overall Study|Other Reasons|2|||
126258918|NCT03756883|454237921|FG001|Overall Study|Other Reasons|4|||
126258919|NCT03756883|454237922|FG002|Overall Study|Other Reasons|0|||
126258920|NCT03235479|454237925|FG000|Overall Study|Lost to Follow-up|8|||
126258921|NCT03235479|454237926|FG001|Overall Study|Lost to Follow-up|11|||
126258922|NCT03235479|454237925|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
126258923|NCT03235479|454237926|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
126258924|NCT03235479|454237925|FG000|Overall Study|Pregnancy|1|||
126258925|NCT03235479|454237926|FG001|Overall Study|Pregnancy|0|||
126258926|NCT03235479|454237925|FG000|Overall Study|Protocol Deviation|1|||
126258927|NCT03235479|454237926|FG001|Overall Study|Protocol Deviation|3|||
126258928|NCT03235479|454237925|FG000|Overall Study|Technical Problems|3|||
126258929|NCT03235479|454237926|FG001|Overall Study|Technical Problems|2|||
126258930|NCT03235479|454237925|FG000|Overall Study|Withdrawal by Subject|2|||
126258931|NCT03235479|454237926|FG001|Overall Study|Withdrawal by Subject|2|||
126258932|NCT03235479|454237925|FG000|Overall Study|Other Reasons|3|||
126258933|NCT03235479|454237926|FG001|Overall Study|Other Reasons|5|||
126258934|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
126258935|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
126258936|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
126258937|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
126258938|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
126258939|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
126258940|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126258941|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126258942|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
126258943|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
126258944|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
126258945|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126258946|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
126258947|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
126258948|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
126258949|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
126258950|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Death|2|||
126258951|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Death|1|||
126258952|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Death|0|||
126258953|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Death|0|||
126258954|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
126258955|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
126258956|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
126258957|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
126258958|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
126258959|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
126258960|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
126359207|NCT02533674|454607322|FG007|Dose Level VIII|Never treated|1|||
126030488|NCT04763265|453408281|FG000|Overall Study|Withdrawal by Subject|0|||
126030489|NCT04763265|453408282|FG001|Overall Study|Withdrawal by Subject|1|||
126030490|NCT05609760|453408295|FG000|Overall Study|Lost to Follow-up|0|||
126030491|NCT05609760|453408296|FG001|Overall Study|Lost to Follow-up|1|||
126030492|NCT05609760|453408295|FG000|Overall Study|Withdrawal by Subject|1|||
126030493|NCT05609760|453408296|FG001|Overall Study|Withdrawal by Subject|0|||
126030494|NCT04049643|453408297|FG000|Overall Study|Lack of Efficacy|1|||
126030495|NCT04049643|453408298|FG001|Overall Study|Lack of Efficacy|1|||
126030496|NCT04049643|453408299|FG002|Overall Study|Lack of Efficacy|0|||
126030497|NCT04049643|453408297|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
126359208|NCT01292473|454607326|FG000|Overall Study|Adverse Event|1|||
126359209|NCT01292473|454607327|FG001|Overall Study|Adverse Event|0|||
126030498|NCT04049643|453408298|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
126030499|NCT04049643|453408299|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
126030500|NCT05089734|453408300|FG000|Overall Study|Still on study|122|||
126030501|NCT05089734|453408301|FG001|Overall Study|Still on study|101|||
126030502|NCT05089734|453408300|FG000|Overall Study|Death|161|||
126030503|NCT05089734|453408301|FG001|Overall Study|Death|179|||
126030504|NCT05089734|453408300|FG000|Overall Study|Withdrew consent|11|||
126030505|NCT05089734|453408301|FG001|Overall Study|Withdrew consent|24|||
126030506|NCT05089734|453408300|FG000|Overall Study|Lost to Follow-up|5|||
126030507|NCT05089734|453408301|FG001|Overall Study|Lost to Follow-up|0|||
126030508|NCT05302596|453408302|FG000|Overall Study|Withdrawal by Subject|1|||
126030509|NCT05302596|453408303|FG001|Overall Study|Withdrawal by Subject|1|||
126030510|NCT04353661|453410821|FG000|Overall Study|Protocol Violation|0|||
126096108|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
126096109|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
126096110|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
126096111|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
126096112|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
126096113|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
126096114|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
126096115|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
126096116|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
126030511|NCT04353661|453410822|FG001|Overall Study|Protocol Violation|0|||
126030512|NCT04353661|453410823|FG002|Overall Study|Protocol Violation|1|||
126030513|NCT04353661|453410821|FG000|Overall Study|Study termination by the Sponsor|1|||
126030514|NCT04353661|453410822|FG001|Overall Study|Study termination by the Sponsor|1|||
126030515|NCT04353661|453410823|FG002|Overall Study|Study termination by the Sponsor|1|||
126030516|NCT00667251|453410824|FG000|Overall Study|Disease progression|232|||
126030517|NCT00667251|453410825|FG001|Overall Study|Disease progression|203|||
126030518|NCT00667251|453410824|FG000|Overall Study|Toxicity|44|||
126030519|NCT00667251|453410825|FG001|Overall Study|Toxicity|23|||
126030520|NCT00667251|453410824|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
126030521|NCT00667251|453410825|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
126030522|NCT00667251|453410824|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
126030523|NCT00667251|453410825|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
126030524|NCT00667251|453410824|FG000|Overall Study|Symptomatic progression|8|||
126030525|NCT00667251|453410825|FG001|Overall Study|Symptomatic progression|4|||
126096117|NCT00700427|453644611|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
126096118|NCT00700427|453644612|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
126096119|NCT00700427|453644613|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
126096120|NCT00700427|453644614|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
126096121|NCT00700427|453644615|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
126030526|NCT00667251|453410824|FG000|Overall Study|Death|6|||
126030527|NCT00667251|453410825|FG001|Overall Study|Death|11|||
126030528|NCT00667251|453410824|FG000|Overall Study|Intercurrent illness|5|||
126030529|NCT00667251|453410825|FG001|Overall Study|Intercurrent illness|6|||
126030530|NCT00667251|453410824|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
126030531|NCT00667251|453410825|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
126258961|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
126258962|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
126096122|NCT00424385|453644616|FG000|Cohort 0|Withdrawal by Subject|5|||
126096123|NCT00424385|453644616|FG000|Cohort 0|Physician Decision|1|||
126258963|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
126258964|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
126258965|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
126258966|NCT03110380|454237938|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
126258967|NCT03110380|454237939|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
126258968|NCT03110380|454237940|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
126258969|NCT03110380|454237941|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
126096124|NCT00424385|453644616|FG000|Cohort 1|Withdrawal by Subject|1|||
126096125|NCT02683876|453644617|FG000|Overall Study|samples damaged during shipping|2|||
126096126|NCT02683876|453644618|FG001|Overall Study|samples damaged during shipping|0|||
126096127|NCT03231800|453644625|FG000|Overall Study|Lost to Follow-up|0|||
126258970|NCT03110380|454237938|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
126258971|NCT03110380|454237939|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
126258972|NCT03110380|454237940|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
126258973|NCT03110380|454237941|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
126258974|NCT03110380|454237938|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
126258975|NCT03110380|454237939|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
126030532|NCT00667251|453410824|FG000|Overall Study|Randomized not Treated|4|||
126030533|NCT00667251|453410825|FG001|Overall Study|Randomized not Treated|1|||
126030534|NCT02727699|453410826|FG000|Overall Study|Adverse Event|2|||
126030535|NCT02727699|453410827|FG001|Overall Study|Adverse Event|0|||
126030536|NCT02727699|453410826|FG000|Overall Study|Withdrawal by Subject|5|||
126030537|NCT02727699|453410827|FG001|Overall Study|Withdrawal by Subject|3|||
126030538|NCT02727699|453410826|FG000|Overall Study|Protocol Violation|0|||
126030539|NCT02727699|453410827|FG001|Overall Study|Protocol Violation|1|||
126030540|NCT02727699|453410826|FG000|Overall Study|Physician Decision|0|||
126030541|NCT02727699|453410827|FG001|Overall Study|Physician Decision|1|||
126030542|NCT02727699|453410826|FG000|Overall Study|Lost to Follow-up|1|||
126030543|NCT02727699|453410827|FG001|Overall Study|Lost to Follow-up|0|||
126030544|NCT02727699|453410826|FG000|Overall Study|Sponsor Decision|1|||
126030545|NCT02727699|453410827|FG001|Overall Study|Sponsor Decision|0|||
126030546|NCT02995434|453410828|FG000|Overall Study|Adverse Event|1|||
126030547|NCT02995434|453410829|FG001|Overall Study|Adverse Event|0|||
126030548|NCT02995434|453410828|FG000|Overall Study|Withdrawal by Subject|6|||
126030549|NCT02995434|453410829|FG001|Overall Study|Withdrawal by Subject|3|||
126030550|NCT03779204|453410830|FG000|Overall Study|Lost to Follow-up|2|||
126030551|NCT03779204|453410831|FG001|Overall Study|Lost to Follow-up|0|||
126030552|NCT04318548|453410841|FG000|Overall Study|Adverse Event|0|||
126030553|NCT04318548|453410842|FG001|Overall Study|Adverse Event|0|||
126030554|NCT04318548|453410843|FG002|Overall Study|Adverse Event|1|||
126030555|NCT04318548|453410841|FG000|Overall Study|Lost to Follow-up|6|||
126030556|NCT04318548|453410842|FG001|Overall Study|Lost to Follow-up|13|||
126030557|NCT04318548|453410843|FG002|Overall Study|Lost to Follow-up|9|||
126030558|NCT04318548|453410841|FG000|Overall Study|Protocol Violation|1|||
126030559|NCT04318548|453410842|FG001|Overall Study|Protocol Violation|0|||
126030560|NCT04318548|453410843|FG002|Overall Study|Protocol Violation|2|||
126030561|NCT04318548|453410841|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
126030562|NCT04318548|453410842|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
126030563|NCT04318548|453410843|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
126030564|NCT04318548|453410841|FG000|Overall Study|Migrated / moved from the study area|0|||
126030565|NCT04318548|453410842|FG001|Overall Study|Migrated / moved from the study area|0|||
126030566|NCT04318548|453410843|FG002|Overall Study|Migrated / moved from the study area|1|||
126030567|NCT04318548|453410841|FG000|Overall Study|Other|1|||
126030568|NCT04318548|453410842|FG001|Overall Study|Other|2|||
126030569|NCT04318548|453410843|FG002|Overall Study|Other|3|||
126030570|NCT04179500|453410844|FG000|Treatment|Withdrawal by Subject|1|||
126030571|NCT04179500|453410844|FG000|Treatment|Adverse Event|2|||
126030572|NCT04179500|453410844|FG000|Treatment|pyrazinamide resistance|1|||
126258976|NCT03110380|454237940|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
126030573|NCT04927065|453410845|FG000|First Booster|Adverse Event|1|||
126030574|NCT04927065|453410846|FG001|First Booster|Adverse Event|0|||
126030575|NCT04927065|453410847|FG002|First Booster|Adverse Event|0|||
126030576|NCT04927065|453410848|FG003|First Booster|Adverse Event|0|||
126030577|NCT04927065|453410849|FG004|First Booster|Adverse Event|0|||
126030578|NCT04927065|453410850|FG005|First Booster|Adverse Event|0|||
126030579|NCT04927065|453410851|FG006|First Booster|Adverse Event|0|||
126030580|NCT04927065|453410852|FG007|First Booster|Adverse Event|1|||
126030581|NCT04927065|453410853|FG008|First Booster|Adverse Event|0|||
126030582|NCT04927065|453410854|FG009|First Booster|Adverse Event|0|||
126030583|NCT04927065|453410855|FG010|First Booster|Adverse Event|0|||
126096128|NCT03231800|453644626|FG001|Overall Study|Lost to Follow-up|2|||
126030584|NCT04927065|453410856|FG011|First Booster|Adverse Event|0|||
126030585|NCT04927065|453410857|FG012|First Booster|Adverse Event|0|||
126030586|NCT04927065|453410858|FG013|First Booster|Adverse Event|0|||
126030587|NCT04927065|453410859|FG014|First Booster|Adverse Event|0|||
126030588|NCT04927065|453410860|FG015|First Booster|Adverse Event|0|||
126030589|NCT04927065|453410845|FG000|First Booster|Death|1|||
126030590|NCT04927065|453410846|FG001|First Booster|Death|0|||
126030591|NCT04927065|453410847|FG002|First Booster|Death|0|||
126030592|NCT04927065|453410848|FG003|First Booster|Death|1|||
126030593|NCT04927065|453410849|FG004|First Booster|Death|0|||
126030594|NCT04927065|453410850|FG005|First Booster|Death|1|||
126030595|NCT04927065|453410851|FG006|First Booster|Death|0|||
126030596|NCT04927065|453410852|FG007|First Booster|Death|0|||
126030597|NCT04927065|453410853|FG008|First Booster|Death|0|||
126030598|NCT04927065|453410854|FG009|First Booster|Death|0|||
126030599|NCT04927065|453410855|FG010|First Booster|Death|0|||
126030600|NCT04927065|453410856|FG011|First Booster|Death|0|||
126030601|NCT04927065|453410857|FG012|First Booster|Death|0|||
126030602|NCT04927065|453410858|FG013|First Booster|Death|0|||
126030603|NCT04927065|453410859|FG014|First Booster|Death|0|||
126030604|NCT04927065|453410860|FG015|First Booster|Death|0|||
126030605|NCT04927065|453410845|FG000|First Booster|Lost to Follow-up|8|||
126030606|NCT04927065|453410846|FG001|First Booster|Lost to Follow-up|20|||
126030607|NCT04927065|453410847|FG002|First Booster|Lost to Follow-up|0|||
126030608|NCT04927065|453410848|FG003|First Booster|Lost to Follow-up|11|||
126030609|NCT04927065|453410849|FG004|First Booster|Lost to Follow-up|43|||
126030610|NCT04927065|453410850|FG005|First Booster|Lost to Follow-up|30|||
126030611|NCT04927065|453410851|FG006|First Booster|Lost to Follow-up|28|||
126030612|NCT04927065|453410852|FG007|First Booster|Lost to Follow-up|23|||
126030613|NCT04927065|453410853|FG008|First Booster|Lost to Follow-up|4|||
126030614|NCT04927065|453410854|FG009|First Booster|Lost to Follow-up|15|||
126030615|NCT04927065|453410855|FG010|First Booster|Lost to Follow-up|0|||
126030616|NCT04927065|453410856|FG011|First Booster|Lost to Follow-up|0|||
126030617|NCT04927065|453410857|FG012|First Booster|Lost to Follow-up|0|||
126030618|NCT04927065|453410858|FG013|First Booster|Lost to Follow-up|0|||
126030619|NCT04927065|453410859|FG014|First Booster|Lost to Follow-up|0|||
126030620|NCT04927065|453410860|FG015|First Booster|Lost to Follow-up|0|||
126030621|NCT04927065|453410845|FG000|First Booster|Physician Decision|1|||
126030622|NCT04927065|453410846|FG001|First Booster|Physician Decision|0|||
126030623|NCT04927065|453410847|FG002|First Booster|Physician Decision|0|||
126030624|NCT04927065|453410848|FG003|First Booster|Physician Decision|3|||
126030625|NCT04927065|453410849|FG004|First Booster|Physician Decision|1|||
126030626|NCT04927065|453410850|FG005|First Booster|Physician Decision|1|||
126030627|NCT04927065|453410851|FG006|First Booster|Physician Decision|0|||
126030628|NCT04927065|453410852|FG007|First Booster|Physician Decision|3|||
126030629|NCT04927065|453410853|FG008|First Booster|Physician Decision|0|||
126030630|NCT04927065|453410854|FG009|First Booster|Physician Decision|0|||
126030631|NCT04927065|453410855|FG010|First Booster|Physician Decision|0|||
126030632|NCT04927065|453410856|FG011|First Booster|Physician Decision|0|||
126030633|NCT04927065|453410857|FG012|First Booster|Physician Decision|0|||
126030634|NCT04927065|453410858|FG013|First Booster|Physician Decision|0|||
126030635|NCT04927065|453410859|FG014|First Booster|Physician Decision|0|||
126030636|NCT04927065|453410860|FG015|First Booster|Physician Decision|0|||
126030637|NCT04927065|453410845|FG000|First Booster|Protocol Violation|4|||
126030638|NCT04927065|453410846|FG001|First Booster|Protocol Violation|4|||
126030639|NCT04927065|453410847|FG002|First Booster|Protocol Violation|0|||
126030640|NCT04927065|453410848|FG003|First Booster|Protocol Violation|3|||
126030641|NCT04927065|453410849|FG004|First Booster|Protocol Violation|0|||
126030642|NCT04927065|453410850|FG005|First Booster|Protocol Violation|0|||
126030643|NCT04927065|453410851|FG006|First Booster|Protocol Violation|0|||
126030644|NCT04927065|453410852|FG007|First Booster|Protocol Violation|2|||
126030645|NCT04927065|453410853|FG008|First Booster|Protocol Violation|0|||
126258977|NCT03110380|454237941|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
126258978|NCT04480307|454237942|FG000|Overall Study|Withdrawal by Subject|0|||
126030646|NCT04927065|453410854|FG009|First Booster|Protocol Violation|0|||
126030647|NCT04927065|453410855|FG010|First Booster|Protocol Violation|0|||
126030648|NCT04927065|453410856|FG011|First Booster|Protocol Violation|0|||
126030649|NCT04927065|453410857|FG012|First Booster|Protocol Violation|0|||
126030650|NCT04927065|453410858|FG013|First Booster|Protocol Violation|0|||
126030651|NCT04927065|453410859|FG014|First Booster|Protocol Violation|0|||
126030652|NCT04927065|453410860|FG015|First Booster|Protocol Violation|0|||
126030653|NCT04927065|453410845|FG000|First Booster|Withdrawal by Subject|8|||
126030654|NCT04927065|453410846|FG001|First Booster|Withdrawal by Subject|23|||
126030655|NCT04927065|453410847|FG002|First Booster|Withdrawal by Subject|0|||
126030656|NCT04927065|453410848|FG003|First Booster|Withdrawal by Subject|19|||
126030657|NCT04927065|453410849|FG004|First Booster|Withdrawal by Subject|20|||
126030658|NCT04927065|453410850|FG005|First Booster|Withdrawal by Subject|15|||
126030659|NCT04927065|453410851|FG006|First Booster|Withdrawal by Subject|6|||
126030660|NCT04927065|453410852|FG007|First Booster|Withdrawal by Subject|24|||
126030661|NCT04927065|453410853|FG008|First Booster|Withdrawal by Subject|0|||
126030662|NCT04927065|453410854|FG009|First Booster|Withdrawal by Subject|4|||
126030663|NCT04927065|453410855|FG010|First Booster|Withdrawal by Subject|0|||
126030664|NCT04927065|453410856|FG011|First Booster|Withdrawal by Subject|0|||
126030665|NCT04927065|453410857|FG012|First Booster|Withdrawal by Subject|0|||
126030666|NCT04927065|453410858|FG013|First Booster|Withdrawal by Subject|0|||
126030667|NCT04927065|453410859|FG014|First Booster|Withdrawal by Subject|0|||
126030668|NCT04927065|453410860|FG015|First Booster|Withdrawal by Subject|0|||
126359210|NCT01292473|454607328|FG002|Overall Study|Adverse Event|1|||
126359211|NCT01292473|454607329|FG003|Overall Study|Adverse Event|1|||
126359212|NCT01292473|454607326|FG000|Overall Study|Lost to Follow-up|1|||
126359213|NCT01292473|454607327|FG001|Overall Study|Lost to Follow-up|1|||
126359214|NCT01292473|454607328|FG002|Overall Study|Lost to Follow-up|2|||
126359215|NCT01292473|454607329|FG003|Overall Study|Lost to Follow-up|2|||
126359216|NCT01292473|454607326|FG000|Overall Study|Withdrawal by Subject|3|||
126359217|NCT01292473|454607327|FG001|Overall Study|Withdrawal by Subject|4|||
126359218|NCT01292473|454607328|FG002|Overall Study|Withdrawal by Subject|3|||
126359219|NCT01292473|454607329|FG003|Overall Study|Withdrawal by Subject|3|||
126359220|NCT01292473|454607326|FG000|Overall Study|Physician Decision|0|||
126359221|NCT01292473|454607327|FG001|Overall Study|Physician Decision|1|||
126359222|NCT01292473|454607328|FG002|Overall Study|Physician Decision|0|||
126359223|NCT01292473|454607329|FG003|Overall Study|Physician Decision|0|||
126359224|NCT01292473|454607326|FG000|Overall Study|Disease Progression|0|||
126359225|NCT01292473|454607327|FG001|Overall Study|Disease Progression|1|||
126359226|NCT01292473|454607328|FG002|Overall Study|Disease Progression|3|||
126359227|NCT01292473|454607329|FG003|Overall Study|Disease Progression|6|||
126359228|NCT00458705|454607336|FG000|Overall Study|Adverse Event|4|||
126359229|NCT00458705|454607336|FG000|Overall Study|Not Treated|1|||
126359230|NCT01717859|454607338|FG000|Overall Study|Adverse Event|5|||
126359231|NCT01717859|454607338|FG000|Overall Study|Moved out of state|1|||
126359232|NCT01717859|454607338|FG000|Overall Study|Patient concerned about mental health|1|||
126359233|NCT01717859|454607338|FG000|Overall Study|Lost to Follow-up|1|||
126359234|NCT01717859|454607338|FG000|Overall Study|Withdrawal by Subject|2|||
126359235|NCT04389671|454607339|FG000|Overall Study|Death|7|||
126030669|NCT04927065|453410845|FG000|First Booster|Other Than Specified|1|||
126359236|NCT01111292|454607340|FG000|Treatment|Physician Decision|1|||
126359237|NCT01111292|454607341|FG001|Treatment|Physician Decision|1|||
126359238|NCT05463705|454607345|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
126359239|NCT05463705|454607346|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
126030670|NCT04927065|453410846|FG001|First Booster|Other Than Specified|1|||
126030671|NCT04927065|453410847|FG002|First Booster|Other Than Specified|0|||
126030672|NCT04927065|453410848|FG003|First Booster|Other Than Specified|1|||
126030673|NCT04927065|453410849|FG004|First Booster|Other Than Specified|2|||
126258979|NCT04480307|454237943|FG001|Overall Study|Withdrawal by Subject|1|||
126258980|NCT04480307|454237944|FG002|Overall Study|Withdrawal by Subject|0|||
126258981|NCT04480307|454237945|FG003|Overall Study|Withdrawal by Subject|0|||
126030674|NCT04927065|453410850|FG005|First Booster|Other Than Specified|3|||
126030675|NCT04927065|453410851|FG006|First Booster|Other Than Specified|2|||
126030676|NCT04927065|453410852|FG007|First Booster|Other Than Specified|6|||
126030677|NCT04927065|453410853|FG008|First Booster|Other Than Specified|0|||
126096129|NCT03231800|453644625|FG000|Overall Study|Protocol Violation|1|||
126096130|NCT03231800|453644626|FG001|Overall Study|Protocol Violation|1|||
126096131|NCT03231800|453644625|FG000|Overall Study|reason not provided|2|||
126096132|NCT03231800|453644626|FG001|Overall Study|reason not provided|0|||
126096133|NCT00859222|453644627|FG000|Overall Study|Adverse Event|2|||
126096134|NCT00859222|453644628|FG001|Overall Study|Adverse Event|3|||
126096135|NCT00859222|453644629|FG002|Overall Study|Adverse Event|6|||
126096136|NCT00859222|453644630|FG003|Overall Study|Adverse Event|24|||
126096137|NCT00859222|453644631|FG004|Overall Study|Adverse Event|15|||
126096138|NCT00859222|453644627|FG000|Overall Study|DLT|1|||
126096139|NCT00859222|453644628|FG001|Overall Study|DLT|0|||
126096140|NCT00859222|453644629|FG002|Overall Study|DLT|0|||
126096141|NCT00859222|453644630|FG003|Overall Study|DLT|0|||
126096142|NCT00859222|453644631|FG004|Overall Study|DLT|0|||
126096143|NCT00400725|453644642|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
126096144|NCT00400725|453644643|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
126096145|NCT00400725|453644644|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
126096146|NCT00400725|453644642|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
126096147|NCT00400725|453644643|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
126096148|NCT00400725|453644644|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
126096149|NCT00400725|453644642|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
126096150|NCT00400725|453644643|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
126096151|NCT00400725|453644644|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
126096152|NCT00400725|453644642|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
126096153|NCT00400725|453644643|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
126096154|NCT00400725|453644644|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
126096155|NCT00400725|453644642|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
126096156|NCT00400725|453644643|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
126096157|NCT00400725|453644644|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
126096158|NCT00400725|453644642|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
126096159|NCT00400725|453644643|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
126096160|NCT00400725|453644644|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
126096161|NCT00400725|453644642|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
126096162|NCT00400725|453644643|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
126096163|NCT00400725|453644644|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
126096164|NCT00400725|453644642|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
126096165|NCT00400725|453644643|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
125880018|NCT02326155|452858735|FG001|Overall Study|except for study close|13|||
125880019|NCT05024032|452858736|FG000|Overall Study|Withdrawal by Subject|0|||
125880020|NCT05024032|452858737|FG001|Overall Study|Withdrawal by Subject|3|||
125880021|NCT05024032|452858738|FG002|Overall Study|Withdrawal by Subject|4|||
125880022|NCT05024032|452858736|FG000|Overall Study|Adverse Event|0|||
125880023|NCT05024032|452858737|FG001|Overall Study|Adverse Event|1|||
125880024|NCT05024032|452858738|FG002|Overall Study|Adverse Event|0|||
125880025|NCT05024032|452858736|FG000|Overall Study|Protocol Deviation|1|||
125880026|NCT05024032|452858737|FG001|Overall Study|Protocol Deviation|0|||
125880027|NCT05024032|452858738|FG002|Overall Study|Protocol Deviation|0|||
125880028|NCT03591406|452858741|FG000|Overall Study|Adverse Event|5|||
125880029|NCT03591406|452858742|FG001|Overall Study|Adverse Event|3|||
125880030|NCT03591406|452858741|FG000|Overall Study|Protocol Violation|2|||
125880031|NCT03591406|452858742|FG001|Overall Study|Protocol Violation|1|||
125880032|NCT03591406|452858741|FG000|Overall Study|Withdrawal by Subject|0|||
125880033|NCT03591406|452858742|FG001|Overall Study|Withdrawal by Subject|5|||
126096166|NCT00400725|453644644|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
126096167|NCT00400725|453644642|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
126096168|NCT00400725|453644643|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
126096169|NCT00400725|453644644|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
126258982|NCT04480307|454237942|FG000|Overall Study|Adverse Event|0|||
125880034|NCT02066181|452858743|FG000|Overall Study|Withdrawal by Subject|1|||
125880035|NCT02066181|452858744|FG001|Overall Study|Withdrawal by Subject|1|||
125880036|NCT01083771|452858745|FG000|Overall Study|non-compliant|2|||
125880037|NCT01083771|452858745|FG000|Overall Study|Withdrawal by Subject|3|||
126096170|NCT00888927|453644652|FG000|Overall Study|Adverse Event|0|||
126096171|NCT00888927|453644653|FG001|Overall Study|Adverse Event|0|||
126030678|NCT04927065|453410854|FG009|First Booster|Other Than Specified|4|||
126030679|NCT04927065|453410855|FG010|First Booster|Other Than Specified|0|||
126030680|NCT04927065|453410856|FG011|First Booster|Other Than Specified|0|||
126030681|NCT04927065|453410857|FG012|First Booster|Other Than Specified|0|||
126030682|NCT04927065|453410858|FG013|First Booster|Other Than Specified|0|||
126030683|NCT04927065|453410859|FG014|First Booster|Other Than Specified|0|||
126030684|NCT04927065|453410860|FG015|First Booster|Other Than Specified|0|||
126030685|NCT04927065|453410845|FG000|Second Booster|Death|0|||
126030686|NCT04927065|453410846|FG001|Second Booster|Death|0|||
126030687|NCT04927065|453410847|FG002|Second Booster|Death|0|||
126030688|NCT04927065|453410848|FG003|Second Booster|Death|0|||
126030689|NCT04927065|453410849|FG004|Second Booster|Death|0|||
126258983|NCT04480307|454237943|FG001|Overall Study|Adverse Event|0|||
125880038|NCT00939393|452858748|FG000|Overall Study|Withdrawal by Subject|1|||
126258984|NCT04480307|454237944|FG002|Overall Study|Adverse Event|0|||
126258985|NCT04480307|454237945|FG003|Overall Study|Adverse Event|1|||
126258986|NCT01609582|454237947|FG000|Overall Study|Adverse Event|20|||
126258987|NCT01609582|454237948|FG001|Overall Study|Adverse Event|18|||
126258988|NCT01609582|454237947|FG000|Overall Study|Lost to Follow-up|10|||
126258989|NCT01609582|454237948|FG001|Overall Study|Lost to Follow-up|10|||
126258990|NCT01609582|454237947|FG000|Overall Study|Withdrawal by Subject|21|||
126258991|NCT01609582|454237948|FG001|Overall Study|Withdrawal by Subject|15|||
126258992|NCT01609582|454237947|FG000|Overall Study|Study Terminated by Sponsor|1543|||
126258993|NCT01609582|454237948|FG001|Overall Study|Study Terminated by Sponsor|1548|||
126258994|NCT01609582|454237947|FG000|Overall Study|Other|9|||
126258995|NCT01609582|454237948|FG001|Overall Study|Other|10|||
126258996|NCT01609582|454237947|FG000|Overall Study|Randomized, but not treated|0|||
126258997|NCT01609582|454237948|FG001|Overall Study|Randomized, but not treated|3|||
126258998|NCT00819767|454237949|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126258999|NCT00819767|454237950|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126259000|NCT00808509|454237954|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
126259001|NCT00808509|454237955|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
126259002|NCT00808509|454237954|FG000|Randomized Phase|Reduced methotrexate dose|1|||
126259003|NCT00808509|454237955|FG001|Randomized Phase|Reduced methotrexate dose|2|||
126259004|NCT00808509|454237954|FG000|Randomized Phase|Patient refused rescue therapy|0|||
126259005|NCT00808509|454237955|FG001|Randomized Phase|Patient refused rescue therapy|3|||
126259006|NCT02762994|454237960|FG000|Overall Study|Withdrawal by Subject|0|||
126259007|NCT02762994|454237961|FG001|Overall Study|Withdrawal by Subject|1|||
126259008|NCT02762994|454237962|FG002|Overall Study|Withdrawal by Subject|2|||
126259009|NCT02762994|454237963|FG003|Overall Study|Withdrawal by Subject|0|||
126259010|NCT02762994|454237960|FG000|Overall Study|Protocol Violation|1|||
126259011|NCT02762994|454237961|FG001|Overall Study|Protocol Violation|0|||
126259012|NCT02762994|454237962|FG002|Overall Study|Protocol Violation|0|||
126259013|NCT02762994|454237963|FG003|Overall Study|Protocol Violation|2|||
125880039|NCT00939393|452858749|FG001|Overall Study|Withdrawal by Subject|0|||
125880040|NCT00939393|452858748|FG000|Overall Study|Lost to Follow-up|3|||
125880041|NCT00939393|452858749|FG001|Overall Study|Lost to Follow-up|0|||
126259014|NCT04234464|454237964|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
126259015|NCT04234464|454237965|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
126259016|NCT01701973|454237966|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259017|NCT01701973|454237967|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
126259018|NCT01701973|454237968|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125880042|NCT02851615|452858750|FG000|Overall Study|Cognitive Issue|1|||
125880043|NCT02851615|452858751|FG001|Overall Study|Cognitive Issue|0|||
125880044|NCT02851615|452858750|FG000|Overall Study|Lost to Follow-up|0|||
126030690|NCT04927065|453410850|FG005|Second Booster|Death|0|||
126030691|NCT04927065|453410851|FG006|Second Booster|Death|0|||
126030692|NCT04927065|453410852|FG007|Second Booster|Death|0|||
126030693|NCT04927065|453410853|FG008|Second Booster|Death|0|||
126259019|NCT01701973|454237969|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259020|NCT01701973|454237970|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126030694|NCT04927065|453410854|FG009|Second Booster|Death|0|||
126259021|NCT01701973|454237971|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259022|NCT01701973|454237972|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259023|NCT01701973|454237973|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259024|NCT02412722|454237976|FG000|Overall Study|Adverse Event|0|||
126259025|NCT02412722|454237977|FG001|Overall Study|Adverse Event|2|||
126259026|NCT02412722|454237978|FG002|Overall Study|Adverse Event|0|||
126259027|NCT02412722|454237979|FG003|Overall Study|Adverse Event|3|||
126259028|NCT02412722|454237980|FG004|Overall Study|Adverse Event|0|||
126030695|NCT04927065|453410855|FG010|Second Booster|Death|2|||
126030696|NCT04927065|453410856|FG011|Second Booster|Death|0|||
126259029|NCT02412722|454237981|FG005|Overall Study|Adverse Event|3|||
126259030|NCT02412722|454237976|FG000|Overall Study|Progressive Disease|6|||
126259031|NCT02412722|454237977|FG001|Overall Study|Progressive Disease|4|||
126030697|NCT04927065|453410857|FG012|Second Booster|Death|2|||
126030698|NCT04927065|453410858|FG013|Second Booster|Death|2|||
126030699|NCT04927065|453410859|FG014|Second Booster|Death|0|||
126030700|NCT04927065|453410860|FG015|Second Booster|Death|0|||
126030701|NCT04927065|453410845|FG000|Second Booster|Lost to Follow-up|0|||
126030702|NCT04927065|453410846|FG001|Second Booster|Lost to Follow-up|0|||
126030703|NCT04927065|453410847|FG002|Second Booster|Lost to Follow-up|3|||
126030704|NCT04927065|453410848|FG003|Second Booster|Lost to Follow-up|0|||
126030705|NCT04927065|453410849|FG004|Second Booster|Lost to Follow-up|0|||
126030706|NCT04927065|453410850|FG005|Second Booster|Lost to Follow-up|0|||
126030707|NCT04927065|453410851|FG006|Second Booster|Lost to Follow-up|0|||
126030708|NCT04927065|453410852|FG007|Second Booster|Lost to Follow-up|0|||
126030709|NCT04927065|453410853|FG008|Second Booster|Lost to Follow-up|0|||
126030710|NCT04927065|453410854|FG009|Second Booster|Lost to Follow-up|0|||
126030711|NCT04927065|453410855|FG010|Second Booster|Lost to Follow-up|14|||
126030712|NCT04927065|453410856|FG011|Second Booster|Lost to Follow-up|10|||
126030713|NCT04927065|453410857|FG012|Second Booster|Lost to Follow-up|13|||
126030714|NCT04927065|453410858|FG013|Second Booster|Lost to Follow-up|16|||
126030715|NCT04927065|453410859|FG014|Second Booster|Lost to Follow-up|0|||
126030716|NCT04927065|453410860|FG015|Second Booster|Lost to Follow-up|0|||
126030717|NCT04927065|453410845|FG000|Second Booster|Physician Decision|0|||
126030718|NCT04927065|453410846|FG001|Second Booster|Physician Decision|0|||
126030719|NCT04927065|453410847|FG002|Second Booster|Physician Decision|0|||
126030720|NCT04927065|453410848|FG003|Second Booster|Physician Decision|0|||
126030721|NCT04927065|453410849|FG004|Second Booster|Physician Decision|0|||
126259032|NCT02412722|454237978|FG002|Overall Study|Progressive Disease|4|||
126259033|NCT02412722|454237979|FG003|Overall Study|Progressive Disease|9|||
126259034|NCT02412722|454237980|FG004|Overall Study|Progressive Disease|3|||
126259035|NCT02412722|454237981|FG005|Overall Study|Progressive Disease|3|||
126359240|NCT05463705|454607347|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
126359241|NCT05463705|454607348|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
126359242|NCT05463705|454607349|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
126359243|NCT05463705|454607350|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
126359244|NCT01530997|454607356|FG000|Overall Study|Physician Decision|1|||
126359245|NCT01530997|454607356|FG000|Overall Study|Withdrawal by Subject|1|||
126359246|NCT02181738|454607359|FG000|Overall Study|Participant Withdrew Consent|2|||
126359247|NCT02181738|454607360|FG001|Overall Study|Participant Withdrew Consent|1|||
126359248|NCT02181738|454607361|FG002|Overall Study|Participant Withdrew Consent|1|||
126359249|NCT02181738|454607362|FG003|Overall Study|Participant Withdrew Consent|1|||
126359250|NCT02181738|454607359|FG000|Overall Study|Lost to Follow-up|1|||
126359251|NCT02181738|454607360|FG001|Overall Study|Lost to Follow-up|2|||
126359252|NCT02181738|454607361|FG002|Overall Study|Lost to Follow-up|1|||
126359253|NCT02181738|454607362|FG003|Overall Study|Lost to Follow-up|1|||
126359254|NCT02181738|454607359|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
126359255|NCT02181738|454607360|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
126359256|NCT02181738|454607361|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
126359257|NCT02181738|454607362|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
126359258|NCT02181738|454607359|FG000|Overall Study|Poor/Non-Compliance|1|||
126359259|NCT02181738|454607360|FG001|Overall Study|Poor/Non-Compliance|0|||
126359260|NCT02181738|454607361|FG002|Overall Study|Poor/Non-Compliance|2|||
126359261|NCT02181738|454607362|FG003|Overall Study|Poor/Non-Compliance|1|||
126359262|NCT02181738|454607359|FG000|Overall Study|Disease Progression|28|||
126359263|NCT02181738|454607360|FG001|Overall Study|Disease Progression|35|||
126359264|NCT02181738|454607361|FG002|Overall Study|Disease Progression|40|||
126359265|NCT02181738|454607362|FG003|Overall Study|Disease Progression|0|||
126359266|NCT02181738|454607359|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
126359267|NCT02181738|454607360|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
126359268|NCT02181738|454607361|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
126030722|NCT04927065|453410850|FG005|Second Booster|Physician Decision|0|||
126030723|NCT04927065|453410851|FG006|Second Booster|Physician Decision|0|||
126030724|NCT04927065|453410852|FG007|Second Booster|Physician Decision|0|||
126030725|NCT04927065|453410853|FG008|Second Booster|Physician Decision|0|||
126030726|NCT04927065|453410854|FG009|Second Booster|Physician Decision|0|||
126030727|NCT04927065|453410855|FG010|Second Booster|Physician Decision|0|||
126030728|NCT04927065|453410856|FG011|Second Booster|Physician Decision|3|||
126030729|NCT04927065|453410857|FG012|Second Booster|Physician Decision|0|||
126030730|NCT04927065|453410858|FG013|Second Booster|Physician Decision|1|||
126030731|NCT04927065|453410859|FG014|Second Booster|Physician Decision|0|||
126030732|NCT04927065|453410860|FG015|Second Booster|Physician Decision|0|||
126259036|NCT02412722|454237976|FG000|Overall Study|Withdrawal by Subject|2|||
126259037|NCT02412722|454237977|FG001|Overall Study|Withdrawal by Subject|0|||
126259038|NCT02412722|454237978|FG002|Overall Study|Withdrawal by Subject|1|||
126259039|NCT02412722|454237979|FG003|Overall Study|Withdrawal by Subject|2|||
126259040|NCT02412722|454237980|FG004|Overall Study|Withdrawal by Subject|1|||
126259041|NCT02412722|454237981|FG005|Overall Study|Withdrawal by Subject|1|||
126259042|NCT02412722|454237976|FG000|Overall Study|Lost to Follow-up|0|||
126259043|NCT02412722|454237977|FG001|Overall Study|Lost to Follow-up|0|||
126259044|NCT02412722|454237978|FG002|Overall Study|Lost to Follow-up|0|||
126259045|NCT02412722|454237979|FG003|Overall Study|Lost to Follow-up|0|||
126259046|NCT02412722|454237980|FG004|Overall Study|Lost to Follow-up|1|||
126259047|NCT02412722|454237981|FG005|Overall Study|Lost to Follow-up|0|||
126259048|NCT02412722|454237976|FG000|Overall Study|Received drug in run-in and discontinued|0|||
126259049|NCT02412722|454237977|FG001|Overall Study|Received drug in run-in and discontinued|2|||
126259050|NCT02412722|454237978|FG002|Overall Study|Received drug in run-in and discontinued|0|||
126259051|NCT02412722|454237979|FG003|Overall Study|Received drug in run-in and discontinued|0|||
126259052|NCT02412722|454237980|FG004|Overall Study|Received drug in run-in and discontinued|0|||
126259053|NCT02412722|454237981|FG005|Overall Study|Received drug in run-in and discontinued|0|||
126259054|NCT02412722|454237976|FG000|Overall Study|Reason not Specified|3|||
126259055|NCT02412722|454237977|FG001|Overall Study|Reason not Specified|0|||
126259056|NCT02412722|454237978|FG002|Overall Study|Reason not Specified|2|||
126259057|NCT02412722|454237979|FG003|Overall Study|Reason not Specified|1|||
126259058|NCT02412722|454237980|FG004|Overall Study|Reason not Specified|2|||
126259059|NCT02412722|454237981|FG005|Overall Study|Reason not Specified|6|||
126259060|NCT02941523|454237982|FG000|Monotherapy|Withdrawal by Subject|0|||
126259061|NCT02941523|454237983|FG001|Monotherapy|Withdrawal by Subject|1|||
126259062|NCT02941523|454237982|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
126259063|NCT02941523|454237983|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
126259064|NCT02941523|454237982|FG000|Carboplatin Combination Therapy|Death|1|||
126259065|NCT02941523|454237983|FG001|Carboplatin Combination Therapy|Death|2|||
126259066|NCT02941523|454237982|FG000|Carboplatin Combination Therapy|Disease progression|2|||
126259067|NCT02941523|454237983|FG001|Carboplatin Combination Therapy|Disease progression|0|||
126259068|NCT02941523|454237982|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
126259069|NCT02941523|454237983|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
126259070|NCT04449341|454237984|FG000|Overall Study|Protocol Violation|1|||
126259071|NCT04449341|454237985|FG001|Overall Study|Protocol Violation|0|||
126259072|NCT01899326|454237987|FG000|Overall Study|Withdrawal by Subject|1|||
126259073|NCT01899326|454237987|FG000|Overall Study|Adverse Event|2|||
126259074|NCT01899326|454237987|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
126259075|NCT00373425|454237988|FG000|Overall Study|Relapse of NSCLC|116|||
126259076|NCT00373425|454237989|FG001|Overall Study|Relapse of NSCLC|104|||
126259077|NCT00373425|454237990|FG002|Overall Study|Relapse of NSCLC|19|||
126259078|NCT00373425|454237991|FG003|Overall Study|Relapse of NSCLC|2|||
126259079|NCT00373425|454237992|FG004|Overall Study|Relapse of NSCLC|26|||
126259080|NCT00373425|454237988|FG000|Overall Study|Adverse Event|191|||
126259081|NCT00373425|454237989|FG001|Overall Study|Adverse Event|22|||
126259082|NCT00373425|454237990|FG002|Overall Study|Adverse Event|59|||
126259083|NCT00373425|454237991|FG003|Overall Study|Adverse Event|0|||
126259084|NCT00373425|454237992|FG004|Overall Study|Adverse Event|34|||
126259085|NCT00373425|454237988|FG000|Overall Study|Patient request|35|||
126259086|NCT00373425|454237989|FG001|Overall Study|Patient request|18|||
126259087|NCT00373425|454237990|FG002|Overall Study|Patient request|43|||
126259088|NCT00373425|454237991|FG003|Overall Study|Patient request|6|||
126259089|NCT00373425|454237992|FG004|Overall Study|Patient request|7|||
126259090|NCT00373425|454237988|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
126259091|NCT00373425|454237989|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
126096172|NCT00888927|453644654|FG002|Overall Study|Adverse Event|0|||
126259092|NCT00373425|454237990|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
126259093|NCT00373425|454237991|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
126259094|NCT00373425|454237992|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
126259095|NCT00373425|454237988|FG000|Overall Study|Death|7|||
126259096|NCT00373425|454237989|FG001|Overall Study|Death|0|||
126259097|NCT00373425|454237990|FG002|Overall Study|Death|3|||
126259098|NCT00373425|454237991|FG003|Overall Study|Death|1|||
126259099|NCT00373425|454237992|FG004|Overall Study|Death|0|||
126259100|NCT00551616|454237995|FG000|Overall Study|Lost to Follow-up|48|||
126259101|NCT00551616|454237996|FG001|Overall Study|Lost to Follow-up|40|||
126259102|NCT01263561|454237997|FG000|Overall Study|Death|1|||
126259103|NCT01263561|454237998|FG001|Overall Study|Death|2|||
126259104|NCT03942211|454237999|FG000|Overall Study|Death|1|||
126259105|NCT03942211|454238000|FG001|Overall Study|Death|0|||
126259106|NCT03942211|454237999|FG000|Overall Study|Study terminated by sponsor|5|||
126259107|NCT03942211|454238000|FG001|Overall Study|Study terminated by sponsor|3|||
126259108|NCT03942211|454237999|FG000|Overall Study|Adverse Event|0|||
126259109|NCT03942211|454238000|FG001|Overall Study|Adverse Event|1|||
125880045|NCT02851615|452858751|FG001|Overall Study|Lost to Follow-up|4|||
125880046|NCT03714672|452858760|FG000|Overall Study|Adverse Event|0|||
125880047|NCT03714672|452858761|FG001|Overall Study|Adverse Event|0|||
125880048|NCT03714672|452858762|FG002|Overall Study|Adverse Event|3|||
126259110|NCT01396421|454238001|FG000|Overall Study|Lost to Follow-up|0|||
126030733|NCT04927065|453410845|FG000|Second Booster|Withdrawal by Subject|0|||
126096173|NCT00888927|453644655|FG003|Overall Study|Adverse Event|1|||
126096174|NCT00888927|453644652|FG000|Overall Study|Withdrawal of consent|0|||
126259111|NCT01396421|454238002|FG001|Overall Study|Lost to Follow-up|0|||
126259112|NCT01396421|454238003|FG002|Overall Study|Lost to Follow-up|0|||
126259113|NCT01396421|454238004|FG003|Overall Study|Lost to Follow-up|1|||
126259114|NCT01396421|454238001|FG000|Overall Study|Adverse Event|17|||
126259115|NCT01396421|454238002|FG001|Overall Study|Adverse Event|15|||
126259116|NCT01396421|454238003|FG002|Overall Study|Adverse Event|12|||
126259117|NCT01396421|454238004|FG003|Overall Study|Adverse Event|32|||
126259118|NCT01396421|454238001|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
126259119|NCT01396421|454238002|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
126259120|NCT01396421|454238003|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
126259121|NCT01396421|454238004|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
126259122|NCT01396421|454238001|FG000|Overall Study|Physician Decision|1|||
126259123|NCT01396421|454238002|FG001|Overall Study|Physician Decision|1|||
126259124|NCT01396421|454238003|FG002|Overall Study|Physician Decision|0|||
126259125|NCT01396421|454238004|FG003|Overall Study|Physician Decision|3|||
126259126|NCT01396421|454238001|FG000|Overall Study|Withdrawal by Subject|31|||
126259127|NCT01396421|454238002|FG001|Overall Study|Withdrawal by Subject|24|||
126259128|NCT01396421|454238003|FG002|Overall Study|Withdrawal by Subject|13|||
126259129|NCT01396421|454238004|FG003|Overall Study|Withdrawal by Subject|21|||
126259130|NCT01396421|454238001|FG000|Overall Study|Protocol Deviation|2|||
126259131|NCT01396421|454238002|FG001|Overall Study|Protocol Deviation|1|||
126259132|NCT01396421|454238003|FG002|Overall Study|Protocol Deviation|1|||
126259133|NCT01396421|454238004|FG003|Overall Study|Protocol Deviation|0|||
126259134|NCT01396421|454238001|FG000|Overall Study|Lack of Efficacy|7|||
126259135|NCT01396421|454238002|FG001|Overall Study|Lack of Efficacy|17|||
126259136|NCT01396421|454238003|FG002|Overall Study|Lack of Efficacy|7|||
126259137|NCT01396421|454238004|FG003|Overall Study|Lack of Efficacy|18|||
126259138|NCT00569777|454238008|FG000|Overall Study|Withdrawal by Subject|4|||
126259139|NCT00569777|454238009|FG001|Overall Study|Withdrawal by Subject|0|||
126259140|NCT00569777|454238008|FG000|Overall Study|Adverse Event|3|||
126259141|NCT00569777|454238009|FG001|Overall Study|Adverse Event|0|||
126259142|NCT00569777|454238008|FG000|Overall Study|Lost to Follow-up|1|||
126259143|NCT00569777|454238009|FG001|Overall Study|Lost to Follow-up|0|||
126259144|NCT00569777|454238008|FG000|Overall Study|scheduled eye surgery|0|||
126259145|NCT00569777|454238009|FG001|Overall Study|scheduled eye surgery|1|||
126259146|NCT00569777|454238008|FG000|Overall Study|did not meet exclusion criteria|1|||
126259147|NCT00569777|454238009|FG001|Overall Study|did not meet exclusion criteria|2|||
126259148|NCT00569777|454238008|FG000|Overall Study|pregnant|1|||
125880049|NCT03714672|452858763|FG003|Overall Study|Adverse Event|0|||
125880050|NCT03714672|452858760|FG000|Overall Study|Physician Decision|0|||
126030734|NCT04927065|453410846|FG001|Second Booster|Withdrawal by Subject|0|||
126030735|NCT04927065|453410847|FG002|Second Booster|Withdrawal by Subject|4|||
126030736|NCT04927065|453410848|FG003|Second Booster|Withdrawal by Subject|0|||
126030737|NCT04927065|453410849|FG004|Second Booster|Withdrawal by Subject|0|||
126030738|NCT04927065|453410850|FG005|Second Booster|Withdrawal by Subject|0|||
126030739|NCT04927065|453410851|FG006|Second Booster|Withdrawal by Subject|0|||
126030740|NCT04927065|453410852|FG007|Second Booster|Withdrawal by Subject|0|||
126030741|NCT04927065|453410853|FG008|Second Booster|Withdrawal by Subject|0|||
126030742|NCT04927065|453410854|FG009|Second Booster|Withdrawal by Subject|0|||
126030743|NCT04927065|453410855|FG010|Second Booster|Withdrawal by Subject|3|||
126030744|NCT04927065|453410856|FG011|Second Booster|Withdrawal by Subject|16|||
126030745|NCT04927065|453410857|FG012|Second Booster|Withdrawal by Subject|13|||
126030746|NCT04927065|453410858|FG013|Second Booster|Withdrawal by Subject|9|||
126030747|NCT04927065|453410859|FG014|Second Booster|Withdrawal by Subject|0|||
126259149|NCT00569777|454238009|FG001|Overall Study|pregnant|0|||
126030748|NCT04927065|453410860|FG015|Second Booster|Withdrawal by Subject|0|||
125880051|NCT03714672|452858761|FG001|Overall Study|Physician Decision|1|||
125880052|NCT03714672|452858762|FG002|Overall Study|Physician Decision|0|||
126030749|NCT04927065|453410845|FG000|Second Booster|Other Than Specified|0|||
126030750|NCT04927065|453410846|FG001|Second Booster|Other Than Specified|0|||
126096175|NCT00888927|453644653|FG001|Overall Study|Withdrawal of consent|0|||
126259150|NCT01835548|454238014|FG000|Dose Optimization Period|Adverse Event|0|||
126259151|NCT01835548|454238015|FG001|Dose Optimization Period|Adverse Event|0|||
126259152|NCT01835548|454238016|FG002|Dose Optimization Period|Adverse Event|1|||
126259153|NCT01835548|454238014|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
126259154|NCT01835548|454238015|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
126259155|NCT01835548|454238016|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
126259156|NCT01835548|454238014|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126259157|NCT01835548|454238015|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126259158|NCT01835548|454238016|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126030751|NCT04927065|453410847|FG002|Second Booster|Other Than Specified|0|||
126030752|NCT04927065|453410848|FG003|Second Booster|Other Than Specified|0|||
126030753|NCT04927065|453410849|FG004|Second Booster|Other Than Specified|0|||
126030754|NCT04927065|453410850|FG005|Second Booster|Other Than Specified|0|||
126259159|NCT01835548|454238014|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126259160|NCT01835548|454238015|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126259161|NCT01835548|454238016|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126259162|NCT00537017|454238017|FG000|Treatment Phase|Adverse Event|19|||
126259163|NCT00537017|454238017|FG000|Treatment Phase|Withdrawal by Subject|13|||
126259164|NCT00537017|454238017|FG000|Treatment Phase|Protocol Violation|2|||
126259165|NCT00537017|454238017|FG000|Follow-up Phase|Withdrawal by Subject|9|||
126259166|NCT03168906|454238022|FG000|Overall Study|Lack of Efficacy|6|||
126259167|NCT03168906|454238023|FG001|Overall Study|Lack of Efficacy|6|||
126259168|NCT01321697|454238024|FG000|Overall Study|Study Terminated|7|||
126259169|NCT02447887|454239580|FG000|Overall Study|Study was terminated|3|||
126259170|NCT02839798|454239581|FG000|Overall Study|Withdrawal by Subject|2|||
126259171|NCT01989676|454239583|FG000|Overall Study|Death|52|||
126259172|NCT01989676|454239584|FG001|Overall Study|Death|60|||
126259173|NCT01989676|454239583|FG000|Overall Study|Protocol Violation|2|||
126259174|NCT01989676|454239584|FG001|Overall Study|Protocol Violation|1|||
126259175|NCT01989676|454239583|FG000|Overall Study|Lost to Follow-up|8|||
126259176|NCT01989676|454239584|FG001|Overall Study|Lost to Follow-up|18|||
126259177|NCT01989676|454239583|FG000|Overall Study|No longer willing to participate in study|26|||
126259178|NCT01989676|454239584|FG001|Overall Study|No longer willing to participate in study|26|||
126259179|NCT01989676|454239583|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
126259180|NCT01989676|454239584|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
126259181|NCT01989676|454239583|FG000|Overall Study|Other|4|||
126259182|NCT01989676|454239584|FG001|Overall Study|Other|3|||
126259183|NCT03941834|454239585|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
126259184|NCT03941834|454239586|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
126259185|NCT03941834|454239587|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
126259186|NCT03941834|454239585|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
126259187|NCT03941834|454239586|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
126259188|NCT03941834|454239587|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
126259189|NCT03941834|454239585|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
126259190|NCT03941834|454239586|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
126259191|NCT03941834|454239587|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
126259192|NCT03941834|454239585|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
126259193|NCT03941834|454239586|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
126259194|NCT03941834|454239587|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
126259195|NCT03941834|454239585|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
126259196|NCT03941834|454239586|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
126259197|NCT03941834|454239587|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
126259198|NCT03941834|454239585|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
126259199|NCT03941834|454239586|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
126259200|NCT03941834|454239587|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
126259201|NCT01560819|454239591|FG000|Overall Study|Physician Decision|1|||
126259202|NCT01560819|454239592|FG001|Overall Study|Physician Decision|0|||
126259203|NCT02788513|454239593|FG000|Overall Study|Withdrawal by Subject|3|||
126259204|NCT02788513|454239594|FG001|Overall Study|Withdrawal by Subject|0|||
126259205|NCT02788513|454239595|FG002|Overall Study|Withdrawal by Subject|2|||
126259206|NCT02788513|454239596|FG003|Overall Study|Withdrawal by Subject|3|||
126259207|NCT02788513|454239597|FG004|Overall Study|Withdrawal by Subject|1|||
126259208|NCT02788513|454239593|FG000|Overall Study|Lost to Follow-up|1|||
126259209|NCT02788513|454239594|FG001|Overall Study|Lost to Follow-up|0|||
126259210|NCT02788513|454239595|FG002|Overall Study|Lost to Follow-up|0|||
126259211|NCT02788513|454239596|FG003|Overall Study|Lost to Follow-up|0|||
126259212|NCT02788513|454239597|FG004|Overall Study|Lost to Follow-up|1|||
126259213|NCT02788513|454239593|FG000|Overall Study|Adverse Event|5|||
126259214|NCT02788513|454239594|FG001|Overall Study|Adverse Event|8|||
126259215|NCT02788513|454239595|FG002|Overall Study|Adverse Event|4|||
126259216|NCT02788513|454239596|FG003|Overall Study|Adverse Event|2|||
126259217|NCT02788513|454239597|FG004|Overall Study|Adverse Event|2|||
126259218|NCT02788513|454239593|FG000|Overall Study|Protocol Violation|0|||
126259219|NCT02788513|454239594|FG001|Overall Study|Protocol Violation|0|||
126359269|NCT02181738|454607362|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
126359270|NCT02181738|454607359|FG000|Overall Study|Study Drug Toxicity|6|||
126030755|NCT04927065|453410851|FG006|Second Booster|Other Than Specified|0|||
126259220|NCT02788513|454239595|FG002|Overall Study|Protocol Violation|1|||
126259221|NCT02788513|454239596|FG003|Overall Study|Protocol Violation|1|||
126259222|NCT02788513|454239597|FG004|Overall Study|Protocol Violation|0|||
126259223|NCT02788513|454239593|FG000|Overall Study|Subject decided to stop taking treatment|0|||
126259224|NCT02788513|454239594|FG001|Overall Study|Subject decided to stop taking treatment|0|||
125880053|NCT03714672|452858763|FG003|Overall Study|Physician Decision|0|||
125880054|NCT03714672|452858760|FG000|Overall Study|Other Reason|1|||
125880055|NCT03714672|452858761|FG001|Overall Study|Other Reason|2|||
125880056|NCT03714672|452858762|FG002|Overall Study|Other Reason|1|||
125880057|NCT03714672|452858763|FG003|Overall Study|Other Reason|1|||
125880058|NCT03714672|452858760|FG000|Overall Study|Lost to Follow-up|1|||
125880059|NCT03714672|452858761|FG001|Overall Study|Lost to Follow-up|1|||
125880060|NCT03714672|452858762|FG002|Overall Study|Lost to Follow-up|0|||
125880061|NCT03714672|452858763|FG003|Overall Study|Lost to Follow-up|0|||
125880062|NCT00371150|452858764|FG000|Overall Study|Lost to Follow-up|3|||
125880063|NCT00371150|452858765|FG001|Overall Study|Lost to Follow-up|2|||
125880064|NCT02345070|452858767|FG000|Overall Study|Adverse Event|12|||
125880065|NCT02345070|452858768|FG001|Overall Study|Adverse Event|8|||
125880066|NCT02345070|452858769|FG002|Overall Study|Adverse Event|16|||
125880067|NCT02345070|452858767|FG000|Overall Study|Poor compliance to protocol|2|||
125880068|NCT02345070|452858768|FG001|Overall Study|Poor compliance to protocol|0|||
125880069|NCT02345070|452858769|FG002|Overall Study|Poor compliance to protocol|0|||
125880070|NCT02345070|452858767|FG000|Overall Study|Other than specified above|6|||
125880071|NCT02345070|452858768|FG001|Overall Study|Other than specified above|3|||
125880072|NCT02345070|452858769|FG002|Overall Study|Other than specified above|7|||
125880073|NCT00321620|452858775|FG000|Overall Study|Death|269|||
125880074|NCT00321620|452858776|FG001|Overall Study|Death|294|||
125880075|NCT00321620|452858775|FG000|Overall Study|Withdrawal by Subject|164|||
125880076|NCT00321620|452858776|FG001|Overall Study|Withdrawal by Subject|147|||
126030756|NCT04927065|453410852|FG007|Second Booster|Other Than Specified|0|||
126030757|NCT04927065|453410853|FG008|Second Booster|Other Than Specified|0|||
126030758|NCT04927065|453410854|FG009|Second Booster|Other Than Specified|0|||
126030759|NCT04927065|453410855|FG010|Second Booster|Other Than Specified|1|||
126030760|NCT04927065|453410856|FG011|Second Booster|Other Than Specified|1|||
126030761|NCT04927065|453410857|FG012|Second Booster|Other Than Specified|4|||
126030762|NCT04927065|453410858|FG013|Second Booster|Other Than Specified|0|||
126030763|NCT04927065|453410859|FG014|Second Booster|Other Than Specified|0|||
126030764|NCT04927065|453410860|FG015|Second Booster|Other Than Specified|0|||
126030765|NCT04927065|453410845|FG000|Third Booster|Lost to Follow-up|0|||
126030766|NCT04927065|453410846|FG001|Third Booster|Lost to Follow-up|0|||
126030767|NCT04927065|453410847|FG002|Third Booster|Lost to Follow-up|0|||
126030768|NCT04927065|453410848|FG003|Third Booster|Lost to Follow-up|0|||
126030769|NCT04927065|453410849|FG004|Third Booster|Lost to Follow-up|0|||
126030770|NCT04927065|453410850|FG005|Third Booster|Lost to Follow-up|0|||
126030771|NCT04927065|453410851|FG006|Third Booster|Lost to Follow-up|0|||
126030772|NCT04927065|453410852|FG007|Third Booster|Lost to Follow-up|0|||
126030773|NCT04927065|453410853|FG008|Third Booster|Lost to Follow-up|0|||
126030774|NCT04927065|453410854|FG009|Third Booster|Lost to Follow-up|0|||
125880077|NCT00321620|452858775|FG000|Overall Study|Disease progression|113|||
126030775|NCT04927065|453410855|FG010|Third Booster|Lost to Follow-up|0|||
125880078|NCT00321620|452858776|FG001|Overall Study|Disease progression|117|||
125880079|NCT00321620|452858775|FG000|Overall Study|Adverse Event|43|||
126030776|NCT04927065|453410856|FG011|Third Booster|Lost to Follow-up|0|||
126030777|NCT04927065|453410857|FG012|Third Booster|Lost to Follow-up|0|||
126030778|NCT04927065|453410858|FG013|Third Booster|Lost to Follow-up|0|||
126030779|NCT04927065|453410859|FG014|Third Booster|Lost to Follow-up|0|||
126259225|NCT02788513|454239595|FG002|Overall Study|Subject decided to stop taking treatment|1|||
126259226|NCT02788513|454239596|FG003|Overall Study|Subject decided to stop taking treatment|0|||
126259227|NCT02788513|454239597|FG004|Overall Study|Subject decided to stop taking treatment|0|||
126259228|NCT02788513|454239593|FG000|Overall Study|Decision by the study team|0|||
126259229|NCT02788513|454239594|FG001|Overall Study|Decision by the study team|0|||
126259230|NCT02788513|454239595|FG002|Overall Study|Decision by the study team|0|||
126259231|NCT02788513|454239596|FG003|Overall Study|Decision by the study team|0|||
126259232|NCT02788513|454239597|FG004|Overall Study|Decision by the study team|1|||
126259233|NCT00114231|454239599|FG000|Overall Study|No consent|2|||
126259234|NCT00114231|454239600|FG001|Overall Study|No consent|0|||
126259235|NCT00114231|454239599|FG000|Overall Study|QARC requirement not met|1|||
126259236|NCT00114231|454239600|FG001|Overall Study|QARC requirement not met|0|||
126259237|NCT00114231|454239599|FG000|Overall Study|Suspected metastatic disease|1|||
126259238|NCT00114231|454239600|FG001|Overall Study|Suspected metastatic disease|0|||
126259239|NCT00114231|454239599|FG000|Overall Study|No adenocarcinoma|1|||
126259240|NCT00114231|454239600|FG001|Overall Study|No adenocarcinoma|0|||
126259241|NCT00114231|454239599|FG000|Overall Study|Low creatinine clearance|0|||
126259242|NCT00114231|454239600|FG001|Overall Study|Low creatinine clearance|1|||
126259243|NCT00114231|454239599|FG000|Overall Study|Tumor size > 4cm|1|||
126259244|NCT00114231|454239600|FG001|Overall Study|Tumor size > 4cm|0|||
126259245|NCT00114231|454239599|FG000|Overall Study|Tumor fixed on digital exam|0|||
126259246|NCT00114231|454239600|FG001|Overall Study|Tumor fixed on digital exam|1|||
126259247|NCT00114231|454239599|FG000|Overall Study|No Absolute Neutrophil Count|2|||
126259248|NCT00114231|454239600|FG001|Overall Study|No Absolute Neutrophil Count|0|||
126259249|NCT00114231|454239599|FG000|Overall Study|Biopsy done after registration|1|||
126096176|NCT00888927|453644654|FG002|Overall Study|Withdrawal of consent|0|||
126096177|NCT00888927|453644655|FG003|Overall Study|Withdrawal of consent|1|||
126096178|NCT01080716|453644656|FG000|Part 1|Physician Decision|1|||
126259250|NCT00114231|454239600|FG001|Overall Study|Biopsy done after registration|0|||
126259251|NCT02356211|454239603|FG000|Overall Study|Withdrawal by Subject|2|||
126259252|NCT02356211|454239604|FG001|Overall Study|Withdrawal by Subject|2|||
126259253|NCT02356211|454239603|FG000|Overall Study|ineligible|1|||
126259254|NCT02356211|454239604|FG001|Overall Study|ineligible|8|||
126096179|NCT01080716|453644657|FG001|Part 1|Physician Decision|0|||
126259255|NCT01976728|454239605|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
126096180|NCT01080716|453644658|FG002|Part 1|Physician Decision|0|||
126096181|NCT01080716|453644659|FG003|Part 1|Physician Decision|0|||
126096182|NCT03189745|453644660|FG000|Overall Study|Conflict in work schedule of participant|1|||
126096183|NCT03189745|453644661|FG001|Overall Study|Conflict in work schedule of participant|1|||
126096184|NCT01056718|453644662|FG000|Overall Study|Withdrawal by Subject|2|||
126096185|NCT01056718|453644662|FG000|Overall Study|Ischemia on baseline stress test|1|||
126096186|NCT05086276|453644663|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
126259256|NCT01976728|454239606|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
126259257|NCT01976728|454239607|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
126259258|NCT01976728|454239608|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
126259259|NCT00966381|454239610|FG000|Overall Study|Withdrawal by Subject|2|||
126259260|NCT00966381|454239611|FG001|Overall Study|Withdrawal by Subject|2|||
126259261|NCT01124695|454239612|FG000|Overall Study|Disease progression|77|||
126259262|NCT01124695|454239612|FG000|Overall Study|Adverse Event|11|||
126259263|NCT01124695|454239612|FG000|Overall Study|Death|1|||
126259264|NCT01124695|454239612|FG000|Overall Study|Withdrawal by Subject|7|||
126259265|NCT01124695|454239612|FG000|Overall Study|Physician Decision|3|||
126259266|NCT01124695|454239612|FG000|Overall Study|Alternative therapy|9|||
126259267|NCT01124695|454239612|FG000|Overall Study|No documentation that patient went off treatment|4|||
126259268|NCT01124695|454239612|FG000|Overall Study|Ineligible|9|||
126259269|NCT01124695|454239612|FG000|Overall Study|Ineligible and never start treatment|2|||
126259270|NCT02668822|454239616|FG000|Overall Study|Protocol Violation|2|||
126259271|NCT02668822|454239617|FG001|Overall Study|Protocol Violation|0|||
126259272|NCT02668822|454239616|FG000|Overall Study|Study Terminated by Sponsor|7|||
126259273|NCT02668822|454239617|FG001|Overall Study|Study Terminated by Sponsor|9|||
126259274|NCT01522950|454239618|FG000|Overall Study|Withdrawal by Subject|3|||
126259275|NCT01522950|454239619|FG001|Overall Study|Withdrawal by Subject|2|||
126259276|NCT01522950|454239620|FG002|Overall Study|Withdrawal by Subject|1|||
126259277|NCT01522950|454239618|FG000|Overall Study|Adverse Event|3|||
126259278|NCT01522950|454239619|FG001|Overall Study|Adverse Event|1|||
126259279|NCT01522950|454239620|FG002|Overall Study|Adverse Event|1|||
126259280|NCT01522950|454239618|FG000|Overall Study|Protocol Violation|0|||
126259281|NCT01522950|454239619|FG001|Overall Study|Protocol Violation|0|||
126259282|NCT01522950|454239620|FG002|Overall Study|Protocol Violation|2|||
126259283|NCT01522950|454239618|FG000|Overall Study|Death|0|||
126259284|NCT01522950|454239619|FG001|Overall Study|Death|1|||
126259285|NCT01522950|454239620|FG002|Overall Study|Death|1|||
126259286|NCT01522950|454239618|FG000|Overall Study|Study Medication Sensitivity|0|||
126259287|NCT01522950|454239619|FG001|Overall Study|Study Medication Sensitivity|1|||
126259288|NCT01522950|454239620|FG002|Overall Study|Study Medication Sensitivity|0|||
126259289|NCT00298740|454239623|FG000|Overall Study|Lack of Efficacy|6|||
126259290|NCT00298740|454239623|FG000|Overall Study|Withdrawal by Subject|3|||
126259291|NCT01345318|454239625|FG000|Overall Study|Adverse Event|16|||
126259292|NCT01345318|454239625|FG000|Overall Study|Lack of Efficacy|17|||
126259293|NCT01345318|454239625|FG000|Overall Study|Lost to Follow-up|2|||
126259294|NCT01345318|454239625|FG000|Overall Study|Protocol Violation|1|||
126259295|NCT01345318|454239625|FG000|Overall Study|Withdrawal by Subject|41|||
126259296|NCT01345318|454239625|FG000|Overall Study|Other|3|||
126259297|NCT00317642|454239626|FG000|Overall Study|Not Received Either Study Drug|1|||
126259298|NCT00317642|454239627|FG001|Overall Study|Not Received Either Study Drug|3|||
126259299|NCT00317642|454239626|FG000|Overall Study|Physician Decision|15|||
126259300|NCT00317642|454239627|FG001|Overall Study|Physician Decision|7|||
126259301|NCT00317642|454239626|FG000|Overall Study|Participant declined treatment|14|||
126096187|NCT05086276|453644664|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
126259302|NCT00317642|454239627|FG001|Overall Study|Participant declined treatment|3|||
126259303|NCT00317642|454239626|FG000|Overall Study|Adverse Event|17|||
126259304|NCT00317642|454239627|FG001|Overall Study|Adverse Event|5|||
126259305|NCT00317642|454239626|FG000|Overall Study|Treatment Failure|56|||
126259306|NCT00317642|454239627|FG001|Overall Study|Treatment Failure|102|||
126259307|NCT00317642|454239626|FG000|Overall Study|Disease Recurrence|1|||
126096188|NCT00777088|453644665|FG000|Overall Study|PED Treatment not attempted|1|||
126259308|NCT00317642|454239627|FG001|Overall Study|Disease Recurrence|2|||
126259309|NCT00317642|454239626|FG000|Overall Study|Death|14|||
126259310|NCT00317642|454239627|FG001|Overall Study|Death|7|||
126259311|NCT00317642|454239626|FG000|Overall Study|Not Continue to Consolidation|2|||
126259312|NCT00317642|454239627|FG001|Overall Study|Not Continue to Consolidation|0|||
126096189|NCT00287690|453644666|FG000|Overall Study|Protocol Violation|20|||
126096190|NCT00287690|453644667|FG001|Overall Study|Protocol Violation|26|||
126096191|NCT03592745|453644668|FG000|Overall Study|Adverse Event|0|||
126259313|NCT00317642|454239626|FG000|Overall Study|Withdrawal by Subject|0|||
126259314|NCT00317642|454239627|FG001|Overall Study|Withdrawal by Subject|1|||
126259315|NCT00317642|454239626|FG000|Overall Study|Referred For Transplantation|1|||
126259316|NCT00317642|454239627|FG001|Overall Study|Referred For Transplantation|0|||
126259317|NCT00317642|454239626|FG000|Overall Study|AML Not Centrally Confirmed|1|||
126259318|NCT00317642|454239627|FG001|Overall Study|AML Not Centrally Confirmed|5|||
126259319|NCT01049412|454239629|FG000|Period I|Withdrawal by Subject|4|||
126259320|NCT01049412|454239630|FG001|Period I|Withdrawal by Subject|6|||
126096192|NCT03592745|453644669|FG001|Overall Study|Adverse Event|2|||
126096193|NCT03592745|453644668|FG000|Overall Study|Lost to Follow-up|2|||
126096194|NCT03592745|453644669|FG001|Overall Study|Lost to Follow-up|0|||
126096195|NCT03592745|453644668|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
126096196|NCT03592745|453644669|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
126096197|NCT05017103|453644670|FG000|Overall Study|Death|2|||
126096198|NCT03117998|453644673|FG000|Overall Study|Adverse Event|1|||
126096199|NCT03117998|453644674|FG001|Overall Study|Adverse Event|0|||
126096200|NCT03117998|453644675|FG002|Overall Study|Adverse Event|0|||
126096201|NCT03117998|453644676|FG003|Overall Study|Adverse Event|0|||
126096202|NCT03117998|453644677|FG004|Overall Study|Adverse Event|0|||
126096203|NCT03117998|453644678|FG005|Overall Study|Adverse Event|0|||
126096204|NCT03117998|453644673|FG000|Overall Study|Withdrawal by Subject|0|||
126096205|NCT03117998|453644674|FG001|Overall Study|Withdrawal by Subject|0|||
126096206|NCT03117998|453644675|FG002|Overall Study|Withdrawal by Subject|2|||
126096207|NCT03117998|453644676|FG003|Overall Study|Withdrawal by Subject|3|||
126096208|NCT03117998|453644677|FG004|Overall Study|Withdrawal by Subject|3|||
126096209|NCT03117998|453644678|FG005|Overall Study|Withdrawal by Subject|0|||
126096210|NCT03117998|453644673|FG000|Overall Study|Physician Decision|0|||
126096211|NCT03117998|453644674|FG001|Overall Study|Physician Decision|1|||
126259321|NCT01049412|454239629|FG000|Period I|Lost to Follow-up|2|||
126259322|NCT01049412|454239630|FG001|Period I|Lost to Follow-up|2|||
126259323|NCT01049412|454239629|FG000|Period I|Physician Decision|0|||
126259324|NCT01049412|454239630|FG001|Period I|Physician Decision|3|||
126259325|NCT01049412|454239629|FG000|Period I|Protocol Violation|1|||
126259326|NCT01049412|454239630|FG001|Period I|Protocol Violation|2|||
126359271|NCT02181738|454607360|FG001|Overall Study|Study Drug Toxicity|11|||
126359272|NCT02181738|454607361|FG002|Overall Study|Study Drug Toxicity|8|||
126359273|NCT02181738|454607362|FG003|Overall Study|Study Drug Toxicity|1|||
126359274|NCT02181738|454607359|FG000|Overall Study|Other Reasons|14|||
126359275|NCT02181738|454607360|FG001|Overall Study|Other Reasons|16|||
126359276|NCT02181738|454607361|FG002|Overall Study|Other Reasons|28|||
126359277|NCT02181738|454607362|FG003|Overall Study|Other Reasons|0|||
126359278|NCT02181738|454607359|FG000|Overall Study|Maximum Clinical Benefit|3|||
126359279|NCT02181738|454607360|FG001|Overall Study|Maximum Clinical Benefit|0|||
126096212|NCT03117998|453644675|FG002|Overall Study|Physician Decision|1|||
126096213|NCT03117998|453644676|FG003|Overall Study|Physician Decision|0|||
126096214|NCT03117998|453644677|FG004|Overall Study|Physician Decision|0|||
126096215|NCT03117998|453644678|FG005|Overall Study|Physician Decision|0|||
126096216|NCT03117998|453644673|FG000|Overall Study|Lost to Follow-up|0|||
126096217|NCT03117998|453644674|FG001|Overall Study|Lost to Follow-up|0|||
126096218|NCT03117998|453644675|FG002|Overall Study|Lost to Follow-up|0|||
126096219|NCT03117998|453644676|FG003|Overall Study|Lost to Follow-up|1|||
126096220|NCT03117998|453644677|FG004|Overall Study|Lost to Follow-up|4|||
126259327|NCT01049412|454239629|FG000|Period I|Adverse Event|1|||
126259328|NCT01049412|454239630|FG001|Period I|Adverse Event|0|||
126259329|NCT01049412|454239629|FG000|Period II|Withdrawal by Subject|2|||
126259330|NCT01049412|454239630|FG001|Period II|Withdrawal by Subject|3|||
126259331|NCT01049412|454239629|FG000|Period II|Adverse Event|1|||
126259332|NCT01049412|454239630|FG001|Period II|Adverse Event|0|||
126259333|NCT01049412|454239629|FG000|Period II|Lost to Follow-up|1|||
126259334|NCT01049412|454239630|FG001|Period II|Lost to Follow-up|0|||
126259335|NCT01355302|454239635|FG000|Phase 1b|Death|4|||
126259336|NCT01355302|454239636|FG001|Phase 1b|Death|0|||
126259337|NCT01355302|454239637|FG002|Phase 1b|Death|0|||
126259338|NCT01355302|454239635|FG000|Phase 1b|Study terminated by sponsor|2|||
126259339|NCT01355302|454239636|FG001|Phase 1b|Study terminated by sponsor|0|||
126259340|NCT01355302|454239637|FG002|Phase 1b|Study terminated by sponsor|0|||
126259341|NCT00693225|454239638|FG000|Overall Study|Lost to Follow-up|1|||
126259342|NCT00693225|454239639|FG001|Overall Study|Lost to Follow-up|2|||
126259343|NCT00693225|454239638|FG000|Overall Study|Adverse Event|1|||
126259344|NCT00693225|454239639|FG001|Overall Study|Adverse Event|3|||
126259345|NCT01315028|454239640|FG000|Overall Study|Lost to Follow-up|1|||
126259346|NCT01315028|454239641|FG001|Overall Study|Lost to Follow-up|0|||
126259347|NCT01315028|454239640|FG000|Overall Study|Death|0|||
126259348|NCT01315028|454239641|FG001|Overall Study|Death|1|||
126259349|NCT02531594|454239642|FG000|Overall Study|Withdrawal by Subject|7|||
126359280|NCT02181738|454607361|FG002|Overall Study|Maximum Clinical Benefit|1|||
126359281|NCT02181738|454607362|FG003|Overall Study|Maximum Clinical Benefit|0|||
126096221|NCT03117998|453644678|FG005|Overall Study|Lost to Follow-up|0|||
126096222|NCT03117998|453644673|FG000|Overall Study|Subject noncompliance|0|||
126096223|NCT03117998|453644674|FG001|Overall Study|Subject noncompliance|0|||
126259350|NCT02531594|454239643|FG001|Overall Study|Withdrawal by Subject|8|||
126259351|NCT03750695|454239645|FG000|Overall Study|Lost to Follow-up|0|||
126259352|NCT03750695|454239646|FG001|Overall Study|Lost to Follow-up|1|||
126359282|NCT02181738|454607359|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126030780|NCT04927065|453410860|FG015|Third Booster|Lost to Follow-up|1|||
126030781|NCT04927065|453410845|FG000|Third Booster|Withdrawal by Subject|0|||
126030782|NCT04927065|453410846|FG001|Third Booster|Withdrawal by Subject|0|||
126030783|NCT04927065|453410847|FG002|Third Booster|Withdrawal by Subject|0|||
126030784|NCT04927065|453410848|FG003|Third Booster|Withdrawal by Subject|0|||
126030785|NCT04927065|453410849|FG004|Third Booster|Withdrawal by Subject|0|||
126030786|NCT04927065|453410850|FG005|Third Booster|Withdrawal by Subject|0|||
126030787|NCT04927065|453410851|FG006|Third Booster|Withdrawal by Subject|0|||
126030788|NCT04927065|453410852|FG007|Third Booster|Withdrawal by Subject|0|||
126030789|NCT04927065|453410853|FG008|Third Booster|Withdrawal by Subject|0|||
126030790|NCT04927065|453410854|FG009|Third Booster|Withdrawal by Subject|0|||
126030791|NCT04927065|453410855|FG010|Third Booster|Withdrawal by Subject|0|||
126030792|NCT04927065|453410856|FG011|Third Booster|Withdrawal by Subject|0|||
126030793|NCT04927065|453410857|FG012|Third Booster|Withdrawal by Subject|0|||
126030794|NCT04927065|453410858|FG013|Third Booster|Withdrawal by Subject|0|||
126030795|NCT04927065|453410859|FG014|Third Booster|Withdrawal by Subject|0|||
126030796|NCT04927065|453410860|FG015|Third Booster|Withdrawal by Subject|1|||
126030797|NCT04347161|453410863|FG000|Overall Study|Death|0|||
126030798|NCT04347161|453410864|FG001|Overall Study|Death|2|||
126030799|NCT04347161|453410863|FG000|Overall Study|Withdrawal by Subject|1|||
126030800|NCT04347161|453410864|FG001|Overall Study|Withdrawal by Subject|0|||
126030801|NCT04347161|453410863|FG000|Overall Study|Lost to Follow-up|0|||
126030802|NCT04347161|453410864|FG001|Overall Study|Lost to Follow-up|1|||
126030803|NCT04347161|453410863|FG000|Overall Study|No longer on study medication|1|||
126030804|NCT04347161|453410864|FG001|Overall Study|No longer on study medication|1|||
126030805|NCT04169373|453410865|FG000|Week 1 to Week 14|Adverse Event|1|||
126030806|NCT04169373|453410866|FG001|Week 1 to Week 14|Adverse Event|0|||
126030807|NCT04169373|453410867|FG002|Week 1 to Week 14|Adverse Event|1|||
126030808|NCT04169373|453410868|FG003|Week 1 to Week 14|Adverse Event|2|||
126030809|NCT04169373|453410865|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
126030810|NCT04169373|453410866|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
126030811|NCT04169373|453410867|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
126030812|NCT04169373|453410868|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
126030813|NCT04169373|453410865|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
126030814|NCT04169373|453410866|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
126030815|NCT04169373|453410867|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
126030816|NCT04169373|453410868|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
126030817|NCT04169373|453410865|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
126030818|NCT04169373|453410866|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
126030819|NCT04169373|453410867|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
126030820|NCT04169373|453410868|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
126030821|NCT04169373|453410865|FG000|Week 1 to Week 14|Other|1|||
126030822|NCT04169373|453410866|FG001|Week 1 to Week 14|Other|3|||
126030823|NCT04169373|453410867|FG002|Week 1 to Week 14|Other|3|||
126030824|NCT04169373|453410868|FG003|Week 1 to Week 14|Other|5|||
126030825|NCT04169373|453410865|FG000|Week 14 to Week 52|Adverse Event|1|||
126030826|NCT04169373|453410866|FG001|Week 14 to Week 52|Adverse Event|0|||
126030827|NCT04169373|453410867|FG002|Week 14 to Week 52|Adverse Event|0|||
126030828|NCT04169373|453410868|FG003|Week 14 to Week 52|Adverse Event|1|||
126030829|NCT04169373|453410865|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
126030830|NCT04169373|453410866|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
126030831|NCT04169373|453410867|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
126030832|NCT04169373|453410868|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
126030833|NCT04169373|453410865|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
126030834|NCT04169373|453410866|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
126030835|NCT04169373|453410867|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
126030836|NCT04169373|453410868|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
126030837|NCT04169373|453410865|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
126030838|NCT04169373|453410866|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
126030839|NCT04169373|453410867|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
126030840|NCT04169373|453410868|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
126030841|NCT04169373|453410865|FG000|Week 14 to Week 52|Other|4|||
126030842|NCT04169373|453410866|FG001|Week 14 to Week 52|Other|5|||
126030843|NCT04169373|453410867|FG002|Week 14 to Week 52|Other|4|||
126030844|NCT04169373|453410868|FG003|Week 14 to Week 52|Other|5|||
126030845|NCT04169373|453410865|FG000|Week 14 to Week 52|Ongoing|0|||
126030846|NCT04169373|453410866|FG001|Week 14 to Week 52|Ongoing|1|||
126030847|NCT04169373|453410867|FG002|Week 14 to Week 52|Ongoing|0|||
126030848|NCT04169373|453410868|FG003|Week 14 to Week 52|Ongoing|0|||
126030849|NCT01999075|453410869|FG000|Overall Study|Lost to Follow-up|0|||
126030850|NCT01999075|453410870|FG001|Overall Study|Lost to Follow-up|2|||
126030851|NCT01999075|453410869|FG000|Overall Study|Withdrawal by Subject|2|||
126030852|NCT01999075|453410870|FG001|Overall Study|Withdrawal by Subject|7|||
126030853|NCT01999075|453410869|FG000|Overall Study|Enrolled in drug trial|3|||
126096224|NCT03117998|453644675|FG002|Overall Study|Subject noncompliance|1|||
126096225|NCT03117998|453644676|FG003|Overall Study|Subject noncompliance|0|||
126096226|NCT03117998|453644677|FG004|Overall Study|Subject noncompliance|0|||
126096227|NCT03117998|453644678|FG005|Overall Study|Subject noncompliance|2|||
126096228|NCT03117998|453644673|FG000|Overall Study|Protocol Violation|0|||
126096229|NCT03117998|453644674|FG001|Overall Study|Protocol Violation|0|||
126096230|NCT03117998|453644675|FG002|Overall Study|Protocol Violation|0|||
126096231|NCT03117998|453644676|FG003|Overall Study|Protocol Violation|0|||
126096232|NCT03117998|453644677|FG004|Overall Study|Protocol Violation|0|||
126096233|NCT03117998|453644678|FG005|Overall Study|Protocol Violation|1|||
126096234|NCT00350103|453644682|FG000|Overall Study|Adverse Event|12|||
126096235|NCT00350103|453644683|FG001|Overall Study|Adverse Event|29|||
126096236|NCT00350103|453644684|FG002|Overall Study|Adverse Event|17|||
126096237|NCT00350103|453644682|FG000|Overall Study|Lack of Efficacy|5|||
126096238|NCT00350103|453644683|FG001|Overall Study|Lack of Efficacy|1|||
126096239|NCT00350103|453644684|FG002|Overall Study|Lack of Efficacy|3|||
126096240|NCT00350103|453644682|FG000|Overall Study|Withdrawal by Subject|6|||
126359283|NCT02181738|454607360|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126359284|NCT02181738|454607361|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
126096241|NCT00350103|453644683|FG001|Overall Study|Withdrawal by Subject|6|||
126096242|NCT00350103|453644684|FG002|Overall Study|Withdrawal by Subject|8|||
126359285|NCT02181738|454607362|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126359286|NCT01691482|454607366|FG000|Treatment Period 2|Adverse Event|0|||
126359287|NCT01691482|454607367|FG001|Treatment Period 2|Adverse Event|1|||
126359288|NCT01691482|454607366|FG000|Treatment Period 2|Protocol Violation|1|||
126359289|NCT01691482|454607367|FG001|Treatment Period 2|Protocol Violation|1|||
126359290|NCT00183391|454607368|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
126359291|NCT00183391|454607369|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
126359292|NCT00183391|454607368|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
126359293|NCT00183391|454607369|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
126030854|NCT01999075|453410870|FG001|Overall Study|Enrolled in drug trial|1|||
126030855|NCT01999075|453410869|FG000|Overall Study|Became ineligible|0|||
126096243|NCT00350103|453644682|FG000|Overall Study|Protocol Violation|0|||
126096244|NCT00350103|453644683|FG001|Overall Study|Protocol Violation|0|||
126096245|NCT00350103|453644684|FG002|Overall Study|Protocol Violation|1|||
126096246|NCT00350103|453644682|FG000|Overall Study|Unsatisfactory Compliance|2|||
126359294|NCT00395512|454607370|FG000|Overall Study|Adverse Event|3|||
126030856|NCT01999075|453410870|FG001|Overall Study|Became ineligible|2|||
126030857|NCT05948670|453410873|FG000|Overall Study|Protocol Violation|6|||
126030858|NCT05948670|453410874|FG001|Overall Study|Protocol Violation|8|||
126030859|NCT05948670|453410873|FG000|Overall Study|Withdrawal by Subject|0|||
126030860|NCT05948670|453410874|FG001|Overall Study|Withdrawal by Subject|1|||
126030861|NCT03699709|453410875|FG000|Overall Study|Death|1|||
126030862|NCT03699709|453410876|FG001|Overall Study|Death|2|||
126030863|NCT03699709|453410875|FG000|Overall Study|Lost to Follow-up|10|||
126030864|NCT03699709|453410876|FG001|Overall Study|Lost to Follow-up|3|||
126030865|NCT03699709|453410875|FG000|Overall Study|Withdrawal by Subject|5|||
126030866|NCT03699709|453410876|FG001|Overall Study|Withdrawal by Subject|0|||
126030867|NCT03699709|453410875|FG000|Overall Study|incarcerated|1|||
126030868|NCT03699709|453410876|FG001|Overall Study|incarcerated|0|||
126030869|NCT03699709|453410875|FG000|Overall Study|scheduled, but no show|0|||
126030870|NCT03699709|453410876|FG001|Overall Study|scheduled, but no show|1|||
126030871|NCT04562649|453410878|FG000|Overall Study|Withdrawal by Subject|11|||
126030872|NCT04562649|453410879|FG001|Overall Study|Withdrawal by Subject|8|||
126030873|NCT04562649|453410878|FG000|Overall Study|Lost to Follow-up|26|||
126030874|NCT04562649|453410879|FG001|Overall Study|Lost to Follow-up|20|||
126030875|NCT03675282|453410880|FG000|Overall Study|Lost to Follow-up|4|||
126030876|NCT03675282|453410881|FG001|Overall Study|Lost to Follow-up|8|||
126030877|NCT03675282|453410882|FG002|Overall Study|Lost to Follow-up|1|||
126030878|NCT03675282|453410883|FG003|Overall Study|Lost to Follow-up|0|||
126030879|NCT03675282|453410884|FG004|Overall Study|Lost to Follow-up|2|||
126030880|NCT03675282|453410885|FG005|Overall Study|Lost to Follow-up|7|||
126030881|NCT03675282|453410880|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
126030882|NCT03675282|453410881|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
126030883|NCT03675282|453410882|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
126359295|NCT00395512|454607371|FG001|Overall Study|Adverse Event|8|||
126030884|NCT03675282|453410883|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
126096247|NCT00350103|453644683|FG001|Overall Study|Unsatisfactory Compliance|2|||
126096248|NCT00350103|453644684|FG002|Overall Study|Unsatisfactory Compliance|1|||
126096249|NCT00350103|453644682|FG000|Overall Study|Investigator´s decision|1|||
126096250|NCT00350103|453644683|FG001|Overall Study|Investigator´s decision|1|||
126030885|NCT03675282|453410884|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
126030886|NCT03675282|453410885|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
126030887|NCT03675282|453410880|FG000|Overall Study|Physician Decision|1|||
126030888|NCT03675282|453410881|FG001|Overall Study|Physician Decision|0|||
126030889|NCT03675282|453410882|FG002|Overall Study|Physician Decision|0|||
126259353|NCT01264835|454239649|FG000|Overall Study|Lost to Follow-up|1|||
126259354|NCT01203917|454239650|FG000|Overall Study|Death|29|||
126259355|NCT01203917|454239650|FG000|Overall Study|Lost to Follow-up|2|||
126259356|NCT01203917|454239650|FG000|Overall Study|Withdrawal by Subject|3|||
126259357|NCT01203917|454239650|FG000|Overall Study|Due to objective disease progression|1|||
126259358|NCT01203917|454239650|FG000|Overall Study|Due to EGFR M+I patient|1|||
126259359|NCT04660032|454239658|FG000|Overall Study|Protocol Violation|1|||
126259360|NCT04660032|454239659|FG001|Overall Study|Protocol Violation|1|||
126259361|NCT01466036|454239670|FG000|Overall Study|Death|1|||
126259362|NCT01466036|454239671|FG001|Overall Study|Death|1|||
126259363|NCT01466036|454239670|FG000|Overall Study|Physician Decision|0|||
126259364|NCT01466036|454239671|FG001|Overall Study|Physician Decision|4|||
126259365|NCT01466036|454239670|FG000|Overall Study|Adverse Event|2|||
126259366|NCT01466036|454239671|FG001|Overall Study|Adverse Event|6|||
126259367|NCT01466036|454239670|FG000|Overall Study|Withdrawal by Subject|2|||
126259368|NCT01466036|454239671|FG001|Overall Study|Withdrawal by Subject|8|||
126259369|NCT01466036|454239670|FG000|Overall Study|progression/relapse|14|||
126259370|NCT01466036|454239671|FG001|Overall Study|progression/relapse|21|||
126259371|NCT01466036|454239670|FG000|Overall Study|prolonged treatment delay|1|||
126259372|NCT01466036|454239671|FG001|Overall Study|prolonged treatment delay|1|||
126259373|NCT00985231|454239672|FG000|Overall Study|ineligible|1|||
126259374|NCT00985231|454239673|FG001|Overall Study|ineligible|0|||
126259375|NCT00985231|454239672|FG000|Overall Study|Protocol Violation|1|||
126259376|NCT00985231|454239673|FG001|Overall Study|Protocol Violation|0|||
126259377|NCT00985231|454239672|FG000|Overall Study|Withdrawal by Subject|1|||
126259378|NCT00985231|454239673|FG001|Overall Study|Withdrawal by Subject|0|||
126259379|NCT00985231|454239672|FG000|Overall Study|Lost to Follow-up|0|||
126259380|NCT00985231|454239673|FG001|Overall Study|Lost to Follow-up|1|||
126259381|NCT00985231|454239672|FG000|Overall Study|Study related symptoms & complaints|0|||
126259382|NCT00985231|454239673|FG001|Overall Study|Study related symptoms & complaints|2|||
126259383|NCT05103657|454239674|FG000|Overall Study|Other reasons than listed|9|||
126259384|NCT05103657|454239675|FG001|Overall Study|Other reasons than listed|8|||
126259385|NCT05103657|454239674|FG000|Overall Study|Protocol deviation|2|||
126259386|NCT05103657|454239675|FG001|Overall Study|Protocol deviation|2|||
126259387|NCT05103657|454239674|FG000|Overall Study|No reason available|5|||
126259388|NCT05103657|454239675|FG001|Overall Study|No reason available|4|||
126259389|NCT05103657|454239674|FG000|Overall Study|Burden of study procedures|3|||
126259390|NCT05103657|454239675|FG001|Overall Study|Burden of study procedures|1|||
126259391|NCT05103657|454239674|FG000|Overall Study|Perceived lack of efficacy|1|||
126259392|NCT05103657|454239675|FG001|Overall Study|Perceived lack of efficacy|1|||
126259393|NCT05103657|454239674|FG000|Overall Study|Adverse Event|6|||
126259394|NCT05103657|454239675|FG001|Overall Study|Adverse Event|14|||
126259395|NCT05103657|454239674|FG000|Overall Study|Not Treated|1|||
126259396|NCT05103657|454239675|FG001|Overall Study|Not Treated|1|||
126259397|NCT00109850|454239679|FG000|Overall Study|Adverse Event|1|||
126259398|NCT00109850|454239679|FG000|Overall Study|Death|2|||
126259399|NCT00109850|454239679|FG000|Overall Study|Ineligible|1|||
126259400|NCT00476593|454239680|FG000|Overall Study|Lost to Follow-up|10|||
126259401|NCT00476593|454239681|FG001|Overall Study|Lost to Follow-up|2|||
126259402|NCT00476593|454239682|FG002|Overall Study|Lost to Follow-up|8|||
126259403|NCT00476593|454239683|FG003|Overall Study|Lost to Follow-up|22|||
126259404|NCT03635983|454239684|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
126259405|NCT03635983|454239685|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
126259406|NCT03635983|454239684|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126259407|NCT03635983|454239685|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126259408|NCT03635983|454239684|FG000|Pre-Treatment Period|Other reasons|0|||
126259409|NCT03635983|454239685|FG001|Pre-Treatment Period|Other reasons|1|||
126259410|NCT03635983|454239684|FG000|Pre-Treatment Period|Disease Progression|0|||
126259411|NCT03635983|454239685|FG001|Pre-Treatment Period|Disease Progression|1|||
126259412|NCT03635983|454239684|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
126259413|NCT03635983|454239685|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
126259414|NCT03635983|454239684|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
126259415|NCT03635983|454239685|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
126259416|NCT03635983|454239684|FG000|Treatment Period|Withdrawal by Subject|3|||
126259417|NCT03635983|454239685|FG001|Treatment Period|Withdrawal by Subject|5|||
126259418|NCT03635983|454239684|FG000|Treatment Period|Death|3|||
126259419|NCT03635983|454239685|FG001|Treatment Period|Death|5|||
126259420|NCT03635983|454239684|FG000|Treatment Period|Poor/Non-compliance|2|||
126259421|NCT03635983|454239685|FG001|Treatment Period|Poor/Non-compliance|1|||
126259422|NCT03635983|454239684|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
126259423|NCT03635983|454239685|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
126259424|NCT03635983|454239684|FG000|Treatment Period|Other reasons|7|||
126259425|NCT03635983|454239685|FG001|Treatment Period|Other reasons|4|||
126259426|NCT03635983|454239684|FG000|Treatment Period|Disease progression|230|||
126259427|NCT03635983|454239685|FG001|Treatment Period|Disease progression|201|||
126259428|NCT03635983|454239684|FG000|Treatment Period|Study drug toxicity|35|||
126259429|NCT03635983|454239685|FG001|Treatment Period|Study drug toxicity|36|||
126259430|NCT03635983|454239684|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
126259431|NCT03635983|454239685|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
126259432|NCT03635983|454239684|FG000|Treatment Period|Maximum clinical benefit|3|||
126259433|NCT03635983|454239685|FG001|Treatment Period|Maximum clinical benefit|5|||
126259434|NCT03635983|454239684|FG000|Treatment Period|Administrative reason by the sponsor|1|||
126259435|NCT03635983|454239685|FG001|Treatment Period|Administrative reason by the sponsor|2|||
126259436|NCT03635983|454239684|FG000|Treatment Period|Lost to Follow-up|0|||
126259437|NCT03635983|454239685|FG001|Treatment Period|Lost to Follow-up|1|||
126259438|NCT03430011|454239686|FG000|Pre-Treatment|Death|1|||
126259439|NCT03430011|454239687|FG001|Pre-Treatment|Death|0|||
126259440|NCT03430011|454239688|FG002|Pre-Treatment|Death|0|||
126259441|NCT03430011|454239689|FG003|Pre-Treatment|Death|0|||
126259442|NCT03430011|454239690|FG004|Pre-Treatment|Death|1|||
126259443|NCT03430011|454239691|FG005|Pre-Treatment|Death|0|||
126259444|NCT03430011|454239692|FG006|Pre-Treatment|Death|1|||
126259445|NCT03430011|454239693|FG007|Pre-Treatment|Death|0|||
126259446|NCT03430011|454239686|FG000|Pre-Treatment|Screen Fail|0|||
126259447|NCT03430011|454239687|FG001|Pre-Treatment|Screen Fail|0|||
126259448|NCT03430011|454239688|FG002|Pre-Treatment|Screen Fail|0|||
126259449|NCT03430011|454239689|FG003|Pre-Treatment|Screen Fail|0|||
126259450|NCT03430011|454239690|FG004|Pre-Treatment|Screen Fail|1|||
126259451|NCT03430011|454239691|FG005|Pre-Treatment|Screen Fail|0|||
126259452|NCT03430011|454239692|FG006|Pre-Treatment|Screen Fail|0|||
126259453|NCT03430011|454239693|FG007|Pre-Treatment|Screen Fail|0|||
126259454|NCT03430011|454239686|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259455|NCT03430011|454239687|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259456|NCT03430011|454239688|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
126259457|NCT03430011|454239689|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259458|NCT03430011|454239690|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259459|NCT03430011|454239691|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259460|NCT03430011|454239692|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259461|NCT03430011|454239693|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259462|NCT03430011|454239686|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
126259463|NCT03430011|454239687|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
126259464|NCT03430011|454239688|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
126259465|NCT03430011|454239689|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
126259466|NCT03430011|454239690|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
126259467|NCT03430011|454239691|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
126259468|NCT03430011|454239692|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
126259469|NCT03430011|454239693|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
126259470|NCT03430011|454239686|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
126259471|NCT03430011|454239687|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
126259472|NCT03430011|454239688|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
126259473|NCT03430011|454239689|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
126259474|NCT03430011|454239690|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
126259475|NCT03430011|454239691|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
126259476|NCT03430011|454239692|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
126259477|NCT03430011|454239693|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
126259478|NCT03430011|454239686|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
126259479|NCT03430011|454239687|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
126259480|NCT03430011|454239688|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
126259481|NCT03430011|454239689|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
126259482|NCT03430011|454239690|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
126259483|NCT03430011|454239691|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
126259484|NCT03430011|454239692|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
126259485|NCT03430011|454239693|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
126096251|NCT00350103|453644684|FG002|Overall Study|Investigator´s decision|0|||
126096252|NCT00350103|453644682|FG000|Overall Study|Exclusion criteria met|0|||
126096253|NCT00350103|453644683|FG001|Overall Study|Exclusion criteria met|0|||
126259486|NCT03430011|454239686|FG000|JCARH125 Treatment|Death|4|||
126359296|NCT00395512|454607372|FG002|Overall Study|Adverse Event|6|||
126096254|NCT00350103|453644684|FG002|Overall Study|Exclusion criteria met|1|||
126259487|NCT03430011|454239687|FG001|JCARH125 Treatment|Death|19|||
126259488|NCT03430011|454239688|FG002|JCARH125 Treatment|Death|10|||
126259489|NCT03430011|454239689|FG003|JCARH125 Treatment|Death|8|||
126259490|NCT03430011|454239690|FG004|JCARH125 Treatment|Death|5|||
126259491|NCT03430011|454239691|FG005|JCARH125 Treatment|Death|3|||
126259492|NCT03430011|454239692|FG006|JCARH125 Treatment|Death|4|||
126259493|NCT03430011|454239693|FG007|JCARH125 Treatment|Death|2|||
126259494|NCT03430011|454239686|FG000|JCARH125 Treatment|Other reasons|1|||
126096255|NCT00350103|453644682|FG000|Overall Study|Patient relocated|0|||
126259495|NCT03430011|454239687|FG001|JCARH125 Treatment|Other reasons|0|||
126259496|NCT03430011|454239688|FG002|JCARH125 Treatment|Other reasons|4|||
126259497|NCT03430011|454239689|FG003|JCARH125 Treatment|Other reasons|2|||
126259498|NCT03430011|454239690|FG004|JCARH125 Treatment|Other reasons|2|||
126259499|NCT03430011|454239691|FG005|JCARH125 Treatment|Other reasons|1|||
126259500|NCT03430011|454239692|FG006|JCARH125 Treatment|Other reasons|3|||
126259501|NCT03430011|454239693|FG007|JCARH125 Treatment|Other reasons|2|||
126259502|NCT04126343|454239695|FG000|Overall Study|Adverse Event|0|||
126259503|NCT04126343|454239696|FG001|Overall Study|Adverse Event|0|||
126259504|NCT04126343|454239697|FG002|Overall Study|Adverse Event|0|||
126259505|NCT04126343|454239698|FG003|Overall Study|Adverse Event|0|||
126259506|NCT04126343|454239699|FG004|Overall Study|Adverse Event|0|||
126259507|NCT04126343|454239700|FG005|Overall Study|Adverse Event|1|||
126259508|NCT04126343|454239695|FG000|Overall Study|Withdrawal by Subject|0|||
126259509|NCT04126343|454239696|FG001|Overall Study|Withdrawal by Subject|0|||
126259510|NCT04126343|454239697|FG002|Overall Study|Withdrawal by Subject|0|||
126259511|NCT04126343|454239698|FG003|Overall Study|Withdrawal by Subject|1|||
126259512|NCT04126343|454239699|FG004|Overall Study|Withdrawal by Subject|0|||
126259513|NCT04126343|454239700|FG005|Overall Study|Withdrawal by Subject|0|||
126259514|NCT04126343|454239695|FG000|Overall Study|Related to COVID-19 pandemic|3|||
126259515|NCT04126343|454239696|FG001|Overall Study|Related to COVID-19 pandemic|4|||
126259516|NCT04126343|454239697|FG002|Overall Study|Related to COVID-19 pandemic|3|||
126259517|NCT04126343|454239698|FG003|Overall Study|Related to COVID-19 pandemic|3|||
126259518|NCT04126343|454239699|FG004|Overall Study|Related to COVID-19 pandemic|3|||
126259519|NCT04126343|454239700|FG005|Overall Study|Related to COVID-19 pandemic|3|||
126259520|NCT01235442|454239701|FG000|Overall Study|Lost to Follow-up|12|||
126259521|NCT01235442|454239702|FG001|Overall Study|Lost to Follow-up|10|||
126259522|NCT01235442|454239701|FG000|Overall Study|Death|0|||
126259523|NCT01235442|454239702|FG001|Overall Study|Death|2|||
126259524|NCT01235442|454239701|FG000|Overall Study|Pregnancy|1|||
126259525|NCT01235442|454239702|FG001|Overall Study|Pregnancy|1|||
126259526|NCT01235442|454239701|FG000|Overall Study|Ineligibility determined|5|||
126259527|NCT01235442|454239702|FG001|Overall Study|Ineligibility determined|4|||
126259528|NCT01235442|454239701|FG000|Overall Study|Protocol Violation|3|||
126259529|NCT01235442|454239702|FG001|Overall Study|Protocol Violation|3|||
126259530|NCT01235442|454239701|FG000|Overall Study|Adverse Event|4|||
126259531|NCT01235442|454239702|FG001|Overall Study|Adverse Event|6|||
126259532|NCT01235442|454239701|FG000|Overall Study|Withdrawal by Subject|15|||
126259533|NCT01235442|454239702|FG001|Overall Study|Withdrawal by Subject|9|||
126259534|NCT01235442|454239701|FG000|Overall Study|Lack of Efficacy|1|||
126259535|NCT01235442|454239702|FG001|Overall Study|Lack of Efficacy|3|||
126259536|NCT01235442|454239701|FG000|Overall Study|Noncompliance|1|||
126259537|NCT01235442|454239702|FG001|Overall Study|Noncompliance|2|||
126259538|NCT01235442|454239701|FG000|Overall Study|Administrative decision|1|||
126259539|NCT01235442|454239702|FG001|Overall Study|Administrative decision|2|||
126259540|NCT01235442|454239701|FG000|Overall Study|Other unspecified|1|||
126259541|NCT01235442|454239702|FG001|Overall Study|Other unspecified|2|||
126259542|NCT00084799|454239703|FG000|Overall Study|Disease Progression|1|||
126259543|NCT00084799|454239704|FG001|Overall Study|Disease Progression|0|||
126259544|NCT03712124|454239707|FG000|Overall Study|Protocol Violation|1|||
126259545|NCT03712124|454239708|FG001|Overall Study|Protocol Violation|0|||
126259546|NCT04499482|454239710|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
126259547|NCT04330157|454239711|FG000|Overall Study|Protocol Violation|4|||
126259548|NCT04330157|454239711|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
126259549|NCT04314843|454239712|FG000|Overall Study|Death|2|||
126259550|NCT04314843|454239713|FG001|Overall Study|Death|2|||
126259551|NCT04314843|454239712|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
126259552|NCT04314843|454239713|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
126259553|NCT04718129|454239714|FG000|Overall Study|Lost to Follow-up|6|||
126259554|NCT04718129|454239715|FG001|Overall Study|Lost to Follow-up|7|||
126259555|NCT01378962|454239716|FG000|Overall Study|Death|14|||
126259556|NCT01378962|454239716|FG000|Overall Study|Lost to Follow-up|1|||
126259557|NCT01378962|454239716|FG000|Overall Study|Other|2|||
126259558|NCT02030535|454239717|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
126259559|NCT01588548|454239718|FG000|Overall Study|Withdrawal by Subject|0|||
126259560|NCT01588548|454239719|FG001|Overall Study|Withdrawal by Subject|1|||
126259561|NCT01588548|454239720|FG002|Overall Study|Withdrawal by Subject|1|||
126259562|NCT01588548|454239721|FG003|Overall Study|Withdrawal by Subject|1|||
126359297|NCT00395512|454607373|FG003|Overall Study|Adverse Event|6|||
126259563|NCT01588548|454239722|FG004|Overall Study|Withdrawal by Subject|2|||
126259564|NCT01588548|454239723|FG005|Overall Study|Withdrawal by Subject|3|||
126259565|NCT01588548|454239718|FG000|Overall Study|Adverse Event|0|||
126259566|NCT01588548|454239719|FG001|Overall Study|Adverse Event|0|||
126359298|NCT00395512|454607370|FG000|Overall Study|Protocol Violation|2|||
126259567|NCT01588548|454239720|FG002|Overall Study|Adverse Event|1|||
126259568|NCT01588548|454239721|FG003|Overall Study|Adverse Event|2|||
126259569|NCT01588548|454239722|FG004|Overall Study|Adverse Event|1|||
126259570|NCT01588548|454239723|FG005|Overall Study|Adverse Event|0|||
126259571|NCT01588548|454239718|FG000|Overall Study|Condition Under Investigation Worsened|3|||
126259572|NCT01588548|454239719|FG001|Overall Study|Condition Under Investigation Worsened|6|||
126259573|NCT01588548|454239720|FG002|Overall Study|Condition Under Investigation Worsened|4|||
126259574|NCT01588548|454239721|FG003|Overall Study|Condition Under Investigation Worsened|4|||
126259575|NCT01588548|454239722|FG004|Overall Study|Condition Under Investigation Worsened|3|||
126259576|NCT01588548|454239723|FG005|Overall Study|Condition Under Investigation Worsened|3|||
126259577|NCT00292227|454239724|FG000|Patch Period|Adverse Event|1|||
126259578|NCT00292227|454239725|FG001|Patch Period|Adverse Event|0|||
126259579|NCT00292227|454239726|FG002|Patch Period|Adverse Event|2|||
126030890|NCT03675282|453410883|FG003|Overall Study|Physician Decision|0|||
126030891|NCT03675282|453410884|FG004|Overall Study|Physician Decision|0|||
126030892|NCT03675282|453410885|FG005|Overall Study|Physician Decision|0|||
126030893|NCT03056040|453410889|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
126030894|NCT03056040|453410890|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
126030895|NCT03056040|453410889|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
126030896|NCT03056040|453410890|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
126030897|NCT03056040|453410889|FG000|Primary Evaluation Period|Pregnancy|0|||
126030898|NCT03056040|453410890|FG001|Primary Evaluation Period|Pregnancy|1|||
126030899|NCT03056040|453410889|FG000|Primary Evaluation Period|Randomized, not treated|1|||
126030900|NCT03056040|453410890|FG001|Primary Evaluation Period|Randomized, not treated|1|||
126030901|NCT03056040|453410889|FG000|Extension Period|Physician Decision|3|||
126030902|NCT03056040|453410890|FG001|Extension Period|Physician Decision|3|||
126030903|NCT03056040|453410889|FG000|Extension Period|Lost to Follow-up|0|||
126030904|NCT03056040|453410890|FG001|Extension Period|Lost to Follow-up|1|||
126030905|NCT03056040|453410889|FG000|Extension Period|Death|0|||
126030906|NCT03056040|453410890|FG001|Extension Period|Death|3|||
126030907|NCT03056040|453410889|FG000|Extension Period|Withdrawal by Subject|1|||
126030908|NCT03056040|453410890|FG001|Extension Period|Withdrawal by Subject|0|||
126030909|NCT04029688|453410893|FG000|Overall Study|Death|8|||
126030910|NCT04029688|453410894|FG001|Overall Study|Death|3|||
126030911|NCT04029688|453410895|FG002|Overall Study|Death|6|||
126030912|NCT04029688|453410896|FG003|Overall Study|Death|2|||
126030913|NCT04029688|453410897|FG004|Overall Study|Death|5|||
126030914|NCT04029688|453410898|FG005|Overall Study|Death|0|||
126030915|NCT04029688|453410899|FG006|Overall Study|Death|2|||
126030916|NCT04029688|453410900|FG007|Overall Study|Death|3|||
126030917|NCT04029688|453410893|FG000|Overall Study|Study Terminated by Sponsor|0|||
126030918|NCT04029688|453410894|FG001|Overall Study|Study Terminated by Sponsor|0|||
126030919|NCT04029688|453410895|FG002|Overall Study|Study Terminated by Sponsor|0|||
126030920|NCT04029688|453410896|FG003|Overall Study|Study Terminated by Sponsor|0|||
126030921|NCT04029688|453410897|FG004|Overall Study|Study Terminated by Sponsor|1|||
126030922|NCT04029688|453410898|FG005|Overall Study|Study Terminated by Sponsor|3|||
126030923|NCT04029688|453410899|FG006|Overall Study|Study Terminated by Sponsor|1|||
126030924|NCT04029688|453410900|FG007|Overall Study|Study Terminated by Sponsor|3|||
126030925|NCT04029688|453410893|FG000|Overall Study|Withdrawal by Subject|0|||
126030926|NCT04029688|453410894|FG001|Overall Study|Withdrawal by Subject|0|||
126030927|NCT04029688|453410895|FG002|Overall Study|Withdrawal by Subject|0|||
126030928|NCT04029688|453410896|FG003|Overall Study|Withdrawal by Subject|1|||
126030929|NCT04029688|453410897|FG004|Overall Study|Withdrawal by Subject|0|||
126030930|NCT04029688|453410898|FG005|Overall Study|Withdrawal by Subject|0|||
126030931|NCT04029688|453410899|FG006|Overall Study|Withdrawal by Subject|0|||
126030932|NCT04029688|453410900|FG007|Overall Study|Withdrawal by Subject|0|||
126030933|NCT05875142|453410901|FG000|Overall Study|Lost to Follow-up|0|||
126030934|NCT05875142|453410902|FG001|Overall Study|Lost to Follow-up|1|||
126030935|NCT05875142|453410903|FG002|Overall Study|Lost to Follow-up|1|||
126030936|NCT02677298|453410904|FG000|Double Blind Phase|Adverse Event|2|||
126030937|NCT02677298|453410905|FG001|Double Blind Phase|Adverse Event|1|||
126030938|NCT02677298|453410906|FG002|Double Blind Phase|Adverse Event|0|||
126030939|NCT02677298|453410904|FG000|Double Blind Phase|Physician Decision|5|||
126030940|NCT02677298|453410905|FG001|Double Blind Phase|Physician Decision|0|||
126030941|NCT02677298|453410906|FG002|Double Blind Phase|Physician Decision|0|||
126030942|NCT02677298|453410904|FG000|Double Blind Phase|Lost to Follow-up|11|||
126030943|NCT02677298|453410905|FG001|Double Blind Phase|Lost to Follow-up|7|||
126030944|NCT02677298|453410906|FG002|Double Blind Phase|Lost to Follow-up|0|||
126030945|NCT02677298|453410904|FG000|Double Blind Phase|Withdrawal by Subject|11|||
126030946|NCT02677298|453410905|FG001|Double Blind Phase|Withdrawal by Subject|8|||
126030947|NCT02677298|453410906|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126030948|NCT02677298|453410904|FG000|Double Blind Phase|No study drug available at site|0|||
126030949|NCT02677298|453410905|FG001|Double Blind Phase|No study drug available at site|1|||
126259580|NCT00292227|454239724|FG000|Patch Period|Withdrawal by Subject|0|||
126259581|NCT00292227|454239725|FG001|Patch Period|Withdrawal by Subject|0|||
126030950|NCT02677298|453410906|FG002|Double Blind Phase|No study drug available at site|0|||
126030951|NCT02677298|453410904|FG000|Open Label Phase|Adverse Event|0|||
126030952|NCT02677298|453410905|FG001|Open Label Phase|Adverse Event|0|||
126030953|NCT02677298|453410906|FG002|Open Label Phase|Adverse Event|4|||
126030954|NCT02677298|453410904|FG000|Open Label Phase|Physician Decision|0|||
126030955|NCT02677298|453410905|FG001|Open Label Phase|Physician Decision|0|||
126030956|NCT02677298|453410906|FG002|Open Label Phase|Physician Decision|1|||
126030957|NCT02677298|453410904|FG000|Open Label Phase|Lost to Follow-up|0|||
126030958|NCT02677298|453410905|FG001|Open Label Phase|Lost to Follow-up|0|||
126030959|NCT02677298|453410906|FG002|Open Label Phase|Lost to Follow-up|17|||
126030960|NCT02677298|453410904|FG000|Open Label Phase|Withdrawal by Subject|0|||
126030961|NCT02677298|453410905|FG001|Open Label Phase|Withdrawal by Subject|0|||
126030962|NCT02677298|453410906|FG002|Open Label Phase|Withdrawal by Subject|38|||
126030963|NCT03611621|453410920|FG000|Overall Study|Graft loss|3|||
126096256|NCT00350103|453644683|FG001|Overall Study|Patient relocated|0|||
126259582|NCT00292227|454239726|FG002|Patch Period|Withdrawal by Subject|1|||
126259583|NCT03257254|454239727|FG000|Overall Study|Withdrawal by Subject|7|||
126259584|NCT03257254|454239727|FG000|Overall Study|Lost to Follow-up|9|||
126259585|NCT03257254|454239727|FG000|Overall Study|Study discontinued by sponsor|5|||
126259586|NCT00442546|454239728|FG000|Overall Study|Adverse Event|11|||
126259587|NCT00442546|454239729|FG001|Overall Study|Adverse Event|17|||
126259588|NCT00442546|454239730|FG002|Overall Study|Adverse Event|13|||
126259589|NCT00442546|454239728|FG000|Overall Study|Lost to Follow-up|1|||
126259590|NCT00442546|454239729|FG001|Overall Study|Lost to Follow-up|2|||
126259591|NCT00442546|454239730|FG002|Overall Study|Lost to Follow-up|1|||
126259592|NCT00442546|454239728|FG000|Overall Study|Other|4|||
126259593|NCT00442546|454239729|FG001|Overall Study|Other|9|||
125880080|NCT00321620|452858776|FG001|Overall Study|Adverse Event|56|||
125880081|NCT00321620|452858775|FG000|Overall Study|Lost to Follow-up|13|||
125880082|NCT00321620|452858776|FG001|Overall Study|Lost to Follow-up|9|||
125880083|NCT00321620|452858775|FG000|Overall Study|Physician Decision|4|||
125880084|NCT00321620|452858776|FG001|Overall Study|Physician Decision|1|||
125880085|NCT00321620|452858775|FG000|Overall Study|Noncompliance|14|||
125880086|NCT00321620|452858776|FG001|Overall Study|Noncompliance|7|||
125880087|NCT00321620|452858775|FG000|Overall Study|Protocol deviation|4|||
125880088|NCT00321620|452858776|FG001|Overall Study|Protocol deviation|3|||
125880089|NCT00321620|452858775|FG000|Overall Study|Ineligibility determined|2|||
125880090|NCT00321620|452858776|FG001|Overall Study|Ineligibility determined|3|||
125880091|NCT00321620|452858775|FG000|Overall Study|Participant request|75|||
125880092|NCT00321620|452858776|FG001|Overall Study|Participant request|52|||
125880093|NCT00321620|452858775|FG000|Overall Study|Other|42|||
125880094|NCT00321620|452858776|FG001|Overall Study|Other|33|||
125880095|NCT03304626|452858779|FG000|Overall Study|Adverse Event|1|||
125880096|NCT03304626|452858780|FG001|Overall Study|Adverse Event|0|||
125880097|NCT03304626|452858779|FG000|Overall Study|Lack of Efficacy|1|||
125880098|NCT03304626|452858780|FG001|Overall Study|Lack of Efficacy|1|||
125880099|NCT03219723|452858781|FG000|Overall Study|Case Report Forms Uncollected|6|||
125880100|NCT03219723|452858781|FG000|Overall Study|Protocol Deviation|4|||
125880101|NCT03137381|452858782|FG000|Overall Study|Adverse Event|3|||
125880102|NCT03137381|452858783|FG001|Overall Study|Adverse Event|0|||
125880103|NCT03137381|452858784|FG002|Overall Study|Adverse Event|2|||
125880104|NCT03137381|452858785|FG003|Overall Study|Adverse Event|0|||
125880105|NCT03137381|452858782|FG000|Overall Study|Lost to Follow-up|2|||
125880106|NCT03137381|452858783|FG001|Overall Study|Lost to Follow-up|1|||
125880107|NCT03137381|452858784|FG002|Overall Study|Lost to Follow-up|1|||
125880108|NCT03137381|452858785|FG003|Overall Study|Lost to Follow-up|0|||
125880109|NCT03137381|452858782|FG000|Overall Study|Protocol deviation|1|||
125880110|NCT03137381|452858783|FG001|Overall Study|Protocol deviation|1|||
125880111|NCT03137381|452858784|FG002|Overall Study|Protocol deviation|0|||
125880112|NCT03137381|452858785|FG003|Overall Study|Protocol deviation|1|||
126030964|NCT03611621|453410920|FG000|Overall Study|Death|3|||
126030965|NCT03611621|453410920|FG000|Overall Study|Lost to Follow-up|1|||
126030966|NCT03039023|453410921|FG000|Overall Study|Withdrawal by Subject|1|||
126030967|NCT03039023|453410922|FG001|Overall Study|Withdrawal by Subject|0|||
126030968|NCT03039023|453410923|FG002|Overall Study|Withdrawal by Subject|1|||
126030969|NCT03039023|453410924|FG003|Overall Study|Withdrawal by Subject|1|||
126030970|NCT03039023|453410925|FG004|Overall Study|Withdrawal by Subject|0|||
126030971|NCT03039023|453410921|FG000|Overall Study|Physician Decision|0|||
126030972|NCT03039023|453410922|FG001|Overall Study|Physician Decision|0|||
126030973|NCT03039023|453410923|FG002|Overall Study|Physician Decision|0|||
126030974|NCT03039023|453410924|FG003|Overall Study|Physician Decision|1|||
126030975|NCT03039023|453410925|FG004|Overall Study|Physician Decision|0|||
126030976|NCT04130438|453410926|FG000|Overall Study|Lost to Follow-up|0|||
126030977|NCT04130438|453410927|FG001|Overall Study|Lost to Follow-up|0|||
126030978|NCT04130438|453410928|FG002|Overall Study|Lost to Follow-up|1|||
126030979|NCT04739956|453410933|FG000|Overall Study|Withdrawal by Subject|1|||
126030980|NCT04739956|453410934|FG001|Overall Study|Withdrawal by Subject|1|||
126030981|NCT03519581|453410937|FG000|Overall Study|Lost to Follow-up|3|||
126030982|NCT03519581|453410938|FG001|Overall Study|Lost to Follow-up|2|||
126030983|NCT03519581|453410937|FG000|Overall Study|Adverse Event|5|||
126030984|NCT03519581|453410938|FG001|Overall Study|Adverse Event|2|||
126030985|NCT03519581|453410937|FG000|Overall Study|Withdrawal by Subject|2|||
126030986|NCT03519581|453410938|FG001|Overall Study|Withdrawal by Subject|0|||
126030987|NCT03519581|453410937|FG000|Overall Study|Change to insurance|2|||
126030988|NCT03519581|453410938|FG001|Overall Study|Change to insurance|1|||
126030989|NCT03519581|453410937|FG000|Overall Study|Other|2|||
126030990|NCT03519581|453410938|FG001|Overall Study|Other|4|||
126259594|NCT00442546|454239730|FG002|Overall Study|Other|6|||
125880113|NCT03137381|452858782|FG000|Overall Study|Withdrawal by Investigator|0|||
125880114|NCT03137381|452858783|FG001|Overall Study|Withdrawal by Investigator|1|||
126030991|NCT05268393|453410939|FG000|Overall Study|Withdrawal by Subject|2|||
126030992|NCT05268393|453410940|FG001|Overall Study|Withdrawal by Subject|1|||
126030993|NCT03396926|453410941|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
126096257|NCT00350103|453644684|FG002|Overall Study|Patient relocated|1|||
126030994|NCT03396926|453410942|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
126030995|NCT04764448|453410943|FG000|Overall Study|Study terminated by sponsor|2|||
126030996|NCT04764448|453410944|FG001|Overall Study|Study terminated by sponsor|2|||
126030997|NCT04764448|453410945|FG002|Overall Study|Study terminated by sponsor|5|||
126030998|NCT04764448|453410943|FG000|Overall Study|Withdrawal by Subject|3|||
126030999|NCT04764448|453410944|FG001|Overall Study|Withdrawal by Subject|3|||
126031000|NCT04764448|453410945|FG002|Overall Study|Withdrawal by Subject|1|||
126031001|NCT05256706|453410946|FG000|Overall Study|Lost to Follow-up|9|||
126031002|NCT05256706|453410947|FG001|Overall Study|Lost to Follow-up|3|||
126031003|NCT05256706|453410946|FG000|Overall Study|Withdrawal by Subject|7|||
126031004|NCT05256706|453410947|FG001|Overall Study|Withdrawal by Subject|11|||
126031005|NCT05256706|453410946|FG000|Overall Study|Screen Failures|3|||
126031006|NCT05256706|453410947|FG001|Overall Study|Screen Failures|0|||
126031007|NCT01997840|453410948|FG000|Overall Study|Lost to Follow-up|0|||
126031008|NCT01997840|453410949|FG001|Overall Study|Lost to Follow-up|0|||
126031009|NCT01997840|453410950|FG002|Overall Study|Lost to Follow-up|1|||
126031010|NCT01997840|453410951|FG003|Overall Study|Lost to Follow-up|0|||
126031011|NCT01997840|453410948|FG000|Overall Study|Withdrawal by participant|0|||
126031012|NCT01997840|453410949|FG001|Overall Study|Withdrawal by participant|0|||
126031013|NCT01997840|453410950|FG002|Overall Study|Withdrawal by participant|8|||
126031014|NCT01997840|453410951|FG003|Overall Study|Withdrawal by participant|1|||
126031015|NCT01997840|453410948|FG000|Overall Study|Physician Decision|0|||
126259595|NCT00442546|454239728|FG000|Overall Study|Withdrawal by Subject|5|||
126259596|NCT00442546|454239729|FG001|Overall Study|Withdrawal by Subject|5|||
126259597|NCT00442546|454239730|FG002|Overall Study|Withdrawal by Subject|7|||
126259598|NCT00442546|454239728|FG000|Overall Study|Randomized But Not Treated|5|||
126259599|NCT00442546|454239729|FG001|Overall Study|Randomized But Not Treated|4|||
126259600|NCT00442546|454239730|FG002|Overall Study|Randomized But Not Treated|6|||
126259601|NCT03840382|454239731|FG000|Overall Study|Lost to Follow-up|11|||
126259602|NCT03180528|454240728|FG000|Overall Study|Adverse Event|1|||
126259603|NCT03180528|454240728|FG000|Overall Study|Withdrawal by Subject|1|||
126259604|NCT03180528|454240728|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
126259605|NCT04703855|454240729|FG000|Overall Study|Heart Transplant|1|||
126259606|NCT00097786|454240733|FG000|Overall Study|lost to follow-up for all-cause death|296|||
126259607|NCT00097786|454240734|FG001|Overall Study|lost to follow-up for all-cause death|292|||
126259608|NCT00097786|454240735|FG002|Overall Study|lost to follow-up for all-cause death|313|||
126259609|NCT00097786|454240736|FG003|Overall Study|lost to follow-up for all-cause death|310|||
126259610|NCT02000531|454240737|FG000|Overall Study|Lost to Follow-up|1|||
126259611|NCT02000531|454240738|FG001|Overall Study|Lost to Follow-up|0|||
126259612|NCT02000531|454240737|FG000|Overall Study|Discontinued due to data cut-off|3|||
126259613|NCT02000531|454240738|FG001|Overall Study|Discontinued due to data cut-off|8|||
126259614|NCT01239472|454240741|FG000|Overall Study|Withdrawal by Subject|5|||
126259615|NCT01239472|454240742|FG001|Overall Study|Withdrawal by Subject|1|||
126259616|NCT01239472|454240741|FG000|Overall Study|Adverse Event|0|||
126259617|NCT01239472|454240742|FG001|Overall Study|Adverse Event|1|||
126259618|NCT01239472|454240741|FG000|Overall Study|Lack of Efficacy|0|||
126259619|NCT01239472|454240742|FG001|Overall Study|Lack of Efficacy|1|||
126259620|NCT01280617|454240747|FG000|Overall Study|Adverse Event|0|||
126259621|NCT01280617|454240748|FG001|Overall Study|Adverse Event|1|||
126259622|NCT05966090|454240749|FG000|Overall Study|Lost to Follow-up|6|||
126259623|NCT05966090|454240750|FG001|Overall Study|Lost to Follow-up|6|||
126259624|NCT05966090|454240749|FG000|Overall Study|Adverse Event|1|||
126259625|NCT05966090|454240750|FG001|Overall Study|Adverse Event|1|||
126259626|NCT05966090|454240749|FG000|Overall Study|Withdrawal by Subject|1|||
126259627|NCT05966090|454240750|FG001|Overall Study|Withdrawal by Subject|1|||
126259628|NCT05966090|454240749|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126259629|NCT05966090|454240750|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126259630|NCT05966090|454240749|FG000|Overall Study|Other|1|||
126259631|NCT05966090|454240750|FG001|Overall Study|Other|1|||
126259632|NCT00337428|454240751|FG000|Overall Study|Withdrawal by Subject|1|||
126259633|NCT00337428|454240752|FG001|Overall Study|Withdrawal by Subject|2|||
126259634|NCT00337428|454240751|FG000|Overall Study|Lack of Time|1|||
126259635|NCT00337428|454240752|FG001|Overall Study|Lack of Time|1|||
126259636|NCT00337428|454240751|FG000|Overall Study|Unwilling to Continue|1|||
126259637|NCT00337428|454240752|FG001|Overall Study|Unwilling to Continue|0|||
126259638|NCT00337428|454240751|FG000|Overall Study|Anorexia|1|||
126259639|NCT00337428|454240752|FG001|Overall Study|Anorexia|0|||
126259640|NCT02001051|454240753|FG000|Overall Study|Deemed not eligible following enrollment|0|||
126359299|NCT00395512|454607371|FG001|Overall Study|Protocol Violation|3|||
126359300|NCT00395512|454607372|FG002|Overall Study|Protocol Violation|6|||
126359301|NCT00395512|454607373|FG003|Overall Study|Protocol Violation|7|||
126031016|NCT01997840|453410949|FG001|Overall Study|Physician Decision|0|||
126031017|NCT01997840|453410950|FG002|Overall Study|Physician Decision|3|||
126031018|NCT01997840|453410951|FG003|Overall Study|Physician Decision|0|||
126031019|NCT01997840|453410948|FG000|Overall Study|Progressive disease|3|||
126359302|NCT00395512|454607370|FG000|Overall Study|Lost to Follow-up|2|||
126031020|NCT01997840|453410949|FG001|Overall Study|Progressive disease|4|||
126031021|NCT01997840|453410950|FG002|Overall Study|Progressive disease|57|||
126031022|NCT01997840|453410951|FG003|Overall Study|Progressive disease|8|||
126031023|NCT01997840|453410948|FG000|Overall Study|Other reasons|0|||
126031024|NCT01997840|453410949|FG001|Overall Study|Other reasons|0|||
126031025|NCT01997840|453410950|FG002|Overall Study|Other reasons|1|||
126031026|NCT01997840|453410951|FG003|Overall Study|Other reasons|0|||
126031027|NCT01997840|453410948|FG000|Overall Study|Adverse Event|0|||
126031028|NCT01997840|453410949|FG001|Overall Study|Adverse Event|0|||
126031029|NCT01997840|453410950|FG002|Overall Study|Adverse Event|15|||
126031030|NCT01997840|453410951|FG003|Overall Study|Adverse Event|2|||
126031031|NCT03850678|453410952|FG000|Overall Study|Withdrawal by Subject|3|||
126031032|NCT03850678|453410953|FG001|Overall Study|Withdrawal by Subject|0|||
126031033|NCT03850678|453410952|FG000|Overall Study|Experimenter Error|1|||
126031034|NCT03850678|453410953|FG001|Overall Study|Experimenter Error|1|||
126031035|NCT03850678|453410952|FG000|Overall Study|Did Not Condition To Experiment|7|||
126031036|NCT03850678|453410953|FG001|Overall Study|Did Not Condition To Experiment|2|||
126031037|NCT01494662|453410961|FG000|Overall Study|Withdrawal by Subject|0|||
126031038|NCT01494662|453410962|FG001|Overall Study|Withdrawal by Subject|0|||
126031039|NCT01494662|453410963|FG002|Overall Study|Withdrawal by Subject|1|||
126031040|NCT01494662|453410964|FG003|Overall Study|Withdrawal by Subject|0|||
126031041|NCT01494662|453410965|FG004|Overall Study|Withdrawal by Subject|0|||
126031042|NCT01494662|453410966|FG005|Overall Study|Withdrawal by Subject|0|||
126031043|NCT01494662|453410967|FG006|Overall Study|Withdrawal by Subject|0|||
126031044|NCT01494662|453410961|FG000|Overall Study|Physician Decision|0|||
126031045|NCT01494662|453410962|FG001|Overall Study|Physician Decision|0|||
126031046|NCT01494662|453410963|FG002|Overall Study|Physician Decision|1|||
126031047|NCT01494662|453410964|FG003|Overall Study|Physician Decision|0|||
126031048|NCT01494662|453410965|FG004|Overall Study|Physician Decision|0|||
126031049|NCT01494662|453410966|FG005|Overall Study|Physician Decision|0|||
126259641|NCT02001051|454240754|FG001|Overall Study|Deemed not eligible following enrollment|1|||
126259642|NCT04205162|454240760|FG000|Overall Study|Lost to Follow-up|1|||
126259643|NCT04205162|454240761|FG001|Overall Study|Lost to Follow-up|0|||
126259644|NCT04205162|454240760|FG000|Overall Study|Withdrawal by Subject|2|||
126259645|NCT04205162|454240761|FG001|Overall Study|Withdrawal by Subject|0|||
126259646|NCT04205162|454240760|FG000|Overall Study|University closure due to COVID-19|1|||
126031050|NCT01494662|453410967|FG006|Overall Study|Physician Decision|0|||
126031051|NCT05311384|453410968|FG000|Overall Study|Uncontrolled health conditions|2|||
126031052|NCT05311384|453410968|FG000|Overall Study|Withdrawal by Subject|1|||
126031053|NCT04322643|453410969|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
126031054|NCT03891667|453410970|FG000|Overall Study|Physician Decision|1|||
126031055|NCT03891667|453410971|FG001|Overall Study|Physician Decision|1|||
126031056|NCT03891667|453410970|FG000|Overall Study|COVID related pause|1|||
126031057|NCT03891667|453410971|FG001|Overall Study|COVID related pause|0|||
126031058|NCT03891667|453410970|FG000|Overall Study|Withdrawal by Subject|0|||
126031059|NCT03891667|453410971|FG001|Overall Study|Withdrawal by Subject|1|||
126031060|NCT03891667|453410970|FG000|Overall Study|Adverse Event|0|||
126031061|NCT03891667|453410971|FG001|Overall Study|Adverse Event|1|||
126031062|NCT05710107|453410978|FG000|Overall Study|Withdrawal by Subject|1|||
126031063|NCT05710107|453410979|FG001|Overall Study|Withdrawal by Subject|1|||
126031064|NCT05710107|453410978|FG000|Overall Study|Lost to Follow-up|8|||
126031065|NCT05710107|453410979|FG001|Overall Study|Lost to Follow-up|9|||
126259647|NCT04205162|454240761|FG001|Overall Study|University closure due to COVID-19|0|||
126031066|NCT05710107|453410978|FG000|Overall Study|Unable to place assigned block|2|||
126031067|NCT05710107|453410979|FG001|Overall Study|Unable to place assigned block|0|||
126031068|NCT05710107|453410978|FG000|Overall Study|Withdrawn by study team|0|||
126031069|NCT05710107|453410979|FG001|Overall Study|Withdrawn by study team|1|||
126031070|NCT05076708|453410980|FG000|Overall Study|Withdrawal by Subject|4|||
126259648|NCT01011556|454240763|FG000|Overall Study|Adverse Event|1|||
126259649|NCT01011556|454240764|FG001|Overall Study|Adverse Event|3|||
126259650|NCT01011556|454240765|FG002|Overall Study|Adverse Event|2|||
126031071|NCT05076708|453410980|FG000|Overall Study|Lost to study during switch phase|8|||
126259651|NCT01011556|454240766|FG003|Overall Study|Adverse Event|1|||
126031072|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Other|0|||
126031073|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Other|0|||
126031074|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Other|0|||
126031075|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Other|0|||
126031076|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Other|0|||
126031077|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Other|0|||
126031078|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Other|0|||
126031079|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Other|0|||
126031080|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Other|0|||
126259652|NCT01011556|454240763|FG000|Overall Study|Lost to Follow-up|1|||
126259653|NCT01011556|454240764|FG001|Overall Study|Lost to Follow-up|0|||
126259654|NCT01011556|454240765|FG002|Overall Study|Lost to Follow-up|0|||
126259655|NCT01011556|454240766|FG003|Overall Study|Lost to Follow-up|0|||
126259656|NCT01011556|454240763|FG000|Overall Study|Physician Decision|1|||
126259657|NCT01011556|454240764|FG001|Overall Study|Physician Decision|0|||
126259658|NCT01011556|454240765|FG002|Overall Study|Physician Decision|0|||
126259659|NCT01011556|454240766|FG003|Overall Study|Physician Decision|1|||
126259660|NCT01011556|454240763|FG000|Overall Study|Protocol Violation|0|||
126259661|NCT01011556|454240764|FG001|Overall Study|Protocol Violation|1|||
126259662|NCT01011556|454240765|FG002|Overall Study|Protocol Violation|0|||
126259663|NCT01011556|454240766|FG003|Overall Study|Protocol Violation|0|||
126259664|NCT01011556|454240763|FG000|Overall Study|Withdrawal by Subject|1|||
126259665|NCT01011556|454240764|FG001|Overall Study|Withdrawal by Subject|2|||
126259666|NCT01011556|454240765|FG002|Overall Study|Withdrawal by Subject|4|||
126259667|NCT01011556|454240766|FG003|Overall Study|Withdrawal by Subject|4|||
126259668|NCT01011556|454240763|FG000|Overall Study|Sponsor decision|0|||
126259669|NCT01011556|454240764|FG001|Overall Study|Sponsor decision|1|||
126259670|NCT01011556|454240765|FG002|Overall Study|Sponsor decision|1|||
126259671|NCT01011556|454240766|FG003|Overall Study|Sponsor decision|2|||
126259672|NCT01011556|454240763|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
126259673|NCT01011556|454240764|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
126259674|NCT01011556|454240765|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
126259675|NCT01011556|454240766|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
126259676|NCT01546519|454240771|FG000|Overall Study|Adverse Event|0|||
126259677|NCT01546519|454240772|FG001|Overall Study|Adverse Event|0|||
126259678|NCT01546519|454240773|FG002|Overall Study|Adverse Event|1|||
126259679|NCT01546519|454240774|FG003|Overall Study|Adverse Event|1|||
126259680|NCT01546519|454240771|FG000|Overall Study|Death|0|||
126259681|NCT01546519|454240772|FG001|Overall Study|Death|1|||
126259682|NCT01546519|454240773|FG002|Overall Study|Death|3|||
126259683|NCT01546519|454240774|FG003|Overall Study|Death|1|||
126259684|NCT01546519|454240771|FG000|Overall Study|related to disease progression|2|||
126259685|NCT01546519|454240772|FG001|Overall Study|related to disease progression|2|||
126259686|NCT01546519|454240773|FG002|Overall Study|related to disease progression|2|||
126259687|NCT01546519|454240774|FG003|Overall Study|related to disease progression|1|||
126259688|NCT01546519|454240771|FG000|Overall Study|Physician Decision|6|||
126259689|NCT01546519|454240772|FG001|Overall Study|Physician Decision|5|||
126259690|NCT01546519|454240773|FG002|Overall Study|Physician Decision|2|||
126259691|NCT01546519|454240774|FG003|Overall Study|Physician Decision|3|||
126259692|NCT01546519|454240771|FG000|Overall Study|Withdrawal by Subject|1|||
126259693|NCT01546519|454240772|FG001|Overall Study|Withdrawal by Subject|0|||
126259694|NCT01546519|454240773|FG002|Overall Study|Withdrawal by Subject|0|||
126259695|NCT01546519|454240774|FG003|Overall Study|Withdrawal by Subject|0|||
126359303|NCT00395512|454607371|FG001|Overall Study|Lost to Follow-up|6|||
126359304|NCT00395512|454607372|FG002|Overall Study|Lost to Follow-up|5|||
125880115|NCT03137381|452858784|FG002|Overall Study|Withdrawal by Investigator|1|||
125880116|NCT03137381|452858785|FG003|Overall Study|Withdrawal by Investigator|0|||
125880117|NCT03137381|452858782|FG000|Overall Study|Withdrawal by Subject|3|||
125880118|NCT03137381|452858783|FG001|Overall Study|Withdrawal by Subject|4|||
125880119|NCT03137381|452858784|FG002|Overall Study|Withdrawal by Subject|3|||
125880120|NCT03137381|452858785|FG003|Overall Study|Withdrawal by Subject|0|||
125880121|NCT03137381|452858782|FG000|Overall Study|Pregnancy|0|||
125880122|NCT03137381|452858783|FG001|Overall Study|Pregnancy|0|||
125880123|NCT03137381|452858784|FG002|Overall Study|Pregnancy|1|||
125880124|NCT03137381|452858785|FG003|Overall Study|Pregnancy|0|||
126259696|NCT00263887|454240777|FG000|Overall Study|Withdrawal by Subject|1|||
126359305|NCT00395512|454607373|FG003|Overall Study|Lost to Follow-up|5|||
126359306|NCT00395512|454607370|FG000|Overall Study|Withdrawal by Subject|6|||
126359307|NCT00395512|454607371|FG001|Overall Study|Withdrawal by Subject|5|||
126359308|NCT00395512|454607372|FG002|Overall Study|Withdrawal by Subject|5|||
126359309|NCT00395512|454607373|FG003|Overall Study|Withdrawal by Subject|12|||
126359310|NCT00395512|454607370|FG000|Overall Study|Physician Decision|6|||
126359311|NCT00395512|454607371|FG001|Overall Study|Physician Decision|4|||
126359312|NCT00395512|454607372|FG002|Overall Study|Physician Decision|2|||
126359313|NCT00395512|454607373|FG003|Overall Study|Physician Decision|2|||
126359314|NCT00395512|454607370|FG000|Overall Study|Other|1|||
126359315|NCT00395512|454607371|FG001|Overall Study|Other|1|||
126359316|NCT00395512|454607372|FG002|Overall Study|Other|0|||
126359317|NCT00395512|454607373|FG003|Overall Study|Other|0|||
126359318|NCT00395512|454607370|FG000|Overall Study|Hyperglycemic Rescue|18|||
126359319|NCT00395512|454607371|FG001|Overall Study|Hyperglycemic Rescue|10|||
125880125|NCT00459316|452858790|FG000|Steps 1 & 2|Other eligibility failure|1|||
125880126|NCT00459316|452858791|FG001|Steps 1 & 2|Other eligibility failure|1|||
126031081|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Other|0|||
126031082|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Other|1|||
126031083|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Other|1|||
126259697|NCT00263887|454240778|FG001|Overall Study|Withdrawal by Subject|1|||
126259698|NCT00263887|454240777|FG000|Overall Study|Lung transplantation|1|||
126259699|NCT00263887|454240778|FG001|Overall Study|Lung transplantation|2|||
126259700|NCT00263887|454240777|FG000|Overall Study|Too ill to attend visit|1|||
126259701|NCT00263887|454240778|FG001|Overall Study|Too ill to attend visit|0|||
126259702|NCT00263887|454240777|FG000|Overall Study|Adverse Event|0|||
126259703|NCT00263887|454240778|FG001|Overall Study|Adverse Event|2|||
126259704|NCT00263887|454240777|FG000|Overall Study|Disease progression|0|||
126259705|NCT00263887|454240778|FG001|Overall Study|Disease progression|1|||
126259706|NCT00263887|454240777|FG000|Overall Study|Lack of Efficacy|0|||
126259707|NCT00263887|454240778|FG001|Overall Study|Lack of Efficacy|1|||
126259708|NCT00779402|454240779|FG000|Treatment Phase 1|Disease Progression|1|||
126259709|NCT00779402|454240780|FG001|Treatment Phase 1|Disease Progression|0|||
126259710|NCT00779402|454240779|FG000|Treatment Phase 1|Adverse Event|2|||
126259711|NCT00779402|454240780|FG001|Treatment Phase 1|Adverse Event|0|||
126259712|NCT00779402|454240779|FG000|Treatment Phase 1|Protocol Violation|1|||
126259713|NCT00779402|454240780|FG001|Treatment Phase 1|Protocol Violation|0|||
126259714|NCT00779402|454240779|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
126259715|NCT00779402|454240780|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
126259716|NCT00779402|454240779|FG000|Treatment Phase 1|Lost to Follow-up|0|||
126259717|NCT00779402|454240780|FG001|Treatment Phase 1|Lost to Follow-up|1|||
126259718|NCT00779402|454240779|FG000|Treatment Phase 1|Death|0|||
126259719|NCT00779402|454240780|FG001|Treatment Phase 1|Death|1|||
126259720|NCT00779402|454240779|FG000|Treatment Phase 1|Intercurrent Illness|1|||
126259721|NCT00779402|454240780|FG001|Treatment Phase 1|Intercurrent Illness|1|||
126259722|NCT00779402|454240779|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
126259723|NCT00779402|454240780|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
126259724|NCT00779402|454240779|FG000|Treatment Phase 1|Other|4|||
126259725|NCT00779402|454240780|FG001|Treatment Phase 1|Other|2|||
126259726|NCT00779402|454240779|FG000|Treatment Phase 1|Closure of Study|3|||
126259727|NCT00779402|454240780|FG001|Treatment Phase 1|Closure of Study|2|||
126259728|NCT00779402|454240779|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
126259729|NCT00779402|454240780|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
126259730|NCT00779402|454240779|FG000|Surveillance Phase|Protocol Violation|0|||
126031084|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Other|1|||
126259731|NCT00779402|454240780|FG001|Surveillance Phase|Protocol Violation|1|||
126259732|NCT00779402|454240779|FG000|Surveillance Phase|Patient refused to continue|22|||
126359320|NCT00395512|454607372|FG002|Overall Study|Hyperglycemic Rescue|4|||
126096258|NCT00350103|453644682|FG000|Overall Study|Need for prohibited medication|1|||
126259733|NCT00779402|454240780|FG001|Surveillance Phase|Patient refused to continue|14|||
126259734|NCT00779402|454240779|FG000|Surveillance Phase|Lost to Follow-up|2|||
126259735|NCT00779402|454240780|FG001|Surveillance Phase|Lost to Follow-up|1|||
126259736|NCT00779402|454240779|FG000|Surveillance Phase|Death|0|||
126259737|NCT00779402|454240780|FG001|Surveillance Phase|Death|1|||
126259738|NCT00779402|454240779|FG000|Surveillance Phase|Intercurrent Illness|2|||
126259739|NCT00779402|454240780|FG001|Surveillance Phase|Intercurrent Illness|0|||
126259740|NCT00779402|454240779|FG000|Surveillance Phase|Other|5|||
126259741|NCT00779402|454240780|FG001|Surveillance Phase|Other|5|||
126259742|NCT00779402|454240779|FG000|Surveillance Phase|Withdrawal by Subject|4|||
126259743|NCT00779402|454240780|FG001|Surveillance Phase|Withdrawal by Subject|1|||
126259744|NCT00779402|454240779|FG000|Surveillance Phase|Closure of study|5|||
126259745|NCT00779402|454240780|FG001|Surveillance Phase|Closure of study|6|||
126259746|NCT00779402|454240779|FG000|Surveillance Phase|Completed Protocol Visits|3|||
126259747|NCT00779402|454240780|FG001|Surveillance Phase|Completed Protocol Visits|2|||
126259748|NCT00779402|454240779|FG000|Long-term Follow-up|Patient refused to continue|2|||
126259749|NCT00779402|454240780|FG001|Long-term Follow-up|Patient refused to continue|0|||
126259750|NCT00779402|454240779|FG000|Long-term Follow-up|Other|5|||
126259751|NCT00779402|454240780|FG001|Long-term Follow-up|Other|0|||
126259752|NCT00779402|454240779|FG000|Long-term Follow-up|Closure of Study|8|||
126259753|NCT00779402|454240780|FG001|Long-term Follow-up|Closure of Study|4|||
126259754|NCT00779402|454240779|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
126259755|NCT00779402|454240780|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
126259756|NCT01519947|454240785|FG000|Overall Study|Death|0|||
126259757|NCT01519947|454240786|FG001|Overall Study|Death|0|||
126259758|NCT01519947|454240787|FG002|Overall Study|Death|0|||
126259759|NCT01519947|454240788|FG003|Overall Study|Death|1|||
126259760|NCT01519947|454240785|FG000|Overall Study|Protocol Violation|0|||
126259761|NCT01519947|454240786|FG001|Overall Study|Protocol Violation|0|||
126259762|NCT01519947|454240787|FG002|Overall Study|Protocol Violation|2|||
126259763|NCT01519947|454240788|FG003|Overall Study|Protocol Violation|1|||
126259764|NCT01519947|454240785|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
126259765|NCT01519947|454240786|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
126259766|NCT01519947|454240787|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
126259767|NCT01519947|454240788|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
126259768|NCT01519947|454240785|FG000|Overall Study|Development of Anemia|0|||
126259769|NCT01519947|454240786|FG001|Overall Study|Development of Anemia|1|||
126259770|NCT01519947|454240787|FG002|Overall Study|Development of Anemia|0|||
126259771|NCT01519947|454240788|FG003|Overall Study|Development of Anemia|1|||
126259772|NCT01519947|454240785|FG000|Overall Study|Blood Transfusion|0|||
126259773|NCT01519947|454240786|FG001|Overall Study|Blood Transfusion|1|||
126259774|NCT01519947|454240787|FG002|Overall Study|Blood Transfusion|1|||
126259775|NCT01519947|454240788|FG003|Overall Study|Blood Transfusion|0|||
126259776|NCT01519947|454240785|FG000|Overall Study|Withdrawal by Subject|0|||
126259777|NCT01519947|454240786|FG001|Overall Study|Withdrawal by Subject|1|||
126259778|NCT01519947|454240787|FG002|Overall Study|Withdrawal by Subject|0|||
126259779|NCT01519947|454240788|FG003|Overall Study|Withdrawal by Subject|1|||
126259780|NCT01519947|454240785|FG000|Overall Study|Lost to Follow-up|0|||
126259781|NCT01519947|454240786|FG001|Overall Study|Lost to Follow-up|0|||
126259782|NCT01519947|454240787|FG002|Overall Study|Lost to Follow-up|3|||
126259783|NCT01519947|454240788|FG003|Overall Study|Lost to Follow-up|2|||
126259784|NCT01519947|454240785|FG000|Overall Study|Poor Response|1|||
126259785|NCT01519947|454240786|FG001|Overall Study|Poor Response|0|||
126259786|NCT01519947|454240787|FG002|Overall Study|Poor Response|0|||
126259787|NCT01519947|454240788|FG003|Overall Study|Poor Response|1|||
126259788|NCT01519947|454240785|FG000|Overall Study|Adverse Event|1|||
126259789|NCT01519947|454240786|FG001|Overall Study|Adverse Event|0|||
126031085|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Other|0|||
126259790|NCT01519947|454240787|FG002|Overall Study|Adverse Event|1|||
126259791|NCT01519947|454240788|FG003|Overall Study|Adverse Event|1|||
126259792|NCT00707434|454240793|FG000|Overall Study|Adverse Event|1|||
126259793|NCT04364763|454240794|FG000|Overall Study|Death|1|||
126259794|NCT04364763|454240795|FG001|Overall Study|Death|2|||
126259795|NCT04364763|454240794|FG000|Overall Study|Lost to Follow-up|1|||
126259796|NCT04364763|454240795|FG001|Overall Study|Lost to Follow-up|0|||
126259797|NCT01386125|454240796|FG000|Overall Study|Lost to Follow-up|3|||
126259798|NCT01386125|454240797|FG001|Overall Study|Lost to Follow-up|9|||
126259799|NCT01386125|454240796|FG000|Overall Study|Physician Decision|0|||
126259800|NCT01386125|454240797|FG001|Overall Study|Physician Decision|1|||
126359321|NCT00395512|454607373|FG003|Overall Study|Hyperglycemic Rescue|6|||
126359322|NCT01986751|454607374|FG000|Overall Study|improperly consented|10|||
126359323|NCT01986751|454607375|FG001|Overall Study|improperly consented|2|||
126359324|NCT01478087|454607376|FG000|Overall Study|due to sponsor closing study|1|||
126359325|NCT04576949|454607377|FG000|Overall Study|Adverse Event|1|||
126359326|NCT04576949|454607378|FG001|Overall Study|Adverse Event|3|||
126359327|NCT04576949|454607379|FG002|Overall Study|Adverse Event|2|||
126359328|NCT04576949|454607377|FG000|Overall Study|Withdrawal by Subject|41|||
126359329|NCT04576949|454607378|FG001|Overall Study|Withdrawal by Subject|26|||
126359330|NCT04576949|454607379|FG002|Overall Study|Withdrawal by Subject|18|||
126359331|NCT04576949|454607377|FG000|Overall Study|Physician Decision|3|||
126359332|NCT04576949|454607378|FG001|Overall Study|Physician Decision|0|||
126359333|NCT04576949|454607379|FG002|Overall Study|Physician Decision|0|||
126359334|NCT04576949|454607377|FG000|Overall Study|Death|0|||
126359335|NCT04576949|454607378|FG001|Overall Study|Death|1|||
126359336|NCT04576949|454607379|FG002|Overall Study|Death|0|||
126359337|NCT04576949|454607377|FG000|Overall Study|Lost to Follow-up|29|||
126359338|NCT04576949|454607378|FG001|Overall Study|Lost to Follow-up|37|||
126359339|NCT04576949|454607379|FG002|Overall Study|Lost to Follow-up|24|||
126359340|NCT04576949|454607377|FG000|Overall Study|Other, Not Specified|2|||
126359341|NCT04576949|454607378|FG001|Overall Study|Other, Not Specified|3|||
126359342|NCT04576949|454607379|FG002|Overall Study|Other, Not Specified|1|||
126359343|NCT04576949|454607377|FG000|Overall Study|Other|1|||
126359344|NCT04576949|454607378|FG001|Overall Study|Other|0|||
126359345|NCT04576949|454607379|FG002|Overall Study|Other|0|||
126359346|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
126359347|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
126359348|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
126359349|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
126359350|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
126359351|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
126359352|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
126359353|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
126031086|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Other|3|||
126359354|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
126359355|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
126359356|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
126359357|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
126359358|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
126031087|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Other|1|||
126359359|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
125880127|NCT00459316|452858792|FG002|Steps 1 & 2|Other eligibility failure|0|||
126031088|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Other|1|||
126031089|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Other|0|||
126259801|NCT01386125|454240796|FG000|Overall Study|Protocol Violation|5|||
126259802|NCT01386125|454240797|FG001|Overall Study|Protocol Violation|7|||
126259803|NCT01386125|454240796|FG000|Overall Study|Disease Progress|1|||
126259804|NCT01386125|454240797|FG001|Overall Study|Disease Progress|2|||
126259805|NCT01386125|454240796|FG000|Overall Study|Withdrawal by Subject|13|||
126259806|NCT01386125|454240797|FG001|Overall Study|Withdrawal by Subject|12|||
126259807|NCT01386125|454240796|FG000|Overall Study|Adverse Event|2|||
126259808|NCT01386125|454240797|FG001|Overall Study|Adverse Event|5|||
126259809|NCT01386125|454240796|FG000|Overall Study|Lack of Efficacy|0|||
126259810|NCT01386125|454240797|FG001|Overall Study|Lack of Efficacy|1|||
126259811|NCT01386125|454240796|FG000|Overall Study|Participant Leaving Country|1|||
126259812|NCT01386125|454240797|FG001|Overall Study|Participant Leaving Country|0|||
126259813|NCT02359864|454240799|FG000|Overall Study|Withdrawal by Subject|1|||
126259814|NCT02359864|454240800|FG001|Overall Study|Withdrawal by Subject|0|||
126259815|NCT00725764|454240801|FG000|Overall Study|Withdrawal by Subject|2|||
126259816|NCT00725764|454240801|FG000|Overall Study|Physician Decision|1|||
126259817|NCT00725764|454240801|FG000|Overall Study|Progressive Disease|7|||
126259818|NCT00725764|454240801|FG000|Overall Study|Lost to Follow-up|1|||
126259819|NCT00725764|454240801|FG000|Overall Study|Death|1|||
126259820|NCT00725764|454240801|FG000|Overall Study|Participant non compliant with protocol|1|||
126259821|NCT00725764|454240801|FG000|Overall Study|Decline in performance status|1|||
126259822|NCT01928615|454240802|FG000|Overall Study|Study Terminated by Sponsor|2|||
126259823|NCT00732160|454240806|FG000|Overall Study|Adverse Event|1|||
126259824|NCT00732160|454240807|FG001|Overall Study|Adverse Event|0|||
126259825|NCT00732160|454240808|FG002|Overall Study|Adverse Event|1|||
126259826|NCT00732160|454240809|FG003|Overall Study|Adverse Event|1|||
126259827|NCT00732160|454240806|FG000|Overall Study|scheduling|4|||
126259828|NCT00732160|454240807|FG001|Overall Study|scheduling|4|||
126259829|NCT00732160|454240808|FG002|Overall Study|scheduling|2|||
126259830|NCT00732160|454240809|FG003|Overall Study|scheduling|1|||
126259831|NCT00090753|454240813|FG000|First Treatment Period|Adverse Event|20|||
126259832|NCT00090753|454240814|FG001|First Treatment Period|Adverse Event|8|||
126259833|NCT00090753|454240813|FG000|First Treatment Period|Death|88|||
126259834|NCT00090753|454240814|FG001|First Treatment Period|Death|62|||
126259835|NCT00090753|454240813|FG000|First Treatment Period|Lack of Efficacy|2|||
126259836|NCT00090753|454240814|FG001|First Treatment Period|Lack of Efficacy|1|||
126259837|NCT00090753|454240813|FG000|First Treatment Period|Refused Treatment|32|||
126259838|NCT00090753|454240814|FG001|First Treatment Period|Refused Treatment|25|||
126259839|NCT00090753|454240813|FG000|First Treatment Period|Lost to Follow-up|4|||
126259840|NCT00090753|454240814|FG001|First Treatment Period|Lost to Follow-up|4|||
126259841|NCT00090753|454240813|FG000|First Treatment Period|Renal Transplant|70|||
126259842|NCT00090753|454240814|FG001|First Treatment Period|Renal Transplant|50|||
126259843|NCT00090753|454240813|FG000|First Treatment Period|Mircera Commercialization|1|||
126259844|NCT00090753|454240814|FG001|First Treatment Period|Mircera Commercialization|0|||
126259845|NCT00090753|454240813|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
126259846|NCT00090753|454240814|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
126259847|NCT00090753|454240813|FG000|Extended Treatment Period|Adverse Event|11|||
126259848|NCT00090753|454240814|FG001|Extended Treatment Period|Adverse Event|0|||
126259849|NCT00090753|454240813|FG000|Extended Treatment Period|Death|58|||
126259850|NCT00090753|454240814|FG001|Extended Treatment Period|Death|30|||
126259851|NCT00090753|454240813|FG000|Extended Treatment Period|Lack of Efficacy|1|||
126259852|NCT00090753|454240814|FG001|Extended Treatment Period|Lack of Efficacy|0|||
126259853|NCT00090753|454240813|FG000|Extended Treatment Period|Refused Treatment|18|||
126259854|NCT00090753|454240814|FG001|Extended Treatment Period|Refused Treatment|12|||
126259855|NCT00090753|454240813|FG000|Extended Treatment Period|Lost to Follow-up|3|||
126259856|NCT00090753|454240814|FG001|Extended Treatment Period|Lost to Follow-up|1|||
126259857|NCT00090753|454240813|FG000|Extended Treatment Period|Renal Transplant|15|||
126259858|NCT00090753|454240814|FG001|Extended Treatment Period|Renal Transplant|12|||
126259859|NCT00090753|454240813|FG000|Extended Treatment Period|Mircera Commercialization|188|||
126259860|NCT00090753|454240814|FG001|Extended Treatment Period|Mircera Commercialization|93|||
126259861|NCT00090753|454240813|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
126259862|NCT00090753|454240814|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
126259863|NCT01256060|454240819|FG000|Overall Study|Lost to Follow-up|0|||
126259864|NCT01256060|454240820|FG001|Overall Study|Lost to Follow-up|1|||
126259865|NCT01256060|454240821|FG002|Overall Study|Lost to Follow-up|0|||
126259866|NCT01256060|454240822|FG003|Overall Study|Lost to Follow-up|0|||
126259867|NCT01808248|454240831|FG000|Overall Study|Lack of Efficacy|3|||
126259868|NCT01808248|454240831|FG000|Overall Study|Withdrawal by Subject|1|||
126259869|NCT01808248|454240831|FG000|Overall Study|Lost to Follow-up|1|||
126259870|NCT00436917|454240832|FG000|Overall Study|Withdrawal by Subject|13|||
126259871|NCT00436917|454240832|FG000|Overall Study|Adverse Event|2|||
126259872|NCT00436917|454240832|FG000|Overall Study|Physician Decision|1|||
126259873|NCT00436917|454240832|FG000|Overall Study|Death|1|||
126259874|NCT00436917|454240832|FG000|Overall Study|Lost to Follow-up|1|||
126259875|NCT00436917|454240832|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
126259876|NCT00436917|454240832|FG000|Overall Study|Increased creatinine|1|||
126359360|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
126359361|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
126096259|NCT00350103|453644683|FG001|Overall Study|Need for prohibited medication|0|||
126096260|NCT00350103|453644684|FG002|Overall Study|Need for prohibited medication|0|||
126096261|NCT00350103|453644682|FG000|Overall Study|Personal reasons|0|||
126359362|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
126359363|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
126359364|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
126359365|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
126359366|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
126359367|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
126359368|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
126359369|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
126359370|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
126359371|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
126359372|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
126359373|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
126359374|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
126359375|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
126359376|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
126359377|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
126359378|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
126359379|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
126359380|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
126359381|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
126359382|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
126359383|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
126359384|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
126359385|NCT01489358|454607383|FG000|Overall Study|Lost to Follow-up|0|||
126359386|NCT01489358|454607384|FG001|Overall Study|Lost to Follow-up|0|||
126359387|NCT01489358|454607385|FG002|Overall Study|Lost to Follow-up|2|||
126359388|NCT00736476|454607386|FG000|Overall Study|Adverse Event|1|||
126359389|NCT00736476|454607387|FG001|Overall Study|Adverse Event|0|||
126359390|NCT03518203|454607392|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
126359391|NCT03518203|454607392|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
126359392|NCT02829957|454607393|FG000|Overall Study|Lost to Follow-up|2|||
126359393|NCT02829957|454607394|FG001|Overall Study|Lost to Follow-up|1|||
126359394|NCT04560309|454607396|FG000|Overall Study|Meet drop out criteria|1|||
126359395|NCT04560309|454607397|FG001|Overall Study|Meet drop out criteria|1|||
126359396|NCT01370538|454607400|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
126359397|NCT01370538|454607401|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
126359398|NCT01370538|454607400|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126359399|NCT01370538|454607401|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126359400|NCT01370538|454607400|FG000|Overall Study|Adverse Event|1|||
126359401|NCT01370538|454607401|FG001|Overall Study|Adverse Event|0|||
126259877|NCT00436917|454240832|FG000|Overall Study|Personal conflicts of patient|1|||
126259878|NCT00761176|454240837|FG000|Overall Study|Death|1|||
126259879|NCT00761176|454240838|FG001|Overall Study|Death|0|||
126259880|NCT00761176|454240837|FG000|Overall Study|Withdrawal by Subject|1|||
126259881|NCT00761176|454240838|FG001|Overall Study|Withdrawal by Subject|1|||
126259882|NCT01083680|454240843|FG000|Overall Study|Lost to Follow-up|2758|||
126259883|NCT01083680|454240843|FG000|Overall Study|Withdrawal by Subject|1086|||
126259884|NCT05766787|454240844|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
126259885|NCT05766787|454240845|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
126259886|NCT05766787|454240844|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
126259887|NCT05766787|454240845|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
126259888|NCT05766787|454240844|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
126259889|NCT05766787|454240845|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
126259890|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
126259891|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
126259892|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
126259893|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
126259894|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
126259895|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
126259896|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
126259897|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
126259898|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
126259899|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
126259900|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
126259901|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
126259902|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
126259903|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
126259904|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
126259905|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
126259906|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
126259907|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
126259908|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
126259909|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
126259910|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
126259911|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
126259912|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
126259913|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
126259914|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
126259915|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
126259916|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
126259917|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
126259918|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
126259919|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
126259920|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
126259921|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
126259922|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
126259923|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
126259924|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
126259925|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
126259926|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
126259927|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
126259928|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
126259929|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
126259930|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
126259931|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
126259932|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
126259933|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
126259934|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
126259935|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
126259936|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
126259937|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
126259938|NCT02124902|454242285|FG000|Overall Study|Adverse Event|7|||
125880128|NCT00459316|452858790|FG000|Steps 1 & 2|Death|1|||
125880129|NCT00459316|452858791|FG001|Steps 1 & 2|Death|1|||
125880130|NCT00459316|452858792|FG002|Steps 1 & 2|Death|0|||
125880131|NCT00459316|452858790|FG000|Steps 1 & 2|Not able to get to clinic|7|||
125880132|NCT00459316|452858791|FG001|Steps 1 & 2|Not able to get to clinic|4|||
125880133|NCT00459316|452858792|FG002|Steps 1 & 2|Not able to get to clinic|0|||
125880134|NCT00459316|452858790|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
126259939|NCT02124902|454242286|FG001|Overall Study|Adverse Event|2|||
126259940|NCT02124902|454242285|FG000|Overall Study|Went to alternative treatment|4|||
126259941|NCT02124902|454242286|FG001|Overall Study|Went to alternative treatment|0|||
126259942|NCT02124902|454242285|FG000|Overall Study|Withdrawal by Subject|2|||
126259943|NCT02124902|454242286|FG001|Overall Study|Withdrawal by Subject|1|||
126259944|NCT02124902|454242285|FG000|Overall Study|Physician Decision|2|||
126259945|NCT02124902|454242286|FG001|Overall Study|Physician Decision|0|||
126259946|NCT02124902|454242285|FG000|Overall Study|Not eligible|1|||
125880135|NCT00459316|452858791|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
125880136|NCT00459316|452858792|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
125880137|NCT00459316|452858790|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
126096262|NCT00350103|453644683|FG001|Overall Study|Personal reasons|0|||
126259947|NCT02124902|454242286|FG001|Overall Study|Not eligible|0|||
126259948|NCT02124902|454242285|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
126259949|NCT02124902|454242286|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
126259950|NCT00802178|454242287|FG000|Overall Study|Lack of Efficacy|36|||
126359402|NCT01370538|454607400|FG000|Overall Study|Protocol Violation|8|||
126359403|NCT01370538|454607401|FG001|Overall Study|Protocol Violation|5|||
126359404|NCT01370538|454607400|FG000|Overall Study|Development of study specific withdrawal|1|||
126359405|NCT01370538|454607401|FG001|Overall Study|Development of study specific withdrawal|1|||
126359406|NCT01370538|454607400|FG000|Overall Study|Lost to follow up|6|||
126359407|NCT01370538|454607401|FG001|Overall Study|Lost to follow up|10|||
126359408|NCT04193527|454607402|FG000|Overall Study|Other|1|||
126359409|NCT04193527|454607403|FG001|Overall Study|Other|1|||
126359410|NCT04193527|454607404|FG002|Overall Study|Other|0|||
126359411|NCT02366130|454607405|FG000|Overall Study|Withdrawal by Subject|3|||
126359412|NCT02366130|454607405|FG000|Overall Study|Ineligible|6|||
126359413|NCT00567112|454607406|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
126359414|NCT00567112|454607407|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
126359415|NCT00567112|454607408|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
126359416|NCT00567112|454607406|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
126359417|NCT00567112|454607407|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
126359418|NCT00567112|454607408|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
126359419|NCT00567112|454607406|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
126359420|NCT00567112|454607407|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
126359421|NCT00567112|454607408|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
126359422|NCT01945242|454607419|FG000|Overall Study|Physician Decision|3|||
126359423|NCT01945242|454607420|FG001|Overall Study|Physician Decision|3|||
126359424|NCT05661734|454607421|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
126359425|NCT05661734|454607421|FG000|Overall Study|Lost to Follow-up|13|||
126359426|NCT05661734|454607421|FG000|Overall Study|Enrolled but not dosed|2|||
126359427|NCT01125748|454607422|FG000|Overall Study|Adverse Event|0|||
126359428|NCT01125748|454607423|FG001|Overall Study|Adverse Event|2|||
126359429|NCT01125748|454607422|FG000|Overall Study|Lost to Follow-up|0|||
126359430|NCT01125748|454607423|FG001|Overall Study|Lost to Follow-up|1|||
126359431|NCT01125748|454607422|FG000|Overall Study|Physician Decision|8|||
126359432|NCT01125748|454607423|FG001|Overall Study|Physician Decision|7|||
126359433|NCT01125748|454607422|FG000|Overall Study|Patient Decision to Withdraw|2|||
126359434|NCT01125748|454607423|FG001|Overall Study|Patient Decision to Withdraw|4|||
126359435|NCT02405962|454607424|FG000|Overall Study|Lost to Follow-up|1|||
126359436|NCT02405962|454607425|FG001|Overall Study|Lost to Follow-up|4|||
126359437|NCT02405962|454607424|FG000|Overall Study|A participant has moved to another place|0|||
126359438|NCT02405962|454607425|FG001|Overall Study|A participant has moved to another place|1|||
126359439|NCT01028391|454607426|FG000|Overall Study|Adverse Event|4|||
126359440|NCT01028391|454607427|FG001|Overall Study|Adverse Event|0|||
126359441|NCT01028391|454607426|FG000|Overall Study|Lack of Efficacy|0|||
126359442|NCT01028391|454607427|FG001|Overall Study|Lack of Efficacy|2|||
126359443|NCT01028391|454607426|FG000|Overall Study|Lost to Follow-up|3|||
126359444|NCT01028391|454607427|FG001|Overall Study|Lost to Follow-up|4|||
126359445|NCT01028391|454607426|FG000|Overall Study|Physician Decision|0|||
126359446|NCT01028391|454607427|FG001|Overall Study|Physician Decision|1|||
126359447|NCT01028391|454607426|FG000|Overall Study|Withdrawal by Subject|6|||
126359448|NCT01028391|454607427|FG001|Overall Study|Withdrawal by Subject|3|||
126359449|NCT01028391|454607426|FG000|Overall Study|Needed excluded medication|1|||
126359450|NCT01028391|454607427|FG001|Overall Study|Needed excluded medication|1|||
126359451|NCT01026038|454607428|FG000|Overall Study|Lost to Follow-up|1|||
126359452|NCT01026038|454607429|FG001|Overall Study|Lost to Follow-up|1|||
126359453|NCT01026038|454607430|FG002|Overall Study|Lost to Follow-up|0|||
126359454|NCT03601052|454607431|FG000|Overall Study|Lost to Follow-up|2|||
126359455|NCT00837330|454607432|FG000|Overall Study|Lost to Follow-up|1|||
126359456|NCT00837330|454607433|FG001|Overall Study|Lost to Follow-up|3|||
126359457|NCT01184118|454607434|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
126359458|NCT01184118|454607434|FG000|Overall Study|No physiologic confirmation of asthma|8|||
126359459|NCT01184118|454607434|FG000|Overall Study|FEV1 <60% predicted|2|||
126359460|NCT01184118|454607434|FG000|Overall Study|Exclusionary medical condition|2|||
126359461|NCT01184118|454607434|FG000|Overall Study|Withdrawal by Subject|5|||
126259951|NCT00802178|454242287|FG000|Overall Study|Insufficient tolerability (IT)|17|||
126259952|NCT00802178|454242287|FG000|Overall Study|Withdrawal by Subject|18|||
126259953|NCT00802178|454242287|FG000|Overall Study|Other|32|||
126259954|NCT00802178|454242287|FG000|Overall Study|Lack of efficacy and patient wish|1|||
126259955|NCT00802178|454242287|FG000|Overall Study|IT and patient wish|8|||
126259956|NCT00802178|454242287|FG000|Overall Study|Patients wish and other reason|1|||
126259957|NCT04100096|454242288|FG000|Overall Study|Adverse Event|19|||
126259958|NCT04100096|454242289|FG001|Overall Study|Adverse Event|7|||
126259959|NCT04100096|454242288|FG000|Overall Study|Lack of Efficacy|0|||
126259960|NCT04100096|454242289|FG001|Overall Study|Lack of Efficacy|1|||
126259961|NCT04100096|454242288|FG000|Overall Study|Lost to Follow-up|13|||
126259962|NCT04100096|454242289|FG001|Overall Study|Lost to Follow-up|11|||
126259963|NCT04100096|454242288|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126259964|NCT04100096|454242289|FG001|Overall Study|Non-Compliance With Study Drug|3|||
126259965|NCT04100096|454242288|FG000|Overall Study|Protocol Deviation|1|||
126259966|NCT04100096|454242289|FG001|Overall Study|Protocol Deviation|1|||
126259967|NCT04100096|454242288|FG000|Overall Study|Withdrawal by Participant|13|||
126259968|NCT04100096|454242289|FG001|Overall Study|Withdrawal by Participant|15|||
126259969|NCT00831233|454242293|FG000|Overall Study|Adverse Event|0|||
126259970|NCT00831233|454242294|FG001|Overall Study|Adverse Event|1|||
126259971|NCT00831233|454242293|FG000|Overall Study|Protocol Violation|1|||
126259972|NCT00831233|454242294|FG001|Overall Study|Protocol Violation|0|||
126259973|NCT00831233|454242293|FG000|Overall Study|Selection Criteria Not Met|2|||
126259974|NCT00831233|454242294|FG001|Overall Study|Selection Criteria Not Met|0|||
126259975|NCT02211014|454242295|FG000|Overall Study|Adverse Event|0|||
126259976|NCT02211014|454242296|FG001|Overall Study|Adverse Event|2|||
126259977|NCT02211014|454242295|FG000|Overall Study|Physician Decision|1|||
126259978|NCT02211014|454242296|FG001|Overall Study|Physician Decision|2|||
126259979|NCT02211014|454242295|FG000|Overall Study|Started another cancer therapy|1|||
126259980|NCT02211014|454242296|FG001|Overall Study|Started another cancer therapy|0|||
126259981|NCT02211014|454242295|FG000|Overall Study|Withdrawal by Subject|0|||
126259982|NCT02211014|454242296|FG001|Overall Study|Withdrawal by Subject|1|||
126259983|NCT02211014|454242295|FG000|Overall Study|In agreement with patient, no benefit|0|||
126259984|NCT02211014|454242296|FG001|Overall Study|In agreement with patient, no benefit|1|||
126259985|NCT02916693|454242297|FG000|Overall Study|Lost to Follow-up|7|||
126259986|NCT00529217|454242298|FG000|Overall Study|Lack of Efficacy|2|||
126259987|NCT00529217|454242298|FG000|Overall Study|Unable to adhere to study schedule|2|||
126259988|NCT01098110|454242300|FG000|Overall Study|Withdrawal by Subject|14|||
126259989|NCT01098110|454242301|FG001|Overall Study|Withdrawal by Subject|24|||
126259990|NCT01098110|454242302|FG002|Overall Study|Withdrawal by Subject|19|||
126259991|NCT01098110|454242300|FG000|Overall Study|Adverse Event|30|||
126259992|NCT01098110|454242301|FG001|Overall Study|Adverse Event|32|||
126259993|NCT01098110|454242302|FG002|Overall Study|Adverse Event|43|||
126259994|NCT01098110|454242300|FG000|Overall Study|Lack of Efficacy|13|||
126259995|NCT01098110|454242301|FG001|Overall Study|Lack of Efficacy|9|||
126259996|NCT01098110|454242302|FG002|Overall Study|Lack of Efficacy|27|||
126259997|NCT01098110|454242300|FG000|Overall Study|Other|4|||
126259998|NCT01098110|454242301|FG001|Overall Study|Other|7|||
126259999|NCT01098110|454242302|FG002|Overall Study|Other|5|||
126260000|NCT01098110|454242300|FG000|Overall Study|Untreated|1|||
126260001|NCT01098110|454242301|FG001|Overall Study|Untreated|1|||
126260002|NCT01098110|454242302|FG002|Overall Study|Untreated|0|||
126260003|NCT01999894|454242303|FG000|Overall Study|Adverse Event|9|||
126260004|NCT01999894|454242303|FG000|Overall Study|Lack of Efficacy|5|||
126260005|NCT01999894|454242303|FG000|Overall Study|Protocol Violation|1|||
126260006|NCT01999894|454242303|FG000|Overall Study|Withdrawal by Subject|7|||
126260007|NCT01999894|454242303|FG000|Overall Study|Lost to Follow-up|10|||
126260008|NCT01999894|454242303|FG000|Overall Study|Other Reason|3|||
126260009|NCT01999894|454242303|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
126260010|NCT02147587|454242304|FG000|Overall Study|Adverse Event|9|||
126260011|NCT02147587|454242305|FG001|Overall Study|Adverse Event|4|||
126260012|NCT02147587|454242304|FG000|Overall Study|Lack of Efficacy|2|||
126260013|NCT02147587|454242305|FG001|Overall Study|Lack of Efficacy|1|||
126359462|NCT01049828|454607440|FG000|Overall Study|Claustrophibia and Frustration|2|||
126359463|NCT02946996|454607441|FG000|Overall Study|non-evaluable|3|||
126359464|NCT02946996|454607442|FG001|Overall Study|non-evaluable|6|||
126359465|NCT02946996|454607443|FG002|Overall Study|non-evaluable|5|||
126359466|NCT03572218|454607446|FG000|Overall Study|Lost to Follow-up|3|||
126260014|NCT02274948|454242308|FG000|Overall Study|Lost to Follow-up|28|||
126260015|NCT02274948|454242309|FG001|Overall Study|Lost to Follow-up|25|||
126260016|NCT02274948|454242308|FG000|Overall Study|Withdrawal by Subject|64|||
126260017|NCT02274948|454242309|FG001|Overall Study|Withdrawal by Subject|58|||
126260018|NCT02274948|454242308|FG000|Overall Study|Stopped on family Practitioner advice|2|||
126260019|NCT02274948|454242309|FG001|Overall Study|Stopped on family Practitioner advice|5|||
126260020|NCT02274948|454242308|FG000|Overall Study|Left the area|4|||
126359467|NCT03572218|454607447|FG001|Overall Study|Lost to Follow-up|2|||
126260021|NCT02274948|454242309|FG001|Overall Study|Left the area|3|||
126260022|NCT00530348|454242310|FG000|Overall Study|Adverse Event|5|||
126260023|NCT00530348|454242311|FG001|Overall Study|Adverse Event|1|||
126260024|NCT00530348|454242310|FG000|Overall Study|Death|0|||
126260025|NCT00530348|454242311|FG001|Overall Study|Death|1|||
126260026|NCT00530348|454242310|FG000|Overall Study|Lack of Efficacy|2|||
126260027|NCT00530348|454242311|FG001|Overall Study|Lack of Efficacy|0|||
126260028|NCT00530348|454242310|FG000|Overall Study|Lost to Follow-up|0|||
126260029|NCT00530348|454242311|FG001|Overall Study|Lost to Follow-up|2|||
126260030|NCT00530348|454242310|FG000|Overall Study|Physician Decision|1|||
126260031|NCT00530348|454242311|FG001|Overall Study|Physician Decision|2|||
126260032|NCT00530348|454242310|FG000|Overall Study|Pregnancy|1|||
126260033|NCT00530348|454242311|FG001|Overall Study|Pregnancy|0|||
126260034|NCT00530348|454242310|FG000|Overall Study|Withdrawal by Subject|12|||
126260035|NCT00530348|454242311|FG001|Overall Study|Withdrawal by Subject|12|||
126260036|NCT00530348|454242310|FG000|Overall Study|Randomised in error|1|||
126260037|NCT00530348|454242311|FG001|Overall Study|Randomised in error|0|||
126260038|NCT00530348|454242310|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
126260039|NCT00530348|454242311|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
126260040|NCT00676494|454242312|FG000|Overall Study|Missed Visit|8|||
126260041|NCT00676494|454242312|FG000|Overall Study|Withdrawal by Subject|6|||
126260042|NCT01740791|454242313|FG000|Overall Study|Randomized but never treated|5|||
126260043|NCT01740791|454242314|FG001|Overall Study|Randomized but never treated|3|||
126260044|NCT01740791|454242315|FG002|Overall Study|Randomized but never treated|2|||
126260045|NCT01740791|454242316|FG003|Overall Study|Randomized but never treated|2|||
126260046|NCT01740791|454242317|FG004|Overall Study|Randomized but never treated|1|||
126260047|NCT01740791|454242318|FG005|Overall Study|Randomized but never treated|3|||
126260048|NCT01740791|454242313|FG000|Overall Study|Lost to Follow-up|2|||
126260049|NCT01740791|454242314|FG001|Overall Study|Lost to Follow-up|0|||
126260050|NCT01740791|454242315|FG002|Overall Study|Lost to Follow-up|2|||
126260051|NCT01740791|454242316|FG003|Overall Study|Lost to Follow-up|3|||
126260052|NCT01740791|454242317|FG004|Overall Study|Lost to Follow-up|2|||
126260053|NCT01740791|454242318|FG005|Overall Study|Lost to Follow-up|3|||
126260054|NCT01740791|454242313|FG000|Overall Study|Withdrew Consent|4|||
126260055|NCT01740791|454242314|FG001|Overall Study|Withdrew Consent|0|||
126260056|NCT01740791|454242315|FG002|Overall Study|Withdrew Consent|1|||
126260057|NCT01740791|454242316|FG003|Overall Study|Withdrew Consent|2|||
126260058|NCT01740791|454242317|FG004|Overall Study|Withdrew Consent|0|||
126260059|NCT01740791|454242318|FG005|Overall Study|Withdrew Consent|3|||
126260060|NCT01740791|454242313|FG000|Overall Study|Investigator's discretion|1|||
126260061|NCT01740791|454242314|FG001|Overall Study|Investigator's discretion|0|||
126260062|NCT01740791|454242315|FG002|Overall Study|Investigator's discretion|1|||
126260063|NCT01740791|454242316|FG003|Overall Study|Investigator's discretion|0|||
126260064|NCT01740791|454242317|FG004|Overall Study|Investigator's discretion|0|||
126260065|NCT01740791|454242318|FG005|Overall Study|Investigator's discretion|1|||
126260066|NCT01740791|454242313|FG000|Overall Study|Adverse Event|0|||
126260067|NCT01740791|454242314|FG001|Overall Study|Adverse Event|0|||
126260068|NCT01740791|454242315|FG002|Overall Study|Adverse Event|0|||
126260069|NCT01740791|454242316|FG003|Overall Study|Adverse Event|0|||
126260070|NCT01740791|454242317|FG004|Overall Study|Adverse Event|0|||
126260071|NCT01740791|454242318|FG005|Overall Study|Adverse Event|1|||
126260072|NCT01463982|454242319|FG000|Overall Study|Withdrawal by Subject|0|||
126260073|NCT01463982|454242320|FG001|Overall Study|Withdrawal by Subject|1|||
126260074|NCT01463982|454242321|FG002|Overall Study|Withdrawal by Subject|1|||
126260075|NCT01463982|454242322|FG003|Overall Study|Withdrawal by Subject|0|||
126260076|NCT01463982|454242319|FG000|Overall Study|Treatment delay over 5 week|0|||
126260077|NCT01463982|454242320|FG001|Overall Study|Treatment delay over 5 week|0|||
126260078|NCT01463982|454242321|FG002|Overall Study|Treatment delay over 5 week|1|||
126260079|NCT01463982|454242322|FG003|Overall Study|Treatment delay over 5 week|0|||
126260080|NCT04220775|454242323|FG000|Overall Study|Adverse Event|1|||
126260081|NCT04220775|454242324|FG001|Overall Study|Adverse Event|0|||
126260082|NCT04220775|454242323|FG000|Overall Study|Disease Progression|1|||
126260083|NCT04220775|454242324|FG001|Overall Study|Disease Progression|0|||
126260084|NCT00931463|454242325|FG000|Overall Study|Death|8|||
126260085|NCT00931463|454242326|FG001|Overall Study|Death|4|||
126260086|NCT00931463|454242325|FG000|Overall Study|Withdrawal by Subject|5|||
126260087|NCT00931463|454242326|FG001|Overall Study|Withdrawal by Subject|0|||
126260088|NCT00931463|454242325|FG000|Overall Study|Lost to Follow-up|4|||
126260089|NCT00931463|454242326|FG001|Overall Study|Lost to Follow-up|1|||
126260090|NCT03170869|454242327|FG000|Overall Study|Protocol Violation|5|||
126260091|NCT03170869|454242327|FG000|Overall Study|Early study termination|3|||
126260092|NCT00220727|454242330|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
126260093|NCT00220727|454242331|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
126260094|NCT02020967|454242332|FG000|Overall Study|Withdrawal by Subject|51|||
126260095|NCT03507686|454242333|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
126260096|NCT03507686|454242334|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
126260097|NCT03507686|454242333|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
126260098|NCT03507686|454242334|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
125880138|NCT00459316|452858791|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
125880139|NCT00459316|452858792|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
126260099|NCT03507686|454242333|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
126260100|NCT03507686|454242334|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
126260101|NCT03507686|454242333|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
126260102|NCT03507686|454242334|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
126260103|NCT03507686|454242333|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
126260104|NCT03507686|454242334|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
126260105|NCT03507686|454242333|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
126260106|NCT03507686|454242334|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
126260107|NCT02508116|454242337|FG000|Overall Study|Lost to Follow-up|2|||
126260108|NCT02508116|454242338|FG001|Overall Study|Lost to Follow-up|3|||
126260109|NCT02508116|454242337|FG000|Overall Study|Withdrawal by Subject|3|||
126260110|NCT02508116|454242338|FG001|Overall Study|Withdrawal by Subject|2|||
126260111|NCT02508116|454242337|FG000|Overall Study|Protocol Violation|1|||
126260112|NCT02508116|454242338|FG001|Overall Study|Protocol Violation|2|||
126260113|NCT02508116|454242337|FG000|Overall Study|Physician Decision|2|||
126260114|NCT02508116|454242338|FG001|Overall Study|Physician Decision|0|||
126260115|NCT00983528|454242339|FG000|Overall Study|Death|4|||
126260116|NCT00983528|454242339|FG000|Overall Study|Lost to Follow-up|1|||
126260117|NCT00983528|454242339|FG000|Overall Study|Study Terminated|1|||
126260118|NCT00575380|454242340|FG000|Overall Study|Withdrawal by Subject|1|||
126260119|NCT00575380|454242341|FG001|Overall Study|Withdrawal by Subject|0|||
126260120|NCT00575380|454242340|FG000|Overall Study|Adverse Event|0|||
126260121|NCT00575380|454242341|FG001|Overall Study|Adverse Event|1|||
126260122|NCT00575380|454242340|FG000|Overall Study|Various|0|||
126260123|NCT00575380|454242341|FG001|Overall Study|Various|2|||
126260124|NCT00559364|454242342|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
126260125|NCT00559364|454242343|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
126260126|NCT00330460|454242346|FG000|Overall Study|Physician Decision|1|||
126260127|NCT00330460|454242347|FG001|Overall Study|Physician Decision|0|||
126260128|NCT00330460|454242346|FG000|Overall Study|Adverse Event|10|||
126260129|NCT00330460|454242347|FG001|Overall Study|Adverse Event|8|||
126260130|NCT00330460|454242346|FG000|Overall Study|Withdrawal by Subject|18|||
126260131|NCT00330460|454242347|FG001|Overall Study|Withdrawal by Subject|17|||
126260132|NCT00330460|454242346|FG000|Overall Study|Death|1|||
126260133|NCT00330460|454242347|FG001|Overall Study|Death|1|||
126260134|NCT00330460|454242346|FG000|Overall Study|Ineligibility determined|1|||
126260135|NCT00330460|454242347|FG001|Overall Study|Ineligibility determined|3|||
126260136|NCT00330460|454242346|FG000|Overall Study|Lost to Follow-up|8|||
126260137|NCT00330460|454242347|FG001|Overall Study|Lost to Follow-up|3|||
126260138|NCT00330460|454242346|FG000|Overall Study|Noncompliance|2|||
126260139|NCT00330460|454242347|FG001|Overall Study|Noncompliance|1|||
126260140|NCT00330460|454242346|FG000|Overall Study|Other|1|||
126260141|NCT00330460|454242347|FG001|Overall Study|Other|0|||
126260142|NCT02663882|454242352|FG000|Overall Study|Lost to Follow-up|4|||
126260143|NCT02663882|454242353|FG001|Overall Study|Lost to Follow-up|2|||
126260144|NCT00602537|454242354|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
126260145|NCT00602537|454242355|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
126260146|NCT00602537|454242354|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
126260147|NCT00602537|454242355|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
125880140|NCT00459316|452858790|FG000|Steps 1 & 2|Lost to Follow-up|5|||
126096263|NCT00350103|453644684|FG002|Overall Study|Personal reasons|1|||
126260148|NCT00602537|454242354|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
126260149|NCT00602537|454242355|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
126260150|NCT00602537|454242354|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
126260151|NCT00602537|454242355|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
126260152|NCT00602537|454242354|FG000|Follow Up Study Comparison|Adverse Event|1|||
126260153|NCT00602537|454242355|FG001|Follow Up Study Comparison|Adverse Event|0|||
126260154|NCT00602537|454242354|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
125880141|NCT00459316|452858791|FG001|Steps 1 & 2|Lost to Follow-up|0|||
126031090|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031091|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
126260155|NCT00602537|454242355|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
126260156|NCT00602537|454242354|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
126260157|NCT00602537|454242355|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
126260158|NCT00388037|454242356|FG000|Overall Study|Protocol Violation|1|||
126260159|NCT00869440|454242359|FG000|Overall Study|Withdrawal by Subject|1|||
126260160|NCT00869440|454242360|FG001|Overall Study|Withdrawal by Subject|0|||
126260161|NCT00869440|454242361|FG002|Overall Study|Withdrawal by Subject|0|||
126260162|NCT00869440|454242362|FG003|Overall Study|Withdrawal by Subject|0|||
126260163|NCT00869440|454242359|FG000|Overall Study|Physician Decision|1|||
126260164|NCT00869440|454242360|FG001|Overall Study|Physician Decision|1|||
126260165|NCT00869440|454242361|FG002|Overall Study|Physician Decision|0|||
126260166|NCT00869440|454242362|FG003|Overall Study|Physician Decision|0|||
126260167|NCT03573817|454242363|FG000|Overall Study|Adverse Event|0|||
126031092|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031093|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031094|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031095|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
126260168|NCT03573817|454242364|FG001|Overall Study|Adverse Event|2|||
126260169|NCT03573817|454242363|FG000|Overall Study|Protocol Violation|0|||
126260170|NCT03573817|454242364|FG001|Overall Study|Protocol Violation|1|||
126260171|NCT03573817|454242363|FG000|Overall Study|Withdrawal by Subject|1|||
126031096|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
126031097|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
126260172|NCT03573817|454242364|FG001|Overall Study|Withdrawal by Subject|1|||
126260173|NCT02013531|454242365|FG000|Overall Study|Lost to Follow-up|3|||
126260174|NCT02013531|454242365|FG000|Overall Study|Met Withdrawal Criteria|1|||
126260175|NCT02013531|454242365|FG000|Overall Study|Withdrawal by Subject|1|||
126260176|NCT03546647|454242366|FG000|Overall Study|Adverse Event|1|||
126260177|NCT03546647|454242367|FG001|Overall Study|Adverse Event|0|||
126260178|NCT02400476|454242368|FG000|Overall Study|Adverse Event|57|||
126260179|NCT02400476|454242369|FG001|Overall Study|Adverse Event|10|||
126260180|NCT02400476|454242370|FG002|Overall Study|Adverse Event|22|||
126260181|NCT02400476|454242371|FG003|Overall Study|Adverse Event|19|||
126260182|NCT02400476|454242372|FG004|Overall Study|Adverse Event|5|||
126260183|NCT02400476|454242373|FG005|Overall Study|Adverse Event|8|||
126260184|NCT02400476|454242368|FG000|Overall Study|Withdrawal by Subject|4|||
126260185|NCT02400476|454242369|FG001|Overall Study|Withdrawal by Subject|1|||
126260186|NCT02400476|454242370|FG002|Overall Study|Withdrawal by Subject|12|||
126260187|NCT02400476|454242371|FG003|Overall Study|Withdrawal by Subject|7|||
126260188|NCT02400476|454242372|FG004|Overall Study|Withdrawal by Subject|5|||
126260189|NCT02400476|454242373|FG005|Overall Study|Withdrawal by Subject|5|||
126260190|NCT02400476|454242368|FG000|Overall Study|Lost to Follow-up|0|||
126260191|NCT02400476|454242369|FG001|Overall Study|Lost to Follow-up|0|||
126260192|NCT02400476|454242370|FG002|Overall Study|Lost to Follow-up|0|||
126096264|NCT00350103|453644682|FG000|Overall Study|Patient stopped feeling pain|1|||
126260193|NCT02400476|454242371|FG003|Overall Study|Lost to Follow-up|1|||
126260194|NCT02400476|454242372|FG004|Overall Study|Lost to Follow-up|3|||
126260195|NCT02400476|454242373|FG005|Overall Study|Lost to Follow-up|1|||
126260196|NCT02400476|454242368|FG000|Overall Study|Physician Decision|0|||
125880142|NCT00459316|452858792|FG002|Steps 1 & 2|Lost to Follow-up|2|||
126260197|NCT02400476|454242369|FG001|Overall Study|Physician Decision|0|||
126260198|NCT02400476|454242370|FG002|Overall Study|Physician Decision|1|||
126260199|NCT02400476|454242371|FG003|Overall Study|Physician Decision|1|||
126260200|NCT02400476|454242372|FG004|Overall Study|Physician Decision|0|||
126260201|NCT02400476|454242373|FG005|Overall Study|Physician Decision|1|||
126260202|NCT02400476|454242368|FG000|Overall Study|Other, Disease Progression|0|||
126260203|NCT02400476|454242369|FG001|Overall Study|Other, Disease Progression|1|||
125880143|NCT00459316|452858790|FG000|Step 3|Withdrawal by Subject|3|||
126260204|NCT02400476|454242370|FG002|Overall Study|Other, Disease Progression|2|||
126260205|NCT02400476|454242371|FG003|Overall Study|Other, Disease Progression|1|||
126260206|NCT02400476|454242372|FG004|Overall Study|Other, Disease Progression|2|||
126260207|NCT02400476|454242373|FG005|Overall Study|Other, Disease Progression|1|||
126260208|NCT02400476|454242368|FG000|Overall Study|Other, Decreased Quality of Life|0|||
126260209|NCT02400476|454242369|FG001|Overall Study|Other, Decreased Quality of Life|0|||
126260210|NCT02400476|454242370|FG002|Overall Study|Other, Decreased Quality of Life|2|||
126260211|NCT02400476|454242371|FG003|Overall Study|Other, Decreased Quality of Life|0|||
125880144|NCT00459316|452858791|FG001|Step 3|Withdrawal by Subject|0|||
125880145|NCT00459316|452858792|FG002|Step 3|Withdrawal by Subject|1|||
125880146|NCT01980017|452858793|FG000|Overall Study|Lost to Follow-up|30|||
125880147|NCT01980017|452858794|FG001|Overall Study|Lost to Follow-up|21|||
125880148|NCT01980017|452858793|FG000|Overall Study|Death|0|||
126260212|NCT02400476|454242372|FG004|Overall Study|Other, Decreased Quality of Life|0|||
126260213|NCT02400476|454242373|FG005|Overall Study|Other, Decreased Quality of Life|0|||
126260214|NCT02400476|454242368|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
126260215|NCT02400476|454242369|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
126260216|NCT02400476|454242370|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
126260217|NCT02400476|454242371|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
126031098|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
126260218|NCT02400476|454242372|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
126260219|NCT02400476|454242373|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
126260220|NCT00612677|454242378|FG000|Overall Study|study closed before treatment started|1|||
126260221|NCT00613730|454242387|FG000|Overall Study|Disease progression|2|||
126260222|NCT00613730|454242387|FG000|Overall Study|Administrative decision|1|||
126260223|NCT00479388|454242388|FG000|Overall Study|Adverse Event|90|||
126260224|NCT00479388|454242389|FG001|Overall Study|Adverse Event|45|||
126260225|NCT00479388|454242388|FG000|Overall Study|Lost to Follow-up|0|||
126260226|NCT00479388|454242389|FG001|Overall Study|Lost to Follow-up|2|||
126260227|NCT00479388|454242388|FG000|Overall Study|Protocol Violation|10|||
126260228|NCT00479388|454242389|FG001|Overall Study|Protocol Violation|9|||
126260229|NCT00479388|454242388|FG000|Overall Study|Withdrawal by Subject|32|||
126260230|NCT00479388|454242389|FG001|Overall Study|Withdrawal by Subject|17|||
126260231|NCT01876368|454242392|FG000|Overall Study|Adverse Event|2|||
125880149|NCT01980017|452858794|FG001|Overall Study|Death|1|||
126031099|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031100|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031101|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031102|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
126031103|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031104|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
126260232|NCT01876368|454242393|FG001|Overall Study|Adverse Event|5|||
126260233|NCT01876368|454242392|FG000|Overall Study|Lack of Efficacy|1|||
125880150|NCT03044106|452858795|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
125880151|NCT03044106|452858796|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
125880152|NCT02057250|452858797|FG000|AID Assessment Phase|Adverse Event|3|||
125880153|NCT02057250|452858798|FG001|AID Assessment Phase|Adverse Event|2|||
125880154|NCT02057250|452858799|FG002|AID Assessment Phase|Adverse Event|6|||
126260234|NCT01876368|454242393|FG001|Overall Study|Lack of Efficacy|0|||
126260235|NCT01876368|454242392|FG000|Overall Study|Lost to Follow-up|0|||
126260236|NCT01876368|454242393|FG001|Overall Study|Lost to Follow-up|1|||
126260237|NCT01876368|454242392|FG000|Overall Study|Non-compliance with study treatment|0|||
126260238|NCT01876368|454242393|FG001|Overall Study|Non-compliance with study treatment|1|||
125880155|NCT02057250|452858800|FG003|AID Assessment Phase|Adverse Event|1|||
125880156|NCT02057250|452858801|FG004|AID Assessment Phase|Adverse Event|0|||
126260239|NCT01876368|454242392|FG000|Overall Study|Physician Decision|0|||
126260240|NCT01876368|454242393|FG001|Overall Study|Physician Decision|2|||
126260241|NCT01876368|454242392|FG000|Overall Study|Protocol deviation|3|||
125880157|NCT02057250|452858797|FG000|AID Assessment Phase|Other than specified above|1|||
125880158|NCT02057250|452858798|FG001|AID Assessment Phase|Other than specified above|1|||
126031105|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031106|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031107|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
126031108|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126260242|NCT01876368|454242393|FG001|Overall Study|Protocol deviation|3|||
126260243|NCT01876368|454242392|FG000|Overall Study|Subject/guardian decision|3|||
126260244|NCT01876368|454242393|FG001|Overall Study|Subject/guardian decision|1|||
126260245|NCT01955044|454242394|FG000|Overall Study|Death|1|||
126260246|NCT01955044|454242395|FG001|Overall Study|Death|1|||
126260247|NCT01955044|454242396|FG002|Overall Study|Death|0|||
126260248|NCT01644149|454242397|FG000|Overall Study|Withdrawal by Subject|1|||
126260249|NCT01644149|454242398|FG001|Overall Study|Withdrawal by Subject|0|||
126260250|NCT01644149|454242397|FG000|Overall Study|Lost to Follow-up|3|||
126260251|NCT01644149|454242398|FG001|Overall Study|Lost to Follow-up|1|||
126260252|NCT02093923|454242401|FG000|Overall Study|Lost to Follow-up|0|||
126260253|NCT02093923|454242402|FG001|Overall Study|Lost to Follow-up|0|||
126260254|NCT02093923|454242403|FG002|Overall Study|Lost to Follow-up|0|||
126260255|NCT02093923|454242404|FG003|Overall Study|Lost to Follow-up|1|||
126260256|NCT02093923|454242405|FG004|Overall Study|Lost to Follow-up|0|||
126260257|NCT02093923|454242401|FG000|Overall Study|Screen failure after randomization|0|||
126260258|NCT02093923|454242402|FG001|Overall Study|Screen failure after randomization|0|||
126260259|NCT02093923|454242403|FG002|Overall Study|Screen failure after randomization|0|||
126260260|NCT02093923|454242404|FG003|Overall Study|Screen failure after randomization|1|||
126260261|NCT02093923|454242405|FG004|Overall Study|Screen failure after randomization|0|||
126260262|NCT00248170|454242406|FG000|Overall Study|Withdrawal by Subject|71|||
126359468|NCT03572218|454607446|FG000|Overall Study|No longer available for study visits|2|||
126359469|NCT03572218|454607447|FG001|Overall Study|No longer available for study visits|1|||
126359470|NCT03572218|454607446|FG000|Overall Study|No longer interested|1|||
126359471|NCT03572218|454607447|FG001|Overall Study|No longer interested|2|||
126359472|NCT00286455|454607448|FG000|Overall Study|Hyperglycemia rescue|19|||
126359473|NCT00286455|454607449|FG001|Overall Study|Hyperglycemia rescue|13|||
126359474|NCT00286455|454607450|FG002|Overall Study|Hyperglycemia rescue|10|||
126359475|NCT00286455|454607448|FG000|Overall Study|Adverse Event|1|||
126359476|NCT00286455|454607449|FG001|Overall Study|Adverse Event|3|||
126359477|NCT00286455|454607450|FG002|Overall Study|Adverse Event|2|||
126359478|NCT00286455|454607448|FG000|Overall Study|Lost to Follow-up|0|||
126359479|NCT00286455|454607449|FG001|Overall Study|Lost to Follow-up|3|||
126359480|NCT00286455|454607450|FG002|Overall Study|Lost to Follow-up|3|||
126359481|NCT00286455|454607448|FG000|Overall Study|Physician Decision|3|||
126359482|NCT00286455|454607449|FG001|Overall Study|Physician Decision|0|||
126359483|NCT00286455|454607450|FG002|Overall Study|Physician Decision|2|||
126359484|NCT00286455|454607448|FG000|Overall Study|Protocol Violation|1|||
126359485|NCT00286455|454607449|FG001|Overall Study|Protocol Violation|1|||
126359486|NCT00286455|454607450|FG002|Overall Study|Protocol Violation|0|||
126359487|NCT00286455|454607448|FG000|Overall Study|Participant Non-compliance|1|||
126359488|NCT00286455|454607449|FG001|Overall Study|Participant Non-compliance|0|||
126359489|NCT00286455|454607450|FG002|Overall Study|Participant Non-compliance|0|||
126359490|NCT00286455|454607448|FG000|Overall Study|Withdrawal by Subject|0|||
126359491|NCT00286455|454607449|FG001|Overall Study|Withdrawal by Subject|8|||
126359492|NCT00286455|454607450|FG002|Overall Study|Withdrawal by Subject|7|||
126359493|NCT04359680|454608977|FG000|Overall Study|Withdrawal by Subject|29|||
126359494|NCT04359680|454608978|FG001|Overall Study|Withdrawal by Subject|24|||
126359495|NCT04359680|454608977|FG000|Overall Study|Adverse Event|6|||
126359496|NCT04359680|454608978|FG001|Overall Study|Adverse Event|2|||
126359497|NCT04359680|454608977|FG000|Overall Study|Lost to Follow-up|56|||
126359498|NCT04359680|454608978|FG001|Overall Study|Lost to Follow-up|59|||
126359499|NCT04359680|454608977|FG000|Overall Study|Protocol Violation|3|||
126359500|NCT04359680|454608978|FG001|Overall Study|Protocol Violation|5|||
126359501|NCT04359680|454608977|FG000|Overall Study|Physician Decision|1|||
126359502|NCT04359680|454608978|FG001|Overall Study|Physician Decision|1|||
126359503|NCT04359680|454608977|FG000|Overall Study|Sponsor Decision|0|||
126359504|NCT04359680|454608978|FG001|Overall Study|Sponsor Decision|1|||
126359505|NCT03931785|454608980|FG000|Overall Study|Lost to Follow-up|4|||
126359506|NCT03931785|454608981|FG001|Overall Study|Lost to Follow-up|1|||
126359507|NCT03931785|454608982|FG002|Overall Study|Lost to Follow-up|4|||
126359508|NCT03931785|454608983|FG003|Overall Study|Lost to Follow-up|3|||
126359509|NCT03931785|454608980|FG000|Overall Study|Adverse Event|1|||
126359510|NCT03931785|454608981|FG001|Overall Study|Adverse Event|0|||
126359511|NCT03931785|454608982|FG002|Overall Study|Adverse Event|3|||
126359512|NCT03931785|454608983|FG003|Overall Study|Adverse Event|4|||
126359513|NCT03931785|454608980|FG000|Overall Study|Protocol Violation|0|||
126359514|NCT03931785|454608981|FG001|Overall Study|Protocol Violation|1|||
126359515|NCT03931785|454608982|FG002|Overall Study|Protocol Violation|0|||
126359516|NCT03931785|454608983|FG003|Overall Study|Protocol Violation|0|||
126359517|NCT03931785|454608980|FG000|Overall Study|Noncompliance With Study drug|0|||
126359518|NCT03931785|454608981|FG001|Overall Study|Noncompliance With Study drug|1|||
126031109|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031110|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031111|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031112|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031113|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031114|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031115|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
126031116|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031117|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031118|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031119|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031120|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031121|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031122|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031123|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031124|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031125|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126031126|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031127|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031128|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031129|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031130|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031131|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031132|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031133|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031134|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031135|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
126031136|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031137|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031138|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031139|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031140|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031141|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031142|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031143|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
126031144|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Death|0|||
126031145|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Death|0|||
126031146|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Death|0|||
126031147|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Death|0|||
126031148|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Death|0|||
126031149|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Death|0|||
126031150|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Death|0|||
126031151|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Death|0|||
126031152|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Death|0|||
126031153|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Death|1|||
126031154|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Death|0|||
126260263|NCT00248170|454242407|FG001|Overall Study|Withdrawal by Subject|79|||
126260264|NCT00248170|454242406|FG000|Overall Study|Protocol Violation|35|||
126260265|NCT00248170|454242407|FG001|Overall Study|Protocol Violation|30|||
126260266|NCT00248170|454242406|FG000|Overall Study|Lost to Follow-up|28|||
126031155|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Death|1|||
126031156|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Death|0|||
126031157|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Death|1|||
126031158|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Death|0|||
126260267|NCT00248170|454242407|FG001|Overall Study|Lost to Follow-up|35|||
126031159|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Death|0|||
126031160|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Death|2|||
126031161|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Death|0|||
126031162|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
126260268|NCT00248170|454242406|FG000|Overall Study|Disease progression|196|||
126031163|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
126260269|NCT00248170|454242407|FG001|Overall Study|Disease progression|216|||
126260270|NCT00248170|454242406|FG000|Overall Study|Death|28|||
126260271|NCT00248170|454242407|FG001|Overall Study|Death|47|||
126260272|NCT00248170|454242406|FG000|Overall Study|Adverse Event|311|||
126260273|NCT00248170|454242407|FG001|Overall Study|Adverse Event|296|||
126260274|NCT00248170|454242406|FG000|Overall Study|Administrative problems|22|||
126260275|NCT00248170|454242407|FG001|Overall Study|Administrative problems|25|||
126260276|NCT00248170|454242406|FG000|Overall Study|Abnormal test procedure(s) result|49|||
126260277|NCT00248170|454242407|FG001|Overall Study|Abnormal test procedure(s) result|61|||
126260278|NCT00248170|454242406|FG000|Overall Study|Abnormal laboratory values|4|||
126260279|NCT00248170|454242407|FG001|Overall Study|Abnormal laboratory values|0|||
126260280|NCT00248170|454242406|FG000|Overall Study|Protocol deviation|17|||
126260281|NCT00248170|454242407|FG001|Overall Study|Protocol deviation|19|||
126260282|NCT01557582|454242408|FG000|Overall Study|Protocol Violation|4|||
126260283|NCT01557582|454242408|FG000|Overall Study|Operator error|2|||
126260284|NCT02843659|454242409|FG000|Overall Study|Subject Withdrew Consent|0|||
126260285|NCT02843659|454242410|FG001|Overall Study|Subject Withdrew Consent|0|||
126260286|NCT02843659|454242411|FG002|Overall Study|Subject Withdrew Consent|1|||
126260287|NCT02843659|454242409|FG000|Overall Study|Administrative Reason by Sponsor|4|||
126260288|NCT02843659|454242410|FG001|Overall Study|Administrative Reason by Sponsor|5|||
126260289|NCT02843659|454242411|FG002|Overall Study|Administrative Reason by Sponsor|4|||
126260290|NCT02843659|454242409|FG000|Overall Study|Adverse Event|0|||
126260291|NCT02843659|454242410|FG001|Overall Study|Adverse Event|1|||
126260292|NCT02843659|454242411|FG002|Overall Study|Adverse Event|0|||
126260293|NCT02413294|454242415|FG000|Overall Study|Withdrawal by Subject|1|||
126260294|NCT01253317|454242422|FG000|Overall Study|Adverse Event|2|||
126260295|NCT01619579|454245373|FG000|Overall Study|Withdrawal by Subject|0|||
126260296|NCT01619579|454245374|FG001|Overall Study|Withdrawal by Subject|3|||
126260297|NCT02012452|454245378|FG000|Overall Study|Lost to Follow-up|2|||
126260298|NCT02012452|454245379|FG001|Overall Study|Lost to Follow-up|1|||
126260299|NCT02012452|454245378|FG000|Overall Study|Withdrawal by Subject|4|||
126260300|NCT02012452|454245379|FG001|Overall Study|Withdrawal by Subject|0|||
126260301|NCT02688387|454245380|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260302|NCT02688387|454245381|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260303|NCT02688387|454245382|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
126260304|NCT02688387|454245383|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260305|NCT02688387|454245384|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260306|NCT02688387|454245385|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260307|NCT02688387|454245386|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260308|NCT02688387|454245387|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260309|NCT02688387|454245388|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260310|NCT02688387|454245389|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260311|NCT02688387|454245390|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260312|NCT02688387|454245391|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260313|NCT02688387|454245392|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260314|NCT02688387|454245393|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260315|NCT02688387|454245394|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260316|NCT02688387|454245395|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260317|NCT02688387|454245396|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260318|NCT02688387|454245397|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260319|NCT02688387|454245398|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260320|NCT02688387|454245399|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260321|NCT02688387|454245400|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260322|NCT02688387|454245401|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260323|NCT02688387|454245380|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260324|NCT02688387|454245381|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260325|NCT02688387|454245382|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260326|NCT02688387|454245383|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
126260327|NCT02688387|454245384|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260328|NCT02688387|454245385|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260329|NCT02688387|454245386|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260330|NCT02688387|454245387|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260331|NCT02688387|454245388|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260332|NCT02688387|454245389|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260333|NCT02688387|454245390|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260334|NCT02688387|454245391|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260335|NCT02688387|454245392|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260336|NCT02688387|454245393|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260337|NCT02688387|454245394|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260338|NCT02688387|454245395|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260339|NCT02688387|454245396|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260340|NCT02688387|454245397|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260341|NCT02688387|454245398|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260342|NCT02688387|454245399|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260343|NCT02688387|454245400|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260344|NCT02688387|454245401|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260345|NCT02688387|454245380|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260346|NCT02688387|454245381|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
126260347|NCT02688387|454245382|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260348|NCT02688387|454245383|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260349|NCT02688387|454245384|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260350|NCT02688387|454245385|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260351|NCT02688387|454245386|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260352|NCT02688387|454245387|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260353|NCT02688387|454245388|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260354|NCT02688387|454245389|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260355|NCT02688387|454245390|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260356|NCT02688387|454245391|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260357|NCT02688387|454245392|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260358|NCT02688387|454245393|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260359|NCT02688387|454245394|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260360|NCT02688387|454245395|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260361|NCT02688387|454245396|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260362|NCT02688387|454245397|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260363|NCT02688387|454245398|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260364|NCT02688387|454245399|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260365|NCT02688387|454245400|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260366|NCT02688387|454245401|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260367|NCT02688387|454245380|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260368|NCT02688387|454245381|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260369|NCT02688387|454245382|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
126260370|NCT02688387|454245383|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260371|NCT02688387|454245384|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
125880159|NCT02057250|452858799|FG002|AID Assessment Phase|Other than specified above|1|||
125880160|NCT02057250|452858800|FG003|AID Assessment Phase|Other than specified above|1|||
125880161|NCT02057250|452858801|FG004|AID Assessment Phase|Other than specified above|0|||
125880162|NCT02057250|452858797|FG000|Extension Phase|Adverse Event|0|||
125880163|NCT02057250|452858798|FG001|Extension Phase|Adverse Event|0|||
126096265|NCT00350103|453644683|FG001|Overall Study|Patient stopped feeling pain|0|||
126096266|NCT00350103|453644684|FG002|Overall Study|Patient stopped feeling pain|0|||
126096267|NCT00350103|453644682|FG000|Overall Study|PR greater than 250ms|0|||
126096268|NCT00350103|453644683|FG001|Overall Study|PR greater than 250ms|0|||
126096269|NCT00350103|453644684|FG002|Overall Study|PR greater than 250ms|1|||
126096270|NCT00350103|453644682|FG000|Overall Study|Wrong calculation of QT interval|0|||
126096271|NCT00350103|453644683|FG001|Overall Study|Wrong calculation of QT interval|0|||
126096272|NCT00350103|453644684|FG002|Overall Study|Wrong calculation of QT interval|1|||
126096273|NCT00350103|453644682|FG000|Overall Study|Sponsor mistake|1|||
126096274|NCT00350103|453644683|FG001|Overall Study|Sponsor mistake|0|||
126096275|NCT00350103|453644684|FG002|Overall Study|Sponsor mistake|0|||
126096276|NCT00350103|453644682|FG000|Overall Study|Randomization mistake|0|||
126096277|NCT00350103|453644683|FG001|Overall Study|Randomization mistake|1|||
126096278|NCT00350103|453644684|FG002|Overall Study|Randomization mistake|1|||
126096279|NCT00350103|453644682|FG000|Overall Study|Sponsor´s decision|0|||
126096280|NCT00350103|453644683|FG001|Overall Study|Sponsor´s decision|1|||
125880164|NCT02057250|452858799|FG002|Extension Phase|Adverse Event|0|||
125880165|NCT02057250|452858800|FG003|Extension Phase|Adverse Event|0|||
125880166|NCT02057250|452858801|FG004|Extension Phase|Adverse Event|15|||
125880167|NCT02057250|452858797|FG000|Extension Phase|Lack of Efficacy|0|||
125880168|NCT02057250|452858798|FG001|Extension Phase|Lack of Efficacy|0|||
125880169|NCT02057250|452858799|FG002|Extension Phase|Lack of Efficacy|0|||
125880170|NCT02057250|452858800|FG003|Extension Phase|Lack of Efficacy|0|||
125880171|NCT02057250|452858801|FG004|Extension Phase|Lack of Efficacy|10|||
125880172|NCT02057250|452858797|FG000|Extension Phase|Entered in this period but not treated|0|||
125880173|NCT02057250|452858798|FG001|Extension Phase|Entered in this period but not treated|0|||
125880174|NCT02057250|452858799|FG002|Extension Phase|Entered in this period but not treated|0|||
125880175|NCT02057250|452858800|FG003|Extension Phase|Entered in this period but not treated|0|||
125880176|NCT02057250|452858801|FG004|Extension Phase|Entered in this period but not treated|4|||
125880177|NCT02057250|452858797|FG000|Extension Phase|Other than specified above|0|||
125880178|NCT02057250|452858798|FG001|Extension Phase|Other than specified above|0|||
125880179|NCT02057250|452858799|FG002|Extension Phase|Other than specified above|0|||
125880180|NCT02057250|452858800|FG003|Extension Phase|Other than specified above|0|||
125880181|NCT02057250|452858801|FG004|Extension Phase|Other than specified above|7|||
125880182|NCT00423579|452858803|FG000|Overall Study|Lost to Follow-up|3|||
125880183|NCT00423579|452858804|FG001|Overall Study|Lost to Follow-up|0|||
125880184|NCT00423579|452858803|FG000|Overall Study|Protocol Violation|1|||
125880185|NCT00423579|452858804|FG001|Overall Study|Protocol Violation|3|||
125880186|NCT00423579|452858803|FG000|Overall Study|Diagnosis of diabetes|0|||
125880187|NCT00423579|452858804|FG001|Overall Study|Diagnosis of diabetes|1|||
125880188|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
125880189|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
125880190|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
125880191|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
125880192|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
126096281|NCT00350103|453644684|FG002|Overall Study|Sponsor´s decision|0|||
126096282|NCT00350103|453644682|FG000|Overall Study|Lost, Reason unknown|1|||
126096283|NCT00350103|453644683|FG001|Overall Study|Lost, Reason unknown|1|||
126096284|NCT00350103|453644684|FG002|Overall Study|Lost, Reason unknown|0|||
126096285|NCT04828837|453644685|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
126096286|NCT04828837|453644686|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
126096287|NCT04828837|453644685|FG000|Overall Study|Lost to Follow-up|2|||
126096288|NCT04828837|453644686|FG001|Overall Study|Lost to Follow-up|6|||
126096289|NCT04828837|453644685|FG000|Overall Study|Lack of Efficacy|1|||
126096290|NCT04828837|453644686|FG001|Overall Study|Lack of Efficacy|0|||
126096291|NCT04828837|453644685|FG000|Overall Study|Admitted due to pneumothorax.|1|||
126096292|NCT04828837|453644686|FG001|Overall Study|Admitted due to pneumothorax.|0|||
126096293|NCT04828837|453644685|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
126096294|NCT04828837|453644686|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
126096295|NCT00320528|453644687|FG000|Study Period II|Adverse Event|3|||
126096296|NCT00320528|453644688|FG001|Study Period II|Adverse Event|4|||
126096297|NCT00320528|453644689|FG002|Study Period II|Adverse Event|8|||
126096298|NCT00320528|453644687|FG000|Study Period II|Parent/Caregiver Decision|8|||
126096299|NCT00320528|453644688|FG001|Study Period II|Parent/Caregiver Decision|3|||
125880193|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
125880194|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
125880195|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
126096300|NCT00320528|453644689|FG002|Study Period II|Parent/Caregiver Decision|11|||
125880196|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
126096301|NCT00320528|453644687|FG000|Study Period II|Withdrawal by Subject|0|||
126096302|NCT00320528|453644688|FG001|Study Period II|Withdrawal by Subject|1|||
126096303|NCT00320528|453644689|FG002|Study Period II|Withdrawal by Subject|1|||
126096304|NCT00320528|453644687|FG000|Study Period II|Entry Criteria Exclusion|0|||
126096305|NCT00320528|453644688|FG001|Study Period II|Entry Criteria Exclusion|2|||
126096306|NCT00320528|453644689|FG002|Study Period II|Entry Criteria Exclusion|2|||
126260372|NCT02688387|454245385|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260373|NCT02688387|454245386|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260374|NCT02688387|454245387|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260375|NCT02688387|454245388|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260376|NCT02688387|454245389|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260377|NCT02688387|454245390|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260378|NCT02688387|454245391|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260379|NCT02688387|454245392|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260380|NCT02688387|454245393|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260381|NCT02688387|454245394|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260382|NCT02688387|454245395|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260383|NCT02688387|454245396|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260384|NCT02688387|454245397|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260385|NCT02688387|454245398|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260386|NCT02688387|454245399|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260387|NCT02688387|454245400|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260388|NCT02688387|454245401|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260389|NCT02688387|454245380|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
126260390|NCT02688387|454245381|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260391|NCT02688387|454245382|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260392|NCT02688387|454245383|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260393|NCT02688387|454245384|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260394|NCT02688387|454245385|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260395|NCT02688387|454245386|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260396|NCT02688387|454245387|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260397|NCT02688387|454245388|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260398|NCT02688387|454245389|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260399|NCT02688387|454245390|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260400|NCT02688387|454245391|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260401|NCT02688387|454245392|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260402|NCT02688387|454245393|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260403|NCT02688387|454245394|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260404|NCT02688387|454245395|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260405|NCT02688387|454245396|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260406|NCT02688387|454245397|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260407|NCT02688387|454245398|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125880197|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
126096307|NCT00320528|453644687|FG000|Study Period III|Adverse Event|1|||
126096308|NCT00320528|453644688|FG001|Study Period III|Adverse Event|0|||
126096309|NCT00320528|453644689|FG002|Study Period III|Adverse Event|0|||
126096310|NCT00320528|453644687|FG000|Study Period III|Lost to Follow-up|1|||
126096311|NCT00320528|453644688|FG001|Study Period III|Lost to Follow-up|0|||
126096312|NCT00320528|453644689|FG002|Study Period III|Lost to Follow-up|0|||
126096313|NCT00320528|453644687|FG000|Study Period III|Withdrawal by Subject|1|||
126260408|NCT02688387|454245399|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260409|NCT02688387|454245400|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260410|NCT02688387|454245401|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126096314|NCT00320528|453644688|FG001|Study Period III|Withdrawal by Subject|1|||
126260411|NCT02688387|454245380|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260412|NCT02688387|454245381|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260413|NCT02688387|454245382|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126096315|NCT00320528|453644689|FG002|Study Period III|Withdrawal by Subject|2|||
126096316|NCT00320528|453644687|FG000|Study Period III|Lack of Efficacy|2|||
126260414|NCT02688387|454245383|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260415|NCT02688387|454245384|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260416|NCT02688387|454245385|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260417|NCT02688387|454245386|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260418|NCT02688387|454245387|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260419|NCT02688387|454245388|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260420|NCT02688387|454245389|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260421|NCT02688387|454245390|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
126260422|NCT02688387|454245391|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260423|NCT02688387|454245392|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260424|NCT02688387|454245393|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260425|NCT02688387|454245394|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260426|NCT02688387|454245395|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260427|NCT02688387|454245396|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260428|NCT02688387|454245397|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260429|NCT02688387|454245398|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260430|NCT02688387|454245399|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260431|NCT02688387|454245400|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125880198|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
126096317|NCT00320528|453644688|FG001|Study Period III|Lack of Efficacy|0|||
126096318|NCT00320528|453644689|FG002|Study Period III|Lack of Efficacy|0|||
126096319|NCT00320528|453644687|FG000|Study Period III|Parent/Caregiver Decision|14|||
126096320|NCT00320528|453644688|FG001|Study Period III|Parent/Caregiver Decision|3|||
126096321|NCT00320528|453644689|FG002|Study Period III|Parent/Caregiver Decision|11|||
126096322|NCT00320528|453644687|FG000|Study Period III|Protocol Violation|0|||
126096323|NCT00320528|453644688|FG001|Study Period III|Protocol Violation|1|||
126096324|NCT00320528|453644689|FG002|Study Period III|Protocol Violation|0|||
126096325|NCT00320528|453644687|FG000|Study Period III|Physician Decision|0|||
126096326|NCT00320528|453644688|FG001|Study Period III|Physician Decision|1|||
126096327|NCT00320528|453644689|FG002|Study Period III|Physician Decision|2|||
126096328|NCT00320528|453644687|FG000|Study Period III|Sponsor Decision|0|||
126096329|NCT00320528|453644688|FG001|Study Period III|Sponsor Decision|0|||
126096330|NCT00320528|453644689|FG002|Study Period III|Sponsor Decision|1|||
126096331|NCT00320528|453644687|FG000|Study Period III|Atomoxetine Commercially Available|68|||
126096332|NCT00320528|453644688|FG001|Study Period III|Atomoxetine Commercially Available|25|||
126096333|NCT00320528|453644689|FG002|Study Period III|Atomoxetine Commercially Available|90|||
126096334|NCT00545753|453644690|FG000|Overall Study|Withdrawal by Subject|0|||
126096335|NCT00545753|453644691|FG001|Overall Study|Withdrawal by Subject|1|||
126096336|NCT00545753|453644692|FG002|Overall Study|Withdrawal by Subject|10|||
126096337|NCT00545753|453644690|FG000|Overall Study|Lost to Follow-up|13|||
126096338|NCT00545753|453644691|FG001|Overall Study|Lost to Follow-up|3|||
126096339|NCT00545753|453644692|FG002|Overall Study|Lost to Follow-up|12|||
126096340|NCT00545753|453644690|FG000|Overall Study|Protocol Violation|3|||
126096341|NCT00545753|453644691|FG001|Overall Study|Protocol Violation|1|||
126096342|NCT00545753|453644692|FG002|Overall Study|Protocol Violation|4|||
126096343|NCT03014479|453644693|FG000|Overall Study|Adverse Event|0|||
126096344|NCT03014479|453644694|FG001|Overall Study|Adverse Event|1|||
126096345|NCT03014479|453644693|FG000|Overall Study|Voluntary Withdrawal|0|||
126096346|NCT03014479|453644694|FG001|Overall Study|Voluntary Withdrawal|2|||
126096347|NCT03014479|453644693|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
126096348|NCT03014479|453644694|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
126096349|NCT01394978|453644700|FG000|Overall Study|Withdrawal by Subject|2|||
126096350|NCT01394978|453644701|FG001|Overall Study|Withdrawal by Subject|4|||
126096351|NCT01394978|453644700|FG000|Overall Study|Lost to Follow-up|13|||
126096352|NCT01394978|453644701|FG001|Overall Study|Lost to Follow-up|20|||
126096353|NCT01394978|453644700|FG000|Overall Study|Death|6|||
126096354|NCT01394978|453644701|FG001|Overall Study|Death|7|||
126096355|NCT01081132|453644702|FG000|Overall Study|Lack of Efficacy|25|||
126096356|NCT01081132|453644703|FG001|Overall Study|Lack of Efficacy|9|||
126260432|NCT02688387|454245401|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260433|NCT02688387|454245380|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260434|NCT02688387|454245381|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126096357|NCT01081132|453644702|FG000|Overall Study|Withdrawal by Subject|13|||
126260435|NCT02688387|454245382|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260436|NCT02688387|454245383|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126096358|NCT01081132|453644703|FG001|Overall Study|Withdrawal by Subject|16|||
126096359|NCT01081132|453644702|FG000|Overall Study|Lost to Follow-up|4|||
126096360|NCT01081132|453644703|FG001|Overall Study|Lost to Follow-up|11|||
126096361|NCT01081132|453644702|FG000|Overall Study|Adverse Event|3|||
126096362|NCT01081132|453644703|FG001|Overall Study|Adverse Event|9|||
126260437|NCT02688387|454245384|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260438|NCT02688387|454245385|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260439|NCT02688387|454245386|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260440|NCT02688387|454245387|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260441|NCT02688387|454245388|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260442|NCT02688387|454245389|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260443|NCT02688387|454245390|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260444|NCT02688387|454245391|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260445|NCT02688387|454245392|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260446|NCT02688387|454245393|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260447|NCT02688387|454245394|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
126260448|NCT02688387|454245395|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260449|NCT02688387|454245396|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260450|NCT02688387|454245397|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260451|NCT02688387|454245398|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260452|NCT02688387|454245399|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260453|NCT02688387|454245400|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260454|NCT02688387|454245401|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260455|NCT02688387|454245380|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260456|NCT02688387|454245381|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260457|NCT02688387|454245382|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260458|NCT02688387|454245383|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260459|NCT02688387|454245384|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260460|NCT02688387|454245385|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260461|NCT02688387|454245386|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260462|NCT02688387|454245387|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260463|NCT02688387|454245388|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260464|NCT02688387|454245389|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260465|NCT02688387|454245390|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260466|NCT02688387|454245391|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260467|NCT02688387|454245392|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260468|NCT02688387|454245393|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260469|NCT02688387|454245394|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260470|NCT02688387|454245395|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260471|NCT02688387|454245396|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260472|NCT02688387|454245397|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260473|NCT02688387|454245398|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260474|NCT02688387|454245399|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260475|NCT02688387|454245400|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
126260476|NCT02688387|454245401|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126096363|NCT01081132|453644702|FG000|Overall Study|Non Compliance|4|||
126260477|NCT02688387|454245380|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125880199|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
125880200|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
125880201|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
125880202|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
125880203|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
125880204|NCT03773978|452858809|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
125880205|NCT03773978|452858810|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
125880206|NCT03773978|452858809|FG000|DBW Period|Adverse Event|2|||
125880207|NCT03773978|452858810|FG001|DBW Period|Adverse Event|2|||
126260478|NCT02688387|454245381|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260479|NCT02688387|454245382|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260480|NCT02688387|454245383|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260481|NCT02688387|454245384|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260482|NCT02688387|454245385|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260483|NCT02688387|454245386|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260484|NCT02688387|454245387|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260485|NCT02688387|454245388|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260486|NCT02688387|454245389|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260487|NCT02688387|454245390|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260488|NCT02688387|454245391|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260489|NCT02688387|454245392|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260490|NCT02688387|454245393|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260491|NCT02688387|454245394|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260492|NCT02688387|454245395|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260493|NCT02688387|454245396|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260494|NCT02688387|454245397|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260495|NCT02688387|454245398|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
126260496|NCT02688387|454245399|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260497|NCT02688387|454245400|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
126260498|NCT02688387|454245401|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260499|NCT02688387|454245380|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125880208|NCT03773978|452858809|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
126260500|NCT02688387|454245381|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260501|NCT02688387|454245382|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260502|NCT02688387|454245383|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260503|NCT02688387|454245384|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260504|NCT02688387|454245385|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260505|NCT02688387|454245386|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260506|NCT02688387|454245387|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260507|NCT02688387|454245388|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260508|NCT02688387|454245389|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260509|NCT02688387|454245390|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260510|NCT02688387|454245391|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260511|NCT02688387|454245392|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260512|NCT02688387|454245393|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260513|NCT02688387|454245394|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125880209|NCT03773978|452858810|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
125880210|NCT03773978|452858809|FG000|DBW Period|Withdrawal by Subject|2|||
126260514|NCT02688387|454245395|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260515|NCT02688387|454245396|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260516|NCT02688387|454245397|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260517|NCT02688387|454245398|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260518|NCT02688387|454245399|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
126260519|NCT02688387|454245400|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260520|NCT02688387|454245401|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260521|NCT02938442|454245404|FG000|Overall Study|Death|0|||
126260522|NCT02938442|454245405|FG001|Overall Study|Death|1|||
126260523|NCT02938442|454245404|FG000|Overall Study|Lost to Follow-up|0|||
126260524|NCT02938442|454245405|FG001|Overall Study|Lost to Follow-up|1|||
126260525|NCT02938442|454245404|FG000|Overall Study|Physician Decision|0|||
126260526|NCT02938442|454245405|FG001|Overall Study|Physician Decision|1|||
126260527|NCT02938442|454245404|FG000|Overall Study|Withdrawal by Subject|2|||
126260528|NCT02938442|454245405|FG001|Overall Study|Withdrawal by Subject|0|||
126260529|NCT04403399|454245407|FG000|Period 2|Physician Decision|0|||
126260530|NCT04403399|454245408|FG001|Period 2|Physician Decision|1|||
126260531|NCT01606228|454245409|FG000|Overall Study|Lost to Follow-up|20|||
126260532|NCT01606228|454245409|FG000|Overall Study|Withdrawal by Subject|3|||
126260533|NCT01606228|454245409|FG000|Overall Study|Non-compliant|3|||
126260534|NCT01606228|454245409|FG000|Overall Study|Lack of Efficacy|2|||
126260535|NCT01606228|454245409|FG000|Overall Study|Adverse Event|1|||
126260536|NCT00546910|454245410|FG000|Overall Study|Adverse Event|2|||
126260537|NCT00546910|454245411|FG001|Overall Study|Adverse Event|3|||
126260538|NCT00546910|454245410|FG000|Overall Study|Lack of Efficacy|5|||
126260539|NCT00546910|454245411|FG001|Overall Study|Lack of Efficacy|7|||
126260540|NCT00546910|454245410|FG000|Overall Study|Physician Decision|0|||
126260541|NCT00546910|454245411|FG001|Overall Study|Physician Decision|1|||
126260542|NCT00546910|454245410|FG000|Overall Study|Withdrawal by Subject|2|||
126260543|NCT00546910|454245411|FG001|Overall Study|Withdrawal by Subject|0|||
126260544|NCT01115855|454245412|FG000|Overall Study|Adverse Event|16|||
126260545|NCT01115855|454245413|FG001|Overall Study|Adverse Event|18|||
126260546|NCT01115855|454245412|FG000|Overall Study|Death|6|||
126260547|NCT01115855|454245413|FG001|Overall Study|Death|5|||
126260548|NCT01115855|454245412|FG000|Overall Study|Lab Abnormality|1|||
126260549|NCT01115855|454245413|FG001|Overall Study|Lab Abnormality|1|||
126260550|NCT01115855|454245412|FG000|Overall Study|Protocol Violation|0|||
126260551|NCT01115855|454245413|FG001|Overall Study|Protocol Violation|1|||
126260552|NCT01115855|454245412|FG000|Overall Study|Withdrawal by Subject|5|||
126260553|NCT01115855|454245413|FG001|Overall Study|Withdrawal by Subject|5|||
126260554|NCT01115855|454245412|FG000|Overall Study|Other|8|||
126260555|NCT01115855|454245413|FG001|Overall Study|Other|6|||
126260556|NCT01915940|454245415|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
126260557|NCT01915940|454245416|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
126260558|NCT01915940|454245417|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
126260559|NCT01915940|454245415|FG000|Treatment Period|Decision of Participant|0|||
126260560|NCT01915940|454245416|FG001|Treatment Period|Decision of Participant|1|||
126260561|NCT01915940|454245417|FG002|Treatment Period|Decision of Participant|3|||
126260562|NCT01915940|454245415|FG000|Treatment Period|Adverse Event|0|||
126260563|NCT01915940|454245416|FG001|Treatment Period|Adverse Event|9|||
126260564|NCT01915940|454245417|FG002|Treatment Period|Adverse Event|1|||
126260565|NCT01915940|454245415|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
126260566|NCT01915940|454245416|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
126260567|NCT01915940|454245417|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
126260568|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
126260569|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
126260570|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
126260571|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
126260572|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
126260573|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
126260574|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
126260575|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
126260576|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
126260577|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
126260578|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
126260579|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
126260580|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
126260581|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
126260582|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
126260583|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
126260584|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
126260585|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
126260586|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
126260587|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
126260588|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
126260589|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
126260590|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
126260591|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
126260592|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
126260593|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
126260594|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
126260595|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
126260596|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
126260597|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
126260598|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
126260599|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
126260600|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
126260601|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
126260602|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
126260603|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
126260604|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
126260605|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
126260606|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
126260607|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
126260608|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
126260609|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
126260610|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
126260611|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
126260612|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
126260613|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
126260614|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
126260615|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
126260616|NCT01647711|454245423|FG000|Overall Study|Progressive disease|6|||
126260617|NCT01647711|454245424|FG001|Overall Study|Progressive disease|2|||
126260618|NCT01647711|454245425|FG002|Overall Study|Progressive disease|6|||
126260619|NCT01647711|454245426|FG003|Overall Study|Progressive disease|8|||
126260620|NCT01647711|454245427|FG004|Overall Study|Progressive disease|2|||
126260621|NCT01647711|454245423|FG000|Overall Study|Other adverse event|0|||
126260622|NCT01647711|454245424|FG001|Overall Study|Other adverse event|0|||
126260623|NCT01647711|454245425|FG002|Overall Study|Other adverse event|2|||
126260624|NCT01647711|454245426|FG003|Overall Study|Other adverse event|0|||
126260625|NCT01647711|454245427|FG004|Overall Study|Other adverse event|2|||
126260626|NCT01647711|454245423|FG000|Overall Study|Protocol Violation|0|||
126260627|NCT01647711|454245424|FG001|Overall Study|Protocol Violation|0|||
126260628|NCT01647711|454245425|FG002|Overall Study|Protocol Violation|0|||
126260629|NCT01647711|454245426|FG003|Overall Study|Protocol Violation|0|||
126260630|NCT01647711|454245427|FG004|Overall Study|Protocol Violation|1|||
126260631|NCT01647711|454245423|FG000|Overall Study|Refused to continue taking medication|0|||
126031164|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
126031165|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
126031166|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
126260632|NCT01647711|454245424|FG001|Overall Study|Refused to continue taking medication|0|||
126260633|NCT01647711|454245425|FG002|Overall Study|Refused to continue taking medication|0|||
126260634|NCT01647711|454245426|FG003|Overall Study|Refused to continue taking medication|2|||
126260635|NCT01647711|454245427|FG004|Overall Study|Refused to continue taking medication|1|||
126260636|NCT01647711|454245423|FG000|Overall Study|Other reason not defined|0|||
126260637|NCT01647711|454245424|FG001|Overall Study|Other reason not defined|1|||
126260638|NCT01647711|454245425|FG002|Overall Study|Other reason not defined|1|||
126260639|NCT01647711|454245426|FG003|Overall Study|Other reason not defined|1|||
126260640|NCT01647711|454245427|FG004|Overall Study|Other reason not defined|0|||
126260641|NCT01796964|454245445|FG000|Overall Study|Adverse Event|1|||
126031167|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
126031168|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
126031169|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
126031170|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
126031171|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
126031172|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
126031173|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
126260642|NCT01796964|454245446|FG001|Overall Study|Adverse Event|1|||
126260643|NCT01796964|454245445|FG000|Overall Study|Death|1|||
126260644|NCT01796964|454245446|FG001|Overall Study|Death|0|||
126260645|NCT01796964|454245445|FG000|Overall Study|Protocol Violation|0|||
126260646|NCT01796964|454245446|FG001|Overall Study|Protocol Violation|1|||
126260647|NCT01796964|454245445|FG000|Overall Study|Withdrawal by Subject|1|||
126260648|NCT01796964|454245446|FG001|Overall Study|Withdrawal by Subject|1|||
126260649|NCT04025684|454245447|FG000|Overall Study|Withdrawal by Subject|1|||
126260650|NCT04025684|454245448|FG001|Overall Study|Withdrawal by Subject|1|||
126260651|NCT04025684|454245449|FG002|Overall Study|Withdrawal by Subject|0|||
126260652|NCT04025684|454245450|FG003|Overall Study|Withdrawal by Subject|0|||
126260653|NCT04025684|454245447|FG000|Overall Study|Multiple reasons|1|||
126260654|NCT04025684|454245448|FG001|Overall Study|Multiple reasons|3|||
126260655|NCT04025684|454245449|FG002|Overall Study|Multiple reasons|0|||
126260656|NCT04025684|454245450|FG003|Overall Study|Multiple reasons|1|||
126260657|NCT01844531|454245451|FG000|Overall Study|Withdrawal by Subject|0|||
126260658|NCT01844531|454245452|FG001|Overall Study|Withdrawal by Subject|1|||
126260659|NCT01844531|454245453|FG002|Overall Study|Withdrawal by Subject|0|||
126260660|NCT01844531|454245454|FG003|Overall Study|Withdrawal by Subject|0|||
126260661|NCT02744755|454245455|FG000|Study Period 1|Protocol Violation|2|||
126260662|NCT02744755|454245456|FG001|Study Period 1|Protocol Violation|1|||
126260663|NCT02744755|454245455|FG000|Study Period 1|not defined|0|||
126260664|NCT02744755|454245456|FG001|Study Period 1|not defined|1|||
126260665|NCT02744755|454245455|FG000|Study Period 1|Pregnancy|1|||
126260666|NCT02744755|454245456|FG001|Study Period 1|Pregnancy|0|||
126260667|NCT02744755|454245455|FG000|Study Period 1|Adverse Event|1|||
126260668|NCT02744755|454245456|FG001|Study Period 1|Adverse Event|1|||
126260669|NCT02744755|454245455|FG000|Study Period 1|Lost to Follow-up|1|||
126260670|NCT02744755|454245456|FG001|Study Period 1|Lost to Follow-up|1|||
126260671|NCT02744755|454245455|FG000|Study Period 1|Lack of Efficacy|1|||
126260672|NCT02744755|454245456|FG001|Study Period 1|Lack of Efficacy|0|||
126260673|NCT02744755|454245455|FG000|Study Period 1|Withdrawal by Subject|8|||
126260674|NCT02744755|454245456|FG001|Study Period 1|Withdrawal by Subject|4|||
126260675|NCT02744755|454245455|FG000|Study Period 2|Adverse Event|5|||
126260676|NCT02744755|454245456|FG001|Study Period 2|Adverse Event|0|||
126260677|NCT02744755|454245455|FG000|Study Period 2|Protocol Violation|1|||
126260678|NCT02744755|454245456|FG001|Study Period 2|Protocol Violation|0|||
126260679|NCT02744755|454245455|FG000|Study Period 2|not defined|3|||
126260680|NCT02744755|454245456|FG001|Study Period 2|not defined|2|||
126260681|NCT02744755|454245455|FG000|Study Period 2|Lost to Follow-up|0|||
126260682|NCT02744755|454245456|FG001|Study Period 2|Lost to Follow-up|2|||
126260683|NCT02744755|454245455|FG000|Study Period 2|Withdrawal by Subject|2|||
126260684|NCT02744755|454245456|FG001|Study Period 2|Withdrawal by Subject|2|||
126260685|NCT02744755|454245455|FG000|Study Period 2|Lack of Efficacy|3|||
126260686|NCT02744755|454245456|FG001|Study Period 2|Lack of Efficacy|2|||
126260687|NCT00089076|454245460|FG000|Overall Study|Alternate Therapy|1|||
126260688|NCT00089076|454245460|FG000|Overall Study|Withdrawal by Subject|2|||
126260689|NCT00089076|454245460|FG000|Overall Study|Progression|7|||
126260690|NCT01009515|454245461|FG000|Overall Study|Withdrawal by Subject|3|||
126260691|NCT00983476|454245466|FG000|Overall Study|Did not receive intervention|17|||
126260692|NCT00983476|454245467|FG001|Overall Study|Did not receive intervention|22|||
126260693|NCT00983476|454245468|FG002|Overall Study|Did not receive intervention|0|||
126260694|NCT01175473|454245470|FG000|Overall Study|Adverse Event|2|||
126260695|NCT01175473|454245471|FG001|Overall Study|Adverse Event|2|||
126260696|NCT02539368|454245474|FG000|Overall Study|Death|4|||
126260697|NCT02539368|454245475|FG001|Overall Study|Death|2|||
126260698|NCT02539368|454245476|FG002|Overall Study|Death|1|||
126031174|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
126031175|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
126260699|NCT02539368|454245477|FG003|Overall Study|Death|0|||
126260700|NCT02539368|454245478|FG004|Overall Study|Death|0|||
126260701|NCT02539368|454245474|FG000|Overall Study|Withdrawal by Subject|44|||
126031176|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
126031177|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
126031178|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
126260702|NCT02539368|454245475|FG001|Overall Study|Withdrawal by Subject|35|||
126260703|NCT02539368|454245476|FG002|Overall Study|Withdrawal by Subject|9|||
126260704|NCT02539368|454245477|FG003|Overall Study|Withdrawal by Subject|1|||
126260705|NCT02539368|454245478|FG004|Overall Study|Withdrawal by Subject|3|||
126260706|NCT02539368|454245474|FG000|Overall Study|Physician Decision|49|||
126260707|NCT02539368|454245475|FG001|Overall Study|Physician Decision|15|||
126260708|NCT02539368|454245476|FG002|Overall Study|Physician Decision|7|||
126260709|NCT02539368|454245477|FG003|Overall Study|Physician Decision|0|||
126260710|NCT02539368|454245478|FG004|Overall Study|Physician Decision|2|||
126260711|NCT02539368|454245474|FG000|Overall Study|Lost to Follow-up|96|||
126031179|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
126031180|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Adverse Event|0|||
126031181|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Adverse Event|0|||
126260712|NCT02539368|454245475|FG001|Overall Study|Lost to Follow-up|21|||
126260713|NCT02539368|454245476|FG002|Overall Study|Lost to Follow-up|16|||
126260714|NCT02539368|454245477|FG003|Overall Study|Lost to Follow-up|4|||
126260715|NCT02539368|454245478|FG004|Overall Study|Lost to Follow-up|3|||
126260716|NCT02539368|454245474|FG000|Overall Study|Adverse Event|44|||
126260717|NCT02539368|454245475|FG001|Overall Study|Adverse Event|5|||
126260718|NCT02539368|454245476|FG002|Overall Study|Adverse Event|9|||
126260719|NCT02539368|454245477|FG003|Overall Study|Adverse Event|0|||
126260720|NCT02539368|454245478|FG004|Overall Study|Adverse Event|3|||
126260721|NCT02539368|454245474|FG000|Overall Study|Participant Non-compliant|13|||
126260722|NCT02539368|454245475|FG001|Overall Study|Participant Non-compliant|2|||
126260723|NCT02539368|454245476|FG002|Overall Study|Participant Non-compliant|1|||
126260724|NCT02539368|454245477|FG003|Overall Study|Participant Non-compliant|1|||
126260725|NCT02539368|454245478|FG004|Overall Study|Participant Non-compliant|0|||
126260726|NCT02539368|454245474|FG000|Overall Study|Other|145|||
126260727|NCT02539368|454245475|FG001|Overall Study|Other|18|||
126260728|NCT02539368|454245476|FG002|Overall Study|Other|24|||
126260729|NCT02539368|454245477|FG003|Overall Study|Other|1|||
126260730|NCT02539368|454245478|FG004|Overall Study|Other|3|||
126260731|NCT02539368|454245474|FG000|Overall Study|Missing|10|||
126260732|NCT02539368|454245475|FG001|Overall Study|Missing|3|||
126260733|NCT02539368|454245476|FG002|Overall Study|Missing|0|||
126260734|NCT02539368|454245477|FG003|Overall Study|Missing|0|||
126260735|NCT02539368|454245478|FG004|Overall Study|Missing|0|||
126260736|NCT03558139|454245481|FG000|Overall Study|Consent Withdrawn|1|||
126260737|NCT03558139|454245482|FG001|Overall Study|Consent Withdrawn|1|||
126260738|NCT03558139|454245483|FG002|Overall Study|Consent Withdrawn|4|||
126260739|NCT03558139|454245481|FG000|Overall Study|Death|5|||
126260740|NCT03558139|454245482|FG001|Overall Study|Death|3|||
126260741|NCT03558139|454245483|FG002|Overall Study|Death|8|||
126260742|NCT03558139|454245481|FG000|Overall Study|Lost to Follow-up|0|||
126260743|NCT03558139|454245482|FG001|Overall Study|Lost to Follow-up|0|||
126260744|NCT03558139|454245483|FG002|Overall Study|Lost to Follow-up|3|||
126260745|NCT03558139|454245481|FG000|Overall Study|Study Ended Per Protocol|0|||
126260746|NCT03558139|454245482|FG001|Overall Study|Study Ended Per Protocol|3|||
126260747|NCT03558139|454245483|FG002|Overall Study|Study Ended Per Protocol|6|||
126260748|NCT02752802|454245484|FG000|Overall Study|Contrast Volume Not Collected|1|||
126260749|NCT02752802|454245485|FG001|Overall Study|Contrast Volume Not Collected|0|||
126260750|NCT02808819|454245486|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
126260751|NCT02808819|454245487|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
126260752|NCT02808819|454245486|FG000|Overall Study|Withdrawal by Subject|10|||
126260753|NCT02808819|454245487|FG001|Overall Study|Withdrawal by Subject|13|||
126260754|NCT02808819|454245486|FG000|Overall Study|Site terminated by sponsor|2|||
126031182|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Adverse Event|0|||
126260755|NCT02808819|454245487|FG001|Overall Study|Site terminated by sponsor|0|||
126260756|NCT02808819|454245486|FG000|Overall Study|Pregnancy|1|||
126260757|NCT02808819|454245487|FG001|Overall Study|Pregnancy|0|||
126260758|NCT02808819|454245486|FG000|Overall Study|Lost to Follow-up|1|||
126260759|NCT02808819|454245487|FG001|Overall Study|Lost to Follow-up|6|||
126260760|NCT02808819|454245486|FG000|Overall Study|Protocol Violation|0|||
126260761|NCT02808819|454245487|FG001|Overall Study|Protocol Violation|1|||
126260762|NCT02808819|454245486|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
126260763|NCT02808819|454245487|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
126260764|NCT02808819|454245486|FG000|Overall Study|Death|1|||
126260765|NCT02808819|454245487|FG001|Overall Study|Death|0|||
126260766|NCT02808819|454245486|FG000|Overall Study|Adverse Event|3|||
126260767|NCT02808819|454245487|FG001|Overall Study|Adverse Event|4|||
126260768|NCT00588731|454245488|FG000|Overall Study|Withdrawal by Subject|3|||
126260769|NCT00588731|454245489|FG001|Overall Study|Withdrawal by Subject|2|||
126260770|NCT03417830|454245490|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
126260771|NCT03417830|454245491|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
126260772|NCT00823199|454245492|FG000|Overall Study|Withdrawal by Subject|2|||
125880211|NCT03773978|452858810|FG001|DBW Period|Withdrawal by Subject|1|||
126031183|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Adverse Event|0|||
126260773|NCT00268892|454245493|FG000|Overall Study|Adverse Event|14|||
126260774|NCT00268892|454245494|FG001|Overall Study|Adverse Event|17|||
126260775|NCT00268892|454245495|FG002|Overall Study|Adverse Event|20|||
126260776|NCT00268892|454245493|FG000|Overall Study|Lack of Efficacy|1|||
126260777|NCT00268892|454245494|FG001|Overall Study|Lack of Efficacy|3|||
126260778|NCT00268892|454245495|FG002|Overall Study|Lack of Efficacy|0|||
126260779|NCT00268892|454245493|FG000|Overall Study|Withdrawal by Subject|14|||
126260780|NCT00268892|454245494|FG001|Overall Study|Withdrawal by Subject|15|||
126260781|NCT00268892|454245495|FG002|Overall Study|Withdrawal by Subject|13|||
126260782|NCT00268892|454245493|FG000|Overall Study|Physician Decision|0|||
126260783|NCT00268892|454245494|FG001|Overall Study|Physician Decision|1|||
126260784|NCT00268892|454245495|FG002|Overall Study|Physician Decision|0|||
126031184|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Adverse Event|0|||
126031185|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Adverse Event|0|||
126031186|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Adverse Event|2|||
126031187|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Adverse Event|0|||
126031188|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Adverse Event|0|||
126031189|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Adverse Event|0|||
126031190|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Adverse Event|1|||
126031191|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Adverse Event|2|||
126031192|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Adverse Event|0|||
126031193|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Adverse Event|1|||
126031194|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Adverse Event|0|||
126031195|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Adverse Event|0|||
126031196|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Adverse Event|1|||
126031197|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Adverse Event|0|||
126031198|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
126031199|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
126031200|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
126031201|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
126031202|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
126031203|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
126031204|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
126031205|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
126031206|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
126031207|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
126031208|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
126031209|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
126031210|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
126031211|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
126031212|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
126031213|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
126031214|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
126031215|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
126031216|NCT03269136|453410984|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031217|NCT03269136|453410985|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031218|NCT03269136|453410986|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031219|NCT03269136|453410987|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031220|NCT03269136|453410988|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031221|NCT03269136|453410989|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031222|NCT03269136|453410990|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031223|NCT03269136|453410991|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031224|NCT03269136|453410992|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126260785|NCT00268892|454245493|FG000|Overall Study|Lost to Follow-up|5|||
126260786|NCT00268892|454245494|FG001|Overall Study|Lost to Follow-up|2|||
126260787|NCT00268892|454245495|FG002|Overall Study|Lost to Follow-up|4|||
126260788|NCT00268892|454245493|FG000|Overall Study|Protocol Violation|0|||
126260789|NCT00268892|454245494|FG001|Overall Study|Protocol Violation|1|||
126260790|NCT00268892|454245495|FG002|Overall Study|Protocol Violation|0|||
126260791|NCT00268892|454245493|FG000|Overall Study|Disease Progression|1|||
126260792|NCT00268892|454245494|FG001|Overall Study|Disease Progression|1|||
126260793|NCT00268892|454245495|FG002|Overall Study|Disease Progression|0|||
126260794|NCT00268892|454245493|FG000|Overall Study|Trial Site Closed|4|||
126260795|NCT00268892|454245494|FG001|Overall Study|Trial Site Closed|2|||
126260796|NCT00268892|454245495|FG002|Overall Study|Trial Site Closed|2|||
126260797|NCT01640184|454245496|FG000|Overall Study|Death|1|||
126260798|NCT01640184|454245497|FG001|Overall Study|Death|0|||
126260799|NCT01640184|454245498|FG002|Overall Study|Death|0|||
126260800|NCT01640184|454245496|FG000|Overall Study|Lost to Follow-up|4|||
126260801|NCT01640184|454245497|FG001|Overall Study|Lost to Follow-up|1|||
126260802|NCT01640184|454245498|FG002|Overall Study|Lost to Follow-up|0|||
126260803|NCT01640184|454245496|FG000|Overall Study|Physician Decision|3|||
126260804|NCT01640184|454245497|FG001|Overall Study|Physician Decision|0|||
126260805|NCT01640184|454245498|FG002|Overall Study|Physician Decision|0|||
126260806|NCT01640184|454245496|FG000|Overall Study|Withdrawal by Subject|0|||
126260807|NCT01640184|454245497|FG001|Overall Study|Withdrawal by Subject|1|||
126260808|NCT01640184|454245498|FG002|Overall Study|Withdrawal by Subject|1|||
126260809|NCT01640184|454245496|FG000|Overall Study|Protocol Violation|0|||
126260810|NCT01640184|454245497|FG001|Overall Study|Protocol Violation|0|||
126260811|NCT01640184|454245498|FG002|Overall Study|Protocol Violation|1|||
126260812|NCT01684878|454245499|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
126260813|NCT01684878|454245500|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
126260814|NCT01684878|454245501|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
126260815|NCT01684878|454245502|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
126260816|NCT01684878|454245499|FG000|Part 1: Safety Run in Phase|Death|15|||
126260817|NCT01684878|454245500|FG001|Part 1: Safety Run in Phase|Death|20|||
126260818|NCT01684878|454245501|FG002|Part 1: Safety Run in Phase|Death|0|||
126260819|NCT01684878|454245502|FG003|Part 1: Safety Run in Phase|Death|0|||
126260820|NCT01684878|454245499|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
126260821|NCT01684878|454245500|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
126260822|NCT01684878|454245501|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
126260823|NCT01684878|454245502|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
126260824|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
126260825|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
126260826|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
126260827|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
126260828|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
126260829|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
126260830|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
126260831|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
126260832|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Death|0|||
126260833|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Death|0|||
126260834|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Death|62|||
126260835|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Death|68|||
126260836|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
126260837|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
126260838|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
126260839|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
126031225|NCT03269136|453410993|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126260840|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
126260841|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
126260842|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
126260843|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
126260844|NCT02692482|454245506|FG000|Overall Study|Death|2|||
126260845|NCT02692482|454245507|FG001|Overall Study|Death|2|||
126260846|NCT02692482|454245506|FG000|Overall Study|Withdrawal by Subject|1|||
126260847|NCT02692482|454245507|FG001|Overall Study|Withdrawal by Subject|2|||
126260848|NCT01435031|454245508|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
126260849|NCT01435031|454245508|FG000|ITT at 1 Month|Death|1|||
126260850|NCT01435031|454245508|FG000|ITT at 1 Month|Lost to Follow-up|4|||
126260851|NCT01435031|454245508|FG000|ITT at 6 Months|Death|2|||
126260852|NCT01435031|454245508|FG000|ITT at 6 Months|Lost to Follow-up|3|||
126260853|NCT01435031|454245508|FG000|ITT at 1 Year|Death|1|||
126260854|NCT01435031|454245508|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
126260855|NCT01435031|454245508|FG000|ITT at 1 Year|Lost to Follow-up|6|||
126260856|NCT01435031|454245508|FG000|ITT at 2 Years|Death|7|||
126260857|NCT01435031|454245508|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
126260858|NCT01435031|454245508|FG000|ITT at 2 Years|Lost to Follow-up|4|||
126260859|NCT01435031|454245508|FG000|ITT at 3 Years|Death|5|||
126260860|NCT01435031|454245508|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
126260861|NCT01435031|454245508|FG000|ITT at 3 Years|Lost to Follow-up|4|||
126260862|NCT01435031|454245508|FG000|ITT at 4 Years|Death|4|||
126260863|NCT01435031|454245508|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
126260864|NCT01435031|454245508|FG000|ITT at 4 Years|Lost to Follow-up|1|||
126260865|NCT02927834|454245509|FG000|Overall Study|Lost to Follow-up|1|||
126260866|NCT02927834|454245510|FG001|Overall Study|Lost to Follow-up|2|||
126260867|NCT02927834|454245511|FG002|Overall Study|Lost to Follow-up|2|||
126260868|NCT02260258|454245514|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
126260869|NCT02260258|454245515|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
126260870|NCT01610063|454245516|FG000|Overall Study|Lost to Follow-up|42|||
126260871|NCT01610063|454245517|FG001|Overall Study|Lost to Follow-up|20|||
126260872|NCT04405739|454245518|FG000|Overall Study|Adverse Event|0|||
126260873|NCT04405739|454245519|FG001|Overall Study|Adverse Event|1|||
126260874|NCT04405739|454245520|FG002|Overall Study|Adverse Event|0|||
126260875|NCT04405739|454245521|FG003|Overall Study|Adverse Event|0|||
126260876|NCT04405739|454245518|FG000|Overall Study|Lost to Follow-up|0|||
126260877|NCT04405739|454245519|FG001|Overall Study|Lost to Follow-up|2|||
126260878|NCT04405739|454245520|FG002|Overall Study|Lost to Follow-up|1|||
126260879|NCT04405739|454245521|FG003|Overall Study|Lost to Follow-up|3|||
126260880|NCT04405739|454245518|FG000|Overall Study|Withdrawal by Subject|0|||
126260881|NCT04405739|454245519|FG001|Overall Study|Withdrawal by Subject|2|||
126260882|NCT04405739|454245520|FG002|Overall Study|Withdrawal by Subject|1|||
126260883|NCT04405739|454245521|FG003|Overall Study|Withdrawal by Subject|1|||
126260884|NCT04405739|454245518|FG000|Overall Study|Death|0|||
126260885|NCT04405739|454245519|FG001|Overall Study|Death|0|||
126260886|NCT04405739|454245520|FG002|Overall Study|Death|1|||
126260887|NCT04405739|454245521|FG003|Overall Study|Death|0|||
126260888|NCT04405739|454245518|FG000|Overall Study|Transferred to rehab|0|||
126260889|NCT04405739|454245519|FG001|Overall Study|Transferred to rehab|0|||
126260890|NCT04405739|454245520|FG002|Overall Study|Transferred to rehab|0|||
126260891|NCT04405739|454245521|FG003|Overall Study|Transferred to rehab|1|||
126260892|NCT04405739|454245518|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
126260893|NCT04405739|454245519|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
126260894|NCT04405739|454245520|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
126260895|NCT04405739|454245521|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
126260896|NCT01436643|454245522|FG000|2-week Pre-treatment|Abnormal test result|0|||
126260897|NCT01436643|454245523|FG001|2-week Pre-treatment|Abnormal test result|0|||
126260898|NCT01436643|454245524|FG002|2-week Pre-treatment|Abnormal test result|0|||
126260899|NCT01436643|454245525|FG003|2-week Pre-treatment|Abnormal test result|1|||
126260900|NCT01436643|454245522|FG000|2-week Pre-treatment|Adverse Event|0|||
126260901|NCT01436643|454245523|FG001|2-week Pre-treatment|Adverse Event|0|||
126260902|NCT01436643|454245524|FG002|2-week Pre-treatment|Adverse Event|0|||
126260903|NCT01436643|454245525|FG003|2-week Pre-treatment|Adverse Event|5|||
126260904|NCT01436643|454245522|FG000|2-week Pre-treatment|Protocol Violation|0|||
126260905|NCT01436643|454245523|FG001|2-week Pre-treatment|Protocol Violation|0|||
126260906|NCT01436643|454245524|FG002|2-week Pre-treatment|Protocol Violation|0|||
126260907|NCT01436643|454245525|FG003|2-week Pre-treatment|Protocol Violation|4|||
126260908|NCT01436643|454245522|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
126260909|NCT01436643|454245523|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
126260910|NCT01436643|454245524|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
126260911|NCT01436643|454245525|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
126260912|NCT01436643|454245522|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
125880212|NCT03773978|452858809|FG000|DBW Period|Due to epidemic or pandemic|5|||
126260913|NCT01436643|454245523|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
126260914|NCT01436643|454245524|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
126260915|NCT01436643|454245525|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
126260916|NCT01436643|454245522|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
126260917|NCT01436643|454245523|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
126260918|NCT01436643|454245524|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
126260919|NCT01436643|454245525|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
126260920|NCT01867606|454245526|FG000|Overall Study|Withdrawal by Subject|10|||
126260921|NCT01867606|454245527|FG001|Overall Study|Withdrawal by Subject|14|||
126260922|NCT01867606|454245526|FG000|Overall Study|Protocol Violation|0|||
126260923|NCT01867606|454245527|FG001|Overall Study|Protocol Violation|1|||
126260924|NCT02056652|454245533|FG000|Overall Study|Withdrawal by Subject|1|||
126260925|NCT02056652|454245534|FG001|Overall Study|Withdrawal by Subject|0|||
126260926|NCT02056652|454245533|FG000|Overall Study|Lost to Follow-up|0|||
126260927|NCT02056652|454245534|FG001|Overall Study|Lost to Follow-up|3|||
126260928|NCT03234608|454245541|FG000|Overall Study|Lost to Follow-up|23|||
126260929|NCT03234608|454245542|FG001|Overall Study|Lost to Follow-up|21|||
126260930|NCT02105701|454245543|FG000|Overall Study|Lost to Follow-up|1|||
126260931|NCT02105701|454245544|FG001|Overall Study|Lost to Follow-up|0|||
126260932|NCT02105701|454245545|FG002|Overall Study|Lost to Follow-up|2|||
126260933|NCT02105701|454245546|FG003|Overall Study|Lost to Follow-up|1|||
126260934|NCT02105701|454245543|FG000|Overall Study|Protocol Violation|0|||
126260935|NCT02105701|454245544|FG001|Overall Study|Protocol Violation|0|||
126260936|NCT02105701|454245545|FG002|Overall Study|Protocol Violation|1|||
126260937|NCT02105701|454245546|FG003|Overall Study|Protocol Violation|0|||
126260938|NCT02105701|454245543|FG000|Overall Study|Withdrawal by Subject|2|||
126260939|NCT02105701|454245544|FG001|Overall Study|Withdrawal by Subject|1|||
126260940|NCT02105701|454245545|FG002|Overall Study|Withdrawal by Subject|0|||
126260941|NCT02105701|454245546|FG003|Overall Study|Withdrawal by Subject|1|||
126260942|NCT02105701|454245543|FG000|Overall Study|Death|1|||
126260943|NCT02105701|454245544|FG001|Overall Study|Death|0|||
126260944|NCT02105701|454245545|FG002|Overall Study|Death|0|||
126260945|NCT02105701|454245546|FG003|Overall Study|Death|0|||
126260946|NCT04230876|454245547|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
126260947|NCT04230876|454245548|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
126260948|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
126260949|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260950|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260951|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260952|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260953|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260954|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260955|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260956|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260957|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
126260958|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260959|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260960|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260961|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260962|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260963|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260964|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260965|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260966|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
126260967|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260968|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260969|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260970|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260971|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260972|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260973|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260974|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260975|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
126260976|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260977|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260978|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260979|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260980|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260981|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126359519|NCT03931785|454608982|FG002|Overall Study|Noncompliance With Study drug|0|||
126031226|NCT03269136|453410994|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031227|NCT03269136|453410995|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126096364|NCT01081132|453644703|FG001|Overall Study|Non Compliance|2|||
126096365|NCT01081132|453644702|FG000|Overall Study|Lack Of Compliance|0|||
126096366|NCT01081132|453644703|FG001|Overall Study|Lack Of Compliance|1|||
126096367|NCT01081132|453644702|FG000|Overall Study|Missed Visits|1|||
126096368|NCT01081132|453644703|FG001|Overall Study|Missed Visits|1|||
126096369|NCT01081132|453644702|FG000|Overall Study|Stopped Taking Meds|2|||
126096370|NCT01081132|453644703|FG001|Overall Study|Stopped Taking Meds|0|||
126096371|NCT01081132|453644702|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
126096372|NCT01081132|453644703|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
126096373|NCT01081132|453644702|FG000|Overall Study|Declined Taper Phase|0|||
126096374|NCT01081132|453644703|FG001|Overall Study|Declined Taper Phase|1|||
126096375|NCT01081132|453644702|FG000|Overall Study|Protocol Violation|3|||
126031228|NCT03269136|453410996|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
126031229|NCT03269136|453410997|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
126031230|NCT03269136|453410998|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
126096376|NCT01081132|453644703|FG001|Overall Study|Protocol Violation|1|||
126096377|NCT02101385|453644706|FG000|Study Treatment|Disease Progression|9|||
126096378|NCT02101385|453644707|FG001|Study Treatment|Disease Progression|3|||
126096379|NCT02101385|453644706|FG000|Study Treatment|Alternative therapy|0|||
126096380|NCT02101385|453644707|FG001|Study Treatment|Alternative therapy|1|||
126096381|NCT02101385|453644706|FG000|Study Treatment|No treatment, per protocol criteria|0|||
126096382|NCT02101385|453644707|FG001|Study Treatment|No treatment, per protocol criteria|4|||
126096383|NCT02101385|453644706|FG000|Study Treatment|Patient Non compliance|0|||
126031231|NCT03269136|453410999|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031232|NCT03269136|453411000|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
126031233|NCT03269136|453411001|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126031234|NCT03269136|453410984|FG000|Part 2A: Dose Expansion|Other|0|||
126031235|NCT03269136|453410985|FG001|Part 2A: Dose Expansion|Other|0|||
126031236|NCT03269136|453410986|FG002|Part 2A: Dose Expansion|Other|0|||
126031237|NCT03269136|453410987|FG003|Part 2A: Dose Expansion|Other|0|||
126031238|NCT03269136|453410988|FG004|Part 2A: Dose Expansion|Other|0|||
126031239|NCT03269136|453410989|FG005|Part 2A: Dose Expansion|Other|0|||
126031240|NCT03269136|453410990|FG006|Part 2A: Dose Expansion|Other|0|||
126031241|NCT03269136|453410991|FG007|Part 2A: Dose Expansion|Other|0|||
126031242|NCT03269136|453410992|FG008|Part 2A: Dose Expansion|Other|0|||
126031243|NCT03269136|453410993|FG009|Part 2A: Dose Expansion|Other|0|||
126031244|NCT03269136|453410994|FG010|Part 2A: Dose Expansion|Other|0|||
126031245|NCT03269136|453410995|FG011|Part 2A: Dose Expansion|Other|0|||
126031246|NCT03269136|453410996|FG012|Part 2A: Dose Expansion|Other|0|||
126031247|NCT03269136|453410997|FG013|Part 2A: Dose Expansion|Other|0|||
126031248|NCT03269136|453410998|FG014|Part 2A: Dose Expansion|Other|0|||
126031249|NCT03269136|453410999|FG015|Part 2A: Dose Expansion|Other|0|||
126031250|NCT03269136|453411000|FG016|Part 2A: Dose Expansion|Other|0|||
126031251|NCT03269136|453411001|FG017|Part 2A: Dose Expansion|Other|1|||
126031252|NCT03269136|453410984|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031253|NCT03269136|453410985|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031254|NCT03269136|453410986|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031255|NCT03269136|453410987|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031256|NCT03269136|453410988|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031257|NCT03269136|453410989|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031258|NCT03269136|453410990|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031259|NCT03269136|453410991|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031260|NCT03269136|453410992|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031261|NCT03269136|453410993|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031262|NCT03269136|453410994|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031263|NCT03269136|453410995|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031264|NCT03269136|453410996|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031265|NCT03269136|453410997|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031266|NCT03269136|453410998|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126031267|NCT03269136|453410999|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126096384|NCT02101385|453644707|FG001|Study Treatment|Patient Non compliance|2|||
126096385|NCT02101385|453644706|FG000|Study Treatment|Withdrawal by Subject|5|||
126096386|NCT02101385|453644707|FG001|Study Treatment|Withdrawal by Subject|2|||
126096387|NCT02101385|453644706|FG000|Study Treatment|screen failure|1|||
126260982|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260983|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260984|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
126260985|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260986|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260987|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126031268|NCT03269136|453411000|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126260988|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260989|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260990|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260991|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260992|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260993|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
126260994|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260995|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260996|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260997|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260998|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260999|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126261000|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126261001|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126261002|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
126261003|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261004|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261005|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261006|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261007|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261008|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261009|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261010|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261011|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
126261012|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
126261013|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
126261014|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
126261015|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
126261016|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
126261017|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
126261018|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
126261019|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
126261020|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261021|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261022|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261023|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261024|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
126261025|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261026|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261027|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
126261028|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261029|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
126261030|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
126261031|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261032|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261033|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261034|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261035|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261036|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261037|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261038|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
126261039|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
126261040|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
126261041|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
126261042|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
126261043|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
126261044|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
126261045|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
126261046|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
126261047|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261048|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261049|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
126261050|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261051|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126031269|NCT03269136|453411001|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
126031270|NCT03269136|453410984|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
126031271|NCT03269136|453410985|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
126031272|NCT03269136|453410986|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
126261052|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261053|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261054|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261055|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261056|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261057|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
126261058|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261059|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
126261060|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261061|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261062|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
126261063|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
126261064|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261065|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
126261066|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
126261067|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
126261068|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
126261069|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
126261070|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
126261071|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
126261072|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
126261073|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
126261074|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261075|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126031273|NCT03269136|453410987|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
126031274|NCT03269136|453410988|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
126031275|NCT03269136|453410989|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
126031276|NCT03269136|453410990|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
126031277|NCT03269136|453410991|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
126031278|NCT03269136|453410992|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
126031279|NCT03269136|453410993|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
126031280|NCT03269136|453410994|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
126031281|NCT03269136|453410995|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
126031282|NCT03269136|453410996|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
126031283|NCT03269136|453410997|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
126031284|NCT03269136|453410998|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
126031285|NCT03269136|453410999|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
126031286|NCT03269136|453411000|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
126031287|NCT03269136|453411001|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
126031288|NCT03269136|453410984|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
126031289|NCT03269136|453410985|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
126261076|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261077|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261078|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261079|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261080|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
126261081|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261082|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261083|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
126261084|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
126261085|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
126261086|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
126261087|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
126261088|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
126261089|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
126261090|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
126261091|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
126261092|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261093|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
126261094|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261095|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261096|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261097|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261098|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
126261099|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261100|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261101|NCT01662362|454245563|FG000|Overall Study|Lost to Follow-up|38|||
126261102|NCT03078478|454245568|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
126261103|NCT03078478|454245569|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
126261104|NCT03078478|454245568|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
126261105|NCT03078478|454245569|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
126261106|NCT03078478|454245568|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
126261107|NCT03078478|454245569|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
126261108|NCT03078478|454245568|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
126261109|NCT03078478|454245569|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
126261110|NCT03078478|454245568|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
126261111|NCT03078478|454245569|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
126261112|NCT03078478|454245568|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
126261113|NCT03078478|454245569|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
126261114|NCT03078478|454245568|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
126261115|NCT03078478|454245569|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
126261116|NCT03078478|454245568|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
126261117|NCT03078478|454245569|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
126096388|NCT02101385|453644707|FG001|Study Treatment|screen failure|0|||
126096389|NCT02101385|453644706|FG000|Study Treatment|AE/Side Effects/Complications|8|||
126261118|NCT01181531|454245570|FG000|Overall Study|Other|17|||
126261119|NCT01181531|454245571|FG001|Overall Study|Other|12|||
126261120|NCT01181531|454245570|FG000|Overall Study|Partial consent by subject withdrawn|0|||
126261121|NCT01181531|454245571|FG001|Overall Study|Partial consent by subject withdrawn|1|||
126261122|NCT01181531|454245570|FG000|Overall Study|Physician Decision|3|||
126261123|NCT01181531|454245571|FG001|Overall Study|Physician Decision|1|||
126261124|NCT01181531|454245570|FG000|Overall Study|Noncompliance|2|||
126261125|NCT01181531|454245571|FG001|Overall Study|Noncompliance|2|||
126261126|NCT01181531|454245570|FG000|Overall Study|Ineligibility determined|1|||
126261127|NCT01181531|454245571|FG001|Overall Study|Ineligibility determined|2|||
126261128|NCT01181531|454245570|FG000|Overall Study|Protocol Specified Criteria|15|||
126261129|NCT01181531|454245571|FG001|Overall Study|Protocol Specified Criteria|8|||
126261130|NCT01181531|454245570|FG000|Overall Study|Pregnancy|0|||
126261131|NCT01181531|454245571|FG001|Overall Study|Pregnancy|1|||
126261132|NCT01181531|454245570|FG000|Overall Study|Withdrawal by Subject|8|||
126261133|NCT01181531|454245571|FG001|Overall Study|Withdrawal by Subject|7|||
126261134|NCT01181531|454245570|FG000|Overall Study|Protocol Violation|6|||
126261135|NCT01181531|454245571|FG001|Overall Study|Protocol Violation|6|||
126261136|NCT01181531|454245570|FG000|Overall Study|Death|9|||
126261137|NCT01181531|454245571|FG001|Overall Study|Death|12|||
126261138|NCT01181531|454245570|FG000|Overall Study|Adverse Event|0|||
126261139|NCT01181531|454245571|FG001|Overall Study|Adverse Event|1|||
126261140|NCT00987831|454245573|FG000|Overall Study|Never flared in 12 months|1|||
126261141|NCT00987831|454245574|FG001|Overall Study|Never flared in 12 months|0|||
126261142|NCT00987831|454245575|FG002|Overall Study|Never flared in 12 months|0|||
126261143|NCT00987831|454245573|FG000|Overall Study|Lost to Follow-up|0|||
126261144|NCT00987831|454245574|FG001|Overall Study|Lost to Follow-up|3|||
126261145|NCT00987831|454245575|FG002|Overall Study|Lost to Follow-up|0|||
126261146|NCT03253094|454245576|FG000|Overall Study|Adverse Event|2|||
126261147|NCT03253094|454245577|FG001|Overall Study|Adverse Event|0|||
126031290|NCT03269136|453410986|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
126031291|NCT03269136|453410987|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
126031292|NCT03269136|453410988|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
126031293|NCT03269136|453410989|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
126261148|NCT03253094|454245578|FG002|Overall Study|Adverse Event|0|||
126261149|NCT03253094|454245579|FG003|Overall Study|Adverse Event|0|||
126261150|NCT03253094|454245580|FG004|Overall Study|Adverse Event|0|||
126261151|NCT03253094|454245581|FG005|Overall Study|Adverse Event|0|||
126261152|NCT03253094|454245576|FG000|Overall Study|Lack of Efficacy|0|||
126261153|NCT03253094|454245577|FG001|Overall Study|Lack of Efficacy|0|||
126261154|NCT03253094|454245578|FG002|Overall Study|Lack of Efficacy|2|||
126261155|NCT03253094|454245579|FG003|Overall Study|Lack of Efficacy|1|||
126261156|NCT03253094|454245580|FG004|Overall Study|Lack of Efficacy|2|||
126261157|NCT03253094|454245581|FG005|Overall Study|Lack of Efficacy|1|||
126096390|NCT02101385|453644707|FG001|Study Treatment|AE/Side Effects/Complications|0|||
126096391|NCT02101385|453644706|FG000|Study Treatment|Lost to Follow-up|1|||
126096392|NCT02101385|453644707|FG001|Study Treatment|Lost to Follow-up|0|||
126096393|NCT02101385|453644706|FG000|Study Treatment|Disease Progression before treatment|1|||
126096394|NCT02101385|453644707|FG001|Study Treatment|Disease Progression before treatment|0|||
126096395|NCT02101385|453644706|FG000|Study Treatment|Death|1|||
126096396|NCT02101385|453644707|FG001|Study Treatment|Death|0|||
126096397|NCT02101385|453644706|FG000|Follow up|Lost to Follow-up|4|||
126096398|NCT02101385|453644707|FG001|Follow up|Lost to Follow-up|9|||
126096399|NCT02101385|453644706|FG000|Follow up|Refused to follow up|5|||
126096400|NCT02101385|453644707|FG001|Follow up|Refused to follow up|4|||
126096401|NCT02101385|453644706|FG000|Follow up|Death|21|||
126096402|NCT02101385|453644707|FG001|Follow up|Death|39|||
126096403|NCT02101385|453644706|FG000|Follow up|study completed|33|||
126096404|NCT02101385|453644707|FG001|Follow up|study completed|52|||
126096405|NCT02101385|453644706|FG000|Follow up|screen failure|2|||
126096406|NCT02101385|453644707|FG001|Follow up|screen failure|0|||
126359520|NCT03931785|454608983|FG003|Overall Study|Noncompliance With Study drug|0|||
126359521|NCT03931785|454608980|FG000|Overall Study|Other Not specified|0|||
126359522|NCT03931785|454608981|FG001|Overall Study|Other Not specified|2|||
126359523|NCT03931785|454608982|FG002|Overall Study|Other Not specified|2|||
126359524|NCT03931785|454608983|FG003|Overall Study|Other Not specified|2|||
126359525|NCT03931785|454608980|FG000|Overall Study|Withdrawal by Subject|0|||
126359526|NCT03931785|454608981|FG001|Overall Study|Withdrawal by Subject|2|||
126359527|NCT03931785|454608982|FG002|Overall Study|Withdrawal by Subject|4|||
126359528|NCT03931785|454608983|FG003|Overall Study|Withdrawal by Subject|1|||
126359529|NCT03931785|454608980|FG000|Overall Study|Pregnancy|0|||
126359530|NCT03931785|454608981|FG001|Overall Study|Pregnancy|0|||
126359531|NCT03931785|454608982|FG002|Overall Study|Pregnancy|0|||
126359532|NCT03931785|454608983|FG003|Overall Study|Pregnancy|1|||
126359533|NCT04605588|454608986|FG000|Overall Study|Withdrawal by Subject|1|||
126359534|NCT04605588|454608987|FG001|Overall Study|Withdrawal by Subject|0|||
126359535|NCT01230814|454608988|FG000|Overall Study|Lost to Follow-up|11|||
126359536|NCT01230814|454608989|FG001|Overall Study|Lost to Follow-up|3|||
126359537|NCT01230814|454608988|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
126359538|NCT01230814|454608989|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
126359539|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
126359540|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
126359541|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
126359542|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
126359543|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
126359544|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
126359545|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
126359546|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
126359547|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
126359548|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
126359549|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
126359550|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
126359551|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
126359552|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
126031294|NCT03269136|453410990|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
126031295|NCT03269136|453410991|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
126031296|NCT03269136|453410992|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
126031297|NCT03269136|453410993|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
126031298|NCT03269136|453410994|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
126031299|NCT03269136|453410995|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
126031300|NCT03269136|453410996|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
126031301|NCT03269136|453410997|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
126031302|NCT03269136|453410998|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
126031303|NCT03269136|453410999|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
126031304|NCT03269136|453411000|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
126031305|NCT03269136|453411001|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
126031306|NCT03269136|453410984|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
126031307|NCT03269136|453410985|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
126031308|NCT03269136|453410986|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
126031309|NCT03269136|453410987|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
126096407|NCT02101385|453644706|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
126096408|NCT02101385|453644707|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
126359553|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
126359554|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
126359555|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
126031310|NCT03269136|453410988|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
126359556|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
126359557|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
126359558|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
126359559|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
126359560|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
126359561|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
126359562|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
126359563|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
126359564|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
126359565|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
126359566|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
126359567|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
126359568|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
126359569|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
126359570|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
126359571|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
126359572|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
126359573|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
126359574|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
126359575|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
126359576|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
126359577|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
126359578|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
126359579|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
126359580|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
126359581|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
126359582|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
126359583|NCT01529112|454609000|FG000|Overall Study|Adverse Event|2|||
126359584|NCT01529112|454609001|FG001|Overall Study|Adverse Event|0|||
126359585|NCT01529112|454609000|FG000|Overall Study|Death|59|||
126359586|NCT01529112|454609001|FG001|Overall Study|Death|38|||
126359587|NCT01529112|454609000|FG000|Overall Study|Protocol Violation|1|||
126359588|NCT01529112|454609001|FG001|Overall Study|Protocol Violation|0|||
126359589|NCT01529112|454609000|FG000|Overall Study|Withdrawal by Subject|7|||
126359590|NCT01529112|454609001|FG001|Overall Study|Withdrawal by Subject|3|||
126359591|NCT02255279|454609002|FG000|Overall Study|Lost to Follow-up|2|||
126103471|NCT04620811|453672168|FG001|Overall Study|Elevation of ALT or AST|0|||
126359592|NCT02255279|454609003|FG001|Overall Study|Lost to Follow-up|2|||
126359593|NCT02255279|454609002|FG000|Overall Study|Protocol Violation|0|||
126359594|NCT02255279|454609003|FG001|Overall Study|Protocol Violation|1|||
126359595|NCT02255279|454609002|FG000|Overall Study|Withdrawal by Subject|3|||
126261158|NCT03253094|454245576|FG000|Overall Study|Lost to Follow-up|0|||
126261159|NCT03253094|454245577|FG001|Overall Study|Lost to Follow-up|0|||
126261160|NCT03253094|454245578|FG002|Overall Study|Lost to Follow-up|1|||
126261161|NCT03253094|454245579|FG003|Overall Study|Lost to Follow-up|1|||
126261162|NCT03253094|454245580|FG004|Overall Study|Lost to Follow-up|0|||
126261163|NCT03253094|454245581|FG005|Overall Study|Lost to Follow-up|1|||
126261164|NCT03253094|454245576|FG000|Overall Study|Physician Decision|1|||
125880213|NCT03773978|452858810|FG001|DBW Period|Due to epidemic or pandemic|6|||
125880214|NCT03773978|452858809|FG000|DBW Period|Study team decision|1|||
125880215|NCT03773978|452858810|FG001|DBW Period|Study team decision|0|||
126261165|NCT03253094|454245577|FG001|Overall Study|Physician Decision|0|||
126261166|NCT03253094|454245578|FG002|Overall Study|Physician Decision|0|||
126261167|NCT03253094|454245579|FG003|Overall Study|Physician Decision|1|||
126261168|NCT03253094|454245580|FG004|Overall Study|Physician Decision|0|||
126261169|NCT03253094|454245581|FG005|Overall Study|Physician Decision|2|||
126261170|NCT03253094|454245576|FG000|Overall Study|Withdrawal by Subject|1|||
126261171|NCT03253094|454245577|FG001|Overall Study|Withdrawal by Subject|2|||
126261172|NCT03253094|454245578|FG002|Overall Study|Withdrawal by Subject|1|||
126261173|NCT03253094|454245579|FG003|Overall Study|Withdrawal by Subject|0|||
126261174|NCT03253094|454245580|FG004|Overall Study|Withdrawal by Subject|3|||
126261175|NCT03253094|454245581|FG005|Overall Study|Withdrawal by Subject|0|||
126261176|NCT03253094|454245576|FG000|Overall Study|Other|0|||
126261177|NCT03253094|454245577|FG001|Overall Study|Other|1|||
126261178|NCT03253094|454245578|FG002|Overall Study|Other|2|||
126261179|NCT03253094|454245579|FG003|Overall Study|Other|1|||
126261180|NCT03253094|454245580|FG004|Overall Study|Other|0|||
126261181|NCT03253094|454245581|FG005|Overall Study|Other|0|||
126261182|NCT02339090|454245582|FG000|Overall Study|Adverse Event|1|||
126261183|NCT02339090|454245583|FG001|Overall Study|Adverse Event|0|||
126261184|NCT02339090|454245582|FG000|Overall Study|Lost to Follow-up|0|||
126261185|NCT02339090|454245583|FG001|Overall Study|Lost to Follow-up|1|||
126261186|NCT02339090|454245582|FG000|Overall Study|Non-compliance With Study Drug|0|||
126261187|NCT02339090|454245583|FG001|Overall Study|Non-compliance With Study Drug|1|||
126261188|NCT02339090|454245582|FG000|Overall Study|Withdrawal by Subject|2|||
126261189|NCT02339090|454245583|FG001|Overall Study|Withdrawal by Subject|1|||
126261190|NCT02339090|454245582|FG000|Overall Study|Poor Growth|3|||
126261191|NCT02339090|454245583|FG001|Overall Study|Poor Growth|0|||
126261192|NCT02339090|454245582|FG000|Overall Study|Randomized but not treated|0|||
126261193|NCT02339090|454245583|FG001|Overall Study|Randomized but not treated|2|||
126261194|NCT02737592|454245586|FG000|Overall Study|Withdrawal by Subject|1|||
126261195|NCT00576303|454245588|FG000|Dose Titration Period|Early withdrawal|17|||
126261196|NCT00576303|454245588|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
126261197|NCT00576303|454245588|FG000|Long Term Safety Period|Early withdrawal|16|||
126261198|NCT00810602|454245589|FG000|Overall Study|Withdrawal by Subject|8|||
126261199|NCT00810602|454245590|FG001|Overall Study|Withdrawal by Subject|3|||
126261200|NCT02792218|454245591|FG000|Overall Study|Patient/guardian decision|15|||
126261201|NCT02792218|454245592|FG001|Overall Study|Patient/guardian decision|42|||
126261202|NCT02792218|454245591|FG000|Overall Study|Adverse Event|15|||
126261203|NCT02792218|454245592|FG001|Overall Study|Adverse Event|14|||
126261204|NCT02792218|454245591|FG000|Overall Study|Lost to Follow-up|10|||
126261205|NCT02792218|454245592|FG001|Overall Study|Lost to Follow-up|5|||
126261206|NCT02792218|454245591|FG000|Overall Study|Lack of Efficacy|1|||
126261207|NCT02792218|454245592|FG001|Overall Study|Lack of Efficacy|12|||
126261208|NCT02792218|454245591|FG000|Overall Study|Physician Decision|4|||
126261209|NCT02792218|454245592|FG001|Overall Study|Physician Decision|4|||
126261210|NCT02792218|454245591|FG000|Overall Study|Protocol deviation|3|||
126261211|NCT02792218|454245592|FG001|Overall Study|Protocol deviation|2|||
126261212|NCT02792218|454245591|FG000|Overall Study|New therapy for study indication|0|||
126261213|NCT02792218|454245592|FG001|Overall Study|New therapy for study indication|1|||
126261214|NCT02792218|454245591|FG000|Overall Study|Non-compliance with study treatment|0|||
126261215|NCT02792218|454245592|FG001|Overall Study|Non-compliance with study treatment|1|||
126261216|NCT02792218|454245591|FG000|Overall Study|Pregnancy|1|||
126261217|NCT02792218|454245592|FG001|Overall Study|Pregnancy|0|||
126261218|NCT00824369|454245593|FG000|Overall Study|Nolonger willing to participate in study|1|||
126261219|NCT00824369|454245594|FG001|Overall Study|Nolonger willing to participate in study|0|||
126261220|NCT00824369|454245595|FG002|Overall Study|Nolonger willing to participate in study|1|||
126261221|NCT00824369|454245596|FG003|Overall Study|Nolonger willing to participate in study|2|||
126261222|NCT00824369|454245597|FG004|Overall Study|Nolonger willing to participate in study|0|||
126261223|NCT00824369|454245598|FG005|Overall Study|Nolonger willing to participate in study|1|||
126261224|NCT00824369|454245593|FG000|Overall Study|Lost to Follow-up|0|||
126261225|NCT00824369|454245594|FG001|Overall Study|Lost to Follow-up|0|||
126261226|NCT00824369|454245595|FG002|Overall Study|Lost to Follow-up|0|||
126261227|NCT00824369|454245596|FG003|Overall Study|Lost to Follow-up|0|||
126261228|NCT00824369|454245597|FG004|Overall Study|Lost to Follow-up|1|||
126261229|NCT00824369|454245598|FG005|Overall Study|Lost to Follow-up|0|||
126261230|NCT04034355|454245626|FG000|Overall Study|Study terminated by Sponsor|10|||
126261231|NCT04034355|454245627|FG001|Overall Study|Study terminated by Sponsor|17|||
126261232|NCT04034355|454245626|FG000|Overall Study|Withdrawal by Subject|12|||
126261233|NCT04034355|454245627|FG001|Overall Study|Withdrawal by Subject|11|||
126261234|NCT04034355|454245626|FG000|Overall Study|Site terminated by Sponsor|4|||
126261235|NCT04034355|454245627|FG001|Overall Study|Site terminated by Sponsor|5|||
126261236|NCT04034355|454245626|FG000|Overall Study|Adverse Event|2|||
126261237|NCT04034355|454245627|FG001|Overall Study|Adverse Event|0|||
126261238|NCT04034355|454245626|FG000|Overall Study|Death|1|||
126261239|NCT04034355|454245627|FG001|Overall Study|Death|1|||
126261240|NCT04034355|454245626|FG000|Overall Study|Not reported|2|||
126261241|NCT04034355|454245627|FG001|Overall Study|Not reported|0|||
126261242|NCT04034355|454245626|FG000|Overall Study|Lost to Follow-up|1|||
126261243|NCT04034355|454245627|FG001|Overall Study|Lost to Follow-up|0|||
126261244|NCT04034355|454245626|FG000|Overall Study|Physician Decision|1|||
126261245|NCT04034355|454245627|FG001|Overall Study|Physician Decision|0|||
126261246|NCT04034355|454245626|FG000|Overall Study|Protocol Violation|0|||
126261247|NCT04034355|454245627|FG001|Overall Study|Protocol Violation|1|||
126261248|NCT04034355|454245626|FG000|Overall Study|Progressive disease|1|||
126261249|NCT04034355|454245627|FG001|Overall Study|Progressive disease|0|||
126261250|NCT02190279|454248119|FG000|Overall Study|Withdrawal consent|1|||
126261251|NCT02190279|454248120|FG001|Overall Study|Withdrawal consent|0|||
126261252|NCT02190279|454248121|FG002|Overall Study|Withdrawal consent|1|||
126261253|NCT02190279|454248119|FG000|Overall Study|Lost to Follow-up|2|||
126261254|NCT02190279|454248120|FG001|Overall Study|Lost to Follow-up|0|||
126261255|NCT02190279|454248121|FG002|Overall Study|Lost to Follow-up|0|||
126261256|NCT02190279|454248119|FG000|Overall Study|Refused further treatment|0|||
126261257|NCT02190279|454248120|FG001|Overall Study|Refused further treatment|0|||
126261258|NCT02190279|454248121|FG002|Overall Study|Refused further treatment|1|||
126261259|NCT02190279|454248119|FG000|Overall Study|Screening failure|0|||
126261260|NCT02190279|454248120|FG001|Overall Study|Screening failure|0|||
126261261|NCT02190279|454248121|FG002|Overall Study|Screening failure|1|||
126261262|NCT01467479|454248122|FG000|Overall Study|No Study Medication|1|||
126261263|NCT01467479|454248123|FG001|Overall Study|No Study Medication|0|||
126261264|NCT01467479|454248124|FG002|Overall Study|No Study Medication|2|||
126261265|NCT01467479|454248122|FG000|Overall Study|Adverse Event|1|||
126261266|NCT01467479|454248123|FG001|Overall Study|Adverse Event|2|||
126261267|NCT01467479|454248124|FG002|Overall Study|Adverse Event|0|||
126261268|NCT01467479|454248122|FG000|Overall Study|Death|0|||
126261269|NCT01467479|454248123|FG001|Overall Study|Death|0|||
126261270|NCT01467479|454248124|FG002|Overall Study|Death|1|||
126261271|NCT01467479|454248122|FG000|Overall Study|Lost to Follow-up|2|||
126261272|NCT01467479|454248123|FG001|Overall Study|Lost to Follow-up|5|||
126261273|NCT01467479|454248124|FG002|Overall Study|Lost to Follow-up|3|||
126261274|NCT01467479|454248122|FG000|Overall Study|Withdrawal of Consent|3|||
126261275|NCT01467479|454248123|FG001|Overall Study|Withdrawal of Consent|7|||
126261276|NCT01467479|454248124|FG002|Overall Study|Withdrawal of Consent|7|||
126261277|NCT01467479|454248122|FG000|Overall Study|Study Terminated by Sponsor|1|||
126261278|NCT01467479|454248123|FG001|Overall Study|Study Terminated by Sponsor|3|||
126261279|NCT01467479|454248124|FG002|Overall Study|Study Terminated by Sponsor|3|||
126261280|NCT01467479|454248122|FG000|Overall Study|Other|1|||
126261281|NCT01467479|454248123|FG001|Overall Study|Other|0|||
126261282|NCT01467479|454248124|FG002|Overall Study|Other|0|||
126261283|NCT01197417|454248137|FG000|Overall Study|Physician Decision|3|||
126261284|NCT01197417|454248138|FG001|Overall Study|Physician Decision|2|||
126261285|NCT01197417|454248137|FG000|Overall Study|Withdrawal by Subject|2|||
126261286|NCT01197417|454248138|FG001|Overall Study|Withdrawal by Subject|4|||
126261287|NCT01197417|454248137|FG000|Overall Study|Site miscommunication|0|||
126261288|NCT01197417|454248138|FG001|Overall Study|Site miscommunication|1|||
126261289|NCT01197417|454248137|FG000|Overall Study|Subject transferred to intensive care|0|||
126261290|NCT01197417|454248138|FG001|Overall Study|Subject transferred to intensive care|1|||
126261291|NCT01197417|454248137|FG000|Overall Study|Not consented in time to receive drug|0|||
126261292|NCT01197417|454248138|FG001|Overall Study|Not consented in time to receive drug|1|||
126261293|NCT01197417|454248137|FG000|Overall Study|Hypotension|1|||
126261294|NCT01197417|454248138|FG001|Overall Study|Hypotension|2|||
126261295|NCT01197417|454248137|FG000|Overall Study|Found to be ineligible|2|||
126261296|NCT01197417|454248138|FG001|Overall Study|Found to be ineligible|5|||
126261297|NCT01197417|454248137|FG000|Overall Study|No 25-hour magnesium level|0|||
126261298|NCT01197417|454248138|FG001|Overall Study|No 25-hour magnesium level|2|||
126261299|NCT02070757|454248139|FG000|Overall Study|Adverse Event|107|||
126261300|NCT02070757|454248140|FG001|Overall Study|Adverse Event|99|||
126261301|NCT02070757|454248139|FG000|Overall Study|Lost to Follow-up|7|||
126261302|NCT02070757|454248140|FG001|Overall Study|Lost to Follow-up|4|||
126261303|NCT02070757|454248139|FG000|Overall Study|Protocol Violation|0|||
126261304|NCT02070757|454248140|FG001|Overall Study|Protocol Violation|4|||
126261305|NCT02070757|454248139|FG000|Overall Study|Withdrawal by Subject|1|||
126261306|NCT02070757|454248140|FG001|Overall Study|Withdrawal by Subject|3|||
126261307|NCT02070757|454248139|FG000|Overall Study|Investigator Decision|0|||
126261308|NCT02070757|454248140|FG001|Overall Study|Investigator Decision|2|||
126261309|NCT02070757|454248139|FG000|Overall Study|Discharged from Study Hospital|2|||
126261310|NCT02070757|454248140|FG001|Overall Study|Discharged from Study Hospital|2|||
126261311|NCT01546922|454248141|FG000|First Period of 10 Weeks|Protocol Violation|3|||
126031311|NCT03269136|453410989|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
126031312|NCT03269136|453410990|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
126031313|NCT03269136|453410991|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
126031314|NCT03269136|453410992|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
126031315|NCT03269136|453410993|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
126261312|NCT01546922|454248142|FG001|First Period of 10 Weeks|Protocol Violation|1|||
126261313|NCT01546922|454248141|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
126261314|NCT01546922|454248142|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
126261315|NCT01546922|454248141|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
126261316|NCT01546922|454248142|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
126261317|NCT01546922|454248141|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
126031316|NCT03269136|453410994|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
126031317|NCT03269136|453410995|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
126031318|NCT03269136|453410996|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
126031319|NCT03269136|453410997|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
126031320|NCT03269136|453410998|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
126031321|NCT03269136|453410999|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
126031322|NCT03269136|453411000|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
126031323|NCT03269136|453411001|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
126031324|NCT04717492|453411002|FG000|Overall Study|Withdrawal by Subject|2|||
126031325|NCT04717492|453411003|FG001|Overall Study|Withdrawal by Subject|13|||
126031326|NCT04717492|453411002|FG000|Overall Study|Lost to Follow-up|2|||
126031327|NCT04717492|453411003|FG001|Overall Study|Lost to Follow-up|9|||
126031328|NCT04456517|453411004|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
126031329|NCT04456517|453411005|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
126031330|NCT04055090|453411006|FG000|Overall Study|screen failure|1|||
126031331|NCT04055090|453411007|FG001|Overall Study|screen failure|0|||
126031332|NCT04055090|453411006|FG000|Overall Study|Withdrawal by Subject|1|||
126031333|NCT04055090|453411007|FG001|Overall Study|Withdrawal by Subject|0|||
126103472|NCT04620811|453672167|FG000|Overall Study|Other|3|||
126261318|NCT01546922|454248142|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
126261319|NCT01546922|454248141|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
126261320|NCT01546922|454248142|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
126261321|NCT01613378|454248148|FG000|Overall Study|Lack of Efficacy|13|||
126261322|NCT01613378|454248148|FG000|Overall Study|Adverse Event|11|||
126261323|NCT01613378|454248148|FG000|Overall Study|Withdrawal by Subject|8|||
126261324|NCT01613378|454248148|FG000|Overall Study|Death|2|||
126261325|NCT01613378|454248148|FG000|Overall Study|Lost to Follow-up|1|||
126261326|NCT01613378|454248148|FG000|Overall Study|Other Reason|4|||
126261327|NCT00792623|454248158|FG000|Overall Study|Adverse Event|2|||
126261328|NCT00792623|454248158|FG000|Overall Study|Withdrawal by Subject|5|||
126261329|NCT00880087|454248159|FG000|Overall Study|Lost to Follow-up|0|||
126261330|NCT00880087|454248160|FG001|Overall Study|Lost to Follow-up|2|||
126261331|NCT01311557|454248161|FG000|Overall Study|Serious adverse event|0|||
126261332|NCT01311557|454248162|FG001|Overall Study|Serious adverse event|1|||
126261333|NCT01311557|454248161|FG000|Overall Study|Protocol Violation|4|||
126261334|NCT01311557|454248162|FG001|Overall Study|Protocol Violation|2|||
126261335|NCT01311557|454248161|FG000|Overall Study|Lost to Follow-up|0|||
126261336|NCT01311557|454248162|FG001|Overall Study|Lost to Follow-up|1|||
126261337|NCT01311557|454248161|FG000|Overall Study|Withdrawal by Subject|1|||
126261338|NCT01311557|454248162|FG001|Overall Study|Withdrawal by Subject|2|||
126261339|NCT00572039|454248163|FG000|Overall Study|Withdrawal by Subject|9|||
126261340|NCT00572039|454248164|FG001|Overall Study|Withdrawal by Subject|6|||
126261341|NCT00572039|454248163|FG000|Overall Study|Death|2|||
126261342|NCT00572039|454248164|FG001|Overall Study|Death|3|||
126261343|NCT00572039|454248163|FG000|Overall Study|Ill|5|||
126261344|NCT00572039|454248164|FG001|Overall Study|Ill|1|||
126261345|NCT01470417|454248167|FG000|Overall Study|Disease progression|0|||
126261346|NCT01470417|454248168|FG001|Overall Study|Disease progression|2|||
126261347|NCT02418455|454248169|FG000|48-Week Treatment Period|Other- Not Specified|1|||
126261348|NCT02418455|454248169|FG000|Continuation Period|Sponsor Decision|7|||
126261349|NCT02973321|454248170|FG000|Overall Study|Other than specified|0|||
126261350|NCT02973321|454248171|FG001|Overall Study|Other than specified|5|||
126261351|NCT02973321|454248172|FG002|Overall Study|Other than specified|3|||
126261352|NCT02973321|454248173|FG003|Overall Study|Other than specified|3|||
126261353|NCT02973321|454248174|FG004|Overall Study|Other than specified|1|||
126261354|NCT02973321|454248170|FG000|Overall Study|Lack of Efficacy|0|||
126261355|NCT02973321|454248171|FG001|Overall Study|Lack of Efficacy|0|||
126261356|NCT02973321|454248172|FG002|Overall Study|Lack of Efficacy|0|||
126261357|NCT02973321|454248173|FG003|Overall Study|Lack of Efficacy|0|||
126261358|NCT02973321|454248174|FG004|Overall Study|Lack of Efficacy|1|||
126261359|NCT02973321|454248170|FG000|Overall Study|Adverse Event|1|||
126261360|NCT02973321|454248171|FG001|Overall Study|Adverse Event|10|||
126261361|NCT02973321|454248172|FG002|Overall Study|Adverse Event|11|||
126261362|NCT02973321|454248173|FG003|Overall Study|Adverse Event|13|||
126261363|NCT02973321|454248174|FG004|Overall Study|Adverse Event|3|||
126031334|NCT05071807|453411008|FG000|Overall Study|Withdrawal by Subject|4|||
126031335|NCT05071807|453411009|FG001|Overall Study|Withdrawal by Subject|0|||
126031336|NCT05071807|453411008|FG000|Overall Study|Unrelated medical issues|3|||
126031337|NCT05071807|453411009|FG001|Overall Study|Unrelated medical issues|0|||
126031338|NCT05071807|453411008|FG000|Overall Study|Relocated|0|||
126031339|NCT05071807|453411009|FG001|Overall Study|Relocated|1|||
126031340|NCT04072380|453411011|FG000|Overall Study|Adverse Event|4|||
126031341|NCT04072380|453411012|FG001|Overall Study|Adverse Event|6|||
126031342|NCT04072380|453411013|FG002|Overall Study|Adverse Event|0|||
126031343|NCT04072380|453411011|FG000|Overall Study|Withdrawal by Subject|3|||
126031344|NCT04072380|453411012|FG001|Overall Study|Withdrawal by Subject|1|||
126031345|NCT04072380|453411013|FG002|Overall Study|Withdrawal by Subject|1|||
126031346|NCT04072380|453411011|FG000|Overall Study|Physician Decision|2|||
126031347|NCT04072380|453411012|FG001|Overall Study|Physician Decision|0|||
126103473|NCT04620811|453672168|FG001|Overall Study|Other|5|||
126261364|NCT01790113|454248181|FG000|Overall Study|Adverse Event|2|||
126261365|NCT01790113|454248182|FG001|Overall Study|Adverse Event|7|||
126261366|NCT01790113|454248181|FG000|Overall Study|Study ended due to FDA clearance|1|||
126261367|NCT01790113|454248182|FG001|Overall Study|Study ended due to FDA clearance|68|||
126261368|NCT00194792|454248183|FG000|Overall Study|Withdrawal by Subject|1|||
126031348|NCT04072380|453411013|FG002|Overall Study|Physician Decision|0|||
126261369|NCT01714739|454248184|FG000|Overall Study|Disease progression|3|||
126261370|NCT01714739|454248185|FG001|Overall Study|Disease progression|5|||
126261371|NCT01714739|454248186|FG002|Overall Study|Disease progression|5|||
126261372|NCT01714739|454248187|FG003|Overall Study|Disease progression|204|||
126261373|NCT01714739|454248188|FG004|Overall Study|Disease progression|1|||
126261374|NCT01714739|454248189|FG005|Overall Study|Disease progression|3|||
126261375|NCT01714739|454248190|FG006|Overall Study|Disease progression|5|||
126031349|NCT04072380|453411011|FG000|Overall Study|Protocol Violation|0|||
126031350|NCT04072380|453411012|FG001|Overall Study|Protocol Violation|2|||
126031351|NCT04072380|453411013|FG002|Overall Study|Protocol Violation|3|||
126031352|NCT04072380|453411011|FG000|Overall Study|Intercurrent Illness and Others|3|||
126031353|NCT04072380|453411012|FG001|Overall Study|Intercurrent Illness and Others|5|||
126031354|NCT04072380|453411013|FG002|Overall Study|Intercurrent Illness and Others|6|||
126031355|NCT05551637|453411014|FG000|Overall Study|Lack of Efficacy|0|||
126031356|NCT05551637|453411015|FG001|Overall Study|Lack of Efficacy|6|||
126031357|NCT05551637|453411014|FG000|Overall Study|Lost to Follow-up|1|||
126031358|NCT05551637|453411015|FG001|Overall Study|Lost to Follow-up|1|||
126031359|NCT05282173|453411019|FG000|Overall Study|Missed|3|||
126031360|NCT05282173|453411020|FG001|Overall Study|Missed|2|||
126031361|NCT05282173|453411021|FG002|Overall Study|Missed|4|||
126031362|NCT05351554|453411022|FG000|Overall Study|Study terminated by sponsor|1|||
126031363|NCT03774082|453411023|FG000|Overall Study|Death|6|||
126031364|NCT03774082|453411024|FG001|Overall Study|Death|3|||
126031365|NCT03774082|453411025|FG002|Overall Study|Death|2|||
126031366|NCT03774082|453411023|FG000|Overall Study|Subject decision|0|||
126031367|NCT03774082|453411024|FG001|Overall Study|Subject decision|3|||
126031368|NCT03774082|453411025|FG002|Overall Study|Subject decision|0|||
126031369|NCT03774082|453411023|FG000|Overall Study|Lost to Follow-up|2|||
126031370|NCT03774082|453411024|FG001|Overall Study|Lost to Follow-up|0|||
126031371|NCT03774082|453411025|FG002|Overall Study|Lost to Follow-up|0|||
126031372|NCT03774082|453411023|FG000|Overall Study|Guardian decision|0|||
126031373|NCT03774082|453411024|FG001|Overall Study|Guardian decision|0|||
126031374|NCT03774082|453411025|FG002|Overall Study|Guardian decision|1|||
126031375|NCT03774082|453411023|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
126031376|NCT03774082|453411024|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
126031377|NCT03774082|453411025|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
126031378|NCT05093829|453411026|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
126031379|NCT05093829|453411027|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
126031380|NCT05093829|453411028|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
126031381|NCT05093829|453411029|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
126031382|NCT05093829|453411030|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
126031383|NCT04241068|453412253|FG000|Core Treatment Period|Adverse Event|91|||
126031384|NCT04241068|453412253|FG000|Core Treatment Period|Change of Treatment|4|||
126031385|NCT04241068|453412253|FG000|Core Treatment Period|Consent Withdrawn|143|||
126031386|NCT04241068|453412253|FG000|Core Treatment Period|Death|26|||
126031387|NCT04241068|453412253|FG000|Core Treatment Period|Disease Progression|67|||
126031388|NCT04241068|453412253|FG000|Core Treatment Period|Investigator Decision|40|||
126031389|NCT04241068|453412253|FG000|Core Treatment Period|Loss of Capacity|9|||
126031390|NCT04241068|453412253|FG000|Core Treatment Period|Lost to Follow-up|11|||
126031391|NCT04241068|453412253|FG000|Core Treatment Period|Relocation|4|||
126031392|NCT04241068|453412253|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
126031393|NCT04241068|453412253|FG000|Core Treatment Period|Study Visit Burden|40|||
126031394|NCT04241068|453412253|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
126031395|NCT04241068|453412253|FG000|Core Treatment Period|Missing|2|||
126031396|NCT04241068|453412253|FG000|Core Treatment Period|Reason Not Specified|41|||
126031397|NCT04241068|453412253|FG000|LTE Period|Adverse Event|19|||
126031398|NCT04241068|453412253|FG000|LTE Period|Change of Treatment|1|||
126031399|NCT04241068|453412253|FG000|LTE Period|Consent Withdrawn|71|||
126031400|NCT04241068|453412253|FG000|LTE Period|Death|8|||
126031401|NCT04241068|453412253|FG000|LTE Period|Disease Progression|11|||
126031402|NCT04241068|453412253|FG000|LTE Period|Investigator Decision|12|||
126261376|NCT01714739|454248184|FG000|Overall Study|Study drug toxicity|1|||
126261377|NCT01714739|454248185|FG001|Overall Study|Study drug toxicity|1|||
126261378|NCT01714739|454248186|FG002|Overall Study|Study drug toxicity|1|||
126261379|NCT01714739|454248187|FG003|Overall Study|Study drug toxicity|15|||
126031403|NCT04241068|453412253|FG000|LTE Period|Loss of Capacity|2|||
126031404|NCT04241068|453412253|FG000|LTE Period|Lost to Follow-up|7|||
126031405|NCT04241068|453412253|FG000|LTE Period|Relocation|6|||
126096409|NCT02101385|453644706|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
126261380|NCT01714739|454248188|FG004|Overall Study|Study drug toxicity|0|||
126261381|NCT01714739|454248189|FG005|Overall Study|Study drug toxicity|0|||
126031406|NCT04241068|453412253|FG000|LTE Period|Site Terminated by Sponsor|26|||
126031407|NCT04241068|453412253|FG000|LTE Period|Study Terminated by Sponsor|276|||
126031408|NCT04241068|453412253|FG000|LTE Period|Study Visit Burden|10|||
126031409|NCT04241068|453412253|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
126031410|NCT04241068|453412253|FG000|LTE Period|Reason Not Specified|65|||
126031411|NCT04492007|453412254|FG000|Overall Study|Lost to Follow-up|1|||
126031412|NCT04492007|453412255|FG001|Overall Study|Lost to Follow-up|1|||
126261382|NCT01714739|454248190|FG006|Overall Study|Study drug toxicity|5|||
126031413|NCT04492007|453412256|FG002|Overall Study|Lost to Follow-up|2|||
126031414|NCT04492007|453412257|FG003|Overall Study|Lost to Follow-up|2|||
126031415|NCT04492007|453412254|FG000|Overall Study|Protocol Violation|1|||
126031416|NCT04492007|453412255|FG001|Overall Study|Protocol Violation|1|||
126031417|NCT04492007|453412256|FG002|Overall Study|Protocol Violation|1|||
126031418|NCT04492007|453412257|FG003|Overall Study|Protocol Violation|1|||
126261383|NCT01714739|454248184|FG000|Overall Study|Death|0|||
126261384|NCT01714739|454248185|FG001|Overall Study|Death|0|||
126261385|NCT01714739|454248186|FG002|Overall Study|Death|0|||
126261386|NCT01714739|454248187|FG003|Overall Study|Death|1|||
126261387|NCT01714739|454248188|FG004|Overall Study|Death|0|||
126261388|NCT01714739|454248189|FG005|Overall Study|Death|0|||
126261389|NCT01714739|454248190|FG006|Overall Study|Death|0|||
126261390|NCT01714739|454248184|FG000|Overall Study|Adverse Event unrelated to drug|0|||
126261391|NCT01714739|454248185|FG001|Overall Study|Adverse Event unrelated to drug|0|||
126261392|NCT01714739|454248186|FG002|Overall Study|Adverse Event unrelated to drug|3|||
126261393|NCT01714739|454248187|FG003|Overall Study|Adverse Event unrelated to drug|21|||
126261394|NCT01714739|454248188|FG004|Overall Study|Adverse Event unrelated to drug|0|||
126261395|NCT01714739|454248189|FG005|Overall Study|Adverse Event unrelated to drug|0|||
126261396|NCT01714739|454248190|FG006|Overall Study|Adverse Event unrelated to drug|0|||
126261397|NCT01714739|454248184|FG000|Overall Study|Participant request to stop therapy|0|||
126261398|NCT01714739|454248185|FG001|Overall Study|Participant request to stop therapy|1|||
126261399|NCT01714739|454248186|FG002|Overall Study|Participant request to stop therapy|0|||
126261400|NCT01714739|454248187|FG003|Overall Study|Participant request to stop therapy|6|||
126261401|NCT01714739|454248188|FG004|Overall Study|Participant request to stop therapy|0|||
126261402|NCT01714739|454248189|FG005|Overall Study|Participant request to stop therapy|0|||
126261403|NCT01714739|454248190|FG006|Overall Study|Participant request to stop therapy|0|||
126261404|NCT01714739|454248184|FG000|Overall Study|Participant withdrew consent|0|||
126261405|NCT01714739|454248185|FG001|Overall Study|Participant withdrew consent|1|||
126261406|NCT01714739|454248186|FG002|Overall Study|Participant withdrew consent|0|||
126261407|NCT01714739|454248187|FG003|Overall Study|Participant withdrew consent|8|||
126261408|NCT01714739|454248188|FG004|Overall Study|Participant withdrew consent|0|||
126261409|NCT01714739|454248189|FG005|Overall Study|Participant withdrew consent|0|||
126261410|NCT01714739|454248190|FG006|Overall Study|Participant withdrew consent|0|||
126261411|NCT01714739|454248184|FG000|Overall Study|Lost to Follow-up|0|||
126261412|NCT01714739|454248185|FG001|Overall Study|Lost to Follow-up|0|||
126261413|NCT01714739|454248186|FG002|Overall Study|Lost to Follow-up|0|||
126261414|NCT01714739|454248187|FG003|Overall Study|Lost to Follow-up|1|||
126261415|NCT01714739|454248188|FG004|Overall Study|Lost to Follow-up|0|||
126261416|NCT01714739|454248189|FG005|Overall Study|Lost to Follow-up|0|||
126261417|NCT01714739|454248190|FG006|Overall Study|Lost to Follow-up|0|||
126261418|NCT01714739|454248184|FG000|Overall Study|Maximum clinical benefit|0|||
126261419|NCT01714739|454248185|FG001|Overall Study|Maximum clinical benefit|1|||
126261420|NCT01714739|454248186|FG002|Overall Study|Maximum clinical benefit|1|||
126261421|NCT01714739|454248187|FG003|Overall Study|Maximum clinical benefit|3|||
126261422|NCT01714739|454248188|FG004|Overall Study|Maximum clinical benefit|0|||
126261423|NCT01714739|454248189|FG005|Overall Study|Maximum clinical benefit|0|||
126261424|NCT01714739|454248190|FG006|Overall Study|Maximum clinical benefit|0|||
126261425|NCT01714739|454248184|FG000|Overall Study|Poor/non-comliance|0|||
126261426|NCT01714739|454248185|FG001|Overall Study|Poor/non-comliance|1|||
126261427|NCT01714739|454248186|FG002|Overall Study|Poor/non-comliance|0|||
126261428|NCT01714739|454248187|FG003|Overall Study|Poor/non-comliance|1|||
126261429|NCT01714739|454248188|FG004|Overall Study|Poor/non-comliance|0|||
126031419|NCT04492007|453412254|FG000|Overall Study|Withdrawal by Subject|0|||
126031420|NCT04492007|453412255|FG001|Overall Study|Withdrawal by Subject|0|||
126031421|NCT04492007|453412256|FG002|Overall Study|Withdrawal by Subject|1|||
126031422|NCT04492007|453412257|FG003|Overall Study|Withdrawal by Subject|1|||
126031423|NCT01413100|453412260|FG000|Overall Study|Withdrawal by Subject|1|||
126261430|NCT01714739|454248189|FG005|Overall Study|Poor/non-comliance|0|||
126261431|NCT01714739|454248190|FG006|Overall Study|Poor/non-comliance|0|||
126261432|NCT01714739|454248184|FG000|Overall Study|No longer meets study criteria|0|||
126261433|NCT01714739|454248185|FG001|Overall Study|No longer meets study criteria|0|||
126261434|NCT01714739|454248186|FG002|Overall Study|No longer meets study criteria|0|||
126261435|NCT01714739|454248187|FG003|Overall Study|No longer meets study criteria|1|||
126261436|NCT01714739|454248188|FG004|Overall Study|No longer meets study criteria|0|||
126261437|NCT01714739|454248189|FG005|Overall Study|No longer meets study criteria|0|||
126261438|NCT01714739|454248190|FG006|Overall Study|No longer meets study criteria|0|||
126261439|NCT01714739|454248184|FG000|Overall Study|Other reason|0|||
126261440|NCT01714739|454248185|FG001|Overall Study|Other reason|0|||
126261441|NCT01714739|454248186|FG002|Overall Study|Other reason|0|||
126261442|NCT01714739|454248187|FG003|Overall Study|Other reason|3|||
126261443|NCT01714739|454248188|FG004|Overall Study|Other reason|1|||
126261444|NCT01714739|454248189|FG005|Overall Study|Other reason|0|||
126261445|NCT01714739|454248190|FG006|Overall Study|Other reason|0|||
126261446|NCT03585959|454248191|FG000|Overall Study|Physician Decision|1|||
126031424|NCT05369403|453412261|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
126031425|NCT05369403|453412262|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
126031426|NCT05369403|453412263|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
126261447|NCT03585959|454248191|FG000|Overall Study|Unsuccessful Procedure|2|||
126261448|NCT00865514|454248192|FG000|Overall Study|Infusion cost exceeded funding|2|||
126261449|NCT03920280|454248193|FG000|Overall Study|Adverse Event|2|||
126261450|NCT03920280|454248194|FG001|Overall Study|Adverse Event|3|||
126261451|NCT03920280|454248193|FG000|Overall Study|Lost to Follow-up|0|||
126261452|NCT03920280|454248194|FG001|Overall Study|Lost to Follow-up|1|||
126261453|NCT03920280|454248193|FG000|Overall Study|Withdrawal by Subject|1|||
126261454|NCT03920280|454248194|FG001|Overall Study|Withdrawal by Subject|1|||
126261455|NCT03920280|454248193|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
126261456|NCT03920280|454248194|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
126261457|NCT01857206|454248196|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
126261458|NCT01857206|454248197|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
126261459|NCT01857206|454248196|FG000|Overall Study|Lost to Follow-up|9|||
126261460|NCT01857206|454248197|FG001|Overall Study|Lost to Follow-up|6|||
126261461|NCT01857206|454248196|FG000|Overall Study|Unclassified|3|||
126261462|NCT01857206|454248197|FG001|Overall Study|Unclassified|3|||
126261463|NCT01857206|454248196|FG000|Overall Study|Withdrawal by Subject|1|||
126261464|NCT01857206|454248197|FG001|Overall Study|Withdrawal by Subject|0|||
126261465|NCT01857973|454248199|FG000|Overall Study|Subject did not meet required BG range|3|||
126261466|NCT01857973|454248199|FG000|Overall Study|drop out after 3 failed attempts|1|||
126261467|NCT01857973|454248199|FG000|Overall Study|Physician Decision|1|||
126261468|NCT01731886|454248208|FG000|Overall Study|Death|1|||
126261469|NCT01731886|454248209|FG001|Overall Study|Death|0|||
126261470|NCT01731886|454248208|FG000|Overall Study|Never started treatment|0|||
126261471|NCT01731886|454248209|FG001|Overall Study|Never started treatment|1|||
126261472|NCT01731886|454248208|FG000|Overall Study|Non-compliant|1|||
126261473|NCT01731886|454248209|FG001|Overall Study|Non-compliant|0|||
126261474|NCT00129116|454248210|FG000|Primary Phase|Lost to Follow-up|1|||
126261475|NCT00129116|454248211|FG001|Primary Phase|Lost to Follow-up|1|||
126261476|NCT00129116|454248212|FG002|Primary Phase|Lost to Follow-up|0|||
126261477|NCT00129116|454248213|FG003|Primary Phase|Lost to Follow-up|1|||
126261478|NCT00129116|454248214|FG004|Primary Phase|Lost to Follow-up|1|||
126261479|NCT00129116|454248210|FG000|Primary Phase|Protocol Violation|0|||
126261480|NCT00129116|454248211|FG001|Primary Phase|Protocol Violation|1|||
126261481|NCT00129116|454248212|FG002|Primary Phase|Protocol Violation|0|||
126261482|NCT00129116|454248213|FG003|Primary Phase|Protocol Violation|0|||
126261483|NCT00129116|454248214|FG004|Primary Phase|Protocol Violation|0|||
126261484|NCT00129116|454248210|FG000|Primary Phase|Adverse Event|1|||
126261485|NCT00129116|454248211|FG001|Primary Phase|Adverse Event|1|||
126261486|NCT00129116|454248212|FG002|Primary Phase|Adverse Event|0|||
126261487|NCT00129116|454248213|FG003|Primary Phase|Adverse Event|0|||
126261488|NCT00129116|454248214|FG004|Primary Phase|Adverse Event|0|||
126261489|NCT00129116|454248210|FG000|Primary Phase|Withdrawal by Subject|0|||
126261490|NCT00129116|454248211|FG001|Primary Phase|Withdrawal by Subject|1|||
126261491|NCT00129116|454248212|FG002|Primary Phase|Withdrawal by Subject|0|||
126261492|NCT00129116|454248213|FG003|Primary Phase|Withdrawal by Subject|0|||
126261493|NCT00129116|454248214|FG004|Primary Phase|Withdrawal by Subject|0|||
126103474|NCT01078675|453672169|FG000|Overall Study|Withdrawal by Subject|7|||
126261494|NCT00129116|454248210|FG000|Primary Phase|Other|0|||
126261495|NCT00129116|454248211|FG001|Primary Phase|Other|0|||
126261496|NCT00129116|454248212|FG002|Primary Phase|Other|1|||
126261497|NCT00129116|454248213|FG003|Primary Phase|Other|0|||
126261498|NCT00129116|454248214|FG004|Primary Phase|Other|0|||
126261499|NCT00129116|454248210|FG000|Booster Phase|Lost to Follow-up|2|||
126261500|NCT00129116|454248211|FG001|Booster Phase|Lost to Follow-up|0|||
126261501|NCT00129116|454248212|FG002|Booster Phase|Lost to Follow-up|0|||
126261502|NCT00129116|454248213|FG003|Booster Phase|Lost to Follow-up|0|||
126261503|NCT00129116|454248214|FG004|Booster Phase|Lost to Follow-up|1|||
126261504|NCT00271024|454248215|FG000|Overall Study|Lost Interest|3|||
126261505|NCT00271024|454248216|FG001|Overall Study|Lost Interest|4|||
126261506|NCT00271024|454248217|FG002|Overall Study|Lost Interest|2|||
126261507|NCT00271024|454248218|FG003|Overall Study|Lost Interest|3|||
126261508|NCT00271024|454248215|FG000|Overall Study|Unknown/Unspecified|11|||
126261509|NCT00271024|454248216|FG001|Overall Study|Unknown/Unspecified|11|||
126261510|NCT00271024|454248217|FG002|Overall Study|Unknown/Unspecified|8|||
126096410|NCT02101385|453644707|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
126096411|NCT02101385|453644706|FG000|Follow up|Withdrawal by Subject|2|||
126096412|NCT02101385|453644707|FG001|Follow up|Withdrawal by Subject|2|||
126096413|NCT02101385|453644706|FG000|Follow up|PI requested closure of site|0|||
126096414|NCT02101385|453644707|FG001|Follow up|PI requested closure of site|5|||
126096415|NCT02432196|453644708|FG000|Overall Study|Exit - did not receive study device|1|||
126096416|NCT02432196|453644708|FG000|Overall Study|Death|2|||
126096417|NCT02432196|453644708|FG000|Overall Study|Reoperation|3|||
126096418|NCT05038163|453644709|FG000|Stage 1|Did not complete survey|374|||
126096419|NCT05038163|453644710|FG001|Stage 1|Did not complete survey|0|||
126096420|NCT05038163|453644711|FG002|Stage 1|Did not complete survey|0|||
126096421|NCT05038163|453644712|FG003|Stage 1|Did not complete survey|0|||
126096422|NCT05038163|453644713|FG004|Stage 1|Did not complete survey|0|||
126096423|NCT05038163|453644714|FG005|Stage 1|Did not complete survey|0|||
126096424|NCT05038163|453644709|FG000|Stage 2|Did not complete Stage 2 survey|0|||
126096425|NCT05038163|453644710|FG001|Stage 2|Did not complete Stage 2 survey|29|||
126096426|NCT05038163|453644711|FG002|Stage 2|Did not complete Stage 2 survey|30|||
126096427|NCT05038163|453644712|FG003|Stage 2|Did not complete Stage 2 survey|24|||
126096428|NCT05038163|453644713|FG004|Stage 2|Did not complete Stage 2 survey|21|||
126096429|NCT05038163|453644714|FG005|Stage 2|Did not complete Stage 2 survey|100|||
126096430|NCT01905150|453644715|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
126096431|NCT01905150|453644716|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
126261511|NCT00271024|454248218|FG003|Overall Study|Unknown/Unspecified|4|||
126261512|NCT00271024|454248215|FG000|Overall Study|Protocol Violation|1|||
126261513|NCT00271024|454248216|FG001|Overall Study|Protocol Violation|6|||
126261514|NCT00271024|454248217|FG002|Overall Study|Protocol Violation|5|||
126261515|NCT00271024|454248218|FG003|Overall Study|Protocol Violation|11|||
126261516|NCT00271024|454248215|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
126261517|NCT00271024|454248216|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
126261518|NCT00271024|454248217|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
126261519|NCT00271024|454248218|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
126261520|NCT00271024|454248215|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
126261521|NCT00271024|454248216|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
126261522|NCT00271024|454248217|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
126261523|NCT00271024|454248218|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
126261524|NCT02487082|454248222|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
126261525|NCT02487082|454248223|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
126261526|NCT02487082|454248222|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
126261527|NCT02487082|454248223|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
126261528|NCT00003531|454248224|FG000|Overall Study|Not evaluable|10|||
126261529|NCT00251316|454248225|FG000|Overall Study|Physician Decision|2|||
126261530|NCT00251316|454248226|FG001|Overall Study|Physician Decision|3|||
126261531|NCT00346164|454248227|FG000|Overall Study|Adverse Event|0|||
126261532|NCT00346164|454248228|FG001|Overall Study|Adverse Event|0|||
126261533|NCT00346164|454248229|FG002|Overall Study|Adverse Event|0|||
126261534|NCT00346164|454248230|FG003|Overall Study|Adverse Event|1|||
126261535|NCT00346164|454248227|FG000|Overall Study|Lack of Efficacy|0|||
126261536|NCT00346164|454248228|FG001|Overall Study|Lack of Efficacy|1|||
126261537|NCT00346164|454248229|FG002|Overall Study|Lack of Efficacy|7|||
126261538|NCT00346164|454248230|FG003|Overall Study|Lack of Efficacy|25|||
126261539|NCT00346164|454248227|FG000|Overall Study|Physician Decision|0|||
126261540|NCT00346164|454248228|FG001|Overall Study|Physician Decision|1|||
126261541|NCT00346164|454248229|FG002|Overall Study|Physician Decision|2|||
126261542|NCT00346164|454248230|FG003|Overall Study|Physician Decision|27|||
126261543|NCT00346164|454248227|FG000|Overall Study|Protocol Violation|6|||
126261544|NCT00346164|454248228|FG001|Overall Study|Protocol Violation|2|||
126096432|NCT01147536|453644717|FG000|Overall Study|Administrative study close|2|||
126096433|NCT01147536|453644717|FG000|Overall Study|Death|1|||
126096434|NCT03762200|453644720|FG000|Overall Study|Death|2|||
126096435|NCT02631577|453644721|FG000|Overall Study|Death|1|||
126096436|NCT02631577|453644722|FG001|Overall Study|Death|7|||
126261545|NCT00346164|454248229|FG002|Overall Study|Protocol Violation|10|||
126261546|NCT00346164|454248230|FG003|Overall Study|Protocol Violation|4|||
126261547|NCT00346164|454248227|FG000|Overall Study|Withdrawal by Subject|0|||
126261548|NCT00346164|454248228|FG001|Overall Study|Withdrawal by Subject|0|||
126261549|NCT00346164|454248229|FG002|Overall Study|Withdrawal by Subject|2|||
126261550|NCT00346164|454248230|FG003|Overall Study|Withdrawal by Subject|0|||
126261551|NCT00346164|454248227|FG000|Overall Study|Ineligible|11|||
126031427|NCT05369403|453412261|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
126031428|NCT05369403|453412262|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
126031429|NCT05369403|453412263|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
126031430|NCT05369403|453412261|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
126031431|NCT05369403|453412262|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
126031432|NCT05369403|453412263|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
126031433|NCT05369403|453412261|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
126031434|NCT05369403|453412262|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
126031435|NCT05369403|453412263|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
126031436|NCT05369403|453412261|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
126031437|NCT05369403|453412262|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
126031438|NCT05369403|453412263|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
126031439|NCT05369403|453412261|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
126031440|NCT05369403|453412262|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
126031441|NCT05369403|453412263|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
126031442|NCT05369403|453412261|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
126031443|NCT05369403|453412262|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
126031444|NCT05369403|453412263|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
126031445|NCT05369403|453412261|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
126031446|NCT05369403|453412262|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
126031447|NCT05369403|453412263|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
126031448|NCT05369403|453412261|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
126031449|NCT05369403|453412262|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
126031450|NCT05369403|453412263|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
126031451|NCT05369403|453412261|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
126031452|NCT05369403|453412262|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
126031453|NCT05369403|453412263|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
126031454|NCT05369403|453412261|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
126031455|NCT05369403|453412262|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
126031456|NCT05369403|453412263|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
126031457|NCT03792256|453412267|FG000|Overall Study|Death|0|||
126031458|NCT03792256|453412268|FG001|Overall Study|Death|1|||
126031459|NCT03792256|453412267|FG000|Overall Study|Lack of Efficacy|0|||
126031460|NCT03792256|453412268|FG001|Overall Study|Lack of Efficacy|1|||
126031461|NCT03792256|453412267|FG000|Overall Study|Withdrawal by Subject|0|||
126031462|NCT03792256|453412268|FG001|Overall Study|Withdrawal by Subject|1|||
126031463|NCT01748448|453412271|FG000|Treatment Period|Consent withdrawn by subject|1|||
126031464|NCT01748448|453412272|FG001|Treatment Period|Consent withdrawn by subject|0|||
126031465|NCT01748448|453412271|FG000|Treatment Period|Adverse Event|1|||
126031466|NCT01748448|453412272|FG001|Treatment Period|Adverse Event|0|||
126031467|NCT01748448|453412271|FG000|Treatment Period|Personal|0|||
126031468|NCT01748448|453412272|FG001|Treatment Period|Personal|1|||
126031469|NCT02907099|453412273|FG000|Overall Study|Adverse Event|1|||
126031470|NCT02907099|453412273|FG000|Overall Study|Withdrawal by Subject|2|||
126031471|NCT02907099|453412273|FG000|Overall Study|Screen Fail|2|||
126031472|NCT04977947|453412274|FG000|Overall Study|Lost to Follow-up|1|||
126031473|NCT04977947|453412275|FG001|Overall Study|Lost to Follow-up|1|||
126031474|NCT05784662|453412276|FG000|Overall Study|Lost to Follow-up|21|||
126031475|NCT05784662|453412277|FG001|Overall Study|Lost to Follow-up|17|||
126031476|NCT04274764|453412288|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
126031477|NCT04274764|453412289|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
126031478|NCT03232138|453412291|FG000|Overall Study|Physician Decision|1|||
126031479|NCT03232138|453412292|FG001|Overall Study|Physician Decision|0|||
126031480|NCT03232138|453412291|FG000|Overall Study|Adverse Event|2|||
126031481|NCT03232138|453412292|FG001|Overall Study|Adverse Event|0|||
126031482|NCT03232138|453412291|FG000|Overall Study|Withdrawal by Subject|1|||
126031483|NCT03232138|453412292|FG001|Overall Study|Withdrawal by Subject|2|||
126031484|NCT04142788|453412293|FG000|Overall Study|Trial terminated prematurely|2|||
126031485|NCT04142788|453412294|FG001|Overall Study|Trial terminated prematurely|2|||
126031486|NCT03920111|453412295|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
126031487|NCT03920111|453412296|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
126031488|NCT03920111|453412297|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
126261552|NCT00346164|454248228|FG001|Overall Study|Ineligible|2|||
126031489|NCT05516147|453412298|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
126096437|NCT02631577|453644721|FG000|Overall Study|Withdrawal by Subject|0|||
126096438|NCT02631577|453644722|FG001|Overall Study|Withdrawal by Subject|3|||
126031490|NCT03853746|453412302|FG000|Overall Study|Withdrawal by Subject|1|||
126031491|NCT00999804|453412303|FG000|Overall Study|Lack of Efficacy|9|||
126031492|NCT00999804|453412304|FG001|Overall Study|Lack of Efficacy|2|||
126031493|NCT00999804|453412303|FG000|Overall Study|Adverse Event|4|||
126031494|NCT00999804|453412304|FG001|Overall Study|Adverse Event|3|||
126031495|NCT00999804|453412303|FG000|Overall Study|Withdrawal by Subject|4|||
126031496|NCT00999804|453412304|FG001|Overall Study|Withdrawal by Subject|0|||
126031497|NCT00999804|453412303|FG000|Overall Study|Death|1|||
126031498|NCT00999804|453412304|FG001|Overall Study|Death|0|||
126031499|NCT00999804|453412303|FG000|Overall Study|Ineligible|3|||
126031500|NCT00999804|453412304|FG001|Overall Study|Ineligible|0|||
126031501|NCT04166773|453412318|FG000|Overall Study|Adverse Event|2|||
126031502|NCT04166773|453412319|FG001|Overall Study|Adverse Event|0|||
126031503|NCT04166773|453412320|FG002|Overall Study|Adverse Event|2|||
126031504|NCT04166773|453412321|FG003|Overall Study|Adverse Event|1|||
126031505|NCT04166773|453412318|FG000|Overall Study|Lost to Follow-up|4|||
126031506|NCT04166773|453412319|FG001|Overall Study|Lost to Follow-up|2|||
126031507|NCT04166773|453412320|FG002|Overall Study|Lost to Follow-up|1|||
126031508|NCT04166773|453412321|FG003|Overall Study|Lost to Follow-up|3|||
126031509|NCT04166773|453412318|FG000|Overall Study|Physician Decision|0|||
126031510|NCT04166773|453412319|FG001|Overall Study|Physician Decision|0|||
126031511|NCT04166773|453412320|FG002|Overall Study|Physician Decision|0|||
126031512|NCT04166773|453412321|FG003|Overall Study|Physician Decision|1|||
126031513|NCT04166773|453412318|FG000|Overall Study|Withdrawal by Subject|1|||
126031514|NCT04166773|453412319|FG001|Overall Study|Withdrawal by Subject|1|||
126031515|NCT04166773|453412320|FG002|Overall Study|Withdrawal by Subject|2|||
126031516|NCT04166773|453412321|FG003|Overall Study|Withdrawal by Subject|5|||
126031517|NCT04952909|453412328|FG000|Overall Study|Death|3|||
126031518|NCT03150810|453412335|FG000|Overall Study|Death|4|||
126031519|NCT03150810|453412336|FG001|Overall Study|Death|8|||
126031520|NCT03150810|453412337|FG002|Overall Study|Death|7|||
126031521|NCT03150810|453412338|FG003|Overall Study|Death|2|||
126031522|NCT03150810|453412339|FG004|Overall Study|Death|2|||
126031523|NCT03150810|453412340|FG005|Overall Study|Death|10|||
126031524|NCT03150810|453412341|FG006|Overall Study|Death|8|||
126031525|NCT03150810|453412342|FG007|Overall Study|Death|6|||
126031526|NCT03150810|453412343|FG008|Overall Study|Death|18|||
126031527|NCT03150810|453412344|FG009|Overall Study|Death|3|||
126031528|NCT03150810|453412345|FG010|Overall Study|Death|19|||
126031529|NCT03150810|453412346|FG011|Overall Study|Death|1|||
126031530|NCT03150810|453412347|FG012|Overall Study|Death|19|||
126031531|NCT03150810|453412335|FG000|Overall Study|Withdrawal by Subject|0|||
126031532|NCT03150810|453412336|FG001|Overall Study|Withdrawal by Subject|1|||
126031533|NCT03150810|453412337|FG002|Overall Study|Withdrawal by Subject|1|||
126031534|NCT03150810|453412338|FG003|Overall Study|Withdrawal by Subject|1|||
126031535|NCT03150810|453412339|FG004|Overall Study|Withdrawal by Subject|0|||
126031536|NCT03150810|453412340|FG005|Overall Study|Withdrawal by Subject|0|||
126031537|NCT03150810|453412341|FG006|Overall Study|Withdrawal by Subject|2|||
126031538|NCT03150810|453412342|FG007|Overall Study|Withdrawal by Subject|0|||
126031539|NCT03150810|453412343|FG008|Overall Study|Withdrawal by Subject|2|||
126031540|NCT03150810|453412344|FG009|Overall Study|Withdrawal by Subject|0|||
126031541|NCT03150810|453412345|FG010|Overall Study|Withdrawal by Subject|1|||
126031542|NCT03150810|453412346|FG011|Overall Study|Withdrawal by Subject|0|||
126031543|NCT03150810|453412347|FG012|Overall Study|Withdrawal by Subject|1|||
126031544|NCT03150810|453412335|FG000|Overall Study|Sponsor Decision|0|||
126031545|NCT03150810|453412336|FG001|Overall Study|Sponsor Decision|2|||
126031546|NCT03150810|453412337|FG002|Overall Study|Sponsor Decision|0|||
126031547|NCT03150810|453412338|FG003|Overall Study|Sponsor Decision|0|||
126031548|NCT03150810|453412339|FG004|Overall Study|Sponsor Decision|1|||
126031549|NCT03150810|453412340|FG005|Overall Study|Sponsor Decision|1|||
126031550|NCT03150810|453412341|FG006|Overall Study|Sponsor Decision|0|||
126031551|NCT03150810|453412342|FG007|Overall Study|Sponsor Decision|0|||
126031552|NCT03150810|453412343|FG008|Overall Study|Sponsor Decision|1|||
126031553|NCT03150810|453412344|FG009|Overall Study|Sponsor Decision|0|||
126031554|NCT03150810|453412345|FG010|Overall Study|Sponsor Decision|0|||
126031555|NCT03150810|453412346|FG011|Overall Study|Sponsor Decision|0|||
126031556|NCT03150810|453412347|FG012|Overall Study|Sponsor Decision|5|||
126031557|NCT03150810|453412335|FG000|Overall Study|Lost to Follow-up|0|||
126031558|NCT03150810|453412336|FG001|Overall Study|Lost to Follow-up|1|||
126031559|NCT03150810|453412337|FG002|Overall Study|Lost to Follow-up|1|||
126031560|NCT03150810|453412338|FG003|Overall Study|Lost to Follow-up|0|||
126031561|NCT03150810|453412339|FG004|Overall Study|Lost to Follow-up|0|||
126031562|NCT03150810|453412340|FG005|Overall Study|Lost to Follow-up|0|||
126031563|NCT03150810|453412341|FG006|Overall Study|Lost to Follow-up|1|||
126031564|NCT03150810|453412342|FG007|Overall Study|Lost to Follow-up|0|||
126031565|NCT03150810|453412343|FG008|Overall Study|Lost to Follow-up|0|||
126031566|NCT03150810|453412344|FG009|Overall Study|Lost to Follow-up|0|||
126031567|NCT03150810|453412345|FG010|Overall Study|Lost to Follow-up|1|||
126031568|NCT03150810|453412346|FG011|Overall Study|Lost to Follow-up|0|||
126031569|NCT03150810|453412347|FG012|Overall Study|Lost to Follow-up|0|||
126031570|NCT03150810|453412335|FG000|Overall Study|Physician Decision|0|||
126031571|NCT03150810|453412336|FG001|Overall Study|Physician Decision|0|||
125880216|NCT01033019|452858811|FG000|Overall Study|Withdrawal by Subject|1|||
125880217|NCT01033019|452858812|FG001|Overall Study|Withdrawal by Subject|0|||
126261553|NCT00346164|454248229|FG002|Overall Study|Ineligible|2|||
126261554|NCT00346164|454248230|FG003|Overall Study|Ineligible|23|||
126261555|NCT00346164|454248227|FG000|Overall Study|Refusal of further protocol therapy|0|||
126261556|NCT00346164|454248228|FG001|Overall Study|Refusal of further protocol therapy|1|||
126261557|NCT00346164|454248229|FG002|Overall Study|Refusal of further protocol therapy|3|||
126261558|NCT00346164|454248230|FG003|Overall Study|Refusal of further protocol therapy|15|||
126261559|NCT00346164|454248227|FG000|Overall Study|Inability to start week 16 tx on time|0|||
126359596|NCT02255279|454609003|FG001|Overall Study|Withdrawal by Subject|6|||
126261560|NCT00346164|454248228|FG001|Overall Study|Inability to start week 16 tx on time|0|||
126261561|NCT00346164|454248229|FG002|Overall Study|Inability to start week 16 tx on time|0|||
126261562|NCT00346164|454248230|FG003|Overall Study|Inability to start week 16 tx on time|11|||
126261563|NCT00467831|454248231|FG000|Overall Study|Death|2|||
126261564|NCT00467831|454248231|FG000|Overall Study|Withdrawal by Subject|1|||
126261565|NCT01198873|454248232|FG000|Overall Study|Adverse Event|4|||
126261566|NCT01198873|454248233|FG001|Overall Study|Adverse Event|7|||
126261567|NCT01198873|454248232|FG000|Overall Study|Study closure|29|||
126261568|NCT01198873|454248233|FG001|Overall Study|Study closure|23|||
126261569|NCT01198873|454248232|FG000|Overall Study|Other than above|4|||
126261570|NCT01198873|454248233|FG001|Overall Study|Other than above|2|||
126261571|NCT03139240|454248234|FG000|Overall Study|Lost to Follow-up|0|||
126261572|NCT03139240|454248235|FG001|Overall Study|Lost to Follow-up|1|||
126261573|NCT03139240|454248236|FG002|Overall Study|Lost to Follow-up|1|||
126261574|NCT03139240|454248237|FG003|Overall Study|Lost to Follow-up|0|||
126261575|NCT00171340|454248238|FG000|Overall Study|Adverse Event|46|||
126261576|NCT00171340|454248239|FG001|Overall Study|Adverse Event|42|||
126261577|NCT00171340|454248238|FG000|Overall Study|Lack of Efficacy|29|||
126261578|NCT00171340|454248239|FG001|Overall Study|Lack of Efficacy|41|||
126261579|NCT00171340|454248238|FG000|Overall Study|Protocol Violation|7|||
126261580|NCT00171340|454248239|FG001|Overall Study|Protocol Violation|8|||
126261581|NCT00171340|454248238|FG000|Overall Study|Withdrawal by Subject|22|||
126261582|NCT00171340|454248239|FG001|Overall Study|Withdrawal by Subject|19|||
126261583|NCT00171340|454248238|FG000|Overall Study|Lost to Follow-up|0|||
126261584|NCT00171340|454248239|FG001|Overall Study|Lost to Follow-up|5|||
126261585|NCT00171340|454248238|FG000|Overall Study|Abnormal Laboratory Results|2|||
126261586|NCT00171340|454248239|FG001|Overall Study|Abnormal Laboratory Results|0|||
126261587|NCT00171340|454248238|FG000|Overall Study|Abnormal Test Procedure Results|6|||
126261588|NCT00171340|454248239|FG001|Overall Study|Abnormal Test Procedure Results|11|||
126261589|NCT00171340|454248238|FG000|Overall Study|No Longer Required Study Drug|1|||
126261590|NCT00171340|454248239|FG001|Overall Study|No Longer Required Study Drug|1|||
126261591|NCT00171340|454248238|FG000|Overall Study|Administrative Problems|5|||
126261592|NCT00171340|454248239|FG001|Overall Study|Administrative Problems|2|||
126261593|NCT00171340|454248238|FG000|Overall Study|Death|6|||
126261594|NCT00171340|454248239|FG001|Overall Study|Death|6|||
126261595|NCT01998243|454248240|FG000|Overall Study|Pregnancy|0|||
126261596|NCT01998243|454248241|FG001|Overall Study|Pregnancy|1|||
126261597|NCT01998243|454248240|FG000|Overall Study|Protocol Violation|5|||
126261598|NCT01998243|454248241|FG001|Overall Study|Protocol Violation|2|||
126261599|NCT01998243|454248240|FG000|Overall Study|Withdrawal by Subject|3|||
126261600|NCT01998243|454248241|FG001|Overall Study|Withdrawal by Subject|4|||
126261601|NCT04569786|454248242|FG000|Overall Study|Lost to Follow-up|1|||
126261602|NCT04569786|454248243|FG001|Overall Study|Lost to Follow-up|0|||
126261603|NCT04569786|454248244|FG002|Overall Study|Lost to Follow-up|4|||
126261604|NCT04569786|454248245|FG003|Overall Study|Lost to Follow-up|1|||
126261605|NCT04569786|454248246|FG004|Overall Study|Lost to Follow-up|0|||
126261606|NCT04569786|454248242|FG000|Overall Study|Withdrawal by Subject|0|||
126261607|NCT04569786|454248243|FG001|Overall Study|Withdrawal by Subject|0|||
126359597|NCT03607695|454609004|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
126359598|NCT03607695|454609004|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
126359599|NCT02741193|454609005|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
126359600|NCT02741193|454609005|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
126359601|NCT02502383|454609006|FG000|Overall Study|Lost to Follow-up|130|||
126359602|NCT02502383|454609007|FG001|Overall Study|Lost to Follow-up|131|||
126359603|NCT02502383|454609006|FG000|Overall Study|Withdrawal by Subject|31|||
126359604|NCT02502383|454609007|FG001|Overall Study|Withdrawal by Subject|24|||
126359605|NCT00363467|454609008|FG000|Overall Study|Physician Decision|1|||
126359606|NCT00527748|454609011|FG000|Overall Study|Other|3|||
126359607|NCT01093885|454609015|FG000|Overall Study|Adverse Event|4|||
126359608|NCT01093885|454609015|FG000|Overall Study|Lost to Follow-up|1|||
126359609|NCT04621786|454609016|FG000|Overall Study|Lost to Follow-up|9|||
126261608|NCT04569786|454248244|FG002|Overall Study|Withdrawal by Subject|0|||
126261609|NCT04569786|454248245|FG003|Overall Study|Withdrawal by Subject|5|||
126261610|NCT04569786|454248246|FG004|Overall Study|Withdrawal by Subject|1|||
126261611|NCT04569786|454248242|FG000|Overall Study|Physician Decision|0|||
126261612|NCT04569786|454248243|FG001|Overall Study|Physician Decision|0|||
126261613|NCT04569786|454248244|FG002|Overall Study|Physician Decision|0|||
126261614|NCT04569786|454248245|FG003|Overall Study|Physician Decision|1|||
126261615|NCT04569786|454248246|FG004|Overall Study|Physician Decision|0|||
126261616|NCT02563769|454248253|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
126261617|NCT02563769|454248254|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
126261618|NCT02563769|454248255|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
126261619|NCT00690482|454248256|FG000|Overall Study|Adverse Event|2|||
126261620|NCT00690482|454248257|FG001|Overall Study|Adverse Event|1|||
126261621|NCT00690482|454248256|FG000|Overall Study|Incorrect enrolment|0|||
126261622|NCT00690482|454248257|FG001|Overall Study|Incorrect enrolment|1|||
126261623|NCT00690482|454248256|FG000|Overall Study|Study-specific discontinuation criteria|1|||
126261624|NCT00690482|454248257|FG001|Overall Study|Study-specific discontinuation criteria|0|||
126261625|NCT00690482|454248256|FG000|Overall Study|Intake of prohibited medicine|1|||
126261626|NCT00690482|454248257|FG001|Overall Study|Intake of prohibited medicine|0|||
126261627|NCT00690482|454248256|FG000|Overall Study|withdrew consent at rand.day|0|||
126261628|NCT00690482|454248257|FG001|Overall Study|withdrew consent at rand.day|1|||
126261629|NCT02820740|454248258|FG000|Overall Study|Did not have procedure|2|||
126261630|NCT03718117|454248262|FG000|Overall Study|Death|12|||
126261631|NCT03718117|454248263|FG001|Overall Study|Death|11|||
126261632|NCT03718117|454248264|FG002|Overall Study|Death|0|||
126261633|NCT03718117|454248262|FG000|Overall Study|Other|0|||
126261634|NCT03718117|454248263|FG001|Overall Study|Other|1|||
126261635|NCT03718117|454248264|FG002|Overall Study|Other|0|||
126261636|NCT03718117|454248262|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
126261637|NCT03718117|454248263|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
126261638|NCT03718117|454248264|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
126261639|NCT03718117|454248262|FG000|Overall Study|Participant not met eligibility criteria|0|||
126261640|NCT03718117|454248263|FG001|Overall Study|Participant not met eligibility criteria|0|||
126261641|NCT03718117|454248264|FG002|Overall Study|Participant not met eligibility criteria|2|||
126261642|NCT03069417|454248265|FG000|Overall Study|Lost to Follow-up|2|||
126261643|NCT03069417|454248266|FG001|Overall Study|Lost to Follow-up|0|||
126261644|NCT03069417|454248265|FG000|Overall Study|Reason Unknown|4|||
126261645|NCT03069417|454248266|FG001|Overall Study|Reason Unknown|7|||
126261646|NCT04117945|454248267|FG000|Overall Study|Death|1|||
126261647|NCT04117945|454248268|FG001|Overall Study|Death|0|||
126261648|NCT04117945|454248267|FG000|Overall Study|Withdrawal by Subject|3|||
126261649|NCT04117945|454248268|FG001|Overall Study|Withdrawal by Subject|1|||
126261650|NCT04117945|454248267|FG000|Overall Study|Disease Progression|0|||
126261651|NCT04117945|454248268|FG001|Overall Study|Disease Progression|2|||
126261652|NCT04117945|454248267|FG000|Overall Study|Ineligible|8|||
126261653|NCT04117945|454248268|FG001|Overall Study|Ineligible|7|||
126261654|NCT00402025|454248269|FG000|Overall Study|Adverse Event|0|||
126261655|NCT00402025|454248270|FG001|Overall Study|Adverse Event|0|||
126261656|NCT00402025|454248271|FG002|Overall Study|Adverse Event|2|||
126261657|NCT00402025|454248269|FG000|Overall Study|Death|0|||
126261658|NCT00402025|454248270|FG001|Overall Study|Death|1|||
126261659|NCT00402025|454248271|FG002|Overall Study|Death|5|||
126261660|NCT00402025|454248269|FG000|Overall Study|Disease Progression|1|||
126261661|NCT00402025|454248270|FG001|Overall Study|Disease Progression|1|||
126261662|NCT00402025|454248271|FG002|Overall Study|Disease Progression|2|||
126261663|NCT00402025|454248269|FG000|Overall Study|Physician Decision|1|||
126261664|NCT00402025|454248270|FG001|Overall Study|Physician Decision|1|||
126261665|NCT00402025|454248271|FG002|Overall Study|Physician Decision|0|||
126261666|NCT00402025|454248269|FG000|Overall Study|Participant Decision|0|||
126261667|NCT00402025|454248270|FG001|Overall Study|Participant Decision|0|||
126261668|NCT00402025|454248271|FG002|Overall Study|Participant Decision|1|||
126261669|NCT01917968|454248273|FG000|Overall Study|Death|3|||
126261670|NCT01917968|454248274|FG001|Overall Study|Death|2|||
126261671|NCT01917968|454248273|FG000|Overall Study|Lost to Follow-up|21|||
126359610|NCT04621786|454609016|FG000|Overall Study|Protocol Violation|3|||
126261672|NCT01917968|454248274|FG001|Overall Study|Lost to Follow-up|39|||
126261673|NCT01917968|454248273|FG000|Overall Study|Physician Decision|1|||
126261674|NCT01917968|454248274|FG001|Overall Study|Physician Decision|2|||
126261675|NCT01917968|454248273|FG000|Overall Study|Withdrawal by Subject|20|||
126261676|NCT01917968|454248274|FG001|Overall Study|Withdrawal by Subject|35|||
126261677|NCT01917968|454248273|FG000|Overall Study|Subject Relocation|5|||
126261678|NCT01917968|454248274|FG001|Overall Study|Subject Relocation|1|||
126261679|NCT01917968|454248273|FG000|Overall Study|36M Missed Visit|3|||
126261680|NCT01917968|454248274|FG001|Overall Study|36M Missed Visit|2|||
126261681|NCT01917968|454248273|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
126261682|NCT01917968|454248274|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
126261683|NCT01917968|454248273|FG000|Overall Study|Change in Family Circumstances|0|||
126261684|NCT01917968|454248274|FG001|Overall Study|Change in Family Circumstances|1|||
126261685|NCT01917968|454248273|FG000|Overall Study|No Data Available|0|||
126261686|NCT01917968|454248274|FG001|Overall Study|No Data Available|2|||
126261687|NCT02148445|454248279|FG000|Overall Study|Death|1|||
126261688|NCT02148445|454248280|FG001|Overall Study|Death|3|||
126261689|NCT03450629|454248281|FG000|Overall Study|Adverse Event|15|||
126261690|NCT03450629|454248282|FG001|Overall Study|Adverse Event|14|||
126261691|NCT03450629|454248281|FG000|Overall Study|Physician Decision|2|||
126261692|NCT03450629|454248282|FG001|Overall Study|Physician Decision|2|||
126261693|NCT03450629|454248281|FG000|Overall Study|Lack of Efficacy|2|||
126261694|NCT03450629|454248282|FG001|Overall Study|Lack of Efficacy|0|||
126261695|NCT03450629|454248281|FG000|Overall Study|Lost to Follow-up|4|||
126261696|NCT03450629|454248282|FG001|Overall Study|Lost to Follow-up|2|||
126261697|NCT03450629|454248281|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126261698|NCT03450629|454248282|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
126261699|NCT03450629|454248281|FG000|Overall Study|Non-Compliance With Study Drug|2|||
126261700|NCT03450629|454248282|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126261701|NCT03450629|454248281|FG000|Overall Study|Protocol Violation|11|||
126261702|NCT03450629|454248282|FG001|Overall Study|Protocol Violation|8|||
126261703|NCT03450629|454248281|FG000|Overall Study|Withdrawal by Subject|12|||
126261704|NCT03450629|454248282|FG001|Overall Study|Withdrawal by Subject|6|||
126261705|NCT03438006|454248283|FG000|Overall Study|Adverse Event|1|||
126261706|NCT03438006|454248283|FG000|Overall Study|Lost to Follow-up|67|||
126261707|NCT03438006|454248283|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
126261708|NCT03438006|454248283|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
126261709|NCT00955721|454248294|FG000|Overall Study|Physician Decision|1|||
126261710|NCT00955721|454248295|FG001|Overall Study|Physician Decision|0|||
126261711|NCT00955721|454248294|FG000|Overall Study|Death|1|||
126261712|NCT00955721|454248295|FG001|Overall Study|Death|0|||
126261713|NCT00955721|454248294|FG000|Overall Study|Withdrawal by Subject|1|||
126261714|NCT00955721|454248295|FG001|Overall Study|Withdrawal by Subject|0|||
126261715|NCT00749411|454248299|FG000|Overall Study|Adverse Event|0|||
126261716|NCT00749411|454248300|FG001|Overall Study|Adverse Event|2|||
126261717|NCT00749411|454248299|FG000|Overall Study|Lack of Efficacy|0|||
126261718|NCT00749411|454248300|FG001|Overall Study|Lack of Efficacy|1|||
126261719|NCT00749411|454248299|FG000|Overall Study|Protocol Violation|1|||
126261720|NCT00749411|454248300|FG001|Overall Study|Protocol Violation|1|||
126261721|NCT00749411|454248299|FG000|Overall Study|Protocol-defined stopping criteria|0|||
126261722|NCT00749411|454248300|FG001|Overall Study|Protocol-defined stopping criteria|1|||
126261723|NCT03183141|454248302|FG000|Overall Study|Withdrawal by Subject|2|||
126261724|NCT03183141|454248303|FG001|Overall Study|Withdrawal by Subject|4|||
126261725|NCT03183141|454248302|FG000|Overall Study|Death|0|||
126261726|NCT03183141|454248303|FG001|Overall Study|Death|8|||
126261727|NCT02756637|454248305|FG000|Overall Study|Not eligible for initial SWOG study|10|||
126261728|NCT02756637|454248306|FG001|Overall Study|Not eligible for initial SWOG study|10|||
126261729|NCT02756637|454248305|FG000|Overall Study|No available NLR value|44|||
126261730|NCT02756637|454248306|FG001|Overall Study|No available NLR value|44|||
126261731|NCT02756637|454248305|FG000|Overall Study|Did not complete curative therapy|33|||
126261732|NCT02756637|454248306|FG001|Overall Study|Did not complete curative therapy|0|||
126261733|NCT01507090|454248307|FG000|Overall Study|incomplete dataset|18|||
126261734|NCT03581188|454249603|FG000|Overall Study|Inclusion criteria not met|3|||
126261735|NCT03581188|454249604|FG001|Overall Study|Inclusion criteria not met|2|||
126261736|NCT03581188|454249603|FG000|Overall Study|Lost to Follow-up|5|||
126261737|NCT03581188|454249604|FG001|Overall Study|Lost to Follow-up|5|||
126261738|NCT03581188|454249603|FG000|Overall Study|Discontinued intervention|11|||
126261739|NCT03581188|454249604|FG001|Overall Study|Discontinued intervention|8|||
126261740|NCT01937351|454249605|FG000|Overall Study|Withdrawal by Subject|4|||
126261741|NCT01937351|454249606|FG001|Overall Study|Withdrawal by Subject|2|||
126096439|NCT05618912|453644729|FG000|Overall Study|Lost to Follow-up|14|||
126096440|NCT05618912|453644730|FG001|Overall Study|Lost to Follow-up|19|||
126096441|NCT05110690|453644731|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
126261742|NCT01937351|454249605|FG000|Overall Study|Death|1|||
126261743|NCT01937351|454249606|FG001|Overall Study|Death|0|||
126261744|NCT01937351|454249605|FG000|Overall Study|Not treated w device, per protocol fail|4|||
126261745|NCT01937351|454249606|FG001|Overall Study|Not treated w device, per protocol fail|0|||
126261746|NCT01961687|454249607|FG000|Overall Study|Lost to Follow-up|19|||
126261747|NCT01961687|454249607|FG000|Overall Study|Re-operation|17|||
126359611|NCT02123511|454609017|FG000|Overall Study|Cancelled treatment|1|||
126261748|NCT01961687|454249607|FG000|Overall Study|Death|7|||
126261749|NCT01961687|454249607|FG000|Overall Study|Withdrawal by Subject|6|||
126261750|NCT01961687|454249607|FG000|Overall Study|Adverse Event|6|||
126261751|NCT01961687|454249607|FG000|Overall Study|Moved to area without study site|2|||
126261752|NCT01961687|454249607|FG000|Overall Study|Sponsor decision|2|||
126261753|NCT01961687|454249607|FG000|Overall Study|Physician Decision|1|||
126261754|NCT01961687|454249607|FG000|Overall Study|Unable to meet follow-up requirements|1|||
126261755|NCT02284347|454249608|FG000|Overall Study|Lost to Follow-up|2|||
126261756|NCT02284347|454249608|FG000|Overall Study|Withdrawn prior to treatment|1|||
126359612|NCT02123511|454609018|FG001|Overall Study|Cancelled treatment|0|||
126261757|NCT02999984|454249609|FG000|Overall Study|Treatment Failure|1|||
126261758|NCT01316419|454249610|FG000|Overall Study|Not treated|103|||
126261759|NCT01316419|454249610|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
126261760|NCT01316419|454249610|FG000|Overall Study|Lost to Follow-up|19|||
126261761|NCT00754013|454249613|FG000|Overall Study|Lost to Follow-up|1|||
126261762|NCT00754013|454249614|FG001|Overall Study|Lost to Follow-up|1|||
126261763|NCT00754013|454249613|FG000|Overall Study|didn't return after study termed|3|||
126261764|NCT00754013|454249614|FG001|Overall Study|didn't return after study termed|4|||
126261765|NCT04039919|454249615|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126261766|NCT04039919|454249616|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126261767|NCT04039919|454249617|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126261768|NCT04039919|454249618|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126261769|NCT04039919|454249619|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126261770|NCT04039919|454249615|FG000|Treatment Period 1|Sponsor's decision|0|||
126261771|NCT04039919|454249616|FG001|Treatment Period 1|Sponsor's decision|0|||
126261772|NCT04039919|454249617|FG002|Treatment Period 1|Sponsor's decision|0|||
126261773|NCT04039919|454249618|FG003|Treatment Period 1|Sponsor's decision|0|||
126261774|NCT04039919|454249619|FG004|Treatment Period 1|Sponsor's decision|16|||
126261775|NCT04039919|454249615|FG000|Treatment Period 5|Withdrawal by Subject|1|||
126261776|NCT04039919|454249616|FG001|Treatment Period 5|Withdrawal by Subject|0|||
126261777|NCT04039919|454249617|FG002|Treatment Period 5|Withdrawal by Subject|0|||
126261778|NCT04039919|454249618|FG003|Treatment Period 5|Withdrawal by Subject|0|||
126261779|NCT04039919|454249619|FG004|Treatment Period 5|Withdrawal by Subject|0|||
126261780|NCT02310789|454249620|FG000|Overall Study|Adverse Event|1|||
126261781|NCT00983918|454249621|FG000|Overall Study|conversion to open cholecystectomy|0|||
126261782|NCT00983918|454249622|FG001|Overall Study|conversion to open cholecystectomy|2|||
126261783|NCT00983918|454249623|FG002|Overall Study|conversion to open cholecystectomy|2|||
126261784|NCT00983918|454249624|FG003|Overall Study|conversion to open cholecystectomy|2|||
126261785|NCT00794417|454249625|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
126261786|NCT00794417|454249626|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
126261787|NCT00794417|454249627|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
126261788|NCT00794417|454249628|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
126261789|NCT00794417|454249625|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
126261790|NCT00794417|454249626|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
126261791|NCT00794417|454249627|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
126261792|NCT00794417|454249628|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
126261793|NCT00794417|454249625|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
126261794|NCT00794417|454249626|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
126261795|NCT00794417|454249627|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
126261796|NCT00794417|454249628|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
126261797|NCT00794417|454249625|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
126261798|NCT00794417|454249626|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
126261799|NCT00794417|454249627|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
126261800|NCT00794417|454249628|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
126261801|NCT00794417|454249625|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
126261802|NCT00794417|454249626|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
126261803|NCT00794417|454249627|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
126261804|NCT00794417|454249628|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
126261805|NCT00794417|454249625|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
126261806|NCT00794417|454249626|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
126261807|NCT00794417|454249627|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
126261808|NCT00794417|454249628|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
126261809|NCT01652729|454249629|FG000|Overall Study|Withdrawal by Subject|14|||
126261810|NCT01652729|454249630|FG001|Overall Study|Withdrawal by Subject|7|||
126261811|NCT01652729|454249631|FG002|Overall Study|Withdrawal by Subject|7|||
126261812|NCT01652729|454249629|FG000|Overall Study|Adverse Event|4|||
126261813|NCT01652729|454249630|FG001|Overall Study|Adverse Event|0|||
126261814|NCT01652729|454249631|FG002|Overall Study|Adverse Event|3|||
126261815|NCT01652729|454249629|FG000|Overall Study|Physician Decision|1|||
126261816|NCT01652729|454249630|FG001|Overall Study|Physician Decision|0|||
126261817|NCT01652729|454249631|FG002|Overall Study|Physician Decision|1|||
126261818|NCT01652729|454249629|FG000|Overall Study|Protocol Violation|1|||
126261819|NCT01652729|454249630|FG001|Overall Study|Protocol Violation|0|||
126261820|NCT01652729|454249631|FG002|Overall Study|Protocol Violation|0|||
126261821|NCT01652729|454249629|FG000|Overall Study|Lost to Follow-up|6|||
126261822|NCT01652729|454249630|FG001|Overall Study|Lost to Follow-up|6|||
126261823|NCT01652729|454249631|FG002|Overall Study|Lost to Follow-up|3|||
126261824|NCT01652729|454249629|FG000|Overall Study|Administrative|1|||
126261825|NCT01652729|454249630|FG001|Overall Study|Administrative|0|||
126261826|NCT01652729|454249631|FG002|Overall Study|Administrative|0|||
126261827|NCT00483548|454249632|FG000|Overall Study|Randomized; not treated with study drug|1|||
126261828|NCT00483548|454249633|FG001|Overall Study|Randomized; not treated with study drug|3|||
126261829|NCT00483548|454249632|FG000|Overall Study|Adverse Event|25|||
126261830|NCT00483548|454249633|FG001|Overall Study|Adverse Event|14|||
126261831|NCT00483548|454249632|FG000|Overall Study|Laboratory abnormality|1|||
126031572|NCT03150810|453412337|FG002|Overall Study|Physician Decision|0|||
126031573|NCT03150810|453412338|FG003|Overall Study|Physician Decision|0|||
126031574|NCT03150810|453412339|FG004|Overall Study|Physician Decision|0|||
126031575|NCT03150810|453412340|FG005|Overall Study|Physician Decision|1|||
126031576|NCT03150810|453412341|FG006|Overall Study|Physician Decision|1|||
126031577|NCT03150810|453412342|FG007|Overall Study|Physician Decision|0|||
126031578|NCT03150810|453412343|FG008|Overall Study|Physician Decision|0|||
126031579|NCT03150810|453412344|FG009|Overall Study|Physician Decision|0|||
126031580|NCT03150810|453412345|FG010|Overall Study|Physician Decision|0|||
126031581|NCT03150810|453412346|FG011|Overall Study|Physician Decision|0|||
126031582|NCT03150810|453412347|FG012|Overall Study|Physician Decision|0|||
126031583|NCT03150810|453412335|FG000|Overall Study|Site withdrawal from study|0|||
126031584|NCT03150810|453412336|FG001|Overall Study|Site withdrawal from study|1|||
126031585|NCT03150810|453412337|FG002|Overall Study|Site withdrawal from study|0|||
126031586|NCT03150810|453412338|FG003|Overall Study|Site withdrawal from study|0|||
126031587|NCT03150810|453412339|FG004|Overall Study|Site withdrawal from study|0|||
126031588|NCT03150810|453412340|FG005|Overall Study|Site withdrawal from study|0|||
126031589|NCT03150810|453412341|FG006|Overall Study|Site withdrawal from study|0|||
126031590|NCT03150810|453412342|FG007|Overall Study|Site withdrawal from study|0|||
126031591|NCT03150810|453412343|FG008|Overall Study|Site withdrawal from study|0|||
126031592|NCT03150810|453412344|FG009|Overall Study|Site withdrawal from study|1|||
126031593|NCT03150810|453412345|FG010|Overall Study|Site withdrawal from study|1|||
126031594|NCT03150810|453412346|FG011|Overall Study|Site withdrawal from study|0|||
126031595|NCT03150810|453412347|FG012|Overall Study|Site withdrawal from study|0|||
126031596|NCT03150810|453412335|FG000|Overall Study|Hospice|0|||
126031597|NCT03150810|453412336|FG001|Overall Study|Hospice|0|||
126031598|NCT03150810|453412337|FG002|Overall Study|Hospice|0|||
126031599|NCT03150810|453412338|FG003|Overall Study|Hospice|0|||
126031600|NCT03150810|453412339|FG004|Overall Study|Hospice|0|||
126031601|NCT03150810|453412340|FG005|Overall Study|Hospice|1|||
126031602|NCT03150810|453412341|FG006|Overall Study|Hospice|0|||
126031603|NCT03150810|453412342|FG007|Overall Study|Hospice|0|||
126031604|NCT03150810|453412343|FG008|Overall Study|Hospice|0|||
126031605|NCT03150810|453412344|FG009|Overall Study|Hospice|0|||
126031606|NCT03150810|453412345|FG010|Overall Study|Hospice|0|||
126031607|NCT03150810|453412346|FG011|Overall Study|Hospice|0|||
126031608|NCT03150810|453412347|FG012|Overall Study|Hospice|0|||
126031609|NCT03150810|453412335|FG000|Overall Study|Participant relocated abroad.|0|||
126031610|NCT03150810|453412336|FG001|Overall Study|Participant relocated abroad.|0|||
126031611|NCT03150810|453412337|FG002|Overall Study|Participant relocated abroad.|0|||
126031612|NCT03150810|453412338|FG003|Overall Study|Participant relocated abroad.|0|||
126031613|NCT03150810|453412339|FG004|Overall Study|Participant relocated abroad.|0|||
126031614|NCT03150810|453412340|FG005|Overall Study|Participant relocated abroad.|1|||
126031615|NCT03150810|453412341|FG006|Overall Study|Participant relocated abroad.|0|||
126031616|NCT03150810|453412342|FG007|Overall Study|Participant relocated abroad.|0|||
126031617|NCT03150810|453412343|FG008|Overall Study|Participant relocated abroad.|0|||
126031618|NCT03150810|453412344|FG009|Overall Study|Participant relocated abroad.|0|||
126031619|NCT03150810|453412345|FG010|Overall Study|Participant relocated abroad.|0|||
126031620|NCT03150810|453412346|FG011|Overall Study|Participant relocated abroad.|0|||
126031621|NCT03150810|453412347|FG012|Overall Study|Participant relocated abroad.|0|||
126031622|NCT03150810|453412335|FG000|Overall Study|Transferred care to oncologist|0|||
126031623|NCT03150810|453412336|FG001|Overall Study|Transferred care to oncologist|0|||
126031624|NCT03150810|453412337|FG002|Overall Study|Transferred care to oncologist|0|||
126031625|NCT03150810|453412338|FG003|Overall Study|Transferred care to oncologist|0|||
126031626|NCT03150810|453412339|FG004|Overall Study|Transferred care to oncologist|0|||
126031627|NCT03150810|453412340|FG005|Overall Study|Transferred care to oncologist|0|||
126031628|NCT03150810|453412341|FG006|Overall Study|Transferred care to oncologist|2|||
126031629|NCT03150810|453412342|FG007|Overall Study|Transferred care to oncologist|0|||
126031630|NCT03150810|453412343|FG008|Overall Study|Transferred care to oncologist|0|||
126031631|NCT03150810|453412344|FG009|Overall Study|Transferred care to oncologist|0|||
126031632|NCT03150810|453412345|FG010|Overall Study|Transferred care to oncologist|0|||
126031633|NCT03150810|453412346|FG011|Overall Study|Transferred care to oncologist|0|||
126031634|NCT03150810|453412347|FG012|Overall Study|Transferred care to oncologist|0|||
126031635|NCT05116787|453412348|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
126031636|NCT05116787|453412349|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
126031637|NCT05116787|453412348|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
126031638|NCT05116787|453412349|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
126031639|NCT05116787|453412348|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
126031640|NCT05116787|453412349|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
126031641|NCT05116787|453412348|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
126031642|NCT05116787|453412349|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
126031643|NCT05478499|453412356|FG000|Overall Study|Adverse Event|4|||
126031644|NCT05478499|453412357|FG001|Overall Study|Adverse Event|2|||
126096442|NCT05110690|453644731|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
126096443|NCT05110690|453644731|FG000|Completion of Intervention|Lost to Follow-up|1|||
126096444|NCT05110690|453644731|FG000|Completion of Intervention|Death|1|||
126096445|NCT05110690|453644731|FG000|Completion of Intervention|Withdrawal by Subject|2|||
126096446|NCT03973931|453644732|FG000|Overall Study|Lost to Follow-up|47|||
126096447|NCT03973931|453644733|FG001|Overall Study|Lost to Follow-up|63|||
126096448|NCT03973931|453644734|FG002|Overall Study|Lost to Follow-up|51|||
126096449|NCT03973931|453644735|FG003|Overall Study|Lost to Follow-up|54|||
126096450|NCT03973931|453644732|FG000|Overall Study|opted out|6|||
126096451|NCT03973931|453644733|FG001|Overall Study|opted out|5|||
126096452|NCT03973931|453644734|FG002|Overall Study|opted out|5|||
126096453|NCT03973931|453644735|FG003|Overall Study|opted out|1|||
126096454|NCT01302067|453646460|FG000|Overall Study|Death|0|||
126261832|NCT00483548|454249633|FG001|Overall Study|Laboratory abnormality|2|||
126261833|NCT00483548|454249632|FG000|Overall Study|Lack of Efficacy|4|||
126261834|NCT00483548|454249633|FG001|Overall Study|Lack of Efficacy|8|||
126261835|NCT00483548|454249632|FG000|Overall Study|Protocol Violation|11|||
126261836|NCT00483548|454249633|FG001|Overall Study|Protocol Violation|7|||
126261837|NCT00483548|454249632|FG000|Overall Study|Pregnancy|1|||
126261838|NCT00483548|454249633|FG001|Overall Study|Pregnancy|0|||
126261839|NCT00483548|454249632|FG000|Overall Study|Protocol required discontinuation|6|||
126261840|NCT00483548|454249633|FG001|Overall Study|Protocol required discontinuation|6|||
126261841|NCT00483548|454249632|FG000|Overall Study|Unable to comply with protocol schedule|1|||
126261842|NCT00483548|454249633|FG001|Overall Study|Unable to comply with protocol schedule|0|||
126261843|NCT00483548|454249632|FG000|Overall Study|Non-compliance with medication|2|||
126261844|NCT00483548|454249633|FG001|Overall Study|Non-compliance with medication|0|||
126261845|NCT00483548|454249632|FG000|Overall Study|Lost to Follow-up|3|||
126261846|NCT00483548|454249633|FG001|Overall Study|Lost to Follow-up|4|||
126261847|NCT00483548|454249632|FG000|Overall Study|Withdrawal by Subject|5|||
126261848|NCT00483548|454249633|FG001|Overall Study|Withdrawal by Subject|2|||
126261849|NCT02694549|454249636|FG000|Overall Study|screen failures|2|||
126359613|NCT02123511|454609017|FG000|Overall Study|Incomplete data|1|||
126359614|NCT02123511|454609018|FG001|Overall Study|Incomplete data|3|||
126359615|NCT02123511|454609017|FG000|Overall Study|Ineligible|0|||
126359616|NCT02123511|454609018|FG001|Overall Study|Ineligible|1|||
126031645|NCT05478499|453412356|FG000|Overall Study|Withdrawal by Subject|3|||
126031646|NCT05478499|453412357|FG001|Overall Study|Withdrawal by Subject|2|||
126031647|NCT05478499|453412356|FG000|Overall Study|Lack of Efficacy|1|||
126031648|NCT05478499|453412357|FG001|Overall Study|Lack of Efficacy|0|||
126031649|NCT05478499|453412356|FG000|Overall Study|Lost to Follow-up|1|||
126359617|NCT01975285|454609021|FG000|Overall Study|Failed Block and follow up|2|||
126359618|NCT01975285|454609022|FG001|Overall Study|Failed Block and follow up|2|||
126359619|NCT01750281|454609023|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
126031650|NCT05478499|453412357|FG001|Overall Study|Lost to Follow-up|0|||
126031651|NCT05478499|453412356|FG000|Overall Study|Other reasons|0|||
126031652|NCT05478499|453412357|FG001|Overall Study|Other reasons|1|||
126031653|NCT02962895|453412358|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
126031654|NCT02962895|453412359|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
126031655|NCT02962895|453412360|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
126031656|NCT02962895|453412361|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
126031657|NCT02962895|453412362|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
126031658|NCT02962895|453412363|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
126031659|NCT02962895|453412364|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
126031660|NCT02962895|453412358|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126096455|NCT01302067|453646461|FG001|Overall Study|Death|0|||
126261850|NCT01534078|454249637|FG000|Overall Study|Death|1|||
126359620|NCT01750281|454609024|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
126359621|NCT01750281|454609025|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
126359622|NCT01750281|454609023|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
126359623|NCT01750281|454609024|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
126359624|NCT01750281|454609025|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
126359625|NCT01750281|454609023|FG000|Overall Study|Did not receive treatment|0|||
126359626|NCT01750281|454609024|FG001|Overall Study|Did not receive treatment|1|||
126359627|NCT01750281|454609025|FG002|Overall Study|Did not receive treatment|0|||
126359628|NCT01122680|454609027|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
126359629|NCT01122680|454609028|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
126359630|NCT01122680|454609029|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
126359631|NCT01122680|454609030|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
126031661|NCT02962895|453412359|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
126096456|NCT01302067|453646462|FG002|Overall Study|Death|1|||
126261851|NCT01534078|454249637|FG000|Overall Study|Withdrawal by Subject|1|||
126096457|NCT01302067|453646460|FG000|Overall Study|Physician Decision|9|||
126096458|NCT01302067|453646461|FG001|Overall Study|Physician Decision|5|||
126261852|NCT01223235|454249638|FG000|Overall Study|Withdrawal by Subject|1|||
126261853|NCT04364737|454249642|FG000|Overall Study|Withdrawal by Subject|4|||
126096459|NCT01302067|453646462|FG002|Overall Study|Physician Decision|14|||
126096460|NCT01302067|453646460|FG000|Overall Study|Lack of Efficacy|8|||
126096461|NCT01302067|453646461|FG001|Overall Study|Lack of Efficacy|4|||
126096462|NCT01302067|453646462|FG002|Overall Study|Lack of Efficacy|2|||
126096463|NCT01302067|453646460|FG000|Overall Study|Lost to Follow-up|9|||
126261854|NCT04364737|454249643|FG001|Overall Study|Withdrawal by Subject|9|||
126261855|NCT04364737|454249642|FG000|Overall Study|Lost to Follow-up|1|||
126261856|NCT04364737|454249643|FG001|Overall Study|Lost to Follow-up|1|||
126261857|NCT01220609|454249644|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
126261858|NCT01220609|454249644|FG000|Overall Study|Ineligible- Wrong cell type|1|||
126261859|NCT01220609|454249644|FG000|Overall Study|Ineligible-Never treated|1|||
126261860|NCT02225665|454249645|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
126261861|NCT02225665|454249646|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
126261862|NCT02225665|454249645|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
126261863|NCT02225665|454249646|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
126261864|NCT00614822|454249652|FG000|Overall Study|Adverse Event|3|||
126261865|NCT01557920|454249653|FG000|Overall Study|Withdrawal by Subject|2|||
126261866|NCT01557920|454249654|FG001|Overall Study|Withdrawal by Subject|3|||
126261867|NCT01557920|454249653|FG000|Overall Study|Lack of Efficacy|1|||
126261868|NCT01557920|454249654|FG001|Overall Study|Lack of Efficacy|0|||
126261869|NCT02674386|454249659|FG000|Overall Study|Lost to Follow-up|0|||
126261870|NCT02674386|454249660|FG001|Overall Study|Lost to Follow-up|1|||
126261871|NCT02674386|454249661|FG002|Overall Study|Lost to Follow-up|1|||
126096464|NCT01302067|453646461|FG001|Overall Study|Lost to Follow-up|4|||
126096465|NCT01302067|453646462|FG002|Overall Study|Lost to Follow-up|15|||
126096466|NCT01302067|453646460|FG000|Overall Study|Withdrawal by Subject|13|||
126261872|NCT02674386|454249659|FG000|Overall Study|Withdrawal by Subject|0|||
126261873|NCT02674386|454249660|FG001|Overall Study|Withdrawal by Subject|4|||
126261874|NCT02674386|454249661|FG002|Overall Study|Withdrawal by Subject|0|||
126261875|NCT02674386|454249659|FG000|Overall Study|Other|0|||
126261876|NCT02674386|454249660|FG001|Overall Study|Other|1|||
126261877|NCT02674386|454249661|FG002|Overall Study|Other|0|||
126261878|NCT02674386|454249659|FG000|Overall Study|Enrolled but not evaluated|0|||
126261879|NCT02674386|454249660|FG001|Overall Study|Enrolled but not evaluated|4|||
126261880|NCT02674386|454249661|FG002|Overall Study|Enrolled but not evaluated|0|||
126261881|NCT01439724|454249666|FG000|Overall Study|missing consultation|9|||
126261882|NCT01439724|454249667|FG001|Overall Study|missing consultation|8|||
126261883|NCT01040793|454249672|FG000|Overall Study|Adverse Event|5|||
126261884|NCT01040793|454249673|FG001|Overall Study|Adverse Event|3|||
126096467|NCT01302067|453646461|FG001|Overall Study|Withdrawal by Subject|6|||
126096468|NCT01302067|453646462|FG002|Overall Study|Withdrawal by Subject|10|||
126096469|NCT01302067|453646460|FG000|Overall Study|Other|1|||
126096470|NCT01302067|453646461|FG001|Overall Study|Other|1|||
126096471|NCT01302067|453646462|FG002|Overall Study|Other|3|||
126096472|NCT01302067|453646460|FG000|Overall Study|Protocol Violation|11|||
126096473|NCT01302067|453646461|FG001|Overall Study|Protocol Violation|0|||
126096474|NCT01302067|453646462|FG002|Overall Study|Protocol Violation|8|||
126096475|NCT01302067|453646460|FG000|Overall Study|Adverse Event|27|||
126096476|NCT01302067|453646461|FG001|Overall Study|Adverse Event|14|||
126096477|NCT01302067|453646462|FG002|Overall Study|Adverse Event|45|||
126096478|NCT02738203|453646464|FG000|Overall Study|Failed IUD Insertion|2|||
126096479|NCT02738203|453646465|FG001|Overall Study|Failed IUD Insertion|2|||
126096480|NCT02738203|453646464|FG000|Overall Study|Protocol Violation|0|||
126096481|NCT02738203|453646465|FG001|Overall Study|Protocol Violation|1|||
126096482|NCT03241927|453646466|FG000|Overall Study|study terminated|1|||
126096483|NCT03241927|453646467|FG001|Overall Study|study terminated|0|||
126096484|NCT00423943|453646468|FG000|Overall Study|Withdrawal by Subject|3|||
126096485|NCT00423943|453646469|FG001|Overall Study|Withdrawal by Subject|1|||
126096486|NCT02383056|453646470|FG000|Overall Study|Adverse Event|1|||
126096487|NCT02383056|453646471|FG001|Overall Study|Adverse Event|0|||
126261885|NCT01040793|454249674|FG002|Overall Study|Adverse Event|0|||
126261886|NCT01040793|454249675|FG003|Overall Study|Adverse Event|2|||
126261887|NCT01040793|454249676|FG004|Overall Study|Adverse Event|2|||
126261888|NCT01040793|454249677|FG005|Overall Study|Adverse Event|1|||
126096488|NCT02383056|453646470|FG000|Overall Study|Lost to Follow-up|0|||
126096489|NCT02383056|453646471|FG001|Overall Study|Lost to Follow-up|2|||
126261889|NCT01040793|454249672|FG000|Overall Study|Protocol Violation|1|||
126261890|NCT01040793|454249673|FG001|Overall Study|Protocol Violation|1|||
126261891|NCT01040793|454249674|FG002|Overall Study|Protocol Violation|1|||
126261892|NCT01040793|454249675|FG003|Overall Study|Protocol Violation|0|||
126261893|NCT01040793|454249676|FG004|Overall Study|Protocol Violation|1|||
126261894|NCT01040793|454249677|FG005|Overall Study|Protocol Violation|0|||
126359632|NCT01122680|454609027|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
126096490|NCT03245151|453646472|FG000|Overall Study|Withdrawal by Subject|2|||
126096491|NCT03245151|453646473|FG001|Overall Study|Withdrawal by Subject|0|||
126096492|NCT03245151|453646474|FG002|Overall Study|Withdrawal by Subject|0|||
126096493|NCT03245151|453646475|FG003|Overall Study|Withdrawal by Subject|2|||
126261895|NCT01040793|454249672|FG000|Overall Study|Lost to Follow-up|0|||
126261896|NCT01040793|454249673|FG001|Overall Study|Lost to Follow-up|1|||
126261897|NCT01040793|454249674|FG002|Overall Study|Lost to Follow-up|1|||
126261898|NCT01040793|454249675|FG003|Overall Study|Lost to Follow-up|0|||
126261899|NCT01040793|454249676|FG004|Overall Study|Lost to Follow-up|0|||
126261900|NCT01040793|454249677|FG005|Overall Study|Lost to Follow-up|0|||
126261901|NCT01040793|454249672|FG000|Overall Study|Withdrawal by Subject|0|||
126261902|NCT01040793|454249673|FG001|Overall Study|Withdrawal by Subject|0|||
126261903|NCT01040793|454249674|FG002|Overall Study|Withdrawal by Subject|0|||
126261904|NCT01040793|454249675|FG003|Overall Study|Withdrawal by Subject|2|||
126261905|NCT01040793|454249676|FG004|Overall Study|Withdrawal by Subject|0|||
126261906|NCT01040793|454249677|FG005|Overall Study|Withdrawal by Subject|0|||
126261907|NCT01040793|454249672|FG000|Overall Study|Other reasons not listed above|0|||
126261908|NCT01040793|454249673|FG001|Overall Study|Other reasons not listed above|0|||
126261909|NCT01040793|454249674|FG002|Overall Study|Other reasons not listed above|1|||
126261910|NCT01040793|454249675|FG003|Overall Study|Other reasons not listed above|0|||
126261911|NCT01040793|454249676|FG004|Overall Study|Other reasons not listed above|1|||
126261912|NCT01040793|454249677|FG005|Overall Study|Other reasons not listed above|0|||
126261913|NCT00939627|454249682|FG000|Overall Study|Disease Progression|16|||
126261914|NCT00939627|454249683|FG001|Overall Study|Disease Progression|12|||
126046481|NCT02467270|453468228|FG002|Overall Study|Reason not Specified|1|||
126261915|NCT00939627|454249684|FG002|Overall Study|Disease Progression|0|||
126261916|NCT00939627|454249682|FG000|Overall Study|Adverse Event|6|||
126261917|NCT00939627|454249683|FG001|Overall Study|Adverse Event|7|||
126261918|NCT00939627|454249684|FG002|Overall Study|Adverse Event|0|||
126261919|NCT00939627|454249682|FG000|Overall Study|Death|0|||
126261920|NCT00939627|454249683|FG001|Overall Study|Death|2|||
126261921|NCT00939627|454249684|FG002|Overall Study|Death|0|||
126261922|NCT00939627|454249682|FG000|Overall Study|Withdrawal by Subject|2|||
126261923|NCT00939627|454249683|FG001|Overall Study|Withdrawal by Subject|4|||
126261924|NCT00939627|454249684|FG002|Overall Study|Withdrawal by Subject|0|||
126261925|NCT00939627|454249682|FG000|Overall Study|Other complicating disease|1|||
126261926|NCT00939627|454249683|FG001|Overall Study|Other complicating disease|1|||
126261927|NCT00939627|454249684|FG002|Overall Study|Other complicating disease|0|||
126261928|NCT00939627|454249682|FG000|Overall Study|Not compliant|2|||
126261929|NCT00939627|454249683|FG001|Overall Study|Not compliant|0|||
126261930|NCT00939627|454249684|FG002|Overall Study|Not compliant|0|||
126261931|NCT00939627|454249682|FG000|Overall Study|No off-tx reason given|0|||
126261932|NCT00939627|454249683|FG001|Overall Study|No off-tx reason given|2|||
126261933|NCT00939627|454249684|FG002|Overall Study|No off-tx reason given|0|||
126261934|NCT03297294|454249685|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
126261935|NCT03297294|454249686|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
126261936|NCT03297294|454249687|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126261937|NCT03297294|454249688|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126261938|NCT03297294|454249689|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126261939|NCT03297294|454249685|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
126261940|NCT03297294|454249686|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
126261941|NCT03297294|454249687|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126261942|NCT03297294|454249688|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126261943|NCT03297294|454249689|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126261944|NCT03297294|454249685|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
126261945|NCT03297294|454249686|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
126261946|NCT03297294|454249687|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126261947|NCT03297294|454249688|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126261948|NCT03297294|454249689|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126261949|NCT03297294|454249685|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
126261950|NCT03297294|454249686|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
126261951|NCT03297294|454249687|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126261952|NCT03297294|454249688|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126261953|NCT03297294|454249689|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126261954|NCT03297294|454249685|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
126261955|NCT03297294|454249686|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
126261956|NCT03297294|454249687|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
126261957|NCT03297294|454249688|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
126261958|NCT03297294|454249689|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
126261959|NCT02039063|454249692|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
126261960|NCT02039063|454249693|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
126261961|NCT02039063|454249694|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
126261962|NCT02039063|454249695|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
126261963|NCT02039063|454249692|FG000|Treatment Phase|Progression of disease|0|||
126261964|NCT02039063|454249693|FG001|Treatment Phase|Progression of disease|0|||
126261965|NCT02039063|454249694|FG002|Treatment Phase|Progression of disease|1|||
126261966|NCT02039063|454249695|FG003|Treatment Phase|Progression of disease|1|||
126261967|NCT02039063|454249692|FG000|Extension Phase|Inadequate therapeutic effect|0|||
126261968|NCT02039063|454249693|FG001|Extension Phase|Inadequate therapeutic effect|1|||
126261969|NCT02039063|454249694|FG002|Extension Phase|Inadequate therapeutic effect|2|||
126261970|NCT02039063|454249695|FG003|Extension Phase|Inadequate therapeutic effect|0|||
126261971|NCT02039063|454249692|FG000|Extension Phase|Progression of disease|0|||
126261972|NCT02039063|454249693|FG001|Extension Phase|Progression of disease|0|||
126261973|NCT02039063|454249694|FG002|Extension Phase|Progression of disease|0|||
126261974|NCT02039063|454249695|FG003|Extension Phase|Progression of disease|1|||
126261975|NCT02039063|454249692|FG000|Extension Phase|Adverse Event|0|||
126261976|NCT02039063|454249693|FG001|Extension Phase|Adverse Event|0|||
126261977|NCT02039063|454249694|FG002|Extension Phase|Adverse Event|1|||
126261978|NCT02039063|454249695|FG003|Extension Phase|Adverse Event|0|||
126261979|NCT01056640|454249696|FG000|Overall Study|Withdrawal by Subject|11|||
126261980|NCT01056640|454249697|FG001|Overall Study|Withdrawal by Subject|8|||
126261981|NCT01056640|454249696|FG000|Overall Study|Death|15|||
126261982|NCT01056640|454249697|FG001|Overall Study|Death|4|||
126261983|NCT02492841|454249698|FG000|Overall Study|Lost to Follow-up|34|||
126261984|NCT02492841|454249699|FG001|Overall Study|Lost to Follow-up|31|||
126261985|NCT02492841|454249700|FG002|Overall Study|Lost to Follow-up|35|||
126261986|NCT00104247|454249710|FG000|Overall Study|Withdrawal by Subject|1|||
126261987|NCT00104247|454249711|FG001|Overall Study|Withdrawal by Subject|0|||
126261988|NCT00104247|454249710|FG000|Overall Study|Noncompliant with dosing|0|||
126261989|NCT00104247|454249711|FG001|Overall Study|Noncompliant with dosing|1|||
126261990|NCT00063882|454249717|FG000|Overall Study|Protocol Violation|3|||
126261991|NCT00063882|454249718|FG001|Overall Study|Protocol Violation|3|||
126261992|NCT00063882|454249717|FG000|Overall Study|Withdrawal by Subject|2|||
126261993|NCT00063882|454249718|FG001|Overall Study|Withdrawal by Subject|1|||
126261994|NCT01930175|454249719|FG000|Core Study|Lost to Follow-up|0|||
126261995|NCT01930175|454249720|FG001|Core Study|Lost to Follow-up|1|||
126261996|NCT01930175|454249721|FG002|Core Study|Lost to Follow-up|0|||
126261997|NCT01930175|454249719|FG000|Core Study|Adverse Event|0|||
126261998|NCT01930175|454249720|FG001|Core Study|Adverse Event|0|||
126261999|NCT01930175|454249721|FG002|Core Study|Adverse Event|1|||
126262000|NCT00834899|454249722|FG000|Overall Study|Withdrawal by Subject|1|||
126262001|NCT00834899|454249723|FG001|Overall Study|Withdrawal by Subject|1|||
126262002|NCT03314662|454249724|FG000|Overall Study|Withdrawal by Subject|1|||
126262003|NCT03314662|454249725|FG001|Overall Study|Withdrawal by Subject|1|||
126262004|NCT03314662|454249726|FG002|Overall Study|Withdrawal by Subject|1|||
126262005|NCT03314662|454249724|FG000|Overall Study|Lost to Follow-up|5|||
126262006|NCT03314662|454249725|FG001|Overall Study|Lost to Follow-up|4|||
126262007|NCT03314662|454249726|FG002|Overall Study|Lost to Follow-up|4|||
126262008|NCT03314662|454249724|FG000|Overall Study|Death|2|||
126262009|NCT03314662|454249725|FG001|Overall Study|Death|0|||
126262010|NCT03314662|454249726|FG002|Overall Study|Death|0|||
126262011|NCT00925301|454249731|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
126262012|NCT00925301|454249732|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
126262013|NCT00925301|454249733|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
126262014|NCT00925301|454249734|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
126262015|NCT00925301|454249731|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
126262016|NCT00925301|454249732|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
126262017|NCT00925301|454249733|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
126262018|NCT00925301|454249734|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
126262019|NCT00925301|454249731|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
126262020|NCT00925301|454249732|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
126262021|NCT00925301|454249733|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
126262022|NCT00925301|454249734|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
126262023|NCT00925301|454249731|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
126262024|NCT00925301|454249732|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
126262025|NCT00925301|454249733|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
126262026|NCT00925301|454249734|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
126262027|NCT00925301|454249731|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
126262028|NCT00925301|454249732|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
126262029|NCT00925301|454249733|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
126262030|NCT00925301|454249734|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
126262031|NCT00925301|454249731|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
126262032|NCT00925301|454249732|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
126262033|NCT00925301|454249733|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
126262034|NCT00925301|454249734|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
126096494|NCT03245151|453646476|FG004|Overall Study|Withdrawal by Subject|1|||
126096495|NCT03245151|453646472|FG000|Overall Study|Death|3|||
126096496|NCT03245151|453646473|FG001|Overall Study|Death|14|||
126096497|NCT03245151|453646474|FG002|Overall Study|Death|9|||
126096498|NCT03245151|453646475|FG003|Overall Study|Death|16|||
126096499|NCT03245151|453646476|FG004|Overall Study|Death|7|||
126096500|NCT03245151|453646472|FG000|Overall Study|Sponsor's decision|0|||
126096501|NCT03245151|453646473|FG001|Overall Study|Sponsor's decision|1|||
126096502|NCT03245151|453646474|FG002|Overall Study|Sponsor's decision|0|||
126096503|NCT03245151|453646475|FG003|Overall Study|Sponsor's decision|0|||
126096504|NCT03245151|453646476|FG004|Overall Study|Sponsor's decision|0|||
126096505|NCT03507777|453646477|FG000|Overall Study|Lost to Follow-up|5|||
126096506|NCT03507777|453646478|FG001|Overall Study|Lost to Follow-up|7|||
126096507|NCT03507777|453646477|FG000|Overall Study|Withdrawal by Subject|6|||
126096508|NCT03507777|453646478|FG001|Overall Study|Withdrawal by Subject|11|||
126096509|NCT03507777|453646477|FG000|Overall Study|Death|30|||
126096510|NCT03507777|453646478|FG001|Overall Study|Death|44|||
126096511|NCT03507777|453646477|FG000|Overall Study|Other Reasons|3|||
126096512|NCT03507777|453646478|FG001|Overall Study|Other Reasons|8|||
126096513|NCT04772898|453646481|FG000|Overall Study|Withdrawal by Subject|0|||
126096514|NCT04772898|453646482|FG001|Overall Study|Withdrawal by Subject|1|||
126096515|NCT01327495|453646483|FG000|Overall Study|Adverse Event|2|||
126096516|NCT01327495|453646484|FG001|Overall Study|Adverse Event|1|||
126096517|NCT01327495|453646485|FG002|Overall Study|Adverse Event|1|||
126096518|NCT01327495|453646486|FG003|Overall Study|Adverse Event|0|||
126096519|NCT01327495|453646487|FG004|Overall Study|Adverse Event|0|||
126096520|NCT01327495|453646488|FG005|Overall Study|Adverse Event|2|||
126096521|NCT01327495|453646483|FG000|Overall Study|Withdrawal by Subject|0|||
126096522|NCT01327495|453646484|FG001|Overall Study|Withdrawal by Subject|1|||
126096523|NCT01327495|453646485|FG002|Overall Study|Withdrawal by Subject|1|||
126096524|NCT01327495|453646486|FG003|Overall Study|Withdrawal by Subject|0|||
126096525|NCT01327495|453646487|FG004|Overall Study|Withdrawal by Subject|1|||
126096526|NCT01327495|453646488|FG005|Overall Study|Withdrawal by Subject|0|||
126096527|NCT01327495|453646483|FG000|Overall Study|Physician Decision|0|||
126096528|NCT01327495|453646484|FG001|Overall Study|Physician Decision|0|||
126096529|NCT01327495|453646485|FG002|Overall Study|Physician Decision|0|||
126096530|NCT01327495|453646486|FG003|Overall Study|Physician Decision|0|||
126096531|NCT01327495|453646487|FG004|Overall Study|Physician Decision|2|||
126096532|NCT01327495|453646488|FG005|Overall Study|Physician Decision|0|||
126096533|NCT00006011|453646489|FG000|Overall Study|Disease progression|13|||
126096534|NCT00006011|453646490|FG001|Overall Study|Disease progression|6|||
126096535|NCT00006011|453646491|FG002|Overall Study|Disease progression|26|||
126096536|NCT00006011|453646489|FG000|Overall Study|Refused further treatment|15|||
126262035|NCT00925301|454249731|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
126262036|NCT00925301|454249732|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
126262037|NCT00925301|454249733|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
126262038|NCT00925301|454249734|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
126262039|NCT01117766|454249735|FG000|First Intervention|Adverse Event|0|||
126262040|NCT01117766|454249736|FG001|First Intervention|Adverse Event|1|||
126262041|NCT01117766|454249735|FG000|First Intervention|Protocol Violation|1|||
126096537|NCT00006011|453646490|FG001|Overall Study|Refused further treatment|13|||
126096538|NCT00006011|453646491|FG002|Overall Study|Refused further treatment|26|||
126096539|NCT00006011|453646489|FG000|Overall Study|Adverse Event|15|||
126096540|NCT00006011|453646490|FG001|Overall Study|Adverse Event|39|||
126096541|NCT00006011|453646491|FG002|Overall Study|Adverse Event|5|||
126096542|NCT00006011|453646489|FG000|Overall Study|Death|0|||
126096543|NCT00006011|453646490|FG001|Overall Study|Death|1|||
126096544|NCT00006011|453646491|FG002|Overall Study|Death|2|||
126096545|NCT00006011|453646489|FG000|Overall Study|Other|4|||
125880218|NCT04672239|452858816|FG000|Week 2 Survey|Failed survey check items|1|||
126262042|NCT01117766|454249736|FG001|First Intervention|Protocol Violation|0|||
126262043|NCT01117766|454249735|FG000|Washout Period|Protocol Violation|0|||
126262044|NCT01117766|454249736|FG001|Washout Period|Protocol Violation|2|||
126262045|NCT01117766|454249735|FG000|Second Intervention|Lost to Follow-up|1|||
126262046|NCT01117766|454249736|FG001|Second Intervention|Lost to Follow-up|0|||
126262047|NCT01117766|454249735|FG000|Second Intervention|Other|1|||
126262048|NCT01117766|454249736|FG001|Second Intervention|Other|2|||
126262049|NCT01117766|454249735|FG000|Second Intervention|Adverse Event|0|||
126262050|NCT01117766|454249736|FG001|Second Intervention|Adverse Event|2|||
126262051|NCT01117766|454249735|FG000|Second Intervention|Withdrawal by Subject|0|||
126262052|NCT01117766|454249736|FG001|Second Intervention|Withdrawal by Subject|1|||
126262053|NCT01117987|454249737|FG000|Overall Study|Protocol deviation|0|||
126262054|NCT01117987|454249738|FG001|Overall Study|Protocol deviation|1|||
126262055|NCT01117987|454249737|FG000|Overall Study|Subject no longer requires study drug|1|||
126262056|NCT01117987|454249738|FG001|Overall Study|Subject no longer requires study drug|0|||
126262057|NCT01117987|454249737|FG000|Overall Study|Lost to Follow-up|1|||
126262058|NCT01117987|454249738|FG001|Overall Study|Lost to Follow-up|1|||
126262059|NCT01117987|454249737|FG000|Overall Study|Abnormal test procedure result|2|||
126262060|NCT01117987|454249738|FG001|Overall Study|Abnormal test procedure result|0|||
126262061|NCT01117987|454249737|FG000|Overall Study|Lack of Efficacy|3|||
126262062|NCT01117987|454249738|FG001|Overall Study|Lack of Efficacy|4|||
126262063|NCT01117987|454249737|FG000|Overall Study|Death|5|||
126262064|NCT01117987|454249738|FG001|Overall Study|Death|10|||
126262065|NCT01117987|454249737|FG000|Overall Study|Withdrawal by Subject|5|||
126262066|NCT01117987|454249738|FG001|Overall Study|Withdrawal by Subject|10|||
126262067|NCT01117987|454249737|FG000|Overall Study|Adverse Event|19|||
126262068|NCT01117987|454249738|FG001|Overall Study|Adverse Event|26|||
126262069|NCT01117987|454249737|FG000|Overall Study|Administrative problems|25|||
126262070|NCT01117987|454249738|FG001|Overall Study|Administrative problems|22|||
126262071|NCT02244424|454249739|FG000|Overall Study|Lost to Follow-up|20|||
126262072|NCT02244424|454249740|FG001|Overall Study|Lost to Follow-up|10|||
126262073|NCT04232540|454249741|FG000|Overall Study|Lost to Follow-up|1|||
126262074|NCT04232540|454249742|FG001|Overall Study|Lost to Follow-up|0|||
126262075|NCT03064438|454251147|FG000|Overall Study|Lost to Follow-up|1|||
126262076|NCT03064438|454251148|FG001|Overall Study|Lost to Follow-up|0|||
126262077|NCT03064438|454251147|FG000|Overall Study|Withdrawal by Subject|0|||
126262078|NCT03064438|454251148|FG001|Overall Study|Withdrawal by Subject|1|||
126262079|NCT01684215|454251152|FG000|Phase 1, Part 1|Adverse Event|1|||
126262080|NCT01684215|454251153|FG001|Phase 1, Part 1|Adverse Event|0|||
126262081|NCT01684215|454251154|FG002|Phase 1, Part 1|Adverse Event|0|||
126262082|NCT01684215|454251155|FG003|Phase 1, Part 1|Adverse Event|0|||
126262083|NCT01684215|454251152|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
126262084|NCT01684215|454251153|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
126262085|NCT01684215|454251154|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
126262086|NCT01684215|454251155|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
126262087|NCT01684215|454251152|FG000|Phase 1, Part 2|Adverse Event|0|||
126262088|NCT01684215|454251153|FG001|Phase 1, Part 2|Adverse Event|0|||
126262089|NCT01684215|454251154|FG002|Phase 1, Part 2|Adverse Event|1|||
126262090|NCT01684215|454251155|FG003|Phase 1, Part 2|Adverse Event|0|||
126262091|NCT01684215|454251152|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
126262092|NCT01684215|454251153|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
126262093|NCT01684215|454251154|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
126046482|NCT00495677|453468230|FG000|Stage 1 (25 Days)|Adverse Event|0|||
126262094|NCT01684215|454251155|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
125880219|NCT04672239|452858817|FG001|Week 2 Survey|Failed survey check items|2|||
126262095|NCT01684215|454251152|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
126262096|NCT01684215|454251153|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
126262097|NCT01684215|454251154|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
126262098|NCT01684215|454251155|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
126262099|NCT01684215|454251152|FG000|Phase 2|Death|0|||
126262100|NCT01684215|454251153|FG001|Phase 2|Death|0|||
126262101|NCT01684215|454251154|FG002|Phase 2|Death|0|||
126262102|NCT01684215|454251155|FG003|Phase 2|Death|8|||
126262103|NCT01684215|454251152|FG000|Phase 2|Study terminated by sponsor|0|||
126262104|NCT01684215|454251153|FG001|Phase 2|Study terminated by sponsor|0|||
126262105|NCT01684215|454251154|FG002|Phase 2|Study terminated by sponsor|0|||
126262106|NCT01684215|454251155|FG003|Phase 2|Study terminated by sponsor|30|||
126262107|NCT01684215|454251152|FG000|Phase 2|Enrolled but not treated|0|||
126262108|NCT01684215|454251153|FG001|Phase 2|Enrolled but not treated|0|||
126262109|NCT01684215|454251154|FG002|Phase 2|Enrolled but not treated|0|||
126262110|NCT01684215|454251155|FG003|Phase 2|Enrolled but not treated|1|||
126262111|NCT01684215|454251152|FG000|Phase 2|Lost to Follow-up|0|||
126262112|NCT01684215|454251153|FG001|Phase 2|Lost to Follow-up|0|||
126262113|NCT01684215|454251154|FG002|Phase 2|Lost to Follow-up|0|||
126262114|NCT01684215|454251155|FG003|Phase 2|Lost to Follow-up|4|||
126262115|NCT01301482|454251156|FG000|Overall Study|Withdrawal by Subject|1|||
126262116|NCT00480324|454251159|FG000|Overall Study|Adverse Event|1|||
126359633|NCT01122680|454609028|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
126031662|NCT02962895|453412360|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126031663|NCT02962895|453412361|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126031664|NCT02962895|453412362|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126031665|NCT02962895|453412363|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126031666|NCT02962895|453412364|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126031667|NCT02962895|453412358|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126031668|NCT02962895|453412359|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
126031669|NCT02962895|453412360|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
126031670|NCT02962895|453412361|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126031671|NCT02962895|453412362|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126031672|NCT02962895|453412363|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126031673|NCT02962895|453412364|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126031674|NCT02962895|453412358|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
126031675|NCT02962895|453412359|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126031676|NCT02962895|453412360|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126031677|NCT02962895|453412361|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126031678|NCT02962895|453412362|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126031679|NCT02962895|453412363|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126031680|NCT02962895|453412364|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126031681|NCT02962895|453412358|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126031682|NCT02962895|453412359|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
126031683|NCT02962895|453412360|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126031684|NCT02962895|453412361|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126031685|NCT02962895|453412362|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126031686|NCT02962895|453412363|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126031687|NCT02962895|453412364|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126031688|NCT02962895|453412358|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126031689|NCT02962895|453412359|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126031690|NCT02962895|453412360|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126031691|NCT02962895|453412361|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
126031692|NCT02962895|453412362|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126031693|NCT02962895|453412363|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126031694|NCT02962895|453412364|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126031695|NCT02962895|453412358|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126031696|NCT02962895|453412359|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126031697|NCT02962895|453412360|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126031698|NCT02962895|453412361|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126031699|NCT02962895|453412362|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126031700|NCT02962895|453412363|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126031701|NCT02962895|453412364|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
126031702|NCT02962895|453412358|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126031703|NCT02962895|453412359|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126031704|NCT02962895|453412360|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126031705|NCT02962895|453412361|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126031706|NCT02962895|453412362|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
126031707|NCT02962895|453412363|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126031708|NCT02962895|453412364|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
126031709|NCT02962895|453412358|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126031710|NCT02962895|453412359|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126031711|NCT02962895|453412360|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126031712|NCT02962895|453412361|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126031713|NCT02962895|453412362|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126031714|NCT02962895|453412363|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126031715|NCT02962895|453412364|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
126031716|NCT02962895|453412358|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126031717|NCT02962895|453412359|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
126031718|NCT02962895|453412360|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126031719|NCT02962895|453412361|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126031720|NCT02962895|453412362|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126359634|NCT01122680|454609029|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
126359635|NCT01122680|454609030|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
126359636|NCT01122680|454609027|FG000|Period 1 (4 Weeks)|Other|1|||
126359637|NCT01122680|454609028|FG001|Period 1 (4 Weeks)|Other|1|||
126359638|NCT01122680|454609029|FG002|Period 1 (4 Weeks)|Other|0|||
126359639|NCT01122680|454609030|FG003|Period 1 (4 Weeks)|Other|0|||
126359640|NCT01122680|454609027|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
126359641|NCT01122680|454609028|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
126359642|NCT01122680|454609029|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
126359643|NCT01122680|454609030|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
126359644|NCT01122680|454609027|FG000|Period 2 (4 Weeks)|Other|1|||
126359645|NCT01122680|454609028|FG001|Period 2 (4 Weeks)|Other|0|||
126359646|NCT01122680|454609029|FG002|Period 2 (4 Weeks)|Other|0|||
126262117|NCT00480324|454251160|FG001|Overall Study|Adverse Event|1|||
126262118|NCT00480324|454251159|FG000|Overall Study|Protocol Violation|0|||
126262119|NCT00480324|454251160|FG001|Overall Study|Protocol Violation|1|||
126262120|NCT00480324|454251159|FG000|Overall Study|Withdrawal by Subject|14|||
126262121|NCT00480324|454251160|FG001|Overall Study|Withdrawal by Subject|5|||
126262122|NCT00480324|454251159|FG000|Overall Study|Lost to Follow-up|17|||
126262123|NCT00480324|454251160|FG001|Overall Study|Lost to Follow-up|8|||
126262124|NCT00480324|454251159|FG000|Overall Study|Subject's mother pregnant|0|||
126262125|NCT00480324|454251160|FG001|Overall Study|Subject's mother pregnant|1|||
126262126|NCT01552369|454251161|FG000|Overall Study|Did not consent to extended follow up|8|||
126262127|NCT01552369|454251162|FG001|Overall Study|Did not consent to extended follow up|9|||
126262128|NCT00977548|454251164|FG000|Overall Study|Ineligible|4|||
126262129|NCT00977548|454251164|FG000|Overall Study|Adverse Event|8|||
126262130|NCT00977548|454251164|FG000|Overall Study|Withdrawal by Subject|1|||
126262131|NCT04086641|454251166|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
126262132|NCT04086641|454251167|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
126262133|NCT03438539|454251175|FG000|Overall Study|Lost to Follow-up|8|||
126262134|NCT03438539|454251176|FG001|Overall Study|Lost to Follow-up|4|||
126262135|NCT03438539|454251177|FG002|Overall Study|Lost to Follow-up|10|||
126262136|NCT03438539|454251178|FG003|Overall Study|Lost to Follow-up|9|||
126262137|NCT03438539|454251179|FG004|Overall Study|Lost to Follow-up|3|||
126262138|NCT03438539|454251180|FG005|Overall Study|Lost to Follow-up|8|||
126262139|NCT04213209|454251181|FG000|Overall Study|Protocol Violation|1|||
126262140|NCT04213209|454251182|FG001|Overall Study|Protocol Violation|0|||
126262141|NCT04213209|454251183|FG002|Overall Study|Protocol Violation|0|||
126262142|NCT04213209|454251184|FG003|Overall Study|Protocol Violation|0|||
126262143|NCT04213209|454251185|FG004|Overall Study|Protocol Violation|0|||
126262144|NCT04213209|454251186|FG005|Overall Study|Protocol Violation|0|||
126262145|NCT02065713|454251191|FG000|Overall Study|Adverse Event|0|||
126262146|NCT02065713|454251192|FG001|Overall Study|Adverse Event|1|||
126262147|NCT02065713|454251191|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126262148|NCT02065713|454251192|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126262149|NCT00126126|454251195|FG000|Overall Study|Lost to Follow-up|0|||
126262150|NCT00126126|454251196|FG001|Overall Study|Lost to Follow-up|2|||
126262151|NCT02459665|454251197|FG000|Overall Study|Withdrawal by Subject|0|||
126262152|NCT02459665|454251198|FG001|Overall Study|Withdrawal by Subject|1|||
126262153|NCT02459665|454251199|FG002|Overall Study|Withdrawal by Subject|1|||
126262154|NCT02459665|454251200|FG003|Overall Study|Withdrawal by Subject|2|||
126262155|NCT00868296|454251201|FG000|Overall Study|Adverse Event|0|||
126262156|NCT00868296|454251202|FG001|Overall Study|Adverse Event|2|||
126262157|NCT00868296|454251201|FG000|Overall Study|Withdrawal by Subject|0|||
126262158|NCT00868296|454251202|FG001|Overall Study|Withdrawal by Subject|1|||
126262159|NCT00986570|454251207|FG000|Overall Study|Lost to Follow-up|6|||
126262160|NCT00986570|454251207|FG000|Overall Study|Potential bias for objective assessment|1|||
126262161|NCT00804141|454251208|FG000|Overall Study|Adverse Event|157|||
126262162|NCT00804141|454251208|FG000|Overall Study|Death|4|||
126359647|NCT01122680|454609030|FG003|Period 2 (4 Weeks)|Other|0|||
126359648|NCT01122680|454609027|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
126359649|NCT01122680|454609028|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
126031721|NCT02962895|453412363|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126262163|NCT00804141|454251208|FG000|Overall Study|Failed to return|96|||
126262164|NCT00804141|454251208|FG000|Overall Study|Investigator request|8|||
126262165|NCT00804141|454251208|FG000|Overall Study|Protocol Violation|85|||
126262166|NCT00804141|454251208|FG000|Overall Study|Withdrawal by Subject|131|||
126262167|NCT00804141|454251208|FG000|Overall Study|Lack of Efficacy|46|||
126262168|NCT00804141|454251208|FG000|Overall Study|Other than specified|30|||
126262169|NCT00804141|454251208|FG000|Overall Study|Enrolled but not treated|6|||
126359650|NCT01122680|454609029|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
126359651|NCT01122680|454609030|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
126262170|NCT01501110|454251209|FG000|Overall Study|Death|0|||
126359652|NCT01122680|454609027|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126359653|NCT01122680|454609028|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
126262171|NCT01501110|454251210|FG001|Overall Study|Death|1|||
126262172|NCT02075606|454251211|FG000|Overall Study|Adverse Event|5|||
126262173|NCT02075606|454251211|FG000|Overall Study|Withdrawal by Subject|1|||
126262174|NCT02075606|454251211|FG000|Overall Study|Death|1|||
126262175|NCT02075606|454251211|FG000|Overall Study|Investigator's decision|1|||
126262176|NCT02075606|454251211|FG000|Overall Study|Symptom management|1|||
126359654|NCT01122680|454609029|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126262177|NCT02075606|454251211|FG000|Overall Study|Increasing Symptoms|1|||
126262178|NCT02462486|454251212|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
126262179|NCT02462486|454251213|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
126262180|NCT02462486|454251214|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
126262181|NCT02462486|454251212|FG000|Overall Study|Adverse Event|53|||
126262182|NCT02462486|454251213|FG001|Overall Study|Adverse Event|48|||
126262183|NCT02462486|454251214|FG002|Overall Study|Adverse Event|21|||
126262184|NCT02462486|454251212|FG000|Overall Study|Lack of Efficacy|6|||
126262185|NCT02462486|454251213|FG001|Overall Study|Lack of Efficacy|12|||
126262186|NCT02462486|454251214|FG002|Overall Study|Lack of Efficacy|3|||
126262187|NCT02462486|454251212|FG000|Overall Study|Lost to Follow-up|3|||
126262188|NCT02462486|454251213|FG001|Overall Study|Lost to Follow-up|4|||
126262189|NCT02462486|454251214|FG002|Overall Study|Lost to Follow-up|2|||
126262190|NCT02462486|454251212|FG000|Overall Study|Withdrawal by Subject|25|||
126262191|NCT02462486|454251213|FG001|Overall Study|Withdrawal by Subject|22|||
126262192|NCT02462486|454251214|FG002|Overall Study|Withdrawal by Subject|19|||
126262193|NCT02462486|454251212|FG000|Overall Study|Protocol Violation|3|||
126262194|NCT02462486|454251213|FG001|Overall Study|Protocol Violation|1|||
126262195|NCT02462486|454251214|FG002|Overall Study|Protocol Violation|1|||
126262196|NCT02462486|454251212|FG000|Overall Study|Reason not Specified|3|||
126262197|NCT02462486|454251213|FG001|Overall Study|Reason not Specified|4|||
126262198|NCT02462486|454251214|FG002|Overall Study|Reason not Specified|3|||
126262199|NCT02310763|454251215|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
126262200|NCT02310763|454251216|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
126262201|NCT02310763|454251217|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
126359655|NCT01122680|454609030|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126359656|NCT01550965|454609031|FG000|Overall Study|Adverse Event|26|||
126359657|NCT01550965|454609031|FG000|Overall Study|Withdrawal by Subject|10|||
126359658|NCT01550965|454609031|FG000|Overall Study|Lost to Follow-up|2|||
126359659|NCT01550965|454609031|FG000|Overall Study|Lack of Efficacy|59|||
126359660|NCT01550965|454609031|FG000|Overall Study|Other|13|||
126359661|NCT03016403|454609034|FG000|Baseline|Death|5|||
126359662|NCT03016403|454609035|FG001|Baseline|Death|8|||
126359663|NCT03016403|454609036|FG002|Baseline|Death|1|||
126359664|NCT03016403|454609037|FG003|Baseline|Death|0|||
126359665|NCT03016403|454609034|FG000|Baseline|Withdrawal by Subject|2|||
126359666|NCT03016403|454609035|FG001|Baseline|Withdrawal by Subject|8|||
126359667|NCT03016403|454609036|FG002|Baseline|Withdrawal by Subject|4|||
126359668|NCT03016403|454609037|FG003|Baseline|Withdrawal by Subject|10|||
126359669|NCT03016403|454609034|FG000|Baseline|Lost to Follow-up|9|||
126359670|NCT03016403|454609035|FG001|Baseline|Lost to Follow-up|11|||
126359671|NCT03016403|454609036|FG002|Baseline|Lost to Follow-up|6|||
126359672|NCT03016403|454609037|FG003|Baseline|Lost to Follow-up|24|||
126359673|NCT03016403|454609034|FG000|6-week Follow-up|Death|1|||
126359674|NCT03016403|454609035|FG001|6-week Follow-up|Death|4|||
126359675|NCT03016403|454609036|FG002|6-week Follow-up|Death|0|||
126359676|NCT03016403|454609037|FG003|6-week Follow-up|Death|0|||
126359677|NCT03016403|454609034|FG000|6-week Follow-up|Lost to Follow-up|2|||
126359678|NCT03016403|454609035|FG001|6-week Follow-up|Lost to Follow-up|7|||
126359679|NCT03016403|454609036|FG002|6-week Follow-up|Lost to Follow-up|4|||
126359680|NCT03016403|454609037|FG003|6-week Follow-up|Lost to Follow-up|8|||
126359681|NCT03016403|454609034|FG000|6-week Follow-up|Withdrawal by Subject|0|||
126359682|NCT03016403|454609035|FG001|6-week Follow-up|Withdrawal by Subject|2|||
126359683|NCT03016403|454609036|FG002|6-week Follow-up|Withdrawal by Subject|0|||
126359684|NCT03016403|454609037|FG003|6-week Follow-up|Withdrawal by Subject|1|||
126359685|NCT03016403|454609034|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
126359686|NCT03016403|454609035|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
126359687|NCT03016403|454609036|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
126359688|NCT03016403|454609037|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
126262202|NCT02310763|454251215|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
126359689|NCT03016403|454609034|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
126359690|NCT03016403|454609035|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
126359691|NCT03016403|454609036|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
126359692|NCT03016403|454609037|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
126359693|NCT03016403|454609034|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
126031722|NCT02962895|453412364|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126031723|NCT02962895|453412358|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126031724|NCT02962895|453412359|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126031725|NCT02962895|453412360|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126031726|NCT02962895|453412361|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126031727|NCT02962895|453412362|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
126031728|NCT02962895|453412363|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126262203|NCT02310763|454251216|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
126262204|NCT02310763|454251217|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
126262205|NCT02310763|454251215|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
126262206|NCT02310763|454251216|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
126262207|NCT02310763|454251217|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
126262208|NCT02310763|454251215|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
126262209|NCT02310763|454251216|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
126262210|NCT02310763|454251217|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
126262211|NCT02310763|454251215|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
126262212|NCT02310763|454251216|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
126262213|NCT02310763|454251217|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
126262214|NCT03877926|454251222|FG000|Overall Study|Adverse Event|1|||
126262215|NCT03877926|454251223|FG001|Overall Study|Adverse Event|0|||
126262216|NCT03877926|454251224|FG002|Overall Study|Adverse Event|0|||
126262217|NCT03877926|454251225|FG003|Overall Study|Adverse Event|0|||
126262218|NCT03877926|454251222|FG000|Overall Study|Death|2|||
126262219|NCT03877926|454251223|FG001|Overall Study|Death|2|||
126262220|NCT03877926|454251224|FG002|Overall Study|Death|2|||
126262221|NCT03877926|454251225|FG003|Overall Study|Death|0|||
126262222|NCT03877926|454251222|FG000|Overall Study|Lost to Follow-up|41|||
126262223|NCT03877926|454251223|FG001|Overall Study|Lost to Follow-up|52|||
126262224|NCT03877926|454251224|FG002|Overall Study|Lost to Follow-up|45|||
126262225|NCT03877926|454251225|FG003|Overall Study|Lost to Follow-up|17|||
126262226|NCT03877926|454251222|FG000|Overall Study|Physician Decision|2|||
126262227|NCT03877926|454251223|FG001|Overall Study|Physician Decision|0|||
126262228|NCT03877926|454251224|FG002|Overall Study|Physician Decision|2|||
126262229|NCT03877926|454251225|FG003|Overall Study|Physician Decision|0|||
126262230|NCT03877926|454251222|FG000|Overall Study|Withdrawal by Subject|18|||
126262231|NCT03877926|454251223|FG001|Overall Study|Withdrawal by Subject|21|||
126262232|NCT03877926|454251224|FG002|Overall Study|Withdrawal by Subject|12|||
126262233|NCT03877926|454251225|FG003|Overall Study|Withdrawal by Subject|4|||
126262234|NCT03877926|454251222|FG000|Overall Study|Other - Various|4|||
126262235|NCT03877926|454251223|FG001|Overall Study|Other - Various|1|||
126262236|NCT03877926|454251224|FG002|Overall Study|Other - Various|1|||
126262237|NCT03877926|454251225|FG003|Overall Study|Other - Various|0|||
126031729|NCT02962895|453412364|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126031730|NCT02962895|453412358|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126031731|NCT02962895|453412359|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126031732|NCT02962895|453412360|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126031733|NCT02962895|453412361|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126031734|NCT02962895|453412362|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
126031735|NCT02962895|453412363|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126031736|NCT02962895|453412364|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126031737|NCT02962895|453412358|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
126031738|NCT02962895|453412359|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
126031739|NCT02962895|453412360|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
126031740|NCT02962895|453412361|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
126031741|NCT02962895|453412362|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
126031742|NCT02962895|453412363|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
126031743|NCT02962895|453412364|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
126031744|NCT02962895|453412358|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
126031745|NCT02962895|453412359|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
126031746|NCT02962895|453412360|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
126031747|NCT02962895|453412361|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
126031748|NCT02962895|453412362|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
126031749|NCT02962895|453412363|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
126262238|NCT03877926|454251222|FG000|Overall Study|Not Treated|3|||
126262239|NCT03877926|454251223|FG001|Overall Study|Not Treated|1|||
126262240|NCT03877926|454251224|FG002|Overall Study|Not Treated|1|||
126262241|NCT03877926|454251225|FG003|Overall Study|Not Treated|0|||
126262242|NCT03554317|454251227|FG000|Overall Study|Withdrawal by Subject|1|||
126262243|NCT03554317|454251227|FG000|Overall Study|PSA Progression|3|||
126262244|NCT03554317|454251227|FG000|Overall Study|Radiographic Progression|4|||
126262245|NCT00124462|454251230|FG000|Overall Study|Lost to Follow-up|3|||
126262246|NCT00124462|454251231|FG001|Overall Study|Lost to Follow-up|3|||
126262247|NCT00124462|454251230|FG000|Overall Study|Physician Decision|3|||
126262248|NCT00124462|454251231|FG001|Overall Study|Physician Decision|4|||
126262249|NCT00124462|454251230|FG000|Overall Study|Withdrawal by Subject|4|||
126262250|NCT00124462|454251231|FG001|Overall Study|Withdrawal by Subject|5|||
126262251|NCT00124462|454251230|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
126262252|NCT00124462|454251231|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
126262253|NCT00537199|454251232|FG000|Overall Study|Study Terminated|1|||
126262254|NCT02776553|454251237|FG000|Overall Study|Lost to Follow-up|1|||
126262255|NCT02776553|454251238|FG001|Overall Study|Lost to Follow-up|0|||
126262256|NCT02776553|454251237|FG000|Overall Study|got liver transplant|1|||
126262257|NCT02776553|454251238|FG001|Overall Study|got liver transplant|2|||
126262258|NCT02776553|454251237|FG000|Overall Study|had other surgery|1|||
126262259|NCT02776553|454251238|FG001|Overall Study|had other surgery|0|||
126262260|NCT02776553|454251237|FG000|Overall Study|Protocol Violation|0|||
126262261|NCT02776553|454251238|FG001|Overall Study|Protocol Violation|1|||
126262262|NCT00941720|454251240|FG000|Overall Study|Withdrawal by Subject|1|||
126262263|NCT00941720|454251240|FG000|Overall Study|Insurance denied participation|11|||
126262264|NCT00941720|454251240|FG000|Overall Study|ineligible|2|||
126262265|NCT01682148|454251241|FG000|Overall Study|Withdrawal by Subject|2|||
126262266|NCT01682148|454251242|FG001|Overall Study|Withdrawal by Subject|0|||
126262267|NCT01682148|454251241|FG000|Overall Study|Lost to Follow-up|1|||
126262268|NCT01682148|454251242|FG001|Overall Study|Lost to Follow-up|2|||
126262269|NCT01682148|454251241|FG000|Overall Study|Protocol Violation|1|||
126262270|NCT01682148|454251242|FG001|Overall Study|Protocol Violation|1|||
126262271|NCT02087176|454251246|FG000|Overall Study|Withdrawal by Subject|1|||
126262272|NCT02087176|454251246|FG000|Overall Study|Death|10|||
126262273|NCT02087176|454251246|FG000|Overall Study|Censored|19|||
126262274|NCT02087176|454251246|FG000|Overall Study|Study Terminated by Sponsor|2|||
126262275|NCT03648879|454251247|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
126262276|NCT03812991|454251250|FG000|Overall Study|Lost to Follow-up|3|||
126262277|NCT03812991|454251251|FG001|Overall Study|Lost to Follow-up|1|||
126262278|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
126262279|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
126262280|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
126262281|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
126262282|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
126262283|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
126262284|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
126262285|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
126262286|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
126262287|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
126262288|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
126262289|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
126262290|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
126262291|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
126262292|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
126262293|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
126262294|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
126262295|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
126262296|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
126262297|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
126262298|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
126262299|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
126262300|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
126262301|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
126262302|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
126262303|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
126262304|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
126262305|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
126262306|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
126031750|NCT02962895|453412364|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
126031751|NCT04177823|453413937|FG000|Overall Study|Physician Decision|1|||
126031752|NCT04177823|453413937|FG000|Overall Study|Withdrawal by Subject|1|||
126031753|NCT05178316|453413938|FG000|Overall Study|Adverse Event|5|||
126031754|NCT05178316|453413939|FG001|Overall Study|Adverse Event|4|||
126031755|NCT05178316|453413940|FG002|Overall Study|Adverse Event|9|||
126031756|NCT05178316|453413938|FG000|Overall Study|Enrolled in Error|1|||
126031757|NCT05178316|453413939|FG001|Overall Study|Enrolled in Error|2|||
126031758|NCT05178316|453413940|FG002|Overall Study|Enrolled in Error|1|||
126031759|NCT05178316|453413938|FG000|Overall Study|Lost to Follow-up|3|||
126031760|NCT05178316|453413939|FG001|Overall Study|Lost to Follow-up|15|||
126031761|NCT05178316|453413940|FG002|Overall Study|Lost to Follow-up|11|||
126031762|NCT05178316|453413938|FG000|Overall Study|Noncompliance|1|||
126031763|NCT05178316|453413939|FG001|Overall Study|Noncompliance|3|||
126031764|NCT05178316|453413940|FG002|Overall Study|Noncompliance|1|||
126031765|NCT05178316|453413938|FG000|Overall Study|Other|0|||
126031766|NCT05178316|453413939|FG001|Overall Study|Other|1|||
126031767|NCT05178316|453413940|FG002|Overall Study|Other|0|||
126031768|NCT05178316|453413938|FG000|Overall Study|Physician Decision|0|||
126031769|NCT05178316|453413939|FG001|Overall Study|Physician Decision|3|||
126031770|NCT05178316|453413940|FG002|Overall Study|Physician Decision|2|||
126031771|NCT05178316|453413938|FG000|Overall Study|Protocol deviation|1|||
126031772|NCT05178316|453413939|FG001|Overall Study|Protocol deviation|0|||
126031773|NCT05178316|453413940|FG002|Overall Study|Protocol deviation|1|||
126031774|NCT05178316|453413938|FG000|Overall Study|Sponsor decision|1|||
126031775|NCT05178316|453413939|FG001|Overall Study|Sponsor decision|0|||
126031776|NCT05178316|453413940|FG002|Overall Study|Sponsor decision|1|||
126031777|NCT05178316|453413938|FG000|Overall Study|Withdrawal by Subject|5|||
126031778|NCT05178316|453413939|FG001|Overall Study|Withdrawal by Subject|11|||
126031779|NCT05178316|453413940|FG002|Overall Study|Withdrawal by Subject|5|||
126031780|NCT03457142|453413943|FG000|Overall Study|Death|1|||
126031781|NCT04760678|453413944|FG000|Overall Study|Death|13|||
126031782|NCT04760678|453413944|FG000|Overall Study|Lost to Follow-up|48|||
126031783|NCT04760678|453413944|FG000|Overall Study|Withdrawal by Subject|1|||
126031784|NCT03338933|453413949|FG000|Screening Visit|Lost to Follow-up|1|||
126031785|NCT03338933|453413950|FG001|Screening Visit|Lost to Follow-up|3|||
126031786|NCT03338933|453413951|FG002|Screening Visit|Lost to Follow-up|1|||
126031787|NCT03338933|453413952|FG003|Screening Visit|Lost to Follow-up|4|||
126031788|NCT03338933|453413949|FG000|Screening Visit|Screen fail after consent|2|||
126031789|NCT03338933|453413950|FG001|Screening Visit|Screen fail after consent|7|||
126031790|NCT03338933|453413951|FG002|Screening Visit|Screen fail after consent|1|||
126031791|NCT03338933|453413952|FG003|Screening Visit|Screen fail after consent|4|||
126031792|NCT03338933|453413949|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
126031793|NCT03338933|453413950|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
126031794|NCT03338933|453413951|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
126031795|NCT03338933|453413952|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
126031796|NCT03338933|453413949|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
126031797|NCT03338933|453413950|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
126031798|NCT03338933|453413951|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
126031799|NCT03338933|453413952|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
126031800|NCT03338933|453413949|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
126031801|NCT03338933|453413950|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
126031802|NCT03338933|453413951|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
126031803|NCT03338933|453413952|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
126031804|NCT02924272|453413956|FG000|Overall Study|Site Terminated by Sponsor|4|||
126031805|NCT02924272|453413957|FG001|Overall Study|Site Terminated by Sponsor|1|||
126031806|NCT02924272|453413956|FG000|Overall Study|Withdrawal by Subject|2|||
126031807|NCT02924272|453413957|FG001|Overall Study|Withdrawal by Subject|0|||
126031808|NCT02924272|453413956|FG000|Overall Study|Adverse Event|3|||
126031809|NCT02924272|453413957|FG001|Overall Study|Adverse Event|0|||
126031810|NCT02924272|453413956|FG000|Overall Study|Progressive Disease|11|||
126031811|NCT02924272|453413957|FG001|Overall Study|Progressive Disease|8|||
126031812|NCT02924272|453413956|FG000|Overall Study|Clinical Deterioration|1|||
126031813|NCT02924272|453413957|FG001|Overall Study|Clinical Deterioration|0|||
126359694|NCT03016403|454609035|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
126359695|NCT03016403|454609036|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
126359696|NCT03016403|454609037|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
126359697|NCT00225758|454609038|FG000|Overall Study|Adverse Event|4|||
126359698|NCT00564070|454609039|FG000|Overall Study|Lost to Follow-up|9|||
126359699|NCT00564070|454609040|FG001|Overall Study|Lost to Follow-up|7|||
126031814|NCT02924272|453413956|FG000|Overall Study|Death|1|||
126031815|NCT02924272|453413957|FG001|Overall Study|Death|0|||
126046483|NCT00495677|453468231|FG001|Stage 1 (25 Days)|Adverse Event|0|||
125880220|NCT04672239|452858818|FG002|Week 2 Survey|Failed survey check items|3|||
125880221|NCT04672239|452858816|FG000|Week 2 Survey|Partially completed survey|7|||
125880222|NCT04672239|452858817|FG001|Week 2 Survey|Partially completed survey|1|||
125880223|NCT04672239|452858818|FG002|Week 2 Survey|Partially completed survey|4|||
125880224|NCT04672239|452858816|FG000|Week 2 Survey|Withdrawal by Subject|0|||
125880225|NCT04672239|452858817|FG001|Week 2 Survey|Withdrawal by Subject|1|||
125880226|NCT04672239|452858818|FG002|Week 2 Survey|Withdrawal by Subject|0|||
125880227|NCT04672239|452858816|FG000|Week 2 Survey|Lost to Follow-up|3|||
125880228|NCT04672239|452858817|FG001|Week 2 Survey|Lost to Follow-up|2|||
125880229|NCT04672239|452858818|FG002|Week 2 Survey|Lost to Follow-up|5|||
125880230|NCT04672239|452858816|FG000|Week 6 Survey|Failed survey check items|2|||
125880231|NCT04672239|452858817|FG001|Week 6 Survey|Failed survey check items|2|||
125880232|NCT04672239|452858818|FG002|Week 6 Survey|Failed survey check items|2|||
125880233|NCT04672239|452858816|FG000|Week 6 Survey|Partially completed survey|3|||
125880234|NCT04672239|452858817|FG001|Week 6 Survey|Partially completed survey|3|||
125880235|NCT04672239|452858818|FG002|Week 6 Survey|Partially completed survey|2|||
125880236|NCT04672239|452858816|FG000|Week 6 Survey|Withdrawal by Subject|1|||
126262307|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
126262308|NCT00895037|454251254|FG000|Overall Study|Death|0|||
126262309|NCT00895037|454251255|FG001|Overall Study|Death|2|||
126262310|NCT00895037|454251256|FG002|Overall Study|Death|1|||
126262311|NCT01029392|454251259|FG000|Overall Study|Withdrawal by Subject|18|||
126262312|NCT01029392|454251260|FG001|Overall Study|Withdrawal by Subject|11|||
126262313|NCT01029392|454251259|FG000|Overall Study|Physician Decision|2|||
126262314|NCT01029392|454251260|FG001|Overall Study|Physician Decision|0|||
126262315|NCT01103479|454251261|FG000|Overall Study|Up to date with CRC screening|1|||
126262316|NCT01103479|454251262|FG001|Overall Study|Up to date with CRC screening|9|||
126262317|NCT01103479|454251263|FG002|Overall Study|Up to date with CRC screening|12|||
126262318|NCT01103479|454251261|FG000|Overall Study|Family history of CRC|1|||
126262319|NCT01103479|454251262|FG001|Overall Study|Family history of CRC|0|||
126262320|NCT01103479|454251263|FG002|Overall Study|Family history of CRC|2|||
126262321|NCT01103479|454251261|FG000|Overall Study|Active cancer|1|||
126262322|NCT01103479|454251262|FG001|Overall Study|Active cancer|0|||
126262323|NCT01103479|454251263|FG002|Overall Study|Active cancer|0|||
126262324|NCT01103479|454251261|FG000|Overall Study|Saw non-study physician|2|||
126262325|NCT01103479|454251262|FG001|Overall Study|Saw non-study physician|0|||
126262326|NCT01103479|454251263|FG002|Overall Study|Saw non-study physician|0|||
126262327|NCT00605917|454251264|FG000|Overall Study|Protocol Violation|79|||
126262328|NCT00890552|454251265|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
126262329|NCT00890552|454251265|FG000|On-treatment|Early prog disease/ death|10|||
126262330|NCT00724373|454251268|FG000|Overall Study|Adverse Event|41|||
126262331|NCT00724373|454251268|FG000|Overall Study|Lack of Efficacy|82|||
126262332|NCT00724373|454251268|FG000|Overall Study|Lost to Follow-up|7|||
126262333|NCT00724373|454251268|FG000|Overall Study|Non-compliance|2|||
126262334|NCT00724373|454251268|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
126262335|NCT00724373|454251268|FG000|Overall Study|Participant moved away|1|||
126262336|NCT00724373|454251268|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
126262337|NCT00724373|454251268|FG000|Overall Study|Only to have 24 week regimen|1|||
126262338|NCT00724373|454251268|FG000|Overall Study|Viral Relapse|1|||
126262339|NCT00724373|454251268|FG000|Overall Study|Acute HCV infection|1|||
126262340|NCT00724373|454251268|FG000|Overall Study|Drug Relapse|1|||
126262341|NCT00724373|454251268|FG000|Overall Study|Tolerability|23|||
126262342|NCT02549573|454251269|FG000|Overall Study|Withdrawal by Subject|0|||
126262343|NCT02549573|454251270|FG001|Overall Study|Withdrawal by Subject|2|||
126262344|NCT02549573|454251269|FG000|Overall Study|Protocol Violation|0|||
126262345|NCT02549573|454251270|FG001|Overall Study|Protocol Violation|1|||
126262346|NCT03043560|454251271|FG000|Overall Study|Discontinued Intervention|1|||
126262347|NCT03043560|454251272|FG001|Overall Study|Discontinued Intervention|2|||
126262348|NCT03043560|454251271|FG000|Overall Study|Lost to Follow-up|0|||
126262349|NCT03043560|454251272|FG001|Overall Study|Lost to Follow-up|1|||
125880237|NCT04672239|452858817|FG001|Week 6 Survey|Withdrawal by Subject|1|||
125880238|NCT04672239|452858818|FG002|Week 6 Survey|Withdrawal by Subject|1|||
126262350|NCT00438659|454251273|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
125880239|NCT04672239|452858816|FG000|Week 6 Survey|Withdrawn by PI|0|||
125880240|NCT04672239|452858817|FG001|Week 6 Survey|Withdrawn by PI|1|||
126262351|NCT00438659|454251274|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
126262352|NCT00438659|454251273|FG000|Overall Study|Cancel|5|||
125880241|NCT04672239|452858818|FG002|Week 6 Survey|Withdrawn by PI|0|||
126262353|NCT00438659|454251274|FG001|Overall Study|Cancel|2|||
126262354|NCT03366194|454251278|FG000|Overall Study|Lost to Follow-up|2|||
126262355|NCT03123783|454251279|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262356|NCT03123783|454251280|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
126262357|NCT03123783|454251281|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262358|NCT03123783|454251282|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262359|NCT03123783|454251283|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262360|NCT03123783|454251284|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262361|NCT03123783|454251285|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262362|NCT03123783|454251279|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
126262363|NCT03123783|454251280|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
126262364|NCT03123783|454251281|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
126262365|NCT03123783|454251282|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
126262366|NCT03123783|454251283|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
126262367|NCT03123783|454251284|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
126262368|NCT03123783|454251285|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
126262369|NCT03123783|454251279|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
126262370|NCT03123783|454251280|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
126262371|NCT03123783|454251281|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
126262372|NCT03123783|454251282|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
126262373|NCT03123783|454251283|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
126262374|NCT03123783|454251284|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
126262375|NCT03123783|454251285|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
126262376|NCT03123783|454251279|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262377|NCT03123783|454251280|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262378|NCT03123783|454251281|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262379|NCT03123783|454251282|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262380|NCT03123783|454251283|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
126262381|NCT03123783|454251284|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262382|NCT03123783|454251285|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262383|NCT01730040|454252773|FG000|Overall Study|Randomized but not treated|0|||
126262384|NCT01730040|454252774|FG001|Overall Study|Randomized but not treated|0|||
126262385|NCT01730040|454252775|FG002|Overall Study|Randomized but not treated|0|||
126262386|NCT01730040|454252776|FG003|Overall Study|Randomized but not treated|0|||
126262387|NCT01730040|454252777|FG004|Overall Study|Randomized but not treated|0|||
126262388|NCT01730040|454252778|FG005|Overall Study|Randomized but not treated|1|||
126262389|NCT01730040|454252779|FG006|Overall Study|Randomized but not treated|0|||
126262390|NCT01730040|454252773|FG000|Overall Study|Subject moved|0|||
126262391|NCT01730040|454252774|FG001|Overall Study|Subject moved|0|||
126262392|NCT01730040|454252775|FG002|Overall Study|Subject moved|1|||
126262393|NCT01730040|454252776|FG003|Overall Study|Subject moved|0|||
126262394|NCT01730040|454252777|FG004|Overall Study|Subject moved|0|||
126262395|NCT01730040|454252778|FG005|Overall Study|Subject moved|0|||
126262396|NCT01730040|454252779|FG006|Overall Study|Subject moved|1|||
126262397|NCT01730040|454252773|FG000|Overall Study|Physician Decision|0|||
126262398|NCT01730040|454252774|FG001|Overall Study|Physician Decision|0|||
126262399|NCT01730040|454252775|FG002|Overall Study|Physician Decision|0|||
126262400|NCT01730040|454252776|FG003|Overall Study|Physician Decision|0|||
126262401|NCT01730040|454252777|FG004|Overall Study|Physician Decision|0|||
126262402|NCT01730040|454252778|FG005|Overall Study|Physician Decision|1|||
126262403|NCT01730040|454252779|FG006|Overall Study|Physician Decision|1|||
126262404|NCT01730040|454252773|FG000|Overall Study|Other than specified|7|||
126262405|NCT01730040|454252774|FG001|Overall Study|Other than specified|8|||
126262406|NCT01730040|454252775|FG002|Overall Study|Other than specified|5|||
126262407|NCT01730040|454252776|FG003|Overall Study|Other than specified|5|||
126262408|NCT01730040|454252777|FG004|Overall Study|Other than specified|5|||
126262409|NCT01730040|454252778|FG005|Overall Study|Other than specified|4|||
126262410|NCT01730040|454252779|FG006|Overall Study|Other than specified|4|||
125880242|NCT04672239|452858816|FG000|Week 6 Survey|Lost to Follow-up|12|||
125880243|NCT04672239|452858817|FG001|Week 6 Survey|Lost to Follow-up|2|||
125880244|NCT04672239|452858818|FG002|Week 6 Survey|Lost to Follow-up|5|||
125880245|NCT04672239|452858816|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
126262411|NCT01730040|454252773|FG000|Overall Study|Adverse Event|4|||
126262412|NCT01730040|454252774|FG001|Overall Study|Adverse Event|3|||
126262413|NCT01730040|454252775|FG002|Overall Study|Adverse Event|5|||
126262414|NCT01730040|454252776|FG003|Overall Study|Adverse Event|3|||
126262415|NCT01730040|454252777|FG004|Overall Study|Adverse Event|1|||
125880246|NCT04672239|452858817|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
126046484|NCT00495677|453468232|FG002|Stage 1 (25 Days)|Adverse Event|1|||
126262416|NCT01730040|454252778|FG005|Overall Study|Adverse Event|1|||
126262417|NCT01730040|454252779|FG006|Overall Study|Adverse Event|2|||
126262418|NCT01730040|454252773|FG000|Overall Study|Poor compliance to protocol|2|||
126262419|NCT01730040|454252774|FG001|Overall Study|Poor compliance to protocol|4|||
126262420|NCT01730040|454252775|FG002|Overall Study|Poor compliance to protocol|0|||
126262421|NCT01730040|454252776|FG003|Overall Study|Poor compliance to protocol|0|||
126262422|NCT01730040|454252777|FG004|Overall Study|Poor compliance to protocol|0|||
126262423|NCT01730040|454252778|FG005|Overall Study|Poor compliance to protocol|0|||
126262424|NCT01730040|454252779|FG006|Overall Study|Poor compliance to protocol|1|||
126262425|NCT03346070|454252782|FG000|Overall Study|Death|0|||
126262426|NCT03346070|454252783|FG001|Overall Study|Death|0|||
126262427|NCT03346070|454252784|FG002|Overall Study|Death|0|||
126262428|NCT03346070|454252785|FG003|Overall Study|Death|0|||
126262429|NCT03346070|454252786|FG004|Overall Study|Death|1|||
126262430|NCT03346070|454252782|FG000|Overall Study|Lost to Follow-up|0|||
126262431|NCT03346070|454252783|FG001|Overall Study|Lost to Follow-up|1|||
126262432|NCT03346070|454252784|FG002|Overall Study|Lost to Follow-up|2|||
126262433|NCT03346070|454252785|FG003|Overall Study|Lost to Follow-up|0|||
126262434|NCT03346070|454252786|FG004|Overall Study|Lost to Follow-up|0|||
126262435|NCT03346070|454252782|FG000|Overall Study|Physician Decision|0|||
126262436|NCT03346070|454252783|FG001|Overall Study|Physician Decision|0|||
126262437|NCT03346070|454252784|FG002|Overall Study|Physician Decision|0|||
126262438|NCT03346070|454252785|FG003|Overall Study|Physician Decision|1|||
126262439|NCT03346070|454252786|FG004|Overall Study|Physician Decision|1|||
126262440|NCT03346070|454252782|FG000|Overall Study|Withdrawal by Subject|1|||
126262441|NCT03346070|454252783|FG001|Overall Study|Withdrawal by Subject|0|||
126262442|NCT03346070|454252784|FG002|Overall Study|Withdrawal by Subject|0|||
126262443|NCT03346070|454252785|FG003|Overall Study|Withdrawal by Subject|1|||
126262444|NCT03346070|454252786|FG004|Overall Study|Withdrawal by Subject|0|||
126262445|NCT03346070|454252782|FG000|Overall Study|Study medication not received as planned|2|||
126262446|NCT03346070|454252783|FG001|Overall Study|Study medication not received as planned|3|||
126262447|NCT03346070|454252784|FG002|Overall Study|Study medication not received as planned|2|||
126262448|NCT03346070|454252785|FG003|Overall Study|Study medication not received as planned|3|||
126262449|NCT03346070|454252786|FG004|Overall Study|Study medication not received as planned|2|||
126262450|NCT03346070|454252782|FG000|Overall Study|Screen Failure|0|||
126262451|NCT03346070|454252783|FG001|Overall Study|Screen Failure|0|||
126262452|NCT03346070|454252784|FG002|Overall Study|Screen Failure|0|||
126262453|NCT03346070|454252785|FG003|Overall Study|Screen Failure|1|||
126262454|NCT03346070|454252786|FG004|Overall Study|Screen Failure|1|||
126262455|NCT01042535|454252787|FG000|Overall Study|disease progression prior to treatment|3|||
126262456|NCT01042535|454252787|FG000|Overall Study|disease progression during treatment|3|||
126262457|NCT01042535|454252787|FG000|Overall Study|complications from other disease|2|||
126262458|NCT01546142|454252788|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
126262459|NCT01546142|454252789|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
126262460|NCT01546142|454252788|FG000|Overall Study|Subject Noncompliance|1|||
126262461|NCT01546142|454252789|FG001|Overall Study|Subject Noncompliance|1|||
126262462|NCT01546142|454252788|FG000|Overall Study|Adverse Event|6|||
126262463|NCT01546142|454252789|FG001|Overall Study|Adverse Event|3|||
126262464|NCT01546142|454252788|FG000|Overall Study|Lost to Follow-up|20|||
126262465|NCT01546142|454252789|FG001|Overall Study|Lost to Follow-up|15|||
126262466|NCT01546142|454252788|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
126262467|NCT01546142|454252789|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
126262468|NCT01546142|454252788|FG000|Overall Study|Subject Randomized but Not Treated|1|||
126262469|NCT01546142|454252789|FG001|Overall Study|Subject Randomized but Not Treated|0|||
126262470|NCT03919448|454252793|FG000|Overall Study|Withdrawal by Subject|1|||
126262471|NCT03919448|454252794|FG001|Overall Study|Withdrawal by Subject|0|||
126262472|NCT03919448|454252795|FG002|Overall Study|Withdrawal by Subject|0|||
126262473|NCT01286558|454252801|FG000|Overall Study|Adverse Event|1|||
126262474|NCT01286558|454252802|FG001|Overall Study|Adverse Event|1|||
126262475|NCT01286558|454252801|FG000|Overall Study|Withdrawal by Subject|0|||
126262476|NCT01286558|454252802|FG001|Overall Study|Withdrawal by Subject|1|||
126262477|NCT01005329|454252807|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
126262478|NCT01272921|454252810|FG000|Overall Study|Protocol Violation|2|||
126262479|NCT01272921|454252811|FG001|Overall Study|Protocol Violation|1|||
126262480|NCT01132664|454252812|FG000|Phase lb|Adverse Event|0|||
126262481|NCT01132664|454252813|FG001|Phase lb|Adverse Event|1|||
126262482|NCT01132664|454252814|FG002|Phase lb|Adverse Event|0|||
126262483|NCT01132664|454252815|FG003|Phase lb|Adverse Event|0|||
126262484|NCT01132664|454252816|FG004|Phase lb|Adverse Event|0|||
126262485|NCT01132664|454252812|FG000|Phase lb|Withdrawal by Subject|1|||
126262486|NCT01132664|454252813|FG001|Phase lb|Withdrawal by Subject|2|||
126262487|NCT01132664|454252814|FG002|Phase lb|Withdrawal by Subject|0|||
126262488|NCT01132664|454252815|FG003|Phase lb|Withdrawal by Subject|0|||
126262489|NCT01132664|454252816|FG004|Phase lb|Withdrawal by Subject|0|||
126262490|NCT01132664|454252812|FG000|Phase lb|Disease Progression|4|||
126262491|NCT01132664|454252813|FG001|Phase lb|Disease Progression|9|||
126262492|NCT01132664|454252814|FG002|Phase lb|Disease Progression|0|||
126262493|NCT01132664|454252815|FG003|Phase lb|Disease Progression|0|||
126262494|NCT01132664|454252816|FG004|Phase lb|Disease Progression|0|||
126262495|NCT01132664|454252812|FG000|Phase ll|Death|0|||
126262496|NCT01132664|454252813|FG001|Phase ll|Death|0|||
126262497|NCT01132664|454252814|FG002|Phase ll|Death|2|||
126262498|NCT01132664|454252815|FG003|Phase ll|Death|0|||
126262499|NCT01132664|454252816|FG004|Phase ll|Death|0|||
126262500|NCT01132664|454252812|FG000|Phase ll|Adverse Event|0|||
126262501|NCT01132664|454252813|FG001|Phase ll|Adverse Event|0|||
126262502|NCT01132664|454252814|FG002|Phase ll|Adverse Event|10|||
126262503|NCT01132664|454252815|FG003|Phase ll|Adverse Event|0|||
126262504|NCT01132664|454252816|FG004|Phase ll|Adverse Event|0|||
126262505|NCT01132664|454252812|FG000|Phase ll|Withdrawal by Subject|0|||
126262506|NCT01132664|454252813|FG001|Phase ll|Withdrawal by Subject|0|||
126262507|NCT01132664|454252814|FG002|Phase ll|Withdrawal by Subject|3|||
126262508|NCT01132664|454252815|FG003|Phase ll|Withdrawal by Subject|0|||
126262509|NCT01132664|454252816|FG004|Phase ll|Withdrawal by Subject|0|||
126262510|NCT01132664|454252812|FG000|Phase ll|Disease progression|0|||
126262511|NCT01132664|454252813|FG001|Phase ll|Disease progression|0|||
126262512|NCT01132664|454252814|FG002|Phase ll|Disease progression|35|||
126262513|NCT01132664|454252815|FG003|Phase ll|Disease progression|0|||
126262514|NCT01132664|454252816|FG004|Phase ll|Disease progression|0|||
126262515|NCT01132664|454252812|FG000|BM Cohort|Disease progression|0|||
126262516|NCT01132664|454252813|FG001|BM Cohort|Disease progression|0|||
126262517|NCT01132664|454252814|FG002|BM Cohort|Disease progression|0|||
126262518|NCT01132664|454252815|FG003|BM Cohort|Disease progression|3|||
126262519|NCT01132664|454252816|FG004|BM Cohort|Disease progression|4|||
126262520|NCT01132664|454252812|FG000|BM Cohort|Adverse Event|0|||
126262521|NCT01132664|454252813|FG001|BM Cohort|Adverse Event|0|||
126262522|NCT01132664|454252814|FG002|BM Cohort|Adverse Event|0|||
126262523|NCT01132664|454252815|FG003|BM Cohort|Adverse Event|0|||
126262524|NCT01132664|454252816|FG004|BM Cohort|Adverse Event|1|||
126262525|NCT01132664|454252812|FG000|BM Cohort|Withdrawal by Subject|0|||
126262526|NCT01132664|454252813|FG001|BM Cohort|Withdrawal by Subject|0|||
126262527|NCT01132664|454252814|FG002|BM Cohort|Withdrawal by Subject|0|||
126262528|NCT01132664|454252815|FG003|BM Cohort|Withdrawal by Subject|0|||
126262529|NCT01132664|454252816|FG004|BM Cohort|Withdrawal by Subject|1|||
126262530|NCT00655850|454252817|FG000|Overall Study|Death|2|||
126262531|NCT00655850|454252817|FG000|Overall Study|Withdrawal by Subject|1|||
126262532|NCT01567826|454252820|FG000|Overall Study|Lost to Follow-up|3|||
126262533|NCT01567826|454252821|FG001|Overall Study|Lost to Follow-up|2|||
126262534|NCT00573170|454252827|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
126262535|NCT00573170|454252828|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
126262536|NCT00573170|454252829|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
126262537|NCT00573170|454252830|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
126262538|NCT00573170|454252831|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
126262539|NCT00573170|454252832|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
126262540|NCT00573170|454252827|FG000|First Washout Period|Adverse Event|1|||
126262541|NCT00573170|454252828|FG001|First Washout Period|Adverse Event|1|||
126262542|NCT00573170|454252829|FG002|First Washout Period|Adverse Event|0|||
126262543|NCT00573170|454252830|FG003|First Washout Period|Adverse Event|0|||
126262544|NCT00573170|454252831|FG004|First Washout Period|Adverse Event|0|||
126262545|NCT00573170|454252832|FG005|First Washout Period|Adverse Event|1|||
126359700|NCT00564070|454609039|FG000|Overall Study|Worsening depression, referred to care|3|||
126359701|NCT00564070|454609040|FG001|Overall Study|Worsening depression, referred to care|0|||
126359702|NCT03142334|454609044|FG000|Overall Study|Death|18|||
126262546|NCT00573170|454252827|FG000|First Washout Period|Lack of Efficacy|0|||
126262547|NCT00573170|454252828|FG001|First Washout Period|Lack of Efficacy|0|||
126262548|NCT00573170|454252829|FG002|First Washout Period|Lack of Efficacy|0|||
126262549|NCT00573170|454252830|FG003|First Washout Period|Lack of Efficacy|0|||
126262550|NCT00573170|454252831|FG004|First Washout Period|Lack of Efficacy|0|||
126262551|NCT00573170|454252832|FG005|First Washout Period|Lack of Efficacy|1|||
126262552|NCT00573170|454252827|FG000|First Washout Period|Lost to Follow-up|1|||
126262553|NCT00573170|454252828|FG001|First Washout Period|Lost to Follow-up|1|||
126262554|NCT00573170|454252829|FG002|First Washout Period|Lost to Follow-up|0|||
126262555|NCT00573170|454252830|FG003|First Washout Period|Lost to Follow-up|2|||
126262556|NCT00573170|454252831|FG004|First Washout Period|Lost to Follow-up|0|||
126262557|NCT00573170|454252832|FG005|First Washout Period|Lost to Follow-up|2|||
125880247|NCT04672239|452858818|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
125880248|NCT04672239|452858816|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
126096546|NCT00006011|453646490|FG001|Overall Study|Other|2|||
126096547|NCT00006011|453646491|FG002|Overall Study|Other|5|||
126096548|NCT00006011|453646489|FG000|Overall Study|Ineligible|18|||
126096549|NCT00006011|453646490|FG001|Overall Study|Ineligible|16|||
126096550|NCT00006011|453646491|FG002|Overall Study|Ineligible|9|||
126096551|NCT00774930|453646497|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
126096552|NCT00774930|453646498|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
126096553|NCT00774930|453646497|FG000|DB Phase|Adverse Event|1|||
126096554|NCT00774930|453646498|FG001|DB Phase|Adverse Event|2|||
126096555|NCT00774930|453646497|FG000|DB Phase|Subject Decision|1|||
126096556|NCT00774930|453646498|FG001|DB Phase|Subject Decision|5|||
126096557|NCT00774930|453646497|FG000|DB Phase|Sponsor Decision|0|||
126096558|NCT00774930|453646498|FG001|DB Phase|Sponsor Decision|1|||
126096559|NCT00774930|453646497|FG000|DB Phase|Disease Progression|1|||
126096560|NCT00774930|453646498|FG001|DB Phase|Disease Progression|1|||
126096561|NCT00774930|453646497|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
126096562|NCT00774930|453646498|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
126096563|NCT00774930|453646497|FG000|IOL Phase|Adverse Event|1|||
126096564|NCT00774930|453646498|FG001|IOL Phase|Adverse Event|1|||
126096565|NCT00774930|453646497|FG000|IOL Phase|Subject Decision|4|||
126096566|NCT00774930|453646498|FG001|IOL Phase|Subject Decision|3|||
126096567|NCT00774930|453646497|FG000|IOL Phase|Physician Decision|3|||
126096568|NCT00774930|453646498|FG001|IOL Phase|Physician Decision|2|||
126096569|NCT00774930|453646497|FG000|IOL Phase|Sponsor Decision|1|||
126096570|NCT00774930|453646498|FG001|IOL Phase|Sponsor Decision|0|||
126096571|NCT00774930|453646497|FG000|IOL Phase|Disease Progression|2|||
126359703|NCT03142334|454609045|FG001|Overall Study|Death|33|||
126359704|NCT03142334|454609044|FG000|Overall Study|Withdrawal by Subject|15|||
126096572|NCT00774930|453646498|FG001|IOL Phase|Disease Progression|1|||
126096573|NCT00774930|453646497|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
126096574|NCT00774930|453646498|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
126359705|NCT03142334|454609045|FG001|Overall Study|Withdrawal by Subject|11|||
126359706|NCT03142334|454609044|FG000|Overall Study|Ongoing on trial follow up|463|||
126359707|NCT03142334|454609045|FG001|Overall Study|Ongoing on trial follow up|454|||
126359708|NCT03071965|454609046|FG000|Overall Study|Adverse Event|0|||
126359709|NCT03071965|454609047|FG001|Overall Study|Adverse Event|0|||
126359710|NCT03071965|454609048|FG002|Overall Study|Adverse Event|1|||
126359711|NCT03071965|454609049|FG003|Overall Study|Adverse Event|0|||
126359712|NCT03071965|454609046|FG000|Overall Study|Death|0|||
126359713|NCT03071965|454609047|FG001|Overall Study|Death|0|||
126359714|NCT03071965|454609048|FG002|Overall Study|Death|1|||
126359715|NCT03071965|454609049|FG003|Overall Study|Death|1|||
126359716|NCT03071965|454609046|FG000|Overall Study|COVID-19|0|||
126359717|NCT03071965|454609047|FG001|Overall Study|COVID-19|1|||
126359718|NCT03071965|454609048|FG002|Overall Study|COVID-19|0|||
126359719|NCT03071965|454609049|FG003|Overall Study|COVID-19|1|||
126359720|NCT03071965|454609046|FG000|Overall Study|Other Health Reason|0|||
126096575|NCT00774930|453646497|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
126096576|NCT00774930|453646498|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
126096577|NCT00774930|453646497|FG000|IOL Phase|Other|1|||
126096578|NCT00774930|453646498|FG001|IOL Phase|Other|0|||
126096579|NCT00774930|453646497|FG000|IOL Phase|Brain radiation|0|||
126096580|NCT00774930|453646498|FG001|IOL Phase|Brain radiation|1|||
126096581|NCT00774930|453646497|FG000|LTOLE Phase|Adverse Event|7|||
126359721|NCT03071965|454609047|FG001|Overall Study|Other Health Reason|0|||
126359722|NCT03071965|454609048|FG002|Overall Study|Other Health Reason|0|||
126359723|NCT03071965|454609049|FG003|Overall Study|Other Health Reason|1|||
125880249|NCT04672239|452858817|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
126096582|NCT00774930|453646498|FG001|LTOLE Phase|Adverse Event|3|||
126096583|NCT00774930|453646497|FG000|LTOLE Phase|Subject decision|0|||
126096584|NCT00774930|453646498|FG001|LTOLE Phase|Subject decision|5|||
126096585|NCT00774930|453646497|FG000|LTOLE Phase|Physician Decision|4|||
126096586|NCT00774930|453646498|FG001|LTOLE Phase|Physician Decision|1|||
126096587|NCT00774930|453646497|FG000|LTOLE Phase|Sponsor decision|2|||
126096588|NCT00774930|453646498|FG001|LTOLE Phase|Sponsor decision|1|||
126359724|NCT01217047|454609050|FG000|Overall Study|Lost to Follow-up|0|||
126262558|NCT00573170|454252827|FG000|First Washout Period|Withdrawal by Subject|2|||
126262559|NCT00573170|454252828|FG001|First Washout Period|Withdrawal by Subject|0|||
126262560|NCT00573170|454252829|FG002|First Washout Period|Withdrawal by Subject|0|||
126262561|NCT00573170|454252830|FG003|First Washout Period|Withdrawal by Subject|2|||
126262562|NCT00573170|454252831|FG004|First Washout Period|Withdrawal by Subject|3|||
126262563|NCT00573170|454252832|FG005|First Washout Period|Withdrawal by Subject|3|||
126262564|NCT00573170|454252827|FG000|First Washout Period|Other|4|||
126262565|NCT00573170|454252828|FG001|First Washout Period|Other|0|||
126262566|NCT00573170|454252829|FG002|First Washout Period|Other|1|||
126262567|NCT00573170|454252830|FG003|First Washout Period|Other|1|||
126262568|NCT00573170|454252831|FG004|First Washout Period|Other|0|||
126262569|NCT00573170|454252832|FG005|First Washout Period|Other|0|||
126262570|NCT00573170|454252827|FG000|Second Washout Period|Adverse Event|1|||
126262571|NCT00573170|454252828|FG001|Second Washout Period|Adverse Event|0|||
126262572|NCT00573170|454252829|FG002|Second Washout Period|Adverse Event|0|||
126262573|NCT00573170|454252830|FG003|Second Washout Period|Adverse Event|0|||
126262574|NCT00573170|454252831|FG004|Second Washout Period|Adverse Event|1|||
126262575|NCT00573170|454252832|FG005|Second Washout Period|Adverse Event|0|||
126262576|NCT00573170|454252827|FG000|Second Washout Period|Protocol Violation|2|||
126262577|NCT00573170|454252828|FG001|Second Washout Period|Protocol Violation|1|||
126262578|NCT00573170|454252829|FG002|Second Washout Period|Protocol Violation|1|||
126262579|NCT00573170|454252830|FG003|Second Washout Period|Protocol Violation|0|||
126262580|NCT00573170|454252831|FG004|Second Washout Period|Protocol Violation|0|||
126262581|NCT00573170|454252832|FG005|Second Washout Period|Protocol Violation|0|||
126262582|NCT00573170|454252827|FG000|Second Washout Period|Withdrawal by Subject|1|||
126262583|NCT00573170|454252828|FG001|Second Washout Period|Withdrawal by Subject|1|||
126262584|NCT00573170|454252829|FG002|Second Washout Period|Withdrawal by Subject|2|||
126262585|NCT00573170|454252830|FG003|Second Washout Period|Withdrawal by Subject|0|||
126262586|NCT00573170|454252831|FG004|Second Washout Period|Withdrawal by Subject|1|||
126262587|NCT00573170|454252832|FG005|Second Washout Period|Withdrawal by Subject|0|||
126262588|NCT00573170|454252827|FG000|Second Washout Period|Lost to Follow-up|0|||
126262589|NCT00573170|454252828|FG001|Second Washout Period|Lost to Follow-up|0|||
126262590|NCT00573170|454252829|FG002|Second Washout Period|Lost to Follow-up|0|||
126262591|NCT00573170|454252830|FG003|Second Washout Period|Lost to Follow-up|1|||
126262592|NCT00573170|454252831|FG004|Second Washout Period|Lost to Follow-up|0|||
126262593|NCT00573170|454252832|FG005|Second Washout Period|Lost to Follow-up|0|||
126262594|NCT00573170|454252827|FG000|Second Washout Period|Other|1|||
126262595|NCT00573170|454252828|FG001|Second Washout Period|Other|2|||
126262596|NCT00573170|454252829|FG002|Second Washout Period|Other|1|||
126262597|NCT00573170|454252830|FG003|Second Washout Period|Other|4|||
126262598|NCT00573170|454252831|FG004|Second Washout Period|Other|6|||
126262599|NCT00573170|454252832|FG005|Second Washout Period|Other|2|||
126262600|NCT00573170|454252827|FG000|Third Treatment Period|Withdrawal by Subject|1|||
126262601|NCT00573170|454252828|FG001|Third Treatment Period|Withdrawal by Subject|0|||
126262602|NCT00573170|454252829|FG002|Third Treatment Period|Withdrawal by Subject|0|||
126031816|NCT02924272|453413956|FG000|Overall Study|Reason Not Specified|1|||
126031817|NCT02924272|453413957|FG001|Overall Study|Reason Not Specified|0|||
126031818|NCT02100813|453413962|FG000|Overall Study|Adverse Event|0|||
126031819|NCT02100813|453413963|FG001|Overall Study|Adverse Event|0|||
126031820|NCT02100813|453413964|FG002|Overall Study|Adverse Event|0|||
126031821|NCT02100813|453413965|FG003|Overall Study|Adverse Event|0|||
126262603|NCT00573170|454252830|FG003|Third Treatment Period|Withdrawal by Subject|0|||
126262604|NCT00573170|454252831|FG004|Third Treatment Period|Withdrawal by Subject|0|||
126359725|NCT01217047|454609051|FG001|Overall Study|Lost to Follow-up|1|||
126359726|NCT01217047|454609052|FG002|Overall Study|Lost to Follow-up|0|||
126359727|NCT05529173|454609053|FG000|Overall Study|Physician Decision|3|||
126359728|NCT05529173|454609054|FG001|Overall Study|Physician Decision|6|||
126359729|NCT05529173|454609053|FG000|Overall Study|Sample shipment delay more than one day|4|||
126359730|NCT05529173|454609054|FG001|Overall Study|Sample shipment delay more than one day|0|||
126359731|NCT05587998|454609055|FG000|Overall Study|Withdrawal by Subject|1|||
126359732|NCT05587998|454609056|FG001|Overall Study|Withdrawal by Subject|1|||
126359733|NCT05587998|454609055|FG000|Overall Study|Not treated|3|||
126359734|NCT05587998|454609056|FG001|Overall Study|Not treated|1|||
126359735|NCT05587998|454609055|FG000|Overall Study|Non-compliance with study procedures|0|||
126031822|NCT02100813|453413966|FG004|Overall Study|Adverse Event|0|||
126031823|NCT02100813|453413967|FG005|Overall Study|Adverse Event|0|||
126031824|NCT02100813|453413968|FG006|Overall Study|Adverse Event|0|||
126031825|NCT02100813|453413969|FG007|Overall Study|Adverse Event|1|||
126262605|NCT00573170|454252832|FG005|Third Treatment Period|Withdrawal by Subject|0|||
126262606|NCT00573170|454252827|FG000|Third Treatment Period|Lost to Follow-up|0|||
126262607|NCT00573170|454252828|FG001|Third Treatment Period|Lost to Follow-up|0|||
126262608|NCT00573170|454252829|FG002|Third Treatment Period|Lost to Follow-up|0|||
126262609|NCT00573170|454252830|FG003|Third Treatment Period|Lost to Follow-up|0|||
126262610|NCT00573170|454252831|FG004|Third Treatment Period|Lost to Follow-up|0|||
126262611|NCT00573170|454252832|FG005|Third Treatment Period|Lost to Follow-up|2|||
126031826|NCT03575897|453413971|FG000|Overall Study|Lost to Follow-up|12|||
126031827|NCT03575897|453413972|FG001|Overall Study|Lost to Follow-up|13|||
126262612|NCT00608517|454252834|FG000|Overall Study|Death|1|||
126262613|NCT00608517|454252835|FG001|Overall Study|Death|0|||
126262614|NCT00608517|454252836|FG002|Overall Study|Death|0|||
126262615|NCT00493454|454252838|FG000|Overall Study|Withdrawal by Subject|1|||
126262616|NCT00103038|454252839|FG000|Overall Study|Withdrawal by Subject|8|||
126262617|NCT00103038|454252839|FG000|Overall Study|Screen failure|3|||
126262618|NCT00103038|454252839|FG000|Overall Study|Death|1|||
126262619|NCT00103038|454252839|FG000|Overall Study|Physician Decision|1|||
126262620|NCT03649412|454252846|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
126262621|NCT03649412|454252847|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
126262622|NCT03649412|454252846|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
126262623|NCT03649412|454252847|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
126031828|NCT04359108|453413973|FG000|Overall Study|Withdrawal by Subject|1|||
126031829|NCT04359108|453413974|FG001|Overall Study|Withdrawal by Subject|0|||
126031830|NCT04359108|453413973|FG000|Overall Study|Unable or too feeble to walk independently|0|||
126031831|NCT04359108|453413974|FG001|Overall Study|Unable or too feeble to walk independently|2|||
126031832|NCT04359108|453413973|FG000|Overall Study|Argus II system stopped functioning|0|||
126031833|NCT04359108|453413974|FG001|Overall Study|Argus II system stopped functioning|1|||
126031834|NCT04359108|453413973|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
126031835|NCT04359108|453413974|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
126031836|NCT06393088|453413975|FG000|Overall Study|Withdrawal by Subject|0|||
126031837|NCT06393088|453413976|FG001|Overall Study|Withdrawal by Subject|2|||
126031838|NCT02515773|453413977|FG000|Overall Study|Withdrawal by Subject|12|||
126031839|NCT02515773|453413978|FG001|Overall Study|Withdrawal by Subject|2|||
126031840|NCT02515773|453413977|FG000|Overall Study|Lost to Follow-up|119|||
126031841|NCT02515773|453413978|FG001|Overall Study|Lost to Follow-up|126|||
126096589|NCT00774930|453646497|FG000|LTOLE Phase|Disease Progression|2|||
126096590|NCT00774930|453646498|FG001|LTOLE Phase|Disease Progression|5|||
126096591|NCT00774930|453646497|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
126096592|NCT00774930|453646498|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
126096593|NCT00774930|453646497|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
126096594|NCT00774930|453646498|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
126096595|NCT00766363|453646503|FG000|Overall Study|Withdrawal by Subject|1|||
126096596|NCT00766363|453646504|FG001|Overall Study|Withdrawal by Subject|0|||
126096597|NCT00766363|453646505|FG002|Overall Study|Withdrawal by Subject|0|||
126262624|NCT03649412|454252846|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
126031842|NCT02515773|453413977|FG000|Overall Study|Discharged from Clinic Services|53|||
126031843|NCT02515773|453413978|FG001|Overall Study|Discharged from Clinic Services|84|||
126031844|NCT02515773|453413977|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
126031845|NCT02515773|453413978|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
126031846|NCT02515773|453413977|FG000|Overall Study|Follow-up at non-study site|8|||
126031847|NCT02515773|453413978|FG001|Overall Study|Follow-up at non-study site|16|||
126031848|NCT02515773|453413977|FG000|Overall Study|Moved from area|9|||
126031849|NCT02515773|453413978|FG001|Overall Study|Moved from area|14|||
126031850|NCT03903146|453413979|FG000|Overall Study|Lost to Follow-up|6|||
126031851|NCT03903146|453413980|FG001|Overall Study|Lost to Follow-up|4|||
126031852|NCT03903146|453413979|FG000|Overall Study|Withdrawal by Subject|0|||
126031853|NCT03903146|453413980|FG001|Overall Study|Withdrawal by Subject|1|||
126031854|NCT04176965|453413981|FG000|Overall Study|Death|1|||
126031855|NCT04176965|453413982|FG001|Overall Study|Death|2|||
126031856|NCT04176965|453413981|FG000|Overall Study|Lost to Follow-up|10|||
126031857|NCT04176965|453413982|FG001|Overall Study|Lost to Follow-up|2|||
126031858|NCT04176965|453413981|FG000|Overall Study|Withdrawal by Subject|6|||
126031859|NCT04176965|453413982|FG001|Overall Study|Withdrawal by Subject|1|||
126031860|NCT02919683|453413983|FG000|Post-Surgery Follow-Up|Death|2|||
126031861|NCT02919683|453413984|FG001|Post-Surgery Follow-Up|Death|2|||
126031862|NCT02919683|453413983|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
126031863|NCT02919683|453413984|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
126031864|NCT03652688|453413985|FG000|Baseline|Withdrawal by Subject|0|||
126031865|NCT03652688|453413986|FG001|Baseline|Withdrawal by Subject|3|||
126262625|NCT03649412|454252847|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126262626|NCT03649412|454252846|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
126262627|NCT03649412|454252847|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
126262628|NCT03649412|454252846|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
126262629|NCT03649412|454252847|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
126262630|NCT03649412|454252846|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
126031866|NCT03652688|453413985|FG000|Follow-up|Lost to Follow-up|56|||
126096598|NCT00766363|453646506|FG003|Overall Study|Withdrawal by Subject|0|||
126096599|NCT00766363|453646503|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
126096600|NCT00766363|453646504|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
126262631|NCT03649412|454252847|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
126096601|NCT00766363|453646505|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
126096602|NCT00766363|453646506|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
126262632|NCT02865395|454252848|FG000|Overall Study|Physician Decision|6|||
126262633|NCT02865395|454252849|FG001|Overall Study|Physician Decision|10|||
126262634|NCT02865395|454252850|FG002|Overall Study|Physician Decision|7|||
126262635|NCT01483625|454252851|FG000|Overall Study|Adverse Event|1|||
126262636|NCT01483625|454252852|FG001|Overall Study|Adverse Event|1|||
126262637|NCT01483625|454252851|FG000|Overall Study|Refused to continue medication|2|||
126262638|NCT01483625|454252852|FG001|Overall Study|Refused to continue medication|1|||
126262639|NCT01483625|454252851|FG000|Overall Study|Due to other reason|1|||
126262640|NCT01483625|454252852|FG001|Overall Study|Due to other reason|0|||
126262641|NCT04019054|454252856|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
126262642|NCT04019054|454252857|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
126262643|NCT04019054|454252856|FG000|Overall Study|Withdrawal by Subject|3|||
126262644|NCT04019054|454252857|FG001|Overall Study|Withdrawal by Subject|1|||
126262645|NCT05444543|454252858|FG000|Overall Study|Withdrawal by Subject|1|||
126262646|NCT05444543|454252859|FG001|Overall Study|Withdrawal by Subject|0|||
126262647|NCT05444543|454252858|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
126262648|NCT05444543|454252859|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
126262649|NCT05444543|454252858|FG000|Overall Study|Adverse Event|0|||
126262650|NCT05444543|454252859|FG001|Overall Study|Adverse Event|1|||
126262651|NCT05444543|454252858|FG000|Overall Study|Family relocating at a distance from study site|0|||
126262652|NCT05444543|454252859|FG001|Overall Study|Family relocating at a distance from study site|1|||
126262653|NCT01261624|454252860|FG000|Week 0 to Week 12|Disease Progression|1|||
126262654|NCT01261624|454252861|FG001|Week 0 to Week 12|Disease Progression|1|||
126262655|NCT01261624|454252860|FG000|Week 0 to Week 12|Insufficient Response|0|||
126262656|NCT01261624|454252861|FG001|Week 0 to Week 12|Insufficient Response|2|||
126262657|NCT01261624|454252860|FG000|Week 13 to Week 24|Insufficient Response|0|||
126262658|NCT01261624|454252861|FG001|Week 13 to Week 24|Insufficient Response|1|||
126262659|NCT01719562|454252864|FG000|Overall Study|Lost to Follow-up|1|||
126262660|NCT01719562|454252865|FG001|Overall Study|Lost to Follow-up|0|||
126262661|NCT01719562|454252864|FG000|Overall Study|Death|1|||
126262662|NCT01719562|454252865|FG001|Overall Study|Death|0|||
126262663|NCT01719562|454252864|FG000|Overall Study|New cancer diagnosis|1|||
126262664|NCT01719562|454252865|FG001|Overall Study|New cancer diagnosis|0|||
126262665|NCT00860743|454252868|FG000|Overall Study|Withdrawal by Subject|3|||
126262666|NCT00860743|454252869|FG001|Overall Study|Withdrawal by Subject|0|||
126262667|NCT03827018|454252870|FG000|Overall Study|Adverse Event|1|||
126262668|NCT03827018|454252871|FG001|Overall Study|Adverse Event|0|||
126262669|NCT03827018|454252870|FG000|Overall Study|Withdrawal by Subject|2|||
126262670|NCT03827018|454252871|FG001|Overall Study|Withdrawal by Subject|2|||
126262671|NCT03827018|454252870|FG000|Overall Study|Lack of Efficacy|0|||
126262672|NCT03827018|454252871|FG001|Overall Study|Lack of Efficacy|1|||
126096603|NCT01153321|453646507|FG000|Overall Study|Development of study withdrawal criteria|0|||
126096604|NCT01153321|453646508|FG001|Overall Study|Development of study withdrawal criteria|1|||
126096605|NCT01153321|453646507|FG000|Overall Study|Withdrawal by Subject|0|||
126096606|NCT01153321|453646508|FG001|Overall Study|Withdrawal by Subject|1|||
126262673|NCT00775528|454252876|FG000|Overall Study|Protocol Violation|1|||
126262674|NCT00350402|454252877|FG000|Overall Study|Lost to Follow-up|1|||
126262675|NCT00350402|454252878|FG001|Overall Study|Lost to Follow-up|1|||
126262676|NCT01884688|454252881|FG000|Overall Study|Screen Failure|2|||
126262677|NCT04099641|454252885|FG000|Overall Study|Death|46|||
126262678|NCT04099641|454252886|FG001|Overall Study|Death|12|||
126262679|NCT04099641|454252885|FG000|Overall Study|Lost to Follow-up|1|||
126262680|NCT04099641|454252886|FG001|Overall Study|Lost to Follow-up|0|||
126262681|NCT04099641|454252885|FG000|Overall Study|Withdrawal by Subject|2|||
126262682|NCT04099641|454252886|FG001|Overall Study|Withdrawal by Subject|0|||
126262683|NCT04798482|454252902|FG000|Overall Study|Physician Decision|1|||
126262684|NCT04798482|454252902|FG000|Overall Study|Lost eligibility|1|||
126262685|NCT01192399|454252903|FG000|Overall Study|Lack of Efficacy|2|||
126262686|NCT01534637|454252904|FG000|Overall Study|Physician Decision|3|||
126262687|NCT01534637|454252904|FG000|Overall Study|Lack of Efficacy|3|||
126096607|NCT01153321|453646507|FG000|Overall Study|Adverse Event|1|||
126096608|NCT01153321|453646508|FG001|Overall Study|Adverse Event|1|||
126262688|NCT01534637|454252904|FG000|Overall Study|Withdrawal by Subject|1|||
126262689|NCT01534637|454252904|FG000|Overall Study|Adverse Event|1|||
126262690|NCT01534637|454252904|FG000|Overall Study|Liver Mets before treatment|1|||
126262691|NCT03903159|454252906|FG000|Overall Study|Discharged with Staff Approval|2|||
126262692|NCT03903159|454252906|FG000|Overall Study|Discharged at Staff Request|2|||
126262693|NCT03903159|454252906|FG000|Overall Study|Discharged Against Staff Advice|1|||
126262694|NCT02443545|454252907|FG000|Overall Study|Adverse Event|1|||
126262695|NCT02443545|454252908|FG001|Overall Study|Adverse Event|1|||
126262696|NCT02443545|454252907|FG000|Overall Study|Lost to Follow-up|0|||
126262697|NCT02443545|454252908|FG001|Overall Study|Lost to Follow-up|2|||
126262698|NCT02443545|454252907|FG000|Overall Study|Physician Decision|3|||
126262699|NCT02443545|454252908|FG001|Overall Study|Physician Decision|0|||
126031867|NCT03652688|453413986|FG001|Follow-up|Lost to Follow-up|54|||
126031868|NCT03468218|453413987|FG000|Overall Study|Adverse Event|5|||
126031869|NCT03468218|453413987|FG000|Overall Study|Progressive Disease|16|||
126031870|NCT03468218|453413987|FG000|Overall Study|Death|1|||
126031871|NCT03468218|453413987|FG000|Overall Study|Alternate therapy|1|||
126031872|NCT03468218|453413987|FG000|Overall Study|Withdrawal by Subject|2|||
126031873|NCT03829410|453413989|FG000|Overall Study|Adverse Event|1|||
126031874|NCT03829410|453413990|FG001|Overall Study|Adverse Event|0|||
126031875|NCT03829410|453413991|FG002|Overall Study|Adverse Event|1|||
126031876|NCT03829410|453413992|FG003|Overall Study|Adverse Event|4|||
126031877|NCT03829410|453413989|FG000|Overall Study|Physician Decision|0|||
126031878|NCT03829410|453413990|FG001|Overall Study|Physician Decision|0|||
126031879|NCT03829410|453413991|FG002|Overall Study|Physician Decision|0|||
126031880|NCT03829410|453413992|FG003|Overall Study|Physician Decision|2|||
126031881|NCT03829410|453413989|FG000|Overall Study|Disease Progressing|3|||
126031882|NCT03829410|453413990|FG001|Overall Study|Disease Progressing|4|||
126031883|NCT03829410|453413991|FG002|Overall Study|Disease Progressing|2|||
126031884|NCT03829410|453413992|FG003|Overall Study|Disease Progressing|31|||
126031885|NCT03829410|453413989|FG000|Overall Study|Miscellaneous|2|||
126031886|NCT03829410|453413990|FG001|Overall Study|Miscellaneous|4|||
126031887|NCT03829410|453413991|FG002|Overall Study|Miscellaneous|3|||
126031888|NCT03829410|453413992|FG003|Overall Study|Miscellaneous|10|||
126031889|NCT03033576|453413993|FG000|Overall Study|Ineligible|1|||
126031890|NCT03033576|453413994|FG001|Overall Study|Ineligible|1|||
126031891|NCT03033576|453413993|FG000|Overall Study|Adverse Event|4|||
126031892|NCT03033576|453413994|FG001|Overall Study|Adverse Event|20|||
126031893|NCT03033576|453413993|FG000|Overall Study|Progression/relapse|9|||
126031894|NCT03033576|453413994|FG001|Overall Study|Progression/relapse|36|||
126031895|NCT03033576|453413993|FG000|Overall Study|Death|1|||
126031896|NCT03033576|453413994|FG001|Overall Study|Death|1|||
126031897|NCT03033576|453413993|FG000|Overall Study|Patient refusal|1|||
126031898|NCT03033576|453413994|FG001|Overall Study|Patient refusal|6|||
126031899|NCT03033576|453413993|FG000|Overall Study|Other, unspecified reasons|0|||
126031900|NCT03033576|453413994|FG001|Overall Study|Other, unspecified reasons|4|||
126031901|NCT03033576|453413993|FG000|Overall Study|Currently on protocol therapy|0|||
126031902|NCT03033576|453413994|FG001|Overall Study|Currently on protocol therapy|2|||
126031903|NCT05179837|453413995|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
126031904|NCT05179837|453413995|FG000|Overall Study|Device malfunctioned|1|||
126031905|NCT05179837|453413995|FG000|Overall Study|Image quality too low|2|||
126031906|NCT03719443|453413996|FG000|Overall Study|Lost to Follow-up|0|||
126031907|NCT03719443|453413997|FG001|Overall Study|Lost to Follow-up|0|||
126262700|NCT02443545|454252907|FG000|Overall Study|Protocol Violation|8|||
126031908|NCT03719443|453413998|FG002|Overall Study|Lost to Follow-up|1|||
125880250|NCT04672239|452858818|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
125880251|NCT04672239|452858816|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
125880252|NCT04672239|452858817|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
125880253|NCT04672239|452858818|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
125880254|NCT04672239|452858816|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
125880255|NCT04672239|452858817|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
125880256|NCT04672239|452858818|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
125880257|NCT04672239|452858816|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
125880258|NCT04672239|452858817|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
125880259|NCT04672239|452858818|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
125880260|NCT04672239|452858816|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
125880261|NCT04672239|452858817|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
125880262|NCT04672239|452858818|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
125880263|NCT04672239|452858816|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
125880264|NCT04672239|452858817|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
125880265|NCT04672239|452858818|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
125880266|NCT05408429|452858822|FG000|Overall Study|Lost to Follow-up|1|||
125880267|NCT05408429|452858823|FG001|Overall Study|Lost to Follow-up|1|||
125880268|NCT05408429|452858824|FG002|Overall Study|Lost to Follow-up|0|||
125880269|NCT05408429|452858822|FG000|Overall Study|Withdrawal by Subject|5|||
125880270|NCT05408429|452858823|FG001|Overall Study|Withdrawal by Subject|0|||
125880271|NCT05408429|452858824|FG002|Overall Study|Withdrawal by Subject|1|||
125880272|NCT01074970|452858826|FG000|Overall Study|Never Treated|0|||
125880273|NCT01074970|452858827|FG001|Overall Study|Never Treated|0|||
125880274|NCT01074970|452858828|FG002|Overall Study|Never Treated|8|||
125880275|NCT01074970|452858829|FG003|Overall Study|Never Treated|1|||
125880276|NCT01074970|452858826|FG000|Overall Study|Adverse Event|1|||
125880277|NCT01074970|452858827|FG001|Overall Study|Adverse Event|0|||
125880278|NCT01074970|452858828|FG002|Overall Study|Adverse Event|4|||
125880279|NCT01074970|452858829|FG003|Overall Study|Adverse Event|3|||
125880280|NCT01074970|452858826|FG000|Overall Study|Disease progression during treatment|3|||
125880281|NCT01074970|452858827|FG001|Overall Study|Disease progression during treatment|1|||
125880282|NCT01074970|452858828|FG002|Overall Study|Disease progression during treatment|2|||
125880283|NCT01074970|452858829|FG003|Overall Study|Disease progression during treatment|9|||
125880284|NCT01074970|452858826|FG000|Overall Study|Lost to Follow-up|0|||
125880285|NCT01074970|452858827|FG001|Overall Study|Lost to Follow-up|0|||
125880286|NCT01074970|452858828|FG002|Overall Study|Lost to Follow-up|1|||
126096609|NCT01177800|453646510|FG000|Overall Study|Adverse Event|9|||
126096610|NCT01177800|453646511|FG001|Overall Study|Adverse Event|3|||
126096611|NCT01177800|453646510|FG000|Overall Study|Protocol Violation|0|||
126096612|NCT01177800|453646511|FG001|Overall Study|Protocol Violation|1|||
126096613|NCT01177800|453646510|FG000|Overall Study|Physician Decision|1|||
126096614|NCT01177800|453646511|FG001|Overall Study|Physician Decision|0|||
126096615|NCT01177800|453646510|FG000|Overall Study|Withdrawal of informed consent|0|||
126096616|NCT01177800|453646511|FG001|Overall Study|Withdrawal of informed consent|1|||
126096617|NCT03527550|453646512|FG000|Overall Study|Lost to Follow-up|4|||
126262701|NCT02443545|454252908|FG001|Overall Study|Protocol Violation|1|||
126262702|NCT02443545|454252907|FG000|Overall Study|Pregnancy|1|||
126262703|NCT02443545|454252908|FG001|Overall Study|Pregnancy|1|||
126262704|NCT02443545|454252907|FG000|Overall Study|Withdrawal by Subject|6|||
126262705|NCT02443545|454252908|FG001|Overall Study|Withdrawal by Subject|3|||
126262706|NCT02443545|454252907|FG000|Overall Study|Termination of study|20|||
126262707|NCT02443545|454252908|FG001|Overall Study|Termination of study|11|||
126262708|NCT00536484|454252909|FG000|Overall Study|Adverse Event|21|||
126262709|NCT00536484|454252910|FG001|Overall Study|Adverse Event|34|||
126262710|NCT00536484|454252909|FG000|Overall Study|Withdrawal by Subject|11|||
126262711|NCT00536484|454252910|FG001|Overall Study|Withdrawal by Subject|11|||
126262712|NCT00536484|454252909|FG000|Overall Study|Lost to Follow-up|8|||
126262713|NCT00536484|454252910|FG001|Overall Study|Lost to Follow-up|6|||
126262714|NCT00536484|454252909|FG000|Overall Study|Lack of Efficacy|16|||
126262715|NCT00536484|454252910|FG001|Overall Study|Lack of Efficacy|5|||
126262716|NCT00536484|454252909|FG000|Overall Study|Other|4|||
126262717|NCT00536484|454252910|FG001|Overall Study|Other|0|||
126262718|NCT01506908|454252911|FG000|Overall Study|Adverse Event|1|||
126359736|NCT05587998|454609056|FG001|Overall Study|Non-compliance with study procedures|1|||
126262719|NCT01506908|454252912|FG001|Overall Study|Adverse Event|0|||
125880287|NCT01074970|452858829|FG003|Overall Study|Lost to Follow-up|0|||
125880288|NCT01074970|452858826|FG000|Overall Study|Withdrawal by Subject|0|||
126096618|NCT03527550|453646513|FG001|Overall Study|Lost to Follow-up|2|||
125880289|NCT01074970|452858827|FG001|Overall Study|Withdrawal by Subject|0|||
126262720|NCT00440115|454252916|FG000|Overall Study|Death|7|||
126262721|NCT00440115|454252917|FG001|Overall Study|Death|9|||
126262722|NCT00440115|454252918|FG002|Overall Study|Death|5|||
126262723|NCT00440115|454252916|FG000|Overall Study|Incarceration|0|||
126262724|NCT00440115|454252917|FG001|Overall Study|Incarceration|2|||
125880290|NCT01074970|452858828|FG002|Overall Study|Withdrawal by Subject|6|||
126031909|NCT03719443|453413999|FG003|Overall Study|Lost to Follow-up|0|||
126262725|NCT00440115|454252918|FG002|Overall Study|Incarceration|1|||
126262726|NCT00206102|454252920|FG000|Overall Study|Adverse Event|119|||
126262727|NCT00206102|454252921|FG001|Overall Study|Adverse Event|82|||
126262728|NCT00206102|454252920|FG000|Overall Study|Protocol Violation|0|||
126262729|NCT00206102|454252921|FG001|Overall Study|Protocol Violation|2|||
126262730|NCT00206102|454252920|FG000|Overall Study|Lack of therapeutic response|16|||
126262731|NCT00206102|454252921|FG001|Overall Study|Lack of therapeutic response|11|||
126262732|NCT00206102|454252920|FG000|Overall Study|Lost to Follow-up|95|||
126262733|NCT00206102|454252921|FG001|Overall Study|Lost to Follow-up|66|||
126262734|NCT00206102|454252920|FG000|Overall Study|Withdrawal by Subject|118|||
126262735|NCT00206102|454252921|FG001|Overall Study|Withdrawal by Subject|101|||
126262736|NCT00206102|454252920|FG000|Overall Study|Study-specific discontinuation criteria|18|||
126262737|NCT00206102|454252921|FG001|Overall Study|Study-specific discontinuation criteria|17|||
126262738|NCT00206102|454252920|FG000|Overall Study|None of those categories|42|||
126262739|NCT00206102|454252921|FG001|Overall Study|None of those categories|36|||
126262740|NCT02953678|454252922|FG000|Overall Study|Adverse Event|20|||
126262741|NCT02953678|454252922|FG000|Overall Study|Death|7|||
126262742|NCT02953678|454252922|FG000|Overall Study|Physician Decision|23|||
126262743|NCT02953678|454252922|FG000|Overall Study|Progressive Disease of GVHD|7|||
126262744|NCT02953678|454252922|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
126262745|NCT02953678|454252922|FG000|Overall Study|Withdrawal by participant|3|||
126262746|NCT02953678|454252922|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
126262747|NCT02953678|454252922|FG000|Overall Study|Participants were transferred to commercial product.|3|||
126262748|NCT04678817|454254467|FG000|Overall Study|Lost to Follow-up|28|||
126262749|NCT04678817|454254468|FG001|Overall Study|Lost to Follow-up|0|||
126262750|NCT04678817|454254469|FG002|Overall Study|Lost to Follow-up|0|||
126262751|NCT00784134|454254476|FG000|Overall Study|Lost to Follow-up|3|||
126262752|NCT00784134|454254477|FG001|Overall Study|Lost to Follow-up|6|||
126262753|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
126262754|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
126262755|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
126262756|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
126262757|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
126262758|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
126262759|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
126262760|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
126262761|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
126262762|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
126262763|NCT03785145|454254478|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
126262764|NCT03785145|454254479|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
126262765|NCT03785145|454254478|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
126262766|NCT03785145|454254479|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
126262767|NCT03785145|454254478|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
126262768|NCT03785145|454254479|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
126262769|NCT03785145|454254478|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
126262770|NCT03785145|454254479|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
126262771|NCT03785145|454254478|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
126262772|NCT03785145|454254479|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
126262773|NCT03785145|454254478|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
126262774|NCT03785145|454254479|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
126262775|NCT03686150|454254480|FG000|Overall Study|Withdrawal by Subject|1|||
126262776|NCT03686150|454254481|FG001|Overall Study|Withdrawal by Subject|1|||
126262777|NCT03686150|454254482|FG002|Overall Study|Withdrawal by Subject|1|||
126262778|NCT03686150|454254483|FG003|Overall Study|Withdrawal by Subject|0|||
126262779|NCT03686150|454254484|FG004|Overall Study|Withdrawal by Subject|1|||
126262780|NCT03686150|454254485|FG005|Overall Study|Withdrawal by Subject|2|||
126262781|NCT03686150|454254480|FG000|Overall Study|Physician Decision|1|||
126262782|NCT03686150|454254481|FG001|Overall Study|Physician Decision|0|||
126262783|NCT03686150|454254482|FG002|Overall Study|Physician Decision|0|||
126031910|NCT03719443|453414000|FG004|Overall Study|Lost to Follow-up|1|||
126031911|NCT03719443|453414001|FG005|Overall Study|Lost to Follow-up|0|||
126031912|NCT03719443|453414002|FG006|Overall Study|Lost to Follow-up|1|||
126031913|NCT03719443|453413996|FG000|Overall Study|Withdrawal by Subject|0|||
126262784|NCT03686150|454254483|FG003|Overall Study|Physician Decision|0|||
126262785|NCT03686150|454254484|FG004|Overall Study|Physician Decision|0|||
126262786|NCT03686150|454254485|FG005|Overall Study|Physician Decision|1|||
126262787|NCT03686150|454254480|FG000|Overall Study|Lost to Follow-up|0|||
126262788|NCT03686150|454254481|FG001|Overall Study|Lost to Follow-up|1|||
126262789|NCT03686150|454254482|FG002|Overall Study|Lost to Follow-up|0|||
126031914|NCT03719443|453413997|FG001|Overall Study|Withdrawal by Subject|0|||
126096619|NCT03527550|453646512|FG000|Overall Study|Withdrawal by Subject|4|||
126096620|NCT03527550|453646513|FG001|Overall Study|Withdrawal by Subject|1|||
126096621|NCT03527550|453646512|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
126096622|NCT03527550|453646513|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
126096623|NCT00911937|453646514|FG000|Overall Study|Death|1|||
126096624|NCT00911937|453646515|FG001|Overall Study|Death|0|||
126096625|NCT00911937|453646514|FG000|Overall Study|Lost to Follow-up|8|||
125880291|NCT01074970|452858829|FG003|Overall Study|Withdrawal by Subject|4|||
125880292|NCT05565742|452858834|FG000|Overall Study|Withdrawal by Subject|0|||
125880293|NCT05565742|452858835|FG001|Overall Study|Withdrawal by Subject|0|||
125880294|NCT05565742|452858836|FG002|Overall Study|Withdrawal by Subject|2|||
125880295|NCT05565742|452858837|FG003|Overall Study|Withdrawal by Subject|2|||
125880296|NCT05565742|452858838|FG004|Overall Study|Withdrawal by Subject|2|||
125880297|NCT05565742|452858834|FG000|Overall Study|Death|1|||
125880298|NCT05565742|452858835|FG001|Overall Study|Death|0|||
126031915|NCT03719443|453413998|FG002|Overall Study|Withdrawal by Subject|1|||
126031916|NCT03719443|453413999|FG003|Overall Study|Withdrawal by Subject|0|||
126031917|NCT03719443|453414000|FG004|Overall Study|Withdrawal by Subject|0|||
126031918|NCT03719443|453414001|FG005|Overall Study|Withdrawal by Subject|0|||
126031919|NCT03719443|453414002|FG006|Overall Study|Withdrawal by Subject|0|||
126031920|NCT05051124|453414003|FG000|Overall Study|Lost to Follow-up|2|||
126031921|NCT05051124|453414003|FG000|Overall Study|Withdrawal by Subject|1|||
126031922|NCT05051124|453414003|FG000|Overall Study|Residential relocation|2|||
126031923|NCT05051124|453414003|FG000|Overall Study|Death|1|||
126031924|NCT04782973|453414004|FG000|Overall Study|Withdrawal by Subject|5|||
126031925|NCT04782973|453414004|FG000|Overall Study|Protocol Violation|6|||
126031926|NCT04782973|453414004|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
126031927|NCT04924660|453414005|FG000|United States|Death|29|||
126031928|NCT04924660|453414006|FG001|United States|Death|32|||
126031929|NCT04924660|453414007|FG002|United States|Death|34|||
126031930|NCT04924660|453414008|FG003|United States|Death|25|||
126031931|NCT04924660|453414009|FG004|United States|Death|26|||
126031932|NCT04924660|453414010|FG005|United States|Death|23|||
126031933|NCT04924660|453414005|FG000|United States|Lost to Follow-up|15|||
126031934|NCT04924660|453414006|FG001|United States|Lost to Follow-up|10|||
126031935|NCT04924660|453414007|FG002|United States|Lost to Follow-up|13|||
126031936|NCT04924660|453414008|FG003|United States|Lost to Follow-up|5|||
126031937|NCT04924660|453414009|FG004|United States|Lost to Follow-up|19|||
126031938|NCT04924660|453414010|FG005|United States|Lost to Follow-up|20|||
126031939|NCT04924660|453414005|FG000|United States|Withdrawal by Subject|8|||
126031940|NCT04924660|453414006|FG001|United States|Withdrawal by Subject|3|||
126031941|NCT04924660|453414007|FG002|United States|Withdrawal by Subject|3|||
126031942|NCT04924660|453414008|FG003|United States|Withdrawal by Subject|3|||
126031943|NCT04924660|453414009|FG004|United States|Withdrawal by Subject|8|||
126031944|NCT04924660|453414010|FG005|United States|Withdrawal by Subject|4|||
126031945|NCT04924660|453414005|FG000|Spain|Death|0|||
126031946|NCT04924660|453414006|FG001|Spain|Death|0|||
126031947|NCT04924660|453414007|FG002|Spain|Death|0|||
126031948|NCT04924660|453414008|FG003|Spain|Death|0|||
126031949|NCT04924660|453414009|FG004|Spain|Death|0|||
126031950|NCT04924660|453414010|FG005|Spain|Death|2|||
126031951|NCT04924660|453414005|FG000|Spain|Lost to Follow-up|0|||
126096626|NCT00911937|453646515|FG001|Overall Study|Lost to Follow-up|5|||
126262790|NCT03686150|454254483|FG003|Overall Study|Lost to Follow-up|0|||
126262791|NCT03686150|454254484|FG004|Overall Study|Lost to Follow-up|0|||
126262792|NCT03686150|454254485|FG005|Overall Study|Lost to Follow-up|0|||
126262793|NCT03250299|454254488|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
126262794|NCT03250299|454254489|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
126262795|NCT03250299|454254490|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
126262796|NCT03250299|454254491|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
126262797|NCT03250299|454254492|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
126262798|NCT03250299|454254488|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
126262799|NCT03250299|454254489|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
126262800|NCT03250299|454254490|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
126262801|NCT03250299|454254491|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
126262802|NCT03250299|454254492|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
126262803|NCT03250299|454254488|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
126262804|NCT03250299|454254489|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
126262805|NCT03250299|454254490|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
126031952|NCT04924660|453414006|FG001|Spain|Lost to Follow-up|0|||
126031953|NCT04924660|453414007|FG002|Spain|Lost to Follow-up|0|||
126031954|NCT04924660|453414008|FG003|Spain|Lost to Follow-up|0|||
126031955|NCT04924660|453414009|FG004|Spain|Lost to Follow-up|1|||
125880299|NCT05565742|452858836|FG002|Overall Study|Death|0|||
126031956|NCT04924660|453414010|FG005|Spain|Lost to Follow-up|0|||
126031957|NCT04924660|453414005|FG000|Brazil|Death|0|||
126031958|NCT04924660|453414006|FG001|Brazil|Death|0|||
126031959|NCT04924660|453414007|FG002|Brazil|Death|0|||
126031960|NCT04924660|453414008|FG003|Brazil|Death|0|||
126031961|NCT04924660|453414009|FG004|Brazil|Death|1|||
126031962|NCT04924660|453414010|FG005|Brazil|Death|0|||
126031963|NCT04924660|453414005|FG000|Italy|Lost to Follow-up|0|||
126031964|NCT04924660|453414006|FG001|Italy|Lost to Follow-up|0|||
126031965|NCT04924660|453414007|FG002|Italy|Lost to Follow-up|0|||
126031966|NCT04924660|453414008|FG003|Italy|Lost to Follow-up|0|||
126262806|NCT03250299|454254491|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
126262807|NCT03250299|454254492|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
126262808|NCT03250299|454254488|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
126262809|NCT03250299|454254489|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
126262810|NCT03250299|454254490|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
126262811|NCT03250299|454254491|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
126262812|NCT03250299|454254492|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
126262813|NCT01213836|454254506|FG000|Period 1, First Intervention|Adverse Event|2|||
126262814|NCT01213836|454254507|FG001|Period 1, First Intervention|Adverse Event|1|||
126262815|NCT01213836|454254506|FG000|Period 1, First Intervention|Protocol Violation|0|||
126262816|NCT01213836|454254507|FG001|Period 1, First Intervention|Protocol Violation|1|||
126262817|NCT01213836|454254506|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
126262818|NCT01213836|454254507|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
126262819|NCT00255151|454254508|FG000|Overall Study|Adverse Event|10|||
126262820|NCT00255151|454254509|FG001|Overall Study|Adverse Event|6|||
126262821|NCT00255151|454254510|FG002|Overall Study|Adverse Event|9|||
126262822|NCT00255151|454254508|FG000|Overall Study|Lost to Follow-up|4|||
126262823|NCT00255151|454254509|FG001|Overall Study|Lost to Follow-up|3|||
126262824|NCT00255151|454254510|FG002|Overall Study|Lost to Follow-up|4|||
126262825|NCT00255151|454254508|FG000|Overall Study|Withdrawal by Subject|18|||
126262826|NCT00255151|454254509|FG001|Overall Study|Withdrawal by Subject|17|||
126262827|NCT00255151|454254510|FG002|Overall Study|Withdrawal by Subject|8|||
126262828|NCT00255151|454254508|FG000|Overall Study|Noncompliance|0|||
126262829|NCT00255151|454254509|FG001|Overall Study|Noncompliance|1|||
126262830|NCT00255151|454254510|FG002|Overall Study|Noncompliance|2|||
126262831|NCT00255151|454254508|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
126262832|NCT00255151|454254509|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
126262833|NCT00255151|454254510|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
126262834|NCT00255151|454254508|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
126262835|NCT00255151|454254509|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
126262836|NCT00255151|454254510|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
126262837|NCT00255151|454254508|FG000|Overall Study|Possible Barrett's Esophagus|1|||
126262838|NCT00255151|454254509|FG001|Overall Study|Possible Barrett's Esophagus|3|||
126262839|NCT00255151|454254510|FG002|Overall Study|Possible Barrett's Esophagus|8|||
126262840|NCT00255151|454254508|FG000|Overall Study|Esophageal Stricture|0|||
126262841|NCT00255151|454254509|FG001|Overall Study|Esophageal Stricture|0|||
126262842|NCT00255151|454254510|FG002|Overall Study|Esophageal Stricture|1|||
126262843|NCT00255151|454254508|FG000|Overall Study|Therapeutic Failure|11|||
126262844|NCT00255151|454254509|FG001|Overall Study|Therapeutic Failure|2|||
126262845|NCT00255151|454254510|FG002|Overall Study|Therapeutic Failure|3|||
126262846|NCT02676284|454254511|FG000|Overall Study|Withdrawal by Subject|1|||
126262847|NCT01685073|454254512|FG000|Overall Study|Lost to Follow-up|6|||
126262848|NCT01685073|454254513|FG001|Overall Study|Lost to Follow-up|8|||
126262849|NCT01685073|454254512|FG000|Overall Study|Withdrawal by Subject|24|||
126262850|NCT01685073|454254513|FG001|Overall Study|Withdrawal by Subject|24|||
126262851|NCT00107042|454254518|FG000|Overall Study|Lost to Follow-up|9|||
126262852|NCT00107042|454254519|FG001|Overall Study|Lost to Follow-up|7|||
126262853|NCT00107042|454254518|FG000|Overall Study|Withdrawal by Subject|6|||
126262854|NCT00107042|454254519|FG001|Overall Study|Withdrawal by Subject|1|||
126262855|NCT00107042|454254518|FG000|Overall Study|Moved out of area|5|||
126262856|NCT00107042|454254519|FG001|Overall Study|Moved out of area|3|||
126262857|NCT00107042|454254518|FG000|Overall Study|Pregnancy|1|||
126262858|NCT00107042|454254519|FG001|Overall Study|Pregnancy|1|||
126262859|NCT00107042|454254518|FG000|Overall Study|Inadvertent enrollment|0|||
126031967|NCT04924660|453414009|FG004|Italy|Lost to Follow-up|0|||
126031968|NCT04924660|453414010|FG005|Italy|Lost to Follow-up|1|||
126096627|NCT00911937|453646514|FG000|Overall Study|Withdrawal by Subject|10|||
126096628|NCT00911937|453646515|FG001|Overall Study|Withdrawal by Subject|7|||
126031969|NCT04924660|453414005|FG000|South Africa|Death|0|||
126031970|NCT04924660|453414006|FG001|South Africa|Death|0|||
126262860|NCT00107042|454254519|FG001|Overall Study|Inadvertent enrollment|1|||
126359737|NCT03892915|454609060|FG000|Overall Study|Lost to Follow-up|6|||
126262861|NCT00107042|454254518|FG000|Overall Study|vaccinated outside window|1|||
126262862|NCT00107042|454254519|FG001|Overall Study|vaccinated outside window|1|||
126262863|NCT00107042|454254518|FG000|Overall Study|Disallowed medications|0|||
126262864|NCT00107042|454254519|FG001|Overall Study|Disallowed medications|2|||
126262865|NCT01221090|454254521|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
126262866|NCT01221090|454254522|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
126262867|NCT01221090|454254523|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
126359738|NCT03892915|454609061|FG001|Overall Study|Lost to Follow-up|12|||
126031971|NCT04924660|453414007|FG002|South Africa|Death|0|||
126031972|NCT04924660|453414008|FG003|South Africa|Death|0|||
126031973|NCT04924660|453414009|FG004|South Africa|Death|0|||
126031974|NCT04924660|453414010|FG005|South Africa|Death|1|||
126031975|NCT04924660|453414005|FG000|South Africa|Lost to Follow-up|0|||
126031976|NCT04924660|453414006|FG001|South Africa|Lost to Follow-up|0|||
126031977|NCT04924660|453414007|FG002|South Africa|Lost to Follow-up|0|||
126031978|NCT04924660|453414008|FG003|South Africa|Lost to Follow-up|0|||
126031979|NCT04924660|453414009|FG004|South Africa|Lost to Follow-up|0|||
126031980|NCT04924660|453414010|FG005|South Africa|Lost to Follow-up|1|||
126031981|NCT06205407|453414011|FG000|Period 2|Withdrawal by Subject|0|||
126031982|NCT06205407|453414012|FG001|Period 2|Withdrawal by Subject|1|||
126031983|NCT06205407|453414011|FG000|Period 2|Adverse Event|2|||
126031984|NCT06205407|453414012|FG001|Period 2|Adverse Event|1|||
126031985|NCT03557697|453414013|FG000|Overall Study|Withdrawal by Subject|2|||
126031986|NCT03557697|453414014|FG001|Overall Study|Withdrawal by Subject|4|||
126031987|NCT06491433|453414015|FG000|Overall Study|Protocol Violation|51|||
126096629|NCT00911937|453646514|FG000|Overall Study|Withdrawn due to pregnancy|1|||
126262868|NCT01221090|454254524|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
126262869|NCT01221090|454254521|FG000|Overall Study|Withdrawal by Subject|0|||
126262870|NCT01221090|454254522|FG001|Overall Study|Withdrawal by Subject|22|||
126262871|NCT01221090|454254523|FG002|Overall Study|Withdrawal by Subject|27|||
126262872|NCT01221090|454254524|FG003|Overall Study|Withdrawal by Subject|2|||
126262873|NCT00708708|454254525|FG000|Overall Study|Another therapy instead of Enbrel|141|||
126262874|NCT00708708|454254525|FG000|Overall Study|Lost to Follow-up|52|||
126262875|NCT00708708|454254525|FG000|Overall Study|Withdrawal by Subject|51|||
126262876|NCT00708708|454254525|FG000|Overall Study|Intolerance|42|||
126262877|NCT00708708|454254525|FG000|Overall Study|Another therapy along with Enbrel|15|||
126262878|NCT00708708|454254525|FG000|Overall Study|Other unspecified|11|||
126262879|NCT00708708|454254525|FG000|Overall Study|Good effectiveness|9|||
126262880|NCT00708708|454254525|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
126262881|NCT00708708|454254525|FG000|Overall Study|Administrative reasons|7|||
126262882|NCT00708708|454254525|FG000|Overall Study|Lack of effectiveness|4|||
126262883|NCT00708708|454254525|FG000|Overall Study|Lack of compliance|3|||
126262884|NCT00708708|454254525|FG000|Overall Study|Pregnancy|3|||
126262885|NCT00708708|454254525|FG000|Overall Study|Adverse Event|3|||
126262886|NCT00708708|454254525|FG000|Overall Study|Missing values|392|||
126262887|NCT04776746|454254529|FG000|Overall Study|Study terminated by sponsor|61|||
126262888|NCT04776746|454254529|FG000|Overall Study|Adverse Event|5|||
126262889|NCT04776746|454254529|FG000|Overall Study|Death|4|||
126262890|NCT04776746|454254529|FG000|Overall Study|Lack of Efficacy|3|||
126262891|NCT04776746|454254529|FG000|Overall Study|Noncompliance with study drug|2|||
126262892|NCT04776746|454254529|FG000|Overall Study|Not related to COVID-19|2|||
126262893|NCT00440466|454254530|FG000|Overall Study|Death|3|||
126262894|NCT00440466|454254531|FG001|Overall Study|Death|2|||
126031988|NCT06491433|453414015|FG000|Overall Study|consent withdrawal|2|||
126262895|NCT00440466|454254532|FG002|Overall Study|Death|9|||
125880300|NCT05565742|452858837|FG003|Overall Study|Death|0|||
126031989|NCT06491433|453414015|FG000|Overall Study|screen failure|1|||
126031990|NCT04749615|453414017|FG000|Overall Study|Lost to Follow-up|6|||
126096630|NCT00911937|453646515|FG001|Overall Study|Withdrawn due to pregnancy|0|||
126262896|NCT00440466|454254530|FG000|Overall Study|Adverse Event|3|||
126262897|NCT00440466|454254531|FG001|Overall Study|Adverse Event|4|||
126262898|NCT00440466|454254532|FG002|Overall Study|Adverse Event|11|||
126262899|NCT00440466|454254530|FG000|Overall Study|Lost to Follow-up|1|||
126262900|NCT00440466|454254531|FG001|Overall Study|Lost to Follow-up|0|||
126262901|NCT00440466|454254532|FG002|Overall Study|Lost to Follow-up|2|||
126262902|NCT00440466|454254530|FG000|Overall Study|Physician Decision|2|||
126262903|NCT00440466|454254531|FG001|Overall Study|Physician Decision|0|||
126262904|NCT00440466|454254532|FG002|Overall Study|Physician Decision|1|||
126262905|NCT00440466|454254530|FG000|Overall Study|Protocol Violation|2|||
126262906|NCT00440466|454254531|FG001|Overall Study|Protocol Violation|0|||
126262907|NCT00440466|454254532|FG002|Overall Study|Protocol Violation|4|||
126262908|NCT00440466|454254530|FG000|Overall Study|Withdrawal by Subject|2|||
126262909|NCT00440466|454254531|FG001|Overall Study|Withdrawal by Subject|5|||
126262910|NCT00440466|454254532|FG002|Overall Study|Withdrawal by Subject|9|||
126262911|NCT00440466|454254530|FG000|Overall Study|Began Dialysis|0|||
126262912|NCT00440466|454254531|FG001|Overall Study|Began Dialysis|0|||
126262913|NCT00440466|454254532|FG002|Overall Study|Began Dialysis|1|||
126262914|NCT00440466|454254530|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
126262915|NCT00440466|454254531|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
126262916|NCT00440466|454254532|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
126262917|NCT00743509|454254533|FG000|Overall Study|Withdrawal by Subject|2|||
126262918|NCT03768726|454254538|FG000|Treatment Phase|Adverse Event|2|||
126262919|NCT03768726|454254539|FG001|Treatment Phase|Adverse Event|2|||
126262920|NCT03768726|454254538|FG000|Treatment Phase|Lost to Follow-up|1|||
126262921|NCT03768726|454254539|FG001|Treatment Phase|Lost to Follow-up|0|||
126262922|NCT03768726|454254538|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
126262923|NCT03768726|454254539|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
126262924|NCT03768726|454254538|FG000|Treatment Phase|Withdrawal by Subject|3|||
126262925|NCT03768726|454254539|FG001|Treatment Phase|Withdrawal by Subject|1|||
126262926|NCT03768726|454254538|FG000|Follow-Up|Adverse Event|2|||
126262927|NCT03768726|454254539|FG001|Follow-Up|Adverse Event|2|||
126262928|NCT03768726|454254538|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
126262929|NCT03768726|454254539|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
126262930|NCT03768726|454254538|FG000|Follow-Up|Withdrawal by Subject|2|||
126262931|NCT03768726|454254539|FG001|Follow-Up|Withdrawal by Subject|0|||
126262932|NCT03768726|454254538|FG000|Follow-Up|Other|1|||
126262933|NCT03768726|454254539|FG001|Follow-Up|Other|0|||
126262934|NCT01787279|454254540|FG000|Overall Study|Lost to Follow-up|2|||
126262935|NCT01787279|454254540|FG000|Overall Study|Lack of Efficacy|1|||
126262936|NCT00418522|454254541|FG000|Overall Study|Adverse Event|7|||
126262937|NCT00418522|454254542|FG001|Overall Study|Adverse Event|1|||
126262938|NCT00418522|454254541|FG000|Overall Study|Lack of Efficacy|1|||
126262939|NCT00418522|454254542|FG001|Overall Study|Lack of Efficacy|3|||
126262940|NCT00418522|454254541|FG000|Overall Study|Lost to Follow-up|10|||
126262941|NCT00418522|454254542|FG001|Overall Study|Lost to Follow-up|4|||
126262942|NCT00418522|454254541|FG000|Overall Study|Withdrawal by Subject|31|||
126262943|NCT00418522|454254542|FG001|Overall Study|Withdrawal by Subject|7|||
126262944|NCT00418522|454254541|FG000|Overall Study|Other|27|||
126262945|NCT00418522|454254542|FG001|Overall Study|Other|23|||
126262946|NCT00418522|454254541|FG000|Overall Study|Randomized but did not receive treatment|7|||
126262947|NCT00418522|454254542|FG001|Overall Study|Randomized but did not receive treatment|4|||
126262948|NCT02695719|454254543|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
126262949|NCT02695719|454254544|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
126262950|NCT02695719|454254543|FG000|Overall Study|Significant Protocol Deviation|0|||
126262951|NCT02695719|454254544|FG001|Overall Study|Significant Protocol Deviation|1|||
126262952|NCT02695719|454254543|FG000|Overall Study|Voluntary Withdrawal|1|||
126262953|NCT02695719|454254544|FG001|Overall Study|Voluntary Withdrawal|0|||
126262954|NCT04109313|454254548|FG000|Overall Study|Pregnancy|1|||
126262955|NCT04109313|454254548|FG000|Overall Study|Adverse Event|11|||
126262956|NCT04109313|454254548|FG000|Overall Study|Lack of Efficacy|11|||
126262957|NCT04109313|454254548|FG000|Overall Study|Lost to Follow-up|1|||
126262958|NCT04109313|454254548|FG000|Overall Study|Physician Decision|2|||
126262959|NCT04109313|454254548|FG000|Overall Study|Subject Decision|13|||
126262960|NCT04109313|454254548|FG000|Overall Study|Covid-19 situation|2|||
126262961|NCT00892281|454254552|FG000|Overall Study|Adverse Event|65|||
126262962|NCT00892281|454254553|FG001|Overall Study|Adverse Event|8|||
126262963|NCT00892281|454254552|FG000|Overall Study|Lost to Follow-up|81|||
126262964|NCT00892281|454254553|FG001|Overall Study|Lost to Follow-up|8|||
126262965|NCT00892281|454254552|FG000|Overall Study|Pregnancy|1|||
126262966|NCT00892281|454254553|FG001|Overall Study|Pregnancy|0|||
126262967|NCT00892281|454254552|FG000|Overall Study|Protocol Violation|7|||
126262968|NCT00892281|454254553|FG001|Overall Study|Protocol Violation|2|||
126262969|NCT00892281|454254552|FG000|Overall Study|Withdrawal by Subject|86|||
126262970|NCT00892281|454254553|FG001|Overall Study|Withdrawal by Subject|14|||
126262971|NCT00892281|454254552|FG000|Overall Study|Subject failed to return for final visit|2|||
126262972|NCT00892281|454254553|FG001|Overall Study|Subject failed to return for final visit|0|||
126359739|NCT03892915|454609060|FG000|Overall Study|Death|0|||
126359740|NCT03892915|454609061|FG001|Overall Study|Death|2|||
126359741|NCT03892915|454609060|FG000|Overall Study|Withdrawal by Subject|1|||
126359742|NCT03892915|454609061|FG001|Overall Study|Withdrawal by Subject|1|||
126359743|NCT03892915|454609060|FG000|Overall Study|unsuccessful delivery|13|||
126359744|NCT03892915|454609061|FG001|Overall Study|unsuccessful delivery|18|||
126359745|NCT01181128|454609062|FG000|Overall Study|Withdrawal by Subject|2|||
126096631|NCT00911937|453646514|FG000|Overall Study|Adverse Event|11|||
126096632|NCT00911937|453646515|FG001|Overall Study|Adverse Event|25|||
126096633|NCT00911937|453646514|FG000|Overall Study|Lack of Efficacy|11|||
126096634|NCT00911937|453646515|FG001|Overall Study|Lack of Efficacy|6|||
126096635|NCT00911937|453646514|FG000|Overall Study|Did not meet inclusion criteria|9|||
126096636|NCT00911937|453646515|FG001|Overall Study|Did not meet inclusion criteria|11|||
126096637|NCT00911937|453646514|FG000|Overall Study|Protocol Violation|14|||
126096638|NCT00911937|453646515|FG001|Overall Study|Protocol Violation|23|||
126031991|NCT04749615|453414018|FG001|Overall Study|Lost to Follow-up|10|||
126031992|NCT03611491|453414019|FG000|Overall Study|Lost to Follow-up|1|||
126031993|NCT04676022|453414020|FG000|Overall Study|Screen Failure/|1|||
126031994|NCT04676022|453414021|FG001|Overall Study|Screen Failure/|1|||
126031995|NCT04676022|453414022|FG002|Overall Study|Screen Failure/|85|||
126031996|NCT04676022|453414020|FG000|Overall Study|Lost to Follow-up|1|||
126096639|NCT00911937|453646514|FG000|Overall Study|Randomized but not treated|13|||
126096640|NCT00911937|453646515|FG001|Overall Study|Randomized but not treated|13|||
126096641|NCT00911937|453646514|FG000|Overall Study|Other|9|||
126096642|NCT00911937|453646515|FG001|Overall Study|Other|5|||
126096643|NCT01498679|453646517|FG000|Overall Study|Adverse Event|1|||
126096644|NCT01498679|453646518|FG001|Overall Study|Adverse Event|4|||
126096645|NCT01498679|453646517|FG000|Overall Study|Lack of Efficacy|72|||
126096646|NCT01498679|453646518|FG001|Overall Study|Lack of Efficacy|12|||
126096647|NCT01498679|453646517|FG000|Overall Study|Protocol Violation|4|||
126096648|NCT01498679|453646518|FG001|Overall Study|Protocol Violation|0|||
126096649|NCT01498679|453646517|FG000|Overall Study|Physician Decision|0|||
126096650|NCT01498679|453646518|FG001|Overall Study|Physician Decision|2|||
126096651|NCT01498679|453646517|FG000|Overall Study|Withdrawal by Subject|12|||
126096652|NCT01498679|453646518|FG001|Overall Study|Withdrawal by Subject|4|||
126096653|NCT03212989|453646523|FG000|Overall Study|Physician Decision|8|||
126096654|NCT00252577|453646526|FG000|Overall Study|Lost to Follow-up|20|||
126096655|NCT01801735|453646529|FG000|Overall Study|Adverse Event|79|||
126096656|NCT01801735|453646529|FG000|Overall Study|Lack of Efficacy|28|||
126096657|NCT01801735|453646529|FG000|Overall Study|Withdrawal by Subject|27|||
126096658|NCT01801735|453646529|FG000|Overall Study|Protocol Violation|25|||
126096659|NCT01801735|453646529|FG000|Overall Study|Lost to Follow-up|15|||
126096660|NCT01801735|453646529|FG000|Overall Study|Non-compliance with Trial Drug|13|||
126031997|NCT04676022|453414021|FG001|Overall Study|Lost to Follow-up|1|||
126031998|NCT04676022|453414022|FG002|Overall Study|Lost to Follow-up|0|||
126031999|NCT04676022|453414020|FG000|Overall Study|Adverse Event|2|||
126032000|NCT04676022|453414021|FG001|Overall Study|Adverse Event|0|||
126032001|NCT04676022|453414022|FG002|Overall Study|Adverse Event|1|||
126032002|NCT04676022|453414020|FG000|Overall Study|Physician Decision|2|||
126032003|NCT04676022|453414021|FG001|Overall Study|Physician Decision|0|||
126032004|NCT04676022|453414022|FG002|Overall Study|Physician Decision|1|||
126032005|NCT04676022|453414020|FG000|Overall Study|Withdrawal by Subject|3|||
126032006|NCT04676022|453414021|FG001|Overall Study|Withdrawal by Subject|1|||
126032007|NCT04676022|453414022|FG002|Overall Study|Withdrawal by Subject|6|||
126032008|NCT04676022|453414020|FG000|Overall Study|Will not move forward with permanent implant|6|||
126032009|NCT04676022|453414021|FG001|Overall Study|Will not move forward with permanent implant|0|||
126032010|NCT04676022|453414022|FG002|Overall Study|Will not move forward with permanent implant|0|||
126032011|NCT04676022|453414020|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
126032012|NCT04676022|453414021|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
126032013|NCT04676022|453414022|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
125880301|NCT05565742|452858838|FG004|Overall Study|Death|0|||
125880302|NCT05565742|452858834|FG000|Overall Study|Participant Travelled Abroad|0|||
126096661|NCT01801735|453646529|FG000|Overall Study|Physician Decision|3|||
126096662|NCT01801735|453646529|FG000|Overall Study|Death|1|||
126096663|NCT01801735|453646529|FG000|Overall Study|Other, including site closure|19|||
126032014|NCT03194217|453414037|FG000|Overall Study|Adverse Event|0|||
126032015|NCT03194217|453414038|FG001|Overall Study|Adverse Event|2|||
126032016|NCT03194217|453414039|FG002|Overall Study|Adverse Event|3|||
126032017|NCT03194217|453414040|FG003|Overall Study|Adverse Event|3|||
126032018|NCT03194217|453414037|FG000|Overall Study|Failure to meet randomisation criteria|0|||
126262973|NCT00892281|454254552|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
126262974|NCT00892281|454254553|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
126262975|NCT00892281|454254552|FG000|Overall Study|Final visit completed 4 weeks late|0|||
126262976|NCT00892281|454254553|FG001|Overall Study|Final visit completed 4 weeks late|1|||
126262977|NCT00892281|454254552|FG000|Overall Study|Subject completed day after study closed|1|||
126262978|NCT00892281|454254553|FG001|Overall Study|Subject completed day after study closed|0|||
126262979|NCT00892281|454254552|FG000|Overall Study|Family emergency|1|||
126262980|NCT00892281|454254553|FG001|Overall Study|Family emergency|0|||
126262981|NCT00892281|454254552|FG000|Overall Study|Last visit not done - death in family|1|||
126262982|NCT00892281|454254553|FG001|Overall Study|Last visit not done - death in family|0|||
126262983|NCT00892281|454254552|FG000|Overall Study|Did not meet incl/excl criteria|1|||
126262984|NCT00892281|454254553|FG001|Overall Study|Did not meet incl/excl criteria|0|||
126262985|NCT00892281|454254552|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
126262986|NCT00892281|454254553|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
126262987|NCT00892281|454254552|FG000|Overall Study|Unable to redeem the drug voucher|1|||
126262988|NCT00892281|454254553|FG001|Overall Study|Unable to redeem the drug voucher|0|||
126262989|NCT00892281|454254552|FG000|Overall Study|Subject not good candidate for study|1|||
126262990|NCT00892281|454254553|FG001|Overall Study|Subject not good candidate for study|0|||
126262991|NCT00892281|454254552|FG000|Overall Study|Subject did not return for any visits|1|||
126262992|NCT00892281|454254553|FG001|Overall Study|Subject did not return for any visits|0|||
126262993|NCT00892281|454254552|FG000|Overall Study|Subject missed several visits/lost meds|1|||
126262994|NCT00892281|454254553|FG001|Overall Study|Subject missed several visits/lost meds|0|||
126262995|NCT00892281|454254552|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
126262996|NCT00892281|454254553|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
126262997|NCT00892281|454254552|FG000|Overall Study|Scheduled for knee replacement|0|||
126262998|NCT00892281|454254553|FG001|Overall Study|Scheduled for knee replacement|1|||
126262999|NCT00892281|454254552|FG000|Overall Study|PI complained of inadequate compensation|3|||
126263000|NCT00892281|454254553|FG001|Overall Study|PI complained of inadequate compensation|0|||
126263001|NCT00892281|454254552|FG000|Overall Study|Subject lost interest in program|0|||
126263002|NCT00892281|454254553|FG001|Overall Study|Subject lost interest in program|1|||
126263003|NCT00892281|454254552|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
126263004|NCT00892281|454254553|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
126263005|NCT00892281|454254552|FG000|Overall Study|Death in family|1|||
126263006|NCT00892281|454254553|FG001|Overall Study|Death in family|0|||
126263007|NCT00892281|454254552|FG000|Overall Study|Lack of efficacy of study product|2|||
126263008|NCT00892281|454254553|FG001|Overall Study|Lack of efficacy of study product|0|||
126263009|NCT00892281|454254552|FG000|Overall Study|Subject not seen by PI at final visit|1|||
126263010|NCT00892281|454254553|FG001|Overall Study|Subject not seen by PI at final visit|0|||
126263011|NCT00892281|454254552|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
126263012|NCT00892281|454254553|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
126263013|NCT00892281|454254552|FG000|Overall Study|Missed multiple visits|1|||
126263014|NCT00892281|454254553|FG001|Overall Study|Missed multiple visits|0|||
126263015|NCT00892281|454254552|FG000|Overall Study|Missed visits rescheduled out of window|1|||
126263016|NCT00892281|454254553|FG001|Overall Study|Missed visits rescheduled out of window|0|||
126263017|NCT00892281|454254552|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
126263018|NCT00892281|454254553|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
126263019|NCT00892281|454254552|FG000|Overall Study|Subject had history of drug abuse|1|||
126263020|NCT00892281|454254553|FG001|Overall Study|Subject had history of drug abuse|0|||
126263021|NCT00892281|454254552|FG000|Overall Study|Rash on hand|1|||
126263022|NCT00892281|454254553|FG001|Overall Study|Rash on hand|0|||
126263023|NCT00892281|454254552|FG000|Overall Study|Visit 4 date out of window|1|||
126263024|NCT00892281|454254553|FG001|Overall Study|Visit 4 date out of window|0|||
126263025|NCT00865098|454254556|FG000|Overall Study|Progressive disease|1|||
126263026|NCT03702049|454254563|FG000|Overall Study|Lost to Follow-up|4|||
126263027|NCT03702049|454254563|FG000|Overall Study|Physician Decision|1|||
126263028|NCT01833533|454254564|FG000|Overall Study|Adverse Event|0|||
126263029|NCT01833533|454254565|FG001|Overall Study|Adverse Event|1|||
126359746|NCT01181128|454609063|FG001|Overall Study|Withdrawal by Subject|2|||
126263030|NCT01833533|454254564|FG000|Overall Study|Lost to Follow-up|4|||
126359747|NCT01181128|454609064|FG002|Overall Study|Withdrawal by Subject|0|||
126359748|NCT01181128|454609062|FG000|Overall Study|Death|1|||
126359749|NCT01181128|454609063|FG001|Overall Study|Death|0|||
126359750|NCT01181128|454609064|FG002|Overall Study|Death|0|||
126263031|NCT01833533|454254565|FG001|Overall Study|Lost to Follow-up|9|||
126263032|NCT01833533|454254564|FG000|Overall Study|To Enter an Extension Study|0|||
126263033|NCT01833533|454254565|FG001|Overall Study|To Enter an Extension Study|4|||
126263034|NCT01833533|454254564|FG000|Overall Study|Other|2|||
126263035|NCT01833533|454254565|FG001|Overall Study|Other|7|||
126263036|NCT01048502|454254566|FG000|Overall Study|Lost to Follow-up|2|||
126263037|NCT01048502|454254567|FG001|Overall Study|Lost to Follow-up|0|||
126359751|NCT01181128|454609062|FG000|Overall Study|Physician Decision|2|||
126046485|NCT00495677|453468233|FG003|Stage 1 (25 Days)|Adverse Event|0|||
126096664|NCT00560066|453646530|FG000|Overall Study|Death|2|||
126096665|NCT00560066|453646531|FG001|Overall Study|Death|1|||
126096666|NCT00560066|453646530|FG000|Overall Study|Withdrawal by Subject|0|||
126096667|NCT00560066|453646531|FG001|Overall Study|Withdrawal by Subject|3|||
126096668|NCT00560066|453646530|FG000|Overall Study|Lost to Follow-up|4|||
126096669|NCT00560066|453646531|FG001|Overall Study|Lost to Follow-up|10|||
126096670|NCT00560066|453646530|FG000|Overall Study|Protocol Violation|0|||
126096671|NCT00560066|453646531|FG001|Overall Study|Protocol Violation|1|||
126096672|NCT00560066|453646530|FG000|Overall Study|Administrative reason|0|||
126096673|NCT00560066|453646531|FG001|Overall Study|Administrative reason|5|||
126096674|NCT00560066|453646530|FG000|Overall Study|Missing primary reason|0|||
126359752|NCT01181128|454609063|FG001|Overall Study|Physician Decision|0|||
126359753|NCT01181128|454609064|FG002|Overall Study|Physician Decision|0|||
126359754|NCT01181128|454609062|FG000|Overall Study|Adverse Event|0|||
126359755|NCT01181128|454609063|FG001|Overall Study|Adverse Event|2|||
126359756|NCT01181128|454609064|FG002|Overall Study|Adverse Event|0|||
126359757|NCT01181128|454609062|FG000|Overall Study|Other|1|||
126359758|NCT01181128|454609063|FG001|Overall Study|Other|1|||
126359759|NCT01181128|454609064|FG002|Overall Study|Other|1|||
126359760|NCT01362270|454609067|FG000|Overall Study|Withdrawal by Subject|1|||
126032019|NCT03194217|453414038|FG001|Overall Study|Failure to meet randomisation criteria|0|||
126032020|NCT03194217|453414039|FG002|Overall Study|Failure to meet randomisation criteria|0|||
126032021|NCT03194217|453414040|FG003|Overall Study|Failure to meet randomisation criteria|1|||
126032022|NCT03194217|453414037|FG000|Overall Study|Other|0|||
126032023|NCT03194217|453414038|FG001|Overall Study|Other|1|||
126032024|NCT03194217|453414039|FG002|Overall Study|Other|1|||
126032025|NCT03194217|453414040|FG003|Overall Study|Other|0|||
126032026|NCT05481320|453414041|FG000|Overall Study|Withdrawal by Subject|1|||
126032027|NCT05481320|453414042|FG001|Overall Study|Withdrawal by Subject|1|||
126032028|NCT05481320|453414041|FG000|Overall Study|Care recipent passed away|0|||
126032029|NCT05481320|453414042|FG001|Overall Study|Care recipent passed away|1|||
126032030|NCT05481320|453414041|FG000|Overall Study|Out-of-window assessment|0|||
126032031|NCT05481320|453414042|FG001|Overall Study|Out-of-window assessment|1|||
126032032|NCT05481320|453414041|FG000|Overall Study|No longer a primary caregiver|3|||
126032033|NCT05481320|453414042|FG001|Overall Study|No longer a primary caregiver|0|||
126032034|NCT05481320|453414041|FG000|Overall Study|Unable to contact|1|||
126032035|NCT05481320|453414042|FG001|Overall Study|Unable to contact|0|||
126032036|NCT05894577|453414043|FG000|Overall Study|No receipt of study drug|14|||
126032037|NCT05894577|453414044|FG001|Overall Study|No receipt of study drug|13|||
126032038|NCT05894577|453414043|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
126032039|NCT05894577|453414044|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
126096675|NCT00560066|453646531|FG001|Overall Study|Missing primary reason|2|||
126096676|NCT00620282|453646532|FG000|Overall Study|Adverse Event|0|||
126096677|NCT00620282|453646533|FG001|Overall Study|Adverse Event|1|||
126359761|NCT01362270|454609068|FG001|Overall Study|Withdrawal by Subject|0|||
126359762|NCT01362270|454609067|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
126359763|NCT01362270|454609068|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
126096678|NCT00620282|453646534|FG002|Overall Study|Adverse Event|0|||
126096679|NCT00620282|453646532|FG000|Overall Study|Arterial line unable to be placed|0|||
126096680|NCT00620282|453646533|FG001|Overall Study|Arterial line unable to be placed|0|||
126096681|NCT00620282|453646534|FG002|Overall Study|Arterial line unable to be placed|1|||
126096682|NCT00620282|453646532|FG000|Overall Study|Withdrawal by Subject|0|||
126096683|NCT00620282|453646533|FG001|Overall Study|Withdrawal by Subject|1|||
126096684|NCT00620282|453646534|FG002|Overall Study|Withdrawal by Subject|0|||
126096685|NCT01258595|453646535|FG000|Overall Study|Lost to Follow-up|1|||
126096686|NCT01258595|453646536|FG001|Overall Study|Lost to Follow-up|0|||
126096687|NCT01258595|453646535|FG000|Overall Study|Withdrawal by Subject|0|||
126096688|NCT01258595|453646536|FG001|Overall Study|Withdrawal by Subject|1|||
126096689|NCT04738292|453646537|FG000|Overall Study|Death|1|||
126096690|NCT01820585|453646538|FG000|Overall Study|Adverse Event|9|||
126096691|NCT01820585|453646539|FG001|Overall Study|Adverse Event|13|||
126096692|NCT01820585|453646540|FG002|Overall Study|Adverse Event|23|||
126096693|NCT01820585|453646541|FG003|Overall Study|Adverse Event|34|||
126096694|NCT01820585|453646538|FG000|Overall Study|Lack of Efficacy|9|||
126096695|NCT01820585|453646539|FG001|Overall Study|Lack of Efficacy|7|||
126096696|NCT01820585|453646540|FG002|Overall Study|Lack of Efficacy|5|||
126096697|NCT01820585|453646541|FG003|Overall Study|Lack of Efficacy|1|||
126096698|NCT01820585|453646538|FG000|Overall Study|Withdrawal by Subject|3|||
126263038|NCT01048502|454254568|FG002|Overall Study|Lost to Follow-up|0|||
126263039|NCT01048502|454254569|FG003|Overall Study|Lost to Follow-up|0|||
126263040|NCT01048502|454254566|FG000|Overall Study|Adverse Event|1|||
126263041|NCT01048502|454254567|FG001|Overall Study|Adverse Event|0|||
126263042|NCT01048502|454254568|FG002|Overall Study|Adverse Event|0|||
126263043|NCT01048502|454254569|FG003|Overall Study|Adverse Event|0|||
126263044|NCT01048502|454254566|FG000|Overall Study|Withdrawal by Subject|1|||
126263045|NCT01048502|454254567|FG001|Overall Study|Withdrawal by Subject|4|||
126263046|NCT01048502|454254568|FG002|Overall Study|Withdrawal by Subject|5|||
126263047|NCT01048502|454254569|FG003|Overall Study|Withdrawal by Subject|3|||
126263048|NCT01048502|454254566|FG000|Overall Study|Physician Decision|0|||
126263049|NCT01048502|454254567|FG001|Overall Study|Physician Decision|3|||
126263050|NCT01048502|454254568|FG002|Overall Study|Physician Decision|0|||
126263051|NCT01048502|454254569|FG003|Overall Study|Physician Decision|1|||
126263052|NCT01138826|454254570|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
126096699|NCT01820585|453646539|FG001|Overall Study|Withdrawal by Subject|7|||
126096700|NCT01820585|453646540|FG002|Overall Study|Withdrawal by Subject|3|||
126096701|NCT01820585|453646541|FG003|Overall Study|Withdrawal by Subject|8|||
126263053|NCT01138826|454254571|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
126263054|NCT01138826|454254572|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
126096702|NCT01820585|453646538|FG000|Overall Study|Lost to Follow-up|3|||
126096703|NCT01820585|453646539|FG001|Overall Study|Lost to Follow-up|3|||
126096704|NCT01820585|453646540|FG002|Overall Study|Lost to Follow-up|0|||
126096705|NCT01820585|453646541|FG003|Overall Study|Lost to Follow-up|3|||
126096706|NCT01820585|453646538|FG000|Overall Study|Protocol Violation|3|||
126096707|NCT01820585|453646539|FG001|Overall Study|Protocol Violation|1|||
126096708|NCT01820585|453646540|FG002|Overall Study|Protocol Violation|1|||
126263055|NCT01138826|454254573|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
126263056|NCT01138826|454254574|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
126263057|NCT01138826|454254575|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
126263058|NCT05206448|454254576|FG000|Overall Study|Lost to Follow-up|2|||
126263059|NCT05206448|454254577|FG001|Overall Study|Lost to Follow-up|2|||
126263060|NCT05206448|454254576|FG000|Overall Study|Withdrawal by Subject|2|||
126263061|NCT05206448|454254577|FG001|Overall Study|Withdrawal by Subject|0|||
126263062|NCT05206448|454254576|FG000|Overall Study|found ineligible after randomization|1|||
126263063|NCT05206448|454254577|FG001|Overall Study|found ineligible after randomization|1|||
126263064|NCT05206448|454254576|FG000|Overall Study|unable to complete study due to personal constraints|1|||
126263065|NCT05206448|454254577|FG001|Overall Study|unable to complete study due to personal constraints|0|||
126263066|NCT05206448|454254576|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
126263067|NCT05206448|454254577|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
126263068|NCT01333072|454254581|FG000|Overall Study|Lost to Follow-up|3|||
126263069|NCT01333072|454254582|FG001|Overall Study|Lost to Follow-up|0|||
126263070|NCT01333072|454254581|FG000|Overall Study|Adverse Event|2|||
126263071|NCT01333072|454254582|FG001|Overall Study|Adverse Event|4|||
126263072|NCT01333072|454254581|FG000|Overall Study|Physician Decision|1|||
126263073|NCT01333072|454254582|FG001|Overall Study|Physician Decision|0|||
126263074|NCT02457611|454254584|FG000|Overall Study|Lost to Follow-up|3|||
126263075|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
126263076|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
126359764|NCT01362270|454609067|FG000|Overall Study|Met excl. criteria before 1st session|1|||
126359765|NCT01362270|454609068|FG001|Overall Study|Met excl. criteria before 1st session|1|||
126359766|NCT02318277|454609069|FG000|Overall Study|Physician Decision|0|||
126359767|NCT02318277|454609070|FG001|Overall Study|Physician Decision|0|||
126359768|NCT02318277|454609071|FG002|Overall Study|Physician Decision|0|||
126359769|NCT02318277|454609072|FG003|Overall Study|Physician Decision|0|||
126359770|NCT02318277|454609073|FG004|Overall Study|Physician Decision|0|||
126359771|NCT02318277|454609074|FG005|Overall Study|Physician Decision|0|||
126359772|NCT02318277|454609075|FG006|Overall Study|Physician Decision|0|||
126359773|NCT02318277|454609076|FG007|Overall Study|Physician Decision|1|||
126359774|NCT02318277|454609069|FG000|Overall Study|Other|0|||
126359775|NCT02318277|454609070|FG001|Overall Study|Other|0|||
126359776|NCT02318277|454609071|FG002|Overall Study|Other|0|||
126359777|NCT02318277|454609072|FG003|Overall Study|Other|0|||
126359778|NCT02318277|454609073|FG004|Overall Study|Other|0|||
126359779|NCT02318277|454609074|FG005|Overall Study|Other|0|||
126359780|NCT02318277|454609075|FG006|Overall Study|Other|1|||
126359781|NCT02318277|454609076|FG007|Overall Study|Other|0|||
126359782|NCT02318277|454609069|FG000|Overall Study|Withdrawal by Subject|0|||
126359783|NCT02318277|454609070|FG001|Overall Study|Withdrawal by Subject|0|||
126359784|NCT02318277|454609071|FG002|Overall Study|Withdrawal by Subject|1|||
126359785|NCT02318277|454609072|FG003|Overall Study|Withdrawal by Subject|0|||
126359786|NCT02318277|454609073|FG004|Overall Study|Withdrawal by Subject|1|||
126359787|NCT02318277|454609074|FG005|Overall Study|Withdrawal by Subject|1|||
126359788|NCT02318277|454609075|FG006|Overall Study|Withdrawal by Subject|6|||
126359789|NCT02318277|454609076|FG007|Overall Study|Withdrawal by Subject|14|||
126359790|NCT02318277|454609069|FG000|Overall Study|Participant trial terminated by sponsor|0|||
126359791|NCT02318277|454609070|FG001|Overall Study|Participant trial terminated by sponsor|0|||
126359792|NCT02318277|454609071|FG002|Overall Study|Participant trial terminated by sponsor|1|||
126359793|NCT02318277|454609072|FG003|Overall Study|Participant trial terminated by sponsor|0|||
126359794|NCT02318277|454609073|FG004|Overall Study|Participant trial terminated by sponsor|1|||
126359795|NCT02318277|454609074|FG005|Overall Study|Participant trial terminated by sponsor|2|||
126359796|NCT02318277|454609075|FG006|Overall Study|Participant trial terminated by sponsor|5|||
126359797|NCT02318277|454609076|FG007|Overall Study|Participant trial terminated by sponsor|16|||
126359798|NCT02318277|454609069|FG000|Overall Study|Lost to Follow-up|1|||
126359799|NCT02318277|454609070|FG001|Overall Study|Lost to Follow-up|0|||
126359800|NCT02318277|454609071|FG002|Overall Study|Lost to Follow-up|1|||
126096709|NCT01820585|453646541|FG003|Overall Study|Protocol Violation|1|||
126263077|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
126359801|NCT02318277|454609072|FG003|Overall Study|Lost to Follow-up|0|||
126359802|NCT02318277|454609073|FG004|Overall Study|Lost to Follow-up|0|||
126359803|NCT02318277|454609074|FG005|Overall Study|Lost to Follow-up|0|||
125880303|NCT05565742|452858835|FG001|Overall Study|Participant Travelled Abroad|0|||
126263078|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
126263079|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
126263080|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
126263081|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
126263082|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
126263083|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
126032040|NCT05894577|453414043|FG000|Overall Study|Screen Fail|2|||
126032041|NCT05894577|453414044|FG001|Overall Study|Screen Fail|0|||
126032042|NCT05894577|453414043|FG000|Overall Study|Study drug recall|86|||
126032043|NCT05894577|453414044|FG001|Overall Study|Study drug recall|63|||
126032044|NCT03364647|453414049|FG000|Overall Study|Withdrawal by Subject|3|||
126032045|NCT03364647|453414050|FG001|Overall Study|Withdrawal by Subject|1|||
126032046|NCT03476460|453414053|FG000|Overall Study|Withdrawal by Subject|3|||
126032047|NCT03476460|453414054|FG001|Overall Study|Withdrawal by Subject|2|||
126263084|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
126263085|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
126263086|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
126263087|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
126263088|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
126263089|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
126263090|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
126263091|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
126263092|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
126263093|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
126263094|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
126263095|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
126263096|NCT00384293|454254585|FG000|Post-randomization Period|Adverse Event|0|||
126263097|NCT00384293|454254586|FG001|Post-randomization Period|Adverse Event|23|||
126263098|NCT00384293|454254587|FG002|Post-randomization Period|Adverse Event|7|||
126263099|NCT00384293|454254585|FG000|Post-randomization Period|Lost to Follow-up|0|||
126263100|NCT00384293|454254586|FG001|Post-randomization Period|Lost to Follow-up|2|||
126263101|NCT00384293|454254587|FG002|Post-randomization Period|Lost to Follow-up|1|||
126263102|NCT00384293|454254585|FG000|Post-randomization Period|Protocol Violation|0|||
126263103|NCT00384293|454254586|FG001|Post-randomization Period|Protocol Violation|1|||
126263104|NCT00384293|454254587|FG002|Post-randomization Period|Protocol Violation|0|||
126263105|NCT00384293|454254585|FG000|Post-randomization Period|Withdrawal by Subject|0|||
126263106|NCT00384293|454254586|FG001|Post-randomization Period|Withdrawal by Subject|8|||
126263107|NCT00384293|454254587|FG002|Post-randomization Period|Withdrawal by Subject|6|||
126263108|NCT00384293|454254585|FG000|Post-randomization Period|Trial Termination|0|||
126263109|NCT00384293|454254586|FG001|Post-randomization Period|Trial Termination|180|||
126263110|NCT00384293|454254587|FG002|Post-randomization Period|Trial Termination|204|||
126263111|NCT00384293|454254585|FG000|Post-randomization Period|Patient Randomized in Error|0|||
126263112|NCT00384293|454254586|FG001|Post-randomization Period|Patient Randomized in Error|0|||
126263113|NCT00384293|454254587|FG002|Post-randomization Period|Patient Randomized in Error|1|||
126263114|NCT00619359|454254588|FG000|Overall Study|Adverse Event|32|||
126263115|NCT00619359|454254589|FG001|Overall Study|Adverse Event|36|||
126263116|NCT00619359|454254588|FG000|Overall Study|Lost to Follow-up|12|||
126263117|NCT00619359|454254589|FG001|Overall Study|Lost to Follow-up|16|||
126263118|NCT00619359|454254588|FG000|Overall Study|Physician Decision|0|||
126263119|NCT00619359|454254589|FG001|Overall Study|Physician Decision|7|||
126263120|NCT00619359|454254588|FG000|Overall Study|Protocol Violation|1|||
126359804|NCT02318277|454609075|FG006|Overall Study|Lost to Follow-up|3|||
126359805|NCT02318277|454609076|FG007|Overall Study|Lost to Follow-up|4|||
126359806|NCT02318277|454609069|FG000|Overall Study|Death|5|||
126359807|NCT02318277|454609070|FG001|Overall Study|Death|3|||
126359808|NCT02318277|454609071|FG002|Overall Study|Death|1|||
126359809|NCT02318277|454609072|FG003|Overall Study|Death|4|||
126359810|NCT02318277|454609073|FG004|Overall Study|Death|6|||
126359811|NCT02318277|454609074|FG005|Overall Study|Death|5|||
126359812|NCT02318277|454609075|FG006|Overall Study|Death|34|||
126359813|NCT02318277|454609076|FG007|Overall Study|Death|58|||
126359814|NCT02318277|454609069|FG000|Overall Study|Transitioned to Hospice|0|||
126359815|NCT02318277|454609070|FG001|Overall Study|Transitioned to Hospice|0|||
126359816|NCT02318277|454609071|FG002|Overall Study|Transitioned to Hospice|0|||
126359817|NCT02318277|454609072|FG003|Overall Study|Transitioned to Hospice|0|||
126359818|NCT02318277|454609073|FG004|Overall Study|Transitioned to Hospice|0|||
125880304|NCT05565742|452858836|FG002|Overall Study|Participant Travelled Abroad|0|||
126032048|NCT03476460|453414053|FG000|Overall Study|Non-compliance with treatment|3|||
126032049|NCT03476460|453414054|FG001|Overall Study|Non-compliance with treatment|0|||
126263121|NCT00619359|454254589|FG001|Overall Study|Protocol Violation|1|||
126263122|NCT00619359|454254588|FG000|Overall Study|Withdrawal by Subject|19|||
126263123|NCT00619359|454254589|FG001|Overall Study|Withdrawal by Subject|20|||
126263124|NCT00619359|454254588|FG000|Overall Study|Progressive Disease|3|||
126263125|NCT00619359|454254589|FG001|Overall Study|Progressive Disease|1|||
126263126|NCT02502734|454254590|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
126263127|NCT02502734|454254591|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
126263128|NCT02502734|454254590|FG000|Washout Period|Adverse Event|1|||
126263129|NCT02502734|454254591|FG001|Washout Period|Adverse Event|0|||
126263130|NCT02280187|454254594|FG000|Overall Study|Lost to Follow-up|218|||
126263131|NCT02094261|454254595|FG000|Overall Study|Death|24|||
126263132|NCT02094261|454254595|FG000|Overall Study|Lost to Follow-up|1|||
126263133|NCT02094261|454254595|FG000|Overall Study|Withdrawal by Subject|4|||
126263134|NCT02094261|454254595|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
126263135|NCT04668274|454254596|FG000|Part 1 Study Period 1|Adverse Event|3|||
126263136|NCT04668274|454254597|FG001|Part 1 Study Period 1|Adverse Event|0|||
126263137|NCT04668274|454254598|FG002|Part 1 Study Period 1|Adverse Event|0|||
126263138|NCT04668274|454254599|FG003|Part 1 Study Period 1|Adverse Event|0|||
126263139|NCT04668274|454254596|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
126263140|NCT04668274|454254597|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
126263141|NCT04668274|454254598|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
126263142|NCT04668274|454254599|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
126263143|NCT04668274|454254596|FG000|Part 1 Study Period 2|Other|0|||
126263144|NCT04668274|454254597|FG001|Part 1 Study Period 2|Other|1|||
126263145|NCT04668274|454254598|FG002|Part 1 Study Period 2|Other|0|||
126263146|NCT04668274|454254599|FG003|Part 1 Study Period 2|Other|0|||
126263147|NCT04668274|454254596|FG000|Part 1 Study Period 3|Adverse Event|0|||
126263148|NCT04668274|454254597|FG001|Part 1 Study Period 3|Adverse Event|0|||
126263149|NCT04668274|454254598|FG002|Part 1 Study Period 3|Adverse Event|1|||
126263150|NCT04668274|454254599|FG003|Part 1 Study Period 3|Adverse Event|0|||
126263151|NCT04668274|454254596|FG000|Part 1 Study Period 3|Other|0|||
126263152|NCT04668274|454254597|FG001|Part 1 Study Period 3|Other|0|||
126263153|NCT04668274|454254598|FG002|Part 1 Study Period 3|Other|2|||
126263154|NCT04668274|454254599|FG003|Part 1 Study Period 3|Other|0|||
126263155|NCT04668274|454254596|FG000|Part 2 Study Period 4|Other|0|||
126263156|NCT04668274|454254597|FG001|Part 2 Study Period 4|Other|0|||
126263157|NCT04668274|454254598|FG002|Part 2 Study Period 4|Other|0|||
126263158|NCT04668274|454254599|FG003|Part 2 Study Period 4|Other|1|||
126263159|NCT02363439|454254600|FG000|Overall Study|Lack of Efficacy|4|||
126263160|NCT00508027|454254601|FG000|Dose Level 1|Lost to Follow-up|4|||
126263161|NCT00508027|454254601|FG000|Dose Level 1|Withdrawal by Subject|2|||
126263162|NCT00508027|454254601|FG000|Dose Level 1|Physician Decision|2|||
126263163|NCT00508027|454254601|FG000|Dose Level 2|Lost to Follow-up|2|||
126263164|NCT00508027|454254601|FG000|Dose Level 2|Withdrawal by Subject|2|||
126263165|NCT01832402|454254604|FG000|Overall Study|Lost to Follow-up|2|||
126263166|NCT01832402|454254605|FG001|Overall Study|Lost to Follow-up|0|||
126263167|NCT01832402|454254604|FG000|Overall Study|Withdrawal by Subject|3|||
126263168|NCT01832402|454254605|FG001|Overall Study|Withdrawal by Subject|3|||
126263169|NCT01832402|454254604|FG000|Overall Study|Declining Performance status|2|||
126263170|NCT01832402|454254605|FG001|Overall Study|Declining Performance status|1|||
126263171|NCT01202877|454254606|FG000|Overall Study|Disease Progression|0|||
126263172|NCT01202877|454254607|FG001|Overall Study|Disease Progression|1|||
126263173|NCT01202877|454254608|FG002|Overall Study|Disease Progression|2|||
126263174|NCT01202877|454254606|FG000|Overall Study|Adverse Event|0|||
126263175|NCT01202877|454254607|FG001|Overall Study|Adverse Event|0|||
126263176|NCT01202877|454254608|FG002|Overall Study|Adverse Event|2|||
126263177|NCT01202877|454254606|FG000|Overall Study|Withdrawal by Subject|0|||
126263178|NCT01202877|454254607|FG001|Overall Study|Withdrawal by Subject|0|||
126263179|NCT01202877|454254608|FG002|Overall Study|Withdrawal by Subject|1|||
126263180|NCT01202877|454254606|FG000|Overall Study|Death|0|||
126263181|NCT01202877|454254607|FG001|Overall Study|Death|0|||
126263182|NCT01202877|454254608|FG002|Overall Study|Death|1|||
126263183|NCT00396331|454254609|FG000|Overall Study|Failed to mobilize - no transplant|8|||
126263184|NCT00396331|454254609|FG000|Overall Study|Did not go on to transplant|5|||
126263185|NCT00396331|454254609|FG000|Overall Study|Lost to Follow-up|3|||
126263186|NCT00396331|454254609|FG000|Overall Study|Death|16|||
126263187|NCT01382251|454254610|FG000|Overall Study|Surgeries cancelled or delayed|16|||
126263188|NCT01382251|454254611|FG001|Overall Study|Surgeries cancelled or delayed|16|||
126263189|NCT01382251|454254610|FG000|Overall Study|Lost to Follow-up|4|||
126263190|NCT01382251|454254611|FG001|Overall Study|Lost to Follow-up|4|||
126263191|NCT01382251|454254610|FG000|Overall Study|Contacted after study closed|1|||
126263192|NCT01382251|454254611|FG001|Overall Study|Contacted after study closed|1|||
126263193|NCT00562120|454254612|FG000|First Intervention Period|Adverse Event|1|||
126263194|NCT00562120|454254613|FG001|First Intervention Period|Adverse Event|0|||
126263195|NCT00562120|454254614|FG002|First Intervention Period|Adverse Event|0|||
126263196|NCT00562120|454254615|FG003|First Intervention Period|Adverse Event|0|||
126263197|NCT00562120|454254612|FG000|First Intervention Period|Randomized but not Treated|1|||
126263198|NCT00562120|454254613|FG001|First Intervention Period|Randomized but not Treated|0|||
126263199|NCT00562120|454254614|FG002|First Intervention Period|Randomized but not Treated|0|||
126263200|NCT00562120|454254615|FG003|First Intervention Period|Randomized but not Treated|0|||
126263201|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
126263202|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
126263203|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
126263204|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
126263205|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
126263206|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
126263207|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
126263208|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
126263209|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
126263210|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
126263211|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
126263212|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
126263213|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Death|0|||
126263214|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Death|1|||
125880305|NCT05565742|452858837|FG003|Overall Study|Participant Travelled Abroad|0|||
125880306|NCT05565742|452858838|FG004|Overall Study|Participant Travelled Abroad|1|||
125880307|NCT02855125|452858839|FG000|Overall Study|Withdrawal by Subject|2|||
126263215|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Death|0|||
126263216|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Death|0|||
126263217|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
126263218|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
126263219|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
126263220|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
126263221|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
126263222|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
126263223|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
126263224|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
126263225|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
126263226|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
126263227|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
126263228|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
126263229|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Disease Progression|3|||
126263230|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Disease Progression|3|||
126263231|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Disease Progression|0|||
126263232|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Disease Progression|7|||
126263233|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
126263234|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
126263235|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
126263236|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
125880308|NCT02855125|452858840|FG001|Overall Study|Withdrawal by Subject|2|||
126032050|NCT03476460|453414053|FG000|Overall Study|Missing laboratory tests|5|||
126032051|NCT03476460|453414054|FG001|Overall Study|Missing laboratory tests|5|||
126263237|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
126263238|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
126263239|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
126263240|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
126263241|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Adverse Event|0|||
126263242|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Adverse Event|3|||
126263243|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Adverse Event|2|||
126263244|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Adverse Event|2|||
126263245|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
126263246|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
126263247|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
126263248|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
126263249|NCT00545688|454254618|FG000|Follow-Up Period|Death|4|||
126263250|NCT00545688|454254619|FG001|Follow-Up Period|Death|2|||
126263251|NCT00545688|454254620|FG002|Follow-Up Period|Death|2|||
126263252|NCT00545688|454254621|FG003|Follow-Up Period|Death|6|||
126263253|NCT00545688|454254618|FG000|Follow-Up Period|Disease Progression|6|||
126263254|NCT00545688|454254619|FG001|Follow-Up Period|Disease Progression|5|||
126263255|NCT00545688|454254620|FG002|Follow-Up Period|Disease Progression|9|||
126263256|NCT00545688|454254621|FG003|Follow-Up Period|Disease Progression|9|||
126263257|NCT00545688|454254618|FG000|Follow-Up Period|Refused Treatment|6|||
126263258|NCT00545688|454254619|FG001|Follow-Up Period|Refused Treatment|2|||
126263259|NCT00545688|454254620|FG002|Follow-Up Period|Refused Treatment|0|||
126263260|NCT00545688|454254621|FG003|Follow-Up Period|Refused Treatment|2|||
126263261|NCT00545688|454254618|FG000|Follow-Up Period|Lost to Follow-up|3|||
126263262|NCT00545688|454254619|FG001|Follow-Up Period|Lost to Follow-up|3|||
126263263|NCT00545688|454254620|FG002|Follow-Up Period|Lost to Follow-up|3|||
126263264|NCT00545688|454254621|FG003|Follow-Up Period|Lost to Follow-up|1|||
126263265|NCT00545688|454254618|FG000|Follow-Up Period|Unspecified Reason|2|||
126263266|NCT00545688|454254619|FG001|Follow-Up Period|Unspecified Reason|5|||
126263267|NCT00545688|454254620|FG002|Follow-Up Period|Unspecified Reason|6|||
126263268|NCT00545688|454254621|FG003|Follow-Up Period|Unspecified Reason|8|||
126263269|NCT00545688|454254618|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
126263270|NCT00545688|454254619|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
126263271|NCT00545688|454254620|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
126263272|NCT00545688|454254621|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
126263273|NCT00952276|454254624|FG000|Overall Study|Withdrawal by Subject|1|||
126263274|NCT00952276|454254625|FG001|Overall Study|Withdrawal by Subject|0|||
126263275|NCT00952276|454254626|FG002|Overall Study|Withdrawal by Subject|0|||
126263276|NCT00952276|454254627|FG003|Overall Study|Withdrawal by Subject|1|||
126263277|NCT00952276|454254628|FG004|Overall Study|Withdrawal by Subject|0|||
126263278|NCT01010126|454256291|FG000|Overall Study|Withdrawal by Subject|1|||
126263279|NCT01010126|454256292|FG001|Overall Study|Withdrawal by Subject|0|||
126263280|NCT01010126|454256293|FG002|Overall Study|Withdrawal by Subject|1|||
126263281|NCT01010126|454256294|FG003|Overall Study|Withdrawal by Subject|0|||
126263282|NCT01010126|454256295|FG004|Overall Study|Withdrawal by Subject|3|||
126263283|NCT01010126|454256296|FG005|Overall Study|Withdrawal by Subject|0|||
126263284|NCT00595335|454256299|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
126263285|NCT00595335|454256300|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
126263286|NCT00595335|454256299|FG000|Baseline to Six Months|Disease Progression|1|||
126263287|NCT00595335|454256300|FG001|Baseline to Six Months|Disease Progression|1|||
126263288|NCT00595335|454256299|FG000|Baseline to Six Months|Adverse Event|1|||
126263289|NCT00595335|454256300|FG001|Baseline to Six Months|Adverse Event|0|||
126263290|NCT00595335|454256299|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
126263291|NCT00595335|454256300|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
126263292|NCT00595335|454256299|FG000|Six Months to Twelve Months|Disease Progression|1|||
126263293|NCT00595335|454256300|FG001|Six Months to Twelve Months|Disease Progression|0|||
126263294|NCT01647958|454256308|FG000|Initial Study|Lost to Follow-up|2|||
126263295|NCT01647958|454256309|FG001|Initial Study|Lost to Follow-up|3|||
126263296|NCT01647958|454256308|FG000|Continuation Phase|treatment received during Overall Study|39|||
126263297|NCT01647958|454256309|FG001|Continuation Phase|treatment received during Overall Study|0|||
126263298|NCT01647958|454256308|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
126263299|NCT01647958|454256309|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
126263300|NCT00544817|454256310|FG000|Combined Modality|Lack of Efficacy|2|||
126263301|NCT00544817|454256310|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
126263302|NCT00544817|454256310|FG000|Combined Modality|Adverse Event|2|||
126263303|NCT00544817|454256310|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
126263304|NCT00544817|454256310|FG000|No Treatment Interval|Lack of Efficacy|8|||
126263305|NCT00544817|454256310|FG000|No Treatment Interval|Physician Decision|3|||
126263306|NCT00544817|454256310|FG000|No Treatment Interval|Adverse Event|1|||
126263307|NCT00544817|454256310|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
126263308|NCT00544817|454256310|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
126263309|NCT00544817|454256310|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
126263310|NCT01131299|454256311|FG000|Overall Study|Withdrawal by Subject|4|||
126263311|NCT01131299|454256312|FG001|Overall Study|Withdrawal by Subject|7|||
126263312|NCT00140413|454256319|FG000|Overall Study|Lost to Follow-up|1|||
126263313|NCT00140413|454256320|FG001|Overall Study|Lost to Follow-up|0|||
126263314|NCT00140413|454256319|FG000|Overall Study|Withdrawal by Subject|2|||
126263315|NCT00140413|454256320|FG001|Overall Study|Withdrawal by Subject|0|||
126263316|NCT01360866|454256325|FG000|Overall Study|Lost to Follow-up|11|||
126263317|NCT01360866|454256326|FG001|Overall Study|Lost to Follow-up|28|||
126263318|NCT01360866|454256327|FG002|Overall Study|Lost to Follow-up|41|||
126263319|NCT01360866|454256328|FG003|Overall Study|Lost to Follow-up|0|||
126263320|NCT01360866|454256325|FG000|Overall Study|Adverse Event|56|||
126263321|NCT01360866|454256326|FG001|Overall Study|Adverse Event|61|||
126263322|NCT01360866|454256327|FG002|Overall Study|Adverse Event|134|||
126263323|NCT01360866|454256328|FG003|Overall Study|Adverse Event|6|||
126263324|NCT01360866|454256325|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
126263325|NCT01360866|454256326|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
126263326|NCT01360866|454256327|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
126263327|NCT01360866|454256328|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
126263328|NCT01360866|454256325|FG000|Overall Study|Withdrawn by Investigator|9|||
126263329|NCT01360866|454256326|FG001|Overall Study|Withdrawn by Investigator|8|||
126263330|NCT01360866|454256327|FG002|Overall Study|Withdrawn by Investigator|31|||
126263331|NCT01360866|454256328|FG003|Overall Study|Withdrawn by Investigator|2|||
126096710|NCT01820585|453646538|FG000|Overall Study|Subject non-compliance|0|||
126263332|NCT01360866|454256325|FG000|Overall Study|Withdrawal by participant|79|||
126263333|NCT01360866|454256326|FG001|Overall Study|Withdrawal by participant|89|||
126263334|NCT01360866|454256327|FG002|Overall Study|Withdrawal by participant|168|||
126263335|NCT01360866|454256328|FG003|Overall Study|Withdrawal by participant|8|||
126263336|NCT01360866|454256325|FG000|Overall Study|Protocol Deviation|25|||
126263337|NCT01360866|454256326|FG001|Overall Study|Protocol Deviation|33|||
126263338|NCT01360866|454256327|FG002|Overall Study|Protocol Deviation|61|||
126263339|NCT01360866|454256328|FG003|Overall Study|Protocol Deviation|2|||
126263340|NCT01360866|454256325|FG000|Overall Study|Lack of Efficacy|30|||
126263341|NCT01360866|454256326|FG001|Overall Study|Lack of Efficacy|40|||
126263342|NCT01360866|454256327|FG002|Overall Study|Lack of Efficacy|30|||
126263343|NCT01360866|454256328|FG003|Overall Study|Lack of Efficacy|4|||
126263344|NCT01304693|454256329|FG000|Overall Study|Adverse Event|0|||
126263345|NCT01304693|454256330|FG001|Overall Study|Adverse Event|0|||
126263346|NCT01304693|454256331|FG002|Overall Study|Adverse Event|0|||
126263347|NCT01304693|454256332|FG003|Overall Study|Adverse Event|0|||
126263348|NCT01304693|454256333|FG004|Overall Study|Adverse Event|1|||
126263349|NCT01304693|454256329|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
126263350|NCT01304693|454256330|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
126263351|NCT01304693|454256331|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
126263352|NCT01304693|454256332|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
126263353|NCT01304693|454256333|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
126263354|NCT02129647|454256334|FG000|Overall Study|Adverse Event|2|||
126263355|NCT02129647|454256334|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
126263356|NCT01715896|454256335|FG000|Overall Study|Lost to Follow-up|0|||
126263357|NCT01715896|454256336|FG001|Overall Study|Lost to Follow-up|2|||
126263358|NCT01715896|454256335|FG000|Overall Study|Withdrawal by Subject|1|||
126263359|NCT01715896|454256336|FG001|Overall Study|Withdrawal by Subject|4|||
126263360|NCT01715896|454256335|FG000|Overall Study|Other|2|||
126263361|NCT01715896|454256336|FG001|Overall Study|Other|5|||
126263362|NCT01173471|454256342|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126263363|NCT01173471|454256343|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126263364|NCT01173471|454256344|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126263365|NCT01173471|454256345|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
126263366|NCT01173471|454256342|FG000|Overall Study|Condition under investigation worsened|2|||
126263367|NCT01173471|454256343|FG001|Overall Study|Condition under investigation worsened|0|||
126263368|NCT01173471|454256344|FG002|Overall Study|Condition under investigation worsened|0|||
126263369|NCT01173471|454256345|FG003|Overall Study|Condition under investigation worsened|0|||
126263370|NCT01173471|454256342|FG000|Overall Study|Lost to Follow-up|0|||
126263371|NCT01173471|454256343|FG001|Overall Study|Lost to Follow-up|0|||
126263372|NCT01173471|454256344|FG002|Overall Study|Lost to Follow-up|1|||
126263373|NCT01173471|454256345|FG003|Overall Study|Lost to Follow-up|0|||
126263374|NCT01173471|454256342|FG000|Overall Study|Reason given as Other|0|||
126263375|NCT01173471|454256343|FG001|Overall Study|Reason given as Other|0|||
126263376|NCT01173471|454256344|FG002|Overall Study|Reason given as Other|1|||
126263377|NCT01173471|454256345|FG003|Overall Study|Reason given as Other|0|||
126263378|NCT03028740|454256346|FG000|Overall Study|Did not Receive Study Drug|4|||
126263379|NCT03028740|454256347|FG001|Overall Study|Did not Receive Study Drug|5|||
126263380|NCT03028740|454256346|FG000|Overall Study|Adverse Event|8|||
126263381|NCT03028740|454256347|FG001|Overall Study|Adverse Event|26|||
126263382|NCT03028740|454256346|FG000|Overall Study|Lack of Efficacy|0|||
126263383|NCT03028740|454256347|FG001|Overall Study|Lack of Efficacy|1|||
126263384|NCT03028740|454256346|FG000|Overall Study|Withdrawal by Subject|48|||
126263385|NCT03028740|454256347|FG001|Overall Study|Withdrawal by Subject|101|||
126263386|NCT03028740|454256346|FG000|Overall Study|Lost to Follow-up|30|||
126263387|NCT03028740|454256347|FG001|Overall Study|Lost to Follow-up|54|||
126263388|NCT03028740|454256346|FG000|Overall Study|Physician Decision|4|||
126263389|NCT03028740|454256347|FG001|Overall Study|Physician Decision|11|||
126263390|NCT03028740|454256346|FG000|Overall Study|Protocol Violation|4|||
126263391|NCT03028740|454256347|FG001|Overall Study|Protocol Violation|8|||
126263392|NCT03028740|454256346|FG000|Overall Study|Non-compliance with Study Drug|0|||
126263393|NCT03028740|454256347|FG001|Overall Study|Non-compliance with Study Drug|2|||
126263394|NCT03028740|454256346|FG000|Overall Study|Study Terminated by Sponsor|467|||
126263395|NCT03028740|454256347|FG001|Overall Study|Study Terminated by Sponsor|917|||
126263396|NCT03028740|454256346|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
126263397|NCT03028740|454256347|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
126263398|NCT03028740|454256346|FG000|Overall Study|Reason not Specified|1|||
126263399|NCT03028740|454256347|FG001|Overall Study|Reason not Specified|5|||
126263400|NCT00685802|454256353|FG000|Washout Period of 7 Days|Protocol Violation|2|||
126263401|NCT00685802|454256354|FG001|Washout Period of 7 Days|Protocol Violation|0|||
126263402|NCT00685802|454256353|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126263403|NCT00685802|454256354|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126263404|NCT03336242|454256355|FG000|Overall Study|Adverse Event|0|||
126263405|NCT03336242|454256356|FG001|Overall Study|Adverse Event|1|||
126263406|NCT02224573|454256358|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
126263407|NCT02224573|454256359|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
126263408|NCT02224573|454256358|FG000|Treatment Phase|Started on Other IMP|1|||
126263409|NCT02224573|454256359|FG001|Treatment Phase|Started on Other IMP|0|||
126263410|NCT02224573|454256358|FG000|Treatment Phase|Participant Discontinued IMP|0|||
126263411|NCT02224573|454256359|FG001|Treatment Phase|Participant Discontinued IMP|1|||
126263412|NCT02224573|454256358|FG000|Treatment Phase|Lack of Efficacy|15|||
126263413|NCT02224573|454256359|FG001|Treatment Phase|Lack of Efficacy|8|||
126263414|NCT02224573|454256358|FG000|Treatment Phase|Began Commercial Product|1|||
126263415|NCT02224573|454256359|FG001|Treatment Phase|Began Commercial Product|0|||
126263416|NCT02224573|454256358|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
126263417|NCT02224573|454256359|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
126263418|NCT02224573|454256358|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
126263419|NCT02224573|454256359|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
126263420|NCT02224573|454256358|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
126263421|NCT02224573|454256359|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
126263422|NCT02224573|454256358|FG000|Treatment Phase|Continued Compassionate Use|1|||
126263423|NCT02224573|454256359|FG001|Treatment Phase|Continued Compassionate Use|0|||
126263424|NCT02224573|454256358|FG000|Treatment Phase|Lack of Efficiency|2|||
126263425|NCT02224573|454256359|FG001|Treatment Phase|Lack of Efficiency|1|||
126263426|NCT02224573|454256358|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
126263427|NCT02224573|454256359|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
126263428|NCT02224573|454256358|FG000|Treatment Phase|Participant Moved|2|||
126263429|NCT02224573|454256359|FG001|Treatment Phase|Participant Moved|0|||
126263430|NCT02224573|454256358|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
126263431|NCT02224573|454256359|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
126263432|NCT02224573|454256358|FG000|Treatment Phase|Refused Medication|1|||
126263433|NCT02224573|454256359|FG001|Treatment Phase|Refused Medication|1|||
126263434|NCT02224573|454256358|FG000|Treatment Phase|Adverse Event|26|||
126263435|NCT02224573|454256359|FG001|Treatment Phase|Adverse Event|38|||
126263436|NCT02224573|454256358|FG000|Treatment Phase|Placed in Group Home|0|||
126263437|NCT02224573|454256359|FG001|Treatment Phase|Placed in Group Home|1|||
126263438|NCT02224573|454256358|FG000|Treatment Phase|Pursued Other Trials|1|||
126263439|NCT02224573|454256359|FG001|Treatment Phase|Pursued Other Trials|0|||
126263440|NCT02224573|454256358|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
126263441|NCT02224573|454256359|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
126263442|NCT02224573|454256358|FG000|Treatment Phase|Lost to Follow-up|2|||
126263443|NCT02224573|454256359|FG001|Treatment Phase|Lost to Follow-up|1|||
126263444|NCT02224573|454256358|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
126263445|NCT02224573|454256359|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
126263446|NCT02224573|454256358|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
126263447|NCT02224573|454256359|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
126263448|NCT02224573|454256358|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
126263449|NCT02224573|454256359|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
126263450|NCT02224573|454256358|FG000|Taper Phase|Adverse Event|1|||
126263451|NCT02224573|454256359|FG001|Taper Phase|Adverse Event|1|||
126263452|NCT02546362|454256360|FG000|4-week Treatment Period|Lost to Follow-up|1|||
126263453|NCT02546362|454256360|FG000|4-week Treatment Period|Change in medication|2|||
126263454|NCT02546362|454256360|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
126263455|NCT02546362|454256360|FG000|12-week Treatment Period|Lost to Follow-up|2|||
126263456|NCT02546362|454256360|FG000|12-week Treatment Period|Change in medication|1|||
126263457|NCT01557842|454256361|FG000|Overall Study|Lost to Follow-up|0|||
126263458|NCT01557842|454256362|FG001|Overall Study|Lost to Follow-up|1|||
126263459|NCT01557842|454256361|FG000|Overall Study|Death|1|||
126263460|NCT01557842|454256362|FG001|Overall Study|Death|0|||
126263461|NCT01557842|454256361|FG000|Overall Study|Lack of Efficacy|0|||
126263462|NCT01557842|454256362|FG001|Overall Study|Lack of Efficacy|1|||
126263463|NCT01557842|454256361|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
126263464|NCT01557842|454256362|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
126263465|NCT01557842|454256361|FG000|Overall Study|Study Terminated by Sponsor|3|||
126263466|NCT01557842|454256362|FG001|Overall Study|Study Terminated by Sponsor|4|||
126263467|NCT01557842|454256361|FG000|Overall Study|Not Ablated|2|||
126263468|NCT01557842|454256362|FG001|Overall Study|Not Ablated|0|||
126263469|NCT03005067|454256366|FG000|Overall Study|Withdrawal by Subject|3|||
126263470|NCT03005067|454256367|FG001|Overall Study|Withdrawal by Subject|2|||
126263471|NCT03005067|454256366|FG000|Overall Study|Adverse Event|4|||
126263472|NCT03005067|454256367|FG001|Overall Study|Adverse Event|3|||
126263473|NCT03005067|454256366|FG000|Overall Study|Other (reason not specified)|3|||
126263474|NCT03005067|454256367|FG001|Overall Study|Other (reason not specified)|1|||
126263475|NCT03005067|454256366|FG000|Overall Study|Protocol Violation|0|||
126263476|NCT03005067|454256367|FG001|Overall Study|Protocol Violation|1|||
126263477|NCT01661881|454256373|FG000|Overall Study|Disease Progression|1|||
126263478|NCT00949988|454256378|FG000|Overall Study|Withdrawal by Subject|3|||
126263479|NCT05212883|454256381|FG000|Overall Study|Invalid test result|125|||
126263480|NCT03891329|454256394|FG000|Overall Study|Death|5|||
126263481|NCT03891329|454256394|FG000|Overall Study|Lost to Follow-up|4|||
126263482|NCT03891329|454256394|FG000|Overall Study|Physician Decision|4|||
126263483|NCT03891329|454256394|FG000|Overall Study|Device explanted|3|||
126263484|NCT03891329|454256394|FG000|Overall Study|No study device implanted|3|||
126263485|NCT01803269|454256397|FG000|Overall Study|Withdrawal by Subject|3|||
126263486|NCT01803269|454256398|FG001|Overall Study|Withdrawal by Subject|0|||
126263487|NCT01803269|454256399|FG002|Overall Study|Withdrawal by Subject|0|||
126263488|NCT01351350|454256400|FG000|Overall Study|Disease Progression|5|||
126263489|NCT01351350|454256401|FG001|Overall Study|Disease Progression|13|||
126263490|NCT01351350|454256402|FG002|Overall Study|Disease Progression|6|||
126263491|NCT01351350|454256403|FG003|Overall Study|Disease Progression|8|||
126263492|NCT01351350|454256404|FG004|Overall Study|Disease Progression|5|||
126263493|NCT01351350|454256400|FG000|Overall Study|Adverse Event|1|||
126263494|NCT01351350|454256401|FG001|Overall Study|Adverse Event|10|||
126263495|NCT01351350|454256402|FG002|Overall Study|Adverse Event|1|||
126263496|NCT01351350|454256403|FG003|Overall Study|Adverse Event|2|||
126263497|NCT01351350|454256404|FG004|Overall Study|Adverse Event|0|||
126263498|NCT01351350|454256400|FG000|Overall Study|Participant Decision|2|||
126263499|NCT01351350|454256401|FG001|Overall Study|Participant Decision|6|||
126263500|NCT01351350|454256402|FG002|Overall Study|Participant Decision|3|||
126263501|NCT01351350|454256403|FG003|Overall Study|Participant Decision|3|||
126263502|NCT01351350|454256404|FG004|Overall Study|Participant Decision|2|||
126263503|NCT01351350|454256400|FG000|Overall Study|Enrolled but not Treated|0|||
126263504|NCT01351350|454256401|FG001|Overall Study|Enrolled but not Treated|0|||
126263505|NCT01351350|454256402|FG002|Overall Study|Enrolled but not Treated|1|||
126263506|NCT01351350|454256403|FG003|Overall Study|Enrolled but not Treated|0|||
126263507|NCT01351350|454256404|FG004|Overall Study|Enrolled but not Treated|0|||
126263508|NCT04647383|454256407|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
126263509|NCT04647383|454256408|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
126263510|NCT04647383|454256409|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
126263511|NCT04647383|454256410|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
126263512|NCT00873119|454256411|FG000|Overall Study|Patient request|4|||
126263513|NCT00873119|454256412|FG001|Overall Study|Patient request|2|||
126263514|NCT00873119|454256411|FG000|Overall Study|Adverse Event|8|||
126263515|NCT00873119|454256412|FG001|Overall Study|Adverse Event|0|||
126263516|NCT00873119|454256411|FG000|Overall Study|Progressive disease|26|||
126263517|NCT00873119|454256412|FG001|Overall Study|Progressive disease|18|||
126263518|NCT00873119|454256411|FG000|Overall Study|Death|2|||
126263519|NCT00873119|454256412|FG001|Overall Study|Death|1|||
126263520|NCT00873119|454256411|FG000|Overall Study|Other|2|||
126263521|NCT00873119|454256412|FG001|Overall Study|Other|5|||
126263522|NCT00873119|454256411|FG000|Overall Study|Not treated|2|||
126263523|NCT00873119|454256412|FG001|Overall Study|Not treated|0|||
126263524|NCT02339740|454256415|FG000|Overall Study|Death|1|||
126263525|NCT02339740|454256416|FG001|Overall Study|Death|0|||
126263526|NCT02339740|454256415|FG000|Overall Study|Physician Decision|0|||
126263527|NCT02339740|454256416|FG001|Overall Study|Physician Decision|2|||
126263528|NCT02339740|454256415|FG000|Overall Study|Withdrawal by Subject|5|||
126263529|NCT02339740|454256416|FG001|Overall Study|Withdrawal by Subject|1|||
126263530|NCT02339740|454256415|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
126263531|NCT02339740|454256416|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
126263532|NCT02096588|454256417|FG000|Overall Study|Lack of Efficacy|2|||
126263533|NCT02096588|454256418|FG001|Overall Study|Lack of Efficacy|0|||
126263534|NCT02096588|454256417|FG000|Overall Study|Withdrawal by Subject|0|||
126263535|NCT02096588|454256418|FG001|Overall Study|Withdrawal by Subject|1|||
126263536|NCT01258101|454256419|FG000|Overall Study|Adverse Event|5|||
126263537|NCT01258101|454256420|FG001|Overall Study|Adverse Event|6|||
126263538|NCT01258101|454256421|FG002|Overall Study|Adverse Event|0|||
126263539|NCT01258101|454256422|FG003|Overall Study|Adverse Event|0|||
126263540|NCT01258101|454256419|FG000|Overall Study|Extra exclusion criterion amended|2|||
126263541|NCT01258101|454256420|FG001|Overall Study|Extra exclusion criterion amended|1|||
126263542|NCT01258101|454256421|FG002|Overall Study|Extra exclusion criterion amended|1|||
126263543|NCT01258101|454256422|FG003|Overall Study|Extra exclusion criterion amended|1|||
126263544|NCT01258101|454256419|FG000|Overall Study|Informed consent has been withdrawn|2|||
126263545|NCT01258101|454256420|FG001|Overall Study|Informed consent has been withdrawn|2|||
126263546|NCT01258101|454256421|FG002|Overall Study|Informed consent has been withdrawn|1|||
126263547|NCT01258101|454256422|FG003|Overall Study|Informed consent has been withdrawn|1|||
126359819|NCT02318277|454609074|FG005|Overall Study|Transitioned to Hospice|1|||
126359820|NCT02318277|454609075|FG006|Overall Study|Transitioned to Hospice|0|||
126359821|NCT02318277|454609076|FG007|Overall Study|Transitioned to Hospice|0|||
126359822|NCT01520714|454609077|FG000|Overall Study|Protocol Violation|0|||
126359823|NCT01520714|454609078|FG001|Overall Study|Protocol Violation|3|||
126359824|NCT01520714|454609077|FG000|Overall Study|Adverse Event|0|||
126359825|NCT01520714|454609078|FG001|Overall Study|Adverse Event|2|||
126359826|NCT01520714|454609077|FG000|Overall Study|Lack of Efficacy|0|||
126263548|NCT01258101|454256419|FG000|Overall Study|Patient is not able to attend visits|8|||
126263549|NCT01258101|454256420|FG001|Overall Study|Patient is not able to attend visits|9|||
126263550|NCT01258101|454256421|FG002|Overall Study|Patient is not able to attend visits|7|||
126263551|NCT01258101|454256422|FG003|Overall Study|Patient is not able to attend visits|6|||
126263552|NCT01258101|454256419|FG000|Overall Study|Patient´s compliance|4|||
126263553|NCT01258101|454256420|FG001|Overall Study|Patient´s compliance|3|||
126263554|NCT01258101|454256421|FG002|Overall Study|Patient´s compliance|1|||
126263555|NCT01258101|454256422|FG003|Overall Study|Patient´s compliance|2|||
126263556|NCT01258101|454256419|FG000|Overall Study|Lost to Follow-up|5|||
126263557|NCT01258101|454256420|FG001|Overall Study|Lost to Follow-up|5|||
126263558|NCT01258101|454256421|FG002|Overall Study|Lost to Follow-up|0|||
126263559|NCT01258101|454256422|FG003|Overall Study|Lost to Follow-up|6|||
126263560|NCT01258101|454256419|FG000|Overall Study|PCR positive at week 24|0|||
126263561|NCT01258101|454256420|FG001|Overall Study|PCR positive at week 24|0|||
126263562|NCT01258101|454256421|FG002|Overall Study|PCR positive at week 24|0|||
126263563|NCT01258101|454256422|FG003|Overall Study|PCR positive at week 24|1|||
126263564|NCT01258101|454256419|FG000|Overall Study|Other reason|7|||
126263565|NCT01258101|454256420|FG001|Overall Study|Other reason|8|||
126263566|NCT01258101|454256421|FG002|Overall Study|Other reason|1|||
126263567|NCT01258101|454256422|FG003|Overall Study|Other reason|8|||
126263568|NCT00303667|454256423|FG000|Overall Study|Death|0|||
126263569|NCT00303667|454256424|FG001|Overall Study|Death|4|||
126263570|NCT01298778|454256425|FG000|Overall Study|Lost to Follow-up|2|||
126263571|NCT01298778|454256426|FG001|Overall Study|Lost to Follow-up|3|||
126263572|NCT01298778|454256425|FG000|Overall Study|Incorrect use of VAS|1|||
126263573|NCT01298778|454256426|FG001|Overall Study|Incorrect use of VAS|0|||
126263574|NCT01298778|454256425|FG000|Overall Study|Withdrawal by Subject|0|||
126263575|NCT01298778|454256426|FG001|Overall Study|Withdrawal by Subject|1|||
126263576|NCT01298778|454256425|FG000|Overall Study|Protocol Violation|0|||
126263577|NCT01298778|454256426|FG001|Overall Study|Protocol Violation|1|||
126263578|NCT01298778|454256425|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
126263579|NCT01298778|454256426|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
126263580|NCT04965389|454256427|FG000|Overall Study|Other reasons|1|||
126263581|NCT04965389|454256428|FG001|Overall Study|Other reasons|0|||
126263582|NCT04965389|454256429|FG002|Overall Study|Other reasons|0|||
126263583|NCT04965389|454256430|FG003|Overall Study|Other reasons|0|||
126263584|NCT04965389|454256427|FG000|Overall Study|Participant withdrew consent|0|||
126263585|NCT04965389|454256428|FG001|Overall Study|Participant withdrew consent|1|||
126263586|NCT04965389|454256429|FG002|Overall Study|Participant withdrew consent|0|||
126263587|NCT04965389|454256430|FG003|Overall Study|Participant withdrew consent|0|||
126263588|NCT04965389|454256427|FG000|Overall Study|Poor/Non-compliance|0|||
126263589|NCT04965389|454256428|FG001|Overall Study|Poor/Non-compliance|1|||
126263590|NCT04965389|454256429|FG002|Overall Study|Poor/Non-compliance|0|||
126263591|NCT04965389|454256430|FG003|Overall Study|Poor/Non-compliance|0|||
126263592|NCT02377921|454256433|FG000|Overall Study|Subject non-compliance|1|||
126263593|NCT02377921|454256434|FG001|Overall Study|Subject non-compliance|1|||
126263594|NCT00706355|454256440|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
126263595|NCT00706355|454256441|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
126263596|NCT00706355|454256442|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
126263597|NCT00706355|454256443|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
126263598|NCT00706355|454256440|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
126263599|NCT00706355|454256441|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
126263600|NCT00706355|454256442|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
126263601|NCT00706355|454256443|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
126263602|NCT00706355|454256440|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
126263603|NCT00706355|454256441|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
126263604|NCT00706355|454256442|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
126263605|NCT00706355|454256443|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
126263606|NCT00706355|454256440|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
126263607|NCT00706355|454256441|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
126263608|NCT00706355|454256442|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
126263609|NCT00706355|454256443|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
126263610|NCT00706355|454256440|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
126263611|NCT00706355|454256441|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
126263612|NCT00706355|454256442|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
126263613|NCT00706355|454256443|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
126263614|NCT00706355|454256440|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
126263615|NCT00706355|454256441|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
126263616|NCT00706355|454256442|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
126263617|NCT00706355|454256443|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
126263618|NCT00706355|454256440|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
126359827|NCT01520714|454609078|FG001|Overall Study|Lack of Efficacy|1|||
126263619|NCT00706355|454256441|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
126263620|NCT00706355|454256442|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
126263621|NCT00706355|454256443|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
126263622|NCT00706355|454256440|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
126263623|NCT00706355|454256441|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
126263624|NCT00706355|454256442|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
126263625|NCT00706355|454256443|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
126263626|NCT00706355|454256440|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
126263627|NCT00706355|454256441|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
126263628|NCT00706355|454256442|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
126263629|NCT00706355|454256443|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
126263630|NCT01020799|454256446|FG000|Overall Study|Adverse Event|4|||
126263631|NCT01020799|454256447|FG001|Overall Study|Adverse Event|3|||
126263632|NCT01020799|454256448|FG002|Overall Study|Adverse Event|2|||
126263633|NCT01020799|454256446|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
126263634|NCT01020799|454256447|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
126263635|NCT01020799|454256448|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
126263636|NCT01020799|454256446|FG000|Overall Study|Protocol Violation|3|||
126263637|NCT01020799|454256447|FG001|Overall Study|Protocol Violation|2|||
126263638|NCT01020799|454256448|FG002|Overall Study|Protocol Violation|0|||
126263639|NCT01020799|454256446|FG000|Overall Study|Withdrawal by Subject|2|||
126263640|NCT01020799|454256447|FG001|Overall Study|Withdrawal by Subject|2|||
126263641|NCT01020799|454256448|FG002|Overall Study|Withdrawal by Subject|3|||
126263642|NCT01020799|454256446|FG000|Overall Study|Lost to Follow-up|6|||
126263643|NCT01020799|454256447|FG001|Overall Study|Lost to Follow-up|4|||
126263644|NCT01020799|454256448|FG002|Overall Study|Lost to Follow-up|2|||
126263645|NCT01425528|454256451|FG000|Overall Study|Withdrawal by Subject|1|||
126263646|NCT01425528|454256452|FG001|Overall Study|Withdrawal by Subject|1|||
126263647|NCT02985879|454256455|FG000|Overall Study|Adverse Event|7|||
126263648|NCT02985879|454256456|FG001|Overall Study|Adverse Event|9|||
126263649|NCT02985879|454256457|FG002|Overall Study|Adverse Event|7|||
126263650|NCT02985879|454256455|FG000|Overall Study|Withdrew consent|6|||
126263651|NCT02985879|454256456|FG001|Overall Study|Withdrew consent|8|||
126263652|NCT02985879|454256457|FG002|Overall Study|Withdrew consent|10|||
126263653|NCT02985879|454256455|FG000|Overall Study|Lost to Follow-up|1|||
126263654|NCT02985879|454256456|FG001|Overall Study|Lost to Follow-up|0|||
126263655|NCT02985879|454256457|FG002|Overall Study|Lost to Follow-up|2|||
126263656|NCT02985879|454256455|FG000|Overall Study|Other, not specified|62|||
126263657|NCT02985879|454256456|FG001|Overall Study|Other, not specified|58|||
126263658|NCT02985879|454256457|FG002|Overall Study|Other, not specified|58|||
126263659|NCT02658487|454258261|FG000|Overall Study|Death|2|||
126263660|NCT02658487|454258261|FG000|Overall Study|Disease progression|10|||
126263661|NCT02658487|454258261|FG000|Overall Study|Alternative therapy|1|||
126263662|NCT02658487|454258261|FG000|Overall Study|Adverse Event|1|||
126263663|NCT02658487|454258261|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
126263664|NCT02658487|454258261|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
126263665|NCT01885182|454258262|FG000|Overall Study|Adverse Event|11|||
126263666|NCT01885182|454258263|FG001|Overall Study|Adverse Event|13|||
126263667|NCT01885182|454258262|FG000|Overall Study|Withdrawal by Subject|13|||
126263668|NCT01885182|454258263|FG001|Overall Study|Withdrawal by Subject|6|||
126263669|NCT01885182|454258262|FG000|Overall Study|Lost to Follow-up|2|||
126263670|NCT01885182|454258263|FG001|Overall Study|Lost to Follow-up|2|||
126263671|NCT01885182|454258262|FG000|Overall Study|Lack of Efficacy|8|||
126263672|NCT01885182|454258263|FG001|Overall Study|Lack of Efficacy|1|||
126263673|NCT00614926|454258270|FG000|Overall Study|Burden of travel|1|||
126263674|NCT00614926|454258271|FG001|Overall Study|Burden of travel|0|||
126263675|NCT00614926|454258270|FG000|Overall Study|Adverse Event|3|||
126263676|NCT00614926|454258271|FG001|Overall Study|Adverse Event|0|||
126263677|NCT01207440|454258272|FG000|Overall Study|Adverse Event|46|||
126263678|NCT01207440|454258273|FG001|Overall Study|Adverse Event|11|||
126263679|NCT01207440|454258274|FG002|Overall Study|Adverse Event|7|||
126263680|NCT01207440|454258275|FG003|Overall Study|Adverse Event|2|||
126263681|NCT01207440|454258276|FG004|Overall Study|Adverse Event|6|||
126263682|NCT01207440|454258277|FG005|Overall Study|Adverse Event|6|||
126263683|NCT01207440|454258278|FG006|Overall Study|Adverse Event|2|||
126263684|NCT01207440|454258272|FG000|Overall Study|Death|6|||
126359828|NCT00754559|454609082|FG000|Overall Study|Adverse Event|15|||
126263685|NCT01207440|454258273|FG001|Overall Study|Death|3|||
126263686|NCT01207440|454258274|FG002|Overall Study|Death|2|||
126263687|NCT01207440|454258275|FG003|Overall Study|Death|2|||
126263688|NCT01207440|454258276|FG004|Overall Study|Death|7|||
126263689|NCT01207440|454258277|FG005|Overall Study|Death|5|||
126263690|NCT01207440|454258278|FG006|Overall Study|Death|1|||
126263691|NCT01207440|454258272|FG000|Overall Study|Lack of Efficacy|13|||
126263692|NCT01207440|454258273|FG001|Overall Study|Lack of Efficacy|2|||
126263693|NCT01207440|454258274|FG002|Overall Study|Lack of Efficacy|5|||
126263694|NCT01207440|454258275|FG003|Overall Study|Lack of Efficacy|1|||
126359829|NCT00754559|454609082|FG000|Overall Study|Protocol Violation|11|||
126359830|NCT00754559|454609082|FG000|Overall Study|Lack of Efficacy|10|||
126359831|NCT00754559|454609082|FG000|Overall Study|Lost to Follow-up|2|||
126359832|NCT00754559|454609082|FG000|Overall Study|Administrative reason|1|||
126359833|NCT00754559|454609082|FG000|Overall Study|Other|5|||
126359834|NCT00754559|454609082|FG000|Overall Study|Withdrawal by Subject|3|||
126359835|NCT01663987|454609083|FG000|Overall Study|Adverse Event|7|||
126359836|NCT01663987|454609084|FG001|Overall Study|Adverse Event|2|||
126359837|NCT01663987|454609083|FG000|Overall Study|Lost to Follow-up|1|||
126359838|NCT01663987|454609084|FG001|Overall Study|Lost to Follow-up|1|||
126359839|NCT01663987|454609083|FG000|Overall Study|Withdrawal by Subject|2|||
126359840|NCT01663987|454609084|FG001|Overall Study|Withdrawal by Subject|3|||
126359841|NCT01663987|454609083|FG000|Overall Study|Other reason not defined above|3|||
126359842|NCT01663987|454609084|FG001|Overall Study|Other reason not defined above|0|||
126359843|NCT03721965|454609086|FG000|Overall Study|Death|1|||
126359844|NCT03721965|454609086|FG000|Overall Study|Study Terminated by Sponsor|1|||
126359845|NCT04595370|454609087|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
126359846|NCT04595370|454609088|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359847|NCT04595370|454609089|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359848|NCT04595370|454609090|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359849|NCT04595370|454609091|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359850|NCT04595370|454609092|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359851|NCT04595370|454609087|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359852|NCT04595370|454609088|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359853|NCT04595370|454609089|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
126359854|NCT04595370|454609090|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359855|NCT04595370|454609091|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359856|NCT04595370|454609092|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359857|NCT04595370|454609087|FG000|Overall Study|Adverse Event|0|||
126359858|NCT04595370|454609088|FG001|Overall Study|Adverse Event|4|||
126359859|NCT04595370|454609089|FG002|Overall Study|Adverse Event|3|||
126359860|NCT04595370|454609090|FG003|Overall Study|Adverse Event|1|||
126359861|NCT04595370|454609091|FG004|Overall Study|Adverse Event|1|||
126359862|NCT04595370|454609092|FG005|Overall Study|Adverse Event|1|||
126359863|NCT04595370|454609087|FG000|Overall Study|Withdrawal of Consent|1|||
126359864|NCT04595370|454609088|FG001|Overall Study|Withdrawal of Consent|1|||
126359865|NCT04595370|454609089|FG002|Overall Study|Withdrawal of Consent|1|||
126359866|NCT04595370|454609090|FG003|Overall Study|Withdrawal of Consent|0|||
126359867|NCT04595370|454609091|FG004|Overall Study|Withdrawal of Consent|0|||
126359868|NCT04595370|454609092|FG005|Overall Study|Withdrawal of Consent|0|||
126359869|NCT04595370|454609087|FG000|Overall Study|Death|0|||
126359870|NCT04595370|454609088|FG001|Overall Study|Death|1|||
126359871|NCT04595370|454609089|FG002|Overall Study|Death|0|||
126359872|NCT04595370|454609090|FG003|Overall Study|Death|0|||
126359873|NCT04595370|454609091|FG004|Overall Study|Death|1|||
126359874|NCT04595370|454609092|FG005|Overall Study|Death|0|||
126359875|NCT04595370|454609087|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359876|NCT04595370|454609088|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359877|NCT04595370|454609089|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126359878|NCT04595370|454609090|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359879|NCT04595370|454609091|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359880|NCT04595370|454609092|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359881|NCT04595370|454609087|FG000|Overall Study|Withdrawal by Subject|0|||
126359882|NCT04595370|454609088|FG001|Overall Study|Withdrawal by Subject|0|||
126359883|NCT04595370|454609089|FG002|Overall Study|Withdrawal by Subject|1|||
126359884|NCT04595370|454609090|FG003|Overall Study|Withdrawal by Subject|0|||
126359885|NCT04595370|454609091|FG004|Overall Study|Withdrawal by Subject|2|||
126359886|NCT04595370|454609092|FG005|Overall Study|Withdrawal by Subject|0|||
126032052|NCT03476460|453414053|FG000|Overall Study|Adverse Event|0|||
126032053|NCT03476460|453414054|FG001|Overall Study|Adverse Event|1|||
126032054|NCT01606215|453414062|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
126046486|NCT00495677|453468234|FG004|Stage 1 (25 Days)|Adverse Event|0|||
126359887|NCT04595370|454609087|FG000|Overall Study|Lost to Follow-up|0|||
126359888|NCT04595370|454609088|FG001|Overall Study|Lost to Follow-up|0|||
126359889|NCT04595370|454609089|FG002|Overall Study|Lost to Follow-up|0|||
126359890|NCT04595370|454609090|FG003|Overall Study|Lost to Follow-up|0|||
126359891|NCT04595370|454609091|FG004|Overall Study|Lost to Follow-up|1|||
126359892|NCT04595370|454609092|FG005|Overall Study|Lost to Follow-up|0|||
126263695|NCT01207440|454258276|FG004|Overall Study|Lack of Efficacy|2|||
126263696|NCT01207440|454258277|FG005|Overall Study|Lack of Efficacy|3|||
126263697|NCT01207440|454258278|FG006|Overall Study|Lack of Efficacy|0|||
126263698|NCT01207440|454258272|FG000|Overall Study|Lost to Follow-up|0|||
126263699|NCT01207440|454258273|FG001|Overall Study|Lost to Follow-up|0|||
126263700|NCT01207440|454258274|FG002|Overall Study|Lost to Follow-up|2|||
126263701|NCT01207440|454258275|FG003|Overall Study|Lost to Follow-up|1|||
126263702|NCT01207440|454258276|FG004|Overall Study|Lost to Follow-up|0|||
126263703|NCT01207440|454258277|FG005|Overall Study|Lost to Follow-up|0|||
126263704|NCT01207440|454258278|FG006|Overall Study|Lost to Follow-up|0|||
126263705|NCT01207440|454258272|FG000|Overall Study|Non-compliance with Study Drug|3|||
126263706|NCT01207440|454258273|FG001|Overall Study|Non-compliance with Study Drug|0|||
126263707|NCT01207440|454258274|FG002|Overall Study|Non-compliance with Study Drug|1|||
126263708|NCT01207440|454258275|FG003|Overall Study|Non-compliance with Study Drug|0|||
126263709|NCT01207440|454258276|FG004|Overall Study|Non-compliance with Study Drug|0|||
126263710|NCT01207440|454258277|FG005|Overall Study|Non-compliance with Study Drug|0|||
126263711|NCT01207440|454258278|FG006|Overall Study|Non-compliance with Study Drug|0|||
126263712|NCT01207440|454258272|FG000|Overall Study|Physician Decision|6|||
126263713|NCT01207440|454258273|FG001|Overall Study|Physician Decision|5|||
126263714|NCT01207440|454258274|FG002|Overall Study|Physician Decision|5|||
126263715|NCT01207440|454258275|FG003|Overall Study|Physician Decision|0|||
126263716|NCT01207440|454258276|FG004|Overall Study|Physician Decision|1|||
126263717|NCT01207440|454258277|FG005|Overall Study|Physician Decision|0|||
126263718|NCT01207440|454258278|FG006|Overall Study|Physician Decision|0|||
126263719|NCT01207440|454258272|FG000|Overall Study|Progressive Disease|19|||
126263720|NCT01207440|454258273|FG001|Overall Study|Progressive Disease|10|||
126263721|NCT01207440|454258274|FG002|Overall Study|Progressive Disease|19|||
126263722|NCT01207440|454258275|FG003|Overall Study|Progressive Disease|7|||
126263723|NCT01207440|454258276|FG004|Overall Study|Progressive Disease|23|||
126263724|NCT01207440|454258277|FG005|Overall Study|Progressive Disease|27|||
126263725|NCT01207440|454258278|FG006|Overall Study|Progressive Disease|0|||
126263726|NCT01207440|454258272|FG000|Overall Study|Protocol Violation|2|||
126263727|NCT01207440|454258273|FG001|Overall Study|Protocol Violation|0|||
126263728|NCT01207440|454258274|FG002|Overall Study|Protocol Violation|0|||
126263729|NCT01207440|454258275|FG003|Overall Study|Protocol Violation|0|||
126263730|NCT01207440|454258276|FG004|Overall Study|Protocol Violation|0|||
126263731|NCT01207440|454258277|FG005|Overall Study|Protocol Violation|0|||
126263732|NCT01207440|454258278|FG006|Overall Study|Protocol Violation|0|||
126263733|NCT01207440|454258272|FG000|Overall Study|Site Terminated by Sponsor|69|||
126263734|NCT01207440|454258273|FG001|Overall Study|Site Terminated by Sponsor|19|||
126263735|NCT01207440|454258274|FG002|Overall Study|Site Terminated by Sponsor|12|||
126263736|NCT01207440|454258275|FG003|Overall Study|Site Terminated by Sponsor|2|||
126263737|NCT01207440|454258276|FG004|Overall Study|Site Terminated by Sponsor|3|||
126263738|NCT01207440|454258277|FG005|Overall Study|Site Terminated by Sponsor|0|||
126263739|NCT01207440|454258278|FG006|Overall Study|Site Terminated by Sponsor|2|||
126263740|NCT01207440|454258272|FG000|Overall Study|Withdrawal by Subject|29|||
126263741|NCT01207440|454258273|FG001|Overall Study|Withdrawal by Subject|4|||
126263742|NCT01207440|454258274|FG002|Overall Study|Withdrawal by Subject|5|||
126263743|NCT01207440|454258275|FG003|Overall Study|Withdrawal by Subject|3|||
126263744|NCT01207440|454258276|FG004|Overall Study|Withdrawal by Subject|2|||
126263745|NCT01207440|454258277|FG005|Overall Study|Withdrawal by Subject|2|||
126263746|NCT01207440|454258278|FG006|Overall Study|Withdrawal by Subject|0|||
126263747|NCT01207440|454258272|FG000|Overall Study|Reason Not Specified|10|||
125880309|NCT02855125|452858839|FG000|Overall Study|Clinical Disease Progression|5|||
126263748|NCT01207440|454258273|FG001|Overall Study|Reason Not Specified|10|||
126263749|NCT01207440|454258274|FG002|Overall Study|Reason Not Specified|7|||
126263750|NCT01207440|454258275|FG003|Overall Study|Reason Not Specified|0|||
126263751|NCT01207440|454258276|FG004|Overall Study|Reason Not Specified|4|||
126263752|NCT01207440|454258277|FG005|Overall Study|Reason Not Specified|3|||
126263753|NCT01207440|454258278|FG006|Overall Study|Reason Not Specified|0|||
126263754|NCT03341000|454258279|FG000|Overall Study|Adverse Event|1|||
126263755|NCT02813421|454258282|FG000|Overall Study|Withdrawal by Subject|1|||
126263756|NCT02813421|454258283|FG001|Overall Study|Withdrawal by Subject|2|||
126263757|NCT02813421|454258282|FG000|Overall Study|Lost to Follow-up|1|||
126263758|NCT02813421|454258283|FG001|Overall Study|Lost to Follow-up|1|||
126263759|NCT03135899|454258284|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263760|NCT03135899|454258285|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263761|NCT03135899|454258286|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263762|NCT03135899|454258287|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
126359893|NCT04595370|454609087|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
126359894|NCT04595370|454609088|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
126359895|NCT04595370|454609089|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
126359896|NCT04595370|454609090|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
126359897|NCT04595370|454609091|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
126359898|NCT04595370|454609092|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
126359899|NCT04913675|454609093|FG000|Main Study (Up to Week 36)|Death|0|||
126359900|NCT04913675|454609094|FG001|Main Study (Up to Week 36)|Death|2|||
126359901|NCT04913675|454609095|FG002|Main Study (Up to Week 36)|Death|2|||
126359902|NCT04913675|454609096|FG003|Main Study (Up to Week 36)|Death|0|||
126359903|NCT04913675|454609093|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
126359904|NCT04913675|454609094|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
126359905|NCT04913675|454609095|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
126359906|NCT04913675|454609096|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
126263763|NCT03135899|454258288|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263764|NCT03135899|454258289|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263765|NCT03135899|454258290|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
126263766|NCT03135899|454258291|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263767|NCT03135899|454258284|FG000|Overall Study|Withdrawal by Subject|0|||
126263768|NCT03135899|454258285|FG001|Overall Study|Withdrawal by Subject|0|||
126263769|NCT03135899|454258286|FG002|Overall Study|Withdrawal by Subject|0|||
126263770|NCT03135899|454258287|FG003|Overall Study|Withdrawal by Subject|0|||
126263771|NCT03135899|454258288|FG004|Overall Study|Withdrawal by Subject|0|||
126263772|NCT03135899|454258289|FG005|Overall Study|Withdrawal by Subject|2|||
126263773|NCT03135899|454258290|FG006|Overall Study|Withdrawal by Subject|0|||
126263774|NCT03135899|454258291|FG007|Overall Study|Withdrawal by Subject|0|||
126263775|NCT04146363|454258300|FG000|Induction Period|Adverse Event|1|||
126263776|NCT04146363|454258301|FG001|Induction Period|Adverse Event|2|||
126263777|NCT04146363|454258302|FG002|Induction Period|Adverse Event|0|||
126263778|NCT04146363|454258303|FG003|Induction Period|Adverse Event|0|||
126263779|NCT04146363|454258304|FG004|Induction Period|Adverse Event|0|||
126263780|NCT04146363|454258305|FG005|Induction Period|Adverse Event|0|||
126263781|NCT04146363|454258306|FG006|Induction Period|Adverse Event|0|||
126263782|NCT04146363|454258307|FG007|Induction Period|Adverse Event|0|||
126263783|NCT04146363|454258308|FG008|Induction Period|Adverse Event|0|||
126263784|NCT04146363|454258309|FG009|Induction Period|Adverse Event|0|||
126263785|NCT04146363|454258310|FG010|Induction Period|Adverse Event|0|||
126263786|NCT04146363|454258300|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
126263787|NCT04146363|454258301|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
126263788|NCT04146363|454258302|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
126263789|NCT04146363|454258303|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
126263790|NCT04146363|454258304|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
126263791|NCT04146363|454258305|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
126263792|NCT04146363|454258306|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
126263793|NCT04146363|454258307|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
126263794|NCT04146363|454258308|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
126263795|NCT04146363|454258309|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
126263796|NCT04146363|454258310|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
126263797|NCT04146363|454258300|FG000|Induction Period|Lack of Efficacy|7|||
126263798|NCT04146363|454258301|FG001|Induction Period|Lack of Efficacy|2|||
126359907|NCT04913675|454609093|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
126359908|NCT04913675|454609094|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
126359909|NCT04913675|454609095|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
126359910|NCT04913675|454609096|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
126263799|NCT04146363|454258302|FG002|Induction Period|Lack of Efficacy|0|||
126263800|NCT04146363|454258303|FG003|Induction Period|Lack of Efficacy|0|||
126263801|NCT04146363|454258304|FG004|Induction Period|Lack of Efficacy|0|||
126263802|NCT04146363|454258305|FG005|Induction Period|Lack of Efficacy|0|||
126263803|NCT04146363|454258306|FG006|Induction Period|Lack of Efficacy|0|||
126263804|NCT04146363|454258307|FG007|Induction Period|Lack of Efficacy|0|||
126263805|NCT04146363|454258308|FG008|Induction Period|Lack of Efficacy|0|||
126263806|NCT04146363|454258309|FG009|Induction Period|Lack of Efficacy|0|||
126263807|NCT04146363|454258310|FG010|Induction Period|Lack of Efficacy|0|||
126263808|NCT04146363|454258300|FG000|Induction Period|Lost to Follow-up|1|||
126263809|NCT04146363|454258301|FG001|Induction Period|Lost to Follow-up|4|||
126263810|NCT04146363|454258302|FG002|Induction Period|Lost to Follow-up|0|||
126263811|NCT04146363|454258303|FG003|Induction Period|Lost to Follow-up|0|||
126263812|NCT04146363|454258304|FG004|Induction Period|Lost to Follow-up|0|||
126263813|NCT04146363|454258305|FG005|Induction Period|Lost to Follow-up|0|||
126359911|NCT04913675|454609093|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
126359912|NCT04913675|454609094|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
126359913|NCT04913675|454609095|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
126359914|NCT04913675|454609096|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
126359915|NCT04913675|454609093|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
126359916|NCT04913675|454609094|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
126359917|NCT04913675|454609095|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
126359918|NCT04913675|454609096|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
126359919|NCT01341990|454609099|FG000|Overall Study|Adverse Event|0|||
126359920|NCT01341990|454609100|FG001|Overall Study|Adverse Event|1|||
126359921|NCT01341990|454609099|FG000|Overall Study|Torn Study Lens|1|||
126359922|NCT01341990|454609100|FG001|Overall Study|Torn Study Lens|0|||
126359923|NCT01341990|454609099|FG000|Overall Study|Withdrawal by Subject|2|||
126359924|NCT01341990|454609100|FG001|Overall Study|Withdrawal by Subject|0|||
126359925|NCT02489045|454609101|FG000|Overall Study|unable to collect usable data|53|||
126359926|NCT02489045|454609101|FG000|Follow-up|Lost to Follow-up|10|||
126359927|NCT01751685|454609103|FG000|6-mo Followup|Missed study visit|1|||
126359928|NCT01751685|454609104|FG001|6-mo Followup|Missed study visit|0|||
126359929|NCT01751685|454609103|FG000|6-mo Followup|Withdrawal by Subject|2|||
126359930|NCT01751685|454609104|FG001|6-mo Followup|Withdrawal by Subject|2|||
126359931|NCT01751685|454609103|FG000|6-mo Followup|Lost to Follow-up|0|||
126359932|NCT01751685|454609104|FG001|6-mo Followup|Lost to Follow-up|1|||
126359933|NCT01751685|454609103|FG000|12-mo Followup|Lost to Follow-up|5|||
126263814|NCT04146363|454258306|FG006|Induction Period|Lost to Follow-up|0|||
126263815|NCT04146363|454258307|FG007|Induction Period|Lost to Follow-up|0|||
126263816|NCT04146363|454258308|FG008|Induction Period|Lost to Follow-up|0|||
126263817|NCT04146363|454258309|FG009|Induction Period|Lost to Follow-up|0|||
126263818|NCT04146363|454258310|FG010|Induction Period|Lost to Follow-up|0|||
126263819|NCT04146363|454258300|FG000|Induction Period|Positive quantiferon test|0|||
126263820|NCT04146363|454258301|FG001|Induction Period|Positive quantiferon test|1|||
126263821|NCT04146363|454258302|FG002|Induction Period|Positive quantiferon test|0|||
126263822|NCT04146363|454258303|FG003|Induction Period|Positive quantiferon test|0|||
126263823|NCT04146363|454258304|FG004|Induction Period|Positive quantiferon test|0|||
126263824|NCT04146363|454258305|FG005|Induction Period|Positive quantiferon test|0|||
126263825|NCT04146363|454258306|FG006|Induction Period|Positive quantiferon test|0|||
126263826|NCT04146363|454258307|FG007|Induction Period|Positive quantiferon test|0|||
126263827|NCT04146363|454258308|FG008|Induction Period|Positive quantiferon test|0|||
126263828|NCT04146363|454258309|FG009|Induction Period|Positive quantiferon test|0|||
126263829|NCT04146363|454258310|FG010|Induction Period|Positive quantiferon test|0|||
126263830|NCT04146363|454258300|FG000|Induction Period|Protocol Deviation|5|||
126263831|NCT04146363|454258301|FG001|Induction Period|Protocol Deviation|6|||
126263832|NCT04146363|454258302|FG002|Induction Period|Protocol Deviation|0|||
126263833|NCT04146363|454258303|FG003|Induction Period|Protocol Deviation|0|||
126263834|NCT04146363|454258304|FG004|Induction Period|Protocol Deviation|0|||
126263835|NCT04146363|454258305|FG005|Induction Period|Protocol Deviation|0|||
126263836|NCT04146363|454258306|FG006|Induction Period|Protocol Deviation|0|||
126263837|NCT04146363|454258307|FG007|Induction Period|Protocol Deviation|0|||
126263838|NCT04146363|454258308|FG008|Induction Period|Protocol Deviation|0|||
126263839|NCT04146363|454258309|FG009|Induction Period|Protocol Deviation|0|||
126263840|NCT04146363|454258310|FG010|Induction Period|Protocol Deviation|0|||
126263841|NCT04146363|454258300|FG000|Induction Period|Withdrawal by Subject|6|||
126263842|NCT04146363|454258301|FG001|Induction Period|Withdrawal by Subject|3|||
126263843|NCT04146363|454258302|FG002|Induction Period|Withdrawal by Subject|0|||
126263844|NCT04146363|454258303|FG003|Induction Period|Withdrawal by Subject|0|||
126263845|NCT04146363|454258304|FG004|Induction Period|Withdrawal by Subject|0|||
126263846|NCT04146363|454258305|FG005|Induction Period|Withdrawal by Subject|0|||
126263847|NCT04146363|454258306|FG006|Induction Period|Withdrawal by Subject|0|||
126263848|NCT04146363|454258307|FG007|Induction Period|Withdrawal by Subject|0|||
126263849|NCT04146363|454258308|FG008|Induction Period|Withdrawal by Subject|0|||
126263850|NCT04146363|454258309|FG009|Induction Period|Withdrawal by Subject|0|||
126263851|NCT04146363|454258310|FG010|Induction Period|Withdrawal by Subject|0|||
126263852|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
126359934|NCT01751685|454609104|FG001|12-mo Followup|Lost to Follow-up|0|||
126359935|NCT01348490|454609111|FG000|Overall Study|Death|1|||
126359936|NCT01348490|454609111|FG000|Overall Study|Adverse Event|3|||
126359937|NCT01348490|454609111|FG000|Overall Study|Consent withdrawn|7|||
126263853|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263854|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263855|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263856|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263857|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263858|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
126263859|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
126263860|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263861|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263862|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263863|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263864|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263865|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263866|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263867|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263868|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263869|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263870|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
126263871|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263872|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263873|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263874|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263875|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263876|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263877|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263878|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263879|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263880|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
126263881|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
126263882|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263883|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263884|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263885|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263886|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263887|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
126263888|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263889|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263890|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
126263891|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263892|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263893|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263894|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263895|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263896|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263897|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263898|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263899|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263900|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
126263901|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
126263902|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
126263903|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
126263904|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263905|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126032055|NCT01606215|453414063|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
126032056|NCT04592549|453414064|FG000|Overall Study|Withdrawal by Subject|0|||
126032057|NCT04592549|453414065|FG001|Overall Study|Withdrawal by Subject|1|||
126263906|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263907|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125880310|NCT02855125|452858840|FG001|Overall Study|Clinical Disease Progression|4|||
126096711|NCT01820585|453646539|FG001|Overall Study|Subject non-compliance|0|||
126263908|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263909|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
126263910|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263911|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263912|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
126263913|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
126263914|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
126263915|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263916|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263917|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263918|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263919|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263920|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263921|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263922|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263923|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263924|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263925|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263926|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
126263927|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
126263928|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263929|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263930|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263931|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263932|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263933|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263934|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263935|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263936|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263937|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
126263938|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
126263939|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
126263940|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263941|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263942|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263943|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263944|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263945|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263946|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263947|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263948|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
126263949|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
126263950|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263951|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263952|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263953|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263954|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263955|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263956|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263957|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263958|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263959|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
126263960|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
126263961|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263962|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263963|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263964|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263965|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263966|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263967|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263968|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263969|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263970|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
126263971|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
126263972|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
126263973|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263974|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263975|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263976|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263977|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263978|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
126096712|NCT01820585|453646540|FG002|Overall Study|Subject non-compliance|1|||
126263979|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263980|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263981|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263982|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
126263983|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263984|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263985|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263986|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263987|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263988|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263989|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263990|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263991|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263992|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263993|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
126263994|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263995|NCT02914236|454258311|FG000|Overall Study|Lost to Follow-up|1|||
126263996|NCT00706095|454258312|FG000|Overall Study|Progressive Disease|4|||
126263997|NCT00706095|454258313|FG001|Overall Study|Progressive Disease|5|||
126263998|NCT00706095|454258314|FG002|Overall Study|Progressive Disease|3|||
126263999|NCT00706095|454258312|FG000|Overall Study|Clinical Progression|1|||
126264000|NCT00706095|454258313|FG001|Overall Study|Clinical Progression|2|||
126264001|NCT00706095|454258314|FG002|Overall Study|Clinical Progression|2|||
126264002|NCT00706095|454258312|FG000|Overall Study|Withdrawal by Subject|1|||
126264003|NCT00706095|454258313|FG001|Overall Study|Withdrawal by Subject|0|||
126264004|NCT00706095|454258314|FG002|Overall Study|Withdrawal by Subject|0|||
126264005|NCT00856830|454258315|FG000|Irinotecan & Bendamustine|Death|0|||
126264006|NCT00856830|454258316|FG001|Irinotecan & Bendamustine|Death|0|||
126264007|NCT00856830|454258317|FG002|Irinotecan & Bendamustine|Death|0|||
126264008|NCT00856830|454258318|FG003|Irinotecan & Bendamustine|Death|2|||
126264009|NCT00856830|454258315|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
126264010|NCT00856830|454258316|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
126264011|NCT00856830|454258317|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
126264012|NCT00856830|454258318|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
126264013|NCT00918463|454258320|FG000|Overall Study|Death|1|||
126264014|NCT00918463|454258320|FG000|Overall Study|Lack of Efficacy|1|||
126264015|NCT01014624|454258324|FG000|Overall Study|Adverse Event|0|||
126264016|NCT01014624|454258325|FG001|Overall Study|Adverse Event|1|||
126264017|NCT01014624|454258324|FG000|Overall Study|Protocol Violation|1|||
126264018|NCT01014624|454258325|FG001|Overall Study|Protocol Violation|0|||
126264019|NCT01014624|454258324|FG000|Overall Study|Withdrawal by Subject|1|||
126264020|NCT01014624|454258325|FG001|Overall Study|Withdrawal by Subject|0|||
126264021|NCT02954159|454258327|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
126264022|NCT02954159|454258328|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
126264023|NCT02954159|454258327|FG000|Overall Study|Withdrawal by Subject|0|||
126264024|NCT02954159|454258328|FG001|Overall Study|Withdrawal by Subject|1|||
126264025|NCT01117337|454258332|FG000|Overall Study|Lost to Follow-up|4|||
126264026|NCT01117337|454258333|FG001|Overall Study|Lost to Follow-up|0|||
126264027|NCT03575871|454258334|FG000|Overall Study|Adverse Event|5|||
126264028|NCT03575871|454258335|FG001|Overall Study|Adverse Event|5|||
126264029|NCT03575871|454258336|FG002|Overall Study|Adverse Event|8|||
126264030|NCT03575871|454258334|FG000|Overall Study|Death|1|||
126264031|NCT03575871|454258335|FG001|Overall Study|Death|0|||
126264032|NCT03575871|454258336|FG002|Overall Study|Death|0|||
126264033|NCT03575871|454258334|FG000|Overall Study|Lack of Efficacy|5|||
126264034|NCT03575871|454258335|FG001|Overall Study|Lack of Efficacy|4|||
126264035|NCT03575871|454258336|FG002|Overall Study|Lack of Efficacy|7|||
126264036|NCT03575871|454258334|FG000|Overall Study|Lost to Follow-up|1|||
126264037|NCT03575871|454258335|FG001|Overall Study|Lost to Follow-up|1|||
126264038|NCT03575871|454258336|FG002|Overall Study|Lost to Follow-up|1|||
126264039|NCT03575871|454258334|FG000|Overall Study|Protocol Deviation|1|||
126359938|NCT01348490|454609111|FG000|Overall Study|Disease progression|3|||
126359939|NCT01348490|454609111|FG000|Overall Study|Lost to Follow-up|1|||
126359940|NCT01348490|454609111|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
126359941|NCT01348490|454609111|FG000|Overall Study|Other Unspecified|8|||
126359942|NCT01117350|454609116|FG000|Comparative Period|Not Treated|5|||
126359943|NCT01117350|454609117|FG001|Comparative Period|Not Treated|8|||
126264040|NCT03575871|454258335|FG001|Overall Study|Protocol Deviation|1|||
126264041|NCT03575871|454258336|FG002|Overall Study|Protocol Deviation|1|||
126264042|NCT03575871|454258334|FG000|Overall Study|Withdrawal by Subject|6|||
126264043|NCT03575871|454258335|FG001|Overall Study|Withdrawal by Subject|1|||
126264044|NCT03575871|454258336|FG002|Overall Study|Withdrawal by Subject|9|||
126264045|NCT03575871|454258334|FG000|Overall Study|Other than specified|2|||
126264046|NCT03575871|454258335|FG001|Overall Study|Other than specified|2|||
126264047|NCT03575871|454258336|FG002|Overall Study|Other than specified|0|||
126264048|NCT01744093|454258340|FG000|Overall Study|Withdrawal by Subject|6|||
126264049|NCT01744093|454258341|FG001|Overall Study|Withdrawal by Subject|1|||
126264050|NCT01570283|454258342|FG000|Cohort 1: Dose Level 1|Death|0|||
126264051|NCT01570283|454258343|FG001|Cohort 1: Dose Level 1|Death|1|||
126264052|NCT01570283|454258344|FG002|Cohort 1: Dose Level 1|Death|0|||
126264053|NCT01570283|454258345|FG003|Cohort 1: Dose Level 1|Death|0|||
126264054|NCT01570283|454258346|FG004|Cohort 1: Dose Level 1|Death|0|||
126264055|NCT01570283|454258347|FG005|Cohort 1: Dose Level 1|Death|0|||
126264056|NCT01570283|454258342|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264057|NCT01570283|454258343|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
126264058|NCT01570283|454258344|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264059|NCT01570283|454258345|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264060|NCT01570283|454258346|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264061|NCT01570283|454258347|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264062|NCT01570283|454258342|FG000|Cohort 2: Dose Level 2|Death|0|||
126264063|NCT01570283|454258343|FG001|Cohort 2: Dose Level 2|Death|0|||
126264064|NCT01570283|454258344|FG002|Cohort 2: Dose Level 2|Death|1|||
126264065|NCT01570283|454258345|FG003|Cohort 2: Dose Level 2|Death|0|||
126264066|NCT01570283|454258346|FG004|Cohort 2: Dose Level 2|Death|0|||
126264067|NCT01570283|454258347|FG005|Cohort 2: Dose Level 2|Death|0|||
126264068|NCT01570283|454258342|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264069|NCT01570283|454258343|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264070|NCT01570283|454258344|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264071|NCT01570283|454258345|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
126264072|NCT01570283|454258346|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264073|NCT01570283|454258347|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264074|NCT01570283|454258342|FG000|Cohort 3: Dose Level 3|Death|0|||
126264075|NCT01570283|454258343|FG001|Cohort 3: Dose Level 3|Death|0|||
126264076|NCT01570283|454258344|FG002|Cohort 3: Dose Level 3|Death|0|||
126264077|NCT01570283|454258345|FG003|Cohort 3: Dose Level 3|Death|0|||
126264078|NCT01570283|454258346|FG004|Cohort 3: Dose Level 3|Death|0|||
126264079|NCT01570283|454258347|FG005|Cohort 3: Dose Level 3|Death|1|||
126264080|NCT01570283|454258342|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264081|NCT01570283|454258343|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264082|NCT01570283|454258344|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264083|NCT01570283|454258345|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264084|NCT01570283|454258346|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264085|NCT01570283|454258347|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
126264086|NCT00355472|454258360|FG000|Overall Study|Physician Decision|1|||
126264087|NCT03095118|454258361|FG000|Overall Study|Adverse Event|1|||
126264088|NCT03095118|454258361|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
126264089|NCT03847194|454258362|FG000|Overall Study|Lost to Follow-up|2|||
126264090|NCT03847194|454258363|FG001|Overall Study|Lost to Follow-up|5|||
126264091|NCT03847194|454258362|FG000|Overall Study|Withdrawal by Subject|1|||
126264092|NCT03847194|454258363|FG001|Overall Study|Withdrawal by Subject|2|||
126264093|NCT03847194|454258362|FG000|Overall Study|Death|0|||
126032058|NCT04592549|453414066|FG002|Overall Study|Withdrawal by Subject|0|||
126264094|NCT03847194|454258363|FG001|Overall Study|Death|1|||
126264095|NCT02408120|454258364|FG000|Overall Study|Withdrawal by Subject|0|||
126264096|NCT02408120|454258365|FG001|Overall Study|Withdrawal by Subject|1|||
126264097|NCT02408120|454258364|FG000|Overall Study|Treatment Refusal|1|||
126264098|NCT02408120|454258365|FG001|Overall Study|Treatment Refusal|0|||
126264099|NCT02408120|454258364|FG000|Overall Study|Received Steroids|1|||
126264100|NCT02408120|454258365|FG001|Overall Study|Received Steroids|1|||
126264101|NCT02408120|454258364|FG000|Overall Study|Discharged same day|1|||
126264102|NCT02408120|454258365|FG001|Overall Study|Discharged same day|1|||
126264103|NCT02408120|454258364|FG000|Overall Study|Did not receive insulin|1|||
126264104|NCT02408120|454258365|FG001|Overall Study|Did not receive insulin|2|||
126264105|NCT00680186|454258370|FG000|Overall Study|Adverse Event|47|||
126264106|NCT00680186|454258371|FG001|Overall Study|Adverse Event|44|||
126264107|NCT00680186|454258370|FG000|Overall Study|Protocol Violation|31|||
126264108|NCT00680186|454258371|FG001|Overall Study|Protocol Violation|26|||
126264109|NCT00680186|454258370|FG000|Overall Study|Lost to Follow-up|11|||
126264110|NCT00680186|454258371|FG001|Overall Study|Lost to Follow-up|6|||
126264111|NCT00680186|454258370|FG000|Overall Study|Withdrawal by Subject|32|||
126264112|NCT00680186|454258371|FG001|Overall Study|Withdrawal by Subject|39|||
126046487|NCT00495677|453468235|FG005|Stage 1 (25 Days)|Adverse Event|0|||
126264113|NCT00680186|454258370|FG000|Overall Study|Other|4|||
126264114|NCT00680186|454258371|FG001|Overall Study|Other|1|||
126264115|NCT00285584|454258379|FG000|Month 3|Lost to Follow-up|3|||
126264116|NCT00285584|454258380|FG001|Month 3|Lost to Follow-up|3|||
126264117|NCT00285584|454258379|FG000|Month 3|Withdrawal by Subject|1|||
126264118|NCT00285584|454258380|FG001|Month 3|Withdrawal by Subject|0|||
126264119|NCT00285584|454258379|FG000|Month 6|Lost to Follow-up|0|||
126264120|NCT00285584|454258380|FG001|Month 6|Lost to Follow-up|1|||
126264121|NCT00466726|454258381|FG000|Overall Study|Not evaluable for response|14|||
126264122|NCT01376310|454258382|FG000|Overall Study|Study closed/terminated|1|||
126264123|NCT01376310|454258383|FG001|Overall Study|Study closed/terminated|2|||
126264124|NCT01376310|454258382|FG000|Overall Study|Withdrawal by Subject|8|||
126264125|NCT01376310|454258383|FG001|Overall Study|Withdrawal by Subject|2|||
126264126|NCT01376310|454258382|FG000|Overall Study|Physician Decision|26|||
126264127|NCT01376310|454258383|FG001|Overall Study|Physician Decision|7|||
126264128|NCT01376310|454258382|FG000|Overall Study|Lost to Follow-up|1|||
126264129|NCT01376310|454258383|FG001|Overall Study|Lost to Follow-up|0|||
126264130|NCT00645944|454258384|FG000|Randomized|Withdrawal by Subject|1|||
126264131|NCT00645944|454258385|FG001|Randomized|Withdrawal by Subject|2|||
126264132|NCT00645944|454258384|FG000|Received Medication|Adverse Event|2|||
126264133|NCT00645944|454258385|FG001|Received Medication|Adverse Event|1|||
126264134|NCT00645944|454258384|FG000|Received Medication|Withdrawal by Subject|1|||
126264135|NCT00645944|454258385|FG001|Received Medication|Withdrawal by Subject|1|||
126264136|NCT00645944|454258384|FG000|Received Medication|Lost to Follow-up|1|||
126264137|NCT00645944|454258385|FG001|Received Medication|Lost to Follow-up|0|||
126264138|NCT00645944|454258384|FG000|Received Medication|Protocol Violation|2|||
126264139|NCT00645944|454258385|FG001|Received Medication|Protocol Violation|1|||
126264140|NCT01807117|454258387|FG000|Overall Study|Physician Decision|2|||
126264141|NCT01807117|454258387|FG000|Overall Study|Disease diagnosis not a study disease|1|||
126264142|NCT01523587|454258388|FG000|Overall Study|Other than listed|5|||
126264143|NCT01523587|454258389|FG001|Overall Study|Other than listed|5|||
126264144|NCT01523587|454258388|FG000|Overall Study|Worsening of underlying cancer disease|19|||
126264145|NCT01523587|454258389|FG001|Overall Study|Worsening of underlying cancer disease|34|||
126264146|NCT01523587|454258388|FG000|Overall Study|Adverse Event|68|||
126264147|NCT01523587|454258389|FG001|Overall Study|Adverse Event|52|||
126264148|NCT01523587|454258388|FG000|Overall Study|Protocol Violation|5|||
126264149|NCT01523587|454258389|FG001|Overall Study|Protocol Violation|3|||
126264150|NCT01523587|454258388|FG000|Overall Study|Lost to Follow-up|2|||
126264151|NCT01523587|454258389|FG001|Overall Study|Lost to Follow-up|2|||
126264152|NCT01523587|454258388|FG000|Overall Study|Withdrawal by Subject|28|||
126264153|NCT01523587|454258389|FG001|Overall Study|Withdrawal by Subject|20|||
126264154|NCT01523587|454258388|FG000|Overall Study|Withdrew due to Progressive disease|265|||
126264155|NCT01523587|454258389|FG001|Overall Study|Withdrew due to Progressive disease|279|||
126264156|NCT01523587|454258388|FG000|Overall Study|Randomised but bot treated|6|||
126264157|NCT01523587|454258389|FG001|Overall Study|Randomised but bot treated|2|||
126264158|NCT02709486|454258390|FG000|Overall Study|Adverse Event|2|||
126264159|NCT02709486|454258391|FG001|Overall Study|Adverse Event|5|||
126264160|NCT02709486|454258392|FG002|Overall Study|Adverse Event|3|||
126264161|NCT02709486|454258390|FG000|Overall Study|Death|0|||
126264162|NCT02709486|454258391|FG001|Overall Study|Death|0|||
126264163|NCT02709486|454258392|FG002|Overall Study|Death|2|||
126264164|NCT02709486|454258390|FG000|Overall Study|Insufficient clinical response|7|||
126264165|NCT02709486|454258391|FG001|Overall Study|Insufficient clinical response|3|||
126264166|NCT02709486|454258392|FG002|Overall Study|Insufficient clinical response|3|||
126264167|NCT02709486|454258390|FG000|Overall Study|Lost to Follow-up|3|||
126264168|NCT02709486|454258391|FG001|Overall Study|Lost to Follow-up|2|||
126264169|NCT02709486|454258392|FG002|Overall Study|Lost to Follow-up|2|||
126264170|NCT02709486|454258390|FG000|Overall Study|Other|0|||
126264171|NCT02709486|454258391|FG001|Overall Study|Other|2|||
126264172|NCT02709486|454258392|FG002|Overall Study|Other|3|||
126264173|NCT02709486|454258390|FG000|Overall Study|Withdrawal by Subject|32|||
126264174|NCT02709486|454258391|FG001|Overall Study|Withdrawal by Subject|22|||
126264175|NCT02709486|454258392|FG002|Overall Study|Withdrawal by Subject|32|||
126032059|NCT04592549|453414067|FG003|Overall Study|Withdrawal by Subject|1|||
126032060|NCT04592549|453414068|FG004|Overall Study|Withdrawal by Subject|1|||
126264176|NCT04179019|454258402|FG000|Overall Study|Lost to Follow-up|2|||
126264177|NCT04179019|454258402|FG000|Overall Study|Physician Decision|2|||
126264178|NCT04179019|454258402|FG000|Overall Study|Withdrawal by Subject|5|||
126264179|NCT04179019|454258402|FG000|Overall Study|Adverse Event|4|||
126264180|NCT02610816|454258403|FG000|Phase 1|Withdrawal by Subject|2|||
126264181|NCT02610816|454258404|FG001|Phase 1|Withdrawal by Subject|6|||
126264182|NCT02610816|454258405|FG002|Phase 1|Withdrawal by Subject|0|||
126264183|NCT02610816|454258406|FG003|Phase 1|Withdrawal by Subject|0|||
126032061|NCT04592549|453414069|FG005|Overall Study|Withdrawal by Subject|0|||
126264184|NCT02610816|454258403|FG000|Phase 1|Lost to Follow-up|2|||
126264185|NCT02610816|454258404|FG001|Phase 1|Lost to Follow-up|1|||
126264186|NCT02610816|454258405|FG002|Phase 1|Lost to Follow-up|0|||
126264187|NCT02610816|454258406|FG003|Phase 1|Lost to Follow-up|0|||
126264188|NCT02610816|454258403|FG000|Phase 1|Physician Decision|0|||
126264189|NCT02610816|454258404|FG001|Phase 1|Physician Decision|1|||
126264190|NCT02610816|454258405|FG002|Phase 1|Physician Decision|0|||
126264191|NCT02610816|454258406|FG003|Phase 1|Physician Decision|0|||
126264192|NCT02610816|454258403|FG000|Phase 2|Withdrawal by Subject|0|||
126264193|NCT02610816|454258404|FG001|Phase 2|Withdrawal by Subject|0|||
126264194|NCT02610816|454258405|FG002|Phase 2|Withdrawal by Subject|9|||
126264195|NCT02610816|454258406|FG003|Phase 2|Withdrawal by Subject|3|||
126264196|NCT02610816|454258403|FG000|Phase 2|Lost to Follow-up|0|||
126264197|NCT02610816|454258404|FG001|Phase 2|Lost to Follow-up|0|||
126264198|NCT02610816|454258405|FG002|Phase 2|Lost to Follow-up|2|||
126264199|NCT02610816|454258406|FG003|Phase 2|Lost to Follow-up|0|||
126264200|NCT02610816|454258403|FG000|Phase 2|Physician Decision|0|||
126264201|NCT02610816|454258404|FG001|Phase 2|Physician Decision|0|||
126264202|NCT02610816|454258405|FG002|Phase 2|Physician Decision|0|||
126264203|NCT02610816|454258406|FG003|Phase 2|Physician Decision|2|||
126264204|NCT02610816|454258403|FG000|Phase 2|Pregnancy|0|||
126264205|NCT02610816|454258404|FG001|Phase 2|Pregnancy|0|||
126264206|NCT02610816|454258405|FG002|Phase 2|Pregnancy|0|||
126264207|NCT02610816|454258406|FG003|Phase 2|Pregnancy|1|||
126264208|NCT01855048|454258407|FG000|Overall Study|Withdrawal by Subject|0|||
126264209|NCT01855048|454258408|FG001|Overall Study|Withdrawal by Subject|1|||
126264210|NCT01855048|454258409|FG002|Overall Study|Withdrawal by Subject|0|||
126264211|NCT01855048|454258410|FG003|Overall Study|Withdrawal by Subject|0|||
126264212|NCT01855048|454258411|FG004|Overall Study|Withdrawal by Subject|1|||
126264213|NCT01855048|454258412|FG005|Overall Study|Withdrawal by Subject|0|||
126264214|NCT02691741|454258413|FG000|Overall Study|Adverse Event|0|||
126264215|NCT02691741|454258414|FG001|Overall Study|Adverse Event|2|||
126264216|NCT02691741|454258413|FG000|Overall Study|Lost to Follow-up|1|||
126264217|NCT02691741|454258414|FG001|Overall Study|Lost to Follow-up|0|||
126264218|NCT02691741|454258413|FG000|Overall Study|Physician Decision|0|||
126264219|NCT02691741|454258414|FG001|Overall Study|Physician Decision|1|||
126264220|NCT02691741|454258413|FG000|Overall Study|Withdrawal by Subject|0|||
126264221|NCT02691741|454258414|FG001|Overall Study|Withdrawal by Subject|4|||
126264222|NCT02139124|454258415|FG000|Overall Study|Adverse Event|2|||
126264223|NCT02139124|454258416|FG001|Overall Study|Adverse Event|0|||
126264224|NCT02139124|454258417|FG002|Overall Study|Adverse Event|1|||
126264225|NCT02139124|454258418|FG003|Overall Study|Adverse Event|2|||
126264226|NCT02139124|454258419|FG004|Overall Study|Adverse Event|5|||
126264227|NCT02139124|454258415|FG000|Overall Study|Withdrawal by Subject|2|||
126264228|NCT02139124|454258416|FG001|Overall Study|Withdrawal by Subject|2|||
126264229|NCT02139124|454258417|FG002|Overall Study|Withdrawal by Subject|2|||
126264230|NCT02139124|454258418|FG003|Overall Study|Withdrawal by Subject|2|||
126264231|NCT02139124|454258419|FG004|Overall Study|Withdrawal by Subject|3|||
126264232|NCT02139124|454258415|FG000|Overall Study|Protocol Violation|0|||
126264233|NCT02139124|454258416|FG001|Overall Study|Protocol Violation|0|||
126264234|NCT02139124|454258417|FG002|Overall Study|Protocol Violation|0|||
126264235|NCT02139124|454258418|FG003|Overall Study|Protocol Violation|1|||
126264236|NCT02139124|454258419|FG004|Overall Study|Protocol Violation|1|||
126264237|NCT02139124|454258415|FG000|Overall Study|non-compliant|1|||
126264238|NCT02139124|454258416|FG001|Overall Study|non-compliant|0|||
126264239|NCT02139124|454258417|FG002|Overall Study|non-compliant|0|||
126264240|NCT02139124|454258418|FG003|Overall Study|non-compliant|2|||
126264241|NCT02139124|454258419|FG004|Overall Study|non-compliant|0|||
126264242|NCT02139124|454258415|FG000|Overall Study|incarceration|0|||
126264243|NCT02139124|454258416|FG001|Overall Study|incarceration|0|||
126264244|NCT02139124|454258417|FG002|Overall Study|incarceration|1|||
126264245|NCT02139124|454258418|FG003|Overall Study|incarceration|0|||
126264246|NCT02139124|454258419|FG004|Overall Study|incarceration|0|||
126264247|NCT02139124|454258415|FG000|Overall Study|subject moved|1|||
126264248|NCT02139124|454258416|FG001|Overall Study|subject moved|0|||
126264249|NCT02139124|454258417|FG002|Overall Study|subject moved|0|||
126264250|NCT02139124|454258418|FG003|Overall Study|subject moved|0|||
126264251|NCT02139124|454258419|FG004|Overall Study|subject moved|0|||
126264252|NCT02139124|454258415|FG000|Overall Study|Lost to Follow-up|3|||
126264253|NCT02139124|454258416|FG001|Overall Study|Lost to Follow-up|2|||
126264254|NCT02139124|454258417|FG002|Overall Study|Lost to Follow-up|0|||
126264255|NCT02139124|454258418|FG003|Overall Study|Lost to Follow-up|5|||
126264256|NCT02139124|454258419|FG004|Overall Study|Lost to Follow-up|4|||
126264257|NCT03465436|454258420|FG000|Period 1|Protocol Violation|0|||
126264258|NCT03465436|454258421|FG001|Period 1|Protocol Violation|0|||
126264259|NCT03465436|454258422|FG002|Period 1|Protocol Violation|1|||
126264260|NCT03465436|454258423|FG003|Period 1|Protocol Violation|0|||
126264261|NCT03465436|454258420|FG000|Period 2|Protocol Violation|0|||
126264262|NCT03465436|454258421|FG001|Period 2|Protocol Violation|1|||
126264263|NCT03465436|454258422|FG002|Period 2|Protocol Violation|0|||
126264264|NCT03465436|454258423|FG003|Period 2|Protocol Violation|0|||
126264265|NCT03465436|454258420|FG000|Period 3|Protocol Violation|1|||
126264266|NCT03465436|454258421|FG001|Period 3|Protocol Violation|1|||
126264267|NCT03465436|454258422|FG002|Period 3|Protocol Violation|0|||
126264268|NCT03465436|454258423|FG003|Period 3|Protocol Violation|0|||
126264269|NCT03465436|454258420|FG000|Period 4|Protocol Violation|0|||
126264270|NCT03465436|454258421|FG001|Period 4|Protocol Violation|0|||
126264271|NCT03465436|454258422|FG002|Period 4|Protocol Violation|1|||
126264272|NCT03465436|454258423|FG003|Period 4|Protocol Violation|0|||
126264273|NCT02697773|454258424|FG000|Overall Study|Adverse Event|2|||
126264274|NCT02697773|454258425|FG001|Overall Study|Adverse Event|1|||
126264275|NCT02697773|454258426|FG002|Overall Study|Adverse Event|2|||
126264276|NCT02697773|454258424|FG000|Overall Study|Death|0|||
126264277|NCT02697773|454258425|FG001|Overall Study|Death|0|||
126264278|NCT02697773|454258426|FG002|Overall Study|Death|2|||
126264279|NCT02697773|454258424|FG000|Overall Study|Lack of Efficacy|4|||
126264280|NCT02697773|454258425|FG001|Overall Study|Lack of Efficacy|6|||
126264281|NCT02697773|454258426|FG002|Overall Study|Lack of Efficacy|6|||
126264282|NCT02697773|454258424|FG000|Overall Study|Lost to Follow-up|5|||
126264283|NCT02697773|454258425|FG001|Overall Study|Lost to Follow-up|5|||
126264284|NCT02697773|454258426|FG002|Overall Study|Lost to Follow-up|7|||
126264285|NCT02697773|454258424|FG000|Overall Study|Other|15|||
126264286|NCT02697773|454258425|FG001|Overall Study|Other|11|||
126264287|NCT02697773|454258426|FG002|Overall Study|Other|10|||
126264288|NCT02697773|454258424|FG000|Overall Study|Protocol Violation|1|||
126264289|NCT02697773|454258425|FG001|Overall Study|Protocol Violation|1|||
126264290|NCT02697773|454258426|FG002|Overall Study|Protocol Violation|0|||
126264291|NCT02697773|454258424|FG000|Overall Study|Withdrawal by Subject|10|||
126264292|NCT02697773|454258425|FG001|Overall Study|Withdrawal by Subject|13|||
126264293|NCT02697773|454258426|FG002|Overall Study|Withdrawal by Subject|13|||
126264294|NCT02697773|454258424|FG000|Overall Study|Randomized but not treated|1|||
126264295|NCT02697773|454258425|FG001|Overall Study|Randomized but not treated|1|||
126264296|NCT02697773|454258426|FG002|Overall Study|Randomized but not treated|0|||
126264297|NCT00613834|454258427|FG000|Overall Study|Withdrawal by Subject|0|||
126264298|NCT00613834|454258428|FG001|Overall Study|Withdrawal by Subject|3|||
126264299|NCT00842530|454258429|FG000|Overall Study|Serious adverse event|0|||
126264300|NCT00842530|454258430|FG001|Overall Study|Serious adverse event|6|||
126264301|NCT00842530|454258429|FG000|Overall Study|Other adverse event|6|||
126264302|NCT00842530|454258430|FG001|Overall Study|Other adverse event|1|||
126264303|NCT00842530|454258429|FG000|Overall Study|Protocol Violation|32|||
126264304|NCT00842530|454258430|FG001|Overall Study|Protocol Violation|14|||
126264305|NCT00842530|454258429|FG000|Overall Study|Lost to Follow-up|6|||
126264306|NCT00842530|454258430|FG001|Overall Study|Lost to Follow-up|8|||
126264307|NCT00842530|454258429|FG000|Overall Study|Withdrawal by Subject|73|||
126264308|NCT00842530|454258430|FG001|Overall Study|Withdrawal by Subject|28|||
126264309|NCT02939950|454258433|FG000|Overall Study|Lost to Follow-up|13|||
126264310|NCT02939950|454258434|FG001|Overall Study|Lost to Follow-up|16|||
126264311|NCT02939950|454258433|FG000|Overall Study|Positive slit lamp findings|0|||
126264312|NCT02939950|454258434|FG001|Overall Study|Positive slit lamp findings|1|||
126264313|NCT02939950|454258433|FG000|Overall Study|Chalazion upper lid|0|||
126264314|NCT02939950|454258434|FG001|Overall Study|Chalazion upper lid|1|||
126264315|NCT02939950|454258433|FG000|Overall Study|Lack of motivation|0|||
126264316|NCT02939950|454258434|FG001|Overall Study|Lack of motivation|2|||
126264317|NCT02939950|454258433|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
126264318|NCT02939950|454258434|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
126264319|NCT02939950|454258433|FG000|Overall Study|Military orders|1|||
126264320|NCT02939950|454258434|FG001|Overall Study|Military orders|0|||
126264321|NCT02939950|454258433|FG000|Overall Study|Participant Relocated|5|||
126264322|NCT02939950|454258434|FG001|Overall Study|Participant Relocated|3|||
126264323|NCT02939950|454258433|FG000|Overall Study|Study related symptoms|8|||
126264324|NCT02939950|454258434|FG001|Overall Study|Study related symptoms|8|||
126264325|NCT02939950|454258433|FG000|Overall Study|Unacceptable lens movement|2|||
126264326|NCT02939950|454258434|FG001|Overall Study|Unacceptable lens movement|0|||
126264327|NCT02939950|454258433|FG000|Overall Study|Protocol Violation|6|||
126264328|NCT02939950|454258434|FG001|Overall Study|Protocol Violation|3|||
126264329|NCT02939950|454258433|FG000|Overall Study|Physician Decision|2|||
126264330|NCT02939950|454258434|FG001|Overall Study|Physician Decision|0|||
126264331|NCT02939950|454258433|FG000|Overall Study|Pregnancy|6|||
126264332|NCT02939950|454258434|FG001|Overall Study|Pregnancy|7|||
126264333|NCT02939950|454258433|FG000|Overall Study|Withdrawal by Subject|12|||
126264334|NCT02939950|454258434|FG001|Overall Study|Withdrawal by Subject|28|||
126264335|NCT02939950|454258433|FG000|Overall Study|Adverse Event|7|||
126032062|NCT04592549|453414064|FG000|Overall Study|Lost to Follow-up|2|||
126264336|NCT02939950|454258434|FG001|Overall Study|Adverse Event|3|||
126264337|NCT02939950|454258433|FG000|Overall Study|Randomized, not dispensed|1|||
126264338|NCT02939950|454258434|FG001|Overall Study|Randomized, not dispensed|0|||
126264339|NCT02939950|454258433|FG000|Overall Study|Ineligible at Baseline|2|||
126264340|NCT02939950|454258434|FG001|Overall Study|Ineligible at Baseline|8|||
126264341|NCT02243293|454258438|FG000|Overall Study|Adverse Event|1|||
126264342|NCT02243293|454258439|FG001|Overall Study|Adverse Event|0|||
126264343|NCT02243293|454258440|FG002|Overall Study|Adverse Event|0|||
126096713|NCT01820585|453646541|FG003|Overall Study|Subject non-compliance|2|||
126096714|NCT01820585|453646538|FG000|Overall Study|at sponsor request|0|||
126264344|NCT02243293|454258441|FG003|Overall Study|Adverse Event|0|||
126264345|NCT02243293|454258442|FG004|Overall Study|Adverse Event|0|||
126264346|NCT02243293|454258443|FG005|Overall Study|Adverse Event|0|||
126264347|NCT02243293|454258444|FG006|Overall Study|Adverse Event|0|||
126264348|NCT02243293|454258445|FG007|Overall Study|Adverse Event|0|||
126264349|NCT02243293|454258446|FG008|Overall Study|Adverse Event|0|||
126264350|NCT02243293|454258447|FG009|Overall Study|Adverse Event|0|||
126264351|NCT02243293|454258448|FG010|Overall Study|Adverse Event|0|||
126264352|NCT02243293|454258449|FG011|Overall Study|Adverse Event|0|||
126264353|NCT02243293|454258450|FG012|Overall Study|Adverse Event|0|||
126264354|NCT02243293|454258451|FG013|Overall Study|Adverse Event|0|||
126264355|NCT02243293|454258452|FG014|Overall Study|Adverse Event|0|||
126264356|NCT02243293|454258453|FG015|Overall Study|Adverse Event|1|||
126264357|NCT02243293|454258454|FG016|Overall Study|Adverse Event|0|||
126264358|NCT02243293|454258455|FG017|Overall Study|Adverse Event|0|||
126264359|NCT02243293|454258456|FG018|Overall Study|Adverse Event|0|||
126264360|NCT02243293|454258457|FG019|Overall Study|Adverse Event|0|||
126264361|NCT02243293|454258458|FG020|Overall Study|Adverse Event|1|||
126264362|NCT02243293|454258459|FG021|Overall Study|Adverse Event|0|||
126264363|NCT02243293|454258438|FG000|Overall Study|Withdrawal by Subject|1|||
126264364|NCT02243293|454258439|FG001|Overall Study|Withdrawal by Subject|0|||
126264365|NCT02243293|454258440|FG002|Overall Study|Withdrawal by Subject|0|||
126264366|NCT02243293|454258441|FG003|Overall Study|Withdrawal by Subject|0|||
126264367|NCT02243293|454258442|FG004|Overall Study|Withdrawal by Subject|0|||
126264368|NCT02243293|454258443|FG005|Overall Study|Withdrawal by Subject|0|||
126264369|NCT02243293|454258444|FG006|Overall Study|Withdrawal by Subject|0|||
126264370|NCT02243293|454258445|FG007|Overall Study|Withdrawal by Subject|0|||
126264371|NCT02243293|454258446|FG008|Overall Study|Withdrawal by Subject|0|||
126264372|NCT02243293|454258447|FG009|Overall Study|Withdrawal by Subject|1|||
126264373|NCT02243293|454258448|FG010|Overall Study|Withdrawal by Subject|0|||
126264374|NCT02243293|454258449|FG011|Overall Study|Withdrawal by Subject|1|||
126264375|NCT02243293|454258450|FG012|Overall Study|Withdrawal by Subject|0|||
126264376|NCT02243293|454258451|FG013|Overall Study|Withdrawal by Subject|0|||
126264377|NCT02243293|454258452|FG014|Overall Study|Withdrawal by Subject|0|||
126264378|NCT02243293|454258453|FG015|Overall Study|Withdrawal by Subject|0|||
126264379|NCT02243293|454258454|FG016|Overall Study|Withdrawal by Subject|0|||
126264380|NCT02243293|454258455|FG017|Overall Study|Withdrawal by Subject|0|||
126264381|NCT02243293|454258456|FG018|Overall Study|Withdrawal by Subject|0|||
126264382|NCT02243293|454258457|FG019|Overall Study|Withdrawal by Subject|0|||
126264383|NCT02243293|454258458|FG020|Overall Study|Withdrawal by Subject|0|||
126264384|NCT02243293|454258459|FG021|Overall Study|Withdrawal by Subject|1|||
126264385|NCT02243293|454258438|FG000|Overall Study|Lost to Follow-up|0|||
126264386|NCT02243293|454258439|FG001|Overall Study|Lost to Follow-up|1|||
126264387|NCT02243293|454258440|FG002|Overall Study|Lost to Follow-up|1|||
126264388|NCT02243293|454258441|FG003|Overall Study|Lost to Follow-up|1|||
126264389|NCT02243293|454258442|FG004|Overall Study|Lost to Follow-up|0|||
126264390|NCT02243293|454258443|FG005|Overall Study|Lost to Follow-up|0|||
126264391|NCT02243293|454258444|FG006|Overall Study|Lost to Follow-up|3|||
126264392|NCT02243293|454258445|FG007|Overall Study|Lost to Follow-up|0|||
126264393|NCT02243293|454258446|FG008|Overall Study|Lost to Follow-up|0|||
126264394|NCT02243293|454258447|FG009|Overall Study|Lost to Follow-up|0|||
126264395|NCT02243293|454258448|FG010|Overall Study|Lost to Follow-up|0|||
126264396|NCT02243293|454258449|FG011|Overall Study|Lost to Follow-up|2|||
126264397|NCT02243293|454258450|FG012|Overall Study|Lost to Follow-up|0|||
126264398|NCT02243293|454258451|FG013|Overall Study|Lost to Follow-up|0|||
126264399|NCT02243293|454258452|FG014|Overall Study|Lost to Follow-up|0|||
126264400|NCT02243293|454258453|FG015|Overall Study|Lost to Follow-up|0|||
126264401|NCT02243293|454258454|FG016|Overall Study|Lost to Follow-up|3|||
126264402|NCT02243293|454258455|FG017|Overall Study|Lost to Follow-up|1|||
126264403|NCT02243293|454258456|FG018|Overall Study|Lost to Follow-up|0|||
126264404|NCT02243293|454258457|FG019|Overall Study|Lost to Follow-up|0|||
126264405|NCT02243293|454258458|FG020|Overall Study|Lost to Follow-up|1|||
126264406|NCT02243293|454258459|FG021|Overall Study|Lost to Follow-up|2|||
126264407|NCT02243293|454258438|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
126264408|NCT02243293|454258439|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
126264409|NCT02243293|454258440|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
126264410|NCT02243293|454258441|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
126264411|NCT02243293|454258442|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
126264412|NCT02243293|454258443|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
126264413|NCT02243293|454258444|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
126264414|NCT02243293|454258445|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
126096715|NCT01820585|453646539|FG001|Overall Study|at sponsor request|0|||
126096716|NCT01820585|453646540|FG002|Overall Study|at sponsor request|1|||
126264415|NCT02243293|454258446|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
126264416|NCT02243293|454258447|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
126264417|NCT02243293|454258448|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
126264418|NCT02243293|454258449|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
126264419|NCT02243293|454258450|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
126264420|NCT02243293|454258451|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
126264421|NCT02243293|454258452|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
126264422|NCT02243293|454258453|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
126264423|NCT02243293|454258454|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
126264424|NCT02243293|454258455|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
126264425|NCT02243293|454258456|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
126264426|NCT02243293|454258457|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
126264427|NCT02243293|454258458|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
126264428|NCT02243293|454258459|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
126264429|NCT02243293|454258438|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
126264430|NCT02243293|454258439|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
126264431|NCT02243293|454258440|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
126264432|NCT02243293|454258441|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
126264433|NCT02243293|454258442|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
126264434|NCT02243293|454258443|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
126264435|NCT02243293|454258444|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
126264436|NCT02243293|454258445|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
126264437|NCT02243293|454258446|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
126264438|NCT02243293|454258447|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
126264439|NCT02243293|454258448|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
126264440|NCT02243293|454258449|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
126264441|NCT02243293|454258450|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
126264442|NCT02243293|454258451|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
126359944|NCT01117350|454609116|FG000|Comparative Period|Adverse Event|6|||
126359945|NCT01117350|454609117|FG001|Comparative Period|Adverse Event|33|||
126359946|NCT01117350|454609116|FG000|Comparative Period|Lost to Follow-up|11|||
126359947|NCT01117350|454609117|FG001|Comparative Period|Lost to Follow-up|7|||
126032063|NCT04592549|453414065|FG001|Overall Study|Lost to Follow-up|0|||
126032064|NCT04592549|453414066|FG002|Overall Study|Lost to Follow-up|0|||
126032065|NCT04592549|453414067|FG003|Overall Study|Lost to Follow-up|1|||
126032066|NCT04592549|453414068|FG004|Overall Study|Lost to Follow-up|1|||
126096717|NCT01820585|453646541|FG003|Overall Study|at sponsor request|0|||
126096718|NCT01820585|453646538|FG000|Overall Study|Pregnancy|0|||
126096719|NCT01820585|453646539|FG001|Overall Study|Pregnancy|1|||
126096720|NCT01820585|453646540|FG002|Overall Study|Pregnancy|0|||
126096721|NCT01820585|453646541|FG003|Overall Study|Pregnancy|0|||
126096722|NCT01712659|453646542|FG000|Dose Escalation|Physician Decision|0|||
126096723|NCT01712659|453646543|FG001|Dose Escalation|Physician Decision|1|||
126032067|NCT04592549|453414069|FG005|Overall Study|Lost to Follow-up|1|||
126032068|NCT05184192|453414070|FG000|Overall Study|Lost to Follow-up|4|||
126096724|NCT01712659|453646544|FG002|Dose Escalation|Physician Decision|0|||
126096725|NCT01712659|453646545|FG003|Dose Escalation|Physician Decision|0|||
126096726|NCT01712659|453646546|FG004|Dose Escalation|Physician Decision|0|||
126359948|NCT01117350|454609116|FG000|Comparative Period|Withdrawal by Subject|9|||
126032069|NCT05184192|453414071|FG001|Overall Study|Lost to Follow-up|7|||
126032070|NCT05184192|453414070|FG000|Overall Study|Adverse Event|1|||
126032071|NCT05184192|453414071|FG001|Overall Study|Adverse Event|4|||
126032072|NCT05184192|453414070|FG000|Overall Study|PI withdrawal|1|||
126032073|NCT05184192|453414071|FG001|Overall Study|PI withdrawal|2|||
126032074|NCT05184192|453414070|FG000|Overall Study|Withdrew due to adverse effect|1|||
126032075|NCT05184192|453414071|FG001|Overall Study|Withdrew due to adverse effect|0|||
126032076|NCT05184192|453414070|FG000|Overall Study|Medication schedule|1|||
126032077|NCT05184192|453414071|FG001|Overall Study|Medication schedule|0|||
126032078|NCT05184192|453414070|FG000|Overall Study|Concern for adverse effects|0|||
126032079|NCT05184192|453414071|FG001|Overall Study|Concern for adverse effects|4|||
126032080|NCT03640312|453414082|FG000|Overall Study|Lost to Follow-up|3|||
126032081|NCT03640312|453414083|FG001|Overall Study|Lost to Follow-up|6|||
126032082|NCT04948697|453414084|FG000|Overall Study|Progressive disease|27|||
126032083|NCT04948697|453414085|FG001|Overall Study|Progressive disease|18|||
126032084|NCT04948697|453414084|FG000|Overall Study|Adverse Event|14|||
126032085|NCT04948697|453414085|FG001|Overall Study|Adverse Event|4|||
126032086|NCT04948697|453414084|FG000|Overall Study|Participant moved to long term extension study|7|||
126032087|NCT04948697|453414085|FG001|Overall Study|Participant moved to long term extension study|4|||
126032088|NCT04948697|453414084|FG000|Overall Study|Withdrawal by Subject|10|||
126032089|NCT04948697|453414085|FG001|Overall Study|Withdrawal by Subject|0|||
126032090|NCT04948697|453414084|FG000|Overall Study|Closed by Sponsor|3|||
126032091|NCT04948697|453414085|FG001|Overall Study|Closed by Sponsor|2|||
126032092|NCT04948697|453414084|FG000|Overall Study|Physician Decision|0|||
126032093|NCT04948697|453414085|FG001|Overall Study|Physician Decision|2|||
126032094|NCT04948697|453414084|FG000|Overall Study|Lost to Follow-up|0|||
126032095|NCT04948697|453414085|FG001|Overall Study|Lost to Follow-up|1|||
126096727|NCT01712659|453646542|FG000|Dose Escalation|Unable to take study drug|0|||
126032096|NCT04948697|453414084|FG000|Overall Study|Other-Miscellaneous|1|||
126032097|NCT04948697|453414085|FG001|Overall Study|Other-Miscellaneous|0|||
126032098|NCT04948697|453414084|FG000|Overall Study|Randomized but not treated|0|||
126032099|NCT04948697|453414085|FG001|Overall Study|Randomized but not treated|1|||
126032100|NCT04229992|453415672|FG000|Overall Study|Withdrawal by Subject|0|||
126032101|NCT04229992|453415673|FG001|Overall Study|Withdrawal by Subject|2|||
126032102|NCT04229992|453415674|FG002|Overall Study|Withdrawal by Subject|1|||
126032103|NCT04229992|453415675|FG003|Overall Study|Withdrawal by Subject|1|||
126032104|NCT04229992|453415672|FG000|Overall Study|Adverse Event|1|||
126032105|NCT04229992|453415673|FG001|Overall Study|Adverse Event|1|||
126032106|NCT04229992|453415674|FG002|Overall Study|Adverse Event|3|||
126032107|NCT04229992|453415675|FG003|Overall Study|Adverse Event|1|||
126032108|NCT04229992|453415672|FG000|Overall Study|Lost to Follow-up|0|||
126032109|NCT04229992|453415673|FG001|Overall Study|Lost to Follow-up|0|||
126032110|NCT04229992|453415674|FG002|Overall Study|Lost to Follow-up|0|||
126032111|NCT04229992|453415675|FG003|Overall Study|Lost to Follow-up|1|||
126032112|NCT03770273|453415676|FG000|Overall Study|Adverse Event|2|||
126032113|NCT03770273|453415677|FG001|Overall Study|Adverse Event|0|||
126032114|NCT03770273|453415676|FG000|Overall Study|Lost to Follow-up|1|||
126032115|NCT03770273|453415677|FG001|Overall Study|Lost to Follow-up|1|||
126032116|NCT00418886|453415678|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
126032117|NCT00418886|453415679|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
126032118|NCT00418886|453415678|FG000|Randomized Period|Death|122|||
126032119|NCT00418886|453415679|FG001|Randomized Period|Death|147|||
126032120|NCT00418886|453415678|FG000|Randomized Period|Withdrawal by Subject|9|||
126032121|NCT00418886|453415679|FG001|Randomized Period|Withdrawal by Subject|10|||
126032122|NCT00418886|453415678|FG000|Randomized Period|Lost to Follow-up|4|||
126032123|NCT00418886|453415679|FG001|Randomized Period|Lost to Follow-up|6|||
126032124|NCT00418886|453415678|FG000|Randomized Period|withdrawn due to other reason|1|||
126032125|NCT00418886|453415679|FG001|Randomized Period|withdrawn due to other reason|0|||
126032126|NCT00418886|453415678|FG000|Randomized Period|randomised but no treatment received|0|||
126032127|NCT00418886|453415679|FG001|Randomized Period|randomised but no treatment received|1|||
126032128|NCT04060654|453415680|FG000|Overall Study|Withdrawal by Subject|1|||
126032129|NCT04060654|453415680|FG000|Overall Study|Lost to Follow-up|5|||
126032130|NCT03707951|453415681|FG000|Overall Study|Lost to Follow-up|8|||
126032131|NCT03707951|453415682|FG001|Overall Study|Lost to Follow-up|17|||
126032132|NCT03707951|453415681|FG000|Overall Study|Withdrawal by Subject|6|||
126032133|NCT03707951|453415682|FG001|Overall Study|Withdrawal by Subject|6|||
126032134|NCT04887129|453415683|FG000|Overall Study|Lost to Follow-up|0|||
126032135|NCT04887129|453415684|FG001|Overall Study|Lost to Follow-up|24|||
126032136|NCT04887129|453415683|FG000|Overall Study|Withdrawal by Subject|9|||
126032137|NCT04887129|453415684|FG001|Overall Study|Withdrawal by Subject|57|||
126032138|NCT04887129|453415683|FG000|Overall Study|Other|2|||
126032139|NCT04887129|453415684|FG001|Overall Study|Other|9|||
126032140|NCT02921230|453415691|FG000|Overall Study|Withdrawal by Subject|20|||
126032141|NCT02921230|453415692|FG001|Overall Study|Withdrawal by Subject|8|||
126032142|NCT02921230|453415691|FG000|Overall Study|Death|12|||
126032143|NCT02921230|453415692|FG001|Overall Study|Death|3|||
126032144|NCT02921230|453415691|FG000|Overall Study|Protocol Violation|17|||
126032145|NCT02921230|453415692|FG001|Overall Study|Protocol Violation|6|||
126032146|NCT02921230|453415691|FG000|Overall Study|Early completion|5|||
126032147|NCT02921230|453415692|FG001|Overall Study|Early completion|1|||
126032148|NCT02921230|453415691|FG000|Overall Study|Pending data entry|1|||
126032149|NCT02921230|453415692|FG001|Overall Study|Pending data entry|0|||
126032150|NCT03436290|453415693|FG000|Overall Study|Post-randomization Exclusion|1|||
126032151|NCT03436290|453415694|FG001|Overall Study|Post-randomization Exclusion|0|||
126032152|NCT03436290|453415693|FG000|Overall Study|Death|6|||
126032153|NCT03436290|453415694|FG001|Overall Study|Death|0|||
126032154|NCT03436290|453415693|FG000|Overall Study|Withdrawal by Subject|4|||
126032155|NCT03436290|453415694|FG001|Overall Study|Withdrawal by Subject|0|||
126032156|NCT03436290|453415693|FG000|Overall Study|Protocol Violation|30|||
126032157|NCT03436290|453415694|FG001|Overall Study|Protocol Violation|0|||
126032158|NCT05177848|453415699|FG000|Overall Study|Lost to Follow-up|1|||
126032159|NCT05177848|453415700|FG001|Overall Study|Lost to Follow-up|4|||
126032160|NCT05177848|453415699|FG000|Overall Study|Discontinued|2|||
126032161|NCT05177848|453415700|FG001|Overall Study|Discontinued|1|||
126032162|NCT01084876|453415701|FG000|Main Study Treatment Period|Adverse Event|12|||
126032163|NCT01084876|453415702|FG001|Main Study Treatment Period|Adverse Event|7|||
126032164|NCT01084876|453415701|FG000|Main Study Treatment Period|Disease Progression|41|||
126032165|NCT01084876|453415702|FG001|Main Study Treatment Period|Disease Progression|24|||
126032166|NCT01084876|453415701|FG000|Main Study Treatment Period|Physician Decision|2|||
126032167|NCT01084876|453415702|FG001|Main Study Treatment Period|Physician Decision|0|||
126032168|NCT01084876|453415701|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
126032169|NCT01084876|453415702|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
126032170|NCT01084876|453415701|FG000|Main Study Treatment Period|Other Reason|0|||
126032171|NCT01084876|453415702|FG001|Main Study Treatment Period|Other Reason|1|||
126032172|NCT01084876|453415701|FG000|Main Study Treatment Period|Other|0|||
126032173|NCT01084876|453415702|FG001|Main Study Treatment Period|Other|1|||
126032174|NCT01084876|453415701|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
126032175|NCT01084876|453415702|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
126032176|NCT01084876|453415701|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
126032177|NCT01084876|453415702|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
126032178|NCT01084876|453415701|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
126032179|NCT01084876|453415702|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
126032180|NCT01084876|453415701|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
126032181|NCT01084876|453415702|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
126032182|NCT01084876|453415701|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
126032183|NCT01084876|453415702|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
126032184|NCT01084876|453415701|FG000|Treatment Period Beyond Cycle 8|Other|6|||
126032185|NCT01084876|453415702|FG001|Treatment Period Beyond Cycle 8|Other|9|||
126032186|NCT04509674|453415705|FG000|Overall Study|Not treated|33|||
126032187|NCT04509674|453415706|FG001|Overall Study|Not treated|26|||
126032188|NCT04509674|453415705|FG000|Overall Study|Protocol Violation|9|||
126032189|NCT04509674|453415706|FG001|Overall Study|Protocol Violation|10|||
126032190|NCT04509674|453415705|FG000|Overall Study|Lost to Follow-up|31|||
126032191|NCT04509674|453415706|FG001|Overall Study|Lost to Follow-up|39|||
126032192|NCT04509674|453415705|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
126032193|NCT04509674|453415706|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
126032194|NCT04509674|453415705|FG000|Overall Study|Adverse event, serious fatal event|11|||
126032195|NCT04509674|453415706|FG001|Overall Study|Adverse event, serious fatal event|4|||
126032196|NCT04509674|453415705|FG000|Overall Study|Adverse event, non-fatal event|107|||
126032197|NCT04509674|453415706|FG001|Overall Study|Adverse event, non-fatal event|118|||
126032198|NCT04509674|453415705|FG000|Overall Study|Other reason than listed|106|||
126032199|NCT04509674|453415706|FG001|Overall Study|Other reason than listed|95|||
126032200|NCT03197662|453415707|FG000|Overall Study|Withdrawn by family|0|||
126032201|NCT03197662|453415708|FG001|Overall Study|Withdrawn by family|2|||
126032202|NCT01214616|453415709|FG000|Overall Study|Progressive disease|2|||
126032203|NCT01214616|453415710|FG001|Overall Study|Progressive disease|2|||
126032204|NCT01214616|453415711|FG002|Overall Study|Progressive disease|2|||
126032205|NCT01214616|453415712|FG003|Overall Study|Progressive disease|4|||
126032206|NCT01214616|453415709|FG000|Overall Study|Dose limiting toxicity|0|||
126032207|NCT01214616|453415710|FG001|Overall Study|Dose limiting toxicity|2|||
126032208|NCT01214616|453415711|FG002|Overall Study|Dose limiting toxicity|0|||
126032209|NCT01214616|453415712|FG003|Overall Study|Dose limiting toxicity|0|||
126032210|NCT01214616|453415709|FG000|Overall Study|Other adverse events|0|||
126032211|NCT01214616|453415710|FG001|Overall Study|Other adverse events|1|||
126032212|NCT01214616|453415711|FG002|Overall Study|Other adverse events|1|||
126032213|NCT01214616|453415712|FG003|Overall Study|Other adverse events|1|||
126032214|NCT01214616|453415709|FG000|Overall Study|Withdrawal by Subject|1|||
126032215|NCT01214616|453415710|FG001|Overall Study|Withdrawal by Subject|0|||
126032216|NCT01214616|453415711|FG002|Overall Study|Withdrawal by Subject|0|||
126032217|NCT01214616|453415712|FG003|Overall Study|Withdrawal by Subject|1|||
126032218|NCT03721952|453415713|FG000|Overall Study|Lost to Follow-up|0|||
126032219|NCT03721952|453415714|FG001|Overall Study|Lost to Follow-up|0|||
126032220|NCT03721952|453415715|FG002|Overall Study|Lost to Follow-up|2|||
126032221|NCT03721952|453415716|FG003|Overall Study|Lost to Follow-up|0|||
126032222|NCT03721952|453415717|FG004|Overall Study|Lost to Follow-up|0|||
126032223|NCT03721952|453415713|FG000|Overall Study|Protocol Violation|0|||
126032224|NCT03721952|453415714|FG001|Overall Study|Protocol Violation|1|||
126032225|NCT03721952|453415715|FG002|Overall Study|Protocol Violation|0|||
126032226|NCT03721952|453415716|FG003|Overall Study|Protocol Violation|0|||
126032227|NCT03721952|453415717|FG004|Overall Study|Protocol Violation|0|||
126032228|NCT03721952|453415713|FG000|Overall Study|Withdrawal by Subject|1|||
126032229|NCT03721952|453415714|FG001|Overall Study|Withdrawal by Subject|0|||
126032230|NCT03721952|453415715|FG002|Overall Study|Withdrawal by Subject|40|||
126032231|NCT03721952|453415716|FG003|Overall Study|Withdrawal by Subject|28|||
126032232|NCT03721952|453415717|FG004|Overall Study|Withdrawal by Subject|0|||
126032233|NCT05292365|453415718|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
126032234|NCT05292365|453415719|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
126032235|NCT05292365|453415720|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
126032236|NCT05292365|453415721|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
126032237|NCT04495894|453415730|FG000|Overall Study|Withdrawal by Subject|2|||
126032238|NCT04495894|453415731|FG001|Overall Study|Withdrawal by Subject|0|||
126032239|NCT04495894|453415732|FG002|Overall Study|Withdrawal by Subject|2|||
126032240|NCT04495894|453415733|FG003|Overall Study|Withdrawal by Subject|3|||
126264443|NCT02243293|454258452|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
126264444|NCT02243293|454258453|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
126264445|NCT02243293|454258454|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
126032241|NCT04495894|453415730|FG000|Overall Study|Early termination|0|||
126032242|NCT04495894|453415731|FG001|Overall Study|Early termination|0|||
126032243|NCT04495894|453415732|FG002|Overall Study|Early termination|3|||
126032244|NCT04495894|453415733|FG003|Overall Study|Early termination|0|||
126032245|NCT05579899|453415735|FG000|Overall Study|Lost to Follow-up|3|||
126032246|NCT05579899|453415736|FG001|Overall Study|Lost to Follow-up|1|||
126032247|NCT05579899|453415735|FG000|Overall Study|Adverse Event|0|||
126032248|NCT05579899|453415736|FG001|Overall Study|Adverse Event|3|||
126032249|NCT05579899|453415735|FG000|Overall Study|Pregnancy|0|||
126032250|NCT05579899|453415736|FG001|Overall Study|Pregnancy|1|||
126032251|NCT05579899|453415735|FG000|Overall Study|Withdrawal by Subject|0|||
126032252|NCT05579899|453415736|FG001|Overall Study|Withdrawal by Subject|3|||
126032253|NCT04064164|453415739|FG000|Overall Study|Withdrawal by Subject|8|||
126032254|NCT04064164|453415740|FG001|Overall Study|Withdrawal by Subject|8|||
126032255|NCT01000961|453415742|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
126032256|NCT01000961|453415743|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126032257|NCT01000961|453415742|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
126032258|NCT01000961|453415743|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
126032259|NCT04633122|453415744|FG000|Overall Study|Remained on treatment|19|||
126032260|NCT04633122|453415745|FG001|Overall Study|Remained on treatment|14|||
126032261|NCT04633122|453415744|FG000|Overall Study|Survival follow-up stopped|22|||
126032262|NCT04633122|453415745|FG001|Overall Study|Survival follow-up stopped|25|||
126032263|NCT04185298|453415746|FG000|Overall Study|Lost to Follow-up|1|||
126032264|NCT04185298|453415747|FG001|Overall Study|Lost to Follow-up|3|||
126032265|NCT04185298|453415746|FG000|Overall Study|Withdrawal by Subject|0|||
126032266|NCT04185298|453415747|FG001|Overall Study|Withdrawal by Subject|3|||
126032267|NCT01798498|453415748|FG000|Overall Study|Lost to Follow-up|1|||
126032268|NCT03896789|453415749|FG000|Baseline|Lost to Follow-up|1|||
126032269|NCT03896789|453415750|FG001|Baseline|Lost to Follow-up|2|||
126032270|NCT03896789|453415749|FG000|Baseline|Death|3|||
126032271|NCT03896789|453415750|FG001|Baseline|Death|6|||
126032272|NCT03896789|453415749|FG000|Post-Randomization|Lost to Follow-up|12|||
126032273|NCT03896789|453415750|FG001|Post-Randomization|Lost to Follow-up|11|||
126032274|NCT03896789|453415749|FG000|Post-Randomization|Death|12|||
126032275|NCT03896789|453415750|FG001|Post-Randomization|Death|13|||
126032276|NCT04015167|453415758|FG000|Overall Study|Lost to Follow-up|40|||
126032277|NCT04015167|453415758|FG000|Overall Study|Adverse Event|5|||
126032278|NCT04015167|453415758|FG000|Overall Study|Withdrawal by Subject|2|||
125880311|NCT02855125|452858839|FG000|Overall Study|Radiologic Disease Progression|36|||
125880312|NCT02855125|452858840|FG001|Overall Study|Radiologic Disease Progression|39|||
125880313|NCT02855125|452858839|FG000|Overall Study|Adverse Event|11|||
125880314|NCT02855125|452858840|FG001|Overall Study|Adverse Event|7|||
125880315|NCT02855125|452858839|FG000|Overall Study|Physician Decision|1|||
125880316|NCT02855125|452858840|FG001|Overall Study|Physician Decision|0|||
125880317|NCT02855125|452858839|FG000|Overall Study|On Treatment|9|||
125880318|NCT02855125|452858840|FG001|Overall Study|On Treatment|11|||
125880319|NCT02855125|452858839|FG000|Overall Study|Randomized but not treated|0|||
125880320|NCT02855125|452858840|FG001|Overall Study|Randomized but not treated|1|||
125880321|NCT04467905|452858841|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
125880322|NCT04467905|452858842|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
125880323|NCT04467905|452858843|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
125880324|NCT04467905|452858841|FG000|Overall Study|Conversion to SR|0|||
125880325|NCT04467905|452858842|FG001|Overall Study|Conversion to SR|0|||
125880326|NCT04467905|452858843|FG002|Overall Study|Conversion to SR|3|||
125880327|NCT04467905|452858841|FG000|Overall Study|Technical issue with Holter ECG|0|||
125880328|NCT04467905|452858842|FG001|Overall Study|Technical issue with Holter ECG|0|||
126032279|NCT04015167|453415758|FG000|Overall Study|Subject went to jail|1|||
125880329|NCT04467905|452858843|FG002|Overall Study|Technical issue with Holter ECG|3|||
125880330|NCT04467905|452858841|FG000|Overall Study|Hemodynamic instability|0|||
125880331|NCT04467905|452858842|FG001|Overall Study|Hemodynamic instability|0|||
126032280|NCT03382652|453415759|FG000|Overall Study|Lost to Follow-up|6|||
126032281|NCT03382652|453415759|FG000|Overall Study|Death|4|||
126032282|NCT03382652|453415759|FG000|Overall Study|Revision|5|||
126264446|NCT02243293|454258455|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
126264447|NCT02243293|454258456|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
126264448|NCT02243293|454258457|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
126264449|NCT02243293|454258458|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
125880332|NCT04467905|452858843|FG002|Overall Study|Hemodynamic instability|1|||
125880333|NCT04467905|452858841|FG000|Overall Study|Site misinterpretation of protocol|0|||
126032283|NCT03382652|453415759|FG000|Overall Study|Patient withdrew|3|||
126032284|NCT03382652|453415759|FG000|Overall Study|Other reasons|21|||
126032285|NCT04858321|453415760|FG000|Overall Study|Withdrawal by Subject|3|||
126032286|NCT04810650|453415764|FG000|Overall Study|Disenrolled in error|0|||
126032287|NCT04810650|453415765|FG001|Overall Study|Disenrolled in error|0|||
126032288|NCT04810650|453415766|FG002|Overall Study|Disenrolled in error|0|||
126032289|NCT04810650|453415767|FG003|Overall Study|Disenrolled in error|0|||
126032290|NCT04810650|453415768|FG004|Overall Study|Disenrolled in error|0|||
126032291|NCT04810650|453415769|FG005|Overall Study|Disenrolled in error|0|||
126032292|NCT04810650|453415770|FG006|Overall Study|Disenrolled in error|0|||
125880334|NCT04467905|452858842|FG001|Overall Study|Site misinterpretation of protocol|0|||
125880335|NCT04467905|452858843|FG002|Overall Study|Site misinterpretation of protocol|1|||
125880336|NCT03204188|452858848|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
125880337|NCT03204188|452858848|FG000|Immunotherapy Phase (1 Year)|Death|1|||
126032293|NCT04810650|453415771|FG007|Overall Study|Disenrolled in error|0|||
126032294|NCT04810650|453415772|FG008|Overall Study|Disenrolled in error|1|||
126032295|NCT04810650|453415773|FG009|Overall Study|Disenrolled in error|0|||
126032296|NCT04810650|453415774|FG010|Overall Study|Disenrolled in error|0|||
126032297|NCT04810650|453415775|FG011|Overall Study|Disenrolled in error|0|||
126264450|NCT02243293|454258459|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
126264451|NCT01118117|454258460|FG000|Overall Study|Death|8|||
126264452|NCT01118117|454258461|FG001|Overall Study|Death|0|||
126264453|NCT01118117|454258460|FG000|Overall Study|Lost to Follow-up|6|||
126032298|NCT04810650|453415776|FG012|Overall Study|Disenrolled in error|0|||
126032299|NCT04810650|453415777|FG013|Overall Study|Disenrolled in error|0|||
126032300|NCT04810650|453415764|FG000|Overall Study|Death|0|||
126032301|NCT04810650|453415765|FG001|Overall Study|Death|0|||
126032302|NCT04810650|453415766|FG002|Overall Study|Death|0|||
126032303|NCT04810650|453415767|FG003|Overall Study|Death|0|||
126032304|NCT04810650|453415768|FG004|Overall Study|Death|0|||
126032305|NCT04810650|453415769|FG005|Overall Study|Death|0|||
126032306|NCT04810650|453415770|FG006|Overall Study|Death|2|||
126032307|NCT04810650|453415771|FG007|Overall Study|Death|2|||
126032308|NCT04810650|453415772|FG008|Overall Study|Death|0|||
126032309|NCT04810650|453415773|FG009|Overall Study|Death|1|||
126032310|NCT04810650|453415774|FG010|Overall Study|Death|0|||
126032311|NCT04810650|453415775|FG011|Overall Study|Death|0|||
126032312|NCT04810650|453415776|FG012|Overall Study|Death|2|||
126032313|NCT04810650|453415777|FG013|Overall Study|Death|1|||
126032314|NCT04810650|453415764|FG000|Overall Study|Moved/transferred care|0|||
126032315|NCT04810650|453415765|FG001|Overall Study|Moved/transferred care|0|||
126032316|NCT04810650|453415766|FG002|Overall Study|Moved/transferred care|0|||
126032317|NCT04810650|453415767|FG003|Overall Study|Moved/transferred care|0|||
126032318|NCT04810650|453415768|FG004|Overall Study|Moved/transferred care|0|||
126032319|NCT04810650|453415769|FG005|Overall Study|Moved/transferred care|0|||
126032320|NCT04810650|453415770|FG006|Overall Study|Moved/transferred care|0|||
126032321|NCT04810650|453415771|FG007|Overall Study|Moved/transferred care|1|||
126032322|NCT04810650|453415772|FG008|Overall Study|Moved/transferred care|12|||
126032323|NCT04810650|453415773|FG009|Overall Study|Moved/transferred care|10|||
126032324|NCT04810650|453415774|FG010|Overall Study|Moved/transferred care|0|||
126032325|NCT04810650|453415775|FG011|Overall Study|Moved/transferred care|0|||
126032326|NCT04810650|453415776|FG012|Overall Study|Moved/transferred care|0|||
126032327|NCT04810650|453415777|FG013|Overall Study|Moved/transferred care|0|||
126032328|NCT04810650|453415764|FG000|Overall Study|Lost to Follow-up|15|||
126032329|NCT04810650|453415765|FG001|Overall Study|Lost to Follow-up|12|||
126032330|NCT04810650|453415766|FG002|Overall Study|Lost to Follow-up|7|||
126032331|NCT04810650|453415767|FG003|Overall Study|Lost to Follow-up|9|||
126032332|NCT04810650|453415768|FG004|Overall Study|Lost to Follow-up|10|||
126032333|NCT04810650|453415769|FG005|Overall Study|Lost to Follow-up|6|||
126032334|NCT04810650|453415770|FG006|Overall Study|Lost to Follow-up|0|||
126032335|NCT04810650|453415771|FG007|Overall Study|Lost to Follow-up|0|||
126032336|NCT04810650|453415772|FG008|Overall Study|Lost to Follow-up|0|||
126032337|NCT04810650|453415773|FG009|Overall Study|Lost to Follow-up|0|||
126032338|NCT04810650|453415774|FG010|Overall Study|Lost to Follow-up|1|||
126032339|NCT04810650|453415775|FG011|Overall Study|Lost to Follow-up|0|||
126032340|NCT04810650|453415776|FG012|Overall Study|Lost to Follow-up|3|||
126032341|NCT04810650|453415777|FG013|Overall Study|Lost to Follow-up|9|||
126032342|NCT04810650|453415764|FG000|Overall Study|Participant declined|0|||
126032343|NCT04810650|453415765|FG001|Overall Study|Participant declined|0|||
126032344|NCT04810650|453415766|FG002|Overall Study|Participant declined|0|||
126032345|NCT04810650|453415767|FG003|Overall Study|Participant declined|0|||
126032346|NCT04810650|453415768|FG004|Overall Study|Participant declined|0|||
126032347|NCT04810650|453415769|FG005|Overall Study|Participant declined|0|||
126032348|NCT04810650|453415770|FG006|Overall Study|Participant declined|0|||
126032349|NCT04810650|453415771|FG007|Overall Study|Participant declined|0|||
126032350|NCT04810650|453415772|FG008|Overall Study|Participant declined|0|||
126032351|NCT04810650|453415773|FG009|Overall Study|Participant declined|0|||
126032352|NCT04810650|453415774|FG010|Overall Study|Participant declined|2|||
126032353|NCT04810650|453415775|FG011|Overall Study|Participant declined|0|||
126032354|NCT04810650|453415776|FG012|Overall Study|Participant declined|0|||
126032355|NCT04810650|453415777|FG013|Overall Study|Participant declined|0|||
126032356|NCT05794243|453415778|FG000|Overall Study|Withdrawal by Subject|1|||
126032357|NCT05794243|453415779|FG001|Overall Study|Withdrawal by Subject|0|||
126032358|NCT05794243|453415780|FG002|Overall Study|Withdrawal by Subject|1|||
126032359|NCT05794243|453415778|FG000|Overall Study|Physician Decision|0|||
126032360|NCT05794243|453415779|FG001|Overall Study|Physician Decision|3|||
126032361|NCT05794243|453415780|FG002|Overall Study|Physician Decision|1|||
126032362|NCT05057247|453415784|FG000|Overall Study|Death|4|||
126032363|NCT05057247|453415784|FG000|Overall Study|Physician Decision|3|||
126032364|NCT05057247|453415784|FG000|Overall Study|Progressive Disease|7|||
126032365|NCT05057247|453415784|FG000|Overall Study|Withdrawal by Subject|3|||
126032366|NCT05057247|453415784|FG000|Overall Study|Adverse Event|6|||
126032367|NCT05057247|453415784|FG000|Overall Study|Subject Non-Compliance|1|||
126032368|NCT05057247|453415784|FG000|Overall Study|On treatment|2|||
126032369|NCT02761057|453415787|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
126032370|NCT02761057|453415788|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
126032371|NCT02761057|453415789|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
126032372|NCT02761057|453415790|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
126032373|NCT02761057|453415787|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
126032374|NCT02761057|453415788|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
126032375|NCT02761057|453415789|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
126359949|NCT01117350|454609117|FG001|Comparative Period|Withdrawal by Subject|13|||
126359950|NCT01117350|454609116|FG000|Comparative Period|Protocol Violation|8|||
126359951|NCT01117350|454609117|FG001|Comparative Period|Protocol Violation|12|||
126359952|NCT01117350|454609116|FG000|Comparative Period|Lack of Efficacy|1|||
126359953|NCT01117350|454609117|FG001|Comparative Period|Lack of Efficacy|0|||
126359954|NCT01117350|454609116|FG000|Comparative Period|Physician Decision|0|||
126359955|NCT01117350|454609117|FG001|Comparative Period|Physician Decision|1|||
126359956|NCT01117350|454609116|FG000|Comparative Period|Move to another city/country|2|||
126359957|NCT01117350|454609117|FG001|Comparative Period|Move to another city/country|1|||
126359958|NCT01117350|454609116|FG000|Extension Period|Not included in extension, not treated|0|||
126359959|NCT01117350|454609117|FG001|Extension Period|Not included in extension, not treated|50|||
126359960|NCT01117350|454609116|FG000|Extension Period|Adverse Event|0|||
126359961|NCT01117350|454609117|FG001|Extension Period|Adverse Event|2|||
126359962|NCT01117350|454609116|FG000|Extension Period|Protocol Violation|0|||
126359963|NCT01117350|454609117|FG001|Extension Period|Protocol Violation|2|||
126359964|NCT01117350|454609116|FG000|Extension Period|Lost to Follow-up|0|||
126359965|NCT01117350|454609117|FG001|Extension Period|Lost to Follow-up|2|||
126359966|NCT01117350|454609116|FG000|Extension Period|Withdrawal by Subject|0|||
126359967|NCT01117350|454609117|FG001|Extension Period|Withdrawal by Subject|3|||
126359968|NCT01117350|454609116|FG000|Extension Period|Lack of Efficacy|0|||
126359969|NCT01117350|454609117|FG001|Extension Period|Lack of Efficacy|2|||
126359970|NCT01117350|454609116|FG000|Extension Period|Inclusion criteria not respected|0|||
126359971|NCT01117350|454609117|FG001|Extension Period|Inclusion criteria not respected|1|||
126359972|NCT01117350|454609116|FG000|Extension Period|Prohibited medication|0|||
126359973|NCT01117350|454609117|FG001|Extension Period|Prohibited medication|1|||
126359974|NCT00800384|454609118|FG000|Overall Study|Withdrawal by Subject|24|||
126359975|NCT00800384|454609119|FG001|Overall Study|Withdrawal by Subject|17|||
126359976|NCT00800384|454609118|FG000|Overall Study|Lost to Follow-up|17|||
126359977|NCT00800384|454609119|FG001|Overall Study|Lost to Follow-up|26|||
126032376|NCT02761057|453415790|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
126032377|NCT02761057|453415787|FG000|Overall Study|Currently On Study Treatment|0|||
126096728|NCT01712659|453646543|FG001|Dose Escalation|Unable to take study drug|1|||
126096729|NCT01712659|453646544|FG002|Dose Escalation|Unable to take study drug|0|||
126096730|NCT01712659|453646545|FG003|Dose Escalation|Unable to take study drug|0|||
126096731|NCT01712659|453646546|FG004|Dose Escalation|Unable to take study drug|0|||
126096732|NCT01712659|453646542|FG000|Dose Expansion|Early disease progression|1|||
126096733|NCT01712659|453646543|FG001|Dose Expansion|Early disease progression|0|||
126096734|NCT01712659|453646544|FG002|Dose Expansion|Early disease progression|0|||
126032378|NCT02761057|453415788|FG001|Overall Study|Currently On Study Treatment|3|||
126032379|NCT02761057|453415789|FG002|Overall Study|Currently On Study Treatment|0|||
126032380|NCT02761057|453415790|FG003|Overall Study|Currently On Study Treatment|0|||
126032381|NCT02761057|453415787|FG000|Overall Study|Adverse Event|11|||
126032382|NCT02761057|453415788|FG001|Overall Study|Adverse Event|9|||
126032383|NCT02761057|453415789|FG002|Overall Study|Adverse Event|5|||
126032384|NCT02761057|453415790|FG003|Overall Study|Adverse Event|3|||
126032385|NCT02761057|453415787|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
126032386|NCT02761057|453415788|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
126032387|NCT02761057|453415789|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
126032388|NCT02761057|453415790|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
126032389|NCT02761057|453415787|FG000|Overall Study|Progression/Relapse|29|||
126032390|NCT02761057|453415788|FG001|Overall Study|Progression/Relapse|27|||
126032391|NCT02761057|453415789|FG002|Overall Study|Progression/Relapse|20|||
126032392|NCT02761057|453415790|FG003|Overall Study|Progression/Relapse|23|||
126032393|NCT02761057|453415787|FG000|Overall Study|Death|2|||
126032394|NCT02761057|453415788|FG001|Overall Study|Death|2|||
126032395|NCT02761057|453415789|FG002|Overall Study|Death|1|||
126032396|NCT02761057|453415790|FG003|Overall Study|Death|1|||
126032397|NCT02761057|453415787|FG000|Overall Study|Other - Not Protocol Specified|2|||
126032398|NCT02761057|453415788|FG001|Overall Study|Other - Not Protocol Specified|1|||
126032399|NCT02761057|453415789|FG002|Overall Study|Other - Not Protocol Specified|2|||
126096735|NCT01712659|453646545|FG003|Dose Expansion|Early disease progression|0|||
126096736|NCT01712659|453646546|FG004|Dose Expansion|Early disease progression|0|||
126096737|NCT01712659|453646542|FG000|Dose Expansion|Physician Decision|1|||
126096738|NCT01712659|453646543|FG001|Dose Expansion|Physician Decision|0|||
126096739|NCT01712659|453646544|FG002|Dose Expansion|Physician Decision|0|||
126096740|NCT01712659|453646545|FG003|Dose Expansion|Physician Decision|0|||
126359978|NCT01027754|454610707|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
126359979|NCT01027754|454610708|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
126359980|NCT01027754|454610707|FG000|Overall Study|Withdrawal by Subject|0|||
126359981|NCT01027754|454610708|FG001|Overall Study|Withdrawal by Subject|5|||
126359982|NCT00326495|454610709|FG000|Overall Study|Switched to alternative treatment|1|||
126359983|NCT00326495|454610709|FG000|Overall Study|Disease progression before treatment|1|||
126359984|NCT00326495|454610709|FG000|Overall Study|Refused further treatment|2|||
126032400|NCT02761057|453415790|FG003|Overall Study|Other - Not Protocol Specified|0|||
126032401|NCT04788511|453415791|FG000|Overall Study|Withdrawal by Subject|2|||
126032402|NCT04788511|453415792|FG001|Overall Study|Withdrawal by Subject|1|||
126032403|NCT04788511|453415791|FG000|Overall Study|Lost to Follow-up|2|||
126032404|NCT04788511|453415792|FG001|Overall Study|Lost to Follow-up|7|||
126032405|NCT04788511|453415791|FG000|Overall Study|Death|3|||
126032406|NCT04788511|453415792|FG001|Overall Study|Death|4|||
126032407|NCT04652700|453415795|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
126032408|NCT04652700|453415796|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
126032409|NCT04652700|453415795|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
126032410|NCT04652700|453415796|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
126032411|NCT04652700|453415795|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
126032412|NCT04652700|453415796|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
126032413|NCT04652700|453415795|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
126032414|NCT04652700|453415796|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
126032415|NCT04652700|453415795|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
126032416|NCT04652700|453415796|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
126032417|NCT04652700|453415795|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
126032418|NCT04652700|453415796|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
126032419|NCT04652700|453415795|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
126032420|NCT04652700|453415796|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
126032421|NCT04652700|453415795|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
126032422|NCT04652700|453415796|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
126032423|NCT04652700|453415795|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
126032424|NCT04652700|453415796|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
126032425|NCT06037369|453415799|FG000|Overall Study|Lost to Follow-up|0|||
126032426|NCT06037369|453415800|FG001|Overall Study|Lost to Follow-up|1|||
126032427|NCT04209465|453415801|FG000|Overall Study|Adverse Event|0|||
126032428|NCT04209465|453415802|FG001|Overall Study|Adverse Event|0|||
126032429|NCT04209465|453415803|FG002|Overall Study|Adverse Event|0|||
126032430|NCT04209465|453415804|FG003|Overall Study|Adverse Event|0|||
126032431|NCT04209465|453415805|FG004|Overall Study|Adverse Event|0|||
126032432|NCT04209465|453415806|FG005|Overall Study|Adverse Event|1|||
126032433|NCT04209465|453415807|FG006|Overall Study|Adverse Event|0|||
126032434|NCT04209465|453415808|FG007|Overall Study|Adverse Event|0|||
126032435|NCT04209465|453415809|FG008|Overall Study|Adverse Event|1|||
126032436|NCT04209465|453415810|FG009|Overall Study|Adverse Event|0|||
126032437|NCT04209465|453415811|FG010|Overall Study|Adverse Event|2|||
126032438|NCT04209465|453415812|FG011|Overall Study|Adverse Event|1|||
126032439|NCT04209465|453415813|FG012|Overall Study|Adverse Event|1|||
126032440|NCT04209465|453415801|FG000|Overall Study|Death|1|||
126032441|NCT04209465|453415802|FG001|Overall Study|Death|0|||
126032442|NCT04209465|453415803|FG002|Overall Study|Death|0|||
126032443|NCT04209465|453415804|FG003|Overall Study|Death|0|||
126032444|NCT04209465|453415805|FG004|Overall Study|Death|2|||
126032445|NCT04209465|453415806|FG005|Overall Study|Death|7|||
126032446|NCT04209465|453415807|FG006|Overall Study|Death|2|||
126032447|NCT04209465|453415808|FG007|Overall Study|Death|2|||
126032448|NCT04209465|453415809|FG008|Overall Study|Death|1|||
126032449|NCT04209465|453415810|FG009|Overall Study|Death|1|||
126032450|NCT04209465|453415811|FG010|Overall Study|Death|1|||
126032451|NCT04209465|453415812|FG011|Overall Study|Death|0|||
126032452|NCT04209465|453415813|FG012|Overall Study|Death|10|||
126032453|NCT04209465|453415801|FG000|Overall Study|Physician Decision|0|||
126032454|NCT04209465|453415802|FG001|Overall Study|Physician Decision|1|||
126032455|NCT04209465|453415803|FG002|Overall Study|Physician Decision|0|||
126032456|NCT04209465|453415804|FG003|Overall Study|Physician Decision|0|||
126032457|NCT04209465|453415805|FG004|Overall Study|Physician Decision|0|||
126032458|NCT04209465|453415806|FG005|Overall Study|Physician Decision|0|||
126032459|NCT04209465|453415807|FG006|Overall Study|Physician Decision|0|||
126032460|NCT04209465|453415808|FG007|Overall Study|Physician Decision|0|||
126032461|NCT04209465|453415809|FG008|Overall Study|Physician Decision|0|||
126032462|NCT04209465|453415810|FG009|Overall Study|Physician Decision|0|||
126032463|NCT04209465|453415811|FG010|Overall Study|Physician Decision|0|||
126032464|NCT04209465|453415812|FG011|Overall Study|Physician Decision|0|||
126032465|NCT04209465|453415813|FG012|Overall Study|Physician Decision|0|||
126032466|NCT04209465|453415801|FG000|Overall Study|Progressive Disease|0|||
126032467|NCT04209465|453415802|FG001|Overall Study|Progressive Disease|0|||
126032468|NCT04209465|453415803|FG002|Overall Study|Progressive Disease|1|||
126032469|NCT04209465|453415804|FG003|Overall Study|Progressive Disease|2|||
126032470|NCT04209465|453415805|FG004|Overall Study|Progressive Disease|8|||
126032471|NCT04209465|453415806|FG005|Overall Study|Progressive Disease|5|||
126032472|NCT04209465|453415807|FG006|Overall Study|Progressive Disease|3|||
126032473|NCT04209465|453415808|FG007|Overall Study|Progressive Disease|4|||
126032474|NCT04209465|453415809|FG008|Overall Study|Progressive Disease|1|||
126032475|NCT04209465|453415810|FG009|Overall Study|Progressive Disease|3|||
126032476|NCT04209465|453415811|FG010|Overall Study|Progressive Disease|2|||
126032477|NCT04209465|453415812|FG011|Overall Study|Progressive Disease|1|||
126032478|NCT04209465|453415813|FG012|Overall Study|Progressive Disease|0|||
126032479|NCT04209465|453415801|FG000|Overall Study|Withdrawal by Subject|0|||
126032480|NCT04209465|453415802|FG001|Overall Study|Withdrawal by Subject|0|||
126032481|NCT04209465|453415803|FG002|Overall Study|Withdrawal by Subject|0|||
126032482|NCT04209465|453415804|FG003|Overall Study|Withdrawal by Subject|0|||
126032483|NCT04209465|453415805|FG004|Overall Study|Withdrawal by Subject|0|||
126032484|NCT04209465|453415806|FG005|Overall Study|Withdrawal by Subject|1|||
126032485|NCT04209465|453415807|FG006|Overall Study|Withdrawal by Subject|2|||
126032486|NCT04209465|453415808|FG007|Overall Study|Withdrawal by Subject|0|||
126032487|NCT04209465|453415809|FG008|Overall Study|Withdrawal by Subject|1|||
126032488|NCT04209465|453415810|FG009|Overall Study|Withdrawal by Subject|0|||
126032489|NCT04209465|453415811|FG010|Overall Study|Withdrawal by Subject|0|||
126032490|NCT04209465|453415812|FG011|Overall Study|Withdrawal by Subject|2|||
126032491|NCT04209465|453415813|FG012|Overall Study|Withdrawal by Subject|2|||
126032492|NCT04209465|453415801|FG000|Overall Study|Lost to Follow-up|0|||
126032493|NCT04209465|453415802|FG001|Overall Study|Lost to Follow-up|0|||
126032494|NCT04209465|453415803|FG002|Overall Study|Lost to Follow-up|0|||
126032495|NCT04209465|453415804|FG003|Overall Study|Lost to Follow-up|0|||
126032496|NCT04209465|453415805|FG004|Overall Study|Lost to Follow-up|0|||
126032497|NCT04209465|453415806|FG005|Overall Study|Lost to Follow-up|1|||
126032498|NCT04209465|453415807|FG006|Overall Study|Lost to Follow-up|0|||
126032499|NCT04209465|453415808|FG007|Overall Study|Lost to Follow-up|0|||
126032500|NCT04209465|453415809|FG008|Overall Study|Lost to Follow-up|1|||
126032501|NCT04209465|453415810|FG009|Overall Study|Lost to Follow-up|0|||
126032502|NCT04209465|453415811|FG010|Overall Study|Lost to Follow-up|0|||
126032503|NCT04209465|453415812|FG011|Overall Study|Lost to Follow-up|1|||
126032504|NCT04209465|453415813|FG012|Overall Study|Lost to Follow-up|0|||
126032505|NCT04209465|453415801|FG000|Overall Study|Started new therapy|0|||
126032506|NCT04209465|453415802|FG001|Overall Study|Started new therapy|0|||
126032507|NCT04209465|453415803|FG002|Overall Study|Started new therapy|0|||
126032508|NCT04209465|453415804|FG003|Overall Study|Started new therapy|0|||
126032509|NCT04209465|453415805|FG004|Overall Study|Started new therapy|0|||
126032510|NCT04209465|453415806|FG005|Overall Study|Started new therapy|1|||
126032511|NCT04209465|453415807|FG006|Overall Study|Started new therapy|0|||
126032512|NCT04209465|453415808|FG007|Overall Study|Started new therapy|0|||
126032513|NCT04209465|453415809|FG008|Overall Study|Started new therapy|0|||
126032514|NCT04209465|453415810|FG009|Overall Study|Started new therapy|0|||
126032515|NCT04209465|453415811|FG010|Overall Study|Started new therapy|0|||
126032516|NCT04209465|453415812|FG011|Overall Study|Started new therapy|0|||
126032517|NCT04209465|453415813|FG012|Overall Study|Started new therapy|0|||
126032518|NCT04209465|453415801|FG000|Overall Study|Study terminated early by sponsor|0|||
126032519|NCT04209465|453415802|FG001|Overall Study|Study terminated early by sponsor|0|||
126032520|NCT04209465|453415803|FG002|Overall Study|Study terminated early by sponsor|0|||
126032521|NCT04209465|453415804|FG003|Overall Study|Study terminated early by sponsor|0|||
126032522|NCT04209465|453415805|FG004|Overall Study|Study terminated early by sponsor|0|||
126032523|NCT04209465|453415806|FG005|Overall Study|Study terminated early by sponsor|0|||
126032524|NCT04209465|453415807|FG006|Overall Study|Study terminated early by sponsor|3|||
126032525|NCT04209465|453415808|FG007|Overall Study|Study terminated early by sponsor|0|||
126032526|NCT04209465|453415809|FG008|Overall Study|Study terminated early by sponsor|0|||
126032527|NCT04209465|453415810|FG009|Overall Study|Study terminated early by sponsor|0|||
126032528|NCT04209465|453415811|FG010|Overall Study|Study terminated early by sponsor|0|||
126032529|NCT04209465|453415812|FG011|Overall Study|Study terminated early by sponsor|0|||
126032530|NCT04209465|453415813|FG012|Overall Study|Study terminated early by sponsor|3|||
126032531|NCT04209465|453415801|FG000|Overall Study|Other|0|||
126032532|NCT04209465|453415802|FG001|Overall Study|Other|0|||
126032533|NCT04209465|453415803|FG002|Overall Study|Other|0|||
126032534|NCT04209465|453415804|FG003|Overall Study|Other|0|||
126032535|NCT04209465|453415805|FG004|Overall Study|Other|0|||
126032536|NCT04209465|453415806|FG005|Overall Study|Other|0|||
126032537|NCT04209465|453415807|FG006|Overall Study|Other|0|||
126032538|NCT04209465|453415808|FG007|Overall Study|Other|0|||
126032539|NCT04209465|453415809|FG008|Overall Study|Other|1|||
126032540|NCT04209465|453415810|FG009|Overall Study|Other|0|||
126032541|NCT04209465|453415811|FG010|Overall Study|Other|0|||
126032542|NCT04209465|453415812|FG011|Overall Study|Other|0|||
126032543|NCT04209465|453415813|FG012|Overall Study|Other|0|||
126032544|NCT04277442|453415821|FG000|Overall Study|Death|1|||
126032545|NCT04876118|453415822|FG000|Overall Study|Pregnancy|1|||
126032546|NCT04876118|453415822|FG000|Overall Study|Withdrawal by Subject|14|||
126032547|NCT03092518|453415823|FG000|Overall Study|Ineligible|2|||
126032548|NCT02547987|453415824|FG000|Overall Study|Withdrawal by Subject|1|||
126032549|NCT02547987|453415824|FG000|Overall Study|Adverse Event|2|||
126032550|NCT04925986|453415825|FG000|Overall Study|Death|0|||
126032551|NCT04925986|453415826|FG001|Overall Study|Death|0|||
126032552|NCT04925986|453415827|FG002|Overall Study|Death|2|||
126032553|NCT04925986|453415828|FG003|Overall Study|Death|0|||
126032554|NCT04925986|453415825|FG000|Overall Study|Lack of Efficacy|1|||
126032555|NCT04925986|453415826|FG001|Overall Study|Lack of Efficacy|2|||
126032556|NCT04925986|453415827|FG002|Overall Study|Lack of Efficacy|0|||
126032557|NCT04925986|453415828|FG003|Overall Study|Lack of Efficacy|1|||
126032558|NCT04925986|453415825|FG000|Overall Study|Withdrawal by Subject|0|||
126032559|NCT04925986|453415826|FG001|Overall Study|Withdrawal by Subject|0|||
126032560|NCT04925986|453415827|FG002|Overall Study|Withdrawal by Subject|1|||
126032561|NCT04925986|453415828|FG003|Overall Study|Withdrawal by Subject|2|||
126032562|NCT06181760|453415829|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
126032563|NCT06181760|453415830|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
126032564|NCT06181760|453415831|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
126032565|NCT06181760|453415832|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
126032566|NCT04770532|453415833|FG000|Overall Study|Withdrawal by Subject|0|||
126032567|NCT04770532|453415834|FG001|Overall Study|Withdrawal by Subject|3|||
126032568|NCT04770532|453415833|FG000|Overall Study|Physician Decision|1|||
126032569|NCT04770532|453415834|FG001|Overall Study|Physician Decision|0|||
126032570|NCT04770532|453415833|FG000|Overall Study|Death|2|||
126032571|NCT04770532|453415834|FG001|Overall Study|Death|2|||
126032572|NCT04938492|453415835|FG000|Overall Study|Lost to Follow-up|17|||
126032573|NCT04938492|453415836|FG001|Overall Study|Lost to Follow-up|18|||
126032574|NCT04025554|453415837|FG000|Overall Study|Adverse Event|3|||
126032575|NCT04338061|453415840|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
126032576|NCT04338061|453415841|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
126032577|NCT04338061|453415840|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
126032578|NCT04338061|453415841|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
126032579|NCT04338061|453415840|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
126032580|NCT04338061|453415841|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
126032581|NCT04338061|453415840|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
126032582|NCT04338061|453415841|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
126032583|NCT04338061|453415840|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
126032584|NCT04338061|453415841|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
126032585|NCT04338061|453415840|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
126032586|NCT04338061|453415841|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
126032587|NCT04338061|453415840|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
126032588|NCT04338061|453415841|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
126032589|NCT04338061|453415840|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
126032590|NCT04338061|453415841|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
126032591|NCT04338061|453415840|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
126032592|NCT04338061|453415841|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
126032593|NCT04338061|453415840|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
126032594|NCT04338061|453415841|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
126032595|NCT04338061|453415840|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
126032596|NCT04338061|453415841|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
126032597|NCT04338061|453415840|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
126032598|NCT04338061|453415841|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
126032599|NCT05030233|453415846|FG000|Overall Study|withdrawn for transfer|1|||
126032600|NCT05030233|453415847|FG001|Overall Study|withdrawn for transfer|0|||
126032601|NCT03365882|453415848|FG000|Randomization|Still Receiving Protocol Treatment|2|||
126032602|NCT03365882|453415849|FG001|Randomization|Still Receiving Protocol Treatment|0|||
126032603|NCT03365882|453415848|FG000|Randomization|Adverse Event|1|||
126032604|NCT03365882|453415849|FG001|Randomization|Adverse Event|2|||
126032605|NCT03365882|453415848|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
126032606|NCT03365882|453415849|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
126032607|NCT03365882|453415848|FG000|Randomization|Progression/Relapse|21|||
126032608|NCT03365882|453415849|FG001|Randomization|Progression/Relapse|3|||
126032609|NCT03365882|453415848|FG000|Randomization|Death|1|||
126032610|NCT03365882|453415849|FG001|Randomization|Death|0|||
126032611|NCT03365882|453415848|FG000|Randomization|Other - Not Protocol Specified|1|||
126032612|NCT03365882|453415849|FG001|Randomization|Other - Not Protocol Specified|1|||
126032613|NCT03365882|453415848|FG000|Randomization|Major Protocol Deviation|0|||
126032614|NCT03365882|453415849|FG001|Randomization|Major Protocol Deviation|1|||
126032615|NCT03365882|453415848|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
126032616|NCT03365882|453415849|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
126032617|NCT03365882|453415848|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
126032618|NCT03365882|453415849|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
126032619|NCT03365882|453415848|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
126032620|NCT03365882|453415849|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
126032621|NCT03365882|453415848|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
126032622|NCT03365882|453415849|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
126032623|NCT04971395|453418748|FG000|Overall Study|Withdrawal by Subject|0|||
126032624|NCT04971395|453418749|FG001|Overall Study|Withdrawal by Subject|1|||
126032625|NCT04971395|453418750|FG002|Overall Study|Withdrawal by Subject|0|||
126032626|NCT03771417|453418751|FG000|Overall Study|Withdrawal by Subject|1|||
126032627|NCT03771417|453418752|FG001|Overall Study|Withdrawal by Subject|0|||
126032628|NCT03771417|453418753|FG002|Overall Study|Withdrawal by Subject|0|||
126032629|NCT03771417|453418751|FG000|Overall Study|Covid-19 Shutdown|0|||
126032630|NCT03771417|453418752|FG001|Overall Study|Covid-19 Shutdown|1|||
126032631|NCT03771417|453418753|FG002|Overall Study|Covid-19 Shutdown|0|||
126032632|NCT05308004|453418758|FG000|Overall Study|Not seen by Palliative Care NP|0|||
126032633|NCT05308004|453418759|FG001|Overall Study|Not seen by Palliative Care NP|1|||
126032634|NCT01160211|453418763|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
126032635|NCT01160211|453418764|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
126032636|NCT01160211|453418765|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
126032637|NCT01160211|453418763|FG000|Overall Study|Lost to Follow-up|4|||
126032638|NCT01160211|453418764|FG001|Overall Study|Lost to Follow-up|8|||
126032639|NCT01160211|453418765|FG002|Overall Study|Lost to Follow-up|4|||
126032640|NCT01160211|453418763|FG000|Overall Study|Physician Decision|1|||
126032641|NCT01160211|453418764|FG001|Overall Study|Physician Decision|0|||
126032642|NCT01160211|453418765|FG002|Overall Study|Physician Decision|0|||
126032643|NCT01160211|453418763|FG000|Overall Study|Withdrawal by Subject|4|||
126032644|NCT01160211|453418764|FG001|Overall Study|Withdrawal by Subject|2|||
126032645|NCT01160211|453418765|FG002|Overall Study|Withdrawal by Subject|2|||
126032646|NCT01160211|453418763|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
126032647|NCT01160211|453418764|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
126032648|NCT01160211|453418765|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
126032649|NCT02577835|453418766|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
126032650|NCT04342494|453418767|FG000|Overall Study|Questionnaire partially completed|1|||
126032651|NCT04342494|453418768|FG001|Overall Study|Questionnaire partially completed|0|||
126032652|NCT04342494|453418769|FG002|Overall Study|Questionnaire partially completed|2|||
126032653|NCT04342494|453418770|FG003|Overall Study|Questionnaire partially completed|0|||
126032654|NCT04342494|453418771|FG004|Overall Study|Questionnaire partially completed|1|||
126032655|NCT04342494|453418767|FG000|Overall Study|Lost to Follow-up|49|||
126032656|NCT04342494|453418768|FG001|Overall Study|Lost to Follow-up|38|||
126032657|NCT04342494|453418769|FG002|Overall Study|Lost to Follow-up|34|||
126032658|NCT04342494|453418770|FG003|Overall Study|Lost to Follow-up|34|||
126032659|NCT04342494|453418771|FG004|Overall Study|Lost to Follow-up|35|||
126032660|NCT05409183|453418772|FG000|Complete Study|Adverse Event|1|||
126032661|NCT05409183|453418773|FG001|Complete Study|Adverse Event|2|||
126032662|NCT05409183|453418772|FG000|Complete Study|Withdrawal by Subject|3|||
126032663|NCT05409183|453418773|FG001|Complete Study|Withdrawal by Subject|0|||
126032664|NCT02274662|453418774|FG000|Overall Study|Death|1|||
126032665|NCT02274662|453418774|FG000|Overall Study|Lost to Follow-up|3|||
126032666|NCT04806451|453418775|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
126032667|NCT04806451|453418776|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
126032668|NCT04806451|453418775|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
126032669|NCT04806451|453418776|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
126032670|NCT04806451|453418775|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
126032671|NCT04806451|453418776|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
126032672|NCT05835336|453418777|FG000|Overall Study|Withdrawal by Subject|5|||
126032673|NCT05835336|453418777|FG000|Overall Study|Did not complete the personalization process|3|||
126032674|NCT02936752|453418778|FG000|Overall Study|Death|2|||
126032675|NCT02936752|453418779|FG001|Overall Study|Death|1|||
126032676|NCT02936752|453418778|FG000|Overall Study|Physician Decision|4|||
126032677|NCT02936752|453418779|FG001|Overall Study|Physician Decision|0|||
126032678|NCT02936752|453418778|FG000|Overall Study|Withdrawal by Subject|0|||
126032679|NCT02936752|453418779|FG001|Overall Study|Withdrawal by Subject|2|||
126032680|NCT04489771|453418780|FG000|Overall Study|Death|27|||
126032681|NCT04489771|453418781|FG001|Overall Study|Death|25|||
126032682|NCT04489771|453418780|FG000|Overall Study|Withdrawal by Subject|1|||
126359985|NCT00326495|454610709|FG000|Overall Study|Subject off study before assessment|1|||
126359986|NCT03280615|454610711|FG000|Overall Study|Lost to Follow-up|1|||
126359987|NCT03280615|454610712|FG001|Overall Study|Lost to Follow-up|2|||
126359988|NCT03280615|454610711|FG000|Overall Study|Adverse Event|1|||
126359989|NCT03280615|454610712|FG001|Overall Study|Adverse Event|1|||
126359990|NCT03280615|454610711|FG000|Overall Study|Withdrawal by Subject|2|||
126359991|NCT03280615|454610712|FG001|Overall Study|Withdrawal by Subject|2|||
126359992|NCT00432991|454610715|FG000|Overall Study|Protocol Violation|7|||
126032683|NCT04489771|453418781|FG001|Overall Study|Withdrawal by Subject|0|||
126032684|NCT04489771|453418780|FG000|Overall Study|Participants Ongoing in Study|50|||
126032685|NCT04489771|453418781|FG001|Overall Study|Participants Ongoing in Study|51|||
126032686|NCT02979522|453418788|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
126032687|NCT02979522|453418789|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
126032688|NCT02979522|453418788|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
126032689|NCT02979522|453418789|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
126032690|NCT04059484|453418793|FG000|Overall Study|Adverse Event|2|||
126032691|NCT04059484|453418794|FG001|Overall Study|Adverse Event|5|||
126032692|NCT04059484|453418793|FG000|Overall Study|Withdrawal by Subject|5|||
126032693|NCT04059484|453418794|FG001|Overall Study|Withdrawal by Subject|3|||
126032694|NCT04059484|453418793|FG000|Overall Study|Progressive disease|112|||
126032695|NCT04059484|453418794|FG001|Overall Study|Progressive disease|112|||
126032696|NCT04059484|453418793|FG000|Overall Study|Other|8|||
126032697|NCT04059484|453418794|FG001|Overall Study|Other|3|||
126032698|NCT04059484|453418793|FG000|Overall Study|Ongoing|20|||
126032699|NCT04059484|453418794|FG001|Overall Study|Ongoing|20|||
126032700|NCT02949362|453418795|FG000|Retrospective Period|Inform consent not signed by participant|4|||
126032701|NCT02949362|453418796|FG001|Retrospective Period|Inform consent not signed by participant|1|||
126032702|NCT02949362|453418797|FG002|Retrospective Period|Inform consent not signed by participant|0|||
126032703|NCT02949362|453418798|FG003|Retrospective Period|Inform consent not signed by participant|0|||
126032704|NCT02949362|453418795|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
126032705|NCT02949362|453418796|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
126032706|NCT02949362|453418797|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
126032707|NCT02949362|453418798|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
126032708|NCT02949362|453418795|FG000|Prospective Period|Other|0|||
126032709|NCT02949362|453418796|FG001|Prospective Period|Other|0|||
126032710|NCT02949362|453418797|FG002|Prospective Period|Other|0|||
126032711|NCT02949362|453418798|FG003|Prospective Period|Other|4|||
126032712|NCT03199469|453418802|FG000|Overall Study|Randomized, not treated|0|||
126032713|NCT03199469|453418803|FG001|Overall Study|Randomized, not treated|3|||
126032714|NCT03199469|453418802|FG000|Overall Study|Withdrawal by Subject|1|||
126032715|NCT03199469|453418803|FG001|Overall Study|Withdrawal by Subject|0|||
126032716|NCT03199469|453418802|FG000|Overall Study|Death|1|||
126032717|NCT03199469|453418803|FG001|Overall Study|Death|3|||
126032718|NCT03199469|453418802|FG000|Overall Study|Ongoing|5|||
126032719|NCT03199469|453418803|FG001|Overall Study|Ongoing|14|||
126032720|NCT05453773|453418807|FG000|Overall Study|Withdrawal by Subject|3|||
126032721|NCT05453773|453418807|FG000|Overall Study|Lost to Follow-up|3|||
126032722|NCT05453773|453418807|FG000|Overall Study|Difficult Blood Draw|3|||
126032723|NCT02023866|453418808|FG000|Overall Study|Non-compliance|2|||
126032724|NCT02023866|453418808|FG000|Overall Study|Adverse Event|3|||
126032725|NCT02023866|453418808|FG000|Overall Study|Withdrawal by Subject|1|||
126032726|NCT03307343|453418809|FG000|Overall Study|Withdrawal by Subject|1|||
126032727|NCT03307343|453418810|FG001|Overall Study|Withdrawal by Subject|2|||
126032728|NCT03307343|453418809|FG000|Overall Study|Pregnancy|0|||
126032729|NCT03307343|453418810|FG001|Overall Study|Pregnancy|2|||
126032730|NCT03307343|453418809|FG000|Overall Study|Physician Decision|1|||
126032731|NCT03307343|453418810|FG001|Overall Study|Physician Decision|0|||
126032732|NCT03307343|453418809|FG000|Overall Study|Lost to Follow-up|0|||
126032733|NCT03307343|453418810|FG001|Overall Study|Lost to Follow-up|2|||
126032734|NCT04683744|453418811|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
126032735|NCT04683744|453418812|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
126359993|NCT00432991|454610716|FG001|Overall Study|Protocol Violation|12|||
126359994|NCT00903344|454610717|FG000|Overall Study|Pregnancy|2|||
126359995|NCT00903344|454610718|FG001|Overall Study|Pregnancy|3|||
126032736|NCT04683744|453418813|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
126032737|NCT03447470|453418816|FG000|Overall Study|Death|0|||
126032738|NCT03447470|453418817|FG001|Overall Study|Death|1|||
126032739|NCT03447470|453418818|FG002|Overall Study|Death|3|||
126032740|NCT03447470|453418819|FG003|Overall Study|Death|0|||
126032741|NCT03447470|453418820|FG004|Overall Study|Death|1|||
126032742|NCT03447470|453418821|FG005|Overall Study|Death|0|||
126032743|NCT03447470|453418822|FG006|Overall Study|Death|3|||
126032744|NCT03447470|453418823|FG007|Overall Study|Death|3|||
126032745|NCT03447470|453418824|FG008|Overall Study|Death|1|||
126032746|NCT03447470|453418816|FG000|Overall Study|Withdrawal by Subject|1|||
126032747|NCT03447470|453418817|FG001|Overall Study|Withdrawal by Subject|0|||
126032748|NCT03447470|453418818|FG002|Overall Study|Withdrawal by Subject|0|||
126032749|NCT03447470|453418819|FG003|Overall Study|Withdrawal by Subject|0|||
126032750|NCT03447470|453418820|FG004|Overall Study|Withdrawal by Subject|1|||
126032751|NCT03447470|453418821|FG005|Overall Study|Withdrawal by Subject|0|||
126032752|NCT03447470|453418822|FG006|Overall Study|Withdrawal by Subject|1|||
126032753|NCT03447470|453418823|FG007|Overall Study|Withdrawal by Subject|1|||
126032754|NCT03447470|453418824|FG008|Overall Study|Withdrawal by Subject|3|||
126032755|NCT03447470|453418816|FG000|Overall Study|Treatment discontinued|3|||
126032756|NCT03447470|453418817|FG001|Overall Study|Treatment discontinued|2|||
126032757|NCT03447470|453418818|FG002|Overall Study|Treatment discontinued|4|||
126032758|NCT03447470|453418819|FG003|Overall Study|Treatment discontinued|6|||
126032759|NCT03447470|453418820|FG004|Overall Study|Treatment discontinued|2|||
126032760|NCT03447470|453418821|FG005|Overall Study|Treatment discontinued|1|||
126032761|NCT03447470|453418822|FG006|Overall Study|Treatment discontinued|2|||
126032762|NCT03447470|453418823|FG007|Overall Study|Treatment discontinued|4|||
126032763|NCT03447470|453418824|FG008|Overall Study|Treatment discontinued|3|||
126032764|NCT04624633|453418825|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
126032765|NCT04624633|453418826|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
126032766|NCT04624633|453418825|FG000|Overall Study|Death|1|||
126032767|NCT04624633|453418826|FG001|Overall Study|Death|0|||
126032768|NCT04316871|453418827|FG000|Overall Study|Protocol Violation|2|||
126032769|NCT04316871|453418828|FG001|Overall Study|Protocol Violation|2|||
126032770|NCT04316871|453418829|FG002|Overall Study|Protocol Violation|2|||
126032771|NCT04316871|453418830|FG003|Overall Study|Protocol Violation|2|||
126032772|NCT05087992|453418831|FG000|Overall Study|Adverse Event|0|||
126032773|NCT05087992|453418832|FG001|Overall Study|Adverse Event|1|||
126032774|NCT05087992|453418833|FG002|Overall Study|Adverse Event|0|||
126032775|NCT05087992|453418831|FG000|Overall Study|Withdrawal by Subject|2|||
126032776|NCT05087992|453418832|FG001|Overall Study|Withdrawal by Subject|0|||
126032777|NCT05087992|453418833|FG002|Overall Study|Withdrawal by Subject|0|||
126032778|NCT05087992|453418831|FG000|Overall Study|clinical disease progression|3|||
126032779|NCT05087992|453418832|FG001|Overall Study|clinical disease progression|1|||
126032780|NCT05087992|453418833|FG002|Overall Study|clinical disease progression|0|||
126032781|NCT05087992|453418831|FG000|Overall Study|objective disease progression|4|||
126032782|NCT05087992|453418832|FG001|Overall Study|objective disease progression|1|||
126032783|NCT05087992|453418833|FG002|Overall Study|objective disease progression|0|||
126032784|NCT01842542|453418834|FG000|Overall Study|Withdrawal by Subject|2|||
126032785|NCT01842542|453418834|FG000|Overall Study|Lack of Efficacy|1|||
126032786|NCT01842542|453418834|FG000|Overall Study|Protocol Non-compliance|2|||
126032787|NCT01842542|453418834|FG000|Overall Study|Lost to Follow-up|1|||
126032788|NCT01369355|453418841|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
126032789|NCT01369355|453418842|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
126032790|NCT01369355|453418843|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
126032791|NCT01369355|453418844|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
126032792|NCT01369355|453418845|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
126032793|NCT01369355|453418846|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
126032794|NCT01369355|453418847|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
126032795|NCT01369355|453418848|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
126032796|NCT01369355|453418849|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
126032797|NCT01369355|453418841|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
126032798|NCT01369355|453418842|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
126032799|NCT01369355|453418843|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
126032800|NCT01369355|453418844|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
126032801|NCT01369355|453418845|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
126032802|NCT01369355|453418846|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
126032803|NCT01369355|453418847|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
126032804|NCT01369355|453418848|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
126032805|NCT01369355|453418849|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
126032806|NCT01369355|453418841|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126032807|NCT01369355|453418842|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
126032808|NCT01369355|453418843|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
126032809|NCT01369355|453418844|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126032810|NCT01369355|453418845|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126032811|NCT01369355|453418846|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
126032812|NCT01369355|453418847|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126032813|NCT01369355|453418848|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126032814|NCT01369355|453418849|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126032815|NCT01369355|453418841|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
126032816|NCT01369355|453418842|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
126032817|NCT01369355|453418843|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
126032818|NCT01369355|453418844|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
126032819|NCT01369355|453418845|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
126032820|NCT01369355|453418846|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
126032821|NCT01369355|453418847|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
126032822|NCT01369355|453418848|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
126032823|NCT01369355|453418849|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
126032824|NCT01369355|453418841|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
126032825|NCT01369355|453418842|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
126032826|NCT01369355|453418843|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
126032827|NCT01369355|453418844|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
126032828|NCT01369355|453418845|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
126032829|NCT01369355|453418846|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
126032830|NCT01369355|453418847|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
126032831|NCT01369355|453418848|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
126032832|NCT01369355|453418849|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
126032833|NCT01369355|453418841|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
126032834|NCT01369355|453418842|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
126032835|NCT01369355|453418843|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
126032836|NCT01369355|453418844|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
126032837|NCT01369355|453418845|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
126032838|NCT01369355|453418846|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
126032839|NCT01369355|453418847|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
126032840|NCT01369355|453418848|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
126032841|NCT01369355|453418849|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
126032842|NCT01369355|453418841|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
126032843|NCT01369355|453418842|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
126032844|NCT01369355|453418843|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
126032845|NCT01369355|453418844|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
126032846|NCT01369355|453418845|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
126032847|NCT01369355|453418846|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
126032848|NCT01369355|453418847|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
126032849|NCT01369355|453418848|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
126032850|NCT01369355|453418849|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
126032851|NCT01369355|453418841|FG000|Long-term Extension (Week 44-272)|Death|0|||
126032852|NCT01369355|453418842|FG001|Long-term Extension (Week 44-272)|Death|0|||
126032853|NCT01369355|453418843|FG002|Long-term Extension (Week 44-272)|Death|0|||
126032854|NCT01369355|453418844|FG003|Long-term Extension (Week 44-272)|Death|0|||
126032855|NCT01369355|453418845|FG004|Long-term Extension (Week 44-272)|Death|0|||
126032856|NCT01369355|453418846|FG005|Long-term Extension (Week 44-272)|Death|0|||
126032857|NCT01369355|453418847|FG006|Long-term Extension (Week 44-272)|Death|0|||
126032858|NCT01369355|453418848|FG007|Long-term Extension (Week 44-272)|Death|1|||
126032859|NCT01369355|453418849|FG008|Long-term Extension (Week 44-272)|Death|3|||
126032860|NCT01369355|453418841|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126032861|NCT01369355|453418842|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126032862|NCT01369355|453418843|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126032863|NCT01369355|453418844|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126032864|NCT01369355|453418845|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126032865|NCT01369355|453418846|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126032866|NCT01369355|453418847|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
126032867|NCT01369355|453418848|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
126032868|NCT01369355|453418849|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
126032869|NCT01369355|453418841|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126032870|NCT01369355|453418842|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126032871|NCT01369355|453418843|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126032872|NCT01369355|453418844|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126032873|NCT01369355|453418845|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126032874|NCT01369355|453418846|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126032875|NCT01369355|453418847|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126032876|NCT01369355|453418848|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
126032877|NCT01369355|453418849|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
126032878|NCT01369355|453418841|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
126032879|NCT01369355|453418842|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
126032880|NCT01369355|453418843|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
126032881|NCT01369355|453418844|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
126032882|NCT01369355|453418845|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
126032883|NCT01369355|453418846|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
126032884|NCT01369355|453418847|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
126032885|NCT01369355|453418848|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
126032886|NCT01369355|453418849|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
126032887|NCT01369355|453418841|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126032888|NCT01369355|453418842|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
125880338|NCT03204188|452858848|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
125880339|NCT03204188|452858848|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
126032889|NCT01369355|453418843|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126032890|NCT01369355|453418844|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126032891|NCT01369355|453418845|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126032892|NCT01369355|453418846|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126032893|NCT01369355|453418847|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
126032894|NCT01369355|453418848|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
126032895|NCT01369355|453418849|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
126032896|NCT01369355|453418841|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126032897|NCT01369355|453418842|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126032898|NCT01369355|453418843|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126032899|NCT01369355|453418844|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126032900|NCT01369355|453418845|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126032901|NCT01369355|453418846|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126032902|NCT01369355|453418847|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
126032903|NCT01369355|453418848|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
126032904|NCT01369355|453418849|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
126032905|NCT01369355|453418841|FG000|Long-term Extension (Week 44-272)|Other|0|||
126032906|NCT01369355|453418842|FG001|Long-term Extension (Week 44-272)|Other|0|||
126032907|NCT01369355|453418843|FG002|Long-term Extension (Week 44-272)|Other|0|||
126032908|NCT01369355|453418844|FG003|Long-term Extension (Week 44-272)|Other|0|||
126032909|NCT01369355|453418845|FG004|Long-term Extension (Week 44-272)|Other|0|||
126032910|NCT01369355|453418846|FG005|Long-term Extension (Week 44-272)|Other|0|||
126032911|NCT01369355|453418847|FG006|Long-term Extension (Week 44-272)|Other|110|||
126032912|NCT01369355|453418848|FG007|Long-term Extension (Week 44-272)|Other|9|||
126032913|NCT01369355|453418849|FG008|Long-term Extension (Week 44-272)|Other|17|||
126032914|NCT01824394|453418852|FG000|Overall Study|Early Termination|1|||
126032915|NCT01824394|453418853|FG001|Overall Study|Early Termination|1|||
126032916|NCT01824394|453418854|FG002|Overall Study|Early Termination|3|||
126032917|NCT01824394|453418852|FG000|Overall Study|Withdrawn due to Study Termination|91|||
126032918|NCT01824394|453418853|FG001|Overall Study|Withdrawn due to Study Termination|83|||
126032919|NCT01824394|453418854|FG002|Overall Study|Withdrawn due to Study Termination|41|||
126032920|NCT01824394|453418852|FG000|Overall Study|Lost to Follow-up|0|||
126032921|NCT01824394|453418853|FG001|Overall Study|Lost to Follow-up|9|||
126032922|NCT01824394|453418854|FG002|Overall Study|Lost to Follow-up|3|||
126032923|NCT01824394|453418852|FG000|Overall Study|Death|3|||
126032924|NCT01824394|453418853|FG001|Overall Study|Death|2|||
126032925|NCT01824394|453418854|FG002|Overall Study|Death|4|||
126032926|NCT01824394|453418852|FG000|Overall Study|Discontinued Subjects|1|||
126032927|NCT01824394|453418853|FG001|Overall Study|Discontinued Subjects|1|||
126032928|NCT01824394|453418854|FG002|Overall Study|Discontinued Subjects|2|||
126032929|NCT01824394|453418852|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
126032930|NCT01824394|453418853|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
126032931|NCT01824394|453418854|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
126032932|NCT00227344|453418855|FG000|Overall Study|study terminated early|12|||
126032933|NCT00227344|453418856|FG001|Overall Study|study terminated early|5|||
126032934|NCT01987895|453418857|FG000|Overall Study|Withdrawal by Subject|12|||
126032935|NCT01987895|453418858|FG001|Overall Study|Withdrawal by Subject|7|||
126032936|NCT01987895|453418857|FG000|Overall Study|Physician Decision|8|||
126032937|NCT01987895|453418858|FG001|Overall Study|Physician Decision|10|||
126032938|NCT01987895|453418857|FG000|Overall Study|Death|7|||
126032939|NCT01987895|453418858|FG001|Overall Study|Death|7|||
126032940|NCT01987895|453418857|FG000|Overall Study|Lost to Follow-up|3|||
126032941|NCT01987895|453418858|FG001|Overall Study|Lost to Follow-up|5|||
126032942|NCT01987895|453418857|FG000|Overall Study|randomized before giving IC|0|||
126032943|NCT01987895|453418858|FG001|Overall Study|randomized before giving IC|1|||
126032944|NCT05364671|453418859|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
126032945|NCT05364671|453418860|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
126032946|NCT05364671|453418859|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
126032947|NCT05364671|453418860|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
126264454|NCT01118117|454258461|FG001|Overall Study|Lost to Follow-up|0|||
126032948|NCT05364671|453418859|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
126032949|NCT05364671|453418860|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
126032950|NCT05364671|453418859|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
126032951|NCT05364671|453418860|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
126032952|NCT05364671|453418859|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
126032953|NCT05364671|453418860|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
126032954|NCT02359890|453418861|FG000|Overall Study|Not meeting eligibility|4|||
126032955|NCT02359890|453418861|FG000|Overall Study|Never treated with study catheter|6|||
126032956|NCT05256017|453418862|FG000|Treatment Period|Withdrawal by Subject|1|||
126032957|NCT05256017|453418863|FG001|Treatment Period|Withdrawal by Subject|1|||
126032958|NCT05256017|453418862|FG000|Follow-up|Lost to Follow-up|7|||
126032959|NCT05256017|453418863|FG001|Follow-up|Lost to Follow-up|1|||
126032960|NCT05256017|453418862|FG000|Follow-up|Withdrawal by Subject|1|||
126032961|NCT05256017|453418863|FG001|Follow-up|Withdrawal by Subject|0|||
126032962|NCT05256017|453418862|FG000|Follow-up|Death|0|||
126032963|NCT05256017|453418863|FG001|Follow-up|Death|1|||
126032964|NCT05780437|453418866|FG000|Overall Study|Withdrawal by Subject|22|||
126032965|NCT05780437|453418867|FG001|Overall Study|Withdrawal by Subject|16|||
126032966|NCT03536754|453418868|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
126032967|NCT03536754|453418869|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
126032968|NCT03536754|453418870|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
126032969|NCT03536754|453418871|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
126032970|NCT03536754|453418872|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
126032971|NCT03536754|453418868|FG000|Open Label Extension|Other|0|||
126032972|NCT03536754|453418869|FG001|Open Label Extension|Other|0|||
126032973|NCT03536754|453418870|FG002|Open Label Extension|Other|0|||
126032974|NCT03536754|453418871|FG003|Open Label Extension|Other|0|||
126032975|NCT03536754|453418872|FG004|Open Label Extension|Other|1|||
126032976|NCT03452579|453418873|FG000|Overall Study|Death|0|||
126032977|NCT03452579|453418874|FG001|Overall Study|Death|1|||
126032978|NCT03452579|453418873|FG000|Overall Study|Withdrawal by Subject|2|||
126032979|NCT03452579|453418874|FG001|Overall Study|Withdrawal by Subject|0|||
126032980|NCT03452579|453418873|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
126032981|NCT03452579|453418874|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
126032982|NCT03452579|453418873|FG000|Overall Study|Physician Decision|1|||
126032983|NCT03452579|453418874|FG001|Overall Study|Physician Decision|1|||
126032984|NCT03452579|453418873|FG000|Overall Study|Adverse Event|1|||
126032985|NCT03452579|453418874|FG001|Overall Study|Adverse Event|4|||
126032986|NCT05603143|453418888|FG000|Overall Study|Withdrew consent|6|||
126032987|NCT05603143|453418889|FG001|Overall Study|Withdrew consent|2|||
126032988|NCT05603143|453418888|FG000|Overall Study|Randomized but never treated|0|||
126032989|NCT05603143|453418889|FG001|Overall Study|Randomized but never treated|3|||
126032990|NCT05603143|453418888|FG000|Overall Study|Adverse Event|2|||
126032991|NCT05603143|453418889|FG001|Overall Study|Adverse Event|0|||
126032992|NCT05603143|453418888|FG000|Overall Study|Death|0|||
126032993|NCT05603143|453418889|FG001|Overall Study|Death|1|||
126032994|NCT05603143|453418888|FG000|Overall Study|Investigator's discretion|1|||
126032995|NCT05603143|453418889|FG001|Overall Study|Investigator's discretion|0|||
126032996|NCT05603143|453418888|FG000|Overall Study|Lost to Follow-up|0|||
126032997|NCT05603143|453418889|FG001|Overall Study|Lost to Follow-up|1|||
126032998|NCT05603143|453418888|FG000|Overall Study|Protocol Violation|0|||
126032999|NCT05603143|453418889|FG001|Overall Study|Protocol Violation|1|||
126033000|NCT05783102|453418890|FG000|Overall Study|Lost to Follow-up|1|||
126033001|NCT05783102|453418890|FG000|Overall Study|Withdrawal by Subject|2|||
126033002|NCT05647304|453418891|FG000|Overall Study|Withdrawal by Subject|1|||
126033003|NCT05647304|453418892|FG001|Overall Study|Withdrawal by Subject|0|||
126033004|NCT05008835|453418893|FG000|Overall Study|Adverse Event|5|||
126033005|NCT05008835|453418894|FG001|Overall Study|Adverse Event|2|||
126033006|NCT05008835|453418895|FG002|Overall Study|Adverse Event|1|||
126033007|NCT05008835|453418893|FG000|Overall Study|Lack of Efficacy|0|||
126033008|NCT05008835|453418894|FG001|Overall Study|Lack of Efficacy|0|||
126033009|NCT05008835|453418895|FG002|Overall Study|Lack of Efficacy|1|||
126033010|NCT05008835|453418893|FG000|Overall Study|Study terminated by sponsor|0|||
126033011|NCT05008835|453418894|FG001|Overall Study|Study terminated by sponsor|0|||
126033012|NCT05008835|453418895|FG002|Overall Study|Study terminated by sponsor|1|||
126033013|NCT05008835|453418893|FG000|Overall Study|Not further specified|3|||
126033014|NCT05008835|453418894|FG001|Overall Study|Not further specified|2|||
126033015|NCT05008835|453418895|FG002|Overall Study|Not further specified|1|||
126033016|NCT04171999|453418896|FG000|Overall Study|deemed ineligible after randomization|2|||
126033017|NCT04171999|453418897|FG001|Overall Study|deemed ineligible after randomization|1|||
126033018|NCT04505904|453418898|FG000|Overall Study|Withdrawal by Subject|1|||
126033019|NCT04505904|453418899|FG001|Overall Study|Withdrawal by Subject|2|||
126033020|NCT04505904|453418900|FG002|Overall Study|Withdrawal by Subject|0|||
126033021|NCT04505904|453418901|FG003|Overall Study|Withdrawal by Subject|0|||
126033022|NCT04505904|453418898|FG000|Overall Study|Physician Decision|1|||
126033023|NCT04505904|453418899|FG001|Overall Study|Physician Decision|0|||
126033024|NCT04505904|453418900|FG002|Overall Study|Physician Decision|0|||
126033025|NCT04505904|453418901|FG003|Overall Study|Physician Decision|0|||
126033026|NCT04505904|453418898|FG000|Overall Study|Adverse Event|0|||
126033027|NCT04505904|453418899|FG001|Overall Study|Adverse Event|1|||
126033028|NCT04505904|453418900|FG002|Overall Study|Adverse Event|0|||
126033029|NCT04505904|453418901|FG003|Overall Study|Adverse Event|0|||
126033030|NCT03544281|453418902|FG000|Main Study Phase|Death|3|||
126033031|NCT03544281|453418903|FG001|Main Study Phase|Death|2|||
126033032|NCT03544281|453418904|FG002|Main Study Phase|Death|6|||
126033033|NCT03544281|453418905|FG003|Main Study Phase|Death|8|||
126033034|NCT03544281|453418906|FG004|Main Study Phase|Death|4|||
126033035|NCT03544281|453418907|FG005|Main Study Phase|Death|2|||
126033036|NCT03544281|453418908|FG006|Main Study Phase|Death|4|||
126033037|NCT03544281|453418909|FG007|Main Study Phase|Death|5|||
126033038|NCT03544281|453418910|FG008|Main Study Phase|Death|5|||
126033039|NCT03544281|453418911|FG009|Main Study Phase|Death|8|||
126033040|NCT03544281|453418912|FG010|Main Study Phase|Death|6|||
126033041|NCT03544281|453418913|FG011|Main Study Phase|Death|4|||
126033042|NCT03544281|453418914|FG012|Main Study Phase|Death|0|||
126033043|NCT03544281|453418915|FG013|Main Study Phase|Death|0|||
126033044|NCT03544281|453418916|FG014|Main Study Phase|Death|0|||
126033045|NCT03544281|453418917|FG015|Main Study Phase|Death|0|||
126033046|NCT03544281|453418918|FG016|Main Study Phase|Death|0|||
126033047|NCT03544281|453418919|FG017|Main Study Phase|Death|0|||
126033048|NCT03544281|453418920|FG018|Main Study Phase|Death|0|||
126033049|NCT03544281|453418921|FG019|Main Study Phase|Death|0|||
126033050|NCT03544281|453418922|FG020|Main Study Phase|Death|0|||
126033051|NCT03544281|453418923|FG021|Main Study Phase|Death|0|||
126033052|NCT03544281|453418902|FG000|Main Study Phase|Lost to Follow-up|0|||
126033053|NCT03544281|453418903|FG001|Main Study Phase|Lost to Follow-up|0|||
126033054|NCT03544281|453418904|FG002|Main Study Phase|Lost to Follow-up|0|||
126033055|NCT03544281|453418905|FG003|Main Study Phase|Lost to Follow-up|0|||
126033056|NCT03544281|453418906|FG004|Main Study Phase|Lost to Follow-up|0|||
126033057|NCT03544281|453418907|FG005|Main Study Phase|Lost to Follow-up|0|||
126033058|NCT03544281|453418908|FG006|Main Study Phase|Lost to Follow-up|0|||
126033059|NCT03544281|453418909|FG007|Main Study Phase|Lost to Follow-up|0|||
126033060|NCT03544281|453418910|FG008|Main Study Phase|Lost to Follow-up|0|||
126033061|NCT03544281|453418911|FG009|Main Study Phase|Lost to Follow-up|0|||
126033062|NCT03544281|453418912|FG010|Main Study Phase|Lost to Follow-up|1|||
126033063|NCT03544281|453418913|FG011|Main Study Phase|Lost to Follow-up|0|||
126033064|NCT03544281|453418914|FG012|Main Study Phase|Lost to Follow-up|0|||
126033065|NCT03544281|453418915|FG013|Main Study Phase|Lost to Follow-up|0|||
126033066|NCT03544281|453418916|FG014|Main Study Phase|Lost to Follow-up|0|||
126033067|NCT03544281|453418917|FG015|Main Study Phase|Lost to Follow-up|0|||
126033068|NCT03544281|453418918|FG016|Main Study Phase|Lost to Follow-up|0|||
126033069|NCT03544281|453418919|FG017|Main Study Phase|Lost to Follow-up|0|||
126033070|NCT03544281|453418920|FG018|Main Study Phase|Lost to Follow-up|0|||
126033071|NCT03544281|453418921|FG019|Main Study Phase|Lost to Follow-up|0|||
126033072|NCT03544281|453418922|FG020|Main Study Phase|Lost to Follow-up|0|||
126033073|NCT03544281|453418923|FG021|Main Study Phase|Lost to Follow-up|0|||
126033074|NCT03544281|453418902|FG000|Main Study Phase|Physician Decision|0|||
126033075|NCT03544281|453418903|FG001|Main Study Phase|Physician Decision|0|||
126033076|NCT03544281|453418904|FG002|Main Study Phase|Physician Decision|0|||
126033077|NCT03544281|453418905|FG003|Main Study Phase|Physician Decision|0|||
126033078|NCT03544281|453418906|FG004|Main Study Phase|Physician Decision|0|||
126033079|NCT03544281|453418907|FG005|Main Study Phase|Physician Decision|0|||
126033080|NCT03544281|453418908|FG006|Main Study Phase|Physician Decision|0|||
126033081|NCT03544281|453418909|FG007|Main Study Phase|Physician Decision|1|||
126033082|NCT03544281|453418910|FG008|Main Study Phase|Physician Decision|0|||
126033083|NCT03544281|453418911|FG009|Main Study Phase|Physician Decision|0|||
126033084|NCT03544281|453418912|FG010|Main Study Phase|Physician Decision|0|||
126033085|NCT03544281|453418913|FG011|Main Study Phase|Physician Decision|0|||
126033086|NCT03544281|453418914|FG012|Main Study Phase|Physician Decision|0|||
126033087|NCT03544281|453418915|FG013|Main Study Phase|Physician Decision|0|||
126033088|NCT03544281|453418916|FG014|Main Study Phase|Physician Decision|0|||
126033089|NCT03544281|453418917|FG015|Main Study Phase|Physician Decision|0|||
126033090|NCT03544281|453418918|FG016|Main Study Phase|Physician Decision|0|||
126033091|NCT03544281|453418919|FG017|Main Study Phase|Physician Decision|0|||
126033092|NCT03544281|453418920|FG018|Main Study Phase|Physician Decision|0|||
126033093|NCT03544281|453418921|FG019|Main Study Phase|Physician Decision|0|||
126033094|NCT03544281|453418922|FG020|Main Study Phase|Physician Decision|0|||
126033095|NCT03544281|453418923|FG021|Main Study Phase|Physician Decision|0|||
126033096|NCT03544281|453418902|FG000|Main Study Phase|Withdrawal by Subject|2|||
126096741|NCT01712659|453646546|FG004|Dose Expansion|Physician Decision|0|||
126096742|NCT00548262|453646547|FG000|Overall Study|Death|21|||
126096743|NCT00548262|453646547|FG000|Overall Study|Adverse Event|2|||
126096744|NCT00548262|453646547|FG000|Overall Study|Lack of Efficacy|4|||
126096745|NCT00548262|453646547|FG000|Overall Study|Lost to Follow-up|1|||
126096746|NCT00548262|453646547|FG000|Overall Study|Other|3|||
126096747|NCT00548262|453646547|FG000|Overall Study|Withdrawal by Subject|1|||
126096748|NCT02442336|453646551|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
126096749|NCT02442336|453646551|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
126096750|NCT02442336|453646551|FG000|Overall Study|Lost to Follow-up|11|||
126096751|NCT00844532|453646553|FG000|Overall Study|Death|16|||
126096752|NCT00844532|453646553|FG000|Overall Study|Withdrawal by Subject|16|||
126096753|NCT00844532|453646553|FG000|Overall Study|Lost to Follow-up|7|||
126096754|NCT01993927|453646554|FG000|Overall Study|Case Report Forms Uncollected|18|||
126096755|NCT01993927|453646554|FG000|Overall Study|Protocol Violation|11|||
126096756|NCT00895154|453646555|FG000|Overall Study|Lost to Follow-up|1|||
126096757|NCT00895154|453646556|FG001|Overall Study|Lost to Follow-up|1|||
126096758|NCT00895154|453646555|FG000|Overall Study|Withdrawal by Subject|0|||
126096759|NCT00895154|453646556|FG001|Overall Study|Withdrawal by Subject|1|||
126096760|NCT02729831|453646558|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
126096761|NCT02729831|453646559|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
126096762|NCT02729831|453646560|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
126096763|NCT02729831|453646561|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
126096764|NCT02729831|453646558|FG000|1 Week Post-visit|Lost to Follow-up|43|||
126096765|NCT02729831|453646559|FG001|1 Week Post-visit|Lost to Follow-up|40|||
126096766|NCT02729831|453646560|FG002|1 Week Post-visit|Lost to Follow-up|38|||
126096767|NCT02729831|453646561|FG003|1 Week Post-visit|Lost to Follow-up|36|||
126096768|NCT02729831|453646558|FG000|6 Month Follow-up|Lost to Follow-up|54|||
126096769|NCT02729831|453646559|FG001|6 Month Follow-up|Lost to Follow-up|51|||
126096770|NCT02729831|453646560|FG002|6 Month Follow-up|Lost to Follow-up|48|||
126096771|NCT02729831|453646561|FG003|6 Month Follow-up|Lost to Follow-up|42|||
126096772|NCT02729831|453646558|FG000|6 Month Follow-up|Death|1|||
126096773|NCT02729831|453646559|FG001|6 Month Follow-up|Death|3|||
126096774|NCT02729831|453646560|FG002|6 Month Follow-up|Death|0|||
126096775|NCT02729831|453646561|FG003|6 Month Follow-up|Death|1|||
126096776|NCT01747551|453646562|FG000|Overall Study|Progressive Disease|24|||
126096777|NCT01747551|453646563|FG001|Overall Study|Progressive Disease|17|||
126096778|NCT01747551|453646562|FG000|Overall Study|Death|3|||
126096779|NCT01747551|453646563|FG001|Overall Study|Death|1|||
126096780|NCT01747551|453646562|FG000|Overall Study|Adverse Event|7|||
126096781|NCT01747551|453646563|FG001|Overall Study|Adverse Event|1|||
126096782|NCT01747551|453646562|FG000|Overall Study|Prolonged Treatment Delay|2|||
126096783|NCT01747551|453646563|FG001|Overall Study|Prolonged Treatment Delay|0|||
126096784|NCT01747551|453646562|FG000|Overall Study|Withdrawal by Subject|3|||
126096785|NCT01747551|453646563|FG001|Overall Study|Withdrawal by Subject|1|||
126096786|NCT01747551|453646562|FG000|Overall Study|Physician Decision|2|||
126096787|NCT01747551|453646563|FG001|Overall Study|Physician Decision|1|||
126096788|NCT01747551|453646562|FG000|Overall Study|Other|2|||
126096789|NCT01747551|453646563|FG001|Overall Study|Other|0|||
126096790|NCT01142115|453646564|FG000|First Intervention|Lack of Efficacy|1|||
126096791|NCT01142115|453646565|FG001|First Intervention|Lack of Efficacy|1|||
126096792|NCT01142115|453646564|FG000|First Intervention|Adverse Event|1|||
126096793|NCT01142115|453646565|FG001|First Intervention|Adverse Event|0|||
126096794|NCT03208036|453646566|FG000|Baseline Assessment|Withdrawal by Subject|1|||
126096795|NCT03208036|453646567|FG001|Baseline Assessment|Withdrawal by Subject|1|||
126096796|NCT03208036|453646566|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
126096797|NCT03208036|453646567|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
126096798|NCT03208036|453646566|FG000|Intervention|Withdrawal by Subject|3|||
126096799|NCT03208036|453646567|FG001|Intervention|Withdrawal by Subject|2|||
126096800|NCT03208036|453646566|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
126096801|NCT03208036|453646567|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
126096802|NCT02091206|453646568|FG000|Treatment Period|Adverse Event|0|||
126096803|NCT02091206|453646569|FG001|Treatment Period|Adverse Event|1|||
126096804|NCT02091206|453646570|FG002|Treatment Period|Adverse Event|0|||
126096805|NCT02091206|453646571|FG003|Treatment Period|Adverse Event|0|||
126096806|NCT02091206|453646568|FG000|Treatment Period|Met withdrawal criteria|0|||
126096807|NCT02091206|453646569|FG001|Treatment Period|Met withdrawal criteria|0|||
126096808|NCT02091206|453646570|FG002|Treatment Period|Met withdrawal criteria|1|||
126096809|NCT02091206|453646571|FG003|Treatment Period|Met withdrawal criteria|0|||
126096810|NCT02091206|453646568|FG000|Taper Period|Participant refused study drug|1|||
126096811|NCT02091206|453646569|FG001|Taper Period|Participant refused study drug|0|||
126096812|NCT02091206|453646570|FG002|Taper Period|Participant refused study drug|0|||
126096813|NCT02091206|453646571|FG003|Taper Period|Participant refused study drug|1|||
126096814|NCT02091206|453646568|FG000|Taper Period|Lost to Follow-up|0|||
126096815|NCT02091206|453646569|FG001|Taper Period|Lost to Follow-up|0|||
126033097|NCT03544281|453418903|FG001|Main Study Phase|Withdrawal by Subject|0|||
126033098|NCT03544281|453418904|FG002|Main Study Phase|Withdrawal by Subject|1|||
126033099|NCT03544281|453418905|FG003|Main Study Phase|Withdrawal by Subject|2|||
126033100|NCT03544281|453418906|FG004|Main Study Phase|Withdrawal by Subject|0|||
126033101|NCT03544281|453418907|FG005|Main Study Phase|Withdrawal by Subject|0|||
126033102|NCT03544281|453418908|FG006|Main Study Phase|Withdrawal by Subject|0|||
126033103|NCT03544281|453418909|FG007|Main Study Phase|Withdrawal by Subject|0|||
126033104|NCT03544281|453418910|FG008|Main Study Phase|Withdrawal by Subject|2|||
126033105|NCT03544281|453418911|FG009|Main Study Phase|Withdrawal by Subject|3|||
126033106|NCT03544281|453418912|FG010|Main Study Phase|Withdrawal by Subject|0|||
126033107|NCT03544281|453418913|FG011|Main Study Phase|Withdrawal by Subject|4|||
126033108|NCT03544281|453418914|FG012|Main Study Phase|Withdrawal by Subject|0|||
126033109|NCT03544281|453418915|FG013|Main Study Phase|Withdrawal by Subject|0|||
126033110|NCT03544281|453418916|FG014|Main Study Phase|Withdrawal by Subject|0|||
126033111|NCT03544281|453418917|FG015|Main Study Phase|Withdrawal by Subject|0|||
126033112|NCT03544281|453418918|FG016|Main Study Phase|Withdrawal by Subject|0|||
126033113|NCT03544281|453418919|FG017|Main Study Phase|Withdrawal by Subject|0|||
126033114|NCT03544281|453418920|FG018|Main Study Phase|Withdrawal by Subject|0|||
126033115|NCT03544281|453418921|FG019|Main Study Phase|Withdrawal by Subject|0|||
126033116|NCT03544281|453418922|FG020|Main Study Phase|Withdrawal by Subject|0|||
126033117|NCT03544281|453418923|FG021|Main Study Phase|Withdrawal by Subject|0|||
126033118|NCT03544281|453418902|FG000|Main Study Phase|Ongoing|3|||
126033119|NCT03544281|453418903|FG001|Main Study Phase|Ongoing|1|||
126033120|NCT03544281|453418904|FG002|Main Study Phase|Ongoing|2|||
126033121|NCT03544281|453418905|FG003|Main Study Phase|Ongoing|4|||
126033122|NCT03544281|453418906|FG004|Main Study Phase|Ongoing|2|||
126033123|NCT03544281|453418907|FG005|Main Study Phase|Ongoing|4|||
126033124|NCT03544281|453418908|FG006|Main Study Phase|Ongoing|4|||
126033125|NCT03544281|453418909|FG007|Main Study Phase|Ongoing|0|||
126033126|NCT03544281|453418910|FG008|Main Study Phase|Ongoing|2|||
126033127|NCT03544281|453418911|FG009|Main Study Phase|Ongoing|2|||
126033128|NCT03544281|453418912|FG010|Main Study Phase|Ongoing|1|||
126033129|NCT03544281|453418913|FG011|Main Study Phase|Ongoing|0|||
126033130|NCT03544281|453418914|FG012|Main Study Phase|Ongoing|0|||
126033131|NCT03544281|453418915|FG013|Main Study Phase|Ongoing|0|||
126033132|NCT03544281|453418916|FG014|Main Study Phase|Ongoing|0|||
126033133|NCT03544281|453418917|FG015|Main Study Phase|Ongoing|0|||
126033134|NCT03544281|453418918|FG016|Main Study Phase|Ongoing|0|||
126033135|NCT03544281|453418919|FG017|Main Study Phase|Ongoing|0|||
126033136|NCT03544281|453418920|FG018|Main Study Phase|Ongoing|0|||
126033137|NCT03544281|453418921|FG019|Main Study Phase|Ongoing|0|||
126033138|NCT03544281|453418922|FG020|Main Study Phase|Ongoing|0|||
126033139|NCT03544281|453418923|FG021|Main Study Phase|Ongoing|0|||
126033140|NCT03544281|453418902|FG000|Main Study Phase|Investigator Site Closed|0|||
126033141|NCT03544281|453418903|FG001|Main Study Phase|Investigator Site Closed|0|||
126033142|NCT03544281|453418904|FG002|Main Study Phase|Investigator Site Closed|0|||
126033143|NCT03544281|453418905|FG003|Main Study Phase|Investigator Site Closed|0|||
126033144|NCT03544281|453418906|FG004|Main Study Phase|Investigator Site Closed|0|||
126033145|NCT03544281|453418907|FG005|Main Study Phase|Investigator Site Closed|0|||
126033146|NCT03544281|453418908|FG006|Main Study Phase|Investigator Site Closed|0|||
126033147|NCT03544281|453418909|FG007|Main Study Phase|Investigator Site Closed|0|||
126033148|NCT03544281|453418910|FG008|Main Study Phase|Investigator Site Closed|0|||
126033149|NCT03544281|453418911|FG009|Main Study Phase|Investigator Site Closed|1|||
126033150|NCT03544281|453418912|FG010|Main Study Phase|Investigator Site Closed|0|||
126033151|NCT03544281|453418913|FG011|Main Study Phase|Investigator Site Closed|0|||
126033152|NCT03544281|453418914|FG012|Main Study Phase|Investigator Site Closed|0|||
126033153|NCT03544281|453418915|FG013|Main Study Phase|Investigator Site Closed|0|||
126033154|NCT03544281|453418916|FG014|Main Study Phase|Investigator Site Closed|0|||
126033155|NCT03544281|453418917|FG015|Main Study Phase|Investigator Site Closed|0|||
126033156|NCT03544281|453418918|FG016|Main Study Phase|Investigator Site Closed|0|||
126033157|NCT03544281|453418919|FG017|Main Study Phase|Investigator Site Closed|0|||
126033158|NCT03544281|453418920|FG018|Main Study Phase|Investigator Site Closed|0|||
126033159|NCT03544281|453418921|FG019|Main Study Phase|Investigator Site Closed|0|||
126033160|NCT03544281|453418922|FG020|Main Study Phase|Investigator Site Closed|0|||
126033161|NCT03544281|453418923|FG021|Main Study Phase|Investigator Site Closed|0|||
126033162|NCT03544281|453418902|FG000|Main Study Phase|Did not receive study treatment|0|||
126033163|NCT03544281|453418903|FG001|Main Study Phase|Did not receive study treatment|0|||
126033164|NCT03544281|453418904|FG002|Main Study Phase|Did not receive study treatment|0|||
126033165|NCT03544281|453418905|FG003|Main Study Phase|Did not receive study treatment|0|||
126033166|NCT03544281|453418906|FG004|Main Study Phase|Did not receive study treatment|0|||
126033167|NCT03544281|453418907|FG005|Main Study Phase|Did not receive study treatment|0|||
126033168|NCT03544281|453418908|FG006|Main Study Phase|Did not receive study treatment|1|||
126033169|NCT03544281|453418909|FG007|Main Study Phase|Did not receive study treatment|0|||
126033170|NCT03544281|453418910|FG008|Main Study Phase|Did not receive study treatment|0|||
126033171|NCT03544281|453418911|FG009|Main Study Phase|Did not receive study treatment|0|||
126033172|NCT03544281|453418912|FG010|Main Study Phase|Did not receive study treatment|0|||
126033173|NCT03544281|453418913|FG011|Main Study Phase|Did not receive study treatment|0|||
126033174|NCT03544281|453418914|FG012|Main Study Phase|Did not receive study treatment|0|||
126033175|NCT03544281|453418915|FG013|Main Study Phase|Did not receive study treatment|0|||
126033176|NCT03544281|453418916|FG014|Main Study Phase|Did not receive study treatment|0|||
126033177|NCT03544281|453418917|FG015|Main Study Phase|Did not receive study treatment|0|||
126033178|NCT03544281|453418918|FG016|Main Study Phase|Did not receive study treatment|0|||
126033179|NCT03544281|453418919|FG017|Main Study Phase|Did not receive study treatment|0|||
126033180|NCT03544281|453418920|FG018|Main Study Phase|Did not receive study treatment|0|||
126033181|NCT03544281|453418921|FG019|Main Study Phase|Did not receive study treatment|0|||
126033182|NCT03544281|453418922|FG020|Main Study Phase|Did not receive study treatment|0|||
126033183|NCT03544281|453418923|FG021|Main Study Phase|Did not receive study treatment|0|||
126033184|NCT03544281|453418902|FG000|PACT Phase|Adverse Event|0|||
126033185|NCT03544281|453418903|FG001|PACT Phase|Adverse Event|0|||
126033186|NCT03544281|453418904|FG002|PACT Phase|Adverse Event|0|||
126033187|NCT03544281|453418905|FG003|PACT Phase|Adverse Event|0|||
126033188|NCT03544281|453418906|FG004|PACT Phase|Adverse Event|0|||
126033189|NCT03544281|453418907|FG005|PACT Phase|Adverse Event|0|||
126033190|NCT03544281|453418908|FG006|PACT Phase|Adverse Event|0|||
126033191|NCT03544281|453418909|FG007|PACT Phase|Adverse Event|0|||
126033192|NCT03544281|453418910|FG008|PACT Phase|Adverse Event|0|||
126033193|NCT03544281|453418911|FG009|PACT Phase|Adverse Event|0|||
126033194|NCT03544281|453418912|FG010|PACT Phase|Adverse Event|0|||
126033195|NCT03544281|453418913|FG011|PACT Phase|Adverse Event|0|||
126033196|NCT03544281|453418914|FG012|PACT Phase|Adverse Event|1|||
126033197|NCT03544281|453418915|FG013|PACT Phase|Adverse Event|0|||
126033198|NCT03544281|453418916|FG014|PACT Phase|Adverse Event|0|||
126033199|NCT03544281|453418917|FG015|PACT Phase|Adverse Event|0|||
126033200|NCT03544281|453418918|FG016|PACT Phase|Adverse Event|0|||
126033201|NCT03544281|453418919|FG017|PACT Phase|Adverse Event|1|||
126033202|NCT03544281|453418920|FG018|PACT Phase|Adverse Event|1|||
126033203|NCT03544281|453418921|FG019|PACT Phase|Adverse Event|0|||
126033204|NCT03544281|453418922|FG020|PACT Phase|Adverse Event|0|||
126033205|NCT03544281|453418923|FG021|PACT Phase|Adverse Event|0|||
126033206|NCT04282148|453418927|FG000|Overall Study|Death|7|||
126033207|NCT04282148|453418927|FG000|Overall Study|Withdrawal by Subject|1|||
126033208|NCT04282148|453418927|FG000|Overall Study|Physician Decision|1|||
126033209|NCT05084508|453418928|FG000|Overall Study|Lost to Follow-up|6|||
126033210|NCT05084508|453418929|FG001|Overall Study|Lost to Follow-up|3|||
126033211|NCT05084508|453418930|FG002|Overall Study|Lost to Follow-up|7|||
126033212|NCT05084508|453418931|FG003|Overall Study|Lost to Follow-up|3|||
126033213|NCT05084508|453418928|FG000|Overall Study|Withdrawal by Subject|0|||
126033214|NCT05084508|453418929|FG001|Overall Study|Withdrawal by Subject|2|||
126033215|NCT05084508|453418930|FG002|Overall Study|Withdrawal by Subject|3|||
126033216|NCT05084508|453418931|FG003|Overall Study|Withdrawal by Subject|1|||
126033217|NCT05084508|453418928|FG000|Overall Study|Other|0|||
126033218|NCT05084508|453418929|FG001|Overall Study|Other|0|||
126033219|NCT05084508|453418930|FG002|Overall Study|Other|0|||
126033220|NCT05084508|453418931|FG003|Overall Study|Other|1|||
126033221|NCT05296525|453418932|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
126033222|NCT05296525|453418933|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
126033223|NCT05296525|453418934|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
126033224|NCT05296525|453418935|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
126033225|NCT04065841|453418940|FG000|Overall Study|Adverse Event|4|||
126033226|NCT04065841|453418941|FG001|Overall Study|Adverse Event|2|||
126033227|NCT04065841|453418942|FG002|Overall Study|Adverse Event|10|||
126033228|NCT04065841|453418943|FG003|Overall Study|Adverse Event|1|||
126033229|NCT04065841|453418940|FG000|Overall Study|Lost to Follow-up|1|||
126033230|NCT04065841|453418941|FG001|Overall Study|Lost to Follow-up|2|||
126033231|NCT04065841|453418942|FG002|Overall Study|Lost to Follow-up|2|||
126033232|NCT04065841|453418943|FG003|Overall Study|Lost to Follow-up|2|||
126033233|NCT04065841|453418940|FG000|Overall Study|Physician Decision|1|||
126033234|NCT04065841|453418941|FG001|Overall Study|Physician Decision|0|||
126033235|NCT04065841|453418942|FG002|Overall Study|Physician Decision|0|||
126033236|NCT04065841|453418943|FG003|Overall Study|Physician Decision|0|||
126033237|NCT04065841|453418940|FG000|Overall Study|Protocol Violation|0|||
126033238|NCT04065841|453418941|FG001|Overall Study|Protocol Violation|1|||
126033239|NCT04065841|453418942|FG002|Overall Study|Protocol Violation|0|||
126033240|NCT04065841|453418943|FG003|Overall Study|Protocol Violation|0|||
126033241|NCT04065841|453418940|FG000|Overall Study|Study terminated by Sponsor|22|||
126033242|NCT04065841|453418941|FG001|Overall Study|Study terminated by Sponsor|16|||
126033243|NCT04065841|453418942|FG002|Overall Study|Study terminated by Sponsor|28|||
126033244|NCT04065841|453418943|FG003|Overall Study|Study terminated by Sponsor|17|||
126033245|NCT04065841|453418940|FG000|Overall Study|Withdrawal by Subject|1|||
126033246|NCT04065841|453418941|FG001|Overall Study|Withdrawal by Subject|1|||
126033247|NCT04065841|453418942|FG002|Overall Study|Withdrawal by Subject|2|||
126033248|NCT04065841|453418943|FG003|Overall Study|Withdrawal by Subject|0|||
126033249|NCT01420237|453418944|FG000|Overall Study|Death|13|||
126033250|NCT01420237|453418944|FG000|Overall Study|Withdrawal by Subject|41|||
126033251|NCT01420237|453418944|FG000|Overall Study|Lost to Follow-up|32|||
126033252|NCT01420237|453418944|FG000|Overall Study|Adverse Event|10|||
126033253|NCT01420237|453418944|FG000|Overall Study|Investigative Site Termination|43|||
126033254|NCT01420237|453418944|FG000|Overall Study|Censored because study device not implanted|21|||
126033255|NCT01420237|453418944|FG000|Overall Study|Censored because surgery not performed|2|||
126096816|NCT02091206|453646570|FG002|Taper Period|Lost to Follow-up|0|||
126033256|NCT01420237|453418944|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
126033257|NCT01420237|453418944|FG000|Overall Study|Sponsor terminated study early|127|||
126033258|NCT03631784|453418946|FG000|Overall Study|Participants Ongoing|1|||
126033259|NCT03631784|453418947|FG001|Overall Study|Participants Ongoing|0|||
126033260|NCT03631784|453418946|FG000|Overall Study|Withdrawal by Subject|3|||
126033261|NCT03631784|453418947|FG001|Overall Study|Withdrawal by Subject|3|||
126033262|NCT03631784|453418946|FG000|Overall Study|Sponsor's Decision|36|||
126033263|NCT03631784|453418947|FG001|Overall Study|Sponsor's Decision|52|||
126033264|NCT03631784|453418946|FG000|Overall Study|Lost to Follow-up|1|||
126033265|NCT03631784|453418947|FG001|Overall Study|Lost to Follow-up|0|||
126033266|NCT03631784|453418946|FG000|Overall Study|Death|71|||
126033267|NCT03631784|453418947|FG001|Overall Study|Death|49|||
126033268|NCT04437615|453418949|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
126033269|NCT02035787|453420782|FG000|Overall Study- 12 Months|Adverse Event|3|||
126033270|NCT02035787|453420783|FG001|Overall Study- 12 Months|Adverse Event|0|||
126033271|NCT02035787|453420782|FG000|Overall Study- 12 Months|Complete response|4|||
126033272|NCT02035787|453420783|FG001|Overall Study- 12 Months|Complete response|1|||
126033273|NCT02035787|453420782|FG000|Overall Study- 12 Months|Protocol Violation|1|||
126033274|NCT02035787|453420783|FG001|Overall Study- 12 Months|Protocol Violation|1|||
126033275|NCT06414213|453420784|FG000|Overall Study|Lost to Follow-up|1|||
126033276|NCT06414213|453420785|FG001|Overall Study|Lost to Follow-up|1|||
126033277|NCT06414213|453420786|FG002|Overall Study|Lost to Follow-up|3|||
126033278|NCT01396278|453420787|FG000|Overall Study|Adverse Event|0|||
126096817|NCT02091206|453646571|FG003|Taper Period|Lost to Follow-up|1|||
126033279|NCT01396278|453420788|FG001|Overall Study|Adverse Event|0|||
126033280|NCT01396278|453420789|FG002|Overall Study|Adverse Event|0|||
126033281|NCT01396278|453420790|FG003|Overall Study|Adverse Event|2|||
126033282|NCT01396278|453420791|FG004|Overall Study|Adverse Event|0|||
126033283|NCT01396278|453420787|FG000|Overall Study|Withdraw due to trial termination|2|||
126033284|NCT01396278|453420788|FG001|Overall Study|Withdraw due to trial termination|1|||
126033285|NCT01396278|453420789|FG002|Overall Study|Withdraw due to trial termination|1|||
126033286|NCT01396278|453420790|FG003|Overall Study|Withdraw due to trial termination|0|||
126033287|NCT01396278|453420791|FG004|Overall Study|Withdraw due to trial termination|2|||
126033288|NCT04515576|453420794|FG000|Overall Study|Withdrawal by Subject|0|||
126033289|NCT04515576|453420795|FG001|Overall Study|Withdrawal by Subject|0|||
126033290|NCT04515576|453420796|FG002|Overall Study|Withdrawal by Subject|0|||
126033291|NCT04515576|453420797|FG003|Overall Study|Withdrawal by Subject|0|||
126033292|NCT04515576|453420798|FG004|Overall Study|Withdrawal by Subject|0|||
126033293|NCT04515576|453420799|FG005|Overall Study|Withdrawal by Subject|1|||
126033294|NCT05028634|453420800|FG000|Overall Study|Withdrawal by Subject|0|||
126033295|NCT05028634|453420801|FG001|Overall Study|Withdrawal by Subject|1|||
126033296|NCT05653427|453420802|FG000|Overall Study|Study Terminated by Sponsor|13|||
126033297|NCT04256941|453420810|FG000|Overall Study|Withdrawal by Subject|0|||
126033298|NCT04256941|453420811|FG001|Overall Study|Withdrawal by Subject|1|||
126033299|NCT04256941|453420810|FG000|Overall Study|Death|1|||
126033300|NCT04256941|453420811|FG001|Overall Study|Death|0|||
126033301|NCT04256941|453420810|FG000|Overall Study|Disease Progession|0|||
126033302|NCT04256941|453420811|FG001|Overall Study|Disease Progession|2|||
126033303|NCT02908477|453420818|FG000|Overall Study|Withdrawal by Subject|8|||
126033304|NCT02908477|453420819|FG001|Overall Study|Withdrawal by Subject|28|||
126033305|NCT02140554|453420820|FG000|Overall Study|Withdrawal of consent|1|||
126033306|NCT02140554|453420821|FG001|Overall Study|Withdrawal of consent|0|||
126033307|NCT02140554|453420822|FG002|Overall Study|Withdrawal of consent|4|||
126033308|NCT02140554|453420820|FG000|Overall Study|Physician Decision|1|||
126033309|NCT02140554|453420821|FG001|Overall Study|Physician Decision|0|||
126033310|NCT02140554|453420822|FG002|Overall Study|Physician Decision|2|||
126033311|NCT02140554|453420820|FG000|Overall Study|Death|0|||
126033312|NCT02140554|453420821|FG001|Overall Study|Death|0|||
126033313|NCT02140554|453420822|FG002|Overall Study|Death|1|||
126033314|NCT02140554|453420820|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
126033315|NCT02140554|453420821|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
126033316|NCT02140554|453420822|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
126033317|NCT05659537|453420823|FG000|Overall Study|Adverse Event|5|||
126033318|NCT05659537|453420823|FG000|Overall Study|Lost to Follow-up|4|||
126033319|NCT05659537|453420823|FG000|Overall Study|Withdrawal by Subject|13|||
126033320|NCT05659537|453420823|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
126033321|NCT05659537|453420823|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
126033322|NCT05659537|453420823|FG000|Overall Study|Participant was suffering from anaemia|1|||
126033323|NCT04728347|453420824|FG000|Overall Study|Sponsor decision|0|||
126033324|NCT04728347|453420825|FG001|Overall Study|Sponsor decision|0|||
126033325|NCT04728347|453420826|FG002|Overall Study|Sponsor decision|1|||
126033326|NCT04728347|453420827|FG003|Overall Study|Sponsor decision|0|||
126033327|NCT03953508|453420829|FG000|Baseline|Lost to Follow-up|3|||
126033328|NCT03953508|453420830|FG001|Baseline|Lost to Follow-up|2|||
126033329|NCT03953508|453420829|FG000|6-month Follow-up|Lost to Follow-up|62|||
126033330|NCT03953508|453420830|FG001|6-month Follow-up|Lost to Follow-up|70|||
126033331|NCT04526704|453420836|FG000|Overall Study|Adverse Event|1|||
126033332|NCT04526704|453420837|FG001|Overall Study|Adverse Event|0|||
126033333|NCT04526704|453420836|FG000|Overall Study|Physician Decision|1|||
126033334|NCT04526704|453420837|FG001|Overall Study|Physician Decision|0|||
126033335|NCT04526704|453420836|FG000|Overall Study|Withdrawal by Subject|2|||
126033336|NCT04526704|453420837|FG001|Overall Study|Withdrawal by Subject|0|||
126033337|NCT00881621|453420838|FG000|Overall Study|Physician Decision|34|||
126033338|NCT03936322|453420843|FG000|Overall Study|Lost to Follow-up|1|||
126033339|NCT03936322|453420843|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
126033340|NCT05434078|453420845|FG000|Overall Study|Lost to Follow-up|2|||
126033341|NCT05434078|453420846|FG001|Overall Study|Lost to Follow-up|1|||
126033342|NCT05434078|453420845|FG000|Overall Study|Withdrawal by Subject|1|||
126033343|NCT05434078|453420846|FG001|Overall Study|Withdrawal by Subject|0|||
126033344|NCT02734290|453420850|FG000|Overall Study|Adverse Event|1|||
126033345|NCT02734290|453420851|FG001|Overall Study|Adverse Event|0|||
126033346|NCT02734290|453420850|FG000|Overall Study|Death|1|||
126033347|NCT02734290|453420851|FG001|Overall Study|Death|0|||
126033348|NCT03158129|453420852|FG000|Overall Study|Adverse Event|0|||
126033349|NCT03158129|453420853|FG001|Overall Study|Adverse Event|1|||
126033350|NCT03158129|453420854|FG002|Overall Study|Adverse Event|0|||
126033351|NCT03158129|453420855|FG003|Overall Study|Adverse Event|0|||
126033352|NCT03158129|453420852|FG000|Overall Study|Death|0|||
126359996|NCT00903344|454610717|FG000|Overall Study|Lost to Follow-up|3|||
126033353|NCT03158129|453420853|FG001|Overall Study|Death|0|||
126033354|NCT03158129|453420854|FG002|Overall Study|Death|0|||
126103475|NCT01078675|453672170|FG001|Overall Study|Withdrawal by Subject|3|||
126033355|NCT03158129|453420855|FG003|Overall Study|Death|1|||
126033356|NCT03158129|453420852|FG000|Overall Study|High surgical risk|1|||
126033357|NCT03158129|453420853|FG001|Overall Study|High surgical risk|1|||
126033358|NCT03158129|453420854|FG002|Overall Study|High surgical risk|0|||
126033359|NCT03158129|453420855|FG003|Overall Study|High surgical risk|0|||
126033360|NCT03158129|453420852|FG000|Overall Study|Progression|1|||
126033361|NCT03158129|453420853|FG001|Overall Study|Progression|1|||
126033362|NCT03158129|453420854|FG002|Overall Study|Progression|0|||
126033363|NCT03158129|453420855|FG003|Overall Study|Progression|0|||
126033364|NCT03158129|453420852|FG000|Overall Study|Lack of resectability|0|||
126033365|NCT03158129|453420853|FG001|Overall Study|Lack of resectability|1|||
126033366|NCT03158129|453420854|FG002|Overall Study|Lack of resectability|0|||
126033367|NCT03158129|453420855|FG003|Overall Study|Lack of resectability|0|||
126033368|NCT03158129|453420852|FG000|Overall Study|Declined surgery|0|||
126033369|NCT03158129|453420853|FG001|Overall Study|Declined surgery|1|||
126033370|NCT03158129|453420854|FG002|Overall Study|Declined surgery|0|||
126033371|NCT03158129|453420855|FG003|Overall Study|Declined surgery|0|||
126033372|NCT03158129|453420852|FG000|Overall Study|No longer surgical candidate|0|||
126033373|NCT03158129|453420853|FG001|Overall Study|No longer surgical candidate|0|||
126033374|NCT03158129|453420854|FG002|Overall Study|No longer surgical candidate|0|||
126033375|NCT03158129|453420855|FG003|Overall Study|No longer surgical candidate|1|||
126033376|NCT03867500|453420860|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
126033377|NCT05119023|453420861|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
126033378|NCT05119023|453420861|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
126033379|NCT05119023|453420861|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
126033380|NCT02485938|453420872|FG000|Overall Study|Withdrawal of consent|2|||
126033381|NCT02485938|453420873|FG001|Overall Study|Withdrawal of consent|0|||
126033382|NCT04963270|453420874|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
126033383|NCT04963270|453420875|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
126033384|NCT04963270|453420876|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
126033385|NCT04963270|453420877|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
126033386|NCT04963270|453420874|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126033387|NCT04963270|453420875|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
126033388|NCT04963270|453420876|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126033389|NCT04963270|453420877|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126033390|NCT04963270|453420874|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
126033391|NCT04963270|453420875|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126033392|NCT04963270|453420876|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126033393|NCT04963270|453420877|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126033394|NCT04963270|453420874|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
126033395|NCT04963270|453420875|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
126033396|NCT04963270|453420876|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
126033397|NCT04963270|453420877|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
126033398|NCT04963270|453420874|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
126033399|NCT04963270|453420875|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
126033400|NCT04963270|453420876|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
126033401|NCT04963270|453420877|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
126033402|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
126033403|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
126033404|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
126033405|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
126033406|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
126033407|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
126033408|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
126359997|NCT00903344|454610718|FG001|Overall Study|Lost to Follow-up|0|||
125880340|NCT02419001|452860290|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
125880341|NCT02419001|452860291|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
126033409|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
126033410|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
126033411|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
126033412|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
126033413|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
126033414|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
126033415|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
126033416|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
126033417|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
126033418|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
126033419|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
126033420|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
126046488|NCT00495677|453468236|FG006|Stage 1 (25 Days)|Adverse Event|0|||
125880342|NCT01198795|452860292|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
126033421|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
126033422|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
126033423|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
126033424|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
126033425|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
126033426|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
126033427|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
126033428|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
126033429|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
126033430|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
126033431|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
126033432|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
126033433|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
126033434|NCT04963270|453420874|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
126033435|NCT04963270|453420875|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
126033436|NCT04963270|453420876|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
126033437|NCT04963270|453420877|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
126033438|NCT04927364|453420882|FG000|Overall Study|Withdrawal by Subject|3|||
126033439|NCT04927364|453420882|FG000|Overall Study|Unable to complete preassessment MRI|1|||
126033440|NCT03560609|453420885|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
126033441|NCT03560609|453420886|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
126033442|NCT04632992|453420890|FG000|Overall Study|Adverse Event|0|||
126033443|NCT04632992|453420891|FG001|Overall Study|Adverse Event|0|||
126033444|NCT04632992|453420892|FG002|Overall Study|Adverse Event|0|||
126033445|NCT04632992|453420893|FG003|Overall Study|Adverse Event|0|||
126033446|NCT04632992|453420894|FG004|Overall Study|Adverse Event|0|||
126033447|NCT04632992|453420895|FG005|Overall Study|Adverse Event|0|||
126033448|NCT04632992|453420896|FG006|Overall Study|Adverse Event|0|||
126033449|NCT04632992|453420897|FG007|Overall Study|Adverse Event|0|||
126033450|NCT04632992|453420898|FG008|Overall Study|Adverse Event|0|||
126033451|NCT04632992|453420899|FG009|Overall Study|Adverse Event|0|||
126033452|NCT04632992|453420900|FG010|Overall Study|Adverse Event|0|||
126033453|NCT04632992|453420901|FG011|Overall Study|Adverse Event|0|||
126033454|NCT04632992|453420902|FG012|Overall Study|Adverse Event|1|||
126033455|NCT04632992|453420903|FG013|Overall Study|Adverse Event|0|||
126033456|NCT04632992|453420890|FG000|Overall Study|Death|17|||
126033457|NCT04632992|453420891|FG001|Overall Study|Death|1|||
126033458|NCT04632992|453420892|FG002|Overall Study|Death|14|||
126033459|NCT04632992|453420893|FG003|Overall Study|Death|14|||
126033460|NCT04632992|453420894|FG004|Overall Study|Death|13|||
126033461|NCT04632992|453420895|FG005|Overall Study|Death|6|||
126033462|NCT04632992|453420896|FG006|Overall Study|Death|7|||
126033463|NCT04632992|453420897|FG007|Overall Study|Death|12|||
126033464|NCT04632992|453420898|FG008|Overall Study|Death|15|||
126033465|NCT04632992|453420899|FG009|Overall Study|Death|20|||
126033466|NCT04632992|453420900|FG010|Overall Study|Death|8|||
126033467|NCT04632992|453420901|FG011|Overall Study|Death|2|||
126033468|NCT04632992|453420902|FG012|Overall Study|Death|10|||
126033469|NCT04632992|453420903|FG013|Overall Study|Death|1|||
126033470|NCT04632992|453420890|FG000|Overall Study|Lost to Follow-up|1|||
126264455|NCT01118117|454258460|FG000|Overall Study|Missed 12 Month Visit|7|||
126033471|NCT04632992|453420891|FG001|Overall Study|Lost to Follow-up|0|||
126033472|NCT04632992|453420892|FG002|Overall Study|Lost to Follow-up|1|||
126033473|NCT04632992|453420893|FG003|Overall Study|Lost to Follow-up|0|||
126033474|NCT04632992|453420894|FG004|Overall Study|Lost to Follow-up|2|||
126033475|NCT04632992|453420895|FG005|Overall Study|Lost to Follow-up|0|||
126033476|NCT04632992|453420896|FG006|Overall Study|Lost to Follow-up|1|||
126033477|NCT04632992|453420897|FG007|Overall Study|Lost to Follow-up|1|||
126033478|NCT04632992|453420898|FG008|Overall Study|Lost to Follow-up|1|||
126033479|NCT04632992|453420899|FG009|Overall Study|Lost to Follow-up|1|||
126264456|NCT01118117|454258461|FG001|Overall Study|Missed 12 Month Visit|0|||
126264457|NCT02181296|454258467|FG000|Overall Study|Lost to Follow-up|7|||
126264458|NCT02181296|454258468|FG001|Overall Study|Lost to Follow-up|6|||
126264459|NCT02149121|454258469|FG000|Main Study Period|Lack of Efficacy|2|||
126264460|NCT02149121|454258470|FG001|Main Study Period|Lack of Efficacy|2|||
126264461|NCT02149121|454258471|FG002|Main Study Period|Lack of Efficacy|1|||
126264462|NCT02149121|454258472|FG003|Main Study Period|Lack of Efficacy|0|||
126264463|NCT02149121|454258473|FG004|Main Study Period|Lack of Efficacy|0|||
126264464|NCT02149121|454258474|FG005|Main Study Period|Lack of Efficacy|0|||
126264465|NCT02149121|454258475|FG006|Main Study Period|Lack of Efficacy|0|||
126264466|NCT02149121|454258469|FG000|Main Study Period|Withdrawal by Subject|9|||
126264467|NCT02149121|454258470|FG001|Main Study Period|Withdrawal by Subject|5|||
126264468|NCT02149121|454258471|FG002|Main Study Period|Withdrawal by Subject|1|||
126264469|NCT02149121|454258472|FG003|Main Study Period|Withdrawal by Subject|0|||
126033480|NCT04632992|453420900|FG010|Overall Study|Lost to Follow-up|2|||
126033481|NCT04632992|453420901|FG011|Overall Study|Lost to Follow-up|0|||
126033482|NCT04632992|453420902|FG012|Overall Study|Lost to Follow-up|0|||
126033483|NCT04632992|453420903|FG013|Overall Study|Lost to Follow-up|0|||
126033484|NCT04632992|453420890|FG000|Overall Study|Reason not Specified|2|||
126033485|NCT04632992|453420891|FG001|Overall Study|Reason not Specified|0|||
126033486|NCT04632992|453420892|FG002|Overall Study|Reason not Specified|1|||
126033487|NCT04632992|453420893|FG003|Overall Study|Reason not Specified|1|||
126033488|NCT04632992|453420894|FG004|Overall Study|Reason not Specified|0|||
126033489|NCT04632992|453420895|FG005|Overall Study|Reason not Specified|0|||
126033490|NCT04632992|453420896|FG006|Overall Study|Reason not Specified|0|||
126033491|NCT04632992|453420897|FG007|Overall Study|Reason not Specified|0|||
126033492|NCT04632992|453420898|FG008|Overall Study|Reason not Specified|0|||
126033493|NCT04632992|453420899|FG009|Overall Study|Reason not Specified|0|||
126033494|NCT04632992|453420900|FG010|Overall Study|Reason not Specified|1|||
126033495|NCT04632992|453420901|FG011|Overall Study|Reason not Specified|0|||
126033496|NCT04632992|453420902|FG012|Overall Study|Reason not Specified|0|||
126033497|NCT04632992|453420903|FG013|Overall Study|Reason not Specified|0|||
126033498|NCT04632992|453420890|FG000|Overall Study|Physician Decision|0|||
126033499|NCT04632992|453420891|FG001|Overall Study|Physician Decision|0|||
126033500|NCT04632992|453420892|FG002|Overall Study|Physician Decision|0|||
126033501|NCT04632992|453420893|FG003|Overall Study|Physician Decision|2|||
126033502|NCT04632992|453420894|FG004|Overall Study|Physician Decision|1|||
126033503|NCT04632992|453420895|FG005|Overall Study|Physician Decision|0|||
126033504|NCT04632992|453420896|FG006|Overall Study|Physician Decision|0|||
126033505|NCT04632992|453420897|FG007|Overall Study|Physician Decision|0|||
126033506|NCT04632992|453420898|FG008|Overall Study|Physician Decision|0|||
126033507|NCT04632992|453420899|FG009|Overall Study|Physician Decision|0|||
126033508|NCT04632992|453420900|FG010|Overall Study|Physician Decision|0|||
126033509|NCT04632992|453420901|FG011|Overall Study|Physician Decision|0|||
126033510|NCT04632992|453420902|FG012|Overall Study|Physician Decision|3|||
126033511|NCT04632992|453420903|FG013|Overall Study|Physician Decision|0|||
126033512|NCT04632992|453420890|FG000|Overall Study|Progressive Disease|0|||
126033513|NCT04632992|453420891|FG001|Overall Study|Progressive Disease|0|||
126033514|NCT04632992|453420892|FG002|Overall Study|Progressive Disease|0|||
126033515|NCT04632992|453420893|FG003|Overall Study|Progressive Disease|0|||
126033516|NCT04632992|453420894|FG004|Overall Study|Progressive Disease|1|||
126033517|NCT04632992|453420895|FG005|Overall Study|Progressive Disease|0|||
126033518|NCT04632992|453420896|FG006|Overall Study|Progressive Disease|0|||
126033519|NCT04632992|453420897|FG007|Overall Study|Progressive Disease|0|||
126033520|NCT04632992|453420898|FG008|Overall Study|Progressive Disease|0|||
126033521|NCT04632992|453420899|FG009|Overall Study|Progressive Disease|1|||
126033522|NCT04632992|453420900|FG010|Overall Study|Progressive Disease|1|||
126033523|NCT04632992|453420901|FG011|Overall Study|Progressive Disease|0|||
126033524|NCT04632992|453420902|FG012|Overall Study|Progressive Disease|2|||
126033525|NCT04632992|453420903|FG013|Overall Study|Progressive Disease|0|||
126033526|NCT04632992|453420890|FG000|Overall Study|Withdrawal by Subject|4|||
126033527|NCT04632992|453420891|FG001|Overall Study|Withdrawal by Subject|1|||
126033528|NCT04632992|453420892|FG002|Overall Study|Withdrawal by Subject|5|||
126033529|NCT04632992|453420893|FG003|Overall Study|Withdrawal by Subject|4|||
126033530|NCT04632992|453420894|FG004|Overall Study|Withdrawal by Subject|3|||
126033531|NCT04632992|453420895|FG005|Overall Study|Withdrawal by Subject|3|||
126033532|NCT04632992|453420896|FG006|Overall Study|Withdrawal by Subject|0|||
126033533|NCT04632992|453420897|FG007|Overall Study|Withdrawal by Subject|5|||
126033534|NCT04632992|453420898|FG008|Overall Study|Withdrawal by Subject|0|||
126033535|NCT04632992|453420899|FG009|Overall Study|Withdrawal by Subject|2|||
126033536|NCT04632992|453420900|FG010|Overall Study|Withdrawal by Subject|8|||
126033537|NCT04632992|453420901|FG011|Overall Study|Withdrawal by Subject|0|||
126033538|NCT04632992|453420902|FG012|Overall Study|Withdrawal by Subject|1|||
126033539|NCT04632992|453420903|FG013|Overall Study|Withdrawal by Subject|1|||
126033540|NCT04187833|453420904|FG000|Overall Study|Withdrawal by Subject|1|||
126033541|NCT03097549|453420905|FG000|Overall Study|Withdrawal by Subject|1|||
126033542|NCT03097549|453420906|FG001|Overall Study|Withdrawal by Subject|0|||
125880343|NCT01198795|452860292|FG000|Overall Study|Withdrawal by Subject|17|||
125880344|NCT01198795|452860292|FG000|Overall Study|Lost to Follow-up|15|||
125880345|NCT01198795|452860292|FG000|Overall Study|Adverse Event|9|||
125880346|NCT01198795|452860292|FG000|Overall Study|Lack of Efficacy|5|||
125880347|NCT01198795|452860292|FG000|Overall Study|Protocol Violation|2|||
125880348|NCT01198795|452860292|FG000|Overall Study|Other Reason|4|||
125880349|NCT00744497|452860293|FG000|Overall Study|Withdrawal by Subject|21|||
125880350|NCT00744497|452860294|FG001|Overall Study|Withdrawal by Subject|18|||
125880351|NCT00744497|452860293|FG000|Overall Study|Death|11|||
125880352|NCT00744497|452860294|FG001|Overall Study|Death|9|||
125880353|NCT00744497|452860293|FG000|Overall Study|Lost to Follow-up|4|||
125880354|NCT00744497|452860294|FG001|Overall Study|Lost to Follow-up|2|||
125880355|NCT00744497|452860293|FG000|Overall Study|Poor compliance/noncompliance|9|||
125880356|NCT00744497|452860294|FG001|Overall Study|Poor compliance/noncompliance|5|||
125880357|NCT00744497|452860293|FG000|Overall Study|No longer meets study criteria|7|||
125880358|NCT00744497|452860294|FG001|Overall Study|No longer meets study criteria|3|||
125880359|NCT00744497|452860293|FG000|Overall Study|Administrative Reason By Sponsor|25|||
125880360|NCT00744497|452860294|FG001|Overall Study|Administrative Reason By Sponsor|8|||
125880361|NCT00744497|452860293|FG000|Overall Study|Disease progression|312|||
125880362|NCT00744497|452860294|FG001|Overall Study|Disease progression|219|||
125880363|NCT00744497|452860293|FG000|Overall Study|Study drug toxicity|68|||
125880364|NCT00744497|452860294|FG001|Overall Study|Study drug toxicity|141|||
125880365|NCT00744497|452860293|FG000|Overall Study|Adverse event unrelated to study drug|78|||
125880366|NCT00744497|452860294|FG001|Overall Study|Adverse event unrelated to study drug|122|||
125880367|NCT00744497|452860293|FG000|Overall Study|Patient requested to stop study drug|65|||
125880368|NCT00744497|452860294|FG001|Overall Study|Patient requested to stop study drug|80|||
125880369|NCT00744497|452860293|FG000|Overall Study|Maximum clinical benefit|141|||
125880370|NCT00744497|452860294|FG001|Overall Study|Maximum clinical benefit|142|||
125880371|NCT00744497|452860293|FG000|Overall Study|Not defined|19|||
125880372|NCT00744497|452860294|FG001|Overall Study|Not defined|13|||
125880373|NCT00936715|452860329|FG000|Overall Study|Investigators Discretion|1|||
125880374|NCT00936715|452860329|FG000|Overall Study|Protocol Violation|1|||
125880375|NCT00936715|452860329|FG000|Overall Study|Safety or Tolerability Reasons|4|||
125880376|NCT03819114|452860330|FG000|Overall Study|Protocol Violation|0|||
125880377|NCT03819114|452860331|FG001|Overall Study|Protocol Violation|1|||
125880378|NCT03819114|452860332|FG002|Overall Study|Protocol Violation|1|||
125880379|NCT03819114|452860333|FG003|Overall Study|Protocol Violation|0|||
125880380|NCT03819114|452860330|FG000|Overall Study|Lost to Follow-up|0|||
125880381|NCT03819114|452860331|FG001|Overall Study|Lost to Follow-up|0|||
125880382|NCT03819114|452860332|FG002|Overall Study|Lost to Follow-up|1|||
125880383|NCT03819114|452860333|FG003|Overall Study|Lost to Follow-up|0|||
125880384|NCT02492763|452860334|FG000|Overall Study|Withdrawal by Subject|0|||
125880385|NCT02492763|452860335|FG001|Overall Study|Withdrawal by Subject|2|||
125880386|NCT02492763|452860336|FG002|Overall Study|Withdrawal by Subject|1|||
125880387|NCT02492763|452860337|FG003|Overall Study|Withdrawal by Subject|0|||
125880388|NCT02492763|452860334|FG000|Overall Study|Adverse Event|3|||
125880389|NCT02492763|452860335|FG001|Overall Study|Adverse Event|1|||
125880390|NCT02492763|452860336|FG002|Overall Study|Adverse Event|1|||
125880391|NCT02492763|452860337|FG003|Overall Study|Adverse Event|2|||
125880392|NCT02492763|452860334|FG000|Overall Study|Death|0|||
125880393|NCT02492763|452860335|FG001|Overall Study|Death|0|||
125880394|NCT02492763|452860336|FG002|Overall Study|Death|1|||
125880395|NCT02492763|452860337|FG003|Overall Study|Death|0|||
125880396|NCT02492763|452860334|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125880397|NCT02492763|452860335|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
126096818|NCT00700778|453646572|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
126096819|NCT03381339|453646573|FG000|Overall Study|Protocol Violation|4|||
125880398|NCT02492763|452860336|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125880399|NCT02492763|452860337|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125880400|NCT02492763|452860334|FG000|Overall Study|Lost to Follow-up|0|||
125880401|NCT02492763|452860335|FG001|Overall Study|Lost to Follow-up|0|||
125880402|NCT02492763|452860336|FG002|Overall Study|Lost to Follow-up|1|||
125880403|NCT02492763|452860337|FG003|Overall Study|Lost to Follow-up|0|||
125880404|NCT02492763|452860334|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125880405|NCT02492763|452860335|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125880406|NCT02492763|452860336|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125880407|NCT02492763|452860337|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125880408|NCT02492763|452860334|FG000|Overall Study|Screen Failure|0|||
125880409|NCT02492763|452860335|FG001|Overall Study|Screen Failure|0|||
125880410|NCT02492763|452860336|FG002|Overall Study|Screen Failure|0|||
125880411|NCT02492763|452860337|FG003|Overall Study|Screen Failure|1|||
125880412|NCT02492763|452860334|FG000|Overall Study|Study Terminated by Sponsor|13|||
125880413|NCT02492763|452860335|FG001|Overall Study|Study Terminated by Sponsor|10|||
125880414|NCT02492763|452860336|FG002|Overall Study|Study Terminated by Sponsor|6|||
125880415|NCT02492763|452860337|FG003|Overall Study|Study Terminated by Sponsor|10|||
125880416|NCT01337960|452860338|FG000|Overall Study|Lost to Follow-up|1|||
125880417|NCT01337960|452860339|FG001|Overall Study|Lost to Follow-up|0|||
126033543|NCT03097549|453420905|FG000|Overall Study|Lost to Follow-up|1|||
126033544|NCT03097549|453420906|FG001|Overall Study|Lost to Follow-up|0|||
126033545|NCT02547233|453420907|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
126033546|NCT02547233|453420908|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
126033547|NCT02547233|453420907|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
126033548|NCT02547233|453420908|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
126033549|NCT02547233|453420907|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
126033550|NCT02547233|453420908|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
126033551|NCT02547233|453420907|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
126033552|NCT02547233|453420908|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
126033553|NCT02547233|453420907|FG000|12-month Follow-up|Withdrawal by Subject|10|||
126033554|NCT02547233|453420908|FG001|12-month Follow-up|Withdrawal by Subject|10|||
126033555|NCT02547233|453420907|FG000|12-month Follow-up|Lost to Follow-up|3|||
126033556|NCT02547233|453420908|FG001|12-month Follow-up|Lost to Follow-up|3|||
126033557|NCT02547233|453420907|FG000|12-month Follow-up|Lack of Efficacy|1|||
126033558|NCT02547233|453420908|FG001|12-month Follow-up|Lack of Efficacy|2|||
126033559|NCT02547233|453420907|FG000|12-month Follow-up|Protocol Violation|0|||
126033560|NCT02547233|453420908|FG001|12-month Follow-up|Protocol Violation|1|||
126033561|NCT02547233|453420907|FG000|12-month Follow-up|Other|0|||
126033562|NCT02547233|453420908|FG001|12-month Follow-up|Other|1|||
126033563|NCT02146378|453420909|FG000|Overall Study|No information of administration|2|||
126033564|NCT03603600|453420910|FG000|Overall Study|Withdrawal by Subject|5|||
126033565|NCT03603600|453420911|FG001|Overall Study|Withdrawal by Subject|7|||
126033566|NCT03603600|453420910|FG000|Overall Study|Lost to Follow-up|2|||
126033567|NCT03603600|453420911|FG001|Overall Study|Lost to Follow-up|3|||
126033568|NCT03603600|453420910|FG000|Overall Study|Death|3|||
126033569|NCT03603600|453420911|FG001|Overall Study|Death|1|||
126033570|NCT03603600|453420910|FG000|Overall Study|Physician Decision|2|||
126033571|NCT03603600|453420911|FG001|Overall Study|Physician Decision|1|||
126033572|NCT03603600|453420910|FG000|Overall Study|Other reason|1|||
126033573|NCT03603600|453420911|FG001|Overall Study|Other reason|0|||
126033574|NCT05170009|453420912|FG000|Overall Study|Physician Decision|0|||
126033575|NCT05170009|453420913|FG001|Overall Study|Physician Decision|1|||
126033576|NCT03524612|453420919|FG000|Overall Study|Lack of Efficacy|10|||
126033577|NCT03524612|453420919|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
126033578|NCT03524612|453420919|FG000|Overall Study|Adverse Event|10|||
126033579|NCT03524612|453420919|FG000|Overall Study|Withdrawal by Subject|7|||
126033580|NCT03524612|453420919|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
126033581|NCT03524612|453420919|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
126033582|NCT03524612|453420919|FG000|Overall Study|New therapy for study indication|6|||
126033583|NCT03524612|453420919|FG000|Overall Study|Death|3|||
126033584|NCT03524612|453420919|FG000|Overall Study|Lost to Follow-up|2|||
126033585|NCT03524612|453420919|FG000|Overall Study|Protocol Violation|1|||
126033586|NCT05457647|453420920|FG000|Overall Study|Lost to Follow-up|3|||
126033587|NCT02683447|453420921|FG000|Overall Study|Lost to Follow-up|2|||
126033588|NCT03448107|453420922|FG000|Overall Study|Lost to Follow-up|229|||
126033589|NCT03448107|453420923|FG001|Overall Study|Lost to Follow-up|258|||
126033590|NCT03115476|453420924|FG000|LP0084-1369|Death|1|||
126033591|NCT03115476|453420925|FG001|LP0084-1369|Death|0|||
126033592|NCT03115476|453420926|FG002|LP0084-1369|Death|2|||
126033593|NCT03115476|453420924|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
126096820|NCT03381339|453646574|FG001|Overall Study|Protocol Violation|3|||
125880418|NCT01337960|452860340|FG002|Overall Study|Lost to Follow-up|0|||
126033594|NCT03115476|453420925|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
126033595|NCT03115476|453420926|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
126033596|NCT02489903|453420927|FG000|Screening|Screen Failure|24|||
126033597|NCT02489903|453420928|FG001|Screening|Screen Failure|0|||
126033598|NCT02489903|453420929|FG002|Screening|Screen Failure|0|||
126033599|NCT02489903|453420930|FG003|Screening|Screen Failure|8|||
126033600|NCT02489903|453420927|FG000|Randomized and Received Treatment|Protocol Violation|0|||
126033601|NCT02489903|453420928|FG001|Randomized and Received Treatment|Protocol Violation|1|||
126033602|NCT02489903|453420929|FG002|Randomized and Received Treatment|Protocol Violation|0|||
126033603|NCT02489903|453420930|FG003|Randomized and Received Treatment|Protocol Violation|0|||
125880419|NCT01337960|452860338|FG000|Overall Study|Withdrawal by Subject|1|||
126033604|NCT02489903|453420927|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
126033605|NCT02489903|453420928|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
126033606|NCT02489903|453420929|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
126033607|NCT02489903|453420930|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
126033608|NCT02489903|453420927|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
126033609|NCT02489903|453420928|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
126033610|NCT02489903|453420929|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
126033611|NCT02489903|453420930|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
126033612|NCT02489903|453420927|FG000|Randomized and Received Treatment|Death|10|||
126033613|NCT02489903|453420928|FG001|Randomized and Received Treatment|Death|1|||
126033614|NCT02489903|453420929|FG002|Randomized and Received Treatment|Death|0|||
126033615|NCT02489903|453420930|FG003|Randomized and Received Treatment|Death|0|||
126033616|NCT05257486|453420934|FG000|Overall Study|Protocol Violation|3|||
126033617|NCT04542317|453420935|FG000|Overall Study|Care recipients passed away|18|||
126033618|NCT04542317|453420936|FG001|Overall Study|Care recipients passed away|13|||
126033619|NCT04542317|453420935|FG000|Overall Study|No longer a primary caregiver|5|||
126033620|NCT04542317|453420936|FG001|Overall Study|No longer a primary caregiver|1|||
126033621|NCT04542317|453420935|FG000|Overall Study|Withdrawal by Subject|4|||
126033622|NCT04542317|453420936|FG001|Overall Study|Withdrawal by Subject|2|||
126033623|NCT04542317|453420935|FG000|Overall Study|Caregivers passed away|0|||
126033624|NCT04542317|453420936|FG001|Overall Study|Caregivers passed away|2|||
126033625|NCT04700163|453420937|FG000|Overall Study|Lost to Follow-up|0|||
126033626|NCT04700163|453420938|FG001|Overall Study|Lost to Follow-up|0|||
126033627|NCT04700163|453420939|FG002|Overall Study|Lost to Follow-up|0|||
126033628|NCT04700163|453420940|FG003|Overall Study|Lost to Follow-up|0|||
126033629|NCT04700163|453420941|FG004|Overall Study|Lost to Follow-up|0|||
126033630|NCT04700163|453420942|FG005|Overall Study|Lost to Follow-up|1|||
126033631|NCT03976362|453420945|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
126033632|NCT03976362|453420946|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
126033633|NCT03976362|453420947|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
126033634|NCT03976362|453420945|FG000|Induction Phase|Death|62|||
126033635|NCT03976362|453420946|FG001|Induction Phase|Death|0|||
126033636|NCT03976362|453420947|FG002|Induction Phase|Death|0|||
126033637|NCT03976362|453420945|FG000|Maintenance Phase|Participants Ongoing|0|||
126033638|NCT03976362|453420946|FG001|Maintenance Phase|Participants Ongoing|106|||
126033639|NCT03976362|453420947|FG002|Maintenance Phase|Participants Ongoing|103|||
126033640|NCT03976362|453420945|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126033641|NCT03976362|453420946|FG001|Maintenance Phase|Withdrawal by Subject|4|||
126033642|NCT03976362|453420947|FG002|Maintenance Phase|Withdrawal by Subject|4|||
126033643|NCT03976362|453420945|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
126033644|NCT03976362|453420946|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
126033645|NCT03976362|453420947|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
126033646|NCT03976362|453420945|FG000|Maintenance Phase|Death|0|||
126033647|NCT03976362|453420946|FG001|Maintenance Phase|Death|186|||
126033648|NCT03976362|453420947|FG002|Maintenance Phase|Death|187|||
126033649|NCT00613106|453420948|FG000|Overall Study|Adverse Event|3|||
126033650|NCT00613106|453420949|FG001|Overall Study|Adverse Event|1|||
126033651|NCT00613106|453420948|FG000|Overall Study|Withdrawal by Subject|6|||
126033652|NCT00613106|453420949|FG001|Overall Study|Withdrawal by Subject|3|||
126033653|NCT00613106|453420948|FG000|Overall Study|Lost to Follow-up|7|||
126033654|NCT00613106|453420949|FG001|Overall Study|Lost to Follow-up|2|||
126033655|NCT00613106|453420948|FG000|Overall Study|misc|4|||
126033656|NCT00613106|453420949|FG001|Overall Study|misc|3|||
126033657|NCT05126433|453420954|FG000|Overall Study|Withdrawal by Subject|3|||
126033658|NCT05126433|453420955|FG001|Overall Study|Withdrawal by Subject|0|||
126033659|NCT05126433|453420956|FG002|Overall Study|Withdrawal by Subject|4|||
126033660|NCT05126433|453420954|FG000|Overall Study|Death|9|||
126033661|NCT05126433|453420955|FG001|Overall Study|Death|3|||
126033662|NCT05126433|453420956|FG002|Overall Study|Death|5|||
126033663|NCT05126433|453420954|FG000|Overall Study|Study Terminated by sponsor|0|||
126033664|NCT05126433|453420955|FG001|Overall Study|Study Terminated by sponsor|1|||
126033665|NCT05126433|453420956|FG002|Overall Study|Study Terminated by sponsor|2|||
126033666|NCT05126433|453420954|FG000|Overall Study|Progressive Disease|1|||
126033667|NCT05126433|453420955|FG001|Overall Study|Progressive Disease|4|||
126033668|NCT05126433|453420956|FG002|Overall Study|Progressive Disease|3|||
126033669|NCT05126433|453420954|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
126033670|NCT05126433|453420955|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
126033671|NCT05126433|453420956|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
126033672|NCT04492722|453420962|FG000|Overall Study|Adverse Event|7|||
126033673|NCT04492722|453420963|FG001|Overall Study|Adverse Event|2|||
126033674|NCT04492722|453420964|FG002|Overall Study|Adverse Event|3|||
126033675|NCT04492722|453420965|FG003|Overall Study|Adverse Event|0|||
126033676|NCT04492722|453420962|FG000|Overall Study|Death|0|||
126033677|NCT04492722|453420963|FG001|Overall Study|Death|0|||
126096821|NCT03381339|453646573|FG000|Overall Study|Lost to Follow-up|0|||
126033678|NCT04492722|453420964|FG002|Overall Study|Death|0|||
126033679|NCT04492722|453420965|FG003|Overall Study|Death|1|||
126033680|NCT04492722|453420962|FG000|Overall Study|Lost to Follow-up|0|||
126033681|NCT04492722|453420963|FG001|Overall Study|Lost to Follow-up|1|||
126033682|NCT04492722|453420964|FG002|Overall Study|Lost to Follow-up|0|||
126033683|NCT04492722|453420965|FG003|Overall Study|Lost to Follow-up|1|||
126033684|NCT04492722|453420962|FG000|Overall Study|Physician Decision|0|||
126033685|NCT04492722|453420963|FG001|Overall Study|Physician Decision|3|||
126033686|NCT04492722|453420964|FG002|Overall Study|Physician Decision|1|||
126033687|NCT04492722|453420965|FG003|Overall Study|Physician Decision|1|||
126033688|NCT04492722|453420962|FG000|Overall Study|Withdrawal by Subject|6|||
126033689|NCT04492722|453420963|FG001|Overall Study|Withdrawal by Subject|6|||
126033690|NCT04492722|453420964|FG002|Overall Study|Withdrawal by Subject|0|||
126033691|NCT04492722|453420965|FG003|Overall Study|Withdrawal by Subject|3|||
126033692|NCT04492722|453420962|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
126033693|NCT04492722|453420963|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
126033694|NCT04492722|453420964|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
126033695|NCT04492722|453420965|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
126033696|NCT04492722|453420962|FG000|Overall Study|Due to Covid-19 pandemic|7|||
126033697|NCT04492722|453420963|FG001|Overall Study|Due to Covid-19 pandemic|3|||
126033698|NCT04492722|453420964|FG002|Overall Study|Due to Covid-19 pandemic|7|||
126033699|NCT04492722|453420965|FG003|Overall Study|Due to Covid-19 pandemic|6|||
126033700|NCT04492722|453420962|FG000|Overall Study|Failure to meet randomisation criteria|2|||
126033701|NCT04492722|453420963|FG001|Overall Study|Failure to meet randomisation criteria|3|||
126033702|NCT04492722|453420964|FG002|Overall Study|Failure to meet randomisation criteria|4|||
126033703|NCT04492722|453420965|FG003|Overall Study|Failure to meet randomisation criteria|2|||
126033704|NCT04492722|453420962|FG000|Overall Study|Early termination from the study|54|||
126033705|NCT04492722|453420963|FG001|Overall Study|Early termination from the study|51|||
126033706|NCT04492722|453420964|FG002|Overall Study|Early termination from the study|50|||
126033707|NCT04492722|453420965|FG003|Overall Study|Early termination from the study|50|||
126033708|NCT04492722|453420962|FG000|Overall Study|Missing|3|||
126033709|NCT04492722|453420963|FG001|Overall Study|Missing|0|||
126033710|NCT04492722|453420964|FG002|Overall Study|Missing|0|||
126033711|NCT04492722|453420965|FG003|Overall Study|Missing|5|||
126033712|NCT04492722|453420962|FG000|Overall Study|Participants who did not receive treatment|0|||
126033713|NCT04492722|453420963|FG001|Overall Study|Participants who did not receive treatment|1|||
126033714|NCT04492722|453420964|FG002|Overall Study|Participants who did not receive treatment|4|||
126033715|NCT04492722|453420965|FG003|Overall Study|Participants who did not receive treatment|0|||
126033716|NCT05590403|453423027|FG000|Overall Study|Lost to Follow-up|13|||
126033717|NCT05590403|453423028|FG001|Overall Study|Lost to Follow-up|1|||
126033718|NCT05590403|453423029|FG002|Overall Study|Lost to Follow-up|7|||
126033719|NCT05590403|453423030|FG003|Overall Study|Lost to Follow-up|3|||
126033720|NCT05590403|453423031|FG004|Overall Study|Lost to Follow-up|4|||
126033721|NCT05590403|453423027|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
126033722|NCT05590403|453423028|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
126033723|NCT05590403|453423029|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
126033724|NCT05590403|453423030|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
126033725|NCT05590403|453423031|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
126033726|NCT05590403|453423027|FG000|Overall Study|Other|2|||
126033727|NCT05590403|453423028|FG001|Overall Study|Other|0|||
126033728|NCT05590403|453423029|FG002|Overall Study|Other|2|||
126033729|NCT05590403|453423030|FG003|Overall Study|Other|2|||
126033730|NCT05590403|453423031|FG004|Overall Study|Other|0|||
126033731|NCT05590403|453423027|FG000|Overall Study|Migrated / moved from the study area|1|||
126033732|NCT05590403|453423028|FG001|Overall Study|Migrated / moved from the study area|1|||
126033733|NCT05590403|453423029|FG002|Overall Study|Migrated / moved from the study area|0|||
126033734|NCT05590403|453423030|FG003|Overall Study|Migrated / moved from the study area|3|||
126033735|NCT05590403|453423031|FG004|Overall Study|Migrated / moved from the study area|1|||
126033736|NCT05590403|453423027|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
126033737|NCT05590403|453423028|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
126033738|NCT05590403|453423029|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
126033739|NCT05590403|453423030|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
126033740|NCT05590403|453423031|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
126033741|NCT04856163|453423032|FG000|Overall Study|Lost to Follow-up|97|||
126096822|NCT03381339|453646574|FG001|Overall Study|Lost to Follow-up|1|||
126033742|NCT04856163|453423033|FG001|Overall Study|Lost to Follow-up|100|||
126033743|NCT02737436|453423037|FG000|Washout Period|Lost to Follow-up|5|||
126033744|NCT02737436|453423038|FG001|Washout Period|Lost to Follow-up|11|||
126033745|NCT02737436|453423037|FG000|Data Analysis|Scanning data problems|5|||
126033746|NCT02737436|453423038|FG001|Data Analysis|Scanning data problems|8|||
126033747|NCT02105766|453423039|FG000|Overall Study|Physician Decision|1|||
126033748|NCT02105766|453423040|FG001|Overall Study|Physician Decision|1|||
126033749|NCT02105766|453423041|FG002|Overall Study|Physician Decision|0|||
126033750|NCT02105766|453423039|FG000|Overall Study|Lost to Follow-up|2|||
126033751|NCT02105766|453423040|FG001|Overall Study|Lost to Follow-up|0|||
126033752|NCT02105766|453423041|FG002|Overall Study|Lost to Follow-up|0|||
126033753|NCT02105766|453423039|FG000|Overall Study|Death|1|||
126033754|NCT02105766|453423040|FG001|Overall Study|Death|1|||
126033755|NCT02105766|453423041|FG002|Overall Study|Death|0|||
126033756|NCT03701399|453423042|FG000|Overall Study|Adverse Event|3|||
126033757|NCT03701399|453423043|FG001|Overall Study|Adverse Event|5|||
126033758|NCT03701399|453423042|FG000|Overall Study|Withdrawal by Subject|6|||
126033759|NCT03701399|453423043|FG001|Overall Study|Withdrawal by Subject|3|||
126033760|NCT03701399|453423042|FG000|Overall Study|Investigators decision|1|||
126033761|NCT03701399|453423043|FG001|Overall Study|Investigators decision|2|||
126033762|NCT03701399|453423042|FG000|Overall Study|Lost to Follow-up|1|||
126033763|NCT03701399|453423043|FG001|Overall Study|Lost to Follow-up|2|||
126033764|NCT03701399|453423042|FG000|Overall Study|Death|1|||
126033765|NCT03701399|453423043|FG001|Overall Study|Death|1|||
126033766|NCT03701399|453423042|FG000|Overall Study|Randomized but not treated|1|||
126033767|NCT03701399|453423043|FG001|Overall Study|Randomized but not treated|0|||
126033768|NCT00554788|453423044|FG000|Overall Study|Adverse Event|0|||
126033769|NCT00554788|453423045|FG001|Overall Study|Adverse Event|1|||
126033770|NCT00554788|453423046|FG002|Overall Study|Adverse Event|2|||
126033771|NCT00554788|453423044|FG000|Overall Study|Lost to Follow-up|4|||
126033772|NCT00554788|453423045|FG001|Overall Study|Lost to Follow-up|3|||
126033773|NCT00554788|453423046|FG002|Overall Study|Lost to Follow-up|3|||
126033774|NCT00554788|453423044|FG000|Overall Study|Physician Decision|1|||
126033775|NCT00554788|453423045|FG001|Overall Study|Physician Decision|1|||
126033776|NCT00554788|453423046|FG002|Overall Study|Physician Decision|3|||
126033777|NCT00554788|453423044|FG000|Overall Study|Withdrawal by Subject|0|||
126033778|NCT00554788|453423045|FG001|Overall Study|Withdrawal by Subject|0|||
126033779|NCT00554788|453423046|FG002|Overall Study|Withdrawal by Subject|1|||
126033780|NCT00554788|453423044|FG000|Overall Study|Refusal of further protocol therapy|0|||
126033781|NCT00554788|453423045|FG001|Overall Study|Refusal of further protocol therapy|1|||
126033782|NCT00554788|453423046|FG002|Overall Study|Refusal of further protocol therapy|1|||
126033783|NCT00554788|453423044|FG000|Overall Study|Progressive disease|0|||
126033784|NCT00554788|453423045|FG001|Overall Study|Progressive disease|0|||
126033785|NCT00554788|453423046|FG002|Overall Study|Progressive disease|3|||
126033786|NCT00554788|453423044|FG000|Overall Study|Ineligible|2|||
126033787|NCT00554788|453423045|FG001|Overall Study|Ineligible|0|||
126033788|NCT00554788|453423046|FG002|Overall Study|Ineligible|1|||
126033789|NCT03897465|453423048|FG000|Overall Study|Lost to Follow-up|2|||
126033790|NCT03897465|453423049|FG001|Overall Study|Lost to Follow-up|1|||
126033791|NCT03897465|453423048|FG000|Overall Study|Adverse Event|2|||
126033792|NCT03897465|453423049|FG001|Overall Study|Adverse Event|0|||
126033793|NCT03897465|453423048|FG000|Overall Study|complete healing by V2|1|||
126033794|NCT03897465|453423049|FG001|Overall Study|complete healing by V2|0|||
126033795|NCT03897465|453423048|FG000|Overall Study|occurence of exclusion criterion|1|||
126033796|NCT03897465|453423049|FG001|Overall Study|occurence of exclusion criterion|1|||
126033797|NCT03897465|453423048|FG000|Overall Study|Other|1|||
126033798|NCT03897465|453423049|FG001|Overall Study|Other|0|||
126033799|NCT03134196|453423064|FG000|Overall Study|Death|2|||
126033800|NCT03134196|453423065|FG001|Overall Study|Death|1|||
126033801|NCT03134196|453423064|FG000|Overall Study|Lost to Follow-up|13|||
126033802|NCT03134196|453423065|FG001|Overall Study|Lost to Follow-up|15|||
126033803|NCT03134196|453423064|FG000|Overall Study|Physician Decision|0|||
126033804|NCT03134196|453423065|FG001|Overall Study|Physician Decision|1|||
126033805|NCT03134196|453423064|FG000|Overall Study|Withdrawal by Subject|19|||
126033806|NCT03134196|453423065|FG001|Overall Study|Withdrawal by Subject|12|||
126033807|NCT03134196|453423064|FG000|Overall Study|Site Unable to Contact Participant|2|||
126033808|NCT03134196|453423065|FG001|Overall Study|Site Unable to Contact Participant|0|||
126033809|NCT03134196|453423064|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
126033810|NCT03134196|453423065|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
126033811|NCT03134196|453423064|FG000|Overall Study|Scheduling Conflict|1|||
126033812|NCT03134196|453423065|FG001|Overall Study|Scheduling Conflict|0|||
126033813|NCT06516705|453423070|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
126033814|NCT06516705|453423071|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
126033815|NCT06516705|453423070|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
126033816|NCT06516705|453423071|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
126033817|NCT06516705|453423070|FG000|T3 ( 3 Month After Education)|covid-19|1|||
126033818|NCT06516705|453423071|FG001|T3 ( 3 Month After Education)|covid-19|2|||
126033819|NCT06516705|453423070|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
126033820|NCT06516705|453423071|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
126096823|NCT04927247|453646577|FG000|Overall Study|Other|2|||
126096824|NCT04927247|453646578|FG001|Overall Study|Other|1|||
126033821|NCT06516705|453423070|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
126033822|NCT06516705|453423071|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
126033823|NCT06516705|453423070|FG000|T4 ( 6 Month After Education)|covid-19|3|||
126033824|NCT06516705|453423071|FG001|T4 ( 6 Month After Education)|covid-19|2|||
126033825|NCT06516705|453423070|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
126033826|NCT06516705|453423071|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
126033827|NCT04292223|453423072|FG000|Overall Study|Adverse Event|1|||
126033828|NCT04292223|453423072|FG000|Overall Study|Lost to Follow-up|1|||
126033829|NCT04292223|453423072|FG000|Overall Study|Noncompliance with study drug|2|||
126033830|NCT04292223|453423072|FG000|Overall Study|Patient moved out of the state|1|||
126033831|NCT04719390|453423073|FG000|Overall Study|Withdrawal by Subject|1|||
126033832|NCT00753545|453423074|FG000|Overall Study|Death|98|||
126033833|NCT00753545|453423075|FG001|Overall Study|Death|112|||
126033834|NCT00753545|453423074|FG000|Overall Study|Lost to Follow-up|2|||
126033835|NCT00753545|453423075|FG001|Overall Study|Lost to Follow-up|3|||
126033836|NCT00753545|453423074|FG000|Overall Study|Protocol Violation|1|||
126033837|NCT00753545|453423075|FG001|Overall Study|Protocol Violation|0|||
126033838|NCT00753545|453423074|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
126033839|NCT00753545|453423075|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
126033840|NCT06190691|453423076|FG000|Overall Study|Adverse Event|2|||
126033841|NCT06190691|453423077|FG001|Overall Study|Adverse Event|0|||
126033842|NCT06190691|453423078|FG002|Overall Study|Adverse Event|0|||
126033843|NCT06190691|453423079|FG003|Overall Study|Adverse Event|0|||
126033844|NCT05746455|453423080|FG000|Overall Study|Discharged from Clinical Service|1|||
126033845|NCT05746455|453423080|FG000|Overall Study|Lost to Follow-up|1|||
126033846|NCT03016754|453423084|FG000|Overall Study|Death|5|||
126033847|NCT03016754|453423085|FG001|Overall Study|Death|4|||
126033848|NCT03016754|453423086|FG002|Overall Study|Death|5|||
126033849|NCT03016754|453423087|FG003|Overall Study|Death|1|||
126033850|NCT03016754|453423084|FG000|Overall Study|Lost to Follow-up|23|||
126033851|NCT03016754|453423085|FG001|Overall Study|Lost to Follow-up|17|||
126033852|NCT03016754|453423086|FG002|Overall Study|Lost to Follow-up|4|||
126033853|NCT03016754|453423087|FG003|Overall Study|Lost to Follow-up|2|||
126033854|NCT03016754|453423084|FG000|Overall Study|Withdrawal by Subject|6|||
126033855|NCT03016754|453423085|FG001|Overall Study|Withdrawal by Subject|6|||
126033856|NCT03016754|453423086|FG002|Overall Study|Withdrawal by Subject|2|||
126033857|NCT03016754|453423087|FG003|Overall Study|Withdrawal by Subject|2|||
126033858|NCT03016754|453423084|FG000|Overall Study|Other/Unknown|2|||
126033859|NCT03016754|453423085|FG001|Overall Study|Other/Unknown|4|||
126033860|NCT03016754|453423086|FG002|Overall Study|Other/Unknown|2|||
126033861|NCT03016754|453423087|FG003|Overall Study|Other/Unknown|1|||
126033862|NCT03016754|453423084|FG000|Overall Study|Protocol Violation|0|||
126033863|NCT03016754|453423085|FG001|Overall Study|Protocol Violation|0|||
126033864|NCT03016754|453423086|FG002|Overall Study|Protocol Violation|0|||
126033865|NCT03016754|453423087|FG003|Overall Study|Protocol Violation|4|||
126033866|NCT03839940|453423088|FG000|Overall Study|Withdrawal by Subject|3|||
126033867|NCT03839940|453423089|FG001|Overall Study|Withdrawal by Subject|0|||
126033868|NCT03839940|453423088|FG000|Overall Study|Protocol Violation|0|||
126033869|NCT03839940|453423089|FG001|Overall Study|Protocol Violation|1|||
126033870|NCT03839940|453423088|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
126033871|NCT03839940|453423089|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
126033872|NCT03241745|453423090|FG000|Overall Study|Adverse Event|7|||
126033873|NCT03241745|453423090|FG000|Overall Study|Death|1|||
126033874|NCT03241745|453423090|FG000|Overall Study|Withdrawal by Subject|5|||
126033875|NCT03241745|453423090|FG000|Overall Study|Treatment delay >28 days|2|||
126033876|NCT03241745|453423090|FG000|Overall Study|Lack of Efficacy|14|||
126033877|NCT03023410|453423091|FG000|Overall Study|study termination|0|||
126033878|NCT03023410|453423092|FG001|Overall Study|study termination|1|||
125880420|NCT01337960|452860339|FG001|Overall Study|Withdrawal by Subject|0|||
125880421|NCT01337960|452860340|FG002|Overall Study|Withdrawal by Subject|0|||
125880422|NCT01747876|452860342|FG000|Overall Study|Adverse Event|1|||
125880423|NCT01747876|452860343|FG001|Overall Study|Adverse Event|0|||
125880424|NCT01747876|452860344|FG002|Overall Study|Adverse Event|2|||
125880425|NCT01747876|452860342|FG000|Overall Study|Withdrawal by Subject|0|||
125880426|NCT01747876|452860343|FG001|Overall Study|Withdrawal by Subject|1|||
125880427|NCT01747876|452860344|FG002|Overall Study|Withdrawal by Subject|1|||
125880428|NCT01747876|452860342|FG000|Overall Study|Disease progression|4|||
125880429|NCT01747876|452860343|FG001|Overall Study|Disease progression|13|||
126033879|NCT04799899|453423094|FG000|Overall Study|Lost to Follow-up|2|||
126033880|NCT04799899|453423095|FG001|Overall Study|Lost to Follow-up|4|||
126033881|NCT00470704|453423096|FG000|Overall Study|Withdrawal by Subject|4|||
126033882|NCT00470704|453423097|FG001|Overall Study|Withdrawal by Subject|3|||
126033883|NCT00470704|453423096|FG000|Overall Study|Relapse/Progression|37|||
126033884|NCT00470704|453423097|FG001|Overall Study|Relapse/Progression|42|||
126033885|NCT00470704|453423096|FG000|Overall Study|toxicity|0|||
126033886|NCT00470704|453423097|FG001|Overall Study|toxicity|1|||
126033887|NCT04019873|453423098|FG000|Overall Study|Discontinued from the treatment|1|||
126033888|NCT04019873|453423099|FG001|Overall Study|Discontinued from the treatment|39|||
126033889|NCT04019873|453423100|FG002|Overall Study|Discontinued from the treatment|2|||
126033890|NCT04091750|453423110|FG000|Overall Study|Adverse Event|4|||
126033891|NCT04091750|453423110|FG000|Overall Study|Withdrawal by Subject|1|||
126033892|NCT02919306|453423111|FG000|Overall Study|Withdrawal by Subject|1|||
126033893|NCT02919306|453423112|FG001|Overall Study|Withdrawal by Subject|0|||
126033894|NCT02919306|453423111|FG000|Overall Study|Protocol Violation|1|||
126033895|NCT02919306|453423112|FG001|Overall Study|Protocol Violation|0|||
126033896|NCT04473222|453423113|FG000|Overall Study|Lost to Follow-up|13|||
126033897|NCT04473222|453423114|FG001|Overall Study|Lost to Follow-up|13|||
126033898|NCT04473222|453423113|FG000|Overall Study|Withdrawal by Subject|0|||
126033899|NCT04473222|453423114|FG001|Overall Study|Withdrawal by Subject|1|||
126033900|NCT04473222|453423113|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
126033901|NCT04473222|453423114|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
126033902|NCT04293055|453423115|FG000|Overall Study|Lost to Follow-up|1|||
126033903|NCT04293055|453423116|FG001|Overall Study|Lost to Follow-up|1|||
126033904|NCT04293055|453423115|FG000|Overall Study|Did not trigger randomization|6|||
126033905|NCT04293055|453423116|FG001|Overall Study|Did not trigger randomization|5|||
126033906|NCT04195698|453423125|FG000|Overall Study|Adverse Event|4|||
126033907|NCT04195698|453423126|FG001|Overall Study|Adverse Event|11|||
126033908|NCT04195698|453423125|FG000|Overall Study|Withdrawal by Subject|9|||
126033909|NCT04195698|453423126|FG001|Overall Study|Withdrawal by Subject|10|||
126033910|NCT04195698|453423125|FG000|Overall Study|Lost to Follow-up|5|||
126033911|NCT04195698|453423126|FG001|Overall Study|Lost to Follow-up|4|||
126033912|NCT04195698|453423125|FG000|Overall Study|Lack of Efficacy|2|||
126033913|NCT04195698|453423126|FG001|Overall Study|Lack of Efficacy|10|||
126033914|NCT04195698|453423125|FG000|Overall Study|Other|5|||
126033915|NCT04195698|453423126|FG001|Overall Study|Other|4|||
126033916|NCT05459688|453423127|FG000|Overall Study|Lost to Follow-up|6|||
126033917|NCT05459688|453423127|FG000|Overall Study|Physician Decision|1|||
126033918|NCT05459688|453423127|FG000|Overall Study|Withdrawal by Subject|19|||
126033919|NCT05459688|453423127|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
126033920|NCT04908722|453423128|FG000|Overall Study|Protocol deviation|1|||
126033921|NCT04908722|453423129|FG001|Overall Study|Protocol deviation|0|||
126033922|NCT04908722|453423130|FG002|Overall Study|Protocol deviation|0|||
126033923|NCT04908722|453423131|FG003|Overall Study|Protocol deviation|0|||
126033924|NCT04908722|453423132|FG004|Overall Study|Protocol deviation|0|||
126033925|NCT04908722|453423133|FG005|Overall Study|Protocol deviation|1|||
126033926|NCT04908722|453423128|FG000|Overall Study|Lost to Follow-up|33|||
126033927|NCT04908722|453423129|FG001|Overall Study|Lost to Follow-up|33|||
125880430|NCT01747876|452860344|FG002|Overall Study|Disease progression|8|||
125880431|NCT01747876|452860342|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
126033928|NCT04908722|453423130|FG002|Overall Study|Lost to Follow-up|36|||
126033929|NCT04908722|453423131|FG003|Overall Study|Lost to Follow-up|30|||
126096825|NCT04927247|453646577|FG000|Overall Study|Physician Decision|0|||
126033930|NCT04908722|453423132|FG004|Overall Study|Lost to Follow-up|32|||
126033931|NCT04908722|453423133|FG005|Overall Study|Lost to Follow-up|34|||
126033932|NCT04908722|453423128|FG000|Overall Study|Physician Decision|1|||
126033933|NCT04908722|453423129|FG001|Overall Study|Physician Decision|1|||
126033934|NCT04908722|453423130|FG002|Overall Study|Physician Decision|1|||
126033935|NCT04908722|453423131|FG003|Overall Study|Physician Decision|2|||
126033936|NCT04908722|453423132|FG004|Overall Study|Physician Decision|0|||
126033937|NCT04908722|453423133|FG005|Overall Study|Physician Decision|0|||
126033938|NCT04908722|453423128|FG000|Overall Study|Death|1|||
126033939|NCT04908722|453423129|FG001|Overall Study|Death|0|||
126033940|NCT04908722|453423130|FG002|Overall Study|Death|0|||
126033941|NCT04908722|453423131|FG003|Overall Study|Death|0|||
126033942|NCT04908722|453423132|FG004|Overall Study|Death|0|||
126033943|NCT04908722|453423133|FG005|Overall Study|Death|1|||
126033944|NCT04908722|453423128|FG000|Overall Study|Withdrawal by Subject|12|||
126033945|NCT04908722|453423129|FG001|Overall Study|Withdrawal by Subject|8|||
126033946|NCT04908722|453423130|FG002|Overall Study|Withdrawal by Subject|7|||
126033947|NCT04908722|453423131|FG003|Overall Study|Withdrawal by Subject|6|||
126033948|NCT04908722|453423132|FG004|Overall Study|Withdrawal by Subject|12|||
126033949|NCT04908722|453423133|FG005|Overall Study|Withdrawal by Subject|14|||
126033950|NCT04908722|453423128|FG000|Overall Study|Other|3|||
126033951|NCT04908722|453423129|FG001|Overall Study|Other|1|||
126033952|NCT04908722|453423130|FG002|Overall Study|Other|3|||
126033953|NCT04908722|453423131|FG003|Overall Study|Other|2|||
126033954|NCT04908722|453423132|FG004|Overall Study|Other|4|||
126033955|NCT04908722|453423133|FG005|Overall Study|Other|1|||
126033956|NCT04908722|453423128|FG000|Overall Study|Initiated prohibited medication|0|||
126033957|NCT04908722|453423129|FG001|Overall Study|Initiated prohibited medication|0|||
126033958|NCT04908722|453423130|FG002|Overall Study|Initiated prohibited medication|0|||
126033959|NCT04908722|453423131|FG003|Overall Study|Initiated prohibited medication|1|||
126033960|NCT04908722|453423132|FG004|Overall Study|Initiated prohibited medication|0|||
126033961|NCT04908722|453423133|FG005|Overall Study|Initiated prohibited medication|1|||
126033962|NCT04908722|453423128|FG000|Overall Study|Randomized but not vaccinated|3|||
126033963|NCT04908722|453423129|FG001|Overall Study|Randomized but not vaccinated|1|||
126033964|NCT04908722|453423130|FG002|Overall Study|Randomized but not vaccinated|2|||
126033965|NCT04908722|453423131|FG003|Overall Study|Randomized but not vaccinated|2|||
126033966|NCT04908722|453423132|FG004|Overall Study|Randomized but not vaccinated|3|||
126033967|NCT04908722|453423133|FG005|Overall Study|Randomized but not vaccinated|4|||
126033968|NCT02319759|453423134|FG000|Week 0 - 16|Lack of Efficacy|1|||
126033969|NCT02319759|453423135|FG001|Week 0 - 16|Lack of Efficacy|0|||
126033970|NCT02319759|453423136|FG002|Week 0 - 16|Lack of Efficacy|0|||
126033971|NCT02319759|453423137|FG003|Week 0 - 16|Lack of Efficacy|0|||
126033972|NCT02319759|453423138|FG004|Week 0 - 16|Lack of Efficacy|0|||
126033973|NCT02319759|453423134|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
126033974|NCT02319759|453423135|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
126033975|NCT02319759|453423136|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
126033976|NCT02319759|453423137|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
126033977|NCT02319759|453423138|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
126033978|NCT02319759|453423134|FG000|Week 16 - 24|Lack of Efficacy|1|||
126033979|NCT02319759|453423135|FG001|Week 16 - 24|Lack of Efficacy|0|||
126033980|NCT02319759|453423136|FG002|Week 16 - 24|Lack of Efficacy|1|||
126033981|NCT02319759|453423137|FG003|Week 16 - 24|Lack of Efficacy|0|||
126033982|NCT02319759|453423138|FG004|Week 16 - 24|Lack of Efficacy|0|||
126033983|NCT02319759|453423134|FG000|Week 16 - 24|Lost to Follow-up|1|||
126033984|NCT02319759|453423135|FG001|Week 16 - 24|Lost to Follow-up|0|||
126033985|NCT02319759|453423136|FG002|Week 16 - 24|Lost to Follow-up|0|||
126033986|NCT02319759|453423137|FG003|Week 16 - 24|Lost to Follow-up|0|||
126033987|NCT02319759|453423138|FG004|Week 16 - 24|Lost to Follow-up|0|||
126033988|NCT02319759|453423134|FG000|Week 16 - 24|Withdrawal by Subject|0|||
126033989|NCT02319759|453423135|FG001|Week 16 - 24|Withdrawal by Subject|0|||
126033990|NCT02319759|453423136|FG002|Week 16 - 24|Withdrawal by Subject|2|||
126033991|NCT02319759|453423137|FG003|Week 16 - 24|Withdrawal by Subject|0|||
126033992|NCT02319759|453423138|FG004|Week 16 - 24|Withdrawal by Subject|0|||
126033993|NCT02319759|453423134|FG000|Week 24 - 56|Adverse Event|0|||
126033994|NCT02319759|453423135|FG001|Week 24 - 56|Adverse Event|0|||
126033995|NCT02319759|453423136|FG002|Week 24 - 56|Adverse Event|2|||
126033996|NCT02319759|453423137|FG003|Week 24 - 56|Adverse Event|0|||
126033997|NCT02319759|453423138|FG004|Week 24 - 56|Adverse Event|0|||
126033998|NCT02319759|453423134|FG000|Week 24 - 56|Lack of Efficacy|0|||
126033999|NCT02319759|453423135|FG001|Week 24 - 56|Lack of Efficacy|0|||
126034000|NCT02319759|453423136|FG002|Week 24 - 56|Lack of Efficacy|0|||
126034001|NCT02319759|453423137|FG003|Week 24 - 56|Lack of Efficacy|2|||
126034002|NCT02319759|453423138|FG004|Week 24 - 56|Lack of Efficacy|1|||
125880432|NCT01747876|452860343|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
125880433|NCT01747876|452860344|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
125880434|NCT02379728|452860347|FG000|Overall Study|Lost to Follow-up|1|||
125880435|NCT02379728|452860348|FG001|Overall Study|Lost to Follow-up|0|||
125880436|NCT02379728|452860349|FG002|Overall Study|Lost to Follow-up|3|||
125880437|NCT02379728|452860350|FG003|Overall Study|Lost to Follow-up|0|||
125880438|NCT02379728|452860347|FG000|Overall Study|Withdrawal by Subject|5|||
125880439|NCT02379728|452860348|FG001|Overall Study|Withdrawal by Subject|0|||
125880440|NCT02379728|452860349|FG002|Overall Study|Withdrawal by Subject|5|||
125880441|NCT02379728|452860350|FG003|Overall Study|Withdrawal by Subject|3|||
125880442|NCT02379728|452860347|FG000|Overall Study|Protocol Violation|0|||
125880443|NCT02379728|452860348|FG001|Overall Study|Protocol Violation|0|||
125880444|NCT02379728|452860349|FG002|Overall Study|Protocol Violation|2|||
125880445|NCT02379728|452860350|FG003|Overall Study|Protocol Violation|0|||
125880446|NCT00914316|452860353|FG000|Phase 1|Physician Decision|4|||
125880447|NCT00914316|452860354|FG001|Phase 1|Physician Decision|0|||
125880448|NCT00914316|452860355|FG002|Phase 1|Physician Decision|1|||
125880449|NCT00914316|452860356|FG003|Phase 1|Physician Decision|2|||
125880450|NCT00914316|452860353|FG000|Phase 1|Withdrawal by Subject|0|||
125880451|NCT00914316|452860354|FG001|Phase 1|Withdrawal by Subject|2|||
125880452|NCT00914316|452860355|FG002|Phase 1|Withdrawal by Subject|4|||
125880453|NCT00914316|452860356|FG003|Phase 1|Withdrawal by Subject|0|||
125880454|NCT00914316|452860353|FG000|Phase 1|Adverse Event|1|||
125880455|NCT00914316|452860354|FG001|Phase 1|Adverse Event|0|||
125880456|NCT00914316|452860355|FG002|Phase 1|Adverse Event|0|||
125880457|NCT00914316|452860356|FG003|Phase 1|Adverse Event|0|||
125880458|NCT00914316|452860353|FG000|Phase 2|Withdrawal by Subject|1|||
125880459|NCT00914316|452860354|FG001|Phase 2|Withdrawal by Subject|0|||
125880460|NCT00914316|452860355|FG002|Phase 2|Withdrawal by Subject|1|||
125880461|NCT00914316|452860356|FG003|Phase 2|Withdrawal by Subject|0|||
125880462|NCT05101122|452860358|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
125880463|NCT05101122|452860358|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
125880464|NCT05101122|452860358|FG000|AD313 80/5|Withdrawal by Subject|1|||
125880465|NCT05101122|452860358|FG000|AD313 80/10|Physician Decision|1|||
125880466|NCT03131219|452860360|FG000|Initial Evaluation Period|Adverse Event|2|||
125880467|NCT03131219|452860361|FG001|Initial Evaluation Period|Adverse Event|0|||
125880468|NCT03131219|452860360|FG000|Initial Evaluation Period|Protocol Violation|1|||
125880469|NCT03131219|452860361|FG001|Initial Evaluation Period|Protocol Violation|0|||
126034003|NCT02319759|453423134|FG000|Week 24 - 56|Withdrawal by Subject|0|||
126034004|NCT02319759|453423135|FG001|Week 24 - 56|Withdrawal by Subject|1|||
126034005|NCT02319759|453423136|FG002|Week 24 - 56|Withdrawal by Subject|0|||
126034006|NCT02319759|453423137|FG003|Week 24 - 56|Withdrawal by Subject|0|||
126034007|NCT02319759|453423138|FG004|Week 24 - 56|Withdrawal by Subject|0|||
126034008|NCT02319759|453423134|FG000|Week 24 - 56|Lost to Follow-up|0|||
125880470|NCT03131219|452860360|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
125880471|NCT03131219|452860361|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
126034009|NCT02319759|453423135|FG001|Week 24 - 56|Lost to Follow-up|0|||
126034010|NCT02319759|453423136|FG002|Week 24 - 56|Lost to Follow-up|0|||
125880472|NCT03131219|452860360|FG000|Initial Evaluation Period|Physician Decision|1|||
125880473|NCT03131219|452860361|FG001|Initial Evaluation Period|Physician Decision|0|||
125880474|NCT03131219|452860360|FG000|Extension Period|Physician Decision|1|||
125880475|NCT03131219|452860361|FG001|Extension Period|Physician Decision|0|||
125880476|NCT04945733|452860368|FG000|Overall Study|Physician Decision|1|||
126034011|NCT02319759|453423137|FG003|Week 24 - 56|Lost to Follow-up|0|||
126034012|NCT02319759|453423138|FG004|Week 24 - 56|Lost to Follow-up|1|||
126034013|NCT06424236|453423141|FG000|Overall Study|Adverse Event|0|||
126034014|NCT06424236|453423142|FG001|Overall Study|Adverse Event|1|||
126034015|NCT06424236|453423143|FG002|Overall Study|Adverse Event|0|||
126034016|NCT06424236|453423141|FG000|Overall Study|Withdrawal by Subject|3|||
126034017|NCT06424236|453423142|FG001|Overall Study|Withdrawal by Subject|1|||
126034018|NCT06424236|453423143|FG002|Overall Study|Withdrawal by Subject|2|||
126034019|NCT06424236|453423141|FG000|Overall Study|Physician Decision|0|||
126034020|NCT06424236|453423142|FG001|Overall Study|Physician Decision|1|||
126034021|NCT06424236|453423143|FG002|Overall Study|Physician Decision|0|||
126034022|NCT06424236|453423141|FG000|Overall Study|Study Terminated by Sponsor|11|||
126034023|NCT06424236|453423142|FG001|Overall Study|Study Terminated by Sponsor|20|||
126034024|NCT06424236|453423143|FG002|Overall Study|Study Terminated by Sponsor|16|||
126034025|NCT06424236|453423141|FG000|Overall Study|Lost to Follow-up|0|||
126034026|NCT06424236|453423142|FG001|Overall Study|Lost to Follow-up|1|||
126034027|NCT06424236|453423143|FG002|Overall Study|Lost to Follow-up|0|||
126034028|NCT06424236|453423141|FG000|Overall Study|Disease Progression|0|||
126034029|NCT06424236|453423142|FG001|Overall Study|Disease Progression|1|||
126034030|NCT06424236|453423143|FG002|Overall Study|Disease Progression|2|||
126034031|NCT06424236|453423141|FG000|Overall Study|Other|0|||
126034032|NCT06424236|453423142|FG001|Overall Study|Other|0|||
126034033|NCT06424236|453423143|FG002|Overall Study|Other|1|||
126034034|NCT03339713|453423145|FG000|Overall Study|Lost to Follow-up|2|||
126034035|NCT03339713|453423146|FG001|Overall Study|Lost to Follow-up|1|||
126034036|NCT03339713|453423145|FG000|Overall Study|Protocol Violation|1|||
126034037|NCT03339713|453423146|FG001|Overall Study|Protocol Violation|0|||
126034038|NCT03339713|453423145|FG000|Overall Study|Withdrawal by Subject|1|||
126034039|NCT03339713|453423146|FG001|Overall Study|Withdrawal by Subject|1|||
126034040|NCT01959425|453423147|FG000|Overall Study|Withdrawal by Subject|5|||
126034041|NCT01959425|453423148|FG001|Overall Study|Withdrawal by Subject|4|||
126034042|NCT01959425|453423147|FG000|Overall Study|Lost to Follow-up|1|||
126034043|NCT01959425|453423148|FG001|Overall Study|Lost to Follow-up|0|||
126034044|NCT01959425|453423147|FG000|Overall Study|Discontinued Subjects|6|||
126034045|NCT01959425|453423148|FG001|Overall Study|Discontinued Subjects|4|||
126034046|NCT01902173|453423149|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
126034047|NCT01902173|453423150|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126034048|NCT01902173|453423151|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126034049|NCT01902173|453423152|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126034050|NCT01902173|453423153|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126034051|NCT01902173|453423154|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126034052|NCT01902173|453423149|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
126034053|NCT01902173|453423150|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126034054|NCT01902173|453423151|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126034055|NCT01902173|453423152|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126034056|NCT01902173|453423153|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126034057|NCT01902173|453423154|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126034058|NCT01902173|453423149|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126034059|NCT01902173|453423150|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
126034060|NCT01902173|453423151|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126034061|NCT01902173|453423152|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126034062|NCT01902173|453423153|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126034063|NCT01902173|453423154|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126034064|NCT01902173|453423149|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126034065|NCT01902173|453423150|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
126034066|NCT01902173|453423151|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126034067|NCT01902173|453423152|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126034068|NCT01902173|453423153|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126034069|NCT01902173|453423154|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126034070|NCT01902173|453423149|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126034071|NCT01902173|453423150|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
126034072|NCT01902173|453423151|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126034073|NCT01902173|453423152|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126034074|NCT01902173|453423153|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126034075|NCT01902173|453423154|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126034076|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126034077|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126034078|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
126034079|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126034080|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126034081|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126034082|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126034083|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126034084|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
126034085|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126034086|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126034087|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126034088|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126034089|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126034090|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126034091|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
126034092|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126034093|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126034094|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126034095|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126034096|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126034097|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
126034098|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126034099|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126034100|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126034101|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126034102|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126034103|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126034104|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
126034105|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126034106|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126034107|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126034108|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126034109|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126034110|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
126034111|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126034112|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126034113|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126034114|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126034115|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126034116|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126034117|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
126034118|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126034119|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126034120|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126096826|NCT04927247|453646578|FG001|Overall Study|Physician Decision|1|||
126096827|NCT04927247|453646577|FG000|Overall Study|Adverse Event|1|||
126359998|NCT01524705|454610719|FG000|Overall Study|Adverse Event|2|||
126034121|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126034122|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126034123|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
126034124|NCT01902173|453423149|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126034125|NCT01902173|453423150|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126034126|NCT01902173|453423151|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126096828|NCT04927247|453646578|FG001|Overall Study|Adverse Event|0|||
126096829|NCT00591851|453646579|FG000|Overall Study|Withdrawal by Subject|3|||
126359999|NCT01524705|454610720|FG001|Overall Study|Adverse Event|0|||
126096830|NCT00591851|453646579|FG000|Overall Study|Adverse Event|2|||
126096831|NCT00591851|453646579|FG000|Overall Study|Progressive Disease|1|||
126096832|NCT00760474|453646580|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
126096833|NCT00760474|453646581|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
126096834|NCT00760474|453646580|FG000|Placebo Washout Period|Other|0|||
126096835|NCT00760474|453646581|FG001|Placebo Washout Period|Other|1|||
126096836|NCT00760474|453646580|FG000|Period 2 (P2)|Lost to Follow-up|1|||
126096837|NCT00760474|453646581|FG001|Period 2 (P2)|Lost to Follow-up|0|||
126096838|NCT00760474|453646580|FG000|Period 2 (P2)|Adverse Event|0|||
126096839|NCT00760474|453646581|FG001|Period 2 (P2)|Adverse Event|1|||
126096840|NCT04664400|453646582|FG000|Overall Study|Withdrawal by Subject|2|||
126096841|NCT00515853|453646583|FG000|Overall Study|Lost to Follow-up|9|||
126096842|NCT00515853|453646584|FG001|Overall Study|Lost to Follow-up|13|||
126096843|NCT00515853|453646583|FG000|Overall Study|Withdrawal by Subject|6|||
126096844|NCT00515853|453646584|FG001|Overall Study|Withdrawal by Subject|4|||
126096845|NCT01011153|453646589|FG000|Overall Study|Less than 78 cases completed|8|||
126096846|NCT01011153|453646590|FG001|Overall Study|Less than 78 cases completed|11|||
126096847|NCT01011153|453646591|FG002|Overall Study|Less than 78 cases completed|9|||
126096848|NCT02217501|453646595|FG000|Overall Study|Death|3|||
126096849|NCT02217501|453646596|FG001|Overall Study|Death|4|||
126096850|NCT02019667|453646597|FG000|First Intervention (6 Months)|Adverse Event|0|||
126096851|NCT02019667|453646598|FG001|First Intervention (6 Months)|Adverse Event|1|||
126096852|NCT02019667|453646597|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
126096853|NCT02019667|453646598|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
126096854|NCT02019667|453646597|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
126096855|NCT02019667|453646598|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
126096856|NCT03981861|453646602|FG000|Overall Study|Withdrawal by Subject|3|||
126096857|NCT00432666|453648234|FG000|Main Period|Adverse Event|1|||
126096858|NCT00432666|453648235|FG001|Main Period|Adverse Event|1|||
126096859|NCT00432666|453648234|FG000|Main Period|Consent Withdrawn|1|||
126096860|NCT00432666|453648235|FG001|Main Period|Consent Withdrawn|0|||
126096861|NCT00432666|453648234|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
126096862|NCT00432666|453648235|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
126096863|NCT00432666|453648234|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
126096864|NCT00432666|453648235|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
126096865|NCT00432666|453648234|FG000|Open-Label Extension Period|Adverse Event|5|||
126096866|NCT00432666|453648235|FG001|Open-Label Extension Period|Adverse Event|0|||
126096867|NCT00432666|453648234|FG000|Open-Label Extension Period|Consent withdrawn|10|||
126096868|NCT00432666|453648235|FG001|Open-Label Extension Period|Consent withdrawn|0|||
126096869|NCT00432666|453648234|FG000|Open-Label Extension Period|Physician Decision|3|||
126096870|NCT00432666|453648235|FG001|Open-Label Extension Period|Physician Decision|0|||
126096871|NCT00978627|453648236|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
126096872|NCT00978627|453648237|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
126096873|NCT00978627|453648236|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
126096874|NCT00978627|453648237|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
126096875|NCT00978627|453648236|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
126096876|NCT00978627|453648237|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
126096877|NCT00978627|453648236|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
126096878|NCT00978627|453648237|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
126096879|NCT00978627|453648236|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
126096880|NCT00978627|453648237|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
126096881|NCT00978627|453648236|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
126096882|NCT00978627|453648237|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
126096883|NCT00978627|453648236|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
126096884|NCT00978627|453648237|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
126096885|NCT00978627|453648236|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
126096886|NCT00978627|453648237|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
126096887|NCT00978627|453648236|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
126096888|NCT00978627|453648237|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
126096889|NCT02980731|453648240|FG000|Overall Study|Death|63|||
126096890|NCT02980731|453648240|FG000|Overall Study|Withdrawal by Subject|6|||
126096891|NCT02980731|453648240|FG000|Overall Study|Lost to Follow-up|5|||
126096892|NCT02980731|453648240|FG000|Overall Study|Study terminated by Sponsor|4|||
126096893|NCT02980731|453648240|FG000|Overall Study|Completed survival follow-up period|65|||
126096894|NCT02980731|453648240|FG000|Overall Study|COVID-19 infection|1|||
126096895|NCT02980731|453648240|FG000|Overall Study|Other, not specified|66|||
126096896|NCT02516332|453648241|FG000|Overall Study|Withdrawal by Subject|2|||
126096897|NCT02516332|453648242|FG001|Overall Study|Withdrawal by Subject|1|||
126360000|NCT01524705|454610719|FG000|Overall Study|Death|1|||
126360001|NCT01524705|454610720|FG001|Overall Study|Death|0|||
126360002|NCT01524705|454610719|FG000|Overall Study|Lost to Follow-up|0|||
126360003|NCT01524705|454610720|FG001|Overall Study|Lost to Follow-up|1|||
126096898|NCT02516332|453648243|FG002|Overall Study|Withdrawal by Subject|2|||
126096899|NCT03037931|453648244|FG000|Overall Study|Death|354|||
125880477|NCT04945733|452860369|FG001|Overall Study|Physician Decision|3|||
125880478|NCT04945733|452860370|FG002|Overall Study|Physician Decision|0|||
125880479|NCT04945733|452860368|FG000|Overall Study|Withdrawal by Subject|3|||
125880480|NCT04945733|452860369|FG001|Overall Study|Withdrawal by Subject|3|||
125880481|NCT04945733|452860370|FG002|Overall Study|Withdrawal by Subject|0|||
125880482|NCT05660577|452860373|FG000|Overall Study|Discontinued|9|||
125880483|NCT01709721|452860376|FG000|Open Label Phase|Withdrawal by Subject|0|||
125880484|NCT01709721|452860377|FG001|Open Label Phase|Withdrawal by Subject|0|||
126034127|NCT01902173|453423152|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126034128|NCT01902173|453423153|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126034129|NCT01902173|453423154|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
126034130|NCT02262728|453423156|FG000|Follow-up Phase (3 Years)|Death|0|||
126034131|NCT02262728|453423157|FG001|Follow-up Phase (3 Years)|Death|1|||
126034132|NCT02262728|453423156|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
126034133|NCT02262728|453423157|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
126034134|NCT02262728|453423156|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
126034135|NCT02262728|453423157|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
126034136|NCT04625283|453423158|FG000|Overall Study|post randomization exclusion|28|||
126034137|NCT04625283|453423159|FG001|Overall Study|post randomization exclusion|20|||
126034138|NCT02817776|453423160|FG000|Overall Study|Excluded|33|||
126034139|NCT02817776|453423160|FG000|Overall Study|Lost to Follow-up|20|||
126034140|NCT02817776|453423160|FG000|Overall Study|Withdrawal by Subject|33|||
126034141|NCT02817776|453423160|FG000|Overall Study|Death|2|||
126034142|NCT05540665|453423161|FG000|Overall Study|Study terminated by sponsor|6|||
126034143|NCT05540665|453423162|FG001|Overall Study|Study terminated by sponsor|6|||
126034144|NCT05540665|453423163|FG002|Overall Study|Study terminated by sponsor|7|||
126034145|NCT02619838|453423164|FG000|Overall Study|Lost to Follow-up|9|||
126034146|NCT02619838|453423164|FG000|Overall Study|Withdrawal by Subject|15|||
126034147|NCT04066244|453423167|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
126034148|NCT04066244|453423168|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
126034149|NCT04066244|453423169|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
126034150|NCT04066244|453423170|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
126034151|NCT04066244|453423171|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
126034152|NCT04066244|453423172|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
126034153|NCT04066244|453423167|FG000|Part 2 (Cohort 5)|Death|0|||
126034154|NCT04066244|453423168|FG001|Part 2 (Cohort 5)|Death|0|||
126034155|NCT04066244|453423169|FG002|Part 2 (Cohort 5)|Death|0|||
126034156|NCT04066244|453423170|FG003|Part 2 (Cohort 5)|Death|0|||
126034157|NCT04066244|453423171|FG004|Part 2 (Cohort 5)|Death|0|||
126034158|NCT04066244|453423172|FG005|Part 2 (Cohort 5)|Death|2|||
126034159|NCT04066244|453423167|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126034160|NCT04066244|453423168|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126034161|NCT04066244|453423169|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126034162|NCT04066244|453423170|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126034163|NCT04066244|453423171|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126034164|NCT04066244|453423172|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
126034165|NCT04066244|453423167|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126034166|NCT04066244|453423168|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126034167|NCT04066244|453423169|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126034168|NCT04066244|453423170|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126034169|NCT04066244|453423171|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
126034170|NCT04066244|453423172|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126034171|NCT01073566|453423173|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
126034172|NCT01073566|453423174|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
126360004|NCT01524705|454610719|FG000|Overall Study|Withdrawal by Subject|0|||
126034173|NCT05006872|453423178|FG000|Overall Study|Lost to Follow-up|37|||
126034174|NCT05006872|453423179|FG001|Overall Study|Lost to Follow-up|31|||
126034175|NCT02268253|453423183|FG000|Stage 1|Withdrawal by Subject|1|||
126034176|NCT02268253|453423184|FG001|Stage 1|Withdrawal by Subject|0|||
126034177|NCT02268253|453423185|FG002|Stage 1|Withdrawal by Subject|0|||
126034178|NCT02268253|453423186|FG003|Stage 1|Withdrawal by Subject|0|||
126034179|NCT02268253|453423187|FG004|Stage 1|Withdrawal by Subject|0|||
126034180|NCT02268253|453423188|FG005|Stage 1|Withdrawal by Subject|0|||
126034181|NCT02268253|453423189|FG006|Stage 1|Withdrawal by Subject|0|||
125880485|NCT01709721|452860378|FG002|Open Label Phase|Withdrawal by Subject|5|||
126034182|NCT02268253|453423183|FG000|Stage 1|Death|0|||
126034183|NCT02268253|453423184|FG001|Stage 1|Death|2|||
126034184|NCT02268253|453423185|FG002|Stage 1|Death|2|||
126034185|NCT02268253|453423186|FG003|Stage 1|Death|2|||
126034186|NCT02268253|453423187|FG004|Stage 1|Death|1|||
126034187|NCT02268253|453423188|FG005|Stage 1|Death|1|||
126034188|NCT02268253|453423189|FG006|Stage 1|Death|0|||
126034189|NCT02268253|453423183|FG000|Stage 2|Disease Recurrence/ Progression|0|||
126034190|NCT02268253|453423184|FG001|Stage 2|Disease Recurrence/ Progression|0|||
126034191|NCT02268253|453423185|FG002|Stage 2|Disease Recurrence/ Progression|1|||
126034192|NCT02268253|453423186|FG003|Stage 2|Disease Recurrence/ Progression|0|||
126360005|NCT01524705|454610720|FG001|Overall Study|Withdrawal by Subject|1|||
125880486|NCT01709721|452860376|FG000|Open Label Phase|Adverse Event|0|||
126034193|NCT02268253|453423187|FG004|Stage 2|Disease Recurrence/ Progression|0|||
125880487|NCT01709721|452860377|FG001|Open Label Phase|Adverse Event|0|||
125880488|NCT01709721|452860378|FG002|Open Label Phase|Adverse Event|8|||
125880489|NCT01709721|452860376|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
125880490|NCT01709721|452860377|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
125880491|NCT01709721|452860378|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
125880492|NCT01709721|452860376|FG000|Open Label Phase|Investigator Decision|0|||
125880493|NCT01709721|452860377|FG001|Open Label Phase|Investigator Decision|0|||
125880494|NCT01709721|452860378|FG002|Open Label Phase|Investigator Decision|1|||
125880495|NCT01709721|452860376|FG000|Open Label Phase|Sponsor Decision|0|||
125880496|NCT01709721|452860377|FG001|Open Label Phase|Sponsor Decision|0|||
125880497|NCT01709721|452860378|FG002|Open Label Phase|Sponsor Decision|2|||
125880498|NCT01709721|452860376|FG000|Open Label Phase|Protocol Violation|0|||
125880499|NCT01709721|452860377|FG001|Open Label Phase|Protocol Violation|0|||
125880500|NCT01709721|452860378|FG002|Open Label Phase|Protocol Violation|1|||
125880501|NCT01709721|452860376|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
125880502|NCT01709721|452860377|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
125880503|NCT01709721|452860378|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
125880504|NCT01709721|452860376|FG000|Open Label Phase|Inadequate Pain Control|0|||
125880505|NCT01709721|452860377|FG001|Open Label Phase|Inadequate Pain Control|0|||
125880506|NCT01709721|452860378|FG002|Open Label Phase|Inadequate Pain Control|37|||
126034194|NCT02268253|453423188|FG005|Stage 2|Disease Recurrence/ Progression|0|||
126034195|NCT02268253|453423189|FG006|Stage 2|Disease Recurrence/ Progression|0|||
126034196|NCT02268253|453423183|FG000|Stage 2|Withdrawal by Subject|0|||
126034197|NCT02268253|453423184|FG001|Stage 2|Withdrawal by Subject|0|||
126034198|NCT02268253|453423185|FG002|Stage 2|Withdrawal by Subject|2|||
126034199|NCT02268253|453423186|FG003|Stage 2|Withdrawal by Subject|0|||
126034200|NCT02268253|453423187|FG004|Stage 2|Withdrawal by Subject|0|||
126034201|NCT02268253|453423188|FG005|Stage 2|Withdrawal by Subject|2|||
126034202|NCT02268253|453423189|FG006|Stage 2|Withdrawal by Subject|0|||
126034203|NCT02268253|453423183|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126034204|NCT02268253|453423184|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126034205|NCT02268253|453423185|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
126034206|NCT02268253|453423186|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126034207|NCT02268253|453423187|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126034208|NCT02268253|453423188|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
126034209|NCT02268253|453423189|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126034210|NCT02268253|453423183|FG000|Stage 2|Death|0|||
126034211|NCT02268253|453423184|FG001|Stage 2|Death|0|||
126034212|NCT02268253|453423185|FG002|Stage 2|Death|19|||
126034213|NCT02268253|453423186|FG003|Stage 2|Death|0|||
126034214|NCT02268253|453423187|FG004|Stage 2|Death|0|||
126034215|NCT02268253|453423188|FG005|Stage 2|Death|20|||
126034216|NCT02268253|453423189|FG006|Stage 2|Death|1|||
126034217|NCT02268253|453423183|FG000|Stage 2|Lost to Follow-up|0|||
126034218|NCT02268253|453423184|FG001|Stage 2|Lost to Follow-up|0|||
126034219|NCT02268253|453423185|FG002|Stage 2|Lost to Follow-up|0|||
126034220|NCT02268253|453423186|FG003|Stage 2|Lost to Follow-up|0|||
126034221|NCT02268253|453423187|FG004|Stage 2|Lost to Follow-up|0|||
126034222|NCT02268253|453423188|FG005|Stage 2|Lost to Follow-up|4|||
126034223|NCT02268253|453423189|FG006|Stage 2|Lost to Follow-up|0|||
126034224|NCT02268253|453423183|FG000|Stage 2|Transferred to Hospice|0|||
126034225|NCT02268253|453423184|FG001|Stage 2|Transferred to Hospice|0|||
126034226|NCT02268253|453423185|FG002|Stage 2|Transferred to Hospice|0|||
126034227|NCT02268253|453423186|FG003|Stage 2|Transferred to Hospice|0|||
126034228|NCT02268253|453423187|FG004|Stage 2|Transferred to Hospice|0|||
126034229|NCT02268253|453423188|FG005|Stage 2|Transferred to Hospice|2|||
126034230|NCT02268253|453423189|FG006|Stage 2|Transferred to Hospice|0|||
126034231|NCT02268253|453423183|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
126034232|NCT02268253|453423184|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
126034233|NCT02268253|453423185|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
125880507|NCT01709721|452860376|FG000|Open Label Phase|Other, Specify in text field in database|0|||
126034234|NCT02268253|453423186|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
125880508|NCT01709721|452860377|FG001|Open Label Phase|Other, Specify in text field in database|0|||
125880509|NCT01709721|452860378|FG002|Open Label Phase|Other, Specify in text field in database|14|||
126034235|NCT02268253|453423187|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
126034236|NCT02268253|453423188|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
126034237|NCT02268253|453423189|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
126034238|NCT02268253|453423183|FG000|Stage 3A|Withdrawal by Subject|0|||
126034239|NCT02268253|453423184|FG001|Stage 3A|Withdrawal by Subject|0|||
126034240|NCT02268253|453423185|FG002|Stage 3A|Withdrawal by Subject|2|||
126034241|NCT02268253|453423186|FG003|Stage 3A|Withdrawal by Subject|0|||
126034242|NCT02268253|453423187|FG004|Stage 3A|Withdrawal by Subject|0|||
126034243|NCT02268253|453423188|FG005|Stage 3A|Withdrawal by Subject|0|||
126034244|NCT02268253|453423189|FG006|Stage 3A|Withdrawal by Subject|0|||
126034245|NCT02268253|453423183|FG000|Stage 3A|Physician Decision|0|||
126034246|NCT02268253|453423184|FG001|Stage 3A|Physician Decision|0|||
126034247|NCT02268253|453423185|FG002|Stage 3A|Physician Decision|2|||
126034248|NCT02268253|453423186|FG003|Stage 3A|Physician Decision|0|||
126034249|NCT02268253|453423187|FG004|Stage 3A|Physician Decision|0|||
126034250|NCT02268253|453423188|FG005|Stage 3A|Physician Decision|0|||
126034251|NCT02268253|453423189|FG006|Stage 3A|Physician Decision|0|||
126034252|NCT02268253|453423183|FG000|Stage 3A|Study Terminated by Sponsor|0|||
126034253|NCT02268253|453423184|FG001|Stage 3A|Study Terminated by Sponsor|0|||
126034254|NCT02268253|453423185|FG002|Stage 3A|Study Terminated by Sponsor|2|||
126034255|NCT02268253|453423186|FG003|Stage 3A|Study Terminated by Sponsor|0|||
126034256|NCT02268253|453423187|FG004|Stage 3A|Study Terminated by Sponsor|0|||
126034257|NCT02268253|453423188|FG005|Stage 3A|Study Terminated by Sponsor|0|||
126034258|NCT02268253|453423189|FG006|Stage 3A|Study Terminated by Sponsor|0|||
126034259|NCT02268253|453423183|FG000|Stage 3A|Lost to Follow-up|0|||
126034260|NCT02268253|453423184|FG001|Stage 3A|Lost to Follow-up|0|||
126034261|NCT02268253|453423185|FG002|Stage 3A|Lost to Follow-up|1|||
126034262|NCT02268253|453423186|FG003|Stage 3A|Lost to Follow-up|0|||
126034263|NCT02268253|453423187|FG004|Stage 3A|Lost to Follow-up|0|||
126034264|NCT02268253|453423188|FG005|Stage 3A|Lost to Follow-up|0|||
126034265|NCT02268253|453423189|FG006|Stage 3A|Lost to Follow-up|0|||
126034266|NCT02268253|453423183|FG000|Stage 3A|Death|0|||
126034267|NCT02268253|453423184|FG001|Stage 3A|Death|0|||
126034268|NCT02268253|453423185|FG002|Stage 3A|Death|5|||
126034269|NCT02268253|453423186|FG003|Stage 3A|Death|0|||
126034270|NCT02268253|453423187|FG004|Stage 3A|Death|0|||
126034271|NCT02268253|453423188|FG005|Stage 3A|Death|0|||
126034272|NCT02268253|453423189|FG006|Stage 3A|Death|0|||
126034273|NCT05362487|453423192|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
126034274|NCT04096040|453423193|FG000|Overall Study|Protocol Violation|12|||
126034275|NCT04096040|453423193|FG000|Overall Study|Non-compliant site|4|||
126034276|NCT04973254|453423196|FG000|Overall Study|Not adherent|0|||
126034277|NCT04973254|453423197|FG001|Overall Study|Not adherent|1|||
126034278|NCT04973254|453423198|FG002|Overall Study|Not adherent|0|||
126034279|NCT04629716|453423199|FG000|Overall Study|Lost to Follow-up|7|||
126034280|NCT04629716|453423200|FG001|Overall Study|Lost to Follow-up|3|||
126264470|NCT02149121|454258473|FG004|Main Study Period|Withdrawal by Subject|0|||
126264471|NCT02149121|454258474|FG005|Main Study Period|Withdrawal by Subject|0|||
126264472|NCT02149121|454258475|FG006|Main Study Period|Withdrawal by Subject|0|||
126264473|NCT02149121|454258469|FG000|Main Study Period|Adverse Event|2|||
126264474|NCT02149121|454258470|FG001|Main Study Period|Adverse Event|5|||
126264475|NCT02149121|454258471|FG002|Main Study Period|Adverse Event|1|||
126264476|NCT02149121|454258472|FG003|Main Study Period|Adverse Event|0|||
126264477|NCT02149121|454258473|FG004|Main Study Period|Adverse Event|0|||
126264478|NCT02149121|454258474|FG005|Main Study Period|Adverse Event|0|||
126264479|NCT02149121|454258475|FG006|Main Study Period|Adverse Event|0|||
126264480|NCT02149121|454258469|FG000|Main Study Period|Protocol Violation|2|||
126264481|NCT02149121|454258470|FG001|Main Study Period|Protocol Violation|0|||
126264482|NCT02149121|454258471|FG002|Main Study Period|Protocol Violation|0|||
126264483|NCT02149121|454258472|FG003|Main Study Period|Protocol Violation|0|||
126264484|NCT02149121|454258473|FG004|Main Study Period|Protocol Violation|0|||
126264485|NCT02149121|454258474|FG005|Main Study Period|Protocol Violation|0|||
126264486|NCT02149121|454258475|FG006|Main Study Period|Protocol Violation|0|||
126264487|NCT02149121|454258469|FG000|Main Study Period|Lost to Follow-up|2|||
126264488|NCT02149121|454258470|FG001|Main Study Period|Lost to Follow-up|1|||
126264489|NCT02149121|454258471|FG002|Main Study Period|Lost to Follow-up|0|||
126264490|NCT02149121|454258472|FG003|Main Study Period|Lost to Follow-up|0|||
126264491|NCT02149121|454258473|FG004|Main Study Period|Lost to Follow-up|0|||
126264492|NCT02149121|454258474|FG005|Main Study Period|Lost to Follow-up|0|||
126264493|NCT02149121|454258475|FG006|Main Study Period|Lost to Follow-up|0|||
126264494|NCT02149121|454258469|FG000|Main Study Period|Death|1|||
126264495|NCT02149121|454258470|FG001|Main Study Period|Death|0|||
126034281|NCT04537715|453423201|FG000|Overall Study|Death|3|||
126034282|NCT04537715|453423202|FG001|Overall Study|Death|1|||
126034283|NCT04537715|453423201|FG000|Overall Study|Withdrawal by Subject|3|||
126034284|NCT04537715|453423202|FG001|Overall Study|Withdrawal by Subject|1|||
126034285|NCT04537715|453423201|FG000|Overall Study|Other|4|||
126034286|NCT04537715|453423202|FG001|Overall Study|Other|3|||
126034287|NCT04537715|453423201|FG000|Overall Study|Progressive disease|1|||
126034288|NCT04537715|453423202|FG001|Overall Study|Progressive disease|0|||
126264496|NCT02149121|454258471|FG002|Main Study Period|Death|0|||
126264497|NCT02149121|454258472|FG003|Main Study Period|Death|0|||
126264498|NCT02149121|454258473|FG004|Main Study Period|Death|0|||
126264499|NCT02149121|454258474|FG005|Main Study Period|Death|0|||
126360006|NCT01524705|454610719|FG000|Overall Study|Pancreatic Cancer|0|||
126360007|NCT01524705|454610720|FG001|Overall Study|Pancreatic Cancer|1|||
126360008|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
126360009|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
126360010|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
126360011|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
126360012|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
126360013|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
126096900|NCT03037931|453648245|FG001|Overall Study|Death|367|||
126096901|NCT03037931|453648244|FG000|Overall Study|Lost to Follow-up|7|||
126096902|NCT03037931|453648245|FG001|Overall Study|Lost to Follow-up|4|||
126096903|NCT03037931|453648244|FG000|Overall Study|Withdrawal by Subject|48|||
126096904|NCT03037931|453648245|FG001|Overall Study|Withdrawal by Subject|41|||
126096905|NCT00605215|453648246|FG000|Overall Study|Death|0|||
126096906|NCT00605215|453648247|FG001|Overall Study|Death|0|||
126096907|NCT00605215|453648248|FG002|Overall Study|Death|1|||
126096908|NCT00605215|453648246|FG000|Overall Study|Adverse Event|19|||
126096909|NCT00605215|453648247|FG001|Overall Study|Adverse Event|21|||
126096910|NCT00605215|453648248|FG002|Overall Study|Adverse Event|26|||
126096911|NCT00605215|453648246|FG000|Overall Study|Refusal to sign the re-consent form|8|||
126096912|NCT00605215|453648247|FG001|Overall Study|Refusal to sign the re-consent form|3|||
126096913|NCT00605215|453648248|FG002|Overall Study|Refusal to sign the re-consent form|3|||
126096914|NCT00605215|453648246|FG000|Overall Study|Withdrawal by Subject|39|||
126096915|NCT00605215|453648247|FG001|Overall Study|Withdrawal by Subject|37|||
126096916|NCT00605215|453648248|FG002|Overall Study|Withdrawal by Subject|27|||
126096917|NCT00605215|453648246|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
126096918|NCT00605215|453648247|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
126096919|NCT00605215|453648248|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
126096920|NCT00605215|453648246|FG000|Overall Study|Protocol Violation|3|||
126096921|NCT00605215|453648247|FG001|Overall Study|Protocol Violation|4|||
126096922|NCT00605215|453648248|FG002|Overall Study|Protocol Violation|1|||
126096923|NCT00605215|453648246|FG000|Overall Study|Pregnancy|8|||
126096924|NCT00605215|453648247|FG001|Overall Study|Pregnancy|5|||
126096925|NCT00605215|453648248|FG002|Overall Study|Pregnancy|4|||
126096926|NCT00605215|453648246|FG000|Overall Study|Lost to Follow-up|8|||
126096927|NCT00605215|453648247|FG001|Overall Study|Lost to Follow-up|5|||
126096928|NCT00605215|453648248|FG002|Overall Study|Lost to Follow-up|2|||
126096929|NCT00605215|453648246|FG000|Overall Study|Other than specified|0|||
126096930|NCT00605215|453648247|FG001|Overall Study|Other than specified|2|||
126096931|NCT00605215|453648248|FG002|Overall Study|Other than specified|1|||
126096932|NCT01342341|453648249|FG000|Overall Study|Lost to Follow-up|4|||
126096933|NCT01342341|453648250|FG001|Overall Study|Lost to Follow-up|4|||
126096934|NCT02914275|453648251|FG000|Overall Study|Lost to Follow-up|84|||
126096935|NCT02914275|453648252|FG001|Overall Study|Lost to Follow-up|29|||
126096936|NCT02914275|453648251|FG000|Overall Study|Withdrawal by Subject|26|||
126096937|NCT02914275|453648252|FG001|Overall Study|Withdrawal by Subject|10|||
126096938|NCT02914275|453648251|FG000|Overall Study|Protocol Violation|1|||
126096939|NCT02914275|453648252|FG001|Overall Study|Protocol Violation|1|||
126096940|NCT02914275|453648251|FG000|Overall Study|Physician Decision|3|||
126096941|NCT02914275|453648252|FG001|Overall Study|Physician Decision|1|||
126096942|NCT02914275|453648251|FG000|Overall Study|Other|4|||
126096943|NCT02914275|453648252|FG001|Overall Study|Other|1|||
126096944|NCT02914275|453648251|FG000|Overall Study|Excluded due to invalid informed consent|3|||
126096945|NCT02914275|453648252|FG001|Overall Study|Excluded due to invalid informed consent|0|||
126096946|NCT02704754|453648257|FG000|Overall Study|Lost to Follow-up|1|||
126096947|NCT02704754|453648258|FG001|Overall Study|Lost to Follow-up|1|||
126096948|NCT02704754|453648257|FG000|Overall Study|Lack of Efficacy|1|||
126096949|NCT02704754|453648258|FG001|Overall Study|Lack of Efficacy|0|||
126096950|NCT02704754|453648257|FG000|Overall Study|Withdrawal by Subject|1|||
126096951|NCT02704754|453648258|FG001|Overall Study|Withdrawal by Subject|0|||
126096952|NCT03809429|453648262|FG000|Overall Study|Withdrawal by Subject|7|||
126096953|NCT03809429|453648263|FG001|Overall Study|Withdrawal by Subject|3|||
126096954|NCT03809429|453648262|FG000|Overall Study|Adverse Event|6|||
126096955|NCT03809429|453648263|FG001|Overall Study|Adverse Event|9|||
126096956|NCT03809429|453648262|FG000|Overall Study|COVID-19|3|||
126096957|NCT03809429|453648263|FG001|Overall Study|COVID-19|1|||
126096958|NCT03809429|453648262|FG000|Overall Study|Participant was discontinued by investigator|12|||
126096959|NCT03809429|453648263|FG001|Overall Study|Participant was discontinued by investigator|7|||
126096960|NCT04214600|453648265|FG000|Overall Study|Lost to Follow-up|9|||
126096961|NCT04214600|453648266|FG001|Overall Study|Lost to Follow-up|14|||
126096962|NCT02366468|453648267|FG000|Overall Study|Adverse Event|2|||
126096963|NCT02366468|453648268|FG001|Overall Study|Adverse Event|0|||
126096964|NCT02366468|453648267|FG000|Overall Study|Withdrawal by Subject|1|||
126096965|NCT02366468|453648268|FG001|Overall Study|Withdrawal by Subject|5|||
126096966|NCT02366468|453648267|FG000|Overall Study|Lost to Follow-up|2|||
126096967|NCT02366468|453648268|FG001|Overall Study|Lost to Follow-up|0|||
126096968|NCT02366468|453648267|FG000|Overall Study|Death|1|||
126096969|NCT02366468|453648268|FG001|Overall Study|Death|2|||
126096970|NCT02366468|453648267|FG000|Overall Study|Other|0|||
126096971|NCT02366468|453648268|FG001|Overall Study|Other|2|||
126096972|NCT01552603|453648269|FG000|Overall Study|Physician Decision|1|||
126096973|NCT04797650|453648274|FG000|Overall Study|Reason Not Specified|5|||
126096974|NCT04797650|453648275|FG001|Overall Study|Reason Not Specified|12|||
126096975|NCT04797650|453648276|FG002|Overall Study|Reason Not Specified|5|||
126096976|NCT04797650|453648274|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
126096977|NCT04797650|453648275|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
126096978|NCT04797650|453648276|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
126096979|NCT04797650|453648274|FG000|Overall Study|Lack of Efficacy|1|||
126096980|NCT04797650|453648275|FG001|Overall Study|Lack of Efficacy|0|||
126096981|NCT04797650|453648276|FG002|Overall Study|Lack of Efficacy|1|||
126096982|NCT04797650|453648274|FG000|Overall Study|Non-compliance with Study Drug|0|||
126264500|NCT02149121|454258475|FG006|Main Study Period|Death|0|||
126096983|NCT04797650|453648275|FG001|Overall Study|Non-compliance with Study Drug|0|||
126096984|NCT04797650|453648276|FG002|Overall Study|Non-compliance with Study Drug|2|||
126264501|NCT02149121|454258469|FG000|Main Study Period|Physician Decision|1|||
126264502|NCT02149121|454258470|FG001|Main Study Period|Physician Decision|0|||
126264503|NCT02149121|454258471|FG002|Main Study Period|Physician Decision|0|||
126264504|NCT02149121|454258472|FG003|Main Study Period|Physician Decision|0|||
126264505|NCT02149121|454258473|FG004|Main Study Period|Physician Decision|0|||
126264506|NCT02149121|454258474|FG005|Main Study Period|Physician Decision|0|||
126264507|NCT02149121|454258475|FG006|Main Study Period|Physician Decision|0|||
126264508|NCT02149121|454258469|FG000|Main Study Period|Developed any malignancy|0|||
126264509|NCT02149121|454258470|FG001|Main Study Period|Developed any malignancy|1|||
126264510|NCT02149121|454258471|FG002|Main Study Period|Developed any malignancy|1|||
126264511|NCT02149121|454258472|FG003|Main Study Period|Developed any malignancy|0|||
126264512|NCT02149121|454258473|FG004|Main Study Period|Developed any malignancy|0|||
126264513|NCT02149121|454258474|FG005|Main Study Period|Developed any malignancy|0|||
126264514|NCT02149121|454258475|FG006|Main Study Period|Developed any malignancy|0|||
126264515|NCT02149121|454258469|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
126264516|NCT02149121|454258470|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
126264517|NCT02149121|454258471|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
126264518|NCT02149121|454258472|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
126264519|NCT02149121|454258473|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
126264520|NCT02149121|454258474|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
126264521|NCT02149121|454258475|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
126264522|NCT02149121|454258469|FG000|Main Study Period|Disease progression|0|||
126264523|NCT02149121|454258470|FG001|Main Study Period|Disease progression|1|||
126264524|NCT02149121|454258471|FG002|Main Study Period|Disease progression|0|||
126264525|NCT02149121|454258472|FG003|Main Study Period|Disease progression|0|||
126264526|NCT02149121|454258473|FG004|Main Study Period|Disease progression|0|||
126264527|NCT02149121|454258474|FG005|Main Study Period|Disease progression|0|||
126264528|NCT02149121|454258475|FG006|Main Study Period|Disease progression|0|||
126264529|NCT02149121|454258469|FG000|Extension Study Period|Withdrawal by Subject|0|||
126264530|NCT02149121|454258470|FG001|Extension Study Period|Withdrawal by Subject|0|||
126264531|NCT02149121|454258471|FG002|Extension Study Period|Withdrawal by Subject|0|||
126264532|NCT02149121|454258472|FG003|Extension Study Period|Withdrawal by Subject|1|||
126264533|NCT02149121|454258473|FG004|Extension Study Period|Withdrawal by Subject|0|||
126264534|NCT02149121|454258474|FG005|Extension Study Period|Withdrawal by Subject|2|||
126264535|NCT02149121|454258475|FG006|Extension Study Period|Withdrawal by Subject|0|||
126264536|NCT03166124|454258476|FG000|Treatment Period 1|Adverse Event|0|||
126264537|NCT03166124|454258477|FG001|Treatment Period 1|Adverse Event|0|||
126264538|NCT03166124|454258478|FG002|Treatment Period 1|Adverse Event|1|||
126264539|NCT03166124|454258479|FG003|Treatment Period 1|Adverse Event|0|||
126264540|NCT03166124|454258476|FG000|Wash-out Period|Withdrawal by Subject|0|||
126264541|NCT03166124|454258477|FG001|Wash-out Period|Withdrawal by Subject|1|||
126264542|NCT03166124|454258478|FG002|Wash-out Period|Withdrawal by Subject|0|||
126264543|NCT03166124|454258479|FG003|Wash-out Period|Withdrawal by Subject|1|||
126264544|NCT03166124|454258476|FG000|Wash-out Period|Adverse Event|0|||
126264545|NCT03166124|454258477|FG001|Wash-out Period|Adverse Event|1|||
126264546|NCT03166124|454258478|FG002|Wash-out Period|Adverse Event|1|||
126264547|NCT03166124|454258479|FG003|Wash-out Period|Adverse Event|0|||
126264548|NCT00766831|454258480|FG000|Overall Study|Withdrawal by Subject|4|||
126264549|NCT00766831|454258480|FG000|Overall Study|Lost to Follow-up|3|||
126264550|NCT00766831|454258480|FG000|Overall Study|Adverse Event|20|||
126264551|NCT00766831|454258480|FG000|Overall Study|Protocol Violation|15|||
126264552|NCT00766831|454258480|FG000|Overall Study|Physician Decision|5|||
126264553|NCT00766831|454258480|FG000|Overall Study|Withdrawal of consent|26|||
126264554|NCT00766831|454258480|FG000|Overall Study|Non cooperation by participants|14|||
126264555|NCT00766831|454258480|FG000|Overall Study|Other|28|||
126264556|NCT04974619|454260596|FG000|Overall Study|Lost to Follow-up|0|||
126264557|NCT04974619|454260597|FG001|Overall Study|Lost to Follow-up|0|||
126264558|NCT04974619|454260598|FG002|Overall Study|Lost to Follow-up|1|||
126264559|NCT04974619|454260596|FG000|Overall Study|Withdrawal by Subject|0|||
126264560|NCT04974619|454260597|FG001|Overall Study|Withdrawal by Subject|0|||
126264561|NCT04974619|454260598|FG002|Overall Study|Withdrawal by Subject|1|||
126264562|NCT04974619|454260596|FG000|Overall Study|Protocol Violation|0|||
126264563|NCT04974619|454260597|FG001|Overall Study|Protocol Violation|1|||
126264564|NCT04974619|454260598|FG002|Overall Study|Protocol Violation|0|||
126264565|NCT00493779|454260599|FG000|Overall Study|Logistical issue at site|1|||
126264566|NCT01475253|454260603|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
126264567|NCT01475253|454260604|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
126264568|NCT01475253|454260605|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
126264569|NCT01475253|454260606|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
126264570|NCT01475253|454260603|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
126264571|NCT01475253|454260604|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
126264572|NCT01475253|454260605|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
126264573|NCT01475253|454260606|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
126264574|NCT02148913|454260608|FG000|Overall Study|Death|0|||
126264575|NCT02148913|454260609|FG001|Overall Study|Death|1|||
126264576|NCT02148913|454260610|FG002|Overall Study|Death|0|||
126264577|NCT02148913|454260611|FG003|Overall Study|Death|0|||
126264578|NCT01045993|454260618|FG000|Overall Study|Treated-later found eligibility not met|0|||
126264579|NCT01045993|454260619|FG001|Overall Study|Treated-later found eligibility not met|1|||
126264580|NCT01045993|454260620|FG002|Overall Study|Treated-later found eligibility not met|0|||
126264581|NCT01045993|454260621|FG003|Overall Study|Treated-later found eligibility not met|0|||
126264582|NCT05506358|454260622|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
126264583|NCT05506358|454260623|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
126264584|NCT05506358|454260624|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
126264585|NCT05506358|454260625|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
126264586|NCT05506358|454260626|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
126264587|NCT05506358|454260622|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
126264588|NCT05506358|454260623|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
126264589|NCT05506358|454260624|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
126264590|NCT05506358|454260625|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
126264591|NCT05506358|454260626|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
126264592|NCT05506358|454260622|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
126264593|NCT05506358|454260623|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
126264594|NCT05506358|454260624|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
126264595|NCT05506358|454260625|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
126264596|NCT05506358|454260626|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
126264597|NCT05506358|454260622|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
126264598|NCT05506358|454260623|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
126264599|NCT05506358|454260624|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
126264600|NCT05506358|454260625|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
126264601|NCT05506358|454260626|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
126264602|NCT05506358|454260622|FG000|Overall Study|HbE trait|0|||
126264603|NCT05506358|454260623|FG001|Overall Study|HbE trait|0|||
126264604|NCT05506358|454260624|FG002|Overall Study|HbE trait|0|||
126264605|NCT05506358|454260625|FG003|Overall Study|HbE trait|1|||
126264606|NCT05506358|454260626|FG004|Overall Study|HbE trait|0|||
126264607|NCT01659736|454260627|FG000|Treatment Period|Adverse Event|1|||
126264608|NCT01659736|454260628|FG001|Treatment Period|Adverse Event|1|||
126264609|NCT01659736|454260627|FG000|Treatment Period|Protocol Violation|3|||
126264610|NCT01659736|454260628|FG001|Treatment Period|Protocol Violation|1|||
126264611|NCT01659736|454260627|FG000|Treatment Period|Withdrawal by Subject|1|||
126264612|NCT01659736|454260628|FG001|Treatment Period|Withdrawal by Subject|0|||
126264613|NCT01659736|454260627|FG000|3-month Follow-up|Lost to Follow-up|0|||
126264614|NCT01659736|454260628|FG001|3-month Follow-up|Lost to Follow-up|1|||
126264615|NCT02791893|454260636|FG000|Blinded Phase|Lost to Follow-up|2|||
126264616|NCT02791893|454260637|FG001|Blinded Phase|Lost to Follow-up|2|||
126264617|NCT02791893|454260636|FG000|Blinded Phase|Withdrawal by Subject|1|||
126264618|NCT02791893|454260637|FG001|Blinded Phase|Withdrawal by Subject|2|||
126264619|NCT02791893|454260636|FG000|Open Label Phase|Lost to Follow-up|3|||
126264620|NCT02791893|454260637|FG001|Open Label Phase|Lost to Follow-up|0|||
126264621|NCT02791893|454260636|FG000|Open Label Phase|Withdrawal by Subject|0|||
126264622|NCT02791893|454260637|FG001|Open Label Phase|Withdrawal by Subject|2|||
126264623|NCT00262041|454260638|FG000|Overall Study|Withdrawal by Subject|0|||
126264624|NCT00262041|454260639|FG001|Overall Study|Withdrawal by Subject|3|||
126264625|NCT00262041|454260640|FG002|Overall Study|Withdrawal by Subject|1|||
126264626|NCT00262041|454260638|FG000|Overall Study|Lost to Follow-up|1|||
126264627|NCT00262041|454260639|FG001|Overall Study|Lost to Follow-up|1|||
126264628|NCT00262041|454260640|FG002|Overall Study|Lost to Follow-up|5|||
126264629|NCT00262041|454260638|FG000|Overall Study|Unable to classify|1|||
126264630|NCT00262041|454260639|FG001|Overall Study|Unable to classify|0|||
126264631|NCT00262041|454260640|FG002|Overall Study|Unable to classify|0|||
126264632|NCT02384941|454260643|FG000|Overall Study|Adverse Event|11|||
126264633|NCT02384941|454260644|FG001|Overall Study|Adverse Event|13|||
126264634|NCT02384941|454260645|FG002|Overall Study|Adverse Event|17|||
126264635|NCT02384941|454260643|FG000|Overall Study|Lost to Follow-up|3|||
126264636|NCT02384941|454260644|FG001|Overall Study|Lost to Follow-up|2|||
126264637|NCT02384941|454260645|FG002|Overall Study|Lost to Follow-up|1|||
126264638|NCT02384941|454260643|FG000|Overall Study|Non-Compliance With Study Drug|2|||
126264639|NCT02384941|454260644|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126264640|NCT02384941|454260645|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126264641|NCT02384941|454260643|FG000|Overall Study|Physician Decision|1|||
126264642|NCT02384941|454260644|FG001|Overall Study|Physician Decision|1|||
126264643|NCT02384941|454260645|FG002|Overall Study|Physician Decision|0|||
126264644|NCT02384941|454260643|FG000|Overall Study|Protocol Violation|3|||
126264645|NCT02384941|454260644|FG001|Overall Study|Protocol Violation|0|||
126264646|NCT02384941|454260645|FG002|Overall Study|Protocol Violation|0|||
126264647|NCT02384941|454260643|FG000|Overall Study|Withdrawal by Subject|26|||
126264648|NCT02384941|454260644|FG001|Overall Study|Withdrawal by Subject|19|||
126264649|NCT02384941|454260645|FG002|Overall Study|Withdrawal by Subject|20|||
126264650|NCT02384941|454260643|FG000|Overall Study|Pregnancy|0|||
126264651|NCT02384941|454260644|FG001|Overall Study|Pregnancy|0|||
126264652|NCT02384941|454260645|FG002|Overall Study|Pregnancy|1|||
126264653|NCT02384941|454260643|FG000|Overall Study|Other than specified above|4|||
126264654|NCT02384941|454260644|FG001|Overall Study|Other than specified above|0|||
126264655|NCT02384941|454260645|FG002|Overall Study|Other than specified above|1|||
126264656|NCT00252174|454260648|FG000|Overall Study|Withdrawal by Subject|0|||
126264657|NCT00252174|454260649|FG001|Overall Study|Withdrawal by Subject|1|||
126264658|NCT00252174|454260650|FG002|Overall Study|Withdrawal by Subject|0|||
126264659|NCT02025010|454260651|FG000|Overall Study|Symptomatic or radiographic progression|36|||
126264660|NCT02025010|454260651|FG000|Overall Study|Adverse Event|6|||
126264661|NCT02025010|454260651|FG000|Overall Study|Physician Decision|7|||
126264662|NCT02025010|454260651|FG000|Overall Study|Withdrawal by Subject|3|||
126264663|NCT02025010|454260651|FG000|Overall Study|Intercurrent illness|3|||
126264664|NCT02025010|454260651|FG000|Overall Study|Patients still on treatment|3|||
126264665|NCT02025010|454260651|FG000|Overall Study|Never initiate the treatment|2|||
126264666|NCT00484419|454260656|FG000|Overall Study|Adverse Event|3|||
126264667|NCT00484419|454260657|FG001|Overall Study|Adverse Event|0|||
126264668|NCT00484419|454260658|FG002|Overall Study|Adverse Event|0|||
126264669|NCT00484419|454260656|FG000|Overall Study|Lost to Follow-up|1|||
126264670|NCT00484419|454260657|FG001|Overall Study|Lost to Follow-up|0|||
126264671|NCT00484419|454260658|FG002|Overall Study|Lost to Follow-up|2|||
126264672|NCT00484419|454260656|FG000|Overall Study|Withdrawal by Subject|3|||
126264673|NCT00484419|454260657|FG001|Overall Study|Withdrawal by Subject|1|||
126264674|NCT00484419|454260658|FG002|Overall Study|Withdrawal by Subject|1|||
126264675|NCT00484419|454260656|FG000|Overall Study|subject met discontinuation criteria|2|||
126264676|NCT00484419|454260657|FG001|Overall Study|subject met discontinuation criteria|2|||
126264677|NCT00484419|454260658|FG002|Overall Study|subject met discontinuation criteria|4|||
126264678|NCT00484419|454260656|FG000|Overall Study|required restricted medication|1|||
126264679|NCT00484419|454260657|FG001|Overall Study|required restricted medication|0|||
126264680|NCT00484419|454260658|FG002|Overall Study|required restricted medication|1|||
126264681|NCT00484419|454260656|FG000|Overall Study|Physician Decision|1|||
126264682|NCT00484419|454260657|FG001|Overall Study|Physician Decision|1|||
126264683|NCT00484419|454260658|FG002|Overall Study|Physician Decision|1|||
126264684|NCT00484419|454260656|FG000|Overall Study|subject unable to receive medication|1|||
126264685|NCT00484419|454260657|FG001|Overall Study|subject unable to receive medication|0|||
126264686|NCT00484419|454260658|FG002|Overall Study|subject unable to receive medication|0|||
126264687|NCT00484419|454260656|FG000|Overall Study|subject relocated|0|||
126264688|NCT00484419|454260657|FG001|Overall Study|subject relocated|1|||
126264689|NCT00484419|454260658|FG002|Overall Study|subject relocated|0|||
126264690|NCT00484419|454260656|FG000|Overall Study|sponsor decision, randomized in error|0|||
126264691|NCT00484419|454260657|FG001|Overall Study|sponsor decision, randomized in error|0|||
126264692|NCT00484419|454260658|FG002|Overall Study|sponsor decision, randomized in error|2|||
126264693|NCT00102687|454260659|FG000|Initial Period|Withdrawal by Subject|6|||
126264694|NCT00102687|454260660|FG001|Initial Period|Withdrawal by Subject|3|||
126264695|NCT00102687|454260661|FG002|Initial Period|Withdrawal by Subject|5|||
126264696|NCT00102687|454260662|FG003|Initial Period|Withdrawal by Subject|0|||
126264697|NCT00102687|454260663|FG004|Initial Period|Withdrawal by Subject|0|||
126264698|NCT00102687|454260659|FG000|Initial Period|Adverse Event|4|||
126264699|NCT00102687|454260660|FG001|Initial Period|Adverse Event|7|||
126264700|NCT00102687|454260661|FG002|Initial Period|Adverse Event|9|||
126264701|NCT00102687|454260662|FG003|Initial Period|Adverse Event|0|||
126264702|NCT00102687|454260663|FG004|Initial Period|Adverse Event|0|||
126264703|NCT00102687|454260659|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
126264704|NCT00102687|454260660|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
126264705|NCT00102687|454260661|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
126264706|NCT00102687|454260662|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
126264707|NCT00102687|454260663|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
126264708|NCT00102687|454260659|FG000|Initial Period|Protocol Violation|0|||
126264709|NCT00102687|454260660|FG001|Initial Period|Protocol Violation|0|||
126264710|NCT00102687|454260661|FG002|Initial Period|Protocol Violation|2|||
126264711|NCT00102687|454260662|FG003|Initial Period|Protocol Violation|0|||
126264712|NCT00102687|454260663|FG004|Initial Period|Protocol Violation|0|||
126264713|NCT00102687|454260659|FG000|Initial Period|Physician Decision|2|||
126096985|NCT04797650|453648274|FG000|Overall Study|Lost to Follow-up|4|||
126096986|NCT04797650|453648275|FG001|Overall Study|Lost to Follow-up|6|||
126096987|NCT04797650|453648276|FG002|Overall Study|Lost to Follow-up|1|||
126096988|NCT00446043|453648277|FG000|Overall Study|Adverse Event|9|||
126096989|NCT00446043|453648277|FG000|Overall Study|Withdrawal by Subject|70|||
126096990|NCT00446043|453648277|FG000|Overall Study|Protocol Violation|2|||
126096991|NCT00446043|453648277|FG000|Overall Study|Lost to Follow-up|42|||
126096992|NCT00446043|453648277|FG000|Overall Study|Pregnancy|2|||
126096993|NCT00657020|453648280|FG000|PERIOD 1|Adverse Event|0|||
126096994|NCT00657020|453648281|FG001|PERIOD 1|Adverse Event|1|||
126096995|NCT01144052|453648282|FG000|Overall Study|Withdrawal by Subject|1|||
126096996|NCT01144052|453648283|FG001|Overall Study|Withdrawal by Subject|1|||
126096997|NCT02947087|453648284|FG000|Overall Study|Withdrawal by Subject|3|||
126096998|NCT02947087|453648285|FG001|Overall Study|Withdrawal by Subject|2|||
126096999|NCT01879722|453648289|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126097000|NCT01879722|453648290|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
126097001|NCT01879722|453648291|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126097002|NCT01879722|453648292|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
126097003|NCT01879722|453648293|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
126097004|NCT01879722|453648294|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
126097005|NCT01879722|453648295|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
126097006|NCT01879722|453648296|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
126097007|NCT01879722|453648297|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
126097008|NCT01879722|453648298|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
126097009|NCT01879722|453648289|FG000|Overall Study|Voluntary Withdrawal|0|||
126097010|NCT01879722|453648290|FG001|Overall Study|Voluntary Withdrawal|0|||
126097011|NCT01879722|453648291|FG002|Overall Study|Voluntary Withdrawal|0|||
126097012|NCT01879722|453648292|FG003|Overall Study|Voluntary Withdrawal|0|||
126097013|NCT01879722|453648293|FG004|Overall Study|Voluntary Withdrawal|0|||
126097014|NCT01879722|453648294|FG005|Overall Study|Voluntary Withdrawal|0|||
126097015|NCT01879722|453648295|FG006|Overall Study|Voluntary Withdrawal|0|||
126097016|NCT01879722|453648296|FG007|Overall Study|Voluntary Withdrawal|0|||
126097017|NCT01879722|453648297|FG008|Overall Study|Voluntary Withdrawal|1|||
126097018|NCT01879722|453648298|FG009|Overall Study|Voluntary Withdrawal|0|||
126097019|NCT01631227|453648302|FG000|Overall Study|withdrawn consent|27|||
126264714|NCT00102687|454260660|FG001|Initial Period|Physician Decision|9|||
126264715|NCT00102687|454260661|FG002|Initial Period|Physician Decision|6|||
126264716|NCT00102687|454260662|FG003|Initial Period|Physician Decision|0|||
126264717|NCT00102687|454260663|FG004|Initial Period|Physician Decision|0|||
126264718|NCT00102687|454260659|FG000|Initial Period|Sponsor's decision|0|||
126264719|NCT00102687|454260660|FG001|Initial Period|Sponsor's decision|1|||
126264720|NCT00102687|454260661|FG002|Initial Period|Sponsor's decision|1|||
126264721|NCT00102687|454260662|FG003|Initial Period|Sponsor's decision|0|||
126264722|NCT00102687|454260663|FG004|Initial Period|Sponsor's decision|0|||
126264723|NCT00102687|454260659|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
126360014|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
126360015|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
126360016|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
126360017|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
126360018|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
126360019|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
126360020|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
126097020|NCT01631227|453648303|FG001|Overall Study|withdrawn consent|21|||
126097021|NCT01631227|453648302|FG000|Overall Study|Adverse Event|1|||
126097022|NCT01631227|453648303|FG001|Overall Study|Adverse Event|0|||
126264724|NCT00102687|454260660|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
126264725|NCT00102687|454260661|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
126097023|NCT01631227|453648302|FG000|Overall Study|administrative|2|||
126264726|NCT00102687|454260662|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
126264727|NCT00102687|454260663|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
126264728|NCT00102687|454260659|FG000|Initial Period|Death|1|||
126264729|NCT00102687|454260660|FG001|Initial Period|Death|1|||
126264730|NCT00102687|454260661|FG002|Initial Period|Death|1|||
126264731|NCT00102687|454260662|FG003|Initial Period|Death|0|||
126264732|NCT00102687|454260663|FG004|Initial Period|Death|0|||
126264733|NCT00102687|454260659|FG000|Maintenance Period|Withdrawal by Subject|4|||
126264734|NCT00102687|454260660|FG001|Maintenance Period|Withdrawal by Subject|0|||
126264735|NCT00102687|454260661|FG002|Maintenance Period|Withdrawal by Subject|2|||
126264736|NCT00102687|454260662|FG003|Maintenance Period|Withdrawal by Subject|3|||
126264737|NCT00102687|454260663|FG004|Maintenance Period|Withdrawal by Subject|1|||
126264738|NCT00102687|454260659|FG000|Maintenance Period|Adverse Event|1|||
126264739|NCT00102687|454260660|FG001|Maintenance Period|Adverse Event|0|||
126264740|NCT00102687|454260661|FG002|Maintenance Period|Adverse Event|0|||
126264741|NCT00102687|454260662|FG003|Maintenance Period|Adverse Event|1|||
126264742|NCT00102687|454260663|FG004|Maintenance Period|Adverse Event|3|||
126264743|NCT00102687|454260659|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
126264744|NCT00102687|454260660|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
126264745|NCT00102687|454260661|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
126264746|NCT00102687|454260662|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
126264747|NCT00102687|454260663|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
126264748|NCT00102687|454260659|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
126264749|NCT00102687|454260660|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
126264750|NCT00102687|454260661|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
126264751|NCT00102687|454260662|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
125880510|NCT01709721|452860376|FG000|Randomized Phase|Adverse Event|0|||
125880511|NCT01709721|452860377|FG001|Randomized Phase|Adverse Event|1|||
125880512|NCT01709721|452860378|FG002|Randomized Phase|Adverse Event|0|||
125880513|NCT01709721|452860376|FG000|Randomized Phase|Lost to Follow-up|1|||
125880514|NCT01709721|452860377|FG001|Randomized Phase|Lost to Follow-up|0|||
125880515|NCT01709721|452860378|FG002|Randomized Phase|Lost to Follow-up|0|||
125880516|NCT01709721|452860376|FG000|Randomized Phase|Inadequate Pain Control|1|||
125880517|NCT01709721|452860377|FG001|Randomized Phase|Inadequate Pain Control|2|||
125880518|NCT01709721|452860378|FG002|Randomized Phase|Inadequate Pain Control|0|||
125880519|NCT01709721|452860376|FG000|Randomized Phase|Other, Specify text field in database|1|||
125880520|NCT01709721|452860377|FG001|Randomized Phase|Other, Specify text field in database|3|||
125880521|NCT01709721|452860378|FG002|Randomized Phase|Other, Specify text field in database|0|||
125880522|NCT00763035|452860379|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
125880523|NCT00763035|452860380|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
125880524|NCT00763035|452860379|FG000|First Intervention|Adverse Event|0|||
125880525|NCT00763035|452860380|FG001|First Intervention|Adverse Event|1|||
125880526|NCT00763035|452860379|FG000|Second Intervention|Adverse Event|1|||
125880527|NCT00763035|452860380|FG001|Second Intervention|Adverse Event|0|||
125880528|NCT00763035|452860379|FG000|Second Intervention|Physician Decision|2|||
125880529|NCT00763035|452860380|FG001|Second Intervention|Physician Decision|0|||
125880530|NCT02131259|452860381|FG000|Overall Study|Progressive disease|751|||
125880531|NCT02131259|452860381|FG000|Overall Study|Adverse Event|341|||
125880532|NCT02131259|452860381|FG000|Overall Study|Lost to Follow-up|7|||
126034289|NCT03461276|453423203|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
126034290|NCT03461276|453423204|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
126264752|NCT00102687|454260663|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
126264753|NCT00102687|454260659|FG000|Maintenance Period|Death|0|||
126264754|NCT00102687|454260660|FG001|Maintenance Period|Death|0|||
126264755|NCT00102687|454260661|FG002|Maintenance Period|Death|0|||
126264756|NCT00102687|454260662|FG003|Maintenance Period|Death|1|||
126264757|NCT00102687|454260663|FG004|Maintenance Period|Death|1|||
126264758|NCT00102687|454260659|FG000|Maintenance Period|Physician Decision|1|||
126264759|NCT00102687|454260660|FG001|Maintenance Period|Physician Decision|2|||
126264760|NCT00102687|454260661|FG002|Maintenance Period|Physician Decision|3|||
126264761|NCT00102687|454260662|FG003|Maintenance Period|Physician Decision|0|||
126264762|NCT00102687|454260663|FG004|Maintenance Period|Physician Decision|4|||
126264763|NCT01341587|454260664|FG000|Overall Study|Lost to Follow-up|2|||
126264764|NCT01341587|454260665|FG001|Overall Study|Lost to Follow-up|0|||
126264765|NCT01341587|454260664|FG000|Overall Study|stopped using the meters|2|||
126264766|NCT01341587|454260665|FG001|Overall Study|stopped using the meters|10|||
126264767|NCT01144403|454260666|FG000|Overall Study|Lost to Follow-up|3|||
126264768|NCT01144403|454260666|FG000|Overall Study|Death|1|||
126264769|NCT01144403|454260666|FG000|Overall Study|Adverse Event|1|||
126264770|NCT03176784|454260667|FG000|Overall Study|Lost to Follow-up|77|||
126264771|NCT03176784|454260668|FG001|Overall Study|Lost to Follow-up|79|||
126264772|NCT03176784|454260669|FG002|Overall Study|Lost to Follow-up|79|||
126264773|NCT03176784|454260670|FG003|Overall Study|Lost to Follow-up|49|||
125880533|NCT02131259|452860381|FG000|Overall Study|Relocation|32|||
125880534|NCT02131259|452860381|FG000|Overall Study|Other|63|||
126264774|NCT03176784|454260667|FG000|Overall Study|Withdrawal by Subject|28|||
126264775|NCT03176784|454260668|FG001|Overall Study|Withdrawal by Subject|34|||
126264776|NCT03176784|454260669|FG002|Overall Study|Withdrawal by Subject|34|||
126264777|NCT03176784|454260670|FG003|Overall Study|Withdrawal by Subject|21|||
126264778|NCT01825837|454260671|FG000|PART I|Withdrawal by Subject|0|||
126264779|NCT01825837|454260672|FG001|PART I|Withdrawal by Subject|0|||
126264780|NCT01825837|454260673|FG002|PART I|Withdrawal by Subject|0|||
126264781|NCT01825837|454260674|FG003|PART I|Withdrawal by Subject|6|||
126097024|NCT01631227|453648303|FG001|Overall Study|administrative|1|||
126264782|NCT01825837|454260671|FG000|PART I|Patient non-compliance|0|||
126264783|NCT01825837|454260672|FG001|PART I|Patient non-compliance|0|||
126264784|NCT01825837|454260673|FG002|PART I|Patient non-compliance|0|||
126264785|NCT01825837|454260674|FG003|PART I|Patient non-compliance|1|||
126264786|NCT01825837|454260671|FG000|PART I|Treatment failure|0|||
126264787|NCT01825837|454260672|FG001|PART I|Treatment failure|0|||
126264788|NCT01825837|454260673|FG002|PART I|Treatment failure|0|||
126264789|NCT01825837|454260674|FG003|PART I|Treatment failure|7|||
126264790|NCT01825837|454260671|FG000|PART I|reason unspecified|0|||
126264791|NCT01825837|454260672|FG001|PART I|reason unspecified|0|||
126264792|NCT01825837|454260673|FG002|PART I|reason unspecified|0|||
126264793|NCT01825837|454260674|FG003|PART I|reason unspecified|3|||
126264794|NCT01825837|454260671|FG000|PART II|Withdrawal by Subject|3|||
126264795|NCT01825837|454260672|FG001|PART II|Withdrawal by Subject|3|||
126264796|NCT01825837|454260673|FG002|PART II|Withdrawal by Subject|7|||
126264797|NCT01825837|454260674|FG003|PART II|Withdrawal by Subject|0|||
126264798|NCT01825837|454260671|FG000|PART II|Patient non-compliance|5|||
126264799|NCT01825837|454260672|FG001|PART II|Patient non-compliance|2|||
126264800|NCT01825837|454260673|FG002|PART II|Patient non-compliance|4|||
126264801|NCT01825837|454260674|FG003|PART II|Patient non-compliance|0|||
126264802|NCT01825837|454260671|FG000|PART II|Adverse Event|3|||
126264803|NCT01825837|454260672|FG001|PART II|Adverse Event|3|||
126264804|NCT01825837|454260673|FG002|PART II|Adverse Event|1|||
126264805|NCT01825837|454260674|FG003|PART II|Adverse Event|0|||
126264806|NCT01825837|454260671|FG000|PART II|Treatment failure|6|||
126264807|NCT01825837|454260672|FG001|PART II|Treatment failure|4|||
126264808|NCT01825837|454260673|FG002|PART II|Treatment failure|5|||
126264809|NCT01825837|454260674|FG003|PART II|Treatment failure|0|||
126264810|NCT01825837|454260671|FG000|PART II|reason unspecified|2|||
126264811|NCT01825837|454260672|FG001|PART II|reason unspecified|2|||
125880535|NCT02131259|452860381|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
125880536|NCT02131259|452860381|FG000|Overall Study|Progressive disease/relocation|1|||
125880537|NCT02131259|452860381|FG000|Overall Study|Progressive disease/other|2|||
125880538|NCT02131259|452860381|FG000|Overall Study|AE/lost to follow-up|1|||
125880539|NCT02131259|452860381|FG000|Overall Study|AE/other|1|||
125880540|NCT02131259|452860381|FG000|Overall Study|Progressive disease/AE/other|1|||
125880541|NCT02131259|452860381|FG000|Overall Study|Missing|3|||
125880542|NCT02161016|452860384|FG000|Overall Study|withdrawn by IRB|1|||
125880543|NCT00003475|452860385|FG000|Overall Study|Not evaluable|13|||
125880544|NCT03675126|452860389|FG000|Overall Study|Study Terminated by Sponsor|9|||
125880545|NCT03675126|452860389|FG000|Overall Study|Death|2|||
125880546|NCT03675126|452860389|FG000|Overall Study|Withdrawal by Subject|4|||
125880547|NCT00001959|452860390|FG000|Overall Study|newly diagnosed colon cancer|1|||
125880548|NCT00001959|452860390|FG000|Overall Study|disabling sedation|1|||
125880549|NCT00001959|452860390|FG000|Overall Study|non-compliance|1|||
125880550|NCT04189952|452860395|FG000|Follow-up Period|Death|1|||
125880551|NCT04189952|452860395|FG000|Follow-up Period|Withdrawal by Subject|1|||
125880552|NCT01052493|452860396|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
125880553|NCT01052493|452860397|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
125880554|NCT01052493|452860398|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
125880555|NCT01498068|452860399|FG000|Overall Study|Withdrawal by Subject|1|||
125880556|NCT01498068|452860400|FG001|Overall Study|Withdrawal by Subject|1|||
125880557|NCT01318915|452860403|FG000|Overall Study|Lost to Follow-up|1|||
125880558|NCT00453206|452860405|FG000|Overall Study|Death|1|||
125880559|NCT00734149|452860407|FG000|Overall Study|Withdrawal by Subject|1|||
125880560|NCT03043794|452860411|FG000|Overall Study|Lost to Follow-up|1|||
125880561|NCT05523089|452860413|FG000|Overall Study|Withdrawal by Subject|1|||
125880562|NCT05523089|452860414|FG001|Overall Study|Withdrawal by Subject|0|||
125880563|NCT05523089|452860415|FG002|Overall Study|Withdrawal by Subject|0|||
125880564|NCT05523089|452860413|FG000|Overall Study|Lost to Follow-up|1|||
125880565|NCT05523089|452860414|FG001|Overall Study|Lost to Follow-up|0|||
125880566|NCT05523089|452860415|FG002|Overall Study|Lost to Follow-up|0|||
125880567|NCT02681523|452860416|FG000|Overall Study|Adverse Event|1|||
125880568|NCT02681523|452860416|FG000|Overall Study|Patient Non-compliance|1|||
125880569|NCT01899040|452860417|FG000|Overall Study|Randomized in error|0|||
125880570|NCT01899040|452860418|FG001|Overall Study|Randomized in error|1|||
125880571|NCT01899040|452860419|FG002|Overall Study|Randomized in error|1|||
125880572|NCT01899040|452860417|FG000|Overall Study|Adverse Event|3|||
125880573|NCT01899040|452860418|FG001|Overall Study|Adverse Event|1|||
125880574|NCT01899040|452860419|FG002|Overall Study|Adverse Event|2|||
125880575|NCT01899040|452860417|FG000|Overall Study|Unspecified reasons|4|||
125880576|NCT01899040|452860418|FG001|Overall Study|Unspecified reasons|4|||
125880577|NCT01899040|452860419|FG002|Overall Study|Unspecified reasons|0|||
125880578|NCT01899040|452860417|FG000|Overall Study|Compliance issues|1|||
125880579|NCT01899040|452860418|FG001|Overall Study|Compliance issues|2|||
125880580|NCT01899040|452860419|FG002|Overall Study|Compliance issues|0|||
125880581|NCT02638220|452860425|FG000|Overall Study|Lost to Follow-up|6|||
125880582|NCT02638220|452860425|FG000|Overall Study|Withdrawal by Subject|3|||
125880583|NCT02638220|452860425|FG000|Overall Study|Physician Decision|1|||
125880584|NCT02638220|452860425|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
126034291|NCT03461276|453423203|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
126034292|NCT03461276|453423204|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
126034293|NCT03461276|453423203|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
126034294|NCT03461276|453423204|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
126264812|NCT01825837|454260673|FG002|PART II|reason unspecified|2|||
126264813|NCT01825837|454260674|FG003|PART II|reason unspecified|0|||
126264814|NCT00904748|454260675|FG000|Overall Study|Withdrawal by Subject|1|||
126264815|NCT00904748|454260676|FG001|Overall Study|Withdrawal by Subject|1|||
126264816|NCT00904748|454260677|FG002|Overall Study|Withdrawal by Subject|1|||
126034295|NCT03461276|453423203|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
126034296|NCT03461276|453423204|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
126264817|NCT00904748|454260678|FG003|Overall Study|Withdrawal by Subject|2|||
126264818|NCT00904748|454260679|FG004|Overall Study|Withdrawal by Subject|0|||
126264819|NCT00904748|454260680|FG005|Overall Study|Withdrawal by Subject|0|||
126264820|NCT00904748|454260675|FG000|Overall Study|Adverse Event|0|||
125880585|NCT04323124|452860428|FG000|Overall Study|Adverse Event|0|||
125880586|NCT04323124|452860429|FG001|Overall Study|Adverse Event|0|||
126034297|NCT03461276|453423203|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
126034298|NCT03461276|453423204|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
126360021|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
126360022|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
126360023|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
125880587|NCT04323124|452860430|FG002|Overall Study|Adverse Event|0|||
125880588|NCT04323124|452860431|FG003|Overall Study|Adverse Event|0|||
125880589|NCT04323124|452860432|FG004|Overall Study|Adverse Event|0|||
125880590|NCT04323124|452860433|FG005|Overall Study|Adverse Event|1|||
126264821|NCT00904748|454260676|FG001|Overall Study|Adverse Event|0|||
126264822|NCT00904748|454260677|FG002|Overall Study|Adverse Event|0|||
126264823|NCT00904748|454260678|FG003|Overall Study|Adverse Event|0|||
126264824|NCT00904748|454260679|FG004|Overall Study|Adverse Event|1|||
126264825|NCT00904748|454260680|FG005|Overall Study|Adverse Event|0|||
126264826|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
126264827|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
126264828|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
126264829|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
126264830|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
126264831|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
126264832|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
126264833|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
126264834|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
126264835|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
126264836|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
126264837|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
126264838|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
126264839|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
126264840|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
126264841|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
126264842|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
126264843|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
126264844|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
126264845|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
126264846|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Unclassified|14|||
126264847|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Unclassified|4|||
126264848|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Unclassified|8|||
126264849|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Unclassified|0|||
126264850|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Unclassified|0|||
126264851|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
126264852|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
126264853|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
126264854|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
126264855|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
126264856|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
126264857|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
126264858|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
126264859|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
126264860|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
126264861|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
126264862|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
126264863|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
125880591|NCT04323124|452860434|FG006|Overall Study|Adverse Event|0|||
125880592|NCT04323124|452860435|FG007|Overall Study|Adverse Event|1|||
125880593|NCT04323124|452860436|FG008|Overall Study|Adverse Event|1|||
126034299|NCT03461276|453423203|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
126034300|NCT03461276|453423204|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
126264864|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
126264865|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
126264866|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
126264867|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
126264868|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
126264869|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
126264870|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
126264871|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
126264872|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
126264873|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
126264874|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
126264875|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
126264876|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
126264877|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
126264878|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
126264879|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
126264880|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
126264881|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
126264882|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
126264883|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
126264884|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
126264885|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
126264886|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
126264887|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
126264888|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
126264889|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
126264890|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
126264891|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
126264892|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
126264893|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
126264894|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
126264895|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
126264896|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
126264897|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
126264898|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
126264899|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
126264900|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
126264901|NCT00767520|454260699|FG000|Overall Study|Participants still on treatment|11|||
126264902|NCT00767520|454260700|FG001|Overall Study|Participants still on treatment|15|||
126264903|NCT00767520|454260699|FG000|Overall Study|Randomized in error and Never treated|0|||
126264904|NCT00767520|454260700|FG001|Overall Study|Randomized in error and Never treated|2|||
126264905|NCT00606502|454260703|FG000|Randomization|Randomized but not treated|3|||
126264906|NCT00606502|454260704|FG001|Randomization|Randomized but not treated|0|||
126264907|NCT00606502|454260703|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
126264908|NCT00606502|454260704|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
126264909|NCT00958126|454260707|FG000|Overall Study|Serious Adverse Event|0|||
126264910|NCT00958126|454260708|FG001|Overall Study|Serious Adverse Event|2|||
126264911|NCT00958126|454260709|FG002|Overall Study|Serious Adverse Event|0|||
126264912|NCT00958126|454260710|FG003|Overall Study|Serious Adverse Event|0|||
126264913|NCT00958126|454260711|FG004|Overall Study|Serious Adverse Event|0|||
126264914|NCT00958126|454260712|FG005|Overall Study|Serious Adverse Event|0|||
126264915|NCT00958126|454260713|FG006|Overall Study|Serious Adverse Event|1|||
126264916|NCT00958126|454260714|FG007|Overall Study|Serious Adverse Event|0|||
126264917|NCT00958126|454260707|FG000|Overall Study|Withdrawal by Subject|0|||
126264918|NCT00958126|454260708|FG001|Overall Study|Withdrawal by Subject|2|||
126264919|NCT00958126|454260709|FG002|Overall Study|Withdrawal by Subject|0|||
126264920|NCT00958126|454260710|FG003|Overall Study|Withdrawal by Subject|0|||
126264921|NCT00958126|454260711|FG004|Overall Study|Withdrawal by Subject|0|||
126264922|NCT00958126|454260712|FG005|Overall Study|Withdrawal by Subject|0|||
126264923|NCT00958126|454260713|FG006|Overall Study|Withdrawal by Subject|0|||
126264924|NCT00958126|454260714|FG007|Overall Study|Withdrawal by Subject|0|||
126264925|NCT00958126|454260707|FG000|Overall Study|Moved away from study area|0|||
126264926|NCT00958126|454260708|FG001|Overall Study|Moved away from study area|0|||
126097025|NCT03020576|453648304|FG000|Overall Study|Withdrawal by Subject|1|||
126097026|NCT03020576|453648305|FG001|Overall Study|Withdrawal by Subject|2|||
126097027|NCT01097707|453648306|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126264927|NCT00958126|454260709|FG002|Overall Study|Moved away from study area|1|||
126264928|NCT00958126|454260710|FG003|Overall Study|Moved away from study area|1|||
126264929|NCT00958126|454260711|FG004|Overall Study|Moved away from study area|0|||
126264930|NCT00958126|454260712|FG005|Overall Study|Moved away from study area|0|||
126264931|NCT00958126|454260713|FG006|Overall Study|Moved away from study area|0|||
126264932|NCT00958126|454260714|FG007|Overall Study|Moved away from study area|0|||
126264933|NCT00958126|454260707|FG000|Overall Study|Lost to Follow-up|1|||
126264934|NCT00958126|454260708|FG001|Overall Study|Lost to Follow-up|5|||
126264935|NCT00958126|454260709|FG002|Overall Study|Lost to Follow-up|9|||
126103476|NCT01078675|453672169|FG000|Overall Study|Protocol Violation|56|||
126264936|NCT00958126|454260710|FG003|Overall Study|Lost to Follow-up|8|||
126264937|NCT00958126|454260711|FG004|Overall Study|Lost to Follow-up|0|||
126264938|NCT00958126|454260712|FG005|Overall Study|Lost to Follow-up|0|||
126264939|NCT00958126|454260713|FG006|Overall Study|Lost to Follow-up|0|||
126264940|NCT00958126|454260714|FG007|Overall Study|Lost to Follow-up|0|||
126264941|NCT00958126|454260707|FG000|Overall Study|Sponsor/Investigator decision|0|||
126264942|NCT00958126|454260708|FG001|Overall Study|Sponsor/Investigator decision|0|||
126264943|NCT00958126|454260709|FG002|Overall Study|Sponsor/Investigator decision|0|||
126264944|NCT00958126|454260710|FG003|Overall Study|Sponsor/Investigator decision|1|||
126264945|NCT00958126|454260711|FG004|Overall Study|Sponsor/Investigator decision|0|||
126264946|NCT00958126|454260712|FG005|Overall Study|Sponsor/Investigator decision|0|||
126264947|NCT00958126|454260713|FG006|Overall Study|Sponsor/Investigator decision|0|||
126264948|NCT00958126|454260714|FG007|Overall Study|Sponsor/Investigator decision|0|||
126264949|NCT00958126|454260707|FG000|Overall Study|Other Reason|0|||
126264950|NCT00958126|454260708|FG001|Overall Study|Other Reason|0|||
126264951|NCT00958126|454260709|FG002|Overall Study|Other Reason|0|||
126264952|NCT00958126|454260710|FG003|Overall Study|Other Reason|1|||
126097028|NCT01097707|453648307|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126097029|NCT01097707|453648308|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126097030|NCT01097707|453648309|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126097031|NCT01097707|453648310|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126097032|NCT01097707|453648306|FG000|Overall Study|Adverse Event|4|||
126097033|NCT01097707|453648307|FG001|Overall Study|Adverse Event|2|||
126097034|NCT01097707|453648308|FG002|Overall Study|Adverse Event|3|||
126097035|NCT01097707|453648309|FG003|Overall Study|Adverse Event|1|||
126264953|NCT00958126|454260711|FG004|Overall Study|Other Reason|0|||
126264954|NCT00958126|454260712|FG005|Overall Study|Other Reason|1|||
126264955|NCT00958126|454260713|FG006|Overall Study|Other Reason|0|||
126264956|NCT00958126|454260714|FG007|Overall Study|Other Reason|0|||
126264957|NCT03401073|454260715|FG000|Overall Study|Lost to Follow-up|1|||
126264958|NCT03401073|454260716|FG001|Overall Study|Lost to Follow-up|2|||
126264959|NCT01470612|454260717|FG000|Overall Study|Adverse Event|20|||
126264960|NCT01470612|454260718|FG001|Overall Study|Adverse Event|80|||
126264961|NCT01470612|454260717|FG000|Overall Study|Death|0|||
126264962|NCT01470612|454260718|FG001|Overall Study|Death|1|||
126264963|NCT01470612|454260717|FG000|Overall Study|Lack of Efficacy|20|||
126264964|NCT01470612|454260718|FG001|Overall Study|Lack of Efficacy|326|||
126264965|NCT01470612|454260717|FG000|Overall Study|Lost to Follow-up|2|||
126264966|NCT01470612|454260718|FG001|Overall Study|Lost to Follow-up|5|||
126264967|NCT01470612|454260717|FG000|Overall Study|Did not meet entrance criteria|0|||
126264968|NCT01470612|454260718|FG001|Overall Study|Did not meet entrance criteria|1|||
126264969|NCT01470612|454260717|FG000|Overall Study|Pregnancy|2|||
126264970|NCT01470612|454260718|FG001|Overall Study|Pregnancy|10|||
126264971|NCT01470612|454260717|FG000|Overall Study|Protocol Violation|2|||
126264972|NCT01470612|454260718|FG001|Overall Study|Protocol Violation|7|||
126264973|NCT01470612|454260717|FG000|Overall Study|Withdrawal by Subject|24|||
126264974|NCT01470612|454260718|FG001|Overall Study|Withdrawal by Subject|79|||
126264975|NCT01470612|454260717|FG000|Overall Study|Other|14|||
126264976|NCT01470612|454260718|FG001|Overall Study|Other|156|||
126264977|NCT02083926|454260722|FG000|Overall Study|Withdrawal by Subject|1|||
126264978|NCT02083926|454260723|FG001|Overall Study|Withdrawal by Subject|0|||
126264979|NCT03438227|454260724|FG000|Overall Study|Withdrawal by Subject|10|||
126264980|NCT03438227|454260725|FG001|Overall Study|Withdrawal by Subject|5|||
126264981|NCT01813071|454260726|FG000|Overall Study|Protocol Violation|0|||
126264982|NCT01813071|454260727|FG001|Overall Study|Protocol Violation|0|||
126264983|NCT01813071|454260728|FG002|Overall Study|Protocol Violation|0|||
126264984|NCT01813071|454260729|FG003|Overall Study|Protocol Violation|0|||
126264985|NCT01813071|454260730|FG004|Overall Study|Protocol Violation|1|||
126264986|NCT01813071|454260731|FG005|Overall Study|Protocol Violation|4|||
126264987|NCT01813071|454260732|FG006|Overall Study|Protocol Violation|2|||
126264988|NCT01813071|454260733|FG007|Overall Study|Protocol Violation|4|||
126264989|NCT01813071|454260734|FG008|Overall Study|Protocol Violation|2|||
126264990|NCT01813071|454260726|FG000|Overall Study|Withdrawal by Subject|0|||
126264991|NCT01813071|454260727|FG001|Overall Study|Withdrawal by Subject|0|||
126264992|NCT01813071|454260728|FG002|Overall Study|Withdrawal by Subject|0|||
126264993|NCT01813071|454260729|FG003|Overall Study|Withdrawal by Subject|0|||
126264994|NCT01813071|454260730|FG004|Overall Study|Withdrawal by Subject|0|||
126264995|NCT01813071|454260731|FG005|Overall Study|Withdrawal by Subject|1|||
126264996|NCT01813071|454260732|FG006|Overall Study|Withdrawal by Subject|0|||
126264997|NCT01813071|454260733|FG007|Overall Study|Withdrawal by Subject|0|||
126264998|NCT01813071|454260734|FG008|Overall Study|Withdrawal by Subject|0|||
126264999|NCT01813071|454260726|FG000|Overall Study|Adverse Event|0|||
126265000|NCT01813071|454260727|FG001|Overall Study|Adverse Event|0|||
126265001|NCT01813071|454260728|FG002|Overall Study|Adverse Event|0|||
126265002|NCT01813071|454260729|FG003|Overall Study|Adverse Event|0|||
126265003|NCT01813071|454260730|FG004|Overall Study|Adverse Event|0|||
126265004|NCT01813071|454260731|FG005|Overall Study|Adverse Event|1|||
126265005|NCT01813071|454260732|FG006|Overall Study|Adverse Event|0|||
126265006|NCT01813071|454260733|FG007|Overall Study|Adverse Event|0|||
126265007|NCT01813071|454260734|FG008|Overall Study|Adverse Event|0|||
126265008|NCT01813071|454260726|FG000|Overall Study|Physician Decision|0|||
126265009|NCT01813071|454260727|FG001|Overall Study|Physician Decision|0|||
126265010|NCT01813071|454260728|FG002|Overall Study|Physician Decision|0|||
126265011|NCT01813071|454260729|FG003|Overall Study|Physician Decision|0|||
126265012|NCT01813071|454260730|FG004|Overall Study|Physician Decision|0|||
126265013|NCT01813071|454260731|FG005|Overall Study|Physician Decision|0|||
126265014|NCT01813071|454260732|FG006|Overall Study|Physician Decision|1|||
126265015|NCT01813071|454260733|FG007|Overall Study|Physician Decision|0|||
126265016|NCT01813071|454260734|FG008|Overall Study|Physician Decision|0|||
126265017|NCT01813071|454260726|FG000|Overall Study|Met inc/exc criteria|0|||
126265018|NCT01813071|454260727|FG001|Overall Study|Met inc/exc criteria|0|||
126265019|NCT01813071|454260728|FG002|Overall Study|Met inc/exc criteria|0|||
126265020|NCT01813071|454260729|FG003|Overall Study|Met inc/exc criteria|0|||
126265021|NCT01813071|454260730|FG004|Overall Study|Met inc/exc criteria|0|||
126265022|NCT01813071|454260731|FG005|Overall Study|Met inc/exc criteria|1|||
126265023|NCT01813071|454260732|FG006|Overall Study|Met inc/exc criteria|0|||
126265024|NCT01813071|454260733|FG007|Overall Study|Met inc/exc criteria|1|||
126265025|NCT01813071|454260734|FG008|Overall Study|Met inc/exc criteria|1|||
126265026|NCT01660022|454260735|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
126265027|NCT01660022|454260736|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
126265028|NCT01660022|454260737|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
126265029|NCT01660022|454260738|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
126265030|NCT01660022|454260739|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
126265031|NCT01660022|454260740|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
126265032|NCT01660022|454260735|FG000|First Sequence (7 Days)|Adverse Event|0|||
126265033|NCT01660022|454260736|FG001|First Sequence (7 Days)|Adverse Event|0|||
126265034|NCT01660022|454260737|FG002|First Sequence (7 Days)|Adverse Event|0|||
126265035|NCT01660022|454260738|FG003|First Sequence (7 Days)|Adverse Event|0|||
126265036|NCT01660022|454260739|FG004|First Sequence (7 Days)|Adverse Event|1|||
126265037|NCT01660022|454260740|FG005|First Sequence (7 Days)|Adverse Event|3|||
126265038|NCT01660022|454260735|FG000|First Sequence (7 Days)|Protocol Violation|0|||
126265039|NCT01660022|454260736|FG001|First Sequence (7 Days)|Protocol Violation|0|||
126265040|NCT01660022|454260737|FG002|First Sequence (7 Days)|Protocol Violation|0|||
126265041|NCT01660022|454260738|FG003|First Sequence (7 Days)|Protocol Violation|0|||
126265042|NCT01660022|454260739|FG004|First Sequence (7 Days)|Protocol Violation|0|||
126265043|NCT01660022|454260740|FG005|First Sequence (7 Days)|Protocol Violation|1|||
126265044|NCT00094094|454260744|FG000|Overall Study|Death|2|||
126265045|NCT00094094|454260744|FG000|Overall Study|Lack of Efficacy|23|||
126265046|NCT00094094|454260744|FG000|Overall Study|Adverse Event|7|||
126265047|NCT01592721|454262784|FG000|Long-term Follow-up|Death|1|||
126265048|NCT02516410|454262785|FG000|Overall Study|Adverse Event|0|||
126265049|NCT02516410|454262786|FG001|Overall Study|Adverse Event|1|||
126265050|NCT02516410|454262785|FG000|Overall Study|Withdrawal by Subject|0|||
126265051|NCT02516410|454262786|FG001|Overall Study|Withdrawal by Subject|1|||
126265052|NCT01432574|454262787|FG000|Overall Study|Moved|2|||
126265053|NCT01432574|454262787|FG000|Overall Study|Not interested|1|||
126265054|NCT02698865|454262796|FG000|Overall Study|Other|11|||
126265055|NCT02698865|454262797|FG001|Overall Study|Other|11|||
126265056|NCT02698865|454262796|FG000|Overall Study|Withdrawal by Subject|20|||
126265057|NCT02698865|454262797|FG001|Overall Study|Withdrawal by Subject|16|||
126265058|NCT02698865|454262796|FG000|Overall Study|Physician Decision|0|||
126265059|NCT02698865|454262797|FG001|Overall Study|Physician Decision|4|||
126265060|NCT02698865|454262796|FG000|Overall Study|Lost to Follow-up|4|||
126265061|NCT02698865|454262797|FG001|Overall Study|Lost to Follow-up|2|||
126265062|NCT03861481|454262798|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
126265063|NCT03861481|454262799|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
126034301|NCT03461276|453423203|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
126034302|NCT03461276|453423204|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
126034303|NCT03461276|453423203|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
126034304|NCT03461276|453423204|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
126034305|NCT03461276|453423203|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
126034306|NCT03461276|453423204|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
126034307|NCT03461276|453423203|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
126034308|NCT03461276|453423204|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
126265064|NCT03861481|454262798|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
126265065|NCT03861481|454262799|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
126265066|NCT03861481|454262798|FG000|Overall Study|Relapse|1|||
126265067|NCT03861481|454262799|FG001|Overall Study|Relapse|0|||
126265068|NCT03861481|454262798|FG000|Overall Study|Withdrawal by Subject|0|||
126265069|NCT03861481|454262799|FG001|Overall Study|Withdrawal by Subject|1|||
126265070|NCT03861481|454262798|FG000|Overall Study|Lack of Efficacy|4|||
126265071|NCT03861481|454262799|FG001|Overall Study|Lack of Efficacy|5|||
126265072|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
126265073|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
126265074|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
126265075|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
126265076|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
126265077|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
126265078|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
126265079|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
126265080|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
126265081|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
126265082|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
126265083|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
126265084|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
126265085|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
126265086|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
126265087|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
126265088|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
126265089|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
126265090|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
126265091|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265092|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265093|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265094|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265095|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265096|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
126265097|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
126265098|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
126265099|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
126265100|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
126265101|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
126265102|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
126265103|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
126265104|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
126265105|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
126265106|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
126265107|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
126265108|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
126265109|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
126265110|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
126265111|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
126265112|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
126265113|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
126265114|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
126265115|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
126265116|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
126265117|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
126265118|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
126265119|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
126265120|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
126265121|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
126265122|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
126265123|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
126265124|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
126265125|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
126265126|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
126265127|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
126265128|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
126265129|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
126265130|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
126265131|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
126265132|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
126360024|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
126360025|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
125880594|NCT04323124|452860437|FG009|Overall Study|Adverse Event|0|||
126265133|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
126265134|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
126097036|NCT01097707|453648310|FG004|Overall Study|Adverse Event|3|||
126097037|NCT01097707|453648306|FG000|Overall Study|Entry Criteria Not Met|2|||
126097038|NCT01097707|453648307|FG001|Overall Study|Entry Criteria Not Met|1|||
126097039|NCT01097707|453648308|FG002|Overall Study|Entry Criteria Not Met|1|||
126097040|NCT01097707|453648309|FG003|Overall Study|Entry Criteria Not Met|0|||
126097041|NCT01097707|453648310|FG004|Overall Study|Entry Criteria Not Met|1|||
126097042|NCT01097707|453648306|FG000|Overall Study|Lack of Efficacy|1|||
126097043|NCT01097707|453648307|FG001|Overall Study|Lack of Efficacy|0|||
126097044|NCT01097707|453648308|FG002|Overall Study|Lack of Efficacy|0|||
126097045|NCT01097707|453648309|FG003|Overall Study|Lack of Efficacy|1|||
126097046|NCT01097707|453648310|FG004|Overall Study|Lack of Efficacy|0|||
126097047|NCT01097707|453648306|FG000|Overall Study|Lost to Follow-up|1|||
126097048|NCT01097707|453648307|FG001|Overall Study|Lost to Follow-up|1|||
126097049|NCT01097707|453648308|FG002|Overall Study|Lost to Follow-up|2|||
126097050|NCT01097707|453648309|FG003|Overall Study|Lost to Follow-up|0|||
126097051|NCT01097707|453648310|FG004|Overall Study|Lost to Follow-up|3|||
126097052|NCT01097707|453648306|FG000|Overall Study|Protocol Violation|2|||
126097053|NCT01097707|453648307|FG001|Overall Study|Protocol Violation|2|||
126097054|NCT01097707|453648308|FG002|Overall Study|Protocol Violation|3|||
126097055|NCT01097707|453648309|FG003|Overall Study|Protocol Violation|2|||
126097056|NCT01097707|453648310|FG004|Overall Study|Protocol Violation|2|||
126097057|NCT01097707|453648306|FG000|Overall Study|Sponsor Decision|31|||
126097058|NCT01097707|453648307|FG001|Overall Study|Sponsor Decision|31|||
126097059|NCT01097707|453648308|FG002|Overall Study|Sponsor Decision|34|||
126097060|NCT01097707|453648309|FG003|Overall Study|Sponsor Decision|35|||
126097061|NCT01097707|453648310|FG004|Overall Study|Sponsor Decision|36|||
126097062|NCT01097707|453648306|FG000|Overall Study|Withdrawal by Subject|3|||
126097063|NCT01097707|453648307|FG001|Overall Study|Withdrawal by Subject|6|||
126097064|NCT01097707|453648308|FG002|Overall Study|Withdrawal by Subject|1|||
126097065|NCT01097707|453648309|FG003|Overall Study|Withdrawal by Subject|4|||
126097066|NCT01097707|453648310|FG004|Overall Study|Withdrawal by Subject|3|||
126097067|NCT01097707|453648306|FG000|Overall Study|Reason unknown|0|||
126097068|NCT01097707|453648307|FG001|Overall Study|Reason unknown|0|||
126097069|NCT01097707|453648308|FG002|Overall Study|Reason unknown|0|||
126097070|NCT01097707|453648309|FG003|Overall Study|Reason unknown|0|||
126097071|NCT01097707|453648310|FG004|Overall Study|Reason unknown|1|||
126097072|NCT01844687|453648313|FG000|Visit 1|Protocol Violation|3|||
126097073|NCT01844687|453648313|FG000|Visit 1|Lost to Follow-up|5|||
126097074|NCT01844687|453648313|FG000|Visit 2|Withdrawal by Subject|1|||
126097075|NCT01844687|453648313|FG000|Visit 2|Protocol Violation|1|||
126097076|NCT01844687|453648313|FG000|Visit 3|Lost to Follow-up|1|||
126097077|NCT01844687|453648313|FG000|Visit 3|Withdrawal by Subject|3|||
126097078|NCT01844687|453648313|FG000|Visit 3|child care problems|1|||
126097079|NCT01844687|453648313|FG000|Visit 4|Pregnancy|1|||
126265135|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
126265136|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
126265137|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
126097080|NCT01844687|453648313|FG000|Visit 4|Lost to Follow-up|1|||
126265138|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
126265139|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
126265140|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
126265141|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
126265142|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
126265143|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
126265144|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
126265145|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
126265146|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
126265147|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
126265148|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
126265149|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
126097081|NCT01844687|453648313|FG000|Visit 4|Withdrawal by Subject|2|||
126097082|NCT05383508|453648322|FG000|Overall Study|Withdrawal by Subject|1|||
126097083|NCT05383508|453648323|FG001|Overall Study|Withdrawal by Subject|0|||
126097084|NCT05383508|453648324|FG002|Overall Study|Withdrawal by Subject|1|||
126097085|NCT05383508|453648325|FG003|Overall Study|Withdrawal by Subject|1|||
126097086|NCT05383508|453648326|FG004|Overall Study|Withdrawal by Subject|2|||
126097087|NCT05383508|453648327|FG005|Overall Study|Withdrawal by Subject|0|||
126097088|NCT00635427|453648328|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
126360026|NCT01755156|454610721|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
126360027|NCT01755156|454610722|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
126360028|NCT01755156|454610721|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
126360029|NCT01755156|454610722|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
126360030|NCT00090402|454610723|FG000|Overall Study|Death|1|||
126360031|NCT00090402|454610724|FG001|Overall Study|Death|1|||
126360032|NCT00090402|454610725|FG002|Overall Study|Death|0|||
126360033|NCT00090402|454610723|FG000|Overall Study|subject moved|0|||
126360034|NCT00090402|454610724|FG001|Overall Study|subject moved|1|||
126360035|NCT00090402|454610725|FG002|Overall Study|subject moved|0|||
126360036|NCT00090402|454610723|FG000|Overall Study|stopped taking study medication|1|||
126360037|NCT00090402|454610724|FG001|Overall Study|stopped taking study medication|0|||
126360038|NCT00090402|454610725|FG002|Overall Study|stopped taking study medication|1|||
126360039|NCT01530256|454610728|FG000|Overall Study|Death|2|||
126360040|NCT02004275|454610730|FG000|Phase 1|Ineligible|0|||
126360041|NCT02004275|454610731|FG001|Phase 1|Ineligible|0|||
126360042|NCT02004275|454610732|FG002|Phase 1|Ineligible|0|||
126360043|NCT02004275|454610733|FG003|Phase 1|Ineligible|1|||
126360044|NCT02004275|454610734|FG004|Phase 1|Ineligible|1|||
126360045|NCT02004275|454610735|FG005|Phase 1|Ineligible|0|||
126360046|NCT02004275|454610730|FG000|Phase 1|Protocol Violation|0|||
126360047|NCT02004275|454610731|FG001|Phase 1|Protocol Violation|0|||
126360048|NCT02004275|454610732|FG002|Phase 1|Protocol Violation|0|||
126360049|NCT02004275|454610733|FG003|Phase 1|Protocol Violation|1|||
126360050|NCT02004275|454610734|FG004|Phase 1|Protocol Violation|0|||
126360051|NCT02004275|454610735|FG005|Phase 1|Protocol Violation|5|||
126360052|NCT02004275|454610730|FG000|Phase 2 Part 1|Ineligible|6|||
126360053|NCT02004275|454610731|FG001|Phase 2 Part 1|Ineligible|9|||
126360054|NCT02004275|454610732|FG002|Phase 2 Part 1|Ineligible|0|||
126360055|NCT02004275|454610733|FG003|Phase 2 Part 1|Ineligible|0|||
126360056|NCT02004275|454610734|FG004|Phase 2 Part 1|Ineligible|0|||
126360057|NCT02004275|454610735|FG005|Phase 2 Part 1|Ineligible|0|||
126360058|NCT02004275|454610730|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
126360059|NCT02004275|454610731|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
126360060|NCT02004275|454610732|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
126360061|NCT02004275|454610733|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
126360062|NCT02004275|454610734|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
126034309|NCT03865498|453423206|FG000|Overall Study|Lack of Efficacy|12|||
126034310|NCT03865498|453423207|FG001|Overall Study|Lack of Efficacy|11|||
126034311|NCT03865498|453423206|FG000|Overall Study|Lost to Follow-up|125|||
126034312|NCT03865498|453423207|FG001|Overall Study|Lost to Follow-up|133|||
126034313|NCT03865498|453423206|FG000|Overall Study|Withdrawal by Subject|2|||
126034314|NCT03865498|453423207|FG001|Overall Study|Withdrawal by Subject|4|||
126034315|NCT03270501|453423214|FG000|Overall Study|Screen failure|6|||
126034316|NCT03270501|453423214|FG000|Overall Study|Lost to Follow-up|2|||
126034317|NCT03270501|453423214|FG000|Overall Study|Adverse Event|1|||
126034318|NCT04137289|453423215|FG000|Overall Study|Death|0|||
126034319|NCT04137289|453423216|FG001|Overall Study|Death|0|||
126034320|NCT04137289|453423217|FG002|Overall Study|Death|0|||
126034321|NCT04137289|453423218|FG003|Overall Study|Death|0|||
126034322|NCT04137289|453423219|FG004|Overall Study|Death|0|||
126034323|NCT04137289|453423220|FG005|Overall Study|Death|0|||
126034324|NCT04137289|453423221|FG006|Overall Study|Death|1|||
126034325|NCT04137289|453423222|FG007|Overall Study|Death|0|||
126034326|NCT04137289|453423223|FG008|Overall Study|Death|0|||
126034327|NCT04137289|453423215|FG000|Overall Study|Clinical disease progression|0|||
126034328|NCT04137289|453423216|FG001|Overall Study|Clinical disease progression|0|||
126034329|NCT04137289|453423217|FG002|Overall Study|Clinical disease progression|0|||
126034330|NCT04137289|453423218|FG003|Overall Study|Clinical disease progression|4|||
126034331|NCT04137289|453423219|FG004|Overall Study|Clinical disease progression|4|||
126034332|NCT04137289|453423220|FG005|Overall Study|Clinical disease progression|2|||
126034333|NCT04137289|453423221|FG006|Overall Study|Clinical disease progression|5|||
126034334|NCT04137289|453423222|FG007|Overall Study|Clinical disease progression|1|||
126034335|NCT04137289|453423223|FG008|Overall Study|Clinical disease progression|0|||
126034336|NCT04137289|453423215|FG000|Overall Study|Lost to Follow-up|0|||
126034337|NCT04137289|453423216|FG001|Overall Study|Lost to Follow-up|0|||
126034338|NCT04137289|453423217|FG002|Overall Study|Lost to Follow-up|0|||
126360063|NCT02004275|454610735|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
126360064|NCT00292370|454610736|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
126360065|NCT00292370|454610737|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
126360066|NCT00292370|454610738|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
126360067|NCT00292370|454610736|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
126034339|NCT04137289|453423218|FG003|Overall Study|Lost to Follow-up|1|||
126034340|NCT04137289|453423219|FG004|Overall Study|Lost to Follow-up|0|||
126034341|NCT04137289|453423220|FG005|Overall Study|Lost to Follow-up|0|||
126360068|NCT00292370|454610737|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
126360069|NCT00292370|454610738|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
126034342|NCT04137289|453423221|FG006|Overall Study|Lost to Follow-up|0|||
125880595|NCT04323124|452860438|FG010|Overall Study|Adverse Event|0|||
125880596|NCT04323124|452860439|FG011|Overall Study|Adverse Event|0|||
125880597|NCT04323124|452860440|FG012|Overall Study|Adverse Event|0|||
126097089|NCT00635427|453648329|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
126097090|NCT00635427|453648330|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
126265150|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
126265151|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
126265152|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
126265153|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
126265154|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
126265155|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
126265156|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
126265157|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
126265158|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
126265159|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
126265160|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
126265161|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
126265162|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
126265163|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
126265164|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
126265165|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
126265166|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
126265167|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
126265168|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
126265169|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
126265170|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
126265171|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
126265172|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
126265173|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
126265174|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Other|0|||
126265175|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Other|0|||
126265176|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Other|1|||
126265177|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Other|2|||
126265178|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Other|0|||
126265179|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Other|1|||
126265180|NCT00773734|454262800|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265181|NCT00773734|454262801|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265182|NCT00773734|454262802|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265183|NCT00773734|454262803|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
126265184|NCT00773734|454262804|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265185|NCT00773734|454262805|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265186|NCT00773734|454262800|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
126265187|NCT00773734|454262801|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
126265188|NCT00773734|454262802|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
126265189|NCT00773734|454262803|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
126265190|NCT00773734|454262804|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
126265191|NCT00773734|454262805|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
126265192|NCT00773734|454262800|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
126265193|NCT00773734|454262801|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
126265194|NCT00773734|454262802|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
126265195|NCT00773734|454262803|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
126265196|NCT00773734|454262804|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
126360070|NCT00292370|454610736|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
126097091|NCT00635427|453648331|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
126097092|NCT00635427|453648332|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
126097093|NCT00635427|453648328|FG000|Overall Study|Death|0|||
126097094|NCT00635427|453648329|FG001|Overall Study|Death|0|||
126265197|NCT00773734|454262805|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
126265198|NCT00773734|454262800|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
126265199|NCT00773734|454262801|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
126265200|NCT00773734|454262802|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
126265201|NCT00773734|454262803|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
126360071|NCT00292370|454610737|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
126360072|NCT00292370|454610738|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
126265202|NCT00773734|454262804|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
126265203|NCT00773734|454262805|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
126265204|NCT01220297|454262808|FG000|Overall Study|Death|2|||
126097095|NCT00635427|453648330|FG002|Overall Study|Death|0|||
126034343|NCT04137289|453423222|FG007|Overall Study|Lost to Follow-up|0|||
126034344|NCT04137289|453423223|FG008|Overall Study|Lost to Follow-up|0|||
126034345|NCT04137289|453423215|FG000|Overall Study|Adverse Event|0|||
126034346|NCT04137289|453423216|FG001|Overall Study|Adverse Event|0|||
126034347|NCT04137289|453423217|FG002|Overall Study|Adverse Event|1|||
126034348|NCT04137289|453423218|FG003|Overall Study|Adverse Event|0|||
126034349|NCT04137289|453423219|FG004|Overall Study|Adverse Event|0|||
126034350|NCT04137289|453423220|FG005|Overall Study|Adverse Event|1|||
126034351|NCT04137289|453423221|FG006|Overall Study|Adverse Event|0|||
126034352|NCT04137289|453423222|FG007|Overall Study|Adverse Event|0|||
126034353|NCT04137289|453423223|FG008|Overall Study|Adverse Event|0|||
126034354|NCT04137289|453423215|FG000|Overall Study|Lack of clinical benefit|0|||
126034355|NCT04137289|453423216|FG001|Overall Study|Lack of clinical benefit|0|||
126034356|NCT04137289|453423217|FG002|Overall Study|Lack of clinical benefit|0|||
126034357|NCT04137289|453423218|FG003|Overall Study|Lack of clinical benefit|0|||
126034358|NCT04137289|453423219|FG004|Overall Study|Lack of clinical benefit|0|||
126034359|NCT04137289|453423220|FG005|Overall Study|Lack of clinical benefit|0|||
126034360|NCT04137289|453423221|FG006|Overall Study|Lack of clinical benefit|0|||
126034361|NCT04137289|453423222|FG007|Overall Study|Lack of clinical benefit|0|||
126034362|NCT04137289|453423223|FG008|Overall Study|Lack of clinical benefit|1|||
126034363|NCT04137289|453423215|FG000|Overall Study|Objective disease progression|1|||
126034364|NCT04137289|453423216|FG001|Overall Study|Objective disease progression|1|||
126034365|NCT04137289|453423217|FG002|Overall Study|Objective disease progression|6|||
126034366|NCT04137289|453423218|FG003|Overall Study|Objective disease progression|18|||
126034367|NCT04137289|453423219|FG004|Overall Study|Objective disease progression|12|||
126034368|NCT04137289|453423220|FG005|Overall Study|Objective disease progression|20|||
126034369|NCT04137289|453423221|FG006|Overall Study|Objective disease progression|18|||
126034370|NCT04137289|453423222|FG007|Overall Study|Objective disease progression|7|||
126034371|NCT04137289|453423223|FG008|Overall Study|Objective disease progression|6|||
126265205|NCT01220297|454262808|FG000|Overall Study|Lost to Follow-up|1|||
126265206|NCT01287039|454262809|FG000|Overall Study|Noncompliance with study procedures|0|||
126265207|NCT01287039|454262810|FG001|Overall Study|Noncompliance with study procedures|1|||
126265208|NCT01287039|454262809|FG000|Overall Study|Change of location/residence|0|||
126265209|NCT01287039|454262810|FG001|Overall Study|Change of location/residence|3|||
126265210|NCT01287039|454262809|FG000|Overall Study|Elective surgery|0|||
126265211|NCT01287039|454262810|FG001|Overall Study|Elective surgery|1|||
126265212|NCT01287039|454262809|FG000|Overall Study|Protocol Violation|2|||
126265213|NCT01287039|454262810|FG001|Overall Study|Protocol Violation|3|||
126265214|NCT01287039|454262809|FG000|Overall Study|Excluded medication taken|1|||
126265215|NCT01287039|454262810|FG001|Overall Study|Excluded medication taken|0|||
126265216|NCT01287039|454262809|FG000|Overall Study|Noncompliance with study medication|0|||
126265217|NCT01287039|454262810|FG001|Overall Study|Noncompliance with study medication|1|||
126265218|NCT01287039|454262809|FG000|Overall Study|Problem with travel|0|||
126265219|NCT01287039|454262810|FG001|Overall Study|Problem with travel|1|||
126265220|NCT01287039|454262809|FG000|Overall Study|Death|1|||
126265221|NCT01287039|454262810|FG001|Overall Study|Death|0|||
126265222|NCT01287039|454262809|FG000|Overall Study|Change of residence|1|||
126265223|NCT01287039|454262810|FG001|Overall Study|Change of residence|0|||
126265224|NCT01287039|454262809|FG000|Overall Study|Adverse Event|7|||
126265225|NCT01287039|454262810|FG001|Overall Study|Adverse Event|4|||
126265226|NCT01287039|454262809|FG000|Overall Study|Withdrawal by Subject|14|||
126265227|NCT01287039|454262810|FG001|Overall Study|Withdrawal by Subject|11|||
126265228|NCT01287039|454262809|FG000|Overall Study|Lost to Follow-up|3|||
126265229|NCT01287039|454262810|FG001|Overall Study|Lost to Follow-up|2|||
126265230|NCT00099268|454262811|FG000|Overall Study|Withdrawal by Subject|46|||
126265231|NCT00099268|454262812|FG001|Overall Study|Withdrawal by Subject|28|||
126265232|NCT00099268|454262811|FG000|Overall Study|Adverse Event|19|||
126265233|NCT00099268|454262812|FG001|Overall Study|Adverse Event|19|||
126265234|NCT00099268|454262811|FG000|Overall Study|Protocol Violation|9|||
126034372|NCT05329220|453423224|FG000|Active Trial Period|Adverse Event|0|||
126034373|NCT05329220|453423225|FG001|Active Trial Period|Adverse Event|0|||
126034374|NCT05329220|453423226|FG002|Active Trial Period|Adverse Event|0|||
126097096|NCT00635427|453648331|FG003|Overall Study|Death|1|||
125880598|NCT04323124|452860441|FG013|Overall Study|Adverse Event|0|||
125880599|NCT04323124|452860442|FG014|Overall Study|Adverse Event|0|||
126034375|NCT05329220|453423227|FG003|Active Trial Period|Adverse Event|0|||
126034376|NCT05329220|453423228|FG004|Active Trial Period|Adverse Event|1|||
126034377|NCT05329220|453423229|FG005|Active Trial Period|Adverse Event|0|||
126034378|NCT05329220|453423224|FG000|Active Trial Period|Lost to Follow-up|0|||
126034379|NCT05329220|453423225|FG001|Active Trial Period|Lost to Follow-up|0|||
126097097|NCT00635427|453648332|FG004|Overall Study|Death|0|||
126265235|NCT00099268|454262812|FG001|Overall Study|Protocol Violation|8|||
126265236|NCT00099268|454262811|FG000|Overall Study|Lost to Follow-up|6|||
126265237|NCT00099268|454262812|FG001|Overall Study|Lost to Follow-up|4|||
126265238|NCT00099268|454262811|FG000|Overall Study|Lack of Efficacy|5|||
126265239|NCT00099268|454262812|FG001|Overall Study|Lack of Efficacy|18|||
126265240|NCT00099268|454262811|FG000|Overall Study|Administrative problems|4|||
125880600|NCT04323124|452860428|FG000|Overall Study|Other|0|||
126265241|NCT00099268|454262812|FG001|Overall Study|Administrative problems|4|||
126265242|NCT00099268|454262811|FG000|Overall Study|Death|3|||
126265243|NCT00099268|454262812|FG001|Overall Study|Death|1|||
126265244|NCT05016622|454262813|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
126265245|NCT05016622|454262813|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
126265246|NCT02581163|454262815|FG000|Overall Study|Failure to return|15|||
126265247|NCT02581163|454262815|FG000|Overall Study|Insufficient virological response|3|||
126265248|NCT02581163|454262815|FG000|Overall Study|Withdrew consent|1|||
126265249|NCT02581163|454262815|FG000|Overall Study|Death|1|||
126265250|NCT02581163|454262815|FG000|Overall Study|Other, not specified|9|||
126265251|NCT03438396|454262816|FG000|Overall Study|Reason Not Specified|9|||
126265252|NCT03438396|454262816|FG000|Overall Study|Withdrawal by Subject|5|||
126265253|NCT03438396|454262816|FG000|Overall Study|Lost to Follow-up|2|||
126265254|NCT03438396|454262816|FG000|Overall Study|Death|85|||
126265255|NCT03438396|454262816|FG000|Overall Study|Not treated|1|||
126265256|NCT02006628|454262817|FG000|Overall Study|Adverse Event|1|||
126265257|NCT02006628|454262818|FG001|Overall Study|Adverse Event|1|||
126265258|NCT02006628|454262817|FG000|Overall Study|Withdrawal by Subject|2|||
126265259|NCT02006628|454262818|FG001|Overall Study|Withdrawal by Subject|1|||
126265260|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
126265261|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
126265262|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
126265263|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
126265264|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
126265265|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
126265266|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
126265267|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
126265268|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
126265269|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
126265270|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
125880601|NCT04323124|452860429|FG001|Overall Study|Other|0|||
125880602|NCT04323124|452860430|FG002|Overall Study|Other|0|||
125880603|NCT04323124|452860431|FG003|Overall Study|Other|0|||
125880604|NCT04323124|452860432|FG004|Overall Study|Other|1|||
125880605|NCT04323124|452860433|FG005|Overall Study|Other|0|||
125880606|NCT04323124|452860434|FG006|Overall Study|Other|0|||
125880607|NCT04323124|452860435|FG007|Overall Study|Other|0|||
126034380|NCT05329220|453423226|FG002|Active Trial Period|Lost to Follow-up|0|||
126034381|NCT05329220|453423227|FG003|Active Trial Period|Lost to Follow-up|0|||
126034382|NCT05329220|453423228|FG004|Active Trial Period|Lost to Follow-up|32|||
126034383|NCT05329220|453423229|FG005|Active Trial Period|Lost to Follow-up|28|||
126034384|NCT05329220|453423224|FG000|Active Trial Period|Physician Decision|0|||
126034385|NCT05329220|453423225|FG001|Active Trial Period|Physician Decision|0|||
126034386|NCT05329220|453423226|FG002|Active Trial Period|Physician Decision|0|||
126034387|NCT05329220|453423227|FG003|Active Trial Period|Physician Decision|0|||
126034388|NCT05329220|453423228|FG004|Active Trial Period|Physician Decision|2|||
126034389|NCT05329220|453423229|FG005|Active Trial Period|Physician Decision|0|||
126034390|NCT05329220|453423224|FG000|Active Trial Period|Protocol Violation|0|||
126034391|NCT05329220|453423225|FG001|Active Trial Period|Protocol Violation|0|||
126097098|NCT00635427|453648328|FG000|Overall Study|Termination Of Study By Sponsor|12|||
126265271|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
126265272|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
126265273|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
126265274|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
126265275|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
126265276|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
126034392|NCT05329220|453423226|FG002|Active Trial Period|Protocol Violation|0|||
126103477|NCT01078675|453672170|FG001|Overall Study|Protocol Violation|0|||
126034393|NCT05329220|453423227|FG003|Active Trial Period|Protocol Violation|0|||
126034394|NCT05329220|453423228|FG004|Active Trial Period|Protocol Violation|1|||
126034395|NCT05329220|453423229|FG005|Active Trial Period|Protocol Violation|3|||
126034396|NCT05329220|453423224|FG000|Active Trial Period|Withdrawal by Subject|0|||
126034397|NCT05329220|453423225|FG001|Active Trial Period|Withdrawal by Subject|0|||
126034398|NCT05329220|453423226|FG002|Active Trial Period|Withdrawal by Subject|0|||
126034399|NCT05329220|453423227|FG003|Active Trial Period|Withdrawal by Subject|1|||
126034400|NCT05329220|453423228|FG004|Active Trial Period|Withdrawal by Subject|12|||
126034401|NCT05329220|453423229|FG005|Active Trial Period|Withdrawal by Subject|13|||
126034402|NCT05329220|453423224|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126034403|NCT05329220|453423225|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126034404|NCT05329220|453423226|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126034405|NCT05329220|453423227|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126034406|NCT05329220|453423228|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126034407|NCT05329220|453423229|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
126034408|NCT05329220|453423224|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126034409|NCT05329220|453423225|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126034410|NCT05329220|453423226|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126034411|NCT05329220|453423227|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126034412|NCT05329220|453423228|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126034413|NCT05329220|453423229|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
126034414|NCT05329220|453423224|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
126034415|NCT05329220|453423225|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
126034416|NCT05329220|453423226|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
126034417|NCT05329220|453423227|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
126265277|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
126265278|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
126034418|NCT05329220|453423228|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
126034419|NCT05329220|453423229|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
126034420|NCT05329220|453423224|FG000|Follow-up Period|Adverse Event|0|||
126034421|NCT05329220|453423225|FG001|Follow-up Period|Adverse Event|0|||
126034422|NCT05329220|453423226|FG002|Follow-up Period|Adverse Event|0|||
126034423|NCT05329220|453423227|FG003|Follow-up Period|Adverse Event|0|||
126034424|NCT05329220|453423228|FG004|Follow-up Period|Adverse Event|2|||
126265279|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
126265280|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
126265281|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
126265282|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
126265283|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
126265284|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
126265285|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
126265286|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
126265287|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
126265288|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
126034425|NCT05329220|453423229|FG005|Follow-up Period|Adverse Event|1|||
126034426|NCT05329220|453423224|FG000|Follow-up Period|Death|0|||
126034427|NCT05329220|453423225|FG001|Follow-up Period|Death|0|||
126034428|NCT05329220|453423226|FG002|Follow-up Period|Death|1|||
126034429|NCT05329220|453423227|FG003|Follow-up Period|Death|1|||
126034430|NCT05329220|453423228|FG004|Follow-up Period|Death|0|||
126034431|NCT05329220|453423229|FG005|Follow-up Period|Death|1|||
126034432|NCT05329220|453423224|FG000|Follow-up Period|Lost to Follow-up|0|||
126034433|NCT05329220|453423225|FG001|Follow-up Period|Lost to Follow-up|1|||
126034434|NCT05329220|453423226|FG002|Follow-up Period|Lost to Follow-up|2|||
126034435|NCT05329220|453423227|FG003|Follow-up Period|Lost to Follow-up|2|||
126034436|NCT05329220|453423228|FG004|Follow-up Period|Lost to Follow-up|113|||
126034437|NCT05329220|453423229|FG005|Follow-up Period|Lost to Follow-up|89|||
126034438|NCT05329220|453423224|FG000|Follow-up Period|Physician Decision|0|||
126034439|NCT05329220|453423225|FG001|Follow-up Period|Physician Decision|0|||
126034440|NCT05329220|453423226|FG002|Follow-up Period|Physician Decision|0|||
126034441|NCT05329220|453423227|FG003|Follow-up Period|Physician Decision|0|||
126034442|NCT05329220|453423228|FG004|Follow-up Period|Physician Decision|2|||
126034443|NCT05329220|453423229|FG005|Follow-up Period|Physician Decision|2|||
126034444|NCT05329220|453423224|FG000|Follow-up Period|Protocol Violation|0|||
126034445|NCT05329220|453423225|FG001|Follow-up Period|Protocol Violation|0|||
126034446|NCT05329220|453423226|FG002|Follow-up Period|Protocol Violation|0|||
126265289|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
126097099|NCT00635427|453648329|FG001|Overall Study|Termination Of Study By Sponsor|6|||
126097100|NCT00635427|453648330|FG002|Overall Study|Termination Of Study By Sponsor|10|||
126097101|NCT00635427|453648331|FG003|Overall Study|Termination Of Study By Sponsor|6|||
126360073|NCT00292370|454610736|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
126360074|NCT00292370|454610737|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
126360075|NCT00292370|454610738|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
126360076|NCT00292370|454610736|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
126360077|NCT00292370|454610737|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
126360078|NCT00292370|454610738|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
126360079|NCT00292370|454610736|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
126360080|NCT00292370|454610737|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
126360081|NCT00292370|454610738|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
126360082|NCT04821245|454610740|FG000|Overall Study|Withdrawal by Subject|3|||
126360083|NCT04821245|454610740|FG000|Overall Study|Physician Decision|1|||
126360084|NCT04821245|454610740|FG000|Overall Study|Protocol Violation|5|||
126360085|NCT01133977|454610743|FG000|Overall Study|Adverse Event|0|||
126360086|NCT01133977|454610744|FG001|Overall Study|Adverse Event|0|||
126360087|NCT01133977|454610745|FG002|Overall Study|Adverse Event|1|||
126360088|NCT01133977|454610746|FG003|Overall Study|Adverse Event|0|||
126360089|NCT01133977|454610747|FG004|Overall Study|Adverse Event|0|||
126360090|NCT01133977|454610743|FG000|Overall Study|Death|1|||
125880608|NCT04323124|452860436|FG008|Overall Study|Other|1|||
125880609|NCT04323124|452860437|FG009|Overall Study|Other|0|||
125880610|NCT04323124|452860438|FG010|Overall Study|Other|0|||
125880611|NCT04323124|452860439|FG011|Overall Study|Other|0|||
125880612|NCT04323124|452860440|FG012|Overall Study|Other|0|||
125880613|NCT04323124|452860441|FG013|Overall Study|Other|0|||
125880614|NCT04323124|452860442|FG014|Overall Study|Other|0|||
125880615|NCT04323124|452860428|FG000|Overall Study|Coming from a red zone (COVID)|0|||
125880616|NCT04323124|452860429|FG001|Overall Study|Coming from a red zone (COVID)|0|||
125880617|NCT04323124|452860430|FG002|Overall Study|Coming from a red zone (COVID)|0|||
125880618|NCT04323124|452860431|FG003|Overall Study|Coming from a red zone (COVID)|0|||
125880619|NCT04323124|452860432|FG004|Overall Study|Coming from a red zone (COVID)|1|||
125880620|NCT04323124|452860433|FG005|Overall Study|Coming from a red zone (COVID)|1|||
125880621|NCT04323124|452860434|FG006|Overall Study|Coming from a red zone (COVID)|0|||
125880622|NCT04323124|452860435|FG007|Overall Study|Coming from a red zone (COVID)|0|||
125880623|NCT04323124|452860436|FG008|Overall Study|Coming from a red zone (COVID)|0|||
125880624|NCT04323124|452860437|FG009|Overall Study|Coming from a red zone (COVID)|0|||
125880625|NCT04323124|452860438|FG010|Overall Study|Coming from a red zone (COVID)|0|||
125880626|NCT04323124|452860439|FG011|Overall Study|Coming from a red zone (COVID)|0|||
125880627|NCT04323124|452860440|FG012|Overall Study|Coming from a red zone (COVID)|0|||
125880628|NCT04323124|452860441|FG013|Overall Study|Coming from a red zone (COVID)|0|||
125880629|NCT04323124|452860442|FG014|Overall Study|Coming from a red zone (COVID)|0|||
125880630|NCT04323124|452860428|FG000|Overall Study|No longer meets eligibility criteria|0|||
125880631|NCT04323124|452860429|FG001|Overall Study|No longer meets eligibility criteria|0|||
126360091|NCT01133977|454610744|FG001|Overall Study|Death|1|||
126360092|NCT01133977|454610745|FG002|Overall Study|Death|1|||
126360093|NCT01133977|454610746|FG003|Overall Study|Death|7|||
126360094|NCT01133977|454610747|FG004|Overall Study|Death|3|||
126360095|NCT01133977|454610743|FG000|Overall Study|Started a New Line of Therapy|2|||
126360096|NCT01133977|454610744|FG001|Overall Study|Started a New Line of Therapy|6|||
126360097|NCT01133977|454610745|FG002|Overall Study|Started a New Line of Therapy|4|||
126360098|NCT01133977|454610746|FG003|Overall Study|Started a New Line of Therapy|25|||
126360099|NCT01133977|454610747|FG004|Overall Study|Started a New Line of Therapy|33|||
126360100|NCT01133977|454610743|FG000|Overall Study|Lost to Follow-up|0|||
126360101|NCT01133977|454610744|FG001|Overall Study|Lost to Follow-up|0|||
126360102|NCT01133977|454610745|FG002|Overall Study|Lost to Follow-up|0|||
125880632|NCT04323124|452860430|FG002|Overall Study|No longer meets eligibility criteria|0|||
125880633|NCT04323124|452860431|FG003|Overall Study|No longer meets eligibility criteria|0|||
125880634|NCT04323124|452860432|FG004|Overall Study|No longer meets eligibility criteria|0|||
125880635|NCT04323124|452860433|FG005|Overall Study|No longer meets eligibility criteria|0|||
126097102|NCT00635427|453648332|FG004|Overall Study|Termination Of Study By Sponsor|6|||
126097103|NCT00635427|453648328|FG000|Overall Study|Withdrawal Of Consent|0|||
126097104|NCT00635427|453648329|FG001|Overall Study|Withdrawal Of Consent|0|||
126360103|NCT01133977|454610746|FG003|Overall Study|Lost to Follow-up|2|||
126360104|NCT01133977|454610747|FG004|Overall Study|Lost to Follow-up|1|||
126360105|NCT01133977|454610743|FG000|Overall Study|Withdrawal by Subject|0|||
125880636|NCT04323124|452860434|FG006|Overall Study|No longer meets eligibility criteria|0|||
125880637|NCT04323124|452860435|FG007|Overall Study|No longer meets eligibility criteria|1|||
126360106|NCT01133977|454610744|FG001|Overall Study|Withdrawal by Subject|0|||
126097105|NCT00635427|453648330|FG002|Overall Study|Withdrawal Of Consent|0|||
126360107|NCT01133977|454610745|FG002|Overall Study|Withdrawal by Subject|0|||
126360108|NCT01133977|454610746|FG003|Overall Study|Withdrawal by Subject|5|||
126034447|NCT05329220|453423227|FG003|Follow-up Period|Protocol Violation|0|||
126034448|NCT05329220|453423228|FG004|Follow-up Period|Protocol Violation|0|||
126034449|NCT05329220|453423229|FG005|Follow-up Period|Protocol Violation|1|||
126034450|NCT05329220|453423224|FG000|Follow-up Period|Withdrawal by Subject|0|||
126034451|NCT05329220|453423225|FG001|Follow-up Period|Withdrawal by Subject|0|||
126034452|NCT05329220|453423226|FG002|Follow-up Period|Withdrawal by Subject|1|||
126034453|NCT05329220|453423227|FG003|Follow-up Period|Withdrawal by Subject|1|||
126034454|NCT05329220|453423228|FG004|Follow-up Period|Withdrawal by Subject|34|||
126034455|NCT05329220|453423229|FG005|Follow-up Period|Withdrawal by Subject|35|||
126034456|NCT05329220|453423224|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126034457|NCT05329220|453423225|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126034458|NCT05329220|453423226|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
126034459|NCT05329220|453423227|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126034460|NCT05329220|453423228|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126034461|NCT05329220|453423229|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126034462|NCT05329220|453423224|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126034463|NCT05329220|453423225|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126034464|NCT05329220|453423226|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126034465|NCT05329220|453423227|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126034466|NCT05329220|453423228|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
126034467|NCT05329220|453423229|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126034468|NCT05329220|453423224|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126034469|NCT05329220|453423225|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126034470|NCT05329220|453423226|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126034471|NCT05329220|453423227|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126034472|NCT05329220|453423228|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
126034473|NCT05329220|453423229|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126034474|NCT05329220|453423224|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126034475|NCT05329220|453423225|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126034476|NCT05329220|453423226|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126034477|NCT05329220|453423227|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126034478|NCT05329220|453423228|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126034479|NCT05329220|453423229|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
126034480|NCT05329220|453423224|FG000|Follow-up Period|EARLY TERMINATION|0|||
126034481|NCT05329220|453423225|FG001|Follow-up Period|EARLY TERMINATION|0|||
126265290|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
126265291|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
126265292|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
126265293|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
126265294|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
126265295|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
126265296|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
125880638|NCT04323124|452860436|FG008|Overall Study|No longer meets eligibility criteria|0|||
125880639|NCT04323124|452860437|FG009|Overall Study|No longer meets eligibility criteria|0|||
126360109|NCT01133977|454610747|FG004|Overall Study|Withdrawal by Subject|1|||
126360110|NCT00662038|454610752|FG000|Overall Study|Reason not specified|3|||
125880640|NCT04323124|452860438|FG010|Overall Study|No longer meets eligibility criteria|0|||
125880641|NCT04323124|452860439|FG011|Overall Study|No longer meets eligibility criteria|0|||
125880642|NCT04323124|452860440|FG012|Overall Study|No longer meets eligibility criteria|0|||
125880643|NCT04323124|452860441|FG013|Overall Study|No longer meets eligibility criteria|1|||
125880644|NCT04323124|452860442|FG014|Overall Study|No longer meets eligibility criteria|1|||
125880645|NCT04323124|452860428|FG000|Overall Study|Study terminated by sponsor|0|||
125880646|NCT04323124|452860429|FG001|Overall Study|Study terminated by sponsor|0|||
125880647|NCT04323124|452860430|FG002|Overall Study|Study terminated by sponsor|0|||
125880648|NCT04323124|452860431|FG003|Overall Study|Study terminated by sponsor|0|||
125880649|NCT04323124|452860432|FG004|Overall Study|Study terminated by sponsor|0|||
125880650|NCT04323124|452860433|FG005|Overall Study|Study terminated by sponsor|0|||
125880651|NCT04323124|452860434|FG006|Overall Study|Study terminated by sponsor|0|||
125880652|NCT04323124|452860435|FG007|Overall Study|Study terminated by sponsor|0|||
125880653|NCT04323124|452860436|FG008|Overall Study|Study terminated by sponsor|0|||
125880654|NCT04323124|452860437|FG009|Overall Study|Study terminated by sponsor|0|||
125880655|NCT04323124|452860438|FG010|Overall Study|Study terminated by sponsor|0|||
125880656|NCT04323124|452860439|FG011|Overall Study|Study terminated by sponsor|2|||
125880657|NCT04323124|452860440|FG012|Overall Study|Study terminated by sponsor|1|||
125880658|NCT04323124|452860441|FG013|Overall Study|Study terminated by sponsor|0|||
126034482|NCT05329220|453423226|FG002|Follow-up Period|EARLY TERMINATION|0|||
126360111|NCT00662038|454610752|FG000|Overall Study|Withdrawn consent|22|||
126360112|NCT00662038|454610752|FG000|Overall Study|Withdrawal by Subject|83|||
126360113|NCT00662038|454610752|FG000|Overall Study|Sponsor decision|1|||
126034483|NCT05329220|453423227|FG003|Follow-up Period|EARLY TERMINATION|0|||
126034484|NCT05329220|453423228|FG004|Follow-up Period|EARLY TERMINATION|0|||
126034485|NCT05329220|453423229|FG005|Follow-up Period|EARLY TERMINATION|1|||
126034486|NCT05329220|453423224|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126034487|NCT05329220|453423225|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126034488|NCT05329220|453423226|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126034489|NCT05329220|453423227|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126034490|NCT05329220|453423228|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126034491|NCT05329220|453423229|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
126034492|NCT05329220|453423224|FG000|Follow-up Period|DROPPED|0|||
126034493|NCT05329220|453423225|FG001|Follow-up Period|DROPPED|0|||
126034494|NCT05329220|453423226|FG002|Follow-up Period|DROPPED|0|||
126034495|NCT05329220|453423227|FG003|Follow-up Period|DROPPED|0|||
126034496|NCT05329220|453423228|FG004|Follow-up Period|DROPPED|0|||
126034497|NCT05329220|453423229|FG005|Follow-up Period|DROPPED|1|||
126034498|NCT05329220|453423224|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126034499|NCT05329220|453423225|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126034500|NCT05329220|453423226|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126034501|NCT05329220|453423227|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126034502|NCT05329220|453423228|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126034503|NCT05329220|453423229|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
126034504|NCT02601313|453423230|FG000|Overall Study|Death|2|||
126034505|NCT02601313|453423231|FG001|Overall Study|Death|41|||
126034506|NCT02601313|453423232|FG002|Overall Study|Death|6|||
126034507|NCT02601313|453423230|FG000|Overall Study|Enrolled but never treated|0|||
126034508|NCT02601313|453423231|FG001|Overall Study|Enrolled but never treated|6|||
126034509|NCT02601313|453423232|FG002|Overall Study|Enrolled but never treated|3|||
126034510|NCT02601313|453423230|FG000|Overall Study|Enrolled, did not initiate AC|4|||
126034511|NCT02601313|453423231|FG001|Overall Study|Enrolled, did not initiate AC|0|||
126034512|NCT02601313|453423232|FG002|Overall Study|Enrolled, did not initiate AC|0|||
126034513|NCT02601313|453423230|FG000|Overall Study|Full consent withdrawal|0|||
126034514|NCT02601313|453423231|FG001|Overall Study|Full consent withdrawal|3|||
126034515|NCT02601313|453423232|FG002|Overall Study|Full consent withdrawal|2|||
126034516|NCT02601313|453423230|FG000|Overall Study|Lost to Follow-up|0|||
126034517|NCT02601313|453423231|FG001|Overall Study|Lost to Follow-up|1|||
126034518|NCT02601313|453423232|FG002|Overall Study|Lost to Follow-up|1|||
126046489|NCT04129164|453468242|FG000|Overall Study|Non-compliance with procedures|0|||
126046490|NCT04129164|453468243|FG001|Overall Study|Non-compliance with procedures|0|||
126046491|NCT04129164|453468244|FG002|Overall Study|Non-compliance with procedures|2|||
126046492|NCT04129164|453468245|FG003|Overall Study|Non-compliance with procedures|0|||
126046493|NCT04129164|453468242|FG000|Overall Study|Adverse Event|0|||
126046494|NCT04129164|453468243|FG001|Overall Study|Adverse Event|0|||
126046495|NCT04129164|453468244|FG002|Overall Study|Adverse Event|2|||
126046496|NCT04129164|453468245|FG003|Overall Study|Adverse Event|0|||
126046497|NCT04129164|453468242|FG000|Overall Study|Pregnancy|0|||
126046498|NCT04129164|453468243|FG001|Overall Study|Pregnancy|0|||
126046499|NCT04129164|453468244|FG002|Overall Study|Pregnancy|0|||
126046500|NCT04129164|453468245|FG003|Overall Study|Pregnancy|1|||
126046501|NCT04129164|453468242|FG000|Overall Study|Withdrawal by Subject|3|||
126046502|NCT04129164|453468243|FG001|Overall Study|Withdrawal by Subject|2|||
126046503|NCT04129164|453468244|FG002|Overall Study|Withdrawal by Subject|4|||
126046504|NCT04129164|453468245|FG003|Overall Study|Withdrawal by Subject|6|||
126046505|NCT04129164|453468242|FG000|Overall Study|Death|0|||
126046506|NCT04129164|453468243|FG001|Overall Study|Death|1|||
126046507|NCT04129164|453468244|FG002|Overall Study|Death|0|||
126046508|NCT04129164|453468245|FG003|Overall Study|Death|0|||
126046509|NCT04129164|453468242|FG000|Overall Study|Lost to Follow-up|0|||
126046510|NCT04129164|453468243|FG001|Overall Study|Lost to Follow-up|1|||
126046511|NCT04129164|453468244|FG002|Overall Study|Lost to Follow-up|0|||
126046512|NCT04129164|453468245|FG003|Overall Study|Lost to Follow-up|0|||
126265297|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
126265298|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
126265299|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
126046513|NCT03868930|453468246|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
126046514|NCT03868930|453468247|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
126046515|NCT03868930|453468246|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
126046516|NCT03868930|453468247|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
125880659|NCT04323124|452860442|FG014|Overall Study|Study terminated by sponsor|0|||
125880660|NCT00489307|452860443|FG000|Overall Study|Death|1|||
125880661|NCT00489307|452860444|FG001|Overall Study|Death|1|||
125880662|NCT00489307|452860443|FG000|Overall Study|Lost to Follow-up|2|||
125880663|NCT00489307|452860444|FG001|Overall Study|Lost to Follow-up|2|||
125880664|NCT00489307|452860443|FG000|Overall Study|Physician Decision|1|||
125880665|NCT00489307|452860444|FG001|Overall Study|Physician Decision|0|||
125880666|NCT00489307|452860443|FG000|Overall Study|Withdrawal by Subject|2|||
125880667|NCT00489307|452860444|FG001|Overall Study|Withdrawal by Subject|4|||
125880668|NCT00489307|452860443|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
125880669|NCT00489307|452860444|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
126265300|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
126265301|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
126265302|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
126265303|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
126265304|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
126265305|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
126265306|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
126265307|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
126265308|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
126265309|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
126265310|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
126265311|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
126265312|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
126265313|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
125880670|NCT00489307|452860443|FG000|Overall Study|Surgery after assignment|1|||
125880671|NCT00489307|452860444|FG001|Overall Study|Surgery after assignment|0|||
125880672|NCT00489307|452860443|FG000|Overall Study|Did not fill up the forms|2|||
126360114|NCT00662038|454610752|FG000|Overall Study|Physician Decision|19|||
126360115|NCT00662038|454610752|FG000|Overall Study|Lung transplantation|44|||
126360116|NCT00662038|454610752|FG000|Overall Study|Lost to Follow-up|1|||
126360117|NCT00662038|454610752|FG000|Overall Study|Death|95|||
126360118|NCT00662038|454610752|FG000|Overall Study|Adverse Event|358|||
126360119|NCT00662038|454610752|FG000|Overall Study|Continued treatment|5|||
125880673|NCT00489307|452860444|FG001|Overall Study|Did not fill up the forms|1|||
125880674|NCT00489307|452860443|FG000|Overall Study|Patient or family refusal|5|||
125880675|NCT00489307|452860444|FG001|Overall Study|Patient or family refusal|9|||
126360120|NCT00397046|454610753|FG000|Overall Study|Disease Progression|3|||
125880676|NCT04586205|452860445|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
125880677|NCT04586205|452860446|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
125880678|NCT02083354|452862581|FG000|Overall Study|Withdrawal by Subject|9|||
125880679|NCT02083354|452862581|FG000|Overall Study|Lost to Follow-up|1|||
125880680|NCT02083354|452862581|FG000|Overall Study|Adverse Event|3|||
125880681|NCT02083354|452862581|FG000|Overall Study|Disease progression|46|||
125880682|NCT02083354|452862581|FG000|Overall Study|Study closed/terminated|5|||
126034519|NCT03812679|453424909|FG000|Overall Study|Adverse Event|2|||
126034520|NCT03812679|453424909|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
126034521|NCT03812679|453424909|FG000|Overall Study|Renal transplant|1|||
126034522|NCT03812679|453424909|FG000|Overall Study|Withdrawal by Subject|1|||
126034523|NCT03812679|453424909|FG000|Overall Study|Termination of study|2|||
126034524|NCT03812679|453424909|FG000|Overall Study|Water device replacement|1|||
126034525|NCT05486078|453424910|FG000|Overall Study|4 drop out and one withdrawn|5|||
126034526|NCT03766009|453424911|FG000|Usual Care|Death|0|||
126034527|NCT03766009|453424912|FG001|Usual Care|Death|0|||
126034528|NCT03766009|453424913|FG002|Usual Care|Death|0|||
126034529|NCT03766009|453424914|FG003|Usual Care|Death|1|||
126034530|NCT03766009|453424915|FG004|Usual Care|Death|0|||
126034531|NCT03766009|453424916|FG005|Usual Care|Death|0|||
126034532|NCT03766009|453424911|FG000|Usual Care|Lost to Follow-up|0|||
126034533|NCT03766009|453424912|FG001|Usual Care|Lost to Follow-up|0|||
126034534|NCT03766009|453424913|FG002|Usual Care|Lost to Follow-up|0|||
126034535|NCT03766009|453424914|FG003|Usual Care|Lost to Follow-up|1|||
126034536|NCT03766009|453424915|FG004|Usual Care|Lost to Follow-up|0|||
126034537|NCT03766009|453424916|FG005|Usual Care|Lost to Follow-up|0|||
126034538|NCT03766009|453424911|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
126034539|NCT03766009|453424912|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
126034540|NCT03766009|453424913|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
126034541|NCT03766009|453424914|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
125880683|NCT04328077|452862582|FG000|Overall Study|Lost to Follow-up|0|||
125880684|NCT04328077|452862583|FG001|Overall Study|Lost to Follow-up|1|||
126034542|NCT03766009|453424915|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
126034543|NCT03766009|453424916|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
126034544|NCT03766009|453424911|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
126265314|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
126265315|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
126265316|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
126265317|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
126265318|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
126265319|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
126265320|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
126265321|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
126265322|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
126265323|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
126265324|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
126265325|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
126265326|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
126265327|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
126265328|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
126265329|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
126265330|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
126265331|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
126265332|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
126265333|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
126265334|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
126265335|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
126265336|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
126265337|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
126265338|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
126265339|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
126265340|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
126265341|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
126265342|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
126265343|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
126265344|NCT03578237|454262822|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
126265345|NCT03578237|454262823|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
126265346|NCT02488330|454262824|FG000|Overall Study|Adverse Event|1|||
126265347|NCT02488330|454262824|FG000|Overall Study|Physician Decision|2|||
126265348|NCT02488330|454262824|FG000|Overall Study|Death|2|||
126265349|NCT02488330|454262824|FG000|Overall Study|Disease Progression|3|||
126265350|NCT02488330|454262824|FG000|Overall Study|Study Termination by Sponsor|4|||
126265351|NCT01206816|454262826|FG000|Overall Study|Protocol Violation|0|||
126265352|NCT01206816|454262827|FG001|Overall Study|Protocol Violation|0|||
126265353|NCT01206816|454262828|FG002|Overall Study|Protocol Violation|1|||
126265354|NCT01206816|454262829|FG003|Overall Study|Protocol Violation|0|||
126034545|NCT03766009|453424912|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
126034546|NCT03766009|453424913|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
126034547|NCT03766009|453424914|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
126034548|NCT03766009|453424915|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
126034549|NCT03766009|453424916|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
126034550|NCT03766009|453424911|FG000|Usual Care|No treatment or declined surgery|0|||
126034551|NCT03766009|453424912|FG001|Usual Care|No treatment or declined surgery|0|||
126034552|NCT03766009|453424913|FG002|Usual Care|No treatment or declined surgery|0|||
126034553|NCT03766009|453424914|FG003|Usual Care|No treatment or declined surgery|2|||
126034554|NCT03766009|453424915|FG004|Usual Care|No treatment or declined surgery|0|||
126034555|NCT03766009|453424916|FG005|Usual Care|No treatment or declined surgery|0|||
126034556|NCT03766009|453424911|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
126034557|NCT03766009|453424912|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
126034558|NCT03766009|453424913|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
126034559|NCT03766009|453424914|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
126360121|NCT00397046|454610754|FG001|Overall Study|Disease Progression|3|||
126360122|NCT00397046|454610755|FG002|Overall Study|Disease Progression|10|||
126360123|NCT00397046|454610756|FG003|Overall Study|Disease Progression|5|||
126360124|NCT00604383|454610765|FG000|Overall Study|Withdrawal by Subject|33|||
126360125|NCT00604383|454610766|FG001|Overall Study|Withdrawal by Subject|31|||
126360126|NCT00604383|454610765|FG000|Overall Study|Lost to Follow-up|24|||
126360127|NCT00604383|454610766|FG001|Overall Study|Lost to Follow-up|19|||
126360128|NCT00604383|454610765|FG000|Overall Study|Death|14|||
126360129|NCT00604383|454610766|FG001|Overall Study|Death|22|||
126097106|NCT00635427|453648331|FG003|Overall Study|Withdrawal Of Consent|2|||
126097107|NCT00635427|453648332|FG004|Overall Study|Withdrawal Of Consent|2|||
126097108|NCT03484273|453648335|FG000|Overall Study|Equipment Malfunction|1|||
126097109|NCT03484273|453648335|FG000|Overall Study|Data excluded from analysis|1|||
126097110|NCT01157676|453648336|FG000|Randomization|Death|1|||
126097111|NCT01157676|453648337|FG001|Randomization|Death|1|||
126097112|NCT01157676|453648336|FG000|Randomization|unresectable|2|||
126097113|NCT01157676|453648337|FG001|Randomization|unresectable|3|||
126097114|NCT01157676|453648336|FG000|Randomization|Withdrawal by Subject|17|||
126097115|NCT01157676|453648337|FG001|Randomization|Withdrawal by Subject|13|||
126097116|NCT01157676|453648336|FG000|Randomization|Physician Decision|1|||
126097117|NCT01157676|453648337|FG001|Randomization|Physician Decision|0|||
126097118|NCT01157676|453648336|FG000|Surgery|underwent open cystectomy|0|||
126097119|NCT01157676|453648337|FG001|Surgery|underwent open cystectomy|4|||
126097120|NCT01157676|453648336|FG000|Surgery|converted to open procedure|0|||
126097121|NCT01157676|453648337|FG001|Surgery|converted to open procedure|5|||
126097122|NCT01157676|453648336|FG000|Surgery|underwent robotic cystectomy|1|||
126097123|NCT01157676|453648337|FG001|Surgery|underwent robotic cystectomy|0|||
126097124|NCT02706899|453648341|FG000|Overall Study|Withdrawal by Subject|1|||
126097125|NCT02706899|453648342|FG001|Overall Study|Withdrawal by Subject|0|||
126097126|NCT02706899|453648341|FG000|Overall Study|Death|8|||
126097127|NCT02706899|453648342|FG001|Overall Study|Death|0|||
126097128|NCT02706899|453648341|FG000|Overall Study|Study Termination by Sponsor|4|||
126097129|NCT02706899|453648342|FG001|Overall Study|Study Termination by Sponsor|6|||
126097130|NCT01435616|453648343|FG000|Overall Study|Adverse Event|39|||
126097131|NCT01435616|453648344|FG001|Overall Study|Adverse Event|21|||
126097132|NCT01435616|453648343|FG000|Overall Study|Death|7|||
126097133|NCT01435616|453648344|FG001|Overall Study|Death|2|||
126097134|NCT01435616|453648343|FG000|Overall Study|Lost to Follow-up|22|||
126097135|NCT01435616|453648344|FG001|Overall Study|Lost to Follow-up|13|||
126097136|NCT01435616|453648343|FG000|Overall Study|Protocol Violation|16|||
126097137|NCT01435616|453648344|FG001|Overall Study|Protocol Violation|13|||
126097138|NCT01435616|453648343|FG000|Overall Study|Withdrawal by Subject|66|||
126097139|NCT01435616|453648344|FG001|Overall Study|Withdrawal by Subject|24|||
126097140|NCT01435616|453648343|FG000|Overall Study|Physician Decision|20|||
126097141|NCT01435616|453648344|FG001|Overall Study|Physician Decision|7|||
126097142|NCT01435616|453648343|FG000|Overall Study|Sponsor Decision|1|||
126097143|NCT01435616|453648344|FG001|Overall Study|Sponsor Decision|0|||
126097144|NCT03122223|453648345|FG000|Overall Study|Withdrawal by Subject|2|||
126097145|NCT03122223|453648346|FG001|Overall Study|Withdrawal by Subject|2|||
126097146|NCT03122223|453648347|FG002|Overall Study|Withdrawal by Subject|1|||
126097147|NCT03122223|453648348|FG003|Overall Study|Withdrawal by Subject|0|||
126097148|NCT03122223|453648345|FG000|Overall Study|Lost to Follow-up|0|||
126097149|NCT03122223|453648346|FG001|Overall Study|Lost to Follow-up|2|||
126097150|NCT03122223|453648347|FG002|Overall Study|Lost to Follow-up|2|||
126097151|NCT03122223|453648348|FG003|Overall Study|Lost to Follow-up|0|||
126360130|NCT00604383|454610765|FG000|Overall Study|Adverse Event|16|||
126360131|NCT00604383|454610766|FG001|Overall Study|Adverse Event|9|||
126360132|NCT00604383|454610765|FG000|Overall Study|Physician Decision|0|||
126360133|NCT00604383|454610766|FG001|Overall Study|Physician Decision|3|||
126360134|NCT00474968|454610769|FG000|Overall Study|Withdrawal by Subject|8|||
126360135|NCT00474968|454610770|FG001|Overall Study|Withdrawal by Subject|7|||
126097152|NCT03122223|453648345|FG000|Overall Study|Participant unable to adhere|1|||
126097153|NCT03122223|453648346|FG001|Overall Study|Participant unable to adhere|1|||
126097154|NCT03122223|453648347|FG002|Overall Study|Participant unable to adhere|1|||
126097155|NCT03122223|453648348|FG003|Overall Study|Participant unable to adhere|0|||
126097156|NCT01151410|453648349|FG000|Overall Study|Withdrawal by Subject|3|||
126097157|NCT01151410|453648350|FG001|Overall Study|Withdrawal by Subject|5|||
126360136|NCT00474968|454610769|FG000|Overall Study|Protocol Violation|9|||
126265355|NCT01206816|454262830|FG004|Overall Study|Protocol Violation|0|||
126265356|NCT01206816|454262831|FG005|Overall Study|Protocol Violation|0|||
126265357|NCT01206816|454262832|FG006|Overall Study|Protocol Violation|0|||
126265358|NCT01206816|454262826|FG000|Overall Study|Withdrawal by Subject|0|||
126265359|NCT01206816|454262827|FG001|Overall Study|Withdrawal by Subject|0|||
126265360|NCT01206816|454262828|FG002|Overall Study|Withdrawal by Subject|1|||
126265361|NCT01206816|454262829|FG003|Overall Study|Withdrawal by Subject|0|||
126265362|NCT01206816|454262830|FG004|Overall Study|Withdrawal by Subject|0|||
126265363|NCT01206816|454262831|FG005|Overall Study|Withdrawal by Subject|0|||
126265364|NCT01206816|454262832|FG006|Overall Study|Withdrawal by Subject|0|||
126265365|NCT01206816|454262826|FG000|Overall Study|Progressive disease|3|||
126265366|NCT01206816|454262827|FG001|Overall Study|Progressive disease|3|||
126265367|NCT01206816|454262828|FG002|Overall Study|Progressive disease|13|||
126265368|NCT01206816|454262829|FG003|Overall Study|Progressive disease|3|||
126265369|NCT01206816|454262830|FG004|Overall Study|Progressive disease|3|||
126265370|NCT01206816|454262831|FG005|Overall Study|Progressive disease|16|||
126265371|NCT01206816|454262832|FG006|Overall Study|Progressive disease|3|||
126265372|NCT01206816|454262826|FG000|Overall Study|Other AE|0|||
126265373|NCT01206816|454262827|FG001|Overall Study|Other AE|0|||
126265374|NCT01206816|454262828|FG002|Overall Study|Other AE|4|||
126265375|NCT01206816|454262829|FG003|Overall Study|Other AE|0|||
126265376|NCT01206816|454262830|FG004|Overall Study|Other AE|0|||
126265377|NCT01206816|454262831|FG005|Overall Study|Other AE|3|||
126265378|NCT01206816|454262832|FG006|Overall Study|Other AE|2|||
126265379|NCT01206816|454262826|FG000|Overall Study|other than stated above|0|||
126265380|NCT01206816|454262827|FG001|Overall Study|other than stated above|0|||
126265381|NCT01206816|454262828|FG002|Overall Study|other than stated above|1|||
126265382|NCT01206816|454262829|FG003|Overall Study|other than stated above|0|||
126034560|NCT03766009|453424915|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
126265383|NCT01206816|454262830|FG004|Overall Study|other than stated above|0|||
126265384|NCT01206816|454262831|FG005|Overall Study|other than stated above|0|||
126265385|NCT01206816|454262832|FG006|Overall Study|other than stated above|1|||
126265386|NCT02493777|454262835|FG000|Overall Study|Lost to Follow-up|0|||
126265387|NCT02493777|454262836|FG001|Overall Study|Lost to Follow-up|1|||
126265388|NCT01642914|454262837|FG000|Overall Study|Adverse Event|11|||
126265389|NCT01642914|454262838|FG001|Overall Study|Adverse Event|7|||
126265390|NCT01642914|454262839|FG002|Overall Study|Adverse Event|15|||
126265391|NCT01642914|454262837|FG000|Overall Study|Lack of Efficacy|9|||
126265392|NCT01642914|454262838|FG001|Overall Study|Lack of Efficacy|4|||
126265393|NCT01642914|454262839|FG002|Overall Study|Lack of Efficacy|2|||
126265394|NCT01642914|454262837|FG000|Overall Study|Protocol Violation|15|||
126265395|NCT01642914|454262838|FG001|Overall Study|Protocol Violation|13|||
126265396|NCT01642914|454262839|FG002|Overall Study|Protocol Violation|6|||
126265397|NCT01642914|454262837|FG000|Overall Study|Withdrawal by Subject|5|||
126265398|NCT01642914|454262838|FG001|Overall Study|Withdrawal by Subject|5|||
126265399|NCT01642914|454262839|FG002|Overall Study|Withdrawal by Subject|10|||
126265400|NCT01642914|454262837|FG000|Overall Study|Lost to Follow-up|5|||
126265401|NCT01642914|454262838|FG001|Overall Study|Lost to Follow-up|3|||
126265402|NCT01642914|454262839|FG002|Overall Study|Lost to Follow-up|7|||
126265403|NCT01642914|454262837|FG000|Overall Study|Other Reason|1|||
126265404|NCT01642914|454262838|FG001|Overall Study|Other Reason|0|||
126265405|NCT01642914|454262839|FG002|Overall Study|Other Reason|0|||
126360137|NCT00474968|454610770|FG001|Overall Study|Protocol Violation|8|||
126360138|NCT00474968|454610769|FG000|Overall Study|Sample not collected|1|||
126360139|NCT00474968|454610770|FG001|Overall Study|Sample not collected|1|||
126360140|NCT00281580|454610771|FG000|Overall Study|Adverse Event|2|||
126360141|NCT00281580|454610772|FG001|Overall Study|Adverse Event|0|||
126360142|NCT00281580|454610773|FG002|Overall Study|Adverse Event|2|||
126360143|NCT00281580|454610774|FG003|Overall Study|Adverse Event|4|||
126360144|NCT00281580|454610775|FG004|Overall Study|Adverse Event|1|||
126360145|NCT00281580|454610776|FG005|Overall Study|Adverse Event|0|||
126360146|NCT00281580|454610777|FG006|Overall Study|Adverse Event|1|||
126360147|NCT00281580|454610778|FG007|Overall Study|Adverse Event|0|||
126360148|NCT00281580|454610779|FG008|Overall Study|Adverse Event|1|||
126360149|NCT00281580|454610780|FG009|Overall Study|Adverse Event|6|||
126360150|NCT00281580|454610781|FG010|Overall Study|Adverse Event|0|||
126360151|NCT00281580|454610782|FG011|Overall Study|Adverse Event|5|||
126360152|NCT00281580|454610783|FG012|Overall Study|Adverse Event|8|||
126360153|NCT00281580|454610784|FG013|Overall Study|Adverse Event|2|||
126360154|NCT00281580|454610785|FG014|Overall Study|Adverse Event|3|||
126360155|NCT00281580|454610786|FG015|Overall Study|Adverse Event|3|||
126360156|NCT00281580|454610771|FG000|Overall Study|Protocol Violation|0|||
126360157|NCT00281580|454610772|FG001|Overall Study|Protocol Violation|0|||
126360158|NCT00281580|454610773|FG002|Overall Study|Protocol Violation|1|||
126360159|NCT00281580|454610774|FG003|Overall Study|Protocol Violation|1|||
126360160|NCT00281580|454610775|FG004|Overall Study|Protocol Violation|0|||
126360161|NCT00281580|454610776|FG005|Overall Study|Protocol Violation|0|||
126360162|NCT00281580|454610777|FG006|Overall Study|Protocol Violation|1|||
126360163|NCT00281580|454610778|FG007|Overall Study|Protocol Violation|0|||
126360164|NCT00281580|454610779|FG008|Overall Study|Protocol Violation|2|||
126265406|NCT01705236|454262840|FG000|Overall Study|Lost to Follow-up|1|||
126265407|NCT01705236|454262840|FG000|Overall Study|Administrative problems|2|||
126265408|NCT01705236|454262840|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126265409|NCT01705236|454262840|FG000|Overall Study|Protocol Violation|3|||
126265410|NCT01705236|454262840|FG000|Overall Study|Abnormal test procedure result(s)|4|||
126265411|NCT01705236|454262840|FG000|Overall Study|Abnormal laboratory value(s)|4|||
126265412|NCT01705236|454262840|FG000|Overall Study|Withdrawal by Subject|5|||
126265413|NCT01705236|454262840|FG000|Overall Study|Adverse Event|5|||
126265414|NCT00171301|454262841|FG000|Overall Study|Death|1|||
126265415|NCT00171301|454262842|FG001|Overall Study|Death|2|||
126265416|NCT00171301|454262841|FG000|Overall Study|Adverse Event|1|||
126265417|NCT00171301|454262842|FG001|Overall Study|Adverse Event|2|||
126265418|NCT00171301|454262841|FG000|Overall Study|Lost to Follow-up|6|||
126265419|NCT00171301|454262842|FG001|Overall Study|Lost to Follow-up|2|||
126265420|NCT00171301|454262841|FG000|Overall Study|Protocol Violation|0|||
126265421|NCT00171301|454262842|FG001|Overall Study|Protocol Violation|2|||
126265422|NCT00171301|454262841|FG000|Overall Study|Withdrawal by Subject|0|||
126265423|NCT00171301|454262842|FG001|Overall Study|Withdrawal by Subject|1|||
126265424|NCT04319159|454262843|FG000|Overall Study|Screening failure|13|||
126265425|NCT04319159|454262843|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
126265426|NCT04319159|454262843|FG000|Overall Study|Withdrawal by Subject|1|||
126034561|NCT03766009|453424916|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
126034562|NCT03766009|453424911|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126034563|NCT03766009|453424912|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
126034564|NCT03766009|453424913|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126034565|NCT03766009|453424914|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126034566|NCT03766009|453424915|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126034567|NCT03766009|453424916|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126034568|NCT03766009|453424911|FG000|Usual Care|Ineligible|0|||
126034569|NCT03766009|453424912|FG001|Usual Care|Ineligible|1|||
126034570|NCT03766009|453424913|FG002|Usual Care|Ineligible|0|||
126034571|NCT03766009|453424914|FG003|Usual Care|Ineligible|0|||
126034572|NCT03766009|453424915|FG004|Usual Care|Ineligible|0|||
126034573|NCT03766009|453424916|FG005|Usual Care|Ineligible|0|||
126034574|NCT03766009|453424911|FG000|Usual Care|Other: Staff turnover|0|||
126034575|NCT03766009|453424912|FG001|Usual Care|Other: Staff turnover|0|||
126034576|NCT03766009|453424913|FG002|Usual Care|Other: Staff turnover|0|||
126034577|NCT03766009|453424914|FG003|Usual Care|Other: Staff turnover|0|||
126034578|NCT03766009|453424915|FG004|Usual Care|Other: Staff turnover|0|||
126034579|NCT03766009|453424916|FG005|Usual Care|Other: Staff turnover|2|||
126034580|NCT04552223|453424917|FG000|Overall Study|Withdrawal by Subject|1|||
126034581|NCT03869866|453424918|FG000|Overall Study|Protocol Violation|1|||
126034582|NCT03869866|453424918|FG000|Overall Study|Withdrawal by Subject|3|||
126034583|NCT00506519|453424920|FG000|Overall Study|Death|4|||
126034584|NCT00506519|453424921|FG001|Overall Study|Death|6|||
126034585|NCT00506519|453424922|FG002|Overall Study|Death|0|||
126034586|NCT00506519|453424920|FG000|Overall Study|Adverse Event|1|||
126034587|NCT00506519|453424921|FG001|Overall Study|Adverse Event|0|||
126034588|NCT00506519|453424922|FG002|Overall Study|Adverse Event|0|||
126034589|NCT01186367|453424923|FG000|Overall Study|Lost to Follow-up|7|||
126034590|NCT01186367|453424924|FG001|Overall Study|Lost to Follow-up|4|||
126034591|NCT01186367|453424925|FG002|Overall Study|Lost to Follow-up|7|||
126034592|NCT01186367|453424923|FG000|Overall Study|Did not receive study treatment|0|||
126034593|NCT01186367|453424924|FG001|Overall Study|Did not receive study treatment|1|||
126034594|NCT01186367|453424925|FG002|Overall Study|Did not receive study treatment|0|||
126034595|NCT02975882|453424926|FG000|Overall Study|Adverse Event|1|||
126034596|NCT02975882|453424927|FG001|Overall Study|Adverse Event|2|||
126034597|NCT02975882|453424928|FG002|Overall Study|Adverse Event|1|||
126034598|NCT02975882|453424929|FG003|Overall Study|Adverse Event|1|||
126034599|NCT02975882|453424926|FG000|Overall Study|Death|0|||
126034600|NCT02975882|453424927|FG001|Overall Study|Death|1|||
126034601|NCT02975882|453424928|FG002|Overall Study|Death|0|||
126034602|NCT02975882|453424929|FG003|Overall Study|Death|0|||
126034603|NCT02975882|453424926|FG000|Overall Study|Lack of Efficacy|3|||
126034604|NCT02975882|453424927|FG001|Overall Study|Lack of Efficacy|7|||
126034605|NCT02975882|453424928|FG002|Overall Study|Lack of Efficacy|4|||
126034606|NCT02975882|453424929|FG003|Overall Study|Lack of Efficacy|3|||
126265427|NCT02100319|454262844|FG000|Overall Study|Case Report Forms Uncollected|11|||
126265428|NCT02100319|454262844|FG000|Overall Study|Protocol Deviation|5|||
126265429|NCT02370914|454262845|FG000|Overall Study|Protocol Violation|2|||
126265430|NCT00754442|454262846|FG000|Overall Study|Withdrawal by Subject|5|||
126265431|NCT00754442|454262847|FG001|Overall Study|Withdrawal by Subject|3|||
125880685|NCT04328077|452862584|FG002|Overall Study|Lost to Follow-up|0|||
126034607|NCT02975882|453424926|FG000|Overall Study|Physician Decision|0|||
126034608|NCT02975882|453424927|FG001|Overall Study|Physician Decision|2|||
126034609|NCT02975882|453424928|FG002|Overall Study|Physician Decision|4|||
126034610|NCT02975882|453424929|FG003|Overall Study|Physician Decision|2|||
126034611|NCT02975882|453424926|FG000|Overall Study|Ineligible|0|||
126034612|NCT02975882|453424927|FG001|Overall Study|Ineligible|1|||
126034613|NCT02975882|453424928|FG002|Overall Study|Ineligible|0|||
126034614|NCT02975882|453424929|FG003|Overall Study|Ineligible|0|||
126034615|NCT02985957|453424930|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126034616|NCT02985957|453424931|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126034617|NCT02985957|453424932|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126034618|NCT02985957|453424933|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126034619|NCT02985957|453424934|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126034620|NCT02985957|453424935|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126034621|NCT02985957|453424936|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126034622|NCT02985957|453424930|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
126034623|NCT02985957|453424931|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126034624|NCT02985957|453424932|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
126034625|NCT02985957|453424933|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
126034626|NCT02985957|453424934|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
126034627|NCT02985957|453424935|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
126034628|NCT02985957|453424936|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
126034629|NCT02985957|453424930|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126034630|NCT02985957|453424931|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126034631|NCT02985957|453424932|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126034632|NCT02985957|453424933|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126034633|NCT02985957|453424934|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126034634|NCT02985957|453424935|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126034635|NCT02985957|453424936|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
126034636|NCT02985957|453424930|FG000|Treatment Period|Death|0|||
126034637|NCT02985957|453424931|FG001|Treatment Period|Death|0|||
126034638|NCT02985957|453424932|FG002|Treatment Period|Death|0|||
126034639|NCT02985957|453424933|FG003|Treatment Period|Death|0|||
126034640|NCT02985957|453424934|FG004|Treatment Period|Death|1|||
126034641|NCT02985957|453424935|FG005|Treatment Period|Death|0|||
126034642|NCT02985957|453424936|FG006|Treatment Period|Death|0|||
126034643|NCT02985957|453424930|FG000|Treatment Period|Participant withdrew consent|0|||
126034644|NCT02985957|453424931|FG001|Treatment Period|Participant withdrew consent|0|||
126034645|NCT02985957|453424932|FG002|Treatment Period|Participant withdrew consent|0|||
126034646|NCT02985957|453424933|FG003|Treatment Period|Participant withdrew consent|1|||
126034647|NCT02985957|453424934|FG004|Treatment Period|Participant withdrew consent|3|||
126034648|NCT02985957|453424935|FG005|Treatment Period|Participant withdrew consent|0|||
126034649|NCT02985957|453424936|FG006|Treatment Period|Participant withdrew consent|1|||
126034650|NCT02985957|453424930|FG000|Treatment Period|Lost to Follow-up|0|||
126034651|NCT02985957|453424931|FG001|Treatment Period|Lost to Follow-up|0|||
126034652|NCT02985957|453424932|FG002|Treatment Period|Lost to Follow-up|0|||
126034653|NCT02985957|453424933|FG003|Treatment Period|Lost to Follow-up|0|||
126034654|NCT02985957|453424934|FG004|Treatment Period|Lost to Follow-up|1|||
126034655|NCT02985957|453424935|FG005|Treatment Period|Lost to Follow-up|0|||
126034656|NCT02985957|453424936|FG006|Treatment Period|Lost to Follow-up|0|||
126034657|NCT02985957|453424930|FG000|Treatment Period|Other reasons|0|||
126034658|NCT02985957|453424931|FG001|Treatment Period|Other reasons|0|||
126034659|NCT02985957|453424932|FG002|Treatment Period|Other reasons|1|||
126034660|NCT02985957|453424933|FG003|Treatment Period|Other reasons|3|||
126034661|NCT02985957|453424934|FG004|Treatment Period|Other reasons|6|||
126034662|NCT02985957|453424935|FG005|Treatment Period|Other reasons|0|||
126360165|NCT00281580|454610780|FG009|Overall Study|Protocol Violation|0|||
126360166|NCT00281580|454610781|FG010|Overall Study|Protocol Violation|1|||
126360167|NCT00281580|454610782|FG011|Overall Study|Protocol Violation|2|||
126360168|NCT00281580|454610783|FG012|Overall Study|Protocol Violation|0|||
126360169|NCT00281580|454610784|FG013|Overall Study|Protocol Violation|1|||
126360170|NCT00281580|454610785|FG014|Overall Study|Protocol Violation|1|||
126360171|NCT00281580|454610786|FG015|Overall Study|Protocol Violation|3|||
126360172|NCT00281580|454610771|FG000|Overall Study|Withdrawal by Subject|3|||
126360173|NCT00281580|454610772|FG001|Overall Study|Withdrawal by Subject|0|||
126360174|NCT00281580|454610773|FG002|Overall Study|Withdrawal by Subject|1|||
126360175|NCT00281580|454610774|FG003|Overall Study|Withdrawal by Subject|1|||
126034663|NCT02985957|453424936|FG006|Treatment Period|Other reasons|1|||
126034664|NCT02985957|453424930|FG000|Treatment Period|Not reported|0|||
126034665|NCT02985957|453424931|FG001|Treatment Period|Not reported|1|||
126034666|NCT02985957|453424932|FG002|Treatment Period|Not reported|2|||
126360176|NCT00281580|454610775|FG004|Overall Study|Withdrawal by Subject|1|||
126360177|NCT00281580|454610776|FG005|Overall Study|Withdrawal by Subject|2|||
126097158|NCT01151410|453648349|FG000|Overall Study|Lost to Follow-up|3|||
126097159|NCT01151410|453648350|FG001|Overall Study|Lost to Follow-up|4|||
126097160|NCT01151410|453648349|FG000|Overall Study|Adverse Event|1|||
126097161|NCT01151410|453648350|FG001|Overall Study|Adverse Event|2|||
126097162|NCT01151410|453648349|FG000|Overall Study|Protocol deviation|2|||
126097163|NCT01151410|453648350|FG001|Overall Study|Protocol deviation|1|||
126097164|NCT01151410|453648349|FG000|Overall Study|Administrative problems|1|||
126097165|NCT01151410|453648350|FG001|Overall Study|Administrative problems|1|||
126097166|NCT01151410|453648349|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126097167|NCT01151410|453648350|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126097168|NCT01151410|453648349|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126097169|NCT01151410|453648350|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126097170|NCT01237587|453648356|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
126097171|NCT01237587|453648357|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
126097172|NCT01237587|453648356|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
126097173|NCT01237587|453648357|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
126097174|NCT01237587|453648356|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
126097175|NCT01237587|453648357|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
126097176|NCT01237587|453648356|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
126097177|NCT01237587|453648357|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
126097178|NCT01237587|453648356|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
126097179|NCT01237587|453648357|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
126097180|NCT01237587|453648356|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
126097181|NCT01237587|453648357|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
126097182|NCT01237587|453648356|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
126097183|NCT01237587|453648357|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
126097184|NCT01237587|453648356|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
126097185|NCT01237587|453648357|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
126097186|NCT01237587|453648356|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
126097187|NCT01237587|453648357|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
126097188|NCT01237587|453648356|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
126097189|NCT01237587|453648357|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
126097190|NCT01237587|453648356|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
126097191|NCT01237587|453648357|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
126097192|NCT01237587|453648356|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
126097193|NCT01237587|453648357|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
126097194|NCT01237587|453648356|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
126097195|NCT01237587|453648357|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
126097196|NCT01237587|453648356|FG000|Taper Phase|Adverse Event|0|||
126097197|NCT01237587|453648357|FG001|Taper Phase|Adverse Event|2|||
126097198|NCT01237587|453648356|FG000|Taper Phase|Protocol Violation|2|||
126097199|NCT01237587|453648357|FG001|Taper Phase|Protocol Violation|0|||
126097200|NCT01237587|453648356|FG000|Taper Phase|Lack of Efficacy|2|||
126097201|NCT01237587|453648357|FG001|Taper Phase|Lack of Efficacy|5|||
126097202|NCT01237587|453648356|FG000|Taper Phase|Parent/Guardian Decision|0|||
126097203|NCT01237587|453648357|FG001|Taper Phase|Parent/Guardian Decision|2|||
126097204|NCT01237587|453648356|FG000|Taper Phase|Sponsor Decision|1|||
126097205|NCT01237587|453648357|FG001|Taper Phase|Sponsor Decision|0|||
126097206|NCT01237587|453648356|FG000|Taper Phase|Withdrawal by Subject|0|||
126097207|NCT01237587|453648357|FG001|Taper Phase|Withdrawal by Subject|1|||
126097208|NCT02656329|453648358|FG000|Overall Study|Lost to Follow-up|2|||
126097209|NCT02656329|453648359|FG001|Overall Study|Lost to Follow-up|3|||
126097210|NCT02656329|453648358|FG000|Overall Study|Withdrawal by Subject|7|||
126097211|NCT02656329|453648359|FG001|Overall Study|Withdrawal by Subject|6|||
126097212|NCT02656329|453648358|FG000|Overall Study|Study termination by Sponsor|150|||
126097213|NCT02656329|453648359|FG001|Overall Study|Study termination by Sponsor|142|||
126097214|NCT02656329|453648358|FG000|Overall Study|Other than specified above|5|||
126097215|NCT02656329|453648359|FG001|Overall Study|Other than specified above|6|||
126097216|NCT01139580|453648360|FG000|Overall Study|Adverse Event|5|||
126097217|NCT01139580|453648361|FG001|Overall Study|Adverse Event|4|||
126097218|NCT01139580|453648360|FG000|Overall Study|Lost to Follow-up|9|||
126097219|NCT01139580|453648361|FG001|Overall Study|Lost to Follow-up|1|||
126097220|NCT01139580|453648360|FG000|Overall Study|Lack of Efficacy|0|||
126097221|NCT01139580|453648361|FG001|Overall Study|Lack of Efficacy|2|||
126097222|NCT01139580|453648360|FG000|Overall Study|Withdrawal by Subject|6|||
126097223|NCT01139580|453648361|FG001|Overall Study|Withdrawal by Subject|9|||
126097224|NCT01139580|453648360|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
126097225|NCT01139580|453648361|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
125880686|NCT04328077|452862585|FG003|Overall Study|Lost to Follow-up|0|||
126097226|NCT01139580|453648360|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
126097227|NCT01139580|453648361|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
126097228|NCT01139580|453648360|FG000|Overall Study|Misrandomized|1|||
126097229|NCT01139580|453648361|FG001|Overall Study|Misrandomized|0|||
126097230|NCT01139580|453648360|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
126097231|NCT01139580|453648361|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
126097232|NCT01139580|453648360|FG000|Overall Study|Participant Randomization in Error|0|||
126097233|NCT01139580|453648361|FG001|Overall Study|Participant Randomization in Error|1|||
126097234|NCT00633880|453648366|FG000|Open Label Titration|Lack of Efficacy|1|||
126097235|NCT00633880|453648367|FG001|Open Label Titration|Lack of Efficacy|0|||
126265432|NCT00296491|454262848|FG000|Overall Study|Low Pollen Counts|18|||
126265433|NCT00296491|454262849|FG001|Overall Study|Low Pollen Counts|26|||
126265434|NCT00296491|454262850|FG002|Overall Study|Low Pollen Counts|25|||
126265435|NCT00296491|454262851|FG003|Overall Study|Low Pollen Counts|16|||
126265436|NCT00296491|454262848|FG000|Overall Study|Protocol Violation|4|||
126265437|NCT00296491|454262849|FG001|Overall Study|Protocol Violation|6|||
126265438|NCT00296491|454262850|FG002|Overall Study|Protocol Violation|2|||
126265439|NCT00296491|454262851|FG003|Overall Study|Protocol Violation|3|||
126265440|NCT00296491|454262848|FG000|Overall Study|Adverse Event|1|||
126265441|NCT00296491|454262849|FG001|Overall Study|Adverse Event|3|||
126265442|NCT00296491|454262850|FG002|Overall Study|Adverse Event|1|||
126265443|NCT00296491|454262851|FG003|Overall Study|Adverse Event|4|||
126265444|NCT00296491|454262848|FG000|Overall Study|Withdrawn due to Asthma|0|||
126265445|NCT00296491|454262849|FG001|Overall Study|Withdrawn due to Asthma|0|||
126265446|NCT00296491|454262850|FG002|Overall Study|Withdrawn due to Asthma|0|||
126265447|NCT00296491|454262851|FG003|Overall Study|Withdrawn due to Asthma|4|||
126265448|NCT00296491|454262848|FG000|Overall Study|Withdrawal by Subject|7|||
126265449|NCT00296491|454262849|FG001|Overall Study|Withdrawal by Subject|3|||
126265450|NCT00296491|454262850|FG002|Overall Study|Withdrawal by Subject|3|||
126265451|NCT00296491|454262851|FG003|Overall Study|Withdrawal by Subject|2|||
126265452|NCT00296491|454262848|FG000|Overall Study|Non-Compliance|12|||
126265453|NCT00296491|454262849|FG001|Overall Study|Non-Compliance|13|||
126265454|NCT00296491|454262850|FG002|Overall Study|Non-Compliance|10|||
126265455|NCT00296491|454262851|FG003|Overall Study|Non-Compliance|14|||
126265456|NCT00296491|454262848|FG000|Overall Study|Lost to Follow-up|0|||
126265457|NCT00296491|454262849|FG001|Overall Study|Lost to Follow-up|2|||
126265458|NCT00296491|454262850|FG002|Overall Study|Lost to Follow-up|2|||
126265459|NCT00296491|454262851|FG003|Overall Study|Lost to Follow-up|0|||
126265460|NCT01300052|454262852|FG000|Overall Study|Adverse Event|3|||
126265461|NCT01300052|454262853|FG001|Overall Study|Adverse Event|0|||
126265462|NCT01300052|454262852|FG000|Overall Study|Withdrawal by Subject|2|||
126265463|NCT01300052|454262853|FG001|Overall Study|Withdrawal by Subject|2|||
126265464|NCT01300052|454262852|FG000|Overall Study|Protocol Violation|1|||
126265465|NCT01300052|454262853|FG001|Overall Study|Protocol Violation|1|||
126265466|NCT01231373|454262854|FG000|Overall Study|Withdrew consent prior to randomization|2|||
126265467|NCT01231373|454262855|FG001|Overall Study|Withdrew consent prior to randomization|1|||
126265468|NCT01231373|454262856|FG002|Overall Study|Withdrew consent prior to randomization|0|||
126265469|NCT01231373|454262857|FG003|Overall Study|Withdrew consent prior to randomization|0|||
126265470|NCT01231373|454262854|FG000|Overall Study|Lost to Follow-up|0|||
126265471|NCT01231373|454262855|FG001|Overall Study|Lost to Follow-up|0|||
126265472|NCT01231373|454262856|FG002|Overall Study|Lost to Follow-up|0|||
126265473|NCT01231373|454262857|FG003|Overall Study|Lost to Follow-up|1|||
126265474|NCT01231373|454262854|FG000|Overall Study|Withdrew Consent|1|||
126265475|NCT01231373|454262855|FG001|Overall Study|Withdrew Consent|0|||
126265476|NCT01231373|454262856|FG002|Overall Study|Withdrew Consent|0|||
126265477|NCT01231373|454262857|FG003|Overall Study|Withdrew Consent|0|||
126265478|NCT03451006|454262858|FG000|Overall Study|Withdrawal by Subject|2|||
126265479|NCT03451006|454262859|FG001|Overall Study|Withdrawal by Subject|2|||
126265480|NCT01929395|454262860|FG000|Overall Study|Did not complete - non-related toxicity|1|||
126265481|NCT01929395|454262861|FG001|Overall Study|Did not complete - non-related toxicity|0|||
126265482|NCT01929395|454262862|FG002|Overall Study|Did not complete - non-related toxicity|0|||
126265483|NCT01929395|454262860|FG000|Overall Study|Withdrawal by Subject|0|||
126265484|NCT01929395|454262861|FG001|Overall Study|Withdrawal by Subject|1|||
126265485|NCT01929395|454262862|FG002|Overall Study|Withdrawal by Subject|0|||
126265486|NCT01929395|454262860|FG000|Overall Study|Screen Fail|0|||
126265487|NCT01929395|454262861|FG001|Overall Study|Screen Fail|0|||
126265488|NCT01929395|454262862|FG002|Overall Study|Screen Fail|1|||
126265489|NCT02547766|454262863|FG000|Overall Study|Withdrawal by Subject|1|||
126265490|NCT00351351|454262866|FG000|Overall Study|surgical access pbs; device issues|9|||
126265491|NCT00351351|454262867|FG001|Overall Study|surgical access pbs; device issues|4|||
126265492|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
126265493|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
126265494|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
126265495|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
126265496|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
126265497|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
126265498|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
126265499|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
126265500|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
126034667|NCT02985957|453424933|FG003|Treatment Period|Not reported|5|||
126034668|NCT02985957|453424934|FG004|Treatment Period|Not reported|0|||
126034669|NCT02985957|453424935|FG005|Treatment Period|Not reported|0|||
126034670|NCT02985957|453424936|FG006|Treatment Period|Not reported|0|||
126034671|NCT02985957|453424930|FG000|Treatment Period|Maximum clinical benefit|0|||
126034672|NCT02985957|453424931|FG001|Treatment Period|Maximum clinical benefit|0|||
126034673|NCT02985957|453424932|FG002|Treatment Period|Maximum clinical benefit|1|||
126034674|NCT02985957|453424933|FG003|Treatment Period|Maximum clinical benefit|1|||
126360178|NCT00281580|454610777|FG006|Overall Study|Withdrawal by Subject|2|||
126034675|NCT02985957|453424934|FG004|Treatment Period|Maximum clinical benefit|0|||
126034676|NCT02985957|453424935|FG005|Treatment Period|Maximum clinical benefit|0|||
126034677|NCT02985957|453424936|FG006|Treatment Period|Maximum clinical benefit|2|||
126034678|NCT02985957|453424930|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
126034679|NCT02985957|453424931|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
126034680|NCT02985957|453424932|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
126034681|NCT02985957|453424933|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
126034682|NCT02985957|453424934|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
126034683|NCT02985957|453424935|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
126034684|NCT02985957|453424936|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
126034685|NCT02985957|453424930|FG000|Treatment Period|Study drug toxicity|1|||
126034686|NCT02985957|453424931|FG001|Treatment Period|Study drug toxicity|23|||
126034687|NCT02985957|453424932|FG002|Treatment Period|Study drug toxicity|20|||
126034688|NCT02985957|453424933|FG003|Treatment Period|Study drug toxicity|11|||
126034689|NCT02985957|453424934|FG004|Treatment Period|Study drug toxicity|19|||
126034690|NCT02985957|453424935|FG005|Treatment Period|Study drug toxicity|3|||
126034691|NCT02985957|453424936|FG006|Treatment Period|Study drug toxicity|5|||
126034692|NCT02985957|453424930|FG000|Treatment Period|Disease progression|0|||
126034693|NCT02985957|453424931|FG001|Treatment Period|Disease progression|16|||
126034694|NCT02985957|453424932|FG002|Treatment Period|Disease progression|20|||
126034695|NCT02985957|453424933|FG003|Treatment Period|Disease progression|39|||
126360179|NCT00281580|454610778|FG007|Overall Study|Withdrawal by Subject|0|||
126360180|NCT00281580|454610779|FG008|Overall Study|Withdrawal by Subject|1|||
126360181|NCT00281580|454610780|FG009|Overall Study|Withdrawal by Subject|4|||
126360182|NCT00281580|454610781|FG010|Overall Study|Withdrawal by Subject|1|||
126360183|NCT00281580|454610782|FG011|Overall Study|Withdrawal by Subject|1|||
126360184|NCT00281580|454610783|FG012|Overall Study|Withdrawal by Subject|2|||
126360185|NCT00281580|454610784|FG013|Overall Study|Withdrawal by Subject|2|||
126360186|NCT00281580|454610785|FG014|Overall Study|Withdrawal by Subject|1|||
126360187|NCT00281580|454610786|FG015|Overall Study|Withdrawal by Subject|5|||
126360188|NCT00281580|454610771|FG000|Overall Study|Lack of Efficacy|2|||
126360189|NCT00281580|454610772|FG001|Overall Study|Lack of Efficacy|1|||
126360190|NCT00281580|454610773|FG002|Overall Study|Lack of Efficacy|1|||
126360191|NCT00281580|454610774|FG003|Overall Study|Lack of Efficacy|6|||
126360192|NCT00281580|454610775|FG004|Overall Study|Lack of Efficacy|2|||
126360193|NCT00281580|454610776|FG005|Overall Study|Lack of Efficacy|0|||
126360194|NCT00281580|454610777|FG006|Overall Study|Lack of Efficacy|0|||
126360195|NCT00281580|454610778|FG007|Overall Study|Lack of Efficacy|0|||
126360196|NCT00281580|454610779|FG008|Overall Study|Lack of Efficacy|0|||
126360197|NCT00281580|454610780|FG009|Overall Study|Lack of Efficacy|0|||
126360198|NCT00281580|454610781|FG010|Overall Study|Lack of Efficacy|0|||
126360199|NCT00281580|454610782|FG011|Overall Study|Lack of Efficacy|1|||
126360200|NCT00281580|454610783|FG012|Overall Study|Lack of Efficacy|0|||
126360201|NCT00281580|454610784|FG013|Overall Study|Lack of Efficacy|2|||
126360202|NCT00281580|454610785|FG014|Overall Study|Lack of Efficacy|1|||
126360203|NCT00281580|454610786|FG015|Overall Study|Lack of Efficacy|0|||
126360204|NCT00281580|454610771|FG000|Overall Study|Lost to Follow-up|0|||
126360205|NCT00281580|454610772|FG001|Overall Study|Lost to Follow-up|0|||
126360206|NCT00281580|454610773|FG002|Overall Study|Lost to Follow-up|0|||
126360207|NCT00281580|454610774|FG003|Overall Study|Lost to Follow-up|3|||
126360208|NCT00281580|454610775|FG004|Overall Study|Lost to Follow-up|0|||
126360209|NCT00281580|454610776|FG005|Overall Study|Lost to Follow-up|1|||
126360210|NCT00281580|454610777|FG006|Overall Study|Lost to Follow-up|0|||
126360211|NCT00281580|454610778|FG007|Overall Study|Lost to Follow-up|1|||
126360212|NCT00281580|454610779|FG008|Overall Study|Lost to Follow-up|2|||
126360213|NCT00281580|454610780|FG009|Overall Study|Lost to Follow-up|1|||
126360214|NCT00281580|454610781|FG010|Overall Study|Lost to Follow-up|1|||
126360215|NCT00281580|454610782|FG011|Overall Study|Lost to Follow-up|0|||
126360216|NCT00281580|454610783|FG012|Overall Study|Lost to Follow-up|1|||
126360217|NCT00281580|454610784|FG013|Overall Study|Lost to Follow-up|0|||
126034696|NCT02985957|453424934|FG004|Treatment Period|Disease progression|29|||
126034697|NCT02985957|453424935|FG005|Treatment Period|Disease progression|11|||
126360218|NCT00281580|454610785|FG014|Overall Study|Lost to Follow-up|0|||
126360219|NCT00281580|454610786|FG015|Overall Study|Lost to Follow-up|0|||
126360220|NCT00281580|454610771|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
126360221|NCT00281580|454610772|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
126360222|NCT00281580|454610773|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
125880687|NCT04328077|452862582|FG000|Overall Study|Withdrawal by Subject|0|||
126097236|NCT00633880|453648368|FG002|Open Label Titration|Lack of Efficacy|0|||
126097237|NCT00633880|453648366|FG000|Open Label Titration|Adverse Event|13|||
126097238|NCT00633880|453648367|FG001|Open Label Titration|Adverse Event|0|||
126097239|NCT00633880|453648368|FG002|Open Label Titration|Adverse Event|0|||
126097240|NCT00633880|453648366|FG000|Open Label Titration|Treatment Failure|55|||
126097241|NCT00633880|453648367|FG001|Open Label Titration|Treatment Failure|0|||
126097242|NCT00633880|453648368|FG002|Open Label Titration|Treatment Failure|0|||
126097243|NCT00633880|453648366|FG000|Open Label Titration|Protocol Violation|6|||
126097244|NCT00633880|453648367|FG001|Open Label Titration|Protocol Violation|0|||
126097245|NCT00633880|453648368|FG002|Open Label Titration|Protocol Violation|0|||
126097246|NCT00633880|453648366|FG000|Open Label Titration|Physician Decision|1|||
126097247|NCT00633880|453648367|FG001|Open Label Titration|Physician Decision|0|||
126097248|NCT00633880|453648368|FG002|Open Label Titration|Physician Decision|0|||
126097249|NCT00633880|453648366|FG000|Open Label Titration|Withdrawal by Subject|4|||
126097250|NCT00633880|453648367|FG001|Open Label Titration|Withdrawal by Subject|0|||
126097251|NCT00633880|453648368|FG002|Open Label Titration|Withdrawal by Subject|0|||
126097252|NCT00847808|453648375|FG000|Overall Study|Adverse Event|7|||
126097253|NCT00847808|453648375|FG000|Overall Study|Protocol Violation|1|||
126097254|NCT00847808|453648375|FG000|Overall Study|Lost to Follow-up|1|||
126097255|NCT00847808|453648375|FG000|Overall Study|Withdrawal by Subject|4|||
126097256|NCT00847808|453648375|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
126097257|NCT00847808|453648375|FG000|Overall Study|Participant Took Excluded Medication|1|||
126097258|NCT05172050|453648382|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
126097259|NCT05172050|453648383|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
126097260|NCT05172050|453648384|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
126097261|NCT05172050|453648382|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
126097262|NCT05172050|453648383|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
126097263|NCT05172050|453648384|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
126097264|NCT05172050|453648382|FG000|Overall Study|Other|2|||
126097265|NCT05172050|453648383|FG001|Overall Study|Other|2|||
126097266|NCT05172050|453648384|FG002|Overall Study|Other|1|||
126097267|NCT03725085|453650145|FG000|Overall Study|Lost to Follow-up|2|||
126097268|NCT01775475|453650146|FG000|Overall Study|Death|3|||
126097269|NCT01775475|453650147|FG001|Overall Study|Death|3|||
126097270|NCT02245737|453650152|FG000|Overall Study|Adverse Event|23|||
126097271|NCT02245737|453650153|FG001|Overall Study|Adverse Event|26|||
126097272|NCT02245737|453650154|FG002|Overall Study|Adverse Event|33|||
126097273|NCT02245737|453650152|FG000|Overall Study|Condition Worsened|9|||
126097274|NCT02245737|453650153|FG001|Overall Study|Condition Worsened|10|||
126097275|NCT02245737|453650154|FG002|Overall Study|Condition Worsened|9|||
126097276|NCT02245737|453650152|FG000|Overall Study|Death|2|||
126097277|NCT02245737|453650153|FG001|Overall Study|Death|4|||
126097278|NCT02245737|453650154|FG002|Overall Study|Death|4|||
126097279|NCT02245737|453650152|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
126097280|NCT02245737|453650153|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
126097281|NCT02245737|453650154|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
126097282|NCT02245737|453650152|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
126097283|NCT02245737|453650153|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
126097284|NCT02245737|453650154|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
126097285|NCT02245737|453650152|FG000|Overall Study|Lost to Follow-up|2|||
126097286|NCT02245737|453650153|FG001|Overall Study|Lost to Follow-up|5|||
126097287|NCT02245737|453650154|FG002|Overall Study|Lost to Follow-up|4|||
126097288|NCT02245737|453650152|FG000|Overall Study|Other-determined by Investigator|9|||
126097289|NCT02245737|453650153|FG001|Overall Study|Other-determined by Investigator|10|||
126097290|NCT02245737|453650154|FG002|Overall Study|Other-determined by Investigator|10|||
126265501|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
126265502|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
126265503|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
126265504|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265505|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265506|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
126097291|NCT02245737|453650152|FG000|Overall Study|Physician Decision|6|||
126097292|NCT02245737|453650153|FG001|Overall Study|Physician Decision|3|||
126097293|NCT02245737|453650154|FG002|Overall Study|Physician Decision|6|||
126265507|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
126265508|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
126097294|NCT02245737|453650152|FG000|Overall Study|Protocol Violation|3|||
126097295|NCT02245737|453650153|FG001|Overall Study|Protocol Violation|2|||
126097296|NCT02245737|453650154|FG002|Overall Study|Protocol Violation|3|||
126097297|NCT02245737|453650152|FG000|Overall Study|Withdrawal by Subject|40|||
126097298|NCT02245737|453650153|FG001|Overall Study|Withdrawal by Subject|41|||
126097299|NCT02245737|453650154|FG002|Overall Study|Withdrawal by Subject|44|||
126265509|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
126034698|NCT02985957|453424936|FG006|Treatment Period|Disease progression|28|||
126034699|NCT02985957|453424930|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
126034700|NCT02985957|453424931|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
126034701|NCT02985957|453424932|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
126034702|NCT02985957|453424933|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
126034703|NCT02985957|453424934|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
126034704|NCT02985957|453424935|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
126034705|NCT02985957|453424936|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
126034706|NCT02985957|453424930|FG000|Treatment Period|Poor/Non-Compliance|0|||
126034707|NCT02985957|453424931|FG001|Treatment Period|Poor/Non-Compliance|0|||
126034708|NCT02985957|453424932|FG002|Treatment Period|Poor/Non-Compliance|0|||
126034709|NCT02985957|453424933|FG003|Treatment Period|Poor/Non-Compliance|0|||
126034710|NCT02985957|453424934|FG004|Treatment Period|Poor/Non-Compliance|1|||
126034711|NCT02985957|453424935|FG005|Treatment Period|Poor/Non-Compliance|1|||
126034712|NCT02985957|453424936|FG006|Treatment Period|Poor/Non-Compliance|0|||
126034713|NCT02985957|453424930|FG000|Treatment Period|Continuing in Treatment Period|0|||
126034714|NCT02985957|453424931|FG001|Treatment Period|Continuing in Treatment Period|1|||
126034715|NCT02985957|453424932|FG002|Treatment Period|Continuing in Treatment Period|0|||
126034716|NCT02985957|453424933|FG003|Treatment Period|Continuing in Treatment Period|4|||
126034717|NCT02985957|453424934|FG004|Treatment Period|Continuing in Treatment Period|4|||
126034718|NCT02985957|453424935|FG005|Treatment Period|Continuing in Treatment Period|0|||
126034719|NCT02985957|453424936|FG006|Treatment Period|Continuing in Treatment Period|0|||
126034720|NCT04802967|453424943|FG000|Part B|Withdrawal by Subject|0|||
126034721|NCT04802967|453424944|FG001|Part B|Withdrawal by Subject|0|||
126034722|NCT04802967|453424945|FG002|Part B|Withdrawal by Subject|0|||
126034723|NCT04802967|453424946|FG003|Part B|Withdrawal by Subject|0|||
126034724|NCT04802967|453424947|FG004|Part B|Withdrawal by Subject|0|||
126034725|NCT04802967|453424948|FG005|Part B|Withdrawal by Subject|1|||
126034726|NCT04802967|453424949|FG006|Part B|Withdrawal by Subject|0|||
126034727|NCT04802967|453424950|FG007|Part B|Withdrawal by Subject|0|||
126034728|NCT04802967|453424951|FG008|Part B|Withdrawal by Subject|0|||
126034729|NCT04802967|453424952|FG009|Part B|Withdrawal by Subject|0|||
126034730|NCT04295798|453424961|FG000|Overall Study|Lost to Follow-up|1|||
126034731|NCT04650269|453424967|FG000|Overall Study|Death|3|||
126034732|NCT04650269|453424967|FG000|Overall Study|Lost to Follow-up|6|||
126034733|NCT01437709|453424968|FG000|Overall Study|Adverse Event|0|||
126034734|NCT01437709|453424969|FG001|Overall Study|Adverse Event|1|||
126034735|NCT01437709|453424970|FG002|Overall Study|Adverse Event|0|||
126034736|NCT01437709|453424968|FG000|Overall Study|Pt trasnferred care|0|||
126034737|NCT01437709|453424969|FG001|Overall Study|Pt trasnferred care|1|||
126034738|NCT01437709|453424970|FG002|Overall Study|Pt trasnferred care|0|||
126034739|NCT00085735|453424971|FG000|Overall Study|Adverse Event|1|||
126034740|NCT00085735|453424972|FG001|Overall Study|Adverse Event|0|||
126034741|NCT00085735|453424973|FG002|Overall Study|Adverse Event|0|||
126034742|NCT00085735|453424974|FG003|Overall Study|Adverse Event|0|||
126034743|NCT00085735|453424975|FG004|Overall Study|Adverse Event|0|||
126034744|NCT00085735|453424976|FG005|Overall Study|Adverse Event|0|||
126034745|NCT00085735|453424971|FG000|Overall Study|Lack of Efficacy|2|||
126034746|NCT00085735|453424972|FG001|Overall Study|Lack of Efficacy|4|||
126034747|NCT00085735|453424973|FG002|Overall Study|Lack of Efficacy|6|||
126034748|NCT00085735|453424974|FG003|Overall Study|Lack of Efficacy|3|||
126034749|NCT00085735|453424975|FG004|Overall Study|Lack of Efficacy|4|||
126034750|NCT00085735|453424976|FG005|Overall Study|Lack of Efficacy|3|||
126034751|NCT00085735|453424971|FG000|Overall Study|Lost to Follow-up|0|||
126034752|NCT00085735|453424972|FG001|Overall Study|Lost to Follow-up|1|||
126034753|NCT00085735|453424973|FG002|Overall Study|Lost to Follow-up|0|||
126034754|NCT00085735|453424974|FG003|Overall Study|Lost to Follow-up|0|||
126034755|NCT00085735|453424975|FG004|Overall Study|Lost to Follow-up|1|||
126034756|NCT00085735|453424976|FG005|Overall Study|Lost to Follow-up|0|||
126034757|NCT00085735|453424971|FG000|Overall Study|Physician Decision|2|||
126034758|NCT00085735|453424972|FG001|Overall Study|Physician Decision|3|||
126034759|NCT00085735|453424973|FG002|Overall Study|Physician Decision|2|||
126034760|NCT00085735|453424974|FG003|Overall Study|Physician Decision|3|||
126034761|NCT00085735|453424975|FG004|Overall Study|Physician Decision|11|||
126034762|NCT00085735|453424976|FG005|Overall Study|Physician Decision|8|||
126034763|NCT00085735|453424971|FG000|Overall Study|Protocol Violation|1|||
126034764|NCT00085735|453424972|FG001|Overall Study|Protocol Violation|0|||
126034765|NCT00085735|453424973|FG002|Overall Study|Protocol Violation|0|||
126034766|NCT00085735|453424974|FG003|Overall Study|Protocol Violation|0|||
126034767|NCT00085735|453424975|FG004|Overall Study|Protocol Violation|0|||
126034768|NCT00085735|453424976|FG005|Overall Study|Protocol Violation|0|||
126034769|NCT00085735|453424971|FG000|Overall Study|Withdrawal by Subject|1|||
126034770|NCT00085735|453424972|FG001|Overall Study|Withdrawal by Subject|0|||
126034771|NCT00085735|453424973|FG002|Overall Study|Withdrawal by Subject|4|||
126034772|NCT00085735|453424974|FG003|Overall Study|Withdrawal by Subject|5|||
126034773|NCT00085735|453424975|FG004|Overall Study|Withdrawal by Subject|7|||
126034774|NCT00085735|453424976|FG005|Overall Study|Withdrawal by Subject|8|||
126034775|NCT00085735|453424971|FG000|Overall Study|Patient ineligible|1|||
126034776|NCT00085735|453424972|FG001|Overall Study|Patient ineligible|0|||
126034777|NCT00085735|453424973|FG002|Overall Study|Patient ineligible|3|||
126034778|NCT00085735|453424974|FG003|Overall Study|Patient ineligible|7|||
126034779|NCT00085735|453424975|FG004|Overall Study|Patient ineligible|17|||
126034780|NCT00085735|453424976|FG005|Overall Study|Patient ineligible|8|||
126034781|NCT00085735|453424971|FG000|Overall Study|Excess residual disease|2|||
126034782|NCT00085735|453424972|FG001|Overall Study|Excess residual disease|2|||
126034783|NCT00085735|453424973|FG002|Overall Study|Excess residual disease|1|||
126034784|NCT00085735|453424974|FG003|Overall Study|Excess residual disease|1|||
126034785|NCT00085735|453424975|FG004|Overall Study|Excess residual disease|1|||
126097300|NCT02245737|453650152|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
126097301|NCT02245737|453650153|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
126097302|NCT02245737|453650154|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
126097303|NCT02245737|453650152|FG000|Overall Study|Sponsor Decision|445|||
126097304|NCT02245737|453650153|FG001|Overall Study|Sponsor Decision|430|||
126097305|NCT02245737|453650154|FG002|Overall Study|Sponsor Decision|432|||
126097306|NCT00618618|453650156|FG000|Overall Study|Patient Request|0|||
126097307|NCT00618618|453650157|FG001|Overall Study|Patient Request|0|||
126097308|NCT00618618|453650158|FG002|Overall Study|Patient Request|2|||
126097309|NCT00618618|453650159|FG003|Overall Study|Patient Request|0|||
126097310|NCT00618618|453650156|FG000|Overall Study|Inability to Complete Study Procedures|0|||
126097311|NCT00618618|453650157|FG001|Overall Study|Inability to Complete Study Procedures|1|||
126097312|NCT00618618|453650158|FG002|Overall Study|Inability to Complete Study Procedures|0|||
126097313|NCT00618618|453650159|FG003|Overall Study|Inability to Complete Study Procedures|0|||
126097314|NCT00618618|453650156|FG000|Overall Study|Lost to Follow-up|3|||
126097315|NCT00618618|453650157|FG001|Overall Study|Lost to Follow-up|0|||
126097316|NCT00618618|453650158|FG002|Overall Study|Lost to Follow-up|0|||
126097317|NCT00618618|453650159|FG003|Overall Study|Lost to Follow-up|1|||
126097318|NCT00618618|453650156|FG000|Overall Study|Non-compliance|1|||
126097319|NCT00618618|453650157|FG001|Overall Study|Non-compliance|1|||
126097320|NCT00618618|453650158|FG002|Overall Study|Non-compliance|0|||
126097321|NCT00618618|453650159|FG003|Overall Study|Non-compliance|0|||
126097322|NCT00618618|453650156|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
126097323|NCT00618618|453650157|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
126097324|NCT00618618|453650158|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
126097325|NCT00618618|453650159|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
126097326|NCT00618618|453650156|FG000|Overall Study|Death|0|||
126097327|NCT00618618|453650157|FG001|Overall Study|Death|1|||
126097328|NCT00618618|453650158|FG002|Overall Study|Death|0|||
126097329|NCT00618618|453650159|FG003|Overall Study|Death|0|||
126097330|NCT02929329|453650160|FG000|Overall Study|Withdrawal by Subject|24|||
126097331|NCT02929329|453650161|FG001|Overall Study|Withdrawal by Subject|21|||
126097332|NCT02929329|453650160|FG000|Overall Study|Lost to Follow-up|26|||
126097333|NCT02929329|453650161|FG001|Overall Study|Lost to Follow-up|20|||
126097334|NCT02929329|453650160|FG000|Overall Study|Death|1054|||
126097335|NCT02929329|453650161|FG001|Overall Study|Death|1051|||
126097336|NCT00309959|453650168|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
126097337|NCT03836716|453650172|FG000|Overall Study|Adverse Event|3|||
126097338|NCT03836716|453650172|FG000|Overall Study|Death|22|||
126097339|NCT03836716|453650172|FG000|Overall Study|Withdrawal by Subject|8|||
126097340|NCT03836716|453650172|FG000|Overall Study|Study terminated by sponsor|87|||
126360223|NCT00281580|454610774|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
126097341|NCT01983254|453650173|FG000|Overall Study|Death|6|||
126097342|NCT01983254|453650174|FG001|Overall Study|Death|6|||
126097343|NCT01983254|453650173|FG000|Overall Study|Lost to Follow-up|17|||
126097344|NCT01983254|453650174|FG001|Overall Study|Lost to Follow-up|16|||
126360224|NCT00281580|454610775|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
126360225|NCT00281580|454610776|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
126360226|NCT00281580|454610777|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
126360227|NCT00281580|454610778|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
126360228|NCT00281580|454610779|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
126360229|NCT00281580|454610780|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
126360230|NCT00281580|454610781|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
126360231|NCT00281580|454610782|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
126360232|NCT00281580|454610783|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
126097345|NCT01983254|453650173|FG000|Overall Study|too ill|11|||
126097346|NCT01983254|453650174|FG001|Overall Study|too ill|8|||
126360233|NCT00281580|454610784|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
126360234|NCT00281580|454610785|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
126034786|NCT00085735|453424976|FG005|Overall Study|Excess residual disease|4|||
126034787|NCT00085735|453424971|FG000|Overall Study|Reason not documented|1|||
126034788|NCT00085735|453424972|FG001|Overall Study|Reason not documented|0|||
126097347|NCT00434213|453650175|FG000|Overall Study|Adverse Event|12|||
126265510|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
126034789|NCT00085735|453424973|FG002|Overall Study|Reason not documented|1|||
126034790|NCT00085735|453424974|FG003|Overall Study|Reason not documented|0|||
126034791|NCT00085735|453424975|FG004|Overall Study|Reason not documented|1|||
126034792|NCT00085735|453424976|FG005|Overall Study|Reason not documented|0|||
126034793|NCT00085735|453424971|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
126034794|NCT00085735|453424972|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
126034795|NCT00085735|453424973|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
126265511|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
126034796|NCT00085735|453424974|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
126034797|NCT00085735|453424975|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
126034798|NCT00085735|453424976|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
126034799|NCT01824875|453424977|FG000|Overall Study|Disease progression|22|||
126034800|NCT01824875|453424978|FG001|Overall Study|Disease progression|15|||
126034801|NCT01824875|453424977|FG000|Overall Study|Withdrawal by Subject|5|||
126034802|NCT01824875|453424978|FG001|Overall Study|Withdrawal by Subject|4|||
126034803|NCT01824875|453424977|FG000|Overall Study|Adverse Event|4|||
126034804|NCT01824875|453424978|FG001|Overall Study|Adverse Event|10|||
126034805|NCT01824875|453424977|FG000|Overall Study|Alternative therapy|3|||
126034806|NCT01824875|453424978|FG001|Overall Study|Alternative therapy|0|||
126034807|NCT01824875|453424977|FG000|Overall Study|Complicating disease|1|||
126034808|NCT01824875|453424978|FG001|Overall Study|Complicating disease|0|||
126034809|NCT01824875|453424977|FG000|Overall Study|Physician Decision|0|||
126034810|NCT01824875|453424978|FG001|Overall Study|Physician Decision|1|||
126034811|NCT01824875|453424977|FG000|Overall Study|Non-compliance|1|||
126034812|NCT01824875|453424978|FG001|Overall Study|Non-compliance|1|||
126034813|NCT01824875|453424977|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
126034814|NCT01824875|453424978|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
126034815|NCT01824875|453424977|FG000|Overall Study|Administrative issues|0|||
126034816|NCT01824875|453424978|FG001|Overall Study|Administrative issues|2|||
126034817|NCT01824875|453424977|FG000|Overall Study|Ineligible or never started treatment|9|||
126034818|NCT01824875|453424978|FG001|Overall Study|Ineligible or never started treatment|5|||
126034819|NCT01824875|453424977|FG000|Overall Study|Other|0|||
126034820|NCT01824875|453424978|FG001|Overall Study|Other|2|||
126034821|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
126034822|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
126034823|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
126034824|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
126034825|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
126034826|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
126034827|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
126034828|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
126034829|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
126034830|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
126034831|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
126034832|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
126034833|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
126034834|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
126034835|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
126034836|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
126034837|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
126034838|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
126034839|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
126097348|NCT00434213|453650175|FG000|Overall Study|Lack of Efficacy|9|||
126097349|NCT00434213|453650175|FG000|Overall Study|Lost to Follow-up|14|||
126097350|NCT00434213|453650175|FG000|Overall Study|Withdrawal by Subject|7|||
126097351|NCT00434213|453650175|FG000|Overall Study|Protocol Violation|3|||
126097352|NCT00434213|453650175|FG000|Overall Study|Unable to comply with study visit window|2|||
126097353|NCT00434213|453650175|FG000|Overall Study|Application site reaction|1|||
126097354|NCT00434213|453650175|FG000|Overall Study|Non-compliant to study schedule|1|||
126097355|NCT01253304|453650176|FG000|Overall Study|Adverse Event|0|||
126097356|NCT01253304|453650177|FG001|Overall Study|Adverse Event|0|||
126097357|NCT01253304|453650178|FG002|Overall Study|Adverse Event|0|||
126097358|NCT01253304|453650179|FG003|Overall Study|Adverse Event|1|||
126097359|NCT00768079|453650182|FG000|Overall Study|Lost to Follow-up|2|||
126097360|NCT00768079|453650183|FG001|Overall Study|Lost to Follow-up|0|||
126097361|NCT00768079|453650184|FG002|Overall Study|Lost to Follow-up|4|||
126034840|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
126034841|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
126034842|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
126034843|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
126034844|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
126034845|NCT01715285|453424979|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
126034846|NCT01715285|453424980|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
126034847|NCT01715285|453424981|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
126034848|NCT01715285|453424979|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
126034849|NCT01715285|453424980|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
126034850|NCT01715285|453424981|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
126034851|NCT01715285|453424979|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
126034852|NCT01715285|453424980|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
126034853|NCT01715285|453424981|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
126034854|NCT01715285|453424979|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
126034855|NCT01715285|453424980|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
126034856|NCT01715285|453424981|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
126034857|NCT01715285|453424979|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
126034858|NCT01715285|453424980|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
126034859|NCT01715285|453424981|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
126034860|NCT01715285|453424979|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
126034861|NCT01715285|453424980|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
126034862|NCT01715285|453424981|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
126034863|NCT02598388|453424982|FG000|Overall Study|Lost to Follow-up|1|||
126034864|NCT02598388|453424983|FG001|Overall Study|Lost to Follow-up|0|||
126034865|NCT02598388|453424984|FG002|Overall Study|Lost to Follow-up|1|||
126034866|NCT02598388|453424985|FG003|Overall Study|Lost to Follow-up|0|||
126034867|NCT02598388|453424986|FG004|Overall Study|Lost to Follow-up|5|||
126034868|NCT02598388|453424987|FG005|Overall Study|Lost to Follow-up|1|||
126034869|NCT02598388|453424988|FG006|Overall Study|Lost to Follow-up|2|||
126097362|NCT00768079|453650182|FG000|Overall Study|Participant incarcerated|0|||
126097363|NCT00768079|453650183|FG001|Overall Study|Participant incarcerated|1|||
126034870|NCT02598388|453424989|FG007|Overall Study|Lost to Follow-up|1|||
126034871|NCT02598388|453424990|FG008|Overall Study|Lost to Follow-up|0|||
126034872|NCT02598388|453424991|FG009|Overall Study|Lost to Follow-up|0|||
126034873|NCT02598388|453424992|FG010|Overall Study|Lost to Follow-up|1|||
126034874|NCT02598388|453424993|FG011|Overall Study|Lost to Follow-up|0|||
126034875|NCT02598388|453424982|FG000|Overall Study|Withdrawal by Subject|0|||
126034876|NCT02598388|453424983|FG001|Overall Study|Withdrawal by Subject|0|||
126034877|NCT02598388|453424984|FG002|Overall Study|Withdrawal by Subject|0|||
126034878|NCT02598388|453424985|FG003|Overall Study|Withdrawal by Subject|0|||
126034879|NCT02598388|453424986|FG004|Overall Study|Withdrawal by Subject|2|||
126034880|NCT02598388|453424987|FG005|Overall Study|Withdrawal by Subject|0|||
126034881|NCT02598388|453424988|FG006|Overall Study|Withdrawal by Subject|2|||
126034882|NCT02598388|453424989|FG007|Overall Study|Withdrawal by Subject|0|||
126034883|NCT02598388|453424990|FG008|Overall Study|Withdrawal by Subject|0|||
126034884|NCT02598388|453424991|FG009|Overall Study|Withdrawal by Subject|1|||
126034885|NCT02598388|453424992|FG010|Overall Study|Withdrawal by Subject|0|||
126034886|NCT02598388|453424993|FG011|Overall Study|Withdrawal by Subject|0|||
126034887|NCT02598388|453424982|FG000|Overall Study|Other|0|||
126034888|NCT02598388|453424983|FG001|Overall Study|Other|0|||
126034889|NCT02598388|453424984|FG002|Overall Study|Other|1|||
126034890|NCT02598388|453424985|FG003|Overall Study|Other|0|||
126034891|NCT02598388|453424986|FG004|Overall Study|Other|3|||
126034892|NCT02598388|453424987|FG005|Overall Study|Other|0|||
126034893|NCT02598388|453424988|FG006|Overall Study|Other|1|||
126034894|NCT02598388|453424989|FG007|Overall Study|Other|0|||
126034895|NCT02598388|453424990|FG008|Overall Study|Other|0|||
126034896|NCT02598388|453424991|FG009|Overall Study|Other|0|||
126034897|NCT02598388|453424992|FG010|Overall Study|Other|0|||
126034898|NCT02598388|453424993|FG011|Overall Study|Other|0|||
126034899|NCT04971681|453425018|FG000|Followup|Lost to Follow-up|1|||
126034900|NCT04971681|453425019|FG001|Followup|Lost to Follow-up|0|||
126034901|NCT00686335|453425020|FG000|Run-in Period|Adverse Event|1|||
126034902|NCT00686335|453425020|FG000|Run-in Period|asthma exacerbation|1|||
126034903|NCT00686335|453425020|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
126034904|NCT04350463|453425025|FG000|Overall Study|Other reason|0|||
126034905|NCT04350463|453425026|FG001|Overall Study|Other reason|0|||
126034906|NCT04350463|453425027|FG002|Overall Study|Other reason|0|||
126034907|NCT04350463|453425028|FG003|Overall Study|Other reason|1|||
126034908|NCT04350463|453425025|FG000|Overall Study|Lost to Follow-up|0|||
126034909|NCT04350463|453425026|FG001|Overall Study|Lost to Follow-up|0|||
126034910|NCT04350463|453425027|FG002|Overall Study|Lost to Follow-up|0|||
126034911|NCT04350463|453425028|FG003|Overall Study|Lost to Follow-up|2|||
126034912|NCT04350463|453425025|FG000|Overall Study|Withdrawal by Subject|4|||
126034913|NCT04350463|453425026|FG001|Overall Study|Withdrawal by Subject|0|||
126034914|NCT04350463|453425027|FG002|Overall Study|Withdrawal by Subject|1|||
126034915|NCT04350463|453425028|FG003|Overall Study|Withdrawal by Subject|4|||
126034916|NCT04350463|453425025|FG000|Overall Study|Adverse Event|0|||
126360235|NCT00281580|454610786|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
126360236|NCT00621322|454610787|FG000|Overall Study|Lost to Follow-up|0|||
126360237|NCT00621322|454610788|FG001|Overall Study|Lost to Follow-up|0|||
126360238|NCT00621322|454610789|FG002|Overall Study|Lost to Follow-up|0|||
126360239|NCT00621322|454610790|FG003|Overall Study|Lost to Follow-up|0|||
126360240|NCT00621322|454610791|FG004|Overall Study|Lost to Follow-up|1|||
126360241|NCT00621322|454610792|FG005|Overall Study|Lost to Follow-up|0|||
126360242|NCT00621322|454610787|FG000|Overall Study|Physician Decision|0|||
126360243|NCT00621322|454610788|FG001|Overall Study|Physician Decision|0|||
126360244|NCT00621322|454610789|FG002|Overall Study|Physician Decision|1|||
126360245|NCT00621322|454610790|FG003|Overall Study|Physician Decision|1|||
126360246|NCT00621322|454610791|FG004|Overall Study|Physician Decision|0|||
126360247|NCT00621322|454610792|FG005|Overall Study|Physician Decision|0|||
126360248|NCT00621322|454610787|FG000|Overall Study|Withdrawal by Subject|0|||
126360249|NCT00621322|454610788|FG001|Overall Study|Withdrawal by Subject|0|||
126360250|NCT00621322|454610789|FG002|Overall Study|Withdrawal by Subject|0|||
126360251|NCT00621322|454610790|FG003|Overall Study|Withdrawal by Subject|1|||
126360252|NCT00621322|454610791|FG004|Overall Study|Withdrawal by Subject|0|||
126360253|NCT00621322|454610792|FG005|Overall Study|Withdrawal by Subject|2|||
126360254|NCT00621322|454610787|FG000|Overall Study|Migrated/moved from study area|1|||
126360255|NCT00621322|454610788|FG001|Overall Study|Migrated/moved from study area|0|||
126360256|NCT00621322|454610789|FG002|Overall Study|Migrated/moved from study area|1|||
126360257|NCT00621322|454610790|FG003|Overall Study|Migrated/moved from study area|1|||
126360258|NCT00621322|454610791|FG004|Overall Study|Migrated/moved from study area|0|||
126034917|NCT04350463|453425026|FG001|Overall Study|Adverse Event|0|||
126034918|NCT04350463|453425027|FG002|Overall Study|Adverse Event|0|||
126034919|NCT04350463|453425028|FG003|Overall Study|Adverse Event|2|||
126034920|NCT04350463|453425025|FG000|Overall Study|Death|27|||
126034921|NCT04350463|453425026|FG001|Overall Study|Death|2|||
126360259|NCT00621322|454610792|FG005|Overall Study|Migrated/moved from study area|2|||
126360260|NCT00576407|454610793|FG000|Overall Study|Death|7|||
126360261|NCT00576407|454610793|FG000|Overall Study|Physician Decision|1|||
125880688|NCT04328077|452862583|FG001|Overall Study|Withdrawal by Subject|1|||
126097364|NCT00768079|453650184|FG002|Overall Study|Participant incarcerated|0|||
126097365|NCT02207569|453650185|FG000|1-Month|Death|6|||
126097366|NCT02207569|453650185|FG000|1-Month|Withdrawal by Subject|2|||
126097367|NCT02207569|453650185|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
126097368|NCT02207569|453650185|FG000|6-Month|Death|8|||
126097369|NCT02207569|453650185|FG000|6-Month|Withdrawal by Subject|2|||
126097370|NCT02207569|453650185|FG000|12-Month|Death|14|||
126097371|NCT02207569|453650185|FG000|12-Month|Withdrawal by Subject|2|||
126097372|NCT02207569|453650185|FG000|24-Month|Death|23|||
126097373|NCT02207569|453650185|FG000|24-Month|Withdrawal by Subject|3|||
126097374|NCT02207569|453650185|FG000|36-Month|Death|23|||
126097375|NCT02207569|453650185|FG000|36-Month|Withdrawal by Subject|4|||
126097376|NCT02207569|453650185|FG000|48-Month|Death|25|||
126097377|NCT02207569|453650185|FG000|48-Month|Withdrawal by Subject|2|||
126097378|NCT02207569|453650185|FG000|48-Month|Lost to Follow-up|4|||
126097379|NCT02207569|453650185|FG000|60-Month|Death|1|||
126097380|NCT02207569|453650185|FG000|60-Month|Lost to Follow-up|1|||
126097381|NCT02207569|453650185|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
126097382|NCT02207569|453650185|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
126097383|NCT03047395|453650188|FG000|Overall Study|Adverse Event|142|||
126097384|NCT03047395|453650188|FG000|Overall Study|Withdrawal by Subject|155|||
126097385|NCT03047395|453650188|FG000|Overall Study|Lost to Follow-up|144|||
126097386|NCT03047395|453650188|FG000|Overall Study|COVID-19 Infection|2|||
126097387|NCT03047395|453650188|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
126097388|NCT03047395|453650188|FG000|Overall Study|Other, Not Specified|117|||
126097389|NCT01859988|453650189|FG000|Overall Study|Withdrawal by Subject|6|||
126097390|NCT01859988|453650190|FG001|Overall Study|Withdrawal by Subject|3|||
126097391|NCT01859988|453650191|FG002|Overall Study|Withdrawal by Subject|4|||
126097392|NCT01859988|453650192|FG003|Overall Study|Withdrawal by Subject|3|||
126097393|NCT01859988|453650193|FG004|Overall Study|Withdrawal by Subject|2|||
126097394|NCT01859988|453650194|FG005|Overall Study|Withdrawal by Subject|2|||
126097395|NCT01859988|453650189|FG000|Overall Study|Lack of Efficacy|1|||
126097396|NCT01859988|453650190|FG001|Overall Study|Lack of Efficacy|1|||
126097397|NCT01859988|453650191|FG002|Overall Study|Lack of Efficacy|5|||
126097398|NCT01859988|453650192|FG003|Overall Study|Lack of Efficacy|0|||
126097399|NCT01859988|453650193|FG004|Overall Study|Lack of Efficacy|7|||
126097400|NCT01859988|453650194|FG005|Overall Study|Lack of Efficacy|9|||
126097401|NCT01859988|453650189|FG000|Overall Study|Physician Decision|1|||
126097402|NCT01859988|453650190|FG001|Overall Study|Physician Decision|3|||
126097403|NCT01859988|453650191|FG002|Overall Study|Physician Decision|1|||
126097404|NCT01859988|453650192|FG003|Overall Study|Physician Decision|3|||
126097405|NCT01859988|453650193|FG004|Overall Study|Physician Decision|4|||
126097406|NCT01859988|453650194|FG005|Overall Study|Physician Decision|1|||
126097407|NCT01859988|453650189|FG000|Overall Study|Adverse Event|2|||
126097408|NCT01859988|453650190|FG001|Overall Study|Adverse Event|1|||
126097409|NCT01859988|453650191|FG002|Overall Study|Adverse Event|3|||
126097410|NCT01859988|453650192|FG003|Overall Study|Adverse Event|1|||
126097411|NCT01859988|453650193|FG004|Overall Study|Adverse Event|2|||
126097412|NCT01859988|453650194|FG005|Overall Study|Adverse Event|2|||
126097413|NCT01859988|453650189|FG000|Overall Study|Lost to Follow-up|1|||
125880689|NCT04328077|452862584|FG002|Overall Study|Withdrawal by Subject|1|||
126097414|NCT01859988|453650190|FG001|Overall Study|Lost to Follow-up|2|||
126097415|NCT01859988|453650191|FG002|Overall Study|Lost to Follow-up|3|||
126097416|NCT01859988|453650192|FG003|Overall Study|Lost to Follow-up|0|||
126360262|NCT00756444|454610794|FG000|Overall Study|Adverse Event|1|||
126360263|NCT00756444|454610795|FG001|Overall Study|Adverse Event|1|||
126360264|NCT00756444|454610794|FG000|Overall Study|Withdrawal by Subject|6|||
126360265|NCT00756444|454610795|FG001|Overall Study|Withdrawal by Subject|8|||
126360266|NCT00756444|454610794|FG000|Overall Study|Lost to Follow-up|0|||
126360267|NCT00756444|454610795|FG001|Overall Study|Lost to Follow-up|1|||
126360268|NCT00756444|454610794|FG000|Overall Study|Death|5|||
126360269|NCT00756444|454610795|FG001|Overall Study|Death|4|||
126360270|NCT00756444|454610794|FG000|Overall Study|Disease Progression|2|||
126360271|NCT00756444|454610795|FG001|Overall Study|Disease Progression|7|||
126360272|NCT00756444|454610794|FG000|Overall Study|Ineligibility Determined|1|||
126360273|NCT00756444|454610795|FG001|Overall Study|Ineligibility Determined|0|||
126097417|NCT01859988|453650193|FG004|Overall Study|Lost to Follow-up|3|||
126097418|NCT01859988|453650194|FG005|Overall Study|Lost to Follow-up|2|||
126097419|NCT01859988|453650189|FG000|Overall Study|Protocol Violation|0|||
126097420|NCT01859988|453650190|FG001|Overall Study|Protocol Violation|0|||
126097421|NCT01859988|453650191|FG002|Overall Study|Protocol Violation|1|||
126097422|NCT01859988|453650192|FG003|Overall Study|Protocol Violation|0|||
126360274|NCT01655069|454610799|FG000|Overall Study|Physician Decision|0|||
126360275|NCT01655069|454610800|FG001|Overall Study|Physician Decision|0|||
126360276|NCT01655069|454610801|FG002|Overall Study|Physician Decision|0|||
125880690|NCT04328077|452862585|FG003|Overall Study|Withdrawal by Subject|3|||
126097423|NCT01859988|453650193|FG004|Overall Study|Protocol Violation|0|||
126097424|NCT01859988|453650194|FG005|Overall Study|Protocol Violation|0|||
126097425|NCT01859988|453650189|FG000|Overall Study|Other than specified above|0|||
126034922|NCT04350463|453425027|FG002|Overall Study|Death|13|||
126034923|NCT04350463|453425028|FG003|Overall Study|Death|26|||
126034924|NCT04111536|453425029|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126034925|NCT04111536|453425030|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126034926|NCT04111536|453425029|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
126034927|NCT04111536|453425030|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
126034928|NCT04111536|453425029|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
126034929|NCT04111536|453425030|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
126034930|NCT04111536|453425029|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
126034931|NCT04111536|453425030|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
126034932|NCT05949788|453425032|FG000|Overall Study|severe birth deformity|2|||
126034933|NCT05949788|453425033|FG001|Overall Study|severe birth deformity|7|||
126034934|NCT05949788|453425032|FG000|Overall Study|twin-twin transfusion syndrome|2|||
126034935|NCT05949788|453425033|FG001|Overall Study|twin-twin transfusion syndrome|7|||
126034936|NCT05949788|453425032|FG000|Overall Study|neonatal hemolytic disease|3|||
126034937|NCT05949788|453425033|FG001|Overall Study|neonatal hemolytic disease|8|||
126034938|NCT05949788|453425032|FG000|Overall Study|death within 14 days after birth|2|||
126034939|NCT05949788|453425033|FG001|Overall Study|death within 14 days after birth|6|||
126034940|NCT05949788|453425032|FG000|Overall Study|transfer to another hospital|2|||
126034941|NCT05949788|453425033|FG001|Overall Study|transfer to another hospital|6|||
126034942|NCT01824537|453425034|FG000|Overall Study|Lost to Follow-up|78|||
126034943|NCT01824537|453425035|FG001|Overall Study|Lost to Follow-up|87|||
126034944|NCT05415722|453425041|FG000|Overall Study|Lost to Follow-up|0|||
126265512|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
126265513|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
126034945|NCT05415722|453425042|FG001|Overall Study|Lost to Follow-up|2|||
126034946|NCT05415722|453425043|FG002|Overall Study|Lost to Follow-up|0|||
126034947|NCT05415722|453425044|FG003|Overall Study|Lost to Follow-up|1|||
126034948|NCT05415722|453425045|FG004|Overall Study|Lost to Follow-up|0|||
126034949|NCT05415722|453425046|FG005|Overall Study|Lost to Follow-up|0|||
126034950|NCT05415722|453425047|FG006|Overall Study|Lost to Follow-up|1|||
126034951|NCT05415722|453425041|FG000|Overall Study|Physician Decision|0|||
126034952|NCT05415722|453425042|FG001|Overall Study|Physician Decision|0|||
126034953|NCT05415722|453425043|FG002|Overall Study|Physician Decision|0|||
126034954|NCT05415722|453425044|FG003|Overall Study|Physician Decision|1|||
126034955|NCT05415722|453425045|FG004|Overall Study|Physician Decision|0|||
126034956|NCT05415722|453425046|FG005|Overall Study|Physician Decision|0|||
126034957|NCT05415722|453425047|FG006|Overall Study|Physician Decision|1|||
126034958|NCT05415722|453425041|FG000|Overall Study|Protocol Violation|0|||
126034959|NCT05415722|453425042|FG001|Overall Study|Protocol Violation|0|||
126034960|NCT05415722|453425043|FG002|Overall Study|Protocol Violation|0|||
126034961|NCT05415722|453425044|FG003|Overall Study|Protocol Violation|1|||
126034962|NCT05415722|453425045|FG004|Overall Study|Protocol Violation|0|||
126034963|NCT05415722|453425046|FG005|Overall Study|Protocol Violation|0|||
126034964|NCT05415722|453425047|FG006|Overall Study|Protocol Violation|0|||
126034965|NCT05415722|453425041|FG000|Overall Study|Sponsor Discretion|0|||
126034966|NCT05415722|453425042|FG001|Overall Study|Sponsor Discretion|0|||
126034967|NCT05415722|453425043|FG002|Overall Study|Sponsor Discretion|0|||
126034968|NCT05415722|453425044|FG003|Overall Study|Sponsor Discretion|0|||
126034969|NCT05415722|453425045|FG004|Overall Study|Sponsor Discretion|1|||
126034970|NCT05415722|453425046|FG005|Overall Study|Sponsor Discretion|1|||
126034971|NCT05415722|453425047|FG006|Overall Study|Sponsor Discretion|0|||
126034972|NCT05415722|453425041|FG000|Overall Study|Withdrawal by Subject|0|||
126034973|NCT05415722|453425042|FG001|Overall Study|Withdrawal by Subject|1|||
126034974|NCT05415722|453425043|FG002|Overall Study|Withdrawal by Subject|0|||
126034975|NCT05415722|453425044|FG003|Overall Study|Withdrawal by Subject|1|||
126034976|NCT05415722|453425045|FG004|Overall Study|Withdrawal by Subject|1|||
126034977|NCT05415722|453425046|FG005|Overall Study|Withdrawal by Subject|0|||
126034978|NCT05415722|453425047|FG006|Overall Study|Withdrawal by Subject|1|||
126034979|NCT03031470|453425049|FG000|Overall Study|Adverse Event|3|||
126034980|NCT03031470|453425050|FG001|Overall Study|Adverse Event|0|||
126034981|NCT03031470|453425049|FG000|Overall Study|Death|3|||
126265514|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
126265515|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
126034982|NCT03031470|453425050|FG001|Overall Study|Death|1|||
126034983|NCT03031470|453425049|FG000|Overall Study|Lost to Follow-up|1|||
126034984|NCT03031470|453425050|FG001|Overall Study|Lost to Follow-up|1|||
126034985|NCT03031470|453425049|FG000|Overall Study|Withdrawal by Subject|1|||
126034986|NCT03031470|453425050|FG001|Overall Study|Withdrawal by Subject|0|||
126034987|NCT03031470|453425049|FG000|Overall Study|Protocol entry criteria not met|0|||
126034988|NCT03031470|453425050|FG001|Overall Study|Protocol entry criteria not met|1|||
126265516|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
126265517|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
126265518|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
126265519|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
126360277|NCT01655069|454610802|FG003|Overall Study|Physician Decision|1|||
126034989|NCT03031470|453425049|FG000|Overall Study|Cancel the operation|0|||
126034990|NCT03031470|453425050|FG001|Overall Study|Cancel the operation|1|||
126034991|NCT04623671|453425053|FG000|Overall Study|Adverse Event|0|||
126034992|NCT04623671|453425054|FG001|Overall Study|Adverse Event|1|||
126034993|NCT04623671|453425053|FG000|Overall Study|Lost to Follow-up|2|||
126034994|NCT04623671|453425054|FG001|Overall Study|Lost to Follow-up|1|||
126034995|NCT04623671|453425053|FG000|Overall Study|Death|5|||
126034996|NCT04623671|453425054|FG001|Overall Study|Death|5|||
126034997|NCT04663737|453425055|FG000|Overall Study|Withdrawal by Subject|2|||
126034998|NCT04663737|453425056|FG001|Overall Study|Withdrawal by Subject|0|||
126034999|NCT01943409|453425057|FG000|Overall Study|resumed oral/entral|24|||
126035000|NCT01943409|453425058|FG001|Overall Study|resumed oral/entral|20|||
126035001|NCT01943409|453425057|FG000|Overall Study|Protocol Violation|14|||
126035002|NCT01943409|453425058|FG001|Overall Study|Protocol Violation|24|||
126035003|NCT01943409|453425057|FG000|Overall Study|Death|3|||
126035004|NCT01943409|453425058|FG001|Overall Study|Death|1|||
126035005|NCT01943409|453425057|FG000|Overall Study|Withdrawal by Subject|4|||
126035006|NCT01943409|453425058|FG001|Overall Study|Withdrawal by Subject|3|||
126035007|NCT03848065|453425059|FG000|Overall Study|Death|0|||
126035008|NCT03848065|453425060|FG001|Overall Study|Death|1|||
126035009|NCT03848065|453425061|FG002|Overall Study|Death|0|||
126035010|NCT03848065|453425059|FG000|Overall Study|Lost to Follow-up|0|||
126035011|NCT03848065|453425060|FG001|Overall Study|Lost to Follow-up|0|||
126035012|NCT03848065|453425061|FG002|Overall Study|Lost to Follow-up|1|||
126035013|NCT03848065|453425059|FG000|Overall Study|Physician Decision|0|||
126035014|NCT03848065|453425060|FG001|Overall Study|Physician Decision|0|||
126035015|NCT03848065|453425061|FG002|Overall Study|Physician Decision|1|||
126035016|NCT03496168|453425068|FG000|Overall Study|Other Reasons|1|||
126035017|NCT03496168|453425068|FG000|Overall Study|Adverse Event|1|||
126035018|NCT05869383|453425069|FG000|Overall Study|Withdrawal by Subject|2|||
126035019|NCT05869383|453425070|FG001|Overall Study|Withdrawal by Subject|0|||
126035020|NCT04137367|453425071|FG000|Overall Study|Lost to Follow-up|8|||
126035021|NCT04137367|453425072|FG001|Overall Study|Lost to Follow-up|6|||
126035022|NCT04137367|453425073|FG002|Overall Study|Lost to Follow-up|4|||
126035023|NCT03907878|453425074|FG000|Treatment Period|Withdrawal by Subject|5|||
126035024|NCT03907878|453425074|FG000|Treatment Period|Adverse Event|4|||
126035025|NCT03907878|453425074|FG000|Treatment Period|Lack of Efficacy|1|||
126035026|NCT03907878|453425074|FG000|Treatment Period|Protocol Violation|1|||
126035027|NCT03907878|453425074|FG000|Follow-up Period|Adverse Event|3|||
126035028|NCT03907878|453425074|FG000|Follow-up Period|Withdrawal by Subject|3|||
126035029|NCT05144009|453425075|FG000|Overall Study|Lost to Follow-up|0|||
126035030|NCT05144009|453425076|FG001|Overall Study|Lost to Follow-up|1|||
126035031|NCT05144009|453425075|FG000|Overall Study|Study Termination by the Sponsor|11|||
126035032|NCT05144009|453425076|FG001|Overall Study|Study Termination by the Sponsor|11|||
126035033|NCT05144009|453425075|FG000|Overall Study|Disease Progression|1|||
126035034|NCT05144009|453425076|FG001|Overall Study|Disease Progression|0|||
126035035|NCT05144009|453425075|FG000|Overall Study|Participant Decision|0|||
126035036|NCT05144009|453425076|FG001|Overall Study|Participant Decision|2|||
126035037|NCT05144009|453425075|FG000|Overall Study|Death|5|||
126035038|NCT05144009|453425076|FG001|Overall Study|Death|10|||
126035039|NCT04499924|453425077|FG000|Overall Study|Study termination by sponsor|4|||
126035040|NCT04499924|453425078|FG001|Overall Study|Study termination by sponsor|6|||
125880691|NCT05291520|452862586|FG000|Overall Study|Lost to Follow-up|0|||
125880692|NCT05291520|452862587|FG001|Overall Study|Lost to Follow-up|0|||
126035041|NCT04499924|453425077|FG000|Overall Study|Withdrawal by Subject|1|||
126035042|NCT04499924|453425078|FG001|Overall Study|Withdrawal by Subject|3|||
126035043|NCT03945292|453427055|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
126035044|NCT03945292|453427056|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126265520|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Death|0|||
126035045|NCT03945292|453427057|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
126035046|NCT03945292|453427058|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126035047|NCT03945292|453427059|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126035048|NCT03945292|453427060|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126035049|NCT03945292|453427061|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126035050|NCT03945292|453427062|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126035051|NCT03945292|453427055|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126035052|NCT03945292|453427056|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126035053|NCT03945292|453427057|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
126035054|NCT03945292|453427058|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126035055|NCT03945292|453427059|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126035056|NCT03945292|453427060|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126035057|NCT03945292|453427061|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126035058|NCT03945292|453427062|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126035059|NCT03945292|453427055|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126035060|NCT03945292|453427056|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126035061|NCT03945292|453427057|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126035062|NCT03945292|453427058|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126035063|NCT03945292|453427059|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126035064|NCT03945292|453427060|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126097426|NCT01859988|453650190|FG001|Overall Study|Other than specified above|2|||
126097427|NCT01859988|453650191|FG002|Overall Study|Other than specified above|11|||
126097428|NCT01859988|453650192|FG003|Overall Study|Other than specified above|3|||
126097429|NCT01859988|453650193|FG004|Overall Study|Other than specified above|5|||
126097430|NCT01859988|453650194|FG005|Overall Study|Other than specified above|3|||
126097431|NCT02081417|453650199|FG000|Overall Study|Lost to Follow-up|26|||
126097432|NCT02081417|453650200|FG001|Overall Study|Lost to Follow-up|23|||
126265521|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Death|1|||
126265522|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Death|0|||
126265523|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Death|0|||
126265524|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
126265525|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
126265526|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
126265527|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
126265528|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
126265529|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
126265530|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
126265531|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
126265532|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Other|1|||
126265533|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Other|3|||
126265534|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Other|0|||
126265535|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Other|0|||
126265536|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
126265537|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
126265538|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
126265539|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
126265540|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Death|1|||
126265541|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Death|0|||
126265542|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Death|0|||
126265543|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Death|0|||
126265544|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
126265545|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
126265546|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
126265547|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
126265548|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
126360278|NCT01655069|454610799|FG000|Overall Study|Adverse Event|6|||
126360279|NCT01655069|454610800|FG001|Overall Study|Adverse Event|7|||
126360280|NCT01655069|454610801|FG002|Overall Study|Adverse Event|2|||
126360281|NCT01655069|454610802|FG003|Overall Study|Adverse Event|3|||
126360282|NCT01655069|454610799|FG000|Overall Study|Lack of Efficacy|0|||
126360283|NCT01655069|454610800|FG001|Overall Study|Lack of Efficacy|1|||
126360284|NCT01655069|454610801|FG002|Overall Study|Lack of Efficacy|0|||
126360285|NCT01655069|454610802|FG003|Overall Study|Lack of Efficacy|0|||
126360286|NCT01655069|454610799|FG000|Overall Study|No Treatment Needed|0|||
126360287|NCT01655069|454610800|FG001|Overall Study|No Treatment Needed|1|||
126360288|NCT01655069|454610801|FG002|Overall Study|No Treatment Needed|0|||
126360289|NCT01655069|454610802|FG003|Overall Study|No Treatment Needed|0|||
126360290|NCT01655069|454610799|FG000|Overall Study|Withdrawal by Subject|2|||
126360291|NCT01655069|454610800|FG001|Overall Study|Withdrawal by Subject|3|||
126360292|NCT01655069|454610801|FG002|Overall Study|Withdrawal by Subject|0|||
126360293|NCT01655069|454610802|FG003|Overall Study|Withdrawal by Subject|0|||
126360294|NCT06399471|454610803|FG000|Overall Study|Withdrawal by Subject|1|||
126360295|NCT03225989|454610804|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
126360296|NCT03225989|454610805|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
126360297|NCT03225989|454610806|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
126265549|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
126265550|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
126097433|NCT02081417|453650199|FG000|Overall Study|Moved Away|1|||
126265551|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
126097434|NCT02081417|453650200|FG001|Overall Study|Moved Away|2|||
126097435|NCT02081417|453650199|FG000|Overall Study|Incarcerated|2|||
126097436|NCT02081417|453650200|FG001|Overall Study|Incarcerated|2|||
126097437|NCT02081417|453650199|FG000|Overall Study|Death|4|||
126097438|NCT02081417|453650200|FG001|Overall Study|Death|3|||
126097439|NCT02081417|453650199|FG000|Overall Study|Withdrawal by Subject|4|||
126097440|NCT02081417|453650200|FG001|Overall Study|Withdrawal by Subject|0|||
126097441|NCT02081417|453650199|FG000|Overall Study|Admitted to Residential Treatment|2|||
126097442|NCT02081417|453650200|FG001|Overall Study|Admitted to Residential Treatment|0|||
126097443|NCT02081417|453650199|FG000|Overall Study|Did not start treatment|17|||
126097444|NCT02081417|453650200|FG001|Overall Study|Did not start treatment|21|||
126097445|NCT01263665|453650206|FG000|Overall Study|Withdrew Consent|1|||
126097446|NCT01263665|453650206|FG000|Overall Study|Lost to Follow-up|3|||
126097447|NCT01263665|453650206|FG000|Overall Study|Death|2|||
126097448|NCT01263665|453650206|FG000|Overall Study|Amputation above the ankle|1|||
126097449|NCT01263665|453650206|FG000|Overall Study|Surgical Bypass|2|||
126097450|NCT00324675|453650208|FG000|Overall Study|Adverse Event|1|||
126097451|NCT00324675|453650209|FG001|Overall Study|Adverse Event|0|||
126097452|NCT04860297|453650210|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
126097453|NCT04860297|453650211|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
126097454|NCT04860297|453650212|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
126097455|NCT04860297|453650213|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
126097456|NCT04860297|453650214|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
126097457|NCT04860297|453650215|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
126097458|NCT04860297|453650216|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
126097459|NCT04860297|453650217|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
126097460|NCT04860297|453650210|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
126097461|NCT04860297|453650211|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
126097462|NCT04860297|453650212|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
126097463|NCT04860297|453650213|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
126097464|NCT04860297|453650214|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
126097465|NCT04860297|453650215|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
126097466|NCT04860297|453650216|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
126097467|NCT04860297|453650217|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
126097468|NCT04860297|453650210|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
126097469|NCT04860297|453650211|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
126097470|NCT04860297|453650212|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
126097471|NCT04860297|453650213|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
126097472|NCT04860297|453650214|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
125880693|NCT05291520|452862588|FG002|Overall Study|Lost to Follow-up|1|||
125880694|NCT01347112|452862589|FG000|Overall Study|Withdrawal by Subject|1|||
126097473|NCT04860297|453650215|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
126097474|NCT04860297|453650216|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
126097475|NCT04860297|453650217|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
126097476|NCT04860297|453650210|FG000|Part B (Booster Dose)|Other Than Specified|0|||
126097477|NCT04860297|453650211|FG001|Part B (Booster Dose)|Other Than Specified|0|||
126097478|NCT04860297|453650212|FG002|Part B (Booster Dose)|Other Than Specified|0|||
126097479|NCT04860297|453650213|FG003|Part B (Booster Dose)|Other Than Specified|0|||
126097480|NCT04860297|453650214|FG004|Part B (Booster Dose)|Other Than Specified|0|||
126097481|NCT04860297|453650215|FG005|Part B (Booster Dose)|Other Than Specified|1|||
126097482|NCT04860297|453650216|FG006|Part B (Booster Dose)|Other Than Specified|1|||
126097483|NCT04860297|453650217|FG007|Part B (Booster Dose)|Other Than Specified|0|||
126097484|NCT04860297|453650210|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
126097485|NCT04860297|453650211|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
125880695|NCT01347112|452862590|FG001|Overall Study|Withdrawal by Subject|7|||
126097486|NCT04860297|453650212|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
126097487|NCT04860297|453650213|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
126097488|NCT04860297|453650214|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
125880696|NCT01347112|452862589|FG000|Overall Study|Lost to Follow-up|3|||
126035065|NCT03945292|453427061|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126035066|NCT03945292|453427062|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
126035067|NCT03524118|453427064|FG000|Overall Study|Lost to Follow-up|0|||
126035068|NCT03524118|453427065|FG001|Overall Study|Lost to Follow-up|0|||
126035069|NCT03524118|453427066|FG002|Overall Study|Lost to Follow-up|0|||
126035070|NCT03524118|453427067|FG003|Overall Study|Lost to Follow-up|0|||
126035071|NCT03524118|453427068|FG004|Overall Study|Lost to Follow-up|1|||
126035072|NCT03524118|453427069|FG005|Overall Study|Lost to Follow-up|0|||
126035073|NCT03524118|453427064|FG000|Overall Study|Other|0|||
126035074|NCT03524118|453427065|FG001|Overall Study|Other|1|||
126035075|NCT03524118|453427066|FG002|Overall Study|Other|0|||
126035076|NCT03524118|453427067|FG003|Overall Study|Other|0|||
126035077|NCT03524118|453427068|FG004|Overall Study|Other|1|||
126035078|NCT03524118|453427069|FG005|Overall Study|Other|1|||
126035079|NCT03524118|453427064|FG000|Overall Study|Physician Decision|0|||
126035080|NCT03524118|453427065|FG001|Overall Study|Physician Decision|0|||
126035081|NCT03524118|453427066|FG002|Overall Study|Physician Decision|0|||
126035082|NCT03524118|453427067|FG003|Overall Study|Physician Decision|0|||
126035083|NCT03524118|453427068|FG004|Overall Study|Physician Decision|1|||
126035084|NCT03524118|453427069|FG005|Overall Study|Physician Decision|0|||
126035085|NCT03524118|453427064|FG000|Overall Study|Protocol Violation|0|||
126035086|NCT03524118|453427065|FG001|Overall Study|Protocol Violation|0|||
126035087|NCT03524118|453427066|FG002|Overall Study|Protocol Violation|1|||
126035088|NCT03524118|453427067|FG003|Overall Study|Protocol Violation|0|||
126035089|NCT03524118|453427068|FG004|Overall Study|Protocol Violation|1|||
126035090|NCT03524118|453427069|FG005|Overall Study|Protocol Violation|0|||
126035091|NCT03524118|453427064|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126035092|NCT03524118|453427065|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126035093|NCT03524118|453427066|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126035094|NCT03524118|453427067|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
126035095|NCT03524118|453427068|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
126035096|NCT03524118|453427069|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126035097|NCT04987320|453427070|FG000|Overall Study|Withdrawal by Subject|0|||
126035098|NCT04987320|453427071|FG001|Overall Study|Withdrawal by Subject|1|||
126035099|NCT03462030|453427074|FG000|Overall Study|Withdrawal by Subject|1|||
126035100|NCT03462030|453427075|FG001|Overall Study|Withdrawal by Subject|1|||
126035101|NCT03371381|453427076|FG000|Overall Study|Death|5|||
126035102|NCT03371381|453427076|FG000|Overall Study|Study terminated by sponsor|3|||
126035103|NCT03371381|453427076|FG000|Overall Study|Other|4|||
126035104|NCT02979327|453427077|FG000|First Intervention|Protocol Violation|1|||
126035105|NCT02979327|453427078|FG001|First Intervention|Protocol Violation|0|||
126035106|NCT05020249|453427079|FG000|Overall Study|Protocol Violation|1|||
126035107|NCT05020249|453427080|FG001|Overall Study|Protocol Violation|0|||
126035108|NCT03628924|453427087|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
126097489|NCT04860297|453650215|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
126097490|NCT04860297|453650216|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
126097491|NCT04860297|453650217|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
126097492|NCT04860297|453650210|FG000|Part B (Booster Dose)|Death|0|||
126097493|NCT04860297|453650211|FG001|Part B (Booster Dose)|Death|0|||
126097494|NCT04860297|453650212|FG002|Part B (Booster Dose)|Death|0|||
126097495|NCT04860297|453650213|FG003|Part B (Booster Dose)|Death|0|||
126097496|NCT04860297|453650214|FG004|Part B (Booster Dose)|Death|1|||
126097497|NCT04860297|453650215|FG005|Part B (Booster Dose)|Death|2|||
126097498|NCT04860297|453650216|FG006|Part B (Booster Dose)|Death|1|||
126097499|NCT04860297|453650217|FG007|Part B (Booster Dose)|Death|0|||
126097500|NCT04860297|453650210|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
126097501|NCT04860297|453650211|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
126265552|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
126265553|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
126265554|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
126265555|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
126035109|NCT03628924|453427088|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126035110|NCT03628924|453427089|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126035111|NCT03628924|453427090|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126035112|NCT03628924|453427091|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126097502|NCT04860297|453650212|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
126097503|NCT04860297|453650213|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
126097504|NCT04860297|453650214|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
126035113|NCT03628924|453427092|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126035114|NCT03628924|453427093|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126035115|NCT03628924|453427087|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126035116|NCT03628924|453427088|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126035117|NCT03628924|453427089|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
126097505|NCT04860297|453650215|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
126097506|NCT04860297|453650216|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
126097507|NCT04860297|453650217|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
126097508|NCT04811131|453650221|FG000|Overall Study|Adverse Event|0|||
126097509|NCT04811131|453650222|FG001|Overall Study|Adverse Event|0|||
126097510|NCT04811131|453650223|FG002|Overall Study|Adverse Event|1|||
126097511|NCT04811131|453650224|FG003|Overall Study|Adverse Event|0|||
126097512|NCT04811131|453650221|FG000|Overall Study|Lack of Efficacy|0|||
126097513|NCT04811131|453650222|FG001|Overall Study|Lack of Efficacy|0|||
126097514|NCT04811131|453650223|FG002|Overall Study|Lack of Efficacy|0|||
126097515|NCT04811131|453650224|FG003|Overall Study|Lack of Efficacy|1|||
126097516|NCT04811131|453650221|FG000|Overall Study|Lost to Follow-up|0|||
126097517|NCT04811131|453650222|FG001|Overall Study|Lost to Follow-up|1|||
126097518|NCT04811131|453650223|FG002|Overall Study|Lost to Follow-up|0|||
126097519|NCT04811131|453650224|FG003|Overall Study|Lost to Follow-up|0|||
126097520|NCT04811131|453650221|FG000|Overall Study|Sponsor request|31|||
126097521|NCT04811131|453650222|FG001|Overall Study|Sponsor request|35|||
126097522|NCT04811131|453650223|FG002|Overall Study|Sponsor request|27|||
126097523|NCT04811131|453650224|FG003|Overall Study|Sponsor request|10|||
126097524|NCT04811131|453650221|FG000|Overall Study|Withdrawal by Subject|3|||
126097525|NCT04811131|453650222|FG001|Overall Study|Withdrawal by Subject|1|||
126097526|NCT04811131|453650223|FG002|Overall Study|Withdrawal by Subject|3|||
126097527|NCT04811131|453650224|FG003|Overall Study|Withdrawal by Subject|1|||
126097528|NCT01528345|453650226|FG000|Overall Study|Adverse Event|10|||
126097529|NCT01528345|453650227|FG001|Overall Study|Adverse Event|1|||
126097530|NCT01528345|453650226|FG000|Overall Study|Death|1|||
126097531|NCT01528345|453650227|FG001|Overall Study|Death|1|||
126097532|NCT01528345|453650226|FG000|Overall Study|Non-compliance with study treatment|1|||
126097533|NCT01528345|453650227|FG001|Overall Study|Non-compliance with study treatment|0|||
126265556|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
126265557|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
126265558|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
126265559|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
126265560|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265561|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
126265562|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
126265563|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
126265564|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
126265565|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
126265566|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
126265567|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
126265568|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
126265569|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
126265570|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
126265571|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
126265572|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
126265573|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
126265574|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
126265575|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
126265576|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
126265577|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
126360298|NCT03225989|454610804|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
126360299|NCT03225989|454610805|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
126360300|NCT03225989|454610806|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
126360301|NCT03225989|454610804|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
126360302|NCT03225989|454610805|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
126360303|NCT03225989|454610806|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
126360304|NCT03225989|454610804|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
126360305|NCT03225989|454610805|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
126360306|NCT03225989|454610806|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
126360307|NCT03225989|454610804|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
126360308|NCT03225989|454610805|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
126360309|NCT03225989|454610806|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
126360310|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
126360311|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
126360312|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
126360313|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
126360314|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
126360315|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
126360316|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
126097534|NCT01528345|453650226|FG000|Overall Study|Progressive Disease|26|||
126097535|NCT01528345|453650227|FG001|Overall Study|Progressive Disease|40|||
126035118|NCT03628924|453427090|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126035119|NCT03628924|453427091|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126035120|NCT03628924|453427092|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126035121|NCT03628924|453427093|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126035122|NCT03628924|453427087|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
126035123|NCT03628924|453427088|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
126035124|NCT03628924|453427089|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
126035125|NCT03628924|453427090|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
126035126|NCT03628924|453427091|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
126035127|NCT03628924|453427092|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
126035128|NCT03628924|453427093|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
126035129|NCT03628924|453427087|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126035130|NCT03628924|453427088|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
126035131|NCT03628924|453427089|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126035132|NCT03628924|453427090|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126035133|NCT03628924|453427091|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126035134|NCT03628924|453427092|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126035135|NCT03628924|453427093|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126035136|NCT03628924|453427087|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
126035137|NCT03628924|453427088|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126035138|NCT03628924|453427089|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
126265578|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
126265579|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
126265580|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Other|3|||
126265581|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Other|0|||
126265582|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Other|4|||
126265583|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Other|1|||
126265584|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
126265585|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
126265586|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
126265587|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
126265588|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
126265589|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
126265590|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
126265591|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
126265592|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
126265593|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
126265594|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
126265595|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
126265596|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265597|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
126265598|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265599|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265600|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
126265601|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
126035139|NCT03628924|453427090|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126035140|NCT03628924|453427091|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126035141|NCT03628924|453427092|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126035142|NCT03628924|453427093|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126035143|NCT03628924|453427087|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
126035144|NCT03628924|453427088|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
126035145|NCT03628924|453427089|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
126035146|NCT03628924|453427090|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
126035147|NCT03628924|453427091|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
126265602|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
126265603|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
126265604|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
126265605|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
126035148|NCT03628924|453427092|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
126097536|NCT01528345|453650226|FG000|Overall Study|Study Terminated by Sponsor|4|||
126265606|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
126265607|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
126265608|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
126265609|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
126035149|NCT03628924|453427093|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
126035150|NCT03628924|453427087|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
126035151|NCT03628924|453427088|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
126035152|NCT03628924|453427089|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
126035153|NCT03628924|453427090|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
126035154|NCT03628924|453427091|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
126035155|NCT03628924|453427092|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
126035156|NCT03628924|453427093|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
126035157|NCT03628924|453427087|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
126097537|NCT01528345|453650227|FG001|Overall Study|Study Terminated by Sponsor|8|||
126097538|NCT01528345|453650226|FG000|Overall Study|Subject/Guardian Decision|5|||
126097539|NCT01528345|453650227|FG001|Overall Study|Subject/Guardian Decision|0|||
126097540|NCT00371683|453650228|FG000|DB Treatment Period-Randomized Patients|Death|1|||
126097541|NCT00371683|453650229|FG001|DB Treatment Period-Randomized Patients|Death|1|||
126097542|NCT00371683|453650228|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
126097543|NCT00371683|453650229|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
126097544|NCT00371683|453650228|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
126097545|NCT00371683|453650229|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
126097546|NCT00371683|453650228|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
126097547|NCT00371683|453650229|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
126097548|NCT00371683|453650228|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
126097549|NCT00371683|453650229|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
126097550|NCT00371683|453650228|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
126097551|NCT00371683|453650229|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
126097552|NCT00371683|453650228|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
126097553|NCT00371683|453650229|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
126097554|NCT00371683|453650228|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
126265610|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
126265611|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
126097555|NCT00371683|453650229|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
126097556|NCT00371683|453650228|FG000|Follow-Up Period - Randomized Patients|Death|0|||
126097557|NCT00371683|453650229|FG001|Follow-Up Period - Randomized Patients|Death|2|||
126097558|NCT00371683|453650228|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
126097559|NCT00371683|453650229|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
126097560|NCT00371683|453650228|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
126097561|NCT00371683|453650229|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
126097562|NCT03181789|453650231|FG000|Overall Study|Withdrawal by Subject|0|||
126097563|NCT03181789|453650232|FG001|Overall Study|Withdrawal by Subject|1|||
126097564|NCT03181789|453650233|FG002|Overall Study|Withdrawal by Subject|1|||
126097565|NCT03181789|453650234|FG003|Overall Study|Withdrawal by Subject|0|||
126097566|NCT03181789|453650231|FG000|Overall Study|Lost to Follow-up|7|||
126097567|NCT03181789|453650232|FG001|Overall Study|Lost to Follow-up|1|||
126097568|NCT03181789|453650233|FG002|Overall Study|Lost to Follow-up|0|||
126097569|NCT03181789|453650234|FG003|Overall Study|Lost to Follow-up|0|||
126097570|NCT03181789|453650231|FG000|Overall Study|Participant unable to adhere to visit|0|||
126265612|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
126265613|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
126265614|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
126265615|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
126265616|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
126265617|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
126265618|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
126097571|NCT03181789|453650232|FG001|Overall Study|Participant unable to adhere to visit|1|||
126360317|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
126097572|NCT03181789|453650233|FG002|Overall Study|Participant unable to adhere to visit|0|||
126360318|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
126360319|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
126360320|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
126360321|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
126360322|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
126360323|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
126360324|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
126360325|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
126360326|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
126360327|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
126360328|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
126265619|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
126265620|NCT03739138|454262873|FG000|Overall Study|Death|0|||
126265621|NCT03739138|454262874|FG001|Overall Study|Death|7|||
126265622|NCT03739138|454262875|FG002|Overall Study|Death|4|||
126265623|NCT03739138|454262876|FG003|Overall Study|Death|13|||
126265624|NCT03739138|454262877|FG004|Overall Study|Death|0|||
126265625|NCT03739138|454262873|FG000|Overall Study|Lost to Follow-up|0|||
126265626|NCT03739138|454262874|FG001|Overall Study|Lost to Follow-up|0|||
126265627|NCT03739138|454262875|FG002|Overall Study|Lost to Follow-up|1|||
126265628|NCT03739138|454262876|FG003|Overall Study|Lost to Follow-up|0|||
126265629|NCT03739138|454262877|FG004|Overall Study|Lost to Follow-up|0|||
126265630|NCT03739138|454262873|FG000|Overall Study|Study Terminated By Sponsor|0|||
126265631|NCT03739138|454262874|FG001|Overall Study|Study Terminated By Sponsor|0|||
126265632|NCT03739138|454262875|FG002|Overall Study|Study Terminated By Sponsor|0|||
126265633|NCT03739138|454262876|FG003|Overall Study|Study Terminated By Sponsor|4|||
126265634|NCT03739138|454262877|FG004|Overall Study|Study Terminated By Sponsor|0|||
126265635|NCT03739138|454262873|FG000|Overall Study|Withdrawal by Subject|0|||
126035158|NCT03628924|453427088|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
126035159|NCT03628924|453427089|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
126035160|NCT03628924|453427090|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
126035161|NCT03628924|453427091|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
126035162|NCT03628924|453427092|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
126035163|NCT03628924|453427093|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
126035164|NCT03628924|453427087|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
126035165|NCT03628924|453427088|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
126035166|NCT03628924|453427089|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
126035167|NCT03628924|453427090|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
126035168|NCT03628924|453427091|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
126035169|NCT03628924|453427092|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
126035170|NCT03628924|453427093|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
126035171|NCT03628924|453427087|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
126035172|NCT03628924|453427088|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
126035173|NCT03628924|453427089|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
126035174|NCT03628924|453427090|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
126035175|NCT03628924|453427091|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
126035176|NCT03628924|453427092|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
126035177|NCT03628924|453427093|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
126035178|NCT03474679|453427100|FG000|Overall Study|Death|7|||
126035179|NCT03474679|453427100|FG000|Overall Study|Withdrawal by Subject|1|||
126035180|NCT05499377|453427103|FG000|Overall Study|Withdrawal by Subject|2|||
126035181|NCT05499377|453427104|FG001|Overall Study|Withdrawal by Subject|0|||
126035182|NCT05499377|453427103|FG000|Overall Study|Physician Decision|1|||
126035183|NCT05499377|453427104|FG001|Overall Study|Physician Decision|0|||
126035184|NCT02573493|453427105|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
126035185|NCT02573493|453427106|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
126035186|NCT02573493|453427107|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
126035187|NCT02573493|453427108|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
126035188|NCT04149704|453427109|FG000|Three Month Follow-up|Death|2|||
126035189|NCT04149704|453427110|FG001|Three Month Follow-up|Death|0|||
126035190|NCT04149704|453427111|FG002|Three Month Follow-up|Death|0|||
126035191|NCT04149704|453427112|FG003|Three Month Follow-up|Death|0|||
126035192|NCT04149704|453427109|FG000|Three Month Follow-up|Lost to Follow-up|1|||
126035193|NCT04149704|453427110|FG001|Three Month Follow-up|Lost to Follow-up|4|||
126035194|NCT04149704|453427111|FG002|Three Month Follow-up|Lost to Follow-up|5|||
126035195|NCT04149704|453427112|FG003|Three Month Follow-up|Lost to Follow-up|5|||
126035196|NCT04149704|453427109|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
126035197|NCT04149704|453427110|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
126035198|NCT04149704|453427111|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
126035199|NCT04149704|453427112|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
126035200|NCT04149704|453427109|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
126035201|NCT04149704|453427110|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
126265636|NCT03739138|454262874|FG001|Overall Study|Withdrawal by Subject|0|||
125880697|NCT01347112|452862590|FG001|Overall Study|Lost to Follow-up|5|||
126035202|NCT04149704|453427111|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
126046517|NCT03868930|453468246|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
126265637|NCT03739138|454262875|FG002|Overall Study|Withdrawal by Subject|0|||
126265638|NCT03739138|454262876|FG003|Overall Study|Withdrawal by Subject|1|||
126265639|NCT03739138|454262877|FG004|Overall Study|Withdrawal by Subject|0|||
126265640|NCT04403763|454262878|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
126035203|NCT04149704|453427112|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
126035204|NCT04332926|453427113|FG000|Overall Study|Withdrawal by Subject|6|||
126035205|NCT04332926|453427113|FG000|Overall Study|Physician Decision|6|||
126097573|NCT03181789|453650234|FG003|Overall Study|Participant unable to adhere to visit|0|||
126097574|NCT02624791|453650235|FG000|Overall Study|Withdrawal by Subject|2|||
126097575|NCT02624791|453650236|FG001|Overall Study|Withdrawal by Subject|0|||
126097576|NCT02624791|453650237|FG002|Overall Study|Withdrawal by Subject|0|||
126097577|NCT02624791|453650238|FG003|Overall Study|Withdrawal by Subject|0|||
126097578|NCT02624791|453650239|FG004|Overall Study|Withdrawal by Subject|0|||
126097579|NCT02624791|453650240|FG005|Overall Study|Withdrawal by Subject|0|||
126097580|NCT01131182|453650241|FG000|Overall Study|Withdrawal by Subject|1|||
126097581|NCT01131182|453650242|FG001|Overall Study|Withdrawal by Subject|1|||
126097582|NCT01131182|453650241|FG000|Overall Study|Lost to Follow-up|14|||
126097583|NCT01131182|453650242|FG001|Overall Study|Lost to Follow-up|15|||
126097584|NCT01131182|453650241|FG000|Overall Study|Other Reason|1|||
126097585|NCT01131182|453650242|FG001|Overall Study|Other Reason|0|||
126097586|NCT00735475|453650243|FG000|Overall Study|Adverse Event|0|||
126097587|NCT00735475|453650244|FG001|Overall Study|Adverse Event|1|||
126097588|NCT00735475|453650243|FG000|Overall Study|Death|1|||
126097589|NCT00735475|453650244|FG001|Overall Study|Death|1|||
126097590|NCT00735475|453650243|FG000|Overall Study|Lost to Follow-up|3|||
126097591|NCT00735475|453650244|FG001|Overall Study|Lost to Follow-up|3|||
126097592|NCT00735475|453650243|FG000|Overall Study|Physician Decision|0|||
126097593|NCT00735475|453650244|FG001|Overall Study|Physician Decision|1|||
126097594|NCT00735475|453650243|FG000|Overall Study|Withdrawal by Subject|4|||
126097595|NCT00735475|453650244|FG001|Overall Study|Withdrawal by Subject|5|||
126097596|NCT04602221|453650247|FG000|Overall Study|Discontinuation of trial treatment|0|||
126097597|NCT04602221|453650248|FG001|Overall Study|Discontinuation of trial treatment|0|||
126097598|NCT04602221|453650249|FG002|Overall Study|Discontinuation of trial treatment|1|||
126097599|NCT04602221|453650250|FG003|Overall Study|Discontinuation of trial treatment|0|||
126097600|NCT04602221|453650251|FG004|Overall Study|Discontinuation of trial treatment|0|||
126097601|NCT04602221|453650252|FG005|Overall Study|Discontinuation of trial treatment|0|||
126097602|NCT04602221|453650253|FG006|Overall Study|Discontinuation of trial treatment|0|||
126097603|NCT04602221|453650254|FG007|Overall Study|Discontinuation of trial treatment|0|||
126097604|NCT04602221|453650255|FG008|Overall Study|Discontinuation of trial treatment|0|||
126097605|NCT04602221|453650256|FG009|Overall Study|Discontinuation of trial treatment|0|||
126097606|NCT04602221|453650257|FG010|Overall Study|Discontinuation of trial treatment|0|||
126097607|NCT04602221|453650258|FG011|Overall Study|Discontinuation of trial treatment|0|||
126097608|NCT04602221|453650259|FG012|Overall Study|Discontinuation of trial treatment|0|||
126097609|NCT04602221|453650260|FG013|Overall Study|Discontinuation of trial treatment|0|||
126097610|NCT04602221|453650261|FG014|Overall Study|Discontinuation of trial treatment|0|||
126097611|NCT04602221|453650262|FG015|Overall Study|Discontinuation of trial treatment|0|||
126097612|NCT04602221|453650263|FG016|Overall Study|Discontinuation of trial treatment|0|||
126097613|NCT04602221|453650264|FG017|Overall Study|Discontinuation of trial treatment|0|||
126097614|NCT04602221|453650247|FG000|Overall Study|Other than listed|0|||
126097615|NCT04602221|453650248|FG001|Overall Study|Other than listed|0|||
126097616|NCT04602221|453650249|FG002|Overall Study|Other than listed|0|||
126097617|NCT04602221|453650250|FG003|Overall Study|Other than listed|0|||
126097618|NCT04602221|453650251|FG004|Overall Study|Other than listed|0|||
126097619|NCT04602221|453650252|FG005|Overall Study|Other than listed|0|||
126097620|NCT04602221|453650253|FG006|Overall Study|Other than listed|0|||
126035254|NCT02677805|453427125|FG000|Double Blind Phase|Lost to Follow-up|8|||
126035255|NCT02677805|453427126|FG001|Double Blind Phase|Lost to Follow-up|3|||
126035256|NCT02677805|453427127|FG002|Double Blind Phase|Lost to Follow-up|0|||
126035257|NCT02677805|453427125|FG000|Double Blind Phase|Withdrawal by Subject|5|||
126035258|NCT02677805|453427126|FG001|Double Blind Phase|Withdrawal by Subject|2|||
126035259|NCT02677805|453427127|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126035260|NCT02677805|453427125|FG000|Open Label Phase|Lost to Follow-up|0|||
126035261|NCT02677805|453427126|FG001|Open Label Phase|Lost to Follow-up|0|||
126035262|NCT02677805|453427127|FG002|Open Label Phase|Lost to Follow-up|10|||
126035263|NCT02677805|453427125|FG000|Open Label Phase|Withdrawal by Subject|0|||
126035264|NCT02677805|453427126|FG001|Open Label Phase|Withdrawal by Subject|0|||
126097621|NCT04602221|453650254|FG007|Overall Study|Other than listed|0|||
126097622|NCT04602221|453650255|FG008|Overall Study|Other than listed|0|||
126097623|NCT04602221|453650256|FG009|Overall Study|Other than listed|0|||
126097624|NCT04602221|453650257|FG010|Overall Study|Other than listed|0|||
126097625|NCT04602221|453650258|FG011|Overall Study|Other than listed|0|||
126097626|NCT04602221|453650259|FG012|Overall Study|Other than listed|0|||
126097627|NCT04602221|453650260|FG013|Overall Study|Other than listed|0|||
126097628|NCT04602221|453650261|FG014|Overall Study|Other than listed|0|||
126097629|NCT04602221|453650262|FG015|Overall Study|Other than listed|1|||
126097630|NCT04602221|453650263|FG016|Overall Study|Other than listed|0|||
126097631|NCT04602221|453650264|FG017|Overall Study|Other than listed|1|||
126265641|NCT04403763|454262879|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
126035265|NCT02677805|453427127|FG002|Open Label Phase|Withdrawal by Subject|6|||
126035266|NCT05714761|453427128|FG000|Overall Study|Lost to Follow-up|3|||
126035267|NCT05714761|453427128|FG000|Overall Study|Withdrawal by Subject|3|||
126035268|NCT05714761|453427128|FG000|Overall Study|unblinding of sensor data|1|||
126035269|NCT05714761|453427128|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
126035270|NCT05714761|453427128|FG000|Overall Study|did not return second CGM sensor|4|||
126035271|NCT05672069|453427129|FG000|Overall Study|Implant removal|1|||
126035272|NCT05672069|453427129|FG000|Overall Study|Lost to Follow-up|2|||
126035273|NCT06019559|453427130|FG000|Overall Study|Withdrawal by Subject|7|||
126035274|NCT06019559|453427131|FG001|Overall Study|Withdrawal by Subject|6|||
126035275|NCT06019559|453427132|FG002|Overall Study|Withdrawal by Subject|5|||
126035276|NCT06019559|453427130|FG000|Overall Study|Lost to Follow-up|2|||
126035277|NCT06019559|453427131|FG001|Overall Study|Lost to Follow-up|0|||
126035278|NCT06019559|453427132|FG002|Overall Study|Lost to Follow-up|3|||
126035279|NCT05213390|453427133|FG000|Overall Study|Withdrawal by Subject|2|||
126035280|NCT05213390|453427133|FG000|Overall Study|Lost to Follow-up|12|||
126035281|NCT05213390|453427133|FG000|Overall Study|Protocol Violation|9|||
126035282|NCT06215521|453427142|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
126035283|NCT06215521|453427143|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
126035284|NCT06215521|453427144|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
126035285|NCT06215521|453427145|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
126035286|NCT06215521|453427146|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
126035287|NCT06215521|453427147|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
126035288|NCT03858634|453427151|FG000|Overall Study|Withdrawal by Subject|1|||
126035289|NCT03858634|453427152|FG001|Overall Study|Withdrawal by Subject|0|||
126035290|NCT03858634|453427151|FG000|Overall Study|Adverse Event|1|||
126035291|NCT03858634|453427152|FG001|Overall Study|Adverse Event|0|||
126035292|NCT03858634|453427151|FG000|Overall Study|Lost to Follow-up|0|||
126035293|NCT03858634|453427152|FG001|Overall Study|Lost to Follow-up|1|||
126035294|NCT03858634|453427151|FG000|Overall Study|Other, Not Specified|1|||
126035295|NCT03858634|453427152|FG001|Overall Study|Other, Not Specified|1|||
126035296|NCT03808818|453427153|FG000|Overall Study|Death|6|||
126035297|NCT03808818|453427154|FG001|Overall Study|Death|6|||
126035298|NCT03808818|453427153|FG000|Overall Study|Withdrawal by Subject|7|||
126035299|NCT03808818|453427154|FG001|Overall Study|Withdrawal by Subject|18|||
126035300|NCT03808818|453427153|FG000|Overall Study|Lost to Follow-up|31|||
126035301|NCT03808818|453427154|FG001|Overall Study|Lost to Follow-up|33|||
126035302|NCT04676763|453427155|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
126035303|NCT04676763|453427156|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
126035304|NCT04676763|453427157|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
126035305|NCT04676763|453427155|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
126035306|NCT04676763|453427156|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
126035307|NCT04676763|453427157|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
126035308|NCT04676763|453427155|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
126035309|NCT04676763|453427156|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
126035310|NCT04676763|453427157|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
126035311|NCT03150173|453427158|FG000|Overall Study|Lost to Follow-up|13|||
126035312|NCT03150173|453427159|FG001|Overall Study|Lost to Follow-up|5|||
126035313|NCT02191618|453427166|FG000|Overall Study|Withdrawal by Subject|3|||
126035314|NCT02191618|453427166|FG000|Overall Study|Missed Visit|4|||
126035315|NCT02310646|453427172|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
126035316|NCT02310646|453427173|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
126035317|NCT02310646|453427172|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
126035318|NCT02310646|453427173|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
126035319|NCT01648023|453427178|FG000|Overall Study|Screen Fail Post Randomization|1|||
126035320|NCT01648023|453427179|FG001|Overall Study|Screen Fail Post Randomization|2|||
126035321|NCT04599062|453427187|FG000|Overall Study|Physician Decision|1|||
126035322|NCT04599062|453427188|FG001|Overall Study|Physician Decision|0|||
126035323|NCT04074759|453427190|FG000|Overall Study|Withdrawal by Subject|0|||
126035324|NCT04074759|453427191|FG001|Overall Study|Withdrawal by Subject|0|||
126035325|NCT04074759|453427192|FG002|Overall Study|Withdrawal by Subject|0|||
126035326|NCT04074759|453427193|FG003|Overall Study|Withdrawal by Subject|0|||
126035327|NCT04074759|453427194|FG004|Overall Study|Withdrawal by Subject|0|||
126035328|NCT04074759|453427195|FG005|Overall Study|Withdrawal by Subject|2|||
126035329|NCT04074759|453427196|FG006|Overall Study|Withdrawal by Subject|0|||
126265642|NCT04403763|454262880|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
126035330|NCT04074759|453427197|FG007|Overall Study|Withdrawal by Subject|2|||
126035331|NCT04074759|453427198|FG008|Overall Study|Withdrawal by Subject|1|||
126035332|NCT04074759|453427199|FG009|Overall Study|Withdrawal by Subject|2|||
126035333|NCT04074759|453427200|FG010|Overall Study|Withdrawal by Subject|9|||
126035334|NCT04074759|453427201|FG011|Overall Study|Withdrawal by Subject|2|||
126035335|NCT04074759|453427202|FG012|Overall Study|Withdrawal by Subject|1|||
126035336|NCT04074759|453427203|FG013|Overall Study|Withdrawal by Subject|3|||
126035337|NCT04074759|453427204|FG014|Overall Study|Withdrawal by Subject|2|||
126035338|NCT04074759|453427205|FG015|Overall Study|Withdrawal by Subject|0|||
126035339|NCT04074759|453427206|FG016|Overall Study|Withdrawal by Subject|0|||
126035340|NCT04074759|453427207|FG017|Overall Study|Withdrawal by Subject|3|||
126035341|NCT04074759|453427208|FG018|Overall Study|Withdrawal by Subject|1|||
126035342|NCT04074759|453427190|FG000|Overall Study|Death|1|||
126035343|NCT04074759|453427191|FG001|Overall Study|Death|0|||
126035344|NCT04074759|453427192|FG002|Overall Study|Death|1|||
126035345|NCT04074759|453427193|FG003|Overall Study|Death|1|||
126035346|NCT04074759|453427194|FG004|Overall Study|Death|2|||
126035347|NCT04074759|453427195|FG005|Overall Study|Death|0|||
126035348|NCT04074759|453427196|FG006|Overall Study|Death|1|||
126035349|NCT04074759|453427197|FG007|Overall Study|Death|0|||
126035350|NCT04074759|453427198|FG008|Overall Study|Death|3|||
126035351|NCT04074759|453427199|FG009|Overall Study|Death|2|||
126097632|NCT04602221|453650247|FG000|Overall Study|Withdrawal by Subject|0|||
126097633|NCT04602221|453650248|FG001|Overall Study|Withdrawal by Subject|0|||
126265643|NCT04403763|454262881|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
126265644|NCT04403763|454262882|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
126265645|NCT04403763|454262883|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
126265646|NCT04403763|454262884|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
126265647|NCT04403763|454262878|FG000|Stage 1|Early termination due to PK tube failure|0|||
126265648|NCT04403763|454262879|FG001|Stage 1|Early termination due to PK tube failure|0|||
126265649|NCT04403763|454262880|FG002|Stage 1|Early termination due to PK tube failure|1|||
126265650|NCT04403763|454262881|FG003|Stage 1|Early termination due to PK tube failure|0|||
126265651|NCT04403763|454262882|FG004|Stage 1|Early termination due to PK tube failure|0|||
126360329|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
126035352|NCT04074759|453427200|FG010|Overall Study|Death|4|||
126035353|NCT04074759|453427201|FG011|Overall Study|Death|1|||
126035354|NCT04074759|453427202|FG012|Overall Study|Death|0|||
126035355|NCT04074759|453427203|FG013|Overall Study|Death|2|||
126035356|NCT04074759|453427204|FG014|Overall Study|Death|1|||
126360330|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
126360331|NCT00601107|454610807|FG000|Overall Study|Adverse Event|0|||
126360332|NCT00601107|454610808|FG001|Overall Study|Adverse Event|1|||
126360333|NCT00601107|454610809|FG002|Overall Study|Adverse Event|3|||
126360334|NCT00601107|454610810|FG003|Overall Study|Adverse Event|0|||
126360335|NCT00601107|454610807|FG000|Overall Study|Withdrawal by Subject|5|||
126360336|NCT00601107|454610808|FG001|Overall Study|Withdrawal by Subject|4|||
126360337|NCT00601107|454610809|FG002|Overall Study|Withdrawal by Subject|7|||
126035357|NCT04074759|453427205|FG015|Overall Study|Death|0|||
126097634|NCT04602221|453650249|FG002|Overall Study|Withdrawal by Subject|0|||
126097635|NCT04602221|453650250|FG003|Overall Study|Withdrawal by Subject|0|||
126097636|NCT04602221|453650251|FG004|Overall Study|Withdrawal by Subject|0|||
126097637|NCT04602221|453650252|FG005|Overall Study|Withdrawal by Subject|0|||
126097638|NCT04602221|453650253|FG006|Overall Study|Withdrawal by Subject|0|||
126097639|NCT04602221|453650254|FG007|Overall Study|Withdrawal by Subject|0|||
126097640|NCT04602221|453650255|FG008|Overall Study|Withdrawal by Subject|0|||
126097641|NCT04602221|453650256|FG009|Overall Study|Withdrawal by Subject|0|||
126097642|NCT04602221|453650257|FG010|Overall Study|Withdrawal by Subject|0|||
126097643|NCT04602221|453650258|FG011|Overall Study|Withdrawal by Subject|0|||
126097644|NCT04602221|453650259|FG012|Overall Study|Withdrawal by Subject|1|||
126097645|NCT04602221|453650260|FG013|Overall Study|Withdrawal by Subject|0|||
126097646|NCT04602221|453650261|FG014|Overall Study|Withdrawal by Subject|0|||
126097647|NCT04602221|453650262|FG015|Overall Study|Withdrawal by Subject|0|||
126097648|NCT04602221|453650263|FG016|Overall Study|Withdrawal by Subject|0|||
126097649|NCT04602221|453650264|FG017|Overall Study|Withdrawal by Subject|0|||
126097650|NCT04602221|453650247|FG000|Overall Study|Lost to Follow-up|0|||
126097651|NCT04602221|453650248|FG001|Overall Study|Lost to Follow-up|0|||
126097652|NCT04602221|453650249|FG002|Overall Study|Lost to Follow-up|0|||
126360338|NCT00601107|454610810|FG003|Overall Study|Withdrawal by Subject|4|||
126360339|NCT00601107|454610807|FG000|Overall Study|Lost to Follow-up|3|||
126360340|NCT00601107|454610808|FG001|Overall Study|Lost to Follow-up|3|||
126360341|NCT00601107|454610809|FG002|Overall Study|Lost to Follow-up|0|||
126035358|NCT04074759|453427206|FG016|Overall Study|Death|1|||
126035359|NCT04074759|453427207|FG017|Overall Study|Death|0|||
126035360|NCT04074759|453427208|FG018|Overall Study|Death|1|||
126035361|NCT04074759|453427190|FG000|Overall Study|Lost to Follow-up|0|||
126035362|NCT04074759|453427191|FG001|Overall Study|Lost to Follow-up|0|||
126035363|NCT04074759|453427192|FG002|Overall Study|Lost to Follow-up|0|||
126035364|NCT04074759|453427193|FG003|Overall Study|Lost to Follow-up|0|||
126035365|NCT04074759|453427194|FG004|Overall Study|Lost to Follow-up|0|||
126035366|NCT04074759|453427195|FG005|Overall Study|Lost to Follow-up|0|||
126035367|NCT04074759|453427196|FG006|Overall Study|Lost to Follow-up|0|||
126035368|NCT04074759|453427197|FG007|Overall Study|Lost to Follow-up|0|||
126035369|NCT04074759|453427198|FG008|Overall Study|Lost to Follow-up|0|||
126097653|NCT04602221|453650250|FG003|Overall Study|Lost to Follow-up|0|||
126097654|NCT04602221|453650251|FG004|Overall Study|Lost to Follow-up|0|||
126097655|NCT04602221|453650252|FG005|Overall Study|Lost to Follow-up|1|||
126360342|NCT00601107|454610810|FG003|Overall Study|Lost to Follow-up|3|||
126360343|NCT00601107|454610807|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
126360344|NCT00601107|454610808|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
126360345|NCT00601107|454610809|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
126360346|NCT00601107|454610810|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
126360347|NCT00601107|454610807|FG000|Overall Study|Worsening of Psoriasis|4|||
126360348|NCT00601107|454610808|FG001|Overall Study|Worsening of Psoriasis|1|||
126360349|NCT00601107|454610809|FG002|Overall Study|Worsening of Psoriasis|1|||
126360350|NCT00601107|454610810|FG003|Overall Study|Worsening of Psoriasis|4|||
126360351|NCT00601107|454610807|FG000|Overall Study|Undefined|1|||
126360352|NCT00601107|454610808|FG001|Overall Study|Undefined|0|||
126360353|NCT00601107|454610809|FG002|Overall Study|Undefined|1|||
126360354|NCT00601107|454610810|FG003|Overall Study|Undefined|0|||
126360355|NCT00147537|454610812|FG000|Phase 1b|Death|0|||
126360356|NCT00147537|454610813|FG001|Phase 1b|Death|1|||
126360357|NCT00147537|454610814|FG002|Phase 1b|Death|2|||
126360358|NCT00147537|454610815|FG003|Phase 1b|Death|1|||
126097656|NCT04602221|453650253|FG006|Overall Study|Lost to Follow-up|0|||
126360359|NCT00147537|454610816|FG004|Phase 1b|Death|2|||
126360360|NCT00147537|454610817|FG005|Phase 1b|Death|2|||
126360361|NCT00147537|454610818|FG006|Phase 1b|Death|1|||
126360362|NCT00147537|454610819|FG007|Phase 1b|Death|3|||
126360363|NCT00147537|454610820|FG008|Phase 1b|Death|9|||
126035370|NCT04074759|453427199|FG009|Overall Study|Lost to Follow-up|0|||
126035371|NCT04074759|453427200|FG010|Overall Study|Lost to Follow-up|1|||
126035372|NCT04074759|453427201|FG011|Overall Study|Lost to Follow-up|0|||
126035373|NCT04074759|453427202|FG012|Overall Study|Lost to Follow-up|0|||
126035374|NCT04074759|453427203|FG013|Overall Study|Lost to Follow-up|0|||
126097657|NCT04602221|453650254|FG007|Overall Study|Lost to Follow-up|0|||
126035375|NCT04074759|453427204|FG014|Overall Study|Lost to Follow-up|0|||
126035376|NCT04074759|453427205|FG015|Overall Study|Lost to Follow-up|0|||
126035377|NCT04074759|453427206|FG016|Overall Study|Lost to Follow-up|1|||
126035378|NCT04074759|453427207|FG017|Overall Study|Lost to Follow-up|0|||
126035379|NCT04074759|453427208|FG018|Overall Study|Lost to Follow-up|1|||
126035380|NCT04074759|453427190|FG000|Overall Study|Other|0|||
126035381|NCT04074759|453427191|FG001|Overall Study|Other|1|||
126035382|NCT04074759|453427192|FG002|Overall Study|Other|1|||
126035383|NCT04074759|453427193|FG003|Overall Study|Other|0|||
126035384|NCT04074759|453427194|FG004|Overall Study|Other|2|||
126035385|NCT04074759|453427195|FG005|Overall Study|Other|1|||
126035386|NCT04074759|453427196|FG006|Overall Study|Other|2|||
126035387|NCT04074759|453427197|FG007|Overall Study|Other|1|||
126035388|NCT04074759|453427198|FG008|Overall Study|Other|1|||
126035389|NCT04074759|453427199|FG009|Overall Study|Other|4|||
126035390|NCT04074759|453427200|FG010|Overall Study|Other|4|||
126035391|NCT04074759|453427201|FG011|Overall Study|Other|2|||
126035392|NCT04074759|453427202|FG012|Overall Study|Other|0|||
126035393|NCT04074759|453427203|FG013|Overall Study|Other|0|||
126035394|NCT04074759|453427204|FG014|Overall Study|Other|0|||
126035395|NCT04074759|453427205|FG015|Overall Study|Other|1|||
126035396|NCT04074759|453427206|FG016|Overall Study|Other|0|||
126035397|NCT04074759|453427207|FG017|Overall Study|Other|0|||
126035398|NCT04074759|453427208|FG018|Overall Study|Other|0|||
126035399|NCT04074759|453427190|FG000|Overall Study|Missing end of study status|0|||
126035400|NCT04074759|453427191|FG001|Overall Study|Missing end of study status|0|||
126035401|NCT04074759|453427192|FG002|Overall Study|Missing end of study status|0|||
126035402|NCT04074759|453427193|FG003|Overall Study|Missing end of study status|0|||
126035403|NCT04074759|453427194|FG004|Overall Study|Missing end of study status|0|||
126035404|NCT04074759|453427195|FG005|Overall Study|Missing end of study status|0|||
126035405|NCT04074759|453427196|FG006|Overall Study|Missing end of study status|0|||
126035406|NCT04074759|453427197|FG007|Overall Study|Missing end of study status|0|||
126035407|NCT04074759|453427198|FG008|Overall Study|Missing end of study status|0|||
126035408|NCT04074759|453427199|FG009|Overall Study|Missing end of study status|0|||
126035409|NCT04074759|453427200|FG010|Overall Study|Missing end of study status|2|||
126035410|NCT04074759|453427201|FG011|Overall Study|Missing end of study status|0|||
126035411|NCT04074759|453427202|FG012|Overall Study|Missing end of study status|0|||
126035412|NCT04074759|453427203|FG013|Overall Study|Missing end of study status|0|||
126035413|NCT04074759|453427204|FG014|Overall Study|Missing end of study status|0|||
126035414|NCT04074759|453427205|FG015|Overall Study|Missing end of study status|0|||
126035415|NCT04074759|453427206|FG016|Overall Study|Missing end of study status|1|||
126035416|NCT04074759|453427207|FG017|Overall Study|Missing end of study status|0|||
126035417|NCT04074759|453427208|FG018|Overall Study|Missing end of study status|0|||
126035418|NCT02231164|453427215|FG000|Overall Study|Adverse Event|1|||
126035419|NCT02231164|453427216|FG001|Overall Study|Adverse Event|1|||
126035420|NCT02231164|453427215|FG000|Overall Study|Lack of Efficacy|4|||
126035421|NCT02231164|453427216|FG001|Overall Study|Lack of Efficacy|3|||
126035422|NCT02231164|453427215|FG000|Overall Study|Withdrawal by Subject|1|||
126035423|NCT02231164|453427216|FG001|Overall Study|Withdrawal by Subject|2|||
126035424|NCT03931174|453427217|FG000|Providers|Staff left organization|26|||
126035425|NCT03931174|453427218|FG001|Providers|Staff left organization|25|||
126035426|NCT03931174|453427217|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
126035427|NCT03931174|453427218|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
126265652|NCT04403763|454262883|FG005|Stage 1|Early termination due to PK tube failure|0|||
126265653|NCT04403763|454262884|FG006|Stage 1|Early termination due to PK tube failure|0|||
126265654|NCT04403763|454262878|FG000|Stage 2A|Adverse Event|0|||
126265655|NCT04403763|454262879|FG001|Stage 2A|Adverse Event|0|||
126265656|NCT04403763|454262880|FG002|Stage 2A|Adverse Event|0|||
126265657|NCT04403763|454262881|FG003|Stage 2A|Adverse Event|0|||
126265658|NCT04403763|454262882|FG004|Stage 2A|Adverse Event|0|||
126265659|NCT04403763|454262883|FG005|Stage 2A|Adverse Event|0|||
126265660|NCT04403763|454262884|FG006|Stage 2A|Adverse Event|1|||
126265661|NCT02470091|454262885|FG000|Overall Study|Withdrawal by Subject|1|||
126035428|NCT03931174|453427217|FG000|Providers|Lost to Follow-up|4|||
126035429|NCT03931174|453427218|FG001|Providers|Lost to Follow-up|4|||
126035430|NCT03931174|453427217|FG000|Patients|Post-consent screening failure|1|||
126035431|NCT03931174|453427218|FG001|Patients|Post-consent screening failure|1|||
126035432|NCT03931174|453427217|FG000|Patients|Death|1|||
126035433|NCT03931174|453427218|FG001|Patients|Death|1|||
126035434|NCT03931174|453427217|FG000|Patients|Lost to Follow-up|60|||
126265662|NCT02470091|454262886|FG001|Overall Study|Withdrawal by Subject|0|||
126265663|NCT02470091|454262885|FG000|Overall Study|Ineligible|0|||
126035435|NCT03931174|453427218|FG001|Patients|Lost to Follow-up|89|||
126035436|NCT03322267|453427219|FG000|Overall Study|Lack of Efficacy|11|||
126035437|NCT03322267|453427219|FG000|Overall Study|Adverse Event|1|||
126265664|NCT02470091|454262886|FG001|Overall Study|Ineligible|2|||
126265665|NCT02903238|454262888|FG000|Overall Study|Lost to Follow-up|4|||
126265666|NCT00720226|454262890|FG000|Overall Study|Withdrawal by Subject|7|||
126035438|NCT03322267|453427219|FG000|Overall Study|Withdrawal by Subject|2|||
126035439|NCT03852472|453427229|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
126035440|NCT03852472|453427230|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
126035441|NCT03852472|453427231|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
126035442|NCT03852472|453427232|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
126035443|NCT03852472|453427233|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
126035444|NCT03852472|453427229|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
126035445|NCT03852472|453427230|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
126035446|NCT03852472|453427231|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
126035447|NCT03852472|453427232|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
126035448|NCT03852472|453427233|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
126035449|NCT03852472|453427229|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
126035450|NCT03852472|453427230|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
126035451|NCT03852472|453427231|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
126035452|NCT03852472|453427232|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
126035453|NCT03852472|453427233|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
126035454|NCT03852472|453427229|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
126035455|NCT03852472|453427230|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
126035456|NCT03852472|453427231|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
126035457|NCT03852472|453427232|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
126035458|NCT03852472|453427233|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
126035459|NCT03852472|453427229|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
126035460|NCT03852472|453427230|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
126035461|NCT03852472|453427231|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
126035462|NCT03852472|453427232|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
126035463|NCT03852472|453427233|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
126035464|NCT03852472|453427229|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
126035465|NCT03852472|453427230|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
126035466|NCT03852472|453427231|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
126035467|NCT03852472|453427232|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
126035468|NCT03852472|453427233|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
126035469|NCT03852472|453427229|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
126035470|NCT03852472|453427230|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
126035471|NCT03852472|453427231|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
126035472|NCT03852472|453427232|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
126035473|NCT03852472|453427233|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
126035474|NCT03852472|453427229|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
126035475|NCT03852472|453427230|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
126035476|NCT03852472|453427231|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
126035477|NCT03852472|453427232|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
126035478|NCT03852472|453427233|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
126035479|NCT03852472|453427229|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
126035480|NCT03852472|453427230|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
126035481|NCT03852472|453427231|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
126035482|NCT03852472|453427232|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
126035483|NCT03852472|453427233|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
126035484|NCT03852472|453427229|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
126035485|NCT03852472|453427230|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
126035486|NCT03852472|453427231|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
126035487|NCT03852472|453427232|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
126035488|NCT03852472|453427233|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
126035489|NCT03852472|453427229|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
126035490|NCT03852472|453427230|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
126035491|NCT03852472|453427231|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
126035492|NCT03852472|453427232|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
126035493|NCT03852472|453427233|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
126035494|NCT03852472|453427229|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
126035495|NCT03852472|453427230|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
126035496|NCT03852472|453427231|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
126035497|NCT03852472|453427232|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
126035498|NCT03852472|453427233|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
126035499|NCT03852472|453427229|FG000|Period 2 - Week 44|Adverse Event|0|||
126035500|NCT03852472|453427230|FG001|Period 2 - Week 44|Adverse Event|3|||
126035501|NCT03852472|453427231|FG002|Period 2 - Week 44|Adverse Event|1|||
126035502|NCT03852472|453427232|FG003|Period 2 - Week 44|Adverse Event|2|||
126035503|NCT03852472|453427233|FG004|Period 2 - Week 44|Adverse Event|2|||
126035504|NCT03852472|453427229|FG000|Period 2 - Week 44|COVID-19 Related|0|||
126035505|NCT03852472|453427230|FG001|Period 2 - Week 44|COVID-19 Related|0|||
126035506|NCT03852472|453427231|FG002|Period 2 - Week 44|COVID-19 Related|0|||
126035507|NCT03852472|453427232|FG003|Period 2 - Week 44|COVID-19 Related|1|||
126035508|NCT03852472|453427233|FG004|Period 2 - Week 44|COVID-19 Related|0|||
126035509|NCT03852472|453427229|FG000|Period 2 - Week 44|Reason not stated|0|||
126035510|NCT03852472|453427230|FG001|Period 2 - Week 44|Reason not stated|0|||
126035511|NCT03852472|453427231|FG002|Period 2 - Week 44|Reason not stated|0|||
126035512|NCT03852472|453427232|FG003|Period 2 - Week 44|Reason not stated|0|||
126035513|NCT03852472|453427233|FG004|Period 2 - Week 44|Reason not stated|1|||
126035514|NCT05977530|453427234|FG000|Overall Study|Withdrawal by Subject|1|||
126035515|NCT05977530|453427234|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
126360364|NCT00147537|454610821|FG009|Phase 1b|Death|0|||
126035516|NCT06457802|453427235|FG000|Overall Study|Early termination of study prior to participant completion|2|||
126035517|NCT06457802|453427236|FG001|Overall Study|Early termination of study prior to participant completion|2|||
126035518|NCT01467427|453427237|FG000|Overall Study|Withdrawal by Subject|1|||
126035519|NCT01467427|453427238|FG001|Overall Study|Withdrawal by Subject|0|||
126035520|NCT01467427|453427237|FG000|Overall Study|Not continuing in extension phase|0|||
126035521|NCT01467427|453427238|FG001|Overall Study|Not continuing in extension phase|2|||
126035522|NCT01467427|453427237|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
126035523|NCT01467427|453427238|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
126035524|NCT01467427|453427237|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
126035525|NCT01467427|453427238|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
126035526|NCT01467427|453427237|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
126035527|NCT01467427|453427238|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
126035528|NCT01467427|453427237|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
126035529|NCT01467427|453427238|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
126035530|NCT03161028|453427239|FG000|Overall Study|Withdrawal by Subject|6|||
126035531|NCT03161028|453427240|FG001|Overall Study|Withdrawal by Subject|4|||
126035532|NCT03161028|453427239|FG000|Overall Study|Adverse Event|5|||
126035533|NCT03161028|453427240|FG001|Overall Study|Adverse Event|1|||
126035534|NCT03161028|453427239|FG000|Overall Study|Study drug side effects|2|||
126035535|NCT03161028|453427240|FG001|Overall Study|Study drug side effects|2|||
126035536|NCT03161028|453427239|FG000|Overall Study|Administrative PD/UP|4|||
126035537|NCT03161028|453427240|FG001|Overall Study|Administrative PD/UP|2|||
126035538|NCT03161028|453427239|FG000|Overall Study|Lost to Follow-up|2|||
126035539|NCT03161028|453427240|FG001|Overall Study|Lost to Follow-up|0|||
126035540|NCT03161028|453427239|FG000|Overall Study|Unable to comply with procedures|1|||
126035541|NCT03161028|453427240|FG001|Overall Study|Unable to comply with procedures|1|||
126035542|NCT00736723|453427241|FG000|Overall Study|Withdrawal by Subject|4|||
126035543|NCT00736723|453427242|FG001|Overall Study|Withdrawal by Subject|3|||
126035544|NCT03492216|453427243|FG000|Overall Study|Death|1|||
126035545|NCT03492216|453427244|FG001|Overall Study|Death|0|||
126035546|NCT03492216|453427245|FG002|Overall Study|Death|4|||
126035547|NCT03492216|453427246|FG003|Overall Study|Death|0|||
126035548|NCT03492216|453427243|FG000|Overall Study|Withdrawal by Subject|5|||
126035549|NCT03492216|453427244|FG001|Overall Study|Withdrawal by Subject|3|||
126035550|NCT03492216|453427245|FG002|Overall Study|Withdrawal by Subject|1|||
126035551|NCT03492216|453427246|FG003|Overall Study|Withdrawal by Subject|1|||
126035552|NCT03492216|453427243|FG000|Overall Study|Lost to Follow-up|9|||
126035553|NCT03492216|453427244|FG001|Overall Study|Lost to Follow-up|2|||
126035554|NCT03492216|453427245|FG002|Overall Study|Lost to Follow-up|7|||
126035555|NCT03492216|453427246|FG003|Overall Study|Lost to Follow-up|8|||
126035556|NCT03492216|453427243|FG000|Overall Study|Moved|5|||
126035557|NCT03492216|453427244|FG001|Overall Study|Moved|3|||
126035558|NCT03492216|453427245|FG002|Overall Study|Moved|3|||
126035559|NCT03492216|453427246|FG003|Overall Study|Moved|5|||
126035560|NCT03492216|453427243|FG000|Overall Study|Too ill|0|||
126035561|NCT03492216|453427244|FG001|Overall Study|Too ill|1|||
126035562|NCT03492216|453427245|FG002|Overall Study|Too ill|0|||
126035563|NCT03492216|453427246|FG003|Overall Study|Too ill|0|||
126035564|NCT03492216|453427243|FG000|Overall Study|Incarcerated|0|||
126035565|NCT03492216|453427244|FG001|Overall Study|Incarcerated|0|||
126035566|NCT03492216|453427245|FG002|Overall Study|Incarcerated|2|||
126035567|NCT03492216|453427246|FG003|Overall Study|Incarcerated|0|||
126035568|NCT00433329|453429344|FG000|Overall Study|Adverse Event|9|||
126035569|NCT00433329|453429344|FG000|Overall Study|Death|4|||
126035570|NCT00433329|453429344|FG000|Overall Study|Withdrew consent|3|||
126035571|NCT00433329|453429344|FG000|Overall Study|Discontinued sildenafil|2|||
126035572|NCT00433329|453429344|FG000|Overall Study|Moved out of state|1|||
126035573|NCT00433329|453429344|FG000|Overall Study|Lost to Follow-up|1|||
126035574|NCT00433329|453429344|FG000|Overall Study|Physician Decision|1|||
126035575|NCT01098812|453429345|FG000|Overall Study|Death|2|||
126035576|NCT01098812|453429346|FG001|Overall Study|Death|0|||
126035577|NCT01098812|453429347|FG002|Overall Study|Death|1|||
126035578|NCT01098812|453429345|FG000|Overall Study|Lost to Follow-up|0|||
126360365|NCT00147537|454610822|FG010|Phase 1b|Death|0|||
126097658|NCT04602221|453650255|FG008|Overall Study|Lost to Follow-up|0|||
126097659|NCT04602221|453650256|FG009|Overall Study|Lost to Follow-up|0|||
126097660|NCT04602221|453650257|FG010|Overall Study|Lost to Follow-up|0|||
126097661|NCT04602221|453650258|FG011|Overall Study|Lost to Follow-up|0|||
126097662|NCT04602221|453650259|FG012|Overall Study|Lost to Follow-up|0|||
126097663|NCT04602221|453650260|FG013|Overall Study|Lost to Follow-up|0|||
126097664|NCT04602221|453650261|FG014|Overall Study|Lost to Follow-up|0|||
126097665|NCT04602221|453650262|FG015|Overall Study|Lost to Follow-up|0|||
126097666|NCT04602221|453650263|FG016|Overall Study|Lost to Follow-up|0|||
126097667|NCT04602221|453650264|FG017|Overall Study|Lost to Follow-up|0|||
126097668|NCT01146782|453650265|FG000|Screening Cohort|Screen Failure|187|||
126097669|NCT01146782|453650265|FG000|Screening Cohort|Lost to Follow-up|4|||
126097670|NCT01146782|453650265|FG000|Screening Cohort|Physician Decision|1|||
126097671|NCT01146782|453650265|FG000|Screening Cohort|Withdrawal by Subject|29|||
126097672|NCT01146782|453650265|FG000|Safety Cohort|Screen Failure|61|||
126097673|NCT01146782|453650265|FG000|Safety Cohort|Withdrawal by Subject|4|||
126097674|NCT01146782|453650265|FG000|Safety Cohort|Control AHI <5|4|||
126097675|NCT01146782|453650265|FG000|Safety Cohort|TST <4 hrs|14|||
126097676|NCT01146782|453650265|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
126097677|NCT01146782|453650265|FG000|Primary Endpoint Cohort|Physician Decision|1|||
126097678|NCT02270515|453650266|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
126097679|NCT02270515|453650266|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
126097680|NCT02270515|453650266|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
126097681|NCT02270515|453650266|FG000|Intervention Period 1: 0-6 Months|Death|7|||
126097682|NCT02270515|453650266|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
126097683|NCT02270515|453650266|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
126097684|NCT02270515|453650266|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
126097685|NCT02270515|453650266|FG000|Intervention Period 2: 6-12 Months|Death|5|||
126097686|NCT02270515|453650266|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
126097687|NCT02270515|453650266|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
126097688|NCT02270515|453650266|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
126097689|NCT02270515|453650266|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
126097690|NCT02270515|453650266|FG000|Intervention Period 3: 12-18 Months|Death|3|||
126097691|NCT02270515|453650266|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
126097692|NCT00589121|453650271|FG000|Overall Study|Protocol Violation|2|||
126097693|NCT00589121|453650272|FG001|Overall Study|Protocol Violation|6|||
126097694|NCT00589121|453650271|FG000|Overall Study|No protocol treatment received|0|||
126097695|NCT00589121|453650272|FG001|Overall Study|No protocol treatment received|1|||
126097696|NCT01758900|453650273|FG000|Overall Study|difficulty for further intubation|7|||
126097697|NCT01758900|453650274|FG001|Overall Study|difficulty for further intubation|8|||
126097698|NCT01892540|453650276|FG000|Overall Study|Did not complete PET/MRI|0|||
126097699|NCT01892540|453650277|FG001|Overall Study|Did not complete PET/MRI|0|||
126097700|NCT01892540|453650278|FG002|Overall Study|Did not complete PET/MRI|2|||
126097701|NCT01892540|453650276|FG000|Overall Study|Did not fit in scanner|0|||
126097702|NCT01892540|453650277|FG001|Overall Study|Did not fit in scanner|0|||
126097703|NCT01892540|453650278|FG002|Overall Study|Did not fit in scanner|1|||
126097704|NCT01370590|453650279|FG000|Period 1|Adverse Event|8|||
126097705|NCT01370590|453650280|FG001|Period 1|Adverse Event|4|||
126097706|NCT01370590|453650279|FG000|Period 1|Lost to Follow-up|2|||
126097707|NCT01370590|453650280|FG001|Period 1|Lost to Follow-up|2|||
126265667|NCT00720226|454262891|FG001|Overall Study|Withdrawal by Subject|4|||
126265668|NCT00733369|454262894|FG000|Overall Study|Lost to Follow-up|2|||
126265669|NCT00733369|454262895|FG001|Overall Study|Lost to Follow-up|1|||
126265670|NCT00733369|454262894|FG000|Overall Study|Adverse Event|4|||
126265671|NCT00733369|454262895|FG001|Overall Study|Adverse Event|4|||
126265672|NCT00733369|454262894|FG000|Overall Study|Protocol Violation|4|||
126265673|NCT00733369|454262895|FG001|Overall Study|Protocol Violation|4|||
126265674|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
126265675|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
126097708|NCT01370590|453650279|FG000|Period 1|Protocol Violation|2|||
126265676|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
126097709|NCT01370590|453650280|FG001|Period 1|Protocol Violation|2|||
126097710|NCT01370590|453650279|FG000|Period 1|Withdrawal by Subject|4|||
126097711|NCT01370590|453650280|FG001|Period 1|Withdrawal by Subject|2|||
126097712|NCT01370590|453650279|FG000|Period 1|Could not access randomization system|0|||
126097713|NCT01370590|453650280|FG001|Period 1|Could not access randomization system|1|||
126097714|NCT01370590|453650279|FG000|Crossover Washout Period|Adverse Event|1|||
126097715|NCT01370590|453650280|FG001|Crossover Washout Period|Adverse Event|4|||
126265677|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
126265678|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
126265679|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
126265680|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
126265681|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
126265682|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
126265683|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
126265684|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
126265685|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
126265686|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
126265687|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
126265688|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
126265689|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
126265690|NCT02510014|454262896|FG000|Treatment Period|Adverse Event|11|||
126265691|NCT02510014|454262897|FG001|Treatment Period|Adverse Event|4|||
126265692|NCT02510014|454262896|FG000|Treatment Period|Withdrawal symptoms|3|||
126265693|NCT02510014|454262897|FG001|Treatment Period|Withdrawal symptoms|0|||
126265694|NCT02510014|454262896|FG000|Treatment Period|Lost to Follow-up|80|||
126265695|NCT02510014|454262897|FG001|Treatment Period|Lost to Follow-up|19|||
126265696|NCT02510014|454262896|FG000|Treatment Period|Physician Decision|5|||
126265697|NCT02510014|454262897|FG001|Treatment Period|Physician Decision|0|||
126265698|NCT02510014|454262896|FG000|Treatment Period|Withdrawal by Subject|67|||
126265699|NCT02510014|454262897|FG001|Treatment Period|Withdrawal by Subject|24|||
126265700|NCT02510014|454262896|FG000|Treatment Period|Withdrawn by the investigator|7|||
126265701|NCT02510014|454262897|FG001|Treatment Period|Withdrawn by the investigator|1|||
126265702|NCT02510014|454262896|FG000|Treatment Period|Protocol Violation|4|||
126265703|NCT02510014|454262897|FG001|Treatment Period|Protocol Violation|4|||
126265704|NCT02510014|454262896|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
126265705|NCT02510014|454262897|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
126265706|NCT01875471|454262901|FG000|Overall Study|Adverse Event|0|||
126035579|NCT01098812|453429346|FG001|Overall Study|Lost to Follow-up|1|||
126035580|NCT01098812|453429347|FG002|Overall Study|Lost to Follow-up|0|||
126035581|NCT01129102|453429348|FG000|Overall Study|No study drug treatment|2|||
126035582|NCT01129102|453429349|FG001|Overall Study|No study drug treatment|3|||
126035583|NCT01129102|453429350|FG002|Overall Study|No study drug treatment|1|||
126035584|NCT01129102|453429348|FG000|Overall Study|Withdrawal by Subject|2|||
126035585|NCT01129102|453429349|FG001|Overall Study|Withdrawal by Subject|0|||
126035586|NCT01129102|453429350|FG002|Overall Study|Withdrawal by Subject|3|||
126035587|NCT01129102|453429348|FG000|Overall Study|Protocol Violation|0|||
126035588|NCT01129102|453429349|FG001|Overall Study|Protocol Violation|1|||
126035589|NCT01129102|453429350|FG002|Overall Study|Protocol Violation|1|||
126035590|NCT01129102|453429348|FG000|Overall Study|Pregnancy|0|||
126035591|NCT01129102|453429349|FG001|Overall Study|Pregnancy|0|||
126035592|NCT01129102|453429350|FG002|Overall Study|Pregnancy|1|||
126035593|NCT01129102|453429348|FG000|Overall Study|Adverse Event|2|||
126035594|NCT01129102|453429349|FG001|Overall Study|Adverse Event|2|||
126035595|NCT01129102|453429350|FG002|Overall Study|Adverse Event|1|||
126035596|NCT01129102|453429348|FG000|Overall Study|Lost to Follow-up|2|||
126035597|NCT01129102|453429349|FG001|Overall Study|Lost to Follow-up|0|||
126035598|NCT01129102|453429350|FG002|Overall Study|Lost to Follow-up|0|||
126035599|NCT03379675|453429355|FG000|Overall Study|Lost to Follow-up|0|||
126035600|NCT03379675|453429356|FG001|Overall Study|Lost to Follow-up|1|||
126035601|NCT03379675|453429357|FG002|Overall Study|Lost to Follow-up|0|||
126035602|NCT03379675|453429355|FG000|Overall Study|Adverse Event|2|||
126035603|NCT03379675|453429356|FG001|Overall Study|Adverse Event|0|||
126035604|NCT03379675|453429357|FG002|Overall Study|Adverse Event|0|||
126035605|NCT03379675|453429355|FG000|Overall Study|Withdrawal by Subject|2|||
126035606|NCT03379675|453429356|FG001|Overall Study|Withdrawal by Subject|1|||
126035607|NCT03379675|453429357|FG002|Overall Study|Withdrawal by Subject|2|||
126035608|NCT03381196|453429361|FG000|Overall Study|Withdrawal by Subject|7|||
126035609|NCT03381196|453429362|FG001|Overall Study|Withdrawal by Subject|7|||
126035610|NCT03381196|453429361|FG000|Overall Study|Other|0|||
126035611|NCT03381196|453429362|FG001|Overall Study|Other|1|||
126035612|NCT03381196|453429361|FG000|Overall Study|Lost to Follow-up|5|||
126035613|NCT03381196|453429362|FG001|Overall Study|Lost to Follow-up|4|||
126035614|NCT03381196|453429361|FG000|Overall Study|Death|0|||
126035615|NCT03381196|453429362|FG001|Overall Study|Death|1|||
126035616|NCT03381196|453429361|FG000|Overall Study|Adverse Event|1|||
126265707|NCT01875471|454262902|FG001|Overall Study|Adverse Event|1|||
126035617|NCT03381196|453429362|FG001|Overall Study|Adverse Event|0|||
126035618|NCT03381196|453429361|FG000|Overall Study|Randomized, not treated|3|||
126035619|NCT03381196|453429362|FG001|Overall Study|Randomized, not treated|6|||
126035620|NCT02675751|453429363|FG000|Overall Study|Lost to Follow-up|16|||
126035621|NCT01539083|453429366|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
126035622|NCT01539083|453429367|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
126035623|NCT01539083|453429368|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
126035624|NCT01539083|453429366|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
126035625|NCT01539083|453429367|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
126035626|NCT01539083|453429368|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
126265708|NCT01875471|454262901|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
126265709|NCT01875471|454262902|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
126265710|NCT01949116|454262906|FG000|Overall Study|Death|2|||
126035627|NCT01539083|453429366|FG000|Before Randomization (VCD Induction)|Death|6|||
126097716|NCT01370590|453650279|FG000|Crossover Washout Period|Lost to Follow-up|2|||
126097717|NCT01370590|453650280|FG001|Crossover Washout Period|Lost to Follow-up|0|||
126265711|NCT01949116|454262907|FG001|Overall Study|Death|0|||
126265712|NCT01949116|454262906|FG000|Overall Study|Lost to Follow-up|1|||
126265713|NCT01949116|454262907|FG001|Overall Study|Lost to Follow-up|3|||
126265714|NCT01949116|454262906|FG000|Overall Study|Withdrawal by Subject|5|||
126265715|NCT01949116|454262907|FG001|Overall Study|Withdrawal by Subject|3|||
126265716|NCT03407118|454262908|FG000|Period 2|Withdrawal by Subject|1|||
126265717|NCT03407118|454262909|FG001|Period 2|Withdrawal by Subject|0|||
126265718|NCT02556307|454262910|FG000|Overall Study|Premature treatment interruption|11|||
126265719|NCT02556307|454262910|FG000|Overall Study|Lost to Follow-up|36|||
126265720|NCT02556307|454262910|FG000|Overall Study|Change to triple therapy|4|||
126265721|NCT02556307|454262910|FG000|Overall Study|Enrolled but not treated|2|||
126265722|NCT00384176|454262914|FG000|Overall Study|Death|239|||
126265723|NCT00384176|454262915|FG001|Overall Study|Death|247|||
126265724|NCT00384176|454262916|FG002|Overall Study|Death|105|||
126265725|NCT00384176|454262914|FG000|Overall Study|Withdrawal by Subject|52|||
126265726|NCT00384176|454262915|FG001|Overall Study|Withdrawal by Subject|48|||
126265727|NCT00384176|454262916|FG002|Overall Study|Withdrawal by Subject|22|||
126265728|NCT00384176|454262914|FG000|Overall Study|Lost to Follow-up|16|||
126265729|NCT00384176|454262915|FG001|Overall Study|Lost to Follow-up|18|||
126265730|NCT00384176|454262916|FG002|Overall Study|Lost to Follow-up|4|||
126265731|NCT00384176|454262914|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
126265732|NCT00384176|454262915|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
126265733|NCT00384176|454262916|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
126265734|NCT00384176|454262914|FG000|Overall Study|Longer QTC as Visit 1|1|||
126265735|NCT00384176|454262915|FG001|Overall Study|Longer QTC as Visit 1|0|||
126265736|NCT00384176|454262916|FG002|Overall Study|Longer QTC as Visit 1|0|||
126265737|NCT00384176|454262914|FG000|Overall Study|Toxicity of treatment|1|||
126265738|NCT00384176|454262915|FG001|Overall Study|Toxicity of treatment|0|||
126265739|NCT00384176|454262916|FG002|Overall Study|Toxicity of treatment|0|||
126265740|NCT00384176|454262914|FG000|Overall Study|Did not receive study treatment|0|||
126265741|NCT00384176|454262915|FG001|Overall Study|Did not receive study treatment|1|||
126035628|NCT01539083|453429367|FG001|Before Randomization (VCD Induction)|Death|0|||
126035629|NCT01539083|453429368|FG002|Before Randomization (VCD Induction)|Death|0|||
126035630|NCT01539083|453429366|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
126035631|NCT01539083|453429367|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
126035632|NCT01539083|453429368|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
126035633|NCT01539083|453429366|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
126035634|NCT01539083|453429367|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
126035635|NCT01539083|453429368|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
126035636|NCT01539083|453429366|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
126035637|NCT01539083|453429367|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
126035638|NCT01539083|453429368|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
126035639|NCT01539083|453429366|FG000|Before Randomization (VCD Induction)|Other|5|||
126035640|NCT01539083|453429367|FG001|Before Randomization (VCD Induction)|Other|0|||
126035641|NCT01539083|453429368|FG002|Before Randomization (VCD Induction)|Other|0|||
126035642|NCT01539083|453429366|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
126035643|NCT01539083|453429367|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
126035644|NCT01539083|453429368|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
126097718|NCT01370590|453650279|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
126265742|NCT00384176|454262916|FG002|Overall Study|Did not receive study treatment|1|||
126265743|NCT00384176|454262914|FG000|Overall Study|Physician Decision|0|||
126265744|NCT00384176|454262915|FG001|Overall Study|Physician Decision|2|||
126265745|NCT00384176|454262916|FG002|Overall Study|Physician Decision|0|||
126265746|NCT00384176|454262914|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
126265747|NCT00384176|454262915|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
126265748|NCT00384176|454262916|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
126035645|NCT01539083|453429366|FG000|After Randomization (TP and VTP)|Other|0|||
126035646|NCT01539083|453429367|FG001|After Randomization (TP and VTP)|Other|1|||
126035647|NCT01539083|453429368|FG002|After Randomization (TP and VTP)|Other|1|||
126035648|NCT01539083|453429366|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
126035649|NCT01539083|453429367|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
126035650|NCT01539083|453429368|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
126035651|NCT01539083|453429366|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
126035652|NCT01539083|453429367|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
126035653|NCT01539083|453429368|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
126035654|NCT01539083|453429366|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
126035655|NCT01539083|453429367|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
126035656|NCT01539083|453429368|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
126035657|NCT01539083|453429366|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
126035658|NCT01539083|453429367|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
126035659|NCT01539083|453429368|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
126035660|NCT01539083|453429366|FG000|After Randomization (TP and VTP)|Death|0|||
126035661|NCT01539083|453429367|FG001|After Randomization (TP and VTP)|Death|6|||
126035662|NCT01539083|453429368|FG002|After Randomization (TP and VTP)|Death|11|||
126035663|NCT04016662|453429369|FG000|Run-In Phase|Death|1|||
126035664|NCT04016662|453429369|FG000|Run-In Phase|Withdrawal by Subject|11|||
126035665|NCT04016662|453429369|FG000|Run-In Phase|Not meeting screening eligibility|9|||
126035666|NCT04016662|453429369|FG000|Run-In Phase|Physician Decision|3|||
126035667|NCT04016662|453429369|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
126035668|NCT04016662|453429369|FG000|PLGS (12 Weeks)|Death|1|||
126035669|NCT04016662|453429369|FG000|SAP (12 Weeks)|Death|1|||
126035670|NCT01802788|453429370|FG000|Overall Study|Withdrawal by Subject|102|||
126035671|NCT01802788|453429371|FG001|Overall Study|Withdrawal by Subject|5|||
126035672|NCT01802788|453429370|FG000|Overall Study|Death|382|||
126035673|NCT01802788|453429371|FG001|Overall Study|Death|18|||
126035674|NCT01802788|453429370|FG000|Overall Study|Lost to Follow-up|31|||
126035675|NCT01802788|453429371|FG001|Overall Study|Lost to Follow-up|2|||
126035676|NCT01802788|453429370|FG000|Overall Study|Physician Decision|3|||
126035677|NCT01802788|453429371|FG001|Overall Study|Physician Decision|0|||
126035678|NCT01802788|453429370|FG000|Overall Study|Patient Non-Compliance|1|||
126035679|NCT01802788|453429371|FG001|Overall Study|Patient Non-Compliance|0|||
126035680|NCT01802788|453429370|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
126035681|NCT01802788|453429371|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
126035682|NCT01802788|453429370|FG000|Overall Study|Other Reasons|19|||
126035683|NCT01802788|453429371|FG001|Overall Study|Other Reasons|0|||
126035684|NCT03021096|453429372|FG000|Overall Study|Lost to Follow-up|4|||
126035685|NCT03021096|453429372|FG000|Overall Study|Protocol Violation|2|||
126035686|NCT00764751|453429384|FG000|Overall Study|Adverse Event|1|||
126035687|NCT00764751|453429385|FG001|Overall Study|Adverse Event|1|||
126035688|NCT00764751|453429384|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
126035689|NCT00764751|453429385|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
126035690|NCT03011333|453429388|FG000|Overall Study|Lost to Follow-up|0|||
126035691|NCT03011333|453429389|FG001|Overall Study|Lost to Follow-up|1|||
126035692|NCT03011333|453429390|FG002|Overall Study|Lost to Follow-up|0|||
126035693|NCT03011333|453429391|FG003|Overall Study|Lost to Follow-up|1|||
126035694|NCT03011333|453429392|FG004|Overall Study|Lost to Follow-up|4|||
126035695|NCT03011333|453429393|FG005|Overall Study|Lost to Follow-up|4|||
126035696|NCT03011333|453429394|FG006|Overall Study|Lost to Follow-up|5|||
126265749|NCT00049842|454262917|FG000|Treatment Phase|Adverse Event|47|||
126265750|NCT00049842|454262918|FG001|Treatment Phase|Adverse Event|12|||
126265751|NCT00049842|454262917|FG000|Treatment Phase|Withdrawal by Subject|35|||
126265752|NCT00049842|454262918|FG001|Treatment Phase|Withdrawal by Subject|46|||
126265753|NCT00049842|454262917|FG000|Treatment Phase|Non-compliance with protocol|7|||
126265754|NCT00049842|454262918|FG001|Treatment Phase|Non-compliance with protocol|8|||
126265755|NCT00049842|454262917|FG000|Treatment Phase|Lost to Follow-up|4|||
126265756|NCT00049842|454262918|FG001|Treatment Phase|Lost to Follow-up|8|||
126265757|NCT00049842|454262917|FG000|Treatment Phase|Administrative|0|||
126265758|NCT00049842|454262918|FG001|Treatment Phase|Administrative|3|||
126035697|NCT02998268|453429398|FG000|Overall Study|Adverse Event|0|||
126035698|NCT02998268|453429399|FG001|Overall Study|Adverse Event|2|||
126035699|NCT02998268|453429398|FG000|Overall Study|Withdrawal by Subject|0|||
126035700|NCT02998268|453429399|FG001|Overall Study|Withdrawal by Subject|1|||
126035701|NCT05269667|453429400|FG000|Overall Study|Study Terminated by Sponsor|4|||
126035702|NCT05399459|453429405|FG000|Overall Study|Randomized but not treated|29|||
126035703|NCT05399459|453429406|FG001|Overall Study|Randomized but not treated|30|||
126035704|NCT05399459|453429407|FG002|Overall Study|Randomized but not treated|38|||
126035705|NCT05399459|453429405|FG000|Overall Study|Lost to Follow-up|1|||
126035706|NCT05399459|453429406|FG001|Overall Study|Lost to Follow-up|0|||
126035707|NCT05399459|453429407|FG002|Overall Study|Lost to Follow-up|0|||
126265759|NCT00049842|454262917|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
126265760|NCT00049842|454262918|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
126265761|NCT00049842|454262917|FG000|Follow-up Phase|Adverse Event|6|||
126035708|NCT05583578|453429408|FG000|Overall Study|Withdrawal by Subject|2|||
126265762|NCT00049842|454262918|FG001|Follow-up Phase|Adverse Event|1|||
126035709|NCT05583578|453429409|FG001|Overall Study|Withdrawal by Subject|0|||
126265763|NCT00049842|454262917|FG000|Follow-up Phase|Other|1|||
126265764|NCT00049842|454262918|FG001|Follow-up Phase|Other|4|||
126265765|NCT00854373|454262919|FG000|Overall Study|Withdrawal by Subject|1|||
126265766|NCT00854373|454262920|FG001|Overall Study|Withdrawal by Subject|3|||
126265767|NCT00854373|454262919|FG000|Overall Study|Forgot to take study drug|1|||
126265768|NCT00854373|454262920|FG001|Overall Study|Forgot to take study drug|1|||
126265769|NCT00307931|454262921|FG000|Overall Study|Adverse Event|1|||
126265770|NCT00293202|454262922|FG000|Overall Study|Withdrawal by Subject|1|||
126265771|NCT00293202|454262923|FG001|Overall Study|Withdrawal by Subject|2|||
126265772|NCT00293202|454262922|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
126265773|NCT00293202|454262923|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
126265774|NCT00293202|454262922|FG000|Overall Study|on-hold due to fistula maturation time|1|||
126265775|NCT00293202|454262923|FG001|Overall Study|on-hold due to fistula maturation time|0|||
126265776|NCT02442271|454262924|FG000|Overall Study|Adverse Event|1|||
126265777|NCT02442271|454262924|FG000|Overall Study|Withdrew Consent|1|||
126265778|NCT02442271|454262924|FG000|Overall Study|Lost to Follow-up|1|||
126265779|NCT02442271|454262924|FG000|Overall Study|Other|1|||
126265780|NCT01560507|454262926|FG000|Overall Study|Lost to Follow-up|3|||
126265781|NCT01560507|454262927|FG001|Overall Study|Lost to Follow-up|1|||
126265782|NCT01560507|454262928|FG002|Overall Study|Lost to Follow-up|2|||
126265783|NCT01560507|454262926|FG000|Overall Study|Withdrawal by Subject|1|||
126265784|NCT01560507|454262927|FG001|Overall Study|Withdrawal by Subject|1|||
126265785|NCT01560507|454262928|FG002|Overall Study|Withdrawal by Subject|0|||
126265786|NCT02080832|454262929|FG000|Overall Study|Excluded from analysis by MRI|9|||
126265787|NCT02080832|454262930|FG001|Overall Study|Excluded from analysis by MRI|10|||
126265788|NCT02080832|454262931|FG002|Overall Study|Excluded from analysis by MRI|14|||
126265789|NCT02080832|454262929|FG000|Overall Study|Lost to Follow-up|0|||
126265790|NCT02080832|454262930|FG001|Overall Study|Lost to Follow-up|2|||
126265791|NCT02080832|454262931|FG002|Overall Study|Lost to Follow-up|2|||
126265792|NCT02427984|454262932|FG000|Overall Study|Lost to Follow-up|13|||
126265793|NCT02427984|454262933|FG001|Overall Study|Lost to Follow-up|5|||
126265794|NCT02427984|454262934|FG002|Overall Study|Lost to Follow-up|18|||
126265795|NCT00788593|454262935|FG000|Placebo Run-in Phase|Adverse Event|2|||
126265796|NCT00788593|454262936|FG001|Placebo Run-in Phase|Adverse Event|0|||
126265797|NCT00788593|454262937|FG002|Placebo Run-in Phase|Adverse Event|0|||
126265798|NCT00788593|454262935|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
126265799|NCT00788593|454262936|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
126265800|NCT00788593|454262937|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
126265801|NCT00788593|454262935|FG000|Placebo Run-in Phase|Protocol Violation|2|||
126265802|NCT00788593|454262936|FG001|Placebo Run-in Phase|Protocol Violation|0|||
126265803|NCT00788593|454262937|FG002|Placebo Run-in Phase|Protocol Violation|0|||
126265804|NCT00788593|454262935|FG000|First Intervention Period|Adverse Event|0|||
126265805|NCT00788593|454262936|FG001|First Intervention Period|Adverse Event|1|||
126265806|NCT00788593|454262937|FG002|First Intervention Period|Adverse Event|0|||
126265807|NCT00788593|454262935|FG000|Second Intervention Period|Lost to Follow-up|0|||
126265808|NCT00788593|454262936|FG001|Second Intervention Period|Lost to Follow-up|1|||
126265809|NCT00788593|454262937|FG002|Second Intervention Period|Lost to Follow-up|0|||
126265810|NCT00788593|454262935|FG000|Second Intervention Period|Other|0|||
126265811|NCT00788593|454262936|FG001|Second Intervention Period|Other|0|||
126265812|NCT00788593|454262937|FG002|Second Intervention Period|Other|1|||
126265813|NCT00515034|454262940|FG000|Overall Study|Adverse Event|2|||
126265814|NCT00515034|454262941|FG001|Overall Study|Adverse Event|0|||
126265815|NCT00515034|454262942|FG002|Overall Study|Adverse Event|1|||
125880698|NCT00313014|452862595|FG000|Overall Study|Withdrawal by Subject|11|||
126035710|NCT02547363|453429410|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
126035711|NCT02547363|453429411|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
126035712|NCT02547363|453429410|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
126035713|NCT02547363|453429411|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
126035714|NCT02547363|453429410|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
126035715|NCT02547363|453429411|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
126265816|NCT00515034|454262943|FG003|Overall Study|Adverse Event|0|||
126265817|NCT00515034|454262940|FG000|Overall Study|Death|4|||
126265818|NCT00515034|454262941|FG001|Overall Study|Death|2|||
126265819|NCT00515034|454262942|FG002|Overall Study|Death|1|||
126265820|NCT00515034|454262943|FG003|Overall Study|Death|3|||
126265821|NCT00515034|454262940|FG000|Overall Study|Withdrawal by Subject|1|||
126265822|NCT00515034|454262941|FG001|Overall Study|Withdrawal by Subject|0|||
125880699|NCT00313014|452862596|FG001|Overall Study|Withdrawal by Subject|7|||
126265823|NCT00515034|454262942|FG002|Overall Study|Withdrawal by Subject|3|||
126265824|NCT00515034|454262943|FG003|Overall Study|Withdrawal by Subject|0|||
126265825|NCT00515034|454262940|FG000|Overall Study|Physician Decision|0|||
126265826|NCT00515034|454262941|FG001|Overall Study|Physician Decision|0|||
126265827|NCT00515034|454262942|FG002|Overall Study|Physician Decision|1|||
126360366|NCT00147537|454610812|FG000|Phase 1b|Lost to Follow-up|2|||
126360367|NCT00147537|454610813|FG001|Phase 1b|Lost to Follow-up|1|||
126360368|NCT00147537|454610814|FG002|Phase 1b|Lost to Follow-up|0|||
126035716|NCT02547363|453429410|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
126097719|NCT01370590|453650280|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
126097720|NCT01370590|453650279|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
126097721|NCT01370590|453650280|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
126097722|NCT01370590|453650279|FG000|Period 2|Adverse Event|0|||
126097723|NCT01370590|453650280|FG001|Period 2|Adverse Event|1|||
126097724|NCT01370590|453650279|FG000|Period 2|Withdrawal by Subject|1|||
126097725|NCT01370590|453650280|FG001|Period 2|Withdrawal by Subject|1|||
126097726|NCT00604825|453650281|FG000|Overall Study|Adverse Event|2|||
126097727|NCT00604825|453650282|FG001|Overall Study|Adverse Event|6|||
126097728|NCT00604825|453650283|FG002|Overall Study|Adverse Event|7|||
126097729|NCT00604825|453650284|FG003|Overall Study|Adverse Event|4|||
126097730|NCT00604825|453650281|FG000|Overall Study|Lost to Follow-up|0|||
126097731|NCT00604825|453650282|FG001|Overall Study|Lost to Follow-up|3|||
126097732|NCT00604825|453650283|FG002|Overall Study|Lost to Follow-up|1|||
126097733|NCT00604825|453650284|FG003|Overall Study|Lost to Follow-up|0|||
126097734|NCT00604825|453650281|FG000|Overall Study|Protocol Violation|0|||
126097735|NCT00604825|453650282|FG001|Overall Study|Protocol Violation|1|||
126097736|NCT00604825|453650283|FG002|Overall Study|Protocol Violation|0|||
126097737|NCT00604825|453650284|FG003|Overall Study|Protocol Violation|0|||
126097738|NCT00604825|453650281|FG000|Overall Study|Withdrawal by Subject|4|||
126097739|NCT00604825|453650282|FG001|Overall Study|Withdrawal by Subject|3|||
126097740|NCT00604825|453650283|FG002|Overall Study|Withdrawal by Subject|5|||
126097741|NCT00604825|453650284|FG003|Overall Study|Withdrawal by Subject|5|||
126097742|NCT00604825|453650281|FG000|Overall Study|Lack of Efficacy|3|||
126097743|NCT00604825|453650282|FG001|Overall Study|Lack of Efficacy|2|||
126097744|NCT00604825|453650283|FG002|Overall Study|Lack of Efficacy|1|||
126097745|NCT00604825|453650284|FG003|Overall Study|Lack of Efficacy|0|||
126097746|NCT00604825|453650281|FG000|Overall Study|Did not meet eligibility criteria|0|||
126097747|NCT00604825|453650282|FG001|Overall Study|Did not meet eligibility criteria|0|||
126097748|NCT00604825|453650283|FG002|Overall Study|Did not meet eligibility criteria|2|||
126097749|NCT00604825|453650284|FG003|Overall Study|Did not meet eligibility criteria|0|||
126097750|NCT00604825|453650281|FG000|Overall Study|Physician Decision|0|||
126097751|NCT00604825|453650282|FG001|Overall Study|Physician Decision|0|||
126097752|NCT00604825|453650283|FG002|Overall Study|Physician Decision|0|||
126097753|NCT00604825|453650284|FG003|Overall Study|Physician Decision|1|||
126097754|NCT00604825|453650281|FG000|Overall Study|Exclusion criterion met|0|||
126097755|NCT00604825|453650282|FG001|Overall Study|Exclusion criterion met|0|||
126097756|NCT00604825|453650283|FG002|Overall Study|Exclusion criterion met|0|||
126097757|NCT00604825|453650284|FG003|Overall Study|Exclusion criterion met|1|||
126097758|NCT04617275|453650285|FG000|Treatment Period|Adverse Event|1|||
126097759|NCT04617275|453650286|FG001|Treatment Period|Adverse Event|6|||
126097760|NCT04617275|453650287|FG002|Treatment Period|Adverse Event|4|||
126097761|NCT04617275|453650288|FG003|Treatment Period|Adverse Event|6|||
126097762|NCT04617275|453650289|FG004|Treatment Period|Adverse Event|7|||
126097763|NCT04617275|453650290|FG005|Treatment Period|Adverse Event|8|||
126097764|NCT04617275|453650291|FG006|Treatment Period|Adverse Event|0|||
126097765|NCT04617275|453650292|FG007|Treatment Period|Adverse Event|12|||
126360369|NCT00147537|454610815|FG003|Phase 1b|Lost to Follow-up|0|||
126360370|NCT00147537|454610816|FG004|Phase 1b|Lost to Follow-up|0|||
126360371|NCT00147537|454610817|FG005|Phase 1b|Lost to Follow-up|0|||
126360372|NCT00147537|454610818|FG006|Phase 1b|Lost to Follow-up|2|||
126360373|NCT00147537|454610819|FG007|Phase 1b|Lost to Follow-up|0|||
126360374|NCT00147537|454610820|FG008|Phase 1b|Lost to Follow-up|1|||
126035717|NCT02547363|453429411|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
126035718|NCT02547363|453429410|FG000|12-month Follow-up|Withdrawal by Subject|4|||
126035719|NCT02547363|453429411|FG001|12-month Follow-up|Withdrawal by Subject|3|||
126035720|NCT02547363|453429410|FG000|12-month Follow-up|Lost to Follow-up|4|||
126035721|NCT02547363|453429411|FG001|12-month Follow-up|Lost to Follow-up|1|||
126035722|NCT02547363|453429410|FG000|12-month Follow-up|Lack of Efficacy|1|||
126035723|NCT02547363|453429411|FG001|12-month Follow-up|Lack of Efficacy|1|||
126035724|NCT02547363|453429410|FG000|12-month Follow-up|Other|1|||
126035725|NCT02547363|453429411|FG001|12-month Follow-up|Other|0|||
126360375|NCT00147537|454610821|FG009|Phase 1b|Lost to Follow-up|0|||
126035726|NCT05201079|453429424|FG000|Overall Study|Adverse Event|7|||
126035727|NCT05201079|453429425|FG001|Overall Study|Adverse Event|11|||
126360376|NCT00147537|454610822|FG010|Phase 1b|Lost to Follow-up|0|||
126360377|NCT00147537|454610812|FG000|Phase 1b|Other|0|||
126035728|NCT05201079|453429424|FG000|Overall Study|Death|1|||
126035729|NCT05201079|453429425|FG001|Overall Study|Death|1|||
126097766|NCT04617275|453650285|FG000|Treatment Period|Lost to Follow-up|0|||
126097767|NCT04617275|453650286|FG001|Treatment Period|Lost to Follow-up|0|||
126097768|NCT04617275|453650287|FG002|Treatment Period|Lost to Follow-up|2|||
126097769|NCT04617275|453650288|FG003|Treatment Period|Lost to Follow-up|0|||
126097770|NCT04617275|453650289|FG004|Treatment Period|Lost to Follow-up|0|||
126097771|NCT04617275|453650290|FG005|Treatment Period|Lost to Follow-up|3|||
126265828|NCT00515034|454262943|FG003|Overall Study|Physician Decision|1|||
126265829|NCT00515034|454262940|FG000|Overall Study|Other|1|||
126265830|NCT00515034|454262941|FG001|Overall Study|Other|0|||
126265831|NCT00515034|454262942|FG002|Overall Study|Other|2|||
126265832|NCT00515034|454262943|FG003|Overall Study|Other|1|||
126265833|NCT01392326|454262948|FG000|Overall Study|Death|2|||
126265834|NCT01392326|454262949|FG001|Overall Study|Death|0|||
126265835|NCT01392326|454262950|FG002|Overall Study|Death|0|||
126265836|NCT01392326|454262948|FG000|Overall Study|Withdrawal by Subject|12|||
126265837|NCT01392326|454262949|FG001|Overall Study|Withdrawal by Subject|11|||
126265838|NCT01392326|454262950|FG002|Overall Study|Withdrawal by Subject|15|||
126265839|NCT01392326|454262948|FG000|Overall Study|Protocol Violation|2|||
126265840|NCT01392326|454262949|FG001|Overall Study|Protocol Violation|0|||
126265841|NCT01392326|454262950|FG002|Overall Study|Protocol Violation|0|||
126265842|NCT01392326|454262948|FG000|Overall Study|Pregnancy|0|||
126265843|NCT01392326|454262949|FG001|Overall Study|Pregnancy|0|||
126265844|NCT01392326|454262950|FG002|Overall Study|Pregnancy|1|||
126265845|NCT01392326|454262948|FG000|Overall Study|Physician Decision|7|||
126265846|NCT01392326|454262949|FG001|Overall Study|Physician Decision|5|||
126035730|NCT05201079|453429424|FG000|Overall Study|Lack of Efficacy|0|||
126035731|NCT05201079|453429425|FG001|Overall Study|Lack of Efficacy|2|||
126035732|NCT05201079|453429424|FG000|Overall Study|Lost to Follow-up|0|||
126035733|NCT05201079|453429425|FG001|Overall Study|Lost to Follow-up|1|||
126035734|NCT05201079|453429424|FG000|Overall Study|Physician Decision|1|||
126035735|NCT05201079|453429425|FG001|Overall Study|Physician Decision|1|||
126035736|NCT05201079|453429424|FG000|Overall Study|Protocol Violation|1|||
126035737|NCT05201079|453429425|FG001|Overall Study|Protocol Violation|0|||
126035738|NCT05201079|453429424|FG000|Overall Study|Withdrawal by Subject|1|||
126035739|NCT05201079|453429425|FG001|Overall Study|Withdrawal by Subject|0|||
126035740|NCT05201079|453429424|FG000|Overall Study|Forbidden medication|9|||
126035741|NCT05201079|453429425|FG001|Overall Study|Forbidden medication|5|||
126035742|NCT05201079|453429424|FG000|Overall Study|Transfer to another hospital|0|||
126035743|NCT05201079|453429425|FG001|Overall Study|Transfer to another hospital|1|||
126035744|NCT05201079|453429424|FG000|Overall Study|Clinical condition|1|||
126035745|NCT05201079|453429425|FG001|Overall Study|Clinical condition|0|||
126035746|NCT05201079|453429424|FG000|Overall Study|SAE and sepsis|1|||
126035747|NCT05201079|453429425|FG001|Overall Study|SAE and sepsis|0|||
126035748|NCT01210807|453429432|FG000|Overall Study|Lost to Follow-up|1|||
126035749|NCT01210807|453429433|FG001|Overall Study|Lost to Follow-up|2|||
126035750|NCT01210807|453429432|FG000|Overall Study|Not implanted bilaterally|2|||
126035751|NCT01210807|453429433|FG001|Overall Study|Not implanted bilaterally|1|||
126035752|NCT05281562|453429434|FG000|Overall Study|Ineligible patient|1|||
126035753|NCT05281562|453429435|FG001|Overall Study|Ineligible patient|0|||
126035754|NCT04436276|453429436|FG000|Overall Study|Adverse Event|0|||
126035755|NCT04436276|453429437|FG001|Overall Study|Adverse Event|0|||
126035756|NCT04436276|453429438|FG002|Overall Study|Adverse Event|0|||
126035757|NCT04436276|453429439|FG003|Overall Study|Adverse Event|0|||
126035758|NCT04436276|453429440|FG004|Overall Study|Adverse Event|0|||
126035759|NCT04436276|453429441|FG005|Overall Study|Adverse Event|0|||
126035760|NCT04436276|453429442|FG006|Overall Study|Adverse Event|0|||
126035761|NCT04436276|453429443|FG007|Overall Study|Adverse Event|0|||
126035762|NCT04436276|453429444|FG008|Overall Study|Adverse Event|0|||
126035763|NCT04436276|453429445|FG009|Overall Study|Adverse Event|0|||
126035764|NCT04436276|453429446|FG010|Overall Study|Adverse Event|0|||
126035765|NCT04436276|453429447|FG011|Overall Study|Adverse Event|0|||
126035766|NCT04436276|453429448|FG012|Overall Study|Adverse Event|0|||
126035767|NCT04436276|453429449|FG013|Overall Study|Adverse Event|0|||
126035768|NCT04436276|453429450|FG014|Overall Study|Adverse Event|0|||
126035769|NCT04436276|453429451|FG015|Overall Study|Adverse Event|0|||
126035770|NCT04436276|453429452|FG016|Overall Study|Adverse Event|1|||
126035771|NCT04436276|453429453|FG017|Overall Study|Adverse Event|0|||
126035772|NCT04436276|453429454|FG018|Overall Study|Adverse Event|0|||
126035773|NCT04436276|453429455|FG019|Overall Study|Adverse Event|0|||
126035774|NCT04436276|453429456|FG020|Overall Study|Adverse Event|0|||
126035775|NCT04436276|453429457|FG021|Overall Study|Adverse Event|0|||
126035776|NCT04436276|453429458|FG022|Overall Study|Adverse Event|0|||
126035777|NCT04436276|453429436|FG000|Overall Study|Death|0|||
126035778|NCT04436276|453429437|FG001|Overall Study|Death|0|||
126035779|NCT04436276|453429438|FG002|Overall Study|Death|0|||
126035780|NCT04436276|453429439|FG003|Overall Study|Death|0|||
126035781|NCT04436276|453429440|FG004|Overall Study|Death|0|||
126035782|NCT04436276|453429441|FG005|Overall Study|Death|0|||
126035783|NCT04436276|453429442|FG006|Overall Study|Death|0|||
126035784|NCT04436276|453429443|FG007|Overall Study|Death|0|||
126035785|NCT04436276|453429444|FG008|Overall Study|Death|0|||
126035786|NCT04436276|453429445|FG009|Overall Study|Death|0|||
126035787|NCT04436276|453429446|FG010|Overall Study|Death|0|||
126265847|NCT01392326|454262950|FG002|Overall Study|Physician Decision|2|||
126265848|NCT01392326|454262948|FG000|Overall Study|Lost to Follow-up|1|||
126265849|NCT01392326|454262949|FG001|Overall Study|Lost to Follow-up|3|||
126265850|NCT01392326|454262950|FG002|Overall Study|Lost to Follow-up|4|||
126265851|NCT01392326|454262948|FG000|Overall Study|Lack of Efficacy|14|||
126035788|NCT04436276|453429447|FG011|Overall Study|Death|0|||
126035789|NCT04436276|453429448|FG012|Overall Study|Death|1|||
126035790|NCT04436276|453429449|FG013|Overall Study|Death|0|||
126035791|NCT04436276|453429450|FG014|Overall Study|Death|1|||
126035792|NCT04436276|453429451|FG015|Overall Study|Death|0|||
126035793|NCT04436276|453429452|FG016|Overall Study|Death|0|||
126035794|NCT04436276|453429453|FG017|Overall Study|Death|0|||
126035795|NCT04436276|453429454|FG018|Overall Study|Death|0|||
126035796|NCT04436276|453429455|FG019|Overall Study|Death|2|||
126035797|NCT04436276|453429456|FG020|Overall Study|Death|0|||
126035798|NCT04436276|453429457|FG021|Overall Study|Death|1|||
126035799|NCT04436276|453429458|FG022|Overall Study|Death|0|||
126035800|NCT04436276|453429436|FG000|Overall Study|Lost to Follow-up|0|||
126035801|NCT04436276|453429437|FG001|Overall Study|Lost to Follow-up|2|||
126035802|NCT04436276|453429438|FG002|Overall Study|Lost to Follow-up|2|||
126035803|NCT04436276|453429439|FG003|Overall Study|Lost to Follow-up|1|||
126035804|NCT04436276|453429440|FG004|Overall Study|Lost to Follow-up|4|||
126035805|NCT04436276|453429441|FG005|Overall Study|Lost to Follow-up|1|||
126035806|NCT04436276|453429442|FG006|Overall Study|Lost to Follow-up|0|||
126035807|NCT04436276|453429443|FG007|Overall Study|Lost to Follow-up|0|||
126035808|NCT04436276|453429444|FG008|Overall Study|Lost to Follow-up|1|||
126035809|NCT04436276|453429445|FG009|Overall Study|Lost to Follow-up|0|||
126035810|NCT04436276|453429446|FG010|Overall Study|Lost to Follow-up|5|||
126035811|NCT04436276|453429447|FG011|Overall Study|Lost to Follow-up|5|||
126035812|NCT04436276|453429448|FG012|Overall Study|Lost to Follow-up|4|||
126035813|NCT04436276|453429449|FG013|Overall Study|Lost to Follow-up|1|||
126035814|NCT04436276|453429450|FG014|Overall Study|Lost to Follow-up|7|||
126035815|NCT04436276|453429451|FG015|Overall Study|Lost to Follow-up|7|||
126035816|NCT04436276|453429452|FG016|Overall Study|Lost to Follow-up|1|||
126035817|NCT04436276|453429453|FG017|Overall Study|Lost to Follow-up|0|||
126035818|NCT04436276|453429454|FG018|Overall Study|Lost to Follow-up|1|||
126035819|NCT04436276|453429455|FG019|Overall Study|Lost to Follow-up|1|||
126035820|NCT04436276|453429456|FG020|Overall Study|Lost to Follow-up|2|||
126097772|NCT04617275|453650291|FG006|Treatment Period|Lost to Follow-up|0|||
126097773|NCT04617275|453650292|FG007|Treatment Period|Lost to Follow-up|2|||
126097774|NCT04617275|453650285|FG000|Treatment Period|No longer meets eligibility criteria|0|||
126097775|NCT04617275|453650286|FG001|Treatment Period|No longer meets eligibility criteria|0|||
126097776|NCT04617275|453650287|FG002|Treatment Period|No longer meets eligibility criteria|0|||
126097777|NCT04617275|453650288|FG003|Treatment Period|No longer meets eligibility criteria|1|||
126097778|NCT04617275|453650289|FG004|Treatment Period|No longer meets eligibility criteria|0|||
126097779|NCT04617275|453650290|FG005|Treatment Period|No longer meets eligibility criteria|0|||
126097780|NCT04617275|453650291|FG006|Treatment Period|No longer meets eligibility criteria|0|||
126097781|NCT04617275|453650292|FG007|Treatment Period|No longer meets eligibility criteria|0|||
126097782|NCT04617275|453650285|FG000|Treatment Period|Other|0|||
126097783|NCT04617275|453650286|FG001|Treatment Period|Other|1|||
126097784|NCT04617275|453650287|FG002|Treatment Period|Other|0|||
126097785|NCT04617275|453650288|FG003|Treatment Period|Other|0|||
126097786|NCT04617275|453650289|FG004|Treatment Period|Other|0|||
126097787|NCT04617275|453650290|FG005|Treatment Period|Other|0|||
126097788|NCT04617275|453650291|FG006|Treatment Period|Other|0|||
126097789|NCT04617275|453650292|FG007|Treatment Period|Other|0|||
126097790|NCT04617275|453650285|FG000|Treatment Period|Withdrawal by Subject|2|||
126097791|NCT04617275|453650286|FG001|Treatment Period|Withdrawal by Subject|0|||
126097792|NCT04617275|453650287|FG002|Treatment Period|Withdrawal by Subject|0|||
126097793|NCT04617275|453650288|FG003|Treatment Period|Withdrawal by Subject|2|||
126097794|NCT04617275|453650289|FG004|Treatment Period|Withdrawal by Subject|2|||
126097795|NCT04617275|453650290|FG005|Treatment Period|Withdrawal by Subject|0|||
126097796|NCT04617275|453650291|FG006|Treatment Period|Withdrawal by Subject|1|||
126097797|NCT04617275|453650292|FG007|Treatment Period|Withdrawal by Subject|2|||
126097798|NCT04617275|453650285|FG000|Follow-up Period|Adverse Event|1|||
126097799|NCT04617275|453650286|FG001|Follow-up Period|Adverse Event|1|||
126035821|NCT04436276|453429457|FG021|Overall Study|Lost to Follow-up|1|||
126097800|NCT04617275|453650287|FG002|Follow-up Period|Adverse Event|2|||
126097801|NCT04617275|453650288|FG003|Follow-up Period|Adverse Event|3|||
126035822|NCT04436276|453429458|FG022|Overall Study|Lost to Follow-up|1|||
126035823|NCT04436276|453429436|FG000|Overall Study|Physician Decision|1|||
126035824|NCT04436276|453429437|FG001|Overall Study|Physician Decision|0|||
126035825|NCT04436276|453429438|FG002|Overall Study|Physician Decision|2|||
126035826|NCT04436276|453429439|FG003|Overall Study|Physician Decision|1|||
126035827|NCT04436276|453429440|FG004|Overall Study|Physician Decision|0|||
126035828|NCT04436276|453429441|FG005|Overall Study|Physician Decision|0|||
126035829|NCT04436276|453429442|FG006|Overall Study|Physician Decision|0|||
126035830|NCT04436276|453429443|FG007|Overall Study|Physician Decision|0|||
126035831|NCT04436276|453429444|FG008|Overall Study|Physician Decision|0|||
126035832|NCT04436276|453429445|FG009|Overall Study|Physician Decision|0|||
126097802|NCT04617275|453650289|FG004|Follow-up Period|Adverse Event|4|||
126097803|NCT04617275|453650290|FG005|Follow-up Period|Adverse Event|3|||
126097804|NCT04617275|453650291|FG006|Follow-up Period|Adverse Event|0|||
126097805|NCT04617275|453650292|FG007|Follow-up Period|Adverse Event|3|||
126097806|NCT04617275|453650285|FG000|Follow-up Period|Lost to Follow-up|0|||
126097807|NCT04617275|453650286|FG001|Follow-up Period|Lost to Follow-up|1|||
126097808|NCT04617275|453650287|FG002|Follow-up Period|Lost to Follow-up|2|||
126097809|NCT04617275|453650288|FG003|Follow-up Period|Lost to Follow-up|0|||
126097810|NCT04617275|453650289|FG004|Follow-up Period|Lost to Follow-up|0|||
126097811|NCT04617275|453650290|FG005|Follow-up Period|Lost to Follow-up|4|||
126097812|NCT04617275|453650291|FG006|Follow-up Period|Lost to Follow-up|0|||
126097813|NCT04617275|453650292|FG007|Follow-up Period|Lost to Follow-up|3|||
126097814|NCT04617275|453650285|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
126097815|NCT04617275|453650286|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
126097816|NCT04617275|453650287|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
126097817|NCT04617275|453650288|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
126265852|NCT01392326|454262949|FG001|Overall Study|Lack of Efficacy|10|||
126265853|NCT01392326|454262950|FG002|Overall Study|Lack of Efficacy|15|||
126265854|NCT01392326|454262948|FG000|Overall Study|Adverse Event|9|||
126265855|NCT01392326|454262949|FG001|Overall Study|Adverse Event|6|||
126265856|NCT01392326|454262950|FG002|Overall Study|Adverse Event|11|||
126265857|NCT04553913|454262953|FG000|Overall Study|patient's block resolved prior to PACU|1|||
126265858|NCT04553913|454262953|FG000|Overall Study|did not use the device properly|5|||
126265859|NCT00710749|454262955|FG000|First Intervention|Withdrawal by Subject|1|||
126265860|NCT00710749|454262956|FG001|First Intervention|Withdrawal by Subject|0|||
126265861|NCT05626803|454265066|FG000|Overall Study|Lost to Follow-up|0|||
126265862|NCT05626803|454265067|FG001|Overall Study|Lost to Follow-up|1|||
126265863|NCT05626803|454265068|FG002|Overall Study|Lost to Follow-up|0|||
126265864|NCT05626803|454265069|FG003|Overall Study|Lost to Follow-up|0|||
126265865|NCT01000610|454265075|FG000|Overall Study|Adverse Event|1|||
126265866|NCT01000610|454265075|FG000|Overall Study|Lost to Follow-up|4|||
126265867|NCT01000610|454265075|FG000|Overall Study|Treatment failure|1|||
126265868|NCT00493246|454265076|FG000|Overall Study|Withdrawal by Subject|0|||
126265869|NCT00493246|454265077|FG001|Overall Study|Withdrawal by Subject|0|||
126265870|NCT00493246|454265078|FG002|Overall Study|Withdrawal by Subject|0|||
126265871|NCT00493246|454265079|FG003|Overall Study|Withdrawal by Subject|0|||
126265872|NCT00493246|454265080|FG004|Overall Study|Withdrawal by Subject|1|||
126265873|NCT00493246|454265081|FG005|Overall Study|Withdrawal by Subject|0|||
126265874|NCT00493246|454265082|FG006|Overall Study|Withdrawal by Subject|0|||
126265875|NCT00493246|454265083|FG007|Overall Study|Withdrawal by Subject|0|||
126265876|NCT00493246|454265076|FG000|Overall Study|No access to draw blood|0|||
126265877|NCT00493246|454265077|FG001|Overall Study|No access to draw blood|0|||
126265878|NCT00493246|454265078|FG002|Overall Study|No access to draw blood|0|||
126265879|NCT00493246|454265079|FG003|Overall Study|No access to draw blood|0|||
126265880|NCT00493246|454265080|FG004|Overall Study|No access to draw blood|0|||
126265881|NCT00493246|454265081|FG005|Overall Study|No access to draw blood|1|||
126265882|NCT00493246|454265082|FG006|Overall Study|No access to draw blood|0|||
126265883|NCT00493246|454265083|FG007|Overall Study|No access to draw blood|0|||
126265884|NCT00493246|454265076|FG000|Overall Study|Lost to Follow-up|0|||
126265885|NCT00493246|454265077|FG001|Overall Study|Lost to Follow-up|0|||
126265886|NCT00493246|454265078|FG002|Overall Study|Lost to Follow-up|0|||
126265887|NCT00493246|454265079|FG003|Overall Study|Lost to Follow-up|0|||
126265888|NCT00493246|454265080|FG004|Overall Study|Lost to Follow-up|0|||
126265889|NCT00493246|454265081|FG005|Overall Study|Lost to Follow-up|0|||
126265890|NCT00493246|454265082|FG006|Overall Study|Lost to Follow-up|1|||
126265891|NCT00493246|454265083|FG007|Overall Study|Lost to Follow-up|0|||
126265892|NCT02631876|454265090|FG000|Overall Study|Death|96|||
126265893|NCT02631876|454265091|FG001|Overall Study|Death|50|||
126265894|NCT02631876|454265090|FG000|Overall Study|Investigator's discretion|1|||
126265895|NCT02631876|454265091|FG001|Overall Study|Investigator's discretion|0|||
126265896|NCT02631876|454265090|FG000|Overall Study|Lost to Follow-up|2|||
126265897|NCT02631876|454265091|FG001|Overall Study|Lost to Follow-up|0|||
126265898|NCT02631876|454265090|FG000|Overall Study|Withdrawal by Subject|16|||
126265899|NCT02631876|454265091|FG001|Overall Study|Withdrawal by Subject|9|||
126265900|NCT02631876|454265090|FG000|Overall Study|Other than specified|4|||
126265901|NCT02631876|454265091|FG001|Overall Study|Other than specified|4|||
126265902|NCT01408563|454265096|FG000|Overall Study|Ineligible after consent/ registration|2|||
126265903|NCT02054130|454265099|FG000|Overall Study|Withdrawal by Subject|4|||
126097818|NCT04617275|453650289|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
126097819|NCT04617275|453650290|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
126097820|NCT04617275|453650291|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
126265904|NCT02054130|454265100|FG001|Overall Study|Withdrawal by Subject|4|||
126265905|NCT02054130|454265101|FG002|Overall Study|Withdrawal by Subject|7|||
126265906|NCT02054130|454265102|FG003|Overall Study|Withdrawal by Subject|10|||
126265907|NCT02054130|454265099|FG000|Overall Study|Death|0|||
126265908|NCT02054130|454265100|FG001|Overall Study|Death|1|||
126265909|NCT02054130|454265101|FG002|Overall Study|Death|0|||
126265910|NCT02054130|454265102|FG003|Overall Study|Death|0|||
126265911|NCT02054130|454265099|FG000|Overall Study|Lost to Follow-up|0|||
126097821|NCT04617275|453650292|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
126097822|NCT04617275|453650285|FG000|Follow-up Period|Other|0|||
126097823|NCT04617275|453650286|FG001|Follow-up Period|Other|1|||
126097824|NCT04617275|453650287|FG002|Follow-up Period|Other|0|||
126097825|NCT04617275|453650288|FG003|Follow-up Period|Other|0|||
126097826|NCT04617275|453650289|FG004|Follow-up Period|Other|0|||
126097827|NCT04617275|453650290|FG005|Follow-up Period|Other|0|||
126097828|NCT04617275|453650291|FG006|Follow-up Period|Other|0|||
126097829|NCT04617275|453650292|FG007|Follow-up Period|Other|0|||
126097830|NCT04617275|453650285|FG000|Follow-up Period|Withdrawal by Subject|2|||
126097831|NCT04617275|453650286|FG001|Follow-up Period|Withdrawal by Subject|0|||
126097832|NCT04617275|453650287|FG002|Follow-up Period|Withdrawal by Subject|0|||
126097833|NCT04617275|453650288|FG003|Follow-up Period|Withdrawal by Subject|2|||
126097834|NCT04617275|453650289|FG004|Follow-up Period|Withdrawal by Subject|2|||
126097835|NCT04617275|453650290|FG005|Follow-up Period|Withdrawal by Subject|0|||
126097836|NCT04617275|453650291|FG006|Follow-up Period|Withdrawal by Subject|1|||
126097837|NCT04617275|453650292|FG007|Follow-up Period|Withdrawal by Subject|2|||
126097838|NCT04927884|453650300|FG000|Overall Study|Progressive Disease|2|||
126097839|NCT05593445|453650301|FG000|12-Week DBVC Period|Adverse Event|1|||
126097840|NCT05593445|453650302|FG001|12-Week DBVC Period|Adverse Event|0|||
125880700|NCT00313014|452862597|FG002|Overall Study|Withdrawal by Subject|5|||
125880701|NCT00313014|452862595|FG000|Overall Study|Adverse Event|14|||
125880702|NCT00313014|452862596|FG001|Overall Study|Adverse Event|29|||
125880703|NCT00313014|452862597|FG002|Overall Study|Adverse Event|16|||
126097841|NCT05593445|453650303|FG002|12-Week DBVC Period|Adverse Event|0|||
126097842|NCT05593445|453650304|FG003|12-Week DBVC Period|Adverse Event|0|||
126097843|NCT05593445|453650301|FG000|12-Week DBVC Period|Physician Decision|0|||
126097844|NCT05593445|453650302|FG001|12-Week DBVC Period|Physician Decision|1|||
126097845|NCT05593445|453650303|FG002|12-Week DBVC Period|Physician Decision|0|||
126097846|NCT05593445|453650304|FG003|12-Week DBVC Period|Physician Decision|0|||
126097847|NCT05593445|453650301|FG000|12-Week DBVC Period|Protocol Violation|0|||
126097848|NCT05593445|453650302|FG001|12-Week DBVC Period|Protocol Violation|1|||
126097849|NCT05593445|453650303|FG002|12-Week DBVC Period|Protocol Violation|0|||
126097850|NCT05593445|453650304|FG003|12-Week DBVC Period|Protocol Violation|0|||
126097851|NCT05593445|453650301|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
126097852|NCT05593445|453650302|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
126097853|NCT05593445|453650303|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
126097854|NCT05593445|453650304|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
126097855|NCT05593445|453650301|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
126265912|NCT02054130|454265100|FG001|Overall Study|Lost to Follow-up|0|||
126265913|NCT02054130|454265101|FG002|Overall Study|Lost to Follow-up|1|||
126265914|NCT02054130|454265102|FG003|Overall Study|Lost to Follow-up|2|||
126265915|NCT02054130|454265099|FG000|Overall Study|Missed dose|4|||
126265916|NCT02054130|454265100|FG001|Overall Study|Missed dose|6|||
126265917|NCT02054130|454265101|FG002|Overall Study|Missed dose|7|||
126265918|NCT02054130|454265102|FG003|Overall Study|Missed dose|10|||
126265919|NCT00094458|454265103|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
126265920|NCT00094458|454265104|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
126265921|NCT00094458|454265105|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
126265922|NCT00094458|454265106|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
126265923|NCT00094458|454265107|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
126265924|NCT00094458|454265108|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
126265925|NCT00094458|454265103|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
126265926|NCT00094458|454265104|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
126265927|NCT00094458|454265105|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
126265928|NCT00094458|454265106|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
126265929|NCT00094458|454265107|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
126265930|NCT00094458|454265108|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
126265931|NCT00094458|454265103|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
126265932|NCT00094458|454265104|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
126265933|NCT00094458|454265105|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
126265934|NCT00094458|454265106|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
126265935|NCT00094458|454265107|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
126265936|NCT00094458|454265108|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
126265937|NCT00094458|454265103|FG000|Main Study: Through Week 30|Adverse Event|38|||
126265938|NCT00094458|454265104|FG001|Main Study: Through Week 30|Adverse Event|20|||
126265939|NCT00094458|454265105|FG002|Main Study: Through Week 30|Adverse Event|28|||
126265940|NCT00094458|454265106|FG003|Main Study: Through Week 30|Adverse Event|0|||
126265941|NCT00094458|454265107|FG004|Main Study: Through Week 30|Adverse Event|0|||
126265942|NCT00094458|454265108|FG005|Main Study: Through Week 30|Adverse Event|0|||
126265943|NCT00094458|454265103|FG000|Main Study: Through Week 30|Death|1|||
125880704|NCT00313014|452862595|FG000|Overall Study|Lost to Follow-up|7|||
126097856|NCT05593445|453650302|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
126097857|NCT05593445|453650303|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
126097858|NCT05593445|453650304|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
126097859|NCT05593445|453650301|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
126097860|NCT05593445|453650302|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
126097861|NCT05593445|453650303|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
126097862|NCT05593445|453650304|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
126097863|NCT05593445|453650301|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
126097864|NCT05593445|453650302|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
126097865|NCT05593445|453650303|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
126097866|NCT05593445|453650304|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
126097867|NCT05593445|453650301|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126097868|NCT05593445|453650302|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126097869|NCT05593445|453650303|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
126097870|NCT05593445|453650304|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126097871|NCT05559476|453650305|FG000|Overall Study|Adverse Event|2|||
126097872|NCT05559476|453650306|FG001|Overall Study|Adverse Event|0|||
126097873|NCT05559476|453650305|FG000|Overall Study|Lost to Follow-up|13|||
126097874|NCT05559476|453650306|FG001|Overall Study|Lost to Follow-up|12|||
126097875|NCT05559476|453650305|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
126097876|NCT05559476|453650306|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
126097877|NCT05559476|453650305|FG000|Overall Study|Other|0|||
126097878|NCT05559476|453650306|FG001|Overall Study|Other|2|||
126097879|NCT00727311|453650307|FG000|Overall Study|Did not receive drug|316|||
126097880|NCT00727311|453650307|FG000|Overall Study|Missing end of therapy data|205|||
126097881|NCT00727311|453650307|FG000|Overall Study|Adverse Event|58|||
126097882|NCT00727311|453650307|FG000|Overall Study|Lack of Efficacy|242|||
126097883|NCT00727311|453650307|FG000|Overall Study|Lost to Follow-up|73|||
126097884|NCT00727311|453650307|FG000|Overall Study|Withdrawal by Subject|77|||
126097885|NCT00727311|453650307|FG000|Overall Study|Other|97|||
126097886|NCT00727311|453650307|FG000|Overall Study|Multiple reasons|39|||
126097887|NCT00969709|453651370|FG000|Overall Study|Adverse Event|3|||
126097888|NCT00969709|453651371|FG001|Overall Study|Adverse Event|13|||
126097889|NCT00969709|453651372|FG002|Overall Study|Adverse Event|26|||
126097890|NCT00969709|453651373|FG003|Overall Study|Adverse Event|12|||
126097891|NCT00969709|453651370|FG000|Overall Study|Lack of Efficacy|7|||
126097892|NCT00969709|453651371|FG001|Overall Study|Lack of Efficacy|4|||
126097893|NCT00969709|453651372|FG002|Overall Study|Lack of Efficacy|1|||
126097894|NCT00969709|453651373|FG003|Overall Study|Lack of Efficacy|3|||
126097895|NCT00969709|453651370|FG000|Overall Study|Protocol Violation|9|||
126097896|NCT00969709|453651371|FG001|Overall Study|Protocol Violation|5|||
126097897|NCT00969709|453651372|FG002|Overall Study|Protocol Violation|9|||
126097898|NCT00969709|453651373|FG003|Overall Study|Protocol Violation|10|||
126097899|NCT00969709|453651370|FG000|Overall Study|Withdrawal by Subject|9|||
126097900|NCT00969709|453651371|FG001|Overall Study|Withdrawal by Subject|12|||
126097901|NCT00969709|453651372|FG002|Overall Study|Withdrawal by Subject|11|||
126097902|NCT00969709|453651373|FG003|Overall Study|Withdrawal by Subject|23|||
126097903|NCT00969709|453651370|FG000|Overall Study|Lost to Follow-up|10|||
126097904|NCT00969709|453651371|FG001|Overall Study|Lost to Follow-up|14|||
126097905|NCT00969709|453651372|FG002|Overall Study|Lost to Follow-up|8|||
126097906|NCT00969709|453651373|FG003|Overall Study|Lost to Follow-up|15|||
126097907|NCT00969709|453651370|FG000|Overall Study|Other reasons|0|||
126097908|NCT00969709|453651371|FG001|Overall Study|Other reasons|0|||
126097909|NCT00969709|453651372|FG002|Overall Study|Other reasons|3|||
126097910|NCT00969709|453651373|FG003|Overall Study|Other reasons|0|||
126265944|NCT00094458|454265104|FG001|Main Study: Through Week 30|Death|0|||
126265945|NCT00094458|454265105|FG002|Main Study: Through Week 30|Death|0|||
126265946|NCT00094458|454265106|FG003|Main Study: Through Week 30|Death|0|||
126265947|NCT00094458|454265107|FG004|Main Study: Through Week 30|Death|0|||
126265948|NCT00094458|454265108|FG005|Main Study: Through Week 30|Death|0|||
126265949|NCT00094458|454265103|FG000|Main Study: Through Week 30|Other|19|||
126265950|NCT00094458|454265104|FG001|Main Study: Through Week 30|Other|16|||
126265951|NCT00094458|454265105|FG002|Main Study: Through Week 30|Other|9|||
126265952|NCT00094458|454265106|FG003|Main Study: Through Week 30|Other|0|||
126265953|NCT00094458|454265107|FG004|Main Study: Through Week 30|Other|0|||
126265954|NCT00094458|454265108|FG005|Main Study: Through Week 30|Other|0|||
126265955|NCT00094458|454265103|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
126265956|NCT00094458|454265104|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
126097911|NCT01238900|453651374|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
126097912|NCT01238900|453651374|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
126265957|NCT00094458|454265105|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
126265958|NCT00094458|454265106|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
126265959|NCT00094458|454265107|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
126097913|NCT02233543|453651377|FG000|Period 1|Withdrawal by Subject|1|||
126097914|NCT02233543|453651378|FG001|Period 1|Withdrawal by Subject|0|||
126097915|NCT02233543|453651377|FG000|Period 1|Participants required other treatment.|2|||
126097916|NCT02233543|453651378|FG001|Period 1|Participants required other treatment.|3|||
126097917|NCT02233543|453651377|FG000|Period 2|Adverse Event|1|||
126265960|NCT00094458|454265108|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
126265961|NCT00094458|454265103|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
126265962|NCT00094458|454265104|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
126265963|NCT00094458|454265105|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
126265964|NCT00094458|454265106|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
126265965|NCT00094458|454265107|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
126265966|NCT00094458|454265108|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
126265967|NCT00094458|454265103|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
126265968|NCT00094458|454265104|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
126265969|NCT00094458|454265105|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
126265970|NCT00094458|454265106|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
126265971|NCT00094458|454265107|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
126265972|NCT00094458|454265108|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
126265973|NCT00094458|454265103|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
126265974|NCT00094458|454265104|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
126265975|NCT00094458|454265105|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
126265976|NCT00094458|454265106|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
126265977|NCT00094458|454265107|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
126265978|NCT00094458|454265108|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
126265979|NCT00094458|454265103|FG000|OLE: Open-Label Extension|Adverse Event|0|||
126265980|NCT00094458|454265104|FG001|OLE: Open-Label Extension|Adverse Event|0|||
126265981|NCT00094458|454265105|FG002|OLE: Open-Label Extension|Adverse Event|0|||
126265982|NCT00094458|454265106|FG003|OLE: Open-Label Extension|Adverse Event|0|||
126265983|NCT00094458|454265107|FG004|OLE: Open-Label Extension|Adverse Event|3|||
126265984|NCT00094458|454265108|FG005|OLE: Open-Label Extension|Adverse Event|4|||
126265985|NCT00094458|454265103|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
126265986|NCT00094458|454265104|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
126265987|NCT00094458|454265105|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
126265988|NCT00094458|454265106|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
126265989|NCT00094458|454265107|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
126265990|NCT00094458|454265108|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
126265991|NCT00094458|454265103|FG000|OLE: Open-Label Extension|Patient decision|0|||
126265992|NCT00094458|454265104|FG001|OLE: Open-Label Extension|Patient decision|0|||
126265993|NCT00094458|454265105|FG002|OLE: Open-Label Extension|Patient decision|0|||
126265994|NCT00094458|454265106|FG003|OLE: Open-Label Extension|Patient decision|0|||
126265995|NCT00094458|454265107|FG004|OLE: Open-Label Extension|Patient decision|1|||
126265996|NCT00094458|454265108|FG005|OLE: Open-Label Extension|Patient decision|0|||
126265997|NCT02017860|454265113|FG000|Overall Study|Adverse Event|1|||
126265998|NCT02017860|454265113|FG000|Overall Study|Withdrawal by Subject|1|||
126265999|NCT03604341|454265116|FG000|Overall Study|Withdrawal by Subject|1|||
126266000|NCT03604341|454265117|FG001|Overall Study|Withdrawal by Subject|1|||
126266001|NCT03604341|454265116|FG000|Overall Study|Adverse Event|1|||
126097918|NCT02233543|453651378|FG001|Period 2|Adverse Event|0|||
126097919|NCT02233543|453651377|FG000|Period 2|Participant required other treatment.|0|||
126097920|NCT02233543|453651378|FG001|Period 2|Participant required other treatment.|1|||
126097921|NCT02233543|453651377|FG000|Period 2|COPD exacerbation|1|||
126097922|NCT02233543|453651378|FG001|Period 2|COPD exacerbation|0|||
126097923|NCT00616902|453651379|FG000|Overall Study|Termination of study|6|||
126097924|NCT00616902|453651380|FG001|Overall Study|Termination of study|6|||
126097925|NCT00266227|453651381|FG000|Initial Treatment|Adverse Event|0|||
126097926|NCT00266227|453651382|FG001|Initial Treatment|Adverse Event|0|||
126097927|NCT00266227|453651383|FG002|Initial Treatment|Adverse Event|13|||
126097928|NCT00266227|453651381|FG000|Initial Treatment|Lost to Follow-up|0|||
126097929|NCT00266227|453651382|FG001|Initial Treatment|Lost to Follow-up|0|||
126097930|NCT00266227|453651383|FG002|Initial Treatment|Lost to Follow-up|6|||
126097931|NCT00266227|453651381|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
126097932|NCT00266227|453651382|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
126097933|NCT00266227|453651383|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
126097934|NCT00266227|453651381|FG000|Initial Treatment|Physician decision to withdraw|0|||
126097935|NCT00266227|453651382|FG001|Initial Treatment|Physician decision to withdraw|0|||
126266002|NCT03604341|454265117|FG001|Overall Study|Adverse Event|0|||
126266003|NCT03604341|454265116|FG000|Overall Study|Protocol Violation|0|||
126266004|NCT03604341|454265117|FG001|Overall Study|Protocol Violation|1|||
126266005|NCT01829113|454265121|FG000|Overall Study|Disease Progression|37|||
126266006|NCT01829113|454265122|FG001|Overall Study|Disease Progression|48|||
126266007|NCT01829113|454265121|FG000|Overall Study|Adverse Event|14|||
126266008|NCT01829113|454265122|FG001|Overall Study|Adverse Event|10|||
126266009|NCT01829113|454265121|FG000|Overall Study|Withdrawal by Subject|17|||
126360378|NCT00147537|454610813|FG001|Phase 1b|Other|0|||
126360379|NCT00147537|454610814|FG002|Phase 1b|Other|2|||
126097936|NCT00266227|453651383|FG002|Initial Treatment|Physician decision to withdraw|12|||
126097937|NCT00266227|453651381|FG000|Initial Treatment|Pregnancy|0|||
126266010|NCT01829113|454265122|FG001|Overall Study|Withdrawal by Subject|10|||
126266011|NCT01829113|454265121|FG000|Overall Study|Death|4|||
126266012|NCT01829113|454265122|FG001|Overall Study|Death|6|||
126266013|NCT01829113|454265121|FG000|Overall Study|Sponsor Decision|1|||
126266014|NCT01829113|454265122|FG001|Overall Study|Sponsor Decision|1|||
126266015|NCT01829113|454265121|FG000|Overall Study|No Study Treatment Received|3|||
126266016|NCT01829113|454265122|FG001|Overall Study|No Study Treatment Received|2|||
126266017|NCT01829113|454265121|FG000|Overall Study|Physician Decision|1|||
126266018|NCT01829113|454265122|FG001|Overall Study|Physician Decision|1|||
126097938|NCT00266227|453651382|FG001|Initial Treatment|Pregnancy|0|||
126097939|NCT00266227|453651383|FG002|Initial Treatment|Pregnancy|1|||
126097940|NCT00266227|453651381|FG000|Retreatment: Up to Week 48|Death|1|||
126097941|NCT00266227|453651382|FG001|Retreatment: Up to Week 48|Death|0|||
126097942|NCT00266227|453651383|FG002|Retreatment: Up to Week 48|Death|0|||
126097943|NCT00266227|453651381|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
126097944|NCT00266227|453651382|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
126097945|NCT00266227|453651383|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
126097946|NCT00266227|453651381|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
126097947|NCT00266227|453651382|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
126097948|NCT00266227|453651383|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
126097949|NCT00266227|453651381|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
126097950|NCT00266227|453651382|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
126097951|NCT00266227|453651383|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
126097952|NCT00266227|453651381|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
126097953|NCT00266227|453651382|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
126097954|NCT00266227|453651383|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
126266019|NCT00897949|454265123|FG000|Overall Study|Adverse Event|1|||
126266020|NCT00897949|454265124|FG001|Overall Study|Adverse Event|1|||
126266021|NCT00897949|454265125|FG002|Overall Study|Adverse Event|0|||
126266022|NCT00897949|454265123|FG000|Overall Study|Lost to Follow-up|0|||
126266023|NCT00897949|454265124|FG001|Overall Study|Lost to Follow-up|2|||
126266024|NCT00897949|454265125|FG002|Overall Study|Lost to Follow-up|1|||
126266025|NCT00897949|454265123|FG000|Overall Study|Protocol Violation|6|||
126266026|NCT00897949|454265124|FG001|Overall Study|Protocol Violation|3|||
126266027|NCT00897949|454265125|FG002|Overall Study|Protocol Violation|1|||
126266028|NCT00897949|454265123|FG000|Overall Study|Withdrawal by Subject|1|||
126266029|NCT00897949|454265124|FG001|Overall Study|Withdrawal by Subject|2|||
126266030|NCT00897949|454265125|FG002|Overall Study|Withdrawal by Subject|0|||
126266031|NCT00897949|454265123|FG000|Overall Study|Patient Uncoorperative|0|||
126266032|NCT00897949|454265124|FG001|Overall Study|Patient Uncoorperative|2|||
126266033|NCT00897949|454265125|FG002|Overall Study|Patient Uncoorperative|1|||
126097955|NCT00266227|453651381|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
126097956|NCT00266227|453651382|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
126097957|NCT00266227|453651383|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
126097958|NCT00266227|453651381|FG000|Retreatment: Week 48 to Week 72|Death|1|||
126097959|NCT00266227|453651382|FG001|Retreatment: Week 48 to Week 72|Death|1|||
126097960|NCT00266227|453651383|FG002|Retreatment: Week 48 to Week 72|Death|0|||
126097961|NCT00266227|453651381|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
126097962|NCT00266227|453651382|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
126097963|NCT00266227|453651383|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
126097964|NCT00266227|453651381|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
126097965|NCT00266227|453651382|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
126097966|NCT00266227|453651383|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
126097967|NCT00266227|453651381|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
126097968|NCT00266227|453651382|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
126097969|NCT00266227|453651383|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
126097970|NCT00266227|453651381|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
126097971|NCT00266227|453651382|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
126097972|NCT00266227|453651383|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
126097973|NCT03573583|453651384|FG000|Overall Study|Lost to Follow-up|1|||
126097974|NCT03573583|453651385|FG001|Overall Study|Lost to Follow-up|0|||
126097975|NCT03573583|453651384|FG000|Overall Study|Withdrawal by Subject|1|||
126097976|NCT03573583|453651385|FG001|Overall Study|Withdrawal by Subject|1|||
126097977|NCT01119105|453651392|FG000|Overall Study|Withdrawal by Subject|1|||
126097978|NCT01119105|453651393|FG001|Overall Study|Withdrawal by Subject|1|||
126097979|NCT01119105|453651394|FG002|Overall Study|Withdrawal by Subject|1|||
126266034|NCT00897949|454265123|FG000|Overall Study|Lost to Follow-up|30|||
126266035|NCT00897949|454265124|FG001|Overall Study|Lost to Follow-up|23|||
126266036|NCT00897949|454265125|FG002|Overall Study|Lost to Follow-up|17|||
126266037|NCT00897949|454265123|FG000|Overall Study|Withdrawal by Subject|24|||
126266038|NCT00897949|454265124|FG001|Overall Study|Withdrawal by Subject|31|||
126360380|NCT00147537|454610815|FG003|Phase 1b|Other|1|||
126360381|NCT00147537|454610816|FG004|Phase 1b|Other|1|||
126266039|NCT00897949|454265125|FG002|Overall Study|Withdrawal by Subject|17|||
126360382|NCT00147537|454610817|FG005|Phase 1b|Other|1|||
126360383|NCT00147537|454610818|FG006|Phase 1b|Other|14|||
126360384|NCT00147537|454610819|FG007|Phase 1b|Other|4|||
126360385|NCT00147537|454610820|FG008|Phase 1b|Other|4|||
126360386|NCT00147537|454610821|FG009|Phase 1b|Other|0|||
126360387|NCT00147537|454610822|FG010|Phase 1b|Other|0|||
126360388|NCT00147537|454610812|FG000|Phase 1b|Withdrawal by Subject|0|||
126266040|NCT00897949|454265123|FG000|Overall Study|Abnormal Prestudy Labs|2|||
126266041|NCT00897949|454265124|FG001|Overall Study|Abnormal Prestudy Labs|3|||
126266042|NCT00897949|454265125|FG002|Overall Study|Abnormal Prestudy Labs|4|||
126266043|NCT00897949|454265123|FG000|Overall Study|Abnormal Baseline ECG|2|||
126266044|NCT00897949|454265124|FG001|Overall Study|Abnormal Baseline ECG|2|||
126266045|NCT00897949|454265125|FG002|Overall Study|Abnormal Baseline ECG|4|||
126266046|NCT00897949|454265123|FG000|Overall Study|Need for Concom. Med.|0|||
126266047|NCT00897949|454265124|FG001|Overall Study|Need for Concom. Med.|1|||
126266048|NCT00897949|454265125|FG002|Overall Study|Need for Concom. Med.|1|||
126266049|NCT00897949|454265123|FG000|Overall Study|Lack of Migraine Attack|29|||
126266050|NCT00897949|454265124|FG001|Overall Study|Lack of Migraine Attack|30|||
126266051|NCT00897949|454265125|FG002|Overall Study|Lack of Migraine Attack|19|||
126266052|NCT00897949|454265123|FG000|Overall Study|Did not take study drug|9|||
126266053|NCT00897949|454265124|FG001|Overall Study|Did not take study drug|3|||
126266054|NCT00897949|454265125|FG002|Overall Study|Did not take study drug|4|||
126266055|NCT01553747|454265126|FG000|Overall Study|Protocol Violation|0|||
126266056|NCT01553747|454265127|FG001|Overall Study|Protocol Violation|2|||
126266057|NCT01553747|454265128|FG002|Overall Study|Protocol Violation|0|||
126266058|NCT01553747|454265126|FG000|Overall Study|Voluntarily withdrew|70|||
126360389|NCT00147537|454610813|FG001|Phase 1b|Withdrawal by Subject|0|||
126360390|NCT00147537|454610814|FG002|Phase 1b|Withdrawal by Subject|0|||
126360391|NCT00147537|454610815|FG003|Phase 1b|Withdrawal by Subject|0|||
126360392|NCT00147537|454610816|FG004|Phase 1b|Withdrawal by Subject|0|||
126360393|NCT00147537|454610817|FG005|Phase 1b|Withdrawal by Subject|0|||
126360394|NCT00147537|454610818|FG006|Phase 1b|Withdrawal by Subject|0|||
126360395|NCT00147537|454610819|FG007|Phase 1b|Withdrawal by Subject|0|||
126360396|NCT00147537|454610820|FG008|Phase 1b|Withdrawal by Subject|2|||
126360397|NCT00147537|454610821|FG009|Phase 1b|Withdrawal by Subject|0|||
126035833|NCT04436276|453429446|FG010|Overall Study|Physician Decision|0|||
126035834|NCT04436276|453429447|FG011|Overall Study|Physician Decision|1|||
126035835|NCT04436276|453429448|FG012|Overall Study|Physician Decision|2|||
126035836|NCT04436276|453429449|FG013|Overall Study|Physician Decision|0|||
126035837|NCT04436276|453429450|FG014|Overall Study|Physician Decision|0|||
126035838|NCT04436276|453429451|FG015|Overall Study|Physician Decision|0|||
126035839|NCT04436276|453429452|FG016|Overall Study|Physician Decision|0|||
126035840|NCT04436276|453429453|FG017|Overall Study|Physician Decision|0|||
126035841|NCT04436276|453429454|FG018|Overall Study|Physician Decision|0|||
126035842|NCT04436276|453429455|FG019|Overall Study|Physician Decision|0|||
126035843|NCT04436276|453429456|FG020|Overall Study|Physician Decision|1|||
126035844|NCT04436276|453429457|FG021|Overall Study|Physician Decision|2|||
126035845|NCT04436276|453429458|FG022|Overall Study|Physician Decision|0|||
126035846|NCT04436276|453429436|FG000|Overall Study|Protocol Violation|0|||
126035847|NCT04436276|453429437|FG001|Overall Study|Protocol Violation|0|||
126035848|NCT04436276|453429438|FG002|Overall Study|Protocol Violation|0|||
126035849|NCT04436276|453429439|FG003|Overall Study|Protocol Violation|0|||
126035850|NCT04436276|453429440|FG004|Overall Study|Protocol Violation|0|||
126035851|NCT04436276|453429441|FG005|Overall Study|Protocol Violation|0|||
126035852|NCT04436276|453429442|FG006|Overall Study|Protocol Violation|0|||
126035853|NCT04436276|453429443|FG007|Overall Study|Protocol Violation|0|||
126035854|NCT04436276|453429444|FG008|Overall Study|Protocol Violation|0|||
126035855|NCT04436276|453429445|FG009|Overall Study|Protocol Violation|0|||
126035856|NCT04436276|453429446|FG010|Overall Study|Protocol Violation|0|||
126266059|NCT01553747|454265127|FG001|Overall Study|Voluntarily withdrew|66|||
126266060|NCT01553747|454265128|FG002|Overall Study|Voluntarily withdrew|74|||
126266061|NCT01553747|454265126|FG000|Overall Study|Adverse event or SAE|32|||
126360398|NCT00147537|454610822|FG010|Phase 1b|Withdrawal by Subject|0|||
126360399|NCT00147537|454610812|FG000|Phase 1b|Randomized but not treated|0|||
126360400|NCT00147537|454610813|FG001|Phase 1b|Randomized but not treated|0|||
126360401|NCT00147537|454610814|FG002|Phase 1b|Randomized but not treated|0|||
126360402|NCT00147537|454610815|FG003|Phase 1b|Randomized but not treated|0|||
126360403|NCT00147537|454610816|FG004|Phase 1b|Randomized but not treated|0|||
126035857|NCT04436276|453429447|FG011|Overall Study|Protocol Violation|0|||
126035858|NCT04436276|453429448|FG012|Overall Study|Protocol Violation|0|||
126035859|NCT04436276|453429449|FG013|Overall Study|Protocol Violation|1|||
126035860|NCT04436276|453429450|FG014|Overall Study|Protocol Violation|0|||
126266062|NCT01553747|454265127|FG001|Overall Study|Adverse event or SAE|28|||
126035861|NCT04436276|453429451|FG015|Overall Study|Protocol Violation|1|||
126035862|NCT04436276|453429452|FG016|Overall Study|Protocol Violation|0|||
126035863|NCT04436276|453429453|FG017|Overall Study|Protocol Violation|0|||
126035864|NCT04436276|453429454|FG018|Overall Study|Protocol Violation|0|||
126266063|NCT01553747|454265128|FG002|Overall Study|Adverse event or SAE|19|||
126266064|NCT01553747|454265126|FG000|Overall Study|Physician decision: other|10|||
126266065|NCT01553747|454265127|FG001|Overall Study|Physician decision: other|8|||
126097980|NCT01119105|453651392|FG000|Overall Study|Lost to Follow-up|0|||
126097981|NCT01119105|453651393|FG001|Overall Study|Lost to Follow-up|2|||
126097982|NCT01119105|453651394|FG002|Overall Study|Lost to Follow-up|5|||
126097983|NCT01119105|453651392|FG000|Overall Study|Adverse Event|1|||
126097984|NCT01119105|453651393|FG001|Overall Study|Adverse Event|0|||
126266066|NCT01553747|454265128|FG002|Overall Study|Physician decision: other|7|||
126266067|NCT01553747|454265126|FG000|Overall Study|Lost to Follow-up|11|||
126266068|NCT01553747|454265127|FG001|Overall Study|Lost to Follow-up|5|||
126266069|NCT01553747|454265128|FG002|Overall Study|Lost to Follow-up|6|||
126266070|NCT01553747|454265126|FG000|Overall Study|Sponsor decision, specify|7|||
126266071|NCT01553747|454265127|FG001|Overall Study|Sponsor decision, specify|5|||
126266072|NCT01553747|454265128|FG002|Overall Study|Sponsor decision, specify|0|||
126266073|NCT01553747|454265126|FG000|Overall Study|Physician decision: lack of efficacy|1|||
126266074|NCT01553747|454265127|FG001|Overall Study|Physician decision: lack of efficacy|5|||
126266075|NCT01553747|454265128|FG002|Overall Study|Physician decision: lack of efficacy|3|||
126266076|NCT02010255|454265137|FG000|Overall Study|Death|0|||
126266077|NCT02010255|454265138|FG001|Overall Study|Death|1|||
126266078|NCT02010255|454265139|FG002|Overall Study|Death|4|||
126266079|NCT02010255|454265140|FG003|Overall Study|Death|4|||
126266080|NCT02010255|454265141|FG004|Overall Study|Death|2|||
126266081|NCT02010255|454265142|FG005|Overall Study|Death|0|||
126266082|NCT02010255|454265143|FG006|Overall Study|Death|1|||
126266083|NCT02010255|454265144|FG007|Overall Study|Death|1|||
126266084|NCT02010255|454265145|FG008|Overall Study|Death|1|||
126266085|NCT02010255|454265146|FG009|Overall Study|Death|0|||
126266086|NCT02010255|454265147|FG010|Overall Study|Death|1|||
126266087|NCT02010255|454265148|FG011|Overall Study|Death|1|||
126266088|NCT02010255|454265149|FG012|Overall Study|Death|0|||
126266089|NCT02010255|454265150|FG013|Overall Study|Death|0|||
126266090|NCT02010255|454265137|FG000|Overall Study|Lack of Efficacy|4|||
126266091|NCT02010255|454265138|FG001|Overall Study|Lack of Efficacy|1|||
126266092|NCT02010255|454265139|FG002|Overall Study|Lack of Efficacy|2|||
126266093|NCT02010255|454265140|FG003|Overall Study|Lack of Efficacy|1|||
126266094|NCT02010255|454265141|FG004|Overall Study|Lack of Efficacy|1|||
126266095|NCT02010255|454265142|FG005|Overall Study|Lack of Efficacy|0|||
126266096|NCT02010255|454265143|FG006|Overall Study|Lack of Efficacy|0|||
126266097|NCT02010255|454265144|FG007|Overall Study|Lack of Efficacy|0|||
126266098|NCT02010255|454265145|FG008|Overall Study|Lack of Efficacy|0|||
126266099|NCT02010255|454265146|FG009|Overall Study|Lack of Efficacy|0|||
126266100|NCT02010255|454265147|FG010|Overall Study|Lack of Efficacy|1|||
126266101|NCT02010255|454265148|FG011|Overall Study|Lack of Efficacy|0|||
126266102|NCT02010255|454265149|FG012|Overall Study|Lack of Efficacy|0|||
126266103|NCT02010255|454265150|FG013|Overall Study|Lack of Efficacy|0|||
126266104|NCT02010255|454265137|FG000|Overall Study|Withdrew Consent|1|||
126266105|NCT02010255|454265138|FG001|Overall Study|Withdrew Consent|0|||
126266106|NCT02010255|454265139|FG002|Overall Study|Withdrew Consent|0|||
126266107|NCT02010255|454265140|FG003|Overall Study|Withdrew Consent|1|||
126266108|NCT02010255|454265141|FG004|Overall Study|Withdrew Consent|0|||
126266109|NCT02010255|454265142|FG005|Overall Study|Withdrew Consent|0|||
126266110|NCT02010255|454265143|FG006|Overall Study|Withdrew Consent|0|||
126266111|NCT02010255|454265144|FG007|Overall Study|Withdrew Consent|0|||
126266112|NCT02010255|454265145|FG008|Overall Study|Withdrew Consent|0|||
126266113|NCT02010255|454265146|FG009|Overall Study|Withdrew Consent|0|||
126266114|NCT02010255|454265147|FG010|Overall Study|Withdrew Consent|0|||
126266115|NCT02010255|454265148|FG011|Overall Study|Withdrew Consent|0|||
126266116|NCT02010255|454265149|FG012|Overall Study|Withdrew Consent|0|||
126266117|NCT02010255|454265150|FG013|Overall Study|Withdrew Consent|0|||
126266118|NCT02010255|454265137|FG000|Overall Study|Adverse Event|1|||
126266119|NCT02010255|454265138|FG001|Overall Study|Adverse Event|0|||
126266120|NCT02010255|454265139|FG002|Overall Study|Adverse Event|0|||
126266121|NCT02010255|454265140|FG003|Overall Study|Adverse Event|0|||
126266122|NCT02010255|454265141|FG004|Overall Study|Adverse Event|0|||
126266123|NCT02010255|454265142|FG005|Overall Study|Adverse Event|0|||
126097985|NCT01119105|453651394|FG002|Overall Study|Adverse Event|1|||
126097986|NCT01119105|453651392|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
126097987|NCT01119105|453651393|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
126266124|NCT02010255|454265143|FG006|Overall Study|Adverse Event|0|||
126266125|NCT02010255|454265144|FG007|Overall Study|Adverse Event|0|||
126097988|NCT01119105|453651394|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
126266126|NCT02010255|454265145|FG008|Overall Study|Adverse Event|0|||
126266127|NCT02010255|454265146|FG009|Overall Study|Adverse Event|0|||
126266128|NCT02010255|454265147|FG010|Overall Study|Adverse Event|0|||
126266129|NCT02010255|454265148|FG011|Overall Study|Adverse Event|0|||
126266130|NCT02010255|454265149|FG012|Overall Study|Adverse Event|0|||
126266131|NCT02010255|454265150|FG013|Overall Study|Adverse Event|0|||
126266132|NCT02010255|454265137|FG000|Overall Study|Lost to Follow-up|0|||
126266133|NCT02010255|454265138|FG001|Overall Study|Lost to Follow-up|0|||
126266134|NCT02010255|454265139|FG002|Overall Study|Lost to Follow-up|1|||
126266135|NCT02010255|454265140|FG003|Overall Study|Lost to Follow-up|0|||
126266136|NCT02010255|454265141|FG004|Overall Study|Lost to Follow-up|1|||
126266137|NCT02010255|454265142|FG005|Overall Study|Lost to Follow-up|0|||
126266138|NCT02010255|454265143|FG006|Overall Study|Lost to Follow-up|0|||
126266139|NCT02010255|454265144|FG007|Overall Study|Lost to Follow-up|0|||
126266140|NCT02010255|454265145|FG008|Overall Study|Lost to Follow-up|0|||
126266141|NCT02010255|454265146|FG009|Overall Study|Lost to Follow-up|0|||
126266142|NCT02010255|454265147|FG010|Overall Study|Lost to Follow-up|0|||
126266143|NCT02010255|454265148|FG011|Overall Study|Lost to Follow-up|0|||
126035865|NCT04436276|453429455|FG019|Overall Study|Protocol Violation|0|||
126035866|NCT04436276|453429456|FG020|Overall Study|Protocol Violation|0|||
126035867|NCT04436276|453429457|FG021|Overall Study|Protocol Violation|0|||
126035868|NCT04436276|453429458|FG022|Overall Study|Protocol Violation|0|||
126035869|NCT04436276|453429436|FG000|Overall Study|Withdrawal by Subject|25|||
126035870|NCT04436276|453429437|FG001|Overall Study|Withdrawal by Subject|22|||
126035871|NCT04436276|453429438|FG002|Overall Study|Withdrawal by Subject|24|||
126035872|NCT04436276|453429439|FG003|Overall Study|Withdrawal by Subject|23|||
126035873|NCT04436276|453429440|FG004|Overall Study|Withdrawal by Subject|14|||
126035874|NCT04436276|453429441|FG005|Overall Study|Withdrawal by Subject|0|||
126035875|NCT04436276|453429442|FG006|Overall Study|Withdrawal by Subject|0|||
126035876|NCT04436276|453429443|FG007|Overall Study|Withdrawal by Subject|1|||
126035877|NCT04436276|453429444|FG008|Overall Study|Withdrawal by Subject|0|||
126035878|NCT04436276|453429445|FG009|Overall Study|Withdrawal by Subject|1|||
126035879|NCT04436276|453429446|FG010|Overall Study|Withdrawal by Subject|17|||
126035880|NCT04436276|453429447|FG011|Overall Study|Withdrawal by Subject|7|||
126035881|NCT04436276|453429448|FG012|Overall Study|Withdrawal by Subject|10|||
126035882|NCT04436276|453429449|FG013|Overall Study|Withdrawal by Subject|6|||
126035883|NCT04436276|453429450|FG014|Overall Study|Withdrawal by Subject|20|||
126035884|NCT04436276|453429451|FG015|Overall Study|Withdrawal by Subject|6|||
126035885|NCT04436276|453429452|FG016|Overall Study|Withdrawal by Subject|11|||
126035886|NCT04436276|453429453|FG017|Overall Study|Withdrawal by Subject|4|||
126035887|NCT04436276|453429454|FG018|Overall Study|Withdrawal by Subject|14|||
126035888|NCT04436276|453429455|FG019|Overall Study|Withdrawal by Subject|24|||
126035889|NCT04436276|453429456|FG020|Overall Study|Withdrawal by Subject|24|||
126035890|NCT04436276|453429457|FG021|Overall Study|Withdrawal by Subject|16|||
126035891|NCT04436276|453429458|FG022|Overall Study|Withdrawal by Subject|14|||
126035892|NCT04436276|453429436|FG000|Overall Study|Other|3|||
126035893|NCT04436276|453429437|FG001|Overall Study|Other|2|||
126035894|NCT04436276|453429438|FG002|Overall Study|Other|5|||
126035895|NCT04436276|453429439|FG003|Overall Study|Other|9|||
126035896|NCT04436276|453429440|FG004|Overall Study|Other|23|||
126035897|NCT04436276|453429441|FG005|Overall Study|Other|1|||
126035898|NCT04436276|453429442|FG006|Overall Study|Other|0|||
126035899|NCT04436276|453429443|FG007|Overall Study|Other|0|||
126035900|NCT04436276|453429444|FG008|Overall Study|Other|0|||
126035901|NCT04436276|453429445|FG009|Overall Study|Other|0|||
126035902|NCT04436276|453429446|FG010|Overall Study|Other|3|||
126035903|NCT04436276|453429447|FG011|Overall Study|Other|1|||
126035904|NCT04436276|453429448|FG012|Overall Study|Other|1|||
126035905|NCT04436276|453429449|FG013|Overall Study|Other|2|||
126035906|NCT04436276|453429450|FG014|Overall Study|Other|3|||
126035907|NCT04436276|453429451|FG015|Overall Study|Other|0|||
126035908|NCT04436276|453429452|FG016|Overall Study|Other|0|||
126035909|NCT04436276|453429453|FG017|Overall Study|Other|6|||
126035910|NCT04436276|453429454|FG018|Overall Study|Other|1|||
126035911|NCT04436276|453429455|FG019|Overall Study|Other|0|||
126035912|NCT04436276|453429456|FG020|Overall Study|Other|2|||
126035913|NCT04436276|453429457|FG021|Overall Study|Other|2|||
126035914|NCT04436276|453429458|FG022|Overall Study|Other|60|||
126035915|NCT05792085|453429461|FG000|Overall Study|Death|0|||
126035916|NCT05792085|453429462|FG001|Overall Study|Death|0|||
126035917|NCT05792085|453429463|FG002|Overall Study|Death|0|||
126035918|NCT05792085|453429464|FG003|Overall Study|Death|0|||
126035919|NCT05792085|453429465|FG004|Overall Study|Death|1|||
126035920|NCT04797897|453429473|FG000|Overall Study|Study Termination by Sponsor|1|||
126035921|NCT04797897|453429474|FG001|Overall Study|Study Termination by Sponsor|1|||
126035922|NCT03024437|453429485|FG000|Overall Study|Adverse Event|0|||
126035923|NCT03024437|453429486|FG001|Overall Study|Adverse Event|1|||
126035924|NCT03024437|453429487|FG002|Overall Study|Adverse Event|3|||
126035925|NCT03024437|453429488|FG003|Overall Study|Adverse Event|5|||
126035926|NCT03024437|453429489|FG004|Overall Study|Adverse Event|0|||
126035927|NCT03024437|453429485|FG000|Overall Study|Physician Decision|1|||
126035928|NCT03024437|453429486|FG001|Overall Study|Physician Decision|0|||
126035929|NCT03024437|453429487|FG002|Overall Study|Physician Decision|0|||
126035930|NCT03024437|453429488|FG003|Overall Study|Physician Decision|1|||
126035931|NCT03024437|453429489|FG004|Overall Study|Physician Decision|0|||
126035932|NCT03024437|453429485|FG000|Overall Study|Disease progression, relapse|1|||
126266144|NCT02010255|454265149|FG012|Overall Study|Lost to Follow-up|0|||
126035933|NCT03024437|453429486|FG001|Overall Study|Disease progression, relapse|0|||
126035934|NCT03024437|453429487|FG002|Overall Study|Disease progression, relapse|0|||
126266145|NCT02010255|454265150|FG013|Overall Study|Lost to Follow-up|0|||
126035935|NCT03024437|453429488|FG003|Overall Study|Disease progression, relapse|3|||
126035936|NCT03024437|453429489|FG004|Overall Study|Disease progression, relapse|0|||
126360404|NCT00147537|454610817|FG005|Phase 1b|Randomized but not treated|0|||
126097989|NCT01119105|453651392|FG000|Overall Study|Other|1|||
126097990|NCT01119105|453651393|FG001|Overall Study|Other|1|||
126097991|NCT01119105|453651394|FG002|Overall Study|Other|0|||
126097992|NCT04988867|453651398|FG000|Overall Study|Study terminated by Sponsor|12|||
126097993|NCT04988867|453651398|FG000|Overall Study|Adverse Event|2|||
126097994|NCT04988867|453651398|FG000|Overall Study|Study drug noncompliance|1|||
126097995|NCT00037830|453651399|FG000|Overall Study|Adverse Event|2|||
126097996|NCT00037830|453651400|FG001|Overall Study|Adverse Event|0|||
126097997|NCT00037830|453651401|FG002|Overall Study|Adverse Event|0|||
126097998|NCT00037830|453651399|FG000|Overall Study|Withdrawal by Subject|4|||
126097999|NCT00037830|453651400|FG001|Overall Study|Withdrawal by Subject|5|||
126098000|NCT00037830|453651401|FG002|Overall Study|Withdrawal by Subject|1|||
126098001|NCT00037830|453651399|FG000|Overall Study|Protocol Violation|2|||
126098002|NCT00037830|453651400|FG001|Overall Study|Protocol Violation|2|||
126098003|NCT00037830|453651401|FG002|Overall Study|Protocol Violation|0|||
126098004|NCT00037830|453651399|FG000|Overall Study|Unrelated Medical Problem|2|||
126098005|NCT00037830|453651400|FG001|Overall Study|Unrelated Medical Problem|0|||
126098006|NCT00037830|453651401|FG002|Overall Study|Unrelated Medical Problem|0|||
126098007|NCT01699503|453651402|FG000|Overall Study|Death|31|||
126098008|NCT01699503|453651403|FG001|Overall Study|Death|40|||
126098009|NCT01699503|453651402|FG000|Overall Study|Withdrawal by Subject|65|||
126098010|NCT01699503|453651403|FG001|Overall Study|Withdrawal by Subject|57|||
126098011|NCT01699503|453651402|FG000|Overall Study|Lost to Follow-up|121|||
126098012|NCT01699503|453651403|FG001|Overall Study|Lost to Follow-up|117|||
126098013|NCT01699503|453651402|FG000|Overall Study|Excluded due to quality|783|||
126098014|NCT01699503|453651403|FG001|Overall Study|Excluded due to quality|791|||
126098015|NCT01236534|453651408|FG000|Overall Study|Adverse Event|3|||
126098016|NCT01236534|453651409|FG001|Overall Study|Adverse Event|0|||
126098017|NCT01014143|453651410|FG000|Second Intervention|Lost to Follow-up|2|||
126098018|NCT01014143|453651411|FG001|Second Intervention|Lost to Follow-up|0|||
126098019|NCT01014143|453651412|FG002|Second Intervention|Lost to Follow-up|0|||
126098020|NCT04638920|453651417|FG000|Overall Study|Withdrawal by Subject|5|||
126098021|NCT03775434|453651418|FG000|Overall Study|Adverse Event|2|||
126098022|NCT03775434|453651418|FG000|Overall Study|Withdrawal by Subject|1|||
126360405|NCT00147537|454610818|FG006|Phase 1b|Randomized but not treated|1|||
126360406|NCT00147537|454610819|FG007|Phase 1b|Randomized but not treated|0|||
126360407|NCT00147537|454610820|FG008|Phase 1b|Randomized but not treated|1|||
126360408|NCT00147537|454610821|FG009|Phase 1b|Randomized but not treated|0|||
126360409|NCT00147537|454610822|FG010|Phase 1b|Randomized but not treated|0|||
126360410|NCT00147537|454610812|FG000|Phase 2|Death|0|||
126360411|NCT00147537|454610813|FG001|Phase 2|Death|0|||
126360412|NCT00147537|454610814|FG002|Phase 2|Death|0|||
126360413|NCT00147537|454610815|FG003|Phase 2|Death|0|||
126360414|NCT00147537|454610816|FG004|Phase 2|Death|0|||
126098023|NCT01871805|453651421|FG000|Phase I|Death|7|||
126098024|NCT01871805|453651422|FG001|Phase I|Death|4|||
126098025|NCT01871805|453651423|FG002|Phase I|Death|6|||
126098026|NCT01871805|453651424|FG003|Phase I|Death|2|||
126098027|NCT01871805|453651425|FG004|Phase I|Death|9|||
126098028|NCT01871805|453651426|FG005|Phase I|Death|0|||
126098029|NCT01871805|453651421|FG000|Phase I|Alive in Survival Follow-up|0|||
126098030|NCT01871805|453651422|FG001|Phase I|Alive in Survival Follow-up|2|||
126098031|NCT01871805|453651423|FG002|Phase I|Alive in Survival Follow-up|4|||
126098032|NCT01871805|453651424|FG003|Phase I|Alive in Survival Follow-up|5|||
126098033|NCT01871805|453651425|FG004|Phase I|Alive in Survival Follow-up|4|||
126098034|NCT01871805|453651426|FG005|Phase I|Alive in Survival Follow-up|0|||
126098035|NCT01871805|453651421|FG000|Phase I|Lost to Follow-up|0|||
126098036|NCT01871805|453651422|FG001|Phase I|Lost to Follow-up|1|||
126098037|NCT01871805|453651423|FG002|Phase I|Lost to Follow-up|3|||
126098038|NCT01871805|453651424|FG003|Phase I|Lost to Follow-up|0|||
126098039|NCT01871805|453651425|FG004|Phase I|Lost to Follow-up|0|||
126098040|NCT01871805|453651426|FG005|Phase I|Lost to Follow-up|0|||
126098041|NCT01871805|453651421|FG000|Phase II|Death|0|||
126098042|NCT01871805|453651422|FG001|Phase II|Death|0|||
126098043|NCT01871805|453651423|FG002|Phase II|Death|0|||
126098044|NCT01871805|453651424|FG003|Phase II|Death|0|||
126098045|NCT01871805|453651425|FG004|Phase II|Death|0|||
126098046|NCT01871805|453651426|FG005|Phase II|Death|45|||
126098047|NCT01871805|453651421|FG000|Phase II|Alive in Survival Follow-up|0|||
126360415|NCT00147537|454610817|FG005|Phase 2|Death|0|||
126360416|NCT00147537|454610818|FG006|Phase 2|Death|0|||
126360417|NCT00147537|454610819|FG007|Phase 2|Death|0|||
126360418|NCT00147537|454610820|FG008|Phase 2|Death|0|||
126098048|NCT01871805|453651422|FG001|Phase II|Alive in Survival Follow-up|0|||
126098049|NCT01871805|453651423|FG002|Phase II|Alive in Survival Follow-up|0|||
126098050|NCT01871805|453651424|FG003|Phase II|Alive in Survival Follow-up|0|||
126098051|NCT01871805|453651425|FG004|Phase II|Alive in Survival Follow-up|0|||
126098052|NCT01871805|453651426|FG005|Phase II|Alive in Survival Follow-up|29|||
126098053|NCT01871805|453651421|FG000|Phase II|Lost to Follow-up|0|||
126098054|NCT01871805|453651422|FG001|Phase II|Lost to Follow-up|0|||
126098055|NCT01871805|453651423|FG002|Phase II|Lost to Follow-up|0|||
126360419|NCT00147537|454610821|FG009|Phase 2|Death|85|||
126266146|NCT02010255|454265137|FG000|Overall Study|Randomized but Not Treated|0|||
126266147|NCT02010255|454265138|FG001|Overall Study|Randomized but Not Treated|0|||
126266148|NCT02010255|454265139|FG002|Overall Study|Randomized but Not Treated|0|||
126360420|NCT00147537|454610822|FG010|Phase 2|Death|31|||
126360421|NCT00147537|454610812|FG000|Phase 2|Lost to Follow-up|0|||
126035937|NCT03024437|453429485|FG000|Overall Study|Disease progression, refractory disease|4|||
126035938|NCT03024437|453429486|FG001|Overall Study|Disease progression, refractory disease|4|||
126266149|NCT02010255|454265140|FG003|Overall Study|Randomized but Not Treated|0|||
126266150|NCT02010255|454265141|FG004|Overall Study|Randomized but Not Treated|0|||
126266151|NCT02010255|454265142|FG005|Overall Study|Randomized but Not Treated|0|||
126266152|NCT02010255|454265143|FG006|Overall Study|Randomized but Not Treated|0|||
126266153|NCT02010255|454265144|FG007|Overall Study|Randomized but Not Treated|0|||
126266154|NCT02010255|454265145|FG008|Overall Study|Randomized but Not Treated|0|||
126266155|NCT02010255|454265146|FG009|Overall Study|Randomized but Not Treated|0|||
126266156|NCT02010255|454265147|FG010|Overall Study|Randomized but Not Treated|0|||
126266157|NCT02010255|454265148|FG011|Overall Study|Randomized but Not Treated|0|||
126266158|NCT02010255|454265149|FG012|Overall Study|Randomized but Not Treated|0|||
126266159|NCT02010255|454265150|FG013|Overall Study|Randomized but Not Treated|1|||
126266160|NCT01134627|454265151|FG000|Overall Study|Adverse Event|47|||
126266161|NCT01134627|454265152|FG001|Overall Study|Adverse Event|31|||
126266162|NCT01134627|454265151|FG000|Overall Study|Lost to Follow-up|1|||
126266163|NCT01134627|454265152|FG001|Overall Study|Lost to Follow-up|2|||
126266164|NCT01134627|454265151|FG000|Overall Study|Protocol Violation|3|||
126266165|NCT01134627|454265152|FG001|Overall Study|Protocol Violation|5|||
126266166|NCT01134627|454265151|FG000|Overall Study|Lack of Efficacy|2|||
126266167|NCT01134627|454265152|FG001|Overall Study|Lack of Efficacy|12|||
126266168|NCT01134627|454265151|FG000|Overall Study|Withdrawal by Subject|4|||
126266169|NCT01134627|454265152|FG001|Overall Study|Withdrawal by Subject|3|||
126266170|NCT01134627|454265151|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
126266171|NCT01134627|454265152|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
126266172|NCT01134627|454265151|FG000|Overall Study|Other|11|||
126266173|NCT01134627|454265152|FG001|Overall Study|Other|14|||
126266174|NCT00977431|454265158|FG000|Overall Study|Other than listed|1|||
126266175|NCT00977431|454265159|FG001|Overall Study|Other than listed|0|||
126266176|NCT00977431|454265160|FG002|Overall Study|Other than listed|0|||
126266177|NCT00977431|454265161|FG003|Overall Study|Other than listed|0|||
126266178|NCT00977431|454265162|FG004|Overall Study|Other than listed|2|||
126266179|NCT00977431|454265158|FG000|Overall Study|Protocol Violation|0|||
126266180|NCT00977431|454265159|FG001|Overall Study|Protocol Violation|0|||
126266181|NCT00977431|454265160|FG002|Overall Study|Protocol Violation|1|||
126266182|NCT00977431|454265161|FG003|Overall Study|Protocol Violation|0|||
126266183|NCT00977431|454265162|FG004|Overall Study|Protocol Violation|0|||
126266184|NCT00977431|454265158|FG000|Overall Study|Adverse Event|3|||
126266185|NCT00977431|454265159|FG001|Overall Study|Adverse Event|0|||
126266186|NCT00977431|454265160|FG002|Overall Study|Adverse Event|4|||
126266187|NCT00977431|454265161|FG003|Overall Study|Adverse Event|0|||
126266188|NCT00977431|454265162|FG004|Overall Study|Adverse Event|6|||
126266189|NCT00977431|454265158|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
126266190|NCT00977431|454265159|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
126035939|NCT03024437|453429487|FG002|Overall Study|Disease progression, refractory disease|2|||
126035940|NCT03024437|453429488|FG003|Overall Study|Disease progression, refractory disease|2|||
126035941|NCT03024437|453429489|FG004|Overall Study|Disease progression, refractory disease|1|||
126035942|NCT03024437|453429485|FG000|Overall Study|Newly diagnosed cancer|0|||
126035943|NCT03024437|453429486|FG001|Overall Study|Newly diagnosed cancer|0|||
126035944|NCT03024437|453429487|FG002|Overall Study|Newly diagnosed cancer|0|||
126035945|NCT03024437|453429488|FG003|Overall Study|Newly diagnosed cancer|1|||
126035946|NCT03024437|453429489|FG004|Overall Study|Newly diagnosed cancer|0|||
126035947|NCT03024437|453429485|FG000|Overall Study|Moved out of state|0|||
126035948|NCT03024437|453429486|FG001|Overall Study|Moved out of state|1|||
126035949|NCT03024437|453429487|FG002|Overall Study|Moved out of state|0|||
126035950|NCT03024437|453429488|FG003|Overall Study|Moved out of state|0|||
126035951|NCT03024437|453429489|FG004|Overall Study|Moved out of state|0|||
126035952|NCT03024437|453429485|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
126035953|NCT03024437|453429486|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
126266191|NCT00977431|454265160|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
126266192|NCT00977431|454265161|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
126266193|NCT00977431|454265162|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
126035954|NCT03024437|453429487|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
126035955|NCT03024437|453429488|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
126098056|NCT01871805|453651424|FG003|Phase II|Lost to Follow-up|0|||
126266194|NCT00977431|454265158|FG000|Overall Study|Progressive disease|2|||
126266195|NCT00977431|454265159|FG001|Overall Study|Progressive disease|6|||
126266196|NCT00977431|454265160|FG002|Overall Study|Progressive disease|1|||
126266197|NCT00977431|454265161|FG003|Overall Study|Progressive disease|3|||
126266198|NCT00977431|454265162|FG004|Overall Study|Progressive disease|5|||
126266199|NCT01010750|454265163|FG000|Second Intervention|Adverse Event|0|||
126098057|NCT01871805|453651425|FG004|Phase II|Lost to Follow-up|0|||
126098058|NCT01871805|453651426|FG005|Phase II|Lost to Follow-up|13|||
126098059|NCT03412747|453651429|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
126098060|NCT03412747|453651430|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
126098061|NCT03412747|453651431|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
126098062|NCT03412747|453651429|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
126098063|NCT03412747|453651430|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
126098064|NCT03412747|453651431|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
126098065|NCT03412747|453651429|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
126098066|NCT03412747|453651430|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
126098067|NCT03412747|453651431|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
126098068|NCT03412747|453651429|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
126098069|NCT03412747|453651430|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
126098070|NCT03412747|453651431|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
126098071|NCT03412747|453651429|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
126098072|NCT03412747|453651430|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
126098073|NCT03412747|453651431|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
126098074|NCT03412747|453651429|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
126098075|NCT03412747|453651430|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
126098076|NCT03412747|453651431|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
126098077|NCT03412747|453651429|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
126098078|NCT03412747|453651430|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
126098079|NCT03412747|453651431|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
126098080|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
126098081|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
126098082|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
126098083|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
126098084|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
126098085|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
126098086|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
126098087|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
126098088|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
126098089|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
126098090|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
126098091|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
126098092|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
126098093|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
126098094|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
126098095|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
126098096|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
126098097|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
126098098|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
126098099|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
126098100|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
126266200|NCT01010750|454265164|FG001|Second Intervention|Adverse Event|1|||
126266201|NCT01010750|454265165|FG002|Second Intervention|Adverse Event|0|||
126266202|NCT01010750|454265166|FG003|Second Intervention|Adverse Event|0|||
126266203|NCT01010750|454265167|FG004|Second Intervention|Adverse Event|0|||
126266204|NCT01010750|454265168|FG005|Second Intervention|Adverse Event|0|||
126266205|NCT02654587|454265169|FG000|Overall Study|patient alive at end of study|22|||
126266206|NCT02654587|454265170|FG001|Overall Study|patient alive at end of study|8|||
126266207|NCT02654587|454265169|FG000|Overall Study|Withdrawal by Subject|1|||
126266208|NCT02654587|454265170|FG001|Overall Study|Withdrawal by Subject|7|||
126266209|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
126266210|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
126266211|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
126266212|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
126266213|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
126266214|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
126266215|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
126266216|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
126266217|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
126266218|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
126266219|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Subject decision|1|||
126266220|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Subject decision|1|||
126266221|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
126266222|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
126266223|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
126266224|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
126266225|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
126266226|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
126266227|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
126266228|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
126266229|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
126266230|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
125880705|NCT00313014|452862596|FG001|Overall Study|Lost to Follow-up|6|||
125880706|NCT00313014|452862597|FG002|Overall Study|Lost to Follow-up|10|||
126035956|NCT03024437|453429489|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
126035957|NCT04625465|453429490|FG000|Overall Study|Lost to Follow-up|2|||
126035958|NCT04625465|453429491|FG001|Overall Study|Lost to Follow-up|2|||
126035959|NCT04625465|453429492|FG002|Overall Study|Lost to Follow-up|1|||
126035960|NCT04625465|453429493|FG003|Overall Study|Lost to Follow-up|0|||
126035961|NCT04625465|453429494|FG004|Overall Study|Lost to Follow-up|0|||
126035962|NCT04625465|453429495|FG005|Overall Study|Lost to Follow-up|2|||
126035963|NCT04625465|453429496|FG006|Overall Study|Lost to Follow-up|0|||
126035964|NCT04625465|453429497|FG007|Overall Study|Lost to Follow-up|0|||
126035965|NCT04625465|453429490|FG000|Overall Study|Death|1|||
126035966|NCT04625465|453429491|FG001|Overall Study|Death|0|||
126035967|NCT04625465|453429492|FG002|Overall Study|Death|0|||
126035968|NCT04625465|453429493|FG003|Overall Study|Death|0|||
126035969|NCT04625465|453429494|FG004|Overall Study|Death|0|||
126035970|NCT04625465|453429495|FG005|Overall Study|Death|0|||
126035971|NCT04625465|453429496|FG006|Overall Study|Death|0|||
126035972|NCT04625465|453429497|FG007|Overall Study|Death|0|||
126035973|NCT04625465|453429490|FG000|Overall Study|Withdrawal by Subject|1|||
126035974|NCT04625465|453429491|FG001|Overall Study|Withdrawal by Subject|0|||
126035975|NCT04625465|453429492|FG002|Overall Study|Withdrawal by Subject|4|||
126035976|NCT04625465|453429493|FG003|Overall Study|Withdrawal by Subject|4|||
126035977|NCT04625465|453429494|FG004|Overall Study|Withdrawal by Subject|4|||
126035978|NCT04625465|453429495|FG005|Overall Study|Withdrawal by Subject|0|||
126035979|NCT04625465|453429496|FG006|Overall Study|Withdrawal by Subject|0|||
126035980|NCT04625465|453429497|FG007|Overall Study|Withdrawal by Subject|0|||
126035981|NCT05566639|453429498|FG000|Overall Study|Adverse Event|1|||
126035982|NCT05566639|453429499|FG001|Overall Study|Adverse Event|1|||
126035983|NCT05566639|453429498|FG000|Overall Study|Serious Adverse Event|1|||
126035984|NCT05566639|453429499|FG001|Overall Study|Serious Adverse Event|3|||
126035985|NCT05566639|453429498|FG000|Overall Study|Death|44|||
126035986|NCT05566639|453429499|FG001|Overall Study|Death|45|||
126035987|NCT05566639|453429498|FG000|Overall Study|Lost to Follow-up|467|||
126035988|NCT05566639|453429499|FG001|Overall Study|Lost to Follow-up|461|||
126035989|NCT05566639|453429498|FG000|Overall Study|Physician Decision|45|||
126035990|NCT05566639|453429499|FG001|Overall Study|Physician Decision|44|||
126035991|NCT05566639|453429498|FG000|Overall Study|Protocol Deviation|4|||
126035992|NCT05566639|453429499|FG001|Overall Study|Protocol Deviation|4|||
126035993|NCT05566639|453429498|FG000|Overall Study|Withdrawal by Subject|277|||
126035994|NCT05566639|453429499|FG001|Overall Study|Withdrawal by Subject|271|||
126035995|NCT05566639|453429498|FG000|Overall Study|Other Than Specified|52|||
126035996|NCT05566639|453429499|FG001|Overall Study|Other Than Specified|64|||
126035997|NCT05239455|453429501|FG000|Overall Study|Adverse Event|1|||
126035998|NCT05239455|453429501|FG000|Overall Study|Sponsor Decision|5|||
126035999|NCT05239455|453429501|FG000|Overall Study|Incomplete Blood Collection|1|||
126036000|NCT02589522|453429502|FG000|Overall Study|Physician Decision|1|||
126036001|NCT02589522|453429503|FG001|Overall Study|Physician Decision|2|||
126036002|NCT02589522|453429504|FG002|Overall Study|Physician Decision|0|||
126036003|NCT02589522|453429502|FG000|Overall Study|Did not start treatment|1|||
126036004|NCT02589522|453429503|FG001|Overall Study|Did not start treatment|0|||
126036005|NCT02589522|453429504|FG002|Overall Study|Did not start treatment|0|||
126036006|NCT04159415|453429505|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126036007|NCT04159415|453429506|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126036008|NCT04159415|453429507|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126036009|NCT04159415|453429508|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126036010|NCT04159415|453429509|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126036011|NCT04159415|453429510|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126036012|NCT04159415|453429511|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
126036013|NCT04159415|453429512|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
126036014|NCT03800654|453429513|FG000|Overall Study|Time constraints|3|||
126036015|NCT03800654|453429514|FG001|Overall Study|Time constraints|3|||
126036016|NCT03800654|453429515|FG002|Overall Study|Time constraints|3|||
126036017|NCT03800654|453429513|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
126036018|NCT03800654|453429514|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
126036019|NCT03800654|453429515|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
126036020|NCT03800654|453429513|FG000|Overall Study|Lost to Follow-up|2|||
126036021|NCT03800654|453429514|FG001|Overall Study|Lost to Follow-up|1|||
126036022|NCT03800654|453429515|FG002|Overall Study|Lost to Follow-up|6|||
126360422|NCT00147537|454610813|FG001|Phase 2|Lost to Follow-up|0|||
125880707|NCT00313014|452862595|FG000|Overall Study|Administrative|9|||
126036023|NCT03800654|453429513|FG000|Overall Study|Medical Health Issue|0|||
126098101|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
126098102|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
126098103|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
126098104|NCT03412747|453651429|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
126098105|NCT03412747|453651430|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
126098106|NCT03412747|453651431|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
126098107|NCT00468104|453651432|FG000|First Intervention|Protocol Violation|2|||
126098108|NCT00468104|453651433|FG001|First Intervention|Protocol Violation|1|||
126098109|NCT00468104|453651432|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
126098110|NCT00468104|453651433|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
126098111|NCT00468104|453651432|FG000|First Intervention|died within 3 weeks|1|||
126098112|NCT00468104|453651433|FG001|First Intervention|died within 3 weeks|0|||
126098113|NCT00468104|453651432|FG000|First Intervention|malposition/blocked chest tube tube|2|||
126098114|NCT00468104|453651433|FG001|First Intervention|malposition/blocked chest tube tube|0|||
126098115|NCT00468104|453651432|FG000|First Intervention|large lung mass with minimal effusion|1|||
126098116|NCT00468104|453651433|FG001|First Intervention|large lung mass with minimal effusion|0|||
126098117|NCT00468104|453651432|FG000|First Intervention|associated prolonged pneumothorax|1|||
126098118|NCT00468104|453651433|FG001|First Intervention|associated prolonged pneumothorax|0|||
126098119|NCT00468104|453651432|FG000|First Intervention|trapped lung|1|||
126098120|NCT00468104|453651433|FG001|First Intervention|trapped lung|0|||
126098121|NCT00468104|453651432|FG000|Second Intervention|Withdrawal by Subject|5|||
126098122|NCT00468104|453651433|FG001|Second Intervention|Withdrawal by Subject|2|||
126098123|NCT00468104|453651432|FG000|Second Intervention|discarded for malposition of chest tube|0|||
126098124|NCT00468104|453651433|FG001|Second Intervention|discarded for malposition of chest tube|2|||
126098125|NCT00381615|453651436|FG000|Overall Study|Withdrawal by Subject|1|||
126098126|NCT00381615|453651437|FG001|Overall Study|Withdrawal by Subject|3|||
126098127|NCT00381615|453651438|FG002|Overall Study|Withdrawal by Subject|0|||
126098128|NCT00381615|453651439|FG003|Overall Study|Withdrawal by Subject|1|||
126098129|NCT00381615|453651436|FG000|Overall Study|Lost to Follow-up|3|||
126098130|NCT00381615|453651437|FG001|Overall Study|Lost to Follow-up|2|||
126098131|NCT00381615|453651438|FG002|Overall Study|Lost to Follow-up|0|||
126098132|NCT00381615|453651439|FG003|Overall Study|Lost to Follow-up|1|||
126098133|NCT00381615|453651436|FG000|Overall Study|Protocol Violation|0|||
126098134|NCT00381615|453651437|FG001|Overall Study|Protocol Violation|0|||
126098135|NCT00381615|453651438|FG002|Overall Study|Protocol Violation|1|||
126098136|NCT00381615|453651439|FG003|Overall Study|Protocol Violation|0|||
126098137|NCT00468559|453651445|FG000|Open-label Treatment Phase|Adverse Event|5|||
126098138|NCT00468559|453651446|FG001|Open-label Treatment Phase|Adverse Event|0|||
126098139|NCT00468559|453651447|FG002|Open-label Treatment Phase|Adverse Event|0|||
126098140|NCT00468559|453651445|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
126098141|NCT00468559|453651446|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
126098142|NCT00468559|453651447|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
126098143|NCT00468559|453651445|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
126098144|NCT00468559|453651446|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
126098145|NCT00468559|453651447|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
126098146|NCT00468559|453651445|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
126098147|NCT00468559|453651446|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
126098148|NCT00468559|453651447|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
126098149|NCT00468559|453651445|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
126098150|NCT00468559|453651446|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
126098151|NCT00468559|453651447|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
126098152|NCT00911768|453651449|FG000|Overall Study|Protocol Violation|5|||
126098153|NCT00911768|453651450|FG001|Overall Study|Protocol Violation|4|||
126098154|NCT00911768|453651449|FG000|Overall Study|Withdrawal by Subject|1|||
126098155|NCT00911768|453651450|FG001|Overall Study|Withdrawal by Subject|0|||
126098156|NCT03538301|453651453|FG000|Overall Study|Adverse Event|1|||
126098157|NCT03538301|453651454|FG001|Overall Study|Adverse Event|4|||
126266231|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
126266232|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
126266233|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
126266234|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
126266235|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
126266236|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
126266237|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
126266238|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
126098158|NCT03538301|453651455|FG002|Overall Study|Adverse Event|4|||
126098159|NCT03538301|453651453|FG000|Overall Study|Death|1|||
126098160|NCT03538301|453651454|FG001|Overall Study|Death|1|||
126098161|NCT03538301|453651455|FG002|Overall Study|Death|0|||
126098162|NCT03538301|453651453|FG000|Overall Study|Physician Decision|0|||
126098163|NCT03538301|453651454|FG001|Overall Study|Physician Decision|1|||
126098164|NCT03538301|453651455|FG002|Overall Study|Physician Decision|0|||
126036024|NCT03800654|453429514|FG001|Overall Study|Medical Health Issue|0|||
126036025|NCT03800654|453429515|FG002|Overall Study|Medical Health Issue|1|||
126266239|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
126266240|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
126266241|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
126266242|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
126266243|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
126266244|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
126036026|NCT03800654|453429513|FG000|Overall Study|Personal Issues|0|||
126036027|NCT03800654|453429514|FG001|Overall Study|Personal Issues|2|||
126036028|NCT03800654|453429515|FG002|Overall Study|Personal Issues|0|||
126036029|NCT03800654|453429513|FG000|Overall Study|Protocol Violation|0|||
126036030|NCT03800654|453429514|FG001|Overall Study|Protocol Violation|1|||
126036031|NCT03800654|453429515|FG002|Overall Study|Protocol Violation|0|||
126036032|NCT01799265|453429516|FG000|Overall Study|Lost to Follow-up|1|||
126036033|NCT01799265|453429517|FG001|Overall Study|Lost to Follow-up|0|||
126036034|NCT01799265|453429516|FG000|Overall Study|Protocol Violation|2|||
126036035|NCT01799265|453429517|FG001|Overall Study|Protocol Violation|1|||
126036036|NCT01799265|453429516|FG000|Overall Study|inadequate sleep study|0|||
126266245|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
126266246|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
126266247|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
126266248|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
126266249|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
126036037|NCT01799265|453429517|FG001|Overall Study|inadequate sleep study|2|||
126036038|NCT03459729|453429518|FG000|Overall Study|Physician Decision|2|||
126036039|NCT02364557|453429522|FG000|Overall Study|Protocol Violation|3|||
126036040|NCT02364557|453429523|FG001|Overall Study|Protocol Violation|1|||
126036041|NCT04200456|453429525|FG000|Overall Study|Physician Decision|0|||
126036042|NCT04200456|453429526|FG001|Overall Study|Physician Decision|1|||
126036043|NCT04200456|453429525|FG000|Overall Study|Withdrawal by Subject|2|||
126036044|NCT04200456|453429526|FG001|Overall Study|Withdrawal by Subject|2|||
126036045|NCT04200456|453429525|FG000|Overall Study|Lack of Efficacy|1|||
126036046|NCT04200456|453429526|FG001|Overall Study|Lack of Efficacy|1|||
126036047|NCT04200456|453429525|FG000|Overall Study|Adverse event, non-fatal|0|||
126036048|NCT04200456|453429526|FG001|Overall Study|Adverse event, non-fatal|1|||
126036049|NCT04200456|453429525|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
126036050|NCT04200456|453429526|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
126036051|NCT04828005|453429527|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
126036052|NCT04828005|453429528|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
126036053|NCT04828005|453429529|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
126036054|NCT04828005|453429530|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
126036055|NCT04828005|453429527|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
126036056|NCT04828005|453429528|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
126036057|NCT04828005|453429529|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
126036058|NCT04828005|453429530|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
126036059|NCT04828005|453429527|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
126036060|NCT04828005|453429528|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
126036061|NCT04828005|453429529|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
126036062|NCT04828005|453429530|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
126036063|NCT04828005|453429527|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
126036064|NCT04828005|453429528|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
126036065|NCT04828005|453429529|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
126036066|NCT04828005|453429530|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
126266250|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
126036067|NCT04828005|453429527|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
126036068|NCT04828005|453429528|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
126036069|NCT04828005|453429529|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
126036070|NCT04828005|453429530|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
126036071|NCT04828005|453429527|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
126036072|NCT04828005|453429528|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
126036073|NCT04828005|453429529|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
126036074|NCT04828005|453429530|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
126266251|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
126266252|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
126266253|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
126266254|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
126266255|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
126266256|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
126266257|NCT00567476|454265178|FG000|Overall Study|Adverse Event|2|||
126266258|NCT00567476|454265179|FG001|Overall Study|Adverse Event|0|||
126266259|NCT00567476|454265178|FG000|Overall Study|Pregnancy|1|||
126266260|NCT00567476|454265179|FG001|Overall Study|Pregnancy|0|||
126266261|NCT00567476|454265178|FG000|Overall Study|Protocol Violation|4|||
126266262|NCT00567476|454265179|FG001|Overall Study|Protocol Violation|1|||
126266263|NCT00567476|454265178|FG000|Overall Study|Lost to Follow-up|0|||
126266264|NCT00567476|454265179|FG001|Overall Study|Lost to Follow-up|1|||
126266265|NCT00567476|454265178|FG000|Overall Study|Administrative issues|1|||
126266266|NCT00567476|454265179|FG001|Overall Study|Administrative issues|0|||
126266267|NCT00567476|454265178|FG000|Overall Study|Medical Decision|0|||
126266268|NCT00567476|454265179|FG001|Overall Study|Medical Decision|1|||
126266269|NCT00567476|454265178|FG000|Overall Study|Non-adherence to protocol|0|||
126266270|NCT00567476|454265179|FG001|Overall Study|Non-adherence to protocol|1|||
126266271|NCT02696031|454265180|FG000|Up to Week 24|Adverse Event|2|||
126266272|NCT02696031|454265181|FG001|Up to Week 24|Adverse Event|4|||
126266273|NCT02696031|454265182|FG002|Up to Week 24|Adverse Event|2|||
126266274|NCT02696031|454265183|FG003|Up to Week 24|Adverse Event|0|||
126266275|NCT02696031|454265184|FG004|Up to Week 24|Adverse Event|0|||
126266276|NCT02696031|454265185|FG005|Up to Week 24|Adverse Event|0|||
126266277|NCT02696031|454265180|FG000|Up to Week 24|Lack of Efficacy|2|||
126266278|NCT02696031|454265181|FG001|Up to Week 24|Lack of Efficacy|1|||
126266279|NCT02696031|454265182|FG002|Up to Week 24|Lack of Efficacy|2|||
126266280|NCT02696031|454265183|FG003|Up to Week 24|Lack of Efficacy|0|||
126266281|NCT02696031|454265184|FG004|Up to Week 24|Lack of Efficacy|0|||
126266282|NCT02696031|454265185|FG005|Up to Week 24|Lack of Efficacy|0|||
126266283|NCT02696031|454265180|FG000|Up to Week 24|Lost to Follow-up|0|||
126266284|NCT02696031|454265181|FG001|Up to Week 24|Lost to Follow-up|1|||
126036075|NCT04828005|453429527|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
126036076|NCT04828005|453429528|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
126036077|NCT04828005|453429529|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
126036078|NCT04828005|453429530|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
126036079|NCT04828005|453429527|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
126036080|NCT04828005|453429528|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
126036081|NCT04828005|453429529|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
126036082|NCT04828005|453429530|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
126036083|NCT04828005|453429527|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
126036084|NCT04828005|453429528|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
126036085|NCT04828005|453429529|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
126266285|NCT02696031|454265182|FG002|Up to Week 24|Lost to Follow-up|1|||
126266286|NCT02696031|454265183|FG003|Up to Week 24|Lost to Follow-up|0|||
126266287|NCT02696031|454265184|FG004|Up to Week 24|Lost to Follow-up|0|||
126266288|NCT02696031|454265185|FG005|Up to Week 24|Lost to Follow-up|0|||
126266289|NCT02696031|454265180|FG000|Up to Week 24|Physician Decision|1|||
126266290|NCT02696031|454265181|FG001|Up to Week 24|Physician Decision|0|||
126266291|NCT02696031|454265182|FG002|Up to Week 24|Physician Decision|1|||
126036086|NCT04828005|453429530|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
126036087|NCT02043678|453430886|FG000|Overall Study|Never treated|11|||
126036088|NCT02043678|453430887|FG001|Overall Study|Never treated|9|||
126036089|NCT02043678|453430886|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
126036090|NCT02043678|453430887|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
126036091|NCT02043678|453430886|FG000|Overall Study|AE without clinical PD|54|||
126036092|NCT02043678|453430887|FG001|Overall Study|AE without clinical PD|36|||
126266292|NCT02696031|454265183|FG003|Up to Week 24|Physician Decision|0|||
126266293|NCT02696031|454265184|FG004|Up to Week 24|Physician Decision|0|||
126266294|NCT02696031|454265185|FG005|Up to Week 24|Physician Decision|0|||
126266295|NCT02696031|454265180|FG000|Up to Week 24|Protocol Violation|1|||
126266296|NCT02696031|454265181|FG001|Up to Week 24|Protocol Violation|0|||
126266297|NCT02696031|454265182|FG002|Up to Week 24|Protocol Violation|0|||
126360423|NCT00147537|454610814|FG002|Phase 2|Lost to Follow-up|0|||
126360424|NCT00147537|454610815|FG003|Phase 2|Lost to Follow-up|0|||
126360425|NCT00147537|454610816|FG004|Phase 2|Lost to Follow-up|0|||
126360426|NCT00147537|454610817|FG005|Phase 2|Lost to Follow-up|0|||
126036093|NCT02043678|453430886|FG000|Overall Study|Lost to Follow-up|1|||
126036094|NCT02043678|453430887|FG001|Overall Study|Lost to Follow-up|1|||
126036095|NCT02043678|453430886|FG000|Overall Study|Other|10|||
126036096|NCT02043678|453430887|FG001|Overall Study|Other|14|||
126036097|NCT02043678|453430886|FG000|Overall Study|Clinical PD|114|||
126266298|NCT02696031|454265183|FG003|Up to Week 24|Protocol Violation|0|||
126266299|NCT02696031|454265184|FG004|Up to Week 24|Protocol Violation|0|||
126266300|NCT02696031|454265185|FG005|Up to Week 24|Protocol Violation|0|||
126266301|NCT02696031|454265180|FG000|Up to Week 24|Withdrawal by Subject|4|||
126266302|NCT02696031|454265181|FG001|Up to Week 24|Withdrawal by Subject|1|||
126360427|NCT00147537|454610818|FG006|Phase 2|Lost to Follow-up|0|||
126266303|NCT02696031|454265182|FG002|Up to Week 24|Withdrawal by Subject|5|||
126266304|NCT02696031|454265183|FG003|Up to Week 24|Withdrawal by Subject|0|||
126266305|NCT02696031|454265184|FG004|Up to Week 24|Withdrawal by Subject|0|||
126266306|NCT02696031|454265185|FG005|Up to Week 24|Withdrawal by Subject|0|||
126266307|NCT02696031|454265180|FG000|Up to Week 52|Adverse Event|4|||
126266308|NCT02696031|454265181|FG001|Up to Week 52|Adverse Event|5|||
126266309|NCT02696031|454265182|FG002|Up to Week 52|Adverse Event|3|||
126266310|NCT02696031|454265183|FG003|Up to Week 52|Adverse Event|0|||
126266311|NCT02696031|454265184|FG004|Up to Week 52|Adverse Event|0|||
126266312|NCT02696031|454265185|FG005|Up to Week 52|Adverse Event|0|||
126098165|NCT03538301|453651453|FG000|Overall Study|Protocol Violation|0|||
126098166|NCT03538301|453651454|FG001|Overall Study|Protocol Violation|0|||
126098167|NCT03538301|453651455|FG002|Overall Study|Protocol Violation|1|||
126098168|NCT03538301|453651453|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
126098169|NCT03538301|453651454|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
126098170|NCT03538301|453651455|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
126098171|NCT02842151|453651458|FG000|Overall Study|Adverse Event|1|||
126098172|NCT02842151|453651458|FG000|Overall Study|Subject moved too far away|1|||
126098173|NCT01879553|453651459|FG000|Overall Study|Withdrawal by Subject|1|||
126098174|NCT01879553|453651460|FG001|Overall Study|Withdrawal by Subject|0|||
126098175|NCT02559895|453651462|FG000|Overall Study|Adverse Event|3|||
126098176|NCT02559895|453651463|FG001|Overall Study|Adverse Event|3|||
126098177|NCT02559895|453651464|FG002|Overall Study|Adverse Event|2|||
126098178|NCT02559895|453651465|FG003|Overall Study|Adverse Event|1|||
126098179|NCT02559895|453651462|FG000|Overall Study|Lack of Efficacy|2|||
126098180|NCT02559895|453651463|FG001|Overall Study|Lack of Efficacy|3|||
126098181|NCT02559895|453651464|FG002|Overall Study|Lack of Efficacy|2|||
126098182|NCT02559895|453651465|FG003|Overall Study|Lack of Efficacy|8|||
126098183|NCT02559895|453651462|FG000|Overall Study|Lost to Follow-up|22|||
126098184|NCT02559895|453651463|FG001|Overall Study|Lost to Follow-up|16|||
126098185|NCT02559895|453651464|FG002|Overall Study|Lost to Follow-up|12|||
126098186|NCT02559895|453651465|FG003|Overall Study|Lost to Follow-up|17|||
126098187|NCT02559895|453651462|FG000|Overall Study|Physician Decision|1|||
126098188|NCT02559895|453651463|FG001|Overall Study|Physician Decision|1|||
126098189|NCT02559895|453651464|FG002|Overall Study|Physician Decision|3|||
126098190|NCT02559895|453651465|FG003|Overall Study|Physician Decision|0|||
126098191|NCT02559895|453651462|FG000|Overall Study|Withdrawal by Subject|16|||
126098192|NCT02559895|453651463|FG001|Overall Study|Withdrawal by Subject|9|||
126098193|NCT02559895|453651464|FG002|Overall Study|Withdrawal by Subject|20|||
126098194|NCT02559895|453651465|FG003|Overall Study|Withdrawal by Subject|9|||
126098195|NCT02559895|453651462|FG000|Overall Study|Study Burden|10|||
126098196|NCT02559895|453651463|FG001|Overall Study|Study Burden|16|||
126098197|NCT02559895|453651464|FG002|Overall Study|Study Burden|12|||
126098198|NCT02559895|453651465|FG003|Overall Study|Study Burden|22|||
126266313|NCT02696031|454265180|FG000|Up to Week 52|Lack of Efficacy|10|||
126266314|NCT02696031|454265181|FG001|Up to Week 52|Lack of Efficacy|7|||
126266315|NCT02696031|454265182|FG002|Up to Week 52|Lack of Efficacy|11|||
126266316|NCT02696031|454265183|FG003|Up to Week 52|Lack of Efficacy|0|||
126266317|NCT02696031|454265184|FG004|Up to Week 52|Lack of Efficacy|0|||
126266318|NCT02696031|454265185|FG005|Up to Week 52|Lack of Efficacy|0|||
126266319|NCT02696031|454265180|FG000|Up to Week 52|Lost to Follow-up|1|||
126266320|NCT02696031|454265181|FG001|Up to Week 52|Lost to Follow-up|1|||
126098199|NCT02559895|453651462|FG000|Overall Study|Other|1|||
126098200|NCT02559895|453651463|FG001|Overall Study|Other|5|||
126098201|NCT02559895|453651464|FG002|Overall Study|Other|3|||
126098202|NCT02559895|453651465|FG003|Overall Study|Other|3|||
126098203|NCT04540887|453651471|FG000|Overall Study|Withdrawal by Subject|2|||
126098204|NCT01262027|453651472|FG000|Overall Study|Adverse Event|1|||
126098205|NCT01262027|453651472|FG000|Overall Study|Withdrawal by Subject|3|||
126098206|NCT01262027|453651472|FG000|Overall Study|Protocol Violation|1|||
126266321|NCT02696031|454265182|FG002|Up to Week 52|Lost to Follow-up|1|||
126266322|NCT02696031|454265183|FG003|Up to Week 52|Lost to Follow-up|0|||
126266323|NCT02696031|454265184|FG004|Up to Week 52|Lost to Follow-up|0|||
126266324|NCT02696031|454265185|FG005|Up to Week 52|Lost to Follow-up|0|||
126266325|NCT02696031|454265180|FG000|Up to Week 52|Physician Decision|1|||
126098207|NCT02665338|453651473|FG000|Overall Study|Withdrawal by Subject|0|||
126098208|NCT02665338|453651474|FG001|Overall Study|Withdrawal by Subject|1|||
126098209|NCT00935818|453651475|FG000|Overall Study|Withdrawal by Subject|45|||
126098210|NCT00935818|453651476|FG001|Overall Study|Withdrawal by Subject|50|||
126098211|NCT00935818|453651475|FG000|Overall Study|Lost to Follow-up|40|||
126098212|NCT00935818|453651476|FG001|Overall Study|Lost to Follow-up|42|||
126098213|NCT00935818|453651475|FG000|Overall Study|Adverse Event|6|||
126098214|NCT00935818|453651476|FG001|Overall Study|Adverse Event|7|||
126098215|NCT00935818|453651475|FG000|Overall Study|Physician Decision|0|||
126098216|NCT00935818|453651476|FG001|Overall Study|Physician Decision|1|||
126266326|NCT02696031|454265181|FG001|Up to Week 52|Physician Decision|1|||
126266327|NCT02696031|454265182|FG002|Up to Week 52|Physician Decision|2|||
126266328|NCT02696031|454265183|FG003|Up to Week 52|Physician Decision|0|||
126266329|NCT02696031|454265184|FG004|Up to Week 52|Physician Decision|0|||
126098217|NCT02317432|453651477|FG000|Overall Study|Death|4|||
126098218|NCT02317432|453651478|FG001|Overall Study|Death|1|||
126098219|NCT02317432|453651477|FG000|Overall Study|Lost to Follow-up|0|||
126098220|NCT02317432|453651478|FG001|Overall Study|Lost to Follow-up|5|||
126098221|NCT02317432|453651477|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
126098222|NCT02317432|453651478|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
126098223|NCT03992846|453651483|FG000|Overall Study|Adverse Event|8|||
126098224|NCT03992846|453651484|FG001|Overall Study|Adverse Event|6|||
126098225|NCT03992846|453651485|FG002|Overall Study|Adverse Event|3|||
126098226|NCT03992846|453651483|FG000|Overall Study|Lost to Follow-up|0|||
126098227|NCT03992846|453651484|FG001|Overall Study|Lost to Follow-up|1|||
126098228|NCT03992846|453651485|FG002|Overall Study|Lost to Follow-up|1|||
126098229|NCT03992846|453651483|FG000|Overall Study|Pregnancy|2|||
126098230|NCT03992846|453651484|FG001|Overall Study|Pregnancy|0|||
126098231|NCT03992846|453651485|FG002|Overall Study|Pregnancy|1|||
126098232|NCT03992846|453651483|FG000|Overall Study|Protocol Violation|1|||
126098233|NCT03992846|453651484|FG001|Overall Study|Protocol Violation|2|||
126266330|NCT02696031|454265185|FG005|Up to Week 52|Physician Decision|0|||
126266331|NCT02696031|454265180|FG000|Up to Week 52|Pregnancy|0|||
126266332|NCT02696031|454265181|FG001|Up to Week 52|Pregnancy|2|||
126266333|NCT02696031|454265182|FG002|Up to Week 52|Pregnancy|0|||
126266334|NCT02696031|454265183|FG003|Up to Week 52|Pregnancy|0|||
126266335|NCT02696031|454265184|FG004|Up to Week 52|Pregnancy|0|||
126266336|NCT02696031|454265185|FG005|Up to Week 52|Pregnancy|0|||
126266337|NCT02696031|454265180|FG000|Up to Week 52|Protocol Violation|1|||
126266338|NCT02696031|454265181|FG001|Up to Week 52|Protocol Violation|0|||
126266339|NCT02696031|454265182|FG002|Up to Week 52|Protocol Violation|0|||
126266340|NCT02696031|454265183|FG003|Up to Week 52|Protocol Violation|0|||
126266341|NCT02696031|454265184|FG004|Up to Week 52|Protocol Violation|0|||
126266342|NCT02696031|454265185|FG005|Up to Week 52|Protocol Violation|0|||
126266343|NCT02696031|454265180|FG000|Up to Week 52|Withdrawal by Subject|12|||
126266344|NCT02696031|454265181|FG001|Up to Week 52|Withdrawal by Subject|3|||
126266345|NCT02696031|454265182|FG002|Up to Week 52|Withdrawal by Subject|9|||
126266346|NCT02696031|454265183|FG003|Up to Week 52|Withdrawal by Subject|0|||
126266347|NCT02696031|454265184|FG004|Up to Week 52|Withdrawal by Subject|0|||
126266348|NCT02696031|454265185|FG005|Up to Week 52|Withdrawal by Subject|0|||
126266349|NCT02696031|454265180|FG000|Up to Week 104|Pregnancy|0|||
126266350|NCT02696031|454265181|FG001|Up to Week 104|Pregnancy|2|||
126266351|NCT02696031|454265182|FG002|Up to Week 104|Pregnancy|1|||
126266352|NCT02696031|454265183|FG003|Up to Week 104|Pregnancy|0|||
126266353|NCT02696031|454265184|FG004|Up to Week 104|Pregnancy|0|||
126266354|NCT02696031|454265185|FG005|Up to Week 104|Pregnancy|0|||
126266355|NCT02696031|454265180|FG000|Up to Week 104|Withdrawal by Subject|15|||
126266356|NCT02696031|454265181|FG001|Up to Week 104|Withdrawal by Subject|10|||
126266357|NCT02696031|454265182|FG002|Up to Week 104|Withdrawal by Subject|16|||
126266358|NCT02696031|454265183|FG003|Up to Week 104|Withdrawal by Subject|0|||
126266359|NCT02696031|454265184|FG004|Up to Week 104|Withdrawal by Subject|0|||
126266360|NCT02696031|454265185|FG005|Up to Week 104|Withdrawal by Subject|0|||
126266361|NCT02696031|454265180|FG000|Up to Week 104|Protocol Violation|1|||
126266362|NCT02696031|454265181|FG001|Up to Week 104|Protocol Violation|0|||
126266363|NCT02696031|454265182|FG002|Up to Week 104|Protocol Violation|0|||
126266364|NCT02696031|454265183|FG003|Up to Week 104|Protocol Violation|0|||
126266365|NCT02696031|454265184|FG004|Up to Week 104|Protocol Violation|0|||
126266366|NCT02696031|454265185|FG005|Up to Week 104|Protocol Violation|0|||
126266367|NCT02696031|454265180|FG000|Up to Week 104|Physician Decision|1|||
126266368|NCT02696031|454265181|FG001|Up to Week 104|Physician Decision|2|||
126266369|NCT02696031|454265182|FG002|Up to Week 104|Physician Decision|3|||
126266370|NCT02696031|454265183|FG003|Up to Week 104|Physician Decision|0|||
126266371|NCT02696031|454265184|FG004|Up to Week 104|Physician Decision|0|||
126266372|NCT02696031|454265185|FG005|Up to Week 104|Physician Decision|0|||
126098234|NCT03992846|453651485|FG002|Overall Study|Protocol Violation|0|||
126098235|NCT03992846|453651483|FG000|Overall Study|Withdrawal by Subject|8|||
126098236|NCT03992846|453651484|FG001|Overall Study|Withdrawal by Subject|10|||
126098237|NCT03992846|453651485|FG002|Overall Study|Withdrawal by Subject|20|||
126266373|NCT02696031|454265180|FG000|Up to Week 104|Lost to Follow-up|2|||
126266374|NCT02696031|454265181|FG001|Up to Week 104|Lost to Follow-up|3|||
126266375|NCT02696031|454265182|FG002|Up to Week 104|Lost to Follow-up|1|||
126266376|NCT02696031|454265183|FG003|Up to Week 104|Lost to Follow-up|0|||
126266377|NCT02696031|454265184|FG004|Up to Week 104|Lost to Follow-up|0|||
126266378|NCT02696031|454265185|FG005|Up to Week 104|Lost to Follow-up|0|||
126266379|NCT02696031|454265180|FG000|Up to Week 104|Lack of Efficacy|13|||
126266380|NCT02696031|454265181|FG001|Up to Week 104|Lack of Efficacy|12|||
126266381|NCT02696031|454265182|FG002|Up to Week 104|Lack of Efficacy|11|||
126266382|NCT02696031|454265183|FG003|Up to Week 104|Lack of Efficacy|0|||
126266383|NCT02696031|454265184|FG004|Up to Week 104|Lack of Efficacy|0|||
126266384|NCT02696031|454265185|FG005|Up to Week 104|Lack of Efficacy|0|||
126266385|NCT02696031|454265180|FG000|Up to Week 104|Adverse Event|7|||
126266386|NCT02696031|454265181|FG001|Up to Week 104|Adverse Event|11|||
126266387|NCT02696031|454265182|FG002|Up to Week 104|Adverse Event|5|||
126266388|NCT02696031|454265183|FG003|Up to Week 104|Adverse Event|0|||
126266389|NCT02696031|454265184|FG004|Up to Week 104|Adverse Event|0|||
126266390|NCT02696031|454265185|FG005|Up to Week 104|Adverse Event|0|||
126036098|NCT02043678|453430887|FG001|Overall Study|Clinical PD|148|||
126036099|NCT02043678|453430886|FG000|Overall Study|Radiological PD|100|||
126036100|NCT02043678|453430887|FG001|Overall Study|Radiological PD|90|||
126036101|NCT02043678|453430886|FG000|Overall Study|Protocol-driven decision point|59|||
126036102|NCT02043678|453430887|FG001|Overall Study|Protocol-driven decision point|58|||
126036103|NCT02043678|453430886|FG000|Overall Study|Withdrawal by Subject|16|||
126036104|NCT02043678|453430887|FG001|Overall Study|Withdrawal by Subject|20|||
126036105|NCT02043678|453430886|FG000|Overall Study|Protocol Violation|1|||
126036106|NCT02043678|453430887|FG001|Overall Study|Protocol Violation|0|||
126036107|NCT02043678|453430886|FG000|Overall Study|Deterioration of general conditions|1|||
126036108|NCT02043678|453430887|FG001|Overall Study|Deterioration of general conditions|1|||
126036109|NCT02043678|453430886|FG000|Overall Study|Logistical difficulties|2|||
126036110|NCT02043678|453430887|FG001|Overall Study|Logistical difficulties|0|||
126036111|NCT02043678|453430886|FG000|Overall Study|Non-compliance with study drug|3|||
126036112|NCT02043678|453430887|FG001|Overall Study|Non-compliance with study drug|1|||
126036113|NCT02043678|453430886|FG000|Overall Study|Physician Decision|4|||
126036114|NCT02043678|453430887|FG001|Overall Study|Physician Decision|3|||
126036115|NCT02043678|453430886|FG000|Overall Study|Subject decision|0|||
126036116|NCT02043678|453430887|FG001|Overall Study|Subject decision|1|||
126036117|NCT02043678|453430886|FG000|Overall Study|Switching to other therapy|3|||
126036118|NCT02043678|453430887|FG001|Overall Study|Switching to other therapy|2|||
126036119|NCT02043678|453430886|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
126036120|NCT02043678|453430887|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
126036121|NCT02043678|453430886|FG000|Overall Study|Missing|1|||
126036122|NCT02043678|453430887|FG001|Overall Study|Missing|0|||
126036123|NCT02043678|453430886|FG000|Overall Study|Adverse Event|0|||
126036124|NCT02043678|453430887|FG001|Overall Study|Adverse Event|1|||
126036125|NCT05543629|453430888|FG000|Overall Study|Death|1|||
126036126|NCT05543629|453430889|FG001|Overall Study|Death|0|||
126036127|NCT05543629|453430890|FG002|Overall Study|Death|1|||
126036128|NCT05543629|453430891|FG003|Overall Study|Death|0|||
126036129|NCT05543629|453430892|FG004|Overall Study|Death|0|||
126036130|NCT05543629|453430893|FG005|Overall Study|Death|1|||
126036131|NCT05543629|453430894|FG006|Overall Study|Death|2|||
126036132|NCT05543629|453430895|FG007|Overall Study|Death|2|||
126036133|NCT05543629|453430888|FG000|Overall Study|Other Reasons|0|||
126036134|NCT05543629|453430889|FG001|Overall Study|Other Reasons|0|||
126036135|NCT05543629|453430890|FG002|Overall Study|Other Reasons|0|||
126036136|NCT05543629|453430891|FG003|Overall Study|Other Reasons|0|||
126036137|NCT05543629|453430892|FG004|Overall Study|Other Reasons|1|||
126036138|NCT05543629|453430893|FG005|Overall Study|Other Reasons|0|||
126036139|NCT05543629|453430894|FG006|Overall Study|Other Reasons|0|||
126036140|NCT05543629|453430895|FG007|Overall Study|Other Reasons|0|||
126036141|NCT05543629|453430888|FG000|Overall Study|Physician Decision|0|||
126036142|NCT05543629|453430889|FG001|Overall Study|Physician Decision|0|||
126036143|NCT05543629|453430890|FG002|Overall Study|Physician Decision|3|||
126036144|NCT05543629|453430891|FG003|Overall Study|Physician Decision|0|||
126036145|NCT05543629|453430892|FG004|Overall Study|Physician Decision|0|||
126036146|NCT05543629|453430893|FG005|Overall Study|Physician Decision|0|||
126036147|NCT05543629|453430894|FG006|Overall Study|Physician Decision|1|||
126036148|NCT05543629|453430895|FG007|Overall Study|Physician Decision|0|||
126036149|NCT05543629|453430888|FG000|Overall Study|Study terminated by Sponsor|1|||
126036150|NCT05543629|453430889|FG001|Overall Study|Study terminated by Sponsor|0|||
126036151|NCT05543629|453430890|FG002|Overall Study|Study terminated by Sponsor|0|||
126266391|NCT02696031|454265180|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126360428|NCT00147537|454610819|FG007|Phase 2|Lost to Follow-up|0|||
126036152|NCT05543629|453430891|FG003|Overall Study|Study terminated by Sponsor|1|||
126036153|NCT05543629|453430892|FG004|Overall Study|Study terminated by Sponsor|0|||
126036154|NCT05543629|453430893|FG005|Overall Study|Study terminated by Sponsor|4|||
126036155|NCT05543629|453430894|FG006|Overall Study|Study terminated by Sponsor|1|||
126036156|NCT05543629|453430895|FG007|Overall Study|Study terminated by Sponsor|0|||
126036157|NCT05543629|453430888|FG000|Overall Study|Withdrawal by Subject|1|||
126266392|NCT02696031|454265181|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
126360429|NCT00147537|454610820|FG008|Phase 2|Lost to Follow-up|0|||
126036158|NCT05543629|453430889|FG001|Overall Study|Withdrawal by Subject|1|||
126036159|NCT05543629|453430890|FG002|Overall Study|Withdrawal by Subject|0|||
126036160|NCT05543629|453430891|FG003|Overall Study|Withdrawal by Subject|2|||
126036161|NCT05543629|453430892|FG004|Overall Study|Withdrawal by Subject|1|||
126036162|NCT05543629|453430893|FG005|Overall Study|Withdrawal by Subject|1|||
126036163|NCT05543629|453430894|FG006|Overall Study|Withdrawal by Subject|1|||
126036164|NCT05543629|453430895|FG007|Overall Study|Withdrawal by Subject|1|||
126036165|NCT05543629|453430888|FG000|Overall Study|Not Reported|2|||
126036166|NCT05543629|453430889|FG001|Overall Study|Not Reported|2|||
126036167|NCT05543629|453430890|FG002|Overall Study|Not Reported|0|||
126036168|NCT05543629|453430891|FG003|Overall Study|Not Reported|0|||
126036169|NCT05543629|453430892|FG004|Overall Study|Not Reported|1|||
126036170|NCT05543629|453430893|FG005|Overall Study|Not Reported|1|||
126036171|NCT05543629|453430894|FG006|Overall Study|Not Reported|3|||
126036172|NCT05543629|453430895|FG007|Overall Study|Not Reported|0|||
126036173|NCT04568603|453430896|FG000|Overall Study|Physician Decision|1|||
126036174|NCT03904147|453430897|FG000|Overall Study|Death|15|||
126036175|NCT03904147|453430898|FG001|Overall Study|Death|13|||
126036176|NCT03904147|453430899|FG002|Overall Study|Death|15|||
126036177|NCT03904147|453430897|FG000|Overall Study|Withdrawal by Subject|7|||
126036178|NCT03904147|453430898|FG001|Overall Study|Withdrawal by Subject|12|||
126036179|NCT03904147|453430899|FG002|Overall Study|Withdrawal by Subject|1|||
126036180|NCT03904147|453430897|FG000|Overall Study|1Y visit completed after 365 days|1|||
126036181|NCT03904147|453430898|FG001|Overall Study|1Y visit completed after 365 days|1|||
126036182|NCT03904147|453430899|FG002|Overall Study|1Y visit completed after 365 days|0|||
126036183|NCT04307355|453430903|FG000|Overall Study|Non-Compliance|3|||
126036184|NCT04307355|453430904|FG001|Overall Study|Non-Compliance|3|||
126036185|NCT04307355|453430905|FG002|Overall Study|Non-Compliance|0|||
126036186|NCT04225273|453430907|FG000|Overall Study|Lost to Follow-up|3|||
126036187|NCT04413708|453430909|FG000|Overall Study|Lost to Follow-up|1|||
126036188|NCT04413708|453430910|FG001|Overall Study|Lost to Follow-up|2|||
126036189|NCT03133546|453430911|FG000|Overall Study|Death|46|||
126036190|NCT03133546|453430912|FG001|Overall Study|Death|43|||
126036191|NCT03133546|453430911|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
126036192|NCT03133546|453430912|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
126036193|NCT06103188|453430913|FG000|Overall Study|Lost to Follow-up|1|||
126036194|NCT06103188|453430914|FG001|Overall Study|Lost to Follow-up|6|||
126036195|NCT06103188|453430915|FG002|Overall Study|Lost to Follow-up|4|||
126036196|NCT01175356|453430920|FG000|Overall Study|Death|1|||
126036197|NCT01175356|453430920|FG000|Overall Study|Lack of Efficacy|12|||
126036198|NCT01175356|453430920|FG000|Overall Study|Lost to Follow-up|1|||
126036199|NCT01175356|453430920|FG000|Overall Study|Physician Decision|23|||
126036200|NCT01175356|453430920|FG000|Overall Study|Ineligible|1|||
126036201|NCT01175356|453430920|FG000|Overall Study|Treatment Slot Not Available|18|||
126036202|NCT01175356|453430920|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
126036203|NCT01175356|453430920|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
126036204|NCT01175356|453430920|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
126036205|NCT01175356|453430920|FG000|Overall Study|Inadequate stem cell for transplant|1|||
126036206|NCT01175356|453430920|FG000|Overall Study|Initiation other tx prior to completion|9|||
126036207|NCT03020199|453430925|FG000|Treatment Period|Adverse Event|0|||
126036208|NCT03020199|453430926|FG001|Treatment Period|Adverse Event|2|||
126036209|NCT03020199|453430925|FG000|Treatment Period|Lack of Efficacy|1|||
126036210|NCT03020199|453430926|FG001|Treatment Period|Lack of Efficacy|6|||
126036211|NCT03020199|453430925|FG000|Treatment Period|Lost to Follow-up|1|||
126036212|NCT03020199|453430926|FG001|Treatment Period|Lost to Follow-up|6|||
126036213|NCT03020199|453430925|FG000|Treatment Period|Physician Decision|0|||
126036214|NCT03020199|453430926|FG001|Treatment Period|Physician Decision|1|||
126036215|NCT03020199|453430925|FG000|Treatment Period|Subject/guardian decision|8|||
126036216|NCT03020199|453430926|FG001|Treatment Period|Subject/guardian decision|15|||
126036217|NCT03020199|453430925|FG000|Treatment Period|Subjects not treated|3|||
126036218|NCT03020199|453430926|FG001|Treatment Period|Subjects not treated|4|||
126036219|NCT03020199|453430925|FG000|Follow-up Period|Disease relapse|32|||
126036220|NCT03020199|453430926|FG001|Follow-up Period|Disease relapse|7|||
126036221|NCT03020199|453430925|FG000|Follow-up Period|Lack of Efficacy|1|||
126036222|NCT03020199|453430926|FG001|Follow-up Period|Lack of Efficacy|2|||
126036223|NCT03020199|453430925|FG000|Follow-up Period|Lost to Follow-up|4|||
126036224|NCT03020199|453430926|FG001|Follow-up Period|Lost to Follow-up|6|||
126036225|NCT03020199|453430925|FG000|Follow-up Period|Physician Decision|2|||
126036226|NCT03020199|453430926|FG001|Follow-up Period|Physician Decision|2|||
126036227|NCT03020199|453430925|FG000|Follow-up Period|Protocol Violation|1|||
126036228|NCT03020199|453430926|FG001|Follow-up Period|Protocol Violation|2|||
126266393|NCT02696031|454265182|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126266394|NCT02696031|454265183|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126036229|NCT03020199|453430925|FG000|Follow-up Period|Study terminated by Sponsor|6|||
126036230|NCT03020199|453430926|FG001|Follow-up Period|Study terminated by Sponsor|3|||
126036231|NCT03020199|453430925|FG000|Follow-up Period|Subject/guardian decision|14|||
126360430|NCT00147537|454610821|FG009|Phase 2|Lost to Follow-up|12|||
126036232|NCT03020199|453430926|FG001|Follow-up Period|Subject/guardian decision|9|||
126036233|NCT04005794|453430929|FG000|Overall Study|Lost to Follow-up|0|||
126036234|NCT04005794|453430930|FG001|Overall Study|Lost to Follow-up|4|||
126036235|NCT04005794|453430931|FG002|Overall Study|Lost to Follow-up|0|||
126036236|NCT04313972|453430932|FG000|Overall Study|Withdrawal by Subject|0|||
126036237|NCT04313972|453430933|FG001|Overall Study|Withdrawal by Subject|1|||
126036238|NCT05808257|453430934|FG000|Overall Study|Lost to Follow-up|8|||
126266395|NCT02696031|454265184|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126266396|NCT02696031|454265185|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126266397|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
126098238|NCT03992846|453651483|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
126098239|NCT03992846|453651484|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
126098240|NCT03992846|453651485|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
126098241|NCT00565851|453652961|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
126098242|NCT00565851|453652962|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
126098243|NCT00565851|453652963|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
126098244|NCT00565851|453652964|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
126098245|NCT00565851|453652965|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
126098246|NCT00565851|453652966|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
126098247|NCT00565851|453652967|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
126098248|NCT00565851|453652968|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
126098249|NCT00565851|453652961|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
126266398|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
126266399|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
126266400|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
126266401|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
126266402|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
126098250|NCT00565851|453652962|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
126098251|NCT00565851|453652963|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
126098252|NCT00565851|453652964|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
126098253|NCT00565851|453652965|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
126098254|NCT00565851|453652966|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
126098255|NCT00565851|453652967|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
126098256|NCT00565851|453652968|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
126098257|NCT00775463|453652969|FG000|Overall Study|Withdrawal by Subject|0|||
126098258|NCT00775463|453652970|FG001|Overall Study|Withdrawal by Subject|1|||
126098259|NCT00775463|453652969|FG000|Overall Study|Adverse Event|7|||
126098260|NCT00775463|453652970|FG001|Overall Study|Adverse Event|9|||
126098261|NCT00775463|453652969|FG000|Overall Study|Protocol Violation|2|||
126098262|NCT00775463|453652970|FG001|Overall Study|Protocol Violation|2|||
126098263|NCT00775463|453652969|FG000|Overall Study|Lost to Follow-up|1|||
126098264|NCT00775463|453652970|FG001|Overall Study|Lost to Follow-up|0|||
126098265|NCT00775463|453652969|FG000|Overall Study|Lack of Efficacy|1|||
126098266|NCT00775463|453652970|FG001|Overall Study|Lack of Efficacy|1|||
126098267|NCT03695237|453652971|FG000|Overall Study|Withdrawal by Subject|1|||
126098268|NCT03695237|453652972|FG001|Overall Study|Withdrawal by Subject|3|||
126098269|NCT03695237|453652971|FG000|Overall Study|Lost to Follow-up|1|||
126098270|NCT03695237|453652972|FG001|Overall Study|Lost to Follow-up|2|||
126098271|NCT03695237|453652971|FG000|Overall Study|Other, Not Specified|8|||
126098272|NCT03695237|453652972|FG001|Overall Study|Other, Not Specified|2|||
126098273|NCT01789567|453652975|FG000|Overall Study|Death|6|||
126098274|NCT00091169|453652976|FG000|Overall Study|Disease progression|3|||
126098275|NCT00091169|453652977|FG001|Overall Study|Disease progression|1|||
126098276|NCT00091169|453652976|FG000|Overall Study|Adverse Event|11|||
126098277|NCT00091169|453652977|FG001|Overall Study|Adverse Event|17|||
126098278|NCT00091169|453652976|FG000|Overall Study|Death|4|||
126098279|NCT00091169|453652977|FG001|Overall Study|Death|1|||
126266403|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
126266404|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
126266405|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
126266406|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
126266407|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
126360431|NCT00147537|454610822|FG010|Phase 2|Lost to Follow-up|4|||
126360432|NCT00147537|454610812|FG000|Phase 2|Other|0|||
126360433|NCT00147537|454610813|FG001|Phase 2|Other|0|||
126360434|NCT00147537|454610814|FG002|Phase 2|Other|0|||
126098280|NCT00091169|453652976|FG000|Overall Study|Withdrawal by Subject|10|||
126098281|NCT00091169|453652977|FG001|Overall Study|Withdrawal by Subject|13|||
126098282|NCT00091169|453652976|FG000|Overall Study|Other|3|||
126098283|NCT00091169|453652977|FG001|Overall Study|Other|4|||
126360435|NCT00147537|454610815|FG003|Phase 2|Other|0|||
126360436|NCT00147537|454610816|FG004|Phase 2|Other|0|||
126360437|NCT00147537|454610817|FG005|Phase 2|Other|0|||
126360438|NCT00147537|454610818|FG006|Phase 2|Other|0|||
126360439|NCT00147537|454610819|FG007|Phase 2|Other|0|||
126360440|NCT00147537|454610820|FG008|Phase 2|Other|0|||
126360441|NCT00147537|454610821|FG009|Phase 2|Other|47|||
126360442|NCT00147537|454610822|FG010|Phase 2|Other|12|||
126360443|NCT00147537|454610812|FG000|Phase 2|Withdrawal by Subject|0|||
126360444|NCT00147537|454610813|FG001|Phase 2|Withdrawal by Subject|0|||
126360445|NCT00147537|454610814|FG002|Phase 2|Withdrawal by Subject|0|||
126360446|NCT00147537|454610815|FG003|Phase 2|Withdrawal by Subject|0|||
126098284|NCT00091169|453652976|FG000|Overall Study|Not start protocol therapy|26|||
126098285|NCT00091169|453652977|FG001|Overall Study|Not start protocol therapy|17|||
126098286|NCT00872989|453652978|FG000|Overall Study|Adverse Event|7|||
126098287|NCT00872989|453652979|FG001|Overall Study|Adverse Event|15|||
126098288|NCT00872989|453652978|FG000|Overall Study|Withdrawal by Subject|8|||
126098289|NCT00872989|453652979|FG001|Overall Study|Withdrawal by Subject|5|||
126098290|NCT00872989|453652978|FG000|Overall Study|Progression/relapse|47|||
126098291|NCT00872989|453652979|FG001|Overall Study|Progression/relapse|35|||
126098292|NCT00872989|453652978|FG000|Overall Study|Not protocol specified|3|||
126098293|NCT00872989|453652979|FG001|Overall Study|Not protocol specified|8|||
126098294|NCT02407990|453652980|FG000|Overall Study|Death|2|||
126098295|NCT02407990|453652981|FG001|Overall Study|Death|22|||
126098296|NCT02407990|453652982|FG002|Overall Study|Death|23|||
126098297|NCT02407990|453652983|FG003|Overall Study|Death|7|||
126098298|NCT02407990|453652984|FG004|Overall Study|Death|17|||
126098299|NCT02407990|453652985|FG005|Overall Study|Death|16|||
126098300|NCT02407990|453652986|FG006|Overall Study|Death|10|||
126098301|NCT02407990|453652987|FG007|Overall Study|Death|248|||
126098302|NCT02407990|453652980|FG000|Overall Study|Lost to Follow-up|0|||
126098303|NCT02407990|453652981|FG001|Overall Study|Lost to Follow-up|1|||
126098304|NCT02407990|453652982|FG002|Overall Study|Lost to Follow-up|0|||
126098305|NCT02407990|453652983|FG003|Overall Study|Lost to Follow-up|0|||
126098306|NCT02407990|453652984|FG004|Overall Study|Lost to Follow-up|0|||
126098307|NCT02407990|453652985|FG005|Overall Study|Lost to Follow-up|0|||
126098308|NCT02407990|453652986|FG006|Overall Study|Lost to Follow-up|0|||
126098309|NCT02407990|453652987|FG007|Overall Study|Lost to Follow-up|17|||
126098310|NCT02407990|453652980|FG000|Overall Study|Progressive Disease|0|||
126098311|NCT02407990|453652981|FG001|Overall Study|Progressive Disease|0|||
126098312|NCT02407990|453652982|FG002|Overall Study|Progressive Disease|0|||
126098313|NCT02407990|453652983|FG003|Overall Study|Progressive Disease|0|||
126098314|NCT02407990|453652984|FG004|Overall Study|Progressive Disease|0|||
126098315|NCT02407990|453652985|FG005|Overall Study|Progressive Disease|0|||
126098316|NCT02407990|453652986|FG006|Overall Study|Progressive Disease|0|||
126098317|NCT02407990|453652987|FG007|Overall Study|Progressive Disease|1|||
126098318|NCT02407990|453652980|FG000|Overall Study|Withdrawal by Subject|0|||
126098319|NCT02407990|453652981|FG001|Overall Study|Withdrawal by Subject|0|||
126098320|NCT02407990|453652982|FG002|Overall Study|Withdrawal by Subject|0|||
126098321|NCT02407990|453652983|FG003|Overall Study|Withdrawal by Subject|0|||
126098322|NCT02407990|453652984|FG004|Overall Study|Withdrawal by Subject|1|||
126098323|NCT02407990|453652985|FG005|Overall Study|Withdrawal by Subject|0|||
126098324|NCT02407990|453652986|FG006|Overall Study|Withdrawal by Subject|0|||
126098325|NCT02407990|453652987|FG007|Overall Study|Withdrawal by Subject|30|||
126098326|NCT02407990|453652980|FG000|Overall Study|Study Terminated by Sponsor|1|||
126098327|NCT02407990|453652981|FG001|Overall Study|Study Terminated by Sponsor|3|||
126098328|NCT02407990|453652982|FG002|Overall Study|Study Terminated by Sponsor|3|||
126098329|NCT02407990|453652983|FG003|Overall Study|Study Terminated by Sponsor|0|||
126098330|NCT02407990|453652984|FG004|Overall Study|Study Terminated by Sponsor|3|||
126098331|NCT02407990|453652985|FG005|Overall Study|Study Terminated by Sponsor|4|||
126098332|NCT02407990|453652986|FG006|Overall Study|Study Terminated by Sponsor|3|||
126098333|NCT02407990|453652987|FG007|Overall Study|Study Terminated by Sponsor|37|||
126098334|NCT02407990|453652980|FG000|Overall Study|Logistics|0|||
126098335|NCT02407990|453652981|FG001|Overall Study|Logistics|0|||
126098336|NCT02407990|453652982|FG002|Overall Study|Logistics|0|||
126098337|NCT02407990|453652983|FG003|Overall Study|Logistics|0|||
126098338|NCT02407990|453652984|FG004|Overall Study|Logistics|0|||
126098339|NCT02407990|453652985|FG005|Overall Study|Logistics|0|||
126098340|NCT02407990|453652986|FG006|Overall Study|Logistics|0|||
126098341|NCT02407990|453652987|FG007|Overall Study|Logistics|1|||
126098342|NCT02407990|453652980|FG000|Overall Study|Rolled into long-term extension study|0|||
126098343|NCT02407990|453652981|FG001|Overall Study|Rolled into long-term extension study|0|||
126098344|NCT02407990|453652982|FG002|Overall Study|Rolled into long-term extension study|0|||
126098345|NCT02407990|453652983|FG003|Overall Study|Rolled into long-term extension study|0|||
126098346|NCT02407990|453652984|FG004|Overall Study|Rolled into long-term extension study|0|||
126098347|NCT02407990|453652985|FG005|Overall Study|Rolled into long-term extension study|0|||
126098348|NCT02407990|453652986|FG006|Overall Study|Rolled into long-term extension study|0|||
126098349|NCT02407990|453652987|FG007|Overall Study|Rolled into long-term extension study|1|||
126098350|NCT00734097|453652988|FG000|Screening|Protocol Violation|12|||
126098351|NCT00734097|453652988|FG000|Screening|Withdrawal by Subject|5|||
126098352|NCT00734097|453652988|FG000|Screening|Lost to Follow-up|2|||
126098353|NCT00734097|453652988|FG000|Screening|Unconfirmed pregnancy|1|||
126098354|NCT00734097|453652988|FG000|Open Label|Lost to Follow-up|7|||
126098355|NCT00734097|453652988|FG000|Open Label|Withdrawal by Subject|5|||
126098356|NCT00734097|453652988|FG000|Open Label|Protocol Violation|4|||
126360447|NCT00147537|454610816|FG004|Phase 2|Withdrawal by Subject|0|||
126360448|NCT00147537|454610817|FG005|Phase 2|Withdrawal by Subject|0|||
126360449|NCT00147537|454610818|FG006|Phase 2|Withdrawal by Subject|0|||
126360450|NCT00147537|454610819|FG007|Phase 2|Withdrawal by Subject|0|||
126360451|NCT00147537|454610820|FG008|Phase 2|Withdrawal by Subject|0|||
126360452|NCT00147537|454610821|FG009|Phase 2|Withdrawal by Subject|16|||
126266408|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
126266409|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266410|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266411|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266412|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
126266413|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266414|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266415|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266416|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266417|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266418|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266419|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
126266420|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266421|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
126036239|NCT05808257|453430935|FG001|Overall Study|Lost to Follow-up|8|||
126036240|NCT04568486|453430936|FG000|Overall Study|Withdrawal by Subject|26|||
126036241|NCT04568486|453430936|FG000|Overall Study|Lost to Follow-up|7|||
126036242|NCT04042233|453430937|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
126036243|NCT04042233|453430938|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
126036244|NCT04042233|453430937|FG000|Overall Study|Protocol Violation|0|||
126036245|NCT04042233|453430938|FG001|Overall Study|Protocol Violation|2|||
126036246|NCT04907851|453430941|FG000|Overall Study|Consent withdrawn|1|||
126036247|NCT04907851|453430942|FG001|Overall Study|Consent withdrawn|2|||
126036248|NCT04907851|453430943|FG002|Overall Study|Consent withdrawn|0|||
126036249|NCT04907851|453430941|FG000|Overall Study|Death|5|||
126036250|NCT04907851|453430942|FG001|Overall Study|Death|15|||
126036251|NCT04907851|453430943|FG002|Overall Study|Death|10|||
126036252|NCT05477186|453430949|FG000|Overall Study|Vaccine not administered|0|||
126036253|NCT05477186|453430950|FG001|Overall Study|Vaccine not administered|2|||
126036254|NCT05477186|453430951|FG002|Overall Study|Vaccine not administered|1|||
126036255|NCT05477186|453430952|FG003|Overall Study|Vaccine not administered|0|||
126036256|NCT05477186|453430953|FG004|Overall Study|Vaccine not administered|1|||
126036257|NCT05477186|453430954|FG005|Overall Study|Vaccine not administered|0|||
126036258|NCT05477186|453430955|FG006|Overall Study|Vaccine not administered|0|||
126036259|NCT05477186|453430949|FG000|Overall Study|Withdrawal by Subject|1|||
126036260|NCT05477186|453430950|FG001|Overall Study|Withdrawal by Subject|0|||
126036261|NCT05477186|453430951|FG002|Overall Study|Withdrawal by Subject|0|||
126036262|NCT05477186|453430952|FG003|Overall Study|Withdrawal by Subject|0|||
126036263|NCT05477186|453430953|FG004|Overall Study|Withdrawal by Subject|0|||
126036264|NCT05477186|453430954|FG005|Overall Study|Withdrawal by Subject|1|||
126036265|NCT05477186|453430955|FG006|Overall Study|Withdrawal by Subject|0|||
126036266|NCT05477186|453430949|FG000|Overall Study|Lost to Follow-up|1|||
126036267|NCT05477186|453430950|FG001|Overall Study|Lost to Follow-up|0|||
126036268|NCT05477186|453430951|FG002|Overall Study|Lost to Follow-up|2|||
126036269|NCT05477186|453430952|FG003|Overall Study|Lost to Follow-up|1|||
126036270|NCT05477186|453430953|FG004|Overall Study|Lost to Follow-up|1|||
126036271|NCT05477186|453430954|FG005|Overall Study|Lost to Follow-up|0|||
126036272|NCT05477186|453430955|FG006|Overall Study|Lost to Follow-up|2|||
126036273|NCT00324805|453430956|FG000|Overall Study|Adverse Event|62|||
126036274|NCT00324805|453430957|FG001|Overall Study|Adverse Event|203|||
126036275|NCT00324805|453430956|FG000|Overall Study|Progression|7|||
126036276|NCT00324805|453430957|FG001|Overall Study|Progression|35|||
126036277|NCT00324805|453430956|FG000|Overall Study|Withdrawal by Subject|51|||
126036278|NCT00324805|453430957|FG001|Overall Study|Withdrawal by Subject|174|||
126036279|NCT00324805|453430956|FG000|Overall Study|Death|6|||
126036280|NCT00324805|453430957|FG001|Overall Study|Death|9|||
126036281|NCT00324805|453430956|FG000|Overall Study|Alternative therapy|4|||
126036282|NCT00324805|453430957|FG001|Overall Study|Alternative therapy|8|||
126036283|NCT00324805|453430956|FG000|Overall Study|Other complicating disease|1|||
126036284|NCT00324805|453430957|FG001|Overall Study|Other complicating disease|9|||
126036285|NCT00324805|453430956|FG000|Overall Study|Other reasons|7|||
126036286|NCT00324805|453430957|FG001|Overall Study|Other reasons|26|||
126036287|NCT00324805|453430956|FG000|Overall Study|Other|0|||
126098357|NCT03730480|453652995|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
126036288|NCT00324805|453430957|FG001|Overall Study|Other|2|||
126036289|NCT00324805|453430956|FG000|Overall Study|Did not start therapy|12|||
126036290|NCT00324805|453430957|FG001|Overall Study|Did not start therapy|17|||
126036291|NCT01919554|453430958|FG000|Overall Study|Withdrawal by Subject|0|||
126036292|NCT01919554|453430959|FG001|Overall Study|Withdrawal by Subject|0|||
126036293|NCT01919554|453430960|FG002|Overall Study|Withdrawal by Subject|1|||
126036294|NCT01919554|453430961|FG003|Overall Study|Withdrawal by Subject|1|||
126036295|NCT05386030|453430963|FG000|Overall Study|Death|1|||
126036296|NCT05386030|453430964|FG001|Overall Study|Death|0|||
126098358|NCT01227577|453652996|FG000|Overall Study|Protocol deviation|3|||
126098359|NCT01227577|453652996|FG000|Overall Study|Death|3|||
126098360|NCT01227577|453652996|FG000|Overall Study|Administrative problems|2|||
126098361|NCT01227577|453652996|FG000|Overall Study|Lost to Follow-up|1|||
126098362|NCT01227577|453652996|FG000|Overall Study|Withdrawal by Subject|4|||
126098363|NCT01227577|453652996|FG000|Overall Study|Lack of Efficacy|5|||
126098364|NCT01227577|453652996|FG000|Overall Study|Adverse Event|17|||
126098365|NCT00852540|453652997|FG000|Overall Study|Adverse Event|10|||
126098366|NCT00852540|453652998|FG001|Overall Study|Adverse Event|3|||
126098367|NCT00852540|453652997|FG000|Overall Study|Lack of Efficacy|15|||
126098368|NCT00852540|453652998|FG001|Overall Study|Lack of Efficacy|3|||
126098369|NCT00852540|453652997|FG000|Overall Study|Protocol Violation|1|||
126098370|NCT00852540|453652998|FG001|Overall Study|Protocol Violation|2|||
126098371|NCT00852540|453652997|FG000|Overall Study|Lost to Follow-up|2|||
126098372|NCT00852540|453652998|FG001|Overall Study|Lost to Follow-up|3|||
126098373|NCT00852540|453652997|FG000|Overall Study|Investigator Discretion|2|||
126098374|NCT00852540|453652998|FG001|Overall Study|Investigator Discretion|3|||
126098375|NCT00852540|453652997|FG000|Overall Study|Withdrawal by Subject|3|||
126098376|NCT00852540|453652998|FG001|Overall Study|Withdrawal by Subject|1|||
126098377|NCT00852540|453652997|FG000|Overall Study|Did Not Receive Study Drug|3|||
126098378|NCT00852540|453652998|FG001|Overall Study|Did Not Receive Study Drug|3|||
126098379|NCT01639495|453652999|FG000|Overall Study|Lost to Follow-up|6|||
126098380|NCT01639495|453652999|FG000|Overall Study|Consented but didn't have study catheter|4|||
126098381|NCT01639495|453652999|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
126098382|NCT01639495|453652999|FG000|Overall Study|No radiofrequency energy applied|2|||
126098383|NCT01183234|453653000|FG000|First Intervention|Adverse Event|1|||
126098384|NCT01183234|453653001|FG001|First Intervention|Adverse Event|0|||
126098385|NCT01639560|453653005|FG000|Overall Study|Withdrawal by Subject|9|||
126098386|NCT01639560|453653006|FG001|Overall Study|Withdrawal by Subject|14|||
126098387|NCT01639560|453653005|FG000|Overall Study|Lack of Efficacy|1|||
126098388|NCT01639560|453653006|FG001|Overall Study|Lack of Efficacy|2|||
126098389|NCT01639560|453653005|FG000|Overall Study|Lost to Follow-up|9|||
126098390|NCT01639560|453653006|FG001|Overall Study|Lost to Follow-up|11|||
126098391|NCT01639560|453653005|FG000|Overall Study|Adverse Event|0|||
126098392|NCT01639560|453653006|FG001|Overall Study|Adverse Event|2|||
126098393|NCT01004848|453653007|FG000|Overall Study|Lost to Follow-up|55|||
126098394|NCT01004848|453653008|FG001|Overall Study|Lost to Follow-up|45|||
126098395|NCT01160289|453653009|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
126098396|NCT01160289|453653010|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126098397|NCT01160289|453653011|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126098398|NCT01160289|453653012|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126098399|NCT01160289|453653013|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126098400|NCT01160289|453653014|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126098401|NCT01160289|453653009|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
126098402|NCT01160289|453653010|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126098403|NCT01160289|453653011|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126098404|NCT01160289|453653012|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126098405|NCT01160289|453653013|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126098406|NCT01160289|453653014|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126098407|NCT01160289|453653009|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
126098408|NCT01160289|453653010|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126098409|NCT01160289|453653011|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126098410|NCT01160289|453653012|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126266422|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
126266423|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
126266424|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
126098411|NCT01160289|453653013|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126266425|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
126098412|NCT01160289|453653014|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126098413|NCT01160289|453653009|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
126098414|NCT01160289|453653010|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126098415|NCT01160289|453653011|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126098416|NCT01160289|453653012|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126098417|NCT01160289|453653013|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126098418|NCT01160289|453653014|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126098419|NCT01160289|453653009|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
126098420|NCT01160289|453653010|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126266426|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
126266427|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
126266428|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
126266429|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
126266430|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
126266431|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
126266432|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
126266433|NCT02777918|454265186|FG000|Overall Study|Medical reasons|1|||
126266434|NCT02777918|454265187|FG001|Overall Study|Medical reasons|2|||
126266435|NCT02777918|454265186|FG000|Overall Study|Too busy / stressed|1|||
126266436|NCT02777918|454265187|FG001|Overall Study|Too busy / stressed|1|||
126266437|NCT02777918|454265186|FG000|Overall Study|Withdrawal by Subject|1|||
126266438|NCT02777918|454265187|FG001|Overall Study|Withdrawal by Subject|1|||
126266439|NCT01338987|454265188|FG000|Overall Study|enrolled on new protocol|0|||
126266440|NCT01338987|454265189|FG001|Overall Study|enrolled on new protocol|0|||
126266441|NCT01338987|454265190|FG002|Overall Study|enrolled on new protocol|1|||
126266442|NCT01338987|454265191|FG003|Overall Study|enrolled on new protocol|0|||
126266443|NCT01338987|454265192|FG004|Overall Study|enrolled on new protocol|0|||
126266444|NCT01338987|454265188|FG000|Overall Study|Disease progression on study|2|||
126266445|NCT01338987|454265189|FG001|Overall Study|Disease progression on study|1|||
126266446|NCT01338987|454265190|FG002|Overall Study|Disease progression on study|1|||
126266447|NCT01338987|454265191|FG003|Overall Study|Disease progression on study|0|||
125880708|NCT00313014|452862596|FG001|Overall Study|Administrative|6|||
126266448|NCT01338987|454265192|FG004|Overall Study|Disease progression on study|0|||
126266449|NCT00058214|454265193|FG000|Overall Study|Adverse Event|1|||
126266450|NCT03856593|454265206|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
126266451|NCT03856593|454265207|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
126266452|NCT01491035|454265209|FG000|Overall Study|Lost to Follow-up|0|||
126266453|NCT01491035|454265210|FG001|Overall Study|Lost to Follow-up|0|||
126266454|NCT01491035|454265211|FG002|Overall Study|Lost to Follow-up|0|||
126266455|NCT01491035|454265212|FG003|Overall Study|Lost to Follow-up|0|||
126266456|NCT01491035|454265213|FG004|Overall Study|Lost to Follow-up|1|||
126036297|NCT05386030|453430963|FG000|Overall Study|Physician Decision|2|||
126036298|NCT05386030|453430964|FG001|Overall Study|Physician Decision|1|||
126036299|NCT05386030|453430963|FG000|Overall Study|Lost to Follow-up|19|||
126036300|NCT05386030|453430964|FG001|Overall Study|Lost to Follow-up|7|||
126036301|NCT05386030|453430963|FG000|Overall Study|Withdrawal by Subject|20|||
126036302|NCT05386030|453430964|FG001|Overall Study|Withdrawal by Subject|10|||
126036303|NCT05386030|453430963|FG000|Overall Study|Eligibility criteria violation|1|||
126036304|NCT05386030|453430964|FG001|Overall Study|Eligibility criteria violation|1|||
126036305|NCT05386030|453430963|FG000|Overall Study|Personal Reasons|1|||
126036306|NCT05386030|453430964|FG001|Overall Study|Personal Reasons|0|||
126036307|NCT04719832|453430965|FG000|Overall Study|Adverse Event|2|||
126036308|NCT04719832|453430966|FG001|Overall Study|Adverse Event|0|||
126036309|NCT04719832|453430965|FG000|Overall Study|Lack of Efficacy|2|||
126036310|NCT04719832|453430966|FG001|Overall Study|Lack of Efficacy|4|||
126036311|NCT04719832|453430965|FG000|Overall Study|Lost to Follow-up|0|||
126036312|NCT04719832|453430966|FG001|Overall Study|Lost to Follow-up|2|||
126036313|NCT04719832|453430965|FG000|Overall Study|Physician Decision|0|||
126036314|NCT04719832|453430966|FG001|Overall Study|Physician Decision|1|||
126098421|NCT01160289|453653011|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126098422|NCT01160289|453653012|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126098423|NCT01160289|453653013|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
125880709|NCT00313014|452862597|FG002|Overall Study|Administrative|14|||
126036315|NCT04719832|453430965|FG000|Overall Study|Pregnancy|1|||
126036316|NCT04719832|453430966|FG001|Overall Study|Pregnancy|1|||
126266457|NCT01491035|454265214|FG005|Overall Study|Lost to Follow-up|0|||
126266458|NCT01491035|454265215|FG006|Overall Study|Lost to Follow-up|0|||
126036317|NCT04719832|453430965|FG000|Overall Study|Withdrawal by Subject|5|||
126036318|NCT04719832|453430966|FG001|Overall Study|Withdrawal by Subject|5|||
126036319|NCT04719832|453430965|FG000|Overall Study|Randomized, not treated|0|||
126036320|NCT04719832|453430966|FG001|Overall Study|Randomized, not treated|2|||
126036321|NCT04719832|453430965|FG000|Overall Study|GCP violations|4|||
126036322|NCT04719832|453430966|FG001|Overall Study|GCP violations|7|||
126036323|NCT04880863|453430967|FG000|Overall Study|Adverse Event|1|||
126036324|NCT04880863|453430967|FG000|Overall Study|Patient decision|2|||
126036325|NCT04880863|453430967|FG000|Overall Study|Confirmed Disease Progression|15|||
126036326|NCT04880863|453430967|FG000|Overall Study|Death|3|||
126036327|NCT04880863|453430967|FG000|Overall Study|Physician Decision|4|||
126036328|NCT04880863|453430967|FG000|Overall Study|Unconfirmed Disease Progression|4|||
126036329|NCT04880863|453430967|FG000|Overall Study|Withdrawal by Subject|2|||
126036330|NCT04880863|453430967|FG000|Overall Study|Study discontinuation by the sponsor|4|||
126036331|NCT04880863|453430967|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
126036332|NCT04880863|453430967|FG000|Overall Study|Not received study drug NAP|2|||
126036333|NCT04898673|453430968|FG000|Overall Study|Screenfail|1|||
126036334|NCT04898673|453430969|FG001|Overall Study|Screenfail|0|||
126036335|NCT03899259|453430972|FG000|Overall Study|Adverse Event|5|||
126036336|NCT03899259|453430973|FG001|Overall Study|Adverse Event|4|||
126036337|NCT03899259|453430974|FG002|Overall Study|Adverse Event|6|||
126036338|NCT03899259|453430972|FG000|Overall Study|Lack of Efficacy|5|||
126036339|NCT03899259|453430973|FG001|Overall Study|Lack of Efficacy|0|||
126036340|NCT03899259|453430974|FG002|Overall Study|Lack of Efficacy|2|||
126036341|NCT03899259|453430972|FG000|Overall Study|Pregnancy|3|||
126036342|NCT03899259|453430973|FG001|Overall Study|Pregnancy|0|||
126036343|NCT03899259|453430974|FG002|Overall Study|Pregnancy|1|||
126036344|NCT03899259|453430972|FG000|Overall Study|Physician Decision|0|||
126036345|NCT03899259|453430973|FG001|Overall Study|Physician Decision|1|||
126036346|NCT03899259|453430974|FG002|Overall Study|Physician Decision|0|||
126036347|NCT03899259|453430972|FG000|Overall Study|Protocol Deviation|1|||
126036348|NCT03899259|453430973|FG001|Overall Study|Protocol Deviation|1|||
126036349|NCT03899259|453430974|FG002|Overall Study|Protocol Deviation|1|||
126036350|NCT03899259|453430972|FG000|Overall Study|Withdrawal by Subject|8|||
126036351|NCT03899259|453430973|FG001|Overall Study|Withdrawal by Subject|10|||
126036352|NCT03899259|453430974|FG002|Overall Study|Withdrawal by Subject|12|||
126036353|NCT03899259|453430972|FG000|Overall Study|Lost to Follow-up|5|||
126036354|NCT03899259|453430973|FG001|Overall Study|Lost to Follow-up|6|||
126036355|NCT03899259|453430974|FG002|Overall Study|Lost to Follow-up|2|||
126036356|NCT03899259|453430972|FG000|Overall Study|Lack of Adherence|1|||
126036357|NCT03899259|453430973|FG001|Overall Study|Lack of Adherence|0|||
126036358|NCT03899259|453430974|FG002|Overall Study|Lack of Adherence|0|||
126036359|NCT03899259|453430972|FG000|Overall Study|Screen Failure|1|||
126036360|NCT03899259|453430973|FG001|Overall Study|Screen Failure|0|||
126036361|NCT03899259|453430974|FG002|Overall Study|Screen Failure|0|||
126036362|NCT03899259|453430972|FG000|Overall Study|Ongoing Study Participation|127|||
126036363|NCT03899259|453430973|FG001|Overall Study|Ongoing Study Participation|134|||
126036364|NCT03899259|453430974|FG002|Overall Study|Ongoing Study Participation|210|||
126036365|NCT05670587|453430975|FG000|Overall Study|Withdrawal by Subject|3|||
126036366|NCT01197378|453430976|FG000|Overall Study|Adverse Event|3|||
126036367|NCT01197378|453430976|FG000|Overall Study|Withdrawal by Subject|1|||
126036368|NCT01197378|453430976|FG000|Overall Study|Physician Decision|1|||
126036369|NCT01197378|453430976|FG000|Overall Study|Other|2|||
126036370|NCT01544114|453430980|FG000|Overall Study|Withdrawal by Subject|0|||
126036371|NCT01544114|453430981|FG001|Overall Study|Withdrawal by Subject|0|||
126036372|NCT01544114|453430982|FG002|Overall Study|Withdrawal by Subject|3|||
126036373|NCT01544114|453430980|FG000|Overall Study|Lost to Follow-up|0|||
126036374|NCT01544114|453430981|FG001|Overall Study|Lost to Follow-up|2|||
126036375|NCT01544114|453430982|FG002|Overall Study|Lost to Follow-up|0|||
126036376|NCT01544114|453430980|FG000|Overall Study|Adverse Event|1|||
126036377|NCT01544114|453430981|FG001|Overall Study|Adverse Event|1|||
126036378|NCT01544114|453430982|FG002|Overall Study|Adverse Event|2|||
126036379|NCT01544114|453430980|FG000|Overall Study|Protocol Violation|0|||
126036380|NCT01544114|453430981|FG001|Overall Study|Protocol Violation|1|||
126036381|NCT01544114|453430982|FG002|Overall Study|Protocol Violation|0|||
126036382|NCT01733316|453430987|FG000|RP103 Phase|Non-compliance|1|||
126036383|NCT01733316|453430987|FG000|Long Term Extension Phase|Adverse Event|1|||
126036384|NCT01733316|453430987|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
126036385|NCT01733316|453430987|FG000|Long Term Extension Phase|Sponsor Decision|2|||
126036386|NCT03058289|453430988|FG000|Overall Study|Radiographic Deterioration|0|||
126036387|NCT03058289|453430989|FG001|Overall Study|Radiographic Deterioration|3|||
126036388|NCT03058289|453430990|FG002|Overall Study|Radiographic Deterioration|1|||
126036389|NCT03058289|453430991|FG003|Overall Study|Radiographic Deterioration|2|||
126036390|NCT03058289|453430992|FG004|Overall Study|Radiographic Deterioration|6|||
126036391|NCT03058289|453430993|FG005|Overall Study|Radiographic Deterioration|3|||
126036392|NCT03058289|453430994|FG006|Overall Study|Radiographic Deterioration|0|||
126036393|NCT03058289|453430995|FG007|Overall Study|Radiographic Deterioration|4|||
126036394|NCT03058289|453430996|FG008|Overall Study|Radiographic Deterioration|2|||
126036395|NCT03058289|453430988|FG000|Overall Study|Adverse Event|2|||
126036396|NCT03058289|453430989|FG001|Overall Study|Adverse Event|0|||
126036397|NCT03058289|453430990|FG002|Overall Study|Adverse Event|1|||
126036398|NCT03058289|453430991|FG003|Overall Study|Adverse Event|3|||
126036399|NCT03058289|453430992|FG004|Overall Study|Adverse Event|1|||
126036400|NCT03058289|453430993|FG005|Overall Study|Adverse Event|0|||
126036401|NCT03058289|453430994|FG006|Overall Study|Adverse Event|1|||
126036402|NCT03058289|453430995|FG007|Overall Study|Adverse Event|3|||
126036403|NCT03058289|453430996|FG008|Overall Study|Adverse Event|0|||
126036404|NCT03058289|453430988|FG000|Overall Study|Withdrawal by Subject|0|||
126036405|NCT03058289|453430989|FG001|Overall Study|Withdrawal by Subject|0|||
126036406|NCT03058289|453430990|FG002|Overall Study|Withdrawal by Subject|0|||
126036407|NCT03058289|453430991|FG003|Overall Study|Withdrawal by Subject|2|||
126036408|NCT03058289|453430992|FG004|Overall Study|Withdrawal by Subject|0|||
126036409|NCT03058289|453430993|FG005|Overall Study|Withdrawal by Subject|2|||
126036410|NCT03058289|453430994|FG006|Overall Study|Withdrawal by Subject|0|||
126036411|NCT03058289|453430995|FG007|Overall Study|Withdrawal by Subject|4|||
126036412|NCT03058289|453430996|FG008|Overall Study|Withdrawal by Subject|1|||
126036413|NCT03058289|453430988|FG000|Overall Study|Physician Decision|1|||
126036414|NCT03058289|453430989|FG001|Overall Study|Physician Decision|0|||
126036415|NCT03058289|453430990|FG002|Overall Study|Physician Decision|0|||
126036416|NCT03058289|453430991|FG003|Overall Study|Physician Decision|2|||
126036417|NCT03058289|453430992|FG004|Overall Study|Physician Decision|1|||
125880710|NCT00313014|452862595|FG000|Overall Study|Lack of Efficacy|52|||
126036418|NCT03058289|453430993|FG005|Overall Study|Physician Decision|0|||
126036419|NCT03058289|453430994|FG006|Overall Study|Physician Decision|2|||
126036420|NCT03058289|453430995|FG007|Overall Study|Physician Decision|3|||
126036421|NCT03058289|453430996|FG008|Overall Study|Physician Decision|0|||
126036422|NCT03058289|453430988|FG000|Overall Study|Clinical Deterioration|2|||
126036423|NCT03058289|453430989|FG001|Overall Study|Clinical Deterioration|0|||
126036424|NCT03058289|453430990|FG002|Overall Study|Clinical Deterioration|0|||
126036425|NCT03058289|453430991|FG003|Overall Study|Clinical Deterioration|2|||
126036426|NCT03058289|453430992|FG004|Overall Study|Clinical Deterioration|1|||
126036427|NCT03058289|453430993|FG005|Overall Study|Clinical Deterioration|1|||
126036428|NCT03058289|453430994|FG006|Overall Study|Clinical Deterioration|0|||
126036429|NCT03058289|453430995|FG007|Overall Study|Clinical Deterioration|3|||
126036430|NCT03058289|453430996|FG008|Overall Study|Clinical Deterioration|2|||
126036431|NCT03058289|453430988|FG000|Overall Study|Lost to Follow-up|0|||
126036432|NCT03058289|453430989|FG001|Overall Study|Lost to Follow-up|0|||
126036433|NCT03058289|453430990|FG002|Overall Study|Lost to Follow-up|0|||
126036434|NCT03058289|453430991|FG003|Overall Study|Lost to Follow-up|0|||
126036435|NCT03058289|453430992|FG004|Overall Study|Lost to Follow-up|1|||
126036436|NCT03058289|453430993|FG005|Overall Study|Lost to Follow-up|0|||
126036437|NCT03058289|453430994|FG006|Overall Study|Lost to Follow-up|0|||
126036438|NCT03058289|453430995|FG007|Overall Study|Lost to Follow-up|0|||
126036439|NCT03058289|453430996|FG008|Overall Study|Lost to Follow-up|0|||
126036440|NCT03058289|453430988|FG000|Overall Study|Refused Further Treatment|0|||
126036441|NCT03058289|453430989|FG001|Overall Study|Refused Further Treatment|0|||
126036442|NCT03058289|453430990|FG002|Overall Study|Refused Further Treatment|1|||
126036443|NCT03058289|453430991|FG003|Overall Study|Refused Further Treatment|0|||
126036444|NCT03058289|453430992|FG004|Overall Study|Refused Further Treatment|1|||
126036445|NCT03058289|453430993|FG005|Overall Study|Refused Further Treatment|0|||
126036446|NCT03058289|453430994|FG006|Overall Study|Refused Further Treatment|0|||
126036447|NCT03058289|453430995|FG007|Overall Study|Refused Further Treatment|0|||
126036448|NCT03058289|453430996|FG008|Overall Study|Refused Further Treatment|0|||
126036449|NCT03058289|453430988|FG000|Overall Study|Rapid Progression of Disease|0|||
126036450|NCT03058289|453430989|FG001|Overall Study|Rapid Progression of Disease|0|||
126036451|NCT03058289|453430990|FG002|Overall Study|Rapid Progression of Disease|0|||
126036452|NCT03058289|453430991|FG003|Overall Study|Rapid Progression of Disease|1|||
126036453|NCT03058289|453430992|FG004|Overall Study|Rapid Progression of Disease|0|||
126036454|NCT03058289|453430993|FG005|Overall Study|Rapid Progression of Disease|0|||
126036455|NCT03058289|453430994|FG006|Overall Study|Rapid Progression of Disease|0|||
126360453|NCT00147537|454610822|FG010|Phase 2|Withdrawal by Subject|4|||
126360454|NCT00147537|454610812|FG000|Phase 2|Randomized but not treated|0|||
126360455|NCT00147537|454610813|FG001|Phase 2|Randomized but not treated|0|||
126360456|NCT00147537|454610814|FG002|Phase 2|Randomized but not treated|0|||
126360457|NCT00147537|454610815|FG003|Phase 2|Randomized but not treated|0|||
126360458|NCT00147537|454610816|FG004|Phase 2|Randomized but not treated|0|||
126360459|NCT00147537|454610817|FG005|Phase 2|Randomized but not treated|0|||
126360460|NCT00147537|454610818|FG006|Phase 2|Randomized but not treated|0|||
126360461|NCT00147537|454610819|FG007|Phase 2|Randomized but not treated|0|||
126360462|NCT00147537|454610820|FG008|Phase 2|Randomized but not treated|0|||
126036456|NCT03058289|453430995|FG007|Overall Study|Rapid Progression of Disease|0|||
126036457|NCT03058289|453430996|FG008|Overall Study|Rapid Progression of Disease|0|||
126036458|NCT05546411|453430999|FG000|Overall Study|Progressive Disease|1|||
126036459|NCT05546411|453431000|FG001|Overall Study|Progressive Disease|0|||
126036460|NCT05546411|453430999|FG000|Overall Study|Adverse Event|0|||
126036461|NCT05546411|453431000|FG001|Overall Study|Adverse Event|1|||
126036462|NCT05546411|453430999|FG000|Overall Study|Metastatic disease|1|||
126036463|NCT05546411|453431000|FG001|Overall Study|Metastatic disease|0|||
126036464|NCT02606422|453431001|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
126036465|NCT02606422|453431002|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
126036466|NCT02606422|453431001|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
126036467|NCT02606422|453431002|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
126036468|NCT02606422|453431001|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
126036469|NCT02606422|453431002|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
126036470|NCT02606422|453431001|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
126360463|NCT00147537|454610821|FG009|Phase 2|Randomized but not treated|1|||
126360464|NCT00147537|454610822|FG010|Phase 2|Randomized but not treated|1|||
126360465|NCT02006654|454610824|FG000|Overall Study|Withdrawal before treatment|4|||
126360466|NCT02006654|454610825|FG001|Overall Study|Withdrawal before treatment|2|||
126360467|NCT02006654|454610824|FG000|Overall Study|Adverse Event|16|||
126036471|NCT02606422|453431002|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
126036472|NCT06182033|453431006|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
126036473|NCT06182033|453431007|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
126036474|NCT06182033|453431006|FG000|Overall Study|Target child relocation|1|||
126360468|NCT02006654|454610825|FG001|Overall Study|Adverse Event|17|||
126036475|NCT06182033|453431007|FG001|Overall Study|Target child relocation|1|||
126036476|NCT06182033|453431006|FG000|Overall Study|Withdrawal by Subject|1|||
126036477|NCT06182033|453431007|FG001|Overall Study|Withdrawal by Subject|0|||
126036478|NCT02151981|453431008|FG000|Overall Study|Death|184|||
126036479|NCT02151981|453431009|FG001|Overall Study|Death|88|||
126036480|NCT02151981|453431008|FG000|Overall Study|Lost to Follow-up|7|||
126098424|NCT01160289|453653014|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126098425|NCT01160289|453653009|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
126098426|NCT01160289|453653010|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126098427|NCT01160289|453653011|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126098428|NCT01160289|453653012|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126098429|NCT01160289|453653013|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126098430|NCT01160289|453653014|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126098431|NCT01160289|453653009|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
126098432|NCT01160289|453653010|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126098433|NCT01160289|453653011|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126098434|NCT01160289|453653012|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126098435|NCT01160289|453653013|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126098436|NCT01160289|453653014|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126098437|NCT01160289|453653009|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
126098438|NCT01160289|453653010|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126098439|NCT01160289|453653011|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126098440|NCT01160289|453653012|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126098441|NCT01160289|453653013|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126098442|NCT01160289|453653014|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
125880711|NCT00313014|452862596|FG001|Overall Study|Lack of Efficacy|25|||
125880712|NCT00313014|452862597|FG002|Overall Study|Lack of Efficacy|16|||
125880713|NCT01772316|452862600|FG000|Overall Study|Serious adverse event|1|||
125880714|NCT01772316|452862600|FG000|Overall Study|Inform consent withdrawn|1|||
125880715|NCT01772316|452862600|FG000|Overall Study|Withdrawn by sponsor decision|5|||
125880716|NCT01391546|452862602|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
125880717|NCT01391546|452862603|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
125880718|NCT03363841|452862607|FG000|Overall Study|Adverse Event|1|||
126036481|NCT02151981|453431009|FG001|Overall Study|Lost to Follow-up|1|||
126036482|NCT02151981|453431008|FG000|Overall Study|Withdrawal by Subject|27|||
126036483|NCT02151981|453431009|FG001|Overall Study|Withdrawal by Subject|21|||
126036484|NCT02151981|453431008|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126098443|NCT01160289|453653009|FG000|Post-Randomization Period|Adverse Event|0|||
126098444|NCT01160289|453653010|FG001|Post-Randomization Period|Adverse Event|4|||
126098445|NCT01160289|453653011|FG002|Post-Randomization Period|Adverse Event|4|||
126098446|NCT01160289|453653012|FG003|Post-Randomization Period|Adverse Event|2|||
126098447|NCT01160289|453653013|FG004|Post-Randomization Period|Adverse Event|0|||
126098448|NCT01160289|453653014|FG005|Post-Randomization Period|Adverse Event|0|||
126098449|NCT01160289|453653009|FG000|Post-Randomization Period|Death|0|||
126098450|NCT01160289|453653010|FG001|Post-Randomization Period|Death|0|||
126098451|NCT01160289|453653011|FG002|Post-Randomization Period|Death|0|||
126098452|NCT01160289|453653012|FG003|Post-Randomization Period|Death|1|||
126098453|NCT01160289|453653013|FG004|Post-Randomization Period|Death|0|||
126036485|NCT02151981|453431009|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126036486|NCT02151981|453431008|FG000|Overall Study|Other reasons|1|||
126036487|NCT02151981|453431009|FG001|Overall Study|Other reasons|2|||
126036488|NCT01946789|453431013|FG000|Overall Study|Death|0|||
126098454|NCT01160289|453653014|FG005|Post-Randomization Period|Death|0|||
126098455|NCT01160289|453653009|FG000|Post-Randomization Period|Lack of Efficacy|0|||
126098456|NCT01160289|453653010|FG001|Post-Randomization Period|Lack of Efficacy|1|||
126098457|NCT01160289|453653011|FG002|Post-Randomization Period|Lack of Efficacy|0|||
126098458|NCT01160289|453653012|FG003|Post-Randomization Period|Lack of Efficacy|3|||
126098459|NCT01160289|453653013|FG004|Post-Randomization Period|Lack of Efficacy|0|||
126098460|NCT01160289|453653014|FG005|Post-Randomization Period|Lack of Efficacy|0|||
126098461|NCT01160289|453653009|FG000|Post-Randomization Period|Lost to Follow-up|0|||
126098462|NCT01160289|453653010|FG001|Post-Randomization Period|Lost to Follow-up|3|||
126098463|NCT01160289|453653011|FG002|Post-Randomization Period|Lost to Follow-up|2|||
126266459|NCT01491035|454265216|FG007|Overall Study|Lost to Follow-up|0|||
126036489|NCT01946789|453431014|FG001|Overall Study|Death|2|||
126098464|NCT01160289|453653012|FG003|Post-Randomization Period|Lost to Follow-up|5|||
126098465|NCT01160289|453653013|FG004|Post-Randomization Period|Lost to Follow-up|3|||
126098466|NCT01160289|453653014|FG005|Post-Randomization Period|Lost to Follow-up|4|||
126036490|NCT01946789|453431015|FG002|Overall Study|Death|1|||
126036491|NCT01946789|453431016|FG003|Overall Study|Death|1|||
125880719|NCT03363841|452862607|FG000|Overall Study|Withdrawal by Subject|1|||
125880720|NCT03363841|452862607|FG000|Overall Study|Death|7|||
126036492|NCT01946789|453431017|FG004|Overall Study|Death|1|||
126266460|NCT01277718|454265221|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
126266461|NCT01277718|454265222|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
126266462|NCT01277718|454265221|FG000|Period 2 - Second Intervention|Physician Decision|0|||
126266463|NCT01277718|454265222|FG001|Period 2 - Second Intervention|Physician Decision|2|||
126266464|NCT01524913|454265223|FG000|Overall Study|Lost to Follow-up|4|||
126266465|NCT01524913|454265224|FG001|Overall Study|Lost to Follow-up|0|||
126266466|NCT01524913|454265225|FG002|Overall Study|Lost to Follow-up|0|||
126266467|NCT03351231|454265239|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
126266468|NCT03351231|454265239|FG000|Combination Therapy Period|Disease progression|2|||
126266469|NCT03351231|454265239|FG000|Combination Therapy Period|Study drug toxicity|1|||
126266470|NCT03351231|454265239|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
126266471|NCT03351231|454265239|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
126266472|NCT03351231|454265239|FG000|Safety Follow-Up Period|Other reason|2|||
126266473|NCT02858726|454265240|FG000|Overall Study|Adverse Event|4|||
126266474|NCT02858726|454265241|FG001|Overall Study|Adverse Event|4|||
126036493|NCT01946789|453431018|FG005|Overall Study|Death|1|||
126036494|NCT01946789|453431019|FG006|Overall Study|Death|3|||
126036495|NCT01946789|453431020|FG007|Overall Study|Death|1|||
126036496|NCT01946789|453431021|FG008|Overall Study|Death|2|||
126098467|NCT01160289|453653009|FG000|Post-Randomization Period|Physician Decision|0|||
126036497|NCT01946789|453431013|FG000|Overall Study|Progressive Disease|0|||
126036498|NCT01946789|453431014|FG001|Overall Study|Progressive Disease|0|||
126036499|NCT01946789|453431015|FG002|Overall Study|Progressive Disease|1|||
126036500|NCT01946789|453431016|FG003|Overall Study|Progressive Disease|0|||
126036501|NCT01946789|453431017|FG004|Overall Study|Progressive Disease|0|||
126036502|NCT01946789|453431018|FG005|Overall Study|Progressive Disease|2|||
126036503|NCT01946789|453431019|FG006|Overall Study|Progressive Disease|0|||
126036504|NCT01946789|453431020|FG007|Overall Study|Progressive Disease|0|||
126036505|NCT01946789|453431021|FG008|Overall Study|Progressive Disease|0|||
126036506|NCT01946789|453431013|FG000|Overall Study|Withdrawal by Subject|0|||
126036507|NCT01946789|453431014|FG001|Overall Study|Withdrawal by Subject|0|||
126036508|NCT01946789|453431015|FG002|Overall Study|Withdrawal by Subject|0|||
126036509|NCT01946789|453431016|FG003|Overall Study|Withdrawal by Subject|2|||
126036510|NCT01946789|453431017|FG004|Overall Study|Withdrawal by Subject|1|||
126036511|NCT01946789|453431018|FG005|Overall Study|Withdrawal by Subject|0|||
126036512|NCT01946789|453431019|FG006|Overall Study|Withdrawal by Subject|1|||
126036513|NCT01946789|453431020|FG007|Overall Study|Withdrawal by Subject|0|||
126036514|NCT01946789|453431021|FG008|Overall Study|Withdrawal by Subject|0|||
126036515|NCT05374798|453431022|FG000|Overall Study|Lost to Follow-up|2|||
126036516|NCT05374798|453431022|FG000|Overall Study|Withdrawal by Subject|2|||
126036517|NCT05374798|453431022|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
126036518|NCT05576155|453431023|FG000|Overall Study|Withdrawal by Subject|1|||
126036519|NCT05576155|453431024|FG001|Overall Study|Withdrawal by Subject|1|||
126036520|NCT01275677|453431026|FG000|Overall Study|Not at risk for recurrence.|1|||
126036521|NCT01275677|453431027|FG001|Overall Study|Not at risk for recurrence.|1|||
126036522|NCT01275677|453431026|FG000|Overall Study|No follow-up|26|||
126036523|NCT01275677|453431027|FG001|Overall Study|No follow-up|37|||
126036524|NCT01275677|453431026|FG000|Overall Study|No clinical follow up.|1|||
126036525|NCT01275677|453431027|FG001|Overall Study|No clinical follow up.|4|||
126036526|NCT05309291|453431029|FG000|Overall Study|Adverse Event|0|||
126036527|NCT05309291|453431030|FG001|Overall Study|Adverse Event|1|||
126036528|NCT05209152|453431033|FG000|Overall Study|Sponsor decision|1|||
126036529|NCT05209152|453431034|FG001|Overall Study|Sponsor decision|2|||
126036530|NCT05209152|453431033|FG000|Overall Study|Death|3|||
126036531|NCT05209152|453431034|FG001|Overall Study|Death|1|||
126036532|NCT03287817|453432997|FG000|Overall Study|Progressive disease|4|||
126036533|NCT03287817|453432998|FG001|Overall Study|Progressive disease|2|||
126036534|NCT03287817|453432999|FG002|Overall Study|Progressive disease|3|||
126036535|NCT03287817|453433000|FG003|Overall Study|Progressive disease|10|||
126036536|NCT03287817|453433001|FG004|Overall Study|Progressive disease|8|||
126036537|NCT03287817|453432997|FG000|Overall Study|Death|0|||
126036538|NCT03287817|453432998|FG001|Overall Study|Death|0|||
126036539|NCT03287817|453432999|FG002|Overall Study|Death|2|||
126036540|NCT03287817|453433000|FG003|Overall Study|Death|3|||
126266475|NCT02858726|454265242|FG002|Overall Study|Adverse Event|9|||
126036541|NCT03287817|453433001|FG004|Overall Study|Death|4|||
126036542|NCT03287817|453432997|FG000|Overall Study|Physician Decision|0|||
126036543|NCT03287817|453432998|FG001|Overall Study|Physician Decision|0|||
126266476|NCT02858726|454265243|FG003|Overall Study|Adverse Event|1|||
126266477|NCT02858726|454265240|FG000|Overall Study|Physician Decision|0|||
126360469|NCT02006654|454610824|FG000|Overall Study|Death|1|||
126036544|NCT03287817|453432999|FG002|Overall Study|Physician Decision|0|||
126360470|NCT02006654|454610825|FG001|Overall Study|Death|0|||
126036545|NCT03287817|453433000|FG003|Overall Study|Physician Decision|1|||
126266478|NCT02858726|454265241|FG001|Overall Study|Physician Decision|0|||
126036546|NCT03287817|453433001|FG004|Overall Study|Physician Decision|0|||
126036547|NCT03287817|453432997|FG000|Overall Study|Withdrawal by Subject|0|||
126036548|NCT03287817|453432998|FG001|Overall Study|Withdrawal by Subject|0|||
126266479|NCT02858726|454265242|FG002|Overall Study|Physician Decision|1|||
126266480|NCT02858726|454265243|FG003|Overall Study|Physician Decision|0|||
126266481|NCT02858726|454265240|FG000|Overall Study|Protocol Violation|0|||
126266482|NCT02858726|454265241|FG001|Overall Study|Protocol Violation|0|||
126266483|NCT02858726|454265242|FG002|Overall Study|Protocol Violation|0|||
126266484|NCT02858726|454265243|FG003|Overall Study|Protocol Violation|1|||
126266485|NCT02858726|454265240|FG000|Overall Study|Study Terminated by Sponsor|0|||
126266486|NCT02858726|454265241|FG001|Overall Study|Study Terminated by Sponsor|0|||
126266487|NCT02858726|454265242|FG002|Overall Study|Study Terminated by Sponsor|0|||
126266488|NCT02858726|454265243|FG003|Overall Study|Study Terminated by Sponsor|1|||
126266489|NCT02858726|454265240|FG000|Overall Study|Withdrawal by Subject|1|||
126266490|NCT02858726|454265241|FG001|Overall Study|Withdrawal by Subject|2|||
126266491|NCT02858726|454265242|FG002|Overall Study|Withdrawal by Subject|1|||
126266492|NCT02858726|454265243|FG003|Overall Study|Withdrawal by Subject|0|||
126266493|NCT02858726|454265240|FG000|Overall Study|Noncompliance|0|||
126266494|NCT02858726|454265241|FG001|Overall Study|Noncompliance|1|||
126266495|NCT02858726|454265242|FG002|Overall Study|Noncompliance|0|||
126266496|NCT02858726|454265243|FG003|Overall Study|Noncompliance|0|||
126266497|NCT00233987|454265248|FG000|Overall Study|Withdrawal by Subject|1|||
126266498|NCT00233987|454265248|FG000|Overall Study|Lack of Efficacy|2|||
126266499|NCT00233987|454265248|FG000|Overall Study|Reason Under Review|1|||
126266500|NCT00233987|454265248|FG000|Overall Study|Other - Not Protocol Specified|5|||
126266501|NCT00233987|454265248|FG000|Overall Study|Eligible but No Treatment Received|2|||
126266502|NCT00233987|454265248|FG000|Overall Study|Ineligible|4|||
126266503|NCT00518622|454265249|FG000|Overall Study|Lost to Follow-up|0|||
126266504|NCT00518622|454265250|FG001|Overall Study|Lost to Follow-up|0|||
126266505|NCT00518622|454265251|FG002|Overall Study|Lost to Follow-up|1|||
126266506|NCT00518622|454265252|FG003|Overall Study|Lost to Follow-up|0|||
126266507|NCT00518622|454265253|FG004|Overall Study|Lost to Follow-up|0|||
126266508|NCT00518622|454265254|FG005|Overall Study|Lost to Follow-up|0|||
126266509|NCT00518622|454265255|FG006|Overall Study|Lost to Follow-up|0|||
126266510|NCT00518622|454265256|FG007|Overall Study|Lost to Follow-up|0|||
126266511|NCT00518622|454265249|FG000|Overall Study|Study medication taken incorrectly|0|||
126266512|NCT00518622|454265250|FG001|Overall Study|Study medication taken incorrectly|1|||
126266513|NCT00518622|454265251|FG002|Overall Study|Study medication taken incorrectly|0|||
126266514|NCT00518622|454265252|FG003|Overall Study|Study medication taken incorrectly|0|||
126266515|NCT00518622|454265253|FG004|Overall Study|Study medication taken incorrectly|0|||
126266516|NCT00518622|454265254|FG005|Overall Study|Study medication taken incorrectly|0|||
126266517|NCT00518622|454265255|FG006|Overall Study|Study medication taken incorrectly|0|||
126266518|NCT00518622|454265256|FG007|Overall Study|Study medication taken incorrectly|0|||
126266519|NCT01688726|454265257|FG000|Overall Study|Adverse Event|1|||
126266520|NCT01688726|454265258|FG001|Overall Study|Adverse Event|0|||
126266521|NCT01688726|454265257|FG000|Overall Study|Relocated abroad|0|||
126266522|NCT01688726|454265258|FG001|Overall Study|Relocated abroad|1|||
126266523|NCT04920916|454267344|FG000|Phase IIa 60 Day Study|Death|2|||
126266524|NCT04920916|454267345|FG001|Phase IIa 60 Day Study|Death|5|||
126266525|NCT04920916|454267344|FG000|1 Year Follow up (Phone Call)|Death|1|||
126266526|NCT04920916|454267345|FG001|1 Year Follow up (Phone Call)|Death|3|||
126266527|NCT04920916|454267344|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
126266528|NCT04920916|454267345|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
126266529|NCT00973765|454267346|FG000|Overall Study|Lost to Follow-up|8|||
126266530|NCT00973765|454267347|FG001|Overall Study|Lost to Follow-up|14|||
126266531|NCT02011113|454267348|FG000|Overall Study|Adverse Event|4|||
126266532|NCT02011113|454267348|FG000|Overall Study|Disease Progression (DP)|16|||
126266533|NCT02011113|454267348|FG000|Overall Study|Death|1|||
126266534|NCT02011113|454267348|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
126036549|NCT03287817|453432999|FG002|Overall Study|Withdrawal by Subject|0|||
126036550|NCT03287817|453433000|FG003|Overall Study|Withdrawal by Subject|0|||
126036551|NCT03287817|453433001|FG004|Overall Study|Withdrawal by Subject|4|||
126036552|NCT06181227|453433002|FG000|Overall Study|Study terminated by sponsor|7|||
126036553|NCT06181227|453433003|FG001|Overall Study|Study terminated by sponsor|9|||
126036554|NCT03854227|453433007|FG000|Overall Study|Adverse Event|0|||
126036555|NCT03854227|453433008|FG001|Overall Study|Adverse Event|0|||
126266535|NCT02011113|454267348|FG000|Overall Study|Investigator's judgement- DP|3|||
126266536|NCT02011113|454267348|FG000|Overall Study|Study terminated by sponsor|11|||
126266537|NCT01892657|454267351|FG000|Overall Study|Withdrawal by Subject|6|||
126266538|NCT01892657|454267351|FG000|Overall Study|Protocol Violation|12|||
126266539|NCT00468728|454267362|FG000|Treatment|criteria for mITT population|4|||
126266540|NCT00468728|454267363|FG001|Treatment|criteria for mITT population|11|||
126266541|NCT00468728|454267362|FG000|Follow-up|mITT failure|34|||
126266542|NCT00468728|454267363|FG001|Follow-up|mITT failure|31|||
126266543|NCT03251963|454267364|FG000|Overall Study|inappropriate Xa level timing|6|||
126266544|NCT03251963|454267365|FG001|Overall Study|inappropriate Xa level timing|3|||
126266545|NCT03251963|454267364|FG000|Overall Study|no peak Xa level drawn|2|||
126266546|NCT03251963|454267365|FG001|Overall Study|no peak Xa level drawn|0|||
125880721|NCT03363841|452862607|FG000|Overall Study|Physician Decision|1|||
126036556|NCT03854227|453433009|FG002|Overall Study|Adverse Event|0|||
126036557|NCT03854227|453433010|FG003|Overall Study|Adverse Event|1|||
126036558|NCT03854227|453433011|FG004|Overall Study|Adverse Event|0|||
126036559|NCT03854227|453433012|FG005|Overall Study|Adverse Event|0|||
126266547|NCT03251963|454267364|FG000|Overall Study|bled prior to Xa level|1|||
126266548|NCT03251963|454267365|FG001|Overall Study|bled prior to Xa level|2|||
126266549|NCT04505293|454267366|FG000|Overall Study|Lost to Follow-up|2|||
126266550|NCT04505293|454267366|FG000|Overall Study|Withdrawal by Subject|6|||
126266551|NCT04505293|454267366|FG000|Overall Study|CT scan unreadable|277|||
126266552|NCT02712333|454267369|FG000|First Period|Withdrawal by Subject|3|||
126266553|NCT02712333|454267370|FG001|First Period|Withdrawal by Subject|2|||
126266554|NCT03463993|454267371|FG000|Overall Study|Lost to Follow-up|7|||
126266555|NCT03463993|454267372|FG001|Overall Study|Lost to Follow-up|8|||
126266556|NCT03463993|454267371|FG000|Overall Study|Withdrawal by Subject|2|||
126266557|NCT03463993|454267372|FG001|Overall Study|Withdrawal by Subject|0|||
126266558|NCT03463993|454267371|FG000|Overall Study|Protocol Violation|4|||
126266559|NCT03463993|454267372|FG001|Overall Study|Protocol Violation|1|||
126266560|NCT03463993|454267371|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
126266561|NCT03463993|454267372|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
126266562|NCT03463993|454267371|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
126266563|NCT03463993|454267372|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
126266564|NCT01478828|454267373|FG000|Overall Study|Adverse Event|1|||
126266565|NCT00757848|454267388|FG000|Overall Study|Voluntary discontinuation|1|||
126266566|NCT00757848|454267389|FG001|Overall Study|Voluntary discontinuation|0|||
126266567|NCT00757848|454267388|FG000|Overall Study|Adverse Event|1|||
126266568|NCT00757848|454267389|FG001|Overall Study|Adverse Event|2|||
126266569|NCT00757848|454267388|FG000|Overall Study|Incorrect enrolment|1|||
126266570|NCT00757848|454267389|FG001|Overall Study|Incorrect enrolment|0|||
126266571|NCT03978091|454267392|FG000|Overall Study|Lost to Follow-up|0|||
126266572|NCT03978091|454267393|FG001|Overall Study|Lost to Follow-up|0|||
126266573|NCT03978091|454267394|FG002|Overall Study|Lost to Follow-up|1|||
126266574|NCT03978091|454267395|FG003|Overall Study|Lost to Follow-up|0|||
126266575|NCT03978091|454267396|FG004|Overall Study|Lost to Follow-up|0|||
126266576|NCT03978091|454267397|FG005|Overall Study|Lost to Follow-up|0|||
126266577|NCT03978091|454267392|FG000|Overall Study|Withdrawal by Subject|0|||
126266578|NCT03978091|454267393|FG001|Overall Study|Withdrawal by Subject|0|||
126266579|NCT03978091|454267394|FG002|Overall Study|Withdrawal by Subject|0|||
126266580|NCT03978091|454267395|FG003|Overall Study|Withdrawal by Subject|1|||
126266581|NCT03978091|454267396|FG004|Overall Study|Withdrawal by Subject|1|||
126266582|NCT03978091|454267397|FG005|Overall Study|Withdrawal by Subject|0|||
126266583|NCT02595008|454267402|FG000|Overall Study|Enrolled In Error|1|||
126266584|NCT02595008|454267403|FG001|Overall Study|Enrolled In Error|0|||
126266585|NCT03078582|454267406|FG000|Overall Study|Adverse Event|0|||
126266586|NCT03078582|454267407|FG001|Overall Study|Adverse Event|8|||
126266587|NCT01843348|454267410|FG000|Overall Study|Withdrawal by Subject|4|||
126266588|NCT01843348|454267411|FG001|Overall Study|Withdrawal by Subject|16|||
126266589|NCT01843348|454267412|FG002|Overall Study|Withdrawal by Subject|18|||
126266590|NCT01843348|454267410|FG000|Overall Study|Lost to Follow-up|5|||
126266591|NCT01843348|454267411|FG001|Overall Study|Lost to Follow-up|4|||
126266592|NCT01843348|454267412|FG002|Overall Study|Lost to Follow-up|2|||
126266593|NCT01843348|454267410|FG000|Overall Study|Death|5|||
126266594|NCT01843348|454267411|FG001|Overall Study|Death|3|||
126266595|NCT01843348|454267412|FG002|Overall Study|Death|4|||
126266596|NCT01843348|454267410|FG000|Overall Study|Graft loss/retransplantation|5|||
126266597|NCT01843348|454267411|FG001|Overall Study|Graft loss/retransplantation|8|||
126266598|NCT01843348|454267412|FG002|Overall Study|Graft loss/retransplantation|11|||
126266599|NCT01843348|454267410|FG000|Overall Study|Various reasons|4|||
126266600|NCT01843348|454267411|FG001|Overall Study|Various reasons|9|||
126266601|NCT01843348|454267412|FG002|Overall Study|Various reasons|6|||
126266602|NCT02039414|454267421|FG000|Overall Study|Delivered|1|||
126266603|NCT02039414|454267422|FG001|Overall Study|Delivered|1|||
126266604|NCT02039414|454267421|FG000|Overall Study|Lost to Follow-up|2|||
126266605|NCT02039414|454267422|FG001|Overall Study|Lost to Follow-up|0|||
126036560|NCT03854227|453433013|FG006|Overall Study|Adverse Event|1|||
126036561|NCT03854227|453433014|FG007|Overall Study|Adverse Event|0|||
126266606|NCT02039414|454267421|FG000|Overall Study|Protocol Violation|3|||
126266607|NCT02039414|454267422|FG001|Overall Study|Protocol Violation|1|||
126266608|NCT02972502|454267425|FG000|Overall Study|Lost to Follow-up|3|||
126266609|NCT02972502|454267426|FG001|Overall Study|Lost to Follow-up|1|||
126266610|NCT02972502|454267425|FG000|Overall Study|Withdrawal by Subject|1|||
126266611|NCT02972502|454267426|FG001|Overall Study|Withdrawal by Subject|1|||
126266612|NCT01347866|454267429|FG000|Overall Study|Death|0|||
126266613|NCT01347866|454267430|FG001|Overall Study|Death|0|||
126266614|NCT01347866|454267431|FG002|Overall Study|Death|0|||
126036562|NCT03854227|453433015|FG008|Overall Study|Adverse Event|0|||
126266615|NCT01347866|454267432|FG003|Overall Study|Death|1|||
126266616|NCT01347866|454267433|FG004|Overall Study|Death|2|||
126266617|NCT01347866|454267434|FG005|Overall Study|Death|2|||
126266618|NCT01347866|454267435|FG006|Overall Study|Death|1|||
126036563|NCT03854227|453433016|FG009|Overall Study|Adverse Event|3|||
126036564|NCT03854227|453433017|FG010|Overall Study|Adverse Event|0|||
126036565|NCT03854227|453433018|FG011|Overall Study|Adverse Event|1|||
126036566|NCT03854227|453433007|FG000|Overall Study|Death|0|||
126036567|NCT03854227|453433008|FG001|Overall Study|Death|0|||
126036568|NCT03854227|453433009|FG002|Overall Study|Death|0|||
126036569|NCT03854227|453433010|FG003|Overall Study|Death|0|||
126036570|NCT03854227|453433011|FG004|Overall Study|Death|0|||
126266619|NCT01347866|454267436|FG007|Overall Study|Death|0|||
126266620|NCT01347866|454267437|FG008|Overall Study|Death|4|||
126266621|NCT01347866|454267438|FG009|Overall Study|Death|1|||
126266622|NCT01347866|454267439|FG010|Overall Study|Death|3|||
126266623|NCT01347866|454267440|FG011|Overall Study|Death|1|||
126266624|NCT01347866|454267441|FG012|Overall Study|Death|2|||
126266625|NCT01347866|454267442|FG013|Overall Study|Death|0|||
126266626|NCT01347866|454267443|FG014|Overall Study|Death|0|||
126266627|NCT01347866|454267444|FG015|Overall Study|Death|1|||
126266628|NCT01347866|454267445|FG016|Overall Study|Death|0|||
126266629|NCT01347866|454267429|FG000|Overall Study|Lost to Follow-up|0|||
126266630|NCT01347866|454267430|FG001|Overall Study|Lost to Follow-up|0|||
126266631|NCT01347866|454267431|FG002|Overall Study|Lost to Follow-up|0|||
126266632|NCT01347866|454267432|FG003|Overall Study|Lost to Follow-up|0|||
126266633|NCT01347866|454267433|FG004|Overall Study|Lost to Follow-up|0|||
126266634|NCT01347866|454267434|FG005|Overall Study|Lost to Follow-up|0|||
126266635|NCT01347866|454267435|FG006|Overall Study|Lost to Follow-up|0|||
126266636|NCT01347866|454267436|FG007|Overall Study|Lost to Follow-up|1|||
126266637|NCT01347866|454267437|FG008|Overall Study|Lost to Follow-up|1|||
126266638|NCT01347866|454267438|FG009|Overall Study|Lost to Follow-up|0|||
126266639|NCT01347866|454267439|FG010|Overall Study|Lost to Follow-up|0|||
126266640|NCT01347866|454267440|FG011|Overall Study|Lost to Follow-up|0|||
126266641|NCT01347866|454267441|FG012|Overall Study|Lost to Follow-up|0|||
126266642|NCT01347866|454267442|FG013|Overall Study|Lost to Follow-up|0|||
126266643|NCT01347866|454267443|FG014|Overall Study|Lost to Follow-up|0|||
126266644|NCT01347866|454267444|FG015|Overall Study|Lost to Follow-up|0|||
126266645|NCT01347866|454267445|FG016|Overall Study|Lost to Follow-up|0|||
126266646|NCT01347866|454267429|FG000|Overall Study|Other|3|||
126266647|NCT01347866|454267430|FG001|Overall Study|Other|1|||
126266648|NCT01347866|454267431|FG002|Overall Study|Other|1|||
126266649|NCT01347866|454267432|FG003|Overall Study|Other|4|||
126266650|NCT01347866|454267433|FG004|Overall Study|Other|5|||
126266651|NCT01347866|454267434|FG005|Overall Study|Other|0|||
126266652|NCT01347866|454267435|FG006|Overall Study|Other|5|||
126266653|NCT01347866|454267436|FG007|Overall Study|Other|3|||
126266654|NCT01347866|454267437|FG008|Overall Study|Other|22|||
126266655|NCT01347866|454267438|FG009|Overall Study|Other|5|||
126266656|NCT01347866|454267439|FG010|Overall Study|Other|0|||
126266657|NCT01347866|454267440|FG011|Overall Study|Other|3|||
126266658|NCT01347866|454267441|FG012|Overall Study|Other|4|||
126266659|NCT01347866|454267442|FG013|Overall Study|Other|4|||
126266660|NCT01347866|454267443|FG014|Overall Study|Other|2|||
126266661|NCT01347866|454267444|FG015|Overall Study|Other|3|||
126266662|NCT01347866|454267445|FG016|Overall Study|Other|0|||
126266663|NCT01347866|454267429|FG000|Overall Study|Subject refused further follow-up|2|||
126266664|NCT01347866|454267430|FG001|Overall Study|Subject refused further follow-up|0|||
126098468|NCT01160289|453653010|FG001|Post-Randomization Period|Physician Decision|0|||
126098469|NCT01160289|453653011|FG002|Post-Randomization Period|Physician Decision|1|||
126098470|NCT01160289|453653012|FG003|Post-Randomization Period|Physician Decision|0|||
126036571|NCT03854227|453433012|FG005|Overall Study|Death|1|||
126036572|NCT03854227|453433013|FG006|Overall Study|Death|0|||
126098471|NCT01160289|453653013|FG004|Post-Randomization Period|Physician Decision|0|||
126036573|NCT03854227|453433014|FG007|Overall Study|Death|0|||
126036574|NCT03854227|453433015|FG008|Overall Study|Death|0|||
126098472|NCT01160289|453653014|FG005|Post-Randomization Period|Physician Decision|0|||
126098473|NCT01160289|453653009|FG000|Post-Randomization Period|Protocol Violation|0|||
126098474|NCT01160289|453653010|FG001|Post-Randomization Period|Protocol Violation|4|||
126266665|NCT01347866|454267431|FG002|Overall Study|Subject refused further follow-up|0|||
126036575|NCT03854227|453433016|FG009|Overall Study|Death|1|||
126036576|NCT03854227|453433017|FG010|Overall Study|Death|0|||
126098475|NCT01160289|453653011|FG002|Post-Randomization Period|Protocol Violation|2|||
126266666|NCT01347866|454267432|FG003|Overall Study|Subject refused further follow-up|2|||
126266667|NCT01347866|454267433|FG004|Overall Study|Subject refused further follow-up|0|||
126266668|NCT01347866|454267434|FG005|Overall Study|Subject refused further follow-up|1|||
126266669|NCT01347866|454267435|FG006|Overall Study|Subject refused further follow-up|0|||
126266670|NCT01347866|454267436|FG007|Overall Study|Subject refused further follow-up|0|||
126036577|NCT03854227|453433018|FG011|Overall Study|Death|1|||
126036578|NCT03854227|453433007|FG000|Overall Study|Physician Decision|0|||
126036579|NCT03854227|453433008|FG001|Overall Study|Physician Decision|0|||
126266671|NCT01347866|454267437|FG008|Overall Study|Subject refused further follow-up|4|||
126266672|NCT01347866|454267438|FG009|Overall Study|Subject refused further follow-up|1|||
126266673|NCT01347866|454267439|FG010|Overall Study|Subject refused further follow-up|0|||
126266674|NCT01347866|454267440|FG011|Overall Study|Subject refused further follow-up|0|||
126098476|NCT01160289|453653012|FG003|Post-Randomization Period|Protocol Violation|0|||
126098477|NCT01160289|453653013|FG004|Post-Randomization Period|Protocol Violation|1|||
126098478|NCT01160289|453653014|FG005|Post-Randomization Period|Protocol Violation|3|||
126098479|NCT01160289|453653009|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
126098480|NCT01160289|453653010|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
126036580|NCT03854227|453433009|FG002|Overall Study|Physician Decision|0|||
126036581|NCT03854227|453433010|FG003|Overall Study|Physician Decision|0|||
126036582|NCT03854227|453433011|FG004|Overall Study|Physician Decision|0|||
126036583|NCT03854227|453433012|FG005|Overall Study|Physician Decision|1|||
126036584|NCT03854227|453433013|FG006|Overall Study|Physician Decision|0|||
126036585|NCT03854227|453433014|FG007|Overall Study|Physician Decision|0|||
126036586|NCT03854227|453433015|FG008|Overall Study|Physician Decision|1|||
126036587|NCT03854227|453433016|FG009|Overall Study|Physician Decision|1|||
126036588|NCT03854227|453433017|FG010|Overall Study|Physician Decision|0|||
126036589|NCT03854227|453433018|FG011|Overall Study|Physician Decision|1|||
126036590|NCT03854227|453433007|FG000|Overall Study|Progressive disease|1|||
126036591|NCT03854227|453433008|FG001|Overall Study|Progressive disease|1|||
126036592|NCT03854227|453433009|FG002|Overall Study|Progressive disease|1|||
126036593|NCT03854227|453433010|FG003|Overall Study|Progressive disease|2|||
126036594|NCT03854227|453433011|FG004|Overall Study|Progressive disease|3|||
126036595|NCT03854227|453433012|FG005|Overall Study|Progressive disease|1|||
126098481|NCT01160289|453653011|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
126098482|NCT01160289|453653012|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
126266675|NCT01347866|454267441|FG012|Overall Study|Subject refused further follow-up|1|||
126266676|NCT01347866|454267442|FG013|Overall Study|Subject refused further follow-up|3|||
126266677|NCT01347866|454267443|FG014|Overall Study|Subject refused further follow-up|1|||
126266678|NCT01347866|454267444|FG015|Overall Study|Subject refused further follow-up|0|||
126266679|NCT01347866|454267445|FG016|Overall Study|Subject refused further follow-up|2|||
126266680|NCT00430950|454267446|FG000|Overall Study|Adverse Event|7|||
126266681|NCT00430950|454267447|FG001|Overall Study|Adverse Event|6|||
126266682|NCT00430950|454267446|FG000|Overall Study|Withdrawal by Subject|1|||
126266683|NCT00430950|454267447|FG001|Overall Study|Withdrawal by Subject|0|||
126266684|NCT00430950|454267446|FG000|Overall Study|concomitant medication,etc.|5|||
126266685|NCT00430950|454267447|FG001|Overall Study|concomitant medication,etc.|7|||
126266686|NCT02429934|454267450|FG000|Overall Study|Withdrawal by Subject|0|||
126266687|NCT02429934|454267451|FG001|Overall Study|Withdrawal by Subject|2|||
126266688|NCT02429934|454267450|FG000|Overall Study|Adverse Event|2|||
126266689|NCT02429934|454267451|FG001|Overall Study|Adverse Event|0|||
126266690|NCT02429934|454267450|FG000|Overall Study|Lost to Follow-up|1|||
126266691|NCT02429934|454267451|FG001|Overall Study|Lost to Follow-up|1|||
126266692|NCT02429934|454267450|FG000|Overall Study|Physician Decision|1|||
126266693|NCT02429934|454267451|FG001|Overall Study|Physician Decision|0|||
126266694|NCT00869024|454267452|FG000|Overall Study|Death|2|||
126266695|NCT00869024|454267453|FG001|Overall Study|Death|3|||
126266696|NCT00869024|454267452|FG000|Overall Study|Lost to Follow-up|0|||
126266697|NCT00869024|454267453|FG001|Overall Study|Lost to Follow-up|1|||
126266698|NCT00869024|454267452|FG000|Overall Study|Protocol Violation|0|||
126266699|NCT00869024|454267453|FG001|Overall Study|Protocol Violation|1|||
126266700|NCT00831623|454267458|FG000|Overall Study|Withdrawal by Subject|9|||
126266701|NCT00831623|454267458|FG000|Overall Study|Lost to Follow-up|1|||
126266702|NCT00831623|454267458|FG000|Overall Study|Not 2 years post-treatment|12|||
126266703|NCT01564459|454267459|FG000|Run-In|Adverse Event|7|||
126266704|NCT01564459|454267460|FG001|Run-In|Adverse Event|0|||
126266705|NCT01564459|454267461|FG002|Run-In|Adverse Event|0|||
126266706|NCT01564459|454267459|FG000|Run-In|Lost to Follow-up|1|||
126266707|NCT01564459|454267460|FG001|Run-In|Lost to Follow-up|0|||
126266708|NCT01564459|454267461|FG002|Run-In|Lost to Follow-up|0|||
126266709|NCT01564459|454267459|FG000|Run-In|Non-compliance with study drug|2|||
126266710|NCT01564459|454267460|FG001|Run-In|Non-compliance with study drug|0|||
126266711|NCT01564459|454267461|FG002|Run-In|Non-compliance with study drug|0|||
126266712|NCT01564459|454267459|FG000|Run-In|Protocol Violation|1|||
126266713|NCT01564459|454267460|FG001|Run-In|Protocol Violation|0|||
126266714|NCT01564459|454267461|FG002|Run-In|Protocol Violation|0|||
126266715|NCT01564459|454267459|FG000|Run-In|Withdrawal by Subject|1|||
126266716|NCT01564459|454267460|FG001|Run-In|Withdrawal by Subject|0|||
126266717|NCT01564459|454267461|FG002|Run-In|Withdrawal by Subject|0|||
126266718|NCT01564459|454267459|FG000|Double-blind Treatment|Adverse Event|0|||
126360471|NCT02006654|454610824|FG000|Overall Study|Withdrawal by Subject|14|||
126036596|NCT03854227|453433013|FG006|Overall Study|Progressive disease|2|||
126036597|NCT03854227|453433014|FG007|Overall Study|Progressive disease|5|||
126036598|NCT03854227|453433015|FG008|Overall Study|Progressive disease|2|||
126266719|NCT01564459|454267460|FG001|Double-blind Treatment|Adverse Event|0|||
126266720|NCT01564459|454267461|FG002|Double-blind Treatment|Adverse Event|1|||
126036599|NCT03854227|453433016|FG009|Overall Study|Progressive disease|5|||
126036600|NCT03854227|453433017|FG010|Overall Study|Progressive disease|1|||
126036601|NCT03854227|453433018|FG011|Overall Study|Progressive disease|6|||
126036602|NCT03854227|453433007|FG000|Overall Study|Study terminated by sponsor|0|||
126266721|NCT00706992|454267469|FG000|Overall Study|Study termination|5|||
126266722|NCT00706992|454267470|FG001|Overall Study|Study termination|5|||
126266723|NCT00706992|454267471|FG002|Overall Study|Study termination|6|||
126266724|NCT00706992|454267472|FG003|Overall Study|Study termination|2|||
126266725|NCT00706992|454267473|FG004|Overall Study|Study termination|3|||
126266726|NCT00706992|454267474|FG005|Overall Study|Study termination|2|||
126266727|NCT00706992|454267475|FG006|Overall Study|Study termination|3|||
126266728|NCT00706992|454267469|FG000|Overall Study|Disease progression before treatment|0|||
126266729|NCT00706992|454267470|FG001|Overall Study|Disease progression before treatment|0|||
126266730|NCT00706992|454267471|FG002|Overall Study|Disease progression before treatment|0|||
126266731|NCT00706992|454267472|FG003|Overall Study|Disease progression before treatment|0|||
126266732|NCT00706992|454267473|FG004|Overall Study|Disease progression before treatment|1|||
126266733|NCT00706992|454267474|FG005|Overall Study|Disease progression before treatment|0|||
126266734|NCT00706992|454267475|FG006|Overall Study|Disease progression before treatment|0|||
126266735|NCT03545191|454267476|FG000|Overall Study|Death|1|||
126266736|NCT03545191|454267477|FG001|Overall Study|Death|0|||
126266737|NCT03545191|454267478|FG002|Overall Study|Death|0|||
126266738|NCT03545191|454267476|FG000|Overall Study|Adverse Event|4|||
126266739|NCT03545191|454267477|FG001|Overall Study|Adverse Event|2|||
126266740|NCT03545191|454267478|FG002|Overall Study|Adverse Event|7|||
126266741|NCT03545191|454267476|FG000|Overall Study|Other reasons|3|||
126266742|NCT03545191|454267477|FG001|Overall Study|Other reasons|11|||
126266743|NCT03545191|454267478|FG002|Overall Study|Other reasons|8|||
126266744|NCT03545191|454267476|FG000|Overall Study|Withdrawal by Subject|13|||
126266745|NCT03545191|454267477|FG001|Overall Study|Withdrawal by Subject|10|||
126266746|NCT03545191|454267478|FG002|Overall Study|Withdrawal by Subject|12|||
126266747|NCT03545191|454267476|FG000|Overall Study|Lost to Follow-up|1|||
126266748|NCT03545191|454267477|FG001|Overall Study|Lost to Follow-up|2|||
126266749|NCT03545191|454267478|FG002|Overall Study|Lost to Follow-up|3|||
126266750|NCT02377063|454267482|FG000|Overall Study|Non-compliance|5|||
126266751|NCT02746627|454267488|FG000|Overall Study|Withdrawal by Subject|1|||
126266752|NCT02746627|454267489|FG001|Overall Study|Withdrawal by Subject|1|||
126266753|NCT02746627|454267490|FG002|Overall Study|Withdrawal by Subject|1|||
126266754|NCT02340221|454267493|FG000|Overall Study|Death|100|||
126266755|NCT02340221|454267494|FG001|Overall Study|Death|197|||
126266756|NCT02340221|454267493|FG000|Overall Study|Withdrawal by Participant|24|||
126266757|NCT02340221|454267494|FG001|Overall Study|Withdrawal by Participant|37|||
126266758|NCT02340221|454267493|FG000|Overall Study|Lost to Follow-up|4|||
126266759|NCT02340221|454267494|FG001|Overall Study|Lost to Follow-up|15|||
126266760|NCT02340221|454267493|FG000|Overall Study|Reason Not Specified|85|||
126266761|NCT02340221|454267494|FG001|Overall Study|Reason Not Specified|165|||
126266762|NCT02340221|454267493|FG000|Overall Study|Study Terminated by Sponsor|1|||
126266763|NCT02340221|454267494|FG001|Overall Study|Study Terminated by Sponsor|3|||
126266764|NCT03499119|454267495|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
126266765|NCT03499119|454267496|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
126266766|NCT03499119|454267497|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
126266767|NCT03499119|454267498|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
126266768|NCT03499119|454267495|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
126266769|NCT03499119|454267496|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
126266770|NCT03499119|454267497|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
126266771|NCT03499119|454267498|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
126266772|NCT03499119|454267495|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
126266773|NCT03499119|454267496|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
126266774|NCT03499119|454267497|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
126266775|NCT03499119|454267498|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
126266776|NCT03499119|454267495|FG000|Optional Extension Phase|Lost to Follow-up|0|||
126266777|NCT03499119|454267496|FG001|Optional Extension Phase|Lost to Follow-up|0|||
126266778|NCT03499119|454267497|FG002|Optional Extension Phase|Lost to Follow-up|0|||
126266779|NCT03499119|454267498|FG003|Optional Extension Phase|Lost to Follow-up|1|||
126266780|NCT03499119|454267495|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
126266781|NCT03499119|454267496|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
126266782|NCT03499119|454267497|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
126266783|NCT03499119|454267498|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
126036603|NCT03854227|453433008|FG001|Overall Study|Study terminated by sponsor|0|||
126266784|NCT03499119|454267495|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
126266785|NCT03499119|454267496|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
126266786|NCT03499119|454267497|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
126266787|NCT03499119|454267498|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
126266788|NCT00588640|454267499|FG000|Overall Study|Physician Decision|1|||
126036604|NCT03854227|453433009|FG002|Overall Study|Study terminated by sponsor|0|||
126266789|NCT00588640|454267499|FG000|Overall Study|Ineligible Patient|1|||
126266790|NCT01481324|454267500|FG000|Overall Study|Missing Data|0|||
126266791|NCT01481324|454267501|FG001|Overall Study|Missing Data|2|||
126266792|NCT01481324|454267502|FG002|Overall Study|Missing Data|2|||
126266793|NCT01172821|454267503|FG000|Overall Study|Adverse Event|5|||
126266794|NCT01172821|454267504|FG001|Overall Study|Adverse Event|2|||
126266795|NCT01172821|454267505|FG002|Overall Study|Adverse Event|2|||
126266796|NCT01172821|454267506|FG003|Overall Study|Adverse Event|7|||
126266797|NCT01172821|454267503|FG000|Overall Study|Protocol Violation|0|||
126266798|NCT01172821|454267504|FG001|Overall Study|Protocol Violation|2|||
126266799|NCT01172821|454267505|FG002|Overall Study|Protocol Violation|1|||
126266800|NCT01172821|454267506|FG003|Overall Study|Protocol Violation|2|||
126266801|NCT01172821|454267503|FG000|Overall Study|Lost to Follow-up|4|||
126266802|NCT01172821|454267504|FG001|Overall Study|Lost to Follow-up|1|||
126266803|NCT01172821|454267505|FG002|Overall Study|Lost to Follow-up|2|||
126266804|NCT01172821|454267506|FG003|Overall Study|Lost to Follow-up|2|||
126266805|NCT01172821|454267503|FG000|Overall Study|Withdrawal by Subject|2|||
126266806|NCT01172821|454267504|FG001|Overall Study|Withdrawal by Subject|3|||
126266807|NCT01172821|454267505|FG002|Overall Study|Withdrawal by Subject|3|||
126266808|NCT01172821|454267506|FG003|Overall Study|Withdrawal by Subject|3|||
126266809|NCT01172821|454267503|FG000|Overall Study|Other|3|||
126266810|NCT01172821|454267504|FG001|Overall Study|Other|4|||
126266811|NCT01172821|454267505|FG002|Overall Study|Other|5|||
126266812|NCT01172821|454267506|FG003|Overall Study|Other|3|||
126266813|NCT00003138|454269210|FG000|Step 1|Reasons off treatment not documented|60|||
126266814|NCT00003138|454269211|FG001|Step 1|Reasons off treatment not documented|57|||
126266815|NCT00003138|454269210|FG000|Step 1|Never started treatment|1|||
126266816|NCT00003138|454269211|FG001|Step 1|Never started treatment|0|||
126266817|NCT00003138|454269210|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
126266818|NCT00003138|454269211|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
126266819|NCT00003138|454269210|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
126266820|NCT00003138|454269211|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
126266821|NCT00003138|454269210|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
126266822|NCT00003138|454269211|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
126266823|NCT00003138|454269210|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
126266824|NCT00003138|454269211|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
126266825|NCT04495283|454269213|FG000|Overall Study|Physician Decision|0|||
126266826|NCT04495283|454269214|FG001|Overall Study|Physician Decision|0|||
126266827|NCT04495283|454269215|FG002|Overall Study|Physician Decision|1|||
126266828|NCT04495283|454269213|FG000|Overall Study|Withdrawal by Subject|0|||
126266829|NCT04495283|454269214|FG001|Overall Study|Withdrawal by Subject|1|||
126266830|NCT04495283|454269215|FG002|Overall Study|Withdrawal by Subject|1|||
126266831|NCT04495283|454269213|FG000|Overall Study|Other|1|||
126266832|NCT04495283|454269214|FG001|Overall Study|Other|0|||
126266833|NCT04495283|454269215|FG002|Overall Study|Other|1|||
126266834|NCT05142566|454269218|FG000|Overall Study|Protocol Violation|1|||
126266835|NCT02246439|454269219|FG000|Overall Study|Adverse Event|3|||
126266836|NCT02246439|454269220|FG001|Overall Study|Adverse Event|0|||
126266837|NCT02246439|454269219|FG000|Overall Study|Lost to Follow-up|7|||
126266838|NCT02246439|454269220|FG001|Overall Study|Lost to Follow-up|5|||
126266839|NCT02246439|454269219|FG000|Overall Study|Protocol Violation|0|||
126266840|NCT02246439|454269220|FG001|Overall Study|Protocol Violation|2|||
126266841|NCT02246439|454269219|FG000|Overall Study|Physician Decision|0|||
126266842|NCT02246439|454269220|FG001|Overall Study|Physician Decision|1|||
126266843|NCT02246439|454269219|FG000|Overall Study|Unkonwn|1|||
126266844|NCT02246439|454269220|FG001|Overall Study|Unkonwn|3|||
126266845|NCT02246439|454269219|FG000|Overall Study|Withdrawal by Subject|1|||
126266846|NCT02246439|454269220|FG001|Overall Study|Withdrawal by Subject|0|||
126266847|NCT01553279|454269221|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
126266848|NCT01553279|454269222|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
126266849|NCT01553279|454269221|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
126266850|NCT01553279|454269222|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
126266851|NCT01553279|454269221|FG000|Interim Period|Withdrawal by Subject|2|||
126266852|NCT01553279|454269222|FG001|Interim Period|Withdrawal by Subject|2|||
126266853|NCT01553279|454269221|FG000|Interim Period|Lost to Follow-up|1|||
126266854|NCT01553279|454269222|FG001|Interim Period|Lost to Follow-up|0|||
126266855|NCT01553279|454269221|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
126266856|NCT01553279|454269222|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
126266857|NCT01553279|454269221|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
126266858|NCT01553279|454269222|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
126266859|NCT00380692|454269223|FG000|Study Period II - Double Blind|Adverse Event|1|||
126266860|NCT00380692|454269224|FG001|Study Period II - Double Blind|Adverse Event|0|||
126266861|NCT00380692|454269223|FG000|Study Period II - Double Blind|Protocol Violation|2|||
126266862|NCT00380692|454269224|FG001|Study Period II - Double Blind|Protocol Violation|2|||
126266863|NCT00380692|454269223|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
126266864|NCT00380692|454269224|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
126266865|NCT00380692|454269223|FG000|Study Period II - Double Blind|Physician Decision|0|||
126266866|NCT00380692|454269224|FG001|Study Period II - Double Blind|Physician Decision|1|||
126266867|NCT00380692|454269223|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
126266868|NCT00380692|454269224|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
126266869|NCT00380692|454269223|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
126266870|NCT00380692|454269224|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
126266871|NCT00380692|454269223|FG000|Study Period III - Open Label|Adverse Event|5|||
126266872|NCT00380692|454269224|FG001|Study Period III - Open Label|Adverse Event|3|||
126266873|NCT00380692|454269223|FG000|Study Period III - Open Label|Protocol Violation|0|||
126266874|NCT00380692|454269224|FG001|Study Period III - Open Label|Protocol Violation|0|||
126266875|NCT00380692|454269223|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
126266876|NCT00380692|454269224|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
126266877|NCT00380692|454269223|FG000|Study Period III - Open Label|Physician Decision|0|||
126266878|NCT00380692|454269224|FG001|Study Period III - Open Label|Physician Decision|3|||
126266879|NCT00380692|454269223|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
126266880|NCT00380692|454269224|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
126266881|NCT00380692|454269223|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
126266882|NCT00380692|454269224|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
126266883|NCT03955471|454269225|FG000|Overall Study|Death|22|||
126266884|NCT03955471|454269225|FG000|Overall Study|Lost to Follow-up|1|||
126266885|NCT03955471|454269225|FG000|Overall Study|Withdrawal by Subject|6|||
126266886|NCT03955471|454269225|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
126266887|NCT02177136|454269240|FG000|DB Phase|Withdrawal by Subject|2|||
126266888|NCT02177136|454269241|FG001|DB Phase|Withdrawal by Subject|0|||
126266889|NCT02177136|454269242|FG002|DB Phase|Withdrawal by Subject|0|||
126266890|NCT02177136|454269243|FG003|DB Phase|Withdrawal by Subject|0|||
126266891|NCT02177136|454269240|FG000|DB Phase|Discontinued Due to Pruritus|1|||
126266892|NCT02177136|454269241|FG001|DB Phase|Discontinued Due to Pruritus|3|||
126266893|NCT02177136|454269242|FG002|DB Phase|Discontinued Due to Pruritus|0|||
126266894|NCT02177136|454269243|FG003|DB Phase|Discontinued Due to Pruritus|0|||
126266895|NCT02177136|454269240|FG000|DB Phase|Adverse Event|3|||
126266896|NCT02177136|454269241|FG001|DB Phase|Adverse Event|2|||
126266897|NCT02177136|454269242|FG002|DB Phase|Adverse Event|3|||
126266898|NCT02177136|454269243|FG003|DB Phase|Adverse Event|0|||
126266899|NCT02177136|454269240|FG000|DB Phase|Protocol Violation|0|||
126266900|NCT02177136|454269241|FG001|DB Phase|Protocol Violation|0|||
126266901|NCT02177136|454269242|FG002|DB Phase|Protocol Violation|1|||
126266902|NCT02177136|454269243|FG003|DB Phase|Protocol Violation|0|||
126266903|NCT02177136|454269240|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
126266904|NCT02177136|454269241|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
126266905|NCT02177136|454269242|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
126266906|NCT02177136|454269243|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
126266907|NCT02177136|454269240|FG000|LTSE Phase|Withdrawal by Subject|0|||
126266908|NCT02177136|454269241|FG001|LTSE Phase|Withdrawal by Subject|0|||
126266909|NCT02177136|454269242|FG002|LTSE Phase|Withdrawal by Subject|0|||
126266910|NCT02177136|454269243|FG003|LTSE Phase|Withdrawal by Subject|6|||
126266911|NCT02177136|454269240|FG000|LTSE Phase|Adverse Event|0|||
126266912|NCT02177136|454269241|FG001|LTSE Phase|Adverse Event|0|||
126266913|NCT02177136|454269242|FG002|LTSE Phase|Adverse Event|0|||
126266914|NCT02177136|454269243|FG003|LTSE Phase|Adverse Event|10|||
126036605|NCT03854227|453433010|FG003|Overall Study|Study terminated by sponsor|0|||
126036606|NCT03854227|453433011|FG004|Overall Study|Study terminated by sponsor|0|||
126036607|NCT03854227|453433012|FG005|Overall Study|Study terminated by sponsor|0|||
126036608|NCT03854227|453433013|FG006|Overall Study|Study terminated by sponsor|0|||
126266915|NCT02177136|454269240|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
126266916|NCT02177136|454269241|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
126266917|NCT02177136|454269242|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
126266918|NCT02177136|454269243|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
126266919|NCT02177136|454269240|FG000|LTSE Phase|Physician Decision|0|||
126266920|NCT02177136|454269241|FG001|LTSE Phase|Physician Decision|0|||
126266921|NCT02177136|454269242|FG002|LTSE Phase|Physician Decision|0|||
126266922|NCT02177136|454269243|FG003|LTSE Phase|Physician Decision|2|||
126266923|NCT02177136|454269240|FG000|LTSE Phase|Lost to Follow-up|0|||
126266924|NCT02177136|454269241|FG001|LTSE Phase|Lost to Follow-up|0|||
126266925|NCT02177136|454269242|FG002|LTSE Phase|Lost to Follow-up|0|||
126266926|NCT02177136|454269243|FG003|LTSE Phase|Lost to Follow-up|1|||
126266927|NCT02177136|454269240|FG000|LTSE Phase|Participant Moved|0|||
126266928|NCT02177136|454269241|FG001|LTSE Phase|Participant Moved|0|||
126266929|NCT02177136|454269242|FG002|LTSE Phase|Participant Moved|0|||
126266930|NCT02177136|454269243|FG003|LTSE Phase|Participant Moved|1|||
126266931|NCT01386684|454269244|FG000|Overall Study|Lost to Follow-up|51|||
126266932|NCT01386684|454269244|FG000|Overall Study|Other|51|||
126266933|NCT01386684|454269244|FG000|Overall Study|Death|47|||
126266934|NCT01386684|454269244|FG000|Overall Study|Withdrawal of Consent|44|||
126266935|NCT01386684|454269244|FG000|Overall Study|Alternative Therapy Required|37|||
126266936|NCT01386684|454269244|FG000|Overall Study|Disease Progression|28|||
126266937|NCT01386684|454269244|FG000|Overall Study|Adverse Event|20|||
126266938|NCT01386684|454269244|FG000|Overall Study|Noncompliance|8|||
126266939|NCT01386684|454269244|FG000|Overall Study|Protocol Violation|4|||
126266940|NCT01386684|454269244|FG000|Overall Study|Missing|3|||
126266941|NCT01032018|454269245|FG000|Overall Study|Lost to Follow-up|6|||
126266942|NCT01032018|454269246|FG001|Overall Study|Lost to Follow-up|5|||
126266943|NCT01032018|454269245|FG000|Overall Study|Death|0|||
126266944|NCT01032018|454269246|FG001|Overall Study|Death|1|||
126266945|NCT03247517|454269253|FG000|Overall Study|Adverse Event|0|||
126266946|NCT03247517|454269254|FG001|Overall Study|Adverse Event|4|||
126266947|NCT03247517|454269255|FG002|Overall Study|Adverse Event|2|||
126266948|NCT03247517|454269253|FG000|Overall Study|Lost to Follow-up|2|||
126266949|NCT03247517|454269254|FG001|Overall Study|Lost to Follow-up|6|||
126266950|NCT03247517|454269255|FG002|Overall Study|Lost to Follow-up|4|||
126266951|NCT03247517|454269253|FG000|Overall Study|Consent withdrawn by caregiver|1|||
126266952|NCT03247517|454269254|FG001|Overall Study|Consent withdrawn by caregiver|4|||
126266953|NCT03247517|454269255|FG002|Overall Study|Consent withdrawn by caregiver|7|||
126266954|NCT03247517|454269253|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
126266955|NCT03247517|454269254|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
126266956|NCT03247517|454269255|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
126266957|NCT03247517|454269253|FG000|Overall Study|Protocol Violation|0|||
126266958|NCT03247517|454269254|FG001|Overall Study|Protocol Violation|2|||
126266959|NCT03247517|454269255|FG002|Overall Study|Protocol Violation|0|||
126266960|NCT03247517|454269253|FG000|Overall Study|Multiple reasons|3|||
126266961|NCT03247517|454269254|FG001|Overall Study|Multiple reasons|1|||
126266962|NCT03247517|454269255|FG002|Overall Study|Multiple reasons|0|||
126266963|NCT03265288|454269256|FG000|Overall Study|Adverse Event|0|||
126266964|NCT03265288|454269257|FG001|Overall Study|Adverse Event|1|||
126266965|NCT03265288|454269256|FG000|Overall Study|Withdrawal by Subject|13|||
126266966|NCT03265288|454269257|FG001|Overall Study|Withdrawal by Subject|5|||
126266967|NCT03265288|454269256|FG000|Overall Study|Drug Withdrawn|3|||
126266968|NCT03265288|454269257|FG001|Overall Study|Drug Withdrawn|3|||
126266969|NCT03265288|454269256|FG000|Overall Study|Any Other Reason|7|||
126266970|NCT03265288|454269257|FG001|Overall Study|Any Other Reason|3|||
126266971|NCT03197558|454269258|FG000|Overall Study|Tubes not placed|1|||
126266972|NCT02072148|454269269|FG000|Overall Study|withdrew prior to surgery|23|||
126266973|NCT02072148|454269270|FG001|Overall Study|withdrew prior to surgery|0|||
126266974|NCT02072148|454269271|FG002|Overall Study|withdrew prior to surgery|0|||
126266975|NCT02072148|454269269|FG000|Overall Study|Death|0|||
126266976|NCT02072148|454269270|FG001|Overall Study|Death|0|||
126266977|NCT02072148|454269271|FG002|Overall Study|Death|1|||
126266978|NCT02072148|454269269|FG000|Overall Study|Withdrawal by Subject|0|||
126266979|NCT02072148|454269270|FG001|Overall Study|Withdrawal by Subject|13|||
126266980|NCT02072148|454269271|FG002|Overall Study|Withdrawal by Subject|12|||
126266981|NCT00158756|454269277|FG000|Overall Study|Withdrawal by Subject|5|||
126266982|NCT00158756|454269278|FG001|Overall Study|Withdrawal by Subject|0|||
126266983|NCT00158756|454269279|FG002|Overall Study|Withdrawal by Subject|6|||
126360472|NCT02006654|454610825|FG001|Overall Study|Withdrawal by Subject|12|||
126360473|NCT02006654|454610824|FG000|Overall Study|Protocol Violation|5|||
126360474|NCT02006654|454610825|FG001|Overall Study|Protocol Violation|8|||
126360475|NCT02006654|454610824|FG000|Overall Study|Lost to Follow-up|1|||
126360476|NCT02006654|454610825|FG001|Overall Study|Lost to Follow-up|0|||
126360477|NCT02006654|454610824|FG000|Overall Study|patient's will|2|||
126360478|NCT02006654|454610825|FG001|Overall Study|patient's will|1|||
126360479|NCT02006654|454610824|FG000|Overall Study|insufficient compliance|1|||
126360480|NCT02006654|454610825|FG001|Overall Study|insufficient compliance|0|||
126266984|NCT00158756|454269280|FG003|Overall Study|Withdrawal by Subject|1|||
126266985|NCT00158756|454269281|FG004|Overall Study|Withdrawal by Subject|3|||
126266986|NCT00158756|454269277|FG000|Overall Study|Adverse Event|0|||
126266987|NCT00158756|454269278|FG001|Overall Study|Adverse Event|0|||
126266988|NCT00158756|454269279|FG002|Overall Study|Adverse Event|1|||
126266989|NCT00158756|454269280|FG003|Overall Study|Adverse Event|0|||
126266990|NCT00158756|454269281|FG004|Overall Study|Adverse Event|0|||
126266991|NCT00158756|454269277|FG000|Overall Study|Serious adverse event|0|||
126266992|NCT00158756|454269278|FG001|Overall Study|Serious adverse event|0|||
126266993|NCT00158756|454269279|FG002|Overall Study|Serious adverse event|1|||
126266994|NCT00158756|454269280|FG003|Overall Study|Serious adverse event|0|||
126266995|NCT00158756|454269281|FG004|Overall Study|Serious adverse event|0|||
126266996|NCT04132336|454269282|FG000|Overall Study|Investigator Decision|0|||
126360481|NCT02006654|454610824|FG000|Overall Study|worsening cognitive condition|0|||
126266997|NCT04132336|454269283|FG001|Overall Study|Investigator Decision|1|||
126266998|NCT04132336|454269284|FG002|Overall Study|Investigator Decision|0|||
126266999|NCT04132336|454269285|FG003|Overall Study|Investigator Decision|0|||
125880722|NCT01744977|452862608|FG000|Overall Study|Withdrawal by Subject|1|||
125880723|NCT01744977|452862609|FG001|Overall Study|Withdrawal by Subject|2|||
126267000|NCT04132336|454269286|FG004|Overall Study|Investigator Decision|0|||
126267001|NCT04132336|454269287|FG005|Overall Study|Investigator Decision|0|||
126267002|NCT04132336|454269288|FG006|Overall Study|Investigator Decision|0|||
126267003|NCT02528123|454269289|FG000|Overall Study|Lost to Follow-up|1|||
126267004|NCT01939496|454269291|FG000|Overall Study|Adverse Event|2|||
126267005|NCT01939496|454269292|FG001|Overall Study|Adverse Event|0|||
126267006|NCT01939496|454269293|FG002|Overall Study|Adverse Event|0|||
126267007|NCT01939496|454269291|FG000|Overall Study|Lost to Follow-up|1|||
126267008|NCT01939496|454269292|FG001|Overall Study|Lost to Follow-up|1|||
126267009|NCT01939496|454269293|FG002|Overall Study|Lost to Follow-up|0|||
126267010|NCT01939496|454269291|FG000|Overall Study|Physician Decision|1|||
126267011|NCT01939496|454269292|FG001|Overall Study|Physician Decision|0|||
126267012|NCT01939496|454269293|FG002|Overall Study|Physician Decision|0|||
126267013|NCT01939496|454269291|FG000|Overall Study|Protocol Violation|3|||
126267014|NCT01939496|454269292|FG001|Overall Study|Protocol Violation|0|||
126267015|NCT01939496|454269293|FG002|Overall Study|Protocol Violation|0|||
126267016|NCT01939496|454269291|FG000|Overall Study|Withdrawal by Subject|0|||
126267017|NCT01939496|454269292|FG001|Overall Study|Withdrawal by Subject|1|||
126267018|NCT01939496|454269293|FG002|Overall Study|Withdrawal by Subject|1|||
126267019|NCT01939496|454269291|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
126267020|NCT01939496|454269292|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
126267021|NCT01939496|454269293|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
126267022|NCT01939496|454269291|FG000|Overall Study|Other|2|||
126267023|NCT01939496|454269292|FG001|Overall Study|Other|0|||
126267024|NCT01939496|454269293|FG002|Overall Study|Other|1|||
126267025|NCT03052322|454269294|FG000|Overall Study|Other un-specified|1|||
126267026|NCT03052322|454269295|FG001|Overall Study|Other un-specified|2|||
126267027|NCT03052322|454269294|FG000|Overall Study|Withdrawal by Subject|10|||
126267028|NCT03052322|454269295|FG001|Overall Study|Withdrawal by Subject|9|||
126267029|NCT03052322|454269294|FG000|Overall Study|Death|0|||
126267030|NCT03052322|454269295|FG001|Overall Study|Death|2|||
126267031|NCT03052322|454269294|FG000|Overall Study|Lack of Efficacy|1|||
126267032|NCT03052322|454269295|FG001|Overall Study|Lack of Efficacy|2|||
126267033|NCT03052322|454269294|FG000|Overall Study|Protocol Violation|1|||
126267034|NCT03052322|454269295|FG001|Overall Study|Protocol Violation|0|||
126267035|NCT03052322|454269294|FG000|Overall Study|Lost to Follow-up|2|||
126267036|NCT03052322|454269295|FG001|Overall Study|Lost to Follow-up|4|||
126267037|NCT03052322|454269294|FG000|Overall Study|Adverse Event|6|||
126267038|NCT03052322|454269295|FG001|Overall Study|Adverse Event|13|||
126267039|NCT00136318|454269298|FG000|Overall Study|Adverse Event|5|||
126267040|NCT00136318|454269299|FG001|Overall Study|Adverse Event|5|||
126267041|NCT00136318|454269298|FG000|Overall Study|Withdrawal by Subject|2|||
126267042|NCT00136318|454269299|FG001|Overall Study|Withdrawal by Subject|2|||
126267043|NCT00775606|454269302|FG000|Overall Study|Study sponsor terminated funding|3|||
126267044|NCT00775606|454269303|FG001|Overall Study|Study sponsor terminated funding|0|||
126267045|NCT02278718|454269304|FG000|Overall Study|Adverse Event|1|||
125880724|NCT01744977|452862608|FG000|Overall Study|Death|2|||
126267046|NCT02278718|454269305|FG001|Overall Study|Adverse Event|0|||
126267047|NCT02278718|454269304|FG000|Overall Study|Lost to Follow-up|2|||
126267048|NCT02278718|454269305|FG001|Overall Study|Lost to Follow-up|4|||
126267049|NCT02278718|454269304|FG000|Overall Study|Withdrawal by Subject|1|||
126267050|NCT02278718|454269305|FG001|Overall Study|Withdrawal by Subject|4|||
126267051|NCT02278718|454269304|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
126267052|NCT02278718|454269305|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
126267053|NCT02278718|454269304|FG000|Overall Study|Missing|0|||
126267054|NCT02278718|454269305|FG001|Overall Study|Missing|1|||
126267055|NCT01546649|454269306|FG000|Overall Study|Adverse Event|4|||
126267056|NCT01546649|454269307|FG001|Overall Study|Adverse Event|5|||
126267057|NCT01546649|454269306|FG000|Overall Study|Protocol Violation|1|||
126267058|NCT01546649|454269307|FG001|Overall Study|Protocol Violation|0|||
126267059|NCT01546649|454269306|FG000|Overall Study|Lack of Efficacy|1|||
126267060|NCT01546649|454269307|FG001|Overall Study|Lack of Efficacy|0|||
126267061|NCT01546649|454269306|FG000|Overall Study|Recurrence|1|||
126267062|NCT01546649|454269307|FG001|Overall Study|Recurrence|1|||
126267063|NCT01546649|454269306|FG000|Overall Study|Discovery of secondary cancer|0|||
126267064|NCT01546649|454269307|FG001|Overall Study|Discovery of secondary cancer|1|||
126267065|NCT01546649|454269306|FG000|Overall Study|Withdrawal by Subject|1|||
126267066|NCT01546649|454269307|FG001|Overall Study|Withdrawal by Subject|2|||
126267067|NCT04440449|454269308|FG000|Overall Study|Lost to Follow-up|2|||
126267068|NCT04440449|454269309|FG001|Overall Study|Lost to Follow-up|0|||
126267069|NCT03212794|454269310|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
126267070|NCT03212794|454269311|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
126267071|NCT03212794|454269310|FG000|Overall Study|Lost to Follow-up|5|||
126267072|NCT03212794|454269311|FG001|Overall Study|Lost to Follow-up|6|||
126267073|NCT03212794|454269310|FG000|Overall Study|Incarcerated; unable to participate|2|||
126267074|NCT03212794|454269311|FG001|Overall Study|Incarcerated; unable to participate|0|||
126267075|NCT03212794|454269310|FG000|Overall Study|Withdrawal by Subject|1|||
126267076|NCT03212794|454269311|FG001|Overall Study|Withdrawal by Subject|0|||
126267077|NCT03212794|454269310|FG000|Overall Study|Death|0|||
126267078|NCT03212794|454269311|FG001|Overall Study|Death|1|||
126267079|NCT03212794|454269310|FG000|Overall Study|Found to be ineligible after allocation|0|||
126267080|NCT03212794|454269311|FG001|Overall Study|Found to be ineligible after allocation|1|||
126267081|NCT03212794|454269310|FG000|Overall Study|Relocated out of area|2|||
126267082|NCT03212794|454269311|FG001|Overall Study|Relocated out of area|0|||
126267083|NCT01763918|454269312|FG000|Overall Study|Withdrawal by Subject|2|||
126267084|NCT01763918|454269313|FG001|Overall Study|Withdrawal by Subject|1|||
126267085|NCT01763918|454269314|FG002|Overall Study|Withdrawal by Subject|1|||
126267086|NCT01763918|454269315|FG003|Overall Study|Withdrawal by Subject|2|||
126267087|NCT01763918|454269312|FG000|Overall Study|Sponsor Decision|4|||
126267088|NCT01763918|454269313|FG001|Overall Study|Sponsor Decision|0|||
126267089|NCT01763918|454269314|FG002|Overall Study|Sponsor Decision|9|||
126267090|NCT01763918|454269315|FG003|Overall Study|Sponsor Decision|0|||
126267091|NCT03395639|454269316|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
126267092|NCT03395639|454269317|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
126267093|NCT03395639|454269318|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
126267094|NCT03395639|454269316|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
126267095|NCT03395639|454269317|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
126267096|NCT03395639|454269318|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
126267097|NCT03395639|454269316|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
126267098|NCT03395639|454269317|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
126267099|NCT03395639|454269318|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
126267100|NCT03395639|454269316|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
126267101|NCT03395639|454269317|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
126267102|NCT03395639|454269318|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
126267103|NCT03395639|454269316|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
126267104|NCT03395639|454269317|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
126267105|NCT03395639|454269318|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
126267106|NCT00942331|454269319|FG000|Overall Study|Did not start treatment|15|||
126267107|NCT00942331|454269320|FG001|Overall Study|Did not start treatment|22|||
126267108|NCT00597116|454269323|FG000|Overall Study|Adverse Event|2|||
126267109|NCT00597116|454269324|FG001|Overall Study|Adverse Event|1|||
126267110|NCT00597116|454269323|FG000|Overall Study|Withdrawal by Subject|0|||
126267111|NCT00597116|454269324|FG001|Overall Study|Withdrawal by Subject|2|||
126267112|NCT00597116|454269323|FG000|Overall Study|Physician Decision|0|||
126267113|NCT00597116|454269324|FG001|Overall Study|Physician Decision|1|||
126267114|NCT00597116|454269323|FG000|Overall Study|Death|0|||
126267115|NCT00597116|454269324|FG001|Overall Study|Death|1|||
126267116|NCT00597116|454269323|FG000|Overall Study|Lost to Follow-up|1|||
126267117|NCT00597116|454269324|FG001|Overall Study|Lost to Follow-up|0|||
126267118|NCT00597116|454269323|FG000|Overall Study|Progressive disease|11|||
126267119|NCT00597116|454269324|FG001|Overall Study|Progressive disease|6|||
126267120|NCT03832738|454269326|FG000|Overall Study|Withdrawal by Subject|6|||
126267121|NCT03832738|454269327|FG001|Overall Study|Withdrawal by Subject|7|||
126267122|NCT03832738|454269328|FG002|Overall Study|Withdrawal by Subject|16|||
126267123|NCT03832738|454269326|FG000|Overall Study|Physician Decision|0|||
126267124|NCT03832738|454269327|FG001|Overall Study|Physician Decision|1|||
126267125|NCT03832738|454269328|FG002|Overall Study|Physician Decision|2|||
126267126|NCT03832738|454269326|FG000|Overall Study|Adverse Event|2|||
126267127|NCT03832738|454269327|FG001|Overall Study|Adverse Event|3|||
126267128|NCT03832738|454269328|FG002|Overall Study|Adverse Event|1|||
126267129|NCT03832738|454269326|FG000|Overall Study|Pregnancy|0|||
126267130|NCT03832738|454269327|FG001|Overall Study|Pregnancy|1|||
126267131|NCT03832738|454269328|FG002|Overall Study|Pregnancy|0|||
126267132|NCT03977701|454269329|FG000|Overall Study|COVID-19 pandemic|0|||
126267133|NCT03977701|454269330|FG001|Overall Study|COVID-19 pandemic|0|||
126267134|NCT03977701|454269331|FG002|Overall Study|COVID-19 pandemic|0|||
126267135|NCT03977701|454269332|FG003|Overall Study|COVID-19 pandemic|0|||
126267136|NCT03977701|454269333|FG004|Overall Study|COVID-19 pandemic|0|||
126267137|NCT03977701|454269334|FG005|Overall Study|COVID-19 pandemic|1|||
126267138|NCT03977701|454269335|FG006|Overall Study|COVID-19 pandemic|0|||
126267139|NCT03977701|454269336|FG007|Overall Study|COVID-19 pandemic|1|||
126267140|NCT03977701|454269337|FG008|Overall Study|COVID-19 pandemic|0|||
126267141|NCT03977701|454269338|FG009|Overall Study|COVID-19 pandemic|0|||
126267142|NCT00702208|454269339|FG000|Overall Study|Lost to Follow-up|28|||
126267143|NCT00702208|454269339|FG000|Overall Study|Did not self-lavage|1|||
126098483|NCT01160289|453653013|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
126098484|NCT01160289|453653014|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
126098485|NCT01160289|453653009|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
126098486|NCT01160289|453653010|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
126098487|NCT01160289|453653011|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
126098488|NCT01160289|453653012|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
126098489|NCT01160289|453653013|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
126098490|NCT01160289|453653014|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
126098491|NCT01160289|453653009|FG000|Post-Randomization Period|Sponsor Decision|0|||
126098492|NCT01160289|453653010|FG001|Post-Randomization Period|Sponsor Decision|1|||
126098493|NCT01160289|453653011|FG002|Post-Randomization Period|Sponsor Decision|0|||
126098494|NCT01160289|453653012|FG003|Post-Randomization Period|Sponsor Decision|0|||
126098495|NCT01160289|453653013|FG004|Post-Randomization Period|Sponsor Decision|0|||
126098496|NCT01160289|453653014|FG005|Post-Randomization Period|Sponsor Decision|0|||
126098497|NCT03292432|453653018|FG000|Overall Study|Lost to Follow-up|11|||
126098498|NCT03292432|453653019|FG001|Overall Study|Lost to Follow-up|8|||
126098499|NCT03292432|453653018|FG000|Overall Study|Death|2|||
126267144|NCT00702208|454269339|FG000|Overall Study|Unsatisfactory colposcopy|2|||
126267145|NCT02220725|454269340|FG000|Overall Study|Lost to Follow-up|0|||
126267146|NCT02220725|454269341|FG001|Overall Study|Lost to Follow-up|0|||
126267147|NCT02220725|454269342|FG002|Overall Study|Lost to Follow-up|0|||
126267148|NCT02220725|454269343|FG003|Overall Study|Lost to Follow-up|1|||
126267149|NCT02220725|454269340|FG000|Overall Study|Withdrawal by Subject|0|||
126267150|NCT02220725|454269341|FG001|Overall Study|Withdrawal by Subject|0|||
126267151|NCT02220725|454269342|FG002|Overall Study|Withdrawal by Subject|0|||
126267152|NCT02220725|454269343|FG003|Overall Study|Withdrawal by Subject|1|||
126267153|NCT03487848|454269344|FG000|Overall Study|Lost to Follow-up|1|||
126267154|NCT00731549|454269345|FG000|Overall Study|Lost to Follow-up|19|||
126267155|NCT00731549|454269345|FG000|Overall Study|Met withdrawal criteria|24|||
126267156|NCT00731549|454269345|FG000|Overall Study|Physician Decision|16|||
126267157|NCT00731549|454269345|FG000|Overall Study|Withdrawal by Subject|89|||
126267158|NCT00731549|454269345|FG000|Overall Study|Protocol deviation|1|||
126267159|NCT00731549|454269345|FG000|Overall Study|Adverse Event|31|||
126267160|NCT00731549|454269345|FG000|Overall Study|Lack of efficacy with AE|37|||
126267161|NCT00731549|454269345|FG000|Overall Study|Lack of efficacy without AE|6|||
126267162|NCT01393730|454269346|FG000|Overall Study|Withdrawal by Subject|3|||
126267163|NCT01393730|454269346|FG000|Overall Study|Other|2|||
125880725|NCT01744977|452862609|FG001|Overall Study|Death|3|||
125880726|NCT01744977|452862608|FG000|Overall Study|Lost to Follow-up|2|||
126098500|NCT03292432|453653019|FG001|Overall Study|Death|1|||
126098501|NCT03292432|453653018|FG000|Overall Study|Withdrawal by Subject|1|||
126267164|NCT01393730|454269346|FG000|Overall Study|Adverse Event|1|||
126267165|NCT00103402|454269347|FG000|Overall Study|Adverse Event|3|||
126267166|NCT00103402|454269348|FG001|Overall Study|Adverse Event|4|||
126267167|NCT00103402|454269347|FG000|Overall Study|Lost to Follow-up|8|||
126267168|NCT00103402|454269348|FG001|Overall Study|Lost to Follow-up|7|||
126267169|NCT00103402|454269347|FG000|Overall Study|Dissatisfied/No longer interested|6|||
126360482|NCT02006654|454610825|FG001|Overall Study|worsening cognitive condition|1|||
126360483|NCT02006654|454610824|FG000|Overall Study|faecal incontinence|0|||
126360484|NCT02006654|454610825|FG001|Overall Study|faecal incontinence|1|||
126360485|NCT02006654|454610824|FG000|Overall Study|mood disorder|0|||
126360486|NCT02006654|454610825|FG001|Overall Study|mood disorder|1|||
126360487|NCT02006654|454610824|FG000|Overall Study|disallowed medication|1|||
126360488|NCT02006654|454610825|FG001|Overall Study|disallowed medication|0|||
126360489|NCT02006654|454610824|FG000|Overall Study|moving out of state|0|||
126360490|NCT02006654|454610825|FG001|Overall Study|moving out of state|1|||
126360491|NCT00478140|454610826|FG000|Overall Study|Clinical Disease Progression|1|||
126360492|NCT00676689|454610829|FG000|Overall Study|Screen Failure|2|||
126360493|NCT00676689|454610829|FG000|Overall Study|Death|2|||
126360494|NCT00676689|454610829|FG000|Overall Study|Lost to Follow-up|4|||
126360495|NCT00676689|454610829|FG000|Overall Study|Physician Decision|1|||
126360496|NCT00676689|454610829|FG000|Overall Study|Withdrawal by Subject|3|||
126036609|NCT03854227|453433014|FG007|Overall Study|Study terminated by sponsor|0|||
126036610|NCT03854227|453433015|FG008|Overall Study|Study terminated by sponsor|0|||
126036611|NCT03854227|453433016|FG009|Overall Study|Study terminated by sponsor|1|||
126036612|NCT03854227|453433017|FG010|Overall Study|Study terminated by sponsor|0|||
126036613|NCT03854227|453433018|FG011|Overall Study|Study terminated by sponsor|0|||
126036614|NCT03854227|453433007|FG000|Overall Study|Withdrawal by Subject|0|||
126036615|NCT03854227|453433008|FG001|Overall Study|Withdrawal by Subject|0|||
126036616|NCT03854227|453433009|FG002|Overall Study|Withdrawal by Subject|1|||
126036617|NCT03854227|453433010|FG003|Overall Study|Withdrawal by Subject|0|||
126036618|NCT03854227|453433011|FG004|Overall Study|Withdrawal by Subject|0|||
126036619|NCT03854227|453433012|FG005|Overall Study|Withdrawal by Subject|0|||
126036620|NCT03854227|453433013|FG006|Overall Study|Withdrawal by Subject|0|||
126036621|NCT03854227|453433014|FG007|Overall Study|Withdrawal by Subject|0|||
126036622|NCT03854227|453433015|FG008|Overall Study|Withdrawal by Subject|0|||
126036623|NCT03854227|453433016|FG009|Overall Study|Withdrawal by Subject|1|||
126036624|NCT03854227|453433017|FG010|Overall Study|Withdrawal by Subject|1|||
126036625|NCT03854227|453433018|FG011|Overall Study|Withdrawal by Subject|0|||
126036626|NCT03854227|453433007|FG000|Overall Study|Disease relapse|0|||
126036627|NCT03854227|453433008|FG001|Overall Study|Disease relapse|0|||
126036628|NCT03854227|453433009|FG002|Overall Study|Disease relapse|0|||
126036629|NCT03854227|453433010|FG003|Overall Study|Disease relapse|0|||
126036630|NCT03854227|453433011|FG004|Overall Study|Disease relapse|0|||
126036631|NCT03854227|453433012|FG005|Overall Study|Disease relapse|0|||
126036632|NCT03854227|453433013|FG006|Overall Study|Disease relapse|0|||
126036633|NCT03854227|453433014|FG007|Overall Study|Disease relapse|0|||
126036634|NCT03854227|453433015|FG008|Overall Study|Disease relapse|1|||
126036635|NCT03854227|453433016|FG009|Overall Study|Disease relapse|0|||
126036636|NCT03854227|453433017|FG010|Overall Study|Disease relapse|0|||
126036637|NCT03854227|453433018|FG011|Overall Study|Disease relapse|0|||
126036638|NCT03854227|453433007|FG000|Overall Study|Global deterioration of health status|0|||
126036639|NCT03854227|453433008|FG001|Overall Study|Global deterioration of health status|0|||
126036640|NCT03854227|453433009|FG002|Overall Study|Global deterioration of health status|0|||
126036641|NCT03854227|453433010|FG003|Overall Study|Global deterioration of health status|0|||
126036642|NCT03854227|453433011|FG004|Overall Study|Global deterioration of health status|0|||
126036643|NCT03854227|453433012|FG005|Overall Study|Global deterioration of health status|1|||
126036644|NCT03854227|453433013|FG006|Overall Study|Global deterioration of health status|0|||
126036645|NCT03854227|453433014|FG007|Overall Study|Global deterioration of health status|1|||
126036646|NCT03854227|453433015|FG008|Overall Study|Global deterioration of health status|0|||
126036647|NCT03854227|453433016|FG009|Overall Study|Global deterioration of health status|0|||
126036648|NCT03854227|453433017|FG010|Overall Study|Global deterioration of health status|0|||
126036649|NCT03854227|453433018|FG011|Overall Study|Global deterioration of health status|0|||
126036650|NCT03854227|453433007|FG000|Overall Study|Refused further treatment|0|||
126036651|NCT03854227|453433008|FG001|Overall Study|Refused further treatment|0|||
126360497|NCT00676689|454610829|FG000|Overall Study|Continuing FU|49|||
126360498|NCT03438656|454610830|FG000|Overall Study|Lost to Follow-up|2|||
126036652|NCT03854227|453433009|FG002|Overall Study|Refused further treatment|0|||
126036653|NCT03854227|453433010|FG003|Overall Study|Refused further treatment|0|||
126036654|NCT03854227|453433011|FG004|Overall Study|Refused further treatment|0|||
126036655|NCT03854227|453433012|FG005|Overall Study|Refused further treatment|0|||
126036656|NCT03854227|453433013|FG006|Overall Study|Refused further treatment|0|||
126267170|NCT00103402|454269348|FG001|Overall Study|Dissatisfied/No longer interested|6|||
126267171|NCT00103402|454269347|FG000|Overall Study|Personal constraints/Other|5|||
126267172|NCT00103402|454269348|FG001|Overall Study|Personal constraints/Other|0|||
126267173|NCT02333487|454269349|FG000|Overall Study|Adverse Event|0|||
126267174|NCT02333487|454269350|FG001|Overall Study|Adverse Event|2|||
126267175|NCT02333487|454269351|FG002|Overall Study|Adverse Event|0|||
126267176|NCT01583218|454269353|FG000|Overall Study|Withdrawal by Subject|43|||
126267177|NCT01583218|454269354|FG001|Overall Study|Withdrawal by Subject|29|||
126267178|NCT01583218|454269353|FG000|Overall Study|Death|206|||
126267179|NCT01583218|454269354|FG001|Overall Study|Death|211|||
126267180|NCT01583218|454269353|FG000|Overall Study|Lost to Follow-up|11|||
126267181|NCT01583218|454269354|FG001|Overall Study|Lost to Follow-up|17|||
126267182|NCT01583218|454269353|FG000|Overall Study|Adverse event or serious adverse event|3|||
126267183|NCT01583218|454269354|FG001|Overall Study|Adverse event or serious adverse event|3|||
126267184|NCT01583218|454269353|FG000|Overall Study|Patient /Family decision|3|||
126267185|NCT01583218|454269354|FG001|Overall Study|Patient /Family decision|0|||
126267186|NCT01583218|454269353|FG000|Overall Study|Cannot contact patient directly|1|||
126267187|NCT01583218|454269354|FG001|Overall Study|Cannot contact patient directly|2|||
126267188|NCT01583218|454269353|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
126267189|NCT01583218|454269354|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
126267190|NCT01583218|454269353|FG000|Overall Study|Patient did not wish to attend visits|0|||
126267191|NCT01583218|454269354|FG001|Overall Study|Patient did not wish to attend visits|1|||
126267192|NCT01583218|454269353|FG000|Overall Study|Patient randomized but not dosed|17|||
126267193|NCT01583218|454269354|FG001|Overall Study|Patient randomized but not dosed|16|||
126267194|NCT01583218|454269353|FG000|Overall Study|Patient was assessed via phone in person|1|||
126267195|NCT01583218|454269354|FG001|Overall Study|Patient was assessed via phone in person|0|||
126267196|NCT01583218|454269353|FG000|Overall Study|Patient deemed ineligible after random|2|||
126267197|NCT01583218|454269354|FG001|Overall Study|Patient deemed ineligible after random|0|||
126267198|NCT01583218|454269353|FG000|Overall Study|Patient was early terminated from study|0|||
126267199|NCT01583218|454269354|FG001|Overall Study|Patient was early terminated from study|1|||
126267200|NCT01583218|454269353|FG000|Overall Study|Patient was randomized due to mistake|1|||
126267201|NCT01583218|454269354|FG001|Overall Study|Patient was randomized due to mistake|0|||
126267202|NCT01583218|454269353|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
126267203|NCT01583218|454269354|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
126267204|NCT01583218|454269353|FG000|Overall Study|Withdraw of consent on day of random|1|||
126267205|NCT01583218|454269354|FG001|Overall Study|Withdraw of consent on day of random|0|||
126267206|NCT00712985|454269357|FG000|Overall Study|1 withdrew prior to start of drug|1|||
126267207|NCT00712985|454269357|FG000|Overall Study|1 patient moved out of state|1|||
126267208|NCT00712985|454269357|FG000|Overall Study|Lack of Efficacy|3|||
126267209|NCT01299805|454269360|FG000|Overall Study|Adverse Event|2|||
126267210|NCT01299805|454269361|FG001|Overall Study|Adverse Event|0|||
126267211|NCT00123955|454269365|FG000|Overall Study|Adverse Event|1|||
126267212|NCT00123955|454269366|FG001|Overall Study|Adverse Event|0|||
126267213|NCT00123955|454269365|FG000|Overall Study|Withdrawal by Subject|4|||
126267214|NCT00123955|454269366|FG001|Overall Study|Withdrawal by Subject|3|||
126267215|NCT00123955|454269365|FG000|Overall Study|Death|0|||
126267216|NCT00123955|454269366|FG001|Overall Study|Death|1|||
126267217|NCT03334721|454269367|FG000|Overall Study|Withdrawal by Subject|1|||
126267218|NCT03334721|454269368|FG001|Overall Study|Withdrawal by Subject|0|||
126267219|NCT03334721|454269367|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
126267220|NCT03334721|454269368|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
126267221|NCT01663727|454269370|FG000|Overall Study|Death|161|||
126267222|NCT01663727|454269371|FG001|Overall Study|Death|155|||
126267223|NCT01663727|454269370|FG000|Overall Study|Lost to Follow-up|10|||
126267224|NCT01663727|454269371|FG001|Overall Study|Lost to Follow-up|8|||
126267225|NCT01663727|454269370|FG000|Overall Study|Withdrawal by Subject|18|||
126267226|NCT01663727|454269371|FG001|Overall Study|Withdrawal by Subject|25|||
126360499|NCT00563316|454610833|FG000|Overall Study|Adverse Event|2|||
126360500|NCT00563316|454610833|FG000|Overall Study|Physician Decision|1|||
126360501|NCT00563316|454610833|FG000|Overall Study|Lost to Follow-up|2|||
126360502|NCT00563316|454610833|FG000|Overall Study|Death|1|||
126360503|NCT00563316|454610833|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
126360504|NCT00563316|454610833|FG000|Overall Study|Other|1|||
126360505|NCT04401293|454610839|FG000|Overall Study|Withdrawal by Subject|1|||
126360506|NCT04401293|454610840|FG001|Overall Study|Withdrawal by Subject|3|||
126360507|NCT00694161|454610841|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
126360508|NCT00694161|454610841|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
126360509|NCT00694161|454610841|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
126360510|NCT03111732|454610842|FG000|Overall Study|Enrolled in different study|1|||
126360511|NCT03111732|454610842|FG000|Overall Study|Progressive disease|3|||
126360512|NCT03111732|454610842|FG000|Overall Study|Withdrawal by Subject|1|||
126360513|NCT01108055|454610843|FG000|Overall Study|Ineligible|11|||
126360514|NCT01108055|454610843|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
126267227|NCT01663727|454269370|FG000|Overall Study|Study Terminated|51|||
126267228|NCT01663727|454269371|FG001|Overall Study|Study Terminated|50|||
126267229|NCT01663727|454269370|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
126267230|NCT01663727|454269371|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
126267231|NCT01663727|454269370|FG000|Overall Study|Withdrawal prior to dosing.|1|||
126267232|NCT01663727|454269371|FG001|Overall Study|Withdrawal prior to dosing.|0|||
126267233|NCT04969861|454269373|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
126267234|NCT04969861|454269374|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
126267235|NCT04718194|454270843|FG000|Overall Study|Withdrawal by Subject|3|||
126267236|NCT04718194|454270844|FG001|Overall Study|Withdrawal by Subject|0|||
126267237|NCT04718194|454270843|FG000|Overall Study|Lost to Follow-up|3|||
126267238|NCT04718194|454270844|FG001|Overall Study|Lost to Follow-up|0|||
126267239|NCT02091141|454270846|FG000|Overall Study|Death|280|||
126267240|NCT02091141|454270847|FG001|Overall Study|Death|118|||
126267241|NCT02091141|454270848|FG002|Overall Study|Death|46|||
126267242|NCT02091141|454270849|FG003|Overall Study|Death|13|||
126267243|NCT02091141|454270850|FG004|Overall Study|Death|31|||
126267244|NCT02091141|454270851|FG005|Overall Study|Death|16|||
126267245|NCT02091141|454270852|FG006|Overall Study|Death|12|||
126267246|NCT02091141|454270846|FG000|Overall Study|Withdrawal by Subject|21|||
126267247|NCT02091141|454270847|FG001|Overall Study|Withdrawal by Subject|13|||
126267248|NCT02091141|454270848|FG002|Overall Study|Withdrawal by Subject|3|||
126267249|NCT02091141|454270849|FG003|Overall Study|Withdrawal by Subject|2|||
126267250|NCT02091141|454270850|FG004|Overall Study|Withdrawal by Subject|2|||
126267251|NCT02091141|454270851|FG005|Overall Study|Withdrawal by Subject|3|||
126267252|NCT02091141|454270852|FG006|Overall Study|Withdrawal by Subject|0|||
126267253|NCT02091141|454270846|FG000|Overall Study|Lost to Follow-up|21|||
126267254|NCT02091141|454270847|FG001|Overall Study|Lost to Follow-up|5|||
126267255|NCT02091141|454270848|FG002|Overall Study|Lost to Follow-up|1|||
126267256|NCT02091141|454270849|FG003|Overall Study|Lost to Follow-up|0|||
126267257|NCT02091141|454270850|FG004|Overall Study|Lost to Follow-up|1|||
126267258|NCT02091141|454270851|FG005|Overall Study|Lost to Follow-up|2|||
126267259|NCT02091141|454270852|FG006|Overall Study|Lost to Follow-up|0|||
126267260|NCT02091141|454270846|FG000|Overall Study|Reason Not Specified|6|||
126267261|NCT02091141|454270847|FG001|Overall Study|Reason Not Specified|5|||
126267262|NCT02091141|454270848|FG002|Overall Study|Reason Not Specified|2|||
126267263|NCT02091141|454270849|FG003|Overall Study|Reason Not Specified|0|||
126267264|NCT02091141|454270850|FG004|Overall Study|Reason Not Specified|0|||
126267265|NCT02091141|454270851|FG005|Overall Study|Reason Not Specified|0|||
126267266|NCT02091141|454270852|FG006|Overall Study|Reason Not Specified|1|||
126267267|NCT02091141|454270846|FG000|Overall Study|Study Ended by Sponsor|1|||
126267268|NCT02091141|454270847|FG001|Overall Study|Study Ended by Sponsor|9|||
126267269|NCT02091141|454270848|FG002|Overall Study|Study Ended by Sponsor|0|||
126267270|NCT02091141|454270849|FG003|Overall Study|Study Ended by Sponsor|0|||
126267271|NCT02091141|454270850|FG004|Overall Study|Study Ended by Sponsor|0|||
126267272|NCT02091141|454270851|FG005|Overall Study|Study Ended by Sponsor|0|||
126267273|NCT02091141|454270852|FG006|Overall Study|Study Ended by Sponsor|0|||
126267274|NCT02091141|454270846|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267275|NCT02091141|454270847|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
126267276|NCT02091141|454270848|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267277|NCT02091141|454270849|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267278|NCT02091141|454270850|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267279|NCT02091141|454270851|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267280|NCT02091141|454270852|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267281|NCT00605865|454270853|FG000|Overall Study|Protocol Violation|115|||
126267282|NCT02119286|454270854|FG000|Overall Study|Adverse Event|9|||
126267283|NCT02119286|454270855|FG001|Overall Study|Adverse Event|7|||
126267284|NCT02119286|454270856|FG002|Overall Study|Adverse Event|2|||
126267285|NCT02119286|454270854|FG000|Overall Study|Lack of Efficacy|11|||
126267286|NCT02119286|454270855|FG001|Overall Study|Lack of Efficacy|3|||
126267287|NCT02119286|454270856|FG002|Overall Study|Lack of Efficacy|4|||
126267288|NCT02119286|454270854|FG000|Overall Study|Lost to Follow-up|2|||
126267289|NCT02119286|454270855|FG001|Overall Study|Lost to Follow-up|0|||
126267290|NCT02119286|454270856|FG002|Overall Study|Lost to Follow-up|1|||
126267291|NCT02119286|454270854|FG000|Overall Study|Withdrawal by Subject|4|||
126267292|NCT02119286|454270855|FG001|Overall Study|Withdrawal by Subject|1|||
126267293|NCT02119286|454270856|FG002|Overall Study|Withdrawal by Subject|0|||
126267294|NCT00619112|454270857|FG000|Overall Study|Adverse Event|1|||
126267295|NCT00619112|454270858|FG001|Overall Study|Adverse Event|2|||
126267296|NCT01996332|454270859|FG000|Overall Study|Adverse Event|117|||
126267297|NCT01996332|454270859|FG000|Overall Study|Lack of Efficacy|1245|||
126267298|NCT01996332|454270859|FG000|Overall Study|Death|264|||
126267299|NCT01996332|454270859|FG000|Overall Study|Protocol Violation|9|||
126267300|NCT01996332|454270859|FG000|Overall Study|Withdrawal by Subject|71|||
126267301|NCT01996332|454270859|FG000|Overall Study|Other|20|||
126267302|NCT01996332|454270859|FG000|Overall Study|Clinical Deterioration|28|||
126267303|NCT01996332|454270859|FG000|Overall Study|Physician Decision|17|||
126267304|NCT01996332|454270859|FG000|Overall Study|Lost to Follow-up|34|||
126267305|NCT02113189|454270860|FG000|Overall Study|Lost to follow up|2|||
126267306|NCT02113189|454270861|FG001|Overall Study|Lost to follow up|1|||
126267307|NCT02113189|454270862|FG002|Overall Study|Lost to follow up|3|||
126267308|NCT01388166|454270863|FG000|Overall Study|Adverse Event|16|||
126267309|NCT01388166|454270863|FG000|Overall Study|Lost to Follow-up|30|||
126267310|NCT01388166|454270863|FG000|Overall Study|Others than specified above|13|||
126267311|NCT00430495|454270864|FG000|Overall Study|Adverse Event|2|||
126267312|NCT00430495|454270865|FG001|Overall Study|Adverse Event|3|||
126267313|NCT00430495|454270866|FG002|Overall Study|Adverse Event|2|||
126267314|NCT00430495|454270867|FG003|Overall Study|Adverse Event|0|||
126267315|NCT00430495|454270864|FG000|Overall Study|Death|0|||
126267316|NCT00430495|454270865|FG001|Overall Study|Death|0|||
126267317|NCT00430495|454270866|FG002|Overall Study|Death|1|||
126267318|NCT00430495|454270867|FG003|Overall Study|Death|0|||
126267319|NCT00430495|454270864|FG000|Overall Study|Lost to Follow-up|0|||
126267320|NCT00430495|454270865|FG001|Overall Study|Lost to Follow-up|1|||
126267321|NCT00430495|454270866|FG002|Overall Study|Lost to Follow-up|4|||
126267322|NCT00430495|454270867|FG003|Overall Study|Lost to Follow-up|0|||
126267323|NCT00430495|454270864|FG000|Overall Study|Protocol Violation|1|||
126267324|NCT00430495|454270865|FG001|Overall Study|Protocol Violation|0|||
126267325|NCT00430495|454270866|FG002|Overall Study|Protocol Violation|1|||
126267326|NCT00430495|454270867|FG003|Overall Study|Protocol Violation|0|||
126267327|NCT00430495|454270864|FG000|Overall Study|Disease Progression|1|||
126267328|NCT00430495|454270865|FG001|Overall Study|Disease Progression|1|||
126267329|NCT00430495|454270866|FG002|Overall Study|Disease Progression|0|||
126267330|NCT00430495|454270867|FG003|Overall Study|Disease Progression|0|||
126267331|NCT00430495|454270864|FG000|Overall Study|Other|8|||
126267332|NCT00430495|454270865|FG001|Overall Study|Other|2|||
126267333|NCT00430495|454270866|FG002|Overall Study|Other|5|||
126267334|NCT00430495|454270867|FG003|Overall Study|Other|4|||
126267335|NCT00430495|454270864|FG000|Overall Study|Randomized but not Treated|2|||
126267336|NCT00430495|454270865|FG001|Overall Study|Randomized but not Treated|0|||
126267337|NCT00430495|454270866|FG002|Overall Study|Randomized but not Treated|0|||
126267338|NCT00430495|454270867|FG003|Overall Study|Randomized but not Treated|0|||
126267339|NCT02751359|454270868|FG000|Overall Study|Lost to Follow-up|1|||
126267340|NCT02400671|454270869|FG000|Overall Study|Death|5|||
126267341|NCT02400671|454270870|FG001|Overall Study|Death|3|||
126267342|NCT02400671|454270871|FG002|Overall Study|Death|4|||
126267343|NCT02400671|454270869|FG000|Overall Study|Lost to Follow-up|20|||
126267344|NCT02400671|454270870|FG001|Overall Study|Lost to Follow-up|27|||
126267345|NCT02400671|454270871|FG002|Overall Study|Lost to Follow-up|24|||
126267346|NCT02400671|454270869|FG000|Overall Study|Withdrawal by Subject|2|||
126267347|NCT02400671|454270870|FG001|Overall Study|Withdrawal by Subject|2|||
126267348|NCT02400671|454270871|FG002|Overall Study|Withdrawal by Subject|0|||
126267349|NCT02145026|454270872|FG000|Overall Study|Adverse Event|2|||
126267350|NCT02145026|454270872|FG000|Overall Study|Death|4|||
126267351|NCT02145026|454270872|FG000|Overall Study|Withdrawal by Subject|2|||
126267352|NCT02145026|454270872|FG000|Overall Study|Physician Decision|4|||
126267353|NCT01429051|454270873|FG000|Titration Phase|Death|1|||
126267354|NCT01429051|454270873|FG000|Titration Phase|Withdrawal by Subject|7|||
126267355|NCT01429051|454270873|FG000|Titration Phase|Physician Decision|1|||
126267356|NCT01429051|454270873|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
126267357|NCT01429051|454270873|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
126267358|NCT01429051|454270873|FG000|Efficacy Phase|Adverse Event|1|||
126267359|NCT01429051|454270873|FG000|Efficacy Phase|Death|1|||
126267360|NCT01429051|454270873|FG000|Tolerability Phase|Death|5|||
126267361|NCT01429051|454270873|FG000|Tolerability Phase|Adverse Event|2|||
126267362|NCT01429051|454270873|FG000|Tolerability Phase|Withdrawal by Subject|5|||
126267363|NCT01429051|454270873|FG000|Tolerability Phase|Physician Decision|1|||
126267364|NCT01429051|454270873|FG000|Tolerability Phase|Other|2|||
126267365|NCT00857792|454270874|FG000|Overall Study|inadequate image quality for analysis|12|||
126267366|NCT01797835|454270875|FG000|Overall Study|Lost to Follow-up|31|||
126267367|NCT01797835|454270876|FG001|Overall Study|Lost to Follow-up|27|||
126267368|NCT04295135|454270884|FG000|Overall Study|Withdrawal by Subject|2|||
126267369|NCT04295135|454270885|FG001|Overall Study|Withdrawal by Subject|1|||
126267370|NCT04295135|454270884|FG000|Overall Study|Subject left organization|8|||
126267371|NCT04295135|454270885|FG001|Overall Study|Subject left organization|4|||
126267372|NCT03484117|454270886|FG000|Overall Study|Lost to Follow-up|1|||
126267373|NCT03484117|454270887|FG001|Overall Study|Lost to Follow-up|3|||
126267374|NCT03484117|454270886|FG000|Overall Study|Declined participation in exit assess|1|||
126267375|NCT03484117|454270887|FG001|Overall Study|Declined participation in exit assess|1|||
126267376|NCT00289874|454270888|FG000|Overall Study|Adverse Event|1|||
126267377|NCT00289874|454270889|FG001|Overall Study|Adverse Event|5|||
126267378|NCT00289874|454270888|FG000|Overall Study|Lost to Follow-up|1|||
126267379|NCT00289874|454270889|FG001|Overall Study|Lost to Follow-up|1|||
126267380|NCT00289874|454270888|FG000|Overall Study|Protocol Violation|3|||
126267381|NCT00289874|454270889|FG001|Overall Study|Protocol Violation|2|||
126267382|NCT00289874|454270888|FG000|Overall Study|Did not meet eligibility|1|||
126098502|NCT03292432|453653019|FG001|Overall Study|Withdrawal by Subject|2|||
126098503|NCT03292432|453653018|FG000|Overall Study|Site closed before any data collected|1|||
126098504|NCT03292432|453653019|FG001|Overall Study|Site closed before any data collected|0|||
126267383|NCT00289874|454270889|FG001|Overall Study|Did not meet eligibility|0|||
126267384|NCT03835325|454270890|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
126267385|NCT03835325|454270890|FG000|Overall Study|Selection failure|1|||
126267386|NCT01901874|454270891|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
126267387|NCT01901874|454270891|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
126267388|NCT01901874|454270891|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
126267389|NCT01901874|454270891|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
126267390|NCT01901874|454270891|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
126267391|NCT01901874|454270891|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
126267392|NCT00770692|454270898|FG000|Overall Study|Withdrawal by Subject|7|||
126267393|NCT00770692|454270899|FG001|Overall Study|Withdrawal by Subject|9|||
126267394|NCT00770692|454270900|FG002|Overall Study|Withdrawal by Subject|9|||
126267395|NCT00770692|454270901|FG003|Overall Study|Withdrawal by Subject|6|||
126267396|NCT00770692|454270898|FG000|Overall Study|Adverse Event|3|||
126267397|NCT00770692|454270899|FG001|Overall Study|Adverse Event|0|||
126267398|NCT00770692|454270900|FG002|Overall Study|Adverse Event|4|||
126267399|NCT00770692|454270901|FG003|Overall Study|Adverse Event|4|||
126267400|NCT00770692|454270898|FG000|Overall Study|Investigator judgment|2|||
126267401|NCT00770692|454270899|FG001|Overall Study|Investigator judgment|0|||
126267402|NCT00770692|454270900|FG002|Overall Study|Investigator judgment|1|||
126267403|NCT00770692|454270901|FG003|Overall Study|Investigator judgment|1|||
126267404|NCT01138111|454270903|FG000|Overall Study|Withdrawal by Subject|5|||
126267405|NCT01138111|454270903|FG000|Overall Study|Adverse Event|1|||
126267406|NCT01138111|454270903|FG000|Overall Study|Death|1|||
126267407|NCT01138111|454270903|FG000|Overall Study|Lost to Follow-up|2|||
126267408|NCT00560937|454270906|FG000|Overall Study|Withdrawal by Subject|0|||
126267409|NCT00560937|454270907|FG001|Overall Study|Withdrawal by Subject|1|||
126267410|NCT00560937|454270906|FG000|Overall Study|Physician Decision|1|||
126267411|NCT00560937|454270907|FG001|Overall Study|Physician Decision|1|||
126267412|NCT03629028|454270908|FG000|Overall Study|Lost to Follow-up|26|||
126267413|NCT03629028|454270909|FG001|Overall Study|Lost to Follow-up|23|||
126267414|NCT03629028|454270908|FG000|Overall Study|Pregnancy|4|||
126267415|NCT03629028|454270909|FG001|Overall Study|Pregnancy|2|||
126267416|NCT03629028|454270908|FG000|Overall Study|intolerance to examination|2|||
126267417|NCT03629028|454270909|FG001|Overall Study|intolerance to examination|0|||
126267418|NCT02025751|454270912|FG000|Overall Study|Lost to Follow-up|1|||
126267419|NCT02025751|454270913|FG001|Overall Study|Lost to Follow-up|0|||
126267420|NCT02025751|454270912|FG000|Overall Study|Adverse Event|0|||
126267421|NCT02025751|454270913|FG001|Overall Study|Adverse Event|1|||
126267422|NCT02025751|454270912|FG000|Overall Study|Physician Decision|0|||
126267423|NCT02025751|454270913|FG001|Overall Study|Physician Decision|1|||
126267424|NCT02025751|454270912|FG000|Overall Study|Withdrawal by Subject|0|||
126267425|NCT02025751|454270913|FG001|Overall Study|Withdrawal by Subject|1|||
126267426|NCT00653991|454270914|FG000|3 Month Follow-up|Participant would not respond|150|||
126267427|NCT00653991|454270915|FG001|3 Month Follow-up|Participant would not respond|157|||
126267428|NCT00653991|454270914|FG000|6 Month Follow-up|Participant would not respond|133|||
126267429|NCT00653991|454270915|FG001|6 Month Follow-up|Participant would not respond|141|||
126360515|NCT03339453|454610846|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
126098505|NCT01156792|453653024|FG000|Overall Study|Adverse Event|1|||
126267430|NCT01846273|454270916|FG000|Overall Study|Adverse Event|9|||
126267431|NCT01846273|454270917|FG001|Overall Study|Adverse Event|7|||
126267432|NCT01846273|454270918|FG002|Overall Study|Adverse Event|0|||
126267433|NCT01846273|454270916|FG000|Overall Study|Subject withdrew consent|5|||
126267434|NCT01846273|454270917|FG001|Overall Study|Subject withdrew consent|8|||
126267435|NCT01846273|454270918|FG002|Overall Study|Subject withdrew consent|0|||
126267436|NCT01846273|454270916|FG000|Overall Study|Lost to Follow-up|2|||
126267437|NCT01846273|454270917|FG001|Overall Study|Lost to Follow-up|1|||
126267438|NCT01846273|454270918|FG002|Overall Study|Lost to Follow-up|0|||
126267439|NCT01846273|454270916|FG000|Overall Study|Administrative problems|1|||
126267440|NCT01846273|454270917|FG001|Overall Study|Administrative problems|0|||
126267441|NCT01846273|454270918|FG002|Overall Study|Administrative problems|0|||
126360516|NCT03339453|454610847|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
126267442|NCT01846273|454270916|FG000|Overall Study|Death|2|||
126267443|NCT01846273|454270917|FG001|Overall Study|Death|1|||
126267444|NCT01846273|454270918|FG002|Overall Study|Death|0|||
126267445|NCT01846273|454270916|FG000|Overall Study|Disease Progression|0|||
126267446|NCT01846273|454270917|FG001|Overall Study|Disease Progression|4|||
126267447|NCT01846273|454270918|FG002|Overall Study|Disease Progression|0|||
126267448|NCT01846273|454270916|FG000|Overall Study|Protocol Deviation|2|||
126267449|NCT01846273|454270917|FG001|Overall Study|Protocol Deviation|3|||
126267450|NCT01846273|454270918|FG002|Overall Study|Protocol Deviation|0|||
126267451|NCT01846273|454270916|FG000|Overall Study|Physician Decision|1|||
126267452|NCT01846273|454270917|FG001|Overall Study|Physician Decision|2|||
126267453|NCT01846273|454270918|FG002|Overall Study|Physician Decision|0|||
126267454|NCT00891839|454270919|FG000|Overall Study|Adverse Event|2|||
126267455|NCT00891839|454270919|FG000|Overall Study|Withdrawal by Subject|2|||
126267456|NCT00891839|454270919|FG000|Overall Study|Disease progression|3|||
126267457|NCT00456495|454270922|FG000|Overall Study|Physician Decision|2|||
126267458|NCT02939014|454270923|FG000|Overall Study|Lost to Follow-up|1|||
126267459|NCT02939014|454270924|FG001|Overall Study|Lost to Follow-up|0|||
126267460|NCT02939014|454270923|FG000|Overall Study|Death|4|||
126267461|NCT02939014|454270924|FG001|Overall Study|Death|3|||
126267462|NCT03864042|454270925|FG000|DDI Phase|Adverse Event|2|||
126267463|NCT03864042|454270926|FG001|DDI Phase|Adverse Event|0|||
126267464|NCT03864042|454270927|FG002|DDI Phase|Adverse Event|0|||
126267465|NCT03864042|454270925|FG000|DDI Phase|Physician Decision|1|||
126267466|NCT03864042|454270926|FG001|DDI Phase|Physician Decision|0|||
126267467|NCT03864042|454270927|FG002|DDI Phase|Physician Decision|0|||
126267468|NCT03864042|454270925|FG000|DDI Phase|Progressive Disease|1|||
126267469|NCT03864042|454270926|FG001|DDI Phase|Progressive Disease|0|||
126267470|NCT03864042|454270927|FG002|DDI Phase|Progressive Disease|0|||
126267471|NCT03864042|454270925|FG000|Post-DDI Phase|Adverse Event|5|||
126267472|NCT03864042|454270926|FG001|Post-DDI Phase|Adverse Event|3|||
126267473|NCT03864042|454270927|FG002|Post-DDI Phase|Adverse Event|2|||
126267474|NCT03864042|454270925|FG000|Post-DDI Phase|Progressive Disease|11|||
126267475|NCT03864042|454270926|FG001|Post-DDI Phase|Progressive Disease|6|||
126267476|NCT03864042|454270927|FG002|Post-DDI Phase|Progressive Disease|13|||
126267477|NCT03864042|454270925|FG000|Post-DDI Phase|Discretion of investigator|1|||
126267478|NCT03864042|454270926|FG001|Post-DDI Phase|Discretion of investigator|1|||
126267479|NCT03864042|454270927|FG002|Post-DDI Phase|Discretion of investigator|0|||
126267480|NCT03864042|454270925|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
126267481|NCT03864042|454270926|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
126267482|NCT03864042|454270927|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
126267483|NCT03864042|454270925|FG000|Post-DDI Phase|Withdrawal of consent|1|||
126267484|NCT03864042|454270926|FG001|Post-DDI Phase|Withdrawal of consent|2|||
126267485|NCT03864042|454270927|FG002|Post-DDI Phase|Withdrawal of consent|0|||
126267486|NCT05069155|454270928|FG000|Overall Study|Withdrawal by Subject|1|||
126267487|NCT05069155|454270929|FG001|Overall Study|Withdrawal by Subject|3|||
126267488|NCT01297322|454270930|FG000|Overall Study|Lost to Follow-up|1|||
126267489|NCT01297322|454270931|FG001|Overall Study|Lost to Follow-up|0|||
126267490|NCT01297322|454270930|FG000|Overall Study|Withdrawal by Subject|0|||
126267491|NCT01297322|454270931|FG001|Overall Study|Withdrawal by Subject|1|||
126267492|NCT01297322|454270930|FG000|Overall Study|Protocol Violation|0|||
126267493|NCT01297322|454270931|FG001|Overall Study|Protocol Violation|3|||
126267494|NCT01111019|454270932|FG000|Overall Study|Withdrew Prematurely|2|||
126267495|NCT01111019|454270932|FG000|Overall Study|Other|1|||
126267496|NCT02674061|454270935|FG000|Overall Study|Death|229|||
126267497|NCT02674061|454270936|FG001|Overall Study|Death|77|||
126267498|NCT02674061|454270935|FG000|Overall Study|Lost to Follow-up|3|||
126267499|NCT02674061|454270936|FG001|Overall Study|Lost to Follow-up|3|||
126267500|NCT02674061|454270935|FG000|Overall Study|Withdrawal by Subject|9|||
126267501|NCT02674061|454270936|FG001|Overall Study|Withdrawal by Subject|1|||
126267502|NCT02674061|454270935|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
126267503|NCT02674061|454270936|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
126267504|NCT01558297|454270942|FG000|Overall Study|Withdrawal by Subject|2|||
126267505|NCT01558297|454270943|FG001|Overall Study|Withdrawal by Subject|2|||
126267506|NCT01558297|454270944|FG002|Overall Study|Withdrawal by Subject|1|||
126267507|NCT01334710|454270945|FG000|Overall Study|Trial was terminated|3|||
126267508|NCT00375492|454270946|FG000|Overall Study|Adverse Event|4|||
126267509|NCT00375492|454270947|FG001|Overall Study|Adverse Event|5|||
126267510|NCT00375492|454270946|FG000|Overall Study|Entry Criteria Not Met|0|||
126267511|NCT00375492|454270947|FG001|Overall Study|Entry Criteria Not Met|1|||
126267512|NCT00375492|454270946|FG000|Overall Study|Loss of Glucose Control|0|||
126267513|NCT00375492|454270947|FG001|Overall Study|Loss of Glucose Control|1|||
126267514|NCT00375492|454270946|FG000|Overall Study|Lost to Follow-up|10|||
126267515|NCT00375492|454270947|FG001|Overall Study|Lost to Follow-up|5|||
126267516|NCT00375492|454270946|FG000|Overall Study|Physician Decision|0|||
126267517|NCT00375492|454270947|FG001|Overall Study|Physician Decision|4|||
126267518|NCT00375492|454270946|FG000|Overall Study|Protocol Violation|6|||
126267519|NCT00375492|454270947|FG001|Overall Study|Protocol Violation|3|||
126267520|NCT00375492|454270946|FG000|Overall Study|Sponsor Decision|0|||
126360517|NCT02151604|454610850|FG000|Overall Study|Lost to Follow-up|3|||
126360518|NCT02151604|454610850|FG000|Overall Study|Withdrawal by Subject|2|||
126360519|NCT02151604|454610850|FG000|Overall Study|Physician Decision|3|||
126360520|NCT02151604|454610850|FG000|Overall Study|Death|1|||
126360521|NCT04495478|454610851|FG000|Overall Study|Withdrawal by Subject|0|||
126360522|NCT04495478|454610852|FG001|Overall Study|Withdrawal by Subject|0|||
126360523|NCT04495478|454610853|FG002|Overall Study|Withdrawal by Subject|0|||
126360524|NCT04495478|454610854|FG003|Overall Study|Withdrawal by Subject|1|||
126360525|NCT04495478|454610855|FG004|Overall Study|Withdrawal by Subject|0|||
126360526|NCT04495478|454610856|FG005|Overall Study|Withdrawal by Subject|0|||
126360527|NCT04495478|454610857|FG006|Overall Study|Withdrawal by Subject|0|||
126360528|NCT04495478|454610851|FG000|Overall Study|Physician Decision|0|||
126360529|NCT04495478|454610852|FG001|Overall Study|Physician Decision|1|||
126360530|NCT04495478|454610853|FG002|Overall Study|Physician Decision|0|||
126360531|NCT04495478|454610854|FG003|Overall Study|Physician Decision|0|||
126360532|NCT04495478|454610855|FG004|Overall Study|Physician Decision|1|||
126360533|NCT04495478|454610856|FG005|Overall Study|Physician Decision|0|||
126267521|NCT00375492|454270947|FG001|Overall Study|Sponsor Decision|1|||
126267522|NCT00375492|454270946|FG000|Overall Study|Withdrawal by Subject|6|||
126267523|NCT00375492|454270947|FG001|Overall Study|Withdrawal by Subject|6|||
126267524|NCT01902628|454270948|FG000|Overall Study|Withdrawal of participant's consent|7|||
126267525|NCT01902628|454270948|FG000|Overall Study|Adverse Event|41|||
126267526|NCT01902628|454270948|FG000|Overall Study|Lost to Follow-up|35|||
126267527|NCT01232491|454270949|FG000|Overall Study|Adverse Event|13|||
126267528|NCT01232491|454270950|FG001|Overall Study|Adverse Event|8|||
126267529|NCT01232491|454270949|FG000|Overall Study|Lack of Efficacy|1|||
126267530|NCT01232491|454270950|FG001|Overall Study|Lack of Efficacy|5|||
126267531|NCT01232491|454270949|FG000|Overall Study|Protocol Violation|13|||
126267532|NCT01232491|454270950|FG001|Overall Study|Protocol Violation|11|||
126267533|NCT01232491|454270949|FG000|Overall Study|Withdrawal Criteria|12|||
126267534|NCT01232491|454270950|FG001|Overall Study|Withdrawal Criteria|21|||
126267535|NCT01232491|454270949|FG000|Overall Study|Other|21|||
126267536|NCT01232491|454270950|FG001|Overall Study|Other|18|||
126267537|NCT02522403|454272376|FG000|Overall Study|Lost to Follow-up|2|||
126267538|NCT02522403|454272377|FG001|Overall Study|Lost to Follow-up|2|||
126267539|NCT02522403|454272376|FG000|Overall Study|Withdrawal by Subject|2|||
126267540|NCT02522403|454272377|FG001|Overall Study|Withdrawal by Subject|4|||
126267541|NCT03340064|454272378|FG000|First Period|Adverse Event, non-fatal|2|||
126267542|NCT03340064|454272379|FG001|First Period|Adverse Event, non-fatal|0|||
126267543|NCT03340064|454272378|FG000|First Period|Lack of Efficacy|3|||
126267544|NCT03340064|454272379|FG001|First Period|Lack of Efficacy|0|||
126267545|NCT03340064|454272378|FG000|Second Period|Adverse Event, non-fatal|1|||
126267546|NCT03340064|454272379|FG001|Second Period|Adverse Event, non-fatal|1|||
126267547|NCT03340064|454272378|FG000|Second Period|Lack of Efficacy|11|||
126267548|NCT03340064|454272379|FG001|Second Period|Lack of Efficacy|0|||
126267549|NCT03340064|454272378|FG000|Second Period|Physician Decision|3|||
126267550|NCT03340064|454272379|FG001|Second Period|Physician Decision|0|||
126267551|NCT03340064|454272378|FG000|Second Period|Withdrawal by Subject|2|||
126267552|NCT03340064|454272379|FG001|Second Period|Withdrawal by Subject|1|||
126267553|NCT03340064|454272378|FG000|Second Period|Approved Drug Available For Indication|1|||
126267554|NCT03340064|454272379|FG001|Second Period|Approved Drug Available For Indication|0|||
126267555|NCT03340064|454272378|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
126267556|NCT03340064|454272379|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
126267557|NCT00856973|454272382|FG000|Overall Study|Adverse Event|5|||
126267558|NCT00856973|454272383|FG001|Overall Study|Adverse Event|5|||
126267559|NCT00856973|454272384|FG002|Overall Study|Adverse Event|3|||
126267560|NCT00856973|454272382|FG000|Overall Study|Lost to Follow-up|6|||
126267561|NCT00856973|454272383|FG001|Overall Study|Lost to Follow-up|3|||
126267562|NCT00856973|454272384|FG002|Overall Study|Lost to Follow-up|5|||
126360534|NCT04495478|454610857|FG006|Overall Study|Physician Decision|0|||
126360535|NCT03312114|454612646|FG000|Overall Study|All the five enrolled dropped out of the|5|||
126360536|NCT00944645|454612647|FG000|Period 2|Adverse Event|1|||
126267563|NCT00856973|454272382|FG000|Overall Study|Physician Decision|0|||
126360537|NCT00944645|454612648|FG001|Period 2|Adverse Event|0|||
126267564|NCT00856973|454272383|FG001|Overall Study|Physician Decision|3|||
126360538|NCT00944645|454612647|FG000|Period 2|Lost to Follow-up|0|||
126360539|NCT00944645|454612648|FG001|Period 2|Lost to Follow-up|3|||
126360540|NCT00944645|454612647|FG000|Period 2|Withdrawal by Subject|7|||
126267565|NCT00856973|454272384|FG002|Overall Study|Physician Decision|1|||
126267566|NCT00856973|454272382|FG000|Overall Study|Protocol Violation|1|||
126267567|NCT00856973|454272383|FG001|Overall Study|Protocol Violation|2|||
126360541|NCT00944645|454612648|FG001|Period 2|Withdrawal by Subject|6|||
126360542|NCT03537729|454612649|FG000|Overall Study|Death|2|||
126360543|NCT03537729|454612650|FG001|Overall Study|Death|2|||
126267568|NCT00856973|454272384|FG002|Overall Study|Protocol Violation|1|||
126267569|NCT00856973|454272382|FG000|Overall Study|Withdrawal by Subject|13|||
126267570|NCT00856973|454272383|FG001|Overall Study|Withdrawal by Subject|16|||
126360544|NCT03537729|454612651|FG002|Overall Study|Death|7|||
126360545|NCT03537729|454612649|FG000|Overall Study|Withdrawal by Subject|3|||
126267571|NCT00856973|454272384|FG002|Overall Study|Withdrawal by Subject|15|||
126267572|NCT00856973|454272382|FG000|Overall Study|Other|11|||
126267573|NCT00856973|454272383|FG001|Overall Study|Other|12|||
126267574|NCT00856973|454272384|FG002|Overall Study|Other|13|||
126267575|NCT04556552|454272386|FG000|Overall Study|Lost to Follow-up|1|||
126267576|NCT04556552|454272387|FG001|Overall Study|Lost to Follow-up|0|||
126267577|NCT04556552|454272386|FG000|Overall Study|Claustrophobia|0|||
126267578|NCT04556552|454272387|FG001|Overall Study|Claustrophobia|1|||
126267579|NCT04556552|454272386|FG000|Overall Study|Inability to continue|0|||
126267580|NCT04556552|454272387|FG001|Overall Study|Inability to continue|1|||
126267581|NCT03439852|454272388|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
126267582|NCT03439852|454272389|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
126267583|NCT03439852|454272388|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
126267584|NCT03439852|454272389|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
126267585|NCT03439852|454272388|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
126267586|NCT03439852|454272389|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
126267587|NCT01215513|454272390|FG000|Overall Study|Not completed CS42|9|||
126267588|NCT01215513|454272390|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
126267589|NCT01215513|454272390|FG000|Overall Study|Adverse event (CS42A)|2|||
126267590|NCT01215513|454272390|FG000|Overall Study|Physician decision (CS42A)|6|||
126267591|NCT01215513|454272390|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
126267592|NCT01215513|454272390|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
126267593|NCT02858492|454272391|FG000|Overall Study|Withdrawal by Subject|0|||
126267594|NCT02858492|454272392|FG001|Overall Study|Withdrawal by Subject|1|||
126267595|NCT02858492|454272393|FG002|Overall Study|Withdrawal by Subject|0|||
126267596|NCT02858492|454272394|FG003|Overall Study|Withdrawal by Subject|1|||
126267597|NCT02858492|454272391|FG000|Overall Study|Adverse Event|0|||
126267598|NCT02858492|454272392|FG001|Overall Study|Adverse Event|0|||
126267599|NCT02858492|454272393|FG002|Overall Study|Adverse Event|0|||
126267600|NCT02858492|454272394|FG003|Overall Study|Adverse Event|3|||
126267601|NCT02858492|454272391|FG000|Overall Study|Lack of Efficacy|0|||
126267602|NCT02858492|454272392|FG001|Overall Study|Lack of Efficacy|0|||
126267603|NCT02858492|454272393|FG002|Overall Study|Lack of Efficacy|0|||
126267604|NCT02858492|454272394|FG003|Overall Study|Lack of Efficacy|1|||
126267605|NCT02858492|454272391|FG000|Overall Study|Protocol defined stopping criteria|0|||
126267606|NCT02858492|454272392|FG001|Overall Study|Protocol defined stopping criteria|0|||
126267607|NCT02858492|454272393|FG002|Overall Study|Protocol defined stopping criteria|0|||
126267608|NCT02858492|454272394|FG003|Overall Study|Protocol defined stopping criteria|1|||
126267609|NCT02040779|454272397|FG000|Overall Study|Adverse Event|1|||
126267610|NCT02040779|454272398|FG001|Overall Study|Adverse Event|0|||
126267611|NCT02040779|454272399|FG002|Overall Study|Adverse Event|0|||
126267612|NCT02040779|454272397|FG000|Overall Study|Withdrawal by Subject|4|||
126267613|NCT02040779|454272398|FG001|Overall Study|Withdrawal by Subject|1|||
126267614|NCT02040779|454272399|FG002|Overall Study|Withdrawal by Subject|3|||
126267615|NCT02040779|454272397|FG000|Overall Study|Non-compliance|0|||
126267616|NCT02040779|454272398|FG001|Overall Study|Non-compliance|1|||
126267617|NCT02040779|454272399|FG002|Overall Study|Non-compliance|0|||
126267618|NCT02040779|454272397|FG000|Overall Study|Protocol Violation|2|||
126267619|NCT02040779|454272398|FG001|Overall Study|Protocol Violation|1|||
126267620|NCT02040779|454272399|FG002|Overall Study|Protocol Violation|0|||
126267621|NCT02040779|454272397|FG000|Overall Study|Lost to Follow-up|1|||
126267622|NCT02040779|454272398|FG001|Overall Study|Lost to Follow-up|2|||
126267623|NCT02040779|454272399|FG002|Overall Study|Lost to Follow-up|1|||
126360546|NCT03537729|454612650|FG001|Overall Study|Withdrawal by Subject|3|||
126360547|NCT03537729|454612651|FG002|Overall Study|Withdrawal by Subject|0|||
126360548|NCT03537729|454612649|FG000|Overall Study|Subject Moved|8|||
126360549|NCT03537729|454612650|FG001|Overall Study|Subject Moved|5|||
126360550|NCT03537729|454612651|FG002|Overall Study|Subject Moved|4|||
126360551|NCT03537729|454612649|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
126360552|NCT03537729|454612650|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
126360553|NCT03537729|454612651|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
126360554|NCT03537729|454612649|FG000|Overall Study|COVID-19 Site Restrictions|11|||
126360555|NCT03537729|454612650|FG001|Overall Study|COVID-19 Site Restrictions|15|||
126360556|NCT03537729|454612651|FG002|Overall Study|COVID-19 Site Restrictions|18|||
126360557|NCT03537729|454612649|FG000|Overall Study|Decline in Health|5|||
126360558|NCT03537729|454612650|FG001|Overall Study|Decline in Health|9|||
126360559|NCT03537729|454612651|FG002|Overall Study|Decline in Health|4|||
126360560|NCT03537729|454612649|FG000|Overall Study|Determined Ineligible|0|||
126360561|NCT03537729|454612650|FG001|Overall Study|Determined Ineligible|0|||
126360562|NCT03537729|454612651|FG002|Overall Study|Determined Ineligible|1|||
126360563|NCT02562040|454612653|FG000|Overall Study|Lost to Follow-up|20|||
126360564|NCT02562040|454612654|FG001|Overall Study|Lost to Follow-up|28|||
126360565|NCT02562040|454612653|FG000|Overall Study|Withdrawal by Subject|8|||
126360566|NCT02562040|454612654|FG001|Overall Study|Withdrawal by Subject|7|||
126360567|NCT02562040|454612653|FG000|Overall Study|Adverse Event|1|||
126267624|NCT02040779|454272397|FG000|Overall Study|Lack of Efficacy|4|||
126267625|NCT02040779|454272398|FG001|Overall Study|Lack of Efficacy|2|||
126267626|NCT02040779|454272399|FG002|Overall Study|Lack of Efficacy|0|||
126267627|NCT02132637|454272400|FG000|Study Period 1|Withdrawal by Subject|0|||
126267628|NCT02132637|454272401|FG001|Study Period 1|Withdrawal by Subject|4|||
126267629|NCT02132637|454272400|FG000|Study Period 1|Physician Decision|1|||
126267630|NCT02132637|454272401|FG001|Study Period 1|Physician Decision|0|||
126267631|NCT02132637|454272400|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
126267632|NCT02132637|454272401|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
126267633|NCT02132637|454272400|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
126267634|NCT02132637|454272401|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
126267635|NCT00652028|454272402|FG000|Overall Study|Adverse Event|1|||
126267636|NCT00652028|454272403|FG001|Overall Study|Adverse Event|0|||
126267637|NCT00652028|454272404|FG002|Overall Study|Adverse Event|0|||
126267638|NCT00652028|454272405|FG003|Overall Study|Adverse Event|0|||
126267639|NCT00652028|454272402|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
126267640|NCT00652028|454272403|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
126267641|NCT00652028|454272404|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
126267642|NCT00652028|454272405|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
126267643|NCT00652028|454272402|FG000|Overall Study|Physician Decision|0|||
126267644|NCT00652028|454272403|FG001|Overall Study|Physician Decision|0|||
126267645|NCT00652028|454272404|FG002|Overall Study|Physician Decision|1|||
126267646|NCT00652028|454272405|FG003|Overall Study|Physician Decision|0|||
126267647|NCT00931268|454272409|FG000|Overall Study|Lost to Follow-up|6|||
126267648|NCT03656874|454272415|FG000|Overall Study|Lost to Follow-up|3|||
126267649|NCT03656874|454272416|FG001|Overall Study|Lost to Follow-up|17|||
126267650|NCT00584844|454272417|FG000|Overall Study|Withdrawal by Subject|59|||
126267651|NCT00584844|454272417|FG000|Overall Study|Screen Failure|20|||
126267652|NCT03001219|454272422|FG000|Proof of Concept|Study Termination by Sponsor|0|||
126267653|NCT03001219|454272423|FG001|Proof of Concept|Study Termination by Sponsor|1|||
126267654|NCT03001219|454272422|FG000|Proof of Concept|Withdrawal by Subject|0|||
126267655|NCT03001219|454272423|FG001|Proof of Concept|Withdrawal by Subject|4|||
126267656|NCT03001219|454272422|FG000|Proof of Concept|Protocol Deviation|0|||
126360568|NCT02562040|454612654|FG001|Overall Study|Adverse Event|0|||
126360569|NCT01654250|454612655|FG000|Overall Study|Lost to Follow-up|1|||
126360570|NCT01654250|454612656|FG001|Overall Study|Lost to Follow-up|0|||
126360571|NCT01862029|454612657|FG000|Overall Study|Physician Decision|1|||
126360572|NCT00504556|454612658|FG000|Overall Study|Adverse Event|11|||
126360573|NCT00504556|454612659|FG001|Overall Study|Adverse Event|11|||
126360574|NCT00504556|454612660|FG002|Overall Study|Adverse Event|14|||
126360575|NCT00504556|454612661|FG003|Overall Study|Adverse Event|13|||
126360576|NCT00504556|454612662|FG004|Overall Study|Adverse Event|5|||
126360577|NCT00504556|454612658|FG000|Overall Study|Death|3|||
126360578|NCT00504556|454612659|FG001|Overall Study|Death|3|||
126360579|NCT00504556|454612660|FG002|Overall Study|Death|1|||
126360580|NCT00504556|454612661|FG003|Overall Study|Death|0|||
126360581|NCT00504556|454612662|FG004|Overall Study|Death|2|||
126360582|NCT00504556|454612658|FG000|Overall Study|Protocol Violation|1|||
126360583|NCT00504556|454612659|FG001|Overall Study|Protocol Violation|3|||
126360584|NCT00504556|454612660|FG002|Overall Study|Protocol Violation|2|||
126360585|NCT00504556|454612661|FG003|Overall Study|Protocol Violation|1|||
126360586|NCT00504556|454612662|FG004|Overall Study|Protocol Violation|2|||
126360587|NCT00504556|454612658|FG000|Overall Study|Lost to Follow-up|0|||
126360588|NCT00504556|454612659|FG001|Overall Study|Lost to Follow-up|0|||
126360589|NCT00504556|454612660|FG002|Overall Study|Lost to Follow-up|1|||
126360590|NCT00504556|454612661|FG003|Overall Study|Lost to Follow-up|1|||
126360591|NCT00504556|454612662|FG004|Overall Study|Lost to Follow-up|1|||
126360592|NCT00504556|454612658|FG000|Overall Study|Withdrawal by Subject|16|||
126360593|NCT00504556|454612659|FG001|Overall Study|Withdrawal by Subject|16|||
126360594|NCT00504556|454612660|FG002|Overall Study|Withdrawal by Subject|7|||
126360595|NCT00504556|454612661|FG003|Overall Study|Withdrawal by Subject|8|||
126360596|NCT00504556|454612662|FG004|Overall Study|Withdrawal by Subject|12|||
126360597|NCT00504556|454612658|FG000|Overall Study|administrative reasons|0|||
126360598|NCT00504556|454612659|FG001|Overall Study|administrative reasons|2|||
126360599|NCT00504556|454612660|FG002|Overall Study|administrative reasons|2|||
126360600|NCT00504556|454612661|FG003|Overall Study|administrative reasons|1|||
126360601|NCT00504556|454612662|FG004|Overall Study|administrative reasons|2|||
126360602|NCT00504556|454612658|FG000|Overall Study|did not meet entry criteria|2|||
126360603|NCT00504556|454612659|FG001|Overall Study|did not meet entry criteria|0|||
126360604|NCT00504556|454612660|FG002|Overall Study|did not meet entry criteria|1|||
126360605|NCT00504556|454612661|FG003|Overall Study|did not meet entry criteria|1|||
126360606|NCT00504556|454612662|FG004|Overall Study|did not meet entry criteria|0|||
126360607|NCT00504556|454612658|FG000|Overall Study|data monitor committee decision|0|||
126360608|NCT00504556|454612659|FG001|Overall Study|data monitor committee decision|0|||
126360609|NCT00504556|454612660|FG002|Overall Study|data monitor committee decision|0|||
126360610|NCT00504556|454612661|FG003|Overall Study|data monitor committee decision|100|||
126360611|NCT00504556|454612662|FG004|Overall Study|data monitor committee decision|0|||
126360612|NCT00504556|454612658|FG000|Overall Study|Other|2|||
126360613|NCT00504556|454612659|FG001|Overall Study|Other|2|||
126360614|NCT00504556|454612660|FG002|Overall Study|Other|2|||
126360615|NCT00504556|454612661|FG003|Overall Study|Other|3|||
126360616|NCT00504556|454612662|FG004|Overall Study|Other|0|||
126360617|NCT00504556|454612658|FG000|Overall Study|not in safety analysis set|0|||
126360618|NCT00504556|454612659|FG001|Overall Study|not in safety analysis set|1|||
126360619|NCT00504556|454612660|FG002|Overall Study|not in safety analysis set|1|||
126360620|NCT00504556|454612661|FG003|Overall Study|not in safety analysis set|0|||
126360621|NCT00504556|454612662|FG004|Overall Study|not in safety analysis set|1|||
126360622|NCT01013870|454612663|FG000|Overall Study|Lost to Follow-up|1|||
126360623|NCT01013870|454612664|FG001|Overall Study|Lost to Follow-up|3|||
126360624|NCT01386645|454612665|FG000|Overall Study|Physician Decision|0|||
126360625|NCT01386645|454612666|FG001|Overall Study|Physician Decision|0|||
126360626|NCT01386645|454612667|FG002|Overall Study|Physician Decision|1|||
126360627|NCT01386645|454612665|FG000|Overall Study|Withdrawal by Subject|0|||
126267657|NCT03001219|454272423|FG001|Proof of Concept|Protocol Deviation|1|||
126267658|NCT03001219|454272422|FG000|Proof of Concept|Adverse Event|1|||
126267659|NCT03001219|454272423|FG001|Proof of Concept|Adverse Event|1|||
126267660|NCT03001219|454272422|FG000|Proof of Concept|Physician Decision|1|||
126267661|NCT03001219|454272423|FG001|Proof of Concept|Physician Decision|0|||
126267662|NCT03001219|454272422|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
126267663|NCT03001219|454272423|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
126267664|NCT03001219|454272422|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
126267665|NCT03001219|454272423|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
126267666|NCT03001219|454272422|FG000|Extension Period Analysis|Physician Decision|0|||
126267667|NCT03001219|454272423|FG001|Extension Period Analysis|Physician Decision|1|||
126267668|NCT03001219|454272422|FG000|Extension Period Analysis|Adverse Event|1|||
126267669|NCT03001219|454272423|FG001|Extension Period Analysis|Adverse Event|1|||
126267670|NCT03001219|454272422|FG000|Extension Period Analysis|Protocol Deviation|0|||
126267671|NCT03001219|454272423|FG001|Extension Period Analysis|Protocol Deviation|1|||
126267672|NCT03001219|454272422|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
126267673|NCT03001219|454272423|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
126267674|NCT01195103|454272424|FG000|Overall Study|Withdrawal by Subject|1|||
126267675|NCT01195103|454272425|FG001|Overall Study|Withdrawal by Subject|0|||
126267676|NCT01195103|454272426|FG002|Overall Study|Withdrawal by Subject|0|||
126267677|NCT03733210|454272427|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
126267678|NCT03733210|454272428|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
126267679|NCT03760250|454272429|FG000|Overall Study|Withdrawal by Subject|1|||
126267680|NCT03760250|454272429|FG000|Overall Study|Physician Decision|1|||
126267681|NCT04421586|454272430|FG000|Overall Study|Death|0|||
126267682|NCT04421586|454272431|FG001|Overall Study|Death|1|||
126267683|NCT04421586|454272430|FG000|Overall Study|Lost to Follow-up|2|||
126267684|NCT04421586|454272431|FG001|Overall Study|Lost to Follow-up|2|||
126267685|NCT04421586|454272430|FG000|Overall Study|Withdrawn by PI|1|||
126267686|NCT04421586|454272431|FG001|Overall Study|Withdrawn by PI|0|||
126267687|NCT04421586|454272430|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
126267688|NCT04421586|454272431|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
126267689|NCT05065983|454272433|FG000|Overall Study|Lost to Follow-up|2|||
126267690|NCT00986180|454272434|FG000|Overall Study|Adverse Event|21|||
126267691|NCT00986180|454272435|FG001|Overall Study|Adverse Event|23|||
126267692|NCT00986180|454272434|FG000|Overall Study|Lack of Efficacy|4|||
126267693|NCT00986180|454272435|FG001|Overall Study|Lack of Efficacy|3|||
126267694|NCT00986180|454272434|FG000|Overall Study|Lost to Follow-up|5|||
126267695|NCT00986180|454272435|FG001|Overall Study|Lost to Follow-up|7|||
126360628|NCT01386645|454612666|FG001|Overall Study|Withdrawal by Subject|1|||
126360629|NCT01386645|454612667|FG002|Overall Study|Withdrawal by Subject|1|||
126360630|NCT03142451|454612677|FG000|Overall Study|Adverse Event|5|||
126360631|NCT03142451|454612678|FG001|Overall Study|Adverse Event|2|||
126360632|NCT03142451|454612677|FG000|Overall Study|Lost to Follow-up|25|||
126360633|NCT03142451|454612678|FG001|Overall Study|Lost to Follow-up|8|||
126360634|NCT03142451|454612677|FG000|Overall Study|Participant request|24|||
126360635|NCT03142451|454612678|FG001|Overall Study|Participant request|12|||
126360636|NCT03142451|454612677|FG000|Overall Study|Protocol Violation|3|||
126360637|NCT03142451|454612678|FG001|Overall Study|Protocol Violation|1|||
126360638|NCT03142451|454612677|FG000|Overall Study|Other|1|||
126267696|NCT00986180|454272434|FG000|Overall Study|Physician Decision|1|||
126360639|NCT03142451|454612678|FG001|Overall Study|Other|1|||
126360640|NCT03048019|454612679|FG000|Overall Study|Adverse Event|1|||
126267697|NCT00986180|454272435|FG001|Overall Study|Physician Decision|3|||
126267698|NCT00986180|454272434|FG000|Overall Study|Protocol Violation|2|||
126267699|NCT00986180|454272435|FG001|Overall Study|Protocol Violation|0|||
126267700|NCT00986180|454272434|FG000|Overall Study|Withdrawal by Subject|1|||
126360641|NCT03048019|454612680|FG001|Overall Study|Adverse Event|0|||
126267701|NCT00986180|454272435|FG001|Overall Study|Withdrawal by Subject|9|||
126267702|NCT00986180|454272434|FG000|Overall Study|Miscellanies|10|||
126267703|NCT00986180|454272435|FG001|Overall Study|Miscellanies|11|||
126267704|NCT01765582|454272436|FG000|Overall Study|Other|3|||
126267705|NCT01765582|454272437|FG001|Overall Study|Other|6|||
126267706|NCT01765582|454272438|FG002|Overall Study|Other|9|||
126267707|NCT01765582|454272436|FG000|Overall Study|Lost to Follow-up|2|||
126267708|NCT01765582|454272437|FG001|Overall Study|Lost to Follow-up|2|||
126267709|NCT01765582|454272438|FG002|Overall Study|Lost to Follow-up|1|||
126267710|NCT01765582|454272436|FG000|Overall Study|Death|31|||
126267711|NCT01765582|454272437|FG001|Overall Study|Death|36|||
126267712|NCT01765582|454272438|FG002|Overall Study|Death|33|||
126267713|NCT01765582|454272436|FG000|Overall Study|Sponsor Decision|46|||
126267714|NCT01765582|454272437|FG001|Overall Study|Sponsor Decision|42|||
126267715|NCT01765582|454272438|FG002|Overall Study|Sponsor Decision|42|||
126267716|NCT01765582|454272436|FG000|Overall Study|Withdrawal of Consent|11|||
126267717|NCT01765582|454272437|FG001|Overall Study|Withdrawal of Consent|6|||
126267718|NCT01765582|454272438|FG002|Overall Study|Withdrawal of Consent|10|||
126267719|NCT01691820|454272439|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
126267720|NCT01691820|454272440|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
126267721|NCT01691820|454272439|FG000|Overall Study|Migrated/moved from study area|7|||
126267722|NCT01691820|454272440|FG001|Overall Study|Migrated/moved from study area|4|||
126267723|NCT01691820|454272439|FG000|Overall Study|Lost to Follow-up|6|||
126267724|NCT01691820|454272440|FG001|Overall Study|Lost to Follow-up|17|||
126267725|NCT01691820|454272439|FG000|Overall Study|Other (unspecified)|4|||
126267726|NCT01691820|454272440|FG001|Overall Study|Other (unspecified)|1|||
126267727|NCT00076804|454272445|FG000|Overall Study|Death|9|||
126267728|NCT00076804|454272446|FG001|Overall Study|Death|20|||
126267729|NCT00076804|454272445|FG000|Overall Study|Lost to Follow-up|9|||
126267730|NCT00076804|454272446|FG001|Overall Study|Lost to Follow-up|9|||
126267731|NCT00076804|454272445|FG000|Overall Study|Withdrawal by Subject|10|||
126267732|NCT00076804|454272446|FG001|Overall Study|Withdrawal by Subject|8|||
126267733|NCT00076804|454272445|FG000|Overall Study|Early study Closure|32|||
126267734|NCT00076804|454272446|FG001|Overall Study|Early study Closure|32|||
126267735|NCT01615263|454272448|FG000|Overall Study|Post-randomization exclusion|0|||
126267736|NCT01615263|454272449|FG001|Overall Study|Post-randomization exclusion|2|||
126267737|NCT00857259|454272450|FG000|Overall Study|Protocol Violation|1|||
126267738|NCT00857259|454272451|FG001|Overall Study|Protocol Violation|0|||
126267739|NCT00857259|454272452|FG002|Overall Study|Protocol Violation|1|||
126267740|NCT02701413|454272453|FG000|Overall Study|Withdrawal by Subject|7|||
126267741|NCT02701413|454272454|FG001|Overall Study|Withdrawal by Subject|11|||
126267742|NCT01370213|454272455|FG000|Overall Study|Early Death|1|||
126267743|NCT01370213|454272456|FG001|Overall Study|Early Death|0|||
126267744|NCT01370213|454272457|FG002|Overall Study|Early Death|0|||
126267745|NCT01370213|454272455|FG000|Overall Study|Not evaluable|0|||
126267746|NCT01370213|454272456|FG001|Overall Study|Not evaluable|2|||
126267747|NCT01370213|454272457|FG002|Overall Study|Not evaluable|0|||
126267748|NCT01321008|454272463|FG000|Overall Study|Early Study Termination|1|||
126267749|NCT03852459|454272468|FG000|Overall Study|Adverse Event|2|||
126267750|NCT03852459|454272469|FG001|Overall Study|Adverse Event|2|||
126267751|NCT03852459|454272468|FG000|Overall Study|Withdrawal by Subject|1|||
126267752|NCT03852459|454272469|FG001|Overall Study|Withdrawal by Subject|1|||
126267753|NCT00257920|454272471|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
126267754|NCT00257920|454272472|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
126267755|NCT00257920|454272471|FG000|Period: Second Intervention|Other|2|||
126267756|NCT00257920|454272472|FG001|Period: Second Intervention|Other|1|||
126267757|NCT03097588|454272477|FG000|Overall Study|Adverse Event|1|||
126267758|NCT02687360|454272478|FG000|Overall Study|Withdrawal by Subject|3|||
126267759|NCT02687360|454272479|FG001|Overall Study|Withdrawal by Subject|0|||
126267760|NCT03456960|454272480|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126098506|NCT01156792|453653024|FG000|Overall Study|Lack of Efficacy|36|||
126267761|NCT03456960|454272481|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126267762|NCT03456960|454272482|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
126267763|NCT03456960|454272483|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
126267764|NCT03456960|454272484|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126267765|NCT03456960|454272485|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126267766|NCT03456960|454272480|FG000|Period 2 (1 Day)|Adverse Event|1|||
126360642|NCT01716559|454612688|FG000|Overall Study|Adverse Event|11|||
126360643|NCT01716559|454612688|FG000|Overall Study|Death|21|||
126360644|NCT01716559|454612688|FG000|Overall Study|Withdrawal by Subject|4|||
126360645|NCT01716559|454612688|FG000|Overall Study|Other withdrawal reason|75|||
126360646|NCT02773537|454612697|FG000|Overall Study|Lost to Follow-up|0|||
125880727|NCT01744977|452862609|FG001|Overall Study|Lost to Follow-up|0|||
126267767|NCT03456960|454272481|FG001|Period 2 (1 Day)|Adverse Event|0|||
126267768|NCT03456960|454272482|FG002|Period 2 (1 Day)|Adverse Event|0|||
126267769|NCT03456960|454272483|FG003|Period 2 (1 Day)|Adverse Event|1|||
126267770|NCT03456960|454272484|FG004|Period 2 (1 Day)|Adverse Event|0|||
126267771|NCT03456960|454272485|FG005|Period 2 (1 Day)|Adverse Event|0|||
126267772|NCT02989168|454272486|FG000|Overall Study|Withdrawal by Subject|2|||
126267773|NCT02989168|454272487|FG001|Overall Study|Withdrawal by Subject|0|||
126267774|NCT02989168|454272486|FG000|Overall Study|Physician Decision|0|||
126267775|NCT02989168|454272487|FG001|Overall Study|Physician Decision|1|||
126267776|NCT02989168|454272486|FG000|Overall Study|Adverse Event|1|||
126267777|NCT02989168|454272487|FG001|Overall Study|Adverse Event|2|||
126267778|NCT02989168|454272486|FG000|Overall Study|Sponsor stopped study.|1|||
126267779|NCT02989168|454272487|FG001|Overall Study|Sponsor stopped study.|0|||
126267780|NCT03828448|454272488|FG000|Overall Study|Sponsor's Discretion|34|||
126267781|NCT02037165|454272489|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
126267782|NCT02037165|454272490|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
126267783|NCT02037165|454272491|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
126267784|NCT02037165|454272492|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
126267785|NCT02037165|454272493|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
126267786|NCT00532935|454272494|FG000|Overall Study|Adverse Event|11|||
126267787|NCT00532935|454272495|FG001|Overall Study|Adverse Event|12|||
126267788|NCT00532935|454272494|FG000|Overall Study|Lack of Efficacy|0|||
126267789|NCT00532935|454272495|FG001|Overall Study|Lack of Efficacy|3|||
126267790|NCT00532935|454272494|FG000|Overall Study|Lost to Follow-up|10|||
126267791|NCT00532935|454272495|FG001|Overall Study|Lost to Follow-up|6|||
126267792|NCT00532935|454272494|FG000|Overall Study|Physician Decision|4|||
126267793|NCT00532935|454272495|FG001|Overall Study|Physician Decision|5|||
126267794|NCT00532935|454272494|FG000|Overall Study|Pregnancy|1|||
126267795|NCT00532935|454272495|FG001|Overall Study|Pregnancy|0|||
126267796|NCT00532935|454272494|FG000|Overall Study|Protocol Violation|4|||
126267797|NCT00532935|454272495|FG001|Overall Study|Protocol Violation|2|||
126267798|NCT00532935|454272494|FG000|Overall Study|Withdrawal by Subject|10|||
126267799|NCT00532935|454272495|FG001|Overall Study|Withdrawal by Subject|9|||
126267800|NCT00532935|454272494|FG000|Overall Study|Protocol Specific Criteria|11|||
126267801|NCT00532935|454272495|FG001|Overall Study|Protocol Specific Criteria|15|||
126267802|NCT01300923|454272496|FG000|Overall Study|Physician Decision|0|||
126267803|NCT01300923|454272497|FG001|Overall Study|Physician Decision|2|||
126267804|NCT01568866|454272498|FG000|Overall Study|Disease Progression|208|||
126267805|NCT01568866|454272499|FG001|Overall Study|Disease Progression|183|||
126267806|NCT01568866|454272498|FG000|Overall Study|Adverse Event|94|||
126267807|NCT01568866|454272499|FG001|Overall Study|Adverse Event|96|||
126267808|NCT01568866|454272498|FG000|Overall Study|Patient Request|55|||
126267809|NCT01568866|454272499|FG001|Overall Study|Patient Request|71|||
126267810|NCT01568866|454272498|FG000|Overall Study|Physician Decision|40|||
126267811|NCT01568866|454272499|FG001|Overall Study|Physician Decision|32|||
126267812|NCT01568866|454272498|FG000|Overall Study|Withdrawal by Subject|19|||
126267813|NCT01568866|454272499|FG001|Overall Study|Withdrawal by Subject|11|||
126267814|NCT01568866|454272498|FG000|Overall Study|Death|10|||
126267815|NCT01568866|454272499|FG001|Overall Study|Death|18|||
126267816|NCT01568866|454272498|FG000|Overall Study|Protocol Non-compliance|2|||
126267817|NCT01568866|454272499|FG001|Overall Study|Protocol Non-compliance|4|||
126267818|NCT01568866|454272498|FG000|Overall Study|Lost to Follow-up|1|||
126267819|NCT01568866|454272499|FG001|Overall Study|Lost to Follow-up|0|||
126267820|NCT01568866|454272498|FG000|Overall Study|Randomized but Not Dosed|9|||
126267821|NCT01568866|454272499|FG001|Overall Study|Randomized but Not Dosed|1|||
126267822|NCT01698775|454272500|FG000|Phase A|Adverse Event|2|||
126267823|NCT01698775|454272501|FG001|Phase A|Adverse Event|1|||
126360647|NCT02773537|454612698|FG001|Overall Study|Lost to Follow-up|1|||
126360648|NCT02773537|454612699|FG002|Overall Study|Lost to Follow-up|4|||
126360649|NCT01840163|454612700|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
126360650|NCT01840163|454612701|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
126360651|NCT01840163|454612700|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
126360652|NCT01840163|454612701|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
126360653|NCT01840163|454612700|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
126360654|NCT01840163|454612701|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
126360655|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
126360656|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
126267824|NCT01698775|454272500|FG000|Phase A|Death|1|||
126267825|NCT01698775|454272501|FG001|Phase A|Death|1|||
126267826|NCT01698775|454272500|FG000|Phase A|Lack of Efficacy|1|||
126267827|NCT01698775|454272501|FG001|Phase A|Lack of Efficacy|0|||
126267828|NCT01698775|454272500|FG000|Phase A|Lost to Follow-up|1|||
126098507|NCT01156792|453653024|FG000|Overall Study|Protocol Violation|6|||
126098508|NCT01156792|453653024|FG000|Overall Study|Lost to Follow-up|3|||
126098509|NCT01156792|453653024|FG000|Overall Study|Physician Decision|3|||
126098510|NCT01156792|453653024|FG000|Overall Study|Withdrawal by Subject|9|||
126098511|NCT01156792|453653024|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
126098512|NCT01474434|453653025|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
126098513|NCT01474434|453653026|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
126098514|NCT01474434|453653027|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
126098515|NCT01474434|453653028|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
126098516|NCT01474434|453653025|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
126098517|NCT01474434|453653026|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
126098518|NCT01474434|453653027|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
126098519|NCT01474434|453653028|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
126098520|NCT01474434|453653025|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
126098521|NCT01474434|453653026|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
126098522|NCT01474434|453653027|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
126098523|NCT01474434|453653028|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
126098524|NCT00495586|453653034|FG000|Overall Study|Withdrawal by Subject|4|||
126098525|NCT00495586|453653035|FG001|Overall Study|Withdrawal by Subject|4|||
126098526|NCT02038543|453653036|FG000|Overall Study|Screen Failure|0|||
126098527|NCT02038543|453653037|FG001|Overall Study|Screen Failure|0|||
126267829|NCT01698775|454272501|FG001|Phase A|Lost to Follow-up|2|||
126267830|NCT01698775|454272500|FG000|Phase A|Protocol Violation|1|||
126267831|NCT01698775|454272501|FG001|Phase A|Protocol Violation|0|||
126267832|NCT01698775|454272500|FG000|Phase A|Withdrawal by Subject|3|||
126267833|NCT01698775|454272501|FG001|Phase A|Withdrawal by Subject|4|||
126267834|NCT01698775|454272500|FG000|Phase A|Kidney [transplant]|0|||
126267835|NCT01698775|454272501|FG001|Phase A|Kidney [transplant]|1|||
126267836|NCT01698775|454272500|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
126267837|NCT01698775|454272501|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
126267838|NCT01698775|454272500|FG000|Phase B|Adverse Event|6|||
126267839|NCT01698775|454272501|FG001|Phase B|Adverse Event|3|||
126267840|NCT01698775|454272500|FG000|Phase B|Death|0|||
126267841|NCT01698775|454272501|FG001|Phase B|Death|1|||
126267842|NCT01698775|454272500|FG000|Phase B|Lack of Efficacy|0|||
126267843|NCT01698775|454272501|FG001|Phase B|Lack of Efficacy|1|||
126267844|NCT01698775|454272500|FG000|Phase B|Lost to Follow-up|0|||
126267845|NCT01698775|454272501|FG001|Phase B|Lost to Follow-up|1|||
126267846|NCT01698775|454272500|FG000|Phase B|Physician Decision|1|||
126267847|NCT01698775|454272501|FG001|Phase B|Physician Decision|1|||
126267848|NCT01698775|454272500|FG000|Phase B|Protocol Violation|1|||
126267849|NCT01698775|454272501|FG001|Phase B|Protocol Violation|1|||
126267850|NCT01698775|454272500|FG000|Phase B|Withdrawal by Subject|6|||
126267851|NCT01698775|454272501|FG001|Phase B|Withdrawal by Subject|2|||
126267852|NCT01244061|454272504|FG000|Overall Study|Death|1|||
126267853|NCT01244061|454272505|FG001|Overall Study|Death|0|||
126267854|NCT01244061|454272504|FG000|Overall Study|Did not meet entrance criteria|1|||
126267855|NCT01244061|454272505|FG001|Overall Study|Did not meet entrance criteria|0|||
126267856|NCT01244061|454272504|FG000|Overall Study|Lack of Efficacy|1|||
126267857|NCT01244061|454272505|FG001|Overall Study|Lack of Efficacy|3|||
126267858|NCT01244061|454272504|FG000|Overall Study|Lost to Follow-up|34|||
126267859|NCT01244061|454272505|FG001|Overall Study|Lost to Follow-up|30|||
126267860|NCT01244061|454272504|FG000|Overall Study|Withdrawal by Subject|29|||
126267861|NCT01244061|454272505|FG001|Overall Study|Withdrawal by Subject|46|||
126267862|NCT01244061|454272504|FG000|Overall Study|Other|8|||
126267863|NCT01244061|454272505|FG001|Overall Study|Other|19|||
126267864|NCT01244061|454272504|FG000|Overall Study|Protocol Violation|1|||
126267865|NCT01244061|454272505|FG001|Overall Study|Protocol Violation|1|||
126267866|NCT01244061|454272504|FG000|Overall Study|Adverse Event|5|||
126360657|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
126360658|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
126360659|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
126360660|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
126360661|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
126098528|NCT02038543|453653038|FG002|Overall Study|Screen Failure|0|||
126098529|NCT02038543|453653039|FG003|Overall Study|Screen Failure|1|||
126098530|NCT02038543|453653036|FG000|Overall Study|Withdrawal by Subject|0|||
126267867|NCT01244061|454272505|FG001|Overall Study|Adverse Event|2|||
126267868|NCT01244061|454272504|FG000|Overall Study|Randomized but not treated|2|||
126267869|NCT01244061|454272505|FG001|Overall Study|Randomized but not treated|2|||
126267870|NCT02384850|454272506|FG000|Overall Study|Withdrawal by Subject|2|||
126267871|NCT02384850|454272507|FG001|Overall Study|Withdrawal by Subject|2|||
126267872|NCT02013375|454272508|FG000|Overall Study|Did not engraft|1|||
126267873|NCT02013375|454272508|FG000|Overall Study|Did not engraft|1|||
126267874|NCT02932228|454272512|FG000|Overall Study|Death|8|||
126267875|NCT02932228|454272513|FG001|Overall Study|Death|23|||
126098531|NCT02038543|453653037|FG001|Overall Study|Withdrawal by Subject|0|||
126267876|NCT02932228|454272512|FG000|Overall Study|not eligible upon chart review|2|||
126267877|NCT02932228|454272513|FG001|Overall Study|not eligible upon chart review|5|||
126267878|NCT00793780|454273828|FG000|Overall Study|Withdrawal by Subject|2|||
126267879|NCT00793780|454273829|FG001|Overall Study|Withdrawal by Subject|1|||
126267880|NCT03310411|454273832|FG000|Period 1|Adverse Event|0|||
126267881|NCT03310411|454273833|FG001|Period 1|Adverse Event|0|||
126267882|NCT03310411|454273834|FG002|Period 1|Adverse Event|0|||
126267883|NCT03310411|454273835|FG003|Period 1|Adverse Event|1|||
126267884|NCT03623386|454273838|FG000|Overall Study|Protocol Violation|3|||
126267885|NCT03623386|454273839|FG001|Overall Study|Protocol Violation|2|||
126267886|NCT03623386|454273840|FG002|Overall Study|Protocol Violation|0|||
126267887|NCT03623386|454273838|FG000|Overall Study|Physician Decision|1|||
126267888|NCT03623386|454273839|FG001|Overall Study|Physician Decision|1|||
126267889|NCT03623386|454273840|FG002|Overall Study|Physician Decision|0|||
126267890|NCT03623386|454273838|FG000|Overall Study|Lost to Follow-up|0|||
126267891|NCT03623386|454273839|FG001|Overall Study|Lost to Follow-up|2|||
126267892|NCT03623386|454273840|FG002|Overall Study|Lost to Follow-up|0|||
126267893|NCT03623386|454273838|FG000|Overall Study|COVID-19|0|||
126267894|NCT03623386|454273839|FG001|Overall Study|COVID-19|1|||
126267895|NCT03623386|454273840|FG002|Overall Study|COVID-19|0|||
126267896|NCT04271735|454273845|FG000|Overall Study|Physician Decision|2|||
126267897|NCT04271735|454273846|FG001|Overall Study|Physician Decision|0|||
126267898|NCT00515541|454273847|FG000|Overall Study|Physician Decision|0|||
126267899|NCT00515541|454273848|FG001|Overall Study|Physician Decision|2|||
126267900|NCT00515541|454273849|FG002|Overall Study|Physician Decision|0|||
126267901|NCT00515541|454273850|FG003|Overall Study|Physician Decision|1|||
126267902|NCT00515541|454273847|FG000|Overall Study|No show for appointments|0|||
126267903|NCT00515541|454273848|FG001|Overall Study|No show for appointments|1|||
126267904|NCT00515541|454273849|FG002|Overall Study|No show for appointments|0|||
126267905|NCT00515541|454273850|FG003|Overall Study|No show for appointments|2|||
126267906|NCT00515541|454273847|FG000|Overall Study|Withdrawal by Subject|0|||
126267907|NCT00515541|454273848|FG001|Overall Study|Withdrawal by Subject|2|||
126267908|NCT00515541|454273849|FG002|Overall Study|Withdrawal by Subject|0|||
126267909|NCT00515541|454273850|FG003|Overall Study|Withdrawal by Subject|2|||
126267910|NCT00922272|454273854|FG000|Open-label Phase|Adverse Event|5|||
126267911|NCT00922272|454273855|FG001|Open-label Phase|Adverse Event|0|||
126267912|NCT00922272|454273854|FG000|Open-label Phase|Protocol Violation|1|||
126267913|NCT00922272|454273855|FG001|Open-label Phase|Protocol Violation|0|||
126267914|NCT00922272|454273854|FG000|Open-label Phase|Withdrawal by Subject|11|||
126267915|NCT00922272|454273855|FG001|Open-label Phase|Withdrawal by Subject|0|||
126267916|NCT00922272|454273854|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
126267917|NCT00922272|454273855|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
126267918|NCT00922272|454273854|FG000|Open-label Phase|Withdrawal criteria met|5|||
126267919|NCT00922272|454273855|FG001|Open-label Phase|Withdrawal criteria met|0|||
126267920|NCT00922272|454273854|FG000|Double-blind Phase|Adverse Event|1|||
126267921|NCT00922272|454273855|FG001|Double-blind Phase|Adverse Event|1|||
126267922|NCT00922272|454273854|FG000|Double-blind Phase|Withdrawal by Subject|1|||
126267923|NCT00922272|454273855|FG001|Double-blind Phase|Withdrawal by Subject|1|||
126267924|NCT00922272|454273854|FG000|Double-blind Phase|Lost to Follow-up|2|||
126267925|NCT00922272|454273855|FG001|Double-blind Phase|Lost to Follow-up|1|||
126267926|NCT00922272|454273854|FG000|Double-blind Phase|Withdrawal criteria met|1|||
126267927|NCT00922272|454273855|FG001|Double-blind Phase|Withdrawal criteria met|1|||
126267928|NCT00922272|454273854|FG000|Double-blind Phase|Noncompliance|1|||
126267929|NCT00922272|454273855|FG001|Double-blind Phase|Noncompliance|1|||
126267930|NCT00922272|454273854|FG000|Double-blind Phase|Positive urine drug screen|1|||
126267931|NCT00922272|454273855|FG001|Double-blind Phase|Positive urine drug screen|1|||
126267932|NCT02588950|454273856|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
126267933|NCT02588950|454273857|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
126267934|NCT02588950|454273858|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
126267935|NCT02588950|454273859|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
126267936|NCT02588950|454273856|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
126267937|NCT02588950|454273857|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
126267938|NCT02588950|454273858|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
126267939|NCT02588950|454273859|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
126267940|NCT03188718|454273860|FG000|Overall Study|Participant noncompliance|4|||
126267941|NCT03188718|454273860|FG000|Overall Study|Withdrawal by Subject|1|||
126267942|NCT03188718|454273860|FG000|Overall Study|Device failure|3|||
126267943|NCT02072824|454273863|FG000|Overall Study|Insufficient clinical response|1|||
126267944|NCT02072824|454273864|FG001|Overall Study|Insufficient clinical response|0|||
126267945|NCT02072824|454273865|FG002|Overall Study|Insufficient clinical response|1|||
126267946|NCT02072824|454273863|FG000|Overall Study|No longer willing to participate|1|||
126267947|NCT02072824|454273864|FG001|Overall Study|No longer willing to participate|0|||
126267948|NCT02072824|454273865|FG002|Overall Study|No longer willing to participate|1|||
126267949|NCT02072824|454273863|FG000|Overall Study|Medication error|0|||
126267950|NCT02072824|454273864|FG001|Overall Study|Medication error|1|||
126267951|NCT02072824|454273865|FG002|Overall Study|Medication error|0|||
126267952|NCT02072824|454273863|FG000|Overall Study|Adverse Event|0|||
126267953|NCT02072824|454273864|FG001|Overall Study|Adverse Event|0|||
126267954|NCT02072824|454273865|FG002|Overall Study|Adverse Event|1|||
126267955|NCT03084367|454273866|FG000|Overall Study|Lost to Follow-up|32|||
126267956|NCT03084367|454273866|FG000|Overall Study|Withdrawal by Subject|4|||
126267957|NCT03084367|454273866|FG000|Overall Study|Other|1|||
126267958|NCT00841906|454273867|FG000|Overall Study|Withdrawal by Subject|2|||
126267959|NCT00841906|454273868|FG001|Overall Study|Withdrawal by Subject|0|||
126267960|NCT02667288|454273871|FG000|Overall Study|Protocol Violation|5|||
126267961|NCT02667288|454273871|FG000|Overall Study|Lost to Follow-up|3|||
126267962|NCT02667288|454273871|FG000|Overall Study|Withdrawal by Subject|5|||
126267963|NCT00912093|454273872|FG000|The Controlled Phase|Death|0|||
126267964|NCT00912093|454273873|FG001|The Controlled Phase|Death|1|||
126267965|NCT00912093|454273874|FG002|The Controlled Phase|Death|0|||
126267966|NCT00912093|454273875|FG003|The Controlled Phase|Death|0|||
126267967|NCT00912093|454273876|FG004|The Controlled Phase|Death|0|||
126267968|NCT00912093|454273872|FG000|The Controlled Phase|Medical Condition|0|||
126267969|NCT00912093|454273873|FG001|The Controlled Phase|Medical Condition|1|||
126267970|NCT00912093|454273874|FG002|The Controlled Phase|Medical Condition|0|||
126267971|NCT00912093|454273875|FG003|The Controlled Phase|Medical Condition|0|||
126267972|NCT00912093|454273876|FG004|The Controlled Phase|Medical Condition|0|||
126267973|NCT00912093|454273872|FG000|The Controlled Phase|Lost to Follow-up|0|||
126267974|NCT00912093|454273873|FG001|The Controlled Phase|Lost to Follow-up|0|||
126267975|NCT00912093|454273874|FG002|The Controlled Phase|Lost to Follow-up|0|||
126267976|NCT00912093|454273875|FG003|The Controlled Phase|Lost to Follow-up|0|||
126267977|NCT00912093|454273876|FG004|The Controlled Phase|Lost to Follow-up|1|||
126267978|NCT00127036|454273877|FG000|Overall Study|Insufficient Data for Analysis|6|||
126267979|NCT00127036|454273878|FG001|Overall Study|Insufficient Data for Analysis|11|||
126267980|NCT00127036|454273877|FG000|Overall Study|Screen Failure|2|||
126267981|NCT00127036|454273878|FG001|Overall Study|Screen Failure|0|||
126267982|NCT04397445|454273881|FG000|Overall Study|Withdrawal by Subject|1|||
126267983|NCT04397445|454273882|FG001|Overall Study|Withdrawal by Subject|0|||
126267984|NCT04397445|454273883|FG002|Overall Study|Withdrawal by Subject|0|||
126267985|NCT04397445|454273884|FG003|Overall Study|Withdrawal by Subject|0|||
126267986|NCT03921151|454273885|FG000|Overall Study|Withdrawal by Subject|11|||
126267987|NCT03921151|454273886|FG001|Overall Study|Withdrawal by Subject|16|||
126267988|NCT00270257|454273890|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
126267989|NCT00270257|454273891|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
126267990|NCT02621034|454273892|FG000|Overall Study|Lost to Follow-up|3|||
126267991|NCT02621034|454273893|FG001|Overall Study|Lost to Follow-up|2|||
126267992|NCT02621034|454273894|FG002|Overall Study|Lost to Follow-up|5|||
126267993|NCT02963441|454273895|FG000|Overall Study|Protocol violation or withdrawn|8|||
126267994|NCT02963441|454273895|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
126267995|NCT02963441|454273895|FG000|Overall Study|IDx-DR insufficient quality|33|||
126267996|NCT02669940|454273898|FG000|Overall Study|Failure to return|0|||
126267997|NCT02669940|454273899|FG001|Overall Study|Failure to return|3|||
126267998|NCT02669940|454273898|FG000|Overall Study|Insufficient follow-up data|1|||
126267999|NCT02669940|454273899|FG001|Overall Study|Insufficient follow-up data|0|||
126268000|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Adverse Event|9|||
126268001|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Adverse Event|4|||
126268002|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Adverse Event|5|||
126268003|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Adverse Event|9|||
126268004|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Adverse Event|8|||
126268005|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Adverse Event|0|||
126268006|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Adverse Event|0|||
126268007|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
126268008|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
126268009|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
126268010|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
126268011|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
126268012|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
126268013|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
126268014|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Death|1|||
126268015|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Death|1|||
126268016|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Death|1|||
126268017|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Death|1|||
126268018|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Death|0|||
126268019|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Death|0|||
126036657|NCT03854227|453433014|FG007|Overall Study|Refused further treatment|0|||
126036658|NCT03854227|453433015|FG008|Overall Study|Refused further treatment|0|||
126036659|NCT03854227|453433016|FG009|Overall Study|Refused further treatment|1|||
126268020|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Death|0|||
126268021|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
126268022|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
126268023|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
126268024|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
126268025|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
126268026|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
126268027|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
126268028|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268029|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268030|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
126268031|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268032|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268033|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268034|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268035|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
126268036|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
126268037|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
126268038|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
126268039|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
126268040|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
126268041|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
126268042|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Other|2|||
126268043|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Other|9|||
126268044|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Other|9|||
126268045|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Other|3|||
126268046|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Other|2|||
126268047|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Other|0|||
126268048|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Other|0|||
126268049|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
126268050|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
126268051|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
126268052|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
126268053|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
126268054|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
126268055|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
126268056|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
126268057|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
126268058|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
126268059|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
126268060|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
126268061|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
126268062|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
126268063|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
126268064|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
126268065|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
126268066|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
126268067|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
126268068|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
126268069|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
126268070|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Death|0|||
126268071|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Death|0|||
126268072|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Death|0|||
126268073|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Death|0|||
126268074|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Death|0|||
126268075|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Death|0|||
126268076|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Death|1|||
126268077|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
126268078|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
126268079|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
126268080|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
126268081|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
126268082|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
126036660|NCT03854227|453433017|FG010|Overall Study|Refused further treatment|0|||
126036661|NCT03854227|453433018|FG011|Overall Study|Refused further treatment|1|||
126268083|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
126036662|NCT03854227|453433007|FG000|Overall Study|Other|0|||
126268084|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Other|1|||
126268085|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Other|0|||
126268086|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Other|0|||
126268087|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Other|1|||
126268088|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Other|0|||
126268089|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Other|1|||
126268090|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Other|2|||
126268091|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268092|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268093|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
126268094|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268095|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268096|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268097|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
126268098|NCT00616941|454273907|FG000|Overall Study|Progressive Disease|1|||
126268099|NCT00616941|454273908|FG001|Overall Study|Progressive Disease|2|||
126268100|NCT00616941|454273909|FG002|Overall Study|Progressive Disease|1|||
126268101|NCT00616941|454273907|FG000|Overall Study|Adverse Event|0|||
126268102|NCT00616941|454273908|FG001|Overall Study|Adverse Event|1|||
126268103|NCT00616941|454273909|FG002|Overall Study|Adverse Event|1|||
125880728|NCT01744977|452862608|FG000|Overall Study|No longer meets inclusion|6|||
125880729|NCT01744977|452862609|FG001|Overall Study|No longer meets inclusion|0|||
126098532|NCT02038543|453653038|FG002|Overall Study|Withdrawal by Subject|0|||
126098533|NCT02038543|453653039|FG003|Overall Study|Withdrawal by Subject|1|||
126268104|NCT00616941|454273907|FG000|Overall Study|Subject Non-compliance|0|||
126268105|NCT00616941|454273908|FG001|Overall Study|Subject Non-compliance|0|||
126268106|NCT00616941|454273909|FG002|Overall Study|Subject Non-compliance|1|||
126268107|NCT00616941|454273907|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
126268108|NCT00616941|454273908|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
126268109|NCT00616941|454273909|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
126268110|NCT00616941|454273907|FG000|Overall Study|Vaccination Suspended|0|||
126268111|NCT00616941|454273908|FG001|Overall Study|Vaccination Suspended|0|||
126268112|NCT00616941|454273909|FG002|Overall Study|Vaccination Suspended|3|||
126268113|NCT02372071|454273910|FG000|Overall Study|Protocol Violation|18|||
126268114|NCT00714493|454273911|FG000|Overall Study|Adverse Event|11|||
126268115|NCT00714493|454273911|FG000|Overall Study|Death|3|||
126268116|NCT00714493|454273911|FG000|Overall Study|Lack of Efficacy|10|||
126268117|NCT00714493|454273911|FG000|Overall Study|Lost to Follow-up|3|||
126268118|NCT00714493|454273911|FG000|Overall Study|Protocol Violation|12|||
126268119|NCT00714493|454273911|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
126268120|NCT00714493|454273911|FG000|Overall Study|OTHER|2|||
126268121|NCT00506129|454273912|FG000|Overall Study|Disease Progression/Relapse|15|||
126268122|NCT00506129|454273912|FG000|Overall Study|Death|7|||
126268123|NCT01400919|454273913|FG000|Overall Study|Withdrawal by Subject|4|||
126268124|NCT01400919|454273913|FG000|Overall Study|Lost to Follow-up|2|||
126268125|NCT01400919|454273913|FG000|Overall Study|Missed visit|2|||
126268126|NCT00251719|454273914|FG000|Overall Study|Adverse Event|14|||
126268127|NCT00251719|454273915|FG001|Overall Study|Adverse Event|8|||
126268128|NCT00251719|454273916|FG002|Overall Study|Adverse Event|7|||
126268129|NCT00251719|454273914|FG000|Overall Study|Protocol Violation|1|||
126268130|NCT00251719|454273915|FG001|Overall Study|Protocol Violation|1|||
126268131|NCT00251719|454273916|FG002|Overall Study|Protocol Violation|1|||
126268132|NCT00251719|454273914|FG000|Overall Study|Lost to Follow-up|5|||
126268133|NCT00251719|454273915|FG001|Overall Study|Lost to Follow-up|11|||
126268134|NCT00251719|454273916|FG002|Overall Study|Lost to Follow-up|8|||
126268135|NCT00251719|454273914|FG000|Overall Study|Withdrawal by Subject|14|||
126268136|NCT00251719|454273915|FG001|Overall Study|Withdrawal by Subject|12|||
126268137|NCT00251719|454273916|FG002|Overall Study|Withdrawal by Subject|11|||
126268138|NCT00251719|454273914|FG000|Overall Study|Lack of Efficacy|2|||
126268139|NCT00251719|454273915|FG001|Overall Study|Lack of Efficacy|1|||
126268140|NCT00251719|454273916|FG002|Overall Study|Lack of Efficacy|0|||
126268141|NCT00251719|454273914|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
126268142|NCT00251719|454273915|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
126268143|NCT00251719|454273916|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
126268144|NCT00251719|454273914|FG000|Overall Study|Investigator decision|1|||
126268145|NCT00251719|454273915|FG001|Overall Study|Investigator decision|1|||
126098534|NCT00158860|453653040|FG000|Overall Study|Adverse Event|3|||
126098535|NCT00158860|453653041|FG001|Overall Study|Adverse Event|6|||
126098536|NCT00158860|453653040|FG000|Overall Study|Lost to Follow-up|11|||
126098537|NCT00158860|453653041|FG001|Overall Study|Lost to Follow-up|17|||
126098538|NCT00158860|453653040|FG000|Overall Study|Protocol Violation|8|||
126098539|NCT00158860|453653041|FG001|Overall Study|Protocol Violation|23|||
126268146|NCT00251719|454273916|FG002|Overall Study|Investigator decision|0|||
126268147|NCT00251719|454273914|FG000|Overall Study|Noncompliance|2|||
126268148|NCT00251719|454273915|FG001|Overall Study|Noncompliance|3|||
126268149|NCT00251719|454273916|FG002|Overall Study|Noncompliance|1|||
126268150|NCT00251719|454273914|FG000|Overall Study|Barrett's esophagus|2|||
126098540|NCT00158860|453653040|FG000|Overall Study|Withdrawal by Subject|7|||
126268151|NCT00251719|454273915|FG001|Overall Study|Barrett's esophagus|2|||
126098541|NCT00158860|453653041|FG001|Overall Study|Withdrawal by Subject|17|||
126098542|NCT00158860|453653040|FG000|Overall Study|MOVING OUT OF STATE|1|||
126098543|NCT00158860|453653041|FG001|Overall Study|MOVING OUT OF STATE|0|||
126098544|NCT00158860|453653040|FG000|Overall Study|Pregnancy|3|||
126098545|NCT00158860|453653041|FG001|Overall Study|Pregnancy|3|||
126098546|NCT00158860|453653040|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
126098547|NCT00158860|453653041|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
126268152|NCT00251719|454273916|FG002|Overall Study|Barrett's esophagus|0|||
126268153|NCT04392583|454273919|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
126268154|NCT02408068|454273920|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268155|NCT02408068|454273921|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268156|NCT02408068|454273922|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
126268157|NCT02408068|454273923|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268158|NCT02408068|454273924|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268159|NCT02408068|454273925|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268160|NCT02303041|454273929|FG000|Overall Study|Adverse Event|1|||
126268161|NCT02303041|454273930|FG001|Overall Study|Adverse Event|2|||
126268162|NCT01621191|454273933|FG000|Overall Study|Adverse Event|9|||
126268163|NCT01621191|454273933|FG000|Overall Study|Withdrawal by Subject|8|||
126268164|NCT01621191|454273933|FG000|Overall Study|Lack of Efficacy|6|||
126268165|NCT01621191|454273933|FG000|Overall Study|Lost to Follow-up|1|||
126268166|NCT01621191|454273933|FG000|Overall Study|Site Removed From Study|1|||
126268167|NCT00706381|454273934|FG000|Overall Study|Lost to Follow-up|0|||
126268168|NCT00706381|454273935|FG001|Overall Study|Lost to Follow-up|1|||
126268169|NCT00706381|454273936|FG002|Overall Study|Lost to Follow-up|1|||
126268170|NCT00706381|454273937|FG003|Overall Study|Lost to Follow-up|0|||
126268171|NCT01782482|454273945|FG000|Overall Study|Adverse Event|2|||
126268172|NCT01782482|454273946|FG001|Overall Study|Adverse Event|1|||
126268173|NCT01782482|454273945|FG000|Overall Study|Lost to Follow-up|2|||
126268174|NCT01782482|454273946|FG001|Overall Study|Lost to Follow-up|3|||
126360662|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
126360663|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
126360664|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
126360665|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
126360666|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
126360667|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Other|6|||
126360668|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Other|3|||
126360669|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Other|0|||
126360670|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
126360671|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126360672|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126360673|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
126360674|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
126360675|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
126360676|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Adverse Event|0|||
126360677|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Adverse Event|0|||
126360678|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Adverse Event|21|||
126360679|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
126360680|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
126360681|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
126360682|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
126360683|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
126360684|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
126360685|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
126268175|NCT01782482|454273945|FG000|Overall Study|Physician Decision|1|||
126098548|NCT00158860|453653040|FG000|Overall Study|SPONSOR REQUEST|0|||
126268176|NCT01782482|454273946|FG001|Overall Study|Physician Decision|0|||
126268177|NCT01782482|454273945|FG000|Overall Study|Protocol Violation|1|||
126268178|NCT01782482|454273946|FG001|Overall Study|Protocol Violation|0|||
126268179|NCT01782482|454273945|FG000|Overall Study|Withdrawal by Subject|2|||
126268180|NCT01782482|454273946|FG001|Overall Study|Withdrawal by Subject|3|||
126268181|NCT01782482|454273945|FG000|Overall Study|Randomized in Error|2|||
126360686|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
126360687|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
126360688|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Administrative|0|||
126360689|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Administrative|0|||
126360690|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Administrative|36|||
126360691|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Other|0|||
126360692|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Other|0|||
126360693|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Other|9|||
126360694|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
126360695|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
126360696|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
126360697|NCT03774810|454612710|FG000|Phase 1|Lack of Efficacy|21|||
126360698|NCT03774810|454612711|FG001|Phase 1|Lack of Efficacy|0|||
126360699|NCT03774810|454612712|FG002|Phase 1|Lack of Efficacy|0|||
126360700|NCT03774810|454612713|FG003|Phase 1|Lack of Efficacy|0|||
126360701|NCT03774810|454612714|FG004|Phase 1|Lack of Efficacy|0|||
126360702|NCT03774810|454612710|FG000|Phase 1|Withdrawal by Subject|9|||
126360703|NCT03774810|454612711|FG001|Phase 1|Withdrawal by Subject|0|||
126360704|NCT03774810|454612712|FG002|Phase 1|Withdrawal by Subject|0|||
126360705|NCT03774810|454612713|FG003|Phase 1|Withdrawal by Subject|0|||
126360706|NCT03774810|454612714|FG004|Phase 1|Withdrawal by Subject|0|||
126360707|NCT03774810|454612710|FG000|Phase 1|Lost to Follow-up|2|||
126360708|NCT03774810|454612711|FG001|Phase 1|Lost to Follow-up|0|||
126360709|NCT03774810|454612712|FG002|Phase 1|Lost to Follow-up|0|||
126360710|NCT03774810|454612713|FG003|Phase 1|Lost to Follow-up|0|||
126360711|NCT03774810|454612714|FG004|Phase 1|Lost to Follow-up|0|||
126360712|NCT03774810|454612710|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
126360713|NCT03774810|454612711|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
126360714|NCT03774810|454612712|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
126360715|NCT03774810|454612713|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
126360716|NCT03774810|454612714|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
126360717|NCT03774810|454612710|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
126360718|NCT03774810|454612711|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
126360719|NCT03774810|454612712|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
126360720|NCT03774810|454612713|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
126360721|NCT03774810|454612714|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
126360722|NCT03774810|454612710|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
126360723|NCT03774810|454612711|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
126360724|NCT03774810|454612712|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
126360725|NCT03774810|454612713|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
126360726|NCT03774810|454612714|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
126360727|NCT03774810|454612710|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
126360728|NCT03774810|454612711|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
126360729|NCT03774810|454612712|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
126360730|NCT03774810|454612713|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
126360731|NCT03774810|454612714|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
126360732|NCT03774810|454612710|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
126360733|NCT03774810|454612711|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
126360734|NCT03774810|454612712|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
126360735|NCT03774810|454612713|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
126360736|NCT03774810|454612714|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
126360737|NCT03774810|454612710|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
126360738|NCT03774810|454612711|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
126360739|NCT03774810|454612712|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
126360740|NCT03774810|454612713|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
126360741|NCT03774810|454612714|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
126360742|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
126360743|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
126360744|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
126360745|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
126360746|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
126360747|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
126360748|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
126360749|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
126360750|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
126360751|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
126360752|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
126360753|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
126360754|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
126360755|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
126360756|NCT00290758|454612715|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
126360757|NCT00290758|454612716|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
126360758|NCT04914000|454612717|FG000|Overall Study|Lost to Follow-up|8|||
126360759|NCT04914000|454612717|FG000|Overall Study|Withdrawal by Subject|1|||
126360760|NCT01429623|454612718|FG000|Overall Study|Death|1|||
126360761|NCT01429623|454612719|FG001|Overall Study|Death|0|||
126360762|NCT01429623|454612718|FG000|Overall Study|Adverse Event|7|||
126268182|NCT01782482|454273946|FG001|Overall Study|Randomized in Error|2|||
126268183|NCT01782482|454273945|FG000|Overall Study|Habitually wearing toric lens OS|0|||
126268184|NCT01782482|454273946|FG001|Overall Study|Habitually wearing toric lens OS|1|||
126268185|NCT00038649|454273948|FG000|Overall Study|Adverse Event|9|||
126268186|NCT00995085|454273949|FG000|Overall Study|Withdrawal by Subject|5|||
126268187|NCT03096847|454273955|FG000|Overall Study|Other|2|||
126268188|NCT03096847|454273956|FG001|Overall Study|Other|1|||
126268189|NCT03096847|454273957|FG002|Overall Study|Other|2|||
126268190|NCT03096847|454273955|FG000|Overall Study|Lost to Follow-up|1|||
126268191|NCT03096847|454273956|FG001|Overall Study|Lost to Follow-up|0|||
126268192|NCT03096847|454273957|FG002|Overall Study|Lost to Follow-up|1|||
126268193|NCT03096847|454273955|FG000|Overall Study|Death|6|||
126268194|NCT03096847|454273956|FG001|Overall Study|Death|0|||
126268195|NCT03096847|454273957|FG002|Overall Study|Death|2|||
126268196|NCT03096847|454273955|FG000|Overall Study|Protocol Violation|3|||
126268197|NCT03096847|454273956|FG001|Overall Study|Protocol Violation|0|||
126268198|NCT03096847|454273957|FG002|Overall Study|Protocol Violation|6|||
126268199|NCT03096847|454273955|FG000|Overall Study|Physician Decision|12|||
126268200|NCT03096847|454273956|FG001|Overall Study|Physician Decision|2|||
126268201|NCT03096847|454273957|FG002|Overall Study|Physician Decision|8|||
126268202|NCT03096847|454273955|FG000|Overall Study|Withdrawal by Subject|24|||
126268203|NCT03096847|454273956|FG001|Overall Study|Withdrawal by Subject|1|||
126360763|NCT01429623|454612719|FG001|Overall Study|Adverse Event|14|||
126360764|NCT01429623|454612718|FG000|Overall Study|Withdrawal by Subject|19|||
126360765|NCT01429623|454612719|FG001|Overall Study|Withdrawal by Subject|13|||
126360766|NCT01429623|454612718|FG000|Overall Study|Physician Decision|2|||
126360767|NCT01429623|454612719|FG001|Overall Study|Physician Decision|3|||
126360768|NCT01429623|454612718|FG000|Overall Study|Protocol Violation|3|||
126360769|NCT01429623|454612719|FG001|Overall Study|Protocol Violation|2|||
126360770|NCT01429623|454612718|FG000|Overall Study|Assorted|1|||
126360771|NCT01429623|454612719|FG001|Overall Study|Assorted|2|||
126360772|NCT01429623|454612718|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
126360773|NCT01429623|454612719|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
126360774|NCT01429623|454612718|FG000|Overall Study|No post baseline data|4|||
126360775|NCT01429623|454612719|FG001|Overall Study|No post baseline data|4|||
126360776|NCT01896986|454612721|FG000|Overall Study|samples lost|14|||
126360777|NCT01896986|454612722|FG001|Overall Study|samples lost|23|||
126360778|NCT04189588|454612727|FG000|Overall Study|Death|0|||
126360779|NCT04189588|454612728|FG001|Overall Study|Death|1|||
126360780|NCT04189588|454612727|FG000|Overall Study|Lost to Follow-up|0|||
126098549|NCT00158860|453653041|FG001|Overall Study|SPONSOR REQUEST|1|||
126098550|NCT00158860|453653040|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
126098551|NCT00158860|453653041|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
126098552|NCT00158860|453653040|FG000|Overall Study|Closed per sponsor|0|||
126268204|NCT03096847|454273957|FG002|Overall Study|Withdrawal by Subject|12|||
126360781|NCT04189588|454612728|FG001|Overall Study|Lost to Follow-up|1|||
126360782|NCT01061710|454612730|FG000|Overall Study|Protocol Violation|14|||
126360783|NCT03757715|454612731|FG000|Overall Study|Lost to Follow-up|4|||
126360784|NCT03757715|454612732|FG001|Overall Study|Lost to Follow-up|9|||
126360785|NCT03757715|454612731|FG000|Overall Study|Withdrawal by Subject|1|||
126360786|NCT03757715|454612732|FG001|Overall Study|Withdrawal by Subject|1|||
126360787|NCT03156621|454612733|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
126360788|NCT03156621|454612734|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
126098553|NCT00158860|453653041|FG001|Overall Study|Closed per sponsor|1|||
126268205|NCT03096847|454273955|FG000|Overall Study|Adverse Event|72|||
126268206|NCT03096847|454273956|FG001|Overall Study|Adverse Event|6|||
126268207|NCT03096847|454273957|FG002|Overall Study|Adverse Event|28|||
126268208|NCT03096847|454273955|FG000|Overall Study|Progressive disease|97|||
126268209|NCT03096847|454273956|FG001|Overall Study|Progressive disease|10|||
126268210|NCT03096847|454273957|FG002|Overall Study|Progressive disease|78|||
126360789|NCT03156621|454612733|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126360790|NCT03156621|454612734|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
126360791|NCT03302936|454612735|FG000|Overall Study|Protocol Violation|3|||
126360792|NCT03302936|454612736|FG001|Overall Study|Protocol Violation|4|||
126036663|NCT03854227|453433008|FG001|Overall Study|Other|0|||
126036664|NCT03854227|453433009|FG002|Overall Study|Other|0|||
126268211|NCT03096847|454273955|FG000|Overall Study|Non-compliance with study medication|1|||
126268212|NCT03096847|454273956|FG001|Overall Study|Non-compliance with study medication|0|||
126268213|NCT03096847|454273957|FG002|Overall Study|Non-compliance with study medication|0|||
126268214|NCT03096847|454273955|FG000|Overall Study|New therapy for study indication|1|||
126268215|NCT03096847|454273956|FG001|Overall Study|New therapy for study indication|0|||
126268216|NCT03096847|454273957|FG002|Overall Study|New therapy for study indication|1|||
126268217|NCT02749292|454273958|FG000|Overall Study|Physician Decision|1|||
126268218|NCT02749292|454273959|FG001|Overall Study|Physician Decision|0|||
126268219|NCT02749292|454273958|FG000|Overall Study|Withdrawal by Subject|5|||
126268220|NCT02749292|454273959|FG001|Overall Study|Withdrawal by Subject|7|||
126268221|NCT02749292|454273958|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
126268222|NCT02749292|454273959|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
126268223|NCT02749292|454273958|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
126268224|NCT02749292|454273959|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
126268225|NCT02749292|454273958|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
126268226|NCT02749292|454273959|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
126268227|NCT02749292|454273958|FG000|Overall Study|Adverse Event|4|||
126268228|NCT02749292|454273959|FG001|Overall Study|Adverse Event|1|||
126268229|NCT02749292|454273958|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
126268230|NCT02749292|454273959|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
126268231|NCT02749292|454273958|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
126268232|NCT02749292|454273959|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
126268233|NCT02749292|454273958|FG000|Overall Study|Requiring glucocorticoids|0|||
126268234|NCT02749292|454273959|FG001|Overall Study|Requiring glucocorticoids|3|||
126268235|NCT02749292|454273958|FG000|Overall Study|Cancer|1|||
126268236|NCT02749292|454273959|FG001|Overall Study|Cancer|0|||
126268237|NCT02458092|454273960|FG000|Overall Study|Withdrawal by Subject|1|||
126268238|NCT02458092|454273961|FG001|Overall Study|Withdrawal by Subject|0|||
126036665|NCT03854227|453433010|FG003|Overall Study|Other|0|||
126036666|NCT03854227|453433011|FG004|Overall Study|Other|0|||
126268239|NCT00251641|454273964|FG000|Overall Study|Adverse Event|80|||
126268240|NCT00251641|454273965|FG001|Overall Study|Adverse Event|8|||
126268241|NCT00251641|454273964|FG000|Overall Study|Lack of Efficacy|2|||
126268242|NCT00251641|454273965|FG001|Overall Study|Lack of Efficacy|1|||
126268243|NCT00251641|454273964|FG000|Overall Study|Progression of Disease|0|||
126268244|NCT00251641|454273965|FG001|Overall Study|Progression of Disease|2|||
126268245|NCT00251641|454273964|FG000|Overall Study|Lost to Follow-up|3|||
126268246|NCT00251641|454273965|FG001|Overall Study|Lost to Follow-up|3|||
126268247|NCT00251641|454273964|FG000|Overall Study|Withdrawal by Subject|6|||
126268248|NCT00251641|454273965|FG001|Overall Study|Withdrawal by Subject|8|||
126268249|NCT00251641|454273964|FG000|Overall Study|Protocol Violation|10|||
126268250|NCT00251641|454273965|FG001|Overall Study|Protocol Violation|2|||
126268251|NCT00251641|454273964|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
126268252|NCT00251641|454273965|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
126268253|NCT00251641|454273964|FG000|Overall Study|Switched Treatment|9|||
126268254|NCT00251641|454273965|FG001|Overall Study|Switched Treatment|63|||
126268255|NCT02093221|454273968|FG000|Overall Study|Adverse Event|1|||
126268256|NCT02093221|454273969|FG001|Overall Study|Adverse Event|0|||
126268257|NCT02093221|454273970|FG002|Overall Study|Adverse Event|0|||
126268258|NCT02093221|454273971|FG003|Overall Study|Adverse Event|0|||
126268259|NCT02093221|454273972|FG004|Overall Study|Adverse Event|0|||
126268260|NCT02093221|454273968|FG000|Overall Study|Withdrawal by Subject|1|||
126360793|NCT01259024|454612739|FG000|Overall Study|Physician Decision|1|||
126360794|NCT01657500|454612740|FG000|Overall Study|set impropperly matched|3|||
126360795|NCT01657500|454612741|FG001|Overall Study|set impropperly matched|3|||
126360796|NCT01657500|454612740|FG000|Overall Study|Lost to Follow-up|2|||
126360797|NCT01657500|454612741|FG001|Overall Study|Lost to Follow-up|2|||
126360798|NCT00986102|454612745|FG000|Overall Study|Lost to Follow-up|0|||
126360799|NCT00986102|454612746|FG001|Overall Study|Lost to Follow-up|1|||
126360800|NCT00986102|454612747|FG002|Overall Study|Lost to Follow-up|0|||
126036667|NCT03854227|453433012|FG005|Overall Study|Other|0|||
126268261|NCT02093221|454273969|FG001|Overall Study|Withdrawal by Subject|1|||
126268262|NCT02093221|454273970|FG002|Overall Study|Withdrawal by Subject|4|||
126268263|NCT02093221|454273971|FG003|Overall Study|Withdrawal by Subject|1|||
126360801|NCT00986102|454612748|FG003|Overall Study|Lost to Follow-up|1|||
126360802|NCT00986102|454612745|FG000|Overall Study|Withdrawal by Subject|1|||
126360803|NCT00986102|454612746|FG001|Overall Study|Withdrawal by Subject|1|||
126360804|NCT00986102|454612747|FG002|Overall Study|Withdrawal by Subject|0|||
126036668|NCT03854227|453433013|FG006|Overall Study|Other|0|||
126036669|NCT03854227|453433014|FG007|Overall Study|Other|0|||
126268264|NCT02093221|454273972|FG004|Overall Study|Withdrawal by Subject|1|||
126268265|NCT02093221|454273968|FG000|Overall Study|Lost to Follow-up|2|||
126268266|NCT02093221|454273969|FG001|Overall Study|Lost to Follow-up|0|||
126098554|NCT01029652|453653042|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
126268267|NCT02093221|454273970|FG002|Overall Study|Lost to Follow-up|1|||
126268268|NCT02093221|454273971|FG003|Overall Study|Lost to Follow-up|1|||
126268269|NCT02093221|454273972|FG004|Overall Study|Lost to Follow-up|0|||
126268270|NCT02093221|454273968|FG000|Overall Study|Death|0|||
126268271|NCT02093221|454273969|FG001|Overall Study|Death|1|||
126268272|NCT02093221|454273970|FG002|Overall Study|Death|0|||
126268273|NCT02093221|454273971|FG003|Overall Study|Death|0|||
126268274|NCT02093221|454273972|FG004|Overall Study|Death|0|||
126268275|NCT02093221|454273968|FG000|Overall Study|Protocol Violation|0|||
126268276|NCT02093221|454273969|FG001|Overall Study|Protocol Violation|1|||
126268277|NCT02093221|454273970|FG002|Overall Study|Protocol Violation|0|||
126268278|NCT02093221|454273971|FG003|Overall Study|Protocol Violation|0|||
126268279|NCT02093221|454273972|FG004|Overall Study|Protocol Violation|0|||
126268280|NCT02093221|454273968|FG000|Overall Study|Study termination|6|||
126360805|NCT00986102|454612748|FG003|Overall Study|Withdrawal by Subject|0|||
126360806|NCT06083493|454612749|FG000|Overall Study|Technical issues with the interventional device|2|||
126360807|NCT06083493|454612750|FG001|Overall Study|Technical issues with the interventional device|2|||
126360808|NCT06083493|454612749|FG000|Overall Study|Performed incorrect visual task|1|||
126360809|NCT06083493|454612750|FG001|Overall Study|Performed incorrect visual task|0|||
126360810|NCT06083493|454612749|FG000|Overall Study|Insufficient baseline performance|0|||
126360811|NCT06083493|454612750|FG001|Overall Study|Insufficient baseline performance|1|||
126360812|NCT04034056|454612751|FG000|Overall Study|Withdrawal by Subject|2|||
126360813|NCT04034056|454612751|FG000|Overall Study|Reason Not Specified|13|||
126360814|NCT04034056|454612751|FG000|Overall Study|Adverse Event|56|||
126360815|NCT01260311|454612761|FG000|Overall Study|Adverse Event|11|||
126360816|NCT01260311|454612761|FG000|Overall Study|Lack of Efficacy|4|||
126360817|NCT01260311|454612761|FG000|Overall Study|Lost to Follow-up|25|||
126360818|NCT01260311|454612761|FG000|Overall Study|Withdrawal by Subject|6|||
126360819|NCT01260311|454612761|FG000|Overall Study|Financial Constraints|77|||
126360820|NCT01260311|454612761|FG000|Overall Study|Gone to Province|2|||
126360821|NCT01260311|454612761|FG000|Overall Study|Medication Stopped|1|||
126360822|NCT01260311|454612761|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
126360823|NCT01452789|454612762|FG000|Overall Study|Withdrawal by Subject|3|||
126360824|NCT01452789|454612763|FG001|Overall Study|Withdrawal by Subject|2|||
126360825|NCT00066170|454612764|FG000|Overall Study|Adverse Event|2|||
126360826|NCT00066170|454612765|FG001|Overall Study|Adverse Event|4|||
126360827|NCT00066170|454612766|FG002|Overall Study|Adverse Event|1|||
126360828|NCT00066170|454612767|FG003|Overall Study|Adverse Event|7|||
126360829|NCT00066170|454612764|FG000|Overall Study|Serious Adverse Event|0|||
126360830|NCT00066170|454612765|FG001|Overall Study|Serious Adverse Event|0|||
126360831|NCT00066170|454612766|FG002|Overall Study|Serious Adverse Event|1|||
126360832|NCT00066170|454612767|FG003|Overall Study|Serious Adverse Event|1|||
126360833|NCT00066170|454612764|FG000|Overall Study|Lost to Follow-up|0|||
126360834|NCT00066170|454612765|FG001|Overall Study|Lost to Follow-up|1|||
126360835|NCT00066170|454612766|FG002|Overall Study|Lost to Follow-up|0|||
126360836|NCT00066170|454612767|FG003|Overall Study|Lost to Follow-up|0|||
126360837|NCT00066170|454612764|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
126360838|NCT00066170|454612765|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
126360839|NCT00066170|454612766|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
126360840|NCT00066170|454612767|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
126360841|NCT00066170|454612764|FG000|Overall Study|Protocol Violation|3|||
126360842|NCT00066170|454612765|FG001|Overall Study|Protocol Violation|0|||
126360843|NCT00066170|454612766|FG002|Overall Study|Protocol Violation|0|||
126360844|NCT00066170|454612767|FG003|Overall Study|Protocol Violation|0|||
126360845|NCT00066170|454612764|FG000|Overall Study|Other|1|||
126360846|NCT00066170|454612765|FG001|Overall Study|Other|5|||
126360847|NCT00066170|454612766|FG002|Overall Study|Other|2|||
126360848|NCT00066170|454612767|FG003|Overall Study|Other|0|||
126360849|NCT03722030|454612768|FG000|Overall Study|Withdrawal by Subject|1|||
126360850|NCT03722030|454612769|FG001|Overall Study|Withdrawal by Subject|0|||
126360851|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Adverse Event|14|||
126360852|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Adverse Event|27|||
126360853|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Adverse Event|60|||
126360854|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Adverse Event|0|||
126360855|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Adverse Event|0|||
126360856|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Pregnancy|0|||
126360857|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Pregnancy|7|||
126360858|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Pregnancy|9|||
126360859|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Pregnancy|0|||
126360860|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Pregnancy|0|||
126098555|NCT01029652|453653043|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
126268281|NCT02093221|454273969|FG001|Overall Study|Study termination|5|||
126268282|NCT02093221|454273970|FG002|Overall Study|Study termination|4|||
126268283|NCT02093221|454273971|FG003|Overall Study|Study termination|6|||
126268284|NCT02093221|454273972|FG004|Overall Study|Study termination|7|||
126360861|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
126360862|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
126268285|NCT04932941|454273980|FG000|Overall Study|Lost to Follow-up|3|||
126268286|NCT04932941|454273981|FG001|Overall Study|Lost to Follow-up|1|||
126268287|NCT04932941|454273980|FG000|Overall Study|Withdrawal by Subject|7|||
126268288|NCT04932941|454273981|FG001|Overall Study|Withdrawal by Subject|4|||
126268289|NCT04932941|454273980|FG000|Overall Study|Other|4|||
126268290|NCT04932941|454273981|FG001|Overall Study|Other|2|||
126268291|NCT01929031|454273984|FG000|Overall Study|Adverse Event|3|||
126268292|NCT01929031|454273985|FG001|Overall Study|Adverse Event|1|||
126268293|NCT01929031|454273986|FG002|Overall Study|Adverse Event|1|||
126268294|NCT01929031|454273987|FG003|Overall Study|Adverse Event|0|||
126268295|NCT01929031|454273988|FG004|Overall Study|Adverse Event|0|||
126268296|NCT01929031|454273989|FG005|Overall Study|Adverse Event|0|||
126268297|NCT01929031|454273984|FG000|Overall Study|Protocol Violation|1|||
126268298|NCT01929031|454273985|FG001|Overall Study|Protocol Violation|0|||
126268299|NCT01929031|454273986|FG002|Overall Study|Protocol Violation|0|||
126268300|NCT01929031|454273987|FG003|Overall Study|Protocol Violation|0|||
126268301|NCT01929031|454273988|FG004|Overall Study|Protocol Violation|0|||
126268302|NCT01929031|454273989|FG005|Overall Study|Protocol Violation|1|||
126268303|NCT01929031|454273984|FG000|Overall Study|Reason other than specified above|0|||
126268304|NCT01929031|454273985|FG001|Overall Study|Reason other than specified above|1|||
126268305|NCT01929031|454273986|FG002|Overall Study|Reason other than specified above|0|||
126268306|NCT01929031|454273987|FG003|Overall Study|Reason other than specified above|0|||
126268307|NCT01929031|454273988|FG004|Overall Study|Reason other than specified above|1|||
126268308|NCT01929031|454273989|FG005|Overall Study|Reason other than specified above|0|||
126268309|NCT02394730|454273995|FG000|Overall Study|Lost to Follow-up|1|||
126268310|NCT02394730|454273996|FG001|Overall Study|Lost to Follow-up|0|||
126268311|NCT02394730|454273995|FG000|Overall Study|Withdrawal by Subject|0|||
126268312|NCT02394730|454273996|FG001|Overall Study|Withdrawal by Subject|1|||
126268313|NCT04905290|454275790|FG000|Overall Study|Adverse Event|4|||
126268314|NCT04905290|454275790|FG000|Overall Study|Death|2|||
126268315|NCT04905290|454275790|FG000|Overall Study|Withdrawal by Subject|4|||
126268316|NCT04905290|454275790|FG000|Overall Study|Physician Decision|2|||
126268317|NCT04905290|454275790|FG000|Overall Study|Lost to Follow-up|2|||
126268318|NCT04905290|454275790|FG000|Overall Study|Screen Failure|2|||
126268319|NCT04905290|454275790|FG000|Overall Study|Unsuccessful Procedure|2|||
126268320|NCT00821873|454275791|FG000|Overall Study|Lost to Follow-up|4|||
126268321|NCT01995266|454275793|FG000|Overall Study|Death|1|||
126268322|NCT01995266|454275793|FG000|Overall Study|Lack of Efficacy|6|||
126268323|NCT01995266|454275793|FG000|Overall Study|Adverse Event|2|||
126268324|NCT03596151|454275794|FG000|Overall Study|Withdrawal by Subject|1|||
126268325|NCT00729248|454275796|FG000|Overall Study|Physician Decision|2|||
126268326|NCT03222583|454275801|FG000|Overall Study|Withdrawal by Subject|3|||
126268327|NCT03222583|454275802|FG001|Overall Study|Withdrawal by Subject|3|||
126268328|NCT03222583|454275801|FG000|Overall Study|Lost to Follow-up|1|||
126268329|NCT03222583|454275802|FG001|Overall Study|Lost to Follow-up|0|||
126268330|NCT03222583|454275801|FG000|Overall Study|Other|1|||
126268331|NCT03222583|454275802|FG001|Overall Study|Other|3|||
126268332|NCT03573505|454275803|FG000|Overall Study|Adverse Event|1|||
126268333|NCT03573505|454275804|FG001|Overall Study|Adverse Event|1|||
126268334|NCT03573505|454275803|FG000|Overall Study|Consent withdrawn|0|||
126268335|NCT03573505|454275804|FG001|Overall Study|Consent withdrawn|1|||
126268336|NCT03573505|454275803|FG000|Overall Study|Disease progression|0|||
126268337|NCT03573505|454275804|FG001|Overall Study|Disease progression|1|||
126268338|NCT03573505|454275803|FG000|Overall Study|Site Terminated by Sponsor|1|||
126360863|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
126360864|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
126360865|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
126360866|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
126360867|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
126360868|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
126360869|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
126360870|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
126360871|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Death|1|||
126268339|NCT03573505|454275804|FG001|Overall Study|Site Terminated by Sponsor|1|||
126268340|NCT03573505|454275803|FG000|Overall Study|Study terminated by sponsor|50|||
126268341|NCT03573505|454275804|FG001|Overall Study|Study terminated by sponsor|45|||
126268342|NCT03573505|454275803|FG000|Overall Study|Reason not specified|0|||
126268343|NCT03573505|454275804|FG001|Overall Study|Reason not specified|1|||
126360872|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Death|2|||
126360873|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Death|2|||
126268344|NCT03573505|454275803|FG000|Overall Study|Death|0|||
126268345|NCT03573505|454275804|FG001|Overall Study|Death|4|||
126268346|NCT04280705|454275805|FG000|Overall Study|Enrolled but not treated|4|||
126268347|NCT04280705|454275806|FG001|Overall Study|Enrolled but not treated|10|||
126268348|NCT04280705|454275805|FG000|Overall Study|Physician Decision|1|||
126268349|NCT04280705|454275806|FG001|Overall Study|Physician Decision|0|||
126268350|NCT04280705|454275805|FG000|Overall Study|Withdrawal by Subject|7|||
126268351|NCT04280705|454275806|FG001|Overall Study|Withdrawal by Subject|9|||
126268352|NCT04280705|454275805|FG000|Overall Study|Adverse Event|0|||
126268353|NCT04280705|454275806|FG001|Overall Study|Adverse Event|4|||
126268354|NCT04280705|454275805|FG000|Overall Study|Transferred to another hospital|1|||
126268355|NCT04280705|454275806|FG001|Overall Study|Transferred to another hospital|1|||
126268356|NCT04268316|454275809|FG000|Overall Study|Withdrawal by Subject|2|||
126268357|NCT04268316|454275810|FG001|Overall Study|Withdrawal by Subject|1|||
126268358|NCT04268316|454275811|FG002|Overall Study|Withdrawal by Subject|0|||
126268359|NCT04032158|454275818|FG000|Overall Study|Study Termination|2|||
126268360|NCT04032158|454275819|FG001|Overall Study|Study Termination|1|||
126268361|NCT01196078|454275820|FG000|Overall Study|Withdrawal by Subject|3|||
126268362|NCT01196078|454275821|FG001|Overall Study|Withdrawal by Subject|5|||
126268363|NCT01196078|454275820|FG000|Overall Study|Adverse Event|4|||
126268364|NCT01196078|454275821|FG001|Overall Study|Adverse Event|4|||
126268365|NCT01196078|454275820|FG000|Overall Study|Protocol Violation|2|||
126268366|NCT01196078|454275821|FG001|Overall Study|Protocol Violation|1|||
126268367|NCT01196078|454275820|FG000|Overall Study|Lack of Efficacy|17|||
126268368|NCT01196078|454275821|FG001|Overall Study|Lack of Efficacy|23|||
126268369|NCT01196078|454275820|FG000|Overall Study|Lost to Follow-up|1|||
126268370|NCT01196078|454275821|FG001|Overall Study|Lost to Follow-up|0|||
126268371|NCT01196078|454275820|FG000|Overall Study|Death|6|||
126268372|NCT01196078|454275821|FG001|Overall Study|Death|4|||
126268373|NCT01403064|454275822|FG000|Overall Study|Death|0|||
126268374|NCT01403064|454275823|FG001|Overall Study|Death|0|||
126268375|NCT01403064|454275824|FG002|Overall Study|Death|1|||
126268376|NCT01403064|454275825|FG003|Overall Study|Death|1|||
126268377|NCT01403064|454275822|FG000|Overall Study|Withdrawal by Subject|0|||
126268378|NCT01403064|454275823|FG001|Overall Study|Withdrawal by Subject|0|||
126268379|NCT01403064|454275824|FG002|Overall Study|Withdrawal by Subject|1|||
126268380|NCT01403064|454275825|FG003|Overall Study|Withdrawal by Subject|1|||
126268381|NCT01403064|454275822|FG000|Overall Study|Other|1|||
126268382|NCT01403064|454275823|FG001|Overall Study|Other|0|||
126268383|NCT01403064|454275824|FG002|Overall Study|Other|2|||
126268384|NCT01403064|454275825|FG003|Overall Study|Other|1|||
126268385|NCT04688931|454275837|FG000|Overall Study|Adverse Event|4|||
126268386|NCT04688931|454275838|FG001|Overall Study|Adverse Event|1|||
126268387|NCT04688931|454275837|FG000|Overall Study|Withdrawal by Subject|5|||
126268388|NCT04688931|454275838|FG001|Overall Study|Withdrawal by Subject|16|||
126268389|NCT04688931|454275837|FG000|Overall Study|Physician Decision|3|||
126268390|NCT04688931|454275838|FG001|Overall Study|Physician Decision|5|||
126268391|NCT04688931|454275837|FG000|Overall Study|Noncompliance|0|||
126268392|NCT04688931|454275838|FG001|Overall Study|Noncompliance|1|||
126268393|NCT04688931|454275837|FG000|Overall Study|Lost to Follow-up|1|||
126268394|NCT04688931|454275838|FG001|Overall Study|Lost to Follow-up|3|||
126268395|NCT04688931|454275837|FG000|Overall Study|Randomization Error|3|||
126268396|NCT04688931|454275838|FG001|Overall Study|Randomization Error|0|||
126268397|NCT04688931|454275837|FG000|Overall Study|Not Eligible|1|||
126268398|NCT04688931|454275838|FG001|Overall Study|Not Eligible|3|||
126268399|NCT04688931|454275837|FG000|Overall Study|Disease Progression|0|||
126268400|NCT04688931|454275838|FG001|Overall Study|Disease Progression|2|||
126268401|NCT04688931|454275837|FG000|Overall Study|Sponsor Requirement|1|||
126268402|NCT04688931|454275838|FG001|Overall Study|Sponsor Requirement|1|||
126268403|NCT04688931|454275837|FG000|Overall Study|Other Reason|1|||
126268404|NCT04688931|454275838|FG001|Overall Study|Other Reason|2|||
126268405|NCT00450619|454275839|FG000|Overall Study|refused treatment after randomization|2|||
126268406|NCT00450619|454275840|FG001|Overall Study|refused treatment after randomization|0|||
126268407|NCT00450619|454275839|FG000|Overall Study|did not progress; refused further trmt|1|||
126268408|NCT00450619|454275840|FG001|Overall Study|did not progress; refused further trmt|1|||
126268409|NCT00450619|454275839|FG000|Overall Study|Adverse Event|1|||
126268410|NCT00450619|454275840|FG001|Overall Study|Adverse Event|0|||
126268411|NCT01968694|454275860|FG000|Washout (1 Month)|Lost to Follow-up|0|||
126268412|NCT01968694|454275861|FG001|Washout (1 Month)|Lost to Follow-up|1|||
126268413|NCT02836496|454275864|FG000|Overall Study|Adverse Event|2|||
126268414|NCT02836496|454275865|FG001|Overall Study|Adverse Event|1|||
126268415|NCT02836496|454275864|FG000|Overall Study|Withdrawal by Subject|0|||
126268416|NCT02836496|454275865|FG001|Overall Study|Withdrawal by Subject|1|||
126268417|NCT00354341|454275866|FG000|Overall Study|Adverse Event|1|||
126268418|NCT00354341|454275867|FG001|Overall Study|Adverse Event|0|||
126268419|NCT00354341|454275866|FG000|Overall Study|Death|0|||
126268420|NCT00354341|454275867|FG001|Overall Study|Death|2|||
126268421|NCT00354341|454275866|FG000|Overall Study|Refused treatment|1|||
126268422|NCT00354341|454275867|FG001|Overall Study|Refused treatment|2|||
126268423|NCT00354341|454275866|FG000|Overall Study|Failure to return|0|||
126268424|NCT00354341|454275867|FG001|Overall Study|Failure to return|1|||
126268425|NCT00354341|454275866|FG000|Overall Study|Other|1|||
126268426|NCT00354341|454275867|FG001|Overall Study|Other|2|||
126268427|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
126268428|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
126268429|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
126268430|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
126268431|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
126268432|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
126268433|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
126268434|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
126268435|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
126268436|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
126268437|NCT03822832|454275868|FG000|Re-allocation|Not re-allocated to open label period|2|||
126268438|NCT03822832|454275869|FG001|Re-allocation|Not re-allocated to open label period|6|||
126268439|NCT03822832|454275868|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
126268440|NCT03822832|454275869|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
126268441|NCT03822832|454275868|FG000|Period 2 - Open Label Period|Adverse Event|0|||
126268442|NCT03822832|454275869|FG001|Period 2 - Open Label Period|Adverse Event|3|||
126268443|NCT01732874|454275870|FG000|Overall Study|Withdrawal by Subject|5|||
126268444|NCT01732874|454275871|FG001|Overall Study|Withdrawal by Subject|1|||
126268445|NCT01732874|454275870|FG000|Overall Study|Death of Infant|3|||
126268446|NCT01732874|454275871|FG001|Overall Study|Death of Infant|2|||
126268447|NCT00557076|454275878|FG000|Overall Study|Unblinding|0|||
126268448|NCT00557076|454275879|FG001|Overall Study|Unblinding|1|||
126268449|NCT00688376|454275880|FG000|Double-Blind Phase|Adverse Event|4|||
126268450|NCT00688376|454275881|FG001|Double-Blind Phase|Adverse Event|4|||
126268451|NCT00688376|454275880|FG000|Double-Blind Phase|Protocol Violation|1|||
126268452|NCT00688376|454275881|FG001|Double-Blind Phase|Protocol Violation|2|||
126268453|NCT00688376|454275880|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
126268454|NCT00688376|454275881|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
126268455|NCT00688376|454275880|FG000|Double-Blind Phase|Not treated|0|||
126268456|NCT00688376|454275881|FG001|Double-Blind Phase|Not treated|1|||
126268457|NCT00688376|454275880|FG000|Blinded Extension Phase|Adverse Event|3|||
126360874|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Death|0|||
126360875|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Death|0|||
126360876|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
126360877|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
126360878|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
126360879|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
126360880|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
126360881|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
126360882|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
126360883|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
126360884|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
126360885|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
126360886|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
126360887|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
126360888|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
126360889|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
126360890|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
126360891|NCT00098293|454612770|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
126360892|NCT00098293|454612771|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
126360893|NCT00098293|454612772|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
126360894|NCT00098293|454612773|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
126360895|NCT00098293|454612774|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
126360896|NCT00098293|454612770|FG000|Open-label (OL) Phase|Adverse Event|0|||
126360897|NCT00098293|454612771|FG001|Open-label (OL) Phase|Adverse Event|3|||
126360898|NCT00098293|454612772|FG002|Open-label (OL) Phase|Adverse Event|7|||
126360899|NCT00098293|454612773|FG003|Open-label (OL) Phase|Adverse Event|6|||
126360900|NCT00098293|454612774|FG004|Open-label (OL) Phase|Adverse Event|0|||
126268458|NCT00688376|454275881|FG001|Blinded Extension Phase|Adverse Event|4|||
126268459|NCT00688376|454275880|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
126268460|NCT00688376|454275881|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
126268461|NCT00688376|454275880|FG000|Blinded Extension Phase|Physician Decision|1|||
126268462|NCT00688376|454275881|FG001|Blinded Extension Phase|Physician Decision|0|||
126360901|NCT00098293|454612770|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
126360902|NCT00098293|454612771|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
126360903|NCT00098293|454612772|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
126268463|NCT00688376|454275880|FG000|Blinded Extension Phase|Other|1|||
126268464|NCT00688376|454275881|FG001|Blinded Extension Phase|Other|0|||
126268465|NCT00846521|454275883|FG000|Overall Study|Withdrawal by Subject|5|||
126268466|NCT00846521|454275883|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
126036670|NCT03854227|453433015|FG008|Overall Study|Other|1|||
126036671|NCT03854227|453433016|FG009|Overall Study|Other|1|||
126036672|NCT03854227|453433017|FG010|Overall Study|Other|0|||
126036673|NCT03854227|453433018|FG011|Overall Study|Other|0|||
126036674|NCT03668236|453433019|FG000|90-day Follow-up|Withdrawal by Subject|3|||
126036675|NCT03668236|453433020|FG001|90-day Follow-up|Withdrawal by Subject|2|||
126036676|NCT03668236|453433019|FG000|90-day Follow-up|Lost to Follow-up|3|||
126036677|NCT03668236|453433020|FG001|90-day Follow-up|Lost to Follow-up|1|||
126036678|NCT03668236|453433019|FG000|Baseline Characteristics|Lost to Follow-up|9|||
126268467|NCT00846521|454275883|FG000|Overall Study|Protocol Violation|1|||
126268468|NCT01246011|454275885|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
126268469|NCT01246011|454275886|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
126268470|NCT01246011|454275887|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
126268471|NCT01246011|454275885|FG000|Overall Study|Withdrawal by Subject|0|||
126268472|NCT01246011|454275886|FG001|Overall Study|Withdrawal by Subject|0|||
126036679|NCT03668236|453433020|FG001|Baseline Characteristics|Lost to Follow-up|5|||
126268473|NCT01246011|454275887|FG002|Overall Study|Withdrawal by Subject|1|||
126268474|NCT01780987|454275890|FG000|Overall Study|Adverse Event|0|||
126268475|NCT01780987|454275891|FG001|Overall Study|Adverse Event|4|||
126268476|NCT01780987|454275890|FG000|Overall Study|Withdrawal by Subject|2|||
126268477|NCT01780987|454275891|FG001|Overall Study|Withdrawal by Subject|0|||
126268478|NCT01780987|454275890|FG000|Overall Study|Request of Changing Hospital|0|||
126268479|NCT01780987|454275891|FG001|Overall Study|Request of Changing Hospital|1|||
126268480|NCT01780987|454275890|FG000|Overall Study|Changing Residence|1|||
126268481|NCT01780987|454275891|FG001|Overall Study|Changing Residence|0|||
126268482|NCT01780987|454275890|FG000|Overall Study|Not Receiving any Study Medication|0|||
126268483|NCT01780987|454275891|FG001|Overall Study|Not Receiving any Study Medication|1|||
126268484|NCT02138136|454275895|FG000|Overall Study|Protocol Violation|4|||
126268485|NCT02138136|454275895|FG000|Overall Study|Physician Decision|7|||
126268486|NCT02138136|454275895|FG000|Overall Study|Lack of Efficacy|35|||
126268487|NCT02138136|454275895|FG000|Overall Study|Pregnancy|2|||
126268488|NCT02138136|454275895|FG000|Overall Study|Adverse Event|18|||
126268489|NCT02138136|454275895|FG000|Overall Study|Withdrawal by Subject|36|||
126268490|NCT02138136|454275895|FG000|Overall Study|Lost to Follow-up|32|||
126268491|NCT02138136|454275895|FG000|Overall Study|Withdrawn by Sponsor|5|||
126268492|NCT03979820|454275898|FG000|Overall Study|Protocol Violation|1|||
126268493|NCT03979820|454275899|FG001|Overall Study|Protocol Violation|0|||
126268494|NCT03979820|454275900|FG002|Overall Study|Protocol Violation|0|||
126268495|NCT03979820|454275901|FG003|Overall Study|Protocol Violation|0|||
126268496|NCT03979820|454275898|FG000|Overall Study|Withdrawal by Subject|0|||
126360904|NCT00098293|454612773|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
126360905|NCT00098293|454612774|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
126360906|NCT00098293|454612770|FG000|Open-label (OL) Phase|Pregnancy|0|||
126036680|NCT03668236|453433019|FG000|1-year Follow-up|Withdrawal by Subject|17|||
126268497|NCT03979820|454275899|FG001|Overall Study|Withdrawal by Subject|0|||
126268498|NCT03979820|454275900|FG002|Overall Study|Withdrawal by Subject|1|||
126268499|NCT03979820|454275901|FG003|Overall Study|Withdrawal by Subject|0|||
126268500|NCT03979820|454275898|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
126360907|NCT00098293|454612771|FG001|Open-label (OL) Phase|Pregnancy|1|||
126360908|NCT00098293|454612772|FG002|Open-label (OL) Phase|Pregnancy|0|||
126360909|NCT00098293|454612773|FG003|Open-label (OL) Phase|Pregnancy|3|||
126360910|NCT00098293|454612774|FG004|Open-label (OL) Phase|Pregnancy|0|||
126360911|NCT00098293|454612770|FG000|Open-label (OL) Phase|Protocol Violation|0|||
126360912|NCT00098293|454612771|FG001|Open-label (OL) Phase|Protocol Violation|6|||
126360913|NCT00098293|454612772|FG002|Open-label (OL) Phase|Protocol Violation|13|||
126360914|NCT00098293|454612773|FG003|Open-label (OL) Phase|Protocol Violation|16|||
126360915|NCT00098293|454612774|FG004|Open-label (OL) Phase|Protocol Violation|0|||
126360916|NCT00098293|454612770|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
126360917|NCT00098293|454612771|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
126360918|NCT00098293|454612772|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
126360919|NCT00098293|454612773|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
126360920|NCT00098293|454612774|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
126360921|NCT00098293|454612770|FG000|Open-label (OL) Phase|Death|0|||
126036681|NCT03668236|453433020|FG001|1-year Follow-up|Withdrawal by Subject|15|||
126268501|NCT03979820|454275899|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
126268502|NCT03979820|454275900|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
126268503|NCT03979820|454275901|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
126268504|NCT00160641|454275902|FG000|Overall Study|Adverse Event|102|||
126268505|NCT00160641|454275902|FG000|Overall Study|Withdrawal by Subject|87|||
126360922|NCT00098293|454612771|FG001|Open-label (OL) Phase|Death|2|||
126036682|NCT06132282|453433026|FG000|Overall Study|Lost to Follow-up|31|||
126036683|NCT04376502|453433032|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
126360923|NCT00098293|454612772|FG002|Open-label (OL) Phase|Death|3|||
126360924|NCT00098293|454612773|FG003|Open-label (OL) Phase|Death|0|||
126360925|NCT00098293|454612774|FG004|Open-label (OL) Phase|Death|0|||
126268506|NCT00160641|454275902|FG000|Overall Study|Lost to Follow-up|8|||
126268507|NCT00160641|454275902|FG000|Overall Study|Lack of Efficacy|12|||
126268508|NCT00160641|454275902|FG000|Overall Study|Protocol Violation|3|||
126268509|NCT00160641|454275902|FG000|Overall Study|Other|9|||
126268510|NCT01640873|454275903|FG000|Overall Study|Protocol Violation|2|||
126268511|NCT01640873|454275904|FG001|Overall Study|Protocol Violation|1|||
126268512|NCT02192164|454275918|FG000|Overall Study|Other|8|||
126268513|NCT02192164|454275918|FG000|Overall Study|Withdrawal by Subject|1|||
126268514|NCT02192164|454275918|FG000|Overall Study|Physician Decision|4|||
126268515|NCT02192164|454275918|FG000|Overall Study|Did not meet the exclusion criteria|1|||
126268516|NCT00359788|454275921|FG000|Overall Study|Adverse Event|11|||
126268517|NCT00359788|454275922|FG001|Overall Study|Adverse Event|10|||
126268518|NCT00359788|454275921|FG000|Overall Study|Lack of Efficacy|1|||
126268519|NCT00359788|454275922|FG001|Overall Study|Lack of Efficacy|2|||
126268520|NCT00359788|454275921|FG000|Overall Study|Lost to Follow-up|3|||
126268521|NCT00359788|454275922|FG001|Overall Study|Lost to Follow-up|2|||
126268522|NCT00359788|454275921|FG000|Overall Study|Withdrawal by Subject|4|||
126268523|NCT00359788|454275922|FG001|Overall Study|Withdrawal by Subject|1|||
126268524|NCT00359788|454275921|FG000|Overall Study|Protocol Violation|4|||
126268525|NCT00359788|454275922|FG001|Overall Study|Protocol Violation|2|||
126268526|NCT02143583|454275923|FG000|Overall Study|Withdrawal by Subject|1|||
126268527|NCT02143583|454275924|FG001|Overall Study|Withdrawal by Subject|0|||
126268528|NCT02143583|454275925|FG002|Overall Study|Withdrawal by Subject|1|||
126268529|NCT02143583|454275923|FG000|Overall Study|husband illness|0|||
126268530|NCT02143583|454275924|FG001|Overall Study|husband illness|0|||
126268531|NCT02143583|454275925|FG002|Overall Study|husband illness|1|||
126268532|NCT00673933|454275926|FG000|Overall Study|Withdrawal by Subject|2|||
126268533|NCT00673933|454275926|FG000|Overall Study|Lost to Follow-up|1|||
126268534|NCT01366443|454275927|FG000|Overall Study|Lost to Follow-up|2|||
126268535|NCT01366443|454275927|FG000|Overall Study|Under 18 yo|1|||
126268536|NCT05816200|454275928|FG000|Overall Study|Lost to Follow-up|2|||
126268537|NCT05816200|454275929|FG001|Overall Study|Lost to Follow-up|1|||
126268538|NCT00369382|454275930|FG000|Overall Study|Death|0|||
126268539|NCT00369382|454275931|FG001|Overall Study|Death|2|||
126268540|NCT00369382|454275930|FG000|Overall Study|Physician Decision|2|||
126268541|NCT00369382|454275931|FG001|Overall Study|Physician Decision|1|||
126268542|NCT00369382|454275930|FG000|Overall Study|Withdrawal by Subject|5|||
126268543|NCT00369382|454275931|FG001|Overall Study|Withdrawal by Subject|0|||
126268544|NCT00369382|454275930|FG000|Overall Study|Randomized, not treated|2|||
126268545|NCT00369382|454275931|FG001|Overall Study|Randomized, not treated|0|||
126268546|NCT00369382|454275930|FG000|Overall Study|Other|1|||
126268547|NCT00369382|454275931|FG001|Overall Study|Other|0|||
126268548|NCT01673698|454275934|FG000|Overall Study|Lost to Follow-up|51|||
126268549|NCT01673698|454275935|FG001|Overall Study|Lost to Follow-up|13|||
126360926|NCT00098293|454612770|FG000|Supplemental Phase (SP)|Death|0|||
126360927|NCT00098293|454612771|FG001|Supplemental Phase (SP)|Death|0|||
126360928|NCT00098293|454612772|FG002|Supplemental Phase (SP)|Death|0|||
126360929|NCT00098293|454612773|FG003|Supplemental Phase (SP)|Death|0|||
126360930|NCT00098293|454612774|FG004|Supplemental Phase (SP)|Death|1|||
126360931|NCT00098293|454612770|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
126360932|NCT00098293|454612771|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
126360933|NCT00098293|454612772|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
126360934|NCT00098293|454612773|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
126360935|NCT00098293|454612774|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
126360936|NCT00098293|454612770|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
126360937|NCT00098293|454612771|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
126360938|NCT00098293|454612772|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
126360939|NCT00098293|454612773|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
126360940|NCT00098293|454612774|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
126360941|NCT00098293|454612770|FG000|Supplemental Phase (SP)|Other|0|||
126360942|NCT00098293|454612771|FG001|Supplemental Phase (SP)|Other|0|||
126360943|NCT00098293|454612772|FG002|Supplemental Phase (SP)|Other|0|||
126360944|NCT00098293|454612773|FG003|Supplemental Phase (SP)|Other|0|||
126360945|NCT00098293|454612774|FG004|Supplemental Phase (SP)|Other|22|||
126360946|NCT01370642|454612775|FG000|Overall Study|Adverse Event|2|||
126360947|NCT01370642|454612776|FG001|Overall Study|Adverse Event|1|||
126360948|NCT01370642|454612777|FG002|Overall Study|Adverse Event|1|||
126360949|NCT01370642|454612775|FG000|Overall Study|Detectable HCV RNA|0|||
126036684|NCT03748953|453433033|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
126268550|NCT00507546|454275936|FG000|Overall Study|Withdrawal by Subject|1|||
126268551|NCT00507546|454275937|FG001|Overall Study|Withdrawal by Subject|0|||
126268552|NCT00507546|454275936|FG000|Overall Study|Protocol Violation|1|||
126268553|NCT00507546|454275937|FG001|Overall Study|Protocol Violation|0|||
126268554|NCT00507546|454275936|FG000|Overall Study|Physician Decision|0|||
126268555|NCT00507546|454275937|FG001|Overall Study|Physician Decision|1|||
126268556|NCT00448136|454275938|FG000|Overall Study|Death|3|||
126360950|NCT01370642|454612776|FG001|Overall Study|Detectable HCV RNA|0|||
126360951|NCT01370642|454612777|FG002|Overall Study|Detectable HCV RNA|22|||
126360952|NCT01370642|454612775|FG000|Overall Study|Lost to Follow-up|0|||
126268557|NCT00448136|454275939|FG001|Overall Study|Death|8|||
126268558|NCT00448136|454275938|FG000|Overall Study|Investigator's decision (progression)|1|||
126268559|NCT00448136|454275939|FG001|Overall Study|Investigator's decision (progression)|0|||
126268560|NCT00609466|454275940|FG000|Overall Study|Withdrawal by Subject|0|||
126268561|NCT00609466|454275941|FG001|Overall Study|Withdrawal by Subject|1|||
126268562|NCT00609466|454275942|FG002|Overall Study|Withdrawal by Subject|1|||
126268563|NCT00609466|454275940|FG000|Overall Study|Adverse Event|2|||
126268564|NCT00609466|454275941|FG001|Overall Study|Adverse Event|3|||
126268565|NCT00609466|454275942|FG002|Overall Study|Adverse Event|1|||
126268566|NCT00609466|454275940|FG000|Overall Study|Lack of Efficacy|0|||
126268567|NCT00609466|454275941|FG001|Overall Study|Lack of Efficacy|2|||
126268568|NCT00609466|454275942|FG002|Overall Study|Lack of Efficacy|2|||
126268569|NCT03512262|454275943|FG000|Overall Study|Adverse Event|8|||
126268570|NCT03512262|454275944|FG001|Overall Study|Adverse Event|3|||
126268571|NCT03512262|454275943|FG000|Overall Study|Death (non-treatment emergent)|1|||
126268572|NCT03512262|454275944|FG001|Overall Study|Death (non-treatment emergent)|0|||
126268573|NCT03512262|454275943|FG000|Overall Study|Withdrawal by Subject|17|||
126268574|NCT03512262|454275944|FG001|Overall Study|Withdrawal by Subject|9|||
126268575|NCT03512262|454275943|FG000|Overall Study|Lost to Follow-up|7|||
126268576|NCT03512262|454275944|FG001|Overall Study|Lost to Follow-up|1|||
126268577|NCT03512262|454275943|FG000|Overall Study|Other than Specified|2|||
126268578|NCT03512262|454275944|FG001|Overall Study|Other than Specified|2|||
126268579|NCT03407430|454275947|FG000|Washout|Protocol Violation|1|||
126268580|NCT03407430|454275948|FG001|Washout|Protocol Violation|0|||
126268581|NCT03510182|454275949|FG000|Overall Study|Withdrawal by Subject|2|||
126268582|NCT01195272|454275950|FG000|Overall Study|Adverse Event|1|||
126268583|NCT01195272|454275950|FG000|Overall Study|Lack of Efficacy|3|||
126268584|NCT03295318|454277420|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
126268585|NCT03295318|454277421|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
126268586|NCT03295318|454277422|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
126268587|NCT03295318|454277420|FG000|Overall Study|Death|1|||
126268588|NCT03295318|454277421|FG001|Overall Study|Death|1|||
126268589|NCT03295318|454277422|FG002|Overall Study|Death|1|||
126268590|NCT03295318|454277420|FG000|Overall Study|Protocol Violation|4|||
126268591|NCT03295318|454277421|FG001|Overall Study|Protocol Violation|3|||
126268592|NCT03295318|454277422|FG002|Overall Study|Protocol Violation|3|||
126268593|NCT03295318|454277420|FG000|Overall Study|Withdrawal by Subject|0|||
126268594|NCT03295318|454277421|FG001|Overall Study|Withdrawal by Subject|0|||
126268595|NCT03295318|454277422|FG002|Overall Study|Withdrawal by Subject|1|||
126268596|NCT03295318|454277420|FG000|Overall Study|Subject discontinued due to travel|0|||
126268597|NCT03295318|454277421|FG001|Overall Study|Subject discontinued due to travel|1|||
126268598|NCT03295318|454277422|FG002|Overall Study|Subject discontinued due to travel|0|||
126268599|NCT04319718|454277423|FG000|Overall Study|Adverse Event|0|||
126268600|NCT04319718|454277424|FG001|Overall Study|Adverse Event|2|||
126268601|NCT04319718|454277423|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
126268602|NCT04319718|454277424|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
126268603|NCT01288053|454277425|FG000|Overall Study|Death|1|||
126268604|NCT00144781|454277426|FG000|Overall Study|Adverse Event|0|||
126268605|NCT00144781|454277427|FG001|Overall Study|Adverse Event|1|||
126268606|NCT00144781|454277428|FG002|Overall Study|Adverse Event|0|||
126268607|NCT00144781|454277429|FG003|Overall Study|Adverse Event|0|||
126268608|NCT00144781|454277426|FG000|Overall Study|Non-compliant|0|||
126268609|NCT00144781|454277427|FG001|Overall Study|Non-compliant|1|||
126268610|NCT00144781|454277428|FG002|Overall Study|Non-compliant|0|||
126268611|NCT00144781|454277429|FG003|Overall Study|Non-compliant|0|||
126268612|NCT02068092|454277430|FG000|Overall Study|Physician Decision|2|||
126268613|NCT02068092|454277430|FG000|Overall Study|Adverse Event|2|||
126268614|NCT02068092|454277430|FG000|Overall Study|Lost to Follow-up|4|||
126268615|NCT02068092|454277430|FG000|Overall Study|Withdrawal by Subject|2|||
126036685|NCT03748953|453433034|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
126036686|NCT03748953|453433033|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
126036687|NCT03748953|453433034|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
126268616|NCT03502707|454277431|FG000|Overall Study|Adverse Event|0|||
126268617|NCT03502707|454277432|FG001|Overall Study|Adverse Event|0|||
126268618|NCT03502707|454277433|FG002|Overall Study|Adverse Event|0|||
126268619|NCT03502707|454277434|FG003|Overall Study|Adverse Event|0|||
126268620|NCT03502707|454277435|FG004|Overall Study|Adverse Event|0|||
126268621|NCT03502707|454277436|FG005|Overall Study|Adverse Event|0|||
126268622|NCT03502707|454277437|FG006|Overall Study|Adverse Event|0|||
126268623|NCT03502707|454277438|FG007|Overall Study|Adverse Event|0|||
126268624|NCT03502707|454277439|FG008|Overall Study|Adverse Event|0|||
126268625|NCT03502707|454277440|FG009|Overall Study|Adverse Event|0|||
126268626|NCT03502707|454277441|FG010|Overall Study|Adverse Event|0|||
126268627|NCT03502707|454277442|FG011|Overall Study|Adverse Event|0|||
126268628|NCT03502707|454277443|FG012|Overall Study|Adverse Event|0|||
126268629|NCT03502707|454277444|FG013|Overall Study|Adverse Event|0|||
126268630|NCT03502707|454277445|FG014|Overall Study|Adverse Event|0|||
126268631|NCT03502707|454277446|FG015|Overall Study|Adverse Event|1|||
126268632|NCT03502707|454277447|FG016|Overall Study|Adverse Event|5|||
126268633|NCT03502707|454277448|FG017|Overall Study|Adverse Event|0|||
126268634|NCT03502707|454277431|FG000|Overall Study|Death|0|||
126268635|NCT03502707|454277432|FG001|Overall Study|Death|0|||
126268636|NCT03502707|454277433|FG002|Overall Study|Death|0|||
126268637|NCT03502707|454277434|FG003|Overall Study|Death|1|||
126268638|NCT03502707|454277435|FG004|Overall Study|Death|0|||
126268639|NCT03502707|454277436|FG005|Overall Study|Death|0|||
126268640|NCT03502707|454277437|FG006|Overall Study|Death|0|||
126268641|NCT03502707|454277438|FG007|Overall Study|Death|0|||
126268642|NCT03502707|454277439|FG008|Overall Study|Death|1|||
126268643|NCT03502707|454277440|FG009|Overall Study|Death|1|||
126268644|NCT03502707|454277441|FG010|Overall Study|Death|0|||
126268645|NCT03502707|454277442|FG011|Overall Study|Death|0|||
126268646|NCT03502707|454277443|FG012|Overall Study|Death|1|||
126268647|NCT03502707|454277444|FG013|Overall Study|Death|0|||
126268648|NCT03502707|454277445|FG014|Overall Study|Death|0|||
126268649|NCT03502707|454277446|FG015|Overall Study|Death|1|||
126268650|NCT03502707|454277447|FG016|Overall Study|Death|0|||
126268651|NCT03502707|454277448|FG017|Overall Study|Death|0|||
126268652|NCT03502707|454277431|FG000|Overall Study|Lost to Follow-up|0|||
126268653|NCT03502707|454277432|FG001|Overall Study|Lost to Follow-up|0|||
126268654|NCT03502707|454277433|FG002|Overall Study|Lost to Follow-up|0|||
126268655|NCT03502707|454277434|FG003|Overall Study|Lost to Follow-up|0|||
126268656|NCT03502707|454277435|FG004|Overall Study|Lost to Follow-up|0|||
126268657|NCT03502707|454277436|FG005|Overall Study|Lost to Follow-up|0|||
126268658|NCT03502707|454277437|FG006|Overall Study|Lost to Follow-up|0|||
126268659|NCT03502707|454277438|FG007|Overall Study|Lost to Follow-up|5|||
126268660|NCT03502707|454277439|FG008|Overall Study|Lost to Follow-up|0|||
126268661|NCT03502707|454277440|FG009|Overall Study|Lost to Follow-up|2|||
126268662|NCT03502707|454277441|FG010|Overall Study|Lost to Follow-up|1|||
126268663|NCT03502707|454277442|FG011|Overall Study|Lost to Follow-up|2|||
126268664|NCT03502707|454277443|FG012|Overall Study|Lost to Follow-up|1|||
126268665|NCT03502707|454277444|FG013|Overall Study|Lost to Follow-up|1|||
126268666|NCT03502707|454277445|FG014|Overall Study|Lost to Follow-up|0|||
126268667|NCT03502707|454277446|FG015|Overall Study|Lost to Follow-up|4|||
126268668|NCT03502707|454277447|FG016|Overall Study|Lost to Follow-up|9|||
126268669|NCT03502707|454277448|FG017|Overall Study|Lost to Follow-up|2|||
126268670|NCT03502707|454277431|FG000|Overall Study|Physician Decision|0|||
126268671|NCT03502707|454277432|FG001|Overall Study|Physician Decision|0|||
126268672|NCT03502707|454277433|FG002|Overall Study|Physician Decision|0|||
126268673|NCT03502707|454277434|FG003|Overall Study|Physician Decision|0|||
126268674|NCT03502707|454277435|FG004|Overall Study|Physician Decision|0|||
126268675|NCT03502707|454277436|FG005|Overall Study|Physician Decision|0|||
126268676|NCT03502707|454277437|FG006|Overall Study|Physician Decision|0|||
126268677|NCT03502707|454277438|FG007|Overall Study|Physician Decision|0|||
126268678|NCT03502707|454277439|FG008|Overall Study|Physician Decision|2|||
126268679|NCT03502707|454277440|FG009|Overall Study|Physician Decision|1|||
126268680|NCT03502707|454277441|FG010|Overall Study|Physician Decision|0|||
126268681|NCT03502707|454277442|FG011|Overall Study|Physician Decision|0|||
126268682|NCT03502707|454277443|FG012|Overall Study|Physician Decision|0|||
126268683|NCT03502707|454277444|FG013|Overall Study|Physician Decision|0|||
126360953|NCT01370642|454612776|FG001|Overall Study|Lost to Follow-up|0|||
126360954|NCT01370642|454612777|FG002|Overall Study|Lost to Follow-up|1|||
126360955|NCT01370642|454612775|FG000|Overall Study|Physician Decision|4|||
126360956|NCT01370642|454612776|FG001|Overall Study|Physician Decision|1|||
126036688|NCT03748953|453433033|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
126036689|NCT03748953|453433034|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
126268684|NCT03502707|454277445|FG014|Overall Study|Physician Decision|1|||
126268685|NCT03502707|454277446|FG015|Overall Study|Physician Decision|3|||
126268686|NCT03502707|454277447|FG016|Overall Study|Physician Decision|0|||
126268687|NCT03502707|454277448|FG017|Overall Study|Physician Decision|0|||
126268688|NCT03502707|454277431|FG000|Overall Study|Protocol Violation|0|||
126268689|NCT03502707|454277432|FG001|Overall Study|Protocol Violation|0|||
126268690|NCT03502707|454277433|FG002|Overall Study|Protocol Violation|0|||
126268691|NCT03502707|454277434|FG003|Overall Study|Protocol Violation|0|||
126268692|NCT03502707|454277435|FG004|Overall Study|Protocol Violation|0|||
126268693|NCT03502707|454277436|FG005|Overall Study|Protocol Violation|0|||
126268694|NCT03502707|454277437|FG006|Overall Study|Protocol Violation|0|||
126360957|NCT01370642|454612777|FG002|Overall Study|Physician Decision|2|||
126360958|NCT01370642|454612775|FG000|Overall Study|Withdrawal by Subject|2|||
126036690|NCT03748953|453433033|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
126268695|NCT03502707|454277438|FG007|Overall Study|Protocol Violation|0|||
126268696|NCT03502707|454277439|FG008|Overall Study|Protocol Violation|0|||
126268697|NCT03502707|454277440|FG009|Overall Study|Protocol Violation|0|||
126268698|NCT03502707|454277441|FG010|Overall Study|Protocol Violation|0|||
126268699|NCT03502707|454277442|FG011|Overall Study|Protocol Violation|0|||
126268700|NCT03502707|454277443|FG012|Overall Study|Protocol Violation|0|||
126268701|NCT03502707|454277444|FG013|Overall Study|Protocol Violation|0|||
126268702|NCT03502707|454277445|FG014|Overall Study|Protocol Violation|0|||
126268703|NCT03502707|454277446|FG015|Overall Study|Protocol Violation|1|||
126268704|NCT03502707|454277447|FG016|Overall Study|Protocol Violation|0|||
126268705|NCT03502707|454277448|FG017|Overall Study|Protocol Violation|0|||
126268706|NCT03502707|454277431|FG000|Overall Study|Withdrawal by Subject|1|||
126268707|NCT03502707|454277432|FG001|Overall Study|Withdrawal by Subject|1|||
126268708|NCT03502707|454277433|FG002|Overall Study|Withdrawal by Subject|0|||
126268709|NCT03502707|454277434|FG003|Overall Study|Withdrawal by Subject|0|||
126268710|NCT03502707|454277435|FG004|Overall Study|Withdrawal by Subject|0|||
126268711|NCT03502707|454277436|FG005|Overall Study|Withdrawal by Subject|2|||
126268712|NCT03502707|454277437|FG006|Overall Study|Withdrawal by Subject|0|||
126268713|NCT03502707|454277438|FG007|Overall Study|Withdrawal by Subject|3|||
126268714|NCT03502707|454277439|FG008|Overall Study|Withdrawal by Subject|1|||
126268715|NCT03502707|454277440|FG009|Overall Study|Withdrawal by Subject|2|||
126268716|NCT03502707|454277441|FG010|Overall Study|Withdrawal by Subject|12|||
126268717|NCT03502707|454277442|FG011|Overall Study|Withdrawal by Subject|23|||
126268718|NCT03502707|454277443|FG012|Overall Study|Withdrawal by Subject|5|||
126268719|NCT03502707|454277444|FG013|Overall Study|Withdrawal by Subject|3|||
126268720|NCT03502707|454277445|FG014|Overall Study|Withdrawal by Subject|3|||
126268721|NCT03502707|454277446|FG015|Overall Study|Withdrawal by Subject|43|||
126268722|NCT03502707|454277447|FG016|Overall Study|Withdrawal by Subject|44|||
126268723|NCT03502707|454277448|FG017|Overall Study|Withdrawal by Subject|18|||
126268724|NCT03502707|454277431|FG000|Overall Study|Sponsor's Decision|1|||
126268725|NCT03502707|454277432|FG001|Overall Study|Sponsor's Decision|0|||
126268726|NCT03502707|454277433|FG002|Overall Study|Sponsor's Decision|0|||
126268727|NCT03502707|454277434|FG003|Overall Study|Sponsor's Decision|0|||
126268728|NCT03502707|454277435|FG004|Overall Study|Sponsor's Decision|0|||
126268729|NCT03502707|454277436|FG005|Overall Study|Sponsor's Decision|0|||
126268730|NCT03502707|454277437|FG006|Overall Study|Sponsor's Decision|0|||
126268731|NCT03502707|454277438|FG007|Overall Study|Sponsor's Decision|0|||
126268732|NCT03502707|454277439|FG008|Overall Study|Sponsor's Decision|0|||
126268733|NCT03502707|454277440|FG009|Overall Study|Sponsor's Decision|1|||
126268734|NCT03502707|454277441|FG010|Overall Study|Sponsor's Decision|0|||
126268735|NCT03502707|454277442|FG011|Overall Study|Sponsor's Decision|0|||
126268736|NCT03502707|454277443|FG012|Overall Study|Sponsor's Decision|0|||
126268737|NCT03502707|454277444|FG013|Overall Study|Sponsor's Decision|0|||
126268738|NCT03502707|454277445|FG014|Overall Study|Sponsor's Decision|0|||
126268739|NCT03502707|454277446|FG015|Overall Study|Sponsor's Decision|2|||
126268740|NCT03502707|454277447|FG016|Overall Study|Sponsor's Decision|1|||
126268741|NCT03502707|454277448|FG017|Overall Study|Sponsor's Decision|0|||
126268742|NCT03502707|454277431|FG000|Overall Study|Initiated Prohibited Medication|0|||
126268743|NCT03502707|454277432|FG001|Overall Study|Initiated Prohibited Medication|0|||
126268744|NCT03502707|454277433|FG002|Overall Study|Initiated Prohibited Medication|0|||
126268745|NCT03502707|454277434|FG003|Overall Study|Initiated Prohibited Medication|0|||
126268746|NCT03502707|454277435|FG004|Overall Study|Initiated Prohibited Medication|0|||
126268747|NCT03502707|454277436|FG005|Overall Study|Initiated Prohibited Medication|0|||
126268748|NCT03502707|454277437|FG006|Overall Study|Initiated Prohibited Medication|0|||
126268749|NCT03502707|454277438|FG007|Overall Study|Initiated Prohibited Medication|0|||
126268750|NCT03502707|454277439|FG008|Overall Study|Initiated Prohibited Medication|0|||
126268751|NCT03502707|454277440|FG009|Overall Study|Initiated Prohibited Medication|0|||
126268752|NCT03502707|454277441|FG010|Overall Study|Initiated Prohibited Medication|0|||
126268753|NCT03502707|454277442|FG011|Overall Study|Initiated Prohibited Medication|0|||
126268754|NCT03502707|454277443|FG012|Overall Study|Initiated Prohibited Medication|0|||
126268755|NCT03502707|454277444|FG013|Overall Study|Initiated Prohibited Medication|0|||
126268756|NCT03502707|454277445|FG014|Overall Study|Initiated Prohibited Medication|0|||
126268757|NCT03502707|454277446|FG015|Overall Study|Initiated Prohibited Medication|0|||
126268758|NCT03502707|454277447|FG016|Overall Study|Initiated Prohibited Medication|1|||
126268759|NCT03502707|454277448|FG017|Overall Study|Initiated Prohibited Medication|0|||
126268760|NCT03502707|454277431|FG000|Overall Study|Other|0|||
126268761|NCT03502707|454277432|FG001|Overall Study|Other|0|||
126268762|NCT03502707|454277433|FG002|Overall Study|Other|0|||
126268763|NCT03502707|454277434|FG003|Overall Study|Other|0|||
126268764|NCT03502707|454277435|FG004|Overall Study|Other|0|||
126268765|NCT03502707|454277436|FG005|Overall Study|Other|0|||
126268766|NCT03502707|454277437|FG006|Overall Study|Other|0|||
126268767|NCT03502707|454277438|FG007|Overall Study|Other|0|||
126268768|NCT03502707|454277439|FG008|Overall Study|Other|1|||
126268769|NCT03502707|454277440|FG009|Overall Study|Other|1|||
126268770|NCT03502707|454277441|FG010|Overall Study|Other|2|||
126268771|NCT03502707|454277442|FG011|Overall Study|Other|0|||
126268772|NCT03502707|454277443|FG012|Overall Study|Other|0|||
126268773|NCT03502707|454277444|FG013|Overall Study|Other|0|||
126268774|NCT03502707|454277445|FG014|Overall Study|Other|0|||
126268775|NCT03502707|454277446|FG015|Overall Study|Other|4|||
126268776|NCT03502707|454277447|FG016|Overall Study|Other|1|||
126268777|NCT03502707|454277448|FG017|Overall Study|Other|0|||
126268778|NCT03502707|454277431|FG000|Overall Study|Randomized but not vaccinated|0|||
126268779|NCT03502707|454277432|FG001|Overall Study|Randomized but not vaccinated|0|||
126268780|NCT03502707|454277433|FG002|Overall Study|Randomized but not vaccinated|0|||
126036691|NCT03748953|453433034|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
126360959|NCT01370642|454612776|FG001|Overall Study|Withdrawal by Subject|4|||
126360960|NCT01370642|454612777|FG002|Overall Study|Withdrawal by Subject|3|||
126360961|NCT01796470|454612784|FG000|Overall Study|Adverse Event|4|||
126360962|NCT01796470|454612785|FG001|Overall Study|Adverse Event|2|||
126360963|NCT01796470|454612786|FG002|Overall Study|Adverse Event|2|||
126360964|NCT01796470|454612787|FG003|Overall Study|Adverse Event|1|||
126360965|NCT01796470|454612788|FG004|Overall Study|Adverse Event|3|||
126360966|NCT01796470|454612784|FG000|Overall Study|Death|2|||
126360967|NCT01796470|454612785|FG001|Overall Study|Death|0|||
126360968|NCT01796470|454612786|FG002|Overall Study|Death|0|||
126360969|NCT01796470|454612787|FG003|Overall Study|Death|0|||
126360970|NCT01796470|454612788|FG004|Overall Study|Death|1|||
126360971|NCT01796470|454612784|FG000|Overall Study|Initiated New Therapy|9|||
126360972|NCT01796470|454612785|FG001|Overall Study|Initiated New Therapy|0|||
126360973|NCT01796470|454612786|FG002|Overall Study|Initiated New Therapy|0|||
126360974|NCT01796470|454612787|FG003|Overall Study|Initiated New Therapy|0|||
126360975|NCT01796470|454612788|FG004|Overall Study|Initiated New Therapy|2|||
126036692|NCT03748953|453433033|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
126036693|NCT03748953|453433034|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
126036694|NCT04044768|453433036|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
126360976|NCT01796470|454612784|FG000|Overall Study|Lost to Follow-up|0|||
126360977|NCT01796470|454612785|FG001|Overall Study|Lost to Follow-up|1|||
126360978|NCT01796470|454612786|FG002|Overall Study|Lost to Follow-up|0|||
126360979|NCT01796470|454612787|FG003|Overall Study|Lost to Follow-up|0|||
126360980|NCT01796470|454612788|FG004|Overall Study|Lost to Follow-up|0|||
126360981|NCT01796470|454612784|FG000|Overall Study|Physician Decision|5|||
126360982|NCT01796470|454612785|FG001|Overall Study|Physician Decision|4|||
126360983|NCT01796470|454612786|FG002|Overall Study|Physician Decision|1|||
126360984|NCT01796470|454612787|FG003|Overall Study|Physician Decision|0|||
126360985|NCT01796470|454612788|FG004|Overall Study|Physician Decision|1|||
126036695|NCT04044768|453433037|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
126036696|NCT01574274|453433038|FG000|Overall Study|Ineligible|0|||
126036697|NCT01574274|453433039|FG001|Overall Study|Ineligible|1|||
126036698|NCT01574274|453433038|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
126036699|NCT01574274|453433039|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
126036700|NCT01574274|453433038|FG000|Overall Study|Ph+ B-ALL|3|||
126268781|NCT03502707|454277434|FG003|Overall Study|Randomized but not vaccinated|0|||
126268782|NCT03502707|454277435|FG004|Overall Study|Randomized but not vaccinated|0|||
126268783|NCT03502707|454277436|FG005|Overall Study|Randomized but not vaccinated|0|||
126268784|NCT03502707|454277437|FG006|Overall Study|Randomized but not vaccinated|0|||
126268785|NCT03502707|454277438|FG007|Overall Study|Randomized but not vaccinated|0|||
126268786|NCT03502707|454277439|FG008|Overall Study|Randomized but not vaccinated|0|||
126268787|NCT03502707|454277440|FG009|Overall Study|Randomized but not vaccinated|0|||
126268788|NCT03502707|454277441|FG010|Overall Study|Randomized but not vaccinated|0|||
126268789|NCT03502707|454277442|FG011|Overall Study|Randomized but not vaccinated|1|||
126268790|NCT03502707|454277443|FG012|Overall Study|Randomized but not vaccinated|0|||
126268791|NCT03502707|454277444|FG013|Overall Study|Randomized but not vaccinated|0|||
126268792|NCT03502707|454277445|FG014|Overall Study|Randomized but not vaccinated|0|||
126268793|NCT03502707|454277446|FG015|Overall Study|Randomized but not vaccinated|0|||
126268794|NCT03502707|454277447|FG016|Overall Study|Randomized but not vaccinated|0|||
126268795|NCT03502707|454277448|FG017|Overall Study|Randomized but not vaccinated|1|||
126268796|NCT01045421|454277449|FG000|Phase 1|Progressive Disease|0|||
126268797|NCT01045421|454277450|FG001|Phase 1|Progressive Disease|0|||
126268798|NCT01045421|454277451|FG002|Phase 1|Progressive Disease|0|||
126268799|NCT01045421|454277452|FG003|Phase 1|Progressive Disease|0|||
126268800|NCT01045421|454277453|FG004|Phase 1|Progressive Disease|1|||
126268801|NCT01045421|454277454|FG005|Phase 1|Progressive Disease|0|||
126268802|NCT01045421|454277455|FG006|Phase 1|Progressive Disease|0|||
126268803|NCT01045421|454277456|FG007|Phase 1|Progressive Disease|0|||
126268804|NCT01045421|454277457|FG008|Phase 1|Progressive Disease|0|||
126268805|NCT01045421|454277458|FG009|Phase 1|Progressive Disease|0|||
126268806|NCT01045421|454277459|FG010|Phase 1|Progressive Disease|0|||
126268807|NCT01045421|454277449|FG000|Phase 1|Withdrawal by Subject|0|||
126268808|NCT01045421|454277450|FG001|Phase 1|Withdrawal by Subject|0|||
126268809|NCT01045421|454277451|FG002|Phase 1|Withdrawal by Subject|0|||
126268810|NCT01045421|454277452|FG003|Phase 1|Withdrawal by Subject|1|||
126268811|NCT01045421|454277453|FG004|Phase 1|Withdrawal by Subject|0|||
126268812|NCT01045421|454277454|FG005|Phase 1|Withdrawal by Subject|0|||
126268813|NCT01045421|454277455|FG006|Phase 1|Withdrawal by Subject|0|||
126268814|NCT01045421|454277456|FG007|Phase 1|Withdrawal by Subject|0|||
126268815|NCT01045421|454277457|FG008|Phase 1|Withdrawal by Subject|0|||
126268816|NCT01045421|454277458|FG009|Phase 1|Withdrawal by Subject|0|||
126268817|NCT01045421|454277459|FG010|Phase 1|Withdrawal by Subject|0|||
126268818|NCT01045421|454277449|FG000|Phase 2|Progressive Disease|0|||
126268819|NCT01045421|454277450|FG001|Phase 2|Progressive Disease|0|||
126268820|NCT01045421|454277451|FG002|Phase 2|Progressive Disease|0|||
126268821|NCT01045421|454277452|FG003|Phase 2|Progressive Disease|0|||
126268822|NCT01045421|454277453|FG004|Phase 2|Progressive Disease|0|||
126268823|NCT01045421|454277454|FG005|Phase 2|Progressive Disease|0|||
126268824|NCT01045421|454277455|FG006|Phase 2|Progressive Disease|0|||
126268825|NCT01045421|454277456|FG007|Phase 2|Progressive Disease|1|||
126268826|NCT01045421|454277457|FG008|Phase 2|Progressive Disease|1|||
126268827|NCT01045421|454277458|FG009|Phase 2|Progressive Disease|1|||
126268828|NCT01045421|454277459|FG010|Phase 2|Progressive Disease|1|||
126268829|NCT01045421|454277449|FG000|Phase 2|Death|0|||
126268830|NCT01045421|454277450|FG001|Phase 2|Death|0|||
126268831|NCT01045421|454277451|FG002|Phase 2|Death|0|||
126268832|NCT01045421|454277452|FG003|Phase 2|Death|0|||
126268833|NCT01045421|454277453|FG004|Phase 2|Death|0|||
126268834|NCT01045421|454277454|FG005|Phase 2|Death|0|||
126268835|NCT01045421|454277455|FG006|Phase 2|Death|0|||
126268836|NCT01045421|454277456|FG007|Phase 2|Death|1|||
126036701|NCT01574274|453433039|FG001|Overall Study|Ph+ B-ALL|4|||
126036702|NCT01574274|453433038|FG000|Overall Study|Induction Death|2|||
126268837|NCT01045421|454277457|FG008|Phase 2|Death|1|||
126268838|NCT01045421|454277458|FG009|Phase 2|Death|2|||
126268839|NCT01045421|454277459|FG010|Phase 2|Death|0|||
126268840|NCT01045421|454277449|FG000|Phase 2|Other|0|||
126268841|NCT01045421|454277450|FG001|Phase 2|Other|0|||
126268842|NCT01045421|454277451|FG002|Phase 2|Other|0|||
126268843|NCT01045421|454277452|FG003|Phase 2|Other|0|||
126268844|NCT01045421|454277453|FG004|Phase 2|Other|0|||
126268845|NCT01045421|454277454|FG005|Phase 2|Other|0|||
126268846|NCT01045421|454277455|FG006|Phase 2|Other|0|||
126268847|NCT01045421|454277456|FG007|Phase 2|Other|3|||
126268848|NCT01045421|454277457|FG008|Phase 2|Other|0|||
126268849|NCT01045421|454277458|FG009|Phase 2|Other|0|||
126268850|NCT01045421|454277459|FG010|Phase 2|Other|1|||
126268851|NCT02221037|454277460|FG000|Overall Study|Physician Decision|0|||
126268852|NCT02221037|454277461|FG001|Overall Study|Physician Decision|0|||
126268853|NCT02221037|454277462|FG002|Overall Study|Physician Decision|1|||
126268854|NCT02221037|454277463|FG003|Overall Study|Physician Decision|0|||
126268855|NCT04551911|454277464|FG000|Overall Study|Lost to Follow-up|2|||
126268856|NCT04551911|454277465|FG001|Overall Study|Lost to Follow-up|1|||
126268857|NCT04551911|454277464|FG000|Overall Study|Withdrawal by Subject|10|||
126268858|NCT04551911|454277465|FG001|Overall Study|Withdrawal by Subject|10|||
126268859|NCT04551911|454277464|FG000|Overall Study|Did not receive the study drug|3|||
126268860|NCT04551911|454277465|FG001|Overall Study|Did not receive the study drug|4|||
126268861|NCT01030341|454277466|FG000|Overall Study|Withdrawal by Subject|1|||
126268862|NCT01030341|454277466|FG000|Overall Study|Lost to Follow-up|2|||
126268863|NCT01884311|454277467|FG000|Overall Study|Withdrawal by Subject|3|||
126268864|NCT01884311|454277467|FG000|Overall Study|withdrew consent due to AEs|1|||
126268865|NCT01884311|454277467|FG000|Overall Study|Precautionary measure|1|||
126268866|NCT02307266|454277468|FG000|Overall Study|Adverse Event|3|||
126268867|NCT02307266|454277469|FG001|Overall Study|Adverse Event|1|||
126268868|NCT02307266|454277470|FG002|Overall Study|Adverse Event|5|||
126268869|NCT02307266|454277468|FG000|Overall Study|Withdrawal by Subject|2|||
126268870|NCT02307266|454277469|FG001|Overall Study|Withdrawal by Subject|0|||
126268871|NCT02307266|454277470|FG002|Overall Study|Withdrawal by Subject|1|||
126268872|NCT02307266|454277468|FG000|Overall Study|Lost to Follow-up|3|||
126268873|NCT02307266|454277469|FG001|Overall Study|Lost to Follow-up|0|||
126268874|NCT02307266|454277470|FG002|Overall Study|Lost to Follow-up|0|||
126268875|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Death|89|||
126268876|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Death|193|||
126268877|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Death|198|||
126268878|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
126268879|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
126268880|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
126268881|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
126268882|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
126268883|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
126268884|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
126268885|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
126268886|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
126268887|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
126268888|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
126268889|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
126268890|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
126268891|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
126268892|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
126268893|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
126268894|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
126268895|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
126268896|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Death|36|||
126268897|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Death|87|||
126268898|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Death|100|||
126268899|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
126268900|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
126268901|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
126268902|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Physician Decision|0|||
126268903|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Physician Decision|1|||
126268904|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Physician Decision|0|||
126268905|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
126268906|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
126268907|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
126268908|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
126268909|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
126268910|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
126268911|NCT02031458|454277483|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
126268912|NCT02031458|454277484|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
126268913|NCT02031458|454277485|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
126268914|NCT02031458|454277483|FG000|Baseline to May 8, 2015|On Treatment|43|||
126268915|NCT02031458|454277484|FG001|Baseline to May 8, 2015|On Treatment|81|||
126268916|NCT02031458|454277485|FG002|Baseline to May 8, 2015|On Treatment|73|||
126268917|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
126268918|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
126268919|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
126268920|NCT05855616|454277486|FG000|Overall Study|Lost to Follow-up|1|||
126268921|NCT05855616|454277487|FG001|Overall Study|Lost to Follow-up|2|||
126268922|NCT00059787|454277488|FG000|Overall Study|Adverse Event|13|||
126268923|NCT00059787|454277488|FG000|Overall Study|disease progression|2|||
126268924|NCT00059787|454277488|FG000|Overall Study|ineligible|1|||
126268925|NCT00059787|454277488|FG000|Overall Study|Other|4|||
126268926|NCT00103311|454277495|FG000|Overall Study|Lost to Follow-up|1|||
126268927|NCT00103311|454277496|FG001|Overall Study|Lost to Follow-up|0|||
126268928|NCT00103311|454277495|FG000|Overall Study|Withdrawal by Subject|2|||
126268929|NCT00103311|454277496|FG001|Overall Study|Withdrawal by Subject|1|||
126268930|NCT00103311|454277495|FG000|Overall Study|Adverse Event|1|||
126268931|NCT00103311|454277496|FG001|Overall Study|Adverse Event|0|||
126268932|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
126268933|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
126268934|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
126268935|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
126268936|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
126268937|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
126268938|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
126268939|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
126036703|NCT01574274|453433039|FG001|Overall Study|Induction Death|0|||
126036704|NCT01574274|453433038|FG000|Overall Study|Induction Failure|4|||
126036705|NCT01574274|453433039|FG001|Overall Study|Induction Failure|1|||
126036706|NCT01574274|453433038|FG000|Overall Study|Adverse Event|16|||
126036707|NCT01574274|453433039|FG001|Overall Study|Adverse Event|13|||
126036708|NCT01574274|453433038|FG000|Overall Study|Remission Death|1|||
126036709|NCT01574274|453433039|FG001|Overall Study|Remission Death|0|||
126036710|NCT01574274|453433038|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
126036711|NCT01574274|453433039|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
126036712|NCT01574274|453433038|FG000|Overall Study|Other, unknown|3|||
126036713|NCT01574274|453433039|FG001|Overall Study|Other, unknown|2|||
126036714|NCT05089019|453433040|FG000|Period 1|Withdrawal by Subject|0|||
126268940|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Various|0|||
126268941|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Various|9|||
126268942|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Adverse Event|23|||
126268943|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Adverse Event|0|||
126268944|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Death|2|||
126268945|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Death|0|||
126268946|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
126268947|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
126268948|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
126268949|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
126268950|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Various|3|||
126268951|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Various|0|||
126268952|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
126268953|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
126268954|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
126268955|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
126268956|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
126268957|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
126268958|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
126268959|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
126268960|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
126268961|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
126268962|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
126268963|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
126268964|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
126268965|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
126268966|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Various|4|||
126036715|NCT05089019|453433041|FG001|Period 1|Withdrawal by Subject|1|||
126036716|NCT05089019|453433040|FG000|Washout Period|Adverse Event|3|||
126268967|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Various|0|||
126268968|NCT01959035|454277500|FG000|Overall Study|Adverse Event|5|||
126268969|NCT01959035|454277500|FG000|Overall Study|Withdrawal by Subject|4|||
126268970|NCT01959035|454277500|FG000|Overall Study|Lost to Follow-up|1|||
126268971|NCT01959035|454277500|FG000|Overall Study|Other (no primary reason given)|1|||
126268972|NCT02034058|454277501|FG000|Overall Study|Death|3|||
126268973|NCT03254602|454277502|FG000|Overall Study|Lost to Follow-up|4|||
126268974|NCT02963311|454277507|FG000|Overall Study|Withdrawal by Subject|1|||
126268975|NCT02963311|454277507|FG000|Overall Study|Screen Failure|4|||
126268976|NCT04492020|454277514|FG000|Overall Study|Adverse Event|1|||
126268977|NCT04492020|454277515|FG001|Overall Study|Adverse Event|3|||
126268978|NCT04492020|454277514|FG000|Overall Study|Withdrawal by Subject|4|||
126268979|NCT04492020|454277515|FG001|Overall Study|Withdrawal by Subject|3|||
126268980|NCT04492020|454277514|FG000|Overall Study|Lost to Follow-up|4|||
126268981|NCT04492020|454277515|FG001|Overall Study|Lost to Follow-up|3|||
126268982|NCT04492020|454277514|FG000|Overall Study|Protocol Violation|5|||
126268983|NCT04492020|454277515|FG001|Overall Study|Protocol Violation|2|||
126268984|NCT04492020|454277514|FG000|Overall Study|Lack of Qualifying Event|25|||
126268985|NCT04492020|454277515|FG001|Overall Study|Lack of Qualifying Event|27|||
126268986|NCT04492020|454277514|FG000|Overall Study|Non-compliance with Study Drug|2|||
126268987|NCT04492020|454277515|FG001|Overall Study|Non-compliance with Study Drug|1|||
126268988|NCT02792959|454277520|FG000|Overall Study|Protocol Violation|1|||
126268989|NCT03914950|454277524|FG000|Overall Study|Physician Decision|54|||
126268990|NCT00003875|454277531|FG000|Overall Study|Screen Failed|1|||
126268991|NCT04168190|454277532|FG000|Overall Study|Lost to Follow-up|0|||
126268992|NCT04168190|454277533|FG001|Overall Study|Lost to Follow-up|1|||
126268993|NCT04168190|454277534|FG002|Overall Study|Lost to Follow-up|0|||
126268994|NCT04168190|454277535|FG003|Overall Study|Lost to Follow-up|7|||
126268995|NCT04168190|454277536|FG004|Overall Study|Lost to Follow-up|5|||
126268996|NCT04168190|454277532|FG000|Overall Study|Withdrawal by Subject|1|||
126268997|NCT04168190|454277533|FG001|Overall Study|Withdrawal by Subject|0|||
126268998|NCT04168190|454277534|FG002|Overall Study|Withdrawal by Subject|0|||
126268999|NCT04168190|454277535|FG003|Overall Study|Withdrawal by Subject|2|||
126269000|NCT04168190|454277536|FG004|Overall Study|Withdrawal by Subject|4|||
126269001|NCT04168190|454277532|FG000|Overall Study|Death|0|||
126269002|NCT04168190|454277533|FG001|Overall Study|Death|0|||
126269003|NCT04168190|454277534|FG002|Overall Study|Death|0|||
126269004|NCT04168190|454277535|FG003|Overall Study|Death|1|||
126269005|NCT04168190|454277536|FG004|Overall Study|Death|0|||
126269006|NCT01070771|454277537|FG000|Overall Study|Adverse Event|2|||
126269007|NCT01070771|454277537|FG000|Overall Study|Protocol Violation|1|||
126269008|NCT00629265|454277538|FG000|Overall Study|Lost to Follow-up|4|||
126269009|NCT00629265|454277539|FG001|Overall Study|Lost to Follow-up|5|||
126269010|NCT00629265|454277538|FG000|Overall Study|Withdrawal by Subject|11|||
126269011|NCT00629265|454277539|FG001|Overall Study|Withdrawal by Subject|8|||
126269012|NCT00629265|454277538|FG000|Overall Study|Death|1|||
126269013|NCT00629265|454277539|FG001|Overall Study|Death|0|||
126269014|NCT00629265|454277538|FG000|Overall Study|Adverse Event|2|||
126269015|NCT00629265|454277539|FG001|Overall Study|Adverse Event|0|||
126269016|NCT00629265|454277538|FG000|Overall Study|HNC Recurrence|4|||
126269017|NCT00629265|454277539|FG001|Overall Study|HNC Recurrence|0|||
126269018|NCT00629265|454277538|FG000|Overall Study|Other CA Requiring Treatment|1|||
126269019|NCT00629265|454277539|FG001|Overall Study|Other CA Requiring Treatment|3|||
126269020|NCT00629265|454277538|FG000|Overall Study|Needed Esophageal Dilation|4|||
126269021|NCT00629265|454277539|FG001|Overall Study|Needed Esophageal Dilation|1|||
126269022|NCT00629265|454277538|FG000|Overall Study|Unrelated Medical Complications|3|||
126269023|NCT00629265|454277539|FG001|Overall Study|Unrelated Medical Complications|1|||
126269024|NCT00629265|454277538|FG000|Overall Study|Unknown Reason|2|||
126269025|NCT00629265|454277539|FG001|Overall Study|Unknown Reason|2|||
126269026|NCT04465630|454277540|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
126269027|NCT04465630|454277540|FG000|Overall Study|Screen failure|8|||
126269028|NCT04465630|454277540|FG000|Overall Study|Baseline failure|16|||
126360986|NCT01796470|454612784|FG000|Overall Study|Progressive Disease|7|||
126360987|NCT01796470|454612785|FG001|Overall Study|Progressive Disease|7|||
126360988|NCT01796470|454612786|FG002|Overall Study|Progressive Disease|3|||
126360989|NCT01796470|454612787|FG003|Overall Study|Progressive Disease|2|||
126360990|NCT01796470|454612788|FG004|Overall Study|Progressive Disease|0|||
126360991|NCT01796470|454612784|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
126360992|NCT01796470|454612785|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
126360993|NCT01796470|454612786|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
126360994|NCT01796470|454612787|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
126360995|NCT01796470|454612788|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
126360996|NCT01796470|454612784|FG000|Overall Study|Withdrawal by Subject|7|||
126360997|NCT01796470|454612785|FG001|Overall Study|Withdrawal by Subject|0|||
126360998|NCT01796470|454612786|FG002|Overall Study|Withdrawal by Subject|0|||
126360999|NCT01796470|454612787|FG003|Overall Study|Withdrawal by Subject|0|||
126361000|NCT01796470|454612788|FG004|Overall Study|Withdrawal by Subject|1|||
126361001|NCT01927861|454612789|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
126361002|NCT01927861|454612790|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
126361003|NCT01927861|454612789|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
126361004|NCT01927861|454612790|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
126361005|NCT00987935|454612791|FG000|Overall Study|Progressive disease|3|||
126361006|NCT00987935|454612792|FG001|Overall Study|Progressive disease|2|||
126269029|NCT04355663|454277541|FG000|Overall Study|Physician Decision|2|||
126269030|NCT04355663|454277542|FG001|Overall Study|Physician Decision|7|||
126269031|NCT04355663|454277543|FG002|Overall Study|Physician Decision|0|||
126269032|NCT04355663|454277541|FG000|Overall Study|Adverse Event|0|||
126269033|NCT04355663|454277542|FG001|Overall Study|Adverse Event|0|||
126269034|NCT04355663|454277543|FG002|Overall Study|Adverse Event|1|||
126269035|NCT04355663|454277541|FG000|Overall Study|Withdrawal by Subject|0|||
126269036|NCT04355663|454277542|FG001|Overall Study|Withdrawal by Subject|8|||
126269037|NCT04355663|454277543|FG002|Overall Study|Withdrawal by Subject|3|||
126269038|NCT01230892|454277544|FG000|Overall Study|Withdrawal by Subject|1|||
126269039|NCT01230892|454277545|FG001|Overall Study|Withdrawal by Subject|1|||
126269040|NCT01230892|454277544|FG000|Overall Study|Lost to Follow-up|2|||
126269041|NCT01230892|454277545|FG001|Overall Study|Lost to Follow-up|0|||
126269042|NCT00679913|454277546|FG000|Overall Study|Protocol Violation|18|||
126269043|NCT00679913|454277547|FG001|Overall Study|Protocol Violation|13|||
126269044|NCT01144364|454277551|FG000|Induction Phase|Disease progression|14|||
126269045|NCT01144364|454277552|FG001|Induction Phase|Disease progression|0|||
126269046|NCT01144364|454277553|FG002|Induction Phase|Disease progression|0|||
126269047|NCT01144364|454277551|FG000|Induction Phase|Adverse Event|9|||
126269048|NCT01144364|454277552|FG001|Induction Phase|Adverse Event|0|||
126269049|NCT01144364|454277553|FG002|Induction Phase|Adverse Event|0|||
126269050|NCT01144364|454277551|FG000|Induction Phase|Death|1|||
126269051|NCT01144364|454277552|FG001|Induction Phase|Death|0|||
126269052|NCT01144364|454277553|FG002|Induction Phase|Death|0|||
126269053|NCT01144364|454277551|FG000|Induction Phase|Withdrawal by Subject|1|||
126269054|NCT01144364|454277552|FG001|Induction Phase|Withdrawal by Subject|0|||
126269055|NCT01144364|454277553|FG002|Induction Phase|Withdrawal by Subject|0|||
126269056|NCT01144364|454277551|FG000|Induction Phase|Lost to Follow-up|2|||
126269057|NCT01144364|454277552|FG001|Induction Phase|Lost to Follow-up|0|||
126269058|NCT01144364|454277553|FG002|Induction Phase|Lost to Follow-up|0|||
126269059|NCT01144364|454277551|FG000|Induction Phase|Physician Decision|1|||
126269060|NCT01144364|454277552|FG001|Induction Phase|Physician Decision|0|||
126269061|NCT01144364|454277553|FG002|Induction Phase|Physician Decision|0|||
126269062|NCT01144364|454277551|FG000|Induction Phase|Stable disease|2|||
126269063|NCT01144364|454277552|FG001|Induction Phase|Stable disease|0|||
126269064|NCT01144364|454277553|FG002|Induction Phase|Stable disease|0|||
126269065|NCT01144364|454277551|FG000|Induction Phase|Secondary neoplasia|1|||
126269066|NCT01144364|454277552|FG001|Induction Phase|Secondary neoplasia|0|||
126269067|NCT01144364|454277553|FG002|Induction Phase|Secondary neoplasia|0|||
126361007|NCT00987935|454612793|FG002|Overall Study|Progressive disease|3|||
126361008|NCT00987935|454612794|FG003|Overall Study|Progressive disease|2|||
126361009|NCT00987935|454612795|FG004|Overall Study|Progressive disease|5|||
126361010|NCT00987935|454612796|FG005|Overall Study|Progressive disease|3|||
126269068|NCT01144364|454277551|FG000|Induction Phase|Protocol Violation|1|||
126269069|NCT01144364|454277552|FG001|Induction Phase|Protocol Violation|0|||
126269070|NCT01144364|454277553|FG002|Induction Phase|Protocol Violation|0|||
126269071|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
126361011|NCT00987935|454612797|FG006|Overall Study|Progressive disease|9|||
126361012|NCT00987935|454612798|FG007|Overall Study|Progressive disease|48|||
126361013|NCT00987935|454612799|FG008|Overall Study|Progressive disease|23|||
126361014|NCT00987935|454612791|FG000|Overall Study|Adverse Event|0|||
126361015|NCT00987935|454612792|FG001|Overall Study|Adverse Event|1|||
126361016|NCT00987935|454612793|FG002|Overall Study|Adverse Event|0|||
126269072|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
126269073|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
126269074|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
126361017|NCT00987935|454612794|FG003|Overall Study|Adverse Event|1|||
126036717|NCT05089019|453433041|FG001|Washout Period|Adverse Event|4|||
126036718|NCT05089019|453433040|FG000|Washout Period|Lost to Follow-up|1|||
126036719|NCT05089019|453433041|FG001|Washout Period|Lost to Follow-up|0|||
126361018|NCT00987935|454612795|FG004|Overall Study|Adverse Event|1|||
126361019|NCT00987935|454612796|FG005|Overall Study|Adverse Event|0|||
126361020|NCT00987935|454612797|FG006|Overall Study|Adverse Event|2|||
126361021|NCT00987935|454612798|FG007|Overall Study|Adverse Event|10|||
126361022|NCT00987935|454612799|FG008|Overall Study|Adverse Event|6|||
126361023|NCT00987935|454612791|FG000|Overall Study|Refused to continue taking trial med.|1|||
126361024|NCT00987935|454612792|FG001|Overall Study|Refused to continue taking trial med.|0|||
126361025|NCT00987935|454612793|FG002|Overall Study|Refused to continue taking trial med.|0|||
126361026|NCT00987935|454612794|FG003|Overall Study|Refused to continue taking trial med.|0|||
126361027|NCT00987935|454612795|FG004|Overall Study|Refused to continue taking trial med.|1|||
126361028|NCT00987935|454612796|FG005|Overall Study|Refused to continue taking trial med.|0|||
126361029|NCT00987935|454612797|FG006|Overall Study|Refused to continue taking trial med.|4|||
126361030|NCT00987935|454612798|FG007|Overall Study|Refused to continue taking trial med.|4|||
126361031|NCT00987935|454612799|FG008|Overall Study|Refused to continue taking trial med.|2|||
126036720|NCT05089019|453433040|FG000|Washout Period|Physician Decision|2|||
126036721|NCT05089019|453433041|FG001|Washout Period|Physician Decision|0|||
126036722|NCT05089019|453433040|FG000|Washout Period|Withdrawal by Subject|6|||
126361032|NCT00987935|454612791|FG000|Overall Study|Reason other than those specified above|0|||
126361033|NCT00987935|454612792|FG001|Overall Study|Reason other than those specified above|0|||
126036723|NCT05089019|453433041|FG001|Washout Period|Withdrawal by Subject|3|||
126036724|NCT05089019|453433040|FG000|Period 2|Adverse Event|4|||
126036725|NCT05089019|453433041|FG001|Period 2|Adverse Event|2|||
126036726|NCT05089019|453433040|FG000|Period 2|Lost to Follow-up|1|||
126036727|NCT05089019|453433041|FG001|Period 2|Lost to Follow-up|0|||
126036728|NCT05089019|453433040|FG000|Period 2|Withdrawal by Subject|0|||
126361034|NCT00987935|454612793|FG002|Overall Study|Reason other than those specified above|0|||
126361035|NCT00987935|454612794|FG003|Overall Study|Reason other than those specified above|0|||
126361036|NCT00987935|454612795|FG004|Overall Study|Reason other than those specified above|0|||
126361037|NCT00987935|454612796|FG005|Overall Study|Reason other than those specified above|0|||
126361038|NCT00987935|454612797|FG006|Overall Study|Reason other than those specified above|0|||
126036729|NCT05089019|453433041|FG001|Period 2|Withdrawal by Subject|1|||
126036730|NCT01593917|453433046|FG000|Overall Study|Death|67|||
126046518|NCT03868930|453468247|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
126036731|NCT01593917|453433046|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
126036732|NCT01593917|453433046|FG000|Overall Study|Withdrawal by Subject|23|||
126036733|NCT01593917|453433046|FG000|Overall Study|Lost to Follow-up|12|||
126036734|NCT01593917|453433046|FG000|Overall Study|Protocol Violation|5|||
126036735|NCT01593917|453433046|FG000|Overall Study|Physician Decision|3|||
126036736|NCT03216057|453433049|FG000|Overall Study|Lost to Follow-up|2|||
126036737|NCT03216057|453433050|FG001|Overall Study|Lost to Follow-up|2|||
126269075|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
126269076|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
126269077|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Death|0|||
126269078|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Death|2|||
126269079|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Death|0|||
126269080|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
126269081|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
126269082|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
126269083|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
126269084|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
126269085|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
126269086|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
126269087|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
126269088|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
126269089|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
126269090|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
126269091|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
126269092|NCT01301508|454277556|FG000|Overall Study|Withdrawal by Subject|1|||
126269093|NCT01301508|454277557|FG001|Overall Study|Withdrawal by Subject|2|||
126269094|NCT01301508|454277556|FG000|Overall Study|Lost to Follow-up|0|||
126269095|NCT01301508|454277557|FG001|Overall Study|Lost to Follow-up|1|||
126269096|NCT00851643|454277558|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
126269097|NCT00851643|454277559|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269098|NCT00851643|454277560|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269099|NCT00851643|454277561|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269100|NCT00851643|454277562|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269101|NCT00851643|454277563|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269102|NCT00851643|454277558|FG000|Base Study (Up to 12 Months)|Other|0|||
126269103|NCT00851643|454277559|FG001|Base Study (Up to 12 Months)|Other|0|||
126269104|NCT00851643|454277560|FG002|Base Study (Up to 12 Months)|Other|0|||
126269105|NCT00851643|454277561|FG003|Base Study (Up to 12 Months)|Other|0|||
126269106|NCT00851643|454277562|FG004|Base Study (Up to 12 Months)|Other|0|||
126269107|NCT00851643|454277563|FG005|Base Study (Up to 12 Months)|Other|1|||
126269108|NCT00851643|454277558|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
126269109|NCT00851643|454277559|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
126269110|NCT00851643|454277560|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
126269111|NCT00851643|454277561|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
126269112|NCT00851643|454277562|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
126269113|NCT00851643|454277563|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
126269114|NCT00851643|454277558|FG000|Extension Study (Up to 36 Months)|Moved|0|||
126269115|NCT00851643|454277559|FG001|Extension Study (Up to 36 Months)|Moved|2|||
126269116|NCT00851643|454277560|FG002|Extension Study (Up to 36 Months)|Moved|1|||
126269117|NCT00851643|454277561|FG003|Extension Study (Up to 36 Months)|Moved|1|||
126269118|NCT00851643|454277562|FG004|Extension Study (Up to 36 Months)|Moved|0|||
126269119|NCT00851643|454277563|FG005|Extension Study (Up to 36 Months)|Moved|1|||
126269120|NCT02707861|454277566|FG000|Overall Study|Went onto commercial drug|30|||
126269121|NCT02707861|454277567|FG001|Overall Study|Went onto commercial drug|23|||
126269122|NCT02707861|454277566|FG000|Overall Study|Adverse Event|2|||
126269123|NCT02707861|454277567|FG001|Overall Study|Adverse Event|3|||
126269124|NCT02707861|454277566|FG000|Overall Study|Death|5|||
126269125|NCT02707861|454277567|FG001|Overall Study|Death|2|||
126269126|NCT02707861|454277566|FG000|Overall Study|Lack of Efficacy|0|||
126269127|NCT02707861|454277567|FG001|Overall Study|Lack of Efficacy|2|||
126269128|NCT02707861|454277566|FG000|Overall Study|Physician Decision|1|||
126269129|NCT02707861|454277567|FG001|Overall Study|Physician Decision|4|||
126036738|NCT04564742|453433051|FG000|Overall Study|Lost to Follow-up|1|||
126269130|NCT02707861|454277566|FG000|Overall Study|Withdrawal by Subject|2|||
126269131|NCT02707861|454277567|FG001|Overall Study|Withdrawal by Subject|1|||
126269132|NCT02707861|454277566|FG000|Overall Study|Lost to Follow-up|1|||
126269133|NCT02707861|454277567|FG001|Overall Study|Lost to Follow-up|3|||
126269134|NCT01940497|454277568|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
126269135|NCT01940497|454277569|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
126269136|NCT01940497|454277568|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
126269137|NCT01940497|454277569|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
126269138|NCT01940497|454277568|FG000|Overall Study|Violation of Entry Criteria|1|||
126036739|NCT04564742|453433052|FG001|Overall Study|Lost to Follow-up|0|||
126036740|NCT04564742|453433051|FG000|Overall Study|Consent Withdrawal|4|||
126269139|NCT01940497|454277569|FG001|Overall Study|Violation of Entry Criteria|1|||
126269140|NCT01940497|454277568|FG000|Overall Study|Refused Treatment|1|||
126269141|NCT01940497|454277569|FG001|Overall Study|Refused Treatment|3|||
126269142|NCT01940497|454277568|FG000|Overall Study|Withdrew Consent|6|||
126269143|NCT01940497|454277569|FG001|Overall Study|Withdrew Consent|2|||
126269144|NCT01940497|454277568|FG000|Overall Study|Administrative/Other|1|||
126269145|NCT01940497|454277569|FG001|Overall Study|Administrative/Other|1|||
126269146|NCT01641133|454277570|FG000|Overall Study|Protocol Violation|0|||
126269147|NCT01641133|454277571|FG001|Overall Study|Protocol Violation|1|||
126269148|NCT01641133|454277572|FG002|Overall Study|Protocol Violation|1|||
126269149|NCT01641133|454277570|FG000|Overall Study|Migrated/moved from study area|5|||
126269150|NCT01641133|454277571|FG001|Overall Study|Migrated/moved from study area|3|||
126269151|NCT01641133|454277572|FG002|Overall Study|Migrated/moved from study area|1|||
126269152|NCT01641133|454277570|FG000|Overall Study|Adverse Event|0|||
126269153|NCT01641133|454277571|FG001|Overall Study|Adverse Event|0|||
126269154|NCT01641133|454277572|FG002|Overall Study|Adverse Event|1|||
126269155|NCT01641133|454277570|FG000|Overall Study|Withdrawal by Subject|5|||
126269156|NCT01641133|454277571|FG001|Overall Study|Withdrawal by Subject|3|||
126269157|NCT01641133|454277572|FG002|Overall Study|Withdrawal by Subject|3|||
126269158|NCT01641133|454277570|FG000|Overall Study|Lost to Follow-up|0|||
126269159|NCT01641133|454277571|FG001|Overall Study|Lost to Follow-up|2|||
126269160|NCT01641133|454277572|FG002|Overall Study|Lost to Follow-up|2|||
126269161|NCT03123861|454277573|FG000|Overall Study|Protocol Violation|1|||
126269162|NCT03123861|454277574|FG001|Overall Study|Protocol Violation|1|||
126269163|NCT03123861|454277573|FG000|Overall Study|Withdrawal by Subject|2|||
126269164|NCT03123861|454277574|FG001|Overall Study|Withdrawal by Subject|2|||
126269165|NCT02206620|454277575|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126269166|NCT02206620|454277576|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126269167|NCT02206620|454277575|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
126269168|NCT02206620|454277576|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
126269169|NCT00807248|454279014|FG000|Overall Study|Adverse Event|1|||
126269170|NCT00807248|454279015|FG001|Overall Study|Adverse Event|2|||
126269171|NCT00807248|454279016|FG002|Overall Study|Adverse Event|2|||
126269172|NCT00807248|454279017|FG003|Overall Study|Adverse Event|6|||
126269173|NCT00807248|454279014|FG000|Overall Study|Lack of Efficacy|14|||
126269174|NCT00807248|454279015|FG001|Overall Study|Lack of Efficacy|4|||
126269175|NCT00807248|454279016|FG002|Overall Study|Lack of Efficacy|8|||
126269176|NCT00807248|454279017|FG003|Overall Study|Lack of Efficacy|3|||
126269177|NCT00807248|454279014|FG000|Overall Study|Protocol Violation|0|||
126269178|NCT00807248|454279015|FG001|Overall Study|Protocol Violation|1|||
126269179|NCT00807248|454279016|FG002|Overall Study|Protocol Violation|1|||
126269180|NCT00807248|454279017|FG003|Overall Study|Protocol Violation|0|||
126269181|NCT00807248|454279014|FG000|Overall Study|Withdrawal of Consent|5|||
126269182|NCT00807248|454279015|FG001|Overall Study|Withdrawal of Consent|5|||
126269183|NCT00807248|454279016|FG002|Overall Study|Withdrawal of Consent|5|||
126269184|NCT00807248|454279017|FG003|Overall Study|Withdrawal of Consent|5|||
126269185|NCT00807248|454279014|FG000|Overall Study|Lost to Follow-up|1|||
126269186|NCT00807248|454279015|FG001|Overall Study|Lost to Follow-up|0|||
126269187|NCT00807248|454279016|FG002|Overall Study|Lost to Follow-up|0|||
126269188|NCT00807248|454279017|FG003|Overall Study|Lost to Follow-up|0|||
126269189|NCT00807248|454279014|FG000|Overall Study|Other Reason|0|||
126269190|NCT00807248|454279015|FG001|Overall Study|Other Reason|0|||
126361039|NCT00987935|454612798|FG007|Overall Study|Reason other than those specified above|0|||
126361040|NCT00987935|454612799|FG008|Overall Study|Reason other than those specified above|1|||
126361041|NCT01089543|454612800|FG000|Overall Study|Withdrawal by Subject|2|||
126361042|NCT01089543|454612801|FG001|Overall Study|Withdrawal by Subject|3|||
126361043|NCT01089543|454612802|FG002|Overall Study|Withdrawal by Subject|3|||
126361044|NCT01089543|454612803|FG003|Overall Study|Withdrawal by Subject|1|||
126361045|NCT01089543|454612800|FG000|Overall Study|Physician Decision|1|||
126361046|NCT01089543|454612801|FG001|Overall Study|Physician Decision|0|||
126269191|NCT00807248|454279016|FG002|Overall Study|Other Reason|2|||
126269192|NCT00807248|454279017|FG003|Overall Study|Other Reason|0|||
126269193|NCT00609518|454279019|FG000|Overall Study|Death from Study Disease|32|||
126269194|NCT00609518|454279020|FG001|Overall Study|Death from Study Disease|32|||
126269195|NCT00609518|454279019|FG000|Overall Study|Withdrawal by Subject|5|||
126269196|NCT00609518|454279020|FG001|Overall Study|Withdrawal by Subject|3|||
126269197|NCT00609518|454279019|FG000|Overall Study|Lost to Follow-up|3|||
126269198|NCT00609518|454279020|FG001|Overall Study|Lost to Follow-up|0|||
126269199|NCT00609518|454279019|FG000|Overall Study|Physician Decision|1|||
126269200|NCT00609518|454279020|FG001|Overall Study|Physician Decision|3|||
126269201|NCT00609518|454279019|FG000|Overall Study|Death from Adverse Event|2|||
126269202|NCT00609518|454279020|FG001|Overall Study|Death from Adverse Event|2|||
126269203|NCT00292188|454279024|FG000|Single-Blind|Adverse Event|14|||
126269204|NCT00292188|454279025|FG001|Single-Blind|Adverse Event|0|||
126269205|NCT00292188|454279026|FG002|Single-Blind|Adverse Event|0|||
126269206|NCT00292188|454279024|FG000|Single-Blind|Lack of Efficacy|2|||
126269207|NCT00292188|454279025|FG001|Single-Blind|Lack of Efficacy|0|||
126361047|NCT01089543|454612802|FG002|Overall Study|Physician Decision|0|||
126361048|NCT01089543|454612803|FG003|Overall Study|Physician Decision|1|||
126361049|NCT01089543|454612800|FG000|Overall Study|Adverse Event|0|||
126361050|NCT01089543|454612801|FG001|Overall Study|Adverse Event|1|||
126361051|NCT01089543|454612802|FG002|Overall Study|Adverse Event|0|||
126361052|NCT01089543|454612803|FG003|Overall Study|Adverse Event|0|||
126361053|NCT00345592|454612805|FG000|Overall Study|Death|14|||
126361054|NCT00345592|454612806|FG001|Overall Study|Death|16|||
126361055|NCT00345592|454612805|FG000|Overall Study|Withdrawal by Subject|11|||
126361056|NCT00345592|454612806|FG001|Overall Study|Withdrawal by Subject|8|||
126361057|NCT01248468|454612807|FG000|Overall Study|Administrative problem|1|||
126361058|NCT01248468|454612808|FG001|Overall Study|Administrative problem|0|||
126361059|NCT01248468|454612809|FG002|Overall Study|Administrative problem|0|||
126361060|NCT01248468|454612807|FG000|Overall Study|Lost to Follow-up|9|||
126361061|NCT01248468|454612808|FG001|Overall Study|Lost to Follow-up|12|||
126361062|NCT01248468|454612809|FG002|Overall Study|Lost to Follow-up|4|||
126361063|NCT01248468|454612807|FG000|Overall Study|Pregnancy|1|||
126361064|NCT01248468|454612808|FG001|Overall Study|Pregnancy|0|||
126361065|NCT01248468|454612809|FG002|Overall Study|Pregnancy|0|||
126361066|NCT01248468|454612807|FG000|Overall Study|Withdrawal by Subject|4|||
126361067|NCT01248468|454612808|FG001|Overall Study|Withdrawal by Subject|2|||
126361068|NCT01248468|454612809|FG002|Overall Study|Withdrawal by Subject|0|||
126361069|NCT02176525|454612811|FG000|Overall Study|Adverse Event|0|||
126361070|NCT02176525|454612812|FG001|Overall Study|Adverse Event|0|||
126361071|NCT02176525|454612813|FG002|Overall Study|Adverse Event|0|||
126361072|NCT02176525|454612814|FG003|Overall Study|Adverse Event|1|||
126361073|NCT02176525|454612815|FG004|Overall Study|Adverse Event|1|||
126361074|NCT02176525|454612816|FG005|Overall Study|Adverse Event|0|||
126361075|NCT02176525|454612817|FG006|Overall Study|Adverse Event|1|||
126361076|NCT02176525|454612818|FG007|Overall Study|Adverse Event|0|||
126361077|NCT02176525|454612811|FG000|Overall Study|not treated|1|||
126361078|NCT02176525|454612812|FG001|Overall Study|not treated|0|||
126361079|NCT02176525|454612813|FG002|Overall Study|not treated|0|||
126361080|NCT02176525|454612814|FG003|Overall Study|not treated|0|||
126361081|NCT02176525|454612815|FG004|Overall Study|not treated|0|||
126361082|NCT02176525|454612816|FG005|Overall Study|not treated|1|||
126361083|NCT02176525|454612817|FG006|Overall Study|not treated|0|||
126361084|NCT02176525|454612818|FG007|Overall Study|not treated|0|||
126361085|NCT00468546|454612819|FG000|Week 24 Analysis|Lack of Efficacy|83|||
126361086|NCT00468546|454612820|FG001|Week 24 Analysis|Lack of Efficacy|37|||
126361087|NCT00468546|454612819|FG000|Week 24 Analysis|Refused treatment|5|||
126361088|NCT00468546|454612820|FG001|Week 24 Analysis|Refused treatment|5|||
126361089|NCT00468546|454612819|FG000|Week 24 Analysis|Adverse Event|1|||
126361090|NCT00468546|454612820|FG001|Week 24 Analysis|Adverse Event|8|||
126361091|NCT00468546|454612819|FG000|Week 24 Analysis|Failure to return|3|||
126361092|NCT00468546|454612820|FG001|Week 24 Analysis|Failure to return|4|||
126361093|NCT00468546|454612819|FG000|Week 24 Analysis|Rescue therapy|2|||
126361094|NCT00468546|454612820|FG001|Week 24 Analysis|Rescue therapy|0|||
126361095|NCT00468546|454612819|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
126361096|NCT00468546|454612820|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
126361097|NCT00468546|454612819|FG000|Week 24 Analysis|Due to clinical hold|1|||
126361098|NCT00468546|454612820|FG001|Week 24 Analysis|Due to clinical hold|0|||
126361099|NCT00468546|454612819|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
126361100|NCT00468546|454612820|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
126361101|NCT00468546|454612819|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
126361102|NCT00468546|454612820|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
126361103|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
126361104|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
126361105|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Death|1|||
126361106|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Death|0|||
126361107|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
126361108|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
126361109|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
126361110|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
126361111|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
126361112|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
126361113|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
126361114|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
126361115|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
126361116|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
126361117|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Other|17|||
126361118|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Other|14|||
126361119|NCT01245049|454612826|FG000|Overall Study|Migrated/moved from study area|0|||
126361120|NCT01245049|454612827|FG001|Overall Study|Migrated/moved from study area|1|||
126361121|NCT01245049|454612826|FG000|Overall Study|Withdrawal by Subject|0|||
126361122|NCT01245049|454612827|FG001|Overall Study|Withdrawal by Subject|1|||
126361123|NCT01245049|454612826|FG000|Overall Study|Lost to Follow-up|1|||
126036741|NCT04564742|453433052|FG001|Overall Study|Consent Withdrawal|4|||
126269208|NCT00292188|454279026|FG002|Single-Blind|Lack of Efficacy|0|||
126269209|NCT00292188|454279024|FG000|Single-Blind|Laboratory Abnormality|5|||
126269210|NCT00292188|454279025|FG001|Single-Blind|Laboratory Abnormality|0|||
126269211|NCT00292188|454279026|FG002|Single-Blind|Laboratory Abnormality|0|||
126036742|NCT03313076|453433056|FG000|Overall Study|Withdrawal by Subject|2|||
126036743|NCT03313076|453433057|FG001|Overall Study|Withdrawal by Subject|0|||
126036744|NCT03313076|453433058|FG002|Overall Study|Withdrawal by Subject|0|||
126036745|NCT03313076|453433059|FG003|Overall Study|Withdrawal by Subject|0|||
126036746|NCT03313076|453433056|FG000|Overall Study|Lost to Follow-up|0|||
126036747|NCT03313076|453433057|FG001|Overall Study|Lost to Follow-up|2|||
126036748|NCT03313076|453433058|FG002|Overall Study|Lost to Follow-up|2|||
126036749|NCT03313076|453433059|FG003|Overall Study|Lost to Follow-up|2|||
126036750|NCT04119843|453433060|FG000|Overall Study|Adverse Event|3|||
126036751|NCT04119843|453433060|FG000|Overall Study|Death|1|||
126036752|NCT02841579|453433061|FG000|Overall Study|Death|1|||
126036753|NCT02841579|453433061|FG000|Overall Study|Adverse Event|1|||
126036754|NCT02841579|453433061|FG000|Overall Study|Lack of Efficacy|9|||
126036755|NCT05270408|453433067|FG000|Started Treatment|Withdrawal by Subject|0|||
126036756|NCT05270408|453433068|FG001|Started Treatment|Withdrawal by Subject|0|||
126036757|NCT05270408|453433069|FG002|Started Treatment|Withdrawal by Subject|3|||
126036758|NCT05270408|453433067|FG000|Started Treatment|Adverse Event|0|||
126036759|NCT05270408|453433068|FG001|Started Treatment|Adverse Event|0|||
126036760|NCT05270408|453433069|FG002|Started Treatment|Adverse Event|1|||
126036761|NCT05270408|453433067|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
126036762|NCT05270408|453433068|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
126036763|NCT05270408|453433069|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
126036764|NCT03768505|453433070|FG000|Overall Study|sponsor decision|76|||
126036765|NCT03768505|453433070|FG000|Overall Study|Death|35|||
126036766|NCT03768505|453433070|FG000|Overall Study|Other -Various|30|||
126269212|NCT00292188|454279024|FG000|Single-Blind|Lost to Follow-up|3|||
126269213|NCT00292188|454279025|FG001|Single-Blind|Lost to Follow-up|0|||
126269214|NCT00292188|454279026|FG002|Single-Blind|Lost to Follow-up|0|||
126269215|NCT00292188|454279024|FG000|Single-Blind|Other|77|||
126269216|NCT00292188|454279025|FG001|Single-Blind|Other|0|||
126269217|NCT00292188|454279026|FG002|Single-Blind|Other|0|||
126269218|NCT00292188|454279024|FG000|Single-Blind|Withdrawal by Subject|12|||
126269219|NCT00292188|454279025|FG001|Single-Blind|Withdrawal by Subject|0|||
126269220|NCT00292188|454279026|FG002|Single-Blind|Withdrawal by Subject|0|||
126269221|NCT00292188|454279024|FG000|Single-Blind|Did not receive treatment|1|||
126269222|NCT00292188|454279025|FG001|Single-Blind|Did not receive treatment|0|||
126269223|NCT00292188|454279026|FG002|Single-Blind|Did not receive treatment|0|||
126269224|NCT00292188|454279024|FG000|Double-Blind|Adverse Event|0|||
126269225|NCT00292188|454279025|FG001|Double-Blind|Adverse Event|25|||
126269226|NCT00292188|454279026|FG002|Double-Blind|Adverse Event|9|||
126269227|NCT00292188|454279024|FG000|Double-Blind|Lack of Efficacy|0|||
126269228|NCT00292188|454279025|FG001|Double-Blind|Lack of Efficacy|2|||
126269229|NCT00292188|454279026|FG002|Double-Blind|Lack of Efficacy|12|||
126269230|NCT00292188|454279024|FG000|Double-Blind|Lost to Follow-up|0|||
126269231|NCT00292188|454279025|FG001|Double-Blind|Lost to Follow-up|1|||
126269232|NCT00292188|454279026|FG002|Double-Blind|Lost to Follow-up|0|||
126269233|NCT00292188|454279024|FG000|Double-Blind|Other|0|||
126269234|NCT00292188|454279025|FG001|Double-Blind|Other|3|||
126269235|NCT00292188|454279026|FG002|Double-Blind|Other|4|||
126269236|NCT00292188|454279024|FG000|Double-Blind|Withdrawal by Subject|0|||
126269237|NCT00292188|454279025|FG001|Double-Blind|Withdrawal by Subject|0|||
126269238|NCT00292188|454279026|FG002|Double-Blind|Withdrawal by Subject|3|||
126269239|NCT00292188|454279024|FG000|Double-Blind|Laboratory Abnormality|0|||
126269240|NCT00292188|454279025|FG001|Double-Blind|Laboratory Abnormality|0|||
126269241|NCT00292188|454279026|FG002|Double-Blind|Laboratory Abnormality|1|||
126269242|NCT00824616|454279027|FG000|Overall Study|Adverse Event|2|||
126269243|NCT00824616|454279028|FG001|Overall Study|Adverse Event|1|||
126269244|NCT00824616|454279027|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
126269245|NCT00824616|454279028|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
126269246|NCT00824616|454279027|FG000|Overall Study|Hyperglycemia|1|||
126269247|NCT00824616|454279028|FG001|Overall Study|Hyperglycemia|1|||
126269248|NCT00824616|454279027|FG000|Overall Study|Lack of Efficacy|2|||
126269249|NCT00824616|454279028|FG001|Overall Study|Lack of Efficacy|1|||
126361124|NCT01245049|454612827|FG001|Overall Study|Lost to Follow-up|2|||
126361125|NCT00450749|454612828|FG000|Overall Study|Withdrawal by Subject|0|||
126361126|NCT00450749|454612829|FG001|Overall Study|Withdrawal by Subject|0|||
126361127|NCT00450749|454612830|FG002|Overall Study|Withdrawal by Subject|2|||
126361128|NCT00450749|454612828|FG000|Overall Study|Noncompliant|0|||
126036767|NCT03768505|453433070|FG000|Overall Study|Withdrawal by Subject|22|||
126036768|NCT03768505|453433070|FG000|Overall Study|Lost to Follow-up|6|||
126036769|NCT04032704|453433072|FG000|Part A|Withdrawal by Subject|0|||
126036770|NCT04032704|453433073|FG001|Part A|Withdrawal by Subject|0|||
126036771|NCT04032704|453433074|FG002|Part A|Withdrawal by Subject|3|||
126036772|NCT04032704|453433075|FG003|Part A|Withdrawal by Subject|0|||
126361129|NCT00450749|454612829|FG001|Overall Study|Noncompliant|1|||
126361130|NCT00450749|454612830|FG002|Overall Study|Noncompliant|0|||
126361131|NCT01213251|454615171|FG000|Overall Study|Death|2|||
126361132|NCT01213251|454615172|FG001|Overall Study|Death|1|||
126361133|NCT01213251|454615173|FG002|Overall Study|Death|2|||
126361134|NCT01213251|454615171|FG000|Overall Study|Exit|3|||
126361135|NCT01213251|454615172|FG001|Overall Study|Exit|2|||
126361136|NCT01213251|454615173|FG002|Overall Study|Exit|8|||
126361137|NCT01213251|454615171|FG000|Overall Study|Protocol Violation|1|||
126361138|NCT01213251|454615172|FG001|Overall Study|Protocol Violation|1|||
126361139|NCT01213251|454615173|FG002|Overall Study|Protocol Violation|0|||
126361140|NCT01213251|454615171|FG000|Overall Study|Missed 18-Month Follow-up|0|||
126361141|NCT01213251|454615172|FG001|Overall Study|Missed 18-Month Follow-up|0|||
126361142|NCT01213251|454615173|FG002|Overall Study|Missed 18-Month Follow-up|1|||
126361143|NCT02529488|454615174|FG000|Overall Study|Adverse Event|1|||
126361144|NCT02529488|454615174|FG000|Overall Study|Death|3|||
126361145|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
126361146|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361147|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361148|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361149|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361150|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
126361151|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361152|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
126361153|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361154|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
126361155|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361156|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361157|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361158|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361159|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
126361160|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126036773|NCT04032704|453433076|FG004|Part A|Withdrawal by Subject|1|||
126036774|NCT04032704|453433077|FG005|Part A|Withdrawal by Subject|7|||
126036775|NCT04032704|453433078|FG006|Part A|Withdrawal by Subject|0|||
126036776|NCT04032704|453433079|FG007|Part A|Withdrawal by Subject|0|||
126361161|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126361162|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126036777|NCT04032704|453433080|FG008|Part A|Withdrawal by Subject|0|||
126036778|NCT04032704|453433081|FG009|Part A|Withdrawal by Subject|0|||
125880730|NCT02156076|452862612|FG000|Treatment Period|no longer meets study criteria|0|||
126269250|NCT00824616|454279027|FG000|Overall Study|Lost to Follow-up|0|||
126269251|NCT00824616|454279028|FG001|Overall Study|Lost to Follow-up|1|||
126269252|NCT00824616|454279027|FG000|Overall Study|Withdrawal by Subject|1|||
126269253|NCT00824616|454279028|FG001|Overall Study|Withdrawal by Subject|1|||
126269254|NCT02923674|454279035|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
126269255|NCT02923674|454279036|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
126269256|NCT02923674|454279037|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
126269257|NCT02923674|454279035|FG000|Overall Study|Lost to Follow-up|7|||
126269258|NCT02923674|454279036|FG001|Overall Study|Lost to Follow-up|12|||
126269259|NCT02923674|454279037|FG002|Overall Study|Lost to Follow-up|7|||
126269260|NCT02923674|454279035|FG000|Overall Study|Problem with intervention|2|||
126269261|NCT02923674|454279036|FG001|Overall Study|Problem with intervention|2|||
126269262|NCT02923674|454279037|FG002|Overall Study|Problem with intervention|1|||
126269263|NCT02923674|454279035|FG000|Overall Study|Adverse Event|3|||
126269264|NCT02923674|454279036|FG001|Overall Study|Adverse Event|1|||
126269265|NCT02923674|454279037|FG002|Overall Study|Adverse Event|1|||
126269266|NCT02923674|454279035|FG000|Overall Study|Withdrawal by Subject|2|||
126269267|NCT02923674|454279036|FG001|Overall Study|Withdrawal by Subject|2|||
126269268|NCT02923674|454279037|FG002|Overall Study|Withdrawal by Subject|2|||
126269269|NCT01055132|454279038|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
126269270|NCT01055132|454279039|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
126269271|NCT01055132|454279038|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
126269272|NCT01055132|454279039|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
126269273|NCT00158600|454279040|FG000|Overall Study|unable to commit time to study|0|||
126269274|NCT00158600|454279041|FG001|Overall Study|unable to commit time to study|1|||
126269275|NCT00158600|454279040|FG000|Overall Study|Adverse Event|2|||
126269276|NCT00158600|454279041|FG001|Overall Study|Adverse Event|1|||
126269277|NCT00158600|454279040|FG000|Overall Study|Death|1|||
126269278|NCT00158600|454279041|FG001|Overall Study|Death|0|||
126269279|NCT00158600|454279040|FG000|Overall Study|Withdrawal by Subject|2|||
126269280|NCT00158600|454279041|FG001|Overall Study|Withdrawal by Subject|2|||
126269281|NCT02618408|454279042|FG000|Overall Study|Withdrawal by Subject|1|||
126269282|NCT02618408|454279043|FG001|Overall Study|Withdrawal by Subject|0|||
126269283|NCT02618408|454279044|FG002|Overall Study|Withdrawal by Subject|4|||
126269284|NCT02618408|454279042|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
126269285|NCT02618408|454279043|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
126269286|NCT02618408|454279044|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
126269287|NCT02618408|454279042|FG000|Overall Study|Lost to Follow-up|4|||
126269288|NCT02618408|454279043|FG001|Overall Study|Lost to Follow-up|2|||
126269289|NCT02618408|454279044|FG002|Overall Study|Lost to Follow-up|6|||
126269290|NCT02618408|454279042|FG000|Overall Study|Adverse Event|4|||
126269291|NCT02618408|454279043|FG001|Overall Study|Adverse Event|0|||
126269292|NCT02618408|454279044|FG002|Overall Study|Adverse Event|10|||
126269293|NCT02618408|454279042|FG000|Overall Study|Physician Decision|1|||
126269294|NCT02618408|454279043|FG001|Overall Study|Physician Decision|1|||
126269295|NCT02618408|454279044|FG002|Overall Study|Physician Decision|2|||
126269296|NCT02618408|454279042|FG000|Overall Study|Protocol Violation|1|||
126269297|NCT02618408|454279043|FG001|Overall Study|Protocol Violation|1|||
126269298|NCT02618408|454279044|FG002|Overall Study|Protocol Violation|2|||
126269299|NCT02618408|454279042|FG000|Overall Study|Other, Multiple Categories|0|||
126269300|NCT02618408|454279043|FG001|Overall Study|Other, Multiple Categories|0|||
126269301|NCT02618408|454279044|FG002|Overall Study|Other, Multiple Categories|4|||
126269302|NCT02575911|454279048|FG000|Overall Study|Lost to Follow-up|1|||
126269303|NCT01249365|454279049|FG000|Overall Study|Lost to Follow-up|1|||
126269304|NCT01460901|454279050|FG000|Overall Study|Withdrawal by Subject|2|||
126269305|NCT02566993|454279051|FG000|Overall Study|Randomized but not treated|5|||
126269306|NCT02566993|454279052|FG001|Overall Study|Randomized but not treated|16|||
126269307|NCT02566993|454279051|FG000|Overall Study|Progressive disease|213|||
126269308|NCT02566993|454279052|FG001|Overall Study|Progressive disease|152|||
126269309|NCT02566993|454279051|FG000|Overall Study|Withdrawal by Subject|12|||
126269310|NCT02566993|454279052|FG001|Overall Study|Withdrawal by Subject|28|||
126269311|NCT02566993|454279051|FG000|Overall Study|Death|17|||
126269312|NCT02566993|454279052|FG001|Overall Study|Death|23|||
126269313|NCT02566993|454279051|FG000|Overall Study|Physician Decision|10|||
126269314|NCT02566993|454279052|FG001|Overall Study|Physician Decision|17|||
126269315|NCT02566993|454279051|FG000|Overall Study|Study drug-related adverse event|20|||
126269316|NCT02566993|454279052|FG001|Overall Study|Study drug-related adverse event|41|||
126269317|NCT02566993|454279051|FG000|Overall Study|Non study drug-related adverse event|9|||
126269318|NCT02566993|454279052|FG001|Overall Study|Non study drug-related adverse event|9|||
126269319|NCT02566993|454279051|FG000|Overall Study|Symptomatic deterioration|9|||
126269320|NCT02566993|454279052|FG001|Overall Study|Symptomatic deterioration|16|||
126269321|NCT02566993|454279051|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
126269322|NCT02566993|454279052|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
126036779|NCT04032704|453433082|FG010|Part A|Withdrawal by Subject|0|||
126036780|NCT04032704|453433083|FG011|Part A|Withdrawal by Subject|0|||
126269323|NCT02566993|454279051|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
126269324|NCT02566993|454279052|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
126269325|NCT02566993|454279051|FG000|Overall Study|Screening failure|2|||
126269326|NCT02566993|454279052|FG001|Overall Study|Screening failure|0|||
126269327|NCT02566993|454279051|FG000|Overall Study|Lost to Follow-up|0|||
126269328|NCT02566993|454279052|FG001|Overall Study|Lost to Follow-up|1|||
126269329|NCT02566993|454279051|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
126269330|NCT02566993|454279052|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
126269331|NCT01169532|454279058|FG000|Overall Study|Withdrawal by Subject|1|||
126269332|NCT03127644|454279066|FG000|Overall Study|Study-specific withdrawal criteria|0|||
126269333|NCT03127644|454279067|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126269334|NCT03127644|454279068|FG002|Overall Study|Study-specific withdrawal criteria|2|||
126269335|NCT02032706|454279069|FG000|Overall Study|Did not qualify|5|||
126269336|NCT02032706|454279069|FG000|Overall Study|Protocol Violation|1|||
126269337|NCT01156142|454279072|FG000|Overall Study|Withdrawal by Subject|8|||
126269338|NCT01156142|454279073|FG001|Overall Study|Withdrawal by Subject|6|||
126269339|NCT01156142|454279072|FG000|Overall Study|Ineligible|0|||
126269340|NCT01156142|454279073|FG001|Overall Study|Ineligible|1|||
126269341|NCT00893737|454279074|FG000|Overall Study|Adverse Event|4|||
126269342|NCT00893737|454279074|FG000|Overall Study|Withdrawal by Subject|2|||
126269343|NCT00893737|454279074|FG000|Overall Study|Lost to Follow-up|6|||
126269344|NCT02140411|454279075|FG000|Overall Study|Adverse Event|1|||
126269345|NCT03981419|454279078|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
126269346|NCT03981419|454279079|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
126269347|NCT01330459|454279084|FG000|Overall Study|Physician Decision|0|||
126269348|NCT01330459|454279085|FG001|Overall Study|Physician Decision|2|||
126269349|NCT00895947|454279087|FG000|Overall Study|Adverse Event|3|||
126269350|NCT00895947|454279088|FG001|Overall Study|Adverse Event|4|||
126269351|NCT00895947|454279087|FG000|Overall Study|Lost to Follow-up|3|||
126269352|NCT00895947|454279088|FG001|Overall Study|Lost to Follow-up|4|||
126269353|NCT00895947|454279087|FG000|Overall Study|Protocol Violation|4|||
126269354|NCT00895947|454279088|FG001|Overall Study|Protocol Violation|2|||
126269355|NCT00895947|454279087|FG000|Overall Study|Withdrawal by Subject|2|||
126269356|NCT00895947|454279088|FG001|Overall Study|Withdrawal by Subject|0|||
126269357|NCT04620135|454279091|FG000|Study Completion|Adverse Event|2|||
126269358|NCT04620135|454279092|FG001|Study Completion|Adverse Event|3|||
126269359|NCT04620135|454279091|FG000|Study Completion|Withdrawal by Subject|2|||
126269360|NCT04620135|454279092|FG001|Study Completion|Withdrawal by Subject|0|||
126269361|NCT02005887|454279101|FG000|Overall Study|Protocol Violation|0|||
126269362|NCT02005887|454279102|FG001|Overall Study|Protocol Violation|2|||
126269363|NCT01550744|454279103|FG000|Open-Label|Lost to Follow-up|7|||
126269364|NCT01550744|454279104|FG001|Open-Label|Lost to Follow-up|0|||
126269365|NCT01550744|454279105|FG002|Open-Label|Lost to Follow-up|0|||
126269366|NCT01550744|454279103|FG000|Open-Label|Withdrawal by Subject|13|||
126269367|NCT01550744|454279104|FG001|Open-Label|Withdrawal by Subject|0|||
126269368|NCT01550744|454279105|FG002|Open-Label|Withdrawal by Subject|0|||
126269369|NCT01550744|454279103|FG000|Open-Label|Adverse Event|11|||
126269370|NCT01550744|454279104|FG001|Open-Label|Adverse Event|0|||
126269371|NCT01550744|454279105|FG002|Open-Label|Adverse Event|0|||
126269372|NCT01550744|454279103|FG000|Open-Label|Lack of Efficacy|4|||
126269373|NCT01550744|454279104|FG001|Open-Label|Lack of Efficacy|0|||
126269374|NCT01550744|454279105|FG002|Open-Label|Lack of Efficacy|0|||
126269375|NCT01550744|454279103|FG000|Open-Label|Protocol Violation|4|||
126269376|NCT01550744|454279104|FG001|Open-Label|Protocol Violation|0|||
126269377|NCT01550744|454279105|FG002|Open-Label|Protocol Violation|0|||
126269378|NCT01550744|454279103|FG000|Open-Label|Not all 3 study drug injections received|2|||
126269379|NCT01550744|454279104|FG001|Open-Label|Not all 3 study drug injections received|0|||
126269380|NCT01550744|454279105|FG002|Open-Label|Not all 3 study drug injections received|0|||
126269381|NCT01550744|454279103|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
125880731|NCT02156076|452862613|FG001|Treatment Period|no longer meets study criteria|0|||
126036781|NCT04032704|453433084|FG012|Part A|Withdrawal by Subject|0|||
126269382|NCT01550744|454279104|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
126269383|NCT01550744|454279105|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
126269384|NCT01550744|454279103|FG000|Open-Label|Other|1|||
126269385|NCT01550744|454279104|FG001|Open-Label|Other|0|||
126269386|NCT01550744|454279105|FG002|Open-Label|Other|0|||
126269387|NCT01550744|454279103|FG000|Double-Blind|Lost to Follow-up|0|||
126269388|NCT01550744|454279104|FG001|Double-Blind|Lost to Follow-up|6|||
126269389|NCT01550744|454279105|FG002|Double-Blind|Lost to Follow-up|12|||
126269390|NCT01550744|454279103|FG000|Double-Blind|Withdrawal by Subject|0|||
126269391|NCT01550744|454279104|FG001|Double-Blind|Withdrawal by Subject|2|||
126269392|NCT01550744|454279105|FG002|Double-Blind|Withdrawal by Subject|15|||
126269393|NCT01550744|454279103|FG000|Double-Blind|Adverse Event|0|||
126036782|NCT04032704|453433085|FG013|Part A|Withdrawal by Subject|0|||
126269394|NCT01550744|454279104|FG001|Double-Blind|Adverse Event|4|||
126269395|NCT01550744|454279105|FG002|Double-Blind|Adverse Event|15|||
126269396|NCT01550744|454279103|FG000|Double-Blind|Death|0|||
126269397|NCT01550744|454279104|FG001|Double-Blind|Death|1|||
126269398|NCT01550744|454279105|FG002|Double-Blind|Death|0|||
126269399|NCT01550744|454279103|FG000|Double-Blind|Lack of Efficacy|0|||
126269400|NCT01550744|454279104|FG001|Double-Blind|Lack of Efficacy|2|||
126269401|NCT01550744|454279105|FG002|Double-Blind|Lack of Efficacy|8|||
126269402|NCT01550744|454279103|FG000|Double-Blind|Protocol Violation|0|||
126269403|NCT01550744|454279104|FG001|Double-Blind|Protocol Violation|0|||
126269404|NCT01550744|454279105|FG002|Double-Blind|Protocol Violation|4|||
126269405|NCT01550744|454279103|FG000|Double-Blind|Pregnancy|0|||
126269406|NCT01550744|454279104|FG001|Double-Blind|Pregnancy|0|||
126269407|NCT01550744|454279105|FG002|Double-Blind|Pregnancy|3|||
126269408|NCT01550744|454279103|FG000|Double-Blind|Other|0|||
126269409|NCT01550744|454279104|FG001|Double-Blind|Other|2|||
126269410|NCT01550744|454279105|FG002|Double-Blind|Other|10|||
126269411|NCT01660334|454279106|FG000|Overall Study|Lost to Follow-up|1|||
126269412|NCT00311311|454279108|FG000|Overall Study|Adverse Event|3|||
126269413|NCT00311311|454279109|FG001|Overall Study|Adverse Event|2|||
126269414|NCT00311311|454279108|FG000|Overall Study|Withdrawal by Subject|1|||
126269415|NCT00311311|454279109|FG001|Overall Study|Withdrawal by Subject|1|||
126269416|NCT00311311|454279108|FG000|Overall Study|Noncompliance|0|||
126269417|NCT00311311|454279109|FG001|Overall Study|Noncompliance|1|||
126269418|NCT00311311|454279108|FG000|Overall Study|Study Termination by Sponsor|3|||
126269419|NCT00311311|454279109|FG001|Overall Study|Study Termination by Sponsor|4|||
126269420|NCT00311311|454279108|FG000|Overall Study|Death|1|||
126269421|NCT00311311|454279109|FG001|Overall Study|Death|0|||
126269422|NCT00311311|454279108|FG000|Overall Study|Lack of ancillary assistance|0|||
126269423|NCT00311311|454279109|FG001|Overall Study|Lack of ancillary assistance|1|||
126269424|NCT00988065|454279111|FG000|Overall Study|Adverse Event|4|||
126269425|NCT00988065|454279112|FG001|Overall Study|Adverse Event|10|||
126269426|NCT00988065|454279113|FG002|Overall Study|Adverse Event|2|||
126269427|NCT00988065|454279111|FG000|Overall Study|Lost to Follow-up|1|||
126269428|NCT00988065|454279112|FG001|Overall Study|Lost to Follow-up|2|||
126361163|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126361164|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126361165|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126361166|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
126361167|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361168|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361169|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361170|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361171|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
126361172|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361173|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361174|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
126361175|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361176|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361177|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361178|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361179|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361180|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361181|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361182|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361183|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361184|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361185|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
126036783|NCT04032704|453433086|FG014|Part A|Withdrawal by Subject|0|||
126269429|NCT00988065|454279113|FG002|Overall Study|Lost to Follow-up|2|||
126269430|NCT00988065|454279111|FG000|Overall Study|Subject withdrew consent|3|||
126269431|NCT00988065|454279112|FG001|Overall Study|Subject withdrew consent|5|||
126269432|NCT00988065|454279113|FG002|Overall Study|Subject withdrew consent|2|||
126269433|NCT00988065|454279111|FG000|Overall Study|Noncompliance with protocol|5|||
126269434|NCT00988065|454279112|FG001|Overall Study|Noncompliance with protocol|6|||
126269435|NCT00988065|454279113|FG002|Overall Study|Noncompliance with protocol|9|||
126269436|NCT02685202|454279114|FG000|Overall Study|Lost to Follow-up|9|||
126269437|NCT01229735|454279115|FG000|Overall Study|Lack of Efficacy|8|||
126269438|NCT01229735|454279116|FG001|Overall Study|Lack of Efficacy|8|||
126269439|NCT01229735|454279115|FG000|Overall Study|Protocol Violation|13|||
126269440|NCT01229735|454279116|FG001|Overall Study|Protocol Violation|8|||
126269441|NCT01229735|454279115|FG000|Overall Study|Lost to Follow-up|0|||
126269442|NCT01229735|454279116|FG001|Overall Study|Lost to Follow-up|2|||
126269443|NCT01229735|454279115|FG000|Overall Study|Withdrawal by Subject|18|||
126269444|NCT01229735|454279116|FG001|Overall Study|Withdrawal by Subject|17|||
126269445|NCT01229735|454279115|FG000|Overall Study|Other Reason|13|||
126269446|NCT01229735|454279116|FG001|Overall Study|Other Reason|10|||
126269447|NCT01229735|454279115|FG000|Overall Study|SAE, non-fatal|0|||
126269448|NCT01229735|454279116|FG001|Overall Study|SAE, non-fatal|4|||
126269449|NCT01229735|454279115|FG000|Overall Study|AE, non-serious non-fatal|13|||
126269450|NCT01229735|454279116|FG001|Overall Study|AE, non-serious non-fatal|17|||
126269451|NCT01229735|454279115|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126269452|NCT01229735|454279116|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126269453|NCT02787408|454279117|FG000|Overall Study|Death|16|||
126269454|NCT02787408|454279117|FG000|Overall Study|Withdrawal by Subject|1|||
126269455|NCT02787408|454279117|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
126269456|NCT00985712|454279118|FG000|Overall Study|Adverse Event|0|||
126269457|NCT00985712|454279119|FG001|Overall Study|Adverse Event|1|||
126269458|NCT00985712|454279118|FG000|Overall Study|Lost to Follow-up|2|||
126269459|NCT00985712|454279119|FG001|Overall Study|Lost to Follow-up|2|||
126269460|NCT00985712|454279118|FG000|Overall Study|Protocol Violation|0|||
126269461|NCT00985712|454279119|FG001|Overall Study|Protocol Violation|1|||
126269462|NCT00985712|454279118|FG000|Overall Study|Withdrawal by Subject|4|||
126269463|NCT00985712|454279119|FG001|Overall Study|Withdrawal by Subject|1|||
126269464|NCT00985712|454279118|FG000|Overall Study|Sponsor decision|0|||
126269465|NCT00985712|454279119|FG001|Overall Study|Sponsor decision|2|||
126269466|NCT00876018|454279122|FG000|Overall Study|Lost to Follow-up|0|||
126269467|NCT00876018|454279123|FG001|Overall Study|Lost to Follow-up|1|||
126269468|NCT00876018|454279124|FG002|Overall Study|Lost to Follow-up|1|||
126269469|NCT00876018|454279122|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
126269470|NCT00876018|454279123|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
126269471|NCT00876018|454279124|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
126269472|NCT00725621|454279125|FG000|Overall Study|Adverse Event|25|||
126269473|NCT00725621|454279125|FG000|Overall Study|Lack of Efficacy|46|||
126269474|NCT00725621|454279125|FG000|Overall Study|Withdrawal by Subject|57|||
126269475|NCT00725621|454279125|FG000|Overall Study|Physician Decision|19|||
126269476|NCT00725621|454279125|FG000|Overall Study|Lost to Follow-up|52|||
126269477|NCT00725621|454279125|FG000|Overall Study|Non-compliance|8|||
126269478|NCT00725621|454279125|FG000|Overall Study|Continued treatment by other physician|6|||
126269479|NCT00725621|454279125|FG000|Overall Study|Switched to other study|1|||
126269480|NCT00725621|454279125|FG000|Overall Study|Switched to other drug|1|||
126269481|NCT00725621|454279125|FG000|Overall Study|Prepared for elective surgery|1|||
126269482|NCT00725621|454279125|FG000|Overall Study|Reason not specified|55|||
126269483|NCT01189500|454279126|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
126269484|NCT01189500|454279126|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
126269485|NCT00062751|454279127|FG000|Overall Study|Disease progression|24|||
126269486|NCT00062751|454279128|FG001|Overall Study|Disease progression|17|||
126269487|NCT00062751|454279129|FG002|Overall Study|Disease progression|24|||
126269488|NCT00062751|454279130|FG003|Overall Study|Disease progression|2|||
126361186|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
126036784|NCT04032704|453433087|FG015|Part A|Withdrawal by Subject|0|||
126036785|NCT04032704|453433088|FG016|Part A|Withdrawal by Subject|0|||
126036786|NCT04032704|453433089|FG017|Part A|Withdrawal by Subject|0|||
126036787|NCT04032704|453433072|FG000|Part A|Lost to Follow-up|1|||
126036788|NCT04032704|453433073|FG001|Part A|Lost to Follow-up|0|||
126269489|NCT00062751|454279131|FG004|Overall Study|Disease progression|2|||
126269490|NCT00062751|454279127|FG000|Overall Study|Adverse Event|4|||
126269491|NCT00062751|454279128|FG001|Overall Study|Adverse Event|7|||
126269492|NCT00062751|454279129|FG002|Overall Study|Adverse Event|2|||
126269493|NCT00062751|454279130|FG003|Overall Study|Adverse Event|2|||
126269494|NCT00062751|454279131|FG004|Overall Study|Adverse Event|2|||
126269495|NCT00062751|454279127|FG000|Overall Study|Other|2|||
126269496|NCT00062751|454279128|FG001|Overall Study|Other|3|||
126269497|NCT00062751|454279129|FG002|Overall Study|Other|1|||
126269498|NCT00062751|454279130|FG003|Overall Study|Other|0|||
126269499|NCT00062751|454279131|FG004|Overall Study|Other|1|||
126269500|NCT00062751|454279127|FG000|Overall Study|Withdrawal by Subject|1|||
126269501|NCT00062751|454279128|FG001|Overall Study|Withdrawal by Subject|2|||
126269502|NCT00062751|454279129|FG002|Overall Study|Withdrawal by Subject|2|||
126269503|NCT00062751|454279130|FG003|Overall Study|Withdrawal by Subject|1|||
126036789|NCT04032704|453433074|FG002|Part A|Lost to Follow-up|0|||
126036790|NCT04032704|453433075|FG003|Part A|Lost to Follow-up|0|||
126036791|NCT04032704|453433076|FG004|Part A|Lost to Follow-up|0|||
126269504|NCT00062751|454279131|FG004|Overall Study|Withdrawal by Subject|0|||
126269505|NCT00062751|454279127|FG000|Overall Study|Symptomatic deterioration|1|||
126269506|NCT00062751|454279128|FG001|Overall Study|Symptomatic deterioration|1|||
126269507|NCT00062751|454279129|FG002|Overall Study|Symptomatic deterioration|0|||
126269508|NCT00062751|454279130|FG003|Overall Study|Symptomatic deterioration|0|||
126269509|NCT00062751|454279131|FG004|Overall Study|Symptomatic deterioration|1|||
126269510|NCT00062751|454279127|FG000|Overall Study|Death|1|||
126269511|NCT00062751|454279128|FG001|Overall Study|Death|0|||
126269512|NCT00062751|454279129|FG002|Overall Study|Death|1|||
126269513|NCT00062751|454279130|FG003|Overall Study|Death|0|||
126269514|NCT00062751|454279131|FG004|Overall Study|Death|0|||
126269515|NCT01346774|454279132|FG000|Overall Study|Did not take a single dose|6|||
126269516|NCT01346774|454279133|FG001|Overall Study|Did not take a single dose|4|||
126269517|NCT01346774|454279132|FG000|Overall Study|Lost to Follow-up|3|||
126269518|NCT01346774|454279133|FG001|Overall Study|Lost to Follow-up|4|||
126269519|NCT01346774|454279132|FG000|Overall Study|Withdrawal by Subject|1|||
126269520|NCT01346774|454279133|FG001|Overall Study|Withdrawal by Subject|4|||
126269521|NCT01346774|454279132|FG000|Overall Study|Protocol Violation|2|||
126269522|NCT01346774|454279133|FG001|Overall Study|Protocol Violation|3|||
126269523|NCT01346774|454279132|FG000|Overall Study|Adverse Event|1|||
126269524|NCT01346774|454279133|FG001|Overall Study|Adverse Event|2|||
126269525|NCT00502801|454279134|FG000|Treatment Period|Withdrawal by Subject|3|||
126269526|NCT00502801|454279134|FG000|Treatment Period|Adverse Event|7|||
126269527|NCT00502801|454279134|FG000|Treatment Period|Death|14|||
126269528|NCT00502801|454279134|FG000|Treatment Period|OTHER|30|||
126269529|NCT00502801|454279134|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
126269530|NCT00502801|454279134|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
126269531|NCT00502801|454279134|FG000|End of Therapy to Test of Cure|Death|3|||
126269532|NCT00502801|454279134|FG000|End of Therapy to Test of Cure|OTHER|2|||
126269533|NCT00444457|454279138|FG000|Infant Series|Other|0|||
126269534|NCT00444457|454279139|FG001|Infant Series|Other|1|||
126269535|NCT00444457|454279140|FG002|Infant Series|Other|0|||
126269536|NCT00444457|454279141|FG003|Infant Series|Other|0|||
126269537|NCT00444457|454279138|FG000|Infant Series|Parent or legal guardian request|18|||
126269538|NCT00444457|454279139|FG001|Infant Series|Parent or legal guardian request|29|||
126269539|NCT00444457|454279140|FG002|Infant Series|Parent or legal guardian request|34|||
126269540|NCT00444457|454279141|FG003|Infant Series|Parent or legal guardian request|14|||
126269541|NCT00444457|454279138|FG000|Infant Series|Lost to Follow-up|10|||
126269542|NCT00444457|454279139|FG001|Infant Series|Lost to Follow-up|11|||
126269543|NCT00444457|454279140|FG002|Infant Series|Lost to Follow-up|7|||
126269544|NCT00444457|454279141|FG003|Infant Series|Lost to Follow-up|6|||
126269545|NCT00444457|454279138|FG000|Infant Series|Protocol Violation|16|||
126269546|NCT00444457|454279139|FG001|Infant Series|Protocol Violation|8|||
126269547|NCT00444457|454279140|FG002|Infant Series|Protocol Violation|6|||
126269548|NCT00444457|454279141|FG003|Infant Series|Protocol Violation|3|||
126269549|NCT00444457|454279138|FG000|Infant Series|Failed to return|5|||
126269550|NCT00444457|454279139|FG001|Infant Series|Failed to return|4|||
126269551|NCT00444457|454279140|FG002|Infant Series|Failed to return|4|||
126269552|NCT00444457|454279141|FG003|Infant Series|Failed to return|2|||
126269553|NCT00444457|454279138|FG000|Infant Series|Investigator request|4|||
126269554|NCT00444457|454279139|FG001|Infant Series|Investigator request|3|||
126269555|NCT00444457|454279140|FG002|Infant Series|Investigator request|3|||
126269556|NCT00444457|454279141|FG003|Infant Series|Investigator request|2|||
126269557|NCT00444457|454279138|FG000|Infant Series|Other|0|||
126269558|NCT00444457|454279139|FG001|Infant Series|Other|2|||
126269559|NCT00444457|454279140|FG002|Infant Series|Other|4|||
126269560|NCT00444457|454279141|FG003|Infant Series|Other|0|||
126269561|NCT00444457|454279138|FG000|Infant Series|Adverse Event|1|||
126269562|NCT00444457|454279139|FG001|Infant Series|Adverse Event|2|||
126269563|NCT00444457|454279140|FG002|Infant Series|Adverse Event|2|||
126269564|NCT00444457|454279141|FG003|Infant Series|Adverse Event|0|||
126269565|NCT00444457|454279138|FG000|Infant Series|Death|0|||
126269566|NCT00444457|454279139|FG001|Infant Series|Death|1|||
126269567|NCT00444457|454279140|FG002|Infant Series|Death|1|||
126269568|NCT00444457|454279141|FG003|Infant Series|Death|1|||
126269569|NCT00444457|454279138|FG000|After Infant Series|Other|0|||
126269570|NCT00444457|454279139|FG001|After Infant Series|Other|1|||
126269571|NCT00444457|454279140|FG002|After Infant Series|Other|1|||
126269572|NCT00444457|454279141|FG003|After Infant Series|Other|1|||
126269573|NCT00444457|454279138|FG000|After Infant Series|Parent or legal guardian request|4|||
126269574|NCT00444457|454279139|FG001|After Infant Series|Parent or legal guardian request|11|||
126269575|NCT00444457|454279140|FG002|After Infant Series|Parent or legal guardian request|6|||
126269576|NCT00444457|454279141|FG003|After Infant Series|Parent or legal guardian request|3|||
126269577|NCT00444457|454279138|FG000|After Infant Series|Failed to return|7|||
126269578|NCT00444457|454279139|FG001|After Infant Series|Failed to return|6|||
126269579|NCT00444457|454279140|FG002|After Infant Series|Failed to return|5|||
126269580|NCT00444457|454279141|FG003|After Infant Series|Failed to return|1|||
126269581|NCT00444457|454279138|FG000|After Infant Series|Lost to Follow-up|5|||
126269582|NCT00444457|454279139|FG001|After Infant Series|Lost to Follow-up|5|||
126036792|NCT04032704|453433077|FG005|Part A|Lost to Follow-up|0|||
126036793|NCT04032704|453433078|FG006|Part A|Lost to Follow-up|0|||
126036794|NCT04032704|453433079|FG007|Part A|Lost to Follow-up|0|||
126036795|NCT04032704|453433080|FG008|Part A|Lost to Follow-up|0|||
126036796|NCT04032704|453433081|FG009|Part A|Lost to Follow-up|0|||
126036797|NCT04032704|453433082|FG010|Part A|Lost to Follow-up|0|||
126036798|NCT04032704|453433083|FG011|Part A|Lost to Follow-up|0|||
126036799|NCT04032704|453433084|FG012|Part A|Lost to Follow-up|0|||
126036800|NCT04032704|453433085|FG013|Part A|Lost to Follow-up|0|||
126269583|NCT00444457|454279140|FG002|After Infant Series|Lost to Follow-up|5|||
126269584|NCT00444457|454279141|FG003|After Infant Series|Lost to Follow-up|2|||
126269585|NCT00444457|454279138|FG000|After Infant Series|Protocol Violation|2|||
126269586|NCT00444457|454279139|FG001|After Infant Series|Protocol Violation|4|||
126269587|NCT00444457|454279140|FG002|After Infant Series|Protocol Violation|2|||
126269588|NCT00444457|454279141|FG003|After Infant Series|Protocol Violation|2|||
126269589|NCT00444457|454279138|FG000|After Infant Series|Adverse Event|2|||
126269590|NCT00444457|454279139|FG001|After Infant Series|Adverse Event|2|||
126269591|NCT00444457|454279140|FG002|After Infant Series|Adverse Event|0|||
126269592|NCT00444457|454279141|FG003|After Infant Series|Adverse Event|0|||
126269593|NCT00444457|454279138|FG000|After Infant Series|Investigator request|0|||
126269594|NCT00444457|454279139|FG001|After Infant Series|Investigator request|0|||
126269595|NCT00444457|454279140|FG002|After Infant Series|Investigator request|0|||
126269596|NCT00444457|454279141|FG003|After Infant Series|Investigator request|1|||
126269597|NCT00444457|454279138|FG000|After Infant Series|Other|0|||
126269598|NCT00444457|454279139|FG001|After Infant Series|Other|1|||
126269599|NCT00444457|454279140|FG002|After Infant Series|Other|0|||
126269600|NCT00444457|454279141|FG003|After Infant Series|Other|0|||
126269601|NCT00444457|454279138|FG000|Toddler Dose|Lost to Follow-up|4|||
126269602|NCT00444457|454279139|FG001|Toddler Dose|Lost to Follow-up|1|||
126269603|NCT00444457|454279140|FG002|Toddler Dose|Lost to Follow-up|1|||
126269604|NCT00444457|454279141|FG003|Toddler Dose|Lost to Follow-up|3|||
126269605|NCT00444457|454279138|FG000|Toddler Dose|Failed to return|2|||
126269606|NCT00444457|454279139|FG001|Toddler Dose|Failed to return|2|||
126269607|NCT00444457|454279140|FG002|Toddler Dose|Failed to return|1|||
126269608|NCT00444457|454279141|FG003|Toddler Dose|Failed to return|3|||
126269609|NCT00444457|454279138|FG000|Toddler Dose|Parent or legal guardian request|0|||
126269610|NCT00444457|454279139|FG001|Toddler Dose|Parent or legal guardian request|3|||
126269611|NCT00444457|454279140|FG002|Toddler Dose|Parent or legal guardian request|2|||
126269612|NCT00444457|454279141|FG003|Toddler Dose|Parent or legal guardian request|1|||
126269613|NCT00444457|454279138|FG000|Toddler Dose|Protocol Violation|1|||
126269614|NCT00444457|454279139|FG001|Toddler Dose|Protocol Violation|0|||
126269615|NCT00444457|454279140|FG002|Toddler Dose|Protocol Violation|0|||
126269616|NCT00444457|454279141|FG003|Toddler Dose|Protocol Violation|1|||
126269617|NCT01602965|454279144|FG000|Overall Study|Lost to Follow-up|4|||
126269618|NCT01602965|454279145|FG001|Overall Study|Lost to Follow-up|2|||
126269619|NCT00321737|454279146|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
126269620|NCT00321737|454279147|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
126269621|NCT00321737|454279148|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
126269622|NCT00321737|454279146|FG000|Overall Study|Adverse Event|11|||
126361187|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
126361188|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
126361189|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
126361190|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
126361191|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
126361192|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
126361193|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
126361194|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
126098556|NCT01029652|453653042|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
126269623|NCT00321737|454279147|FG001|Overall Study|Adverse Event|3|||
126269624|NCT00321737|454279148|FG002|Overall Study|Adverse Event|6|||
126269625|NCT00321737|454279146|FG000|Overall Study|Lost to Follow-up|5|||
126269626|NCT00321737|454279147|FG001|Overall Study|Lost to Follow-up|5|||
126269627|NCT00321737|454279148|FG002|Overall Study|Lost to Follow-up|6|||
126269628|NCT00321737|454279146|FG000|Overall Study|Withdrawal by Subject|19|||
126269629|NCT00321737|454279147|FG001|Overall Study|Withdrawal by Subject|12|||
126269630|NCT00321737|454279148|FG002|Overall Study|Withdrawal by Subject|17|||
126269631|NCT00321737|454279146|FG000|Overall Study|Protocol Violation|0|||
126361195|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126269632|NCT00321737|454279147|FG001|Overall Study|Protocol Violation|0|||
126269633|NCT00321737|454279148|FG002|Overall Study|Protocol Violation|1|||
126269634|NCT00321737|454279146|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
126036801|NCT04032704|453433086|FG014|Part A|Lost to Follow-up|0|||
126036802|NCT04032704|453433087|FG015|Part A|Lost to Follow-up|0|||
126036803|NCT04032704|453433088|FG016|Part A|Lost to Follow-up|0|||
126036804|NCT04032704|453433089|FG017|Part A|Lost to Follow-up|0|||
126269635|NCT00321737|454279147|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
126269636|NCT00321737|454279148|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
126269637|NCT00321737|454279146|FG000|Overall Study|Possible Barrett's Esophagus|2|||
126269638|NCT00321737|454279147|FG001|Overall Study|Possible Barrett's Esophagus|1|||
126269639|NCT00321737|454279148|FG002|Overall Study|Possible Barrett's Esophagus|1|||
126269640|NCT00321737|454279146|FG000|Overall Study|Therapeutic Failure|6|||
126269641|NCT00321737|454279147|FG001|Overall Study|Therapeutic Failure|0|||
126269642|NCT00321737|454279148|FG002|Overall Study|Therapeutic Failure|2|||
126269643|NCT00321737|454279146|FG000|Overall Study|Pregnancy|0|||
126269644|NCT00321737|454279147|FG001|Overall Study|Pregnancy|2|||
126269645|NCT00321737|454279148|FG002|Overall Study|Pregnancy|0|||
126269646|NCT00321737|454279146|FG000|Overall Study|Noncompliance|2|||
126269647|NCT00321737|454279147|FG001|Overall Study|Noncompliance|0|||
126269648|NCT00321737|454279148|FG002|Overall Study|Noncompliance|0|||
126269649|NCT00321737|454279146|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
126269650|NCT00321737|454279147|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
126269651|NCT00321737|454279148|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
126269652|NCT02283294|454279149|FG000|Overall Study|Lost to Follow-up|1|||
126269653|NCT02283294|454279150|FG001|Overall Study|Lost to Follow-up|1|||
126269654|NCT02283294|454279149|FG000|Overall Study|Withdrawal by Subject|1|||
126269655|NCT02283294|454279150|FG001|Overall Study|Withdrawal by Subject|6|||
126269656|NCT02283294|454279149|FG000|Overall Study|Protocol Violation|1|||
126269657|NCT02283294|454279150|FG001|Overall Study|Protocol Violation|0|||
126269658|NCT02283294|454279149|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
126269659|NCT02283294|454279150|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
126269660|NCT01769339|454279151|FG000|Overall Study|Lost to Follow-up|42|||
126269661|NCT01769339|454279151|FG000|Overall Study|Adverse Event|1|||
126269662|NCT00290251|454279152|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269663|NCT00290251|454279153|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269664|NCT00290251|454279154|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269665|NCT00290251|454279155|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269666|NCT00290251|454279156|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269667|NCT00290251|454279157|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
126269668|NCT00290251|454279152|FG000|Treatment 1 (Months 2-4)|headache|0|||
126269669|NCT00290251|454279153|FG001|Treatment 1 (Months 2-4)|headache|0|||
126269670|NCT00290251|454279154|FG002|Treatment 1 (Months 2-4)|headache|0|||
126269671|NCT00290251|454279155|FG003|Treatment 1 (Months 2-4)|headache|0|||
126269672|NCT00290251|454279156|FG004|Treatment 1 (Months 2-4)|headache|1|||
126269673|NCT00290251|454279157|FG005|Treatment 1 (Months 2-4)|headache|0|||
126269674|NCT00290251|454279152|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269675|NCT00290251|454279153|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269676|NCT00290251|454279154|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269677|NCT00290251|454279155|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
126269678|NCT00290251|454279156|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269679|NCT00290251|454279157|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269680|NCT04062448|454281647|FG000|Overall Study|Lost to Follow-up|1|||
126269681|NCT04062448|454281647|FG000|Overall Study|Withdrawal by Subject|2|||
126269682|NCT05101486|454281648|FG000|Overall Study|Death|1|||
126269683|NCT05101486|454281649|FG001|Overall Study|Death|0|||
126269684|NCT05101486|454281650|FG002|Overall Study|Death|1|||
126269685|NCT05101486|454281648|FG000|Overall Study|Lost to Follow-up|12|||
126269686|NCT05101486|454281649|FG001|Overall Study|Lost to Follow-up|8|||
126269687|NCT05101486|454281650|FG002|Overall Study|Lost to Follow-up|17|||
126269688|NCT05101486|454281648|FG000|Overall Study|Physician Decision|1|||
126269689|NCT05101486|454281649|FG001|Overall Study|Physician Decision|0|||
126269690|NCT05101486|454281650|FG002|Overall Study|Physician Decision|0|||
126269691|NCT05101486|454281648|FG000|Overall Study|Protocol Violation|0|||
126269692|NCT05101486|454281649|FG001|Overall Study|Protocol Violation|0|||
126269693|NCT05101486|454281650|FG002|Overall Study|Protocol Violation|1|||
126361196|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
126361197|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126361198|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126361199|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126361200|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126361201|NCT01557244|454615179|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
126361202|NCT01557244|454615180|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
126361203|NCT01557244|454615181|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
126361204|NCT01557244|454615182|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
126269694|NCT05101486|454281648|FG000|Overall Study|Withdrawal by Subject|5|||
126269695|NCT05101486|454281649|FG001|Overall Study|Withdrawal by Subject|2|||
126269696|NCT05101486|454281650|FG002|Overall Study|Withdrawal by Subject|4|||
126269697|NCT05101486|454281648|FG000|Overall Study|Randomized but not vaccinated|1|||
126269698|NCT05101486|454281649|FG001|Overall Study|Randomized but not vaccinated|1|||
126269699|NCT05101486|454281650|FG002|Overall Study|Randomized but not vaccinated|1|||
126269700|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
126269701|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
126036805|NCT04032704|453433072|FG000|Part A|Death|9|||
126036806|NCT04032704|453433073|FG001|Part A|Death|2|||
126036807|NCT04032704|453433074|FG002|Part A|Death|10|||
126036808|NCT04032704|453433075|FG003|Part A|Death|7|||
126036809|NCT04032704|453433076|FG004|Part A|Death|4|||
126269702|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
126269703|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
126269704|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
126269705|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
126269706|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
126269707|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
126269708|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
126269709|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
126269710|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
126269711|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
126269712|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
126269713|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
126269714|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
126269715|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Other|3|||
126269716|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Other|0|||
126269717|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Other|0|||
126269718|NCT02788045|454281651|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
126269719|NCT02788045|454281652|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
126269720|NCT02788045|454281653|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
126269721|NCT02788045|454281651|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
126269722|NCT02788045|454281652|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
126269723|NCT02788045|454281653|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
126269724|NCT02788045|454281651|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
126269725|NCT02788045|454281652|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
126269726|NCT02788045|454281653|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
126269727|NCT03188666|454281654|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
126269728|NCT03188666|454281655|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
126269729|NCT03188666|454281656|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
126269730|NCT03188666|454281657|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
126269731|NCT03188666|454281654|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
126269732|NCT03188666|454281655|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
126269733|NCT03188666|454281656|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
126269734|NCT03188666|454281657|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
126269735|NCT03188666|454281654|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
126269736|NCT03188666|454281655|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
126269737|NCT03188666|454281656|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
126269738|NCT03188666|454281657|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
126269739|NCT03188666|454281654|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
126269740|NCT03188666|454281655|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
126269741|NCT03188666|454281656|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
126269742|NCT03188666|454281657|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
126269743|NCT03696953|454281658|FG000|Overall Study|Withdrawal by Subject|6|||
126269744|NCT03696953|454281659|FG001|Overall Study|Withdrawal by Subject|1|||
126269745|NCT03696953|454281658|FG000|Overall Study|missed GBS swabs|2|||
126269746|NCT03696953|454281659|FG001|Overall Study|missed GBS swabs|2|||
126269747|NCT03696953|454281658|FG000|Overall Study|lost study bottle containing capsules|2|||
126269748|NCT03696953|454281659|FG001|Overall Study|lost study bottle containing capsules|0|||
126269749|NCT03696953|454281658|FG000|Overall Study|Premature birth|1|||
126269750|NCT03696953|454281659|FG001|Overall Study|Premature birth|4|||
126269751|NCT03696953|454281658|FG000|Overall Study|Gestational hypertension|1|||
126269752|NCT03696953|454281659|FG001|Overall Study|Gestational hypertension|1|||
126269753|NCT03696953|454281658|FG000|Overall Study|Gestational diabetes|2|||
126269754|NCT03696953|454281659|FG001|Overall Study|Gestational diabetes|1|||
126269755|NCT03696953|454281658|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
126269756|NCT03696953|454281659|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
126269757|NCT03696953|454281658|FG000|Overall Study|Changed prenatal provider|1|||
126269758|NCT03696953|454281659|FG001|Overall Study|Changed prenatal provider|1|||
126269759|NCT04908683|454281660|FG000|Overall Study|Failure to meet continuation criteria|34|||
126269760|NCT04908683|454281661|FG001|Overall Study|Failure to meet continuation criteria|22|||
126269761|NCT04908683|454281660|FG000|Overall Study|Initiated prohibited medication|3|||
126269762|NCT04908683|454281661|FG001|Overall Study|Initiated prohibited medication|0|||
126269763|NCT04908683|454281660|FG000|Overall Study|Randomized by mistake|1|||
126361205|NCT01557244|454615183|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
126361206|NCT01557244|454615184|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
126361207|NCT01557244|454615185|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
126036810|NCT04032704|453433077|FG005|Part A|Death|5|||
126036811|NCT04032704|453433078|FG006|Part A|Death|0|||
126036812|NCT04032704|453433079|FG007|Part A|Death|0|||
126269764|NCT04908683|454281661|FG001|Overall Study|Randomized by mistake|0|||
126269765|NCT04908683|454281660|FG000|Overall Study|Lost to Follow-up|679|||
126269766|NCT04908683|454281661|FG001|Overall Study|Lost to Follow-up|341|||
126269767|NCT04908683|454281660|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
126269768|NCT04908683|454281661|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
126269769|NCT04908683|454281660|FG000|Overall Study|Physician Decision|44|||
126269770|NCT04908683|454281661|FG001|Overall Study|Physician Decision|35|||
126269771|NCT04908683|454281660|FG000|Overall Study|Technical problems|12|||
126269772|NCT04908683|454281661|FG001|Overall Study|Technical problems|9|||
126269773|NCT04908683|454281660|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
126269774|NCT04908683|454281661|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
126269775|NCT04908683|454281660|FG000|Overall Study|Protocol Violation|2|||
126269776|NCT04908683|454281661|FG001|Overall Study|Protocol Violation|0|||
126269777|NCT04908683|454281660|FG000|Overall Study|Withdrawal by Subject|1188|||
126269778|NCT04908683|454281661|FG001|Overall Study|Withdrawal by Subject|570|||
126269779|NCT04908683|454281660|FG000|Overall Study|Site Closure by Sponsor|6|||
126269780|NCT04908683|454281661|FG001|Overall Study|Site Closure by Sponsor|3|||
126269781|NCT04908683|454281660|FG000|Overall Study|Adverse Event|21|||
126269782|NCT04908683|454281661|FG001|Overall Study|Adverse Event|11|||
126269783|NCT04908683|454281660|FG000|Overall Study|Death|101|||
126269784|NCT04908683|454281661|FG001|Overall Study|Death|61|||
126269785|NCT04908683|454281660|FG000|Overall Study|Sponsor's decision|14398|||
126269786|NCT04908683|454281661|FG001|Overall Study|Sponsor's decision|7205|||
126269787|NCT04908683|454281660|FG000|Overall Study|Other|92|||
126269788|NCT04908683|454281661|FG001|Overall Study|Other|50|||
126269789|NCT04908683|454281660|FG000|Overall Study|Randomized not vaccinated|108|||
126269790|NCT04908683|454281661|FG001|Overall Study|Randomized not vaccinated|52|||
126098557|NCT01029652|453653043|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
126098558|NCT01029652|453653042|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
126098559|NCT01029652|453653043|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
126098560|NCT01029652|453653042|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
126098561|NCT01029652|453653043|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
126098562|NCT01029652|453653042|FG000|Core Study (0-12 Weeks)|Death|0|||
126098563|NCT01029652|453653043|FG001|Core Study (0-12 Weeks)|Death|1|||
126098564|NCT01029652|453653042|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
126098565|NCT01029652|453653043|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
126269791|NCT03047473|454281663|FG000|Overall Study|Lost to Follow-up|2|||
126269792|NCT06204887|454281664|FG000|Overall Study|Lost to Follow-up|3|||
126269793|NCT06204887|454281665|FG001|Overall Study|Lost to Follow-up|4|||
126269794|NCT06204887|454281666|FG002|Overall Study|Lost to Follow-up|1|||
126269795|NCT06204887|454281667|FG003|Overall Study|Lost to Follow-up|6|||
126269796|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
126269797|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
126269798|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
126269799|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
126269800|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
126269801|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
126269802|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
126269803|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
126269804|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
126269805|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
126269806|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
126269807|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
126269808|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
126269809|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
126269810|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
126269811|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
126269812|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
126269813|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
126269814|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
126269815|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
126269816|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
126269817|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
126269818|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
126269819|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
126269820|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
126269821|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
126098566|NCT01029652|453653042|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
126098567|NCT01029652|453653043|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
126361208|NCT01557244|454615179|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
126361209|NCT01557244|454615180|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
126361210|NCT01557244|454615181|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361211|NCT01557244|454615182|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361212|NCT01557244|454615183|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361213|NCT01557244|454615184|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361214|NCT01557244|454615185|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361215|NCT01557244|454615179|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361216|NCT01557244|454615180|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361217|NCT01557244|454615181|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361218|NCT01557244|454615182|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
126361219|NCT01557244|454615183|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361220|NCT01557244|454615184|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361221|NCT01557244|454615185|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361222|NCT01557244|454615179|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
126361223|NCT01557244|454615180|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
126361224|NCT01557244|454615181|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361225|NCT01557244|454615182|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361226|NCT01557244|454615183|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361227|NCT01557244|454615184|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361228|NCT01557244|454615185|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361229|NCT02365064|454615191|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
126361230|NCT02365064|454615192|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
126361231|NCT02365064|454615191|FG000|Overall Study|Withdrawal by Subject|6|||
126361232|NCT02365064|454615192|FG001|Overall Study|Withdrawal by Subject|9|||
126361233|NCT02365064|454615191|FG000|Overall Study|Treatment intolerance|2|||
126361234|NCT02365064|454615192|FG001|Overall Study|Treatment intolerance|4|||
126361235|NCT00348374|454615195|FG000|Overall Study|Adverse Event|1|||
126361236|NCT00348374|454615196|FG001|Overall Study|Adverse Event|4|||
126361237|NCT00348374|454615195|FG000|Overall Study|Lost to Follow-up|1|||
126361238|NCT00348374|454615196|FG001|Overall Study|Lost to Follow-up|3|||
126361239|NCT00348374|454615195|FG000|Overall Study|Withdrawal by Subject|5|||
126361240|NCT00348374|454615196|FG001|Overall Study|Withdrawal by Subject|5|||
126361241|NCT00348374|454615195|FG000|Overall Study|Other|11|||
126361242|NCT00348374|454615196|FG001|Overall Study|Other|12|||
126361243|NCT00348374|454615195|FG000|Overall Study|ongoing at date of cutoff|1|||
126361244|NCT00348374|454615196|FG001|Overall Study|ongoing at date of cutoff|1|||
126361245|NCT00348374|454615195|FG000|Overall Study|randomized but did not receive treatment|0|||
126361246|NCT00348374|454615196|FG001|Overall Study|randomized but did not receive treatment|7|||
126361247|NCT02595437|454615205|FG000|Triferic Via IV|Withdrawal by Subject|1|||
126361248|NCT02070380|454615208|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
126361249|NCT02070380|454615209|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
126361250|NCT02070380|454615210|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
126361251|NCT02070380|454615211|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
126361252|NCT02070380|454615208|FG000|Second Injection|Image sets missing or technically inadeq|0|||
126361253|NCT02070380|454615209|FG001|Second Injection|Image sets missing or technically inadeq|1|||
126361254|NCT02070380|454615210|FG002|Second Injection|Image sets missing or technically inadeq|0|||
126361255|NCT02070380|454615211|FG003|Second Injection|Image sets missing or technically inadeq|0|||
126361256|NCT02070380|454615208|FG000|Second Injection|Protocol Violation|0|||
126361257|NCT02070380|454615209|FG001|Second Injection|Protocol Violation|1|||
126361258|NCT02070380|454615210|FG002|Second Injection|Protocol Violation|1|||
126361259|NCT02070380|454615211|FG003|Second Injection|Protocol Violation|5|||
126361260|NCT02105012|454615217|FG000|Overall Study|Withdrawal by Subject|11|||
126361261|NCT02105012|454615217|FG000|Overall Study|Protocol Specified Criteria|9|||
126361262|NCT02105012|454615217|FG000|Overall Study|Lost to Follow-up|4|||
126361263|NCT02105012|454615217|FG000|Overall Study|Protocol Violation|4|||
126361264|NCT02105012|454615217|FG000|Overall Study|Physician Decision|3|||
126361265|NCT02105012|454615217|FG000|Overall Study|Adverse Event|1|||
126036813|NCT04032704|453433080|FG008|Part A|Death|0|||
126036814|NCT04032704|453433081|FG009|Part A|Death|0|||
126361266|NCT02105012|454615217|FG000|Overall Study|Lack of Efficacy|1|||
126361267|NCT00493285|454615218|FG000|Overall Study|Lost to Follow-up|0|||
126361268|NCT00493285|454615219|FG001|Overall Study|Lost to Follow-up|0|||
126361269|NCT00493285|454615220|FG002|Overall Study|Lost to Follow-up|0|||
126361270|NCT00493285|454615221|FG003|Overall Study|Lost to Follow-up|0|||
126361271|NCT00493285|454615222|FG004|Overall Study|Lost to Follow-up|1|||
126361272|NCT00493285|454615223|FG005|Overall Study|Lost to Follow-up|0|||
126361273|NCT04535362|454615224|FG000|Overall Study|Lost to Follow-up|3|||
126361274|NCT04535362|454615225|FG001|Overall Study|Lost to Follow-up|1|||
126036815|NCT04032704|453433082|FG010|Part A|Death|0|||
126269822|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
126269823|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
126269824|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
126269825|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
126269826|NCT02935686|454281668|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
126269827|NCT02935686|454281669|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
126269828|NCT02935686|454281670|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
126269829|NCT02935686|454281671|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
126269830|NCT02935686|454281672|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
126269831|NCT02935686|454281668|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
126269832|NCT02935686|454281669|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
126269833|NCT02935686|454281670|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
126269834|NCT02935686|454281671|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
126269835|NCT02935686|454281672|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
126269836|NCT02935686|454281668|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
126269837|NCT02935686|454281669|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
126269838|NCT02935686|454281670|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
126269839|NCT02935686|454281671|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
126269840|NCT02935686|454281672|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
126269841|NCT02935686|454281668|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
126269842|NCT02935686|454281669|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
126269843|NCT02935686|454281670|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
126269844|NCT02935686|454281671|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
126269845|NCT02935686|454281672|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
126269846|NCT02935686|454281668|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
126269847|NCT02935686|454281669|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
126269848|NCT02935686|454281670|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
126269849|NCT02935686|454281671|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
126269850|NCT02935686|454281672|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
126269851|NCT00062010|454281673|FG000|Overall Study|Ineligible|3|||
126269852|NCT02856880|454281674|FG000|Overall Study|Withdrawal of consent|1|||
126269853|NCT00573157|454281675|FG000|Overall Study|Adverse Event|3|||
126269854|NCT00573157|454281676|FG001|Overall Study|Adverse Event|1|||
126269855|NCT00573157|454281675|FG000|Overall Study|Other|1|||
126269856|NCT00573157|454281676|FG001|Overall Study|Other|1|||
126269857|NCT02944383|454281677|FG000|Overall Study|Lost to Follow-up|0|||
126269858|NCT02944383|454281678|FG001|Overall Study|Lost to Follow-up|0|||
126269859|NCT02944383|454281679|FG002|Overall Study|Lost to Follow-up|1|||
126269860|NCT02944383|454281677|FG000|Overall Study|Withdrawal by Subject|1|||
126269861|NCT02944383|454281678|FG001|Overall Study|Withdrawal by Subject|0|||
126269862|NCT02944383|454281679|FG002|Overall Study|Withdrawal by Subject|0|||
126269863|NCT01183221|454281682|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
126269864|NCT01183221|454281683|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
126269865|NCT02444793|454281687|FG000|Overall Study|Lost to Follow-up|2|||
126269866|NCT02444793|454281688|FG001|Overall Study|Lost to Follow-up|2|||
126269867|NCT02444793|454281689|FG002|Overall Study|Lost to Follow-up|0|||
126269868|NCT02444793|454281690|FG003|Overall Study|Lost to Follow-up|0|||
126269869|NCT02444793|454281687|FG000|Overall Study|Death|0|||
126269870|NCT02444793|454281688|FG001|Overall Study|Death|3|||
126269871|NCT02444793|454281689|FG002|Overall Study|Death|0|||
126269872|NCT02444793|454281690|FG003|Overall Study|Death|0|||
126269873|NCT02444793|454281687|FG000|Overall Study|Other|0|||
126269874|NCT02444793|454281688|FG001|Overall Study|Other|0|||
126269875|NCT02444793|454281689|FG002|Overall Study|Other|2|||
126269876|NCT02444793|454281690|FG003|Overall Study|Other|0|||
126269877|NCT02444793|454281687|FG000|Overall Study|Objective progression or relapse|9|||
126269878|NCT02444793|454281688|FG001|Overall Study|Objective progression or relapse|1|||
126269879|NCT02444793|454281689|FG002|Overall Study|Objective progression or relapse|2|||
126269880|NCT02444793|454281690|FG003|Overall Study|Objective progression or relapse|3|||
126361275|NCT03791060|454615226|FG000|Overall Study|Withdrawal by Subject|1|||
126361276|NCT03436420|454615233|FG000|Overall Study|Lack of Efficacy|3|||
126361277|NCT02619812|454615234|FG000|Overall Study|Withdrawal by Subject|0|||
126361278|NCT02619812|454615235|FG001|Overall Study|Withdrawal by Subject|0|||
126269881|NCT02504671|454281691|FG000|Overall Study|Withdrawal by Subject|1|||
126269882|NCT02504671|454281692|FG001|Overall Study|Withdrawal by Subject|5|||
126269883|NCT02504671|454281693|FG002|Overall Study|Withdrawal by Subject|4|||
126269884|NCT02504671|454281694|FG003|Overall Study|Withdrawal by Subject|4|||
126269885|NCT02504671|454281695|FG004|Overall Study|Withdrawal by Subject|5|||
126361279|NCT02619812|454615236|FG002|Overall Study|Withdrawal by Subject|1|||
126269886|NCT02504671|454281696|FG005|Overall Study|Withdrawal by Subject|3|||
126269887|NCT02504671|454281691|FG000|Overall Study|Lack of Efficacy|1|||
126269888|NCT02504671|454281692|FG001|Overall Study|Lack of Efficacy|3|||
126361280|NCT02619812|454615237|FG003|Overall Study|Withdrawal by Subject|2|||
126361281|NCT00981175|454615238|FG000|Primary Dose Vaccination|Adverse Event|1|||
126361282|NCT00981175|454615239|FG001|Primary Dose Vaccination|Adverse Event|0|||
126361283|NCT00981175|454615238|FG000|Primary Dose Vaccination|Protocol Violation|0|||
126361284|NCT00981175|454615239|FG001|Primary Dose Vaccination|Protocol Violation|1|||
126361285|NCT00981175|454615238|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
126361286|NCT00981175|454615239|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
126361287|NCT00981175|454615238|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
126361288|NCT00981175|454615239|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
126361289|NCT01658735|454615242|FG000|Overall Study|Lack of Efficacy|1|||
126361290|NCT01658735|454615243|FG001|Overall Study|Lack of Efficacy|0|||
126361291|NCT01658735|454615244|FG002|Overall Study|Lack of Efficacy|1|||
126361292|NCT01658735|454615242|FG000|Overall Study|Lost to Follow-up|1|||
126361293|NCT01658735|454615243|FG001|Overall Study|Lost to Follow-up|1|||
126361294|NCT01658735|454615244|FG002|Overall Study|Lost to Follow-up|0|||
126361295|NCT01658735|454615242|FG000|Overall Study|Protocol Violation|0|||
126361296|NCT01658735|454615243|FG001|Overall Study|Protocol Violation|1|||
126361297|NCT01658735|454615244|FG002|Overall Study|Protocol Violation|0|||
126361298|NCT01658735|454615242|FG000|Overall Study|Withdrawal by Subject|3|||
126361299|NCT01658735|454615243|FG001|Overall Study|Withdrawal by Subject|5|||
126361300|NCT01658735|454615244|FG002|Overall Study|Withdrawal by Subject|3|||
126361301|NCT01379937|454615245|FG000|Overall Study|Protocol Violation|0|||
126361302|NCT01379937|454615246|FG001|Overall Study|Protocol Violation|0|||
126361303|NCT01379937|454615247|FG002|Overall Study|Protocol Violation|0|||
126361304|NCT01379937|454615248|FG003|Overall Study|Protocol Violation|1|||
126361305|NCT01379937|454615245|FG000|Overall Study|Consent withdrawal|0|||
126361306|NCT01379937|454615246|FG001|Overall Study|Consent withdrawal|1|||
126361307|NCT01379937|454615247|FG002|Overall Study|Consent withdrawal|0|||
126361308|NCT01379937|454615248|FG003|Overall Study|Consent withdrawal|0|||
126361309|NCT01379937|454615245|FG000|Overall Study|Lost to Follow-up|1|||
126361310|NCT01379937|454615246|FG001|Overall Study|Lost to Follow-up|2|||
126361311|NCT01379937|454615247|FG002|Overall Study|Lost to Follow-up|2|||
126361312|NCT01379937|454615248|FG003|Overall Study|Lost to Follow-up|0|||
126361313|NCT01104870|454615249|FG000|Overall Study|Adverse Event|1|||
126361314|NCT01104870|454615250|FG001|Overall Study|Adverse Event|1|||
126361315|NCT01104870|454615251|FG002|Overall Study|Adverse Event|0|||
126361316|NCT01104870|454615249|FG000|Overall Study|Death|0|||
126361317|NCT01104870|454615250|FG001|Overall Study|Death|0|||
126361318|NCT01104870|454615251|FG002|Overall Study|Death|1|||
126361319|NCT01104870|454615249|FG000|Overall Study|Withdrawal by Subject|0|||
126361320|NCT01104870|454615250|FG001|Overall Study|Withdrawal by Subject|0|||
126361321|NCT01104870|454615251|FG002|Overall Study|Withdrawal by Subject|1|||
126361322|NCT00079781|454615263|FG000|Pre-implant Period|Withdrawal by Subject|2|||
126361323|NCT00079781|454615264|FG001|Pre-implant Period|Withdrawal by Subject|0|||
126361324|NCT00079781|454615265|FG002|Pre-implant Period|Withdrawal by Subject|0|||
126361325|NCT00079781|454615263|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
126361326|NCT00079781|454615264|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
126361327|NCT00079781|454615265|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
126361328|NCT00079781|454615263|FG000|Follow-up Period|Withdrawal by Subject|3|||
126361329|NCT00079781|454615264|FG001|Follow-up Period|Withdrawal by Subject|0|||
126361330|NCT00079781|454615265|FG002|Follow-up Period|Withdrawal by Subject|1|||
126361331|NCT00079781|454615263|FG000|Follow-up Period|Lost to Follow-up|1|||
126361332|NCT00079781|454615264|FG001|Follow-up Period|Lost to Follow-up|0|||
126361333|NCT00079781|454615265|FG002|Follow-up Period|Lost to Follow-up|0|||
126361334|NCT00079781|454615263|FG000|Follow-up Period|Death|0|||
126361335|NCT00079781|454615264|FG001|Follow-up Period|Death|0|||
126361336|NCT00079781|454615265|FG002|Follow-up Period|Death|1|||
126361337|NCT04641975|454615266|FG000|Overall Study|Protocol Violation|1|||
126361338|NCT04641975|454615267|FG001|Overall Study|Protocol Violation|2|||
126036816|NCT04032704|453433083|FG011|Part A|Death|0|||
126036817|NCT04032704|453433084|FG012|Part A|Death|0|||
126036818|NCT04032704|453433085|FG013|Part A|Death|0|||
126036819|NCT04032704|453433086|FG014|Part A|Death|0|||
126361339|NCT04641975|454615268|FG002|Overall Study|Protocol Violation|0|||
126361340|NCT04641975|454615269|FG003|Overall Study|Protocol Violation|0|||
126361341|NCT04641975|454615266|FG000|Overall Study|Adverse Event|0|||
126361342|NCT04641975|454615267|FG001|Overall Study|Adverse Event|0|||
126036820|NCT04032704|453433087|FG015|Part A|Death|0|||
126361343|NCT04641975|454615268|FG002|Overall Study|Adverse Event|1|||
126361344|NCT04641975|454615269|FG003|Overall Study|Adverse Event|1|||
126361345|NCT04641975|454615266|FG000|Overall Study|Withdrawal by Subject|1|||
126361346|NCT04641975|454615267|FG001|Overall Study|Withdrawal by Subject|0|||
126361347|NCT04641975|454615268|FG002|Overall Study|Withdrawal by Subject|0|||
126361348|NCT04641975|454615269|FG003|Overall Study|Withdrawal by Subject|0|||
126361349|NCT02067156|454615273|FG000|Overall Study|Lost to Follow-up|4|||
126361350|NCT03596983|454615274|FG000|Overall Study|Withdrawal by Subject|3|||
126036821|NCT04032704|453433088|FG016|Part A|Death|0|||
126036822|NCT04032704|453433089|FG017|Part A|Death|0|||
126361351|NCT05287685|454615275|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
126361352|NCT05287685|454615276|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
126269889|NCT02504671|454281693|FG002|Overall Study|Lack of Efficacy|1|||
126269890|NCT02504671|454281694|FG003|Overall Study|Lack of Efficacy|0|||
126269891|NCT02504671|454281695|FG004|Overall Study|Lack of Efficacy|4|||
126269892|NCT02504671|454281696|FG005|Overall Study|Lack of Efficacy|4|||
126269893|NCT02504671|454281691|FG000|Overall Study|Adverse Event|1|||
126269894|NCT02504671|454281692|FG001|Overall Study|Adverse Event|1|||
126269895|NCT02504671|454281693|FG002|Overall Study|Adverse Event|0|||
126269896|NCT02504671|454281694|FG003|Overall Study|Adverse Event|1|||
126269897|NCT02504671|454281695|FG004|Overall Study|Adverse Event|0|||
126269898|NCT02504671|454281696|FG005|Overall Study|Adverse Event|2|||
126269899|NCT02504671|454281691|FG000|Overall Study|Protocol Violation|2|||
126269900|NCT02504671|454281692|FG001|Overall Study|Protocol Violation|1|||
126269901|NCT02504671|454281693|FG002|Overall Study|Protocol Violation|0|||
126269902|NCT02504671|454281694|FG003|Overall Study|Protocol Violation|0|||
126269903|NCT02504671|454281695|FG004|Overall Study|Protocol Violation|0|||
126269904|NCT02504671|454281696|FG005|Overall Study|Protocol Violation|1|||
126269905|NCT02504671|454281691|FG000|Overall Study|Lost to Follow-up|0|||
126269906|NCT02504671|454281692|FG001|Overall Study|Lost to Follow-up|0|||
126269907|NCT02504671|454281693|FG002|Overall Study|Lost to Follow-up|2|||
126269908|NCT02504671|454281694|FG003|Overall Study|Lost to Follow-up|0|||
126269909|NCT02504671|454281695|FG004|Overall Study|Lost to Follow-up|0|||
126269910|NCT02504671|454281696|FG005|Overall Study|Lost to Follow-up|1|||
126269911|NCT02504671|454281691|FG000|Overall Study|Protocol defined stopping criteria|7|||
126269912|NCT02504671|454281692|FG001|Overall Study|Protocol defined stopping criteria|4|||
126269913|NCT02504671|454281693|FG002|Overall Study|Protocol defined stopping criteria|3|||
126269914|NCT02504671|454281694|FG003|Overall Study|Protocol defined stopping criteria|5|||
126269915|NCT02504671|454281695|FG004|Overall Study|Protocol defined stopping criteria|3|||
126269916|NCT02504671|454281696|FG005|Overall Study|Protocol defined stopping criteria|3|||
126269917|NCT00210249|454281697|FG000|Overall Study|Lost to Follow-up|5|||
126269918|NCT00210249|454281697|FG000|Overall Study|Protocol Violation|11|||
126269919|NCT02518919|454281698|FG000|Overall Study|Protocol Violation|1|||
126269920|NCT02518919|454281699|FG001|Overall Study|Protocol Violation|1|||
126269921|NCT02518919|454281700|FG002|Overall Study|Protocol Violation|2|||
126269922|NCT00599521|454281701|FG000|Overall Study|Lack of Efficacy|4|||
126269923|NCT00599521|454281702|FG001|Overall Study|Lack of Efficacy|8|||
126269924|NCT00599521|454281701|FG000|Overall Study|Adverse Event|4|||
126269925|NCT00599521|454281702|FG001|Overall Study|Adverse Event|1|||
126269926|NCT00599521|454281701|FG000|Overall Study|Withdrawal by Subject|28|||
126269927|NCT00599521|454281702|FG001|Overall Study|Withdrawal by Subject|34|||
126269928|NCT00599521|454281701|FG000|Overall Study|Protocol Violation|1|||
126269929|NCT00599521|454281702|FG001|Overall Study|Protocol Violation|1|||
126269930|NCT00599521|454281701|FG000|Overall Study|Lost to Follow-up|23|||
126269931|NCT00599521|454281702|FG001|Overall Study|Lost to Follow-up|23|||
126269932|NCT00599521|454281701|FG000|Overall Study|Pregnancy|0|||
126269933|NCT00599521|454281702|FG001|Overall Study|Pregnancy|2|||
126269934|NCT04322149|454281704|FG000|Overall Study|Adverse Event|1|||
126269935|NCT04322149|454281705|FG001|Overall Study|Adverse Event|1|||
126269936|NCT04322149|454281706|FG002|Overall Study|Adverse Event|0|||
126269937|NCT04322149|454281707|FG003|Overall Study|Adverse Event|0|||
126269938|NCT04322149|454281704|FG000|Overall Study|Withdrawal by Subject|0|||
126269939|NCT04322149|454281705|FG001|Overall Study|Withdrawal by Subject|0|||
126361353|NCT05287685|454615275|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
126361354|NCT05287685|454615276|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
126361355|NCT03093870|454615277|FG000|Overall Study|Withdrawal by Subject|2|||
126361356|NCT03093870|454615278|FG001|Overall Study|Withdrawal by Subject|6|||
126361357|NCT03093870|454615279|FG002|Overall Study|Withdrawal by Subject|5|||
126361358|NCT03093870|454615277|FG000|Overall Study|Death|1|||
126361359|NCT03093870|454615278|FG001|Overall Study|Death|35|||
126361360|NCT03093870|454615279|FG002|Overall Study|Death|35|||
126361361|NCT03093870|454615277|FG000|Overall Study|Radiographic disease progression|10|||
126361362|NCT03093870|454615278|FG001|Overall Study|Radiographic disease progression|0|||
126361363|NCT03093870|454615279|FG002|Overall Study|Radiographic disease progression|0|||
126361364|NCT03093870|454615277|FG000|Overall Study|Clinical disease progression|1|||
126361365|NCT03093870|454615278|FG001|Overall Study|Clinical disease progression|0|||
126361366|NCT03093870|454615279|FG002|Overall Study|Clinical disease progression|0|||
126361367|NCT03093870|454615277|FG000|Overall Study|Physician Decision|2|||
126361368|NCT03093870|454615278|FG001|Overall Study|Physician Decision|0|||
126361369|NCT03093870|454615279|FG002|Overall Study|Physician Decision|0|||
126361370|NCT03093870|454615277|FG000|Overall Study|Adverse Event|7|||
126361371|NCT03093870|454615278|FG001|Overall Study|Adverse Event|0|||
126269940|NCT04322149|454281706|FG002|Overall Study|Withdrawal by Subject|0|||
126269941|NCT04322149|454281707|FG003|Overall Study|Withdrawal by Subject|2|||
126361372|NCT03093870|454615279|FG002|Overall Study|Adverse Event|0|||
126269942|NCT04322149|454281704|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
126269943|NCT04322149|454281705|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
126269944|NCT04322149|454281706|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
126269945|NCT04322149|454281707|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
126269946|NCT03827564|454281711|FG000|Overall Study|Discontinued due to Study Termination|1|||
126269947|NCT03827564|454281712|FG001|Overall Study|Discontinued due to Study Termination|0|||
126269948|NCT00307034|454281713|FG000|Overall Study|Adverse Event|1|||
126269949|NCT00307034|454281714|FG001|Overall Study|Adverse Event|2|||
126269950|NCT00307034|454281713|FG000|Overall Study|Withdrawal by Subject|1|||
126269951|NCT00307034|454281714|FG001|Overall Study|Withdrawal by Subject|2|||
126269952|NCT00307034|454281713|FG000|Overall Study|Lost to Follow-up|0|||
126269953|NCT00307034|454281714|FG001|Overall Study|Lost to Follow-up|3|||
126269954|NCT00667810|454281715|FG000|Overall Study|Adverse Event|13|||
126269955|NCT00667810|454281716|FG001|Overall Study|Adverse Event|14|||
126269956|NCT00667810|454281717|FG002|Overall Study|Adverse Event|19|||
126269957|NCT00667810|454281718|FG003|Overall Study|Adverse Event|1|||
126269958|NCT00667810|454281715|FG000|Overall Study|Death|1|||
126269959|NCT00667810|454281716|FG001|Overall Study|Death|1|||
126269960|NCT00667810|454281717|FG002|Overall Study|Death|3|||
126269961|NCT00667810|454281718|FG003|Overall Study|Death|0|||
126269962|NCT00667810|454281715|FG000|Overall Study|Lack of Efficacy|1|||
126269963|NCT00667810|454281716|FG001|Overall Study|Lack of Efficacy|0|||
126269964|NCT00667810|454281717|FG002|Overall Study|Lack of Efficacy|2|||
126269965|NCT00667810|454281718|FG003|Overall Study|Lack of Efficacy|0|||
126269966|NCT00667810|454281715|FG000|Overall Study|Lost to Follow-up|1|||
126269967|NCT00667810|454281716|FG001|Overall Study|Lost to Follow-up|4|||
126269968|NCT00667810|454281717|FG002|Overall Study|Lost to Follow-up|2|||
126269969|NCT00667810|454281718|FG003|Overall Study|Lost to Follow-up|0|||
126269970|NCT00667810|454281715|FG000|Overall Study|Physician Decision|1|||
126269971|NCT00667810|454281716|FG001|Overall Study|Physician Decision|1|||
126269972|NCT00667810|454281717|FG002|Overall Study|Physician Decision|2|||
126269973|NCT00667810|454281718|FG003|Overall Study|Physician Decision|0|||
126269974|NCT00667810|454281715|FG000|Overall Study|Protocol Violation|0|||
126269975|NCT00667810|454281716|FG001|Overall Study|Protocol Violation|2|||
126269976|NCT00667810|454281717|FG002|Overall Study|Protocol Violation|0|||
126269977|NCT00667810|454281718|FG003|Overall Study|Protocol Violation|0|||
126269978|NCT00667810|454281715|FG000|Overall Study|Withdrawal by Subject|14|||
126269979|NCT00667810|454281716|FG001|Overall Study|Withdrawal by Subject|20|||
126269980|NCT00667810|454281717|FG002|Overall Study|Withdrawal by Subject|29|||
126269981|NCT00667810|454281718|FG003|Overall Study|Withdrawal by Subject|1|||
126269982|NCT00667810|454281715|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
126269983|NCT00667810|454281716|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
126269984|NCT00667810|454281717|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
126269985|NCT00667810|454281718|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
126269986|NCT00667810|454281715|FG000|Overall Study|Failed to Return|0|||
126269987|NCT00667810|454281716|FG001|Overall Study|Failed to Return|0|||
126269988|NCT00667810|454281717|FG002|Overall Study|Failed to Return|2|||
126269989|NCT00667810|454281718|FG003|Overall Study|Failed to Return|0|||
126269990|NCT00667810|454281715|FG000|Overall Study|Loss of Caregiver|0|||
126269991|NCT00667810|454281716|FG001|Overall Study|Loss of Caregiver|1|||
126269992|NCT00667810|454281717|FG002|Overall Study|Loss of Caregiver|3|||
126269993|NCT00667810|454281718|FG003|Overall Study|Loss of Caregiver|0|||
126269994|NCT00667810|454281715|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
126269995|NCT00667810|454281716|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
126269996|NCT00667810|454281717|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
126269997|NCT00667810|454281718|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
126269998|NCT00667810|454281715|FG000|Overall Study|Other|6|||
126269999|NCT00667810|454281716|FG001|Overall Study|Other|6|||
126270000|NCT00667810|454281717|FG002|Overall Study|Other|5|||
126270001|NCT00667810|454281718|FG003|Overall Study|Other|0|||
126270002|NCT04442490|454281725|FG000|Overall Study|Withdrawal by Subject|18|||
126270003|NCT04442490|454281726|FG001|Overall Study|Withdrawal by Subject|10|||
126270004|NCT04442490|454281725|FG000|Overall Study|Lost to Follow-up|7|||
126270005|NCT04442490|454281726|FG001|Overall Study|Lost to Follow-up|7|||
126361373|NCT03093870|454615277|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
126361374|NCT03093870|454615278|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
126270006|NCT04442490|454281725|FG000|Overall Study|Adverse Event|2|||
126270007|NCT04442490|454281726|FG001|Overall Study|Adverse Event|6|||
126270008|NCT04442490|454281725|FG000|Overall Study|Noncompliance|3|||
126270009|NCT04442490|454281726|FG001|Overall Study|Noncompliance|1|||
126270010|NCT04442490|454281725|FG000|Overall Study|Physician Decision|2|||
126270011|NCT04442490|454281726|FG001|Overall Study|Physician Decision|1|||
126270012|NCT04442490|454281725|FG000|Overall Study|Reason not Specified|2|||
126270013|NCT04442490|454281726|FG001|Overall Study|Reason not Specified|1|||
126270014|NCT04442490|454281725|FG000|Overall Study|Randomized but not Treated|3|||
126270015|NCT04442490|454281726|FG001|Overall Study|Randomized but not Treated|3|||
126270016|NCT02227147|454281727|FG000|Controlled Treatment Period|Adverse Event|4|||
126270017|NCT02227147|454281728|FG001|Controlled Treatment Period|Adverse Event|3|||
126270018|NCT02227147|454281727|FG000|Controlled Treatment Period|Other|2|||
126270019|NCT02227147|454281728|FG001|Controlled Treatment Period|Other|0|||
126270020|NCT02227147|454281727|FG000|Follow-up Period|Other|3|||
126270021|NCT02227147|454281728|FG001|Follow-up Period|Other|5|||
126270022|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
126270023|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
126270024|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
126270025|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
126270026|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
126270027|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
126270028|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
126270029|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
126270030|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
126270031|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
126270032|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
125880732|NCT02156076|452862614|FG002|Treatment Period|no longer meets study criteria|1|||
126270033|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
126270034|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
126270035|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
126270036|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
125880733|NCT02156076|452862615|FG003|Treatment Period|no longer meets study criteria|0|||
125880734|NCT02156076|452862612|FG000|Treatment Period|Poor/non-compliance|0|||
125880735|NCT02156076|452862613|FG001|Treatment Period|Poor/non-compliance|1|||
125880736|NCT02156076|452862614|FG002|Treatment Period|Poor/non-compliance|0|||
125880737|NCT02156076|452862615|FG003|Treatment Period|Poor/non-compliance|0|||
125880738|NCT02156076|452862612|FG000|Treatment Period|Lost to Follow-up|0|||
125880739|NCT02156076|452862613|FG001|Treatment Period|Lost to Follow-up|0|||
125880740|NCT02156076|452862614|FG002|Treatment Period|Lost to Follow-up|0|||
125880741|NCT02156076|452862615|FG003|Treatment Period|Lost to Follow-up|1|||
125880742|NCT02156076|452862612|FG000|Treatment Period|Withdrawal by Subject|0|||
125880743|NCT02156076|452862613|FG001|Treatment Period|Withdrawal by Subject|0|||
125880744|NCT02156076|452862614|FG002|Treatment Period|Withdrawal by Subject|1|||
125880745|NCT02156076|452862615|FG003|Treatment Period|Withdrawal by Subject|0|||
125880746|NCT02156076|452862612|FG000|Treatment Period|Subject request to discontinue treatment|0|||
125880747|NCT02156076|452862613|FG001|Treatment Period|Subject request to discontinue treatment|1|||
125880748|NCT02156076|452862614|FG002|Treatment Period|Subject request to discontinue treatment|0|||
125880749|NCT02156076|452862615|FG003|Treatment Period|Subject request to discontinue treatment|0|||
125880750|NCT02156076|452862612|FG000|Treatment Period|Adverse Event|0|||
125880751|NCT02156076|452862613|FG001|Treatment Period|Adverse Event|0|||
125880752|NCT02156076|452862614|FG002|Treatment Period|Adverse Event|0|||
125880753|NCT02156076|452862615|FG003|Treatment Period|Adverse Event|1|||
125880754|NCT02156076|452862612|FG000|Follow-up Period|Withdrawal by Subject|1|||
125880755|NCT02156076|452862613|FG001|Follow-up Period|Withdrawal by Subject|0|||
125880756|NCT02156076|452862614|FG002|Follow-up Period|Withdrawal by Subject|0|||
125880757|NCT02156076|452862615|FG003|Follow-up Period|Withdrawal by Subject|0|||
125880758|NCT01213472|452862618|FG000|Overall Study|Recurrence/Progressive disease|25|||
125880759|NCT01213472|452862618|FG000|Overall Study|Withdrawal by Subject|1|||
125880760|NCT01213472|452862618|FG000|Overall Study|Physician Decision|1|||
125880761|NCT04225897|452862624|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125880762|NCT04225897|452862625|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
125880763|NCT04225897|452862626|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125880764|NCT04225897|452862627|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126270037|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
126270038|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
126270039|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
126270040|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
126270041|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
126270042|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
126270043|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
126270044|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
126270045|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
126270046|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
126270047|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
126270048|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
125880765|NCT04225897|452862628|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125880766|NCT04225897|452862629|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125880767|NCT04225897|452862630|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126270049|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
126270050|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
125880768|NCT04225897|452862631|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125880769|NCT04225897|452862632|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125880770|NCT04225897|452862633|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125880771|NCT04225897|452862634|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126361375|NCT03093870|454615279|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
126361376|NCT03093870|454615277|FG000|Overall Study|Lost to Follow-up|0|||
126361377|NCT03093870|454615278|FG001|Overall Study|Lost to Follow-up|0|||
126361378|NCT03093870|454615279|FG002|Overall Study|Lost to Follow-up|1|||
126361379|NCT04008069|454615280|FG000|Open-Label Period|Adverse Event|1|||
126361380|NCT04008069|454615281|FG001|Open-Label Period|Adverse Event|0|||
126361381|NCT04008069|454615282|FG002|Open-Label Period|Adverse Event|0|||
126361382|NCT04008069|454615280|FG000|Open-Label Period|Lack of Efficacy|4|||
126361383|NCT04008069|454615281|FG001|Open-Label Period|Lack of Efficacy|0|||
126361384|NCT04008069|454615282|FG002|Open-Label Period|Lack of Efficacy|0|||
126361385|NCT04008069|454615280|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
126270051|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
126270052|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
126270053|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
126270054|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
126270055|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
126270056|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
126270057|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
126270058|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
126270059|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
126270060|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
126270061|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
126270062|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
126270063|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
126270064|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
126270065|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
126270066|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
126270067|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
126270068|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
126270069|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
126270070|NCT01449279|454281733|FG000|Overall Study|Lack of Efficacy|5|||
126270071|NCT01449279|454281733|FG000|Overall Study|Toxicity|2|||
126270072|NCT00505375|454281734|FG000|Overall Study|Death|1|||
126270073|NCT00505375|454281735|FG001|Overall Study|Death|0|||
126270074|NCT00505375|454281734|FG000|Overall Study|Withdrawal by Subject|2|||
126270075|NCT00505375|454281735|FG001|Overall Study|Withdrawal by Subject|2|||
126270076|NCT00505375|454281734|FG000|Overall Study|Lost to Follow-up|0|||
126270077|NCT00505375|454281735|FG001|Overall Study|Lost to Follow-up|2|||
126270078|NCT00505375|454281734|FG000|Overall Study|Pregnancy|1|||
126270079|NCT00505375|454281735|FG001|Overall Study|Pregnancy|0|||
126270080|NCT00505375|454281734|FG000|Overall Study|Travel issues|0|||
126270081|NCT00505375|454281735|FG001|Overall Study|Travel issues|1|||
126270082|NCT03709823|454281736|FG000|Overall Study|Adverse Event|0|||
126270083|NCT03709823|454281737|FG001|Overall Study|Adverse Event|0|||
126270084|NCT03709823|454281738|FG002|Overall Study|Adverse Event|1|||
126270085|NCT03709823|454281739|FG003|Overall Study|Adverse Event|0|||
126270086|NCT03709823|454281740|FG004|Overall Study|Adverse Event|0|||
126270087|NCT03709823|454281741|FG005|Overall Study|Adverse Event|0|||
126270088|NCT03709823|454281736|FG000|Overall Study|Lost to Follow-up|2|||
126270089|NCT03709823|454281737|FG001|Overall Study|Lost to Follow-up|2|||
126270090|NCT03709823|454281738|FG002|Overall Study|Lost to Follow-up|2|||
126270091|NCT03709823|454281739|FG003|Overall Study|Lost to Follow-up|1|||
126270092|NCT03709823|454281740|FG004|Overall Study|Lost to Follow-up|1|||
126270093|NCT03709823|454281741|FG005|Overall Study|Lost to Follow-up|0|||
126270094|NCT03709823|454281736|FG000|Overall Study|Withdrawal by Subject|1|||
126270095|NCT03709823|454281737|FG001|Overall Study|Withdrawal by Subject|3|||
126361386|NCT04008069|454615281|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
126270096|NCT03709823|454281738|FG002|Overall Study|Withdrawal by Subject|0|||
126361387|NCT04008069|454615282|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
126361388|NCT04008069|454615280|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
126270097|NCT03709823|454281739|FG003|Overall Study|Withdrawal by Subject|0|||
126270098|NCT03709823|454281740|FG004|Overall Study|Withdrawal by Subject|0|||
126270099|NCT03709823|454281741|FG005|Overall Study|Withdrawal by Subject|0|||
126270100|NCT03709823|454281736|FG000|Overall Study|Other, Not Specified|0|||
126270101|NCT03709823|454281737|FG001|Overall Study|Other, Not Specified|0|||
126270102|NCT03709823|454281738|FG002|Overall Study|Other, Not Specified|0|||
126270103|NCT03709823|454281739|FG003|Overall Study|Other, Not Specified|1|||
126270104|NCT03709823|454281740|FG004|Overall Study|Other, Not Specified|0|||
126270105|NCT03709823|454281741|FG005|Overall Study|Other, Not Specified|0|||
126270106|NCT04234984|454281742|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
126270107|NCT04234984|454281742|FG000|Follow-up at the Second Time Point|Death|1|||
126270108|NCT04234984|454281742|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
126270109|NCT02038907|454281743|FG000|Overall Study|Protocol Violation|0|||
126270110|NCT02038907|454281744|FG001|Overall Study|Protocol Violation|0|||
126270111|NCT02038907|454281745|FG002|Overall Study|Protocol Violation|0|||
126270112|NCT02038907|454281746|FG003|Overall Study|Protocol Violation|0|||
126270113|NCT02038907|454281747|FG004|Overall Study|Protocol Violation|0|||
126270114|NCT02038907|454281748|FG005|Overall Study|Protocol Violation|0|||
126270115|NCT02038907|454281749|FG006|Overall Study|Protocol Violation|0|||
126270116|NCT02038907|454281750|FG007|Overall Study|Protocol Violation|0|||
126270117|NCT02038907|454281751|FG008|Overall Study|Protocol Violation|0|||
126270118|NCT02038907|454281752|FG009|Overall Study|Protocol Violation|0|||
126270119|NCT02038907|454281753|FG010|Overall Study|Protocol Violation|1|||
126270120|NCT02038907|454281754|FG011|Overall Study|Protocol Violation|0|||
126270121|NCT02038907|454281755|FG012|Overall Study|Protocol Violation|0|||
126270122|NCT02038907|454281756|FG013|Overall Study|Protocol Violation|0|||
126270123|NCT02038907|454281743|FG000|Overall Study|Withdrawal by Subject|0|||
126270124|NCT02038907|454281744|FG001|Overall Study|Withdrawal by Subject|0|||
126270125|NCT02038907|454281745|FG002|Overall Study|Withdrawal by Subject|0|||
126270126|NCT02038907|454281746|FG003|Overall Study|Withdrawal by Subject|0|||
126270127|NCT02038907|454281747|FG004|Overall Study|Withdrawal by Subject|0|||
126270128|NCT02038907|454281748|FG005|Overall Study|Withdrawal by Subject|0|||
126270129|NCT02038907|454281749|FG006|Overall Study|Withdrawal by Subject|0|||
126270130|NCT02038907|454281750|FG007|Overall Study|Withdrawal by Subject|0|||
126270131|NCT02038907|454281751|FG008|Overall Study|Withdrawal by Subject|0|||
126270132|NCT02038907|454281752|FG009|Overall Study|Withdrawal by Subject|0|||
126270133|NCT02038907|454281753|FG010|Overall Study|Withdrawal by Subject|1|||
126270134|NCT02038907|454281754|FG011|Overall Study|Withdrawal by Subject|0|||
126270135|NCT02038907|454281755|FG012|Overall Study|Withdrawal by Subject|0|||
126270136|NCT02038907|454281756|FG013|Overall Study|Withdrawal by Subject|0|||
126270137|NCT04594707|454281760|FG000|Overall Study|Adverse Event|0|||
126270138|NCT04594707|454281761|FG001|Overall Study|Adverse Event|0|||
126270139|NCT04594707|454281762|FG002|Overall Study|Adverse Event|1|||
126270140|NCT04594707|454281760|FG000|Overall Study|Death|0|||
126270141|NCT04594707|454281761|FG001|Overall Study|Death|2|||
126270142|NCT04594707|454281762|FG002|Overall Study|Death|2|||
126270143|NCT04594707|454281760|FG000|Overall Study|Lung Transplant|0|||
126270144|NCT04594707|454281761|FG001|Overall Study|Lung Transplant|0|||
126270145|NCT04594707|454281762|FG002|Overall Study|Lung Transplant|1|||
126270146|NCT04594707|454281760|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
126270147|NCT04594707|454281761|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
126270148|NCT04594707|454281762|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
126270149|NCT04594707|454281760|FG000|Overall Study|Study Terminated By Sponsor|19|||
126270150|NCT04594707|454281761|FG001|Overall Study|Study Terminated By Sponsor|47|||
126270151|NCT04594707|454281762|FG002|Overall Study|Study Terminated By Sponsor|41|||
126270152|NCT04594707|454281760|FG000|Overall Study|Withdrawal by Subject|1|||
126270153|NCT04594707|454281761|FG001|Overall Study|Withdrawal by Subject|0|||
126270154|NCT04594707|454281762|FG002|Overall Study|Withdrawal by Subject|2|||
126270155|NCT01359644|454281765|FG000|Treatment Period|Lack of Efficacy|0|||
126270156|NCT01359644|454281766|FG001|Treatment Period|Lack of Efficacy|1|||
126270157|NCT01359644|454281767|FG002|Treatment Period|Lack of Efficacy|0|||
126270158|NCT01359644|454281768|FG003|Treatment Period|Lack of Efficacy|0|||
126270159|NCT01359644|454281769|FG004|Treatment Period|Lack of Efficacy|0|||
126270160|NCT01359644|454281770|FG005|Treatment Period|Lack of Efficacy|0|||
126270161|NCT01359644|454281771|FG006|Treatment Period|Lack of Efficacy|0|||
126270162|NCT01359644|454281772|FG007|Treatment Period|Lack of Efficacy|0|||
126270163|NCT01359644|454281773|FG008|Treatment Period|Lack of Efficacy|0|||
126270164|NCT01359644|454281774|FG009|Treatment Period|Lack of Efficacy|0|||
126270165|NCT01359644|454281765|FG000|Treatment Period|Adverse Event|0|||
126270166|NCT01359644|454281766|FG001|Treatment Period|Adverse Event|0|||
126270167|NCT01359644|454281767|FG002|Treatment Period|Adverse Event|1|||
126270168|NCT01359644|454281768|FG003|Treatment Period|Adverse Event|0|||
126270169|NCT01359644|454281769|FG004|Treatment Period|Adverse Event|0|||
126270170|NCT01359644|454281770|FG005|Treatment Period|Adverse Event|1|||
126270171|NCT01359644|454281771|FG006|Treatment Period|Adverse Event|0|||
126270172|NCT01359644|454281772|FG007|Treatment Period|Adverse Event|0|||
126270173|NCT01359644|454281773|FG008|Treatment Period|Adverse Event|0|||
126270174|NCT01359644|454281774|FG009|Treatment Period|Adverse Event|0|||
126270175|NCT01359644|454281765|FG000|Treatment Period|Lost to Follow-up|0|||
126270176|NCT01359644|454281766|FG001|Treatment Period|Lost to Follow-up|0|||
126270177|NCT01359644|454281767|FG002|Treatment Period|Lost to Follow-up|0|||
126270178|NCT01359644|454281768|FG003|Treatment Period|Lost to Follow-up|0|||
126270179|NCT01359644|454281769|FG004|Treatment Period|Lost to Follow-up|0|||
126270180|NCT01359644|454281770|FG005|Treatment Period|Lost to Follow-up|1|||
126270181|NCT01359644|454281771|FG006|Treatment Period|Lost to Follow-up|0|||
126270182|NCT01359644|454281772|FG007|Treatment Period|Lost to Follow-up|0|||
126270183|NCT01359644|454281773|FG008|Treatment Period|Lost to Follow-up|0|||
126270184|NCT01359644|454281774|FG009|Treatment Period|Lost to Follow-up|0|||
126270185|NCT01359644|454281765|FG000|Follow-up Period|Withdrawal by Subject|0|||
126270186|NCT01359644|454281766|FG001|Follow-up Period|Withdrawal by Subject|0|||
126270187|NCT01359644|454281767|FG002|Follow-up Period|Withdrawal by Subject|0|||
126270188|NCT01359644|454281768|FG003|Follow-up Period|Withdrawal by Subject|0|||
126270189|NCT01359644|454281769|FG004|Follow-up Period|Withdrawal by Subject|0|||
126270190|NCT01359644|454281770|FG005|Follow-up Period|Withdrawal by Subject|1|||
126270191|NCT01359644|454281771|FG006|Follow-up Period|Withdrawal by Subject|0|||
126270192|NCT01359644|454281772|FG007|Follow-up Period|Withdrawal by Subject|0|||
126270193|NCT01359644|454281773|FG008|Follow-up Period|Withdrawal by Subject|0|||
126270194|NCT01359644|454281774|FG009|Follow-up Period|Withdrawal by Subject|0|||
126270195|NCT01359644|454281765|FG000|Follow-up Period|Lost to Follow-up|0|||
126270196|NCT01359644|454281766|FG001|Follow-up Period|Lost to Follow-up|0|||
126270197|NCT01359644|454281767|FG002|Follow-up Period|Lost to Follow-up|0|||
126270198|NCT01359644|454281768|FG003|Follow-up Period|Lost to Follow-up|0|||
126270199|NCT01359644|454281769|FG004|Follow-up Period|Lost to Follow-up|0|||
126270200|NCT01359644|454281770|FG005|Follow-up Period|Lost to Follow-up|0|||
126270201|NCT01359644|454281771|FG006|Follow-up Period|Lost to Follow-up|1|||
126270202|NCT01359644|454281772|FG007|Follow-up Period|Lost to Follow-up|2|||
126270203|NCT01359644|454281773|FG008|Follow-up Period|Lost to Follow-up|0|||
126270204|NCT01359644|454281774|FG009|Follow-up Period|Lost to Follow-up|0|||
126270205|NCT02130882|454281775|FG000|Overall Study|Withdrawal by Subject|0|||
126270206|NCT02130882|454281776|FG001|Overall Study|Withdrawal by Subject|1|||
126270207|NCT01194973|454281787|FG000|Screening Period|Screen Failure|3|||
126270208|NCT01194973|454281787|FG000|26 Week Treatment Period|Adverse Event|1|||
126270209|NCT01194973|454281787|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
126270210|NCT01194973|454281787|FG000|26 Week Treatment Period|Pregnancy|1|||
126270211|NCT00359632|454281790|FG000|Overall Study|Death|2|||
126270212|NCT00359632|454281791|FG001|Overall Study|Death|0|||
126270213|NCT00359632|454281790|FG000|Overall Study|Adverse Event|1|||
126270214|NCT00359632|454281791|FG001|Overall Study|Adverse Event|0|||
126270215|NCT00359632|454281790|FG000|Overall Study|Non-compliance with visit schedule|1|||
126270216|NCT00359632|454281791|FG001|Overall Study|Non-compliance with visit schedule|0|||
126270217|NCT02615171|454281792|FG000|Overall Study|Lost to Follow-up|2|||
126270218|NCT02615171|454281793|FG001|Overall Study|Lost to Follow-up|1|||
126270219|NCT01000493|454281801|FG000|Overall Study|Adverse Event|3|||
126270220|NCT01000493|454281802|FG001|Overall Study|Adverse Event|6|||
126270221|NCT01000493|454281801|FG000|Overall Study|Lack of Efficacy|1|||
126270222|NCT01000493|454281802|FG001|Overall Study|Lack of Efficacy|1|||
126270223|NCT01000493|454281801|FG000|Overall Study|Protocol Violation|1|||
126270224|NCT01000493|454281802|FG001|Overall Study|Protocol Violation|8|||
126270225|NCT01000493|454281801|FG000|Overall Study|Study closed/terminated|25|||
126270226|NCT01000493|454281802|FG001|Overall Study|Study closed/terminated|23|||
126270227|NCT01000493|454281801|FG000|Overall Study|Lost to Follow-up|5|||
126270228|NCT01000493|454281802|FG001|Overall Study|Lost to Follow-up|9|||
126270229|NCT01000493|454281801|FG000|Overall Study|Physician Decision|1|||
126270230|NCT01000493|454281802|FG001|Overall Study|Physician Decision|1|||
126270231|NCT01000493|454281801|FG000|Overall Study|Withdrawal by Subject|3|||
126270232|NCT01000493|454281802|FG001|Overall Study|Withdrawal by Subject|7|||
126361389|NCT04008069|454615281|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
126361390|NCT04008069|454615282|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
126361391|NCT02134028|454615284|FG000|Overall Study|Lack of Efficacy|1|||
126361392|NCT02134028|454615285|FG001|Overall Study|Lack of Efficacy|0|||
126361393|NCT02134028|454615286|FG002|Overall Study|Lack of Efficacy|3|||
126361394|NCT02134028|454615287|FG003|Overall Study|Lack of Efficacy|2|||
126361395|NCT02134028|454615288|FG004|Overall Study|Lack of Efficacy|1|||
126361396|NCT02134028|454615289|FG005|Overall Study|Lack of Efficacy|2|||
126361397|NCT02134028|454615290|FG006|Overall Study|Lack of Efficacy|1|||
126361398|NCT02134028|454615291|FG007|Overall Study|Lack of Efficacy|0|||
126361399|NCT02134028|454615284|FG000|Overall Study|Poor compliance to protocol|1|||
126361400|NCT02134028|454615285|FG001|Overall Study|Poor compliance to protocol|1|||
126361401|NCT02134028|454615286|FG002|Overall Study|Poor compliance to protocol|3|||
126361402|NCT02134028|454615287|FG003|Overall Study|Poor compliance to protocol|7|||
126361403|NCT02134028|454615288|FG004|Overall Study|Poor compliance to protocol|1|||
126361404|NCT02134028|454615289|FG005|Overall Study|Poor compliance to protocol|1|||
126361405|NCT02134028|454615290|FG006|Overall Study|Poor compliance to protocol|0|||
126361406|NCT02134028|454615291|FG007|Overall Study|Poor compliance to protocol|0|||
126361407|NCT02134028|454615284|FG000|Overall Study|Other unspecified|4|||
126361408|NCT02134028|454615285|FG001|Overall Study|Other unspecified|22|||
126036823|NCT04032704|453433072|FG000|Part B|Other|0|||
126036824|NCT04032704|453433073|FG001|Part B|Other|0|||
126036825|NCT04032704|453433074|FG002|Part B|Other|0|||
126270233|NCT01408628|454281804|FG000|Consented|Withdrawal by Subject|12|||
126270234|NCT01408628|454281804|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
126270235|NCT01408628|454281804|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
126270236|NCT01408628|454281804|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
126270237|NCT01941940|454281805|FG000|Overall Study|Adverse Event|11|||
126270238|NCT01941940|454281805|FG000|Overall Study|Lost to Follow-up|2|||
126270239|NCT01941940|454281805|FG000|Overall Study|Physician Decision|2|||
126270240|NCT01941940|454281805|FG000|Overall Study|Withdrawal by Subject|15|||
126270241|NCT01941940|454281805|FG000|Overall Study|Death|1|||
126270242|NCT01941940|454281805|FG000|Overall Study|Other|1|||
126270243|NCT01941940|454281805|FG000|Overall Study|Other|1|||
126270244|NCT00750308|454281806|FG000|First Treatment|Adverse Event|0|||
126270245|NCT00750308|454281807|FG001|First Treatment|Adverse Event|1|||
126270246|NCT00750308|454281808|FG002|First Treatment|Adverse Event|0|||
126270247|NCT00750308|454281809|FG003|First Treatment|Adverse Event|0|||
126270248|NCT00750308|454281810|FG004|First Treatment|Adverse Event|0|||
126270249|NCT00750308|454281811|FG005|First Treatment|Adverse Event|0|||
126270250|NCT00750308|454281812|FG006|First Treatment|Adverse Event|0|||
126270251|NCT00750308|454281813|FG007|First Treatment|Adverse Event|0|||
126270252|NCT00750308|454281814|FG008|First Treatment|Adverse Event|0|||
126270253|NCT00750308|454281815|FG009|First Treatment|Adverse Event|0|||
126270254|NCT00750308|454281816|FG010|First Treatment|Adverse Event|1|||
126270255|NCT00750308|454281817|FG011|First Treatment|Adverse Event|1|||
126270256|NCT00750308|454281806|FG000|First Treatment|Withdrawal by Subject|0|||
126270257|NCT00750308|454281807|FG001|First Treatment|Withdrawal by Subject|0|||
126270258|NCT00750308|454281808|FG002|First Treatment|Withdrawal by Subject|0|||
126270259|NCT00750308|454281809|FG003|First Treatment|Withdrawal by Subject|1|||
126270260|NCT00750308|454281810|FG004|First Treatment|Withdrawal by Subject|0|||
126270261|NCT00750308|454281811|FG005|First Treatment|Withdrawal by Subject|0|||
126270262|NCT00750308|454281812|FG006|First Treatment|Withdrawal by Subject|0|||
126270263|NCT00750308|454281813|FG007|First Treatment|Withdrawal by Subject|1|||
126270264|NCT00750308|454281814|FG008|First Treatment|Withdrawal by Subject|0|||
126270265|NCT00750308|454281815|FG009|First Treatment|Withdrawal by Subject|0|||
126270266|NCT00750308|454281816|FG010|First Treatment|Withdrawal by Subject|0|||
126270267|NCT00750308|454281817|FG011|First Treatment|Withdrawal by Subject|0|||
126270268|NCT00750308|454281806|FG000|Second Treatment|Adverse Event|0|||
126270269|NCT00750308|454281807|FG001|Second Treatment|Adverse Event|0|||
126270270|NCT00750308|454281808|FG002|Second Treatment|Adverse Event|0|||
126270271|NCT00750308|454281809|FG003|Second Treatment|Adverse Event|0|||
126270272|NCT00750308|454281810|FG004|Second Treatment|Adverse Event|0|||
126270273|NCT00750308|454281811|FG005|Second Treatment|Adverse Event|1|||
126270274|NCT00750308|454281812|FG006|Second Treatment|Adverse Event|0|||
126270275|NCT00750308|454281813|FG007|Second Treatment|Adverse Event|0|||
126036826|NCT04032704|453433075|FG003|Part B|Other|0|||
126036827|NCT04032704|453433076|FG004|Part B|Other|0|||
126270276|NCT00750308|454281814|FG008|Second Treatment|Adverse Event|1|||
126270277|NCT00750308|454281815|FG009|Second Treatment|Adverse Event|0|||
126270278|NCT00750308|454281816|FG010|Second Treatment|Adverse Event|0|||
126270279|NCT00750308|454281817|FG011|Second Treatment|Adverse Event|0|||
126270280|NCT00750308|454281806|FG000|Second Treatment|Withdrawal by Subject|0|||
126270281|NCT00750308|454281807|FG001|Second Treatment|Withdrawal by Subject|0|||
126270282|NCT00750308|454281808|FG002|Second Treatment|Withdrawal by Subject|0|||
126270283|NCT00750308|454281809|FG003|Second Treatment|Withdrawal by Subject|0|||
126270284|NCT00750308|454281810|FG004|Second Treatment|Withdrawal by Subject|1|||
126270285|NCT00750308|454281811|FG005|Second Treatment|Withdrawal by Subject|0|||
126270286|NCT00750308|454281812|FG006|Second Treatment|Withdrawal by Subject|0|||
126098568|NCT01029652|453653042|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
126098569|NCT01029652|453653043|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
126270287|NCT00750308|454281813|FG007|Second Treatment|Withdrawal by Subject|0|||
126270288|NCT00750308|454281814|FG008|Second Treatment|Withdrawal by Subject|0|||
126270289|NCT00750308|454281815|FG009|Second Treatment|Withdrawal by Subject|0|||
126270290|NCT00750308|454281816|FG010|Second Treatment|Withdrawal by Subject|0|||
126270291|NCT00750308|454281817|FG011|Second Treatment|Withdrawal by Subject|0|||
126270292|NCT00750308|454281806|FG000|Third Treatment|Withdrawal by Subject|0|||
126270293|NCT00750308|454281807|FG001|Third Treatment|Withdrawal by Subject|1|||
126270294|NCT00750308|454281808|FG002|Third Treatment|Withdrawal by Subject|0|||
126270295|NCT00750308|454281809|FG003|Third Treatment|Withdrawal by Subject|0|||
126270296|NCT00750308|454281810|FG004|Third Treatment|Withdrawal by Subject|0|||
126270297|NCT00750308|454281811|FG005|Third Treatment|Withdrawal by Subject|0|||
126270298|NCT00750308|454281812|FG006|Third Treatment|Withdrawal by Subject|0|||
126270299|NCT00750308|454281813|FG007|Third Treatment|Withdrawal by Subject|0|||
126270300|NCT00750308|454281814|FG008|Third Treatment|Withdrawal by Subject|0|||
126270301|NCT00750308|454281815|FG009|Third Treatment|Withdrawal by Subject|0|||
126270302|NCT00750308|454281816|FG010|Third Treatment|Withdrawal by Subject|0|||
126270303|NCT00750308|454281817|FG011|Third Treatment|Withdrawal by Subject|0|||
126270304|NCT00513682|454281818|FG000|Washout Phase|Adverse Event|2|||
126270305|NCT03212521|454281823|FG000|Overall Study|Adverse Event|1|||
126270306|NCT03212521|454281823|FG000|Overall Study|Lost to Follow-up|4|||
126270307|NCT03212521|454281823|FG000|Overall Study|Withdrawal by Subject|1|||
126270308|NCT03212521|454281823|FG000|Overall Study|Other|1|||
126270309|NCT01121666|454281826|FG000|Overall Study|Protocol Violation|29|||
126270310|NCT01121666|454281827|FG001|Overall Study|Protocol Violation|10|||
126270311|NCT03176459|454281828|FG000|Overall Study|Lost to Follow-up|5|||
126270312|NCT03176459|454281829|FG001|Overall Study|Lost to Follow-up|7|||
126270313|NCT00541970|454284452|FG000|Month 7|Protocol Violation|9|||
126270314|NCT00541970|454284453|FG001|Month 7|Protocol Violation|13|||
126270315|NCT00541970|454284454|FG002|Month 7|Protocol Violation|11|||
126270316|NCT00541970|454284455|FG003|Month 7|Protocol Violation|5|||
126270317|NCT00541970|454284452|FG000|Month 12|Adverse Event|0|||
126270318|NCT00541970|454284453|FG001|Month 12|Adverse Event|1|||
126270319|NCT00541970|454284454|FG002|Month 12|Adverse Event|1|||
126270320|NCT00541970|454284455|FG003|Month 12|Adverse Event|1|||
126270321|NCT00541970|454284452|FG000|Month 12|Protocol Violation|12|||
126270322|NCT00541970|454284453|FG001|Month 12|Protocol Violation|21|||
126270323|NCT00541970|454284454|FG002|Month 12|Protocol Violation|20|||
126270324|NCT00541970|454284455|FG003|Month 12|Protocol Violation|15|||
126270325|NCT00541970|454284452|FG000|Month 18|Adverse Event|0|||
126270326|NCT00541970|454284453|FG001|Month 18|Adverse Event|1|||
126270327|NCT00541970|454284454|FG002|Month 18|Adverse Event|1|||
126270328|NCT00541970|454284455|FG003|Month 18|Adverse Event|1|||
126270329|NCT00541970|454284452|FG000|Month 18|Protocol Violation|14|||
126270330|NCT00541970|454284453|FG001|Month 18|Protocol Violation|23|||
126270331|NCT00541970|454284454|FG002|Month 18|Protocol Violation|24|||
126270332|NCT00541970|454284455|FG003|Month 18|Protocol Violation|16|||
126270333|NCT00541970|454284452|FG000|Month 24|Adverse Event|0|||
126270334|NCT00541970|454284453|FG001|Month 24|Adverse Event|1|||
126270335|NCT00541970|454284454|FG002|Month 24|Adverse Event|1|||
126270336|NCT00541970|454284455|FG003|Month 24|Adverse Event|1|||
126270337|NCT00541970|454284452|FG000|Month 24|Protocol Violation|29|||
126270338|NCT00541970|454284453|FG001|Month 24|Protocol Violation|31|||
126270339|NCT00541970|454284454|FG002|Month 24|Protocol Violation|31|||
126270340|NCT00541970|454284455|FG003|Month 24|Protocol Violation|21|||
126270341|NCT00541970|454284452|FG000|Month 36|Protocol Violation|61|||
126270342|NCT00541970|454284453|FG001|Month 36|Protocol Violation|66|||
126270343|NCT00541970|454284454|FG002|Month 36|Protocol Violation|66|||
126270344|NCT00541970|454284455|FG003|Month 36|Protocol Violation|60|||
126270345|NCT00541970|454284452|FG000|Month 48|Withdrawal by Subject|2|||
126270346|NCT00541970|454284453|FG001|Month 48|Withdrawal by Subject|4|||
126270347|NCT00541970|454284454|FG002|Month 48|Withdrawal by Subject|4|||
126270348|NCT00541970|454284455|FG003|Month 48|Withdrawal by Subject|2|||
126270349|NCT00541970|454284452|FG000|Month 48|Other|3|||
126270350|NCT00541970|454284453|FG001|Month 48|Other|1|||
126270351|NCT00541970|454284454|FG002|Month 48|Other|1|||
126270352|NCT00541970|454284455|FG003|Month 48|Other|0|||
126270353|NCT00541970|454284452|FG000|Month 48|Lost to Follow-up|66|||
126270354|NCT00541970|454284453|FG001|Month 48|Lost to Follow-up|68|||
126270355|NCT00541970|454284454|FG002|Month 48|Lost to Follow-up|68|||
126098570|NCT01029652|453653042|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
126270356|NCT00541970|454284455|FG003|Month 48|Lost to Follow-up|73|||
126270357|NCT00541970|454284452|FG000|Month 60|Protocol Violation|78|||
126270358|NCT00541970|454284453|FG001|Month 60|Protocol Violation|77|||
126270359|NCT00541970|454284454|FG002|Month 60|Protocol Violation|82|||
126270360|NCT00541970|454284455|FG003|Month 60|Protocol Violation|72|||
126270361|NCT00321828|454284456|FG000|Overall Study|Ineligible|3|||
126270362|NCT00321828|454284456|FG000|Overall Study|No follow up data|1|||
126270363|NCT00858143|454284461|FG000|Overall Study|Adverse Event|16|||
126270364|NCT00858143|454284461|FG000|Overall Study|Lack of Efficacy|4|||
126361409|NCT02134028|454615286|FG002|Overall Study|Other unspecified|33|||
126361410|NCT02134028|454615287|FG003|Overall Study|Other unspecified|64|||
126361411|NCT02134028|454615288|FG004|Overall Study|Other unspecified|8|||
126361412|NCT02134028|454615289|FG005|Overall Study|Other unspecified|6|||
126361413|NCT02134028|454615290|FG006|Overall Study|Other unspecified|2|||
126361414|NCT02134028|454615291|FG007|Overall Study|Other unspecified|1|||
126361415|NCT02134028|454615284|FG000|Overall Study|Adverse Event|3|||
126361416|NCT02134028|454615285|FG001|Overall Study|Adverse Event|19|||
126361417|NCT02134028|454615286|FG002|Overall Study|Adverse Event|13|||
126361418|NCT02134028|454615287|FG003|Overall Study|Adverse Event|32|||
126361419|NCT02134028|454615288|FG004|Overall Study|Adverse Event|4|||
126361420|NCT02134028|454615289|FG005|Overall Study|Adverse Event|5|||
126361421|NCT02134028|454615290|FG006|Overall Study|Adverse Event|1|||
126361422|NCT02134028|454615291|FG007|Overall Study|Adverse Event|2|||
126361423|NCT00819832|454615292|FG000|Overall Study|Sponsor Termination of Study|3|||
126361424|NCT00819832|454615293|FG001|Overall Study|Sponsor Termination of Study|0|||
126270365|NCT00858143|454284461|FG000|Overall Study|Death|7|||
126270366|NCT00858143|454284461|FG000|Overall Study|Other|23|||
126270367|NCT03853148|454284462|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
126270368|NCT03853148|454284463|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
126270369|NCT03853148|454284464|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
126270370|NCT03853148|454284465|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
126270371|NCT00852969|454284466|FG000|Overall Study|Adverse Event|0|||
126270372|NCT00852969|454284467|FG001|Overall Study|Adverse Event|1|||
126270373|NCT00852969|454284466|FG000|Overall Study|Lost to Follow-up|0|||
126270374|NCT00852969|454284467|FG001|Overall Study|Lost to Follow-up|1|||
126270375|NCT00658658|454284468|FG000|Overall Study|Withdrawal by Subject|0|||
126270376|NCT00658658|454284469|FG001|Overall Study|Withdrawal by Subject|1|||
126270377|NCT00658658|454284470|FG002|Overall Study|Withdrawal by Subject|0|||
126270378|NCT00658658|454284471|FG003|Overall Study|Withdrawal by Subject|0|||
126270379|NCT00658658|454284472|FG004|Overall Study|Withdrawal by Subject|0|||
126270380|NCT00658658|454284468|FG000|Overall Study|Death|4|||
126270381|NCT00658658|454284469|FG001|Overall Study|Death|0|||
126270382|NCT00658658|454284470|FG002|Overall Study|Death|0|||
126270383|NCT00658658|454284471|FG003|Overall Study|Death|1|||
126270384|NCT00658658|454284472|FG004|Overall Study|Death|1|||
126270385|NCT00658658|454284468|FG000|Overall Study|Disease Progression|0|||
126270386|NCT00658658|454284469|FG001|Overall Study|Disease Progression|1|||
126270387|NCT00658658|454284470|FG002|Overall Study|Disease Progression|0|||
126270388|NCT00658658|454284471|FG003|Overall Study|Disease Progression|1|||
126270389|NCT00658658|454284472|FG004|Overall Study|Disease Progression|3|||
126270390|NCT00658658|454284468|FG000|Overall Study|Protocol-specified Criteria|1|||
126270391|NCT00658658|454284469|FG001|Overall Study|Protocol-specified Criteria|0|||
126270392|NCT00658658|454284470|FG002|Overall Study|Protocol-specified Criteria|0|||
126270393|NCT00658658|454284471|FG003|Overall Study|Protocol-specified Criteria|0|||
126270394|NCT00658658|454284472|FG004|Overall Study|Protocol-specified Criteria|0|||
126270395|NCT00658658|454284468|FG000|Overall Study|Other|0|||
126270396|NCT00658658|454284469|FG001|Overall Study|Other|0|||
126270397|NCT00658658|454284470|FG002|Overall Study|Other|0|||
126270398|NCT00658658|454284471|FG003|Overall Study|Other|0|||
126270399|NCT00658658|454284472|FG004|Overall Study|Other|1|||
126270400|NCT00678041|454284475|FG000|Overall Study|Physician Decision|5|||
126270401|NCT00678041|454284476|FG001|Overall Study|Physician Decision|5|||
126270402|NCT02358343|454284477|FG000|Screening Intervention|Death|0|||
126270403|NCT02358343|454284478|FG001|Screening Intervention|Death|2|||
126270404|NCT02358343|454284479|FG002|Screening Intervention|Death|0|||
126270405|NCT02358343|454284480|FG003|Screening Intervention|Death|0|||
126361425|NCT00819832|454615294|FG002|Overall Study|Sponsor Termination of Study|0|||
126270406|NCT02358343|454284481|FG004|Screening Intervention|Death|0|||
126361426|NCT00819832|454615295|FG003|Overall Study|Sponsor Termination of Study|0|||
126361427|NCT00819832|454615296|FG004|Overall Study|Sponsor Termination of Study|0|||
126270407|NCT02358343|454284477|FG000|Screening Intervention|Withdrawal by Subject|1|||
126270408|NCT02358343|454284478|FG001|Screening Intervention|Withdrawal by Subject|0|||
126270409|NCT02358343|454284479|FG002|Screening Intervention|Withdrawal by Subject|0|||
126270410|NCT02358343|454284480|FG003|Screening Intervention|Withdrawal by Subject|0|||
126270411|NCT02358343|454284481|FG004|Screening Intervention|Withdrawal by Subject|0|||
126270412|NCT02358343|454284477|FG000|Screening Intervention|Determined Ineligible|5|||
126361428|NCT00819832|454615297|FG005|Overall Study|Sponsor Termination of Study|0|||
126361429|NCT01340170|454615303|FG000|Overall Study|Lost to Follow-up|2|||
126270413|NCT02358343|454284478|FG001|Screening Intervention|Determined Ineligible|6|||
126270414|NCT02358343|454284479|FG002|Screening Intervention|Determined Ineligible|0|||
126270415|NCT02358343|454284480|FG003|Screening Intervention|Determined Ineligible|0|||
126270416|NCT02358343|454284481|FG004|Screening Intervention|Determined Ineligible|0|||
126270417|NCT02358343|454284477|FG000|Comparative Efficacy Trial / Observation|Death|0|||
126270418|NCT02358343|454284478|FG001|Comparative Efficacy Trial / Observation|Death|0|||
126270419|NCT02358343|454284479|FG002|Comparative Efficacy Trial / Observation|Death|2|||
126270420|NCT02358343|454284480|FG003|Comparative Efficacy Trial / Observation|Death|0|||
126270421|NCT02358343|454284481|FG004|Comparative Efficacy Trial / Observation|Death|0|||
126270422|NCT02358343|454284477|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
126270423|NCT02358343|454284478|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
126270424|NCT02358343|454284479|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
126270425|NCT02358343|454284480|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
126270426|NCT02358343|454284481|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
126270427|NCT02358343|454284477|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
126270428|NCT02358343|454284478|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
126270429|NCT02358343|454284479|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
126270430|NCT02358343|454284480|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
126270431|NCT02358343|454284481|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
126270432|NCT00090610|454284484|FG000|Overall Study|Withdrawal by Subject|1|||
126270433|NCT00090610|454284485|FG001|Overall Study|Withdrawal by Subject|1|||
126270434|NCT04498403|454284489|FG000|Overall Study|Adverse Event|1|||
126270435|NCT04498403|454284490|FG001|Overall Study|Adverse Event|0|||
126270436|NCT04498403|454284489|FG000|Overall Study|Study Terminated By Sponsor|29|||
126270437|NCT04498403|454284490|FG001|Overall Study|Study Terminated By Sponsor|10|||
126270438|NCT01951885|454284491|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
126270439|NCT01951885|454284492|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
126270440|NCT01951885|454284491|FG000|Overall Study|Adverse Event|1|||
126270441|NCT01951885|454284492|FG001|Overall Study|Adverse Event|0|||
126270442|NCT01951885|454284491|FG000|Overall Study|Withdrawal by Subject|0|||
126270443|NCT01951885|454284492|FG001|Overall Study|Withdrawal by Subject|1|||
126270444|NCT01951885|454284491|FG000|Overall Study|ineligible due to a change in donor|0|||
126270445|NCT01951885|454284492|FG001|Overall Study|ineligible due to a change in donor|1|||
126270446|NCT01951885|454284491|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
126270447|NCT01951885|454284492|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
126270448|NCT01293539|454284493|FG000|Overall Study|Physician Decision|1|||
126270449|NCT00866658|454284494|FG000|Overall Study|Adverse Event|5|||
126270450|NCT00866658|454284495|FG001|Overall Study|Adverse Event|14|||
126270451|NCT00866658|454284494|FG000|Overall Study|Lack of Efficacy|2|||
126270452|NCT00866658|454284495|FG001|Overall Study|Lack of Efficacy|1|||
126270453|NCT00866658|454284494|FG000|Overall Study|Withdrawal by Subject|1|||
126270454|NCT00866658|454284495|FG001|Overall Study|Withdrawal by Subject|0|||
126270455|NCT00866658|454284494|FG000|Overall Study|Protocol Violation|1|||
126270456|NCT00866658|454284495|FG001|Overall Study|Protocol Violation|1|||
126270457|NCT00866658|454284494|FG000|Overall Study|Familial and Personal Reasons|4|||
126270458|NCT00866658|454284495|FG001|Overall Study|Familial and Personal Reasons|5|||
126270459|NCT01687478|454284498|FG000|Overall Study|Adverse Event|3|||
126270460|NCT01687478|454284499|FG001|Overall Study|Adverse Event|10|||
126270461|NCT01687478|454284498|FG000|Overall Study|Lost to Follow-up|1|||
126270462|NCT01687478|454284499|FG001|Overall Study|Lost to Follow-up|3|||
126270463|NCT01687478|454284498|FG000|Overall Study|Protocol Violation|0|||
126270464|NCT01687478|454284499|FG001|Overall Study|Protocol Violation|2|||
126270465|NCT01687478|454284498|FG000|Overall Study|Withdrawal by Subject|21|||
126270466|NCT01687478|454284499|FG001|Overall Study|Withdrawal by Subject|19|||
126270467|NCT01687478|454284498|FG000|Overall Study|Physician Decision|1|||
126270468|NCT01687478|454284499|FG001|Overall Study|Physician Decision|3|||
126270469|NCT01687478|454284498|FG000|Overall Study|Entry Criteria Not Met|6|||
126270470|NCT01687478|454284499|FG001|Overall Study|Entry Criteria Not Met|2|||
126270471|NCT01700049|454284502|FG000|Overall Study|Withdrawal by Subject|1|||
126361430|NCT01340170|454615304|FG001|Overall Study|Lost to Follow-up|4|||
126270472|NCT01206101|454284503|FG000|Overall Study|Adverse Event|1|||
126270473|NCT01206101|454284504|FG001|Overall Study|Adverse Event|0|||
126270474|NCT01206101|454284503|FG000|Overall Study|Physician Decision|0|||
126270475|NCT01206101|454284504|FG001|Overall Study|Physician Decision|1|||
126270476|NCT01206101|454284503|FG000|Overall Study|Unclassified|1|||
126270477|NCT01206101|454284504|FG001|Overall Study|Unclassified|0|||
126270478|NCT01248013|454284505|FG000|Overall Study|Withdrawal by Subject|14|||
126270479|NCT01859130|454284506|FG000|Overall Study|Death|4|||
126270480|NCT01859130|454284506|FG000|Overall Study|Lost to Follow-up|16|||
126270481|NCT01859130|454284506|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
126270482|NCT01859130|454284506|FG000|Overall Study|Physician Decision|6|||
126270483|NCT01859130|454284506|FG000|Overall Study|Withdrawal by Subject|17|||
126361431|NCT01340170|454615305|FG002|Overall Study|Lost to Follow-up|0|||
126270484|NCT01859130|454284506|FG000|Overall Study|Adverse Event|11|||
126270485|NCT01462318|454284509|FG000|Main Study / TP-DI Study|Other|2|||
126270486|NCT01462318|454284510|FG001|Main Study / TP-DI Study|Other|0|||
126270487|NCT01462318|454284511|FG002|Main Study / TP-DI Study|Other|0|||
126270488|NCT01462318|454284509|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
126270489|NCT01462318|454284510|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
126270490|NCT01462318|454284511|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
126270491|NCT01462318|454284509|FG000|Main Study / TP-DI Study|Adverse Event|4|||
126270492|NCT01462318|454284510|FG001|Main Study / TP-DI Study|Adverse Event|0|||
126270493|NCT01462318|454284511|FG002|Main Study / TP-DI Study|Adverse Event|0|||
126270494|NCT01462318|454284509|FG000|Extension Phase|Lost to Follow-up|0|||
126270495|NCT01462318|454284510|FG001|Extension Phase|Lost to Follow-up|0|||
126270496|NCT01462318|454284511|FG002|Extension Phase|Lost to Follow-up|1|||
126270497|NCT01462318|454284509|FG000|Extension Phase|Other|0|||
126270498|NCT01462318|454284510|FG001|Extension Phase|Other|0|||
126270499|NCT01462318|454284511|FG002|Extension Phase|Other|1|||
126270500|NCT01462318|454284509|FG000|Extension Phase|Disease Progression|0|||
126270501|NCT01462318|454284510|FG001|Extension Phase|Disease Progression|0|||
126270502|NCT01462318|454284511|FG002|Extension Phase|Disease Progression|1|||
126270503|NCT01462318|454284509|FG000|Extension Phase|Withdrawal by Subject|0|||
126270504|NCT01462318|454284510|FG001|Extension Phase|Withdrawal by Subject|0|||
126270505|NCT01462318|454284511|FG002|Extension Phase|Withdrawal by Subject|15|||
126270506|NCT01462318|454284509|FG000|Extension Phase|Investigator Decision|0|||
126270507|NCT01462318|454284510|FG001|Extension Phase|Investigator Decision|0|||
126270508|NCT01462318|454284511|FG002|Extension Phase|Investigator Decision|5|||
126270509|NCT01462318|454284509|FG000|Extension Phase|Adverse Event|0|||
126270510|NCT01462318|454284510|FG001|Extension Phase|Adverse Event|0|||
126270511|NCT01462318|454284511|FG002|Extension Phase|Adverse Event|22|||
126270512|NCT00891371|454284512|FG000|Pre-assignment|Inclusion/exclusion|5|||
126270513|NCT00891371|454284512|FG000|Pre-assignment|Consent withdrawal|1|||
126270514|NCT00891371|454284512|FG000|Treatment|Lack of Efficacy|5|||
126270515|NCT00891371|454284512|FG000|Treatment|Adverse Event|2|||
126270516|NCT00891371|454284512|FG000|Treatment|Death|1|||
126270517|NCT00891371|454284512|FG000|Treatment|Lost to Follow-up|1|||
126270518|NCT02238626|454284513|FG000|Overall Study|Adverse Event|3|||
126270519|NCT02238626|454284514|FG001|Overall Study|Adverse Event|5|||
126270520|NCT02238626|454284515|FG002|Overall Study|Adverse Event|0|||
126270521|NCT02238626|454284516|FG003|Overall Study|Adverse Event|3|||
126270522|NCT02238626|454284513|FG000|Overall Study|Lost to Follow-up|2|||
126270523|NCT02238626|454284514|FG001|Overall Study|Lost to Follow-up|4|||
126270524|NCT02238626|454284515|FG002|Overall Study|Lost to Follow-up|2|||
126270525|NCT02238626|454284516|FG003|Overall Study|Lost to Follow-up|2|||
126270526|NCT02238626|454284513|FG000|Overall Study|Withdrawal by Subject|0|||
126270527|NCT02238626|454284514|FG001|Overall Study|Withdrawal by Subject|3|||
126270528|NCT02238626|454284515|FG002|Overall Study|Withdrawal by Subject|0|||
126270529|NCT02238626|454284516|FG003|Overall Study|Withdrawal by Subject|1|||
126270530|NCT02238626|454284513|FG000|Overall Study|Death|0|||
126270531|NCT02238626|454284514|FG001|Overall Study|Death|0|||
126270532|NCT02238626|454284515|FG002|Overall Study|Death|1|||
126270533|NCT02238626|454284516|FG003|Overall Study|Death|1|||
126270534|NCT02238626|454284513|FG000|Overall Study|Other|0|||
126270535|NCT02238626|454284514|FG001|Overall Study|Other|2|||
126270536|NCT02238626|454284515|FG002|Overall Study|Other|0|||
126270537|NCT02238626|454284516|FG003|Overall Study|Other|0|||
126270538|NCT02622113|454284519|FG000|Overall Study|Adverse Event|4|||
126270539|NCT02622113|454284520|FG001|Overall Study|Adverse Event|4|||
126270540|NCT02622113|454284519|FG000|Overall Study|Physician Decision|0|||
126270541|NCT02622113|454284520|FG001|Overall Study|Physician Decision|1|||
126270542|NCT02622113|454284519|FG000|Overall Study|Withdrawal by Subject|0|||
126270543|NCT02622113|454284520|FG001|Overall Study|Withdrawal by Subject|2|||
126270544|NCT02622113|454284519|FG000|Overall Study|Stopping Criteria|1|||
126270545|NCT02622113|454284520|FG001|Overall Study|Stopping Criteria|3|||
126270546|NCT02746471|454284521|FG000|Overall Study|Death|43|||
126270547|NCT02746471|454284521|FG000|Overall Study|Exited before 36 months|1119|||
126270548|NCT01593696|454284522|FG000|Dose Escalation|Progressive Disease|2|||
126270549|NCT01593696|454284523|FG001|Dose Escalation|Progressive Disease|0|||
126270550|NCT01593696|454284524|FG002|Dose Escalation|Progressive Disease|0|||
126270551|NCT01593696|454284525|FG003|Dose Escalation|Progressive Disease|0|||
126270552|NCT01593696|454284522|FG000|Dose Expansion|Fungal infection|0|||
126270553|NCT01593696|454284523|FG001|Dose Expansion|Fungal infection|0|||
126270554|NCT01593696|454284524|FG002|Dose Expansion|Fungal infection|1|||
126270555|NCT01593696|454284525|FG003|Dose Expansion|Fungal infection|0|||
126270556|NCT01936623|454284526|FG000|Overall Study|Lost to Follow-up|0|||
126270557|NCT01936623|454284527|FG001|Overall Study|Lost to Follow-up|5|||
126270558|NCT03167723|454284528|FG000|Overall Study|Protocol Violation|4|||
126270559|NCT03167723|454284529|FG001|Overall Study|Protocol Violation|6|||
126270560|NCT02992418|454284532|FG000|Overall Study|Withdrawal by Subject|11|||
126270561|NCT02992418|454284533|FG001|Overall Study|Withdrawal by Subject|12|||
126270562|NCT02992418|454284532|FG000|Overall Study|Non-compliance with the protocol|308|||
126270563|NCT02992418|454284533|FG001|Overall Study|Non-compliance with the protocol|308|||
126270564|NCT02992418|454284532|FG000|Overall Study|Lost to Follow-up|27|||
126270565|NCT02992418|454284533|FG001|Overall Study|Lost to Follow-up|22|||
126270566|NCT03246126|454284538|FG000|Overall Study|Withdrawal by Subject|0|||
126270567|NCT03246126|454284539|FG001|Overall Study|Withdrawal by Subject|1|||
126270568|NCT01006135|454284542|FG000|Overall Study|Adverse Event|22|||
126270569|NCT01006135|454284542|FG000|Overall Study|Protocol Violation|14|||
126270570|NCT01006135|454284542|FG000|Overall Study|Lost to Follow-up|32|||
126270571|NCT01006135|454284542|FG000|Overall Study|Other|72|||
126270572|NCT01732484|454284548|FG000|Overall Study|Death|7|||
126270573|NCT01732484|454284548|FG000|Overall Study|Lost to Follow-up|14|||
126270574|NCT01732484|454284548|FG000|Overall Study|chronical illness|5|||
126270575|NCT00928707|454284549|FG000|Overall Study|Protocol Violation|1|||
126270576|NCT00928707|454284550|FG001|Overall Study|Protocol Violation|0|||
126270577|NCT00132028|454284551|FG000|Overall Study|Adverse Event|7|||
126270578|NCT00132028|454284551|FG000|Overall Study|Death|2|||
126270579|NCT00132028|454284551|FG000|Overall Study|Lack of Efficacy|11|||
126270580|NCT00132028|454284551|FG000|Overall Study|Withdrawal by Subject|2|||
126270581|NCT00132028|454284551|FG000|Overall Study|not eligible|2|||
126270582|NCT00132028|454284551|FG000|Overall Study|Physician Decision|3|||
126270583|NCT02731326|454284557|FG000|Overall Study|Withdrawal by Subject|4|||
126270584|NCT02731326|454284558|FG001|Overall Study|Withdrawal by Subject|1|||
126270585|NCT02731326|454284557|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
126270586|NCT02731326|454284558|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
126270587|NCT02731326|454284557|FG000|Overall Study|Discharged without AliveCor|10|||
126270588|NCT02731326|454284558|FG001|Overall Study|Discharged without AliveCor|0|||
126270589|NCT02731326|454284557|FG000|Overall Study|Duplicate Participant|1|||
126270590|NCT02731326|454284558|FG001|Overall Study|Duplicate Participant|1|||
126270591|NCT02272634|454284560|FG000|Overall Study|Adverse Event|1|||
126270592|NCT02272634|454284561|FG001|Overall Study|Adverse Event|0|||
126270593|NCT02272634|454284562|FG002|Overall Study|Adverse Event|0|||
126270594|NCT02272634|454284560|FG000|Overall Study|Protocol Violation|0|||
126270595|NCT02272634|454284561|FG001|Overall Study|Protocol Violation|0|||
126270596|NCT02272634|454284562|FG002|Overall Study|Protocol Violation|1|||
126270597|NCT02272634|454284560|FG000|Overall Study|Withdrawal by Subject|0|||
126270598|NCT02272634|454284561|FG001|Overall Study|Withdrawal by Subject|1|||
126270599|NCT02272634|454284562|FG002|Overall Study|Withdrawal by Subject|0|||
126270600|NCT04647721|454284563|FG000|Overall Study|Withdrawal by Subject|0|||
126270601|NCT04647721|454284564|FG001|Overall Study|Withdrawal by Subject|2|||
126270602|NCT04647721|454284563|FG000|Overall Study|Lost to Follow-up|2|||
126270603|NCT04647721|454284564|FG001|Overall Study|Lost to Follow-up|0|||
126270604|NCT05070546|454284565|FG000|Overall Study|Death|0|||
126270605|NCT05070546|454284566|FG001|Overall Study|Death|0|||
126270606|NCT05070546|454284567|FG002|Overall Study|Death|0|||
126270607|NCT05070546|454284568|FG003|Overall Study|Death|0|||
126270608|NCT05070546|454284569|FG004|Overall Study|Death|0|||
126270609|NCT05070546|454284570|FG005|Overall Study|Death|1|||
126270610|NCT05070546|454284565|FG000|Overall Study|Lost to Follow-up|8|||
126270611|NCT05070546|454284566|FG001|Overall Study|Lost to Follow-up|2|||
126270612|NCT05070546|454284567|FG002|Overall Study|Lost to Follow-up|7|||
126270613|NCT05070546|454284568|FG003|Overall Study|Lost to Follow-up|1|||
126270614|NCT05070546|454284569|FG004|Overall Study|Lost to Follow-up|2|||
126270615|NCT05070546|454284570|FG005|Overall Study|Lost to Follow-up|0|||
126270616|NCT05070546|454284565|FG000|Overall Study|Withdrawal by Subject|1|||
126270617|NCT05070546|454284566|FG001|Overall Study|Withdrawal by Subject|1|||
126270618|NCT05070546|454284567|FG002|Overall Study|Withdrawal by Subject|3|||
126270619|NCT05070546|454284568|FG003|Overall Study|Withdrawal by Subject|0|||
126270620|NCT05070546|454284569|FG004|Overall Study|Withdrawal by Subject|0|||
126270621|NCT05070546|454284570|FG005|Overall Study|Withdrawal by Subject|0|||
126270622|NCT05070546|454284565|FG000|Overall Study|Other|0|||
126270623|NCT05070546|454284566|FG001|Overall Study|Other|0|||
126036828|NCT04032704|453433077|FG005|Part B|Other|0|||
126036829|NCT04032704|453433078|FG006|Part B|Other|0|||
126270624|NCT05070546|454284567|FG002|Overall Study|Other|0|||
126270625|NCT05070546|454284568|FG003|Overall Study|Other|0|||
126270626|NCT05070546|454284569|FG004|Overall Study|Other|3|||
126270627|NCT05070546|454284570|FG005|Overall Study|Other|0|||
126270628|NCT05070546|454284565|FG000|Overall Study|Randomized but not vaccinated|1|||
126270629|NCT05070546|454284566|FG001|Overall Study|Randomized but not vaccinated|0|||
126270630|NCT05070546|454284567|FG002|Overall Study|Randomized but not vaccinated|1|||
126270631|NCT05070546|454284568|FG003|Overall Study|Randomized but not vaccinated|1|||
126270632|NCT05070546|454284569|FG004|Overall Study|Randomized but not vaccinated|3|||
126270633|NCT05070546|454284570|FG005|Overall Study|Randomized but not vaccinated|0|||
126270634|NCT00302081|454284571|FG000|Overall Study|Adverse Event|6|||
126270635|NCT00302081|454284572|FG001|Overall Study|Adverse Event|5|||
126270636|NCT00302081|454284573|FG002|Overall Study|Adverse Event|4|||
126270637|NCT00302081|454284571|FG000|Overall Study|Lost to Follow-up|21|||
126270638|NCT00302081|454284572|FG001|Overall Study|Lost to Follow-up|18|||
126036830|NCT04032704|453433079|FG007|Part B|Other|1|||
126270639|NCT00302081|454284573|FG002|Overall Study|Lost to Follow-up|28|||
126270640|NCT00302081|454284571|FG000|Overall Study|Withdrawal by Subject|8|||
125880772|NCT04225897|452862635|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126270641|NCT00302081|454284572|FG001|Overall Study|Withdrawal by Subject|12|||
126270642|NCT00302081|454284573|FG002|Overall Study|Withdrawal by Subject|8|||
126270643|NCT00302081|454284571|FG000|Overall Study|Protocol Violation|5|||
126270644|NCT00302081|454284572|FG001|Overall Study|Protocol Violation|1|||
126270645|NCT00302081|454284573|FG002|Overall Study|Protocol Violation|2|||
126270646|NCT00302081|454284571|FG000|Overall Study|Lack of Efficacy|1|||
126270647|NCT00302081|454284572|FG001|Overall Study|Lack of Efficacy|0|||
126270648|NCT00302081|454284573|FG002|Overall Study|Lack of Efficacy|5|||
126270649|NCT00302081|454284571|FG000|Overall Study|Death|2|||
126270650|NCT00302081|454284572|FG001|Overall Study|Death|1|||
126270651|NCT00302081|454284573|FG002|Overall Study|Death|0|||
126270652|NCT00302081|454284571|FG000|Overall Study|Other|13|||
126270653|NCT00302081|454284572|FG001|Overall Study|Other|6|||
126270654|NCT00302081|454284573|FG002|Overall Study|Other|5|||
126270655|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
126270656|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
126270657|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
126270658|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
126270659|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
126270660|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
126270661|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
126270662|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
126270663|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
126270664|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
126270665|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
126270666|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
126270667|NCT04771403|454284574|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
126270668|NCT04771403|454284575|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
126270669|NCT04771403|454284574|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
126270670|NCT04771403|454284575|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
126270671|NCT05084963|454284576|FG000|Overall Study|Withdrawal by Subject|0|||
126270672|NCT05084963|454284577|FG001|Overall Study|Withdrawal by Subject|0|||
126270673|NCT05084963|454284578|FG002|Overall Study|Withdrawal by Subject|1|||
126270674|NCT05442866|454284579|FG000|Overall Study|Death|1|||
126270675|NCT05442866|454284579|FG000|Overall Study|Lost to Follow-up|9|||
126270676|NCT05442866|454284579|FG000|Overall Study|Protocol Violation|1|||
126270677|NCT03819049|454284580|FG000|Overall Study|Lost to Follow-up|1|||
126270678|NCT03819049|454284581|FG001|Overall Study|Lost to Follow-up|2|||
126270679|NCT03819049|454284582|FG002|Overall Study|Lost to Follow-up|9|||
126270680|NCT03819049|454284583|FG003|Overall Study|Lost to Follow-up|0|||
126270681|NCT03819049|454284584|FG004|Overall Study|Lost to Follow-up|3|||
126270682|NCT03819049|454284585|FG005|Overall Study|Lost to Follow-up|1|||
126270683|NCT03819049|454284586|FG006|Overall Study|Lost to Follow-up|0|||
126270684|NCT03819049|454284580|FG000|Overall Study|Withdrawal by Subject|0|||
126270685|NCT03819049|454284581|FG001|Overall Study|Withdrawal by Subject|0|||
126270686|NCT03819049|454284582|FG002|Overall Study|Withdrawal by Subject|18|||
126270687|NCT03819049|454284583|FG003|Overall Study|Withdrawal by Subject|0|||
126270688|NCT03819049|454284584|FG004|Overall Study|Withdrawal by Subject|10|||
126270689|NCT03819049|454284585|FG005|Overall Study|Withdrawal by Subject|9|||
126270690|NCT03819049|454284586|FG006|Overall Study|Withdrawal by Subject|1|||
126270691|NCT03819049|454284580|FG000|Overall Study|Ongoing|0|||
126270692|NCT03819049|454284581|FG001|Overall Study|Ongoing|0|||
126270693|NCT03819049|454284582|FG002|Overall Study|Ongoing|75|||
126270694|NCT03819049|454284583|FG003|Overall Study|Ongoing|0|||
126270695|NCT03819049|454284584|FG004|Overall Study|Ongoing|41|||
126270696|NCT03819049|454284585|FG005|Overall Study|Ongoing|0|||
126270697|NCT03819049|454284586|FG006|Overall Study|Ongoing|0|||
126270698|NCT03819049|454284580|FG000|Overall Study|Other|0|||
126270699|NCT03819049|454284581|FG001|Overall Study|Other|0|||
125880773|NCT04225897|452862624|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125880774|NCT04225897|452862625|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125880775|NCT04225897|452862626|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
126270700|NCT03819049|454284582|FG002|Overall Study|Other|2|||
126270701|NCT03819049|454284583|FG003|Overall Study|Other|0|||
126270702|NCT03819049|454284584|FG004|Overall Study|Other|0|||
126270703|NCT03819049|454284585|FG005|Overall Study|Other|0|||
126361432|NCT01340170|454615303|FG000|Overall Study|Implant failure|1|||
126361433|NCT01340170|454615304|FG001|Overall Study|Implant failure|3|||
126361434|NCT01340170|454615305|FG002|Overall Study|Implant failure|0|||
126361435|NCT00472641|454615307|FG000|Overall Study|Lack of Efficacy|3|||
126361436|NCT00472641|454615307|FG000|Overall Study|Adverse Event|3|||
126361437|NCT00472641|454615307|FG000|Overall Study|Lost to Follow-up|1|||
126361438|NCT03721107|454615308|FG000|Overall Study|Adverse Event|1|||
126361439|NCT03721107|454615309|FG001|Overall Study|Adverse Event|1|||
126361440|NCT03721107|454615310|FG002|Overall Study|Adverse Event|6|||
126361441|NCT03721107|454615311|FG003|Overall Study|Adverse Event|5|||
126361442|NCT03721107|454615308|FG000|Overall Study|Lost to Follow-up|2|||
126361443|NCT03721107|454615309|FG001|Overall Study|Lost to Follow-up|0|||
126361444|NCT03721107|454615310|FG002|Overall Study|Lost to Follow-up|3|||
126361445|NCT03721107|454615311|FG003|Overall Study|Lost to Follow-up|0|||
126361446|NCT03721107|454615308|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
126361447|NCT03721107|454615309|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
126361448|NCT03721107|454615310|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
126361449|NCT03721107|454615311|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
126361450|NCT03721107|454615308|FG000|Overall Study|Physician Decision|0|||
126361451|NCT03721107|454615309|FG001|Overall Study|Physician Decision|1|||
126361452|NCT03721107|454615310|FG002|Overall Study|Physician Decision|0|||
126361453|NCT03721107|454615311|FG003|Overall Study|Physician Decision|0|||
126361454|NCT03721107|454615308|FG000|Overall Study|Pregnancy|0|||
126361455|NCT03721107|454615309|FG001|Overall Study|Pregnancy|0|||
126361456|NCT03721107|454615310|FG002|Overall Study|Pregnancy|1|||
126361457|NCT03721107|454615311|FG003|Overall Study|Pregnancy|0|||
126361458|NCT03721107|454615308|FG000|Overall Study|Withdrawal by Subject|1|||
126361459|NCT03721107|454615309|FG001|Overall Study|Withdrawal by Subject|1|||
126361460|NCT03721107|454615310|FG002|Overall Study|Withdrawal by Subject|5|||
126361461|NCT03721107|454615311|FG003|Overall Study|Withdrawal by Subject|5|||
126361462|NCT03721107|454615308|FG000|Overall Study|Other|1|||
126361463|NCT03721107|454615309|FG001|Overall Study|Other|0|||
126361464|NCT03721107|454615310|FG002|Overall Study|Other|0|||
126361465|NCT03721107|454615311|FG003|Overall Study|Other|1|||
126361466|NCT01189227|454615312|FG000|Overall Study|Study terminated due to low accrual|6|||
126361467|NCT01189227|454615313|FG001|Overall Study|Study terminated due to low accrual|3|||
126361468|NCT01608308|454615319|FG000|Overall Study|pretreatment medical and billing reasons|0|||
126361469|NCT01608308|454615320|FG001|Overall Study|pretreatment medical and billing reasons|2|||
126361470|NCT04648241|454615323|FG000|Overall Study|Lost to Follow-up|1|||
126361471|NCT04648241|454615324|FG001|Overall Study|Lost to Follow-up|0|||
126361472|NCT05259722|454615325|FG000|Overall Study|Adverse Event|2|||
126361473|NCT05259722|454615326|FG001|Overall Study|Adverse Event|24|||
126361474|NCT05259722|454615325|FG000|Overall Study|Lost to Follow-up|5|||
126361475|NCT05259722|454615326|FG001|Overall Study|Lost to Follow-up|1|||
126361476|NCT05259722|454615325|FG000|Overall Study|Lack of Efficacy|8|||
126361477|NCT05259722|454615326|FG001|Overall Study|Lack of Efficacy|26|||
126361478|NCT05259722|454615325|FG000|Overall Study|Withdrawal by Subject|15|||
126361479|NCT05259722|454615326|FG001|Overall Study|Withdrawal by Subject|33|||
126361480|NCT05259722|454615325|FG000|Overall Study|Various reasons|3|||
126361481|NCT05259722|454615326|FG001|Overall Study|Various reasons|9|||
126361482|NCT05259722|454615325|FG000|Overall Study|Not exposed to IMP|1|||
126036831|NCT04032704|453433080|FG008|Part B|Other|2|||
126036832|NCT04032704|453433081|FG009|Part B|Other|1|||
126036833|NCT04032704|453433082|FG010|Part B|Other|1|||
126036834|NCT04032704|453433083|FG011|Part B|Other|1|||
126036835|NCT04032704|453433084|FG012|Part B|Other|5|||
126270704|NCT03819049|454284586|FG006|Overall Study|Other|0|||
126270705|NCT03819049|454284580|FG000|Overall Study|Randomized but not vaccinated|0|||
126270706|NCT03819049|454284581|FG001|Overall Study|Randomized but not vaccinated|0|||
126270707|NCT03819049|454284582|FG002|Overall Study|Randomized but not vaccinated|0|||
126270708|NCT03819049|454284583|FG003|Overall Study|Randomized but not vaccinated|1|||
126270709|NCT03819049|454284584|FG004|Overall Study|Randomized but not vaccinated|0|||
126270710|NCT03819049|454284585|FG005|Overall Study|Randomized but not vaccinated|2|||
126270711|NCT03819049|454284586|FG006|Overall Study|Randomized but not vaccinated|1|||
126361483|NCT05259722|454615326|FG001|Overall Study|Not exposed to IMP|12|||
126361484|NCT05259722|454615325|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
126361485|NCT05259722|454615326|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
126361486|NCT00962650|454615327|FG000|Overall Study|Transgastric DP was not completed|2|||
126361487|NCT02268851|454615329|FG000|Overall Study|Death|0|||
126361488|NCT02268851|454615330|FG001|Overall Study|Death|0|||
126361489|NCT02268851|454615331|FG002|Overall Study|Death|0|||
126361490|NCT02268851|454615332|FG003|Overall Study|Death|1|||
126361491|NCT02268851|454615333|FG004|Overall Study|Death|2|||
126361492|NCT02268851|454615334|FG005|Overall Study|Death|1|||
126361493|NCT02268851|454615329|FG000|Overall Study|Adverse Event|0|||
126361494|NCT02268851|454615330|FG001|Overall Study|Adverse Event|0|||
126361495|NCT02268851|454615331|FG002|Overall Study|Adverse Event|0|||
126361496|NCT02268851|454615332|FG003|Overall Study|Adverse Event|0|||
126361497|NCT02268851|454615333|FG004|Overall Study|Adverse Event|2|||
126270712|NCT03819049|454284580|FG000|Overall Study|Physician Decision|0|||
126270713|NCT03819049|454284581|FG001|Overall Study|Physician Decision|0|||
126270714|NCT03819049|454284582|FG002|Overall Study|Physician Decision|0|||
126270715|NCT03819049|454284583|FG003|Overall Study|Physician Decision|0|||
126270716|NCT03819049|454284584|FG004|Overall Study|Physician Decision|0|||
126270717|NCT03819049|454284585|FG005|Overall Study|Physician Decision|0|||
126270718|NCT03819049|454284586|FG006|Overall Study|Physician Decision|1|||
126270719|NCT01616953|454284591|FG000|Overall Study|Lost to Follow-up|1|||
126270720|NCT01616953|454284592|FG001|Overall Study|Lost to Follow-up|0|||
126270721|NCT01616953|454284591|FG000|Overall Study|lack of bone and soft tissue|1|||
126270722|NCT01616953|454284592|FG001|Overall Study|lack of bone and soft tissue|0|||
126270723|NCT01568320|454284593|FG000|Overall Study|Death|20|||
126270724|NCT01568320|454284593|FG000|Overall Study|Lost to Follow-up|9|||
126270725|NCT01568320|454284593|FG000|Overall Study|Withdrawal by Subject|10|||
126270726|NCT01568320|454284593|FG000|Overall Study|Conversion to open repair|1|||
126270727|NCT01568320|454284593|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
126270728|NCT00816361|454284594|FG000|Overall Study|Withdrawal by Subject|0|||
126270729|NCT00816361|454284595|FG001|Overall Study|Withdrawal by Subject|0|||
126270730|NCT00816361|454284596|FG002|Overall Study|Withdrawal by Subject|0|||
126270731|NCT00816361|454284597|FG003|Overall Study|Withdrawal by Subject|0|||
126270732|NCT00816361|454284598|FG004|Overall Study|Withdrawal by Subject|1|||
126270733|NCT00816361|454284599|FG005|Overall Study|Withdrawal by Subject|2|||
126270734|NCT00816361|454284600|FG006|Overall Study|Withdrawal by Subject|0|||
126270735|NCT00816361|454284601|FG007|Overall Study|Withdrawal by Subject|2|||
126270736|NCT00816361|454284602|FG008|Overall Study|Withdrawal by Subject|1|||
126270737|NCT00816361|454284594|FG000|Overall Study|Death|4|||
126270738|NCT00816361|454284595|FG001|Overall Study|Death|3|||
126270739|NCT00816361|454284596|FG002|Overall Study|Death|3|||
126270740|NCT00816361|454284597|FG003|Overall Study|Death|3|||
126270741|NCT00816361|454284598|FG004|Overall Study|Death|1|||
126270742|NCT00816361|454284599|FG005|Overall Study|Death|1|||
126270743|NCT00816361|454284600|FG006|Overall Study|Death|3|||
126270744|NCT00816361|454284601|FG007|Overall Study|Death|7|||
126270745|NCT00816361|454284602|FG008|Overall Study|Death|8|||
126270746|NCT00816361|454284594|FG000|Overall Study|Other|0|||
126270747|NCT00816361|454284595|FG001|Overall Study|Other|0|||
126270748|NCT00816361|454284596|FG002|Overall Study|Other|0|||
126270749|NCT00816361|454284597|FG003|Overall Study|Other|0|||
126270750|NCT00816361|454284598|FG004|Overall Study|Other|0|||
126270751|NCT00816361|454284599|FG005|Overall Study|Other|0|||
126270752|NCT00816361|454284600|FG006|Overall Study|Other|0|||
126270753|NCT00816361|454284601|FG007|Overall Study|Other|0|||
126270754|NCT00816361|454284602|FG008|Overall Study|Other|1|||
126270755|NCT00546572|454284604|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
126270756|NCT00546572|454284605|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
126270757|NCT00546572|454284604|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
126270758|NCT00546572|454284605|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
126270759|NCT00546572|454284604|FG000|Vax 1 / Year 0|Protocol Violation|3|||
126270760|NCT00546572|454284605|FG001|Vax 1 / Year 0|Protocol Violation|4|||
126270761|NCT00546572|454284604|FG000|Vax 1 / Year 0|Death|2|||
126270762|NCT00546572|454284605|FG001|Vax 1 / Year 0|Death|2|||
126270763|NCT00546572|454284604|FG000|Vax 1 / Year 0|Adverse Event|0|||
126270764|NCT00546572|454284605|FG001|Vax 1 / Year 0|Adverse Event|1|||
126270765|NCT00546572|454284604|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
126270766|NCT00546572|454284605|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
126270767|NCT00546572|454284604|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
126270768|NCT00546572|454284605|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
126270769|NCT00546572|454284604|FG000|Vax 2 / Year 1|Other|1|||
126270770|NCT00546572|454284605|FG001|Vax 2 / Year 1|Other|1|||
126270771|NCT00546572|454284604|FG000|Vax 2 / Year 1|Adverse Event|1|||
126270772|NCT00546572|454284605|FG001|Vax 2 / Year 1|Adverse Event|0|||
126270773|NCT00546572|454284604|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
126036836|NCT04032704|453433085|FG013|Part B|Other|13|||
126270774|NCT00546572|454284605|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
126270775|NCT01394952|454284606|FG000|Overall Study|Lost to Follow-up|0|||
126270776|NCT01394952|454284607|FG001|Overall Study|Lost to Follow-up|5|||
126270777|NCT01394952|454284606|FG000|Overall Study|Withdrawal by Subject|10|||
126270778|NCT01394952|454284607|FG001|Overall Study|Withdrawal by Subject|5|||
126270779|NCT01394952|454284606|FG000|Overall Study|Physician Decision|2|||
126036837|NCT04032704|453433086|FG014|Part B|Other|0|||
126270780|NCT01394952|454284607|FG001|Overall Study|Physician Decision|0|||
126270781|NCT01394952|454284606|FG000|Overall Study|Sponsor Decision|5|||
126036838|NCT04032704|453433087|FG015|Part B|Other|0|||
126036839|NCT04032704|453433088|FG016|Part B|Other|0|||
126270782|NCT01394952|454284607|FG001|Overall Study|Sponsor Decision|7|||
126270783|NCT02500641|454284610|FG000|Overall Study|Adverse Event|0|||
126270784|NCT02500641|454284611|FG001|Overall Study|Adverse Event|2|||
126270785|NCT02500641|454284610|FG000|Overall Study|Withdrawal by Subject|4|||
126270786|NCT02500641|454284611|FG001|Overall Study|Withdrawal by Subject|5|||
126270787|NCT02500641|454284610|FG000|Overall Study|Unable to follow study procedures|3|||
126270788|NCT02500641|454284611|FG001|Overall Study|Unable to follow study procedures|2|||
126270789|NCT02500641|454284610|FG000|Overall Study|Protocol Violation|1|||
126270790|NCT02500641|454284611|FG001|Overall Study|Protocol Violation|2|||
126270791|NCT02500641|454284610|FG000|Overall Study|Lost to Follow-up|1|||
126270792|NCT02500641|454284611|FG001|Overall Study|Lost to Follow-up|0|||
126270793|NCT02500641|454284610|FG000|Overall Study|Sponsor decision|1|||
126270794|NCT02500641|454284611|FG001|Overall Study|Sponsor decision|0|||
126270795|NCT02500641|454284610|FG000|Overall Study|Non compliance to study drug|0|||
126270796|NCT02500641|454284611|FG001|Overall Study|Non compliance to study drug|1|||
126270797|NCT00643565|454284613|FG000|Overall Study|Death|12|||
126270798|NCT00643565|454284614|FG001|Overall Study|Death|11|||
126270799|NCT00643565|454284613|FG000|Overall Study|Withdrawal by Subject|4|||
126270800|NCT00643565|454284614|FG001|Overall Study|Withdrawal by Subject|1|||
126270801|NCT00643565|454284613|FG000|Overall Study|Lost to Follow-up|0|||
126270802|NCT00643565|454284614|FG001|Overall Study|Lost to Follow-up|6|||
126270803|NCT00643565|454284613|FG000|Overall Study|Other|7|||
126270804|NCT00643565|454284614|FG001|Overall Study|Other|8|||
126270805|NCT00643565|454284613|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
126270806|NCT00643565|454284614|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
126270807|NCT00643565|454284613|FG000|Overall Study|Recurrence of Disease|2|||
126270808|NCT00643565|454284614|FG001|Overall Study|Recurrence of Disease|1|||
126270809|NCT00643565|454284613|FG000|Overall Study|Progression of Disease|18|||
126270810|NCT00643565|454284614|FG001|Overall Study|Progression of Disease|14|||
126270811|NCT00643565|454284613|FG000|Overall Study|Protocol Violation|3|||
126270812|NCT00643565|454284614|FG001|Overall Study|Protocol Violation|0|||
126270813|NCT00643565|454284613|FG000|Overall Study|Did Not Cooperate|0|||
126270814|NCT00643565|454284614|FG001|Overall Study|Did Not Cooperate|1|||
126270815|NCT00643565|454284613|FG000|Overall Study|Administrative|22|||
126270816|NCT00643565|454284614|FG001|Overall Study|Administrative|16|||
126270817|NCT00643565|454284613|FG000|Overall Study|Adverse Event|5|||
126270818|NCT00643565|454284614|FG001|Overall Study|Adverse Event|8|||
126270819|NCT02317614|454284615|FG000|Overall Study|Lost to Follow-up|1|||
126270820|NCT02317614|454284616|FG001|Overall Study|Lost to Follow-up|1|||
126270821|NCT02317614|454284615|FG000|Overall Study|Withdrawal by Subject|1|||
126270822|NCT02317614|454284616|FG001|Overall Study|Withdrawal by Subject|0|||
126270823|NCT02317614|454284615|FG000|Overall Study|Death|1|||
126270824|NCT02317614|454284616|FG001|Overall Study|Death|1|||
126270825|NCT00669071|454284617|FG000|Overall Study|Lost to Follow-up|3|||
126270826|NCT00669071|454284617|FG000|Overall Study|Final visit 40 days out of window|1|||
126270827|NCT01355159|454284618|FG000|Overall Study|Withdrew consent|39|||
126270828|NCT01355159|454284619|FG001|Overall Study|Withdrew consent|47|||
126270829|NCT01355159|454284618|FG000|Overall Study|No primary outcome data|17|||
126270830|NCT01355159|454284619|FG001|Overall Study|No primary outcome data|11|||
126270831|NCT01355159|454284618|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
126270832|NCT01355159|454284619|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
126270833|NCT01355159|454284618|FG000|Overall Study|Early intrauterine fetal death|6|||
126270834|NCT01355159|454284619|FG001|Overall Study|Early intrauterine fetal death|6|||
126270835|NCT04700280|454284620|FG000|Overall Study|Adverse Event|4|||
126270836|NCT04700280|454284621|FG001|Overall Study|Adverse Event|0|||
126270837|NCT04700280|454284620|FG000|Overall Study|Lack of Efficacy|1|||
126270838|NCT04700280|454284621|FG001|Overall Study|Lack of Efficacy|0|||
126270839|NCT04700280|454284620|FG000|Overall Study|Study terminated by sponsor|5|||
126270840|NCT04700280|454284621|FG001|Overall Study|Study terminated by sponsor|3|||
126270841|NCT04700280|454284620|FG000|Overall Study|Other than specified|1|||
126270842|NCT04700280|454284621|FG001|Overall Study|Other than specified|0|||
126270843|NCT00741936|454284625|FG000|Overall Study|Lost to Follow-up|1|||
126270844|NCT00741936|454284626|FG001|Overall Study|Lost to Follow-up|1|||
126270845|NCT00741936|454284625|FG000|Overall Study|Adverse Event|3|||
126270846|NCT00741936|454284626|FG001|Overall Study|Adverse Event|4|||
126270847|NCT00741936|454284625|FG000|Overall Study|Pregnancy|0|||
126270848|NCT00741936|454284626|FG001|Overall Study|Pregnancy|1|||
126270849|NCT00741936|454284625|FG000|Overall Study|Protocol Violation|2|||
126270850|NCT00741936|454284626|FG001|Overall Study|Protocol Violation|0|||
126270851|NCT00741936|454284625|FG000|Overall Study|Lack of Efficacy|0|||
126270852|NCT00741936|454284626|FG001|Overall Study|Lack of Efficacy|2|||
126270853|NCT00741936|454284625|FG000|Overall Study|Low compliance|3|||
126270854|NCT00741936|454284626|FG001|Overall Study|Low compliance|0|||
126270855|NCT02450526|454284627|FG000|DB Period (Cycle 1)|Adverse Event|0|||
126270856|NCT02450526|454284628|FG001|DB Period (Cycle 1)|Adverse Event|0|||
126270857|NCT02450526|454284629|FG002|DB Period (Cycle 1)|Adverse Event|2|||
126270858|NCT02450526|454284630|FG003|DB Period (Cycle 1)|Adverse Event|0|||
126270859|NCT02450526|454284631|FG004|DB Period (Cycle 1)|Adverse Event|0|||
126270860|NCT02450526|454284627|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
126270861|NCT02450526|454284628|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
126270862|NCT02450526|454284629|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
126270863|NCT02450526|454284630|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
126361498|NCT02268851|454615334|FG005|Overall Study|Adverse Event|2|||
126361499|NCT02268851|454615329|FG000|Overall Study|Withdrawal by Subject|0|||
126270864|NCT02450526|454284631|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
126270865|NCT02450526|454284627|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
126270866|NCT02450526|454284628|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
126270867|NCT02450526|454284629|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
126270868|NCT02450526|454284630|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
126270869|NCT02450526|454284631|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
126270870|NCT02450526|454284627|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
126270871|NCT02450526|454284628|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
126270872|NCT02450526|454284629|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
126270873|NCT02450526|454284630|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
126270874|NCT02450526|454284631|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
126270875|NCT02450526|454284627|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
126270876|NCT02450526|454284628|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
126270877|NCT02450526|454284629|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
126270878|NCT02450526|454284630|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
126270879|NCT02450526|454284631|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
126270880|NCT02450526|454284627|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
126270881|NCT02450526|454284628|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
126270882|NCT02450526|454284629|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
126270883|NCT02450526|454284630|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
126270884|NCT02450526|454284631|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
126270885|NCT02450526|454284627|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
126270886|NCT02450526|454284628|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
126270887|NCT02450526|454284629|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
126270888|NCT02450526|454284630|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
126270889|NCT02450526|454284631|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
126270890|NCT02450526|454284627|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
126270891|NCT02450526|454284628|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
126270892|NCT02450526|454284629|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
126270893|NCT02450526|454284630|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
126270894|NCT02450526|454284631|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
126270895|NCT01970865|454284632|FG000|Overall Study|Death|3|||
126270896|NCT01970865|454284633|FG001|Overall Study|Death|2|||
126270897|NCT01970865|454284634|FG002|Overall Study|Death|3|||
126270898|NCT01970865|454284635|FG003|Overall Study|Death|6|||
126270899|NCT01970865|454284636|FG004|Overall Study|Death|9|||
126270900|NCT01970865|454284637|FG005|Overall Study|Death|3|||
126270901|NCT01970865|454284638|FG006|Overall Study|Death|2|||
126270902|NCT01970865|454284639|FG007|Overall Study|Death|3|||
126270903|NCT01970865|454284640|FG008|Overall Study|Death|2|||
126270904|NCT01970865|454284641|FG009|Overall Study|Death|2|||
126270905|NCT01970865|454284642|FG010|Overall Study|Death|8|||
126270906|NCT01970865|454284643|FG011|Overall Study|Death|13|||
126270907|NCT01970865|454284644|FG012|Overall Study|Death|25|||
126270908|NCT01970865|454284645|FG013|Overall Study|Death|46|||
126270909|NCT01970865|454284646|FG014|Overall Study|Death|37|||
126270910|NCT01970865|454284647|FG015|Overall Study|Death|22|||
126270911|NCT01970865|454284648|FG016|Overall Study|Death|1|||
126270912|NCT01970865|454284649|FG017|Overall Study|Death|17|||
126270913|NCT01970865|454284632|FG000|Overall Study|Lost to Follow-up|0|||
126270914|NCT01970865|454284633|FG001|Overall Study|Lost to Follow-up|0|||
126270915|NCT01970865|454284634|FG002|Overall Study|Lost to Follow-up|0|||
126270916|NCT01970865|454284635|FG003|Overall Study|Lost to Follow-up|1|||
126270917|NCT01970865|454284636|FG004|Overall Study|Lost to Follow-up|1|||
126270918|NCT01970865|454284637|FG005|Overall Study|Lost to Follow-up|0|||
126270919|NCT01970865|454284638|FG006|Overall Study|Lost to Follow-up|0|||
126270920|NCT01970865|454284639|FG007|Overall Study|Lost to Follow-up|0|||
126270921|NCT01970865|454284640|FG008|Overall Study|Lost to Follow-up|0|||
126270922|NCT01970865|454284641|FG009|Overall Study|Lost to Follow-up|0|||
126270923|NCT01970865|454284642|FG010|Overall Study|Lost to Follow-up|1|||
126270924|NCT01970865|454284643|FG011|Overall Study|Lost to Follow-up|0|||
126361500|NCT02268851|454615330|FG001|Overall Study|Withdrawal by Subject|0|||
126270925|NCT01970865|454284644|FG012|Overall Study|Lost to Follow-up|2|||
126270926|NCT01970865|454284645|FG013|Overall Study|Lost to Follow-up|0|||
126270927|NCT01970865|454284646|FG014|Overall Study|Lost to Follow-up|1|||
126270928|NCT01970865|454284647|FG015|Overall Study|Lost to Follow-up|4|||
126270929|NCT01970865|454284648|FG016|Overall Study|Lost to Follow-up|0|||
126270930|NCT01970865|454284649|FG017|Overall Study|Lost to Follow-up|1|||
126270931|NCT01970865|454284632|FG000|Overall Study|Other|0|||
126270932|NCT01970865|454284633|FG001|Overall Study|Other|1|||
126270933|NCT01970865|454284634|FG002|Overall Study|Other|0|||
126270934|NCT01970865|454284635|FG003|Overall Study|Other|1|||
126270935|NCT01970865|454284636|FG004|Overall Study|Other|1|||
126270936|NCT01970865|454284637|FG005|Overall Study|Other|0|||
126270937|NCT01970865|454284638|FG006|Overall Study|Other|1|||
126361501|NCT02268851|454615331|FG002|Overall Study|Withdrawal by Subject|0|||
126270938|NCT01970865|454284639|FG007|Overall Study|Other|0|||
126270939|NCT01970865|454284640|FG008|Overall Study|Other|0|||
126270940|NCT01970865|454284641|FG009|Overall Study|Other|0|||
126270941|NCT01970865|454284642|FG010|Overall Study|Other|2|||
126361502|NCT02268851|454615332|FG003|Overall Study|Withdrawal by Subject|2|||
126361503|NCT02268851|454615333|FG004|Overall Study|Withdrawal by Subject|0|||
126361504|NCT02268851|454615334|FG005|Overall Study|Withdrawal by Subject|1|||
126361505|NCT02268851|454615329|FG000|Overall Study|Progressive Disease|1|||
126361506|NCT02268851|454615330|FG001|Overall Study|Progressive Disease|3|||
126361507|NCT02268851|454615331|FG002|Overall Study|Progressive Disease|0|||
126361508|NCT02268851|454615332|FG003|Overall Study|Progressive Disease|0|||
126361509|NCT02268851|454615333|FG004|Overall Study|Progressive Disease|1|||
126361510|NCT02268851|454615334|FG005|Overall Study|Progressive Disease|4|||
126361511|NCT02268851|454615329|FG000|Overall Study|Physician Decision|0|||
126361512|NCT02268851|454615330|FG001|Overall Study|Physician Decision|0|||
126361513|NCT02268851|454615331|FG002|Overall Study|Physician Decision|1|||
126361514|NCT02268851|454615332|FG003|Overall Study|Physician Decision|0|||
126361515|NCT02268851|454615333|FG004|Overall Study|Physician Decision|0|||
126361516|NCT02268851|454615334|FG005|Overall Study|Physician Decision|1|||
126361517|NCT02268851|454615329|FG000|Overall Study|Patient Compliance|0|||
126361518|NCT02268851|454615330|FG001|Overall Study|Patient Compliance|0|||
126361519|NCT02268851|454615331|FG002|Overall Study|Patient Compliance|0|||
126361520|NCT02268851|454615332|FG003|Overall Study|Patient Compliance|0|||
126361521|NCT02268851|454615333|FG004|Overall Study|Patient Compliance|1|||
126361522|NCT02268851|454615334|FG005|Overall Study|Patient Compliance|1|||
126361523|NCT02268851|454615329|FG000|Overall Study|Co-Morbid Condition|0|||
126361524|NCT02268851|454615330|FG001|Overall Study|Co-Morbid Condition|0|||
126361525|NCT02268851|454615331|FG002|Overall Study|Co-Morbid Condition|0|||
126361526|NCT02268851|454615332|FG003|Overall Study|Co-Morbid Condition|0|||
126361527|NCT02268851|454615333|FG004|Overall Study|Co-Morbid Condition|1|||
126361528|NCT02268851|454615334|FG005|Overall Study|Co-Morbid Condition|1|||
126361529|NCT02539394|454615335|FG000|Overall Study|Protocol Violation|1|||
126361530|NCT02539394|454615336|FG001|Overall Study|Protocol Violation|3|||
126361531|NCT02539394|454615335|FG000|Overall Study|Lost to Follow-up|1|||
126361532|NCT02539394|454615336|FG001|Overall Study|Lost to Follow-up|2|||
126361533|NCT02539394|454615335|FG000|Overall Study|Incomplete dataset|6|||
126361534|NCT02539394|454615336|FG001|Overall Study|Incomplete dataset|6|||
126270942|NCT01970865|454284643|FG011|Overall Study|Other|3|||
126270943|NCT01970865|454284644|FG012|Overall Study|Other|8|||
126270944|NCT01970865|454284645|FG013|Overall Study|Other|3|||
126270945|NCT01970865|454284646|FG014|Overall Study|Other|2|||
126270946|NCT01970865|454284647|FG015|Overall Study|Other|3|||
126270947|NCT01970865|454284648|FG016|Overall Study|Other|0|||
126270948|NCT01970865|454284649|FG017|Overall Study|Other|2|||
126270949|NCT01970865|454284632|FG000|Overall Study|Participant refused further follow-up|0|||
126270950|NCT01970865|454284633|FG001|Overall Study|Participant refused further follow-up|0|||
126270951|NCT01970865|454284634|FG002|Overall Study|Participant refused further follow-up|0|||
126270952|NCT01970865|454284635|FG003|Overall Study|Participant refused further follow-up|2|||
126270953|NCT01970865|454284636|FG004|Overall Study|Participant refused further follow-up|3|||
126270954|NCT01970865|454284637|FG005|Overall Study|Participant refused further follow-up|0|||
126270955|NCT01970865|454284638|FG006|Overall Study|Participant refused further follow-up|0|||
126361535|NCT02205359|454615337|FG000|Overall Study|Death|293|||
126361536|NCT02205359|454615338|FG001|Overall Study|Death|327|||
126361537|NCT02205359|454615337|FG000|Overall Study|Lost to Follow-up|182|||
126361538|NCT02205359|454615338|FG001|Overall Study|Lost to Follow-up|162|||
126361539|NCT02205359|454615337|FG000|Overall Study|Physician Decision|51|||
126361540|NCT02205359|454615338|FG001|Overall Study|Physician Decision|53|||
126361541|NCT02205359|454615337|FG000|Overall Study|Withdrawal by Subject|167|||
126361542|NCT02205359|454615338|FG001|Overall Study|Withdrawal by Subject|169|||
126361543|NCT00236197|454615339|FG000|Overall Study|Withdrawal by Subject|3|||
126361544|NCT00236197|454615340|FG001|Overall Study|Withdrawal by Subject|2|||
126361545|NCT00236197|454615339|FG000|Overall Study|Lost to Follow-up|1|||
126361546|NCT00236197|454615340|FG001|Overall Study|Lost to Follow-up|5|||
126361547|NCT00236197|454615339|FG000|Overall Study|Protocol Violation|0|||
126361548|NCT00236197|454615340|FG001|Overall Study|Protocol Violation|3|||
126361549|NCT00236197|454615339|FG000|Overall Study|Medication non-compliance|1|||
126361550|NCT00236197|454615340|FG001|Overall Study|Medication non-compliance|2|||
126361551|NCT00236197|454615339|FG000|Overall Study|Other|0|||
126361552|NCT00236197|454615340|FG001|Overall Study|Other|2|||
126361553|NCT00992394|454615343|FG000|Overall Study|Lack of Efficacy|6|||
126361554|NCT00992394|454615344|FG001|Overall Study|Lack of Efficacy|3|||
126361555|NCT00992394|454615343|FG000|Overall Study|Adverse Event|4|||
126270956|NCT01970865|454284639|FG007|Overall Study|Participant refused further follow-up|0|||
126270957|NCT01970865|454284640|FG008|Overall Study|Participant refused further follow-up|0|||
126270958|NCT01970865|454284641|FG009|Overall Study|Participant refused further follow-up|0|||
126361556|NCT00992394|454615344|FG001|Overall Study|Adverse Event|5|||
126270959|NCT01970865|454284642|FG010|Overall Study|Participant refused further follow-up|1|||
126361557|NCT00992394|454615343|FG000|Overall Study|Withdrawal by Subject|8|||
126361558|NCT00992394|454615344|FG001|Overall Study|Withdrawal by Subject|2|||
126361559|NCT00992394|454615343|FG000|Overall Study|Physician Decision|1|||
126361560|NCT00992394|454615344|FG001|Overall Study|Physician Decision|0|||
126361561|NCT00992394|454615343|FG000|Overall Study|Protocol Violation|2|||
126361562|NCT00992394|454615344|FG001|Overall Study|Protocol Violation|4|||
126270960|NCT01970865|454284643|FG011|Overall Study|Participant refused further follow-up|4|||
126270961|NCT01970865|454284644|FG012|Overall Study|Participant refused further follow-up|7|||
126270962|NCT01970865|454284645|FG013|Overall Study|Participant refused further follow-up|8|||
126270963|NCT01970865|454284646|FG014|Overall Study|Participant refused further follow-up|3|||
126270964|NCT01970865|454284647|FG015|Overall Study|Participant refused further follow-up|11|||
126270965|NCT01970865|454284648|FG016|Overall Study|Participant refused further follow-up|0|||
126270966|NCT01970865|454284649|FG017|Overall Study|Participant refused further follow-up|6|||
126270967|NCT01855074|454284652|FG000|Overall Study|Adverse Event|1|||
126270968|NCT01855074|454284652|FG000|Overall Study|Lost to Follow-up|4|||
126270969|NCT01855074|454284652|FG000|Overall Study|Withdrawal by Subject|8|||
126270970|NCT01855074|454284652|FG000|Overall Study|Started but not treated|1|||
126270971|NCT01150890|454284653|FG000|Overall Study|Other|0|||
126270972|NCT01150890|454284654|FG001|Overall Study|Other|1|||
126270973|NCT01150890|454284655|FG002|Overall Study|Other|0|||
126270974|NCT01150890|454284656|FG003|Overall Study|Other|2|||
126270975|NCT01150890|454284653|FG000|Overall Study|Pregnancy|0|||
126270976|NCT01150890|454284654|FG001|Overall Study|Pregnancy|0|||
126270977|NCT01150890|454284655|FG002|Overall Study|Pregnancy|0|||
126270978|NCT01150890|454284656|FG003|Overall Study|Pregnancy|1|||
126270979|NCT01150890|454284653|FG000|Overall Study|Administrative Decision|4|||
126270980|NCT01150890|454284654|FG001|Overall Study|Administrative Decision|4|||
126270981|NCT01150890|454284655|FG002|Overall Study|Administrative Decision|5|||
126270982|NCT01150890|454284656|FG003|Overall Study|Administrative Decision|6|||
126270983|NCT01150890|454284653|FG000|Overall Study|Ineligibility determined|0|||
126270984|NCT01150890|454284654|FG001|Overall Study|Ineligibility determined|1|||
126270985|NCT01150890|454284655|FG002|Overall Study|Ineligibility determined|0|||
126270986|NCT01150890|454284656|FG003|Overall Study|Ineligibility determined|0|||
126270987|NCT01150890|454284653|FG000|Overall Study|Adverse Event|0|||
126270988|NCT01150890|454284654|FG001|Overall Study|Adverse Event|0|||
126270989|NCT01150890|454284655|FG002|Overall Study|Adverse Event|2|||
126270990|NCT01150890|454284656|FG003|Overall Study|Adverse Event|0|||
126270991|NCT01150890|454284653|FG000|Overall Study|Withdrawal by Subject|0|||
126270992|NCT01150890|454284654|FG001|Overall Study|Withdrawal by Subject|0|||
126270993|NCT01150890|454284655|FG002|Overall Study|Withdrawal by Subject|2|||
126270994|NCT01150890|454284656|FG003|Overall Study|Withdrawal by Subject|1|||
126270995|NCT01150890|454284653|FG000|Overall Study|Disease progression|0|||
126270996|NCT01150890|454284654|FG001|Overall Study|Disease progression|7|||
126270997|NCT01150890|454284655|FG002|Overall Study|Disease progression|3|||
126270998|NCT01150890|454284656|FG003|Overall Study|Disease progression|7|||
126270999|NCT01079832|454284660|FG000|Overall Study|Withdrawal by Subject|1|||
126271000|NCT06077487|454286566|FG000|Overall Study|Withdrawal by Subject|0|||
126271001|NCT06077487|454286567|FG001|Overall Study|Withdrawal by Subject|1|||
126271002|NCT00759902|454286569|FG000|Overall Study|Adverse Event|0|||
126271003|NCT00759902|454286570|FG001|Overall Study|Adverse Event|1|||
126271004|NCT02128217|454286571|FG000|Overall Study|Lost to Follow-up|0|||
126271005|NCT02128217|454286572|FG001|Overall Study|Lost to Follow-up|1|||
126271006|NCT05071313|454286575|FG000|Overall Study|Lost to Follow-up|17|||
126271007|NCT05071313|454286576|FG001|Overall Study|Lost to Follow-up|10|||
126271008|NCT05071313|454286575|FG000|Overall Study|Physician Decision|1|||
126271009|NCT05071313|454286576|FG001|Overall Study|Physician Decision|6|||
126271010|NCT05071313|454286575|FG000|Overall Study|Death|1|||
126271011|NCT05071313|454286576|FG001|Overall Study|Death|0|||
126271012|NCT05071313|454286575|FG000|Overall Study|Withdrawal by Subject|10|||
126271013|NCT05071313|454286576|FG001|Overall Study|Withdrawal by Subject|15|||
126271014|NCT05071313|454286575|FG000|Overall Study|Other|1|||
126271015|NCT05071313|454286576|FG001|Overall Study|Other|0|||
126271016|NCT05071313|454286575|FG000|Overall Study|Randomized but not vaccinated|4|||
126271017|NCT05071313|454286576|FG001|Overall Study|Randomized but not vaccinated|2|||
126271018|NCT03107026|454286577|FG000|Overall Study|Adverse Event|2|||
126271019|NCT03107026|454286578|FG001|Overall Study|Adverse Event|14|||
126271020|NCT03107026|454286579|FG002|Overall Study|Adverse Event|23|||
126271021|NCT03107026|454286577|FG000|Overall Study|Lost to Follow-up|12|||
126271022|NCT03107026|454286578|FG001|Overall Study|Lost to Follow-up|12|||
126271023|NCT03107026|454286579|FG002|Overall Study|Lost to Follow-up|13|||
126271024|NCT03107026|454286577|FG000|Overall Study|Protocol Violation|1|||
126271025|NCT03107026|454286578|FG001|Overall Study|Protocol Violation|2|||
126271026|NCT03107026|454286579|FG002|Overall Study|Protocol Violation|0|||
126271027|NCT03107026|454286577|FG000|Overall Study|Pregnancy|1|||
126271028|NCT03107026|454286578|FG001|Overall Study|Pregnancy|0|||
126271029|NCT03107026|454286579|FG002|Overall Study|Pregnancy|0|||
126271030|NCT03107026|454286577|FG000|Overall Study|Withdrawal by Subject|13|||
126271031|NCT03107026|454286578|FG001|Overall Study|Withdrawal by Subject|5|||
126271032|NCT03107026|454286579|FG002|Overall Study|Withdrawal by Subject|17|||
126271033|NCT03107026|454286577|FG000|Overall Study|non compliance with study visits|1|||
126271034|NCT03107026|454286578|FG001|Overall Study|non compliance with study visits|2|||
126271035|NCT03107026|454286579|FG002|Overall Study|non compliance with study visits|0|||
126271036|NCT03107026|454286577|FG000|Overall Study|non-compliance with study drug|2|||
126271037|NCT03107026|454286578|FG001|Overall Study|non-compliance with study drug|2|||
126271038|NCT03107026|454286579|FG002|Overall Study|non-compliance with study drug|3|||
126271039|NCT03107026|454286577|FG000|Overall Study|Physician Decision|0|||
126271040|NCT03107026|454286578|FG001|Overall Study|Physician Decision|1|||
126271041|NCT03107026|454286579|FG002|Overall Study|Physician Decision|0|||
126271042|NCT02049450|454286580|FG000|Overall Study|Adverse Event|2|||
126271043|NCT02049450|454286580|FG000|Overall Study|Withdrawal by Subject|1|||
126271044|NCT02049450|454286580|FG000|Overall Study|Patients/guardian decision|1|||
126271045|NCT00577395|454286581|FG000|Overall Study|Study was terminated early by Sponsor|7|||
126271046|NCT00577395|454286582|FG001|Overall Study|Study was terminated early by Sponsor|6|||
126271047|NCT03347422|454286588|FG000|Part A (26 Weeks)|Adverse Event|3|||
126271048|NCT03347422|454286589|FG001|Part A (26 Weeks)|Adverse Event|0|||
126271049|NCT03347422|454286588|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
126271050|NCT03347422|454286589|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
126271051|NCT03347422|454286588|FG000|Part B (149 Weeks)|Adverse Event|0|||
126271052|NCT03347422|454286589|FG001|Part B (149 Weeks)|Adverse Event|1|||
126271053|NCT03347422|454286588|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
126271054|NCT03347422|454286589|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
126271055|NCT03347422|454286588|FG000|Part B (149 Weeks)|Other|1|||
126271056|NCT03347422|454286589|FG001|Part B (149 Weeks)|Other|0|||
126271057|NCT00910091|454286590|FG000|Pre-assignment|Withdrawal by Subject|0|||
126271058|NCT00910091|454286591|FG001|Pre-assignment|Withdrawal by Subject|2|||
126271059|NCT00910091|454286590|FG000|Treatment and Survival|Withdrawal by Subject|3|||
126271060|NCT00910091|454286591|FG001|Treatment and Survival|Withdrawal by Subject|4|||
126271061|NCT00910091|454286590|FG000|Treatment and Survival|Adverse Event|1|||
126271062|NCT00910091|454286591|FG001|Treatment and Survival|Adverse Event|0|||
126271063|NCT01155024|454286592|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
126271064|NCT01155024|454286593|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
126271065|NCT01155024|454286592|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
126271066|NCT01155024|454286593|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
126271067|NCT01155024|454286592|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
126271068|NCT01155024|454286593|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
126271069|NCT03201250|454286596|FG000|Overall Study|screen failures|3|||
126271070|NCT03201250|454286597|FG001|Overall Study|screen failures|0|||
126271071|NCT03201250|454286598|FG002|Overall Study|screen failures|0|||
126271072|NCT01175811|454286600|FG000|Overall Study|Adverse Event|1|||
126271073|NCT01175811|454286601|FG001|Overall Study|Adverse Event|1|||
126271074|NCT01175811|454286600|FG000|Overall Study|Entry criteria not met|3|||
126271075|NCT01175811|454286601|FG001|Overall Study|Entry criteria not met|1|||
126271076|NCT01175811|454286600|FG000|Overall Study|Lack of Efficacy|1|||
126271077|NCT01175811|454286601|FG001|Overall Study|Lack of Efficacy|0|||
126271078|NCT01175811|454286600|FG000|Overall Study|Lost to Follow-up|3|||
126271079|NCT01175811|454286601|FG001|Overall Study|Lost to Follow-up|2|||
126271080|NCT01175811|454286600|FG000|Overall Study|Physician Decision|1|||
126271081|NCT01175811|454286601|FG001|Overall Study|Physician Decision|1|||
126271082|NCT01175811|454286600|FG000|Overall Study|Protocol Violation|1|||
126271083|NCT01175811|454286601|FG001|Overall Study|Protocol Violation|2|||
126271084|NCT01175811|454286600|FG000|Overall Study|Withdrawal by Subject|6|||
126271085|NCT01175811|454286601|FG001|Overall Study|Withdrawal by Subject|7|||
126271086|NCT03579966|454286602|FG000|Overall Study|Adverse Event|6|||
126271087|NCT03579966|454286602|FG000|Overall Study|Lost to Follow-up|4|||
126271088|NCT03579966|454286602|FG000|Overall Study|Physician Decision|10|||
126271089|NCT03579966|454286602|FG000|Overall Study|Pregnancy|1|||
126271090|NCT03579966|454286602|FG000|Overall Study|Withdrawal by Subject|16|||
126271091|NCT03579966|454286602|FG000|Overall Study|Study terminated by Sponsor|22|||
126271092|NCT03579966|454286602|FG000|Overall Study|Protocol Violation|1|||
126271093|NCT01340768|454286603|FG000|Overall Study|Lost to Follow-up|10|||
126271094|NCT01340768|454286604|FG001|Overall Study|Lost to Follow-up|4|||
126271095|NCT01340768|454286603|FG000|Overall Study|Withdrawal by Subject|5|||
126271096|NCT01340768|454286604|FG001|Overall Study|Withdrawal by Subject|1|||
126271097|NCT01340768|454286603|FG000|Overall Study|Other|2|||
126271098|NCT01340768|454286604|FG001|Overall Study|Other|0|||
126271099|NCT03052959|454286605|FG000|Overall Study|Lost to Follow-up|4|||
126271100|NCT03052959|454286606|FG001|Overall Study|Lost to Follow-up|5|||
126271101|NCT01297465|454286607|FG000|Overall Study|Lack of Ovarian Response|1|||
126271102|NCT01297465|454286608|FG001|Overall Study|Lack of Ovarian Response|1|||
126271103|NCT01297465|454286607|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
126271104|NCT01297465|454286608|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126271105|NCT01297465|454286607|FG000|Overall Study|No Oocytes Retrieved|1|||
126271106|NCT01297465|454286608|FG001|Overall Study|No Oocytes Retrieved|1|||
126271107|NCT01297465|454286607|FG000|Overall Study|Poor oocyte quality|0|||
126271108|NCT01297465|454286608|FG001|Overall Study|Poor oocyte quality|1|||
126271109|NCT01297465|454286607|FG000|Overall Study|No Fertilization|6|||
126271110|NCT01297465|454286608|FG001|Overall Study|No Fertilization|4|||
126271111|NCT01297465|454286607|FG000|Overall Study|All Embryos Discarded|0|||
126271112|NCT01297465|454286608|FG001|Overall Study|All Embryos Discarded|1|||
126361563|NCT00992394|454615343|FG000|Overall Study|Lost to Follow-up|2|||
126361564|NCT00992394|454615344|FG001|Overall Study|Lost to Follow-up|0|||
126361565|NCT00992394|454615343|FG000|Overall Study|Other event|1|||
126361566|NCT00992394|454615344|FG001|Overall Study|Other event|0|||
126361567|NCT00537082|454615345|FG000|Overall Study|Adverse Event|6|||
126361568|NCT00537082|454615346|FG001|Overall Study|Adverse Event|6|||
126361569|NCT00537082|454615347|FG002|Overall Study|Adverse Event|3|||
126361570|NCT00537082|454615345|FG000|Overall Study|Protocol Violation|0|||
126361571|NCT00537082|454615346|FG001|Overall Study|Protocol Violation|2|||
126361572|NCT00537082|454615347|FG002|Overall Study|Protocol Violation|1|||
126361573|NCT00537082|454615345|FG000|Overall Study|Lack of Efficacy|0|||
126361574|NCT00537082|454615346|FG001|Overall Study|Lack of Efficacy|0|||
126361575|NCT00537082|454615347|FG002|Overall Study|Lack of Efficacy|2|||
126361576|NCT00537082|454615345|FG000|Overall Study|Withdrawal by Subject|0|||
126361577|NCT00537082|454615346|FG001|Overall Study|Withdrawal by Subject|1|||
126361578|NCT00537082|454615347|FG002|Overall Study|Withdrawal by Subject|0|||
126361579|NCT00537082|454615345|FG000|Overall Study|Discontinued before initiating treatment|3|||
126361580|NCT00537082|454615346|FG001|Overall Study|Discontinued before initiating treatment|0|||
126361581|NCT00537082|454615347|FG002|Overall Study|Discontinued before initiating treatment|0|||
126361582|NCT00655746|454615348|FG000|Overall Study|Withdrawal by Subject|1|||
126361583|NCT01793129|454617195|FG000|Overall Study|Lost to Follow-up|3|||
126361584|NCT01793129|454617196|FG001|Overall Study|Lost to Follow-up|7|||
126361585|NCT01793129|454617195|FG000|Overall Study|Withdrawal by Subject|0|||
126361586|NCT01793129|454617196|FG001|Overall Study|Withdrawal by Subject|2|||
126361587|NCT01926509|454617199|FG000|Overall Study|vital sign met discontinuation criteria|1|||
126361588|NCT01926509|454617200|FG001|Overall Study|vital sign met discontinuation criteria|0|||
126361589|NCT01926509|454617201|FG002|Overall Study|vital sign met discontinuation criteria|0|||
126361590|NCT01926509|454617202|FG003|Overall Study|vital sign met discontinuation criteria|0|||
126361591|NCT03004183|454617203|FG000|Overall Study|Adverse Event|7|||
126361592|NCT03004183|454617203|FG000|Overall Study|Lost to Follow-up|1|||
126361593|NCT03004183|454617203|FG000|Overall Study|Physician Decision|40|||
126361594|NCT03004183|454617203|FG000|Overall Study|Withdrawal by Subject|1|||
126361595|NCT03004183|454617203|FG000|Overall Study|COVID-19|1|||
126361596|NCT03681093|454617204|FG000|Overall Study|Subject decision|0|||
126361597|NCT03681093|454617205|FG001|Overall Study|Subject decision|2|||
126361598|NCT03681093|454617206|FG002|Overall Study|Subject decision|1|||
126361599|NCT02698787|454617207|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
126361600|NCT02698787|454617208|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
126361601|NCT01882829|454617212|FG000|Overall Study|Adverse Event|4|||
126361602|NCT01882829|454617212|FG000|Overall Study|Protocol Violation|1|||
126361603|NCT01882829|454617212|FG000|Overall Study|Withdrawal by Subject|1|||
126361604|NCT01313676|454617215|FG000|Overall Study|Adverse Event|395|||
126361605|NCT01313676|454617216|FG001|Overall Study|Adverse Event|365|||
126361606|NCT01313676|454617217|FG002|Overall Study|Adverse Event|372|||
126361607|NCT01313676|454617218|FG003|Overall Study|Adverse Event|333|||
126361608|NCT01313676|454617215|FG000|Overall Study|Lack of Efficacy|98|||
126361609|NCT01313676|454617216|FG001|Overall Study|Lack of Efficacy|90|||
126361610|NCT01313676|454617217|FG002|Overall Study|Lack of Efficacy|65|||
126361611|NCT01313676|454617218|FG003|Overall Study|Lack of Efficacy|46|||
126361612|NCT01313676|454617215|FG000|Overall Study|Protocol Violation|37|||
126361613|NCT01313676|454617216|FG001|Overall Study|Protocol Violation|44|||
126361614|NCT01313676|454617217|FG002|Overall Study|Protocol Violation|46|||
126361615|NCT01313676|454617218|FG003|Overall Study|Protocol Violation|44|||
126361616|NCT01313676|454617215|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
126361617|NCT01313676|454617216|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
126361618|NCT01313676|454617217|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
126361619|NCT01313676|454617218|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
126361620|NCT01313676|454617215|FG000|Overall Study|Study Closed/terminated|7|||
126361621|NCT01313676|454617216|FG001|Overall Study|Study Closed/terminated|6|||
126361622|NCT01313676|454617217|FG002|Overall Study|Study Closed/terminated|9|||
126361623|NCT01313676|454617218|FG003|Overall Study|Study Closed/terminated|9|||
126361624|NCT01313676|454617215|FG000|Overall Study|Lost to Follow-up|0|||
126361625|NCT01313676|454617216|FG001|Overall Study|Lost to Follow-up|0|||
126361626|NCT01313676|454617217|FG002|Overall Study|Lost to Follow-up|1|||
126361627|NCT01313676|454617218|FG003|Overall Study|Lost to Follow-up|0|||
126361628|NCT01313676|454617215|FG000|Overall Study|Physician Decision|53|||
126361629|NCT01313676|454617216|FG001|Overall Study|Physician Decision|64|||
126361630|NCT01313676|454617217|FG002|Overall Study|Physician Decision|62|||
126361631|NCT01313676|454617218|FG003|Overall Study|Physician Decision|48|||
126361632|NCT01313676|454617215|FG000|Overall Study|Decision by Participant or Proxy|643|||
126361633|NCT01313676|454617216|FG001|Overall Study|Decision by Participant or Proxy|527|||
126361634|NCT01313676|454617217|FG002|Overall Study|Decision by Participant or Proxy|515|||
126361635|NCT01313676|454617218|FG003|Overall Study|Decision by Participant or Proxy|492|||
126361636|NCT01313676|454617215|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
126361637|NCT01313676|454617216|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
126361638|NCT01313676|454617217|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
126361639|NCT01313676|454617218|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
126361640|NCT01313676|454617215|FG000|Overall Study|Investigator Site Closed|12|||
126361641|NCT01313676|454617216|FG001|Overall Study|Investigator Site Closed|11|||
126361642|NCT01313676|454617217|FG002|Overall Study|Investigator Site Closed|15|||
126361643|NCT01313676|454617218|FG003|Overall Study|Investigator Site Closed|10|||
126361644|NCT01313676|454617215|FG000|Overall Study|Missing|1|||
126361645|NCT01313676|454617216|FG001|Overall Study|Missing|1|||
126361646|NCT01313676|454617217|FG002|Overall Study|Missing|1|||
126361647|NCT01313676|454617218|FG003|Overall Study|Missing|0|||
126361648|NCT02469961|454617220|FG000|Overall Study|Physician Decision|4|||
126361649|NCT02469961|454617221|FG001|Overall Study|Physician Decision|1|||
126361650|NCT05130281|454617225|FG000|Overall Study|Withdrawal by Subject|0|||
126361651|NCT05130281|454617226|FG001|Overall Study|Withdrawal by Subject|0|||
126361652|NCT05130281|454617227|FG002|Overall Study|Withdrawal by Subject|1|||
126361653|NCT06844812|454617228|FG000|Overall Study|Lost to Follow-up|5|||
126361654|NCT06844812|454617228|FG000|Overall Study|stigmatization concerns|2|||
126361655|NCT06844812|454617228|FG000|Overall Study|medication refusal|2|||
126361656|NCT06844812|454617228|FG000|Overall Study|concerns about possible side effects|2|||
126361657|NCT06844812|454617228|FG000|Overall Study|wanting to seek another specialist opinion|2|||
126361658|NCT06844812|454617228|FG000|Overall Study|side effects (dizziness)|1|||
126361659|NCT00368849|454617231|FG000|Overall Study|Withdrawal by Subject|0|||
126361660|NCT00368849|454617232|FG001|Overall Study|Withdrawal by Subject|1|||
126361661|NCT00368849|454617231|FG000|Overall Study|Physician Decision|0|||
126361662|NCT00368849|454617232|FG001|Overall Study|Physician Decision|1|||
126361663|NCT01699685|454617236|FG000|Period 1|Adverse Event|1|||
126361664|NCT01699685|454617237|FG001|Period 1|Adverse Event|1|||
126361665|NCT01699685|454617236|FG000|Period 1|Medical or ethical, noncompliance|2|||
126361666|NCT01699685|454617237|FG001|Period 1|Medical or ethical, noncompliance|0|||
126361667|NCT01699685|454617236|FG000|Period 1|Other|0|||
126361668|NCT01699685|454617237|FG001|Period 1|Other|1|||
126361669|NCT01699685|454617236|FG000|Period 1|Patient request|0|||
126361670|NCT01699685|454617237|FG001|Period 1|Patient request|1|||
126361671|NCT01699685|454617236|FG000|Period 2|Lost to Follow-up|1|||
126361672|NCT01699685|454617237|FG001|Period 2|Lost to Follow-up|0|||
126361673|NCT03635996|454617238|FG000|Overall Study|Study terminated by Sponsor|94|||
126361674|NCT03635996|454617238|FG000|Overall Study|Withdrawal by Subject|20|||
126361675|NCT03635996|454617238|FG000|Overall Study|Ablation|26|||
126361676|NCT03635996|454617238|FG000|Overall Study|Adverse Event|7|||
126361677|NCT03635996|454617238|FG000|Overall Study|Physician Decision|3|||
126361678|NCT03635996|454617238|FG000|Overall Study|Prohibited medication|5|||
126361679|NCT03635996|454617238|FG000|Overall Study|Did not meet eligibility criteria|5|||
126361680|NCT03635996|454617238|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
126361681|NCT03635996|454617238|FG000|Overall Study|Protocol Violation|1|||
126361682|NCT03635996|454617238|FG000|Overall Study|Lost to Follow-up|1|||
126361683|NCT05058456|454617239|FG000|Overall Study|Death|1|||
126361684|NCT05058456|454617239|FG000|Overall Study|End of Study data not yet due for release|34|||
126361685|NCT02933151|454617240|FG000|Overall Study|Lost to Follow-up|19|||
126361686|NCT02933151|454617241|FG001|Overall Study|Lost to Follow-up|18|||
126361687|NCT02933151|454617240|FG000|Overall Study|Death|1732|||
126361688|NCT02933151|454617241|FG001|Overall Study|Death|1827|||
126361689|NCT02933151|454617240|FG000|Overall Study|Transplant|210|||
126361690|NCT02933151|454617241|FG001|Overall Study|Transplant|278|||
126361691|NCT02933151|454617240|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
126361692|NCT02933151|454617241|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
126361693|NCT02933151|454617240|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
126361694|NCT02933151|454617241|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
126361695|NCT02933151|454617240|FG000|Overall Study|Recovered Kidney Function|47|||
126361696|NCT02933151|454617241|FG001|Overall Study|Recovered Kidney Function|29|||
126361697|NCT01428713|454617244|FG000|Overall Study|Non-compliance|2|||
126361698|NCT01428713|454617245|FG001|Overall Study|Non-compliance|2|||
126361699|NCT01428713|454617244|FG000|Overall Study|Withdrawal by Subject|1|||
126361700|NCT01428713|454617245|FG001|Overall Study|Withdrawal by Subject|1|||
126361701|NCT01428713|454617244|FG000|Overall Study|Adverse Event|0|||
126361702|NCT01428713|454617245|FG001|Overall Study|Adverse Event|2|||
126361703|NCT00862277|454617246|FG000|Overall Study|Protocol Violation|1|||
126361704|NCT00862277|454617247|FG001|Overall Study|Protocol Violation|2|||
126361705|NCT00862277|454617248|FG002|Overall Study|Protocol Violation|5|||
126361706|NCT00871000|454617249|FG000|Overall Study|Withdrawal by Subject|1|||
126361707|NCT00871000|454617250|FG001|Overall Study|Withdrawal by Subject|0|||
126271113|NCT01297465|454286607|FG000|Overall Study|Intention to Freeze all Embryos|0|||
126271114|NCT01297465|454286608|FG001|Overall Study|Intention to Freeze all Embryos|1|||
126271115|NCT00140426|454286609|FG000|Overall Study|Withdrawal by Subject|0|||
126271116|NCT00140426|454286610|FG001|Overall Study|Withdrawal by Subject|3|||
126271117|NCT02149108|454286611|FG000|Overall Study|Not treated|1|||
126271118|NCT02149108|454286612|FG001|Overall Study|Not treated|2|||
126271119|NCT02149108|454286611|FG000|Overall Study|Progressive Disease (PD)|324|||
126271120|NCT02149108|454286612|FG001|Overall Study|Progressive Disease (PD)|318|||
126271121|NCT02149108|454286611|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
126271122|NCT02149108|454286612|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
126271123|NCT02149108|454286611|FG000|Overall Study|Other Adverse Event (AE)|8|||
126271124|NCT02149108|454286612|FG001|Overall Study|Other Adverse Event (AE)|18|||
126271125|NCT02149108|454286611|FG000|Overall Study|Other not defined above|0|||
126271126|NCT02149108|454286612|FG001|Overall Study|Other not defined above|2|||
126271127|NCT02149108|454286611|FG000|Overall Study|Refusal to continue trial medication|15|||
126271128|NCT02149108|454286612|FG001|Overall Study|Refusal to continue trial medication|11|||
126271129|NCT02149108|454286611|FG000|Overall Study|Lost to Follow-up|1|||
126271130|NCT02149108|454286612|FG001|Overall Study|Lost to Follow-up|0|||
126271131|NCT00950963|454286613|FG000|Overall Study|Lost to Follow-up|29|||
126271132|NCT00950963|454286614|FG001|Overall Study|Lost to Follow-up|24|||
126271133|NCT00848107|454286615|FG000|Overall Study|Lost to Follow-up|2|||
126271134|NCT00848107|454286615|FG000|Overall Study|Withdrawal by Subject|8|||
126271135|NCT00848107|454286615|FG000|Overall Study|Adverse Event|9|||
126271136|NCT00848107|454286615|FG000|Overall Study|Death|1|||
126271137|NCT00848107|454286615|FG000|Overall Study|Pregnancy|1|||
126271138|NCT02335983|454286616|FG000|Overall Study|Sponsor Decision|0|||
126271139|NCT02335983|454286617|FG001|Overall Study|Sponsor Decision|0|||
126271140|NCT02335983|454286618|FG002|Overall Study|Sponsor Decision|1|||
126271141|NCT02335983|454286619|FG003|Overall Study|Sponsor Decision|1|||
126271142|NCT02335983|454286620|FG004|Overall Study|Sponsor Decision|0|||
126271143|NCT02335983|454286621|FG005|Overall Study|Sponsor Decision|1|||
126271144|NCT02335983|454286616|FG000|Overall Study|Withdrawal by Subject|3|||
126271145|NCT02335983|454286617|FG001|Overall Study|Withdrawal by Subject|2|||
126271146|NCT02335983|454286618|FG002|Overall Study|Withdrawal by Subject|2|||
126271147|NCT02335983|454286619|FG003|Overall Study|Withdrawal by Subject|1|||
126271148|NCT02335983|454286620|FG004|Overall Study|Withdrawal by Subject|3|||
126271149|NCT02335983|454286621|FG005|Overall Study|Withdrawal by Subject|9|||
126271150|NCT02335983|454286616|FG000|Overall Study|Death|0|||
126271151|NCT02335983|454286617|FG001|Overall Study|Death|0|||
126271152|NCT02335983|454286618|FG002|Overall Study|Death|2|||
126271153|NCT02335983|454286619|FG003|Overall Study|Death|0|||
126271154|NCT02335983|454286620|FG004|Overall Study|Death|0|||
126271155|NCT02335983|454286621|FG005|Overall Study|Death|0|||
126271156|NCT02335983|454286616|FG000|Overall Study|Lost to Follow-up|0|||
126271157|NCT02335983|454286617|FG001|Overall Study|Lost to Follow-up|0|||
126271158|NCT02335983|454286618|FG002|Overall Study|Lost to Follow-up|0|||
126271159|NCT02335983|454286619|FG003|Overall Study|Lost to Follow-up|0|||
126271160|NCT02335983|454286620|FG004|Overall Study|Lost to Follow-up|0|||
126271161|NCT02335983|454286621|FG005|Overall Study|Lost to Follow-up|1|||
126271162|NCT02335983|454286616|FG000|Overall Study|Protocol Specified Criteria|5|||
126271163|NCT02335983|454286617|FG001|Overall Study|Protocol Specified Criteria|7|||
126271164|NCT02335983|454286618|FG002|Overall Study|Protocol Specified Criteria|27|||
126271165|NCT02335983|454286619|FG003|Overall Study|Protocol Specified Criteria|7|||
126271166|NCT02335983|454286620|FG004|Overall Study|Protocol Specified Criteria|5|||
126271167|NCT02335983|454286621|FG005|Overall Study|Protocol Specified Criteria|21|||
126271168|NCT00987389|454286622|FG000|Overall Study|Ineligible|0|||
126271169|NCT00987389|454286623|FG001|Overall Study|Ineligible|3|||
126271170|NCT00987389|454286624|FG002|Overall Study|Ineligible|0|||
126271171|NCT00987389|454286625|FG003|Overall Study|Ineligible|0|||
126271172|NCT00987389|454286622|FG000|Overall Study|Lost to Follow-up|4|||
126271173|NCT00987389|454286623|FG001|Overall Study|Lost to Follow-up|1|||
126271174|NCT00987389|454286624|FG002|Overall Study|Lost to Follow-up|3|||
126271175|NCT00987389|454286625|FG003|Overall Study|Lost to Follow-up|1|||
126271176|NCT00987389|454286622|FG000|Overall Study|Withdrawal by Subject|4|||
126361708|NCT01052428|454617251|FG000|Overall Study|Death|1|||
126271177|NCT00987389|454286623|FG001|Overall Study|Withdrawal by Subject|3|||
126271178|NCT00987389|454286624|FG002|Overall Study|Withdrawal by Subject|2|||
126271179|NCT00987389|454286625|FG003|Overall Study|Withdrawal by Subject|1|||
126271180|NCT00987389|454286622|FG000|Overall Study|Withdrawn from Treatment|0|||
126271181|NCT00987389|454286623|FG001|Overall Study|Withdrawn from Treatment|1|||
126271182|NCT00987389|454286624|FG002|Overall Study|Withdrawn from Treatment|0|||
126271183|NCT00987389|454286625|FG003|Overall Study|Withdrawn from Treatment|0|||
126271184|NCT00987389|454286622|FG000|Overall Study|Multiple different reasons|1|||
126271185|NCT00987389|454286623|FG001|Overall Study|Multiple different reasons|0|||
126271186|NCT00987389|454286624|FG002|Overall Study|Multiple different reasons|3|||
126271187|NCT00987389|454286625|FG003|Overall Study|Multiple different reasons|1|||
126271188|NCT01831765|454286626|FG000|Overall Study|Lack of Efficacy|1|||
126361709|NCT01052428|454617252|FG001|Overall Study|Death|0|||
126271189|NCT01831765|454286627|FG001|Overall Study|Lack of Efficacy|0|||
126271190|NCT01831765|454286628|FG002|Overall Study|Lack of Efficacy|0|||
126271191|NCT01831765|454286626|FG000|Overall Study|Other, sponsor withdrew subject|0|||
126271192|NCT01831765|454286627|FG001|Overall Study|Other, sponsor withdrew subject|1|||
126271193|NCT01831765|454286628|FG002|Overall Study|Other, sponsor withdrew subject|0|||
126271194|NCT01831765|454286626|FG000|Overall Study|Pregnancy|1|||
126271195|NCT01831765|454286627|FG001|Overall Study|Pregnancy|1|||
126271196|NCT01831765|454286628|FG002|Overall Study|Pregnancy|2|||
126271197|NCT01831765|454286626|FG000|Overall Study|Death|0|||
126271198|NCT01831765|454286627|FG001|Overall Study|Death|1|||
126271199|NCT01831765|454286628|FG002|Overall Study|Death|1|||
126271200|NCT01831765|454286626|FG000|Overall Study|Other, site closed|1|||
126271201|NCT01831765|454286627|FG001|Overall Study|Other, site closed|1|||
126271202|NCT01831765|454286628|FG002|Overall Study|Other, site closed|0|||
126271203|NCT01831765|454286626|FG000|Overall Study|Adverse Event|5|||
126271204|NCT01831765|454286627|FG001|Overall Study|Adverse Event|3|||
126271205|NCT01831765|454286628|FG002|Overall Study|Adverse Event|3|||
126271206|NCT01831765|454286626|FG000|Overall Study|Withdrawal by Subject|22|||
126271207|NCT01831765|454286627|FG001|Overall Study|Withdrawal by Subject|7|||
126271208|NCT01831765|454286628|FG002|Overall Study|Withdrawal by Subject|17|||
126271209|NCT01831765|454286626|FG000|Overall Study|Withdrawal criteria|12|||
126271210|NCT01831765|454286627|FG001|Overall Study|Withdrawal criteria|10|||
126271211|NCT01831765|454286628|FG002|Overall Study|Withdrawal criteria|16|||
126271212|NCT01831765|454286626|FG000|Overall Study|Lost to Follow-up|2|||
126271213|NCT01831765|454286627|FG001|Overall Study|Lost to Follow-up|3|||
126271214|NCT01831765|454286628|FG002|Overall Study|Lost to Follow-up|3|||
126271215|NCT00655876|454286629|FG000|Overall Study|Protocol Violation|9|||
126271216|NCT00655876|454286630|FG001|Overall Study|Protocol Violation|7|||
126271217|NCT00326963|454286631|FG000|Overall Study|Adverse Event|2|||
126271218|NCT00326963|454286631|FG000|Overall Study|Injection site reaction|1|||
126271219|NCT00326963|454286631|FG000|Overall Study|Death|1|||
126271220|NCT00326963|454286631|FG000|Overall Study|Failure to return|10|||
126271221|NCT00326963|454286631|FG000|Overall Study|Withdrawal by Subject|10|||
126271222|NCT00326963|454286631|FG000|Overall Study|Refused treatment / did not cooperate|5|||
126271223|NCT00326963|454286631|FG000|Overall Study|Violation of selection criteria at entry|2|||
126271224|NCT00326963|454286631|FG000|Overall Study|Other protocol violation|1|||
126271225|NCT00326963|454286631|FG000|Overall Study|Administrative / other|1|||
126271226|NCT00507130|454286632|FG000|Overall Study|Lost to Follow-up|0|||
126271227|NCT00507130|454286633|FG001|Overall Study|Lost to Follow-up|0|||
126271228|NCT00507130|454286634|FG002|Overall Study|Lost to Follow-up|1|||
126271229|NCT00507130|454286635|FG003|Overall Study|Lost to Follow-up|1|||
126271230|NCT00507130|454286632|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
126271231|NCT00507130|454286633|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
126271232|NCT00507130|454286634|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
126271233|NCT00507130|454286635|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
126271234|NCT00859586|454286636|FG000|Overall Study|Donors|4|||
126271235|NCT00080938|454286641|FG000|Overall Study|Adverse Event|3|||
126271236|NCT00080938|454286641|FG000|Overall Study|Withdrawal by Subject|6|||
126271237|NCT00080938|454286641|FG000|Overall Study|Death|2|||
126271238|NCT00080938|454286641|FG000|Overall Study|Lack of Efficacy|7|||
126271239|NCT00080938|454286641|FG000|Overall Study|other disease|1|||
126271240|NCT00080938|454286641|FG000|Overall Study|Not started protocol therapy|1|||
126271241|NCT00080938|454286641|FG000|Overall Study|Ineligible|4|||
126271242|NCT00706511|454286644|FG000|Overall Study|Withdrawal by Subject|1|||
126271243|NCT00706511|454286645|FG001|Overall Study|Withdrawal by Subject|0|||
126271244|NCT00706511|454286646|FG002|Overall Study|Withdrawal by Subject|0|||
126271245|NCT00706511|454286647|FG003|Overall Study|Withdrawal by Subject|0|||
126271246|NCT02605993|454286649|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
126271247|NCT02605993|454286650|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
126271248|NCT02605993|454286651|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
126271249|NCT02605993|454286652|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
126271250|NCT02603393|454286653|FG000|Overall Study|Patient/guardian decision|32|||
126271251|NCT02603393|454286654|FG001|Overall Study|Patient/guardian decision|18|||
126271252|NCT02603393|454286653|FG000|Overall Study|Adverse Event|17|||
126271253|NCT02603393|454286654|FG001|Overall Study|Adverse Event|15|||
126271254|NCT02603393|454286653|FG000|Overall Study|Technical problems|4|||
126271255|NCT02603393|454286654|FG001|Overall Study|Technical problems|7|||
126271256|NCT02603393|454286653|FG000|Overall Study|Lack of Efficacy|7|||
126271257|NCT02603393|454286654|FG001|Overall Study|Lack of Efficacy|2|||
126271258|NCT02603393|454286653|FG000|Overall Study|Death|3|||
126271259|NCT02603393|454286654|FG001|Overall Study|Death|4|||
126271260|NCT02603393|454286653|FG000|Overall Study|Physician Decision|3|||
126271261|NCT02603393|454286654|FG001|Overall Study|Physician Decision|3|||
126271262|NCT02603393|454286653|FG000|Overall Study|Protocol deviation|2|||
126271263|NCT02603393|454286654|FG001|Overall Study|Protocol deviation|3|||
126271264|NCT02603393|454286653|FG000|Overall Study|Lost to Follow-up|1|||
126271265|NCT02603393|454286654|FG001|Overall Study|Lost to Follow-up|2|||
126271266|NCT02603393|454286653|FG000|Overall Study|Non-compliance with study treatment|1|||
126271267|NCT02603393|454286654|FG001|Overall Study|Non-compliance with study treatment|0|||
126271268|NCT02603393|454286653|FG000|Overall Study|Sponsor decision|1|||
126271269|NCT02603393|454286654|FG001|Overall Study|Sponsor decision|0|||
126271270|NCT00338455|454286662|FG000|Overall Study|Death|2|||
126271271|NCT00338455|454286663|FG001|Overall Study|Death|1|||
126271272|NCT00338455|454286662|FG000|Overall Study|Physician Decision|1|||
126271273|NCT00338455|454286663|FG001|Overall Study|Physician Decision|0|||
126271274|NCT02266134|454286664|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
126271275|NCT02266134|454286665|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
126271276|NCT02266134|454286666|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
126271277|NCT02266134|454286667|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
126271278|NCT02266134|454286664|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
126271279|NCT02266134|454286665|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
126271280|NCT02266134|454286666|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
126271281|NCT02266134|454286667|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
126271282|NCT02266134|454286664|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
126271283|NCT02266134|454286665|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
126271284|NCT02266134|454286666|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
126271285|NCT02266134|454286667|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
126271286|NCT02266134|454286664|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
126271287|NCT02266134|454286665|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
126271288|NCT02266134|454286666|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
126271289|NCT02266134|454286667|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
126271290|NCT02266134|454286664|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
126271291|NCT02266134|454286665|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
126271292|NCT02266134|454286666|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
126271293|NCT02266134|454286667|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
126271294|NCT02266134|454286664|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
126271295|NCT02266134|454286665|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
126271296|NCT02266134|454286666|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
126271297|NCT02266134|454286667|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
126271298|NCT01437943|454286670|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
126271299|NCT01437943|454286671|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
126271300|NCT01437943|454286670|FG000|Overall Study|Subject expressed pregnancy plans|1|||
126271301|NCT01437943|454286671|FG001|Overall Study|Subject expressed pregnancy plans|0|||
126271302|NCT01437943|454286670|FG000|Overall Study|Adverse Event|2|||
126271303|NCT01437943|454286671|FG001|Overall Study|Adverse Event|0|||
126271304|NCT01986010|454286672|FG000|Overall Study|Adverse Event|0|||
126271305|NCT01986010|454286673|FG001|Overall Study|Adverse Event|1|||
126271306|NCT01986010|454286674|FG002|Overall Study|Adverse Event|0|||
126271307|NCT01986010|454286675|FG003|Overall Study|Adverse Event|0|||
126271308|NCT01986010|454286676|FG004|Overall Study|Adverse Event|0|||
126271309|NCT01986010|454286677|FG005|Overall Study|Adverse Event|0|||
126271310|NCT01986010|454286678|FG006|Overall Study|Adverse Event|0|||
126271311|NCT01986010|454286679|FG007|Overall Study|Adverse Event|0|||
126271312|NCT01986010|454286680|FG008|Overall Study|Adverse Event|0|||
126271313|NCT01986010|454286681|FG009|Overall Study|Adverse Event|0|||
126271314|NCT01986010|454286682|FG010|Overall Study|Adverse Event|0|||
126271315|NCT01986010|454286683|FG011|Overall Study|Adverse Event|0|||
126271316|NCT01986010|454286684|FG012|Overall Study|Adverse Event|0|||
126271317|NCT01986010|454286685|FG013|Overall Study|Adverse Event|0|||
126036840|NCT04032704|453433089|FG017|Part B|Other|0|||
126036841|NCT04032704|453433072|FG000|Part B|Study termination by Sponsor|0|||
126036842|NCT04032704|453433073|FG001|Part B|Study termination by Sponsor|0|||
126036843|NCT04032704|453433074|FG002|Part B|Study termination by Sponsor|0|||
126036844|NCT04032704|453433075|FG003|Part B|Study termination by Sponsor|0|||
126036845|NCT04032704|453433076|FG004|Part B|Study termination by Sponsor|0|||
126036846|NCT04032704|453433077|FG005|Part B|Study termination by Sponsor|0|||
126036847|NCT04032704|453433078|FG006|Part B|Study termination by Sponsor|0|||
126036848|NCT04032704|453433079|FG007|Part B|Study termination by Sponsor|0|||
126036849|NCT04032704|453433080|FG008|Part B|Study termination by Sponsor|1|||
126036850|NCT04032704|453433081|FG009|Part B|Study termination by Sponsor|0|||
126036851|NCT04032704|453433082|FG010|Part B|Study termination by Sponsor|0|||
126036852|NCT04032704|453433083|FG011|Part B|Study termination by Sponsor|0|||
126036853|NCT04032704|453433084|FG012|Part B|Study termination by Sponsor|0|||
126271318|NCT01986010|454286686|FG014|Overall Study|Adverse Event|0|||
126036854|NCT04032704|453433085|FG013|Part B|Study termination by Sponsor|0|||
126271319|NCT01986010|454286687|FG015|Overall Study|Adverse Event|1|||
126271320|NCT01986010|454286688|FG016|Overall Study|Adverse Event|0|||
126036855|NCT04032704|453433086|FG014|Part B|Study termination by Sponsor|0|||
126036856|NCT04032704|453433087|FG015|Part B|Study termination by Sponsor|0|||
126036857|NCT04032704|453433088|FG016|Part B|Study termination by Sponsor|0|||
126036858|NCT04032704|453433089|FG017|Part B|Study termination by Sponsor|0|||
126036859|NCT04032704|453433072|FG000|Part B|Withdrawal by Subject|0|||
126271321|NCT01986010|454286672|FG000|Overall Study|Lost to Follow-up|2|||
126271322|NCT01986010|454286673|FG001|Overall Study|Lost to Follow-up|1|||
126271323|NCT01986010|454286674|FG002|Overall Study|Lost to Follow-up|2|||
126271324|NCT01986010|454286675|FG003|Overall Study|Lost to Follow-up|2|||
126271325|NCT01986010|454286676|FG004|Overall Study|Lost to Follow-up|2|||
126271326|NCT01986010|454286677|FG005|Overall Study|Lost to Follow-up|2|||
126271327|NCT01986010|454286678|FG006|Overall Study|Lost to Follow-up|0|||
126271328|NCT01986010|454286679|FG007|Overall Study|Lost to Follow-up|0|||
126271329|NCT01986010|454286680|FG008|Overall Study|Lost to Follow-up|4|||
126271330|NCT01986010|454286681|FG009|Overall Study|Lost to Follow-up|2|||
126271331|NCT01986010|454286682|FG010|Overall Study|Lost to Follow-up|0|||
126271332|NCT01986010|454286683|FG011|Overall Study|Lost to Follow-up|1|||
126271333|NCT01986010|454286684|FG012|Overall Study|Lost to Follow-up|1|||
126271334|NCT01986010|454286685|FG013|Overall Study|Lost to Follow-up|1|||
126271335|NCT01986010|454286686|FG014|Overall Study|Lost to Follow-up|2|||
126271336|NCT01986010|454286687|FG015|Overall Study|Lost to Follow-up|0|||
126271337|NCT01986010|454286688|FG016|Overall Study|Lost to Follow-up|0|||
126271338|NCT01986010|454286672|FG000|Overall Study|Physician Decision|0|||
126271339|NCT01986010|454286673|FG001|Overall Study|Physician Decision|0|||
126271340|NCT01986010|454286674|FG002|Overall Study|Physician Decision|0|||
126271341|NCT01986010|454286675|FG003|Overall Study|Physician Decision|0|||
126271342|NCT01986010|454286676|FG004|Overall Study|Physician Decision|0|||
126271343|NCT01986010|454286677|FG005|Overall Study|Physician Decision|0|||
126271344|NCT01986010|454286678|FG006|Overall Study|Physician Decision|0|||
126271345|NCT01986010|454286679|FG007|Overall Study|Physician Decision|0|||
126271346|NCT01986010|454286680|FG008|Overall Study|Physician Decision|0|||
126271347|NCT01986010|454286681|FG009|Overall Study|Physician Decision|0|||
126271348|NCT01986010|454286682|FG010|Overall Study|Physician Decision|0|||
126271349|NCT01986010|454286683|FG011|Overall Study|Physician Decision|0|||
126271350|NCT01986010|454286684|FG012|Overall Study|Physician Decision|0|||
126271351|NCT01986010|454286685|FG013|Overall Study|Physician Decision|0|||
126271352|NCT01986010|454286686|FG014|Overall Study|Physician Decision|1|||
126271353|NCT01986010|454286687|FG015|Overall Study|Physician Decision|0|||
126271354|NCT01986010|454286688|FG016|Overall Study|Physician Decision|0|||
126271355|NCT01986010|454286672|FG000|Overall Study|Withdrawal by Subject|2|||
126271356|NCT01986010|454286673|FG001|Overall Study|Withdrawal by Subject|2|||
126271357|NCT01986010|454286674|FG002|Overall Study|Withdrawal by Subject|3|||
126271358|NCT01986010|454286675|FG003|Overall Study|Withdrawal by Subject|0|||
126271359|NCT01986010|454286676|FG004|Overall Study|Withdrawal by Subject|2|||
126271360|NCT01986010|454286677|FG005|Overall Study|Withdrawal by Subject|4|||
126271361|NCT01986010|454286678|FG006|Overall Study|Withdrawal by Subject|0|||
126271362|NCT01986010|454286679|FG007|Overall Study|Withdrawal by Subject|0|||
126271363|NCT01986010|454286680|FG008|Overall Study|Withdrawal by Subject|0|||
126271364|NCT01986010|454286681|FG009|Overall Study|Withdrawal by Subject|0|||
126271365|NCT01986010|454286682|FG010|Overall Study|Withdrawal by Subject|0|||
126271366|NCT01986010|454286683|FG011|Overall Study|Withdrawal by Subject|2|||
126271367|NCT01986010|454286684|FG012|Overall Study|Withdrawal by Subject|0|||
126271368|NCT01986010|454286685|FG013|Overall Study|Withdrawal by Subject|1|||
126271369|NCT01986010|454286686|FG014|Overall Study|Withdrawal by Subject|2|||
126271370|NCT01986010|454286687|FG015|Overall Study|Withdrawal by Subject|0|||
126271371|NCT01986010|454286688|FG016|Overall Study|Withdrawal by Subject|0|||
126271372|NCT01986010|454286672|FG000|Overall Study|Status Not Recorded|2|||
126271373|NCT01986010|454286673|FG001|Overall Study|Status Not Recorded|4|||
126271374|NCT01986010|454286674|FG002|Overall Study|Status Not Recorded|2|||
126271375|NCT01986010|454286675|FG003|Overall Study|Status Not Recorded|0|||
126271376|NCT01986010|454286676|FG004|Overall Study|Status Not Recorded|1|||
126036860|NCT04032704|453433073|FG001|Part B|Withdrawal by Subject|0|||
126036861|NCT04032704|453433074|FG002|Part B|Withdrawal by Subject|0|||
126036862|NCT04032704|453433075|FG003|Part B|Withdrawal by Subject|0|||
126271377|NCT01986010|454286677|FG005|Overall Study|Status Not Recorded|2|||
126271378|NCT01986010|454286678|FG006|Overall Study|Status Not Recorded|0|||
126271379|NCT01986010|454286679|FG007|Overall Study|Status Not Recorded|0|||
126036863|NCT04032704|453433076|FG004|Part B|Withdrawal by Subject|0|||
126036864|NCT04032704|453433077|FG005|Part B|Withdrawal by Subject|0|||
126271380|NCT01986010|454286680|FG008|Overall Study|Status Not Recorded|2|||
126036865|NCT04032704|453433078|FG006|Part B|Withdrawal by Subject|3|||
126098571|NCT01029652|453653043|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
126271381|NCT01986010|454286681|FG009|Overall Study|Status Not Recorded|1|||
126271382|NCT01986010|454286682|FG010|Overall Study|Status Not Recorded|7|||
126271383|NCT01986010|454286683|FG011|Overall Study|Status Not Recorded|7|||
126271384|NCT01986010|454286684|FG012|Overall Study|Status Not Recorded|9|||
126271385|NCT01986010|454286685|FG013|Overall Study|Status Not Recorded|9|||
126271386|NCT01986010|454286686|FG014|Overall Study|Status Not Recorded|5|||
126271387|NCT01986010|454286687|FG015|Overall Study|Status Not Recorded|10|||
126271388|NCT01986010|454286688|FG016|Overall Study|Status Not Recorded|4|||
126271389|NCT01335997|454286689|FG000|Period I and II|Adverse Event|63|||
126271390|NCT01335997|454286690|FG001|Period I and II|Adverse Event|43|||
126271391|NCT01335997|454286689|FG000|Period I and II|Noncompliance with Study Drug|1|||
126271392|NCT01335997|454286690|FG001|Period I and II|Noncompliance with Study Drug|1|||
126271393|NCT01335997|454286689|FG000|Period I and II|Lost to Follow-up|3|||
126271394|NCT01335997|454286690|FG001|Period I and II|Lost to Follow-up|5|||
126271395|NCT01335997|454286689|FG000|Period I and II|Withdrawal by Subject|9|||
126271396|NCT01335997|454286690|FG001|Period I and II|Withdrawal by Subject|4|||
126271397|NCT01335997|454286689|FG000|Period I and II|Study Terminated by Sponsor|406|||
126271398|NCT01335997|454286690|FG001|Period I and II|Study Terminated by Sponsor|415|||
126271399|NCT01335997|454286689|FG000|Period I and II|Protocol Violation|9|||
126271400|NCT01335997|454286690|FG001|Period I and II|Protocol Violation|10|||
126271401|NCT01335997|454286689|FG000|Period I and II|Physician Decision|2|||
126271402|NCT01335997|454286690|FG001|Period I and II|Physician Decision|1|||
126271403|NCT01335997|454286689|FG000|Period III|Adverse Event|0|||
126271404|NCT01335997|454286690|FG001|Period III|Adverse Event|2|||
126271405|NCT01335997|454286689|FG000|Period III|Study Terminated by Sponsor|77|||
126271406|NCT01335997|454286690|FG001|Period III|Study Terminated by Sponsor|76|||
126271407|NCT01335997|454286689|FG000|Period III|Protocol Violation|0|||
126271408|NCT01335997|454286690|FG001|Period III|Protocol Violation|1|||
126271409|NCT01335997|454286689|FG000|Period III|Lost to Follow-up|1|||
126271410|NCT01335997|454286690|FG001|Period III|Lost to Follow-up|0|||
126271411|NCT04740814|454286691|FG000|Overall Study|Adverse Event|3|||
126271412|NCT04740814|454286691|FG000|Overall Study|Protocol Violation|2|||
126271413|NCT04740814|454286691|FG000|Overall Study|Lost to Follow-up|2|||
126271414|NCT04740814|454286691|FG000|Overall Study|Withdrawal by Subject|3|||
126271415|NCT01763684|454286692|FG000|Overall Study|Study terminated early due to low enrollment|126|||
126271416|NCT01763684|454286693|FG001|Overall Study|Study terminated early due to low enrollment|127|||
126271417|NCT01763684|454286692|FG000|Overall Study|Study surgery not performed|7|||
126271418|NCT01763684|454286693|FG001|Overall Study|Study surgery not performed|6|||
126271419|NCT04453202|454286698|FG000|Overall Study|Adverse Event|0|||
126271420|NCT04453202|454286699|FG001|Overall Study|Adverse Event|0|||
126271421|NCT04453202|454286700|FG002|Overall Study|Adverse Event|0|||
126271422|NCT04453202|454286701|FG003|Overall Study|Adverse Event|0|||
126271423|NCT04453202|454286702|FG004|Overall Study|Adverse Event|0|||
126271424|NCT04453202|454286703|FG005|Overall Study|Adverse Event|0|||
126271425|NCT04453202|454286704|FG006|Overall Study|Adverse Event|1|||
126271426|NCT04453202|454286705|FG007|Overall Study|Adverse Event|0|||
126271427|NCT04453202|454286706|FG008|Overall Study|Adverse Event|0|||
126271428|NCT04453202|454286707|FG009|Overall Study|Adverse Event|0|||
126271429|NCT04453202|454286708|FG010|Overall Study|Adverse Event|0|||
126271430|NCT04453202|454286698|FG000|Overall Study|Death|0|||
126271431|NCT04453202|454286699|FG001|Overall Study|Death|0|||
126271432|NCT04453202|454286700|FG002|Overall Study|Death|0|||
126271433|NCT04453202|454286701|FG003|Overall Study|Death|0|||
126271434|NCT04453202|454286702|FG004|Overall Study|Death|0|||
126271435|NCT04453202|454286703|FG005|Overall Study|Death|0|||
126271436|NCT04453202|454286704|FG006|Overall Study|Death|0|||
126271437|NCT04453202|454286705|FG007|Overall Study|Death|0|||
126271438|NCT04453202|454286706|FG008|Overall Study|Death|0|||
126271439|NCT04453202|454286707|FG009|Overall Study|Death|1|||
126271440|NCT04453202|454286708|FG010|Overall Study|Death|0|||
126271441|NCT04453202|454286698|FG000|Overall Study|Lost to Follow-up|0|||
126271442|NCT04453202|454286699|FG001|Overall Study|Lost to Follow-up|1|||
126271443|NCT04453202|454286700|FG002|Overall Study|Lost to Follow-up|0|||
126271444|NCT04453202|454286701|FG003|Overall Study|Lost to Follow-up|1|||
126271445|NCT04453202|454286702|FG004|Overall Study|Lost to Follow-up|0|||
126271446|NCT04453202|454286703|FG005|Overall Study|Lost to Follow-up|0|||
126271447|NCT04453202|454286704|FG006|Overall Study|Lost to Follow-up|0|||
126271448|NCT04453202|454286705|FG007|Overall Study|Lost to Follow-up|0|||
126271449|NCT04453202|454286706|FG008|Overall Study|Lost to Follow-up|0|||
126271450|NCT04453202|454286707|FG009|Overall Study|Lost to Follow-up|1|||
126271451|NCT04453202|454286708|FG010|Overall Study|Lost to Follow-up|1|||
126271452|NCT04453202|454286698|FG000|Overall Study|Withdrawal by Subject|1|||
126271453|NCT04453202|454286699|FG001|Overall Study|Withdrawal by Subject|2|||
126271454|NCT04453202|454286700|FG002|Overall Study|Withdrawal by Subject|1|||
126271455|NCT04453202|454286701|FG003|Overall Study|Withdrawal by Subject|2|||
126036866|NCT04032704|453433079|FG007|Part B|Withdrawal by Subject|2|||
126036867|NCT04032704|453433080|FG008|Part B|Withdrawal by Subject|2|||
126036868|NCT04032704|453433081|FG009|Part B|Withdrawal by Subject|1|||
126271456|NCT04453202|454286702|FG004|Overall Study|Withdrawal by Subject|1|||
126271457|NCT04453202|454286703|FG005|Overall Study|Withdrawal by Subject|1|||
126271458|NCT04453202|454286704|FG006|Overall Study|Withdrawal by Subject|0|||
126271459|NCT04453202|454286705|FG007|Overall Study|Withdrawal by Subject|0|||
126271460|NCT04453202|454286706|FG008|Overall Study|Withdrawal by Subject|0|||
126271461|NCT04453202|454286707|FG009|Overall Study|Withdrawal by Subject|1|||
126271462|NCT04453202|454286708|FG010|Overall Study|Withdrawal by Subject|0|||
126271463|NCT04453202|454286698|FG000|Overall Study|Adverse Event|0|||
126271464|NCT04453202|454286699|FG001|Overall Study|Adverse Event|0|||
126271465|NCT04453202|454286700|FG002|Overall Study|Adverse Event|0|||
126271466|NCT04453202|454286701|FG003|Overall Study|Adverse Event|0|||
126271467|NCT04453202|454286702|FG004|Overall Study|Adverse Event|0|||
126271468|NCT04453202|454286703|FG005|Overall Study|Adverse Event|1|||
126271469|NCT04453202|454286704|FG006|Overall Study|Adverse Event|0|||
126271470|NCT04453202|454286705|FG007|Overall Study|Adverse Event|0|||
126271471|NCT04453202|454286706|FG008|Overall Study|Adverse Event|0|||
126271472|NCT04453202|454286707|FG009|Overall Study|Adverse Event|0|||
126271473|NCT04453202|454286708|FG010|Overall Study|Adverse Event|0|||
126271474|NCT01157897|454286709|FG000|Overall Study|Lost to Follow-up|2|||
126271475|NCT01157897|454286710|FG001|Overall Study|Lost to Follow-up|0|||
126271476|NCT01157897|454286711|FG002|Overall Study|Lost to Follow-up|0|||
126271477|NCT01157897|454286712|FG003|Overall Study|Lost to Follow-up|1|||
126271478|NCT01157897|454286709|FG000|Overall Study|Relocated|0|||
126271479|NCT01157897|454286710|FG001|Overall Study|Relocated|2|||
126271480|NCT01157897|454286711|FG002|Overall Study|Relocated|0|||
126271481|NCT01157897|454286712|FG003|Overall Study|Relocated|0|||
126271482|NCT03276221|454286713|FG000|Overall Study|Lost to Follow-up|6|||
126271483|NCT03276221|454286714|FG001|Overall Study|Lost to Follow-up|2|||
126271484|NCT03276221|454286715|FG002|Overall Study|Lost to Follow-up|0|||
126271485|NCT03276221|454286713|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
126271486|NCT03276221|454286714|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
126271487|NCT03276221|454286715|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
126271488|NCT02912650|454286716|FG000|Overall Study|Withdrawal by Subject|1|||
126271489|NCT02912650|454286717|FG001|Overall Study|Withdrawal by Subject|0|||
126271490|NCT02912650|454286718|FG002|Overall Study|Withdrawal by Subject|1|||
126271491|NCT02912650|454286719|FG003|Overall Study|Withdrawal by Subject|5|||
126271492|NCT02912650|454286716|FG000|Overall Study|Adverse Event|0|||
126271493|NCT02912650|454286717|FG001|Overall Study|Adverse Event|0|||
126271494|NCT02912650|454286718|FG002|Overall Study|Adverse Event|1|||
126271495|NCT02912650|454286719|FG003|Overall Study|Adverse Event|0|||
126271496|NCT02562482|454286721|FG000|Overall Study|Enrolled, but did not receive product|4|||
126271497|NCT02562482|454286722|FG001|Overall Study|Enrolled, but did not receive product|0|||
126271498|NCT02562482|454286721|FG000|Overall Study|Lost to Follow-up|9|||
126271499|NCT02562482|454286722|FG001|Overall Study|Lost to Follow-up|6|||
126271500|NCT02562482|454286721|FG000|Overall Study|Moved from area|2|||
126271501|NCT02562482|454286722|FG001|Overall Study|Moved from area|3|||
126271502|NCT02562482|454286721|FG000|Overall Study|Withdrawal by Subject|5|||
126271503|NCT02562482|454286722|FG001|Overall Study|Withdrawal by Subject|3|||
126271504|NCT02562482|454286721|FG000|Overall Study|Physician Decision|1|||
126271505|NCT02562482|454286722|FG001|Overall Study|Physician Decision|3|||
126271506|NCT02562482|454286721|FG000|Overall Study|Illness/Injury unrelated to product|0|||
126271507|NCT02562482|454286722|FG001|Overall Study|Illness/Injury unrelated to product|1|||
126271508|NCT02980874|454286727|FG000|Overall Study|Adverse Event|2|||
126271509|NCT02980874|454286728|FG001|Overall Study|Adverse Event|7|||
126271510|NCT02980874|454286727|FG000|Overall Study|Withdrawal by Subject|7|||
126271511|NCT02980874|454286728|FG001|Overall Study|Withdrawal by Subject|2|||
126271512|NCT02980874|454286727|FG000|Overall Study|Lost to Follow-up|5|||
126271513|NCT02980874|454286728|FG001|Overall Study|Lost to Follow-up|5|||
126271514|NCT02980874|454286727|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
126271515|NCT02980874|454286728|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
126271516|NCT02980874|454286727|FG000|Overall Study|Unknown study completion status|1|||
126271517|NCT02980874|454286728|FG001|Overall Study|Unknown study completion status|0|||
126271518|NCT02722148|454286729|FG000|Overall Study|Lost to Follow-up|2|||
126271519|NCT02722148|454286729|FG000|Overall Study|Non compliant with treatment regimen|3|||
126271520|NCT02435836|454286730|FG000|Overall Study|Lost to Follow-up|21|||
126271521|NCT02435836|454286730|FG000|Overall Study|Lack of Efficacy|1|||
126271522|NCT02435836|454286730|FG000|Overall Study|Withdrawal by Subject|236|||
126271523|NCT02435836|454286730|FG000|Overall Study|Insufficient Clinical Response|26|||
126271524|NCT02435836|454286730|FG000|Overall Study|Adverse Event|44|||
126271525|NCT02435836|454286730|FG000|Overall Study|Sponsor discontinued trial|167|||
126271526|NCT02435836|454286730|FG000|Overall Study|Noncompliance|27|||
126271527|NCT02435836|454286730|FG000|Overall Study|Protocol Violation|6|||
126271528|NCT02435836|454286730|FG000|Overall Study|Met Withdrawal Criteria|7|||
126271529|NCT02435836|454286730|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
126271530|NCT02041091|454286731|FG000|Treatment|Adverse Event|3|||
126271531|NCT02041091|454286732|FG001|Treatment|Adverse Event|3|||
126271532|NCT02041091|454286731|FG000|Treatment|Withdrawal by Subject|2|||
126271533|NCT02041091|454286732|FG001|Treatment|Withdrawal by Subject|4|||
126271534|NCT02041091|454286731|FG000|Treatment|Physician Decision|1|||
126036869|NCT04032704|453433082|FG010|Part B|Withdrawal by Subject|4|||
126271535|NCT02041091|454286732|FG001|Treatment|Physician Decision|0|||
126271536|NCT02041091|454286731|FG000|Treatment|Sponsor Decision|15|||
126271537|NCT02041091|454286732|FG001|Treatment|Sponsor Decision|16|||
126271538|NCT02041091|454286731|FG000|Treatment|Lost to Follow-up|1|||
126271539|NCT02041091|454286732|FG001|Treatment|Lost to Follow-up|0|||
126271540|NCT02041091|454286731|FG000|Optional Safety Extension Period|Adverse Event|4|||
126271541|NCT02041091|454286732|FG001|Optional Safety Extension Period|Adverse Event|2|||
126271542|NCT02041091|454286731|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
126271543|NCT02041091|454286732|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
126271544|NCT02041091|454286731|FG000|Optional Safety Extension Period|Protocol Violation|2|||
126271545|NCT02041091|454286732|FG001|Optional Safety Extension Period|Protocol Violation|0|||
126271546|NCT02041091|454286731|FG000|Optional Safety Extension Period|Physician Decision|2|||
126271547|NCT02041091|454286732|FG001|Optional Safety Extension Period|Physician Decision|1|||
126271548|NCT02041091|454286731|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
126271549|NCT02041091|454286732|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
126271550|NCT02041091|454286731|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
126271551|NCT02041091|454286732|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
126271552|NCT00922987|454286733|FG000|Overall Study|Insufficient clinical response|1|||
126271553|NCT00922987|454286733|FG000|Overall Study|Protocol Violation|2|||
126271554|NCT00922987|454286733|FG000|Overall Study|Adverse Event|1|||
126271555|NCT00446199|454286734|FG000|Overall Study|Adverse Event|7|||
126271556|NCT00446199|454286735|FG001|Overall Study|Adverse Event|4|||
126271557|NCT00446199|454286736|FG002|Overall Study|Adverse Event|6|||
126271558|NCT00446199|454286737|FG003|Overall Study|Adverse Event|4|||
126271559|NCT00446199|454286734|FG000|Overall Study|Lost to Follow-up|4|||
126271560|NCT00446199|454286735|FG001|Overall Study|Lost to Follow-up|5|||
126271561|NCT00446199|454286736|FG002|Overall Study|Lost to Follow-up|2|||
126271562|NCT00446199|454286737|FG003|Overall Study|Lost to Follow-up|6|||
126271563|NCT00446199|454286734|FG000|Overall Study|Protocol Violation|1|||
126271564|NCT00446199|454286735|FG001|Overall Study|Protocol Violation|2|||
126271565|NCT00446199|454286736|FG002|Overall Study|Protocol Violation|1|||
126271566|NCT00446199|454286737|FG003|Overall Study|Protocol Violation|3|||
126271567|NCT00446199|454286734|FG000|Overall Study|Withdrawal by Subject|2|||
126271568|NCT00446199|454286735|FG001|Overall Study|Withdrawal by Subject|5|||
126271569|NCT00446199|454286736|FG002|Overall Study|Withdrawal by Subject|9|||
126271570|NCT00446199|454286737|FG003|Overall Study|Withdrawal by Subject|10|||
126271571|NCT00446199|454286734|FG000|Overall Study|Site termination|2|||
126271572|NCT00446199|454286735|FG001|Overall Study|Site termination|0|||
126271573|NCT00446199|454286736|FG002|Overall Study|Site termination|0|||
126271574|NCT00446199|454286737|FG003|Overall Study|Site termination|1|||
126271575|NCT00446199|454286734|FG000|Overall Study|Randomization in Error|2|||
126271576|NCT00446199|454286735|FG001|Overall Study|Randomization in Error|0|||
126271577|NCT00446199|454286736|FG002|Overall Study|Randomization in Error|1|||
126271578|NCT00446199|454286737|FG003|Overall Study|Randomization in Error|1|||
126271579|NCT00446199|454286734|FG000|Overall Study|Lack of Efficacy|1|||
126271580|NCT00446199|454286735|FG001|Overall Study|Lack of Efficacy|0|||
126271581|NCT00446199|454286736|FG002|Overall Study|Lack of Efficacy|0|||
126271582|NCT00446199|454286737|FG003|Overall Study|Lack of Efficacy|1|||
126271583|NCT00446199|454286734|FG000|Overall Study|Non-compliant with study drug|1|||
126271584|NCT00446199|454286735|FG001|Overall Study|Non-compliant with study drug|0|||
126271585|NCT00446199|454286736|FG002|Overall Study|Non-compliant with study drug|5|||
126271586|NCT00446199|454286737|FG003|Overall Study|Non-compliant with study drug|0|||
126271587|NCT00446199|454286734|FG000|Overall Study|Non-compliant with visit schedule|1|||
126271588|NCT00446199|454286735|FG001|Overall Study|Non-compliant with visit schedule|1|||
126271589|NCT00446199|454286736|FG002|Overall Study|Non-compliant with visit schedule|1|||
126271590|NCT00446199|454286737|FG003|Overall Study|Non-compliant with visit schedule|2|||
126271591|NCT00446199|454286734|FG000|Overall Study|Hormone fear|0|||
126271592|NCT00446199|454286735|FG001|Overall Study|Hormone fear|0|||
126271593|NCT00446199|454286736|FG002|Overall Study|Hormone fear|0|||
126271594|NCT00446199|454286737|FG003|Overall Study|Hormone fear|1|||
126271595|NCT00446199|454286734|FG000|Overall Study|Lost interest in study participation|0|||
126271596|NCT00446199|454286735|FG001|Overall Study|Lost interest in study participation|1|||
126271597|NCT00446199|454286736|FG002|Overall Study|Lost interest in study participation|0|||
126271598|NCT00446199|454286737|FG003|Overall Study|Lost interest in study participation|0|||
126271599|NCT00446199|454286734|FG000|Overall Study|In-/Exclusion criterion violated|2|||
126036870|NCT04032704|453433083|FG011|Part B|Withdrawal by Subject|6|||
126036871|NCT04032704|453433084|FG012|Part B|Withdrawal by Subject|2|||
126036872|NCT04032704|453433085|FG013|Part B|Withdrawal by Subject|1|||
126036873|NCT04032704|453433086|FG014|Part B|Withdrawal by Subject|0|||
126036874|NCT04032704|453433087|FG015|Part B|Withdrawal by Subject|1|||
126271600|NCT00446199|454286735|FG001|Overall Study|In-/Exclusion criterion violated|1|||
126271601|NCT00446199|454286736|FG002|Overall Study|In-/Exclusion criterion violated|2|||
126271602|NCT00446199|454286737|FG003|Overall Study|In-/Exclusion criterion violated|1|||
126271603|NCT00446199|454286734|FG000|Overall Study|Move|0|||
126271604|NCT00446199|454286735|FG001|Overall Study|Move|1|||
126271605|NCT00446199|454286736|FG002|Overall Study|Move|0|||
126271606|NCT00446199|454286737|FG003|Overall Study|Move|0|||
126271607|NCT03071094|454286738|FG000|Overall Study|Death|1|||
126271608|NCT03071094|454286739|FG001|Overall Study|Death|1|||
126271609|NCT03071094|454286738|FG000|Overall Study|Adverse Event|1|||
126036875|NCT04032704|453433088|FG016|Part B|Withdrawal by Subject|0|||
126036876|NCT04032704|453433089|FG017|Part B|Withdrawal by Subject|0|||
126271610|NCT03071094|454286739|FG001|Overall Study|Adverse Event|0|||
126271611|NCT02312063|454286740|FG000|Overall Study|Withdrawal by Subject|0|||
126271612|NCT02312063|454286741|FG001|Overall Study|Withdrawal by Subject|1|||
126271613|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
126271614|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
126271615|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271616|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271617|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271618|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271619|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271620|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271621|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271622|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271623|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271624|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271625|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271626|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271627|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
126271628|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
126271629|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271630|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271631|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271632|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271633|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271634|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271635|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271636|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271637|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271638|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271639|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271640|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271641|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
126271642|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
126271643|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271644|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271645|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271646|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271647|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271648|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271649|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271650|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271651|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271652|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271653|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271654|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271655|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
126271656|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
126271657|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271658|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271659|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126036877|NCT04032704|453433072|FG000|Part B|Lost to Follow-up|0|||
126036878|NCT04032704|453433073|FG001|Part B|Lost to Follow-up|0|||
126036879|NCT04032704|453433074|FG002|Part B|Lost to Follow-up|0|||
126036880|NCT04032704|453433075|FG003|Part B|Lost to Follow-up|0|||
126036881|NCT04032704|453433076|FG004|Part B|Lost to Follow-up|0|||
126036882|NCT04032704|453433077|FG005|Part B|Lost to Follow-up|0|||
126036883|NCT04032704|453433078|FG006|Part B|Lost to Follow-up|0|||
126036884|NCT04032704|453433079|FG007|Part B|Lost to Follow-up|0|||
126036885|NCT04032704|453433080|FG008|Part B|Lost to Follow-up|0|||
126036886|NCT04032704|453433081|FG009|Part B|Lost to Follow-up|0|||
126036887|NCT04032704|453433082|FG010|Part B|Lost to Follow-up|0|||
126036888|NCT04032704|453433083|FG011|Part B|Lost to Follow-up|1|||
126036889|NCT04032704|453433084|FG012|Part B|Lost to Follow-up|0|||
126036890|NCT04032704|453433085|FG013|Part B|Lost to Follow-up|0|||
126036891|NCT04032704|453433086|FG014|Part B|Lost to Follow-up|0|||
126036892|NCT04032704|453433087|FG015|Part B|Lost to Follow-up|0|||
126036893|NCT04032704|453433088|FG016|Part B|Lost to Follow-up|0|||
126036894|NCT04032704|453433089|FG017|Part B|Lost to Follow-up|0|||
126036895|NCT04032704|453433072|FG000|Part B|Death|0|||
126036896|NCT04032704|453433073|FG001|Part B|Death|0|||
126036897|NCT04032704|453433074|FG002|Part B|Death|0|||
126036898|NCT04032704|453433075|FG003|Part B|Death|0|||
126036899|NCT04032704|453433076|FG004|Part B|Death|0|||
126036900|NCT04032704|453433077|FG005|Part B|Death|0|||
126271660|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271661|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271662|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271663|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271664|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271665|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271666|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271667|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271668|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271669|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
126271670|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
126271671|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271672|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271673|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271674|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271675|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271676|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271677|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271678|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271679|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271680|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271681|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271682|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271683|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
126271684|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
126271685|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271686|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271687|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271688|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271689|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271690|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126036901|NCT04032704|453433078|FG006|Part B|Death|13|||
126036902|NCT04032704|453433079|FG007|Part B|Death|13|||
126036903|NCT04032704|453433080|FG008|Part B|Death|14|||
126036904|NCT04032704|453433081|FG009|Part B|Death|12|||
126036905|NCT04032704|453433082|FG010|Part B|Death|12|||
126036906|NCT04032704|453433083|FG011|Part B|Death|13|||
126036907|NCT04032704|453433084|FG012|Part B|Death|7|||
126036908|NCT04032704|453433085|FG013|Part B|Death|17|||
126036909|NCT04032704|453433086|FG014|Part B|Death|2|||
126036910|NCT04032704|453433087|FG015|Part B|Death|1|||
126036911|NCT04032704|453433088|FG016|Part B|Death|2|||
126036912|NCT04032704|453433089|FG017|Part B|Death|2|||
126036913|NCT02861300|453433090|FG000|Overall Study|Death|0|||
126036914|NCT02861300|453433091|FG001|Overall Study|Death|0|||
126036915|NCT02861300|453433092|FG002|Overall Study|Death|0|||
126036916|NCT02861300|453433093|FG003|Overall Study|Death|0|||
126036917|NCT02861300|453433094|FG004|Overall Study|Death|0|||
126036918|NCT02861300|453433095|FG005|Overall Study|Death|0|||
126036919|NCT02861300|453433096|FG006|Overall Study|Death|24|||
126036920|NCT02861300|453433090|FG000|Overall Study|Delay in treatment|0|||
126036921|NCT02861300|453433091|FG001|Overall Study|Delay in treatment|0|||
126036922|NCT02861300|453433092|FG002|Overall Study|Delay in treatment|0|||
126036923|NCT02861300|453433093|FG003|Overall Study|Delay in treatment|0|||
126036924|NCT02861300|453433094|FG004|Overall Study|Delay in treatment|0|||
126271691|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126036925|NCT02861300|453433095|FG005|Overall Study|Delay in treatment|1|||
126036926|NCT02861300|453433096|FG006|Overall Study|Delay in treatment|0|||
126036927|NCT02861300|453433090|FG000|Overall Study|Disease Progression|0|||
126036928|NCT02861300|453433091|FG001|Overall Study|Disease Progression|1|||
126036929|NCT02861300|453433092|FG002|Overall Study|Disease Progression|0|||
126036930|NCT02861300|453433093|FG003|Overall Study|Disease Progression|0|||
126036931|NCT02861300|453433094|FG004|Overall Study|Disease Progression|0|||
126271692|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271693|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271694|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271695|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271696|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271697|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
126271698|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
126271699|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271700|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271701|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271702|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271703|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271704|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271705|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271706|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271707|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271708|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271709|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271710|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271711|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
126271712|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
126271713|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271714|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271715|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271716|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271717|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271718|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271719|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271720|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271721|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271722|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271723|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271724|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271725|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
126271726|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
126271727|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271728|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126098572|NCT01029652|453653042|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
126098573|NCT01029652|453653043|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
126098574|NCT01029652|453653042|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
126098575|NCT01029652|453653043|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
126271729|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271730|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271731|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271732|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271733|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271734|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271735|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126361710|NCT01052428|454617251|FG000|Overall Study|Withdrawal by Subject|0|||
126036932|NCT02861300|453433095|FG005|Overall Study|Disease Progression|0|||
126036933|NCT02861300|453433096|FG006|Overall Study|Disease Progression|2|||
126098576|NCT01029652|453653042|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
126271736|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271737|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271738|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271739|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
126098577|NCT01029652|453653043|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
126361711|NCT01052428|454617252|FG001|Overall Study|Withdrawal by Subject|1|||
126036934|NCT02861300|453433090|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
126036935|NCT02861300|453433091|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
126036936|NCT02861300|453433092|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
126036937|NCT02861300|453433093|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
126036938|NCT02861300|453433094|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
126036939|NCT02861300|453433095|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
126036940|NCT02861300|453433096|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
126036941|NCT02861300|453433090|FG000|Overall Study|Clinical Complications|0|||
126036942|NCT02861300|453433091|FG001|Overall Study|Clinical Complications|0|||
126036943|NCT02861300|453433092|FG002|Overall Study|Clinical Complications|0|||
126036944|NCT02861300|453433093|FG003|Overall Study|Clinical Complications|0|||
126036945|NCT02861300|453433094|FG004|Overall Study|Clinical Complications|0|||
126036946|NCT02861300|453433095|FG005|Overall Study|Clinical Complications|0|||
126036947|NCT02861300|453433096|FG006|Overall Study|Clinical Complications|1|||
126036948|NCT02465268|453433097|FG000|Overall Study|Withdrawal by Subject|4|||
126036949|NCT02465268|453433098|FG001|Overall Study|Withdrawal by Subject|3|||
126036950|NCT02465268|453433099|FG002|Overall Study|Withdrawal by Subject|1|||
126036951|NCT02465268|453433097|FG000|Overall Study|Not evaluable per protocol criteria|3|||
126036952|NCT02465268|453433098|FG001|Overall Study|Not evaluable per protocol criteria|2|||
126036953|NCT02465268|453433099|FG002|Overall Study|Not evaluable per protocol criteria|1|||
126271740|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
126271741|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271742|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271743|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271744|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271745|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271746|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271747|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271748|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271749|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271750|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271751|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271752|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271753|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
126271754|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
126271755|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271756|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271757|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271758|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271759|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271760|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271761|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271762|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271763|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271764|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271765|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271766|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271767|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
126271768|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
126271769|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271770|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271771|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271772|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271773|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271774|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271775|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271776|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271777|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271778|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271779|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271780|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126036954|NCT02465268|453433097|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
126036955|NCT02465268|453433098|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
126036956|NCT02465268|453433099|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
126036957|NCT02465268|453433097|FG000|Overall Study|Study drug did not pass QA/QC|1|||
126036958|NCT02465268|453433098|FG001|Overall Study|Study drug did not pass QA/QC|0|||
126036959|NCT02465268|453433099|FG002|Overall Study|Study drug did not pass QA/QC|0|||
126036960|NCT02465268|453433097|FG000|Overall Study|Adverse Event|0|||
126036961|NCT02465268|453433098|FG001|Overall Study|Adverse Event|1|||
126036962|NCT02465268|453433099|FG002|Overall Study|Adverse Event|0|||
126036963|NCT02465268|453433097|FG000|Overall Study|Physician Decision|0|||
126036964|NCT02465268|453433098|FG001|Overall Study|Physician Decision|1|||
126036965|NCT02465268|453433099|FG002|Overall Study|Physician Decision|0|||
126036966|NCT01501955|453433102|FG000|Overall Study|Withdrawal by Subject|1|||
126036967|NCT01501955|453433103|FG001|Overall Study|Withdrawal by Subject|0|||
126036968|NCT01501955|453433102|FG000|Overall Study|Adverse Event|1|||
126036969|NCT01501955|453433103|FG001|Overall Study|Adverse Event|3|||
126036970|NCT04524442|453433109|FG000|Overall Study|Subject Decision|1|||
126036971|NCT05228457|453433110|FG000|Overall Study|Withdrawal by Subject|1|||
126036972|NCT05228457|453433111|FG001|Overall Study|Withdrawal by Subject|1|||
126036973|NCT03213691|453433116|FG000|Overall Study|Adverse Event|2|||
126036974|NCT03213691|453433116|FG000|Overall Study|Death|3|||
126036975|NCT03213691|453433116|FG000|Overall Study|Physician Decision|1|||
126036976|NCT03213691|453433116|FG000|Overall Study|Progressive Disease|14|||
126036977|NCT03213691|453433116|FG000|Overall Study|Ineligible|1|||
126036978|NCT01152450|453433119|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
126036979|NCT01152450|453433120|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
126036980|NCT01152450|453433121|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
126036981|NCT01152450|453433122|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
126036982|NCT01152450|453433123|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
126036983|NCT01152450|453433124|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
126036984|NCT01152450|453433119|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
126036985|NCT01152450|453433120|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
126036986|NCT01152450|453433121|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
126036987|NCT01152450|453433122|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
126036988|NCT01152450|453433123|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
126036989|NCT01152450|453433124|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
126036990|NCT01152450|453433119|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126036991|NCT01152450|453433120|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
126036992|NCT01152450|453433121|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
126036993|NCT01152450|453433122|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126036994|NCT01152450|453433123|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126036995|NCT01152450|453433124|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126036996|NCT02966873|453433125|FG000|Overall Study|Lost to Follow-up|16|||
126036997|NCT02966873|453433126|FG001|Overall Study|Lost to Follow-up|15|||
126036998|NCT02626533|453433127|FG000|Overall Study|Protocol Violation|14|||
126036999|NCT02626533|453433127|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
126037000|NCT02626533|453433127|FG000|Overall Study|Withdrawal by Subject|1|||
126037001|NCT04753697|453433128|FG000|Induction Phase|Withdrawal by Subject|12|||
126037002|NCT04753697|453433129|FG001|Induction Phase|Withdrawal by Subject|5|||
126037003|NCT04753697|453433130|FG002|Induction Phase|Withdrawal by Subject|6|||
126037004|NCT04753697|453433128|FG000|Induction Phase|Physician Decision|1|||
126037005|NCT04753697|453433129|FG001|Induction Phase|Physician Decision|0|||
126037006|NCT04753697|453433130|FG002|Induction Phase|Physician Decision|0|||
126037007|NCT04753697|453433128|FG000|Induction Phase|Lost to Follow-up|2|||
126037008|NCT04753697|453433129|FG001|Induction Phase|Lost to Follow-up|2|||
126037009|NCT04753697|453433130|FG002|Induction Phase|Lost to Follow-up|1|||
126037010|NCT04753697|453433128|FG000|Induction Phase|Lack of Efficacy|1|||
126037011|NCT04753697|453433129|FG001|Induction Phase|Lack of Efficacy|0|||
126037012|NCT04753697|453433130|FG002|Induction Phase|Lack of Efficacy|0|||
126271781|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271782|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271783|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271784|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
126271785|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271786|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271787|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271788|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271789|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271790|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271791|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126037013|NCT04753697|453433128|FG000|Maintenance Phase|Physician Decision|0|||
126037014|NCT04753697|453433129|FG001|Maintenance Phase|Physician Decision|0|||
126037015|NCT04753697|453433130|FG002|Maintenance Phase|Physician Decision|1|||
126037016|NCT04753697|453433128|FG000|Maintenance Phase|Withdrawal by Subject|3|||
126361712|NCT03400787|454617253|FG000|Overall Study|Lost to Follow-up|1|||
126037017|NCT04753697|453433129|FG001|Maintenance Phase|Withdrawal by Subject|4|||
126037018|NCT04753697|453433130|FG002|Maintenance Phase|Withdrawal by Subject|6|||
126037019|NCT04753697|453433128|FG000|Maintenance Phase|Lost to Follow-up|2|||
126037020|NCT04753697|453433129|FG001|Maintenance Phase|Lost to Follow-up|2|||
126037021|NCT04753697|453433130|FG002|Maintenance Phase|Lost to Follow-up|0|||
126037022|NCT04753697|453433128|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
126037023|NCT04753697|453433129|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
126037024|NCT04753697|453433130|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
126037025|NCT04753697|453433128|FG000|Maintenance Phase|Adverse Event|0|||
126037026|NCT04753697|453433129|FG001|Maintenance Phase|Adverse Event|1|||
126037027|NCT04753697|453433130|FG002|Maintenance Phase|Adverse Event|1|||
126037028|NCT04753697|453433128|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
126037029|NCT04753697|453433129|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
126037030|NCT04753697|453433130|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
126037031|NCT02723591|453433133|FG000|Overall Study|Adverse Event|48|||
126037032|NCT02723591|453433134|FG001|Overall Study|Adverse Event|40|||
126037033|NCT02723591|453433133|FG000|Overall Study|Death|2|||
126037034|NCT02723591|453433134|FG001|Overall Study|Death|2|||
126037035|NCT02723591|453433133|FG000|Overall Study|Lack of Efficacy|4|||
126037036|NCT02723591|453433134|FG001|Overall Study|Lack of Efficacy|3|||
126037037|NCT02723591|453433133|FG000|Overall Study|Lost to Follow-up|1|||
126037038|NCT02723591|453433134|FG001|Overall Study|Lost to Follow-up|7|||
126037039|NCT02723591|453433133|FG000|Overall Study|Protocol Violation|20|||
126037040|NCT02723591|453433134|FG001|Overall Study|Protocol Violation|23|||
126037041|NCT02723591|453433133|FG000|Overall Study|Withdrawal by Subject|4|||
126037042|NCT02723591|453433134|FG001|Overall Study|Withdrawal by Subject|8|||
126037043|NCT02723591|453433133|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
126037044|NCT02723591|453433134|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
126037045|NCT02723591|453433133|FG000|Overall Study|Miscellaneous|5|||
126037046|NCT02723591|453433134|FG001|Overall Study|Miscellaneous|6|||
126037047|NCT03691935|453433135|FG000|Overall Study|Physician Decision|2|||
126037048|NCT03691935|453433136|FG001|Overall Study|Physician Decision|1|||
126037049|NCT03691935|453433135|FG000|Overall Study|Adverse Event|3|||
126037050|NCT03691935|453433136|FG001|Overall Study|Adverse Event|0|||
126037051|NCT04409353|453433147|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
126037052|NCT04409353|453433148|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
126037053|NCT04409353|453433149|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
126037054|NCT04409353|453433147|FG000|Overall Study|Lost to Follow-up|6|||
126037055|NCT04409353|453433148|FG001|Overall Study|Lost to Follow-up|8|||
126037056|NCT04409353|453433149|FG002|Overall Study|Lost to Follow-up|7|||
126037057|NCT04409353|453433147|FG000|Overall Study|Major surgery during participation window|4|||
126037058|NCT04409353|453433148|FG001|Overall Study|Major surgery during participation window|3|||
126037059|NCT04409353|453433149|FG002|Overall Study|Major surgery during participation window|3|||
126037060|NCT04409353|453433147|FG000|Overall Study|Life event occurred during participation window|3|||
126037061|NCT04409353|453433148|FG001|Overall Study|Life event occurred during participation window|2|||
126037062|NCT04409353|453433149|FG002|Overall Study|Life event occurred during participation window|4|||
126037063|NCT04409353|453433147|FG000|Overall Study|Lack of Efficacy|4|||
126037064|NCT04409353|453433148|FG001|Overall Study|Lack of Efficacy|1|||
126037065|NCT04409353|453433149|FG002|Overall Study|Lack of Efficacy|3|||
126037066|NCT04409353|453433147|FG000|Overall Study|Adverse Event|2|||
126037067|NCT04409353|453433148|FG001|Overall Study|Adverse Event|1|||
126037068|NCT04409353|453433149|FG002|Overall Study|Adverse Event|1|||
126037069|NCT04409353|453433147|FG000|Overall Study|Disease burden - unable to participate|0|||
126037070|NCT04409353|453433148|FG001|Overall Study|Disease burden - unable to participate|1|||
126271792|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271793|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271794|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271795|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271796|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271797|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
126271798|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271799|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271800|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271801|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271802|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271803|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126037071|NCT04409353|453433149|FG002|Overall Study|Disease burden - unable to participate|1|||
126037072|NCT04409353|453433147|FG000|Overall Study|Intervention too complicated|1|||
126037073|NCT04409353|453433148|FG001|Overall Study|Intervention too complicated|0|||
126037074|NCT04409353|453433149|FG002|Overall Study|Intervention too complicated|1|||
126271804|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126361713|NCT03400787|454617254|FG001|Overall Study|Lost to Follow-up|0|||
126037075|NCT04081103|453433150|FG000|Overall Study|Adverse Event|1|||
126037076|NCT04081103|453433151|FG001|Overall Study|Adverse Event|1|||
126037077|NCT04081103|453433152|FG002|Overall Study|Adverse Event|1|||
126037078|NCT04081103|453433150|FG000|Overall Study|Physician Decision|0|||
126037079|NCT04081103|453433151|FG001|Overall Study|Physician Decision|0|||
126037080|NCT04081103|453433152|FG002|Overall Study|Physician Decision|1|||
126037081|NCT05809453|453434874|FG000|Overall Study|Withdrawal by Subject|1|||
126361714|NCT03400787|454617253|FG000|Overall Study|Death|1|||
126361715|NCT03400787|454617254|FG001|Overall Study|Death|0|||
126361716|NCT03400787|454617253|FG000|Overall Study|Protocol Violation|0|||
126361717|NCT03400787|454617254|FG001|Overall Study|Protocol Violation|2|||
126361718|NCT03400787|454617253|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
126361719|NCT03400787|454617254|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
126361720|NCT04432298|454617257|FG000|Overall Study|Other than specified|1|||
126361721|NCT04432298|454617258|FG001|Overall Study|Other than specified|0|||
126361722|NCT04432298|454617257|FG000|Overall Study|Lost to Follow-up|0|||
126361723|NCT04432298|454617258|FG001|Overall Study|Lost to Follow-up|1|||
126361724|NCT04432298|454617257|FG000|Overall Study|Death|3|||
126361725|NCT04432298|454617258|FG001|Overall Study|Death|2|||
126037082|NCT05809453|453434875|FG001|Overall Study|Withdrawal by Subject|0|||
126037083|NCT05809453|453434876|FG002|Overall Study|Withdrawal by Subject|0|||
126037084|NCT05809453|453434877|FG003|Overall Study|Withdrawal by Subject|0|||
126037085|NCT02696707|453434878|FG000|Per Protocol Population|Physician Decision|2|||
126037086|NCT02696707|453434879|FG001|Per Protocol Population|Physician Decision|1|||
126037087|NCT02696707|453434878|FG000|Per Protocol Population|Participant Decision|0|||
126037088|NCT02696707|453434879|FG001|Per Protocol Population|Participant Decision|2|||
126037089|NCT02696707|453434878|FG000|Completed Study as Planned|Reason = LVEF|2|||
126271805|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271806|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271807|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271808|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271809|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271810|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271811|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
126271812|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271813|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271814|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271815|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271816|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271817|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271818|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271819|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271820|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271821|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271822|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271823|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271824|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271825|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
126271826|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
126271827|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271828|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271829|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271830|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271831|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271832|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271833|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271834|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271835|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271836|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271837|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271838|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271839|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271840|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
126271841|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271842|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271843|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271844|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271845|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126361726|NCT04432298|454617257|FG000|Overall Study|Withdrawal by Subject|2|||
126361727|NCT04432298|454617258|FG001|Overall Study|Withdrawal by Subject|0|||
126361728|NCT02451007|454617259|FG000|Overall Study|Withdrawal by Subject|4|||
126361729|NCT02451007|454617259|FG000|Overall Study|Adverse Event|1|||
126037090|NCT02696707|453434879|FG001|Completed Study as Planned|Reason = LVEF|2|||
126037091|NCT02696707|453434878|FG000|Completed Study as Planned|Protocol Violation|2|||
126037092|NCT02696707|453434879|FG001|Completed Study as Planned|Protocol Violation|6|||
126037093|NCT02696707|453434878|FG000|Completed Study as Planned|Metastatic disease|3|||
126037094|NCT02696707|453434879|FG001|Completed Study as Planned|Metastatic disease|0|||
126037095|NCT02696707|453434878|FG000|Completed Study as Planned|Location|1|||
126037096|NCT02696707|453434879|FG001|Completed Study as Planned|Location|1|||
126037097|NCT05251909|453434884|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
126037098|NCT05251909|453434885|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
126037099|NCT05543915|453434886|FG000|Overall Study|Lost to Follow-up|0|||
126271846|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271847|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271848|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271849|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271850|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271851|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271852|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271853|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
126271854|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
126271855|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271856|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271857|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271858|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271859|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271860|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271861|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271862|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271863|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271864|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271865|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271866|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271867|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271868|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271869|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271870|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271871|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271872|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271873|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
126271874|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271875|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271876|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271877|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271878|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271879|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271880|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271881|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271882|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271883|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271884|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271885|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271886|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271887|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
126271888|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271889|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271890|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271891|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271892|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271893|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271894|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271895|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271896|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271897|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271898|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126037100|NCT05543915|453434887|FG001|Overall Study|Lost to Follow-up|1|||
126037101|NCT04233216|453434889|FG000|Overall Study|Lost to Follow-up|1|||
126271899|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271900|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271901|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
126271902|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271903|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271904|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271905|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271906|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271907|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271908|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271909|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271910|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271911|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271912|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271913|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271914|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271915|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
126271916|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271917|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271918|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271919|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271920|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271921|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271922|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271923|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271924|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271925|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271926|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271927|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271928|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271929|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
126271930|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271931|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271932|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271933|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271934|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271935|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271936|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271937|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271938|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271939|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271940|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
126271941|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271942|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
126271943|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
126271944|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271945|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271946|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271947|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271948|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271949|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271950|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271951|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271952|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271953|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271954|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271955|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271956|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271957|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
126271958|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271959|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271960|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271961|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126037102|NCT04233216|453434890|FG001|Overall Study|Lost to Follow-up|0|||
126037103|NCT04233216|453434891|FG002|Overall Study|Lost to Follow-up|2|||
126037104|NCT04233216|453434892|FG003|Overall Study|Lost to Follow-up|0|||
126037105|NCT04233216|453434889|FG000|Overall Study|Physician Decision|0|||
126037106|NCT04233216|453434890|FG001|Overall Study|Physician Decision|3|||
126037107|NCT04233216|453434891|FG002|Overall Study|Physician Decision|0|||
126037108|NCT04233216|453434892|FG003|Overall Study|Physician Decision|2|||
126037109|NCT04233216|453434889|FG000|Overall Study|Withdrawal by Subject|0|||
126037110|NCT04233216|453434890|FG001|Overall Study|Withdrawal by Subject|2|||
126037111|NCT04233216|453434891|FG002|Overall Study|Withdrawal by Subject|1|||
126037112|NCT04233216|453434892|FG003|Overall Study|Withdrawal by Subject|0|||
126037113|NCT03652389|453434895|FG000|Overall Study|Lost to Follow-up|1|||
126037114|NCT03652389|453434896|FG001|Overall Study|Lost to Follow-up|5|||
126271962|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271963|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271964|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271965|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271966|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271967|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271968|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
126271969|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271970|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
126271971|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
126271972|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271973|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271974|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271975|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271976|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271977|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271978|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271979|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271980|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271981|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271982|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271983|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271984|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271985|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271986|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
126271987|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
126271988|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
126271989|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
126271990|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
126271991|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271992|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271993|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271994|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271995|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271996|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271997|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271998|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271999|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126272000|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
126272001|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126272002|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126272003|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126037115|NCT03652389|453434895|FG000|Overall Study|Withdrawal by Subject|5|||
126098578|NCT02095951|453653044|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
126098579|NCT02095951|453653045|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
126098580|NCT00964886|453653046|FG000|Overall Study|Lost to Follow-up|2|||
126098581|NCT00964886|453653047|FG001|Overall Study|Lost to Follow-up|2|||
126037116|NCT03652389|453434896|FG001|Overall Study|Withdrawal by Subject|1|||
126037117|NCT03652389|453434895|FG000|Overall Study|New diagnosis|2|||
126098582|NCT00964886|453653048|FG002|Overall Study|Lost to Follow-up|6|||
126098583|NCT00964886|453653049|FG003|Overall Study|Lost to Follow-up|4|||
126037118|NCT03652389|453434896|FG001|Overall Study|New diagnosis|0|||
126272004|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126272005|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272006|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272007|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272008|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272009|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272010|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272011|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272012|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272013|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272014|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272015|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272016|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272017|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272018|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
126272019|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272020|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272021|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272022|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272023|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272024|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272025|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272026|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272027|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272028|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272029|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
126272030|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
126272031|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
126272032|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272033|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272034|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272035|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272036|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272037|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272038|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272039|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272040|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272041|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272042|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272043|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272044|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272045|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272046|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
126272047|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272048|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272049|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272050|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272051|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272052|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272053|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272054|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272055|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272056|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272057|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272058|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272059|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
126272060|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
126272061|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272062|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272063|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126361730|NCT02451007|454617259|FG000|Overall Study|Disease Progression|2|||
126361731|NCT01034657|454617271|FG000|Core Phase|Withdrawal by Subject|1|||
126361732|NCT01034657|454617272|FG001|Core Phase|Withdrawal by Subject|0|||
126361733|NCT01034657|454617273|FG002|Core Phase|Withdrawal by Subject|0|||
126361734|NCT01034657|454617271|FG000|Core Phase|Lack of Efficacy|2|||
126037119|NCT02815566|453434897|FG000|Overall Study|Adverse Event|1|||
126037120|NCT02815566|453434898|FG001|Overall Study|Adverse Event|1|||
126037121|NCT02815566|453434897|FG000|Overall Study|Withdrawal by Subject|1|||
126037122|NCT02815566|453434898|FG001|Overall Study|Withdrawal by Subject|0|||
126272064|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272065|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272066|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272067|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272068|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272069|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272070|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272071|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272072|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272073|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
126272074|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272075|NCT00594646|454286756|FG000|Overall Study|Withdrawal by Subject|1|||
126272076|NCT00594646|454286756|FG000|Overall Study|Lost to Follow-up|15|||
126272077|NCT03907462|454286759|FG000|Overall Study|Physician Decision|1|||
126272078|NCT03907462|454286760|FG001|Overall Study|Physician Decision|3|||
126272079|NCT03907462|454286761|FG002|Overall Study|Physician Decision|1|||
126272080|NCT03907462|454286759|FG000|Overall Study|Withdrawal by Subject|6|||
126272081|NCT03907462|454286760|FG001|Overall Study|Withdrawal by Subject|3|||
126272082|NCT03907462|454286761|FG002|Overall Study|Withdrawal by Subject|3|||
126272083|NCT03907462|454286759|FG000|Overall Study|Pregnancy|4|||
126272084|NCT03907462|454286760|FG001|Overall Study|Pregnancy|2|||
126272085|NCT03907462|454286761|FG002|Overall Study|Pregnancy|6|||
126272086|NCT03907462|454286759|FG000|Overall Study|Lost to Follow-up|16|||
126272087|NCT03907462|454286760|FG001|Overall Study|Lost to Follow-up|18|||
126272088|NCT03907462|454286761|FG002|Overall Study|Lost to Follow-up|22|||
126272089|NCT03303625|454288935|FG000|Overall Study|Withdrawal by Subject|2|||
126272090|NCT03303625|454288936|FG001|Overall Study|Withdrawal by Subject|0|||
126272091|NCT03303625|454288937|FG002|Overall Study|Withdrawal by Subject|0|||
126272092|NCT03303625|454288938|FG003|Overall Study|Withdrawal by Subject|0|||
126272093|NCT02492880|454288939|FG000|Overall Study|Lost to Follow-up|1|||
126272094|NCT02492880|454288939|FG000|Overall Study|Protocol Violation|1|||
126272095|NCT00554190|454288940|FG000|Overall Study|Termination forms not completed|10|||
126272096|NCT04709835|454288944|FG000|Overall Study|Withdrawal by Subject|0|||
126272097|NCT04709835|454288945|FG001|Overall Study|Withdrawal by Subject|1|||
126272098|NCT04709835|454288946|FG002|Overall Study|Withdrawal by Subject|0|||
126272099|NCT04325204|454288947|FG000|Overall Study|Death|0|||
126272100|NCT04325204|454288948|FG001|Overall Study|Death|1|||
126272101|NCT04325204|454288947|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
126272102|NCT04325204|454288948|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
126272103|NCT04325204|454288947|FG000|Overall Study|Lost to Follow-up|8|||
126272104|NCT04325204|454288948|FG001|Overall Study|Lost to Follow-up|8|||
126272105|NCT04325204|454288947|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
126272106|NCT04325204|454288948|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
126272107|NCT04711902|454288950|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272108|NCT04711902|454288951|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272109|NCT04711902|454288952|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
126272110|NCT04711902|454288953|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272111|NCT04711902|454288954|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272112|NCT04711902|454288955|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272113|NCT04710979|454288956|FG000|Overall Study|Lost to Follow-up|2|||
126272114|NCT04710979|454288957|FG001|Overall Study|Lost to Follow-up|4|||
126272115|NCT04710979|454288956|FG000|Overall Study|Withdrawal by Subject|1|||
126272116|NCT04710979|454288957|FG001|Overall Study|Withdrawal by Subject|0|||
126272117|NCT01561430|454288960|FG000|Overall Study|Adverse Event|0|||
126272118|NCT01561430|454288961|FG001|Overall Study|Adverse Event|0|||
126272119|NCT01561430|454288962|FG002|Overall Study|Adverse Event|3|||
126272120|NCT01561430|454288963|FG003|Overall Study|Adverse Event|1|||
126272121|NCT01561430|454288960|FG000|Overall Study|Withdrawal by Subject|0|||
126272122|NCT01561430|454288961|FG001|Overall Study|Withdrawal by Subject|0|||
126272123|NCT01561430|454288962|FG002|Overall Study|Withdrawal by Subject|1|||
126272124|NCT01561430|454288963|FG003|Overall Study|Withdrawal by Subject|0|||
126272125|NCT01561430|454288960|FG000|Overall Study|Physician Decision|0|||
126272126|NCT01561430|454288961|FG001|Overall Study|Physician Decision|1|||
126361735|NCT01034657|454617272|FG001|Core Phase|Lack of Efficacy|0|||
126361736|NCT01034657|454617273|FG002|Core Phase|Lack of Efficacy|0|||
126037123|NCT02815566|453434897|FG000|Overall Study|Lost to Follow-up|0|||
126037124|NCT02815566|453434898|FG001|Overall Study|Lost to Follow-up|1|||
126272127|NCT01561430|454288962|FG002|Overall Study|Physician Decision|0|||
126037125|NCT03252847|453434904|FG000|Overall Study|Withdrawal by Subject|0|||
126272128|NCT01561430|454288963|FG003|Overall Study|Physician Decision|0|||
126272129|NCT01561430|454288960|FG000|Overall Study|Sponsor Decision|1|||
126272130|NCT01561430|454288961|FG001|Overall Study|Sponsor Decision|14|||
126272131|NCT01561430|454288962|FG002|Overall Study|Sponsor Decision|13|||
126272132|NCT01561430|454288963|FG003|Overall Study|Sponsor Decision|12|||
126272133|NCT02570113|454288966|FG000|Overall Study|Withdrawal by Subject|3|||
126272134|NCT02564211|454288967|FG000|Overall Study|Adverse Event|4|||
126272135|NCT00622466|454288968|FG000|Overall Study|Death|1|||
126272136|NCT00622466|454288968|FG000|Overall Study|Adverse Event|1|||
126272137|NCT00622466|454288968|FG000|Overall Study|Withdrawal by Subject|2|||
126272138|NCT01908816|454288969|FG000|Overall Study|Subject's no longer requires study drug|0|||
126272139|NCT01908816|454288970|FG001|Overall Study|Subject's no longer requires study drug|0|||
126272140|NCT01908816|454288971|FG002|Overall Study|Subject's no longer requires study drug|0|||
126272141|NCT01908816|454288972|FG003|Overall Study|Subject's no longer requires study drug|1|||
126272142|NCT01908816|454288969|FG000|Overall Study|Protocol deviation|1|||
126272143|NCT01908816|454288970|FG001|Overall Study|Protocol deviation|2|||
126272144|NCT01908816|454288971|FG002|Overall Study|Protocol deviation|1|||
126272145|NCT01908816|454288972|FG003|Overall Study|Protocol deviation|1|||
126272146|NCT01908816|454288969|FG000|Overall Study|Withdrawal by Subject|0|||
126272147|NCT01908816|454288970|FG001|Overall Study|Withdrawal by Subject|4|||
126272148|NCT01908816|454288971|FG002|Overall Study|Withdrawal by Subject|2|||
126272149|NCT01908816|454288972|FG003|Overall Study|Withdrawal by Subject|2|||
126272150|NCT01908816|454288969|FG000|Overall Study|Lost to Follow-up|3|||
126272151|NCT01908816|454288970|FG001|Overall Study|Lost to Follow-up|5|||
126272152|NCT01908816|454288971|FG002|Overall Study|Lost to Follow-up|4|||
126272153|NCT01908816|454288972|FG003|Overall Study|Lost to Follow-up|2|||
126272154|NCT01908816|454288969|FG000|Overall Study|Death|1|||
126272155|NCT01908816|454288970|FG001|Overall Study|Death|0|||
126272156|NCT01908816|454288971|FG002|Overall Study|Death|7|||
126272157|NCT01908816|454288972|FG003|Overall Study|Death|1|||
126272158|NCT01908816|454288969|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126272159|NCT01908816|454288970|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
126272160|NCT01908816|454288971|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
126272161|NCT01908816|454288972|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126272162|NCT01908816|454288969|FG000|Overall Study|Early termination|87|||
126272163|NCT01908816|454288970|FG001|Overall Study|Early termination|60|||
126272164|NCT01908816|454288971|FG002|Overall Study|Early termination|43|||
126272165|NCT01908816|454288972|FG003|Overall Study|Early termination|28|||
126272166|NCT05183217|454288973|FG000|Overall Study|Withdrawal by Subject|1|||
126272167|NCT05183217|454288974|FG001|Overall Study|Withdrawal by Subject|1|||
126272168|NCT04585789|454288976|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
126272169|NCT04585789|454288977|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
126361737|NCT01034657|454617271|FG000|Core Phase|Abnormal laboratory value|1|||
126361738|NCT01034657|454617272|FG001|Core Phase|Abnormal laboratory value|0|||
126272170|NCT04585789|454288978|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
126361739|NCT01034657|454617273|FG002|Core Phase|Abnormal laboratory value|0|||
126361740|NCT01034657|454617271|FG000|Core Phase|Adverse Event|8|||
126361741|NCT01034657|454617272|FG001|Core Phase|Adverse Event|0|||
126361742|NCT01034657|454617273|FG002|Core Phase|Adverse Event|0|||
126361743|NCT01034657|454617271|FG000|Core Phase|Protocol Violation|2|||
126361744|NCT01034657|454617272|FG001|Core Phase|Protocol Violation|0|||
126361745|NCT01034657|454617273|FG002|Core Phase|Protocol Violation|0|||
126361746|NCT01034657|454617271|FG000|Randomized Phase|Withdrawal by Subject|0|||
126361747|NCT01034657|454617272|FG001|Randomized Phase|Withdrawal by Subject|2|||
126361748|NCT01034657|454617273|FG002|Randomized Phase|Withdrawal by Subject|0|||
126361749|NCT01034657|454617271|FG000|Randomized Phase|Lack of Efficacy|5|||
126361750|NCT01034657|454617272|FG001|Randomized Phase|Lack of Efficacy|1|||
126361751|NCT01034657|454617273|FG002|Randomized Phase|Lack of Efficacy|0|||
126361752|NCT01034657|454617271|FG000|Randomized Phase|Abnormal laboratory value|0|||
126361753|NCT01034657|454617272|FG001|Randomized Phase|Abnormal laboratory value|1|||
126361754|NCT01034657|454617273|FG002|Randomized Phase|Abnormal laboratory value|0|||
126361755|NCT01034657|454617271|FG000|Randomized Phase|Adverse Event|0|||
126361756|NCT01034657|454617272|FG001|Randomized Phase|Adverse Event|2|||
126272171|NCT04585789|454288976|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
126272172|NCT04585789|454288977|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
126272173|NCT04585789|454288978|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
126272174|NCT00415194|454288981|FG000|Overall Study|Adverse Event|37|||
126272175|NCT00415194|454288982|FG001|Overall Study|Adverse Event|32|||
126272176|NCT00415194|454288981|FG000|Overall Study|Entry Criteria Not Met|4|||
126272177|NCT00415194|454288982|FG001|Overall Study|Entry Criteria Not Met|8|||
126361757|NCT01034657|454617273|FG002|Randomized Phase|Adverse Event|1|||
126361758|NCT01791205|454617274|FG000|Phase II|Lack of Efficacy|6|||
126361759|NCT01791205|454617275|FG001|Phase II|Lack of Efficacy|0|||
126361760|NCT01791205|454617274|FG000|Phase II|Adverse Event|2|||
126361761|NCT01791205|454617275|FG001|Phase II|Adverse Event|0|||
126361762|NCT01791205|454617274|FG000|Phase II|Safety|1|||
126361763|NCT01791205|454617275|FG001|Phase II|Safety|0|||
126361764|NCT01791205|454617274|FG000|Phase II|Lost to Follow-up|1|||
126361765|NCT01791205|454617275|FG001|Phase II|Lost to Follow-up|0|||
126361766|NCT01791205|454617274|FG000|Phase II|Remission of disease|1|||
126361767|NCT01791205|454617275|FG001|Phase II|Remission of disease|0|||
126361768|NCT01791205|454617274|FG000|Phase II|Physician's decision|1|||
126361769|NCT01791205|454617275|FG001|Phase II|Physician's decision|0|||
126361770|NCT02242903|454617276|FG000|Overall Study|Withdrawal by Subject|1|||
126037126|NCT03252847|453434905|FG001|Overall Study|Withdrawal by Subject|0|||
126037127|NCT03252847|453434906|FG002|Overall Study|Withdrawal by Subject|1|||
126037128|NCT03252847|453434907|FG003|Overall Study|Withdrawal by Subject|0|||
126037129|NCT03252847|453434908|FG004|Overall Study|Withdrawal by Subject|0|||
126037130|NCT03252847|453434909|FG005|Overall Study|Withdrawal by Subject|0|||
126037131|NCT03252847|453434910|FG006|Overall Study|Withdrawal by Subject|0|||
126361771|NCT02242903|454617277|FG001|Overall Study|Withdrawal by Subject|0|||
126037132|NCT03252847|453434904|FG000|Overall Study|Other: Patient decision|0|||
126361772|NCT02242903|454617278|FG002|Overall Study|Withdrawal by Subject|0|||
126361773|NCT02242903|454617279|FG003|Overall Study|Withdrawal by Subject|0|||
126037133|NCT03252847|453434905|FG001|Overall Study|Other: Patient decision|0|||
126037134|NCT03252847|453434906|FG002|Overall Study|Other: Patient decision|0|||
126037135|NCT03252847|453434907|FG003|Overall Study|Other: Patient decision|0|||
126037136|NCT03252847|453434908|FG004|Overall Study|Other: Patient decision|1|||
126037137|NCT03252847|453434909|FG005|Overall Study|Other: Patient decision|0|||
126037138|NCT03252847|453434910|FG006|Overall Study|Other: Patient decision|0|||
126037139|NCT05034328|453434911|FG000|Overall Study|Protocol Violation|1|||
126037140|NCT05034328|453434912|FG001|Overall Study|Protocol Violation|0|||
126037141|NCT05034328|453434911|FG000|Overall Study|Lost to Follow-up|0|||
126037142|NCT05034328|453434912|FG001|Overall Study|Lost to Follow-up|10|||
126037143|NCT02993159|453434913|FG000|Overall Study|Withdrawal by Subject|1|||
126037144|NCT02993159|453434914|FG001|Overall Study|Withdrawal by Subject|3|||
126037145|NCT02993159|453434913|FG000|Overall Study|Protocol Violation|1|||
126037146|NCT02993159|453434914|FG001|Overall Study|Protocol Violation|0|||
126037147|NCT02993159|453434913|FG000|Overall Study|Opted out of surgery|2|||
126037148|NCT02993159|453434914|FG001|Overall Study|Opted out of surgery|0|||
126037149|NCT02993159|453434913|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
126037150|NCT02993159|453434914|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
126037151|NCT02993159|453434913|FG000|Overall Study|Physician Decision|0|||
126037152|NCT02993159|453434914|FG001|Overall Study|Physician Decision|1|||
126037153|NCT04992520|453434918|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
126037154|NCT04992520|453434919|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
126037155|NCT04992520|453434920|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
126037156|NCT04992520|453434921|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
126037157|NCT04992520|453434922|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
126037158|NCT04992520|453434923|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
126037159|NCT04992520|453434918|FG000|Part A: First Challenge|Non-compliance|0|||
126037160|NCT04992520|453434919|FG001|Part A: First Challenge|Non-compliance|0|||
126037161|NCT04992520|453434920|FG002|Part A: First Challenge|Non-compliance|0|||
126037162|NCT04992520|453434921|FG003|Part A: First Challenge|Non-compliance|1|||
126037163|NCT04992520|453434922|FG004|Part A: First Challenge|Non-compliance|0|||
126037164|NCT04992520|453434923|FG005|Part A: First Challenge|Non-compliance|0|||
126037165|NCT04992520|453434918|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
126037166|NCT04992520|453434919|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
126037167|NCT04992520|453434920|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
126037168|NCT04992520|453434921|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
126037169|NCT04992520|453434922|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
126037170|NCT04992520|453434923|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
126037171|NCT04992520|453434918|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126037172|NCT04992520|453434919|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126037173|NCT04992520|453434920|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
126037174|NCT04992520|453434921|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126037175|NCT04992520|453434922|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126037176|NCT04992520|453434923|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126037177|NCT03625167|453434926|FG000|Overall Study|Protocol Violation|5|||
126037178|NCT00248287|453434927|FG000|Overall Study|Adverse Event|11|||
126037179|NCT00248287|453434928|FG001|Overall Study|Adverse Event|10|||
126037180|NCT00248287|453434927|FG000|Overall Study|Death|1|||
126037181|NCT00248287|453434928|FG001|Overall Study|Death|0|||
126037182|NCT00248287|453434927|FG000|Overall Study|Lost to Follow-up|0|||
126037183|NCT00248287|453434928|FG001|Overall Study|Lost to Follow-up|1|||
126037184|NCT00248287|453434927|FG000|Overall Study|Investigator Request|4|||
126037185|NCT00248287|453434928|FG001|Overall Study|Investigator Request|3|||
126037186|NCT00248287|453434927|FG000|Overall Study|Patient Request|5|||
126037187|NCT00248287|453434928|FG001|Overall Study|Patient Request|3|||
126037188|NCT00248287|453434927|FG000|Overall Study|Other|3|||
126037189|NCT00248287|453434928|FG001|Overall Study|Other|2|||
126037190|NCT02714257|453434929|FG000|Overall Study|Withdrawal by Subject|6|||
126037191|NCT02714257|453434930|FG001|Overall Study|Withdrawal by Subject|11|||
126037192|NCT02714257|453434929|FG000|Overall Study|Death|3|||
126037193|NCT02714257|453434930|FG001|Overall Study|Death|4|||
126037194|NCT02714257|453434929|FG000|Overall Study|Lost to Follow-up|1|||
126037195|NCT02714257|453434930|FG001|Overall Study|Lost to Follow-up|6|||
126037196|NCT04103580|453434933|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
126037197|NCT04103580|453434934|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
126037198|NCT04103580|453434933|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
126037199|NCT04103580|453434934|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
126272178|NCT00415194|454288981|FG000|Overall Study|Lost to Follow-up|1|||
126037200|NCT04103580|453434933|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
126037201|NCT04103580|453434934|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
126272179|NCT00415194|454288982|FG001|Overall Study|Lost to Follow-up|0|||
126272180|NCT00415194|454288981|FG000|Overall Study|Physician Decision|10|||
126272181|NCT00415194|454288982|FG001|Overall Study|Physician Decision|16|||
126272182|NCT00415194|454288981|FG000|Overall Study|Progressive Disease|180|||
126272183|NCT00415194|454288982|FG001|Overall Study|Progressive Disease|217|||
126272184|NCT00415194|454288981|FG000|Overall Study|Protocol Violation|4|||
126272185|NCT00415194|454288982|FG001|Overall Study|Protocol Violation|2|||
126272186|NCT00415194|454288981|FG000|Overall Study|Withdrawal by Subject|28|||
126272187|NCT00415194|454288982|FG001|Overall Study|Withdrawal by Subject|21|||
126272188|NCT00415194|454288981|FG000|Overall Study|Death Due to Study Disease|26|||
126272189|NCT00415194|454288982|FG001|Overall Study|Death Due to Study Disease|29|||
126272190|NCT00415194|454288981|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
126272191|NCT00415194|454288982|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
126272192|NCT00415194|454288981|FG000|Overall Study|Death Due to Procedural Related AE|0|||
126272193|NCT00415194|454288982|FG001|Overall Study|Death Due to Procedural Related AE|1|||
126272194|NCT00415194|454288981|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
126272195|NCT00415194|454288982|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
126272196|NCT00969540|454288983|FG000|Overall Study|Lost to Follow-up|1|||
126272197|NCT00969540|454288984|FG001|Overall Study|Lost to Follow-up|1|||
126272198|NCT02397408|454288985|FG000|Overall Study|Physician Decision|4|||
126272199|NCT02397408|454288985|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
126272200|NCT00369655|454288986|FG000|Overall Study|Refusal of further treatment|2|||
126272201|NCT01646138|454288987|FG000|Overall Study|Lost to Follow-up|0|||
126272202|NCT01646138|454288988|FG001|Overall Study|Lost to Follow-up|0|||
126272203|NCT01646138|454288989|FG002|Overall Study|Lost to Follow-up|0|||
126272204|NCT01646138|454288990|FG003|Overall Study|Lost to Follow-up|0|||
126272205|NCT01646138|454288991|FG004|Overall Study|Lost to Follow-up|2|||
126272206|NCT01683838|454288992|FG000|Overall Study|Adverse Event|12|||
126272207|NCT01683838|454288993|FG001|Overall Study|Adverse Event|2|||
126272208|NCT01683838|454288992|FG000|Overall Study|Protocol Violation|3|||
126272209|NCT01683838|454288993|FG001|Overall Study|Protocol Violation|1|||
126272210|NCT01683838|454288992|FG000|Overall Study|Withdrawal by Subject|6|||
126272211|NCT01683838|454288993|FG001|Overall Study|Withdrawal by Subject|5|||
126272212|NCT01683838|454288992|FG000|Overall Study|Lost to Follow-up|1|||
126272213|NCT01683838|454288993|FG001|Overall Study|Lost to Follow-up|1|||
126272214|NCT01683838|454288992|FG000|Overall Study|Other|4|||
126361774|NCT02242903|454617280|FG004|Overall Study|Withdrawal by Subject|0|||
126361775|NCT02242903|454617281|FG005|Overall Study|Withdrawal by Subject|0|||
126361776|NCT02242903|454617282|FG006|Overall Study|Withdrawal by Subject|0|||
126361777|NCT04985682|454617285|FG000|Overall Study|Withdrawal by Subject|1|||
126361778|NCT01546987|454617288|FG000|Overall Study|Protocol Violation|3|||
126361779|NCT01546987|454617289|FG001|Overall Study|Protocol Violation|4|||
126272215|NCT01683838|454288993|FG001|Overall Study|Other|3|||
126272216|NCT04049617|454288994|FG000|Overall Study|Adverse Event|0|||
126272217|NCT04049617|454288995|FG001|Overall Study|Adverse Event|0|||
126272218|NCT04049617|454288996|FG002|Overall Study|Adverse Event|0|||
126272219|NCT04049617|454288997|FG003|Overall Study|Adverse Event|1|||
126272220|NCT04049617|454288998|FG004|Overall Study|Adverse Event|0|||
126272221|NCT04049617|454288999|FG005|Overall Study|Adverse Event|0|||
126272222|NCT04049617|454288994|FG000|Overall Study|Death|0|||
126272223|NCT04049617|454288995|FG001|Overall Study|Death|0|||
126272224|NCT04049617|454288996|FG002|Overall Study|Death|0|||
126272225|NCT04049617|454288997|FG003|Overall Study|Death|0|||
126272226|NCT04049617|454288998|FG004|Overall Study|Death|0|||
126272227|NCT04049617|454288999|FG005|Overall Study|Death|1|||
126272228|NCT04049617|454288994|FG000|Overall Study|Lost to Follow-up|0|||
126272229|NCT04049617|454288995|FG001|Overall Study|Lost to Follow-up|0|||
126272230|NCT04049617|454288996|FG002|Overall Study|Lost to Follow-up|0|||
126272231|NCT04049617|454288997|FG003|Overall Study|Lost to Follow-up|1|||
126272232|NCT04049617|454288998|FG004|Overall Study|Lost to Follow-up|0|||
126272233|NCT04049617|454288999|FG005|Overall Study|Lost to Follow-up|0|||
126272234|NCT04049617|454288994|FG000|Overall Study|Withdrew consent|0|||
126272235|NCT04049617|454288995|FG001|Overall Study|Withdrew consent|0|||
126272236|NCT04049617|454288996|FG002|Overall Study|Withdrew consent|1|||
126272237|NCT04049617|454288997|FG003|Overall Study|Withdrew consent|0|||
126361780|NCT03878602|454617290|FG000|Overall Study|cord blood donation|7|||
126361781|NCT03878602|454617291|FG001|Overall Study|cord blood donation|1|||
126272238|NCT04049617|454288998|FG004|Overall Study|Withdrew consent|0|||
126272239|NCT04049617|454288999|FG005|Overall Study|Withdrew consent|0|||
126272240|NCT03551496|454289000|FG000|Overall Study|Death|11|||
126272241|NCT03551496|454289001|FG001|Overall Study|Death|7|||
126272242|NCT03551496|454289000|FG000|Overall Study|Withdrawal by Subject|4|||
126272243|NCT03551496|454289001|FG001|Overall Study|Withdrawal by Subject|3|||
126272244|NCT03551496|454289000|FG000|Overall Study|Other Reasons|1|||
126272245|NCT03551496|454289001|FG001|Overall Study|Other Reasons|0|||
126272246|NCT01524679|454289002|FG000|Overall Study|Lost to Follow-up|1|||
126272247|NCT01524679|454289003|FG001|Overall Study|Lost to Follow-up|4|||
126272248|NCT01524679|454289002|FG000|Overall Study|Withdrawal by Subject|4|||
126361782|NCT03878602|454617290|FG000|Overall Study|incomplete data collection|2|||
126361783|NCT03878602|454617291|FG001|Overall Study|incomplete data collection|0|||
126037202|NCT04103580|453434933|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
126037203|NCT04103580|453434934|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
126037204|NCT04103580|453434933|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
126037205|NCT04103580|453434934|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
126037206|NCT04103580|453434933|FG000|Phase 1 Active Caregiving|Other|3|||
126037207|NCT04103580|453434934|FG001|Phase 1 Active Caregiving|Other|3|||
126037208|NCT04103580|453434933|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
126037209|NCT04103580|453434934|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
126037210|NCT04103580|453434933|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
126037211|NCT04103580|453434934|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
126037212|NCT04103580|453434933|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
126037213|NCT04103580|453434934|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
126037214|NCT04103580|453434933|FG000|Phase 2 Bereavement|Other|8|||
126037215|NCT04103580|453434934|FG001|Phase 2 Bereavement|Other|6|||
126037216|NCT04145440|453434935|FG000|Overall Study|Physician Decision|3|||
126098584|NCT00964886|453653046|FG000|Overall Study|Withdrawal by Subject|6|||
126098585|NCT00964886|453653047|FG001|Overall Study|Withdrawal by Subject|2|||
126272249|NCT01524679|454289003|FG001|Overall Study|Withdrawal by Subject|4|||
126272250|NCT01524679|454289002|FG000|Overall Study|Adverse Event|9|||
126272251|NCT01524679|454289003|FG001|Overall Study|Adverse Event|0|||
126272252|NCT01524679|454289002|FG000|Overall Study|Protocol Violation|1|||
126272253|NCT01524679|454289003|FG001|Overall Study|Protocol Violation|0|||
126272254|NCT01524679|454289002|FG000|Overall Study|Lack of Efficacy|2|||
126272255|NCT01524679|454289003|FG001|Overall Study|Lack of Efficacy|0|||
126272256|NCT01524679|454289002|FG000|Overall Study|e.g.wish for children, relocation|6|||
126272257|NCT01524679|454289003|FG001|Overall Study|e.g.wish for children, relocation|1|||
126272258|NCT01154816|454289004|FG000|Overall Study|Withdrawal by Subject|1|||
126272259|NCT01154816|454289005|FG001|Overall Study|Withdrawal by Subject|0|||
126272260|NCT01154816|454289006|FG002|Overall Study|Withdrawal by Subject|0|||
126272261|NCT01154816|454289007|FG003|Overall Study|Withdrawal by Subject|1|||
126272262|NCT01154816|454289008|FG004|Overall Study|Withdrawal by Subject|0|||
126272263|NCT01154816|454289009|FG005|Overall Study|Withdrawal by Subject|0|||
126272264|NCT01154816|454289010|FG006|Overall Study|Withdrawal by Subject|0|||
126272265|NCT01154816|454289011|FG007|Overall Study|Withdrawal by Subject|0|||
126272266|NCT01154816|454289012|FG008|Overall Study|Withdrawal by Subject|1|||
126272267|NCT01154816|454289013|FG009|Overall Study|Withdrawal by Subject|3|||
126272268|NCT01154816|454289014|FG010|Overall Study|Withdrawal by Subject|0|||
126272269|NCT01154816|454289015|FG011|Overall Study|Withdrawal by Subject|0|||
126272270|NCT01154816|454289004|FG000|Overall Study|Progressive Disease|13|||
126272271|NCT01154816|454289005|FG001|Overall Study|Progressive Disease|8|||
126272272|NCT01154816|454289006|FG002|Overall Study|Progressive Disease|9|||
126272273|NCT01154816|454289007|FG003|Overall Study|Progressive Disease|9|||
126272274|NCT01154816|454289008|FG004|Overall Study|Progressive Disease|8|||
126272275|NCT01154816|454289009|FG005|Overall Study|Progressive Disease|8|||
126272276|NCT01154816|454289010|FG006|Overall Study|Progressive Disease|5|||
126272277|NCT01154816|454289011|FG007|Overall Study|Progressive Disease|6|||
126272278|NCT01154816|454289012|FG008|Overall Study|Progressive Disease|8|||
126272279|NCT01154816|454289013|FG009|Overall Study|Progressive Disease|6|||
126272280|NCT01154816|454289014|FG010|Overall Study|Progressive Disease|10|||
126272281|NCT01154816|454289015|FG011|Overall Study|Progressive Disease|3|||
126272282|NCT01154816|454289004|FG000|Overall Study|Physician Decision|1|||
126272283|NCT01154816|454289005|FG001|Overall Study|Physician Decision|0|||
126272284|NCT01154816|454289006|FG002|Overall Study|Physician Decision|1|||
126272285|NCT01154816|454289007|FG003|Overall Study|Physician Decision|0|||
126272286|NCT01154816|454289008|FG004|Overall Study|Physician Decision|2|||
126272287|NCT01154816|454289009|FG005|Overall Study|Physician Decision|0|||
126037217|NCT04145440|453434936|FG001|Overall Study|Physician Decision|0|||
126037218|NCT04145440|453434935|FG000|Overall Study|Use of prohibited therapy|2|||
126037219|NCT04145440|453434936|FG001|Overall Study|Use of prohibited therapy|3|||
126037220|NCT00104676|453434937|FG000|Overall Study|Death|3|||
126037221|NCT00104676|453434938|FG001|Overall Study|Death|2|||
126098586|NCT00964886|453653048|FG002|Overall Study|Withdrawal by Subject|5|||
126272288|NCT01154816|454289010|FG006|Overall Study|Physician Decision|0|||
126272289|NCT01154816|454289011|FG007|Overall Study|Physician Decision|0|||
126272290|NCT01154816|454289012|FG008|Overall Study|Physician Decision|0|||
126272291|NCT01154816|454289013|FG009|Overall Study|Physician Decision|1|||
126272292|NCT01154816|454289014|FG010|Overall Study|Physician Decision|1|||
126272293|NCT01154816|454289015|FG011|Overall Study|Physician Decision|1|||
126272294|NCT01154816|454289004|FG000|Overall Study|Adverse Event|5|||
126037222|NCT00104676|453434937|FG000|Overall Study|Withdrawal by Subject|0|||
126272295|NCT01154816|454289005|FG001|Overall Study|Adverse Event|2|||
126272296|NCT01154816|454289006|FG002|Overall Study|Adverse Event|0|||
126272297|NCT01154816|454289007|FG003|Overall Study|Adverse Event|0|||
126272298|NCT01154816|454289008|FG004|Overall Study|Adverse Event|0|||
126272299|NCT01154816|454289009|FG005|Overall Study|Adverse Event|0|||
126272300|NCT01154816|454289010|FG006|Overall Study|Adverse Event|1|||
126037223|NCT00104676|453434938|FG001|Overall Study|Withdrawal by Subject|2|||
126037224|NCT00104676|453434937|FG000|Overall Study|treatment interruption|4|||
126037225|NCT00104676|453434938|FG001|Overall Study|treatment interruption|10|||
126037226|NCT03766685|453434958|FG000|Overall Study|Lost to Follow-up|1|||
126037227|NCT03766685|453434959|FG001|Overall Study|Lost to Follow-up|1|||
126037228|NCT03766685|453434960|FG002|Overall Study|Lost to Follow-up|0|||
126037229|NCT03766685|453434961|FG003|Overall Study|Lost to Follow-up|0|||
126037230|NCT03766685|453434958|FG000|Overall Study|Adverse Event, not fatal|0|||
126037231|NCT03766685|453434959|FG001|Overall Study|Adverse Event, not fatal|1|||
126037232|NCT03766685|453434960|FG002|Overall Study|Adverse Event, not fatal|0|||
126037233|NCT03766685|453434961|FG003|Overall Study|Adverse Event, not fatal|1|||
126037234|NCT03766685|453434958|FG000|Overall Study|Withdrawal by Subject|0|||
126037235|NCT03766685|453434959|FG001|Overall Study|Withdrawal by Subject|2|||
126037236|NCT03766685|453434960|FG002|Overall Study|Withdrawal by Subject|0|||
126037237|NCT03766685|453434961|FG003|Overall Study|Withdrawal by Subject|0|||
126037238|NCT03766685|453434958|FG000|Overall Study|Protocol Violation|0|||
126037239|NCT03766685|453434959|FG001|Overall Study|Protocol Violation|1|||
126037240|NCT03766685|453434960|FG002|Overall Study|Protocol Violation|0|||
126037241|NCT03766685|453434961|FG003|Overall Study|Protocol Violation|0|||
126037242|NCT03766685|453434958|FG000|Overall Study|Non-compliance|0|||
126037243|NCT03766685|453434959|FG001|Overall Study|Non-compliance|2|||
126037244|NCT03766685|453434960|FG002|Overall Study|Non-compliance|0|||
126037245|NCT03766685|453434961|FG003|Overall Study|Non-compliance|0|||
126037246|NCT05139810|453434964|FG000|Overall Study|Voluntary Withdrawal|2|||
126037247|NCT05139810|453434965|FG001|Overall Study|Voluntary Withdrawal|1|||
126037248|NCT05139810|453434966|FG002|Overall Study|Voluntary Withdrawal|0|||
126037249|NCT05139810|453434964|FG000|Overall Study|Pregnancy|1|||
126037250|NCT05139810|453434965|FG001|Overall Study|Pregnancy|0|||
126037251|NCT05139810|453434966|FG002|Overall Study|Pregnancy|0|||
126037252|NCT05139810|453434964|FG000|Overall Study|Roll Over to CS7|19|||
126037253|NCT05139810|453434965|FG001|Overall Study|Roll Over to CS7|44|||
126037254|NCT05139810|453434966|FG002|Overall Study|Roll Over to CS7|20|||
126037255|NCT04054193|453434978|FG000|Cycle 1|Physician Decision|1|||
126037256|NCT04054193|453434978|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
126037257|NCT04054193|453434978|FG000|Cycle 1|Allocated but not treated|3|||
126272301|NCT01154816|454289011|FG007|Overall Study|Adverse Event|1|||
126272302|NCT01154816|454289012|FG008|Overall Study|Adverse Event|0|||
126272303|NCT01154816|454289013|FG009|Overall Study|Adverse Event|0|||
126272304|NCT01154816|454289014|FG010|Overall Study|Adverse Event|0|||
126272305|NCT01154816|454289015|FG011|Overall Study|Adverse Event|0|||
126272306|NCT00801099|454289016|FG000|Overall Study|Lost to Follow-up|101|||
126272307|NCT03397771|454289019|FG000|Overall Study|2 erroneously randomized, never treated|3|||
126272308|NCT03397771|454289020|FG001|Overall Study|2 erroneously randomized, never treated|1|||
126272309|NCT03397771|454289019|FG000|Overall Study|Withdrawal by Subject|1|||
126272310|NCT03397771|454289020|FG001|Overall Study|Withdrawal by Subject|3|||
126272311|NCT03397771|454289019|FG000|Overall Study|Protocol Violation|2|||
126272312|NCT03397771|454289020|FG001|Overall Study|Protocol Violation|2|||
126272313|NCT03397771|454289019|FG000|Overall Study|Adverse Event|2|||
126272314|NCT03397771|454289020|FG001|Overall Study|Adverse Event|1|||
126272315|NCT04078126|454289023|FG000|Washout|Study put on hold due to COVID-19|0|||
126272316|NCT04078126|454289024|FG001|Washout|Study put on hold due to COVID-19|2|||
126272317|NCT04078126|454289023|FG000|Period 2|Study put on hold due to COVID-19|1|||
126272318|NCT04078126|454289024|FG001|Period 2|Study put on hold due to COVID-19|1|||
126272319|NCT02455050|454289025|FG000|Treatment Period 1|Lost to Follow-up|1|||
126272320|NCT02455050|454289026|FG001|Treatment Period 1|Lost to Follow-up|1|||
126272321|NCT02455050|454289027|FG002|Treatment Period 1|Lost to Follow-up|1|||
126272322|NCT02455050|454289028|FG003|Treatment Period 1|Lost to Follow-up|2|||
126272323|NCT02455050|454289025|FG000|Treatment Period 2|Lost to Follow-up|1|||
126361784|NCT02191397|454617292|FG000|Overall Study|Adverse Event|28|||
126037258|NCT04054193|453434978|FG000|Cycles 2-3|Physician Decision|2|||
126037259|NCT04054193|453434978|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
126037260|NCT04054193|453434978|FG000|Cycles 2-3|Various reasons|17|||
126037261|NCT03084536|453434979|FG000|Overall Study|Determined to be ineligible|0|||
126037262|NCT03084536|453434980|FG001|Overall Study|Determined to be ineligible|0|||
126272324|NCT02455050|454289026|FG001|Treatment Period 2|Lost to Follow-up|0|||
126361785|NCT02191397|454617293|FG001|Overall Study|Adverse Event|17|||
126037263|NCT03084536|453434981|FG002|Overall Study|Determined to be ineligible|16|||
126037264|NCT03084536|453434979|FG000|Overall Study|Withdrawal by Subject|0|||
126037265|NCT03084536|453434980|FG001|Overall Study|Withdrawal by Subject|0|||
126037266|NCT03084536|453434981|FG002|Overall Study|Withdrawal by Subject|4|||
126037267|NCT03084536|453434979|FG000|Overall Study|Physician Decision|0|||
126037268|NCT03084536|453434980|FG001|Overall Study|Physician Decision|0|||
126037269|NCT03084536|453434981|FG002|Overall Study|Physician Decision|3|||
126037270|NCT03084536|453434979|FG000|Overall Study|Death|0|||
126037271|NCT03084536|453434980|FG001|Overall Study|Death|0|||
126037272|NCT03084536|453434981|FG002|Overall Study|Death|1|||
126272325|NCT02455050|454289027|FG002|Treatment Period 2|Lost to Follow-up|2|||
126361786|NCT02191397|454617292|FG000|Overall Study|Lack of Efficacy|10|||
126272326|NCT02455050|454289028|FG003|Treatment Period 2|Lost to Follow-up|1|||
126272327|NCT02981303|454289029|FG000|Overall Study|Progressive Disease|17|||
126272328|NCT02981303|454289030|FG001|Overall Study|Progressive Disease|37|||
126272329|NCT02981303|454289029|FG000|Overall Study|Adverse Event|1|||
126272330|NCT02981303|454289030|FG001|Overall Study|Adverse Event|4|||
126272331|NCT02981303|454289029|FG000|Overall Study|Withdrawal by Subject|0|||
126272332|NCT02981303|454289030|FG001|Overall Study|Withdrawal by Subject|1|||
126272333|NCT02325518|454289031|FG000|Overall Study|Adverse Event|4|||
126272334|NCT02325518|454289032|FG001|Overall Study|Adverse Event|1|||
126272335|NCT02325518|454289031|FG000|Overall Study|Physician Decision|0|||
126272336|NCT02325518|454289032|FG001|Overall Study|Physician Decision|1|||
126272337|NCT02325518|454289031|FG000|Overall Study|Withdrawal by Subject|0|||
126272338|NCT02325518|454289032|FG001|Overall Study|Withdrawal by Subject|1|||
126272339|NCT03393806|454289035|FG000|Overall Study|Physician Decision|1|||
126272340|NCT03393806|454289036|FG001|Overall Study|Physician Decision|0|||
126272341|NCT00886288|454289037|FG000|Overall Study|no respect of the 12 weeks period|657|||
126272342|NCT00886288|454289038|FG001|Overall Study|no respect of the 12 weeks period|227|||
126272343|NCT00886288|454289037|FG000|Overall Study|Lost to Follow-up|86|||
126272344|NCT00886288|454289038|FG001|Overall Study|Lost to Follow-up|0|||
126272345|NCT01259115|454289039|FG000|Period 1|Adverse Event|1|||
126272346|NCT01259115|454289040|FG001|Period 1|Adverse Event|0|||
126272347|NCT01259115|454289039|FG000|Period 1|Protocol Violation|2|||
126272348|NCT01259115|454289040|FG001|Period 1|Protocol Violation|0|||
126272349|NCT01259115|454289039|FG000|Period 1|Lost to Follow-up|0|||
126272350|NCT01259115|454289040|FG001|Period 1|Lost to Follow-up|1|||
126272351|NCT01259115|454289039|FG000|Period 2|Adverse Event|1|||
126272352|NCT01259115|454289040|FG001|Period 2|Adverse Event|0|||
126272353|NCT01675661|454289041|FG000|Overall Study|Lost to Follow-up|22|||
126272354|NCT01675661|454289042|FG001|Overall Study|Lost to Follow-up|23|||
126272355|NCT01675661|454289041|FG000|Overall Study|Practical problems|9|||
126272356|NCT01675661|454289042|FG001|Overall Study|Practical problems|5|||
126272357|NCT01675661|454289041|FG000|Overall Study|Moved away|5|||
126272358|NCT01675661|454289042|FG001|Overall Study|Moved away|6|||
126272359|NCT01675661|454289041|FG000|Overall Study|Withdrawal by Subject|3|||
126272360|NCT01675661|454289042|FG001|Overall Study|Withdrawal by Subject|7|||
126272361|NCT01675661|454289041|FG000|Overall Study|Physician Decision|0|||
126272362|NCT01675661|454289042|FG001|Overall Study|Physician Decision|2|||
126272363|NCT01675661|454289041|FG000|Overall Study|Death|0|||
126272364|NCT01675661|454289042|FG001|Overall Study|Death|1|||
126272365|NCT01675661|454289041|FG000|Overall Study|Other reason|1|||
126272366|NCT01675661|454289042|FG001|Overall Study|Other reason|2|||
126272367|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272368|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
126272369|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272370|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272371|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272372|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
126272373|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
126272374|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272375|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272376|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272377|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272378|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272379|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272380|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125880776|NCT04225897|452862627|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126272381|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126037273|NCT03084536|453434979|FG000|Overall Study|Lost to Follow-up|0|||
126037274|NCT03084536|453434980|FG001|Overall Study|Lost to Follow-up|0|||
126272382|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272383|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272384|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272385|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272386|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272387|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272388|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272389|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272390|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272391|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272392|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272393|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
126272394|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272395|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272396|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272397|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272398|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272399|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272400|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272401|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272402|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272403|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272404|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272405|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272406|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272407|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272408|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272409|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272410|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272411|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272412|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272413|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272414|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272415|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272416|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272417|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
126272418|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
126272419|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
126272420|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
126272421|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
126272422|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
126272423|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
126272424|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
126272425|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
126272426|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
126272427|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
126272428|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
126272429|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
126272430|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
126272431|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
126272432|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
126272433|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
126272434|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
126272435|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
126272436|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
126272437|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
126272438|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
126272439|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
126272440|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
126272441|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
126272442|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
126037275|NCT03084536|453434981|FG002|Overall Study|Lost to Follow-up|1|||
126037276|NCT03084536|453434979|FG000|Overall Study|Protocol Violation|0|||
126037277|NCT03084536|453434980|FG001|Overall Study|Protocol Violation|0|||
126037278|NCT03084536|453434981|FG002|Overall Study|Protocol Violation|1|||
126361787|NCT02191397|454617293|FG001|Overall Study|Lack of Efficacy|5|||
126037279|NCT03084536|453434979|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
126037280|NCT03084536|453434980|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
126361788|NCT02191397|454617292|FG000|Overall Study|Protocol Violation|0|||
126361789|NCT02191397|454617293|FG001|Overall Study|Protocol Violation|3|||
126361790|NCT02191397|454617292|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
126361791|NCT02191397|454617293|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
126361792|NCT02191397|454617292|FG000|Overall Study|Lost to Follow-up|10|||
126361793|NCT02191397|454617293|FG001|Overall Study|Lost to Follow-up|11|||
126361794|NCT02191397|454617292|FG000|Overall Study|Physician Decision|8|||
126361795|NCT02191397|454617293|FG001|Overall Study|Physician Decision|3|||
126361796|NCT02191397|454617292|FG000|Overall Study|Withdrawal by Subject|22|||
126361797|NCT02191397|454617293|FG001|Overall Study|Withdrawal by Subject|27|||
126361798|NCT04629521|454617294|FG000|Overall Study|Death|1|||
126361799|NCT04629521|454617294|FG000|Overall Study|Lost to Follow-up|3|||
126361800|NCT04629521|454617294|FG000|Overall Study|Subject withdrew consent|3|||
126361801|NCT04629521|454617294|FG000|Overall Study|Enrolled in error|1|||
126361802|NCT01618708|454617295|FG000|Overall Study|Adverse Event|10|||
126361803|NCT01618708|454617296|FG001|Overall Study|Adverse Event|10|||
126361804|NCT01618708|454617295|FG000|Overall Study|Lost to Follow-up|3|||
126361805|NCT01618708|454617296|FG001|Overall Study|Lost to Follow-up|3|||
126361806|NCT01618708|454617295|FG000|Overall Study|Withdrawal by Subject|17|||
126361807|NCT01618708|454617296|FG001|Overall Study|Withdrawal by Subject|22|||
126361808|NCT01618708|454617295|FG000|Overall Study|Lack of Efficacy|8|||
126361809|NCT01618708|454617296|FG001|Overall Study|Lack of Efficacy|8|||
126361810|NCT01618708|454617295|FG000|Overall Study|Technical problems|2|||
126361811|NCT01618708|454617296|FG001|Overall Study|Technical problems|0|||
126361812|NCT01618708|454617295|FG000|Overall Study|Other than specified above|1|||
126361813|NCT01618708|454617296|FG001|Overall Study|Other than specified above|1|||
126361814|NCT01618708|454617295|FG000|Overall Study|Randomized but not treated|3|||
126361815|NCT01618708|454617296|FG001|Overall Study|Randomized but not treated|2|||
126361816|NCT02554474|454617299|FG000|Overall Study|Protocol Violation|1|||
126361817|NCT02554474|454617300|FG001|Overall Study|Protocol Violation|1|||
126361818|NCT02554474|454617299|FG000|Overall Study|Health issue not related to the study|1|||
126361819|NCT02554474|454617300|FG001|Overall Study|Health issue not related to the study|0|||
126361820|NCT02554474|454617299|FG000|Overall Study|Withdrawal by Subject|1|||
126361821|NCT02554474|454617300|FG001|Overall Study|Withdrawal by Subject|1|||
126361822|NCT03211832|454617301|FG000|Overall Study|No longer with agency|32|||
126361823|NCT03211832|454617302|FG001|Overall Study|No longer with agency|49|||
126361824|NCT03211832|454617303|FG002|Overall Study|No longer with agency|30|||
126361825|NCT03211832|454617301|FG000|Overall Study|Declined survey|3|||
126361826|NCT03211832|454617302|FG001|Overall Study|Declined survey|3|||
126361827|NCT03211832|454617303|FG002|Overall Study|Declined survey|2|||
126361828|NCT03211832|454617301|FG000|Overall Study|Not available during data collection|1|||
126361829|NCT03211832|454617302|FG001|Overall Study|Not available during data collection|0|||
126361830|NCT03211832|454617303|FG002|Overall Study|Not available during data collection|2|||
126361831|NCT02991859|454617307|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361832|NCT02991859|454617308|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
126361833|NCT02991859|454617309|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361834|NCT02991859|454617310|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361835|NCT02991859|454617311|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
126361836|NCT02991859|454617312|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361837|NCT02991859|454617313|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361838|NCT02991859|454617314|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361839|NCT02991859|454617315|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361840|NCT02991859|454617316|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361841|NCT02991859|454617317|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361842|NCT02991859|454617318|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361843|NCT02991859|454617319|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361844|NCT02991859|454617320|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361845|NCT02991859|454617321|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361846|NCT02991859|454617322|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361847|NCT02991859|454617323|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361848|NCT02991859|454617307|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361849|NCT02991859|454617308|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361850|NCT02991859|454617309|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361851|NCT02991859|454617310|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361852|NCT02991859|454617311|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361853|NCT02991859|454617312|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361854|NCT02991859|454617313|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361855|NCT02991859|454617314|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361856|NCT02991859|454617315|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361857|NCT02991859|454617316|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361858|NCT02991859|454617317|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361859|NCT02991859|454617318|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361860|NCT02991859|454617319|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
126361861|NCT02991859|454617320|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
126361862|NCT02991859|454617321|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361863|NCT02991859|454617322|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361864|NCT02991859|454617323|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361865|NCT02991859|454617307|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361866|NCT02991859|454617308|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361867|NCT02991859|454617309|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361868|NCT02991859|454617310|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361869|NCT02991859|454617311|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361870|NCT02991859|454617312|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
126361871|NCT02991859|454617313|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361872|NCT02991859|454617314|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361873|NCT02991859|454617315|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361874|NCT02991859|454617316|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361875|NCT02991859|454617317|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361876|NCT02991859|454617318|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361877|NCT02991859|454617319|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126272443|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272444|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272445|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272446|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272447|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272448|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272449|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272450|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272451|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272452|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272453|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272454|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272455|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272456|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272457|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272458|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272459|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272460|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272461|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272462|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272463|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272464|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272465|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272466|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272467|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272468|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272469|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272470|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272471|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272472|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
126272473|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
126272474|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272475|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272476|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
126272477|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272478|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126361878|NCT02991859|454617320|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361879|NCT02991859|454617321|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361880|NCT02991859|454617322|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361881|NCT02991859|454617323|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361882|NCT02991859|454617307|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361883|NCT02991859|454617308|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361884|NCT02991859|454617309|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126037281|NCT03084536|453434981|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
126037282|NCT05704543|453434982|FG000|Overall Study|Withdrawal by Subject|1|||
126037283|NCT05704543|453434983|FG001|Overall Study|Withdrawal by Subject|1|||
126098587|NCT00964886|453653049|FG003|Overall Study|Withdrawal by Subject|3|||
126098588|NCT00964886|453653046|FG000|Overall Study|Adverse Event|3|||
126098589|NCT00964886|453653047|FG001|Overall Study|Adverse Event|1|||
126098590|NCT00964886|453653048|FG002|Overall Study|Adverse Event|5|||
126098591|NCT00964886|453653049|FG003|Overall Study|Adverse Event|2|||
126098592|NCT00964886|453653046|FG000|Overall Study|Protocol Violation|0|||
126098593|NCT00964886|453653047|FG001|Overall Study|Protocol Violation|2|||
126098594|NCT00964886|453653048|FG002|Overall Study|Protocol Violation|0|||
126272479|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272480|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272481|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272482|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272483|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272484|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272485|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272486|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272487|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272488|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272489|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272490|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272491|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272492|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272493|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272494|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272495|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272496|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272497|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272498|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
126272499|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272500|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272501|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272502|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272503|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272504|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272505|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272506|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272507|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272508|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272509|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272510|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272511|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272512|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272513|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272514|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272515|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272516|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272517|NCT02393248|454289043|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272518|NCT02393248|454289044|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272519|NCT02393248|454289045|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272520|NCT02393248|454289046|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272521|NCT02393248|454289047|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272522|NCT02393248|454289048|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272523|NCT02393248|454289049|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272524|NCT02393248|454289050|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272525|NCT02393248|454289051|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272526|NCT02393248|454289052|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272527|NCT02393248|454289053|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272528|NCT02393248|454289054|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
126098595|NCT00964886|453653049|FG003|Overall Study|Protocol Violation|0|||
126361885|NCT02991859|454617310|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361886|NCT02991859|454617311|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361887|NCT02991859|454617312|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361888|NCT02991859|454617313|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361889|NCT02991859|454617314|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361890|NCT02991859|454617315|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361891|NCT02991859|454617316|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
126361892|NCT02991859|454617317|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361893|NCT02991859|454617318|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361894|NCT02991859|454617319|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361895|NCT02991859|454617320|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361896|NCT02991859|454617321|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361897|NCT02991859|454617322|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361898|NCT02991859|454617323|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361899|NCT02991859|454617307|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361900|NCT02991859|454617308|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361901|NCT02991859|454617309|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361902|NCT02991859|454617310|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361903|NCT02991859|454617311|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361904|NCT02991859|454617312|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361905|NCT02991859|454617313|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361906|NCT02991859|454617314|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361907|NCT02991859|454617315|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
126361908|NCT02991859|454617316|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361909|NCT02991859|454617317|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361910|NCT02991859|454617318|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361911|NCT02991859|454617319|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361912|NCT02991859|454617320|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361913|NCT02991859|454617321|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361914|NCT02991859|454617322|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361915|NCT02991859|454617323|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361916|NCT01065766|454617324|FG000|Overall Study|Assessed before the contracted date|1|||
126361917|NCT01065766|454617324|FG000|Overall Study|Contraindication to administration|6|||
126361918|NCT01065766|454617324|FG000|Overall Study|Violated dosage/administration|25|||
126361919|NCT04223687|454617331|FG000|Overall Study|Missing primary outcome|1|||
126361920|NCT04223687|454617332|FG001|Overall Study|Missing primary outcome|0|||
126361921|NCT00425854|454617333|FG000|Overall Study|Progressive Disease|19|||
126361922|NCT00425854|454617334|FG001|Overall Study|Progressive Disease|12|||
126361923|NCT00425854|454617333|FG000|Overall Study|Dose reduction toxicity AE|8|||
126361924|NCT00425854|454617334|FG001|Overall Study|Dose reduction toxicity AE|7|||
126361925|NCT00425854|454617333|FG000|Overall Study|Other Adverse Event|2|||
126361926|NCT00425854|454617334|FG001|Overall Study|Other Adverse Event|2|||
126361927|NCT05652140|454617338|FG000|Overall Study|Lost to Follow-up|7|||
126361928|NCT05652140|454617339|FG001|Overall Study|Lost to Follow-up|16|||
126361929|NCT05652140|454617340|FG002|Overall Study|Lost to Follow-up|22|||
126361930|NCT05652140|454617341|FG003|Overall Study|Lost to Follow-up|31|||
126361931|NCT06048705|454617342|FG000|Overall Study|Physician Decision|1|||
126361932|NCT06048705|454617343|FG001|Overall Study|Physician Decision|0|||
126361933|NCT06048705|454617344|FG002|Overall Study|Physician Decision|0|||
126361934|NCT06048705|454617342|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
126361935|NCT06048705|454617343|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
126361936|NCT06048705|454617344|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
126361937|NCT06048705|454617342|FG000|Overall Study|Death prior to lymphodepletion|0|||
126361938|NCT06048705|454617343|FG001|Overall Study|Death prior to lymphodepletion|0|||
126361939|NCT06048705|454617344|FG002|Overall Study|Death prior to lymphodepletion|1|||
126361940|NCT01016015|454617345|FG000|Overall Study|Not Treated|3|||
126361941|NCT01016015|454617345|FG000|Overall Study|Withdrawal by Subject|1|||
126361942|NCT01016015|454617345|FG000|Overall Study|Adverse Event|15|||
126361943|NCT02057666|454617346|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
126361944|NCT02057666|454617347|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
126037284|NCT05704543|453434984|FG002|Overall Study|Withdrawal by Subject|0|||
126037285|NCT05704543|453434985|FG003|Overall Study|Withdrawal by Subject|2|||
126037286|NCT05704543|453434982|FG000|Overall Study|Lost to Follow-up|1|||
126361945|NCT02057666|454617346|FG000|Double Blind Treatment Period|Poor tolerability|7|||
126361946|NCT02057666|454617347|FG001|Double Blind Treatment Period|Poor tolerability|2|||
126361947|NCT02057666|454617346|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
126361948|NCT02057666|454617347|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
126037287|NCT05704543|453434983|FG001|Overall Study|Lost to Follow-up|2|||
126361949|NCT02057666|454617346|FG000|Double Blind Treatment Period|Physician Decision|1|||
126361950|NCT02057666|454617347|FG001|Double Blind Treatment Period|Physician Decision|0|||
126272529|NCT02393248|454289055|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
126272530|NCT02393248|454289056|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
126272531|NCT02393248|454289057|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
126272532|NCT02393248|454289058|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272533|NCT02393248|454289059|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272534|NCT02393248|454289060|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272535|NCT02393248|454289061|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272536|NCT02393248|454289062|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272537|NCT02393248|454289063|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272538|NCT02393248|454289064|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272539|NCT02393248|454289065|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272540|NCT02393248|454289066|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272541|NCT02393248|454289067|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272542|NCT02393248|454289043|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272543|NCT02393248|454289044|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272544|NCT02393248|454289045|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272545|NCT02393248|454289046|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272546|NCT02393248|454289047|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272547|NCT02393248|454289048|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272548|NCT02393248|454289049|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272549|NCT02393248|454289050|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272550|NCT02393248|454289051|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272551|NCT02393248|454289052|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272552|NCT02393248|454289053|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
126272553|NCT02393248|454289054|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
126272554|NCT02393248|454289055|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272555|NCT02393248|454289056|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272556|NCT02393248|454289057|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272557|NCT02393248|454289058|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272558|NCT02393248|454289059|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272559|NCT02393248|454289060|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272560|NCT02393248|454289061|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272561|NCT02393248|454289062|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272562|NCT02393248|454289063|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272563|NCT02393248|454289064|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272564|NCT02393248|454289065|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272565|NCT02393248|454289066|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272566|NCT02393248|454289067|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272567|NCT02393248|454289043|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
126272568|NCT02393248|454289044|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
126272569|NCT02393248|454289045|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
126272570|NCT02393248|454289046|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
126272571|NCT02393248|454289047|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
126272572|NCT02393248|454289048|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
126272573|NCT02393248|454289049|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
126272574|NCT02393248|454289050|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
126272575|NCT02393248|454289051|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
126272576|NCT02393248|454289052|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
126272577|NCT02393248|454289053|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
126272578|NCT02393248|454289054|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
126272579|NCT02393248|454289055|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
126272580|NCT02393248|454289056|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
126272581|NCT02393248|454289057|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
126272582|NCT02393248|454289058|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
126272583|NCT02393248|454289059|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
126272584|NCT02393248|454289060|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
126272585|NCT02393248|454289061|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
126272586|NCT02393248|454289062|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
126272587|NCT02393248|454289063|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
126272588|NCT02393248|454289064|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
126272589|NCT02393248|454289065|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
126272590|NCT02393248|454289066|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
126272591|NCT02393248|454289067|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
126272592|NCT02393248|454289043|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272593|NCT02393248|454289044|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272594|NCT02393248|454289045|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272595|NCT02393248|454289046|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272596|NCT02393248|454289047|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126037288|NCT05704543|453434984|FG002|Overall Study|Lost to Follow-up|0|||
126037289|NCT05704543|453434985|FG003|Overall Study|Lost to Follow-up|0|||
126037290|NCT04830800|453434994|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
126037291|NCT04830800|453434995|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
126037292|NCT04830800|453434996|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
126272597|NCT02393248|454289048|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272598|NCT02393248|454289049|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272599|NCT02393248|454289050|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272600|NCT02393248|454289051|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272601|NCT02393248|454289052|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272602|NCT02393248|454289053|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272603|NCT02393248|454289054|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
126272604|NCT02393248|454289055|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272605|NCT02393248|454289056|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
126272606|NCT02393248|454289057|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272607|NCT02393248|454289058|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272608|NCT02393248|454289059|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272609|NCT02393248|454289060|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272610|NCT02393248|454289061|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272611|NCT02393248|454289062|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272612|NCT02393248|454289063|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272613|NCT02393248|454289064|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272614|NCT02393248|454289065|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272615|NCT02393248|454289066|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272616|NCT02393248|454289067|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272617|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272618|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272619|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272620|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272621|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272622|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272623|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272624|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272625|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272626|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272627|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272628|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272629|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272630|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272631|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272632|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272633|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272634|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272635|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
126272636|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272637|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
126272638|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
126272639|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272640|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
126272641|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272642|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Death|0|||
126272643|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Death|0|||
126272644|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Death|0|||
126272645|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Death|0|||
126272646|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Death|0|||
126272647|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Death|0|||
126272648|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Death|0|||
126272649|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Death|0|||
126272650|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Death|0|||
126037293|NCT04830800|453434997|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
126037294|NCT04830800|453434998|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
126272651|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Death|0|||
126272652|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Death|0|||
126272653|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Death|0|||
126272654|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Death|0|||
126272655|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Death|0|||
126272656|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Death|0|||
126272657|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Death|1|||
126272658|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Death|7|||
126272659|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Death|5|||
126272660|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Death|5|||
126272661|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Death|3|||
126272662|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Death|7|||
126272663|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Death|5|||
126272664|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Death|6|||
126272665|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Death|3|||
126272666|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Death|0|||
126272667|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272668|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272669|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272670|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272671|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272672|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272673|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272674|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272675|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272676|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272677|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272678|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272679|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272680|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272681|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272682|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272683|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272684|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272685|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272686|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272687|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272688|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272689|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272690|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
126272691|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272692|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Disease Progression|0|||
126272693|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Disease Progression|0|||
126272694|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Disease Progression|0|||
126272695|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Disease Progression|0|||
126272696|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Disease Progression|0|||
126272697|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Disease Progression|0|||
126272698|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Disease Progression|0|||
126272699|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Disease Progression|0|||
126272700|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Disease Progression|0|||
126272701|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Disease Progression|0|||
126272702|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Disease Progression|0|||
126272703|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Disease Progression|0|||
126272704|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Disease Progression|0|||
126272705|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Disease Progression|0|||
126272706|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Disease Progression|0|||
126272707|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Disease Progression|0|||
126272708|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Disease Progression|0|||
126272709|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Disease Progression|0|||
126272710|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Disease Progression|0|||
126272711|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Disease Progression|0|||
126272712|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Disease Progression|2|||
126272713|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Disease Progression|1|||
126272714|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Disease Progression|0|||
126272715|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Disease Progression|0|||
126272716|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Disease Progression|0|||
126272717|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272718|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
126361951|NCT02057666|454617346|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
126272719|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272720|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272721|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272722|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272723|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
126361952|NCT02057666|454617347|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
126272724|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272725|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272726|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272727|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272728|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272729|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272730|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272731|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272732|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272733|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272734|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272735|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272736|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272737|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
126272738|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
126272739|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272740|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272741|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272742|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272743|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272744|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272745|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272746|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272747|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272748|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272749|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272750|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272751|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272752|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272753|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272754|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272755|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272756|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272757|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272758|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272759|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272760|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272761|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272762|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
126272763|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272764|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272765|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272766|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272767|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Adverse Event|0|||
126272768|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Adverse Event|0|||
126272769|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Adverse Event|0|||
126272770|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Adverse Event|0|||
126272771|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Adverse Event|0|||
126272772|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Adverse Event|0|||
126272773|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Adverse Event|0|||
126272774|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Adverse Event|0|||
126272775|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Adverse Event|0|||
126272776|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Adverse Event|0|||
126272777|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Adverse Event|0|||
126272778|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Adverse Event|0|||
126272779|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Adverse Event|0|||
126272780|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Adverse Event|0|||
126272781|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Adverse Event|0|||
126272782|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Adverse Event|0|||
126272783|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Adverse Event|0|||
126272784|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Adverse Event|0|||
126272785|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Adverse Event|0|||
126272786|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Adverse Event|0|||
126272787|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Adverse Event|0|||
126272788|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Adverse Event|0|||
126272789|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Adverse Event|0|||
126272790|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Adverse Event|1|||
126272791|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Adverse Event|0|||
126272792|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272793|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272794|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272795|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272796|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272797|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272798|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272799|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272800|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272801|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272802|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272803|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272804|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272805|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272806|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272807|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272808|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272809|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272810|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272811|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272812|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272813|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272814|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272815|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
126272816|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272817|NCT04765384|454289068|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
126272818|NCT04765384|454289069|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
126272819|NCT04765384|454289070|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
126272820|NCT04765384|454289071|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
126272821|NCT04765384|454289072|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
126272822|NCT04765384|454289073|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
126272823|NCT04765384|454289068|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
126272824|NCT04765384|454289069|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
126272825|NCT04765384|454289070|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
126272826|NCT04765384|454289071|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
126272827|NCT04765384|454289072|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
126272828|NCT04765384|454289073|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
126272829|NCT04765384|454289068|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272830|NCT04765384|454289069|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272831|NCT04765384|454289070|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272832|NCT04765384|454289071|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272833|NCT04765384|454289072|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272834|NCT04765384|454289073|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
126272835|NCT04765384|454289068|FG000|Post-natal: Neonates and Infants|Death|0|||
126361953|NCT02057666|454617346|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
126361954|NCT02057666|454617347|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
126361955|NCT02057666|454617346|FG000|Double Blind Treatment Period|Sponsor's request|70|||
126361956|NCT02057666|454617347|FG001|Double Blind Treatment Period|Sponsor's request|34|||
126361957|NCT02057666|454617346|FG000|Open-Label Treatment Period|Poor tolerability|0|||
126037295|NCT03816332|453435001|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
126272836|NCT04765384|454289069|FG001|Post-natal: Neonates and Infants|Death|0|||
126272837|NCT04765384|454289070|FG002|Post-natal: Neonates and Infants|Death|0|||
126272838|NCT04765384|454289071|FG003|Post-natal: Neonates and Infants|Death|1|||
126272839|NCT04765384|454289072|FG004|Post-natal: Neonates and Infants|Death|0|||
126272840|NCT04765384|454289073|FG005|Post-natal: Neonates and Infants|Death|0|||
126272841|NCT04765384|454289068|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272842|NCT04765384|454289069|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272843|NCT04765384|454289070|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272844|NCT04765384|454289071|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272845|NCT04765384|454289072|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272846|NCT04765384|454289073|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
126272847|NCT01971970|454289074|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
126272848|NCT01971970|454289075|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
126272849|NCT01971970|454289074|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
126272850|NCT01971970|454289075|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
126272851|NCT01971970|454289074|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
126272852|NCT01971970|454289075|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
126272853|NCT01971970|454289074|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
126272854|NCT01971970|454289075|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
126272855|NCT01971970|454289074|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
126272856|NCT01971970|454289075|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
126272857|NCT01971970|454289074|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
126272858|NCT01971970|454289075|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
126272859|NCT01971970|454289074|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
126272860|NCT01971970|454289075|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
126272861|NCT02524730|454289076|FG000|Overall Study|Lost to Follow-up|5|||
126272862|NCT02524730|454289076|FG000|Overall Study|Withdrawal by Subject|18|||
126272863|NCT02524730|454289076|FG000|Overall Study|Death|10|||
126272864|NCT02524730|454289076|FG000|Overall Study|Adverse Event|8|||
126272865|NCT02524730|454289076|FG000|Overall Study|Protocol Violation|1|||
126272866|NCT02524730|454289076|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
126272867|NCT00977379|454289077|FG000|Overall Study|Withdrawal by Subject|1|||
126272868|NCT00977379|454289078|FG001|Overall Study|Withdrawal by Subject|1|||
126272869|NCT00977379|454289077|FG000|Overall Study|Death|7|||
126272870|NCT00977379|454289078|FG001|Overall Study|Death|9|||
126272871|NCT00977379|454289077|FG000|Overall Study|Premature Study Termination|4|||
126272872|NCT00977379|454289078|FG001|Overall Study|Premature Study Termination|0|||
126272873|NCT00977379|454289077|FG000|Overall Study|Participant Moving House|0|||
126272874|NCT00977379|454289078|FG001|Overall Study|Participant Moving House|1|||
126272875|NCT00977379|454289077|FG000|Overall Study|Randomization Error|0|||
126272876|NCT00977379|454289078|FG001|Overall Study|Randomization Error|1|||
126272877|NCT01868893|454289085|FG000|Overall Study|Adverse Event|2|||
126272878|NCT01868893|454289085|FG000|Overall Study|Commercial availability of study drug|17|||
126272879|NCT01868893|454289085|FG000|Overall Study|Neutropenia|1|||
126272880|NCT01783548|454289086|FG000|Overall Study|Adverse Event|8|||
126272881|NCT01783548|454289087|FG001|Overall Study|Adverse Event|4|||
126272882|NCT01783548|454289086|FG000|Overall Study|Withdrawal by Subject|11|||
126272883|NCT01783548|454289087|FG001|Overall Study|Withdrawal by Subject|8|||
126272884|NCT01783548|454289086|FG000|Overall Study|Non-compliance|4|||
126272885|NCT01783548|454289087|FG001|Overall Study|Non-compliance|0|||
126272886|NCT01783548|454289086|FG000|Overall Study|Protocol Violation|2|||
126272887|NCT01783548|454289087|FG001|Overall Study|Protocol Violation|2|||
126272888|NCT01783548|454289086|FG000|Overall Study|Lost to Follow-up|8|||
126272889|NCT01783548|454289087|FG001|Overall Study|Lost to Follow-up|3|||
126272890|NCT01783548|454289086|FG000|Overall Study|Lack of Efficacy|1|||
126272891|NCT01783548|454289087|FG001|Overall Study|Lack of Efficacy|1|||
126272892|NCT00988442|454289088|FG000|Overall Study|Death|1|||
126272893|NCT00988442|454289089|FG001|Overall Study|Death|2|||
126272894|NCT00988442|454289088|FG000|Overall Study|Lost to Follow-up|0|||
126272895|NCT00988442|454289089|FG001|Overall Study|Lost to Follow-up|1|||
126272896|NCT00988442|454289088|FG000|Overall Study|Early Study Closure|29|||
126272897|NCT00988442|454289089|FG001|Overall Study|Early Study Closure|25|||
126272898|NCT05297578|454289092|FG000|Overall Study|Lost to Follow-up|1|||
126272899|NCT05297578|454289093|FG001|Overall Study|Lost to Follow-up|1|||
126272900|NCT05297578|454289094|FG002|Overall Study|Lost to Follow-up|2|||
126272901|NCT05297578|454289095|FG003|Overall Study|Lost to Follow-up|1|||
126272902|NCT05297578|454289092|FG000|Overall Study|Death|0|||
126272903|NCT05297578|454289093|FG001|Overall Study|Death|1|||
126272904|NCT05297578|454289094|FG002|Overall Study|Death|0|||
126272905|NCT05297578|454289095|FG003|Overall Study|Death|0|||
126272906|NCT05297578|454289092|FG000|Overall Study|Withdrawal by Subject|0|||
126272907|NCT05297578|454289093|FG001|Overall Study|Withdrawal by Subject|0|||
126272908|NCT05297578|454289094|FG002|Overall Study|Withdrawal by Subject|1|||
126037296|NCT03816332|453435001|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
126037297|NCT01456949|453435002|FG000|Enrollment|PI death- incomplete data|6|||
126037298|NCT01456949|453435002|FG000|Enrollment|Death|1|||
126037299|NCT01456949|453435002|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
126037300|NCT01456949|453435002|FG000|Enrollment|Physician Decision|10|||
126272909|NCT05297578|454289095|FG003|Overall Study|Withdrawal by Subject|0|||
126272910|NCT01087489|454289096|FG000|Overall Study|enrolled in another VA study|0|||
126272911|NCT01087489|454289097|FG001|Overall Study|enrolled in another VA study|1|||
126272912|NCT01087489|454289096|FG000|Overall Study|Death|0|||
126272913|NCT01087489|454289097|FG001|Overall Study|Death|1|||
126272914|NCT01087489|454289096|FG000|Overall Study|unable to survey by telephone|0|||
126272915|NCT01087489|454289097|FG001|Overall Study|unable to survey by telephone|1|||
126272916|NCT00117325|454289098|FG000|Overall Study|Adverse Event|3|||
126272917|NCT00117325|454289099|FG001|Overall Study|Adverse Event|3|||
126272918|NCT00117325|454289098|FG000|Overall Study|Lost to Follow-up|1|||
126272919|NCT00117325|454289099|FG001|Overall Study|Lost to Follow-up|1|||
126272920|NCT00117325|454289098|FG000|Overall Study|Protocol Violation|2|||
126272921|NCT00117325|454289099|FG001|Overall Study|Protocol Violation|3|||
126272922|NCT00117325|454289098|FG000|Overall Study|Withdrawal by Subject|3|||
126272923|NCT00117325|454289099|FG001|Overall Study|Withdrawal by Subject|2|||
126272924|NCT00117325|454289098|FG000|Overall Study|Lack of Efficacy|1|||
126272925|NCT00117325|454289099|FG001|Overall Study|Lack of Efficacy|0|||
126272926|NCT00117325|454289098|FG000|Overall Study|Use of prohibited medicine|1|||
126272927|NCT00117325|454289099|FG001|Overall Study|Use of prohibited medicine|2|||
126272928|NCT00117325|454289098|FG000|Overall Study|Early termination|1|||
126272929|NCT00117325|454289099|FG001|Overall Study|Early termination|1|||
126272930|NCT00117325|454289098|FG000|Overall Study|Admisnitrative|1|||
126272931|NCT00117325|454289099|FG001|Overall Study|Admisnitrative|0|||
126272932|NCT01974440|454289100|FG000|Overall Study|Lost to Follow-up|7|||
126272933|NCT01974440|454289101|FG001|Overall Study|Lost to Follow-up|7|||
126272934|NCT01974440|454289100|FG000|Overall Study|Withdrawal by Subject|24|||
126272935|NCT01974440|454289101|FG001|Overall Study|Withdrawal by Subject|20|||
126272936|NCT01974440|454289100|FG000|Overall Study|Sponsor decision|109|||
126272937|NCT01974440|454289101|FG001|Overall Study|Sponsor decision|110|||
126272938|NCT02387983|454289102|FG000|Overall Study|Adverse Event|4|||
126272939|NCT02387983|454289102|FG000|Overall Study|Protocol Violation|1|||
126272940|NCT02387983|454289102|FG000|Overall Study|Withdrawal by Subject|2|||
126272941|NCT03569228|454289103|FG000|Overall Study|Withdrawal by PI|0|||
126272942|NCT03569228|454289104|FG001|Overall Study|Withdrawal by PI|0|||
126272943|NCT03569228|454289105|FG002|Overall Study|Withdrawal by PI|2|||
126272944|NCT03569228|454289106|FG003|Overall Study|Withdrawal by PI|2|||
126272945|NCT03569228|454289107|FG004|Overall Study|Withdrawal by PI|1|||
126272946|NCT03569228|454289108|FG005|Overall Study|Withdrawal by PI|0|||
126272947|NCT03569228|454289109|FG006|Overall Study|Withdrawal by PI|0|||
126272948|NCT03569228|454289110|FG007|Overall Study|Withdrawal by PI|0|||
126272949|NCT03569228|454289111|FG008|Overall Study|Withdrawal by PI|0|||
126272950|NCT03569228|454289103|FG000|Overall Study|Lost to Follow-up|0|||
126272951|NCT03569228|454289104|FG001|Overall Study|Lost to Follow-up|0|||
126272952|NCT03569228|454289105|FG002|Overall Study|Lost to Follow-up|0|||
126272953|NCT03569228|454289106|FG003|Overall Study|Lost to Follow-up|0|||
126272954|NCT03569228|454289107|FG004|Overall Study|Lost to Follow-up|0|||
126272955|NCT03569228|454289108|FG005|Overall Study|Lost to Follow-up|0|||
126272956|NCT03569228|454289109|FG006|Overall Study|Lost to Follow-up|0|||
126272957|NCT03569228|454289110|FG007|Overall Study|Lost to Follow-up|0|||
126272958|NCT03569228|454289111|FG008|Overall Study|Lost to Follow-up|1|||
126272959|NCT03569228|454289103|FG000|Overall Study|Screen Fail|2|||
126272960|NCT03569228|454289104|FG001|Overall Study|Screen Fail|2|||
126272961|NCT03569228|454289105|FG002|Overall Study|Screen Fail|1|||
126272962|NCT03569228|454289106|FG003|Overall Study|Screen Fail|1|||
126272963|NCT03569228|454289107|FG004|Overall Study|Screen Fail|1|||
126272964|NCT03569228|454289108|FG005|Overall Study|Screen Fail|3|||
126272965|NCT03569228|454289109|FG006|Overall Study|Screen Fail|1|||
126272966|NCT03569228|454289110|FG007|Overall Study|Screen Fail|5|||
126037301|NCT01456949|453435002|FG000|Enrollment|Withdrawal by Subject|7|||
126037302|NCT01456949|453435002|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
126037303|NCT01456949|453435002|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
126272967|NCT03569228|454289111|FG008|Overall Study|Screen Fail|2|||
126361958|NCT02057666|454617347|FG001|Open-Label Treatment Period|Poor tolerability|1|||
126361959|NCT02057666|454617346|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
126361960|NCT02057666|454617347|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
126037304|NCT01456949|453435002|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
126103478|NCT01078675|453672169|FG000|Overall Study|Provided in CRF for specific reasons|2|||
126272968|NCT06354998|454289112|FG000|Overall Study|Withdrawal by Subject|3|||
126272969|NCT06354998|454289113|FG001|Overall Study|Withdrawal by Subject|0|||
126272970|NCT01103466|454289121|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
126272971|NCT01103466|454289122|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
126272972|NCT01103466|454289123|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
126272973|NCT01103466|454289121|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
126361961|NCT02057666|454617346|FG000|Open-Label Treatment Period|Sponsor's request|0|||
126361962|NCT02057666|454617347|FG001|Open-Label Treatment Period|Sponsor's request|4|||
126361963|NCT00498485|454617352|FG000|Overall Study|Adverse Event|1|||
126361964|NCT00498485|454617353|FG001|Overall Study|Adverse Event|5|||
126361965|NCT01539525|454617354|FG000|Overall Study|Lost to Follow-up|19|||
126361966|NCT01539525|454617355|FG001|Overall Study|Lost to Follow-up|12|||
126361967|NCT01539525|454617356|FG002|Overall Study|Lost to Follow-up|11|||
126361968|NCT01539525|454617354|FG000|Overall Study|Withdrawal by Subject|0|||
126361969|NCT01539525|454617355|FG001|Overall Study|Withdrawal by Subject|3|||
126361970|NCT01539525|454617356|FG002|Overall Study|Withdrawal by Subject|2|||
126361971|NCT01539525|454617354|FG000|Overall Study|Protocol Violation|1|||
126361972|NCT01539525|454617355|FG001|Overall Study|Protocol Violation|1|||
126361973|NCT01539525|454617356|FG002|Overall Study|Protocol Violation|4|||
126361974|NCT01712074|454617357|FG000|Placebo Run-in Period|Adverse Event|2|||
126361975|NCT01712074|454617358|FG001|Placebo Run-in Period|Adverse Event|0|||
126361976|NCT01712074|454617359|FG002|Placebo Run-in Period|Adverse Event|0|||
126361977|NCT01712074|454617357|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
126361978|NCT01712074|454617358|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
126361979|NCT01712074|454617359|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
126361980|NCT01712074|454617357|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
126361981|NCT01712074|454617358|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
126361982|NCT01712074|454617359|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
126361983|NCT01712074|454617357|FG000|Placebo Run-in Period|Other|1|||
126361984|NCT01712074|454617358|FG001|Placebo Run-in Period|Other|0|||
126361985|NCT01712074|454617359|FG002|Placebo Run-in Period|Other|0|||
126361986|NCT01712074|454617357|FG000|Placebo Run-in Period|No longer willing to participate|1|||
126361987|NCT01712074|454617358|FG001|Placebo Run-in Period|No longer willing to participate|0|||
126361988|NCT01712074|454617359|FG002|Placebo Run-in Period|No longer willing to participate|0|||
126361989|NCT01712074|454617357|FG000|Double Blind Period|Adverse Event|0|||
126361990|NCT01712074|454617358|FG001|Double Blind Period|Adverse Event|2|||
126361991|NCT01712074|454617359|FG002|Double Blind Period|Adverse Event|1|||
126361992|NCT01712074|454617357|FG000|Double Blind Period|No longer willing to participate|0|||
126361993|NCT01712074|454617358|FG001|Double Blind Period|No longer willing to participate|2|||
126361994|NCT01712074|454617359|FG002|Double Blind Period|No longer willing to participate|4|||
126361995|NCT01712074|454617357|FG000|Double Blind Period|Death|0|||
126361996|NCT01712074|454617358|FG001|Double Blind Period|Death|1|||
126361997|NCT01712074|454617359|FG002|Double Blind Period|Death|0|||
126361998|NCT01712074|454617357|FG000|Double Blind Period|Lost to Follow-up|0|||
126361999|NCT01712074|454617358|FG001|Double Blind Period|Lost to Follow-up|2|||
126362000|NCT01712074|454617359|FG002|Double Blind Period|Lost to Follow-up|1|||
126362001|NCT01712074|454617357|FG000|Double Blind Period|Other|0|||
126362002|NCT01712074|454617358|FG001|Double Blind Period|Other|4|||
126362003|NCT01712074|454617359|FG002|Double Blind Period|Other|1|||
126362004|NCT01712074|454617357|FG000|Double Blind Period|Protocol Violation|0|||
126362005|NCT01712074|454617358|FG001|Double Blind Period|Protocol Violation|0|||
126362006|NCT01712074|454617359|FG002|Double Blind Period|Protocol Violation|1|||
126362007|NCT01712074|454617357|FG000|Double Blind Period|No longer met eligibility criteria|0|||
126362008|NCT01712074|454617358|FG001|Double Blind Period|No longer met eligibility criteria|3|||
126362009|NCT01712074|454617359|FG002|Double Blind Period|No longer met eligibility criteria|0|||
126362010|NCT01472835|454617362|FG000|Overall Study|Lost to Follow-up|2|||
126362011|NCT01472835|454617363|FG001|Overall Study|Lost to Follow-up|0|||
126362012|NCT02792257|454617387|FG000|Overall Study|Lost to Follow-up|3|||
126362013|NCT02792257|454617388|FG001|Overall Study|Lost to Follow-up|4|||
126362014|NCT02792257|454617387|FG000|Overall Study|Allergy|0|||
126362015|NCT02792257|454617388|FG001|Overall Study|Allergy|1|||
126362016|NCT02792257|454617387|FG000|Overall Study|Protocol Violation|2|||
126037305|NCT01456949|453435002|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
126362017|NCT02792257|454617388|FG001|Overall Study|Protocol Violation|0|||
126362018|NCT02792257|454617387|FG000|Overall Study|Excessive Agitation|0|||
126362019|NCT02792257|454617388|FG001|Overall Study|Excessive Agitation|1|||
126362020|NCT02792257|454617387|FG000|Overall Study|Not Feeling Well|0|||
126362021|NCT02792257|454617388|FG001|Overall Study|Not Feeling Well|1|||
126362022|NCT00553475|454617389|FG000|Overall Study|Adverse Event|7|||
126362023|NCT00553475|454617390|FG001|Overall Study|Adverse Event|17|||
126362024|NCT00553475|454617391|FG002|Overall Study|Adverse Event|13|||
126362025|NCT00553475|454617389|FG000|Overall Study|Lack of Efficacy|7|||
126362026|NCT00553475|454617390|FG001|Overall Study|Lack of Efficacy|1|||
126362027|NCT00553475|454617391|FG002|Overall Study|Lack of Efficacy|0|||
126362028|NCT00553475|454617389|FG000|Overall Study|Withdrawal by Subject|1|||
126362029|NCT00553475|454617390|FG001|Overall Study|Withdrawal by Subject|1|||
126362030|NCT00553475|454617391|FG002|Overall Study|Withdrawal by Subject|0|||
126037306|NCT01456949|453435002|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
126037307|NCT01456949|453435002|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
126037308|NCT01456949|453435002|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
126037309|NCT01456949|453435002|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
126037310|NCT03710603|453435003|FG000|Overall Study|Adverse Event|1|||
126037311|NCT03710603|453435004|FG001|Overall Study|Adverse Event|0|||
126037312|NCT03710603|453435003|FG000|Overall Study|Death|44|||
126037313|NCT03710603|453435004|FG001|Overall Study|Death|34|||
126037314|NCT03710603|453435003|FG000|Overall Study|Lost to Follow-up|3|||
126037315|NCT03710603|453435004|FG001|Overall Study|Lost to Follow-up|5|||
126037316|NCT03710603|453435003|FG000|Overall Study|Withdrawal by Subject|11|||
126037317|NCT03710603|453435004|FG001|Overall Study|Withdrawal by Subject|10|||
126037318|NCT03785964|453435005|FG000|Overall Study|Adverse Event|14|||
126037319|NCT03785964|453435006|FG001|Overall Study|Adverse Event|1|||
126037320|NCT03785964|453435005|FG000|Overall Study|Unqualified Clinical Progression|1|||
126037321|NCT03785964|453435006|FG001|Overall Study|Unqualified Clinical Progression|1|||
126037322|NCT03785964|453435005|FG000|Overall Study|Participant non-compliance|1|||
126037323|NCT03785964|453435006|FG001|Overall Study|Participant non-compliance|1|||
126037324|NCT03785964|453435005|FG000|Overall Study|Not treated|1|||
126037325|NCT03785964|453435006|FG001|Overall Study|Not treated|0|||
126037326|NCT03785964|453435005|FG000|Overall Study|Other reason|5|||
126037327|NCT03785964|453435006|FG001|Overall Study|Other reason|11|||
126037328|NCT03785964|453435005|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
126037329|NCT03785964|453435006|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
126037330|NCT03034356|453435029|FG000|Baseline|Lost to Follow-up|2|||
126037331|NCT03034356|453435030|FG001|Baseline|Lost to Follow-up|4|||
126037332|NCT03034356|453435029|FG000|Baseline|Withdrawal by Subject|2|||
126037333|NCT03034356|453435030|FG001|Baseline|Withdrawal by Subject|0|||
126037334|NCT03034356|453435029|FG000|Baseline|Physician Decision|0|||
126037335|NCT03034356|453435030|FG001|Baseline|Physician Decision|1|||
126037336|NCT03034356|453435029|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
126037337|NCT03034356|453435030|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
126037338|NCT03034356|453435029|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
126037339|NCT03034356|453435030|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
126037340|NCT03034356|453435029|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
126037341|NCT03034356|453435030|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
126037342|NCT03034356|453435029|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
126037343|NCT03034356|453435030|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
126037344|NCT02823145|453435031|FG000|Enrollment|Other|1|||
126037345|NCT02823145|453435032|FG001|Enrollment|Other|0|||
126037346|NCT02823145|453435031|FG000|Treatment|Adverse Event|0|||
126037347|NCT02823145|453435032|FG001|Treatment|Adverse Event|11|||
126272974|NCT01103466|454289122|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
126272975|NCT01103466|454289123|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
126272976|NCT01103466|454289121|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
126272977|NCT01103466|454289122|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
126272978|NCT01103466|454289123|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
126272979|NCT01103466|454289121|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
126272980|NCT01103466|454289122|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
126272981|NCT01103466|454289123|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
126272982|NCT01103466|454289121|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
126272983|NCT01103466|454289122|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
126272984|NCT01103466|454289123|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
126272985|NCT01103466|454289121|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
126272986|NCT01103466|454289122|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
126272987|NCT01103466|454289123|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
126037348|NCT02823145|453435031|FG000|Treatment|Death|0|||
126037349|NCT02823145|453435032|FG001|Treatment|Death|3|||
126037350|NCT02823145|453435031|FG000|Treatment|Family Decision|0|||
126037351|NCT02823145|453435032|FG001|Treatment|Family Decision|1|||
126272988|NCT02331368|454289130|FG000|Overall Study|Withdrawal by Subject|3|||
126272989|NCT02302859|454289131|FG000|Overall Study|Lost Phone|1|||
126272990|NCT02302859|454289132|FG001|Overall Study|Lost Phone|1|||
126272991|NCT02302859|454289131|FG000|Overall Study|Withdrawal by Subject|0|||
126272992|NCT02302859|454289132|FG001|Overall Study|Withdrawal by Subject|1|||
126272993|NCT02283983|454289135|FG000|Overall Study|Inclusion criteria not met|0|||
126037352|NCT02823145|453435031|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
126037353|NCT02823145|453435032|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
126037354|NCT02823145|453435031|FG000|Treatment|Lack of Efficacy|0|||
126037355|NCT02823145|453435032|FG001|Treatment|Lack of Efficacy|48|||
126037356|NCT02823145|453435031|FG000|Treatment|Non-Compliance With E-Diary|0|||
126037357|NCT02823145|453435032|FG001|Treatment|Non-Compliance With E-Diary|1|||
126037358|NCT02823145|453435031|FG000|Treatment|Physician Decision|0|||
126037359|NCT02823145|453435032|FG001|Treatment|Physician Decision|2|||
126037360|NCT02823145|453435031|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
126272994|NCT02283983|454289136|FG001|Overall Study|Inclusion criteria not met|1|||
126272995|NCT02283983|454289135|FG000|Overall Study|Withdrawal by Subject|4|||
126272996|NCT02283983|454289136|FG001|Overall Study|Withdrawal by Subject|2|||
126272997|NCT02283983|454289135|FG000|Overall Study|Protocol Violation|0|||
126272998|NCT02283983|454289136|FG001|Overall Study|Protocol Violation|4|||
126272999|NCT02283983|454289135|FG000|Overall Study|Physician Decision|2|||
126273000|NCT02283983|454289136|FG001|Overall Study|Physician Decision|4|||
126273001|NCT02283983|454289135|FG000|Overall Study|Death|1|||
126273002|NCT02283983|454289136|FG001|Overall Study|Death|0|||
126273003|NCT02283983|454289135|FG000|Overall Study|Adverse Event|1|||
126273004|NCT02283983|454289136|FG001|Overall Study|Adverse Event|0|||
126273005|NCT02283983|454289135|FG000|Overall Study|Lost to Follow-up|9|||
126273006|NCT02283983|454289136|FG001|Overall Study|Lost to Follow-up|8|||
126273007|NCT02283983|454289135|FG000|Overall Study|Relapse|1|||
126273008|NCT02283983|454289136|FG001|Overall Study|Relapse|0|||
126273009|NCT00424775|454289141|FG000|Overall Study|Adverse Event|2|||
126273010|NCT00424775|454289142|FG001|Overall Study|Adverse Event|0|||
126273011|NCT00424775|454289141|FG000|Overall Study|Lack of Efficacy|1|||
126273012|NCT00424775|454289142|FG001|Overall Study|Lack of Efficacy|0|||
126273013|NCT01791153|454289143|FG000|Part 1: Blinded Period|Adverse Event|7|||
126273014|NCT01791153|454289144|FG001|Part 1: Blinded Period|Adverse Event|3|||
126273015|NCT01791153|454289145|FG002|Part 1: Blinded Period|Adverse Event|2|||
126273016|NCT01791153|454289146|FG003|Part 1: Blinded Period|Adverse Event|0|||
126273017|NCT01791153|454289147|FG004|Part 1: Blinded Period|Adverse Event|0|||
126273018|NCT01791153|454289148|FG005|Part 1: Blinded Period|Adverse Event|0|||
126273019|NCT01791153|454289149|FG006|Part 1: Blinded Period|Adverse Event|0|||
126273020|NCT01791153|454289150|FG007|Part 1: Blinded Period|Adverse Event|0|||
126273021|NCT01791153|454289143|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
126273022|NCT01791153|454289144|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
126273023|NCT01791153|454289145|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
126273024|NCT01791153|454289146|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
126273025|NCT01791153|454289147|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
126273026|NCT01791153|454289148|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
126273027|NCT01791153|454289149|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
126273028|NCT01791153|454289150|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
126273029|NCT01791153|454289143|FG000|Part 1: Blinded Period|Non-Compliance|1|||
126273030|NCT01791153|454289144|FG001|Part 1: Blinded Period|Non-Compliance|0|||
126273031|NCT01791153|454289145|FG002|Part 1: Blinded Period|Non-Compliance|0|||
126273032|NCT01791153|454289146|FG003|Part 1: Blinded Period|Non-Compliance|0|||
126273033|NCT01791153|454289147|FG004|Part 1: Blinded Period|Non-Compliance|0|||
126273034|NCT01791153|454289148|FG005|Part 1: Blinded Period|Non-Compliance|0|||
126273035|NCT01791153|454289149|FG006|Part 1: Blinded Period|Non-Compliance|0|||
126273036|NCT01791153|454289150|FG007|Part 1: Blinded Period|Non-Compliance|0|||
126273037|NCT01791153|454289143|FG000|Part 1: Blinded Period|Physician Decision|0|||
126273038|NCT01791153|454289144|FG001|Part 1: Blinded Period|Physician Decision|0|||
126273039|NCT01791153|454289145|FG002|Part 1: Blinded Period|Physician Decision|0|||
126273040|NCT01791153|454289146|FG003|Part 1: Blinded Period|Physician Decision|1|||
126273041|NCT01791153|454289147|FG004|Part 1: Blinded Period|Physician Decision|0|||
126273042|NCT01791153|454289148|FG005|Part 1: Blinded Period|Physician Decision|0|||
126273043|NCT01791153|454289149|FG006|Part 1: Blinded Period|Physician Decision|0|||
126273044|NCT01791153|454289150|FG007|Part 1: Blinded Period|Physician Decision|0|||
126273045|NCT01791153|454289143|FG000|Part 1: Blinded Period|Protocol Violation|0|||
126273046|NCT01791153|454289144|FG001|Part 1: Blinded Period|Protocol Violation|0|||
126273047|NCT01791153|454289145|FG002|Part 1: Blinded Period|Protocol Violation|0|||
126273048|NCT01791153|454289146|FG003|Part 1: Blinded Period|Protocol Violation|1|||
126273049|NCT01791153|454289147|FG004|Part 1: Blinded Period|Protocol Violation|0|||
126273050|NCT01791153|454289148|FG005|Part 1: Blinded Period|Protocol Violation|0|||
126273051|NCT01791153|454289149|FG006|Part 1: Blinded Period|Protocol Violation|0|||
126273052|NCT01791153|454289150|FG007|Part 1: Blinded Period|Protocol Violation|0|||
126273053|NCT01791153|454289143|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
126273054|NCT01791153|454289144|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
126273055|NCT01791153|454289145|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
126273056|NCT01791153|454289146|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
126273057|NCT01791153|454289147|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
126273058|NCT01791153|454289148|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
126273059|NCT01791153|454289149|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
126273060|NCT01791153|454289150|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
126273061|NCT01791153|454289143|FG000|Part 2: Open-label Period|Adverse Event|0|||
126273062|NCT01791153|454289144|FG001|Part 2: Open-label Period|Adverse Event|0|||
126273063|NCT01791153|454289145|FG002|Part 2: Open-label Period|Adverse Event|0|||
126273064|NCT01791153|454289146|FG003|Part 2: Open-label Period|Adverse Event|0|||
126273065|NCT01791153|454289147|FG004|Part 2: Open-label Period|Adverse Event|0|||
126273066|NCT01791153|454289148|FG005|Part 2: Open-label Period|Adverse Event|1|||
126273067|NCT01791153|454289149|FG006|Part 2: Open-label Period|Adverse Event|1|||
126273068|NCT01791153|454289150|FG007|Part 2: Open-label Period|Adverse Event|2|||
126273069|NCT01791153|454289143|FG000|Part 2: Open-label Period|Death|0|||
126273070|NCT01791153|454289144|FG001|Part 2: Open-label Period|Death|0|||
126273071|NCT01791153|454289145|FG002|Part 2: Open-label Period|Death|0|||
126273072|NCT01791153|454289146|FG003|Part 2: Open-label Period|Death|0|||
126273073|NCT01791153|454289147|FG004|Part 2: Open-label Period|Death|0|||
126273074|NCT01791153|454289148|FG005|Part 2: Open-label Period|Death|1|||
126273075|NCT01791153|454289149|FG006|Part 2: Open-label Period|Death|1|||
126273076|NCT01791153|454289150|FG007|Part 2: Open-label Period|Death|1|||
126273077|NCT01791153|454289143|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
126273078|NCT01791153|454289144|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
126273079|NCT01791153|454289145|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
126273080|NCT01791153|454289146|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
126273081|NCT01791153|454289147|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
126273082|NCT01791153|454289148|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
126273083|NCT01791153|454289149|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
126273084|NCT01791153|454289150|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
126273085|NCT01791153|454289143|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
126273086|NCT01791153|454289144|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
126273087|NCT01791153|454289145|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
126273088|NCT01791153|454289146|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
126273089|NCT01791153|454289147|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
126273090|NCT01791153|454289148|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
126273091|NCT01791153|454289149|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
126273092|NCT01791153|454289150|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
126273093|NCT01791153|454289143|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
126273094|NCT01791153|454289144|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
126273095|NCT01791153|454289145|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
126273096|NCT01791153|454289146|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
126273097|NCT01791153|454289147|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
126273098|NCT01791153|454289148|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
126273099|NCT01791153|454289149|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
126362031|NCT00553475|454617389|FG000|Overall Study|Physician Decision|1|||
126362032|NCT00553475|454617390|FG001|Overall Study|Physician Decision|0|||
126362033|NCT00553475|454617391|FG002|Overall Study|Physician Decision|0|||
126362034|NCT00553475|454617389|FG000|Overall Study|Due to moving|0|||
126362035|NCT00553475|454617390|FG001|Overall Study|Due to moving|1|||
126362036|NCT00553475|454617391|FG002|Overall Study|Due to moving|0|||
126362037|NCT01905683|454617394|FG000|Overall Study|Protocol Violation|1|||
126037361|NCT02823145|453435032|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
126273100|NCT01791153|454289150|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
126273101|NCT01791153|454289143|FG000|Part 2: Open-label Period|Physician Decision|0|||
126273102|NCT01791153|454289144|FG001|Part 2: Open-label Period|Physician Decision|0|||
126273103|NCT01791153|454289145|FG002|Part 2: Open-label Period|Physician Decision|0|||
126273104|NCT01791153|454289146|FG003|Part 2: Open-label Period|Physician Decision|0|||
126273105|NCT01791153|454289147|FG004|Part 2: Open-label Period|Physician Decision|1|||
126273106|NCT01791153|454289148|FG005|Part 2: Open-label Period|Physician Decision|1|||
126273107|NCT01791153|454289149|FG006|Part 2: Open-label Period|Physician Decision|0|||
126273108|NCT01791153|454289150|FG007|Part 2: Open-label Period|Physician Decision|0|||
126273109|NCT00975286|454289151|FG000|Overall Study|Adverse Event|9|||
126273110|NCT00975286|454289152|FG001|Overall Study|Adverse Event|19|||
126273111|NCT00975286|454289151|FG000|Overall Study|Protocol Violation|1|||
126273112|NCT00975286|454289152|FG001|Overall Study|Protocol Violation|2|||
126273113|NCT00975286|454289151|FG000|Overall Study|Withdrawal by Subject|0|||
126273114|NCT00975286|454289152|FG001|Overall Study|Withdrawal by Subject|2|||
126273115|NCT00975286|454289151|FG000|Overall Study|Familial and Personal Reasons|2|||
126273116|NCT00975286|454289152|FG001|Overall Study|Familial and Personal Reasons|2|||
126273117|NCT00975286|454289151|FG000|Overall Study|Poor Compliance to Protocol|0|||
126273118|NCT00975286|454289152|FG001|Overall Study|Poor Compliance to Protocol|2|||
126273119|NCT00975286|454289151|FG000|Overall Study|Sponsor Decision|0|||
126273120|NCT00975286|454289152|FG001|Overall Study|Sponsor Decision|2|||
126273121|NCT02357342|454289153|FG000|First 6 Months|Death|2|||
126273122|NCT02357342|454289154|FG001|First 6 Months|Death|0|||
126273123|NCT01674647|454289155|FG000|Treatment Period|Death|4|||
126273124|NCT01674647|454289156|FG001|Treatment Period|Death|1|||
126273125|NCT01674647|454289155|FG000|Treatment Period|Efficacy outcome reached|0|||
126273126|NCT01674647|454289156|FG001|Treatment Period|Efficacy outcome reached|1|||
126273127|NCT01674647|454289155|FG000|Treatment Period|Physician Decision|3|||
126273128|NCT01674647|454289156|FG001|Treatment Period|Physician Decision|1|||
126273129|NCT01674647|454289155|FG000|Treatment Period|Adverse Event|60|||
126273130|NCT01674647|454289156|FG001|Treatment Period|Adverse Event|22|||
126273131|NCT01674647|454289155|FG000|Treatment Period|Non-compliance with study drug|3|||
126273132|NCT01674647|454289156|FG001|Treatment Period|Non-compliance with study drug|0|||
126273133|NCT01674647|454289155|FG000|Treatment Period|Lost to Follow-up|1|||
126273134|NCT01674647|454289156|FG001|Treatment Period|Lost to Follow-up|1|||
126273135|NCT01674647|454289155|FG000|Treatment Period|Withdrawal by Subject|19|||
126273136|NCT01674647|454289156|FG001|Treatment Period|Withdrawal by Subject|16|||
126273137|NCT01674647|454289155|FG000|Treatment Period|Switching to other therapy|5|||
126273138|NCT01674647|454289156|FG001|Treatment Period|Switching to other therapy|2|||
126273139|NCT01674647|454289155|FG000|Treatment Period|Logistical difficulties|5|||
126273140|NCT01674647|454289156|FG001|Treatment Period|Logistical difficulties|8|||
126273141|NCT01674647|454289155|FG000|Treatment Period|Treatment failure|0|||
126273142|NCT01674647|454289156|FG001|Treatment Period|Treatment failure|14|||
126273143|NCT01674647|454289155|FG000|Treatment Period|Protocol Violation|56|||
126273144|NCT01674647|454289156|FG001|Treatment Period|Protocol Violation|36|||
126273145|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Death|3|||
126273146|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Death|2|||
126273147|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
126273148|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
126273149|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
126273150|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
126273151|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
126273152|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
126273153|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
126273154|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
126273155|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
126273156|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
126273157|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
126037362|NCT02823145|453435031|FG000|Treatment|Subject needed to take prohibited medication|0|||
126037363|NCT02823145|453435032|FG001|Treatment|Subject needed to take prohibited medication|1|||
126273158|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
126273159|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
126273160|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
126273161|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
126273162|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
126273163|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
126273164|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
126273165|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
126362038|NCT01905683|454617394|FG000|Overall Study|Re-injection criteria not met; others|13|||
126362039|NCT01905683|454617394|FG000|Overall Study|Physician Decision|1|||
126362040|NCT01905683|454617394|FG000|Overall Study|Lack of Efficacy|8|||
126362041|NCT01905683|454617394|FG000|Overall Study|Withdrawal by Subject|20|||
126362042|NCT01905683|454617394|FG000|Overall Study|Adverse Event|4|||
126362043|NCT01905683|454617394|FG000|Overall Study|Lost to Follow-up|4|||
126362044|NCT02568254|454617396|FG000|Period 2|Adverse Event|0|||
126362045|NCT02568254|454617397|FG001|Period 2|Adverse Event|0|||
126362046|NCT02568254|454617398|FG002|Period 2|Adverse Event|1|||
126362047|NCT02568254|454617399|FG003|Period 2|Adverse Event|0|||
126362048|NCT02568254|454617400|FG004|Period 2|Adverse Event|0|||
126362049|NCT02568254|454617401|FG005|Period 2|Adverse Event|0|||
126362050|NCT02568254|454617396|FG000|Period 3|Unstatisfactory Lens fitting|0|||
126362051|NCT02568254|454617397|FG001|Period 3|Unstatisfactory Lens fitting|0|||
126362052|NCT02568254|454617398|FG002|Period 3|Unstatisfactory Lens fitting|0|||
126362053|NCT02568254|454617399|FG003|Period 3|Unstatisfactory Lens fitting|0|||
126362054|NCT02568254|454617400|FG004|Period 3|Unstatisfactory Lens fitting|1|||
126362055|NCT02568254|454617401|FG005|Period 3|Unstatisfactory Lens fitting|0|||
126362056|NCT01832038|454619012|FG000|Overall Study|Death|5|||
126362057|NCT01832038|454619012|FG000|Overall Study|Adverse Event|50|||
126362058|NCT01832038|454619012|FG000|Overall Study|Lack of Efficacy|81|||
126362059|NCT01832038|454619012|FG000|Overall Study|Protocol Violation|7|||
126362060|NCT01832038|454619012|FG000|Overall Study|Lost to Follow-up|10|||
126362061|NCT01832038|454619012|FG000|Overall Study|Withdrawal by Subject|49|||
126362062|NCT01832038|454619012|FG000|Overall Study|Visit non-compliance|2|||
126362063|NCT01832038|454619012|FG000|Overall Study|Subject refused to return visit|2|||
126362064|NCT01832038|454619012|FG000|Overall Study|Not convenient to come back to site|2|||
126362065|NCT01832038|454619012|FG000|Overall Study|Participant was asked to quit|5|||
126362066|NCT01832038|454619012|FG000|Overall Study|Back home|1|||
126362067|NCT01832038|454619012|FG000|Overall Study|Pregnancy|1|||
126362068|NCT01832038|454619012|FG000|Overall Study|Low compliance|3|||
126362069|NCT01832038|454619012|FG000|Overall Study|Prohibit procedure|2|||
126362070|NCT01832038|454619012|FG000|Overall Study|Not possible to visit the hospital|1|||
126362071|NCT01832038|454619012|FG000|Overall Study|Changes of implementation system|3|||
126362072|NCT01832038|454619012|FG000|Overall Study|Plan to pregnancy|7|||
126362073|NCT01832038|454619012|FG000|Overall Study|Bad mood and has suicidal thought|1|||
126362074|NCT01832038|454619012|FG000|Overall Study|Prohibited concomitant medication|1|||
126362075|NCT01832038|454619012|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
126362076|NCT01832038|454619012|FG000|Overall Study|Subject considered the efficacy was poor|1|||
126362077|NCT00101400|454619017|FG000|Survival Follow-Up|Alive|7|||
126362078|NCT05333965|454619038|FG000|First Intervention|Adverse Event|0|||
126362079|NCT05333965|454619039|FG001|First Intervention|Adverse Event|1|||
126362080|NCT05333965|454619038|FG000|First Intervention|Withdrawal by Subject|0|||
126362081|NCT05333965|454619039|FG001|First Intervention|Withdrawal by Subject|1|||
126362082|NCT00382863|454619040|FG000|Overall Study|Death|9|||
126362083|NCT00382863|454619041|FG001|Overall Study|Death|9|||
126362084|NCT00382863|454619040|FG000|Overall Study|Lost to Follow-up|1|||
126362085|NCT00382863|454619041|FG001|Overall Study|Lost to Follow-up|2|||
126362086|NCT00382863|454619040|FG000|Overall Study|Withdrawal by Subject|5|||
126362087|NCT00382863|454619041|FG001|Overall Study|Withdrawal by Subject|25|||
126362088|NCT02168439|454619042|FG000|Overall Study|Protocol Violation|0|||
126362089|NCT02168439|454619043|FG001|Overall Study|Protocol Violation|2|||
126362090|NCT00605657|454619045|FG000|Overall Study|Adverse Event|1|||
126362091|NCT00605657|454619045|FG000|Overall Study|Protocol Violation|1|||
126362092|NCT02180672|454619046|FG000|Overall Study|Lost to Follow-up|5|||
126362093|NCT02180672|454619047|FG001|Overall Study|Lost to Follow-up|7|||
126362094|NCT02837952|454619048|FG000|Overall Study|Adverse Event|0|||
126362095|NCT02837952|454619049|FG001|Overall Study|Adverse Event|1|||
126362096|NCT02837952|454619048|FG000|Overall Study|Withdrawal by Subject|4|||
126362097|NCT02837952|454619049|FG001|Overall Study|Withdrawal by Subject|5|||
126362098|NCT02837952|454619048|FG000|Overall Study|Medication Error|1|||
126362099|NCT02837952|454619049|FG001|Overall Study|Medication Error|0|||
126362100|NCT01362530|454619050|FG000|Base Study (Cycle 1)|Adverse Event|2|||
126362101|NCT01362530|454619051|FG001|Base Study (Cycle 1)|Adverse Event|0|||
126362102|NCT01362530|454619050|FG000|Base Study (Cycle 1)|Physician Decision|0|||
126362103|NCT01362530|454619051|FG001|Base Study (Cycle 1)|Physician Decision|1|||
126362104|NCT01362530|454619050|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
126362105|NCT01362530|454619051|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
126362106|NCT01362530|454619050|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
126362107|NCT01362530|454619051|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
126362108|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
126362109|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
126362110|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
126362111|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
126362112|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
126362113|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
126362114|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
126362115|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
126362116|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
126362117|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
126362118|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
126362119|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
126362120|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
126362121|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
126362122|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
126362123|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
126362124|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
126362125|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
126362126|NCT03021005|454619063|FG000|Overall Study|Lost to Follow-up|39|||
126362127|NCT03021005|454619064|FG001|Overall Study|Lost to Follow-up|26|||
126362128|NCT00276380|454619067|FG000|Overall Study|Adverse Event|5|||
126362129|NCT00276380|454619068|FG001|Overall Study|Adverse Event|3|||
126362130|NCT00276380|454619067|FG000|Overall Study|Lost to Follow-up|1|||
126362131|NCT00276380|454619068|FG001|Overall Study|Lost to Follow-up|1|||
126362132|NCT00276380|454619067|FG000|Overall Study|Withdrawal by Subject|3|||
126362133|NCT00276380|454619068|FG001|Overall Study|Withdrawal by Subject|6|||
126362134|NCT00276380|454619067|FG000|Overall Study|Death|5|||
126362135|NCT00276380|454619068|FG001|Overall Study|Death|3|||
126362136|NCT00276380|454619067|FG000|Overall Study|Abnormal aPPT Levels|0|||
126362137|NCT00276380|454619068|FG001|Overall Study|Abnormal aPPT Levels|1|||
126362138|NCT03473301|454619069|FG000|Overall Study|Protocol Violation|4|||
126362139|NCT03473301|454619070|FG001|Overall Study|Protocol Violation|0|||
126362140|NCT03473301|454619071|FG002|Overall Study|Protocol Violation|0|||
126362141|NCT03473301|454619069|FG000|Overall Study|Withdrawal by Subject|0|||
126037364|NCT02823145|453435031|FG000|Treatment|Subject transferred to direct access programme|0|||
126037365|NCT02823145|453435032|FG001|Treatment|Subject transferred to direct access programme|1|||
126037366|NCT02823145|453435031|FG000|Treatment|Switching to commercially available drug|0|||
126037367|NCT02823145|453435032|FG001|Treatment|Switching to commercially available drug|11|||
126037368|NCT02823145|453435031|FG000|Treatment|Transitioned to commercial supply of medication|0|||
126037369|NCT02823145|453435032|FG001|Treatment|Transitioned to commercial supply of medication|1|||
126098596|NCT01621568|453653052|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
126098597|NCT01621568|453653053|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
126098598|NCT01621568|453653052|FG000|Week 5-6 No Treatment|Death|1|||
126362142|NCT03473301|454619070|FG001|Overall Study|Withdrawal by Subject|1|||
126362143|NCT03473301|454619071|FG002|Overall Study|Withdrawal by Subject|0|||
126037370|NCT02823145|453435031|FG000|Treatment|Withdrawal By Caregiver|0|||
126037371|NCT02823145|453435032|FG001|Treatment|Withdrawal By Caregiver|1|||
126037372|NCT02823145|453435031|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
126037373|NCT02823145|453435032|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
126037374|NCT02823145|453435031|FG000|Treatment|Withdrawal by Subject|0|||
126037375|NCT02823145|453435032|FG001|Treatment|Withdrawal by Subject|16|||
126037376|NCT02823145|453435031|FG000|Treatment|Reason unknown|0|||
126037377|NCT02823145|453435032|FG001|Treatment|Reason unknown|1|||
126037378|NCT05292391|453435033|FG000|Overall Study|Lost to Follow-up|0|||
126037379|NCT05292391|453435034|FG001|Overall Study|Lost to Follow-up|0|||
126037380|NCT05292391|453435035|FG002|Overall Study|Lost to Follow-up|0|||
126037381|NCT05292391|453435036|FG003|Overall Study|Lost to Follow-up|1|||
126037382|NCT05292391|453435037|FG004|Overall Study|Lost to Follow-up|0|||
126037383|NCT04857723|453435038|FG000|Overall Study|Withdrawal by Subject|2|||
126037384|NCT03221426|453435039|FG000|Overall Study|Ongoing in study|212|||
126098599|NCT01621568|453653053|FG001|Week 5-6 No Treatment|Death|0|||
126362144|NCT03473301|454619069|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
126362145|NCT03473301|454619070|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
126362146|NCT03473301|454619071|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
126362147|NCT04829214|454619072|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
126098600|NCT02334423|453653054|FG000|Overall Study|Protocol Violation|10|||
126362148|NCT04829214|454619073|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
126362149|NCT04829214|454619072|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
126362150|NCT04829214|454619073|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
126362151|NCT02571244|454619075|FG000|Overall Study|Lost to Follow-up|0|||
126098601|NCT02334423|453653055|FG001|Overall Study|Protocol Violation|3|||
126362152|NCT02571244|454619076|FG001|Overall Study|Lost to Follow-up|1|||
126362153|NCT02571244|454619075|FG000|Overall Study|Unable to reach out post discharge|3|||
126362154|NCT02571244|454619076|FG001|Overall Study|Unable to reach out post discharge|0|||
126362155|NCT01696214|454619078|FG000|Overall Study|Lost to Follow-up|1|||
126362156|NCT01696214|454619079|FG001|Overall Study|Lost to Follow-up|0|||
126037385|NCT03221426|453435040|FG001|Overall Study|Ongoing in study|193|||
126037386|NCT03221426|453435041|FG002|Overall Study|Ongoing in study|61|||
126037387|NCT03221426|453435042|FG003|Overall Study|Ongoing in study|55|||
126037388|NCT03221426|453435039|FG000|Overall Study|Withdrawal by Subject|12|||
126037389|NCT03221426|453435040|FG001|Overall Study|Withdrawal by Subject|4|||
126037390|NCT03221426|453435041|FG002|Overall Study|Withdrawal by Subject|2|||
126037391|NCT03221426|453435042|FG003|Overall Study|Withdrawal by Subject|3|||
126037392|NCT03221426|453435039|FG000|Overall Study|Lost to Follow-up|4|||
126037393|NCT03221426|453435040|FG001|Overall Study|Lost to Follow-up|1|||
126037394|NCT03221426|453435041|FG002|Overall Study|Lost to Follow-up|1|||
126273166|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
126273167|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
126273168|NCT01104779|454289158|FG000|Overall Study|Protocol Violation|1|||
126273169|NCT01104779|454289159|FG001|Overall Study|Protocol Violation|2|||
126037395|NCT03221426|453435042|FG003|Overall Study|Lost to Follow-up|0|||
126273170|NCT01104779|454289160|FG002|Overall Study|Protocol Violation|2|||
126273171|NCT01104779|454289158|FG000|Overall Study|Lack of Efficacy|26|||
126273172|NCT01104779|454289159|FG001|Overall Study|Lack of Efficacy|12|||
126273173|NCT01104779|454289160|FG002|Overall Study|Lack of Efficacy|13|||
126273174|NCT01104779|454289158|FG000|Overall Study|Adverse Event|13|||
126273175|NCT01104779|454289159|FG001|Overall Study|Adverse Event|14|||
126273176|NCT01104779|454289160|FG002|Overall Study|Adverse Event|13|||
126273177|NCT01104779|454289158|FG000|Overall Study|Did not meet inc/exc criteria|1|||
126273178|NCT01104779|454289159|FG001|Overall Study|Did not meet inc/exc criteria|1|||
126273179|NCT01104779|454289160|FG002|Overall Study|Did not meet inc/exc criteria|1|||
126273180|NCT01104779|454289158|FG000|Overall Study|Other reasons|0|||
126273181|NCT01104779|454289159|FG001|Overall Study|Other reasons|1|||
126273182|NCT01104779|454289160|FG002|Overall Study|Other reasons|0|||
126273183|NCT01104779|454289158|FG000|Overall Study|Lost to Follow-up|2|||
126273184|NCT01104779|454289159|FG001|Overall Study|Lost to Follow-up|0|||
126273185|NCT01104779|454289160|FG002|Overall Study|Lost to Follow-up|1|||
126273186|NCT01104779|454289158|FG000|Overall Study|Withdrawal by Subject|16|||
126273187|NCT01104779|454289159|FG001|Overall Study|Withdrawal by Subject|25|||
126273188|NCT01104779|454289160|FG002|Overall Study|Withdrawal by Subject|32|||
126273189|NCT03548064|454291002|FG000|Overall Study|Withdrawal by Subject|0|||
126273190|NCT03548064|454291003|FG001|Overall Study|Withdrawal by Subject|0|||
126273191|NCT03548064|454291004|FG002|Overall Study|Withdrawal by Subject|0|||
126273192|NCT03548064|454291005|FG003|Overall Study|Withdrawal by Subject|1|||
126273193|NCT03548064|454291006|FG004|Overall Study|Withdrawal by Subject|0|||
126273194|NCT03548064|454291007|FG005|Overall Study|Withdrawal by Subject|0|||
126273195|NCT03548064|454291008|FG006|Overall Study|Withdrawal by Subject|0|||
126273196|NCT03548064|454291009|FG007|Overall Study|Withdrawal by Subject|0|||
126273197|NCT03548064|454291002|FG000|Overall Study|Lost to Follow-up|0|||
126273198|NCT03548064|454291003|FG001|Overall Study|Lost to Follow-up|0|||
126273199|NCT03548064|454291004|FG002|Overall Study|Lost to Follow-up|0|||
126273200|NCT03548064|454291005|FG003|Overall Study|Lost to Follow-up|0|||
126273201|NCT03548064|454291006|FG004|Overall Study|Lost to Follow-up|2|||
126273202|NCT03548064|454291007|FG005|Overall Study|Lost to Follow-up|0|||
126273203|NCT03548064|454291008|FG006|Overall Study|Lost to Follow-up|0|||
126273204|NCT03548064|454291009|FG007|Overall Study|Lost to Follow-up|0|||
126273205|NCT03548064|454291002|FG000|Overall Study|Covid-19 Pandemic|0|||
126273206|NCT03548064|454291003|FG001|Overall Study|Covid-19 Pandemic|0|||
126273207|NCT03548064|454291004|FG002|Overall Study|Covid-19 Pandemic|0|||
126273208|NCT03548064|454291005|FG003|Overall Study|Covid-19 Pandemic|0|||
126273209|NCT03548064|454291006|FG004|Overall Study|Covid-19 Pandemic|10|||
126273210|NCT03548064|454291007|FG005|Overall Study|Covid-19 Pandemic|3|||
126273211|NCT03548064|454291008|FG006|Overall Study|Covid-19 Pandemic|0|||
126273212|NCT03548064|454291009|FG007|Overall Study|Covid-19 Pandemic|0|||
126273213|NCT05011123|454291010|FG000|Overall Study|Withdrawal by Subject|4|||
126273214|NCT05011123|454291011|FG001|Overall Study|Withdrawal by Subject|2|||
126273215|NCT05011123|454291010|FG000|Overall Study|Lost to Follow-up|7|||
126273216|NCT05011123|454291011|FG001|Overall Study|Lost to Follow-up|6|||
126273217|NCT05011123|454291010|FG000|Overall Study|Ongoing at the time of DBL date|36|||
126273218|NCT05011123|454291011|FG001|Overall Study|Ongoing at the time of DBL date|10|||
126273219|NCT05011123|454291010|FG000|Overall Study|Randomized but did not receive vaccination|1|||
126362157|NCT01696214|454619080|FG002|Overall Study|Lost to Follow-up|0|||
126362158|NCT01696214|454619081|FG003|Overall Study|Lost to Follow-up|0|||
126362159|NCT00452530|454619085|FG000|Overall Study|Death|1|||
126362160|NCT00452530|454619086|FG001|Overall Study|Death|0|||
126362161|NCT00452530|454619085|FG000|Overall Study|Adverse Event|40|||
126273220|NCT05011123|454291011|FG001|Overall Study|Randomized but did not receive vaccination|0|||
126273221|NCT04221789|454291012|FG000|Overall Study|deviation from protoco|22|||
126273222|NCT04221789|454291013|FG001|Overall Study|deviation from protoco|8|||
126273223|NCT05091307|454291014|FG000|Overall Study|Death|0|||
126273224|NCT05091307|454291015|FG001|Overall Study|Death|0|||
126273225|NCT05091307|454291016|FG002|Overall Study|Death|1|||
126037396|NCT03221426|453435039|FG000|Overall Study|Death|174|||
126037397|NCT03221426|453435040|FG001|Overall Study|Death|204|||
126037398|NCT03221426|453435041|FG002|Overall Study|Death|36|||
126362162|NCT00452530|454619086|FG001|Overall Study|Adverse Event|44|||
126362163|NCT00452530|454619085|FG000|Overall Study|Withdrawal by Subject|68|||
126362164|NCT00452530|454619086|FG001|Overall Study|Withdrawal by Subject|57|||
126362165|NCT00452530|454619085|FG000|Overall Study|Lost to Follow-up|1|||
126362166|NCT00452530|454619086|FG001|Overall Study|Lost to Follow-up|0|||
126362167|NCT00452530|454619085|FG000|Overall Study|Poor compliance/noncompliance|1|||
126362168|NCT00452530|454619086|FG001|Overall Study|Poor compliance/noncompliance|2|||
126362169|NCT00452530|454619085|FG000|Overall Study|No longer met study criteria|18|||
126362170|NCT00452530|454619086|FG001|Overall Study|No longer met study criteria|22|||
126362171|NCT00452530|454619085|FG000|Overall Study|Other|7|||
126362172|NCT00452530|454619086|FG001|Overall Study|Other|11|||
126362173|NCT01905267|454619087|FG000|Overall Study|Physician Decision|2|||
126362174|NCT01905267|454619088|FG001|Overall Study|Physician Decision|2|||
126037399|NCT03221426|453435042|FG003|Overall Study|Death|45|||
126037400|NCT02276885|453436655|FG000|Overall Study|Withdrawal by Subject|2|||
126037401|NCT02276885|453436656|FG001|Overall Study|Withdrawal by Subject|0|||
126037402|NCT02276885|453436655|FG000|Overall Study|Lost to Follow-up|5|||
126362175|NCT03888482|454619089|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
126362176|NCT03888482|454619090|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
126362177|NCT03888482|454619089|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
126362178|NCT03888482|454619090|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
126362179|NCT01725308|454619095|FG000|Treatment Period I|Did Not Receive Drug|1|||
126362180|NCT01725308|454619096|FG001|Treatment Period I|Did Not Receive Drug|0|||
126362181|NCT01725308|454619097|FG002|Treatment Period I|Did Not Receive Drug|0|||
126362182|NCT01725308|454619095|FG000|Treatment Period I|Adverse Event|5|||
126362183|NCT01725308|454619096|FG001|Treatment Period I|Adverse Event|4|||
126362184|NCT01725308|454619097|FG002|Treatment Period I|Adverse Event|21|||
126362185|NCT01725308|454619095|FG000|Treatment Period I|Insufficient Response|7|||
126362186|NCT01725308|454619096|FG001|Treatment Period I|Insufficient Response|0|||
126362187|NCT01725308|454619097|FG002|Treatment Period I|Insufficient Response|5|||
126362188|NCT01725308|454619095|FG000|Treatment Period I|Worsening of the Target Disease|8|||
126362189|NCT01725308|454619096|FG001|Treatment Period I|Worsening of the Target Disease|0|||
126362190|NCT01725308|454619097|FG002|Treatment Period I|Worsening of the Target Disease|2|||
126362191|NCT01725308|454619095|FG000|Treatment Period I|Changes in the Episodes|3|||
126362192|NCT01725308|454619096|FG001|Treatment Period I|Changes in the Episodes|0|||
126362193|NCT01725308|454619097|FG002|Treatment Period I|Changes in the Episodes|2|||
126362194|NCT01725308|454619095|FG000|Treatment Period I|Withdrawal of Consent|12|||
126362195|NCT01725308|454619096|FG001|Treatment Period I|Withdrawal of Consent|7|||
126362196|NCT01725308|454619097|FG002|Treatment Period I|Withdrawal of Consent|5|||
126362197|NCT01725308|454619095|FG000|Treatment Period I|Lost to Follow-up|3|||
126362198|NCT01725308|454619096|FG001|Treatment Period I|Lost to Follow-up|2|||
126362199|NCT01725308|454619097|FG002|Treatment Period I|Lost to Follow-up|2|||
126362200|NCT01725308|454619095|FG000|Treatment Period I|Protocol Deviations|3|||
126362201|NCT01725308|454619096|FG001|Treatment Period I|Protocol Deviations|1|||
126362202|NCT01725308|454619097|FG002|Treatment Period I|Protocol Deviations|1|||
126362203|NCT01725308|454619095|FG000|Treatment Period I|Miscellaneous|2|||
126037403|NCT02276885|453436656|FG001|Overall Study|Lost to Follow-up|2|||
126273226|NCT05091307|454291017|FG003|Overall Study|Death|0|||
126273227|NCT05091307|454291014|FG000|Overall Study|Lost to Follow-up|33|||
126273228|NCT05091307|454291015|FG001|Overall Study|Lost to Follow-up|33|||
126273229|NCT05091307|454291016|FG002|Overall Study|Lost to Follow-up|2|||
126273230|NCT05091307|454291017|FG003|Overall Study|Lost to Follow-up|0|||
126273231|NCT05091307|454291014|FG000|Overall Study|Physician Decision|1|||
126273232|NCT05091307|454291015|FG001|Overall Study|Physician Decision|0|||
126273233|NCT05091307|454291016|FG002|Overall Study|Physician Decision|0|||
126273234|NCT05091307|454291017|FG003|Overall Study|Physician Decision|0|||
126273235|NCT05091307|454291014|FG000|Overall Study|Protocol Violation|1|||
126273236|NCT05091307|454291015|FG001|Overall Study|Protocol Violation|0|||
126273237|NCT05091307|454291016|FG002|Overall Study|Protocol Violation|0|||
126273238|NCT05091307|454291017|FG003|Overall Study|Protocol Violation|0|||
126273239|NCT05091307|454291014|FG000|Overall Study|Withdrawal by Subject|16|||
126362204|NCT01725308|454619096|FG001|Treatment Period I|Miscellaneous|0|||
126362205|NCT01725308|454619097|FG002|Treatment Period I|Miscellaneous|3|||
126362206|NCT01725308|454619095|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
126362207|NCT01725308|454619096|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
126362208|NCT01725308|454619097|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
126362209|NCT01725308|454619095|FG000|Treatment Period II|Did Not Receive Drug|4|||
126037404|NCT04171141|453436659|FG000|Overall Study|Adverse Event|0|||
126037405|NCT04171141|453436660|FG001|Overall Study|Adverse Event|0|||
126037406|NCT04171141|453436661|FG002|Overall Study|Adverse Event|2|||
126273240|NCT05091307|454291015|FG001|Overall Study|Withdrawal by Subject|16|||
126273241|NCT05091307|454291016|FG002|Overall Study|Withdrawal by Subject|0|||
126273242|NCT05091307|454291017|FG003|Overall Study|Withdrawal by Subject|1|||
126362210|NCT01725308|454619096|FG001|Treatment Period II|Did Not Receive Drug|0|||
126362211|NCT01725308|454619097|FG002|Treatment Period II|Did Not Receive Drug|0|||
126362212|NCT01725308|454619095|FG000|Treatment Period II|Adverse Event|13|||
126362213|NCT01725308|454619096|FG001|Treatment Period II|Adverse Event|8|||
126362214|NCT01725308|454619097|FG002|Treatment Period II|Adverse Event|20|||
126362215|NCT01725308|454619095|FG000|Treatment Period II|Insufficient Response|2|||
126362216|NCT01725308|454619096|FG001|Treatment Period II|Insufficient Response|4|||
126273243|NCT05091307|454291014|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
126273244|NCT05091307|454291015|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
126273245|NCT05091307|454291016|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
126273246|NCT05091307|454291017|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
126273247|NCT05091307|454291014|FG000|Overall Study|Initiated Prohibited Medication|1|||
126273248|NCT05091307|454291015|FG001|Overall Study|Initiated Prohibited Medication|0|||
126273249|NCT05091307|454291016|FG002|Overall Study|Initiated Prohibited Medication|0|||
126273250|NCT05091307|454291017|FG003|Overall Study|Initiated Prohibited Medication|0|||
126273251|NCT05091307|454291014|FG000|Overall Study|Other|4|||
126273252|NCT05091307|454291015|FG001|Overall Study|Other|4|||
126273253|NCT05091307|454291016|FG002|Overall Study|Other|0|||
126273254|NCT05091307|454291017|FG003|Overall Study|Other|0|||
126273255|NCT05091307|454291014|FG000|Overall Study|Randomized but not vaccinated|0|||
126273256|NCT05091307|454291015|FG001|Overall Study|Randomized but not vaccinated|2|||
126273257|NCT05091307|454291016|FG002|Overall Study|Randomized but not vaccinated|0|||
126273258|NCT05091307|454291017|FG003|Overall Study|Randomized but not vaccinated|0|||
126273259|NCT04732221|454291018|FG000|Base Period|Death|2|||
126273260|NCT04732221|454291019|FG001|Base Period|Death|0|||
126273261|NCT04732221|454291020|FG002|Base Period|Death|0|||
126273262|NCT04732221|454291021|FG003|Base Period|Death|0|||
126273263|NCT04732221|454291022|FG004|Base Period|Death|0|||
126273264|NCT04732221|454291023|FG005|Base Period|Death|0|||
126273265|NCT04732221|454291024|FG006|Base Period|Death|0|||
126273266|NCT04732221|454291018|FG000|Base Period|Withdrawal by Subject|0|||
126273267|NCT04732221|454291019|FG001|Base Period|Withdrawal by Subject|1|||
126273268|NCT04732221|454291020|FG002|Base Period|Withdrawal by Subject|1|||
126273269|NCT04732221|454291021|FG003|Base Period|Withdrawal by Subject|0|||
126273270|NCT04732221|454291022|FG004|Base Period|Withdrawal by Subject|0|||
126273271|NCT04732221|454291023|FG005|Base Period|Withdrawal by Subject|0|||
126273272|NCT04732221|454291024|FG006|Base Period|Withdrawal by Subject|0|||
126273273|NCT04732221|454291018|FG000|Extension Period|Adverse Event|0|||
126273274|NCT04732221|454291019|FG001|Extension Period|Adverse Event|0|||
126273275|NCT04732221|454291020|FG002|Extension Period|Adverse Event|0|||
126273276|NCT04732221|454291021|FG003|Extension Period|Adverse Event|0|||
126273277|NCT04732221|454291022|FG004|Extension Period|Adverse Event|0|||
126273278|NCT04732221|454291023|FG005|Extension Period|Adverse Event|1|||
126273279|NCT04732221|454291024|FG006|Extension Period|Adverse Event|0|||
126273280|NCT04732221|454291018|FG000|Extension Period|Death|0|||
126273281|NCT04732221|454291019|FG001|Extension Period|Death|0|||
126273282|NCT04732221|454291020|FG002|Extension Period|Death|0|||
126273283|NCT04732221|454291021|FG003|Extension Period|Death|0|||
126273284|NCT04732221|454291022|FG004|Extension Period|Death|1|||
126273285|NCT04732221|454291023|FG005|Extension Period|Death|0|||
126273286|NCT04732221|454291024|FG006|Extension Period|Death|2|||
126273287|NCT04732221|454291018|FG000|Extension Period|Pregnancy|0|||
126273288|NCT04732221|454291019|FG001|Extension Period|Pregnancy|0|||
126273289|NCT04732221|454291020|FG002|Extension Period|Pregnancy|0|||
126273290|NCT04732221|454291021|FG003|Extension Period|Pregnancy|0|||
126273291|NCT04732221|454291022|FG004|Extension Period|Pregnancy|1|||
126273292|NCT04732221|454291023|FG005|Extension Period|Pregnancy|0|||
126273293|NCT04732221|454291024|FG006|Extension Period|Pregnancy|0|||
126273294|NCT04732221|454291018|FG000|Extension Period|Sponsors Decision|0|||
126273295|NCT04732221|454291019|FG001|Extension Period|Sponsors Decision|0|||
126273296|NCT04732221|454291020|FG002|Extension Period|Sponsors Decision|0|||
126273297|NCT04732221|454291021|FG003|Extension Period|Sponsors Decision|0|||
126273298|NCT04732221|454291022|FG004|Extension Period|Sponsors Decision|41|||
126273299|NCT04732221|454291023|FG005|Extension Period|Sponsors Decision|40|||
126273300|NCT04732221|454291024|FG006|Extension Period|Sponsors Decision|40|||
126273301|NCT04732221|454291018|FG000|Extension Period|Withdrawal by Subject|0|||
126273302|NCT04732221|454291019|FG001|Extension Period|Withdrawal by Subject|0|||
126273303|NCT04732221|454291020|FG002|Extension Period|Withdrawal by Subject|0|||
126273304|NCT04732221|454291021|FG003|Extension Period|Withdrawal by Subject|0|||
126273305|NCT04732221|454291022|FG004|Extension Period|Withdrawal by Subject|1|||
126273306|NCT04732221|454291023|FG005|Extension Period|Withdrawal by Subject|5|||
126273307|NCT04732221|454291024|FG006|Extension Period|Withdrawal by Subject|2|||
126273308|NCT03747601|454291025|FG000|Overall Study|COVID halt to visits|4|||
126273309|NCT05327816|454291026|FG000|Overall Study|Lost to Follow-up|1|||
126273310|NCT05327816|454291027|FG001|Overall Study|Lost to Follow-up|0|||
126273311|NCT05327816|454291028|FG002|Overall Study|Lost to Follow-up|0|||
126273312|NCT05327816|454291029|FG003|Overall Study|Lost to Follow-up|0|||
126273313|NCT05327816|454291030|FG004|Overall Study|Lost to Follow-up|0|||
126273314|NCT05327816|454291031|FG005|Overall Study|Lost to Follow-up|0|||
126273315|NCT05327816|454291032|FG006|Overall Study|Lost to Follow-up|0|||
126273316|NCT05327816|454291033|FG007|Overall Study|Lost to Follow-up|0|||
126273317|NCT05327816|454291034|FG008|Overall Study|Lost to Follow-up|0|||
126037407|NCT04171141|453436662|FG003|Overall Study|Adverse Event|0|||
126037408|NCT04171141|453436663|FG004|Overall Study|Adverse Event|0|||
126273318|NCT05327816|454291035|FG009|Overall Study|Lost to Follow-up|1|||
126273319|NCT05327816|454291036|FG010|Overall Study|Lost to Follow-up|0|||
126273320|NCT05327816|454291026|FG000|Overall Study|Withdrawal by Subject|0|||
126273321|NCT05327816|454291027|FG001|Overall Study|Withdrawal by Subject|0|||
126273322|NCT05327816|454291028|FG002|Overall Study|Withdrawal by Subject|0|||
126273323|NCT05327816|454291029|FG003|Overall Study|Withdrawal by Subject|0|||
126273324|NCT05327816|454291030|FG004|Overall Study|Withdrawal by Subject|1|||
126273325|NCT05327816|454291031|FG005|Overall Study|Withdrawal by Subject|1|||
126273326|NCT05327816|454291032|FG006|Overall Study|Withdrawal by Subject|0|||
126273327|NCT05327816|454291033|FG007|Overall Study|Withdrawal by Subject|0|||
126273328|NCT05327816|454291034|FG008|Overall Study|Withdrawal by Subject|0|||
126273329|NCT05327816|454291035|FG009|Overall Study|Withdrawal by Subject|0|||
126273330|NCT05327816|454291036|FG010|Overall Study|Withdrawal by Subject|0|||
126273331|NCT05327816|454291026|FG000|Overall Study|Study Terminated by Sponsor|11|||
126273332|NCT05327816|454291027|FG001|Overall Study|Study Terminated by Sponsor|12|||
126273333|NCT05327816|454291028|FG002|Overall Study|Study Terminated by Sponsor|12|||
126273334|NCT05327816|454291029|FG003|Overall Study|Study Terminated by Sponsor|12|||
126273335|NCT05327816|454291030|FG004|Overall Study|Study Terminated by Sponsor|11|||
126273336|NCT05327816|454291031|FG005|Overall Study|Study Terminated by Sponsor|11|||
126273337|NCT05327816|454291032|FG006|Overall Study|Study Terminated by Sponsor|11|||
126273338|NCT05327816|454291033|FG007|Overall Study|Study Terminated by Sponsor|11|||
126273339|NCT05327816|454291034|FG008|Overall Study|Study Terminated by Sponsor|11|||
126273340|NCT05327816|454291035|FG009|Overall Study|Study Terminated by Sponsor|11|||
126273341|NCT05327816|454291036|FG010|Overall Study|Study Terminated by Sponsor|12|||
126273342|NCT05327816|454291026|FG000|Overall Study|Randomized but not treated|0|||
126273343|NCT05327816|454291027|FG001|Overall Study|Randomized but not treated|0|||
126273344|NCT05327816|454291028|FG002|Overall Study|Randomized but not treated|0|||
126273345|NCT05327816|454291029|FG003|Overall Study|Randomized but not treated|0|||
126273346|NCT05327816|454291030|FG004|Overall Study|Randomized but not treated|0|||
126273347|NCT05327816|454291031|FG005|Overall Study|Randomized but not treated|0|||
126273348|NCT05327816|454291032|FG006|Overall Study|Randomized but not treated|1|||
126273349|NCT05327816|454291033|FG007|Overall Study|Randomized but not treated|1|||
126273350|NCT05327816|454291034|FG008|Overall Study|Randomized but not treated|1|||
126273351|NCT05327816|454291035|FG009|Overall Study|Randomized but not treated|0|||
126273352|NCT05327816|454291036|FG010|Overall Study|Randomized but not treated|0|||
126273353|NCT00112866|454291037|FG000|Overall Study|Protocol Violation|1|||
126273354|NCT00112866|454291038|FG001|Overall Study|Protocol Violation|0|||
126273355|NCT00112866|454291037|FG000|Overall Study|did not start treatment post-op|1|||
126273356|NCT00112866|454291038|FG001|Overall Study|did not start treatment post-op|2|||
126273357|NCT01167257|454291039|FG000|Overall Study|Lost to Follow-up|2|||
126273358|NCT01167257|454291040|FG001|Overall Study|Lost to Follow-up|2|||
126273359|NCT01167257|454291039|FG000|Overall Study|Withdrew consent|1|||
126273360|NCT01167257|454291040|FG001|Overall Study|Withdrew consent|1|||
126273361|NCT04305587|454291041|FG000|Overall Study|Withdrawal by Subject|0|||
126273362|NCT04305587|454291042|FG001|Overall Study|Withdrawal by Subject|0|||
126273363|NCT04305587|454291043|FG002|Overall Study|Withdrawal by Subject|0|||
126273364|NCT04305587|454291044|FG003|Overall Study|Withdrawal by Subject|1|||
126273365|NCT04305587|454291045|FG004|Overall Study|Withdrawal by Subject|0|||
126273366|NCT04305587|454291046|FG005|Overall Study|Withdrawal by Subject|0|||
126273367|NCT04305587|454291047|FG006|Overall Study|Withdrawal by Subject|0|||
125880777|NCT04225897|452862628|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125880778|NCT04225897|452862629|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126037409|NCT04171141|453436664|FG005|Overall Study|Adverse Event|0|||
126037410|NCT04171141|453436665|FG006|Overall Study|Adverse Event|0|||
126037411|NCT04171141|453436666|FG007|Overall Study|Adverse Event|0|||
126037412|NCT04171141|453436667|FG008|Overall Study|Adverse Event|0|||
126273368|NCT04305587|454291048|FG007|Overall Study|Withdrawal by Subject|0|||
126273369|NCT04305587|454291049|FG008|Overall Study|Withdrawal by Subject|0|||
126273370|NCT01367665|454291050|FG000|Overall Study|Death|102|||
126273371|NCT01367665|454291051|FG001|Overall Study|Death|19|||
126273372|NCT01367665|454291050|FG000|Overall Study|Lost to Follow-up|222|||
126273373|NCT01367665|454291051|FG001|Overall Study|Lost to Follow-up|22|||
126273374|NCT01367665|454291050|FG000|Overall Study|Not Done|118|||
126273375|NCT01367665|454291051|FG001|Overall Study|Not Done|14|||
126273376|NCT02752906|454291052|FG000|Overall Study|Protocol Violation|2|||
126037413|NCT04171141|453436668|FG009|Overall Study|Adverse Event|0|||
126273377|NCT02752906|454291053|FG001|Overall Study|Protocol Violation|1|||
126273378|NCT02752906|454291052|FG000|Overall Study|Withdrawal by Subject|2|||
126273379|NCT02752906|454291053|FG001|Overall Study|Withdrawal by Subject|2|||
126037414|NCT04171141|453436669|FG010|Overall Study|Adverse Event|0|||
126273380|NCT02752906|454291052|FG000|Overall Study|Lost to Follow-up|3|||
126273381|NCT02752906|454291053|FG001|Overall Study|Lost to Follow-up|2|||
126273382|NCT02771795|454291054|FG000|Overall Study|Withdrawal by Subject|47|||
126273383|NCT02771795|454291055|FG001|Overall Study|Withdrawal by Subject|37|||
126273384|NCT02771795|454291054|FG000|Overall Study|Termination by premature discontinuation of study|168|||
126098602|NCT02930226|453653056|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
126098603|NCT02930226|453653057|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
126273385|NCT02771795|454291055|FG001|Overall Study|Termination by premature discontinuation of study|185|||
126273386|NCT04112173|454291056|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
126273387|NCT02906930|454291057|FG000|Overall Study|Withdrawal by Subject|0|||
126273388|NCT02906930|454291058|FG001|Overall Study|Withdrawal by Subject|5|||
126273389|NCT02906930|454291059|FG002|Overall Study|Withdrawal by Subject|5|||
126273390|NCT02906930|454291060|FG003|Overall Study|Withdrawal by Subject|4|||
126273391|NCT02906930|454291057|FG000|Overall Study|Lost to Follow-up|5|||
126273392|NCT02906930|454291058|FG001|Overall Study|Lost to Follow-up|7|||
126273393|NCT02906930|454291059|FG002|Overall Study|Lost to Follow-up|5|||
126273394|NCT02906930|454291060|FG003|Overall Study|Lost to Follow-up|2|||
126273395|NCT02906930|454291057|FG000|Overall Study|Death|0|||
126273396|NCT02906930|454291058|FG001|Overall Study|Death|0|||
126273397|NCT02906930|454291059|FG002|Overall Study|Death|1|||
126273398|NCT02906930|454291060|FG003|Overall Study|Death|0|||
126273399|NCT02906930|454291057|FG000|Overall Study|Other|1|||
126273400|NCT02906930|454291058|FG001|Overall Study|Other|2|||
126273401|NCT02906930|454291059|FG002|Overall Study|Other|1|||
126273402|NCT02906930|454291060|FG003|Overall Study|Other|2|||
126273403|NCT01383135|454291070|FG000|Overall Study|Not Scanned / Imaged|1|||
126273404|NCT01383135|454291071|FG001|Overall Study|Not Scanned / Imaged|0|||
126273405|NCT01383135|454291072|FG002|Overall Study|Not Scanned / Imaged|1|||
126273406|NCT01383135|454291073|FG003|Overall Study|Not Scanned / Imaged|0|||
126273407|NCT03321630|454291074|FG000|Overall Study|Adverse Event|1|||
126273408|NCT03321630|454291074|FG000|Overall Study|Investigator Discretion|2|||
126273409|NCT03321630|454291074|FG000|Overall Study|Withdrawal by Subject|1|||
126273410|NCT02669758|454291075|FG000|Overall Study|Withdrawal by Subject|43|||
126273411|NCT02669758|454291075|FG000|Overall Study|Lost to Follow-up|19|||
126273412|NCT02669758|454291075|FG000|Overall Study|Adverse Event|16|||
126273413|NCT02669758|454291075|FG000|Overall Study|Non-Compliance with Study Drug|8|||
126273414|NCT02669758|454291075|FG000|Overall Study|Lack of Efficacy|5|||
126273415|NCT02669758|454291075|FG000|Overall Study|Pregnancy|1|||
126273416|NCT02669758|454291075|FG000|Overall Study|Study noncompliance|1|||
126273417|NCT02669758|454291075|FG000|Overall Study|Protocol Violation|1|||
126273418|NCT01468818|454291082|FG000|Overall Study|Death during treatment|2|||
126273419|NCT01212588|454291083|FG000|Overall Study|Physician Decision|0|||
126273420|NCT01212588|454291084|FG001|Overall Study|Physician Decision|1|||
126273421|NCT01212588|454291083|FG000|Overall Study|Protocol Violation|1|||
126273422|NCT01212588|454291084|FG001|Overall Study|Protocol Violation|1|||
126273423|NCT01735955|454291085|FG000|Overall Study|Administrative problems|1|||
126273424|NCT01735955|454291085|FG000|Overall Study|Patient/guardian decision|1|||
126273425|NCT01735955|454291085|FG000|Overall Study|Patient withdrew consent|2|||
126273426|NCT01735955|454291085|FG000|Overall Study|Physician Decision|4|||
126273427|NCT01735955|454291085|FG000|Overall Study|Disease progression|24|||
126273428|NCT01735955|454291085|FG000|Overall Study|Adverse Event|5|||
126273429|NCT03317834|454291088|FG000|Overall Study|Death|2|||
126273430|NCT03317834|454291088|FG000|Overall Study|Device Revision|5|||
126273431|NCT03317834|454291088|FG000|Overall Study|Withdrawal by Subject|13|||
126273432|NCT03317834|454291088|FG000|Overall Study|Lost to Follow-up|13|||
126273433|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
126273434|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
126273435|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273436|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273437|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
126273438|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273439|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273440|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273441|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273442|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273443|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
126273444|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273445|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273446|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273447|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273448|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273449|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273450|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273451|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273452|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
126273453|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273454|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
126273455|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273456|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273457|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273458|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273459|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273460|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273461|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
126273462|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273463|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
126273464|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273465|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273466|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273467|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273468|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273469|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
126273470|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
126273471|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
126273472|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273473|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
126273474|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273475|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273476|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273477|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273478|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273479|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
126273480|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273481|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273482|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273483|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273484|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273485|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273486|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273487|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273488|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273489|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273490|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
126273491|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273492|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273493|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273494|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273495|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273496|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273497|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
126273498|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
126273499|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
126273500|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273501|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273502|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273503|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273504|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273505|NCT03893565|454291098|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
126273506|NCT03893565|454291099|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
126273507|NCT03893565|454291100|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
126273508|NCT03893565|454291101|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
126273509|NCT03893565|454291102|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
126362217|NCT01725308|454619097|FG002|Treatment Period II|Insufficient Response|6|||
126362218|NCT01725308|454619095|FG000|Treatment Period II|Worsening of the Target Disease|1|||
126362219|NCT01725308|454619096|FG001|Treatment Period II|Worsening of the Target Disease|4|||
126273510|NCT03893565|454291103|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
126273511|NCT03893565|454291104|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
126273512|NCT03893565|454291105|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
126273513|NCT03893565|454291106|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
126273514|NCT03893565|454291098|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273515|NCT03893565|454291099|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273516|NCT03893565|454291100|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273517|NCT03893565|454291101|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273518|NCT03893565|454291102|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273519|NCT03893565|454291103|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273520|NCT03893565|454291104|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
126273521|NCT03893565|454291105|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273522|NCT03893565|454291106|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273523|NCT03893565|454291098|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273524|NCT03893565|454291099|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273525|NCT03893565|454291100|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273526|NCT03893565|454291101|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273527|NCT03893565|454291102|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273528|NCT03893565|454291103|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
126273529|NCT03893565|454291104|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
126273530|NCT03893565|454291105|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273531|NCT03893565|454291106|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273532|NCT03893565|454291098|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
126273533|NCT03893565|454291099|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
126273534|NCT03893565|454291100|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
126273535|NCT03893565|454291101|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
126273536|NCT03893565|454291102|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
126273537|NCT03893565|454291103|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
126273538|NCT03893565|454291104|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
126273539|NCT03893565|454291105|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
126273540|NCT03893565|454291106|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
126273541|NCT03893565|454291098|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273542|NCT03893565|454291099|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273543|NCT03893565|454291100|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273544|NCT03893565|454291101|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273545|NCT03893565|454291102|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273546|NCT03893565|454291103|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273547|NCT03893565|454291104|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273548|NCT03893565|454291105|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
126273549|NCT03893565|454291106|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273550|NCT03893565|454291098|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273551|NCT03893565|454291099|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273552|NCT03893565|454291100|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273553|NCT03893565|454291101|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273554|NCT03893565|454291102|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273555|NCT03893565|454291103|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273556|NCT03893565|454291104|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273557|NCT03893565|454291105|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
126273558|NCT03893565|454291106|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273559|NCT03893565|454291098|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273560|NCT03893565|454291099|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273561|NCT03893565|454291100|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273562|NCT03893565|454291101|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273563|NCT03893565|454291102|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273564|NCT03893565|454291103|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273565|NCT03893565|454291104|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273566|NCT03893565|454291105|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
126273567|NCT03893565|454291106|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273568|NCT03893565|454291098|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273569|NCT03893565|454291099|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126306212|NCT01250873|454410239|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
126306213|NCT01250873|454410239|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
126306214|NCT02278939|454410240|FG000|Overall Study|lack of time|1|||
126306215|NCT02278939|454410241|FG001|Overall Study|lack of time|0|||
126037415|NCT04171141|453436670|FG011|Overall Study|Adverse Event|0|||
126037416|NCT04171141|453436671|FG012|Overall Study|Adverse Event|0|||
126037417|NCT04171141|453436672|FG013|Overall Study|Adverse Event|2|||
126037418|NCT04171141|453436673|FG014|Overall Study|Adverse Event|0|||
126037419|NCT04171141|453436674|FG015|Overall Study|Adverse Event|0|||
126037420|NCT04171141|453436659|FG000|Overall Study|Physician Decision|0|||
126037421|NCT04171141|453436660|FG001|Overall Study|Physician Decision|0|||
126037422|NCT04171141|453436661|FG002|Overall Study|Physician Decision|0|||
126037423|NCT04171141|453436662|FG003|Overall Study|Physician Decision|0|||
126037424|NCT04171141|453436663|FG004|Overall Study|Physician Decision|1|||
126037425|NCT04171141|453436664|FG005|Overall Study|Physician Decision|0|||
126037426|NCT04171141|453436665|FG006|Overall Study|Physician Decision|0|||
126037427|NCT04171141|453436666|FG007|Overall Study|Physician Decision|0|||
126037428|NCT04171141|453436667|FG008|Overall Study|Physician Decision|0|||
126037429|NCT04171141|453436668|FG009|Overall Study|Physician Decision|0|||
126037430|NCT04171141|453436669|FG010|Overall Study|Physician Decision|0|||
126037431|NCT04171141|453436670|FG011|Overall Study|Physician Decision|0|||
126037432|NCT04171141|453436671|FG012|Overall Study|Physician Decision|0|||
126037433|NCT04171141|453436672|FG013|Overall Study|Physician Decision|0|||
126037434|NCT04171141|453436673|FG014|Overall Study|Physician Decision|0|||
126037435|NCT04171141|453436674|FG015|Overall Study|Physician Decision|1|||
126037436|NCT04171141|453436659|FG000|Overall Study|Progressive disease|2|||
126273570|NCT03893565|454291100|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125880779|NCT04225897|452862630|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126037437|NCT04171141|453436660|FG001|Overall Study|Progressive disease|3|||
126037438|NCT04171141|453436661|FG002|Overall Study|Progressive disease|4|||
126037439|NCT04171141|453436662|FG003|Overall Study|Progressive disease|7|||
126037440|NCT04171141|453436663|FG004|Overall Study|Progressive disease|1|||
126273571|NCT03893565|454291101|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273572|NCT03893565|454291102|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273573|NCT03893565|454291103|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273574|NCT03893565|454291104|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273575|NCT03893565|454291105|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273576|NCT03893565|454291106|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
126273577|NCT05788289|454291112|FG000|Overall Study|Death|3|||
126273578|NCT00762437|454291113|FG000|Overall Study|Lost to Follow-up|7|||
126273579|NCT00762437|454291113|FG000|Overall Study|Missed final study visit|11|||
126273580|NCT00762437|454291113|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
126273581|NCT00085423|454291118|FG000|Overall Study|Withdrawal by Subject|1|||
126273582|NCT00085423|454291118|FG000|Overall Study|screen failure|1|||
126273583|NCT02440568|454291121|FG000|Overall Study|Death|1|||
126273584|NCT02440568|454291122|FG001|Overall Study|Death|3|||
126273585|NCT02440568|454291123|FG002|Overall Study|Death|4|||
126273586|NCT02440568|454291124|FG003|Overall Study|Death|2|||
126273587|NCT02440568|454291121|FG000|Overall Study|Lack of Efficacy|2|||
126273588|NCT02440568|454291122|FG001|Overall Study|Lack of Efficacy|0|||
126273589|NCT02440568|454291123|FG002|Overall Study|Lack of Efficacy|1|||
126273590|NCT02440568|454291124|FG003|Overall Study|Lack of Efficacy|0|||
126037441|NCT04171141|453436664|FG005|Overall Study|Progressive disease|8|||
126037442|NCT04171141|453436665|FG006|Overall Study|Progressive disease|4|||
126273591|NCT02440568|454291121|FG000|Overall Study|Lost to Follow-up|1|||
126273592|NCT02440568|454291122|FG001|Overall Study|Lost to Follow-up|0|||
126273593|NCT02440568|454291123|FG002|Overall Study|Lost to Follow-up|0|||
126273594|NCT02440568|454291124|FG003|Overall Study|Lost to Follow-up|0|||
126273595|NCT00536263|454291125|FG000|Overall Study|Adverse Event|5|||
126273596|NCT00536263|454291126|FG001|Overall Study|Adverse Event|5|||
126273597|NCT00536263|454291127|FG002|Overall Study|Adverse Event|7|||
126037443|NCT04171141|453436666|FG007|Overall Study|Progressive disease|6|||
126037444|NCT04171141|453436667|FG008|Overall Study|Progressive disease|7|||
126273598|NCT00536263|454291125|FG000|Overall Study|Lost to Follow-up|3|||
126273599|NCT00536263|454291126|FG001|Overall Study|Lost to Follow-up|4|||
126037445|NCT04171141|453436668|FG009|Overall Study|Progressive disease|3|||
126037446|NCT04171141|453436669|FG010|Overall Study|Progressive disease|4|||
126037447|NCT04171141|453436670|FG011|Overall Study|Progressive disease|3|||
126037448|NCT04171141|453436671|FG012|Overall Study|Progressive disease|4|||
126273600|NCT00536263|454291127|FG002|Overall Study|Lost to Follow-up|4|||
126273601|NCT00536263|454291125|FG000|Overall Study|Subject withdrew - not treatment related|2|||
126273602|NCT00536263|454291126|FG001|Overall Study|Subject withdrew - not treatment related|0|||
126273603|NCT00536263|454291127|FG002|Overall Study|Subject withdrew - not treatment related|5|||
126273604|NCT00536263|454291125|FG000|Overall Study|Subject withdrew - treatment related|0|||
126273605|NCT00536263|454291126|FG001|Overall Study|Subject withdrew - treatment related|3|||
126273606|NCT00536263|454291127|FG002|Overall Study|Subject withdrew - treatment related|2|||
126273607|NCT00536263|454291125|FG000|Overall Study|Noncompliance with protocol|0|||
126273608|NCT00536263|454291126|FG001|Overall Study|Noncompliance with protocol|0|||
126273609|NCT00536263|454291127|FG002|Overall Study|Noncompliance with protocol|1|||
126273610|NCT00536263|454291125|FG000|Overall Study|Did not meet protocol eligibility|1|||
126273611|NCT00536263|454291126|FG001|Overall Study|Did not meet protocol eligibility|2|||
126273612|NCT00536263|454291127|FG002|Overall Study|Did not meet protocol eligibility|2|||
126273613|NCT03285308|454291138|FG000|Overall Study|Adverse Event|3|||
126273614|NCT03285308|454291139|FG001|Overall Study|Adverse Event|7|||
126273615|NCT03285308|454291138|FG000|Overall Study|Withdrawal by Subject|8|||
126273616|NCT03285308|454291139|FG001|Overall Study|Withdrawal by Subject|9|||
126273617|NCT03285308|454291138|FG000|Overall Study|Lost to Follow-up|3|||
126273618|NCT03285308|454291139|FG001|Overall Study|Lost to Follow-up|1|||
126273619|NCT03285308|454291138|FG000|Overall Study|Protocol Deviation|6|||
126273620|NCT03285308|454291139|FG001|Overall Study|Protocol Deviation|5|||
126273621|NCT03285308|454291138|FG000|Overall Study|Reason not Specified|0|||
126273622|NCT03285308|454291139|FG001|Overall Study|Reason not Specified|1|||
126273623|NCT03734666|454291143|FG000|Overall Study|Other|7|||
126273624|NCT03734666|454291144|FG001|Overall Study|Other|4|||
126273625|NCT03734666|454291143|FG000|Overall Study|Lost to Follow-up|12|||
126273626|NCT03734666|454291144|FG001|Overall Study|Lost to Follow-up|12|||
126273627|NCT00681590|454291145|FG000|Overall Study|Withdrawal by Subject|2|||
126273628|NCT00681590|454291146|FG001|Overall Study|Withdrawal by Subject|12|||
126273629|NCT01898650|454291148|FG000|Overall Study|the subject would not lie still for imaging|1|||
126273630|NCT01181271|454291153|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
126273631|NCT01181271|454291153|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
126273632|NCT01181271|454291153|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
126273633|NCT01181271|454291153|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
126273634|NCT04156620|454291154|FG000|Overall Study|Adverse event - TP 1|5|||
126273635|NCT04156620|454291155|FG001|Overall Study|Adverse event - TP 1|2|||
126273636|NCT04156620|454291154|FG000|Overall Study|Lost to follow-up TP 1|1|||
126273637|NCT04156620|454291155|FG001|Overall Study|Lost to follow-up TP 1|1|||
126273638|NCT04156620|454291154|FG000|Overall Study|Progressive disease - TP 1|0|||
126273639|NCT04156620|454291155|FG001|Overall Study|Progressive disease - TP 1|1|||
126273640|NCT04156620|454291154|FG000|Overall Study|Subject decision - TP 1|3|||
126273641|NCT04156620|454291155|FG001|Overall Study|Subject decision - TP 1|5|||
126273642|NCT04156620|454291154|FG000|Overall Study|Adverse event - TP 2|5|||
126273643|NCT04156620|454291155|FG001|Overall Study|Adverse event - TP 2|6|||
126273644|NCT04156620|454291154|FG000|Overall Study|Death - TP 2|1|||
126273645|NCT04156620|454291155|FG001|Overall Study|Death - TP 2|0|||
126273646|NCT04156620|454291154|FG000|Overall Study|Lost to follow-up - TP 2|5|||
126273647|NCT04156620|454291155|FG001|Overall Study|Lost to follow-up - TP 2|2|||
126273648|NCT04156620|454291154|FG000|Overall Study|Physician decision - TP 2|4|||
126273649|NCT04156620|454291155|FG001|Overall Study|Physician decision - TP 2|2|||
126273650|NCT04156620|454291154|FG000|Overall Study|Pregnancy - TP 2|1|||
126273651|NCT04156620|454291155|FG001|Overall Study|Pregnancy - TP 2|1|||
126273652|NCT04156620|454291154|FG000|Overall Study|Subject decision - TP 2|11|||
126273653|NCT04156620|454291155|FG001|Overall Study|Subject decision - TP 2|9|||
126273654|NCT04156620|454291154|FG000|Overall Study|New therapy for study indication - TP 2|1|||
126273655|NCT04156620|454291155|FG001|Overall Study|New therapy for study indication - TP 2|0|||
126273656|NCT04135196|454291156|FG000|Overall Study|Lost to Follow-up|8|||
126273657|NCT04135196|454291157|FG001|Overall Study|Lost to Follow-up|7|||
126273658|NCT04135196|454291158|FG002|Overall Study|Lost to Follow-up|8|||
126273659|NCT04135196|454291159|FG003|Overall Study|Lost to Follow-up|9|||
126273660|NCT04135196|454291160|FG004|Overall Study|Lost to Follow-up|1|||
126273661|NCT04135196|454291156|FG000|Overall Study|Pregnancy|0|||
126273662|NCT04135196|454291157|FG001|Overall Study|Pregnancy|0|||
125880780|NCT04225897|452862631|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126273663|NCT04135196|454291158|FG002|Overall Study|Pregnancy|1|||
126273664|NCT04135196|454291159|FG003|Overall Study|Pregnancy|0|||
126273665|NCT04135196|454291160|FG004|Overall Study|Pregnancy|0|||
126273666|NCT04135196|454291156|FG000|Overall Study|Withdrawal by Subject|0|||
126273667|NCT04135196|454291157|FG001|Overall Study|Withdrawal by Subject|0|||
126273668|NCT04135196|454291158|FG002|Overall Study|Withdrawal by Subject|0|||
126273669|NCT04135196|454291159|FG003|Overall Study|Withdrawal by Subject|0|||
126037449|NCT04171141|453436672|FG013|Overall Study|Progressive disease|2|||
126273670|NCT04135196|454291160|FG004|Overall Study|Withdrawal by Subject|1|||
126273671|NCT01753336|454291162|FG000|Overall Study|Patient decision|12|||
126273672|NCT01753336|454291162|FG000|Overall Study|Lost to Follow-up|3|||
126037450|NCT04171141|453436673|FG014|Overall Study|Progressive disease|4|||
126037451|NCT04171141|453436674|FG015|Overall Study|Progressive disease|1|||
126037452|NCT04171141|453436659|FG000|Overall Study|Withdrawal by Subject|0|||
126037453|NCT04171141|453436660|FG001|Overall Study|Withdrawal by Subject|0|||
126037454|NCT04171141|453436661|FG002|Overall Study|Withdrawal by Subject|0|||
126037455|NCT04171141|453436662|FG003|Overall Study|Withdrawal by Subject|1|||
126273673|NCT01753336|454291162|FG000|Overall Study|Physician Decision|2|||
126273674|NCT01753336|454291162|FG000|Overall Study|Sponsor's decision|2|||
126273675|NCT01753336|454291162|FG000|Overall Study|Withdrawal by Subject|1|||
126273676|NCT00914459|454291163|FG000|Overall Study|Protocol Violation|0|||
126273677|NCT00914459|454291164|FG001|Overall Study|Protocol Violation|1|||
126273678|NCT00914459|454291163|FG000|Overall Study|Parent/Legal guardian request|1|||
126273679|NCT00914459|454291164|FG001|Overall Study|Parent/Legal guardian request|0|||
126273680|NCT01661179|454291168|FG000|Overall Study|Death|1|||
126273681|NCT01661179|454291168|FG000|Overall Study|Withdrawal by Subject|1|||
126273682|NCT01661179|454291168|FG000|Overall Study|Other Eligibility criteria|4|||
126273683|NCT01946191|454291169|FG000|Allocation|Did not complete orientation|1|||
126273684|NCT01946191|454291170|FG001|Allocation|Did not complete orientation|1|||
126273685|NCT01946191|454291169|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
126273686|NCT01946191|454291170|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
126273687|NCT01946191|454291169|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
126273688|NCT01946191|454291170|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
126273689|NCT01946191|454291169|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
126273690|NCT01946191|454291170|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
126273691|NCT01629966|454291171|FG000|Overall Study|Pregnancy|0|||
126273692|NCT01629966|454291172|FG001|Overall Study|Pregnancy|1|||
126273693|NCT01629966|454291173|FG002|Overall Study|Pregnancy|0|||
126273694|NCT01629966|454291171|FG000|Overall Study|Lost to Follow-up|10|||
126273695|NCT01629966|454291172|FG001|Overall Study|Lost to Follow-up|13|||
126273696|NCT01629966|454291173|FG002|Overall Study|Lost to Follow-up|9|||
126273697|NCT01629966|454291171|FG000|Overall Study|Withdrawal by Subject|8|||
126273698|NCT01629966|454291172|FG001|Overall Study|Withdrawal by Subject|9|||
126273699|NCT01629966|454291173|FG002|Overall Study|Withdrawal by Subject|16|||
126273700|NCT01629966|454291171|FG000|Overall Study|Protocol Violation|7|||
126273701|NCT01629966|454291172|FG001|Overall Study|Protocol Violation|9|||
126273702|NCT01629966|454291173|FG002|Overall Study|Protocol Violation|7|||
126273703|NCT01629966|454291171|FG000|Overall Study|Lack of Efficacy|5|||
126273704|NCT01629966|454291172|FG001|Overall Study|Lack of Efficacy|2|||
126273705|NCT01629966|454291173|FG002|Overall Study|Lack of Efficacy|4|||
126273706|NCT01629966|454291171|FG000|Overall Study|Adverse Event|11|||
126273707|NCT01629966|454291172|FG001|Overall Study|Adverse Event|18|||
126273708|NCT01629966|454291173|FG002|Overall Study|Adverse Event|30|||
126273709|NCT04188301|454291181|FG000|Month 3|Lost to Follow-up|0|||
126273710|NCT04188301|454291182|FG001|Month 3|Lost to Follow-up|0|||
126273711|NCT04188301|454291183|FG002|Month 3|Lost to Follow-up|1|||
126273712|NCT04188301|454291181|FG000|Month 12|Lost to Follow-up|0|||
126273713|NCT04188301|454291182|FG001|Month 12|Lost to Follow-up|0|||
126273714|NCT04188301|454291183|FG002|Month 12|Lost to Follow-up|2|||
126273715|NCT04188301|454291181|FG000|Month 12|Death|1|||
126273716|NCT04188301|454291182|FG001|Month 12|Death|1|||
126273717|NCT04188301|454291183|FG002|Month 12|Death|0|||
126273718|NCT04188301|454291181|FG000|Month 18|Lost to Follow-up|6|||
126273719|NCT04188301|454291182|FG001|Month 18|Lost to Follow-up|0|||
126273720|NCT04188301|454291183|FG002|Month 18|Lost to Follow-up|0|||
126273721|NCT00006721|454293875|FG000|Overall Study|Adverse Event|0|||
126037456|NCT04171141|453436663|FG004|Overall Study|Withdrawal by Subject|0|||
126273722|NCT00006721|454293876|FG001|Overall Study|Adverse Event|4|||
126273723|NCT00006721|454293877|FG002|Overall Study|Adverse Event|4|||
126273724|NCT00006721|454293875|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126273725|NCT00006721|454293876|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
126273726|NCT00006721|454293877|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
126273727|NCT00006721|454293875|FG000|Overall Study|Progression/Relapse|0|||
126273728|NCT00006721|454293876|FG001|Overall Study|Progression/Relapse|1|||
126037457|NCT04171141|453436664|FG005|Overall Study|Withdrawal by Subject|0|||
126273729|NCT00006721|454293877|FG002|Overall Study|Progression/Relapse|2|||
126273730|NCT00006721|454293875|FG000|Overall Study|Death|0|||
126273731|NCT00006721|454293876|FG001|Overall Study|Death|1|||
126273732|NCT00006721|454293877|FG002|Overall Study|Death|2|||
126273733|NCT00006721|454293875|FG000|Overall Study|Other - Not Protocol Specified|0|||
126306216|NCT02278939|454410240|FG000|Overall Study|Lost to Follow-up|1|||
126306217|NCT02278939|454410241|FG001|Overall Study|Lost to Follow-up|1|||
126306218|NCT02278939|454410240|FG000|Overall Study|death in family|1|||
126306219|NCT02278939|454410241|FG001|Overall Study|death in family|0|||
126306220|NCT02278939|454410240|FG000|Overall Study|family emergency unable to commit|2|||
126306221|NCT02278939|454410241|FG001|Overall Study|family emergency unable to commit|0|||
126306222|NCT01680861|454410246|FG000|Early Post-transplant Period|Protocol Violation|1|||
126306223|NCT01680861|454410247|FG001|Early Post-transplant Period|Protocol Violation|1|||
126273734|NCT00006721|454293876|FG001|Overall Study|Other - Not Protocol Specified|7|||
126273735|NCT00006721|454293877|FG002|Overall Study|Other - Not Protocol Specified|7|||
126273736|NCT00006721|454293875|FG000|Overall Study|Ineligible|2|||
126273737|NCT00006721|454293876|FG001|Overall Study|Ineligible|12|||
126273738|NCT00006721|454293877|FG002|Overall Study|Ineligible|10|||
126273739|NCT00006721|454293875|FG000|Overall Study|Eligible but no Treatment Received|1|||
126273740|NCT00006721|454293876|FG001|Overall Study|Eligible but no Treatment Received|0|||
126273741|NCT00006721|454293877|FG002|Overall Study|Eligible but no Treatment Received|0|||
126273742|NCT01200992|454293886|FG000|Overall Study|Study terminated early|35|||
126273743|NCT01200992|454293887|FG001|Overall Study|Study terminated early|41|||
126273744|NCT01200992|454293886|FG000|Overall Study|Randomized but not treated|2|||
126273745|NCT01200992|454293887|FG001|Overall Study|Randomized but not treated|0|||
126273746|NCT02213510|454293896|FG000|Overall Study|Death|0|||
126273747|NCT02213510|454293897|FG001|Overall Study|Death|1|||
126273748|NCT02213510|454293896|FG000|Overall Study|Lost to Follow-up|1|||
126273749|NCT02213510|454293897|FG001|Overall Study|Lost to Follow-up|0|||
126273750|NCT04241315|454293910|FG000|Overall Study|Withdrawal by Subject|0|||
126273751|NCT04241315|454293911|FG001|Overall Study|Withdrawal by Subject|1|||
126273752|NCT00699283|454293912|FG000|Overall Study|Lack of Efficacy|15|||
126273753|NCT00699283|454293913|FG001|Overall Study|Lack of Efficacy|5|||
126273754|NCT00699283|454293912|FG000|Overall Study|Lost to Follow-up|2|||
126273755|NCT00699283|454293913|FG001|Overall Study|Lost to Follow-up|0|||
126273756|NCT00699283|454293912|FG000|Overall Study|Withdrawal by Subject|1|||
126273757|NCT00699283|454293913|FG001|Overall Study|Withdrawal by Subject|0|||
126273758|NCT00699283|454293912|FG000|Overall Study|Other Reason|5|||
126273759|NCT00699283|454293913|FG001|Overall Study|Other Reason|1|||
126273760|NCT00699283|454293912|FG000|Overall Study|SAE, non-fatal|1|||
126273761|NCT00699283|454293913|FG001|Overall Study|SAE, non-fatal|1|||
126273762|NCT00699283|454293912|FG000|Overall Study|AE, non-serious non-fatal|8|||
126273763|NCT00699283|454293913|FG001|Overall Study|AE, non-serious non-fatal|1|||
126273764|NCT00699283|454293912|FG000|Overall Study|AE of unknown type|1|||
126273765|NCT00699283|454293913|FG001|Overall Study|AE of unknown type|0|||
126273766|NCT00394524|454293914|FG000|Overall Study|Protocol Violation|2|||
126273767|NCT00394524|454293915|FG001|Overall Study|Protocol Violation|3|||
126273768|NCT00394524|454293914|FG000|Overall Study|Death|1|||
126273769|NCT00394524|454293915|FG001|Overall Study|Death|0|||
126273770|NCT00394524|454293914|FG000|Overall Study|Withdrawal by Subject|0|||
126273771|NCT00394524|454293915|FG001|Overall Study|Withdrawal by Subject|1|||
126273772|NCT01398514|454293916|FG000|Overall Study|Adverse Event|1|||
126273773|NCT01398514|454293917|FG001|Overall Study|Adverse Event|0|||
126273774|NCT01398514|454293916|FG000|Overall Study|Non-compliance with study procedures|2|||
126273775|NCT01398514|454293917|FG001|Overall Study|Non-compliance with study procedures|0|||
126273776|NCT01398514|454293916|FG000|Overall Study|Physiologic non-responsiveness|1|||
126273777|NCT01398514|454293917|FG001|Overall Study|Physiologic non-responsiveness|3|||
126273778|NCT01398514|454293916|FG000|Overall Study|Failure to show a conditioned response|4|||
126273779|NCT01398514|454293917|FG001|Overall Study|Failure to show a conditioned response|3|||
126273780|NCT01345175|454293919|FG000|Overall Study|Physician Decision|0|||
126273781|NCT01345175|454293920|FG001|Overall Study|Physician Decision|1|||
126273782|NCT01345175|454293919|FG000|Overall Study|Withdrawal by Subject|1|||
126273783|NCT01345175|454293920|FG001|Overall Study|Withdrawal by Subject|1|||
126273784|NCT01345175|454293919|FG000|Overall Study|Failed to complete BFI|3|||
126362220|NCT01725308|454619097|FG002|Treatment Period II|Worsening of the Target Disease|2|||
126362221|NCT01725308|454619095|FG000|Treatment Period II|Changes in the Episodes|1|||
126362222|NCT01725308|454619096|FG001|Treatment Period II|Changes in the Episodes|0|||
126362223|NCT01725308|454619097|FG002|Treatment Period II|Changes in the Episodes|5|||
126362224|NCT01725308|454619095|FG000|Treatment Period II|Withdrawal of Consent|28|||
126362225|NCT01725308|454619096|FG001|Treatment Period II|Withdrawal of Consent|2|||
126362226|NCT01725308|454619097|FG002|Treatment Period II|Withdrawal of Consent|16|||
126362227|NCT01725308|454619095|FG000|Treatment Period II|Lost to Follow-up|1|||
126362228|NCT01725308|454619096|FG001|Treatment Period II|Lost to Follow-up|5|||
126362229|NCT01725308|454619097|FG002|Treatment Period II|Lost to Follow-up|3|||
126362230|NCT01725308|454619095|FG000|Treatment Period II|Protocol Deviations|0|||
126362231|NCT01725308|454619096|FG001|Treatment Period II|Protocol Deviations|0|||
126362232|NCT01725308|454619097|FG002|Treatment Period II|Protocol Deviations|1|||
126362233|NCT01725308|454619095|FG000|Treatment Period II|Miscellaneous|5|||
126273785|NCT01345175|454293920|FG001|Overall Study|Failed to complete BFI|2|||
126273786|NCT01345175|454293919|FG000|Overall Study|Stopped taking medication|2|||
126273787|NCT01345175|454293920|FG001|Overall Study|Stopped taking medication|2|||
126273788|NCT03537599|454293924|FG000|Overall Study|Disease Progression|2|||
126273789|NCT03537599|454293925|FG001|Overall Study|Disease Progression|1|||
126273790|NCT03537599|454293924|FG000|Overall Study|Death|0|||
126273791|NCT03537599|454293925|FG001|Overall Study|Death|1|||
126273792|NCT01007942|454293926|FG000|Overall Study|Adverse Event|29|||
126273793|NCT01007942|454293927|FG001|Overall Study|Adverse Event|14|||
126362234|NCT01725308|454619096|FG001|Treatment Period II|Miscellaneous|3|||
126362235|NCT01725308|454619097|FG002|Treatment Period II|Miscellaneous|7|||
126362236|NCT04128228|454619098|FG000|Overall Study|Withdrawal by Subject|3|||
126362237|NCT04128228|454619099|FG001|Overall Study|Withdrawal by Subject|3|||
126362238|NCT04128228|454619100|FG002|Overall Study|Withdrawal by Subject|0|||
126362239|NCT04128228|454619101|FG003|Overall Study|Withdrawal by Subject|0|||
126362240|NCT04128228|454619098|FG000|Overall Study|noncompliance|2|||
126362241|NCT04128228|454619099|FG001|Overall Study|noncompliance|2|||
126362242|NCT04128228|454619100|FG002|Overall Study|noncompliance|0|||
126362243|NCT04128228|454619101|FG003|Overall Study|noncompliance|0|||
126362244|NCT03163264|454619102|FG000|Overall Study|Withdrawal by Subject|13|||
126362245|NCT03163264|454619103|FG001|Overall Study|Withdrawal by Subject|3|||
126362246|NCT03163264|454619104|FG002|Overall Study|Withdrawal by Subject|4|||
126362247|NCT03163264|454619105|FG003|Overall Study|Withdrawal by Subject|2|||
126362248|NCT03163264|454619102|FG000|Overall Study|Lost to Follow-up|17|||
126362249|NCT03163264|454619103|FG001|Overall Study|Lost to Follow-up|20|||
126362250|NCT03163264|454619104|FG002|Overall Study|Lost to Follow-up|0|||
126362251|NCT03163264|454619105|FG003|Overall Study|Lost to Follow-up|0|||
126362252|NCT03163264|454619102|FG000|Overall Study|Death|0|||
126362253|NCT03163264|454619103|FG001|Overall Study|Death|2|||
126362254|NCT03163264|454619104|FG002|Overall Study|Death|0|||
126362255|NCT03163264|454619105|FG003|Overall Study|Death|0|||
126362256|NCT00215657|454619108|FG000|Overall Study|Adverse Event|5|||
126362257|NCT00215657|454619109|FG001|Overall Study|Adverse Event|1|||
126362258|NCT00215657|454619110|FG002|Overall Study|Adverse Event|3|||
126362259|NCT00215657|454619111|FG003|Overall Study|Adverse Event|0|||
126362260|NCT00215657|454619112|FG004|Overall Study|Adverse Event|3|||
126362261|NCT00215657|454619113|FG005|Overall Study|Adverse Event|1|||
126362262|NCT00215657|454619114|FG006|Overall Study|Adverse Event|0|||
126362263|NCT00215657|454619115|FG007|Overall Study|Adverse Event|3|||
126362264|NCT00215657|454619108|FG000|Overall Study|Withdrawal by Subject|6|||
126362265|NCT00215657|454619109|FG001|Overall Study|Withdrawal by Subject|3|||
126362266|NCT00215657|454619110|FG002|Overall Study|Withdrawal by Subject|3|||
126362267|NCT00215657|454619111|FG003|Overall Study|Withdrawal by Subject|1|||
126362268|NCT00215657|454619112|FG004|Overall Study|Withdrawal by Subject|6|||
126362269|NCT00215657|454619113|FG005|Overall Study|Withdrawal by Subject|1|||
126362270|NCT00215657|454619114|FG006|Overall Study|Withdrawal by Subject|10|||
126362271|NCT00215657|454619115|FG007|Overall Study|Withdrawal by Subject|3|||
126362272|NCT00215657|454619108|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
126362273|NCT00215657|454619109|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
126362274|NCT00215657|454619110|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
126362275|NCT00215657|454619111|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
126362276|NCT00215657|454619112|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
126362277|NCT00215657|454619113|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
126362278|NCT00215657|454619114|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
126362279|NCT00215657|454619115|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
126362280|NCT00215657|454619108|FG000|Overall Study|Insufficient testosterone response|5|||
126362281|NCT00215657|454619109|FG001|Overall Study|Insufficient testosterone response|4|||
126362282|NCT00215657|454619110|FG002|Overall Study|Insufficient testosterone response|1|||
126362283|NCT00215657|454619111|FG003|Overall Study|Insufficient testosterone response|12|||
126362284|NCT00215657|454619112|FG004|Overall Study|Insufficient testosterone response|8|||
126362285|NCT00215657|454619113|FG005|Overall Study|Insufficient testosterone response|12|||
126362286|NCT00215657|454619114|FG006|Overall Study|Insufficient testosterone response|4|||
126362287|NCT00215657|454619115|FG007|Overall Study|Insufficient testosterone response|7|||
126362288|NCT00215657|454619108|FG000|Overall Study|Other|3|||
126362289|NCT00215657|454619109|FG001|Overall Study|Other|1|||
126362290|NCT00215657|454619110|FG002|Overall Study|Other|2|||
126362291|NCT00215657|454619111|FG003|Overall Study|Other|3|||
126362292|NCT00215657|454619112|FG004|Overall Study|Other|5|||
126362293|NCT00215657|454619113|FG005|Overall Study|Other|4|||
126362294|NCT00215657|454619114|FG006|Overall Study|Other|6|||
126362295|NCT00215657|454619115|FG007|Overall Study|Other|1|||
126362296|NCT03769467|454619116|FG000|Overall Study|Adverse Event|1|||
126037458|NCT04171141|453436665|FG006|Overall Study|Withdrawal by Subject|1|||
126037459|NCT04171141|453436666|FG007|Overall Study|Withdrawal by Subject|0|||
126037460|NCT04171141|453436667|FG008|Overall Study|Withdrawal by Subject|0|||
126037461|NCT04171141|453436668|FG009|Overall Study|Withdrawal by Subject|1|||
126037462|NCT04171141|453436669|FG010|Overall Study|Withdrawal by Subject|0|||
126362297|NCT03769467|454619117|FG001|Overall Study|Adverse Event|1|||
126362298|NCT03769467|454619118|FG002|Overall Study|Adverse Event|0|||
126362299|NCT03769467|454619116|FG000|Overall Study|Death|3|||
126362300|NCT03769467|454619117|FG001|Overall Study|Death|3|||
126362301|NCT03769467|454619118|FG002|Overall Study|Death|0|||
126362302|NCT03769467|454619116|FG000|Overall Study|Study Terminated By Sponsor|2|||
126362303|NCT03769467|454619117|FG001|Overall Study|Study Terminated By Sponsor|1|||
126362304|NCT03769467|454619118|FG002|Overall Study|Study Terminated By Sponsor|0|||
126362305|NCT03769467|454619116|FG000|Overall Study|Withdrawal by Subject|0|||
126362306|NCT03769467|454619117|FG001|Overall Study|Withdrawal by Subject|1|||
126362307|NCT03769467|454619118|FG002|Overall Study|Withdrawal by Subject|0|||
126362308|NCT02614066|454619119|FG000|Overall Study|Death|6|||
126362309|NCT02614066|454619120|FG001|Overall Study|Death|14|||
126362310|NCT02614066|454619121|FG002|Overall Study|Death|11|||
126362311|NCT02614066|454619122|FG003|Overall Study|Death|29|||
126362312|NCT02614066|454619119|FG000|Overall Study|Full consent withdrawn|0|||
126362313|NCT02614066|454619120|FG001|Overall Study|Full consent withdrawn|1|||
126362314|NCT02614066|454619121|FG002|Overall Study|Full consent withdrawn|0|||
126362315|NCT02614066|454619122|FG003|Overall Study|Full consent withdrawn|8|||
126362316|NCT02614066|454619119|FG000|Overall Study|Lost to Follow-up|0|||
126362317|NCT02614066|454619120|FG001|Overall Study|Lost to Follow-up|2|||
126362318|NCT02614066|454619121|FG002|Overall Study|Lost to Follow-up|2|||
126362319|NCT02614066|454619122|FG003|Overall Study|Lost to Follow-up|2|||
126362320|NCT02614066|454619119|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
126362321|NCT02614066|454619120|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
126362322|NCT02614066|454619121|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
126362323|NCT02614066|454619122|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
126362324|NCT02614066|454619119|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
126362325|NCT02614066|454619120|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
126362326|NCT02614066|454619121|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
126362327|NCT02614066|454619122|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
126362328|NCT02614066|454619119|FG000|Overall Study|Reason not specified|0|||
126362329|NCT02614066|454619120|FG001|Overall Study|Reason not specified|2|||
126362330|NCT02614066|454619121|FG002|Overall Study|Reason not specified|1|||
126362331|NCT02614066|454619122|FG003|Overall Study|Reason not specified|1|||
126362332|NCT04565756|454619123|FG000|Overall Study|Withdrawal by Subject|0|||
126362333|NCT04565756|454619124|FG001|Overall Study|Withdrawal by Subject|0|||
126362334|NCT04565756|454619125|FG002|Overall Study|Withdrawal by Subject|0|||
126362335|NCT04565756|454619126|FG003|Overall Study|Withdrawal by Subject|0|||
126362336|NCT04565756|454619127|FG004|Overall Study|Withdrawal by Subject|1|||
126362337|NCT04565756|454619128|FG005|Overall Study|Withdrawal by Subject|0|||
126362338|NCT04565756|454619123|FG000|Overall Study|Protocol Violation|0|||
126362339|NCT04565756|454619124|FG001|Overall Study|Protocol Violation|0|||
126362340|NCT04565756|454619125|FG002|Overall Study|Protocol Violation|0|||
126273794|NCT01007942|454293926|FG000|Overall Study|Abnormal test procedure|0|||
126273795|NCT01007942|454293927|FG001|Overall Study|Abnormal test procedure|1|||
126273796|NCT01007942|454293926|FG000|Overall Study|Disease progression|217|||
126273797|NCT01007942|454293927|FG001|Overall Study|Disease progression|242|||
126273798|NCT01007942|454293926|FG000|Overall Study|New cancer therapy|5|||
126273799|NCT01007942|454293927|FG001|Overall Study|New cancer therapy|1|||
126273800|NCT01007942|454293926|FG000|Overall Study|Protocol Violation|1|||
126273801|NCT01007942|454293927|FG001|Overall Study|Protocol Violation|1|||
126273802|NCT01007942|454293926|FG000|Overall Study|Withdrawal by Subject|19|||
126273803|NCT01007942|454293927|FG001|Overall Study|Withdrawal by Subject|14|||
126273804|NCT01007942|454293926|FG000|Overall Study|Lost to Follow-up|1|||
126273805|NCT01007942|454293927|FG001|Overall Study|Lost to Follow-up|0|||
126273806|NCT01007942|454293926|FG000|Overall Study|Administrative problems|2|||
126273807|NCT01007942|454293927|FG001|Overall Study|Administrative problems|0|||
126273808|NCT01007942|454293926|FG000|Overall Study|Death|3|||
126273809|NCT01007942|454293927|FG001|Overall Study|Death|2|||
126273810|NCT01007942|454293926|FG000|Overall Study|Patients untreated|4|||
126273811|NCT01007942|454293927|FG001|Overall Study|Patients untreated|3|||
126273812|NCT05083585|454293932|FG000|Overall Study|Death|1|||
126273813|NCT05083585|454293933|FG001|Overall Study|Death|1|||
126273814|NCT05083585|454293932|FG000|Overall Study|Lost to Follow-up|1|||
126273815|NCT05083585|454293933|FG001|Overall Study|Lost to Follow-up|1|||
126273816|NCT05083585|454293932|FG000|Overall Study|Withdrawal by Subject|2|||
126273817|NCT05083585|454293933|FG001|Overall Study|Withdrawal by Subject|0|||
126273818|NCT05083585|454293932|FG000|Overall Study|Randomized but not vaccinated|2|||
126273819|NCT05083585|454293933|FG001|Overall Study|Randomized but not vaccinated|0|||
126362341|NCT04565756|454619126|FG003|Overall Study|Protocol Violation|0|||
126362342|NCT04565756|454619127|FG004|Overall Study|Protocol Violation|0|||
126362343|NCT04565756|454619128|FG005|Overall Study|Protocol Violation|1|||
126273820|NCT03929757|454293934|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
126273821|NCT03929757|454293935|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
126273822|NCT03929757|454293936|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
126273823|NCT03929757|454293934|FG000|Main Study: Up to Day 365|Other|1|||
126362344|NCT03069937|454619137|FG000|Overall Study|Second primary malignancy noted|1|||
126362345|NCT00968968|454619138|FG000|Overall Study|Study closed/terminated|10|||
126362346|NCT00968968|454619139|FG001|Overall Study|Study closed/terminated|10|||
126362347|NCT00968968|454619138|FG000|Overall Study|Protocol defined stopping criteria|3|||
126273824|NCT03929757|454293935|FG001|Main Study: Up to Day 365|Other|0|||
126273825|NCT03929757|454293936|FG002|Main Study: Up to Day 365|Other|0|||
126273826|NCT03929757|454293934|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
126273827|NCT03929757|454293935|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
126273828|NCT03929757|454293936|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
126273829|NCT00114166|454293938|FG000|Overall Study|Wrong primary|0|||
126273830|NCT00114166|454293939|FG001|Overall Study|Wrong primary|1|||
126273831|NCT00806286|454293945|FG000|Overall Study|Adverse Event|5|||
126273832|NCT00806286|454293946|FG001|Overall Study|Adverse Event|2|||
126273833|NCT00806286|454293947|FG002|Overall Study|Adverse Event|0|||
126273834|NCT00806286|454293945|FG000|Overall Study|Disease progression|31|||
126273835|NCT00806286|454293946|FG001|Overall Study|Disease progression|38|||
126273836|NCT00806286|454293947|FG002|Overall Study|Disease progression|1|||
126273837|NCT00806286|454293945|FG000|Overall Study|Death|1|||
126273838|NCT00806286|454293946|FG001|Overall Study|Death|6|||
126273839|NCT00806286|454293947|FG002|Overall Study|Death|0|||
126273840|NCT00806286|454293945|FG000|Overall Study|Lost to Follow-up|0|||
126273841|NCT00806286|454293946|FG001|Overall Study|Lost to Follow-up|1|||
126273842|NCT00806286|454293947|FG002|Overall Study|Lost to Follow-up|0|||
126273843|NCT00806286|454293945|FG000|Overall Study|Withdrawal by Subject|8|||
126273844|NCT00806286|454293946|FG001|Overall Study|Withdrawal by Subject|3|||
126273845|NCT00806286|454293947|FG002|Overall Study|Withdrawal by Subject|1|||
126273846|NCT00806286|454293945|FG000|Overall Study|Physician Decision|2|||
126273847|NCT00806286|454293946|FG001|Overall Study|Physician Decision|2|||
126273848|NCT00806286|454293947|FG002|Overall Study|Physician Decision|0|||
126273849|NCT00806286|454293945|FG000|Overall Study|Due to a variety of reasons|7|||
126273850|NCT00806286|454293946|FG001|Overall Study|Due to a variety of reasons|2|||
126273851|NCT00806286|454293947|FG002|Overall Study|Due to a variety of reasons|1|||
126273852|NCT03402750|454293948|FG000|Overall Study|Lost to Follow-up|2|||
126273853|NCT03402750|454293949|FG001|Overall Study|Lost to Follow-up|1|||
126273854|NCT03469336|454293950|FG000|Overall Study|Adverse Event|1|||
126273855|NCT02628743|454293952|FG000|Overall Study|Other|3|||
126273856|NCT02628743|454293952|FG000|Overall Study|Withdrawal by Subject|50|||
126273857|NCT02628743|454293952|FG000|Overall Study|Study Terminated by Sponsor|76|||
126273858|NCT02628743|454293952|FG000|Overall Study|Physician Decision|2|||
126273859|NCT02534844|454293953|FG000|Part B|Withdrawal by Subject|0|||
126273860|NCT02534844|454293954|FG001|Part B|Withdrawal by Subject|0|||
126273861|NCT02534844|454293955|FG002|Part B|Withdrawal by Subject|0|||
126273862|NCT02534844|454293956|FG003|Part B|Withdrawal by Subject|0|||
126273863|NCT02534844|454293957|FG004|Part B|Withdrawal by Subject|2|||
126273864|NCT02534844|454293958|FG005|Part B|Withdrawal by Subject|1|||
126273865|NCT03560986|454293959|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
126273866|NCT03560986|454293960|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
126273867|NCT03560986|454293959|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
126273868|NCT03560986|454293960|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
126273869|NCT03560986|454293959|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
126273870|NCT03560986|454293960|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
126273871|NCT03560986|454293959|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
126273872|NCT03560986|454293960|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
126273873|NCT03560986|454293959|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
126273874|NCT03560986|454293960|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
126273875|NCT03560986|454293959|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
126273876|NCT03560986|454293960|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
126273877|NCT03560986|454293959|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
126273878|NCT03560986|454293960|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
126273879|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
126273880|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
126273881|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
126273882|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
126273883|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
126273884|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
126273885|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
126273886|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
126273887|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
126273888|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
126273889|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
126273890|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
126273891|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
126273892|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
126273893|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
126273894|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
126273895|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
126273896|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
126273897|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
126273898|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
126273899|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Various|0|||
126273900|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Various|0|||
126273901|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Various|0|||
126273902|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Various|25|||
126273903|NCT00593736|454293972|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
126273904|NCT00593736|454293973|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
126273905|NCT00593736|454293974|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
126273906|NCT00593736|454293975|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
126273907|NCT00593736|454293972|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
126273908|NCT00593736|454293973|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
126273909|NCT00593736|454293974|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
126273910|NCT00593736|454293975|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
126273911|NCT00593736|454293972|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
126273912|NCT00593736|454293973|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
126273913|NCT00593736|454293974|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
126273914|NCT00593736|454293975|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
126273915|NCT00593736|454293972|FG000|Treatment Period and Placebo Run-out|Various|1|||
126273916|NCT00593736|454293973|FG001|Treatment Period and Placebo Run-out|Various|1|||
126273917|NCT00593736|454293974|FG002|Treatment Period and Placebo Run-out|Various|1|||
126273918|NCT00593736|454293975|FG003|Treatment Period and Placebo Run-out|Various|0|||
126273919|NCT01857271|454293976|FG000|Overall Study|Lost to Follow-up|1|||
126273920|NCT03493386|454293977|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126273921|NCT03493386|454293978|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
126037463|NCT04171141|453436670|FG011|Overall Study|Withdrawal by Subject|0|||
126037464|NCT04171141|453436671|FG012|Overall Study|Withdrawal by Subject|0|||
126037465|NCT04171141|453436672|FG013|Overall Study|Withdrawal by Subject|0|||
126037466|NCT04171141|453436673|FG014|Overall Study|Withdrawal by Subject|0|||
126273922|NCT03493386|454293979|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126273923|NCT03493386|454293980|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126273924|NCT03825341|454293981|FG000|Overall Study|Withdrawal by Subject|0|||
126273925|NCT03825341|454293982|FG001|Overall Study|Withdrawal by Subject|1|||
126273926|NCT00289536|454293984|FG000|Period 3|Lost to Follow-up|0|||
126037467|NCT04171141|453436674|FG015|Overall Study|Withdrawal by Subject|0|||
126273927|NCT00289536|454293985|FG001|Period 3|Lost to Follow-up|0|||
126273928|NCT00289536|454293986|FG002|Period 3|Lost to Follow-up|1|||
126273929|NCT02116608|454293988|FG000|Overall Study|Lost to Follow-up|0|||
126273930|NCT02116608|454293989|FG001|Overall Study|Lost to Follow-up|0|||
126273931|NCT02116608|454293990|FG002|Overall Study|Lost to Follow-up|1|||
126273932|NCT02116608|454293988|FG000|Overall Study|Physician Decision|0|||
126273933|NCT02116608|454293989|FG001|Overall Study|Physician Decision|1|||
126273934|NCT02116608|454293990|FG002|Overall Study|Physician Decision|0|||
126273935|NCT02116608|454293988|FG000|Overall Study|Death|0|||
126273936|NCT02116608|454293989|FG001|Overall Study|Death|1|||
126273937|NCT02116608|454293990|FG002|Overall Study|Death|0|||
126273938|NCT04053465|454293994|FG000|Overall Study|Withdrawal by Subject|4|||
126273939|NCT04053465|454293995|FG001|Overall Study|Withdrawal by Subject|4|||
126273940|NCT02338193|454293997|FG000|Overall Study|Withdrawal by Subject|0|||
126273941|NCT02338193|454293998|FG001|Overall Study|Withdrawal by Subject|0|||
126273942|NCT02338193|454293999|FG002|Overall Study|Withdrawal by Subject|2|||
126273943|NCT02338193|454293997|FG000|Overall Study|Pregnancy|0|||
126273944|NCT02338193|454293998|FG001|Overall Study|Pregnancy|1|||
126273945|NCT02338193|454293999|FG002|Overall Study|Pregnancy|1|||
126273946|NCT02338193|454293997|FG000|Overall Study|Noncompliant with visits|2|||
126273947|NCT02338193|454293998|FG001|Overall Study|Noncompliant with visits|2|||
126273948|NCT02338193|454293999|FG002|Overall Study|Noncompliant with visits|7|||
126273949|NCT02338193|454293997|FG000|Overall Study|moved out of state|0|||
126273950|NCT02338193|454293998|FG001|Overall Study|moved out of state|1|||
126273951|NCT02338193|454293999|FG002|Overall Study|moved out of state|0|||
126273952|NCT02338193|454293997|FG000|Overall Study|intolerant of side effects|1|||
126273953|NCT02338193|454293998|FG001|Overall Study|intolerant of side effects|0|||
126273954|NCT02338193|454293999|FG002|Overall Study|intolerant of side effects|0|||
126273955|NCT01140503|454294001|FG000|Overall Study|Withdrawal by Subject|1|||
126273956|NCT03201211|454294002|FG000|Overall Study|Adverse Event|1|||
126273957|NCT03201211|454294003|FG001|Overall Study|Adverse Event|0|||
126273958|NCT03201211|454294004|FG002|Overall Study|Adverse Event|0|||
126273959|NCT03201211|454294002|FG000|Overall Study|Protocol Violation|1|||
126273960|NCT03201211|454294003|FG001|Overall Study|Protocol Violation|0|||
126273961|NCT03201211|454294004|FG002|Overall Study|Protocol Violation|0|||
126273962|NCT03201211|454294002|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126273963|NCT03201211|454294003|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126273964|NCT03201211|454294004|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
126273965|NCT03201211|454294002|FG000|Overall Study|OTHER unknown reasons|0|||
126273966|NCT03201211|454294003|FG001|Overall Study|OTHER unknown reasons|1|||
126273967|NCT03201211|454294004|FG002|Overall Study|OTHER unknown reasons|0|||
126273968|NCT01083810|454294005|FG000|Overall Study|Lost to Follow-up|23|||
126273969|NCT01083810|454294006|FG001|Overall Study|Lost to Follow-up|11|||
126273970|NCT01083810|454294007|FG002|Overall Study|Lost to Follow-up|4|||
126273971|NCT01083810|454294005|FG000|Overall Study|Adverse Event|15|||
126273972|NCT01083810|454294006|FG001|Overall Study|Adverse Event|11|||
126273973|NCT01083810|454294007|FG002|Overall Study|Adverse Event|4|||
126273974|NCT01083810|454294005|FG000|Overall Study|Withdrawal by Subject|7|||
126273975|NCT01083810|454294006|FG001|Overall Study|Withdrawal by Subject|2|||
126273976|NCT01083810|454294007|FG002|Overall Study|Withdrawal by Subject|4|||
126273977|NCT01083810|454294005|FG000|Overall Study|Reason not reported|6|||
126273978|NCT01083810|454294006|FG001|Overall Study|Reason not reported|1|||
126273979|NCT01083810|454294007|FG002|Overall Study|Reason not reported|1|||
126273980|NCT01083810|454294005|FG000|Overall Study|Non-compliance|4|||
126273981|NCT01083810|454294006|FG001|Overall Study|Non-compliance|7|||
126273982|NCT01083810|454294007|FG002|Overall Study|Non-compliance|2|||
126273983|NCT01083810|454294005|FG000|Overall Study|Simplification|4|||
126273984|NCT01083810|454294006|FG001|Overall Study|Simplification|1|||
126273985|NCT01083810|454294007|FG002|Overall Study|Simplification|0|||
126273986|NCT01083810|454294005|FG000|Overall Study|Death|2|||
126273987|NCT01083810|454294006|FG001|Overall Study|Death|2|||
126273988|NCT01083810|454294007|FG002|Overall Study|Death|3|||
126273989|NCT01083810|454294005|FG000|Overall Study|Co-morbidities|1|||
126273990|NCT01083810|454294006|FG001|Overall Study|Co-morbidities|0|||
126273991|NCT01083810|454294007|FG002|Overall Study|Co-morbidities|0|||
126273992|NCT01083810|454294005|FG000|Overall Study|Participation in study|1|||
126273993|NCT01083810|454294006|FG001|Overall Study|Participation in study|0|||
126273994|NCT01083810|454294007|FG002|Overall Study|Participation in study|0|||
126273995|NCT01083810|454294005|FG000|Overall Study|Therapy break|1|||
126273996|NCT01083810|454294006|FG001|Overall Study|Therapy break|2|||
126273997|NCT01083810|454294007|FG002|Overall Study|Therapy break|2|||
126273998|NCT01083810|454294005|FG000|Overall Study|Virologic failure|1|||
126273999|NCT01083810|454294006|FG001|Overall Study|Virologic failure|8|||
126274000|NCT01083810|454294007|FG002|Overall Study|Virologic failure|0|||
126274001|NCT02991430|454294010|FG000|Treatment Period 1|Adverse Event|1|||
126274002|NCT02991430|454294011|FG001|Treatment Period 1|Adverse Event|0|||
126274003|NCT02991430|454294012|FG002|Treatment Period 1|Adverse Event|2|||
126274004|NCT02991430|454294010|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126274005|NCT02991430|454294011|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126274006|NCT02991430|454294012|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126274007|NCT02991430|454294010|FG000|Treatment Period 2|Study Termination|6|||
126274008|NCT02991430|454294011|FG001|Treatment Period 2|Study Termination|3|||
126274009|NCT02991430|454294012|FG002|Treatment Period 2|Study Termination|3|||
126274010|NCT02991430|454294010|FG000|Treatment Period 2|Lost to Follow-up|0|||
126274011|NCT02991430|454294011|FG001|Treatment Period 2|Lost to Follow-up|0|||
126274012|NCT02991430|454294012|FG002|Treatment Period 2|Lost to Follow-up|1|||
126274013|NCT02991430|454294010|FG000|Post-treatment Observation Period|Study Termination|3|||
126274014|NCT02991430|454294011|FG001|Post-treatment Observation Period|Study Termination|6|||
126274015|NCT02991430|454294012|FG002|Post-treatment Observation Period|Study Termination|5|||
126274016|NCT03118570|454294013|FG000|Overall Study|Adverse Event|2|||
126274017|NCT03118570|454294014|FG001|Overall Study|Adverse Event|0|||
126274018|NCT03118570|454294015|FG002|Overall Study|Adverse Event|0|||
126274019|NCT03118570|454294016|FG003|Overall Study|Adverse Event|0|||
126274020|NCT03118570|454294017|FG004|Overall Study|Adverse Event|3|||
126274021|NCT03118570|454294013|FG000|Overall Study|Withdrawal by Subject|0|||
126274022|NCT03118570|454294014|FG001|Overall Study|Withdrawal by Subject|1|||
126274023|NCT03118570|454294015|FG002|Overall Study|Withdrawal by Subject|4|||
126274024|NCT03118570|454294016|FG003|Overall Study|Withdrawal by Subject|0|||
126274025|NCT03118570|454294017|FG004|Overall Study|Withdrawal by Subject|1|||
126274026|NCT03118570|454294013|FG000|Overall Study|Lost to Follow-up|2|||
126274027|NCT03118570|454294014|FG001|Overall Study|Lost to Follow-up|3|||
126274028|NCT03118570|454294015|FG002|Overall Study|Lost to Follow-up|1|||
126274029|NCT03118570|454294016|FG003|Overall Study|Lost to Follow-up|0|||
126274030|NCT03118570|454294017|FG004|Overall Study|Lost to Follow-up|1|||
126274031|NCT03118570|454294013|FG000|Overall Study|Other, Not Specified|1|||
126274032|NCT03118570|454294014|FG001|Overall Study|Other, Not Specified|3|||
126274033|NCT03118570|454294015|FG002|Overall Study|Other, Not Specified|0|||
126274034|NCT03118570|454294016|FG003|Overall Study|Other, Not Specified|0|||
126274035|NCT03118570|454294017|FG004|Overall Study|Other, Not Specified|0|||
126274036|NCT03970837|454294018|FG000|Overall Study|Adverse Event|23|||
126274037|NCT03970837|454294019|FG001|Overall Study|Adverse Event|20|||
126274038|NCT03970837|454294020|FG002|Overall Study|Adverse Event|16|||
126274039|NCT03970837|454294021|FG003|Overall Study|Adverse Event|6|||
126274040|NCT03970837|454294022|FG004|Overall Study|Adverse Event|4|||
126274041|NCT03970837|454294023|FG005|Overall Study|Adverse Event|5|||
126274042|NCT03970837|454294024|FG006|Overall Study|Adverse Event|1|||
126274043|NCT03970837|454294025|FG007|Overall Study|Adverse Event|5|||
126274044|NCT03970837|454294026|FG008|Overall Study|Adverse Event|0|||
126274045|NCT03970837|454294027|FG009|Overall Study|Adverse Event|0|||
126274046|NCT03970837|454294028|FG010|Overall Study|Adverse Event|1|||
126274047|NCT03970837|454294029|FG011|Overall Study|Adverse Event|1|||
126274048|NCT03970837|454294018|FG000|Overall Study|Lack of Efficacy|14|||
126274049|NCT03970837|454294019|FG001|Overall Study|Lack of Efficacy|12|||
126274050|NCT03970837|454294020|FG002|Overall Study|Lack of Efficacy|1|||
126274051|NCT03970837|454294021|FG003|Overall Study|Lack of Efficacy|2|||
126274052|NCT03970837|454294022|FG004|Overall Study|Lack of Efficacy|3|||
126274053|NCT03970837|454294023|FG005|Overall Study|Lack of Efficacy|4|||
126274054|NCT03970837|454294024|FG006|Overall Study|Lack of Efficacy|6|||
126274055|NCT03970837|454294025|FG007|Overall Study|Lack of Efficacy|1|||
126274056|NCT03970837|454294026|FG008|Overall Study|Lack of Efficacy|1|||
126274057|NCT03970837|454294027|FG009|Overall Study|Lack of Efficacy|0|||
126274058|NCT03970837|454294028|FG010|Overall Study|Lack of Efficacy|0|||
126274059|NCT03970837|454294029|FG011|Overall Study|Lack of Efficacy|0|||
126274060|NCT03970837|454294018|FG000|Overall Study|Lost to Follow-up|6|||
126274061|NCT03970837|454294019|FG001|Overall Study|Lost to Follow-up|5|||
126274062|NCT03970837|454294020|FG002|Overall Study|Lost to Follow-up|5|||
126274063|NCT03970837|454294021|FG003|Overall Study|Lost to Follow-up|1|||
126274064|NCT03970837|454294022|FG004|Overall Study|Lost to Follow-up|0|||
126362348|NCT00968968|454619139|FG001|Overall Study|Protocol defined stopping criteria|1|||
126362349|NCT00968968|454619138|FG000|Overall Study|Withdrawal by Subject|2|||
126274065|NCT03970837|454294023|FG005|Overall Study|Lost to Follow-up|2|||
126274066|NCT03970837|454294024|FG006|Overall Study|Lost to Follow-up|0|||
126274067|NCT03970837|454294025|FG007|Overall Study|Lost to Follow-up|0|||
126274068|NCT03970837|454294026|FG008|Overall Study|Lost to Follow-up|0|||
126037468|NCT04171141|453436659|FG000|Overall Study|Global deterioration of health status|0|||
126037469|NCT04171141|453436660|FG001|Overall Study|Global deterioration of health status|0|||
126274069|NCT03970837|454294027|FG009|Overall Study|Lost to Follow-up|0|||
126274070|NCT03970837|454294028|FG010|Overall Study|Lost to Follow-up|0|||
126274071|NCT03970837|454294029|FG011|Overall Study|Lost to Follow-up|0|||
126274072|NCT03970837|454294018|FG000|Overall Study|Protocol Violation|1|||
126274073|NCT03970837|454294019|FG001|Overall Study|Protocol Violation|0|||
126274074|NCT03970837|454294020|FG002|Overall Study|Protocol Violation|0|||
126274075|NCT03970837|454294021|FG003|Overall Study|Protocol Violation|0|||
126274076|NCT03970837|454294022|FG004|Overall Study|Protocol Violation|0|||
126274077|NCT03970837|454294023|FG005|Overall Study|Protocol Violation|0|||
126274078|NCT03970837|454294024|FG006|Overall Study|Protocol Violation|0|||
126274079|NCT03970837|454294025|FG007|Overall Study|Protocol Violation|0|||
126362350|NCT00968968|454619139|FG001|Overall Study|Withdrawal by Subject|0|||
126362351|NCT00968968|454619138|FG000|Overall Study|Physician Decision|1|||
126362352|NCT00968968|454619139|FG001|Overall Study|Physician Decision|2|||
126362353|NCT00968968|454619138|FG000|Overall Study|Lost to Follow-up|0|||
126362354|NCT00968968|454619139|FG001|Overall Study|Lost to Follow-up|1|||
126362355|NCT03624036|454619140|FG000|Overall Study|Death|2|||
126362356|NCT03624036|454619141|FG001|Overall Study|Death|3|||
126362357|NCT03624036|454619142|FG002|Overall Study|Death|0|||
126362358|NCT03624036|454619143|FG003|Overall Study|Death|1|||
126362359|NCT03624036|454619140|FG000|Overall Study|Withdrawal by Subject|1|||
126362360|NCT03624036|454619141|FG001|Overall Study|Withdrawal by Subject|0|||
126362361|NCT03624036|454619142|FG002|Overall Study|Withdrawal by Subject|1|||
126362362|NCT03624036|454619143|FG003|Overall Study|Withdrawal by Subject|0|||
126362363|NCT03624036|454619140|FG000|Overall Study|Enrolled but Never Treated|1|||
126362364|NCT03624036|454619141|FG001|Overall Study|Enrolled but Never Treated|0|||
126362365|NCT03624036|454619142|FG002|Overall Study|Enrolled but Never Treated|0|||
126362366|NCT03624036|454619143|FG003|Overall Study|Enrolled but Never Treated|0|||
126362367|NCT03624036|454619140|FG000|Overall Study|Reason not Specified|3|||
126362368|NCT03624036|454619141|FG001|Overall Study|Reason not Specified|0|||
126362369|NCT03624036|454619142|FG002|Overall Study|Reason not Specified|2|||
126362370|NCT03624036|454619143|FG003|Overall Study|Reason not Specified|2|||
126362371|NCT01185366|454619144|FG000|First Line Therapy|Insurance Coverage Denied|1|||
126362372|NCT01185366|454619145|FG001|First Line Therapy|Insurance Coverage Denied|1|||
126362373|NCT01185366|454619144|FG000|First Line Therapy|Withdrawal by Subject|1|||
126362374|NCT01185366|454619145|FG001|First Line Therapy|Withdrawal by Subject|0|||
126362375|NCT01185366|454619144|FG000|First Line Therapy|Lack of Metastatic Site|1|||
126362376|NCT01185366|454619145|FG001|First Line Therapy|Lack of Metastatic Site|0|||
126362377|NCT01185366|454619144|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
126362378|NCT01185366|454619145|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
126362379|NCT01185366|454619144|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
126362380|NCT01185366|454619145|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
126362381|NCT01185366|454619144|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
126362382|NCT01185366|454619145|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
126362383|NCT01185366|454619144|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
126362384|NCT01185366|454619145|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
126362385|NCT02774278|454619146|FG000|Overall Study|Lack of Efficacy|199|||
126362386|NCT02774278|454619146|FG000|Overall Study|Death|29|||
126362387|NCT02774278|454619146|FG000|Overall Study|Adverse event/intercurrent illness|16|||
126362388|NCT02774278|454619146|FG000|Overall Study|Refused treatment/did not cooperate|9|||
126362389|NCT02774278|454619146|FG000|Overall Study|Administrative reasons|6|||
126362390|NCT02774278|454619146|FG000|Overall Study|Withdrawal by Subject|3|||
126362391|NCT02774278|454619146|FG000|Overall Study|Protocol Violation|2|||
126362392|NCT00127933|454619153|FG000|Overall Study|Randomized but not dosed|1|||
126362393|NCT00127933|454619154|FG001|Overall Study|Randomized but not dosed|0|||
126362394|NCT01783938|454619156|FG000|Overall Study|Disease Progression|18|||
126362395|NCT01783938|454619157|FG001|Overall Study|Disease Progression|41|||
126362396|NCT01783938|454619156|FG000|Overall Study|Study Drug Toxicity|27|||
126362397|NCT01783938|454619157|FG001|Overall Study|Study Drug Toxicity|14|||
126362398|NCT01783938|454619156|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
126362399|NCT01783938|454619157|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
126362400|NCT01783938|454619156|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
126362401|NCT01783938|454619157|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
126362402|NCT01783938|454619156|FG000|Overall Study|Participant Withdrew Consent|2|||
126362403|NCT01783938|454619157|FG001|Overall Study|Participant Withdrew Consent|0|||
126362404|NCT01783938|454619156|FG000|Overall Study|Maximum Clinical Benefit|1|||
126362405|NCT01783938|454619157|FG001|Overall Study|Maximum Clinical Benefit|0|||
126362406|NCT01783938|454619156|FG000|Overall Study|Other Reasons|3|||
126362407|NCT01783938|454619157|FG001|Overall Study|Other Reasons|1|||
126362408|NCT03072875|454619162|FG000|Overall Study|Lost to Follow-up|1|||
126362409|NCT03478787|454619163|FG000|Overall Study|Adverse Event|5|||
126362410|NCT03478787|454619164|FG001|Overall Study|Adverse Event|1|||
126362411|NCT03478787|454619163|FG000|Overall Study|Protocol Violation|3|||
126362412|NCT03478787|454619164|FG001|Overall Study|Protocol Violation|0|||
126362413|NCT03478787|454619163|FG000|Overall Study|Lack of Efficacy|7|||
126362414|NCT03478787|454619164|FG001|Overall Study|Lack of Efficacy|1|||
126362415|NCT03478787|454619163|FG000|Overall Study|Lost to Follow-up|9|||
126362416|NCT03478787|454619164|FG001|Overall Study|Lost to Follow-up|5|||
126362417|NCT03478787|454619163|FG000|Overall Study|Withdrawal by Subject|2|||
126362418|NCT03478787|454619164|FG001|Overall Study|Withdrawal by Subject|6|||
126362419|NCT03478787|454619163|FG000|Overall Study|Other, Not Specified|3|||
126362420|NCT03478787|454619164|FG001|Overall Study|Other, Not Specified|0|||
126362421|NCT02413346|454619167|FG000|Overall Study|Adverse Event|6|||
126362422|NCT02413346|454619168|FG001|Overall Study|Adverse Event|6|||
126362423|NCT02413346|454619167|FG000|Overall Study|Withdrawal by Subject|30|||
126362424|NCT02413346|454619168|FG001|Overall Study|Withdrawal by Subject|40|||
126274080|NCT03970837|454294026|FG008|Overall Study|Protocol Violation|0|||
126274081|NCT03970837|454294027|FG009|Overall Study|Protocol Violation|0|||
126274082|NCT03970837|454294028|FG010|Overall Study|Protocol Violation|0|||
126274083|NCT03970837|454294029|FG011|Overall Study|Protocol Violation|0|||
126274084|NCT03970837|454294018|FG000|Overall Study|Physician Decision|5|||
126274085|NCT03970837|454294019|FG001|Overall Study|Physician Decision|8|||
126274086|NCT03970837|454294020|FG002|Overall Study|Physician Decision|4|||
126274087|NCT03970837|454294021|FG003|Overall Study|Physician Decision|1|||
126274088|NCT03970837|454294022|FG004|Overall Study|Physician Decision|5|||
126274089|NCT03970837|454294023|FG005|Overall Study|Physician Decision|2|||
126274090|NCT03970837|454294024|FG006|Overall Study|Physician Decision|4|||
126274091|NCT03970837|454294025|FG007|Overall Study|Physician Decision|5|||
126274092|NCT03970837|454294026|FG008|Overall Study|Physician Decision|0|||
126274093|NCT03970837|454294027|FG009|Overall Study|Physician Decision|1|||
126274094|NCT03970837|454294028|FG010|Overall Study|Physician Decision|0|||
126274095|NCT03970837|454294029|FG011|Overall Study|Physician Decision|0|||
126274096|NCT03970837|454294018|FG000|Overall Study|Withdrawal by Subject|32|||
126274097|NCT03970837|454294019|FG001|Overall Study|Withdrawal by Subject|35|||
126274098|NCT03970837|454294020|FG002|Overall Study|Withdrawal by Subject|12|||
126274099|NCT03970837|454294021|FG003|Overall Study|Withdrawal by Subject|8|||
126274100|NCT03970837|454294022|FG004|Overall Study|Withdrawal by Subject|6|||
126274101|NCT03970837|454294023|FG005|Overall Study|Withdrawal by Subject|8|||
126274102|NCT03970837|454294024|FG006|Overall Study|Withdrawal by Subject|2|||
126274103|NCT03970837|454294025|FG007|Overall Study|Withdrawal by Subject|3|||
126274104|NCT03970837|454294026|FG008|Overall Study|Withdrawal by Subject|0|||
126274105|NCT03970837|454294027|FG009|Overall Study|Withdrawal by Subject|0|||
126274106|NCT03970837|454294028|FG010|Overall Study|Withdrawal by Subject|0|||
126274107|NCT03970837|454294029|FG011|Overall Study|Withdrawal by Subject|1|||
126274108|NCT03970837|454294018|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
126274109|NCT03970837|454294019|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
126274110|NCT03970837|454294020|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
126274111|NCT03970837|454294021|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126274112|NCT03970837|454294022|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
126274113|NCT03970837|454294023|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126274114|NCT03970837|454294024|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126274115|NCT03970837|454294025|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126274116|NCT03970837|454294026|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126274117|NCT03970837|454294027|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126274118|NCT03970837|454294028|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126274119|NCT03970837|454294029|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126274120|NCT03970837|454294018|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274121|NCT03970837|454294019|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274122|NCT03970837|454294020|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274123|NCT03970837|454294021|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274124|NCT03970837|454294022|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274125|NCT03970837|454294023|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274126|NCT03970837|454294024|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
126274127|NCT03970837|454294025|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
126274128|NCT03970837|454294026|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
126274129|NCT03970837|454294027|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
126274130|NCT03970837|454294028|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
126274131|NCT03970837|454294029|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
126274132|NCT00477295|454294032|FG000|Overall Study|Adverse Event|31|||
126274133|NCT00477295|454294033|FG001|Overall Study|Adverse Event|35|||
126274134|NCT00477295|454294032|FG000|Overall Study|Withdrawal by Subject|35|||
126274135|NCT00477295|454294033|FG001|Overall Study|Withdrawal by Subject|24|||
126274136|NCT00477295|454294032|FG000|Overall Study|Lack of Efficacy|23|||
126274137|NCT00477295|454294033|FG001|Overall Study|Lack of Efficacy|23|||
126274138|NCT00477295|454294032|FG000|Overall Study|Protocol Violation|3|||
126274139|NCT00477295|454294033|FG001|Overall Study|Protocol Violation|8|||
126274140|NCT00477295|454294032|FG000|Overall Study|Physician Decision|4|||
126274141|NCT00477295|454294033|FG001|Overall Study|Physician Decision|5|||
126274142|NCT00477295|454294032|FG000|Overall Study|Lost to Follow-up|21|||
126274143|NCT00477295|454294033|FG001|Overall Study|Lost to Follow-up|11|||
126274144|NCT00477295|454294032|FG000|Overall Study|Other|4|||
126274145|NCT00477295|454294033|FG001|Overall Study|Other|3|||
126274146|NCT04568031|454294034|FG000|Overall Study|Lost to Follow-up|1|||
126274147|NCT04568031|454294035|FG001|Overall Study|Lost to Follow-up|0|||
126274148|NCT04568031|454294036|FG002|Overall Study|Lost to Follow-up|0|||
126274149|NCT04568031|454294037|FG003|Overall Study|Lost to Follow-up|0|||
126274150|NCT04568031|454294034|FG000|Overall Study|Physician Decision|1|||
126274151|NCT04568031|454294035|FG001|Overall Study|Physician Decision|0|||
126037470|NCT04171141|453436661|FG002|Overall Study|Global deterioration of health status|0|||
126274152|NCT04568031|454294036|FG002|Overall Study|Physician Decision|1|||
126274153|NCT04568031|454294037|FG003|Overall Study|Physician Decision|0|||
126274154|NCT04568031|454294034|FG000|Overall Study|Withdrawal by Subject|1|||
126274155|NCT04568031|454294035|FG001|Overall Study|Withdrawal by Subject|0|||
126274156|NCT04568031|454294036|FG002|Overall Study|Withdrawal by Subject|4|||
126274157|NCT04568031|454294037|FG003|Overall Study|Withdrawal by Subject|1|||
126274158|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
126274159|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
126274160|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
126274161|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
126274162|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
126274163|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
126274164|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
126274165|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
126274166|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Other|0|||
126274167|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Other|1|||
126274168|NCT04430855|454294038|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
126274169|NCT04430855|454294039|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
126274170|NCT04430855|454294038|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
126274171|NCT04430855|454294039|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
126274172|NCT04430855|454294038|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
126274173|NCT04430855|454294039|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
126274174|NCT01425723|454294040|FG000|Overall Study|Lack of Efficacy|0|||
126274175|NCT01425723|454294041|FG001|Overall Study|Lack of Efficacy|1|||
126274176|NCT01425723|454294040|FG000|Overall Study|Withdrawal by Subject|1|||
126274177|NCT01425723|454294041|FG001|Overall Study|Withdrawal by Subject|4|||
126274178|NCT01425723|454294040|FG000|Overall Study|Lost to Follow-up|0|||
126274179|NCT01425723|454294041|FG001|Overall Study|Lost to Follow-up|3|||
126274180|NCT01425723|454294040|FG000|Overall Study|Physician Decision|2|||
126274181|NCT01425723|454294041|FG001|Overall Study|Physician Decision|0|||
126274182|NCT01425723|454294040|FG000|Overall Study|Other|1|||
126274183|NCT01425723|454294041|FG001|Overall Study|Other|10|||
126274184|NCT00186043|454294042|FG000|Overall Study|Lack of Efficacy|1|||
126274185|NCT00186043|454294043|FG001|Overall Study|Lack of Efficacy|3|||
126274186|NCT00186043|454294042|FG000|Overall Study|Lost to Follow-up|4|||
126274187|NCT00186043|454294043|FG001|Overall Study|Lost to Follow-up|6|||
126274188|NCT00186043|454294042|FG000|Overall Study|Withdrawal by Subject|1|||
126274189|NCT00186043|454294043|FG001|Overall Study|Withdrawal by Subject|0|||
126274190|NCT00186043|454294042|FG000|Overall Study|Adverse Event|7|||
126274191|NCT00186043|454294043|FG001|Overall Study|Adverse Event|3|||
126274192|NCT00186043|454294042|FG000|Overall Study|Protocol Violation|2|||
126274193|NCT00186043|454294043|FG001|Overall Study|Protocol Violation|1|||
126274194|NCT04874636|454294044|FG000|Overall Study|Adverse Event|17|||
126274195|NCT04874636|454294045|FG001|Overall Study|Adverse Event|7|||
126274196|NCT04874636|454294044|FG000|Overall Study|Lost to Follow-up|1|||
126274197|NCT04874636|454294045|FG001|Overall Study|Lost to Follow-up|0|||
126274198|NCT04874636|454294044|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126274199|NCT04874636|454294045|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126274200|NCT04874636|454294044|FG000|Overall Study|Physician Decision|1|||
126274201|NCT04874636|454294045|FG001|Overall Study|Physician Decision|0|||
126274202|NCT04874636|454294044|FG000|Overall Study|Withdrawal by Subject|6|||
126274203|NCT04874636|454294045|FG001|Overall Study|Withdrawal by Subject|5|||
126274204|NCT00228423|454294048|FG000|Overall Study|Adverse Event|2|||
126274205|NCT00228423|454294049|FG001|Overall Study|Adverse Event|5|||
126274206|NCT00228423|454294048|FG000|Overall Study|Withdrawal by Subject|7|||
126274207|NCT00228423|454294049|FG001|Overall Study|Withdrawal by Subject|3|||
126274208|NCT00228423|454294048|FG000|Overall Study|Protocol Violation|1|||
126274209|NCT00228423|454294049|FG001|Overall Study|Protocol Violation|3|||
126274210|NCT00228423|454294048|FG000|Overall Study|Physician Decision|0|||
126274211|NCT00228423|454294049|FG001|Overall Study|Physician Decision|1|||
126274212|NCT03258853|454294063|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
126274213|NCT03258853|454294064|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
126037471|NCT04171141|453436662|FG003|Overall Study|Global deterioration of health status|1|||
126274214|NCT03870477|454294065|FG000|Overall Study|Early Study Termination|1|||
126274215|NCT01709838|454294068|FG000|Overall Study|Withdrawal by Subject|21|||
126274216|NCT01709838|454294068|FG000|Overall Study|Lost to Follow-up|16|||
126274217|NCT01709838|454294068|FG000|Overall Study|Pregnancy|10|||
126274218|NCT01709838|454294068|FG000|Overall Study|Subject/guardian decision|8|||
126274219|NCT01709838|454294068|FG000|Overall Study|Adverse Event|4|||
126274220|NCT01709838|454294068|FG000|Overall Study|Physician Decision|4|||
126274221|NCT01709838|454294068|FG000|Overall Study|Death|3|||
126274222|NCT01709838|454294068|FG000|Overall Study|Protocol Violation|1|||
126274223|NCT03753763|454294076|FG000|Overall Study|Adverse Event|2|||
126274224|NCT03753763|454294077|FG001|Overall Study|Adverse Event|0|||
126274225|NCT03753763|454294076|FG000|Overall Study|Withdrawal by Subject|3|||
126274226|NCT03753763|454294077|FG001|Overall Study|Withdrawal by Subject|1|||
126274227|NCT03753763|454294076|FG000|Overall Study|clinical deterioration|1|||
126274228|NCT03753763|454294077|FG001|Overall Study|clinical deterioration|0|||
126274229|NCT00389831|454294078|FG000|Overall Study|Lack of Efficacy|0|||
126274230|NCT00389831|454294079|FG001|Overall Study|Lack of Efficacy|2|||
126274231|NCT00389831|454294078|FG000|Overall Study|Did not receive treatment.|0|||
126274232|NCT00389831|454294079|FG001|Overall Study|Did not receive treatment.|2|||
126274233|NCT00389831|454294078|FG000|Overall Study|Other reasons|0|||
126274234|NCT00389831|454294079|FG001|Overall Study|Other reasons|2|||
126274235|NCT00389831|454294078|FG000|Overall Study|Lost to Follow-up|0|||
126274236|NCT00389831|454294079|FG001|Overall Study|Lost to Follow-up|1|||
126274237|NCT03433755|454294080|FG000|Overall Study|Lost to Follow-up|1|||
126274238|NCT03433755|454294081|FG001|Overall Study|Lost to Follow-up|0|||
126274239|NCT03433755|454294082|FG002|Overall Study|Lost to Follow-up|0|||
126274240|NCT03433755|454294083|FG003|Overall Study|Lost to Follow-up|0|||
126274241|NCT03433755|454294080|FG000|Overall Study|Decision by Sponsor|1|||
126274242|NCT03433755|454294081|FG001|Overall Study|Decision by Sponsor|0|||
126274243|NCT03433755|454294082|FG002|Overall Study|Decision by Sponsor|0|||
126274244|NCT03433755|454294083|FG003|Overall Study|Decision by Sponsor|0|||
126274245|NCT04941729|454296407|FG000|Overall Study|Death|0|||
126274246|NCT04941729|454296408|FG001|Overall Study|Death|1|||
126274247|NCT04941729|454296407|FG000|Overall Study|Study terminated by sponsor|11|||
126274248|NCT04941729|454296408|FG001|Overall Study|Study terminated by sponsor|10|||
126274249|NCT03190330|454296410|FG000|Overall Study|Adverse Event|2|||
126274250|NCT03190330|454296410|FG000|Overall Study|Death|10|||
126274251|NCT03190330|454296410|FG000|Overall Study|Lost to Follow-up|1|||
126274252|NCT03190330|454296410|FG000|Overall Study|Withdrawal by Subject|6|||
126274253|NCT03190330|454296410|FG000|Overall Study|Progressive Disease|1|||
126274254|NCT03845296|454296419|FG000|Overall Study|On Treatment|2|||
126274255|NCT03845296|454296420|FG001|Overall Study|On Treatment|1|||
126274256|NCT03845296|454296419|FG000|Overall Study|Adverse Event|4|||
126274257|NCT03845296|454296420|FG001|Overall Study|Adverse Event|11|||
126274258|NCT03845296|454296419|FG000|Overall Study|Refusal unrelated to adverse event|0|||
126274259|NCT03845296|454296420|FG001|Overall Study|Refusal unrelated to adverse event|1|||
126274260|NCT03845296|454296419|FG000|Overall Study|Progression/relapse|14|||
126274261|NCT03845296|454296420|FG001|Overall Study|Progression/relapse|18|||
126274262|NCT03845296|454296419|FG000|Overall Study|Death|4|||
126274263|NCT03845296|454296420|FG001|Overall Study|Death|0|||
126274264|NCT03845296|454296419|FG000|Overall Study|Other - not protocol specified|1|||
126274265|NCT03845296|454296420|FG001|Overall Study|Other - not protocol specified|3|||
126274266|NCT02081209|454296423|FG000|Overall Study|Withdrawal by Subject|1|||
126274267|NCT04395001|454296430|FG000|Overall Study|Lost to Follow-up|8|||
126274268|NCT04395001|454296431|FG001|Overall Study|Lost to Follow-up|9|||
126274269|NCT04395001|454296432|FG002|Overall Study|Lost to Follow-up|5|||
126274270|NCT04395001|454296430|FG000|Overall Study|Withdrawal by Subject|3|||
126274271|NCT04395001|454296431|FG001|Overall Study|Withdrawal by Subject|1|||
126274272|NCT04395001|454296432|FG002|Overall Study|Withdrawal by Subject|3|||
126274273|NCT04395001|454296430|FG000|Overall Study|missed appointment|7|||
126274274|NCT04395001|454296431|FG001|Overall Study|missed appointment|4|||
126274275|NCT04395001|454296432|FG002|Overall Study|missed appointment|1|||
126274276|NCT04347122|454296433|FG000|Overall Study|Physician Decision|0|||
126274277|NCT04347122|454296434|FG001|Overall Study|Physician Decision|3|||
126274278|NCT04347122|454296435|FG002|Overall Study|Physician Decision|3|||
126274279|NCT04347122|454296436|FG003|Overall Study|Physician Decision|6|||
126274280|NCT04994483|454296437|FG000|Overall Study|Adverse Event|26|||
126274281|NCT04994483|454296438|FG001|Overall Study|Adverse Event|17|||
126274282|NCT04994483|454296437|FG000|Overall Study|Lost to Follow-up|6|||
126274283|NCT04994483|454296438|FG001|Overall Study|Lost to Follow-up|10|||
126274284|NCT04994483|454296437|FG000|Overall Study|Noncompliance with study drug|8|||
126274285|NCT04994483|454296438|FG001|Overall Study|Noncompliance with study drug|5|||
126274286|NCT04994483|454296437|FG000|Overall Study|Physician Decision|5|||
126274287|NCT04994483|454296438|FG001|Overall Study|Physician Decision|0|||
126274288|NCT04994483|454296437|FG000|Overall Study|Withdrawal by Subject|41|||
126274289|NCT04994483|454296438|FG001|Overall Study|Withdrawal by Subject|38|||
126037472|NCT04171141|453436663|FG004|Overall Study|Global deterioration of health status|0|||
126274290|NCT04994483|454296437|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
126274291|NCT04994483|454296438|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
126274292|NCT04994483|454296437|FG000|Overall Study|Met stopping criteria|1|||
126274293|NCT04994483|454296438|FG001|Overall Study|Met stopping criteria|0|||
126274294|NCT04994483|454296437|FG000|Overall Study|Randomized in error, not treated|4|||
126274295|NCT04994483|454296438|FG001|Overall Study|Randomized in error, not treated|3|||
126274296|NCT04994483|454296437|FG000|Overall Study|Lack of a reliable study partner|0|||
126274297|NCT04994483|454296438|FG001|Overall Study|Lack of a reliable study partner|1|||
126274298|NCT04994483|454296437|FG000|Overall Study|Met MRI exclusion criteria|0|||
126274299|NCT04994483|454296438|FG001|Overall Study|Met MRI exclusion criteria|1|||
126098604|NCT02930226|453653058|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
126098605|NCT02930226|453653059|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
126098606|NCT02930226|453653060|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
126274300|NCT03589768|454296443|FG000|Overall Study|Death|1|||
126274301|NCT03589768|454296444|FG001|Overall Study|Death|0|||
126274302|NCT03589768|454296445|FG002|Overall Study|Death|8|||
126274303|NCT03589768|454296446|FG003|Overall Study|Death|3|||
126274304|NCT03589768|454296443|FG000|Overall Study|Withdrawal by Subject|2|||
126274305|NCT03589768|454296444|FG001|Overall Study|Withdrawal by Subject|0|||
126274306|NCT03589768|454296445|FG002|Overall Study|Withdrawal by Subject|0|||
126274307|NCT03589768|454296446|FG003|Overall Study|Withdrawal by Subject|0|||
126274308|NCT03589768|454296443|FG000|Overall Study|Protocol Violation|1|||
126274309|NCT03589768|454296444|FG001|Overall Study|Protocol Violation|0|||
126274310|NCT03589768|454296445|FG002|Overall Study|Protocol Violation|0|||
126274311|NCT03589768|454296446|FG003|Overall Study|Protocol Violation|0|||
126274312|NCT00191113|454296447|FG000|Core Study|Withdrawal by Subject|25|||
126274313|NCT00191113|454296448|FG001|Core Study|Withdrawal by Subject|9|||
126274314|NCT00191113|454296447|FG000|Core Study|Protocol Violation|6|||
126274315|NCT00191113|454296448|FG001|Core Study|Protocol Violation|2|||
126274316|NCT00191113|454296447|FG000|Core Study|Lost to Follow-up|3|||
126274317|NCT00191113|454296448|FG001|Core Study|Lost to Follow-up|0|||
126274318|NCT00191113|454296447|FG000|Core Study|Adverse Event|0|||
126274319|NCT00191113|454296448|FG001|Core Study|Adverse Event|2|||
126274320|NCT00191113|454296447|FG000|Core Study|Lack of Efficacy|0|||
126274321|NCT00191113|454296448|FG001|Core Study|Lack of Efficacy|2|||
126274322|NCT00191113|454296447|FG000|Core Study|Death|1|||
126274323|NCT00191113|454296448|FG001|Core Study|Death|0|||
126274324|NCT03786718|454296451|FG000|Overall Study|Lost to Follow-up|3|||
126274325|NCT03786718|454296451|FG000|Overall Study|Withdrawal by Subject|1|||
126274326|NCT03786718|454296451|FG000|Overall Study|Did not use the intervention|2|||
126274327|NCT03786718|454296451|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
126274328|NCT00368979|454296452|FG000|Overall Study|Adverse Event|9|||
126274329|NCT00368979|454296453|FG001|Overall Study|Adverse Event|16|||
126274330|NCT00368979|454296452|FG000|Overall Study|Lack of Efficacy|5|||
126274331|NCT00368979|454296453|FG001|Overall Study|Lack of Efficacy|3|||
126274332|NCT00368979|454296452|FG000|Overall Study|Other|3|||
126274333|NCT00368979|454296453|FG001|Overall Study|Other|1|||
126274334|NCT00368979|454296452|FG000|Overall Study|Lost to Follow-up|1|||
126274335|NCT00368979|454296453|FG001|Overall Study|Lost to Follow-up|0|||
126274336|NCT00368979|454296452|FG000|Overall Study|Protocol Violation|2|||
126274337|NCT00368979|454296453|FG001|Overall Study|Protocol Violation|1|||
126274338|NCT00368979|454296452|FG000|Overall Study|Withdrawal by Subject|5|||
126274339|NCT00368979|454296453|FG001|Overall Study|Withdrawal by Subject|9|||
126274340|NCT04645966|454296456|FG000|Vaccination Phase|Adverse Event|1|||
126274341|NCT04645966|454296457|FG001|Vaccination Phase|Adverse Event|0|||
126274342|NCT04645966|454296458|FG002|Vaccination Phase|Adverse Event|0|||
126274343|NCT04645966|454296459|FG003|Vaccination Phase|Adverse Event|0|||
126274344|NCT04645966|454296460|FG004|Vaccination Phase|Adverse Event|0|||
126274345|NCT04645966|454296461|FG005|Vaccination Phase|Adverse Event|0|||
126274346|NCT04645966|454296462|FG006|Vaccination Phase|Adverse Event|1|||
126098607|NCT02930226|453653061|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
126098608|NCT00652327|453653062|FG000|Overall Study|Adverse Event|0|||
126098609|NCT00652327|453653063|FG001|Overall Study|Adverse Event|2|||
126098610|NCT00652327|453653062|FG000|Overall Study|Lost to Follow-up|0|||
126098611|NCT00652327|453653063|FG001|Overall Study|Lost to Follow-up|3|||
126098612|NCT01076647|453653064|FG000|Overall Study|Adverse Event|4|||
126098613|NCT01076647|453653065|FG001|Overall Study|Adverse Event|1|||
126098614|NCT01076647|453653064|FG000|Overall Study|Lack of Efficacy|0|||
126098615|NCT01076647|453653065|FG001|Overall Study|Lack of Efficacy|1|||
126274347|NCT04645966|454296463|FG007|Vaccination Phase|Adverse Event|0|||
126098616|NCT01076647|453653064|FG000|Overall Study|Protocol Violation|7|||
126098617|NCT01076647|453653065|FG001|Overall Study|Protocol Violation|9|||
126098618|NCT01076647|453653064|FG000|Overall Study|Withdrawal criteria|2|||
126274348|NCT04645966|454296464|FG008|Vaccination Phase|Adverse Event|0|||
126274349|NCT04645966|454296456|FG000|Vaccination Phase|Death|0|||
126274350|NCT04645966|454296457|FG001|Vaccination Phase|Death|0|||
126274351|NCT04645966|454296458|FG002|Vaccination Phase|Death|0|||
126274352|NCT04645966|454296459|FG003|Vaccination Phase|Death|0|||
126274353|NCT04645966|454296460|FG004|Vaccination Phase|Death|0|||
126274354|NCT04645966|454296461|FG005|Vaccination Phase|Death|1|||
126274355|NCT04645966|454296462|FG006|Vaccination Phase|Death|0|||
126274356|NCT04645966|454296463|FG007|Vaccination Phase|Death|0|||
126274357|NCT04645966|454296464|FG008|Vaccination Phase|Death|0|||
126274358|NCT04645966|454296456|FG000|Vaccination Phase|Protocol Violation|0|||
126274359|NCT04645966|454296457|FG001|Vaccination Phase|Protocol Violation|0|||
126274360|NCT04645966|454296458|FG002|Vaccination Phase|Protocol Violation|0|||
126274361|NCT04645966|454296459|FG003|Vaccination Phase|Protocol Violation|0|||
126274362|NCT04645966|454296460|FG004|Vaccination Phase|Protocol Violation|1|||
126274363|NCT04645966|454296461|FG005|Vaccination Phase|Protocol Violation|0|||
126274364|NCT04645966|454296462|FG006|Vaccination Phase|Protocol Violation|0|||
126274365|NCT04645966|454296463|FG007|Vaccination Phase|Protocol Violation|0|||
126274366|NCT04645966|454296464|FG008|Vaccination Phase|Protocol Violation|0|||
126274367|NCT04645966|454296456|FG000|Vaccination Phase|Study terminated by sponsor|0|||
126274368|NCT04645966|454296457|FG001|Vaccination Phase|Study terminated by sponsor|0|||
126274369|NCT04645966|454296458|FG002|Vaccination Phase|Study terminated by sponsor|14|||
126274370|NCT04645966|454296459|FG003|Vaccination Phase|Study terminated by sponsor|15|||
126274371|NCT04645966|454296460|FG004|Vaccination Phase|Study terminated by sponsor|47|||
126274372|NCT04645966|454296461|FG005|Vaccination Phase|Study terminated by sponsor|43|||
126274373|NCT04645966|454296462|FG006|Vaccination Phase|Study terminated by sponsor|29|||
126274374|NCT04645966|454296463|FG007|Vaccination Phase|Study terminated by sponsor|29|||
126274375|NCT04645966|454296464|FG008|Vaccination Phase|Study terminated by sponsor|12|||
126274376|NCT04645966|454296456|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
126274377|NCT04645966|454296457|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
126274378|NCT04645966|454296458|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
126274379|NCT04645966|454296459|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
126274380|NCT04645966|454296460|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
126274381|NCT04645966|454296461|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
126274382|NCT04645966|454296462|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
126274383|NCT04645966|454296463|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
126274384|NCT04645966|454296464|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
126274385|NCT04645966|454296456|FG000|Vaccination Phase|Other|0|||
126274386|NCT04645966|454296457|FG001|Vaccination Phase|Other|0|||
126274387|NCT04645966|454296458|FG002|Vaccination Phase|Other|0|||
126274388|NCT04645966|454296459|FG003|Vaccination Phase|Other|0|||
126274389|NCT04645966|454296460|FG004|Vaccination Phase|Other|0|||
126274390|NCT04645966|454296461|FG005|Vaccination Phase|Other|2|||
126274391|NCT04645966|454296462|FG006|Vaccination Phase|Other|0|||
126274392|NCT04645966|454296463|FG007|Vaccination Phase|Other|0|||
126274393|NCT04645966|454296464|FG008|Vaccination Phase|Other|0|||
126274394|NCT04645966|454296456|FG000|Vaccination Phase|Lost to Follow-up|0|||
126274395|NCT04645966|454296457|FG001|Vaccination Phase|Lost to Follow-up|0|||
126274396|NCT04645966|454296458|FG002|Vaccination Phase|Lost to Follow-up|0|||
126274397|NCT04645966|454296459|FG003|Vaccination Phase|Lost to Follow-up|0|||
126274398|NCT04645966|454296460|FG004|Vaccination Phase|Lost to Follow-up|0|||
126274399|NCT04645966|454296461|FG005|Vaccination Phase|Lost to Follow-up|0|||
126274400|NCT04645966|454296462|FG006|Vaccination Phase|Lost to Follow-up|0|||
126274401|NCT04645966|454296463|FG007|Vaccination Phase|Lost to Follow-up|1|||
126274402|NCT04645966|454296464|FG008|Vaccination Phase|Lost to Follow-up|0|||
126274403|NCT04645966|454296456|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
126274404|NCT04645966|454296457|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
126274405|NCT04645966|454296458|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
126274406|NCT04645966|454296459|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
126274407|NCT04645966|454296460|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
126274408|NCT04645966|454296461|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
126274409|NCT04645966|454296462|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
126274410|NCT04645966|454296463|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
126274411|NCT04645966|454296464|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
126274412|NCT04645966|454296456|FG000|Follow-up Phase|Lost to Follow-up|0|||
126274413|NCT04645966|454296457|FG001|Follow-up Phase|Lost to Follow-up|0|||
126274414|NCT04645966|454296458|FG002|Follow-up Phase|Lost to Follow-up|0|||
126274415|NCT04645966|454296459|FG003|Follow-up Phase|Lost to Follow-up|0|||
126274416|NCT04645966|454296460|FG004|Follow-up Phase|Lost to Follow-up|0|||
126274417|NCT04645966|454296461|FG005|Follow-up Phase|Lost to Follow-up|0|||
126274418|NCT04645966|454296462|FG006|Follow-up Phase|Lost to Follow-up|0|||
126274419|NCT04645966|454296463|FG007|Follow-up Phase|Lost to Follow-up|1|||
126274420|NCT04645966|454296464|FG008|Follow-up Phase|Lost to Follow-up|0|||
126274421|NCT04283500|454296468|FG000|Overall Study|Lost to Follow-up|8|||
126274422|NCT04283500|454296468|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
126274423|NCT02006693|454296471|FG000|Overall Study|No Reason Specified|6|||
126274424|NCT02006693|454296472|FG001|Overall Study|No Reason Specified|8|||
126274425|NCT02006693|454296471|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
126274426|NCT02006693|454296472|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
126274427|NCT02006693|454296471|FG000|Overall Study|XEN Implant Explantation|0|||
126274428|NCT02006693|454296472|FG001|Overall Study|XEN Implant Explantation|1|||
126274429|NCT02006693|454296471|FG000|Overall Study|Death|2|||
126274430|NCT02006693|454296472|FG001|Overall Study|Death|2|||
126274431|NCT02006693|454296471|FG000|Overall Study|Lost to Follow-up|4|||
126274432|NCT02006693|454296472|FG001|Overall Study|Lost to Follow-up|1|||
126274433|NCT02006693|454296471|FG000|Overall Study|Patient Decision|4|||
126274434|NCT02006693|454296472|FG001|Overall Study|Patient Decision|0|||
126274435|NCT01119508|454296475|FG000|Overall Study|Adverse Event|56|||
126274436|NCT01119508|454296475|FG000|Overall Study|Withdrawal by Subject|2|||
126274437|NCT01119508|454296475|FG000|Overall Study|Died before tumor response evaluation|1|||
126274438|NCT00265395|454296476|FG000|Overall Study|Adverse Event|3|||
126274439|NCT00265395|454296477|FG001|Overall Study|Adverse Event|6|||
126274440|NCT00265395|454296476|FG000|Overall Study|Lost to Follow-up|2|||
126274441|NCT00265395|454296477|FG001|Overall Study|Lost to Follow-up|1|||
126274442|NCT00265395|454296476|FG000|Overall Study|Withdrawal by Subject|1|||
126274443|NCT00265395|454296477|FG001|Overall Study|Withdrawal by Subject|6|||
126274444|NCT00265395|454296476|FG000|Overall Study|Protocol Violation|2|||
126274445|NCT00265395|454296477|FG001|Overall Study|Protocol Violation|2|||
126274446|NCT00265395|454296476|FG000|Overall Study|Lack of Efficacy|0|||
126274447|NCT00265395|454296477|FG001|Overall Study|Lack of Efficacy|1|||
126274448|NCT00265395|454296476|FG000|Overall Study|Administrative|0|||
126274449|NCT00265395|454296477|FG001|Overall Study|Administrative|1|||
126274450|NCT00123474|454296478|FG000|Randomized to Treatment|Randomized, never treated|1|||
126274451|NCT00123474|454296479|FG001|Randomized to Treatment|Randomized, never treated|4|||
126274452|NCT00123474|454296480|FG002|Randomized to Treatment|Randomized, never treated|2|||
126274453|NCT00123474|454296481|FG003|Randomized to Treatment|Randomized, never treated|1|||
126274454|NCT00123474|454296478|FG000|As Treated at Study Closure|not reported when site closed|1|||
126274455|NCT00123474|454296479|FG001|As Treated at Study Closure|not reported when site closed|0|||
126274456|NCT00123474|454296480|FG002|As Treated at Study Closure|not reported when site closed|1|||
126274457|NCT00123474|454296481|FG003|As Treated at Study Closure|not reported when site closed|0|||
126274458|NCT00123474|454296478|FG000|As Treated at Study Closure|Adverse Event|10|||
126274459|NCT00123474|454296479|FG001|As Treated at Study Closure|Adverse Event|4|||
126274460|NCT00123474|454296480|FG002|As Treated at Study Closure|Adverse Event|10|||
126274461|NCT00123474|454296481|FG003|As Treated at Study Closure|Adverse Event|8|||
126274462|NCT00123474|454296478|FG000|As Treated at Study Closure|Disease Progression|35|||
126274463|NCT00123474|454296479|FG001|As Treated at Study Closure|Disease Progression|42|||
126274464|NCT00123474|454296480|FG002|As Treated at Study Closure|Disease Progression|29|||
126274465|NCT00123474|454296481|FG003|As Treated at Study Closure|Disease Progression|27|||
126274466|NCT00123474|454296478|FG000|As Treated at Study Closure|Investigator Request|12|||
126274467|NCT00123474|454296479|FG001|As Treated at Study Closure|Investigator Request|6|||
126274468|NCT00123474|454296480|FG002|As Treated at Study Closure|Investigator Request|7|||
126274469|NCT00123474|454296481|FG003|As Treated at Study Closure|Investigator Request|5|||
126274470|NCT00123474|454296478|FG000|As Treated at Study Closure|non-specified|54|||
126274471|NCT00123474|454296479|FG001|As Treated at Study Closure|non-specified|47|||
126274472|NCT00123474|454296480|FG002|As Treated at Study Closure|non-specified|57|||
126274473|NCT00123474|454296481|FG003|As Treated at Study Closure|non-specified|60|||
126274474|NCT00123474|454296478|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
126037473|NCT04171141|453436664|FG005|Overall Study|Global deterioration of health status|2|||
126037474|NCT04171141|453436665|FG006|Overall Study|Global deterioration of health status|1|||
126037475|NCT04171141|453436666|FG007|Overall Study|Global deterioration of health status|0|||
126037476|NCT04171141|453436667|FG008|Overall Study|Global deterioration of health status|1|||
126037477|NCT04171141|453436668|FG009|Overall Study|Global deterioration of health status|0|||
126037478|NCT04171141|453436669|FG010|Overall Study|Global deterioration of health status|0|||
126037479|NCT04171141|453436670|FG011|Overall Study|Global deterioration of health status|0|||
126274475|NCT00123474|454296479|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
126274476|NCT00123474|454296480|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
126274477|NCT00123474|454296481|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
126274478|NCT00123474|454296478|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
126274479|NCT00123474|454296479|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
126274480|NCT00123474|454296480|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
126274481|NCT00123474|454296481|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
126274482|NCT01059344|454296482|FG000|Overall Study|Adverse Event|12|||
126274483|NCT01059344|454296483|FG001|Overall Study|Adverse Event|30|||
126274484|NCT01059344|454296482|FG000|Overall Study|Withdrawal by Subject|6|||
126274485|NCT01059344|454296483|FG001|Overall Study|Withdrawal by Subject|9|||
126274486|NCT01059344|454296482|FG000|Overall Study|Lost to Follow-up|1|||
126274487|NCT01059344|454296483|FG001|Overall Study|Lost to Follow-up|1|||
126274488|NCT01059344|454296482|FG000|Overall Study|Other|3|||
126274489|NCT01059344|454296483|FG001|Overall Study|Other|6|||
126274490|NCT01739348|454296484|FG000|Part I (Base Study)|Adverse Event|41|||
126274491|NCT01739348|454296485|FG001|Part I (Base Study)|Adverse Event|52|||
126274492|NCT01739348|454296486|FG002|Part I (Base Study)|Adverse Event|8|||
126274493|NCT01739348|454296487|FG003|Part I (Base Study)|Adverse Event|33|||
126274494|NCT01739348|454296484|FG000|Part I (Base Study)|Death|10|||
126274495|NCT01739348|454296485|FG001|Part I (Base Study)|Death|7|||
126274496|NCT01739348|454296486|FG002|Part I (Base Study)|Death|2|||
126274497|NCT01739348|454296487|FG003|Part I (Base Study)|Death|8|||
126274498|NCT01739348|454296484|FG000|Part I (Base Study)|Lack of Efficacy|3|||
126274499|NCT01739348|454296485|FG001|Part I (Base Study)|Lack of Efficacy|8|||
126274500|NCT01739348|454296486|FG002|Part I (Base Study)|Lack of Efficacy|0|||
126274501|NCT01739348|454296487|FG003|Part I (Base Study)|Lack of Efficacy|7|||
126274502|NCT01739348|454296484|FG000|Part I (Base Study)|Lost to Follow-up|4|||
126274503|NCT01739348|454296485|FG001|Part I (Base Study)|Lost to Follow-up|2|||
126274504|NCT01739348|454296486|FG002|Part I (Base Study)|Lost to Follow-up|4|||
126274505|NCT01739348|454296487|FG003|Part I (Base Study)|Lost to Follow-up|4|||
126037480|NCT04171141|453436671|FG012|Overall Study|Global deterioration of health status|0|||
126037481|NCT04171141|453436672|FG013|Overall Study|Global deterioration of health status|0|||
126037482|NCT04171141|453436673|FG014|Overall Study|Global deterioration of health status|1|||
126037483|NCT04171141|453436674|FG015|Overall Study|Global deterioration of health status|1|||
126037484|NCT04858451|453436677|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
126037485|NCT04858451|453436678|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126037486|NCT04858451|453436679|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126037487|NCT04858451|453436680|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126037488|NCT04858451|453436681|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126037489|NCT04858451|453436682|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126037490|NCT04858451|453436683|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126037491|NCT04858451|453436684|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126037492|NCT04858451|453436685|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126037493|NCT04858451|453436677|FG000|Part 2|Discontinued|0|||
126037494|NCT04858451|453436678|FG001|Part 2|Discontinued|0|||
126037495|NCT04858451|453436679|FG002|Part 2|Discontinued|0|||
126274506|NCT01739348|454296484|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
126274507|NCT01739348|454296485|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
126274508|NCT01739348|454296486|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
126274509|NCT01739348|454296487|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
126274510|NCT01739348|454296484|FG000|Part I (Base Study)|Physician Decision|10|||
126274511|NCT01739348|454296485|FG001|Part I (Base Study)|Physician Decision|7|||
126274512|NCT01739348|454296486|FG002|Part I (Base Study)|Physician Decision|1|||
126274513|NCT01739348|454296487|FG003|Part I (Base Study)|Physician Decision|4|||
126274514|NCT01739348|454296484|FG000|Part I (Base Study)|Protocol Violation|2|||
126274515|NCT01739348|454296485|FG001|Part I (Base Study)|Protocol Violation|0|||
126274516|NCT01739348|454296486|FG002|Part I (Base Study)|Protocol Violation|1|||
126274517|NCT01739348|454296487|FG003|Part I (Base Study)|Protocol Violation|2|||
126274518|NCT01739348|454296484|FG000|Part I (Base Study)|Screen Failure|2|||
126274519|NCT01739348|454296485|FG001|Part I (Base Study)|Screen Failure|0|||
126274520|NCT01739348|454296486|FG002|Part I (Base Study)|Screen Failure|0|||
126274521|NCT01739348|454296487|FG003|Part I (Base Study)|Screen Failure|0|||
126274522|NCT01739348|454296484|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
126274523|NCT01739348|454296485|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
126274524|NCT01739348|454296486|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
126274525|NCT01739348|454296487|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
126274526|NCT01739348|454296484|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
126274527|NCT01739348|454296485|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
126274528|NCT01739348|454296486|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
126274529|NCT01739348|454296487|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
126274530|NCT01739348|454296484|FG000|Part I (Base Study)|Participant Moved|4|||
126274531|NCT01739348|454296485|FG001|Part I (Base Study)|Participant Moved|3|||
126274532|NCT01739348|454296486|FG002|Part I (Base Study)|Participant Moved|1|||
126274533|NCT01739348|454296487|FG003|Part I (Base Study)|Participant Moved|7|||
126274534|NCT01739348|454296484|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
126274535|NCT01739348|454296485|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
126274536|NCT01739348|454296486|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
126274537|NCT01739348|454296487|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
126274538|NCT01739348|454296484|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
126274539|NCT01739348|454296485|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
126274540|NCT01739348|454296486|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
126274541|NCT01739348|454296487|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
126274542|NCT01739348|454296484|FG000|Part II (Extension Study)|Adverse Event|10|||
126274543|NCT01739348|454296485|FG001|Part II (Extension Study)|Adverse Event|11|||
126274544|NCT01739348|454296486|FG002|Part II (Extension Study)|Adverse Event|7|||
126274545|NCT01739348|454296487|FG003|Part II (Extension Study)|Adverse Event|26|||
126274546|NCT01739348|454296484|FG000|Part II (Extension Study)|Death|3|||
126274547|NCT01739348|454296485|FG001|Part II (Extension Study)|Death|3|||
126274548|NCT01739348|454296486|FG002|Part II (Extension Study)|Death|2|||
126274549|NCT01739348|454296487|FG003|Part II (Extension Study)|Death|6|||
126274550|NCT01739348|454296484|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
126274551|NCT01739348|454296485|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
126274552|NCT01739348|454296486|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
126274553|NCT01739348|454296487|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
126274554|NCT01739348|454296484|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
126274555|NCT01739348|454296485|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
126037496|NCT04858451|453436680|FG003|Part 2|Discontinued|0|||
126037497|NCT04858451|453436681|FG004|Part 2|Discontinued|0|||
126037498|NCT04858451|453436682|FG005|Part 2|Discontinued|0|||
126274556|NCT01739348|454296486|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
126274557|NCT01739348|454296487|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
126274558|NCT01739348|454296484|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
126274559|NCT01739348|454296485|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
126037499|NCT04858451|453436683|FG006|Part 2|Discontinued|0|||
126037500|NCT04858451|453436684|FG007|Part 2|Discontinued|0|||
126037501|NCT04858451|453436685|FG008|Part 2|Discontinued|63|||
126037502|NCT03314454|453436686|FG000|Overall Study|Protocol Violation|1|||
126037503|NCT02969707|453436690|FG000|Overall Study|Withdrawal by Subject|6|||
126037504|NCT02969707|453436691|FG001|Overall Study|Withdrawal by Subject|5|||
126037505|NCT02969707|453436690|FG000|Overall Study|Severe anxiety|0|||
126037506|NCT02969707|453436691|FG001|Overall Study|Severe anxiety|1|||
126037507|NCT02969707|453436690|FG000|Overall Study|Positive toxicology screen|0|||
126037508|NCT02969707|453436691|FG001|Overall Study|Positive toxicology screen|2|||
126037509|NCT02969707|453436690|FG000|Overall Study|Claustrophobia|2|||
126037510|NCT02969707|453436691|FG001|Overall Study|Claustrophobia|2|||
126037511|NCT02969707|453436690|FG000|Overall Study|Non-compliance|1|||
126037512|NCT02969707|453436691|FG001|Overall Study|Non-compliance|2|||
126037513|NCT04314713|453436693|FG000|Overall Study|Lost to Follow-up|0|||
126037514|NCT04314713|453436694|FG001|Overall Study|Lost to Follow-up|0|||
126037515|NCT04314713|453436695|FG002|Overall Study|Lost to Follow-up|0|||
126037516|NCT04314713|453436696|FG003|Overall Study|Lost to Follow-up|1|||
126274560|NCT01739348|454296486|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
126274561|NCT01739348|454296487|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
126274562|NCT01739348|454296484|FG000|Part II (Extension Study)|Physician Decision|7|||
126274563|NCT01739348|454296485|FG001|Part II (Extension Study)|Physician Decision|11|||
126274564|NCT01739348|454296486|FG002|Part II (Extension Study)|Physician Decision|6|||
126274565|NCT01739348|454296487|FG003|Part II (Extension Study)|Physician Decision|12|||
126274566|NCT01739348|454296484|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
126274567|NCT01739348|454296485|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
126274568|NCT01739348|454296486|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
126274569|NCT01739348|454296487|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
126274570|NCT01739348|454296484|FG000|Part II (Extension Study)|Participant Moved|3|||
126274571|NCT01739348|454296485|FG001|Part II (Extension Study)|Participant Moved|3|||
126274572|NCT01739348|454296486|FG002|Part II (Extension Study)|Participant Moved|0|||
126274573|NCT01739348|454296487|FG003|Part II (Extension Study)|Participant Moved|3|||
126274574|NCT01739348|454296484|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
126274575|NCT01739348|454296485|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
126274576|NCT01739348|454296486|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
126274577|NCT01739348|454296487|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
126274578|NCT01739348|454296484|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
126274579|NCT01739348|454296485|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
126274580|NCT01739348|454296486|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
126274581|NCT01739348|454296487|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
126274582|NCT00742924|454296491|FG000|Overall Study|Adverse Event|0|||
126274583|NCT00742924|454296492|FG001|Overall Study|Adverse Event|0|||
126274584|NCT00742924|454296493|FG002|Overall Study|Adverse Event|1|||
126274585|NCT00742924|454296494|FG003|Overall Study|Adverse Event|1|||
126274586|NCT00742924|454296491|FG000|Overall Study|Lack of Efficacy|5|||
126274587|NCT00742924|454296492|FG001|Overall Study|Lack of Efficacy|1|||
126274588|NCT00742924|454296493|FG002|Overall Study|Lack of Efficacy|2|||
126274589|NCT00742924|454296494|FG003|Overall Study|Lack of Efficacy|4|||
126274590|NCT00742924|454296491|FG000|Overall Study|Physician Decision|0|||
126274591|NCT00742924|454296492|FG001|Overall Study|Physician Decision|0|||
126274592|NCT00742924|454296493|FG002|Overall Study|Physician Decision|0|||
126274593|NCT00742924|454296494|FG003|Overall Study|Physician Decision|1|||
126274594|NCT00742924|454296491|FG000|Overall Study|Withdrawal by Subject|0|||
126274595|NCT00742924|454296492|FG001|Overall Study|Withdrawal by Subject|1|||
126274596|NCT00742924|454296493|FG002|Overall Study|Withdrawal by Subject|1|||
126274597|NCT00742924|454296494|FG003|Overall Study|Withdrawal by Subject|0|||
126274598|NCT00660400|454296495|FG000|Overall Study|Lack of insurance approval|1|||
126274599|NCT00660400|454296495|FG000|Overall Study|Suboptimal organ function|1|||
126274600|NCT00660400|454296495|FG000|Overall Study|Intracranial hemorrhage|1|||
126274601|NCT00660400|454296495|FG000|Overall Study|Withdrawal by Subject|1|||
126274602|NCT01447420|454296496|FG000|Overall Study|Adverse Event|2|||
126274603|NCT01447420|454296497|FG001|Overall Study|Adverse Event|4|||
126274604|NCT01447420|454296498|FG002|Overall Study|Adverse Event|2|||
126274605|NCT01447420|454296496|FG000|Overall Study|Protocol Violation|3|||
126274606|NCT01447420|454296497|FG001|Overall Study|Protocol Violation|3|||
126274607|NCT01447420|454296498|FG002|Overall Study|Protocol Violation|0|||
126274608|NCT01447420|454296496|FG000|Overall Study|Withdrawal by Subject|4|||
126274609|NCT01447420|454296497|FG001|Overall Study|Withdrawal by Subject|1|||
126274610|NCT01447420|454296498|FG002|Overall Study|Withdrawal by Subject|0|||
126274611|NCT01447420|454296496|FG000|Overall Study|Lack of Efficacy|1|||
126037517|NCT04314713|453436697|FG004|Overall Study|Lost to Follow-up|0|||
126037518|NCT04314713|453436698|FG005|Overall Study|Lost to Follow-up|0|||
126274612|NCT01447420|454296497|FG001|Overall Study|Lack of Efficacy|19|||
126274613|NCT01447420|454296498|FG002|Overall Study|Lack of Efficacy|8|||
126037519|NCT02427464|453436702|FG000|Overall Study|Adverse Event|6|||
126274614|NCT02643355|454296499|FG000|Overall Study|Withdrawal by Subject|1|||
126274615|NCT02643355|454296500|FG001|Overall Study|Withdrawal by Subject|3|||
126274616|NCT02643355|454296499|FG000|Overall Study|Protocol Violation|0|||
126274617|NCT02643355|454296500|FG001|Overall Study|Protocol Violation|2|||
126274618|NCT04524364|454296505|FG000|Overall Study|Physician Decision|3|||
126274619|NCT04524364|454296506|FG001|Overall Study|Physician Decision|6|||
126274620|NCT04524364|454296505|FG000|Overall Study|Adverse Event|0|||
126274621|NCT04524364|454296506|FG001|Overall Study|Adverse Event|1|||
126274622|NCT04524364|454296505|FG000|Overall Study|Investigational device deficiency|0|||
126274623|NCT04524364|454296506|FG001|Overall Study|Investigational device deficiency|1|||
126274624|NCT04524364|454296505|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
126274625|NCT04524364|454296506|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
126274626|NCT04524364|454296505|FG000|Overall Study|Device unavailability|0|||
126274627|NCT04524364|454296506|FG001|Overall Study|Device unavailability|2|||
126274628|NCT04524364|454296505|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
126274629|NCT04524364|454296506|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
126274630|NCT04524364|454296505|FG000|Overall Study|Low International normalized ratio (INR)|1|||
126274631|NCT04524364|454296506|FG001|Overall Study|Low International normalized ratio (INR)|0|||
126274632|NCT00826449|454296507|FG000|Overall Study|Disease Progression|4|||
126274633|NCT00826449|454296507|FG000|Overall Study|Withdrawal by Subject|1|||
126274634|NCT02994940|454296508|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
126274635|NCT02994940|454296509|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
126274636|NCT02994940|454296508|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
126274637|NCT02994940|454296509|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
126274638|NCT02994940|454296508|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
126274639|NCT02994940|454296509|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
126274640|NCT03233230|454296510|FG000|Overall Study|Adverse Event|6|||
126274641|NCT03233230|454296511|FG001|Overall Study|Adverse Event|3|||
126274642|NCT03233230|454296512|FG002|Overall Study|Adverse Event|6|||
126274643|NCT03233230|454296513|FG003|Overall Study|Adverse Event|3|||
126274644|NCT03233230|454296510|FG000|Overall Study|Protocol Violation|1|||
126274645|NCT03233230|454296511|FG001|Overall Study|Protocol Violation|2|||
126274646|NCT03233230|454296512|FG002|Overall Study|Protocol Violation|1|||
126274647|NCT03233230|454296513|FG003|Overall Study|Protocol Violation|1|||
126274648|NCT03233230|454296510|FG000|Overall Study|Lack of Efficacy|1|||
126274649|NCT03233230|454296511|FG001|Overall Study|Lack of Efficacy|0|||
126274650|NCT03233230|454296512|FG002|Overall Study|Lack of Efficacy|0|||
126274651|NCT03233230|454296513|FG003|Overall Study|Lack of Efficacy|0|||
126274652|NCT03233230|454296510|FG000|Overall Study|Other|5|||
126274653|NCT03233230|454296511|FG001|Overall Study|Other|5|||
126274654|NCT03233230|454296512|FG002|Overall Study|Other|5|||
126274655|NCT03233230|454296513|FG003|Overall Study|Other|3|||
126274656|NCT03233230|454296510|FG000|Overall Study|Withdrawal by Subject|2|||
126274657|NCT03233230|454296511|FG001|Overall Study|Withdrawal by Subject|2|||
126274658|NCT03233230|454296512|FG002|Overall Study|Withdrawal by Subject|0|||
126274659|NCT03233230|454296513|FG003|Overall Study|Withdrawal by Subject|1|||
126274660|NCT03233230|454296510|FG000|Overall Study|Lost to Follow-up|0|||
126274661|NCT03233230|454296511|FG001|Overall Study|Lost to Follow-up|3|||
126274662|NCT03233230|454296512|FG002|Overall Study|Lost to Follow-up|0|||
126037520|NCT02427464|453436703|FG001|Overall Study|Adverse Event|1|||
126037521|NCT02427464|453436702|FG000|Overall Study|Lost to Follow-up|16|||
126037522|NCT02427464|453436703|FG001|Overall Study|Lost to Follow-up|5|||
126037523|NCT02427464|453436702|FG000|Overall Study|Physician Decision|2|||
126037524|NCT02427464|453436703|FG001|Overall Study|Physician Decision|0|||
126037525|NCT02427464|453436702|FG000|Overall Study|Withdrawal by Subject|10|||
126037526|NCT02427464|453436703|FG001|Overall Study|Withdrawal by Subject|8|||
126037527|NCT02427464|453436702|FG000|Overall Study|Noncompliance|16|||
126037528|NCT02427464|453436703|FG001|Overall Study|Noncompliance|10|||
126037529|NCT02927236|453436704|FG000|Characterization Phase|Physician Decision|0|||
126037530|NCT02927236|453436705|FG001|Characterization Phase|Physician Decision|3|||
126037531|NCT02927236|453436706|FG002|Characterization Phase|Physician Decision|0|||
126098619|NCT01076647|453653065|FG001|Overall Study|Withdrawal criteria|2|||
126274663|NCT03233230|454296513|FG003|Overall Study|Lost to Follow-up|0|||
126274664|NCT02987959|454296518|FG000|Overall Study|Grantor stopped supply of drugs|6|||
126274665|NCT04126213|454296519|FG000|Overall Study|Lost to Follow-up|9|||
126274666|NCT04126213|454296520|FG001|Overall Study|Lost to Follow-up|1|||
126274667|NCT04126213|454296521|FG002|Overall Study|Lost to Follow-up|5|||
126037532|NCT02927236|453436707|FG003|Characterization Phase|Physician Decision|2|||
126037533|NCT02927236|453436704|FG000|Characterization Phase|Lost to Follow-up|0|||
126274668|NCT04126213|454296522|FG003|Overall Study|Lost to Follow-up|10|||
126274669|NCT04126213|454296523|FG004|Overall Study|Lost to Follow-up|4|||
126362425|NCT02413346|454619167|FG000|Overall Study|Lost to Follow-up|17|||
126037534|NCT02927236|453436705|FG001|Characterization Phase|Lost to Follow-up|0|||
126274670|NCT04126213|454296524|FG005|Overall Study|Lost to Follow-up|7|||
126362426|NCT02413346|454619168|FG001|Overall Study|Lost to Follow-up|21|||
126274671|NCT04126213|454296519|FG000|Overall Study|Withdrawal by Subject|3|||
126274672|NCT04126213|454296520|FG001|Overall Study|Withdrawal by Subject|2|||
126274673|NCT04126213|454296521|FG002|Overall Study|Withdrawal by Subject|1|||
126274674|NCT04126213|454296522|FG003|Overall Study|Withdrawal by Subject|1|||
126274675|NCT04126213|454296523|FG004|Overall Study|Withdrawal by Subject|1|||
126274676|NCT04126213|454296524|FG005|Overall Study|Withdrawal by Subject|1|||
126274677|NCT04126213|454296519|FG000|Overall Study|Other|0|||
126274678|NCT04126213|454296520|FG001|Overall Study|Other|0|||
126274679|NCT04126213|454296521|FG002|Overall Study|Other|2|||
126274680|NCT04126213|454296522|FG003|Overall Study|Other|2|||
126274681|NCT04126213|454296523|FG004|Overall Study|Other|0|||
126274682|NCT04126213|454296524|FG005|Overall Study|Other|1|||
126274683|NCT04126213|454296519|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126274684|NCT04126213|454296520|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126274685|NCT04126213|454296521|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126274686|NCT04126213|454296522|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126274687|NCT04126213|454296523|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126274688|NCT04126213|454296524|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126274689|NCT02853370|454296527|FG000|Overall Study|Physician Decision|1|||
126274690|NCT02853370|454296527|FG000|Overall Study|Lack of Efficacy|2|||
126274691|NCT02853370|454296527|FG000|Overall Study|Death|1|||
126274692|NCT02853370|454296527|FG000|Overall Study|Adverse Event|4|||
126274693|NCT02853370|454296527|FG000|Overall Study|Withdrawal by Subject|3|||
126274694|NCT02196701|454296528|FG000|Overall Study|Adverse Event|1|||
126274695|NCT02196701|454296528|FG000|Overall Study|Lost to Follow-up|1|||
126274696|NCT02196701|454296528|FG000|Overall Study|Non-adherence to Protocol|1|||
126274697|NCT03275064|454296533|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
126274698|NCT03275064|454296534|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
126274699|NCT03275064|454296535|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
126274700|NCT03275064|454296536|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
126274701|NCT03275064|454296537|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
126274702|NCT03275064|454296533|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
126274703|NCT03275064|454296534|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
126274704|NCT03275064|454296535|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
126274705|NCT03275064|454296536|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
126274706|NCT03275064|454296537|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
126274707|NCT03275064|454296533|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
126274708|NCT03275064|454296534|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
126274709|NCT03275064|454296535|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
126274710|NCT03275064|454296536|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
126274711|NCT03275064|454296537|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
126274712|NCT03275064|454296533|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
126274713|NCT03275064|454296534|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
126274714|NCT03275064|454296535|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
126274715|NCT03275064|454296536|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
126274716|NCT03275064|454296537|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
126274717|NCT03275064|454296533|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
126274718|NCT03275064|454296534|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
126274719|NCT03275064|454296535|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
126274720|NCT03275064|454296536|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
126274721|NCT03275064|454296537|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
126274722|NCT04159935|454296538|FG000|Overall Study|Study terminated due to COVID-19|1|||
126274723|NCT04159935|454296539|FG001|Overall Study|Study terminated due to COVID-19|3|||
126274724|NCT01341782|454296540|FG000|Overall Study|Adverse Event|1|||
126274725|NCT01341782|454296541|FG001|Overall Study|Adverse Event|1|||
126274726|NCT01341782|454296540|FG000|Overall Study|Withdrawal by Subject|6|||
126274727|NCT01341782|454296541|FG001|Overall Study|Withdrawal by Subject|5|||
126274728|NCT01341782|454296540|FG000|Overall Study|Missed 3 consecutive doses|0|||
126037535|NCT02927236|453436706|FG002|Characterization Phase|Lost to Follow-up|0|||
126037536|NCT02927236|453436707|FG003|Characterization Phase|Lost to Follow-up|3|||
126037537|NCT02927236|453436704|FG000|Characterization Phase|Withdrawal by Subject|1|||
126037538|NCT02927236|453436705|FG001|Characterization Phase|Withdrawal by Subject|0|||
126037539|NCT02927236|453436706|FG002|Characterization Phase|Withdrawal by Subject|0|||
126037540|NCT02927236|453436707|FG003|Characterization Phase|Withdrawal by Subject|1|||
126037541|NCT02927236|453436704|FG000|Treatment Phase|Adverse Event|1|||
126037542|NCT02927236|453436705|FG001|Treatment Phase|Adverse Event|0|||
126098620|NCT01076647|453653064|FG000|Overall Study|Unclassified|12|||
126098621|NCT01076647|453653065|FG001|Overall Study|Unclassified|12|||
126274729|NCT01341782|454296541|FG001|Overall Study|Missed 3 consecutive doses|4|||
126274730|NCT01341782|454296540|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
126274731|NCT01341782|454296541|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
126274732|NCT01341782|454296540|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
126274733|NCT01341782|454296541|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
126274734|NCT01341782|454296540|FG000|Overall Study|Other|5|||
126274735|NCT01341782|454296541|FG001|Overall Study|Other|0|||
126274736|NCT00620555|454296542|FG000|Overall Study|Adverse Event|4|||
126274737|NCT00620555|454296542|FG000|Overall Study|Protocol Violation|2|||
126098622|NCT02224690|453653077|FG000|Overall Study|Adverse Event|8|||
126098623|NCT02224690|453653078|FG001|Overall Study|Adverse Event|1|||
126098624|NCT02224690|453653077|FG000|Overall Study|Met Withdrawal Criteria|4|||
126098625|NCT02224690|453653078|FG001|Overall Study|Met Withdrawal Criteria|0|||
126098626|NCT02224690|453653077|FG000|Overall Study|Use of G-tube|1|||
126098627|NCT02224690|453653078|FG001|Overall Study|Use of G-tube|0|||
126098628|NCT02224690|453653077|FG000|Overall Study|Did not meet eligibility criteria|1|||
126098629|NCT02224690|453653078|FG001|Overall Study|Did not meet eligibility criteria|0|||
126098630|NCT00141219|453653079|FG000|Overall Study|Protocol violations|5|||
126098631|NCT00141219|453653080|FG001|Overall Study|Protocol violations|4|||
126098632|NCT00141219|453653079|FG000|Overall Study|Adverse Event|8|||
126098633|NCT00141219|453653080|FG001|Overall Study|Adverse Event|6|||
126098634|NCT00141219|453653079|FG000|Overall Study|Lack of Efficacy|5|||
126098635|NCT00141219|453653080|FG001|Overall Study|Lack of Efficacy|4|||
126098636|NCT00141219|453653079|FG000|Overall Study|Withdrawal by Subject|6|||
126098637|NCT00141219|453653080|FG001|Overall Study|Withdrawal by Subject|2|||
126274738|NCT00620555|454296542|FG000|Overall Study|Lack of Efficacy|12|||
126274739|NCT00620555|454296542|FG000|Overall Study|Withdrawal by Subject|1|||
126274740|NCT00620555|454296542|FG000|Overall Study|Choice of other treatment|1|||
126274741|NCT00620555|454296542|FG000|Overall Study|Visit failure against planned|1|||
126274742|NCT00724048|454296543|FG000|Overall Study|Adverse Event|1|||
126274743|NCT00724048|454296544|FG001|Overall Study|Adverse Event|1|||
126274744|NCT00724048|454296545|FG002|Overall Study|Adverse Event|1|||
126274745|NCT00724048|454296546|FG003|Overall Study|Adverse Event|0|||
126274746|NCT00724048|454296543|FG000|Overall Study|Lost to Follow-up|0|||
126274747|NCT00724048|454296544|FG001|Overall Study|Lost to Follow-up|1|||
126274748|NCT00724048|454296545|FG002|Overall Study|Lost to Follow-up|0|||
126274749|NCT00724048|454296546|FG003|Overall Study|Lost to Follow-up|0|||
126274750|NCT00724048|454296543|FG000|Overall Study|Withdrawal by Subject|1|||
126274751|NCT00724048|454296544|FG001|Overall Study|Withdrawal by Subject|2|||
126274752|NCT00724048|454296545|FG002|Overall Study|Withdrawal by Subject|1|||
126274753|NCT00724048|454296546|FG003|Overall Study|Withdrawal by Subject|2|||
126274754|NCT00724048|454296543|FG000|Overall Study|Investigator decision|0|||
126274755|NCT00724048|454296544|FG001|Overall Study|Investigator decision|0|||
126274756|NCT00724048|454296545|FG002|Overall Study|Investigator decision|1|||
126274757|NCT00724048|454296546|FG003|Overall Study|Investigator decision|0|||
126274758|NCT00724048|454296543|FG000|Overall Study|Did not tolerate study drug|0|||
126274759|NCT00724048|454296544|FG001|Overall Study|Did not tolerate study drug|0|||
126274760|NCT00724048|454296545|FG002|Overall Study|Did not tolerate study drug|0|||
126274761|NCT00724048|454296546|FG003|Overall Study|Did not tolerate study drug|1|||
126274762|NCT00724048|454296543|FG000|Overall Study|Other than specified|1|||
126274763|NCT00724048|454296544|FG001|Overall Study|Other than specified|1|||
126274764|NCT00724048|454296545|FG002|Overall Study|Other than specified|0|||
126274765|NCT00724048|454296546|FG003|Overall Study|Other than specified|0|||
126274766|NCT03923530|454296547|FG000|Overall Study|Withdrawal by Subject|1|||
126274767|NCT03923530|454296547|FG000|Overall Study|screen failure|3|||
126274768|NCT00911807|454296550|FG000|Overall Study|Adverse Event|2|||
126274769|NCT00911807|454296551|FG001|Overall Study|Adverse Event|1|||
126274770|NCT00911807|454296552|FG002|Overall Study|Adverse Event|5|||
126274771|NCT00911807|454296550|FG000|Overall Study|Death|0|||
126274772|NCT00911807|454296551|FG001|Overall Study|Death|0|||
126274773|NCT00911807|454296552|FG002|Overall Study|Death|1|||
126274774|NCT00911807|454296550|FG000|Overall Study|Protocol Violation|6|||
126274775|NCT00911807|454296551|FG001|Overall Study|Protocol Violation|4|||
126274776|NCT00911807|454296552|FG002|Overall Study|Protocol Violation|9|||
126274777|NCT00911807|454296550|FG000|Overall Study|Withdrawal by Subject|8|||
126274778|NCT00911807|454296551|FG001|Overall Study|Withdrawal by Subject|10|||
126274779|NCT00911807|454296552|FG002|Overall Study|Withdrawal by Subject|7|||
126274780|NCT00911807|454296550|FG000|Overall Study|Organizational reasons|1|||
126274781|NCT00911807|454296551|FG001|Overall Study|Organizational reasons|3|||
126274782|NCT00911807|454296552|FG002|Overall Study|Organizational reasons|1|||
126274783|NCT00809159|454296553|FG000|Part 1|Adverse Event|1|||
126274784|NCT00809159|454296554|FG001|Part 1|Adverse Event|1|||
126274785|NCT00809159|454296555|FG002|Part 1|Adverse Event|0|||
126274786|NCT00809159|454296556|FG003|Part 1|Adverse Event|0|||
126274787|NCT00809159|454296557|FG004|Part 1|Adverse Event|0|||
126274788|NCT00809159|454296558|FG005|Part 1|Adverse Event|0|||
126274789|NCT00809159|454296553|FG000|Part 1|Lost to Follow-up|1|||
126274790|NCT00809159|454296554|FG001|Part 1|Lost to Follow-up|0|||
126274791|NCT00809159|454296555|FG002|Part 1|Lost to Follow-up|0|||
126274792|NCT00809159|454296556|FG003|Part 1|Lost to Follow-up|0|||
126274793|NCT00809159|454296557|FG004|Part 1|Lost to Follow-up|0|||
126274794|NCT00809159|454296558|FG005|Part 1|Lost to Follow-up|0|||
126274795|NCT00809159|454296553|FG000|Part 1|Withdrawal by Subject|3|||
126274796|NCT00809159|454296554|FG001|Part 1|Withdrawal by Subject|1|||
126274797|NCT00809159|454296555|FG002|Part 1|Withdrawal by Subject|0|||
126274798|NCT00809159|454296556|FG003|Part 1|Withdrawal by Subject|0|||
126274799|NCT00809159|454296557|FG004|Part 1|Withdrawal by Subject|0|||
126274800|NCT00809159|454296558|FG005|Part 1|Withdrawal by Subject|0|||
126274801|NCT00809159|454296553|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
126274802|NCT00809159|454296554|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
126274803|NCT00809159|454296555|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
126274804|NCT00809159|454296556|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
126274805|NCT00809159|454296557|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
126274806|NCT00809159|454296558|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
126274807|NCT00809159|454296553|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
126274808|NCT00809159|454296554|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
126274809|NCT00809159|454296555|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
126274810|NCT00809159|454296556|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
126274811|NCT00809159|454296557|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
126274812|NCT00809159|454296558|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
126274813|NCT00809159|454296553|FG000|Part 1 and 2|Administrative problems|0|||
126274814|NCT00809159|454296554|FG001|Part 1 and 2|Administrative problems|0|||
126274815|NCT00809159|454296555|FG002|Part 1 and 2|Administrative problems|0|||
126274816|NCT00809159|454296556|FG003|Part 1 and 2|Administrative problems|1|||
126274817|NCT00809159|454296557|FG004|Part 1 and 2|Administrative problems|0|||
126274818|NCT00809159|454296558|FG005|Part 1 and 2|Administrative problems|0|||
126274819|NCT00809159|454296553|FG000|Part 1 and 2|Adverse Event|0|||
126274820|NCT00809159|454296554|FG001|Part 1 and 2|Adverse Event|0|||
126274821|NCT00809159|454296555|FG002|Part 1 and 2|Adverse Event|1|||
126274822|NCT00809159|454296556|FG003|Part 1 and 2|Adverse Event|0|||
126274823|NCT00809159|454296557|FG004|Part 1 and 2|Adverse Event|1|||
126274824|NCT00809159|454296558|FG005|Part 1 and 2|Adverse Event|1|||
126274825|NCT00809159|454296553|FG000|Part 1 and 2|Lost to Follow-up|0|||
126274826|NCT00809159|454296554|FG001|Part 1 and 2|Lost to Follow-up|0|||
126274827|NCT00809159|454296555|FG002|Part 1 and 2|Lost to Follow-up|1|||
126274828|NCT00809159|454296556|FG003|Part 1 and 2|Lost to Follow-up|1|||
126274829|NCT00809159|454296557|FG004|Part 1 and 2|Lost to Follow-up|0|||
126274830|NCT00809159|454296558|FG005|Part 1 and 2|Lost to Follow-up|0|||
126274831|NCT00809159|454296553|FG000|Part 1 and 2|Withdrawal by Subject|0|||
126274832|NCT00809159|454296554|FG001|Part 1 and 2|Withdrawal by Subject|0|||
126274833|NCT00809159|454296555|FG002|Part 1 and 2|Withdrawal by Subject|4|||
126274834|NCT00809159|454296556|FG003|Part 1 and 2|Withdrawal by Subject|0|||
126274835|NCT00809159|454296557|FG004|Part 1 and 2|Withdrawal by Subject|0|||
126274836|NCT00809159|454296558|FG005|Part 1 and 2|Withdrawal by Subject|1|||
126274837|NCT01672970|454296561|FG000|Overall Study|Lack of Efficacy|12|||
126274838|NCT01672970|454296561|FG000|Overall Study|Adverse Event|18|||
126274839|NCT01672970|454296561|FG000|Overall Study|Withdrawal by Subject|2|||
126274840|NCT01672970|454296561|FG000|Overall Study|Lost to Follow-up|5|||
126274841|NCT01672970|454296561|FG000|Overall Study|Other|9|||
126274842|NCT01672970|454296561|FG000|Overall Study|Enrolled but not treated|1|||
126274843|NCT03835221|454296566|FG000|Methafilcon A|Withdrawal by Subject|1|||
126274844|NCT01770392|454296568|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
126274845|NCT04639713|454296571|FG000|Overall Study|Protocol Noncompliance|2|||
126274846|NCT04639713|454296571|FG000|Overall Study|Withdrawal by Subject|1|||
126274847|NCT00390221|454296572|FG000|Overall Study|Lost to Follow-up|0|||
126274848|NCT00390221|454296573|FG001|Overall Study|Lost to Follow-up|3|||
126274849|NCT00390221|454296574|FG002|Overall Study|Lost to Follow-up|0|||
126274850|NCT00390221|454296572|FG000|Overall Study|Adverse Event|1|||
126274851|NCT00390221|454296573|FG001|Overall Study|Adverse Event|4|||
126274852|NCT00390221|454296574|FG002|Overall Study|Adverse Event|3|||
126274853|NCT00390221|454296572|FG000|Overall Study|Investigator Decision|0|||
126362427|NCT02413346|454619167|FG000|Overall Study|Protocol Violation|2|||
126362428|NCT02413346|454619168|FG001|Overall Study|Protocol Violation|0|||
126098638|NCT01506609|453653082|FG000|Overall Study|Adverse Event Related to Progression|0|||
126098639|NCT01506609|453653083|FG001|Overall Study|Adverse Event Related to Progression|0|||
126098640|NCT01506609|453653084|FG002|Overall Study|Adverse Event Related to Progression|0|||
126098641|NCT01506609|453653085|FG003|Overall Study|Adverse Event Related to Progression|3|||
126098642|NCT01506609|453653086|FG004|Overall Study|Adverse Event Related to Progression|7|||
126274854|NCT00390221|454296573|FG001|Overall Study|Investigator Decision|0|||
126274855|NCT00390221|454296574|FG002|Overall Study|Investigator Decision|1|||
126274856|NCT00390221|454296572|FG000|Overall Study|Withdrawal by Subject|13|||
126274857|NCT00390221|454296573|FG001|Overall Study|Withdrawal by Subject|9|||
126274858|NCT00390221|454296574|FG002|Overall Study|Withdrawal by Subject|7|||
126274859|NCT00390221|454296572|FG000|Overall Study|Subject Non-compliance|1|||
126274860|NCT00390221|454296573|FG001|Overall Study|Subject Non-compliance|0|||
126274861|NCT00390221|454296574|FG002|Overall Study|Subject Non-compliance|2|||
126274862|NCT00390221|454296572|FG000|Overall Study|Other|3|||
126274863|NCT00390221|454296573|FG001|Overall Study|Other|4|||
126274864|NCT00390221|454296574|FG002|Overall Study|Other|2|||
126274865|NCT02533375|454296577|FG000|Overall Study|Lack of Efficacy|3|||
126274866|NCT02533375|454296577|FG000|Overall Study|Adverse Event|2|||
126362429|NCT02413346|454619167|FG000|Overall Study|Other Miscellaneous Reasons|4|||
126274867|NCT02582866|454296584|FG000|Overall Study|Death|1|||
126274868|NCT02582866|454296584|FG000|Overall Study|Lack of Efficacy|2|||
126274869|NCT02582866|454296584|FG000|Overall Study|Lost to Follow-up|2|||
126274870|NCT02582866|454296584|FG000|Overall Study|Withdrawal by Subject|7|||
126274871|NCT02582866|454296584|FG000|Overall Study|Investigator decision|5|||
126274872|NCT02582866|454296584|FG000|Overall Study|Participant wants to get pregnant|1|||
126274873|NCT02582866|454296584|FG000|Overall Study|Pregnancy|2|||
126274874|NCT02582866|454296584|FG000|Overall Study|Sponsor decision|1|||
126274875|NCT02582866|454296584|FG000|Overall Study|Withdrawal due to personal reasons|1|||
126274876|NCT01193127|454296591|FG000|Randomized|Surgery Cancelled|0|||
126274877|NCT01193127|454296592|FG001|Randomized|Surgery Cancelled|0|||
126274878|NCT01193127|454296593|FG002|Randomized|Surgery Cancelled|0|||
126274879|NCT01193127|454296594|FG003|Randomized|Surgery Cancelled|1|||
126274880|NCT01193127|454296591|FG000|Treated|Withdrawal by Subject|0|||
126274881|NCT01193127|454296592|FG001|Treated|Withdrawal by Subject|0|||
126274882|NCT01193127|454296593|FG002|Treated|Withdrawal by Subject|0|||
126274883|NCT01193127|454296594|FG003|Treated|Withdrawal by Subject|1|||
126274884|NCT03246646|454296597|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
126274885|NCT03246646|454296598|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
126274886|NCT03246646|454296597|FG000|Overall Study|Withdrawal by Subject|3|||
126274887|NCT03246646|454296598|FG001|Overall Study|Withdrawal by Subject|0|||
126274888|NCT03246646|454296597|FG000|Overall Study|Lost to Follow-up|7|||
126274889|NCT03246646|454296598|FG001|Overall Study|Lost to Follow-up|0|||
126274890|NCT02352779|454296601|FG000|Overall Study|Personal Issues|1|||
126274891|NCT02352779|454296602|FG001|Overall Study|Personal Issues|1|||
126274892|NCT02352779|454296603|FG002|Overall Study|Personal Issues|0|||
126274893|NCT02352779|454296601|FG000|Overall Study|Too Many Forms|2|||
126274894|NCT02352779|454296602|FG001|Overall Study|Too Many Forms|0|||
126274895|NCT02352779|454296603|FG002|Overall Study|Too Many Forms|0|||
126274896|NCT02352779|454296601|FG000|Overall Study|Feeling Overwhelmed|1|||
126274897|NCT02352779|454296602|FG001|Overall Study|Feeling Overwhelmed|0|||
126274898|NCT02352779|454296603|FG002|Overall Study|Feeling Overwhelmed|0|||
126274899|NCT02352779|454296601|FG000|Overall Study|Disliked Intervention|1|||
126274900|NCT02352779|454296602|FG001|Overall Study|Disliked Intervention|0|||
126274901|NCT02352779|454296603|FG002|Overall Study|Disliked Intervention|0|||
126274902|NCT02352779|454296601|FG000|Overall Study|Changed Mind|1|||
126274903|NCT02352779|454296602|FG001|Overall Study|Changed Mind|0|||
126274904|NCT02352779|454296603|FG002|Overall Study|Changed Mind|0|||
126274905|NCT02352779|454296601|FG000|Overall Study|Study Related Symptoms|1|||
126274906|NCT02352779|454296602|FG001|Overall Study|Study Related Symptoms|0|||
126274907|NCT02352779|454296603|FG002|Overall Study|Study Related Symptoms|0|||
126274908|NCT02352779|454296601|FG000|Overall Study|Absence of Symptoms|1|||
126274909|NCT02352779|454296602|FG001|Overall Study|Absence of Symptoms|0|||
126274910|NCT02352779|454296603|FG002|Overall Study|Absence of Symptoms|0|||
126274911|NCT02352779|454296601|FG000|Overall Study|Other Medical Reason|0|||
126274912|NCT02352779|454296602|FG001|Overall Study|Other Medical Reason|0|||
126274913|NCT02352779|454296603|FG002|Overall Study|Other Medical Reason|1|||
126274914|NCT02352779|454296601|FG000|Overall Study|No Reason|0|||
126274915|NCT02352779|454296602|FG001|Overall Study|No Reason|0|||
126274916|NCT02352779|454296603|FG002|Overall Study|No Reason|1|||
126274917|NCT00871741|454296604|FG000|Overall Study|Premature study termination|9|||
126274918|NCT00871741|454296605|FG001|Overall Study|Premature study termination|7|||
126274919|NCT01565850|454296610|FG000|Overall Study|Adverse Event|0|||
126274920|NCT01565850|454296611|FG001|Overall Study|Adverse Event|1|||
126274921|NCT01565850|454296610|FG000|Overall Study|Lost to Follow-up|12|||
126274922|NCT01565850|454296611|FG001|Overall Study|Lost to Follow-up|4|||
126274923|NCT01565850|454296610|FG000|Overall Study|Investigator's Discretion|2|||
126274924|NCT01565850|454296611|FG001|Overall Study|Investigator's Discretion|1|||
126037543|NCT02927236|453436706|FG002|Treatment Phase|Adverse Event|1|||
126037544|NCT02927236|453436707|FG003|Treatment Phase|Adverse Event|1|||
126037545|NCT02927236|453436704|FG000|Treatment Phase|Protocol Violation|3|||
126037546|NCT02927236|453436705|FG001|Treatment Phase|Protocol Violation|0|||
126037547|NCT02927236|453436706|FG002|Treatment Phase|Protocol Violation|0|||
126037548|NCT02927236|453436707|FG003|Treatment Phase|Protocol Violation|1|||
126274925|NCT01565850|454296610|FG000|Overall Study|Participant noncompliance|2|||
126037549|NCT02927236|453436704|FG000|Treatment Phase|Lost to Follow-up|1|||
126274926|NCT01565850|454296611|FG001|Overall Study|Participant noncompliance|0|||
126274927|NCT01565850|454296610|FG000|Overall Study|Withdrew Consent|4|||
126274928|NCT01565850|454296611|FG001|Overall Study|Withdrew Consent|2|||
126274929|NCT03611543|454299844|FG000|Overall Study|Withdrawal by Subject|4|||
126274930|NCT03611543|454299845|FG001|Overall Study|Withdrawal by Subject|4|||
126274931|NCT03611543|454299844|FG000|Overall Study|Physician Decision|1|||
126274932|NCT03611543|454299845|FG001|Overall Study|Physician Decision|1|||
126274933|NCT03611543|454299844|FG000|Overall Study|Protocol Violation|2|||
126274934|NCT03611543|454299845|FG001|Overall Study|Protocol Violation|2|||
126274935|NCT03611543|454299844|FG000|Overall Study|Device failure|2|||
126274936|NCT03611543|454299845|FG001|Overall Study|Device failure|2|||
126274937|NCT03611543|454299844|FG000|Overall Study|Missing information|5|||
126274938|NCT03611543|454299845|FG001|Overall Study|Missing information|5|||
126274939|NCT02799095|454299846|FG000|Part A|Adverse Event|1|||
126274940|NCT02799095|454299847|FG001|Part A|Adverse Event|0|||
126274941|NCT02799095|454299848|FG002|Part A|Adverse Event|1|||
126274942|NCT02799095|454299849|FG003|Part A|Adverse Event|4|||
126274943|NCT02799095|454299850|FG004|Part A|Adverse Event|1|||
126274944|NCT02799095|454299851|FG005|Part A|Adverse Event|0|||
126274945|NCT02799095|454299852|FG006|Part A|Adverse Event|0|||
126274946|NCT02799095|454299853|FG007|Part A|Adverse Event|0|||
126274947|NCT02799095|454299854|FG008|Part A|Adverse Event|0|||
126274948|NCT02799095|454299855|FG009|Part A|Adverse Event|0|||
126274949|NCT02799095|454299856|FG010|Part A|Adverse Event|0|||
126274950|NCT02799095|454299857|FG011|Part A|Adverse Event|0|||
126274951|NCT02799095|454299858|FG012|Part A|Adverse Event|0|||
126274952|NCT02799095|454299859|FG013|Part A|Adverse Event|0|||
126274953|NCT02799095|454299860|FG014|Part A|Adverse Event|0|||
126274954|NCT02799095|454299861|FG015|Part A|Adverse Event|0|||
126274955|NCT02799095|454299862|FG016|Part A|Adverse Event|0|||
126274956|NCT02799095|454299846|FG000|Part A|Death|0|||
126274957|NCT02799095|454299847|FG001|Part A|Death|0|||
126274958|NCT02799095|454299848|FG002|Part A|Death|0|||
126274959|NCT02799095|454299849|FG003|Part A|Death|0|||
126274960|NCT02799095|454299850|FG004|Part A|Death|0|||
126274961|NCT02799095|454299851|FG005|Part A|Death|0|||
126274962|NCT02799095|454299852|FG006|Part A|Death|3|||
126274963|NCT02799095|454299853|FG007|Part A|Death|0|||
126274964|NCT02799095|454299854|FG008|Part A|Death|0|||
126274965|NCT02799095|454299855|FG009|Part A|Death|0|||
126274966|NCT02799095|454299856|FG010|Part A|Death|0|||
126274967|NCT02799095|454299857|FG011|Part A|Death|0|||
126274968|NCT02799095|454299858|FG012|Part A|Death|0|||
126274969|NCT02799095|454299859|FG013|Part A|Death|0|||
126274970|NCT02799095|454299860|FG014|Part A|Death|0|||
126274971|NCT02799095|454299861|FG015|Part A|Death|0|||
126274972|NCT02799095|454299862|FG016|Part A|Death|0|||
126274973|NCT02799095|454299846|FG000|Part A|Lost to Follow-up|0|||
126274974|NCT02799095|454299847|FG001|Part A|Lost to Follow-up|1|||
126274975|NCT02799095|454299848|FG002|Part A|Lost to Follow-up|0|||
126274976|NCT02799095|454299849|FG003|Part A|Lost to Follow-up|0|||
126274977|NCT02799095|454299850|FG004|Part A|Lost to Follow-up|0|||
126274978|NCT02799095|454299851|FG005|Part A|Lost to Follow-up|0|||
126274979|NCT02799095|454299852|FG006|Part A|Lost to Follow-up|1|||
126274980|NCT02799095|454299853|FG007|Part A|Lost to Follow-up|0|||
126274981|NCT02799095|454299854|FG008|Part A|Lost to Follow-up|0|||
126274982|NCT02799095|454299855|FG009|Part A|Lost to Follow-up|0|||
126274983|NCT02799095|454299856|FG010|Part A|Lost to Follow-up|0|||
126274984|NCT02799095|454299857|FG011|Part A|Lost to Follow-up|0|||
126274985|NCT02799095|454299858|FG012|Part A|Lost to Follow-up|0|||
126274986|NCT02799095|454299859|FG013|Part A|Lost to Follow-up|0|||
126274987|NCT02799095|454299860|FG014|Part A|Lost to Follow-up|0|||
126274988|NCT02799095|454299861|FG015|Part A|Lost to Follow-up|0|||
126274989|NCT02799095|454299862|FG016|Part A|Lost to Follow-up|0|||
126274990|NCT02799095|454299846|FG000|Part A|Progressive Disease|3|||
126274991|NCT02799095|454299847|FG001|Part A|Progressive Disease|3|||
126274992|NCT02799095|454299848|FG002|Part A|Progressive Disease|3|||
126274993|NCT02799095|454299849|FG003|Part A|Progressive Disease|2|||
126274994|NCT02799095|454299850|FG004|Part A|Progressive Disease|2|||
126274995|NCT02799095|454299851|FG005|Part A|Progressive Disease|0|||
126274996|NCT02799095|454299852|FG006|Part A|Progressive Disease|0|||
126274997|NCT02799095|454299853|FG007|Part A|Progressive Disease|0|||
126274998|NCT02799095|454299854|FG008|Part A|Progressive Disease|0|||
126274999|NCT02799095|454299855|FG009|Part A|Progressive Disease|0|||
126275000|NCT02799095|454299856|FG010|Part A|Progressive Disease|0|||
126275001|NCT02799095|454299857|FG011|Part A|Progressive Disease|0|||
126275002|NCT02799095|454299858|FG012|Part A|Progressive Disease|0|||
126275003|NCT02799095|454299859|FG013|Part A|Progressive Disease|0|||
126275004|NCT02799095|454299860|FG014|Part A|Progressive Disease|0|||
126275005|NCT02799095|454299861|FG015|Part A|Progressive Disease|0|||
126275006|NCT02799095|454299862|FG016|Part A|Progressive Disease|0|||
126275007|NCT02799095|454299846|FG000|Part A|Clinical Progression|1|||
126275008|NCT02799095|454299847|FG001|Part A|Clinical Progression|0|||
126275009|NCT02799095|454299848|FG002|Part A|Clinical Progression|2|||
126275010|NCT02799095|454299849|FG003|Part A|Clinical Progression|1|||
126275011|NCT02799095|454299850|FG004|Part A|Clinical Progression|5|||
126275012|NCT02799095|454299851|FG005|Part A|Clinical Progression|0|||
126275013|NCT02799095|454299852|FG006|Part A|Clinical Progression|0|||
126275014|NCT02799095|454299853|FG007|Part A|Clinical Progression|0|||
126275015|NCT02799095|454299854|FG008|Part A|Clinical Progression|0|||
126275016|NCT02799095|454299855|FG009|Part A|Clinical Progression|0|||
126275017|NCT02799095|454299856|FG010|Part A|Clinical Progression|0|||
126275018|NCT02799095|454299857|FG011|Part A|Clinical Progression|0|||
126275019|NCT02799095|454299858|FG012|Part A|Clinical Progression|0|||
126275020|NCT02799095|454299859|FG013|Part A|Clinical Progression|0|||
126275021|NCT02799095|454299860|FG014|Part A|Clinical Progression|0|||
126275022|NCT02799095|454299861|FG015|Part A|Clinical Progression|0|||
126037550|NCT02927236|453436705|FG001|Treatment Phase|Lost to Follow-up|0|||
126037551|NCT02927236|453436706|FG002|Treatment Phase|Lost to Follow-up|0|||
126275023|NCT02799095|454299862|FG016|Part A|Clinical Progression|0|||
126275024|NCT02799095|454299846|FG000|Part A|Protocol Deviation|0|||
126275025|NCT02799095|454299847|FG001|Part A|Protocol Deviation|0|||
126275026|NCT02799095|454299848|FG002|Part A|Protocol Deviation|1|||
126275027|NCT02799095|454299849|FG003|Part A|Protocol Deviation|0|||
126275028|NCT02799095|454299850|FG004|Part A|Protocol Deviation|0|||
126275029|NCT02799095|454299851|FG005|Part A|Protocol Deviation|0|||
126275030|NCT02799095|454299852|FG006|Part A|Protocol Deviation|0|||
126275031|NCT02799095|454299853|FG007|Part A|Protocol Deviation|0|||
126275032|NCT02799095|454299854|FG008|Part A|Protocol Deviation|0|||
126275033|NCT02799095|454299855|FG009|Part A|Protocol Deviation|0|||
126275034|NCT02799095|454299856|FG010|Part A|Protocol Deviation|0|||
126275035|NCT02799095|454299857|FG011|Part A|Protocol Deviation|0|||
126275036|NCT02799095|454299858|FG012|Part A|Protocol Deviation|0|||
126275037|NCT02799095|454299859|FG013|Part A|Protocol Deviation|0|||
126275038|NCT02799095|454299860|FG014|Part A|Protocol Deviation|0|||
126275039|NCT02799095|454299861|FG015|Part A|Protocol Deviation|0|||
125880781|NCT04225897|452862632|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126275040|NCT02799095|454299862|FG016|Part A|Protocol Deviation|0|||
126275041|NCT02799095|454299846|FG000|Part A|Withdrawal by Subject|0|||
126275042|NCT02799095|454299847|FG001|Part A|Withdrawal by Subject|0|||
125880782|NCT04225897|452862633|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126037552|NCT02927236|453436707|FG003|Treatment Phase|Lost to Follow-up|0|||
126037553|NCT02927236|453436704|FG000|Follow-up Phase|Lost to Follow-up|1|||
126037554|NCT02927236|453436705|FG001|Follow-up Phase|Lost to Follow-up|0|||
126037555|NCT02927236|453436706|FG002|Follow-up Phase|Lost to Follow-up|1|||
126037556|NCT02927236|453436707|FG003|Follow-up Phase|Lost to Follow-up|0|||
126037557|NCT05297565|453436710|FG000|Overall Study|Other Reasons|0|||
126037558|NCT05297565|453436711|FG001|Overall Study|Other Reasons|1|||
126037559|NCT05297565|453436710|FG000|Overall Study|Physician Decision|0|||
126037560|NCT05297565|453436711|FG001|Overall Study|Physician Decision|1|||
126037561|NCT05297565|453436710|FG000|Overall Study|Disease recurrence|1|||
126037562|NCT05297565|453436711|FG001|Overall Study|Disease recurrence|0|||
126037563|NCT05940194|453436731|FG000|Overall Study|Adverse Event|0|||
126275043|NCT02799095|454299848|FG002|Part A|Withdrawal by Subject|0|||
126275044|NCT02799095|454299849|FG003|Part A|Withdrawal by Subject|1|||
126275045|NCT02799095|454299850|FG004|Part A|Withdrawal by Subject|3|||
126275046|NCT02799095|454299851|FG005|Part A|Withdrawal by Subject|1|||
126275047|NCT02799095|454299852|FG006|Part A|Withdrawal by Subject|1|||
126275048|NCT02799095|454299853|FG007|Part A|Withdrawal by Subject|0|||
126362430|NCT02413346|454619168|FG001|Overall Study|Other Miscellaneous Reasons|3|||
126362431|NCT01316900|454619171|FG000|Overall Study|Adverse Event|10|||
126362432|NCT01316900|454619172|FG001|Overall Study|Adverse Event|10|||
126362433|NCT01316900|454619173|FG002|Overall Study|Adverse Event|15|||
126362434|NCT01316900|454619174|FG003|Overall Study|Adverse Event|9|||
126362435|NCT01316900|454619171|FG000|Overall Study|Lack of Efficacy|17|||
126362436|NCT01316900|454619172|FG001|Overall Study|Lack of Efficacy|9|||
126362437|NCT01316900|454619173|FG002|Overall Study|Lack of Efficacy|5|||
126362438|NCT01316900|454619174|FG003|Overall Study|Lack of Efficacy|7|||
126362439|NCT01316900|454619171|FG000|Overall Study|Protocol Violation|7|||
126362440|NCT01316900|454619172|FG001|Overall Study|Protocol Violation|1|||
126362441|NCT01316900|454619173|FG002|Overall Study|Protocol Violation|4|||
126362442|NCT01316900|454619174|FG003|Overall Study|Protocol Violation|0|||
126362443|NCT01316900|454619171|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
126362444|NCT01316900|454619172|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
126362445|NCT01316900|454619173|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
126362446|NCT01316900|454619174|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
126362447|NCT01316900|454619171|FG000|Overall Study|Lost to Follow-up|1|||
126362448|NCT01316900|454619172|FG001|Overall Study|Lost to Follow-up|0|||
126362449|NCT01316900|454619173|FG002|Overall Study|Lost to Follow-up|1|||
126362450|NCT01316900|454619174|FG003|Overall Study|Lost to Follow-up|1|||
126362451|NCT01316900|454619171|FG000|Overall Study|Withdrawal by Subject|7|||
126362452|NCT01316900|454619172|FG001|Overall Study|Withdrawal by Subject|8|||
126362453|NCT01316900|454619173|FG002|Overall Study|Withdrawal by Subject|6|||
126362454|NCT01316900|454619174|FG003|Overall Study|Withdrawal by Subject|9|||
126362455|NCT01684033|454619175|FG000|Period 1, First 30 Days|Adverse Event|1|||
126362456|NCT01684033|454619176|FG001|Period 1, First 30 Days|Adverse Event|1|||
126362457|NCT01684033|454619175|FG000|Period 1, First 30 Days|Noncompliance|1|||
126037564|NCT05940194|453436732|FG001|Overall Study|Adverse Event|1|||
126037565|NCT05940194|453436733|FG002|Overall Study|Adverse Event|0|||
126037566|NCT05940194|453436731|FG000|Overall Study|Migrated/Moved from the study area|2|||
126037567|NCT05940194|453436732|FG001|Overall Study|Migrated/Moved from the study area|2|||
126275049|NCT02799095|454299854|FG008|Part A|Withdrawal by Subject|0|||
126275050|NCT02799095|454299855|FG009|Part A|Withdrawal by Subject|0|||
126275051|NCT02799095|454299856|FG010|Part A|Withdrawal by Subject|0|||
126275052|NCT02799095|454299857|FG011|Part A|Withdrawal by Subject|0|||
126362458|NCT01684033|454619176|FG001|Period 1, First 30 Days|Noncompliance|0|||
126362459|NCT01684033|454619175|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
126275053|NCT02799095|454299858|FG012|Part A|Withdrawal by Subject|0|||
126275054|NCT02799095|454299859|FG013|Part A|Withdrawal by Subject|0|||
126275055|NCT02799095|454299860|FG014|Part A|Withdrawal by Subject|0|||
126275056|NCT02799095|454299861|FG015|Part A|Withdrawal by Subject|0|||
126275057|NCT02799095|454299862|FG016|Part A|Withdrawal by Subject|0|||
126037568|NCT05940194|453436733|FG002|Overall Study|Migrated/Moved from the study area|4|||
126037569|NCT03085810|453436734|FG000|Main Study|Withdrawal by Subject|77|||
126037570|NCT03085810|453436735|FG001|Main Study|Withdrawal by Subject|0|||
126037571|NCT03085810|453436736|FG002|Main Study|Withdrawal by Subject|0|||
126275058|NCT02799095|454299846|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
126275059|NCT02799095|454299847|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
126275060|NCT02799095|454299848|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
126275061|NCT02799095|454299849|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
126275062|NCT02799095|454299850|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
126275063|NCT02799095|454299851|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
126275064|NCT02799095|454299852|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
126275065|NCT02799095|454299853|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
126275066|NCT02799095|454299854|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
126275067|NCT02799095|454299855|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
126275068|NCT02799095|454299856|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
126275069|NCT02799095|454299857|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
126275070|NCT02799095|454299858|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
126275071|NCT02799095|454299859|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
126275072|NCT02799095|454299860|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
126275073|NCT02799095|454299861|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
126275074|NCT02799095|454299862|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
126275075|NCT02799095|454299846|FG000|Part B|Death|0|||
126275076|NCT02799095|454299847|FG001|Part B|Death|0|||
126275077|NCT02799095|454299848|FG002|Part B|Death|0|||
126275078|NCT02799095|454299849|FG003|Part B|Death|0|||
126275079|NCT02799095|454299850|FG004|Part B|Death|0|||
126275080|NCT02799095|454299851|FG005|Part B|Death|0|||
126275081|NCT02799095|454299852|FG006|Part B|Death|0|||
126275082|NCT02799095|454299853|FG007|Part B|Death|7|||
126275083|NCT02799095|454299854|FG008|Part B|Death|7|||
126275084|NCT02799095|454299855|FG009|Part B|Death|0|||
126275085|NCT02799095|454299856|FG010|Part B|Death|0|||
126275086|NCT02799095|454299857|FG011|Part B|Death|0|||
126275087|NCT02799095|454299858|FG012|Part B|Death|0|||
126275088|NCT02799095|454299859|FG013|Part B|Death|0|||
126275089|NCT02799095|454299860|FG014|Part B|Death|0|||
126275090|NCT02799095|454299861|FG015|Part B|Death|0|||
126275091|NCT02799095|454299862|FG016|Part B|Death|0|||
126275092|NCT02799095|454299846|FG000|Part B|Progressive Disease|0|||
126275093|NCT02799095|454299847|FG001|Part B|Progressive Disease|0|||
126275094|NCT02799095|454299848|FG002|Part B|Progressive Disease|0|||
126275095|NCT02799095|454299849|FG003|Part B|Progressive Disease|0|||
126275096|NCT02799095|454299850|FG004|Part B|Progressive Disease|0|||
126275097|NCT02799095|454299851|FG005|Part B|Progressive Disease|0|||
126275098|NCT02799095|454299852|FG006|Part B|Progressive Disease|0|||
126275099|NCT02799095|454299853|FG007|Part B|Progressive Disease|1|||
126275100|NCT02799095|454299854|FG008|Part B|Progressive Disease|0|||
126275101|NCT02799095|454299855|FG009|Part B|Progressive Disease|0|||
126275102|NCT02799095|454299856|FG010|Part B|Progressive Disease|0|||
126275103|NCT02799095|454299857|FG011|Part B|Progressive Disease|0|||
126275104|NCT02799095|454299858|FG012|Part B|Progressive Disease|0|||
126275105|NCT02799095|454299859|FG013|Part B|Progressive Disease|0|||
126275106|NCT02799095|454299860|FG014|Part B|Progressive Disease|0|||
126275107|NCT02799095|454299861|FG015|Part B|Progressive Disease|0|||
126275108|NCT02799095|454299862|FG016|Part B|Progressive Disease|0|||
126275109|NCT02799095|454299846|FG000|Part B|Withdrawal by Subject|0|||
126275110|NCT02799095|454299847|FG001|Part B|Withdrawal by Subject|0|||
126275111|NCT02799095|454299848|FG002|Part B|Withdrawal by Subject|0|||
126275112|NCT02799095|454299849|FG003|Part B|Withdrawal by Subject|0|||
126275113|NCT02799095|454299850|FG004|Part B|Withdrawal by Subject|0|||
126275114|NCT02799095|454299851|FG005|Part B|Withdrawal by Subject|0|||
126275115|NCT02799095|454299852|FG006|Part B|Withdrawal by Subject|0|||
126275116|NCT02799095|454299853|FG007|Part B|Withdrawal by Subject|10|||
126275117|NCT02799095|454299854|FG008|Part B|Withdrawal by Subject|7|||
126275118|NCT02799095|454299855|FG009|Part B|Withdrawal by Subject|0|||
126275119|NCT02799095|454299856|FG010|Part B|Withdrawal by Subject|0|||
126275120|NCT02799095|454299857|FG011|Part B|Withdrawal by Subject|0|||
126037572|NCT03085810|453436734|FG000|Main Study|Terminated By Sponsor|14|||
126037573|NCT03085810|453436735|FG001|Main Study|Terminated By Sponsor|0|||
126275121|NCT02799095|454299858|FG012|Part B|Withdrawal by Subject|0|||
126275122|NCT02799095|454299859|FG013|Part B|Withdrawal by Subject|0|||
126275123|NCT02799095|454299860|FG014|Part B|Withdrawal by Subject|0|||
126275124|NCT02799095|454299861|FG015|Part B|Withdrawal by Subject|0|||
126037574|NCT03085810|453436736|FG002|Main Study|Terminated By Sponsor|0|||
126037575|NCT03085810|453436734|FG000|Main Study|Protocol Violation|15|||
126275125|NCT02799095|454299862|FG016|Part B|Withdrawal by Subject|0|||
126275126|NCT02799095|454299846|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
126275127|NCT02799095|454299847|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
126275128|NCT02799095|454299848|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
126275129|NCT02799095|454299849|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
126275130|NCT02799095|454299850|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
126275131|NCT02799095|454299851|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
126275132|NCT02799095|454299852|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
126275133|NCT02799095|454299853|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
126275134|NCT02799095|454299854|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
126275135|NCT02799095|454299855|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
126275136|NCT02799095|454299856|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
126275137|NCT02799095|454299857|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
126275138|NCT02799095|454299858|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
126275139|NCT02799095|454299859|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
126275140|NCT02799095|454299860|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
126275141|NCT02799095|454299861|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
126275142|NCT02799095|454299862|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
126275143|NCT02799095|454299846|FG000|Part C|Adverse Event|0|||
126275144|NCT02799095|454299847|FG001|Part C|Adverse Event|0|||
126275145|NCT02799095|454299848|FG002|Part C|Adverse Event|0|||
126275146|NCT02799095|454299849|FG003|Part C|Adverse Event|0|||
126275147|NCT02799095|454299850|FG004|Part C|Adverse Event|0|||
126275148|NCT02799095|454299851|FG005|Part C|Adverse Event|0|||
126275149|NCT02799095|454299852|FG006|Part C|Adverse Event|0|||
126275150|NCT02799095|454299853|FG007|Part C|Adverse Event|0|||
126275151|NCT02799095|454299854|FG008|Part C|Adverse Event|0|||
126275152|NCT02799095|454299855|FG009|Part C|Adverse Event|0|||
126275153|NCT02799095|454299856|FG010|Part C|Adverse Event|3|||
126275154|NCT02799095|454299857|FG011|Part C|Adverse Event|1|||
126275155|NCT02799095|454299858|FG012|Part C|Adverse Event|0|||
126275156|NCT02799095|454299859|FG013|Part C|Adverse Event|1|||
126275157|NCT02799095|454299860|FG014|Part C|Adverse Event|0|||
126275158|NCT02799095|454299861|FG015|Part C|Adverse Event|0|||
126275159|NCT02799095|454299862|FG016|Part C|Adverse Event|0|||
126275160|NCT02799095|454299846|FG000|Part C|Death|0|||
126275161|NCT02799095|454299847|FG001|Part C|Death|0|||
126275162|NCT02799095|454299848|FG002|Part C|Death|0|||
126275163|NCT02799095|454299849|FG003|Part C|Death|0|||
126275164|NCT02799095|454299850|FG004|Part C|Death|0|||
126275165|NCT02799095|454299851|FG005|Part C|Death|0|||
126275166|NCT02799095|454299852|FG006|Part C|Death|0|||
126275167|NCT02799095|454299853|FG007|Part C|Death|0|||
126275168|NCT02799095|454299854|FG008|Part C|Death|0|||
126275169|NCT02799095|454299855|FG009|Part C|Death|0|||
126275170|NCT02799095|454299856|FG010|Part C|Death|7|||
126275171|NCT02799095|454299857|FG011|Part C|Death|5|||
126275172|NCT02799095|454299858|FG012|Part C|Death|6|||
126275173|NCT02799095|454299859|FG013|Part C|Death|8|||
126275174|NCT02799095|454299860|FG014|Part C|Death|1|||
126275175|NCT02799095|454299861|FG015|Part C|Death|8|||
126275176|NCT02799095|454299862|FG016|Part C|Death|1|||
126275177|NCT02799095|454299846|FG000|Part C|Lost to Follow-up|0|||
126275178|NCT02799095|454299847|FG001|Part C|Lost to Follow-up|0|||
126275179|NCT02799095|454299848|FG002|Part C|Lost to Follow-up|0|||
126275180|NCT02799095|454299849|FG003|Part C|Lost to Follow-up|0|||
126275181|NCT02799095|454299850|FG004|Part C|Lost to Follow-up|0|||
126275182|NCT02799095|454299851|FG005|Part C|Lost to Follow-up|0|||
126275183|NCT02799095|454299852|FG006|Part C|Lost to Follow-up|0|||
126275184|NCT02799095|454299853|FG007|Part C|Lost to Follow-up|0|||
126275185|NCT02799095|454299854|FG008|Part C|Lost to Follow-up|0|||
126275186|NCT02799095|454299855|FG009|Part C|Lost to Follow-up|0|||
126037576|NCT03085810|453436735|FG001|Main Study|Protocol Violation|0|||
126037577|NCT03085810|453436736|FG002|Main Study|Protocol Violation|0|||
126275187|NCT02799095|454299856|FG010|Part C|Lost to Follow-up|1|||
126275188|NCT02799095|454299857|FG011|Part C|Lost to Follow-up|1|||
126275189|NCT02799095|454299858|FG012|Part C|Lost to Follow-up|1|||
126275190|NCT02799095|454299859|FG013|Part C|Lost to Follow-up|3|||
126275191|NCT02799095|454299860|FG014|Part C|Lost to Follow-up|0|||
126275192|NCT02799095|454299861|FG015|Part C|Lost to Follow-up|0|||
126275193|NCT02799095|454299862|FG016|Part C|Lost to Follow-up|0|||
126275194|NCT02799095|454299846|FG000|Part C|Progressive Disease|0|||
126275195|NCT02799095|454299847|FG001|Part C|Progressive Disease|0|||
126275196|NCT02799095|454299848|FG002|Part C|Progressive Disease|0|||
126037578|NCT03085810|453436734|FG000|Main Study|Physician Decision|13|||
126037579|NCT03085810|453436735|FG001|Main Study|Physician Decision|0|||
126275197|NCT02799095|454299849|FG003|Part C|Progressive Disease|0|||
126275198|NCT02799095|454299850|FG004|Part C|Progressive Disease|0|||
126275199|NCT02799095|454299851|FG005|Part C|Progressive Disease|0|||
126275200|NCT02799095|454299852|FG006|Part C|Progressive Disease|0|||
126275201|NCT02799095|454299853|FG007|Part C|Progressive Disease|0|||
126275202|NCT02799095|454299854|FG008|Part C|Progressive Disease|0|||
126275203|NCT02799095|454299855|FG009|Part C|Progressive Disease|2|||
126275204|NCT02799095|454299856|FG010|Part C|Progressive Disease|13|||
126275205|NCT02799095|454299857|FG011|Part C|Progressive Disease|2|||
126275206|NCT02799095|454299858|FG012|Part C|Progressive Disease|0|||
126275207|NCT02799095|454299859|FG013|Part C|Progressive Disease|1|||
126362460|NCT01684033|454619176|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
126362461|NCT01684033|454619175|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
126362462|NCT01684033|454619176|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
126362463|NCT01684033|454619175|FG000|Period 2, Second 30 Days|Adverse Event|1|||
126362464|NCT01684033|454619176|FG001|Period 2, Second 30 Days|Adverse Event|0|||
126362465|NCT00089583|454619179|FG000|Overall Study|Adverse Event|0|||
126362466|NCT00089583|454619180|FG001|Overall Study|Adverse Event|3|||
126362467|NCT00089583|454619179|FG000|Overall Study|Insufficient Viral Load Response|5|||
126362468|NCT00089583|454619180|FG001|Overall Study|Insufficient Viral Load Response|5|||
126362469|NCT00089583|454619179|FG000|Overall Study|Withdrawal by Subject|0|||
126362470|NCT00089583|454619180|FG001|Overall Study|Withdrawal by Subject|4|||
126362471|NCT00089583|454619179|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
126362472|NCT00089583|454619180|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
126362473|NCT00089583|454619179|FG000|Overall Study|Participant Refused Study Medication|0|||
126362474|NCT00089583|454619180|FG001|Overall Study|Participant Refused Study Medication|2|||
126362475|NCT00089583|454619179|FG000|Overall Study|Non-Compliance|0|||
126362476|NCT00089583|454619180|FG001|Overall Study|Non-Compliance|4|||
126362477|NCT00089583|454619179|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
126362478|NCT00089583|454619180|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
126362479|NCT00089583|454619179|FG000|Overall Study|Participant Management Criteria Met|0|||
126362480|NCT00089583|454619180|FG001|Overall Study|Participant Management Criteria Met|1|||
126362481|NCT00089583|454619179|FG000|Overall Study|Reason Not Provided|0|||
126362482|NCT00089583|454619180|FG001|Overall Study|Reason Not Provided|1|||
126362483|NCT00089583|454619179|FG000|Overall Study|Protocol Violation|0|||
126362484|NCT00089583|454619180|FG001|Overall Study|Protocol Violation|3|||
126362485|NCT00089583|454619179|FG000|Overall Study|Principal Investigator Decision|0|||
126362486|NCT00089583|454619180|FG001|Overall Study|Principal Investigator Decision|10|||
126362487|NCT00089583|454619179|FG000|Overall Study|Start of Disallowed Medication|0|||
126362488|NCT00089583|454619180|FG001|Overall Study|Start of Disallowed Medication|1|||
126362489|NCT00089583|454619179|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
126362490|NCT00089583|454619180|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
126362491|NCT00089583|454619179|FG000|Overall Study|Participant Incarcerated|0|||
126362492|NCT00089583|454619180|FG001|Overall Study|Participant Incarcerated|1|||
126362493|NCT00507507|454619181|FG000|Treatment Period|Lost to Follow-up|0|||
126362494|NCT00507507|454619182|FG001|Treatment Period|Lost to Follow-up|2|||
126362495|NCT00507507|454619181|FG000|Treatment Period|Physician Decision|4|||
126362496|NCT00507507|454619182|FG001|Treatment Period|Physician Decision|1|||
126362497|NCT00507507|454619181|FG000|Treatment Period|Protocol Violation|1|||
125880783|NCT04225897|452862634|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125880784|NCT04225897|452862635|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125880785|NCT04225897|452862624|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125880786|NCT04225897|452862625|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125880787|NCT04225897|452862626|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
125880788|NCT04225897|452862627|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125880789|NCT04225897|452862628|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126362498|NCT00507507|454619182|FG001|Treatment Period|Protocol Violation|2|||
126362499|NCT00507507|454619181|FG000|Treatment Period|Adverse Event|1|||
126362500|NCT00507507|454619182|FG001|Treatment Period|Adverse Event|1|||
126362501|NCT00507507|454619181|FG000|Treatment Period|Withdrawal by Subject|46|||
126362502|NCT00507507|454619182|FG001|Treatment Period|Withdrawal by Subject|47|||
126362503|NCT00507507|454619181|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
126362504|NCT00507507|454619182|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
126362505|NCT00507507|454619181|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
126362506|NCT00507507|454619182|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
126362507|NCT00507507|454619181|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
126362508|NCT00507507|454619182|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
126362509|NCT02916433|454619183|FG000|Overall Study|Withdrawal by Subject|1|||
126362510|NCT02916433|454619184|FG001|Overall Study|Withdrawal by Subject|0|||
126362511|NCT02916433|454619183|FG000|Overall Study|Physician Decision|1|||
126362512|NCT02916433|454619184|FG001|Overall Study|Physician Decision|0|||
126362513|NCT01412983|454619185|FG000|1st Period|Ineligible|0|||
126362514|NCT01412983|454619186|FG001|1st Period|Ineligible|1|||
126362515|NCT01412983|454619185|FG000|1st Period|Positive slit lamp finding|0|||
126362516|NCT01412983|454619186|FG001|1st Period|Positive slit lamp finding|1|||
126362517|NCT01412983|454619185|FG000|1st Period|Unacceptable lens movement|0|||
126362518|NCT01412983|454619186|FG001|1st Period|Unacceptable lens movement|1|||
126362519|NCT01412983|454619185|FG000|1st Period|Inability to maintain wear|0|||
125880790|NCT04225897|452862629|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126362520|NCT01412983|454619186|FG001|1st Period|Inability to maintain wear|1|||
126362521|NCT01623154|454619187|FG000|Overall Study|Did not drink Pranactin Citric|4|||
126362522|NCT00890097|454619188|FG000|Overall Study|Adverse Event|21|||
126362523|NCT00890097|454619189|FG001|Overall Study|Adverse Event|32|||
126275208|NCT02799095|454299860|FG014|Part C|Progressive Disease|0|||
126275209|NCT02799095|454299861|FG015|Part C|Progressive Disease|0|||
126275210|NCT02799095|454299862|FG016|Part C|Progressive Disease|0|||
126275211|NCT02799095|454299846|FG000|Part C|Clinical Progression|0|||
126275212|NCT02799095|454299847|FG001|Part C|Clinical Progression|0|||
126275213|NCT02799095|454299848|FG002|Part C|Clinical Progression|0|||
126275214|NCT02799095|454299849|FG003|Part C|Clinical Progression|0|||
126275215|NCT02799095|454299850|FG004|Part C|Clinical Progression|0|||
126275216|NCT02799095|454299851|FG005|Part C|Clinical Progression|0|||
125880791|NCT04225897|452862630|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125880792|NCT04225897|452862631|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125880793|NCT04225897|452862632|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125880794|NCT04225897|452862633|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126275217|NCT02799095|454299852|FG006|Part C|Clinical Progression|0|||
126275218|NCT02799095|454299853|FG007|Part C|Clinical Progression|0|||
125880795|NCT04225897|452862634|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125880796|NCT04225897|452862635|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125880797|NCT04225897|452862624|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880798|NCT04225897|452862625|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880799|NCT04225897|452862626|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880800|NCT04225897|452862627|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880801|NCT04225897|452862628|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880802|NCT04225897|452862629|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880803|NCT04225897|452862630|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880804|NCT04225897|452862631|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
125880805|NCT04225897|452862632|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880806|NCT04225897|452862633|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880807|NCT04225897|452862634|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125880808|NCT04225897|452862635|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126275219|NCT02799095|454299854|FG008|Part C|Clinical Progression|0|||
126275220|NCT02799095|454299855|FG009|Part C|Clinical Progression|1|||
126275221|NCT02799095|454299856|FG010|Part C|Clinical Progression|3|||
126275222|NCT02799095|454299857|FG011|Part C|Clinical Progression|0|||
126275223|NCT02799095|454299858|FG012|Part C|Clinical Progression|0|||
126275224|NCT02799095|454299859|FG013|Part C|Clinical Progression|1|||
126275225|NCT02799095|454299860|FG014|Part C|Clinical Progression|0|||
126275226|NCT02799095|454299861|FG015|Part C|Clinical Progression|0|||
126275227|NCT02799095|454299862|FG016|Part C|Clinical Progression|0|||
126275228|NCT02799095|454299846|FG000|Part C|Withdrawal by Subject|0|||
126275229|NCT02799095|454299847|FG001|Part C|Withdrawal by Subject|0|||
126275230|NCT02799095|454299848|FG002|Part C|Withdrawal by Subject|0|||
126275231|NCT02799095|454299849|FG003|Part C|Withdrawal by Subject|0|||
126275232|NCT02799095|454299850|FG004|Part C|Withdrawal by Subject|0|||
126275233|NCT02799095|454299851|FG005|Part C|Withdrawal by Subject|0|||
126275234|NCT02799095|454299852|FG006|Part C|Withdrawal by Subject|0|||
126275235|NCT02799095|454299853|FG007|Part C|Withdrawal by Subject|0|||
126275236|NCT02799095|454299854|FG008|Part C|Withdrawal by Subject|0|||
126275237|NCT02799095|454299855|FG009|Part C|Withdrawal by Subject|0|||
126275238|NCT02799095|454299856|FG010|Part C|Withdrawal by Subject|13|||
126275239|NCT02799095|454299857|FG011|Part C|Withdrawal by Subject|15|||
126275240|NCT02799095|454299858|FG012|Part C|Withdrawal by Subject|13|||
126275241|NCT02799095|454299859|FG013|Part C|Withdrawal by Subject|21|||
126275242|NCT02799095|454299860|FG014|Part C|Withdrawal by Subject|0|||
126275243|NCT02799095|454299861|FG015|Part C|Withdrawal by Subject|12|||
126275244|NCT02799095|454299862|FG016|Part C|Withdrawal by Subject|1|||
126275245|NCT02799095|454299846|FG000|Part C|Physician Decision|0|||
126275246|NCT02799095|454299847|FG001|Part C|Physician Decision|0|||
126275247|NCT02799095|454299848|FG002|Part C|Physician Decision|0|||
126275248|NCT02799095|454299849|FG003|Part C|Physician Decision|0|||
126275249|NCT02799095|454299850|FG004|Part C|Physician Decision|0|||
126275250|NCT02799095|454299851|FG005|Part C|Physician Decision|0|||
126275251|NCT02799095|454299852|FG006|Part C|Physician Decision|0|||
126275252|NCT02799095|454299853|FG007|Part C|Physician Decision|0|||
126275253|NCT02799095|454299854|FG008|Part C|Physician Decision|0|||
126275254|NCT02799095|454299855|FG009|Part C|Physician Decision|0|||
126275255|NCT02799095|454299856|FG010|Part C|Physician Decision|1|||
126362524|NCT00890097|454619190|FG002|Overall Study|Adverse Event|28|||
126362525|NCT00890097|454619188|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
126275256|NCT02799095|454299857|FG011|Part C|Physician Decision|0|||
126275257|NCT02799095|454299858|FG012|Part C|Physician Decision|0|||
126275258|NCT02799095|454299859|FG013|Part C|Physician Decision|0|||
126275259|NCT02799095|454299860|FG014|Part C|Physician Decision|0|||
126275260|NCT02799095|454299861|FG015|Part C|Physician Decision|0|||
126275261|NCT02799095|454299862|FG016|Part C|Physician Decision|0|||
126275262|NCT02799095|454299846|FG000|Part C|Other|0|||
126275263|NCT02799095|454299847|FG001|Part C|Other|0|||
126275264|NCT02799095|454299848|FG002|Part C|Other|0|||
126275265|NCT02799095|454299849|FG003|Part C|Other|0|||
126275266|NCT02799095|454299850|FG004|Part C|Other|0|||
126275267|NCT02799095|454299851|FG005|Part C|Other|0|||
126275268|NCT02799095|454299852|FG006|Part C|Other|0|||
126275269|NCT02799095|454299853|FG007|Part C|Other|0|||
126275270|NCT02799095|454299854|FG008|Part C|Other|0|||
126275271|NCT02799095|454299855|FG009|Part C|Other|0|||
126275272|NCT02799095|454299856|FG010|Part C|Other|0|||
126275273|NCT02799095|454299857|FG011|Part C|Other|2|||
126275274|NCT02799095|454299858|FG012|Part C|Other|2|||
126275275|NCT02799095|454299859|FG013|Part C|Other|0|||
126275276|NCT02799095|454299860|FG014|Part C|Other|0|||
126275277|NCT02799095|454299861|FG015|Part C|Other|0|||
126275278|NCT02799095|454299862|FG016|Part C|Other|0|||
126275279|NCT03283319|454299863|FG000|Overall Study|Lost to Follow-up|5|||
126275280|NCT03283319|454299864|FG001|Overall Study|Lost to Follow-up|4|||
126275281|NCT03283319|454299865|FG002|Overall Study|Lost to Follow-up|5|||
126275282|NCT03283319|454299866|FG003|Overall Study|Lost to Follow-up|5|||
126275283|NCT03283319|454299867|FG004|Overall Study|Lost to Follow-up|4|||
126275284|NCT03283319|454299868|FG005|Overall Study|Lost to Follow-up|3|||
126275285|NCT03283319|454299863|FG000|Overall Study|Withdrawal by Subject|2|||
126275286|NCT03283319|454299864|FG001|Overall Study|Withdrawal by Subject|2|||
126275287|NCT03283319|454299865|FG002|Overall Study|Withdrawal by Subject|2|||
126275288|NCT03283319|454299866|FG003|Overall Study|Withdrawal by Subject|1|||
126275289|NCT03283319|454299867|FG004|Overall Study|Withdrawal by Subject|0|||
126275290|NCT03283319|454299868|FG005|Overall Study|Withdrawal by Subject|1|||
126275291|NCT03283319|454299863|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
126275292|NCT03283319|454299864|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
126275293|NCT03283319|454299865|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
126275294|NCT03283319|454299866|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
126275295|NCT03283319|454299867|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
126275296|NCT03283319|454299868|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
125880809|NCT02085460|452862636|FG000|Overall Study|Adverse Event|2|||
126275297|NCT00721630|454299869|FG000|Overall Study|Participant found to be ineligible|1|||
126275298|NCT03186781|454299870|FG000|Overall Study|Lost to Follow-up|0|||
126275299|NCT03186781|454299871|FG001|Overall Study|Lost to Follow-up|0|||
126275300|NCT03186781|454299872|FG002|Overall Study|Lost to Follow-up|1|||
126275301|NCT03186781|454299873|FG003|Overall Study|Lost to Follow-up|0|||
126275302|NCT03186781|454299874|FG004|Overall Study|Lost to Follow-up|1|||
126275303|NCT03186781|454299875|FG005|Overall Study|Lost to Follow-up|0|||
126275304|NCT03186781|454299870|FG000|Overall Study|Moved from Area|0|||
126275305|NCT03186781|454299871|FG001|Overall Study|Moved from Area|0|||
126275306|NCT03186781|454299872|FG002|Overall Study|Moved from Area|0|||
126275307|NCT03186781|454299873|FG003|Overall Study|Moved from Area|0|||
126275308|NCT03186781|454299874|FG004|Overall Study|Moved from Area|1|||
126275309|NCT03186781|454299875|FG005|Overall Study|Moved from Area|0|||
126275310|NCT03186781|454299870|FG000|Overall Study|Withdrawal by Subject|0|||
126275311|NCT03186781|454299871|FG001|Overall Study|Withdrawal by Subject|0|||
126275312|NCT03186781|454299872|FG002|Overall Study|Withdrawal by Subject|0|||
126275313|NCT03186781|454299873|FG003|Overall Study|Withdrawal by Subject|0|||
126275314|NCT03186781|454299874|FG004|Overall Study|Withdrawal by Subject|1|||
126275315|NCT03186781|454299875|FG005|Overall Study|Withdrawal by Subject|0|||
126275316|NCT00792935|454299876|FG000|Overall Study|Adverse Event|2|||
126275317|NCT00792935|454299877|FG001|Overall Study|Adverse Event|1|||
126275318|NCT00792935|454299876|FG000|Overall Study|Lost to Follow-up|0|||
126275319|NCT00792935|454299877|FG001|Overall Study|Lost to Follow-up|1|||
126275320|NCT00792935|454299876|FG000|Overall Study|Protocol Violation|2|||
126275321|NCT00792935|454299877|FG001|Overall Study|Protocol Violation|0|||
126275322|NCT00792935|454299876|FG000|Overall Study|Withdrawal by Subject|0|||
126275323|NCT00792935|454299877|FG001|Overall Study|Withdrawal by Subject|1|||
126275324|NCT04663295|454299878|FG000|Run-in Period|Withdrawal by Subject|3|||
126275325|NCT04663295|454299878|FG000|Overall Study Period|Pregnancy|1|||
126275326|NCT04663295|454299878|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
126275327|NCT03954834|454299879|FG000|Overall Study|Adverse Event|1|||
126275328|NCT03954834|454299880|FG001|Overall Study|Adverse Event|3|||
126275329|NCT03954834|454299881|FG002|Overall Study|Adverse Event|1|||
126275330|NCT03954834|454299882|FG003|Overall Study|Adverse Event|1|||
126275331|NCT03954834|454299879|FG000|Overall Study|Death|0|||
126275332|NCT03954834|454299880|FG001|Overall Study|Death|0|||
126275333|NCT03954834|454299881|FG002|Overall Study|Death|0|||
126275334|NCT03954834|454299882|FG003|Overall Study|Death|1|||
126275335|NCT03954834|454299879|FG000|Overall Study|Physician Decision|0|||
126275336|NCT03954834|454299880|FG001|Overall Study|Physician Decision|1|||
126275337|NCT03954834|454299881|FG002|Overall Study|Physician Decision|0|||
126275338|NCT03954834|454299882|FG003|Overall Study|Physician Decision|2|||
126275339|NCT03954834|454299879|FG000|Overall Study|Protocol Violation|1|||
126275340|NCT03954834|454299880|FG001|Overall Study|Protocol Violation|0|||
126275341|NCT03954834|454299881|FG002|Overall Study|Protocol Violation|0|||
126275342|NCT03954834|454299882|FG003|Overall Study|Protocol Violation|1|||
126275343|NCT03954834|454299879|FG000|Overall Study|Withdrawal by Subject|2|||
126275344|NCT03954834|454299880|FG001|Overall Study|Withdrawal by Subject|3|||
126275345|NCT03954834|454299881|FG002|Overall Study|Withdrawal by Subject|13|||
126275346|NCT03954834|454299882|FG003|Overall Study|Withdrawal by Subject|6|||
126275347|NCT03954834|454299879|FG000|Overall Study|Participant left the country|0|||
126275348|NCT03954834|454299880|FG001|Overall Study|Participant left the country|0|||
125880810|NCT02085460|452862637|FG001|Overall Study|Adverse Event|2|||
125880811|NCT02085460|452862638|FG002|Overall Study|Adverse Event|1|||
126275349|NCT03954834|454299881|FG002|Overall Study|Participant left the country|1|||
125880812|NCT02085460|452862636|FG000|Overall Study|Physician Decision|1|||
126275350|NCT03954834|454299882|FG003|Overall Study|Participant left the country|0|||
126275351|NCT03954834|454299879|FG000|Overall Study|Lost to Follow-up|3|||
126275352|NCT03954834|454299880|FG001|Overall Study|Lost to Follow-up|2|||
126275353|NCT03954834|454299881|FG002|Overall Study|Lost to Follow-up|3|||
126275354|NCT03954834|454299882|FG003|Overall Study|Lost to Follow-up|5|||
126275355|NCT01502410|454299885|FG000|Overall Study|Adverse Event|1|||
126275356|NCT01502410|454299886|FG001|Overall Study|Adverse Event|2|||
126275357|NCT01502410|454299887|FG002|Overall Study|Adverse Event|0|||
126275358|NCT01502410|454299888|FG003|Overall Study|Adverse Event|0|||
126275359|NCT01502410|454299885|FG000|Overall Study|Lack of Efficacy|7|||
125880813|NCT02085460|452862637|FG001|Overall Study|Physician Decision|1|||
126275360|NCT01502410|454299886|FG001|Overall Study|Lack of Efficacy|7|||
126275361|NCT01502410|454299887|FG002|Overall Study|Lack of Efficacy|0|||
126275362|NCT01502410|454299888|FG003|Overall Study|Lack of Efficacy|0|||
126275363|NCT01502410|454299885|FG000|Overall Study|Physician Decision|0|||
126275364|NCT01502410|454299886|FG001|Overall Study|Physician Decision|1|||
126275365|NCT01502410|454299887|FG002|Overall Study|Physician Decision|0|||
126275366|NCT01502410|454299888|FG003|Overall Study|Physician Decision|0|||
126275367|NCT01502410|454299885|FG000|Overall Study|Withdrawal by Subject|2|||
125880814|NCT02085460|452862638|FG002|Overall Study|Physician Decision|2|||
125880815|NCT02085460|452862636|FG000|Overall Study|Withdrawal by Subject|11|||
125880816|NCT02085460|452862637|FG001|Overall Study|Withdrawal by Subject|5|||
125880817|NCT02085460|452862638|FG002|Overall Study|Withdrawal by Subject|7|||
125880818|NCT01285323|452862639|FG000|Overall Study|Adverse Event|9|||
125880819|NCT01285323|452862640|FG001|Overall Study|Adverse Event|8|||
125880820|NCT01285323|452862639|FG000|Overall Study|Lack of Efficacy|4|||
125880821|NCT01285323|452862640|FG001|Overall Study|Lack of Efficacy|2|||
125880822|NCT01285323|452862639|FG000|Overall Study|Withdrawal by Subject|15|||
125880823|NCT01285323|452862640|FG001|Overall Study|Withdrawal by Subject|11|||
125880824|NCT01285323|452862639|FG000|Overall Study|Protocol Violation|1|||
125880825|NCT01285323|452862640|FG001|Overall Study|Protocol Violation|2|||
125880826|NCT01285323|452862639|FG000|Overall Study|Non-compliance with study procedures|2|||
125880827|NCT01285323|452862640|FG001|Overall Study|Non-compliance with study procedures|3|||
125880828|NCT01285323|452862639|FG000|Overall Study|Lost to Follow-up|1|||
125880829|NCT01285323|452862640|FG001|Overall Study|Lost to Follow-up|1|||
126275368|NCT01502410|454299886|FG001|Overall Study|Withdrawal by Subject|0|||
125880830|NCT01285323|452862639|FG000|Overall Study|Other|1|||
125880831|NCT01285323|452862640|FG001|Overall Study|Other|3|||
125880832|NCT02703597|452862641|FG000|Assignment to Baseline|Lost to Follow-up|17|||
125880833|NCT02703597|452862642|FG001|Assignment to Baseline|Lost to Follow-up|16|||
125880834|NCT02703597|452862641|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
125880835|NCT02703597|452862642|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
126275369|NCT01502410|454299887|FG002|Overall Study|Withdrawal by Subject|0|||
126275370|NCT01502410|454299888|FG003|Overall Study|Withdrawal by Subject|0|||
126275371|NCT02903030|454299889|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
126275372|NCT02903030|454299890|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126275373|NCT01284361|454299904|FG000|Overall Study|Withdrawal by Subject|1|||
126275374|NCT01284361|454299904|FG000|Overall Study|Protocol Violation|5|||
126275375|NCT01284361|454299904|FG000|Overall Study|Adverse Event|1|||
126275376|NCT01284361|454299904|FG000|Overall Study|Lost to Follow-up|2|||
126275377|NCT00663026|454299905|FG000|Overall Study|Lost to Follow-up|1|||
126275378|NCT00663026|454299906|FG001|Overall Study|Lost to Follow-up|0|||
126275379|NCT00663026|454299907|FG002|Overall Study|Lost to Follow-up|0|||
126275380|NCT00663026|454299905|FG000|Overall Study|Other|1|||
126275381|NCT00663026|454299906|FG001|Overall Study|Other|2|||
126275382|NCT00663026|454299907|FG002|Overall Study|Other|0|||
126275383|NCT00663026|454299905|FG000|Overall Study|Adverse Event|0|||
126275384|NCT00663026|454299906|FG001|Overall Study|Adverse Event|2|||
126275385|NCT00663026|454299907|FG002|Overall Study|Adverse Event|3|||
126275386|NCT00663026|454299905|FG000|Overall Study|Caregiver Request|0|||
126275387|NCT00663026|454299906|FG001|Overall Study|Caregiver Request|2|||
126275388|NCT00663026|454299907|FG002|Overall Study|Caregiver Request|0|||
126275389|NCT00663026|454299905|FG000|Overall Study|Withdrawal by Subject|0|||
126275390|NCT00663026|454299906|FG001|Overall Study|Withdrawal by Subject|0|||
126275391|NCT00663026|454299907|FG002|Overall Study|Withdrawal by Subject|1|||
126275392|NCT01570686|454299908|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126275393|NCT01570686|454299909|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125880836|NCT02703597|452862641|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
125880837|NCT02703597|452862642|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
125880838|NCT02703597|452862641|FG000|First Post-test to First Follow-up|Site drop out|0|||
126275394|NCT01570686|454299908|FG000|Overall Study|Administrative problems|0|||
126275395|NCT01570686|454299909|FG001|Overall Study|Administrative problems|1|||
126275396|NCT01570686|454299908|FG000|Overall Study|Adverse Event|8|||
126275397|NCT01570686|454299909|FG001|Overall Study|Adverse Event|6|||
126275398|NCT01570686|454299908|FG000|Overall Study|Lost to Follow-up|4|||
126275399|NCT01570686|454299909|FG001|Overall Study|Lost to Follow-up|3|||
125880839|NCT02703597|452862642|FG001|First Post-test to First Follow-up|Site drop out|58|||
126037580|NCT03085810|453436736|FG002|Main Study|Physician Decision|0|||
126037581|NCT03085810|453436734|FG000|Main Study|Lost to Follow-up|17|||
126037582|NCT03085810|453436735|FG001|Main Study|Lost to Follow-up|0|||
126037583|NCT03085810|453436736|FG002|Main Study|Lost to Follow-up|0|||
126037584|NCT03085810|453436734|FG000|Main Study|Adverse Event|25|||
126037585|NCT03085810|453436735|FG001|Main Study|Adverse Event|0|||
126037586|NCT03085810|453436736|FG002|Main Study|Adverse Event|0|||
126037587|NCT03085810|453436734|FG000|Main Study|Pregnancy|7|||
126037588|NCT03085810|453436735|FG001|Main Study|Pregnancy|0|||
126037589|NCT03085810|453436736|FG002|Main Study|Pregnancy|0|||
126037590|NCT03085810|453436734|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
126037591|NCT03085810|453436735|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
126037592|NCT03085810|453436736|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
126037593|NCT03085810|453436734|FG000|Main Study|Lack of Efficacy|10|||
126037594|NCT03085810|453436735|FG001|Main Study|Lack of Efficacy|0|||
126037595|NCT03085810|453436736|FG002|Main Study|Lack of Efficacy|0|||
126037596|NCT03085810|453436734|FG000|Main Study|Death|12|||
126037597|NCT03085810|453436735|FG001|Main Study|Death|0|||
126037598|NCT03085810|453436736|FG002|Main Study|Death|0|||
126037599|NCT03085810|453436734|FG000|Main Study|Disease progression|1|||
126037600|NCT03085810|453436735|FG001|Main Study|Disease progression|0|||
126037601|NCT03085810|453436736|FG002|Main Study|Disease progression|0|||
126037602|NCT03085810|453436734|FG000|Main Study|Site Closure|3|||
126037603|NCT03085810|453436735|FG001|Main Study|Site Closure|0|||
126037604|NCT03085810|453436736|FG002|Main Study|Site Closure|0|||
126037605|NCT03085810|453436734|FG000|Main Study|Planned pregnancy|17|||
126037606|NCT03085810|453436735|FG001|Main Study|Planned pregnancy|0|||
126037607|NCT03085810|453436736|FG002|Main Study|Planned pregnancy|0|||
126037608|NCT03085810|453436734|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
126037609|NCT03085810|453436735|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
126037610|NCT03085810|453436736|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
126037611|NCT03085810|453436734|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
126037612|NCT03085810|453436735|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
126037613|NCT03085810|453436736|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
126037614|NCT03085810|453436734|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
126037615|NCT03085810|453436735|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
126037616|NCT03085810|453436736|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
126275400|NCT01570686|454299908|FG000|Overall Study|Protocol Deviation|3|||
126275401|NCT01570686|454299909|FG001|Overall Study|Protocol Deviation|0|||
126275402|NCT01570686|454299908|FG000|Overall Study|Withdrawal by Subject|4|||
126275403|NCT01570686|454299909|FG001|Overall Study|Withdrawal by Subject|4|||
126275404|NCT01570686|454299908|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126275405|NCT01570686|454299909|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126275406|NCT00754650|454299910|FG000|Overall Study|Disease Progression|2|||
126037617|NCT03085810|453436734|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
126037618|NCT03085810|453436735|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
126037619|NCT03085810|453436736|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
126037620|NCT01959607|453436739|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
126037621|NCT01959607|453436740|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
126275407|NCT00805675|454299911|FG000|Overall Study|Adverse Event|0|||
126037622|NCT01959607|453436741|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126275408|NCT00805675|454299912|FG001|Overall Study|Adverse Event|0|||
126275409|NCT00805675|454299913|FG002|Overall Study|Adverse Event|1|||
126275410|NCT00325195|454299917|FG000|Randomized|Not dosed|5|||
126275411|NCT00325195|454299918|FG001|Randomized|Not dosed|5|||
126275412|NCT00325195|454299919|FG002|Randomized|Not dosed|3|||
126275413|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Adverse Event|15|||
126275414|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Adverse Event|17|||
126275415|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Adverse Event|1|||
126275416|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Death|3|||
126275417|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Death|1|||
126275418|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Death|0|||
126275419|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
126275420|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
126275421|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
126275422|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
126275423|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
126275424|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
126275425|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
126275426|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
126275427|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
126275428|NCT00686075|454299921|FG000|Overall Study|Withdrawal by Subject|4|||
126275429|NCT00686075|454299922|FG001|Overall Study|Withdrawal by Subject|3|||
126275430|NCT00686075|454299923|FG002|Overall Study|Withdrawal by Subject|3|||
126275431|NCT00686075|454299924|FG003|Overall Study|Withdrawal by Subject|7|||
126275432|NCT00686075|454299925|FG004|Overall Study|Withdrawal by Subject|1|||
126275433|NCT00686075|454299926|FG005|Overall Study|Withdrawal by Subject|0|||
126275434|NCT00686075|454299927|FG006|Overall Study|Withdrawal by Subject|0|||
126275435|NCT00686075|454299928|FG007|Overall Study|Withdrawal by Subject|2|||
126275436|NCT00686075|454299929|FG008|Overall Study|Withdrawal by Subject|4|||
126275437|NCT00686075|454299930|FG009|Overall Study|Withdrawal by Subject|6|||
126275438|NCT00686075|454299921|FG000|Overall Study|Lost to Follow-up|3|||
126275439|NCT00686075|454299922|FG001|Overall Study|Lost to Follow-up|6|||
126275440|NCT00686075|454299923|FG002|Overall Study|Lost to Follow-up|3|||
126275441|NCT00686075|454299924|FG003|Overall Study|Lost to Follow-up|2|||
126275442|NCT00686075|454299925|FG004|Overall Study|Lost to Follow-up|3|||
126275443|NCT00686075|454299926|FG005|Overall Study|Lost to Follow-up|3|||
126275444|NCT00686075|454299927|FG006|Overall Study|Lost to Follow-up|0|||
126275445|NCT00686075|454299928|FG007|Overall Study|Lost to Follow-up|0|||
126275446|NCT00686075|454299929|FG008|Overall Study|Lost to Follow-up|2|||
126275447|NCT00686075|454299930|FG009|Overall Study|Lost to Follow-up|3|||
126275448|NCT00686075|454299921|FG000|Overall Study|Other|1|||
126275449|NCT00686075|454299922|FG001|Overall Study|Other|1|||
126275450|NCT00686075|454299923|FG002|Overall Study|Other|0|||
126275451|NCT00686075|454299924|FG003|Overall Study|Other|0|||
126275452|NCT00686075|454299925|FG004|Overall Study|Other|0|||
126275453|NCT00686075|454299926|FG005|Overall Study|Other|0|||
126275454|NCT00686075|454299927|FG006|Overall Study|Other|0|||
126275455|NCT00686075|454299928|FG007|Overall Study|Other|0|||
126275456|NCT00686075|454299929|FG008|Overall Study|Other|0|||
126275457|NCT00686075|454299930|FG009|Overall Study|Other|1|||
126275458|NCT04715932|454299931|FG000|Overall Study|Lost to Follow-up|1|||
126275459|NCT04715932|454299932|FG001|Overall Study|Lost to Follow-up|0|||
126275460|NCT02740699|454299944|FG000|Overall Study|Lost to Follow-up|5|||
126275461|NCT02740699|454299944|FG000|Overall Study|Withdrawal by Subject|14|||
126275462|NCT02740699|454299944|FG000|Overall Study|Physician Decision|5|||
126275463|NCT03783039|454299946|FG000|Overall Study|Death|2|||
126275464|NCT03783039|454299947|FG001|Overall Study|Death|1|||
126275465|NCT01682863|454299948|FG000|Overall Study|Subject/guardian decision|19|||
126275466|NCT01682863|454299949|FG001|Overall Study|Subject/guardian decision|12|||
126275467|NCT01682863|454299950|FG002|Overall Study|Subject/guardian decision|10|||
126275468|NCT01682863|454299948|FG000|Overall Study|Lost to Follow-up|5|||
126275469|NCT01682863|454299949|FG001|Overall Study|Lost to Follow-up|1|||
126275470|NCT01682863|454299950|FG002|Overall Study|Lost to Follow-up|6|||
126275471|NCT01682863|454299948|FG000|Overall Study|Death|1|||
126275472|NCT01682863|454299949|FG001|Overall Study|Death|3|||
126275473|NCT01682863|454299950|FG002|Overall Study|Death|4|||
126362526|NCT00890097|454619189|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
126362527|NCT00890097|454619190|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
126362528|NCT00890097|454619188|FG000|Overall Study|Withdrew Consent|9|||
126362529|NCT00890097|454619189|FG001|Overall Study|Withdrew Consent|6|||
126362530|NCT00890097|454619190|FG002|Overall Study|Withdrew Consent|9|||
126362531|NCT00890097|454619188|FG000|Overall Study|Lost to Follow-up|5|||
126362532|NCT00890097|454619189|FG001|Overall Study|Lost to Follow-up|5|||
126275474|NCT01682863|454299948|FG000|Overall Study|Protocol deviation|1|||
126362533|NCT00890097|454619190|FG002|Overall Study|Lost to Follow-up|5|||
126362534|NCT00890097|454619188|FG000|Overall Study|Noncompliance|0|||
126037623|NCT01959607|453436742|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
126037624|NCT03235544|453436746|FG000|Overall Study|Death|11|||
126037625|NCT03235544|453436747|FG001|Overall Study|Death|31|||
126037626|NCT03235544|453436748|FG002|Overall Study|Death|19|||
126037627|NCT03235544|453436749|FG003|Overall Study|Death|34|||
126037628|NCT03235544|453436746|FG000|Overall Study|Lost to Follow-up|0|||
126037629|NCT03235544|453436747|FG001|Overall Study|Lost to Follow-up|1|||
126037630|NCT03235544|453436748|FG002|Overall Study|Lost to Follow-up|1|||
126037631|NCT03235544|453436749|FG003|Overall Study|Lost to Follow-up|1|||
126037632|NCT03235544|453436746|FG000|Overall Study|Withdrawal by Subject|0|||
126037633|NCT03235544|453436747|FG001|Overall Study|Withdrawal by Subject|3|||
126037634|NCT03235544|453436748|FG002|Overall Study|Withdrawal by Subject|1|||
126037635|NCT03235544|453436749|FG003|Overall Study|Withdrawal by Subject|5|||
126037636|NCT03235544|453436746|FG000|Overall Study|Disease Progression|0|||
126037637|NCT03235544|453436747|FG001|Overall Study|Disease Progression|1|||
126037638|NCT03235544|453436748|FG002|Overall Study|Disease Progression|0|||
126037639|NCT03235544|453436749|FG003|Overall Study|Disease Progression|2|||
126037640|NCT03235544|453436746|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
126037641|NCT03235544|453436747|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
126037642|NCT03235544|453436748|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
126037643|NCT03235544|453436749|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
126037644|NCT03235544|453436746|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
126037645|NCT03235544|453436747|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
126037646|NCT03235544|453436748|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
126037647|NCT03235544|453436749|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
126037648|NCT00950742|453436750|FG000|Overall Study|Other Adverse Event|1|||
125880840|NCT02703597|452862641|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
125880841|NCT02703597|452862642|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
125880842|NCT02703597|452862641|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
125885161|NCT03847896|452876793|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
126037649|NCT00950742|453436751|FG001|Overall Study|Other Adverse Event|0|||
126037650|NCT00950742|453436750|FG000|Overall Study|Withdrawal by Subject|3|||
126037651|NCT00950742|453436751|FG001|Overall Study|Withdrawal by Subject|0|||
126037652|NCT00950742|453436750|FG000|Overall Study|Progressive Disease|6|||
126037653|NCT00950742|453436751|FG001|Overall Study|Progressive Disease|2|||
126037654|NCT00950742|453436750|FG000|Overall Study|Dose limiting toxicity|6|||
126037655|NCT00950742|453436751|FG001|Overall Study|Dose limiting toxicity|0|||
126098643|NCT01506609|453653087|FG005|Overall Study|Adverse Event Related to Progression|3|||
126098644|NCT01506609|453653082|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
126098645|NCT01506609|453653083|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
126098646|NCT01506609|453653084|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
126098647|NCT01506609|453653085|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
126098648|NCT01506609|453653086|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
126098649|NCT01506609|453653087|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
126098650|NCT01506609|453653082|FG000|Overall Study|Withdrawal by Subject|0|||
126098651|NCT01506609|453653083|FG001|Overall Study|Withdrawal by Subject|0|||
126098652|NCT01506609|453653084|FG002|Overall Study|Withdrawal by Subject|0|||
126275475|NCT01682863|454299949|FG001|Overall Study|Protocol deviation|0|||
126275476|NCT01682863|454299950|FG002|Overall Study|Protocol deviation|1|||
126275477|NCT01682863|454299948|FG000|Overall Study|Technical problems|1|||
126275478|NCT01682863|454299949|FG001|Overall Study|Technical problems|0|||
126275479|NCT01682863|454299950|FG002|Overall Study|Technical problems|0|||
126275480|NCT01682863|454299948|FG000|Overall Study|Adverse Event|0|||
126098653|NCT01506609|453653085|FG003|Overall Study|Withdrawal by Subject|9|||
126098654|NCT01506609|453653086|FG004|Overall Study|Withdrawal by Subject|7|||
126098655|NCT01506609|453653087|FG005|Overall Study|Withdrawal by Subject|7|||
126098656|NCT01506609|453653082|FG000|Overall Study|Lost to Follow-up|0|||
126275481|NCT01682863|454299949|FG001|Overall Study|Adverse Event|1|||
126362535|NCT00890097|454619189|FG001|Overall Study|Noncompliance|4|||
126362536|NCT00890097|454619190|FG002|Overall Study|Noncompliance|4|||
126362537|NCT00890097|454619188|FG000|Overall Study|Sponsor Decision|7|||
126362538|NCT00890097|454619189|FG001|Overall Study|Sponsor Decision|11|||
126362539|NCT00890097|454619190|FG002|Overall Study|Sponsor Decision|7|||
126362540|NCT00890097|454619188|FG000|Overall Study|Did not attend final visit|2|||
126362541|NCT00890097|454619189|FG001|Overall Study|Did not attend final visit|3|||
126362542|NCT00890097|454619190|FG002|Overall Study|Did not attend final visit|0|||
126362543|NCT00890097|454619188|FG000|Overall Study|Subject Decision|3|||
126362544|NCT00890097|454619189|FG001|Overall Study|Subject Decision|2|||
126362545|NCT00890097|454619190|FG002|Overall Study|Subject Decision|6|||
126362546|NCT00890097|454619188|FG000|Overall Study|Randomization Error|2|||
126362547|NCT00890097|454619189|FG001|Overall Study|Randomization Error|0|||
126362548|NCT00890097|454619190|FG002|Overall Study|Randomization Error|0|||
126362549|NCT00890097|454619188|FG000|Overall Study|Failed inclusion criteria|3|||
126362550|NCT00890097|454619189|FG001|Overall Study|Failed inclusion criteria|4|||
126362551|NCT00890097|454619190|FG002|Overall Study|Failed inclusion criteria|0|||
125880843|NCT02703597|452862642|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
125880844|NCT02703597|452862641|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
125880845|NCT02703597|452862642|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
125880846|NCT03879772|452862644|FG000|Overall Study|Adverse Event|2|||
125880847|NCT03879772|452862645|FG001|Overall Study|Adverse Event|2|||
125880848|NCT03879772|452862646|FG002|Overall Study|Adverse Event|3|||
125880849|NCT03879772|452862647|FG003|Overall Study|Adverse Event|4|||
125880850|NCT03879772|452862648|FG004|Overall Study|Adverse Event|3|||
125880851|NCT03879772|452862644|FG000|Overall Study|Treatment Failure|1|||
125880852|NCT03879772|452862645|FG001|Overall Study|Treatment Failure|0|||
125880853|NCT03879772|452862646|FG002|Overall Study|Treatment Failure|0|||
125880854|NCT03879772|452862647|FG003|Overall Study|Treatment Failure|2|||
125880855|NCT03879772|452862648|FG004|Overall Study|Treatment Failure|1|||
125880856|NCT03879772|452862644|FG000|Overall Study|Lost to Follow-up|0|||
125880857|NCT03879772|452862645|FG001|Overall Study|Lost to Follow-up|0|||
125880858|NCT03879772|452862646|FG002|Overall Study|Lost to Follow-up|0|||
125880859|NCT03879772|452862647|FG003|Overall Study|Lost to Follow-up|0|||
125880860|NCT03879772|452862648|FG004|Overall Study|Lost to Follow-up|1|||
125880861|NCT03879772|452862644|FG000|Overall Study|Withdrawal by Subject|0|||
125880862|NCT03879772|452862645|FG001|Overall Study|Withdrawal by Subject|1|||
125880863|NCT03879772|452862646|FG002|Overall Study|Withdrawal by Subject|3|||
125880864|NCT03879772|452862647|FG003|Overall Study|Withdrawal by Subject|1|||
125880865|NCT03879772|452862648|FG004|Overall Study|Withdrawal by Subject|1|||
125880866|NCT03879772|452862644|FG000|Overall Study|Protocol Violation|0|||
125880867|NCT03879772|452862645|FG001|Overall Study|Protocol Violation|0|||
126275482|NCT01682863|454299950|FG002|Overall Study|Adverse Event|2|||
126275483|NCT01682863|454299948|FG000|Overall Study|Physician Decision|0|||
126275484|NCT01682863|454299949|FG001|Overall Study|Physician Decision|0|||
126275485|NCT01682863|454299950|FG002|Overall Study|Physician Decision|1|||
126275486|NCT00918138|454299951|FG000|Overall Study|Subject withdrew consent|1|||
126275487|NCT00918138|454299952|FG001|Overall Study|Subject withdrew consent|1|||
126275488|NCT00918138|454299951|FG000|Overall Study|Death|1|||
126275489|NCT00918138|454299952|FG001|Overall Study|Death|0|||
126275490|NCT00552578|454299956|FG000|Overall Study|Lost to Follow-up|1|||
126275491|NCT00552578|454299957|FG001|Overall Study|Lost to Follow-up|1|||
126275492|NCT01136967|454299958|FG000|Overall Study|Adverse Event|9|||
126275493|NCT01136967|454299959|FG001|Overall Study|Adverse Event|12|||
126275494|NCT01136967|454299958|FG000|Overall Study|Participant Choice|8|||
126275495|NCT01136967|454299959|FG001|Overall Study|Participant Choice|3|||
126275496|NCT01136967|454299958|FG000|Overall Study|Lost to Follow-up|0|||
126275497|NCT01136967|454299959|FG001|Overall Study|Lost to Follow-up|1|||
126275498|NCT01136967|454299958|FG000|Overall Study|Withdrawal by Subject|1|||
126275499|NCT01136967|454299959|FG001|Overall Study|Withdrawal by Subject|2|||
126275500|NCT01136967|454299958|FG000|Overall Study|Clinical Progression|3|||
126275501|NCT01136967|454299959|FG001|Overall Study|Clinical Progression|5|||
126275502|NCT01136967|454299958|FG000|Overall Study|Radiation|1|||
126275503|NCT01136967|454299959|FG001|Overall Study|Radiation|0|||
126362552|NCT00890097|454619188|FG000|Overall Study|Transportation|0|||
126362553|NCT00890097|454619189|FG001|Overall Study|Transportation|2|||
125880868|NCT03879772|452862646|FG002|Overall Study|Protocol Violation|3|||
125880869|NCT03879772|452862647|FG003|Overall Study|Protocol Violation|1|||
125880870|NCT03879772|452862648|FG004|Overall Study|Protocol Violation|2|||
125880871|NCT03879772|452862644|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
126275504|NCT01136967|454299958|FG000|Overall Study|Non-compliance|1|||
126275505|NCT01136967|454299959|FG001|Overall Study|Non-compliance|0|||
126275506|NCT01136967|454299958|FG000|Overall Study|Investigator's Choice|1|||
126275507|NCT01136967|454299959|FG001|Overall Study|Investigator's Choice|1|||
126362554|NCT00890097|454619190|FG002|Overall Study|Transportation|0|||
126362555|NCT00890097|454619188|FG000|Overall Study|Subject Moved|0|||
126362556|NCT00890097|454619189|FG001|Overall Study|Subject Moved|4|||
126362557|NCT00890097|454619190|FG002|Overall Study|Subject Moved|0|||
126362558|NCT00890097|454619188|FG000|Overall Study|Protocol Deviation|1|||
125880872|NCT03879772|452862645|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
125880873|NCT03879772|452862646|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
125880874|NCT03879772|452862647|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
125880875|NCT03879772|452862648|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
125880876|NCT03818321|452862651|FG000|Overall Study|Withdrawal by Subject|1|||
125880877|NCT03818321|452862652|FG001|Overall Study|Withdrawal by Subject|2|||
125880878|NCT00106704|452862653|FG000|Overall Study|Adverse Event|10|||
125880879|NCT00106704|452862654|FG001|Overall Study|Adverse Event|7|||
125880880|NCT00106704|452862653|FG000|Overall Study|Death|2|||
125880881|NCT00106704|452862654|FG001|Overall Study|Death|1|||
125880882|NCT00106704|452862653|FG000|Overall Study|Lack of Efficacy|67|||
125880883|NCT00106704|452862654|FG001|Overall Study|Lack of Efficacy|69|||
125880884|NCT00106704|452862653|FG000|Overall Study|Lost to Follow-up|7|||
125880885|NCT00106704|452862654|FG001|Overall Study|Lost to Follow-up|3|||
125880886|NCT00106704|452862653|FG000|Overall Study|Pregnancy|1|||
125880887|NCT00106704|452862654|FG001|Overall Study|Pregnancy|0|||
125880888|NCT00106704|452862653|FG000|Overall Study|Protocol Violation|4|||
125880889|NCT00106704|452862654|FG001|Overall Study|Protocol Violation|7|||
125880890|NCT00106704|452862653|FG000|Overall Study|Withdrawal by Subject|14|||
125880891|NCT00106704|452862654|FG001|Overall Study|Withdrawal by Subject|21|||
125880892|NCT00106704|452862653|FG000|Overall Study|Patient moved|1|||
125880893|NCT00106704|452862654|FG001|Overall Study|Patient moved|0|||
125880894|NCT00106704|452862653|FG000|Overall Study|Site terminated|0|||
125880895|NCT00106704|452862654|FG001|Overall Study|Site terminated|1|||
125880896|NCT00106704|452862653|FG000|Overall Study|Planned major surgery|1|||
125880897|NCT00106704|452862654|FG001|Overall Study|Planned major surgery|0|||
125880898|NCT00106704|452862653|FG000|Overall Study|Patient Received Glycemic Medication|22|||
125880899|NCT00106704|452862654|FG001|Overall Study|Patient Received Glycemic Medication|41|||
125880900|NCT00106704|452862653|FG000|Overall Study|Unable to re-enter US|1|||
126098657|NCT01506609|453653083|FG001|Overall Study|Lost to Follow-up|0|||
126098658|NCT01506609|453653084|FG002|Overall Study|Lost to Follow-up|0|||
126098659|NCT01506609|453653085|FG003|Overall Study|Lost to Follow-up|1|||
126275508|NCT01136967|454299958|FG000|Overall Study|Increase in Lesion Size|0|||
126275509|NCT01136967|454299959|FG001|Overall Study|Increase in Lesion Size|2|||
126275510|NCT01136967|454299958|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
126275511|NCT01136967|454299959|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
126275512|NCT02885181|454299960|FG000|Overall Study|Investigator's Discretion|0|||
126275513|NCT02885181|454299961|FG001|Overall Study|Investigator's Discretion|1|||
126275514|NCT02885181|454299962|FG002|Overall Study|Investigator's Discretion|0|||
126275515|NCT02885181|454299963|FG003|Overall Study|Investigator's Discretion|1|||
126275516|NCT02885181|454299960|FG000|Overall Study|Adverse Event|0|||
126275517|NCT02885181|454299961|FG001|Overall Study|Adverse Event|0|||
126275518|NCT02885181|454299962|FG002|Overall Study|Adverse Event|0|||
126275519|NCT02885181|454299963|FG003|Overall Study|Adverse Event|1|||
126275520|NCT02885181|454299960|FG000|Overall Study|Withdrawal by Subject|0|||
126275521|NCT02885181|454299961|FG001|Overall Study|Withdrawal by Subject|0|||
126275522|NCT02885181|454299962|FG002|Overall Study|Withdrawal by Subject|0|||
126275523|NCT02885181|454299963|FG003|Overall Study|Withdrawal by Subject|1|||
126275524|NCT01716715|454299964|FG000|Overall Study|Never Treated|2|||
126275525|NCT01716715|454299965|FG001|Overall Study|Never Treated|4|||
126275526|NCT04228783|454299966|FG000|Overall Study|Adverse Event|1|||
126275527|NCT04228783|454299967|FG001|Overall Study|Adverse Event|0|||
126275528|NCT04228783|454299968|FG002|Overall Study|Adverse Event|2|||
126275529|NCT04228783|454299969|FG003|Overall Study|Adverse Event|0|||
126362559|NCT00890097|454619189|FG001|Overall Study|Protocol Deviation|1|||
126362560|NCT00890097|454619190|FG002|Overall Study|Protocol Deviation|1|||
126362561|NCT00954538|454619191|FG000|Part III|Withdrawal by Subject|0|||
126362562|NCT00954538|454619192|FG001|Part III|Withdrawal by Subject|0|||
126362563|NCT00954538|454619193|FG002|Part III|Withdrawal by Subject|0|||
126362564|NCT00954538|454619194|FG003|Part III|Withdrawal by Subject|0|||
126362565|NCT00954538|454619195|FG004|Part III|Withdrawal by Subject|1|||
126362566|NCT00954538|454619196|FG005|Part III|Withdrawal by Subject|0|||
126362567|NCT03178942|454619200|FG000|Overall Study|Withdrawal by Subject|2|||
126362568|NCT03178942|454619201|FG001|Overall Study|Withdrawal by Subject|0|||
126362569|NCT03178942|454619200|FG000|Overall Study|Lost to Follow-up|1|||
126362570|NCT03178942|454619201|FG001|Overall Study|Lost to Follow-up|2|||
125880901|NCT00106704|452862654|FG001|Overall Study|Unable to re-enter US|0|||
125880902|NCT00106704|452862653|FG000|Overall Study|Laboratory test|1|||
126275530|NCT04228783|454299970|FG004|Overall Study|Adverse Event|0|||
125880903|NCT00106704|452862654|FG001|Overall Study|Laboratory test|1|||
125880904|NCT03216226|452862657|FG000|Overall Study|Adverse Event|3|||
125880905|NCT03216226|452862658|FG001|Overall Study|Adverse Event|0|||
125880906|NCT03216226|452862657|FG000|Overall Study|Protocol Violation|1|||
126275531|NCT04228783|454299971|FG005|Overall Study|Adverse Event|1|||
126275532|NCT04228783|454299966|FG000|Overall Study|Death|0|||
126275533|NCT04228783|454299967|FG001|Overall Study|Death|0|||
126362571|NCT00107614|454621548|FG000|Overall Study|Physician Decision|10|||
126362572|NCT00107614|454621548|FG000|Overall Study|Death|2|||
126362573|NCT02715856|454621552|FG000|Overall Study|Software Issues|12|||
126362574|NCT02715856|454621553|FG001|Overall Study|Software Issues|7|||
126362575|NCT02715856|454621552|FG000|Overall Study|Death|6|||
126362576|NCT02715856|454621553|FG001|Overall Study|Death|5|||
126362577|NCT02715856|454621552|FG000|Overall Study|Non- Compliant|0|||
126362578|NCT02715856|454621553|FG001|Overall Study|Non- Compliant|40|||
126362579|NCT01772693|454621554|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
126362580|NCT01772693|454621555|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
126362581|NCT01772693|454621554|FG000|Overall Study|Withdrawal by Subject|2|||
126362582|NCT01772693|454621555|FG001|Overall Study|Withdrawal by Subject|0|||
126362583|NCT01772693|454621554|FG000|Overall Study|Alternative Treatment|2|||
126362584|NCT01772693|454621555|FG001|Overall Study|Alternative Treatment|0|||
126362585|NCT02094885|454621558|FG000|Overall Study|Death|1|||
126362586|NCT02094885|454621559|FG001|Overall Study|Death|5|||
126362587|NCT02094885|454621558|FG000|Overall Study|Withdrawn due to age|1|||
126362588|NCT02094885|454621559|FG001|Overall Study|Withdrawn due to age|0|||
126362589|NCT00215553|454621568|FG000|Overall Study|Adverse Event|0|||
126362590|NCT00215553|454621569|FG001|Overall Study|Adverse Event|1|||
126362591|NCT00215553|454621570|FG002|Overall Study|Adverse Event|2|||
126362592|NCT00215553|454621571|FG003|Overall Study|Adverse Event|1|||
126362593|NCT00215553|454621572|FG004|Overall Study|Adverse Event|2|||
126362594|NCT00215553|454621573|FG005|Overall Study|Adverse Event|6|||
126362595|NCT00215553|454621574|FG006|Overall Study|Adverse Event|0|||
126362596|NCT00756314|454621575|FG000|Overall Study|Lost to Follow-up|2|||
126362597|NCT00756314|454621576|FG001|Overall Study|Lost to Follow-up|59|||
126362598|NCT02605967|454621578|FG000|Overall Study|subject / guardian decision|1|||
126362599|NCT02605967|454621579|FG001|Overall Study|subject / guardian decision|2|||
126362600|NCT02605967|454621578|FG000|Overall Study|Physician Decision|10|||
126362601|NCT02605967|454621579|FG001|Overall Study|Physician Decision|1|||
126362602|NCT02605967|454621578|FG000|Overall Study|Death|4|||
126362603|NCT02605967|454621579|FG001|Overall Study|Death|2|||
126362604|NCT02605967|454621578|FG000|Overall Study|Adverse Event|1|||
126362605|NCT02605967|454621579|FG001|Overall Study|Adverse Event|0|||
126362606|NCT02605967|454621578|FG000|Overall Study|progressive disease|66|||
126362607|NCT02605967|454621579|FG001|Overall Study|progressive disease|35|||
126362608|NCT00159874|454621584|FG000|Overall Study|Adverse Event|2|||
126362609|NCT00159874|454621585|FG001|Overall Study|Adverse Event|2|||
126362610|NCT00159874|454621586|FG002|Overall Study|Adverse Event|5|||
126362611|NCT00159874|454621587|FG003|Overall Study|Adverse Event|1|||
126362612|NCT00159874|454621588|FG004|Overall Study|Adverse Event|1|||
126362613|NCT00159874|454621589|FG005|Overall Study|Adverse Event|2|||
126362614|NCT00159874|454621590|FG006|Overall Study|Adverse Event|0|||
126362615|NCT00159874|454621584|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
126362616|NCT00159874|454621585|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
126362617|NCT00159874|454621586|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
126362618|NCT00159874|454621587|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
126362619|NCT00159874|454621588|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
126275534|NCT04228783|454299968|FG002|Overall Study|Death|0|||
126275535|NCT04228783|454299969|FG003|Overall Study|Death|0|||
126275536|NCT04228783|454299970|FG004|Overall Study|Death|1|||
126275537|NCT04228783|454299971|FG005|Overall Study|Death|0|||
126275538|NCT04228783|454299966|FG000|Overall Study|Lost to Follow-up|36|||
126275539|NCT04228783|454299967|FG001|Overall Study|Lost to Follow-up|36|||
126275540|NCT04228783|454299968|FG002|Overall Study|Lost to Follow-up|28|||
126275541|NCT04228783|454299969|FG003|Overall Study|Lost to Follow-up|6|||
126275542|NCT04228783|454299970|FG004|Overall Study|Lost to Follow-up|14|||
126275543|NCT04228783|454299971|FG005|Overall Study|Lost to Follow-up|3|||
126275544|NCT04228783|454299966|FG000|Overall Study|Physician Decision|1|||
126275545|NCT04228783|454299967|FG001|Overall Study|Physician Decision|2|||
126275546|NCT04228783|454299968|FG002|Overall Study|Physician Decision|0|||
126275547|NCT04228783|454299969|FG003|Overall Study|Physician Decision|0|||
126275548|NCT04228783|454299970|FG004|Overall Study|Physician Decision|0|||
126275549|NCT04228783|454299971|FG005|Overall Study|Physician Decision|0|||
126275550|NCT04228783|454299966|FG000|Overall Study|Protocol Violation|0|||
126275551|NCT04228783|454299967|FG001|Overall Study|Protocol Violation|0|||
126275552|NCT04228783|454299968|FG002|Overall Study|Protocol Violation|0|||
126275553|NCT04228783|454299969|FG003|Overall Study|Protocol Violation|1|||
126275554|NCT04228783|454299970|FG004|Overall Study|Protocol Violation|0|||
126275555|NCT04228783|454299971|FG005|Overall Study|Protocol Violation|0|||
126275556|NCT04228783|454299966|FG000|Overall Study|Withdrawal by Subject|6|||
126275557|NCT04228783|454299967|FG001|Overall Study|Withdrawal by Subject|10|||
126275558|NCT04228783|454299968|FG002|Overall Study|Withdrawal by Subject|19|||
126275559|NCT04228783|454299969|FG003|Overall Study|Withdrawal by Subject|1|||
126275560|NCT04228783|454299970|FG004|Overall Study|Withdrawal by Subject|2|||
126275561|NCT04228783|454299971|FG005|Overall Study|Withdrawal by Subject|0|||
126275562|NCT04228783|454299966|FG000|Overall Study|Other|4|||
126275563|NCT04228783|454299967|FG001|Overall Study|Other|3|||
126275564|NCT04228783|454299968|FG002|Overall Study|Other|2|||
126275565|NCT04228783|454299969|FG003|Overall Study|Other|1|||
126275566|NCT04228783|454299970|FG004|Overall Study|Other|0|||
126275567|NCT04228783|454299971|FG005|Overall Study|Other|0|||
126275568|NCT00626392|454299972|FG000|Run-in Period|Adverse Event|0|||
126275569|NCT00626392|454299973|FG001|Run-in Period|Adverse Event|0|||
126275570|NCT00626392|454299974|FG002|Run-in Period|Adverse Event|1|||
126275571|NCT00626392|454299975|FG003|Run-in Period|Adverse Event|0|||
126275572|NCT00626392|454299976|FG004|Run-in Period|Adverse Event|1|||
126275573|NCT00626392|454299977|FG005|Run-in Period|Adverse Event|0|||
126275574|NCT00626392|454299972|FG000|Run-in Period|Withdrawal by Subject|0|||
126275575|NCT00626392|454299973|FG001|Run-in Period|Withdrawal by Subject|1|||
126275576|NCT00626392|454299974|FG002|Run-in Period|Withdrawal by Subject|1|||
126275577|NCT00626392|454299975|FG003|Run-in Period|Withdrawal by Subject|1|||
126275578|NCT00626392|454299976|FG004|Run-in Period|Withdrawal by Subject|3|||
126275579|NCT00626392|454299977|FG005|Run-in Period|Withdrawal by Subject|1|||
126275580|NCT00626392|454299972|FG000|Run-in Period|Noncompliance|1|||
126275581|NCT00626392|454299973|FG001|Run-in Period|Noncompliance|0|||
126275582|NCT00626392|454299974|FG002|Run-in Period|Noncompliance|1|||
126275583|NCT00626392|454299975|FG003|Run-in Period|Noncompliance|0|||
126275584|NCT00626392|454299976|FG004|Run-in Period|Noncompliance|0|||
126275585|NCT00626392|454299977|FG005|Run-in Period|Noncompliance|0|||
126275586|NCT00626392|454299972|FG000|Coadministration Period|Adverse Event|3|||
126275587|NCT00626392|454299973|FG001|Coadministration Period|Adverse Event|1|||
126275588|NCT00626392|454299974|FG002|Coadministration Period|Adverse Event|7|||
126275589|NCT00626392|454299975|FG003|Coadministration Period|Adverse Event|4|||
126275590|NCT00626392|454299976|FG004|Coadministration Period|Adverse Event|3|||
126275591|NCT00626392|454299977|FG005|Coadministration Period|Adverse Event|4|||
126275592|NCT00626392|454299972|FG000|Coadministration Period|Withdrawal by Subject|1|||
126275593|NCT00626392|454299973|FG001|Coadministration Period|Withdrawal by Subject|1|||
126275594|NCT00626392|454299974|FG002|Coadministration Period|Withdrawal by Subject|0|||
126275595|NCT00626392|454299975|FG003|Coadministration Period|Withdrawal by Subject|1|||
126275596|NCT00626392|454299976|FG004|Coadministration Period|Withdrawal by Subject|0|||
126275597|NCT00626392|454299977|FG005|Coadministration Period|Withdrawal by Subject|1|||
126275598|NCT00626392|454299972|FG000|Coadministration Period|Protocol Violation|0|||
126275599|NCT00626392|454299973|FG001|Coadministration Period|Protocol Violation|1|||
126275600|NCT00626392|454299974|FG002|Coadministration Period|Protocol Violation|0|||
126275601|NCT00626392|454299975|FG003|Coadministration Period|Protocol Violation|1|||
126275602|NCT00626392|454299976|FG004|Coadministration Period|Protocol Violation|1|||
126275603|NCT00626392|454299977|FG005|Coadministration Period|Protocol Violation|0|||
126275604|NCT00626392|454299972|FG000|Coadministration Period|Other|0|||
126275605|NCT00626392|454299973|FG001|Coadministration Period|Other|2|||
126275606|NCT00626392|454299974|FG002|Coadministration Period|Other|3|||
126275607|NCT00626392|454299975|FG003|Coadministration Period|Other|1|||
126275608|NCT00626392|454299976|FG004|Coadministration Period|Other|1|||
126275609|NCT00626392|454299977|FG005|Coadministration Period|Other|1|||
126275610|NCT03327792|454299978|FG000|Overall Study|Adverse Event|4|||
126275611|NCT03327792|454299979|FG001|Overall Study|Adverse Event|0|||
126275612|NCT03327792|454299978|FG000|Overall Study|Family/Personal issues|3|||
125880907|NCT03216226|452862658|FG001|Overall Study|Protocol Violation|3|||
125880908|NCT03216226|452862657|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
125880909|NCT03216226|452862658|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
125880910|NCT03216226|452862657|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
125880911|NCT03216226|452862658|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
125880912|NCT03216226|452862657|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
125880913|NCT03216226|452862658|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
125880914|NCT00871975|452862661|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
125880915|NCT00871975|452862661|FG000|Overall Study|Catheters could not be inserted|1|||
125880916|NCT00871975|452862661|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
125880917|NCT00871975|452862661|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
125880918|NCT05249582|452862662|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
125880919|NCT05249582|452862663|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
125880920|NCT05249582|452862662|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
125880921|NCT05249582|452862663|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
125880922|NCT05249582|452862662|FG000|Overall Study|Declined to use virtual reality headset|1|||
125880923|NCT05249582|452862663|FG001|Overall Study|Declined to use virtual reality headset|0|||
125880924|NCT00283296|452862664|FG000|Overall Study|in-home trial not completed|5|||
125880925|NCT02668653|452862665|FG000|Overall Study|Refractory disease|41|||
125880926|NCT02668653|452862666|FG001|Overall Study|Refractory disease|70|||
125880927|NCT02668653|452862665|FG000|Overall Study|Relapse|44|||
125880928|NCT02668653|452862666|FG001|Overall Study|Relapse|65|||
125880929|NCT02668653|452862665|FG000|Overall Study|Adverse Event|58|||
125880930|NCT02668653|452862666|FG001|Overall Study|Adverse Event|23|||
125880931|NCT02668653|452862665|FG000|Overall Study|Subject decision to stop study drug|25|||
125880932|NCT02668653|452862666|FG001|Overall Study|Subject decision to stop study drug|23|||
125880933|NCT02668653|452862665|FG000|Overall Study|Other reasons not specified|16|||
126275613|NCT03327792|454299979|FG001|Overall Study|Family/Personal issues|2|||
126275614|NCT03327792|454299978|FG000|Overall Study|Lost to Follow-up|0|||
126275615|NCT03327792|454299979|FG001|Overall Study|Lost to Follow-up|1|||
126275616|NCT03151811|454299984|FG000|Overall Study|Randomized But Not Treated|18|||
126275617|NCT03151811|454299985|FG001|Overall Study|Randomized But Not Treated|3|||
126275618|NCT03151811|454299984|FG000|Overall Study|Progressive Disease|130|||
126275619|NCT03151811|454299985|FG001|Overall Study|Progressive Disease|170|||
126275620|NCT03151811|454299984|FG000|Overall Study|Adverse Event|49|||
126275621|NCT03151811|454299985|FG001|Overall Study|Adverse Event|40|||
126275622|NCT03151811|454299984|FG000|Overall Study|Lack of Efficacy|6|||
126275623|NCT03151811|454299985|FG001|Overall Study|Lack of Efficacy|8|||
126275624|NCT03151811|454299984|FG000|Overall Study|Physician Decision|21|||
126275625|NCT03151811|454299985|FG001|Overall Study|Physician Decision|9|||
126275626|NCT03151811|454299984|FG000|Overall Study|Withdrawal by Subject|17|||
126275627|NCT03151811|454299985|FG001|Overall Study|Withdrawal by Subject|7|||
126275628|NCT03151811|454299984|FG000|Overall Study|Lost to Follow-up|0|||
126275629|NCT03151811|454299985|FG001|Overall Study|Lost to Follow-up|1|||
126275630|NCT03151811|454299984|FG000|Overall Study|Study Terminated by Sponsor|5|||
126275631|NCT03151811|454299985|FG001|Overall Study|Study Terminated by Sponsor|11|||
126275632|NCT01085734|454299993|FG000|Overall Study|Adverse Event|0|||
126275633|NCT01085734|454299994|FG001|Overall Study|Adverse Event|2|||
126275634|NCT01085734|454299993|FG000|Overall Study|Death|1|||
126275635|NCT01085734|454299994|FG001|Overall Study|Death|0|||
126275636|NCT01085734|454299993|FG000|Overall Study|Lost to Follow-up|0|||
126275637|NCT01085734|454299994|FG001|Overall Study|Lost to Follow-up|1|||
126275638|NCT01085734|454299993|FG000|Overall Study|Withdrawal by Subject|0|||
126275639|NCT01085734|454299994|FG001|Overall Study|Withdrawal by Subject|1|||
126275640|NCT00528411|454299996|FG000|Overall Study|Adverse Event|4|||
126275641|NCT00528411|454299997|FG001|Overall Study|Adverse Event|0|||
126275642|NCT00528411|454299998|FG002|Overall Study|Adverse Event|1|||
126275643|NCT00528411|454299996|FG000|Overall Study|Incorrect Enrolment|1|||
125880934|NCT02668653|452862666|FG001|Overall Study|Other reasons not specified|11|||
125880935|NCT02668653|452862665|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
125880936|NCT02668653|452862666|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
125880937|NCT02668653|452862665|FG000|Overall Study|Investigator decision|10|||
125880938|NCT02668653|452862666|FG001|Overall Study|Investigator decision|7|||
125880939|NCT02668653|452862665|FG000|Overall Study|Failure to meet continuation criteria|5|||
126275644|NCT00528411|454299997|FG001|Overall Study|Incorrect Enrolment|1|||
125880940|NCT02668653|452862666|FG001|Overall Study|Failure to meet continuation criteria|12|||
126098660|NCT01506609|453653086|FG004|Overall Study|Lost to Follow-up|2|||
126275645|NCT00528411|454299998|FG002|Overall Study|Incorrect Enrolment|0|||
126275646|NCT00528411|454299996|FG000|Overall Study|Severe non-compliance to protocol|0|||
126275647|NCT00528411|454299997|FG001|Overall Study|Severe non-compliance to protocol|1|||
126275648|NCT00528411|454299998|FG002|Overall Study|Severe non-compliance to protocol|0|||
126275649|NCT00528411|454299996|FG000|Overall Study|Prior commitment medication|0|||
126098661|NCT01506609|453653087|FG005|Overall Study|Lost to Follow-up|0|||
126098662|NCT01506609|453653082|FG000|Overall Study|Sponsor Discontinued Study|0|||
126098663|NCT01506609|453653083|FG001|Overall Study|Sponsor Discontinued Study|0|||
126098664|NCT01506609|453653084|FG002|Overall Study|Sponsor Discontinued Study|0|||
126098665|NCT01506609|453653085|FG003|Overall Study|Sponsor Discontinued Study|2|||
126098666|NCT01506609|453653086|FG004|Overall Study|Sponsor Discontinued Study|2|||
126098667|NCT01506609|453653087|FG005|Overall Study|Sponsor Discontinued Study|0|||
126098668|NCT01506609|453653082|FG000|Overall Study|Progressive Disease per Protocol|1|||
126098669|NCT01506609|453653083|FG001|Overall Study|Progressive Disease per Protocol|0|||
126275650|NCT00528411|454299997|FG001|Overall Study|Prior commitment medication|1|||
126037684|NCT03701763|453436762|FG000|Placebo-controlled Phase|Adverse Event|1|||
126037685|NCT03701763|453436763|FG001|Placebo-controlled Phase|Adverse Event|5|||
126275651|NCT00528411|454299998|FG002|Overall Study|Prior commitment medication|0|||
126275652|NCT01715571|454299999|FG000|Overall Study|Lost to Follow-up|8|||
126275653|NCT00407758|454300000|FG000|Overall Study|ineligible -improper prior treatment|1|||
126275654|NCT01822275|454300006|FG000|Overall Study|Withdrawal by Subject|3|||
126275655|NCT01822275|454300006|FG000|Overall Study|Adverse Event|3|||
126275656|NCT01822275|454300006|FG000|Overall Study|Progression|14|||
126275657|NCT01822275|454300006|FG000|Overall Study|Physician Decision|2|||
126275658|NCT01458106|454300008|FG000|Overall Study|Withdrawal by Subject|2|||
126275659|NCT01458106|454300009|FG001|Overall Study|Withdrawal by Subject|0|||
126275660|NCT01458106|454300008|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
126275661|NCT01458106|454300009|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
126275662|NCT01458106|454300008|FG000|Overall Study|Withdrawn Per Protocol|0|||
126275663|NCT01458106|454300009|FG001|Overall Study|Withdrawn Per Protocol|1|||
126275664|NCT00073021|454300010|FG000|Overall Study|Protocol Violation|2|||
126275665|NCT00073021|454300011|FG001|Overall Study|Protocol Violation|1|||
126275666|NCT00073021|454300010|FG000|Overall Study|Adverse Event|4|||
126275667|NCT00073021|454300011|FG001|Overall Study|Adverse Event|4|||
126275668|NCT00073021|454300010|FG000|Overall Study|Withdrawal by Subject|6|||
126275669|NCT00073021|454300011|FG001|Overall Study|Withdrawal by Subject|5|||
126275670|NCT00073021|454300010|FG000|Overall Study|Physician Decision|3|||
126275671|NCT00073021|454300011|FG001|Overall Study|Physician Decision|1|||
126275672|NCT00073021|454300010|FG000|Overall Study|Lack of Efficacy|11|||
126275673|NCT00073021|454300011|FG001|Overall Study|Lack of Efficacy|5|||
126275674|NCT00855803|454300012|FG000|Overall Study|Death|2|||
126275675|NCT00855803|454300012|FG000|Overall Study|Lost to Follow-up|2|||
126275676|NCT00855803|454300012|FG000|Overall Study|Technical inability to undergo procedure|2|||
126275677|NCT00855803|454300012|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
126275678|NCT00855803|454300012|FG000|Overall Study|Withdrawal by Subject|3|||
126275679|NCT00855803|454300012|FG000|Overall Study|Physician Decision|3|||
126275680|NCT02132754|454300014|FG000|Overall Study|Adverse Event|0|||
126275681|NCT02132754|454300015|FG001|Overall Study|Adverse Event|0|||
126275682|NCT02132754|454300016|FG002|Overall Study|Adverse Event|0|||
126275683|NCT02132754|454300017|FG003|Overall Study|Adverse Event|0|||
126275684|NCT02132754|454300018|FG004|Overall Study|Adverse Event|0|||
126275685|NCT02132754|454300019|FG005|Overall Study|Adverse Event|0|||
126275686|NCT02132754|454300020|FG006|Overall Study|Adverse Event|0|||
126275687|NCT02132754|454300021|FG007|Overall Study|Adverse Event|0|||
126275688|NCT02132754|454300022|FG008|Overall Study|Adverse Event|0|||
126275689|NCT02132754|454300023|FG009|Overall Study|Adverse Event|0|||
126275690|NCT02132754|454300024|FG010|Overall Study|Adverse Event|0|||
126275691|NCT02132754|454300025|FG011|Overall Study|Adverse Event|0|||
126275692|NCT02132754|454300026|FG012|Overall Study|Adverse Event|0|||
126037686|NCT03701763|453436764|FG002|Placebo-controlled Phase|Adverse Event|0|||
126037687|NCT03701763|453436765|FG003|Placebo-controlled Phase|Adverse Event|0|||
126037688|NCT03701763|453436762|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
126037689|NCT03701763|453436763|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
126275693|NCT02132754|454300027|FG013|Overall Study|Adverse Event|0|||
126275694|NCT02132754|454300028|FG014|Overall Study|Adverse Event|0|||
126275695|NCT02132754|454300029|FG015|Overall Study|Adverse Event|0|||
126275696|NCT02132754|454300030|FG016|Overall Study|Adverse Event|0|||
126275697|NCT02132754|454300031|FG017|Overall Study|Adverse Event|1|||
126275698|NCT02132754|454300032|FG018|Overall Study|Adverse Event|0|||
126275699|NCT02132754|454300033|FG019|Overall Study|Adverse Event|0|||
126275700|NCT02132754|454300034|FG020|Overall Study|Adverse Event|0|||
126275701|NCT02132754|454300035|FG021|Overall Study|Adverse Event|0|||
126275702|NCT02132754|454300036|FG022|Overall Study|Adverse Event|0|||
126275703|NCT02132754|454300037|FG023|Overall Study|Adverse Event|0|||
126275704|NCT02132754|454300038|FG024|Overall Study|Adverse Event|0|||
126275705|NCT02132754|454300039|FG025|Overall Study|Adverse Event|1|||
126275706|NCT02132754|454300040|FG026|Overall Study|Adverse Event|1|||
126275707|NCT02132754|454300041|FG027|Overall Study|Adverse Event|0|||
126275708|NCT02132754|454300042|FG028|Overall Study|Adverse Event|0|||
126275709|NCT02132754|454300043|FG029|Overall Study|Adverse Event|0|||
126275710|NCT02132754|454300044|FG030|Overall Study|Adverse Event|1|||
126275711|NCT02132754|454300045|FG031|Overall Study|Adverse Event|0|||
126275712|NCT02132754|454300046|FG032|Overall Study|Adverse Event|1|||
126275713|NCT02132754|454300047|FG033|Overall Study|Adverse Event|1|||
126275714|NCT02132754|454300014|FG000|Overall Study|Clinical Progression|0|||
126275715|NCT02132754|454300015|FG001|Overall Study|Clinical Progression|0|||
126275716|NCT02132754|454300016|FG002|Overall Study|Clinical Progression|0|||
126275717|NCT02132754|454300017|FG003|Overall Study|Clinical Progression|0|||
126275718|NCT02132754|454300018|FG004|Overall Study|Clinical Progression|0|||
126275719|NCT02132754|454300019|FG005|Overall Study|Clinical Progression|0|||
126275720|NCT02132754|454300020|FG006|Overall Study|Clinical Progression|0|||
126275721|NCT02132754|454300021|FG007|Overall Study|Clinical Progression|0|||
126275722|NCT02132754|454300022|FG008|Overall Study|Clinical Progression|0|||
126275723|NCT02132754|454300023|FG009|Overall Study|Clinical Progression|1|||
126275724|NCT02132754|454300024|FG010|Overall Study|Clinical Progression|0|||
126275725|NCT02132754|454300025|FG011|Overall Study|Clinical Progression|0|||
126275726|NCT02132754|454300026|FG012|Overall Study|Clinical Progression|0|||
126275727|NCT02132754|454300027|FG013|Overall Study|Clinical Progression|0|||
126275728|NCT02132754|454300028|FG014|Overall Study|Clinical Progression|0|||
126275729|NCT02132754|454300029|FG015|Overall Study|Clinical Progression|0|||
126275730|NCT02132754|454300030|FG016|Overall Study|Clinical Progression|1|||
126275731|NCT02132754|454300031|FG017|Overall Study|Clinical Progression|1|||
126275732|NCT02132754|454300032|FG018|Overall Study|Clinical Progression|0|||
126275733|NCT02132754|454300033|FG019|Overall Study|Clinical Progression|1|||
126275734|NCT02132754|454300034|FG020|Overall Study|Clinical Progression|0|||
126275735|NCT02132754|454300035|FG021|Overall Study|Clinical Progression|0|||
126275736|NCT02132754|454300036|FG022|Overall Study|Clinical Progression|1|||
126275737|NCT02132754|454300037|FG023|Overall Study|Clinical Progression|0|||
126275738|NCT02132754|454300038|FG024|Overall Study|Clinical Progression|1|||
126275739|NCT02132754|454300039|FG025|Overall Study|Clinical Progression|1|||
125880941|NCT02668653|452862665|FG000|Overall Study|Lost to Follow-up|1|||
125880942|NCT02668653|452862666|FG001|Overall Study|Lost to Follow-up|0|||
125880943|NCT02668653|452862665|FG000|Overall Study|Pregnancy|0|||
125880944|NCT02668653|452862666|FG001|Overall Study|Pregnancy|1|||
125880945|NCT02668653|452862665|FG000|Overall Study|Death|0|||
125880946|NCT02668653|452862666|FG001|Overall Study|Death|1|||
125880947|NCT02158442|452862669|FG000|Overall Study|Withdrawal by Subject|1|||
125880948|NCT02158442|452862670|FG001|Overall Study|Withdrawal by Subject|0|||
125880949|NCT02158442|452862669|FG000|Overall Study|Perfusion staff not available|1|||
125880950|NCT02158442|452862670|FG001|Overall Study|Perfusion staff not available|0|||
125880951|NCT01294553|452862671|FG000|Overall Study|Duplicated Participants|1|||
125880952|NCT01294553|452862671|FG000|Overall Study|Protocol Violation|268|||
125880953|NCT00926237|452862674|FG000|Overall Study|Withdrawal by Subject|2|||
125880954|NCT00926237|452862675|FG001|Overall Study|Withdrawal by Subject|1|||
125880955|NCT00632229|452862681|FG000|Overall Study|Adverse Event|6|||
125880956|NCT00632229|452862682|FG001|Overall Study|Adverse Event|0|||
125880957|NCT00632229|452862681|FG000|Overall Study|Lost to Follow-up|0|||
125880958|NCT00632229|452862682|FG001|Overall Study|Lost to Follow-up|3|||
125880959|NCT00632229|452862681|FG000|Overall Study|Lack of Efficacy|0|||
125880960|NCT00632229|452862682|FG001|Overall Study|Lack of Efficacy|2|||
125880961|NCT00632229|452862681|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
125880962|NCT00632229|452862682|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
125880963|NCT05386329|452862683|FG000|Overall Study|Lost to Follow-up|3|||
125880964|NCT00577889|452862684|FG000|Overall Study|Withdrawal by Subject|1|||
125880965|NCT00577889|452862685|FG001|Overall Study|Withdrawal by Subject|0|||
125880966|NCT00577889|452862686|FG002|Overall Study|Withdrawal by Subject|0|||
125880967|NCT02667119|452862690|FG000|Overall Study|Lost to Follow-up|3|||
125880968|NCT02667119|452862691|FG001|Overall Study|Lost to Follow-up|0|||
125880969|NCT03783078|452862692|FG000|Overall Study|Death|31|||
125880970|NCT03783078|452862692|FG000|Overall Study|Sponsor Decision|23|||
125880971|NCT03783078|452862692|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125880972|NCT02059278|452862694|FG000|Overall Study|Adverse Event|1|||
125880973|NCT02059278|452862695|FG001|Overall Study|Adverse Event|1|||
126275740|NCT02132754|454300040|FG026|Overall Study|Clinical Progression|0|||
126275741|NCT02132754|454300041|FG027|Overall Study|Clinical Progression|1|||
126275742|NCT02132754|454300042|FG028|Overall Study|Clinical Progression|1|||
126275743|NCT02132754|454300043|FG029|Overall Study|Clinical Progression|0|||
126275744|NCT02132754|454300044|FG030|Overall Study|Clinical Progression|1|||
126275745|NCT02132754|454300045|FG031|Overall Study|Clinical Progression|0|||
126275746|NCT02132754|454300046|FG032|Overall Study|Clinical Progression|0|||
126275747|NCT02132754|454300047|FG033|Overall Study|Clinical Progression|2|||
126275748|NCT02132754|454300014|FG000|Overall Study|Death|0|||
126275749|NCT02132754|454300015|FG001|Overall Study|Death|0|||
126275750|NCT02132754|454300016|FG002|Overall Study|Death|0|||
126275751|NCT02132754|454300017|FG003|Overall Study|Death|0|||
126275752|NCT02132754|454300018|FG004|Overall Study|Death|0|||
126275753|NCT02132754|454300019|FG005|Overall Study|Death|0|||
126275754|NCT02132754|454300020|FG006|Overall Study|Death|0|||
125880974|NCT02059278|452862694|FG000|Overall Study|Lost to Follow-up|1|||
125880975|NCT02059278|452862695|FG001|Overall Study|Lost to Follow-up|0|||
125880976|NCT02059278|452862694|FG000|Overall Study|Withdrawal by Subject|0|||
125880977|NCT02059278|452862695|FG001|Overall Study|Withdrawal by Subject|3|||
125880978|NCT02059278|452862694|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
125880979|NCT02059278|452862695|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
126275755|NCT02132754|454300021|FG007|Overall Study|Death|0|||
126275756|NCT02132754|454300022|FG008|Overall Study|Death|0|||
126275757|NCT02132754|454300023|FG009|Overall Study|Death|0|||
126275758|NCT02132754|454300024|FG010|Overall Study|Death|0|||
126275759|NCT02132754|454300025|FG011|Overall Study|Death|0|||
126275760|NCT02132754|454300026|FG012|Overall Study|Death|0|||
126275761|NCT02132754|454300027|FG013|Overall Study|Death|0|||
126275762|NCT02132754|454300028|FG014|Overall Study|Death|0|||
126275763|NCT02132754|454300029|FG015|Overall Study|Death|1|||
126275764|NCT02132754|454300030|FG016|Overall Study|Death|0|||
126275765|NCT02132754|454300031|FG017|Overall Study|Death|0|||
126275766|NCT02132754|454300032|FG018|Overall Study|Death|0|||
126275767|NCT02132754|454300033|FG019|Overall Study|Death|1|||
126275768|NCT02132754|454300034|FG020|Overall Study|Death|0|||
126275769|NCT02132754|454300035|FG021|Overall Study|Death|1|||
126275770|NCT02132754|454300036|FG022|Overall Study|Death|0|||
126275771|NCT02132754|454300037|FG023|Overall Study|Death|0|||
126275772|NCT02132754|454300038|FG024|Overall Study|Death|0|||
126275773|NCT02132754|454300039|FG025|Overall Study|Death|0|||
126275774|NCT02132754|454300040|FG026|Overall Study|Death|1|||
126275775|NCT02132754|454300041|FG027|Overall Study|Death|0|||
125880980|NCT00737672|452862698|FG000|Overall Study|Graft Abandonment|48|||
126275776|NCT02132754|454300042|FG028|Overall Study|Death|0|||
126275777|NCT02132754|454300043|FG029|Overall Study|Death|0|||
126275778|NCT02132754|454300044|FG030|Overall Study|Death|0|||
126275779|NCT02132754|454300045|FG031|Overall Study|Death|0|||
126275780|NCT02132754|454300046|FG032|Overall Study|Death|0|||
125880981|NCT00737672|452862699|FG001|Overall Study|Graft Abandonment|56|||
125880982|NCT00737672|452862698|FG000|Overall Study|Death|23|||
125880983|NCT00737672|452862699|FG001|Overall Study|Death|22|||
125880984|NCT00737672|452862698|FG000|Overall Study|Withdrawal by Subject|1|||
125880985|NCT00737672|452862699|FG001|Overall Study|Withdrawal by Subject|2|||
125880986|NCT00737672|452862698|FG000|Overall Study|Lost to Follow-up|1|||
125880987|NCT00737672|452862699|FG001|Overall Study|Lost to Follow-up|0|||
125880988|NCT00737672|452862698|FG000|Overall Study|Miscellaneous|7|||
125880989|NCT00737672|452862699|FG001|Overall Study|Miscellaneous|1|||
125880990|NCT00737672|452862698|FG000|Overall Study|Physician Decision|0|||
126037690|NCT03701763|453436764|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
126037691|NCT03701763|453436765|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
126037692|NCT03701763|453436762|FG000|Placebo-controlled Phase|Miscellaneous|2|||
126037693|NCT03701763|453436763|FG001|Placebo-controlled Phase|Miscellaneous|0|||
126275781|NCT02132754|454300047|FG033|Overall Study|Death|2|||
126275782|NCT02132754|454300014|FG000|Overall Study|Excluded Medication|0|||
126275783|NCT02132754|454300015|FG001|Overall Study|Excluded Medication|0|||
126275784|NCT02132754|454300016|FG002|Overall Study|Excluded Medication|0|||
126275785|NCT02132754|454300017|FG003|Overall Study|Excluded Medication|0|||
126275786|NCT02132754|454300018|FG004|Overall Study|Excluded Medication|0|||
126275787|NCT02132754|454300019|FG005|Overall Study|Excluded Medication|0|||
126275788|NCT02132754|454300020|FG006|Overall Study|Excluded Medication|0|||
126275789|NCT02132754|454300021|FG007|Overall Study|Excluded Medication|0|||
126275790|NCT02132754|454300022|FG008|Overall Study|Excluded Medication|0|||
126275791|NCT02132754|454300023|FG009|Overall Study|Excluded Medication|0|||
126275792|NCT02132754|454300024|FG010|Overall Study|Excluded Medication|0|||
126275793|NCT02132754|454300025|FG011|Overall Study|Excluded Medication|0|||
126275794|NCT02132754|454300026|FG012|Overall Study|Excluded Medication|0|||
126275795|NCT02132754|454300027|FG013|Overall Study|Excluded Medication|0|||
126275796|NCT02132754|454300028|FG014|Overall Study|Excluded Medication|0|||
126275797|NCT02132754|454300029|FG015|Overall Study|Excluded Medication|0|||
126275798|NCT02132754|454300030|FG016|Overall Study|Excluded Medication|0|||
126275799|NCT02132754|454300031|FG017|Overall Study|Excluded Medication|0|||
126275800|NCT02132754|454300032|FG018|Overall Study|Excluded Medication|0|||
126275801|NCT02132754|454300033|FG019|Overall Study|Excluded Medication|0|||
126275802|NCT02132754|454300034|FG020|Overall Study|Excluded Medication|1|||
126275803|NCT02132754|454300035|FG021|Overall Study|Excluded Medication|0|||
126275804|NCT02132754|454300036|FG022|Overall Study|Excluded Medication|0|||
126275805|NCT02132754|454300037|FG023|Overall Study|Excluded Medication|0|||
126275806|NCT02132754|454300038|FG024|Overall Study|Excluded Medication|0|||
126275807|NCT02132754|454300039|FG025|Overall Study|Excluded Medication|0|||
126275808|NCT02132754|454300040|FG026|Overall Study|Excluded Medication|0|||
126275809|NCT02132754|454300041|FG027|Overall Study|Excluded Medication|0|||
126275810|NCT02132754|454300042|FG028|Overall Study|Excluded Medication|0|||
126275811|NCT02132754|454300043|FG029|Overall Study|Excluded Medication|0|||
126275812|NCT02132754|454300044|FG030|Overall Study|Excluded Medication|0|||
126275813|NCT02132754|454300045|FG031|Overall Study|Excluded Medication|0|||
126275814|NCT02132754|454300046|FG032|Overall Study|Excluded Medication|0|||
126275815|NCT02132754|454300047|FG033|Overall Study|Excluded Medication|1|||
126275816|NCT02132754|454300014|FG000|Overall Study|Physician Decision|0|||
126275817|NCT02132754|454300015|FG001|Overall Study|Physician Decision|0|||
126275818|NCT02132754|454300016|FG002|Overall Study|Physician Decision|0|||
126275819|NCT02132754|454300017|FG003|Overall Study|Physician Decision|0|||
126275820|NCT02132754|454300018|FG004|Overall Study|Physician Decision|0|||
126275821|NCT02132754|454300019|FG005|Overall Study|Physician Decision|0|||
126275822|NCT02132754|454300020|FG006|Overall Study|Physician Decision|0|||
126275823|NCT02132754|454300021|FG007|Overall Study|Physician Decision|0|||
126275824|NCT02132754|454300022|FG008|Overall Study|Physician Decision|0|||
126275825|NCT02132754|454300023|FG009|Overall Study|Physician Decision|1|||
126275826|NCT02132754|454300024|FG010|Overall Study|Physician Decision|0|||
126275827|NCT02132754|454300025|FG011|Overall Study|Physician Decision|1|||
126275828|NCT02132754|454300026|FG012|Overall Study|Physician Decision|1|||
126275829|NCT02132754|454300027|FG013|Overall Study|Physician Decision|0|||
125880991|NCT00737672|452862699|FG001|Overall Study|Physician Decision|2|||
125880992|NCT02694185|452862700|FG000|Overall Study|Withdrawal by Subject|45|||
126037694|NCT03701763|453436764|FG002|Placebo-controlled Phase|Miscellaneous|0|||
126037695|NCT03701763|453436765|FG003|Placebo-controlled Phase|Miscellaneous|0|||
126037696|NCT03701763|453436762|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
126275830|NCT02132754|454300028|FG014|Overall Study|Physician Decision|0|||
126275831|NCT02132754|454300029|FG015|Overall Study|Physician Decision|1|||
126275832|NCT02132754|454300030|FG016|Overall Study|Physician Decision|0|||
126275833|NCT02132754|454300031|FG017|Overall Study|Physician Decision|0|||
126275834|NCT02132754|454300032|FG018|Overall Study|Physician Decision|0|||
126275835|NCT02132754|454300033|FG019|Overall Study|Physician Decision|0|||
126275836|NCT02132754|454300034|FG020|Overall Study|Physician Decision|0|||
126275837|NCT02132754|454300035|FG021|Overall Study|Physician Decision|0|||
126275838|NCT02132754|454300036|FG022|Overall Study|Physician Decision|0|||
126275839|NCT02132754|454300037|FG023|Overall Study|Physician Decision|0|||
126275840|NCT02132754|454300038|FG024|Overall Study|Physician Decision|1|||
126275841|NCT02132754|454300039|FG025|Overall Study|Physician Decision|0|||
126362620|NCT00159874|454621589|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
126362621|NCT00159874|454621590|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
125880993|NCT02694185|452862701|FG001|Overall Study|Withdrawal by Subject|0|||
126362622|NCT00159874|454621584|FG000|Overall Study|Lack of Efficacy|2|||
126362623|NCT00159874|454621585|FG001|Overall Study|Lack of Efficacy|0|||
126362624|NCT00159874|454621586|FG002|Overall Study|Lack of Efficacy|1|||
126362625|NCT00159874|454621587|FG003|Overall Study|Lack of Efficacy|1|||
126362626|NCT00159874|454621588|FG004|Overall Study|Lack of Efficacy|0|||
126362627|NCT00159874|454621589|FG005|Overall Study|Lack of Efficacy|3|||
126362628|NCT00159874|454621590|FG006|Overall Study|Lack of Efficacy|0|||
126098670|NCT01506609|453653084|FG002|Overall Study|Progressive Disease per Protocol|0|||
126098671|NCT01506609|453653085|FG003|Overall Study|Progressive Disease per Protocol|64|||
126098672|NCT01506609|453653086|FG004|Overall Study|Progressive Disease per Protocol|57|||
126098673|NCT01506609|453653087|FG005|Overall Study|Progressive Disease per Protocol|74|||
126098674|NCT01506609|453653082|FG000|Overall Study|Other, Not Specified|0|||
126098675|NCT01506609|453653083|FG001|Overall Study|Other, Not Specified|0|||
126098676|NCT01506609|453653084|FG002|Overall Study|Other, Not Specified|0|||
126098677|NCT01506609|453653085|FG003|Overall Study|Other, Not Specified|10|||
126098678|NCT01506609|453653086|FG004|Overall Study|Other, Not Specified|7|||
126362629|NCT00159874|454621584|FG000|Overall Study|Lost to Follow-up|1|||
126362630|NCT00159874|454621585|FG001|Overall Study|Lost to Follow-up|0|||
126362631|NCT00159874|454621586|FG002|Overall Study|Lost to Follow-up|3|||
126362632|NCT00159874|454621587|FG003|Overall Study|Lost to Follow-up|0|||
126362633|NCT00159874|454621588|FG004|Overall Study|Lost to Follow-up|1|||
126362634|NCT00159874|454621589|FG005|Overall Study|Lost to Follow-up|2|||
126362635|NCT00159874|454621590|FG006|Overall Study|Lost to Follow-up|1|||
126362636|NCT00159874|454621584|FG000|Overall Study|Other|8|||
126362637|NCT00159874|454621585|FG001|Overall Study|Other|8|||
126362638|NCT00159874|454621586|FG002|Overall Study|Other|8|||
126362639|NCT00159874|454621587|FG003|Overall Study|Other|0|||
126362640|NCT00159874|454621588|FG004|Overall Study|Other|2|||
126362641|NCT00159874|454621589|FG005|Overall Study|Other|1|||
126362642|NCT00159874|454621590|FG006|Overall Study|Other|3|||
126362643|NCT00159874|454621584|FG000|Overall Study|Protocol Violation|0|||
126362644|NCT00159874|454621585|FG001|Overall Study|Protocol Violation|5|||
126362645|NCT00159874|454621586|FG002|Overall Study|Protocol Violation|2|||
126362646|NCT00159874|454621587|FG003|Overall Study|Protocol Violation|0|||
126362647|NCT00159874|454621588|FG004|Overall Study|Protocol Violation|0|||
126362648|NCT00159874|454621589|FG005|Overall Study|Protocol Violation|0|||
126362649|NCT00159874|454621590|FG006|Overall Study|Protocol Violation|0|||
126362650|NCT00159874|454621584|FG000|Overall Study|Death|3|||
125880994|NCT05972993|452862713|FG000|Overall Study|Lost to Follow-up|2|||
125880995|NCT05972993|452862714|FG001|Overall Study|Lost to Follow-up|0|||
125880996|NCT05972993|452862715|FG002|Overall Study|Lost to Follow-up|1|||
125880997|NCT05972993|452862716|FG003|Overall Study|Lost to Follow-up|0|||
125880998|NCT05972993|452862717|FG004|Overall Study|Lost to Follow-up|0|||
125880999|NCT05972993|452862718|FG005|Overall Study|Lost to Follow-up|0|||
125881000|NCT05972993|452862719|FG006|Overall Study|Lost to Follow-up|0|||
125881001|NCT05972993|452862720|FG007|Overall Study|Lost to Follow-up|2|||
125881002|NCT05972993|452862721|FG008|Overall Study|Lost to Follow-up|0|||
125881003|NCT03866577|452862724|FG000|Overall Study|Protocol Violation|0|||
125881004|NCT03866577|452862725|FG001|Overall Study|Protocol Violation|0|||
125881005|NCT03866577|452862726|FG002|Overall Study|Protocol Violation|0|||
125881006|NCT03866577|452862727|FG003|Overall Study|Protocol Violation|0|||
125881007|NCT03866577|452862728|FG004|Overall Study|Protocol Violation|0|||
125881008|NCT03866577|452862729|FG005|Overall Study|Protocol Violation|0|||
125881009|NCT03866577|452862730|FG006|Overall Study|Protocol Violation|0|||
126362651|NCT00159874|454621585|FG001|Overall Study|Death|8|||
126362652|NCT00159874|454621586|FG002|Overall Study|Death|15|||
126362653|NCT00159874|454621587|FG003|Overall Study|Death|0|||
126362654|NCT00159874|454621588|FG004|Overall Study|Death|1|||
125881010|NCT03866577|452862731|FG007|Overall Study|Protocol Violation|0|||
125881011|NCT03866577|452862732|FG008|Overall Study|Protocol Violation|0|||
125881012|NCT03866577|452862733|FG009|Overall Study|Protocol Violation|0|||
125881013|NCT03866577|452862734|FG010|Overall Study|Protocol Violation|0|||
125881014|NCT03866577|452862735|FG011|Overall Study|Protocol Violation|1|||
125881015|NCT03866577|452862736|FG012|Overall Study|Protocol Violation|0|||
125881016|NCT03866577|452862724|FG000|Overall Study|Withdrawal by Subject|0|||
126098679|NCT01506609|453653087|FG005|Overall Study|Other, Not Specified|3|||
126362655|NCT00159874|454621589|FG005|Overall Study|Death|2|||
126362656|NCT00159874|454621590|FG006|Overall Study|Death|0|||
125881017|NCT03866577|452862725|FG001|Overall Study|Withdrawal by Subject|0|||
125881018|NCT03866577|452862726|FG002|Overall Study|Withdrawal by Subject|0|||
125881019|NCT03866577|452862727|FG003|Overall Study|Withdrawal by Subject|0|||
125881020|NCT03866577|452862728|FG004|Overall Study|Withdrawal by Subject|0|||
126362657|NCT00159874|454621584|FG000|Overall Study|Withdrawal by Subject|2|||
126362658|NCT00159874|454621585|FG001|Overall Study|Withdrawal by Subject|6|||
126362659|NCT00159874|454621586|FG002|Overall Study|Withdrawal by Subject|8|||
126362660|NCT00159874|454621587|FG003|Overall Study|Withdrawal by Subject|4|||
126362661|NCT00159874|454621588|FG004|Overall Study|Withdrawal by Subject|3|||
126275842|NCT02132754|454300040|FG026|Overall Study|Physician Decision|0|||
126275843|NCT02132754|454300041|FG027|Overall Study|Physician Decision|0|||
126275844|NCT02132754|454300042|FG028|Overall Study|Physician Decision|0|||
126275845|NCT02132754|454300043|FG029|Overall Study|Physician Decision|0|||
126275846|NCT02132754|454300044|FG030|Overall Study|Physician Decision|0|||
126275847|NCT02132754|454300045|FG031|Overall Study|Physician Decision|1|||
126275848|NCT02132754|454300046|FG032|Overall Study|Physician Decision|0|||
126275849|NCT02132754|454300047|FG033|Overall Study|Physician Decision|3|||
126275850|NCT02132754|454300014|FG000|Overall Study|Progressive Disease|1|||
126275851|NCT02132754|454300015|FG001|Overall Study|Progressive Disease|1|||
126275852|NCT02132754|454300016|FG002|Overall Study|Progressive Disease|1|||
126275853|NCT02132754|454300017|FG003|Overall Study|Progressive Disease|1|||
126275854|NCT02132754|454300018|FG004|Overall Study|Progressive Disease|1|||
126275855|NCT02132754|454300019|FG005|Overall Study|Progressive Disease|1|||
126275856|NCT02132754|454300020|FG006|Overall Study|Progressive Disease|1|||
126275857|NCT02132754|454300021|FG007|Overall Study|Progressive Disease|1|||
126275858|NCT02132754|454300022|FG008|Overall Study|Progressive Disease|1|||
126275859|NCT02132754|454300023|FG009|Overall Study|Progressive Disease|3|||
126275860|NCT02132754|454300024|FG010|Overall Study|Progressive Disease|3|||
126362662|NCT00159874|454621589|FG005|Overall Study|Withdrawal by Subject|2|||
126362663|NCT00159874|454621590|FG006|Overall Study|Withdrawal by Subject|1|||
126362664|NCT00159874|454621584|FG000|Overall Study|Pregnancy|1|||
126362665|NCT00159874|454621585|FG001|Overall Study|Pregnancy|1|||
126362666|NCT00159874|454621586|FG002|Overall Study|Pregnancy|0|||
126362667|NCT00159874|454621587|FG003|Overall Study|Pregnancy|0|||
126362668|NCT00159874|454621588|FG004|Overall Study|Pregnancy|0|||
126362669|NCT00159874|454621589|FG005|Overall Study|Pregnancy|0|||
126362670|NCT00159874|454621590|FG006|Overall Study|Pregnancy|0|||
126362671|NCT01475825|454621594|FG000|Overall Study|Adverse Event|41|||
126362672|NCT01475825|454621595|FG001|Overall Study|Adverse Event|15|||
126362673|NCT01475825|454621596|FG002|Overall Study|Adverse Event|27|||
126362674|NCT01475825|454621597|FG003|Overall Study|Adverse Event|11|||
126362675|NCT01475825|454621594|FG000|Overall Study|Death|1|||
126362676|NCT01475825|454621595|FG001|Overall Study|Death|0|||
126362677|NCT01475825|454621596|FG002|Overall Study|Death|1|||
126362678|NCT01475825|454621597|FG003|Overall Study|Death|0|||
126362679|NCT01475825|454621594|FG000|Overall Study|Lack of Efficacy|0|||
126362680|NCT01475825|454621595|FG001|Overall Study|Lack of Efficacy|0|||
126362681|NCT01475825|454621596|FG002|Overall Study|Lack of Efficacy|1|||
126362682|NCT01475825|454621597|FG003|Overall Study|Lack of Efficacy|0|||
126362683|NCT01475825|454621594|FG000|Overall Study|Lost to Follow-up|0|||
126362684|NCT01475825|454621595|FG001|Overall Study|Lost to Follow-up|0|||
126362685|NCT01475825|454621596|FG002|Overall Study|Lost to Follow-up|3|||
126362686|NCT01475825|454621597|FG003|Overall Study|Lost to Follow-up|1|||
126362687|NCT01475825|454621594|FG000|Overall Study|Non-compliance with Study Drug|1|||
126362688|NCT01475825|454621595|FG001|Overall Study|Non-compliance with Study Drug|2|||
126362689|NCT01475825|454621596|FG002|Overall Study|Non-compliance with Study Drug|4|||
126362690|NCT01475825|454621597|FG003|Overall Study|Non-compliance with Study Drug|0|||
126362691|NCT01475825|454621594|FG000|Overall Study|Other: Not available|0|||
126362692|NCT01475825|454621595|FG001|Overall Study|Other: Not available|0|||
126362693|NCT01475825|454621596|FG002|Overall Study|Other: Not available|2|||
126362694|NCT01475825|454621597|FG003|Overall Study|Other: Not available|0|||
126362695|NCT01475825|454621594|FG000|Overall Study|Protocol Violation|1|||
126362696|NCT01475825|454621595|FG001|Overall Study|Protocol Violation|0|||
126362697|NCT01475825|454621596|FG002|Overall Study|Protocol Violation|0|||
126362698|NCT01475825|454621597|FG003|Overall Study|Protocol Violation|0|||
126362699|NCT01475825|454621594|FG000|Overall Study|Physician Decision|0|||
126362700|NCT01475825|454621595|FG001|Overall Study|Physician Decision|1|||
126362701|NCT01475825|454621596|FG002|Overall Study|Physician Decision|0|||
126362702|NCT01475825|454621597|FG003|Overall Study|Physician Decision|0|||
126362703|NCT01475825|454621594|FG000|Overall Study|Withdrawal by Subject|8|||
126362704|NCT01475825|454621595|FG001|Overall Study|Withdrawal by Subject|3|||
126362705|NCT01475825|454621596|FG002|Overall Study|Withdrawal by Subject|11|||
126362706|NCT01475825|454621597|FG003|Overall Study|Withdrawal by Subject|7|||
126362707|NCT01475825|454621594|FG000|Overall Study|Did not enter OLC|15|||
126362708|NCT01475825|454621595|FG001|Overall Study|Did not enter OLC|11|||
126362709|NCT01475825|454621596|FG002|Overall Study|Did not enter OLC|15|||
126362710|NCT01475825|454621597|FG003|Overall Study|Did not enter OLC|11|||
126362711|NCT00309946|454621600|FG000|Overall Study|Withdrawal by Subject|1|||
126275861|NCT02132754|454300025|FG011|Overall Study|Progressive Disease|2|||
126275862|NCT02132754|454300026|FG012|Overall Study|Progressive Disease|2|||
126275863|NCT02132754|454300027|FG013|Overall Study|Progressive Disease|3|||
126275864|NCT02132754|454300028|FG014|Overall Study|Progressive Disease|2|||
126275865|NCT02132754|454300029|FG015|Overall Study|Progressive Disease|1|||
126275866|NCT02132754|454300030|FG016|Overall Study|Progressive Disease|2|||
126275867|NCT02132754|454300031|FG017|Overall Study|Progressive Disease|1|||
126362712|NCT02662582|454621601|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
126362713|NCT02662582|454621602|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
126362714|NCT02662582|454621601|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
126362715|NCT02662582|454621602|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
126275868|NCT02132754|454300032|FG018|Overall Study|Progressive Disease|3|||
126275869|NCT02132754|454300033|FG019|Overall Study|Progressive Disease|1|||
126275870|NCT02132754|454300034|FG020|Overall Study|Progressive Disease|1|||
126275871|NCT02132754|454300035|FG021|Overall Study|Progressive Disease|3|||
126275872|NCT02132754|454300036|FG022|Overall Study|Progressive Disease|2|||
126275873|NCT02132754|454300037|FG023|Overall Study|Progressive Disease|3|||
126275874|NCT02132754|454300038|FG024|Overall Study|Progressive Disease|0|||
126275875|NCT02132754|454300039|FG025|Overall Study|Progressive Disease|1|||
126275876|NCT02132754|454300040|FG026|Overall Study|Progressive Disease|2|||
126275877|NCT02132754|454300041|FG027|Overall Study|Progressive Disease|1|||
126275878|NCT02132754|454300042|FG028|Overall Study|Progressive Disease|2|||
126275879|NCT02132754|454300043|FG029|Overall Study|Progressive Disease|3|||
126275880|NCT02132754|454300044|FG030|Overall Study|Progressive Disease|1|||
126275881|NCT02132754|454300045|FG031|Overall Study|Progressive Disease|1|||
126275882|NCT02132754|454300046|FG032|Overall Study|Progressive Disease|3|||
126275883|NCT02132754|454300047|FG033|Overall Study|Progressive Disease|6|||
126275884|NCT02132754|454300014|FG000|Overall Study|Screen Failure|0|||
126275885|NCT02132754|454300015|FG001|Overall Study|Screen Failure|0|||
126275886|NCT02132754|454300016|FG002|Overall Study|Screen Failure|0|||
126275887|NCT02132754|454300017|FG003|Overall Study|Screen Failure|0|||
126275888|NCT02132754|454300018|FG004|Overall Study|Screen Failure|0|||
126275889|NCT02132754|454300019|FG005|Overall Study|Screen Failure|0|||
126275890|NCT02132754|454300020|FG006|Overall Study|Screen Failure|0|||
126275891|NCT02132754|454300021|FG007|Overall Study|Screen Failure|0|||
126275892|NCT02132754|454300022|FG008|Overall Study|Screen Failure|0|||
126275893|NCT02132754|454300023|FG009|Overall Study|Screen Failure|0|||
126275894|NCT02132754|454300024|FG010|Overall Study|Screen Failure|0|||
126275895|NCT02132754|454300025|FG011|Overall Study|Screen Failure|0|||
126275896|NCT02132754|454300026|FG012|Overall Study|Screen Failure|0|||
126275897|NCT02132754|454300027|FG013|Overall Study|Screen Failure|0|||
126275898|NCT02132754|454300028|FG014|Overall Study|Screen Failure|0|||
126275899|NCT02132754|454300029|FG015|Overall Study|Screen Failure|0|||
126275900|NCT02132754|454300030|FG016|Overall Study|Screen Failure|0|||
126275901|NCT02132754|454300031|FG017|Overall Study|Screen Failure|0|||
126275902|NCT02132754|454300032|FG018|Overall Study|Screen Failure|0|||
126275903|NCT02132754|454300033|FG019|Overall Study|Screen Failure|1|||
126275904|NCT02132754|454300034|FG020|Overall Study|Screen Failure|0|||
126275905|NCT02132754|454300035|FG021|Overall Study|Screen Failure|1|||
126275906|NCT02132754|454300036|FG022|Overall Study|Screen Failure|0|||
126275907|NCT02132754|454300037|FG023|Overall Study|Screen Failure|0|||
126275908|NCT02132754|454300038|FG024|Overall Study|Screen Failure|0|||
126275909|NCT02132754|454300039|FG025|Overall Study|Screen Failure|0|||
126275910|NCT02132754|454300040|FG026|Overall Study|Screen Failure|0|||
126362716|NCT02662582|454621601|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
125881021|NCT03866577|452862729|FG005|Overall Study|Withdrawal by Subject|0|||
125881022|NCT03866577|452862730|FG006|Overall Study|Withdrawal by Subject|0|||
126037697|NCT03701763|453436763|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
126037698|NCT03701763|453436764|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
126362717|NCT02662582|454621602|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
126362718|NCT02662582|454621601|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126362719|NCT02662582|454621602|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126362720|NCT04135352|454621603|FG000|Overall Study|Not treated-randomization error|0|||
126362721|NCT04135352|454621604|FG001|Overall Study|Not treated-randomization error|0|||
126362722|NCT04135352|454621605|FG002|Overall Study|Not treated-randomization error|1|||
126362723|NCT04135352|454621606|FG003|Overall Study|Not treated-randomization error|0|||
126362724|NCT04135352|454621607|FG004|Overall Study|Not treated-randomization error|0|||
126275911|NCT02132754|454300041|FG027|Overall Study|Screen Failure|0|||
126275912|NCT02132754|454300042|FG028|Overall Study|Screen Failure|0|||
126275913|NCT02132754|454300043|FG029|Overall Study|Screen Failure|0|||
126275914|NCT02132754|454300044|FG030|Overall Study|Screen Failure|0|||
126275915|NCT02132754|454300045|FG031|Overall Study|Screen Failure|0|||
126275916|NCT02132754|454300046|FG032|Overall Study|Screen Failure|0|||
126275917|NCT02132754|454300047|FG033|Overall Study|Screen Failure|0|||
126275918|NCT02132754|454300014|FG000|Overall Study|Transferred to Extension Study|0|||
126275919|NCT02132754|454300015|FG001|Overall Study|Transferred to Extension Study|0|||
126275920|NCT02132754|454300016|FG002|Overall Study|Transferred to Extension Study|0|||
126275921|NCT02132754|454300017|FG003|Overall Study|Transferred to Extension Study|0|||
126275922|NCT02132754|454300018|FG004|Overall Study|Transferred to Extension Study|0|||
126362725|NCT04135352|454621608|FG005|Overall Study|Not treated-randomization error|0|||
126362726|NCT04135352|454621609|FG006|Overall Study|Not treated-randomization error|0|||
126362727|NCT04135352|454621610|FG007|Overall Study|Not treated-randomization error|0|||
126362728|NCT04135352|454621603|FG000|Overall Study|Withdrawal by Subject|0|||
126362729|NCT04135352|454621604|FG001|Overall Study|Withdrawal by Subject|0|||
126362730|NCT04135352|454621605|FG002|Overall Study|Withdrawal by Subject|2|||
126037699|NCT03701763|453436765|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
126037700|NCT03701763|453436762|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
126037701|NCT03701763|453436763|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
126037702|NCT03701763|453436764|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
126037703|NCT03701763|453436765|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
126037704|NCT03701763|453436762|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
126037705|NCT03701763|453436763|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
126037706|NCT03701763|453436764|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
126037707|NCT03701763|453436765|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
126037708|NCT03701763|453436762|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
126037709|NCT03701763|453436763|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
126037710|NCT03701763|453436764|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
126362731|NCT04135352|454621606|FG003|Overall Study|Withdrawal by Subject|0|||
126362732|NCT04135352|454621607|FG004|Overall Study|Withdrawal by Subject|0|||
126362733|NCT04135352|454621608|FG005|Overall Study|Withdrawal by Subject|0|||
126362734|NCT04135352|454621609|FG006|Overall Study|Withdrawal by Subject|0|||
126362735|NCT04135352|454621610|FG007|Overall Study|Withdrawal by Subject|0|||
126362736|NCT04135352|454621603|FG000|Overall Study|Sponsor Decision|0|||
126362737|NCT04135352|454621604|FG001|Overall Study|Sponsor Decision|0|||
126362738|NCT04135352|454621605|FG002|Overall Study|Sponsor Decision|2|||
126362739|NCT04135352|454621606|FG003|Overall Study|Sponsor Decision|5|||
126362740|NCT04135352|454621607|FG004|Overall Study|Sponsor Decision|1|||
126037711|NCT03701763|453436765|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
126037712|NCT03701763|453436762|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
126362741|NCT04135352|454621608|FG005|Overall Study|Sponsor Decision|4|||
126362742|NCT04135352|454621609|FG006|Overall Study|Sponsor Decision|0|||
126362743|NCT04135352|454621610|FG007|Overall Study|Sponsor Decision|0|||
126362744|NCT04135352|454621603|FG000|Overall Study|Physician Decision|0|||
126362745|NCT04135352|454621604|FG001|Overall Study|Physician Decision|0|||
126362746|NCT04135352|454621605|FG002|Overall Study|Physician Decision|1|||
126362747|NCT04135352|454621606|FG003|Overall Study|Physician Decision|0|||
126362748|NCT04135352|454621607|FG004|Overall Study|Physician Decision|1|||
126362749|NCT04135352|454621608|FG005|Overall Study|Physician Decision|0|||
126362750|NCT04135352|454621609|FG006|Overall Study|Physician Decision|0|||
126362751|NCT04135352|454621610|FG007|Overall Study|Physician Decision|0|||
126362752|NCT04135352|454621603|FG000|Overall Study|Death|3|||
126362753|NCT04135352|454621604|FG001|Overall Study|Death|4|||
126362754|NCT04135352|454621605|FG002|Overall Study|Death|7|||
126362755|NCT04135352|454621606|FG003|Overall Study|Death|0|||
126362756|NCT04135352|454621607|FG004|Overall Study|Death|3|||
126362757|NCT04135352|454621608|FG005|Overall Study|Death|1|||
126362758|NCT04135352|454621609|FG006|Overall Study|Death|0|||
126362759|NCT04135352|454621610|FG007|Overall Study|Death|0|||
126362760|NCT00511199|454621611|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
126362761|NCT00511199|454621612|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
125881023|NCT03866577|452862731|FG007|Overall Study|Withdrawal by Subject|0|||
125881024|NCT03866577|452862732|FG008|Overall Study|Withdrawal by Subject|1|||
125881025|NCT03866577|452862733|FG009|Overall Study|Withdrawal by Subject|1|||
125881026|NCT03866577|452862734|FG010|Overall Study|Withdrawal by Subject|0|||
126362762|NCT00511199|454621611|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
126362763|NCT00511199|454621612|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
126362764|NCT00511199|454621611|FG000|Overall Study|Withdrawal of Informed Consent|19|||
126362765|NCT00511199|454621612|FG001|Overall Study|Withdrawal of Informed Consent|4|||
126362766|NCT00511199|454621611|FG000|Overall Study|Pregnancy|6|||
126362767|NCT00511199|454621612|FG001|Overall Study|Pregnancy|3|||
126362768|NCT00511199|454621611|FG000|Overall Study|Pregnancy Wish|16|||
126362769|NCT00511199|454621612|FG001|Overall Study|Pregnancy Wish|8|||
126362770|NCT00511199|454621611|FG000|Overall Study|Lost to Follow-up|40|||
126037713|NCT03701763|453436763|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
126037714|NCT03701763|453436764|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
126037715|NCT03701763|453436765|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
126037716|NCT03701763|453436762|FG000|Apremilast Extension Phase|Adverse Event|0|||
126037717|NCT03701763|453436763|FG001|Apremilast Extension Phase|Adverse Event|0|||
126037718|NCT03701763|453436764|FG002|Apremilast Extension Phase|Adverse Event|3|||
126037719|NCT03701763|453436765|FG003|Apremilast Extension Phase|Adverse Event|1|||
126037720|NCT03701763|453436762|FG000|Apremilast Extension Phase|Miscellaneous|0|||
126037721|NCT03701763|453436763|FG001|Apremilast Extension Phase|Miscellaneous|0|||
126037722|NCT03701763|453436764|FG002|Apremilast Extension Phase|Miscellaneous|2|||
126037723|NCT03701763|453436765|FG003|Apremilast Extension Phase|Miscellaneous|1|||
126037724|NCT03701763|453436762|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
126037725|NCT03701763|453436763|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
126037726|NCT03701763|453436764|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
126037727|NCT03701763|453436765|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
126037728|NCT03701763|453436762|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
126037729|NCT03701763|453436763|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
126037730|NCT03701763|453436764|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
126037731|NCT03701763|453436765|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
126037732|NCT03701763|453436762|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
126037733|NCT03701763|453436763|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
126275923|NCT02132754|454300019|FG005|Overall Study|Transferred to Extension Study|0|||
126275924|NCT02132754|454300020|FG006|Overall Study|Transferred to Extension Study|0|||
126275925|NCT02132754|454300021|FG007|Overall Study|Transferred to Extension Study|0|||
126275926|NCT02132754|454300022|FG008|Overall Study|Transferred to Extension Study|0|||
126275927|NCT02132754|454300023|FG009|Overall Study|Transferred to Extension Study|0|||
126275928|NCT02132754|454300024|FG010|Overall Study|Transferred to Extension Study|0|||
126275929|NCT02132754|454300025|FG011|Overall Study|Transferred to Extension Study|0|||
126275930|NCT02132754|454300026|FG012|Overall Study|Transferred to Extension Study|0|||
126275931|NCT02132754|454300027|FG013|Overall Study|Transferred to Extension Study|0|||
126275932|NCT02132754|454300028|FG014|Overall Study|Transferred to Extension Study|0|||
126275933|NCT02132754|454300029|FG015|Overall Study|Transferred to Extension Study|0|||
126275934|NCT02132754|454300030|FG016|Overall Study|Transferred to Extension Study|0|||
126275935|NCT02132754|454300031|FG017|Overall Study|Transferred to Extension Study|0|||
126275936|NCT02132754|454300032|FG018|Overall Study|Transferred to Extension Study|0|||
126275937|NCT02132754|454300033|FG019|Overall Study|Transferred to Extension Study|0|||
126275938|NCT02132754|454300034|FG020|Overall Study|Transferred to Extension Study|0|||
126275939|NCT02132754|454300035|FG021|Overall Study|Transferred to Extension Study|0|||
126275940|NCT02132754|454300036|FG022|Overall Study|Transferred to Extension Study|0|||
126275941|NCT02132754|454300037|FG023|Overall Study|Transferred to Extension Study|0|||
126275942|NCT02132754|454300038|FG024|Overall Study|Transferred to Extension Study|0|||
126275943|NCT02132754|454300039|FG025|Overall Study|Transferred to Extension Study|0|||
126275944|NCT02132754|454300040|FG026|Overall Study|Transferred to Extension Study|0|||
126275945|NCT02132754|454300041|FG027|Overall Study|Transferred to Extension Study|0|||
126275946|NCT02132754|454300042|FG028|Overall Study|Transferred to Extension Study|0|||
126275947|NCT02132754|454300043|FG029|Overall Study|Transferred to Extension Study|0|||
126275948|NCT02132754|454300044|FG030|Overall Study|Transferred to Extension Study|0|||
126275949|NCT02132754|454300045|FG031|Overall Study|Transferred to Extension Study|0|||
126275950|NCT02132754|454300046|FG032|Overall Study|Transferred to Extension Study|0|||
126275951|NCT02132754|454300047|FG033|Overall Study|Transferred to Extension Study|6|||
126275952|NCT02132754|454300014|FG000|Overall Study|Withdrawal by Subject|0|||
126275953|NCT02132754|454300015|FG001|Overall Study|Withdrawal by Subject|0|||
126275954|NCT02132754|454300016|FG002|Overall Study|Withdrawal by Subject|0|||
126275955|NCT02132754|454300017|FG003|Overall Study|Withdrawal by Subject|0|||
126275956|NCT02132754|454300018|FG004|Overall Study|Withdrawal by Subject|0|||
126275957|NCT02132754|454300019|FG005|Overall Study|Withdrawal by Subject|0|||
126275958|NCT02132754|454300020|FG006|Overall Study|Withdrawal by Subject|0|||
126037734|NCT03701763|453436764|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
126037735|NCT03701763|453436765|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
126037736|NCT03701763|453436762|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
126037737|NCT03701763|453436763|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
126037738|NCT03701763|453436764|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
126275959|NCT02132754|454300021|FG007|Overall Study|Withdrawal by Subject|0|||
126275960|NCT02132754|454300022|FG008|Overall Study|Withdrawal by Subject|0|||
126275961|NCT02132754|454300023|FG009|Overall Study|Withdrawal by Subject|1|||
126362771|NCT00511199|454621612|FG001|Overall Study|Lost to Follow-up|17|||
126037739|NCT03701763|453436765|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
126275962|NCT02132754|454300024|FG010|Overall Study|Withdrawal by Subject|0|||
126275963|NCT02132754|454300025|FG011|Overall Study|Withdrawal by Subject|0|||
126275964|NCT02132754|454300026|FG012|Overall Study|Withdrawal by Subject|1|||
126275965|NCT02132754|454300027|FG013|Overall Study|Withdrawal by Subject|0|||
126275966|NCT02132754|454300028|FG014|Overall Study|Withdrawal by Subject|1|||
126275967|NCT02132754|454300029|FG015|Overall Study|Withdrawal by Subject|2|||
126275968|NCT02132754|454300030|FG016|Overall Study|Withdrawal by Subject|1|||
126275969|NCT02132754|454300031|FG017|Overall Study|Withdrawal by Subject|0|||
126275970|NCT02132754|454300032|FG018|Overall Study|Withdrawal by Subject|0|||
126275971|NCT02132754|454300033|FG019|Overall Study|Withdrawal by Subject|0|||
126275972|NCT02132754|454300034|FG020|Overall Study|Withdrawal by Subject|1|||
126275973|NCT02132754|454300035|FG021|Overall Study|Withdrawal by Subject|0|||
126275974|NCT02132754|454300036|FG022|Overall Study|Withdrawal by Subject|0|||
126275975|NCT02132754|454300037|FG023|Overall Study|Withdrawal by Subject|0|||
126275976|NCT02132754|454300038|FG024|Overall Study|Withdrawal by Subject|1|||
126275977|NCT02132754|454300039|FG025|Overall Study|Withdrawal by Subject|0|||
126275978|NCT02132754|454300040|FG026|Overall Study|Withdrawal by Subject|0|||
126275979|NCT02132754|454300041|FG027|Overall Study|Withdrawal by Subject|1|||
126275980|NCT02132754|454300042|FG028|Overall Study|Withdrawal by Subject|0|||
126275981|NCT02132754|454300043|FG029|Overall Study|Withdrawal by Subject|0|||
126275982|NCT02132754|454300044|FG030|Overall Study|Withdrawal by Subject|0|||
126275983|NCT02132754|454300045|FG031|Overall Study|Withdrawal by Subject|1|||
126275984|NCT02132754|454300046|FG032|Overall Study|Withdrawal by Subject|0|||
126362772|NCT00511199|454621611|FG000|Overall Study|Other Reason|78|||
126362773|NCT00511199|454621612|FG001|Overall Study|Other Reason|37|||
126362774|NCT02739828|454621618|FG000|Overall Study|Adverse Event|1|||
126362775|NCT02739828|454621618|FG000|Overall Study|Lost to Follow-up|4|||
126362776|NCT01953354|454621619|FG000|Overall Study|Withdrawal by Subject|0|||
126362777|NCT01953354|454621620|FG001|Overall Study|Withdrawal by Subject|1|||
126362778|NCT01953354|454621619|FG000|Overall Study|Decision of Sponsor|0|||
126362779|NCT01953354|454621620|FG001|Overall Study|Decision of Sponsor|1|||
126362780|NCT01953354|454621619|FG000|Overall Study|Disease Exacerbation|1|||
126362781|NCT01953354|454621620|FG001|Overall Study|Disease Exacerbation|0|||
126362782|NCT01392495|454621621|FG000|Overall Study|Death|3|||
126362783|NCT01392495|454621621|FG000|Overall Study|Administrative problems|8|||
126362784|NCT01392495|454621621|FG000|Overall Study|Withdrawal by Subject|2|||
126362785|NCT01392495|454621621|FG000|Overall Study|Adverse Event|3|||
126362786|NCT01570192|454621622|FG000|Overall Study|no qualifying organism|6|||
126275985|NCT02132754|454300047|FG033|Overall Study|Withdrawal by Subject|2|||
126275986|NCT03050060|454300050|FG000|Overall Study|Adverse Event|7|||
126275987|NCT03050060|454300050|FG000|Overall Study|Withdrawal by Subject|1|||
126275988|NCT03050060|454300050|FG000|Overall Study|Progression|7|||
126362787|NCT01570192|454621623|FG001|Overall Study|no qualifying organism|12|||
126362788|NCT01570192|454621622|FG000|Overall Study|changed to palliative care|1|||
126362789|NCT01570192|454621623|FG001|Overall Study|changed to palliative care|0|||
126275989|NCT03276780|454300051|FG000|Overall Study|Withdrawal by Subject|5|||
126275990|NCT03276780|454300052|FG001|Overall Study|Withdrawal by Subject|3|||
126275991|NCT03276780|454300051|FG000|Overall Study|Lost to Follow-up|3|||
126275992|NCT03276780|454300052|FG001|Overall Study|Lost to Follow-up|5|||
126275993|NCT03276780|454300051|FG000|Overall Study|Moved out of state|1|||
126275994|NCT03276780|454300052|FG001|Overall Study|Moved out of state|1|||
126275995|NCT03276780|454300051|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
126275996|NCT03276780|454300052|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
126275997|NCT03276780|454300051|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
126275998|NCT03276780|454300052|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
126275999|NCT03665441|454301727|FG000|Overall Study|survival follow up ongoing|23|||
126276000|NCT03665441|454301728|FG001|Overall Study|survival follow up ongoing|0|||
126276001|NCT03665441|454301727|FG000|Overall Study|Patients ongoing on treatment|9|||
126276002|NCT03665441|454301728|FG001|Overall Study|Patients ongoing on treatment|6|||
126276003|NCT03665441|454301727|FG000|Overall Study|Randomized but not treated|7|||
126276004|NCT03665441|454301728|FG001|Overall Study|Randomized but not treated|11|||
126276005|NCT00372411|454301729|FG000|Overall Study|Withdrawal by Subject|3|||
126276006|NCT00372411|454301730|FG001|Overall Study|Withdrawal by Subject|4|||
126276007|NCT00372411|454301731|FG002|Overall Study|Withdrawal by Subject|1|||
126276008|NCT00372411|454301729|FG000|Overall Study|Death|0|||
126276009|NCT00372411|454301730|FG001|Overall Study|Death|2|||
126276010|NCT00372411|454301731|FG002|Overall Study|Death|1|||
126276011|NCT00372411|454301729|FG000|Overall Study|Lost to Follow-up|1|||
126276012|NCT00372411|454301730|FG001|Overall Study|Lost to Follow-up|1|||
126276013|NCT00372411|454301731|FG002|Overall Study|Lost to Follow-up|1|||
126276014|NCT00372411|454301729|FG000|Overall Study|Adverse Event|1|||
126276015|NCT00372411|454301730|FG001|Overall Study|Adverse Event|1|||
126276016|NCT00372411|454301731|FG002|Overall Study|Adverse Event|0|||
126276017|NCT00631657|454301732|FG000|6-Month Treatment Period|Adverse Event|47|||
126276018|NCT00631657|454301733|FG001|6-Month Treatment Period|Adverse Event|0|||
126276019|NCT00631657|454301734|FG002|6-Month Treatment Period|Adverse Event|7|||
126276020|NCT00631657|454301732|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
126276021|NCT00631657|454301733|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
126276022|NCT00631657|454301734|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
126276023|NCT00631657|454301732|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
126276024|NCT00631657|454301733|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
126276025|NCT00631657|454301734|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
126276026|NCT00631657|454301732|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
126276027|NCT00631657|454301733|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
126276028|NCT00631657|454301734|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
126276029|NCT00631657|454301732|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
126276030|NCT00631657|454301733|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
126276031|NCT00631657|454301734|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
126276032|NCT00631657|454301732|FG000|6-Month Treatment Period|Other|16|||
126276033|NCT00631657|454301733|FG001|6-Month Treatment Period|Other|0|||
126276034|NCT00631657|454301734|FG002|6-Month Treatment Period|Other|4|||
126276035|NCT00631657|454301732|FG000|6-Month Treatment Period|Not Treated|2|||
126276036|NCT00631657|454301733|FG001|6-Month Treatment Period|Not Treated|0|||
125881027|NCT03866577|452862735|FG011|Overall Study|Withdrawal by Subject|0|||
125881028|NCT03866577|452862736|FG012|Overall Study|Withdrawal by Subject|0|||
126276037|NCT00631657|454301734|FG002|6-Month Treatment Period|Not Treated|1|||
126276038|NCT00631657|454301732|FG000|7-Day Discontinuation Period|Not Treated|1|||
126037740|NCT03701763|453436762|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
126037741|NCT03701763|453436763|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
126037742|NCT03701763|453436764|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
126037743|NCT03701763|453436765|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
126037744|NCT03701763|453436762|FG000|14-Week Observational Follow-up Phase|Other|0|||
126037745|NCT03701763|453436763|FG001|14-Week Observational Follow-up Phase|Other|0|||
126037746|NCT03701763|453436764|FG002|14-Week Observational Follow-up Phase|Other|1|||
126037747|NCT03701763|453436765|FG003|14-Week Observational Follow-up Phase|Other|0|||
126037748|NCT03701763|453436762|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
126037749|NCT03701763|453436763|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
126037750|NCT03701763|453436764|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
126037751|NCT03701763|453436765|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
126037752|NCT03701763|453436762|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
126037753|NCT03701763|453436763|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
126037754|NCT03701763|453436764|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
126037755|NCT03701763|453436765|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
126037756|NCT00592852|453436767|FG000|Overall Study|Non-compliance|1|||
126037757|NCT00592852|453436767|FG000|Overall Study|Adverse Event|3|||
126037758|NCT00592852|453436767|FG000|Overall Study|Found ineligible|1|||
126037759|NCT00592852|453436767|FG000|Overall Study|Withdrawal by Subject|1|||
126037760|NCT02589795|453436771|FG000|Overall Study|Lost to Follow-up|1|||
126037761|NCT02589795|453436772|FG001|Overall Study|Lost to Follow-up|0|||
126037762|NCT02589795|453436773|FG002|Overall Study|Lost to Follow-up|0|||
126037763|NCT02589795|453436771|FG000|Overall Study|Withdrawal by Subject|0|||
126037764|NCT02589795|453436772|FG001|Overall Study|Withdrawal by Subject|0|||
126037765|NCT02589795|453436773|FG002|Overall Study|Withdrawal by Subject|2|||
126037766|NCT02589795|453436771|FG000|Overall Study|Protocol Violation|0|||
126037767|NCT02589795|453436772|FG001|Overall Study|Protocol Violation|0|||
126037768|NCT02589795|453436773|FG002|Overall Study|Protocol Violation|1|||
126037769|NCT03599661|453436775|FG000|Overall Study|Lost to Follow-up|9|||
126276039|NCT00631657|454301733|FG001|7-Day Discontinuation Period|Not Treated|1|||
126276040|NCT00631657|454301734|FG002|7-Day Discontinuation Period|Not Treated|1|||
126276041|NCT00631657|454301732|FG000|7-Day Discontinuation Period|Other|1|||
126276042|NCT00631657|454301733|FG001|7-Day Discontinuation Period|Other|0|||
126276043|NCT00631657|454301734|FG002|7-Day Discontinuation Period|Other|0|||
126276044|NCT00699374|454301736|FG000|Overall Study|Death|93|||
126276045|NCT00699374|454301737|FG001|Overall Study|Death|83|||
126276046|NCT00699374|454301736|FG000|Overall Study|Adverse Event|70|||
126276047|NCT00699374|454301737|FG001|Overall Study|Adverse Event|67|||
126276048|NCT00699374|454301736|FG000|Overall Study|Global deterioration of health status|7|||
126276049|NCT00699374|454301737|FG001|Overall Study|Global deterioration of health status|8|||
126276050|NCT00699374|454301736|FG000|Overall Study|Lost to Follow-up|3|||
126276051|NCT00699374|454301737|FG001|Overall Study|Lost to Follow-up|5|||
126276052|NCT00699374|454301736|FG000|Overall Study|Withdrawal by Subject|34|||
126276053|NCT00699374|454301737|FG001|Overall Study|Withdrawal by Subject|44|||
126276054|NCT00699374|454301736|FG000|Overall Study|Objective progression or relapse|281|||
126276055|NCT00699374|454301737|FG001|Overall Study|Objective progression or relapse|277|||
126276056|NCT00699374|454301736|FG000|Overall Study|Other|18|||
126276057|NCT00699374|454301737|FG001|Overall Study|Other|15|||
126276058|NCT00699374|454301736|FG000|Overall Study|Protocol Violation|2|||
126276059|NCT00699374|454301737|FG001|Overall Study|Protocol Violation|6|||
126276060|NCT00699374|454301736|FG000|Overall Study|Study terminated by sponsor|13|||
126276061|NCT00699374|454301737|FG001|Overall Study|Study terminated by sponsor|28|||
126276062|NCT00699374|454301736|FG000|Overall Study|Randomized but not treated|4|||
126276063|NCT00699374|454301737|FG001|Overall Study|Randomized but not treated|2|||
126276064|NCT00699374|454301736|FG000|Overall Study|Died 28 days after last dose|5|||
126276065|NCT00699374|454301737|FG001|Overall Study|Died 28 days after last dose|9|||
126276066|NCT03839823|454301740|FG000|Overall Study|Adverse Event|8|||
126276067|NCT03839823|454301741|FG001|Overall Study|Adverse Event|4|||
126276068|NCT03839823|454301740|FG000|Overall Study|Death|1|||
126276069|NCT03839823|454301741|FG001|Overall Study|Death|0|||
126276070|NCT03839823|454301740|FG000|Overall Study|Physician Decision|1|||
126037770|NCT04909801|453436776|FG000|Overall Study|Lack of Efficacy|2|||
126037771|NCT04909801|453436777|FG001|Overall Study|Lack of Efficacy|1|||
126037772|NCT04909801|453436776|FG000|Overall Study|Adverse Event|1|||
126037773|NCT04909801|453436777|FG001|Overall Study|Adverse Event|2|||
126037774|NCT04909801|453436776|FG000|Overall Study|Participant request to discontinue study treatment|1|||
126276071|NCT03839823|454301741|FG001|Overall Study|Physician Decision|5|||
126276072|NCT03839823|454301740|FG000|Overall Study|Progressive Disease (PD)|65|||
126276073|NCT03839823|454301741|FG001|Overall Study|Progressive Disease (PD)|65|||
126276074|NCT03839823|454301740|FG000|Overall Study|Subject Decision|2|||
126276075|NCT03839823|454301741|FG001|Overall Study|Subject Decision|9|||
126362790|NCT01570192|454621622|FG000|Overall Study|Physician Decision|0|||
126362791|NCT01570192|454621623|FG001|Overall Study|Physician Decision|1|||
126362792|NCT02965976|454621624|FG000|Overall Study|Withdrawal by Subject|2|||
126362793|NCT02965976|454621625|FG001|Overall Study|Withdrawal by Subject|0|||
126362794|NCT00806026|454621626|FG000|Overall Study|Death|0|||
126362795|NCT00806026|454621627|FG001|Overall Study|Death|0|||
126362796|NCT00806026|454621628|FG002|Overall Study|Death|0|||
126362797|NCT00806026|454621629|FG003|Overall Study|Death|1|||
126362798|NCT00806026|454621630|FG004|Overall Study|Death|0|||
126362799|NCT00806026|454621631|FG005|Overall Study|Death|0|||
126362800|NCT00806026|454621626|FG000|Overall Study|Did not meet entrance criteria|4|||
126362801|NCT00806026|454621627|FG001|Overall Study|Did not meet entrance criteria|1|||
126362802|NCT00806026|454621628|FG002|Overall Study|Did not meet entrance criteria|2|||
126362803|NCT00806026|454621629|FG003|Overall Study|Did not meet entrance criteria|1|||
126276076|NCT03839823|454301740|FG000|Overall Study|Not Treated|0|||
126276077|NCT03839823|454301741|FG001|Overall Study|Not Treated|10|||
126276078|NCT01517373|454301742|FG000|Run-in Period|Death|1|||
126276079|NCT01517373|454301743|FG001|Run-in Period|Death|0|||
126276080|NCT01517373|454301744|FG002|Run-in Period|Death|0|||
126276081|NCT01517373|454301745|FG003|Run-in Period|Death|0|||
126276082|NCT01517373|454301746|FG004|Run-in Period|Death|0|||
126276083|NCT01517373|454301747|FG005|Run-in Period|Death|0|||
126276084|NCT01517373|454301742|FG000|Run-in Period|Adverse Event|5|||
126276085|NCT01517373|454301743|FG001|Run-in Period|Adverse Event|0|||
126276086|NCT01517373|454301744|FG002|Run-in Period|Adverse Event|0|||
126276087|NCT01517373|454301745|FG003|Run-in Period|Adverse Event|0|||
126276088|NCT01517373|454301746|FG004|Run-in Period|Adverse Event|0|||
126276089|NCT01517373|454301747|FG005|Run-in Period|Adverse Event|0|||
126276090|NCT01517373|454301742|FG000|Run-in Period|Did not meet eligibility criteria|34|||
126276091|NCT01517373|454301743|FG001|Run-in Period|Did not meet eligibility criteria|0|||
126276092|NCT01517373|454301744|FG002|Run-in Period|Did not meet eligibility criteria|0|||
126276093|NCT01517373|454301745|FG003|Run-in Period|Did not meet eligibility criteria|0|||
126276094|NCT01517373|454301746|FG004|Run-in Period|Did not meet eligibility criteria|0|||
126276095|NCT01517373|454301747|FG005|Run-in Period|Did not meet eligibility criteria|0|||
126276096|NCT01517373|454301742|FG000|Run-in Period|Lost to Follow-up|1|||
126276097|NCT01517373|454301743|FG001|Run-in Period|Lost to Follow-up|0|||
126276098|NCT01517373|454301744|FG002|Run-in Period|Lost to Follow-up|0|||
126276099|NCT01517373|454301745|FG003|Run-in Period|Lost to Follow-up|0|||
126276100|NCT01517373|454301746|FG004|Run-in Period|Lost to Follow-up|0|||
126276101|NCT01517373|454301747|FG005|Run-in Period|Lost to Follow-up|0|||
126276102|NCT01517373|454301742|FG000|Run-in Period|Withdrawal by Subject|12|||
126276103|NCT01517373|454301743|FG001|Run-in Period|Withdrawal by Subject|0|||
126276104|NCT01517373|454301744|FG002|Run-in Period|Withdrawal by Subject|0|||
126276105|NCT01517373|454301745|FG003|Run-in Period|Withdrawal by Subject|0|||
126276106|NCT01517373|454301746|FG004|Run-in Period|Withdrawal by Subject|0|||
126276107|NCT01517373|454301747|FG005|Run-in Period|Withdrawal by Subject|0|||
126276108|NCT01517373|454301742|FG000|Run-in Period|Sponsor Decision|3|||
126276109|NCT01517373|454301743|FG001|Run-in Period|Sponsor Decision|0|||
126276110|NCT01517373|454301744|FG002|Run-in Period|Sponsor Decision|0|||
126276111|NCT01517373|454301745|FG003|Run-in Period|Sponsor Decision|0|||
126276112|NCT01517373|454301746|FG004|Run-in Period|Sponsor Decision|0|||
126362804|NCT00806026|454621630|FG004|Overall Study|Did not meet entrance criteria|0|||
126362805|NCT00806026|454621631|FG005|Overall Study|Did not meet entrance criteria|0|||
126362806|NCT00806026|454621626|FG000|Overall Study|Lack of Efficacy|5|||
126362807|NCT00806026|454621627|FG001|Overall Study|Lack of Efficacy|18|||
126362808|NCT00806026|454621628|FG002|Overall Study|Lack of Efficacy|13|||
126362809|NCT00806026|454621629|FG003|Overall Study|Lack of Efficacy|4|||
126362810|NCT00806026|454621630|FG004|Overall Study|Lack of Efficacy|8|||
126362811|NCT00806026|454621631|FG005|Overall Study|Lack of Efficacy|7|||
126362812|NCT00806026|454621626|FG000|Overall Study|Lost to Follow-up|8|||
126362813|NCT00806026|454621627|FG001|Overall Study|Lost to Follow-up|15|||
126362814|NCT00806026|454621628|FG002|Overall Study|Lost to Follow-up|8|||
126362815|NCT00806026|454621629|FG003|Overall Study|Lost to Follow-up|2|||
126362816|NCT00806026|454621630|FG004|Overall Study|Lost to Follow-up|6|||
126362817|NCT00806026|454621631|FG005|Overall Study|Lost to Follow-up|6|||
126362818|NCT00806026|454621626|FG000|Overall Study|Withdrawal by Subject|14|||
126362819|NCT00806026|454621627|FG001|Overall Study|Withdrawal by Subject|17|||
126362820|NCT00806026|454621628|FG002|Overall Study|Withdrawal by Subject|9|||
126362821|NCT00806026|454621629|FG003|Overall Study|Withdrawal by Subject|2|||
126362822|NCT00806026|454621630|FG004|Overall Study|Withdrawal by Subject|5|||
126362823|NCT00806026|454621631|FG005|Overall Study|Withdrawal by Subject|3|||
126276113|NCT01517373|454301747|FG005|Run-in Period|Sponsor Decision|0|||
126276114|NCT01517373|454301742|FG000|Run-in Period|Other|1|||
126276115|NCT01517373|454301743|FG001|Run-in Period|Other|0|||
126362824|NCT00806026|454621626|FG000|Overall Study|Other|3|||
126362825|NCT00806026|454621627|FG001|Overall Study|Other|6|||
126362826|NCT00806026|454621628|FG002|Overall Study|Other|8|||
126362827|NCT00806026|454621629|FG003|Overall Study|Other|2|||
126362828|NCT00806026|454621630|FG004|Overall Study|Other|0|||
126362829|NCT00806026|454621631|FG005|Overall Study|Other|4|||
126098680|NCT01506609|453653082|FG000|Overall Study|Missing / Unknown Reason|1|||
126098681|NCT01506609|453653083|FG001|Overall Study|Missing / Unknown Reason|0|||
126098682|NCT01506609|453653084|FG002|Overall Study|Missing / Unknown Reason|1|||
126276116|NCT01517373|454301744|FG002|Run-in Period|Other|0|||
126276117|NCT01517373|454301745|FG003|Run-in Period|Other|0|||
126276118|NCT01517373|454301746|FG004|Run-in Period|Other|0|||
126276119|NCT01517373|454301747|FG005|Run-in Period|Other|0|||
126276120|NCT01517373|454301742|FG000|Treatment Period|Adverse Event|0|||
126276121|NCT01517373|454301743|FG001|Treatment Period|Adverse Event|0|||
126276122|NCT01517373|454301744|FG002|Treatment Period|Adverse Event|0|||
126276123|NCT01517373|454301745|FG003|Treatment Period|Adverse Event|0|||
126276124|NCT01517373|454301746|FG004|Treatment Period|Adverse Event|0|||
126276125|NCT01517373|454301747|FG005|Treatment Period|Adverse Event|2|||
126276126|NCT01517373|454301742|FG000|Treatment Period|Lost to Follow-up|0|||
126276127|NCT01517373|454301743|FG001|Treatment Period|Lost to Follow-up|0|||
126276128|NCT01517373|454301744|FG002|Treatment Period|Lost to Follow-up|1|||
126276129|NCT01517373|454301745|FG003|Treatment Period|Lost to Follow-up|1|||
126276130|NCT01517373|454301746|FG004|Treatment Period|Lost to Follow-up|0|||
126276131|NCT01517373|454301747|FG005|Treatment Period|Lost to Follow-up|0|||
126276132|NCT01517373|454301742|FG000|Treatment Period|Withdrawal by Subject|0|||
126276133|NCT01517373|454301743|FG001|Treatment Period|Withdrawal by Subject|3|||
126276134|NCT01517373|454301744|FG002|Treatment Period|Withdrawal by Subject|2|||
126276135|NCT01517373|454301745|FG003|Treatment Period|Withdrawal by Subject|2|||
126276136|NCT01517373|454301746|FG004|Treatment Period|Withdrawal by Subject|2|||
126276137|NCT01517373|454301747|FG005|Treatment Period|Withdrawal by Subject|3|||
126276138|NCT01517373|454301742|FG000|Treatment Period|Other|0|||
126276139|NCT01517373|454301743|FG001|Treatment Period|Other|0|||
126276140|NCT01517373|454301744|FG002|Treatment Period|Other|0|||
126276141|NCT01517373|454301745|FG003|Treatment Period|Other|0|||
126276142|NCT01517373|454301746|FG004|Treatment Period|Other|1|||
126276143|NCT01517373|454301747|FG005|Treatment Period|Other|0|||
126276144|NCT01517373|454301742|FG000|Treatment Period|Protocol Violation|0|||
126276145|NCT01517373|454301743|FG001|Treatment Period|Protocol Violation|0|||
126276146|NCT01517373|454301744|FG002|Treatment Period|Protocol Violation|0|||
126276147|NCT01517373|454301745|FG003|Treatment Period|Protocol Violation|0|||
126276148|NCT01517373|454301746|FG004|Treatment Period|Protocol Violation|1|||
126276149|NCT01517373|454301747|FG005|Treatment Period|Protocol Violation|0|||
126276150|NCT01517373|454301742|FG000|Treatment Period|Lack of Efficacy|0|||
126276151|NCT01517373|454301743|FG001|Treatment Period|Lack of Efficacy|1|||
126276152|NCT01517373|454301744|FG002|Treatment Period|Lack of Efficacy|1|||
126276153|NCT01517373|454301745|FG003|Treatment Period|Lack of Efficacy|3|||
126276154|NCT01517373|454301746|FG004|Treatment Period|Lack of Efficacy|2|||
126276155|NCT01517373|454301747|FG005|Treatment Period|Lack of Efficacy|0|||
126276156|NCT01517373|454301742|FG000|Treatment Period|Medication error without AEs|0|||
126276157|NCT01517373|454301743|FG001|Treatment Period|Medication error without AEs|0|||
126276158|NCT01517373|454301744|FG002|Treatment Period|Medication error without AEs|2|||
126276159|NCT01517373|454301745|FG003|Treatment Period|Medication error without AEs|1|||
126276160|NCT01517373|454301746|FG004|Treatment Period|Medication error without AEs|0|||
126276161|NCT01517373|454301747|FG005|Treatment Period|Medication error without AEs|2|||
126276162|NCT04562155|454301749|FG000|Overall Study|COVID-19 pandemic|0|||
126276163|NCT04562155|454301750|FG001|Overall Study|COVID-19 pandemic|0|||
126276164|NCT04562155|454301751|FG002|Overall Study|COVID-19 pandemic|0|||
126276165|NCT04562155|454301752|FG003|Overall Study|COVID-19 pandemic|1|||
126276166|NCT04562155|454301749|FG000|Overall Study|Adverse Event|7|||
126276167|NCT04562155|454301750|FG001|Overall Study|Adverse Event|3|||
126276168|NCT04562155|454301751|FG002|Overall Study|Adverse Event|8|||
126276169|NCT04562155|454301752|FG003|Overall Study|Adverse Event|1|||
126276170|NCT04562155|454301749|FG000|Overall Study|Withdrawal by Subject|3|||
126276171|NCT04562155|454301750|FG001|Overall Study|Withdrawal by Subject|6|||
126276172|NCT04562155|454301751|FG002|Overall Study|Withdrawal by Subject|3|||
126276173|NCT04562155|454301752|FG003|Overall Study|Withdrawal by Subject|3|||
126276174|NCT04562155|454301749|FG000|Overall Study|Participant personal reason|1|||
126276175|NCT04562155|454301750|FG001|Overall Study|Participant personal reason|0|||
126276176|NCT04562155|454301751|FG002|Overall Study|Participant personal reason|2|||
126276177|NCT04562155|454301752|FG003|Overall Study|Participant personal reason|1|||
126276178|NCT01085201|454301755|FG000|Overall Study|Scheduling conflict|1|||
126276179|NCT01085201|454301756|FG001|Overall Study|Scheduling conflict|0|||
126276180|NCT01085201|454301757|FG002|Overall Study|Scheduling conflict|1|||
126276181|NCT01085201|454301758|FG003|Overall Study|Scheduling conflict|0|||
126276182|NCT01085201|454301759|FG004|Overall Study|Scheduling conflict|0|||
126276183|NCT01085201|454301755|FG000|Overall Study|Unknown- no study drug|2|||
126276184|NCT01085201|454301756|FG001|Overall Study|Unknown- no study drug|0|||
126276185|NCT01085201|454301757|FG002|Overall Study|Unknown- no study drug|0|||
126276186|NCT01085201|454301758|FG003|Overall Study|Unknown- no study drug|0|||
126276187|NCT01085201|454301759|FG004|Overall Study|Unknown- no study drug|0|||
126276188|NCT01085201|454301755|FG000|Overall Study|Fond ineligible after consent|0|||
126276189|NCT01085201|454301756|FG001|Overall Study|Fond ineligible after consent|1|||
126276190|NCT01085201|454301757|FG002|Overall Study|Fond ineligible after consent|1|||
126276191|NCT01085201|454301758|FG003|Overall Study|Fond ineligible after consent|0|||
126276192|NCT01085201|454301759|FG004|Overall Study|Fond ineligible after consent|0|||
126276193|NCT04516759|454301761|FG000|Overall Study|Withdrawal by Subject|1|||
126276194|NCT04516759|454301762|FG001|Overall Study|Withdrawal by Subject|1|||
126276195|NCT04516759|454301761|FG000|Overall Study|Other|0|||
126276196|NCT04516759|454301762|FG001|Overall Study|Other|1|||
126276197|NCT00867503|454301766|FG000|Overall Study|Withdrawal by Subject|1|||
126276198|NCT01001988|454301767|FG000|Overall Study|Protocol Violation|84|||
126276199|NCT01001988|454301767|FG000|Overall Study|Withdrawal by Subject|18|||
126276200|NCT01001988|454301767|FG000|Overall Study|Lost to Follow-up|15|||
126276201|NCT00927394|454301770|FG000|Overall Study|Adverse Event|14|||
126276202|NCT00927394|454301771|FG001|Overall Study|Adverse Event|9|||
126276203|NCT00927394|454301770|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
126276204|NCT00927394|454301771|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
126276205|NCT00927394|454301770|FG000|Overall Study|Withdrawal by Subject|20|||
126276206|NCT00927394|454301771|FG001|Overall Study|Withdrawal by Subject|24|||
126276207|NCT00927394|454301770|FG000|Overall Study|Lost to Follow-up|8|||
126276208|NCT00927394|454301771|FG001|Overall Study|Lost to Follow-up|14|||
126276209|NCT00927394|454301770|FG000|Overall Study|Administrative Problem|1|||
126276210|NCT00927394|454301771|FG001|Overall Study|Administrative Problem|0|||
126276211|NCT00927394|454301770|FG000|Overall Study|Death|1|||
126276212|NCT00927394|454301771|FG001|Overall Study|Death|1|||
126276213|NCT00927394|454301770|FG000|Overall Study|Protocol deviation|16|||
126276214|NCT00927394|454301771|FG001|Overall Study|Protocol deviation|13|||
126276215|NCT00927394|454301770|FG000|Overall Study|Randomized in error|0|||
126276216|NCT00927394|454301771|FG001|Overall Study|Randomized in error|1|||
126276217|NCT01221363|454301772|FG000|Overall Study|Pregnancy|1|||
126276218|NCT01221363|454301773|FG001|Overall Study|Pregnancy|0|||
126276219|NCT01221363|454301772|FG000|Overall Study|Withdrawal by Subject|11|||
126276220|NCT01221363|454301773|FG001|Overall Study|Withdrawal by Subject|5|||
126276221|NCT02695537|454301783|FG000|Overall Study|Adverse Event|3|||
126276222|NCT02695537|454301783|FG000|Overall Study|Lack of Efficacy|28|||
126276223|NCT02695537|454301783|FG000|Overall Study|Withdrawal by Subject|4|||
126276224|NCT02695537|454301783|FG000|Overall Study|Protocol Violation|3|||
126276225|NCT03597529|454301784|FG000|Overall Study|Lost to Follow-up|10|||
126276226|NCT03597529|454301785|FG001|Overall Study|Lost to Follow-up|12|||
126276227|NCT03597529|454301784|FG000|Overall Study|Physician Decision|3|||
126276228|NCT03597529|454301785|FG001|Overall Study|Physician Decision|1|||
126276229|NCT03597529|454301784|FG000|Overall Study|Withdrawal by Subject|6|||
126276230|NCT03597529|454301785|FG001|Overall Study|Withdrawal by Subject|3|||
126276231|NCT03597529|454301784|FG000|Overall Study|Non-compliant with study activities|1|||
126276232|NCT03597529|454301785|FG001|Overall Study|Non-compliant with study activities|2|||
126276233|NCT02238795|454301788|FG000|Overall Study|Patient without purpura fulminans|1|||
126276234|NCT04480710|454301791|FG000|Overall Study|Adverse Event|0|||
126037775|NCT04909801|453436777|FG001|Overall Study|Participant request to discontinue study treatment|2|||
126276235|NCT04480710|454301792|FG001|Overall Study|Adverse Event|2|||
126276236|NCT04480710|454301793|FG002|Overall Study|Adverse Event|0|||
126276237|NCT04480710|454301794|FG003|Overall Study|Adverse Event|0|||
126037776|NCT04909801|453436776|FG000|Overall Study|Withdrawal by Subject|2|||
126037777|NCT04909801|453436777|FG001|Overall Study|Withdrawal by Subject|1|||
126037778|NCT04909801|453436776|FG000|Overall Study|other reasons|1|||
126037779|NCT04909801|453436777|FG001|Overall Study|other reasons|1|||
126037780|NCT04117347|453436780|FG000|Overall Study|Adverse Event|0|||
126037781|NCT04117347|453436781|FG001|Overall Study|Adverse Event|0|||
126037782|NCT04117347|453436782|FG002|Overall Study|Adverse Event|1|||
126037783|NCT04117347|453436780|FG000|Overall Study|No time for study|0|||
126276238|NCT04480710|454301791|FG000|Overall Study|Withdrawal by Subject|0|||
126276239|NCT04480710|454301792|FG001|Overall Study|Withdrawal by Subject|1|||
126276240|NCT04480710|454301793|FG002|Overall Study|Withdrawal by Subject|0|||
126276241|NCT04480710|454301794|FG003|Overall Study|Withdrawal by Subject|0|||
126276242|NCT04480710|454301791|FG000|Overall Study|Physician Decision|0|||
126276243|NCT04480710|454301792|FG001|Overall Study|Physician Decision|0|||
126276244|NCT04480710|454301793|FG002|Overall Study|Physician Decision|1|||
126276245|NCT04480710|454301794|FG003|Overall Study|Physician Decision|0|||
126276246|NCT04480021|454301795|FG000|Overall Study|Lost to Follow-up|3|||
126276247|NCT04480021|454301796|FG001|Overall Study|Lost to Follow-up|4|||
126276248|NCT03384654|454301800|FG000|Overall Study|Withdrawal by Subject|0|||
126276249|NCT03384654|454301801|FG001|Overall Study|Withdrawal by Subject|0|||
126276250|NCT03384654|454301802|FG002|Overall Study|Withdrawal by Subject|1|||
126276251|NCT03384654|454301803|FG003|Overall Study|Withdrawal by Subject|0|||
126276252|NCT00423319|454301804|FG000|Overall Study|Death|2|||
126276253|NCT00423319|454301805|FG001|Overall Study|Death|0|||
126276254|NCT00423319|454301804|FG000|Overall Study|Adverse Event|93|||
126276255|NCT00423319|454301805|FG001|Overall Study|Adverse Event|112|||
126276256|NCT00423319|454301804|FG000|Overall Study|Withdrawal by Subject|86|||
126276257|NCT00423319|454301805|FG001|Overall Study|Withdrawal by Subject|99|||
126276258|NCT00423319|454301804|FG000|Overall Study|Lost to Follow-up|4|||
126276259|NCT00423319|454301805|FG001|Overall Study|Lost to Follow-up|3|||
126276260|NCT00423319|454301804|FG000|Overall Study|Poor compliance or noncompliance|1|||
126276261|NCT00423319|454301805|FG001|Overall Study|Poor compliance or noncompliance|1|||
126276262|NCT00423319|454301804|FG000|Overall Study|No longer meets study criteria|15|||
126276263|NCT00423319|454301805|FG001|Overall Study|No longer meets study criteria|15|||
126276264|NCT00423319|454301804|FG000|Overall Study|Other|23|||
126276265|NCT00423319|454301805|FG001|Overall Study|Other|22|||
126276266|NCT01584843|454301806|FG000|First Treatment Period|Adverse Event|0|||
126276267|NCT01584843|454301807|FG001|First Treatment Period|Adverse Event|0|||
126276268|NCT01584843|454301808|FG002|First Treatment Period|Adverse Event|1|||
126276269|NCT01584843|454301809|FG003|First Treatment Period|Adverse Event|0|||
126276270|NCT01584843|454301810|FG004|First Treatment Period|Adverse Event|0|||
126276271|NCT01584843|454301811|FG005|First Treatment Period|Adverse Event|0|||
126276272|NCT01584843|454301806|FG000|First Treatment Period|Protocol Violation|0|||
126276273|NCT01584843|454301807|FG001|First Treatment Period|Protocol Violation|0|||
126276274|NCT01584843|454301808|FG002|First Treatment Period|Protocol Violation|0|||
126276275|NCT01584843|454301809|FG003|First Treatment Period|Protocol Violation|0|||
126276276|NCT01584843|454301810|FG004|First Treatment Period|Protocol Violation|0|||
126276277|NCT01584843|454301811|FG005|First Treatment Period|Protocol Violation|1|||
126276278|NCT01584843|454301806|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276279|NCT01584843|454301807|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276280|NCT01584843|454301808|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276281|NCT01584843|454301809|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276282|NCT01584843|454301810|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276283|NCT01584843|454301811|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
126276284|NCT01584843|454301806|FG000|Second Treatment Period|Withdrawal by Subject|0|||
126276285|NCT01584843|454301807|FG001|Second Treatment Period|Withdrawal by Subject|0|||
126276286|NCT01584843|454301808|FG002|Second Treatment Period|Withdrawal by Subject|0|||
126276287|NCT01584843|454301809|FG003|Second Treatment Period|Withdrawal by Subject|0|||
126276288|NCT01584843|454301810|FG004|Second Treatment Period|Withdrawal by Subject|0|||
126276289|NCT01584843|454301811|FG005|Second Treatment Period|Withdrawal by Subject|1|||
126276290|NCT00311402|454301812|FG000|Overall Study|Adverse Event|118|||
126276291|NCT00311402|454301813|FG001|Overall Study|Adverse Event|105|||
126276292|NCT00311402|454301812|FG000|Overall Study|Lost to Follow-up|0|||
126276293|NCT00311402|454301813|FG001|Overall Study|Lost to Follow-up|3|||
126276294|NCT00311402|454301812|FG000|Overall Study|Withdrawal by Subject|17|||
126276295|NCT00311402|454301813|FG001|Overall Study|Withdrawal by Subject|18|||
126276296|NCT00311402|454301812|FG000|Overall Study|Lack of Efficacy|58|||
126276297|NCT00311402|454301813|FG001|Overall Study|Lack of Efficacy|42|||
126276298|NCT00311402|454301812|FG000|Overall Study|Protocol Violation|7|||
126037784|NCT04117347|453436781|FG001|Overall Study|No time for study|2|||
126037785|NCT04117347|453436782|FG002|Overall Study|No time for study|0|||
126037786|NCT04117347|453436780|FG000|Overall Study|Family emergency|1|||
126037787|NCT04117347|453436781|FG001|Overall Study|Family emergency|0|||
126037788|NCT04117347|453436782|FG002|Overall Study|Family emergency|0|||
126037789|NCT02505984|453436783|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
126037790|NCT02505984|453436784|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
126037791|NCT02505984|453436783|FG000|Overall Study|Unreliable self-report data|1|||
126037792|NCT02505984|453436784|FG001|Overall Study|Unreliable self-report data|0|||
126037793|NCT02505984|453436783|FG000|Overall Study|Study blind opened during assessment|0|||
126037794|NCT02505984|453436784|FG001|Overall Study|Study blind opened during assessment|1|||
126276299|NCT00311402|454301813|FG001|Overall Study|Protocol Violation|6|||
126276300|NCT00311402|454301812|FG000|Overall Study|IRB's rejection etc.|10|||
126276301|NCT00311402|454301813|FG001|Overall Study|IRB's rejection etc.|3|||
126276302|NCT02640053|454301814|FG000|Overall Study|Withdrawal by Subject|2|||
126276303|NCT02640053|454301815|FG001|Overall Study|Withdrawal by Subject|1|||
126276304|NCT02640053|454301814|FG000|Overall Study|Adverse Event|1|||
126276305|NCT02640053|454301815|FG001|Overall Study|Adverse Event|1|||
126276306|NCT02640053|454301814|FG000|Overall Study|Alternative Therapy|1|||
126276307|NCT02640053|454301815|FG001|Overall Study|Alternative Therapy|1|||
126276308|NCT02640053|454301814|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
126276309|NCT02640053|454301815|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
126276310|NCT03283761|454301816|FG000|Study Treatment|Patient Non-Compliance|1|||
126276311|NCT03283761|454301816|FG000|Study Treatment|Alternative Cancer Therapy|7|||
126276312|NCT03283761|454301816|FG000|Study Treatment|Disease progression|21|||
126276313|NCT03283761|454301816|FG000|Study Treatment|Adverse Event|3|||
126276314|NCT03283761|454301816|FG000|Study Treatment|Withdrawal by Subject|4|||
126276315|NCT03283761|454301816|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
126276316|NCT03283761|454301816|FG000|Study Treatment|Symptomatic Deterioration|1|||
126276317|NCT03283761|454301816|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
126276318|NCT03283761|454301816|FG000|Follow up|Lost to Follow-up|1|||
126276319|NCT03283761|454301816|FG000|Follow up|Symptomatic Deterioration|1|||
126276320|NCT03283761|454301816|FG000|Follow up|Death|29|||
126276321|NCT03283761|454301816|FG000|Follow up|study terminated|4|||
126276322|NCT03283761|454301816|FG000|Follow up|Primary Investigator Withdrawal|1|||
126276323|NCT03283761|454301816|FG000|Follow up|Switched to alternative therapy|1|||
126276324|NCT03283761|454301816|FG000|Follow up|Subject is now in Hospice|1|||
126276325|NCT02036775|454301817|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276326|NCT02036775|454301818|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276327|NCT02036775|454301819|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276328|NCT02036775|454301820|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276329|NCT02036775|454301821|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276330|NCT02036775|454301822|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
126276331|NCT01268501|454301823|FG000|Overall Study|Lost to Follow-up|1|||
126276332|NCT01268501|454301823|FG000|Overall Study|Withdrawal by Subject|3|||
126276333|NCT01268501|454301823|FG000|Overall Study|Unacceptable Subjective Vision|3|||
126037795|NCT02505984|453436783|FG000|Overall Study|Noncompliance with study protocol|0|||
126037796|NCT02505984|453436784|FG001|Overall Study|Noncompliance with study protocol|1|||
126037797|NCT05194956|453436785|FG000|Washout Period|Withdrawal by Subject|0|||
126037798|NCT05194956|453436786|FG001|Washout Period|Withdrawal by Subject|2|||
126276334|NCT01268501|454301823|FG000|Overall Study|Handling Difficulties|2|||
126276335|NCT00678886|454301824|FG000|Overall Study|Withdrawal by Subject|0|||
126276336|NCT00678886|454301825|FG001|Overall Study|Withdrawal by Subject|0|||
126276337|NCT00678886|454301826|FG002|Overall Study|Withdrawal by Subject|4|||
126276338|NCT00678886|454301827|FG003|Overall Study|Withdrawal by Subject|6|||
126276339|NCT00678886|454301824|FG000|Overall Study|Physician Decision|0|||
126276340|NCT00678886|454301825|FG001|Overall Study|Physician Decision|0|||
126276341|NCT00678886|454301826|FG002|Overall Study|Physician Decision|1|||
126276342|NCT00678886|454301827|FG003|Overall Study|Physician Decision|1|||
126276343|NCT00678886|454301824|FG000|Overall Study|Lost to Follow-up|0|||
126276344|NCT00678886|454301825|FG001|Overall Study|Lost to Follow-up|0|||
126276345|NCT00678886|454301826|FG002|Overall Study|Lost to Follow-up|3|||
126276346|NCT00678886|454301827|FG003|Overall Study|Lost to Follow-up|2|||
126276347|NCT00678886|454301824|FG000|Overall Study|Other|0|||
126276348|NCT00678886|454301825|FG001|Overall Study|Other|0|||
126276349|NCT00678886|454301826|FG002|Overall Study|Other|1|||
126276350|NCT00678886|454301827|FG003|Overall Study|Other|0|||
126276351|NCT00206323|454301828|FG000|Overall Study|Lack of Efficacy|4|||
126276352|NCT00206323|454301829|FG001|Overall Study|Lack of Efficacy|1|||
126276353|NCT00206323|454301828|FG000|Overall Study|Adverse Event|1|||
126276354|NCT00206323|454301829|FG001|Overall Study|Adverse Event|1|||
126276355|NCT00206323|454301828|FG000|Overall Study|Lost to Follow-up|1|||
126276356|NCT00206323|454301829|FG001|Overall Study|Lost to Follow-up|1|||
126276357|NCT02329847|454301830|FG000|Overall Study|Death|4|||
126276358|NCT02329847|454301831|FG001|Overall Study|Death|4|||
126276359|NCT02329847|454301832|FG002|Overall Study|Death|22|||
126276360|NCT02329847|454301833|FG003|Overall Study|Death|12|||
126276361|NCT02329847|454301834|FG004|Overall Study|Death|20|||
126276362|NCT02329847|454301835|FG005|Overall Study|Death|13|||
126276363|NCT02329847|454301830|FG000|Overall Study|Lost to Follow-up|0|||
126276364|NCT02329847|454301831|FG001|Overall Study|Lost to Follow-up|0|||
126276365|NCT02329847|454301832|FG002|Overall Study|Lost to Follow-up|2|||
126276366|NCT02329847|454301833|FG003|Overall Study|Lost to Follow-up|3|||
126276367|NCT02329847|454301834|FG004|Overall Study|Lost to Follow-up|0|||
126276368|NCT02329847|454301835|FG005|Overall Study|Lost to Follow-up|1|||
126276369|NCT02329847|454301830|FG000|Overall Study|Physician Decision|0|||
126276370|NCT02329847|454301831|FG001|Overall Study|Physician Decision|0|||
126276371|NCT02329847|454301832|FG002|Overall Study|Physician Decision|0|||
126276372|NCT02329847|454301833|FG003|Overall Study|Physician Decision|0|||
126276373|NCT02329847|454301834|FG004|Overall Study|Physician Decision|1|||
126276374|NCT02329847|454301835|FG005|Overall Study|Physician Decision|0|||
126276375|NCT02329847|454301830|FG000|Overall Study|Withdrawal by Subject|2|||
126276376|NCT02329847|454301831|FG001|Overall Study|Withdrawal by Subject|1|||
126276377|NCT02329847|454301832|FG002|Overall Study|Withdrawal by Subject|5|||
126276378|NCT02329847|454301833|FG003|Overall Study|Withdrawal by Subject|7|||
126276379|NCT02329847|454301834|FG004|Overall Study|Withdrawal by Subject|8|||
126276380|NCT02329847|454301835|FG005|Overall Study|Withdrawal by Subject|3|||
126276381|NCT02329847|454301830|FG000|Overall Study|Other|1|||
126276382|NCT02329847|454301831|FG001|Overall Study|Other|2|||
126276383|NCT02329847|454301832|FG002|Overall Study|Other|6|||
126276384|NCT02329847|454301833|FG003|Overall Study|Other|13|||
126276385|NCT02329847|454301834|FG004|Overall Study|Other|10|||
126276386|NCT02329847|454301835|FG005|Overall Study|Other|3|||
126276387|NCT05293639|454301836|FG000|Overall Study|Withdrawal by Subject|1|||
126276388|NCT05293639|454301837|FG001|Overall Study|Withdrawal by Subject|1|||
126276389|NCT05293639|454301838|FG002|Overall Study|Withdrawal by Subject|2|||
126276390|NCT05293639|454301836|FG000|Overall Study|Death|0|||
126276391|NCT05293639|454301837|FG001|Overall Study|Death|1|||
126276392|NCT05293639|454301838|FG002|Overall Study|Death|0|||
126276393|NCT05293639|454301836|FG000|Overall Study|Lost to Follow-up|0|||
126276394|NCT05293639|454301837|FG001|Overall Study|Lost to Follow-up|0|||
126276395|NCT05293639|454301838|FG002|Overall Study|Lost to Follow-up|5|||
126276396|NCT05293639|454301836|FG000|Overall Study|Other|0|||
126276397|NCT05293639|454301837|FG001|Overall Study|Other|0|||
126362830|NCT00806026|454621626|FG000|Overall Study|Protocol Violation|6|||
126362831|NCT00806026|454621627|FG001|Overall Study|Protocol Violation|9|||
126037799|NCT03687086|453436787|FG000|Overall Study|Withdrawal by Subject|3|||
126037800|NCT03687086|453436788|FG001|Overall Study|Withdrawal by Subject|4|||
126276398|NCT05293639|454301838|FG002|Overall Study|Other|1|||
126276399|NCT00827632|454301842|FG000|Overall Study|Lost to Follow-up|8|||
126276400|NCT00827632|454301843|FG001|Overall Study|Lost to Follow-up|12|||
126276401|NCT00827632|454301842|FG000|Overall Study|Early withdrawal|14|||
126276402|NCT00827632|454301843|FG001|Overall Study|Early withdrawal|11|||
126276403|NCT01910389|454301845|FG000|Overall Study|Withdrawal by Subject|2|||
126276404|NCT01910389|454301846|FG001|Overall Study|Withdrawal by Subject|0|||
126276405|NCT01910389|454301845|FG000|Overall Study|Study Closed|13|||
126276406|NCT01910389|454301846|FG001|Overall Study|Study Closed|8|||
126276407|NCT04669691|454301851|FG000|Overall Study|Death|0|||
126276408|NCT04669691|454301852|FG001|Overall Study|Death|1|||
126276409|NCT04669691|454301853|FG002|Overall Study|Death|0|||
126276410|NCT04669691|454301854|FG003|Overall Study|Death|0|||
126276411|NCT04669691|454301855|FG004|Overall Study|Death|0|||
126276412|NCT04669691|454301856|FG005|Overall Study|Death|0|||
126276413|NCT02304458|454301857|FG000|Overall Study|Adverse Event|0|||
126276414|NCT02304458|454301858|FG001|Overall Study|Adverse Event|0|||
126276415|NCT02304458|454301859|FG002|Overall Study|Adverse Event|7|||
126276416|NCT02304458|454301860|FG003|Overall Study|Adverse Event|0|||
126276417|NCT02304458|454301861|FG004|Overall Study|Adverse Event|0|||
126276418|NCT02304458|454301862|FG005|Overall Study|Adverse Event|0|||
126276419|NCT02304458|454301863|FG006|Overall Study|Adverse Event|3|||
126276420|NCT02304458|454301864|FG007|Overall Study|Adverse Event|4|||
126276421|NCT02304458|454301857|FG000|Overall Study|Death|0|||
126276422|NCT02304458|454301858|FG001|Overall Study|Death|0|||
126276423|NCT02304458|454301859|FG002|Overall Study|Death|2|||
126276424|NCT02304458|454301860|FG003|Overall Study|Death|0|||
126276425|NCT02304458|454301861|FG004|Overall Study|Death|0|||
126276426|NCT02304458|454301862|FG005|Overall Study|Death|0|||
126276427|NCT02304458|454301863|FG006|Overall Study|Death|1|||
126037801|NCT03687086|453436787|FG000|Overall Study|Lost to Follow-up|1|||
126037802|NCT03687086|453436788|FG001|Overall Study|Lost to Follow-up|1|||
126037803|NCT03687086|453436787|FG000|Overall Study|Death|1|||
126037804|NCT03687086|453436788|FG001|Overall Study|Death|0|||
126037805|NCT03687086|453436787|FG000|Overall Study|Incomplete assessment|0|||
126037806|NCT03687086|453436788|FG001|Overall Study|Incomplete assessment|2|||
126037807|NCT04201262|453436789|FG000|Overall Study|Adverse Event|1|||
126037808|NCT04201262|453436790|FG001|Overall Study|Adverse Event|2|||
126037809|NCT04201262|453436789|FG000|Overall Study|Continuing in the study|57|||
126037810|NCT04201262|453436790|FG001|Overall Study|Continuing in the study|0|||
126037811|NCT04201262|453436789|FG000|Overall Study|Withdrawal by Subject|0|||
126037812|NCT04201262|453436790|FG001|Overall Study|Withdrawal by Subject|1|||
126037813|NCT05446168|453436791|FG000|Overall Study|Physician Decision|0|||
126037814|NCT05446168|453436792|FG001|Overall Study|Physician Decision|1|||
126037815|NCT03511664|453436793|FG000|Overall Study|Death|457|||
126037816|NCT03511664|453436794|FG001|Overall Study|Death|201|||
126037817|NCT03511664|453436795|FG002|Overall Study|Death|21|||
126037818|NCT03511664|453436793|FG000|Overall Study|Withdrew consent|40|||
126037819|NCT03511664|453436794|FG001|Overall Study|Withdrew consent|63|||
126037820|NCT03511664|453436795|FG002|Overall Study|Withdrew consent|3|||
126037821|NCT03511664|453436793|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
126037822|NCT03511664|453436794|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
126037823|NCT03511664|453436795|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
126037824|NCT03511664|453436793|FG000|Overall Study|Lost to Follow-up|8|||
126037825|NCT03511664|453436794|FG001|Overall Study|Lost to Follow-up|5|||
126037826|NCT03511664|453436795|FG002|Overall Study|Lost to Follow-up|0|||
126098683|NCT01506609|453653085|FG003|Overall Study|Missing / Unknown Reason|4|||
126276428|NCT02304458|454301864|FG007|Overall Study|Death|0|||
126276429|NCT02304458|454301857|FG000|Overall Study|Lack of Efficacy|4|||
126276430|NCT02304458|454301858|FG001|Overall Study|Lack of Efficacy|6|||
126276431|NCT02304458|454301859|FG002|Overall Study|Lack of Efficacy|38|||
126276432|NCT02304458|454301860|FG003|Overall Study|Lack of Efficacy|5|||
126276433|NCT02304458|454301861|FG004|Overall Study|Lack of Efficacy|6|||
126276434|NCT02304458|454301862|FG005|Overall Study|Lack of Efficacy|6|||
126276435|NCT02304458|454301863|FG006|Overall Study|Lack of Efficacy|21|||
126276436|NCT02304458|454301864|FG007|Overall Study|Lack of Efficacy|4|||
126276437|NCT02304458|454301857|FG000|Overall Study|Physician Decision|2|||
126276438|NCT02304458|454301858|FG001|Overall Study|Physician Decision|0|||
126037827|NCT03511664|453436793|FG000|Overall Study|Physician Decision|2|||
126037828|NCT03511664|453436794|FG001|Overall Study|Physician Decision|1|||
126037829|NCT03511664|453436795|FG002|Overall Study|Physician Decision|0|||
126098684|NCT01506609|453653086|FG004|Overall Study|Missing / Unknown Reason|4|||
126037830|NCT03511664|453436793|FG000|Overall Study|Patient non-compliance|1|||
126037831|NCT03511664|453436794|FG001|Overall Study|Patient non-compliance|0|||
126037832|NCT03511664|453436795|FG002|Overall Study|Patient non-compliance|0|||
126037833|NCT05192109|453436799|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
126098685|NCT01506609|453653087|FG005|Overall Study|Missing / Unknown Reason|2|||
126276439|NCT02304458|454301859|FG002|Overall Study|Physician Decision|16|||
126276440|NCT02304458|454301860|FG003|Overall Study|Physician Decision|1|||
126276441|NCT02304458|454301861|FG004|Overall Study|Physician Decision|0|||
125881029|NCT03866577|452862724|FG000|Overall Study|Not qualified for IVIg infusion|0|||
125881030|NCT03866577|452862725|FG001|Overall Study|Not qualified for IVIg infusion|0|||
125881031|NCT03866577|452862726|FG002|Overall Study|Not qualified for IVIg infusion|0|||
125881032|NCT03866577|452862727|FG003|Overall Study|Not qualified for IVIg infusion|0|||
125881033|NCT03866577|452862728|FG004|Overall Study|Not qualified for IVIg infusion|0|||
125881034|NCT03866577|452862729|FG005|Overall Study|Not qualified for IVIg infusion|0|||
125881035|NCT03866577|452862730|FG006|Overall Study|Not qualified for IVIg infusion|0|||
125881036|NCT03866577|452862731|FG007|Overall Study|Not qualified for IVIg infusion|0|||
125881037|NCT03866577|452862732|FG008|Overall Study|Not qualified for IVIg infusion|0|||
125881038|NCT03866577|452862733|FG009|Overall Study|Not qualified for IVIg infusion|1|||
125881039|NCT03866577|452862734|FG010|Overall Study|Not qualified for IVIg infusion|0|||
125881040|NCT03866577|452862735|FG011|Overall Study|Not qualified for IVIg infusion|0|||
125881041|NCT03866577|452862736|FG012|Overall Study|Not qualified for IVIg infusion|0|||
125881042|NCT04825678|452862737|FG000|Overall Study|Decision by Sponsor|2|||
125881043|NCT04825678|452862738|FG001|Overall Study|Decision by Sponsor|3|||
125881044|NCT04825678|452862737|FG000|Overall Study|Withdrawal of Consent From Study|7|||
125881045|NCT04825678|452862738|FG001|Overall Study|Withdrawal of Consent From Study|9|||
125881046|NCT04825678|452862737|FG000|Overall Study|Lost to Follow-up|3|||
125881047|NCT04825678|452862738|FG001|Overall Study|Lost to Follow-up|4|||
125881048|NCT04825678|452862737|FG000|Overall Study|Never Received Investigational Product|1|||
125881049|NCT04825678|452862738|FG001|Overall Study|Never Received Investigational Product|1|||
125881050|NCT03818256|452862739|FG000|Overall Study|Withdrawal by Subject|2|||
125881051|NCT03818256|452862740|FG001|Overall Study|Withdrawal by Subject|2|||
125881052|NCT03818256|452862739|FG000|Overall Study|Adverse Event|3|||
125881053|NCT03818256|452862740|FG001|Overall Study|Adverse Event|1|||
125881054|NCT03818256|452862739|FG000|Overall Study|Lost to Follow-up|0|||
125881055|NCT03818256|452862740|FG001|Overall Study|Lost to Follow-up|5|||
125881056|NCT03818256|452862739|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
125881057|NCT03818256|452862740|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
125881058|NCT03818256|452862739|FG000|Overall Study|Not reporting for scheduled visits|1|||
125881059|NCT03818256|452862740|FG001|Overall Study|Not reporting for scheduled visits|0|||
125881060|NCT03818256|452862739|FG000|Overall Study|Non-compliant with investigational product|1|||
125881061|NCT03818256|452862740|FG001|Overall Study|Non-compliant with investigational product|0|||
125881062|NCT02594124|452862741|FG000|Overall Study|Adverse Event|0|||
125881063|NCT02594124|452862742|FG001|Overall Study|Adverse Event|5|||
125881064|NCT02594124|452862743|FG002|Overall Study|Adverse Event|8|||
125881065|NCT02594124|452862744|FG003|Overall Study|Adverse Event|1|||
125881066|NCT02594124|452862745|FG004|Overall Study|Adverse Event|0|||
125881067|NCT02594124|452862746|FG005|Overall Study|Adverse Event|0|||
125881068|NCT02594124|452862747|FG006|Overall Study|Adverse Event|2|||
125881069|NCT02594124|452862748|FG007|Overall Study|Adverse Event|2|||
125881070|NCT02594124|452862749|FG008|Overall Study|Adverse Event|0|||
125881071|NCT02594124|452862741|FG000|Overall Study|Withdrawal by Subject|2|||
125881072|NCT02594124|452862742|FG001|Overall Study|Withdrawal by Subject|3|||
125881073|NCT02594124|452862743|FG002|Overall Study|Withdrawal by Subject|5|||
125881074|NCT02594124|452862744|FG003|Overall Study|Withdrawal by Subject|1|||
125881075|NCT02594124|452862745|FG004|Overall Study|Withdrawal by Subject|8|||
125881076|NCT02594124|452862746|FG005|Overall Study|Withdrawal by Subject|4|||
125881077|NCT02594124|452862747|FG006|Overall Study|Withdrawal by Subject|13|||
125881078|NCT02594124|452862748|FG007|Overall Study|Withdrawal by Subject|19|||
125881079|NCT02594124|452862749|FG008|Overall Study|Withdrawal by Subject|0|||
125881080|NCT02594124|452862741|FG000|Overall Study|Physician Decision|0|||
125881081|NCT02594124|452862742|FG001|Overall Study|Physician Decision|2|||
125881082|NCT02594124|452862743|FG002|Overall Study|Physician Decision|0|||
125881083|NCT02594124|452862744|FG003|Overall Study|Physician Decision|0|||
125881084|NCT02594124|452862745|FG004|Overall Study|Physician Decision|0|||
126037834|NCT05192109|453436800|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
125881085|NCT02594124|452862746|FG005|Overall Study|Physician Decision|0|||
125881086|NCT02594124|452862747|FG006|Overall Study|Physician Decision|0|||
125881087|NCT02594124|452862748|FG007|Overall Study|Physician Decision|1|||
125881088|NCT02594124|452862749|FG008|Overall Study|Physician Decision|0|||
125881089|NCT02594124|452862741|FG000|Overall Study|Commercial drug|0|||
126037835|NCT05192109|453436801|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126276442|NCT02304458|454301862|FG005|Overall Study|Physician Decision|0|||
126276443|NCT02304458|454301863|FG006|Overall Study|Physician Decision|3|||
126276444|NCT02304458|454301864|FG007|Overall Study|Physician Decision|0|||
126276445|NCT02304458|454301857|FG000|Overall Study|Protocol Violation|0|||
126276446|NCT02304458|454301858|FG001|Overall Study|Protocol Violation|0|||
126276447|NCT02304458|454301859|FG002|Overall Study|Protocol Violation|1|||
126276448|NCT02304458|454301860|FG003|Overall Study|Protocol Violation|0|||
126276449|NCT02304458|454301861|FG004|Overall Study|Protocol Violation|0|||
125881090|NCT02594124|452862742|FG001|Overall Study|Commercial drug|1|||
125881091|NCT02594124|452862743|FG002|Overall Study|Commercial drug|6|||
125881092|NCT02594124|452862744|FG003|Overall Study|Commercial drug|3|||
125881093|NCT02594124|452862745|FG004|Overall Study|Commercial drug|0|||
125881094|NCT02594124|452862746|FG005|Overall Study|Commercial drug|0|||
125881095|NCT02594124|452862747|FG006|Overall Study|Commercial drug|7|||
125881096|NCT02594124|452862748|FG007|Overall Study|Commercial drug|11|||
125881097|NCT02594124|452862749|FG008|Overall Study|Commercial drug|2|||
125881098|NCT02594124|452862741|FG000|Overall Study|Reason Not Specified|1|||
125881099|NCT02594124|452862742|FG001|Overall Study|Reason Not Specified|3|||
125881100|NCT02594124|452862743|FG002|Overall Study|Reason Not Specified|4|||
125881101|NCT02594124|452862744|FG003|Overall Study|Reason Not Specified|0|||
125881102|NCT02594124|452862745|FG004|Overall Study|Reason Not Specified|0|||
125881103|NCT02594124|452862746|FG005|Overall Study|Reason Not Specified|1|||
125881104|NCT02594124|452862747|FG006|Overall Study|Reason Not Specified|1|||
125881105|NCT02594124|452862748|FG007|Overall Study|Reason Not Specified|6|||
125881106|NCT02594124|452862749|FG008|Overall Study|Reason Not Specified|1|||
125881107|NCT02514083|452862754|FG000|Overall Study|Adverse Event|1|||
125881108|NCT01586364|452864534|FG000|Overall Study|Withdrawal by Subject|40|||
125881109|NCT01586364|452864534|FG000|Overall Study|Adverse Event|37|||
125881110|NCT01586364|452864534|FG000|Overall Study|Lost to Follow-up|17|||
125881111|NCT01586364|452864534|FG000|Overall Study|Protocol Violation|16|||
125881112|NCT01586364|452864534|FG000|Overall Study|Lack of Efficacy|1|||
125881113|NCT01586364|452864534|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
125881114|NCT01586364|452864534|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
125881115|NCT01586364|452864534|FG000|Overall Study|Other-Site closure due to PI illness|1|||
125881116|NCT01586364|452864534|FG000|Overall Study|Other-PI discretion, site closing|2|||
125881117|NCT01586364|452864534|FG000|Overall Study|Other-Not specified|1|||
125881118|NCT02121535|452864535|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
125881119|NCT02121535|452864536|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
125881120|NCT02121535|452864535|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
125881121|NCT02121535|452864536|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
126276450|NCT02304458|454301862|FG005|Overall Study|Protocol Violation|0|||
126276451|NCT02304458|454301863|FG006|Overall Study|Protocol Violation|0|||
126276452|NCT02304458|454301864|FG007|Overall Study|Protocol Violation|0|||
126276453|NCT02304458|454301857|FG000|Overall Study|Withdrawal by Subject|1|||
126276454|NCT02304458|454301858|FG001|Overall Study|Withdrawal by Subject|0|||
126276455|NCT02304458|454301859|FG002|Overall Study|Withdrawal by Subject|7|||
126276456|NCT02304458|454301860|FG003|Overall Study|Withdrawal by Subject|0|||
126276457|NCT02304458|454301861|FG004|Overall Study|Withdrawal by Subject|0|||
126276458|NCT02304458|454301862|FG005|Overall Study|Withdrawal by Subject|0|||
126276459|NCT02304458|454301863|FG006|Overall Study|Withdrawal by Subject|1|||
126276460|NCT02304458|454301864|FG007|Overall Study|Withdrawal by Subject|0|||
126276461|NCT03401450|454301865|FG000|Overall Study|Lost to Follow-up|4|||
126276462|NCT03401450|454301866|FG001|Overall Study|Lost to Follow-up|6|||
126276463|NCT03401450|454301865|FG000|Overall Study|Anesthesia plan changed|2|||
126276464|NCT03401450|454301866|FG001|Overall Study|Anesthesia plan changed|2|||
126276465|NCT03401450|454301865|FG000|Overall Study|Did not complete medication diary|4|||
126276466|NCT03401450|454301866|FG001|Overall Study|Did not complete medication diary|2|||
126276467|NCT03401450|454301865|FG000|Overall Study|post surgery medication change|2|||
126276468|NCT03401450|454301866|FG001|Overall Study|post surgery medication change|1|||
125881122|NCT00091949|452864537|FG000|Overall Study|Withdrawal by Subject|117|||
125881123|NCT00091949|452864538|FG001|Overall Study|Withdrawal by Subject|110|||
126276469|NCT03401450|454301865|FG000|Overall Study|Cancelled surgery|0|||
126276470|NCT03401450|454301866|FG001|Overall Study|Cancelled surgery|2|||
126276471|NCT02288182|454301867|FG000|Overall Study|Adverse Event|0|||
126276472|NCT02288182|454301868|FG001|Overall Study|Adverse Event|1|||
126276473|NCT02288182|454301867|FG000|Overall Study|Lost to Follow-up|0|||
126276474|NCT02288182|454301868|FG001|Overall Study|Lost to Follow-up|1|||
126276475|NCT02823652|454301870|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
126037836|NCT05192109|453436802|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126037837|NCT05192109|453436799|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
126037838|NCT05192109|453436800|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
126037839|NCT05192109|453436801|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126276476|NCT02823652|454301871|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
126276477|NCT02823652|454301872|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
126276478|NCT02823652|454301870|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
126276479|NCT02823652|454301871|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
126276480|NCT02823652|454301872|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
126037840|NCT05192109|453436802|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126037841|NCT04577963|453436807|FG000|Part 2|Death|0|||
126037842|NCT04577963|453436808|FG001|Part 2|Death|1|||
126037843|NCT04577963|453436809|FG002|Part 2|Death|8|||
126037844|NCT04577963|453436810|FG003|Part 2|Death|0|||
126037845|NCT04577963|453436811|FG004|Part 2|Death|20|||
126037846|NCT04577963|453436807|FG000|Part 2|Lost to Follow-up|0|||
126037847|NCT04577963|453436808|FG001|Part 2|Lost to Follow-up|0|||
126037848|NCT04577963|453436809|FG002|Part 2|Lost to Follow-up|0|||
126037849|NCT04577963|453436810|FG003|Part 2|Lost to Follow-up|0|||
126037850|NCT04577963|453436811|FG004|Part 2|Lost to Follow-up|2|||
126037851|NCT04577963|453436807|FG000|Part 2|Withdrawal by Subject|0|||
126037852|NCT04577963|453436808|FG001|Part 2|Withdrawal by Subject|0|||
126037853|NCT04577963|453436809|FG002|Part 2|Withdrawal by Subject|0|||
126276481|NCT02823652|454301870|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
126276482|NCT02823652|454301871|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
126276483|NCT02823652|454301872|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
126276484|NCT02823652|454301870|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
126276485|NCT02823652|454301871|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
126276486|NCT02823652|454301872|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
126276487|NCT03567382|454301873|FG000|Overall Study|Lost to Follow-up|1|||
126276488|NCT03567382|454301874|FG001|Overall Study|Lost to Follow-up|21|||
126276489|NCT03567382|454301875|FG002|Overall Study|Lost to Follow-up|1|||
126276490|NCT03567382|454301876|FG003|Overall Study|Lost to Follow-up|21|||
126276491|NCT03567382|454301873|FG000|Overall Study|Withdrawal by Subject|2|||
126276492|NCT03567382|454301874|FG001|Overall Study|Withdrawal by Subject|14|||
126276493|NCT03567382|454301875|FG002|Overall Study|Withdrawal by Subject|1|||
126276494|NCT03567382|454301876|FG003|Overall Study|Withdrawal by Subject|12|||
126276495|NCT00620659|454301879|FG000|Treatment Period 1|Adverse Event|1|||
126276496|NCT00620659|454301880|FG001|Treatment Period 1|Adverse Event|0|||
126276497|NCT00620659|454301881|FG002|Treatment Period 1|Adverse Event|0|||
126276498|NCT00620659|454301882|FG003|Treatment Period 1|Adverse Event|3|||
126276499|NCT00620659|454301883|FG004|Treatment Period 1|Adverse Event|0|||
126276500|NCT00620659|454301884|FG005|Treatment Period 1|Adverse Event|0|||
126276501|NCT00620659|454301879|FG000|Treatment Period 1|Protocol Violation|1|||
126276502|NCT00620659|454301880|FG001|Treatment Period 1|Protocol Violation|0|||
126276503|NCT00620659|454301881|FG002|Treatment Period 1|Protocol Violation|0|||
126276504|NCT00620659|454301882|FG003|Treatment Period 1|Protocol Violation|0|||
126276505|NCT00620659|454301883|FG004|Treatment Period 1|Protocol Violation|0|||
126276506|NCT00620659|454301884|FG005|Treatment Period 1|Protocol Violation|0|||
126276507|NCT00620659|454301879|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126276508|NCT00620659|454301880|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126276509|NCT00620659|454301881|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126276510|NCT00620659|454301882|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126276511|NCT00620659|454301883|FG004|Treatment Period 1|Withdrawal by Subject|1|||
126276512|NCT00620659|454301884|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126276513|NCT00620659|454301879|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276514|NCT00620659|454301880|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276515|NCT00620659|454301881|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276516|NCT00620659|454301882|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
126276517|NCT00620659|454301883|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276518|NCT00620659|454301884|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276519|NCT00620659|454301879|FG000|Treatment Period 2|Adverse Event|0|||
126276520|NCT00620659|454301880|FG001|Treatment Period 2|Adverse Event|3|||
126276521|NCT00620659|454301881|FG002|Treatment Period 2|Adverse Event|0|||
126276522|NCT00620659|454301882|FG003|Treatment Period 2|Adverse Event|0|||
126276523|NCT00620659|454301883|FG004|Treatment Period 2|Adverse Event|2|||
126276524|NCT00620659|454301884|FG005|Treatment Period 2|Adverse Event|0|||
126276525|NCT00620659|454301879|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126276526|NCT00620659|454301880|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126276527|NCT00620659|454301881|FG002|Treatment Period 2|Withdrawal by Subject|1|||
126276528|NCT00620659|454301882|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125881124|NCT00091949|452864537|FG000|Overall Study|Lost to Follow-up|58|||
126037854|NCT04577963|453436810|FG003|Part 2|Withdrawal by Subject|0|||
126037855|NCT04577963|453436811|FG004|Part 2|Withdrawal by Subject|10|||
126037856|NCT04577963|453436807|FG000|Part 2|Progressive disease|0|||
126037857|NCT04577963|453436808|FG001|Part 2|Progressive disease|0|||
126037858|NCT04577963|453436809|FG002|Part 2|Progressive disease|0|||
126037859|NCT04577963|453436810|FG003|Part 2|Progressive disease|0|||
126037860|NCT04577963|453436811|FG004|Part 2|Progressive disease|2|||
126037861|NCT04577963|453436807|FG000|Part 2|Investigator decision|0|||
126037862|NCT04577963|453436808|FG001|Part 2|Investigator decision|0|||
126037863|NCT04577963|453436809|FG002|Part 2|Investigator decision|0|||
126037864|NCT04577963|453436810|FG003|Part 2|Investigator decision|0|||
126037865|NCT04577963|453436811|FG004|Part 2|Investigator decision|1|||
126037866|NCT04577963|453436807|FG000|Part 2|Sponsor terminated study|0|||
126037867|NCT04577963|453436808|FG001|Part 2|Sponsor terminated study|0|||
126037868|NCT04577963|453436809|FG002|Part 2|Sponsor terminated study|3|||
126037869|NCT04577963|453436810|FG003|Part 2|Sponsor terminated study|1|||
126037870|NCT04577963|453436811|FG004|Part 2|Sponsor terminated study|4|||
126037871|NCT02709161|453436812|FG000|Overall Study|Withdrawal by Subject|1|||
126037872|NCT02709161|453436813|FG001|Overall Study|Withdrawal by Subject|0|||
126037873|NCT03257410|453438935|FG000|Overall Study|Adverse Event|2|||
126037874|NCT03257410|453438936|FG001|Overall Study|Adverse Event|3|||
126037875|NCT03257410|453438935|FG000|Overall Study|Protocol Violation|1|||
126037876|NCT03257410|453438936|FG001|Overall Study|Protocol Violation|2|||
126037877|NCT03257410|453438935|FG000|Overall Study|Lost to Follow-up|1|||
126037878|NCT03257410|453438936|FG001|Overall Study|Lost to Follow-up|0|||
126037879|NCT03257410|453438935|FG000|Overall Study|Withdrawal by Subject|1|||
126037880|NCT03257410|453438936|FG001|Overall Study|Withdrawal by Subject|2|||
126037881|NCT03257410|453438935|FG000|Overall Study|Physician Decision|1|||
126037882|NCT03257410|453438936|FG001|Overall Study|Physician Decision|1|||
126276529|NCT00620659|454301883|FG004|Treatment Period 2|Withdrawal by Subject|3|||
126276530|NCT00620659|454301884|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126276531|NCT00620659|454301879|FG000|Placebo Washout Period 2|Adverse Event|2|||
126276532|NCT00620659|454301880|FG001|Placebo Washout Period 2|Adverse Event|0|||
126276533|NCT00620659|454301881|FG002|Placebo Washout Period 2|Adverse Event|0|||
126276534|NCT00620659|454301882|FG003|Placebo Washout Period 2|Adverse Event|0|||
126276535|NCT00620659|454301883|FG004|Placebo Washout Period 2|Adverse Event|0|||
126276536|NCT00620659|454301884|FG005|Placebo Washout Period 2|Adverse Event|0|||
126276537|NCT00620659|454301879|FG000|Treatment Period 3|Adverse Event|0|||
126276538|NCT00620659|454301880|FG001|Treatment Period 3|Adverse Event|2|||
126276539|NCT00620659|454301881|FG002|Treatment Period 3|Adverse Event|0|||
126276540|NCT00620659|454301882|FG003|Treatment Period 3|Adverse Event|0|||
126276541|NCT00620659|454301883|FG004|Treatment Period 3|Adverse Event|0|||
126276542|NCT00620659|454301884|FG005|Treatment Period 3|Adverse Event|0|||
126276543|NCT00620659|454301879|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126276544|NCT00620659|454301880|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126276545|NCT00620659|454301881|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126276546|NCT00620659|454301882|FG003|Treatment Period 3|Withdrawal by Subject|1|||
126276547|NCT00620659|454301883|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126276548|NCT00620659|454301884|FG005|Treatment Period 3|Withdrawal by Subject|0|||
126276549|NCT01214915|454301886|FG000|Overall Study|Adverse Event|8|||
126276550|NCT01214915|454301886|FG000|Overall Study|Lack of Efficacy|3|||
126276551|NCT02056392|454301887|FG000|Overall Study|Lost to Follow-up|0|||
126276552|NCT02056392|454301888|FG001|Overall Study|Lost to Follow-up|1|||
126276553|NCT02056392|454301889|FG002|Overall Study|Lost to Follow-up|2|||
126276554|NCT02056392|454301890|FG003|Overall Study|Lost to Follow-up|0|||
126276555|NCT02056392|454301891|FG004|Overall Study|Lost to Follow-up|0|||
126037883|NCT03257410|453438935|FG000|Overall Study|Renal transplantation|2|||
126037884|NCT03257410|453438936|FG001|Overall Study|Renal transplantation|0|||
126037885|NCT03257410|453438935|FG000|Overall Study|Switch to peritoneal dialysis|1|||
126276556|NCT02056392|454301892|FG005|Overall Study|Lost to Follow-up|0|||
126276557|NCT02056392|454301887|FG000|Overall Study|Protocol Violation|1|||
126276558|NCT02056392|454301888|FG001|Overall Study|Protocol Violation|0|||
126276559|NCT02056392|454301889|FG002|Overall Study|Protocol Violation|1|||
126276560|NCT02056392|454301890|FG003|Overall Study|Protocol Violation|0|||
126276561|NCT02056392|454301891|FG004|Overall Study|Protocol Violation|0|||
126276562|NCT02056392|454301892|FG005|Overall Study|Protocol Violation|0|||
126037886|NCT03257410|453438936|FG001|Overall Study|Switch to peritoneal dialysis|0|||
126037887|NCT03257410|453438935|FG000|Overall Study|Death|3|||
126037888|NCT03257410|453438936|FG001|Overall Study|Death|2|||
126037889|NCT03257410|453438935|FG000|Overall Study|Change to another dialysis center|2|||
126037890|NCT03257410|453438936|FG001|Overall Study|Change to another dialysis center|2|||
126037891|NCT03257410|453438935|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
126276563|NCT02056392|454301887|FG000|Overall Study|Withdrawal by Subject|1|||
126276564|NCT02056392|454301888|FG001|Overall Study|Withdrawal by Subject|0|||
126276565|NCT02056392|454301889|FG002|Overall Study|Withdrawal by Subject|0|||
126276566|NCT02056392|454301890|FG003|Overall Study|Withdrawal by Subject|0|||
126276567|NCT02056392|454301891|FG004|Overall Study|Withdrawal by Subject|1|||
126037892|NCT03257410|453438936|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
126037893|NCT03257410|453438935|FG000|Overall Study|Miscellaneous|2|||
126037894|NCT03257410|453438936|FG001|Overall Study|Miscellaneous|2|||
126037895|NCT03257410|453438935|FG000|Overall Study|Other|0|||
126037896|NCT03257410|453438936|FG001|Overall Study|Other|1|||
126037897|NCT02561247|453438937|FG000|Overall Study|Protocol Violation|1|||
126037898|NCT02561247|453438937|FG000|Overall Study|Withdrawal by Subject|1|||
126037899|NCT02561247|453438937|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
126037900|NCT04231149|453438938|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
126037901|NCT04231149|453438939|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
126037902|NCT04231149|453438940|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
126276568|NCT02056392|454301892|FG005|Overall Study|Withdrawal by Subject|0|||
126276569|NCT04555720|454301895|FG000|Overall Study|Lost to Follow-up|2|||
126276570|NCT04555720|454301896|FG001|Overall Study|Lost to Follow-up|0|||
126276571|NCT04555720|454301897|FG002|Overall Study|Lost to Follow-up|0|||
126276572|NCT04555720|454301898|FG003|Overall Study|Lost to Follow-up|0|||
126276573|NCT04555720|454301895|FG000|Overall Study|Withdrawal by Subject|4|||
126276574|NCT04555720|454301896|FG001|Overall Study|Withdrawal by Subject|6|||
126276575|NCT04555720|454301897|FG002|Overall Study|Withdrawal by Subject|0|||
126276576|NCT04555720|454301898|FG003|Overall Study|Withdrawal by Subject|0|||
126276577|NCT00968799|454301899|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
126276578|NCT00719849|454301900|FG000|Overall Study|Death|0|||
126276579|NCT00719849|454301901|FG001|Overall Study|Death|1|||
126276580|NCT01372774|454301904|FG000|Overall Study|Withdrawal prior to treatment|4|||
126276581|NCT01372774|454301905|FG001|Overall Study|Withdrawal prior to treatment|5|||
126276582|NCT02201290|454301906|FG000|Overall Study|Withdrawal by Subject|2|||
126276583|NCT02201290|454301906|FG000|Overall Study|Lack of Efficacy|2|||
126276584|NCT02201290|454301906|FG000|Overall Study|Adverse Event|1|||
126276585|NCT02022748|454303679|FG000|Overall Study|Adverse Event|1|||
126276586|NCT02022748|454303680|FG001|Overall Study|Adverse Event|1|||
126276587|NCT02022748|454303681|FG002|Overall Study|Adverse Event|0|||
126276588|NCT02022748|454303679|FG000|Overall Study|Withdrawal by Subject|0|||
126276589|NCT02022748|454303680|FG001|Overall Study|Withdrawal by Subject|1|||
126276590|NCT02022748|454303681|FG002|Overall Study|Withdrawal by Subject|0|||
126276591|NCT00633243|454303682|FG000|Overall Study|Withdrawal by Subject|0|||
126276592|NCT00633243|454303683|FG001|Overall Study|Withdrawal by Subject|1|||
126276593|NCT00633243|454303682|FG000|Overall Study|incarceration|0|||
126276594|NCT00633243|454303683|FG001|Overall Study|incarceration|2|||
126276595|NCT00633243|454303682|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
126276596|NCT00633243|454303683|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
126276597|NCT00633243|454303682|FG000|Overall Study|Not comfortable with self-injecting|0|||
125881125|NCT00091949|452864538|FG001|Overall Study|Lost to Follow-up|41|||
125881126|NCT01256788|452864539|FG000|Overall Study|Lost to Follow-up|5|||
126037903|NCT04231149|453438941|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
126276598|NCT00633243|454303683|FG001|Overall Study|Not comfortable with self-injecting|1|||
126276599|NCT00633243|454303682|FG000|Overall Study|Mental Health--Depression|0|||
126276600|NCT00633243|454303683|FG001|Overall Study|Mental Health--Depression|1|||
126276601|NCT00633243|454303682|FG000|Overall Study|Couldn't tolerate side-effects|1|||
126276602|NCT00633243|454303683|FG001|Overall Study|Couldn't tolerate side-effects|1|||
126276603|NCT04345601|454303684|FG000|Overall Study|Death|0|||
126276604|NCT04345601|454303685|FG001|Overall Study|Death|3|||
126276605|NCT04345601|454303686|FG002|Overall Study|Death|2|||
126276606|NCT04345601|454303684|FG000|Overall Study|Lost to Follow-up|0|||
126276607|NCT04345601|454303685|FG001|Overall Study|Lost to Follow-up|0|||
126276608|NCT04345601|454303686|FG002|Overall Study|Lost to Follow-up|2|||
126276609|NCT03700385|454303687|FG000|Overall Study|Lost to Follow-up|1|||
126276610|NCT01555671|454303690|FG000|Overall Study|Physician Decision|20|||
126276611|NCT01555671|454303691|FG001|Overall Study|Physician Decision|25|||
126276612|NCT04590040|454303695|FG000|Treatment Period|Lost to Follow-up|2|||
126276613|NCT04590040|454303696|FG001|Treatment Period|Lost to Follow-up|5|||
126276614|NCT04590040|454303697|FG002|Treatment Period|Lost to Follow-up|0|||
126276615|NCT04590040|454303695|FG000|Treatment Period|Physician Decision|0|||
126276616|NCT04590040|454303696|FG001|Treatment Period|Physician Decision|0|||
126276617|NCT04590040|454303697|FG002|Treatment Period|Physician Decision|2|||
126276618|NCT00000378|454303698|FG000|Overall Study|Lack of Efficacy|16|||
126276619|NCT00000378|454303699|FG001|Overall Study|Lack of Efficacy|14|||
126276620|NCT04003896|454303700|FG000|Overall Study|Withdrawal by Subject|3|||
126276621|NCT04003896|454303700|FG000|Overall Study|Physician Decision|1|||
126276622|NCT01957397|454303703|FG000|Test Period 1|sudden leakage/small bag|1|||
126276623|NCT01957397|454303704|FG001|Test Period 1|sudden leakage/small bag|1|||
126276624|NCT01957397|454303703|FG000|Test Period 1|Withdrawal by Subject|1|||
126276625|NCT01957397|454303704|FG001|Test Period 1|Withdrawal by Subject|0|||
126276626|NCT01957397|454303703|FG000|Test Period 2|Adverse Event|0|||
126276627|NCT01957397|454303704|FG001|Test Period 2|Adverse Event|1|||
126276628|NCT01957397|454303703|FG000|Test Period 3|Adverse Event|1|||
126276629|NCT01957397|454303704|FG001|Test Period 3|Adverse Event|2|||
126276630|NCT01957397|454303703|FG000|Test Period 3|the adhesive did not work|1|||
126276631|NCT01957397|454303704|FG001|Test Period 3|the adhesive did not work|0|||
126276632|NCT00324649|454303705|FG000|Overall Study|Adverse Event|1|||
126276633|NCT00324649|454303706|FG001|Overall Study|Adverse Event|4|||
126276634|NCT00324649|454303705|FG000|Overall Study|Withdrawal by Subject|0|||
126276635|NCT00324649|454303706|FG001|Overall Study|Withdrawal by Subject|1|||
126276636|NCT00324649|454303705|FG000|Overall Study|Noncompliance|1|||
126276637|NCT00324649|454303706|FG001|Overall Study|Noncompliance|0|||
126276638|NCT04713553|454303709|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
126276639|NCT04713553|454303710|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
126276640|NCT04713553|454303711|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
126276641|NCT04713553|454303712|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
125881127|NCT01256788|452864540|FG001|Overall Study|Lost to Follow-up|8|||
126276642|NCT04713553|454303713|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
126276643|NCT04713553|454303714|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
126276644|NCT04713553|454303715|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
126276645|NCT04713553|454303709|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126306224|NCT01940887|454410250|FG000|Year 1|Protocol Violation|0|||
126276646|NCT04713553|454303710|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276647|NCT04713553|454303711|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276648|NCT04713553|454303712|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
126276649|NCT04713553|454303713|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276650|NCT04713553|454303714|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276651|NCT04713553|454303715|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276652|NCT04713553|454303709|FG000|Primary Study (2 Months)|Other|1|||
126276653|NCT04713553|454303710|FG001|Primary Study (2 Months)|Other|2|||
126276654|NCT04713553|454303711|FG002|Primary Study (2 Months)|Other|0|||
126276655|NCT04713553|454303712|FG003|Primary Study (2 Months)|Other|0|||
126276656|NCT04713553|454303713|FG004|Primary Study (2 Months)|Other|1|||
126037904|NCT04231149|453438942|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
126037905|NCT04979442|453438944|FG000|Overall Study|Death|43|||
126037906|NCT04979442|453438945|FG001|Overall Study|Death|30|||
126037907|NCT04979442|453438944|FG000|Overall Study|Withdrawal by Subject|8|||
126037908|NCT04979442|453438945|FG001|Overall Study|Withdrawal by Subject|13|||
126037909|NCT04979442|453438944|FG000|Overall Study|Physician Decision|1|||
126037910|NCT04979442|453438945|FG001|Overall Study|Physician Decision|1|||
126037911|NCT04979442|453438944|FG000|Overall Study|Lost to Follow-up|0|||
126037912|NCT04979442|453438945|FG001|Overall Study|Lost to Follow-up|2|||
126037913|NCT04979442|453438944|FG000|Overall Study|do not want to continue|0|||
126037914|NCT04979442|453438945|FG001|Overall Study|do not want to continue|1|||
126037915|NCT04298983|453438948|FG000|Overall Study|Adverse Event|4|||
126037916|NCT04298983|453438948|FG000|Overall Study|Lack of Efficacy|3|||
126037917|NCT02116530|453438950|FG000|Overall Study|Withdrawal by Subject|1|||
126037918|NCT02116530|453438951|FG001|Overall Study|Withdrawal by Subject|2|||
126037919|NCT02116530|453438950|FG000|Overall Study|Adverse Event|4|||
126037920|NCT02116530|453438951|FG001|Overall Study|Adverse Event|0|||
126037921|NCT02116530|453438950|FG000|Overall Study|Physician Decision|1|||
126037922|NCT02116530|453438951|FG001|Overall Study|Physician Decision|0|||
126037923|NCT02116530|453438950|FG000|Overall Study|Lost to Follow-up|1|||
126037924|NCT02116530|453438951|FG001|Overall Study|Lost to Follow-up|0|||
126037925|NCT02116530|453438950|FG000|Overall Study|Other Medical Problems|2|||
126037926|NCT02116530|453438951|FG001|Overall Study|Other Medical Problems|2|||
125881128|NCT01256788|452864541|FG002|Overall Study|Lost to Follow-up|3|||
125881129|NCT03312634|452864542|FG000|Overall Study|Adverse Event|11|||
125881130|NCT03312634|452864543|FG001|Overall Study|Adverse Event|0|||
125881131|NCT03312634|452864542|FG000|Overall Study|Sponsor request|2|||
126037927|NCT03656510|453438953|FG000|Overall Study|Lost to Follow-up|1|||
126037928|NCT03656510|453438954|FG001|Overall Study|Lost to Follow-up|0|||
126037929|NCT03656510|453438955|FG002|Overall Study|Lost to Follow-up|0|||
126037930|NCT03656510|453438956|FG003|Overall Study|Lost to Follow-up|0|||
126037931|NCT03656510|453438957|FG004|Overall Study|Lost to Follow-up|0|||
126037932|NCT03656510|453438958|FG005|Overall Study|Lost to Follow-up|0|||
126037933|NCT03656510|453438953|FG000|Overall Study|Withdrawal by Subject|1|||
126037934|NCT03656510|453438954|FG001|Overall Study|Withdrawal by Subject|1|||
126037935|NCT03656510|453438955|FG002|Overall Study|Withdrawal by Subject|0|||
126037936|NCT03656510|453438956|FG003|Overall Study|Withdrawal by Subject|1|||
126037937|NCT03656510|453438957|FG004|Overall Study|Withdrawal by Subject|0|||
126037938|NCT03656510|453438958|FG005|Overall Study|Withdrawal by Subject|0|||
126037939|NCT05496231|453438962|FG000|Overall Study|Adverse Event|1|||
126037940|NCT05496231|453438963|FG001|Overall Study|Adverse Event|1|||
126037941|NCT05496231|453438964|FG002|Overall Study|Adverse Event|0|||
126037942|NCT05496231|453438965|FG003|Overall Study|Adverse Event|4|||
126037943|NCT05496231|453438962|FG000|Overall Study|Withdrawal by Subject|5|||
126037944|NCT05496231|453438963|FG001|Overall Study|Withdrawal by Subject|5|||
126037945|NCT05496231|453438964|FG002|Overall Study|Withdrawal by Subject|4|||
126037946|NCT05496231|453438965|FG003|Overall Study|Withdrawal by Subject|11|||
126037947|NCT05496231|453438962|FG000|Overall Study|Migrated/moved from the study area|3|||
126037948|NCT05496231|453438963|FG001|Overall Study|Migrated/moved from the study area|5|||
126037949|NCT05496231|453438964|FG002|Overall Study|Migrated/moved from the study area|3|||
126037950|NCT05496231|453438965|FG003|Overall Study|Migrated/moved from the study area|3|||
126037951|NCT05496231|453438962|FG000|Overall Study|Lost to Follow-up|13|||
126037952|NCT05496231|453438963|FG001|Overall Study|Lost to Follow-up|6|||
126037953|NCT05496231|453438964|FG002|Overall Study|Lost to Follow-up|11|||
126276657|NCT04713553|454303714|FG005|Primary Study (2 Months)|Other|0|||
125881132|NCT03312634|452864543|FG001|Overall Study|Sponsor request|0|||
126037954|NCT05496231|453438965|FG003|Overall Study|Lost to Follow-up|6|||
126037955|NCT05496231|453438962|FG000|Overall Study|Other|9|||
126037956|NCT05496231|453438963|FG001|Overall Study|Other|7|||
126037957|NCT05496231|453438964|FG002|Overall Study|Other|7|||
126037958|NCT05496231|453438965|FG003|Overall Study|Other|8|||
126037959|NCT05029622|453438968|FG000|Overall Study|Lost to Follow-up|1|||
126037960|NCT05671653|453438969|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
126037961|NCT05671653|453438970|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
126276658|NCT04713553|454303715|FG006|Primary Study (2 Months)|Other|0|||
126037962|NCT05671653|453438971|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
126037963|NCT05671653|453438972|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
126276659|NCT04713553|454303709|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
126276660|NCT04713553|454303710|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
126276661|NCT04713553|454303711|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
126276662|NCT04713553|454303712|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
126276663|NCT04713553|454303713|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
126276664|NCT04713553|454303714|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
126276665|NCT04713553|454303715|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
126276666|NCT04713553|454303709|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276667|NCT04713553|454303710|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276668|NCT04713553|454303711|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
126276669|NCT04713553|454303712|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276670|NCT04713553|454303713|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276671|NCT04713553|454303714|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276672|NCT04713553|454303715|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276673|NCT01359969|454303716|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
126276674|NCT02315196|454303722|FG000|Overall Study|Withdrew consent|9|||
126276675|NCT00470067|454303723|FG000|Overall Study|Death|1|||
126276676|NCT00470067|454303723|FG000|Overall Study|Disease Progression|6|||
126276677|NCT04091659|454303724|FG000|Overall Study|Protocol Violation|3|||
126276678|NCT04091659|454303725|FG001|Overall Study|Protocol Violation|0|||
126276679|NCT04091659|454303724|FG000|Overall Study|Lost to Follow-up|0|||
126276680|NCT04091659|454303725|FG001|Overall Study|Lost to Follow-up|1|||
126276681|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
126276682|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
126276683|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
126276684|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
126276685|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
126276686|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
126276687|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
126276688|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
126276689|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
126276690|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
126276691|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Death|1|||
126276692|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Death|0|||
126276693|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Death|0|||
126276694|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Death|0|||
126276695|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Death|0|||
126276696|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
126276697|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
126276698|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
126276699|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
126276700|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
126276701|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
126276702|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
126276703|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
126276704|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
126276705|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
126276706|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
126276707|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
126276708|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
126276709|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
126276710|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
126306225|NCT01940887|454410251|FG001|Year 1|Protocol Violation|1|||
126037964|NCT05671653|453438973|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
126037965|NCT05671653|453438974|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
126037966|NCT05671653|453438975|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
126037967|NCT05671653|453438976|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
126037968|NCT05671653|453438977|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
126037969|NCT05671653|453438978|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
126037970|NCT05671653|453438979|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
126037971|NCT05671653|453438980|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
126276711|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
126276712|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
126276713|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
126276714|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
126276715|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126276716|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
126276717|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126276718|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126276719|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126276720|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126276721|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Other|4|||
126276722|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Other|4|||
126276723|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Other|3|||
126276724|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Other|1|||
126276725|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Other|0|||
126276726|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
126276727|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
126276728|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
126276729|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
126276730|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
126276731|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126276732|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126276733|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126276734|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126276735|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126276736|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Death|1|||
126276737|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Death|0|||
126037972|NCT05671653|453438981|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
126037973|NCT05671653|453438969|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126276738|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Death|0|||
126276739|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Death|0|||
126276740|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Death|0|||
126276741|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
126276742|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
126276743|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126276744|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126276745|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126276746|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126276747|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126276748|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126276749|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126276750|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126276751|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126276752|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
126276753|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126276754|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126276755|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126276756|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
126276757|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126276758|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
126276759|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126276760|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126276761|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
126276762|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
126276763|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
126276764|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
126276765|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
126276766|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Other|4|||
126276767|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Other|5|||
126276768|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Other|4|||
126276769|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Other|0|||
126276770|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Other|0|||
126276771|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
126276772|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
126276773|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
126276774|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
126276775|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
126276776|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126276777|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
126276778|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126276779|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126276780|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126276781|NCT03678285|454303736|FG000|Overall Study|Adverse Event|2|||
126276782|NCT03678285|454303736|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
126276783|NCT03678285|454303736|FG000|Overall Study|Dehydrated prior to start of workout|1|||
126276784|NCT00616629|454303737|FG000|Overall Study|Protocol Violation|1|||
126276785|NCT00616629|454303738|FG001|Overall Study|Protocol Violation|2|||
126276786|NCT00616629|454303739|FG002|Overall Study|Protocol Violation|1|||
126276787|NCT00616629|454303740|FG003|Overall Study|Protocol Violation|0|||
126276788|NCT00616629|454303741|FG004|Overall Study|Protocol Violation|0|||
126276789|NCT00616629|454303737|FG000|Overall Study|AV-block|1|||
126276790|NCT00616629|454303738|FG001|Overall Study|AV-block|0|||
126276791|NCT00616629|454303739|FG002|Overall Study|AV-block|0|||
126276792|NCT00616629|454303740|FG003|Overall Study|AV-block|0|||
126276793|NCT00616629|454303741|FG004|Overall Study|AV-block|0|||
126276794|NCT01475097|454303748|FG000|Overall Study|Protocol Violation|1|||
126276795|NCT01475097|454303749|FG001|Overall Study|Protocol Violation|1|||
126276796|NCT04058067|454303763|FG000|Overall Study|Adverse Event|2|||
126276797|NCT04058067|454303764|FG001|Overall Study|Adverse Event|0|||
126276798|NCT04058067|454303763|FG000|Overall Study|Death|0|||
126276799|NCT04058067|454303764|FG001|Overall Study|Death|1|||
126276800|NCT04058067|454303763|FG000|Overall Study|Physician Decision|3|||
126276801|NCT04058067|454303764|FG001|Overall Study|Physician Decision|1|||
126276802|NCT04058067|454303763|FG000|Overall Study|Protocol Violation|0|||
126276803|NCT04058067|454303764|FG001|Overall Study|Protocol Violation|1|||
126276804|NCT04058067|454303763|FG000|Overall Study|Withdrawal by Subject|7|||
126276805|NCT04058067|454303764|FG001|Overall Study|Withdrawal by Subject|8|||
126276806|NCT05005312|454303765|FG000|Overall Study|Enrolled, but not treated|0|||
126276807|NCT05005312|454303766|FG001|Overall Study|Enrolled, but not treated|1|||
126276808|NCT01283035|454303768|FG000|Overall Study|Subject later found ineligible|1|||
126276809|NCT02704403|454303769|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
126276810|NCT02704403|454303770|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
126276811|NCT02704403|454303769|FG000|Overall Study|Administrative reasons by sponsor|1251|||
126362832|NCT00806026|454621628|FG002|Overall Study|Protocol Violation|9|||
126362833|NCT00806026|454621629|FG003|Overall Study|Protocol Violation|0|||
126362834|NCT00806026|454621630|FG004|Overall Study|Protocol Violation|2|||
126362835|NCT00806026|454621631|FG005|Overall Study|Protocol Violation|3|||
126362836|NCT00806026|454621626|FG000|Overall Study|Adverse Event|52|||
126362837|NCT00806026|454621627|FG001|Overall Study|Adverse Event|35|||
126362838|NCT00806026|454621628|FG002|Overall Study|Adverse Event|44|||
126362839|NCT00806026|454621629|FG003|Overall Study|Adverse Event|17|||
126362840|NCT00806026|454621630|FG004|Overall Study|Adverse Event|9|||
126362841|NCT00806026|454621631|FG005|Overall Study|Adverse Event|9|||
126362842|NCT01687595|454621632|FG000|Overall Study|Withdrawal by Subject|8|||
126362843|NCT01687595|454621633|FG001|Overall Study|Withdrawal by Subject|0|||
126362844|NCT01687595|454621632|FG000|Overall Study|Lost to Follow-up|3|||
126362845|NCT01687595|454621633|FG001|Overall Study|Lost to Follow-up|1|||
126362846|NCT01687595|454621632|FG000|Overall Study|Investigator's decision|1|||
126362847|NCT01687595|454621633|FG001|Overall Study|Investigator's decision|0|||
126362848|NCT01687595|454621632|FG000|Overall Study|Sponsor's decision|1|||
126362849|NCT01687595|454621633|FG001|Overall Study|Sponsor's decision|0|||
126362850|NCT01687595|454621632|FG000|Overall Study|Noncompliance|1|||
126362851|NCT01687595|454621633|FG001|Overall Study|Noncompliance|2|||
126362852|NCT01687595|454621632|FG000|Overall Study|Other than specified|56|||
126362853|NCT01687595|454621633|FG001|Overall Study|Other than specified|7|||
126362854|NCT00489359|454621636|FG000|Overall Study|Death|0|||
126362855|NCT00489359|454621637|FG001|Overall Study|Death|2|||
126362856|NCT00489359|454621636|FG000|Overall Study|Progressive Disease|5|||
126037974|NCT05671653|453438970|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126276812|NCT02704403|454303770|FG001|Overall Study|Administrative reasons by sponsor|616|||
126276813|NCT02704403|454303769|FG000|Overall Study|Death|4|||
126276814|NCT02704403|454303770|FG001|Overall Study|Death|3|||
126276815|NCT02704403|454303769|FG000|Overall Study|Endpoint event|52|||
126276816|NCT02704403|454303770|FG001|Overall Study|Endpoint event|24|||
126276817|NCT02704403|454303769|FG000|Overall Study|Lost to Follow-up|22|||
126276818|NCT02704403|454303770|FG001|Overall Study|Lost to Follow-up|11|||
126276819|NCT02704403|454303769|FG000|Overall Study|Protocol Violation|15|||
126276820|NCT02704403|454303770|FG001|Overall Study|Protocol Violation|15|||
126276821|NCT02704403|454303769|FG000|Overall Study|Adverse Event|2|||
126362857|NCT00489359|454621637|FG001|Overall Study|Progressive Disease|6|||
126362858|NCT00489359|454621636|FG000|Overall Study|Lost to Follow-up|1|||
126362859|NCT00489359|454621637|FG001|Overall Study|Lost to Follow-up|0|||
126362860|NCT00489359|454621636|FG000|Overall Study|Withdrawal by Subject|1|||
126037975|NCT05671653|453438971|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126037976|NCT05671653|453438972|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126037977|NCT05671653|453438973|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126037978|NCT05671653|453438974|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
126037979|NCT05671653|453438975|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126037980|NCT05671653|453438976|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126276822|NCT02704403|454303770|FG001|Overall Study|Adverse Event|0|||
126276823|NCT02704403|454303769|FG000|Overall Study|Withdrawal by Subject|85|||
126276824|NCT02704403|454303770|FG001|Overall Study|Withdrawal by Subject|45|||
126276825|NCT02704403|454303769|FG000|Overall Study|Investigator decision|1|||
126276826|NCT02704403|454303770|FG001|Overall Study|Investigator decision|1|||
126276827|NCT02704403|454303769|FG000|Overall Study|Follow-up not possible|1|||
126276828|NCT02704403|454303770|FG001|Overall Study|Follow-up not possible|2|||
126276829|NCT00851318|454303771|FG000|Overall Study|Withdrawal by Subject|7|||
126276830|NCT00851318|454303772|FG001|Overall Study|Withdrawal by Subject|1|||
126276831|NCT00851318|454303773|FG002|Overall Study|Withdrawal by Subject|5|||
126276832|NCT00851318|454303774|FG003|Overall Study|Withdrawal by Subject|3|||
126276833|NCT00851318|454303771|FG000|Overall Study|Adverse Event|13|||
126276834|NCT00851318|454303772|FG001|Overall Study|Adverse Event|2|||
126276835|NCT00851318|454303773|FG002|Overall Study|Adverse Event|9|||
126276836|NCT00851318|454303774|FG003|Overall Study|Adverse Event|12|||
126276837|NCT00851318|454303771|FG000|Overall Study|Pregnancy|0|||
126276838|NCT00851318|454303772|FG001|Overall Study|Pregnancy|0|||
126276839|NCT00851318|454303773|FG002|Overall Study|Pregnancy|1|||
126276840|NCT00851318|454303774|FG003|Overall Study|Pregnancy|1|||
126276841|NCT00851318|454303771|FG000|Overall Study|Lack of Efficacy|8|||
126276842|NCT00851318|454303772|FG001|Overall Study|Lack of Efficacy|2|||
126276843|NCT00851318|454303773|FG002|Overall Study|Lack of Efficacy|4|||
126276844|NCT00851318|454303774|FG003|Overall Study|Lack of Efficacy|2|||
126276845|NCT00851318|454303771|FG000|Overall Study|Non-compliance with Study Procedures|2|||
126276846|NCT00851318|454303772|FG001|Overall Study|Non-compliance with Study Procedures|0|||
126276847|NCT00851318|454303773|FG002|Overall Study|Non-compliance with Study Procedures|1|||
126276848|NCT00851318|454303774|FG003|Overall Study|Non-compliance with Study Procedures|0|||
126276849|NCT00851318|454303771|FG000|Overall Study|Physician Decision|0|||
126276850|NCT00851318|454303772|FG001|Overall Study|Physician Decision|0|||
126276851|NCT00851318|454303773|FG002|Overall Study|Physician Decision|1|||
126276852|NCT00851318|454303774|FG003|Overall Study|Physician Decision|1|||
126276853|NCT01844856|454303781|FG000|Overall Study|Lost to Follow-up|15|||
126276854|NCT01844856|454303782|FG001|Overall Study|Lost to Follow-up|3|||
126276855|NCT01844856|454303781|FG000|Overall Study|Adverse Event|3|||
126276856|NCT01844856|454303782|FG001|Overall Study|Adverse Event|6|||
126276857|NCT01844856|454303781|FG000|Overall Study|Withdrawal by Subject|3|||
126276858|NCT01844856|454303782|FG001|Overall Study|Withdrawal by Subject|2|||
126276859|NCT01844856|454303781|FG000|Overall Study|Noncompliance|2|||
126276860|NCT01844856|454303782|FG001|Overall Study|Noncompliance|3|||
126276861|NCT01844856|454303781|FG000|Overall Study|Enterococcus Resistant|0|||
126276862|NCT01844856|454303782|FG001|Overall Study|Enterococcus Resistant|1|||
126276863|NCT01844856|454303781|FG000|Overall Study|Inadvertently Not Scheduled|1|||
126276864|NCT01844856|454303782|FG001|Overall Study|Inadvertently Not Scheduled|0|||
126276865|NCT01844856|454303781|FG000|Overall Study|Randomized but was a Screen Failure|0|||
126276866|NCT01844856|454303782|FG001|Overall Study|Randomized but was a Screen Failure|1|||
126276867|NCT01442688|454303783|FG000|First Intervention|Withdrawal by Subject|1|||
126276868|NCT01442688|454303784|FG001|First Intervention|Withdrawal by Subject|0|||
126276869|NCT01442688|454303783|FG000|First Intervention|subject incarcerated|1|||
126276870|NCT01442688|454303784|FG001|First Intervention|subject incarcerated|0|||
126276871|NCT01442688|454303783|FG000|Second Intervention|Adverse Event|1|||
126276872|NCT01442688|454303784|FG001|Second Intervention|Adverse Event|0|||
126276873|NCT01329549|454303791|FG000|Overall Study|Withdrawal by Subject|1|||
126276874|NCT01329549|454303791|FG000|Overall Study|Adverse Event|1|||
126276875|NCT01755767|454303792|FG000|Overall Study|Progressive Disease|8|||
126276876|NCT01755767|454303793|FG001|Overall Study|Progressive Disease|7|||
126276877|NCT01755767|454303794|FG002|Overall Study|Progressive Disease|91|||
126276878|NCT01755767|454303795|FG003|Overall Study|Progressive Disease|43|||
126276879|NCT01755767|454303792|FG000|Overall Study|Clinical Disease Progression|4|||
126276880|NCT01755767|454303793|FG001|Overall Study|Clinical Disease Progression|2|||
126276881|NCT01755767|454303794|FG002|Overall Study|Clinical Disease Progression|29|||
126276882|NCT01755767|454303795|FG003|Overall Study|Clinical Disease Progression|20|||
126276883|NCT01755767|454303792|FG000|Overall Study|Radiographic Disease Progression|9|||
126276884|NCT01755767|454303793|FG001|Overall Study|Radiographic Disease Progression|4|||
126276885|NCT01755767|454303794|FG002|Overall Study|Radiographic Disease Progression|44|||
126276886|NCT01755767|454303795|FG003|Overall Study|Radiographic Disease Progression|27|||
126276887|NCT01755767|454303792|FG000|Overall Study|Adverse Event|6|||
126276888|NCT01755767|454303793|FG001|Overall Study|Adverse Event|0|||
126276889|NCT01755767|454303794|FG002|Overall Study|Adverse Event|28|||
126276890|NCT01755767|454303795|FG003|Overall Study|Adverse Event|11|||
126276891|NCT01755767|454303792|FG000|Overall Study|Death|1|||
126276892|NCT01755767|454303793|FG001|Overall Study|Death|2|||
126276893|NCT01755767|454303794|FG002|Overall Study|Death|15|||
126276894|NCT01755767|454303795|FG003|Overall Study|Death|4|||
126276895|NCT01755767|454303792|FG000|Overall Study|Subject Decision|0|||
126276896|NCT01755767|454303793|FG001|Overall Study|Subject Decision|0|||
126276897|NCT01755767|454303794|FG002|Overall Study|Subject Decision|10|||
126276898|NCT01755767|454303795|FG003|Overall Study|Subject Decision|3|||
126276899|NCT01755767|454303792|FG000|Overall Study|Withdrawal by Subject|0|||
126276900|NCT01755767|454303793|FG001|Overall Study|Withdrawal by Subject|0|||
126276901|NCT01755767|454303794|FG002|Overall Study|Withdrawal by Subject|2|||
126276902|NCT01755767|454303795|FG003|Overall Study|Withdrawal by Subject|1|||
126276903|NCT01755767|454303792|FG000|Overall Study|Other|0|||
126276904|NCT01755767|454303793|FG001|Overall Study|Other|0|||
126276905|NCT01755767|454303794|FG002|Overall Study|Other|2|||
126362861|NCT00489359|454621637|FG001|Overall Study|Withdrawal by Subject|5|||
125881133|NCT03312634|452864542|FG000|Overall Study|Withdrawal by Subject|31|||
125881134|NCT03312634|452864543|FG001|Overall Study|Withdrawal by Subject|9|||
125881135|NCT03312634|452864542|FG000|Overall Study|Enrolled in an interventional study|0|||
125881136|NCT03312634|452864543|FG001|Overall Study|Enrolled in an interventional study|52|||
125881137|NCT03312634|452864542|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
125881138|NCT03312634|452864543|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
125881139|NCT03312634|452864542|FG000|Overall Study|Death|0|||
125881140|NCT03312634|452864543|FG001|Overall Study|Death|1|||
125881141|NCT03312634|452864542|FG000|Overall Study|Non-compliance|0|||
125881142|NCT03312634|452864543|FG001|Overall Study|Non-compliance|2|||
125881143|NCT03312634|452864542|FG000|Overall Study|Lost to Follow-up|0|||
125881144|NCT03312634|452864543|FG001|Overall Study|Lost to Follow-up|1|||
125881145|NCT03312634|452864542|FG000|Overall Study|Enrolled into non-interventional study|0|||
125881146|NCT03312634|452864543|FG001|Overall Study|Enrolled into non-interventional study|5|||
125881147|NCT03312634|452864542|FG000|Overall Study|Worsening clinical condition|0|||
125881148|NCT03312634|452864543|FG001|Overall Study|Worsening clinical condition|1|||
125881149|NCT03312634|452864542|FG000|Overall Study|Participant did not want to travel|0|||
125881150|NCT03312634|452864543|FG001|Overall Study|Participant did not want to travel|1|||
125881151|NCT03312634|452864542|FG000|Overall Study|Physician Decision|1|||
125881152|NCT03312634|452864543|FG001|Overall Study|Physician Decision|0|||
125881153|NCT03312634|452864542|FG000|Overall Study|Other|13|||
125881154|NCT03312634|452864543|FG001|Overall Study|Other|0|||
125881155|NCT00906204|452864546|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
125881156|NCT00906204|452864547|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
125881157|NCT00906204|452864546|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
125881158|NCT00906204|452864547|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
125881159|NCT00906204|452864546|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
125881160|NCT00906204|452864547|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
125881161|NCT00906204|452864546|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
126037981|NCT05671653|453438977|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126037982|NCT05671653|453438978|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126037983|NCT05671653|453438979|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126276906|NCT01755767|454303795|FG003|Overall Study|Other|3|||
126276907|NCT01755767|454303792|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
126276908|NCT01755767|454303793|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
126276909|NCT01755767|454303794|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
126362862|NCT00489359|454621636|FG000|Overall Study|Adverse Event|0|||
125881162|NCT00906204|452864547|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
125881163|NCT00906204|452864546|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
125881164|NCT00906204|452864547|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
125881165|NCT00696072|452864548|FG000|Overall Study|continuing active treatment|10|||
126276910|NCT01755767|454303795|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
126276911|NCT00191165|454303796|FG000|Overall Study|Adverse Event|2|||
126276912|NCT00191165|454303797|FG001|Overall Study|Adverse Event|0|||
126037984|NCT05671653|453438980|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126037985|NCT05671653|453438981|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126037986|NCT05671653|453438969|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126037987|NCT05671653|453438970|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126037988|NCT05671653|453438971|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126037989|NCT05671653|453438972|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126037990|NCT05671653|453438973|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126037991|NCT05671653|453438974|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
126037992|NCT05671653|453438975|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126037993|NCT05671653|453438976|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126276913|NCT00191165|454303796|FG000|Overall Study|Protocol Violation|0|||
126276914|NCT00191165|454303797|FG001|Overall Study|Protocol Violation|1|||
126276915|NCT00191165|454303796|FG000|Overall Study|Participant Moved Away|0|||
126276916|NCT00191165|454303797|FG001|Overall Study|Participant Moved Away|1|||
126276917|NCT00998309|454303802|FG000|Overall Study|Protocol Violation|4|||
126276918|NCT02865460|454303803|FG000|Overall Study|Adverse Event|1|||
126276919|NCT02865460|454303804|FG001|Overall Study|Adverse Event|0|||
126276920|NCT02865460|454303803|FG000|Overall Study|Withdrawal by Subject|1|||
126276921|NCT02865460|454303804|FG001|Overall Study|Withdrawal by Subject|1|||
126276922|NCT02865460|454303803|FG000|Overall Study|Lost to Follow-up|7|||
126276923|NCT02865460|454303804|FG001|Overall Study|Lost to Follow-up|4|||
126276924|NCT02865460|454303803|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
126276925|NCT02865460|454303804|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
126276926|NCT01292226|454303820|FG000|Overall Study|Adverse Event|5|||
126276927|NCT01292226|454303820|FG000|Overall Study|Death|1|||
126276928|NCT01292226|454303820|FG000|Overall Study|Graft loss|1|||
126276929|NCT01292226|454303820|FG000|Overall Study|Protocol Violation|3|||
126276930|NCT01292226|454303820|FG000|Overall Study|Withdrawal by Subject|1|||
126276931|NCT01292226|454303820|FG000|Overall Study|Other|2|||
126276932|NCT01844505|454303821|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
126276933|NCT01844505|454303822|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
126276934|NCT01844505|454303823|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
126276935|NCT01844505|454303821|FG000|Treatment Period|Other Reasons|120|||
126276936|NCT01844505|454303822|FG001|Treatment Period|Other Reasons|136|||
126276937|NCT01844505|454303823|FG002|Treatment Period|Other Reasons|58|||
126276938|NCT01844505|454303821|FG000|Treatment Period|Lost to Follow-up|9|||
126276939|NCT01844505|454303822|FG001|Treatment Period|Lost to Follow-up|11|||
126276940|NCT01844505|454303823|FG002|Treatment Period|Lost to Follow-up|6|||
126276941|NCT01844505|454303821|FG000|Treatment Period|Death|175|||
126276942|NCT01844505|454303822|FG001|Treatment Period|Death|154|||
126276943|NCT01844505|454303823|FG002|Treatment Period|Death|228|||
126276944|NCT03918109|454303832|FG000|Overall Study|Withdrawal by Subject|0|||
126276945|NCT03918109|454303833|FG001|Overall Study|Withdrawal by Subject|0|||
126276946|NCT03918109|454303834|FG002|Overall Study|Withdrawal by Subject|2|||
126276947|NCT03918109|454303835|FG003|Overall Study|Withdrawal by Subject|1|||
126276948|NCT03918109|454303832|FG000|Overall Study|Lost to Follow-up|0|||
126276949|NCT03918109|454303833|FG001|Overall Study|Lost to Follow-up|0|||
126276950|NCT03918109|454303834|FG002|Overall Study|Lost to Follow-up|0|||
126276951|NCT03918109|454303835|FG003|Overall Study|Lost to Follow-up|1|||
126276952|NCT00861198|454303836|FG000|Overall Study|SpyGlass Failed|5|||
126276953|NCT00499174|454303839|FG000|Overall Study|Physician Decision|78|||
126276954|NCT00499174|454303840|FG001|Overall Study|Physician Decision|9|||
126276955|NCT02269163|454303841|FG000|Overall Study|Lost to Follow-up|1|||
126276956|NCT02269163|454303842|FG001|Overall Study|Lost to Follow-up|0|||
126276957|NCT02269163|454303841|FG000|Overall Study|Major protocol violation|0|||
126276958|NCT02269163|454303842|FG001|Overall Study|Major protocol violation|1|||
126276959|NCT02269163|454303841|FG000|Overall Study|Other|2|||
126276960|NCT02269163|454303842|FG001|Overall Study|Other|2|||
126276961|NCT02269163|454303841|FG000|Overall Study|Withdrawal by Subject|0|||
126276962|NCT02269163|454303842|FG001|Overall Study|Withdrawal by Subject|3|||
126276963|NCT02269163|454303841|FG000|Overall Study|Physician Decision|0|||
126276964|NCT02269163|454303842|FG001|Overall Study|Physician Decision|1|||
126276965|NCT01177059|454303848|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
126276966|NCT01177059|454303848|FG000|Overall Study|Withdrew consent|2|||
126276967|NCT01177059|454303848|FG000|Overall Study|Lost to Follow-up|18|||
126276968|NCT03395405|454305531|FG000|Overall Study|Death|0|||
126276969|NCT03395405|454305532|FG001|Overall Study|Death|2|||
126276970|NCT03395405|454305531|FG000|Overall Study|Lost to Follow-up|0|||
126276971|NCT03395405|454305532|FG001|Overall Study|Lost to Follow-up|1|||
126276972|NCT03395405|454305531|FG000|Overall Study|Protocol Violation|0|||
126276973|NCT03395405|454305532|FG001|Overall Study|Protocol Violation|1|||
126276974|NCT03395405|454305531|FG000|Overall Study|Withdrawal by Subject|3|||
126276975|NCT03395405|454305532|FG001|Overall Study|Withdrawal by Subject|1|||
126276976|NCT03395405|454305531|FG000|Overall Study|COVID-19 Pandemic|1|||
126276977|NCT03395405|454305532|FG001|Overall Study|COVID-19 Pandemic|0|||
126276978|NCT00461253|454305533|FG000|Overall Study|Death|985|||
126276979|NCT00461253|454305534|FG001|Overall Study|Death|0|||
126276980|NCT00461253|454305533|FG000|Overall Study|Protocol Violation|613|||
126276981|NCT00461253|454305534|FG001|Overall Study|Protocol Violation|236|||
126276982|NCT00461253|454305533|FG000|Overall Study|no response|2609|||
126276983|NCT00461253|454305534|FG001|Overall Study|no response|11789|||
126276984|NCT00461253|454305533|FG000|Overall Study|administrative|773|||
126276985|NCT00461253|454305534|FG001|Overall Study|administrative|7773|||
126276986|NCT04240392|454305535|FG000|Overall Study|Withdrawal by Subject|13|||
126276987|NCT04240392|454305536|FG001|Overall Study|Withdrawal by Subject|4|||
126276988|NCT04240392|454305535|FG000|Overall Study|Lost to Follow-up|11|||
126276989|NCT04240392|454305536|FG001|Overall Study|Lost to Follow-up|12|||
126276990|NCT01523457|454305537|FG000|Overall Study|Withdrawal by Subject|7|||
126276991|NCT01523457|454305538|FG001|Overall Study|Withdrawal by Subject|2|||
126276992|NCT03047330|454305541|FG000|Sleep Block 1|Withdrawal by Subject|3|||
126276993|NCT02886624|454305543|FG000|12-week Post Treatment Follow-up|Death|1|||
126276994|NCT02886624|454305543|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
126276995|NCT00540293|454305548|FG000|Overall Study|Adverse event related to study drug|10|||
126276996|NCT00540293|454305548|FG000|Overall Study|Adverse event not related to study drug|7|||
126276997|NCT00540293|454305548|FG000|Overall Study|Withdrawal by Subject|6|||
126276998|NCT00540293|454305548|FG000|Overall Study|Protocol violation, & subject schedule|12|||
126276999|NCT02585934|454305551|FG000|Overall Study|Lost to Follow-up|2|||
126277000|NCT02585934|454305552|FG001|Overall Study|Lost to Follow-up|2|||
126277001|NCT02585934|454305551|FG000|Overall Study|Protocol Violation|14|||
126277002|NCT02585934|454305552|FG001|Overall Study|Protocol Violation|11|||
126277003|NCT02585934|454305551|FG000|Overall Study|Adverse Event|21|||
126277004|NCT02585934|454305552|FG001|Overall Study|Adverse Event|22|||
126277005|NCT02585934|454305551|FG000|Overall Study|Physician Decision|3|||
126277006|NCT02585934|454305552|FG001|Overall Study|Physician Decision|2|||
126277007|NCT02585934|454305551|FG000|Overall Study|Withdrawal by Subject|7|||
126277008|NCT02585934|454305552|FG001|Overall Study|Withdrawal by Subject|21|||
126277009|NCT02585934|454305551|FG000|Overall Study|Lack of Efficacy|2|||
126277010|NCT02585934|454305552|FG001|Overall Study|Lack of Efficacy|1|||
126277011|NCT02585934|454305551|FG000|Overall Study|Death|2|||
126277012|NCT02585934|454305552|FG001|Overall Study|Death|0|||
126277013|NCT02585934|454305551|FG000|Overall Study|Caregiver Withdrew Consent|7|||
126277014|NCT02585934|454305552|FG001|Overall Study|Caregiver Withdrew Consent|7|||
126277015|NCT02585934|454305551|FG000|Overall Study|Sponsor Termination|1|||
126277016|NCT02585934|454305552|FG001|Overall Study|Sponsor Termination|2|||
126277017|NCT02585934|454305551|FG000|Overall Study|Another Reason|10|||
126277018|NCT02585934|454305552|FG001|Overall Study|Another Reason|5|||
126277019|NCT02448706|454305553|FG000|Overall Study|Withdrawal by Subject|4|||
126277020|NCT02448706|454305554|FG001|Overall Study|Withdrawal by Subject|3|||
126277021|NCT02448706|454305553|FG000|Overall Study|Protocol Violation|1|||
126277022|NCT02448706|454305554|FG001|Overall Study|Protocol Violation|1|||
126277023|NCT03972163|454305561|FG000|Overall Study|Death|0|||
126277024|NCT03972163|454305562|FG001|Overall Study|Death|1|||
126277025|NCT03400943|454305565|FG000|Treatment Period 1|Adverse Event|0|||
126277026|NCT03400943|454305566|FG001|Treatment Period 1|Adverse Event|0|||
126277027|NCT03400943|454305567|FG002|Treatment Period 1|Adverse Event|0|||
125881166|NCT00696072|452864549|FG001|Overall Study|continuing active treatment|13|||
126277028|NCT03400943|454305568|FG003|Treatment Period 1|Adverse Event|1|||
125881167|NCT00696072|452864548|FG000|Overall Study|Adverse Event|10|||
126277029|NCT03400943|454305565|FG000|Treatment Period 1|Lost to Follow-up|1|||
126098686|NCT00122460|453653088|FG000|Overall Study|investigational study phase ongoing|7|||
126277030|NCT03400943|454305566|FG001|Treatment Period 1|Lost to Follow-up|0|||
126277031|NCT03400943|454305567|FG002|Treatment Period 1|Lost to Follow-up|0|||
126277032|NCT03400943|454305568|FG003|Treatment Period 1|Lost to Follow-up|0|||
126277033|NCT03400943|454305565|FG000|Treatment Period 1|Protocol Violation|0|||
126277034|NCT03400943|454305566|FG001|Treatment Period 1|Protocol Violation|1|||
126277035|NCT03400943|454305567|FG002|Treatment Period 1|Protocol Violation|1|||
126037994|NCT05671653|453438977|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126277036|NCT03400943|454305568|FG003|Treatment Period 1|Protocol Violation|0|||
126277037|NCT03400943|454305565|FG000|Treatment Period 1|Study terminated by sponsor|2|||
126277038|NCT03400943|454305566|FG001|Treatment Period 1|Study terminated by sponsor|0|||
126277039|NCT03400943|454305567|FG002|Treatment Period 1|Study terminated by sponsor|0|||
126277040|NCT03400943|454305568|FG003|Treatment Period 1|Study terminated by sponsor|1|||
126277041|NCT03400943|454305565|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126277042|NCT03400943|454305566|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126277043|NCT03400943|454305567|FG002|Treatment Period 1|Withdrawal by Subject|3|||
126277044|NCT03400943|454305568|FG003|Treatment Period 1|Withdrawal by Subject|1|||
126277045|NCT03400943|454305565|FG000|Treatment Period 1|Other|2|||
126277046|NCT03400943|454305566|FG001|Treatment Period 1|Other|1|||
126277047|NCT03400943|454305567|FG002|Treatment Period 1|Other|2|||
126277048|NCT03400943|454305568|FG003|Treatment Period 1|Other|2|||
126277049|NCT03400943|454305565|FG000|Post-treatment Period 1|Adverse Event|2|||
126277050|NCT03400943|454305566|FG001|Post-treatment Period 1|Adverse Event|0|||
126277051|NCT03400943|454305567|FG002|Post-treatment Period 1|Adverse Event|0|||
126277052|NCT03400943|454305568|FG003|Post-treatment Period 1|Adverse Event|0|||
126277053|NCT03400943|454305565|FG000|Post-treatment Period 1|Protocol Violation|1|||
126277054|NCT03400943|454305566|FG001|Post-treatment Period 1|Protocol Violation|0|||
126277055|NCT03400943|454305567|FG002|Post-treatment Period 1|Protocol Violation|0|||
126277056|NCT03400943|454305568|FG003|Post-treatment Period 1|Protocol Violation|0|||
126277057|NCT03400943|454305565|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
126277058|NCT03400943|454305566|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
126277059|NCT03400943|454305567|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
126277060|NCT03400943|454305568|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
126277061|NCT03400943|454305565|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
126277062|NCT03400943|454305566|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
126277063|NCT03400943|454305567|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
126277064|NCT03400943|454305568|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
126277065|NCT03400943|454305565|FG000|Post-treatment Period 1|Other|2|||
126277066|NCT03400943|454305566|FG001|Post-treatment Period 1|Other|0|||
126277067|NCT03400943|454305567|FG002|Post-treatment Period 1|Other|4|||
126277068|NCT03400943|454305568|FG003|Post-treatment Period 1|Other|5|||
126277069|NCT03400943|454305565|FG000|Treatment Period 2|Study terminated by sponsor|0|||
126277070|NCT03400943|454305566|FG001|Treatment Period 2|Study terminated by sponsor|1|||
126277071|NCT03400943|454305567|FG002|Treatment Period 2|Study terminated by sponsor|0|||
126277072|NCT03400943|454305568|FG003|Treatment Period 2|Study terminated by sponsor|0|||
126277073|NCT03400943|454305565|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126277074|NCT03400943|454305566|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126277075|NCT03400943|454305567|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126277076|NCT03400943|454305568|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126277077|NCT03400943|454305565|FG000|Treatment Period 2|Other|1|||
126277078|NCT03400943|454305566|FG001|Treatment Period 2|Other|6|||
126277079|NCT03400943|454305567|FG002|Treatment Period 2|Other|0|||
126277080|NCT03400943|454305568|FG003|Treatment Period 2|Other|0|||
126277081|NCT03400943|454305565|FG000|Follow-up Period|Withdrawal by Subject|1|||
126277082|NCT03400943|454305566|FG001|Follow-up Period|Withdrawal by Subject|0|||
126277083|NCT03400943|454305567|FG002|Follow-up Period|Withdrawal by Subject|0|||
126277084|NCT03400943|454305568|FG003|Follow-up Period|Withdrawal by Subject|0|||
126277085|NCT02563106|454305569|FG000|Overall Study|Withdrawal by Subject|7|||
126037995|NCT05671653|453438978|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126037996|NCT05671653|453438979|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126277086|NCT02563106|454305570|FG001|Overall Study|Withdrawal by Subject|8|||
126277087|NCT02563106|454305569|FG000|Overall Study|Adverse Event|17|||
126277088|NCT02563106|454305570|FG001|Overall Study|Adverse Event|15|||
126277089|NCT02563106|454305569|FG000|Overall Study|Protocol Violation|1|||
126277090|NCT02563106|454305570|FG001|Overall Study|Protocol Violation|0|||
125881168|NCT00696072|452864549|FG001|Overall Study|Adverse Event|6|||
126037997|NCT05671653|453438980|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126277091|NCT02563106|454305569|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
126277092|NCT02563106|454305570|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
126277093|NCT02563106|454305569|FG000|Overall Study|Lost to Follow-up|3|||
126277094|NCT02563106|454305570|FG001|Overall Study|Lost to Follow-up|2|||
126037998|NCT05671653|453438981|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126037999|NCT05671653|453438969|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038000|NCT05671653|453438970|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038001|NCT05671653|453438971|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038002|NCT05671653|453438972|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038003|NCT05671653|453438973|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038004|NCT05671653|453438974|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038005|NCT05671653|453438975|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126277095|NCT02563106|454305569|FG000|Overall Study|Physician Decision|3|||
126277096|NCT02563106|454305570|FG001|Overall Study|Physician Decision|1|||
126277097|NCT02563106|454305569|FG000|Overall Study|Other reason - not specified|2|||
126277098|NCT02563106|454305570|FG001|Overall Study|Other reason - not specified|1|||
126277099|NCT04729309|454305571|FG000|Period 1|Subject unable to return for Period 2|3|||
126277100|NCT04729309|454305572|FG001|Period 1|Subject unable to return for Period 2|0|||
126277101|NCT04729309|454305571|FG000|Period 1|Lost to Follow-up|1|||
126277102|NCT04729309|454305572|FG001|Period 1|Lost to Follow-up|0|||
126277103|NCT01059539|454305573|FG000|Overall Study|Adverse Event|66|||
126277104|NCT01059539|454305573|FG000|Overall Study|Insufficient Therapeutic Response|26|||
126277105|NCT01059539|454305573|FG000|Overall Study|Protocol Violation|55|||
126277106|NCT01059539|454305573|FG000|Overall Study|Withdrawal of Consent|80|||
126277107|NCT01059539|454305573|FG000|Overall Study|Lost to Follow-up|42|||
126277108|NCT01059539|454305573|FG000|Overall Study|Reason Not Specified|2|||
126277109|NCT00537303|454305574|FG000|Overall Study|Adverse Event|1|||
126277110|NCT00537303|454305575|FG001|Overall Study|Adverse Event|4|||
126277111|NCT00537303|454305574|FG000|Overall Study|Lack of Efficacy|6|||
126277112|NCT00537303|454305575|FG001|Overall Study|Lack of Efficacy|7|||
126277113|NCT00537303|454305574|FG000|Overall Study|Protocol Violation|8|||
126277114|NCT00537303|454305575|FG001|Overall Study|Protocol Violation|4|||
126277115|NCT00537303|454305574|FG000|Overall Study|Withdrawal criteria|3|||
126277116|NCT00537303|454305575|FG001|Overall Study|Withdrawal criteria|3|||
126277117|NCT00537303|454305574|FG000|Overall Study|Unclassified|8|||
126277118|NCT00537303|454305575|FG001|Overall Study|Unclassified|7|||
126277119|NCT02085135|454305577|FG000|Overall Study|Adverse Event|4|||
126277120|NCT02085135|454305578|FG001|Overall Study|Adverse Event|7|||
126277121|NCT02085135|454305577|FG000|Overall Study|Lost to Follow-up|2|||
126277122|NCT02085135|454305578|FG001|Overall Study|Lost to Follow-up|2|||
126277123|NCT02085135|454305577|FG000|Overall Study|Withdrawal by Subject|3|||
126277124|NCT02085135|454305578|FG001|Overall Study|Withdrawal by Subject|0|||
126277125|NCT02085135|454305577|FG000|Overall Study|Lack of Efficacy|2|||
126277126|NCT02085135|454305578|FG001|Overall Study|Lack of Efficacy|0|||
126277127|NCT01777620|454305584|FG000|Overall Study|Subject Withdrawal|1|||
126277128|NCT01777620|454305585|FG001|Overall Study|Subject Withdrawal|0|||
126277129|NCT04005352|454305586|FG000|Overall Study|Adverse Event|4|||
126277130|NCT04005352|454305587|FG001|Overall Study|Adverse Event|5|||
126038006|NCT05671653|453438976|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126277131|NCT04005352|454305586|FG000|Overall Study|Death|4|||
126277132|NCT04005352|454305587|FG001|Overall Study|Death|2|||
126277133|NCT04005352|454305586|FG000|Overall Study|Lost to Follow-up|6|||
126277134|NCT04005352|454305587|FG001|Overall Study|Lost to Follow-up|2|||
126277135|NCT04005352|454305586|FG000|Overall Study|Physician Decision|7|||
126277136|NCT04005352|454305587|FG001|Overall Study|Physician Decision|13|||
126277137|NCT04005352|454305586|FG000|Overall Study|Protocol Violation|0|||
126277138|NCT04005352|454305587|FG001|Overall Study|Protocol Violation|1|||
126038007|NCT05671653|453438977|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
126038008|NCT05671653|453438978|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038009|NCT05671653|453438979|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038010|NCT05671653|453438980|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038011|NCT05671653|453438981|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126038012|NCT05671653|453438969|FG000|Cohort 2 Period 2|Adverse Event|0|||
126038013|NCT05671653|453438970|FG001|Cohort 2 Period 2|Adverse Event|0|||
126038014|NCT05671653|453438971|FG002|Cohort 2 Period 2|Adverse Event|0|||
126038015|NCT05671653|453438972|FG003|Cohort 2 Period 2|Adverse Event|0|||
126038016|NCT05671653|453438973|FG004|Cohort 2 Period 2|Adverse Event|0|||
126038017|NCT05671653|453438974|FG005|Cohort 2 Period 2|Adverse Event|0|||
126038018|NCT05671653|453438975|FG006|Cohort 2 Period 2|Adverse Event|0|||
126038019|NCT05671653|453438976|FG007|Cohort 2 Period 2|Adverse Event|0|||
126038020|NCT05671653|453438977|FG008|Cohort 2 Period 2|Adverse Event|0|||
126038021|NCT05671653|453438978|FG009|Cohort 2 Period 2|Adverse Event|0|||
126038022|NCT05671653|453438979|FG010|Cohort 2 Period 2|Adverse Event|1|||
126038023|NCT05671653|453438980|FG011|Cohort 2 Period 2|Adverse Event|0|||
126038024|NCT05671653|453438981|FG012|Cohort 2 Period 2|Adverse Event|0|||
126038025|NCT05671653|453438969|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
126038026|NCT05671653|453438970|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
126038027|NCT05671653|453438971|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
126038028|NCT05671653|453438972|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
126038029|NCT05671653|453438973|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
126038030|NCT05671653|453438974|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
126038031|NCT05671653|453438975|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
126038032|NCT05671653|453438976|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
126038033|NCT05671653|453438977|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
126038034|NCT05671653|453438978|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
126038035|NCT05671653|453438979|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
126038036|NCT05671653|453438980|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
126038037|NCT05671653|453438981|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
126038038|NCT05671653|453438969|FG000|Cohort 2 Period 2|Pregnancy|0|||
126038039|NCT05671653|453438970|FG001|Cohort 2 Period 2|Pregnancy|0|||
126038040|NCT05671653|453438971|FG002|Cohort 2 Period 2|Pregnancy|0|||
126038041|NCT05671653|453438972|FG003|Cohort 2 Period 2|Pregnancy|0|||
126038042|NCT05671653|453438973|FG004|Cohort 2 Period 2|Pregnancy|0|||
126038043|NCT05671653|453438974|FG005|Cohort 2 Period 2|Pregnancy|0|||
126038044|NCT05671653|453438975|FG006|Cohort 2 Period 2|Pregnancy|0|||
126038045|NCT05671653|453438976|FG007|Cohort 2 Period 2|Pregnancy|0|||
126038046|NCT05671653|453438977|FG008|Cohort 2 Period 2|Pregnancy|0|||
126038047|NCT05671653|453438978|FG009|Cohort 2 Period 2|Pregnancy|0|||
126038048|NCT05671653|453438979|FG010|Cohort 2 Period 2|Pregnancy|1|||
126038049|NCT05671653|453438980|FG011|Cohort 2 Period 2|Pregnancy|0|||
126038050|NCT05671653|453438981|FG012|Cohort 2 Period 2|Pregnancy|0|||
126038051|NCT05671653|453438969|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038052|NCT05671653|453438970|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038053|NCT05671653|453438971|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038054|NCT05671653|453438972|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038055|NCT05671653|453438973|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
126277139|NCT04005352|454305586|FG000|Overall Study|Withdrawal by Subject|28|||
126277140|NCT04005352|454305587|FG001|Overall Study|Withdrawal by Subject|38|||
126277141|NCT00936897|454305588|FG000|Overall Study|Withdrawal by Subject|9|||
126277142|NCT00936897|454305589|FG001|Overall Study|Withdrawal by Subject|19|||
126277143|NCT00936897|454305588|FG000|Overall Study|Adverse Event|4|||
126277144|NCT00936897|454305589|FG001|Overall Study|Adverse Event|13|||
126277145|NCT00936897|454305588|FG000|Overall Study|Other|3|||
126277146|NCT00936897|454305589|FG001|Overall Study|Other|9|||
126277147|NCT00936897|454305588|FG000|Overall Study|Lost to Follow-up|1|||
126277148|NCT00936897|454305589|FG001|Overall Study|Lost to Follow-up|10|||
126277149|NCT00936897|454305588|FG000|Overall Study|Administrative Decision|1|||
126277150|NCT00936897|454305589|FG001|Overall Study|Administrative Decision|2|||
126038056|NCT05671653|453438974|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038057|NCT05671653|453438975|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038058|NCT05671653|453438976|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
126277151|NCT00936897|454305588|FG000|Overall Study|Protocol Violation|1|||
126038059|NCT05671653|453438977|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038060|NCT05671653|453438978|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038061|NCT05671653|453438979|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
126277152|NCT00936897|454305589|FG001|Overall Study|Protocol Violation|1|||
126277153|NCT00936897|454305588|FG000|Overall Study|Ineligibility Determined|0|||
126038062|NCT05671653|453438980|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038063|NCT05671653|453438981|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
126038064|NCT05671653|453438969|FG000|Cohort 2 Period 2|Other|0|||
126038065|NCT05671653|453438970|FG001|Cohort 2 Period 2|Other|0|||
126038066|NCT05671653|453438971|FG002|Cohort 2 Period 2|Other|0|||
126038067|NCT05671653|453438972|FG003|Cohort 2 Period 2|Other|0|||
126038068|NCT05671653|453438973|FG004|Cohort 2 Period 2|Other|0|||
126038069|NCT05671653|453438974|FG005|Cohort 2 Period 2|Other|0|||
126038070|NCT05671653|453438975|FG006|Cohort 2 Period 2|Other|0|||
126038071|NCT05671653|453438976|FG007|Cohort 2 Period 2|Other|0|||
126277154|NCT00936897|454305589|FG001|Overall Study|Ineligibility Determined|3|||
126038072|NCT05671653|453438977|FG008|Cohort 2 Period 2|Other|0|||
126038073|NCT05671653|453438978|FG009|Cohort 2 Period 2|Other|0|||
126038074|NCT05671653|453438979|FG010|Cohort 2 Period 2|Other|1|||
126038075|NCT05671653|453438980|FG011|Cohort 2 Period 2|Other|0|||
126038076|NCT05671653|453438981|FG012|Cohort 2 Period 2|Other|0|||
126038077|NCT05671653|453438969|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038078|NCT05671653|453438970|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038079|NCT05671653|453438971|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038080|NCT05671653|453438972|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038081|NCT05671653|453438973|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038082|NCT05671653|453438974|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038083|NCT05671653|453438975|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038084|NCT05671653|453438976|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038085|NCT05671653|453438977|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038086|NCT05671653|453438978|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038087|NCT05671653|453438979|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038088|NCT05671653|453438980|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
126038089|NCT05671653|453438981|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126038090|NCT03974178|453438982|FG000|Overall Study|Death|0|||
126038091|NCT03974178|453438983|FG001|Overall Study|Death|1|||
126038092|NCT04508309|453438984|FG000|Overall Study|Death|0|||
126038093|NCT04508309|453438985|FG001|Overall Study|Death|0|||
126277155|NCT00936897|454305588|FG000|Overall Study|Noncompliance|0|||
126277156|NCT00936897|454305589|FG001|Overall Study|Noncompliance|2|||
126277157|NCT00936897|454305588|FG000|Overall Study|Death|0|||
126277158|NCT00936897|454305589|FG001|Overall Study|Death|1|||
126277159|NCT00417170|454305590|FG000|Overall Study|Adverse Event|1|||
126277160|NCT00417170|454305591|FG001|Overall Study|Adverse Event|1|||
126277161|NCT00417170|454305590|FG000|Overall Study|Withdrawal by Subject|1|||
126277162|NCT00417170|454305591|FG001|Overall Study|Withdrawal by Subject|1|||
126277163|NCT00417170|454305590|FG000|Overall Study|Lost to Follow-up|0|||
126277164|NCT00417170|454305591|FG001|Overall Study|Lost to Follow-up|1|||
126277165|NCT02792699|454305592|FG000|Overall Study|Adverse Event|1|||
126277166|NCT02792699|454305593|FG001|Overall Study|Adverse Event|2|||
126277167|NCT02792699|454305594|FG002|Overall Study|Adverse Event|4|||
126277168|NCT02792699|454305592|FG000|Overall Study|Withdrawal by Subject|4|||
126277169|NCT02792699|454305593|FG001|Overall Study|Withdrawal by Subject|4|||
126277170|NCT02792699|454305594|FG002|Overall Study|Withdrawal by Subject|3|||
126277171|NCT02792699|454305592|FG000|Overall Study|Lost to Follow-up|0|||
126277172|NCT02792699|454305593|FG001|Overall Study|Lost to Follow-up|1|||
126277173|NCT02792699|454305594|FG002|Overall Study|Lost to Follow-up|2|||
126277174|NCT02792699|454305592|FG000|Overall Study|Physician Decision|2|||
126277175|NCT02792699|454305593|FG001|Overall Study|Physician Decision|0|||
126277176|NCT02792699|454305594|FG002|Overall Study|Physician Decision|0|||
126277177|NCT02792699|454305592|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
126277178|NCT02792699|454305593|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
126277179|NCT02792699|454305594|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
126277180|NCT02792699|454305592|FG000|Overall Study|Other|1|||
126277181|NCT02792699|454305593|FG001|Overall Study|Other|0|||
126277182|NCT02792699|454305594|FG002|Overall Study|Other|0|||
126277183|NCT03464630|454305595|FG000|Overall Study|Lost to Follow-up|62|||
126277184|NCT03464630|454305596|FG001|Overall Study|Lost to Follow-up|52|||
126277185|NCT03464630|454305595|FG000|Overall Study|Withdrawal by Subject|16|||
126277186|NCT03464630|454305596|FG001|Overall Study|Withdrawal by Subject|10|||
126277187|NCT03464630|454305595|FG000|Overall Study|Passive Disengagement|8|||
126277188|NCT03464630|454305596|FG001|Overall Study|Passive Disengagement|4|||
126277189|NCT03196635|454305597|FG000|Overall Study|Withdrawal by Subject|1|||
126277190|NCT00380744|454305602|FG000|Overall Study|Death|0|||
126277191|NCT00380744|454305603|FG001|Overall Study|Death|0|||
126038094|NCT04508309|453438986|FG002|Overall Study|Death|0|||
126038095|NCT04508309|453438987|FG003|Overall Study|Death|0|||
126038096|NCT04508309|453438988|FG004|Overall Study|Death|1|||
126038097|NCT04508309|453438984|FG000|Overall Study|Lost to Follow-up|0|||
126038098|NCT04508309|453438985|FG001|Overall Study|Lost to Follow-up|0|||
126038099|NCT04508309|453438986|FG002|Overall Study|Lost to Follow-up|1|||
126277192|NCT00380744|454305604|FG002|Overall Study|Death|0|||
126277193|NCT00380744|454305605|FG003|Overall Study|Death|0|||
126277194|NCT00380744|454305606|FG004|Overall Study|Death|0|||
126277195|NCT00380744|454305607|FG005|Overall Study|Death|0|||
126277196|NCT00380744|454305608|FG006|Overall Study|Death|1|||
126038100|NCT04508309|453438987|FG003|Overall Study|Lost to Follow-up|1|||
126277197|NCT00380744|454305602|FG000|Overall Study|Withdrawal by Subject|1|||
126277198|NCT00380744|454305603|FG001|Overall Study|Withdrawal by Subject|0|||
126277199|NCT00380744|454305604|FG002|Overall Study|Withdrawal by Subject|0|||
126277200|NCT00380744|454305605|FG003|Overall Study|Withdrawal by Subject|0|||
126277201|NCT00380744|454305606|FG004|Overall Study|Withdrawal by Subject|0|||
126277202|NCT00380744|454305607|FG005|Overall Study|Withdrawal by Subject|0|||
126277203|NCT00380744|454305608|FG006|Overall Study|Withdrawal by Subject|0|||
126277204|NCT01338870|454305609|FG000|Overall Study|Lost to Follow-up|0|||
126277205|NCT01338870|454305610|FG001|Overall Study|Lost to Follow-up|0|||
126277206|NCT01338870|454305611|FG002|Overall Study|Lost to Follow-up|1|||
126277207|NCT01338870|454305612|FG003|Overall Study|Lost to Follow-up|0|||
126277208|NCT01338870|454305613|FG004|Overall Study|Lost to Follow-up|1|||
126277209|NCT01338870|454305614|FG005|Overall Study|Lost to Follow-up|0|||
126277210|NCT01338870|454305609|FG000|Overall Study|Withdrawal by Subject|2|||
126277211|NCT01338870|454305610|FG001|Overall Study|Withdrawal by Subject|3|||
126277212|NCT01338870|454305611|FG002|Overall Study|Withdrawal by Subject|4|||
126277213|NCT01338870|454305612|FG003|Overall Study|Withdrawal by Subject|0|||
126277214|NCT01338870|454305613|FG004|Overall Study|Withdrawal by Subject|0|||
126277215|NCT01338870|454305614|FG005|Overall Study|Withdrawal by Subject|2|||
126277216|NCT01338870|454305609|FG000|Overall Study|Other|3|||
126277217|NCT01338870|454305610|FG001|Overall Study|Other|3|||
126277218|NCT01338870|454305611|FG002|Overall Study|Other|3|||
126277219|NCT01338870|454305612|FG003|Overall Study|Other|2|||
126277220|NCT01338870|454305613|FG004|Overall Study|Other|0|||
126277221|NCT01338870|454305614|FG005|Overall Study|Other|2|||
126277222|NCT01338870|454305609|FG000|Overall Study|Protocol Violation|0|||
126277223|NCT01338870|454305610|FG001|Overall Study|Protocol Violation|2|||
126277224|NCT01338870|454305611|FG002|Overall Study|Protocol Violation|2|||
126277225|NCT01338870|454305612|FG003|Overall Study|Protocol Violation|2|||
126277226|NCT01338870|454305613|FG004|Overall Study|Protocol Violation|1|||
126277227|NCT01338870|454305614|FG005|Overall Study|Protocol Violation|1|||
126277228|NCT01338870|454305609|FG000|Overall Study|Adverse Event|4|||
126277229|NCT01338870|454305610|FG001|Overall Study|Adverse Event|4|||
126277230|NCT01338870|454305611|FG002|Overall Study|Adverse Event|1|||
126277231|NCT01338870|454305612|FG003|Overall Study|Adverse Event|5|||
126277232|NCT01338870|454305613|FG004|Overall Study|Adverse Event|4|||
126277233|NCT01338870|454305614|FG005|Overall Study|Adverse Event|1|||
126277234|NCT02871492|454305617|FG000|Overall Study|Lost to Follow-up|6|||
126277235|NCT02871492|454305618|FG001|Overall Study|Lost to Follow-up|3|||
126277236|NCT02871492|454305619|FG002|Overall Study|Lost to Follow-up|5|||
126277237|NCT02871492|454305617|FG000|Overall Study|Withdrawal by Subject|0|||
126277238|NCT02871492|454305618|FG001|Overall Study|Withdrawal by Subject|0|||
126277239|NCT02871492|454305619|FG002|Overall Study|Withdrawal by Subject|1|||
126277240|NCT04546724|454305620|FG000|Overall Study|Withdrawal by Subject|145|||
126277241|NCT04546724|454305621|FG001|Overall Study|Withdrawal by Subject|41|||
126277242|NCT04546724|454305620|FG000|Overall Study|Adverse Event|1|||
126277243|NCT04546724|454305621|FG001|Overall Study|Adverse Event|1|||
126277244|NCT04546724|454305620|FG000|Overall Study|Lost to Follow-up|186|||
126277245|NCT04546724|454305621|FG001|Overall Study|Lost to Follow-up|63|||
126277246|NCT04546724|454305620|FG000|Overall Study|Physician Decision|8|||
126277247|NCT04546724|454305621|FG001|Overall Study|Physician Decision|2|||
126277248|NCT04546724|454305620|FG000|Overall Study|Death|2|||
126277249|NCT04546724|454305621|FG001|Overall Study|Death|1|||
126277250|NCT04546724|454305620|FG000|Overall Study|subject has been out of town|1|||
126277251|NCT04546724|454305621|FG001|Overall Study|subject has been out of town|0|||
126277252|NCT04546724|454305620|FG000|Overall Study|subject is incarcerated|2|||
126277253|NCT04546724|454305621|FG001|Overall Study|subject is incarcerated|0|||
126277254|NCT04546724|454305620|FG000|Overall Study|subject is relocating|12|||
126277255|NCT04546724|454305621|FG001|Overall Study|subject is relocating|4|||
126277256|NCT04546724|454305620|FG000|Overall Study|Subject in another study|1|||
126277257|NCT04546724|454305621|FG001|Overall Study|Subject in another study|1|||
126277258|NCT02256436|454305622|FG000|Overall Study|Adverse Event|9|||
126277259|NCT02256436|454305623|FG001|Overall Study|Adverse Event|14|||
126277260|NCT02256436|454305622|FG000|Overall Study|Death|216|||
126277261|NCT02256436|454305623|FG001|Overall Study|Death|208|||
126277262|NCT02256436|454305622|FG000|Overall Study|Lost to Follow-up|1|||
126277263|NCT02256436|454305623|FG001|Overall Study|Lost to Follow-up|2|||
126277264|NCT02256436|454305622|FG000|Overall Study|Physician Decision|1|||
126277265|NCT02256436|454305623|FG001|Overall Study|Physician Decision|0|||
126277266|NCT02256436|454305622|FG000|Overall Study|Protocol Violation|0|||
126277267|NCT02256436|454305623|FG001|Overall Study|Protocol Violation|1|||
126277268|NCT02256436|454305622|FG000|Overall Study|Withdrawal by Subject|26|||
126277269|NCT02256436|454305623|FG001|Overall Study|Withdrawal by Subject|10|||
126277270|NCT02256436|454305622|FG000|Overall Study|Transferred to Extension Study|11|||
126277271|NCT02256436|454305623|FG001|Overall Study|Transferred to Extension Study|23|||
126277272|NCT02256436|454305622|FG000|Overall Study|Did Not Continue on Extension Study|8|||
126277273|NCT02256436|454305623|FG001|Overall Study|Did Not Continue on Extension Study|12|||
126362863|NCT00489359|454621637|FG001|Overall Study|Adverse Event|16|||
126277274|NCT01441947|454305624|FG000|Overall Study|Withdrawal by Subject|3|||
126277275|NCT01441947|454305625|FG001|Overall Study|Withdrawal by Subject|0|||
126277276|NCT00077857|454305626|FG000|Overall Study|Adverse Event|30|||
126277277|NCT00077857|454305627|FG001|Overall Study|Adverse Event|32|||
126277278|NCT00077857|454305626|FG000|Overall Study|Death|7|||
126277279|NCT00077857|454305627|FG001|Overall Study|Death|3|||
126277280|NCT00077857|454305626|FG000|Overall Study|Insufficient therapeutic response|112|||
126277281|NCT00077857|454305627|FG001|Overall Study|Insufficient therapeutic response|128|||
126277282|NCT00077857|454305626|FG000|Overall Study|Violation of selection criteria at entry|3|||
126277283|NCT00077857|454305627|FG001|Overall Study|Violation of selection criteria at entry|1|||
126277284|NCT00077857|454305626|FG000|Overall Study|Other protocol violation|0|||
126277285|NCT00077857|454305627|FG001|Overall Study|Other protocol violation|1|||
126277286|NCT00077857|454305626|FG000|Overall Study|Refused treatment|29|||
126277287|NCT00077857|454305627|FG001|Overall Study|Refused treatment|21|||
126277288|NCT00077857|454305626|FG000|Overall Study|Failure to return|5|||
126277289|NCT00077857|454305627|FG001|Overall Study|Failure to return|5|||
126277290|NCT00077857|454305626|FG000|Overall Study|Other|15|||
126277291|NCT00077857|454305627|FG001|Overall Study|Other|13|||
126277292|NCT00468650|454305628|FG000|Overall Study|Lost to Follow-up|4|||
126277293|NCT00468650|454305628|FG000|Overall Study|Withdrawal by Subject|2|||
126277294|NCT00468650|454305628|FG000|Overall Study|Protocol Violation|1|||
126277295|NCT02348723|454305631|FG000|Overall Study|No ablation|21|||
126277296|NCT02348723|454305632|FG001|Overall Study|No ablation|20|||
126277297|NCT02348723|454305631|FG000|Overall Study|Non-compliant with Protocol|1|||
126277298|NCT02348723|454305632|FG001|Overall Study|Non-compliant with Protocol|0|||
126277299|NCT02348723|454305631|FG000|Overall Study|Lost to Follow-up|1|||
126277300|NCT02348723|454305632|FG001|Overall Study|Lost to Follow-up|1|||
126277301|NCT02348723|454305631|FG000|Overall Study|Consent withdrawn|1|||
126277302|NCT02348723|454305632|FG001|Overall Study|Consent withdrawn|3|||
126277303|NCT02348723|454305631|FG000|Overall Study|Reason other than specified|1|||
126277304|NCT02348723|454305632|FG001|Overall Study|Reason other than specified|1|||
126277305|NCT02348723|454305631|FG000|Overall Study|Adverse Event|3|||
126277306|NCT02348723|454305632|FG001|Overall Study|Adverse Event|1|||
126277307|NCT04874155|454305633|FG000|Overall Study|Lost to Follow-up|1|||
126277308|NCT04874155|454305634|FG001|Overall Study|Lost to Follow-up|1|||
126277309|NCT04874155|454305633|FG000|Overall Study|Withdrawal by Subject|2|||
126277310|NCT04874155|454305634|FG001|Overall Study|Withdrawal by Subject|2|||
126277311|NCT03477903|454305639|FG000|Overall Study|Study Terminated by Sponsor|1|||
126277312|NCT03201965|454305640|FG000|Overall Study|Death|5|||
126277313|NCT03201965|454305641|FG001|Overall Study|Death|27|||
126277314|NCT03201965|454305642|FG002|Overall Study|Death|27|||
126277315|NCT03201965|454305640|FG000|Overall Study|Lost to Follow-up|0|||
126277316|NCT03201965|454305641|FG001|Overall Study|Lost to Follow-up|1|||
126277317|NCT03201965|454305642|FG002|Overall Study|Lost to Follow-up|0|||
126277318|NCT03201965|454305640|FG000|Overall Study|Withdrawal by Subject|3|||
126277319|NCT03201965|454305641|FG001|Overall Study|Withdrawal by Subject|13|||
126277320|NCT03201965|454305642|FG002|Overall Study|Withdrawal by Subject|4|||
126277321|NCT03201965|454305640|FG000|Overall Study|Ongoing|20|||
126277322|NCT03201965|454305641|FG001|Overall Study|Ongoing|152|||
126277323|NCT03201965|454305642|FG002|Overall Study|Ongoing|164|||
126277324|NCT00369317|454305643|FG000|Overall Study|Adverse Event|3|||
126277325|NCT00369317|454305643|FG000|Overall Study|Death|1|||
126277326|NCT00369317|454305643|FG000|Overall Study|Lack of Efficacy|5|||
126038101|NCT04508309|453438988|FG004|Overall Study|Lost to Follow-up|0|||
126038102|NCT04508309|453438984|FG000|Overall Study|Withdrawal by Subject|0|||
126038103|NCT04508309|453438985|FG001|Overall Study|Withdrawal by Subject|0|||
126277327|NCT00369317|454305643|FG000|Overall Study|Physician Decision|2|||
126277328|NCT00369317|454305643|FG000|Overall Study|Withdrawal by Subject|8|||
126277329|NCT00369317|454305643|FG000|Overall Study|Ineligible|1|||
126277330|NCT02365558|454305644|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
126277331|NCT02365558|454305645|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
126277332|NCT02365558|454305644|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
126277333|NCT02365558|454305645|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
126277334|NCT02828241|454305654|FG000|Overall Study|Adverse Event|7|||
126277335|NCT02828241|454305655|FG001|Overall Study|Adverse Event|2|||
126277336|NCT02828241|454305654|FG000|Overall Study|Protocol Violation|1|||
126277337|NCT02828241|454305655|FG001|Overall Study|Protocol Violation|0|||
126277338|NCT01197755|454305656|FG000|Overall Study|Adverse Event|8|||
126277339|NCT01197755|454305657|FG001|Overall Study|Adverse Event|10|||
126277340|NCT01197755|454305658|FG002|Overall Study|Adverse Event|10|||
126277341|NCT01197755|454305656|FG000|Overall Study|Study-specific discontinuation criteria|2|||
126277342|NCT01197755|454305657|FG001|Overall Study|Study-specific discontinuation criteria|1|||
126277343|NCT01197755|454305658|FG002|Overall Study|Study-specific discontinuation criteria|0|||
126277344|NCT01197755|454305656|FG000|Overall Study|Entered the long-term extension study|18|||
126277345|NCT01197755|454305657|FG001|Overall Study|Entered the long-term extension study|21|||
126277346|NCT01197755|454305658|FG002|Overall Study|Entered the long-term extension study|35|||
126277347|NCT01197755|454305656|FG000|Overall Study|Lack of therapeutic response|0|||
126277348|NCT01197755|454305657|FG001|Overall Study|Lack of therapeutic response|7|||
126277349|NCT01197755|454305658|FG002|Overall Study|Lack of therapeutic response|4|||
126277350|NCT01197755|454305656|FG000|Overall Study|Severe non-compliance to the protocol|2|||
126277351|NCT01197755|454305657|FG001|Overall Study|Severe non-compliance to the protocol|1|||
126277352|NCT01197755|454305658|FG002|Overall Study|Severe non-compliance to the protocol|2|||
126277353|NCT01197755|454305656|FG000|Overall Study|Withdrawal by Subject|1|||
126277354|NCT01197755|454305657|FG001|Overall Study|Withdrawal by Subject|0|||
126277355|NCT01197755|454305658|FG002|Overall Study|Withdrawal by Subject|0|||
126277356|NCT01197755|454305656|FG000|Overall Study|Lost to Follow-up|0|||
126277357|NCT01197755|454305657|FG001|Overall Study|Lost to Follow-up|0|||
126277358|NCT01197755|454305658|FG002|Overall Study|Lost to Follow-up|1|||
126277359|NCT01197755|454305656|FG000|Overall Study|eg, change in circumstances|7|||
126277360|NCT01197755|454305657|FG001|Overall Study|eg, change in circumstances|3|||
126277361|NCT01197755|454305658|FG002|Overall Study|eg, change in circumstances|2|||
126038104|NCT04508309|453438986|FG002|Overall Study|Withdrawal by Subject|0|||
126038105|NCT04508309|453438987|FG003|Overall Study|Withdrawal by Subject|0|||
126038106|NCT04508309|453438988|FG004|Overall Study|Withdrawal by Subject|1|||
126277362|NCT00758680|454305659|FG000|Overall Study|Adverse Event|0|||
126277363|NCT00758680|454305660|FG001|Overall Study|Adverse Event|0|||
126277364|NCT00758680|454305661|FG002|Overall Study|Adverse Event|0|||
126277365|NCT00758680|454305662|FG003|Overall Study|Adverse Event|0|||
126277366|NCT00758680|454305663|FG004|Overall Study|Adverse Event|0|||
126277367|NCT00758680|454305664|FG005|Overall Study|Adverse Event|0|||
126038107|NCT05526430|453438989|FG000|Overall Study|Withdrawal by Subject|0|||
126038108|NCT05526430|453438990|FG001|Overall Study|Withdrawal by Subject|2|||
126038109|NCT05526430|453438991|FG002|Overall Study|Withdrawal by Subject|0|||
126277368|NCT00758680|454305665|FG006|Overall Study|Adverse Event|0|||
126277369|NCT00758680|454305666|FG007|Overall Study|Adverse Event|1|||
126277370|NCT00758680|454305667|FG008|Overall Study|Adverse Event|0|||
126277371|NCT00758680|454305668|FG009|Overall Study|Adverse Event|1|||
126277372|NCT00758680|454305659|FG000|Overall Study|Laboratory Adverse Event|0|||
126277373|NCT00758680|454305660|FG001|Overall Study|Laboratory Adverse Event|0|||
126277374|NCT00758680|454305661|FG002|Overall Study|Laboratory Adverse Event|0|||
126306226|NCT01940887|454410250|FG000|Year 1|Physician Decision|7|||
126277375|NCT00758680|454305662|FG003|Overall Study|Laboratory Adverse Event|0|||
126277376|NCT00758680|454305663|FG004|Overall Study|Laboratory Adverse Event|0|||
126277377|NCT00758680|454305664|FG005|Overall Study|Laboratory Adverse Event|0|||
126277378|NCT00758680|454305665|FG006|Overall Study|Laboratory Adverse Event|0|||
126277379|NCT00758680|454305666|FG007|Overall Study|Laboratory Adverse Event|0|||
126277380|NCT00758680|454305667|FG008|Overall Study|Laboratory Adverse Event|1|||
126277381|NCT00758680|454305668|FG009|Overall Study|Laboratory Adverse Event|0|||
126277382|NCT00758680|454305659|FG000|Overall Study|Withdrawal by Subject|0|||
126277383|NCT00758680|454305660|FG001|Overall Study|Withdrawal by Subject|0|||
126277384|NCT00758680|454305661|FG002|Overall Study|Withdrawal by Subject|0|||
126277385|NCT00758680|454305662|FG003|Overall Study|Withdrawal by Subject|0|||
126277386|NCT00758680|454305663|FG004|Overall Study|Withdrawal by Subject|0|||
126277387|NCT00758680|454305664|FG005|Overall Study|Withdrawal by Subject|0|||
126277388|NCT00758680|454305665|FG006|Overall Study|Withdrawal by Subject|1|||
126277389|NCT00758680|454305666|FG007|Overall Study|Withdrawal by Subject|0|||
126277390|NCT00758680|454305667|FG008|Overall Study|Withdrawal by Subject|1|||
126277391|NCT00758680|454305668|FG009|Overall Study|Withdrawal by Subject|0|||
126277392|NCT00761865|454305669|FG000|Overall Study|Lost to Follow-up|8|||
126277393|NCT00761865|454305670|FG001|Overall Study|Lost to Follow-up|7|||
126277394|NCT03866902|454305672|FG000|Overall Study|Lost to Follow-up|98|||
126277395|NCT03866902|454305673|FG001|Overall Study|Lost to Follow-up|82|||
126277396|NCT03866902|454305672|FG000|Overall Study|Pregnancy|18|||
126277397|NCT03866902|454305673|FG001|Overall Study|Pregnancy|24|||
126277398|NCT00638027|454305674|FG000|Overall Study|Adverse Event|0|||
126277399|NCT00638027|454305675|FG001|Overall Study|Adverse Event|2|||
126277400|NCT00371397|454305676|FG000|Session 1|Withdrawal by Subject|1|||
126277401|NCT00371397|454305677|FG001|Session 1|Withdrawal by Subject|0|||
126277402|NCT00371397|454305678|FG002|Session 1|Withdrawal by Subject|0|||
126277403|NCT00371397|454305679|FG003|Session 1|Withdrawal by Subject|0|||
126277404|NCT00371397|454305680|FG004|Session 1|Withdrawal by Subject|0|||
126277405|NCT00371397|454305681|FG005|Session 1|Withdrawal by Subject|0|||
126277406|NCT00371397|454305682|FG006|Session 1|Withdrawal by Subject|0|||
126277407|NCT00371397|454305683|FG007|Session 1|Withdrawal by Subject|1|||
126277408|NCT00371397|454305684|FG008|Session 1|Withdrawal by Subject|0|||
126277409|NCT00371397|454305685|FG009|Session 1|Withdrawal by Subject|0|||
126277410|NCT00371397|454305686|FG010|Session 1|Withdrawal by Subject|0|||
126277411|NCT00371397|454305687|FG011|Session 1|Withdrawal by Subject|0|||
126277412|NCT03014180|454305688|FG000|Overall Study|Protocol Violation|2|||
126277413|NCT01284621|454305689|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277414|NCT01284621|454305690|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277415|NCT01284621|454305691|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277416|NCT01284621|454305692|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277417|NCT01284621|454305693|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
126277418|NCT01284621|454305694|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277419|NCT02802631|454305697|FG000|Overall Study|Withdrawal by Subject|1|||
126277420|NCT02802631|454305698|FG001|Overall Study|Withdrawal by Subject|0|||
126277421|NCT02802631|454305699|FG002|Overall Study|Withdrawal by Subject|0|||
126277422|NCT02802631|454305700|FG003|Overall Study|Withdrawal by Subject|0|||
126277423|NCT02802631|454305701|FG004|Overall Study|Withdrawal by Subject|0|||
126277424|NCT02802631|454305702|FG005|Overall Study|Withdrawal by Subject|0|||
126277425|NCT02802631|454305703|FG006|Overall Study|Withdrawal by Subject|0|||
126277426|NCT02802631|454305704|FG007|Overall Study|Withdrawal by Subject|0|||
126277427|NCT02802631|454305697|FG000|Overall Study|Physician Decision|1|||
126277428|NCT02802631|454305698|FG001|Overall Study|Physician Decision|0|||
126277429|NCT02802631|454305699|FG002|Overall Study|Physician Decision|0|||
126277430|NCT02802631|454305700|FG003|Overall Study|Physician Decision|0|||
126277431|NCT02802631|454305701|FG004|Overall Study|Physician Decision|0|||
126277432|NCT02802631|454305702|FG005|Overall Study|Physician Decision|0|||
126277433|NCT02802631|454305703|FG006|Overall Study|Physician Decision|1|||
126277434|NCT02802631|454305704|FG007|Overall Study|Physician Decision|0|||
126277435|NCT02802631|454305697|FG000|Overall Study|Adverse Event|0|||
126277436|NCT02802631|454305698|FG001|Overall Study|Adverse Event|2|||
126277437|NCT02802631|454305699|FG002|Overall Study|Adverse Event|0|||
126277438|NCT02802631|454305700|FG003|Overall Study|Adverse Event|1|||
126277439|NCT02802631|454305701|FG004|Overall Study|Adverse Event|6|||
126277440|NCT02802631|454305702|FG005|Overall Study|Adverse Event|1|||
126277441|NCT02802631|454305703|FG006|Overall Study|Adverse Event|4|||
126277442|NCT02802631|454305704|FG007|Overall Study|Adverse Event|0|||
126277443|NCT02802631|454305697|FG000|Overall Study|Sponsor Decision|0|||
126277444|NCT02802631|454305698|FG001|Overall Study|Sponsor Decision|0|||
126277445|NCT02802631|454305699|FG002|Overall Study|Sponsor Decision|6|||
126277446|NCT02802631|454305700|FG003|Overall Study|Sponsor Decision|0|||
126277447|NCT02802631|454305701|FG004|Overall Study|Sponsor Decision|2|||
126277448|NCT02802631|454305702|FG005|Overall Study|Sponsor Decision|0|||
126277449|NCT02802631|454305703|FG006|Overall Study|Sponsor Decision|0|||
126277450|NCT02802631|454305704|FG007|Overall Study|Sponsor Decision|4|||
126277451|NCT02968849|454305705|FG000|Overall Study|Death|8|||
126277452|NCT02968849|454305706|FG001|Overall Study|Death|10|||
126277453|NCT02968849|454305705|FG000|Overall Study|Lost to Follow-up|31|||
126277454|NCT02968849|454305706|FG001|Overall Study|Lost to Follow-up|29|||
126277455|NCT02968849|454305705|FG000|Overall Study|Withdrawal by Subject|73|||
126277456|NCT02968849|454305706|FG001|Overall Study|Withdrawal by Subject|64|||
126277457|NCT02968849|454305705|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
126277458|NCT02968849|454305706|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
126277459|NCT02968849|454305705|FG000|Overall Study|Physician Decision|6|||
126277460|NCT02968849|454305706|FG001|Overall Study|Physician Decision|9|||
126277461|NCT02968849|454305705|FG000|Overall Study|Other|16|||
126277462|NCT02968849|454305706|FG001|Overall Study|Other|10|||
126277463|NCT00704730|454305708|FG000|Overall Study|Adverse Event|35|||
126277464|NCT00704730|454305709|FG001|Overall Study|Adverse Event|9|||
126277465|NCT00704730|454305708|FG000|Overall Study|Death|11|||
126277466|NCT00704730|454305709|FG001|Overall Study|Death|5|||
126277467|NCT00704730|454305708|FG000|Overall Study|Physician Decision|2|||
126277468|NCT00704730|454305709|FG001|Overall Study|Physician Decision|0|||
126277469|NCT00704730|454305708|FG000|Overall Study|Did not receive drug|5|||
126277470|NCT00704730|454305709|FG001|Overall Study|Did not receive drug|2|||
126277471|NCT00704730|454305708|FG000|Overall Study|Disease progression per PI|58|||
126277472|NCT00704730|454305709|FG001|Overall Study|Disease progression per PI|67|||
126277473|NCT00704730|454305708|FG000|Overall Study|data unavailable|1|||
126277474|NCT00704730|454305709|FG001|Overall Study|data unavailable|0|||
126277475|NCT00704730|454305708|FG000|Overall Study|Withdrawal by Subject|9|||
126277476|NCT00704730|454305709|FG001|Overall Study|Withdrawal by Subject|13|||
126277477|NCT02551666|454305711|FG000|Overall Study|Withdrawal by Subject|1|||
126277478|NCT02551666|454305712|FG001|Overall Study|Withdrawal by Subject|3|||
126277479|NCT03510598|454307255|FG000|Overall Study|Withdrawal by Subject|1|||
126277480|NCT05307510|454307257|FG000|Overall Study|Lost to Follow-up|3|||
126277481|NCT05307510|454307258|FG001|Overall Study|Lost to Follow-up|6|||
126277482|NCT05307510|454307257|FG000|Overall Study|Withdrawal by Subject|0|||
126277483|NCT05307510|454307258|FG001|Overall Study|Withdrawal by Subject|1|||
126277484|NCT00554606|454307265|FG000|Overall Study|Adverse Event|3|||
126277485|NCT00554606|454307265|FG000|Overall Study|Abnormal laboratory values|1|||
126277486|NCT00554606|454307265|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
126277487|NCT00554606|454307265|FG000|Overall Study|Subject withdrew consent|2|||
126277488|NCT00554606|454307265|FG000|Overall Study|Lost to Follow-up|2|||
126277489|NCT00554606|454307265|FG000|Overall Study|Administrative problems|60|||
126277490|NCT00554606|454307265|FG000|Overall Study|Death|1|||
126277491|NCT00554606|454307265|FG000|Overall Study|Protocol deviation|2|||
126362864|NCT03180138|454621638|FG000|Overall Study|Mobile-phone could not be verified|2|||
126362865|NCT03180138|454621639|FG001|Overall Study|Mobile-phone could not be verified|13|||
126362866|NCT03180138|454621640|FG002|Overall Study|Mobile-phone could not be verified|15|||
126277492|NCT00849186|454307274|FG000|Overall Study|Adverse Event|2|||
126277493|NCT00849186|454307274|FG000|Overall Study|Withdrawal by Subject|1|||
126277494|NCT00849186|454307274|FG000|Overall Study|not treated|6|||
126277495|NCT00849186|454307274|FG000|Overall Study|Other|1|||
126362867|NCT03180138|454621638|FG000|Overall Study|No prior immunization records|17|||
126362868|NCT03180138|454621639|FG001|Overall Study|No prior immunization records|0|||
126362869|NCT03180138|454621640|FG002|Overall Study|No prior immunization records|6|||
126362870|NCT03180138|454621638|FG000|Overall Study|Found to be >24 mon after randomization|3|||
126362871|NCT03180138|454621639|FG001|Overall Study|Found to be >24 mon after randomization|0|||
126362872|NCT03180138|454621640|FG002|Overall Study|Found to be >24 mon after randomization|3|||
126362873|NCT02100644|454621642|FG000|LTG Escalation Phase|Adverse Event|9|||
126362874|NCT02100644|454621643|FG001|LTG Escalation Phase|Adverse Event|0|||
126362875|NCT02100644|454621644|FG002|LTG Escalation Phase|Adverse Event|0|||
126277496|NCT00492024|454307275|FG000|Treatment|Adverse Event|3|||
126277497|NCT00492024|454307276|FG001|Treatment|Adverse Event|1|||
126277498|NCT00492024|454307275|FG000|Treatment|Lack of Efficacy|21|||
126277499|NCT00492024|454307276|FG001|Treatment|Lack of Efficacy|20|||
126277500|NCT00492024|454307275|FG000|Treatment|Lost to Follow-up|3|||
126277501|NCT00492024|454307276|FG001|Treatment|Lost to Follow-up|1|||
126362876|NCT02100644|454621642|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
126277502|NCT00492024|454307275|FG000|Treatment|Withdrawal by Subject|2|||
126362877|NCT02100644|454621643|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
126098687|NCT00122460|453653089|FG001|Overall Study|investigational study phase ongoing|1|||
126277503|NCT00492024|454307276|FG001|Treatment|Withdrawal by Subject|0|||
126277504|NCT00492024|454307275|FG000|Follow up|Lack of Efficacy|0|||
126277505|NCT00492024|454307276|FG001|Follow up|Lack of Efficacy|1|||
126277506|NCT00492024|454307275|FG000|Follow up|Lost to Follow-up|1|||
126277507|NCT00492024|454307276|FG001|Follow up|Lost to Follow-up|1|||
126277508|NCT03247816|454307277|FG000|Overall Study|Adverse Event|12|||
126277509|NCT03247816|454307277|FG000|Overall Study|Physician Decision|3|||
126277510|NCT03247816|454307277|FG000|Overall Study|Lack of Efficacy|1|||
126277511|NCT03247816|454307277|FG000|Overall Study|Lost to Follow-up|10|||
126277512|NCT03247816|454307277|FG000|Overall Study|Missing Feraccru stop date|3|||
126277513|NCT03257865|454307284|FG000|Overall Study|Adverse Event|4|||
126277514|NCT03257865|454307285|FG001|Overall Study|Adverse Event|8|||
126277515|NCT03257865|454307284|FG000|Overall Study|Lack of Efficacy|1|||
126277516|NCT03257865|454307285|FG001|Overall Study|Lack of Efficacy|2|||
126277517|NCT03257865|454307284|FG000|Overall Study|Non-compliance with Study Drug|0|||
126277518|NCT03257865|454307285|FG001|Overall Study|Non-compliance with Study Drug|2|||
126277519|NCT03257865|454307284|FG000|Overall Study|Withdrawal by Subject|23|||
126277520|NCT03257865|454307285|FG001|Overall Study|Withdrawal by Subject|17|||
126277521|NCT03257865|454307284|FG000|Overall Study|Physician Decision|3|||
126277522|NCT03257865|454307285|FG001|Overall Study|Physician Decision|1|||
126277523|NCT03257865|454307284|FG000|Overall Study|Other|0|||
126277524|NCT03257865|454307285|FG001|Overall Study|Other|1|||
126277525|NCT03257865|454307284|FG000|Overall Study|Lost to Follow-up|4|||
126277526|NCT03257865|454307285|FG001|Overall Study|Lost to Follow-up|4|||
126277527|NCT02677714|454307286|FG000|Overall Study|Withdrawal by Subject|2|||
126277528|NCT02677714|454307287|FG001|Overall Study|Withdrawal by Subject|0|||
126277529|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
126277530|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
126277531|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
126277532|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
126277533|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
126277534|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
126277535|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
126277536|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
126277537|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
126277538|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
126277539|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
126277540|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
126277541|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
126277542|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
126277543|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
126277544|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
126362878|NCT02100644|454621644|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
126362879|NCT02100644|454621642|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
126362880|NCT02100644|454621643|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
126362881|NCT02100644|454621644|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
126362882|NCT00728182|454621645|FG000|Overall Study|Adverse Event|1|||
126362883|NCT00728182|454621646|FG001|Overall Study|Adverse Event|0|||
126362884|NCT00728182|454621645|FG000|Overall Study|Lost to Follow-up|2|||
126362885|NCT00728182|454621646|FG001|Overall Study|Lost to Follow-up|0|||
126362886|NCT00728182|454621645|FG000|Overall Study|Death|0|||
126362887|NCT00728182|454621646|FG001|Overall Study|Death|2|||
126362888|NCT00728182|454621645|FG000|Overall Study|Protocol Noncompliance|0|||
126362889|NCT00728182|454621646|FG001|Overall Study|Protocol Noncompliance|1|||
126362890|NCT01898091|454621648|FG000|Overall Study|Lost to Follow-up|1|||
126277545|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
126277546|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
126277547|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
126277548|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
126277549|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
126277550|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
126277551|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
126277552|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
126277553|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
126277554|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
126277555|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
126277556|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
126277557|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
126277558|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
126277559|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
126277560|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
126277561|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
126277562|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
126277563|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
126277564|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
126277565|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
126277566|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
126277567|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
126277568|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
126277569|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
126277570|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
126277571|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
126277572|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
126038110|NCT05526430|453438992|FG003|Overall Study|Withdrawal by Subject|0|||
126277573|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
126277574|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
126277575|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
126277576|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
126277577|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
126277578|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
126277579|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
126277580|NCT02538965|454307292|FG000|Treatment Period|Other = Death due to disease progression|1|||
126277581|NCT02538965|454307292|FG000|Treatment Period|Adverse Event|2|||
126277582|NCT02538965|454307292|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
126277583|NCT02538965|454307292|FG000|Treatment Period|Treatment Failure|9|||
126277584|NCT02538965|454307292|FG000|Treatment Period|Disease Progression|1|||
126277585|NCT02538965|454307292|FG000|Treatment Period|Physician Decision|2|||
126277586|NCT02538965|454307292|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
126277587|NCT02538965|454307292|FG000|Follow-Up Period|Withdrawal by Parent|4|||
126277588|NCT00875797|454307293|FG000|Overall Study|Protocol Violation|6|||
126277589|NCT00875797|454307294|FG001|Overall Study|Protocol Violation|3|||
126277590|NCT01955083|454307297|FG000|Overall Study|Lost to Follow-up|1|||
126277591|NCT01955083|454307298|FG001|Overall Study|Lost to Follow-up|1|||
126277592|NCT03583086|454307301|FG000|Overall Study|Death|2|||
126277593|NCT03583086|454307302|FG001|Overall Study|Death|6|||
126277594|NCT03583086|454307303|FG002|Overall Study|Death|12|||
126277595|NCT03583086|454307304|FG003|Overall Study|Death|10|||
126038111|NCT02305888|453438996|FG000|Overall Study|Lost to Follow-up|0|||
126038112|NCT02305888|453438997|FG001|Overall Study|Lost to Follow-up|0|||
126038113|NCT02305888|453438998|FG002|Overall Study|Lost to Follow-up|1|||
126277596|NCT03583086|454307305|FG004|Overall Study|Death|14|||
126277597|NCT03583086|454307306|FG005|Overall Study|Death|14|||
126277598|NCT03583086|454307307|FG006|Overall Study|Death|4|||
126277599|NCT03583086|454307301|FG000|Overall Study|Withdrawal by Subject|0|||
126277600|NCT03583086|454307302|FG001|Overall Study|Withdrawal by Subject|0|||
126277601|NCT03583086|454307303|FG002|Overall Study|Withdrawal by Subject|1|||
126277602|NCT03583086|454307304|FG003|Overall Study|Withdrawal by Subject|0|||
126277603|NCT03583086|454307305|FG004|Overall Study|Withdrawal by Subject|0|||
126277604|NCT03583086|454307306|FG005|Overall Study|Withdrawal by Subject|0|||
126277605|NCT03583086|454307307|FG006|Overall Study|Withdrawal by Subject|1|||
126277606|NCT03583086|454307301|FG000|Overall Study|Refused follow-up|0|||
126277607|NCT03583086|454307302|FG001|Overall Study|Refused follow-up|0|||
126277608|NCT03583086|454307303|FG002|Overall Study|Refused follow-up|1|||
126277609|NCT03583086|454307304|FG003|Overall Study|Refused follow-up|0|||
126277610|NCT03583086|454307305|FG004|Overall Study|Refused follow-up|1|||
126277611|NCT03583086|454307306|FG005|Overall Study|Refused follow-up|0|||
126277612|NCT03583086|454307307|FG006|Overall Study|Refused follow-up|0|||
126277613|NCT03583086|454307301|FG000|Overall Study|Declining Performance Status|0|||
126277614|NCT03583086|454307302|FG001|Overall Study|Declining Performance Status|0|||
126277615|NCT03583086|454307303|FG002|Overall Study|Declining Performance Status|1|||
126277616|NCT03583086|454307304|FG003|Overall Study|Declining Performance Status|0|||
126277617|NCT03583086|454307305|FG004|Overall Study|Declining Performance Status|0|||
126277618|NCT03583086|454307306|FG005|Overall Study|Declining Performance Status|0|||
126277619|NCT03583086|454307307|FG006|Overall Study|Declining Performance Status|0|||
126277620|NCT03583086|454307301|FG000|Overall Study|Still on study|0|||
126277621|NCT03583086|454307302|FG001|Overall Study|Still on study|0|||
126277622|NCT03583086|454307303|FG002|Overall Study|Still on study|0|||
126277623|NCT03583086|454307304|FG003|Overall Study|Still on study|1|||
126277624|NCT03583086|454307305|FG004|Overall Study|Still on study|0|||
126277625|NCT03583086|454307306|FG005|Overall Study|Still on study|0|||
126277626|NCT03583086|454307307|FG006|Overall Study|Still on study|1|||
126277627|NCT03583086|454307301|FG000|Overall Study|Disease progression|0|||
126277628|NCT03583086|454307302|FG001|Overall Study|Disease progression|0|||
126277629|NCT03583086|454307303|FG002|Overall Study|Disease progression|0|||
126277630|NCT03583086|454307304|FG003|Overall Study|Disease progression|0|||
126277631|NCT03583086|454307305|FG004|Overall Study|Disease progression|0|||
126277632|NCT03583086|454307306|FG005|Overall Study|Disease progression|0|||
126277633|NCT03583086|454307307|FG006|Overall Study|Disease progression|1|||
126277634|NCT03583086|454307301|FG000|Overall Study|Undergoing radiation therapy|0|||
126277635|NCT03583086|454307302|FG001|Overall Study|Undergoing radiation therapy|0|||
126277636|NCT03583086|454307303|FG002|Overall Study|Undergoing radiation therapy|0|||
126277637|NCT03583086|454307304|FG003|Overall Study|Undergoing radiation therapy|0|||
126277638|NCT03583086|454307305|FG004|Overall Study|Undergoing radiation therapy|0|||
126277639|NCT03583086|454307306|FG005|Overall Study|Undergoing radiation therapy|0|||
126277640|NCT03583086|454307307|FG006|Overall Study|Undergoing radiation therapy|1|||
126277641|NCT03583086|454307301|FG000|Overall Study|Lost to Follow-up|0|||
126277642|NCT03583086|454307302|FG001|Overall Study|Lost to Follow-up|0|||
125881169|NCT00696072|452864548|FG000|Overall Study|Patient Request|3|||
125881170|NCT00696072|452864549|FG001|Overall Study|Patient Request|7|||
126038114|NCT02305888|453438996|FG000|Overall Study|Adverse Event|0|||
126038115|NCT02305888|453438997|FG001|Overall Study|Adverse Event|1|||
126277643|NCT03583086|454307303|FG002|Overall Study|Lost to Follow-up|0|||
126277644|NCT03583086|454307304|FG003|Overall Study|Lost to Follow-up|0|||
126277645|NCT03583086|454307305|FG004|Overall Study|Lost to Follow-up|0|||
126362891|NCT01898091|454621649|FG001|Overall Study|Lost to Follow-up|1|||
126362892|NCT01898091|454621648|FG000|Overall Study|Withdrawal by Subject|1|||
126362893|NCT01898091|454621649|FG001|Overall Study|Withdrawal by Subject|5|||
126362894|NCT01630811|454621651|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
126362895|NCT01630811|454621652|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
126362896|NCT04818086|454621653|FG000|Overall Study|Physician Decision|1|||
126362897|NCT04818086|454621654|FG001|Overall Study|Physician Decision|0|||
126362898|NCT04818086|454621653|FG000|Overall Study|Withdrawal by Subject|0|||
126362899|NCT04818086|454621654|FG001|Overall Study|Withdrawal by Subject|1|||
126362900|NCT03511209|454621658|FG000|Overall Study|Withdrawal by Subject|2|||
126362901|NCT03511209|454621659|FG001|Overall Study|Withdrawal by Subject|4|||
126362902|NCT03511209|454621658|FG000|Overall Study|Death|1|||
126362903|NCT03511209|454621659|FG001|Overall Study|Death|0|||
126362904|NCT03511209|454621658|FG000|Overall Study|Lost to Follow-up|0|||
126362905|NCT03511209|454621659|FG001|Overall Study|Lost to Follow-up|2|||
126362906|NCT01602666|454621660|FG000|Induction Chemotherapy|Death|2|||
126362907|NCT01602666|454621661|FG001|Induction Chemotherapy|Death|1|||
126362908|NCT01602666|454621660|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
126362909|NCT01602666|454621661|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
126362910|NCT01602666|454621660|FG000|Induction Chemotherapy|Physician Decision|12|||
126362911|NCT01602666|454621661|FG001|Induction Chemotherapy|Physician Decision|5|||
126362912|NCT01602666|454621660|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
126277646|NCT03583086|454307306|FG005|Overall Study|Lost to Follow-up|1|||
126277647|NCT03583086|454307307|FG006|Overall Study|Lost to Follow-up|0|||
126277648|NCT03583086|454307301|FG000|Overall Study|Adverse Event|0|||
126277649|NCT03583086|454307302|FG001|Overall Study|Adverse Event|0|||
126277650|NCT03583086|454307303|FG002|Overall Study|Adverse Event|0|||
126277651|NCT03583086|454307304|FG003|Overall Study|Adverse Event|0|||
126277652|NCT03583086|454307305|FG004|Overall Study|Adverse Event|0|||
126362913|NCT01602666|454621661|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
126362914|NCT01602666|454621660|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
126362915|NCT01602666|454621661|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
126362916|NCT01602666|454621660|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
126362917|NCT01602666|454621661|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
126362918|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
126362919|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
126362920|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
126362921|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
126362922|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
126362923|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
126362924|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
126362925|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
126362926|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
126362927|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
126362928|NCT04754399|454621664|FG000|Overall Study|Adverse Event|5|||
126277653|NCT03583086|454307306|FG005|Overall Study|Adverse Event|1|||
126277654|NCT03583086|454307307|FG006|Overall Study|Adverse Event|0|||
126277655|NCT00128830|454307309|FG000|Overall Study|Adverse Event|10|||
126277656|NCT00128830|454307309|FG000|Overall Study|Withdrawal by Subject|14|||
126277657|NCT00128830|454307309|FG000|Overall Study|Lost to Follow-up|4|||
126277658|NCT00128830|454307309|FG000|Overall Study|Reached a virologic endpoint|29|||
126277659|NCT00128830|454307309|FG000|Overall Study|Non-compliant|4|||
126277660|NCT00128830|454307309|FG000|Overall Study|Discontinued or ineligible for study|2|||
126277661|NCT00128830|454307309|FG000|Overall Study|Other|9|||
126277662|NCT03185013|454307322|FG000|Overall Study|Withdrawal by Subject|5|||
126277663|NCT03185013|454307323|FG001|Overall Study|Withdrawal by Subject|3|||
126277664|NCT03185013|454307322|FG000|Overall Study|Adverse Event|1|||
126277665|NCT03185013|454307323|FG001|Overall Study|Adverse Event|0|||
126277666|NCT03185013|454307322|FG000|Overall Study|Progressive Disease|1|||
126277667|NCT03185013|454307323|FG001|Overall Study|Progressive Disease|0|||
126277668|NCT03185013|454307322|FG000|Overall Study|Lost to Follow-up|8|||
126277669|NCT03185013|454307323|FG001|Overall Study|Lost to Follow-up|2|||
126277670|NCT03185013|454307322|FG000|Overall Study|Physician Decision|1|||
126277671|NCT03185013|454307323|FG001|Overall Study|Physician Decision|0|||
126277672|NCT03185013|454307322|FG000|Overall Study|Protocol Deviation|2|||
126277673|NCT03185013|454307323|FG001|Overall Study|Protocol Deviation|0|||
126277674|NCT03185013|454307322|FG000|Overall Study|Reason not Specified|3|||
126277675|NCT03185013|454307323|FG001|Overall Study|Reason not Specified|2|||
126277676|NCT03185013|454307322|FG000|Overall Study|Death|1|||
126277677|NCT03185013|454307323|FG001|Overall Study|Death|0|||
126277678|NCT00510289|454307327|FG000|Overall Study|Withdrawal by Subject|7|||
126277679|NCT00510289|454307327|FG000|Overall Study|Refused bone marrow biopsy|2|||
126277680|NCT00510289|454307327|FG000|Overall Study|Lost to Follow-up|1|||
126277681|NCT00510289|454307327|FG000|Overall Study|Progressed prior to starting drug|2|||
126277682|NCT00673387|454307330|FG000|Overall Study|Withdrawal by Subject|15|||
126277683|NCT00673387|454307331|FG001|Overall Study|Withdrawal by Subject|16|||
126277684|NCT00673387|454307332|FG002|Overall Study|Withdrawal by Subject|20|||
126277685|NCT00673387|454307333|FG003|Overall Study|Withdrawal by Subject|16|||
126277686|NCT00673387|454307334|FG004|Overall Study|Withdrawal by Subject|18|||
126277687|NCT00673387|454307335|FG005|Overall Study|Withdrawal by Subject|21|||
126277688|NCT00673387|454307336|FG006|Overall Study|Withdrawal by Subject|15|||
126277689|NCT00673387|454307337|FG007|Overall Study|Withdrawal by Subject|21|||
126277690|NCT00673387|454307330|FG000|Overall Study|Adverse Event|3|||
126277691|NCT00673387|454307331|FG001|Overall Study|Adverse Event|1|||
126277692|NCT00673387|454307332|FG002|Overall Study|Adverse Event|5|||
126277693|NCT00673387|454307333|FG003|Overall Study|Adverse Event|2|||
126277694|NCT00673387|454307334|FG004|Overall Study|Adverse Event|6|||
126277695|NCT00673387|454307335|FG005|Overall Study|Adverse Event|2|||
126277696|NCT00673387|454307336|FG006|Overall Study|Adverse Event|5|||
126277697|NCT00673387|454307337|FG007|Overall Study|Adverse Event|5|||
126277698|NCT00673387|454307330|FG000|Overall Study|Physician Decision|0|||
126277699|NCT00673387|454307331|FG001|Overall Study|Physician Decision|0|||
126277700|NCT00673387|454307332|FG002|Overall Study|Physician Decision|0|||
126277701|NCT00673387|454307333|FG003|Overall Study|Physician Decision|0|||
126277702|NCT00673387|454307334|FG004|Overall Study|Physician Decision|0|||
126277703|NCT00673387|454307335|FG005|Overall Study|Physician Decision|5|||
126277704|NCT00673387|454307336|FG006|Overall Study|Physician Decision|1|||
126277705|NCT00673387|454307337|FG007|Overall Study|Physician Decision|1|||
126277706|NCT00673387|454307330|FG000|Overall Study|Protocol Violation|3|||
126277707|NCT00673387|454307331|FG001|Overall Study|Protocol Violation|0|||
126277708|NCT00673387|454307332|FG002|Overall Study|Protocol Violation|1|||
126277709|NCT00673387|454307333|FG003|Overall Study|Protocol Violation|2|||
126277710|NCT00673387|454307334|FG004|Overall Study|Protocol Violation|0|||
126277711|NCT00673387|454307335|FG005|Overall Study|Protocol Violation|1|||
126277712|NCT00673387|454307336|FG006|Overall Study|Protocol Violation|1|||
126277713|NCT00673387|454307337|FG007|Overall Study|Protocol Violation|3|||
126277714|NCT00673387|454307330|FG000|Overall Study|Lost to Follow-up|8|||
126277715|NCT00673387|454307331|FG001|Overall Study|Lost to Follow-up|6|||
126277716|NCT00673387|454307332|FG002|Overall Study|Lost to Follow-up|5|||
126277717|NCT00673387|454307333|FG003|Overall Study|Lost to Follow-up|6|||
126277718|NCT00673387|454307334|FG004|Overall Study|Lost to Follow-up|6|||
126277719|NCT00673387|454307335|FG005|Overall Study|Lost to Follow-up|5|||
126277720|NCT00673387|454307336|FG006|Overall Study|Lost to Follow-up|8|||
126277721|NCT00673387|454307337|FG007|Overall Study|Lost to Follow-up|5|||
126277722|NCT00960115|454307338|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
126277723|NCT00960115|454307339|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
126277724|NCT01094886|454307340|FG000|Overall Study|Adverse Event|2|||
126038116|NCT02305888|453438998|FG002|Overall Study|Adverse Event|0|||
126038117|NCT06232590|453438999|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
126038118|NCT06232590|453439000|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
126038119|NCT04914676|453439001|FG000|Overall Study|Study termination|3|||
126038120|NCT04914676|453439002|FG001|Overall Study|Study termination|0|||
126038121|NCT05200403|453439003|FG000|Overall Study|Withdrawal by Subject|4|||
126038122|NCT05200403|453439004|FG001|Overall Study|Withdrawal by Subject|2|||
126038123|NCT05200403|453439005|FG002|Overall Study|Withdrawal by Subject|6|||
126038124|NCT05073458|453439007|FG000|24-week Double-blind Period|Adverse Event|1|||
126038125|NCT05073458|453439008|FG001|24-week Double-blind Period|Adverse Event|0|||
126038126|NCT05073458|453439007|FG000|24-week Double-blind Period|Physician Decision|1|||
126038127|NCT05073458|453439008|FG001|24-week Double-blind Period|Physician Decision|0|||
126038128|NCT05073458|453439007|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
126038129|NCT05073458|453439008|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
126038130|NCT05073458|453439007|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
126038131|NCT05073458|453439008|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
126038132|NCT05073458|453439007|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
126038133|NCT05073458|453439008|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
126038134|NCT05073458|453439007|FG000|24-week Open-label Period|Adverse Event|1|||
126038135|NCT05073458|453439008|FG001|24-week Open-label Period|Adverse Event|2|||
126038136|NCT05436262|453439009|FG000|Pre-Randomization|Withdrawal by Subject|1|||
126038137|NCT05436262|453439010|FG001|Pre-Randomization|Withdrawal by Subject|0|||
126038138|NCT05436262|453439011|FG002|Pre-Randomization|Withdrawal by Subject|0|||
126038139|NCT05436262|453439009|FG000|Randomization|Withdrawal by Subject|0|||
126038140|NCT05436262|453439010|FG001|Randomization|Withdrawal by Subject|1|||
126038141|NCT05436262|453439011|FG002|Randomization|Withdrawal by Subject|0|||
126038142|NCT05299073|453439012|FG000|Overall Study|Withdrawal by Subject|0|||
126038143|NCT05299073|453439013|FG001|Overall Study|Withdrawal by Subject|0|||
126038144|NCT05299073|453439014|FG002|Overall Study|Withdrawal by Subject|1|||
126038145|NCT05299073|453439012|FG000|Overall Study|Adverse Event|0|||
126277725|NCT01094886|454307340|FG000|Overall Study|Withdrawal by Subject|5|||
126277726|NCT00574912|454307341|FG000|Overall Study|Could not place IV lines.|3|||
126277727|NCT00574912|454307341|FG000|Overall Study|scheduling conflicts|3|||
126277728|NCT00574912|454307341|FG000|Overall Study|Physician Decision|2|||
126277729|NCT04730349|454307343|FG000|Overall Study|Participant withdrew consent|1|||
126277730|NCT04730349|454307344|FG001|Overall Study|Participant withdrew consent|0|||
126277731|NCT04730349|454307343|FG000|Overall Study|Disease progression|6|||
126277732|NCT04730349|454307344|FG001|Overall Study|Disease progression|4|||
126277733|NCT04730349|454307343|FG000|Overall Study|Study drug toxicity|0|||
126277734|NCT04730349|454307344|FG001|Overall Study|Study drug toxicity|1|||
126277735|NCT02377427|454307348|FG000|Part A (Up to Week 20)|Physician Decision|1|||
126277736|NCT02377427|454307349|FG001|Part A (Up to Week 20)|Physician Decision|0|||
126277737|NCT02377427|454307350|FG002|Part A (Up to Week 20)|Physician Decision|0|||
126277738|NCT02377427|454307351|FG003|Part A (Up to Week 20)|Physician Decision|0|||
126277739|NCT02377427|454307352|FG004|Part A (Up to Week 20)|Physician Decision|0|||
126277740|NCT02377427|454307348|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
126277741|NCT02377427|454307349|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
126277742|NCT02377427|454307350|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
126277743|NCT02377427|454307351|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
126277744|NCT02377427|454307352|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125881171|NCT00696072|452864548|FG000|Overall Study|Investigator Request|1|||
126038146|NCT05299073|453439013|FG001|Overall Study|Adverse Event|1|||
126038147|NCT05299073|453439014|FG002|Overall Study|Adverse Event|0|||
126038148|NCT05299073|453439012|FG000|Overall Study|Lost to Follow-up|0|||
126038149|NCT05299073|453439013|FG001|Overall Study|Lost to Follow-up|1|||
126038150|NCT05299073|453439014|FG002|Overall Study|Lost to Follow-up|0|||
126038151|NCT03952338|453439015|FG000|Overall Study|Lost to Follow-up|11|||
126038152|NCT03952338|453439016|FG001|Overall Study|Lost to Follow-up|17|||
126038153|NCT03952338|453439015|FG000|Overall Study|Withdrawal by Subject|1|||
126038154|NCT03952338|453439016|FG001|Overall Study|Withdrawal by Subject|1|||
126038155|NCT03952338|453439015|FG000|Overall Study|Protocol Violation|1|||
126038156|NCT03952338|453439016|FG001|Overall Study|Protocol Violation|0|||
126277745|NCT02377427|454307348|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
126277746|NCT02377427|454307349|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
126277747|NCT02377427|454307350|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
126277748|NCT02377427|454307351|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
126277749|NCT02377427|454307352|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
126277750|NCT02377427|454307348|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
126277751|NCT02377427|454307349|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
126277752|NCT02377427|454307350|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
126277753|NCT02377427|454307351|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
126277754|NCT02377427|454307352|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
126277755|NCT02342639|454307353|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
126277756|NCT02342639|454307354|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
126277757|NCT02342639|454307353|FG000|Overall Study|Protocol Violation|0|||
126277758|NCT02342639|454307354|FG001|Overall Study|Protocol Violation|2|||
126277759|NCT02212379|454307355|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
126277760|NCT02212379|454307355|FG000|From Baseline to Week 48|Adverse Event|7|||
126277761|NCT02212379|454307355|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
126306227|NCT01940887|454410251|FG001|Year 1|Physician Decision|3|||
126306228|NCT01940887|454410250|FG000|Year 1|Death|5|||
126306229|NCT01940887|454410251|FG001|Year 1|Death|3|||
126306230|NCT01940887|454410250|FG000|Year 1|Adverse Event|7|||
126306231|NCT01940887|454410251|FG001|Year 1|Adverse Event|6|||
126306232|NCT01940887|454410250|FG000|Year 1|Withdrawal by Subject|18|||
126306233|NCT01940887|454410251|FG001|Year 1|Withdrawal by Subject|9|||
126306234|NCT01940887|454410250|FG000|Year 1|Lost to Follow-up|2|||
126306235|NCT01940887|454410251|FG001|Year 1|Lost to Follow-up|1|||
126306236|NCT01940887|454410250|FG000|Year 2|Physician Decision|8|||
126306237|NCT01940887|454410251|FG001|Year 2|Physician Decision|1|||
126306238|NCT01940887|454410250|FG000|Year 2|Death|0|||
126306239|NCT01940887|454410251|FG001|Year 2|Death|2|||
126306240|NCT01940887|454410250|FG000|Year 2|Sponsor Decision, early termination|192|||
126306241|NCT01940887|454410251|FG001|Year 2|Sponsor Decision, early termination|203|||
126306242|NCT01940887|454410250|FG000|Year 2|Adverse Event|8|||
126306243|NCT01940887|454410251|FG001|Year 2|Adverse Event|2|||
126306244|NCT01940887|454410250|FG000|Year 2|Withdrawal by Subject|8|||
126306245|NCT01940887|454410251|FG001|Year 2|Withdrawal by Subject|8|||
126306246|NCT01940887|454410250|FG000|Year 2|Lost to Follow-up|1|||
126306247|NCT01940887|454410251|FG001|Year 2|Lost to Follow-up|6|||
126306248|NCT02475265|454410254|FG000|Overall Study|Physician Decision|1|||
126306249|NCT02475265|454410254|FG000|Overall Study|Withdrawal by Subject|2|||
126306250|NCT04590586|454410257|FG000|Overall Study|Death|7|||
126306251|NCT04590586|454410258|FG001|Overall Study|Death|1|||
126306252|NCT04590586|454410259|FG002|Overall Study|Death|37|||
126306253|NCT04590586|454410260|FG003|Overall Study|Death|34|||
126306254|NCT04590586|454410261|FG004|Overall Study|Death|19|||
126306255|NCT04590586|454410262|FG005|Overall Study|Death|3|||
126306256|NCT04590586|454410257|FG000|Overall Study|Lost to Follow-up|3|||
126306257|NCT04590586|454410258|FG001|Overall Study|Lost to Follow-up|0|||
126306258|NCT04590586|454410259|FG002|Overall Study|Lost to Follow-up|11|||
126306259|NCT04590586|454410260|FG003|Overall Study|Lost to Follow-up|11|||
126306260|NCT04590586|454410261|FG004|Overall Study|Lost to Follow-up|6|||
126306261|NCT04590586|454410262|FG005|Overall Study|Lost to Follow-up|0|||
126306262|NCT04590586|454410257|FG000|Overall Study|Withdrawal by Subject|0|||
126306263|NCT04590586|454410258|FG001|Overall Study|Withdrawal by Subject|0|||
126306264|NCT04590586|454410259|FG002|Overall Study|Withdrawal by Subject|6|||
126306265|NCT04590586|454410260|FG003|Overall Study|Withdrawal by Subject|0|||
126306266|NCT04590586|454410261|FG004|Overall Study|Withdrawal by Subject|3|||
126306267|NCT04590586|454410262|FG005|Overall Study|Withdrawal by Subject|0|||
126306268|NCT04590586|454410257|FG000|Overall Study|Other|3|||
126306269|NCT04590586|454410258|FG001|Overall Study|Other|0|||
126306270|NCT04590586|454410259|FG002|Overall Study|Other|1|||
126306271|NCT04590586|454410260|FG003|Overall Study|Other|1|||
126306272|NCT04590586|454410261|FG004|Overall Study|Other|2|||
126306273|NCT04590586|454410262|FG005|Overall Study|Other|1|||
126306274|NCT03063086|454410264|FG000|Overall Study|technical problems|1|||
126306275|NCT03063086|454410265|FG001|Overall Study|technical problems|0|||
126306276|NCT03063086|454410266|FG002|Overall Study|technical problems|0|||
126306277|NCT03063086|454410267|FG003|Overall Study|technical problems|0|||
126306278|NCT03063086|454410268|FG004|Overall Study|technical problems|0|||
126306279|NCT03063086|454410269|FG005|Overall Study|technical problems|0|||
126306280|NCT03063086|454410264|FG000|Overall Study|Adverse Event|1|||
126306281|NCT03063086|454410265|FG001|Overall Study|Adverse Event|1|||
126306282|NCT03063086|454410266|FG002|Overall Study|Adverse Event|1|||
126306283|NCT03063086|454410267|FG003|Overall Study|Adverse Event|1|||
126306284|NCT03063086|454410268|FG004|Overall Study|Adverse Event|0|||
126306285|NCT03063086|454410269|FG005|Overall Study|Adverse Event|0|||
126306286|NCT03063086|454410264|FG000|Overall Study|subject/guardian decision|1|||
126306287|NCT03063086|454410265|FG001|Overall Study|subject/guardian decision|0|||
126277762|NCT02212379|454307355|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
126277763|NCT02212379|454307355|FG000|From Week 48 to Week 96|Adverse Event|1|||
126277764|NCT02212379|454307355|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
126277765|NCT02105974|454307356|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
126277766|NCT02105974|454307357|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
126277767|NCT02105974|454307358|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
126277768|NCT02105974|454307356|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
126277769|NCT02105974|454307357|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
126277770|NCT02105974|454307358|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
126277771|NCT02105974|454307356|FG000|2 Week Run-in Period|Adverse Event|6|||
126277772|NCT02105974|454307357|FG001|2 Week Run-in Period|Adverse Event|0|||
126277773|NCT02105974|454307358|FG002|2 Week Run-in Period|Adverse Event|0|||
126277774|NCT02105974|454307356|FG000|2 Week Run-in Period|Study closed/terminated|1|||
126277775|NCT02105974|454307357|FG001|2 Week Run-in Period|Study closed/terminated|0|||
126277776|NCT02105974|454307358|FG002|2 Week Run-in Period|Study closed/terminated|0|||
126277777|NCT02105974|454307356|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
126277778|NCT02105974|454307357|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
126277779|NCT02105974|454307358|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
126277780|NCT02105974|454307356|FG000|2 Week Run-in Period|Withdrew consent|23|||
126277781|NCT02105974|454307357|FG001|2 Week Run-in Period|Withdrew consent|0|||
126277782|NCT02105974|454307358|FG002|2 Week Run-in Period|Withdrew consent|0|||
126277783|NCT02105974|454307356|FG000|2 Week Run-in Period|Investigator discretion|8|||
126277784|NCT02105974|454307357|FG001|2 Week Run-in Period|Investigator discretion|0|||
126277785|NCT02105974|454307358|FG002|2 Week Run-in Period|Investigator discretion|0|||
126277786|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
126277787|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
126277788|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
126277789|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
126277790|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
126277791|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
126277792|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
126277793|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
126277794|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
126277795|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
126277796|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
126277797|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
126277798|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
126277799|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
126277800|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
126277801|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
126277802|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
126277803|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
126277804|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
126277805|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
126277806|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
126277807|NCT03155945|454307359|FG000|Overall Study|Lost to Follow-up|0|||
125881172|NCT00696072|452864549|FG001|Overall Study|Investigator Request|4|||
125881173|NCT00696072|452864548|FG000|Overall Study|Sponsor Request|0|||
125881174|NCT00696072|452864549|FG001|Overall Study|Sponsor Request|1|||
125881175|NCT00696072|452864548|FG000|Overall Study|Disease Progression|32|||
126277808|NCT03155945|454307360|FG001|Overall Study|Lost to Follow-up|1|||
126277809|NCT03155945|454307359|FG000|Overall Study|Withdrawal by Subject|0|||
125881176|NCT00696072|452864549|FG001|Overall Study|Disease Progression|30|||
126277810|NCT03155945|454307360|FG001|Overall Study|Withdrawal by Subject|1|||
126277811|NCT03155945|454307359|FG000|Overall Study|Other Reason|0|||
126277812|NCT03155945|454307360|FG001|Overall Study|Other Reason|1|||
126277813|NCT02013674|454307363|FG000|Overall Study|Death|0|||
126277814|NCT02013674|454307364|FG001|Overall Study|Death|1|||
126277815|NCT02013674|454307363|FG000|Overall Study|Lost to Follow-up|1|||
126277816|NCT02013674|454307364|FG001|Overall Study|Lost to Follow-up|0|||
126277817|NCT00416884|454307366|FG000|Overall Study|Study terminated due to low accrual|1|||
126277818|NCT02203331|454307367|FG000|Overall Study|Pregnancy|1|||
126277819|NCT02203331|454307368|FG001|Overall Study|Pregnancy|0|||
126277820|NCT02203331|454307369|FG002|Overall Study|Pregnancy|0|||
126277821|NCT02203331|454307370|FG003|Overall Study|Pregnancy|0|||
126277822|NCT02203331|454307371|FG004|Overall Study|Pregnancy|2|||
126277823|NCT02203331|454307372|FG005|Overall Study|Pregnancy|0|||
126277824|NCT02203331|454307367|FG000|Overall Study|Withdrawal by Subject|1|||
126277825|NCT02203331|454307368|FG001|Overall Study|Withdrawal by Subject|0|||
126277826|NCT02203331|454307369|FG002|Overall Study|Withdrawal by Subject|1|||
126277827|NCT02203331|454307370|FG003|Overall Study|Withdrawal by Subject|0|||
126277828|NCT02203331|454307371|FG004|Overall Study|Withdrawal by Subject|0|||
126277829|NCT02203331|454307372|FG005|Overall Study|Withdrawal by Subject|3|||
126277830|NCT02203331|454307367|FG000|Overall Study|Adverse Event|4|||
126277831|NCT02203331|454307368|FG001|Overall Study|Adverse Event|8|||
126277832|NCT02203331|454307369|FG002|Overall Study|Adverse Event|3|||
126277833|NCT02203331|454307370|FG003|Overall Study|Adverse Event|4|||
126277834|NCT02203331|454307371|FG004|Overall Study|Adverse Event|3|||
126277835|NCT02203331|454307372|FG005|Overall Study|Adverse Event|3|||
126277836|NCT02203331|454307367|FG000|Overall Study|Other Reasons|1|||
126277837|NCT02203331|454307368|FG001|Overall Study|Other Reasons|2|||
126277838|NCT02203331|454307369|FG002|Overall Study|Other Reasons|0|||
126277839|NCT02203331|454307370|FG003|Overall Study|Other Reasons|2|||
126277840|NCT02203331|454307371|FG004|Overall Study|Other Reasons|0|||
126277841|NCT02203331|454307372|FG005|Overall Study|Other Reasons|0|||
126277842|NCT02203331|454307367|FG000|Overall Study|Lack of Efficacy|0|||
126277843|NCT02203331|454307368|FG001|Overall Study|Lack of Efficacy|2|||
126277844|NCT02203331|454307369|FG002|Overall Study|Lack of Efficacy|1|||
126277845|NCT02203331|454307370|FG003|Overall Study|Lack of Efficacy|0|||
126277846|NCT02203331|454307371|FG004|Overall Study|Lack of Efficacy|0|||
126277847|NCT02203331|454307372|FG005|Overall Study|Lack of Efficacy|1|||
126277848|NCT02203331|454307367|FG000|Overall Study|Protocol Violation|0|||
126277849|NCT02203331|454307368|FG001|Overall Study|Protocol Violation|2|||
126277850|NCT02203331|454307369|FG002|Overall Study|Protocol Violation|0|||
126277851|NCT02203331|454307370|FG003|Overall Study|Protocol Violation|1|||
126277852|NCT02203331|454307371|FG004|Overall Study|Protocol Violation|1|||
126277853|NCT02203331|454307372|FG005|Overall Study|Protocol Violation|0|||
126362929|NCT04754399|454621664|FG000|Overall Study|Withdrawal by Subject|6|||
126362930|NCT00231465|454621665|FG000|Overall Study|Completed only one cycle|1|||
126362931|NCT00231465|454621665|FG000|Overall Study|Did not have follow up CT scans|1|||
126362932|NCT00025233|454621666|FG000|Overall Study|Ineligible: wrong cell type|1|||
126362933|NCT00025233|454621666|FG000|Overall Study|Ineligible: wrong primary|1|||
126362934|NCT00025233|454621666|FG000|Overall Study|Ineligible: improper prior treatment|1|||
126362935|NCT00025233|454621666|FG000|Overall Study|Never treated|1|||
126362936|NCT00930176|454621668|FG000|Overall Study|Death|1|||
126362937|NCT00401830|454621672|FG000|Overall Study|Adverse Event|10|||
126362938|NCT00401830|454621673|FG001|Overall Study|Adverse Event|18|||
126362939|NCT00401830|454621672|FG000|Overall Study|Lack of Efficacy|11|||
126362940|NCT00401830|454621673|FG001|Overall Study|Lack of Efficacy|5|||
126362941|NCT00401830|454621672|FG000|Overall Study|Withdrawal by Subject|4|||
126362942|NCT00401830|454621673|FG001|Overall Study|Withdrawal by Subject|3|||
126362943|NCT00401830|454621672|FG000|Overall Study|Protocol Violation|3|||
126362944|NCT00401830|454621673|FG001|Overall Study|Protocol Violation|3|||
126362945|NCT00401830|454621672|FG000|Overall Study|Non-compliance with drug study|1|||
126362946|NCT00401830|454621673|FG001|Overall Study|Non-compliance with drug study|0|||
126362947|NCT00401830|454621672|FG000|Overall Study|Lost to Follow-up|1|||
126362948|NCT00401830|454621673|FG001|Overall Study|Lost to Follow-up|3|||
126362949|NCT00401830|454621672|FG000|Overall Study|Other: Personal / Family problems|1|||
126362950|NCT00401830|454621673|FG001|Overall Study|Other: Personal / Family problems|0|||
126362951|NCT00452400|454621674|FG000|Overall Study|Adverse Event|1|||
126362952|NCT00452400|454621675|FG001|Overall Study|Adverse Event|1|||
126362953|NCT00452400|454621676|FG002|Overall Study|Adverse Event|5|||
126277854|NCT02203331|454307367|FG000|Overall Study|Lost to Follow-up|0|||
126362954|NCT00452400|454621677|FG003|Overall Study|Adverse Event|0|||
126362955|NCT00452400|454621678|FG004|Overall Study|Adverse Event|2|||
126362956|NCT00452400|454621674|FG000|Overall Study|Protocol Violation|0|||
126277855|NCT02203331|454307368|FG001|Overall Study|Lost to Follow-up|0|||
126277856|NCT02203331|454307369|FG002|Overall Study|Lost to Follow-up|0|||
126277857|NCT02203331|454307370|FG003|Overall Study|Lost to Follow-up|0|||
126277858|NCT02203331|454307371|FG004|Overall Study|Lost to Follow-up|1|||
126277859|NCT02203331|454307372|FG005|Overall Study|Lost to Follow-up|0|||
126362957|NCT00452400|454621675|FG001|Overall Study|Protocol Violation|0|||
126038157|NCT04850898|453439017|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
126038158|NCT04850898|453439018|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
126038159|NCT05002088|453439019|FG000|Overall Study|Withdrawal by Subject|9|||
126038160|NCT05002088|453439020|FG001|Overall Study|Withdrawal by Subject|0|||
126038161|NCT05002088|453439019|FG000|Overall Study|Lost to Follow-up|0|||
126038162|NCT05002088|453439020|FG001|Overall Study|Lost to Follow-up|1|||
126038163|NCT05002088|453439019|FG000|Overall Study|Death|16|||
126038164|NCT05002088|453439020|FG001|Overall Study|Death|2|||
126038165|NCT05002088|453439019|FG000|Overall Study|Protocol Violation|25|||
126038166|NCT05002088|453439020|FG001|Overall Study|Protocol Violation|7|||
126038167|NCT04068181|453439021|FG000|Overall Study|Death|17|||
126038168|NCT04068181|453439022|FG001|Overall Study|Death|12|||
126038169|NCT04068181|453439023|FG002|Overall Study|Death|4|||
126038170|NCT04068181|453439024|FG003|Overall Study|Death|7|||
126038171|NCT04068181|453439021|FG000|Overall Study|Lost to Follow-up|1|||
126038172|NCT04068181|453439022|FG001|Overall Study|Lost to Follow-up|0|||
126038173|NCT04068181|453439023|FG002|Overall Study|Lost to Follow-up|0|||
126038174|NCT04068181|453439024|FG003|Overall Study|Lost to Follow-up|0|||
126038175|NCT04068181|453439021|FG000|Overall Study|Withdrawal of consent from study|3|||
126038176|NCT04068181|453439022|FG001|Overall Study|Withdrawal of consent from study|0|||
126038177|NCT04068181|453439023|FG002|Overall Study|Withdrawal of consent from study|0|||
126038178|NCT04068181|453439024|FG003|Overall Study|Withdrawal of consent from study|0|||
126038179|NCT05070728|453439025|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
126038180|NCT05070728|453439026|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
126038181|NCT04770402|453439033|FG000|Overall Study|Lost to Follow-up|1|||
126038182|NCT04770402|453439034|FG001|Overall Study|Lost to Follow-up|2|||
126038183|NCT04770402|453439033|FG000|Overall Study|Non-compliance|1|||
126038184|NCT04770402|453439034|FG001|Overall Study|Non-compliance|0|||
126038185|NCT04770402|453439033|FG000|Overall Study|Withdrawal by Subject|0|||
126038186|NCT04770402|453439034|FG001|Overall Study|Withdrawal by Subject|1|||
126038187|NCT04550221|453439036|FG000|Overall Study|Lost to Follow-up|0|||
126038188|NCT04550221|453439037|FG001|Overall Study|Lost to Follow-up|4|||
126038189|NCT04550221|453439036|FG000|Overall Study|Withdrawn|3|||
126038190|NCT04550221|453439037|FG001|Overall Study|Withdrawn|0|||
126038191|NCT04550221|453439036|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
126038192|NCT04550221|453439037|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
126038193|NCT05274074|453439038|FG000|Overall Study|Lost to Follow-up|2|||
126038194|NCT05274074|453439039|FG001|Overall Study|Lost to Follow-up|3|||
126038195|NCT05274074|453439038|FG000|Overall Study|Withdrawal by Subject|1|||
126038196|NCT05274074|453439039|FG001|Overall Study|Withdrawal by Subject|2|||
126038197|NCT04811040|453439040|FG000|Overall Study|Lost to Follow-up|2|||
126038198|NCT04811040|453439041|FG001|Overall Study|Lost to Follow-up|0|||
126038199|NCT04811040|453439042|FG002|Overall Study|Lost to Follow-up|0|||
126038200|NCT04811040|453439043|FG003|Overall Study|Lost to Follow-up|0|||
126038201|NCT04811040|453439040|FG000|Overall Study|Withdrew consent|1|||
126038202|NCT04811040|453439041|FG001|Overall Study|Withdrew consent|1|||
126038203|NCT04811040|453439042|FG002|Overall Study|Withdrew consent|0|||
126038204|NCT04811040|453439043|FG003|Overall Study|Withdrew consent|0|||
126038205|NCT01828099|453439044|FG000|Treatment Period|Adverse Event|24|||
126098688|NCT02595073|453653090|FG000|Overall Study|Progressive Disease|0|||
126277860|NCT04051619|454307379|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
126277861|NCT04051619|454307380|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
126277862|NCT04051619|454307379|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
126277863|NCT04051619|454307380|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
126277864|NCT03610516|454309050|FG000|Treatment Epoch|Adverse Event|3|||
126277865|NCT03610516|454309051|FG001|Treatment Epoch|Adverse Event|1|||
126277866|NCT03610516|454309050|FG000|Treatment Epoch|Death|1|||
126277867|NCT03610516|454309051|FG001|Treatment Epoch|Death|0|||
126277868|NCT03610516|454309050|FG000|Treatment Epoch|Lack of Efficacy|0|||
126277869|NCT03610516|454309051|FG001|Treatment Epoch|Lack of Efficacy|1|||
126277870|NCT03610516|454309050|FG000|Treatment Epoch|No longer requires treatment|1|||
126098689|NCT02595073|453653091|FG001|Overall Study|Progressive Disease|1|||
126277871|NCT03610516|454309051|FG001|Treatment Epoch|No longer requires treatment|0|||
126277872|NCT03610516|454309050|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
126038206|NCT01828099|453439045|FG001|Treatment Period|Adverse Event|23|||
126038207|NCT01828099|453439044|FG000|Treatment Period|Death|10|||
126038208|NCT01828099|453439045|FG001|Treatment Period|Death|12|||
126038209|NCT01828099|453439044|FG000|Treatment Period|Lost to Follow-up|2|||
126038210|NCT01828099|453439045|FG001|Treatment Period|Lost to Follow-up|1|||
126038211|NCT01828099|453439044|FG000|Treatment Period|Non-compliance with study treatment|1|||
126038212|NCT01828099|453439045|FG001|Treatment Period|Non-compliance with study treatment|0|||
126038213|NCT01828099|453439044|FG000|Treatment Period|Physician Decision|17|||
126038214|NCT01828099|453439045|FG001|Treatment Period|Physician Decision|16|||
126038215|NCT01828099|453439044|FG000|Treatment Period|Progressive disease|99|||
126098690|NCT02595073|453653090|FG000|Overall Study|Protocol Violation|2|||
126038216|NCT01828099|453439045|FG001|Treatment Period|Progressive disease|107|||
126038217|NCT01828099|453439044|FG000|Treatment Period|Subject/guardian decision|22|||
126038218|NCT01828099|453439045|FG001|Treatment Period|Subject/guardian decision|26|||
126038219|NCT01828099|453439044|FG000|Treatment Period|Study terminated by Sponsor|13|||
126038220|NCT01828099|453439045|FG001|Treatment Period|Study terminated by Sponsor|1|||
126038221|NCT01828099|453439044|FG000|Treatment Period|Protocol deviation|1|||
126038222|NCT01828099|453439045|FG001|Treatment Period|Protocol deviation|0|||
126277873|NCT03610516|454309051|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
126277874|NCT03610516|454309050|FG000|Treatment Epoch|Physician Decision|8|||
126277875|NCT03610516|454309051|FG001|Treatment Epoch|Physician Decision|5|||
126277876|NCT03610516|454309050|FG000|Treatment Epoch|Protocol Deviation|1|||
126277877|NCT03610516|454309051|FG001|Treatment Epoch|Protocol Deviation|0|||
126277878|NCT03610516|454309050|FG000|Treatment Epoch|Withdrawal by Subject|3|||
126277879|NCT03610516|454309051|FG001|Treatment Epoch|Withdrawal by Subject|1|||
126277880|NCT03610516|454309050|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
126277881|NCT03610516|454309051|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
126277882|NCT03610516|454309050|FG000|Post-Treatment Follow-up|Death|1|||
126277883|NCT03610516|454309051|FG001|Post-Treatment Follow-up|Death|0|||
126277884|NCT00660907|454309055|FG000|Overall Study|Incorrect Enrollment|1|||
126277885|NCT00660907|454309056|FG001|Overall Study|Incorrect Enrollment|1|||
126277886|NCT00660907|454309055|FG000|Overall Study|Adverse Event|33|||
126277887|NCT00660907|454309056|FG001|Overall Study|Adverse Event|19|||
126362958|NCT00452400|454621676|FG002|Overall Study|Protocol Violation|1|||
126038223|NCT01828099|453439044|FG000|Treatment Period|No longer requires treatment|0|||
126038224|NCT01828099|453439045|FG001|Treatment Period|No longer requires treatment|1|||
126038225|NCT01828099|453439044|FG000|Extension-treatment Phase|Adverse Event|0|||
126277888|NCT00660907|454309055|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
126277889|NCT00660907|454309056|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
126277890|NCT00660907|454309055|FG000|Overall Study|Withdrawal by Subject|23|||
126362959|NCT00452400|454621677|FG003|Overall Study|Protocol Violation|0|||
126362960|NCT00452400|454621678|FG004|Overall Study|Protocol Violation|0|||
126362961|NCT00452400|454621674|FG000|Overall Study|Lost to Follow-up|1|||
126362962|NCT00452400|454621675|FG001|Overall Study|Lost to Follow-up|0|||
126362963|NCT00452400|454621676|FG002|Overall Study|Lost to Follow-up|0|||
126362964|NCT00452400|454621677|FG003|Overall Study|Lost to Follow-up|0|||
126362965|NCT00452400|454621678|FG004|Overall Study|Lost to Follow-up|0|||
126362966|NCT00452400|454621674|FG000|Overall Study|Withdrawal by Subject|1|||
126362967|NCT00452400|454621675|FG001|Overall Study|Withdrawal by Subject|0|||
126362968|NCT00452400|454621676|FG002|Overall Study|Withdrawal by Subject|1|||
126362969|NCT00452400|454621677|FG003|Overall Study|Withdrawal by Subject|0|||
126362970|NCT00452400|454621678|FG004|Overall Study|Withdrawal by Subject|0|||
126362971|NCT00452400|454621674|FG000|Overall Study|Lack of Efficacy|2|||
126362972|NCT00452400|454621675|FG001|Overall Study|Lack of Efficacy|0|||
126362973|NCT00452400|454621676|FG002|Overall Study|Lack of Efficacy|0|||
126362974|NCT00452400|454621677|FG003|Overall Study|Lack of Efficacy|0|||
126362975|NCT00452400|454621678|FG004|Overall Study|Lack of Efficacy|0|||
126362976|NCT00452400|454621674|FG000|Overall Study|Other reasons not listed above|0|||
126362977|NCT00452400|454621675|FG001|Overall Study|Other reasons not listed above|0|||
126362978|NCT00452400|454621676|FG002|Overall Study|Other reasons not listed above|0|||
126362979|NCT00452400|454621677|FG003|Overall Study|Other reasons not listed above|1|||
126362980|NCT00452400|454621678|FG004|Overall Study|Other reasons not listed above|1|||
126362981|NCT01943825|454621679|FG000|Overall Study|Lost to Follow-up|9|||
126362982|NCT01943825|454621680|FG001|Overall Study|Lost to Follow-up|3|||
126362983|NCT01943825|454621681|FG002|Overall Study|Lost to Follow-up|12|||
126362984|NCT01943825|454621682|FG003|Overall Study|Lost to Follow-up|8|||
126362985|NCT01943825|454621679|FG000|Overall Study|Withdrawal by Subject|1|||
126362986|NCT01943825|454621680|FG001|Overall Study|Withdrawal by Subject|0|||
126362987|NCT01943825|454621681|FG002|Overall Study|Withdrawal by Subject|3|||
126362988|NCT01943825|454621682|FG003|Overall Study|Withdrawal by Subject|2|||
126362989|NCT01943825|454621679|FG000|Overall Study|Other than specified above|0|||
126362990|NCT01943825|454621680|FG001|Overall Study|Other than specified above|1|||
126362991|NCT01943825|454621681|FG002|Overall Study|Other than specified above|0|||
126362992|NCT01943825|454621682|FG003|Overall Study|Other than specified above|1|||
126362993|NCT01720602|454621683|FG000|Overall Study|Adverse Event|3|||
126362994|NCT01720602|454621683|FG000|Overall Study|Progressive disease on therapy|2|||
126362995|NCT03378635|454621685|FG000|Overall Study|Adverse Event|1|||
126362996|NCT03378635|454621686|FG001|Overall Study|Adverse Event|0|||
126362997|NCT03378635|454621687|FG002|Overall Study|Adverse Event|0|||
126038226|NCT01828099|453439045|FG001|Extension-treatment Phase|Adverse Event|17|||
126038227|NCT01828099|453439044|FG000|Extension-treatment Phase|Death|0|||
126277891|NCT00660907|454309056|FG001|Overall Study|Withdrawal by Subject|32|||
126362998|NCT03378635|454621685|FG000|Overall Study|Withdrawal by Subject|1|||
126362999|NCT03378635|454621686|FG001|Overall Study|Withdrawal by Subject|0|||
126363000|NCT03378635|454621687|FG002|Overall Study|Withdrawal by Subject|0|||
126363001|NCT03425188|454621689|FG000|Overall Study|Withdrawal by Subject|1|||
126363002|NCT00562861|454621692|FG000|Overall Study|Adverse Event|1|||
126277892|NCT00660907|454309055|FG000|Overall Study|Lost to Follow-up|3|||
126277893|NCT00660907|454309056|FG001|Overall Study|Lost to Follow-up|3|||
126277894|NCT00660907|454309055|FG000|Overall Study|Poor/Non-Compliance|5|||
126277895|NCT00660907|454309056|FG001|Overall Study|Poor/Non-Compliance|1|||
126277896|NCT00660907|454309055|FG000|Overall Study|Safety|1|||
126277897|NCT00660907|454309056|FG001|Overall Study|Safety|0|||
126277898|NCT00660907|454309055|FG000|Overall Study|Death|1|||
126277899|NCT00660907|454309056|FG001|Overall Study|Death|3|||
126277900|NCT00660907|454309055|FG000|Overall Study|Various|11|||
126277901|NCT00660907|454309056|FG001|Overall Study|Various|8|||
125881177|NCT00696072|452864548|FG000|Overall Study|Non-specified|1|||
125881178|NCT00696072|452864549|FG001|Overall Study|Non-specified|2|||
125881179|NCT01597596|452864550|FG000|Overall Study|Study terminated by sponsor|1|||
125881180|NCT01597596|452864551|FG001|Overall Study|Study terminated by sponsor|0|||
125881181|NCT01597596|452864550|FG000|Overall Study|Physician Decision|0|||
125881182|NCT01597596|452864551|FG001|Overall Study|Physician Decision|1|||
125881183|NCT02141295|452864572|FG000|Overall Study|Adverse Event|1|||
125881184|NCT02141295|452864573|FG001|Overall Study|Adverse Event|18|||
125881185|NCT02141295|452864574|FG002|Overall Study|Adverse Event|11|||
125881186|NCT02141295|452864572|FG000|Overall Study|Physician Decision|2|||
125881187|NCT02141295|452864573|FG001|Overall Study|Physician Decision|19|||
125881188|NCT02141295|452864574|FG002|Overall Study|Physician Decision|14|||
125881189|NCT02141295|452864572|FG000|Overall Study|Study terminated by sponsor|0|||
125881190|NCT02141295|452864573|FG001|Overall Study|Study terminated by sponsor|6|||
125881191|NCT02141295|452864574|FG002|Overall Study|Study terminated by sponsor|6|||
125881192|NCT02141295|452864572|FG000|Overall Study|Non-compliance|0|||
125881193|NCT02141295|452864573|FG001|Overall Study|Non-compliance|1|||
125881194|NCT02141295|452864574|FG002|Overall Study|Non-compliance|0|||
125881195|NCT02141295|452864572|FG000|Overall Study|Progressive disease|3|||
125881196|NCT02141295|452864573|FG001|Overall Study|Progressive disease|32|||
125881197|NCT02141295|452864574|FG002|Overall Study|Progressive disease|50|||
125881198|NCT02141295|452864572|FG000|Overall Study|Reason not specified|0|||
125881199|NCT02141295|452864573|FG001|Overall Study|Reason not specified|9|||
125881200|NCT02141295|452864574|FG002|Overall Study|Reason not specified|10|||
125881201|NCT02141295|452864572|FG000|Overall Study|Withdrawal by Subject|0|||
125881202|NCT02141295|452864573|FG001|Overall Study|Withdrawal by Subject|9|||
125881203|NCT02141295|452864574|FG002|Overall Study|Withdrawal by Subject|4|||
125881204|NCT01710501|452864575|FG000|Overall Study|Lost to Follow-up|2|||
125881205|NCT01710501|452864576|FG001|Overall Study|Lost to Follow-up|0|||
125881206|NCT01710501|452864577|FG002|Overall Study|Lost to Follow-up|0|||
125881207|NCT02536976|452864578|FG000|Overall Study|Physician Decision|0|||
125881208|NCT02536976|452864579|FG001|Overall Study|Physician Decision|1|||
125881209|NCT01671319|452864582|FG000|Overall Study|Withdrawal by Subject|1|||
125881210|NCT01709084|452864583|FG000|Overall Study|Lost to Follow-up|4|||
125881211|NCT01709084|452864584|FG001|Overall Study|Lost to Follow-up|7|||
125881212|NCT01709084|452864583|FG000|Overall Study|Withdrawal by Subject|2|||
125881213|NCT01709084|452864584|FG001|Overall Study|Withdrawal by Subject|2|||
125881214|NCT01709084|452864583|FG000|Overall Study|Adverse Event|5|||
125881215|NCT01709084|452864584|FG001|Overall Study|Adverse Event|0|||
125881216|NCT01709084|452864583|FG000|Overall Study|Other|5|||
125881217|NCT01709084|452864584|FG001|Overall Study|Other|3|||
125881218|NCT01709084|452864583|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
125881219|NCT01709084|452864584|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
125881220|NCT01709084|452864583|FG000|Overall Study|Not Treated|0|||
125881221|NCT01709084|452864584|FG001|Overall Study|Not Treated|2|||
125881222|NCT02144610|452864585|FG000|Overall Study|Physician Decision|1|||
125881223|NCT02144610|452864586|FG001|Overall Study|Physician Decision|0|||
125881224|NCT02144610|452864585|FG000|Overall Study|Withdrawal by Subject|1|||
125881225|NCT02144610|452864586|FG001|Overall Study|Withdrawal by Subject|5|||
125881226|NCT02144610|452864585|FG000|Overall Study|Death|2|||
125881227|NCT02144610|452864586|FG001|Overall Study|Death|2|||
125881228|NCT02144610|452864585|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
125881229|NCT02144610|452864586|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
125881230|NCT02144610|452864585|FG000|Overall Study|Other|0|||
125881231|NCT02144610|452864586|FG001|Overall Study|Other|1|||
125881232|NCT01054885|452864587|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
125881233|NCT01054885|452864588|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125881234|NCT01054885|452864589|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125881235|NCT01054885|452864590|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125881236|NCT01054885|452864591|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125881237|NCT01054885|452864592|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125881238|NCT01054885|452864593|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126277902|NCT02932306|454309069|FG000|Overall Study|Withdrawal by Subject|16|||
126277903|NCT02932306|454309070|FG001|Overall Study|Withdrawal by Subject|25|||
125881239|NCT01054885|452864587|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
125881240|NCT01054885|452864588|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
125881241|NCT01054885|452864589|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
126277904|NCT02932306|454309069|FG000|Overall Study|Adverse Event|3|||
125881242|NCT01054885|452864590|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
125881243|NCT01054885|452864591|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
125881244|NCT01054885|452864592|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
125881245|NCT01054885|452864593|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
125881246|NCT01054885|452864587|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
125881247|NCT01054885|452864588|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126277905|NCT02932306|454309070|FG001|Overall Study|Adverse Event|0|||
126038228|NCT01828099|453439045|FG001|Extension-treatment Phase|Death|11|||
125881248|NCT01054885|452864589|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125881249|NCT01054885|452864590|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125881250|NCT01054885|452864591|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125881251|NCT01054885|452864592|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125881252|NCT01054885|452864593|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125881253|NCT01054885|452864587|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
125881254|NCT01054885|452864588|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125881255|NCT01054885|452864589|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125881256|NCT01054885|452864590|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126038229|NCT01828099|453439044|FG000|Extension-treatment Phase|Physician Decision|0|||
126038230|NCT01828099|453439045|FG001|Extension-treatment Phase|Physician Decision|5|||
126038231|NCT01828099|453439044|FG000|Extension-treatment Phase|Progressive disease|0|||
126038232|NCT01828099|453439045|FG001|Extension-treatment Phase|Progressive disease|54|||
126038233|NCT01828099|453439044|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
126038234|NCT01828099|453439045|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
126038235|NCT01828099|453439044|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
126038236|NCT01828099|453439045|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
126038237|NCT03905798|453439048|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
126038238|NCT05485779|453439049|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038239|NCT05485779|453439050|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038240|NCT05485779|453439051|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038241|NCT05485779|453439052|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038242|NCT05485779|453439053|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038243|NCT05485779|453439054|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038244|NCT05485779|453439055|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038245|NCT05485779|453439056|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
126038246|NCT05485779|453439057|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
126038247|NCT05485779|453439058|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038248|NCT05485779|453439059|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
126038249|NCT05485779|453439049|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038250|NCT05485779|453439050|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038251|NCT05485779|453439051|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038252|NCT05485779|453439052|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038253|NCT05485779|453439053|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038254|NCT05485779|453439054|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038255|NCT05485779|453439055|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038256|NCT05485779|453439056|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038257|NCT05485779|453439057|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038258|NCT05485779|453439058|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
126038259|NCT05485779|453439059|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
126038260|NCT05485779|453439049|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038261|NCT05485779|453439050|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038262|NCT05485779|453439051|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038263|NCT05485779|453439052|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
126038264|NCT05485779|453439053|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038265|NCT05485779|453439054|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038266|NCT05485779|453439055|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038267|NCT05485779|453439056|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038268|NCT05485779|453439057|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038269|NCT05485779|453439058|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038270|NCT05485779|453439059|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126038271|NCT04498390|453439064|FG000|Overall Study|Adverse Event|0|||
126038272|NCT04498390|453439065|FG001|Overall Study|Adverse Event|0|||
126038273|NCT04498390|453439066|FG002|Overall Study|Adverse Event|1|||
126038274|NCT04498390|453439067|FG003|Overall Study|Adverse Event|0|||
126038275|NCT04498390|453439068|FG004|Overall Study|Adverse Event|0|||
126038276|NCT04498390|453439064|FG000|Overall Study|Withdrawal by Subject|0|||
126277906|NCT02932306|454309069|FG000|Overall Study|Pregnancy|2|||
126277907|NCT02932306|454309070|FG001|Overall Study|Pregnancy|0|||
126277908|NCT02932306|454309069|FG000|Overall Study|Protocol Violation|1|||
126277909|NCT02932306|454309070|FG001|Overall Study|Protocol Violation|1|||
126277910|NCT02932306|454309069|FG000|Overall Study|Noncompliance with Study Drug|1|||
126277911|NCT02932306|454309070|FG001|Overall Study|Noncompliance with Study Drug|1|||
126277912|NCT02932306|454309069|FG000|Overall Study|Lost to Follow-up|36|||
126277913|NCT02932306|454309070|FG001|Overall Study|Lost to Follow-up|40|||
126277914|NCT02932306|454309069|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
126277915|NCT02932306|454309070|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
126277916|NCT02932306|454309069|FG000|Overall Study|Lack of Efficacy|0|||
126277917|NCT02932306|454309070|FG001|Overall Study|Lack of Efficacy|2|||
126277918|NCT02932306|454309069|FG000|Overall Study|Worsening condition|2|||
126277919|NCT02932306|454309070|FG001|Overall Study|Worsening condition|0|||
126277920|NCT02932306|454309069|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
126277921|NCT02932306|454309070|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
126277922|NCT05776862|454309071|FG000|Overall Study|Adverse Event|0|||
126277923|NCT05776862|454309072|FG001|Overall Study|Adverse Event|1|||
126277924|NCT05776862|454309071|FG000|Overall Study|non-compliance|1|||
126277925|NCT05776862|454309072|FG001|Overall Study|non-compliance|0|||
126277926|NCT01199471|454309073|FG000|Overall Study|Protocol Violation|4|||
126277927|NCT01199471|454309073|FG000|Overall Study|Withdrawal by Subject|1|||
126277928|NCT01199471|454309073|FG000|Overall Study|Physician Decision|1|||
126277929|NCT02065700|454309074|FG000|Overall Study|Adverse Event|165|||
126277930|NCT02065700|454309075|FG001|Overall Study|Adverse Event|101|||
126277931|NCT02065700|454309074|FG000|Overall Study|Withdrawal by Subject|90|||
126277932|NCT02065700|454309075|FG001|Overall Study|Withdrawal by Subject|29|||
126277933|NCT02065700|454309074|FG000|Overall Study|Lost to Follow-up|12|||
126277934|NCT02065700|454309075|FG001|Overall Study|Lost to Follow-up|9|||
126277935|NCT02065700|454309074|FG000|Overall Study|Physician Decision|2|||
126277936|NCT02065700|454309075|FG001|Overall Study|Physician Decision|0|||
126277937|NCT02065700|454309074|FG000|Overall Study|Sponsor Request|38|||
126363003|NCT00562861|454621693|FG001|Overall Study|Adverse Event|1|||
126363004|NCT00562861|454621692|FG000|Overall Study|Lack of Efficacy|5|||
126363005|NCT00562861|454621693|FG001|Overall Study|Lack of Efficacy|5|||
126363006|NCT00562861|454621692|FG000|Overall Study|noncompliance, moved|7|||
126363007|NCT00562861|454621693|FG001|Overall Study|noncompliance, moved|2|||
126363008|NCT00562861|454621692|FG000|Overall Study|Lost to Follow-up|7|||
126363009|NCT00562861|454621693|FG001|Overall Study|Lost to Follow-up|3|||
126363010|NCT01694771|454621694|FG000|Overall Study|Adverse Event|18|||
126363011|NCT01694771|454621695|FG001|Overall Study|Adverse Event|16|||
126363012|NCT01694771|454621694|FG000|Overall Study|Lack of Efficacy|1|||
126363013|NCT01694771|454621695|FG001|Overall Study|Lack of Efficacy|0|||
126363014|NCT01694771|454621694|FG000|Overall Study|Non compliance protocol|7|||
126363015|NCT01694771|454621695|FG001|Overall Study|Non compliance protocol|6|||
126363016|NCT01694771|454621694|FG000|Overall Study|Lost to Follow-up|2|||
126363017|NCT01694771|454621695|FG001|Overall Study|Lost to Follow-up|3|||
126363018|NCT01694771|454621694|FG000|Overall Study|Consent withdrawn|7|||
126363019|NCT01694771|454621695|FG001|Overall Study|Consent withdrawn|9|||
126363020|NCT01694771|454621694|FG000|Overall Study|Other reasons|5|||
126363021|NCT01694771|454621695|FG001|Overall Study|Other reasons|6|||
126363022|NCT00289900|454621699|FG000|Overall Study|Adverse Event|28|||
126363023|NCT00289900|454621700|FG001|Overall Study|Adverse Event|40|||
126363024|NCT00289900|454621701|FG002|Overall Study|Adverse Event|13|||
126363025|NCT00289900|454621702|FG003|Overall Study|Adverse Event|19|||
126363026|NCT00289900|454621703|FG004|Overall Study|Adverse Event|20|||
126363027|NCT00289900|454621704|FG005|Overall Study|Adverse Event|33|||
126363028|NCT00289900|454621699|FG000|Overall Study|Lost to Follow-up|7|||
126363029|NCT00289900|454621700|FG001|Overall Study|Lost to Follow-up|7|||
126363030|NCT00289900|454621701|FG002|Overall Study|Lost to Follow-up|8|||
126363031|NCT00289900|454621702|FG003|Overall Study|Lost to Follow-up|8|||
126363032|NCT00289900|454621703|FG004|Overall Study|Lost to Follow-up|4|||
126363033|NCT00289900|454621704|FG005|Overall Study|Lost to Follow-up|8|||
126363034|NCT00289900|454621699|FG000|Overall Study|Participant had flushing|18|||
126363035|NCT00289900|454621700|FG001|Overall Study|Participant had flushing|42|||
126363036|NCT00289900|454621701|FG002|Overall Study|Participant had flushing|1|||
126363037|NCT00289900|454621702|FG003|Overall Study|Participant had flushing|2|||
126363038|NCT00289900|454621703|FG004|Overall Study|Participant had flushing|0|||
126363039|NCT00289900|454621704|FG005|Overall Study|Participant had flushing|4|||
126363040|NCT00289900|454621699|FG000|Overall Study|Other|0|||
126363041|NCT00289900|454621700|FG001|Overall Study|Other|0|||
126363042|NCT00289900|454621701|FG002|Overall Study|Other|0|||
126363043|NCT00289900|454621702|FG003|Overall Study|Other|5|||
126363044|NCT00289900|454621703|FG004|Overall Study|Other|1|||
126363045|NCT00289900|454621704|FG005|Overall Study|Other|0|||
126363046|NCT00289900|454621699|FG000|Overall Study|Participant moved|1|||
126363047|NCT00289900|454621700|FG001|Overall Study|Participant moved|0|||
126363048|NCT00289900|454621701|FG002|Overall Study|Participant moved|0|||
126363049|NCT00289900|454621702|FG003|Overall Study|Participant moved|1|||
126363050|NCT00289900|454621703|FG004|Overall Study|Participant moved|1|||
126363051|NCT00289900|454621704|FG005|Overall Study|Participant moved|1|||
126363052|NCT00289900|454621699|FG000|Overall Study|Withdrawal by Subject|10|||
126363053|NCT00289900|454621700|FG001|Overall Study|Withdrawal by Subject|21|||
126363054|NCT00289900|454621701|FG002|Overall Study|Withdrawal by Subject|8|||
126363055|NCT00289900|454621702|FG003|Overall Study|Withdrawal by Subject|18|||
126363056|NCT00289900|454621703|FG004|Overall Study|Withdrawal by Subject|12|||
126363057|NCT00289900|454621704|FG005|Overall Study|Withdrawal by Subject|11|||
126363058|NCT00289900|454621699|FG000|Overall Study|Protocol Violation|3|||
126363059|NCT00289900|454621700|FG001|Overall Study|Protocol Violation|9|||
126363060|NCT00289900|454621701|FG002|Overall Study|Protocol Violation|2|||
126363061|NCT00289900|454621702|FG003|Overall Study|Protocol Violation|6|||
126363062|NCT00289900|454621703|FG004|Overall Study|Protocol Violation|7|||
126363063|NCT00289900|454621704|FG005|Overall Study|Protocol Violation|4|||
126363064|NCT00289900|454621699|FG000|Overall Study|site terminated|1|||
126363065|NCT00289900|454621700|FG001|Overall Study|site terminated|0|||
126363066|NCT00289900|454621701|FG002|Overall Study|site terminated|1|||
126363067|NCT00289900|454621702|FG003|Overall Study|site terminated|0|||
126363068|NCT00289900|454621703|FG004|Overall Study|site terminated|0|||
126363069|NCT00289900|454621704|FG005|Overall Study|site terminated|0|||
126363070|NCT00289900|454621699|FG000|Overall Study|Not treated|0|||
126363071|NCT00289900|454621700|FG001|Overall Study|Not treated|1|||
126363072|NCT00289900|454621701|FG002|Overall Study|Not treated|0|||
126363073|NCT00289900|454621702|FG003|Overall Study|Not treated|0|||
126363074|NCT00289900|454621703|FG004|Overall Study|Not treated|0|||
126363075|NCT00289900|454621704|FG005|Overall Study|Not treated|0|||
126363076|NCT01152385|454621705|FG000|Overall Study|Withdrawal by Subject|3|||
126363077|NCT01152385|454621706|FG001|Overall Study|Withdrawal by Subject|1|||
126363078|NCT01152385|454621707|FG002|Overall Study|Withdrawal by Subject|1|||
126363079|NCT01152385|454621708|FG003|Overall Study|Withdrawal by Subject|1|||
126363080|NCT01152385|454621705|FG000|Overall Study|Protocol Violation|0|||
126363081|NCT01152385|454621706|FG001|Overall Study|Protocol Violation|0|||
126363082|NCT01152385|454621707|FG002|Overall Study|Protocol Violation|0|||
126363083|NCT01152385|454621708|FG003|Overall Study|Protocol Violation|1|||
126363084|NCT01152385|454621705|FG000|Overall Study|Adverse Event|1|||
125881257|NCT01054885|452864591|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125881258|NCT01054885|452864592|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125881259|NCT01054885|452864593|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125881260|NCT01054885|452864587|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
125881261|NCT01054885|452864588|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
125881262|NCT01054885|452864589|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
125881263|NCT01054885|452864590|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
125881264|NCT01054885|452864591|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
125881265|NCT01054885|452864592|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
125881266|NCT01054885|452864593|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
125881267|NCT01054885|452864587|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
125881268|NCT01054885|452864588|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125881269|NCT01054885|452864589|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125881270|NCT01054885|452864590|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125881271|NCT01054885|452864591|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125881272|NCT01054885|452864592|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125881273|NCT01054885|452864593|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125881274|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125881275|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
125881276|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
125881277|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
125881278|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
125881279|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
125881280|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
125881281|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125881282|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125881283|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
125881284|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
125881285|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125881286|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
125881287|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125881288|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
125881289|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
125881290|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
125881291|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
125881292|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
125881293|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
125881294|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
125881295|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125881296|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
125881297|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
125881298|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
126038277|NCT04498390|453439065|FG001|Overall Study|Withdrawal by Subject|0|||
126038278|NCT04498390|453439066|FG002|Overall Study|Withdrawal by Subject|0|||
126038279|NCT04498390|453439067|FG003|Overall Study|Withdrawal by Subject|1|||
126038280|NCT04498390|453439068|FG004|Overall Study|Withdrawal by Subject|0|||
125881299|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
126038281|NCT04515849|453439069|FG000|Overall Study|Adverse Event|0|||
126038282|NCT04515849|453439070|FG001|Overall Study|Adverse Event|0|||
126038283|NCT04515849|453439071|FG002|Overall Study|Adverse Event|0|||
126363085|NCT01152385|454621706|FG001|Overall Study|Adverse Event|1|||
126363086|NCT01152385|454621707|FG002|Overall Study|Adverse Event|0|||
126363087|NCT01152385|454621708|FG003|Overall Study|Adverse Event|0|||
126363088|NCT01152385|454621705|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126363089|NCT01152385|454621706|FG001|Overall Study|Study-specific withdrawal criteria|1|||
126363090|NCT01152385|454621707|FG002|Overall Study|Study-specific withdrawal criteria|2|||
126363091|NCT01152385|454621708|FG003|Overall Study|Study-specific withdrawal criteria|0|||
126363092|NCT01152385|454621705|FG000|Overall Study|Other|4|||
126363093|NCT01152385|454621706|FG001|Overall Study|Other|3|||
126363094|NCT01152385|454621707|FG002|Overall Study|Other|2|||
126363095|NCT01152385|454621708|FG003|Overall Study|Other|3|||
126363096|NCT02656173|454621709|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
126363097|NCT02656173|454621710|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
126363098|NCT02656173|454621709|FG000|Overall Study|Adverse Event|7|||
126363099|NCT02656173|454621710|FG001|Overall Study|Adverse Event|5|||
126363100|NCT02656173|454621709|FG000|Overall Study|Withdrawal by Subject|1|||
126038284|NCT04515849|453439072|FG003|Overall Study|Adverse Event|1|||
126038285|NCT04515849|453439073|FG004|Overall Study|Adverse Event|2|||
126038286|NCT04515849|453439069|FG000|Overall Study|Death|2|||
126038287|NCT04515849|453439070|FG001|Overall Study|Death|0|||
126038288|NCT04515849|453439071|FG002|Overall Study|Death|0|||
126038289|NCT04515849|453439072|FG003|Overall Study|Death|0|||
126038290|NCT04515849|453439073|FG004|Overall Study|Death|0|||
126038291|NCT04515849|453439069|FG000|Overall Study|Other:family emergency|0|||
126038292|NCT04515849|453439070|FG001|Overall Study|Other:family emergency|0|||
126038293|NCT04515849|453439071|FG002|Overall Study|Other:family emergency|0|||
126038294|NCT04515849|453439072|FG003|Overall Study|Other:family emergency|1|||
126038295|NCT04515849|453439073|FG004|Overall Study|Other:family emergency|0|||
126038296|NCT04515849|453439069|FG000|Overall Study|Other:randomised by error|0|||
126038297|NCT04515849|453439070|FG001|Overall Study|Other:randomised by error|1|||
126038298|NCT04515849|453439071|FG002|Overall Study|Other:randomised by error|0|||
126038299|NCT04515849|453439072|FG003|Overall Study|Other:randomised by error|0|||
126038300|NCT04515849|453439073|FG004|Overall Study|Other:randomised by error|0|||
126038301|NCT04515849|453439069|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
126038302|NCT04515849|453439070|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
126038303|NCT04515849|453439071|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
126038304|NCT04515849|453439072|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
126038305|NCT04515849|453439073|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
126038306|NCT04515849|453439069|FG000|Overall Study|Physician Decision|0|||
126038307|NCT04515849|453439070|FG001|Overall Study|Physician Decision|1|||
126038308|NCT04515849|453439071|FG002|Overall Study|Physician Decision|0|||
126038309|NCT04515849|453439072|FG003|Overall Study|Physician Decision|0|||
126038310|NCT04515849|453439073|FG004|Overall Study|Physician Decision|0|||
126038311|NCT04515849|453439069|FG000|Overall Study|Withdrawal by Subject|1|||
126038312|NCT04515849|453439070|FG001|Overall Study|Withdrawal by Subject|2|||
126038313|NCT04515849|453439071|FG002|Overall Study|Withdrawal by Subject|1|||
126038314|NCT04515849|453439072|FG003|Overall Study|Withdrawal by Subject|0|||
126038315|NCT04515849|453439073|FG004|Overall Study|Withdrawal by Subject|0|||
126038316|NCT05370040|453439076|FG000|Overall Study|Lost to Follow-up|0|||
126038317|NCT05370040|453439077|FG001|Overall Study|Lost to Follow-up|0|||
126038318|NCT05370040|453439078|FG002|Overall Study|Lost to Follow-up|1|||
126038319|NCT05370040|453439079|FG003|Overall Study|Lost to Follow-up|0|||
126038320|NCT05370040|453439080|FG004|Overall Study|Lost to Follow-up|1|||
126038321|NCT05370040|453439081|FG005|Overall Study|Lost to Follow-up|0|||
126038322|NCT04971109|453439085|FG000|Overall Study|Adverse Event|4|||
126038323|NCT04971109|453439086|FG001|Overall Study|Adverse Event|3|||
126038324|NCT04971109|453439085|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
126038325|NCT04971109|453439086|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
126038326|NCT04971109|453439085|FG000|Overall Study|Lost to Follow-up|8|||
126038327|NCT04971109|453439086|FG001|Overall Study|Lost to Follow-up|2|||
126038328|NCT04971109|453439085|FG000|Overall Study|Physician Decision|5|||
126038329|NCT04971109|453439086|FG001|Overall Study|Physician Decision|0|||
126038330|NCT04971109|453439085|FG000|Overall Study|Protocol Violation|0|||
126038331|NCT04971109|453439086|FG001|Overall Study|Protocol Violation|1|||
126038332|NCT04971109|453439085|FG000|Overall Study|Withdrawal by Subject|18|||
126038333|NCT04971109|453439086|FG001|Overall Study|Withdrawal by Subject|3|||
126038334|NCT04971109|453439085|FG000|Overall Study|Subject was randomized in error|1|||
126038335|NCT04971109|453439086|FG001|Overall Study|Subject was randomized in error|0|||
126038336|NCT03987022|453439088|FG000|Overall Study|Lost to Follow-up|2|||
126038337|NCT03987022|453439089|FG001|Overall Study|Lost to Follow-up|2|||
126038338|NCT03987022|453439088|FG000|Overall Study|Withdrawal by Subject|1|||
126038339|NCT03987022|453439089|FG001|Overall Study|Withdrawal by Subject|0|||
126277938|NCT02065700|454309075|FG001|Overall Study|Sponsor Request|15|||
126277939|NCT02065700|454309074|FG000|Overall Study|Treatment Failure|3|||
126277940|NCT02065700|454309075|FG001|Overall Study|Treatment Failure|2|||
126277941|NCT02065700|454309074|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
126277942|NCT02065700|454309075|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
126277943|NCT02065700|454309074|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
126277944|NCT02065700|454309075|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
126277945|NCT02065700|454309074|FG000|Overall Study|Non-compliance with Study Procedures|2|||
126038340|NCT03663569|453440526|FG000|Overall Study|Discontinuation of study|11|||
126038341|NCT03663569|453440526|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
126038342|NCT03663569|453440526|FG000|Overall Study|Deceased patient|6|||
126038343|NCT03663569|453440526|FG000|Overall Study|Lost to Follow-up|18|||
126038344|NCT03663569|453440526|FG000|Overall Study|Withdrawal of consent|5|||
126038345|NCT03663569|453440526|FG000|Overall Study|Patient's request|11|||
126038346|NCT03663569|453440526|FG000|Overall Study|Adverse Event|4|||
126038347|NCT03663569|453440526|FG000|Overall Study|Not come to second visit|3|||
126277946|NCT02065700|454309075|FG001|Overall Study|Non-compliance with Study Procedures|0|||
126277947|NCT02065700|454309074|FG000|Overall Study|Not Defined|21|||
126277948|NCT02065700|454309075|FG001|Overall Study|Not Defined|3|||
126277949|NCT01664130|454309076|FG000|Overall Study|competing secondary disease|2|||
126277950|NCT01161407|454309078|FG000|Overall Study|Protocol Violation|3|||
126277951|NCT01161407|454309079|FG001|Overall Study|Protocol Violation|1|||
126277952|NCT04746794|454309082|FG000|Overall Study|Did not complete any study assessment|50303|||
126277953|NCT04746794|454309083|FG001|Overall Study|Did not complete any study assessment|44997|||
126277954|NCT03207243|454309084|FG000|Overall Study|Adverse Event|2|||
126277955|NCT03207243|454309085|FG001|Overall Study|Adverse Event|2|||
126277956|NCT03207243|454309084|FG000|Overall Study|Loss of Asthma Control|47|||
126277957|NCT03207243|454309085|FG001|Overall Study|Loss of Asthma Control|31|||
126277958|NCT03207243|454309084|FG000|Overall Study|Withdrawal by Subject|2|||
126277959|NCT03207243|454309085|FG001|Overall Study|Withdrawal by Subject|4|||
126277960|NCT03207243|454309084|FG000|Overall Study|Physician Decision|1|||
126277961|NCT03207243|454309085|FG001|Overall Study|Physician Decision|1|||
126363101|NCT02656173|454621710|FG001|Overall Study|Withdrawal by Subject|3|||
126277962|NCT03207243|454309084|FG000|Overall Study|Lost to Follow-up|0|||
126277963|NCT03207243|454309085|FG001|Overall Study|Lost to Follow-up|1|||
126277964|NCT03207243|454309084|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
126277965|NCT03207243|454309085|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
126277966|NCT03207243|454309084|FG000|Overall Study|Protocol Violation|0|||
126363102|NCT02656173|454621709|FG000|Overall Study|Protocol Violation|0|||
126363103|NCT02656173|454621710|FG001|Overall Study|Protocol Violation|1|||
126363104|NCT02656173|454621709|FG000|Overall Study|Miscellaneous|2|||
126363105|NCT02656173|454621710|FG001|Overall Study|Miscellaneous|0|||
126363106|NCT01064622|454621711|FG000|Randomized Phase II|Withdrawal by Subject|2|||
126363107|NCT01064622|454621712|FG001|Randomized Phase II|Withdrawal by Subject|2|||
126363108|NCT01064622|454621711|FG000|Randomized Phase II|Protocol Violation|0|||
126363109|NCT01064622|454621712|FG001|Randomized Phase II|Protocol Violation|1|||
126363110|NCT03289741|454621717|FG000|Overall Study|Adverse Event|1|||
126363111|NCT03289741|454621718|FG001|Overall Study|Adverse Event|1|||
126363112|NCT03289741|454621717|FG000|Overall Study|Physician Decision|2|||
126363113|NCT03289741|454621718|FG001|Overall Study|Physician Decision|2|||
126363114|NCT03289741|454621717|FG000|Overall Study|Withdrawal by Subject|1|||
126363115|NCT03289741|454621718|FG001|Overall Study|Withdrawal by Subject|0|||
126363116|NCT02037984|454621723|FG000|Overall Study|Lack of Efficacy|0|||
126363117|NCT02037984|454621724|FG001|Overall Study|Lack of Efficacy|0|||
126363118|NCT02037984|454621725|FG002|Overall Study|Lack of Efficacy|3|||
126363119|NCT02037984|454621726|FG003|Overall Study|Lack of Efficacy|10|||
126363120|NCT02037984|454621727|FG004|Overall Study|Lack of Efficacy|2|||
126363121|NCT02037984|454621728|FG005|Overall Study|Lack of Efficacy|2|||
126363122|NCT02037984|454621729|FG006|Overall Study|Lack of Efficacy|4|||
126363123|NCT02037984|454621730|FG007|Overall Study|Lack of Efficacy|3|||
126363124|NCT02037984|454621723|FG000|Overall Study|Lost to Follow-up|1|||
126363125|NCT02037984|454621724|FG001|Overall Study|Lost to Follow-up|0|||
126363126|NCT02037984|454621725|FG002|Overall Study|Lost to Follow-up|3|||
126363127|NCT02037984|454621726|FG003|Overall Study|Lost to Follow-up|5|||
126363128|NCT02037984|454621727|FG004|Overall Study|Lost to Follow-up|2|||
126363129|NCT02037984|454621728|FG005|Overall Study|Lost to Follow-up|2|||
126363130|NCT02037984|454621729|FG006|Overall Study|Lost to Follow-up|2|||
126363131|NCT02037984|454621730|FG007|Overall Study|Lost to Follow-up|4|||
126363132|NCT02037984|454621723|FG000|Overall Study|Physician Decision|0|||
126363133|NCT02037984|454621724|FG001|Overall Study|Physician Decision|0|||
126363134|NCT02037984|454621725|FG002|Overall Study|Physician Decision|0|||
126363135|NCT02037984|454621726|FG003|Overall Study|Physician Decision|0|||
126363136|NCT02037984|454621727|FG004|Overall Study|Physician Decision|0|||
126363137|NCT02037984|454621728|FG005|Overall Study|Physician Decision|0|||
126363138|NCT02037984|454621729|FG006|Overall Study|Physician Decision|1|||
126363139|NCT02037984|454621730|FG007|Overall Study|Physician Decision|0|||
126363140|NCT02037984|454621723|FG000|Overall Study|Protocol Violation|0|||
126363141|NCT02037984|454621724|FG001|Overall Study|Protocol Violation|0|||
126363142|NCT02037984|454621725|FG002|Overall Study|Protocol Violation|0|||
126363143|NCT02037984|454621726|FG003|Overall Study|Protocol Violation|0|||
126363144|NCT02037984|454621727|FG004|Overall Study|Protocol Violation|0|||
126363145|NCT02037984|454621728|FG005|Overall Study|Protocol Violation|1|||
126363146|NCT02037984|454621729|FG006|Overall Study|Protocol Violation|2|||
126363147|NCT02037984|454621730|FG007|Overall Study|Protocol Violation|0|||
126363148|NCT02037984|454621723|FG000|Overall Study|Technical Problems|0|||
126363149|NCT02037984|454621724|FG001|Overall Study|Technical Problems|0|||
126363150|NCT02037984|454621725|FG002|Overall Study|Technical Problems|3|||
126363151|NCT02037984|454621726|FG003|Overall Study|Technical Problems|3|||
126277967|NCT03207243|454309085|FG001|Overall Study|Protocol Violation|3|||
126363152|NCT02037984|454621727|FG004|Overall Study|Technical Problems|2|||
126363153|NCT02037984|454621728|FG005|Overall Study|Technical Problems|3|||
126363154|NCT02037984|454621729|FG006|Overall Study|Technical Problems|4|||
126363155|NCT02037984|454621730|FG007|Overall Study|Technical Problems|2|||
126363156|NCT02037984|454621723|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126363157|NCT02037984|454621724|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126363158|NCT02037984|454621725|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
126277968|NCT01422187|454309086|FG000|Overall Study|Personal reason|1|||
126277969|NCT01422187|454309087|FG001|Overall Study|Personal reason|0|||
126277970|NCT01422187|454309088|FG002|Overall Study|Personal reason|0|||
126277971|NCT01422187|454309086|FG000|Overall Study|Lost to Follow-up|0|||
126277972|NCT01422187|454309087|FG001|Overall Study|Lost to Follow-up|1|||
126277973|NCT01422187|454309088|FG002|Overall Study|Lost to Follow-up|0|||
126277974|NCT04015908|454309089|FG000|Overall Study|Lost to Follow-up|0|||
126277975|NCT04015908|454309090|FG001|Overall Study|Lost to Follow-up|1|||
126277976|NCT02227446|454309091|FG000|Overall Study|not eligible post randomization|18|||
126277977|NCT02227446|454309092|FG001|Overall Study|not eligible post randomization|29|||
126277978|NCT02227446|454309091|FG000|Overall Study|Withdrawal by Subject|4|||
126277979|NCT02227446|454309092|FG001|Overall Study|Withdrawal by Subject|5|||
126277980|NCT04623086|454309093|FG000|Overall Study|Withdrawal by Subject|0|||
126277981|NCT04623086|454309094|FG001|Overall Study|Withdrawal by Subject|0|||
126277982|NCT04623086|454309095|FG002|Overall Study|Withdrawal by Subject|10|||
126277983|NCT00715624|454309096|FG000|Overall Study|Adverse Event|12|||
126277984|NCT00715624|454309097|FG001|Overall Study|Adverse Event|37|||
126277985|NCT00715624|454309096|FG000|Overall Study|Lack of Efficacy|11|||
126277986|NCT00715624|454309097|FG001|Overall Study|Lack of Efficacy|11|||
126277987|NCT00715624|454309096|FG000|Overall Study|Lost to Follow-up|1|||
126277988|NCT00715624|454309097|FG001|Overall Study|Lost to Follow-up|2|||
126277989|NCT00715624|454309096|FG000|Overall Study|Protocol Violation|1|||
126277990|NCT00715624|454309097|FG001|Overall Study|Protocol Violation|0|||
126277991|NCT00715624|454309096|FG000|Overall Study|Withdrawal by Subject|11|||
126277992|NCT00715624|454309097|FG001|Overall Study|Withdrawal by Subject|25|||
126277993|NCT00715624|454309096|FG000|Overall Study|Familial and personal reasons|10|||
126277994|NCT00715624|454309097|FG001|Overall Study|Familial and personal reasons|22|||
126277995|NCT00715624|454309096|FG000|Overall Study|Poor compliance|6|||
126277996|NCT00715624|454309097|FG001|Overall Study|Poor compliance|13|||
126277997|NCT00715624|454309096|FG000|Overall Study|Sponsor decision|0|||
125881300|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
126277998|NCT00715624|454309097|FG001|Overall Study|Sponsor decision|4|||
126277999|NCT00715624|454309096|FG000|Overall Study|Incorrect randomization (not treated)|0|||
126278000|NCT00715624|454309097|FG001|Overall Study|Incorrect randomization (not treated)|1|||
126278001|NCT00715624|454309096|FG000|Overall Study|Other|0|||
126278002|NCT00715624|454309097|FG001|Overall Study|Other|1|||
126278003|NCT03200912|454309098|FG000|Overall Study|Adverse Event|3|||
126278004|NCT03200912|454309099|FG001|Overall Study|Adverse Event|0|||
126278005|NCT03200912|454309100|FG002|Overall Study|Adverse Event|0|||
126278006|NCT03200912|454309098|FG000|Overall Study|Withdrawal by Subject|1|||
126278007|NCT03200912|454309099|FG001|Overall Study|Withdrawal by Subject|2|||
126278008|NCT03200912|454309100|FG002|Overall Study|Withdrawal by Subject|4|||
126278009|NCT03200912|454309098|FG000|Overall Study|Non-compliance with study drug|0|||
126278010|NCT03200912|454309099|FG001|Overall Study|Non-compliance with study drug|1|||
126278011|NCT03200912|454309100|FG002|Overall Study|Non-compliance with study drug|0|||
126278012|NCT00229723|454309101|FG000|Concomitant Phase|Adverse Event|4|||
126278013|NCT00229723|454309102|FG001|Concomitant Phase|Adverse Event|2|||
126278014|NCT00229723|454309103|FG002|Concomitant Phase|Adverse Event|5|||
126278015|NCT00229723|454309104|FG003|Concomitant Phase|Adverse Event|2|||
126278016|NCT00229723|454309105|FG004|Concomitant Phase|Adverse Event|0|||
126278017|NCT00229723|454309106|FG005|Concomitant Phase|Adverse Event|1|||
126278018|NCT00229723|454309107|FG006|Concomitant Phase|Adverse Event|2|||
126278019|NCT00229723|454309101|FG000|Concomitant Phase|Objective disease progression|0|||
126278020|NCT00229723|454309102|FG001|Concomitant Phase|Objective disease progression|0|||
126278021|NCT00229723|454309103|FG002|Concomitant Phase|Objective disease progression|0|||
126278022|NCT00229723|454309104|FG003|Concomitant Phase|Objective disease progression|0|||
126278023|NCT00229723|454309105|FG004|Concomitant Phase|Objective disease progression|0|||
126278024|NCT00229723|454309106|FG005|Concomitant Phase|Objective disease progression|0|||
126278025|NCT00229723|454309107|FG006|Concomitant Phase|Objective disease progression|0|||
126278026|NCT00229723|454309101|FG000|Concomitant Phase|Clinical progression|0|||
126278027|NCT00229723|454309102|FG001|Concomitant Phase|Clinical progression|0|||
126278028|NCT00229723|454309103|FG002|Concomitant Phase|Clinical progression|0|||
125881301|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125881302|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
125881303|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
125881304|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
125881305|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
125881306|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
126278029|NCT00229723|454309104|FG003|Concomitant Phase|Clinical progression|0|||
126278030|NCT00229723|454309105|FG004|Concomitant Phase|Clinical progression|0|||
126278031|NCT00229723|454309106|FG005|Concomitant Phase|Clinical progression|0|||
126278032|NCT00229723|454309107|FG006|Concomitant Phase|Clinical progression|1|||
126278033|NCT00229723|454309101|FG000|Concomitant Phase|Lost to Follow-up|0|||
125881307|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
125881308|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
125881309|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125881310|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125881311|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
125881312|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125881313|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125881314|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
126278034|NCT00229723|454309102|FG001|Concomitant Phase|Lost to Follow-up|0|||
126278035|NCT00229723|454309103|FG002|Concomitant Phase|Lost to Follow-up|0|||
126278036|NCT00229723|454309104|FG003|Concomitant Phase|Lost to Follow-up|0|||
126278037|NCT00229723|454309105|FG004|Concomitant Phase|Lost to Follow-up|1|||
126278038|NCT00229723|454309106|FG005|Concomitant Phase|Lost to Follow-up|0|||
126278039|NCT00229723|454309107|FG006|Concomitant Phase|Lost to Follow-up|0|||
126278040|NCT00229723|454309101|FG000|Concomitant Phase|Informed consent withdrawn|3|||
126278041|NCT00229723|454309102|FG001|Concomitant Phase|Informed consent withdrawn|2|||
126278042|NCT00229723|454309103|FG002|Concomitant Phase|Informed consent withdrawn|0|||
126278043|NCT00229723|454309104|FG003|Concomitant Phase|Informed consent withdrawn|2|||
126038348|NCT03663569|453440526|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
126278044|NCT00229723|454309105|FG004|Concomitant Phase|Informed consent withdrawn|0|||
126278045|NCT00229723|454309106|FG005|Concomitant Phase|Informed consent withdrawn|0|||
126278046|NCT00229723|454309107|FG006|Concomitant Phase|Informed consent withdrawn|0|||
126278047|NCT00229723|454309101|FG000|Concomitant Phase|Severe non-compliance|0|||
126278048|NCT00229723|454309102|FG001|Concomitant Phase|Severe non-compliance|1|||
126278049|NCT00229723|454309103|FG002|Concomitant Phase|Severe non-compliance|0|||
126278050|NCT00229723|454309104|FG003|Concomitant Phase|Severe non-compliance|0|||
126278051|NCT00229723|454309105|FG004|Concomitant Phase|Severe non-compliance|1|||
126278052|NCT00229723|454309106|FG005|Concomitant Phase|Severe non-compliance|0|||
125881315|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
125881316|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125881317|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
125881318|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125881319|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125881320|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125881321|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125881322|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125881323|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125881324|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
125881325|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
125881326|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
125881327|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
125881328|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
125881329|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
125881330|NCT01054885|452864587|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125881331|NCT01054885|452864588|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
125881332|NCT01054885|452864589|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125881333|NCT01054885|452864590|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
125881334|NCT01054885|452864591|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
125881335|NCT01054885|452864592|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125881336|NCT01054885|452864593|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
125881337|NCT00214201|452864595|FG000|Overall Study|Withdrawal by Subject|2|||
125881338|NCT00214201|452864596|FG001|Overall Study|Withdrawal by Subject|0|||
125881339|NCT00214201|452864595|FG000|Overall Study|Death|0|||
125881340|NCT00214201|452864596|FG001|Overall Study|Death|2|||
125881341|NCT01399372|452864597|FG000|Overall Study|Protocol Violation|3|||
125881342|NCT01399372|452864598|FG001|Overall Study|Protocol Violation|1|||
125881343|NCT01432730|452864599|FG000|Period 1|Adverse Event|2|||
125881344|NCT01432730|452864600|FG001|Period 1|Adverse Event|0|||
125881345|NCT01432730|452864599|FG000|Period 2|Adverse Event|0|||
125881346|NCT01432730|452864600|FG001|Period 2|Adverse Event|4|||
125881347|NCT01421719|452864605|FG000|Overall Study|Withdrawal by Subject|4|||
125881348|NCT01712399|452864606|FG000|Overall Study|Lost to Follow-up|1|||
125881349|NCT01712399|452864606|FG000|Overall Study|Withdrawal by Subject|39|||
125881350|NCT01712399|452864606|FG000|Overall Study|Death|1|||
125881351|NCT01712399|452864606|FG000|Overall Study|Adverse Event|11|||
125881352|NCT01712399|452864606|FG000|Overall Study|Study closure|345|||
125881353|NCT01942837|452864607|FG000|Overall Study|Death|1|||
125881354|NCT01942837|452864607|FG000|Overall Study|Symptomatic or radiographic progression|49|||
125881355|NCT01942837|452864607|FG000|Overall Study|Adverse Event|6|||
125881356|NCT01942837|452864607|FG000|Overall Study|Physician Decision|3|||
125881357|NCT01942837|452864607|FG000|Overall Study|Withdrawal by Subject|2|||
125881358|NCT01942837|452864607|FG000|Overall Study|Intercurrent Illness|1|||
125881359|NCT01942837|452864607|FG000|Overall Study|On treatment|3|||
125881360|NCT01942837|452864607|FG000|Overall Study|Never initiate the treatment|2|||
125881361|NCT01298648|452864608|FG000|Overall Study|Withdrawal by Subject|2|||
125881362|NCT01298648|452864608|FG000|Overall Study|Lost to Follow-up|21|||
125881363|NCT02038933|452864624|FG000|Overall Study|Disease progression|104|||
125881364|NCT02038933|452864624|FG000|Overall Study|Study drug toxicity|6|||
125881365|NCT02038933|452864624|FG000|Overall Study|Adverse event unrelated to study drug|6|||
125881366|NCT02038933|452864624|FG000|Overall Study|Participant request to discontinue treatment|2|||
125881367|NCT02038933|452864624|FG000|Overall Study|Lost to Follow-up|1|||
125881368|NCT02038933|452864624|FG000|Overall Study|Other reasons|2|||
125881369|NCT03250273|452864625|FG000|Overall Study|Disease Progression|2|||
125881370|NCT03250273|452864626|FG001|Overall Study|Disease Progression|11|||
125881371|NCT03250273|452864625|FG000|Overall Study|Death|0|||
125881372|NCT03250273|452864626|FG001|Overall Study|Death|1|||
125881373|NCT04154904|452864627|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
125881374|NCT04154904|452864628|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
125881375|NCT04154904|452864629|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
125881376|NCT04226742|452864630|FG000|Overall Study|Lost to Follow-up|16|||
125881377|NCT04226742|452864631|FG001|Overall Study|Lost to Follow-up|13|||
125881378|NCT04226742|452864630|FG000|Overall Study|Withdrawal by Subject|5|||
125881379|NCT04226742|452864631|FG001|Overall Study|Withdrawal by Subject|3|||
125881380|NCT01759446|452864633|FG000|Overall Study|Protocol Violation|1|||
125881381|NCT01759446|452864634|FG001|Overall Study|Protocol Violation|0|||
125881382|NCT01759446|452864635|FG002|Overall Study|Protocol Violation|1|||
125881383|NCT01759446|452864636|FG003|Overall Study|Protocol Violation|0|||
125881384|NCT01759446|452864637|FG004|Overall Study|Protocol Violation|0|||
125881385|NCT01759446|452864633|FG000|Overall Study|Withdrawal by Subject|0|||
125881386|NCT01759446|452864634|FG001|Overall Study|Withdrawal by Subject|1|||
125881387|NCT01759446|452864635|FG002|Overall Study|Withdrawal by Subject|0|||
125881388|NCT01759446|452864636|FG003|Overall Study|Withdrawal by Subject|1|||
126278053|NCT00229723|454309107|FG006|Concomitant Phase|Severe non-compliance|0|||
126278054|NCT00229723|454309101|FG000|Concomitant Phase|Other|3|||
126278055|NCT00229723|454309102|FG001|Concomitant Phase|Other|0|||
126278056|NCT00229723|454309103|FG002|Concomitant Phase|Other|1|||
126278057|NCT00229723|454309104|FG003|Concomitant Phase|Other|1|||
126278058|NCT00229723|454309105|FG004|Concomitant Phase|Other|0|||
126278059|NCT00229723|454309106|FG005|Concomitant Phase|Other|2|||
126278060|NCT00229723|454309107|FG006|Concomitant Phase|Other|0|||
126278061|NCT00229723|454309101|FG000|Maintenance Phase|Adverse Event|7|||
126278062|NCT00229723|454309102|FG001|Maintenance Phase|Adverse Event|2|||
126278063|NCT00229723|454309103|FG002|Maintenance Phase|Adverse Event|1|||
125881389|NCT01759446|452864637|FG004|Overall Study|Withdrawal by Subject|0|||
125881390|NCT04646044|452864640|FG000|Overall Study|Lost to Follow-up|0|||
125881391|NCT04646044|452864641|FG001|Overall Study|Lost to Follow-up|0|||
125881392|NCT04646044|452864642|FG002|Overall Study|Lost to Follow-up|1|||
125881393|NCT04646044|452864643|FG003|Overall Study|Lost to Follow-up|0|||
125881394|NCT04646044|452864640|FG000|Overall Study|Withdrawal by Subject|0|||
125881395|NCT04646044|452864641|FG001|Overall Study|Withdrawal by Subject|1|||
125881396|NCT04646044|452864642|FG002|Overall Study|Withdrawal by Subject|0|||
125881397|NCT04646044|452864643|FG003|Overall Study|Withdrawal by Subject|0|||
125881398|NCT02606643|452864644|FG000|Overall Study|did not meet inclusion criteria|1|||
125881399|NCT02606643|452864645|FG001|Overall Study|did not meet inclusion criteria|3|||
125881400|NCT02796170|452864647|FG000|Overall Study|Lost to Follow-up|3|||
125881401|NCT02796170|452864648|FG001|Overall Study|Lost to Follow-up|0|||
125881402|NCT04313244|452864652|FG000|Overall Study|Withdrawal of Consent|3|||
125881403|NCT04313244|452864653|FG001|Overall Study|Withdrawal of Consent|3|||
125881404|NCT04313244|452864652|FG000|Overall Study|Met Exclusion Criteria|1|||
125881405|NCT04313244|452864653|FG001|Overall Study|Met Exclusion Criteria|0|||
125881406|NCT04313244|452864652|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
125881407|NCT04313244|452864653|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
125881408|NCT01472289|452864656|FG000|Overall Study|Death|2|||
125881409|NCT00907335|452864657|FG000|Overall Study|Withdrawal by Subject|2|||
125881410|NCT00907335|452864658|FG001|Overall Study|Withdrawal by Subject|0|||
125881411|NCT00907335|452864657|FG000|Overall Study|Adverse Event|4|||
125881412|NCT00907335|452864658|FG001|Overall Study|Adverse Event|1|||
125881413|NCT00907335|452864657|FG000|Overall Study|Lost to Follow-up|2|||
125881414|NCT00907335|452864658|FG001|Overall Study|Lost to Follow-up|0|||
125881415|NCT00912808|452864659|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
125881416|NCT00912808|452864660|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125881417|NCT00912808|452864659|FG000|Washout|Withdrawal by Subject|0|||
125881418|NCT00912808|452864660|FG001|Washout|Withdrawal by Subject|1|||
125881419|NCT00912808|452864659|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125881420|NCT00912808|452864660|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
125881421|NCT00912808|452864659|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
125881422|NCT00912808|452864660|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
125881423|NCT03873116|452864661|FG000|Part 1|Study drug discontinuation due to rash|0|||
125881424|NCT03873116|452864662|FG001|Part 1|Study drug discontinuation due to rash|0|||
125881425|NCT03873116|452864663|FG002|Part 1|Study drug discontinuation due to rash|0|||
125881426|NCT03873116|452864664|FG003|Part 1|Study drug discontinuation due to rash|0|||
125881427|NCT03873116|452864665|FG004|Part 1|Study drug discontinuation due to rash|0|||
125881428|NCT03873116|452864666|FG005|Part 1|Study drug discontinuation due to rash|1|||
125881429|NCT03873116|452864661|FG000|Part 2|Withdrawal by Subject|0|||
125881430|NCT03873116|452864662|FG001|Part 2|Withdrawal by Subject|0|||
125881431|NCT03873116|452864663|FG002|Part 2|Withdrawal by Subject|1|||
125881432|NCT03873116|452864664|FG003|Part 2|Withdrawal by Subject|0|||
125881433|NCT03873116|452864665|FG004|Part 2|Withdrawal by Subject|0|||
125881434|NCT03873116|452864666|FG005|Part 2|Withdrawal by Subject|0|||
125881435|NCT03873116|452864661|FG000|Part 2|Lab abnormality or AE|0|||
125881436|NCT03873116|452864662|FG001|Part 2|Lab abnormality or AE|0|||
125881437|NCT03873116|452864663|FG002|Part 2|Lab abnormality or AE|0|||
125881438|NCT03873116|452864664|FG003|Part 2|Lab abnormality or AE|0|||
125881439|NCT03873116|452864665|FG004|Part 2|Lab abnormality or AE|1|||
125881440|NCT03873116|452864666|FG005|Part 2|Lab abnormality or AE|0|||
125881441|NCT03873116|452864661|FG000|Part 3|Withdrawal by Subject|0|||
125881442|NCT03873116|452864662|FG001|Part 3|Withdrawal by Subject|0|||
126278064|NCT00229723|454309104|FG003|Maintenance Phase|Adverse Event|4|||
126278065|NCT00229723|454309105|FG004|Maintenance Phase|Adverse Event|7|||
126278066|NCT00229723|454309106|FG005|Maintenance Phase|Adverse Event|5|||
126363159|NCT02037984|454621726|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
125881443|NCT03873116|452864663|FG002|Part 3|Withdrawal by Subject|0|||
125881444|NCT03873116|452864664|FG003|Part 3|Withdrawal by Subject|0|||
125881445|NCT03873116|452864665|FG004|Part 3|Withdrawal by Subject|1|||
125881446|NCT03873116|452864666|FG005|Part 3|Withdrawal by Subject|0|||
125881447|NCT03345784|452864667|FG000|Overall Study|Withdrawal by Subject|2|||
125881448|NCT03345784|452864668|FG001|Overall Study|Withdrawal by Subject|1|||
125881449|NCT00474812|452864678|FG000|Overall Study|Withdrawal by Subject|5|||
125881450|NCT00474812|452864678|FG000|Overall Study|No Initiation of treatment|2|||
126363160|NCT02037984|454621727|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
126363161|NCT02037984|454621728|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
126363162|NCT02037984|454621729|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
126363163|NCT02037984|454621730|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
126363164|NCT02037984|454621723|FG000|Overall Study|Withdrawal by Subject|0|||
126363165|NCT02037984|454621724|FG001|Overall Study|Withdrawal by Subject|0|||
126363166|NCT02037984|454621725|FG002|Overall Study|Withdrawal by Subject|0|||
126098691|NCT02595073|453653091|FG001|Overall Study|Protocol Violation|0|||
126098692|NCT02962960|453653092|FG000|Overall Study|Withdrawal by Subject|1|||
126098693|NCT02962960|453653093|FG001|Overall Study|Withdrawal by Subject|1|||
126098694|NCT02962960|453653094|FG002|Overall Study|Withdrawal by Subject|0|||
126098695|NCT02962960|453653092|FG000|Overall Study|Adverse Event|1|||
126098696|NCT02962960|453653093|FG001|Overall Study|Adverse Event|1|||
126363167|NCT02037984|454621726|FG003|Overall Study|Withdrawal by Subject|1|||
126363168|NCT02037984|454621727|FG004|Overall Study|Withdrawal by Subject|1|||
126363169|NCT02037984|454621728|FG005|Overall Study|Withdrawal by Subject|3|||
126363170|NCT02037984|454621729|FG006|Overall Study|Withdrawal by Subject|0|||
126363171|NCT02037984|454621730|FG007|Overall Study|Withdrawal by Subject|1|||
126363172|NCT00974233|454621731|FG000|Induction Chemoimmunotherapy|Death|2|||
126363173|NCT00974233|454621731|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
126363174|NCT00974233|454621731|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
126363175|NCT00974233|454621731|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
126363176|NCT00974233|454621731|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
126363177|NCT00974233|454621731|FG000|Maintenance Lenalidomide|Adverse Event|8|||
126363178|NCT01691092|454621732|FG000|Overall Study|Lost to Follow-up|10|||
126363179|NCT01691092|454621732|FG000|Overall Study|Physician Decision|4|||
126363180|NCT01691092|454621732|FG000|Overall Study|Withdrawal by Subject|3|||
126363181|NCT01691092|454621732|FG000|Overall Study|non-compliance|3|||
126363182|NCT01691092|454621732|FG000|Overall Study|used for different study|2|||
126363183|NCT01691092|454621732|FG000|Overall Study|screen fail|19|||
126363184|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
126363185|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
126363186|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
126363187|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Adverse Event|5|||
126363188|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Adverse Event|1|||
126363189|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Adverse Event|0|||
126363190|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
126363191|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
126363192|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
126363193|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Death|8|||
126363194|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Death|24|||
126363195|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Death|0|||
126363196|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
126363197|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
126363198|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
126363199|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
126363200|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
126363201|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
126363202|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
126363203|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
126363204|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
126363205|NCT02931539|454621733|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
126363206|NCT02931539|454621734|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
126363207|NCT02931539|454621735|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
126363208|NCT01657942|454621738|FG000|Overall Study|Alternative Treatment|7|||
126363209|NCT01657942|454621738|FG000|Overall Study|Lost to Follow-up|1|||
126363210|NCT03061214|454621739|FG000|Overall Study|Withdrawal by Subject|21|||
126363211|NCT03061214|454621740|FG001|Overall Study|Withdrawal by Subject|26|||
126363212|NCT03061214|454621741|FG002|Overall Study|Withdrawal by Subject|9|||
126363213|NCT03061214|454621739|FG000|Overall Study|Lost to Follow-up|3|||
126363214|NCT03061214|454621740|FG001|Overall Study|Lost to Follow-up|1|||
126363215|NCT03061214|454621741|FG002|Overall Study|Lost to Follow-up|1|||
126363216|NCT03061214|454621739|FG000|Overall Study|Death|1|||
126363217|NCT03061214|454621740|FG001|Overall Study|Death|1|||
126363218|NCT03061214|454621741|FG002|Overall Study|Death|0|||
126363219|NCT01569763|454623401|FG000|Overall Study|Lack of Efficacy|2|||
126363220|NCT01569763|454623402|FG001|Overall Study|Lack of Efficacy|7|||
126363221|NCT01569763|454623401|FG000|Overall Study|Adverse Event|1|||
126363222|NCT01569763|454623402|FG001|Overall Study|Adverse Event|0|||
126363223|NCT03211858|454623404|FG000|Overall Study|Adverse Event|8|||
126363224|NCT03211858|454623405|FG001|Overall Study|Adverse Event|6|||
126363225|NCT03211858|454623404|FG000|Overall Study|Lack of Efficacy|0|||
126098697|NCT02962960|453653094|FG002|Overall Study|Adverse Event|0|||
126098698|NCT02962960|453653092|FG000|Overall Study|Protocol Violation|1|||
126098699|NCT02962960|453653093|FG001|Overall Study|Protocol Violation|0|||
126363226|NCT03211858|454623405|FG001|Overall Study|Lack of Efficacy|4|||
126363227|NCT03211858|454623404|FG000|Overall Study|Poor compliance to protocol|6|||
126363228|NCT03211858|454623405|FG001|Overall Study|Poor compliance to protocol|2|||
126363229|NCT03211858|454623404|FG000|Overall Study|Non-serious Hypoglycemia|1|||
126363230|NCT03211858|454623405|FG001|Overall Study|Non-serious Hypoglycemia|0|||
126363231|NCT03211858|454623404|FG000|Overall Study|Other than specified above|22|||
126363232|NCT03211858|454623405|FG001|Overall Study|Other than specified above|21|||
126363233|NCT03810365|454623407|FG000|Overall Study|Lost to Follow-up|2|||
126363234|NCT03810365|454623408|FG001|Overall Study|Lost to Follow-up|2|||
126363235|NCT03810365|454623407|FG000|Overall Study|Withdrawal by Subject|4|||
126363236|NCT03810365|454623408|FG001|Overall Study|Withdrawal by Subject|5|||
126363237|NCT00185614|454623413|FG000|Inter-treatment Period|Physician Decision|1|||
126363238|NCT00185614|454623413|FG000|Inter-treatment Period|Relapse|2|||
126363239|NCT00185614|454623413|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
126363240|NCT03160573|454623414|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
126363241|NCT03160573|454623415|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
126363242|NCT03160573|454623416|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
126363243|NCT03160573|454623417|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
126363244|NCT02402907|454623421|FG000|Overall Study|Delivered vaginally|9|||
126363245|NCT02402907|454623422|FG001|Overall Study|Delivered vaginally|3|||
126363246|NCT02402907|454623421|FG000|Overall Study|Delivered outside of Sinai|1|||
126363247|NCT02402907|454623422|FG001|Overall Study|Delivered outside of Sinai|1|||
126363248|NCT02402907|454623421|FG000|Overall Study|Lost to follow up after C-Section|10|||
126363249|NCT02402907|454623422|FG001|Overall Study|Lost to follow up after C-Section|23|||
126363250|NCT01423084|454623423|FG000|Overall Study|Adverse Event|0|||
126363251|NCT01423084|454623424|FG001|Overall Study|Adverse Event|1|||
126363252|NCT01423084|454623423|FG000|Overall Study|Withdrawal by Subject|2|||
126363253|NCT01423084|454623424|FG001|Overall Study|Withdrawal by Subject|3|||
126038349|NCT03663569|453440526|FG000|Overall Study|Serious adverse event|1|||
126038350|NCT02844465|453440527|FG000|Overall Study|Screen Failure|36|||
126278067|NCT00229723|454309107|FG006|Maintenance Phase|Adverse Event|2|||
126278068|NCT00229723|454309101|FG000|Maintenance Phase|Objective disease progression|5|||
126278069|NCT00229723|454309102|FG001|Maintenance Phase|Objective disease progression|5|||
126278070|NCT00229723|454309103|FG002|Maintenance Phase|Objective disease progression|3|||
126278071|NCT00229723|454309104|FG003|Maintenance Phase|Objective disease progression|6|||
126278072|NCT00229723|454309105|FG004|Maintenance Phase|Objective disease progression|2|||
126278073|NCT00229723|454309106|FG005|Maintenance Phase|Objective disease progression|9|||
126278074|NCT00229723|454309107|FG006|Maintenance Phase|Objective disease progression|5|||
126278075|NCT00229723|454309101|FG000|Maintenance Phase|Clinical progression|4|||
126278076|NCT00229723|454309102|FG001|Maintenance Phase|Clinical progression|1|||
126278077|NCT00229723|454309103|FG002|Maintenance Phase|Clinical progression|2|||
126038351|NCT02844465|453440527|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
126038352|NCT02844465|453440527|FG000|Overall Study|Withdrawal by Subject|5|||
126278078|NCT00229723|454309104|FG003|Maintenance Phase|Clinical progression|2|||
126278079|NCT00229723|454309105|FG004|Maintenance Phase|Clinical progression|1|||
126278080|NCT00229723|454309106|FG005|Maintenance Phase|Clinical progression|1|||
126278081|NCT00229723|454309107|FG006|Maintenance Phase|Clinical progression|1|||
126363254|NCT00661687|454623425|FG000|Overall Study|Study related symptoms and complaints|5|||
126363255|NCT00661687|454623425|FG000|Overall Study|Positive slit lamp findings|4|||
126038353|NCT02844465|453440527|FG000|Overall Study|Lost to Follow-up|1|||
126038354|NCT02844465|453440527|FG000|Overall Study|Retreatment|1|||
126038355|NCT03819153|453440529|FG000|Overall Study|Withdrawal by Subject|20|||
126038356|NCT03819153|453440530|FG001|Overall Study|Withdrawal by Subject|28|||
126038357|NCT03819153|453440529|FG000|Overall Study|Lost to Follow-up|23|||
126038358|NCT03819153|453440530|FG001|Overall Study|Lost to Follow-up|30|||
126038359|NCT03240016|453440532|FG000|Overall Study|Adverse Event|9|||
126038360|NCT03240016|453440532|FG000|Overall Study|Withdrawal by Subject|7|||
126038361|NCT03240016|453440532|FG000|Overall Study|Death|1|||
126038362|NCT03240016|453440532|FG000|Overall Study|Physician Decision|2|||
126038363|NCT03913442|453440533|FG000|Overall Study|Adverse Event|0|||
126038364|NCT03913442|453440534|FG001|Overall Study|Adverse Event|3|||
126038365|NCT03913442|453440533|FG000|Overall Study|Withdrawal by Subject|5|||
126038366|NCT03913442|453440534|FG001|Overall Study|Withdrawal by Subject|5|||
126038367|NCT03913442|453440533|FG000|Overall Study|Terminations|2|||
126038368|NCT03913442|453440534|FG001|Overall Study|Terminations|1|||
126038369|NCT03913442|453440533|FG000|Overall Study|Lost to Follow-up|2|||
126038370|NCT03913442|453440534|FG001|Overall Study|Lost to Follow-up|2|||
126038371|NCT02460458|453440535|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
126038372|NCT02460458|453440535|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
126038373|NCT02460458|453440535|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
126363256|NCT00661687|454623425|FG000|Overall Study|Inability to maintain wearing schedule|3|||
126363257|NCT00661687|454623425|FG000|Overall Study|Physician Decision|1|||
126363258|NCT00661687|454623425|FG000|Overall Study|Adverse Event|2|||
126363259|NCT02462057|454623426|FG000|Overall Study|Left Vitality|32|||
126363260|NCT02462057|454623427|FG001|Overall Study|Left Vitality|27|||
126363261|NCT02462057|454623428|FG002|Overall Study|Left Vitality|23|||
126363262|NCT02462057|454623429|FG003|Overall Study|Left Vitality|35|||
126363263|NCT02462057|454623430|FG004|Overall Study|Left Vitality|33|||
126363264|NCT02462057|454623426|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
126363265|NCT02462057|454623427|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
126363266|NCT02462057|454623428|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
126363267|NCT02462057|454623429|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
126363268|NCT02462057|454623430|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
126363269|NCT02336555|454623431|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126363270|NCT02336555|454623432|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126363271|NCT02336555|454623431|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
126363272|NCT02336555|454623432|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
126363273|NCT02336555|454623431|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
126363274|NCT02336555|454623432|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
126363275|NCT01633112|454623433|FG000|Overall Study|Lack of Efficacy|1|||
126363276|NCT01633112|454623434|FG001|Overall Study|Lack of Efficacy|6|||
126363277|NCT01633112|454623435|FG002|Overall Study|Lack of Efficacy|13|||
126363278|NCT01633112|454623433|FG000|Overall Study|Abnormal laboratory value(s)|3|||
126363279|NCT01633112|454623434|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126363280|NCT01633112|454623435|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126363281|NCT01633112|454623433|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126363282|NCT01633112|454623434|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126363283|NCT01633112|454623435|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126038374|NCT02460458|453440535|FG000|First Prospective Phase|Lost to Follow-up|84|||
126038375|NCT02460458|453440535|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
126038376|NCT04362254|453440562|FG000|Overall Study|Adverse Event|1|||
126038377|NCT04362254|453440562|FG000|Overall Study|Protocol Violation|1|||
126038378|NCT04362254|453440562|FG000|Overall Study|Due to early termination of the trial|10|||
126038379|NCT04568434|453440565|FG000|Overall Study|Voluntary Withdrawal|0|||
126038380|NCT04568434|453440566|FG001|Overall Study|Voluntary Withdrawal|1|||
126038381|NCT04568434|453440567|FG002|Overall Study|Voluntary Withdrawal|1|||
126038382|NCT04568434|453440565|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
126038383|NCT04568434|453440566|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
126038384|NCT04568434|453440567|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
125881451|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
126038385|NCT04568434|453440565|FG000|Overall Study|Investigator Judgement|1|||
126038386|NCT04568434|453440566|FG001|Overall Study|Investigator Judgement|0|||
125881452|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
126038387|NCT04568434|453440567|FG002|Overall Study|Investigator Judgement|0|||
126038388|NCT05469464|453440568|FG000|Overall Study|Withdrawal by Subject|8|||
125881453|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
126038389|NCT05469464|453440569|FG001|Overall Study|Withdrawal by Subject|7|||
126038390|NCT05469464|453440570|FG002|Overall Study|Withdrawal by Subject|4|||
126038391|NCT05469464|453440571|FG003|Overall Study|Withdrawal by Subject|5|||
126038392|NCT05469464|453440568|FG000|Overall Study|Adverse Event|8|||
126038393|NCT05469464|453440569|FG001|Overall Study|Adverse Event|14|||
126038394|NCT05469464|453440570|FG002|Overall Study|Adverse Event|13|||
126038395|NCT05469464|453440571|FG003|Overall Study|Adverse Event|2|||
126038396|NCT05469464|453440568|FG000|Overall Study|Lost to Follow-up|2|||
126038397|NCT05469464|453440569|FG001|Overall Study|Lost to Follow-up|5|||
126038398|NCT05469464|453440570|FG002|Overall Study|Lost to Follow-up|3|||
126038399|NCT05469464|453440571|FG003|Overall Study|Lost to Follow-up|3|||
126038400|NCT05469464|453440568|FG000|Overall Study|Lack of Efficacy|4|||
126038401|NCT05469464|453440569|FG001|Overall Study|Lack of Efficacy|1|||
126038402|NCT05469464|453440570|FG002|Overall Study|Lack of Efficacy|2|||
126038403|NCT05469464|453440571|FG003|Overall Study|Lack of Efficacy|2|||
126038404|NCT05469464|453440568|FG000|Overall Study|Physician Decision|0|||
126038405|NCT05469464|453440569|FG001|Overall Study|Physician Decision|0|||
126038406|NCT05469464|453440570|FG002|Overall Study|Physician Decision|0|||
126038407|NCT05469464|453440571|FG003|Overall Study|Physician Decision|1|||
126038408|NCT06473662|453440572|FG000|Overall Study|Withdrawal by Subject|1|||
126038409|NCT06473662|453440573|FG001|Overall Study|Withdrawal by Subject|6|||
126038410|NCT06473662|453440574|FG002|Overall Study|Withdrawal by Subject|5|||
126038411|NCT06473662|453440572|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
126038412|NCT06473662|453440573|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
126038413|NCT06473662|453440574|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
126038414|NCT06473662|453440572|FG000|Overall Study|Starting HbA1c below 7%|0|||
126038415|NCT06473662|453440573|FG001|Overall Study|Starting HbA1c below 7%|1|||
126038416|NCT06473662|453440574|FG002|Overall Study|Starting HbA1c below 7%|1|||
125881454|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
125881455|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Adverse Event|2|||
125881456|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Adverse Event|5|||
126098700|NCT02962960|453653094|FG002|Overall Study|Protocol Violation|0|||
126038417|NCT06473662|453440572|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
126038418|NCT06473662|453440573|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
125881457|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Adverse Event|1|||
125881458|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Adverse Event|2|||
125881459|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Death|13|||
125881460|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Death|17|||
125881461|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Death|1|||
125881462|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Death|0|||
125881463|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
125881464|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
125881465|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
125881466|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
125881467|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Disease Progression|2|||
125881468|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Disease Progression|0|||
125881469|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Disease Progression|0|||
125881470|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Disease Progression|0|||
125881471|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
125881472|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
125881473|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
125881474|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
125881475|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
125881476|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
125881477|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
125881478|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
125881479|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
125881480|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
125881481|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
125881482|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
126098701|NCT02971761|453653095|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
126038419|NCT06473662|453440574|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
125881483|NCT03955146|452864688|FG000|DB Period (48 Weeks)|Participant Decision|9|||
125881484|NCT03955146|452864689|FG001|DB Period (48 Weeks)|Participant Decision|12|||
126038420|NCT06473662|453440572|FG000|Overall Study|Did not take medication|2|||
126098702|NCT02549196|453653096|FG000|Overall Study|Protocol Violation|0|||
125881485|NCT03955146|452864690|FG002|DB Period (48 Weeks)|Participant Decision|1|||
125881486|NCT03955146|452864691|FG003|DB Period (48 Weeks)|Participant Decision|1|||
125881487|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
125881488|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
125881489|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
126038421|NCT06473662|453440573|FG001|Overall Study|Did not take medication|3|||
126038422|NCT06473662|453440574|FG002|Overall Study|Did not take medication|2|||
126038423|NCT03463044|453440575|FG000|Overall Study|Lost to Follow-up|0|||
126038424|NCT03463044|453440576|FG001|Overall Study|Lost to Follow-up|0|||
126038425|NCT03463044|453440577|FG002|Overall Study|Lost to Follow-up|0|||
126038426|NCT03463044|453440578|FG003|Overall Study|Lost to Follow-up|0|||
126038427|NCT03463044|453440579|FG004|Overall Study|Lost to Follow-up|0|||
126038428|NCT03463044|453440580|FG005|Overall Study|Lost to Follow-up|0|||
126038429|NCT03463044|453440581|FG006|Overall Study|Lost to Follow-up|0|||
126038430|NCT03463044|453440582|FG007|Overall Study|Lost to Follow-up|1|||
126038431|NCT03463044|453440583|FG008|Overall Study|Lost to Follow-up|0|||
126038432|NCT05764525|453440584|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
126038433|NCT05764525|453440585|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
126038434|NCT05764525|453440584|FG000|Overall Study|Withdrawal by Subject|4|||
126038435|NCT05764525|453440585|FG001|Overall Study|Withdrawal by Subject|8|||
126038436|NCT05764525|453440584|FG000|Overall Study|Physician Decision|1|||
126038437|NCT05764525|453440585|FG001|Overall Study|Physician Decision|0|||
126038438|NCT03334630|453440586|FG000|Overall Study|Withdrawal by Subject|7|||
126038439|NCT03334630|453440587|FG001|Overall Study|Withdrawal by Subject|7|||
126038440|NCT03334630|453440586|FG000|Overall Study|Lost to Follow-up|3|||
126038441|NCT03334630|453440587|FG001|Overall Study|Lost to Follow-up|1|||
126038442|NCT03334630|453440586|FG000|Overall Study|Adverse Event|0|||
126038443|NCT03334630|453440587|FG001|Overall Study|Adverse Event|1|||
126038444|NCT03334630|453440586|FG000|Overall Study|Physician Decision|1|||
126038445|NCT03334630|453440587|FG001|Overall Study|Physician Decision|1|||
126038446|NCT03334630|453440586|FG000|Overall Study|Enrollment closed|2|||
126038447|NCT03334630|453440587|FG001|Overall Study|Enrollment closed|1|||
126038448|NCT03334630|453440586|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
126038449|NCT03334630|453440587|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
126038450|NCT03334630|453440586|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
126038451|NCT03334630|453440587|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
126038452|NCT03030261|453440592|FG000|Overall Study|Still receiving continuation therapy|5|||
126038453|NCT05093842|453440598|FG000|Overall Study|Pregnancy loss|1|||
126038454|NCT05093842|453440599|FG001|Overall Study|Pregnancy loss|1|||
126038455|NCT05093842|453440598|FG000|Overall Study|Lost to Follow-up|6|||
126038456|NCT05093842|453440599|FG001|Overall Study|Lost to Follow-up|0|||
126038457|NCT05093842|453440598|FG000|Overall Study|Physician Decision|0|||
126038458|NCT05093842|453440599|FG001|Overall Study|Physician Decision|1|||
126098703|NCT02549196|453653097|FG001|Overall Study|Protocol Violation|0|||
126038459|NCT03910478|453440600|FG000|Overall Study|Death|13|||
126038460|NCT03910478|453440601|FG001|Overall Study|Death|6|||
126038461|NCT03910478|453440600|FG000|Overall Study|Withdrawal by Subject|23|||
126038462|NCT03910478|453440601|FG001|Overall Study|Withdrawal by Subject|2|||
126278082|NCT00229723|454309101|FG000|Maintenance Phase|Lost to Follow-up|0|||
126278083|NCT00229723|454309102|FG001|Maintenance Phase|Lost to Follow-up|1|||
126278084|NCT00229723|454309103|FG002|Maintenance Phase|Lost to Follow-up|2|||
126278085|NCT00229723|454309104|FG003|Maintenance Phase|Lost to Follow-up|2|||
126278086|NCT00229723|454309105|FG004|Maintenance Phase|Lost to Follow-up|0|||
126278087|NCT00229723|454309106|FG005|Maintenance Phase|Lost to Follow-up|0|||
126278088|NCT00229723|454309107|FG006|Maintenance Phase|Lost to Follow-up|1|||
126278089|NCT00229723|454309101|FG000|Maintenance Phase|Informed consent withdrawn|1|||
126278090|NCT00229723|454309102|FG001|Maintenance Phase|Informed consent withdrawn|0|||
126278091|NCT00229723|454309103|FG002|Maintenance Phase|Informed consent withdrawn|0|||
126278092|NCT00229723|454309104|FG003|Maintenance Phase|Informed consent withdrawn|1|||
126278093|NCT00229723|454309105|FG004|Maintenance Phase|Informed consent withdrawn|1|||
126278094|NCT00229723|454309106|FG005|Maintenance Phase|Informed consent withdrawn|1|||
126278095|NCT00229723|454309107|FG006|Maintenance Phase|Informed consent withdrawn|0|||
126278096|NCT00229723|454309101|FG000|Maintenance Phase|Severe non-compliance|3|||
126278097|NCT00229723|454309102|FG001|Maintenance Phase|Severe non-compliance|1|||
126278098|NCT00229723|454309103|FG002|Maintenance Phase|Severe non-compliance|0|||
126038463|NCT03910478|453440600|FG000|Overall Study|Physician Decision|5|||
126038464|NCT03910478|453440601|FG001|Overall Study|Physician Decision|0|||
126038465|NCT03910478|453440600|FG000|Overall Study|Protocol Violation|1|||
126038466|NCT03910478|453440601|FG001|Overall Study|Protocol Violation|0|||
126038467|NCT03910478|453440600|FG000|Overall Study|Failure to meet continuation criteria|2|||
126038468|NCT03910478|453440601|FG001|Overall Study|Failure to meet continuation criteria|0|||
126038469|NCT03910478|453440600|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
126038470|NCT03910478|453440601|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
126038471|NCT05293171|453440602|FG000|Washout 5 to 7 Days|Adverse Event|1|||
126038472|NCT05293171|453440603|FG001|Washout 5 to 7 Days|Adverse Event|1|||
126038473|NCT05293171|453440604|FG002|Washout 5 to 7 Days|Adverse Event|0|||
126038474|NCT05293171|453440605|FG003|Washout 5 to 7 Days|Adverse Event|0|||
126038475|NCT05293171|453440606|FG004|Washout 5 to 7 Days|Adverse Event|0|||
126038476|NCT05293171|453440607|FG005|Washout 5 to 7 Days|Adverse Event|0|||
126038477|NCT05293171|453440608|FG006|Washout 5 to 7 Days|Adverse Event|0|||
126038478|NCT05293171|453440609|FG007|Washout 5 to 7 Days|Adverse Event|0|||
126038479|NCT05293171|453440610|FG008|Washout 5 to 7 Days|Adverse Event|0|||
126038480|NCT05293171|453440611|FG009|Washout 5 to 7 Days|Adverse Event|0|||
126038481|NCT05293171|453440612|FG010|Washout 5 to 7 Days|Adverse Event|0|||
126038482|NCT05293171|453440613|FG011|Washout 5 to 7 Days|Adverse Event|0|||
126038483|NCT05293171|453440602|FG000|Washout 5 to 7 Days|Adverse Event|0|||
126038484|NCT05293171|453440603|FG001|Washout 5 to 7 Days|Adverse Event|0|||
126038485|NCT05293171|453440604|FG002|Washout 5 to 7 Days|Adverse Event|0|||
126038486|NCT05293171|453440605|FG003|Washout 5 to 7 Days|Adverse Event|0|||
126038487|NCT05293171|453440606|FG004|Washout 5 to 7 Days|Adverse Event|0|||
126038488|NCT05293171|453440607|FG005|Washout 5 to 7 Days|Adverse Event|1|||
126038489|NCT05293171|453440608|FG006|Washout 5 to 7 Days|Adverse Event|0|||
126038490|NCT05293171|453440609|FG007|Washout 5 to 7 Days|Adverse Event|0|||
126038491|NCT05293171|453440610|FG008|Washout 5 to 7 Days|Adverse Event|0|||
126098704|NCT02549196|453653098|FG002|Overall Study|Protocol Violation|0|||
126038492|NCT05293171|453440611|FG009|Washout 5 to 7 Days|Adverse Event|0|||
126038493|NCT05293171|453440612|FG010|Washout 5 to 7 Days|Adverse Event|0|||
126038494|NCT05293171|453440613|FG011|Washout 5 to 7 Days|Adverse Event|0|||
126038495|NCT04066205|453440616|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
126038496|NCT04066205|453440617|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
126038497|NCT04066205|453440616|FG000|T2 Immediate Post-Intervention|did not respond|5|||
126038498|NCT04066205|453440617|FG001|T2 Immediate Post-Intervention|did not respond|3|||
126038499|NCT01712490|453440620|FG000|Overall Study|Ongoing|601|||
126038500|NCT01712490|453440621|FG001|Overall Study|Ongoing|586|||
126038501|NCT01712490|453440620|FG000|Overall Study|Other|11|||
126038502|NCT01712490|453440621|FG001|Overall Study|Other|11|||
126038503|NCT01712490|453440620|FG000|Overall Study|Withdrawal by Subject|36|||
126038504|NCT01712490|453440621|FG001|Overall Study|Withdrawal by Subject|44|||
126038505|NCT01712490|453440620|FG000|Overall Study|Lost to Follow-up|16|||
126038506|NCT01712490|453440621|FG001|Overall Study|Lost to Follow-up|29|||
126038507|NCT03478956|453440622|FG000|Randomized Treatment Period|Adverse Event|1|||
126038508|NCT03478956|453440623|FG001|Randomized Treatment Period|Adverse Event|0|||
126038509|NCT03478956|453440624|FG002|Randomized Treatment Period|Adverse Event|0|||
126038510|NCT03478956|453440625|FG003|Randomized Treatment Period|Adverse Event|0|||
126038511|NCT03478956|453440622|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
126038512|NCT03478956|453440623|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
126038513|NCT03478956|453440624|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
126038514|NCT03478956|453440625|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
126038515|NCT03478956|453440622|FG000|Open Label Extension Period|Adverse Event|0|||
126038516|NCT03478956|453440623|FG001|Open Label Extension Period|Adverse Event|0|||
126038517|NCT03478956|453440624|FG002|Open Label Extension Period|Adverse Event|4|||
126038518|NCT03478956|453440625|FG003|Open Label Extension Period|Adverse Event|0|||
126038519|NCT03478956|453440622|FG000|Open Label Extension Period|Lack of Efficacy|0|||
126038520|NCT03478956|453440623|FG001|Open Label Extension Period|Lack of Efficacy|0|||
126038521|NCT03478956|453440624|FG002|Open Label Extension Period|Lack of Efficacy|8|||
126038522|NCT03478956|453440625|FG003|Open Label Extension Period|Lack of Efficacy|0|||
126038523|NCT03478956|453440622|FG000|Open Label Extension Period|Reason Not Provided|0|||
126038524|NCT03478956|453440623|FG001|Open Label Extension Period|Reason Not Provided|0|||
126038525|NCT03478956|453440624|FG002|Open Label Extension Period|Reason Not Provided|1|||
126038526|NCT03478956|453440625|FG003|Open Label Extension Period|Reason Not Provided|0|||
126278099|NCT00229723|454309104|FG003|Maintenance Phase|Severe non-compliance|0|||
126278100|NCT00229723|454309105|FG004|Maintenance Phase|Severe non-compliance|1|||
126278101|NCT00229723|454309106|FG005|Maintenance Phase|Severe non-compliance|0|||
126278102|NCT00229723|454309107|FG006|Maintenance Phase|Severe non-compliance|0|||
126278103|NCT00229723|454309101|FG000|Maintenance Phase|Other|5|||
126278104|NCT00229723|454309102|FG001|Maintenance Phase|Other|4|||
126278105|NCT00229723|454309103|FG002|Maintenance Phase|Other|1|||
126278106|NCT00229723|454309104|FG003|Maintenance Phase|Other|2|||
126278107|NCT00229723|454309105|FG004|Maintenance Phase|Other|3|||
126278108|NCT00229723|454309106|FG005|Maintenance Phase|Other|3|||
126363284|NCT01633112|454623433|FG000|Overall Study|Administrative problems|1|||
126363285|NCT01633112|454623434|FG001|Overall Study|Administrative problems|2|||
126363286|NCT01633112|454623435|FG002|Overall Study|Administrative problems|5|||
126363287|NCT01633112|454623433|FG000|Overall Study|Adverse Event|16|||
126363288|NCT01633112|454623434|FG001|Overall Study|Adverse Event|18|||
126363289|NCT01633112|454623435|FG002|Overall Study|Adverse Event|20|||
126363290|NCT01633112|454623433|FG000|Overall Study|Lost to Follow-up|7|||
126363291|NCT01633112|454623434|FG001|Overall Study|Lost to Follow-up|19|||
126363292|NCT01633112|454623435|FG002|Overall Study|Lost to Follow-up|6|||
126363293|NCT01633112|454623433|FG000|Overall Study|Protocol Violation|4|||
126363294|NCT01633112|454623434|FG001|Overall Study|Protocol Violation|0|||
126363295|NCT01633112|454623435|FG002|Overall Study|Protocol Violation|2|||
126363296|NCT01633112|454623433|FG000|Overall Study|Subject no longer requires study drug|0|||
126363297|NCT01633112|454623434|FG001|Overall Study|Subject no longer requires study drug|0|||
126363298|NCT01633112|454623435|FG002|Overall Study|Subject no longer requires study drug|1|||
126363299|NCT01633112|454623433|FG000|Overall Study|Withdrawal by Subject|20|||
126363300|NCT01633112|454623434|FG001|Overall Study|Withdrawal by Subject|12|||
126363301|NCT01633112|454623435|FG002|Overall Study|Withdrawal by Subject|41|||
126363302|NCT01633112|454623433|FG000|Overall Study|missing Study Completion CRF|1|||
126038527|NCT03478956|453440622|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
126038528|NCT03478956|453440623|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
126038529|NCT03478956|453440624|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
126278109|NCT00229723|454309107|FG006|Maintenance Phase|Other|1|||
126278110|NCT03421730|454309116|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278111|NCT03421730|454309117|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
126363303|NCT01633112|454623434|FG001|Overall Study|missing Study Completion CRF|1|||
126363304|NCT01633112|454623435|FG002|Overall Study|missing Study Completion CRF|4|||
126038530|NCT03478956|453440625|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
126363305|NCT01959919|454623436|FG000|Overall Study|Did not meet the eligibility criteria|2|||
126363306|NCT01908699|454623437|FG000|Overall Study|Adverse Event|8|||
126363307|NCT01908699|454623438|FG001|Overall Study|Adverse Event|12|||
126363308|NCT01908699|454623437|FG000|Overall Study|Lack of Efficacy|2|||
126363309|NCT01908699|454623438|FG001|Overall Study|Lack of Efficacy|2|||
126363310|NCT01908699|454623437|FG000|Overall Study|Lost to Follow-up|2|||
126363311|NCT01908699|454623438|FG001|Overall Study|Lost to Follow-up|4|||
126363312|NCT01908699|454623437|FG000|Overall Study|Physician Decision|8|||
126363313|NCT01908699|454623438|FG001|Overall Study|Physician Decision|8|||
126363314|NCT01908699|454623437|FG000|Overall Study|Withdrawal by Subject|15|||
126363315|NCT01908699|454623438|FG001|Overall Study|Withdrawal by Subject|10|||
126363316|NCT01908699|454623437|FG000|Overall Study|Pregnancy|0|||
126363317|NCT01908699|454623438|FG001|Overall Study|Pregnancy|1|||
126363318|NCT01908699|454623437|FG000|Overall Study|Randomized in Error|1|||
126363319|NCT01908699|454623438|FG001|Overall Study|Randomized in Error|0|||
126363320|NCT01908699|454623437|FG000|Overall Study|Death|9|||
126363321|NCT01908699|454623438|FG001|Overall Study|Death|12|||
126363322|NCT01908699|454623437|FG000|Overall Study|Progressive Disease|30|||
126363323|NCT01908699|454623438|FG001|Overall Study|Progressive Disease|29|||
126363324|NCT01697501|454623439|FG000|Overall Study|Protocol Violation|2|||
126363325|NCT00889005|454623442|FG000|Overall Study|Lost to Follow-up|4|||
126363326|NCT00889005|454623443|FG001|Overall Study|Lost to Follow-up|2|||
126363327|NCT00889005|454623442|FG000|Overall Study|Withdrawal by Subject|4|||
126363328|NCT00889005|454623443|FG001|Overall Study|Withdrawal by Subject|0|||
126363329|NCT00128492|454623444|FG000|Overall Study|AE unrelated to study|2|||
126363330|NCT00128492|454623445|FG001|Overall Study|AE unrelated to study|9|||
126363331|NCT00128492|454623444|FG000|Overall Study|Study drug intolerance (AE)|2|||
126363332|NCT00128492|454623445|FG001|Overall Study|Study drug intolerance (AE)|8|||
126363333|NCT00128492|454623444|FG000|Overall Study|AE related to study|1|||
126363334|NCT00128492|454623445|FG001|Overall Study|AE related to study|4|||
126363335|NCT00128492|454623444|FG000|Overall Study|Death|1|||
126363336|NCT00128492|454623445|FG001|Overall Study|Death|0|||
126363337|NCT00128492|454623444|FG000|Overall Study|Lost to Follow-up|1|||
126363338|NCT00128492|454623445|FG001|Overall Study|Lost to Follow-up|5|||
126363339|NCT00128492|454623444|FG000|Overall Study|Noncompliance|0|||
126363340|NCT00128492|454623445|FG001|Overall Study|Noncompliance|5|||
126363341|NCT00128492|454623444|FG000|Overall Study|Personal or administrative|10|||
126363342|NCT00128492|454623445|FG001|Overall Study|Personal or administrative|22|||
126363343|NCT00128492|454623444|FG000|Overall Study|Withdrawal by Subject|3|||
126363344|NCT00128492|454623445|FG001|Overall Study|Withdrawal by Subject|5|||
126363345|NCT00128492|454623444|FG000|Overall Study|Pregnancy|0|||
126363346|NCT00128492|454623445|FG001|Overall Study|Pregnancy|1|||
126363347|NCT00692237|454623449|FG000|Overall Study|Withdrawal by Subject|1|||
126363348|NCT00692237|454623450|FG001|Overall Study|Withdrawal by Subject|3|||
126363349|NCT00692237|454623449|FG000|Overall Study|Adverse Event|0|||
126363350|NCT00692237|454623450|FG001|Overall Study|Adverse Event|1|||
126363351|NCT01347086|454623454|FG000|Overall Study|failed screening visit|0|||
126363352|NCT01347086|454623455|FG001|Overall Study|failed screening visit|0|||
126363353|NCT01347086|454623456|FG002|Overall Study|failed screening visit|1|||
126363354|NCT01347086|454623457|FG003|Overall Study|failed screening visit|0|||
126363355|NCT01347086|454623458|FG004|Overall Study|failed screening visit|0|||
126363356|NCT01347086|454623459|FG005|Overall Study|failed screening visit|0|||
126363357|NCT01347086|454623460|FG006|Overall Study|failed screening visit|1|||
126363358|NCT01347086|454623461|FG007|Overall Study|failed screening visit|1|||
126363359|NCT01347086|454623462|FG008|Overall Study|failed screening visit|0|||
126363360|NCT01347086|454623463|FG009|Overall Study|failed screening visit|1|||
126363361|NCT00395447|454623465|FG000|Overall Study|Death|37|||
126363362|NCT00395447|454623466|FG001|Overall Study|Death|32|||
126363363|NCT00395447|454623465|FG000|Overall Study|Lost to Follow-up|52|||
126363364|NCT00395447|454623466|FG001|Overall Study|Lost to Follow-up|43|||
126363365|NCT00395447|454623465|FG000|Overall Study|Withdrawal by Subject|24|||
126363366|NCT00395447|454623466|FG001|Overall Study|Withdrawal by Subject|19|||
126363367|NCT00395447|454623465|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
126363368|NCT00395447|454623466|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
126363369|NCT03111108|454623468|FG000|Overall Study|Death|0|||
126363370|NCT03111108|454623469|FG001|Overall Study|Death|1|||
126363371|NCT03111108|454623468|FG000|Overall Study|Withdrawal by Subject|1|||
126363372|NCT03111108|454623469|FG001|Overall Study|Withdrawal by Subject|0|||
126363373|NCT02771145|454623470|FG000|Overall Study|Adverse Event|3|||
126363374|NCT02771145|454623470|FG000|Overall Study|Lost to Follow-up|1|||
126098705|NCT02549196|453653099|FG003|Overall Study|Protocol Violation|1|||
126363375|NCT02264821|454623471|FG000|Overall Study|Protocol Violation|1|||
126363376|NCT02264821|454623472|FG001|Overall Study|Protocol Violation|3|||
126363377|NCT02264821|454623473|FG002|Overall Study|Protocol Violation|6|||
126363378|NCT05071027|454623474|FG000|Overall Study|Lost to Follow-up|1|||
126363379|NCT05071027|454623475|FG001|Overall Study|Lost to Follow-up|4|||
126363380|NCT02314247|454623476|FG000|Overall Study|Adverse Event|2|||
126363381|NCT02314247|454623477|FG001|Overall Study|Adverse Event|1|||
126363382|NCT02314247|454623478|FG002|Overall Study|Adverse Event|0|||
126363383|NCT02314247|454623476|FG000|Overall Study|Withdrawal by Subject|1|||
126038531|NCT03478956|453440622|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
126038532|NCT03478956|453440623|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
126038533|NCT03478956|453440624|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
126038534|NCT03478956|453440625|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
126038535|NCT03478956|453440622|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
126038536|NCT03478956|453440623|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
126038537|NCT03478956|453440624|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
126038538|NCT03478956|453440625|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
126038539|NCT04800211|453440626|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
126038540|NCT04800211|453440627|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
126038541|NCT04800211|453440628|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
126038542|NCT04800211|453440626|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
126038543|NCT04800211|453440627|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
126038544|NCT04800211|453440628|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
126038545|NCT04800211|453440626|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
126038546|NCT04800211|453440627|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
126038547|NCT04800211|453440628|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
126038548|NCT04800211|453440626|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
126038549|NCT04800211|453440627|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
126038550|NCT04800211|453440628|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
126038551|NCT04800211|453440626|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
126038552|NCT04800211|453440627|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
126038553|NCT04800211|453440628|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
126038554|NCT04800211|453440626|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
126038555|NCT04800211|453440627|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
126038556|NCT04800211|453440628|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
126038557|NCT04800211|453440626|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
126038558|NCT04800211|453440627|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
126038559|NCT04800211|453440628|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
126038560|NCT04800211|453440626|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
126038561|NCT04800211|453440627|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
126038562|NCT04800211|453440628|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
126038563|NCT04800211|453440626|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
126038564|NCT04800211|453440627|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
126038565|NCT04800211|453440628|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
126038566|NCT04800211|453440626|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
126038567|NCT04800211|453440627|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
126038568|NCT04800211|453440628|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
126038569|NCT04800211|453440626|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
126038570|NCT04800211|453440627|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
126038571|NCT04800211|453440628|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
126038572|NCT05170841|453440629|FG000|Single Dose Phase|Adverse Event|1|||
126278112|NCT03421730|454309118|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278113|NCT03421730|454309119|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278114|NCT03421730|454309120|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278115|NCT03421730|454309121|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278116|NCT03421730|454309122|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278117|NCT03421730|454309123|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278118|NCT03421730|454309124|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278119|NCT03421730|454309125|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126038573|NCT05170841|453440630|FG001|Single Dose Phase|Adverse Event|2|||
126038574|NCT05170841|453440631|FG002|Single Dose Phase|Adverse Event|0|||
126038575|NCT05170841|453440632|FG003|Single Dose Phase|Adverse Event|2|||
126038576|NCT05170841|453440629|FG000|Multiple Dose Phase|Adverse Event|1|||
126038577|NCT05170841|453440630|FG001|Multiple Dose Phase|Adverse Event|2|||
126098706|NCT02549196|453653096|FG000|Overall Study|Withdrawal by Subject|1|||
126038578|NCT05170841|453440631|FG002|Multiple Dose Phase|Adverse Event|1|||
126038579|NCT05170841|453440632|FG003|Multiple Dose Phase|Adverse Event|4|||
126038580|NCT05170841|453440629|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
126098707|NCT02549196|453653097|FG001|Overall Study|Withdrawal by Subject|0|||
126098708|NCT02549196|453653098|FG002|Overall Study|Withdrawal by Subject|1|||
126098709|NCT02549196|453653099|FG003|Overall Study|Withdrawal by Subject|0|||
126098710|NCT01103362|453653100|FG000|Overall Study|study terminated|596|||
126098711|NCT02679508|453653101|FG000|Healing Phase|Protocol Violation|1|||
126098712|NCT02679508|453653102|FG001|Healing Phase|Protocol Violation|1|||
126098713|NCT02679508|453653101|FG000|Healing Phase|Lost to Follow-up|1|||
126098714|NCT02679508|453653102|FG001|Healing Phase|Lost to Follow-up|0|||
126098715|NCT02679508|453653101|FG000|Maintenance Phase|Adverse Event|12|||
126098716|NCT02679508|453653102|FG001|Maintenance Phase|Adverse Event|2|||
126098717|NCT02679508|453653101|FG000|Maintenance Phase|Lost to Follow-up|0|||
126098718|NCT02679508|453653102|FG001|Maintenance Phase|Lost to Follow-up|1|||
126098719|NCT02679508|453653101|FG000|Maintenance Phase|Withdrawal by Subject|15|||
126098720|NCT02679508|453653102|FG001|Maintenance Phase|Withdrawal by Subject|8|||
126098721|NCT02679508|453653101|FG000|Maintenance Phase|Other|5|||
126098722|NCT02679508|453653102|FG001|Maintenance Phase|Other|4|||
126098723|NCT03143166|453653103|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
126098724|NCT05000931|453653105|FG000|Overall Study|Lost to Follow-up|1|||
126098725|NCT05326815|453653106|FG000|Overall Study|Withdrawal by Subject|3|||
126098726|NCT05326815|453653106|FG000|Overall Study|Did not complete required labs|6|||
126098727|NCT05326815|453653106|FG000|Overall Study|Screen fail- abnormal labs|5|||
126098728|NCT03562975|453653107|FG000|Overall Study|Death|1|||
126098729|NCT03562975|453653107|FG000|Overall Study|Lost to Follow-up|1|||
126098730|NCT03562975|453653107|FG000|Overall Study|Withdrawal by Subject|1|||
126098731|NCT00925132|453653108|FG000|Overall Study|Withdrawal by Subject|2|||
126098732|NCT00925132|453653109|FG001|Overall Study|Withdrawal by Subject|0|||
126098733|NCT00925132|453653110|FG002|Overall Study|Withdrawal by Subject|0|||
126098734|NCT00925132|453653111|FG003|Overall Study|Withdrawal by Subject|0|||
126098735|NCT00925132|453653112|FG004|Overall Study|Withdrawal by Subject|1|||
126098736|NCT00925132|453653108|FG000|Overall Study|Removed due to disease progression|0|||
126098737|NCT00925132|453653109|FG001|Overall Study|Removed due to disease progression|0|||
126098738|NCT00925132|453653110|FG002|Overall Study|Removed due to disease progression|0|||
126098739|NCT00925132|453653111|FG003|Overall Study|Removed due to disease progression|0|||
126098740|NCT00925132|453653112|FG004|Overall Study|Removed due to disease progression|4|||
126098741|NCT02545933|453653113|FG000|Overall Study|Adverse Event|3|||
126098742|NCT02545933|453653114|FG001|Overall Study|Adverse Event|0|||
126098743|NCT02545933|453653115|FG002|Overall Study|Adverse Event|0|||
126098744|NCT02545933|453653113|FG000|Overall Study|Withdrawal by Subject|2|||
126098745|NCT02545933|453653114|FG001|Overall Study|Withdrawal by Subject|3|||
126098746|NCT02545933|453653115|FG002|Overall Study|Withdrawal by Subject|3|||
126098747|NCT02545933|453653113|FG000|Overall Study|Protocol Violation|1|||
126098748|NCT02545933|453653114|FG001|Overall Study|Protocol Violation|0|||
126098749|NCT02545933|453653115|FG002|Overall Study|Protocol Violation|1|||
126098750|NCT00979134|453653118|FG000|Overall Study|Disease progression|18|||
126098751|NCT00979134|453653119|FG001|Overall Study|Disease progression|2|||
126098752|NCT00979134|453653120|FG002|Overall Study|Disease progression|5|||
126098753|NCT00979134|453653118|FG000|Overall Study|Adverse Event|0|||
126098754|NCT00979134|453653119|FG001|Overall Study|Adverse Event|0|||
126098755|NCT00979134|453653120|FG002|Overall Study|Adverse Event|2|||
126098756|NCT00979134|453653118|FG000|Overall Study|Withdrawal by Subject|1|||
126098757|NCT00979134|453653119|FG001|Overall Study|Withdrawal by Subject|1|||
126098758|NCT00979134|453653120|FG002|Overall Study|Withdrawal by Subject|2|||
126098759|NCT00979134|453653118|FG000|Overall Study|Lost to Follow-up|2|||
126038581|NCT05170841|453440630|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
126038582|NCT05170841|453440631|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
126038583|NCT05170841|453440632|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
126038584|NCT05123586|453440635|FG000|Overall Study|Physician Decision|1|||
126098760|NCT00979134|453653119|FG001|Overall Study|Lost to Follow-up|2|||
126098761|NCT00979134|453653120|FG002|Overall Study|Lost to Follow-up|0|||
126038585|NCT05123586|453440636|FG001|Overall Study|Physician Decision|1|||
126098762|NCT00979134|453653118|FG000|Overall Study|Death|4|||
126098763|NCT00979134|453653119|FG001|Overall Study|Death|0|||
126098764|NCT00979134|453653120|FG002|Overall Study|Death|26|||
126098765|NCT00979134|453653118|FG000|Overall Study|Other|8|||
126098766|NCT00979134|453653119|FG001|Overall Study|Other|1|||
126098767|NCT00979134|453653120|FG002|Overall Study|Other|5|||
126278120|NCT03421730|454309126|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126038586|NCT05123586|453440635|FG000|Overall Study|Withdrawal by Subject|0|||
126098768|NCT05180500|453653123|FG000|Overall Study|Adverse Event|1|||
126038587|NCT05123586|453440636|FG001|Overall Study|Withdrawal by Subject|3|||
126038588|NCT04865289|453440637|FG000|Overall Study|Participant ongoing in study|47|||
126038589|NCT04865289|453440638|FG001|Overall Study|Participant ongoing in study|35|||
126038590|NCT04865289|453440637|FG000|Overall Study|Death|27|||
126038591|NCT04865289|453440638|FG001|Overall Study|Death|21|||
126038592|NCT02733159|453440641|FG000|Overall Study|Adverse Event|1|||
126038593|NCT02733159|453440641|FG000|Overall Study|Lack of disease progression|1|||
126038594|NCT06122194|453440642|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
126038595|NCT06122194|453440643|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
126038596|NCT06122194|453440644|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
126038597|NCT06122194|453440645|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
126038598|NCT02887521|453440652|FG000|Overall Study|Withdrawal by Subject|0|||
126038599|NCT02887521|453440653|FG001|Overall Study|Withdrawal by Subject|3|||
126038600|NCT03626220|453440655|FG000|Overall Study|Withdrawal by Subject|2|||
126038601|NCT03626220|453440656|FG001|Overall Study|Withdrawal by Subject|0|||
126038602|NCT05877976|453441736|FG000|Overall Study|Lost to Follow-up|31|||
126038603|NCT04248725|453441737|FG000|Post-Treatment|Lost to Follow-up|6|||
126038604|NCT04248725|453441738|FG001|Post-Treatment|Lost to Follow-up|5|||
126038605|NCT04248725|453441737|FG000|6-Month Follow Up|Lost to Follow-up|9|||
126038606|NCT04248725|453441738|FG001|6-Month Follow Up|Lost to Follow-up|8|||
126038607|NCT05622812|453441739|FG000|Overall Study|Withdrawal by Subject|1|||
126038608|NCT05622812|453441740|FG001|Overall Study|Withdrawal by Subject|4|||
126038609|NCT05622812|453441739|FG000|Overall Study|Lost to Follow-up|2|||
126038610|NCT05622812|453441740|FG001|Overall Study|Lost to Follow-up|1|||
126038611|NCT03916185|453441741|FG000|Overall Study|Lost to Follow-up|0|||
126038612|NCT03916185|453441742|FG001|Overall Study|Lost to Follow-up|1|||
126038613|NCT03916185|453441743|FG002|Overall Study|Lost to Follow-up|0|||
126038614|NCT03916185|453441744|FG003|Overall Study|Lost to Follow-up|0|||
126038615|NCT03916185|453441741|FG000|Overall Study|Moved|1|||
126038616|NCT03916185|453441742|FG001|Overall Study|Moved|0|||
126038617|NCT03916185|453441743|FG002|Overall Study|Moved|0|||
126038618|NCT03916185|453441744|FG003|Overall Study|Moved|1|||
126038619|NCT03916185|453441741|FG000|Overall Study|Not Able to Get to Clinic|1|||
126038620|NCT03916185|453441742|FG001|Overall Study|Not Able to Get to Clinic|0|||
126038621|NCT03916185|453441743|FG002|Overall Study|Not Able to Get to Clinic|0|||
126038622|NCT03916185|453441744|FG003|Overall Study|Not Able to Get to Clinic|0|||
126038623|NCT02593773|453441758|FG000|Overall Study|Voluntary Withdrawal|3|||
126038624|NCT02593773|453441758|FG000|Overall Study|Study Terminated by Sponsor|31|||
126038625|NCT02593773|453441758|FG000|Overall Study|Death|1|||
126038626|NCT05452460|453441762|FG000|Overall Study|Lost to Follow-up|3|||
126038627|NCT05452460|453441763|FG001|Overall Study|Lost to Follow-up|3|||
126038628|NCT05452460|453441762|FG000|Overall Study|Did not receive intervention|1|||
126038629|NCT05452460|453441763|FG001|Overall Study|Did not receive intervention|0|||
126038630|NCT01208662|453441766|FG000|Induction and Consolidation|Disease Progression|23|||
126038631|NCT01208662|453441767|FG001|Induction and Consolidation|Disease Progression|13|||
126038632|NCT01208662|453441768|FG002|Induction and Consolidation|Disease Progression|0|||
126038633|NCT01208662|453441766|FG000|Induction and Consolidation|Adverse Event|16|||
126278121|NCT03421730|454309127|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278122|NCT03421730|454309116|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278123|NCT03421730|454309117|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278124|NCT03421730|454309118|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278125|NCT03421730|454309119|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126038634|NCT01208662|453441767|FG001|Induction and Consolidation|Adverse Event|18|||
126038635|NCT01208662|453441768|FG002|Induction and Consolidation|Adverse Event|2|||
126038636|NCT01208662|453441766|FG000|Induction and Consolidation|MD or Participant Decision|16|||
126038637|NCT01208662|453441767|FG001|Induction and Consolidation|MD or Participant Decision|34|||
126038638|NCT01208662|453441768|FG002|Induction and Consolidation|MD or Participant Decision|4|||
126038639|NCT01208662|453441766|FG000|Induction and Consolidation|Death|1|||
126038640|NCT01208662|453441767|FG001|Induction and Consolidation|Death|3|||
126038641|NCT01208662|453441768|FG002|Induction and Consolidation|Death|1|||
126038642|NCT01208662|453441766|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
126038643|NCT01208662|453441767|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
126038644|NCT01208662|453441768|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
126038645|NCT01208662|453441766|FG000|Maintenance|Disease Progression|156|||
126038646|NCT01208662|453441767|FG001|Maintenance|Disease Progression|102|||
126038647|NCT01208662|453441768|FG002|Maintenance|Disease Progression|0|||
126038648|NCT01208662|453441766|FG000|Maintenance|Adverse Event|12|||
126038649|NCT01208662|453441767|FG001|Maintenance|Adverse Event|28|||
126038650|NCT01208662|453441768|FG002|Maintenance|Adverse Event|0|||
126038651|NCT01208662|453441766|FG000|Maintenance|MD or Participant Decision|24|||
126038652|NCT01208662|453441767|FG001|Maintenance|MD or Participant Decision|36|||
126038653|NCT01208662|453441768|FG002|Maintenance|MD or Participant Decision|0|||
126038654|NCT01208662|453441766|FG000|Maintenance|Death|0|||
126038655|NCT01208662|453441767|FG001|Maintenance|Death|3|||
126038656|NCT01208662|453441768|FG002|Maintenance|Death|0|||
126038657|NCT01208662|453441766|FG000|Maintenance|Discontinued for other reasons|21|||
126038658|NCT01208662|453441767|FG001|Maintenance|Discontinued for other reasons|31|||
126038659|NCT01208662|453441768|FG002|Maintenance|Discontinued for other reasons|0|||
126038660|NCT01208662|453441766|FG000|Maintenance|Still on Treatment|78|||
126038661|NCT01208662|453441767|FG001|Maintenance|Still on Treatment|89|||
126038662|NCT01208662|453441768|FG002|Maintenance|Still on Treatment|0|||
126038663|NCT00321048|453441769|FG000|Overall Study|Withdrawal by Subject|6|||
126038664|NCT00321048|453441770|FG001|Overall Study|Withdrawal by Subject|8|||
126038665|NCT04707625|453441771|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
126038666|NCT04471246|453441774|FG000|Overall Study|Lost to Follow-up|2|||
126038667|NCT04471246|453441775|FG001|Overall Study|Lost to Follow-up|2|||
126038668|NCT05907174|453441776|FG000|3-Month Assessment|Withdrawal by Subject|0|||
126098769|NCT05180500|453653124|FG001|Overall Study|Adverse Event|0|||
126278126|NCT03421730|454309120|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
126278127|NCT03421730|454309121|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278128|NCT03421730|454309122|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278129|NCT03421730|454309123|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278130|NCT03421730|454309124|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278131|NCT03421730|454309125|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278132|NCT03421730|454309126|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278133|NCT03421730|454309127|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278134|NCT02901548|454309130|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
126278135|NCT01559389|454309139|FG000|Overall Study|Withdrawal by Subject|20|||
126278136|NCT01559389|454309140|FG001|Overall Study|Withdrawal by Subject|20|||
126278137|NCT01696279|454309141|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
126278138|NCT01696279|454309142|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
126278139|NCT01696279|454309143|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
126278140|NCT01696279|454309144|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
126278141|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
126278142|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
126363384|NCT02314247|454623477|FG001|Overall Study|Withdrawal by Subject|3|||
126363385|NCT02314247|454623478|FG002|Overall Study|Withdrawal by Subject|1|||
126363386|NCT02314247|454623476|FG000|Overall Study|Progression of Disease|6|||
126363387|NCT02314247|454623477|FG001|Overall Study|Progression of Disease|2|||
126363388|NCT02314247|454623478|FG002|Overall Study|Progression of Disease|0|||
126363389|NCT01903733|454623479|FG000|Overall Study|Death|23|||
126363390|NCT01903733|454623480|FG001|Overall Study|Death|54|||
126363391|NCT01903733|454623481|FG002|Overall Study|Death|30|||
126363392|NCT01903733|454623482|FG003|Overall Study|Death|98|||
126363393|NCT01903733|454623479|FG000|Overall Study|Participant refused further follow-up|35|||
126363394|NCT01903733|454623480|FG001|Overall Study|Participant refused further follow-up|38|||
126363395|NCT01903733|454623481|FG002|Overall Study|Participant refused further follow-up|13|||
126363396|NCT01903733|454623482|FG003|Overall Study|Participant refused further follow-up|9|||
126363397|NCT01903733|454623479|FG000|Overall Study|Lost to Follow-up|18|||
126363398|NCT01903733|454623480|FG001|Overall Study|Lost to Follow-up|19|||
126363399|NCT01903733|454623481|FG002|Overall Study|Lost to Follow-up|6|||
126363400|NCT01903733|454623482|FG003|Overall Study|Lost to Follow-up|9|||
126363401|NCT01903733|454623479|FG000|Overall Study|Other|10|||
126363402|NCT01903733|454623480|FG001|Overall Study|Other|15|||
126363403|NCT01903733|454623481|FG002|Overall Study|Other|12|||
126363404|NCT01903733|454623482|FG003|Overall Study|Other|3|||
126363405|NCT01903733|454623479|FG000|Overall Study|Missing|2|||
126363406|NCT01903733|454623480|FG001|Overall Study|Missing|0|||
126363407|NCT01903733|454623481|FG002|Overall Study|Missing|0|||
126363408|NCT01903733|454623482|FG003|Overall Study|Missing|0|||
126363409|NCT01903733|454623479|FG000|Overall Study|Investigator request|18|||
126363410|NCT01903733|454623480|FG001|Overall Study|Investigator request|0|||
126363411|NCT01903733|454623481|FG002|Overall Study|Investigator request|0|||
126363412|NCT01903733|454623482|FG003|Overall Study|Investigator request|0|||
126363413|NCT02395627|454623483|FG000|Overall Study|Withdrawal by Subject|0|||
126363414|NCT02395627|454623484|FG001|Overall Study|Withdrawal by Subject|2|||
126363415|NCT02395627|454623485|FG002|Overall Study|Withdrawal by Subject|0|||
126363416|NCT02395627|454623483|FG000|Overall Study|Did not receive pembrolizumab|3|||
126363417|NCT02395627|454623484|FG001|Overall Study|Did not receive pembrolizumab|1|||
126363418|NCT02395627|454623485|FG002|Overall Study|Did not receive pembrolizumab|0|||
126363419|NCT02852005|454623487|FG000|Overall Study|Lost to Follow-up|0|||
126363420|NCT02852005|454623488|FG001|Overall Study|Lost to Follow-up|0|||
126363421|NCT02852005|454623489|FG002|Overall Study|Lost to Follow-up|0|||
126278143|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
126278144|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
126278145|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
126363422|NCT02852005|454623490|FG003|Overall Study|Lost to Follow-up|0|||
126363423|NCT02852005|454623491|FG004|Overall Study|Lost to Follow-up|1|||
126363424|NCT02852005|454623487|FG000|Overall Study|Withdrawal by Subject|1|||
126038669|NCT05907174|453441777|FG001|3-Month Assessment|Withdrawal by Subject|0|||
126038670|NCT05907174|453441778|FG002|3-Month Assessment|Withdrawal by Subject|0|||
126038671|NCT05907174|453441779|FG003|3-Month Assessment|Withdrawal by Subject|1|||
126038672|NCT05907174|453441776|FG000|3-Month Assessment|Lost to Follow-up|1|||
126038673|NCT05907174|453441777|FG001|3-Month Assessment|Lost to Follow-up|1|||
126038674|NCT05907174|453441778|FG002|3-Month Assessment|Lost to Follow-up|1|||
126038675|NCT05907174|453441779|FG003|3-Month Assessment|Lost to Follow-up|1|||
126038676|NCT05907174|453441776|FG000|6-Month Assessment|Death|0|||
126278146|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
126278147|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
126278148|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
126278149|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
126278150|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
126278151|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
126278152|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
126278153|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
126278154|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
125881490|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
125881491|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
125881492|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
125881493|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
125881494|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
125881495|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125881496|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
125881497|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125881498|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125881499|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
125881500|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
125881501|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
125881502|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
125881503|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
125881504|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
125881505|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
125881506|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
125881507|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
125881508|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125881509|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125881510|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125881511|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
125881512|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
125881513|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
125881514|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
125881515|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
125881516|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
125881517|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
125881518|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
125881519|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
125881520|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125881521|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125881522|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125881523|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
125881524|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
125881525|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
125881526|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
126278155|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
126278156|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
126278157|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
126278158|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
126278159|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
126363425|NCT02852005|454623488|FG001|Overall Study|Withdrawal by Subject|0|||
126038677|NCT05907174|453441777|FG001|6-Month Assessment|Death|0|||
126038678|NCT05907174|453441778|FG002|6-Month Assessment|Death|3|||
126038679|NCT05907174|453441779|FG003|6-Month Assessment|Death|0|||
126038680|NCT05907174|453441776|FG000|6-Month Assessment|Withdrawal by Subject|0|||
126098770|NCT05180500|453653123|FG000|Overall Study|Withdrawal by Subject|2|||
126098771|NCT05180500|453653124|FG001|Overall Study|Withdrawal by Subject|0|||
126363426|NCT02852005|454623489|FG002|Overall Study|Withdrawal by Subject|0|||
126098772|NCT00867308|453653125|FG000|Overall Study|Death|1|||
125881527|NCT03955146|452864688|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
125881528|NCT03955146|452864689|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
125881529|NCT03955146|452864690|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
126098773|NCT00867308|453653126|FG001|Overall Study|Death|0|||
126098774|NCT00867308|453653125|FG000|Overall Study|Adverse Event|1|||
126098775|NCT00867308|453653126|FG001|Overall Study|Adverse Event|4|||
126098776|NCT00867308|453653125|FG000|Overall Study|Lack of Efficacy|6|||
126098777|NCT00867308|453653126|FG001|Overall Study|Lack of Efficacy|12|||
126278160|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
126278161|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
126278162|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
126038681|NCT05907174|453441777|FG001|6-Month Assessment|Withdrawal by Subject|0|||
126038682|NCT05907174|453441778|FG002|6-Month Assessment|Withdrawal by Subject|1|||
126038683|NCT05907174|453441779|FG003|6-Month Assessment|Withdrawal by Subject|1|||
126038684|NCT05907174|453441776|FG000|6-Month Assessment|Lost to Follow-up|0|||
126038685|NCT05907174|453441777|FG001|6-Month Assessment|Lost to Follow-up|1|||
126038686|NCT05907174|453441778|FG002|6-Month Assessment|Lost to Follow-up|1|||
126038687|NCT05907174|453441779|FG003|6-Month Assessment|Lost to Follow-up|1|||
126038688|NCT03734679|453441788|FG000|Overall Study|Missed Visit|1|||
126038689|NCT02724969|453441799|FG000|Overall Study|Lost to Follow-up|12|||
126038690|NCT02724969|453441800|FG001|Overall Study|Lost to Follow-up|6|||
126038691|NCT02724969|453441799|FG000|Overall Study|Withdrawal by Subject|3|||
126038692|NCT02724969|453441800|FG001|Overall Study|Withdrawal by Subject|3|||
126038693|NCT02724969|453441799|FG000|Overall Study|Infant demise|0|||
126038694|NCT02724969|453441800|FG001|Overall Study|Infant demise|2|||
126038695|NCT03362476|453441801|FG000|Overall Study|Withdrawal by Subject|0|||
126278163|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
126278164|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
126278165|NCT01696279|454309141|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
126278166|NCT01696279|454309142|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
126278167|NCT01696279|454309143|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
126278168|NCT01696279|454309144|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
126278169|NCT01696279|454309141|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
126278170|NCT01696279|454309142|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
126278171|NCT01696279|454309143|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
126278172|NCT01696279|454309144|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
126278173|NCT01696279|454309141|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
126278174|NCT01696279|454309142|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
126278175|NCT01696279|454309143|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
126278176|NCT01696279|454309144|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
126278177|NCT01696279|454309141|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
126278178|NCT01696279|454309142|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
126278179|NCT01696279|454309143|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
126278180|NCT01696279|454309144|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
126278181|NCT01346293|454309146|FG000|Overall Study|Protocol Violation|30|||
126278182|NCT01346293|454309147|FG001|Overall Study|Protocol Violation|9|||
126278183|NCT01346293|454309146|FG000|Overall Study|Lost to Follow-up|21|||
126278184|NCT01346293|454309147|FG001|Overall Study|Lost to Follow-up|8|||
126278185|NCT01346293|454309146|FG000|Overall Study|Withdrawal by Subject|15|||
126278186|NCT01346293|454309147|FG001|Overall Study|Withdrawal by Subject|4|||
126278187|NCT01346293|454309146|FG000|Overall Study|Other|1|||
126278188|NCT01346293|454309147|FG001|Overall Study|Other|0|||
126278189|NCT03503864|454309152|FG000|Overall Study|Protocol Violation|6|||
126278190|NCT03503864|454309152|FG000|Overall Study|Withdrawal by Subject|7|||
126278191|NCT02639052|454309154|FG000|Overall Study|Lost to Follow-up|1|||
126278192|NCT02730351|454309155|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
126278193|NCT02730351|454309156|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
126278194|NCT02730351|454309155|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
126278195|NCT02730351|454309156|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
126278196|NCT02730351|454309155|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
126278197|NCT02730351|454309156|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
126278198|NCT02730351|454309155|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
126278199|NCT02730351|454309156|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
126278200|NCT02730351|454309155|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
126278201|NCT02730351|454309156|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
126278202|NCT00838435|454309157|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
126278203|NCT00838435|454309157|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
126278204|NCT00838435|454309157|FG000|Part 2 (7 Years)|Adverse Event|2|||
126278205|NCT00838435|454309157|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
126278206|NCT00838435|454309157|FG000|Part 2 (7 Years)|Physician Decision|1|||
126278207|NCT00838435|454309157|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
126278208|NCT00838435|454309157|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
126038696|NCT03362476|453441802|FG001|Overall Study|Withdrawal by Subject|1|||
126038697|NCT05974501|453441803|FG000|Overall Study|Physician Decision|0|||
126038698|NCT05974501|453441804|FG001|Overall Study|Physician Decision|1|||
126038699|NCT04270942|453441805|FG000|Overall Study|Death|1|||
126038700|NCT03571581|453441816|FG000|Overall Study|Death|2|||
126038701|NCT03571581|453441816|FG000|Overall Study|Withdrawal by Subject|2|||
126038702|NCT01309672|453441818|FG000|Overall Study|Lack of Efficacy|20|||
126038703|NCT01309672|453441818|FG000|Overall Study|Other|9|||
126038704|NCT01309672|453441818|FG000|Overall Study|Adverse Event|5|||
126038705|NCT01309672|453441818|FG000|Overall Study|Withdrawal by Subject|3|||
126038706|NCT04737330|453441820|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
126038707|NCT04737330|453441821|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
126038708|NCT04737330|453441820|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
126038709|NCT04737330|453441821|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
126038710|NCT04737330|453441820|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
126038711|NCT04737330|453441821|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
126038712|NCT04737330|453441820|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
126038713|NCT04737330|453441821|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
126038714|NCT04737330|453441820|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
126038715|NCT04737330|453441821|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
126038716|NCT04737330|453441820|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
126038717|NCT04737330|453441821|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
126038718|NCT04625725|453441822|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
126038719|NCT04625725|453441823|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126038720|NCT04625725|453441824|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126038721|NCT04625725|453441825|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126038722|NCT04625725|453441826|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126038723|NCT04625725|453441827|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126038724|NCT04625725|453441822|FG000|Provent Main Study|Withdrawal by Subject|242|||
126038725|NCT04625725|453441823|FG001|Provent Main Study|Withdrawal by Subject|144|||
126038726|NCT04625725|453441824|FG002|Provent Main Study|Withdrawal by Subject|0|||
126038727|NCT04625725|453441825|FG003|Provent Main Study|Withdrawal by Subject|0|||
126038728|NCT04625725|453441826|FG004|Provent Main Study|Withdrawal by Subject|0|||
126038729|NCT04625725|453441827|FG005|Provent Main Study|Withdrawal by Subject|0|||
126038730|NCT04625725|453441822|FG000|Provent Main Study|Physician Decision|5|||
126038731|NCT04625725|453441823|FG001|Provent Main Study|Physician Decision|0|||
126038732|NCT04625725|453441824|FG002|Provent Main Study|Physician Decision|0|||
126038733|NCT04625725|453441825|FG003|Provent Main Study|Physician Decision|0|||
126038734|NCT04625725|453441826|FG004|Provent Main Study|Physician Decision|0|||
126038735|NCT04625725|453441827|FG005|Provent Main Study|Physician Decision|0|||
126038736|NCT04625725|453441822|FG000|Provent Main Study|Protocol Violation|1|||
126038737|NCT04625725|453441823|FG001|Provent Main Study|Protocol Violation|0|||
126038738|NCT04625725|453441824|FG002|Provent Main Study|Protocol Violation|0|||
126038739|NCT04625725|453441825|FG003|Provent Main Study|Protocol Violation|0|||
126038740|NCT04625725|453441826|FG004|Provent Main Study|Protocol Violation|0|||
126038741|NCT04625725|453441827|FG005|Provent Main Study|Protocol Violation|0|||
126038742|NCT04625725|453441822|FG000|Provent Main Study|Lost to Follow-up|357|||
126038743|NCT04625725|453441823|FG001|Provent Main Study|Lost to Follow-up|200|||
126038744|NCT04625725|453441824|FG002|Provent Main Study|Lost to Follow-up|0|||
126038745|NCT04625725|453441825|FG003|Provent Main Study|Lost to Follow-up|0|||
126038746|NCT04625725|453441826|FG004|Provent Main Study|Lost to Follow-up|0|||
126038747|NCT04625725|453441827|FG005|Provent Main Study|Lost to Follow-up|0|||
126038748|NCT04625725|453441822|FG000|Provent Main Study|Death|22|||
126038749|NCT04625725|453441823|FG001|Provent Main Study|Death|10|||
126038750|NCT04625725|453441824|FG002|Provent Main Study|Death|0|||
126038751|NCT04625725|453441825|FG003|Provent Main Study|Death|0|||
126038752|NCT04625725|453441826|FG004|Provent Main Study|Death|0|||
126038753|NCT04625725|453441827|FG005|Provent Main Study|Death|0|||
126038754|NCT04625725|453441822|FG000|Provent Main Study|Adverse Event|2|||
126038755|NCT04625725|453441823|FG001|Provent Main Study|Adverse Event|1|||
126038756|NCT04625725|453441824|FG002|Provent Main Study|Adverse Event|0|||
126038757|NCT04625725|453441825|FG003|Provent Main Study|Adverse Event|0|||
125881530|NCT03955146|452864691|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
125881531|NCT04363320|452864694|FG000|Overall Study|Lost to Follow-up|43|||
125881532|NCT04363320|452864695|FG001|Overall Study|Lost to Follow-up|42|||
125881533|NCT04363320|452864696|FG002|Overall Study|Lost to Follow-up|24|||
125881534|NCT04363320|452864697|FG003|Overall Study|Lost to Follow-up|29|||
125881535|NCT04363320|452864694|FG000|Overall Study|Death|0|||
125881536|NCT04363320|452864695|FG001|Overall Study|Death|0|||
125881537|NCT04363320|452864696|FG002|Overall Study|Death|1|||
125881538|NCT04363320|452864697|FG003|Overall Study|Death|0|||
125881539|NCT02002598|452864698|FG000|Dose Level 1|Withdrawal by Subject|1|||
125881540|NCT02002598|452864699|FG001|Dose Level 1|Withdrawal by Subject|0|||
125881541|NCT02002598|452864700|FG002|Dose Level 1|Withdrawal by Subject|0|||
125881542|NCT02002598|452864701|FG003|Dose Level 1|Withdrawal by Subject|0|||
125881543|NCT02002598|452864702|FG004|Dose Level 1|Withdrawal by Subject|0|||
125881544|NCT05632211|452864703|FG000|Overall Study|Withdrawal by Subject|2|||
125881545|NCT05632211|452864704|FG001|Overall Study|Withdrawal by Subject|0|||
125881546|NCT05632211|452864705|FG002|Overall Study|Withdrawal by Subject|2|||
125881547|NCT05632211|452864703|FG000|Overall Study|Other reasons|1|||
125881548|NCT05632211|452864704|FG001|Overall Study|Other reasons|1|||
125881549|NCT05632211|452864705|FG002|Overall Study|Other reasons|1|||
125881550|NCT02628873|452864706|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
125881551|NCT02628873|452864707|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
125881552|NCT02628873|452864706|FG000|Second Test (1 Hour)|Physician Decision|1|||
125881553|NCT02628873|452864707|FG001|Second Test (1 Hour)|Physician Decision|0|||
125881554|NCT00541658|452864708|FG000|Overall Study|Adverse Event|28|||
125881555|NCT00541658|452864709|FG001|Overall Study|Adverse Event|37|||
125881556|NCT00541658|452864710|FG002|Overall Study|Adverse Event|25|||
125881557|NCT00541658|452864708|FG000|Overall Study|Physician Decision|0|||
125881558|NCT00541658|452864709|FG001|Overall Study|Physician Decision|0|||
125881559|NCT00541658|452864710|FG002|Overall Study|Physician Decision|4|||
125881560|NCT00541658|452864708|FG000|Overall Study|Lost to Follow-up|3|||
125881561|NCT00541658|452864709|FG001|Overall Study|Lost to Follow-up|3|||
125881562|NCT00541658|452864710|FG002|Overall Study|Lost to Follow-up|6|||
125881563|NCT00541658|452864708|FG000|Overall Study|Protocol Violation|0|||
125881564|NCT00541658|452864709|FG001|Overall Study|Protocol Violation|1|||
125881565|NCT00541658|452864710|FG002|Overall Study|Protocol Violation|1|||
125881566|NCT00541658|452864708|FG000|Overall Study|Withdrawal by Subject|28|||
125881567|NCT00541658|452864709|FG001|Overall Study|Withdrawal by Subject|32|||
125881568|NCT00541658|452864710|FG002|Overall Study|Withdrawal by Subject|32|||
125881569|NCT00541658|452864708|FG000|Overall Study|Took No Study Drug|1|||
125881570|NCT00541658|452864709|FG001|Overall Study|Took No Study Drug|0|||
126363427|NCT02852005|454623490|FG003|Overall Study|Withdrawal by Subject|0|||
125881571|NCT00541658|452864710|FG002|Overall Study|Took No Study Drug|0|||
125881572|NCT04123470|452864711|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
125881573|NCT04123470|452864712|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
125881574|NCT04123470|452864711|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
125881575|NCT04123470|452864712|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
125881576|NCT04123470|452864711|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
125881577|NCT04123470|452864712|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
125881578|NCT04123470|452864711|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
125881579|NCT04123470|452864712|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
125881580|NCT02195518|452864713|FG000|Overall Study|Adverse Event|1|||
125881581|NCT02195518|452864713|FG000|Overall Study|Protocol Violation|4|||
125881582|NCT02195518|452864713|FG000|Overall Study|Pregnancy|2|||
126363428|NCT02852005|454623491|FG004|Overall Study|Withdrawal by Subject|0|||
126363429|NCT02294019|454623493|FG000|Overall Study|Adverse Event|2|||
126363430|NCT02294019|454623493|FG000|Overall Study|Protocol Violation|68|||
126363431|NCT02294019|454623493|FG000|Overall Study|Lost to Follow-up|31|||
126363432|NCT02294019|454623493|FG000|Overall Study|Other|1|||
126363433|NCT02294019|454623493|FG000|Overall Study|Withdrawal by Subject|1|||
126363434|NCT02369159|454623494|FG000|Overall Study|Adverse Event|0|||
126363435|NCT02369159|454623495|FG001|Overall Study|Adverse Event|1|||
126363436|NCT02369159|454623494|FG000|Overall Study|Lost to Follow-up|1|||
126363437|NCT02369159|454623495|FG001|Overall Study|Lost to Follow-up|1|||
126363438|NCT02369159|454623494|FG000|Overall Study|Withdrawal by Subject|7|||
126363439|NCT02369159|454623495|FG001|Overall Study|Withdrawal by Subject|0|||
126363440|NCT03769116|454623496|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
125881583|NCT02195518|452864713|FG000|Overall Study|Withdrawal by Subject|1|||
125881584|NCT02195518|452864713|FG000|Overall Study|Lost to Follow-up|1|||
125881585|NCT05530252|452864714|FG000|Overall Study|Lost to Follow-up|1|||
125881586|NCT05530252|452864715|FG001|Overall Study|Lost to Follow-up|1|||
125881587|NCT05530252|452864716|FG002|Overall Study|Lost to Follow-up|1|||
125881588|NCT00911170|452864722|FG000|Treatment Period|Randomized in error|1|||
125881589|NCT00911170|452864723|FG001|Treatment Period|Randomized in error|1|||
125881590|NCT00911170|452864722|FG000|Treatment Period|Ineligibility determined|1|||
126363441|NCT03769116|454623497|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
126363442|NCT03769116|454623496|FG000|Part 3 - Open Label|Physician Decision|1|||
126038758|NCT04625725|453441826|FG004|Provent Main Study|Adverse Event|0|||
126038759|NCT04625725|453441827|FG005|Provent Main Study|Adverse Event|0|||
126038760|NCT04625725|453441822|FG000|Provent Main Study|Participants dosed in sub-study|310|||
126038761|NCT04625725|453441823|FG001|Provent Main Study|Participants dosed in sub-study|193|||
126038762|NCT04625725|453441824|FG002|Provent Main Study|Participants dosed in sub-study|0|||
126038763|NCT04625725|453441825|FG003|Provent Main Study|Participants dosed in sub-study|0|||
126038764|NCT04625725|453441826|FG004|Provent Main Study|Participants dosed in sub-study|0|||
126038765|NCT04625725|453441827|FG005|Provent Main Study|Participants dosed in sub-study|0|||
126038766|NCT04625725|453441822|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
126038767|NCT04625725|453441823|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
126278209|NCT03796039|454309159|FG000|Overall Study|Death|2|||
126278210|NCT03796039|454309160|FG001|Overall Study|Death|1|||
126278211|NCT03796039|454309159|FG000|Overall Study|Withdrawal by Subject|7|||
126278212|NCT03796039|454309160|FG001|Overall Study|Withdrawal by Subject|4|||
126278213|NCT02927366|454309161|FG000|Overall Study|Adverse Event|1|||
126278214|NCT02927366|454309162|FG001|Overall Study|Adverse Event|0|||
126278215|NCT02927366|454309161|FG000|Overall Study|Patient schedule|1|||
126038768|NCT04625725|453441824|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
126038769|NCT04625725|453441825|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
126038770|NCT04625725|453441826|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
126038771|NCT04625725|453441827|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
126038772|NCT04625725|453441822|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
126038773|NCT04625725|453441823|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
126038774|NCT04625725|453441824|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
126038775|NCT04625725|453441825|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
126038776|NCT04625725|453441826|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
126038777|NCT04625725|453441827|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
126278216|NCT02927366|454309162|FG001|Overall Study|Patient schedule|0|||
126278217|NCT00587990|454309163|FG000|Overall Study|Death|0|||
126363443|NCT03769116|454623497|FG001|Part 3 - Open Label|Physician Decision|0|||
126363444|NCT03769116|454623496|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
126038778|NCT04625725|453441822|FG000|Provent Main Study|INCARCERATION|3|||
126038779|NCT04625725|453441823|FG001|Provent Main Study|INCARCERATION|0|||
126038780|NCT04625725|453441824|FG002|Provent Main Study|INCARCERATION|0|||
126038781|NCT04625725|453441825|FG003|Provent Main Study|INCARCERATION|0|||
126038782|NCT04625725|453441826|FG004|Provent Main Study|INCARCERATION|0|||
126038783|NCT04625725|453441827|FG005|Provent Main Study|INCARCERATION|0|||
126038784|NCT04625725|453441822|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
126038785|NCT04625725|453441823|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
126038786|NCT04625725|453441824|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
126038787|NCT04625725|453441825|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
126038788|NCT04625725|453441826|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
126038789|NCT04625725|453441827|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
126038790|NCT04625725|453441822|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
126038791|NCT04625725|453441823|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
126038792|NCT04625725|453441824|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
126038793|NCT04625725|453441825|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
126038794|NCT04625725|453441826|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
126038795|NCT04625725|453441827|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
126038796|NCT04625725|453441822|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
126038797|NCT04625725|453441823|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
126038798|NCT04625725|453441824|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
126038799|NCT04625725|453441825|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
126278218|NCT00587990|454309164|FG001|Overall Study|Death|0|||
126363445|NCT03769116|454623497|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
126363446|NCT01887600|454623505|FG000|Overall Study|Death|39|||
126363447|NCT01887600|454623506|FG001|Overall Study|Death|16|||
126363448|NCT01887600|454623505|FG000|Overall Study|Lack of Efficacy|3|||
126363449|NCT01887600|454623506|FG001|Overall Study|Lack of Efficacy|26|||
126363450|NCT01887600|454623505|FG000|Overall Study|Lost to Follow-up|5|||
126363451|NCT01887600|454623506|FG001|Overall Study|Lost to Follow-up|1|||
126363452|NCT01887600|454623505|FG000|Overall Study|Physician Decision|7|||
126363453|NCT01887600|454623506|FG001|Overall Study|Physician Decision|8|||
126363454|NCT01887600|454623505|FG000|Overall Study|Protocol Deviation|3|||
126363455|NCT01887600|454623506|FG001|Overall Study|Protocol Deviation|0|||
126363456|NCT01887600|454623505|FG000|Overall Study|Withdrawal by Subject|58|||
126363457|NCT01887600|454623506|FG001|Overall Study|Withdrawal by Subject|52|||
126363458|NCT01887600|454623505|FG000|Overall Study|Adverse Event|21|||
126363459|NCT01887600|454623506|FG001|Overall Study|Adverse Event|9|||
126363460|NCT01887600|454623505|FG000|Overall Study|Non-compliance with study drug|3|||
126278219|NCT00587990|454309165|FG002|Overall Study|Death|1|||
126278220|NCT02754856|454309166|FG000|Overall Study|Withdrawal by Subject|1|||
126363461|NCT01887600|454623506|FG001|Overall Study|Non-compliance with study drug|0|||
126363462|NCT01887600|454623505|FG000|Overall Study|Miscellaneous|6|||
125881591|NCT00911170|452864723|FG001|Treatment Period|Ineligibility determined|3|||
125881592|NCT00911170|452864722|FG000|Treatment Period|Protocol deviation|1|||
125881593|NCT00911170|452864723|FG001|Treatment Period|Protocol deviation|2|||
125881594|NCT00911170|452864722|FG000|Treatment Period|Adverse Event|9|||
125881595|NCT00911170|452864723|FG001|Treatment Period|Adverse Event|10|||
125881596|NCT00911170|452864722|FG000|Treatment Period|Withdrawal by Subject|4|||
125881597|NCT00911170|452864723|FG001|Treatment Period|Withdrawal by Subject|4|||
125881598|NCT00911170|452864722|FG000|Treatment Period|Disease progression|0|||
125881599|NCT00911170|452864723|FG001|Treatment Period|Disease progression|2|||
125881600|NCT00911170|452864722|FG000|Treatment Period|Physician Decision|5|||
125881601|NCT00911170|452864723|FG001|Treatment Period|Physician Decision|5|||
125881602|NCT00911170|452864722|FG000|Treatment Period|Lost to Follow-up|0|||
125881603|NCT00911170|452864723|FG001|Treatment Period|Lost to Follow-up|1|||
125881604|NCT00911170|452864722|FG000|Treatment Period|Death|6|||
125881605|NCT00911170|452864723|FG001|Treatment Period|Death|9|||
125881606|NCT00911170|452864722|FG000|Long Term Follow-Up|Continuing in study|274|||
125881607|NCT00911170|452864723|FG001|Long Term Follow-Up|Continuing in study|269|||
125881608|NCT00911170|452864722|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
125881609|NCT00911170|452864723|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
126038800|NCT04625725|453441826|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
126038801|NCT04625725|453441827|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
126038802|NCT04625725|453441822|FG000|Provent Main Study|MISSING REASON|0|||
126278221|NCT01147107|454309167|FG000|Overall Study|Lack of Efficacy|5|||
126278222|NCT01147107|454309168|FG001|Overall Study|Lack of Efficacy|0|||
126278223|NCT01147107|454309167|FG000|Overall Study|Withdrawal by Subject|1|||
126278224|NCT01147107|454309168|FG001|Overall Study|Withdrawal by Subject|1|||
126278225|NCT04693416|454309169|FG000|Overall Study|Lost to Follow-up|13|||
126038803|NCT04625725|453441823|FG001|Provent Main Study|MISSING REASON|1|||
126038804|NCT04625725|453441824|FG002|Provent Main Study|MISSING REASON|0|||
126278226|NCT04693416|454309170|FG001|Overall Study|Lost to Follow-up|0|||
126278227|NCT00474266|454309171|FG000|Overall Study|Withdrawal by Subject|7|||
126278228|NCT00474266|454309172|FG001|Overall Study|Withdrawal by Subject|20|||
126278229|NCT00474266|454309173|FG002|Overall Study|Withdrawal by Subject|4|||
126278230|NCT00474266|454309174|FG003|Overall Study|Withdrawal by Subject|7|||
126278231|NCT02774642|454309175|FG000|Overall Study|Lost to Follow-up|9|||
126278232|NCT02774642|454309176|FG001|Overall Study|Lost to Follow-up|7|||
126363463|NCT01887600|454623506|FG001|Overall Study|Miscellaneous|2|||
126038805|NCT04625725|453441825|FG003|Provent Main Study|MISSING REASON|0|||
126038806|NCT04625725|453441826|FG004|Provent Main Study|MISSING REASON|0|||
126038807|NCT04625725|453441827|FG005|Provent Main Study|MISSING REASON|0|||
126038808|NCT04625725|453441822|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126038809|NCT04625725|453441823|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126038810|NCT04625725|453441824|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126038811|NCT04625725|453441825|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
126038812|NCT04625725|453441826|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126038813|NCT04625725|453441827|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126038814|NCT04625725|453441822|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126038815|NCT04625725|453441823|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126038816|NCT04625725|453441824|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
126038817|NCT04625725|453441825|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126038818|NCT04625725|453441826|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126038819|NCT04625725|453441827|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126038820|NCT04625725|453441822|FG000|Provent Sub Study|Lost to Follow-up|0|||
126038821|NCT04625725|453441823|FG001|Provent Sub Study|Lost to Follow-up|0|||
126038822|NCT04625725|453441824|FG002|Provent Sub Study|Lost to Follow-up|20|||
126038823|NCT04625725|453441825|FG003|Provent Sub Study|Lost to Follow-up|10|||
126038824|NCT04625725|453441826|FG004|Provent Sub Study|Lost to Follow-up|6|||
126038825|NCT04625725|453441827|FG005|Provent Sub Study|Lost to Follow-up|4|||
126038826|NCT04625725|453441822|FG000|Provent Sub Study|Death|0|||
126038827|NCT04625725|453441823|FG001|Provent Sub Study|Death|0|||
126038828|NCT04625725|453441824|FG002|Provent Sub Study|Death|8|||
126363464|NCT01887600|454623505|FG000|Overall Study|Progressive Disease|1|||
126363465|NCT01887600|454623506|FG001|Overall Study|Progressive Disease|0|||
126038829|NCT04625725|453441825|FG003|Provent Sub Study|Death|5|||
126038830|NCT04625725|453441826|FG004|Provent Sub Study|Death|0|||
126038831|NCT04625725|453441827|FG005|Provent Sub Study|Death|1|||
126038832|NCT04625725|453441822|FG000|Provent Sub Study|Adverse Event|0|||
126278233|NCT00426361|454309177|FG000|Overall Study|Lost to Follow-up|3|||
126363466|NCT03688139|454623507|FG000|Overall Study|Lost to Follow-up|2|||
125881610|NCT00911170|452864722|FG000|Long Term Follow-Up|Physician Decision|5|||
125881611|NCT00911170|452864723|FG001|Long Term Follow-Up|Physician Decision|4|||
125881612|NCT00911170|452864722|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
125881613|NCT00911170|452864723|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
125881614|NCT00911170|452864722|FG000|Long Term Follow-Up|Death|116|||
126038833|NCT04625725|453441823|FG001|Provent Sub Study|Adverse Event|0|||
126038834|NCT04625725|453441824|FG002|Provent Sub Study|Adverse Event|0|||
126038835|NCT04625725|453441825|FG003|Provent Sub Study|Adverse Event|0|||
126038836|NCT04625725|453441826|FG004|Provent Sub Study|Adverse Event|0|||
126038837|NCT04625725|453441827|FG005|Provent Sub Study|Adverse Event|1|||
126038838|NCT04625725|453441822|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126038839|NCT04625725|453441823|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126038840|NCT04625725|453441824|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126038841|NCT04625725|453441825|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126038842|NCT04625725|453441826|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
126038843|NCT04625725|453441827|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126038844|NCT04625725|453441822|FG000|Provent Sub Study|Withdrawal by Subject|0|||
126038845|NCT04625725|453441823|FG001|Provent Sub Study|Withdrawal by Subject|0|||
126038846|NCT04625725|453441824|FG002|Provent Sub Study|Withdrawal by Subject|11|||
126038847|NCT04625725|453441825|FG003|Provent Sub Study|Withdrawal by Subject|13|||
126038848|NCT04625725|453441826|FG004|Provent Sub Study|Withdrawal by Subject|5|||
126038849|NCT04625725|453441827|FG005|Provent Sub Study|Withdrawal by Subject|6|||
126038850|NCT04625725|453441822|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126038851|NCT04625725|453441823|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126038852|NCT04625725|453441824|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126038853|NCT04625725|453441825|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126038854|NCT04625725|453441826|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126038855|NCT04625725|453441827|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
126038856|NCT03298451|453441831|FG000|Overall Study|Death|275|||
126363467|NCT03688139|454623508|FG001|Overall Study|Lost to Follow-up|0|||
126363468|NCT03688139|454623507|FG000|Overall Study|Physician Decision|0|||
126363469|NCT03688139|454623508|FG001|Overall Study|Physician Decision|1|||
126363470|NCT03688139|454623507|FG000|Overall Study|Withdrawal by Subject|2|||
126363471|NCT03688139|454623508|FG001|Overall Study|Withdrawal by Subject|3|||
126363472|NCT01390584|454623515|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
126363473|NCT01390584|454623516|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
126363474|NCT01390584|454623517|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
126363475|NCT01835431|454623518|FG000|Overall Study|Adverse Event|1|||
126363476|NCT01835431|454623519|FG001|Overall Study|Adverse Event|0|||
126363477|NCT01835431|454623518|FG000|Overall Study|other|0|||
126363478|NCT01835431|454623519|FG001|Overall Study|other|2|||
126363479|NCT01835431|454623518|FG000|Overall Study|Withdrawal by Subject|6|||
126363480|NCT01835431|454623519|FG001|Overall Study|Withdrawal by Subject|10|||
126363481|NCT01835431|454623518|FG000|Overall Study|Protocol Violation|1|||
126363482|NCT01835431|454623519|FG001|Overall Study|Protocol Violation|0|||
126363483|NCT00655356|454623520|FG000|Overall Study|Withdrawal by Subject|3|||
126363484|NCT00655356|454623521|FG001|Overall Study|Withdrawal by Subject|4|||
126363485|NCT00655356|454623520|FG000|Overall Study|Sponsor Request|10|||
126363486|NCT00655356|454623521|FG001|Overall Study|Sponsor Request|4|||
126363487|NCT00655356|454623520|FG000|Overall Study|Adverse Event|1|||
126363488|NCT00655356|454623521|FG001|Overall Study|Adverse Event|1|||
126363489|NCT00655356|454623520|FG000|Overall Study|Protocol Violation|2|||
126363490|NCT00655356|454623521|FG001|Overall Study|Protocol Violation|1|||
126363491|NCT00655356|454623520|FG000|Overall Study|Other Reason|1|||
126363492|NCT00655356|454623521|FG001|Overall Study|Other Reason|0|||
126363493|NCT02496156|454623522|FG000|Overall Study|Lost to Follow-up|5|||
126363494|NCT02496156|454623523|FG001|Overall Study|Lost to Follow-up|0|||
126363495|NCT02496156|454623522|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
126363496|NCT02496156|454623523|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
126363497|NCT03760666|454623524|FG000|Overall Study|Adverse Event|2|||
126363498|NCT03760666|454623525|FG001|Overall Study|Adverse Event|4|||
126363499|NCT03760666|454623526|FG002|Overall Study|Adverse Event|1|||
126363500|NCT03760666|454623524|FG000|Overall Study|AML Disease Progression|3|||
126363501|NCT03760666|454623525|FG001|Overall Study|AML Disease Progression|3|||
126363502|NCT03760666|454623526|FG002|Overall Study|AML Disease Progression|0|||
126363503|NCT03760666|454623524|FG000|Overall Study|Physician Decision|0|||
126363504|NCT03760666|454623525|FG001|Overall Study|Physician Decision|3|||
126363505|NCT03760666|454623526|FG002|Overall Study|Physician Decision|0|||
126363506|NCT03760666|454623524|FG000|Overall Study|Withdrawal by Subject|0|||
126363507|NCT03760666|454623525|FG001|Overall Study|Withdrawal by Subject|1|||
126363508|NCT03760666|454623526|FG002|Overall Study|Withdrawal by Subject|0|||
126363509|NCT04349098|454623527|FG000|Overall Study|Death|16|||
126363510|NCT04349098|454623528|FG001|Overall Study|Death|8|||
126363511|NCT04349098|454623527|FG000|Overall Study|Lost to Follow-up|11|||
126363512|NCT04349098|454623528|FG001|Overall Study|Lost to Follow-up|8|||
126363513|NCT04349098|454623527|FG000|Overall Study|Withdrawal by Subject|8|||
126363514|NCT04349098|454623528|FG001|Overall Study|Withdrawal by Subject|5|||
126363515|NCT04349098|454623527|FG000|Overall Study|Other|3|||
126363516|NCT04349098|454623528|FG001|Overall Study|Other|5|||
126363517|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
126038857|NCT03298451|453441832|FG001|Overall Study|Death|260|||
125881615|NCT00911170|452864723|FG001|Long Term Follow-Up|Death|121|||
126038858|NCT03298451|453441833|FG002|Overall Study|Death|122|||
126038859|NCT03298451|453441834|FG003|Overall Study|Death|280|||
126038860|NCT03298451|453441831|FG000|Overall Study|Lost to Follow-up|1|||
126038861|NCT03298451|453441832|FG001|Overall Study|Lost to Follow-up|1|||
126038862|NCT03298451|453441833|FG002|Overall Study|Lost to Follow-up|0|||
126038863|NCT03298451|453441834|FG003|Overall Study|Lost to Follow-up|7|||
126038864|NCT03298451|453441831|FG000|Overall Study|Withdrawal by Subject|9|||
126038865|NCT03298451|453441832|FG001|Overall Study|Withdrawal by Subject|7|||
126038866|NCT03298451|453441833|FG002|Overall Study|Withdrawal by Subject|1|||
126038867|NCT03298451|453441834|FG003|Overall Study|Withdrawal by Subject|20|||
126038868|NCT01651403|453441837|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
126038869|NCT01651403|453441838|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
126038870|NCT01651403|453441837|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
126038871|NCT01651403|453441838|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
125881616|NCT01389596|452866930|FG000|Overall Study|Protocol Violation|3|||
126038872|NCT01651403|453441837|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
126038873|NCT01651403|453441838|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
126038874|NCT01651403|453441837|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
126038875|NCT01651403|453441838|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
126038876|NCT01651403|453441837|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
126038877|NCT01651403|453441838|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
126038878|NCT01651403|453441837|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
126038879|NCT01651403|453441838|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
126038880|NCT05873556|453441839|FG000|Overall Study|Lost to Follow-up|4|||
126038881|NCT05873556|453441840|FG001|Overall Study|Lost to Follow-up|1|||
126038882|NCT03381586|453441841|FG000|Overall Study|Adverse Event|1|||
126038883|NCT03381586|453441842|FG001|Overall Study|Adverse Event|1|||
126038884|NCT03381586|453441841|FG000|Overall Study|Protocol Violation|1|||
126038885|NCT03381586|453441842|FG001|Overall Study|Protocol Violation|0|||
126038886|NCT03381586|453441841|FG000|Overall Study|Withdrawal by Subject|1|||
126038887|NCT03381586|453441842|FG001|Overall Study|Withdrawal by Subject|2|||
126038888|NCT05299723|453443454|FG000|Overall Study|Withdrawal by Subject|0|||
126038889|NCT05299723|453443455|FG001|Overall Study|Withdrawal by Subject|2|||
126038890|NCT05299723|453443456|FG002|Overall Study|Withdrawal by Subject|0|||
126038891|NCT03220035|453443457|FG000|Overall Study|Adverse Event|1|||
126038892|NCT03220035|453443457|FG000|Overall Study|Protocol Violation|1|||
126038893|NCT03220035|453443457|FG000|Overall Study|Progressive Disease|2|||
126038894|NCT05934942|453443463|FG000|Run-in Period|Not treated|1|||
126038895|NCT05934942|453443463|FG000|Run-in Period|Withdrawal by Subject|1|||
126038896|NCT04447040|453443464|FG000|Overall Study|Lost to Follow-up|2|||
126038897|NCT04447040|453443465|FG001|Overall Study|Lost to Follow-up|1|||
126038898|NCT04447040|453443466|FG002|Overall Study|Lost to Follow-up|3|||
126038899|NCT04447040|453443467|FG003|Overall Study|Lost to Follow-up|3|||
126038900|NCT04447040|453443468|FG004|Overall Study|Lost to Follow-up|1|||
126038901|NCT04447040|453443469|FG005|Overall Study|Lost to Follow-up|3|||
126038902|NCT04447040|453443464|FG000|Overall Study|Withdrawal by Subject|0|||
126038903|NCT04447040|453443465|FG001|Overall Study|Withdrawal by Subject|1|||
126038904|NCT04447040|453443466|FG002|Overall Study|Withdrawal by Subject|1|||
126038905|NCT04447040|453443467|FG003|Overall Study|Withdrawal by Subject|1|||
126038906|NCT04447040|453443468|FG004|Overall Study|Withdrawal by Subject|0|||
126038907|NCT04447040|453443469|FG005|Overall Study|Withdrawal by Subject|0|||
126038908|NCT04076618|453443470|FG000|Overall Study|Lost to Follow-up|2|||
126038909|NCT04076618|453443471|FG001|Overall Study|Lost to Follow-up|1|||
126038910|NCT04076618|453443472|FG002|Overall Study|Lost to Follow-up|3|||
126038911|NCT04076618|453443470|FG000|Overall Study|Withdrawal by Subject|3|||
126038912|NCT04076618|453443471|FG001|Overall Study|Withdrawal by Subject|1|||
126038913|NCT04076618|453443472|FG002|Overall Study|Withdrawal by Subject|2|||
126038914|NCT04076618|453443470|FG000|Overall Study|Relocated out of state|0|||
126038915|NCT04076618|453443471|FG001|Overall Study|Relocated out of state|2|||
126038916|NCT04076618|453443472|FG002|Overall Study|Relocated out of state|0|||
126038917|NCT04076618|453443470|FG000|Overall Study|COVID concerns|0|||
126038918|NCT04076618|453443471|FG001|Overall Study|COVID concerns|1|||
126038919|NCT04076618|453443472|FG002|Overall Study|COVID concerns|0|||
126038920|NCT04076618|453443470|FG000|Overall Study|Adverse Event|0|||
126038921|NCT04076618|453443471|FG001|Overall Study|Adverse Event|0|||
126038922|NCT04076618|453443472|FG002|Overall Study|Adverse Event|2|||
126038923|NCT01928394|453443473|FG000|Treatment Period|Disease progression|17|||
126038924|NCT01928394|453443474|FG001|Treatment Period|Disease progression|2|||
126038925|NCT01928394|453443475|FG002|Treatment Period|Disease progression|12|||
126038926|NCT01928394|453443476|FG003|Treatment Period|Disease progression|48|||
126038927|NCT01928394|453443477|FG004|Treatment Period|Disease progression|3|||
126038928|NCT01928394|453443478|FG005|Treatment Period|Disease progression|25|||
126038929|NCT01928394|453443479|FG006|Treatment Period|Disease progression|38|||
126038930|NCT01928394|453443480|FG007|Treatment Period|Disease progression|16|||
126038931|NCT01928394|453443481|FG008|Treatment Period|Disease progression|3|||
126038932|NCT01928394|453443482|FG009|Treatment Period|Disease progression|11|||
126038933|NCT01928394|453443483|FG010|Treatment Period|Disease progression|22|||
126038934|NCT01928394|453443484|FG011|Treatment Period|Disease progression|73|||
126278234|NCT00426361|454309178|FG001|Overall Study|Lost to Follow-up|2|||
126278235|NCT00426361|454309179|FG002|Overall Study|Lost to Follow-up|5|||
126278236|NCT00426361|454309177|FG000|Overall Study|Withdrawal by Subject|1|||
126278237|NCT00426361|454309178|FG001|Overall Study|Withdrawal by Subject|3|||
126278238|NCT00426361|454309179|FG002|Overall Study|Withdrawal by Subject|0|||
126278239|NCT04642365|454309182|FG000|Overall Study|Death|3|||
126278240|NCT04642365|454309183|FG001|Overall Study|Death|2|||
126278241|NCT04642365|454309184|FG002|Overall Study|Death|4|||
126038935|NCT01928394|453443485|FG012|Treatment Period|Disease progression|38|||
126038936|NCT01928394|453443486|FG013|Treatment Period|Disease progression|118|||
126038937|NCT01928394|453443487|FG014|Treatment Period|Disease progression|59|||
126038938|NCT01928394|453443488|FG015|Treatment Period|Disease progression|1|||
126038939|NCT01928394|453443489|FG016|Treatment Period|Disease progression|43|||
126038940|NCT01928394|453443490|FG017|Treatment Period|Disease progression|56|||
126038941|NCT01928394|453443491|FG018|Treatment Period|Disease progression|50|||
126278242|NCT04642365|454309185|FG003|Overall Study|Death|5|||
126038942|NCT01928394|453443492|FG019|Treatment Period|Disease progression|71|||
125881617|NCT01389596|452866931|FG001|Overall Study|Protocol Violation|4|||
125881618|NCT01389596|452866932|FG002|Overall Study|Protocol Violation|3|||
125881619|NCT01389596|452866930|FG000|Overall Study|Withdrawal by Subject|1|||
125881620|NCT01389596|452866931|FG001|Overall Study|Withdrawal by Subject|2|||
125881621|NCT01389596|452866932|FG002|Overall Study|Withdrawal by Subject|2|||
125881622|NCT01389596|452866930|FG000|Overall Study|Insufficient Clinical Response|3|||
125881623|NCT01389596|452866931|FG001|Overall Study|Insufficient Clinical Response|4|||
125881624|NCT01389596|452866932|FG002|Overall Study|Insufficient Clinical Response|5|||
125881625|NCT01389596|452866930|FG000|Overall Study|Adverse Event|1|||
125881626|NCT01389596|452866931|FG001|Overall Study|Adverse Event|4|||
125881627|NCT01389596|452866932|FG002|Overall Study|Adverse Event|0|||
125881628|NCT01389596|452866930|FG000|Overall Study|Death|0|||
125881629|NCT01389596|452866931|FG001|Overall Study|Death|1|||
125881630|NCT01389596|452866932|FG002|Overall Study|Death|0|||
125881631|NCT01389596|452866930|FG000|Overall Study|Other Unspecified|2|||
125881632|NCT01389596|452866931|FG001|Overall Study|Other Unspecified|1|||
125881633|NCT01389596|452866932|FG002|Overall Study|Other Unspecified|0|||
125881634|NCT03877510|452866939|FG000|Overall Study|Death|6|||
125881635|NCT03877510|452866939|FG000|Overall Study|Lost to Follow-up|2|||
125881636|NCT03877510|452866939|FG000|Overall Study|Non-compliance with study drug|2|||
125881637|NCT03877510|452866939|FG000|Overall Study|Lack of Efficacy|14|||
125881638|NCT03877510|452866939|FG000|Overall Study|Adverse Event|20|||
125881639|NCT03877510|452866939|FG000|Overall Study|Withdrawal by Subject|22|||
125881640|NCT03877510|452866939|FG000|Overall Study|Miscellaneous|1|||
125881641|NCT02085161|452866941|FG000|Overall Study|Not Treated|1|||
125881642|NCT02085161|452866942|FG001|Overall Study|Not Treated|0|||
125881643|NCT02085161|452866943|FG002|Overall Study|Not Treated|0|||
125881644|NCT02085161|452866944|FG003|Overall Study|Not Treated|0|||
125881645|NCT02085161|452866941|FG000|Overall Study|Adverse Event|8|||
125881646|NCT02085161|452866942|FG001|Overall Study|Adverse Event|5|||
125881647|NCT02085161|452866943|FG002|Overall Study|Adverse Event|4|||
125881648|NCT02085161|452866944|FG003|Overall Study|Adverse Event|5|||
125881649|NCT02085161|452866941|FG000|Overall Study|Protocol Violation|0|||
125881650|NCT02085161|452866942|FG001|Overall Study|Protocol Violation|1|||
125881651|NCT02085161|452866943|FG002|Overall Study|Protocol Violation|0|||
125881652|NCT02085161|452866944|FG003|Overall Study|Protocol Violation|1|||
125881653|NCT02085161|452866941|FG000|Overall Study|Withdrawal by Subject|2|||
125881654|NCT02085161|452866942|FG001|Overall Study|Withdrawal by Subject|4|||
125881655|NCT02085161|452866943|FG002|Overall Study|Withdrawal by Subject|0|||
125881656|NCT02085161|452866944|FG003|Overall Study|Withdrawal by Subject|3|||
125881657|NCT02085161|452866941|FG000|Overall Study|Other Reason|1|||
125881658|NCT02085161|452866942|FG001|Overall Study|Other Reason|0|||
125881659|NCT02085161|452866943|FG002|Overall Study|Other Reason|1|||
125881660|NCT02085161|452866944|FG003|Overall Study|Other Reason|1|||
125881661|NCT01936870|452866949|FG000|Overall Study|No Visit After Treatment|176|||
125881662|NCT01936870|452866949|FG000|Overall Study|Protocol Violation|12|||
125881663|NCT01936870|452866949|FG000|Overall Study|No Drug Administration|1|||
125881664|NCT02399163|452866952|FG000|Overall Study|Adverse Event|2|||
125881665|NCT02399163|452866952|FG000|Overall Study|Protocol Deviation|2|||
125881666|NCT02399163|452866952|FG000|Overall Study|Withdrawal by Participant|5|||
125881667|NCT03910244|452866953|FG000|Overall Study|Adverse Event|14|||
125881668|NCT03910244|452866954|FG001|Overall Study|Adverse Event|0|||
125881669|NCT03910244|452866953|FG000|Overall Study|Death|1|||
125881670|NCT03910244|452866954|FG001|Overall Study|Death|0|||
125881671|NCT03910244|452866953|FG000|Overall Study|Lost to Follow-up|0|||
125881672|NCT03910244|452866954|FG001|Overall Study|Lost to Follow-up|2|||
125881673|NCT03910244|452866953|FG000|Overall Study|Joint withdrawal decision|1|||
125881674|NCT03910244|452866954|FG001|Overall Study|Joint withdrawal decision|0|||
125881675|NCT03910244|452866953|FG000|Overall Study|Study Terminated by Sponsor|7|||
125881676|NCT03910244|452866954|FG001|Overall Study|Study Terminated by Sponsor|4|||
126038943|NCT01928394|453443493|FG020|Treatment Period|Disease progression|30|||
126038944|NCT01928394|453443494|FG021|Treatment Period|Disease progression|31|||
126038945|NCT01928394|453443495|FG022|Treatment Period|Disease progression|31|||
125881677|NCT03910244|452866953|FG000|Overall Study|Physician Decision|1|||
125881678|NCT03910244|452866954|FG001|Overall Study|Physician Decision|0|||
125881679|NCT03910244|452866953|FG000|Overall Study|Protocol Violation|1|||
125881680|NCT03910244|452866954|FG001|Overall Study|Protocol Violation|0|||
125881681|NCT03910244|452866953|FG000|Overall Study|Withdrawal by Subject|7|||
125881682|NCT03910244|452866954|FG001|Overall Study|Withdrawal by Subject|2|||
125881683|NCT03594110|452866955|FG000|Interventional Part|Participant concerned about study treatment|23|||
125881684|NCT03594110|452866956|FG001|Interventional Part|Participant concerned about study treatment|28|||
125881685|NCT03594110|452866955|FG000|Interventional Part|Doctor advice|38|||
125881686|NCT03594110|452866956|FG001|Interventional Part|Doctor advice|40|||
125881687|NCT03594110|452866955|FG000|Interventional Part|Participants' wish|89|||
125881688|NCT03594110|452866956|FG001|Interventional Part|Participants' wish|68|||
125881689|NCT03594110|452866955|FG000|Interventional Part|Adverse event-non-fatal events|119|||
125881690|NCT03594110|452866956|FG001|Interventional Part|Adverse event-non-fatal events|116|||
125881691|NCT03594110|452866955|FG000|Interventional Part|Study drug stopped, reason missing|336|||
126363518|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
126363519|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126363520|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
126363521|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
126363522|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
126363523|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
126363524|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126363525|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126363526|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
126363527|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126363528|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126363529|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126363530|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126363531|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
126363532|NCT01703221|454623529|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
126363533|NCT01703221|454623530|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
126363534|NCT01703221|454623531|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
126363535|NCT01703221|454623529|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
126363536|NCT01703221|454623530|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
126363537|NCT01703221|454623531|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
126363538|NCT01703221|454623529|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
126363539|NCT01703221|454623530|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
126363540|NCT01703221|454623531|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
126363541|NCT05486065|454623532|FG000|Overall Study|Withdrawal by Subject|1|||
126363542|NCT05486065|454623533|FG001|Overall Study|Withdrawal by Subject|5|||
126363543|NCT05486065|454623534|FG002|Overall Study|Withdrawal by Subject|4|||
126363544|NCT05486065|454623535|FG003|Overall Study|Withdrawal by Subject|3|||
126363545|NCT05486065|454623532|FG000|Overall Study|Lost to Follow-up|4|||
126363546|NCT05486065|454623533|FG001|Overall Study|Lost to Follow-up|2|||
126363547|NCT05486065|454623534|FG002|Overall Study|Lost to Follow-up|2|||
126363548|NCT05486065|454623535|FG003|Overall Study|Lost to Follow-up|2|||
126363549|NCT05486065|454623532|FG000|Overall Study|Physician Decision|0|||
126363550|NCT05486065|454623533|FG001|Overall Study|Physician Decision|1|||
126363551|NCT05486065|454623534|FG002|Overall Study|Physician Decision|1|||
126363552|NCT05486065|454623535|FG003|Overall Study|Physician Decision|0|||
126363553|NCT05486065|454623532|FG000|Overall Study|Failure to meet randomization criteria|0|||
126363554|NCT05486065|454623533|FG001|Overall Study|Failure to meet randomization criteria|0|||
126363555|NCT05486065|454623534|FG002|Overall Study|Failure to meet randomization criteria|0|||
126363556|NCT05486065|454623535|FG003|Overall Study|Failure to meet randomization criteria|1|||
126363557|NCT03927846|454623537|FG000|Overall Study|Lost to Follow-up|10|||
126363558|NCT03927846|454623538|FG001|Overall Study|Lost to Follow-up|11|||
126363559|NCT03878069|454623539|FG000|Overall Study|Death|0|||
126363560|NCT03878069|454623540|FG001|Overall Study|Death|1|||
126363561|NCT03878069|454623541|FG002|Overall Study|Death|0|||
126363562|NCT00834587|454623542|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126363563|NCT00834587|454623543|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
126363564|NCT03810495|454623544|FG000|Overall Study|Lost to Follow-up|2|||
126363565|NCT03810495|454623544|FG000|Overall Study|Withdrawal by Subject|1|||
126363566|NCT02536339|454623546|FG000|Overall Study|Death|20|||
126363567|NCT02536339|454623546|FG000|Overall Study|Withdrawal by Subject|3|||
126363568|NCT02536339|454623546|FG000|Overall Study|Lost to Follow-up|2|||
126363569|NCT02536339|454623546|FG000|Overall Study|Treatment discontinued|2|||
126363570|NCT02536339|454623546|FG000|Overall Study|Physician Decision|1|||
126038946|NCT01928394|453443473|FG000|Treatment Period|Study drug toxicity|1|||
126363571|NCT03449147|454623547|FG000|52-week Treatment Period|Death|0|||
126363572|NCT03449147|454623548|FG001|52-week Treatment Period|Death|1|||
126363573|NCT03449147|454623549|FG002|52-week Treatment Period|Death|0|||
126363574|NCT03449147|454623547|FG000|52-week Treatment Period|Lost to Follow-up|6|||
126363575|NCT03449147|454623548|FG001|52-week Treatment Period|Lost to Follow-up|2|||
126363576|NCT03449147|454623549|FG002|52-week Treatment Period|Lost to Follow-up|5|||
126363577|NCT03449147|454623547|FG000|52-week Treatment Period|Other|0|||
126363578|NCT03449147|454623548|FG001|52-week Treatment Period|Other|1|||
125881692|NCT03594110|452866956|FG001|Interventional Part|Study drug stopped, reason missing|294|||
125881693|NCT03594110|452866955|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
125881694|NCT03594110|452866956|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
125881695|NCT03594110|452866955|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
125881696|NCT03594110|452866956|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
125881697|NCT03594110|452866955|FG000|Interventional Part|Contraindicated drug started|32|||
125881698|NCT03594110|452866956|FG001|Interventional Part|Contraindicated drug started|18|||
125881699|NCT03594110|452866955|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
125881700|NCT03594110|452866956|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
125881701|NCT03594110|452866955|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
125881702|NCT03594110|452866956|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
125881703|NCT03594110|452866955|FG000|Non-interventional Part|Withdrawal by Subject|3|||
125881704|NCT03594110|452866956|FG001|Non-interventional Part|Withdrawal by Subject|4|||
125881705|NCT03594110|452866955|FG000|Non-interventional Part|Lost to Follow-up|45|||
125881706|NCT03594110|452866956|FG001|Non-interventional Part|Lost to Follow-up|41|||
125881707|NCT00803569|452866959|FG000|Overall Study|Progressive Disease|3|||
125881708|NCT00803569|452866959|FG000|Overall Study|Noncompliance|1|||
125881709|NCT04041414|452866960|FG000|Overall Study|Lost to Follow-up|1|||
125881710|NCT04041414|452866961|FG001|Overall Study|Lost to Follow-up|2|||
125881711|NCT04004988|452866962|FG000|Period 1|Physician Decision|2|||
125881712|NCT04004988|452866963|FG001|Period 1|Physician Decision|0|||
125881713|NCT04004988|452866962|FG000|Period 1|Withdrawal by Subject|0|||
125881714|NCT04004988|452866963|FG001|Period 1|Withdrawal by Subject|1|||
125881715|NCT04004988|452866962|FG000|Period 1|Adverse Event|1|||
125881716|NCT04004988|452866963|FG001|Period 1|Adverse Event|2|||
125881717|NCT00930046|452866964|FG000|Overall Study|Wound catheter malfunctioned|1|||
125881718|NCT00930046|452866965|FG001|Overall Study|Wound catheter malfunctioned|2|||
125881719|NCT01598532|452866966|FG000|Overall Study|Lost to Follow-up|3|||
125881720|NCT01598532|452866966|FG000|Overall Study|Did not meet inclusion criteria|8|||
125881721|NCT04682366|452866967|FG000|Overall Study|Lost to Follow-up|1|||
125881722|NCT04682366|452866968|FG001|Overall Study|Lost to Follow-up|1|||
125881723|NCT04798196|452866971|FG000|Overall Study|Lost to Follow-up|3|||
125881724|NCT04798196|452866972|FG001|Overall Study|Lost to Follow-up|1|||
125881725|NCT04798196|452866973|FG002|Overall Study|Lost to Follow-up|3|||
125881726|NCT00728689|452866980|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
125881727|NCT00728689|452866981|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
125881728|NCT01867671|452866982|FG000|Overall Study|Adverse Event|5|||
125881729|NCT01867671|452866983|FG001|Overall Study|Adverse Event|3|||
125881730|NCT01867671|452866982|FG000|Overall Study|Anaphylaxis|0|||
125881731|NCT01867671|452866983|FG001|Overall Study|Anaphylaxis|1|||
125881732|NCT01867671|452866982|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
125881733|NCT01867671|452866983|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
125881734|NCT01867671|452866982|FG000|Overall Study|Lost to Follow-up|0|||
125881735|NCT01867671|452866983|FG001|Overall Study|Lost to Follow-up|1|||
125881736|NCT01867671|452866982|FG000|Overall Study|Non-compliance with Study Drug|1|||
125881737|NCT01867671|452866983|FG001|Overall Study|Non-compliance with Study Drug|2|||
125881738|NCT01867671|452866982|FG000|Overall Study|Withdrawal by Subject|21|||
125881739|NCT01867671|452866983|FG001|Overall Study|Withdrawal by Subject|21|||
125881740|NCT01523366|452866984|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125881741|NCT01523366|452866985|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125881742|NCT01523366|452866984|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
125881743|NCT01523366|452866985|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
125881744|NCT04543279|452866986|FG000|Overall Study|Withdrawal by Subject|1|||
125881745|NCT04543279|452866987|FG001|Overall Study|Withdrawal by Subject|0|||
125881746|NCT04543279|452866986|FG000|Overall Study|Adverse Event|1|||
125881747|NCT04543279|452866987|FG001|Overall Study|Adverse Event|0|||
125881748|NCT04543279|452866986|FG000|Overall Study|Physician Decision|1|||
126038947|NCT01928394|453443474|FG001|Treatment Period|Study drug toxicity|1|||
126038948|NCT01928394|453443475|FG002|Treatment Period|Study drug toxicity|3|||
126038949|NCT01928394|453443476|FG003|Treatment Period|Study drug toxicity|3|||
126038950|NCT01928394|453443477|FG004|Treatment Period|Study drug toxicity|0|||
126278243|NCT04642365|454309186|FG004|Overall Study|Death|5|||
126278244|NCT04642365|454309187|FG005|Overall Study|Death|3|||
126278245|NCT04642365|454309188|FG006|Overall Study|Death|2|||
126278246|NCT04642365|454309189|FG007|Overall Study|Death|1|||
126278247|NCT04642365|454309182|FG000|Overall Study|Physician Decision|1|||
126278248|NCT04642365|454309183|FG001|Overall Study|Physician Decision|0|||
126278249|NCT04642365|454309184|FG002|Overall Study|Physician Decision|0|||
126278250|NCT04642365|454309185|FG003|Overall Study|Physician Decision|0|||
126278251|NCT04642365|454309186|FG004|Overall Study|Physician Decision|0|||
125881749|NCT04543279|452866987|FG001|Overall Study|Physician Decision|0|||
125881750|NCT00929695|452866988|FG000|Overall Study|Death|2|||
125881751|NCT00929695|452866989|FG001|Overall Study|Death|1|||
126038951|NCT01928394|453443478|FG005|Treatment Period|Study drug toxicity|9|||
126038952|NCT01928394|453443479|FG006|Treatment Period|Study drug toxicity|7|||
126038953|NCT01928394|453443480|FG007|Treatment Period|Study drug toxicity|1|||
126038954|NCT01928394|453443481|FG008|Treatment Period|Study drug toxicity|0|||
126038955|NCT01928394|453443482|FG009|Treatment Period|Study drug toxicity|5|||
126038956|NCT01928394|453443483|FG010|Treatment Period|Study drug toxicity|2|||
126038957|NCT01928394|453443484|FG011|Treatment Period|Study drug toxicity|3|||
126038958|NCT01928394|453443485|FG012|Treatment Period|Study drug toxicity|7|||
126038959|NCT01928394|453443486|FG013|Treatment Period|Study drug toxicity|5|||
126038960|NCT01928394|453443487|FG014|Treatment Period|Study drug toxicity|12|||
126038961|NCT01928394|453443488|FG015|Treatment Period|Study drug toxicity|0|||
126038962|NCT01928394|453443489|FG016|Treatment Period|Study drug toxicity|3|||
126038963|NCT01928394|453443490|FG017|Treatment Period|Study drug toxicity|3|||
126038964|NCT01928394|453443491|FG018|Treatment Period|Study drug toxicity|12|||
126038965|NCT01928394|453443492|FG019|Treatment Period|Study drug toxicity|15|||
126038966|NCT01928394|453443493|FG020|Treatment Period|Study drug toxicity|4|||
126038967|NCT01928394|453443494|FG021|Treatment Period|Study drug toxicity|7|||
126038968|NCT01928394|453443495|FG022|Treatment Period|Study drug toxicity|4|||
126038969|NCT01928394|453443473|FG000|Treatment Period|AE unrelated to study drug|0|||
126038970|NCT01928394|453443474|FG001|Treatment Period|AE unrelated to study drug|0|||
126038971|NCT01928394|453443475|FG002|Treatment Period|AE unrelated to study drug|2|||
126038972|NCT01928394|453443476|FG003|Treatment Period|AE unrelated to study drug|3|||
126038973|NCT01928394|453443477|FG004|Treatment Period|AE unrelated to study drug|0|||
126038974|NCT01928394|453443478|FG005|Treatment Period|AE unrelated to study drug|5|||
126038975|NCT01928394|453443479|FG006|Treatment Period|AE unrelated to study drug|1|||
126038976|NCT01928394|453443480|FG007|Treatment Period|AE unrelated to study drug|0|||
126038977|NCT01928394|453443481|FG008|Treatment Period|AE unrelated to study drug|0|||
126038978|NCT01928394|453443482|FG009|Treatment Period|AE unrelated to study drug|2|||
126038979|NCT01928394|453443483|FG010|Treatment Period|AE unrelated to study drug|0|||
126038980|NCT01928394|453443484|FG011|Treatment Period|AE unrelated to study drug|12|||
126038981|NCT01928394|453443485|FG012|Treatment Period|AE unrelated to study drug|6|||
126038982|NCT01928394|453443486|FG013|Treatment Period|AE unrelated to study drug|13|||
126038983|NCT01928394|453443487|FG014|Treatment Period|AE unrelated to study drug|6|||
126038984|NCT01928394|453443488|FG015|Treatment Period|AE unrelated to study drug|1|||
126038985|NCT01928394|453443489|FG016|Treatment Period|AE unrelated to study drug|1|||
126038986|NCT01928394|453443490|FG017|Treatment Period|AE unrelated to study drug|6|||
126038987|NCT01928394|453443491|FG018|Treatment Period|AE unrelated to study drug|3|||
126038988|NCT01928394|453443492|FG019|Treatment Period|AE unrelated to study drug|5|||
126038989|NCT01928394|453443493|FG020|Treatment Period|AE unrelated to study drug|1|||
126038990|NCT01928394|453443494|FG021|Treatment Period|AE unrelated to study drug|1|||
126038991|NCT01928394|453443495|FG022|Treatment Period|AE unrelated to study drug|0|||
126038992|NCT01928394|453443473|FG000|Treatment Period|Participant request to stop therapy|0|||
126038993|NCT01928394|453443474|FG001|Treatment Period|Participant request to stop therapy|0|||
126278252|NCT04642365|454309187|FG005|Overall Study|Physician Decision|0|||
126278253|NCT04642365|454309188|FG006|Overall Study|Physician Decision|0|||
126278254|NCT04642365|454309189|FG007|Overall Study|Physician Decision|0|||
126278255|NCT04642365|454309182|FG000|Overall Study|Progressive Disease|1|||
126278256|NCT04642365|454309183|FG001|Overall Study|Progressive Disease|1|||
126278257|NCT04642365|454309184|FG002|Overall Study|Progressive Disease|1|||
126278258|NCT04642365|454309185|FG003|Overall Study|Progressive Disease|0|||
126363579|NCT03449147|454623549|FG002|52-week Treatment Period|Other|2|||
126363580|NCT03449147|454623547|FG000|52-week Treatment Period|Physician Decision|1|||
126363581|NCT03449147|454623548|FG001|52-week Treatment Period|Physician Decision|0|||
126363582|NCT03449147|454623549|FG002|52-week Treatment Period|Physician Decision|3|||
126363583|NCT03449147|454623547|FG000|52-week Treatment Period|Screen Failure|1|||
126363584|NCT03449147|454623548|FG001|52-week Treatment Period|Screen Failure|2|||
126363585|NCT03449147|454623549|FG002|52-week Treatment Period|Screen Failure|0|||
126363586|NCT03449147|454623547|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
126363587|NCT03449147|454623548|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
126363588|NCT03449147|454623549|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
126363589|NCT03449147|454623547|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
126363590|NCT03449147|454623548|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
126363591|NCT03449147|454623549|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
126363592|NCT03449147|454623547|FG000|12-Week Off-Treatment Durability Period|Other|0|||
126363593|NCT03449147|454623548|FG001|12-Week Off-Treatment Durability Period|Other|1|||
126038994|NCT01928394|453443475|FG002|Treatment Period|Participant request to stop therapy|0|||
126038995|NCT01928394|453443476|FG003|Treatment Period|Participant request to stop therapy|0|||
126278259|NCT04642365|454309186|FG004|Overall Study|Progressive Disease|0|||
126038996|NCT01928394|453443477|FG004|Treatment Period|Participant request to stop therapy|0|||
126038997|NCT01928394|453443478|FG005|Treatment Period|Participant request to stop therapy|3|||
126038998|NCT01928394|453443479|FG006|Treatment Period|Participant request to stop therapy|3|||
126278260|NCT04642365|454309187|FG005|Overall Study|Progressive Disease|0|||
126278261|NCT04642365|454309188|FG006|Overall Study|Progressive Disease|1|||
126038999|NCT01928394|453443480|FG007|Treatment Period|Participant request to stop therapy|0|||
126039000|NCT01928394|453443481|FG008|Treatment Period|Participant request to stop therapy|0|||
126039001|NCT01928394|453443482|FG009|Treatment Period|Participant request to stop therapy|0|||
126039002|NCT01928394|453443483|FG010|Treatment Period|Participant request to stop therapy|3|||
126278262|NCT04642365|454309189|FG007|Overall Study|Progressive Disease|0|||
126278263|NCT04642365|454309182|FG000|Overall Study|Study Terminated By Sponsor|0|||
126278264|NCT04642365|454309183|FG001|Overall Study|Study Terminated By Sponsor|2|||
126278265|NCT04642365|454309184|FG002|Overall Study|Study Terminated By Sponsor|1|||
126278266|NCT04642365|454309185|FG003|Overall Study|Study Terminated By Sponsor|1|||
126278267|NCT04642365|454309186|FG004|Overall Study|Study Terminated By Sponsor|1|||
126278268|NCT04642365|454309187|FG005|Overall Study|Study Terminated By Sponsor|2|||
126278269|NCT04642365|454309188|FG006|Overall Study|Study Terminated By Sponsor|2|||
126278270|NCT04642365|454309189|FG007|Overall Study|Study Terminated By Sponsor|1|||
126278271|NCT04642365|454309182|FG000|Overall Study|Symptomatic Deterioration|1|||
126278272|NCT04642365|454309183|FG001|Overall Study|Symptomatic Deterioration|1|||
126278273|NCT04642365|454309184|FG002|Overall Study|Symptomatic Deterioration|0|||
126278274|NCT04642365|454309185|FG003|Overall Study|Symptomatic Deterioration|0|||
126278275|NCT04642365|454309186|FG004|Overall Study|Symptomatic Deterioration|0|||
126278276|NCT04642365|454309187|FG005|Overall Study|Symptomatic Deterioration|1|||
126278277|NCT04642365|454309188|FG006|Overall Study|Symptomatic Deterioration|0|||
126278278|NCT04642365|454309189|FG007|Overall Study|Symptomatic Deterioration|0|||
126278279|NCT04642365|454309182|FG000|Overall Study|Withdrawal by Subject|0|||
126278280|NCT04642365|454309183|FG001|Overall Study|Withdrawal by Subject|0|||
126278281|NCT04642365|454309184|FG002|Overall Study|Withdrawal by Subject|1|||
126039003|NCT01928394|453443484|FG011|Treatment Period|Participant request to stop therapy|2|||
126039004|NCT01928394|453443485|FG012|Treatment Period|Participant request to stop therapy|1|||
126039005|NCT01928394|453443486|FG013|Treatment Period|Participant request to stop therapy|2|||
126039006|NCT01928394|453443487|FG014|Treatment Period|Participant request to stop therapy|4|||
126039007|NCT01928394|453443488|FG015|Treatment Period|Participant request to stop therapy|0|||
126039008|NCT01928394|453443489|FG016|Treatment Period|Participant request to stop therapy|1|||
126039009|NCT01928394|453443490|FG017|Treatment Period|Participant request to stop therapy|3|||
126039010|NCT01928394|453443491|FG018|Treatment Period|Participant request to stop therapy|1|||
125881752|NCT00929695|452866988|FG000|Overall Study|Withdrawal by Subject|0|||
126039011|NCT01928394|453443492|FG019|Treatment Period|Participant request to stop therapy|1|||
126039012|NCT01928394|453443493|FG020|Treatment Period|Participant request to stop therapy|3|||
126278282|NCT04642365|454309185|FG003|Overall Study|Withdrawal by Subject|1|||
126278283|NCT04642365|454309186|FG004|Overall Study|Withdrawal by Subject|0|||
126278284|NCT04642365|454309187|FG005|Overall Study|Withdrawal by Subject|0|||
126039013|NCT01928394|453443494|FG021|Treatment Period|Participant request to stop therapy|1|||
126039014|NCT01928394|453443495|FG022|Treatment Period|Participant request to stop therapy|3|||
126039015|NCT01928394|453443473|FG000|Treatment Period|Participant withdrew consent|0|||
126039016|NCT01928394|453443474|FG001|Treatment Period|Participant withdrew consent|0|||
126039017|NCT01928394|453443475|FG002|Treatment Period|Participant withdrew consent|1|||
126039018|NCT01928394|453443476|FG003|Treatment Period|Participant withdrew consent|1|||
126039019|NCT01928394|453443477|FG004|Treatment Period|Participant withdrew consent|0|||
126278285|NCT04642365|454309188|FG006|Overall Study|Withdrawal by Subject|2|||
126278286|NCT04642365|454309189|FG007|Overall Study|Withdrawal by Subject|0|||
126278287|NCT04642365|454309182|FG000|Overall Study|Adverse Event|0|||
126278288|NCT04642365|454309183|FG001|Overall Study|Adverse Event|0|||
126278289|NCT04642365|454309184|FG002|Overall Study|Adverse Event|0|||
126278290|NCT04642365|454309185|FG003|Overall Study|Adverse Event|0|||
126278291|NCT04642365|454309186|FG004|Overall Study|Adverse Event|0|||
126278292|NCT04642365|454309187|FG005|Overall Study|Adverse Event|0|||
126278293|NCT04642365|454309188|FG006|Overall Study|Adverse Event|0|||
126278294|NCT04642365|454309189|FG007|Overall Study|Adverse Event|1|||
126278295|NCT02478320|454309190|FG000|Overall Study|Adverse Event|2|||
126278296|NCT02478320|454309191|FG001|Overall Study|Adverse Event|0|||
126278297|NCT02478320|454309190|FG000|Overall Study|Death|1|||
126278298|NCT02478320|454309191|FG001|Overall Study|Death|0|||
126278299|NCT02478320|454309190|FG000|Overall Study|Lack of Efficacy|4|||
126278300|NCT02478320|454309191|FG001|Overall Study|Lack of Efficacy|0|||
126278301|NCT02478320|454309190|FG000|Overall Study|Withdrawal by Subject|2|||
126278302|NCT02478320|454309191|FG001|Overall Study|Withdrawal by Subject|0|||
126278303|NCT02478320|454309190|FG000|Overall Study|Screen Failure|3|||
126278304|NCT02478320|454309191|FG001|Overall Study|Screen Failure|0|||
126278305|NCT02011386|454309194|FG000|Overall Study|Non-compliance|2|||
126278306|NCT02011386|454309194|FG000|Overall Study|Lack of Efficacy|3|||
126278307|NCT03255655|454309195|FG000|Overall Study|Lost to Follow-up|7|||
126278308|NCT03255655|454309196|FG001|Overall Study|Lost to Follow-up|4|||
126278309|NCT04428333|454309197|FG000|Overall Study|Physician Decision|5|||
126278310|NCT04428333|454309198|FG001|Overall Study|Physician Decision|6|||
126278311|NCT04428333|454309197|FG000|Overall Study|Withdrawal by Subject|1|||
126278312|NCT04428333|454309198|FG001|Overall Study|Withdrawal by Subject|3|||
126278313|NCT04428333|454309197|FG000|Overall Study|Study Terminated By Sponsor|14|||
126278314|NCT04428333|454309198|FG001|Overall Study|Study Terminated By Sponsor|16|||
126278315|NCT03365011|454309199|FG000|Overall Study|Withdrawal by Subject|1|||
126278316|NCT03365011|454309200|FG001|Overall Study|Withdrawal by Subject|2|||
126278317|NCT04853992|454309201|FG000|Treatment Period A|Adverse Event|0|||
126278318|NCT04853992|454309202|FG001|Treatment Period A|Adverse Event|1|||
126278319|NCT04853992|454309201|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
126278320|NCT04853992|454309202|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
126278321|NCT03582826|454309203|FG000|Overall Study|Lost to Follow-up|39|||
126278322|NCT03582826|454309204|FG001|Overall Study|Lost to Follow-up|0|||
126278323|NCT03582826|454309203|FG000|Overall Study|Withdrawal by Subject|2|||
126278324|NCT03582826|454309204|FG001|Overall Study|Withdrawal by Subject|0|||
126278325|NCT00319982|454309205|FG000|Overall Study|Withdrawal by Subject|1|||
126278326|NCT00319982|454309206|FG001|Overall Study|Withdrawal by Subject|0|||
126278327|NCT02351960|454309207|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
126278328|NCT02351960|454309208|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
126278329|NCT02351960|454309207|FG000|Overall Study|Voluntary Withdrawal|5|||
126278330|NCT02351960|454309208|FG001|Overall Study|Voluntary Withdrawal|4|||
126278331|NCT02351960|454309207|FG000|Overall Study|Significant Protocol Deviation|0|||
126278332|NCT02351960|454309208|FG001|Overall Study|Significant Protocol Deviation|5|||
126278333|NCT03480386|454309209|FG000|Overall Study|Did not complete measures at 3-months|17|||
126278334|NCT03480386|454309210|FG001|Overall Study|Did not complete measures at 3-months|14|||
126278335|NCT03480386|454309209|FG000|Overall Study|No baseline measures|11|||
126278336|NCT03480386|454309210|FG001|Overall Study|No baseline measures|14|||
126278337|NCT03480386|454309209|FG000|Overall Study|Death|0|||
126278338|NCT03480386|454309210|FG001|Overall Study|Death|5|||
126278339|NCT03480386|454309209|FG000|Overall Study|Withdrawal by Subject|12|||
126278340|NCT03480386|454309210|FG001|Overall Study|Withdrawal by Subject|8|||
126278341|NCT03480386|454309209|FG000|Overall Study|Lost to Follow-up|2|||
126278342|NCT03480386|454309210|FG001|Overall Study|Lost to Follow-up|1|||
126278343|NCT03480386|454309209|FG000|Overall Study|Complicating disease|0|||
126278344|NCT03480386|454309210|FG001|Overall Study|Complicating disease|1|||
126278345|NCT03480386|454309209|FG000|Overall Study|Disease progression|3|||
126278346|NCT03480386|454309210|FG001|Overall Study|Disease progression|0|||
126278347|NCT03480386|454309209|FG000|Overall Study|Became ineligible|0|||
126278348|NCT03480386|454309210|FG001|Overall Study|Became ineligible|2|||
126278349|NCT02099682|454309211|FG000|Overall Study|Data Not Available|51|||
126278350|NCT02099682|454309211|FG000|Overall Study|Lost to Follow-up|31|||
126278351|NCT02099682|454309211|FG000|Overall Study|Other|29|||
126278352|NCT05065567|454309212|FG000|Overall Study|Lost to Follow-up|10|||
126278353|NCT05065567|454309213|FG001|Overall Study|Lost to Follow-up|9|||
126363594|NCT03449147|454623549|FG002|12-Week Off-Treatment Durability Period|Other|0|||
126363595|NCT02730169|454624859|FG000|Overall Study|Protocol Violation|1|||
126363596|NCT02730169|454624860|FG001|Overall Study|Protocol Violation|0|||
126363597|NCT02730169|454624861|FG002|Overall Study|Protocol Violation|0|||
126363598|NCT02730169|454624862|FG003|Overall Study|Protocol Violation|1|||
126363599|NCT02730169|454624859|FG000|Overall Study|Adverse Event|2|||
126363600|NCT02730169|454624860|FG001|Overall Study|Adverse Event|3|||
126363601|NCT02730169|454624861|FG002|Overall Study|Adverse Event|3|||
126363602|NCT02730169|454624862|FG003|Overall Study|Adverse Event|0|||
126363603|NCT02730169|454624859|FG000|Overall Study|Adverse Event of Special Interest|0|||
126363604|NCT02730169|454624860|FG001|Overall Study|Adverse Event of Special Interest|1|||
126363605|NCT02730169|454624861|FG002|Overall Study|Adverse Event of Special Interest|2|||
126363606|NCT02730169|454624862|FG003|Overall Study|Adverse Event of Special Interest|0|||
126363607|NCT02730169|454624859|FG000|Overall Study|Withdrawal by Subject|6|||
126363608|NCT02730169|454624860|FG001|Overall Study|Withdrawal by Subject|11|||
126363609|NCT02730169|454624861|FG002|Overall Study|Withdrawal by Subject|6|||
126363610|NCT02730169|454624862|FG003|Overall Study|Withdrawal by Subject|8|||
126363611|NCT02730169|454624859|FG000|Overall Study|Lost to Follow-up|5|||
126363612|NCT02730169|454624860|FG001|Overall Study|Lost to Follow-up|6|||
126363613|NCT02730169|454624861|FG002|Overall Study|Lost to Follow-up|5|||
126363614|NCT02730169|454624862|FG003|Overall Study|Lost to Follow-up|6|||
126363615|NCT02730169|454624859|FG000|Overall Study|Other|0|||
126363616|NCT02730169|454624860|FG001|Overall Study|Other|0|||
126363617|NCT02730169|454624861|FG002|Overall Study|Other|1|||
126363618|NCT02730169|454624862|FG003|Overall Study|Other|1|||
126363619|NCT02144337|454624869|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
126363620|NCT02144337|454624870|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
126363621|NCT02144337|454624869|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
126363622|NCT02144337|454624870|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
126363623|NCT02144337|454624869|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
126363624|NCT02144337|454624870|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
126363625|NCT02144337|454624869|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
126363626|NCT02144337|454624870|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
126363627|NCT02144337|454624869|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
126363628|NCT02144337|454624870|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
126363629|NCT01730729|454624871|FG000|Overall Study|Adverse Event|1|||
126278354|NCT05065567|454309214|FG002|Overall Study|Lost to Follow-up|6|||
126278355|NCT04975191|454310848|FG000|Overall Study|Protocol Violation|1|||
126278356|NCT04975191|454310849|FG001|Overall Study|Protocol Violation|2|||
126278357|NCT04975191|454310850|FG002|Overall Study|Protocol Violation|2|||
126278358|NCT04975191|454310851|FG003|Overall Study|Protocol Violation|2|||
126278359|NCT04975191|454310848|FG000|Overall Study|Lost to Follow-up|13|||
126039020|NCT01928394|453443478|FG005|Treatment Period|Participant withdrew consent|1|||
126039021|NCT01928394|453443479|FG006|Treatment Period|Participant withdrew consent|0|||
126039022|NCT01928394|453443480|FG007|Treatment Period|Participant withdrew consent|1|||
126039023|NCT01928394|453443481|FG008|Treatment Period|Participant withdrew consent|0|||
126039024|NCT01928394|453443482|FG009|Treatment Period|Participant withdrew consent|0|||
126039025|NCT01928394|453443483|FG010|Treatment Period|Participant withdrew consent|1|||
126039026|NCT01928394|453443484|FG011|Treatment Period|Participant withdrew consent|1|||
126039027|NCT01928394|453443485|FG012|Treatment Period|Participant withdrew consent|1|||
126039028|NCT01928394|453443486|FG013|Treatment Period|Participant withdrew consent|0|||
126039029|NCT01928394|453443487|FG014|Treatment Period|Participant withdrew consent|2|||
126039030|NCT01928394|453443488|FG015|Treatment Period|Participant withdrew consent|0|||
126278360|NCT04975191|454310849|FG001|Overall Study|Lost to Follow-up|3|||
126278361|NCT04975191|454310850|FG002|Overall Study|Lost to Follow-up|8|||
126278362|NCT04975191|454310851|FG003|Overall Study|Lost to Follow-up|8|||
126278363|NCT01056289|454310859|FG000|Open-label Phase|Adverse Event|29|||
126278364|NCT01056289|454310860|FG001|Open-label Phase|Adverse Event|0|||
126278365|NCT01056289|454310861|FG002|Open-label Phase|Adverse Event|0|||
126278366|NCT01056289|454310862|FG003|Open-label Phase|Adverse Event|0|||
126278367|NCT01056289|454310859|FG000|Open-label Phase|Lost to Follow-up|30|||
126278368|NCT01056289|454310860|FG001|Open-label Phase|Lost to Follow-up|0|||
126278369|NCT01056289|454310861|FG002|Open-label Phase|Lost to Follow-up|0|||
126278370|NCT01056289|454310862|FG003|Open-label Phase|Lost to Follow-up|0|||
126278371|NCT01056289|454310859|FG000|Open-label Phase|Other|9|||
126278372|NCT01056289|454310860|FG001|Open-label Phase|Other|0|||
126278373|NCT01056289|454310861|FG002|Open-label Phase|Other|0|||
126363630|NCT01730729|454624871|FG000|Overall Study|Death|1|||
126363631|NCT01730729|454624871|FG000|Overall Study|Progressive Disease|12|||
126363632|NCT00449787|454624872|FG000|Overall Study|Lost to Follow-up|10|||
126363633|NCT00449787|454624873|FG001|Overall Study|Lost to Follow-up|8|||
126363634|NCT00449787|454624872|FG000|Overall Study|Did not require medication|95|||
126363635|NCT00449787|454624873|FG001|Overall Study|Did not require medication|92|||
126363636|NCT03701074|454624874|FG000|Overall Study|Physician Decision|1|||
126278374|NCT01056289|454310862|FG003|Open-label Phase|Other|0|||
126363637|NCT03701074|454624875|FG001|Overall Study|Physician Decision|0|||
126278375|NCT01056289|454310859|FG000|Open-label Phase|Protocol Violation|6|||
126278376|NCT01056289|454310860|FG001|Open-label Phase|Protocol Violation|0|||
126278377|NCT01056289|454310861|FG002|Open-label Phase|Protocol Violation|0|||
126278378|NCT01056289|454310862|FG003|Open-label Phase|Protocol Violation|0|||
126278379|NCT01056289|454310859|FG000|Open-label Phase|Withdrawal by Subject|26|||
126278380|NCT01056289|454310860|FG001|Open-label Phase|Withdrawal by Subject|0|||
126278381|NCT01056289|454310861|FG002|Open-label Phase|Withdrawal by Subject|0|||
126278382|NCT01056289|454310862|FG003|Open-label Phase|Withdrawal by Subject|0|||
126278383|NCT01056289|454310859|FG000|Open-label Phase|Lack of Efficacy|18|||
126278384|NCT01056289|454310860|FG001|Open-label Phase|Lack of Efficacy|0|||
126278385|NCT01056289|454310861|FG002|Open-label Phase|Lack of Efficacy|0|||
126278386|NCT01056289|454310862|FG003|Open-label Phase|Lack of Efficacy|0|||
126278387|NCT01056289|454310859|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
126278388|NCT01056289|454310860|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
126278389|NCT01056289|454310861|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
126278390|NCT01056289|454310862|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
126278391|NCT01056289|454310859|FG000|Double-blind Phase|Adverse Event|0|||
126278392|NCT01056289|454310860|FG001|Double-blind Phase|Adverse Event|1|||
126278393|NCT01056289|454310861|FG002|Double-blind Phase|Adverse Event|2|||
126278394|NCT01056289|454310862|FG003|Double-blind Phase|Adverse Event|1|||
126278395|NCT01056289|454310859|FG000|Double-blind Phase|Lost to Follow-up|0|||
126278396|NCT01056289|454310860|FG001|Double-blind Phase|Lost to Follow-up|2|||
126278397|NCT01056289|454310861|FG002|Double-blind Phase|Lost to Follow-up|2|||
126278398|NCT01056289|454310862|FG003|Double-blind Phase|Lost to Follow-up|2|||
126278399|NCT01056289|454310859|FG000|Double-blind Phase|Other|0|||
126278400|NCT01056289|454310860|FG001|Double-blind Phase|Other|0|||
126278401|NCT01056289|454310861|FG002|Double-blind Phase|Other|1|||
126278402|NCT01056289|454310862|FG003|Double-blind Phase|Other|2|||
126278403|NCT01056289|454310859|FG000|Double-blind Phase|Protocol Violation|0|||
126278404|NCT01056289|454310860|FG001|Double-blind Phase|Protocol Violation|0|||
126278405|NCT01056289|454310861|FG002|Double-blind Phase|Protocol Violation|1|||
126278406|NCT01056289|454310862|FG003|Double-blind Phase|Protocol Violation|1|||
126278407|NCT01056289|454310859|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126278408|NCT01056289|454310860|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126278409|NCT01056289|454310861|FG002|Double-blind Phase|Withdrawal by Subject|4|||
126278410|NCT01056289|454310862|FG003|Double-blind Phase|Withdrawal by Subject|2|||
126278411|NCT01056289|454310859|FG000|Double-blind Phase|Discontinuation symptom|0|||
126278412|NCT01056289|454310860|FG001|Double-blind Phase|Discontinuation symptom|1|||
126278413|NCT01056289|454310861|FG002|Double-blind Phase|Discontinuation symptom|2|||
126278414|NCT01056289|454310862|FG003|Double-blind Phase|Discontinuation symptom|2|||
126278415|NCT01056289|454310859|FG000|Double-blind Phase|Physician Decision|0|||
126278416|NCT01056289|454310860|FG001|Double-blind Phase|Physician Decision|0|||
126278417|NCT01056289|454310861|FG002|Double-blind Phase|Physician Decision|1|||
126278418|NCT01056289|454310862|FG003|Double-blind Phase|Physician Decision|0|||
126278419|NCT03333941|454310868|FG000|Overall Study|Lost to Follow-up|10|||
126278420|NCT03333941|454310868|FG000|Overall Study|Death|2|||
126278421|NCT03333941|454310868|FG000|Overall Study|Adverse Event|1|||
126278422|NCT03323437|454310873|FG000|Overall Study|Withdrawal by Subject|0|||
126278423|NCT03323437|454310874|FG001|Overall Study|Withdrawal by Subject|4|||
126039031|NCT01928394|453443489|FG016|Treatment Period|Participant withdrew consent|2|||
126039032|NCT01928394|453443490|FG017|Treatment Period|Participant withdrew consent|1|||
126039033|NCT01928394|453443491|FG018|Treatment Period|Participant withdrew consent|1|||
126039034|NCT01928394|453443492|FG019|Treatment Period|Participant withdrew consent|1|||
126039035|NCT01928394|453443493|FG020|Treatment Period|Participant withdrew consent|0|||
126039036|NCT01928394|453443494|FG021|Treatment Period|Participant withdrew consent|2|||
126039037|NCT01928394|453443495|FG022|Treatment Period|Participant withdrew consent|0|||
126039038|NCT01928394|453443473|FG000|Treatment Period|Poor/non-compliance|0|||
126039039|NCT01928394|453443474|FG001|Treatment Period|Poor/non-compliance|0|||
126039040|NCT01928394|453443475|FG002|Treatment Period|Poor/non-compliance|0|||
126039041|NCT01928394|453443476|FG003|Treatment Period|Poor/non-compliance|1|||
126039042|NCT01928394|453443477|FG004|Treatment Period|Poor/non-compliance|0|||
126039043|NCT01928394|453443478|FG005|Treatment Period|Poor/non-compliance|0|||
126039044|NCT01928394|453443479|FG006|Treatment Period|Poor/non-compliance|0|||
126039045|NCT01928394|453443480|FG007|Treatment Period|Poor/non-compliance|0|||
126039046|NCT01928394|453443481|FG008|Treatment Period|Poor/non-compliance|0|||
126039047|NCT01928394|453443482|FG009|Treatment Period|Poor/non-compliance|0|||
126039048|NCT01928394|453443483|FG010|Treatment Period|Poor/non-compliance|0|||
126039049|NCT01928394|453443484|FG011|Treatment Period|Poor/non-compliance|0|||
126039050|NCT01928394|453443485|FG012|Treatment Period|Poor/non-compliance|1|||
126039051|NCT01928394|453443486|FG013|Treatment Period|Poor/non-compliance|0|||
126039052|NCT01928394|453443487|FG014|Treatment Period|Poor/non-compliance|1|||
126039053|NCT01928394|453443488|FG015|Treatment Period|Poor/non-compliance|0|||
126039054|NCT01928394|453443489|FG016|Treatment Period|Poor/non-compliance|0|||
126039055|NCT01928394|453443490|FG017|Treatment Period|Poor/non-compliance|1|||
126039056|NCT01928394|453443491|FG018|Treatment Period|Poor/non-compliance|0|||
126039057|NCT01928394|453443492|FG019|Treatment Period|Poor/non-compliance|1|||
126039058|NCT01928394|453443493|FG020|Treatment Period|Poor/non-compliance|0|||
126039059|NCT01928394|453443494|FG021|Treatment Period|Poor/non-compliance|0|||
126039060|NCT01928394|453443495|FG022|Treatment Period|Poor/non-compliance|0|||
126039061|NCT01928394|453443473|FG000|Treatment Period|other reason|0|||
126039062|NCT01928394|453443474|FG001|Treatment Period|other reason|0|||
126039063|NCT01928394|453443475|FG002|Treatment Period|other reason|0|||
126278424|NCT00049530|454310880|FG000|Overall Study|Lack of Efficacy|25|||
126278425|NCT00049530|454310880|FG000|Overall Study|Adverse Event|2|||
126278426|NCT00049530|454310880|FG000|Overall Study|Death|1|||
126278427|NCT00049530|454310880|FG000|Overall Study|symptomatic deterioration|1|||
126278428|NCT00049530|454310880|FG000|Overall Study|ineligible|3|||
126278429|NCT02383810|454310881|FG000|Overall Study|Physician Decision|1|||
126278430|NCT02383810|454310882|FG001|Overall Study|Physician Decision|1|||
126278431|NCT02383810|454310883|FG002|Overall Study|Physician Decision|0|||
126278432|NCT02383810|454310884|FG003|Overall Study|Physician Decision|0|||
126278433|NCT02383810|454310885|FG004|Overall Study|Physician Decision|0|||
126278434|NCT02383810|454310886|FG005|Overall Study|Physician Decision|0|||
125881753|NCT00929695|452866989|FG001|Overall Study|Withdrawal by Subject|2|||
125881754|NCT00929695|452866988|FG000|Overall Study|discharge home|4|||
125881755|NCT00929695|452866989|FG001|Overall Study|discharge home|3|||
125881756|NCT00929695|452866988|FG000|Overall Study|incorrect stratification|2|||
125881757|NCT00929695|452866989|FG001|Overall Study|incorrect stratification|0|||
125881758|NCT00887809|452866991|FG000|Overall Study|Patient Not Treated|3|||
125881759|NCT00887809|452866992|FG001|Overall Study|Patient Not Treated|0|||
126039064|NCT01928394|453443476|FG003|Treatment Period|other reason|0|||
126278435|NCT02383810|454310887|FG006|Overall Study|Physician Decision|0|||
126278436|NCT02383810|454310888|FG007|Overall Study|Physician Decision|0|||
126278437|NCT02383810|454310881|FG000|Overall Study|Withdrawal by Subject|2|||
126278438|NCT02383810|454310882|FG001|Overall Study|Withdrawal by Subject|3|||
126278439|NCT02383810|454310883|FG002|Overall Study|Withdrawal by Subject|3|||
126278440|NCT02383810|454310884|FG003|Overall Study|Withdrawal by Subject|3|||
126278441|NCT02383810|454310885|FG004|Overall Study|Withdrawal by Subject|0|||
126039065|NCT01928394|453443477|FG004|Treatment Period|other reason|0|||
126039066|NCT01928394|453443478|FG005|Treatment Period|other reason|0|||
126039067|NCT01928394|453443479|FG006|Treatment Period|other reason|0|||
126039068|NCT01928394|453443480|FG007|Treatment Period|other reason|0|||
126039069|NCT01928394|453443481|FG008|Treatment Period|other reason|0|||
126039070|NCT01928394|453443482|FG009|Treatment Period|other reason|0|||
126039071|NCT01928394|453443483|FG010|Treatment Period|other reason|1|||
126039072|NCT01928394|453443484|FG011|Treatment Period|other reason|1|||
126039073|NCT01928394|453443485|FG012|Treatment Period|other reason|1|||
126039074|NCT01928394|453443486|FG013|Treatment Period|other reason|0|||
126039075|NCT01928394|453443487|FG014|Treatment Period|other reason|1|||
126039076|NCT01928394|453443488|FG015|Treatment Period|other reason|0|||
126039077|NCT01928394|453443489|FG016|Treatment Period|other reason|0|||
126039078|NCT01928394|453443490|FG017|Treatment Period|other reason|0|||
126039079|NCT01928394|453443491|FG018|Treatment Period|other reason|2|||
126039080|NCT01928394|453443492|FG019|Treatment Period|other reason|2|||
126039081|NCT01928394|453443493|FG020|Treatment Period|other reason|0|||
126039082|NCT01928394|453443494|FG021|Treatment Period|other reason|0|||
126039083|NCT01928394|453443495|FG022|Treatment Period|other reason|0|||
126039084|NCT01928394|453443473|FG000|Treatment Period|Maximum clinical benefit|0|||
126039085|NCT01928394|453443474|FG001|Treatment Period|Maximum clinical benefit|0|||
126039086|NCT01928394|453443475|FG002|Treatment Period|Maximum clinical benefit|0|||
126039087|NCT01928394|453443476|FG003|Treatment Period|Maximum clinical benefit|0|||
126363638|NCT03574389|454624879|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
126363639|NCT03574389|454624880|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
126363640|NCT03574389|454624881|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
126363641|NCT03574389|454624882|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
126363642|NCT03574389|454624883|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
126363643|NCT03574389|454624884|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
126363644|NCT03574389|454624885|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
126363645|NCT03574389|454624879|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
126278442|NCT02383810|454310886|FG005|Overall Study|Withdrawal by Subject|0|||
126278443|NCT02383810|454310887|FG006|Overall Study|Withdrawal by Subject|0|||
126278444|NCT02383810|454310888|FG007|Overall Study|Withdrawal by Subject|0|||
126278445|NCT02383810|454310881|FG000|Overall Study|Adverse Event|0|||
126278446|NCT02383810|454310882|FG001|Overall Study|Adverse Event|2|||
126363646|NCT03574389|454624880|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
126363647|NCT03574389|454624881|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
126363648|NCT03574389|454624882|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
125881760|NCT00887809|452866991|FG000|Overall Study|Death|1|||
126039088|NCT01928394|453443477|FG004|Treatment Period|Maximum clinical benefit|0|||
126039089|NCT01928394|453443478|FG005|Treatment Period|Maximum clinical benefit|0|||
126039090|NCT01928394|453443479|FG006|Treatment Period|Maximum clinical benefit|0|||
126039091|NCT01928394|453443480|FG007|Treatment Period|Maximum clinical benefit|0|||
126278447|NCT02383810|454310883|FG002|Overall Study|Adverse Event|4|||
126278448|NCT02383810|454310884|FG003|Overall Study|Adverse Event|5|||
126278449|NCT02383810|454310885|FG004|Overall Study|Adverse Event|0|||
126278450|NCT02383810|454310886|FG005|Overall Study|Adverse Event|1|||
126278451|NCT02383810|454310887|FG006|Overall Study|Adverse Event|1|||
126278452|NCT02383810|454310888|FG007|Overall Study|Adverse Event|0|||
126278453|NCT02383810|454310881|FG000|Overall Study|Lost to Follow-up|0|||
126278454|NCT02383810|454310882|FG001|Overall Study|Lost to Follow-up|1|||
126278455|NCT02383810|454310883|FG002|Overall Study|Lost to Follow-up|0|||
126278456|NCT02383810|454310884|FG003|Overall Study|Lost to Follow-up|1|||
126278457|NCT02383810|454310885|FG004|Overall Study|Lost to Follow-up|0|||
126278458|NCT02383810|454310886|FG005|Overall Study|Lost to Follow-up|0|||
126278459|NCT02383810|454310887|FG006|Overall Study|Lost to Follow-up|0|||
126278460|NCT02383810|454310888|FG007|Overall Study|Lost to Follow-up|0|||
126278461|NCT02383810|454310881|FG000|Overall Study|other|0|||
126278462|NCT02383810|454310882|FG001|Overall Study|other|0|||
126278463|NCT02383810|454310883|FG002|Overall Study|other|0|||
126278464|NCT02383810|454310884|FG003|Overall Study|other|2|||
126278465|NCT02383810|454310885|FG004|Overall Study|other|0|||
126278466|NCT02383810|454310886|FG005|Overall Study|other|0|||
126278467|NCT02383810|454310887|FG006|Overall Study|other|0|||
126098778|NCT00867308|453653125|FG000|Overall Study|Withdrawal by Subject|1|||
126098779|NCT00867308|453653126|FG001|Overall Study|Withdrawal by Subject|2|||
126098780|NCT05917470|453653132|FG000|Overall Study|Progressive Disease|1|||
126098781|NCT05917470|453653133|FG001|Overall Study|Progressive Disease|1|||
126278468|NCT02383810|454310888|FG007|Overall Study|other|0|||
126278469|NCT02383810|454310881|FG000|Overall Study|subject did not receive study treatment|0|||
126278470|NCT02383810|454310882|FG001|Overall Study|subject did not receive study treatment|1|||
126278471|NCT02383810|454310883|FG002|Overall Study|subject did not receive study treatment|0|||
126278472|NCT02383810|454310884|FG003|Overall Study|subject did not receive study treatment|0|||
126278473|NCT02383810|454310885|FG004|Overall Study|subject did not receive study treatment|0|||
126278474|NCT02383810|454310886|FG005|Overall Study|subject did not receive study treatment|0|||
126278475|NCT02383810|454310887|FG006|Overall Study|subject did not receive study treatment|0|||
126278476|NCT02383810|454310888|FG007|Overall Study|subject did not receive study treatment|0|||
126278477|NCT01635283|454310891|FG000|Overall Study|Tumor Progression|3|||
126278478|NCT01635283|454310891|FG000|Overall Study|Lost to Follow-up|1|||
126278479|NCT01433549|454310892|FG000|Phase 2: Second Study Product|Adverse Event|0|||
126278480|NCT01433549|454310893|FG001|Phase 2: Second Study Product|Adverse Event|1|||
126278481|NCT03511326|454310896|FG000|Overall Study|Withdrawal by Subject|1|||
126278482|NCT01305044|454310897|FG000|Overall Study|Withdrawal by Subject|3|||
126278483|NCT01305044|454310898|FG001|Overall Study|Withdrawal by Subject|6|||
126278484|NCT04628793|454310899|FG000|Overall Study|Study terminated by sponsor|0|||
126278485|NCT04628793|454310900|FG001|Overall Study|Study terminated by sponsor|0|||
126278486|NCT04628793|454310901|FG002|Overall Study|Study terminated by sponsor|8|||
126278487|NCT04628793|454310899|FG000|Overall Study|Withdrawal by Subject|2|||
126278488|NCT04628793|454310900|FG001|Overall Study|Withdrawal by Subject|3|||
126278489|NCT04628793|454310901|FG002|Overall Study|Withdrawal by Subject|0|||
126278490|NCT04628793|454310899|FG000|Overall Study|Lost to Follow-up|0|||
126278491|NCT04628793|454310900|FG001|Overall Study|Lost to Follow-up|1|||
126278492|NCT04628793|454310901|FG002|Overall Study|Lost to Follow-up|0|||
126278493|NCT01696058|454310903|FG000|Overall Study|Adverse Event|21|||
126278494|NCT01696058|454310904|FG001|Overall Study|Adverse Event|11|||
126278495|NCT01696058|454310903|FG000|Overall Study|Lack of Efficacy|2|||
126278496|NCT01696058|454310904|FG001|Overall Study|Lack of Efficacy|3|||
126278497|NCT01696058|454310903|FG000|Overall Study|Protocol Violation|9|||
126278498|NCT01696058|454310904|FG001|Overall Study|Protocol Violation|3|||
126278499|NCT01696058|454310903|FG000|Overall Study|Lost to Follow-up|2|||
126278500|NCT01696058|454310904|FG001|Overall Study|Lost to Follow-up|5|||
126278501|NCT01696058|454310903|FG000|Overall Study|Withdrawal by Subject|4|||
126098782|NCT05917470|453653134|FG002|Overall Study|Progressive Disease|2|||
126278502|NCT01696058|454310904|FG001|Overall Study|Withdrawal by Subject|6|||
126278503|NCT01696058|454310903|FG000|Overall Study|Other reason prematurely discontinued|5|||
126278504|NCT01696058|454310904|FG001|Overall Study|Other reason prematurely discontinued|3|||
126278505|NCT02278055|454310905|FG000|Overall Study|Adverse Event|1|||
126278506|NCT02278055|454310905|FG000|Overall Study|Lost to Follow-up|1|||
126278507|NCT02278055|454310905|FG000|Overall Study|Withdrawal by Subject|2|||
126278508|NCT02278055|454310905|FG000|Overall Study|Progressive Disease|4|||
126278509|NCT01934335|454310906|FG000|Overall Study|Withdrawal by Subject|1|||
126039092|NCT01928394|453443481|FG008|Treatment Period|Maximum clinical benefit|0|||
126039093|NCT01928394|453443482|FG009|Treatment Period|Maximum clinical benefit|0|||
126039094|NCT01928394|453443483|FG010|Treatment Period|Maximum clinical benefit|1|||
126039095|NCT01928394|453443484|FG011|Treatment Period|Maximum clinical benefit|1|||
126039096|NCT01928394|453443485|FG012|Treatment Period|Maximum clinical benefit|0|||
126098783|NCT05917470|453653135|FG003|Overall Study|Progressive Disease|3|||
126098784|NCT05917470|453653136|FG004|Overall Study|Progressive Disease|1|||
126098785|NCT05917470|453653137|FG005|Overall Study|Progressive Disease|1|||
126098786|NCT05917470|453653138|FG006|Overall Study|Progressive Disease|0|||
126098787|NCT05917470|453653139|FG007|Overall Study|Progressive Disease|0|||
126098788|NCT05917470|453653132|FG000|Overall Study|Withdrawal by Subject|0|||
126039097|NCT01928394|453443486|FG013|Treatment Period|Maximum clinical benefit|0|||
126039098|NCT01928394|453443487|FG014|Treatment Period|Maximum clinical benefit|1|||
126039099|NCT01928394|453443488|FG015|Treatment Period|Maximum clinical benefit|0|||
126039100|NCT01928394|453443489|FG016|Treatment Period|Maximum clinical benefit|0|||
126039101|NCT01928394|453443490|FG017|Treatment Period|Maximum clinical benefit|1|||
126039102|NCT01928394|453443491|FG018|Treatment Period|Maximum clinical benefit|1|||
126039103|NCT01928394|453443492|FG019|Treatment Period|Maximum clinical benefit|0|||
126098789|NCT05917470|453653133|FG001|Overall Study|Withdrawal by Subject|0|||
126098790|NCT05917470|453653134|FG002|Overall Study|Withdrawal by Subject|1|||
126098791|NCT05917470|453653135|FG003|Overall Study|Withdrawal by Subject|0|||
126039104|NCT01928394|453443493|FG020|Treatment Period|Maximum clinical benefit|2|||
126039105|NCT01928394|453443494|FG021|Treatment Period|Maximum clinical benefit|0|||
126039106|NCT01928394|453443495|FG022|Treatment Period|Maximum clinical benefit|0|||
126039107|NCT01928394|453443473|FG000|Treatment Period|Lost to Follow-up|0|||
126039108|NCT01928394|453443474|FG001|Treatment Period|Lost to Follow-up|0|||
126039109|NCT01928394|453443475|FG002|Treatment Period|Lost to Follow-up|0|||
126039110|NCT01928394|453443476|FG003|Treatment Period|Lost to Follow-up|0|||
126039111|NCT01928394|453443477|FG004|Treatment Period|Lost to Follow-up|0|||
126098792|NCT05917470|453653136|FG004|Overall Study|Withdrawal by Subject|0|||
126098793|NCT05917470|453653137|FG005|Overall Study|Withdrawal by Subject|0|||
126098794|NCT05917470|453653138|FG006|Overall Study|Withdrawal by Subject|0|||
126098795|NCT05917470|453653139|FG007|Overall Study|Withdrawal by Subject|0|||
126098796|NCT05917470|453653132|FG000|Overall Study|Sponsor Decision|0|||
126098797|NCT05917470|453653133|FG001|Overall Study|Sponsor Decision|0|||
126098798|NCT05917470|453653134|FG002|Overall Study|Sponsor Decision|1|||
126098799|NCT05917470|453653135|FG003|Overall Study|Sponsor Decision|0|||
126039112|NCT01928394|453443478|FG005|Treatment Period|Lost to Follow-up|0|||
126039113|NCT01928394|453443479|FG006|Treatment Period|Lost to Follow-up|0|||
126039114|NCT01928394|453443480|FG007|Treatment Period|Lost to Follow-up|0|||
126039115|NCT01928394|453443481|FG008|Treatment Period|Lost to Follow-up|0|||
126039116|NCT01928394|453443482|FG009|Treatment Period|Lost to Follow-up|0|||
126039117|NCT01928394|453443483|FG010|Treatment Period|Lost to Follow-up|0|||
126039118|NCT01928394|453443484|FG011|Treatment Period|Lost to Follow-up|0|||
126039119|NCT01928394|453443485|FG012|Treatment Period|Lost to Follow-up|0|||
126039120|NCT01928394|453443486|FG013|Treatment Period|Lost to Follow-up|0|||
126039121|NCT01928394|453443487|FG014|Treatment Period|Lost to Follow-up|0|||
126039122|NCT01928394|453443488|FG015|Treatment Period|Lost to Follow-up|0|||
126039123|NCT01928394|453443489|FG016|Treatment Period|Lost to Follow-up|0|||
126039124|NCT01928394|453443490|FG017|Treatment Period|Lost to Follow-up|0|||
126039125|NCT01928394|453443491|FG018|Treatment Period|Lost to Follow-up|0|||
126039126|NCT01928394|453443492|FG019|Treatment Period|Lost to Follow-up|0|||
126039127|NCT01928394|453443493|FG020|Treatment Period|Lost to Follow-up|0|||
126039128|NCT01928394|453443494|FG021|Treatment Period|Lost to Follow-up|0|||
126039129|NCT01928394|453443495|FG022|Treatment Period|Lost to Follow-up|1|||
126098800|NCT05917470|453653136|FG004|Overall Study|Sponsor Decision|2|||
126098801|NCT05917470|453653137|FG005|Overall Study|Sponsor Decision|1|||
126098802|NCT05917470|453653138|FG006|Overall Study|Sponsor Decision|3|||
126039130|NCT01928394|453443473|FG000|Treatment Period|Death|0|||
126039131|NCT01928394|453443474|FG001|Treatment Period|Death|0|||
126039132|NCT01928394|453443475|FG002|Treatment Period|Death|0|||
126039133|NCT01928394|453443476|FG003|Treatment Period|Death|0|||
126039134|NCT01928394|453443477|FG004|Treatment Period|Death|0|||
126039135|NCT01928394|453443478|FG005|Treatment Period|Death|0|||
126039136|NCT01928394|453443479|FG006|Treatment Period|Death|0|||
126039137|NCT01928394|453443480|FG007|Treatment Period|Death|0|||
126039138|NCT01928394|453443481|FG008|Treatment Period|Death|0|||
126039139|NCT01928394|453443482|FG009|Treatment Period|Death|0|||
126098803|NCT05917470|453653139|FG007|Overall Study|Sponsor Decision|3|||
126098804|NCT05917470|453653132|FG000|Overall Study|Adverse Event|0|||
126278510|NCT01934335|454310907|FG001|Overall Study|Withdrawal by Subject|1|||
126039140|NCT01928394|453443483|FG010|Treatment Period|Death|0|||
126039141|NCT01928394|453443484|FG011|Treatment Period|Death|0|||
126039142|NCT01928394|453443485|FG012|Treatment Period|Death|0|||
126039143|NCT01928394|453443486|FG013|Treatment Period|Death|1|||
126039144|NCT01928394|453443487|FG014|Treatment Period|Death|2|||
126039145|NCT01928394|453443488|FG015|Treatment Period|Death|0|||
126039146|NCT01928394|453443489|FG016|Treatment Period|Death|0|||
126039147|NCT01928394|453443490|FG017|Treatment Period|Death|0|||
126039148|NCT01928394|453443491|FG018|Treatment Period|Death|0|||
126039149|NCT01928394|453443492|FG019|Treatment Period|Death|0|||
126039150|NCT01928394|453443493|FG020|Treatment Period|Death|0|||
126039151|NCT01928394|453443494|FG021|Treatment Period|Death|0|||
126039152|NCT01928394|453443495|FG022|Treatment Period|Death|0|||
126039153|NCT01928394|453443473|FG000|Follow-up Period|Participant withdrew consent|3|||
126039154|NCT01928394|453443474|FG001|Follow-up Period|Participant withdrew consent|0|||
126039155|NCT01928394|453443475|FG002|Follow-up Period|Participant withdrew consent|1|||
126039156|NCT01928394|453443476|FG003|Follow-up Period|Participant withdrew consent|4|||
126039157|NCT01928394|453443477|FG004|Follow-up Period|Participant withdrew consent|0|||
126039158|NCT01928394|453443478|FG005|Follow-up Period|Participant withdrew consent|2|||
126039159|NCT01928394|453443479|FG006|Follow-up Period|Participant withdrew consent|5|||
126039160|NCT01928394|453443480|FG007|Follow-up Period|Participant withdrew consent|1|||
126039161|NCT01928394|453443481|FG008|Follow-up Period|Participant withdrew consent|0|||
126039162|NCT01928394|453443482|FG009|Follow-up Period|Participant withdrew consent|0|||
126039163|NCT01928394|453443483|FG010|Follow-up Period|Participant withdrew consent|5|||
126039164|NCT01928394|453443484|FG011|Follow-up Period|Participant withdrew consent|8|||
126098805|NCT05917470|453653133|FG001|Overall Study|Adverse Event|0|||
126278511|NCT05384171|454310908|FG000|Overall Study|Lost to Follow-up|9|||
126278512|NCT05384171|454310909|FG001|Overall Study|Lost to Follow-up|9|||
126098806|NCT05917470|453653134|FG002|Overall Study|Adverse Event|0|||
126098807|NCT05917470|453653135|FG003|Overall Study|Adverse Event|0|||
126098808|NCT05917470|453653136|FG004|Overall Study|Adverse Event|0|||
126098809|NCT05917470|453653137|FG005|Overall Study|Adverse Event|1|||
126098810|NCT05917470|453653138|FG006|Overall Study|Adverse Event|0|||
126098811|NCT05917470|453653139|FG007|Overall Study|Adverse Event|0|||
126098812|NCT03647488|453655558|FG000|Overall Study|Progressive disease|10|||
126098813|NCT03647488|453655559|FG001|Overall Study|Progressive disease|0|||
126098814|NCT03647488|453655560|FG002|Overall Study|Progressive disease|0|||
126098815|NCT03647488|453655558|FG000|Overall Study|Adverse Event|5|||
126098816|NCT03647488|453655559|FG001|Overall Study|Adverse Event|0|||
126098817|NCT03647488|453655560|FG002|Overall Study|Adverse Event|0|||
126098818|NCT03647488|453655558|FG000|Overall Study|Clinical progression|2|||
126098819|NCT03647488|453655559|FG001|Overall Study|Clinical progression|0|||
126098820|NCT03647488|453655560|FG002|Overall Study|Clinical progression|0|||
126098821|NCT03647488|453655558|FG000|Overall Study|Participant refused to take investigational product|1|||
126098822|NCT03647488|453655559|FG001|Overall Study|Participant refused to take investigational product|0|||
126098823|NCT03647488|453655560|FG002|Overall Study|Participant refused to take investigational product|0|||
126098824|NCT03694275|453655561|FG000|Overall Study|Adverse Event|0|||
126098825|NCT03694275|453655562|FG001|Overall Study|Adverse Event|1|||
126098826|NCT03694275|453655561|FG000|Overall Study|Reason not Specified|0|||
126098827|NCT03694275|453655562|FG001|Overall Study|Reason not Specified|1|||
126098828|NCT03541174|453655563|FG000|Part 1 Double-Blind|Adverse Event|6|||
126098829|NCT03541174|453655564|FG001|Part 1 Double-Blind|Adverse Event|5|||
126098830|NCT03541174|453655565|FG002|Part 1 Double-Blind|Adverse Event|2|||
126098831|NCT03541174|453655566|FG003|Part 1 Double-Blind|Adverse Event|0|||
126098832|NCT03541174|453655567|FG004|Part 1 Double-Blind|Adverse Event|0|||
126098833|NCT03541174|453655568|FG005|Part 1 Double-Blind|Adverse Event|0|||
126098834|NCT03541174|453655563|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
126098835|NCT03541174|453655564|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
126098836|NCT03541174|453655565|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
126098837|NCT03541174|453655566|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
126098838|NCT03541174|453655567|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
126098839|NCT03541174|453655568|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
126098840|NCT03541174|453655563|FG000|Part 1 Double-Blind|Other reasons|3|||
126098841|NCT03541174|453655564|FG001|Part 1 Double-Blind|Other reasons|2|||
126098842|NCT03541174|453655565|FG002|Part 1 Double-Blind|Other reasons|3|||
126278513|NCT05384171|454310908|FG000|Overall Study|Withdrawal by Subject|3|||
126278514|NCT05384171|454310909|FG001|Overall Study|Withdrawal by Subject|0|||
126278515|NCT00106964|454310910|FG000|Overall Study|Lost to Follow-up|8|||
126278516|NCT00106964|454310911|FG001|Overall Study|Lost to Follow-up|6|||
126278517|NCT00106964|454310912|FG002|Overall Study|Lost to Follow-up|2|||
126278518|NCT00106964|454310910|FG000|Overall Study|Pregnancy|2|||
126039165|NCT01928394|453443485|FG012|Follow-up Period|Participant withdrew consent|2|||
126039166|NCT01928394|453443486|FG013|Follow-up Period|Participant withdrew consent|12|||
126039167|NCT01928394|453443487|FG014|Follow-up Period|Participant withdrew consent|7|||
126098843|NCT03541174|453655566|FG003|Part 1 Double-Blind|Other reasons|0|||
126278519|NCT00106964|454310911|FG001|Overall Study|Pregnancy|3|||
126278520|NCT00106964|454310912|FG002|Overall Study|Pregnancy|2|||
126278521|NCT00106964|454310910|FG000|Overall Study|Death|1|||
126278522|NCT00106964|454310911|FG001|Overall Study|Death|1|||
126278523|NCT00106964|454310912|FG002|Overall Study|Death|0|||
126278524|NCT00106964|454310910|FG000|Overall Study|Incarceration|0|||
126278525|NCT00106964|454310911|FG001|Overall Study|Incarceration|1|||
126278526|NCT00106964|454310912|FG002|Overall Study|Incarceration|0|||
126278527|NCT00106964|454310910|FG000|Overall Study|Site Funding Terminated|0|||
126278528|NCT00106964|454310911|FG001|Overall Study|Site Funding Terminated|1|||
126278529|NCT00106964|454310912|FG002|Overall Study|Site Funding Terminated|1|||
126278530|NCT00106964|454310910|FG000|Overall Study|Failure to adhere|2|||
126278531|NCT00106964|454310911|FG001|Overall Study|Failure to adhere|0|||
126278532|NCT00106964|454310912|FG002|Overall Study|Failure to adhere|0|||
126278533|NCT00106964|454310910|FG000|Overall Study|Did not meet eligibility criteria|0|||
126278534|NCT00106964|454310911|FG001|Overall Study|Did not meet eligibility criteria|2|||
126278535|NCT00106964|454310912|FG002|Overall Study|Did not meet eligibility criteria|2|||
126278536|NCT00106964|454310910|FG000|Overall Study|Required disallowed medication|0|||
126278537|NCT00106964|454310911|FG001|Overall Study|Required disallowed medication|1|||
126278538|NCT00106964|454310912|FG002|Overall Study|Required disallowed medication|0|||
126278539|NCT00168818|454310917|FG000|Overall Study|Adverse Event|23|||
126278540|NCT00168818|454310918|FG001|Overall Study|Adverse Event|29|||
126278541|NCT00168818|454310919|FG002|Overall Study|Adverse Event|31|||
126278542|NCT00168818|454310917|FG000|Overall Study|Protocol Violation|16|||
126278543|NCT00168818|454310918|FG001|Overall Study|Protocol Violation|11|||
126278544|NCT00168818|454310919|FG002|Overall Study|Protocol Violation|11|||
126278545|NCT00168818|454310917|FG000|Overall Study|Lost to Follow-up|13|||
126278546|NCT00168818|454310918|FG001|Overall Study|Lost to Follow-up|4|||
126278547|NCT00168818|454310919|FG002|Overall Study|Lost to Follow-up|15|||
126278548|NCT00168818|454310917|FG000|Overall Study|Withdrawal by Subject|43|||
126278549|NCT00168818|454310918|FG001|Overall Study|Withdrawal by Subject|41|||
126278550|NCT00168818|454310919|FG002|Overall Study|Withdrawal by Subject|37|||
126278551|NCT00168818|454310917|FG000|Overall Study|Other|22|||
126278552|NCT00168818|454310918|FG001|Overall Study|Other|24|||
126278553|NCT00168818|454310919|FG002|Overall Study|Other|30|||
126278554|NCT00168818|454310917|FG000|Treatment|Adverse Event|77|||
126278555|NCT00168818|454310918|FG001|Treatment|Adverse Event|89|||
126278556|NCT00168818|454310919|FG002|Treatment|Adverse Event|68|||
126278557|NCT00168818|454310917|FG000|Treatment|Protocol Violation|8|||
126278558|NCT00168818|454310918|FG001|Treatment|Protocol Violation|11|||
126278559|NCT00168818|454310919|FG002|Treatment|Protocol Violation|11|||
126278560|NCT00168818|454310917|FG000|Treatment|Lost to Follow-up|0|||
126278561|NCT00168818|454310918|FG001|Treatment|Lost to Follow-up|2|||
126278562|NCT00168818|454310919|FG002|Treatment|Lost to Follow-up|1|||
126278563|NCT00168818|454310917|FG000|Treatment|Withdrawal by Subject|25|||
126278564|NCT00168818|454310918|FG001|Treatment|Withdrawal by Subject|20|||
126278565|NCT00168818|454310919|FG002|Treatment|Withdrawal by Subject|22|||
126278566|NCT00168818|454310917|FG000|Treatment|Other|23|||
126278567|NCT00168818|454310918|FG001|Treatment|Other|29|||
126098844|NCT03541174|453655567|FG004|Part 1 Double-Blind|Other reasons|0|||
126098845|NCT03541174|453655568|FG005|Part 1 Double-Blind|Other reasons|0|||
126098846|NCT03541174|453655563|FG000|Part 2 Single-Blind|Adverse Event|0|||
126098847|NCT03541174|453655564|FG001|Part 2 Single-Blind|Adverse Event|0|||
126098848|NCT03541174|453655565|FG002|Part 2 Single-Blind|Adverse Event|0|||
126098849|NCT03541174|453655566|FG003|Part 2 Single-Blind|Adverse Event|25|||
126098850|NCT03541174|453655567|FG004|Part 2 Single-Blind|Adverse Event|0|||
126098851|NCT03541174|453655568|FG005|Part 2 Single-Blind|Adverse Event|0|||
126098852|NCT03541174|453655563|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
126098853|NCT03541174|453655564|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
126098854|NCT03541174|453655565|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
126098855|NCT03541174|453655566|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
126098856|NCT03541174|453655567|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
126098857|NCT03541174|453655568|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
126098858|NCT03541174|453655563|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
126098859|NCT03541174|453655564|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
126098860|NCT03541174|453655565|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
126098861|NCT03541174|453655566|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
126098862|NCT03541174|453655567|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
126098863|NCT03541174|453655568|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
126098864|NCT03541174|453655563|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
126098865|NCT03541174|453655564|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
126098866|NCT03541174|453655565|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
126278568|NCT00168818|454310919|FG002|Treatment|Other|31|||
126278569|NCT01994291|454310920|FG000|Overall Study|Adverse Event|4|||
126278570|NCT01994291|454310921|FG001|Overall Study|Adverse Event|1|||
126278571|NCT01994291|454310922|FG002|Overall Study|Adverse Event|3|||
126278572|NCT01994291|454310920|FG000|Overall Study|Lost to Follow-up|1|||
126278573|NCT01994291|454310921|FG001|Overall Study|Lost to Follow-up|1|||
126278574|NCT01994291|454310922|FG002|Overall Study|Lost to Follow-up|0|||
126278575|NCT01994291|454310920|FG000|Overall Study|Does not meet entrance criteria|1|||
126278576|NCT01994291|454310921|FG001|Overall Study|Does not meet entrance criteria|0|||
126278577|NCT01994291|454310922|FG002|Overall Study|Does not meet entrance criteria|0|||
126278578|NCT01994291|454310920|FG000|Overall Study|Medication error without associated AE|1|||
126278579|NCT01994291|454310921|FG001|Overall Study|Medication error without associated AE|0|||
126278580|NCT01994291|454310922|FG002|Overall Study|Medication error without associated AE|1|||
126278581|NCT01994291|454310920|FG000|Overall Study|Protocol Violation|1|||
126278582|NCT01994291|454310921|FG001|Overall Study|Protocol Violation|0|||
126278583|NCT01994291|454310922|FG002|Overall Study|Protocol Violation|0|||
126278584|NCT01994291|454310920|FG000|Overall Study|Withdrawal by Subject|6|||
126278585|NCT01994291|454310921|FG001|Overall Study|Withdrawal by Subject|3|||
126278586|NCT01994291|454310922|FG002|Overall Study|Withdrawal by Subject|5|||
126278587|NCT01994291|454310920|FG000|Overall Study|Other|1|||
126278588|NCT01994291|454310921|FG001|Overall Study|Other|2|||
126278589|NCT01994291|454310922|FG002|Overall Study|Other|0|||
126278590|NCT02309138|454310925|FG000|Overall Study|Withdrawal by Subject|44|||
126278591|NCT02309138|454310926|FG001|Overall Study|Withdrawal by Subject|15|||
126278592|NCT02309138|454310925|FG000|Overall Study|Protocol Violation|4|||
126278593|NCT02309138|454310926|FG001|Overall Study|Protocol Violation|2|||
126278594|NCT02309138|454310925|FG000|Overall Study|delivered before visit 2|0|||
126278595|NCT02309138|454310926|FG001|Overall Study|delivered before visit 2|1|||
126278596|NCT00735397|454310929|FG000|Overall Study|Adverse Event|194|||
126278597|NCT00735397|454310929|FG000|Overall Study|Lost to Follow-up|33|||
126278598|NCT00735397|454310929|FG000|Overall Study|Participant choice|252|||
126278599|NCT00735397|454310929|FG000|Overall Study|Inadequate therapeutic effect|202|||
126278600|NCT00735397|454310929|FG000|Overall Study|Administrative/Other|502|||
126278601|NCT03016975|454310934|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
126278602|NCT03016975|454310935|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
126278603|NCT03016975|454310936|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
126098867|NCT03541174|453655566|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
126098868|NCT03541174|453655567|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
126098869|NCT03541174|453655568|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
126098870|NCT03541174|453655563|FG000|Part 2 Single-Blind|Death|0|||
126278604|NCT03016975|454310934|FG000|At 6 Months Follow-up|Death|2|||
126278605|NCT03016975|454310935|FG001|At 6 Months Follow-up|Death|0|||
126098871|NCT03541174|453655564|FG001|Part 2 Single-Blind|Death|0|||
126278606|NCT03016975|454310936|FG002|At 6 Months Follow-up|Death|0|||
126278607|NCT03016975|454310934|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
126278608|NCT03016975|454310935|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
126363649|NCT03574389|454624883|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
126363650|NCT03574389|454624884|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
126363651|NCT03574389|454624885|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
126363652|NCT03574389|454624879|FG000|Vaccination Period|Other|6|||
126363653|NCT03574389|454624880|FG001|Vaccination Period|Other|0|||
125881761|NCT00887809|452866992|FG001|Overall Study|Death|0|||
125881762|NCT01352715|452866995|FG000|Overall Study|Death|3|||
125881763|NCT01352715|452866996|FG001|Overall Study|Death|3|||
125881764|NCT01352715|452866995|FG000|Overall Study|Lost to Follow-up|5|||
125881765|NCT01352715|452866996|FG001|Overall Study|Lost to Follow-up|7|||
125881766|NCT01352715|452866995|FG000|Overall Study|Withdrawal by Subject|4|||
125881767|NCT01352715|452866996|FG001|Overall Study|Withdrawal by Subject|8|||
125881768|NCT01352715|452866995|FG000|Overall Study|site closure|16|||
125881769|NCT01352715|452866996|FG001|Overall Study|site closure|15|||
125881770|NCT01352715|452866995|FG000|Overall Study|no final visit in closeout period|15|||
125881771|NCT01352715|452866996|FG001|Overall Study|no final visit in closeout period|12|||
125881772|NCT01352715|452866995|FG000|Overall Study|major ineligibility|2|||
125881773|NCT01352715|452866996|FG001|Overall Study|major ineligibility|1|||
125881774|NCT04596267|452866997|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
125881775|NCT04596267|452866998|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
125881776|NCT04596267|452866997|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
125881777|NCT04596267|452866998|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
125881778|NCT00071058|452866999|FG000|Overall Study|brain tumor-removed from study|1|||
125881779|NCT02000440|452867000|FG000|Overall Study|Adverse Event|3|||
125881780|NCT02000440|452867000|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
125881781|NCT04109547|452867001|FG000|Overall Study|Withdrawal by Subject|3|||
125881782|NCT04109547|452867002|FG001|Overall Study|Withdrawal by Subject|2|||
125881783|NCT04109547|452867003|FG002|Overall Study|Withdrawal by Subject|6|||
125881784|NCT04109547|452867004|FG003|Overall Study|Withdrawal by Subject|6|||
125881785|NCT04109547|452867001|FG000|Overall Study|Lost to Follow-up|0|||
125881786|NCT04109547|452867002|FG001|Overall Study|Lost to Follow-up|0|||
125881787|NCT04109547|452867003|FG002|Overall Study|Lost to Follow-up|0|||
126363654|NCT03574389|454624881|FG002|Vaccination Period|Other|0|||
126363655|NCT03574389|454624882|FG003|Vaccination Period|Other|0|||
125881788|NCT04109547|452867004|FG003|Overall Study|Lost to Follow-up|1|||
126278609|NCT03016975|454310936|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
126278610|NCT03016975|454310934|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
126278611|NCT03016975|454310935|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
126278612|NCT03016975|454310936|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
126278613|NCT03016975|454310934|FG000|At 6 Months Follow-up|Aborted implant|1|||
126278614|NCT03016975|454310935|FG001|At 6 Months Follow-up|Aborted implant|0|||
126278615|NCT03016975|454310936|FG002|At 6 Months Follow-up|Aborted implant|0|||
126278616|NCT03016975|454310934|FG000|At 2 Year Follow-up|Death|1|||
126278617|NCT03016975|454310935|FG001|At 2 Year Follow-up|Death|0|||
126278618|NCT03016975|454310936|FG002|At 2 Year Follow-up|Death|0|||
126278619|NCT03016975|454310934|FG000|At 3 Year Follow-up|Death|1|||
126278620|NCT03016975|454310935|FG001|At 3 Year Follow-up|Death|0|||
126278621|NCT03016975|454310936|FG002|At 3 Year Follow-up|Death|0|||
126278622|NCT03016975|454310934|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
126278623|NCT03016975|454310935|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
126278624|NCT03016975|454310936|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
126278625|NCT03016975|454310934|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
126278626|NCT03016975|454310935|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
126278627|NCT03016975|454310936|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
126278628|NCT01590797|454310939|FG000|Overall Study|Adverse Event|4|||
126278629|NCT01590797|454310940|FG001|Overall Study|Adverse Event|3|||
126278630|NCT01590797|454310939|FG000|Overall Study|Lack of Efficacy|0|||
126278631|NCT01590797|454310940|FG001|Overall Study|Lack of Efficacy|2|||
126278632|NCT01590797|454310939|FG000|Overall Study|Lost to Follow-up|0|||
126278633|NCT01590797|454310940|FG001|Overall Study|Lost to Follow-up|1|||
126278634|NCT01590797|454310939|FG000|Overall Study|Protocol Violation|4|||
126278635|NCT01590797|454310940|FG001|Overall Study|Protocol Violation|1|||
125881789|NCT04109547|452867001|FG000|Overall Study|Physician Decision|1|||
125881790|NCT04109547|452867002|FG001|Overall Study|Physician Decision|2|||
125881791|NCT04109547|452867003|FG002|Overall Study|Physician Decision|0|||
125881792|NCT04109547|452867004|FG003|Overall Study|Physician Decision|0|||
125881793|NCT01550003|452867005|FG000|Overall Study|Adverse Event|0|||
126363656|NCT03574389|454624883|FG004|Vaccination Period|Other|0|||
126363657|NCT03574389|454624884|FG005|Vaccination Period|Other|0|||
125881794|NCT01550003|452867006|FG001|Overall Study|Adverse Event|9|||
125881795|NCT01550003|452867007|FG002|Overall Study|Adverse Event|15|||
126278636|NCT01590797|454310939|FG000|Overall Study|Withdrawal by Subject|7|||
126278637|NCT01590797|454310940|FG001|Overall Study|Withdrawal by Subject|5|||
126278638|NCT01590797|454310939|FG000|Overall Study|Other Protocol Specified Criteria|2|||
126278639|NCT01590797|454310940|FG001|Overall Study|Other Protocol Specified Criteria|4|||
126278640|NCT00901576|454310944|FG000|Second Intervention|Withdrawal by Subject|0|||
126363658|NCT03574389|454624885|FG006|Vaccination Period|Other|0|||
126039168|NCT01928394|453443488|FG015|Follow-up Period|Participant withdrew consent|0|||
126039169|NCT01928394|453443489|FG016|Follow-up Period|Participant withdrew consent|5|||
126039170|NCT01928394|453443490|FG017|Follow-up Period|Participant withdrew consent|3|||
126039171|NCT01928394|453443491|FG018|Follow-up Period|Participant withdrew consent|2|||
126039172|NCT01928394|453443492|FG019|Follow-up Period|Participant withdrew consent|7|||
126039173|NCT01928394|453443493|FG020|Follow-up Period|Participant withdrew consent|4|||
126039174|NCT01928394|453443494|FG021|Follow-up Period|Participant withdrew consent|6|||
126039175|NCT01928394|453443495|FG022|Follow-up Period|Participant withdrew consent|2|||
126039176|NCT01928394|453443473|FG000|Follow-up Period|Death|0|||
126039177|NCT01928394|453443474|FG001|Follow-up Period|Death|0|||
126039178|NCT01928394|453443475|FG002|Follow-up Period|Death|2|||
126039179|NCT01928394|453443476|FG003|Follow-up Period|Death|6|||
126039180|NCT01928394|453443477|FG004|Follow-up Period|Death|0|||
126039181|NCT01928394|453443478|FG005|Follow-up Period|Death|6|||
126039182|NCT01928394|453443479|FG006|Follow-up Period|Death|6|||
126039183|NCT01928394|453443480|FG007|Follow-up Period|Death|2|||
126039184|NCT01928394|453443481|FG008|Follow-up Period|Death|1|||
126039185|NCT01928394|453443482|FG009|Follow-up Period|Death|2|||
126039186|NCT01928394|453443483|FG010|Follow-up Period|Death|4|||
126039187|NCT01928394|453443484|FG011|Follow-up Period|Death|12|||
126039188|NCT01928394|453443485|FG012|Follow-up Period|Death|11|||
126039189|NCT01928394|453443486|FG013|Follow-up Period|Death|25|||
126039190|NCT01928394|453443487|FG014|Follow-up Period|Death|18|||
126039191|NCT01928394|453443488|FG015|Follow-up Period|Death|0|||
126039192|NCT01928394|453443489|FG016|Follow-up Period|Death|6|||
126039193|NCT01928394|453443490|FG017|Follow-up Period|Death|5|||
126098872|NCT03541174|453655565|FG002|Part 2 Single-Blind|Death|0|||
126278641|NCT00901576|454310945|FG001|Second Intervention|Withdrawal by Subject|0|||
126278642|NCT00901576|454310946|FG002|Second Intervention|Withdrawal by Subject|0|||
126278643|NCT00901576|454310947|FG003|Second Intervention|Withdrawal by Subject|1|||
126278644|NCT00901576|454310948|FG004|Second Intervention|Withdrawal by Subject|0|||
126278645|NCT00901576|454310949|FG005|Second Intervention|Withdrawal by Subject|1|||
126278646|NCT00901576|454310944|FG000|Second Intervention|Physician Decision|1|||
126278647|NCT00901576|454310945|FG001|Second Intervention|Physician Decision|0|||
126278648|NCT00901576|454310946|FG002|Second Intervention|Physician Decision|0|||
126278649|NCT00901576|454310947|FG003|Second Intervention|Physician Decision|0|||
126278650|NCT00901576|454310948|FG004|Second Intervention|Physician Decision|0|||
126278651|NCT00901576|454310949|FG005|Second Intervention|Physician Decision|0|||
126278652|NCT01228019|454310950|FG000|Overall Study|Dose Violation|70|||
126278653|NCT01228019|454310950|FG000|Overall Study|Duplicate enrollment|1|||
126278654|NCT01228019|454310950|FG000|Overall Study|Missing pre-treatment data|72|||
126278655|NCT01228019|454310950|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
126278656|NCT01228019|454310950|FG000|Overall Study|Violation of Entry Criterion|9|||
126278657|NCT04106661|454310953|FG000|Overall Study|Protocol Violation|3|||
126278658|NCT04106661|454310954|FG001|Overall Study|Protocol Violation|0|||
126278659|NCT04106661|454310953|FG000|Overall Study|Scheduling difficulties|1|||
126278660|NCT04106661|454310954|FG001|Overall Study|Scheduling difficulties|1|||
126278661|NCT00530218|454310957|FG000|Overall Study|CMV Not Detected|13|||
126278662|NCT00530218|454310957|FG000|Overall Study|Death|12|||
126278663|NCT02910063|454310965|FG000|Phase 2|Withdrawal by Subject|3|||
126278664|NCT02910063|454310966|FG001|Phase 2|Withdrawal by Subject|0|||
126278665|NCT02910063|454310967|FG002|Phase 2|Withdrawal by Subject|0|||
126363659|NCT03574389|454624879|FG000|Vaccination Period|Adverse Event|0|||
126039194|NCT01928394|453443491|FG018|Follow-up Period|Death|13|||
126039195|NCT01928394|453443492|FG019|Follow-up Period|Death|13|||
126039196|NCT01928394|453443493|FG020|Follow-up Period|Death|5|||
126039197|NCT01928394|453443494|FG021|Follow-up Period|Death|3|||
126039198|NCT01928394|453443495|FG022|Follow-up Period|Death|2|||
126039199|NCT01928394|453443473|FG000|Follow-up Period|other reason|0|||
126039200|NCT01928394|453443474|FG001|Follow-up Period|other reason|0|||
126039201|NCT01928394|453443475|FG002|Follow-up Period|other reason|0|||
126039202|NCT01928394|453443476|FG003|Follow-up Period|other reason|0|||
126039203|NCT01928394|453443477|FG004|Follow-up Period|other reason|0|||
126278666|NCT02910063|454310965|FG000|Phase 2|Lost to Follow-up|1|||
126278667|NCT02910063|454310966|FG001|Phase 2|Lost to Follow-up|0|||
126278668|NCT02910063|454310967|FG002|Phase 2|Lost to Follow-up|0|||
126278669|NCT02910063|454310965|FG000|Phase 2|Death|24|||
126278670|NCT02910063|454310966|FG001|Phase 2|Death|0|||
126278671|NCT02910063|454310967|FG002|Phase 2|Death|0|||
126039204|NCT01928394|453443478|FG005|Follow-up Period|other reason|0|||
126039205|NCT01928394|453443479|FG006|Follow-up Period|other reason|1|||
126039206|NCT01928394|453443480|FG007|Follow-up Period|other reason|3|||
126039207|NCT01928394|453443481|FG008|Follow-up Period|other reason|0|||
126039208|NCT01928394|453443482|FG009|Follow-up Period|other reason|0|||
126039209|NCT01928394|453443483|FG010|Follow-up Period|other reason|2|||
126039210|NCT01928394|453443484|FG011|Follow-up Period|other reason|1|||
126039211|NCT01928394|453443485|FG012|Follow-up Period|other reason|0|||
126039212|NCT01928394|453443486|FG013|Follow-up Period|other reason|1|||
126039213|NCT01928394|453443487|FG014|Follow-up Period|other reason|4|||
126098873|NCT03541174|453655566|FG003|Part 2 Single-Blind|Death|5|||
126278672|NCT00813800|454310970|FG000|Overall Study|Screen Failure after Consent|2|||
125881796|NCT01550003|452867005|FG000|Overall Study|Lack of Efficacy|4|||
125881797|NCT01550003|452867006|FG001|Overall Study|Lack of Efficacy|11|||
125881798|NCT01550003|452867007|FG002|Overall Study|Lack of Efficacy|15|||
125881799|NCT01550003|452867005|FG000|Overall Study|Protocol Violation|0|||
125881800|NCT01550003|452867006|FG001|Overall Study|Protocol Violation|3|||
125881801|NCT01550003|452867007|FG002|Overall Study|Protocol Violation|2|||
125881802|NCT01550003|452867005|FG000|Overall Study|Lost to Follow-up|1|||
125881803|NCT01550003|452867006|FG001|Overall Study|Lost to Follow-up|4|||
125881804|NCT01550003|452867007|FG002|Overall Study|Lost to Follow-up|8|||
125881805|NCT01550003|452867005|FG000|Overall Study|Consent withdrawn|2|||
125881806|NCT01550003|452867006|FG001|Overall Study|Consent withdrawn|11|||
125881807|NCT01550003|452867007|FG002|Overall Study|Consent withdrawn|23|||
125881808|NCT01550003|452867005|FG000|Overall Study|Missing|1|||
125881809|NCT01550003|452867006|FG001|Overall Study|Missing|0|||
125881810|NCT01550003|452867007|FG002|Overall Study|Missing|2|||
125881811|NCT01550003|452867005|FG000|Overall Study|Study closure as announced by sponsor|7|||
125881812|NCT01550003|452867006|FG001|Overall Study|Study closure as announced by sponsor|6|||
125881813|NCT01550003|452867007|FG002|Overall Study|Study closure as announced by sponsor|24|||
125881814|NCT01550003|452867005|FG000|Overall Study|Protocol Noncompliance|1|||
125881815|NCT01550003|452867006|FG001|Overall Study|Protocol Noncompliance|0|||
125881816|NCT01550003|452867007|FG002|Overall Study|Protocol Noncompliance|0|||
125881817|NCT01550003|452867005|FG000|Overall Study|Study closure|0|||
125881818|NCT01550003|452867006|FG001|Overall Study|Study closure|1|||
125881819|NCT01550003|452867007|FG002|Overall Study|Study closure|1|||
125881820|NCT01550003|452867005|FG000|Overall Study|Patient reached adulthood|0|||
125881821|NCT01550003|452867006|FG001|Overall Study|Patient reached adulthood|1|||
125881822|NCT01550003|452867007|FG002|Overall Study|Patient reached adulthood|0|||
125881823|NCT01550003|452867005|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
125881824|NCT01550003|452867006|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
125881825|NCT01550003|452867007|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
125881826|NCT01550003|452867005|FG000|Overall Study|Sponsor's order|0|||
125881827|NCT01550003|452867006|FG001|Overall Study|Sponsor's order|3|||
125881828|NCT01550003|452867007|FG002|Overall Study|Sponsor's order|3|||
125881829|NCT01550003|452867005|FG000|Overall Study|Sponsor's decision|1|||
125881830|NCT01550003|452867006|FG001|Overall Study|Sponsor's decision|5|||
125881831|NCT01550003|452867007|FG002|Overall Study|Sponsor's decision|4|||
125881832|NCT01550003|452867005|FG000|Overall Study|Subject mother passed away|0|||
125881833|NCT01550003|452867006|FG001|Overall Study|Subject mother passed away|1|||
125881834|NCT01550003|452867007|FG002|Overall Study|Subject mother passed away|0|||
125881835|NCT01550003|452867005|FG000|Overall Study|Discontinuation|0|||
125881836|NCT01550003|452867006|FG001|Overall Study|Discontinuation|1|||
125881837|NCT01550003|452867007|FG002|Overall Study|Discontinuation|0|||
125881838|NCT01550003|452867005|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
125881839|NCT01550003|452867006|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
125881840|NCT01550003|452867007|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
125881841|NCT01550003|452867005|FG000|Overall Study|Site closure|0|||
125881842|NCT01550003|452867006|FG001|Overall Study|Site closure|2|||
125881843|NCT01550003|452867007|FG002|Overall Study|Site closure|0|||
125881844|NCT01550003|452867005|FG000|Overall Study|Pregnancy|0|||
125881845|NCT01550003|452867006|FG001|Overall Study|Pregnancy|1|||
125881846|NCT01550003|452867007|FG002|Overall Study|Pregnancy|0|||
125881847|NCT01550003|452867005|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
125881848|NCT01550003|452867006|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
125881849|NCT01550003|452867007|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
125881850|NCT01550003|452867005|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
125881851|NCT01550003|452867006|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
125881852|NCT01550003|452867007|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
125881853|NCT01550003|452867005|FG000|Overall Study|Switching to adult rheumatologist|0|||
125881854|NCT01550003|452867006|FG001|Overall Study|Switching to adult rheumatologist|0|||
125881855|NCT01550003|452867007|FG002|Overall Study|Switching to adult rheumatologist|1|||
125881856|NCT01550003|452867005|FG000|Overall Study|Patient transition to adult care|0|||
125881857|NCT01550003|452867006|FG001|Overall Study|Patient transition to adult care|0|||
125881858|NCT01550003|452867007|FG002|Overall Study|Patient transition to adult care|1|||
125881859|NCT01550003|452867005|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
125881860|NCT01550003|452867006|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
125881861|NCT01550003|452867007|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
126278673|NCT00813800|454310970|FG000|Overall Study|Adverse Event|1|||
125881862|NCT01550003|452867005|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
125881863|NCT01550003|452867006|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
125881864|NCT01550003|452867007|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
125881865|NCT01550003|452867005|FG000|Overall Study|Per Sponsor request|1|||
125881866|NCT01550003|452867006|FG001|Overall Study|Per Sponsor request|0|||
125881867|NCT01550003|452867007|FG002|Overall Study|Per Sponsor request|1|||
125881868|NCT01550003|452867005|FG000|Overall Study|Patient not compliance|0|||
126278674|NCT00813800|454310970|FG000|Overall Study|Worsening of depression|2|||
126278675|NCT00813800|454310970|FG000|Overall Study|Physician Decision|1|||
126278676|NCT03456453|454310971|FG000|Overall Study|Withdrawal by Subject|2|||
126278677|NCT03456453|454310972|FG001|Overall Study|Withdrawal by Subject|0|||
126278678|NCT03456453|454310971|FG000|Overall Study|Not released to community|1|||
126278679|NCT03456453|454310972|FG001|Overall Study|Not released to community|5|||
126278680|NCT03456453|454310971|FG000|Overall Study|Lost to Follow-up|0|||
126278681|NCT03456453|454310972|FG001|Overall Study|Lost to Follow-up|2|||
126278682|NCT01144715|454310973|FG000|Overall Study|Lost to Follow-up|2|||
126278683|NCT01144715|454310974|FG001|Overall Study|Lost to Follow-up|1|||
126278684|NCT01144715|454310973|FG000|Overall Study|Withdrawal by Subject|2|||
126278685|NCT01144715|454310974|FG001|Overall Study|Withdrawal by Subject|1|||
126278686|NCT01144715|454310973|FG000|Overall Study|Adverse Event|0|||
126278687|NCT01144715|454310974|FG001|Overall Study|Adverse Event|1|||
126278688|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
126278689|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
126278690|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
126278691|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
126278692|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
126278693|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
126278694|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
126278695|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
126278696|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
126278697|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
125881869|NCT01550003|452867006|FG001|Overall Study|Patient not compliance|0|||
125881870|NCT01550003|452867007|FG002|Overall Study|Patient not compliance|1|||
125881871|NCT01550003|452867005|FG000|Overall Study|Non-compliance|0|||
125881872|NCT01550003|452867006|FG001|Overall Study|Non-compliance|0|||
125881873|NCT01550003|452867007|FG002|Overall Study|Non-compliance|1|||
125881874|NCT01550003|452867005|FG000|Overall Study|Study closed|0|||
125881875|NCT01550003|452867006|FG001|Overall Study|Study closed|1|||
125881876|NCT01550003|452867007|FG002|Overall Study|Study closed|0|||
125881877|NCT01550003|452867005|FG000|Overall Study|Transitioned to adult rheumatology|0|||
125881878|NCT01550003|452867006|FG001|Overall Study|Transitioned to adult rheumatology|0|||
125881879|NCT01550003|452867007|FG002|Overall Study|Transitioned to adult rheumatology|1|||
125881880|NCT01656408|452867008|FG000|Overall Study|Adverse Event|0|||
125881881|NCT01656408|452867009|FG001|Overall Study|Adverse Event|0|||
125881882|NCT01656408|452867010|FG002|Overall Study|Adverse Event|1|||
125881883|NCT01656408|452867011|FG003|Overall Study|Adverse Event|0|||
126278698|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
125881884|NCT01656408|452867012|FG004|Overall Study|Adverse Event|0|||
126278699|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
126278700|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
126278701|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
126278702|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
126278703|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
126278704|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
126278705|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
126278706|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
126278707|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
126278708|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
126278709|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
126278710|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
126278711|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
126278712|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
126278713|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
126278714|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
126278715|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
126278716|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
126278717|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
125881885|NCT01656408|452867013|FG005|Overall Study|Adverse Event|1|||
125881886|NCT01656408|452867014|FG006|Overall Study|Adverse Event|1|||
125881887|NCT01656408|452867015|FG007|Overall Study|Adverse Event|0|||
125881888|NCT01656408|452867016|FG008|Overall Study|Adverse Event|1|||
125881889|NCT01656408|452867017|FG009|Overall Study|Adverse Event|0|||
126278718|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
126278719|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
126278720|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
126278721|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
126278722|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
126278723|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
125881890|NCT01656408|452867008|FG000|Overall Study|Physician Decision|1|||
126278724|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
126278725|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
126278726|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
126278727|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
126278728|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
126278729|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
126278730|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
126278731|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
126278732|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
126278733|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
126278734|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
126278735|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
126278736|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
126278737|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
126278738|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
126278739|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
126278740|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
126278741|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
126278742|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
126278743|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
126278744|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
126278745|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
126278746|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
126278747|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
126278748|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
126278749|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
126278750|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
126278751|NCT02369458|454310978|FG000|Overall Study|Determined to be not eligible|1|||
126278752|NCT02369458|454310979|FG001|Overall Study|Determined to be not eligible|0|||
126278753|NCT04572893|454310980|FG000|Part A|Adverse Event|1|||
126278754|NCT04572893|454310981|FG001|Part A|Adverse Event|0|||
126278755|NCT04572893|454310982|FG002|Part A|Adverse Event|0|||
126278756|NCT04572893|454310983|FG003|Part A|Adverse Event|0|||
126278757|NCT04572893|454310984|FG004|Part A|Adverse Event|0|||
126278758|NCT04572893|454310985|FG005|Part A|Adverse Event|0|||
126278759|NCT04572893|454310986|FG006|Part A|Adverse Event|0|||
126278760|NCT04572893|454310980|FG000|Part B|Withdrawal by Subject|0|||
126278761|NCT04572893|454310981|FG001|Part B|Withdrawal by Subject|0|||
126278762|NCT04572893|454310982|FG002|Part B|Withdrawal by Subject|0|||
126278763|NCT04572893|454310983|FG003|Part B|Withdrawal by Subject|0|||
126278764|NCT04572893|454310984|FG004|Part B|Withdrawal by Subject|0|||
126278765|NCT04572893|454310985|FG005|Part B|Withdrawal by Subject|1|||
126278766|NCT04572893|454310986|FG006|Part B|Withdrawal by Subject|0|||
126278767|NCT04572893|454310980|FG000|Part B|Study terminated by sponsor|0|||
126278768|NCT04572893|454310981|FG001|Part B|Study terminated by sponsor|0|||
126278769|NCT04572893|454310982|FG002|Part B|Study terminated by sponsor|0|||
126278770|NCT04572893|454310983|FG003|Part B|Study terminated by sponsor|0|||
126278771|NCT04572893|454310984|FG004|Part B|Study terminated by sponsor|7|||
126278772|NCT04572893|454310985|FG005|Part B|Study terminated by sponsor|5|||
126278773|NCT04572893|454310986|FG006|Part B|Study terminated by sponsor|3|||
126278774|NCT04572893|454310980|FG000|Part B|Lost to Follow-up|0|||
126278775|NCT04572893|454310981|FG001|Part B|Lost to Follow-up|0|||
126278776|NCT04572893|454310982|FG002|Part B|Lost to Follow-up|0|||
126278777|NCT04572893|454310983|FG003|Part B|Lost to Follow-up|0|||
126278778|NCT04572893|454310984|FG004|Part B|Lost to Follow-up|0|||
126278779|NCT04572893|454310985|FG005|Part B|Lost to Follow-up|0|||
126278780|NCT04572893|454310986|FG006|Part B|Lost to Follow-up|1|||
126278781|NCT04572893|454310980|FG000|Part B|Adverse Event|0|||
126278782|NCT04572893|454310981|FG001|Part B|Adverse Event|0|||
126278783|NCT04572893|454310982|FG002|Part B|Adverse Event|0|||
126278784|NCT04572893|454310983|FG003|Part B|Adverse Event|0|||
126278785|NCT04572893|454310984|FG004|Part B|Adverse Event|1|||
126278786|NCT04572893|454310985|FG005|Part B|Adverse Event|1|||
126278787|NCT04572893|454310986|FG006|Part B|Adverse Event|0|||
126278788|NCT00121134|454310987|FG000|Overall Study|Progression of Disease|5|||
126278789|NCT00121134|454310988|FG001|Overall Study|Progression of Disease|3|||
126363660|NCT03574389|454624880|FG001|Vaccination Period|Adverse Event|1|||
126363661|NCT03574389|454624881|FG002|Vaccination Period|Adverse Event|0|||
126278790|NCT00121134|454310989|FG002|Overall Study|Progression of Disease|4|||
126278791|NCT00121134|454310990|FG003|Overall Study|Progression of Disease|2|||
126278792|NCT00121134|454310987|FG000|Overall Study|Toxicity|4|||
126278793|NCT00121134|454310988|FG001|Overall Study|Toxicity|7|||
126278794|NCT00121134|454310989|FG002|Overall Study|Toxicity|13|||
126278795|NCT00121134|454310990|FG003|Overall Study|Toxicity|5|||
126278796|NCT00121134|454310987|FG000|Overall Study|Physician Decision|6|||
126039214|NCT01928394|453443488|FG015|Follow-up Period|other reason|0|||
126039215|NCT01928394|453443489|FG016|Follow-up Period|other reason|2|||
126039216|NCT01928394|453443490|FG017|Follow-up Period|other reason|0|||
126039217|NCT01928394|453443491|FG018|Follow-up Period|other reason|1|||
126039218|NCT01928394|453443492|FG019|Follow-up Period|other reason|1|||
126039219|NCT01928394|453443493|FG020|Follow-up Period|other reason|0|||
126039220|NCT01928394|453443494|FG021|Follow-up Period|other reason|0|||
126039221|NCT01928394|453443495|FG022|Follow-up Period|other reason|1|||
126039222|NCT01928394|453443473|FG000|Follow-up Period|Lost to Follow-up|0|||
126039223|NCT01928394|453443474|FG001|Follow-up Period|Lost to Follow-up|0|||
126039224|NCT01928394|453443475|FG002|Follow-up Period|Lost to Follow-up|0|||
126039225|NCT01928394|453443476|FG003|Follow-up Period|Lost to Follow-up|0|||
126039226|NCT01928394|453443477|FG004|Follow-up Period|Lost to Follow-up|0|||
126039227|NCT01928394|453443478|FG005|Follow-up Period|Lost to Follow-up|0|||
126278797|NCT00121134|454310988|FG001|Overall Study|Physician Decision|4|||
126278798|NCT00121134|454310989|FG002|Overall Study|Physician Decision|4|||
126278799|NCT00121134|454310990|FG003|Overall Study|Physician Decision|1|||
126278800|NCT00121134|454310987|FG000|Overall Study|Treatment Delay|1|||
126278801|NCT00121134|454310988|FG001|Overall Study|Treatment Delay|0|||
126278802|NCT00121134|454310989|FG002|Overall Study|Treatment Delay|0|||
126278803|NCT00121134|454310990|FG003|Overall Study|Treatment Delay|0|||
126278804|NCT00121134|454310987|FG000|Overall Study|Intercurrent Illness|0|||
126278805|NCT00121134|454310988|FG001|Overall Study|Intercurrent Illness|0|||
126278806|NCT00121134|454310989|FG002|Overall Study|Intercurrent Illness|0|||
126278807|NCT00121134|454310990|FG003|Overall Study|Intercurrent Illness|1|||
126278808|NCT00121134|454310987|FG000|Overall Study|Patient Personal Reasons|0|||
126278809|NCT00121134|454310988|FG001|Overall Study|Patient Personal Reasons|1|||
126278810|NCT00121134|454310989|FG002|Overall Study|Patient Personal Reasons|0|||
126278811|NCT00121134|454310990|FG003|Overall Study|Patient Personal Reasons|0|||
126278812|NCT00197496|454310997|FG000|Baseline to Discharge|not interested|1|||
126278813|NCT00197496|454310998|FG001|Baseline to Discharge|not interested|0|||
126278814|NCT00197496|454310997|FG000|Baseline to Discharge|MRSA|1|||
126278815|NCT00197496|454310998|FG001|Baseline to Discharge|MRSA|0|||
126278816|NCT00197496|454310997|FG000|Baseline to Discharge|Physician Decision|0|||
126278817|NCT00197496|454310998|FG001|Baseline to Discharge|Physician Decision|1|||
126278818|NCT00197496|454310997|FG000|Baseline to Discharge|Protocol Violation|0|||
126278819|NCT00197496|454310998|FG001|Baseline to Discharge|Protocol Violation|1|||
126278820|NCT00197496|454310997|FG000|Follow-up|Lost to Follow-up|2|||
126278821|NCT00197496|454310998|FG001|Follow-up|Lost to Follow-up|1|||
126278822|NCT00857584|454311004|FG000|Overall Study|Lack of Efficacy|1|||
126278823|NCT00857584|454311005|FG001|Overall Study|Lack of Efficacy|2|||
126278824|NCT00857584|454311004|FG000|Overall Study|Adverse Event|2|||
126278825|NCT00857584|454311005|FG001|Overall Study|Adverse Event|2|||
126278826|NCT00857584|454311004|FG000|Overall Study|Physician Decision|1|||
126278827|NCT00857584|454311005|FG001|Overall Study|Physician Decision|1|||
126278828|NCT00418821|454311006|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
126278829|NCT00259272|454311007|FG000|Overall Study|Adverse Event|2|||
126278830|NCT00259272|454311008|FG001|Overall Study|Adverse Event|1|||
126278831|NCT00259272|454311009|FG002|Overall Study|Adverse Event|0|||
126278832|NCT00259272|454311010|FG003|Overall Study|Adverse Event|3|||
126278833|NCT00259272|454311007|FG000|Overall Study|Lack of Efficacy|5|||
126278834|NCT00259272|454311008|FG001|Overall Study|Lack of Efficacy|1|||
126278835|NCT00259272|454311009|FG002|Overall Study|Lack of Efficacy|2|||
126278836|NCT00259272|454311010|FG003|Overall Study|Lack of Efficacy|6|||
126278837|NCT00259272|454311007|FG000|Overall Study|Physician Decision|1|||
126278838|NCT00259272|454311008|FG001|Overall Study|Physician Decision|2|||
126039228|NCT01928394|453443479|FG006|Follow-up Period|Lost to Follow-up|0|||
126039229|NCT01928394|453443480|FG007|Follow-up Period|Lost to Follow-up|0|||
126039230|NCT01928394|453443481|FG008|Follow-up Period|Lost to Follow-up|0|||
126278839|NCT00259272|454311009|FG002|Overall Study|Physician Decision|1|||
126278840|NCT00259272|454311010|FG003|Overall Study|Physician Decision|3|||
126278841|NCT00259272|454311007|FG000|Overall Study|Protocol Violation|2|||
126278842|NCT00259272|454311008|FG001|Overall Study|Protocol Violation|0|||
126278843|NCT00259272|454311009|FG002|Overall Study|Protocol Violation|0|||
126278844|NCT00259272|454311010|FG003|Overall Study|Protocol Violation|1|||
126278845|NCT00259272|454311007|FG000|Overall Study|Sponsor Decision|0|||
126278846|NCT00259272|454311008|FG001|Overall Study|Sponsor Decision|1|||
126278847|NCT00259272|454311009|FG002|Overall Study|Sponsor Decision|0|||
126278848|NCT00259272|454311010|FG003|Overall Study|Sponsor Decision|0|||
126278849|NCT00259272|454311007|FG000|Overall Study|Withdrawal by Subject|4|||
126278850|NCT00259272|454311008|FG001|Overall Study|Withdrawal by Subject|2|||
126278851|NCT00259272|454311009|FG002|Overall Study|Withdrawal by Subject|2|||
126039231|NCT01928394|453443482|FG009|Follow-up Period|Lost to Follow-up|0|||
126039232|NCT01928394|453443483|FG010|Follow-up Period|Lost to Follow-up|0|||
126039233|NCT01928394|453443484|FG011|Follow-up Period|Lost to Follow-up|1|||
126039234|NCT01928394|453443485|FG012|Follow-up Period|Lost to Follow-up|1|||
126098874|NCT03541174|453655567|FG004|Part 2 Single-Blind|Death|0|||
126278852|NCT00259272|454311010|FG003|Overall Study|Withdrawal by Subject|7|||
126278853|NCT00259272|454311007|FG000|Overall Study|Lost to Follow-up|1|||
126039235|NCT01928394|453443486|FG013|Follow-up Period|Lost to Follow-up|0|||
126039236|NCT01928394|453443487|FG014|Follow-up Period|Lost to Follow-up|1|||
126039237|NCT01928394|453443488|FG015|Follow-up Period|Lost to Follow-up|0|||
126039238|NCT01928394|453443489|FG016|Follow-up Period|Lost to Follow-up|1|||
126039239|NCT01928394|453443490|FG017|Follow-up Period|Lost to Follow-up|0|||
126039240|NCT01928394|453443491|FG018|Follow-up Period|Lost to Follow-up|0|||
126039241|NCT01928394|453443492|FG019|Follow-up Period|Lost to Follow-up|0|||
126039242|NCT01928394|453443493|FG020|Follow-up Period|Lost to Follow-up|0|||
126039243|NCT01928394|453443494|FG021|Follow-up Period|Lost to Follow-up|0|||
126039244|NCT01928394|453443495|FG022|Follow-up Period|Lost to Follow-up|1|||
126039245|NCT04433208|453443496|FG000|Overall Study|Withdrawal by Subject|0|||
126039246|NCT04433208|453443497|FG001|Overall Study|Withdrawal by Subject|1|||
126039247|NCT04433208|453443498|FG002|Overall Study|Withdrawal by Subject|1|||
126039248|NCT04433208|453443499|FG003|Overall Study|Withdrawal by Subject|0|||
126098875|NCT03541174|453655568|FG005|Part 2 Single-Blind|Death|0|||
126278854|NCT00259272|454311008|FG001|Overall Study|Lost to Follow-up|0|||
126278855|NCT00259272|454311009|FG002|Overall Study|Lost to Follow-up|0|||
126278856|NCT00259272|454311010|FG003|Overall Study|Lost to Follow-up|1|||
126278857|NCT00805467|454312524|FG000|Overall Study|Lack of Efficacy|0|||
126278858|NCT00805467|454312525|FG001|Overall Study|Lack of Efficacy|8|||
126278859|NCT00805467|454312526|FG002|Overall Study|Lack of Efficacy|13|||
126278860|NCT00805467|454312527|FG003|Overall Study|Lack of Efficacy|86|||
126278861|NCT00805467|454312524|FG000|Overall Study|Lost to Follow-up|0|||
126278862|NCT00805467|454312525|FG001|Overall Study|Lost to Follow-up|1|||
126098876|NCT03541174|453655563|FG000|Part 2 Single-Blind|Pregnancy|0|||
126098877|NCT03541174|453655564|FG001|Part 2 Single-Blind|Pregnancy|0|||
126278863|NCT00805467|454312526|FG002|Overall Study|Lost to Follow-up|7|||
126278864|NCT00805467|454312527|FG003|Overall Study|Lost to Follow-up|21|||
126278865|NCT00805467|454312524|FG000|Overall Study|Withdrawal by Subject|0|||
126278866|NCT00805467|454312525|FG001|Overall Study|Withdrawal by Subject|6|||
126278867|NCT00805467|454312526|FG002|Overall Study|Withdrawal by Subject|45|||
126278868|NCT00805467|454312527|FG003|Overall Study|Withdrawal by Subject|50|||
126098878|NCT03541174|453655565|FG002|Part 2 Single-Blind|Pregnancy|0|||
126098879|NCT03541174|453655566|FG003|Part 2 Single-Blind|Pregnancy|1|||
126098880|NCT03541174|453655567|FG004|Part 2 Single-Blind|Pregnancy|0|||
126278869|NCT00805467|454312524|FG000|Overall Study|Protocol Violation|0|||
126278870|NCT00805467|454312525|FG001|Overall Study|Protocol Violation|3|||
126278871|NCT00805467|454312526|FG002|Overall Study|Protocol Violation|0|||
126278872|NCT00805467|454312527|FG003|Overall Study|Protocol Violation|5|||
126278873|NCT00805467|454312524|FG000|Overall Study|Adverse Event|0|||
126098881|NCT03541174|453655568|FG005|Part 2 Single-Blind|Pregnancy|0|||
126098882|NCT03541174|453655563|FG000|Part 2 Single-Blind|Other reasons|0|||
126098883|NCT03541174|453655564|FG001|Part 2 Single-Blind|Other reasons|0|||
126098884|NCT03541174|453655565|FG002|Part 2 Single-Blind|Other reasons|0|||
126098885|NCT03541174|453655566|FG003|Part 2 Single-Blind|Other reasons|32|||
126098886|NCT03541174|453655567|FG004|Part 2 Single-Blind|Other reasons|0|||
126098887|NCT03541174|453655568|FG005|Part 2 Single-Blind|Other reasons|0|||
126098888|NCT03541174|453655563|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
126098889|NCT03541174|453655564|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
126098890|NCT03541174|453655565|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
126098891|NCT03541174|453655566|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
126098892|NCT03541174|453655567|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
126098893|NCT03541174|453655568|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
126098894|NCT03541174|453655563|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
126098895|NCT03541174|453655564|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
126098896|NCT03541174|453655565|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
126278874|NCT00805467|454312525|FG001|Overall Study|Adverse Event|13|||
126039249|NCT04433208|453443500|FG004|Overall Study|Withdrawal by Subject|2|||
126039250|NCT04433208|453443501|FG005|Overall Study|Withdrawal by Subject|1|||
126098897|NCT03541174|453655566|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
126098898|NCT03541174|453655567|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
126098899|NCT03541174|453655568|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
126039251|NCT04433208|453443496|FG000|Overall Study|Lost to Follow-up|0|||
126039252|NCT04433208|453443497|FG001|Overall Study|Lost to Follow-up|0|||
126039253|NCT04433208|453443498|FG002|Overall Study|Lost to Follow-up|0|||
126098900|NCT03541174|453655563|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126098901|NCT03541174|453655564|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126098902|NCT03541174|453655565|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126098903|NCT03541174|453655566|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126278875|NCT00805467|454312526|FG002|Overall Study|Adverse Event|26|||
126278876|NCT00805467|454312527|FG003|Overall Study|Adverse Event|57|||
126278877|NCT00805467|454312524|FG000|Overall Study|Death|0|||
126278878|NCT00805467|454312525|FG001|Overall Study|Death|2|||
126278879|NCT00805467|454312526|FG002|Overall Study|Death|7|||
126278880|NCT00805467|454312527|FG003|Overall Study|Death|5|||
126278881|NCT00805467|454312524|FG000|Overall Study|Physician Decision|0|||
126278882|NCT00805467|454312525|FG001|Overall Study|Physician Decision|1|||
126278883|NCT00805467|454312526|FG002|Overall Study|Physician Decision|2|||
126278884|NCT00805467|454312527|FG003|Overall Study|Physician Decision|6|||
126278885|NCT00805467|454312524|FG000|Overall Study|Not reported|0|||
126278886|NCT00805467|454312525|FG001|Overall Study|Not reported|0|||
126278887|NCT00805467|454312526|FG002|Overall Study|Not reported|3|||
126278888|NCT00805467|454312527|FG003|Overall Study|Not reported|7|||
126278889|NCT00213135|454312528|FG000|Overall Study|Adverse Event|9|||
126278890|NCT00213135|454312529|FG001|Overall Study|Adverse Event|5|||
126278891|NCT00213135|454312530|FG002|Overall Study|Adverse Event|5|||
126278892|NCT00213135|454312528|FG000|Overall Study|Lost to Follow-up|11|||
126278893|NCT00213135|454312529|FG001|Overall Study|Lost to Follow-up|8|||
126278894|NCT00213135|454312530|FG002|Overall Study|Lost to Follow-up|4|||
126278895|NCT00213135|454312528|FG000|Overall Study|Protocol Violation|4|||
126278896|NCT00213135|454312529|FG001|Overall Study|Protocol Violation|4|||
126278897|NCT00213135|454312530|FG002|Overall Study|Protocol Violation|10|||
126278898|NCT00213135|454312528|FG000|Overall Study|Death|1|||
126278899|NCT00213135|454312529|FG001|Overall Study|Death|1|||
126278900|NCT00213135|454312530|FG002|Overall Study|Death|2|||
126278901|NCT00213135|454312528|FG000|Overall Study|Disease progression|4|||
126278902|NCT00213135|454312529|FG001|Overall Study|Disease progression|5|||
126278903|NCT00213135|454312530|FG002|Overall Study|Disease progression|21|||
126278904|NCT00213135|454312528|FG000|Overall Study|Other|21|||
126278905|NCT00213135|454312529|FG001|Overall Study|Other|12|||
126278906|NCT00213135|454312530|FG002|Overall Study|Other|15|||
126278907|NCT02618759|454312539|FG000|Overall Study|Lost to Follow-up|0|||
126278908|NCT02618759|454312540|FG001|Overall Study|Lost to Follow-up|1|||
126278909|NCT02618759|454312539|FG000|Overall Study|Withdrawal by Subject|1|||
126278910|NCT02618759|454312540|FG001|Overall Study|Withdrawal by Subject|0|||
126278911|NCT02618759|454312539|FG000|Overall Study|Other Reasons|1|||
126278912|NCT02618759|454312540|FG001|Overall Study|Other Reasons|4|||
126278913|NCT02856555|454312543|FG000|Overall Study|Adverse Event|1|||
126278914|NCT02856555|454312544|FG001|Overall Study|Adverse Event|0|||
126278915|NCT02856555|454312545|FG002|Overall Study|Adverse Event|0|||
126278916|NCT02856555|454312543|FG000|Overall Study|Lost to Follow-up|1|||
126278917|NCT02856555|454312544|FG001|Overall Study|Lost to Follow-up|3|||
126278918|NCT02856555|454312545|FG002|Overall Study|Lost to Follow-up|0|||
126278919|NCT02856555|454312543|FG000|Overall Study|Withdrawal by Subject|3|||
126278920|NCT02856555|454312544|FG001|Overall Study|Withdrawal by Subject|0|||
126278921|NCT02856555|454312545|FG002|Overall Study|Withdrawal by Subject|0|||
126278922|NCT02856555|454312543|FG000|Overall Study|Randomized but Never Treated|0|||
126278923|NCT02856555|454312544|FG001|Overall Study|Randomized but Never Treated|1|||
126278924|NCT02856555|454312545|FG002|Overall Study|Randomized but Never Treated|0|||
126278925|NCT01724489|454312546|FG000|Overall Study|Adverse Event|8|||
126278926|NCT01724489|454312547|FG001|Overall Study|Adverse Event|3|||
126278927|NCT01724489|454312546|FG000|Overall Study|Surgery, medication|1|||
126278928|NCT01724489|454312547|FG001|Overall Study|Surgery, medication|1|||
126278929|NCT01724489|454312546|FG000|Overall Study|Lost to Follow-up|1|||
126278930|NCT01724489|454312547|FG001|Overall Study|Lost to Follow-up|2|||
126278931|NCT01724489|454312546|FG000|Overall Study|Withdrawal by Subject|6|||
126278932|NCT01724489|454312547|FG001|Overall Study|Withdrawal by Subject|6|||
126278933|NCT04576923|454312548|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
126278934|NCT00923273|454312551|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
126278935|NCT00923273|454312552|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
126278936|NCT00923273|454312553|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
126278937|NCT00923273|454312554|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
126278938|NCT00923273|454312555|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
126363662|NCT03574389|454624882|FG003|Vaccination Period|Adverse Event|0|||
126363663|NCT03574389|454624883|FG004|Vaccination Period|Adverse Event|0|||
126363664|NCT03574389|454624884|FG005|Vaccination Period|Adverse Event|0|||
126098904|NCT03541174|453655567|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126278939|NCT00923273|454312551|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
126278940|NCT00923273|454312552|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
126278941|NCT00923273|454312553|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
126278942|NCT00923273|454312554|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
126363665|NCT03574389|454624885|FG006|Vaccination Period|Adverse Event|0|||
126278943|NCT00923273|454312555|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
126278944|NCT00605540|454312556|FG000|Overall Study|Death|15|||
126363666|NCT03574389|454624879|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
126363667|NCT03574389|454624880|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
126278945|NCT00605540|454312556|FG000|Overall Study|Lost to Follow-up|23|||
126278946|NCT01473524|454312559|FG000|DB Phase|Adverse Event|4|||
126278947|NCT01473524|454312560|FG001|DB Phase|Adverse Event|8|||
126278948|NCT01473524|454312561|FG002|DB Phase|Adverse Event|2|||
126278949|NCT01473524|454312562|FG003|DB Phase|Adverse Event|0|||
126278950|NCT01473524|454312563|FG004|DB Phase|Adverse Event|0|||
125881891|NCT01656408|452867009|FG001|Overall Study|Physician Decision|0|||
125881892|NCT01656408|452867010|FG002|Overall Study|Physician Decision|1|||
125881893|NCT01656408|452867011|FG003|Overall Study|Physician Decision|0|||
125881894|NCT01656408|452867012|FG004|Overall Study|Physician Decision|1|||
125881895|NCT01656408|452867013|FG005|Overall Study|Physician Decision|1|||
125881896|NCT01656408|452867014|FG006|Overall Study|Physician Decision|0|||
125881897|NCT01656408|452867015|FG007|Overall Study|Physician Decision|1|||
125881898|NCT01656408|452867016|FG008|Overall Study|Physician Decision|1|||
125881899|NCT01656408|452867017|FG009|Overall Study|Physician Decision|3|||
125881900|NCT01690143|452867020|FG000|Overall Study|Withdrawal by Subject|1|||
125881901|NCT03777982|452867021|FG000|Overall Study|Physician Decision|0|||
125881902|NCT03777982|452867022|FG001|Overall Study|Physician Decision|1|||
125881903|NCT00870740|452867023|FG000|Overall Study|Adverse Event|2|||
125881904|NCT00870740|452867024|FG001|Overall Study|Adverse Event|1|||
125881905|NCT00870740|452867025|FG002|Overall Study|Adverse Event|3|||
125881906|NCT00870740|452867026|FG003|Overall Study|Adverse Event|2|||
126278951|NCT01473524|454312564|FG005|DB Phase|Adverse Event|0|||
126278952|NCT01473524|454312559|FG000|DB Phase|Death|1|||
126278953|NCT01473524|454312560|FG001|DB Phase|Death|0|||
126278954|NCT01473524|454312561|FG002|DB Phase|Death|0|||
126278955|NCT01473524|454312562|FG003|DB Phase|Death|0|||
126278956|NCT01473524|454312563|FG004|DB Phase|Death|0|||
126278957|NCT01473524|454312564|FG005|DB Phase|Death|0|||
126278958|NCT01473524|454312559|FG000|DB Phase|Withdrawal by Subject|2|||
126278959|NCT01473524|454312560|FG001|DB Phase|Withdrawal by Subject|1|||
126278960|NCT01473524|454312561|FG002|DB Phase|Withdrawal by Subject|1|||
126278961|NCT01473524|454312562|FG003|DB Phase|Withdrawal by Subject|0|||
126278962|NCT01473524|454312563|FG004|DB Phase|Withdrawal by Subject|0|||
126278963|NCT01473524|454312564|FG005|DB Phase|Withdrawal by Subject|0|||
126039254|NCT04433208|453443499|FG003|Overall Study|Lost to Follow-up|0|||
126039255|NCT04433208|453443500|FG004|Overall Study|Lost to Follow-up|0|||
126039256|NCT04433208|453443501|FG005|Overall Study|Lost to Follow-up|1|||
126039257|NCT04299464|453443504|FG000|Overall Study|Adverse Event|1|||
126039258|NCT04299464|453443505|FG001|Overall Study|Adverse Event|0|||
126039259|NCT04299464|453443506|FG002|Overall Study|Adverse Event|2|||
126039260|NCT04299464|453443504|FG000|Overall Study|Non-compliance with Study Drug|1|||
126039261|NCT04299464|453443505|FG001|Overall Study|Non-compliance with Study Drug|0|||
126039262|NCT04299464|453443506|FG002|Overall Study|Non-compliance with Study Drug|0|||
126039263|NCT04299464|453443504|FG000|Overall Study|Reason not Specified|0|||
126039264|NCT04299464|453443505|FG001|Overall Study|Reason not Specified|1|||
126039265|NCT04299464|453443506|FG002|Overall Study|Reason not Specified|3|||
126039266|NCT04299464|453443504|FG000|Overall Study|Physician Decision|0|||
126039267|NCT04299464|453443505|FG001|Overall Study|Physician Decision|1|||
126039268|NCT04299464|453443506|FG002|Overall Study|Physician Decision|1|||
126039269|NCT04299464|453443504|FG000|Overall Study|Withdrawal by Subject|0|||
126039270|NCT04299464|453443505|FG001|Overall Study|Withdrawal by Subject|2|||
126039271|NCT04299464|453443506|FG002|Overall Study|Withdrawal by Subject|1|||
126039272|NCT03386578|453443508|FG000|PK Component|Lost to Follow-up|0|||
126039273|NCT03386578|453443509|FG001|PK Component|Lost to Follow-up|1|||
126039274|NCT03386578|453443510|FG002|PK Component|Lost to Follow-up|0|||
126039275|NCT03386578|453443511|FG003|PK Component|Lost to Follow-up|0|||
126039276|NCT03386578|453443512|FG004|PK Component|Lost to Follow-up|0|||
126039277|NCT03386578|453443513|FG005|PK Component|Lost to Follow-up|0|||
126039278|NCT03386578|453443514|FG006|PK Component|Lost to Follow-up|1|||
126039279|NCT03386578|453443515|FG007|PK Component|Lost to Follow-up|0|||
126039280|NCT03386578|453443516|FG008|PK Component|Lost to Follow-up|0|||
126039281|NCT03386578|453443517|FG009|PK Component|Lost to Follow-up|0|||
126039282|NCT03386578|453443508|FG000|PK Component|Stillbirth/Abortion|0|||
126039283|NCT03386578|453443509|FG001|PK Component|Stillbirth/Abortion|0|||
126039284|NCT03386578|453443510|FG002|PK Component|Stillbirth/Abortion|0|||
126039285|NCT03386578|453443511|FG003|PK Component|Stillbirth/Abortion|0|||
126278964|NCT01473524|454312559|FG000|LTSE Phase|Withdrawal by Subject|0|||
126278965|NCT01473524|454312560|FG001|LTSE Phase|Withdrawal by Subject|0|||
126278966|NCT01473524|454312561|FG002|LTSE Phase|Withdrawal by Subject|0|||
125881907|NCT00870740|452867027|FG004|Overall Study|Adverse Event|1|||
125881908|NCT00870740|452867028|FG005|Overall Study|Adverse Event|6|||
125881909|NCT00870740|452867023|FG000|Overall Study|Consent Withdrawn|6|||
125881910|NCT00870740|452867024|FG001|Overall Study|Consent Withdrawn|3|||
126039286|NCT03386578|453443512|FG004|PK Component|Stillbirth/Abortion|0|||
126039287|NCT03386578|453443513|FG005|PK Component|Stillbirth/Abortion|2|||
126039288|NCT03386578|453443514|FG006|PK Component|Stillbirth/Abortion|0|||
126039289|NCT03386578|453443515|FG007|PK Component|Stillbirth/Abortion|0|||
126039290|NCT03386578|453443516|FG008|PK Component|Stillbirth/Abortion|0|||
126039291|NCT03386578|453443517|FG009|PK Component|Stillbirth/Abortion|0|||
126039292|NCT03386578|453443508|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126278967|NCT01473524|454312562|FG003|LTSE Phase|Withdrawal by Subject|3|||
126278968|NCT01473524|454312563|FG004|LTSE Phase|Withdrawal by Subject|3|||
126278969|NCT01473524|454312564|FG005|LTSE Phase|Withdrawal by Subject|6|||
126278970|NCT01473524|454312559|FG000|LTSE Phase|Death|0|||
126278971|NCT01473524|454312560|FG001|LTSE Phase|Death|0|||
126278972|NCT01473524|454312561|FG002|LTSE Phase|Death|0|||
126039293|NCT03386578|453443509|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126039294|NCT03386578|453443510|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
126039295|NCT03386578|453443511|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
126039296|NCT03386578|453443512|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126039297|NCT03386578|453443513|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126039298|NCT03386578|453443514|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126039299|NCT03386578|453443515|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
126039300|NCT03386578|453443516|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
126039301|NCT03386578|453443517|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126039302|NCT03386578|453443508|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126039303|NCT03386578|453443509|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126039304|NCT03386578|453443510|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
126039305|NCT03386578|453443511|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
126039306|NCT03386578|453443512|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126039307|NCT03386578|453443513|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126039308|NCT03386578|453443514|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126039309|NCT03386578|453443515|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
126039310|NCT03386578|453443516|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
126039311|NCT03386578|453443517|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126039312|NCT03386578|453443508|FG000|PrEP Comparison Component Step 1|Death|0|||
126039313|NCT03386578|453443509|FG001|PrEP Comparison Component Step 1|Death|0|||
126039314|NCT03386578|453443510|FG002|PrEP Comparison Component Step 1|Death|1|||
126039315|NCT03386578|453443511|FG003|PrEP Comparison Component Step 1|Death|0|||
126039316|NCT03386578|453443512|FG004|PrEP Comparison Component Step 1|Death|0|||
126039317|NCT03386578|453443513|FG005|PrEP Comparison Component Step 1|Death|0|||
126039318|NCT03386578|453443514|FG006|PrEP Comparison Component Step 1|Death|0|||
126039319|NCT03386578|453443515|FG007|PrEP Comparison Component Step 1|Death|9|||
126039320|NCT03386578|453443516|FG008|PrEP Comparison Component Step 1|Death|5|||
126039321|NCT03386578|453443517|FG009|PrEP Comparison Component Step 1|Death|0|||
126039322|NCT03386578|453443508|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126039323|NCT03386578|453443509|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126039324|NCT03386578|453443510|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126039325|NCT03386578|453443511|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
126039326|NCT03386578|453443512|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126039327|NCT03386578|453443513|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126039328|NCT03386578|453443514|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126039329|NCT03386578|453443515|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126039330|NCT03386578|453443516|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
126039331|NCT03386578|453443517|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126039332|NCT03386578|453443508|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126039333|NCT03386578|453443509|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126039334|NCT03386578|453443510|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126039335|NCT03386578|453443511|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126039336|NCT03386578|453443512|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126039337|NCT03386578|453443513|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126363668|NCT03574389|454624881|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
126039338|NCT03386578|453443514|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126039339|NCT03386578|453443515|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
126039340|NCT03386578|453443516|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
126039341|NCT03386578|453443517|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126039342|NCT03386578|453443508|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126039343|NCT03386578|453443509|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126039344|NCT03386578|453443510|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126039345|NCT03386578|453443511|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126039346|NCT03386578|453443512|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126039347|NCT03386578|453443513|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126039348|NCT03386578|453443514|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126039349|NCT03386578|453443515|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
126039350|NCT03386578|453443516|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
126039351|NCT03386578|453443517|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126039352|NCT04766892|453443521|FG000|Overall Study|Withdrawal by Subject|1|||
126039353|NCT04766892|453443521|FG000|Overall Study|Lost to Follow-up|1|||
126039354|NCT04766892|453443521|FG000|Overall Study|Adverse Event|3|||
126039355|NCT04766892|453443521|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
126039356|NCT04778397|453443522|FG000|Overall Study|Death|59|||
126278973|NCT01473524|454312562|FG003|LTSE Phase|Death|0|||
126278974|NCT01473524|454312563|FG004|LTSE Phase|Death|1|||
126278975|NCT01473524|454312564|FG005|LTSE Phase|Death|0|||
126278976|NCT01473524|454312559|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
126278977|NCT01473524|454312560|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
126278978|NCT01473524|454312561|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
126278979|NCT01473524|454312562|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
126278980|NCT01473524|454312563|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
126278981|NCT01473524|454312564|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
126278982|NCT01473524|454312559|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
126278983|NCT01473524|454312560|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
126278984|NCT01473524|454312561|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
126278985|NCT01473524|454312562|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
126278986|NCT01473524|454312563|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
126278987|NCT01473524|454312564|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
126278988|NCT01473524|454312559|FG000|LTSE Phase|Lost to Follow-up|0|||
126278989|NCT01473524|454312560|FG001|LTSE Phase|Lost to Follow-up|0|||
126278990|NCT01473524|454312561|FG002|LTSE Phase|Lost to Follow-up|0|||
126278991|NCT01473524|454312562|FG003|LTSE Phase|Lost to Follow-up|1|||
126278992|NCT01473524|454312563|FG004|LTSE Phase|Lost to Follow-up|3|||
126278993|NCT01473524|454312564|FG005|LTSE Phase|Lost to Follow-up|2|||
126278994|NCT01473524|454312559|FG000|LTSE Phase|Principal Investigator Decision|0|||
126278995|NCT01473524|454312560|FG001|LTSE Phase|Principal Investigator Decision|0|||
126278996|NCT01473524|454312561|FG002|LTSE Phase|Principal Investigator Decision|0|||
126278997|NCT01473524|454312562|FG003|LTSE Phase|Principal Investigator Decision|1|||
126278998|NCT01473524|454312563|FG004|LTSE Phase|Principal Investigator Decision|1|||
126278999|NCT01473524|454312564|FG005|LTSE Phase|Principal Investigator Decision|3|||
126279000|NCT01473524|454312559|FG000|LTSE Phase|Liver Transplantation|0|||
126279001|NCT01473524|454312560|FG001|LTSE Phase|Liver Transplantation|0|||
126279002|NCT01473524|454312561|FG002|LTSE Phase|Liver Transplantation|0|||
126279003|NCT01473524|454312562|FG003|LTSE Phase|Liver Transplantation|0|||
126279004|NCT01473524|454312563|FG004|LTSE Phase|Liver Transplantation|0|||
126279005|NCT01473524|454312564|FG005|LTSE Phase|Liver Transplantation|1|||
126279006|NCT01473524|454312559|FG000|LTSE Phase|Pregnancy|0|||
126279007|NCT01473524|454312560|FG001|LTSE Phase|Pregnancy|0|||
126279008|NCT01473524|454312561|FG002|LTSE Phase|Pregnancy|0|||
126279009|NCT01473524|454312562|FG003|LTSE Phase|Pregnancy|1|||
126279010|NCT01473524|454312563|FG004|LTSE Phase|Pregnancy|0|||
126279011|NCT01473524|454312564|FG005|LTSE Phase|Pregnancy|0|||
126279012|NCT01473524|454312559|FG000|LTSE Phase|Protocol Violation|0|||
126279013|NCT01473524|454312560|FG001|LTSE Phase|Protocol Violation|0|||
126279014|NCT01473524|454312561|FG002|LTSE Phase|Protocol Violation|0|||
126279015|NCT01473524|454312562|FG003|LTSE Phase|Protocol Violation|0|||
126279016|NCT01473524|454312563|FG004|LTSE Phase|Protocol Violation|0|||
126279017|NCT01473524|454312564|FG005|LTSE Phase|Protocol Violation|1|||
126279018|NCT01544179|454312565|FG000|Overall Study|Death|50|||
126279019|NCT01544179|454312566|FG001|Overall Study|Death|37|||
126279020|NCT01544179|454312565|FG000|Overall Study|Lost to Follow-up|0|||
126279021|NCT01544179|454312566|FG001|Overall Study|Lost to Follow-up|1|||
126279022|NCT01544179|454312565|FG000|Overall Study|Adverse Event|0|||
126279023|NCT01544179|454312566|FG001|Overall Study|Adverse Event|1|||
126279024|NCT01544179|454312565|FG000|Overall Study|Withdrawal by Subject|12|||
126279025|NCT01544179|454312566|FG001|Overall Study|Withdrawal by Subject|7|||
126279026|NCT01544179|454312565|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
126279027|NCT01544179|454312566|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126279028|NCT00282919|454312567|FG000|Overall Study|Lack of Efficacy|4|||
126279029|NCT00282919|454312567|FG000|Overall Study|Withdrawal by Subject|1|||
126279030|NCT00282919|454312567|FG000|Overall Study|Asymptomatic Parasitemia|2|||
126279031|NCT01438996|454312570|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
126279032|NCT01438996|454312571|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
125881911|NCT00870740|452867025|FG002|Overall Study|Consent Withdrawn|4|||
125881912|NCT00870740|452867026|FG003|Overall Study|Consent Withdrawn|6|||
126279033|NCT01438996|454312572|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
126279034|NCT02540850|454312573|FG000|Overall Study|Lost to Follow-up|69|||
126279035|NCT02540850|454312574|FG001|Overall Study|Lost to Follow-up|66|||
126363669|NCT03574389|454624882|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
125881913|NCT00870740|452867027|FG004|Overall Study|Consent Withdrawn|6|||
125881914|NCT00870740|452867028|FG005|Overall Study|Consent Withdrawn|5|||
125881915|NCT00870740|452867023|FG000|Overall Study|Investigator Decision|2|||
126279036|NCT02540850|454312575|FG002|Overall Study|Lost to Follow-up|34|||
126279037|NCT02861014|454312576|FG000|Primary Analysis|Adverse Event|7|||
126279038|NCT02861014|454312576|FG000|Primary Analysis|Death|1|||
126279039|NCT02861014|454312576|FG000|Primary Analysis|Lack of Efficacy|3|||
126279040|NCT02861014|454312576|FG000|Primary Analysis|Physician Decision|2|||
126279041|NCT02861014|454312576|FG000|Primary Analysis|Pregnancy|4|||
126279042|NCT02861014|454312576|FG000|Primary Analysis|Protocol Violation|2|||
126363670|NCT03574389|454624883|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
126279043|NCT02861014|454312576|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
126039357|NCT04778397|453443523|FG001|Overall Study|Death|54|||
126039358|NCT04778397|453443524|FG002|Overall Study|Death|11|||
126039359|NCT04778397|453443525|FG003|Overall Study|Death|9|||
126039360|NCT04778397|453443522|FG000|Overall Study|Study Terminated by Sponsor|34|||
126279044|NCT02861014|454312576|FG000|Primary Analysis|Withdrawal by Subject|14|||
126279045|NCT02861014|454312576|FG000|Primary Analysis|Commercial ocrelizumab|3|||
126279046|NCT02861014|454312576|FG000|Safety Follow-up|Adverse Event|1|||
126279047|NCT02861014|454312576|FG000|Safety Follow-up|Pregnancy|1|||
126279048|NCT02861014|454312576|FG000|Safety Follow-up|Withdrawal by Subject|9|||
126279049|NCT02861014|454312576|FG000|Safety Follow-up|Study terminated by sponsor|1|||
126279050|NCT02861014|454312576|FG000|Safety Follow-up|Physician Decision|1|||
126279051|NCT02861014|454312576|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
126279052|NCT02861014|454312576|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
126279053|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
126279054|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
126279055|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
126279056|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
126279057|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
126279058|NCT03201445|454312583|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
126279059|NCT03201445|454312584|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
126279060|NCT03201445|454312583|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
126279061|NCT03201445|454312584|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
126279062|NCT03201445|454312583|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
126279063|NCT03201445|454312584|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
126279064|NCT03201445|454312583|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
126279065|NCT03201445|454312584|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
126279066|NCT03201445|454312583|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
126279067|NCT03201445|454312584|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
126279068|NCT03201445|454312583|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
126279069|NCT03201445|454312584|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
126279070|NCT03201445|454312583|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
126279071|NCT03201445|454312584|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
126279072|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
126279073|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
126279074|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
126279075|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
126279076|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
126279077|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
126279078|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
126279079|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
126279080|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
126279081|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
126279082|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
126279083|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
126279084|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
126279085|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
126279086|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
126279087|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
126279088|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
126279089|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
126279090|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
126279091|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
126279092|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
126279093|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
126279094|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
126279095|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
126279096|NCT03201445|454312583|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
126279097|NCT03201445|454312584|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
126279098|NCT03201445|454312583|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
126039361|NCT04778397|453443523|FG001|Overall Study|Study Terminated by Sponsor|42|||
126039362|NCT04778397|453443524|FG002|Overall Study|Study Terminated by Sponsor|15|||
126039363|NCT04778397|453443525|FG003|Overall Study|Study Terminated by Sponsor|12|||
126279099|NCT03201445|454312584|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
126279100|NCT02087189|454312585|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
126279101|NCT01189487|454312590|FG000|Overall Study|Lack of Efficacy|2|||
126363671|NCT03574389|454624884|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
126039364|NCT04778397|453443522|FG000|Overall Study|Withdrew Consent|5|||
126279102|NCT01189487|454312590|FG000|Overall Study|Adverse Event|1|||
126279103|NCT04630158|454312591|FG000|Overall Study|Adverse Event|1|||
126279104|NCT04630158|454312592|FG001|Overall Study|Adverse Event|1|||
126279105|NCT04630158|454312593|FG002|Overall Study|Adverse Event|1|||
126279106|NCT04630158|454312591|FG000|Overall Study|Physician Decision|0|||
126279107|NCT04630158|454312592|FG001|Overall Study|Physician Decision|2|||
126279108|NCT04630158|454312593|FG002|Overall Study|Physician Decision|0|||
126279109|NCT04630158|454312591|FG000|Overall Study|Protocol Violation|1|||
126279110|NCT04630158|454312592|FG001|Overall Study|Protocol Violation|0|||
126279111|NCT04630158|454312593|FG002|Overall Study|Protocol Violation|1|||
126279112|NCT04630158|454312591|FG000|Overall Study|Withdrawal by Subject|2|||
126279113|NCT04630158|454312592|FG001|Overall Study|Withdrawal by Subject|1|||
126279114|NCT04630158|454312593|FG002|Overall Study|Withdrawal by Subject|2|||
126279115|NCT03136965|454312596|FG000|Overall Study|Lost to Follow-up|0|||
125881916|NCT00870740|452867024|FG001|Overall Study|Investigator Decision|0|||
125881917|NCT00870740|452867025|FG002|Overall Study|Investigator Decision|1|||
125881918|NCT00870740|452867026|FG003|Overall Study|Investigator Decision|0|||
125881919|NCT00870740|452867027|FG004|Overall Study|Investigator Decision|0|||
125881920|NCT00870740|452867028|FG005|Overall Study|Investigator Decision|0|||
125881921|NCT00870740|452867023|FG000|Overall Study|Subject Non-compliance|0|||
125881922|NCT00870740|452867024|FG001|Overall Study|Subject Non-compliance|0|||
125881923|NCT00870740|452867025|FG002|Overall Study|Subject Non-compliance|0|||
125881924|NCT00870740|452867026|FG003|Overall Study|Subject Non-compliance|0|||
125881925|NCT00870740|452867027|FG004|Overall Study|Subject Non-compliance|0|||
125881926|NCT00870740|452867028|FG005|Overall Study|Subject Non-compliance|1|||
125881927|NCT00870740|452867023|FG000|Overall Study|Death|0|||
125881928|NCT00870740|452867024|FG001|Overall Study|Death|0|||
125881929|NCT00870740|452867025|FG002|Overall Study|Death|0|||
125881930|NCT00870740|452867026|FG003|Overall Study|Death|0|||
125881931|NCT00870740|452867027|FG004|Overall Study|Death|1|||
125881932|NCT00870740|452867028|FG005|Overall Study|Death|0|||
125881933|NCT00870740|452867023|FG000|Overall Study|Other|2|||
125881934|NCT00870740|452867024|FG001|Overall Study|Other|5|||
125881935|NCT00870740|452867025|FG002|Overall Study|Other|2|||
125881936|NCT00870740|452867026|FG003|Overall Study|Other|4|||
125881937|NCT00870740|452867027|FG004|Overall Study|Other|3|||
125881938|NCT00870740|452867028|FG005|Overall Study|Other|5|||
125881939|NCT03592186|452867029|FG000|Overall Study|Withdrawal by Subject|1|||
125881940|NCT03592186|452867030|FG001|Overall Study|Withdrawal by Subject|0|||
125881941|NCT03592186|452867029|FG000|Overall Study|Lost to Follow-up|16|||
125881942|NCT03592186|452867030|FG001|Overall Study|Lost to Follow-up|11|||
125881943|NCT03755934|452867031|FG000|Overall Study|Adverse Event|4|||
125881944|NCT03755934|452867032|FG001|Overall Study|Adverse Event|1|||
125881945|NCT03755934|452867033|FG002|Overall Study|Adverse Event|1|||
125881946|NCT03755934|452867034|FG003|Overall Study|Adverse Event|3|||
125881947|NCT03755934|452867031|FG000|Overall Study|Physician Decision|2|||
125881948|NCT03755934|452867032|FG001|Overall Study|Physician Decision|0|||
125881949|NCT03755934|452867033|FG002|Overall Study|Physician Decision|0|||
125881950|NCT03755934|452867034|FG003|Overall Study|Physician Decision|1|||
125881951|NCT03755934|452867031|FG000|Overall Study|Withdrawal by Subject|5|||
125881952|NCT03755934|452867032|FG001|Overall Study|Withdrawal by Subject|0|||
125881953|NCT03755934|452867033|FG002|Overall Study|Withdrawal by Subject|0|||
125881954|NCT03755934|452867034|FG003|Overall Study|Withdrawal by Subject|1|||
125881955|NCT03755934|452867031|FG000|Overall Study|Other|3|||
125881956|NCT03755934|452867032|FG001|Overall Study|Other|1|||
125881957|NCT03755934|452867033|FG002|Overall Study|Other|3|||
125881958|NCT03755934|452867034|FG003|Overall Study|Other|1|||
125881959|NCT00307801|452867037|FG000|Overall Study|Adverse Event|12|||
125881960|NCT00307801|452867038|FG001|Overall Study|Adverse Event|4|||
125881961|NCT00307801|452867037|FG000|Overall Study|Withdrawal by Subject|9|||
125881962|NCT00307801|452867038|FG001|Overall Study|Withdrawal by Subject|4|||
125881963|NCT00307801|452867037|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
125881964|NCT00307801|452867038|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
125881965|NCT00307801|452867037|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
125881966|NCT00307801|452867038|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
125881967|NCT00307801|452867037|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
125881968|NCT00307801|452867038|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
126279116|NCT03136965|454312597|FG001|Overall Study|Lost to Follow-up|1|||
126279117|NCT03136965|454312598|FG002|Overall Study|Lost to Follow-up|0|||
126279118|NCT03496610|454312599|FG000|Overall Study|Lost to Follow-up|3|||
126279119|NCT03496610|454312600|FG001|Overall Study|Lost to Follow-up|2|||
126279120|NCT03496610|454312599|FG000|Overall Study|Physician Decision|1|||
126279121|NCT03496610|454312600|FG001|Overall Study|Physician Decision|0|||
126279122|NCT03496610|454312599|FG000|Overall Study|Withdrawal by Subject|1|||
126279123|NCT03496610|454312600|FG001|Overall Study|Withdrawal by Subject|0|||
125881969|NCT00307801|452867037|FG000|Overall Study|Wrong Randomization|1|||
125881970|NCT00307801|452867038|FG001|Overall Study|Wrong Randomization|0|||
125881971|NCT00307801|452867037|FG000|Overall Study|Lack of Efficacy|0|||
125881972|NCT00307801|452867038|FG001|Overall Study|Lack of Efficacy|2|||
126039365|NCT04778397|453443523|FG001|Overall Study|Withdrew Consent|4|||
126039366|NCT04778397|453443524|FG002|Overall Study|Withdrew Consent|1|||
126279124|NCT04435184|454312601|FG000|Overall Study|follow-up blood draws missing|3|||
126279125|NCT04435184|454312602|FG001|Overall Study|follow-up blood draws missing|5|||
126279126|NCT02714426|454312603|FG000|Overall Study|Withdrawal by Subject|2|||
126279127|NCT02714426|454312604|FG001|Overall Study|Withdrawal by Subject|2|||
126279128|NCT01860677|454312608|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
126279129|NCT01860677|454312609|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
126279130|NCT04762277|454312610|FG000|Overall Study|Withdrawal by Subject|0|||
126279131|NCT04762277|454312611|FG001|Overall Study|Withdrawal by Subject|2|||
126279132|NCT04762277|454312610|FG000|Overall Study|Protocol Violation|0|||
126279133|NCT04762277|454312611|FG001|Overall Study|Protocol Violation|1|||
126279134|NCT04762277|454312610|FG000|Overall Study|Adverse Event|1|||
126279135|NCT04762277|454312611|FG001|Overall Study|Adverse Event|0|||
126279136|NCT00642278|454312612|FG000|Overall Study|Adverse Event|2|||
126279137|NCT00642278|454312613|FG001|Overall Study|Adverse Event|1|||
126279138|NCT00642278|454312614|FG002|Overall Study|Adverse Event|3|||
126279139|NCT00642278|454312615|FG003|Overall Study|Adverse Event|1|||
126279140|NCT00642278|454312616|FG004|Overall Study|Adverse Event|2|||
126279141|NCT00642278|454312617|FG005|Overall Study|Adverse Event|2|||
126279142|NCT00642278|454312618|FG006|Overall Study|Adverse Event|0|||
126279143|NCT00642278|454312612|FG000|Overall Study|Lack of Efficacy|0|||
126279144|NCT00642278|454312613|FG001|Overall Study|Lack of Efficacy|1|||
126279145|NCT00642278|454312614|FG002|Overall Study|Lack of Efficacy|0|||
126279146|NCT00642278|454312615|FG003|Overall Study|Lack of Efficacy|0|||
126279147|NCT00642278|454312616|FG004|Overall Study|Lack of Efficacy|0|||
126279148|NCT00642278|454312617|FG005|Overall Study|Lack of Efficacy|0|||
126279149|NCT00642278|454312618|FG006|Overall Study|Lack of Efficacy|0|||
126279150|NCT00642278|454312612|FG000|Overall Study|Lost to Follow-up|5|||
126279151|NCT00642278|454312613|FG001|Overall Study|Lost to Follow-up|1|||
126279152|NCT00642278|454312614|FG002|Overall Study|Lost to Follow-up|0|||
126279153|NCT00642278|454312615|FG003|Overall Study|Lost to Follow-up|1|||
126279154|NCT00642278|454312616|FG004|Overall Study|Lost to Follow-up|0|||
126279155|NCT00642278|454312617|FG005|Overall Study|Lost to Follow-up|1|||
126279156|NCT00642278|454312618|FG006|Overall Study|Lost to Follow-up|1|||
126279157|NCT00642278|454312612|FG000|Overall Study|Physician Decision|0|||
126279158|NCT00642278|454312613|FG001|Overall Study|Physician Decision|0|||
126279159|NCT00642278|454312614|FG002|Overall Study|Physician Decision|0|||
126279160|NCT00642278|454312615|FG003|Overall Study|Physician Decision|1|||
126279161|NCT00642278|454312616|FG004|Overall Study|Physician Decision|0|||
126279162|NCT00642278|454312617|FG005|Overall Study|Physician Decision|0|||
126279163|NCT00642278|454312618|FG006|Overall Study|Physician Decision|0|||
126279164|NCT00642278|454312612|FG000|Overall Study|Protocol Violation|0|||
126279165|NCT00642278|454312613|FG001|Overall Study|Protocol Violation|0|||
126279166|NCT00642278|454312614|FG002|Overall Study|Protocol Violation|1|||
126279167|NCT00642278|454312615|FG003|Overall Study|Protocol Violation|1|||
126279168|NCT00642278|454312616|FG004|Overall Study|Protocol Violation|0|||
126279169|NCT00642278|454312617|FG005|Overall Study|Protocol Violation|1|||
126279170|NCT00642278|454312618|FG006|Overall Study|Protocol Violation|2|||
126279171|NCT00642278|454312612|FG000|Overall Study|Withdrawal by Subject|1|||
126039367|NCT04778397|453443525|FG003|Overall Study|Withdrew Consent|1|||
126039368|NCT04778397|453443522|FG000|Overall Study|Reason Not Specified|1|||
126039369|NCT04778397|453443523|FG001|Overall Study|Reason Not Specified|3|||
126039370|NCT04778397|453443524|FG002|Overall Study|Reason Not Specified|0|||
126039371|NCT04778397|453443525|FG003|Overall Study|Reason Not Specified|2|||
126039372|NCT04778397|453443522|FG000|Overall Study|Lost to Follow-up|2|||
126039373|NCT04778397|453443523|FG001|Overall Study|Lost to Follow-up|1|||
126039374|NCT04778397|453443524|FG002|Overall Study|Lost to Follow-up|0|||
126039375|NCT04778397|453443525|FG003|Overall Study|Lost to Follow-up|1|||
126098905|NCT03541174|453655568|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
126098906|NCT03541174|453655563|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
126279172|NCT00642278|454312613|FG001|Overall Study|Withdrawal by Subject|1|||
126279173|NCT00642278|454312614|FG002|Overall Study|Withdrawal by Subject|1|||
126279174|NCT00642278|454312615|FG003|Overall Study|Withdrawal by Subject|3|||
126279175|NCT00642278|454312616|FG004|Overall Study|Withdrawal by Subject|6|||
126279176|NCT00642278|454312617|FG005|Overall Study|Withdrawal by Subject|2|||
126279177|NCT00642278|454312618|FG006|Overall Study|Withdrawal by Subject|2|||
126279178|NCT00642278|454312612|FG000|Overall Study|Noncompliance with study drug regimen|0|||
126279179|NCT00642278|454312613|FG001|Overall Study|Noncompliance with study drug regimen|0|||
126279180|NCT00642278|454312614|FG002|Overall Study|Noncompliance with study drug regimen|0|||
126039376|NCT05906784|453443527|FG000|Overall Study|Lost to Follow-up|2|||
126039377|NCT05906784|453443528|FG001|Overall Study|Lost to Follow-up|1|||
126098907|NCT03541174|453655564|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
126279181|NCT00642278|454312615|FG003|Overall Study|Noncompliance with study drug regimen|1|||
126279182|NCT00642278|454312616|FG004|Overall Study|Noncompliance with study drug regimen|0|||
126098908|NCT03541174|453655565|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
126279183|NCT00642278|454312617|FG005|Overall Study|Noncompliance with study drug regimen|0|||
126279184|NCT00642278|454312618|FG006|Overall Study|Noncompliance with study drug regimen|0|||
126279185|NCT00642278|454312612|FG000|Overall Study|Other|2|||
126279186|NCT00642278|454312613|FG001|Overall Study|Other|1|||
126279187|NCT00642278|454312614|FG002|Overall Study|Other|0|||
126279188|NCT00642278|454312615|FG003|Overall Study|Other|1|||
126279189|NCT00642278|454312616|FG004|Overall Study|Other|0|||
126279190|NCT00642278|454312617|FG005|Overall Study|Other|1|||
126279191|NCT00642278|454312618|FG006|Overall Study|Other|0|||
126279192|NCT00090363|454312619|FG000|Overall Study|Lost to Follow-up|1|||
126279193|NCT00090363|454312620|FG001|Overall Study|Lost to Follow-up|2|||
126279194|NCT00090363|454312621|FG002|Overall Study|Lost to Follow-up|1|||
126279195|NCT00090363|454312619|FG000|Overall Study|Withdrawal by Subject|7|||
126279196|NCT00090363|454312620|FG001|Overall Study|Withdrawal by Subject|7|||
126279197|NCT00090363|454312621|FG002|Overall Study|Withdrawal by Subject|6|||
126279198|NCT00090363|454312619|FG000|Overall Study|Study-specific discontinuation criteria|75|||
126279199|NCT00090363|454312620|FG001|Overall Study|Study-specific discontinuation criteria|74|||
126279200|NCT00090363|454312621|FG002|Overall Study|Study-specific discontinuation criteria|62|||
126279201|NCT00090363|454312619|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126279202|NCT00090363|454312620|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126279203|NCT00090363|454312621|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126279204|NCT00090363|454312619|FG000|Overall Study|Consent expired|7|||
126279205|NCT00090363|454312620|FG001|Overall Study|Consent expired|10|||
126279206|NCT00090363|454312621|FG002|Overall Study|Consent expired|9|||
126279207|NCT00090363|454312619|FG000|Overall Study|Reasons not specified|2|||
126279208|NCT00090363|454312620|FG001|Overall Study|Reasons not specified|1|||
126279209|NCT00090363|454312621|FG002|Overall Study|Reasons not specified|1|||
126279210|NCT00090363|454312619|FG000|Overall Study|Continuing on study off treatment|14|||
126279211|NCT00090363|454312620|FG001|Overall Study|Continuing on study off treatment|13|||
126279212|NCT00090363|454312621|FG002|Overall Study|Continuing on study off treatment|16|||
126279213|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
126279214|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126279215|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
126279216|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126363672|NCT03574389|454624885|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
126363673|NCT01682603|454624886|FG000|Overall Study|Lost to Follow-up|3|||
126363674|NCT00993473|454624887|FG000|Overall Study|Adverse Event|0|||
126098909|NCT03541174|453655566|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
126098910|NCT03541174|453655567|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
126098911|NCT03541174|453655568|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
126098912|NCT03541174|453655563|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126103479|NCT01078675|453672170|FG001|Overall Study|Provided in CRF for specific reasons|3|||
126279217|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126279218|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
126279219|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126279220|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126279221|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
126279222|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
126279223|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
126279224|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
126279225|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
126279226|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
126279227|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
126279228|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
126279229|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126279230|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126279231|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126279232|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126279233|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
126279234|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
126279235|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
126279236|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
126279237|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
126279238|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125881973|NCT00307801|452867037|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
125881974|NCT00307801|452867038|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
126279239|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
126279240|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
126279241|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125881975|NCT00307801|452867037|FG000|Overall Study|Frustration with e-diary|1|||
125881976|NCT00307801|452867038|FG001|Overall Study|Frustration with e-diary|0|||
125881977|NCT00307801|452867037|FG000|Overall Study|Protocol Violation|3|||
125881978|NCT00307801|452867038|FG001|Overall Study|Protocol Violation|2|||
125881979|NCT00307801|452867037|FG000|Overall Study|No reason specified|2|||
125881980|NCT00307801|452867038|FG001|Overall Study|No reason specified|0|||
125881981|NCT00307801|452867037|FG000|Overall Study|Pregnancy|0|||
125881982|NCT00307801|452867038|FG001|Overall Study|Pregnancy|1|||
125881983|NCT00551642|452867044|FG000|Treatment Period|Protocol Deviation|6|||
125881984|NCT00551642|452867045|FG001|Treatment Period|Protocol Deviation|11|||
125881985|NCT00551642|452867044|FG000|Treatment Period|Delivery device failure|1|||
125881986|NCT00551642|452867045|FG001|Treatment Period|Delivery device failure|3|||
125881987|NCT00551642|452867044|FG000|Treatment Period|Physician Decision|0|||
125881988|NCT00551642|452867045|FG001|Treatment Period|Physician Decision|1|||
125881989|NCT00551642|452867044|FG000|Treatment Period|Death|33|||
125881990|NCT00551642|452867045|FG001|Treatment Period|Death|31|||
125881991|NCT00551642|452867044|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
125881992|NCT00551642|452867045|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
126098913|NCT03541174|453655564|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126098914|NCT03541174|453655565|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126279242|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
126279243|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
126279244|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
126279245|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
126279246|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
126279247|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
126279248|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
126279249|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
126279250|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
126279251|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
126279252|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
126279253|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
126279254|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126279255|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126279256|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
126279257|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126279258|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
126279259|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
126279260|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
126279261|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
126279262|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
126279263|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
126279264|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
126279265|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
126279266|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
126279267|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
126279268|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
126279269|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
126279270|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
126279271|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
126279272|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
126279273|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
126279274|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
125881993|NCT00551642|452867044|FG000|Treatment Period|Adverse Event|15|||
126098915|NCT03541174|453655566|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126098916|NCT03541174|453655567|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
126098917|NCT03541174|453655568|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126098918|NCT02217332|453655571|FG000|Overall Study|Adverse Event|3|||
126279275|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125881994|NCT00551642|452867045|FG001|Treatment Period|Adverse Event|12|||
125881995|NCT00551642|452867044|FG000|Treatment Period|Withdrawal by Subject|2|||
125881996|NCT00551642|452867045|FG001|Treatment Period|Withdrawal by Subject|1|||
125881997|NCT00361296|452867047|FG000|Overall Study|Physician Decision|1|||
125881998|NCT00361296|452867047|FG000|Overall Study|Lack of Efficacy|2|||
125881999|NCT00198822|452867048|FG000|Overall Study|Lost to Follow-up|14|||
125882000|NCT00198822|452867049|FG001|Overall Study|Lost to Follow-up|20|||
125882001|NCT00198822|452867050|FG002|Overall Study|Lost to Follow-up|21|||
126279276|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
126279277|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
126279278|NCT06281171|454312635|FG000|Timepoint 2|Lost to Follow-up|6|||
126279279|NCT06281171|454312636|FG001|Timepoint 2|Lost to Follow-up|4|||
125882002|NCT03011099|452867051|FG000|Overall Study|Withdrawal by Subject|0|||
126039378|NCT05906784|453443529|FG002|Overall Study|Lost to Follow-up|1|||
126039379|NCT05906784|453443530|FG003|Overall Study|Lost to Follow-up|1|||
126039380|NCT02668692|453443531|FG000|Overall Study|Adverse Event|1|||
126039381|NCT02668692|453443532|FG001|Overall Study|Adverse Event|0|||
126039382|NCT01627574|453443536|FG000|Overall Study|Withdrawal by Subject|8|||
126039383|NCT01627574|453443537|FG001|Overall Study|Withdrawal by Subject|5|||
126039384|NCT01627574|453443536|FG000|Overall Study|Lost to Follow-up|13|||
126039385|NCT01627574|453443537|FG001|Overall Study|Lost to Follow-up|13|||
126039386|NCT04730739|453443538|FG000|Overall Study|Death|1|||
126039387|NCT04707469|453443544|FG000|Overall Study|Site closure|0|||
126039388|NCT04707469|453443545|FG001|Overall Study|Site closure|2|||
126039389|NCT04707469|453443546|FG002|Overall Study|Site closure|0|||
126039390|NCT04707469|453443544|FG000|Overall Study|Physician Decision|2|||
126039391|NCT04707469|453443545|FG001|Overall Study|Physician Decision|2|||
126039392|NCT04707469|453443546|FG002|Overall Study|Physician Decision|2|||
126039393|NCT04707469|453443544|FG000|Overall Study|Death|1|||
126039394|NCT04707469|453443545|FG001|Overall Study|Death|6|||
126039395|NCT04707469|453443546|FG002|Overall Study|Death|2|||
126039396|NCT04707469|453443544|FG000|Overall Study|Lost to Follow-up|9|||
126039397|NCT04707469|453443545|FG001|Overall Study|Lost to Follow-up|19|||
126039398|NCT04707469|453443546|FG002|Overall Study|Lost to Follow-up|14|||
126039399|NCT04707469|453443544|FG000|Overall Study|Withdrawal by Subject|17|||
126039400|NCT04707469|453443545|FG001|Overall Study|Withdrawal by Subject|16|||
126279280|NCT06281171|454312635|FG000|Timepoint 3|Lost to Follow-up|0|||
126279281|NCT06281171|454312636|FG001|Timepoint 3|Lost to Follow-up|5|||
126279282|NCT00205803|454312640|FG000|Infant Series|Lost to Follow-up|10|||
126279283|NCT00205803|454312641|FG001|Infant Series|Lost to Follow-up|4|||
126279284|NCT00205803|454312640|FG000|Infant Series|Withdrawal by Subject|2|||
126279285|NCT00205803|454312641|FG001|Infant Series|Withdrawal by Subject|5|||
126279286|NCT00205803|454312640|FG000|Infant Series|Physician Decision|3|||
126279287|NCT00205803|454312641|FG001|Infant Series|Physician Decision|1|||
126279288|NCT00205803|454312640|FG000|Infant Series|Protocol Violation|1|||
126279289|NCT00205803|454312641|FG001|Infant Series|Protocol Violation|0|||
126279290|NCT00205803|454312640|FG000|Infant Series|Lost Kaiser coverage|0|||
126279291|NCT00205803|454312641|FG001|Infant Series|Lost Kaiser coverage|1|||
126279292|NCT00205803|454312640|FG000|Infant Series|Non-compliant|1|||
126279293|NCT00205803|454312641|FG001|Infant Series|Non-compliant|0|||
126279294|NCT00205803|454312640|FG000|Infant Series|Sponsor request|1|||
126279295|NCT00205803|454312641|FG001|Infant Series|Sponsor request|0|||
126279296|NCT00205803|454312640|FG000|After Infant Series|Adverse Event|1|||
126279297|NCT00205803|454312641|FG001|After Infant Series|Adverse Event|1|||
126279298|NCT00205803|454312640|FG000|After Infant Series|Protocol Violation|1|||
126279299|NCT00205803|454312641|FG001|After Infant Series|Protocol Violation|1|||
126279300|NCT00205803|454312640|FG000|After Infant Series|Lost to Follow-up|2|||
126279301|NCT00205803|454312641|FG001|After Infant Series|Lost to Follow-up|1|||
126279302|NCT00205803|454312640|FG000|After Infant Series|Physician Decision|3|||
126279303|NCT00205803|454312641|FG001|After Infant Series|Physician Decision|2|||
126279304|NCT00205803|454312640|FG000|After Infant Series|Withdrawal by Subject|1|||
126279305|NCT00205803|454312641|FG001|After Infant Series|Withdrawal by Subject|4|||
126279306|NCT00205803|454312640|FG000|After Infant Series|Other|10|||
126279307|NCT00205803|454312641|FG001|After Infant Series|Other|4|||
126279308|NCT00205803|454312640|FG000|Toddler Dose|Lost to Follow-up|2|||
126279309|NCT00205803|454312641|FG001|Toddler Dose|Lost to Follow-up|3|||
126039401|NCT04707469|453443546|FG002|Overall Study|Withdrawal by Subject|12|||
126039402|NCT04677738|453443547|FG000|Overall Study|Withdrawal by Subject|4|||
126039403|NCT04677738|453443548|FG001|Overall Study|Withdrawal by Subject|2|||
126279310|NCT01102374|454312650|FG000|Overall Study|Death|9|||
126279311|NCT01102374|454312651|FG001|Overall Study|Death|13|||
126039404|NCT03249090|453443551|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
126039405|NCT03249090|453443552|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
126098919|NCT02217332|453655571|FG000|Overall Study|Dose interruption >1 month|1|||
126279312|NCT01102374|454312650|FG000|Overall Study|Lost to Follow-up|7|||
126279313|NCT01102374|454312651|FG001|Overall Study|Lost to Follow-up|6|||
126279314|NCT02071849|454312652|FG000|6-month Primary Endpoint|Did not receive device|4|||
126098920|NCT02217332|453655571|FG000|Overall Study|Protocol Violation (eligibility)|1|||
126279315|NCT02071849|454312652|FG000|6-month Primary Endpoint|Adverse Event|1|||
126279316|NCT02071849|454312652|FG000|2-year Extended Follow-up|Adverse Event|1|||
126363675|NCT00993473|454624888|FG001|Overall Study|Adverse Event|2|||
126279317|NCT04619992|454312653|FG000|Overall Study|Withdrawal by Subject|1|||
126279318|NCT04619992|454312654|FG001|Overall Study|Withdrawal by Subject|0|||
126279319|NCT00658021|454312655|FG000|28-Week Treatment Period|Adverse Event|3|||
126039406|NCT03249090|453443551|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
126039407|NCT03249090|453443552|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
126039408|NCT03249090|453443551|FG000|3 Month Time Point|Voluntary withdrawal|6|||
126039409|NCT03249090|453443552|FG001|3 Month Time Point|Voluntary withdrawal|3|||
126039410|NCT03249090|453443551|FG000|3 Month Time Point|Changed oncology practice|4|||
126039411|NCT03249090|453443552|FG001|3 Month Time Point|Changed oncology practice|2|||
126279320|NCT00658021|454312656|FG001|28-Week Treatment Period|Adverse Event|1|||
126279321|NCT00658021|454312657|FG002|28-Week Treatment Period|Adverse Event|0|||
126279322|NCT00658021|454312655|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
126279323|NCT00658021|454312656|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
126279324|NCT00658021|454312657|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
126279325|NCT00658021|454312655|FG000|28-Week Treatment Period|Protocol Violation|0|||
126279326|NCT00658021|454312656|FG001|28-Week Treatment Period|Protocol Violation|2|||
126279327|NCT00658021|454312657|FG002|28-Week Treatment Period|Protocol Violation|1|||
126279328|NCT00658021|454312655|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
126279329|NCT00658021|454312656|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
126279330|NCT00658021|454312657|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
126279331|NCT00658021|454312655|FG000|28-Week Treatment Period|Physician Decision|1|||
126279332|NCT00658021|454312656|FG001|28-Week Treatment Period|Physician Decision|2|||
126279333|NCT00658021|454312657|FG002|28-Week Treatment Period|Physician Decision|1|||
126279334|NCT00658021|454312655|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
126279335|NCT00658021|454312656|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
126279336|NCT00658021|454312657|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
126279337|NCT00658021|454312655|FG000|28-Week Treatment Period|Loss of glucose control|1|||
126363676|NCT00993473|454624887|FG000|Overall Study|Protocol Violation|1|||
126363677|NCT00993473|454624888|FG001|Overall Study|Protocol Violation|2|||
126363678|NCT00993473|454624887|FG000|Overall Study|Lost to Follow-up|1|||
126363679|NCT00993473|454624888|FG001|Overall Study|Lost to Follow-up|0|||
126279338|NCT00658021|454312656|FG001|28-Week Treatment Period|Loss of glucose control|1|||
126279339|NCT00658021|454312657|FG002|28-Week Treatment Period|Loss of glucose control|10|||
126279340|NCT00658021|454312655|FG000|28-Week Treatment Period|Other|2|||
126039412|NCT03249090|453443551|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
126039413|NCT03249090|453443552|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
126039414|NCT03249090|453443551|FG000|12 Month Time Point|Voluntary withdrawal|35|||
126039415|NCT03249090|453443552|FG001|12 Month Time Point|Voluntary withdrawal|4|||
126039416|NCT03249090|453443551|FG000|12 Month Time Point|Changed oncology practice|20|||
126039417|NCT03249090|453443552|FG001|12 Month Time Point|Changed oncology practice|9|||
126039418|NCT01346540|453443553|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
126039419|NCT01346540|453443554|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
126039420|NCT01346540|453443553|FG000|Overall Study|Adverse Event|0|||
126039421|NCT01346540|453443554|FG001|Overall Study|Adverse Event|4|||
126039422|NCT05147116|453443559|FG000|Overall Study|Withdrawal by Subject|0|||
126039423|NCT05147116|453443560|FG001|Overall Study|Withdrawal by Subject|1|||
126039424|NCT03672916|453443561|FG000|Overall Study|Death|6|||
126039425|NCT03672916|453443561|FG000|Overall Study|Lost to Follow-up|29|||
126363680|NCT00993473|454624887|FG000|Overall Study|Withdrawal by Subject|1|||
126363681|NCT00993473|454624888|FG001|Overall Study|Withdrawal by Subject|5|||
126039426|NCT03672916|453443561|FG000|Overall Study|Adverse Event|6|||
126039427|NCT03672916|453443561|FG000|Overall Study|Withdrawal by Subject|11|||
126039428|NCT04197336|453443562|FG000|Overall Study|Withdrawal by Subject|1|||
126039429|NCT04585815|453443563|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
126039430|NCT04585815|453443564|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
126039431|NCT04585815|453443565|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
126039432|NCT04585815|453443566|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
126039433|NCT04585815|453443567|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
126039434|NCT04585815|453443568|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
126039435|NCT04585815|453443569|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
126098921|NCT02217332|453655571|FG000|Overall Study|Withdrawal by Subject|1|||
126098922|NCT02217332|453655571|FG000|Overall Study|Lost to Follow-up|1|||
126279341|NCT00658021|454312656|FG001|28-Week Treatment Period|Other|3|||
126363682|NCT00993473|454624887|FG000|Overall Study|Technical problem with CGM device|0|||
126363683|NCT00993473|454624888|FG001|Overall Study|Technical problem with CGM device|1|||
126363684|NCT00993473|454624887|FG000|Overall Study|Family event|1|||
126363685|NCT00993473|454624888|FG001|Overall Study|Family event|0|||
126363686|NCT03439072|454624889|FG000|Overall Study|Withdrawal by Subject|2|||
126363687|NCT03439072|454624890|FG001|Overall Study|Withdrawal by Subject|3|||
126363688|NCT03439072|454624889|FG000|Overall Study|Physician Decision|0|||
126363689|NCT03439072|454624890|FG001|Overall Study|Physician Decision|1|||
126363690|NCT01537432|454624891|FG000|Overall Study|Lost to Follow-up|3|||
126363691|NCT01537432|454624892|FG001|Overall Study|Lost to Follow-up|1|||
126363692|NCT01537432|454624891|FG000|Overall Study|Withdrawal by Subject|0|||
126363693|NCT01537432|454624892|FG001|Overall Study|Withdrawal by Subject|1|||
126363694|NCT01537432|454624891|FG000|Overall Study|Administrative problems|1|||
126039436|NCT04585815|453443563|FG000|Sub-study A- Treatment Phase|Death|0|||
126039437|NCT04585815|453443564|FG001|Sub-study A- Treatment Phase|Death|1|||
126039438|NCT04585815|453443565|FG002|Sub-study A- Treatment Phase|Death|0|||
126039439|NCT04585815|453443566|FG003|Sub-study A- Treatment Phase|Death|0|||
126363695|NCT01537432|454624892|FG001|Overall Study|Administrative problems|0|||
126363696|NCT01537432|454624891|FG000|Overall Study|Adverse Event|1|||
126279342|NCT00658021|454312657|FG002|28-Week Treatment Period|Other|1|||
126279343|NCT00658021|454312655|FG000|28-Week Treatment Period|Did not receive treatment|2|||
126279344|NCT00658021|454312656|FG001|28-Week Treatment Period|Did not receive treatment|0|||
126039440|NCT04585815|453443567|FG004|Sub-study A- Treatment Phase|Death|0|||
126039441|NCT04585815|453443568|FG005|Sub-study A- Treatment Phase|Death|0|||
126039442|NCT04585815|453443569|FG006|Sub-study A- Treatment Phase|Death|0|||
126279345|NCT00658021|454312657|FG002|28-Week Treatment Period|Did not receive treatment|0|||
126279346|NCT00658021|454312655|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
126279347|NCT00658021|454312656|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
126279348|NCT00658021|454312657|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
126279349|NCT00658021|454312655|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
126279350|NCT00658021|454312656|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
126279351|NCT00658021|454312657|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
126279352|NCT02092467|454312658|FG000|Overall Study|Death|49|||
126279353|NCT02092467|454312659|FG001|Overall Study|Death|66|||
126279354|NCT02092467|454312660|FG002|Overall Study|Death|38|||
126039443|NCT04585815|453443563|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
126279355|NCT02092467|454312658|FG000|Overall Study|Lost to Follow-up|38|||
126039444|NCT04585815|453443564|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126098923|NCT04058366|453655572|FG000|Overall Study|Adverse Event|14|||
126279356|NCT02092467|454312659|FG001|Overall Study|Lost to Follow-up|35|||
126279357|NCT02092467|454312660|FG002|Overall Study|Lost to Follow-up|40|||
126279358|NCT02092467|454312658|FG000|Overall Study|Global Deterioration of Health Status|1|||
126279359|NCT02092467|454312659|FG001|Overall Study|Global Deterioration of Health Status|0|||
126279360|NCT02092467|454312660|FG002|Overall Study|Global Deterioration of Health Status|0|||
126279361|NCT02092467|454312658|FG000|Overall Study|Other|32|||
126279362|NCT02092467|454312659|FG001|Overall Study|Other|30|||
126279363|NCT02092467|454312660|FG002|Overall Study|Other|24|||
126279364|NCT02092467|454312658|FG000|Overall Study|Withdrawal by Subject|282|||
126279365|NCT02092467|454312659|FG001|Overall Study|Withdrawal by Subject|327|||
126279366|NCT02092467|454312660|FG002|Overall Study|Withdrawal by Subject|289|||
126279367|NCT02092467|454312658|FG000|Overall Study|Randomized but not treated|2|||
126279368|NCT02092467|454312659|FG001|Overall Study|Randomized but not treated|1|||
126279369|NCT02092467|454312660|FG002|Overall Study|Randomized but not treated|7|||
126279370|NCT02952898|454312662|FG000|Overall Study|Withdrawal by Subject|10|||
126279371|NCT02952898|454312663|FG001|Overall Study|Withdrawal by Subject|8|||
126279372|NCT02952898|454312664|FG002|Overall Study|Withdrawal by Subject|8|||
126279373|NCT02952898|454312662|FG000|Overall Study|Adverse Event|8|||
126279374|NCT02952898|454312663|FG001|Overall Study|Adverse Event|8|||
126279375|NCT02952898|454312664|FG002|Overall Study|Adverse Event|3|||
126279376|NCT02952898|454312662|FG000|Overall Study|Lost to Follow-up|3|||
126279377|NCT02952898|454312663|FG001|Overall Study|Lost to Follow-up|2|||
126279378|NCT02952898|454312664|FG002|Overall Study|Lost to Follow-up|2|||
126279379|NCT02952898|454312662|FG000|Overall Study|Non-compliance with study drug|1|||
126279380|NCT02952898|454312663|FG001|Overall Study|Non-compliance with study drug|1|||
126279381|NCT02952898|454312664|FG002|Overall Study|Non-compliance with study drug|2|||
126279382|NCT01908907|454314402|FG000|Overall Study|Physician Decision|1|||
126279383|NCT01908907|454314403|FG001|Overall Study|Physician Decision|0|||
126279384|NCT01908907|454314402|FG000|Overall Study|Protocol Violation|1|||
126279385|NCT01908907|454314403|FG001|Overall Study|Protocol Violation|0|||
126279386|NCT00761657|454314404|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
126279387|NCT00761657|454314405|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
126279388|NCT00761657|454314406|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
126279389|NCT00761657|454314407|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
126279390|NCT00761657|454314408|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
126279391|NCT00761657|454314409|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
126279392|NCT00761657|454314410|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
126279393|NCT00761657|454314411|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
126279394|NCT00761657|454314412|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
126279395|NCT00761657|454314404|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279396|NCT00761657|454314405|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279397|NCT00761657|454314406|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
126279398|NCT00761657|454314407|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
126279399|NCT00761657|454314408|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279400|NCT00761657|454314409|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279401|NCT00761657|454314410|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279402|NCT00761657|454314411|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279403|NCT00761657|454314412|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279404|NCT00761657|454314404|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
126279405|NCT00761657|454314405|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
126279406|NCT00761657|454314406|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
126279407|NCT00761657|454314407|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
126279408|NCT00761657|454314408|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
126279409|NCT00761657|454314409|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
126279410|NCT00761657|454314410|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
126279411|NCT00761657|454314411|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
126279412|NCT00761657|454314412|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
126279413|NCT00761657|454314404|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
126279414|NCT00761657|454314405|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
126279415|NCT00761657|454314406|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
126279416|NCT00761657|454314407|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
126279417|NCT00761657|454314408|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
126279418|NCT00761657|454314409|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
126279419|NCT00761657|454314410|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
126279420|NCT00761657|454314411|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
126279421|NCT00761657|454314412|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
126279422|NCT00359801|454314413|FG000|Overall Study|Lost to Follow-up|72|||
126279423|NCT00359801|454314414|FG001|Overall Study|Lost to Follow-up|58|||
126279424|NCT00359801|454314413|FG000|Overall Study|Withdrawal by Subject|143|||
126279425|NCT00359801|454314414|FG001|Overall Study|Withdrawal by Subject|96|||
126279426|NCT00359801|454314413|FG000|Overall Study|Other|66|||
126039445|NCT04585815|453443565|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126039446|NCT04585815|453443566|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126039447|NCT04585815|453443567|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126039448|NCT04585815|453443568|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126039449|NCT04585815|453443569|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126039450|NCT04585815|453443563|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126039451|NCT04585815|453443564|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
126039452|NCT04585815|453443565|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126039453|NCT04585815|453443566|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126039454|NCT04585815|453443567|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126039455|NCT04585815|453443568|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126039456|NCT04585815|453443569|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126039457|NCT04585815|453443563|FG000|Sub-study A- Treatment Phase|Other|1|||
126039458|NCT04585815|453443564|FG001|Sub-study A- Treatment Phase|Other|0|||
126039459|NCT04585815|453443565|FG002|Sub-study A- Treatment Phase|Other|0|||
126039460|NCT04585815|453443566|FG003|Sub-study A- Treatment Phase|Other|0|||
126039461|NCT04585815|453443567|FG004|Sub-study A- Treatment Phase|Other|0|||
126039462|NCT04585815|453443568|FG005|Sub-study A- Treatment Phase|Other|0|||
126039463|NCT04585815|453443569|FG006|Sub-study A- Treatment Phase|Other|0|||
126039464|NCT04585815|453443563|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
126039465|NCT04585815|453443564|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
126039466|NCT04585815|453443565|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126039467|NCT04585815|453443566|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126039468|NCT04585815|453443567|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126039469|NCT04585815|453443568|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126039470|NCT04585815|453443569|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126039471|NCT04585815|453443563|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126039472|NCT04585815|453443564|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
126039473|NCT04585815|453443565|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126039474|NCT04585815|453443566|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126039475|NCT04585815|453443567|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126039476|NCT04585815|453443568|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126039477|NCT04585815|453443569|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126039478|NCT04585815|453443563|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
126039479|NCT04585815|453443564|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
126039480|NCT04585815|453443565|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
126039481|NCT04585815|453443566|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
126039482|NCT04585815|453443567|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
126039483|NCT04585815|453443568|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
126039484|NCT04585815|453443569|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
126039485|NCT04585815|453443563|FG000|Sub-study B- Treatment Phase|Death|0|||
126039486|NCT04585815|453443564|FG001|Sub-study B- Treatment Phase|Death|0|||
126039487|NCT04585815|453443565|FG002|Sub-study B- Treatment Phase|Death|0|||
126039488|NCT04585815|453443566|FG003|Sub-study B- Treatment Phase|Death|1|||
126039489|NCT04585815|453443567|FG004|Sub-study B- Treatment Phase|Death|0|||
126039490|NCT04585815|453443568|FG005|Sub-study B- Treatment Phase|Death|0|||
126039491|NCT04585815|453443569|FG006|Sub-study B- Treatment Phase|Death|0|||
126039492|NCT04585815|453443563|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126039493|NCT04585815|453443564|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126039494|NCT04585815|453443565|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126039495|NCT04585815|453443566|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
126039496|NCT04585815|453443567|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126039497|NCT04585815|453443568|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
126039498|NCT04585815|453443569|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126039499|NCT04585815|453443563|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126039500|NCT04585815|453443564|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126039501|NCT04585815|453443565|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126039502|NCT04585815|453443566|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
126039503|NCT04585815|453443567|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126039504|NCT04585815|453443568|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126039505|NCT04585815|453443569|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126039506|NCT04585815|453443563|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126039507|NCT04585815|453443564|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
125882003|NCT03011099|452867052|FG001|Overall Study|Withdrawal by Subject|2|||
126039508|NCT04585815|453443565|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126039509|NCT04585815|453443566|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126039510|NCT04585815|453443567|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126279427|NCT00359801|454314414|FG001|Overall Study|Other|46|||
126279428|NCT00359801|454314413|FG000|Overall Study|Final Status Unknown: missing data|7|||
126279429|NCT00359801|454314414|FG001|Overall Study|Final Status Unknown: missing data|4|||
126279430|NCT00359801|454314413|FG000|Overall Study|Sponsor Decision|17|||
126279431|NCT00359801|454314414|FG001|Overall Study|Sponsor Decision|16|||
126279432|NCT00270855|454314419|FG000|Overall Study|Withdrawal by Subject|8|||
126279433|NCT00270855|454314420|FG001|Overall Study|Withdrawal by Subject|8|||
126279434|NCT02152605|454314423|FG000|Overall Study|Adverse Event|6|||
126279435|NCT02152605|454314424|FG001|Overall Study|Adverse Event|8|||
126279436|NCT02152605|454314423|FG000|Overall Study|Lack of Efficacy|7|||
126279437|NCT02152605|454314424|FG001|Overall Study|Lack of Efficacy|4|||
126279438|NCT02152605|454314423|FG000|Overall Study|Protocol deviation|1|||
126279439|NCT02152605|454314424|FG001|Overall Study|Protocol deviation|4|||
126279440|NCT02152605|454314423|FG000|Overall Study|Lost to Follow-up|1|||
126279441|NCT02152605|454314424|FG001|Overall Study|Lost to Follow-up|0|||
126279442|NCT02152605|454314423|FG000|Overall Study|Withdrew consent|4|||
126279443|NCT02152605|454314424|FG001|Overall Study|Withdrew consent|2|||
126279444|NCT02500043|454314425|FG000|Overall Study|Randomized, but not Treated|2|||
126279445|NCT02500043|454314426|FG001|Overall Study|Randomized, but not Treated|2|||
126279446|NCT02500043|454314425|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
126279447|NCT02500043|454314426|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
126279448|NCT02500043|454314425|FG000|Overall Study|Adverse Event|33|||
126279449|NCT02500043|454314426|FG001|Overall Study|Adverse Event|11|||
126279450|NCT02500043|454314425|FG000|Overall Study|Clinical Progression|54|||
126279451|NCT02500043|454314426|FG001|Overall Study|Clinical Progression|35|||
126279452|NCT02500043|454314425|FG000|Overall Study|Radiological Progression|192|||
126279453|NCT02500043|454314426|FG001|Overall Study|Radiological Progression|110|||
126279454|NCT02500043|454314425|FG000|Overall Study|Physician's Decision|11|||
126279455|NCT02500043|454314426|FG001|Overall Study|Physician's Decision|3|||
126279456|NCT02500043|454314425|FG000|Overall Study|Withdrawal by Subject|14|||
126279457|NCT02500043|454314426|FG001|Overall Study|Withdrawal by Subject|4|||
126279458|NCT02500043|454314425|FG000|Overall Study|Death|11|||
126279459|NCT02500043|454314426|FG001|Overall Study|Death|2|||
126279460|NCT02500043|454314425|FG000|Overall Study|Protocol Deviation|1|||
126279461|NCT02500043|454314426|FG001|Overall Study|Protocol Deviation|0|||
126279462|NCT03151408|454314427|FG000|Overall Study|Adverse Event|24|||
126279463|NCT03151408|454314428|FG001|Overall Study|Adverse Event|23|||
126279464|NCT03151408|454314427|FG000|Overall Study|Death|46|||
126279465|NCT03151408|454314428|FG001|Overall Study|Death|26|||
126279466|NCT03151408|454314427|FG000|Overall Study|Physician Decision|13|||
126279467|NCT03151408|454314428|FG001|Overall Study|Physician Decision|19|||
126279468|NCT03151408|454314427|FG000|Overall Study|Withdrawal by Subject|16|||
126279469|NCT03151408|454314428|FG001|Overall Study|Withdrawal by Subject|20|||
126279470|NCT03151408|454314427|FG000|Overall Study|Progressive disease|45|||
126279471|NCT03151408|454314428|FG001|Overall Study|Progressive disease|61|||
126279472|NCT03151408|454314427|FG000|Overall Study|non-compliance by patient|1|||
126279473|NCT03151408|454314428|FG001|Overall Study|non-compliance by patient|0|||
126279474|NCT03151408|454314427|FG000|Overall Study|other reasons|56|||
126279475|NCT03151408|454314428|FG001|Overall Study|other reasons|52|||
126279476|NCT03151408|454314427|FG000|Overall Study|randomized and not treated|2|||
126279477|NCT03151408|454314428|FG001|Overall Study|randomized and not treated|2|||
126279478|NCT00837473|454314429|FG000|Overall Study|Lost to Follow-up|1|||
126279479|NCT00837473|454314429|FG000|Overall Study|Withdrawal by Subject|2|||
126279480|NCT00926783|454314430|FG000|Overall Study|Incomplete CFAE Procedures|3|||
126279481|NCT00926783|454314431|FG001|Overall Study|Incomplete CFAE Procedures|3|||
126279482|NCT02549027|454314433|FG000|Washout After Period 4|Withdrawal by Subject|0|||
126279483|NCT02549027|454314434|FG001|Washout After Period 4|Withdrawal by Subject|1|||
126279484|NCT02549027|454314435|FG002|Washout After Period 4|Withdrawal by Subject|1|||
126279485|NCT02549027|454314436|FG003|Washout After Period 4|Withdrawal by Subject|1|||
126279486|NCT02549027|454314437|FG004|Washout After Period 4|Withdrawal by Subject|0|||
126279487|NCT02549027|454314438|FG005|Washout After Period 4|Withdrawal by Subject|0|||
126279488|NCT02549027|454314433|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279489|NCT02549027|454314434|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279490|NCT02549027|454314435|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279491|NCT02549027|454314436|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279492|NCT02549027|454314437|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
126279493|NCT02549027|454314438|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279494|NCT02186834|454314439|FG000|Dose Escalation|Death|0|||
126279495|NCT02186834|454314440|FG001|Dose Escalation|Death|0|||
126279496|NCT02186834|454314441|FG002|Dose Escalation|Death|0|||
126279497|NCT02186834|454314442|FG003|Dose Escalation|Death|1|||
126279498|NCT02186834|454314443|FG004|Dose Escalation|Death|0|||
126279499|NCT02186834|454314444|FG005|Dose Escalation|Death|0|||
126279500|NCT02186834|454314439|FG000|Treatment at RP2D|Died prior to treatment|0|||
126279501|NCT02186834|454314440|FG001|Treatment at RP2D|Died prior to treatment|0|||
126279502|NCT02186834|454314441|FG002|Treatment at RP2D|Died prior to treatment|0|||
126279503|NCT02186834|454314442|FG003|Treatment at RP2D|Died prior to treatment|0|||
126279504|NCT02186834|454314443|FG004|Treatment at RP2D|Died prior to treatment|0|||
126279505|NCT02186834|454314444|FG005|Treatment at RP2D|Died prior to treatment|1|||
126279506|NCT01421511|454314450|FG000|Overall Study|Lost to Follow-up|11|||
126279507|NCT01421511|454314451|FG001|Overall Study|Lost to Follow-up|14|||
126279508|NCT01421511|454314450|FG000|Overall Study|Randomized but didn't receive study drug|1|||
126279509|NCT01421511|454314451|FG001|Overall Study|Randomized but didn't receive study drug|7|||
126279510|NCT01421511|454314450|FG000|Overall Study|Physician Decision|0|||
126279511|NCT01421511|454314451|FG001|Overall Study|Physician Decision|1|||
126279512|NCT01421511|454314450|FG000|Overall Study|Withdrawal by Subject|6|||
126279513|NCT01421511|454314451|FG001|Overall Study|Withdrawal by Subject|5|||
126279514|NCT01421511|454314450|FG000|Overall Study|Death|1|||
126279515|NCT01421511|454314451|FG001|Overall Study|Death|1|||
126279516|NCT00749892|454314452|FG000|Overall Study|Withdrawal by Subject|3|||
126279517|NCT04581369|454314453|FG000|Overall Study|Death|7|||
126279518|NCT04581369|454314454|FG001|Overall Study|Death|6|||
126279519|NCT04581369|454314455|FG002|Overall Study|Death|0|||
126279520|NCT04581369|454314453|FG000|Overall Study|Lost to Follow-up|7|||
126279521|NCT04581369|454314454|FG001|Overall Study|Lost to Follow-up|3|||
126279522|NCT04581369|454314455|FG002|Overall Study|Lost to Follow-up|0|||
126279523|NCT04581369|454314453|FG000|Overall Study|liver transplant|2|||
126279524|NCT04581369|454314454|FG001|Overall Study|liver transplant|2|||
126279525|NCT04581369|454314455|FG002|Overall Study|liver transplant|0|||
126279526|NCT04581369|454314453|FG000|Overall Study|transitioned to hospice care|0|||
126279527|NCT04581369|454314454|FG001|Overall Study|transitioned to hospice care|5|||
126279528|NCT04581369|454314455|FG002|Overall Study|transitioned to hospice care|0|||
126279529|NCT00780910|454314456|FG000|Overall Study|Adverse Event|2|||
126279530|NCT01111825|454314459|FG000|Overall Study|Withdrawal by Subject|0|||
126279531|NCT01111825|454314460|FG001|Overall Study|Withdrawal by Subject|0|||
126279532|NCT01111825|454314461|FG002|Overall Study|Withdrawal by Subject|1|||
126279533|NCT01111825|454314462|FG003|Overall Study|Withdrawal by Subject|0|||
126279534|NCT01111825|454314459|FG000|Overall Study|Lost to Follow-up|0|||
126279535|NCT01111825|454314460|FG001|Overall Study|Lost to Follow-up|0|||
126279536|NCT01111825|454314461|FG002|Overall Study|Lost to Follow-up|3|||
126279537|NCT01111825|454314462|FG003|Overall Study|Lost to Follow-up|1|||
126279538|NCT01111825|454314459|FG000|Overall Study|Adverse Event|2|||
126279539|NCT01111825|454314460|FG001|Overall Study|Adverse Event|1|||
126039511|NCT04585815|453443568|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126039512|NCT04585815|453443569|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
126039513|NCT04585815|453443563|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
126039514|NCT04585815|453443564|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
126039515|NCT04585815|453443565|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
126039516|NCT04585815|453443566|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
126039517|NCT04585815|453443567|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
126039518|NCT04585815|453443568|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
126039519|NCT04585815|453443569|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
126039520|NCT04585815|453443563|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
126039521|NCT04585815|453443564|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
126039522|NCT04585815|453443565|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
126039523|NCT04585815|453443566|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
126039524|NCT04585815|453443567|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
126039525|NCT04585815|453443568|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
126039526|NCT04585815|453443569|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
126039527|NCT04585815|453443563|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
126039528|NCT04585815|453443564|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
126039529|NCT04585815|453443565|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
126039530|NCT04585815|453443566|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
126039531|NCT04585815|453443567|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
126039532|NCT04585815|453443568|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
126039533|NCT04585815|453443569|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
126039534|NCT04585815|453443563|FG000|Sub-study B- Follow-up Phase|Death|0|||
126039535|NCT04585815|453443564|FG001|Sub-study B- Follow-up Phase|Death|0|||
126039536|NCT04585815|453443565|FG002|Sub-study B- Follow-up Phase|Death|1|||
126039537|NCT04585815|453443566|FG003|Sub-study B- Follow-up Phase|Death|3|||
126039538|NCT04585815|453443567|FG004|Sub-study B- Follow-up Phase|Death|0|||
126039539|NCT04585815|453443568|FG005|Sub-study B- Follow-up Phase|Death|0|||
126039540|NCT04585815|453443569|FG006|Sub-study B- Follow-up Phase|Death|1|||
126039541|NCT04295512|453443577|FG000|Overall Study|Lack of family response to schedule assessment|0|||
126039542|NCT04295512|453443578|FG001|Overall Study|Lack of family response to schedule assessment|0|||
126039543|NCT04295512|453443579|FG002|Overall Study|Lack of family response to schedule assessment|0|||
126039544|NCT04295512|453443580|FG003|Overall Study|Lack of family response to schedule assessment|2|||
126039545|NCT04295512|453443577|FG000|Overall Study|Therapist did not refer eligible family|7|||
126039546|NCT04295512|453443578|FG001|Overall Study|Therapist did not refer eligible family|7|||
126039547|NCT04295512|453443579|FG002|Overall Study|Therapist did not refer eligible family|0|||
126279540|NCT01111825|454314461|FG002|Overall Study|Adverse Event|4|||
126279541|NCT01111825|454314462|FG003|Overall Study|Adverse Event|0|||
126279542|NCT01111825|454314459|FG000|Overall Study|Disease Progression|1|||
126279543|NCT01111825|454314460|FG001|Overall Study|Disease Progression|0|||
126279544|NCT01111825|454314461|FG002|Overall Study|Disease Progression|0|||
126279545|NCT01111825|454314462|FG003|Overall Study|Disease Progression|0|||
126279546|NCT01111825|454314459|FG000|Overall Study|Discontinuation by Sponsor|0|||
126279547|NCT01111825|454314460|FG001|Overall Study|Discontinuation by Sponsor|0|||
126279548|NCT01111825|454314461|FG002|Overall Study|Discontinuation by Sponsor|0|||
126279549|NCT01111825|454314462|FG003|Overall Study|Discontinuation by Sponsor|20|||
126279550|NCT02552303|454314472|FG000|Allocation|Withdrawal by Subject|2|||
126279551|NCT02552303|454314473|FG001|Allocation|Withdrawal by Subject|1|||
126279552|NCT02552303|454314474|FG002|Allocation|Withdrawal by Subject|1|||
126279553|NCT02552303|454314475|FG003|Allocation|Withdrawal by Subject|1|||
126279554|NCT02552303|454314472|FG000|Allocation|ineligible|1|||
126279555|NCT02552303|454314473|FG001|Allocation|ineligible|1|||
126279556|NCT02552303|454314474|FG002|Allocation|ineligible|0|||
126279557|NCT02552303|454314475|FG003|Allocation|ineligible|0|||
126279558|NCT02552303|454314472|FG000|Follow-Up|Lost to Follow-up|0|||
126279559|NCT02552303|454314473|FG001|Follow-Up|Lost to Follow-up|0|||
126039548|NCT04295512|453443580|FG003|Overall Study|Therapist did not refer eligible family|0|||
126039549|NCT04587453|453443581|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
126279560|NCT02552303|454314474|FG002|Follow-Up|Lost to Follow-up|1|||
126279561|NCT02552303|454314475|FG003|Follow-Up|Lost to Follow-up|0|||
126279562|NCT02552303|454314472|FG000|Follow-Up|ineligible|0|||
126279563|NCT02552303|454314473|FG001|Follow-Up|ineligible|2|||
126279564|NCT02552303|454314474|FG002|Follow-Up|ineligible|0|||
126363697|NCT01537432|454624892|FG001|Overall Study|Adverse Event|0|||
126039550|NCT04587453|453443582|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
126039551|NCT05623228|453443585|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
126039552|NCT05623228|453443586|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126039553|NCT05623228|453443587|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126279565|NCT02552303|454314475|FG003|Follow-Up|ineligible|0|||
126279566|NCT01377987|454314476|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
126279567|NCT01377987|454314477|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
126279568|NCT00469144|454314480|FG000|Overall Study|Death|0|||
126098924|NCT04058366|453655572|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
126279569|NCT00469144|454314481|FG001|Overall Study|Death|1|||
126279570|NCT00469144|454314480|FG000|Overall Study|No Response|5|||
126279571|NCT00469144|454314481|FG001|Overall Study|No Response|5|||
126279572|NCT00469144|454314480|FG000|Overall Study|Progressive Disease|1|||
126279573|NCT00469144|454314481|FG001|Overall Study|Progressive Disease|0|||
126279574|NCT02794246|454314482|FG000|Overall Study|Withdrawal by Subject|2|||
126279575|NCT02794246|454314482|FG000|Overall Study|Physician Decision|4|||
126279576|NCT04602546|454314483|FG000|Overall Study|Training|2|||
126279577|NCT04602546|454314484|FG001|Overall Study|Training|2|||
126279578|NCT04602546|454314485|FG002|Overall Study|Training|1|||
126279579|NCT04602546|454314486|FG003|Overall Study|Training|2|||
126279580|NCT04602546|454314487|FG004|Overall Study|Training|0|||
126279581|NCT04602546|454314483|FG000|Overall Study|Randomized with disqualified data|2|||
126279582|NCT04602546|454314484|FG001|Overall Study|Randomized with disqualified data|0|||
126279583|NCT04602546|454314485|FG002|Overall Study|Randomized with disqualified data|2|||
126279584|NCT04602546|454314486|FG003|Overall Study|Randomized with disqualified data|5|||
126279585|NCT04602546|454314487|FG004|Overall Study|Randomized with disqualified data|3|||
126279586|NCT01775189|454314488|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279587|NCT01775189|454314489|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
126279588|NCT01775189|454314490|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279589|NCT01775189|454314491|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279590|NCT01775189|454314492|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279591|NCT01775189|454314493|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279592|NCT01775189|454314494|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279593|NCT01775189|454314488|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279594|NCT01775189|454314489|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
126279595|NCT01775189|454314490|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279596|NCT01775189|454314491|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279597|NCT01775189|454314492|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279598|NCT01775189|454314493|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279599|NCT01775189|454314494|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279600|NCT01775189|454314488|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126279601|NCT01775189|454314489|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
126279602|NCT01775189|454314490|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
126279603|NCT01775189|454314491|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126279604|NCT01775189|454314492|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126363698|NCT01537432|454624891|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126363699|NCT01537432|454624892|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126363700|NCT03707821|454624893|FG000|Overall Study|Protocol Violation|0|||
126363701|NCT03707821|454624894|FG001|Overall Study|Protocol Violation|1|||
126363702|NCT03707821|454624893|FG000|Overall Study|Unsatisfactory Visual Response|1|||
126363703|NCT03707821|454624894|FG001|Overall Study|Unsatisfactory Visual Response|0|||
126363704|NCT03707821|454624893|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
126363705|NCT03707821|454624894|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
126363706|NCT05122143|454624897|FG000|Overall Study|Adverse Event|1|||
126363707|NCT05122143|454624898|FG001|Overall Study|Adverse Event|0|||
126363708|NCT05122143|454624899|FG002|Overall Study|Adverse Event|0|||
126363709|NCT05122143|454624900|FG003|Overall Study|Adverse Event|0|||
126363710|NCT05122143|454624901|FG004|Overall Study|Adverse Event|1|||
126363711|NCT05122143|454624902|FG005|Overall Study|Adverse Event|0|||
126363712|NCT05122143|454624897|FG000|Overall Study|Protocol non-compliance|0|||
126363713|NCT05122143|454624898|FG001|Overall Study|Protocol non-compliance|0|||
126363714|NCT05122143|454624899|FG002|Overall Study|Protocol non-compliance|1|||
126363715|NCT05122143|454624900|FG003|Overall Study|Protocol non-compliance|0|||
126363716|NCT05122143|454624901|FG004|Overall Study|Protocol non-compliance|0|||
126363717|NCT05122143|454624902|FG005|Overall Study|Protocol non-compliance|0|||
126363718|NCT05122143|454624897|FG000|Overall Study|Covid contact|0|||
126363719|NCT05122143|454624898|FG001|Overall Study|Covid contact|0|||
126363720|NCT05122143|454624899|FG002|Overall Study|Covid contact|0|||
126363721|NCT05122143|454624900|FG003|Overall Study|Covid contact|0|||
126363722|NCT05122143|454624901|FG004|Overall Study|Covid contact|1|||
126363723|NCT05122143|454624902|FG005|Overall Study|Covid contact|0|||
126363724|NCT03766906|454624903|FG000|Overall Study|Withdrawal by Subject|6|||
126363725|NCT02624687|454624904|FG000|Overall Study|Withdrawal by Subject|1|||
126363726|NCT02624687|454624905|FG001|Overall Study|Withdrawal by Subject|1|||
126363727|NCT02624687|454624904|FG000|Overall Study|medical leave from work|0|||
126279605|NCT01775189|454314493|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126279606|NCT01775189|454314494|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126279607|NCT01775189|454314488|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279608|NCT01775189|454314489|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279609|NCT01775189|454314490|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279610|NCT01775189|454314491|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279611|NCT01775189|454314492|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279612|NCT01775189|454314493|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
126279613|NCT01775189|454314494|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279614|NCT01775189|454314488|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279615|NCT01775189|454314489|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279616|NCT01775189|454314490|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279617|NCT01775189|454314491|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
126279618|NCT01775189|454314492|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279619|NCT01775189|454314493|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279620|NCT01775189|454314494|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279621|NCT01775189|454314488|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279622|NCT01775189|454314489|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279623|NCT01775189|454314490|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279624|NCT01775189|454314491|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
126279625|NCT01775189|454314492|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279626|NCT01775189|454314493|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279627|NCT01775189|454314494|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
126279628|NCT00856375|454314497|FG000|Overall Study|Other|0|||
126279629|NCT00856375|454314498|FG001|Overall Study|Other|1|||
126279630|NCT00856375|454314497|FG000|Overall Study|Death|32|||
126279631|NCT00856375|454314498|FG001|Overall Study|Death|30|||
126279632|NCT00856375|454314497|FG000|Overall Study|Sponsor Terminated Study|7|||
126279633|NCT00856375|454314498|FG001|Overall Study|Sponsor Terminated Study|7|||
126279634|NCT00856375|454314497|FG000|Overall Study|Withdrawal by Subject|2|||
126279635|NCT00856375|454314498|FG001|Overall Study|Withdrawal by Subject|1|||
126279636|NCT00856375|454314497|FG000|Overall Study|Lost to Follow-up|1|||
126279637|NCT00856375|454314498|FG001|Overall Study|Lost to Follow-up|2|||
126279638|NCT02121392|454314500|FG000|Prior to Intervention|Protocol Violation|40|||
126279639|NCT02121392|454314501|FG001|Prior to Intervention|Protocol Violation|35|||
126279640|NCT02121392|454314500|FG000|Prior to Intervention|Withdrawal by Subject|8|||
126279641|NCT02121392|454314501|FG001|Prior to Intervention|Withdrawal by Subject|6|||
126363728|NCT02624687|454624905|FG001|Overall Study|medical leave from work|1|||
126363729|NCT00552279|454624906|FG000|Overall Study|Adverse Event|0|||
126363730|NCT00552279|454624907|FG001|Overall Study|Adverse Event|1|||
126363731|NCT00552279|454624906|FG000|Overall Study|Withdrawal by Subject|12|||
126363732|NCT00552279|454624907|FG001|Overall Study|Withdrawal by Subject|1|||
126363733|NCT00552279|454624906|FG000|Overall Study|Lost to Follow-up|1|||
126363734|NCT00552279|454624907|FG001|Overall Study|Lost to Follow-up|0|||
126363735|NCT00552279|454624906|FG000|Overall Study|Other|1|||
126363736|NCT00552279|454624907|FG001|Overall Study|Other|1|||
126363737|NCT01651208|454624909|FG000|Overall Study|Lost to Follow-up|14|||
126363738|NCT01651208|454624910|FG001|Overall Study|Lost to Follow-up|16|||
126363739|NCT00836901|454624911|FG000|First Intervention|Withdrawal by Subject|1|||
126363740|NCT00836901|454624912|FG001|First Intervention|Withdrawal by Subject|0|||
126363741|NCT05463952|454624916|FG000|Treatment|Progressive disease|4|||
126363742|NCT05463952|454624916|FG000|Treatment|Ongoing|2|||
126363743|NCT05261490|454624917|FG000|Overall Study|Other|1|||
126363744|NCT05261490|454624918|FG001|Overall Study|Other|0|||
126363745|NCT05261490|454624919|FG002|Overall Study|Other|0|||
126363746|NCT05261490|454624917|FG000|Overall Study|Study Terminated by Sponsor|1|||
126363747|NCT05261490|454624918|FG001|Overall Study|Study Terminated by Sponsor|1|||
126363748|NCT05261490|454624919|FG002|Overall Study|Study Terminated by Sponsor|4|||
126363749|NCT05261490|454624917|FG000|Overall Study|Death|1|||
126363750|NCT05261490|454624918|FG001|Overall Study|Death|2|||
126039554|NCT05623228|453443588|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126039555|NCT05623228|453443589|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126039556|NCT05623228|453443590|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126039557|NCT05623228|453443591|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126363751|NCT05261490|454624919|FG002|Overall Study|Death|0|||
126363752|NCT04191733|454624932|FG000|Overall Study|Withdrawn due to study closure|13|||
126363753|NCT04191733|454624933|FG001|Overall Study|Withdrawn due to study closure|14|||
126279642|NCT02121392|454314500|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
126279643|NCT02121392|454314501|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
126279644|NCT02121392|454314500|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
126279645|NCT02121392|454314501|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
126279646|NCT00741286|454314502|FG000|Overall Study|Lost to Follow-up|15|||
126279647|NCT00741286|454314503|FG001|Overall Study|Lost to Follow-up|10|||
126279648|NCT00741286|454314502|FG000|Overall Study|Adverse Event|1|||
126279649|NCT00741286|454314503|FG001|Overall Study|Adverse Event|6|||
126279650|NCT00741286|454314502|FG000|Overall Study|Protocol Violation|3|||
126279651|NCT00741286|454314503|FG001|Overall Study|Protocol Violation|2|||
126279652|NCT00741286|454314502|FG000|Overall Study|Primary Outcome|1|||
126279653|NCT00741286|454314503|FG001|Overall Study|Primary Outcome|1|||
126279654|NCT01352416|454314504|FG000|Overall Study|Physician Decision|1|||
126279655|NCT01352416|454314505|FG001|Overall Study|Physician Decision|2|||
126363754|NCT04191733|454624932|FG000|Overall Study|Withdrawal by Subject|2|||
126363755|NCT04191733|454624933|FG001|Overall Study|Withdrawal by Subject|4|||
126363756|NCT04191733|454624932|FG000|Overall Study|Physician Decision|1|||
126363757|NCT04191733|454624933|FG001|Overall Study|Physician Decision|1|||
126103480|NCT01078675|453672169|FG000|Overall Study|Adverse Event|3|||
126363758|NCT04191733|454624932|FG000|Overall Study|Lost to Follow-up|5|||
126279656|NCT01352416|454314506|FG002|Overall Study|Physician Decision|2|||
126279657|NCT01352416|454314507|FG003|Overall Study|Physician Decision|1|||
126279658|NCT01831258|454314508|FG000|Overall Study|Withdrawal by Subject|2|||
126279659|NCT01831258|454314509|FG001|Overall Study|Withdrawal by Subject|1|||
126363759|NCT04191733|454624933|FG001|Overall Study|Lost to Follow-up|6|||
126363760|NCT04191733|454624932|FG000|Overall Study|Death|0|||
126363761|NCT04191733|454624933|FG001|Overall Study|Death|1|||
126363762|NCT01714063|454624939|FG000|Overall Study|Equipment malfunction|2|||
126363763|NCT01646216|454624940|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
126039558|NCT05623228|453443592|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126039559|NCT05623228|453443585|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
126039560|NCT05623228|453443586|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126279660|NCT01831258|454314508|FG000|Overall Study|Lost to Follow-up|3|||
126279661|NCT01831258|454314509|FG001|Overall Study|Lost to Follow-up|2|||
126279662|NCT00811928|454314522|FG000|Overall Study|AEs and SAEs Including Death|7|||
126279663|NCT00811928|454314523|FG001|Overall Study|AEs and SAEs Including Death|11|||
126279664|NCT00811928|454314522|FG000|Overall Study|Withdrawal by Subject|18|||
126279665|NCT00811928|454314523|FG001|Overall Study|Withdrawal by Subject|12|||
126039561|NCT05623228|453443587|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
126039562|NCT05623228|453443588|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
126039563|NCT05623228|453443589|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126039564|NCT05623228|453443590|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126039565|NCT05623228|453443591|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126039566|NCT05623228|453443592|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126039567|NCT04141891|453443593|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
126039568|NCT04141891|453443594|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
126039569|NCT04141891|453443593|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
126039570|NCT04141891|453443594|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
126039571|NCT04141891|453443593|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
126039572|NCT04141891|453443594|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
126039573|NCT04141891|453443593|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
126039574|NCT04141891|453443594|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
126039575|NCT04141891|453443593|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
126039576|NCT04141891|453443594|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
126039577|NCT04141891|453443593|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
126039578|NCT04141891|453443594|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
126039579|NCT04141891|453443593|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
126039580|NCT04141891|453443594|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
126039581|NCT04141891|453443593|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
126039582|NCT04141891|453443594|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
126039583|NCT04141891|453443593|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
126039584|NCT04141891|453443594|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
126039585|NCT04141891|453443593|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
126039586|NCT04141891|453443594|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
126039587|NCT04141891|453443593|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
126039588|NCT04141891|453443594|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
126039589|NCT04141891|453443593|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
126039590|NCT04141891|453443594|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
126039591|NCT04141891|453443593|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
126039592|NCT04141891|453443594|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
126039593|NCT04141891|453443593|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
126039594|NCT04141891|453443594|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
126039595|NCT04032847|453443602|FG000|Overall Study|Study termination by sponsor|8|||
126039596|NCT04032847|453443603|FG001|Overall Study|Study termination by sponsor|0|||
126039597|NCT04032847|453443604|FG002|Overall Study|Study termination by sponsor|4|||
126039598|NCT04032847|453443602|FG000|Overall Study|Death|12|||
126039599|NCT04032847|453443603|FG001|Overall Study|Death|0|||
126039600|NCT04032847|453443604|FG002|Overall Study|Death|0|||
126039601|NCT04032847|453443602|FG000|Overall Study|Progressive disease|2|||
126039602|NCT04032847|453443603|FG001|Overall Study|Progressive disease|0|||
126039603|NCT04032847|453443604|FG002|Overall Study|Progressive disease|1|||
126039604|NCT03213665|453443605|FG000|Overall Study|Adverse Event|1|||
126039605|NCT03213665|453443605|FG000|Overall Study|Physician Decision|2|||
126039606|NCT03213665|453443605|FG000|Overall Study|Withdrawal by Subject|3|||
126039607|NCT03213665|453443605|FG000|Overall Study|Progressive Disease|13|||
126039608|NCT03056573|453443606|FG000|Overall Study|Death|2|||
126039609|NCT03056573|453443607|FG001|Overall Study|Death|4|||
126039610|NCT03056573|453443606|FG000|Overall Study|Withdrawal by Subject|2|||
126039611|NCT03056573|453443607|FG001|Overall Study|Withdrawal by Subject|0|||
126279666|NCT00811928|454314522|FG000|Overall Study|Did Not Take Study Drug|3|||
126279667|NCT00811928|454314523|FG001|Overall Study|Did Not Take Study Drug|0|||
126279668|NCT00811928|454314522|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
126279669|NCT00811928|454314523|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
126039612|NCT03056573|453443606|FG000|Overall Study|Lost to Follow-up|1|||
126039613|NCT03056573|453443607|FG001|Overall Study|Lost to Follow-up|1|||
126039614|NCT04689256|453443608|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
126046519|NCT03868930|453468246|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
126279670|NCT00811928|454314522|FG000|Overall Study|Investigator Decision|2|||
126363764|NCT01646216|454624941|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
126279671|NCT00811928|454314523|FG001|Overall Study|Investigator Decision|1|||
126279672|NCT00811928|454314522|FG000|Overall Study|Poor Compliance|2|||
126279673|NCT00811928|454314523|FG001|Overall Study|Poor Compliance|5|||
126279674|NCT00171951|454314524|FG000|Overall Study|Adverse Event|1|||
126039615|NCT04689256|453443609|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
126039616|NCT05104463|453443612|FG000|Overall Study|Adverse Event|1|||
126039617|NCT05104463|453443613|FG001|Overall Study|Adverse Event|1|||
126039618|NCT05104463|453443612|FG000|Overall Study|Lost to Follow-up|1|||
126039619|NCT05104463|453443613|FG001|Overall Study|Lost to Follow-up|1|||
126039620|NCT05104463|453443612|FG000|Overall Study|Physician Decision|1|||
126039621|NCT05104463|453443613|FG001|Overall Study|Physician Decision|0|||
126039622|NCT05104463|453443612|FG000|Overall Study|Protocol Violation|0|||
126039623|NCT05104463|453443613|FG001|Overall Study|Protocol Violation|2|||
126039624|NCT05104463|453443612|FG000|Overall Study|Withdrawal by Subject|1|||
126039625|NCT05104463|453443613|FG001|Overall Study|Withdrawal by Subject|1|||
126039626|NCT05267470|453443615|FG000|Overall Study|Decision by sponsor|0|||
126039627|NCT05267470|453443616|FG001|Overall Study|Decision by sponsor|3|||
126039628|NCT05267470|453443617|FG002|Overall Study|Decision by sponsor|19|||
126039629|NCT05267470|453443618|FG003|Overall Study|Decision by sponsor|7|||
126039630|NCT05267470|453443619|FG004|Overall Study|Decision by sponsor|3|||
126039631|NCT05267470|453443615|FG000|Overall Study|Withdrawal by Subject|1|||
126039632|NCT05267470|453443616|FG001|Overall Study|Withdrawal by Subject|1|||
126039633|NCT05267470|453443617|FG002|Overall Study|Withdrawal by Subject|2|||
126039634|NCT05267470|453443618|FG003|Overall Study|Withdrawal by Subject|2|||
126039635|NCT05267470|453443619|FG004|Overall Study|Withdrawal by Subject|0|||
126039636|NCT05267470|453443615|FG000|Overall Study|Death|3|||
126039637|NCT05267470|453443616|FG001|Overall Study|Death|5|||
126039638|NCT05267470|453443617|FG002|Overall Study|Death|8|||
126039639|NCT05267470|453443618|FG003|Overall Study|Death|18|||
126039640|NCT05267470|453443619|FG004|Overall Study|Death|1|||
126039641|NCT05267470|453443615|FG000|Overall Study|Lost to Follow-up|0|||
126039642|NCT05267470|453443616|FG001|Overall Study|Lost to Follow-up|0|||
126039643|NCT05267470|453443617|FG002|Overall Study|Lost to Follow-up|0|||
126039644|NCT05267470|453443618|FG003|Overall Study|Lost to Follow-up|1|||
126039645|NCT05267470|453443619|FG004|Overall Study|Lost to Follow-up|0|||
126039646|NCT04230681|453443626|FG000|Overall Study|Physician Decision|2|||
126039647|NCT04230681|453443627|FG001|Overall Study|Physician Decision|3|||
126039648|NCT04230681|453443626|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
126039649|NCT04230681|453443627|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
126039650|NCT04230681|453443626|FG000|Overall Study|IV inadvertently removed|0|||
126039651|NCT04230681|453443627|FG001|Overall Study|IV inadvertently removed|1|||
126039652|NCT00696111|453444894|FG000|Overall Study|Withdrawal by Subject|17|||
126039653|NCT02433379|453444895|FG000|Overall Study|Screen Failures|55|||
126039654|NCT02433379|453444895|FG000|Overall Study|Death|57|||
126039655|NCT02433379|453444895|FG000|Overall Study|Total Withdrawals|209|||
126039656|NCT02038777|453444898|FG000|Overall Study|Death|0|||
126039657|NCT02038777|453444899|FG001|Overall Study|Death|2|||
126039658|NCT02038777|453444900|FG002|Overall Study|Death|0|||
126039659|NCT02038777|453444901|FG003|Overall Study|Death|1|||
126039660|NCT02038777|453444902|FG004|Overall Study|Death|2|||
126039661|NCT02038777|453444903|FG005|Overall Study|Death|4|||
126039662|NCT02038777|453444904|FG006|Overall Study|Death|0|||
126039663|NCT02038777|453444905|FG007|Overall Study|Death|11|||
126039664|NCT02038777|453444898|FG000|Overall Study|Lost to Follow-up|0|||
126039665|NCT02038777|453444899|FG001|Overall Study|Lost to Follow-up|0|||
126039666|NCT02038777|453444900|FG002|Overall Study|Lost to Follow-up|0|||
126039667|NCT02038777|453444901|FG003|Overall Study|Lost to Follow-up|1|||
126039668|NCT02038777|453444902|FG004|Overall Study|Lost to Follow-up|0|||
126039669|NCT02038777|453444903|FG005|Overall Study|Lost to Follow-up|0|||
126039670|NCT02038777|453444904|FG006|Overall Study|Lost to Follow-up|0|||
126039671|NCT02038777|453444905|FG007|Overall Study|Lost to Follow-up|0|||
126279675|NCT00171951|454314524|FG000|Overall Study|Abnormal Laboratory Values|2|||
126279676|NCT00171951|454314524|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126039672|NCT02038777|453444898|FG000|Overall Study|Other|0|||
126039673|NCT02038777|453444899|FG001|Overall Study|Other|1|||
126039674|NCT02038777|453444900|FG002|Overall Study|Other|0|||
126098925|NCT04058366|453655572|FG000|Overall Study|Commercial drug is available for participants|6|||
126098926|NCT04058366|453655572|FG000|Overall Study|Death|1|||
126279677|NCT00171951|454314524|FG000|Overall Study|Participants Withdrew Consent|3|||
126039675|NCT02038777|453444901|FG003|Overall Study|Other|2|||
126039676|NCT02038777|453444902|FG004|Overall Study|Other|1|||
126039677|NCT02038777|453444903|FG005|Overall Study|Other|0|||
126039678|NCT02038777|453444904|FG006|Overall Study|Other|0|||
126039679|NCT02038777|453444905|FG007|Overall Study|Other|0|||
126039680|NCT02038777|453444898|FG000|Overall Study|Randomized but not treated|0|||
126039681|NCT02038777|453444899|FG001|Overall Study|Randomized but not treated|1|||
126039682|NCT02038777|453444900|FG002|Overall Study|Randomized but not treated|0|||
126039683|NCT02038777|453444901|FG003|Overall Study|Randomized but not treated|0|||
126039684|NCT02038777|453444902|FG004|Overall Study|Randomized but not treated|0|||
126279678|NCT00171951|454314524|FG000|Overall Study|New Cancer Therapy|5|||
126279679|NCT00171951|454314524|FG000|Overall Study|Reason not Specified|2|||
126279680|NCT00396812|454314525|FG000|Overall Study|Physician Decision|1|||
126279681|NCT00233402|454314526|FG000|Overall Study|No pathology data|12|||
126279682|NCT00233402|454314527|FG001|Overall Study|No pathology data|9|||
126279683|NCT00233402|454314526|FG000|Overall Study|No Ta/T1|89|||
126279684|NCT00233402|454314527|FG001|Overall Study|No Ta/T1|94|||
126279685|NCT00233402|454314526|FG000|Overall Study|Lost to follow up etc|3|||
126279686|NCT00233402|454314527|FG001|Overall Study|Lost to follow up etc|21|||
126279687|NCT03485365|454314532|FG000|Overall Study|Protocol Violation|0|||
126279688|NCT03485365|454314533|FG001|Overall Study|Protocol Violation|0|||
126279689|NCT03485365|454314534|FG002|Overall Study|Protocol Violation|0|||
126279690|NCT03485365|454314535|FG003|Overall Study|Protocol Violation|1|||
126279691|NCT03485365|454314536|FG004|Overall Study|Protocol Violation|0|||
126279692|NCT03485365|454314537|FG005|Overall Study|Protocol Violation|0|||
126279693|NCT03485365|454314538|FG006|Overall Study|Protocol Violation|1|||
126279694|NCT03485365|454314539|FG007|Overall Study|Protocol Violation|0|||
126279695|NCT03485365|454314540|FG008|Overall Study|Protocol Violation|0|||
126279696|NCT04868968|454314543|FG000|Overall Study|Lost to Follow-up|1|||
126279697|NCT02752087|454314546|FG000|Washout|Physician Decision|1|||
126279698|NCT02752087|454314547|FG001|Washout|Physician Decision|0|||
126039685|NCT02038777|453444903|FG005|Overall Study|Randomized but not treated|0|||
126039686|NCT02038777|453444904|FG006|Overall Study|Randomized but not treated|0|||
126039687|NCT02038777|453444905|FG007|Overall Study|Randomized but not treated|0|||
126039688|NCT02038777|453444898|FG000|Overall Study|Started Chemotherapy|1|||
126039689|NCT02038777|453444899|FG001|Overall Study|Started Chemotherapy|0|||
126039690|NCT02038777|453444900|FG002|Overall Study|Started Chemotherapy|3|||
126039691|NCT02038777|453444901|FG003|Overall Study|Started Chemotherapy|0|||
126039692|NCT02038777|453444902|FG004|Overall Study|Started Chemotherapy|0|||
126039693|NCT02038777|453444903|FG005|Overall Study|Started Chemotherapy|0|||
126039694|NCT02038777|453444904|FG006|Overall Study|Started Chemotherapy|0|||
126039695|NCT02038777|453444905|FG007|Overall Study|Started Chemotherapy|0|||
126039696|NCT02038777|453444898|FG000|Overall Study|participation terminated by sponsor|0|||
126039697|NCT02038777|453444899|FG001|Overall Study|participation terminated by sponsor|0|||
126039698|NCT02038777|453444900|FG002|Overall Study|participation terminated by sponsor|0|||
126039699|NCT02038777|453444901|FG003|Overall Study|participation terminated by sponsor|0|||
126039700|NCT02038777|453444902|FG004|Overall Study|participation terminated by sponsor|0|||
126039701|NCT02038777|453444903|FG005|Overall Study|participation terminated by sponsor|0|||
126039702|NCT02038777|453444904|FG006|Overall Study|participation terminated by sponsor|1|||
126039703|NCT02038777|453444905|FG007|Overall Study|participation terminated by sponsor|1|||
126039704|NCT03676192|453444906|FG000|Induction Study Period|Adverse Event|21|||
126039705|NCT03676192|453444907|FG001|Induction Study Period|Adverse Event|20|||
126039706|NCT03676192|453444906|FG000|Induction Study Period|Death|23|||
126039707|NCT03676192|453444907|FG001|Induction Study Period|Death|20|||
126039708|NCT03676192|453444906|FG000|Induction Study Period|Lost to Follow-up|3|||
126039709|NCT03676192|453444907|FG001|Induction Study Period|Lost to Follow-up|3|||
126039710|NCT03676192|453444906|FG000|Induction Study Period|Physician Decision|6|||
126039711|NCT03676192|453444907|FG001|Induction Study Period|Physician Decision|3|||
126039712|NCT03676192|453444906|FG000|Induction Study Period|Progressive Disease|32|||
126039713|NCT03676192|453444907|FG001|Induction Study Period|Progressive Disease|21|||
126039714|NCT03676192|453444906|FG000|Induction Study Period|Protocol Violation|1|||
126039715|NCT03676192|453444907|FG001|Induction Study Period|Protocol Violation|2|||
126039716|NCT03676192|453444906|FG000|Induction Study Period|Withdrawal by Subject|20|||
126039717|NCT03676192|453444907|FG001|Induction Study Period|Withdrawal by Subject|15|||
126039718|NCT04079218|453444908|FG000|Overall Study|Death|1|||
126279699|NCT01547130|454314548|FG000|Overall Study|Lost to Follow-up|9|||
126279700|NCT01547130|454314549|FG001|Overall Study|Lost to Follow-up|5|||
126279701|NCT00843635|454314550|FG000|Overall Study|Adverse Event|2|||
126279702|NCT00843635|454314551|FG001|Overall Study|Adverse Event|2|||
126279703|NCT00843635|454314552|FG002|Overall Study|Adverse Event|0|||
126279704|NCT00896480|454314554|FG000|Overall Study|Disease progression/recurrence|21|||
126279705|NCT03553576|454314558|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
126279706|NCT03553576|454314559|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
126039719|NCT04079218|453444909|FG001|Overall Study|Death|0|||
126039720|NCT04079218|453444908|FG000|Overall Study|Withdrawal by Subject|3|||
126039721|NCT04079218|453444909|FG001|Overall Study|Withdrawal by Subject|0|||
126039722|NCT04079218|453444908|FG000|Overall Study|Physician Decision|4|||
126039723|NCT04079218|453444909|FG001|Overall Study|Physician Decision|0|||
126279707|NCT03553576|454314558|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
126279708|NCT03553576|454314559|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
126279709|NCT03553576|454314558|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
126279710|NCT03553576|454314559|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
126279711|NCT03553576|454314558|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
126279712|NCT03553576|454314559|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
126279713|NCT03553576|454314558|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
126279714|NCT03553576|454314559|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
126039724|NCT04079218|453444908|FG000|Overall Study|Lost to Follow-up|0|||
126039725|NCT04079218|453444909|FG001|Overall Study|Lost to Follow-up|1|||
126039726|NCT02424617|453444914|FG000|Overall Study|Adverse Event|0|||
126039727|NCT02424617|453444915|FG001|Overall Study|Adverse Event|1|||
126039728|NCT02424617|453444916|FG002|Overall Study|Adverse Event|0|||
126039729|NCT02424617|453444917|FG003|Overall Study|Adverse Event|0|||
126039730|NCT02424617|453444914|FG000|Overall Study|Investigator Decision|0|||
126039731|NCT02424617|453444915|FG001|Overall Study|Investigator Decision|0|||
126039732|NCT02424617|453444916|FG002|Overall Study|Investigator Decision|0|||
126039733|NCT02424617|453444917|FG003|Overall Study|Investigator Decision|1|||
126039734|NCT02424617|453444914|FG000|Overall Study|Withdrawal by Subject|1|||
126039735|NCT02424617|453444915|FG001|Overall Study|Withdrawal by Subject|1|||
126039736|NCT02424617|453444916|FG002|Overall Study|Withdrawal by Subject|0|||
126039737|NCT02424617|453444917|FG003|Overall Study|Withdrawal by Subject|1|||
126039738|NCT02424617|453444914|FG000|Overall Study|Progressive Disease|7|||
126039739|NCT02424617|453444915|FG001|Overall Study|Progressive Disease|6|||
126039740|NCT02424617|453444916|FG002|Overall Study|Progressive Disease|11|||
126039741|NCT02424617|453444917|FG003|Overall Study|Progressive Disease|10|||
126039742|NCT02424617|453444914|FG000|Overall Study|Other|0|||
126039743|NCT02424617|453444915|FG001|Overall Study|Other|0|||
126039744|NCT02424617|453444916|FG002|Overall Study|Other|0|||
126039745|NCT02424617|453444917|FG003|Overall Study|Other|1|||
126039746|NCT02694822|453444918|FG000|Phase 1|Death|2|||
126039747|NCT02694822|453444919|FG001|Phase 1|Death|1|||
126039748|NCT02694822|453444920|FG002|Phase 1|Death|6|||
126039749|NCT02694822|453444921|FG003|Phase 1|Death|6|||
126039750|NCT02694822|453444922|FG004|Phase 1|Death|3|||
126039751|NCT02694822|453444923|FG005|Phase 1|Death|0|||
126039752|NCT02694822|453444918|FG000|Phase 1|Withdrawal by Subject|2|||
126039753|NCT02694822|453444919|FG001|Phase 1|Withdrawal by Subject|2|||
126039754|NCT02694822|453444920|FG002|Phase 1|Withdrawal by Subject|4|||
126039755|NCT02694822|453444921|FG003|Phase 1|Withdrawal by Subject|8|||
126039756|NCT02694822|453444922|FG004|Phase 1|Withdrawal by Subject|1|||
126039757|NCT02694822|453444923|FG005|Phase 1|Withdrawal by Subject|0|||
126039758|NCT02694822|453444918|FG000|Phase 2|Death|0|||
126039759|NCT02694822|453444919|FG001|Phase 2|Death|0|||
126039760|NCT02694822|453444920|FG002|Phase 2|Death|0|||
126039761|NCT02694822|453444921|FG003|Phase 2|Death|0|||
126039762|NCT02694822|453444922|FG004|Phase 2|Death|0|||
126039763|NCT02694822|453444923|FG005|Phase 2|Death|26|||
126039764|NCT02694822|453444918|FG000|Phase 2|Withdrawal by Subject|0|||
126039765|NCT02694822|453444919|FG001|Phase 2|Withdrawal by Subject|0|||
126039766|NCT02694822|453444920|FG002|Phase 2|Withdrawal by Subject|0|||
126039767|NCT02694822|453444921|FG003|Phase 2|Withdrawal by Subject|0|||
126039768|NCT02694822|453444922|FG004|Phase 2|Withdrawal by Subject|0|||
126039769|NCT02694822|453444923|FG005|Phase 2|Withdrawal by Subject|13|||
126039770|NCT02694822|453444918|FG000|Phase 2|Administrative Study Closure|0|||
126039771|NCT02694822|453444919|FG001|Phase 2|Administrative Study Closure|0|||
126039772|NCT02694822|453444920|FG002|Phase 2|Administrative Study Closure|0|||
126039773|NCT02694822|453444921|FG003|Phase 2|Administrative Study Closure|0|||
126039774|NCT02694822|453444922|FG004|Phase 2|Administrative Study Closure|0|||
126039775|NCT02694822|453444923|FG005|Phase 2|Administrative Study Closure|2|||
126039776|NCT02694822|453444918|FG000|Phase 2|Lost to Follow-up|0|||
126039777|NCT02694822|453444919|FG001|Phase 2|Lost to Follow-up|0|||
126039778|NCT02694822|453444920|FG002|Phase 2|Lost to Follow-up|0|||
126039779|NCT02694822|453444921|FG003|Phase 2|Lost to Follow-up|0|||
126039780|NCT02694822|453444922|FG004|Phase 2|Lost to Follow-up|0|||
126279715|NCT03553576|454314558|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
126039781|NCT02694822|453444923|FG005|Phase 2|Lost to Follow-up|1|||
126039782|NCT02694822|453444918|FG000|Phase 2|Participant Transferred to Another Site|0|||
126039783|NCT02694822|453444919|FG001|Phase 2|Participant Transferred to Another Site|0|||
126039784|NCT02694822|453444920|FG002|Phase 2|Participant Transferred to Another Site|0|||
126039785|NCT02694822|453444921|FG003|Phase 2|Participant Transferred to Another Site|0|||
126039786|NCT02694822|453444922|FG004|Phase 2|Participant Transferred to Another Site|0|||
126039787|NCT02694822|453444923|FG005|Phase 2|Participant Transferred to Another Site|1|||
126039788|NCT01868997|453444924|FG000|Overall Study|Adverse Event|2|||
126039789|NCT01868997|453444925|FG001|Overall Study|Adverse Event|5|||
126039790|NCT01868997|453444924|FG000|Overall Study|Lack of Efficacy|2|||
126039791|NCT01868997|453444925|FG001|Overall Study|Lack of Efficacy|0|||
126039792|NCT01868997|453444924|FG000|Overall Study|Other|3|||
126039793|NCT01868997|453444925|FG001|Overall Study|Other|1|||
126039794|NCT02052882|453444933|FG000|Overall Study|Not treated|11|||
126039795|NCT02052882|453444933|FG000|Overall Study|Protocol Violation|1|||
126039796|NCT02052882|453444933|FG000|Overall Study|Inadequate testing|1|||
126039797|NCT04314778|453444950|FG000|Overall Study|Lost to Follow-up|5|||
126039798|NCT04314778|453444951|FG001|Overall Study|Lost to Follow-up|3|||
126039799|NCT04685135|453444952|FG000|Overall Study|Death|126|||
126039800|NCT04685135|453444953|FG001|Overall Study|Death|53|||
126039801|NCT04685135|453444952|FG000|Overall Study|Withdrawal by Subject|12|||
126039802|NCT04685135|453444953|FG001|Overall Study|Withdrawal by Subject|16|||
126039803|NCT03476343|453444954|FG000|Overall Study|Clinical exam moved to another scanner|7|||
126039804|NCT03476343|453444954|FG000|Overall Study|Clinical order cancelled|4|||
126039805|NCT03476343|453444954|FG000|Overall Study|Neonate did not settle down for the scan|1|||
126039806|NCT03088878|453444955|FG000|Overall Study|Adverse Event|0|||
126039807|NCT03088878|453444956|FG001|Overall Study|Adverse Event|0|||
126039808|NCT03088878|453444957|FG002|Overall Study|Adverse Event|0|||
126039809|NCT03088878|453444958|FG003|Overall Study|Adverse Event|0|||
126039810|NCT03088878|453444959|FG004|Overall Study|Adverse Event|4|||
126039811|NCT03088878|453444960|FG005|Overall Study|Adverse Event|2|||
126039812|NCT03088878|453444961|FG006|Overall Study|Adverse Event|1|||
126039813|NCT03088878|453444962|FG007|Overall Study|Adverse Event|0|||
126039814|NCT03088878|453444963|FG008|Overall Study|Adverse Event|0|||
126039815|NCT03088878|453444964|FG009|Overall Study|Adverse Event|0|||
126039816|NCT03088878|453444965|FG010|Overall Study|Adverse Event|0|||
126039817|NCT03088878|453444966|FG011|Overall Study|Adverse Event|0|||
126039818|NCT03088878|453444967|FG012|Overall Study|Adverse Event|5|||
126039819|NCT03088878|453444968|FG013|Overall Study|Adverse Event|3|||
126039820|NCT03088878|453444955|FG000|Overall Study|Clinical Progression|0|||
126039821|NCT03088878|453444956|FG001|Overall Study|Clinical Progression|0|||
126039822|NCT03088878|453444957|FG002|Overall Study|Clinical Progression|0|||
126039823|NCT03088878|453444958|FG003|Overall Study|Clinical Progression|0|||
126039824|NCT03088878|453444959|FG004|Overall Study|Clinical Progression|2|||
126039825|NCT03088878|453444960|FG005|Overall Study|Clinical Progression|0|||
126279716|NCT03553576|454314559|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
126279717|NCT03553576|454314558|FG000|Overall Study|Physician Decision|2|||
126279718|NCT03553576|454314559|FG001|Overall Study|Physician Decision|5|||
126279719|NCT05038800|454314561|FG000|Overall Study|Death|1|||
126279720|NCT05038800|454314562|FG001|Overall Study|Death|1|||
126279721|NCT05038800|454314563|FG002|Overall Study|Death|5|||
126279722|NCT05038800|454314564|FG003|Overall Study|Death|3|||
126279723|NCT05038800|454314565|FG004|Overall Study|Death|1|||
126279724|NCT05038800|454314561|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126279725|NCT05038800|454314562|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126279726|NCT05038800|454314563|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126279727|NCT05038800|454314564|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126279728|NCT05038800|454314565|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126279729|NCT05038800|454314561|FG000|Overall Study|Lack of Efficacy|0|||
126279730|NCT05038800|454314562|FG001|Overall Study|Lack of Efficacy|0|||
126279731|NCT05038800|454314563|FG002|Overall Study|Lack of Efficacy|0|||
126279732|NCT05038800|454314564|FG003|Overall Study|Lack of Efficacy|0|||
126279733|NCT05038800|454314565|FG004|Overall Study|Lack of Efficacy|1|||
126279734|NCT01104792|454314566|FG000|Overall Study|Adverse Event|77|||
126279735|NCT01104792|454314566|FG000|Overall Study|Insufficient Therapeutic Response|22|||
126279736|NCT01104792|454314566|FG000|Overall Study|Protocol Violation|45|||
126279737|NCT01104792|454314566|FG000|Overall Study|Withdrawal of Consent|179|||
126279738|NCT01104792|454314566|FG000|Overall Study|Lost to Follow-up|43|||
126279739|NCT01104792|454314566|FG000|Overall Study|Reasons Not Specified|27|||
126279740|NCT01104792|454314566|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
126279741|NCT00103610|454314570|FG000|Overall Study|Entered Rescue Procedure|10|||
126279742|NCT00103610|454314571|FG001|Overall Study|Entered Rescue Procedure|52|||
126279743|NCT00103610|454314570|FG000|Overall Study|Death|16|||
126279744|NCT00103610|454314571|FG001|Overall Study|Death|12|||
126279745|NCT00103610|454314570|FG000|Overall Study|Elective Withdrawal|4|||
126279746|NCT00103610|454314571|FG001|Overall Study|Elective Withdrawal|0|||
126279747|NCT00103610|454314570|FG000|Overall Study|Lost to Follow-up|3|||
126279748|NCT00103610|454314571|FG001|Overall Study|Lost to Follow-up|1|||
126039826|NCT03088878|453444961|FG006|Overall Study|Clinical Progression|0|||
126279749|NCT00103610|454314570|FG000|Overall Study|Adverse Event|2|||
126279750|NCT00103610|454314571|FG001|Overall Study|Adverse Event|2|||
126039827|NCT03088878|453444962|FG007|Overall Study|Clinical Progression|0|||
126279751|NCT00103610|454314570|FG000|Overall Study|Other|2|||
126279752|NCT00103610|454314571|FG001|Overall Study|Other|7|||
126279753|NCT00103610|454314570|FG000|Overall Study|Failed mobilization|1|||
126279754|NCT00103610|454314571|FG001|Overall Study|Failed mobilization|5|||
126279755|NCT00103610|454314570|FG000|Overall Study|Noncompliance|0|||
126279756|NCT00103610|454314571|FG001|Overall Study|Noncompliance|1|||
126279757|NCT03301623|454314572|FG000|Overall Study|Death|3|||
126279758|NCT03301623|454314573|FG001|Overall Study|Death|1|||
126279759|NCT03301623|454314572|FG000|Overall Study|Withdrawal by Subject|11|||
126039828|NCT03088878|453444963|FG008|Overall Study|Clinical Progression|0|||
126039829|NCT03088878|453444964|FG009|Overall Study|Clinical Progression|0|||
126039830|NCT03088878|453444965|FG010|Overall Study|Clinical Progression|0|||
126279760|NCT03301623|454314573|FG001|Overall Study|Withdrawal by Subject|13|||
126279761|NCT03301623|454314572|FG000|Overall Study|Lost to Follow-up|3|||
126279762|NCT03301623|454314573|FG001|Overall Study|Lost to Follow-up|1|||
126279763|NCT04400682|454314582|FG000|Period 1|Withdrawal by Subject|1|||
126279764|NCT04400682|454314583|FG001|Period 1|Withdrawal by Subject|4|||
126279765|NCT02293863|454314584|FG000|Overall Study|Death|4|||
126279766|NCT02293863|454314585|FG001|Overall Study|Death|6|||
126279767|NCT02293863|454314586|FG002|Overall Study|Death|4|||
126279768|NCT02293863|454314584|FG000|Overall Study|Lost to Follow-up|2|||
126279769|NCT02293863|454314585|FG001|Overall Study|Lost to Follow-up|2|||
126279770|NCT02293863|454314586|FG002|Overall Study|Lost to Follow-up|2|||
126279771|NCT02293863|454314584|FG000|Overall Study|Withdrawal by Subject|3|||
126279772|NCT02293863|454314585|FG001|Overall Study|Withdrawal by Subject|3|||
126279773|NCT02293863|454314586|FG002|Overall Study|Withdrawal by Subject|1|||
126279774|NCT02293863|454314584|FG000|Overall Study|Reason Not Specified|0|||
126279775|NCT02293863|454314585|FG001|Overall Study|Reason Not Specified|2|||
126279776|NCT02293863|454314586|FG002|Overall Study|Reason Not Specified|2|||
126279777|NCT03462459|454314592|FG000|Overall Study|Death|1|||
126279778|NCT03462459|454314593|FG001|Overall Study|Death|0|||
126279779|NCT03462459|454314592|FG000|Overall Study|Lack of Efficacy|2|||
126279780|NCT03462459|454314593|FG001|Overall Study|Lack of Efficacy|4|||
126279781|NCT03462459|454314592|FG000|Overall Study|Lost to Follow-up|1|||
126279782|NCT03462459|454314593|FG001|Overall Study|Lost to Follow-up|3|||
126279783|NCT03462459|454314592|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
126279784|NCT03462459|454314593|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
126279785|NCT03462459|454314592|FG000|Overall Study|Withdrawal by Subject|3|||
126279786|NCT03462459|454314593|FG001|Overall Study|Withdrawal by Subject|2|||
126279787|NCT03462459|454314592|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
126279788|NCT03462459|454314593|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
126279789|NCT04042376|454314595|FG000|Overall Study|Withdrawal by Subject|1|||
126279790|NCT04042376|454314595|FG000|Overall Study|Death|3|||
126279791|NCT00478244|454316108|FG000|Overall Study|Did not receive transplant|1|||
126279792|NCT02929056|454316109|FG000|Overall Study|Lost to Follow-up|0|||
126279793|NCT02929056|454316110|FG001|Overall Study|Lost to Follow-up|1|||
126279794|NCT03132155|454316111|FG000|Overall Study|Lack of Efficacy|6|||
126279795|NCT03132155|454316111|FG000|Overall Study|Lost to Follow-up|1|||
126279796|NCT03132155|454316111|FG000|Overall Study|Withdrawal by Subject|1|||
126279797|NCT02925403|454316115|FG000|Overall Study|Lost to Follow-up|0|||
126279798|NCT02925403|454316116|FG001|Overall Study|Lost to Follow-up|1|||
126279799|NCT00459043|454316117|FG000|Overall Study|Withdrawal by Subject|1|||
126279800|NCT00459043|454316118|FG001|Overall Study|Withdrawal by Subject|0|||
126279801|NCT02899195|454316121|FG000|Concurrent Durvalumab|Adverse Event|4|||
126279802|NCT02899195|454316121|FG000|Concurrent Durvalumab|Physician Decision|1|||
126279803|NCT02899195|454316121|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
126279804|NCT02899195|454316121|FG000|Concurrent Durvalumab|Progressive Disease|5|||
126279805|NCT02899195|454316121|FG000|Maintenance Durvalumab|Adverse Event|1|||
126279806|NCT02899195|454316121|FG000|Maintenance Durvalumab|Physician Decision|1|||
126279807|NCT02899195|454316121|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
126279808|NCT02899195|454316121|FG000|Maintenance Durvalumab|Progressive Disease|31|||
126279809|NCT03156504|454316123|FG000|Overall Study|Withdrawal by Subject|1|||
126279810|NCT00450801|454316124|FG000|Overall Study|Death|1|||
126279811|NCT03452137|454316125|FG000|Overall Study|Death|67|||
126279812|NCT03452137|454316126|FG001|Overall Study|Death|70|||
126279813|NCT03452137|454316125|FG000|Overall Study|Lost to Follow-up|4|||
126279814|NCT03452137|454316126|FG001|Overall Study|Lost to Follow-up|2|||
126279815|NCT03452137|454316125|FG000|Overall Study|Physician Decision|0|||
126279816|NCT03452137|454316126|FG001|Overall Study|Physician Decision|1|||
126279817|NCT03452137|454316125|FG000|Overall Study|Study Terminated by Sponsor|120|||
126279818|NCT03452137|454316126|FG001|Overall Study|Study Terminated by Sponsor|121|||
126279819|NCT03452137|454316125|FG000|Overall Study|Withdrawal by Subject|12|||
126279820|NCT03452137|454316126|FG001|Overall Study|Withdrawal by Subject|9|||
126098927|NCT04058366|453655572|FG000|Overall Study|Other non-compliance|2|||
126279821|NCT01396512|454316127|FG000|Overall Study|Withdrawal by Subject|0|||
126279822|NCT01396512|454316128|FG001|Overall Study|Withdrawal by Subject|1|||
126279823|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
126279824|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
126039831|NCT03088878|453444966|FG011|Overall Study|Clinical Progression|0|||
126039832|NCT03088878|453444967|FG012|Overall Study|Clinical Progression|0|||
126279825|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
126279826|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
126279827|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
126279828|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
126279829|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
126279830|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
126279831|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
126279832|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
126279833|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
126279834|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
126279835|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
126279836|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
126279837|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
126279838|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
126279839|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
126279840|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
126279841|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
126279842|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
126279843|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
126279844|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
126279845|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
126279846|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
126039833|NCT03088878|453444968|FG013|Overall Study|Clinical Progression|0|||
126279847|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
126279848|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
126279849|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
126279850|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
126279851|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
126279852|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
126279853|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
126279854|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
126279855|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
126279856|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
126279857|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
126279858|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
126279859|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
126279860|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
126279861|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
126279862|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
126279863|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
126279864|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
126039834|NCT03088878|453444955|FG000|Overall Study|Death|0|||
125882004|NCT02072668|452867056|FG000|Second Intervention|Lost to Follow-up|1|||
126279865|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
125882005|NCT02072668|452867057|FG001|Second Intervention|Lost to Follow-up|0|||
125882006|NCT01409707|452867058|FG000|Overall Study|Withdrawal by Subject|5|||
125882007|NCT01409707|452867059|FG001|Overall Study|Withdrawal by Subject|17|||
125882008|NCT01409707|452867060|FG002|Overall Study|Withdrawal by Subject|16|||
126279866|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
126279867|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
126279868|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
126279869|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
125882009|NCT04482647|452867061|FG000|Overall Study|Time constraints|2|||
125882010|NCT04482647|452867061|FG000|Overall Study|Health issues|1|||
125882011|NCT04482647|452867061|FG000|Overall Study|Death in the family|1|||
125882012|NCT04482647|452867061|FG000|Overall Study|Disliked the intervention|1|||
125882013|NCT04482647|452867061|FG000|Overall Study|No reasons specified|7|||
125882014|NCT04163341|452867064|FG000|Overall Study|Withdrawal by Subject|2|||
125882015|NCT04163341|452867065|FG001|Overall Study|Withdrawal by Subject|0|||
125882016|NCT04163341|452867064|FG000|Overall Study|Lost to Follow-up|3|||
125882017|NCT04163341|452867065|FG001|Overall Study|Lost to Follow-up|4|||
125882018|NCT02484391|452867067|FG000|Overall Study|Lack of Efficacy|15|||
125882019|NCT02484391|452867068|FG001|Overall Study|Lack of Efficacy|14|||
125882020|NCT02484391|452867069|FG002|Overall Study|Lack of Efficacy|3|||
126039835|NCT03088878|453444956|FG001|Overall Study|Death|0|||
126039836|NCT03088878|453444957|FG002|Overall Study|Death|0|||
126039837|NCT03088878|453444958|FG003|Overall Study|Death|0|||
126039838|NCT03088878|453444959|FG004|Overall Study|Death|2|||
126039839|NCT03088878|453444960|FG005|Overall Study|Death|0|||
126039840|NCT03088878|453444961|FG006|Overall Study|Death|0|||
126039841|NCT03088878|453444962|FG007|Overall Study|Death|0|||
126039842|NCT03088878|453444963|FG008|Overall Study|Death|0|||
126039843|NCT03088878|453444964|FG009|Overall Study|Death|0|||
126039844|NCT03088878|453444965|FG010|Overall Study|Death|0|||
126039845|NCT03088878|453444966|FG011|Overall Study|Death|1|||
126039846|NCT03088878|453444967|FG012|Overall Study|Death|0|||
126039847|NCT03088878|453444968|FG013|Overall Study|Death|0|||
126039848|NCT03088878|453444955|FG000|Overall Study|Disease Progression|1|||
126039849|NCT03088878|453444956|FG001|Overall Study|Disease Progression|2|||
126039850|NCT03088878|453444957|FG002|Overall Study|Disease Progression|3|||
126039851|NCT03088878|453444958|FG003|Overall Study|Disease Progression|0|||
126039852|NCT03088878|453444959|FG004|Overall Study|Disease Progression|3|||
126039853|NCT03088878|453444960|FG005|Overall Study|Disease Progression|0|||
126039854|NCT03088878|453444961|FG006|Overall Study|Disease Progression|0|||
126039855|NCT03088878|453444962|FG007|Overall Study|Disease Progression|0|||
126039856|NCT03088878|453444963|FG008|Overall Study|Disease Progression|0|||
126039857|NCT03088878|453444964|FG009|Overall Study|Disease Progression|0|||
126039858|NCT03088878|453444965|FG010|Overall Study|Disease Progression|0|||
126039859|NCT03088878|453444966|FG011|Overall Study|Disease Progression|0|||
126039860|NCT03088878|453444967|FG012|Overall Study|Disease Progression|1|||
126039861|NCT03088878|453444968|FG013|Overall Study|Disease Progression|1|||
126039862|NCT03088878|453444955|FG000|Overall Study|Initiation of Alternative Treatment|0|||
126039863|NCT03088878|453444956|FG001|Overall Study|Initiation of Alternative Treatment|0|||
126039864|NCT03088878|453444957|FG002|Overall Study|Initiation of Alternative Treatment|0|||
126039865|NCT03088878|453444958|FG003|Overall Study|Initiation of Alternative Treatment|1|||
126039866|NCT03088878|453444959|FG004|Overall Study|Initiation of Alternative Treatment|0|||
126039867|NCT03088878|453444960|FG005|Overall Study|Initiation of Alternative Treatment|0|||
126039868|NCT03088878|453444961|FG006|Overall Study|Initiation of Alternative Treatment|0|||
126039869|NCT03088878|453444962|FG007|Overall Study|Initiation of Alternative Treatment|1|||
126039870|NCT03088878|453444963|FG008|Overall Study|Initiation of Alternative Treatment|1|||
126039871|NCT03088878|453444964|FG009|Overall Study|Initiation of Alternative Treatment|0|||
126039872|NCT03088878|453444965|FG010|Overall Study|Initiation of Alternative Treatment|0|||
126039873|NCT03088878|453444966|FG011|Overall Study|Initiation of Alternative Treatment|0|||
126039874|NCT03088878|453444967|FG012|Overall Study|Initiation of Alternative Treatment|0|||
126039875|NCT03088878|453444968|FG013|Overall Study|Initiation of Alternative Treatment|0|||
126039876|NCT03088878|453444955|FG000|Overall Study|Withdrawal by Subject|0|||
126039877|NCT03088878|453444956|FG001|Overall Study|Withdrawal by Subject|0|||
126039878|NCT03088878|453444957|FG002|Overall Study|Withdrawal by Subject|0|||
126039879|NCT03088878|453444958|FG003|Overall Study|Withdrawal by Subject|1|||
126039880|NCT03088878|453444959|FG004|Overall Study|Withdrawal by Subject|4|||
126039881|NCT03088878|453444960|FG005|Overall Study|Withdrawal by Subject|1|||
126039882|NCT03088878|453444961|FG006|Overall Study|Withdrawal by Subject|1|||
126039883|NCT03088878|453444962|FG007|Overall Study|Withdrawal by Subject|0|||
126039884|NCT03088878|453444963|FG008|Overall Study|Withdrawal by Subject|1|||
126039885|NCT03088878|453444964|FG009|Overall Study|Withdrawal by Subject|2|||
126039886|NCT03088878|453444965|FG010|Overall Study|Withdrawal by Subject|0|||
126039887|NCT03088878|453444966|FG011|Overall Study|Withdrawal by Subject|2|||
126039888|NCT03088878|453444967|FG012|Overall Study|Withdrawal by Subject|1|||
126039889|NCT03088878|453444968|FG013|Overall Study|Withdrawal by Subject|0|||
126039890|NCT03088878|453444955|FG000|Overall Study|Terminated by Sponsor|2|||
126039891|NCT03088878|453444956|FG001|Overall Study|Terminated by Sponsor|1|||
126039892|NCT03088878|453444957|FG002|Overall Study|Terminated by Sponsor|0|||
126039893|NCT03088878|453444958|FG003|Overall Study|Terminated by Sponsor|1|||
126039894|NCT03088878|453444959|FG004|Overall Study|Terminated by Sponsor|6|||
126039895|NCT03088878|453444960|FG005|Overall Study|Terminated by Sponsor|0|||
126039896|NCT03088878|453444961|FG006|Overall Study|Terminated by Sponsor|0|||
126039897|NCT03088878|453444962|FG007|Overall Study|Terminated by Sponsor|0|||
126039898|NCT03088878|453444963|FG008|Overall Study|Terminated by Sponsor|0|||
126039899|NCT03088878|453444964|FG009|Overall Study|Terminated by Sponsor|0|||
126039900|NCT03088878|453444965|FG010|Overall Study|Terminated by Sponsor|3|||
126039901|NCT03088878|453444966|FG011|Overall Study|Terminated by Sponsor|13|||
126039902|NCT03088878|453444967|FG012|Overall Study|Terminated by Sponsor|2|||
126039903|NCT03088878|453444968|FG013|Overall Study|Terminated by Sponsor|1|||
126039904|NCT03088878|453444955|FG000|Overall Study|Completed 2 years of Treatment|0|||
126039905|NCT03088878|453444956|FG001|Overall Study|Completed 2 years of Treatment|0|||
126039906|NCT03088878|453444957|FG002|Overall Study|Completed 2 years of Treatment|0|||
126039907|NCT03088878|453444958|FG003|Overall Study|Completed 2 years of Treatment|0|||
126039908|NCT03088878|453444959|FG004|Overall Study|Completed 2 years of Treatment|0|||
126039909|NCT03088878|453444960|FG005|Overall Study|Completed 2 years of Treatment|0|||
126039910|NCT03088878|453444961|FG006|Overall Study|Completed 2 years of Treatment|1|||
126039911|NCT03088878|453444962|FG007|Overall Study|Completed 2 years of Treatment|0|||
126039912|NCT03088878|453444963|FG008|Overall Study|Completed 2 years of Treatment|0|||
126039913|NCT03088878|453444964|FG009|Overall Study|Completed 2 years of Treatment|1|||
126039914|NCT03088878|453444965|FG010|Overall Study|Completed 2 years of Treatment|0|||
126039915|NCT03088878|453444966|FG011|Overall Study|Completed 2 years of Treatment|0|||
126039916|NCT03088878|453444967|FG012|Overall Study|Completed 2 years of Treatment|8|||
126039917|NCT03088878|453444968|FG013|Overall Study|Completed 2 years of Treatment|3|||
126039918|NCT03088878|453444955|FG000|Overall Study|Physician Decision|0|||
126039919|NCT03088878|453444956|FG001|Overall Study|Physician Decision|0|||
126039920|NCT03088878|453444957|FG002|Overall Study|Physician Decision|0|||
126039921|NCT03088878|453444958|FG003|Overall Study|Physician Decision|0|||
126039922|NCT03088878|453444959|FG004|Overall Study|Physician Decision|0|||
126039923|NCT03088878|453444960|FG005|Overall Study|Physician Decision|0|||
126039924|NCT03088878|453444961|FG006|Overall Study|Physician Decision|0|||
126039925|NCT03088878|453444962|FG007|Overall Study|Physician Decision|2|||
126039926|NCT03088878|453444963|FG008|Overall Study|Physician Decision|1|||
126039927|NCT03088878|453444964|FG009|Overall Study|Physician Decision|0|||
126039928|NCT03088878|453444965|FG010|Overall Study|Physician Decision|0|||
126039929|NCT03088878|453444966|FG011|Overall Study|Physician Decision|0|||
126039930|NCT03088878|453444967|FG012|Overall Study|Physician Decision|0|||
126039931|NCT03088878|453444968|FG013|Overall Study|Physician Decision|1|||
126039932|NCT03088878|453444955|FG000|Overall Study|COVID Related noncompliance|0|||
126039933|NCT03088878|453444956|FG001|Overall Study|COVID Related noncompliance|0|||
126039934|NCT03088878|453444957|FG002|Overall Study|COVID Related noncompliance|0|||
126039935|NCT03088878|453444958|FG003|Overall Study|COVID Related noncompliance|0|||
126039936|NCT03088878|453444959|FG004|Overall Study|COVID Related noncompliance|0|||
126039937|NCT03088878|453444960|FG005|Overall Study|COVID Related noncompliance|0|||
126039938|NCT03088878|453444961|FG006|Overall Study|COVID Related noncompliance|0|||
126279870|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
126279871|NCT00261443|454316129|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
126279872|NCT00261443|454316130|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
126279873|NCT00261443|454316131|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
126279874|NCT00261443|454316129|FG000|3: Assessment of Relapse|Adverse Event|0|||
126279875|NCT00261443|454316130|FG001|3: Assessment of Relapse|Adverse Event|15|||
126279876|NCT00261443|454316131|FG002|3: Assessment of Relapse|Adverse Event|19|||
126039939|NCT03088878|453444962|FG007|Overall Study|COVID Related noncompliance|0|||
126039940|NCT03088878|453444963|FG008|Overall Study|COVID Related noncompliance|0|||
126039941|NCT03088878|453444964|FG009|Overall Study|COVID Related noncompliance|0|||
126039942|NCT03088878|453444965|FG010|Overall Study|COVID Related noncompliance|0|||
126279877|NCT00261443|454316129|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
126279878|NCT00261443|454316130|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
126279879|NCT00261443|454316131|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
126279880|NCT00261443|454316129|FG000|3: Assessment of Relapse|Death|0|||
126279881|NCT00261443|454316130|FG001|3: Assessment of Relapse|Death|0|||
126279882|NCT00261443|454316131|FG002|3: Assessment of Relapse|Death|1|||
126279883|NCT00261443|454316129|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
126039943|NCT03088878|453444966|FG011|Overall Study|COVID Related noncompliance|0|||
126098928|NCT04058366|453655572|FG000|Overall Study|Other|6|||
126279884|NCT00261443|454316130|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
126279885|NCT00261443|454316131|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
126039944|NCT03088878|453444967|FG012|Overall Study|COVID Related noncompliance|0|||
126039945|NCT03088878|453444968|FG013|Overall Study|COVID Related noncompliance|1|||
126039946|NCT03088878|453444955|FG000|Overall Study|Drug or Study Noncompliance|0|||
126039947|NCT03088878|453444956|FG001|Overall Study|Drug or Study Noncompliance|0|||
126279886|NCT00261443|454316129|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
126279887|NCT00261443|454316130|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
126279888|NCT00261443|454316131|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
126279889|NCT00261443|454316129|FG000|3: Assessment of Relapse|Pregnancy|0|||
126279890|NCT00261443|454316130|FG001|3: Assessment of Relapse|Pregnancy|2|||
126279891|NCT00261443|454316131|FG002|3: Assessment of Relapse|Pregnancy|1|||
126279892|NCT00261443|454316129|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
126279893|NCT00261443|454316130|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
126279894|NCT00261443|454316131|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
126279895|NCT00261443|454316129|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
126279896|NCT00261443|454316130|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
126279897|NCT00261443|454316131|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
126279898|NCT00261443|454316129|FG000|3: Assessment of Relapse|Other Reasons|0|||
126279899|NCT00261443|454316130|FG001|3: Assessment of Relapse|Other Reasons|4|||
126279900|NCT00261443|454316131|FG002|3: Assessment of Relapse|Other Reasons|3|||
126279901|NCT00261443|454316129|FG000|4: Extension Phase|Adverse Event|0|||
126279902|NCT00261443|454316130|FG001|4: Extension Phase|Adverse Event|1|||
126279903|NCT00261443|454316131|FG002|4: Extension Phase|Adverse Event|0|||
126279904|NCT00261443|454316129|FG000|4: Extension Phase|Withdrawal by Subject|0|||
126279905|NCT00261443|454316130|FG001|4: Extension Phase|Withdrawal by Subject|1|||
126279906|NCT00261443|454316131|FG002|4: Extension Phase|Withdrawal by Subject|2|||
126279907|NCT00261443|454316129|FG000|4: Extension Phase|Lost to Follow-up|0|||
126279908|NCT00261443|454316130|FG001|4: Extension Phase|Lost to Follow-up|1|||
126279909|NCT00261443|454316131|FG002|4: Extension Phase|Lost to Follow-up|0|||
126279910|NCT02755649|454316132|FG000|Overall Study|Transitioned into OLE study|99|||
126279911|NCT02755649|454316133|FG001|Overall Study|Transitioned into OLE study|98|||
126279912|NCT02755649|454316134|FG002|Overall Study|Transitioned into OLE study|100|||
126279913|NCT02755649|454316132|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
126279914|NCT02755649|454316133|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
126279915|NCT02755649|454316134|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
126279916|NCT02755649|454316132|FG000|Overall Study|Physician Decision|0|||
126279917|NCT02755649|454316133|FG001|Overall Study|Physician Decision|0|||
126279918|NCT02755649|454316134|FG002|Overall Study|Physician Decision|2|||
126279919|NCT02755649|454316132|FG000|Overall Study|Withdrawal by Subject|0|||
126279920|NCT02755649|454316133|FG001|Overall Study|Withdrawal by Subject|1|||
126279921|NCT02755649|454316134|FG002|Overall Study|Withdrawal by Subject|0|||
126279922|NCT02755649|454316132|FG000|Overall Study|Undecided|1|||
126279923|NCT02755649|454316133|FG001|Overall Study|Undecided|0|||
126279924|NCT02755649|454316134|FG002|Overall Study|Undecided|0|||
126279925|NCT01286753|454316135|FG000|Overall Study|Adverse Event|7|||
126279926|NCT01286753|454316136|FG001|Overall Study|Adverse Event|6|||
126279927|NCT01286753|454316135|FG000|Overall Study|Progression|11|||
126279928|NCT01286753|454316136|FG001|Overall Study|Progression|13|||
126279929|NCT01286753|454316135|FG000|Overall Study|Refused Treatment|1|||
126279930|NCT01286753|454316136|FG001|Overall Study|Refused Treatment|0|||
126279931|NCT01286753|454316135|FG000|Overall Study|Withdrawal of Consent|0|||
126279932|NCT01286753|454316136|FG001|Overall Study|Withdrawal of Consent|2|||
126279933|NCT01286753|454316135|FG000|Overall Study|Discontinued to Join Extension Study|6|||
126279934|NCT01286753|454316136|FG001|Overall Study|Discontinued to Join Extension Study|4|||
126279935|NCT01286753|454316135|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
126279936|NCT01286753|454316136|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
126279937|NCT02094417|454316144|FG000|Overall Study|Adverse Event|0|||
126279938|NCT02094417|454316145|FG001|Overall Study|Adverse Event|0|||
126279939|NCT02094417|454316146|FG002|Overall Study|Adverse Event|0|||
126279940|NCT02094417|454316147|FG003|Overall Study|Adverse Event|1|||
126279941|NCT02094417|454316144|FG000|Overall Study|Eligibility criteria|0|||
126279942|NCT02094417|454316145|FG001|Overall Study|Eligibility criteria|1|||
126279943|NCT02094417|454316146|FG002|Overall Study|Eligibility criteria|0|||
126279944|NCT02094417|454316147|FG003|Overall Study|Eligibility criteria|0|||
126279945|NCT02094417|454316144|FG000|Overall Study|No responder|4|||
126279946|NCT02094417|454316145|FG001|Overall Study|No responder|4|||
126279947|NCT02094417|454316146|FG002|Overall Study|No responder|4|||
126279948|NCT02094417|454316147|FG003|Overall Study|No responder|3|||
126279949|NCT02094417|454316144|FG000|Overall Study|Unable to conduct observations or assess|0|||
126279950|NCT02094417|454316145|FG001|Overall Study|Unable to conduct observations or assess|1|||
126279951|NCT02094417|454316146|FG002|Overall Study|Unable to conduct observations or assess|0|||
126039948|NCT03088878|453444957|FG002|Overall Study|Drug or Study Noncompliance|0|||
126039949|NCT03088878|453444958|FG003|Overall Study|Drug or Study Noncompliance|0|||
126279952|NCT02094417|454316147|FG003|Overall Study|Unable to conduct observations or assess|0|||
126279953|NCT02094417|454316144|FG000|Overall Study|Withdrawal by Subject|1|||
126279954|NCT02094417|454316145|FG001|Overall Study|Withdrawal by Subject|2|||
126279955|NCT02094417|454316146|FG002|Overall Study|Withdrawal by Subject|1|||
126279956|NCT02094417|454316147|FG003|Overall Study|Withdrawal by Subject|3|||
126039950|NCT03088878|453444959|FG004|Overall Study|Drug or Study Noncompliance|0|||
126279957|NCT03301649|454316150|FG000|Overall Study|Need alternate therapy due to live lice|17|||
126279958|NCT03301649|454316151|FG001|Overall Study|Need alternate therapy due to live lice|25|||
126279959|NCT03301649|454316152|FG002|Overall Study|Need alternate therapy due to live lice|81|||
126279960|NCT03301649|454316150|FG000|Overall Study|Lost to Follow-up|11|||
126279961|NCT03301649|454316151|FG001|Overall Study|Lost to Follow-up|11|||
126279962|NCT03301649|454316152|FG002|Overall Study|Lost to Follow-up|3|||
126279963|NCT03301649|454316150|FG000|Overall Study|Protocol Violation|0|||
126279964|NCT03301649|454316151|FG001|Overall Study|Protocol Violation|1|||
126279965|NCT03301649|454316152|FG002|Overall Study|Protocol Violation|1|||
126279966|NCT03301649|454316150|FG000|Overall Study|Withdrawal by Subject|10|||
126279967|NCT03301649|454316151|FG001|Overall Study|Withdrawal by Subject|4|||
126279968|NCT03301649|454316152|FG002|Overall Study|Withdrawal by Subject|0|||
126279969|NCT03301649|454316150|FG000|Overall Study|Other than specified|5|||
126279970|NCT03301649|454316151|FG001|Overall Study|Other than specified|3|||
126279971|NCT03301649|454316152|FG002|Overall Study|Other than specified|0|||
126279972|NCT01564537|454316153|FG000|Overall Study|Site Terminated by Sponsor|1|||
126279973|NCT01564537|454316154|FG001|Overall Study|Site Terminated by Sponsor|0|||
126279974|NCT01564537|454316153|FG000|Overall Study|Withdrawal by Subject|12|||
126279975|NCT01564537|454316154|FG001|Overall Study|Withdrawal by Subject|14|||
126279976|NCT01564537|454316153|FG000|Overall Study|Lost to Follow-up|7|||
126279977|NCT01564537|454316154|FG001|Overall Study|Lost to Follow-up|3|||
126279978|NCT01564537|454316153|FG000|Overall Study|Reason not specified|81|||
126279979|NCT01564537|454316154|FG001|Overall Study|Reason not specified|82|||
126279980|NCT01635218|454316155|FG000|Overall Study|Lost to Follow-up|3|||
126279981|NCT01635218|454316156|FG001|Overall Study|Lost to Follow-up|7|||
126279982|NCT01635218|454316157|FG002|Overall Study|Lost to Follow-up|6|||
126279983|NCT03559400|454316158|FG000|Overall Study|Lost to Follow-up|9|||
126279984|NCT03559400|454316159|FG001|Overall Study|Lost to Follow-up|7|||
126279985|NCT03559400|454316158|FG000|Overall Study|Death|0|||
126279986|NCT03559400|454316159|FG001|Overall Study|Death|2|||
126279987|NCT03262038|454316160|FG000|Overall Study|Withdrawal by Subject|0|||
126279988|NCT03262038|454316161|FG001|Overall Study|Withdrawal by Subject|1|||
126279989|NCT02679235|454316162|FG000|Overall Study|Withdrawal by Subject|3|||
126279990|NCT02679235|454316162|FG000|Overall Study|Adverse Event|1|||
126279991|NCT00094861|454316163|FG000|Overall Study|Adverse Event|5|||
126279992|NCT00094861|454316164|FG001|Overall Study|Adverse Event|2|||
126279993|NCT00094861|454316163|FG000|Overall Study|Withdrawal by Subject|5|||
126279994|NCT00094861|454316164|FG001|Overall Study|Withdrawal by Subject|3|||
126279995|NCT00094861|454316163|FG000|Overall Study|Physician Decision|1|||
126279996|NCT00094861|454316164|FG001|Overall Study|Physician Decision|1|||
126098929|NCT00603304|453655573|FG000|Overall Study|Lost to Follow-up|5|||
126098930|NCT00603304|453655574|FG001|Overall Study|Lost to Follow-up|7|||
126098931|NCT00603304|453655573|FG000|Overall Study|Withdrawal by Subject|8|||
126098932|NCT00603304|453655574|FG001|Overall Study|Withdrawal by Subject|5|||
126098933|NCT00603304|453655573|FG000|Overall Study|Protocol Violation|1|||
126098934|NCT00603304|453655574|FG001|Overall Study|Protocol Violation|0|||
126098935|NCT00603304|453655573|FG000|Overall Study|Adverse Event|4|||
126098936|NCT00603304|453655574|FG001|Overall Study|Adverse Event|2|||
126098937|NCT00603304|453655573|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
126279997|NCT00094861|454316163|FG000|Overall Study|Lost to Follow-up|0|||
126279998|NCT00094861|454316164|FG001|Overall Study|Lost to Follow-up|1|||
126279999|NCT00094861|454316163|FG000|Overall Study|Death|4|||
126098938|NCT00603304|453655574|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
126280000|NCT00094861|454316164|FG001|Overall Study|Death|2|||
126280001|NCT00094861|454316163|FG000|Overall Study|Other|3|||
126280002|NCT00094861|454316164|FG001|Overall Study|Other|0|||
126280003|NCT00253448|454316170|FG000|Overall Study|Withdrawal by Subject|1|||
126098939|NCT00603304|453655573|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
126280004|NCT02564887|454316171|FG000|Overall Study|Lost to Follow-up|6|||
126280005|NCT02564887|454316172|FG001|Overall Study|Lost to Follow-up|0|||
126280006|NCT00000620|454316173|FG000|Overall Study|Death|86|||
126280007|NCT00000620|454316174|FG001|Overall Study|Death|67|||
126280008|NCT00000620|454316175|FG002|Overall Study|Death|112|||
126280009|NCT00000620|454316176|FG003|Overall Study|Death|126|||
126280010|NCT00000620|454316177|FG004|Overall Study|Death|64|||
126280011|NCT00000620|454316178|FG005|Overall Study|Death|77|||
126039951|NCT03088878|453444960|FG005|Overall Study|Drug or Study Noncompliance|0|||
126039952|NCT03088878|453444961|FG006|Overall Study|Drug or Study Noncompliance|0|||
126039953|NCT03088878|453444962|FG007|Overall Study|Drug or Study Noncompliance|0|||
126039954|NCT03088878|453444963|FG008|Overall Study|Drug or Study Noncompliance|0|||
126039955|NCT03088878|453444964|FG009|Overall Study|Drug or Study Noncompliance|0|||
126039956|NCT03088878|453444965|FG010|Overall Study|Drug or Study Noncompliance|0|||
126039957|NCT03088878|453444966|FG011|Overall Study|Drug or Study Noncompliance|0|||
126039958|NCT03088878|453444967|FG012|Overall Study|Drug or Study Noncompliance|1|||
126039959|NCT03088878|453444968|FG013|Overall Study|Drug or Study Noncompliance|0|||
126039960|NCT01221948|453444987|FG000|Overall Study|Physician Decision|5|||
126039961|NCT01221948|453444987|FG000|Overall Study|Withdrawal by Subject|2|||
126039962|NCT01221948|453444987|FG000|Overall Study|not disclosed|2|||
126039963|NCT01221948|453444987|FG000|Overall Study|Death|1|||
126280012|NCT00000620|454316179|FG006|Overall Study|Death|91|||
126280013|NCT00000620|454316180|FG007|Overall Study|Death|95|||
126039964|NCT01221948|453444987|FG000|Overall Study|Protocol Violation|4|||
126039965|NCT00746096|453444988|FG000|Overall Study|Adverse Event|1|||
126039966|NCT00746096|453444989|FG001|Overall Study|Adverse Event|0|||
126039967|NCT00746096|453444988|FG000|Overall Study|Withdrawal by Subject|5|||
126039968|NCT00746096|453444989|FG001|Overall Study|Withdrawal by Subject|1|||
126039969|NCT00746096|453444988|FG000|Overall Study|Lost to Follow-up|2|||
126039970|NCT00746096|453444989|FG001|Overall Study|Lost to Follow-up|1|||
126039971|NCT00746096|453444988|FG000|Overall Study|Protocol Violation|1|||
126039972|NCT00746096|453444989|FG001|Overall Study|Protocol Violation|0|||
126039973|NCT00746096|453444988|FG000|Overall Study|No study drug treatment|1|||
126039974|NCT00746096|453444989|FG001|Overall Study|No study drug treatment|1|||
126039975|NCT04059185|453444990|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
126039976|NCT04059185|453444991|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
126039977|NCT04059185|453444992|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
126039978|NCT04059185|453444990|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
126039979|NCT04059185|453444991|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
126039980|NCT04059185|453444992|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
126039981|NCT04059185|453444990|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
126039982|NCT04059185|453444991|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
126039983|NCT04059185|453444992|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
126280014|NCT00000620|454316173|FG000|Overall Study|Lost to Follow-up|14|||
126280015|NCT00000620|454316174|FG001|Overall Study|Lost to Follow-up|14|||
126280016|NCT00000620|454316175|FG002|Overall Study|Lost to Follow-up|14|||
126280017|NCT00000620|454316176|FG003|Overall Study|Lost to Follow-up|14|||
126280018|NCT00000620|454316177|FG004|Overall Study|Lost to Follow-up|15|||
126280019|NCT00000620|454316178|FG005|Overall Study|Lost to Follow-up|15|||
126280020|NCT00000620|454316179|FG006|Overall Study|Lost to Follow-up|13|||
126039984|NCT04059185|453444990|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
126280021|NCT00000620|454316180|FG007|Overall Study|Lost to Follow-up|14|||
126280022|NCT00000620|454316173|FG000|Overall Study|Withdrawal by Subject|40|||
126280023|NCT00000620|454316174|FG001|Overall Study|Withdrawal by Subject|27|||
126280024|NCT00000620|454316175|FG002|Overall Study|Withdrawal by Subject|28|||
126280025|NCT00000620|454316176|FG003|Overall Study|Withdrawal by Subject|27|||
126280026|NCT00000620|454316177|FG004|Overall Study|Withdrawal by Subject|30|||
126280027|NCT00000620|454316178|FG005|Overall Study|Withdrawal by Subject|32|||
126280028|NCT00000620|454316179|FG006|Overall Study|Withdrawal by Subject|32|||
126280029|NCT00000620|454316180|FG007|Overall Study|Withdrawal by Subject|21|||
126280030|NCT00000620|454316173|FG000|Overall Study|missed closeout visit|22|||
126280031|NCT00000620|454316174|FG001|Overall Study|missed closeout visit|28|||
126280032|NCT00000620|454316175|FG002|Overall Study|missed closeout visit|16|||
126280033|NCT00000620|454316176|FG003|Overall Study|missed closeout visit|11|||
126280034|NCT00000620|454316177|FG004|Overall Study|missed closeout visit|26|||
126039985|NCT04059185|453444991|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
126039986|NCT04059185|453444992|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
126039987|NCT04059185|453444990|FG000|Longitudinal Assessment-Adults Only|Death|4|||
126039988|NCT04059185|453444991|FG001|Longitudinal Assessment-Adults Only|Death|4|||
126039989|NCT04059185|453444992|FG002|Longitudinal Assessment-Adults Only|Death|3|||
126103481|NCT01078675|453672170|FG001|Overall Study|Adverse Event|0|||
126280035|NCT00000620|454316178|FG005|Overall Study|missed closeout visit|28|||
126280036|NCT00000620|454316179|FG006|Overall Study|missed closeout visit|13|||
126280037|NCT00000620|454316180|FG007|Overall Study|missed closeout visit|16|||
126280038|NCT01199016|454316181|FG000|Overall Study|No longer meets eligibility criteria|4|||
126280039|NCT01199016|454316181|FG000|Overall Study|Entrance criteria|5|||
126280040|NCT01199016|454316181|FG000|Overall Study|Protocol Violation|9|||
126280041|NCT01199016|454316181|FG000|Overall Study|Other|13|||
126280042|NCT01199016|454316181|FG000|Overall Study|Withdrawal by Subject|21|||
126280043|NCT01199016|454316181|FG000|Overall Study|Lost to Follow-up|25|||
126280044|NCT00314951|454316190|FG000|Treatment|Didn't meet criteria for mITT population|16|||
126280045|NCT00314951|454316191|FG001|Treatment|Didn't meet criteria for mITT population|11|||
126280046|NCT00314951|454316190|FG000|Follow-up|mITT failure|44|||
126280047|NCT00314951|454316191|FG001|Follow-up|mITT failure|34|||
126280048|NCT05320887|454316194|FG000|Overall Study|Lost to Follow-up|0|||
126280049|NCT05320887|454316195|FG001|Overall Study|Lost to Follow-up|3|||
126280050|NCT05320887|454316196|FG002|Overall Study|Lost to Follow-up|0|||
126280051|NCT05320887|454316197|FG003|Overall Study|Lost to Follow-up|0|||
126280052|NCT02015065|454316202|FG000|Overall Study|Death on study|1|||
126280053|NCT02015065|454316203|FG001|Overall Study|Death on study|2|||
126280054|NCT02015065|454316204|FG002|Overall Study|Death on study|1|||
126280055|NCT01671332|454316237|FG000|Overall Study|Withdrawal by Subject|1|||
126280056|NCT01671332|454316238|FG001|Overall Study|Withdrawal by Subject|1|||
126280057|NCT02728843|454316239|FG000|Overall Study|Adverse Event|0|||
126280058|NCT02728843|454316240|FG001|Overall Study|Adverse Event|2|||
126280059|NCT02728843|454316241|FG002|Overall Study|Adverse Event|3|||
126280060|NCT02728843|454316242|FG003|Overall Study|Adverse Event|1|||
126280061|NCT02728843|454316243|FG004|Overall Study|Adverse Event|2|||
126280062|NCT02728843|454316239|FG000|Overall Study|Lack of Efficacy|0|||
126280063|NCT02728843|454316240|FG001|Overall Study|Lack of Efficacy|1|||
126280064|NCT02728843|454316241|FG002|Overall Study|Lack of Efficacy|1|||
126280065|NCT02728843|454316242|FG003|Overall Study|Lack of Efficacy|0|||
126280066|NCT02728843|454316243|FG004|Overall Study|Lack of Efficacy|0|||
126280067|NCT02728843|454316239|FG000|Overall Study|Protocol Violation|2|||
126280068|NCT02728843|454316240|FG001|Overall Study|Protocol Violation|0|||
126280069|NCT02728843|454316241|FG002|Overall Study|Protocol Violation|4|||
126280070|NCT02728843|454316242|FG003|Overall Study|Protocol Violation|2|||
126280071|NCT02728843|454316243|FG004|Overall Study|Protocol Violation|2|||
126280072|NCT02728843|454316239|FG000|Overall Study|Withdrawal by Subject|1|||
126280073|NCT02728843|454316240|FG001|Overall Study|Withdrawal by Subject|0|||
126280074|NCT02728843|454316241|FG002|Overall Study|Withdrawal by Subject|0|||
126280075|NCT02728843|454316242|FG003|Overall Study|Withdrawal by Subject|1|||
126280076|NCT02728843|454316243|FG004|Overall Study|Withdrawal by Subject|0|||
126280077|NCT02728843|454316239|FG000|Overall Study|Use of rescue medication|0|||
126280078|NCT02728843|454316240|FG001|Overall Study|Use of rescue medication|2|||
126280079|NCT02728843|454316241|FG002|Overall Study|Use of rescue medication|0|||
126280080|NCT02728843|454316242|FG003|Overall Study|Use of rescue medication|2|||
126280081|NCT02728843|454316243|FG004|Overall Study|Use of rescue medication|1|||
126280082|NCT01806506|454316245|FG000|Overall Study|Lost to Follow-up|2|||
126280083|NCT01806506|454316246|FG001|Overall Study|Lost to Follow-up|1|||
126280084|NCT04844762|454316251|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280085|NCT04844762|454316252|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280086|NCT04844762|454316253|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
126280087|NCT04844762|454316254|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280088|NCT04844762|454316255|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280089|NCT04844762|454316256|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280090|NCT04844762|454316251|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
126280091|NCT04844762|454316252|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
126280092|NCT04844762|454316253|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
126280093|NCT04844762|454316254|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
126280094|NCT04844762|454316255|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
126280095|NCT04844762|454316256|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
126280096|NCT04844762|454316251|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280097|NCT04844762|454316252|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280098|NCT04844762|454316253|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280099|NCT04844762|454316254|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
126280100|NCT04844762|454316255|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280101|NCT04844762|454316256|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280102|NCT04844762|454316251|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126103482|NCT01691768|453672171|FG000|Overall Study|Death|0|||
126280103|NCT04844762|454316252|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280104|NCT04844762|454316253|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
126280105|NCT04844762|454316254|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
126280106|NCT04844762|454316255|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
126280107|NCT04844762|454316256|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280108|NCT04844762|454316251|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
126280109|NCT04844762|454316252|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
126280110|NCT04844762|454316253|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280111|NCT04844762|454316254|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280112|NCT04844762|454316255|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280113|NCT04844762|454316256|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280114|NCT04844762|454316251|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280115|NCT04844762|454316252|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280116|NCT04844762|454316253|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280117|NCT04844762|454316254|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280118|NCT04844762|454316255|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280119|NCT04844762|454316256|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280120|NCT04844762|454316251|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280121|NCT04844762|454316252|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280122|NCT04844762|454316253|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280123|NCT04844762|454316254|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280124|NCT04844762|454316255|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
126280125|NCT04844762|454316256|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280126|NCT04844762|454316251|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
126280127|NCT04844762|454316252|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280128|NCT04844762|454316253|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280129|NCT04844762|454316254|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280130|NCT04844762|454316255|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280131|NCT04844762|454316256|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280132|NCT04844762|454316251|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280133|NCT04844762|454316252|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280134|NCT04844762|454316253|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280135|NCT04844762|454316254|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280136|NCT04844762|454316255|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280137|NCT04844762|454316256|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280138|NCT04844762|454316251|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280139|NCT04844762|454316252|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
126280140|NCT04844762|454316253|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280141|NCT04844762|454316254|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280142|NCT04844762|454316255|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280143|NCT04844762|454316256|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280144|NCT04844762|454316251|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280145|NCT04844762|454316252|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280146|NCT04844762|454316253|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280147|NCT04844762|454316254|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
126280148|NCT04844762|454316255|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280149|NCT04844762|454316256|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280150|NCT00477633|454316257|FG000|Overall Study|Did not receive treatment|23|||
126280151|NCT00477633|454316257|FG000|Overall Study|Adverse Event|143|||
126280152|NCT00477633|454316257|FG000|Overall Study|Pregnancy|23|||
126280153|NCT00477633|454316257|FG000|Overall Study|Lost to Follow-up|271|||
126280154|NCT00477633|454316257|FG000|Overall Study|Withdrawal by Subject|149|||
126280155|NCT00477633|454316257|FG000|Overall Study|Protocol Violation|25|||
126280156|NCT00477633|454316257|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
126280157|NCT04123561|454316263|FG000|Overall Study|Lost to Follow-up|20|||
126280158|NCT04123561|454316264|FG001|Overall Study|Lost to Follow-up|12|||
126280159|NCT04123561|454316265|FG002|Overall Study|Lost to Follow-up|5|||
126280160|NCT04123561|454316263|FG000|Overall Study|Withdrawal by Subject|9|||
126280161|NCT04123561|454316264|FG001|Overall Study|Withdrawal by Subject|7|||
126280162|NCT04123561|454316265|FG002|Overall Study|Withdrawal by Subject|9|||
126280163|NCT04123561|454316263|FG000|Overall Study|Lack of Efficacy|7|||
126280164|NCT04123561|454316264|FG001|Overall Study|Lack of Efficacy|8|||
126280165|NCT04123561|454316265|FG002|Overall Study|Lack of Efficacy|6|||
126280166|NCT04123561|454316263|FG000|Overall Study|Adverse Event|5|||
126280167|NCT04123561|454316264|FG001|Overall Study|Adverse Event|2|||
126280168|NCT04123561|454316265|FG002|Overall Study|Adverse Event|3|||
126280169|NCT04123561|454316263|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
126280170|NCT04123561|454316264|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
126280171|NCT04123561|454316265|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
126280172|NCT04123561|454316263|FG000|Overall Study|Death|0|||
126280173|NCT04123561|454316264|FG001|Overall Study|Death|0|||
126280174|NCT04123561|454316265|FG002|Overall Study|Death|1|||
126280175|NCT04123561|454316263|FG000|Overall Study|Protocol Violation|0|||
126280176|NCT04123561|454316264|FG001|Overall Study|Protocol Violation|1|||
126280177|NCT04123561|454316265|FG002|Overall Study|Protocol Violation|0|||
126280178|NCT01374269|454316273|FG000|Overall Study|Withdrawal by Subject|4|||
126280179|NCT01374269|454316274|FG001|Overall Study|Withdrawal by Subject|0|||
126280180|NCT01374269|454316273|FG000|Overall Study|Lost to Follow-up|1|||
126280181|NCT01374269|454316274|FG001|Overall Study|Lost to Follow-up|3|||
126280182|NCT01374269|454316273|FG000|Overall Study|closed research|1|||
126280183|NCT01374269|454316274|FG001|Overall Study|closed research|2|||
126280184|NCT01987479|454316275|FG000|Overall Study|Protocol Violation|1|||
126280185|NCT01987479|454316275|FG000|Overall Study|Physician Decision|2|||
126280186|NCT01987479|454316275|FG000|Overall Study|Participant/legal guardian decision|1|||
126280187|NCT01987479|454316275|FG000|Overall Study|Other|5|||
126280188|NCT01987479|454316275|FG000|Overall Study|Lost to Follow-up|1|||
126280189|NCT01987479|454316275|FG000|Overall Study|Adverse Event|7|||
126280190|NCT00278889|454316276|FG000|Overall Study|Withdrawal by Subject|0|||
126280191|NCT00278889|454316277|FG001|Overall Study|Withdrawal by Subject|5|||
126280192|NCT00278889|454316278|FG002|Overall Study|Withdrawal by Subject|3|||
126280193|NCT00278889|454316276|FG000|Overall Study|Lost to Follow-up|1|||
126280194|NCT00278889|454316277|FG001|Overall Study|Lost to Follow-up|1|||
126280195|NCT00278889|454316278|FG002|Overall Study|Lost to Follow-up|0|||
126280196|NCT00278889|454316276|FG000|Overall Study|Death|24|||
126280197|NCT00278889|454316277|FG001|Overall Study|Death|21|||
126280198|NCT00278889|454316278|FG002|Overall Study|Death|17|||
126280199|NCT04998851|454318248|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
125882021|NCT02484391|452867067|FG000|Overall Study|Lost to Follow-up|0|||
125882022|NCT02484391|452867068|FG001|Overall Study|Lost to Follow-up|0|||
125882023|NCT02484391|452867069|FG002|Overall Study|Lost to Follow-up|2|||
125882024|NCT02484391|452867067|FG000|Overall Study|Physician Decision|1|||
125882025|NCT02484391|452867068|FG001|Overall Study|Physician Decision|3|||
125882026|NCT02484391|452867069|FG002|Overall Study|Physician Decision|0|||
125882027|NCT02484391|452867067|FG000|Overall Study|Went to Transplant|5|||
125882028|NCT02484391|452867068|FG001|Overall Study|Went to Transplant|3|||
125882029|NCT02484391|452867069|FG002|Overall Study|Went to Transplant|2|||
125882030|NCT00905164|452867072|FG000|Period 1|Protocol Violation|0|||
125882031|NCT00905164|452867073|FG001|Period 1|Protocol Violation|1|||
125882032|NCT04730804|452867078|FG000|Overall Study|Physician Decision|0|||
125882033|NCT04730804|452867079|FG001|Overall Study|Physician Decision|0|||
125882034|NCT04730804|452867080|FG002|Overall Study|Physician Decision|0|||
125882035|NCT04730804|452867081|FG003|Overall Study|Physician Decision|0|||
125882036|NCT04730804|452867082|FG004|Overall Study|Physician Decision|0|||
125882037|NCT04730804|452867083|FG005|Overall Study|Physician Decision|1|||
125882038|NCT04730804|452867078|FG000|Overall Study|Withdrawal by Subject|0|||
125882039|NCT04730804|452867079|FG001|Overall Study|Withdrawal by Subject|0|||
125882040|NCT04730804|452867080|FG002|Overall Study|Withdrawal by Subject|0|||
125882041|NCT04730804|452867081|FG003|Overall Study|Withdrawal by Subject|0|||
125882042|NCT04730804|452867082|FG004|Overall Study|Withdrawal by Subject|1|||
125882043|NCT04730804|452867083|FG005|Overall Study|Withdrawal by Subject|2|||
125882044|NCT05366738|452868933|FG000|Overall Study|Adverse Event|0|||
125882045|NCT05366738|452868934|FG001|Overall Study|Adverse Event|1|||
125882046|NCT05366738|452868935|FG002|Overall Study|Adverse Event|0|||
125882047|NCT01124006|452868936|FG000|Overall Study|Withdrawal by Subject|2|||
126039990|NCT03756662|453444993|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
126039991|NCT03295721|453445001|FG000|Overall Study|Adverse Event|1|||
126280200|NCT04998851|454318249|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
126280201|NCT04998851|454318248|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
125882048|NCT01124006|452868937|FG001|Overall Study|Withdrawal by Subject|2|||
125882049|NCT01124006|452868938|FG002|Overall Study|Withdrawal by Subject|0|||
125882050|NCT01124006|452868936|FG000|Overall Study|Lost to Follow-up|1|||
125882051|NCT01124006|452868937|FG001|Overall Study|Lost to Follow-up|0|||
125882052|NCT01124006|452868938|FG002|Overall Study|Lost to Follow-up|1|||
125882053|NCT01124006|452868936|FG000|Overall Study|Other|0|||
125882054|NCT01124006|452868937|FG001|Overall Study|Other|0|||
126039992|NCT03295721|453445002|FG001|Overall Study|Adverse Event|0|||
126280202|NCT04998851|454318249|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
126280203|NCT04933968|454318253|FG000|Overall Study|Adverse Event|0|||
125882055|NCT01124006|452868938|FG002|Overall Study|Other|1|||
126280204|NCT04933968|454318254|FG001|Overall Study|Adverse Event|0|||
126280205|NCT04933968|454318255|FG002|Overall Study|Adverse Event|1|||
126280206|NCT04933968|454318256|FG003|Overall Study|Adverse Event|1|||
126280207|NCT04933968|454318257|FG004|Overall Study|Adverse Event|0|||
125882056|NCT03841604|452868943|FG000|Overall Study|Withdrawal by Subject|3|||
125882057|NCT03841604|452868944|FG001|Overall Study|Withdrawal by Subject|1|||
125882058|NCT03841604|452868943|FG000|Overall Study|Adverse Event|4|||
125882059|NCT03841604|452868944|FG001|Overall Study|Adverse Event|2|||
125882060|NCT03841604|452868943|FG000|Overall Study|Physician Decision|1|||
125882061|NCT03841604|452868944|FG001|Overall Study|Physician Decision|0|||
125882062|NCT01417377|452868947|FG000|Overall Study|Lost to Follow-up|12|||
125882063|NCT01417377|452868947|FG000|Overall Study|Enrolled, but not treated|1|||
125882064|NCT02113982|452868948|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
125882065|NCT02113982|452868949|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
125882066|NCT02113982|452868950|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
125882067|NCT02113982|452868951|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
125882068|NCT02113982|452868952|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
125882069|NCT02113982|452868953|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
125882070|NCT02113982|452868954|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
125882071|NCT02113982|452868955|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
125882072|NCT02113982|452868956|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
125882073|NCT02113982|452868957|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
125882074|NCT02113982|452868958|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
125882075|NCT02113982|452868959|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
125882076|NCT02113982|452868960|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
125882077|NCT02113982|452868961|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
125882078|NCT02113982|452868948|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
125882079|NCT02113982|452868949|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
125882080|NCT02113982|452868950|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
125882081|NCT02113982|452868951|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
125882082|NCT02113982|452868952|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
125882083|NCT02113982|452868953|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
125882084|NCT02113982|452868954|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
125882085|NCT02113982|452868955|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
125882086|NCT02113982|452868956|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
125882087|NCT02113982|452868957|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
125882088|NCT02113982|452868958|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
125882089|NCT02113982|452868959|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
125882090|NCT02113982|452868960|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
126039993|NCT03295721|453445003|FG002|Overall Study|Adverse Event|0|||
126039994|NCT03295721|453445001|FG000|Overall Study|Lost to Follow-up|1|||
125882091|NCT02113982|452868961|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
125882092|NCT02113982|452868948|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882093|NCT02113982|452868949|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126039995|NCT03295721|453445002|FG001|Overall Study|Lost to Follow-up|1|||
126280208|NCT04933968|454318258|FG005|Overall Study|Adverse Event|0|||
126280209|NCT04933968|454318253|FG000|Overall Study|Lost to Follow-up|1|||
126280210|NCT04933968|454318254|FG001|Overall Study|Lost to Follow-up|0|||
126280211|NCT04933968|454318255|FG002|Overall Study|Lost to Follow-up|1|||
126280212|NCT04933968|454318256|FG003|Overall Study|Lost to Follow-up|0|||
126280213|NCT04933968|454318257|FG004|Overall Study|Lost to Follow-up|0|||
126280214|NCT04933968|454318258|FG005|Overall Study|Lost to Follow-up|0|||
126280215|NCT04933968|454318253|FG000|Overall Study|Randomized not treated|1|||
126280216|NCT04933968|454318254|FG001|Overall Study|Randomized not treated|0|||
126280217|NCT04933968|454318255|FG002|Overall Study|Randomized not treated|0|||
126280218|NCT04933968|454318256|FG003|Overall Study|Randomized not treated|0|||
126280219|NCT04933968|454318257|FG004|Overall Study|Randomized not treated|0|||
126280220|NCT04933968|454318258|FG005|Overall Study|Randomized not treated|0|||
126280221|NCT04933968|454318253|FG000|Overall Study|Sponsor terminated study|0|||
126280222|NCT04933968|454318254|FG001|Overall Study|Sponsor terminated study|0|||
126280223|NCT04933968|454318255|FG002|Overall Study|Sponsor terminated study|0|||
126280224|NCT04933968|454318256|FG003|Overall Study|Sponsor terminated study|1|||
126280225|NCT04933968|454318257|FG004|Overall Study|Sponsor terminated study|2|||
126280226|NCT04933968|454318258|FG005|Overall Study|Sponsor terminated study|0|||
126280227|NCT04933968|454318253|FG000|Overall Study|Other|0|||
126280228|NCT04933968|454318254|FG001|Overall Study|Other|0|||
126280229|NCT04933968|454318255|FG002|Overall Study|Other|0|||
126280230|NCT04933968|454318256|FG003|Overall Study|Other|1|||
126280231|NCT04933968|454318257|FG004|Overall Study|Other|0|||
126280232|NCT04933968|454318258|FG005|Overall Study|Other|0|||
126280233|NCT04933968|454318253|FG000|Overall Study|Missing|1|||
126280234|NCT04933968|454318254|FG001|Overall Study|Missing|3|||
126280235|NCT04933968|454318255|FG002|Overall Study|Missing|2|||
126280236|NCT04933968|454318256|FG003|Overall Study|Missing|1|||
126280237|NCT04933968|454318257|FG004|Overall Study|Missing|1|||
126280238|NCT04933968|454318258|FG005|Overall Study|Missing|0|||
126280239|NCT00509366|454318259|FG000|Overall Study|Not Treated (Screen Failure)|1|||
126280240|NCT00509366|454318260|FG001|Overall Study|Not Treated (Screen Failure)|1|||
126280241|NCT00509366|454318261|FG002|Overall Study|Not Treated (Screen Failure)|1|||
126280242|NCT00509366|454318262|FG003|Overall Study|Not Treated (Screen Failure)|0|||
126280243|NCT00509366|454318263|FG004|Overall Study|Not Treated (Screen Failure)|0|||
126280244|NCT02119819|454318264|FG000|Overall Study|Adverse Event|3|||
126280245|NCT02119819|454318265|FG001|Overall Study|Adverse Event|1|||
126280246|NCT02119819|454318266|FG002|Overall Study|Adverse Event|2|||
126280247|NCT02119819|454318267|FG003|Overall Study|Adverse Event|3|||
126280248|NCT02119819|454318268|FG004|Overall Study|Adverse Event|0|||
126280249|NCT02119819|454318269|FG005|Overall Study|Adverse Event|1|||
126280250|NCT02119819|454318264|FG000|Overall Study|Lack of Efficacy|0|||
126280251|NCT02119819|454318265|FG001|Overall Study|Lack of Efficacy|0|||
126280252|NCT02119819|454318266|FG002|Overall Study|Lack of Efficacy|0|||
126280253|NCT02119819|454318267|FG003|Overall Study|Lack of Efficacy|0|||
126280254|NCT02119819|454318268|FG004|Overall Study|Lack of Efficacy|0|||
126280255|NCT02119819|454318269|FG005|Overall Study|Lack of Efficacy|1|||
126280256|NCT02119819|454318264|FG000|Overall Study|Lost to Follow-up|0|||
126280257|NCT02119819|454318265|FG001|Overall Study|Lost to Follow-up|0|||
126280258|NCT02119819|454318266|FG002|Overall Study|Lost to Follow-up|1|||
126280259|NCT02119819|454318267|FG003|Overall Study|Lost to Follow-up|2|||
126280260|NCT02119819|454318268|FG004|Overall Study|Lost to Follow-up|1|||
126280261|NCT02119819|454318269|FG005|Overall Study|Lost to Follow-up|2|||
126280262|NCT02119819|454318264|FG000|Overall Study|Physician Decision|1|||
126280263|NCT02119819|454318265|FG001|Overall Study|Physician Decision|1|||
126280264|NCT02119819|454318266|FG002|Overall Study|Physician Decision|0|||
126280265|NCT02119819|454318267|FG003|Overall Study|Physician Decision|0|||
126280266|NCT02119819|454318268|FG004|Overall Study|Physician Decision|0|||
126280267|NCT02119819|454318269|FG005|Overall Study|Physician Decision|1|||
126280268|NCT02119819|454318264|FG000|Overall Study|Withdrawal by Subject|5|||
126280269|NCT02119819|454318265|FG001|Overall Study|Withdrawal by Subject|3|||
126280270|NCT02119819|454318266|FG002|Overall Study|Withdrawal by Subject|0|||
126280271|NCT02119819|454318267|FG003|Overall Study|Withdrawal by Subject|0|||
126280272|NCT02119819|454318268|FG004|Overall Study|Withdrawal by Subject|6|||
126280273|NCT02119819|454318269|FG005|Overall Study|Withdrawal by Subject|10|||
126280274|NCT02119819|454318264|FG000|Overall Study|Jury Duty|0|||
126280275|NCT02119819|454318265|FG001|Overall Study|Jury Duty|0|||
126280276|NCT02119819|454318266|FG002|Overall Study|Jury Duty|1|||
126280277|NCT02119819|454318267|FG003|Overall Study|Jury Duty|0|||
126280278|NCT02119819|454318268|FG004|Overall Study|Jury Duty|0|||
126280279|NCT02119819|454318269|FG005|Overall Study|Jury Duty|0|||
126280280|NCT02119819|454318264|FG000|Overall Study|Protocol Violation|0|||
126039996|NCT03295721|453445003|FG002|Overall Study|Lost to Follow-up|1|||
126039997|NCT03295721|453445001|FG000|Overall Study|Withdrawal by Subject|1|||
126039998|NCT03295721|453445002|FG001|Overall Study|Withdrawal by Subject|0|||
126039999|NCT03295721|453445003|FG002|Overall Study|Withdrawal by Subject|1|||
126040000|NCT03295721|453445001|FG000|Overall Study|Death|0|||
126040001|NCT03295721|453445002|FG001|Overall Study|Death|0|||
126040002|NCT03295721|453445003|FG002|Overall Study|Death|1|||
126040003|NCT05090683|453445008|FG000|Overall Study|Lost to Follow-up|10|||
126040004|NCT05090683|453445009|FG001|Overall Study|Lost to Follow-up|2|||
126280281|NCT02119819|454318265|FG001|Overall Study|Protocol Violation|0|||
126280282|NCT02119819|454318266|FG002|Overall Study|Protocol Violation|0|||
126280283|NCT02119819|454318267|FG003|Overall Study|Protocol Violation|1|||
126280284|NCT02119819|454318268|FG004|Overall Study|Protocol Violation|0|||
126040005|NCT05090683|453445008|FG000|Overall Study|Withdrawal by Subject|15|||
126040006|NCT05090683|453445009|FG001|Overall Study|Withdrawal by Subject|0|||
126040007|NCT03325985|453445010|FG000|Overall Study|Lost to Follow-up|122|||
126040008|NCT03325985|453445011|FG001|Overall Study|Lost to Follow-up|26|||
126040009|NCT03325985|453445012|FG002|Overall Study|Lost to Follow-up|141|||
126040010|NCT03325985|453445013|FG003|Overall Study|Lost to Follow-up|28|||
126040011|NCT03325985|453445010|FG000|Overall Study|Death|99|||
126040012|NCT03325985|453445011|FG001|Overall Study|Death|36|||
126040013|NCT03325985|453445012|FG002|Overall Study|Death|94|||
126040014|NCT03325985|453445013|FG003|Overall Study|Death|32|||
126040015|NCT02684227|453445015|FG000|Overall Study|Adverse Event|1|||
126040016|NCT02684227|453445016|FG001|Overall Study|Adverse Event|7|||
126040017|NCT02684227|453445015|FG000|Overall Study|Death|0|||
126040018|NCT02684227|453445016|FG001|Overall Study|Death|2|||
126040019|NCT02684227|453445015|FG000|Overall Study|Withdrawal by Subject|0|||
126040020|NCT02684227|453445016|FG001|Overall Study|Withdrawal by Subject|1|||
126040021|NCT02684227|453445015|FG000|Overall Study|Progressive Disease|0|||
126040022|NCT02684227|453445016|FG001|Overall Study|Progressive Disease|2|||
126040023|NCT03606408|453445017|FG000|Overall Study|Adverse Event|13|||
125882094|NCT02113982|452868950|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882095|NCT02113982|452868951|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882096|NCT02113982|452868952|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882097|NCT02113982|452868953|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882098|NCT02113982|452868954|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
125882099|NCT02113982|452868955|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882100|NCT02113982|452868956|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882101|NCT02113982|452868957|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882102|NCT02113982|452868958|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882103|NCT02113982|452868959|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882104|NCT02113982|452868960|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882105|NCT02113982|452868961|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125882106|NCT02113982|452868948|FG000|Stage 1: Dose Escalation|Transplant|0|||
126040024|NCT03606408|453445017|FG000|Overall Study|Withdrawal by Subject|7|||
126040025|NCT03606408|453445017|FG000|Overall Study|Physician Decision|4|||
126280285|NCT02119819|454318269|FG005|Overall Study|Protocol Violation|0|||
126280286|NCT02119819|454318264|FG000|Overall Study|Left the city to get a job|0|||
126280287|NCT02119819|454318265|FG001|Overall Study|Left the city to get a job|0|||
126280288|NCT02119819|454318266|FG002|Overall Study|Left the city to get a job|0|||
126280289|NCT02119819|454318267|FG003|Overall Study|Left the city to get a job|1|||
126280290|NCT02119819|454318268|FG004|Overall Study|Left the city to get a job|0|||
126280291|NCT02119819|454318269|FG005|Overall Study|Left the city to get a job|0|||
126280292|NCT02699684|454318270|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
126280293|NCT02699684|454318271|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
126280294|NCT01145508|454318272|FG000|Overall Study|Adverse Event|1|||
125882107|NCT02113982|452868949|FG001|Stage 1: Dose Escalation|Transplant|1|||
125882108|NCT02113982|452868950|FG002|Stage 1: Dose Escalation|Transplant|0|||
125882109|NCT02113982|452868951|FG003|Stage 1: Dose Escalation|Transplant|0|||
126040026|NCT03606408|453445017|FG000|Overall Study|Lack of Efficacy|2|||
126280295|NCT01145508|454318273|FG001|Overall Study|Adverse Event|0|||
126280296|NCT01145508|454318272|FG000|Overall Study|Death|1|||
126280297|NCT01145508|454318273|FG001|Overall Study|Death|0|||
125882110|NCT02113982|452868952|FG004|Stage 1: Dose Escalation|Transplant|0|||
125882111|NCT02113982|452868953|FG005|Stage 1: Dose Escalation|Transplant|1|||
126040027|NCT03606408|453445017|FG000|Overall Study|Death|1|||
126040028|NCT03606408|453445017|FG000|Overall Study|new therapy for study indication|1|||
126040029|NCT03556293|453445018|FG000|Overall Study|Ineligible for analysis|1904|||
126040030|NCT03556293|453445019|FG001|Overall Study|Ineligible for analysis|1471|||
126040031|NCT03556293|453445020|FG002|Overall Study|Ineligible for analysis|1091|||
126280298|NCT01145508|454318272|FG000|Overall Study|Physician Decision|2|||
126040032|NCT03556293|453445021|FG003|Overall Study|Ineligible for analysis|1269|||
126040033|NCT05828017|453445022|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
126280299|NCT01145508|454318273|FG001|Overall Study|Physician Decision|1|||
125882112|NCT02113982|452868954|FG006|Stage 1: Dose Escalation|Transplant|0|||
126280300|NCT01145508|454318272|FG000|Overall Study|Never started treatment|1|||
126280301|NCT01145508|454318273|FG001|Overall Study|Never started treatment|1|||
126280302|NCT04839692|454318274|FG000|Overall Study|Withdrawal by Subject|0|||
126280303|NCT04839692|454318275|FG001|Overall Study|Withdrawal by Subject|3|||
126280304|NCT04839692|454318274|FG000|Overall Study|Physician Decision|1|||
126280305|NCT04839692|454318275|FG001|Overall Study|Physician Decision|0|||
126280306|NCT03146962|454318276|FG000|Overall Study|Lost to Follow-up|1|||
126280307|NCT03146962|454318277|FG001|Overall Study|Lost to Follow-up|1|||
126280308|NCT03146962|454318278|FG002|Overall Study|Lost to Follow-up|0|||
126280309|NCT03146962|454318279|FG003|Overall Study|Lost to Follow-up|0|||
126280310|NCT03146962|454318280|FG004|Overall Study|Lost to Follow-up|0|||
126280311|NCT03146962|454318281|FG005|Overall Study|Lost to Follow-up|0|||
126280312|NCT03146962|454318282|FG006|Overall Study|Lost to Follow-up|0|||
126280313|NCT03146962|454318283|FG007|Overall Study|Lost to Follow-up|0|||
126280314|NCT03146962|454318284|FG008|Overall Study|Lost to Follow-up|0|||
126280315|NCT03146962|454318285|FG009|Overall Study|Lost to Follow-up|0|||
126280316|NCT03146962|454318276|FG000|Overall Study|Adverse Event|0|||
126280317|NCT03146962|454318277|FG001|Overall Study|Adverse Event|3|||
126280318|NCT03146962|454318278|FG002|Overall Study|Adverse Event|0|||
126280319|NCT03146962|454318279|FG003|Overall Study|Adverse Event|0|||
126280320|NCT03146962|454318280|FG004|Overall Study|Adverse Event|0|||
126280321|NCT03146962|454318281|FG005|Overall Study|Adverse Event|0|||
126280322|NCT03146962|454318282|FG006|Overall Study|Adverse Event|0|||
126280323|NCT03146962|454318283|FG007|Overall Study|Adverse Event|1|||
126280324|NCT03146962|454318284|FG008|Overall Study|Adverse Event|0|||
126280325|NCT03146962|454318285|FG009|Overall Study|Adverse Event|0|||
126280326|NCT03146962|454318276|FG000|Overall Study|Withdrawal by Subject|0|||
126040034|NCT04294641|453447109|FG000|Overall Study|Screen failure|4|||
126040035|NCT03308877|453447110|FG000|Overall Study|Lost to Follow-up|32|||
126040036|NCT03308877|453447111|FG001|Overall Study|Lost to Follow-up|28|||
126040037|NCT04359654|453447120|FG000|Overall Study|Withdrawal by Subject|1|||
126040038|NCT04359654|453447121|FG001|Overall Study|Withdrawal by Subject|0|||
126040039|NCT04359654|453447120|FG000|Overall Study|Adverse Event|0|||
126040040|NCT04359654|453447121|FG001|Overall Study|Adverse Event|1|||
126040041|NCT04024020|453447124|FG000|Overall Study|Withdrawal by Subject|2|||
126040042|NCT04024020|453447125|FG001|Overall Study|Withdrawal by Subject|2|||
126040043|NCT05646355|453447126|FG000|Overall Study|Lost to Follow-up|1|||
126040044|NCT05646355|453447127|FG001|Overall Study|Lost to Follow-up|0|||
126040045|NCT05646355|453447126|FG000|Overall Study|translated materials not available for pilot|2|||
126040046|NCT05646355|453447127|FG001|Overall Study|translated materials not available for pilot|0|||
126040047|NCT05646355|453447126|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
126040048|NCT05646355|453447127|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
126040049|NCT03523572|453447130|FG000|Dose Escalation|Progressive disease|1|||
126040050|NCT03523572|453447131|FG001|Dose Escalation|Progressive disease|0|||
126040051|NCT03523572|453447132|FG002|Dose Escalation|Progressive disease|0|||
126040052|NCT03523572|453447133|FG003|Dose Escalation|Progressive disease|0|||
126040053|NCT03523572|453447134|FG004|Dose Escalation|Progressive disease|0|||
126040054|NCT03523572|453447135|FG005|Dose Escalation|Progressive disease|0|||
126040055|NCT03523572|453447130|FG000|Dose Escalation|Clinical Progression|0|||
126040056|NCT03523572|453447131|FG001|Dose Escalation|Clinical Progression|1|||
126040057|NCT03523572|453447132|FG002|Dose Escalation|Clinical Progression|0|||
126040058|NCT03523572|453447133|FG003|Dose Escalation|Clinical Progression|0|||
126040059|NCT03523572|453447134|FG004|Dose Escalation|Clinical Progression|0|||
126040060|NCT03523572|453447135|FG005|Dose Escalation|Clinical Progression|0|||
126040061|NCT03523572|453447130|FG000|Dose Escalation|Adverse Event|2|||
126040062|NCT03523572|453447131|FG001|Dose Escalation|Adverse Event|0|||
126040063|NCT03523572|453447132|FG002|Dose Escalation|Adverse Event|0|||
126040064|NCT03523572|453447133|FG003|Dose Escalation|Adverse Event|0|||
126040065|NCT03523572|453447134|FG004|Dose Escalation|Adverse Event|0|||
126040066|NCT03523572|453447135|FG005|Dose Escalation|Adverse Event|0|||
126040067|NCT03523572|453447130|FG000|Dose Escalation|Physician Decision|1|||
126040068|NCT03523572|453447131|FG001|Dose Escalation|Physician Decision|1|||
126040069|NCT03523572|453447132|FG002|Dose Escalation|Physician Decision|0|||
126040070|NCT03523572|453447133|FG003|Dose Escalation|Physician Decision|0|||
126040071|NCT03523572|453447134|FG004|Dose Escalation|Physician Decision|0|||
126040072|NCT03523572|453447135|FG005|Dose Escalation|Physician Decision|0|||
126040073|NCT03523572|453447130|FG000|Dose Expansion|Progressive Disease|0|||
126040074|NCT03523572|453447131|FG001|Dose Expansion|Progressive Disease|0|||
126040075|NCT03523572|453447132|FG002|Dose Expansion|Progressive Disease|9|||
126040076|NCT03523572|453447133|FG003|Dose Expansion|Progressive Disease|11|||
126040077|NCT03523572|453447134|FG004|Dose Expansion|Progressive Disease|15|||
126040078|NCT03523572|453447135|FG005|Dose Expansion|Progressive Disease|2|||
126040079|NCT03523572|453447130|FG000|Dose Expansion|Clinical Progression|0|||
126040080|NCT03523572|453447131|FG001|Dose Expansion|Clinical Progression|0|||
126280327|NCT03146962|454318277|FG001|Overall Study|Withdrawal by Subject|0|||
126280328|NCT03146962|454318278|FG002|Overall Study|Withdrawal by Subject|0|||
126280329|NCT03146962|454318279|FG003|Overall Study|Withdrawal by Subject|0|||
126280330|NCT03146962|454318280|FG004|Overall Study|Withdrawal by Subject|1|||
126280331|NCT03146962|454318281|FG005|Overall Study|Withdrawal by Subject|0|||
126280332|NCT03146962|454318282|FG006|Overall Study|Withdrawal by Subject|0|||
126280333|NCT03146962|454318283|FG007|Overall Study|Withdrawal by Subject|0|||
126280334|NCT03146962|454318284|FG008|Overall Study|Withdrawal by Subject|0|||
126280335|NCT03146962|454318285|FG009|Overall Study|Withdrawal by Subject|0|||
126280336|NCT03146962|454318276|FG000|Overall Study|Death|0|||
126280337|NCT03146962|454318277|FG001|Overall Study|Death|1|||
126280338|NCT03146962|454318278|FG002|Overall Study|Death|0|||
126280339|NCT03146962|454318279|FG003|Overall Study|Death|0|||
126280340|NCT03146962|454318280|FG004|Overall Study|Death|0|||
126363765|NCT01646216|454624940|FG000|Overall Study|Did not complete training|0|||
126040081|NCT03523572|453447132|FG002|Dose Expansion|Clinical Progression|2|||
126040082|NCT03523572|453447133|FG003|Dose Expansion|Clinical Progression|2|||
126363766|NCT01646216|454624941|FG001|Overall Study|Did not complete training|2|||
126040083|NCT03523572|453447134|FG004|Dose Expansion|Clinical Progression|2|||
126040084|NCT03523572|453447135|FG005|Dose Expansion|Clinical Progression|0|||
126040085|NCT03523572|453447130|FG000|Dose Expansion|Adverse Event|0|||
126040086|NCT03523572|453447131|FG001|Dose Expansion|Adverse Event|0|||
126040087|NCT03523572|453447132|FG002|Dose Expansion|Adverse Event|10|||
126040088|NCT03523572|453447133|FG003|Dose Expansion|Adverse Event|1|||
126040089|NCT03523572|453447134|FG004|Dose Expansion|Adverse Event|5|||
126280341|NCT03146962|454318281|FG005|Overall Study|Death|0|||
126280342|NCT03146962|454318282|FG006|Overall Study|Death|0|||
126280343|NCT03146962|454318283|FG007|Overall Study|Death|0|||
126280344|NCT03146962|454318284|FG008|Overall Study|Death|0|||
126280345|NCT03146962|454318285|FG009|Overall Study|Death|0|||
125882113|NCT02113982|452868955|FG007|Stage 1: Dose Escalation|Transplant|0|||
125882114|NCT02113982|452868956|FG008|Stage 1: Dose Escalation|Transplant|0|||
125882115|NCT02113982|452868957|FG009|Stage 1: Dose Escalation|Transplant|0|||
125882116|NCT02113982|452868958|FG010|Stage 1: Dose Escalation|Transplant|0|||
125882117|NCT02113982|452868959|FG011|Stage 1: Dose Escalation|Transplant|0|||
125882118|NCT02113982|452868960|FG012|Stage 1: Dose Escalation|Transplant|0|||
125882119|NCT02113982|452868961|FG013|Stage 1: Dose Escalation|Transplant|0|||
125882120|NCT02113982|452868948|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
125882121|NCT02113982|452868949|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
125882122|NCT02113982|452868950|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
125882123|NCT02113982|452868951|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
125882124|NCT02113982|452868952|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
125882125|NCT02113982|452868953|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
125882126|NCT02113982|452868954|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
125882127|NCT02113982|452868955|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
125882128|NCT02113982|452868956|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
125882129|NCT02113982|452868957|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
125882130|NCT02113982|452868958|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
125882131|NCT02113982|452868959|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
125882132|NCT02113982|452868960|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
125882133|NCT02113982|452868961|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
125882134|NCT02113982|452868948|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
125882135|NCT02113982|452868949|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
125882136|NCT02113982|452868950|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
125882137|NCT02113982|452868951|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
125882138|NCT02113982|452868952|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
125882139|NCT02113982|452868953|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
125882140|NCT02113982|452868954|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
125882141|NCT02113982|452868955|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
125882142|NCT02113982|452868956|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
125882143|NCT02113982|452868957|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
125882144|NCT02113982|452868958|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
125882145|NCT02113982|452868959|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
125882146|NCT02113982|452868960|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
125882147|NCT02113982|452868961|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
125882148|NCT02113982|452868948|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
125882149|NCT02113982|452868949|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
125882150|NCT02113982|452868950|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
125882151|NCT02113982|452868951|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
125882152|NCT02113982|452868952|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
126040090|NCT03523572|453447135|FG005|Dose Expansion|Adverse Event|2|||
126040091|NCT03523572|453447130|FG000|Dose Expansion|Withdrawal by Subject|0|||
126040092|NCT03523572|453447131|FG001|Dose Expansion|Withdrawal by Subject|0|||
126040093|NCT03523572|453447132|FG002|Dose Expansion|Withdrawal by Subject|1|||
126280346|NCT03146962|454318276|FG000|Overall Study|COVID Precautions|1|||
126280347|NCT03146962|454318277|FG001|Overall Study|COVID Precautions|0|||
126280348|NCT03146962|454318278|FG002|Overall Study|COVID Precautions|0|||
126280349|NCT03146962|454318279|FG003|Overall Study|COVID Precautions|0|||
126280350|NCT03146962|454318280|FG004|Overall Study|COVID Precautions|0|||
126280351|NCT03146962|454318281|FG005|Overall Study|COVID Precautions|0|||
126280352|NCT03146962|454318282|FG006|Overall Study|COVID Precautions|0|||
126280353|NCT03146962|454318283|FG007|Overall Study|COVID Precautions|0|||
126280354|NCT03146962|454318284|FG008|Overall Study|COVID Precautions|0|||
126280355|NCT03146962|454318285|FG009|Overall Study|COVID Precautions|0|||
126280356|NCT03146962|454318276|FG000|Overall Study|Physician Decision|0|||
126280357|NCT03146962|454318277|FG001|Overall Study|Physician Decision|0|||
126280358|NCT03146962|454318278|FG002|Overall Study|Physician Decision|0|||
126280359|NCT03146962|454318279|FG003|Overall Study|Physician Decision|0|||
126280360|NCT03146962|454318280|FG004|Overall Study|Physician Decision|0|||
126280361|NCT03146962|454318281|FG005|Overall Study|Physician Decision|0|||
126280362|NCT03146962|454318282|FG006|Overall Study|Physician Decision|0|||
126280363|NCT03146962|454318283|FG007|Overall Study|Physician Decision|0|||
126280364|NCT03146962|454318284|FG008|Overall Study|Physician Decision|0|||
126280365|NCT03146962|454318285|FG009|Overall Study|Physician Decision|1|||
126280366|NCT03146962|454318276|FG000|Overall Study|Started New Treatment|0|||
126280367|NCT03146962|454318277|FG001|Overall Study|Started New Treatment|1|||
126280368|NCT03146962|454318278|FG002|Overall Study|Started New Treatment|0|||
126280369|NCT03146962|454318279|FG003|Overall Study|Started New Treatment|0|||
125882153|NCT02113982|452868953|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
125882154|NCT02113982|452868954|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
125882155|NCT02113982|452868955|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
126040094|NCT03523572|453447133|FG003|Dose Expansion|Withdrawal by Subject|1|||
126280370|NCT03146962|454318280|FG004|Overall Study|Started New Treatment|0|||
126280371|NCT03146962|454318281|FG005|Overall Study|Started New Treatment|0|||
126280372|NCT03146962|454318282|FG006|Overall Study|Started New Treatment|0|||
126280373|NCT03146962|454318283|FG007|Overall Study|Started New Treatment|0|||
126280374|NCT03146962|454318284|FG008|Overall Study|Started New Treatment|0|||
126280375|NCT03146962|454318285|FG009|Overall Study|Started New Treatment|0|||
126280376|NCT00264550|454318286|FG000|Overall Study|Death|0|||
126280377|NCT00264550|454318287|FG001|Overall Study|Death|3|||
126280378|NCT00264550|454318288|FG002|Overall Study|Death|0|||
126280379|NCT00264550|454318289|FG003|Overall Study|Death|0|||
126280380|NCT00264550|454318286|FG000|Overall Study|Lost to Follow-up|3|||
126280381|NCT00264550|454318287|FG001|Overall Study|Lost to Follow-up|1|||
126280382|NCT00264550|454318288|FG002|Overall Study|Lost to Follow-up|1|||
126280383|NCT00264550|454318289|FG003|Overall Study|Lost to Follow-up|1|||
126363767|NCT01646216|454624940|FG000|Overall Study|Investigator decision|1|||
126363768|NCT01646216|454624941|FG001|Overall Study|Investigator decision|1|||
126363769|NCT02633527|454624942|FG000|Overall Study|Failed to meet eligibility|0|||
126363770|NCT02633527|454624943|FG001|Overall Study|Failed to meet eligibility|1|||
126363771|NCT02633527|454624944|FG002|Overall Study|Failed to meet eligibility|1|||
126363772|NCT02633527|454624945|FG003|Overall Study|Failed to meet eligibility|0|||
126363773|NCT02633527|454624946|FG004|Overall Study|Failed to meet eligibility|1|||
126363774|NCT02633527|454624942|FG000|Overall Study|Adverse Event|0|||
126363775|NCT02633527|454624943|FG001|Overall Study|Adverse Event|4|||
126363776|NCT02633527|454624944|FG002|Overall Study|Adverse Event|3|||
126363777|NCT02633527|454624945|FG003|Overall Study|Adverse Event|1|||
126363778|NCT02633527|454624946|FG004|Overall Study|Adverse Event|5|||
126363779|NCT02633527|454624942|FG000|Overall Study|Lost to Follow-up|1|||
126363780|NCT02633527|454624943|FG001|Overall Study|Lost to Follow-up|2|||
126363781|NCT02633527|454624944|FG002|Overall Study|Lost to Follow-up|5|||
126363782|NCT02633527|454624945|FG003|Overall Study|Lost to Follow-up|5|||
126363783|NCT02633527|454624946|FG004|Overall Study|Lost to Follow-up|4|||
126363784|NCT02633527|454624942|FG000|Overall Study|Withdrawal by Subject|0|||
126363785|NCT02633527|454624943|FG001|Overall Study|Withdrawal by Subject|3|||
126363786|NCT02633527|454624944|FG002|Overall Study|Withdrawal by Subject|5|||
126363787|NCT02633527|454624945|FG003|Overall Study|Withdrawal by Subject|4|||
126363788|NCT02633527|454624946|FG004|Overall Study|Withdrawal by Subject|4|||
126363789|NCT02633527|454624942|FG000|Overall Study|Protocol Violation|0|||
126363790|NCT02633527|454624943|FG001|Overall Study|Protocol Violation|1|||
126363791|NCT02633527|454624944|FG002|Overall Study|Protocol Violation|1|||
126363792|NCT02633527|454624945|FG003|Overall Study|Protocol Violation|1|||
126363793|NCT02633527|454624946|FG004|Overall Study|Protocol Violation|1|||
126363794|NCT02633527|454624942|FG000|Overall Study|Physician Decision|0|||
126363795|NCT02633527|454624943|FG001|Overall Study|Physician Decision|0|||
126363796|NCT02633527|454624944|FG002|Overall Study|Physician Decision|0|||
126363797|NCT02633527|454624945|FG003|Overall Study|Physician Decision|0|||
126363798|NCT02633527|454624946|FG004|Overall Study|Physician Decision|1|||
126363799|NCT02633527|454624942|FG000|Overall Study|Administrative reason|1|||
126363800|NCT02633527|454624943|FG001|Overall Study|Administrative reason|0|||
126363801|NCT02633527|454624944|FG002|Overall Study|Administrative reason|0|||
126363802|NCT02633527|454624945|FG003|Overall Study|Administrative reason|1|||
126363803|NCT02633527|454624946|FG004|Overall Study|Administrative reason|0|||
126363804|NCT02633527|454624942|FG000|Overall Study|Multiple reasons|1|||
126363805|NCT02633527|454624943|FG001|Overall Study|Multiple reasons|0|||
126363806|NCT02633527|454624944|FG002|Overall Study|Multiple reasons|2|||
126363807|NCT02633527|454624945|FG003|Overall Study|Multiple reasons|2|||
126363808|NCT02633527|454624946|FG004|Overall Study|Multiple reasons|1|||
126363809|NCT01681849|454624949|FG000|Overall Study|Protocol Violation|2|||
126363810|NCT01681849|454624950|FG001|Overall Study|Protocol Violation|0|||
126363811|NCT01681849|454624951|FG002|Overall Study|Protocol Violation|0|||
126363812|NCT01681849|454624949|FG000|Overall Study|Withdrawal by Subject|3|||
126363813|NCT01681849|454624950|FG001|Overall Study|Withdrawal by Subject|5|||
126363814|NCT01681849|454624951|FG002|Overall Study|Withdrawal by Subject|33|||
126363815|NCT01681849|454624949|FG000|Overall Study|Lost to Follow-up|3|||
126363816|NCT01681849|454624950|FG001|Overall Study|Lost to Follow-up|2|||
126363817|NCT01681849|454624951|FG002|Overall Study|Lost to Follow-up|6|||
126363818|NCT02420314|454624954|FG000|Overall Study|Withdrawal by Subject|1|||
126280384|NCT00264550|454318286|FG000|Overall Study|Adverse Event|23|||
126363819|NCT02420314|454624954|FG000|Overall Study|Protocol Violation|1|||
126363820|NCT03760068|454624955|FG000|Overall Study|Withdrawal by Subject|7|||
126363821|NCT03760068|454624956|FG001|Overall Study|Withdrawal by Subject|8|||
126363822|NCT03760068|454624955|FG000|Overall Study|Adverse Event|1|||
126363823|NCT03760068|454624956|FG001|Overall Study|Adverse Event|2|||
126363824|NCT03760068|454624955|FG000|Overall Study|Administrative Decision by Sponsor|0|||
126363825|NCT03760068|454624956|FG001|Overall Study|Administrative Decision by Sponsor|2|||
126363826|NCT03760068|454624955|FG000|Overall Study|Physician Decision|1|||
126363827|NCT03760068|454624956|FG001|Overall Study|Physician Decision|2|||
126280385|NCT00264550|454318287|FG001|Overall Study|Adverse Event|18|||
126280386|NCT00264550|454318288|FG002|Overall Study|Adverse Event|9|||
126280387|NCT00264550|454318289|FG003|Overall Study|Adverse Event|14|||
126363828|NCT03760068|454624955|FG000|Overall Study|Lost to Follow-up|4|||
126363829|NCT03760068|454624956|FG001|Overall Study|Lost to Follow-up|9|||
126363830|NCT03760068|454624955|FG000|Overall Study|Subject Moved Out of State|1|||
126363831|NCT03760068|454624956|FG001|Overall Study|Subject Moved Out of State|0|||
126040095|NCT03523572|453447134|FG004|Dose Expansion|Withdrawal by Subject|0|||
126040096|NCT03523572|453447135|FG005|Dose Expansion|Withdrawal by Subject|0|||
126040097|NCT03523572|453447130|FG000|Dose Expansion|Physician Decision|0|||
126040098|NCT03523572|453447131|FG001|Dose Expansion|Physician Decision|0|||
126098940|NCT00603304|453655574|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
126098941|NCT00603304|453655573|FG000|Overall Study|Exclusionary Medication|2|||
126098942|NCT00603304|453655574|FG001|Overall Study|Exclusionary Medication|3|||
126098943|NCT00603304|453655573|FG000|Overall Study|Non-Compliant|0|||
126040099|NCT03523572|453447132|FG002|Dose Expansion|Physician Decision|1|||
126040100|NCT03523572|453447133|FG003|Dose Expansion|Physician Decision|0|||
126040101|NCT03523572|453447134|FG004|Dose Expansion|Physician Decision|1|||
126040102|NCT03523572|453447135|FG005|Dose Expansion|Physician Decision|0|||
126040103|NCT03523572|453447130|FG000|Dose Expansion|Miscellaneous|0|||
126040104|NCT03523572|453447131|FG001|Dose Expansion|Miscellaneous|0|||
126040105|NCT03523572|453447132|FG002|Dose Expansion|Miscellaneous|0|||
126040106|NCT03523572|453447133|FG003|Dose Expansion|Miscellaneous|0|||
126040107|NCT03523572|453447134|FG004|Dose Expansion|Miscellaneous|3|||
126040108|NCT03523572|453447135|FG005|Dose Expansion|Miscellaneous|0|||
126040109|NCT05269966|453447136|FG000|Overall Study|Adverse Event|4|||
126040110|NCT05269966|453447136|FG000|Overall Study|Withdrawal by Subject|1|||
126040111|NCT05269966|453447136|FG000|Overall Study|Lost to Follow-up|4|||
126040112|NCT05269966|453447136|FG000|Overall Study|Physician Decision|1|||
126040113|NCT03519178|453447152|FG000|PF-06873600 Treatment|Adverse Event|0|||
126040114|NCT03519178|453447153|FG001|PF-06873600 Treatment|Adverse Event|0|||
126040115|NCT03519178|453447154|FG002|PF-06873600 Treatment|Adverse Event|0|||
126040116|NCT03519178|453447155|FG003|PF-06873600 Treatment|Adverse Event|0|||
126040117|NCT03519178|453447156|FG004|PF-06873600 Treatment|Adverse Event|0|||
126040118|NCT03519178|453447157|FG005|PF-06873600 Treatment|Adverse Event|0|||
126040119|NCT03519178|453447158|FG006|PF-06873600 Treatment|Adverse Event|0|||
126040120|NCT03519178|453447159|FG007|PF-06873600 Treatment|Adverse Event|2|||
126040121|NCT03519178|453447160|FG008|PF-06873600 Treatment|Adverse Event|1|||
126040122|NCT03519178|453447161|FG009|PF-06873600 Treatment|Adverse Event|0|||
126040123|NCT03519178|453447162|FG010|PF-06873600 Treatment|Adverse Event|0|||
126040124|NCT03519178|453447163|FG011|PF-06873600 Treatment|Adverse Event|0|||
126040125|NCT03519178|453447164|FG012|PF-06873600 Treatment|Adverse Event|1|||
126040126|NCT03519178|453447165|FG013|PF-06873600 Treatment|Adverse Event|3|||
126040127|NCT03519178|453447166|FG014|PF-06873600 Treatment|Adverse Event|2|||
126040128|NCT03519178|453447152|FG000|PF-06873600 Treatment|Death|0|||
126040129|NCT03519178|453447153|FG001|PF-06873600 Treatment|Death|0|||
126040130|NCT03519178|453447154|FG002|PF-06873600 Treatment|Death|0|||
126040131|NCT03519178|453447155|FG003|PF-06873600 Treatment|Death|0|||
126040132|NCT03519178|453447156|FG004|PF-06873600 Treatment|Death|0|||
126040133|NCT03519178|453447157|FG005|PF-06873600 Treatment|Death|0|||
126040134|NCT03519178|453447158|FG006|PF-06873600 Treatment|Death|0|||
126040135|NCT03519178|453447159|FG007|PF-06873600 Treatment|Death|0|||
126040136|NCT03519178|453447160|FG008|PF-06873600 Treatment|Death|1|||
126040137|NCT03519178|453447161|FG009|PF-06873600 Treatment|Death|1|||
126040138|NCT03519178|453447162|FG010|PF-06873600 Treatment|Death|0|||
126040139|NCT03519178|453447163|FG011|PF-06873600 Treatment|Death|0|||
126040140|NCT03519178|453447164|FG012|PF-06873600 Treatment|Death|0|||
126040141|NCT03519178|453447165|FG013|PF-06873600 Treatment|Death|0|||
126040142|NCT03519178|453447166|FG014|PF-06873600 Treatment|Death|1|||
126040143|NCT03519178|453447152|FG000|PF-06873600 Treatment|Physician Decision|0|||
126040144|NCT03519178|453447153|FG001|PF-06873600 Treatment|Physician Decision|0|||
126040145|NCT03519178|453447154|FG002|PF-06873600 Treatment|Physician Decision|0|||
126040146|NCT03519178|453447155|FG003|PF-06873600 Treatment|Physician Decision|0|||
126040147|NCT03519178|453447156|FG004|PF-06873600 Treatment|Physician Decision|0|||
126040148|NCT03519178|453447157|FG005|PF-06873600 Treatment|Physician Decision|0|||
126098944|NCT00603304|453655574|FG001|Overall Study|Non-Compliant|1|||
126098945|NCT00603304|453655573|FG000|Overall Study|Moved Away|0|||
126098946|NCT00603304|453655574|FG001|Overall Study|Moved Away|2|||
126098947|NCT00603304|453655573|FG000|Overall Study|Other|2|||
126098948|NCT00603304|453655574|FG001|Overall Study|Other|0|||
126098949|NCT00603304|453655573|FG000|Overall Study|Patient Decision|2|||
126280388|NCT00264550|454318286|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126280389|NCT00264550|454318287|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
126280390|NCT00264550|454318288|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
126040149|NCT03519178|453447158|FG006|PF-06873600 Treatment|Physician Decision|0|||
126040150|NCT03519178|453447159|FG007|PF-06873600 Treatment|Physician Decision|1|||
126040151|NCT03519178|453447160|FG008|PF-06873600 Treatment|Physician Decision|0|||
126040152|NCT03519178|453447161|FG009|PF-06873600 Treatment|Physician Decision|0|||
126040153|NCT03519178|453447162|FG010|PF-06873600 Treatment|Physician Decision|1|||
126098950|NCT00603304|453655574|FG001|Overall Study|Patient Decision|0|||
126098951|NCT04343872|453655575|FG000|Overall Study|Lost to Follow-up|6|||
126040154|NCT03519178|453447163|FG011|PF-06873600 Treatment|Physician Decision|0|||
126040155|NCT03519178|453447164|FG012|PF-06873600 Treatment|Physician Decision|0|||
126040156|NCT03519178|453447165|FG013|PF-06873600 Treatment|Physician Decision|4|||
126280391|NCT00264550|454318289|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
126363832|NCT03460704|454624960|FG000|Overall Study|Withdrawal by Subject|11|||
126363833|NCT03460704|454624961|FG001|Overall Study|Withdrawal by Subject|14|||
126363834|NCT03460704|454624960|FG000|Overall Study|Study terminated by the Sponsor|29|||
126363835|NCT03460704|454624961|FG001|Overall Study|Study terminated by the Sponsor|19|||
126363836|NCT03460704|454624960|FG000|Overall Study|Adverse Event|10|||
126363837|NCT03460704|454624961|FG001|Overall Study|Adverse Event|5|||
126363838|NCT03460704|454624960|FG000|Overall Study|Death|3|||
126363839|NCT03460704|454624961|FG001|Overall Study|Death|2|||
126363840|NCT03460704|454624960|FG000|Overall Study|Non-Compliance with Study Drug|3|||
126363841|NCT03460704|454624961|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126363842|NCT03460704|454624960|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126363843|NCT03460704|454624961|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
126363844|NCT03460704|454624960|FG000|Overall Study|Other|2|||
126363845|NCT03460704|454624961|FG001|Overall Study|Other|1|||
126363846|NCT02913326|454624966|FG000|Overall Study|Reason not listed|0|||
126363847|NCT02913326|454624967|FG001|Overall Study|Reason not listed|1|||
126363848|NCT02913326|454624966|FG000|Overall Study|Lost to Follow-up|0|||
126363849|NCT02913326|454624967|FG001|Overall Study|Lost to Follow-up|1|||
126363850|NCT02913326|454624966|FG000|Overall Study|Adverse Event|1|||
126363851|NCT02913326|454624967|FG001|Overall Study|Adverse Event|0|||
126363852|NCT01767857|454624968|FG000|Overall Study|Adverse Event|27|||
126363853|NCT01767857|454624969|FG001|Overall Study|Adverse Event|7|||
126363854|NCT01767857|454624968|FG000|Overall Study|Death|28|||
126363855|NCT01767857|454624969|FG001|Overall Study|Death|13|||
126363856|NCT01767857|454624968|FG000|Overall Study|Lack of Efficacy|299|||
125882156|NCT02113982|452868956|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
125882157|NCT02113982|452868957|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
125882158|NCT02113982|452868958|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
125882159|NCT02113982|452868959|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
126363857|NCT01767857|454624969|FG001|Overall Study|Lack of Efficacy|151|||
126363858|NCT01767857|454624968|FG000|Overall Study|Lost to Follow-up|1|||
125882160|NCT02113982|452868960|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
125882161|NCT02113982|452868961|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
125882162|NCT02113982|452868948|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
125882163|NCT02113982|452868949|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
126363859|NCT01767857|454624969|FG001|Overall Study|Lost to Follow-up|1|||
126363860|NCT01767857|454624968|FG000|Overall Study|Withdrawal by Subject|38|||
126363861|NCT01767857|454624969|FG001|Overall Study|Withdrawal by Subject|18|||
126363862|NCT01767857|454624968|FG000|Overall Study|Physician Decision|17|||
126363863|NCT01767857|454624969|FG001|Overall Study|Physician Decision|10|||
126363864|NCT01767857|454624968|FG000|Overall Study|Protocol Terminated|1|||
126363865|NCT01767857|454624969|FG001|Overall Study|Protocol Terminated|0|||
126363866|NCT01767857|454624968|FG000|Overall Study|Randomized But Never Treated|19|||
125882164|NCT02113982|452868950|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
125882165|NCT02113982|452868951|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
125882166|NCT02113982|452868952|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
126040157|NCT03519178|453447166|FG014|PF-06873600 Treatment|Physician Decision|1|||
126040158|NCT03519178|453447152|FG000|PF-06873600 Treatment|Progressive disease|1|||
126040159|NCT03519178|453447153|FG001|PF-06873600 Treatment|Progressive disease|1|||
126040160|NCT03519178|453447154|FG002|PF-06873600 Treatment|Progressive disease|1|||
126040161|NCT03519178|453447155|FG003|PF-06873600 Treatment|Progressive disease|1|||
126040162|NCT03519178|453447156|FG004|PF-06873600 Treatment|Progressive disease|6|||
126040163|NCT03519178|453447157|FG005|PF-06873600 Treatment|Progressive disease|7|||
126040164|NCT03519178|453447158|FG006|PF-06873600 Treatment|Progressive disease|3|||
126040165|NCT03519178|453447159|FG007|PF-06873600 Treatment|Progressive disease|7|||
126040166|NCT03519178|453447160|FG008|PF-06873600 Treatment|Progressive disease|3|||
126040167|NCT03519178|453447161|FG009|PF-06873600 Treatment|Progressive disease|5|||
126040168|NCT03519178|453447162|FG010|PF-06873600 Treatment|Progressive disease|4|||
126040169|NCT03519178|453447163|FG011|PF-06873600 Treatment|Progressive disease|3|||
126040170|NCT03519178|453447164|FG012|PF-06873600 Treatment|Progressive disease|4|||
126040171|NCT03519178|453447165|FG013|PF-06873600 Treatment|Progressive disease|28|||
126040172|NCT03519178|453447166|FG014|PF-06873600 Treatment|Progressive disease|7|||
126040173|NCT03519178|453447152|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
126363867|NCT01767857|454624969|FG001|Overall Study|Randomized But Never Treated|13|||
126363868|NCT01514422|454624970|FG000|Overall Study|Lost to Follow-up|1|||
126040174|NCT03519178|453447153|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
126040175|NCT03519178|453447154|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
126363869|NCT04126174|454624971|FG000|Overall Study|Lost to Follow-up|3|||
126363870|NCT04126174|454624972|FG001|Overall Study|Lost to Follow-up|3|||
126363871|NCT00420056|454624987|FG000|Overall Study|Objective progression or relapse|17|||
126363872|NCT01044459|454624996|FG000|Overall Study|Withdrawal by Subject|21|||
126363873|NCT01044459|454624997|FG001|Overall Study|Withdrawal by Subject|28|||
126363874|NCT01044459|454624996|FG000|Overall Study|Terminated by Sponsor|22|||
126040176|NCT03519178|453447155|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
126363875|NCT01044459|454624997|FG001|Overall Study|Terminated by Sponsor|21|||
126363876|NCT01044459|454624996|FG000|Overall Study|Adverse Event|22|||
126280392|NCT00264550|454318286|FG000|Overall Study|Discontinued oral study agent|0|||
126280393|NCT00264550|454318287|FG001|Overall Study|Discontinued oral study agent|1|||
126280394|NCT00264550|454318288|FG002|Overall Study|Discontinued oral study agent|0|||
126280395|NCT00264550|454318289|FG003|Overall Study|Discontinued oral study agent|0|||
126280396|NCT00264550|454318286|FG000|Overall Study|Other|13|||
126280397|NCT00264550|454318287|FG001|Overall Study|Other|7|||
126280398|NCT00264550|454318288|FG002|Overall Study|Other|3|||
126280399|NCT00264550|454318289|FG003|Overall Study|Other|9|||
126280400|NCT02246114|454318290|FG000|Overall Study|miscarriage|1|||
126280401|NCT02246114|454318291|FG001|Overall Study|miscarriage|0|||
126040177|NCT03519178|453447156|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
126040178|NCT03519178|453447157|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
126280402|NCT01439009|454318297|FG000|Overall Study|Physician Decision|5|||
126280403|NCT01439009|454318298|FG001|Overall Study|Physician Decision|3|||
126280404|NCT01439009|454318297|FG000|Overall Study|Protocol Violation|2|||
126280405|NCT01439009|454318298|FG001|Overall Study|Protocol Violation|0|||
126280406|NCT01439009|454318297|FG000|Overall Study|Deviation of exclusion criteria|1|||
126280407|NCT01439009|454318298|FG001|Overall Study|Deviation of exclusion criteria|0|||
126280408|NCT00696787|454318300|FG000|Overall Study|Adverse Event|1|||
126280409|NCT00696787|454318301|FG001|Overall Study|Adverse Event|0|||
126280410|NCT00696787|454318302|FG002|Overall Study|Adverse Event|6|||
126280411|NCT00696787|454318300|FG000|Overall Study|Discontinuation by Sponsor|9|||
126280412|NCT00696787|454318301|FG001|Overall Study|Discontinuation by Sponsor|13|||
126280413|NCT00696787|454318302|FG002|Overall Study|Discontinuation by Sponsor|14|||
126280414|NCT00696787|454318300|FG000|Overall Study|Lack of Efficacy|0|||
126280415|NCT00696787|454318301|FG001|Overall Study|Lack of Efficacy|1|||
126280416|NCT00696787|454318302|FG002|Overall Study|Lack of Efficacy|0|||
126280417|NCT00696787|454318300|FG000|Overall Study|Lost to Follow-up|4|||
126280418|NCT00696787|454318301|FG001|Overall Study|Lost to Follow-up|0|||
126280419|NCT00696787|454318302|FG002|Overall Study|Lost to Follow-up|3|||
126280420|NCT00696787|454318300|FG000|Overall Study|Withdrawal by Subject|0|||
126280421|NCT00696787|454318301|FG001|Overall Study|Withdrawal by Subject|3|||
126280422|NCT00696787|454318302|FG002|Overall Study|Withdrawal by Subject|2|||
126280423|NCT00696787|454318300|FG000|Overall Study|Failed to return|1|||
126040179|NCT03519178|453447158|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
126098952|NCT04343872|453655576|FG001|Overall Study|Lost to Follow-up|3|||
126280424|NCT00696787|454318301|FG001|Overall Study|Failed to return|3|||
126280425|NCT00696787|454318302|FG002|Overall Study|Failed to return|1|||
126280426|NCT00129389|454318305|FG000|Overall Study|Adverse Event|19|||
126280427|NCT00129389|454318306|FG001|Overall Study|Adverse Event|87|||
126280428|NCT00129389|454318305|FG000|Overall Study|Death|0|||
126280429|NCT00129389|454318306|FG001|Overall Study|Death|1|||
126280430|NCT00129389|454318305|FG000|Overall Study|Lost to Follow-up|2|||
126280431|NCT00129389|454318306|FG001|Overall Study|Lost to Follow-up|1|||
126280432|NCT00129389|454318305|FG000|Overall Study|Physician Decision|0|||
126280433|NCT00129389|454318306|FG001|Overall Study|Physician Decision|4|||
126280434|NCT00129389|454318305|FG000|Overall Study|Protocol Violation|0|||
126280435|NCT00129389|454318306|FG001|Overall Study|Protocol Violation|6|||
126280436|NCT00129389|454318305|FG000|Overall Study|Withdrawal by Subject|9|||
126280437|NCT00129389|454318306|FG001|Overall Study|Withdrawal by Subject|23|||
126280438|NCT00129389|454318305|FG000|Overall Study|Relapse|1|||
126280439|NCT00129389|454318306|FG001|Overall Study|Relapse|0|||
126280440|NCT00129389|454318305|FG000|Overall Study|Not eligible|1|||
126280441|NCT00129389|454318306|FG001|Overall Study|Not eligible|2|||
126280442|NCT00129389|454318305|FG000|Overall Study|Crossed to the other arm|1|||
126280443|NCT00129389|454318306|FG001|Overall Study|Crossed to the other arm|16|||
126280444|NCT01191944|454318309|FG000|Overall Study|Adverse Event|11|||
126280445|NCT01191944|454318310|FG001|Overall Study|Adverse Event|12|||
126280446|NCT01191944|454318309|FG000|Overall Study|Protocol Violation|1|||
126280447|NCT01191944|454318310|FG001|Overall Study|Protocol Violation|2|||
126280448|NCT01191944|454318309|FG000|Overall Study|Withdrawal by Subject|4|||
126280449|NCT01191944|454318310|FG001|Overall Study|Withdrawal by Subject|2|||
126280450|NCT01191944|454318309|FG000|Overall Study|Other|1|||
126280451|NCT01191944|454318310|FG001|Overall Study|Other|3|||
126280452|NCT00603837|454318313|FG000|Overall Study|Physician Decision|3|||
126280453|NCT00603837|454318314|FG001|Overall Study|Physician Decision|0|||
126280454|NCT04611529|454318315|FG000|2-day Follow up|Lost to Follow-up|5|||
126280455|NCT04611529|454318316|FG001|2-day Follow up|Lost to Follow-up|6|||
126280456|NCT04611529|454318317|FG002|2-day Follow up|Lost to Follow-up|3|||
126280457|NCT00425373|454318384|FG000|Overall Study|Adverse Event|2|||
126280458|NCT00425373|454318385|FG001|Overall Study|Adverse Event|2|||
126280459|NCT00425373|454318386|FG002|Overall Study|Adverse Event|0|||
126280460|NCT00425373|454318387|FG003|Overall Study|Adverse Event|1|||
126280461|NCT00425373|454318388|FG004|Overall Study|Adverse Event|4|||
126280462|NCT00425373|454318389|FG005|Overall Study|Adverse Event|6|||
126280463|NCT00425373|454318390|FG006|Overall Study|Adverse Event|2|||
126280464|NCT00425373|454318391|FG007|Overall Study|Adverse Event|3|||
126280465|NCT00425373|454318392|FG008|Overall Study|Adverse Event|8|||
126280466|NCT00425373|454318384|FG000|Overall Study|Lost to Follow-up|0|||
126280467|NCT00425373|454318385|FG001|Overall Study|Lost to Follow-up|1|||
126280468|NCT00425373|454318386|FG002|Overall Study|Lost to Follow-up|0|||
126280469|NCT00425373|454318387|FG003|Overall Study|Lost to Follow-up|0|||
126280470|NCT00425373|454318388|FG004|Overall Study|Lost to Follow-up|1|||
126280471|NCT00425373|454318389|FG005|Overall Study|Lost to Follow-up|0|||
126040180|NCT03519178|453447159|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
126040181|NCT03519178|453447160|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
126040182|NCT03519178|453447161|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
126040183|NCT03519178|453447162|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
126040184|NCT03519178|453447163|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
126040185|NCT03519178|453447164|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
126040186|NCT03519178|453447165|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
126040187|NCT03519178|453447166|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
126040188|NCT03519178|453447152|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
126103483|NCT01691768|453672172|FG001|Overall Study|Death|2|||
126280472|NCT00425373|454318390|FG006|Overall Study|Lost to Follow-up|0|||
126280473|NCT00425373|454318391|FG007|Overall Study|Lost to Follow-up|0|||
126280474|NCT00425373|454318392|FG008|Overall Study|Lost to Follow-up|0|||
126280475|NCT00425373|454318384|FG000|Overall Study|Protocol Violation|1|||
126280476|NCT00425373|454318385|FG001|Overall Study|Protocol Violation|0|||
126280477|NCT00425373|454318386|FG002|Overall Study|Protocol Violation|1|||
126280478|NCT00425373|454318387|FG003|Overall Study|Protocol Violation|0|||
126280479|NCT00425373|454318388|FG004|Overall Study|Protocol Violation|0|||
126280480|NCT00425373|454318389|FG005|Overall Study|Protocol Violation|0|||
126280481|NCT00425373|454318390|FG006|Overall Study|Protocol Violation|0|||
126280482|NCT00425373|454318391|FG007|Overall Study|Protocol Violation|5|||
126280483|NCT00425373|454318392|FG008|Overall Study|Protocol Violation|3|||
126280484|NCT00425373|454318384|FG000|Overall Study|Withdrawal by Subject|2|||
126280485|NCT00425373|454318385|FG001|Overall Study|Withdrawal by Subject|0|||
126280486|NCT00425373|454318386|FG002|Overall Study|Withdrawal by Subject|2|||
126280487|NCT00425373|454318387|FG003|Overall Study|Withdrawal by Subject|1|||
126280488|NCT00425373|454318388|FG004|Overall Study|Withdrawal by Subject|4|||
126280489|NCT00425373|454318389|FG005|Overall Study|Withdrawal by Subject|0|||
126280490|NCT00425373|454318390|FG006|Overall Study|Withdrawal by Subject|2|||
126280491|NCT00425373|454318391|FG007|Overall Study|Withdrawal by Subject|2|||
126280492|NCT00425373|454318392|FG008|Overall Study|Withdrawal by Subject|2|||
126280493|NCT00425373|454318384|FG000|Overall Study|Lack of Efficacy|0|||
126280494|NCT00425373|454318385|FG001|Overall Study|Lack of Efficacy|0|||
126280495|NCT00425373|454318386|FG002|Overall Study|Lack of Efficacy|0|||
126280496|NCT00425373|454318387|FG003|Overall Study|Lack of Efficacy|0|||
126280497|NCT00425373|454318388|FG004|Overall Study|Lack of Efficacy|1|||
126280498|NCT00425373|454318389|FG005|Overall Study|Lack of Efficacy|3|||
126280499|NCT00425373|454318390|FG006|Overall Study|Lack of Efficacy|3|||
126280500|NCT00425373|454318391|FG007|Overall Study|Lack of Efficacy|0|||
125882167|NCT02113982|452868953|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
126280501|NCT00425373|454318392|FG008|Overall Study|Lack of Efficacy|5|||
126040189|NCT03519178|453447153|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
126280502|NCT01851330|454318393|FG000|Overall Study|Lack of Efficacy|10|||
126280503|NCT01851330|454318394|FG001|Overall Study|Lack of Efficacy|9|||
126280504|NCT01851330|454318395|FG002|Overall Study|Lack of Efficacy|2|||
126280505|NCT01851330|454318393|FG000|Overall Study|Lost to Follow-up|1|||
126280506|NCT01851330|454318394|FG001|Overall Study|Lost to Follow-up|6|||
126280507|NCT01851330|454318395|FG002|Overall Study|Lost to Follow-up|9|||
126280508|NCT01851330|454318393|FG000|Overall Study|Withdrew Consent|2|||
126280509|NCT01851330|454318394|FG001|Overall Study|Withdrew Consent|1|||
126280510|NCT01851330|454318395|FG002|Overall Study|Withdrew Consent|0|||
126280511|NCT01851330|454318393|FG000|Overall Study|Investigator's Discretion|0|||
126280512|NCT01851330|454318394|FG001|Overall Study|Investigator's Discretion|0|||
126280513|NCT01851330|454318395|FG002|Overall Study|Investigator's Discretion|1|||
126280514|NCT02368314|454318399|FG000|Overall Study|Withdrawal by Subject|2|||
126280515|NCT02368314|454318400|FG001|Overall Study|Withdrawal by Subject|1|||
126280516|NCT02368314|454318399|FG000|Overall Study|Adverse Event|1|||
126280517|NCT02368314|454318400|FG001|Overall Study|Adverse Event|2|||
126280518|NCT01307111|454318403|FG000|IUD Insertion|Lost to Follow-up|2|||
126280519|NCT01307111|454318404|FG001|IUD Insertion|Lost to Follow-up|0|||
126280520|NCT01307111|454318403|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
126280521|NCT01307111|454318404|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
126280522|NCT02842073|454318412|FG000|Overall Study|Withdrawal by Subject|1|||
126280523|NCT00195338|454318413|FG000|Overall Study|Lost to Follow-up|2|||
126280524|NCT00195338|454318413|FG000|Overall Study|Adverse Event|5|||
126280525|NCT00195338|454318413|FG000|Overall Study|Lack of Efficacy|1|||
126280526|NCT00195338|454318413|FG000|Overall Study|Early closure of the site|4|||
126280527|NCT01333397|454318414|FG000|Overall Study|Lost to Follow-up|1|||
126280528|NCT01333397|454318415|FG001|Overall Study|Lost to Follow-up|0|||
126280529|NCT01333397|454318416|FG002|Overall Study|Lost to Follow-up|0|||
126280530|NCT01333397|454318417|FG003|Overall Study|Lost to Follow-up|1|||
126280531|NCT01333397|454318418|FG004|Overall Study|Lost to Follow-up|0|||
126280532|NCT01085357|454318419|FG000|Overall Study|Adverse Event|1|||
126280533|NCT01085357|454318420|FG001|Overall Study|Adverse Event|1|||
126280534|NCT01085357|454318419|FG000|Overall Study|Subject Decision|4|||
126280535|NCT01085357|454318420|FG001|Overall Study|Subject Decision|3|||
126280536|NCT01085357|454318419|FG000|Overall Study|Investigator Decision|1|||
126280537|NCT01085357|454318420|FG001|Overall Study|Investigator Decision|1|||
126280538|NCT01085357|454318419|FG000|Overall Study|Death|11|||
126280539|NCT01085357|454318420|FG001|Overall Study|Death|1|||
126280540|NCT01085357|454318419|FG000|Overall Study|Lost to Follow-up|2|||
126280541|NCT01085357|454318420|FG001|Overall Study|Lost to Follow-up|0|||
126280542|NCT02289456|454318430|FG000|Induction Period|Death|2|||
126280543|NCT02289456|454318430|FG000|Induction Period|Adverse Event|11|||
126280544|NCT02289456|454318430|FG000|Induction Period|Progressive Disease (PD)|4|||
126280545|NCT02289456|454318430|FG000|Induction Period|Symptomatic Deterioration|4|||
126280546|NCT02289456|454318430|FG000|Induction Period|Withdrawal by Subject|2|||
126280547|NCT02289456|454318430|FG000|Induction Period|Miscellaneous|1|||
126280548|NCT02289456|454318430|FG000|Monotherapy Period|Death|1|||
126280549|NCT02289456|454318430|FG000|Monotherapy Period|Adverse Event|1|||
126280550|NCT02289456|454318430|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
126280551|NCT02289456|454318430|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
126280552|NCT02289456|454318430|FG000|Monotherapy Period|Withdrawal by Subject|2|||
126280553|NCT02289456|454318430|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
126280554|NCT02289456|454318430|FG000|Monotherapy Period|Miscellaneous|1|||
126280555|NCT00920790|454318431|FG000|Overall Study|aggravation of general condition|14|||
126280556|NCT01661062|454318434|FG000|Overall Study|Completed Treatment Off Study|3|||
126280557|NCT01661062|454318434|FG000|Overall Study|Withdrawal by Subject|2|||
126280558|NCT04411914|454318435|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
126280559|NCT04411914|454318436|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
126280560|NCT00895414|454318442|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
126280561|NCT00895414|454318443|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
126280562|NCT00895414|454318442|FG000|First Intervention (14 Days)|Physician Decision|0|||
126280563|NCT00895414|454318443|FG001|First Intervention (14 Days)|Physician Decision|1|||
126280564|NCT00252239|454318444|FG000|Overall Study|Withdrawal by Subject|1|||
126280565|NCT00252239|454318445|FG001|Overall Study|Withdrawal by Subject|0|||
126280566|NCT00252239|454318446|FG002|Overall Study|Withdrawal by Subject|0|||
126280567|NCT00252239|454318447|FG003|Overall Study|Withdrawal by Subject|1|||
126280568|NCT00252239|454318444|FG000|Overall Study|Lost to Follow-up|0|||
126280569|NCT00252239|454318445|FG001|Overall Study|Lost to Follow-up|0|||
126098953|NCT02480153|453655577|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
126280570|NCT00252239|454318446|FG002|Overall Study|Lost to Follow-up|2|||
126280571|NCT00252239|454318447|FG003|Overall Study|Lost to Follow-up|0|||
126280572|NCT00478426|454318448|FG000|Overall Study|Withdrawal by Subject|1|||
126280573|NCT03489109|454318455|FG000|Overall Study|Lost to Follow-up|1|||
126280574|NCT03489109|454318456|FG001|Overall Study|Lost to Follow-up|2|||
126280575|NCT02181790|454318457|FG000|Overall Study|study terminated|2|||
126280576|NCT02181790|454318458|FG001|Overall Study|study terminated|0|||
126280577|NCT00908310|454318459|FG000|Overall Study|Death|37|||
126280578|NCT00908310|454318459|FG000|Overall Study|Withdrawal by Subject|7|||
126280579|NCT00908310|454318459|FG000|Overall Study|Lost to Follow-up|7|||
126280580|NCT00908310|454318459|FG000|Overall Study|Screening failure|5|||
126280581|NCT00908310|454318459|FG000|Overall Study|Other reasons|4|||
126280582|NCT02785952|454318460|FG000|Overall Study|Adverse Event|31|||
126280583|NCT02785952|454318461|FG001|Overall Study|Adverse Event|19|||
125882168|NCT02113982|452868954|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
125882169|NCT02113982|452868955|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
125882170|NCT02113982|452868956|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
125882171|NCT02113982|452868957|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
125882172|NCT02113982|452868958|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
125882173|NCT02113982|452868959|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
126280584|NCT02785952|454318460|FG000|Overall Study|Refusal unrelated to adverse events|10|||
126280585|NCT02785952|454318461|FG001|Overall Study|Refusal unrelated to adverse events|5|||
126280586|NCT02785952|454318460|FG000|Overall Study|Disease progression/relapse|61|||
126280587|NCT02785952|454318461|FG001|Overall Study|Disease progression/relapse|89|||
126280588|NCT02785952|454318460|FG000|Overall Study|Death|11|||
125882174|NCT02113982|452868960|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
125882175|NCT02113982|452868961|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
125882176|NCT02113982|452868948|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882177|NCT02113982|452868949|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
126280589|NCT02785952|454318461|FG001|Overall Study|Death|7|||
126280590|NCT02785952|454318460|FG000|Overall Study|Other- not protocol specified|6|||
126280591|NCT02785952|454318461|FG001|Overall Study|Other- not protocol specified|4|||
126280592|NCT02785952|454318460|FG000|Overall Study|On protocol treatment|6|||
125882178|NCT02113982|452868950|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
126280593|NCT02785952|454318461|FG001|Overall Study|On protocol treatment|3|||
126280594|NCT00351533|454318462|FG000|Overall Study|Extubated before first BAL|1|||
126280595|NCT00351533|454318463|FG001|Overall Study|Extubated before first BAL|0|||
126280596|NCT00351533|454318462|FG000|Overall Study|Lost to Follow-up|1|||
126280597|NCT00351533|454318463|FG001|Overall Study|Lost to Follow-up|3|||
126280598|NCT00351533|454318462|FG000|Overall Study|Physician Decision|0|||
126280599|NCT00351533|454318463|FG001|Overall Study|Physician Decision|1|||
126280600|NCT00351533|454318462|FG000|Overall Study|Withdrawal by Subject|0|||
126280601|NCT00351533|454318463|FG001|Overall Study|Withdrawal by Subject|1|||
126280602|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
126280603|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
126280604|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
126280605|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
126280606|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
126280607|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
126280608|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
126280609|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
126363877|NCT01044459|454624997|FG001|Overall Study|Adverse Event|20|||
126363878|NCT01044459|454624996|FG000|Overall Study|Lack of Efficacy|23|||
126363879|NCT01044459|454624997|FG001|Overall Study|Lack of Efficacy|12|||
126363880|NCT01044459|454624996|FG000|Overall Study|Protocol Violation|11|||
126363881|NCT01044459|454624997|FG001|Overall Study|Protocol Violation|16|||
126363882|NCT01044459|454624996|FG000|Overall Study|Other Reason|7|||
126363883|NCT01044459|454624997|FG001|Overall Study|Other Reason|14|||
126363884|NCT01044459|454624996|FG000|Overall Study|COPD exacerbation|9|||
126363885|NCT01044459|454624997|FG001|Overall Study|COPD exacerbation|8|||
126363886|NCT01044459|454624996|FG000|Overall Study|Lost to Follow-up|18|||
126363887|NCT01044459|454624997|FG001|Overall Study|Lost to Follow-up|12|||
126363888|NCT04105725|454624998|FG000|Primary Intervention|Lost to Follow-up|0|||
126363889|NCT04105725|454624999|FG001|Primary Intervention|Lost to Follow-up|2|||
126363890|NCT04105725|454624998|FG000|Primary Intervention|Withdrawal by Subject|0|||
126363891|NCT04105725|454624999|FG001|Primary Intervention|Withdrawal by Subject|1|||
126363892|NCT04634331|454625000|FG000|Overall Study|Withdrawal by Subject|2|||
126363893|NCT04634331|454625001|FG001|Overall Study|Withdrawal by Subject|2|||
126363894|NCT00176254|454625002|FG000|Overall Study|Lost to Follow-up|1|||
126363895|NCT02457546|454626659|FG000|Overall Study|Other reasons|4|||
126363896|NCT02457546|454626660|FG001|Overall Study|Other reasons|1|||
126363897|NCT02457546|454626659|FG000|Overall Study|Refused to complete study/procedures|1|||
126363898|NCT02457546|454626660|FG001|Overall Study|Refused to complete study/procedures|1|||
126363899|NCT02457546|454626659|FG000|Overall Study|Lost to Follow-up|4|||
126363900|NCT02457546|454626660|FG001|Overall Study|Lost to Follow-up|1|||
126363901|NCT02457546|454626659|FG000|Overall Study|Adverse Event|0|||
126363902|NCT02457546|454626660|FG001|Overall Study|Adverse Event|1|||
126363903|NCT05069415|454626661|FG000|Overall Study|Withdrawal by Subject|2|||
126280610|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
126280611|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
126280612|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
126280613|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
126363904|NCT05069415|454626662|FG001|Overall Study|Withdrawal by Subject|0|||
126280614|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
126280615|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
126280616|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
126280617|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
126280618|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
126280619|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
126280620|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
126280621|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
126280622|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Death|1|||
126280623|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Death|0|||
126280624|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Death|0|||
126280625|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Death|0|||
126280626|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Death|0|||
126280627|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Death|1|||
126280628|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Death|0|||
126280629|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Death|0|||
126280630|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Death|0|||
126280631|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Death|0|||
126280632|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Death|0|||
126280633|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Death|0|||
126280634|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Death|0|||
126280635|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Death|0|||
126280636|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Death|0|||
126280637|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Death|0|||
126280638|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Death|0|||
126280639|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Death|0|||
126280640|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Death|0|||
126280641|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Death|0|||
126280642|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
126280643|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
126280644|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
126280645|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
126280646|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
126280647|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
126280648|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
126280649|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
126280650|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
126280651|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
126280652|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
126280653|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
126280654|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
126280655|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
126280656|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
126280657|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
126280658|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
126280659|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
126280660|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
126280661|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
126280662|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280663|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
126280664|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280665|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
126280666|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
126280667|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
126280668|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
126280669|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280670|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280671|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280672|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280673|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280674|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280675|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280676|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280677|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280678|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280679|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280680|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280681|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280682|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
126280683|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
126280684|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
126280685|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
126280686|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
126040190|NCT03519178|453447154|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
126363905|NCT05069415|454626661|FG000|Overall Study|Adverse Event|2|||
126363906|NCT05069415|454626662|FG001|Overall Study|Adverse Event|0|||
126363907|NCT00203242|454626665|FG000|Overall Study|Lost to Follow-up|1|||
126098954|NCT02480153|453655578|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
126098955|NCT02480153|453655579|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
126098956|NCT02480153|453655577|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
126098957|NCT02480153|453655578|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
126098958|NCT02480153|453655579|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
126098959|NCT02480153|453655577|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
126098960|NCT02480153|453655578|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
126098961|NCT02480153|453655579|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
126098962|NCT02480153|453655577|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
126098963|NCT02480153|453655578|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
126098964|NCT02480153|453655579|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
126280687|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
126040191|NCT03519178|453447155|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
126040192|NCT03519178|453447156|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
126040193|NCT03519178|453447157|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
126040194|NCT03519178|453447158|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
126040195|NCT03519178|453447159|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
126040196|NCT03519178|453447160|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
126040197|NCT03519178|453447161|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
126040198|NCT03519178|453447162|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
126040199|NCT03519178|453447163|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
126040200|NCT03519178|453447164|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
126040201|NCT03519178|453447165|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
126040202|NCT03519178|453447166|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
126040203|NCT03519178|453447152|FG000|PF-06873600 Treatment|Refused further treatment|0|||
126040204|NCT03519178|453447153|FG001|PF-06873600 Treatment|Refused further treatment|1|||
126040205|NCT03519178|453447154|FG002|PF-06873600 Treatment|Refused further treatment|0|||
126040206|NCT03519178|453447155|FG003|PF-06873600 Treatment|Refused further treatment|0|||
126040207|NCT03519178|453447156|FG004|PF-06873600 Treatment|Refused further treatment|1|||
126040208|NCT03519178|453447157|FG005|PF-06873600 Treatment|Refused further treatment|0|||
126040209|NCT03519178|453447158|FG006|PF-06873600 Treatment|Refused further treatment|0|||
126040210|NCT03519178|453447159|FG007|PF-06873600 Treatment|Refused further treatment|0|||
126040211|NCT03519178|453447160|FG008|PF-06873600 Treatment|Refused further treatment|0|||
126040212|NCT03519178|453447161|FG009|PF-06873600 Treatment|Refused further treatment|0|||
126040213|NCT03519178|453447162|FG010|PF-06873600 Treatment|Refused further treatment|0|||
126040214|NCT03519178|453447163|FG011|PF-06873600 Treatment|Refused further treatment|0|||
126040215|NCT03519178|453447164|FG012|PF-06873600 Treatment|Refused further treatment|0|||
126040216|NCT03519178|453447165|FG013|PF-06873600 Treatment|Refused further treatment|0|||
126040217|NCT03519178|453447166|FG014|PF-06873600 Treatment|Refused further treatment|1|||
126040218|NCT03519178|453447152|FG000|PF-06873600 Treatment|Other|0|||
126040219|NCT03519178|453447153|FG001|PF-06873600 Treatment|Other|0|||
126040220|NCT03519178|453447154|FG002|PF-06873600 Treatment|Other|0|||
126040221|NCT03519178|453447155|FG003|PF-06873600 Treatment|Other|0|||
126040222|NCT03519178|453447156|FG004|PF-06873600 Treatment|Other|0|||
126040223|NCT03519178|453447157|FG005|PF-06873600 Treatment|Other|0|||
126040224|NCT03519178|453447158|FG006|PF-06873600 Treatment|Other|0|||
126040225|NCT03519178|453447159|FG007|PF-06873600 Treatment|Other|0|||
126040226|NCT03519178|453447160|FG008|PF-06873600 Treatment|Other|1|||
126040227|NCT03519178|453447161|FG009|PF-06873600 Treatment|Other|0|||
126040228|NCT03519178|453447162|FG010|PF-06873600 Treatment|Other|0|||
126280688|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
126280689|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
126280690|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
126280691|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
126280692|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
126363908|NCT00866775|454626666|FG000|Overall Study|Adverse Event|5|||
126040229|NCT03519178|453447163|FG011|PF-06873600 Treatment|Other|0|||
126103484|NCT01691768|453672171|FG000|Overall Study|Lost to Follow-up|4|||
126040230|NCT03519178|453447164|FG012|PF-06873600 Treatment|Other|0|||
126040231|NCT03519178|453447165|FG013|PF-06873600 Treatment|Other|1|||
126040232|NCT03519178|453447166|FG014|PF-06873600 Treatment|Other|3|||
126040233|NCT03519178|453447152|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
126040234|NCT03519178|453447153|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
126040235|NCT03519178|453447154|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
126280693|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
126040236|NCT03519178|453447155|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
126040237|NCT03519178|453447156|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
126040238|NCT03519178|453447157|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
126040239|NCT03519178|453447158|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
126280694|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
126280695|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
126280696|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
126280697|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
126280698|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
126280699|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
126280700|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
126280701|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
126280702|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
126280703|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
126280704|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
126280705|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
126280706|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
126280707|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
126280708|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
126280709|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
126280710|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
126280711|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
126280712|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
126280713|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
126280714|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
126280715|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
126280716|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
126280717|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
126280718|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
126280719|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
126280720|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
126280721|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
126280722|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Death|0|||
126280723|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Death|0|||
126280724|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Death|0|||
126280725|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Death|0|||
126280726|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Death|0|||
126280727|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Death|0|||
126280728|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Death|0|||
126280729|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Death|0|||
126363909|NCT00866775|454626667|FG001|Overall Study|Adverse Event|19|||
126363910|NCT00866775|454626666|FG000|Overall Study|Death|1|||
126363911|NCT00866775|454626667|FG001|Overall Study|Death|0|||
126363912|NCT00866775|454626666|FG000|Overall Study|Lost to Follow-up|0|||
126363913|NCT00866775|454626667|FG001|Overall Study|Lost to Follow-up|4|||
126363914|NCT00866775|454626666|FG000|Overall Study|Physician Decision|0|||
126363915|NCT00866775|454626667|FG001|Overall Study|Physician Decision|3|||
126363916|NCT00866775|454626666|FG000|Overall Study|Protocol Violation|3|||
126363917|NCT00866775|454626667|FG001|Overall Study|Protocol Violation|4|||
126363918|NCT00866775|454626666|FG000|Overall Study|Withdrawal by Subject|4|||
126363919|NCT00866775|454626667|FG001|Overall Study|Withdrawal by Subject|4|||
126363920|NCT00866775|454626666|FG000|Overall Study|met exit criteria|23|||
126363921|NCT00866775|454626667|FG001|Overall Study|met exit criteria|17|||
126363922|NCT00866775|454626666|FG000|Overall Study|discontinued due to communication error|0|||
126363923|NCT00866775|454626667|FG001|Overall Study|discontinued due to communication error|1|||
126363924|NCT01661595|454626668|FG000|Phase 1: Week 0-4|Adverse Event|1|||
126363925|NCT01661595|454626669|FG001|Phase 1: Week 0-4|Adverse Event|0|||
126363926|NCT01661595|454626670|FG002|Phase 1: Week 0-4|Adverse Event|0|||
126363927|NCT01661595|454626671|FG003|Phase 1: Week 0-4|Adverse Event|0|||
126363928|NCT01661595|454626668|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
126363929|NCT01661595|454626669|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
126363930|NCT01661595|454626670|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
126363931|NCT01661595|454626671|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
126363932|NCT01500135|454626672|FG000|Overall Study|Withdrawal of Consent|4|||
126363933|NCT01500135|454626673|FG001|Overall Study|Withdrawal of Consent|0|||
126363934|NCT01500135|454626672|FG000|Overall Study|Lost to Follow-up|6|||
126363935|NCT01500135|454626673|FG001|Overall Study|Lost to Follow-up|4|||
126363936|NCT01500135|454626672|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
126363937|NCT01500135|454626673|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
126363938|NCT01500135|454626672|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
126363939|NCT01500135|454626673|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
126040240|NCT03519178|453447159|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
126280730|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Death|0|||
126280731|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Death|2|||
126280732|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Death|0|||
126280733|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Death|1|||
126040241|NCT03519178|453447160|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
126040242|NCT03519178|453447161|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
126040243|NCT03519178|453447162|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
126040244|NCT03519178|453447163|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
126040245|NCT03519178|453447164|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
126040246|NCT03519178|453447165|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
126040247|NCT03519178|453447166|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
126040248|NCT03519178|453447152|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040249|NCT03519178|453447153|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040250|NCT03519178|453447154|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040251|NCT03519178|453447155|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040252|NCT03519178|453447156|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040253|NCT03519178|453447157|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040254|NCT03519178|453447158|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040255|NCT03519178|453447159|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040256|NCT03519178|453447160|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040257|NCT03519178|453447161|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
126098965|NCT02480153|453655577|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
126098966|NCT02480153|453655578|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
126280734|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Death|1|||
126280735|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Death|0|||
126280736|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Death|0|||
126280737|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Death|0|||
126280738|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Death|0|||
126280739|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Death|0|||
126280740|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Death|0|||
126280741|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Death|0|||
126280742|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
126280743|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
126280744|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
126280745|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
126280746|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
126280747|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
126280748|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
126280749|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
126280750|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
126280751|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
126280752|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
126280753|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
126280754|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
126280755|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
126280756|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
126280757|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
126280758|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
126280759|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
126280760|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
126280761|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
126280762|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280763|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280764|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126363940|NCT01500135|454626672|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
126363941|NCT01500135|454626673|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
126363942|NCT01500135|454626672|FG000|Overall Study|Participant was a Safety Concern|1|||
126363943|NCT01500135|454626673|FG001|Overall Study|Participant was a Safety Concern|0|||
126363944|NCT01500135|454626672|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
126363945|NCT01500135|454626673|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
126363946|NCT00912509|454626674|FG000|Overall Study|Lost to Follow-up|1|||
126363947|NCT00912509|454626675|FG001|Overall Study|Lost to Follow-up|0|||
126363948|NCT00912509|454626674|FG000|Overall Study|Lack of Efficacy|4|||
126363949|NCT00912509|454626675|FG001|Overall Study|Lack of Efficacy|3|||
126363950|NCT05166902|454626677|FG000|First Intervention|Lost to Follow-up|0|||
126363951|NCT05166902|454626678|FG001|First Intervention|Lost to Follow-up|1|||
126040258|NCT03519178|453447162|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040259|NCT03519178|453447163|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
126040260|NCT03519178|453447164|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
126280765|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280766|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280767|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280768|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280769|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280770|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280771|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
126280772|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
126280773|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
126280774|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
126280775|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280776|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280777|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280778|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280779|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280780|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280781|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280782|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
126280783|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
126280784|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
126280785|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
125882179|NCT02113982|452868951|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882180|NCT02113982|452868952|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882181|NCT02113982|452868953|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882182|NCT02113982|452868954|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882183|NCT02113982|452868955|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
125882184|NCT02113982|452868956|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882185|NCT02113982|452868957|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
125882186|NCT02113982|452868958|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
125882187|NCT02113982|452868959|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882188|NCT02113982|452868960|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882189|NCT02113982|452868961|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
125882190|NCT02113982|452868948|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882191|NCT02113982|452868949|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126280786|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
126280787|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
126280788|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
126280789|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
126280790|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
126280791|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
126280792|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
126280793|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
126280794|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
126280795|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
126280796|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
126280797|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
126280798|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
126280799|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
126280800|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
126280801|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
126280802|NCT00996892|454318465|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
126280803|NCT00996892|454318466|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
126280804|NCT00996892|454318467|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
126280805|NCT00996892|454318468|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
126280806|NCT00996892|454318469|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
126280807|NCT00996892|454318470|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
126280808|NCT00996892|454318471|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
126280809|NCT00996892|454318472|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
126280810|NCT00996892|454318473|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
126280811|NCT00996892|454318474|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
126280812|NCT00996892|454318475|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
126280813|NCT00996892|454318476|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
126280814|NCT00996892|454318477|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
126280815|NCT00996892|454318478|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
126280816|NCT00996892|454318479|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
126280817|NCT00996892|454318480|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
126280818|NCT00996892|454318481|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
126280819|NCT00996892|454318482|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
125882192|NCT02113982|452868950|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126103485|NCT01691768|453672172|FG001|Overall Study|Lost to Follow-up|3|||
126280820|NCT00996892|454318483|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
126280821|NCT00996892|454318484|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
126280822|NCT00996892|454318465|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
126280823|NCT00996892|454318466|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
126280824|NCT00996892|454318467|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
126280825|NCT00996892|454318468|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
126280826|NCT00996892|454318469|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
126363952|NCT01998477|454626679|FG000|Overall Study|Lost to Follow-up|4|||
126363953|NCT01998477|454626680|FG001|Overall Study|Lost to Follow-up|5|||
126280827|NCT00996892|454318470|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
126280828|NCT00996892|454318471|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
126280829|NCT00996892|454318472|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
126280830|NCT00996892|454318473|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
126280831|NCT00996892|454318474|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
126280832|NCT00996892|454318475|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
126280833|NCT00996892|454318476|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
126280834|NCT00996892|454318477|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
126280835|NCT00996892|454318478|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
126280836|NCT00996892|454318479|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
126280837|NCT00996892|454318480|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
126280838|NCT00996892|454318481|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
126280839|NCT00996892|454318482|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
126280840|NCT00996892|454318483|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
126280841|NCT00996892|454318484|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
126280842|NCT00996892|454318465|FG000|Expansion Stage 2|Adverse Event|0|||
126280843|NCT00996892|454318466|FG001|Expansion Stage 2|Adverse Event|0|||
126280844|NCT00996892|454318467|FG002|Expansion Stage 2|Adverse Event|0|||
126280845|NCT00996892|454318468|FG003|Expansion Stage 2|Adverse Event|0|||
126280846|NCT00996892|454318469|FG004|Expansion Stage 2|Adverse Event|0|||
126280847|NCT00996892|454318470|FG005|Expansion Stage 2|Adverse Event|0|||
126280848|NCT00996892|454318471|FG006|Expansion Stage 2|Adverse Event|0|||
126280849|NCT00996892|454318472|FG007|Expansion Stage 2|Adverse Event|0|||
126280850|NCT00996892|454318473|FG008|Expansion Stage 2|Adverse Event|0|||
126280851|NCT00996892|454318474|FG009|Expansion Stage 2|Adverse Event|0|||
126363954|NCT01998477|454626679|FG000|Overall Study|Withdrawal by Subject|6|||
126363955|NCT01998477|454626680|FG001|Overall Study|Withdrawal by Subject|0|||
126363956|NCT00779909|454626681|FG000|Overall Study|Lost to Follow-up|1|||
126363957|NCT00779909|454626682|FG001|Overall Study|Lost to Follow-up|0|||
126363958|NCT00779909|454626683|FG002|Overall Study|Lost to Follow-up|0|||
126363959|NCT00779909|454626684|FG003|Overall Study|Lost to Follow-up|1|||
126040261|NCT03519178|453447165|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
126040262|NCT03519178|453447166|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
126280852|NCT00996892|454318475|FG010|Expansion Stage 2|Adverse Event|0|||
126280853|NCT00996892|454318476|FG011|Expansion Stage 2|Adverse Event|0|||
126280854|NCT00996892|454318477|FG012|Expansion Stage 2|Adverse Event|0|||
126280855|NCT00996892|454318478|FG013|Expansion Stage 2|Adverse Event|0|||
126280856|NCT00996892|454318479|FG014|Expansion Stage 2|Adverse Event|0|||
126280857|NCT00996892|454318480|FG015|Expansion Stage 2|Adverse Event|0|||
126363960|NCT00779909|454626681|FG000|Overall Study|Withdrawal by Subject|0|||
126363961|NCT00779909|454626682|FG001|Overall Study|Withdrawal by Subject|1|||
126363962|NCT00779909|454626683|FG002|Overall Study|Withdrawal by Subject|0|||
126363963|NCT00779909|454626684|FG003|Overall Study|Withdrawal by Subject|0|||
126363964|NCT03523585|454626685|FG000|Overall Study|Progressive Disease|174|||
126363965|NCT03523585|454626686|FG001|Overall Study|Progressive Disease|64|||
126363966|NCT03523585|454626687|FG002|Overall Study|Progressive Disease|77|||
126363967|NCT03523585|454626685|FG000|Overall Study|Adverse Event|74|||
126363968|NCT03523585|454626686|FG001|Overall Study|Adverse Event|5|||
126363969|NCT03523585|454626687|FG002|Overall Study|Adverse Event|9|||
126363970|NCT03523585|454626685|FG000|Overall Study|Withdrawal by Subject|30|||
126363971|NCT03523585|454626686|FG001|Overall Study|Withdrawal by Subject|11|||
126363972|NCT03523585|454626687|FG002|Overall Study|Withdrawal by Subject|6|||
126363973|NCT03523585|454626685|FG000|Overall Study|Clinical Progression|23|||
126363974|NCT03523585|454626686|FG001|Overall Study|Clinical Progression|5|||
126363975|NCT03523585|454626687|FG002|Overall Study|Clinical Progression|10|||
126363976|NCT03523585|454626685|FG000|Overall Study|Death|4|||
126363977|NCT03523585|454626686|FG001|Overall Study|Death|0|||
126363978|NCT03523585|454626687|FG002|Overall Study|Death|1|||
126363979|NCT03523585|454626685|FG000|Overall Study|Physician Decision|2|||
126363980|NCT03523585|454626686|FG001|Overall Study|Physician Decision|1|||
126363981|NCT03523585|454626687|FG002|Overall Study|Physician Decision|0|||
126363982|NCT03523585|454626685|FG000|Overall Study|Lost to Follow-up|1|||
126363983|NCT03523585|454626686|FG001|Overall Study|Lost to Follow-up|0|||
126363984|NCT03523585|454626687|FG002|Overall Study|Lost to Follow-up|0|||
126363985|NCT03523585|454626685|FG000|Overall Study|Miscellaneous|1|||
126363986|NCT03523585|454626686|FG001|Overall Study|Miscellaneous|0|||
126363987|NCT03523585|454626687|FG002|Overall Study|Miscellaneous|0|||
126363988|NCT03523585|454626685|FG000|Overall Study|Protocol Deviation|1|||
126363989|NCT03523585|454626686|FG001|Overall Study|Protocol Deviation|0|||
126363990|NCT03523585|454626687|FG002|Overall Study|Protocol Deviation|1|||
126363991|NCT03523585|454626685|FG000|Overall Study|Randomized But Not Treated|2|||
126363992|NCT03523585|454626686|FG001|Overall Study|Randomized But Not Treated|4|||
126040263|NCT03519178|453447152|FG000|PF-06873600 Treatment|Ongoing|0|||
126040264|NCT03519178|453447153|FG001|PF-06873600 Treatment|Ongoing|0|||
126040265|NCT03519178|453447154|FG002|PF-06873600 Treatment|Ongoing|0|||
126363993|NCT03523585|454626687|FG002|Overall Study|Randomized But Not Treated|3|||
126363994|NCT05345405|454626688|FG000|Overall Study|Withdrawal by Subject|2|||
126363995|NCT05345405|454626689|FG001|Overall Study|Withdrawal by Subject|0|||
126363996|NCT05345405|454626690|FG002|Overall Study|Withdrawal by Subject|0|||
126363997|NCT05345405|454626688|FG000|Overall Study|Did not meet eligibility criteria|0|||
126363998|NCT05345405|454626689|FG001|Overall Study|Did not meet eligibility criteria|2|||
126363999|NCT05345405|454626690|FG002|Overall Study|Did not meet eligibility criteria|0|||
126364000|NCT05345405|454626688|FG000|Overall Study|Lost to Follow-up|0|||
126364001|NCT05345405|454626689|FG001|Overall Study|Lost to Follow-up|0|||
126364002|NCT05345405|454626690|FG002|Overall Study|Lost to Follow-up|1|||
126364003|NCT02872142|454626698|FG000|Overall Study|Adverse Event|2|||
126364004|NCT02872142|454626698|FG000|Overall Study|Death|1|||
126364005|NCT02872142|454626698|FG000|Overall Study|Participant Decision|3|||
126364006|NCT01903720|454626699|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
126364007|NCT01903720|454626699|FG000|Overall Study|Adverse Event|1|||
126364008|NCT01903720|454626699|FG000|Overall Study|Rescinding of informed consent|2|||
126364009|NCT01903720|454626699|FG000|Overall Study|Lost to Follow-up|2|||
126364010|NCT01903720|454626699|FG000|Overall Study|Treatment with alternative drug|1|||
126364011|NCT02244957|454626700|FG000|Overall Study|Lack of Efficacy|1|||
126364012|NCT02244957|454626701|FG001|Overall Study|Lack of Efficacy|0|||
126364013|NCT02150863|454626702|FG000|Overall Study|Lost to Follow-up|0|||
126364014|NCT02150863|454626703|FG001|Overall Study|Lost to Follow-up|1|||
126364015|NCT02150863|454626704|FG002|Overall Study|Lost to Follow-up|0|||
126364016|NCT00830336|454626705|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
126364017|NCT00830336|454626706|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
126364018|NCT01853280|454626713|FG000|Overall Study|Lack of Efficacy|2|||
126364019|NCT01853280|454626714|FG001|Overall Study|Lack of Efficacy|2|||
126364020|NCT01853280|454626713|FG000|Overall Study|Lost to Follow-up|0|||
126040266|NCT03519178|453447155|FG003|PF-06873600 Treatment|Ongoing|0|||
126364021|NCT01853280|454626714|FG001|Overall Study|Lost to Follow-up|1|||
126364022|NCT01853280|454626713|FG000|Overall Study|Physician Decision|0|||
126364023|NCT01853280|454626714|FG001|Overall Study|Physician Decision|1|||
126364024|NCT01853280|454626713|FG000|Overall Study|Withdrawal by Subject|0|||
126364025|NCT01853280|454626714|FG001|Overall Study|Withdrawal by Subject|1|||
126364026|NCT01853280|454626713|FG000|Overall Study|Ineligible|0|||
126364027|NCT01853280|454626714|FG001|Overall Study|Ineligible|1|||
126280858|NCT00996892|454318481|FG016|Expansion Stage 2|Adverse Event|0|||
126280859|NCT00996892|454318482|FG017|Expansion Stage 2|Adverse Event|0|||
126280860|NCT00996892|454318483|FG018|Expansion Stage 2|Adverse Event|3|||
126280861|NCT00996892|454318484|FG019|Expansion Stage 2|Adverse Event|0|||
126280862|NCT00996892|454318465|FG000|Expansion Stage 2|Death|0|||
126280863|NCT00996892|454318466|FG001|Expansion Stage 2|Death|0|||
126280864|NCT00996892|454318467|FG002|Expansion Stage 2|Death|0|||
126280865|NCT00996892|454318468|FG003|Expansion Stage 2|Death|0|||
126280866|NCT00996892|454318469|FG004|Expansion Stage 2|Death|0|||
126280867|NCT00996892|454318470|FG005|Expansion Stage 2|Death|0|||
126280868|NCT00996892|454318471|FG006|Expansion Stage 2|Death|0|||
126280869|NCT00996892|454318472|FG007|Expansion Stage 2|Death|0|||
126280870|NCT00996892|454318473|FG008|Expansion Stage 2|Death|0|||
126280871|NCT00996892|454318474|FG009|Expansion Stage 2|Death|0|||
126280872|NCT00996892|454318475|FG010|Expansion Stage 2|Death|0|||
126280873|NCT00996892|454318476|FG011|Expansion Stage 2|Death|0|||
126280874|NCT00996892|454318477|FG012|Expansion Stage 2|Death|0|||
126280875|NCT00996892|454318478|FG013|Expansion Stage 2|Death|0|||
126280876|NCT00996892|454318479|FG014|Expansion Stage 2|Death|0|||
126280877|NCT00996892|454318480|FG015|Expansion Stage 2|Death|0|||
126280878|NCT00996892|454318481|FG016|Expansion Stage 2|Death|0|||
126280879|NCT00996892|454318482|FG017|Expansion Stage 2|Death|0|||
126280880|NCT00996892|454318483|FG018|Expansion Stage 2|Death|2|||
126280881|NCT00996892|454318484|FG019|Expansion Stage 2|Death|0|||
126280882|NCT00996892|454318465|FG000|Expansion Stage 2|Physician Decision|0|||
126280883|NCT00996892|454318466|FG001|Expansion Stage 2|Physician Decision|0|||
126280884|NCT00996892|454318467|FG002|Expansion Stage 2|Physician Decision|0|||
126280885|NCT00996892|454318468|FG003|Expansion Stage 2|Physician Decision|0|||
126280886|NCT00996892|454318469|FG004|Expansion Stage 2|Physician Decision|0|||
126280887|NCT00996892|454318470|FG005|Expansion Stage 2|Physician Decision|0|||
126280888|NCT00996892|454318471|FG006|Expansion Stage 2|Physician Decision|0|||
126280889|NCT00996892|454318472|FG007|Expansion Stage 2|Physician Decision|0|||
126280890|NCT00996892|454318473|FG008|Expansion Stage 2|Physician Decision|0|||
126280891|NCT00996892|454318474|FG009|Expansion Stage 2|Physician Decision|0|||
126280892|NCT00996892|454318475|FG010|Expansion Stage 2|Physician Decision|0|||
126280893|NCT00996892|454318476|FG011|Expansion Stage 2|Physician Decision|0|||
126280894|NCT00996892|454318477|FG012|Expansion Stage 2|Physician Decision|0|||
126280895|NCT00996892|454318478|FG013|Expansion Stage 2|Physician Decision|0|||
126280896|NCT00996892|454318479|FG014|Expansion Stage 2|Physician Decision|0|||
126280897|NCT00996892|454318480|FG015|Expansion Stage 2|Physician Decision|0|||
126280898|NCT00996892|454318481|FG016|Expansion Stage 2|Physician Decision|0|||
126280899|NCT00996892|454318482|FG017|Expansion Stage 2|Physician Decision|0|||
126280900|NCT00996892|454318483|FG018|Expansion Stage 2|Physician Decision|1|||
126280901|NCT00996892|454318484|FG019|Expansion Stage 2|Physician Decision|0|||
126280902|NCT00996892|454318465|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
126280903|NCT00996892|454318466|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
126280904|NCT00996892|454318467|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
126280905|NCT00996892|454318468|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
126280906|NCT00996892|454318469|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
126280907|NCT00996892|454318470|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
126280908|NCT00996892|454318471|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
126280909|NCT00996892|454318472|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
126280910|NCT00996892|454318473|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
126280911|NCT00996892|454318474|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
126280912|NCT00996892|454318475|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
126280913|NCT00996892|454318476|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
126280914|NCT00996892|454318477|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
126364028|NCT00104884|454626715|FG000|Overall Study|Disease progression|4|||
126364029|NCT03032484|454626716|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
125882193|NCT02113982|452868951|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882194|NCT02113982|452868952|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882195|NCT02113982|452868953|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882196|NCT02113982|452868954|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126364030|NCT03032484|454626717|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
126364031|NCT03032484|454626716|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
126364032|NCT03032484|454626717|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
126364033|NCT01229111|454626718|FG000|Overall Study|Death|1|||
126364034|NCT01689649|454626721|FG000|Overall Study|Lack of Efficacy|3|||
126364035|NCT01689649|454626721|FG000|Overall Study|Non-compliance|11|||
126364036|NCT01689649|454626721|FG000|Overall Study|Protocol Violation|3|||
126364037|NCT01689649|454626721|FG000|Overall Study|Lost to Follow-up|5|||
125882197|NCT02113982|452868955|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
126280915|NCT00996892|454318478|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
126280916|NCT00996892|454318479|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
126280917|NCT00996892|454318480|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
126364038|NCT04893811|454626722|FG000|Vaccination Phase|Death|1|||
126364039|NCT04893811|454626723|FG001|Vaccination Phase|Death|0|||
126364040|NCT04893811|454626722|FG000|Vaccination Phase|Lost to Follow-up|1|||
126364041|NCT04893811|454626723|FG001|Vaccination Phase|Lost to Follow-up|1|||
126364042|NCT04893811|454626722|FG000|Vaccination Phase|Protocol Violation|2|||
126364043|NCT04893811|454626723|FG001|Vaccination Phase|Protocol Violation|0|||
126364044|NCT04893811|454626722|FG000|Vaccination Phase|Withdrawal by Subject|2|||
126364045|NCT04893811|454626723|FG001|Vaccination Phase|Withdrawal by Subject|1|||
126364046|NCT04893811|454626722|FG000|Vaccination Phase|Other|0|||
126364047|NCT04893811|454626723|FG001|Vaccination Phase|Other|1|||
126364048|NCT04893811|454626722|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
126364049|NCT04893811|454626723|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
126364050|NCT04893811|454626722|FG000|Follow-up Phase|Lost to Follow-up|0|||
126364051|NCT04893811|454626723|FG001|Follow-up Phase|Lost to Follow-up|1|||
126364052|NCT03268499|454626724|FG000|Overall Study|Withdrawal by Subject|2|||
126364053|NCT03268499|454626725|FG001|Overall Study|Withdrawal by Subject|1|||
126364054|NCT03760081|454626729|FG000|Overall Study|Miscellaneous|0|||
126364055|NCT03760081|454626730|FG001|Overall Study|Miscellaneous|1|||
126364056|NCT03760081|454626729|FG000|Overall Study|Progressive Disease|5|||
126364057|NCT03760081|454626730|FG001|Overall Study|Progressive Disease|10|||
126364058|NCT03760081|454626729|FG000|Overall Study|Death|1|||
126364059|NCT03760081|454626730|FG001|Overall Study|Death|1|||
126364060|NCT03533491|454626731|FG000|Overall Study|Lost to Follow-up|2|||
126364061|NCT01725282|454626734|FG000|Overall Study|Adverse Event|1|||
126364062|NCT01725282|454626735|FG001|Overall Study|Adverse Event|3|||
126364063|NCT01725282|454626736|FG002|Overall Study|Adverse Event|6|||
126364064|NCT01725282|454626737|FG003|Overall Study|Adverse Event|4|||
126364065|NCT01725282|454626734|FG000|Overall Study|Exacerbation of Target Disease|1|||
126364066|NCT01725282|454626735|FG001|Overall Study|Exacerbation of Target Disease|0|||
126364067|NCT01725282|454626736|FG002|Overall Study|Exacerbation of Target Disease|0|||
126364068|NCT01725282|454626737|FG003|Overall Study|Exacerbation of Target Disease|1|||
126364069|NCT01725282|454626734|FG000|Overall Study|Met Exclusion Criteria|0|||
126364070|NCT01725282|454626735|FG001|Overall Study|Met Exclusion Criteria|0|||
126364071|NCT01725282|454626736|FG002|Overall Study|Met Exclusion Criteria|1|||
126364072|NCT01725282|454626737|FG003|Overall Study|Met Exclusion Criteria|0|||
126280918|NCT00996892|454318481|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
126280919|NCT00996892|454318482|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
126280920|NCT00996892|454318483|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
126280921|NCT00996892|454318484|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
126280922|NCT00996892|454318465|FG000|Expansion Stage 2|Disease Progression|0|||
126280923|NCT00996892|454318466|FG001|Expansion Stage 2|Disease Progression|0|||
126280924|NCT00996892|454318467|FG002|Expansion Stage 2|Disease Progression|0|||
126280925|NCT00996892|454318468|FG003|Expansion Stage 2|Disease Progression|0|||
126280926|NCT00996892|454318469|FG004|Expansion Stage 2|Disease Progression|0|||
126280927|NCT00996892|454318470|FG005|Expansion Stage 2|Disease Progression|0|||
126280928|NCT00996892|454318471|FG006|Expansion Stage 2|Disease Progression|0|||
126364073|NCT01725282|454626734|FG000|Overall Study|Study Site Withdrawal|0|||
126280929|NCT00996892|454318472|FG007|Expansion Stage 2|Disease Progression|0|||
126364074|NCT01725282|454626735|FG001|Overall Study|Study Site Withdrawal|1|||
126364075|NCT01725282|454626736|FG002|Overall Study|Study Site Withdrawal|0|||
126364076|NCT01725282|454626737|FG003|Overall Study|Study Site Withdrawal|0|||
126364077|NCT01725282|454626734|FG000|Overall Study|Withdrawal by Subject|0|||
126364078|NCT01725282|454626735|FG001|Overall Study|Withdrawal by Subject|0|||
126364079|NCT01725282|454626736|FG002|Overall Study|Withdrawal by Subject|1|||
126364080|NCT01725282|454626737|FG003|Overall Study|Withdrawal by Subject|1|||
126364081|NCT01725282|454626734|FG000|Overall Study|Lack of Efficacy|0|||
126364082|NCT01725282|454626735|FG001|Overall Study|Lack of Efficacy|1|||
126280930|NCT00996892|454318473|FG008|Expansion Stage 2|Disease Progression|0|||
126364083|NCT01725282|454626736|FG002|Overall Study|Lack of Efficacy|0|||
126280931|NCT00996892|454318474|FG009|Expansion Stage 2|Disease Progression|0|||
126280932|NCT00996892|454318475|FG010|Expansion Stage 2|Disease Progression|0|||
126280933|NCT00996892|454318476|FG011|Expansion Stage 2|Disease Progression|0|||
126280934|NCT00996892|454318477|FG012|Expansion Stage 2|Disease Progression|0|||
126280935|NCT00996892|454318478|FG013|Expansion Stage 2|Disease Progression|0|||
126280936|NCT00996892|454318479|FG014|Expansion Stage 2|Disease Progression|0|||
126280937|NCT00996892|454318480|FG015|Expansion Stage 2|Disease Progression|0|||
126280938|NCT00996892|454318481|FG016|Expansion Stage 2|Disease Progression|0|||
126280939|NCT00996892|454318482|FG017|Expansion Stage 2|Disease Progression|0|||
126280940|NCT00996892|454318483|FG018|Expansion Stage 2|Disease Progression|28|||
126280941|NCT00996892|454318484|FG019|Expansion Stage 2|Disease Progression|0|||
126280942|NCT00996892|454318465|FG000|Expansion Stage 2A|Adverse Event|0|||
126280943|NCT00996892|454318466|FG001|Expansion Stage 2A|Adverse Event|0|||
126280944|NCT00996892|454318467|FG002|Expansion Stage 2A|Adverse Event|0|||
126280945|NCT00996892|454318468|FG003|Expansion Stage 2A|Adverse Event|0|||
126280946|NCT00996892|454318469|FG004|Expansion Stage 2A|Adverse Event|0|||
126280947|NCT00996892|454318470|FG005|Expansion Stage 2A|Adverse Event|0|||
126280948|NCT00996892|454318471|FG006|Expansion Stage 2A|Adverse Event|0|||
126280949|NCT00996892|454318472|FG007|Expansion Stage 2A|Adverse Event|0|||
126280950|NCT00996892|454318473|FG008|Expansion Stage 2A|Adverse Event|0|||
126280951|NCT00996892|454318474|FG009|Expansion Stage 2A|Adverse Event|0|||
126280952|NCT00996892|454318475|FG010|Expansion Stage 2A|Adverse Event|0|||
126280953|NCT00996892|454318476|FG011|Expansion Stage 2A|Adverse Event|0|||
126280954|NCT00996892|454318477|FG012|Expansion Stage 2A|Adverse Event|0|||
126364084|NCT01725282|454626737|FG003|Overall Study|Lack of Efficacy|1|||
126364085|NCT04064567|454626738|FG000|Overall Study|Lost to Follow-up|23|||
126364086|NCT04064567|454626739|FG001|Overall Study|Lost to Follow-up|22|||
126364087|NCT04064567|454626738|FG000|Overall Study|Withdrawal by Subject|0|||
126364088|NCT04064567|454626739|FG001|Overall Study|Withdrawal by Subject|1|||
126364089|NCT04064567|454626738|FG000|Overall Study|Reincarcerated|7|||
126364090|NCT04064567|454626739|FG001|Overall Study|Reincarcerated|10|||
126364091|NCT04064567|454626738|FG000|Overall Study|Moved out of U.S.|0|||
126364092|NCT04064567|454626739|FG001|Overall Study|Moved out of U.S.|1|||
126364093|NCT04576481|454626741|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
126364094|NCT04576481|454626742|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
126364095|NCT04576481|454626743|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
126364096|NCT04576481|454626744|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
126364097|NCT01946880|454626745|FG000|Overall Study|Lost to Follow-up|1|||
126364098|NCT01946880|454626746|FG001|Overall Study|Lost to Follow-up|0|||
126364099|NCT01946880|454626745|FG000|Overall Study|Physician Decision|1|||
126364100|NCT01946880|454626746|FG001|Overall Study|Physician Decision|1|||
126364101|NCT01946880|454626745|FG000|Overall Study|Withdrawal by Subject|3|||
126364102|NCT01946880|454626746|FG001|Overall Study|Withdrawal by Subject|2|||
126364103|NCT01946880|454626745|FG000|Overall Study|Met Primary Endpoint|1|||
126364104|NCT01946880|454626746|FG001|Overall Study|Met Primary Endpoint|0|||
126364105|NCT01946880|454626745|FG000|Overall Study|Personal and Family Issues|1|||
126364106|NCT01946880|454626746|FG001|Overall Study|Personal and Family Issues|0|||
126364107|NCT01682720|454626749|FG000|Overall Study|Randomized but Not Treated|0|||
126364108|NCT01682720|454626750|FG001|Overall Study|Randomized but Not Treated|1|||
126364109|NCT01682720|454626751|FG002|Overall Study|Randomized but Not Treated|1|||
126364110|NCT01682720|454626752|FG003|Overall Study|Randomized but Not Treated|0|||
126364111|NCT01682720|454626749|FG000|Overall Study|Terminated by Sponsor|83|||
126364112|NCT01682720|454626750|FG001|Overall Study|Terminated by Sponsor|0|||
126280955|NCT00996892|454318478|FG013|Expansion Stage 2A|Adverse Event|0|||
126280956|NCT00996892|454318479|FG014|Expansion Stage 2A|Adverse Event|0|||
126364113|NCT01682720|454626751|FG002|Overall Study|Terminated by Sponsor|0|||
126364114|NCT01682720|454626752|FG003|Overall Study|Terminated by Sponsor|0|||
126364115|NCT01682720|454626749|FG000|Overall Study|Efficacy Failure|0|||
126364116|NCT01682720|454626750|FG001|Overall Study|Efficacy Failure|3|||
126364117|NCT01682720|454626751|FG002|Overall Study|Efficacy Failure|3|||
126364118|NCT01682720|454626752|FG003|Overall Study|Efficacy Failure|30|||
126364119|NCT01682720|454626749|FG000|Overall Study|Lost to Follow-up|1|||
126364120|NCT01682720|454626750|FG001|Overall Study|Lost to Follow-up|1|||
126364121|NCT01682720|454626751|FG002|Overall Study|Lost to Follow-up|0|||
126364122|NCT01682720|454626752|FG003|Overall Study|Lost to Follow-up|6|||
126364123|NCT01682720|454626749|FG000|Overall Study|Subject Withdrew Consent|0|||
126364124|NCT01682720|454626750|FG001|Overall Study|Subject Withdrew Consent|0|||
126364125|NCT01682720|454626751|FG002|Overall Study|Subject Withdrew Consent|2|||
126364126|NCT01682720|454626752|FG003|Overall Study|Subject Withdrew Consent|2|||
126364127|NCT01682720|454626749|FG000|Overall Study|Adverse Event|1|||
126364128|NCT01682720|454626750|FG001|Overall Study|Adverse Event|0|||
126364129|NCT01682720|454626751|FG002|Overall Study|Adverse Event|1|||
126040267|NCT03519178|453447156|FG004|PF-06873600 Treatment|Ongoing|0|||
126280957|NCT00996892|454318480|FG015|Expansion Stage 2A|Adverse Event|0|||
126280958|NCT00996892|454318481|FG016|Expansion Stage 2A|Adverse Event|0|||
126280959|NCT00996892|454318482|FG017|Expansion Stage 2A|Adverse Event|0|||
126280960|NCT00996892|454318483|FG018|Expansion Stage 2A|Adverse Event|0|||
126040268|NCT03519178|453447157|FG005|PF-06873600 Treatment|Ongoing|0|||
126040269|NCT03519178|453447158|FG006|PF-06873600 Treatment|Ongoing|0|||
126040270|NCT03519178|453447159|FG007|PF-06873600 Treatment|Ongoing|0|||
126040271|NCT03519178|453447160|FG008|PF-06873600 Treatment|Ongoing|0|||
126040272|NCT03519178|453447161|FG009|PF-06873600 Treatment|Ongoing|0|||
126280961|NCT00996892|454318484|FG019|Expansion Stage 2A|Adverse Event|8|||
126280962|NCT00996892|454318465|FG000|Expansion Stage 2A|Physician Decision|0|||
126280963|NCT00996892|454318466|FG001|Expansion Stage 2A|Physician Decision|0|||
126280964|NCT00996892|454318467|FG002|Expansion Stage 2A|Physician Decision|0|||
126280965|NCT00996892|454318468|FG003|Expansion Stage 2A|Physician Decision|0|||
126280966|NCT00996892|454318469|FG004|Expansion Stage 2A|Physician Decision|0|||
126280967|NCT00996892|454318470|FG005|Expansion Stage 2A|Physician Decision|0|||
126280968|NCT00996892|454318471|FG006|Expansion Stage 2A|Physician Decision|0|||
126280969|NCT00996892|454318472|FG007|Expansion Stage 2A|Physician Decision|0|||
126280970|NCT00996892|454318473|FG008|Expansion Stage 2A|Physician Decision|0|||
126280971|NCT00996892|454318474|FG009|Expansion Stage 2A|Physician Decision|0|||
126280972|NCT00996892|454318475|FG010|Expansion Stage 2A|Physician Decision|0|||
126280973|NCT00996892|454318476|FG011|Expansion Stage 2A|Physician Decision|0|||
126280974|NCT00996892|454318477|FG012|Expansion Stage 2A|Physician Decision|0|||
126280975|NCT00996892|454318478|FG013|Expansion Stage 2A|Physician Decision|0|||
126280976|NCT00996892|454318479|FG014|Expansion Stage 2A|Physician Decision|0|||
126280977|NCT00996892|454318480|FG015|Expansion Stage 2A|Physician Decision|0|||
126280978|NCT00996892|454318481|FG016|Expansion Stage 2A|Physician Decision|0|||
126280979|NCT00996892|454318482|FG017|Expansion Stage 2A|Physician Decision|0|||
126280980|NCT00996892|454318483|FG018|Expansion Stage 2A|Physician Decision|0|||
126280981|NCT00996892|454318484|FG019|Expansion Stage 2A|Physician Decision|2|||
126280982|NCT00996892|454318465|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
126280983|NCT00996892|454318466|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
126280984|NCT00996892|454318467|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
126280985|NCT00996892|454318468|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
126280986|NCT00996892|454318469|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
126280987|NCT00996892|454318470|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
126280988|NCT00996892|454318471|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
126280989|NCT00996892|454318472|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
126280990|NCT00996892|454318473|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
126280991|NCT00996892|454318474|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
126280992|NCT00996892|454318475|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
126280993|NCT00996892|454318476|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
126280994|NCT00996892|454318477|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
126280995|NCT00996892|454318478|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
126280996|NCT00996892|454318479|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
126280997|NCT00996892|454318480|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
126280998|NCT00996892|454318481|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
126280999|NCT00996892|454318482|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
126281000|NCT00996892|454318483|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
126281001|NCT00996892|454318484|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
126281002|NCT00996892|454318465|FG000|Expansion Stage 2A|Disease Progression|0|||
126281003|NCT00996892|454318466|FG001|Expansion Stage 2A|Disease Progression|0|||
126281004|NCT00996892|454318467|FG002|Expansion Stage 2A|Disease Progression|0|||
126281005|NCT00996892|454318468|FG003|Expansion Stage 2A|Disease Progression|0|||
126281006|NCT00996892|454318469|FG004|Expansion Stage 2A|Disease Progression|0|||
126281007|NCT00996892|454318470|FG005|Expansion Stage 2A|Disease Progression|0|||
126281008|NCT00996892|454318471|FG006|Expansion Stage 2A|Disease Progression|0|||
126281009|NCT00996892|454318472|FG007|Expansion Stage 2A|Disease Progression|0|||
126281010|NCT00996892|454318473|FG008|Expansion Stage 2A|Disease Progression|0|||
126281011|NCT00996892|454318474|FG009|Expansion Stage 2A|Disease Progression|0|||
126281012|NCT00996892|454318475|FG010|Expansion Stage 2A|Disease Progression|0|||
126281013|NCT00996892|454318476|FG011|Expansion Stage 2A|Disease Progression|0|||
126281014|NCT00996892|454318477|FG012|Expansion Stage 2A|Disease Progression|0|||
126281015|NCT00996892|454318478|FG013|Expansion Stage 2A|Disease Progression|0|||
126281016|NCT00996892|454318479|FG014|Expansion Stage 2A|Disease Progression|0|||
126281017|NCT00996892|454318480|FG015|Expansion Stage 2A|Disease Progression|0|||
126281018|NCT00996892|454318481|FG016|Expansion Stage 2A|Disease Progression|0|||
126281019|NCT00996892|454318482|FG017|Expansion Stage 2A|Disease Progression|0|||
126281020|NCT00996892|454318483|FG018|Expansion Stage 2A|Disease Progression|0|||
126281021|NCT00996892|454318484|FG019|Expansion Stage 2A|Disease Progression|31|||
126040273|NCT03519178|453447162|FG010|PF-06873600 Treatment|Ongoing|0|||
126040274|NCT03519178|453447163|FG011|PF-06873600 Treatment|Ongoing|0|||
126281022|NCT01653912|454318485|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281023|NCT01653912|454318486|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
126281024|NCT01653912|454318487|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281025|NCT01653912|454318488|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281026|NCT01653912|454318489|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281027|NCT01653912|454318490|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281028|NCT01653912|454318485|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281029|NCT01653912|454318486|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281030|NCT01653912|454318487|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
126281031|NCT01653912|454318488|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281032|NCT01653912|454318489|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281033|NCT01653912|454318490|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281034|NCT01653912|454318485|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281035|NCT01653912|454318486|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281036|NCT01653912|454318487|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281037|NCT01653912|454318488|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
126281038|NCT01653912|454318489|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281039|NCT01653912|454318490|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281040|NCT01653912|454318485|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281041|NCT01653912|454318486|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281042|NCT01653912|454318487|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281043|NCT01653912|454318488|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
126281044|NCT01653912|454318489|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281045|NCT01653912|454318490|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281046|NCT01653912|454318485|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281047|NCT01653912|454318486|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281048|NCT01653912|454318487|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281049|NCT01653912|454318488|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281050|NCT01653912|454318489|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281051|NCT01653912|454318490|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
126281052|NCT01653912|454318485|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281053|NCT01653912|454318486|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281054|NCT01653912|454318487|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281055|NCT01653912|454318488|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281056|NCT01653912|454318489|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281057|NCT01653912|454318490|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
126281058|NCT01653912|454318485|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281059|NCT01653912|454318486|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281060|NCT01653912|454318487|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281061|NCT01653912|454318488|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281062|NCT01653912|454318489|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281063|NCT01653912|454318490|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
126281064|NCT00602641|454320698|FG000|Overall Study|Never started protocol therapy|6|||
126281065|NCT00602641|454320699|FG001|Overall Study|Never started protocol therapy|2|||
126281066|NCT00602641|454320698|FG000|Overall Study|Still on treatment at time of analysis|8|||
126281067|NCT00602641|454320699|FG001|Overall Study|Still on treatment at time of analysis|15|||
126281068|NCT00602641|454320698|FG000|Overall Study|Adverse Event|62|||
126281069|NCT00602641|454320699|FG001|Overall Study|Adverse Event|53|||
126281070|NCT00602641|454320698|FG000|Overall Study|Disease progression|38|||
126281071|NCT00602641|454320699|FG001|Overall Study|Disease progression|55|||
126281072|NCT00602641|454320698|FG000|Overall Study|Death|6|||
126281073|NCT00602641|454320699|FG001|Overall Study|Death|5|||
126281074|NCT00602641|454320698|FG000|Overall Study|Withdrawal by Subject|15|||
126281075|NCT00602641|454320699|FG001|Overall Study|Withdrawal by Subject|12|||
126281076|NCT00602641|454320698|FG000|Overall Study|Alternative therapy|5|||
126281077|NCT00602641|454320699|FG001|Overall Study|Alternative therapy|2|||
126281078|NCT00602641|454320698|FG000|Overall Study|Other Complicating Disease|5|||
126281079|NCT00602641|454320699|FG001|Overall Study|Other Complicating Disease|2|||
126281080|NCT00602641|454320698|FG000|Overall Study|Physician Decision|5|||
126281081|NCT00602641|454320699|FG001|Overall Study|Physician Decision|4|||
126281082|NCT00602641|454320698|FG000|Overall Study|Administrative Closure|1|||
126281083|NCT00602641|454320699|FG001|Overall Study|Administrative Closure|1|||
126281084|NCT00602641|454320698|FG000|Overall Study|Other|3|||
126281085|NCT00602641|454320699|FG001|Overall Study|Other|1|||
126281086|NCT03408639|454320705|FG000|Overall Study|Death|5|||
126281087|NCT03408639|454320706|FG001|Overall Study|Death|5|||
126281088|NCT03408639|454320705|FG000|Overall Study|Lost to Follow-up|1|||
126281089|NCT03408639|454320706|FG001|Overall Study|Lost to Follow-up|4|||
126098967|NCT02480153|453655579|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
126364130|NCT01682720|454626752|FG003|Overall Study|Adverse Event|1|||
126281090|NCT03408639|454320705|FG000|Overall Study|Withdrawal by Subject|2|||
126281091|NCT03408639|454320706|FG001|Overall Study|Withdrawal by Subject|7|||
126281092|NCT03408639|454320705|FG000|Overall Study|Physician Decision|3|||
126281093|NCT03408639|454320706|FG001|Overall Study|Physician Decision|6|||
126281094|NCT00070499|454320707|FG000|Overall Study|Adverse Event|6|||
126281095|NCT00070499|454320708|FG001|Overall Study|Adverse Event|6|||
126281096|NCT00070499|454320709|FG002|Overall Study|Adverse Event|19|||
126281097|NCT00070499|454320710|FG003|Overall Study|Adverse Event|15|||
126281098|NCT00070499|454320707|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
126281099|NCT00070499|454320708|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
126281100|NCT00070499|454320709|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
126281101|NCT00070499|454320710|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
126281102|NCT00070499|454320707|FG000|Overall Study|Progression/relapse|4|||
126281103|NCT00070499|454320708|FG001|Overall Study|Progression/relapse|2|||
126281104|NCT00070499|454320709|FG002|Overall Study|Progression/relapse|1|||
126281105|NCT00070499|454320710|FG003|Overall Study|Progression/relapse|4|||
126281106|NCT00070499|454320707|FG000|Overall Study|Death|1|||
126281107|NCT00070499|454320708|FG001|Overall Study|Death|1|||
126281108|NCT00070499|454320709|FG002|Overall Study|Death|1|||
126281109|NCT00070499|454320710|FG003|Overall Study|Death|2|||
126281110|NCT00070499|454320707|FG000|Overall Study|Other - not protocol specified|7|||
126281111|NCT00070499|454320708|FG001|Overall Study|Other - not protocol specified|3|||
126281112|NCT00070499|454320709|FG002|Overall Study|Other - not protocol specified|12|||
126281113|NCT00070499|454320710|FG003|Overall Study|Other - not protocol specified|20|||
126281114|NCT00070499|454320707|FG000|Overall Study|Still on protocol treatment|10|||
126281115|NCT00070499|454320708|FG001|Overall Study|Still on protocol treatment|4|||
126281116|NCT00070499|454320709|FG002|Overall Study|Still on protocol treatment|79|||
126281117|NCT00070499|454320710|FG003|Overall Study|Still on protocol treatment|57|||
126281118|NCT00070499|454320707|FG000|Overall Study|Did not start treatment|1|||
126281119|NCT00070499|454320708|FG001|Overall Study|Did not start treatment|0|||
126281120|NCT00070499|454320709|FG002|Overall Study|Did not start treatment|0|||
126281121|NCT00070499|454320710|FG003|Overall Study|Did not start treatment|2|||
126281122|NCT00070499|454320707|FG000|Overall Study|Not eligible|2|||
126281123|NCT00070499|454320708|FG001|Overall Study|Not eligible|5|||
126281124|NCT00070499|454320709|FG002|Overall Study|Not eligible|3|||
126281125|NCT00070499|454320710|FG003|Overall Study|Not eligible|2|||
126281126|NCT00587860|454320718|FG000|Overall Study|Lost to Follow-up|2|||
126281127|NCT00587860|454320719|FG001|Overall Study|Lost to Follow-up|2|||
126281128|NCT00587860|454320718|FG000|Overall Study|Withdrawal by Subject|3|||
126281129|NCT00587860|454320719|FG001|Overall Study|Withdrawal by Subject|3|||
126281130|NCT01371747|454320722|FG000|Overall Study|Adverse Event|4|||
126281131|NCT01371747|454320723|FG001|Overall Study|Adverse Event|2|||
126281132|NCT01371747|454320724|FG002|Overall Study|Adverse Event|7|||
126281133|NCT01371747|454320725|FG003|Overall Study|Adverse Event|2|||
126281134|NCT01371747|454320726|FG004|Overall Study|Adverse Event|2|||
126281135|NCT01371747|454320727|FG005|Overall Study|Adverse Event|2|||
126281136|NCT01371747|454320722|FG000|Overall Study|Death|1|||
126281137|NCT01371747|454320723|FG001|Overall Study|Death|0|||
126281138|NCT01371747|454320724|FG002|Overall Study|Death|4|||
126281139|NCT01371747|454320725|FG003|Overall Study|Death|1|||
126281140|NCT01371747|454320726|FG004|Overall Study|Death|2|||
126281141|NCT01371747|454320727|FG005|Overall Study|Death|0|||
126281142|NCT01371747|454320722|FG000|Overall Study|Abnormal Renal Function|0|||
126281143|NCT01371747|454320723|FG001|Overall Study|Abnormal Renal Function|2|||
126281144|NCT01371747|454320724|FG002|Overall Study|Abnormal Renal Function|0|||
126364131|NCT04204902|454626753|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
126364132|NCT04204902|454626754|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
126281145|NCT01371747|454320725|FG003|Overall Study|Abnormal Renal Function|1|||
126281146|NCT01371747|454320726|FG004|Overall Study|Abnormal Renal Function|0|||
126281147|NCT01371747|454320727|FG005|Overall Study|Abnormal Renal Function|1|||
126281148|NCT01371747|454320722|FG000|Overall Study|High Serum Potassium Results|1|||
126281149|NCT01371747|454320723|FG001|Overall Study|High Serum Potassium Results|1|||
126281150|NCT01371747|454320724|FG002|Overall Study|High Serum Potassium Results|1|||
126281151|NCT01371747|454320725|FG003|Overall Study|High Serum Potassium Results|2|||
126281152|NCT01371747|454320726|FG004|Overall Study|High Serum Potassium Results|0|||
126281153|NCT01371747|454320727|FG005|Overall Study|High Serum Potassium Results|2|||
126281154|NCT01371747|454320722|FG000|Overall Study|Low Serum Potassium Results|1|||
126281155|NCT01371747|454320723|FG001|Overall Study|Low Serum Potassium Results|1|||
126281156|NCT01371747|454320724|FG002|Overall Study|Low Serum Potassium Results|1|||
126281157|NCT01371747|454320725|FG003|Overall Study|Low Serum Potassium Results|1|||
126281158|NCT01371747|454320726|FG004|Overall Study|Low Serum Potassium Results|0|||
126281159|NCT01371747|454320727|FG005|Overall Study|Low Serum Potassium Results|3|||
126281160|NCT01371747|454320722|FG000|Overall Study|Protocol Violation|0|||
126281161|NCT01371747|454320723|FG001|Overall Study|Protocol Violation|0|||
126281162|NCT01371747|454320724|FG002|Overall Study|Protocol Violation|1|||
126281163|NCT01371747|454320725|FG003|Overall Study|Protocol Violation|0|||
126281164|NCT01371747|454320726|FG004|Overall Study|Protocol Violation|0|||
126281165|NCT01371747|454320727|FG005|Overall Study|Protocol Violation|0|||
126281166|NCT01371747|454320722|FG000|Overall Study|Non-Compliance|3|||
126281167|NCT01371747|454320723|FG001|Overall Study|Non-Compliance|4|||
126281168|NCT01371747|454320724|FG002|Overall Study|Non-Compliance|3|||
126281169|NCT01371747|454320725|FG003|Overall Study|Non-Compliance|0|||
126281170|NCT01371747|454320726|FG004|Overall Study|Non-Compliance|0|||
126281171|NCT01371747|454320727|FG005|Overall Study|Non-Compliance|1|||
126281172|NCT01371747|454320722|FG000|Overall Study|Physician Decision|0|||
126281173|NCT01371747|454320723|FG001|Overall Study|Physician Decision|0|||
126281174|NCT01371747|454320724|FG002|Overall Study|Physician Decision|0|||
126281175|NCT01371747|454320725|FG003|Overall Study|Physician Decision|0|||
126364133|NCT04525183|454626757|FG000|Overall Study|Withdrawal by Subject|0|||
126364134|NCT04525183|454626758|FG001|Overall Study|Withdrawal by Subject|0|||
126364135|NCT04525183|454626759|FG002|Overall Study|Withdrawal by Subject|3|||
126364136|NCT04525183|454626757|FG000|Overall Study|Study non-compliance|0|||
126364137|NCT04525183|454626758|FG001|Overall Study|Study non-compliance|0|||
126364138|NCT04525183|454626759|FG002|Overall Study|Study non-compliance|1|||
126364139|NCT04525183|454626757|FG000|Overall Study|Recurrent disease before starting on study|0|||
126364140|NCT04525183|454626758|FG001|Overall Study|Recurrent disease before starting on study|0|||
126364141|NCT04525183|454626759|FG002|Overall Study|Recurrent disease before starting on study|1|||
125882198|NCT02113982|452868956|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882199|NCT02113982|452868957|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
125882200|NCT02113982|452868958|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882201|NCT02113982|452868959|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882202|NCT02113982|452868960|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882203|NCT02113982|452868961|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125882204|NCT02113982|452868948|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126040275|NCT03519178|453447164|FG012|PF-06873600 Treatment|Ongoing|0|||
126040276|NCT03519178|453447165|FG013|PF-06873600 Treatment|Ongoing|1|||
126040277|NCT03519178|453447166|FG014|PF-06873600 Treatment|Ongoing|6|||
126040278|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040279|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040280|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040281|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040282|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040283|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040284|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040285|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040286|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040287|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126281176|NCT01371747|454320726|FG004|Overall Study|Physician Decision|1|||
126281177|NCT01371747|454320727|FG005|Overall Study|Physician Decision|0|||
126281178|NCT01371747|454320722|FG000|Overall Study|Withdrawal by Subject|6|||
126281179|NCT01371747|454320723|FG001|Overall Study|Withdrawal by Subject|12|||
126281180|NCT01371747|454320724|FG002|Overall Study|Withdrawal by Subject|5|||
126281181|NCT01371747|454320725|FG003|Overall Study|Withdrawal by Subject|2|||
126281182|NCT01371747|454320726|FG004|Overall Study|Withdrawal by Subject|2|||
126281183|NCT01371747|454320727|FG005|Overall Study|Withdrawal by Subject|4|||
126281184|NCT01371747|454320722|FG000|Overall Study|Other Reasons|2|||
126281185|NCT01371747|454320723|FG001|Overall Study|Other Reasons|1|||
126281186|NCT01371747|454320724|FG002|Overall Study|Other Reasons|2|||
126281187|NCT01371747|454320725|FG003|Overall Study|Other Reasons|0|||
126281188|NCT01371747|454320726|FG004|Overall Study|Other Reasons|0|||
126281189|NCT01371747|454320727|FG005|Overall Study|Other Reasons|1|||
126281190|NCT03092219|454320728|FG000|Overall Study|Protocol Violation|7|||
126281191|NCT03092219|454320729|FG001|Overall Study|Protocol Violation|4|||
126281192|NCT00580788|454320732|FG000|Overall Study|Adverse Event|0|||
126281193|NCT00580788|454320733|FG001|Overall Study|Adverse Event|0|||
126281194|NCT00580788|454320734|FG002|Overall Study|Adverse Event|0|||
126281195|NCT00580788|454320735|FG003|Overall Study|Adverse Event|1|||
126281196|NCT04971187|454320736|FG000|Overall Study|Screen failures|2|||
126281197|NCT01443728|454320737|FG000|Overall Study|Lost to Follow-up|2|||
126281198|NCT01443728|454320738|FG001|Overall Study|Lost to Follow-up|0|||
126281199|NCT01443728|454320737|FG000|Overall Study|Withdrawal by Subject|1|||
126281200|NCT01443728|454320738|FG001|Overall Study|Withdrawal by Subject|1|||
126281201|NCT01443728|454320737|FG000|Overall Study|Adverse Event|0|||
126281202|NCT01443728|454320738|FG001|Overall Study|Adverse Event|2|||
126281203|NCT02906358|454320739|FG000|Overall Study|Withdrawal by Subject|10|||
126281204|NCT02906358|454320740|FG001|Overall Study|Withdrawal by Subject|7|||
126281205|NCT02906358|454320739|FG000|Overall Study|Lost to Follow-up|12|||
126281206|NCT02906358|454320740|FG001|Overall Study|Lost to Follow-up|15|||
126281207|NCT02045147|454320742|FG000|Overall Study|Withdrawal by Subject|2|||
126281208|NCT02045147|454320743|FG001|Overall Study|Withdrawal by Subject|0|||
126281209|NCT02045147|454320744|FG002|Overall Study|Withdrawal by Subject|0|||
126281210|NCT02045147|454320745|FG003|Overall Study|Withdrawal by Subject|0|||
126281211|NCT02045147|454320746|FG004|Overall Study|Withdrawal by Subject|0|||
126281212|NCT02045147|454320747|FG005|Overall Study|Withdrawal by Subject|0|||
126364142|NCT00979407|454626760|FG000|Overall Study|Withdrawal by Subject|3|||
126364143|NCT00979407|454626761|FG001|Overall Study|Withdrawal by Subject|4|||
126364144|NCT00979407|454626760|FG000|Overall Study|Lost to Follow-up|3|||
126040288|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040289|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126281213|NCT02045147|454320748|FG006|Overall Study|Withdrawal by Subject|0|||
126281214|NCT02045147|454320749|FG007|Overall Study|Withdrawal by Subject|1|||
126281215|NCT02045147|454320742|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
126281216|NCT02045147|454320743|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
126281217|NCT02045147|454320744|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
126281218|NCT02045147|454320745|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
126281219|NCT02045147|454320746|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
126281220|NCT02045147|454320747|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
126281221|NCT02045147|454320748|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
126281222|NCT02045147|454320749|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
126281223|NCT04497948|454320752|FG000|Overall Study|Death|2|||
126364145|NCT00979407|454626761|FG001|Overall Study|Lost to Follow-up|3|||
126364146|NCT01166646|454626762|FG000|Overall Study|Protocol Violation|0|||
126364147|NCT01166646|454626763|FG001|Overall Study|Protocol Violation|1|||
126364148|NCT01166646|454626762|FG000|Overall Study|Adverse Event|1|||
126364149|NCT01166646|454626763|FG001|Overall Study|Adverse Event|0|||
126364150|NCT01335685|454626765|FG000|Overall Study|Study Terminated by Sponsor|2|||
126281224|NCT03760185|454320753|FG000|Overall Study|Lost to Follow-up|1|||
126281225|NCT03760185|454320754|FG001|Overall Study|Lost to Follow-up|1|||
126281226|NCT02954991|454320755|FG000|Overall Study|Death|92|||
126281227|NCT02954991|454320756|FG001|Overall Study|Death|11|||
126281228|NCT02954991|454320757|FG002|Overall Study|Death|2|||
126281229|NCT02954991|454320755|FG000|Overall Study|Lost to Follow-up|3|||
126281230|NCT02954991|454320756|FG001|Overall Study|Lost to Follow-up|2|||
126281231|NCT02954991|454320757|FG002|Overall Study|Lost to Follow-up|0|||
126281232|NCT02954991|454320755|FG000|Overall Study|Withdrawal by Subject|9|||
126281233|NCT02954991|454320756|FG001|Overall Study|Withdrawal by Subject|8|||
126364151|NCT01335685|454626766|FG001|Overall Study|Study Terminated by Sponsor|1|||
126364152|NCT01335685|454626767|FG002|Overall Study|Study Terminated by Sponsor|1|||
126364153|NCT01335685|454626768|FG003|Overall Study|Study Terminated by Sponsor|10|||
126364154|NCT01335685|454626769|FG004|Overall Study|Study Terminated by Sponsor|0|||
126040290|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040291|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
126040292|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126040293|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Death|0|||
126040294|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Death|0|||
126281234|NCT02954991|454320757|FG002|Overall Study|Withdrawal by Subject|1|||
126281235|NCT02954991|454320755|FG000|Overall Study|Study Terminated by Sponsor|18|||
126281236|NCT02954991|454320756|FG001|Overall Study|Study Terminated by Sponsor|10|||
126281237|NCT02954991|454320757|FG002|Overall Study|Study Terminated by Sponsor|1|||
126281238|NCT02954991|454320755|FG000|Overall Study|Miscellaneous|2|||
126281239|NCT02954991|454320756|FG001|Overall Study|Miscellaneous|1|||
126281240|NCT02954991|454320757|FG002|Overall Study|Miscellaneous|1|||
126281241|NCT02052011|454320758|FG000|Overall Study|Lost to Follow-up|3|||
126281242|NCT02052011|454320759|FG001|Overall Study|Lost to Follow-up|0|||
126281243|NCT02052011|454320758|FG000|Overall Study|Withdrawal by Subject|1|||
126281244|NCT02052011|454320759|FG001|Overall Study|Withdrawal by Subject|2|||
126281245|NCT02648932|454320760|FG000|Overall Study|No transplant|3|||
126281246|NCT02648932|454320761|FG001|Overall Study|No transplant|1|||
126281247|NCT02960490|454320762|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
126281248|NCT02960490|454320763|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
126281249|NCT02960490|454320764|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281250|NCT02960490|454320765|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281251|NCT02960490|454320766|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281252|NCT02960490|454320767|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281253|NCT02960490|454320768|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281254|NCT02960490|454320769|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281255|NCT02960490|454320770|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281256|NCT02960490|454320771|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281257|NCT02960490|454320762|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281258|NCT02960490|454320763|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
126281259|NCT02960490|454320764|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281260|NCT02960490|454320765|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281261|NCT02960490|454320766|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281262|NCT02960490|454320767|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281263|NCT02960490|454320768|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281264|NCT02960490|454320769|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281265|NCT02960490|454320770|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281266|NCT02960490|454320771|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281267|NCT02960490|454320762|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
126281268|NCT02960490|454320763|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
126281269|NCT02960490|454320764|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281270|NCT02960490|454320765|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281271|NCT02960490|454320766|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281272|NCT02960490|454320767|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281273|NCT02960490|454320768|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281274|NCT02960490|454320769|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281275|NCT02960490|454320770|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281276|NCT02960490|454320771|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281277|NCT02960490|454320762|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
126281278|NCT02960490|454320763|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
126281279|NCT02960490|454320764|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281280|NCT02960490|454320765|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281281|NCT02960490|454320766|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281282|NCT02960490|454320767|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281283|NCT02960490|454320768|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281284|NCT02960490|454320769|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281285|NCT02960490|454320770|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281286|NCT02960490|454320771|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281287|NCT02960490|454320762|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281288|NCT02960490|454320763|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281289|NCT02960490|454320764|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
126281290|NCT02960490|454320765|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
126281291|NCT02960490|454320766|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281292|NCT02960490|454320767|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
126281293|NCT02960490|454320768|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126364155|NCT01335685|454626770|FG005|Overall Study|Study Terminated by Sponsor|4|||
126040295|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Death|0|||
126364156|NCT01335685|454626771|FG006|Overall Study|Study Terminated by Sponsor|2|||
126364157|NCT01335685|454626772|FG007|Overall Study|Study Terminated by Sponsor|3|||
126364158|NCT01335685|454626765|FG000|Overall Study|Withdrawal by Subject|1|||
126281294|NCT02960490|454320769|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281295|NCT02960490|454320770|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281296|NCT02960490|454320771|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281297|NCT02960490|454320762|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281298|NCT02960490|454320763|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281299|NCT02960490|454320764|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
126281300|NCT02960490|454320765|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281301|NCT02960490|454320766|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
126281302|NCT02960490|454320767|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281303|NCT02960490|454320768|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281304|NCT02960490|454320769|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126364159|NCT01335685|454626766|FG001|Overall Study|Withdrawal by Subject|0|||
126364160|NCT01335685|454626767|FG002|Overall Study|Withdrawal by Subject|0|||
125882205|NCT02113982|452868949|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125882206|NCT02113982|452868950|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126364161|NCT01335685|454626768|FG003|Overall Study|Withdrawal by Subject|1|||
126364162|NCT01335685|454626769|FG004|Overall Study|Withdrawal by Subject|0|||
126364163|NCT01335685|454626770|FG005|Overall Study|Withdrawal by Subject|0|||
126364164|NCT01335685|454626771|FG006|Overall Study|Withdrawal by Subject|0|||
126364165|NCT01335685|454626772|FG007|Overall Study|Withdrawal by Subject|0|||
126364166|NCT01335685|454626765|FG000|Overall Study|Reason not Specified|0|||
126364167|NCT01335685|454626766|FG001|Overall Study|Reason not Specified|0|||
126364168|NCT01335685|454626767|FG002|Overall Study|Reason not Specified|1|||
126364169|NCT01335685|454626768|FG003|Overall Study|Reason not Specified|0|||
126364170|NCT01335685|454626769|FG004|Overall Study|Reason not Specified|0|||
126364171|NCT01335685|454626770|FG005|Overall Study|Reason not Specified|1|||
126364172|NCT01335685|454626771|FG006|Overall Study|Reason not Specified|0|||
126364173|NCT01335685|454626772|FG007|Overall Study|Reason not Specified|0|||
126364174|NCT03777020|454626775|FG000|Overall Study|Withdrawal by Subject|4|||
126364175|NCT03777020|454626776|FG001|Overall Study|Withdrawal by Subject|4|||
126364176|NCT03777020|454626775|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
126364177|NCT03777020|454626776|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
126364178|NCT00489476|454626777|FG000|Overall Study|Lost to Follow-up|0|||
126364179|NCT00489476|454626778|FG001|Overall Study|Lost to Follow-up|1|||
126364180|NCT00489476|454626779|FG002|Overall Study|Lost to Follow-up|0|||
126364181|NCT00489476|454626780|FG003|Overall Study|Lost to Follow-up|0|||
125882207|NCT02113982|452868951|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125882208|NCT02113982|452868952|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126281305|NCT02960490|454320770|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126364182|NCT00480025|454626781|FG000|Overall Study|Protocol Violation|12|||
126281306|NCT02960490|454320771|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281307|NCT02960490|454320762|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
126281308|NCT02960490|454320763|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
126281309|NCT02960490|454320764|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
126281310|NCT02960490|454320765|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
126281311|NCT02960490|454320766|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
126281312|NCT02960490|454320767|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
126281313|NCT02960490|454320768|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
126281314|NCT02960490|454320769|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
126281315|NCT02960490|454320770|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
126281316|NCT02960490|454320771|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
126281317|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281318|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281319|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281320|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281321|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281322|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281323|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
126281324|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
125882209|NCT02113982|452868953|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126281325|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
126281326|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281327|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126364183|NCT00480025|454626782|FG001|Overall Study|Protocol Violation|7|||
126364184|NCT00480025|454626781|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
126364185|NCT00480025|454626782|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
126364186|NCT00480025|454626781|FG000|Overall Study|Disease Progression / Recurrence|449|||
126281328|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126040296|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Death|0|||
126040297|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Death|0|||
126040298|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Death|0|||
126040299|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Death|0|||
126040300|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Death|0|||
126040301|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Death|0|||
126040302|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Death|1|||
126040303|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Death|0|||
126040304|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Death|0|||
126040305|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Death|0|||
126040306|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Death|0|||
126040307|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Death|1|||
126040308|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040309|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040310|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040311|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040312|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040313|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040314|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040315|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040316|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040317|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040318|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040319|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040320|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040321|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126040322|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
126040323|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126040324|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126040325|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126040326|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126040327|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126281329|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281330|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281331|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281332|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281333|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281334|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
126281335|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281336|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281337|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281338|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281339|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281340|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281341|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281342|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281343|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
126281344|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
126281345|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
126281346|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
126281347|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281348|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281349|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281350|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281351|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281352|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281353|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
126040328|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126281354|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281355|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281356|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126040329|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126040330|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126040331|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126040332|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126281357|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281358|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281359|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281360|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281361|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281362|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281363|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281364|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
126281365|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281366|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281367|NCT01266031|454320772|FG000|Overall Study|Not treated|0|||
126281368|NCT01266031|454320773|FG001|Overall Study|Not treated|3|||
126281369|NCT01266031|454320774|FG002|Overall Study|Not treated|2|||
126281370|NCT01434810|454320777|FG000|Overall Study|Did not receive treatment|11|||
126281371|NCT01434810|454320778|FG001|Overall Study|Did not receive treatment|3|||
126281372|NCT01434810|454320777|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
126281373|NCT01434810|454320778|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
126281374|NCT02252406|454320780|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
126281375|NCT02252406|454320781|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
126281376|NCT02252406|454320780|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
126281377|NCT02252406|454320781|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
126281378|NCT02252406|454320780|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
126281379|NCT02252406|454320781|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
126281380|NCT02252406|454320780|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
126281381|NCT02252406|454320781|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
126281382|NCT02252406|454320780|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
126281383|NCT02252406|454320781|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
126281384|NCT02533180|454320784|FG000|Overall Study|Death|0|||
126281385|NCT02533180|454320785|FG001|Overall Study|Death|2|||
126281386|NCT02533180|454320784|FG000|Overall Study|Lost to Follow-up|0|||
126281387|NCT02533180|454320785|FG001|Overall Study|Lost to Follow-up|1|||
126281388|NCT02533180|454320784|FG000|Overall Study|Physician Decision|0|||
126281389|NCT02533180|454320785|FG001|Overall Study|Physician Decision|1|||
126281390|NCT02533180|454320784|FG000|Overall Study|Withdrawal by Subject|2|||
126281391|NCT02533180|454320785|FG001|Overall Study|Withdrawal by Subject|5|||
126281392|NCT02533180|454320784|FG000|Overall Study|Screen Failure|37|||
126281393|NCT02533180|454320785|FG001|Overall Study|Screen Failure|0|||
126281394|NCT02533180|454320784|FG000|Overall Study|Protocol Deviation|0|||
126281395|NCT02533180|454320785|FG001|Overall Study|Protocol Deviation|1|||
126281396|NCT02533180|454320784|FG000|Overall Study|Non-compliance|0|||
126281397|NCT02533180|454320785|FG001|Overall Study|Non-compliance|1|||
126281398|NCT00447876|454320786|FG000|Overall Study|Withdrawal by Subject|1|||
126281399|NCT00447876|454320787|FG001|Overall Study|Withdrawal by Subject|4|||
126281400|NCT00447876|454320786|FG000|Overall Study|Lost to Follow-up|1|||
126281401|NCT00447876|454320787|FG001|Overall Study|Lost to Follow-up|0|||
126281402|NCT00447876|454320786|FG000|Overall Study|Deterioration of symptomology|1|||
126281403|NCT00447876|454320787|FG001|Overall Study|Deterioration of symptomology|0|||
126281404|NCT01609023|454320790|FG000|Overall Study|Lack of Efficacy|3|||
126281405|NCT01609023|454320790|FG000|Overall Study|Withdrawal by Subject|4|||
126281406|NCT01609023|454320790|FG000|Overall Study|Lost to Follow-up|8|||
126281407|NCT01609023|454320790|FG000|Overall Study|Toxicity|3|||
126281408|NCT01609023|454320790|FG000|Overall Study|Disease progression|10|||
126281409|NCT01609023|454320790|FG000|Overall Study|Physician Decision|2|||
126281410|NCT01609023|454320790|FG000|Overall Study|Death|2|||
126281411|NCT01609023|454320790|FG000|Overall Study|Personal reasons|1|||
126281412|NCT02047734|454320791|FG000|Overall Study|Adverse Event|18|||
126281413|NCT02047734|454320792|FG001|Overall Study|Adverse Event|13|||
126281414|NCT02047734|454320793|FG002|Overall Study|Adverse Event|13|||
126281415|NCT02047734|454320791|FG000|Overall Study|Lack of Efficacy|4|||
126281416|NCT02047734|454320792|FG001|Overall Study|Lack of Efficacy|5|||
126281417|NCT02047734|454320793|FG002|Overall Study|Lack of Efficacy|1|||
126281418|NCT02047734|454320791|FG000|Overall Study|Protocol Violation|3|||
126281419|NCT02047734|454320792|FG001|Overall Study|Protocol Violation|1|||
126281420|NCT02047734|454320793|FG002|Overall Study|Protocol Violation|1|||
126281421|NCT02047734|454320791|FG000|Overall Study|Lost to Follow-up|1|||
126281422|NCT02047734|454320792|FG001|Overall Study|Lost to Follow-up|4|||
126281423|NCT02047734|454320793|FG002|Overall Study|Lost to Follow-up|0|||
126281424|NCT02047734|454320791|FG000|Overall Study|Death|0|||
126281425|NCT02047734|454320792|FG001|Overall Study|Death|1|||
126281426|NCT02047734|454320793|FG002|Overall Study|Death|0|||
126281427|NCT02047734|454320791|FG000|Overall Study|Withdrawal by Subject|30|||
126281428|NCT02047734|454320792|FG001|Overall Study|Withdrawal by Subject|31|||
126281429|NCT02047734|454320793|FG002|Overall Study|Withdrawal by Subject|19|||
126281430|NCT02047734|454320791|FG000|Overall Study|Physician Decision|7|||
126281431|NCT02047734|454320792|FG001|Overall Study|Physician Decision|6|||
126281432|NCT02047734|454320793|FG002|Overall Study|Physician Decision|5|||
126281433|NCT02047734|454320791|FG000|Overall Study|Miscellaneous|2|||
126281434|NCT02047734|454320792|FG001|Overall Study|Miscellaneous|4|||
126281435|NCT02047734|454320793|FG002|Overall Study|Miscellaneous|6|||
126281436|NCT02047734|454320791|FG000|Overall Study|Did Not Receive Study Drug|2|||
126281437|NCT02047734|454320792|FG001|Overall Study|Did Not Receive Study Drug|4|||
126281438|NCT02047734|454320793|FG002|Overall Study|Did Not Receive Study Drug|1|||
126281439|NCT02952586|454320800|FG000|Lead-In Phase (7 Days)|Death|0|||
126281440|NCT02952586|454320801|FG001|Lead-In Phase (7 Days)|Death|1|||
126281441|NCT02952586|454320800|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
126281442|NCT02952586|454320801|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
126281443|NCT02952586|454320800|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
126281444|NCT02952586|454320801|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
126281445|NCT02952586|454320800|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
126281446|NCT02952586|454320801|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
126281447|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
126281448|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
126281449|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
126281450|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
126281451|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
126281452|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
126281453|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
126281454|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
126281455|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
126281456|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
126281457|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
126281458|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
126281459|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
126281460|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
126281461|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Death|3|||
126281462|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Death|8|||
126281463|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
126281464|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
126281465|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
126281466|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
126281467|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
126281468|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
126281469|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
126281470|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
126281471|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
126281472|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
126281473|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Other|1|||
126281474|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Other|1|||
126281475|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Death|5|||
126281476|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Death|8|||
126281477|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
126281478|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
126281479|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
126281480|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
126281481|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
126281482|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
126281483|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
126281484|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
126281485|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Other|1|||
126281486|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Other|0|||
126364187|NCT00480025|454626782|FG001|Overall Study|Disease Progression / Recurrence|224|||
126364188|NCT00480025|454626781|FG000|Overall Study|Adverse Event|44|||
126364189|NCT00480025|454626782|FG001|Overall Study|Adverse Event|12|||
126364190|NCT00480025|454626781|FG000|Overall Study|Other|70|||
126364191|NCT00480025|454626782|FG001|Overall Study|Other|29|||
126364192|NCT00480025|454626781|FG000|Overall Study|SAE including intercurrent illness|76|||
126364193|NCT00480025|454626782|FG001|Overall Study|SAE including intercurrent illness|42|||
126364194|NCT03726879|454626787|FG000|Overall Study|Death|11|||
126364195|NCT03726879|454626788|FG001|Overall Study|Death|13|||
126040333|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126364196|NCT03726879|454626787|FG000|Overall Study|Physician Decision|0|||
126364197|NCT03726879|454626788|FG001|Overall Study|Physician Decision|2|||
126364198|NCT03726879|454626787|FG000|Overall Study|Protocol Violation|0|||
126040334|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126364199|NCT03726879|454626788|FG001|Overall Study|Protocol Violation|1|||
126364200|NCT03726879|454626787|FG000|Overall Study|Withdrawal by Subject|5|||
126364201|NCT03726879|454626788|FG001|Overall Study|Withdrawal by Subject|6|||
126364202|NCT03726879|454626787|FG000|Overall Study|TSH result is unstable|0|||
126364203|NCT03726879|454626788|FG001|Overall Study|TSH result is unstable|1|||
126364204|NCT03726879|454626787|FG000|Overall Study|Disease relapse|1|||
126364205|NCT03726879|454626788|FG001|Overall Study|Disease relapse|0|||
126364206|NCT03726879|454626787|FG000|Overall Study|Lost to Follow-up|3|||
126364207|NCT03726879|454626788|FG001|Overall Study|Lost to Follow-up|0|||
126364208|NCT02766478|454626789|FG000|Overall Study|Withdrawal by Subject|1|||
126364209|NCT02766478|454626790|FG001|Overall Study|Withdrawal by Subject|1|||
126364210|NCT05626686|454626791|FG000|Overall Study|Protocol Violation|3|||
126364211|NCT05626686|454626791|FG000|Overall Study|Withdrawal by Subject|3|||
126364212|NCT01093573|454626792|FG000|Overall Study|Physician Decision|0|||
126364213|NCT01093573|454626793|FG001|Overall Study|Physician Decision|0|||
126364214|NCT01093573|454626794|FG002|Overall Study|Physician Decision|1|||
126364215|NCT01093573|454626792|FG000|Overall Study|Insurance Denied|0|||
126364216|NCT01093573|454626793|FG001|Overall Study|Insurance Denied|0|||
126364217|NCT01093573|454626794|FG002|Overall Study|Insurance Denied|1|||
126364218|NCT00581100|454628246|FG000|Overall Study|Death|1|||
126364219|NCT00581100|454628247|FG001|Overall Study|Death|0|||
126364220|NCT00581100|454628246|FG000|Overall Study|Adverse Event|2|||
126364221|NCT00581100|454628247|FG001|Overall Study|Adverse Event|1|||
126364222|NCT00581100|454628246|FG000|Overall Study|Withdrawal by Subject|1|||
126364223|NCT00581100|454628247|FG001|Overall Study|Withdrawal by Subject|4|||
126364224|NCT00581100|454628246|FG000|Overall Study|Other|3|||
126364225|NCT00581100|454628247|FG001|Overall Study|Other|0|||
126364226|NCT04744831|454628248|FG000|Overall Study|Progressive Disease|31|||
126281487|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Death|17|||
126281488|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Death|11|||
126281489|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
126281490|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
126281491|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
126281492|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
126281493|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
126281494|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
126281495|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
126281496|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
126281497|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
126281498|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
126281499|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
126281500|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
126281501|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
126281502|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
126281503|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Other|2|||
126281504|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Other|1|||
126281505|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
126281506|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
126281507|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Death|12|||
126281508|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Death|10|||
126281509|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
126281510|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
126364227|NCT04744831|454628249|FG001|Overall Study|Progressive Disease|27|||
126364228|NCT04744831|454628250|FG002|Overall Study|Progressive Disease|25|||
126364229|NCT04744831|454628248|FG000|Overall Study|Adverse Event|3|||
126281511|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
126281512|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
126281513|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Other|7|||
126281514|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Other|5|||
126281515|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
126281516|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
126364230|NCT04744831|454628249|FG001|Overall Study|Adverse Event|3|||
126364231|NCT04744831|454628250|FG002|Overall Study|Adverse Event|3|||
126364232|NCT04744831|454628248|FG000|Overall Study|Clinical Progression|3|||
126364233|NCT04744831|454628249|FG001|Overall Study|Clinical Progression|2|||
126364234|NCT04744831|454628250|FG002|Overall Study|Clinical Progression|5|||
126281517|NCT02952586|454320800|FG000|LT Follow-up (up to 45 Months)|Death|51|||
126281518|NCT02952586|454320801|FG001|LT Follow-up (up to 45 Months)|Death|31|||
126364235|NCT04744831|454628248|FG000|Overall Study|Other|0|||
126364236|NCT04744831|454628249|FG001|Overall Study|Other|2|||
126364237|NCT04744831|454628250|FG002|Overall Study|Other|1|||
126364238|NCT04744831|454628248|FG000|Overall Study|Death|0|||
126364239|NCT04744831|454628249|FG001|Overall Study|Death|2|||
126364240|NCT04744831|454628250|FG002|Overall Study|Death|1|||
126364241|NCT04616196|454628260|FG000|Overall Study|Progressive Disease|3|||
126364242|NCT04616196|454628261|FG001|Overall Study|Progressive Disease|0|||
126364243|NCT04616196|454628262|FG002|Overall Study|Progressive Disease|4|||
126364244|NCT04616196|454628263|FG003|Overall Study|Progressive Disease|1|||
126040335|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126281519|NCT02952586|454320800|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
126281520|NCT02952586|454320801|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
126281521|NCT02952586|454320800|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
126281522|NCT02952586|454320801|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
126281523|NCT02952586|454320800|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
126281524|NCT02952586|454320801|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
126281525|NCT00492778|454320802|FG000|Overall Study|Ineligible by Pathology Review|8|||
126281526|NCT00492778|454320803|FG001|Overall Study|Ineligible by Pathology Review|1|||
126281527|NCT00789035|454320804|FG000|Overall Study|Adverse Event|0|||
126281528|NCT00789035|454320805|FG001|Overall Study|Adverse Event|2|||
126281529|NCT00789035|454320806|FG002|Overall Study|Adverse Event|0|||
126281530|NCT00789035|454320807|FG003|Overall Study|Adverse Event|1|||
126281531|NCT00789035|454320808|FG004|Overall Study|Adverse Event|3|||
126281532|NCT00789035|454320804|FG000|Overall Study|Lack of Efficacy|3|||
126281533|NCT00789035|454320805|FG001|Overall Study|Lack of Efficacy|0|||
126281534|NCT00789035|454320806|FG002|Overall Study|Lack of Efficacy|0|||
126281535|NCT00789035|454320807|FG003|Overall Study|Lack of Efficacy|0|||
126281536|NCT00789035|454320808|FG004|Overall Study|Lack of Efficacy|2|||
126281537|NCT00789035|454320804|FG000|Overall Study|Protocol Violation|1|||
126281538|NCT00789035|454320805|FG001|Overall Study|Protocol Violation|0|||
126281539|NCT00789035|454320806|FG002|Overall Study|Protocol Violation|0|||
126281540|NCT00789035|454320807|FG003|Overall Study|Protocol Violation|0|||
126281541|NCT00789035|454320808|FG004|Overall Study|Protocol Violation|0|||
126281542|NCT00789035|454320804|FG000|Overall Study|Withdrawal by Subject|0|||
126281543|NCT00789035|454320805|FG001|Overall Study|Withdrawal by Subject|2|||
126281544|NCT00789035|454320806|FG002|Overall Study|Withdrawal by Subject|0|||
126281545|NCT00789035|454320807|FG003|Overall Study|Withdrawal by Subject|0|||
126281546|NCT00789035|454320808|FG004|Overall Study|Withdrawal by Subject|0|||
126281547|NCT00789035|454320804|FG000|Overall Study|Other reason not defined above|2|||
126281548|NCT00789035|454320805|FG001|Overall Study|Other reason not defined above|3|||
126281549|NCT00789035|454320806|FG002|Overall Study|Other reason not defined above|1|||
126281550|NCT00789035|454320807|FG003|Overall Study|Other reason not defined above|0|||
126281551|NCT00789035|454320808|FG004|Overall Study|Other reason not defined above|1|||
126281552|NCT01118975|454320809|FG000|Overall Study|Adverse Event|0|||
126281553|NCT01118975|454320810|FG001|Overall Study|Adverse Event|1|||
126281554|NCT00789737|454320821|FG000|Overall Study|Withdrawal by Subject|13|||
126281555|NCT00789737|454320822|FG001|Overall Study|Withdrawal by Subject|22|||
126281556|NCT00789737|454320821|FG000|Overall Study|Lost to Follow-up|10|||
126281557|NCT00789737|454320822|FG001|Overall Study|Lost to Follow-up|14|||
126281558|NCT00789737|454320821|FG000|Overall Study|Adverse Event|8|||
126281559|NCT00789737|454320822|FG001|Overall Study|Adverse Event|8|||
126281560|NCT00789737|454320821|FG000|Overall Study|Protocol Violation|3|||
126281561|NCT00789737|454320822|FG001|Overall Study|Protocol Violation|0|||
126281562|NCT00789737|454320821|FG000|Overall Study|Lack of Efficacy|3|||
126281563|NCT00789737|454320822|FG001|Overall Study|Lack of Efficacy|0|||
126281564|NCT00789737|454320821|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
126281565|NCT00789737|454320822|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
126281566|NCT00789737|454320821|FG000|Overall Study|Other|11|||
126281567|NCT00789737|454320822|FG001|Overall Study|Other|7|||
126281568|NCT00384930|454320823|FG000|Overall Study|Adverse Event|5|||
126281569|NCT00384930|454320824|FG001|Overall Study|Adverse Event|4|||
126281570|NCT00384930|454320825|FG002|Overall Study|Adverse Event|12|||
126281571|NCT00384930|454320826|FG003|Overall Study|Adverse Event|11|||
126281572|NCT00384930|454320827|FG004|Overall Study|Adverse Event|14|||
126040336|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
126281573|NCT00384930|454320823|FG000|Overall Study|Entry Criteria Not Met|2|||
126281574|NCT00384930|454320824|FG001|Overall Study|Entry Criteria Not Met|6|||
126281575|NCT00384930|454320825|FG002|Overall Study|Entry Criteria Not Met|7|||
126281576|NCT00384930|454320826|FG003|Overall Study|Entry Criteria Not Met|8|||
126040337|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
126281577|NCT00384930|454320827|FG004|Overall Study|Entry Criteria Not Met|4|||
126281578|NCT00384930|454320823|FG000|Overall Study|Lack of Efficacy|1|||
126281579|NCT00384930|454320824|FG001|Overall Study|Lack of Efficacy|1|||
126281580|NCT00384930|454320825|FG002|Overall Study|Lack of Efficacy|2|||
126281581|NCT00384930|454320826|FG003|Overall Study|Lack of Efficacy|1|||
126281582|NCT00384930|454320827|FG004|Overall Study|Lack of Efficacy|2|||
126281583|NCT00384930|454320823|FG000|Overall Study|Lost to Follow-up|5|||
126281584|NCT00384930|454320824|FG001|Overall Study|Lost to Follow-up|3|||
126281585|NCT00384930|454320825|FG002|Overall Study|Lost to Follow-up|0|||
126281586|NCT00384930|454320826|FG003|Overall Study|Lost to Follow-up|4|||
126281587|NCT00384930|454320827|FG004|Overall Study|Lost to Follow-up|6|||
126281588|NCT00384930|454320823|FG000|Overall Study|Physician Decision|0|||
126281589|NCT00384930|454320824|FG001|Overall Study|Physician Decision|1|||
126281590|NCT00384930|454320825|FG002|Overall Study|Physician Decision|1|||
126281591|NCT00384930|454320826|FG003|Overall Study|Physician Decision|0|||
126281592|NCT00384930|454320827|FG004|Overall Study|Physician Decision|1|||
126281593|NCT00384930|454320823|FG000|Overall Study|Protocol Violation|1|||
126281594|NCT00384930|454320824|FG001|Overall Study|Protocol Violation|0|||
126281595|NCT00384930|454320825|FG002|Overall Study|Protocol Violation|1|||
126281596|NCT00384930|454320826|FG003|Overall Study|Protocol Violation|6|||
126281597|NCT00384930|454320827|FG004|Overall Study|Protocol Violation|4|||
126281598|NCT00384930|454320823|FG000|Overall Study|Sponsor Decision|3|||
126281599|NCT00384930|454320824|FG001|Overall Study|Sponsor Decision|4|||
126281600|NCT00384930|454320825|FG002|Overall Study|Sponsor Decision|0|||
126281601|NCT00384930|454320826|FG003|Overall Study|Sponsor Decision|5|||
126281602|NCT00384930|454320827|FG004|Overall Study|Sponsor Decision|0|||
126281603|NCT00384930|454320823|FG000|Overall Study|Withdrawal by Subject|9|||
126281604|NCT00384930|454320824|FG001|Overall Study|Withdrawal by Subject|7|||
126281605|NCT00384930|454320825|FG002|Overall Study|Withdrawal by Subject|7|||
126281606|NCT00384930|454320826|FG003|Overall Study|Withdrawal by Subject|6|||
126281607|NCT00384930|454320827|FG004|Overall Study|Withdrawal by Subject|16|||
126281608|NCT00384930|454320823|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
126281609|NCT00384930|454320824|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
126281610|NCT00384930|454320825|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
126281611|NCT00384930|454320826|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
126281612|NCT00384930|454320827|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
126281613|NCT02613182|454320828|FG000|Overall Study|Death|6|||
126281614|NCT02613182|454320828|FG000|Overall Study|Physician Decision|1|||
126281615|NCT02613182|454320828|FG000|Overall Study|Study Terminated by Sponsor|21|||
126281616|NCT02613182|454320828|FG000|Overall Study|Withdrawal by Subject|6|||
126281617|NCT03968978|454320829|FG000|Overall Study|Adverse Event|1|||
126281618|NCT03968978|454320830|FG001|Overall Study|Adverse Event|0|||
126281619|NCT00025259|454320832|FG000|Overall Study|Death|1|||
126281620|NCT00025259|454320833|FG001|Overall Study|Death|3|||
126281621|NCT00025259|454320834|FG002|Overall Study|Death|0|||
126281622|NCT00025259|454320835|FG003|Overall Study|Death|3|||
126281623|NCT00025259|454320836|FG004|Overall Study|Death|0|||
126281624|NCT00025259|454320837|FG005|Overall Study|Death|1|||
126281625|NCT00025259|454320838|FG006|Overall Study|Death|2|||
126281626|NCT00025259|454320832|FG000|Overall Study|Lack of Efficacy|2|||
126281627|NCT00025259|454320833|FG001|Overall Study|Lack of Efficacy|46|||
126281628|NCT00025259|454320834|FG002|Overall Study|Lack of Efficacy|60|||
126281629|NCT00025259|454320835|FG003|Overall Study|Lack of Efficacy|78|||
126281630|NCT00025259|454320836|FG004|Overall Study|Lack of Efficacy|11|||
126281631|NCT00025259|454320837|FG005|Overall Study|Lack of Efficacy|30|||
126281632|NCT00025259|454320838|FG006|Overall Study|Lack of Efficacy|38|||
126281633|NCT00025259|454320832|FG000|Overall Study|Lost to Follow-up|2|||
126281634|NCT00025259|454320833|FG001|Overall Study|Lost to Follow-up|9|||
126281635|NCT00025259|454320834|FG002|Overall Study|Lost to Follow-up|13|||
126281636|NCT00025259|454320835|FG003|Overall Study|Lost to Follow-up|13|||
126281637|NCT00025259|454320836|FG004|Overall Study|Lost to Follow-up|1|||
126281638|NCT00025259|454320837|FG005|Overall Study|Lost to Follow-up|3|||
126281639|NCT00025259|454320838|FG006|Overall Study|Lost to Follow-up|1|||
126281640|NCT00025259|454320832|FG000|Overall Study|Physician Decision|12|||
126281641|NCT00025259|454320833|FG001|Overall Study|Physician Decision|1|||
126281642|NCT00025259|454320834|FG002|Overall Study|Physician Decision|0|||
126281643|NCT00025259|454320835|FG003|Overall Study|Physician Decision|5|||
126281644|NCT00025259|454320836|FG004|Overall Study|Physician Decision|4|||
126281645|NCT00025259|454320837|FG005|Overall Study|Physician Decision|2|||
126281646|NCT00025259|454320838|FG006|Overall Study|Physician Decision|1|||
126281647|NCT00025259|454320832|FG000|Overall Study|Protocol Violation|3|||
126281648|NCT00025259|454320833|FG001|Overall Study|Protocol Violation|2|||
126281649|NCT00025259|454320834|FG002|Overall Study|Protocol Violation|2|||
126281650|NCT00025259|454320835|FG003|Overall Study|Protocol Violation|1|||
126281651|NCT00025259|454320836|FG004|Overall Study|Protocol Violation|2|||
126281652|NCT00025259|454320837|FG005|Overall Study|Protocol Violation|1|||
126281653|NCT00025259|454320838|FG006|Overall Study|Protocol Violation|3|||
126281654|NCT00025259|454320832|FG000|Overall Study|Withdrawal by Subject|9|||
126281655|NCT00025259|454320833|FG001|Overall Study|Withdrawal by Subject|27|||
126281656|NCT00025259|454320834|FG002|Overall Study|Withdrawal by Subject|6|||
126281657|NCT00025259|454320835|FG003|Overall Study|Withdrawal by Subject|14|||
126281658|NCT00025259|454320836|FG004|Overall Study|Withdrawal by Subject|11|||
126281659|NCT00025259|454320837|FG005|Overall Study|Withdrawal by Subject|8|||
126281660|NCT00025259|454320838|FG006|Overall Study|Withdrawal by Subject|3|||
126281661|NCT00025259|454320832|FG000|Overall Study|Ineligible|14|||
126281662|NCT00025259|454320833|FG001|Overall Study|Ineligible|1|||
126040338|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126281663|NCT00025259|454320834|FG002|Overall Study|Ineligible|0|||
126281664|NCT00025259|454320835|FG003|Overall Study|Ineligible|0|||
126281665|NCT00025259|454320836|FG004|Overall Study|Ineligible|6|||
126281666|NCT00025259|454320837|FG005|Overall Study|Ineligible|0|||
126281667|NCT00025259|454320838|FG006|Overall Study|Ineligible|1|||
126281668|NCT00025259|454320832|FG000|Overall Study|Randomization error|1|||
126281669|NCT00025259|454320833|FG001|Overall Study|Randomization error|0|||
126281670|NCT00025259|454320834|FG002|Overall Study|Randomization error|0|||
126281671|NCT00025259|454320835|FG003|Overall Study|Randomization error|0|||
126040339|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040340|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040341|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040342|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040343|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040344|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126281672|NCT00025259|454320836|FG004|Overall Study|Randomization error|1|||
126281673|NCT00025259|454320837|FG005|Overall Study|Randomization error|7|||
126281674|NCT00025259|454320838|FG006|Overall Study|Randomization error|2|||
126281675|NCT00025259|454320832|FG000|Overall Study|Adverse Event|1|||
126281676|NCT00025259|454320833|FG001|Overall Study|Adverse Event|0|||
126281677|NCT00025259|454320834|FG002|Overall Study|Adverse Event|0|||
126281678|NCT00025259|454320835|FG003|Overall Study|Adverse Event|0|||
126281679|NCT00025259|454320836|FG004|Overall Study|Adverse Event|0|||
126281680|NCT00025259|454320837|FG005|Overall Study|Adverse Event|0|||
126281681|NCT00025259|454320838|FG006|Overall Study|Adverse Event|0|||
126281682|NCT01449370|454320839|FG000|Overall Study|Disease Progression|5|||
126281683|NCT01449370|454320840|FG001|Overall Study|Disease Progression|4|||
126281684|NCT01449370|454320841|FG002|Overall Study|Disease Progression|8|||
126281685|NCT01449370|454320842|FG003|Overall Study|Disease Progression|3|||
126281686|NCT01449370|454320843|FG004|Overall Study|Disease Progression|3|||
126281687|NCT01449370|454320844|FG005|Overall Study|Disease Progression|3|||
126281688|NCT01449370|454320845|FG006|Overall Study|Disease Progression|3|||
126281689|NCT01449370|454320846|FG007|Overall Study|Disease Progression|2|||
126281690|NCT01449370|454320847|FG008|Overall Study|Disease Progression|9|||
126281691|NCT01449370|454320848|FG009|Overall Study|Disease Progression|1|||
126281692|NCT01449370|454320849|FG010|Overall Study|Disease Progression|3|||
126281693|NCT01449370|454320850|FG011|Overall Study|Disease Progression|3|||
126281694|NCT01449370|454320851|FG012|Overall Study|Disease Progression|2|||
126281695|NCT01449370|454320852|FG013|Overall Study|Disease Progression|8|||
126281696|NCT01449370|454320853|FG014|Overall Study|Disease Progression|3|||
126281697|NCT01449370|454320854|FG015|Overall Study|Disease Progression|1|||
126281698|NCT01449370|454320855|FG016|Overall Study|Disease Progression|4|||
126281699|NCT01449370|454320856|FG017|Overall Study|Disease Progression|3|||
126281700|NCT01449370|454320857|FG018|Overall Study|Disease Progression|1|||
126281701|NCT01449370|454320858|FG019|Overall Study|Disease Progression|2|||
126281702|NCT01449370|454320859|FG020|Overall Study|Disease Progression|5|||
126281703|NCT01449370|454320860|FG021|Overall Study|Disease Progression|2|||
126281704|NCT01449370|454320861|FG022|Overall Study|Disease Progression|3|||
126281705|NCT01449370|454320862|FG023|Overall Study|Disease Progression|7|||
126281706|NCT01449370|454320863|FG024|Overall Study|Disease Progression|3|||
126281707|NCT01449370|454320839|FG000|Overall Study|Adverse Event|1|||
126281708|NCT01449370|454320840|FG001|Overall Study|Adverse Event|2|||
126281709|NCT01449370|454320841|FG002|Overall Study|Adverse Event|0|||
126281710|NCT01449370|454320842|FG003|Overall Study|Adverse Event|1|||
126281711|NCT01449370|454320843|FG004|Overall Study|Adverse Event|0|||
126281712|NCT01449370|454320844|FG005|Overall Study|Adverse Event|0|||
126281713|NCT01449370|454320845|FG006|Overall Study|Adverse Event|0|||
126281714|NCT01449370|454320846|FG007|Overall Study|Adverse Event|0|||
126281715|NCT01449370|454320847|FG008|Overall Study|Adverse Event|1|||
126281716|NCT01449370|454320848|FG009|Overall Study|Adverse Event|1|||
126281717|NCT01449370|454320849|FG010|Overall Study|Adverse Event|0|||
126281718|NCT01449370|454320850|FG011|Overall Study|Adverse Event|0|||
126281719|NCT01449370|454320851|FG012|Overall Study|Adverse Event|0|||
126281720|NCT01449370|454320852|FG013|Overall Study|Adverse Event|2|||
126281721|NCT01449370|454320853|FG014|Overall Study|Adverse Event|0|||
126281722|NCT01449370|454320854|FG015|Overall Study|Adverse Event|1|||
126281723|NCT01449370|454320855|FG016|Overall Study|Adverse Event|0|||
126281724|NCT01449370|454320856|FG017|Overall Study|Adverse Event|0|||
126281725|NCT01449370|454320857|FG018|Overall Study|Adverse Event|1|||
126281726|NCT01449370|454320858|FG019|Overall Study|Adverse Event|1|||
126281727|NCT01449370|454320859|FG020|Overall Study|Adverse Event|0|||
126281728|NCT01449370|454320860|FG021|Overall Study|Adverse Event|1|||
126281729|NCT01449370|454320861|FG022|Overall Study|Adverse Event|0|||
126281730|NCT01449370|454320862|FG023|Overall Study|Adverse Event|1|||
126281731|NCT01449370|454320863|FG024|Overall Study|Adverse Event|3|||
126281732|NCT01449370|454320839|FG000|Overall Study|Participant Decision|0|||
126281733|NCT01449370|454320840|FG001|Overall Study|Participant Decision|0|||
126281734|NCT01449370|454320841|FG002|Overall Study|Participant Decision|0|||
126281735|NCT01449370|454320842|FG003|Overall Study|Participant Decision|0|||
126281736|NCT01449370|454320843|FG004|Overall Study|Participant Decision|0|||
126281737|NCT01449370|454320844|FG005|Overall Study|Participant Decision|0|||
126281738|NCT01449370|454320845|FG006|Overall Study|Participant Decision|0|||
126281739|NCT01449370|454320846|FG007|Overall Study|Participant Decision|1|||
125882210|NCT02113982|452868954|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125882211|NCT02113982|452868955|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
125882212|NCT02113982|452868956|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125882213|NCT02113982|452868957|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126040345|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040346|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040347|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
126281740|NCT01449370|454320847|FG008|Overall Study|Participant Decision|1|||
125882214|NCT02113982|452868958|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125882215|NCT02113982|452868959|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125882216|NCT02113982|452868960|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125882217|NCT02113982|452868961|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125882218|NCT02113982|452868948|FG000|Stage 2: Cohort Expansion|Transplant|0|||
125882219|NCT02113982|452868949|FG001|Stage 2: Cohort Expansion|Transplant|0|||
125882220|NCT02113982|452868950|FG002|Stage 2: Cohort Expansion|Transplant|0|||
125882221|NCT02113982|452868951|FG003|Stage 2: Cohort Expansion|Transplant|0|||
125882222|NCT02113982|452868952|FG004|Stage 2: Cohort Expansion|Transplant|0|||
125882223|NCT02113982|452868953|FG005|Stage 2: Cohort Expansion|Transplant|0|||
125882224|NCT02113982|452868954|FG006|Stage 2: Cohort Expansion|Transplant|0|||
125882225|NCT02113982|452868955|FG007|Stage 2: Cohort Expansion|Transplant|0|||
125882226|NCT02113982|452868956|FG008|Stage 2: Cohort Expansion|Transplant|0|||
125882227|NCT02113982|452868957|FG009|Stage 2: Cohort Expansion|Transplant|4|||
125882228|NCT02113982|452868958|FG010|Stage 2: Cohort Expansion|Transplant|2|||
125882229|NCT02113982|452868959|FG011|Stage 2: Cohort Expansion|Transplant|0|||
125882230|NCT02113982|452868960|FG012|Stage 2: Cohort Expansion|Transplant|0|||
125882231|NCT02113982|452868961|FG013|Stage 2: Cohort Expansion|Transplant|0|||
125882232|NCT02113982|452868948|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
125882233|NCT02113982|452868949|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
125882234|NCT02113982|452868950|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
125882235|NCT02113982|452868951|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
125882236|NCT02113982|452868952|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
125882237|NCT02113982|452868953|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
126040348|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040349|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040350|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126040351|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
126040352|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
126281741|NCT01449370|454320848|FG009|Overall Study|Participant Decision|0|||
126281742|NCT01449370|454320849|FG010|Overall Study|Participant Decision|0|||
126281743|NCT01449370|454320850|FG011|Overall Study|Participant Decision|0|||
126281744|NCT01449370|454320851|FG012|Overall Study|Participant Decision|1|||
126281745|NCT01449370|454320852|FG013|Overall Study|Participant Decision|1|||
126281746|NCT01449370|454320853|FG014|Overall Study|Participant Decision|0|||
126281747|NCT01449370|454320854|FG015|Overall Study|Participant Decision|1|||
126281748|NCT01449370|454320855|FG016|Overall Study|Participant Decision|3|||
126281749|NCT01449370|454320856|FG017|Overall Study|Participant Decision|0|||
126281750|NCT01449370|454320857|FG018|Overall Study|Participant Decision|1|||
126281751|NCT01449370|454320858|FG019|Overall Study|Participant Decision|0|||
126281752|NCT01449370|454320859|FG020|Overall Study|Participant Decision|0|||
126281753|NCT01449370|454320860|FG021|Overall Study|Participant Decision|1|||
126281754|NCT01449370|454320861|FG022|Overall Study|Participant Decision|0|||
126281755|NCT01449370|454320862|FG023|Overall Study|Participant Decision|0|||
126281756|NCT01449370|454320863|FG024|Overall Study|Participant Decision|1|||
126281757|NCT01449370|454320839|FG000|Overall Study|Lost to Follow-up|0|||
126040353|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040354|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126281758|NCT01449370|454320840|FG001|Overall Study|Lost to Follow-up|0|||
126281759|NCT01449370|454320841|FG002|Overall Study|Lost to Follow-up|0|||
126281760|NCT01449370|454320842|FG003|Overall Study|Lost to Follow-up|0|||
126281761|NCT01449370|454320843|FG004|Overall Study|Lost to Follow-up|0|||
126281762|NCT01449370|454320844|FG005|Overall Study|Lost to Follow-up|0|||
126281763|NCT01449370|454320845|FG006|Overall Study|Lost to Follow-up|0|||
126281764|NCT01449370|454320846|FG007|Overall Study|Lost to Follow-up|0|||
126281765|NCT01449370|454320847|FG008|Overall Study|Lost to Follow-up|0|||
126281766|NCT01449370|454320848|FG009|Overall Study|Lost to Follow-up|0|||
126281767|NCT01449370|454320849|FG010|Overall Study|Lost to Follow-up|0|||
126364245|NCT04616196|454628260|FG000|Overall Study|Death|2|||
126364246|NCT04616196|454628261|FG001|Overall Study|Death|4|||
126364247|NCT04616196|454628262|FG002|Overall Study|Death|1|||
126364248|NCT04616196|454628263|FG003|Overall Study|Death|0|||
125882238|NCT02113982|452868954|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
125882239|NCT02113982|452868955|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
125882240|NCT02113982|452868956|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
125882241|NCT02113982|452868957|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
126281768|NCT01449370|454320850|FG011|Overall Study|Lost to Follow-up|0|||
126281769|NCT01449370|454320851|FG012|Overall Study|Lost to Follow-up|0|||
126281770|NCT01449370|454320852|FG013|Overall Study|Lost to Follow-up|0|||
126281771|NCT01449370|454320853|FG014|Overall Study|Lost to Follow-up|0|||
126281772|NCT01449370|454320854|FG015|Overall Study|Lost to Follow-up|0|||
126281773|NCT01449370|454320855|FG016|Overall Study|Lost to Follow-up|0|||
126281774|NCT01449370|454320856|FG017|Overall Study|Lost to Follow-up|0|||
126281775|NCT01449370|454320857|FG018|Overall Study|Lost to Follow-up|0|||
126281776|NCT01449370|454320858|FG019|Overall Study|Lost to Follow-up|0|||
126364249|NCT04616196|454628260|FG000|Overall Study|Withdrawal by Subject|0|||
125882242|NCT02113982|452868958|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
125882243|NCT02113982|452868959|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
125882244|NCT02113982|452868960|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
125882245|NCT02113982|452868961|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
125882246|NCT02113982|452868948|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
125882247|NCT02113982|452868949|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
125882248|NCT02113982|452868950|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
125882249|NCT02113982|452868951|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
125882250|NCT02113982|452868952|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
125882251|NCT02113982|452868953|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
125882252|NCT02113982|452868954|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
125882253|NCT02113982|452868955|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
125882254|NCT02113982|452868956|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
125882255|NCT02113982|452868957|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
125882256|NCT02113982|452868958|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
125882257|NCT02113982|452868959|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
125882258|NCT02113982|452868960|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
125882259|NCT02113982|452868961|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
125882260|NCT02113982|452868948|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882261|NCT02113982|452868949|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882262|NCT02113982|452868950|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882263|NCT02113982|452868951|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882264|NCT02113982|452868952|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882265|NCT02113982|452868953|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882266|NCT02113982|452868954|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882267|NCT02113982|452868955|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882268|NCT02113982|452868956|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882269|NCT02113982|452868957|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882270|NCT02113982|452868958|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882271|NCT02113982|452868959|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
126364250|NCT04616196|454628261|FG001|Overall Study|Withdrawal by Subject|2|||
126364251|NCT04616196|454628262|FG002|Overall Study|Withdrawal by Subject|0|||
126364252|NCT04616196|454628263|FG003|Overall Study|Withdrawal by Subject|0|||
126364253|NCT04616196|454628260|FG000|Overall Study|Lost to Follow-up|1|||
126364254|NCT04616196|454628261|FG001|Overall Study|Lost to Follow-up|0|||
126364255|NCT04616196|454628262|FG002|Overall Study|Lost to Follow-up|0|||
126364256|NCT04616196|454628263|FG003|Overall Study|Lost to Follow-up|0|||
126364257|NCT04616196|454628260|FG000|Overall Study|Sponsor request|2|||
126364258|NCT04616196|454628261|FG001|Overall Study|Sponsor request|1|||
126364259|NCT04616196|454628262|FG002|Overall Study|Sponsor request|1|||
126364260|NCT04616196|454628263|FG003|Overall Study|Sponsor request|2|||
125882272|NCT02113982|452868960|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
125882273|NCT02113982|452868961|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
126040355|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040356|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040357|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040358|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040359|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040360|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040361|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040362|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040363|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040364|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126040365|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126281777|NCT01449370|454320859|FG020|Overall Study|Lost to Follow-up|1|||
126281778|NCT01449370|454320860|FG021|Overall Study|Lost to Follow-up|0|||
126364261|NCT05401409|454628264|FG000|Overall Study|Lost to Follow-up|1|||
126364262|NCT05401409|454628265|FG001|Overall Study|Lost to Follow-up|0|||
125882274|NCT02113982|452868948|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
125882275|NCT02113982|452868949|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
125882276|NCT02113982|452868950|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
125882277|NCT02113982|452868951|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
126364263|NCT02371889|454628266|FG000|Overall Study|Adverse medication effect|11|||
126364264|NCT02371889|454628267|FG001|Overall Study|Adverse medication effect|2|||
126281779|NCT01449370|454320861|FG022|Overall Study|Lost to Follow-up|0|||
126281780|NCT01449370|454320862|FG023|Overall Study|Lost to Follow-up|0|||
126281781|NCT01449370|454320863|FG024|Overall Study|Lost to Follow-up|0|||
126281782|NCT01449370|454320839|FG000|Overall Study|Other|0|||
126281783|NCT01449370|454320840|FG001|Overall Study|Other|0|||
126281784|NCT01449370|454320841|FG002|Overall Study|Other|0|||
126281785|NCT01449370|454320842|FG003|Overall Study|Other|0|||
126281786|NCT01449370|454320843|FG004|Overall Study|Other|0|||
126281787|NCT01449370|454320844|FG005|Overall Study|Other|0|||
126281788|NCT01449370|454320845|FG006|Overall Study|Other|0|||
126281789|NCT01449370|454320846|FG007|Overall Study|Other|0|||
126281790|NCT01449370|454320847|FG008|Overall Study|Other|1|||
126281791|NCT01449370|454320848|FG009|Overall Study|Other|1|||
126281792|NCT01449370|454320849|FG010|Overall Study|Other|0|||
126281793|NCT01449370|454320850|FG011|Overall Study|Other|0|||
126281794|NCT01449370|454320851|FG012|Overall Study|Other|0|||
126281795|NCT01449370|454320852|FG013|Overall Study|Other|0|||
126281796|NCT01449370|454320853|FG014|Overall Study|Other|0|||
126281797|NCT01449370|454320854|FG015|Overall Study|Other|0|||
126281798|NCT01449370|454320855|FG016|Overall Study|Other|0|||
126281799|NCT01449370|454320856|FG017|Overall Study|Other|0|||
126281800|NCT01449370|454320857|FG018|Overall Study|Other|0|||
126281801|NCT01449370|454320858|FG019|Overall Study|Other|0|||
126281802|NCT01449370|454320859|FG020|Overall Study|Other|0|||
126281803|NCT01449370|454320860|FG021|Overall Study|Other|0|||
126281804|NCT01449370|454320861|FG022|Overall Study|Other|1|||
126281805|NCT01449370|454320862|FG023|Overall Study|Other|1|||
126281806|NCT01449370|454320863|FG024|Overall Study|Other|0|||
126281807|NCT01449370|454320839|FG000|Overall Study|Medication Prohibited by Protocol|0|||
126281808|NCT01449370|454320840|FG001|Overall Study|Medication Prohibited by Protocol|0|||
126281809|NCT01449370|454320841|FG002|Overall Study|Medication Prohibited by Protocol|0|||
126281810|NCT01449370|454320842|FG003|Overall Study|Medication Prohibited by Protocol|0|||
126281811|NCT01449370|454320843|FG004|Overall Study|Medication Prohibited by Protocol|0|||
126281812|NCT01449370|454320844|FG005|Overall Study|Medication Prohibited by Protocol|0|||
126281813|NCT01449370|454320845|FG006|Overall Study|Medication Prohibited by Protocol|0|||
126281814|NCT01449370|454320846|FG007|Overall Study|Medication Prohibited by Protocol|0|||
126281815|NCT01449370|454320847|FG008|Overall Study|Medication Prohibited by Protocol|0|||
126040366|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
126040367|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
126040368|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126281816|NCT01449370|454320848|FG009|Overall Study|Medication Prohibited by Protocol|0|||
126281817|NCT01449370|454320849|FG010|Overall Study|Medication Prohibited by Protocol|0|||
126281818|NCT01449370|454320850|FG011|Overall Study|Medication Prohibited by Protocol|0|||
126281819|NCT01449370|454320851|FG012|Overall Study|Medication Prohibited by Protocol|0|||
126281820|NCT01449370|454320852|FG013|Overall Study|Medication Prohibited by Protocol|0|||
126281821|NCT01449370|454320853|FG014|Overall Study|Medication Prohibited by Protocol|0|||
126281822|NCT01449370|454320854|FG015|Overall Study|Medication Prohibited by Protocol|0|||
126364265|NCT02371889|454628266|FG000|Overall Study|Lost to Follow-up|6|||
126364266|NCT02371889|454628267|FG001|Overall Study|Lost to Follow-up|5|||
126364267|NCT02371889|454628266|FG000|Overall Study|Personal time constraints|2|||
126364268|NCT02371889|454628267|FG001|Overall Study|Personal time constraints|4|||
126364269|NCT02371889|454628266|FG000|Overall Study|Lack of Efficacy|0|||
126364270|NCT02371889|454628267|FG001|Overall Study|Lack of Efficacy|2|||
126364271|NCT02371889|454628266|FG000|Overall Study|Relapse|0|||
126364272|NCT02371889|454628267|FG001|Overall Study|Relapse|1|||
126364273|NCT05520333|454628268|FG000|Overall Study|Lost to Follow-up|3|||
126364274|NCT05520333|454628269|FG001|Overall Study|Lost to Follow-up|6|||
126364275|NCT02579759|454628270|FG000|Overall Study|Protocol Violation|2|||
126364276|NCT02579759|454628271|FG001|Overall Study|Protocol Violation|0|||
126364277|NCT02579759|454628272|FG002|Overall Study|Protocol Violation|0|||
126364278|NCT02579759|454628270|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
126364279|NCT02579759|454628271|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
126364280|NCT02579759|454628272|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
126364281|NCT02579759|454628270|FG000|Overall Study|BfArM hold|13|||
126364282|NCT02579759|454628271|FG001|Overall Study|BfArM hold|12|||
126364283|NCT02579759|454628272|FG002|Overall Study|BfArM hold|12|||
126364284|NCT02579759|454628270|FG000|Overall Study|Sponsor stopped Dose 2|0|||
126364285|NCT02579759|454628271|FG001|Overall Study|Sponsor stopped Dose 2|41|||
126364286|NCT02579759|454628272|FG002|Overall Study|Sponsor stopped Dose 2|0|||
125882278|NCT02113982|452868952|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
126281823|NCT01449370|454320855|FG016|Overall Study|Medication Prohibited by Protocol|0|||
126364287|NCT02579759|454628270|FG000|Overall Study|Non compliance|0|||
126364288|NCT02579759|454628271|FG001|Overall Study|Non compliance|1|||
126281824|NCT01449370|454320856|FG017|Overall Study|Medication Prohibited by Protocol|0|||
126281825|NCT01449370|454320857|FG018|Overall Study|Medication Prohibited by Protocol|0|||
126364289|NCT02579759|454628272|FG002|Overall Study|Non compliance|0|||
126364290|NCT02579759|454628270|FG000|Overall Study|Pregnancy|0|||
126364291|NCT02579759|454628271|FG001|Overall Study|Pregnancy|1|||
126364292|NCT02579759|454628272|FG002|Overall Study|Pregnancy|0|||
126281826|NCT01449370|454320858|FG019|Overall Study|Medication Prohibited by Protocol|0|||
126281827|NCT01449370|454320859|FG020|Overall Study|Medication Prohibited by Protocol|0|||
126281828|NCT01449370|454320860|FG021|Overall Study|Medication Prohibited by Protocol|0|||
126281829|NCT01449370|454320861|FG022|Overall Study|Medication Prohibited by Protocol|0|||
126281830|NCT01449370|454320862|FG023|Overall Study|Medication Prohibited by Protocol|1|||
126281831|NCT01449370|454320863|FG024|Overall Study|Medication Prohibited by Protocol|0|||
126281832|NCT01449370|454320839|FG000|Overall Study|Death|0|||
126281833|NCT01449370|454320840|FG001|Overall Study|Death|0|||
126281834|NCT01449370|454320841|FG002|Overall Study|Death|0|||
126281835|NCT01449370|454320842|FG003|Overall Study|Death|0|||
126281836|NCT01449370|454320843|FG004|Overall Study|Death|0|||
126281837|NCT01449370|454320844|FG005|Overall Study|Death|0|||
126281838|NCT01449370|454320845|FG006|Overall Study|Death|0|||
126281839|NCT01449370|454320846|FG007|Overall Study|Death|0|||
126281840|NCT01449370|454320847|FG008|Overall Study|Death|0|||
126281841|NCT01449370|454320848|FG009|Overall Study|Death|0|||
126281842|NCT01449370|454320849|FG010|Overall Study|Death|0|||
126281843|NCT01449370|454320850|FG011|Overall Study|Death|0|||
126281844|NCT01449370|454320851|FG012|Overall Study|Death|0|||
126281845|NCT01449370|454320852|FG013|Overall Study|Death|0|||
126281846|NCT01449370|454320853|FG014|Overall Study|Death|0|||
126281847|NCT01449370|454320854|FG015|Overall Study|Death|0|||
126281848|NCT01449370|454320855|FG016|Overall Study|Death|0|||
126281849|NCT01449370|454320856|FG017|Overall Study|Death|0|||
126281850|NCT01449370|454320857|FG018|Overall Study|Death|0|||
126281851|NCT01449370|454320858|FG019|Overall Study|Death|0|||
126281852|NCT01449370|454320859|FG020|Overall Study|Death|0|||
126281853|NCT01449370|454320860|FG021|Overall Study|Death|0|||
126281854|NCT01449370|454320861|FG022|Overall Study|Death|0|||
126281855|NCT01449370|454320862|FG023|Overall Study|Death|0|||
126281856|NCT01449370|454320863|FG024|Overall Study|Death|1|||
126281857|NCT00863772|454320864|FG000|Overall Study|Adverse Event|1|||
126281858|NCT00863772|454320865|FG001|Overall Study|Adverse Event|4|||
126281859|NCT00863772|454320866|FG002|Overall Study|Adverse Event|0|||
126281860|NCT00863772|454320864|FG000|Overall Study|Lack of Efficacy|4|||
126281861|NCT00863772|454320865|FG001|Overall Study|Lack of Efficacy|2|||
126281862|NCT00863772|454320866|FG002|Overall Study|Lack of Efficacy|4|||
126281863|NCT00863772|454320864|FG000|Overall Study|Lost to Follow-up|5|||
126281864|NCT00863772|454320865|FG001|Overall Study|Lost to Follow-up|1|||
126281865|NCT00863772|454320866|FG002|Overall Study|Lost to Follow-up|1|||
126281866|NCT00863772|454320864|FG000|Overall Study|Protocol Violation|2|||
126281867|NCT00863772|454320865|FG001|Overall Study|Protocol Violation|0|||
126281868|NCT00863772|454320866|FG002|Overall Study|Protocol Violation|2|||
126281869|NCT00863772|454320864|FG000|Overall Study|Withdrawal by Subject|4|||
126281870|NCT00863772|454320865|FG001|Overall Study|Withdrawal by Subject|7|||
126281871|NCT00863772|454320866|FG002|Overall Study|Withdrawal by Subject|5|||
126281872|NCT00863772|454320864|FG000|Overall Study|Study terminated by sponsor|44|||
126281873|NCT00863772|454320865|FG001|Overall Study|Study terminated by sponsor|45|||
126281874|NCT00863772|454320866|FG002|Overall Study|Study terminated by sponsor|36|||
126281875|NCT00863772|454320864|FG000|Overall Study|Entered extension study|6|||
126364293|NCT02579759|454628270|FG000|Overall Study|Inclusion/exclusion criteria|0|||
126364294|NCT02579759|454628271|FG001|Overall Study|Inclusion/exclusion criteria|0|||
126364295|NCT02579759|454628272|FG002|Overall Study|Inclusion/exclusion criteria|1|||
126364296|NCT02579759|454628270|FG000|Overall Study|Adverse Event|4|||
126364297|NCT02579759|454628271|FG001|Overall Study|Adverse Event|3|||
126364298|NCT02579759|454628272|FG002|Overall Study|Adverse Event|1|||
126364299|NCT02579759|454628270|FG000|Overall Study|Withdrawal by Subject|3|||
126364300|NCT02579759|454628271|FG001|Overall Study|Withdrawal by Subject|3|||
126364301|NCT02579759|454628272|FG002|Overall Study|Withdrawal by Subject|5|||
126364302|NCT02579759|454628270|FG000|Overall Study|Lost to Follow-up|2|||
126364303|NCT02579759|454628271|FG001|Overall Study|Lost to Follow-up|2|||
126364304|NCT02579759|454628272|FG002|Overall Study|Lost to Follow-up|2|||
126364305|NCT03412591|454628275|FG000|Overall Study|Withdrawal by Subject|1|||
126364306|NCT03412591|454628276|FG001|Overall Study|Withdrawal by Subject|8|||
126364307|NCT03412591|454628275|FG000|Overall Study|Adverse Event|0|||
126364308|NCT03412591|454628276|FG001|Overall Study|Adverse Event|1|||
126364309|NCT00160563|454628277|FG000|Overall Study|Adverse Event|1|||
126364310|NCT00160563|454628278|FG001|Overall Study|Adverse Event|1|||
126364311|NCT00160563|454628279|FG002|Overall Study|Adverse Event|1|||
126364312|NCT00160563|454628277|FG000|Overall Study|Lost to Follow-up|1|||
126364313|NCT00160563|454628278|FG001|Overall Study|Lost to Follow-up|1|||
126364314|NCT00160563|454628279|FG002|Overall Study|Lost to Follow-up|2|||
126364315|NCT00160563|454628277|FG000|Overall Study|Protocol Violation|0|||
126364316|NCT00160563|454628278|FG001|Overall Study|Protocol Violation|0|||
126364317|NCT00160563|454628279|FG002|Overall Study|Protocol Violation|3|||
126364318|NCT00160563|454628277|FG000|Overall Study|Withdrawal by Subject|1|||
126364319|NCT00160563|454628278|FG001|Overall Study|Withdrawal by Subject|2|||
126281876|NCT00863772|454320865|FG001|Overall Study|Entered extension study|4|||
126281877|NCT00863772|454320866|FG002|Overall Study|Entered extension study|9|||
126281878|NCT00863772|454320864|FG000|Overall Study|Other|1|||
126281879|NCT00863772|454320865|FG001|Overall Study|Other|2|||
126281880|NCT00863772|454320866|FG002|Overall Study|Other|4|||
126281881|NCT00863772|454320864|FG000|Overall Study|Randomized but not Treated|1|||
126281882|NCT00863772|454320865|FG001|Overall Study|Randomized but not Treated|0|||
126281883|NCT00863772|454320866|FG002|Overall Study|Randomized but not Treated|0|||
126281884|NCT00534404|454320869|FG000|Overall Study|Death|0|||
126281885|NCT00534404|454320870|FG001|Overall Study|Death|0|||
126281886|NCT00534404|454320871|FG002|Overall Study|Death|2|||
126281887|NCT00534404|454320869|FG000|Overall Study|Withdrawal by Subject|8|||
126281888|NCT00534404|454320870|FG001|Overall Study|Withdrawal by Subject|2|||
126281889|NCT00534404|454320871|FG002|Overall Study|Withdrawal by Subject|38|||
126281890|NCT00534404|454320869|FG000|Overall Study|Removed by study staff|2|||
126281891|NCT00534404|454320870|FG001|Overall Study|Removed by study staff|3|||
126281892|NCT00534404|454320871|FG002|Overall Study|Removed by study staff|1|||
126281893|NCT00534404|454320869|FG000|Overall Study|Lost to Follow-up|170|||
126281894|NCT00534404|454320870|FG001|Overall Study|Lost to Follow-up|138|||
126281895|NCT00534404|454320871|FG002|Overall Study|Lost to Follow-up|201|||
126281896|NCT00315731|454320876|FG000|Overall Study|Lost to Follow-up|1|||
126281897|NCT00315731|454320876|FG000|Overall Study|Death|5|||
126281898|NCT04614246|454320877|FG000|Overall Study|Adverse Event|0|||
126281899|NCT04614246|454320878|FG001|Overall Study|Adverse Event|1|||
126281900|NCT04614246|454320879|FG002|Overall Study|Adverse Event|1|||
126281901|NCT04614246|454320880|FG003|Overall Study|Adverse Event|2|||
126281902|NCT04614246|454320881|FG004|Overall Study|Adverse Event|1|||
126281903|NCT04614246|454320877|FG000|Overall Study|Lost to Follow-up|0|||
126281904|NCT04614246|454320878|FG001|Overall Study|Lost to Follow-up|1|||
126281905|NCT04614246|454320879|FG002|Overall Study|Lost to Follow-up|0|||
126281906|NCT04614246|454320880|FG003|Overall Study|Lost to Follow-up|1|||
126281907|NCT04614246|454320881|FG004|Overall Study|Lost to Follow-up|3|||
126281908|NCT04614246|454320877|FG000|Overall Study|Other reason|0|||
126281909|NCT04614246|454320878|FG001|Overall Study|Other reason|1|||
126281910|NCT04614246|454320879|FG002|Overall Study|Other reason|2|||
126281911|NCT04614246|454320880|FG003|Overall Study|Other reason|0|||
126281912|NCT04614246|454320881|FG004|Overall Study|Other reason|0|||
126281913|NCT04614246|454320877|FG000|Overall Study|Withdrawal by Subject|4|||
126281914|NCT04614246|454320878|FG001|Overall Study|Withdrawal by Subject|2|||
126281915|NCT04614246|454320879|FG002|Overall Study|Withdrawal by Subject|4|||
126281916|NCT04614246|454320880|FG003|Overall Study|Withdrawal by Subject|3|||
126281917|NCT04614246|454320881|FG004|Overall Study|Withdrawal by Subject|4|||
126281918|NCT04614246|454320877|FG000|Overall Study|Physician Decision|0|||
126281919|NCT04614246|454320878|FG001|Overall Study|Physician Decision|2|||
126281920|NCT04614246|454320879|FG002|Overall Study|Physician Decision|1|||
126281921|NCT04614246|454320880|FG003|Overall Study|Physician Decision|0|||
126281922|NCT04614246|454320881|FG004|Overall Study|Physician Decision|0|||
126281923|NCT04614246|454320877|FG000|Overall Study|Study terminated by sponsor|10|||
126281924|NCT04614246|454320878|FG001|Overall Study|Study terminated by sponsor|15|||
126281925|NCT04614246|454320879|FG002|Overall Study|Study terminated by sponsor|12|||
126281926|NCT04614246|454320880|FG003|Overall Study|Study terminated by sponsor|13|||
126281927|NCT04614246|454320881|FG004|Overall Study|Study terminated by sponsor|9|||
126281928|NCT04614246|454320877|FG000|Overall Study|Pregnancy|2|||
126281929|NCT04614246|454320878|FG001|Overall Study|Pregnancy|0|||
126281930|NCT04614246|454320879|FG002|Overall Study|Pregnancy|1|||
126281931|NCT04614246|454320880|FG003|Overall Study|Pregnancy|0|||
126281932|NCT04614246|454320881|FG004|Overall Study|Pregnancy|0|||
126364320|NCT00160563|454628279|FG002|Overall Study|Withdrawal by Subject|3|||
126364321|NCT00160563|454628277|FG000|Overall Study|Other (listed in the study report)|48|||
126364322|NCT00160563|454628278|FG001|Overall Study|Other (listed in the study report)|40|||
126364323|NCT00160563|454628279|FG002|Overall Study|Other (listed in the study report)|81|||
126364324|NCT00160563|454628277|FG000|Overall Study|Missing reason|0|||
126364325|NCT00160563|454628278|FG001|Overall Study|Missing reason|1|||
126364326|NCT00160563|454628279|FG002|Overall Study|Missing reason|0|||
126364327|NCT04157738|454628280|FG000|Overall Study|Moved out of state|0|||
126364328|NCT04157738|454628281|FG001|Overall Study|Moved out of state|2|||
126364329|NCT04157738|454628280|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
126281933|NCT00725205|454320882|FG000|Overall Study|Adverse Event|22|||
126364330|NCT04157738|454628281|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
126364331|NCT00347269|454628287|FG000|Overall Study|Lost to Follow-up|74|||
126364332|NCT00347269|454628288|FG001|Overall Study|Lost to Follow-up|65|||
126364333|NCT00347269|454628287|FG000|Overall Study|Withdrawal by Subject|18|||
126364334|NCT00347269|454628288|FG001|Overall Study|Withdrawal by Subject|38|||
126364335|NCT00347269|454628287|FG000|Overall Study|Death|2|||
126364336|NCT00347269|454628288|FG001|Overall Study|Death|3|||
126364337|NCT04102514|454628289|FG000|Overall Study|Death|3|||
126364338|NCT04102514|454628290|FG001|Overall Study|Death|0|||
126364339|NCT04102514|454628291|FG002|Overall Study|Death|0|||
126364340|NCT04102514|454628292|FG003|Overall Study|Death|0|||
126364341|NCT04102514|454628289|FG000|Overall Study|Lost to Follow-up|0|||
126364342|NCT04102514|454628290|FG001|Overall Study|Lost to Follow-up|0|||
126364343|NCT04102514|454628291|FG002|Overall Study|Lost to Follow-up|3|||
126364344|NCT04102514|454628292|FG003|Overall Study|Lost to Follow-up|0|||
126281934|NCT00725205|454320882|FG000|Overall Study|Investigator Discontinued|1|||
126281935|NCT00725205|454320882|FG000|Overall Study|Non-compliance With Protocol|14|||
126281936|NCT00725205|454320882|FG000|Overall Study|Other|8|||
126281937|NCT00725205|454320882|FG000|Overall Study|Protocol Defined Clinical Event|1|||
126281938|NCT00725205|454320882|FG000|Overall Study|Treatment Failure|41|||
126281939|NCT01680497|454320883|FG000|Overall Study|Lost to Follow-up|2|||
126281940|NCT01200069|454322873|FG000|Overall Study|Withdrawal by Subject|0|||
126281941|NCT01200069|454322874|FG001|Overall Study|Withdrawal by Subject|1|||
126281942|NCT02883049|454322875|FG000|Induction|Adverse Event|52|||
126281943|NCT02883049|454322876|FG001|Induction|Adverse Event|2|||
126281944|NCT02883049|454322877|FG002|Induction|Adverse Event|0|||
126281945|NCT02883049|454322878|FG003|Induction|Adverse Event|0|||
126364345|NCT04102514|454628289|FG000|Overall Study|Physician Decision|0|||
126364346|NCT04102514|454628290|FG001|Overall Study|Physician Decision|0|||
126364347|NCT04102514|454628291|FG002|Overall Study|Physician Decision|1|||
126364348|NCT04102514|454628292|FG003|Overall Study|Physician Decision|0|||
126364349|NCT04102514|454628289|FG000|Overall Study|Withdrawal by Subject|7|||
126364350|NCT04102514|454628290|FG001|Overall Study|Withdrawal by Subject|13|||
126364351|NCT04102514|454628291|FG002|Overall Study|Withdrawal by Subject|7|||
126364352|NCT04102514|454628292|FG003|Overall Study|Withdrawal by Subject|14|||
126364353|NCT04102514|454628289|FG000|Overall Study|Moved to longterm care facility|6|||
126364354|NCT04102514|454628290|FG001|Overall Study|Moved to longterm care facility|0|||
126364355|NCT04102514|454628291|FG002|Overall Study|Moved to longterm care facility|4|||
126364356|NCT04102514|454628292|FG003|Overall Study|Moved to longterm care facility|0|||
126364357|NCT00595075|454628314|FG000|Overall Study|Withdrawal by Subject|1|||
126364358|NCT00595075|454628315|FG001|Overall Study|Withdrawal by Subject|0|||
126364359|NCT00456365|454628316|FG000|Overall Study|Lost to Follow-up|1|||
126364360|NCT00456365|454628317|FG001|Overall Study|Lost to Follow-up|3|||
126364361|NCT00456365|454628316|FG000|Overall Study|Withdrawal by Subject|4|||
126364362|NCT00456365|454628317|FG001|Overall Study|Withdrawal by Subject|7|||
126364363|NCT00456365|454628316|FG000|Overall Study|Pregnancy|1|||
126364364|NCT00456365|454628317|FG001|Overall Study|Pregnancy|1|||
126364365|NCT00456365|454628316|FG000|Overall Study|oncologic diagnosis|1|||
126364366|NCT00456365|454628317|FG001|Overall Study|oncologic diagnosis|1|||
126364367|NCT05451329|454628318|FG000|Overall Study|Adverse Event|1|||
126364368|NCT05451329|454628319|FG001|Overall Study|Adverse Event|1|||
126364369|NCT05451329|454628320|FG002|Overall Study|Adverse Event|0|||
126364370|NCT05451329|454628318|FG000|Overall Study|Withdrawal by Subject|1|||
126364371|NCT05451329|454628319|FG001|Overall Study|Withdrawal by Subject|0|||
126364372|NCT05451329|454628320|FG002|Overall Study|Withdrawal by Subject|0|||
126364373|NCT05451329|454628318|FG000|Overall Study|Investigational Product Lot exchange|1|||
126364374|NCT05451329|454628319|FG001|Overall Study|Investigational Product Lot exchange|1|||
126364375|NCT05451329|454628320|FG002|Overall Study|Investigational Product Lot exchange|0|||
126364376|NCT02202577|454628321|FG000|Overall Study|Lost to Follow-up|6|||
126364377|NCT02202577|454628322|FG001|Overall Study|Lost to Follow-up|16|||
126364378|NCT02202577|454628321|FG000|Overall Study|Protocol Violation|7|||
126364379|NCT02202577|454628322|FG001|Overall Study|Protocol Violation|3|||
126281946|NCT02883049|454322879|FG004|Induction|Adverse Event|0|||
126281947|NCT02883049|454322880|FG005|Induction|Adverse Event|0|||
126364380|NCT00069953|454628323|FG000|Overall Study|Protocol Violation|2|||
126364381|NCT02034565|454628324|FG000|Overall Study|Adverse Event|1|||
126281948|NCT02883049|454322881|FG006|Induction|Adverse Event|0|||
126281949|NCT02883049|454322882|FG007|Induction|Adverse Event|0|||
126281950|NCT02883049|454322883|FG008|Induction|Adverse Event|0|||
126281951|NCT02883049|454322884|FG009|Induction|Adverse Event|0|||
126281952|NCT02883049|454322885|FG010|Induction|Adverse Event|0|||
126281953|NCT02883049|454322886|FG011|Induction|Adverse Event|0|||
126281954|NCT02883049|454322887|FG012|Induction|Adverse Event|0|||
126281955|NCT02883049|454322888|FG013|Induction|Adverse Event|0|||
126281956|NCT02883049|454322889|FG014|Induction|Adverse Event|0|||
126281957|NCT02883049|454322890|FG015|Induction|Adverse Event|0|||
126281958|NCT02883049|454322875|FG000|Induction|Death|76|||
126281959|NCT02883049|454322876|FG001|Induction|Death|8|||
126281960|NCT02883049|454322877|FG002|Induction|Death|0|||
126281961|NCT02883049|454322878|FG003|Induction|Death|0|||
126281962|NCT02883049|454322879|FG004|Induction|Death|0|||
126281963|NCT02883049|454322880|FG005|Induction|Death|0|||
126281964|NCT02883049|454322881|FG006|Induction|Death|0|||
126281965|NCT02883049|454322882|FG007|Induction|Death|0|||
126281966|NCT02883049|454322883|FG008|Induction|Death|0|||
126281967|NCT02883049|454322884|FG009|Induction|Death|0|||
126281968|NCT02883049|454322885|FG010|Induction|Death|0|||
126281969|NCT02883049|454322886|FG011|Induction|Death|0|||
126281970|NCT02883049|454322887|FG012|Induction|Death|0|||
126281971|NCT02883049|454322888|FG013|Induction|Death|0|||
126281972|NCT02883049|454322889|FG014|Induction|Death|0|||
126281973|NCT02883049|454322890|FG015|Induction|Death|0|||
126281974|NCT02883049|454322875|FG000|Induction|Lost to Follow-up|2|||
126281975|NCT02883049|454322876|FG001|Induction|Lost to Follow-up|0|||
126281976|NCT02883049|454322877|FG002|Induction|Lost to Follow-up|0|||
126281977|NCT02883049|454322878|FG003|Induction|Lost to Follow-up|0|||
126281978|NCT02883049|454322879|FG004|Induction|Lost to Follow-up|0|||
126281979|NCT02883049|454322880|FG005|Induction|Lost to Follow-up|0|||
126281980|NCT02883049|454322881|FG006|Induction|Lost to Follow-up|0|||
126281981|NCT02883049|454322882|FG007|Induction|Lost to Follow-up|0|||
126281982|NCT02883049|454322883|FG008|Induction|Lost to Follow-up|0|||
126281983|NCT02883049|454322884|FG009|Induction|Lost to Follow-up|0|||
126281984|NCT02883049|454322885|FG010|Induction|Lost to Follow-up|0|||
126281985|NCT02883049|454322886|FG011|Induction|Lost to Follow-up|0|||
126281986|NCT02883049|454322887|FG012|Induction|Lost to Follow-up|0|||
126281987|NCT02883049|454322888|FG013|Induction|Lost to Follow-up|0|||
126281988|NCT02883049|454322889|FG014|Induction|Lost to Follow-up|0|||
126281989|NCT02883049|454322890|FG015|Induction|Lost to Follow-up|0|||
126281990|NCT02883049|454322875|FG000|Induction|Physician Decision|1407|||
126281991|NCT02883049|454322876|FG001|Induction|Physician Decision|8|||
126281992|NCT02883049|454322877|FG002|Induction|Physician Decision|0|||
126281993|NCT02883049|454322878|FG003|Induction|Physician Decision|0|||
126281994|NCT02883049|454322879|FG004|Induction|Physician Decision|0|||
126281995|NCT02883049|454322880|FG005|Induction|Physician Decision|0|||
126281996|NCT02883049|454322881|FG006|Induction|Physician Decision|0|||
126281997|NCT02883049|454322882|FG007|Induction|Physician Decision|0|||
126281998|NCT02883049|454322883|FG008|Induction|Physician Decision|0|||
126281999|NCT02883049|454322884|FG009|Induction|Physician Decision|0|||
126282000|NCT02883049|454322885|FG010|Induction|Physician Decision|0|||
126282001|NCT02883049|454322886|FG011|Induction|Physician Decision|0|||
126282002|NCT02883049|454322887|FG012|Induction|Physician Decision|0|||
126282003|NCT02883049|454322888|FG013|Induction|Physician Decision|0|||
126282004|NCT02883049|454322889|FG014|Induction|Physician Decision|0|||
126282005|NCT02883049|454322890|FG015|Induction|Physician Decision|0|||
126282006|NCT02883049|454322875|FG000|Induction|Protocol Violation|6|||
126282007|NCT02883049|454322876|FG001|Induction|Protocol Violation|0|||
126282008|NCT02883049|454322877|FG002|Induction|Protocol Violation|0|||
126282009|NCT02883049|454322878|FG003|Induction|Protocol Violation|0|||
126282010|NCT02883049|454322879|FG004|Induction|Protocol Violation|0|||
126282011|NCT02883049|454322880|FG005|Induction|Protocol Violation|0|||
126282012|NCT02883049|454322881|FG006|Induction|Protocol Violation|0|||
126282013|NCT02883049|454322882|FG007|Induction|Protocol Violation|0|||
126282014|NCT02883049|454322883|FG008|Induction|Protocol Violation|0|||
126282015|NCT02883049|454322884|FG009|Induction|Protocol Violation|0|||
126282016|NCT02883049|454322885|FG010|Induction|Protocol Violation|0|||
126282017|NCT02883049|454322886|FG011|Induction|Protocol Violation|0|||
126282018|NCT02883049|454322887|FG012|Induction|Protocol Violation|0|||
126282019|NCT02883049|454322888|FG013|Induction|Protocol Violation|0|||
126282020|NCT02883049|454322889|FG014|Induction|Protocol Violation|0|||
126282021|NCT02883049|454322890|FG015|Induction|Protocol Violation|0|||
126282022|NCT02883049|454322875|FG000|Induction|Withdrawal by Subject|6|||
126282023|NCT02883049|454322876|FG001|Induction|Withdrawal by Subject|0|||
126282024|NCT02883049|454322877|FG002|Induction|Withdrawal by Subject|0|||
126282025|NCT02883049|454322878|FG003|Induction|Withdrawal by Subject|0|||
126282026|NCT02883049|454322879|FG004|Induction|Withdrawal by Subject|0|||
126282027|NCT02883049|454322880|FG005|Induction|Withdrawal by Subject|0|||
126282028|NCT02883049|454322881|FG006|Induction|Withdrawal by Subject|0|||
126282029|NCT02883049|454322882|FG007|Induction|Withdrawal by Subject|0|||
126282030|NCT02883049|454322883|FG008|Induction|Withdrawal by Subject|0|||
126282031|NCT02883049|454322884|FG009|Induction|Withdrawal by Subject|0|||
126282032|NCT02883049|454322885|FG010|Induction|Withdrawal by Subject|0|||
126282033|NCT02883049|454322886|FG011|Induction|Withdrawal by Subject|0|||
126282034|NCT02883049|454322887|FG012|Induction|Withdrawal by Subject|0|||
126282035|NCT02883049|454322888|FG013|Induction|Withdrawal by Subject|0|||
126282036|NCT02883049|454322889|FG014|Induction|Withdrawal by Subject|0|||
126282037|NCT02883049|454322890|FG015|Induction|Withdrawal by Subject|0|||
126282038|NCT02883049|454322875|FG000|Induction|Ineligible|35|||
126282039|NCT02883049|454322876|FG001|Induction|Ineligible|1|||
126282040|NCT02883049|454322877|FG002|Induction|Ineligible|0|||
126282041|NCT02883049|454322878|FG003|Induction|Ineligible|0|||
126282042|NCT02883049|454322879|FG004|Induction|Ineligible|0|||
126282043|NCT02883049|454322880|FG005|Induction|Ineligible|0|||
126282044|NCT02883049|454322881|FG006|Induction|Ineligible|0|||
126282045|NCT02883049|454322882|FG007|Induction|Ineligible|0|||
126282046|NCT02883049|454322883|FG008|Induction|Ineligible|0|||
126282047|NCT02883049|454322884|FG009|Induction|Ineligible|0|||
126282048|NCT02883049|454322885|FG010|Induction|Ineligible|0|||
126282049|NCT02883049|454322886|FG011|Induction|Ineligible|0|||
126282050|NCT02883049|454322887|FG012|Induction|Ineligible|0|||
126282051|NCT02883049|454322888|FG013|Induction|Ineligible|0|||
126282052|NCT02883049|454322889|FG014|Induction|Ineligible|0|||
126282053|NCT02883049|454322890|FG015|Induction|Ineligible|0|||
126282054|NCT02883049|454322875|FG000|Induction|Refusal of further protocol therapy|466|||
126282055|NCT02883049|454322876|FG001|Induction|Refusal of further protocol therapy|2|||
126282056|NCT02883049|454322877|FG002|Induction|Refusal of further protocol therapy|0|||
126282057|NCT02883049|454322878|FG003|Induction|Refusal of further protocol therapy|0|||
126282058|NCT02883049|454322879|FG004|Induction|Refusal of further protocol therapy|0|||
126282059|NCT02883049|454322880|FG005|Induction|Refusal of further protocol therapy|0|||
126282060|NCT02883049|454322881|FG006|Induction|Refusal of further protocol therapy|0|||
126282061|NCT02883049|454322882|FG007|Induction|Refusal of further protocol therapy|0|||
126282062|NCT02883049|454322883|FG008|Induction|Refusal of further protocol therapy|0|||
126282063|NCT02883049|454322884|FG009|Induction|Refusal of further protocol therapy|0|||
126282064|NCT02883049|454322885|FG010|Induction|Refusal of further protocol therapy|0|||
126282065|NCT02883049|454322886|FG011|Induction|Refusal of further protocol therapy|0|||
126282066|NCT02883049|454322887|FG012|Induction|Refusal of further protocol therapy|0|||
126282067|NCT02883049|454322888|FG013|Induction|Refusal of further protocol therapy|0|||
126282068|NCT02883049|454322889|FG014|Induction|Refusal of further protocol therapy|0|||
126282069|NCT02883049|454322890|FG015|Induction|Refusal of further protocol therapy|0|||
126282070|NCT02883049|454322875|FG000|Induction|Identified as Ph+ patients|279|||
126282071|NCT02883049|454322876|FG001|Induction|Identified as Ph+ patients|1|||
126282072|NCT02883049|454322877|FG002|Induction|Identified as Ph+ patients|0|||
126282073|NCT02883049|454322878|FG003|Induction|Identified as Ph+ patients|0|||
126282074|NCT02883049|454322879|FG004|Induction|Identified as Ph+ patients|0|||
126282075|NCT02883049|454322880|FG005|Induction|Identified as Ph+ patients|0|||
126282076|NCT02883049|454322881|FG006|Induction|Identified as Ph+ patients|0|||
126282077|NCT02883049|454322882|FG007|Induction|Identified as Ph+ patients|0|||
126282078|NCT02883049|454322883|FG008|Induction|Identified as Ph+ patients|0|||
126282079|NCT02883049|454322884|FG009|Induction|Identified as Ph+ patients|0|||
126282080|NCT02883049|454322885|FG010|Induction|Identified as Ph+ patients|0|||
126282081|NCT02883049|454322886|FG011|Induction|Identified as Ph+ patients|0|||
126282082|NCT02883049|454322887|FG012|Induction|Identified as Ph+ patients|0|||
126282083|NCT02883049|454322888|FG013|Induction|Identified as Ph+ patients|0|||
126282084|NCT02883049|454322889|FG014|Induction|Identified as Ph+ patients|0|||
126282085|NCT02883049|454322890|FG015|Induction|Identified as Ph+ patients|0|||
126282086|NCT02883049|454322875|FG000|Induction|M3 Marrow at Day29|8|||
126282087|NCT02883049|454322876|FG001|Induction|M3 Marrow at Day29|1|||
126282088|NCT02883049|454322877|FG002|Induction|M3 Marrow at Day29|0|||
126282089|NCT02883049|454322878|FG003|Induction|M3 Marrow at Day29|0|||
126282090|NCT02883049|454322879|FG004|Induction|M3 Marrow at Day29|0|||
126282091|NCT02883049|454322880|FG005|Induction|M3 Marrow at Day29|0|||
126282092|NCT02883049|454322881|FG006|Induction|M3 Marrow at Day29|0|||
126282093|NCT02883049|454322882|FG007|Induction|M3 Marrow at Day29|0|||
126282094|NCT02883049|454322883|FG008|Induction|M3 Marrow at Day29|0|||
126282095|NCT02883049|454322884|FG009|Induction|M3 Marrow at Day29|0|||
126282096|NCT02883049|454322885|FG010|Induction|M3 Marrow at Day29|0|||
126282097|NCT02883049|454322886|FG011|Induction|M3 Marrow at Day29|0|||
126282098|NCT02883049|454322887|FG012|Induction|M3 Marrow at Day29|0|||
126282099|NCT02883049|454322888|FG013|Induction|M3 Marrow at Day29|0|||
126282100|NCT02883049|454322889|FG014|Induction|M3 Marrow at Day29|0|||
126282101|NCT02883049|454322890|FG015|Induction|M3 Marrow at Day29|0|||
126282102|NCT02883049|454322875|FG000|Induction|Inevaluable|33|||
126364382|NCT02034565|454628325|FG001|Overall Study|Adverse Event|0|||
126282103|NCT02883049|454322876|FG001|Induction|Inevaluable|1|||
126282104|NCT02883049|454322877|FG002|Induction|Inevaluable|0|||
126282105|NCT02883049|454322878|FG003|Induction|Inevaluable|0|||
126282106|NCT02883049|454322879|FG004|Induction|Inevaluable|0|||
126364383|NCT00113373|454628326|FG000|Overall Study|Ineligible: wrong primary|1|||
126282107|NCT02883049|454322880|FG005|Induction|Inevaluable|0|||
126282108|NCT02883049|454322881|FG006|Induction|Inevaluable|0|||
126282109|NCT02883049|454322882|FG007|Induction|Inevaluable|0|||
126364384|NCT00113373|454628326|FG000|Overall Study|Ineligible: second primary|1|||
126364385|NCT00113373|454628326|FG000|Overall Study|Never Treated|1|||
126364386|NCT00829868|454628327|FG000|Washout|Physician Decision|1|||
126364387|NCT00829868|454628328|FG001|Washout|Physician Decision|0|||
126364388|NCT02799043|454628330|FG000|Overall Study|Adverse Event|0|||
126364389|NCT02799043|454628331|FG001|Overall Study|Adverse Event|1|||
126364390|NCT02799043|454628330|FG000|Overall Study|Death|1|||
126364391|NCT02799043|454628331|FG001|Overall Study|Death|1|||
126364392|NCT02799043|454628330|FG000|Overall Study|Lost to Follow-up|3|||
126364393|NCT02799043|454628331|FG001|Overall Study|Lost to Follow-up|6|||
126364394|NCT02799043|454628330|FG000|Overall Study|Withdrawal by Subject|4|||
126364395|NCT02799043|454628331|FG001|Overall Study|Withdrawal by Subject|4|||
126364396|NCT02799043|454628330|FG000|Overall Study|Moved to different country|0|||
125882279|NCT02113982|452868953|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
125882280|NCT02113982|452868954|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
126364397|NCT02799043|454628331|FG001|Overall Study|Moved to different country|1|||
126364398|NCT02799043|454628330|FG000|Overall Study|Trial Screen Failure|1|||
126364399|NCT02799043|454628331|FG001|Overall Study|Trial Screen Failure|0|||
126364400|NCT02799043|454628330|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
126364401|NCT02799043|454628331|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
126364402|NCT06091956|454628332|FG000|Overall Study|Withdrawal by Subject|1|||
126364403|NCT06091956|454628332|FG000|Overall Study|Complicating Disease|1|||
126364404|NCT00803049|454628347|FG000|Overall Study|Adverse Event|21|||
126282110|NCT02883049|454322883|FG008|Induction|Inevaluable|0|||
126282111|NCT02883049|454322884|FG009|Induction|Inevaluable|0|||
126282112|NCT02883049|454322885|FG010|Induction|Inevaluable|0|||
126282113|NCT02883049|454322886|FG011|Induction|Inevaluable|0|||
126282114|NCT02883049|454322887|FG012|Induction|Inevaluable|0|||
126282115|NCT02883049|454322888|FG013|Induction|Inevaluable|0|||
126282116|NCT02883049|454322889|FG014|Induction|Inevaluable|0|||
126282117|NCT02883049|454322890|FG015|Induction|Inevaluable|0|||
126282118|NCT02883049|454322875|FG000|Induction|Identified as VHR at end of Induction|244|||
126282119|NCT02883049|454322876|FG001|Induction|Identified as VHR at end of Induction|0|||
126282120|NCT02883049|454322877|FG002|Induction|Identified as VHR at end of Induction|0|||
126282121|NCT02883049|454322878|FG003|Induction|Identified as VHR at end of Induction|0|||
126282122|NCT02883049|454322879|FG004|Induction|Identified as VHR at end of Induction|0|||
126282123|NCT02883049|454322880|FG005|Induction|Identified as VHR at end of Induction|0|||
126282124|NCT02883049|454322881|FG006|Induction|Identified as VHR at end of Induction|0|||
126282125|NCT02883049|454322882|FG007|Induction|Identified as VHR at end of Induction|0|||
126282126|NCT02883049|454322883|FG008|Induction|Identified as VHR at end of Induction|0|||
126364405|NCT00803049|454628348|FG001|Overall Study|Adverse Event|33|||
126282127|NCT02883049|454322884|FG009|Induction|Identified as VHR at end of Induction|0|||
126282128|NCT02883049|454322885|FG010|Induction|Identified as VHR at end of Induction|0|||
126364406|NCT00803049|454628349|FG002|Overall Study|Adverse Event|13|||
126364407|NCT00803049|454628350|FG003|Overall Study|Adverse Event|27|||
126364408|NCT00803049|454628347|FG000|Overall Study|Lack of Efficacy|10|||
126364409|NCT00803049|454628348|FG001|Overall Study|Lack of Efficacy|19|||
126364410|NCT00803049|454628349|FG002|Overall Study|Lack of Efficacy|6|||
126364411|NCT00803049|454628350|FG003|Overall Study|Lack of Efficacy|13|||
126364412|NCT00803049|454628347|FG000|Overall Study|Lost to Follow-up|0|||
126364413|NCT00803049|454628348|FG001|Overall Study|Lost to Follow-up|2|||
126364414|NCT00803049|454628349|FG002|Overall Study|Lost to Follow-up|0|||
126364415|NCT00803049|454628350|FG003|Overall Study|Lost to Follow-up|3|||
126364416|NCT00803049|454628347|FG000|Overall Study|Death|2|||
126364417|NCT00803049|454628348|FG001|Overall Study|Death|1|||
126364418|NCT00803049|454628349|FG002|Overall Study|Death|0|||
126364419|NCT00803049|454628350|FG003|Overall Study|Death|2|||
126364420|NCT00803049|454628347|FG000|Overall Study|Progressive Disease|6|||
126364421|NCT00803049|454628348|FG001|Overall Study|Progressive Disease|10|||
126364422|NCT00803049|454628349|FG002|Overall Study|Progressive Disease|6|||
126364423|NCT00803049|454628350|FG003|Overall Study|Progressive Disease|6|||
126364424|NCT00803049|454628347|FG000|Overall Study|Withdrawal by Subject|19|||
126364425|NCT00803049|454628348|FG001|Overall Study|Withdrawal by Subject|43|||
125882281|NCT02113982|452868955|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
125882282|NCT02113982|452868956|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
126282129|NCT02883049|454322886|FG011|Induction|Identified as VHR at end of Induction|0|||
126282130|NCT02883049|454322887|FG012|Induction|Identified as VHR at end of Induction|0|||
126364426|NCT00803049|454628349|FG002|Overall Study|Withdrawal by Subject|16|||
126364427|NCT00803049|454628350|FG003|Overall Study|Withdrawal by Subject|44|||
126364428|NCT00803049|454628347|FG000|Overall Study|Protocol Violation|0|||
126364429|NCT00803049|454628348|FG001|Overall Study|Protocol Violation|1|||
126364430|NCT00803049|454628349|FG002|Overall Study|Protocol Violation|1|||
126364431|NCT00803049|454628350|FG003|Overall Study|Protocol Violation|0|||
126364432|NCT00803049|454628347|FG000|Overall Study|Randomized and Not Treated|0|||
126364433|NCT00803049|454628348|FG001|Overall Study|Randomized and Not Treated|0|||
126364434|NCT00803049|454628349|FG002|Overall Study|Randomized and Not Treated|0|||
126364435|NCT00803049|454628350|FG003|Overall Study|Randomized and Not Treated|2|||
126364436|NCT00803049|454628347|FG000|Overall Study|Other than Specified Above|3|||
125882283|NCT02113982|452868957|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
126282131|NCT02883049|454322888|FG013|Induction|Identified as VHR at end of Induction|0|||
126282132|NCT02883049|454322889|FG014|Induction|Identified as VHR at end of Induction|0|||
126282133|NCT02883049|454322890|FG015|Induction|Identified as VHR at end of Induction|0|||
126282134|NCT02883049|454322875|FG000|Induction|Moved to another non-COG institution|3|||
126282135|NCT02883049|454322876|FG001|Induction|Moved to another non-COG institution|0|||
126282136|NCT02883049|454322877|FG002|Induction|Moved to another non-COG institution|0|||
126282137|NCT02883049|454322878|FG003|Induction|Moved to another non-COG institution|0|||
126282138|NCT02883049|454322879|FG004|Induction|Moved to another non-COG institution|0|||
126282139|NCT02883049|454322880|FG005|Induction|Moved to another non-COG institution|0|||
126282140|NCT02883049|454322881|FG006|Induction|Moved to another non-COG institution|0|||
126282141|NCT02883049|454322882|FG007|Induction|Moved to another non-COG institution|0|||
126282142|NCT02883049|454322883|FG008|Induction|Moved to another non-COG institution|0|||
126282143|NCT02883049|454322884|FG009|Induction|Moved to another non-COG institution|0|||
126282144|NCT02883049|454322885|FG010|Induction|Moved to another non-COG institution|0|||
126282145|NCT02883049|454322886|FG011|Induction|Moved to another non-COG institution|0|||
126282146|NCT02883049|454322887|FG012|Induction|Moved to another non-COG institution|0|||
126282147|NCT02883049|454322888|FG013|Induction|Moved to another non-COG institution|0|||
126282148|NCT02883049|454322889|FG014|Induction|Moved to another non-COG institution|0|||
126282149|NCT02883049|454322890|FG015|Induction|Moved to another non-COG institution|0|||
126282150|NCT02883049|454322875|FG000|Induction|Randomization closed|41|||
126282151|NCT02883049|454322876|FG001|Induction|Randomization closed|0|||
126282152|NCT02883049|454322877|FG002|Induction|Randomization closed|0|||
126282153|NCT02883049|454322878|FG003|Induction|Randomization closed|0|||
126282154|NCT02883049|454322879|FG004|Induction|Randomization closed|0|||
126282155|NCT02883049|454322880|FG005|Induction|Randomization closed|0|||
126282156|NCT02883049|454322881|FG006|Induction|Randomization closed|0|||
126282157|NCT02883049|454322882|FG007|Induction|Randomization closed|0|||
126282158|NCT02883049|454322883|FG008|Induction|Randomization closed|0|||
126282159|NCT02883049|454322884|FG009|Induction|Randomization closed|0|||
126282160|NCT02883049|454322885|FG010|Induction|Randomization closed|0|||
126282161|NCT02883049|454322886|FG011|Induction|Randomization closed|0|||
125882284|NCT02113982|452868958|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
125882285|NCT02113982|452868959|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
125882286|NCT02113982|452868960|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
125882287|NCT02113982|452868961|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
125882288|NCT02113982|452868948|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882289|NCT02113982|452868949|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882290|NCT02113982|452868950|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882291|NCT02113982|452868951|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882292|NCT02113982|452868952|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882293|NCT02113982|452868953|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882294|NCT02113982|452868954|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882295|NCT02113982|452868955|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882296|NCT02113982|452868956|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882297|NCT02113982|452868957|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882298|NCT02113982|452868958|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126282162|NCT02883049|454322887|FG012|Induction|Randomization closed|0|||
126282163|NCT02883049|454322888|FG013|Induction|Randomization closed|0|||
126282164|NCT02883049|454322889|FG014|Induction|Randomization closed|0|||
126282165|NCT02883049|454322890|FG015|Induction|Randomization closed|0|||
126282166|NCT02883049|454322875|FG000|Induction|MRD negative|36|||
126282167|NCT02883049|454322876|FG001|Induction|MRD negative|0|||
126282168|NCT02883049|454322877|FG002|Induction|MRD negative|0|||
126282169|NCT02883049|454322878|FG003|Induction|MRD negative|0|||
126282170|NCT02883049|454322879|FG004|Induction|MRD negative|0|||
126282171|NCT02883049|454322880|FG005|Induction|MRD negative|0|||
126282172|NCT02883049|454322881|FG006|Induction|MRD negative|0|||
126282173|NCT02883049|454322882|FG007|Induction|MRD negative|0|||
126282174|NCT02883049|454322883|FG008|Induction|MRD negative|0|||
126282175|NCT02883049|454322884|FG009|Induction|MRD negative|0|||
126282176|NCT02883049|454322885|FG010|Induction|MRD negative|0|||
126282177|NCT02883049|454322886|FG011|Induction|MRD negative|0|||
126282178|NCT02883049|454322887|FG012|Induction|MRD negative|0|||
126282179|NCT02883049|454322888|FG013|Induction|MRD negative|0|||
126282180|NCT02883049|454322889|FG014|Induction|MRD negative|0|||
126282181|NCT02883049|454322890|FG015|Induction|MRD negative|0|||
126282182|NCT02883049|454322875|FG000|Induction|Identified as HR patients|165|||
126282183|NCT02883049|454322876|FG001|Induction|Identified as HR patients|0|||
126282184|NCT02883049|454322877|FG002|Induction|Identified as HR patients|0|||
126282185|NCT02883049|454322878|FG003|Induction|Identified as HR patients|0|||
126282186|NCT02883049|454322879|FG004|Induction|Identified as HR patients|0|||
126282187|NCT02883049|454322880|FG005|Induction|Identified as HR patients|0|||
126282188|NCT02883049|454322881|FG006|Induction|Identified as HR patients|0|||
126282189|NCT02883049|454322882|FG007|Induction|Identified as HR patients|0|||
126282190|NCT02883049|454322883|FG008|Induction|Identified as HR patients|0|||
126282191|NCT02883049|454322884|FG009|Induction|Identified as HR patients|0|||
126282192|NCT02883049|454322885|FG010|Induction|Identified as HR patients|0|||
126282193|NCT02883049|454322886|FG011|Induction|Identified as HR patients|0|||
126282194|NCT02883049|454322887|FG012|Induction|Identified as HR patients|0|||
126282195|NCT02883049|454322888|FG013|Induction|Identified as HR patients|0|||
126282196|NCT02883049|454322889|FG014|Induction|Identified as HR patients|0|||
126282197|NCT02883049|454322890|FG015|Induction|Identified as HR patients|0|||
126282198|NCT02883049|454322875|FG000|Induction|Developed SMN|0|||
126282199|NCT02883049|454322876|FG001|Induction|Developed SMN|1|||
126282200|NCT02883049|454322877|FG002|Induction|Developed SMN|0|||
126282201|NCT02883049|454322878|FG003|Induction|Developed SMN|0|||
126282202|NCT02883049|454322879|FG004|Induction|Developed SMN|0|||
126282203|NCT02883049|454322880|FG005|Induction|Developed SMN|0|||
126282204|NCT02883049|454322881|FG006|Induction|Developed SMN|0|||
126282205|NCT02883049|454322882|FG007|Induction|Developed SMN|0|||
126282206|NCT02883049|454322883|FG008|Induction|Developed SMN|0|||
126282207|NCT02883049|454322884|FG009|Induction|Developed SMN|0|||
126282208|NCT02883049|454322885|FG010|Induction|Developed SMN|0|||
126282209|NCT02883049|454322886|FG011|Induction|Developed SMN|0|||
126282210|NCT02883049|454322887|FG012|Induction|Developed SMN|0|||
126282211|NCT02883049|454322888|FG013|Induction|Developed SMN|0|||
126282212|NCT02883049|454322889|FG014|Induction|Developed SMN|0|||
126282213|NCT02883049|454322890|FG015|Induction|Developed SMN|0|||
126282214|NCT02883049|454322875|FG000|Induction|Enrolled onto another COG study|72|||
126282215|NCT02883049|454322876|FG001|Induction|Enrolled onto another COG study|0|||
126282216|NCT02883049|454322877|FG002|Induction|Enrolled onto another COG study|0|||
126282217|NCT02883049|454322878|FG003|Induction|Enrolled onto another COG study|0|||
126282218|NCT02883049|454322879|FG004|Induction|Enrolled onto another COG study|0|||
126282219|NCT02883049|454322880|FG005|Induction|Enrolled onto another COG study|0|||
126282220|NCT02883049|454322881|FG006|Induction|Enrolled onto another COG study|0|||
126282221|NCT02883049|454322882|FG007|Induction|Enrolled onto another COG study|0|||
126282222|NCT02883049|454322883|FG008|Induction|Enrolled onto another COG study|0|||
126282223|NCT02883049|454322884|FG009|Induction|Enrolled onto another COG study|0|||
126282224|NCT02883049|454322885|FG010|Induction|Enrolled onto another COG study|0|||
126282225|NCT02883049|454322886|FG011|Induction|Enrolled onto another COG study|0|||
126282226|NCT02883049|454322887|FG012|Induction|Enrolled onto another COG study|0|||
126282227|NCT02883049|454322888|FG013|Induction|Enrolled onto another COG study|0|||
126282228|NCT02883049|454322889|FG014|Induction|Enrolled onto another COG study|0|||
126282229|NCT02883049|454322890|FG015|Induction|Enrolled onto another COG study|0|||
126282230|NCT02883049|454322875|FG000|Induction|Incomplete induction data|17|||
126282231|NCT02883049|454322876|FG001|Induction|Incomplete induction data|0|||
126282232|NCT02883049|454322877|FG002|Induction|Incomplete induction data|0|||
126282233|NCT02883049|454322878|FG003|Induction|Incomplete induction data|0|||
126282234|NCT02883049|454322879|FG004|Induction|Incomplete induction data|0|||
126282235|NCT02883049|454322880|FG005|Induction|Incomplete induction data|0|||
126282236|NCT02883049|454322881|FG006|Induction|Incomplete induction data|0|||
126282237|NCT02883049|454322882|FG007|Induction|Incomplete induction data|0|||
126282238|NCT02883049|454322883|FG008|Induction|Incomplete induction data|0|||
126282239|NCT02883049|454322884|FG009|Induction|Incomplete induction data|0|||
126282240|NCT02883049|454322885|FG010|Induction|Incomplete induction data|0|||
126282241|NCT02883049|454322886|FG011|Induction|Incomplete induction data|0|||
126282242|NCT02883049|454322887|FG012|Induction|Incomplete induction data|0|||
126282243|NCT02883049|454322888|FG013|Induction|Incomplete induction data|0|||
126282244|NCT02883049|454322889|FG014|Induction|Incomplete induction data|0|||
126282245|NCT02883049|454322890|FG015|Induction|Incomplete induction data|0|||
126282246|NCT02883049|454322875|FG000|Post Induction|Adverse Event|0|||
126282247|NCT02883049|454322876|FG001|Post Induction|Adverse Event|0|||
126282248|NCT02883049|454322877|FG002|Post Induction|Adverse Event|0|||
126282249|NCT02883049|454322878|FG003|Post Induction|Adverse Event|7|||
126282250|NCT02883049|454322879|FG004|Post Induction|Adverse Event|8|||
126282251|NCT02883049|454322880|FG005|Post Induction|Adverse Event|3|||
126282252|NCT02883049|454322881|FG006|Post Induction|Adverse Event|4|||
126282253|NCT02883049|454322882|FG007|Post Induction|Adverse Event|5|||
126282254|NCT02883049|454322883|FG008|Post Induction|Adverse Event|6|||
126282255|NCT02883049|454322884|FG009|Post Induction|Adverse Event|7|||
126282256|NCT02883049|454322885|FG010|Post Induction|Adverse Event|2|||
126282257|NCT02883049|454322886|FG011|Post Induction|Adverse Event|2|||
126282258|NCT02883049|454322887|FG012|Post Induction|Adverse Event|0|||
126282259|NCT02883049|454322888|FG013|Post Induction|Adverse Event|0|||
126282260|NCT02883049|454322889|FG014|Post Induction|Adverse Event|5|||
126282261|NCT02883049|454322890|FG015|Post Induction|Adverse Event|2|||
126282262|NCT02883049|454322875|FG000|Post Induction|Death|0|||
125882299|NCT02113982|452868959|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
126282263|NCT02883049|454322876|FG001|Post Induction|Death|0|||
126282264|NCT02883049|454322877|FG002|Post Induction|Death|0|||
126282265|NCT02883049|454322878|FG003|Post Induction|Death|9|||
126282266|NCT02883049|454322879|FG004|Post Induction|Death|9|||
126282267|NCT02883049|454322880|FG005|Post Induction|Death|0|||
126282268|NCT02883049|454322881|FG006|Post Induction|Death|1|||
126282269|NCT02883049|454322882|FG007|Post Induction|Death|6|||
126282270|NCT02883049|454322883|FG008|Post Induction|Death|5|||
126282271|NCT02883049|454322884|FG009|Post Induction|Death|3|||
126282272|NCT02883049|454322885|FG010|Post Induction|Death|1|||
126282273|NCT02883049|454322886|FG011|Post Induction|Death|0|||
126282274|NCT02883049|454322887|FG012|Post Induction|Death|1|||
126282275|NCT02883049|454322888|FG013|Post Induction|Death|1|||
126282276|NCT02883049|454322889|FG014|Post Induction|Death|10|||
126282277|NCT02883049|454322890|FG015|Post Induction|Death|2|||
126282278|NCT02883049|454322875|FG000|Post Induction|Lost to Follow-up|0|||
126282279|NCT02883049|454322876|FG001|Post Induction|Lost to Follow-up|0|||
126282280|NCT02883049|454322877|FG002|Post Induction|Lost to Follow-up|0|||
126282281|NCT02883049|454322878|FG003|Post Induction|Lost to Follow-up|0|||
126282282|NCT02883049|454322879|FG004|Post Induction|Lost to Follow-up|1|||
126282283|NCT02883049|454322880|FG005|Post Induction|Lost to Follow-up|1|||
126282284|NCT02883049|454322881|FG006|Post Induction|Lost to Follow-up|0|||
126282285|NCT02883049|454322882|FG007|Post Induction|Lost to Follow-up|0|||
126282286|NCT02883049|454322883|FG008|Post Induction|Lost to Follow-up|3|||
126282287|NCT02883049|454322884|FG009|Post Induction|Lost to Follow-up|0|||
126282288|NCT02883049|454322885|FG010|Post Induction|Lost to Follow-up|1|||
126282289|NCT02883049|454322886|FG011|Post Induction|Lost to Follow-up|0|||
126282290|NCT02883049|454322887|FG012|Post Induction|Lost to Follow-up|0|||
126282291|NCT02883049|454322888|FG013|Post Induction|Lost to Follow-up|0|||
126282292|NCT02883049|454322889|FG014|Post Induction|Lost to Follow-up|0|||
126282293|NCT02883049|454322890|FG015|Post Induction|Lost to Follow-up|0|||
126282294|NCT02883049|454322875|FG000|Post Induction|Physician Decision|0|||
126282295|NCT02883049|454322876|FG001|Post Induction|Physician Decision|0|||
126282296|NCT02883049|454322877|FG002|Post Induction|Physician Decision|0|||
126282297|NCT02883049|454322878|FG003|Post Induction|Physician Decision|27|||
126282298|NCT02883049|454322879|FG004|Post Induction|Physician Decision|27|||
126282299|NCT02883049|454322880|FG005|Post Induction|Physician Decision|23|||
126282300|NCT02883049|454322881|FG006|Post Induction|Physician Decision|30|||
126282301|NCT02883049|454322882|FG007|Post Induction|Physician Decision|56|||
126282302|NCT02883049|454322883|FG008|Post Induction|Physician Decision|85|||
126282303|NCT02883049|454322884|FG009|Post Induction|Physician Decision|12|||
126282304|NCT02883049|454322885|FG010|Post Induction|Physician Decision|5|||
126282305|NCT02883049|454322886|FG011|Post Induction|Physician Decision|14|||
126282306|NCT02883049|454322887|FG012|Post Induction|Physician Decision|1|||
126282307|NCT02883049|454322888|FG013|Post Induction|Physician Decision|11|||
126282308|NCT02883049|454322889|FG014|Post Induction|Physician Decision|19|||
126282309|NCT02883049|454322890|FG015|Post Induction|Physician Decision|5|||
126040369|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126282310|NCT02883049|454322875|FG000|Post Induction|Protocol Violation|0|||
126282311|NCT02883049|454322876|FG001|Post Induction|Protocol Violation|0|||
126282312|NCT02883049|454322877|FG002|Post Induction|Protocol Violation|0|||
126282313|NCT02883049|454322878|FG003|Post Induction|Protocol Violation|0|||
126282314|NCT02883049|454322879|FG004|Post Induction|Protocol Violation|0|||
126282315|NCT02883049|454322880|FG005|Post Induction|Protocol Violation|0|||
126282316|NCT02883049|454322881|FG006|Post Induction|Protocol Violation|0|||
126282317|NCT02883049|454322882|FG007|Post Induction|Protocol Violation|1|||
126282318|NCT02883049|454322883|FG008|Post Induction|Protocol Violation|0|||
126282319|NCT02883049|454322884|FG009|Post Induction|Protocol Violation|0|||
126282320|NCT02883049|454322885|FG010|Post Induction|Protocol Violation|0|||
126282321|NCT02883049|454322886|FG011|Post Induction|Protocol Violation|0|||
126282322|NCT02883049|454322887|FG012|Post Induction|Protocol Violation|0|||
126282323|NCT02883049|454322888|FG013|Post Induction|Protocol Violation|0|||
126282324|NCT02883049|454322889|FG014|Post Induction|Protocol Violation|0|||
126282325|NCT02883049|454322890|FG015|Post Induction|Protocol Violation|0|||
126282326|NCT02883049|454322875|FG000|Post Induction|Withdrawal by Subject|0|||
126282327|NCT02883049|454322876|FG001|Post Induction|Withdrawal by Subject|0|||
126282328|NCT02883049|454322877|FG002|Post Induction|Withdrawal by Subject|0|||
126040370|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126040371|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126040372|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126040373|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126282329|NCT02883049|454322878|FG003|Post Induction|Withdrawal by Subject|5|||
126282330|NCT02883049|454322879|FG004|Post Induction|Withdrawal by Subject|2|||
126282331|NCT02883049|454322880|FG005|Post Induction|Withdrawal by Subject|1|||
126282332|NCT02883049|454322881|FG006|Post Induction|Withdrawal by Subject|0|||
126282333|NCT02883049|454322882|FG007|Post Induction|Withdrawal by Subject|0|||
126282334|NCT02883049|454322883|FG008|Post Induction|Withdrawal by Subject|2|||
126282335|NCT02883049|454322884|FG009|Post Induction|Withdrawal by Subject|0|||
126282336|NCT02883049|454322885|FG010|Post Induction|Withdrawal by Subject|1|||
126282337|NCT02883049|454322886|FG011|Post Induction|Withdrawal by Subject|1|||
126282338|NCT02883049|454322887|FG012|Post Induction|Withdrawal by Subject|0|||
126282339|NCT02883049|454322888|FG013|Post Induction|Withdrawal by Subject|0|||
126282340|NCT02883049|454322889|FG014|Post Induction|Withdrawal by Subject|1|||
126282341|NCT02883049|454322890|FG015|Post Induction|Withdrawal by Subject|0|||
126282342|NCT02883049|454322875|FG000|Post Induction|Ineligible|0|||
126282343|NCT02883049|454322876|FG001|Post Induction|Ineligible|0|||
126282344|NCT02883049|454322877|FG002|Post Induction|Ineligible|2|||
126282345|NCT02883049|454322878|FG003|Post Induction|Ineligible|0|||
126282346|NCT02883049|454322879|FG004|Post Induction|Ineligible|0|||
126282347|NCT02883049|454322880|FG005|Post Induction|Ineligible|0|||
126282348|NCT02883049|454322881|FG006|Post Induction|Ineligible|1|||
126282349|NCT02883049|454322882|FG007|Post Induction|Ineligible|0|||
126282350|NCT02883049|454322883|FG008|Post Induction|Ineligible|0|||
126282351|NCT02883049|454322884|FG009|Post Induction|Ineligible|0|||
126282352|NCT02883049|454322885|FG010|Post Induction|Ineligible|1|||
126282353|NCT02883049|454322886|FG011|Post Induction|Ineligible|0|||
126282354|NCT02883049|454322887|FG012|Post Induction|Ineligible|0|||
126282355|NCT02883049|454322888|FG013|Post Induction|Ineligible|0|||
126282356|NCT02883049|454322889|FG014|Post Induction|Ineligible|0|||
126282357|NCT02883049|454322890|FG015|Post Induction|Ineligible|1|||
126282358|NCT02883049|454322875|FG000|Post Induction|Refusal of further protocol therapy|0|||
126364437|NCT00803049|454628348|FG001|Overall Study|Other than Specified Above|9|||
126040374|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126282359|NCT02883049|454322876|FG001|Post Induction|Refusal of further protocol therapy|0|||
126364438|NCT00803049|454628349|FG002|Overall Study|Other than Specified Above|2|||
126282360|NCT02883049|454322877|FG002|Post Induction|Refusal of further protocol therapy|0|||
126364439|NCT00803049|454628350|FG003|Overall Study|Other than Specified Above|5|||
126364440|NCT01421459|454628351|FG000|Overall Study|Adverse Event|6|||
126364441|NCT01421459|454628352|FG001|Overall Study|Adverse Event|10|||
126364442|NCT01421459|454628351|FG000|Overall Study|Death|1|||
126364443|NCT01421459|454628352|FG001|Overall Study|Death|1|||
126364444|NCT01421459|454628351|FG000|Overall Study|Lack of Efficacy|1|||
126364445|NCT01421459|454628352|FG001|Overall Study|Lack of Efficacy|2|||
126364446|NCT01421459|454628351|FG000|Overall Study|Lost to Follow-up|8|||
126364447|NCT01421459|454628352|FG001|Overall Study|Lost to Follow-up|9|||
126364448|NCT01421459|454628351|FG000|Overall Study|Physician Decision|9|||
126364449|NCT01421459|454628352|FG001|Overall Study|Physician Decision|9|||
126364450|NCT01421459|454628351|FG000|Overall Study|Protocol Violation|8|||
126364451|NCT01421459|454628352|FG001|Overall Study|Protocol Violation|5|||
126364452|NCT01421459|454628351|FG000|Overall Study|Withdrawal by Subject|12|||
126364453|NCT01421459|454628352|FG001|Overall Study|Withdrawal by Subject|16|||
126364454|NCT04439903|454628363|FG000|Overall Study|Withdrawal by Subject|2|||
126364455|NCT04439903|454628363|FG000|Overall Study|Screen Failure|1|||
126364456|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
126364457|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
126364458|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
126364459|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
126364460|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
126364461|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
126364462|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
126364463|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
126364464|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
126364465|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
126364466|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
126364467|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
126282361|NCT02883049|454322878|FG003|Post Induction|Refusal of further protocol therapy|11|||
126282362|NCT02883049|454322879|FG004|Post Induction|Refusal of further protocol therapy|15|||
126364468|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
126364469|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
126282363|NCT02883049|454322880|FG005|Post Induction|Refusal of further protocol therapy|9|||
126282364|NCT02883049|454322881|FG006|Post Induction|Refusal of further protocol therapy|13|||
126364470|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
126040375|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126040376|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126040377|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
126040378|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126040379|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126040380|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126040381|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
126040382|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
126040383|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040384|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040385|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040386|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040387|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040388|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040389|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040390|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040391|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040392|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
126040393|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040394|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040395|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040396|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
126040397|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126040398|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040399|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040400|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040401|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040402|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040403|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040404|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040405|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040406|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040407|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040408|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040409|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040410|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040411|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126040412|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
126040413|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Other|0|||
126040414|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Other|0|||
126040415|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Other|0|||
126040416|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Other|0|||
126040417|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Other|0|||
126040418|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Other|0|||
126040419|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Other|0|||
126040420|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Other|0|||
126040421|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Other|0|||
126040422|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Other|0|||
126040423|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Other|0|||
126040424|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Other|0|||
126040425|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Other|0|||
126040426|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Other|1|||
126040427|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Other|3|||
126282365|NCT02883049|454322882|FG007|Post Induction|Refusal of further protocol therapy|5|||
126282366|NCT02883049|454322883|FG008|Post Induction|Refusal of further protocol therapy|21|||
126282367|NCT02883049|454322884|FG009|Post Induction|Refusal of further protocol therapy|7|||
126282368|NCT02883049|454322885|FG010|Post Induction|Refusal of further protocol therapy|0|||
126282369|NCT02883049|454322886|FG011|Post Induction|Refusal of further protocol therapy|7|||
126282370|NCT02883049|454322887|FG012|Post Induction|Refusal of further protocol therapy|3|||
126282371|NCT02883049|454322888|FG013|Post Induction|Refusal of further protocol therapy|0|||
126040428|NCT03519178|453447152|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
126282372|NCT02883049|454322889|FG014|Post Induction|Refusal of further protocol therapy|4|||
126040429|NCT03519178|453447153|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040430|NCT03519178|453447154|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040431|NCT03519178|453447155|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040432|NCT03519178|453447156|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040433|NCT03519178|453447157|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040434|NCT03519178|453447158|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040435|NCT03519178|453447159|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040436|NCT03519178|453447160|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040437|NCT03519178|453447161|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040438|NCT03519178|453447162|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040439|NCT03519178|453447163|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040440|NCT03519178|453447164|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
126040441|NCT03519178|453447165|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
126040442|NCT03519178|453447166|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
126040443|NCT03519178|453447152|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
126040444|NCT03519178|453447153|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
126040445|NCT03519178|453447154|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
126040446|NCT03519178|453447155|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
126040447|NCT03519178|453447156|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
126282373|NCT02883049|454322890|FG015|Post Induction|Refusal of further protocol therapy|1|||
126282374|NCT02883049|454322875|FG000|Post Induction|Inevaluable|0|||
126282375|NCT02883049|454322876|FG001|Post Induction|Inevaluable|0|||
126282376|NCT02883049|454322877|FG002|Post Induction|Inevaluable|0|||
126282377|NCT02883049|454322878|FG003|Post Induction|Inevaluable|1|||
126282378|NCT02883049|454322879|FG004|Post Induction|Inevaluable|1|||
126282379|NCT02883049|454322880|FG005|Post Induction|Inevaluable|2|||
126282380|NCT02883049|454322881|FG006|Post Induction|Inevaluable|7|||
126282381|NCT02883049|454322882|FG007|Post Induction|Inevaluable|6|||
126282382|NCT02883049|454322883|FG008|Post Induction|Inevaluable|4|||
126282383|NCT02883049|454322884|FG009|Post Induction|Inevaluable|4|||
126282384|NCT02883049|454322885|FG010|Post Induction|Inevaluable|1|||
126282385|NCT02883049|454322886|FG011|Post Induction|Inevaluable|1|||
126282386|NCT02883049|454322887|FG012|Post Induction|Inevaluable|2|||
126282387|NCT02883049|454322888|FG013|Post Induction|Inevaluable|0|||
126282388|NCT02883049|454322889|FG014|Post Induction|Inevaluable|0|||
126282389|NCT02883049|454322890|FG015|Post Induction|Inevaluable|1|||
126282390|NCT02883049|454322875|FG000|Post Induction|Moved to another non-COG institution|0|||
126282391|NCT02883049|454322876|FG001|Post Induction|Moved to another non-COG institution|0|||
126282392|NCT02883049|454322877|FG002|Post Induction|Moved to another non-COG institution|0|||
126282393|NCT02883049|454322878|FG003|Post Induction|Moved to another non-COG institution|0|||
126282394|NCT02883049|454322879|FG004|Post Induction|Moved to another non-COG institution|0|||
126282395|NCT02883049|454322880|FG005|Post Induction|Moved to another non-COG institution|0|||
126282396|NCT02883049|454322881|FG006|Post Induction|Moved to another non-COG institution|0|||
126282397|NCT02883049|454322882|FG007|Post Induction|Moved to another non-COG institution|2|||
126282398|NCT02883049|454322883|FG008|Post Induction|Moved to another non-COG institution|2|||
126282399|NCT02883049|454322884|FG009|Post Induction|Moved to another non-COG institution|0|||
126282400|NCT02883049|454322885|FG010|Post Induction|Moved to another non-COG institution|0|||
126282401|NCT02883049|454322886|FG011|Post Induction|Moved to another non-COG institution|1|||
126282402|NCT02883049|454322887|FG012|Post Induction|Moved to another non-COG institution|0|||
126282403|NCT02883049|454322888|FG013|Post Induction|Moved to another non-COG institution|0|||
126282404|NCT02883049|454322889|FG014|Post Induction|Moved to another non-COG institution|0|||
126282405|NCT02883049|454322890|FG015|Post Induction|Moved to another non-COG institution|0|||
126282406|NCT02883049|454322875|FG000|Post Induction|Randomization closed|0|||
126282407|NCT02883049|454322876|FG001|Post Induction|Randomization closed|0|||
126282408|NCT02883049|454322877|FG002|Post Induction|Randomization closed|0|||
126282409|NCT02883049|454322878|FG003|Post Induction|Randomization closed|0|||
126282410|NCT02883049|454322879|FG004|Post Induction|Randomization closed|0|||
126282411|NCT02883049|454322880|FG005|Post Induction|Randomization closed|0|||
126040448|NCT03519178|453447157|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
126040449|NCT03519178|453447158|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
126040450|NCT03519178|453447159|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
126282412|NCT02883049|454322881|FG006|Post Induction|Randomization closed|0|||
126282413|NCT02883049|454322882|FG007|Post Induction|Randomization closed|20|||
126282414|NCT02883049|454322883|FG008|Post Induction|Randomization closed|0|||
126282415|NCT02883049|454322884|FG009|Post Induction|Randomization closed|0|||
126282416|NCT02883049|454322885|FG010|Post Induction|Randomization closed|0|||
126282417|NCT02883049|454322886|FG011|Post Induction|Randomization closed|0|||
126282418|NCT02883049|454322887|FG012|Post Induction|Randomization closed|0|||
126282419|NCT02883049|454322888|FG013|Post Induction|Randomization closed|0|||
126364471|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
126364472|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
126040451|NCT03519178|453447160|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
126282420|NCT02883049|454322889|FG014|Post Induction|Randomization closed|0|||
126282421|NCT02883049|454322890|FG015|Post Induction|Randomization closed|0|||
126282422|NCT02883049|454322875|FG000|Post Induction|MRD negative|0|||
126282423|NCT02883049|454322876|FG001|Post Induction|MRD negative|0|||
126282424|NCT02883049|454322877|FG002|Post Induction|MRD negative|0|||
126282425|NCT02883049|454322878|FG003|Post Induction|MRD negative|0|||
126282426|NCT02883049|454322879|FG004|Post Induction|MRD negative|0|||
126282427|NCT02883049|454322880|FG005|Post Induction|MRD negative|0|||
126282428|NCT02883049|454322881|FG006|Post Induction|MRD negative|0|||
126282429|NCT02883049|454322882|FG007|Post Induction|MRD negative|11|||
126282430|NCT02883049|454322883|FG008|Post Induction|MRD negative|0|||
126282431|NCT02883049|454322884|FG009|Post Induction|MRD negative|0|||
126282432|NCT02883049|454322885|FG010|Post Induction|MRD negative|0|||
126282433|NCT02883049|454322886|FG011|Post Induction|MRD negative|0|||
126282434|NCT02883049|454322887|FG012|Post Induction|MRD negative|0|||
126282435|NCT02883049|454322888|FG013|Post Induction|MRD negative|0|||
126282436|NCT02883049|454322889|FG014|Post Induction|MRD negative|0|||
126282437|NCT02883049|454322890|FG015|Post Induction|MRD negative|0|||
126282438|NCT02883049|454322875|FG000|Post Induction|Developed SMN|0|||
126282439|NCT02883049|454322876|FG001|Post Induction|Developed SMN|0|||
126282440|NCT02883049|454322877|FG002|Post Induction|Developed SMN|0|||
126282441|NCT02883049|454322878|FG003|Post Induction|Developed SMN|0|||
126282442|NCT02883049|454322879|FG004|Post Induction|Developed SMN|1|||
126282443|NCT02883049|454322880|FG005|Post Induction|Developed SMN|0|||
126282444|NCT02883049|454322881|FG006|Post Induction|Developed SMN|1|||
126282445|NCT02883049|454322882|FG007|Post Induction|Developed SMN|0|||
126282446|NCT02883049|454322883|FG008|Post Induction|Developed SMN|0|||
126282447|NCT02883049|454322884|FG009|Post Induction|Developed SMN|0|||
126282448|NCT02883049|454322885|FG010|Post Induction|Developed SMN|1|||
126282449|NCT02883049|454322886|FG011|Post Induction|Developed SMN|1|||
126282450|NCT02883049|454322887|FG012|Post Induction|Developed SMN|0|||
126282451|NCT02883049|454322888|FG013|Post Induction|Developed SMN|0|||
126282452|NCT02883049|454322889|FG014|Post Induction|Developed SMN|1|||
126282453|NCT02883049|454322890|FG015|Post Induction|Developed SMN|0|||
126282454|NCT02883049|454322875|FG000|Post Induction|Enrolled onto another COG study|0|||
126282455|NCT02883049|454322876|FG001|Post Induction|Enrolled onto another COG study|0|||
126282456|NCT02883049|454322877|FG002|Post Induction|Enrolled onto another COG study|0|||
126282457|NCT02883049|454322878|FG003|Post Induction|Enrolled onto another COG study|1|||
126282458|NCT02883049|454322879|FG004|Post Induction|Enrolled onto another COG study|1|||
126282459|NCT02883049|454322880|FG005|Post Induction|Enrolled onto another COG study|0|||
126282460|NCT02883049|454322881|FG006|Post Induction|Enrolled onto another COG study|0|||
126282461|NCT02883049|454322882|FG007|Post Induction|Enrolled onto another COG study|4|||
126282462|NCT02883049|454322883|FG008|Post Induction|Enrolled onto another COG study|0|||
126282463|NCT02883049|454322884|FG009|Post Induction|Enrolled onto another COG study|0|||
126282464|NCT02883049|454322885|FG010|Post Induction|Enrolled onto another COG study|0|||
126282465|NCT02883049|454322886|FG011|Post Induction|Enrolled onto another COG study|2|||
126282466|NCT02883049|454322887|FG012|Post Induction|Enrolled onto another COG study|0|||
126282467|NCT02883049|454322888|FG013|Post Induction|Enrolled onto another COG study|1|||
126282468|NCT02883049|454322889|FG014|Post Induction|Enrolled onto another COG study|0|||
126282469|NCT02883049|454322890|FG015|Post Induction|Enrolled onto another COG study|0|||
126282470|NCT02883049|454322875|FG000|Post Induction|Recurrent leukemia|0|||
126282471|NCT02883049|454322876|FG001|Post Induction|Recurrent leukemia|0|||
126282472|NCT02883049|454322877|FG002|Post Induction|Recurrent leukemia|0|||
126282473|NCT02883049|454322878|FG003|Post Induction|Recurrent leukemia|17|||
126282474|NCT02883049|454322879|FG004|Post Induction|Recurrent leukemia|12|||
126282475|NCT02883049|454322880|FG005|Post Induction|Recurrent leukemia|4|||
126282476|NCT02883049|454322881|FG006|Post Induction|Recurrent leukemia|1|||
126282477|NCT02883049|454322882|FG007|Post Induction|Recurrent leukemia|13|||
126282478|NCT02883049|454322883|FG008|Post Induction|Recurrent leukemia|27|||
126282479|NCT02883049|454322884|FG009|Post Induction|Recurrent leukemia|5|||
126282480|NCT02883049|454322885|FG010|Post Induction|Recurrent leukemia|3|||
126282481|NCT02883049|454322886|FG011|Post Induction|Recurrent leukemia|12|||
126282482|NCT02883049|454322887|FG012|Post Induction|Recurrent leukemia|1|||
126282483|NCT02883049|454322888|FG013|Post Induction|Recurrent leukemia|1|||
126282484|NCT02883049|454322889|FG014|Post Induction|Recurrent leukemia|9|||
126282485|NCT02883049|454322890|FG015|Post Induction|Recurrent leukemia|3|||
126282486|NCT02883049|454322875|FG000|Post Induction|Induction Failure|0|||
126282487|NCT02883049|454322876|FG001|Post Induction|Induction Failure|0|||
126282488|NCT02883049|454322877|FG002|Post Induction|Induction Failure|0|||
126282489|NCT02883049|454322878|FG003|Post Induction|Induction Failure|0|||
126282490|NCT02883049|454322879|FG004|Post Induction|Induction Failure|0|||
126282491|NCT02883049|454322880|FG005|Post Induction|Induction Failure|0|||
126282492|NCT02883049|454322881|FG006|Post Induction|Induction Failure|0|||
126282493|NCT02883049|454322882|FG007|Post Induction|Induction Failure|2|||
126282494|NCT02883049|454322883|FG008|Post Induction|Induction Failure|2|||
126282495|NCT02883049|454322884|FG009|Post Induction|Induction Failure|0|||
126364473|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
126364474|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
126364475|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
126364476|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
126364477|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
126364478|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
126364479|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
126364480|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
126364481|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
126364482|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
126364483|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
126364484|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
126364485|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
126364486|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Death|0|||
126364487|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Death|0|||
126364488|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Death|0|||
126364489|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Death|0|||
126364490|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Death|1|||
126364491|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
126364492|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
126364493|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
126364494|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
126364495|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
126364496|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
126364497|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
126364498|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
126364499|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
126364500|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
126364501|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
126364502|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
126364503|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
126364504|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
126364505|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
126364506|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
126364507|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
126364508|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
126364509|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
126364510|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
126364511|NCT04042311|454628373|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
126364512|NCT04042311|454628373|FG000|Overall Study|Unable to tolerate|4|||
126364513|NCT04042311|454628373|FG000|Overall Study|Concurrent illness|2|||
126364514|NCT04042311|454628373|FG000|Overall Study|Adverse Event|2|||
126364515|NCT04042311|454628373|FG000|Overall Study|No longer meeting inclusion criteria|2|||
126364516|NCT04042311|454628373|FG000|Overall Study|No reason given|1|||
126364517|NCT04042311|454628373|FG000|Overall Study|Withdrawal by Subject|4|||
126364518|NCT03382873|454628374|FG000|Overall Study|Lost to Follow-up|9|||
126364519|NCT03382873|454628375|FG001|Overall Study|Lost to Follow-up|10|||
126364520|NCT03382873|454628374|FG000|Overall Study|Withdrawal by Subject|6|||
126364521|NCT03382873|454628375|FG001|Overall Study|Withdrawal by Subject|11|||
126364522|NCT03382873|454628374|FG000|Overall Study|Visit not completed due to pandemic|16|||
126364523|NCT03382873|454628375|FG001|Overall Study|Visit not completed due to pandemic|41|||
126364524|NCT03996395|454628378|FG000|Overall Study|Lost to Follow-up|4|||
126364525|NCT03996395|454628378|FG000|Overall Study|Withdrawal by Subject|1|||
126364526|NCT03996395|454628378|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
126364527|NCT02061085|454628381|FG000|Overall Study|Adverse Event|8|||
126364528|NCT03247673|454628382|FG000|Overall Study|Withdrawal by Subject|1|||
126364529|NCT03247673|454628383|FG001|Overall Study|Withdrawal by Subject|0|||
126364530|NCT03247673|454628384|FG002|Overall Study|Withdrawal by Subject|3|||
126364531|NCT03247673|454628382|FG000|Overall Study|Lost to Follow-up|0|||
126364532|NCT03247673|454628383|FG001|Overall Study|Lost to Follow-up|0|||
126364533|NCT03247673|454628384|FG002|Overall Study|Lost to Follow-up|1|||
126364534|NCT02097225|454628385|FG000|Dose Level 4|Adverse Event|0|||
126364535|NCT02097225|454628386|FG001|Dose Level 4|Adverse Event|0|||
126364536|NCT02097225|454628387|FG002|Dose Level 4|Adverse Event|0|||
126364537|NCT02097225|454628388|FG003|Dose Level 4|Adverse Event|0|||
126364538|NCT02097225|454628389|FG004|Dose Level 4|Adverse Event|1|||
126364539|NCT01027351|454628391|FG000|Overall Study|Withdrawal by Subject|1|||
126364540|NCT01027351|454628392|FG001|Overall Study|Withdrawal by Subject|0|||
126364541|NCT01027351|454628393|FG002|Overall Study|Withdrawal by Subject|1|||
126364542|NCT01027351|454628394|FG003|Overall Study|Withdrawal by Subject|0|||
126364543|NCT01027351|454628395|FG004|Overall Study|Withdrawal by Subject|3|||
126364544|NCT01027351|454628396|FG005|Overall Study|Withdrawal by Subject|5|||
126364545|NCT01027351|454628391|FG000|Overall Study|Lost to Follow-up|1|||
126364546|NCT01027351|454628392|FG001|Overall Study|Lost to Follow-up|1|||
126282496|NCT02883049|454322885|FG010|Post Induction|Induction Failure|0|||
126282497|NCT02883049|454322886|FG011|Post Induction|Induction Failure|0|||
126282498|NCT02883049|454322887|FG012|Post Induction|Induction Failure|0|||
126040452|NCT03519178|453447161|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
126040453|NCT03519178|453447162|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
126040454|NCT03519178|453447163|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
126040455|NCT03519178|453447164|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
126040456|NCT03519178|453447165|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
126040457|NCT03519178|453447166|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
126040458|NCT03519178|453447152|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
126040459|NCT03519178|453447153|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
126282499|NCT02883049|454322888|FG013|Post Induction|Induction Failure|2|||
126282500|NCT02883049|454322889|FG014|Post Induction|Induction Failure|0|||
126282501|NCT02883049|454322890|FG015|Post Induction|Induction Failure|0|||
126282502|NCT01924754|454322894|FG000|Overall Study|Lost to Follow-up|1|||
126282503|NCT01924754|454322895|FG001|Overall Study|Lost to Follow-up|2|||
126282504|NCT01924754|454322896|FG002|Overall Study|Lost to Follow-up|1|||
126282505|NCT01924754|454322894|FG000|Overall Study|Pregnancy|0|||
126282506|NCT01924754|454322895|FG001|Overall Study|Pregnancy|1|||
126282507|NCT01924754|454322896|FG002|Overall Study|Pregnancy|2|||
126282508|NCT02245412|454322899|FG000|Treatment Period|Death|1|||
126282509|NCT02245412|454322900|FG001|Treatment Period|Death|1|||
126282510|NCT02245412|454322901|FG002|Treatment Period|Death|0|||
126282511|NCT02245412|454322899|FG000|Treatment Period|Physician Decision|1|||
126282512|NCT02245412|454322900|FG001|Treatment Period|Physician Decision|1|||
126282513|NCT02245412|454322901|FG002|Treatment Period|Physician Decision|0|||
126282514|NCT02245412|454322899|FG000|Treatment Period|Withdrawal by Subject|2|||
126282515|NCT02245412|454322900|FG001|Treatment Period|Withdrawal by Subject|1|||
126282516|NCT02245412|454322901|FG002|Treatment Period|Withdrawal by Subject|0|||
126282517|NCT02245412|454322899|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
126282518|NCT02245412|454322900|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
126282519|NCT02245412|454322901|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
126282520|NCT02245412|454322899|FG000|Follow-Up Period|Death|4|||
126282521|NCT02245412|454322900|FG001|Follow-Up Period|Death|2|||
126282522|NCT02245412|454322901|FG002|Follow-Up Period|Death|1|||
126282523|NCT02245412|454322899|FG000|Follow-Up Period|Physician Decision|1|||
126282524|NCT02245412|454322900|FG001|Follow-Up Period|Physician Decision|0|||
126282525|NCT02245412|454322901|FG002|Follow-Up Period|Physician Decision|0|||
126282526|NCT02245412|454322899|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
126282527|NCT02245412|454322900|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
126282528|NCT02245412|454322901|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
126282529|NCT00369486|454322902|FG000|4-Week Visit|Missed visit|2|||
126282530|NCT00369486|454322903|FG001|4-Week Visit|Missed visit|2|||
126282531|NCT00369486|454322904|FG002|4-Week Visit|Missed visit|0|||
126282532|NCT00369486|454322905|FG003|4-Week Visit|Missed visit|2|||
126282533|NCT00369486|454322906|FG004|4-Week Visit|Missed visit|1|||
126282534|NCT00369486|454322902|FG000|4-Week Visit|Dropped|0|||
126282535|NCT00369486|454322903|FG001|4-Week Visit|Dropped|0|||
126282536|NCT00369486|454322904|FG002|4-Week Visit|Dropped|1|||
126282537|NCT00369486|454322905|FG003|4-Week Visit|Dropped|0|||
126282538|NCT00369486|454322906|FG004|4-Week Visit|Dropped|0|||
126282539|NCT00369486|454322902|FG000|8-Week Visit|Missed visit|0|||
126282540|NCT00369486|454322903|FG001|8-Week Visit|Missed visit|1|||
126282541|NCT00369486|454322904|FG002|8-Week Visit|Missed visit|0|||
126282542|NCT00369486|454322905|FG003|8-Week Visit|Missed visit|0|||
126282543|NCT00369486|454322906|FG004|8-Week Visit|Missed visit|1|||
126282544|NCT00369486|454322902|FG000|8-Week Visit|Dropped|0|||
126282545|NCT00369486|454322903|FG001|8-Week Visit|Dropped|0|||
126282546|NCT00369486|454322904|FG002|8-Week Visit|Dropped|0|||
126282547|NCT00369486|454322905|FG003|8-Week Visit|Dropped|1|||
126282548|NCT00369486|454322906|FG004|8-Week Visit|Dropped|0|||
126282549|NCT00369486|454322902|FG000|17-Week Visit|Missed visit|0|||
126282550|NCT00369486|454322903|FG001|17-Week Visit|Missed visit|0|||
126282551|NCT00369486|454322904|FG002|17-Week Visit|Missed visit|1|||
126282552|NCT00369486|454322905|FG003|17-Week Visit|Missed visit|1|||
126282553|NCT00369486|454322906|FG004|17-Week Visit|Missed visit|1|||
126282554|NCT00369486|454322902|FG000|34-Week Visit|Dropped|0|||
126282555|NCT00369486|454322903|FG001|34-Week Visit|Dropped|1|||
126282556|NCT00369486|454322904|FG002|34-Week Visit|Dropped|1|||
126282557|NCT00369486|454322905|FG003|34-Week Visit|Dropped|3|||
126282558|NCT00369486|454322906|FG004|34-Week Visit|Dropped|3|||
126282559|NCT01392963|454322907|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
126282560|NCT01392963|454322908|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
126282561|NCT01392963|454322907|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
126282562|NCT01392963|454322908|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
126282563|NCT01392963|454322907|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
126282564|NCT01392963|454322908|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
126282565|NCT00402116|454322909|FG000|Overall Study|Jaw infection after surgery-other|1|||
126282566|NCT00402116|454322910|FG001|Overall Study|Jaw infection after surgery-other|0|||
126282567|NCT00402116|454322911|FG002|Overall Study|Jaw infection after surgery-other|0|||
126282568|NCT00402116|454322909|FG000|Overall Study|Withdrawal by Subject|1|||
126282569|NCT00402116|454322910|FG001|Overall Study|Withdrawal by Subject|0|||
126282570|NCT00402116|454322911|FG002|Overall Study|Withdrawal by Subject|5|||
126282571|NCT00402116|454322909|FG000|Overall Study|Treatment completed per protocol|1|||
126282572|NCT00402116|454322910|FG001|Overall Study|Treatment completed per protocol|1|||
126282573|NCT00402116|454322911|FG002|Overall Study|Treatment completed per protocol|2|||
126282574|NCT00402116|454322909|FG000|Overall Study|other complicating disease|0|||
126282575|NCT00402116|454322910|FG001|Overall Study|other complicating disease|0|||
126282576|NCT00402116|454322911|FG002|Overall Study|other complicating disease|2|||
126282577|NCT00402116|454322909|FG000|Overall Study|Disease Progression|0|||
126282578|NCT00402116|454322910|FG001|Overall Study|Disease Progression|4|||
126282579|NCT00402116|454322911|FG002|Overall Study|Disease Progression|38|||
126282580|NCT00402116|454322909|FG000|Overall Study|mistaken thrombocytopenia|0|||
126282581|NCT00402116|454322910|FG001|Overall Study|mistaken thrombocytopenia|0|||
126282582|NCT00402116|454322911|FG002|Overall Study|mistaken thrombocytopenia|1|||
126282583|NCT00402116|454322909|FG000|Overall Study|decline related hyponatremia/tumor|0|||
126282584|NCT00402116|454322910|FG001|Overall Study|decline related hyponatremia/tumor|0|||
126282585|NCT00402116|454322911|FG002|Overall Study|decline related hyponatremia/tumor|1|||
126282586|NCT00402116|454322909|FG000|Overall Study|Adverse Event|0|||
126282587|NCT00402116|454322910|FG001|Overall Study|Adverse Event|1|||
126282588|NCT00402116|454322911|FG002|Overall Study|Adverse Event|6|||
126282589|NCT04778904|454322912|FG000|Overall Study|Protocol Violation|1|||
126282590|NCT04778904|454322913|FG001|Overall Study|Protocol Violation|0|||
126282591|NCT04778904|454322914|FG002|Overall Study|Protocol Violation|0|||
126282592|NCT04778904|454322915|FG003|Overall Study|Protocol Violation|0|||
126282593|NCT04778904|454322912|FG000|Overall Study|Withdrawal by Subject|0|||
126282594|NCT04778904|454322913|FG001|Overall Study|Withdrawal by Subject|0|||
126282595|NCT04778904|454322914|FG002|Overall Study|Withdrawal by Subject|1|||
126282596|NCT04778904|454322915|FG003|Overall Study|Withdrawal by Subject|0|||
126282597|NCT05048329|454322922|FG000|Overall Study|Withdrawal by Subject|1|||
126282598|NCT05048329|454322922|FG000|Overall Study|Screenfail|1|||
126282599|NCT03772717|454322923|FG000|Overall Study|Withdrawal by Subject|2|||
126282600|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
126282601|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
126282602|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
126282603|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
126282604|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
126282605|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
126282606|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
126282607|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
126282608|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
126282609|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
126282610|NCT02856802|454322924|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
126282611|NCT02856802|454322925|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
126282612|NCT04138043|454322926|FG000|Overall Study|Withdrawal by Subject|0|||
126282613|NCT04138043|454322927|FG001|Overall Study|Withdrawal by Subject|1|||
126282614|NCT01403051|454322928|FG000|Overall Study|Protocol Violation|2|||
126282615|NCT01403051|454322929|FG001|Overall Study|Protocol Violation|0|||
126282616|NCT01403051|454322928|FG000|Overall Study|Death|1|||
126282617|NCT01403051|454322929|FG001|Overall Study|Death|0|||
126282618|NCT01403051|454322928|FG000|Overall Study|Withdrawal by Subject|2|||
126282619|NCT01403051|454322929|FG001|Overall Study|Withdrawal by Subject|1|||
126282620|NCT01403051|454322928|FG000|Overall Study|Lost to Follow-up|5|||
126282621|NCT01403051|454322929|FG001|Overall Study|Lost to Follow-up|5|||
126282622|NCT00287586|454322939|FG000|Overall Study|Withdrew Consent|19|||
126282623|NCT00287586|454322940|FG001|Overall Study|Withdrew Consent|30|||
126282624|NCT00287586|454322939|FG000|Overall Study|Lost to Follow-up|5|||
126282625|NCT00287586|454322940|FG001|Overall Study|Lost to Follow-up|4|||
126282626|NCT00287586|454322939|FG000|Overall Study|Death|2|||
126282627|NCT00287586|454322940|FG001|Overall Study|Death|3|||
126282628|NCT00287586|454322939|FG000|Overall Study|Elevated Hematocrit|3|||
126282629|NCT00287586|454322940|FG001|Overall Study|Elevated Hematocrit|0|||
126282630|NCT00287586|454322939|FG000|Overall Study|Rash|3|||
126282631|NCT00287586|454322940|FG001|Overall Study|Rash|0|||
126282632|NCT00287586|454322939|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
126282633|NCT00287586|454322940|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
126282634|NCT00287586|454322939|FG000|Overall Study|Stroke|2|||
126282635|NCT00287586|454322940|FG001|Overall Study|Stroke|0|||
126282636|NCT00287586|454322939|FG000|Overall Study|Myocardial Infarction|1|||
126282637|NCT00287586|454322940|FG001|Overall Study|Myocardial Infarction|0|||
126282638|NCT00287586|454322939|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
126282639|NCT00287586|454322940|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
126282640|NCT00287586|454322939|FG000|Overall Study|Cognitive Impairment|1|||
126282641|NCT00287586|454322940|FG001|Overall Study|Cognitive Impairment|0|||
126282642|NCT00287586|454322939|FG000|Overall Study|Pancreatic Cancer|1|||
126282643|NCT00287586|454322940|FG001|Overall Study|Pancreatic Cancer|3|||
126282644|NCT00287586|454322939|FG000|Overall Study|Sleep Apnea|1|||
126282645|NCT00287586|454322940|FG001|Overall Study|Sleep Apnea|0|||
126282646|NCT00287586|454322939|FG000|Overall Study|Shoulder Pain|1|||
126282647|NCT00287586|454322940|FG001|Overall Study|Shoulder Pain|0|||
126282648|NCT00287586|454322939|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
126282649|NCT00287586|454322940|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
126282650|NCT00287586|454322939|FG000|Overall Study|Nonadherence|1|||
126282651|NCT00287586|454322940|FG001|Overall Study|Nonadherence|1|||
126282652|NCT00287586|454322939|FG000|Overall Study|Enrolled in Another Study|1|||
126282653|NCT00287586|454322940|FG001|Overall Study|Enrolled in Another Study|0|||
126282654|NCT00287586|454322939|FG000|Overall Study|Major Depression|0|||
126282655|NCT00287586|454322940|FG001|Overall Study|Major Depression|2|||
126282656|NCT00287586|454322939|FG000|Overall Study|Lung Cancer|0|||
126282657|NCT00287586|454322940|FG001|Overall Study|Lung Cancer|2|||
126282658|NCT00287586|454322939|FG000|Overall Study|Elevated IPSS Score|0|||
126282659|NCT00287586|454322940|FG001|Overall Study|Elevated IPSS Score|1|||
126282660|NCT00287586|454322939|FG000|Overall Study|Retroperitoneal Cancer|0|||
126282661|NCT00287586|454322940|FG001|Overall Study|Retroperitoneal Cancer|1|||
126282662|NCT00287586|454322939|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
126282663|NCT00287586|454322940|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
126282664|NCT00287586|454322939|FG000|Overall Study|Mood Swings and Irritability|0|||
126282665|NCT00287586|454322940|FG001|Overall Study|Mood Swings and Irritability|1|||
126282666|NCT00287586|454322939|FG000|Overall Study|Bradycardia|0|||
126282667|NCT00287586|454322940|FG001|Overall Study|Bradycardia|1|||
126282668|NCT00287586|454322939|FG000|Overall Study|Itchy Swollen Eyes|0|||
126282669|NCT00287586|454322940|FG001|Overall Study|Itchy Swollen Eyes|1|||
126282670|NCT00287586|454322939|FG000|Overall Study|Recurrent Melanoma|0|||
126282671|NCT00287586|454322940|FG001|Overall Study|Recurrent Melanoma|1|||
126282672|NCT03743415|454322942|FG000|Overall Study|Death|5|||
126282673|NCT03743415|454322943|FG001|Overall Study|Death|3|||
126282674|NCT03743415|454322944|FG002|Overall Study|Death|1|||
126282675|NCT03743415|454322945|FG003|Overall Study|Death|4|||
126282676|NCT03743415|454322946|FG004|Overall Study|Death|0|||
126282677|NCT03743415|454322947|FG005|Overall Study|Death|0|||
126282678|NCT03743415|454322948|FG006|Overall Study|Death|0|||
126282679|NCT03743415|454322949|FG007|Overall Study|Death|0|||
126282680|NCT03743415|454322950|FG008|Overall Study|Death|1|||
126282681|NCT03743415|454322951|FG009|Overall Study|Death|0|||
126282682|NCT03743415|454322942|FG000|Overall Study|Withdrawal by Subject|1|||
126282683|NCT03743415|454322943|FG001|Overall Study|Withdrawal by Subject|0|||
126282684|NCT03743415|454322944|FG002|Overall Study|Withdrawal by Subject|4|||
126282685|NCT03743415|454322945|FG003|Overall Study|Withdrawal by Subject|5|||
126282686|NCT03743415|454322946|FG004|Overall Study|Withdrawal by Subject|5|||
126098968|NCT02480153|453655577|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
126098969|NCT02480153|453655578|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
126098970|NCT02480153|453655579|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
126098971|NCT02480153|453655577|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
126282687|NCT03743415|454322947|FG005|Overall Study|Withdrawal by Subject|2|||
126282688|NCT03743415|454322948|FG006|Overall Study|Withdrawal by Subject|2|||
126282689|NCT03743415|454322949|FG007|Overall Study|Withdrawal by Subject|5|||
126282690|NCT03743415|454322950|FG008|Overall Study|Withdrawal by Subject|9|||
126282691|NCT03743415|454322951|FG009|Overall Study|Withdrawal by Subject|10|||
126282692|NCT03743415|454322942|FG000|Overall Study|Lost to Follow-up|2|||
126282693|NCT03743415|454322943|FG001|Overall Study|Lost to Follow-up|0|||
126098972|NCT02480153|453655578|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
126282694|NCT03743415|454322944|FG002|Overall Study|Lost to Follow-up|2|||
126282695|NCT03743415|454322945|FG003|Overall Study|Lost to Follow-up|1|||
126282696|NCT03743415|454322946|FG004|Overall Study|Lost to Follow-up|1|||
126282697|NCT03743415|454322947|FG005|Overall Study|Lost to Follow-up|0|||
126282698|NCT03743415|454322948|FG006|Overall Study|Lost to Follow-up|1|||
126282699|NCT03743415|454322949|FG007|Overall Study|Lost to Follow-up|4|||
126282700|NCT03743415|454322950|FG008|Overall Study|Lost to Follow-up|13|||
126282701|NCT03743415|454322951|FG009|Overall Study|Lost to Follow-up|13|||
126282702|NCT02242045|454322955|FG000|Overall Study|Investigator's Discretion|1|||
126282703|NCT02242045|454322955|FG000|Overall Study|Progressive Disease|2|||
126282704|NCT02242045|454322955|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
126282705|NCT02242045|454322955|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
126282706|NCT02473523|454322956|FG000|Overall Study|Death|1|||
126282707|NCT02473523|454322956|FG000|Overall Study|Lost to Follow-up|1|||
126282708|NCT00976911|454322959|FG000|Overall Study|Withdrawal by Subject|4|||
126282709|NCT00976911|454322960|FG001|Overall Study|Withdrawal by Subject|6|||
126282710|NCT00976911|454322959|FG000|Overall Study|Death|138|||
126282711|NCT00976911|454322960|FG001|Overall Study|Death|126|||
126282712|NCT00976911|454322959|FG000|Overall Study|Adverse Event|0|||
126282713|NCT00976911|454322960|FG001|Overall Study|Adverse Event|1|||
126282714|NCT00976911|454322959|FG000|Overall Study|Protocol Violation|2|||
126282715|NCT00976911|454322960|FG001|Overall Study|Protocol Violation|0|||
126282716|NCT00976911|454322959|FG000|Overall Study|Other|8|||
126282717|NCT00976911|454322960|FG001|Overall Study|Other|9|||
126282718|NCT00976911|454322959|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
126282719|NCT00976911|454322960|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
126282720|NCT00576316|454322961|FG000|Overall Study|Adverse Event|9|||
126282721|NCT00576316|454322961|FG000|Overall Study|Withdrawal by Subject|2|||
126282722|NCT00576316|454322961|FG000|Overall Study|Protocol Violation|9|||
126282723|NCT04893018|454322964|FG000|Overall Study|Lost to Follow-up|1|||
126282724|NCT04893018|454322965|FG001|Overall Study|Lost to Follow-up|0|||
126282725|NCT04893018|454322964|FG000|Overall Study|Withdrawal by Subject|2|||
126282726|NCT04893018|454322965|FG001|Overall Study|Withdrawal by Subject|0|||
126282727|NCT04893018|454322964|FG000|Overall Study|Study Terminated|1|||
126282728|NCT04893018|454322965|FG001|Overall Study|Study Terminated|2|||
126282729|NCT00005957|454322967|FG000|Overall Study|No treated|3|||
126282730|NCT00005957|454322968|FG001|Overall Study|No treated|9|||
126282731|NCT00005957|454322967|FG000|Overall Study|Crossover to the other arm|5|||
126282732|NCT00005957|454322968|FG001|Overall Study|Crossover to the other arm|19|||
126282733|NCT00799825|454322969|FG000|Overall Study|Adverse Event|1|||
126282734|NCT00799825|454322969|FG000|Overall Study|Withdrawal by Subject|6|||
126282735|NCT00799825|454322969|FG000|Overall Study|Lost to Follow-up|38|||
126282736|NCT00799825|454322969|FG000|Overall Study|Pregnancy|3|||
126282737|NCT02439970|454322970|FG000|Overall Study|Study Terminated|2|||
126282738|NCT02439970|454322971|FG001|Overall Study|Study Terminated|3|||
126282739|NCT03717012|454322972|FG000|Overall Study|Due to trial termination|1|||
126282740|NCT03717012|454322973|FG001|Overall Study|Due to trial termination|2|||
126282741|NCT03717012|454322972|FG000|Overall Study|Protocol Violation|0|||
126282742|NCT03717012|454322973|FG001|Overall Study|Protocol Violation|2|||
126282743|NCT03717012|454322972|FG000|Overall Study|Adverse Event|0|||
126282744|NCT03717012|454322973|FG001|Overall Study|Adverse Event|1|||
126282745|NCT03717012|454322972|FG000|Overall Study|Lung transplant|0|||
126282746|NCT03717012|454322973|FG001|Overall Study|Lung transplant|1|||
126282747|NCT02640690|454322974|FG000|Overall Study|Lost to Follow-up|7|||
126282748|NCT02640690|454322975|FG001|Overall Study|Lost to Follow-up|7|||
126282749|NCT02640690|454322974|FG000|Overall Study|Withdrawal by Subject|16|||
126282750|NCT02640690|454322975|FG001|Overall Study|Withdrawal by Subject|20|||
126282751|NCT02640690|454322974|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
126282752|NCT02640690|454322975|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
126282753|NCT01520870|454322976|FG000|Overall Study|Withdrawal by Subject|2|||
126282754|NCT02910011|454322979|FG000|Overall Study|Physician Decision|2|||
126282755|NCT02463357|454322980|FG000|Overall Study|Withdrawal by Subject|1|||
126282756|NCT02463357|454322981|FG001|Overall Study|Withdrawal by Subject|0|||
126282757|NCT02463357|454322982|FG002|Overall Study|Withdrawal by Subject|0|||
126282758|NCT02463357|454322983|FG003|Overall Study|Withdrawal by Subject|0|||
126282759|NCT02463357|454322984|FG004|Overall Study|Withdrawal by Subject|0|||
126282760|NCT02463357|454322980|FG000|Overall Study|Withdrawal by Subject|0|||
126282761|NCT02463357|454322981|FG001|Overall Study|Withdrawal by Subject|0|||
126282762|NCT02463357|454322982|FG002|Overall Study|Withdrawal by Subject|0|||
126282763|NCT02463357|454322983|FG003|Overall Study|Withdrawal by Subject|0|||
126282764|NCT02463357|454322984|FG004|Overall Study|Withdrawal by Subject|1|||
126282765|NCT01399658|454322987|FG000|Overall Study|Ineligible|1|||
126282766|NCT01399658|454322987|FG000|Overall Study|Machine Technical Issue|3|||
126282767|NCT01399658|454322987|FG000|Overall Study|Alternative therapy|1|||
126282768|NCT01399658|454322987|FG000|Overall Study|No reason given|1|||
126282769|NCT02460679|454322988|FG000|Overall Study|Investigator Decision|1|||
126282770|NCT02460679|454322988|FG000|Overall Study|Withdrawal by Subject|4|||
126282771|NCT02620579|454322989|FG000|Overall Study|Physician Decision|0|||
126282772|NCT02620579|454322990|FG001|Overall Study|Physician Decision|0|||
126282773|NCT02620579|454322991|FG002|Overall Study|Physician Decision|0|||
126282774|NCT02620579|454322992|FG003|Overall Study|Physician Decision|1|||
126282775|NCT02620579|454322989|FG000|Overall Study|Withdrawal by Subject|0|||
126282776|NCT02620579|454322990|FG001|Overall Study|Withdrawal by Subject|1|||
126282777|NCT02620579|454322991|FG002|Overall Study|Withdrawal by Subject|1|||
126282778|NCT02620579|454322992|FG003|Overall Study|Withdrawal by Subject|0|||
126282779|NCT00796107|454322998|FG000|Overall Study|Lack of Efficacy|1|||
126282780|NCT00796107|454322998|FG000|Overall Study|Progressive Disease|5|||
126282781|NCT01721317|454323000|FG000|Overall Study|Study Closed / Terminated|2|||
126282782|NCT01721317|454323001|FG001|Overall Study|Study Closed / Terminated|2|||
126282783|NCT01721317|454323000|FG000|Overall Study|Physician Decision|0|||
126282784|NCT01721317|454323001|FG001|Overall Study|Physician Decision|1|||
126282785|NCT01721317|454323000|FG000|Overall Study|Withdrawal by Subject|0|||
126282786|NCT01721317|454323001|FG001|Overall Study|Withdrawal by Subject|1|||
126282787|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
126282788|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
126282789|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
126282790|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
126282791|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
126282792|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
126282793|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
126282794|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
126282795|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126282796|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126282797|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126282798|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126282799|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126282800|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
126282801|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
126282802|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
126282803|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
126282804|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
126282805|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
126282806|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
126282807|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
126282808|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126282809|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
126282810|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126282811|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126282812|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
126282813|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
126282814|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
126282815|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
126282816|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
126282817|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
126282818|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
126282819|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
126282820|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
126282821|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
126282822|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
126282823|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
126282824|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
126282825|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
126282826|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
126282827|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
126282828|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
126282829|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
126282830|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
126282831|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
126282832|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
126282833|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
126282834|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
126282835|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
126282836|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
126282837|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
126282838|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
126282839|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
126282840|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
126282841|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
126282842|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
126282843|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
126282844|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
126282845|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
126282846|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
126282847|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
126282848|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
126282849|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
126282850|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
126282851|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
126282852|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Death|0|||
126282853|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Death|1|||
126282854|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Death|0|||
126282855|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Death|0|||
126282856|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Death|0|||
126282857|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126282858|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
126282859|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126282860|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126282861|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126282862|NCT02806024|454323016|FG000|Overall Study|Night Delivery|1|||
126282863|NCT02806024|454323017|FG001|Overall Study|Night Delivery|1|||
126282864|NCT02806024|454323016|FG000|Overall Study|DVT during antepartum admission|0|||
126282865|NCT02806024|454323017|FG001|Overall Study|DVT during antepartum admission|1|||
126282866|NCT02892149|454323018|FG000|Overall Study|Death|262|||
126282867|NCT02892149|454323019|FG001|Overall Study|Death|278|||
126282868|NCT02892149|454323018|FG000|Overall Study|Withdrawal by Subject|53|||
126282869|NCT02892149|454323019|FG001|Overall Study|Withdrawal by Subject|47|||
126282870|NCT02892149|454323018|FG000|Overall Study|Lost to Follow-up|37|||
126282871|NCT02892149|454323019|FG001|Overall Study|Lost to Follow-up|31|||
126282872|NCT01994850|454323020|FG000|Overall Study|Physician Decision|1|||
126282873|NCT01994850|454323020|FG000|Overall Study|Withdrawal by Subject|1|||
126282874|NCT00339144|454323023|FG000|Overall Study|Disease progression|5|||
126282875|NCT00339144|454323024|FG001|Overall Study|Disease progression|2|||
126282876|NCT00339144|454323025|FG002|Overall Study|Disease progression|2|||
126282877|NCT00339144|454323023|FG000|Overall Study|Study drug toxicity|3|||
126282878|NCT00339144|454323024|FG001|Overall Study|Study drug toxicity|1|||
126282879|NCT00339144|454323025|FG002|Overall Study|Study drug toxicity|1|||
126282880|NCT00339144|454323023|FG000|Overall Study|Participant's request to discontinuation|1|||
126282881|NCT00339144|454323024|FG001|Overall Study|Participant's request to discontinuation|0|||
126282882|NCT00339144|454323025|FG002|Overall Study|Participant's request to discontinuation|1|||
126282883|NCT02257385|454323026|FG000|Overall Study|Adverse Event|12|||
126282884|NCT02257385|454323027|FG001|Overall Study|Adverse Event|8|||
126282885|NCT02257385|454323026|FG000|Overall Study|Lack of Efficacy|1|||
126282886|NCT02257385|454323027|FG001|Overall Study|Lack of Efficacy|2|||
126282887|NCT02257385|454323026|FG000|Overall Study|Protocol Violation|5|||
126282888|NCT02257385|454323027|FG001|Overall Study|Protocol Violation|7|||
126282889|NCT02257385|454323026|FG000|Overall Study|Lost to Follow-up|0|||
126282890|NCT02257385|454323027|FG001|Overall Study|Lost to Follow-up|1|||
126282891|NCT02257385|454323026|FG000|Overall Study|Withdrawal by Subject|4|||
126282892|NCT02257385|454323027|FG001|Overall Study|Withdrawal by Subject|4|||
126282893|NCT04988087|454323031|FG000|Overall Study|Adverse Event|4|||
126282894|NCT04988087|454323032|FG001|Overall Study|Adverse Event|0|||
126282895|NCT04988087|454323033|FG002|Overall Study|Adverse Event|0|||
126282896|NCT04988087|454323034|FG003|Overall Study|Adverse Event|0|||
126282897|NCT04988087|454323031|FG000|Overall Study|Withdrawal by Subject|1|||
126282898|NCT04988087|454323032|FG001|Overall Study|Withdrawal by Subject|1|||
126282899|NCT04988087|454323033|FG002|Overall Study|Withdrawal by Subject|0|||
126282900|NCT04988087|454323034|FG003|Overall Study|Withdrawal by Subject|0|||
126282901|NCT04988087|454323031|FG000|Overall Study|Technical problems|7|||
126282902|NCT04988087|454323032|FG001|Overall Study|Technical problems|9|||
126282903|NCT04988087|454323033|FG002|Overall Study|Technical problems|1|||
126282904|NCT04988087|454323034|FG003|Overall Study|Technical problems|2|||
126282905|NCT02458287|454323035|FG000|Overall Study|Adverse Event|0|||
126282906|NCT02458287|454323036|FG001|Overall Study|Adverse Event|0|||
126282907|NCT02458287|454323037|FG002|Overall Study|Adverse Event|0|||
126282908|NCT02458287|454323038|FG003|Overall Study|Adverse Event|1|||
126282909|NCT02458287|454323035|FG000|Overall Study|Lost to Follow-up|0|||
126282910|NCT02458287|454323036|FG001|Overall Study|Lost to Follow-up|1|||
126282911|NCT02458287|454323037|FG002|Overall Study|Lost to Follow-up|1|||
126282912|NCT02458287|454323038|FG003|Overall Study|Lost to Follow-up|0|||
126282913|NCT02458287|454323035|FG000|Overall Study|Protocol Violation|0|||
126282914|NCT02458287|454323036|FG001|Overall Study|Protocol Violation|1|||
126282915|NCT02458287|454323037|FG002|Overall Study|Protocol Violation|0|||
126282916|NCT02458287|454323038|FG003|Overall Study|Protocol Violation|0|||
126282917|NCT02458287|454323035|FG000|Overall Study|Withdrawal by Subject|0|||
126282918|NCT02458287|454323036|FG001|Overall Study|Withdrawal by Subject|2|||
126364547|NCT01027351|454628393|FG002|Overall Study|Lost to Follow-up|0|||
126282919|NCT02458287|454323037|FG002|Overall Study|Withdrawal by Subject|2|||
126364548|NCT01027351|454628394|FG003|Overall Study|Lost to Follow-up|1|||
126364549|NCT01027351|454628395|FG004|Overall Study|Lost to Follow-up|6|||
126364550|NCT01027351|454628396|FG005|Overall Study|Lost to Follow-up|0|||
126364551|NCT01027351|454628391|FG000|Overall Study|Inappropriate enrollment|0|||
126364552|NCT01027351|454628392|FG001|Overall Study|Inappropriate enrollment|0|||
126364553|NCT01027351|454628393|FG002|Overall Study|Inappropriate enrollment|0|||
126364554|NCT01027351|454628394|FG003|Overall Study|Inappropriate enrollment|0|||
126364555|NCT01027351|454628395|FG004|Overall Study|Inappropriate enrollment|1|||
126364556|NCT01027351|454628396|FG005|Overall Study|Inappropriate enrollment|0|||
126364557|NCT01027351|454628391|FG000|Overall Study|Protocol Violation|1|||
126364558|NCT01027351|454628392|FG001|Overall Study|Protocol Violation|0|||
126364559|NCT01027351|454628393|FG002|Overall Study|Protocol Violation|0|||
126364560|NCT01027351|454628394|FG003|Overall Study|Protocol Violation|1|||
126364561|NCT01027351|454628395|FG004|Overall Study|Protocol Violation|1|||
126364562|NCT01027351|454628396|FG005|Overall Study|Protocol Violation|0|||
126364563|NCT02971137|454628397|FG000|Overall Study|Lost to Follow-up|44|||
126364564|NCT02971137|454628398|FG001|Overall Study|Lost to Follow-up|56|||
126364565|NCT02757963|454628399|FG000|Overall Study|Adverse Event|3|||
126364566|NCT02757963|454628399|FG000|Overall Study|Reached Stopping Criteria|1054|||
126364567|NCT02757963|454628399|FG000|Overall Study|Lost to Follow-up|5|||
126364568|NCT02757963|454628399|FG000|Overall Study|Physician Decision|1|||
126364569|NCT02757963|454628399|FG000|Overall Study|Withdrawal by Subject|34|||
126364570|NCT00911157|454628400|FG000|Overall Study|Adverse Event|4|||
126364571|NCT00911157|454628401|FG001|Overall Study|Adverse Event|1|||
126364572|NCT00911157|454628400|FG000|Overall Study|Withdrawal by Subject|1|||
126364573|NCT00911157|454628401|FG001|Overall Study|Withdrawal by Subject|1|||
126364574|NCT00911157|454628400|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
126364575|NCT00911157|454628401|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
126364576|NCT00911157|454628400|FG000|Overall Study|Need to treat for lung cancer|1|||
126364577|NCT00911157|454628401|FG001|Overall Study|Need to treat for lung cancer|0|||
126364578|NCT04650893|454628402|FG000|Overall Study|Lost to Follow-up|11|||
126364579|NCT04650893|454628403|FG001|Overall Study|Lost to Follow-up|10|||
126364580|NCT04650893|454628404|FG002|Overall Study|Lost to Follow-up|11|||
126364581|NCT05346640|454628410|FG000|Overall Study|Lack of Efficacy|2|||
126364582|NCT05346640|454628410|FG000|Overall Study|Lost to Follow-up|14|||
126364583|NCT05346640|454628410|FG000|Overall Study|Protocol Violation|4|||
126364584|NCT05346640|454628410|FG000|Overall Study|Withdrawal by Subject|2|||
126364585|NCT05346640|454628410|FG000|Overall Study|Physiological Complications|3|||
126364586|NCT05346640|454628410|FG000|Overall Study|Other Reason|3|||
126364587|NCT01197300|454630246|FG000|Overall Study|Lost to Follow-up|0|||
126364588|NCT01197300|454630247|FG001|Overall Study|Lost to Follow-up|1|||
126364589|NCT01197300|454630246|FG000|Overall Study|Protocol Violation|0|||
126364590|NCT01197300|454630247|FG001|Overall Study|Protocol Violation|1|||
126364591|NCT02113878|454630248|FG000|Overall Study|Adverse Event|1|||
126364592|NCT02113878|454630249|FG001|Overall Study|Adverse Event|0|||
126364593|NCT02113878|454630248|FG000|Overall Study|Withdrawal by Subject|1|||
126364594|NCT02113878|454630249|FG001|Overall Study|Withdrawal by Subject|0|||
126364595|NCT02113878|454630248|FG000|Overall Study|patient non-compliance|1|||
126364596|NCT02113878|454630249|FG001|Overall Study|patient non-compliance|0|||
126364597|NCT04129398|454630252|FG000|Overall Study|Physician Decision|2|||
126364598|NCT03058952|454630253|FG000|Overall Study|Adverse Event|1|||
126364599|NCT03058952|454630254|FG001|Overall Study|Adverse Event|0|||
126364600|NCT03058952|454630253|FG000|Overall Study|Lost to Follow-up|15|||
126364601|NCT03058952|454630254|FG001|Overall Study|Lost to Follow-up|15|||
126364602|NCT03058952|454630253|FG000|Overall Study|Withdrawal by Subject|7|||
126364603|NCT03058952|454630254|FG001|Overall Study|Withdrawal by Subject|11|||
126364604|NCT03837509|454630257|FG000|Phase 1|Death|5|||
126364605|NCT03837509|454630258|FG001|Phase 1|Death|2|||
126364606|NCT03837509|454630259|FG002|Phase 1|Death|0|||
126364607|NCT03837509|454630260|FG003|Phase 1|Death|0|||
126364608|NCT03837509|454630261|FG004|Phase 1|Death|0|||
126364609|NCT03837509|454630257|FG000|Phase 2|Death|0|||
126364610|NCT03837509|454630258|FG001|Phase 2|Death|0|||
126364611|NCT03837509|454630259|FG002|Phase 2|Death|0|||
126364612|NCT03837509|454630260|FG003|Phase 2|Death|1|||
126364613|NCT03837509|454630261|FG004|Phase 2|Death|1|||
126364614|NCT01251965|454630262|FG000|Overall Study|Participant/physician decision|1|||
126364615|NCT01251965|454630263|FG001|Overall Study|Participant/physician decision|2|||
126364616|NCT01251965|454630264|FG002|Overall Study|Participant/physician decision|0|||
126364617|NCT01251965|454630262|FG000|Overall Study|Death|0|||
126364618|NCT01251965|454630263|FG001|Overall Study|Death|0|||
126364619|NCT01251965|454630264|FG002|Overall Study|Death|11|||
126364620|NCT02363283|454630265|FG000|Overall Study|Withdrawal by Subject|1|||
126364621|NCT02363283|454630265|FG000|Overall Study|Not eligible due to transaminitis|1|||
126364622|NCT00530257|454630271|FG000|Overall Study|Lost to Follow-up|1|||
126364623|NCT02410200|454630272|FG000|Overall Study|Adverse Event|2|||
126364624|NCT01897896|454630273|FG000|Overall Study|Death|1|||
126364625|NCT01897896|454630274|FG001|Overall Study|Death|0|||
125882300|NCT02113982|452868960|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882301|NCT02113982|452868961|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125882302|NCT02113982|452868948|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
125882303|NCT02113982|452868949|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
125882304|NCT02113982|452868950|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
125882305|NCT02113982|452868951|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
125882306|NCT02113982|452868952|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
125882307|NCT02113982|452868953|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
125882308|NCT02113982|452868954|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
125882309|NCT02113982|452868955|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
125882310|NCT02113982|452868956|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
125882311|NCT02113982|452868957|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
125882312|NCT02113982|452868958|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
125882313|NCT02113982|452868959|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
125882314|NCT02113982|452868960|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
125882315|NCT02113982|452868961|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
125882316|NCT02113982|452868948|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882317|NCT02113982|452868949|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882318|NCT02113982|452868950|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882319|NCT02113982|452868951|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882320|NCT02113982|452868952|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882321|NCT02113982|452868953|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882322|NCT02113982|452868954|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882323|NCT02113982|452868955|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882324|NCT02113982|452868956|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882325|NCT02113982|452868957|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126040460|NCT03519178|453447154|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
126040461|NCT03519178|453447155|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
126040462|NCT03519178|453447156|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
126040463|NCT03519178|453447157|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
126040464|NCT03519178|453447158|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
126282920|NCT02458287|454323038|FG003|Overall Study|Withdrawal by Subject|1|||
126282921|NCT02458287|454323035|FG000|Overall Study|Relocated Out of State|0|||
126282922|NCT02458287|454323036|FG001|Overall Study|Relocated Out of State|0|||
126282923|NCT02458287|454323037|FG002|Overall Study|Relocated Out of State|0|||
126282924|NCT02458287|454323038|FG003|Overall Study|Relocated Out of State|1|||
126282925|NCT02800642|454323041|FG000|Overall Study|Death|3|||
126282926|NCT02800642|454323041|FG000|Overall Study|Other|10|||
126282927|NCT02800642|454323041|FG000|Overall Study|Physician Decision|2|||
126282928|NCT02800642|454323041|FG000|Overall Study|Adverse Event|6|||
126282929|NCT02800642|454323041|FG000|Overall Study|Withdrawal by Subject|3|||
126282930|NCT02800642|454323041|FG000|Overall Study|Lost to Follow-up|1|||
126282931|NCT03371459|454323048|FG000|Washout|Lost to Follow-up|0|||
126282932|NCT03371459|454323049|FG001|Washout|Lost to Follow-up|1|||
126282933|NCT01589497|454323050|FG000|Overall Study|Withdrawal by Subject|0|||
126282934|NCT01589497|454323051|FG001|Overall Study|Withdrawal by Subject|1|||
126282935|NCT01589497|454323052|FG002|Overall Study|Withdrawal by Subject|0|||
126282936|NCT01589497|454323053|FG003|Overall Study|Withdrawal by Subject|1|||
126282937|NCT01589497|454323050|FG000|Overall Study|Death|1|||
126282938|NCT01589497|454323051|FG001|Overall Study|Death|0|||
126282939|NCT01589497|454323052|FG002|Overall Study|Death|0|||
126282940|NCT01589497|454323053|FG003|Overall Study|Death|0|||
126282941|NCT01589497|454323050|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
126282942|NCT01589497|454323051|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
126282943|NCT01589497|454323052|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
126282944|NCT01589497|454323053|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
126282945|NCT02521376|454323056|FG000|Overall Study|Enrolled, But Not Treated|1|||
126282946|NCT02521376|454323057|FG001|Overall Study|Enrolled, But Not Treated|0|||
126282947|NCT02521376|454323058|FG002|Overall Study|Enrolled, But Not Treated|0|||
126282948|NCT02521376|454323059|FG003|Overall Study|Enrolled, But Not Treated|0|||
126282949|NCT03597464|454323064|FG000|Overall Study|Withdrawal by Subject|4|||
126282950|NCT03597464|454323065|FG001|Overall Study|Withdrawal by Subject|5|||
126282951|NCT03597464|454323064|FG000|Overall Study|Lost to Follow-up|3|||
126282952|NCT03597464|454323065|FG001|Overall Study|Lost to Follow-up|1|||
126282953|NCT03597464|454323064|FG000|Overall Study|Pregnancy|3|||
126282954|NCT03597464|454323065|FG001|Overall Study|Pregnancy|1|||
126282955|NCT03597464|454323064|FG000|Overall Study|Lack of Efficacy|2|||
126282956|NCT03597464|454323065|FG001|Overall Study|Lack of Efficacy|0|||
126282957|NCT03597464|454323064|FG000|Overall Study|Physician Decision|2|||
126282958|NCT03597464|454323065|FG001|Overall Study|Physician Decision|2|||
126282959|NCT03597464|454323064|FG000|Overall Study|Protocol Violation|1|||
126282960|NCT03597464|454323065|FG001|Overall Study|Protocol Violation|1|||
126282961|NCT03597464|454323064|FG000|Overall Study|Adverse Event|0|||
126282962|NCT03597464|454323065|FG001|Overall Study|Adverse Event|2|||
126282963|NCT03597464|454323064|FG000|Overall Study|Death|0|||
126282964|NCT03597464|454323065|FG001|Overall Study|Death|3|||
126040465|NCT03519178|453447159|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
126040466|NCT03519178|453447160|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
126040467|NCT03519178|453447161|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
126040468|NCT03519178|453447162|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
126040469|NCT03519178|453447163|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
126040470|NCT03519178|453447164|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
126040471|NCT03519178|453447165|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
126040472|NCT03519178|453447166|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
126040473|NCT03519178|453447152|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040474|NCT03519178|453447153|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040475|NCT03519178|453447154|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040476|NCT03519178|453447155|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040477|NCT03519178|453447156|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040478|NCT03519178|453447157|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040479|NCT03519178|453447158|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040480|NCT03519178|453447159|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040481|NCT03519178|453447160|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040482|NCT03519178|453447161|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040483|NCT03519178|453447162|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
126040484|NCT03519178|453447163|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040485|NCT03519178|453447164|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040486|NCT03519178|453447165|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040487|NCT03519178|453447166|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126040488|NCT03519178|453447152|FG000|Follow-Up|Death|0|||
126040489|NCT03519178|453447153|FG001|Follow-Up|Death|0|||
126040490|NCT03519178|453447154|FG002|Follow-Up|Death|1|||
126040491|NCT03519178|453447155|FG003|Follow-Up|Death|0|||
126040492|NCT03519178|453447156|FG004|Follow-Up|Death|0|||
126040493|NCT03519178|453447157|FG005|Follow-Up|Death|0|||
126040494|NCT03519178|453447158|FG006|Follow-Up|Death|0|||
126040495|NCT03519178|453447159|FG007|Follow-Up|Death|0|||
126040496|NCT03519178|453447160|FG008|Follow-Up|Death|3|||
126040497|NCT03519178|453447161|FG009|Follow-Up|Death|1|||
126040498|NCT03519178|453447162|FG010|Follow-Up|Death|0|||
126040499|NCT03519178|453447163|FG011|Follow-Up|Death|0|||
126040500|NCT03519178|453447164|FG012|Follow-Up|Death|2|||
126040501|NCT03519178|453447165|FG013|Follow-Up|Death|0|||
126040502|NCT03519178|453447166|FG014|Follow-Up|Death|0|||
126040503|NCT03519178|453447152|FG000|Follow-Up|Lost to Follow-up|0|||
126040504|NCT03519178|453447153|FG001|Follow-Up|Lost to Follow-up|0|||
126040505|NCT03519178|453447154|FG002|Follow-Up|Lost to Follow-up|0|||
126040506|NCT03519178|453447155|FG003|Follow-Up|Lost to Follow-up|0|||
126040507|NCT03519178|453447156|FG004|Follow-Up|Lost to Follow-up|0|||
126040508|NCT03519178|453447157|FG005|Follow-Up|Lost to Follow-up|3|||
126040509|NCT03519178|453447158|FG006|Follow-Up|Lost to Follow-up|1|||
126040510|NCT03519178|453447159|FG007|Follow-Up|Lost to Follow-up|4|||
126282965|NCT02542605|454323068|FG000|Part B: Challenge Phase|Sponsor decision|1|||
126282966|NCT02542605|454323069|FG001|Part B: Challenge Phase|Sponsor decision|0|||
126040511|NCT03519178|453447160|FG008|Follow-Up|Lost to Follow-up|1|||
126040512|NCT03519178|453447161|FG009|Follow-Up|Lost to Follow-up|0|||
126040513|NCT03519178|453447162|FG010|Follow-Up|Lost to Follow-up|0|||
126040514|NCT03519178|453447163|FG011|Follow-Up|Lost to Follow-up|0|||
126040515|NCT03519178|453447164|FG012|Follow-Up|Lost to Follow-up|0|||
126040516|NCT03519178|453447165|FG013|Follow-Up|Lost to Follow-up|0|||
126040517|NCT03519178|453447166|FG014|Follow-Up|Lost to Follow-up|0|||
126040518|NCT03519178|453447152|FG000|Follow-Up|Withdrawal by Subject|1|||
126040519|NCT03519178|453447153|FG001|Follow-Up|Withdrawal by Subject|2|||
126282967|NCT02542605|454323070|FG002|Part B: Challenge Phase|Sponsor decision|0|||
126282968|NCT02542605|454323068|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
126282969|NCT02542605|454323069|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
126282970|NCT02542605|454323070|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
126282971|NCT02682927|454323072|FG000|Overall Study|Adverse Event|0|||
126282972|NCT02682927|454323073|FG001|Overall Study|Adverse Event|0|||
126282973|NCT02682927|454323074|FG002|Overall Study|Adverse Event|5|||
126282974|NCT02682927|454323075|FG003|Overall Study|Adverse Event|1|||
126282975|NCT02682927|454323076|FG004|Overall Study|Adverse Event|0|||
126282976|NCT02682927|454323077|FG005|Overall Study|Adverse Event|2|||
126282977|NCT02682927|454323072|FG000|Overall Study|Death|0|||
126282978|NCT02682927|454323073|FG001|Overall Study|Death|0|||
126282979|NCT02682927|454323074|FG002|Overall Study|Death|0|||
126282980|NCT02682927|454323075|FG003|Overall Study|Death|1|||
126282981|NCT02682927|454323076|FG004|Overall Study|Death|0|||
126282982|NCT02682927|454323077|FG005|Overall Study|Death|0|||
126282983|NCT02682927|454323072|FG000|Overall Study|Lack of Efficacy|1|||
126282984|NCT02682927|454323073|FG001|Overall Study|Lack of Efficacy|0|||
126282985|NCT02682927|454323074|FG002|Overall Study|Lack of Efficacy|0|||
126282986|NCT02682927|454323075|FG003|Overall Study|Lack of Efficacy|1|||
126282987|NCT02682927|454323076|FG004|Overall Study|Lack of Efficacy|0|||
126282988|NCT02682927|454323077|FG005|Overall Study|Lack of Efficacy|0|||
126282989|NCT02682927|454323072|FG000|Overall Study|Other|0|||
126282990|NCT02682927|454323073|FG001|Overall Study|Other|0|||
126282991|NCT02682927|454323074|FG002|Overall Study|Other|0|||
126282992|NCT02682927|454323075|FG003|Overall Study|Other|2|||
126282993|NCT02682927|454323076|FG004|Overall Study|Other|0|||
126282994|NCT02682927|454323077|FG005|Overall Study|Other|0|||
126282995|NCT02682927|454323072|FG000|Overall Study|Withdrawal by Subject|2|||
126282996|NCT02682927|454323073|FG001|Overall Study|Withdrawal by Subject|0|||
126282997|NCT02682927|454323074|FG002|Overall Study|Withdrawal by Subject|1|||
126282998|NCT02682927|454323075|FG003|Overall Study|Withdrawal by Subject|0|||
126282999|NCT02682927|454323076|FG004|Overall Study|Withdrawal by Subject|1|||
126283000|NCT02682927|454323077|FG005|Overall Study|Withdrawal by Subject|1|||
126283001|NCT00340678|454323086|FG000|Overall Study|Lost to Follow-up|1|||
126283002|NCT00340678|454323087|FG001|Overall Study|Lost to Follow-up|0|||
126283003|NCT00340678|454323088|FG002|Overall Study|Lost to Follow-up|0|||
126283004|NCT00340678|454323089|FG003|Overall Study|Lost to Follow-up|0|||
126283005|NCT02766283|454323090|FG000|Overall Study|Lost to Follow-up|27|||
126283006|NCT04007991|454323091|FG000|Overall Study|Withdrawal by Subject|1|||
126283007|NCT04007991|454323092|FG001|Overall Study|Withdrawal by Subject|1|||
126283008|NCT04007991|454323091|FG000|Overall Study|Physician Decision|1|||
126283009|NCT04007991|454323092|FG001|Overall Study|Physician Decision|1|||
126283010|NCT04007991|454323091|FG000|Overall Study|Non-compliance with Study Drug|0|||
126283011|NCT04007991|454323092|FG001|Overall Study|Non-compliance with Study Drug|1|||
126283012|NCT04007991|454323091|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
126283013|NCT04007991|454323092|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
126283014|NCT04007991|454323091|FG000|Overall Study|Adverse event, non-fatal|5|||
126283015|NCT04007991|454323092|FG001|Overall Study|Adverse event, non-fatal|0|||
126283016|NCT04007991|454323091|FG000|Overall Study|Lost to Follow-up|2|||
126283017|NCT04007991|454323092|FG001|Overall Study|Lost to Follow-up|1|||
126283018|NCT05314816|454323093|FG000|Overall Study|Lost to Follow-up|5|||
126283019|NCT05314816|454323094|FG001|Overall Study|Lost to Follow-up|0|||
126283020|NCT05314816|454323095|FG002|Overall Study|Lost to Follow-up|1|||
126283021|NCT05314816|454323093|FG000|Overall Study|Protocol Violation|13|||
126283022|NCT05314816|454323094|FG001|Overall Study|Protocol Violation|8|||
126283023|NCT05314816|454323095|FG002|Overall Study|Protocol Violation|0|||
126283024|NCT01810302|454324640|FG000|Overall Study|Death|1|||
126283025|NCT01810302|454324641|FG001|Overall Study|Death|0|||
126283026|NCT01810302|454324640|FG000|Overall Study|Physician Decision|0|||
126283027|NCT01810302|454324641|FG001|Overall Study|Physician Decision|1|||
126283028|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #1|24|||
126283029|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #1|0|||
126283030|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
126283031|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
126283032|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283033|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283034|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
126283035|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
126283036|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
126283037|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
126306288|NCT03063086|454410266|FG002|Overall Study|subject/guardian decision|0|||
126283038|NCT03888066|454324645|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283039|NCT03888066|454324646|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283040|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283041|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283042|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
126283043|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
126283044|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283045|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283046|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
126283047|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283048|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #2|5|||
126283049|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #2|0|||
126283050|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
126283051|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
126283052|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
126283053|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
126283054|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
126283055|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
126283056|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #3|11|||
126283057|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #3|0|||
126283058|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
126283059|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
126283060|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
126283061|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283062|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283063|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283064|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4|3|||
126283065|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4|0|||
126283066|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
126364626|NCT01897896|454630273|FG000|Overall Study|Adverse Event|11|||
126364627|NCT01897896|454630274|FG001|Overall Study|Adverse Event|1|||
126364628|NCT01897896|454630273|FG000|Overall Study|Lost to Follow-up|1|||
126364629|NCT01897896|454630274|FG001|Overall Study|Lost to Follow-up|0|||
126364630|NCT01897896|454630273|FG000|Overall Study|Non-compliance with study drug dosing|1|||
126364631|NCT01897896|454630274|FG001|Overall Study|Non-compliance with study drug dosing|1|||
126364632|NCT01897896|454630273|FG000|Overall Study|Withdrawal by Subject|7|||
126364633|NCT01897896|454630274|FG001|Overall Study|Withdrawal by Subject|1|||
126364634|NCT01897896|454630273|FG000|Overall Study|Require drug that interfere with study|1|||
126364635|NCT01897896|454630274|FG001|Overall Study|Require drug that interfere with study|4|||
126364636|NCT01897896|454630273|FG000|Overall Study|Protocol Violation|1|||
126364637|NCT01897896|454630274|FG001|Overall Study|Protocol Violation|1|||
126364638|NCT01897896|454630273|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
126364639|NCT01897896|454630274|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
126364640|NCT01897896|454630273|FG000|Overall Study|Caregiver can no longer participate|0|||
126364641|NCT01897896|454630274|FG001|Overall Study|Caregiver can no longer participate|2|||
126283067|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
126283068|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
126283069|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
126283070|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
126283071|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283072|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
126364642|NCT01897896|454630273|FG000|Overall Study|Other than specified|2|||
126364643|NCT01897896|454630274|FG001|Overall Study|Other than specified|1|||
126364644|NCT02801578|454630291|FG000|Overall Study|Adverse Event|2|||
126364645|NCT00668642|454630292|FG000|First Off-cycle|Cancer progression|1|||
126364646|NCT00668642|454630293|FG001|First Off-cycle|Cancer progression|0|||
126364647|NCT00668642|454630292|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
126364648|NCT00668642|454630293|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
126364649|NCT02003898|454630294|FG000|Overall Study|Death|3|||
126364650|NCT02003898|454630294|FG000|Overall Study|Lost to Follow-up|12|||
126364651|NCT02003898|454630294|FG000|Overall Study|Withdrawal by Subject|52|||
126364652|NCT03682367|454630297|FG000|Overall Study|Protocol Violation|2|||
126364653|NCT03682367|454630298|FG001|Overall Study|Protocol Violation|1|||
126364654|NCT03682367|454630297|FG000|Overall Study|Closed Study Early|0|||
126364655|NCT03682367|454630298|FG001|Overall Study|Closed Study Early|3|||
126364656|NCT00770679|454630299|FG000|Overall Study|Lost to Follow-up|3|||
126364657|NCT00770679|454630299|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
126364658|NCT00129974|454630300|FG000|Overall Study|Other|1|||
126364659|NCT00414609|454630301|FG000|Core Study|Adverse Event|9|||
126364660|NCT00414609|454630302|FG001|Core Study|Adverse Event|11|||
126364661|NCT00414609|454630303|FG002|Core Study|Adverse Event|0|||
126364662|NCT00414609|454630301|FG000|Core Study|Abnormal laboratory values|0|||
126364663|NCT00414609|454630302|FG001|Core Study|Abnormal laboratory values|1|||
126364664|NCT00414609|454630303|FG002|Core Study|Abnormal laboratory values|0|||
126364665|NCT00414609|454630301|FG000|Core Study|Abnormal test procedure results|1|||
126364666|NCT00414609|454630302|FG001|Core Study|Abnormal test procedure results|1|||
126364667|NCT00414609|454630303|FG002|Core Study|Abnormal test procedure results|0|||
126283073|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
126283074|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
126283075|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283076|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
126283077|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283078|NCT03888066|454324645|FG000|Run-in Phase|AE (Adverse Event)|17|||
126283079|NCT03888066|454324646|FG001|Run-in Phase|AE (Adverse Event)|0|||
126283080|NCT03888066|454324645|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
126283081|NCT03888066|454324646|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
126283082|NCT03888066|454324645|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283083|NCT03888066|454324646|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283084|NCT03888066|454324645|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283085|NCT03888066|454324646|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283086|NCT03888066|454324645|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
126283087|NCT03888066|454324646|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283088|NCT03888066|454324645|FG000|Run-in Phase|Withdrawal by Subject|43|||
126283089|NCT03888066|454324646|FG001|Run-in Phase|Withdrawal by Subject|0|||
126283090|NCT03888066|454324645|FG000|Run-in Phase|AE; Physician Decision|1|||
126283091|NCT03888066|454324646|FG001|Run-in Phase|AE; Physician Decision|0|||
126364668|NCT00414609|454630301|FG000|Core Study|Protocol deviation|0|||
126364669|NCT00414609|454630302|FG001|Core Study|Protocol deviation|1|||
126364670|NCT00414609|454630303|FG002|Core Study|Protocol deviation|0|||
126364671|NCT00414609|454630301|FG000|Core Study|Patient withdrew consent|10|||
126364672|NCT00414609|454630302|FG001|Core Study|Patient withdrew consent|11|||
126364673|NCT00414609|454630303|FG002|Core Study|Patient withdrew consent|0|||
126364674|NCT00414609|454630301|FG000|Core Study|Lost to Follow-up|7|||
126283092|NCT03888066|454324645|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
126283093|NCT03888066|454324646|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283094|NCT03888066|454324645|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
126283095|NCT03888066|454324646|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
126283096|NCT03888066|454324645|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
126283097|NCT03888066|454324646|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283098|NCT03888066|454324645|FG000|Run-in Phase|Death|1|||
126283099|NCT03888066|454324646|FG001|Run-in Phase|Death|0|||
126283100|NCT03888066|454324645|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
126283101|NCT03888066|454324646|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
126283102|NCT03888066|454324645|FG000|Run-in Phase|Physician Decision|1|||
126283103|NCT03888066|454324646|FG001|Run-in Phase|Physician Decision|0|||
126364675|NCT00414609|454630302|FG001|Core Study|Lost to Follow-up|4|||
126364676|NCT00414609|454630303|FG002|Core Study|Lost to Follow-up|0|||
126364677|NCT00414609|454630301|FG000|Core Study|Administrative problems|0|||
126364678|NCT00414609|454630302|FG001|Core Study|Administrative problems|2|||
126364679|NCT00414609|454630303|FG002|Core Study|Administrative problems|0|||
126364680|NCT00414609|454630301|FG000|Core Study|Death|7|||
126364681|NCT00414609|454630302|FG001|Core Study|Death|14|||
126364682|NCT00414609|454630303|FG002|Core Study|Death|0|||
126364683|NCT00414609|454630301|FG000|Extension Study|Adverse Event|0|||
126364684|NCT00414609|454630302|FG001|Extension Study|Adverse Event|0|||
126364685|NCT00414609|454630303|FG002|Extension Study|Adverse Event|14|||
126364686|NCT00414609|454630301|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
126364687|NCT00414609|454630302|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
126364688|NCT00414609|454630303|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
126364689|NCT00414609|454630301|FG000|Extension Study|Withdrawal by Subject|0|||
126364690|NCT00414609|454630302|FG001|Extension Study|Withdrawal by Subject|0|||
126364691|NCT00414609|454630303|FG002|Extension Study|Withdrawal by Subject|13|||
126364692|NCT00414609|454630301|FG000|Extension Study|Lost to Follow-up|0|||
126364693|NCT00414609|454630302|FG001|Extension Study|Lost to Follow-up|0|||
126364694|NCT00414609|454630303|FG002|Extension Study|Lost to Follow-up|10|||
126364695|NCT00414609|454630301|FG000|Extension Study|Administrative problems|0|||
126364696|NCT00414609|454630302|FG001|Extension Study|Administrative problems|0|||
126364697|NCT00414609|454630303|FG002|Extension Study|Administrative problems|1|||
126364698|NCT00414609|454630301|FG000|Extension Study|Death|0|||
126364699|NCT00414609|454630302|FG001|Extension Study|Death|0|||
126364700|NCT00414609|454630303|FG002|Extension Study|Death|17|||
126364701|NCT00814983|454630308|FG000|Overall Study|Screen failure|1|||
126364702|NCT00814983|454630309|FG001|Overall Study|Screen failure|0|||
126364703|NCT00814983|454630308|FG000|Overall Study|Withdrawal by Subject|1|||
126364704|NCT00814983|454630309|FG001|Overall Study|Withdrawal by Subject|0|||
126364705|NCT00814983|454630308|FG000|Overall Study|Graft failure|1|||
126364706|NCT00814983|454630309|FG001|Overall Study|Graft failure|0|||
126364707|NCT03627468|454630310|FG000|Overall Study|Adverse Event|5|||
126364708|NCT03627468|454630311|FG001|Overall Study|Adverse Event|33|||
126364709|NCT03627468|454630310|FG000|Overall Study|Withdrawal by Subject|13|||
126364710|NCT03627468|454630311|FG001|Overall Study|Withdrawal by Subject|23|||
126364711|NCT03627468|454630310|FG000|Overall Study|Physician Decision|1|||
126364712|NCT03627468|454630311|FG001|Overall Study|Physician Decision|0|||
126364713|NCT03627468|454630310|FG000|Overall Study|Protocol Violation|0|||
126364714|NCT03627468|454630311|FG001|Overall Study|Protocol Violation|2|||
126364715|NCT03627468|454630310|FG000|Overall Study|Lost to Follow-up|10|||
126364716|NCT03627468|454630311|FG001|Overall Study|Lost to Follow-up|16|||
126364717|NCT03627468|454630310|FG000|Overall Study|Death|1|||
126364718|NCT03627468|454630311|FG001|Overall Study|Death|0|||
126364719|NCT03627468|454630310|FG000|Overall Study|Pregnancy|1|||
126364720|NCT03627468|454630311|FG001|Overall Study|Pregnancy|1|||
126364721|NCT03627468|454630310|FG000|Overall Study|Lack of Efficacy|0|||
126364722|NCT03627468|454630311|FG001|Overall Study|Lack of Efficacy|2|||
126364723|NCT03627468|454630310|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
126364724|NCT03627468|454630311|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
126364725|NCT01047540|454630312|FG000|Overall Study|Protocol Violation|1|||
126364726|NCT01047540|454630313|FG001|Overall Study|Protocol Violation|0|||
126364727|NCT01047540|454630314|FG002|Overall Study|Protocol Violation|0|||
126364728|NCT01047540|454630315|FG003|Overall Study|Protocol Violation|0|||
126364729|NCT01047540|454630316|FG004|Overall Study|Protocol Violation|0|||
126364730|NCT01047540|454630312|FG000|Overall Study|Lost to Follow-up|1|||
126364731|NCT01047540|454630313|FG001|Overall Study|Lost to Follow-up|0|||
126364732|NCT01047540|454630314|FG002|Overall Study|Lost to Follow-up|0|||
126364733|NCT01047540|454630315|FG003|Overall Study|Lost to Follow-up|0|||
126364734|NCT01047540|454630316|FG004|Overall Study|Lost to Follow-up|0|||
126364735|NCT01047540|454630312|FG000|Overall Study|Withdrawal by Subject|1|||
126364736|NCT01047540|454630313|FG001|Overall Study|Withdrawal by Subject|0|||
126364737|NCT01047540|454630314|FG002|Overall Study|Withdrawal by Subject|3|||
126364738|NCT01047540|454630315|FG003|Overall Study|Withdrawal by Subject|0|||
126364739|NCT01047540|454630316|FG004|Overall Study|Withdrawal by Subject|1|||
126364740|NCT01047540|454630312|FG000|Overall Study|Pregnancy|1|||
126283104|NCT03888066|454324645|FG000|Run-in Phase|Protocol Violation|13|||
126283105|NCT03888066|454324646|FG001|Run-in Phase|Protocol Violation|0|||
126283106|NCT03888066|454324645|FG000|Run-in Phase|Sponsor Request|34|||
126283107|NCT03888066|454324646|FG001|Run-in Phase|Sponsor Request|0|||
126283108|NCT03888066|454324645|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
126283109|NCT03888066|454324646|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
126283110|NCT03888066|454324645|FG000|Run-in Phase|Withdrawal Of Consent|1|||
126283111|NCT03888066|454324646|FG001|Run-in Phase|Withdrawal Of Consent|0|||
126283112|NCT03888066|454324645|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
126283113|NCT03888066|454324646|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
126283114|NCT03888066|454324645|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
126283115|NCT03888066|454324646|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
126283116|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
126283117|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
126283118|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
126283119|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
126283120|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
126283121|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
126283122|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
126283123|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
126283124|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
126283125|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
126283126|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
126283127|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
126283128|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
126283129|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
126283130|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
126283131|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
126283132|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
126283133|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
126283134|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
126283135|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
126283136|NCT03278626|454324647|FG000|Overall Study|Death|2|||
126283137|NCT03278626|454324647|FG000|Overall Study|Toxicity|1|||
126283138|NCT03278626|454324647|FG000|Overall Study|Disease Progression|2|||
126283139|NCT05013008|454324649|FG000|Overall Study|Exclusion from mBFAS|5|||
126283140|NCT05013008|454324650|FG001|Overall Study|Exclusion from mBFAS|25|||
126283141|NCT04981717|454324651|FG000|Overall Study|Protocol Violation|0|||
126283142|NCT04981717|454324652|FG001|Overall Study|Protocol Violation|3|||
126283143|NCT04981717|454324651|FG000|Overall Study|Adverse Event|1|||
126283144|NCT04981717|454324652|FG001|Overall Study|Adverse Event|3|||
126283145|NCT04981717|454324651|FG000|Overall Study|Pregnancy|1|||
126283146|NCT04981717|454324652|FG001|Overall Study|Pregnancy|0|||
126283147|NCT04981717|454324651|FG000|Overall Study|Physician Decision|1|||
126283148|NCT04981717|454324652|FG001|Overall Study|Physician Decision|0|||
126283149|NCT04981717|454324651|FG000|Overall Study|Sponsor Request|157|||
126283150|NCT04981717|454324652|FG001|Overall Study|Sponsor Request|172|||
126283151|NCT04981717|454324651|FG000|Overall Study|Lost to Follow-up|4|||
126283152|NCT04981717|454324652|FG001|Overall Study|Lost to Follow-up|5|||
126283153|NCT04981717|454324651|FG000|Overall Study|Withdrawal by Subject|50|||
126283154|NCT04981717|454324652|FG001|Overall Study|Withdrawal by Subject|37|||
126283155|NCT02207634|454324653|FG000|Overall Study|Withdrawal by Subject|21|||
126283156|NCT02207634|454324654|FG001|Overall Study|Withdrawal by Subject|31|||
126283157|NCT02207634|454324653|FG000|Overall Study|Lost to Follow-up|1|||
126283158|NCT02207634|454324654|FG001|Overall Study|Lost to Follow-up|0|||
126283159|NCT00887289|454324655|FG000|Overall Study|Lack of Efficacy|14|||
126283160|NCT00887289|454324655|FG000|Overall Study|Adverse Event|27|||
126283161|NCT00887289|454324655|FG000|Overall Study|Withdrawal by Subject|26|||
126283162|NCT00887289|454324655|FG000|Overall Study|Lost to Follow-up|8|||
126364741|NCT01047540|454630313|FG001|Overall Study|Pregnancy|0|||
126364742|NCT01047540|454630314|FG002|Overall Study|Pregnancy|0|||
126364743|NCT01047540|454630315|FG003|Overall Study|Pregnancy|0|||
126364744|NCT01047540|454630316|FG004|Overall Study|Pregnancy|0|||
126364745|NCT01047540|454630312|FG000|Overall Study|Adverse Event|1|||
126364746|NCT01047540|454630313|FG001|Overall Study|Adverse Event|0|||
126364747|NCT01047540|454630314|FG002|Overall Study|Adverse Event|0|||
126364748|NCT01047540|454630315|FG003|Overall Study|Adverse Event|0|||
126364749|NCT01047540|454630316|FG004|Overall Study|Adverse Event|0|||
126364750|NCT01437189|454630320|FG000|Overall Study|Adverse Event|3|||
126364751|NCT01437189|454630320|FG000|Overall Study|Lack of Efficacy|4|||
126364752|NCT01437189|454630320|FG000|Overall Study|Withdrawal by Subject|8|||
126364753|NCT03654326|454630321|FG000|Overall Study|Withdrawal by Subject|5|||
126364754|NCT03654326|454630322|FG001|Overall Study|Withdrawal by Subject|3|||
126364755|NCT03654326|454630321|FG000|Overall Study|Physician Decision|0|||
126364756|NCT03654326|454630322|FG001|Overall Study|Physician Decision|1|||
126040520|NCT03519178|453447154|FG002|Follow-Up|Withdrawal by Subject|2|||
126040521|NCT03519178|453447155|FG003|Follow-Up|Withdrawal by Subject|3|||
126040522|NCT03519178|453447156|FG004|Follow-Up|Withdrawal by Subject|5|||
126040523|NCT03519178|453447157|FG005|Follow-Up|Withdrawal by Subject|1|||
126040524|NCT03519178|453447158|FG006|Follow-Up|Withdrawal by Subject|2|||
126040525|NCT03519178|453447159|FG007|Follow-Up|Withdrawal by Subject|6|||
126040526|NCT03519178|453447160|FG008|Follow-Up|Withdrawal by Subject|5|||
126040527|NCT03519178|453447161|FG009|Follow-Up|Withdrawal by Subject|2|||
126040528|NCT03519178|453447162|FG010|Follow-Up|Withdrawal by Subject|3|||
126040529|NCT03519178|453447163|FG011|Follow-Up|Withdrawal by Subject|5|||
126040530|NCT03519178|453447164|FG012|Follow-Up|Withdrawal by Subject|2|||
126040531|NCT03519178|453447165|FG013|Follow-Up|Withdrawal by Subject|0|||
126040532|NCT03519178|453447166|FG014|Follow-Up|Withdrawal by Subject|0|||
126040533|NCT03519178|453447152|FG000|Follow-Up|Other|0|||
126040534|NCT03519178|453447153|FG001|Follow-Up|Other|0|||
126040535|NCT03519178|453447154|FG002|Follow-Up|Other|0|||
126040536|NCT03519178|453447155|FG003|Follow-Up|Other|0|||
126040537|NCT03519178|453447156|FG004|Follow-Up|Other|0|||
126040538|NCT03519178|453447157|FG005|Follow-Up|Other|0|||
126040539|NCT03519178|453447158|FG006|Follow-Up|Other|0|||
126040540|NCT03519178|453447159|FG007|Follow-Up|Other|1|||
126040541|NCT03519178|453447160|FG008|Follow-Up|Other|0|||
126040542|NCT03519178|453447161|FG009|Follow-Up|Other|0|||
126040543|NCT03519178|453447162|FG010|Follow-Up|Other|0|||
126040544|NCT03519178|453447163|FG011|Follow-Up|Other|0|||
126040545|NCT03519178|453447164|FG012|Follow-Up|Other|0|||
126040546|NCT03519178|453447165|FG013|Follow-Up|Other|0|||
126040547|NCT03519178|453447166|FG014|Follow-Up|Other|0|||
126040548|NCT03519178|453447152|FG000|Long-term Follow-up|Death|0|||
126040549|NCT03519178|453447153|FG001|Long-term Follow-up|Death|0|||
126040550|NCT03519178|453447154|FG002|Long-term Follow-up|Death|0|||
126040551|NCT03519178|453447155|FG003|Long-term Follow-up|Death|0|||
126040552|NCT03519178|453447156|FG004|Long-term Follow-up|Death|0|||
126040553|NCT03519178|453447157|FG005|Long-term Follow-up|Death|0|||
126040554|NCT03519178|453447158|FG006|Long-term Follow-up|Death|0|||
126040555|NCT03519178|453447159|FG007|Long-term Follow-up|Death|0|||
126040556|NCT03519178|453447160|FG008|Long-term Follow-up|Death|0|||
126040557|NCT03519178|453447161|FG009|Long-term Follow-up|Death|0|||
126040558|NCT03519178|453447162|FG010|Long-term Follow-up|Death|0|||
126040559|NCT03519178|453447163|FG011|Long-term Follow-up|Death|0|||
126040560|NCT03519178|453447164|FG012|Long-term Follow-up|Death|0|||
126283163|NCT00887289|454324655|FG000|Overall Study|Other|20|||
126283164|NCT00591773|454324658|FG000|Overall Study|Adverse Event|9|||
126283165|NCT00591773|454324659|FG001|Overall Study|Adverse Event|9|||
126283166|NCT00591773|454324660|FG002|Overall Study|Adverse Event|6|||
126283167|NCT00591773|454324658|FG000|Overall Study|Protocol Violation|2|||
126283168|NCT00591773|454324659|FG001|Overall Study|Protocol Violation|3|||
126283169|NCT00591773|454324660|FG002|Overall Study|Protocol Violation|0|||
126283170|NCT00591773|454324658|FG000|Overall Study|Lost to Follow-up|1|||
126283171|NCT00591773|454324659|FG001|Overall Study|Lost to Follow-up|4|||
126283172|NCT00591773|454324660|FG002|Overall Study|Lost to Follow-up|1|||
126283173|NCT00591773|454324658|FG000|Overall Study|Withdrawal by Subject|2|||
126283174|NCT00591773|454324659|FG001|Overall Study|Withdrawal by Subject|5|||
126283175|NCT00591773|454324660|FG002|Overall Study|Withdrawal by Subject|3|||
126040561|NCT03519178|453447165|FG013|Long-term Follow-up|Death|4|||
126040562|NCT03519178|453447166|FG014|Long-term Follow-up|Death|4|||
126040563|NCT03519178|453447152|FG000|Long-term Follow-up|Lost to Follow-up|0|||
126040564|NCT03519178|453447153|FG001|Long-term Follow-up|Lost to Follow-up|0|||
126283176|NCT00591773|454324658|FG000|Overall Study|Lack of Efficacy|1|||
126283177|NCT00591773|454324659|FG001|Overall Study|Lack of Efficacy|2|||
126283178|NCT00591773|454324660|FG002|Overall Study|Lack of Efficacy|2|||
126283179|NCT00591773|454324658|FG000|Overall Study|Other|1|||
126283180|NCT00591773|454324659|FG001|Overall Study|Other|1|||
126040565|NCT03519178|453447154|FG002|Long-term Follow-up|Lost to Follow-up|0|||
126040566|NCT03519178|453447155|FG003|Long-term Follow-up|Lost to Follow-up|0|||
126040567|NCT03519178|453447156|FG004|Long-term Follow-up|Lost to Follow-up|0|||
126040568|NCT03519178|453447157|FG005|Long-term Follow-up|Lost to Follow-up|0|||
126040569|NCT03519178|453447158|FG006|Long-term Follow-up|Lost to Follow-up|0|||
126040570|NCT03519178|453447159|FG007|Long-term Follow-up|Lost to Follow-up|0|||
126040571|NCT03519178|453447160|FG008|Long-term Follow-up|Lost to Follow-up|0|||
126040572|NCT03519178|453447161|FG009|Long-term Follow-up|Lost to Follow-up|0|||
126040573|NCT03519178|453447162|FG010|Long-term Follow-up|Lost to Follow-up|0|||
126283181|NCT00591773|454324660|FG002|Overall Study|Other|4|||
126283182|NCT00459355|454324661|FG000|Overall Study|Subject no longer met inc criteria|20|||
126283183|NCT00459355|454324662|FG001|Overall Study|Subject no longer met inc criteria|18|||
126283184|NCT02135614|454324663|FG000|Overall Study|Randomized but Not Treated|2|||
126364757|NCT03654326|454630321|FG000|Overall Study|Unable to adhere to study schedule|0|||
126364758|NCT03654326|454630322|FG001|Overall Study|Unable to adhere to study schedule|1|||
126364759|NCT03654326|454630321|FG000|Overall Study|Lost to Follow-up|1|||
126364760|NCT03654326|454630322|FG001|Overall Study|Lost to Follow-up|1|||
126364761|NCT00835549|454630323|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
126364762|NCT00835549|454630324|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126364763|NCT00619918|454630325|FG000|Overall Study|Withdrawal by Subject|4|||
126364764|NCT00619918|454630326|FG001|Overall Study|Withdrawal by Subject|3|||
126364765|NCT00619918|454630325|FG000|Overall Study|Physician Decision|2|||
126364766|NCT00619918|454630326|FG001|Overall Study|Physician Decision|4|||
126364767|NCT00619918|454630325|FG000|Overall Study|Transfer to outside facility|3|||
126364768|NCT00619918|454630326|FG001|Overall Study|Transfer to outside facility|3|||
126364769|NCT00619918|454630325|FG000|Overall Study|Left before receiving first dose|7|||
126364770|NCT00619918|454630326|FG001|Overall Study|Left before receiving first dose|6|||
126364771|NCT00619918|454630325|FG000|Overall Study|ICU admission|4|||
126364772|NCT00619918|454630326|FG001|Overall Study|ICU admission|6|||
126364773|NCT05524948|454630338|FG000|Overall Study|Withdrawal by Subject|1|||
126364774|NCT05524948|454630339|FG001|Overall Study|Withdrawal by Subject|0|||
126364775|NCT05524948|454630338|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
126364776|NCT05524948|454630339|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
126364777|NCT04661839|454630344|FG000|Overall Study|Not Treated|0|||
126364778|NCT04661839|454630345|FG001|Overall Study|Not Treated|0|||
126364779|NCT04661839|454630346|FG002|Overall Study|Not Treated|1|||
126364780|NCT04661839|454630347|FG003|Overall Study|Not Treated|0|||
126364781|NCT04661839|454630344|FG000|Overall Study|Lost to Follow-up|1|||
126364782|NCT04661839|454630345|FG001|Overall Study|Lost to Follow-up|0|||
126364783|NCT04661839|454630346|FG002|Overall Study|Lost to Follow-up|0|||
126364784|NCT04661839|454630347|FG003|Overall Study|Lost to Follow-up|1|||
126364785|NCT02758626|454630349|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
126364786|NCT02758626|454630350|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
126364787|NCT02758626|454630349|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
126364788|NCT02758626|454630350|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
126364789|NCT02758626|454630349|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
126364790|NCT02758626|454630350|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
126364791|NCT02758626|454630349|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
126364792|NCT02758626|454630350|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
126364793|NCT00855166|454630351|FG000|Overall Study|Adverse Event|0|||
126364794|NCT00855166|454630352|FG001|Overall Study|Adverse Event|2|||
126364795|NCT00855166|454630351|FG000|Overall Study|Death|0|||
126364796|NCT00855166|454630352|FG001|Overall Study|Death|1|||
126364797|NCT00855166|454630351|FG000|Overall Study|Withdrawal by Subject|1|||
126364798|NCT00855166|454630352|FG001|Overall Study|Withdrawal by Subject|4|||
126364799|NCT00855166|454630351|FG000|Overall Study|Poor/non-compliance|2|||
126364800|NCT00855166|454630352|FG001|Overall Study|Poor/non-compliance|0|||
126364801|NCT00855166|454630351|FG000|Overall Study|Administrative reasons by sponsor|1|||
126364802|NCT00855166|454630352|FG001|Overall Study|Administrative reasons by sponsor|0|||
126364803|NCT00855166|454630351|FG000|Overall Study|Subject no longer meets study criteria|1|||
126364804|NCT00855166|454630352|FG001|Overall Study|Subject no longer meets study criteria|1|||
126364805|NCT01848457|454630355|FG000|Overall Study|Death|1|||
126364806|NCT01848457|454630356|FG001|Overall Study|Death|0|||
126283185|NCT02135614|454324664|FG001|Overall Study|Randomized but Not Treated|1|||
126283186|NCT02135614|454324663|FG000|Overall Study|Adverse Event|0|||
126283187|NCT02135614|454324664|FG001|Overall Study|Adverse Event|1|||
126283188|NCT02135614|454324663|FG000|Overall Study|Death|1|||
126040574|NCT03519178|453447163|FG011|Long-term Follow-up|Lost to Follow-up|0|||
126040575|NCT03519178|453447164|FG012|Long-term Follow-up|Lost to Follow-up|0|||
126283189|NCT02135614|454324664|FG001|Overall Study|Death|0|||
126283190|NCT02135614|454324663|FG000|Overall Study|Investigator's Discretion|0|||
126283191|NCT02135614|454324664|FG001|Overall Study|Investigator's Discretion|1|||
126283192|NCT02135614|454324663|FG000|Overall Study|Withdrew Consent|2|||
126283193|NCT02135614|454324664|FG001|Overall Study|Withdrew Consent|2|||
126283194|NCT02135614|454324663|FG000|Overall Study|Lost to Follow-up|3|||
126364807|NCT01848457|454630357|FG002|Overall Study|Death|0|||
126364808|NCT01848457|454630358|FG003|Overall Study|Death|0|||
126364809|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
126364810|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
126364811|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
126364812|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
126364813|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
126364814|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
126364815|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
126364816|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
126364817|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
126364818|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
126364819|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
126364820|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
126364821|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
126364822|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
126364823|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
126364824|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
126364825|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
126364826|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
126364827|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
126364828|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
126364829|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
126364830|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
126364831|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
126364832|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
126364833|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
126364834|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
126364835|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
126364836|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
126364837|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
126364838|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
126364839|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
126364840|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
126364841|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
126364842|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
126364843|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
126364844|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
126364845|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364846|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364847|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364848|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
126364849|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364850|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364851|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
126364852|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
126364853|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
126364854|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
126364855|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
126364856|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
126364857|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
126364858|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
126364859|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
126364860|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
126364861|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
126364862|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
126364863|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
126283195|NCT02135614|454324664|FG001|Overall Study|Lost to Follow-up|0|||
126283196|NCT01275729|454324673|FG000|Overall Study|Death|3|||
126283197|NCT01275729|454324673|FG000|Overall Study|Withdrawal by Subject|1|||
126283198|NCT00582010|454324676|FG000|Overall Study|Death|0|||
126283199|NCT00582010|454324677|FG001|Overall Study|Death|1|||
126283200|NCT02681510|454324678|FG000|Overall Study|Withdrawal by Subject|1|||
126283201|NCT02681510|454324678|FG000|Overall Study|Lost to Follow-up|9|||
126283202|NCT04315506|454324679|FG000|Overall Study|Lost to Follow-up|74|||
126283203|NCT04315506|454324680|FG001|Overall Study|Lost to Follow-up|82|||
126283204|NCT04315506|454324679|FG000|Overall Study|Withdrawal by Subject|8|||
126283205|NCT04315506|454324680|FG001|Overall Study|Withdrawal by Subject|8|||
126283206|NCT04315506|454324679|FG000|Overall Study|Physician Decision|0|||
126283207|NCT04315506|454324680|FG001|Overall Study|Physician Decision|1|||
126283208|NCT00958893|454324681|FG000|Overall Study|Study prematurely terminated|4|||
126283209|NCT03593395|454324682|FG000|Overall Study|Lost to Follow-up|48|||
126283210|NCT03593395|454324683|FG001|Overall Study|Lost to Follow-up|3|||
126283211|NCT03593395|454324682|FG000|Overall Study|Withdrawal by Subject|5|||
126283212|NCT03593395|454324683|FG001|Overall Study|Withdrawal by Subject|24|||
126283213|NCT03593395|454324682|FG000|Overall Study|Death|2|||
126283214|NCT03593395|454324683|FG001|Overall Study|Death|3|||
126283215|NCT03593395|454324682|FG000|Overall Study|Physician Decision|0|||
126283216|NCT03593395|454324683|FG001|Overall Study|Physician Decision|6|||
126283217|NCT03593395|454324682|FG000|Overall Study|Participant Relocated|19|||
126283218|NCT03593395|454324683|FG001|Overall Study|Participant Relocated|3|||
126283219|NCT03593395|454324682|FG000|Overall Study|No Information|1|||
126283220|NCT03593395|454324683|FG001|Overall Study|No Information|7|||
126283221|NCT00741338|454324684|FG000|Overall Study|Adverse Event|0|||
126283222|NCT00741338|454324685|FG001|Overall Study|Adverse Event|1|||
126283223|NCT01098474|454324688|FG000|Active Phase|Other|0|||
126283224|NCT01098474|454324689|FG001|Active Phase|Other|0|||
126283225|NCT01098474|454324690|FG002|Active Phase|Other|3|||
126283226|NCT01098474|454324691|FG003|Active Phase|Other|0|||
126283227|NCT01098474|454324692|FG004|Active Phase|Other|0|||
126283228|NCT01098474|454324693|FG005|Active Phase|Other|0|||
126283229|NCT01098474|454324688|FG000|Active Phase|Withdrawal by Subject|1|||
126283230|NCT01098474|454324689|FG001|Active Phase|Withdrawal by Subject|1|||
126283231|NCT01098474|454324690|FG002|Active Phase|Withdrawal by Subject|2|||
126283232|NCT01098474|454324691|FG003|Active Phase|Withdrawal by Subject|0|||
126283233|NCT01098474|454324692|FG004|Active Phase|Withdrawal by Subject|0|||
126283234|NCT01098474|454324693|FG005|Active Phase|Withdrawal by Subject|0|||
126283235|NCT01098474|454324688|FG000|Active Phase|Lost to Follow-up|1|||
126283236|NCT01098474|454324689|FG001|Active Phase|Lost to Follow-up|0|||
126283237|NCT01098474|454324690|FG002|Active Phase|Lost to Follow-up|0|||
126283238|NCT01098474|454324691|FG003|Active Phase|Lost to Follow-up|0|||
126283239|NCT01098474|454324692|FG004|Active Phase|Lost to Follow-up|0|||
126283240|NCT01098474|454324693|FG005|Active Phase|Lost to Follow-up|0|||
126283241|NCT01098474|454324688|FG000|Follow Up Phase|Travelled out of study area|0|||
126283242|NCT01098474|454324689|FG001|Follow Up Phase|Travelled out of study area|0|||
126283243|NCT01098474|454324690|FG002|Follow Up Phase|Travelled out of study area|0|||
126283244|NCT01098474|454324691|FG003|Follow Up Phase|Travelled out of study area|0|||
126283245|NCT01098474|454324692|FG004|Follow Up Phase|Travelled out of study area|1|||
126283246|NCT01098474|454324693|FG005|Follow Up Phase|Travelled out of study area|0|||
126283247|NCT01098474|454324688|FG000|Follow Up Phase|Other|0|||
126283248|NCT01098474|454324689|FG001|Follow Up Phase|Other|0|||
126283249|NCT01098474|454324690|FG002|Follow Up Phase|Other|0|||
126283250|NCT01098474|454324691|FG003|Follow Up Phase|Other|0|||
126283251|NCT01098474|454324692|FG004|Follow Up Phase|Other|0|||
126283252|NCT01098474|454324693|FG005|Follow Up Phase|Other|4|||
126283253|NCT01098474|454324688|FG000|Follow Up Phase|Withdrawal by Subject|0|||
126283254|NCT01098474|454324689|FG001|Follow Up Phase|Withdrawal by Subject|0|||
126283255|NCT01098474|454324690|FG002|Follow Up Phase|Withdrawal by Subject|0|||
126283256|NCT01098474|454324691|FG003|Follow Up Phase|Withdrawal by Subject|2|||
126283257|NCT01098474|454324692|FG004|Follow Up Phase|Withdrawal by Subject|0|||
126283258|NCT01098474|454324693|FG005|Follow Up Phase|Withdrawal by Subject|1|||
126283259|NCT01098474|454324688|FG000|Follow Up Phase|Lost to Follow-up|0|||
126283260|NCT01098474|454324689|FG001|Follow Up Phase|Lost to Follow-up|0|||
126283261|NCT01098474|454324690|FG002|Follow Up Phase|Lost to Follow-up|0|||
126283262|NCT01098474|454324691|FG003|Follow Up Phase|Lost to Follow-up|0|||
126283263|NCT01098474|454324692|FG004|Follow Up Phase|Lost to Follow-up|1|||
126040576|NCT03519178|453447165|FG013|Long-term Follow-up|Lost to Follow-up|1|||
126040577|NCT03519178|453447166|FG014|Long-term Follow-up|Lost to Follow-up|1|||
126040578|NCT03519178|453447152|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
126040579|NCT03519178|453447153|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
126040580|NCT03519178|453447154|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
126040581|NCT03519178|453447155|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
126040582|NCT03519178|453447156|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
126040583|NCT03519178|453447157|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
126040584|NCT03519178|453447158|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
126040585|NCT03519178|453447159|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
126040586|NCT03519178|453447160|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
126040587|NCT03519178|453447161|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
126040588|NCT03519178|453447162|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
126040589|NCT03519178|453447163|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
126364864|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
126040590|NCT03519178|453447164|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
126040591|NCT03519178|453447165|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
126040592|NCT03519178|453447166|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
126040593|NCT03519178|453447152|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
126040594|NCT03519178|453447153|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
126040595|NCT03519178|453447154|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
126040596|NCT03519178|453447155|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
126040597|NCT03519178|453447156|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
126040598|NCT03519178|453447157|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
126040599|NCT03519178|453447158|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
126040600|NCT03519178|453447159|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
126040601|NCT03519178|453447160|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
126040602|NCT03519178|453447161|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
126040603|NCT03519178|453447162|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
126040604|NCT03519178|453447163|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
126364865|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
126364866|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
126364867|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
126364868|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
125882326|NCT02113982|452868958|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882327|NCT02113982|452868959|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882328|NCT02113982|452868960|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
125882329|NCT02113982|452868961|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125882330|NCT02113982|452868948|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882331|NCT02113982|452868949|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882332|NCT02113982|452868950|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882333|NCT02113982|452868951|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882334|NCT02113982|452868952|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882335|NCT02113982|452868953|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882336|NCT02113982|452868954|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882337|NCT02113982|452868955|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882338|NCT02113982|452868956|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882339|NCT02113982|452868957|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882340|NCT02113982|452868958|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882341|NCT02113982|452868959|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125882342|NCT02113982|452868960|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
126040605|NCT03519178|453447164|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
126040606|NCT03519178|453447165|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
126040607|NCT03519178|453447166|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
126040608|NCT03519178|453447152|FG000|Long-term Follow-up|Other|0|||
126040609|NCT03519178|453447153|FG001|Long-term Follow-up|Other|0|||
126040610|NCT03519178|453447154|FG002|Long-term Follow-up|Other|0|||
126040611|NCT03519178|453447155|FG003|Long-term Follow-up|Other|0|||
126040612|NCT03519178|453447156|FG004|Long-term Follow-up|Other|0|||
126040613|NCT03519178|453447157|FG005|Long-term Follow-up|Other|0|||
126040614|NCT03519178|453447158|FG006|Long-term Follow-up|Other|0|||
126040615|NCT03519178|453447159|FG007|Long-term Follow-up|Other|0|||
126040616|NCT03519178|453447160|FG008|Long-term Follow-up|Other|0|||
126040617|NCT03519178|453447161|FG009|Long-term Follow-up|Other|0|||
126040618|NCT03519178|453447162|FG010|Long-term Follow-up|Other|0|||
126040619|NCT03519178|453447163|FG011|Long-term Follow-up|Other|0|||
126040620|NCT03519178|453447164|FG012|Long-term Follow-up|Other|0|||
126040621|NCT03519178|453447165|FG013|Long-term Follow-up|Other|0|||
126364869|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
125882343|NCT02113982|452868961|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
126040622|NCT03519178|453447166|FG014|Long-term Follow-up|Other|1|||
126040623|NCT03519178|453447152|FG000|Long-term Follow-up|Ongoing|0|||
126040624|NCT03519178|453447153|FG001|Long-term Follow-up|Ongoing|0|||
126283264|NCT01098474|454324693|FG005|Follow Up Phase|Lost to Follow-up|0|||
126283265|NCT00101283|454324696|FG000|Overall Study|Withdrawal by Subject|0|||
126283266|NCT00101283|454324697|FG001|Overall Study|Withdrawal by Subject|1|||
126283267|NCT00101283|454324696|FG000|Overall Study|Insurance Refusal|0|||
126283268|NCT00101283|454324697|FG001|Overall Study|Insurance Refusal|1|||
126283269|NCT00101283|454324696|FG000|Overall Study|Prostate Cancer Recurrence|0|||
126283270|NCT00101283|454324697|FG001|Overall Study|Prostate Cancer Recurrence|1|||
126283271|NCT00595309|454324698|FG000|Overall Study|Lost to Follow-up|1|||
126283272|NCT00595309|454324698|FG000|Overall Study|planned vaccination against yellow fever|1|||
126283273|NCT00595309|454324698|FG000|Overall Study|acute infection after V0|1|||
126283274|NCT00595309|454324698|FG000|Overall Study|personal reason|1|||
126283275|NCT00626561|454324699|FG000|Overall Study|Withdrawal by Subject|2|||
126283276|NCT00626561|454324699|FG000|Overall Study|Disease Progression|2|||
126283277|NCT00398866|454324706|FG000|Overall Study|Adverse Event|1|||
126283278|NCT00398866|454324707|FG001|Overall Study|Adverse Event|0|||
126283279|NCT00398866|454324708|FG002|Overall Study|Adverse Event|0|||
126283280|NCT00398866|454324706|FG000|Overall Study|Lack of Efficacy|0|||
126283281|NCT00398866|454324707|FG001|Overall Study|Lack of Efficacy|0|||
126283282|NCT00398866|454324708|FG002|Overall Study|Lack of Efficacy|1|||
126283283|NCT00398866|454324706|FG000|Overall Study|Lost to Follow-up|7|||
126283284|NCT00398866|454324707|FG001|Overall Study|Lost to Follow-up|6|||
126283285|NCT00398866|454324708|FG002|Overall Study|Lost to Follow-up|4|||
126283286|NCT00398866|454324706|FG000|Overall Study|Withdrawal by Subject|5|||
126283287|NCT00398866|454324707|FG001|Overall Study|Withdrawal by Subject|1|||
126283288|NCT00398866|454324708|FG002|Overall Study|Withdrawal by Subject|2|||
126283289|NCT00398866|454324706|FG000|Overall Study|Unable to complete requirements of study|1|||
126283290|NCT00398866|454324707|FG001|Overall Study|Unable to complete requirements of study|1|||
126283291|NCT00398866|454324708|FG002|Overall Study|Unable to complete requirements of study|1|||
126283292|NCT00606632|454324709|FG000|Overall Study|Withdrawal by Subject|13|||
126283293|NCT00606632|454324709|FG000|Overall Study|Miscellaneous reasons|9|||
126283294|NCT00704132|454324713|FG000|Overall Study|Clinical Adverse Experience|1|||
126283295|NCT00704132|454324714|FG001|Overall Study|Clinical Adverse Experience|0|||
126283296|NCT00704132|454324713|FG000|Overall Study|Lack of Efficacy|0|||
126283297|NCT00704132|454324714|FG001|Overall Study|Lack of Efficacy|1|||
126283298|NCT00704132|454324713|FG000|Overall Study|Withdrawal by Subject|0|||
126283299|NCT00704132|454324714|FG001|Overall Study|Withdrawal by Subject|1|||
126283300|NCT00442962|454324715|FG000|Overall Study|Pregnancy|1|||
126283301|NCT00442962|454324715|FG000|Overall Study|Lost to Follow-up|7|||
126283302|NCT03633825|454324716|FG000|Enrollment|Did not post on network|5066|||
126283303|NCT03633825|454324717|FG001|Enrollment|Did not post on network|5080|||
126283304|NCT03633825|454324716|FG000|Enrollment|Post not classified as crisis|13967|||
126283305|NCT03633825|454324717|FG001|Enrollment|Post not classified as crisis|13757|||
126283306|NCT03633825|454324716|FG000|Follow up|Lost to Follow-up|478|||
126283307|NCT03633825|454324717|FG001|Follow up|Lost to Follow-up|450|||
126283308|NCT02756208|454324721|FG000|Overall Study|Withdrawal by Subject|1|||
126283309|NCT02756208|454324722|FG001|Overall Study|Withdrawal by Subject|0|||
126283310|NCT02756208|454324723|FG002|Overall Study|Withdrawal by Subject|1|||
126283311|NCT02756208|454324724|FG003|Overall Study|Withdrawal by Subject|3|||
126283312|NCT02756208|454324721|FG000|Overall Study|Lost to Follow-up|3|||
126283313|NCT02756208|454324722|FG001|Overall Study|Lost to Follow-up|1|||
126283314|NCT02756208|454324723|FG002|Overall Study|Lost to Follow-up|1|||
126283315|NCT02756208|454324724|FG003|Overall Study|Lost to Follow-up|1|||
126283316|NCT02756208|454324721|FG000|Overall Study|Physician Decision|1|||
126283317|NCT02756208|454324722|FG001|Overall Study|Physician Decision|0|||
126283318|NCT02756208|454324723|FG002|Overall Study|Physician Decision|0|||
126283319|NCT02756208|454324724|FG003|Overall Study|Physician Decision|0|||
126283320|NCT02756208|454324721|FG000|Overall Study|Protocol Violation|0|||
126283321|NCT02756208|454324722|FG001|Overall Study|Protocol Violation|1|||
126283322|NCT02756208|454324723|FG002|Overall Study|Protocol Violation|0|||
126283323|NCT02756208|454324724|FG003|Overall Study|Protocol Violation|0|||
126283324|NCT04841577|454324726|FG000|Overall Study|Adverse Event|5|||
126283325|NCT04841577|454324727|FG001|Overall Study|Adverse Event|10|||
126283326|NCT04841577|454324726|FG000|Overall Study|Lost to Follow-up|8|||
126283327|NCT04841577|454324727|FG001|Overall Study|Lost to Follow-up|7|||
126283328|NCT04841577|454324726|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
126283329|NCT04841577|454324727|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
126283330|NCT04841577|454324726|FG000|Overall Study|Other|0|||
126283331|NCT04841577|454324727|FG001|Overall Study|Other|1|||
126283332|NCT00182325|454324728|FG000|Overall Study|Lost to Follow-up|7|||
126283333|NCT00182325|454324729|FG001|Overall Study|Lost to Follow-up|7|||
126283334|NCT00182325|454324728|FG000|Overall Study|Miscarriage|5|||
126283335|NCT00182325|454324729|FG001|Overall Study|Miscarriage|3|||
126283336|NCT00182325|454324728|FG000|Overall Study|Did not complete survey|22|||
126283337|NCT00182325|454324729|FG001|Overall Study|Did not complete survey|43|||
126364870|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
126283338|NCT01420965|454324732|FG000|Overall Study|Withdrawal by Subject|1|||
126283339|NCT01420965|454324733|FG001|Overall Study|Withdrawal by Subject|0|||
126283340|NCT01420965|454324734|FG002|Overall Study|Withdrawal by Subject|0|||
125882344|NCT02113982|452868948|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882345|NCT02113982|452868949|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882346|NCT02113982|452868950|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882347|NCT02113982|452868951|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882348|NCT02113982|452868952|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882349|NCT02113982|452868953|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882350|NCT02113982|452868954|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126283341|NCT01420965|454324732|FG000|Overall Study|Adverse Event|0|||
126283342|NCT01420965|454324733|FG001|Overall Study|Adverse Event|1|||
126283343|NCT01420965|454324734|FG002|Overall Study|Adverse Event|0|||
126283344|NCT01890434|454324739|FG000|Overall Study|Adverse Event|8|||
126283345|NCT01890434|454324739|FG000|Overall Study|PCI at external hospital|1|||
126283346|NCT01890434|454324739|FG000|Overall Study|Assessment discrepancy|1|||
126283347|NCT01890434|454324739|FG000|Overall Study|CRC didn't contact participant for FU|1|||
126283348|NCT01890434|454324739|FG000|Overall Study|Could not get whole set of images|1|||
126283349|NCT01890434|454324739|FG000|Overall Study|Decline to return for GSPECT|1|||
126283350|NCT01890434|454324739|FG000|Overall Study|GSPECT at rest was not done|1|||
126283351|NCT01890434|454324739|FG000|Overall Study|Participant didn't complete MRI|1|||
126283352|NCT01890434|454324739|FG000|Overall Study|Uncontactable by phone|1|||
126283353|NCT01890434|454324739|FG000|Overall Study|Moved out of position|1|||
126283354|NCT01890434|454324739|FG000|Overall Study|Unable to contact|1|||
126283355|NCT01890434|454324739|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
126283356|NCT03280381|454324740|FG000|Overall Study|Physician Decision|0|||
126283357|NCT03280381|454324741|FG001|Overall Study|Physician Decision|2|||
126283358|NCT01141205|454324742|FG000|Overall Study|Physician Decision|1|||
126283359|NCT01141205|454324743|FG001|Overall Study|Physician Decision|1|||
126283360|NCT01141205|454324742|FG000|Overall Study|Lost to Follow-up|1|||
126283361|NCT01141205|454324743|FG001|Overall Study|Lost to Follow-up|0|||
126283362|NCT01141205|454324742|FG000|Overall Study|Withdrawal by Subject|1|||
126283363|NCT01141205|454324743|FG001|Overall Study|Withdrawal by Subject|1|||
126283364|NCT01822366|454324745|FG000|Overall Study|Lost to Follow-up|5|||
126283365|NCT01822366|454324746|FG001|Overall Study|Lost to Follow-up|1|||
126283366|NCT01822366|454324747|FG002|Overall Study|Lost to Follow-up|5|||
126283367|NCT01822366|454324748|FG003|Overall Study|Lost to Follow-up|1|||
126283368|NCT01822366|454324745|FG000|Overall Study|Withdrawal by Subject|0|||
126283369|NCT01822366|454324746|FG001|Overall Study|Withdrawal by Subject|6|||
126283370|NCT01822366|454324747|FG002|Overall Study|Withdrawal by Subject|0|||
126283371|NCT01822366|454324748|FG003|Overall Study|Withdrawal by Subject|6|||
126283372|NCT01822366|454324745|FG000|Overall Study|Partial Intervention Completion|0|||
126283373|NCT01822366|454324746|FG001|Overall Study|Partial Intervention Completion|15|||
126283374|NCT01822366|454324747|FG002|Overall Study|Partial Intervention Completion|0|||
126283375|NCT01822366|454324748|FG003|Overall Study|Partial Intervention Completion|15|||
126283376|NCT03276078|454324749|FG000|Overall Study|Adverse Event|1|||
126283377|NCT02552732|454324750|FG000|Overall Study|Lost to Follow-up|2|||
126283378|NCT02552732|454324750|FG000|Overall Study|Physician Decision|1|||
126283379|NCT02552732|454324750|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
126283380|NCT02552732|454324750|FG000|Overall Study|Withdrawal by Subject|6|||
126283381|NCT02290223|454324751|FG000|6 Months|Lost to Follow-up|9|||
126283382|NCT02290223|454324752|FG001|6 Months|Lost to Follow-up|6|||
126283383|NCT02290223|454324751|FG000|6 Months|Withdrawal by Subject|5|||
126283384|NCT02290223|454324752|FG001|6 Months|Withdrawal by Subject|0|||
126283385|NCT02290223|454324751|FG000|6 Months|deceased (not related to study)|2|||
126283386|NCT02290223|454324752|FG001|6 Months|deceased (not related to study)|0|||
126283387|NCT02290223|454324751|FG000|12 Months|Lost to Follow-up|16|||
126283388|NCT02290223|454324752|FG001|12 Months|Lost to Follow-up|10|||
126283389|NCT02290223|454324751|FG000|12 Months|Refusal|0|||
126283390|NCT02290223|454324752|FG001|12 Months|Refusal|1|||
126283391|NCT02027428|454324756|FG000|Induction|Never treated|7|||
126283392|NCT02027428|454324757|FG001|Induction|Never treated|0|||
126040625|NCT03519178|453447154|FG002|Long-term Follow-up|Ongoing|0|||
126283393|NCT02027428|454324758|FG002|Induction|Never treated|0|||
126283394|NCT02027428|454324756|FG000|Induction|Progressive disease|77|||
126283395|NCT02027428|454324757|FG001|Induction|Progressive disease|0|||
126283396|NCT02027428|454324758|FG002|Induction|Progressive disease|0|||
126283397|NCT02027428|454324756|FG000|Induction|Adverse Event|51|||
126283398|NCT02027428|454324757|FG001|Induction|Adverse Event|0|||
126283399|NCT02027428|454324758|FG002|Induction|Adverse Event|0|||
126283400|NCT02027428|454324756|FG000|Induction|Withdrawal by Subject|22|||
126283401|NCT02027428|454324757|FG001|Induction|Withdrawal by Subject|0|||
126283402|NCT02027428|454324758|FG002|Induction|Withdrawal by Subject|0|||
126040626|NCT03519178|453447155|FG003|Long-term Follow-up|Ongoing|0|||
126283403|NCT02027428|454324756|FG000|Induction|Death|21|||
126283404|NCT02027428|454324757|FG001|Induction|Death|0|||
126283405|NCT02027428|454324758|FG002|Induction|Death|0|||
126283406|NCT02027428|454324756|FG000|Induction|Symptomatic deterioration|16|||
126283407|NCT02027428|454324757|FG001|Induction|Symptomatic deterioration|0|||
126283408|NCT02027428|454324758|FG002|Induction|Symptomatic deterioration|0|||
126283409|NCT02027428|454324756|FG000|Induction|Study terminated by sponsor|12|||
126283410|NCT02027428|454324757|FG001|Induction|Study terminated by sponsor|0|||
126283411|NCT02027428|454324758|FG002|Induction|Study terminated by sponsor|0|||
126283412|NCT02027428|454324756|FG000|Induction|Protocol Violation|1|||
126283413|NCT02027428|454324757|FG001|Induction|Protocol Violation|0|||
126283414|NCT02027428|454324758|FG002|Induction|Protocol Violation|0|||
126283415|NCT02027428|454324756|FG000|Induction|Miscellaneous|14|||
126283416|NCT02027428|454324757|FG001|Induction|Miscellaneous|0|||
126283417|NCT02027428|454324758|FG002|Induction|Miscellaneous|0|||
126283418|NCT02027428|454324756|FG000|Induction|Induction Treatment Ongoing|4|||
126283419|NCT02027428|454324757|FG001|Induction|Induction Treatment Ongoing|0|||
126283420|NCT02027428|454324758|FG002|Induction|Induction Treatment Ongoing|0|||
126283421|NCT02027428|454324756|FG000|Maintenance|Death|0|||
126283422|NCT02027428|454324757|FG001|Maintenance|Death|3|||
126283423|NCT02027428|454324758|FG002|Maintenance|Death|2|||
126283424|NCT02027428|454324756|FG000|Maintenance|Adverse Event|0|||
126283425|NCT02027428|454324757|FG001|Maintenance|Adverse Event|21|||
126283426|NCT02027428|454324758|FG002|Maintenance|Adverse Event|1|||
126283427|NCT02027428|454324756|FG000|Maintenance|Progressive disease|0|||
126283428|NCT02027428|454324757|FG001|Maintenance|Progressive disease|84|||
126283429|NCT02027428|454324758|FG002|Maintenance|Progressive disease|47|||
126283430|NCT02027428|454324756|FG000|Maintenance|Symptomatic deterioration|0|||
126283431|NCT02027428|454324757|FG001|Maintenance|Symptomatic deterioration|4|||
126283432|NCT02027428|454324758|FG002|Maintenance|Symptomatic deterioration|1|||
126283433|NCT02027428|454324756|FG000|Maintenance|Withdrawal by Subject|0|||
126283434|NCT02027428|454324757|FG001|Maintenance|Withdrawal by Subject|6|||
126283435|NCT02027428|454324758|FG002|Maintenance|Withdrawal by Subject|5|||
126283436|NCT02027428|454324756|FG000|Maintenance|Protocol Violation|0|||
126283437|NCT02027428|454324757|FG001|Maintenance|Protocol Violation|0|||
126283438|NCT02027428|454324758|FG002|Maintenance|Protocol Violation|1|||
126283439|NCT02027428|454324756|FG000|Maintenance|Other|0|||
126283440|NCT02027428|454324757|FG001|Maintenance|Other|6|||
126283441|NCT02027428|454324758|FG002|Maintenance|Other|3|||
126283442|NCT02027428|454324756|FG000|Survival Follow-up|Death|0|||
125882351|NCT02113982|452868955|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126283443|NCT02027428|454324757|FG001|Survival Follow-up|Death|78|||
126283444|NCT02027428|454324758|FG002|Survival Follow-up|Death|45|||
126283445|NCT02027428|454324756|FG000|Survival Follow-up|Lost to Follow-up|0|||
126283446|NCT02027428|454324757|FG001|Survival Follow-up|Lost to Follow-up|1|||
126283447|NCT02027428|454324758|FG002|Survival Follow-up|Lost to Follow-up|1|||
126283448|NCT01004003|454324759|FG000|Overall Study|Progressive disease|2|||
126283449|NCT01004003|454324760|FG001|Overall Study|Progressive disease|1|||
126283450|NCT01004003|454324761|FG002|Overall Study|Progressive disease|1|||
126283451|NCT01004003|454324762|FG003|Overall Study|Progressive disease|0|||
126283452|NCT01004003|454324763|FG004|Overall Study|Progressive disease|2|||
126283453|NCT01004003|454324764|FG005|Overall Study|Progressive disease|1|||
126283454|NCT01004003|454324765|FG006|Overall Study|Progressive disease|1|||
126283455|NCT01004003|454324766|FG007|Overall Study|Progressive disease|39|||
126283456|NCT01004003|454324767|FG008|Overall Study|Progressive disease|22|||
126283457|NCT01004003|454324759|FG000|Overall Study|Adverse Event|4|||
126283458|NCT01004003|454324760|FG001|Overall Study|Adverse Event|2|||
126283459|NCT01004003|454324761|FG002|Overall Study|Adverse Event|3|||
126283460|NCT01004003|454324762|FG003|Overall Study|Adverse Event|3|||
126283461|NCT01004003|454324763|FG004|Overall Study|Adverse Event|2|||
126283462|NCT01004003|454324764|FG005|Overall Study|Adverse Event|2|||
126283463|NCT01004003|454324765|FG006|Overall Study|Adverse Event|7|||
126283464|NCT01004003|454324766|FG007|Overall Study|Adverse Event|21|||
126283465|NCT01004003|454324767|FG008|Overall Study|Adverse Event|6|||
126283466|NCT01004003|454324759|FG000|Overall Study|Refused to continue taking trial med.|0|||
126283467|NCT01004003|454324760|FG001|Overall Study|Refused to continue taking trial med.|0|||
126283468|NCT01004003|454324761|FG002|Overall Study|Refused to continue taking trial med.|0|||
126283469|NCT01004003|454324762|FG003|Overall Study|Refused to continue taking trial med.|0|||
126283470|NCT01004003|454324763|FG004|Overall Study|Refused to continue taking trial med.|0|||
126283471|NCT01004003|454324764|FG005|Overall Study|Refused to continue taking trial med.|0|||
126283472|NCT01004003|454324765|FG006|Overall Study|Refused to continue taking trial med.|0|||
126283473|NCT01004003|454324766|FG007|Overall Study|Refused to continue taking trial med.|0|||
126283474|NCT01004003|454324767|FG008|Overall Study|Refused to continue taking trial med.|2|||
126283475|NCT01004003|454324759|FG000|Overall Study|Other|0|||
126283476|NCT01004003|454324760|FG001|Overall Study|Other|0|||
126283477|NCT01004003|454324761|FG002|Overall Study|Other|0|||
126283478|NCT01004003|454324762|FG003|Overall Study|Other|0|||
126364871|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
126364872|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
126364873|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
126364874|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
126364875|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
126364876|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
126364877|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
126364878|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
126364879|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
126364880|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
126364881|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
126364882|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
126364883|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
126364884|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
126364885|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
126364886|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
126364887|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
126364888|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
126364889|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
126364890|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
126364891|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
126364892|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
126364893|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
126364894|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
126364895|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
126364896|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
126364897|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
126364898|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
126364899|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
126364900|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
126364901|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
126364902|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
126364903|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
126364904|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
126364905|NCT03131479|454630365|FG000|Overall Study|Adverse Event|0|||
126364906|NCT03131479|454630366|FG001|Overall Study|Adverse Event|0|||
126364907|NCT03131479|454630367|FG002|Overall Study|Adverse Event|1|||
126040627|NCT03519178|453447156|FG004|Long-term Follow-up|Ongoing|0|||
126040628|NCT03519178|453447157|FG005|Long-term Follow-up|Ongoing|0|||
126040629|NCT03519178|453447158|FG006|Long-term Follow-up|Ongoing|0|||
126040630|NCT03519178|453447159|FG007|Long-term Follow-up|Ongoing|0|||
126040631|NCT03519178|453447160|FG008|Long-term Follow-up|Ongoing|0|||
126040632|NCT03519178|453447161|FG009|Long-term Follow-up|Ongoing|0|||
126364908|NCT03131479|454630368|FG003|Overall Study|Adverse Event|1|||
126040633|NCT03519178|453447162|FG010|Long-term Follow-up|Ongoing|0|||
126283479|NCT01004003|454324763|FG004|Overall Study|Other|0|||
126283480|NCT01004003|454324764|FG005|Overall Study|Other|1|||
126283481|NCT01004003|454324765|FG006|Overall Study|Other|0|||
126283482|NCT01004003|454324766|FG007|Overall Study|Other|0|||
126283483|NCT01004003|454324767|FG008|Overall Study|Other|0|||
126283484|NCT01130597|454324768|FG000|Overall Study|Protocol-specified (High K+)|1|||
126283485|NCT01130597|454324768|FG000|Overall Study|Adverse Event|4|||
126283486|NCT01130597|454324768|FG000|Overall Study|Death|1|||
126283487|NCT01130597|454324768|FG000|Overall Study|Protocol Violation|1|||
126283488|NCT05819203|454324776|FG000|Overall Study|Protocol Violation|1|||
126283489|NCT05819203|454324777|FG001|Overall Study|Protocol Violation|2|||
126283490|NCT05819203|454324776|FG000|Overall Study|Withdrawal by Subject|1|||
126283491|NCT05819203|454324777|FG001|Overall Study|Withdrawal by Subject|0|||
126283492|NCT02185053|454324778|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
126283493|NCT02185053|454324779|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
126283494|NCT02185053|454324780|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
126283495|NCT02185053|454324778|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
126283496|NCT02185053|454324779|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
126283497|NCT02185053|454324780|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
126283498|NCT02185053|454324778|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
126283499|NCT02185053|454324779|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
126283500|NCT02185053|454324780|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
126283501|NCT02185053|454324778|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
126283502|NCT02185053|454324779|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
126283503|NCT02185053|454324780|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
126283504|NCT02185053|454324778|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
126283505|NCT02185053|454324779|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
126283506|NCT02185053|454324780|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
126283507|NCT02185053|454324778|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
126283508|NCT02185053|454324779|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
126283509|NCT02185053|454324780|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
126283510|NCT02185053|454324778|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
126283511|NCT02185053|454324779|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
126283512|NCT02185053|454324780|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
126283513|NCT02185053|454324778|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
126283514|NCT02185053|454324779|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
126283515|NCT02185053|454324780|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
126283516|NCT00143247|454324782|FG000|Overall Study|Death|8|||
126283517|NCT00143247|454324782|FG000|Overall Study|Adverse Event|19|||
126283518|NCT00143247|454324782|FG000|Overall Study|Lack of Efficacy|3|||
126283519|NCT00143247|454324782|FG000|Overall Study|Withdrawal by Subject|55|||
126283520|NCT00143247|454324782|FG000|Overall Study|Study terminated by sponsor|31|||
126283521|NCT00143247|454324782|FG000|Overall Study|Protocol Violation|15|||
126283522|NCT00143247|454324782|FG000|Overall Study|Lost to Follow-up|12|||
126364909|NCT03131479|454630369|FG004|Overall Study|Adverse Event|0|||
126283523|NCT00143247|454324782|FG000|Overall Study|following inaccurate lab adverse event|1|||
126283524|NCT00143247|454324782|FG000|Overall Study|Other|12|||
126283525|NCT02126826|454326412|FG000|Overall Study|Withdrawal by Subject|0|||
126283526|NCT02126826|454326413|FG001|Overall Study|Withdrawal by Subject|0|||
126283527|NCT02126826|454326414|FG002|Overall Study|Withdrawal by Subject|0|||
126283528|NCT02126826|454326415|FG003|Overall Study|Withdrawal by Subject|1|||
126283529|NCT02126826|454326416|FG004|Overall Study|Withdrawal by Subject|0|||
126283530|NCT02126826|454326417|FG005|Overall Study|Withdrawal by Subject|0|||
126283531|NCT02126826|454326418|FG006|Overall Study|Withdrawal by Subject|0|||
126283532|NCT01762800|454326425|FG000|Overall Study|Adverse Event|8|||
126283533|NCT01762800|454326426|FG001|Overall Study|Adverse Event|13|||
126283534|NCT01762800|454326425|FG000|Overall Study|Lack of Efficacy|3|||
126283535|NCT01762800|454326426|FG001|Overall Study|Lack of Efficacy|2|||
126283536|NCT01762800|454326425|FG000|Overall Study|Study Closed/Terminated|0|||
126283537|NCT01762800|454326426|FG001|Overall Study|Study Closed/Terminated|1|||
126283538|NCT01762800|454326425|FG000|Overall Study|Physician Decision|1|||
126283539|NCT01762800|454326426|FG001|Overall Study|Physician Decision|1|||
126283540|NCT01762800|454326425|FG000|Overall Study|Withdrawal by Subject|7|||
126283541|NCT01762800|454326426|FG001|Overall Study|Withdrawal by Subject|4|||
126283542|NCT02111603|454326430|FG000|Overall Study|Withdrawal by Subject|1|||
126283543|NCT03106987|454326431|FG000|Overall Study|Death|37|||
126283544|NCT03106987|454326432|FG001|Overall Study|Death|22|||
126283545|NCT03106987|454326433|FG002|Overall Study|Death|12|||
126283546|NCT03106987|454326434|FG003|Overall Study|Death|8|||
126283547|NCT03106987|454326431|FG000|Overall Study|Lost to Follow-up|2|||
126283548|NCT03106987|454326432|FG001|Overall Study|Lost to Follow-up|0|||
126283549|NCT03106987|454326433|FG002|Overall Study|Lost to Follow-up|2|||
126283550|NCT03106987|454326434|FG003|Overall Study|Lost to Follow-up|2|||
126283551|NCT03106987|454326431|FG000|Overall Study|Withdrawal by Subject|5|||
126283552|NCT03106987|454326432|FG001|Overall Study|Withdrawal by Subject|1|||
126283553|NCT03106987|454326433|FG002|Overall Study|Withdrawal by Subject|4|||
126283554|NCT03106987|454326434|FG003|Overall Study|Withdrawal by Subject|1|||
126283555|NCT02114385|454326436|FG000|Overall Study|Withdrawal by Subject|3|||
126283556|NCT02114385|454326437|FG001|Overall Study|Withdrawal by Subject|2|||
126283557|NCT02114385|454326436|FG000|Overall Study|Lost to Follow-up|0|||
126283558|NCT02114385|454326437|FG001|Overall Study|Lost to Follow-up|6|||
126283559|NCT01753297|454326439|FG000|Overall Study|Lost to Follow-up|7|||
126283560|NCT01753297|454326440|FG001|Overall Study|Lost to Follow-up|2|||
126283561|NCT01753297|454326439|FG000|Overall Study|Withdrawal by Subject|26|||
126283562|NCT01753297|454326440|FG001|Overall Study|Withdrawal by Subject|23|||
126283563|NCT01753297|454326439|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
125882352|NCT02113982|452868956|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882353|NCT02113982|452868957|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882354|NCT02113982|452868958|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882355|NCT02113982|452868959|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125882356|NCT02113982|452868960|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
125882357|NCT02113982|452868961|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
125882358|NCT02113982|452868948|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882359|NCT02113982|452868949|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882360|NCT02113982|452868950|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882361|NCT02113982|452868951|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882362|NCT02113982|452868952|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882363|NCT02113982|452868953|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882364|NCT02113982|452868954|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882365|NCT02113982|452868955|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882366|NCT02113982|452868956|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882367|NCT02113982|452868957|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882368|NCT02113982|452868958|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882369|NCT02113982|452868959|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125882370|NCT02113982|452868960|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
125882371|NCT02113982|452868961|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
125882372|NCT02113982|452868948|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882373|NCT02113982|452868949|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882374|NCT02113982|452868950|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882375|NCT02113982|452868951|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882376|NCT02113982|452868952|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882377|NCT02113982|452868953|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882378|NCT02113982|452868954|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882379|NCT02113982|452868955|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882380|NCT02113982|452868956|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882381|NCT02113982|452868957|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882382|NCT02113982|452868958|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882383|NCT02113982|452868959|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882384|NCT02113982|452868960|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
125882385|NCT02113982|452868961|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125882386|NCT02113982|452868948|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882387|NCT02113982|452868949|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882388|NCT02113982|452868950|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882389|NCT02113982|452868951|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882390|NCT02113982|452868952|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882391|NCT02113982|452868953|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882392|NCT02113982|452868954|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882393|NCT02113982|452868955|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882394|NCT02113982|452868956|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126040634|NCT03519178|453447163|FG011|Long-term Follow-up|Ongoing|0|||
126283564|NCT01753297|454326440|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
126283565|NCT01753297|454326439|FG000|Overall Study|Death|0|||
126283566|NCT01753297|454326440|FG001|Overall Study|Death|2|||
126283567|NCT01753297|454326439|FG000|Overall Study|Did not attend end of study visit|7|||
126283568|NCT01753297|454326440|FG001|Overall Study|Did not attend end of study visit|8|||
126283569|NCT01174043|454326443|FG000|Overall Study|Disease progression|5|||
126283570|NCT01174043|454326443|FG000|Overall Study|Adverse Event|3|||
126283571|NCT01174043|454326443|FG000|Overall Study|Death|1|||
126283572|NCT01174043|454326443|FG000|Overall Study|Withdrawal by Subject|2|||
126283573|NCT01645787|454326449|FG000|Washout (2 Weeks)|Adverse Event|1|||
126283574|NCT01645787|454326450|FG001|Washout (2 Weeks)|Adverse Event|0|||
126283575|NCT01371539|454326451|FG000|Period One: One Week|Lost to Follow-up|0|||
126283576|NCT01371539|454326452|FG001|Period One: One Week|Lost to Follow-up|1|||
126283577|NCT01371539|454326451|FG000|Period Two: One Week|Lost to Follow-up|0|||
126283578|NCT01371539|454326452|FG001|Period Two: One Week|Lost to Follow-up|1|||
126283579|NCT01371539|454326451|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
126283580|NCT01371539|454326452|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
126283581|NCT01371539|454326451|FG000|Period Two: One Week|Time/job conflict|0|||
126283582|NCT01371539|454326452|FG001|Period Two: One Week|Time/job conflict|1|||
126283583|NCT01524978|454326469|FG000|Overall Study|Other|16|||
126283584|NCT01524978|454326470|FG001|Overall Study|Other|2|||
126283585|NCT01524978|454326471|FG002|Overall Study|Other|1|||
126283586|NCT01524978|454326472|FG003|Overall Study|Other|2|||
126283587|NCT01524978|454326473|FG004|Overall Study|Other|1|||
126283588|NCT01524978|454326474|FG005|Overall Study|Other|3|||
126283589|NCT01524978|454326475|FG006|Overall Study|Other|17|||
126283590|NCT01524978|454326476|FG007|Overall Study|Other|1|||
126283591|NCT01524978|454326477|FG008|Overall Study|Other|2|||
126283592|NCT01524978|454326478|FG009|Overall Study|Other|2|||
126283593|NCT01524978|454326479|FG010|Overall Study|Other|5|||
126283594|NCT01524978|454326469|FG000|Overall Study|Withdrawal by Subject|12|||
126283595|NCT01524978|454326470|FG001|Overall Study|Withdrawal by Subject|0|||
126283596|NCT01524978|454326471|FG002|Overall Study|Withdrawal by Subject|1|||
126283597|NCT01524978|454326472|FG003|Overall Study|Withdrawal by Subject|1|||
126283598|NCT01524978|454326473|FG004|Overall Study|Withdrawal by Subject|3|||
126283599|NCT01524978|454326474|FG005|Overall Study|Withdrawal by Subject|1|||
126283600|NCT01524978|454326475|FG006|Overall Study|Withdrawal by Subject|6|||
126283601|NCT01524978|454326476|FG007|Overall Study|Withdrawal by Subject|2|||
126283602|NCT01524978|454326477|FG008|Overall Study|Withdrawal by Subject|4|||
126283603|NCT01524978|454326478|FG009|Overall Study|Withdrawal by Subject|0|||
126283604|NCT01524978|454326479|FG010|Overall Study|Withdrawal by Subject|5|||
126283605|NCT01524978|454326469|FG000|Overall Study|Lost to Follow-up|0|||
126283606|NCT01524978|454326470|FG001|Overall Study|Lost to Follow-up|0|||
126283607|NCT01524978|454326471|FG002|Overall Study|Lost to Follow-up|3|||
126283608|NCT01524978|454326472|FG003|Overall Study|Lost to Follow-up|0|||
126283609|NCT01524978|454326473|FG004|Overall Study|Lost to Follow-up|1|||
126283610|NCT01524978|454326474|FG005|Overall Study|Lost to Follow-up|1|||
126283611|NCT01524978|454326475|FG006|Overall Study|Lost to Follow-up|2|||
126283612|NCT01524978|454326476|FG007|Overall Study|Lost to Follow-up|0|||
126283613|NCT01524978|454326477|FG008|Overall Study|Lost to Follow-up|1|||
126283614|NCT01524978|454326478|FG009|Overall Study|Lost to Follow-up|1|||
126283615|NCT01524978|454326479|FG010|Overall Study|Lost to Follow-up|1|||
126283616|NCT01524978|454326469|FG000|Overall Study|Death|34|||
126283617|NCT01524978|454326470|FG001|Overall Study|Death|2|||
126283618|NCT01524978|454326471|FG002|Overall Study|Death|5|||
126283619|NCT01524978|454326472|FG003|Overall Study|Death|24|||
126283620|NCT01524978|454326473|FG004|Overall Study|Death|4|||
126283621|NCT01524978|454326474|FG005|Overall Study|Death|4|||
126283622|NCT01524978|454326475|FG006|Overall Study|Death|1|||
126283623|NCT01524978|454326476|FG007|Overall Study|Death|9|||
126283624|NCT01524978|454326477|FG008|Overall Study|Death|5|||
126283625|NCT01524978|454326478|FG009|Overall Study|Death|6|||
126040635|NCT03519178|453447164|FG012|Long-term Follow-up|Ongoing|0|||
126283626|NCT01524978|454326479|FG010|Overall Study|Death|17|||
126283627|NCT02165735|454326482|FG000|Overall Study|Lost to Follow-up|12|||
126283628|NCT02165735|454326483|FG001|Overall Study|Lost to Follow-up|10|||
126283629|NCT02165735|454326482|FG000|Overall Study|Withdrawal by Subject|3|||
126283630|NCT02165735|454326483|FG001|Overall Study|Withdrawal by Subject|0|||
126283631|NCT02165735|454326482|FG000|Overall Study|Participant indicated lack of time|1|||
126283632|NCT02165735|454326483|FG001|Overall Study|Participant indicated lack of time|3|||
126283633|NCT02165735|454326482|FG000|Overall Study|Protocol Violation|0|||
126283634|NCT02165735|454326483|FG001|Overall Study|Protocol Violation|1|||
126283635|NCT03066258|454326484|FG000|Overall Study|Death|1|||
126283636|NCT03066258|454326485|FG001|Overall Study|Death|0|||
126283637|NCT03066258|454326486|FG002|Overall Study|Death|0|||
126283638|NCT03066258|454326487|FG003|Overall Study|Death|0|||
126283639|NCT03066258|454326488|FG004|Overall Study|Death|1|||
126283640|NCT02784795|454326489|FG000|Overall Study|Progressive Disease|2|||
126283641|NCT02784795|454326490|FG001|Overall Study|Progressive Disease|1|||
126283642|NCT02784795|454326491|FG002|Overall Study|Progressive Disease|1|||
126283643|NCT02784795|454326492|FG003|Overall Study|Progressive Disease|0|||
126283644|NCT02784795|454326493|FG004|Overall Study|Progressive Disease|2|||
126283645|NCT02784795|454326494|FG005|Overall Study|Progressive Disease|0|||
126283646|NCT02784795|454326495|FG006|Overall Study|Progressive Disease|2|||
126283647|NCT02784795|454326496|FG007|Overall Study|Progressive Disease|0|||
126283648|NCT02784795|454326497|FG008|Overall Study|Progressive Disease|0|||
126283649|NCT02784795|454326498|FG009|Overall Study|Progressive Disease|0|||
126283650|NCT02784795|454326499|FG010|Overall Study|Progressive Disease|1|||
126283651|NCT02784795|454326500|FG011|Overall Study|Progressive Disease|0|||
126283652|NCT02784795|454326489|FG000|Overall Study|Adverse Event|1|||
126283653|NCT02784795|454326490|FG001|Overall Study|Adverse Event|0|||
126283654|NCT02784795|454326491|FG002|Overall Study|Adverse Event|0|||
126283655|NCT02784795|454326492|FG003|Overall Study|Adverse Event|1|||
126283656|NCT02784795|454326493|FG004|Overall Study|Adverse Event|0|||
126283657|NCT02784795|454326494|FG005|Overall Study|Adverse Event|0|||
126283658|NCT02784795|454326495|FG006|Overall Study|Adverse Event|1|||
126283659|NCT02784795|454326496|FG007|Overall Study|Adverse Event|0|||
126283660|NCT02784795|454326497|FG008|Overall Study|Adverse Event|0|||
126283661|NCT02784795|454326498|FG009|Overall Study|Adverse Event|0|||
126283662|NCT02784795|454326499|FG010|Overall Study|Adverse Event|0|||
126283663|NCT02784795|454326500|FG011|Overall Study|Adverse Event|2|||
126283664|NCT02784795|454326489|FG000|Overall Study|Withdrawal by Subject|1|||
126283665|NCT02784795|454326490|FG001|Overall Study|Withdrawal by Subject|0|||
126283666|NCT02784795|454326491|FG002|Overall Study|Withdrawal by Subject|2|||
126283667|NCT02784795|454326492|FG003|Overall Study|Withdrawal by Subject|1|||
126283668|NCT02784795|454326493|FG004|Overall Study|Withdrawal by Subject|3|||
126283669|NCT02784795|454326494|FG005|Overall Study|Withdrawal by Subject|0|||
126283670|NCT02784795|454326495|FG006|Overall Study|Withdrawal by Subject|0|||
126283671|NCT02784795|454326496|FG007|Overall Study|Withdrawal by Subject|1|||
126283672|NCT02784795|454326497|FG008|Overall Study|Withdrawal by Subject|0|||
126283673|NCT02784795|454326498|FG009|Overall Study|Withdrawal by Subject|0|||
126283674|NCT02784795|454326499|FG010|Overall Study|Withdrawal by Subject|0|||
126283675|NCT02784795|454326500|FG011|Overall Study|Withdrawal by Subject|2|||
126283676|NCT02784795|454326489|FG000|Overall Study|Death|0|||
126283677|NCT02784795|454326490|FG001|Overall Study|Death|0|||
126283678|NCT02784795|454326491|FG002|Overall Study|Death|0|||
126283679|NCT02784795|454326492|FG003|Overall Study|Death|0|||
126283680|NCT02784795|454326493|FG004|Overall Study|Death|1|||
126283681|NCT02784795|454326494|FG005|Overall Study|Death|0|||
126283682|NCT02784795|454326495|FG006|Overall Study|Death|0|||
126283683|NCT02784795|454326496|FG007|Overall Study|Death|0|||
126283684|NCT02784795|454326497|FG008|Overall Study|Death|0|||
126283685|NCT02784795|454326498|FG009|Overall Study|Death|0|||
126283686|NCT02784795|454326499|FG010|Overall Study|Death|0|||
126283687|NCT02784795|454326500|FG011|Overall Study|Death|0|||
126283688|NCT02784795|454326489|FG000|Overall Study|Physician Decision|0|||
126283689|NCT02784795|454326490|FG001|Overall Study|Physician Decision|0|||
126283690|NCT02784795|454326491|FG002|Overall Study|Physician Decision|0|||
126283691|NCT02784795|454326492|FG003|Overall Study|Physician Decision|0|||
126283692|NCT02784795|454326493|FG004|Overall Study|Physician Decision|0|||
126283693|NCT02784795|454326494|FG005|Overall Study|Physician Decision|0|||
126283694|NCT02784795|454326495|FG006|Overall Study|Physician Decision|1|||
126283695|NCT02784795|454326496|FG007|Overall Study|Physician Decision|0|||
126283696|NCT02784795|454326497|FG008|Overall Study|Physician Decision|0|||
126283697|NCT02784795|454326498|FG009|Overall Study|Physician Decision|0|||
126283698|NCT02784795|454326499|FG010|Overall Study|Physician Decision|0|||
126283699|NCT02784795|454326500|FG011|Overall Study|Physician Decision|0|||
126283700|NCT00185588|454326503|FG000|Overall Study|Adverse Event|3|||
126283701|NCT00185588|454326504|FG001|Overall Study|Adverse Event|1|||
126283702|NCT00185588|454326505|FG002|Overall Study|Adverse Event|4|||
126283703|NCT00185588|454326506|FG003|Overall Study|Adverse Event|2|||
126283704|NCT00185588|454326503|FG000|Overall Study|Lost to Follow-up|0|||
126283705|NCT00185588|454326504|FG001|Overall Study|Lost to Follow-up|0|||
126283706|NCT00185588|454326505|FG002|Overall Study|Lost to Follow-up|1|||
126283707|NCT00185588|454326506|FG003|Overall Study|Lost to Follow-up|2|||
126283708|NCT00185588|454326503|FG000|Overall Study|Withdrawal by Subject|0|||
126283709|NCT00185588|454326504|FG001|Overall Study|Withdrawal by Subject|1|||
126283710|NCT00185588|454326505|FG002|Overall Study|Withdrawal by Subject|0|||
126283711|NCT00185588|454326506|FG003|Overall Study|Withdrawal by Subject|0|||
126283712|NCT00185588|454326503|FG000|Overall Study|Physician Decision|0|||
126283713|NCT00185588|454326504|FG001|Overall Study|Physician Decision|0|||
125882395|NCT02113982|452868957|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882396|NCT02113982|452868958|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882397|NCT02113982|452868959|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882398|NCT02113982|452868960|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
125882399|NCT02113982|452868961|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125882400|NCT02113982|452868948|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882401|NCT02113982|452868949|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882402|NCT02113982|452868950|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882403|NCT02113982|452868951|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882404|NCT02113982|452868952|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882405|NCT02113982|452868953|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882406|NCT02113982|452868954|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882407|NCT02113982|452868955|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882408|NCT02113982|452868956|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882409|NCT02113982|452868957|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882410|NCT02113982|452868958|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882411|NCT02113982|452868959|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125882412|NCT02113982|452868960|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
125882413|NCT02113982|452868961|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126283714|NCT00185588|454326505|FG002|Overall Study|Physician Decision|1|||
126283715|NCT00185588|454326506|FG003|Overall Study|Physician Decision|0|||
125882414|NCT01774721|452868962|FG000|Overall Study|Death|133|||
125882415|NCT01774721|452868963|FG001|Overall Study|Death|152|||
125882416|NCT01774721|452868962|FG000|Overall Study|Withdrawal by Subject|20|||
125882417|NCT01774721|452868963|FG001|Overall Study|Withdrawal by Subject|14|||
125882418|NCT01774721|452868962|FG000|Overall Study|Lost to Follow-up|6|||
125882419|NCT01774721|452868963|FG001|Overall Study|Lost to Follow-up|7|||
125882420|NCT01774721|452868962|FG000|Overall Study|Did not meet eligibility criteria|0|||
125882421|NCT01774721|452868963|FG001|Overall Study|Did not meet eligibility criteria|3|||
125882422|NCT01774721|452868962|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
125882423|NCT01774721|452868963|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
125882424|NCT01774721|452868962|FG000|Overall Study|Study terminated by sponsor|5|||
125882425|NCT01774721|452868963|FG001|Overall Study|Study terminated by sponsor|0|||
125882426|NCT01774721|452868962|FG000|Overall Study|Disease progression|5|||
125882427|NCT01774721|452868963|FG001|Overall Study|Disease progression|0|||
125882428|NCT01907854|452868964|FG000|Overall Study|Protocol Violation|1|||
125882429|NCT01907854|452868965|FG001|Overall Study|Protocol Violation|1|||
125882430|NCT01907854|452868964|FG000|Overall Study|Withdrawal by Subject|9|||
125882431|NCT01907854|452868965|FG001|Overall Study|Withdrawal by Subject|7|||
125882432|NCT01907854|452868964|FG000|Overall Study|Lost to Follow-up|2|||
125882433|NCT01907854|452868965|FG001|Overall Study|Lost to Follow-up|2|||
125882434|NCT01907854|452868964|FG000|Overall Study|Unclassified|4|||
125882435|NCT01907854|452868965|FG001|Overall Study|Unclassified|3|||
125882436|NCT03774576|452868968|FG000|Period 2|Adverse Event|1|||
125882437|NCT02351817|452868969|FG000|Period 1|Adverse Event|1|||
125882438|NCT02351817|452868970|FG001|Period 1|Adverse Event|2|||
125882439|NCT02351817|452868969|FG000|Period 1|Lack of Efficacy|0|||
125882440|NCT02351817|452868970|FG001|Period 1|Lack of Efficacy|1|||
125882441|NCT02351817|452868969|FG000|Period 2|Adverse Event|0|||
125882442|NCT02351817|452868970|FG001|Period 2|Adverse Event|2|||
125882443|NCT02351817|452868969|FG000|Period 2|Protocol Violation|1|||
125882444|NCT02351817|452868970|FG001|Period 2|Protocol Violation|0|||
125882445|NCT02488915|452868973|FG000|Overall Study|Death|21|||
125882446|NCT02488915|452868973|FG000|Overall Study|Lost to Follow-up|4|||
125882447|NCT02488915|452868973|FG000|Overall Study|Withdrawal by Subject|1|||
125882448|NCT00684021|452868976|FG000|Overall Study|MRI Contraindicated|1|||
126283716|NCT02604407|454326507|FG000|Overall Study|Adverse Event|0|||
126283717|NCT02604407|454326508|FG001|Overall Study|Adverse Event|7|||
126283718|NCT02604407|454326509|FG002|Overall Study|Adverse Event|5|||
126283719|NCT02604407|454326507|FG000|Overall Study|Protocol Violation|2|||
125882449|NCT00684021|452868977|FG001|Overall Study|MRI Contraindicated|1|||
125882450|NCT00684021|452868978|FG002|Overall Study|MRI Contraindicated|1|||
125882451|NCT00684021|452868979|FG003|Overall Study|MRI Contraindicated|0|||
125882452|NCT00684021|452868976|FG000|Overall Study|MRI not performed|0|||
125882453|NCT00684021|452868977|FG001|Overall Study|MRI not performed|1|||
126283720|NCT02604407|454326508|FG001|Overall Study|Protocol Violation|0|||
126283721|NCT02604407|454326509|FG002|Overall Study|Protocol Violation|0|||
126283722|NCT02604407|454326507|FG000|Overall Study|Withdrawal by Subject|3|||
125882454|NCT00684021|452868978|FG002|Overall Study|MRI not performed|1|||
125882455|NCT00684021|452868979|FG003|Overall Study|MRI not performed|2|||
126283723|NCT02604407|454326508|FG001|Overall Study|Withdrawal by Subject|3|||
126283724|NCT02604407|454326509|FG002|Overall Study|Withdrawal by Subject|5|||
126283725|NCT02604407|454326507|FG000|Overall Study|Lost to Follow-up|2|||
126283726|NCT02604407|454326508|FG001|Overall Study|Lost to Follow-up|1|||
126283727|NCT02604407|454326509|FG002|Overall Study|Lost to Follow-up|2|||
126283728|NCT02604407|454326507|FG000|Overall Study|Lack of Efficacy|1|||
126283729|NCT02604407|454326508|FG001|Overall Study|Lack of Efficacy|0|||
126283730|NCT02604407|454326509|FG002|Overall Study|Lack of Efficacy|0|||
126283731|NCT02604407|454326507|FG000|Overall Study|Other|3|||
126283732|NCT02604407|454326508|FG001|Overall Study|Other|1|||
126283733|NCT02604407|454326509|FG002|Overall Study|Other|4|||
126283734|NCT00652340|454326512|FG000|Overall Study|Had not progressed.|4|||
126283735|NCT00652340|454326513|FG001|Overall Study|Had not progressed.|3|||
126283736|NCT03682107|454326514|FG000|Overall Study|Withdrawal by Subject|0|||
126283737|NCT03682107|454326515|FG001|Overall Study|Withdrawal by Subject|1|||
126283738|NCT03682107|454326516|FG002|Overall Study|Withdrawal by Subject|0|||
126283739|NCT03682107|454326517|FG003|Overall Study|Withdrawal by Subject|0|||
126283740|NCT03682107|454326518|FG004|Overall Study|Withdrawal by Subject|0|||
126283741|NCT00214383|454326519|FG000|Overall Study|Lost to Follow-up|16|||
126283742|NCT00214383|454326520|FG001|Overall Study|Lost to Follow-up|26|||
126283743|NCT03607487|454326521|FG000|Overall Study|Withdrawal by Subject|2|||
126283744|NCT03607487|454326522|FG001|Overall Study|Withdrawal by Subject|0|||
126283745|NCT03607487|454326523|FG002|Overall Study|Withdrawal by Subject|0|||
126283746|NCT03607487|454326524|FG003|Overall Study|Withdrawal by Subject|1|||
126283747|NCT02125877|454326527|FG000|Overall Study|Physician Decision|1|||
126283748|NCT02125877|454326528|FG001|Overall Study|Physician Decision|0|||
126283749|NCT02125877|454326527|FG000|Overall Study|Death|0|||
126283750|NCT02125877|454326528|FG001|Overall Study|Death|1|||
126283751|NCT02125877|454326527|FG000|Overall Study|Administrative problems|0|||
126283752|NCT02125877|454326528|FG001|Overall Study|Administrative problems|1|||
126283753|NCT02125877|454326527|FG000|Overall Study|Participant/guardian decision|0|||
126283754|NCT02125877|454326528|FG001|Overall Study|Participant/guardian decision|2|||
126283755|NCT02125877|454326527|FG000|Overall Study|Withdrawal by Subject|2|||
126283756|NCT02125877|454326528|FG001|Overall Study|Withdrawal by Subject|1|||
126283757|NCT02125877|454326527|FG000|Overall Study|Protocol deviation|4|||
126283758|NCT02125877|454326528|FG001|Overall Study|Protocol deviation|1|||
126283759|NCT02125877|454326527|FG000|Overall Study|Adverse Event|6|||
126283760|NCT02125877|454326528|FG001|Overall Study|Adverse Event|4|||
126283761|NCT02655666|454326532|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
126283762|NCT01267994|454326533|FG000|Overall Study|Adverse Event|2|||
126283763|NCT05199090|454326537|FG000|Overall Study|Adverse Event|1|||
126283764|NCT05199090|454326538|FG001|Overall Study|Adverse Event|4|||
126283765|NCT05199090|454326539|FG002|Overall Study|Adverse Event|0|||
126283766|NCT05199090|454326540|FG003|Overall Study|Adverse Event|0|||
126283767|NCT05199090|454326541|FG004|Overall Study|Adverse Event|0|||
126283768|NCT05199090|454326542|FG005|Overall Study|Adverse Event|0|||
126283769|NCT05199090|454326537|FG000|Overall Study|Lost to Follow-up|1|||
126283770|NCT05199090|454326538|FG001|Overall Study|Lost to Follow-up|0|||
126283771|NCT05199090|454326539|FG002|Overall Study|Lost to Follow-up|1|||
126283772|NCT05199090|454326540|FG003|Overall Study|Lost to Follow-up|4|||
126283773|NCT05199090|454326541|FG004|Overall Study|Lost to Follow-up|0|||
126283774|NCT05199090|454326542|FG005|Overall Study|Lost to Follow-up|5|||
126283775|NCT05199090|454326537|FG000|Overall Study|Physician Decision|0|||
126283776|NCT05199090|454326538|FG001|Overall Study|Physician Decision|0|||
126283777|NCT05199090|454326539|FG002|Overall Study|Physician Decision|0|||
126283778|NCT05199090|454326540|FG003|Overall Study|Physician Decision|0|||
126283779|NCT05199090|454326541|FG004|Overall Study|Physician Decision|0|||
126040636|NCT03519178|453447165|FG013|Long-term Follow-up|Ongoing|1|||
126040637|NCT03519178|453447166|FG014|Long-term Follow-up|Ongoing|0|||
126040638|NCT02240238|453447167|FG000|Phase 1|Adverse Event|0|||
126040639|NCT02240238|453447168|FG001|Phase 1|Adverse Event|0|||
126040640|NCT02240238|453447169|FG002|Phase 1|Adverse Event|0|||
126040641|NCT02240238|453447170|FG003|Phase 1|Adverse Event|0|||
126040642|NCT02240238|453447171|FG004|Phase 1|Adverse Event|0|||
126040643|NCT02240238|453447172|FG005|Phase 1|Adverse Event|0|||
126040644|NCT02240238|453447173|FG006|Phase 1|Adverse Event|3|||
126040645|NCT02240238|453447174|FG007|Phase 1|Adverse Event|1|||
126040646|NCT02240238|453447175|FG008|Phase 1|Adverse Event|0|||
126040647|NCT02240238|453447176|FG009|Phase 1|Adverse Event|0|||
126040648|NCT02240238|453447177|FG010|Phase 1|Adverse Event|0|||
126040649|NCT02240238|453447178|FG011|Phase 1|Adverse Event|0|||
126040650|NCT02240238|453447167|FG000|Phase 1|Death|0|||
126040651|NCT02240238|453447168|FG001|Phase 1|Death|0|||
126040652|NCT02240238|453447169|FG002|Phase 1|Death|0|||
126040653|NCT02240238|453447170|FG003|Phase 1|Death|0|||
125882456|NCT00684021|452868976|FG000|Overall Study|Death|1|||
125882457|NCT00684021|452868977|FG001|Overall Study|Death|0|||
125882458|NCT00684021|452868978|FG002|Overall Study|Death|0|||
125882459|NCT00684021|452868979|FG003|Overall Study|Death|0|||
125882460|NCT00927953|452868980|FG000|Overall Study|Death|2|||
125882461|NCT00927953|452868981|FG001|Overall Study|Death|1|||
125882462|NCT02976038|452868982|FG000|Overall Study|Physician Decision|22|||
125882463|NCT02976038|452868982|FG000|Overall Study|Withdrawal by Subject|3|||
125882464|NCT02976038|452868982|FG000|Overall Study|Lost to Follow-up|2|||
125882465|NCT02976038|452868982|FG000|Overall Study|Adverse Event|1|||
125882466|NCT01046396|452868983|FG000|Overall Study|Withdrawal by Subject|5|||
125882467|NCT01208207|452868984|FG000|Part I|Adverse Event|19|||
125882468|NCT01208207|452868985|FG001|Part I|Adverse Event|2|||
125882469|NCT01208207|452868986|FG002|Part I|Adverse Event|6|||
125882470|NCT01208207|452868987|FG003|Part I|Adverse Event|0|||
125882471|NCT01208207|452868988|FG004|Part I|Adverse Event|0|||
125882472|NCT01208207|452868989|FG005|Part I|Adverse Event|0|||
125882473|NCT01208207|452868990|FG006|Part I|Adverse Event|0|||
125882474|NCT01208207|452868984|FG000|Part I|Lack of Efficacy|21|||
125882475|NCT01208207|452868985|FG001|Part I|Lack of Efficacy|3|||
126040654|NCT02240238|453447171|FG004|Phase 1|Death|0|||
126040655|NCT02240238|453447172|FG005|Phase 1|Death|1|||
126040656|NCT02240238|453447173|FG006|Phase 1|Death|0|||
126040657|NCT02240238|453447174|FG007|Phase 1|Death|0|||
126040658|NCT02240238|453447175|FG008|Phase 1|Death|0|||
126040659|NCT02240238|453447176|FG009|Phase 1|Death|0|||
126040660|NCT02240238|453447177|FG010|Phase 1|Death|0|||
126040661|NCT02240238|453447178|FG011|Phase 1|Death|0|||
126283780|NCT05199090|454326542|FG005|Overall Study|Physician Decision|1|||
125882476|NCT01208207|452868986|FG002|Part I|Lack of Efficacy|2|||
125882477|NCT01208207|452868987|FG003|Part I|Lack of Efficacy|0|||
126040662|NCT02240238|453447167|FG000|Phase 1|Sponsor termination|0|||
126040663|NCT02240238|453447168|FG001|Phase 1|Sponsor termination|0|||
126040664|NCT02240238|453447169|FG002|Phase 1|Sponsor termination|0|||
126040665|NCT02240238|453447170|FG003|Phase 1|Sponsor termination|0|||
126283781|NCT05199090|454326537|FG000|Overall Study|Study terminated by sponsor|0|||
126283782|NCT05199090|454326538|FG001|Overall Study|Study terminated by sponsor|6|||
126283783|NCT05199090|454326539|FG002|Overall Study|Study terminated by sponsor|0|||
126283784|NCT05199090|454326540|FG003|Overall Study|Study terminated by sponsor|0|||
126283785|NCT05199090|454326541|FG004|Overall Study|Study terminated by sponsor|0|||
126283786|NCT05199090|454326542|FG005|Overall Study|Study terminated by sponsor|5|||
126283787|NCT05199090|454326537|FG000|Overall Study|Subject decision|0|||
126283788|NCT05199090|454326538|FG001|Overall Study|Subject decision|4|||
126283789|NCT05199090|454326539|FG002|Overall Study|Subject decision|0|||
126283790|NCT05199090|454326540|FG003|Overall Study|Subject decision|2|||
126283791|NCT05199090|454326541|FG004|Overall Study|Subject decision|5|||
126283792|NCT05199090|454326542|FG005|Overall Study|Subject decision|2|||
126283793|NCT04759768|454326543|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
126283794|NCT04759768|454326544|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
126283795|NCT04759768|454326543|FG000|Washout (7 Days)|Physician Decision|0|||
126283796|NCT04759768|454326544|FG001|Washout (7 Days)|Physician Decision|1|||
126283797|NCT04873934|454326547|FG000|Overall Study|Adverse Event|0|||
126283798|NCT04873934|454326548|FG001|Overall Study|Adverse Event|1|||
126283799|NCT04873934|454326547|FG000|Overall Study|Death|0|||
126283800|NCT04873934|454326548|FG001|Overall Study|Death|2|||
126283801|NCT04873934|454326547|FG000|Overall Study|Lost to Follow-up|13|||
126283802|NCT04873934|454326548|FG001|Overall Study|Lost to Follow-up|9|||
126283803|NCT04873934|454326547|FG000|Overall Study|Physician Decision|1|||
126283804|NCT04873934|454326548|FG001|Overall Study|Physician Decision|1|||
126364910|NCT03131479|454630365|FG000|Overall Study|Subject/Guardian Decision|0|||
126364911|NCT03131479|454630366|FG001|Overall Study|Subject/Guardian Decision|0|||
126364912|NCT03131479|454630367|FG002|Overall Study|Subject/Guardian Decision|0|||
125882478|NCT01208207|452868988|FG004|Part I|Lack of Efficacy|0|||
126098973|NCT02480153|453655579|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
126098974|NCT02480153|453655577|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
126098975|NCT02480153|453655578|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
126283805|NCT04873934|454326547|FG000|Overall Study|Protocol deviation|2|||
126283806|NCT04873934|454326548|FG001|Overall Study|Protocol deviation|1|||
126364913|NCT03131479|454630368|FG003|Overall Study|Subject/Guardian Decision|1|||
126364914|NCT03131479|454630369|FG004|Overall Study|Subject/Guardian Decision|0|||
126364915|NCT02899754|454630372|FG000|Overall Study|Lost to Follow-up|7|||
126364916|NCT02899754|454630373|FG001|Overall Study|Lost to Follow-up|9|||
126364917|NCT04818229|454630374|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
126364918|NCT04818229|454630375|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
126364919|NCT04818229|454630376|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
126283807|NCT04873934|454326547|FG000|Overall Study|Subject decision|1|||
126283808|NCT04873934|454326548|FG001|Overall Study|Subject decision|8|||
126283809|NCT04873934|454326547|FG000|Overall Study|Withdrew consent|0|||
126283810|NCT04873934|454326548|FG001|Overall Study|Withdrew consent|4|||
126283811|NCT04873934|454326547|FG000|Overall Study|Missing|1|||
126040666|NCT02240238|453447171|FG004|Phase 1|Sponsor termination|0|||
126040667|NCT02240238|453447172|FG005|Phase 1|Sponsor termination|1|||
126040668|NCT02240238|453447173|FG006|Phase 1|Sponsor termination|0|||
126040669|NCT02240238|453447174|FG007|Phase 1|Sponsor termination|0|||
126040670|NCT02240238|453447175|FG008|Phase 1|Sponsor termination|0|||
126040671|NCT02240238|453447176|FG009|Phase 1|Sponsor termination|0|||
126040672|NCT02240238|453447177|FG010|Phase 1|Sponsor termination|0|||
126283812|NCT04873934|454326548|FG001|Overall Study|Missing|0|||
126283813|NCT05794503|454326549|FG000|Overall Study|Operation Cancelled|2|||
126283814|NCT05794503|454326550|FG001|Overall Study|Operation Cancelled|0|||
126283815|NCT05794503|454326549|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
126283816|NCT05794503|454326550|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
126283817|NCT05794503|454326549|FG000|Overall Study|Protocol Violation|1|||
126040673|NCT02240238|453447178|FG011|Phase 1|Sponsor termination|0|||
126040674|NCT02240238|453447167|FG000|Phase 1|Withdrawal by Subject|0|||
126040675|NCT02240238|453447168|FG001|Phase 1|Withdrawal by Subject|0|||
126040676|NCT02240238|453447169|FG002|Phase 1|Withdrawal by Subject|0|||
126040677|NCT02240238|453447170|FG003|Phase 1|Withdrawal by Subject|0|||
126040678|NCT02240238|453447171|FG004|Phase 1|Withdrawal by Subject|0|||
126040679|NCT02240238|453447172|FG005|Phase 1|Withdrawal by Subject|2|||
126040680|NCT02240238|453447173|FG006|Phase 1|Withdrawal by Subject|0|||
126040681|NCT02240238|453447174|FG007|Phase 1|Withdrawal by Subject|0|||
126040682|NCT02240238|453447175|FG008|Phase 1|Withdrawal by Subject|0|||
126040683|NCT02240238|453447176|FG009|Phase 1|Withdrawal by Subject|0|||
126040684|NCT02240238|453447177|FG010|Phase 1|Withdrawal by Subject|0|||
126283818|NCT05794503|454326550|FG001|Overall Study|Protocol Violation|0|||
126283819|NCT03052127|454326551|FG000|Overall Study|Withdrawal by Subject|0|||
126283820|NCT03052127|454326552|FG001|Overall Study|Withdrawal by Subject|0|||
126283821|NCT03052127|454326553|FG002|Overall Study|Withdrawal by Subject|0|||
126283822|NCT03052127|454326554|FG003|Overall Study|Withdrawal by Subject|0|||
126283823|NCT03052127|454326555|FG004|Overall Study|Withdrawal by Subject|0|||
126283824|NCT03052127|454326556|FG005|Overall Study|Withdrawal by Subject|0|||
126283825|NCT03052127|454326557|FG006|Overall Study|Withdrawal by Subject|0|||
126283826|NCT03052127|454326558|FG007|Overall Study|Withdrawal by Subject|1|||
126040685|NCT02240238|453447178|FG011|Phase 1|Withdrawal by Subject|0|||
126040686|NCT02240238|453447167|FG000|Phase 1|Physician Decision|0|||
126040687|NCT02240238|453447168|FG001|Phase 1|Physician Decision|0|||
126283827|NCT03052127|454326559|FG008|Overall Study|Withdrawal by Subject|1|||
126283828|NCT03052127|454326560|FG009|Overall Study|Withdrawal by Subject|1|||
126283829|NCT03052127|454326561|FG010|Overall Study|Withdrawal by Subject|0|||
126283830|NCT03052127|454326562|FG011|Overall Study|Withdrawal by Subject|0|||
126283831|NCT03052127|454326551|FG000|Overall Study|Discontinuation by Sponsor|0|||
126283832|NCT03052127|454326552|FG001|Overall Study|Discontinuation by Sponsor|0|||
126283833|NCT03052127|454326553|FG002|Overall Study|Discontinuation by Sponsor|0|||
126283834|NCT03052127|454326554|FG003|Overall Study|Discontinuation by Sponsor|0|||
126040688|NCT02240238|453447169|FG002|Phase 1|Physician Decision|0|||
126040689|NCT02240238|453447170|FG003|Phase 1|Physician Decision|0|||
126040690|NCT02240238|453447171|FG004|Phase 1|Physician Decision|0|||
126040691|NCT02240238|453447172|FG005|Phase 1|Physician Decision|2|||
126040692|NCT02240238|453447173|FG006|Phase 1|Physician Decision|0|||
126283835|NCT03052127|454326555|FG004|Overall Study|Discontinuation by Sponsor|0|||
126283836|NCT03052127|454326556|FG005|Overall Study|Discontinuation by Sponsor|0|||
126283837|NCT03052127|454326557|FG006|Overall Study|Discontinuation by Sponsor|0|||
126283838|NCT03052127|454326558|FG007|Overall Study|Discontinuation by Sponsor|0|||
126283839|NCT03052127|454326559|FG008|Overall Study|Discontinuation by Sponsor|4|||
126283840|NCT03052127|454326560|FG009|Overall Study|Discontinuation by Sponsor|2|||
126283841|NCT03052127|454326561|FG010|Overall Study|Discontinuation by Sponsor|5|||
126283842|NCT03052127|454326562|FG011|Overall Study|Discontinuation by Sponsor|13|||
126040693|NCT02240238|453447174|FG007|Phase 1|Physician Decision|0|||
126040694|NCT02240238|453447175|FG008|Phase 1|Physician Decision|0|||
126040695|NCT02240238|453447176|FG009|Phase 1|Physician Decision|0|||
126283843|NCT03052127|454326551|FG000|Overall Study|Inability to comply with trial requirements|0|||
126283844|NCT03052127|454326552|FG001|Overall Study|Inability to comply with trial requirements|0|||
126283845|NCT03052127|454326553|FG002|Overall Study|Inability to comply with trial requirements|1|||
126283846|NCT03052127|454326554|FG003|Overall Study|Inability to comply with trial requirements|0|||
126283847|NCT03052127|454326555|FG004|Overall Study|Inability to comply with trial requirements|0|||
126283848|NCT03052127|454326556|FG005|Overall Study|Inability to comply with trial requirements|0|||
126283849|NCT03052127|454326557|FG006|Overall Study|Inability to comply with trial requirements|0|||
126283850|NCT03052127|454326558|FG007|Overall Study|Inability to comply with trial requirements|0|||
126283851|NCT03052127|454326559|FG008|Overall Study|Inability to comply with trial requirements|0|||
126283852|NCT03052127|454326560|FG009|Overall Study|Inability to comply with trial requirements|0|||
126283853|NCT03052127|454326561|FG010|Overall Study|Inability to comply with trial requirements|0|||
126283854|NCT03052127|454326562|FG011|Overall Study|Inability to comply with trial requirements|0|||
126283855|NCT03052127|454326551|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
126283856|NCT03052127|454326552|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283857|NCT03052127|454326553|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283858|NCT03052127|454326554|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283859|NCT03052127|454326555|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
126283860|NCT03052127|454326556|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
126283861|NCT03052127|454326557|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
126283862|NCT03052127|454326558|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283863|NCT03052127|454326559|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283864|NCT03052127|454326560|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283865|NCT03052127|454326561|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283866|NCT03052127|454326562|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283867|NCT03694327|454326565|FG000|Overall Study|Lost to Follow-up|13|||
126283868|NCT03694327|454326566|FG001|Overall Study|Lost to Follow-up|23|||
126283869|NCT01464931|454326569|FG000|Overall Study|Withdrawal by Subject|1|||
126283870|NCT01464931|454326570|FG001|Overall Study|Withdrawal by Subject|0|||
126283871|NCT01982812|454326571|FG000|Overall Study|Death|1|||
126283872|NCT01982812|454326572|FG001|Overall Study|Death|5|||
126283873|NCT01982812|454326571|FG000|Overall Study|Adverse Event|0|||
126283874|NCT01982812|454326572|FG001|Overall Study|Adverse Event|5|||
126283875|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
126283876|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
126283877|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283878|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283879|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283880|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283881|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283882|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283883|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283884|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283885|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
126364920|NCT04818229|454630374|FG000|Overall Study|Adverse Event|3|||
126040696|NCT02240238|453447177|FG010|Phase 1|Physician Decision|0|||
126364921|NCT04818229|454630375|FG001|Overall Study|Adverse Event|1|||
126364922|NCT04818229|454630376|FG002|Overall Study|Adverse Event|1|||
126364923|NCT04818229|454630374|FG000|Overall Study|Withdrawal by Subject|0|||
126364924|NCT04818229|454630375|FG001|Overall Study|Withdrawal by Subject|0|||
126364925|NCT04818229|454630376|FG002|Overall Study|Withdrawal by Subject|2|||
126364926|NCT04818229|454630374|FG000|Overall Study|Lost to Follow-up|0|||
126364927|NCT04818229|454630375|FG001|Overall Study|Lost to Follow-up|0|||
126364928|NCT04818229|454630376|FG002|Overall Study|Lost to Follow-up|1|||
126364929|NCT04082364|454630377|FG000|Overall Study|Death|23|||
126364930|NCT04082364|454630378|FG001|Overall Study|Death|1|||
126364931|NCT04082364|454630379|FG002|Overall Study|Death|1|||
126364932|NCT04082364|454630380|FG003|Overall Study|Death|2|||
126364933|NCT04082364|454630381|FG004|Overall Study|Death|1|||
126364934|NCT04082364|454630377|FG000|Overall Study|Lost to Follow-up|1|||
126364935|NCT04082364|454630378|FG001|Overall Study|Lost to Follow-up|0|||
126364936|NCT04082364|454630379|FG002|Overall Study|Lost to Follow-up|0|||
126364937|NCT04082364|454630380|FG003|Overall Study|Lost to Follow-up|0|||
126364938|NCT04082364|454630381|FG004|Overall Study|Lost to Follow-up|1|||
126364939|NCT04082364|454630377|FG000|Overall Study|Physician Decision|1|||
126364940|NCT04082364|454630378|FG001|Overall Study|Physician Decision|1|||
126364941|NCT04082364|454630379|FG002|Overall Study|Physician Decision|0|||
126364942|NCT04082364|454630380|FG003|Overall Study|Physician Decision|2|||
126364943|NCT04082364|454630381|FG004|Overall Study|Physician Decision|1|||
126364944|NCT04082364|454630377|FG000|Overall Study|Withdrawal by Subject|1|||
126364945|NCT04082364|454630378|FG001|Overall Study|Withdrawal by Subject|1|||
126364946|NCT04082364|454630379|FG002|Overall Study|Withdrawal by Subject|0|||
126364947|NCT04082364|454630380|FG003|Overall Study|Withdrawal by Subject|0|||
126283886|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
126283887|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283888|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283889|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283890|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283891|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283892|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283893|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283894|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283895|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283896|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
126283897|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283898|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283899|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283900|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283901|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283902|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283903|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283904|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283905|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
126283906|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283907|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283908|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283909|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283910|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283911|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283912|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283913|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283914|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283915|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
125882479|NCT01208207|452868989|FG005|Part I|Lack of Efficacy|0|||
126283916|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
126283917|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283918|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283919|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283920|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283921|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283922|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283923|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283924|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283925|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
126283926|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
126283927|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283928|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283929|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125882480|NCT01208207|452868990|FG006|Part I|Lack of Efficacy|0|||
126040697|NCT02240238|453447178|FG011|Phase 1|Physician Decision|0|||
126283930|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283931|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283932|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283933|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283934|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283935|NCT04784533|454326573|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283936|NCT04784533|454326574|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283937|NCT04784533|454326575|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
126283938|NCT04784533|454326576|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283939|NCT04784533|454326577|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283940|NCT04784533|454326578|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283941|NCT04784533|454326579|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283942|NCT04784533|454326580|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283943|NCT04784533|454326581|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283944|NCT04784533|454326582|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283945|NCT04784533|454326573|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283946|NCT04784533|454326574|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283947|NCT04784533|454326575|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283948|NCT04784533|454326576|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283949|NCT04784533|454326577|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283950|NCT04784533|454326578|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283951|NCT04784533|454326579|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283952|NCT04784533|454326580|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283953|NCT04784533|454326581|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
126283954|NCT04784533|454326582|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283955|NCT04784533|454326573|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283956|NCT04784533|454326574|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283957|NCT04784533|454326575|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283958|NCT04784533|454326576|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283959|NCT04784533|454326577|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283960|NCT04784533|454326578|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283961|NCT04784533|454326579|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283962|NCT04784533|454326580|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283963|NCT04784533|454326581|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
126283964|NCT04784533|454326582|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
126283965|NCT00307437|454326583|FG000|Controlled Period|Adverse Event|7|||
126283966|NCT00307437|454326584|FG001|Controlled Period|Adverse Event|2|||
126283967|NCT00307437|454326585|FG002|Controlled Period|Adverse Event|5|||
126283968|NCT00307437|454326586|FG003|Controlled Period|Adverse Event|0|||
126283969|NCT00307437|454326587|FG004|Controlled Period|Adverse Event|0|||
126283970|NCT00307437|454326588|FG005|Controlled Period|Adverse Event|0|||
126283971|NCT00307437|454326589|FG006|Controlled Period|Adverse Event|0|||
126283972|NCT00307437|454326583|FG000|Controlled Period|Death|0|||
126283973|NCT00307437|454326584|FG001|Controlled Period|Death|0|||
126283974|NCT00307437|454326585|FG002|Controlled Period|Death|1|||
126283975|NCT00307437|454326586|FG003|Controlled Period|Death|0|||
126283976|NCT00307437|454326587|FG004|Controlled Period|Death|0|||
126283977|NCT00307437|454326588|FG005|Controlled Period|Death|0|||
126283978|NCT00307437|454326589|FG006|Controlled Period|Death|0|||
126283979|NCT00307437|454326583|FG000|Controlled Period|Lack of Efficacy|2|||
126283980|NCT00307437|454326584|FG001|Controlled Period|Lack of Efficacy|0|||
126283981|NCT00307437|454326585|FG002|Controlled Period|Lack of Efficacy|0|||
126283982|NCT00307437|454326586|FG003|Controlled Period|Lack of Efficacy|0|||
126283983|NCT00307437|454326587|FG004|Controlled Period|Lack of Efficacy|0|||
126283984|NCT00307437|454326588|FG005|Controlled Period|Lack of Efficacy|0|||
126283985|NCT00307437|454326589|FG006|Controlled Period|Lack of Efficacy|0|||
126283986|NCT00307437|454326583|FG000|Controlled Period|Lost to Follow-up|2|||
126283987|NCT00307437|454326584|FG001|Controlled Period|Lost to Follow-up|3|||
126283988|NCT00307437|454326585|FG002|Controlled Period|Lost to Follow-up|0|||
126283989|NCT00307437|454326586|FG003|Controlled Period|Lost to Follow-up|0|||
126040698|NCT02240238|453447167|FG000|Phase 2|Adverse Event|0|||
126283990|NCT00307437|454326587|FG004|Controlled Period|Lost to Follow-up|0|||
126283991|NCT00307437|454326588|FG005|Controlled Period|Lost to Follow-up|0|||
126283992|NCT00307437|454326589|FG006|Controlled Period|Lost to Follow-up|0|||
126283993|NCT00307437|454326583|FG000|Controlled Period|Other|5|||
126040699|NCT02240238|453447168|FG001|Phase 2|Adverse Event|0|||
126283994|NCT00307437|454326584|FG001|Controlled Period|Other|1|||
126283995|NCT00307437|454326585|FG002|Controlled Period|Other|3|||
126283996|NCT00307437|454326586|FG003|Controlled Period|Other|0|||
126283997|NCT00307437|454326587|FG004|Controlled Period|Other|0|||
126040700|NCT02240238|453447169|FG002|Phase 2|Adverse Event|0|||
126283998|NCT00307437|454326588|FG005|Controlled Period|Other|0|||
126283999|NCT00307437|454326589|FG006|Controlled Period|Other|0|||
126040701|NCT02240238|453447170|FG003|Phase 2|Adverse Event|0|||
125882481|NCT01208207|452868984|FG000|Part I|Lost to Follow-up|6|||
125882482|NCT01208207|452868985|FG001|Part I|Lost to Follow-up|1|||
125882483|NCT01208207|452868986|FG002|Part I|Lost to Follow-up|0|||
125882484|NCT01208207|452868987|FG003|Part I|Lost to Follow-up|0|||
125882485|NCT01208207|452868988|FG004|Part I|Lost to Follow-up|0|||
125882486|NCT01208207|452868989|FG005|Part I|Lost to Follow-up|0|||
125882487|NCT01208207|452868990|FG006|Part I|Lost to Follow-up|0|||
125882488|NCT01208207|452868984|FG000|Part I|Non-Compliance With Study Drug|1|||
126040702|NCT02240238|453447171|FG004|Phase 2|Adverse Event|0|||
126040703|NCT02240238|453447172|FG005|Phase 2|Adverse Event|0|||
125882489|NCT01208207|452868985|FG001|Part I|Non-Compliance With Study Drug|0|||
125882490|NCT01208207|452868986|FG002|Part I|Non-Compliance With Study Drug|1|||
126040704|NCT02240238|453447173|FG006|Phase 2|Adverse Event|0|||
126040705|NCT02240238|453447174|FG007|Phase 2|Adverse Event|0|||
126040706|NCT02240238|453447175|FG008|Phase 2|Adverse Event|0|||
126040707|NCT02240238|453447176|FG009|Phase 2|Adverse Event|7|||
126040708|NCT02240238|453447177|FG010|Phase 2|Adverse Event|14|||
126040709|NCT02240238|453447178|FG011|Phase 2|Adverse Event|2|||
126040710|NCT02240238|453447167|FG000|Phase 2|Death|0|||
126040711|NCT02240238|453447168|FG001|Phase 2|Death|0|||
126040712|NCT02240238|453447169|FG002|Phase 2|Death|0|||
126040713|NCT02240238|453447170|FG003|Phase 2|Death|0|||
126040714|NCT02240238|453447171|FG004|Phase 2|Death|0|||
126040715|NCT02240238|453447172|FG005|Phase 2|Death|0|||
126040716|NCT02240238|453447173|FG006|Phase 2|Death|0|||
126040717|NCT02240238|453447174|FG007|Phase 2|Death|0|||
126040718|NCT02240238|453447175|FG008|Phase 2|Death|0|||
126284000|NCT00307437|454326583|FG000|After Controlled Period|Adverse Event|0|||
126284001|NCT00307437|454326584|FG001|After Controlled Period|Adverse Event|0|||
126284002|NCT00307437|454326585|FG002|After Controlled Period|Adverse Event|0|||
126284003|NCT00307437|454326586|FG003|After Controlled Period|Adverse Event|18|||
126284004|NCT00307437|454326587|FG004|After Controlled Period|Adverse Event|16|||
126284005|NCT00307437|454326588|FG005|After Controlled Period|Adverse Event|31|||
126284006|NCT00307437|454326589|FG006|After Controlled Period|Adverse Event|40|||
126284007|NCT00307437|454326583|FG000|After Controlled Period|Death|0|||
126284008|NCT00307437|454326584|FG001|After Controlled Period|Death|0|||
126284009|NCT00307437|454326585|FG002|After Controlled Period|Death|0|||
126284010|NCT00307437|454326586|FG003|After Controlled Period|Death|3|||
126284011|NCT00307437|454326587|FG004|After Controlled Period|Death|1|||
126284012|NCT00307437|454326588|FG005|After Controlled Period|Death|1|||
126284013|NCT00307437|454326589|FG006|After Controlled Period|Death|3|||
126284014|NCT00307437|454326583|FG000|After Controlled Period|Lack of Efficacy|0|||
126284015|NCT00307437|454326584|FG001|After Controlled Period|Lack of Efficacy|0|||
126284016|NCT00307437|454326585|FG002|After Controlled Period|Lack of Efficacy|0|||
126284017|NCT00307437|454326586|FG003|After Controlled Period|Lack of Efficacy|15|||
126284018|NCT00307437|454326587|FG004|After Controlled Period|Lack of Efficacy|17|||
126284019|NCT00307437|454326588|FG005|After Controlled Period|Lack of Efficacy|37|||
126284020|NCT00307437|454326589|FG006|After Controlled Period|Lack of Efficacy|24|||
126284021|NCT00307437|454326583|FG000|After Controlled Period|Lost to Follow-up|0|||
126284022|NCT00307437|454326584|FG001|After Controlled Period|Lost to Follow-up|0|||
126284023|NCT00307437|454326585|FG002|After Controlled Period|Lost to Follow-up|0|||
126284024|NCT00307437|454326586|FG003|After Controlled Period|Lost to Follow-up|7|||
126284025|NCT00307437|454326587|FG004|After Controlled Period|Lost to Follow-up|12|||
126284026|NCT00307437|454326588|FG005|After Controlled Period|Lost to Follow-up|13|||
126284027|NCT00307437|454326589|FG006|After Controlled Period|Lost to Follow-up|18|||
126284028|NCT00307437|454326583|FG000|After Controlled Period|Other|0|||
126284029|NCT00307437|454326584|FG001|After Controlled Period|Other|0|||
126284030|NCT00307437|454326585|FG002|After Controlled Period|Other|0|||
126284031|NCT00307437|454326586|FG003|After Controlled Period|Other|15|||
126040719|NCT02240238|453447176|FG009|Phase 2|Death|3|||
126040720|NCT02240238|453447177|FG010|Phase 2|Death|2|||
126040721|NCT02240238|453447178|FG011|Phase 2|Death|1|||
126040722|NCT02240238|453447167|FG000|Phase 2|Disease progression|0|||
126284032|NCT00307437|454326587|FG004|After Controlled Period|Other|9|||
126284033|NCT00307437|454326588|FG005|After Controlled Period|Other|40|||
126284034|NCT00307437|454326589|FG006|After Controlled Period|Other|28|||
125882491|NCT01208207|452868987|FG003|Part I|Non-Compliance With Study Drug|0|||
125882492|NCT01208207|452868988|FG004|Part I|Non-Compliance With Study Drug|0|||
125882493|NCT01208207|452868989|FG005|Part I|Non-Compliance With Study Drug|0|||
125882494|NCT01208207|452868990|FG006|Part I|Non-Compliance With Study Drug|0|||
126040723|NCT02240238|453447168|FG001|Phase 2|Disease progression|0|||
126040724|NCT02240238|453447169|FG002|Phase 2|Disease progression|0|||
126284035|NCT00338728|454326595|FG000|Overall Study|Screen Failure|14|||
125882495|NCT01208207|452868984|FG000|Part I|Physician Decision|0|||
126040725|NCT02240238|453447170|FG003|Phase 2|Disease progression|0|||
126040726|NCT02240238|453447171|FG004|Phase 2|Disease progression|0|||
126040727|NCT02240238|453447172|FG005|Phase 2|Disease progression|0|||
126040728|NCT02240238|453447173|FG006|Phase 2|Disease progression|0|||
126040729|NCT02240238|453447174|FG007|Phase 2|Disease progression|0|||
126040730|NCT02240238|453447175|FG008|Phase 2|Disease progression|0|||
126040731|NCT02240238|453447176|FG009|Phase 2|Disease progression|5|||
126284036|NCT00708227|454326602|FG000|Overall Study|Physician Decision|0|||
126040732|NCT02240238|453447177|FG010|Phase 2|Disease progression|11|||
126040733|NCT02240238|453447178|FG011|Phase 2|Disease progression|1|||
126040734|NCT02240238|453447167|FG000|Phase 2|Withdrawal by Subject|0|||
126040735|NCT02240238|453447168|FG001|Phase 2|Withdrawal by Subject|0|||
126040736|NCT02240238|453447169|FG002|Phase 2|Withdrawal by Subject|0|||
126284037|NCT00708227|454326603|FG001|Overall Study|Physician Decision|3|||
126284038|NCT00708227|454326604|FG002|Overall Study|Physician Decision|1|||
126284039|NCT00708227|454326605|FG003|Overall Study|Physician Decision|2|||
126284040|NCT00708227|454326602|FG000|Overall Study|Withdrawal by Subject|1|||
126284041|NCT00708227|454326603|FG001|Overall Study|Withdrawal by Subject|2|||
126284042|NCT00708227|454326604|FG002|Overall Study|Withdrawal by Subject|0|||
126284043|NCT00708227|454326605|FG003|Overall Study|Withdrawal by Subject|1|||
126284044|NCT03654599|454326607|FG000|Overall Study|Lost to Follow-up|14|||
126284045|NCT03654599|454326608|FG001|Overall Study|Lost to Follow-up|12|||
126284046|NCT03654599|454326607|FG000|Overall Study|Death|8|||
126284047|NCT03654599|454326608|FG001|Overall Study|Death|6|||
126284048|NCT03654599|454326607|FG000|Overall Study|Withdrawal by Subject|6|||
126284049|NCT03654599|454326608|FG001|Overall Study|Withdrawal by Subject|4|||
126284050|NCT03765788|454328805|FG000|Overall Study|Subject decision|2|||
126284051|NCT03765788|454328806|FG001|Overall Study|Subject decision|3|||
126284052|NCT03765788|454328805|FG000|Overall Study|Physician Decision|2|||
126284053|NCT03765788|454328806|FG001|Overall Study|Physician Decision|4|||
126284054|NCT03765788|454328805|FG000|Overall Study|Death|0|||
126284055|NCT03765788|454328806|FG001|Overall Study|Death|1|||
126284056|NCT03765788|454328805|FG000|Overall Study|Lost to Follow-up|1|||
126284057|NCT03765788|454328806|FG001|Overall Study|Lost to Follow-up|0|||
126284058|NCT01659125|454328807|FG000|Overall Study|Withdrawal by Subject|2|||
126284059|NCT01659125|454328807|FG000|Overall Study|Lost to Follow-up|7|||
126284060|NCT01659125|454328807|FG000|Overall Study|Technical Problem|1|||
126284061|NCT01659125|454328807|FG000|Overall Study|Time Constraints|2|||
126284062|NCT01659125|454328807|FG000|Overall Study|Failed to Start Treatment|2|||
126284063|NCT02640482|454328808|FG000|Overall Study|Lost to Follow-up|3|||
126284064|NCT02640482|454328809|FG001|Overall Study|Lost to Follow-up|0|||
126284065|NCT02013817|454328812|FG000|Overall Study|Adverse Event|12|||
126284066|NCT02013817|454328812|FG000|Overall Study|Withdrawal by Subject|4|||
126284067|NCT02013817|454328812|FG000|Overall Study|Death|2|||
126284068|NCT02013817|454328812|FG000|Overall Study|Other|9|||
126284069|NCT03055624|454328819|FG000|Overall Study|Study closed|9|||
126284070|NCT02794870|454328823|FG000|Overall Study|Withdrawal by Subject|2|||
126284071|NCT02794870|454328824|FG001|Overall Study|Withdrawal by Subject|0|||
126284072|NCT03336528|454328825|FG000|Overall Study|Protocol Violation|1|||
126284073|NCT03336528|454328826|FG001|Overall Study|Protocol Violation|1|||
126284074|NCT03336528|454328825|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
126284075|NCT03336528|454328826|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
126284076|NCT03336528|454328825|FG000|Overall Study|Did not receive study medication|1|||
126284077|NCT03336528|454328826|FG001|Overall Study|Did not receive study medication|2|||
126284078|NCT00230178|454328831|FG000|Overall Study|Adverse Event|1|||
126284079|NCT00230178|454328832|FG001|Overall Study|Adverse Event|5|||
126284080|NCT00230178|454328833|FG002|Overall Study|Adverse Event|2|||
126284081|NCT00230178|454328831|FG000|Overall Study|Withdrawal by Subject|0|||
126284082|NCT00230178|454328832|FG001|Overall Study|Withdrawal by Subject|0|||
126284083|NCT00230178|454328833|FG002|Overall Study|Withdrawal by Subject|1|||
126284084|NCT00230178|454328831|FG000|Overall Study|Various other reasons|3|||
126284085|NCT00230178|454328832|FG001|Overall Study|Various other reasons|2|||
126284086|NCT00230178|454328833|FG002|Overall Study|Various other reasons|4|||
126284087|NCT04974749|454328850|FG000|Overall Study|Withdrawal by Subject|2|||
126284088|NCT04974749|454328850|FG000|Overall Study|Gestation|1|||
126284089|NCT04414618|454328851|FG000|Overall Study|Death|3|||
126284090|NCT04414618|454328852|FG001|Overall Study|Death|3|||
126284091|NCT04414618|454328851|FG000|Overall Study|Withdrawal by Subject|2|||
126284092|NCT04414618|454328852|FG001|Overall Study|Withdrawal by Subject|1|||
126040737|NCT02240238|453447170|FG003|Phase 2|Withdrawal by Subject|0|||
126284093|NCT04414618|454328851|FG000|Overall Study|Lost to Follow-up|2|||
126284094|NCT04414618|454328852|FG001|Overall Study|Lost to Follow-up|3|||
126284095|NCT04414618|454328851|FG000|Overall Study|Physician Decision|1|||
126284096|NCT04414618|454328852|FG001|Overall Study|Physician Decision|0|||
126364948|NCT04082364|454630381|FG004|Overall Study|Withdrawal by Subject|1|||
126040738|NCT02240238|453447171|FG004|Phase 2|Withdrawal by Subject|0|||
126040739|NCT02240238|453447172|FG005|Phase 2|Withdrawal by Subject|0|||
126040740|NCT02240238|453447173|FG006|Phase 2|Withdrawal by Subject|0|||
126284097|NCT00362336|454328853|FG000|Overall Study|Serious Adverse Event|1|||
126284098|NCT00362336|454328854|FG001|Overall Study|Serious Adverse Event|0|||
126284099|NCT00362336|454328855|FG002|Overall Study|Serious Adverse Event|1|||
126284100|NCT00362336|454328853|FG000|Overall Study|Protocol Violation|0|||
126284101|NCT00362336|454328854|FG001|Overall Study|Protocol Violation|0|||
126284102|NCT00362336|454328855|FG002|Overall Study|Protocol Violation|1|||
126284103|NCT00362336|454328853|FG000|Overall Study|Lost to Follow-up|6|||
126284104|NCT00362336|454328854|FG001|Overall Study|Lost to Follow-up|4|||
126284105|NCT00362336|454328855|FG002|Overall Study|Lost to Follow-up|0|||
126284106|NCT00362336|454328853|FG000|Overall Study|Withdrawal by Subject|3|||
126284107|NCT00362336|454328854|FG001|Overall Study|Withdrawal by Subject|3|||
126284108|NCT00362336|454328855|FG002|Overall Study|Withdrawal by Subject|1|||
126284109|NCT00658879|454328856|FG000|Overall Study|Protocol Violation|1|||
126284110|NCT00616421|454328859|FG000|Overall Study|Withdrawal by Subject|9|||
125882496|NCT01208207|452868985|FG001|Part I|Physician Decision|1|||
125882497|NCT01208207|452868986|FG002|Part I|Physician Decision|0|||
125882498|NCT01208207|452868987|FG003|Part I|Physician Decision|0|||
125882499|NCT01208207|452868988|FG004|Part I|Physician Decision|0|||
125882500|NCT01208207|452868989|FG005|Part I|Physician Decision|0|||
125882501|NCT01208207|452868990|FG006|Part I|Physician Decision|0|||
125882502|NCT01208207|452868984|FG000|Part I|Progressive Disease|1|||
125882503|NCT01208207|452868985|FG001|Part I|Progressive Disease|0|||
125882504|NCT01208207|452868986|FG002|Part I|Progressive Disease|0|||
125882505|NCT01208207|452868987|FG003|Part I|Progressive Disease|0|||
126284111|NCT00616421|454328860|FG001|Overall Study|Withdrawal by Subject|11|||
126284112|NCT00616421|454328861|FG002|Overall Study|Withdrawal by Subject|8|||
125882506|NCT01208207|452868988|FG004|Part I|Progressive Disease|0|||
126284113|NCT00616421|454328859|FG000|Overall Study|Lost to Follow-up|12|||
126284114|NCT00616421|454328860|FG001|Overall Study|Lost to Follow-up|26|||
126284115|NCT00616421|454328861|FG002|Overall Study|Lost to Follow-up|30|||
126284116|NCT00616421|454328859|FG000|Overall Study|Inappropriate enrollment|3|||
126284117|NCT00616421|454328860|FG001|Overall Study|Inappropriate enrollment|0|||
126284118|NCT00616421|454328861|FG002|Overall Study|Inappropriate enrollment|1|||
126284119|NCT00616421|454328859|FG000|Overall Study|Administrative reason|1|||
126284120|NCT00616421|454328860|FG001|Overall Study|Administrative reason|0|||
126284121|NCT00616421|454328861|FG002|Overall Study|Administrative reason|0|||
126284122|NCT00616421|454328859|FG000|Overall Study|Protocol Violation|0|||
126284123|NCT00616421|454328860|FG001|Overall Study|Protocol Violation|1|||
126284124|NCT00616421|454328861|FG002|Overall Study|Protocol Violation|2|||
126284125|NCT00616421|454328859|FG000|Overall Study|Unable to classify|1|||
126284126|NCT00616421|454328860|FG001|Overall Study|Unable to classify|0|||
126284127|NCT00616421|454328861|FG002|Overall Study|Unable to classify|0|||
126284128|NCT02661217|454328862|FG000|Overall Study|Physician Decision|12|||
126284129|NCT02661217|454328863|FG001|Overall Study|Physician Decision|15|||
126284130|NCT02661217|454328862|FG000|Overall Study|Lost to Follow-up|1|||
126284131|NCT02661217|454328863|FG001|Overall Study|Lost to Follow-up|4|||
126284132|NCT02661217|454328862|FG000|Overall Study|Protocol Deviation|0|||
125882507|NCT01208207|452868989|FG005|Part I|Progressive Disease|0|||
125882508|NCT01208207|452868990|FG006|Part I|Progressive Disease|0|||
125882509|NCT01208207|452868984|FG000|Part I|Protocol Violation|8|||
125882510|NCT01208207|452868985|FG001|Part I|Protocol Violation|0|||
126040741|NCT02240238|453447174|FG007|Phase 2|Withdrawal by Subject|0|||
126040742|NCT02240238|453447175|FG008|Phase 2|Withdrawal by Subject|0|||
126040743|NCT02240238|453447176|FG009|Phase 2|Withdrawal by Subject|1|||
126284133|NCT02661217|454328863|FG001|Overall Study|Protocol Deviation|4|||
126284134|NCT02661217|454328862|FG000|Overall Study|Non-compliance with study treatment|5|||
126284135|NCT02661217|454328863|FG001|Overall Study|Non-compliance with study treatment|5|||
126284136|NCT02661217|454328862|FG000|Overall Study|Death|21|||
126284137|NCT02661217|454328863|FG001|Overall Study|Death|15|||
126284138|NCT02661217|454328862|FG000|Overall Study|Adverse Event|10|||
126284139|NCT02661217|454328863|FG001|Overall Study|Adverse Event|8|||
126284140|NCT02661217|454328862|FG000|Overall Study|Withdrawal by Subject|15|||
126284141|NCT02661217|454328863|FG001|Overall Study|Withdrawal by Subject|19|||
126284142|NCT02661217|454328862|FG000|Overall Study|Did not enter follow-up epoch|7|||
126284143|NCT02661217|454328863|FG001|Overall Study|Did not enter follow-up epoch|10|||
126284144|NCT02661217|454328862|FG000|Overall Study|Death - no study drug received|1|||
126284145|NCT02661217|454328863|FG001|Overall Study|Death - no study drug received|2|||
125882511|NCT01208207|452868986|FG002|Part I|Protocol Violation|2|||
125882512|NCT01208207|452868987|FG003|Part I|Protocol Violation|0|||
126284146|NCT02661217|454328862|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
125882513|NCT01208207|452868988|FG004|Part I|Protocol Violation|0|||
125882514|NCT01208207|452868989|FG005|Part I|Protocol Violation|0|||
125882515|NCT01208207|452868990|FG006|Part I|Protocol Violation|0|||
126284147|NCT02661217|454328863|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
126284148|NCT00196326|454328864|FG000|Overall Study|Did not meet protocol requirements|64|||
126284149|NCT00196326|454328864|FG000|Overall Study|Non-compliance with the protocol|81|||
126284150|NCT00196326|454328864|FG000|Overall Study|Physician Decision|3|||
126284151|NCT00196326|454328864|FG000|Overall Study|Withdrawal by Subject|225|||
126284152|NCT00196326|454328864|FG000|Overall Study|Adverse Event|253|||
126284153|NCT00196326|454328864|FG000|Overall Study|Pregnancy|34|||
126284154|NCT00196326|454328864|FG000|Overall Study|Lost to Follow-up|304|||
125882516|NCT01208207|452868984|FG000|Part I|Withdrawal by Subject|14|||
125882517|NCT01208207|452868985|FG001|Part I|Withdrawal by Subject|4|||
125882518|NCT01208207|452868986|FG002|Part I|Withdrawal by Subject|4|||
125882519|NCT01208207|452868987|FG003|Part I|Withdrawal by Subject|0|||
125882520|NCT01208207|452868988|FG004|Part I|Withdrawal by Subject|0|||
126040744|NCT02240238|453447177|FG010|Phase 2|Withdrawal by Subject|1|||
126284155|NCT00196326|454328864|FG000|Overall Study|Other|22|||
126284156|NCT02481869|454328873|FG000|Overall Study|Lost to Follow-up|3|||
126284157|NCT02481869|454328874|FG001|Overall Study|Lost to Follow-up|4|||
126284158|NCT02481869|454328873|FG000|Overall Study|Withdrawal by Subject|2|||
126284159|NCT02481869|454328874|FG001|Overall Study|Withdrawal by Subject|0|||
126284160|NCT00711880|454328875|FG000|Overall Study|Adverse Event|11|||
126284161|NCT00711880|454328876|FG001|Overall Study|Adverse Event|2|||
126284162|NCT00711880|454328875|FG000|Overall Study|Patient non-compliance|1|||
126284163|NCT00711880|454328876|FG001|Overall Study|Patient non-compliance|0|||
126284164|NCT00711880|454328875|FG000|Overall Study|Lack of Efficacy|1|||
126284165|NCT00711880|454328876|FG001|Overall Study|Lack of Efficacy|5|||
126284166|NCT03908437|454328879|FG000|Overall Study|Death|0|||
126284167|NCT03908437|454328880|FG001|Overall Study|Death|1|||
126284168|NCT03908437|454328879|FG000|Overall Study|Lost to Follow-up|31|||
126284169|NCT03908437|454328880|FG001|Overall Study|Lost to Follow-up|24|||
126284170|NCT05445492|454328881|FG000|Overall Study|Physician Decision|1|||
126284171|NCT00191191|454328882|FG000|Overall Study|Entry Criteria Exclusion|2|||
126284172|NCT00191191|454328883|FG001|Overall Study|Entry Criteria Exclusion|0|||
126284173|NCT00191191|454328882|FG000|Overall Study|Treated with Another Systemic Agent|1|||
126284174|NCT00191191|454328883|FG001|Overall Study|Treated with Another Systemic Agent|1|||
126284175|NCT00191191|454328882|FG000|Overall Study|Adverse Event|11|||
126284176|NCT00191191|454328883|FG001|Overall Study|Adverse Event|21|||
126284177|NCT00191191|454328882|FG000|Overall Study|Progressive Disease|84|||
126284178|NCT00191191|454328883|FG001|Overall Study|Progressive Disease|72|||
126284179|NCT00191191|454328882|FG000|Overall Study|Toxicity After Dose Reduction|7|||
126284180|NCT00191191|454328883|FG001|Overall Study|Toxicity After Dose Reduction|8|||
126284181|NCT00191191|454328882|FG000|Overall Study|Family/Caregiver Decision|5|||
126284182|NCT00191191|454328883|FG001|Overall Study|Family/Caregiver Decision|7|||
126284183|NCT00191191|454328882|FG000|Overall Study|Lost to Follow-up|1|||
126284184|NCT00191191|454328883|FG001|Overall Study|Lost to Follow-up|0|||
126284185|NCT00191191|454328882|FG000|Overall Study|Physician Decision|3|||
126284186|NCT00191191|454328883|FG001|Overall Study|Physician Decision|2|||
126284187|NCT00191191|454328882|FG000|Overall Study|Good Clinical Practice Violation|0|||
126284188|NCT00191191|454328883|FG001|Overall Study|Good Clinical Practice Violation|1|||
126284189|NCT04238650|454328884|FG000|Overall Study|Withdrawal by Subject|0|||
126284190|NCT04238650|454328885|FG001|Overall Study|Withdrawal by Subject|1|||
126284191|NCT03348163|454328886|FG000|Overall Study|Withdrawal by Subject|2|||
126284192|NCT03348163|454328887|FG001|Overall Study|Withdrawal by Subject|0|||
126284193|NCT02370238|454328888|FG000|Overall Study|Death|42|||
126284194|NCT02370238|454328889|FG001|Overall Study|Death|35|||
126284195|NCT02370238|454328888|FG000|Overall Study|Lost to Follow-up|1|||
126284196|NCT02370238|454328889|FG001|Overall Study|Lost to Follow-up|3|||
126284197|NCT02370238|454328888|FG000|Overall Study|Withdrawal by Subject|2|||
126284198|NCT02370238|454328889|FG001|Overall Study|Withdrawal by Subject|6|||
126284199|NCT02370238|454328888|FG000|Overall Study|Other|2|||
126284200|NCT02370238|454328889|FG001|Overall Study|Other|1|||
126284201|NCT01295320|454328892|FG000|Overall Study|Adverse Event|2|||
126284202|NCT01295320|454328892|FG000|Overall Study|Lost to Follow-up|4|||
126284203|NCT01295320|454328892|FG000|Overall Study|Withdrawal by Subject|2|||
126284204|NCT01295320|454328892|FG000|Overall Study|Subject was bedridden|1|||
126284205|NCT01295320|454328892|FG000|Overall Study|Unable to travel|1|||
126284206|NCT04342819|454328893|FG000|Overall Study|Declined|4|||
126284207|NCT04342819|454328893|FG000|Overall Study|Not meeeting selection criteria|1|||
126284208|NCT01569295|454328894|FG000|Overall Study|Progressive Disease|75|||
126284209|NCT01569295|454328895|FG001|Overall Study|Progressive Disease|139|||
126284210|NCT01569295|454328894|FG000|Overall Study|Adverse Event|39|||
126284211|NCT01569295|454328895|FG001|Overall Study|Adverse Event|14|||
126284212|NCT01569295|454328894|FG000|Overall Study|Withdrawal by Subject|25|||
126284213|NCT01569295|454328895|FG001|Overall Study|Withdrawal by Subject|12|||
126284214|NCT01569295|454328894|FG000|Overall Study|Death|19|||
126284215|NCT01569295|454328895|FG001|Overall Study|Death|15|||
126284216|NCT01569295|454328894|FG000|Overall Study|Physician Decision|13|||
126284217|NCT01569295|454328895|FG001|Overall Study|Physician Decision|18|||
126284218|NCT01569295|454328894|FG000|Overall Study|Study Terminated by Sponsor|24|||
126364949|NCT04082364|454630377|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
126364950|NCT04082364|454630378|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
126284219|NCT01569295|454328895|FG001|Overall Study|Study Terminated by Sponsor|2|||
126284220|NCT01569295|454328894|FG000|Overall Study|Other Reason not Specified|3|||
126284221|NCT01569295|454328895|FG001|Overall Study|Other Reason not Specified|5|||
126284222|NCT01569295|454328894|FG000|Overall Study|Non-Compliance with Study Drug|6|||
126284223|NCT01569295|454328895|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126284224|NCT01569295|454328894|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
126284225|NCT01569295|454328895|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
126284226|NCT01569295|454328894|FG000|Overall Study|Lost to Follow-up|1|||
126284227|NCT01569295|454328895|FG001|Overall Study|Lost to Follow-up|1|||
126284228|NCT03597295|454328896|FG000|Overall Study|Death|70|||
126284229|NCT03597295|454328896|FG000|Overall Study|Lost to Follow-up|7|||
126284230|NCT00879411|454328897|FG000|Overall Study|lost to follow-up (non-AE)|162|||
126284231|NCT01884337|454328898|FG000|Treatment|Adverse Event|2|||
126284232|NCT01884337|454328899|FG001|Treatment|Adverse Event|2|||
126284233|NCT01884337|454328898|FG000|Treatment|Subj. request to discont. treatment|2|||
126284234|NCT01884337|454328899|FG001|Treatment|Subj. request to discont. treatment|0|||
126284235|NCT01884337|454328898|FG000|Follow-up Period|Lost to Follow-up|1|||
126284236|NCT01884337|454328899|FG001|Follow-up Period|Lost to Follow-up|1|||
126284237|NCT00428116|454328900|FG000|Overall Study|Death|1|||
126284238|NCT00428116|454328901|FG001|Overall Study|Death|0|||
126284239|NCT00428116|454328900|FG000|Overall Study|Withdrawal by Subject|1|||
126284240|NCT00428116|454328901|FG001|Overall Study|Withdrawal by Subject|0|||
126284241|NCT00428116|454328900|FG000|Overall Study|Lost to Follow-up|1|||
126284242|NCT00428116|454328901|FG001|Overall Study|Lost to Follow-up|0|||
126284243|NCT02455518|454328902|FG000|Overall Study|Protocol Violation|0|||
126284244|NCT02455518|454328903|FG001|Overall Study|Protocol Violation|1|||
126284245|NCT02455518|454328904|FG002|Overall Study|Protocol Violation|1|||
126284246|NCT02455518|454328905|FG003|Overall Study|Protocol Violation|3|||
126284247|NCT01038297|454328906|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
126284248|NCT01038297|454328907|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
126284249|NCT01038297|454328908|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
126284250|NCT01973595|454328912|FG000|Washout|Withdrawal by Subject|1|||
126284251|NCT01973595|454328913|FG001|Washout|Withdrawal by Subject|0|||
126284252|NCT01973595|454328914|FG002|Washout|Withdrawal by Subject|1|||
126284253|NCT01973595|454328915|FG003|Washout|Withdrawal by Subject|0|||
126284254|NCT02508935|454328916|FG000|Overall Study|Withdrawal by Subject|1|||
126284255|NCT02508935|454328916|FG000|Overall Study|Withdrawal by Caregiver|8|||
126284256|NCT02508935|454328916|FG000|Overall Study|Pain Score <4|1|||
126284257|NCT02508935|454328916|FG000|Overall Study|Emesis|3|||
126284258|NCT02508935|454328916|FG000|Overall Study|Adverse Event|3|||
126284259|NCT02508935|454328916|FG000|Overall Study|Protocol Violation|1|||
126284260|NCT02508935|454328916|FG000|Overall Study|Physician Decision|1|||
126284261|NCT02508935|454328916|FG000|Overall Study|Trial terminated by sponsor|5|||
126284262|NCT03837743|454328921|FG000|Overall Study|Adverse Event|1|||
126284263|NCT03837743|454328921|FG000|Overall Study|Withdrawal by Subject|2|||
126284264|NCT01210612|454328923|FG000|Overall Study|Withdrawal by Subject|0|||
126284265|NCT01210612|454328924|FG001|Overall Study|Withdrawal by Subject|2|||
126284266|NCT01275430|454328925|FG000|Overall Study|Adverse Event|1|||
126284267|NCT01275430|454328925|FG000|Overall Study|No Contrast Injection|6|||
126284268|NCT01275430|454328925|FG000|Overall Study|Device Malfunction|1|||
126284269|NCT01275430|454328925|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
126284270|NCT00710866|454328928|FG000|Overall Study|Protocol Violation|5|||
126284271|NCT00710866|454328929|FG001|Overall Study|Protocol Violation|4|||
126284272|NCT00710866|454328928|FG000|Overall Study|Withdrawal by Subject|2|||
126284273|NCT00710866|454328929|FG001|Overall Study|Withdrawal by Subject|1|||
126284274|NCT00710866|454328928|FG000|Overall Study|Lost to Follow-up|1|||
126284275|NCT00710866|454328929|FG001|Overall Study|Lost to Follow-up|0|||
126284276|NCT00710866|454328928|FG000|Overall Study|Failed to meet eligibility|1|||
126284277|NCT00710866|454328929|FG001|Overall Study|Failed to meet eligibility|1|||
126284278|NCT00086281|454328930|FG000|Phase 1|Adverse Event|0|||
126284279|NCT00086281|454328931|FG001|Phase 1|Adverse Event|0|||
126284280|NCT00086281|454328932|FG002|Phase 1|Adverse Event|0|||
126284281|NCT00086281|454328933|FG003|Phase 1|Adverse Event|0|||
126284282|NCT00086281|454328934|FG004|Phase 1|Adverse Event|0|||
126284283|NCT00086281|454328935|FG005|Phase 1|Adverse Event|0|||
126284284|NCT00086281|454328936|FG006|Phase 1|Adverse Event|0|||
126284285|NCT00086281|454328937|FG007|Phase 1|Adverse Event|0|||
126284286|NCT00086281|454328938|FG008|Phase 1|Adverse Event|0|||
126284287|NCT00086281|454328939|FG009|Phase 1|Adverse Event|1|||
126284288|NCT00086281|454328940|FG010|Phase 1|Adverse Event|2|||
126284289|NCT00086281|454328941|FG011|Phase 1|Adverse Event|1|||
126284290|NCT00086281|454328942|FG012|Phase 1|Adverse Event|1|||
126284291|NCT00086281|454328943|FG013|Phase 1|Adverse Event|1|||
126284292|NCT00086281|454328944|FG014|Phase 1|Adverse Event|2|||
126284293|NCT00086281|454328930|FG000|Phase 1|Protocol Violation|0|||
126284294|NCT00086281|454328931|FG001|Phase 1|Protocol Violation|0|||
126284295|NCT00086281|454328932|FG002|Phase 1|Protocol Violation|0|||
126284296|NCT00086281|454328933|FG003|Phase 1|Protocol Violation|0|||
126284297|NCT00086281|454328934|FG004|Phase 1|Protocol Violation|0|||
126284298|NCT00086281|454328935|FG005|Phase 1|Protocol Violation|0|||
126284299|NCT00086281|454328936|FG006|Phase 1|Protocol Violation|0|||
126284300|NCT00086281|454328937|FG007|Phase 1|Protocol Violation|0|||
126284301|NCT00086281|454328938|FG008|Phase 1|Protocol Violation|0|||
126284302|NCT00086281|454328939|FG009|Phase 1|Protocol Violation|0|||
126284303|NCT00086281|454328940|FG010|Phase 1|Protocol Violation|1|||
126284304|NCT00086281|454328941|FG011|Phase 1|Protocol Violation|0|||
126284305|NCT00086281|454328942|FG012|Phase 1|Protocol Violation|0|||
126284306|NCT00086281|454328943|FG013|Phase 1|Protocol Violation|0|||
126284307|NCT00086281|454328944|FG014|Phase 1|Protocol Violation|0|||
126284308|NCT00086281|454328930|FG000|Phase 1|Serious Adverse Event|0|||
126284309|NCT00086281|454328931|FG001|Phase 1|Serious Adverse Event|0|||
126284310|NCT00086281|454328932|FG002|Phase 1|Serious Adverse Event|0|||
126284311|NCT00086281|454328933|FG003|Phase 1|Serious Adverse Event|0|||
126284312|NCT00086281|454328934|FG004|Phase 1|Serious Adverse Event|0|||
126040745|NCT02240238|453447178|FG011|Phase 2|Withdrawal by Subject|0|||
126284313|NCT00086281|454328935|FG005|Phase 1|Serious Adverse Event|0|||
126284314|NCT00086281|454328936|FG006|Phase 1|Serious Adverse Event|0|||
126284315|NCT00086281|454328937|FG007|Phase 1|Serious Adverse Event|0|||
126284316|NCT00086281|454328938|FG008|Phase 1|Serious Adverse Event|0|||
126284317|NCT00086281|454328939|FG009|Phase 1|Serious Adverse Event|0|||
126284318|NCT00086281|454328940|FG010|Phase 1|Serious Adverse Event|0|||
126284319|NCT00086281|454328941|FG011|Phase 1|Serious Adverse Event|0|||
126284320|NCT00086281|454328942|FG012|Phase 1|Serious Adverse Event|0|||
126284321|NCT00086281|454328943|FG013|Phase 1|Serious Adverse Event|0|||
126284322|NCT00086281|454328944|FG014|Phase 1|Serious Adverse Event|1|||
126284323|NCT00086281|454328930|FG000|Phase 2|Adverse Event|0|||
126284324|NCT00086281|454328931|FG001|Phase 2|Adverse Event|0|||
126284325|NCT00086281|454328932|FG002|Phase 2|Adverse Event|0|||
126284326|NCT00086281|454328933|FG003|Phase 2|Adverse Event|0|||
126284327|NCT00086281|454328934|FG004|Phase 2|Adverse Event|0|||
126284328|NCT00086281|454328935|FG005|Phase 2|Adverse Event|0|||
126284329|NCT00086281|454328936|FG006|Phase 2|Adverse Event|0|||
126284330|NCT00086281|454328937|FG007|Phase 2|Adverse Event|0|||
126284331|NCT00086281|454328938|FG008|Phase 2|Adverse Event|0|||
126284332|NCT00086281|454328939|FG009|Phase 2|Adverse Event|0|||
126284333|NCT00086281|454328940|FG010|Phase 2|Adverse Event|0|||
126284334|NCT00086281|454328941|FG011|Phase 2|Adverse Event|0|||
126284335|NCT00086281|454328942|FG012|Phase 2|Adverse Event|1|||
126284336|NCT00086281|454328943|FG013|Phase 2|Adverse Event|1|||
126284337|NCT00086281|454328944|FG014|Phase 2|Adverse Event|0|||
126284338|NCT02996487|454328945|FG000|Overall Study|Lost to Follow-up|1|||
126284339|NCT02996487|454328946|FG001|Overall Study|Lost to Follow-up|1|||
126284340|NCT02996487|454328947|FG002|Overall Study|Lost to Follow-up|0|||
126284341|NCT02996487|454328945|FG000|Overall Study|Death|0|||
126284342|NCT02996487|454328946|FG001|Overall Study|Death|1|||
126284343|NCT02996487|454328947|FG002|Overall Study|Death|0|||
126284344|NCT02996487|454328945|FG000|Overall Study|Withdrawal by Subject|2|||
126284345|NCT02996487|454328946|FG001|Overall Study|Withdrawal by Subject|3|||
126284346|NCT02996487|454328947|FG002|Overall Study|Withdrawal by Subject|0|||
126284347|NCT01301729|454328949|FG000|Overall Study|Withdrawal by Subject|2|||
126284348|NCT01301729|454328949|FG000|Overall Study|Participant did not Return for Treatment|1|||
126284349|NCT01301729|454328949|FG000|Overall Study|Violated Selection Criteria|1|||
126284350|NCT03071276|454328950|FG000|Overall Study|Adverse Event|1|||
126284351|NCT03071276|454328950|FG000|Overall Study|Lack of Efficacy|14|||
126284352|NCT03390426|454328951|FG000|Overall Study|Protocol Violation|0|||
126284353|NCT03390426|454328952|FG001|Overall Study|Protocol Violation|1|||
126284354|NCT02516553|454328957|FG000|Overall Study|Progressive disease|2|||
126284355|NCT02516553|454328958|FG001|Overall Study|Progressive disease|2|||
126284356|NCT02516553|454328959|FG002|Overall Study|Progressive disease|3|||
126284357|NCT02516553|454328960|FG003|Overall Study|Progressive disease|5|||
126284358|NCT02516553|454328961|FG004|Overall Study|Progressive disease|3|||
126284359|NCT02516553|454328962|FG005|Overall Study|Progressive disease|0|||
125882521|NCT01208207|452868989|FG005|Part I|Withdrawal by Subject|0|||
126284360|NCT02516553|454328963|FG006|Overall Study|Progressive disease|5|||
126284361|NCT02516553|454328964|FG007|Overall Study|Progressive disease|5|||
125882522|NCT01208207|452868990|FG006|Part I|Withdrawal by Subject|0|||
126284362|NCT02516553|454328965|FG008|Overall Study|Progressive disease|11|||
126284363|NCT02516553|454328966|FG009|Overall Study|Progressive disease|3|||
126284364|NCT02516553|454328967|FG010|Overall Study|Progressive disease|10|||
126284365|NCT02516553|454328968|FG011|Overall Study|Progressive disease|8|||
126284366|NCT02516553|454328969|FG012|Overall Study|Progressive disease|8|||
126284367|NCT02516553|454328970|FG013|Overall Study|Progressive disease|2|||
126284368|NCT02516553|454328971|FG014|Overall Study|Progressive disease|2|||
126284369|NCT02516553|454328972|FG015|Overall Study|Progressive disease|2|||
126284370|NCT02516553|454328973|FG016|Overall Study|Progressive disease|1|||
126284371|NCT02516553|454328974|FG017|Overall Study|Progressive disease|9|||
126284372|NCT02516553|454328975|FG018|Overall Study|Progressive disease|12|||
126284373|NCT02516553|454328976|FG019|Overall Study|Progressive disease|7|||
126284374|NCT02516553|454328977|FG020|Overall Study|Progressive disease|16|||
126284375|NCT02516553|454328978|FG021|Overall Study|Progressive disease|18|||
126284376|NCT02516553|454328957|FG000|Overall Study|Dose limiting toxicity|0|||
126284377|NCT02516553|454328958|FG001|Overall Study|Dose limiting toxicity|0|||
126284378|NCT02516553|454328959|FG002|Overall Study|Dose limiting toxicity|0|||
126284379|NCT02516553|454328960|FG003|Overall Study|Dose limiting toxicity|0|||
126284380|NCT02516553|454328961|FG004|Overall Study|Dose limiting toxicity|3|||
126284381|NCT02516553|454328962|FG005|Overall Study|Dose limiting toxicity|1|||
126284382|NCT02516553|454328963|FG006|Overall Study|Dose limiting toxicity|1|||
126284383|NCT02516553|454328964|FG007|Overall Study|Dose limiting toxicity|0|||
126284384|NCT02516553|454328965|FG008|Overall Study|Dose limiting toxicity|1|||
126284385|NCT02516553|454328966|FG009|Overall Study|Dose limiting toxicity|0|||
126284386|NCT02516553|454328967|FG010|Overall Study|Dose limiting toxicity|0|||
126284387|NCT02516553|454328968|FG011|Overall Study|Dose limiting toxicity|1|||
126284388|NCT02516553|454328969|FG012|Overall Study|Dose limiting toxicity|0|||
126284389|NCT02516553|454328970|FG013|Overall Study|Dose limiting toxicity|1|||
126284390|NCT02516553|454328971|FG014|Overall Study|Dose limiting toxicity|0|||
126284391|NCT02516553|454328972|FG015|Overall Study|Dose limiting toxicity|0|||
126284392|NCT02516553|454328973|FG016|Overall Study|Dose limiting toxicity|1|||
126284393|NCT02516553|454328974|FG017|Overall Study|Dose limiting toxicity|1|||
126284394|NCT02516553|454328975|FG018|Overall Study|Dose limiting toxicity|0|||
126284395|NCT02516553|454328976|FG019|Overall Study|Dose limiting toxicity|2|||
126284396|NCT02516553|454328977|FG020|Overall Study|Dose limiting toxicity|0|||
126284397|NCT02516553|454328978|FG021|Overall Study|Dose limiting toxicity|0|||
126284398|NCT02516553|454328957|FG000|Overall Study|Other Adverse Events|0|||
126284399|NCT02516553|454328958|FG001|Overall Study|Other Adverse Events|0|||
126284400|NCT02516553|454328959|FG002|Overall Study|Other Adverse Events|0|||
126284401|NCT02516553|454328960|FG003|Overall Study|Other Adverse Events|1|||
126284402|NCT02516553|454328961|FG004|Overall Study|Other Adverse Events|0|||
126284403|NCT02516553|454328962|FG005|Overall Study|Other Adverse Events|1|||
126284404|NCT02516553|454328963|FG006|Overall Study|Other Adverse Events|0|||
126284405|NCT02516553|454328964|FG007|Overall Study|Other Adverse Events|0|||
126284406|NCT02516553|454328965|FG008|Overall Study|Other Adverse Events|0|||
126284407|NCT02516553|454328966|FG009|Overall Study|Other Adverse Events|1|||
126284408|NCT02516553|454328967|FG010|Overall Study|Other Adverse Events|3|||
126284409|NCT02516553|454328968|FG011|Overall Study|Other Adverse Events|2|||
126284410|NCT02516553|454328969|FG012|Overall Study|Other Adverse Events|0|||
126284411|NCT02516553|454328970|FG013|Overall Study|Other Adverse Events|1|||
126284412|NCT02516553|454328971|FG014|Overall Study|Other Adverse Events|0|||
126284413|NCT02516553|454328972|FG015|Overall Study|Other Adverse Events|0|||
126284414|NCT02516553|454328973|FG016|Overall Study|Other Adverse Events|0|||
126284415|NCT02516553|454328974|FG017|Overall Study|Other Adverse Events|2|||
126284416|NCT02516553|454328975|FG018|Overall Study|Other Adverse Events|1|||
126284417|NCT02516553|454328976|FG019|Overall Study|Other Adverse Events|2|||
126284418|NCT02516553|454328977|FG020|Overall Study|Other Adverse Events|2|||
126284419|NCT02516553|454328978|FG021|Overall Study|Other Adverse Events|1|||
126284420|NCT02516553|454328957|FG000|Overall Study|Refused to continue trial medication|0|||
126284421|NCT02516553|454328958|FG001|Overall Study|Refused to continue trial medication|0|||
126284422|NCT02516553|454328959|FG002|Overall Study|Refused to continue trial medication|0|||
126284423|NCT02516553|454328960|FG003|Overall Study|Refused to continue trial medication|0|||
126284424|NCT02516553|454328961|FG004|Overall Study|Refused to continue trial medication|0|||
126284425|NCT02516553|454328962|FG005|Overall Study|Refused to continue trial medication|0|||
126284426|NCT02516553|454328963|FG006|Overall Study|Refused to continue trial medication|0|||
126284427|NCT02516553|454328964|FG007|Overall Study|Refused to continue trial medication|0|||
126284428|NCT02516553|454328965|FG008|Overall Study|Refused to continue trial medication|0|||
126284429|NCT02516553|454328966|FG009|Overall Study|Refused to continue trial medication|0|||
126284430|NCT02516553|454328967|FG010|Overall Study|Refused to continue trial medication|1|||
126284431|NCT02516553|454328968|FG011|Overall Study|Refused to continue trial medication|0|||
126284432|NCT02516553|454328969|FG012|Overall Study|Refused to continue trial medication|0|||
126284433|NCT02516553|454328970|FG013|Overall Study|Refused to continue trial medication|0|||
126284434|NCT02516553|454328971|FG014|Overall Study|Refused to continue trial medication|0|||
126284435|NCT02516553|454328972|FG015|Overall Study|Refused to continue trial medication|0|||
126284436|NCT02516553|454328973|FG016|Overall Study|Refused to continue trial medication|0|||
126284437|NCT02516553|454328974|FG017|Overall Study|Refused to continue trial medication|0|||
126284438|NCT02516553|454328975|FG018|Overall Study|Refused to continue trial medication|1|||
126284439|NCT02516553|454328976|FG019|Overall Study|Refused to continue trial medication|0|||
126284440|NCT02516553|454328977|FG020|Overall Study|Refused to continue trial medication|0|||
126284441|NCT02516553|454328978|FG021|Overall Study|Refused to continue trial medication|1|||
126284442|NCT02516553|454328957|FG000|Overall Study|other reasons than listed|0|||
126284443|NCT02516553|454328958|FG001|Overall Study|other reasons than listed|0|||
126284444|NCT02516553|454328959|FG002|Overall Study|other reasons than listed|0|||
126284445|NCT02516553|454328960|FG003|Overall Study|other reasons than listed|0|||
126284446|NCT02516553|454328961|FG004|Overall Study|other reasons than listed|0|||
126284447|NCT02516553|454328962|FG005|Overall Study|other reasons than listed|0|||
126284448|NCT02516553|454328963|FG006|Overall Study|other reasons than listed|0|||
126284449|NCT02516553|454328964|FG007|Overall Study|other reasons than listed|1|||
126284450|NCT02516553|454328965|FG008|Overall Study|other reasons than listed|1|||
126284451|NCT02516553|454328966|FG009|Overall Study|other reasons than listed|0|||
126284452|NCT02516553|454328967|FG010|Overall Study|other reasons than listed|1|||
126284453|NCT02516553|454328968|FG011|Overall Study|other reasons than listed|1|||
126284454|NCT02516553|454328969|FG012|Overall Study|other reasons than listed|0|||
126284455|NCT02516553|454328970|FG013|Overall Study|other reasons than listed|0|||
126284456|NCT02516553|454328971|FG014|Overall Study|other reasons than listed|0|||
126284457|NCT02516553|454328972|FG015|Overall Study|other reasons than listed|0|||
126284458|NCT02516553|454328973|FG016|Overall Study|other reasons than listed|0|||
126284459|NCT02516553|454328974|FG017|Overall Study|other reasons than listed|0|||
126284460|NCT02516553|454328975|FG018|Overall Study|other reasons than listed|0|||
126284461|NCT02516553|454328976|FG019|Overall Study|other reasons than listed|0|||
126284462|NCT02516553|454328977|FG020|Overall Study|other reasons than listed|2|||
126284463|NCT02516553|454328978|FG021|Overall Study|other reasons than listed|2|||
126284464|NCT02924727|454328981|FG000|Overall Study|Withdrawal by Subject|2|||
126284465|NCT02924727|454328982|FG001|Overall Study|Withdrawal by Subject|4|||
126284466|NCT02924727|454328981|FG000|Overall Study|Lost to Follow-up|2|||
126284467|NCT02924727|454328982|FG001|Overall Study|Lost to Follow-up|5|||
126284468|NCT02924727|454328981|FG000|Overall Study|Death|221|||
126284469|NCT02924727|454328982|FG001|Overall Study|Death|247|||
126284470|NCT02924727|454328981|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
126284471|NCT02924727|454328982|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
126284472|NCT04102189|454328985|FG000|Overall Study|Withdrawal by Subject|1|||
126284473|NCT04102189|454328986|FG001|Overall Study|Withdrawal by Subject|2|||
126284474|NCT04102189|454328985|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126284475|NCT04102189|454328986|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126284476|NCT04102189|454328985|FG000|Overall Study|Lost to Follow-up|1|||
126284477|NCT04102189|454328986|FG001|Overall Study|Lost to Follow-up|0|||
126284478|NCT02933255|454328991|FG000|Overall Study|Discontinued due to study closure.|1|||
126284479|NCT02933255|454328992|FG001|Overall Study|Discontinued due to study closure.|0|||
126284480|NCT04803305|454328993|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
126284481|NCT04803305|454328994|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
126284482|NCT04803305|454328993|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
126284483|NCT04803305|454328994|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
126284484|NCT04803305|454328993|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
126284485|NCT04803305|454328994|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
126284486|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
126284487|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
126284488|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
126284489|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
126284490|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
126284491|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
126284492|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
126284493|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
126284494|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
126284495|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
126284496|NCT03316547|454328996|FG000|Overall Study|Death|3|||
126284497|NCT03316547|454328997|FG001|Overall Study|Death|1|||
126284498|NCT03316547|454328996|FG000|Overall Study|Lost to Follow-up|6|||
126284499|NCT03316547|454328997|FG001|Overall Study|Lost to Follow-up|6|||
126284500|NCT03316547|454328996|FG000|Overall Study|Withdrawal by Subject|3|||
126364951|NCT04082364|454630379|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
126364952|NCT04082364|454630380|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
126364953|NCT04082364|454630381|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
126364954|NCT04082364|454630377|FG000|Overall Study|Disease progression|0|||
126364955|NCT04082364|454630378|FG001|Overall Study|Disease progression|0|||
126364956|NCT04082364|454630379|FG002|Overall Study|Disease progression|0|||
126364957|NCT04082364|454630380|FG003|Overall Study|Disease progression|1|||
126364958|NCT04082364|454630381|FG004|Overall Study|Disease progression|0|||
126364959|NCT03186378|454630382|FG000|Overall Study|Lost to Follow-up|1|||
125882523|NCT01208207|452868984|FG000|Part II|Withdrawal by Subject|0|||
126284501|NCT03316547|454328997|FG001|Overall Study|Withdrawal by Subject|2|||
126284502|NCT03316547|454328996|FG000|Overall Study|Transfer to another hospital|6|||
126284503|NCT03316547|454328997|FG001|Overall Study|Transfer to another hospital|4|||
126284504|NCT00721227|454328998|FG000|Overall Study|Lost to Follow-up|3|||
126284505|NCT00721227|454328999|FG001|Overall Study|Lost to Follow-up|0|||
125882524|NCT01208207|452868985|FG001|Part II|Withdrawal by Subject|0|||
126364960|NCT03186378|454630383|FG001|Overall Study|Lost to Follow-up|0|||
126284506|NCT00721227|454328998|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
126284507|NCT00721227|454328999|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
126284508|NCT02759692|454329000|FG000|Period 1|Test article no longer available|1|||
126284509|NCT02759692|454329001|FG001|Period 1|Test article no longer available|1|||
126284510|NCT02759692|454329000|FG000|Period 1|No longer meets eligibility criteria.|1|||
126284511|NCT02759692|454329001|FG001|Period 1|No longer meets eligibility criteria.|0|||
126284512|NCT02759692|454329000|FG000|Period 1|Miss-Randomized|1|||
126284513|NCT02759692|454329001|FG001|Period 1|Miss-Randomized|1|||
126284514|NCT02759692|454329000|FG000|Period 2|Lost to Follow-up|1|||
126284515|NCT02759692|454329001|FG001|Period 2|Lost to Follow-up|0|||
126284516|NCT02759692|454329000|FG000|Period 2|Test article no longer available|0|||
126284517|NCT02759692|454329001|FG001|Period 2|Test article no longer available|1|||
126284518|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
126284519|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
126284520|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
126284521|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
126284522|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
126284523|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
126284524|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
126284525|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
126284526|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
126284527|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
126284528|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
126284529|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
126284530|NCT00451178|454329002|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
126284531|NCT00451178|454329003|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
126284532|NCT00451178|454329002|FG000|Prior to Maintenance Therapy|PD|2|||
126284533|NCT00451178|454329003|FG001|Prior to Maintenance Therapy|PD|0|||
126284534|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
126284535|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
126284536|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
126284537|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
126284538|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
126284539|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
126284540|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
126284541|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
126284542|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
126284543|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
126284544|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
126284545|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
126284546|NCT00451178|454329002|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
126284547|NCT00451178|454329003|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
126284548|NCT01243775|454329004|FG000|Overall Study|Withdrawal by Subject|2|||
126284549|NCT03207867|454329005|FG000|Overall Study|Adverse Event|1|||
126284550|NCT03207867|454329006|FG001|Overall Study|Adverse Event|0|||
126284551|NCT03207867|454329007|FG002|Overall Study|Adverse Event|1|||
126284552|NCT03207867|454329008|FG003|Overall Study|Adverse Event|0|||
126284553|NCT03207867|454329009|FG004|Overall Study|Adverse Event|0|||
126284554|NCT03207867|454329010|FG005|Overall Study|Adverse Event|2|||
126284555|NCT03207867|454329011|FG006|Overall Study|Adverse Event|1|||
126284556|NCT03207867|454329012|FG007|Overall Study|Adverse Event|1|||
126284557|NCT03207867|454329013|FG008|Overall Study|Adverse Event|2|||
126284558|NCT03207867|454329014|FG009|Overall Study|Adverse Event|2|||
126284559|NCT03207867|454329015|FG010|Overall Study|Adverse Event|0|||
126284560|NCT03207867|454329016|FG011|Overall Study|Adverse Event|0|||
126284561|NCT03207867|454329017|FG012|Overall Study|Adverse Event|0|||
126284562|NCT03207867|454329018|FG013|Overall Study|Adverse Event|0|||
126284563|NCT03207867|454329019|FG014|Overall Study|Adverse Event|0|||
126284564|NCT03207867|454329020|FG015|Overall Study|Adverse Event|0|||
126284565|NCT03207867|454329021|FG016|Overall Study|Adverse Event|3|||
126284566|NCT03207867|454329022|FG017|Overall Study|Adverse Event|1|||
126284567|NCT03207867|454329023|FG018|Overall Study|Adverse Event|2|||
126284568|NCT03207867|454329024|FG019|Overall Study|Adverse Event|1|||
126284569|NCT03207867|454329025|FG020|Overall Study|Adverse Event|0|||
126284570|NCT03207867|454329026|FG021|Overall Study|Adverse Event|0|||
126284571|NCT03207867|454329027|FG022|Overall Study|Adverse Event|0|||
126284572|NCT03207867|454329028|FG023|Overall Study|Adverse Event|0|||
126284573|NCT03207867|454329005|FG000|Overall Study|Death|0|||
126284574|NCT03207867|454329006|FG001|Overall Study|Death|0|||
126284575|NCT03207867|454329007|FG002|Overall Study|Death|0|||
126284576|NCT03207867|454329008|FG003|Overall Study|Death|0|||
126040746|NCT02240238|453447167|FG000|Phase 2|Physician Decision|0|||
126040747|NCT02240238|453447168|FG001|Phase 2|Physician Decision|0|||
126284577|NCT03207867|454329009|FG004|Overall Study|Death|0|||
126284578|NCT03207867|454329010|FG005|Overall Study|Death|1|||
126284579|NCT03207867|454329011|FG006|Overall Study|Death|0|||
126284580|NCT03207867|454329012|FG007|Overall Study|Death|3|||
126284581|NCT03207867|454329013|FG008|Overall Study|Death|1|||
126284582|NCT03207867|454329014|FG009|Overall Study|Death|2|||
126284583|NCT03207867|454329015|FG010|Overall Study|Death|0|||
126284584|NCT03207867|454329016|FG011|Overall Study|Death|1|||
126284585|NCT03207867|454329017|FG012|Overall Study|Death|0|||
126284586|NCT03207867|454329018|FG013|Overall Study|Death|1|||
126284587|NCT03207867|454329019|FG014|Overall Study|Death|0|||
126284588|NCT03207867|454329020|FG015|Overall Study|Death|0|||
126284589|NCT03207867|454329021|FG016|Overall Study|Death|0|||
126284590|NCT03207867|454329022|FG017|Overall Study|Death|2|||
126284591|NCT03207867|454329023|FG018|Overall Study|Death|0|||
126284592|NCT03207867|454329024|FG019|Overall Study|Death|1|||
126284593|NCT03207867|454329025|FG020|Overall Study|Death|0|||
126284594|NCT03207867|454329026|FG021|Overall Study|Death|0|||
126284595|NCT03207867|454329027|FG022|Overall Study|Death|0|||
126284596|NCT03207867|454329028|FG023|Overall Study|Death|0|||
126284597|NCT03207867|454329005|FG000|Overall Study|Physician Decision|3|||
126284598|NCT03207867|454329006|FG001|Overall Study|Physician Decision|5|||
126284599|NCT03207867|454329007|FG002|Overall Study|Physician Decision|0|||
126284600|NCT03207867|454329008|FG003|Overall Study|Physician Decision|3|||
126284601|NCT03207867|454329009|FG004|Overall Study|Physician Decision|2|||
126284602|NCT03207867|454329010|FG005|Overall Study|Physician Decision|0|||
126284603|NCT03207867|454329011|FG006|Overall Study|Physician Decision|0|||
126284604|NCT03207867|454329012|FG007|Overall Study|Physician Decision|0|||
126284605|NCT03207867|454329013|FG008|Overall Study|Physician Decision|4|||
126284606|NCT03207867|454329014|FG009|Overall Study|Physician Decision|2|||
126284607|NCT03207867|454329015|FG010|Overall Study|Physician Decision|0|||
126284608|NCT03207867|454329016|FG011|Overall Study|Physician Decision|4|||
126284609|NCT03207867|454329017|FG012|Overall Study|Physician Decision|0|||
126284610|NCT03207867|454329018|FG013|Overall Study|Physician Decision|0|||
126284611|NCT03207867|454329019|FG014|Overall Study|Physician Decision|2|||
126284612|NCT03207867|454329020|FG015|Overall Study|Physician Decision|1|||
126284613|NCT03207867|454329021|FG016|Overall Study|Physician Decision|1|||
126284614|NCT03207867|454329022|FG017|Overall Study|Physician Decision|2|||
126284615|NCT03207867|454329023|FG018|Overall Study|Physician Decision|1|||
126284616|NCT03207867|454329024|FG019|Overall Study|Physician Decision|3|||
126284617|NCT03207867|454329025|FG020|Overall Study|Physician Decision|0|||
126284618|NCT03207867|454329026|FG021|Overall Study|Physician Decision|0|||
126284619|NCT03207867|454329027|FG022|Overall Study|Physician Decision|0|||
126284620|NCT03207867|454329028|FG023|Overall Study|Physician Decision|0|||
126284621|NCT03207867|454329005|FG000|Overall Study|Progressive Disease|7|||
126284622|NCT03207867|454329006|FG001|Overall Study|Progressive Disease|7|||
126284623|NCT03207867|454329007|FG002|Overall Study|Progressive Disease|9|||
126284624|NCT03207867|454329008|FG003|Overall Study|Progressive Disease|10|||
126284625|NCT03207867|454329009|FG004|Overall Study|Progressive Disease|11|||
126284626|NCT03207867|454329010|FG005|Overall Study|Progressive Disease|10|||
126284627|NCT03207867|454329011|FG006|Overall Study|Progressive Disease|9|||
126284628|NCT03207867|454329012|FG007|Overall Study|Progressive Disease|8|||
126284629|NCT03207867|454329013|FG008|Overall Study|Progressive Disease|19|||
126284630|NCT03207867|454329014|FG009|Overall Study|Progressive Disease|23|||
126284631|NCT03207867|454329015|FG010|Overall Study|Progressive Disease|2|||
126284632|NCT03207867|454329016|FG011|Overall Study|Progressive Disease|24|||
126284633|NCT03207867|454329017|FG012|Overall Study|Progressive Disease|3|||
126284634|NCT03207867|454329018|FG013|Overall Study|Progressive Disease|11|||
126284635|NCT03207867|454329019|FG014|Overall Study|Progressive Disease|9|||
126284636|NCT03207867|454329020|FG015|Overall Study|Progressive Disease|5|||
126364961|NCT02514746|454630384|FG000|Overall Study|Chronically Ill|1|||
126364962|NCT02514746|454630385|FG001|Overall Study|Chronically Ill|2|||
125882525|NCT01208207|452868986|FG002|Part II|Withdrawal by Subject|0|||
126284637|NCT03207867|454329021|FG016|Overall Study|Progressive Disease|10|||
126284638|NCT03207867|454329022|FG017|Overall Study|Progressive Disease|14|||
126040748|NCT02240238|453447169|FG002|Phase 2|Physician Decision|0|||
126040749|NCT02240238|453447170|FG003|Phase 2|Physician Decision|0|||
126284639|NCT03207867|454329023|FG018|Overall Study|Progressive Disease|13|||
126284640|NCT03207867|454329024|FG019|Overall Study|Progressive Disease|14|||
126284641|NCT03207867|454329025|FG020|Overall Study|Progressive Disease|6|||
126284642|NCT03207867|454329026|FG021|Overall Study|Progressive Disease|3|||
126284643|NCT03207867|454329027|FG022|Overall Study|Progressive Disease|3|||
126284644|NCT03207867|454329028|FG023|Overall Study|Progressive Disease|3|||
126284645|NCT03207867|454329005|FG000|Overall Study|Patient/guardian Decision|0|||
126284646|NCT03207867|454329006|FG001|Overall Study|Patient/guardian Decision|0|||
126284647|NCT03207867|454329007|FG002|Overall Study|Patient/guardian Decision|1|||
126284648|NCT03207867|454329008|FG003|Overall Study|Patient/guardian Decision|1|||
126284649|NCT03207867|454329009|FG004|Overall Study|Patient/guardian Decision|1|||
126284650|NCT03207867|454329010|FG005|Overall Study|Patient/guardian Decision|2|||
126284651|NCT03207867|454329011|FG006|Overall Study|Patient/guardian Decision|1|||
126284652|NCT03207867|454329012|FG007|Overall Study|Patient/guardian Decision|0|||
126284653|NCT03207867|454329013|FG008|Overall Study|Patient/guardian Decision|1|||
126284654|NCT03207867|454329014|FG009|Overall Study|Patient/guardian Decision|0|||
126284655|NCT03207867|454329015|FG010|Overall Study|Patient/guardian Decision|0|||
126284656|NCT03207867|454329016|FG011|Overall Study|Patient/guardian Decision|1|||
126284657|NCT03207867|454329017|FG012|Overall Study|Patient/guardian Decision|0|||
126284658|NCT03207867|454329018|FG013|Overall Study|Patient/guardian Decision|1|||
126284659|NCT03207867|454329019|FG014|Overall Study|Patient/guardian Decision|2|||
126284660|NCT03207867|454329020|FG015|Overall Study|Patient/guardian Decision|0|||
126284661|NCT03207867|454329021|FG016|Overall Study|Patient/guardian Decision|1|||
126284662|NCT03207867|454329022|FG017|Overall Study|Patient/guardian Decision|3|||
126284663|NCT03207867|454329023|FG018|Overall Study|Patient/guardian Decision|4|||
126284664|NCT03207867|454329024|FG019|Overall Study|Patient/guardian Decision|1|||
126284665|NCT03207867|454329025|FG020|Overall Study|Patient/guardian Decision|0|||
126284666|NCT03207867|454329026|FG021|Overall Study|Patient/guardian Decision|0|||
126284667|NCT03207867|454329027|FG022|Overall Study|Patient/guardian Decision|0|||
126284668|NCT03207867|454329028|FG023|Overall Study|Patient/guardian Decision|0|||
126284669|NCT02447744|454329029|FG000|Overall Study|Withdrawal by Subject|3|||
126284670|NCT02447744|454329030|FG001|Overall Study|Withdrawal by Subject|1|||
126284671|NCT02447744|454329029|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
126284672|NCT02447744|454329030|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
126284673|NCT05422625|454329031|FG000|Overall Study|Withdrawal by Subject|1|||
126284674|NCT05422625|454329032|FG001|Overall Study|Withdrawal by Subject|0|||
126306289|NCT03063086|454410267|FG003|Overall Study|subject/guardian decision|0|||
126306290|NCT03063086|454410268|FG004|Overall Study|subject/guardian decision|0|||
126306291|NCT03063086|454410269|FG005|Overall Study|subject/guardian decision|0|||
126306292|NCT03063086|454410264|FG000|Overall Study|Non-compliance with study treatment|0|||
126306293|NCT03063086|454410265|FG001|Overall Study|Non-compliance with study treatment|0|||
126306294|NCT03063086|454410266|FG002|Overall Study|Non-compliance with study treatment|0|||
126306295|NCT03063086|454410267|FG003|Overall Study|Non-compliance with study treatment|1|||
126306296|NCT03063086|454410268|FG004|Overall Study|Non-compliance with study treatment|0|||
126306297|NCT03063086|454410269|FG005|Overall Study|Non-compliance with study treatment|1|||
126306298|NCT03063086|454410264|FG000|Overall Study|Physician Decision|0|||
126306299|NCT03063086|454410265|FG001|Overall Study|Physician Decision|0|||
126306300|NCT03063086|454410266|FG002|Overall Study|Physician Decision|0|||
126306301|NCT03063086|454410267|FG003|Overall Study|Physician Decision|1|||
126306302|NCT03063086|454410268|FG004|Overall Study|Physician Decision|0|||
126306303|NCT03063086|454410269|FG005|Overall Study|Physician Decision|0|||
126306304|NCT02218736|454410270|FG000|Overall Study|Withdrawal by Subject|10|||
126306305|NCT02218736|454410271|FG001|Overall Study|Withdrawal by Subject|9|||
126306306|NCT02218736|454410270|FG000|Overall Study|Protocol Violation|2|||
126306307|NCT02218736|454410271|FG001|Overall Study|Protocol Violation|0|||
126306308|NCT02244463|454410274|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
126306309|NCT02244463|454410275|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306310|NCT02244463|454410276|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306311|NCT02244463|454410277|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306312|NCT02244463|454410278|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306313|NCT02244463|454410279|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306314|NCT02244463|454410274|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
126306315|NCT02244463|454410275|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
126306316|NCT02244463|454410276|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
126306317|NCT02244463|454410277|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
126306318|NCT02244463|454410278|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
126306319|NCT02244463|454410279|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
126306320|NCT02244463|454410274|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306321|NCT02244463|454410275|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
126306322|NCT02244463|454410276|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306323|NCT02244463|454410277|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306324|NCT02244463|454410278|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306325|NCT02244463|454410279|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306326|NCT02244463|454410274|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126306327|NCT02244463|454410275|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126306328|NCT02244463|454410276|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
126306329|NCT02244463|454410277|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126306330|NCT02244463|454410278|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126306331|NCT02244463|454410279|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126284675|NCT03922529|454331015|FG000|Overall Study|Withdrawal by Subject|13|||
126284676|NCT03922529|454331016|FG001|Overall Study|Withdrawal by Subject|12|||
126284677|NCT03922529|454331015|FG000|Overall Study|Death|7|||
126284678|NCT03922529|454331016|FG001|Overall Study|Death|12|||
126284679|NCT03922529|454331015|FG000|Overall Study|Lost to Follow-up|12|||
126284680|NCT03922529|454331016|FG001|Overall Study|Lost to Follow-up|19|||
126284681|NCT03922529|454331015|FG000|Overall Study|Adverse Event|1|||
126284682|NCT03922529|454331016|FG001|Overall Study|Adverse Event|0|||
126284683|NCT03922529|454331015|FG000|Overall Study|Death after withdrawal|1|||
126284684|NCT03922529|454331016|FG001|Overall Study|Death after withdrawal|0|||
126284685|NCT03922529|454331015|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
126284686|NCT03922529|454331016|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
126284687|NCT03922529|454331015|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
126284688|NCT03922529|454331016|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
126284689|NCT02017015|454331017|FG000|Overall Study|Adverse Event|9|||
126284690|NCT02017015|454331017|FG000|Overall Study|Withdrawal by Subject|21|||
126284691|NCT02017015|454331017|FG000|Overall Study|Death|4|||
126284692|NCT02017015|454331017|FG000|Overall Study|Progressive Disease|31|||
126284693|NCT02017015|454331017|FG000|Overall Study|Non-compliance with study drug|2|||
126284694|NCT02017015|454331017|FG000|Overall Study|Physician Decision|2|||
126284695|NCT01277601|454331020|FG000|Overall Study|Adverse Event|5|||
126284696|NCT01277601|454331021|FG001|Overall Study|Adverse Event|3|||
126284697|NCT01277601|454331022|FG002|Overall Study|Adverse Event|0|||
126284698|NCT01277601|454331023|FG003|Overall Study|Adverse Event|7|||
126284699|NCT01277601|454331020|FG000|Overall Study|Withdrawal by Subject|18|||
126284700|NCT01277601|454331021|FG001|Overall Study|Withdrawal by Subject|21|||
126284701|NCT01277601|454331022|FG002|Overall Study|Withdrawal by Subject|8|||
126284702|NCT01277601|454331023|FG003|Overall Study|Withdrawal by Subject|17|||
126284703|NCT01277601|454331020|FG000|Overall Study|Lost to Follow-up|7|||
126284704|NCT01277601|454331021|FG001|Overall Study|Lost to Follow-up|9|||
126284705|NCT01277601|454331022|FG002|Overall Study|Lost to Follow-up|4|||
126284706|NCT01277601|454331023|FG003|Overall Study|Lost to Follow-up|2|||
126284707|NCT01277601|454331020|FG000|Overall Study|Physician Decision|3|||
126284708|NCT01277601|454331021|FG001|Overall Study|Physician Decision|5|||
126284709|NCT01277601|454331022|FG002|Overall Study|Physician Decision|1|||
126284710|NCT01277601|454331023|FG003|Overall Study|Physician Decision|6|||
126284711|NCT01277601|454331020|FG000|Overall Study|Pregnancy|2|||
126284712|NCT01277601|454331021|FG001|Overall Study|Pregnancy|2|||
126284713|NCT01277601|454331022|FG002|Overall Study|Pregnancy|4|||
126284714|NCT01277601|454331023|FG003|Overall Study|Pregnancy|1|||
126284715|NCT01277601|454331020|FG000|Overall Study|Noncompliance with Study Drug|1|||
126284716|NCT01277601|454331021|FG001|Overall Study|Noncompliance with Study Drug|3|||
126284717|NCT01277601|454331022|FG002|Overall Study|Noncompliance with Study Drug|2|||
126284718|NCT01277601|454331023|FG003|Overall Study|Noncompliance with Study Drug|0|||
126284719|NCT01277601|454331020|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
126284720|NCT01277601|454331021|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
126284721|NCT01277601|454331022|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
126284722|NCT01277601|454331023|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
126284723|NCT01277601|454331020|FG000|Overall Study|Protocol Violation|0|||
126284724|NCT01277601|454331021|FG001|Overall Study|Protocol Violation|2|||
126284725|NCT01277601|454331022|FG002|Overall Study|Protocol Violation|5|||
126284726|NCT01277601|454331023|FG003|Overall Study|Protocol Violation|0|||
126284727|NCT01277601|454331020|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
126284728|NCT01277601|454331021|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
126284729|NCT01277601|454331022|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
126284730|NCT01277601|454331023|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
126284731|NCT02291510|454331024|FG000|Overall Study|Adverse Event|0|||
126284732|NCT02291510|454331025|FG001|Overall Study|Adverse Event|0|||
126284733|NCT02291510|454331026|FG002|Overall Study|Adverse Event|0|||
126284734|NCT02291510|454331027|FG003|Overall Study|Adverse Event|1|||
126284735|NCT06390839|454331028|FG000|Overall Study|Ineligible|2|||
126284736|NCT06390839|454331028|FG000|Overall Study|Never start protocol therapy|3|||
126284737|NCT06390839|454331028|FG000|Overall Study|Adverse Event|1|||
126284738|NCT06390839|454331028|FG000|Overall Study|Alternative therapy|2|||
126284739|NCT06390839|454331028|FG000|Overall Study|Death|3|||
126284740|NCT06390839|454331028|FG000|Overall Study|Disease progression|28|||
126364963|NCT02514746|454630384|FG000|Overall Study|Physician Decision|4|||
126284741|NCT06390839|454331028|FG000|Overall Study|Withdrawal by Subject|2|||
126284742|NCT06390839|454331028|FG000|Overall Study|Complicating disease|1|||
126284743|NCT06390839|454331028|FG000|Overall Study|Noncompliance|1|||
126284744|NCT03203850|454331029|FG000|Overall Study|Subject/guardian decision|4|||
126284745|NCT03203850|454331030|FG001|Overall Study|Subject/guardian decision|3|||
126284746|NCT03203850|454331029|FG000|Overall Study|Adverse Event|3|||
126284747|NCT03203850|454331030|FG001|Overall Study|Adverse Event|0|||
126284748|NCT03203850|454331029|FG000|Overall Study|Death|1|||
126284749|NCT03203850|454331030|FG001|Overall Study|Death|0|||
126284750|NCT01272037|454331031|FG000|Overall Study|Death|25|||
126284751|NCT01272037|454331032|FG001|Overall Study|Death|28|||
126284752|NCT01272037|454331031|FG000|Overall Study|Adverse Event|12|||
126284753|NCT01272037|454331032|FG001|Overall Study|Adverse Event|7|||
126284754|NCT01272037|454331031|FG000|Overall Study|Withdrawal by Subject|175|||
126284755|NCT01272037|454331032|FG001|Overall Study|Withdrawal by Subject|93|||
126284756|NCT01272037|454331031|FG000|Overall Study|Disease progression|70|||
126284757|NCT01272037|454331032|FG001|Overall Study|Disease progression|111|||
126284758|NCT01272037|454331031|FG000|Overall Study|Other reason|42|||
126284759|NCT01272037|454331032|FG001|Overall Study|Other reason|41|||
126284760|NCT01272037|454331031|FG000|Overall Study|Delinquent data|24|||
126284761|NCT01272037|454331032|FG001|Overall Study|Delinquent data|19|||
126284762|NCT01272037|454331031|FG000|Overall Study|Reason under review|33|||
126284763|NCT01272037|454331032|FG001|Overall Study|Reason under review|29|||
126284764|NCT01272037|454331031|FG000|Overall Study|On treatment|626|||
126284765|NCT01272037|454331032|FG001|Overall Study|On treatment|632|||
126284766|NCT00678210|454331034|FG000|Overall Study|Adverse Event|1|||
126284767|NCT00678210|454331035|FG001|Overall Study|Adverse Event|2|||
126284768|NCT00678210|454331036|FG002|Overall Study|Adverse Event|3|||
126284769|NCT00678210|454331037|FG003|Overall Study|Adverse Event|3|||
126284770|NCT00678210|454331034|FG000|Overall Study|Lack of Efficacy|2|||
126284771|NCT00678210|454331035|FG001|Overall Study|Lack of Efficacy|3|||
126284772|NCT00678210|454331036|FG002|Overall Study|Lack of Efficacy|1|||
126284773|NCT00678210|454331037|FG003|Overall Study|Lack of Efficacy|9|||
126284774|NCT00678210|454331034|FG000|Overall Study|Lost to Follow-up|4|||
126284775|NCT00678210|454331035|FG001|Overall Study|Lost to Follow-up|2|||
126284776|NCT00678210|454331036|FG002|Overall Study|Lost to Follow-up|0|||
126284777|NCT00678210|454331037|FG003|Overall Study|Lost to Follow-up|1|||
126284778|NCT00678210|454331034|FG000|Overall Study|Withdrawal by Subject|3|||
126284779|NCT00678210|454331035|FG001|Overall Study|Withdrawal by Subject|4|||
126284780|NCT00678210|454331036|FG002|Overall Study|Withdrawal by Subject|1|||
126284781|NCT00678210|454331037|FG003|Overall Study|Withdrawal by Subject|7|||
126284782|NCT00678210|454331034|FG000|Overall Study|Other|1|||
126284783|NCT00678210|454331035|FG001|Overall Study|Other|0|||
126284784|NCT00678210|454331036|FG002|Overall Study|Other|1|||
126284785|NCT00678210|454331037|FG003|Overall Study|Other|0|||
126284786|NCT04825912|454331038|FG000|Overall Study|Death|3|||
126284787|NCT04825912|454331038|FG000|Overall Study|Withdrawal by Subject|1|||
126284788|NCT02077140|454331039|FG000|Overall Study|Lost to Follow-up|4|||
126284789|NCT02077140|454331040|FG001|Overall Study|Lost to Follow-up|1|||
126284790|NCT02077140|454331041|FG002|Overall Study|Lost to Follow-up|2|||
126284791|NCT02077140|454331042|FG003|Overall Study|Lost to Follow-up|2|||
126284792|NCT02077140|454331043|FG004|Overall Study|Lost to Follow-up|3|||
126284793|NCT02077140|454331039|FG000|Overall Study|Withdrawal by Subject|0|||
126284794|NCT02077140|454331040|FG001|Overall Study|Withdrawal by Subject|1|||
126284795|NCT02077140|454331041|FG002|Overall Study|Withdrawal by Subject|0|||
126284796|NCT02077140|454331042|FG003|Overall Study|Withdrawal by Subject|2|||
126284797|NCT02077140|454331043|FG004|Overall Study|Withdrawal by Subject|2|||
126284798|NCT00974922|454331044|FG000|Overall Study|study terminated|24|||
126284799|NCT01173120|454331047|FG000|Overall Study|Lack of Efficacy|2|||
126284800|NCT01173120|454331047|FG000|Overall Study|Lost to Follow-up|1|||
126284801|NCT01173120|454331047|FG000|Overall Study|Participant Decision|2|||
126284802|NCT01173120|454331047|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
126284803|NCT01173120|454331047|FG000|Overall Study|Switch-Participant Decision|12|||
126284804|NCT01173120|454331047|FG000|Overall Study|Switch-Difficulty With Device|12|||
126284805|NCT00517881|454331048|FG000|Overall Study|Protocol Violation|2|||
126284806|NCT00517881|454331048|FG000|Overall Study|Adverse Event|1|||
126284807|NCT00517881|454331048|FG000|Overall Study|Renal transplantation|2|||
126284808|NCT00113763|454331049|FG000|Overall Study|Adverse Event|5|||
126284809|NCT00113763|454331050|FG001|Overall Study|Adverse Event|2|||
126284810|NCT00113763|454331049|FG000|Overall Study|Disease Progression|28|||
126284811|NCT00113763|454331050|FG001|Overall Study|Disease Progression|14|||
126284812|NCT00113763|454331049|FG000|Overall Study|Lost to Follow-up|10|||
125882526|NCT01208207|452868987|FG003|Part II|Withdrawal by Subject|10|||
126284813|NCT00113763|454331050|FG001|Overall Study|Lost to Follow-up|0|||
126284814|NCT00113763|454331049|FG000|Overall Study|Withdrawal by Subject|1|||
126284815|NCT00113763|454331050|FG001|Overall Study|Withdrawal by Subject|4|||
126284816|NCT00113763|454331049|FG000|Overall Study|Other|27|||
126284817|NCT00113763|454331050|FG001|Overall Study|Other|6|||
126284818|NCT00113763|454331049|FG000|Overall Study|Non-compliance|1|||
126284819|NCT00113763|454331050|FG001|Overall Study|Non-compliance|0|||
125882527|NCT01208207|452868988|FG004|Part II|Withdrawal by Subject|9|||
125882528|NCT01208207|452868989|FG005|Part II|Withdrawal by Subject|3|||
125882529|NCT01208207|452868990|FG006|Part II|Withdrawal by Subject|5|||
126284820|NCT00113763|454331049|FG000|Overall Study|Ongoing|1|||
126284821|NCT00113763|454331050|FG001|Overall Study|Ongoing|0|||
126284822|NCT01207583|454331051|FG000|Overall Study|Withdrawal by Subject|0|||
126284823|NCT01207583|454331052|FG001|Overall Study|Withdrawal by Subject|3|||
126284824|NCT01207583|454331053|FG002|Overall Study|Withdrawal by Subject|1|||
126284825|NCT01207583|454331051|FG000|Overall Study|Participant failed to return|1|||
126284826|NCT01207583|454331052|FG001|Overall Study|Participant failed to return|0|||
126284827|NCT01207583|454331053|FG002|Overall Study|Participant failed to return|0|||
126284828|NCT01207583|454331051|FG000|Overall Study|Lost to Follow-up|0|||
126284829|NCT01207583|454331052|FG001|Overall Study|Lost to Follow-up|2|||
126284830|NCT01207583|454331053|FG002|Overall Study|Lost to Follow-up|0|||
126284831|NCT01383707|454331058|FG000|Overall Study|Consent withdrawal|6|||
126284832|NCT01383707|454331058|FG000|Overall Study|Death|19|||
126284833|NCT01383707|454331058|FG000|Overall Study|Other|8|||
126284834|NCT01383707|454331058|FG000|Overall Study|Sponsor's decision|2|||
126284835|NCT01383707|454331058|FG000|Overall Study|Adverse Event|14|||
126284836|NCT01383707|454331058|FG000|Overall Study|Progressive disease|23|||
126284837|NCT02129608|454331059|FG000|Overall Study|Lost to Follow-up|0|||
126364964|NCT02514746|454630385|FG001|Overall Study|Physician Decision|2|||
126364965|NCT02514746|454630384|FG000|Overall Study|Withdrawal by Subject|12|||
126364966|NCT02514746|454630385|FG001|Overall Study|Withdrawal by Subject|10|||
126364967|NCT02514746|454630384|FG000|Overall Study|Other|5|||
126364968|NCT02514746|454630385|FG001|Overall Study|Other|1|||
126364969|NCT02181413|454630386|FG000|Overall Study|Withdrawal by Subject|45|||
126364970|NCT02181413|454630387|FG001|Overall Study|Withdrawal by Subject|61|||
126364971|NCT02181413|454630386|FG000|Overall Study|Reason Not Specified|2|||
126364972|NCT02181413|454630387|FG001|Overall Study|Reason Not Specified|5|||
126364973|NCT02181413|454630386|FG000|Overall Study|Lost to Follow-up|8|||
126364974|NCT02181413|454630387|FG001|Overall Study|Lost to Follow-up|7|||
126364975|NCT00050011|454630389|FG000|Overall Study|Adverse Event|41|||
126364976|NCT00050011|454630390|FG001|Overall Study|Adverse Event|46|||
126364977|NCT00050011|454630389|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126364978|NCT00050011|454630390|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126364979|NCT00050011|454630389|FG000|Overall Study|Abnormal test procedure results|0|||
126364980|NCT00050011|454630390|FG001|Overall Study|Abnormal test procedure results|1|||
126284838|NCT02129608|454331060|FG001|Overall Study|Lost to Follow-up|1|||
126284839|NCT02129608|454331061|FG002|Overall Study|Lost to Follow-up|1|||
126364981|NCT00050011|454630389|FG000|Overall Study|Lack of Efficacy|16|||
126284840|NCT02129608|454331059|FG000|Overall Study|Withdrawal by Subject|0|||
126284841|NCT02129608|454331060|FG001|Overall Study|Withdrawal by Subject|0|||
126364982|NCT00050011|454630390|FG001|Overall Study|Lack of Efficacy|21|||
126364983|NCT00050011|454630389|FG000|Overall Study|Participant condition no longer required|1|||
126364984|NCT00050011|454630390|FG001|Overall Study|Participant condition no longer required|0|||
125882530|NCT01208207|452868984|FG000|Part II|Adverse Event|0|||
125882531|NCT01208207|452868985|FG001|Part II|Adverse Event|0|||
125882532|NCT01208207|452868986|FG002|Part II|Adverse Event|0|||
126284842|NCT02129608|454331061|FG002|Overall Study|Withdrawal by Subject|2|||
126284843|NCT00451204|454331062|FG000|Overall Study|Adverse Event|4|||
126284844|NCT00451204|454331063|FG001|Overall Study|Adverse Event|6|||
126284845|NCT00451204|454331062|FG000|Overall Study|Lack of Efficacy|4|||
126364985|NCT00050011|454630389|FG000|Overall Study|Protocol Violation|4|||
126040750|NCT02240238|453447171|FG004|Phase 2|Physician Decision|0|||
126040751|NCT02240238|453447172|FG005|Phase 2|Physician Decision|0|||
126040752|NCT02240238|453447173|FG006|Phase 2|Physician Decision|0|||
126040753|NCT02240238|453447174|FG007|Phase 2|Physician Decision|0|||
126040754|NCT02240238|453447175|FG008|Phase 2|Physician Decision|0|||
126040755|NCT02240238|453447176|FG009|Phase 2|Physician Decision|1|||
126040756|NCT02240238|453447177|FG010|Phase 2|Physician Decision|3|||
126040757|NCT02240238|453447178|FG011|Phase 2|Physician Decision|0|||
126040758|NCT02240238|453447167|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040759|NCT02240238|453447168|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040760|NCT02240238|453447169|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040761|NCT02240238|453447170|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040762|NCT02240238|453447171|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040763|NCT02240238|453447172|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040764|NCT02240238|453447173|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040765|NCT02240238|453447174|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040766|NCT02240238|453447175|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040767|NCT02240238|453447176|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
126040768|NCT02240238|453447177|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126040769|NCT02240238|453447178|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126284846|NCT00451204|454331063|FG001|Overall Study|Lack of Efficacy|4|||
126284847|NCT00451204|454331062|FG000|Overall Study|Lost to Follow-up|4|||
126040770|NCT02240238|453447167|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126284848|NCT00451204|454331063|FG001|Overall Study|Lost to Follow-up|4|||
126284849|NCT00451204|454331062|FG000|Overall Study|Protocol Violation|1|||
126284850|NCT00451204|454331063|FG001|Overall Study|Protocol Violation|0|||
126284851|NCT00451204|454331062|FG000|Overall Study|Patient refusal|8|||
126284852|NCT00451204|454331063|FG001|Overall Study|Patient refusal|4|||
126284853|NCT00451204|454331062|FG000|Overall Study|Other|1|||
126284854|NCT00451204|454331063|FG001|Overall Study|Other|2|||
126284855|NCT01582152|454331064|FG000|Overall Study|Disease Progression|4|||
126284856|NCT01582152|454331065|FG001|Overall Study|Disease Progression|5|||
126284857|NCT01582152|454331064|FG000|Overall Study|Adverse Event|2|||
126284858|NCT01582152|454331065|FG001|Overall Study|Adverse Event|1|||
126284859|NCT02437903|454331068|FG000|Overall Study|Adverse Event|1|||
126040771|NCT02240238|453447168|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126284860|NCT02437903|454331068|FG000|Overall Study|Withdrawal by Subject|1|||
126284861|NCT02437903|454331068|FG000|Overall Study|Lost to Follow-up|3|||
126284862|NCT04172597|454331072|FG000|Overall Study|Disease Progression|0|||
126284863|NCT04172597|454331073|FG001|Overall Study|Disease Progression|0|||
126284864|NCT04172597|454331074|FG002|Overall Study|Disease Progression|0|||
126284865|NCT04172597|454331075|FG003|Overall Study|Disease Progression|0|||
126284866|NCT04172597|454331076|FG004|Overall Study|Disease Progression|1|||
126284867|NCT00794339|454331077|FG000|Overall Study|Withdrawal by Subject|3|||
126284868|NCT00794339|454331077|FG000|Overall Study|Ineligible|4|||
126284869|NCT00794339|454331077|FG000|Overall Study|Tx prior to ATSM|3|||
126284870|NCT00794339|454331077|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
126284871|NCT00794339|454331077|FG000|Overall Study|Tx not per protocol|1|||
126284872|NCT01611857|454331078|FG000|Overall Study|Withdrawal by Subject|0|||
126284873|NCT01611857|454331079|FG001|Overall Study|Withdrawal by Subject|2|||
126040772|NCT02240238|453447169|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040773|NCT02240238|453447170|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040774|NCT02240238|453447171|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040775|NCT02240238|453447172|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040776|NCT02240238|453447173|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040777|NCT02240238|453447174|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040778|NCT02240238|453447175|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040779|NCT02240238|453447176|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
126040780|NCT02240238|453447177|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040781|NCT02240238|453447178|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126040782|NCT02240238|453447167|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126040783|NCT02240238|453447168|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126040784|NCT02240238|453447169|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126040785|NCT02240238|453447170|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126284874|NCT02540083|454331084|FG000|Overall Study|Withdrawal by Subject|16|||
126284875|NCT01372748|454331085|FG000|Overall Study|Lost to Follow-up|16|||
125882533|NCT01208207|452868987|FG003|Part II|Adverse Event|5|||
125882534|NCT01208207|452868988|FG004|Part II|Adverse Event|9|||
126284876|NCT01372748|454331086|FG001|Overall Study|Lost to Follow-up|34|||
126284877|NCT01372748|454331085|FG000|Overall Study|Withdrawal by Subject|7|||
126284878|NCT01372748|454331086|FG001|Overall Study|Withdrawal by Subject|5|||
126284879|NCT00134901|454331087|FG000|Overall Study|Lost to Follow-up|5|||
126284880|NCT00134901|454331088|FG001|Overall Study|Lost to Follow-up|5|||
126284881|NCT00134901|454331087|FG000|Overall Study|discontinued intervention|12|||
126284882|NCT00134901|454331088|FG001|Overall Study|discontinued intervention|10|||
126284883|NCT04289363|454331089|FG000|Overall Study|Lost to Follow-up|14|||
126284884|NCT04289363|454331090|FG001|Overall Study|Lost to Follow-up|0|||
126284885|NCT01807065|454331091|FG000|Overall Study|Receive no sip-T due to IV access|1|||
126284886|NCT01807065|454331092|FG001|Overall Study|Receive no sip-T due to IV access|1|||
126284887|NCT00445432|454331093|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
126284888|NCT00445432|454331094|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
126284889|NCT00445432|454331095|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
126284890|NCT00445432|454331096|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
126284891|NCT00445432|454331093|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
126284892|NCT00445432|454331094|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
126284893|NCT00445432|454331095|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
126284894|NCT00445432|454331096|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
126284895|NCT00445432|454331093|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
126284896|NCT00445432|454331094|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
126284897|NCT00445432|454331095|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
126284898|NCT00445432|454331096|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
126284899|NCT00445432|454331093|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
126284900|NCT00445432|454331094|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
126284901|NCT00445432|454331095|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
126284902|NCT00445432|454331096|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
126284903|NCT00445432|454331093|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
126284904|NCT00445432|454331094|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
126284905|NCT00445432|454331095|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
126284906|NCT00445432|454331096|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
126284907|NCT00445432|454331093|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
126284908|NCT00445432|454331094|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
126284909|NCT00445432|454331095|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
126284910|NCT00445432|454331096|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
126284911|NCT00445432|454331093|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
126284912|NCT00445432|454331094|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
126284913|NCT00445432|454331095|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
126284914|NCT00445432|454331096|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
126284915|NCT00356525|454331100|FG000|Overall Study|Progressive Disease|8|||
126284916|NCT00356525|454331101|FG001|Overall Study|Progressive Disease|5|||
126284917|NCT00356525|454331102|FG002|Overall Study|Progressive Disease|4|||
125882535|NCT01208207|452868989|FG005|Part II|Adverse Event|4|||
125882536|NCT01208207|452868990|FG006|Part II|Adverse Event|2|||
125882537|NCT01208207|452868984|FG000|Part II|Lack of Efficacy|0|||
126284918|NCT00356525|454331103|FG003|Overall Study|Progressive Disease|2|||
126284919|NCT00356525|454331100|FG000|Overall Study|Adverse Event|1|||
126284920|NCT00356525|454331101|FG001|Overall Study|Adverse Event|3|||
126284921|NCT00356525|454331102|FG002|Overall Study|Adverse Event|1|||
126284922|NCT00356525|454331103|FG003|Overall Study|Adverse Event|1|||
126284923|NCT00356525|454331100|FG000|Overall Study|Lost to Follow-up|1|||
126284924|NCT00356525|454331101|FG001|Overall Study|Lost to Follow-up|0|||
126284925|NCT00356525|454331102|FG002|Overall Study|Lost to Follow-up|0|||
126284926|NCT00356525|454331103|FG003|Overall Study|Lost to Follow-up|0|||
126284927|NCT00356525|454331100|FG000|Overall Study|Physician Decision|2|||
126284928|NCT00356525|454331101|FG001|Overall Study|Physician Decision|2|||
126284929|NCT00356525|454331102|FG002|Overall Study|Physician Decision|2|||
126284930|NCT00356525|454331103|FG003|Overall Study|Physician Decision|1|||
126284931|NCT00356525|454331100|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
126284932|NCT00356525|454331101|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
126364986|NCT00050011|454630390|FG001|Overall Study|Protocol Violation|10|||
126364987|NCT00050011|454630389|FG000|Overall Study|Withdrawal by Subject|34|||
126364988|NCT00050011|454630390|FG001|Overall Study|Withdrawal by Subject|26|||
126364989|NCT00050011|454630389|FG000|Overall Study|Lost to Follow-up|7|||
125882538|NCT01208207|452868985|FG001|Part II|Lack of Efficacy|0|||
125882539|NCT01208207|452868986|FG002|Part II|Lack of Efficacy|0|||
125882540|NCT01208207|452868987|FG003|Part II|Lack of Efficacy|6|||
126364990|NCT00050011|454630390|FG001|Overall Study|Lost to Follow-up|9|||
126364991|NCT00050011|454630389|FG000|Overall Study|Administrative problems|10|||
126364992|NCT00050011|454630390|FG001|Overall Study|Administrative problems|6|||
126364993|NCT00050011|454630389|FG000|Overall Study|Death|7|||
126364994|NCT00050011|454630390|FG001|Overall Study|Death|4|||
125882541|NCT01208207|452868988|FG004|Part II|Lack of Efficacy|4|||
125882542|NCT01208207|452868989|FG005|Part II|Lack of Efficacy|3|||
125882543|NCT01208207|452868990|FG006|Part II|Lack of Efficacy|3|||
125882544|NCT01208207|452868984|FG000|Part II|Lost to Follow-up|0|||
125882545|NCT01208207|452868985|FG001|Part II|Lost to Follow-up|0|||
125882546|NCT01208207|452868986|FG002|Part II|Lost to Follow-up|0|||
125882547|NCT01208207|452868987|FG003|Part II|Lost to Follow-up|4|||
125882548|NCT01208207|452868988|FG004|Part II|Lost to Follow-up|0|||
125882549|NCT01208207|452868989|FG005|Part II|Lost to Follow-up|2|||
125882550|NCT01208207|452868990|FG006|Part II|Lost to Follow-up|1|||
125882551|NCT01208207|452868984|FG000|Part II|Non-Compliance With Study Drug|0|||
125882552|NCT01208207|452868985|FG001|Part II|Non-Compliance With Study Drug|0|||
125882553|NCT01208207|452868986|FG002|Part II|Non-Compliance With Study Drug|0|||
125882554|NCT01208207|452868987|FG003|Part II|Non-Compliance With Study Drug|4|||
125882555|NCT01208207|452868988|FG004|Part II|Non-Compliance With Study Drug|1|||
125882556|NCT01208207|452868989|FG005|Part II|Non-Compliance With Study Drug|1|||
125882557|NCT01208207|452868990|FG006|Part II|Non-Compliance With Study Drug|0|||
125882558|NCT01208207|452868984|FG000|Part II|Physician Decision|0|||
125882559|NCT01208207|452868985|FG001|Part II|Physician Decision|0|||
125882560|NCT01208207|452868986|FG002|Part II|Physician Decision|0|||
125882561|NCT01208207|452868987|FG003|Part II|Physician Decision|1|||
125882562|NCT01208207|452868988|FG004|Part II|Physician Decision|0|||
125882563|NCT01208207|452868989|FG005|Part II|Physician Decision|2|||
125882564|NCT01208207|452868990|FG006|Part II|Physician Decision|0|||
126284933|NCT00356525|454331102|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
126284934|NCT00356525|454331103|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
126284935|NCT00356525|454331100|FG000|Overall Study|Withdrawal by Subject|1|||
125882565|NCT01208207|452868984|FG000|Part II|Protocol Violation|0|||
125882566|NCT01208207|452868985|FG001|Part II|Protocol Violation|0|||
125882567|NCT01208207|452868986|FG002|Part II|Protocol Violation|0|||
125882568|NCT01208207|452868987|FG003|Part II|Protocol Violation|1|||
126284936|NCT00356525|454331101|FG001|Overall Study|Withdrawal by Subject|1|||
126284937|NCT00356525|454331102|FG002|Overall Study|Withdrawal by Subject|0|||
126284938|NCT00356525|454331103|FG003|Overall Study|Withdrawal by Subject|3|||
126284939|NCT00356525|454331100|FG000|Overall Study|Death|0|||
126284940|NCT00356525|454331101|FG001|Overall Study|Death|0|||
126284941|NCT00356525|454331102|FG002|Overall Study|Death|0|||
126284942|NCT00356525|454331103|FG003|Overall Study|Death|1|||
126284943|NCT00356525|454331100|FG000|Overall Study|Sponsor Decision|0|||
126284944|NCT00356525|454331101|FG001|Overall Study|Sponsor Decision|0|||
126284945|NCT00356525|454331102|FG002|Overall Study|Sponsor Decision|0|||
126284946|NCT00356525|454331103|FG003|Overall Study|Sponsor Decision|1|||
126284947|NCT00462904|454331104|FG000|Overall Study|Lost to Follow-up|1|||
126284948|NCT04036110|454331107|FG000|Overall Study|Lost to Follow-up|3|||
126284949|NCT04036110|454331108|FG001|Overall Study|Lost to Follow-up|2|||
126284950|NCT04036110|454331109|FG002|Overall Study|Lost to Follow-up|1|||
126284951|NCT04036110|454331107|FG000|Overall Study|Study Suspended|4|||
126284952|NCT04036110|454331108|FG001|Overall Study|Study Suspended|5|||
126284953|NCT04036110|454331109|FG002|Overall Study|Study Suspended|1|||
126284954|NCT00396565|454331112|FG000|Overall Study|Physician Decision|3|||
126284955|NCT00396565|454331113|FG001|Overall Study|Physician Decision|1|||
126284956|NCT00396565|454331114|FG002|Overall Study|Physician Decision|2|||
126284957|NCT00396565|454331112|FG000|Overall Study|Adverse Event|5|||
126284958|NCT00396565|454331113|FG001|Overall Study|Adverse Event|13|||
126284959|NCT00396565|454331114|FG002|Overall Study|Adverse Event|3|||
126284960|NCT00396565|454331112|FG000|Overall Study|Withdrawal by Subject|8|||
126284961|NCT00396565|454331113|FG001|Overall Study|Withdrawal by Subject|13|||
126284962|NCT00396565|454331114|FG002|Overall Study|Withdrawal by Subject|1|||
126284963|NCT00396565|454331112|FG000|Overall Study|Lack of Efficacy|32|||
126284964|NCT00396565|454331113|FG001|Overall Study|Lack of Efficacy|64|||
125882569|NCT01208207|452868988|FG004|Part II|Protocol Violation|0|||
125882570|NCT01208207|452868989|FG005|Part II|Protocol Violation|0|||
125882571|NCT01208207|452868990|FG006|Part II|Protocol Violation|0|||
125882572|NCT01208207|452868984|FG000|Part II|Technical Problems|0|||
125882573|NCT01208207|452868985|FG001|Part II|Technical Problems|0|||
126284965|NCT00396565|454331114|FG002|Overall Study|Lack of Efficacy|11|||
126284966|NCT04324021|454331117|FG000|Overall Study|Adverse Event|1|||
125882574|NCT01208207|452868986|FG002|Part II|Technical Problems|0|||
125882575|NCT01208207|452868987|FG003|Part II|Technical Problems|1|||
125882576|NCT01208207|452868988|FG004|Part II|Technical Problems|0|||
125882577|NCT01208207|452868989|FG005|Part II|Technical Problems|1|||
125882578|NCT01208207|452868990|FG006|Part II|Technical Problems|0|||
125882579|NCT00702221|452868991|FG000|Overall Study|Adverse Event|4|||
125882580|NCT00702221|452868992|FG001|Overall Study|Adverse Event|3|||
125882581|NCT03995368|452868993|FG000|Overall Study|Lost to Follow-up|1|||
125882582|NCT03995368|452868994|FG001|Overall Study|Lost to Follow-up|4|||
125882583|NCT03995368|452868995|FG002|Overall Study|Lost to Follow-up|1|||
126284967|NCT04324021|454331118|FG001|Overall Study|Adverse Event|0|||
126284968|NCT04324021|454331119|FG002|Overall Study|Adverse Event|0|||
126284969|NCT04324021|454331117|FG000|Overall Study|Lack of Efficacy|0|||
126284970|NCT04324021|454331118|FG001|Overall Study|Lack of Efficacy|0|||
126364995|NCT00050011|454630389|FG000|Overall Study|Unknown - Reason is missing|0|||
126364996|NCT00050011|454630390|FG001|Overall Study|Unknown - Reason is missing|2|||
126364997|NCT04903093|454630397|FG000|Overall Study|Withdrawal by Subject|0|||
126364998|NCT04903093|454630398|FG001|Overall Study|Withdrawal by Subject|0|||
126364999|NCT04903093|454630399|FG002|Overall Study|Withdrawal by Subject|0|||
126365000|NCT04903093|454630400|FG003|Overall Study|Withdrawal by Subject|1|||
126365001|NCT04903093|454630401|FG004|Overall Study|Withdrawal by Subject|0|||
126365002|NCT04903093|454630402|FG005|Overall Study|Withdrawal by Subject|0|||
126365003|NCT03973489|454630408|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
126365004|NCT03973489|454630409|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365005|NCT03973489|454630410|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365006|NCT03973489|454630411|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365007|NCT03973489|454630412|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
126365008|NCT03973489|454630413|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365009|NCT03973489|454630414|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365010|NCT03973489|454630415|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365011|NCT03973489|454630408|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365012|NCT03973489|454630409|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365013|NCT03973489|454630410|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365014|NCT03973489|454630411|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
126365015|NCT03973489|454630412|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
126365016|NCT03973489|454630413|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365017|NCT03973489|454630414|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365018|NCT03973489|454630415|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365019|NCT03973489|454630408|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365020|NCT03973489|454630409|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365021|NCT03973489|454630410|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365022|NCT03973489|454630411|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365023|NCT03973489|454630412|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
126365024|NCT03973489|454630413|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365025|NCT03973489|454630414|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
126365026|NCT03973489|454630415|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365027|NCT03973489|454630408|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
126365028|NCT03973489|454630409|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365029|NCT03973489|454630410|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365030|NCT03973489|454630411|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
126365031|NCT03973489|454630412|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365032|NCT03973489|454630413|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365033|NCT03973489|454630414|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365034|NCT03973489|454630415|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365035|NCT03973489|454630408|FG000|Second Intervention (1 Day)|Adverse Event|0|||
126365036|NCT03973489|454630409|FG001|Second Intervention (1 Day)|Adverse Event|0|||
126365037|NCT03973489|454630410|FG002|Second Intervention (1 Day)|Adverse Event|0|||
125882584|NCT03995368|452868993|FG000|Overall Study|Did not meet inclusion criteria|1|||
125882585|NCT03995368|452868994|FG001|Overall Study|Did not meet inclusion criteria|6|||
126365038|NCT03973489|454630411|FG003|Second Intervention (1 Day)|Adverse Event|1|||
126365039|NCT03973489|454630412|FG004|Second Intervention (1 Day)|Adverse Event|0|||
126365040|NCT03973489|454630413|FG005|Second Intervention (1 Day)|Adverse Event|0|||
126365041|NCT03973489|454630414|FG006|Second Intervention (1 Day)|Adverse Event|0|||
126365042|NCT03973489|454630415|FG007|Second Intervention (1 Day)|Adverse Event|0|||
125882586|NCT03995368|452868995|FG002|Overall Study|Did not meet inclusion criteria|3|||
125882587|NCT03995368|452868993|FG000|Overall Study|Withdrawal by Subject|0|||
125882588|NCT03995368|452868994|FG001|Overall Study|Withdrawal by Subject|1|||
125882589|NCT03995368|452868995|FG002|Overall Study|Withdrawal by Subject|1|||
125882590|NCT01658436|452868998|FG000|Overall Study|Adverse Event|6|||
126040786|NCT02240238|453447171|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126040787|NCT02240238|453447172|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126040788|NCT02240238|453447173|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126040789|NCT02240238|453447174|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126365043|NCT00392288|454630416|FG000|Overall Study|Adverse Event|17|||
126365044|NCT00392288|454630417|FG001|Overall Study|Adverse Event|7|||
126365045|NCT00392288|454630418|FG002|Overall Study|Adverse Event|8|||
126365046|NCT00392288|454630416|FG000|Overall Study|Lack of Efficacy|8|||
126365047|NCT00392288|454630417|FG001|Overall Study|Lack of Efficacy|5|||
126365048|NCT00392288|454630418|FG002|Overall Study|Lack of Efficacy|3|||
126040790|NCT02240238|453447175|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126365049|NCT00392288|454630416|FG000|Overall Study|Protocol Violation|1|||
125882591|NCT01658436|452868999|FG001|Overall Study|Adverse Event|5|||
125882592|NCT01658436|452868998|FG000|Overall Study|Physician Decision|1|||
126284971|NCT04324021|454331119|FG002|Overall Study|Lack of Efficacy|1|||
126284972|NCT04324021|454331117|FG000|Overall Study|Death|1|||
126284973|NCT04324021|454331118|FG001|Overall Study|Death|1|||
126284974|NCT04324021|454331119|FG002|Overall Study|Death|0|||
126284975|NCT03097991|454331120|FG000|Overall Study|Didn't meet study criteria|8|||
126284976|NCT03097991|454331121|FG001|Overall Study|Didn't meet study criteria|0|||
126284977|NCT03097991|454331120|FG000|Overall Study|Withdrawal by Subject|12|||
126284978|NCT03097991|454331121|FG001|Overall Study|Withdrawal by Subject|6|||
126284979|NCT03097991|454331120|FG000|Overall Study|Death of Baby|3|||
126284980|NCT03097991|454331121|FG001|Overall Study|Death of Baby|1|||
126284981|NCT03097991|454331120|FG000|Overall Study|Lost to Follow-up|24|||
126284982|NCT03097991|454331121|FG001|Overall Study|Lost to Follow-up|38|||
126284983|NCT03097991|454331120|FG000|Overall Study|Adverse Event|3|||
126284984|NCT03097991|454331121|FG001|Overall Study|Adverse Event|5|||
126284985|NCT00246324|454331122|FG000|Overall Study|Withdrawal by Subject|1|||
126284986|NCT02006732|454331123|FG000|Overall Study|Adverse Event|10|||
126284987|NCT02006732|454331124|FG001|Overall Study|Adverse Event|7|||
126284988|NCT02006732|454331125|FG002|Overall Study|Adverse Event|4|||
126284989|NCT02006732|454331126|FG003|Overall Study|Adverse Event|2|||
126284990|NCT02006732|454331123|FG000|Overall Study|Lack of Efficacy|6|||
126284991|NCT02006732|454331124|FG001|Overall Study|Lack of Efficacy|3|||
126284992|NCT02006732|454331125|FG002|Overall Study|Lack of Efficacy|1|||
126284993|NCT02006732|454331126|FG003|Overall Study|Lack of Efficacy|1|||
126284994|NCT02006732|454331123|FG000|Overall Study|Protocol Violation|1|||
126284995|NCT02006732|454331124|FG001|Overall Study|Protocol Violation|1|||
126284996|NCT02006732|454331125|FG002|Overall Study|Protocol Violation|0|||
126284997|NCT02006732|454331126|FG003|Overall Study|Protocol Violation|0|||
126284998|NCT02006732|454331123|FG000|Overall Study|Lost to Follow-up|0|||
126284999|NCT02006732|454331124|FG001|Overall Study|Lost to Follow-up|1|||
126285000|NCT02006732|454331125|FG002|Overall Study|Lost to Follow-up|0|||
126285001|NCT02006732|454331126|FG003|Overall Study|Lost to Follow-up|0|||
126285002|NCT02006732|454331123|FG000|Overall Study|Withdrawal by Subject|3|||
126285003|NCT02006732|454331124|FG001|Overall Study|Withdrawal by Subject|0|||
126285004|NCT02006732|454331125|FG002|Overall Study|Withdrawal by Subject|4|||
126285005|NCT02006732|454331126|FG003|Overall Study|Withdrawal by Subject|1|||
126285006|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
126285007|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
126285008|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
126285009|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Death|1|||
126285010|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Death|3|||
126285011|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Death|1|||
126285012|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
126285013|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
126285014|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
126285015|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
126285016|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
126285017|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
126285018|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
126285019|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
126285020|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
126285021|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
126285022|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
126285023|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
126285024|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
126285025|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
126285026|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
126285027|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
126285028|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
126285029|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
126285030|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
126285031|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
126285032|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
126285033|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
126285034|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
126285035|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
126285036|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
126285037|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
126285038|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
126285039|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
126285040|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
126285041|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
126285042|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
126285043|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
126285044|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
126285045|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
126285046|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
126285047|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
126285048|NCT00299130|454331127|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
126285049|NCT00299130|454331128|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
126285050|NCT00299130|454331129|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
126285051|NCT00299130|454331127|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
126285052|NCT00299130|454331128|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
126285053|NCT00299130|454331129|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
126285054|NCT00299130|454331127|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
126285055|NCT00299130|454331128|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
126285056|NCT00299130|454331129|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
126285057|NCT01198132|454331130|FG000|Overall Study|Withdrawal by Subject|4|||
126285058|NCT01198132|454331131|FG001|Overall Study|Withdrawal by Subject|5|||
126285059|NCT01198132|454331130|FG000|Overall Study|Physician Decision|5|||
126285060|NCT01198132|454331131|FG001|Overall Study|Physician Decision|4|||
126285061|NCT01198132|454331130|FG000|Overall Study|Other Unspecified|3|||
126285062|NCT01198132|454331131|FG001|Overall Study|Other Unspecified|6|||
126285063|NCT01198132|454331130|FG000|Overall Study|Lack of Efficacy|2|||
126285064|NCT01198132|454331131|FG001|Overall Study|Lack of Efficacy|3|||
126285065|NCT01198132|454331130|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
126285066|NCT01198132|454331131|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
126285067|NCT01198132|454331130|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
126285068|NCT01198132|454331131|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
126285069|NCT01198132|454331130|FG000|Overall Study|Adverse Event|0|||
126285070|NCT01198132|454331131|FG001|Overall Study|Adverse Event|1|||
126285071|NCT01198132|454331130|FG000|Overall Study|Protocol Violation|1|||
126285072|NCT01198132|454331131|FG001|Overall Study|Protocol Violation|0|||
126285073|NCT03516513|454331132|FG000|Overall Study|Withdrawal by Subject|2|||
126285074|NCT03516513|454331133|FG001|Overall Study|Withdrawal by Subject|2|||
126285075|NCT03516513|454331134|FG002|Overall Study|Withdrawal by Subject|0|||
126285076|NCT03516513|454331135|FG003|Overall Study|Withdrawal by Subject|0|||
126285077|NCT01098487|454331136|FG000|Overall Study|Adverse Event|22|||
126285078|NCT01098487|454331136|FG000|Overall Study|Lack of Efficacy|11|||
126285079|NCT01098487|454331136|FG000|Overall Study|Withdrawal by Subject|7|||
126285080|NCT01098487|454331136|FG000|Overall Study|Lost to Follow-up|3|||
126365050|NCT00392288|454630417|FG001|Overall Study|Protocol Violation|3|||
126365051|NCT00392288|454630418|FG002|Overall Study|Protocol Violation|1|||
126365052|NCT00392288|454630416|FG000|Overall Study|Lost to Follow-up|1|||
126365053|NCT00392288|454630417|FG001|Overall Study|Lost to Follow-up|1|||
126365054|NCT00392288|454630418|FG002|Overall Study|Lost to Follow-up|1|||
126365055|NCT00392288|454630416|FG000|Overall Study|Withdrawal by Subject|1|||
126365056|NCT00392288|454630417|FG001|Overall Study|Withdrawal by Subject|0|||
126365057|NCT00392288|454630418|FG002|Overall Study|Withdrawal by Subject|2|||
126365058|NCT00392288|454630416|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
126365059|NCT00392288|454630417|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
126365060|NCT00392288|454630418|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
126365061|NCT00392288|454630416|FG000|Overall Study|Other|3|||
126365062|NCT00392288|454630417|FG001|Overall Study|Other|4|||
126365063|NCT00392288|454630418|FG002|Overall Study|Other|1|||
126365064|NCT02544763|454630419|FG000|Overall Study|Adverse Event|8|||
126365065|NCT02544763|454630420|FG001|Overall Study|Adverse Event|8|||
126365066|NCT02544763|454630421|FG002|Overall Study|Adverse Event|0|||
126365067|NCT02544763|454630419|FG000|Overall Study|Withdrawn by parent/guardian|1|||
126365068|NCT02544763|454630420|FG001|Overall Study|Withdrawn by parent/guardian|1|||
126365069|NCT02544763|454630421|FG002|Overall Study|Withdrawn by parent/guardian|1|||
126365070|NCT02544763|454630419|FG000|Overall Study|Met withdrawal criteria|0|||
126365071|NCT02544763|454630420|FG001|Overall Study|Met withdrawal criteria|2|||
126365072|NCT02544763|454630421|FG002|Overall Study|Met withdrawal criteria|0|||
126365073|NCT02544763|454630419|FG000|Overall Study|Physician Decision|0|||
126365074|NCT02544763|454630420|FG001|Overall Study|Physician Decision|1|||
126365075|NCT02544763|454630421|FG002|Overall Study|Physician Decision|0|||
126365076|NCT02544763|454630419|FG000|Overall Study|Difficulties taking IMP|1|||
126365077|NCT02544763|454630420|FG001|Overall Study|Difficulties taking IMP|0|||
126365078|NCT02544763|454630421|FG002|Overall Study|Difficulties taking IMP|0|||
126365079|NCT04755231|454630422|FG000|Overall Study|Lost to Follow-up|5|||
126365080|NCT04755231|454630422|FG000|Overall Study|Withdrawal by Subject|5|||
126365081|NCT02613507|454630431|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
126365082|NCT02613507|454630432|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
126365083|NCT02613507|454630431|FG000|Pre-Treamtent|Participant withdrew consent|0|||
126365084|NCT02613507|454630432|FG001|Pre-Treamtent|Participant withdrew consent|4|||
126285081|NCT01098487|454331136|FG000|Overall Study|Physician Decision|1|||
125882593|NCT01658436|452868999|FG001|Overall Study|Physician Decision|0|||
125882594|NCT01658436|452868998|FG000|Overall Study|Progressive disease|12|||
125882595|NCT01658436|452868999|FG001|Overall Study|Progressive disease|4|||
125882596|NCT01658436|452868998|FG000|Overall Study|Study terminated by sponsor|0|||
125882597|NCT01658436|452868999|FG001|Overall Study|Study terminated by sponsor|1|||
125882598|NCT01658436|452868998|FG000|Overall Study|Subject/guardian decision|0|||
125882599|NCT01658436|452868999|FG001|Overall Study|Subject/guardian decision|1|||
125882600|NCT01658436|452868998|FG000|Overall Study|Death|1|||
125882601|NCT01658436|452868999|FG001|Overall Study|Death|0|||
125882602|NCT01217229|452869000|FG000|Overall Study|Adverse Event|1|||
125882603|NCT01217229|452869000|FG000|Overall Study|Disease progression, deterioration|2|||
125882604|NCT01217229|452869000|FG000|Overall Study|Disease progression, Cheson criteria|14|||
125882605|NCT01217229|452869000|FG000|Overall Study|Protocol Violation|1|||
125882606|NCT01217229|452869000|FG000|Overall Study|Disease progression not confirmed|2|||
125882607|NCT03987503|452869001|FG000|Overall Study|Lost to Follow-up|20|||
125882608|NCT03987503|452869001|FG000|Overall Study|Withdrawal by Subject|2|||
126285082|NCT00345631|454331137|FG000|Overall Study|Withdrawal by Subject|1|||
126285083|NCT00345631|454331138|FG001|Overall Study|Withdrawal by Subject|0|||
126285084|NCT00345631|454331139|FG002|Overall Study|Withdrawal by Subject|1|||
126285085|NCT00345631|454331137|FG000|Overall Study|Adverse Event|0|||
126285086|NCT00345631|454331138|FG001|Overall Study|Adverse Event|1|||
126285087|NCT00345631|454331139|FG002|Overall Study|Adverse Event|0|||
126285088|NCT00345631|454331137|FG000|Overall Study|Lost to Follow-up|3|||
126285089|NCT00345631|454331138|FG001|Overall Study|Lost to Follow-up|7|||
126285090|NCT00345631|454331139|FG002|Overall Study|Lost to Follow-up|4|||
126285091|NCT00345631|454331137|FG000|Overall Study|Other reasons|0|||
126285092|NCT00345631|454331138|FG001|Overall Study|Other reasons|0|||
126285093|NCT00345631|454331139|FG002|Overall Study|Other reasons|1|||
126285094|NCT01885195|454331140|FG000|Overall Study|Adverse Event|29|||
126285095|NCT01885195|454331140|FG000|Overall Study|Death|1|||
126285096|NCT01885195|454331140|FG000|Overall Study|Disease Progression|67|||
126285097|NCT01885195|454331140|FG000|Overall Study|Protocol Deviation|2|||
126285098|NCT01885195|454331140|FG000|Overall Study|Physician Decision|3|||
126285099|NCT01885195|454331140|FG000|Overall Study|Patient/guardian decision|8|||
126285100|NCT00509795|454331143|FG000|Overall Study|Adverse Event|4|||
126285101|NCT00509795|454331144|FG001|Overall Study|Adverse Event|3|||
126285102|NCT00509795|454331145|FG002|Overall Study|Adverse Event|5|||
126285103|NCT00509795|454331146|FG003|Overall Study|Adverse Event|4|||
126285104|NCT00509795|454331143|FG000|Overall Study|Death|3|||
126285105|NCT00509795|454331144|FG001|Overall Study|Death|1|||
126285106|NCT00509795|454331145|FG002|Overall Study|Death|2|||
126285107|NCT00509795|454331146|FG003|Overall Study|Death|7|||
126285108|NCT00509795|454331143|FG000|Overall Study|Lack of Efficacy|0|||
126285109|NCT00509795|454331144|FG001|Overall Study|Lack of Efficacy|0|||
126285110|NCT00509795|454331145|FG002|Overall Study|Lack of Efficacy|2|||
126285111|NCT00509795|454331146|FG003|Overall Study|Lack of Efficacy|2|||
126285112|NCT00509795|454331143|FG000|Overall Study|Lost to Follow-up|1|||
126285113|NCT00509795|454331144|FG001|Overall Study|Lost to Follow-up|2|||
126285114|NCT00509795|454331145|FG002|Overall Study|Lost to Follow-up|4|||
126285115|NCT00509795|454331146|FG003|Overall Study|Lost to Follow-up|4|||
126285116|NCT00509795|454331143|FG000|Overall Study|OTHER|1|||
126285117|NCT00509795|454331144|FG001|Overall Study|OTHER|0|||
126285118|NCT00509795|454331145|FG002|Overall Study|OTHER|4|||
126285119|NCT00509795|454331146|FG003|Overall Study|OTHER|1|||
126285120|NCT00509795|454331143|FG000|Overall Study|Protocol Violation|3|||
126285121|NCT00509795|454331144|FG001|Overall Study|Protocol Violation|0|||
126285122|NCT00509795|454331145|FG002|Overall Study|Protocol Violation|3|||
126285123|NCT00509795|454331146|FG003|Overall Study|Protocol Violation|1|||
126285124|NCT00509795|454331143|FG000|Overall Study|Withdrawal by Subject|10|||
126285125|NCT00509795|454331144|FG001|Overall Study|Withdrawal by Subject|5|||
126285126|NCT00509795|454331145|FG002|Overall Study|Withdrawal by Subject|7|||
126285127|NCT00509795|454331146|FG003|Overall Study|Withdrawal by Subject|8|||
126285128|NCT00912912|454331150|FG000|Overall Study|Withdrawal by Subject|1|||
126285129|NCT00912912|454331150|FG000|Overall Study|Disease Progression|3|||
126285130|NCT00306995|454331151|FG000|Study Part I|Withdrawal by Subject|0|||
126040791|NCT02240238|453447176|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126285131|NCT00306995|454331152|FG001|Study Part I|Withdrawal by Subject|0|||
126285132|NCT00306995|454331153|FG002|Study Part I|Withdrawal by Subject|0|||
126040792|NCT02240238|453447177|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
126285133|NCT00306995|454331154|FG003|Study Part I|Withdrawal by Subject|0|||
126285134|NCT00306995|454331155|FG004|Study Part I|Withdrawal by Subject|0|||
126285135|NCT00306995|454331156|FG005|Study Part I|Withdrawal by Subject|0|||
126285136|NCT00306995|454331157|FG006|Study Part I|Withdrawal by Subject|1|||
126285137|NCT00306995|454331151|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
126285138|NCT00306995|454331152|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
125882609|NCT01929317|452869011|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
125882610|NCT01929317|452869012|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
125882611|NCT01929317|452869011|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
125882612|NCT01929317|452869012|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
125882613|NCT01929317|452869011|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
125882614|NCT01929317|452869012|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
125882615|NCT01929317|452869011|FG000|Long-term Phase|Adverse Event|5|||
125882616|NCT01929317|452869012|FG001|Long-term Phase|Adverse Event|1|||
125882617|NCT01929317|452869011|FG000|Long-term Phase|Physician Decision|3|||
125882618|NCT01929317|452869012|FG001|Long-term Phase|Physician Decision|0|||
125882619|NCT01929317|452869011|FG000|Long-term Phase|Withdrawal by Subject|4|||
125882620|NCT01929317|452869012|FG001|Long-term Phase|Withdrawal by Subject|0|||
125882621|NCT01929317|452869011|FG000|Long-term Phase|Protocol Violation|1|||
125882622|NCT01929317|452869012|FG001|Long-term Phase|Protocol Violation|0|||
125882623|NCT01929317|452869011|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
125882624|NCT01929317|452869012|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
125882625|NCT01929317|452869011|FG000|Long-term Phase|Study Closed/Terminated|5|||
125882626|NCT01929317|452869012|FG001|Long-term Phase|Study Closed/Terminated|3|||
125882627|NCT04322526|452869013|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
126285139|NCT00306995|454331153|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
126285140|NCT00306995|454331154|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
126285141|NCT00306995|454331155|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
126285142|NCT00306995|454331156|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
126285143|NCT00306995|454331157|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
126285144|NCT04324073|454332903|FG000|Overall Study|withdrew consent|0|||
126285145|NCT04324073|454332904|FG001|Overall Study|withdrew consent|4|||
126285146|NCT04324073|454332905|FG002|Overall Study|withdrew consent|2|||
126285147|NCT04324073|454332906|FG003|Overall Study|withdrew consent|8|||
126285148|NCT05833139|454332907|FG000|Study Period 2|Adverse Event|1|||
126285149|NCT00371033|454332908|FG000|Overall Study|Lost to Follow-up|3|||
126285150|NCT00371033|454332909|FG001|Overall Study|Lost to Follow-up|2|||
126285151|NCT00371033|454332908|FG000|Overall Study|No longer interested|2|||
126285152|NCT00371033|454332909|FG001|Overall Study|No longer interested|0|||
126285153|NCT00371033|454332908|FG000|Overall Study|Uknown|3|||
126285154|NCT00371033|454332909|FG001|Overall Study|Uknown|1|||
126285155|NCT04158245|454332910|FG000|Overall Study|Lost to Follow-up|1|||
126285156|NCT03842228|454332913|FG000|Overall Study|Adverse Event|1|||
126285157|NCT03842228|454332914|FG001|Overall Study|Adverse Event|1|||
126285158|NCT03842228|454332915|FG002|Overall Study|Adverse Event|1|||
126285159|NCT03842228|454332916|FG003|Overall Study|Adverse Event|0|||
126285160|NCT03842228|454332917|FG004|Overall Study|Adverse Event|0|||
126285161|NCT03842228|454332918|FG005|Overall Study|Adverse Event|0|||
126285162|NCT03842228|454332919|FG006|Overall Study|Adverse Event|0|||
126285163|NCT03842228|454332913|FG000|Overall Study|Death|0|||
126285164|NCT03842228|454332914|FG001|Overall Study|Death|1|||
126285165|NCT03842228|454332915|FG002|Overall Study|Death|0|||
126285166|NCT03842228|454332916|FG003|Overall Study|Death|0|||
126285167|NCT03842228|454332917|FG004|Overall Study|Death|0|||
126285168|NCT03842228|454332918|FG005|Overall Study|Death|0|||
126285169|NCT03842228|454332919|FG006|Overall Study|Death|0|||
126285170|NCT03842228|454332913|FG000|Overall Study|Withdrawal by Subject|0|||
126285171|NCT03842228|454332914|FG001|Overall Study|Withdrawal by Subject|0|||
126285172|NCT03842228|454332915|FG002|Overall Study|Withdrawal by Subject|2|||
126285173|NCT03842228|454332916|FG003|Overall Study|Withdrawal by Subject|1|||
126285174|NCT03842228|454332917|FG004|Overall Study|Withdrawal by Subject|0|||
126285175|NCT03842228|454332918|FG005|Overall Study|Withdrawal by Subject|0|||
126285176|NCT03842228|454332919|FG006|Overall Study|Withdrawal by Subject|2|||
126285177|NCT03842228|454332913|FG000|Overall Study|Progression|8|||
126285178|NCT03842228|454332914|FG001|Overall Study|Progression|1|||
125882628|NCT04322526|452869014|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
125882629|NCT04322526|452869013|FG000|Washout (1 Week)|Lost to Follow-up|1|||
126285179|NCT03842228|454332915|FG002|Overall Study|Progression|7|||
126285180|NCT03842228|454332916|FG003|Overall Study|Progression|5|||
126285181|NCT03842228|454332917|FG004|Overall Study|Progression|4|||
126285182|NCT03842228|454332918|FG005|Overall Study|Progression|2|||
126285183|NCT03842228|454332919|FG006|Overall Study|Progression|3|||
126285184|NCT02567435|454332920|FG000|Overall Study|Death|1|||
125882630|NCT04322526|452869014|FG001|Washout (1 Week)|Lost to Follow-up|2|||
126285185|NCT02567435|454332921|FG001|Overall Study|Death|1|||
126285186|NCT02567435|454332922|FG002|Overall Study|Death|0|||
126285187|NCT02567435|454332923|FG003|Overall Study|Death|0|||
126285188|NCT02567435|454332920|FG000|Overall Study|Ineligible|1|||
126285189|NCT02567435|454332921|FG001|Overall Study|Ineligible|3|||
126285190|NCT02567435|454332922|FG002|Overall Study|Ineligible|0|||
126285191|NCT02567435|454332923|FG003|Overall Study|Ineligible|0|||
126285192|NCT02567435|454332920|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
125882631|NCT01716234|452869015|FG000|Overall Study|Protocol Violation|0|||
125882632|NCT01716234|452869016|FG001|Overall Study|Protocol Violation|0|||
126285193|NCT02567435|454332921|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
126285194|NCT02567435|454332922|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
126040793|NCT02240238|453447178|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126040794|NCT02240238|453447167|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040795|NCT02240238|453447168|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040796|NCT02240238|453447169|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040797|NCT02240238|453447170|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040798|NCT02240238|453447171|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040799|NCT02240238|453447172|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040800|NCT02240238|453447173|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040801|NCT02240238|453447174|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040802|NCT02240238|453447175|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040803|NCT02240238|453447176|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040804|NCT02240238|453447177|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
126040805|NCT02240238|453447178|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126040806|NCT02240238|453447167|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040807|NCT02240238|453447168|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040808|NCT02240238|453447169|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040809|NCT02240238|453447170|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040810|NCT02240238|453447171|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040811|NCT02240238|453447172|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040812|NCT02240238|453447173|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040813|NCT02240238|453447174|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040814|NCT02240238|453447175|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040815|NCT02240238|453447176|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040816|NCT02240238|453447177|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
126040817|NCT02240238|453447178|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126040818|NCT02240238|453447167|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040819|NCT02240238|453447168|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040820|NCT02240238|453447169|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040821|NCT02240238|453447170|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040822|NCT02240238|453447171|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040823|NCT02240238|453447172|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040824|NCT02240238|453447173|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040825|NCT02240238|453447174|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040826|NCT02240238|453447175|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040827|NCT02240238|453447176|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040828|NCT02240238|453447177|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
126040829|NCT02240238|453447178|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126040830|NCT02240238|453447167|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126040831|NCT02240238|453447168|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126285195|NCT02567435|454332923|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
126285196|NCT06390826|454332924|FG000|Overall Study|Never Start Protocol Therapy|1|||
126285197|NCT06390826|454332924|FG000|Overall Study|Adverse Event|1|||
126285198|NCT06390826|454332924|FG000|Overall Study|Disease Progression|8|||
126285199|NCT04458922|454332926|FG000|Overall Study|Withdrawal by Subject|1|||
126285200|NCT04458922|454332927|FG001|Overall Study|Withdrawal by Subject|0|||
126285201|NCT04458922|454332928|FG002|Overall Study|Withdrawal by Subject|2|||
126285202|NCT04458922|454332926|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
126285203|NCT04458922|454332927|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
126285204|NCT04458922|454332928|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
126285205|NCT04458922|454332926|FG000|Overall Study|Adverse Event|1|||
126285206|NCT04458922|454332927|FG001|Overall Study|Adverse Event|0|||
126285207|NCT04458922|454332928|FG002|Overall Study|Adverse Event|0|||
126285208|NCT04458922|454332926|FG000|Overall Study|Started new study|0|||
126285209|NCT04458922|454332927|FG001|Overall Study|Started new study|0|||
126285210|NCT04458922|454332928|FG002|Overall Study|Started new study|1|||
126285211|NCT04458922|454332926|FG000|Overall Study|Progressive disease|6|||
126285212|NCT04458922|454332927|FG001|Overall Study|Progressive disease|8|||
126285213|NCT04458922|454332928|FG002|Overall Study|Progressive disease|2|||
126285214|NCT04458922|454332926|FG000|Overall Study|Death|1|||
126285215|NCT04458922|454332927|FG001|Overall Study|Death|0|||
126285216|NCT04458922|454332928|FG002|Overall Study|Death|2|||
126285217|NCT04458922|454332926|FG000|Overall Study|Participant started chemotherapy|0|||
126285218|NCT04458922|454332927|FG001|Overall Study|Participant started chemotherapy|1|||
126285219|NCT04458922|454332928|FG002|Overall Study|Participant started chemotherapy|0|||
126285220|NCT06351371|454332929|FG000|Overall Study|Mutation Status Not Confirmed|9|||
126285221|NCT06351371|454332929|FG000|Overall Study|Ineligible|1|||
126285222|NCT06351371|454332929|FG000|Overall Study|Adverse Event|4|||
126285223|NCT06351371|454332929|FG000|Overall Study|Death|1|||
126285224|NCT06351371|454332929|FG000|Overall Study|Disease progression|14|||
126285225|NCT06351371|454332929|FG000|Overall Study|Withdrawal by Subject|3|||
126285226|NCT06351371|454332929|FG000|Overall Study|Physician Decision|3|||
126285227|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
126285228|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
126285229|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
126285230|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
126285231|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
126285232|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
126285233|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
126285234|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
126285235|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
126285236|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
126285237|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
126285238|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
126285239|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
126285240|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
126285241|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
126285242|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
126285243|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
126285244|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
126285245|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
126285246|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
126285247|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
126285248|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
126285249|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
126285250|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
126285251|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
126285252|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
126285253|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
126285254|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
126285255|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
126285256|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
126285257|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
126285258|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
126285259|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
126285260|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
126285261|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
126285262|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
126285263|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Other than specified|0|||
126285264|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Other than specified|0|||
126285265|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Other than specified|1|||
126285266|NCT04856930|454332931|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
126285267|NCT04856930|454332932|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
126285268|NCT04856930|454332933|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
126285269|NCT04856930|454332931|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
126285270|NCT04856930|454332932|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
126285271|NCT04856930|454332933|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
126285272|NCT04856930|454332931|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
126285273|NCT04856930|454332932|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
126285274|NCT04856930|454332933|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
126285275|NCT04856930|454332931|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
126285276|NCT04856930|454332932|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
126285277|NCT04856930|454332933|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
126285278|NCT01009814|454332934|FG000|Overall Study|No longer met study criteria|1|||
126285279|NCT01009814|454332935|FG001|Overall Study|No longer met study criteria|1|||
126285280|NCT01009814|454332936|FG002|Overall Study|No longer met study criteria|0|||
126040832|NCT02240238|453447169|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126040833|NCT02240238|453447170|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126285281|NCT01009814|454332937|FG003|Overall Study|No longer met study criteria|0|||
126285282|NCT01009814|454332938|FG004|Overall Study|No longer met study criteria|0|||
126285283|NCT00618371|454332939|FG000|Overall Study|Withdrawal by Subject|2|||
126285284|NCT03965689|454332942|FG000|Overall Study|Too sick to get study intervention|2|||
126285285|NCT03022084|454332943|FG000|Overall Study|Lost to Follow-up|2|||
126285286|NCT03022084|454332944|FG001|Overall Study|Lost to Follow-up|3|||
125882633|NCT01716234|452869017|FG002|Overall Study|Protocol Violation|0|||
126285287|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
126285288|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
126285289|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
126285290|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
126285291|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
126285292|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285293|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285294|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285295|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285296|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285297|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
126285298|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
126285299|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
126285300|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
126285301|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
126285302|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285303|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285304|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285305|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285306|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285307|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
126285308|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
126285309|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
126285310|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
126285311|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
126285312|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285313|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285314|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285315|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285316|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285317|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
126285318|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
126285319|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
126285320|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
126285321|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
126285322|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285323|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285324|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285325|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285326|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285327|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285328|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285329|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285330|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
126285331|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285332|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285333|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285334|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285335|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285336|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285337|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
126285338|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
126285339|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
126285340|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
126285341|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
126285342|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285343|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285344|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285345|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285346|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285347|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285348|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285349|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285350|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
125882634|NCT01716234|452869018|FG003|Overall Study|Protocol Violation|1|||
126285351|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285352|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285353|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285354|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285355|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285356|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285357|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
126285358|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
126285359|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
126285360|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
126285361|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
126285362|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
126285363|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
126285364|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
126285365|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
126285366|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
126285367|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285368|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285369|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285370|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285371|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285372|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
126285373|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
126285374|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
126285375|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
126285376|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
126285377|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285378|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285379|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285380|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285381|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285382|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
126285383|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
126285384|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
126285385|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
126285386|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
126285387|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285388|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285389|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285390|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285391|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285392|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
126285393|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
126285394|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
126285395|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
126285396|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
126285397|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285398|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285399|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285400|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285401|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285402|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285403|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
126285404|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285405|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
126285406|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
126285407|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285408|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285409|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285410|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285411|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285412|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285413|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285414|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
126285415|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
126365085|NCT02613507|454630431|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
126285416|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285417|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
126285418|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
126365086|NCT02613507|454630432|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
126365087|NCT02613507|454630431|FG000|Treatment|Not reported|3|||
126365088|NCT02613507|454630432|FG001|Treatment|Not reported|0|||
126365089|NCT02613507|454630431|FG000|Treatment|Other reasons|8|||
126365090|NCT02613507|454630432|FG001|Treatment|Other reasons|0|||
126365091|NCT02613507|454630431|FG000|Treatment|Participant no longer meets criteria|3|||
126365092|NCT02613507|454630432|FG001|Treatment|Participant no longer meets criteria|0|||
126365093|NCT02613507|454630431|FG000|Treatment|Maximum clinical benefit|5|||
126365094|NCT02613507|454630432|FG001|Treatment|Maximum clinical benefit|10|||
126365095|NCT02613507|454630431|FG000|Treatment|Lost to Follow-up|1|||
126365096|NCT02613507|454630432|FG001|Treatment|Lost to Follow-up|0|||
126365097|NCT02613507|454630431|FG000|Treatment|Participant withdrew consent|0|||
126285419|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
126285420|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
126285421|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
126285422|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
126285423|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
126285424|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
126285425|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
126285426|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
126285427|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Other|0|||
126285428|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Other|0|||
126285429|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Other|0|||
126285430|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Other|0|||
126285431|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Other|0|||
126285432|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Other|0|||
126285433|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Other|0|||
126285434|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Other|0|||
126285435|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Other|1|||
126285436|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Other|1|||
126285437|NCT04948333|454332955|FG000|Overall Study|Adverse Event|6|||
126285438|NCT04948333|454332956|FG001|Overall Study|Adverse Event|4|||
126285439|NCT04948333|454332957|FG002|Overall Study|Adverse Event|0|||
126285440|NCT04948333|454332958|FG003|Overall Study|Adverse Event|2|||
126285441|NCT04948333|454332955|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
126285442|NCT04948333|454332956|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126285443|NCT04948333|454332957|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126285444|NCT04948333|454332958|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126285445|NCT04948333|454332955|FG000|Overall Study|Progressive Disease|1|||
126285446|NCT04948333|454332956|FG001|Overall Study|Progressive Disease|5|||
126285447|NCT04948333|454332957|FG002|Overall Study|Progressive Disease|0|||
126285448|NCT04948333|454332958|FG003|Overall Study|Progressive Disease|0|||
126285449|NCT04948333|454332955|FG000|Overall Study|Physician Decision|2|||
126285450|NCT04948333|454332956|FG001|Overall Study|Physician Decision|2|||
126285451|NCT04948333|454332957|FG002|Overall Study|Physician Decision|0|||
126285452|NCT04948333|454332958|FG003|Overall Study|Physician Decision|0|||
126285453|NCT04948333|454332955|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
126285454|NCT04948333|454332956|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
126285455|NCT04948333|454332957|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
126285456|NCT04948333|454332958|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
126285457|NCT04948333|454332955|FG000|Overall Study|Withdrawal by Subject|2|||
126285458|NCT04948333|454332956|FG001|Overall Study|Withdrawal by Subject|0|||
126285459|NCT04948333|454332957|FG002|Overall Study|Withdrawal by Subject|0|||
126285460|NCT04948333|454332958|FG003|Overall Study|Withdrawal by Subject|1|||
126285461|NCT04948333|454332955|FG000|Overall Study|Protocol Violation|0|||
126285462|NCT04948333|454332956|FG001|Overall Study|Protocol Violation|1|||
126285463|NCT04948333|454332957|FG002|Overall Study|Protocol Violation|0|||
126285464|NCT04948333|454332958|FG003|Overall Study|Protocol Violation|0|||
126285465|NCT04948333|454332955|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
126285466|NCT04948333|454332956|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
126285467|NCT04948333|454332957|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
126285468|NCT04948333|454332958|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
126285469|NCT01625988|454332959|FG000|Overall Study|Lost to Follow-up|5|||
126285470|NCT01625988|454332960|FG001|Overall Study|Lost to Follow-up|6|||
126285471|NCT01625988|454332959|FG000|Overall Study|Withdrawal by Subject|8|||
126285472|NCT01625988|454332960|FG001|Overall Study|Withdrawal by Subject|3|||
125882635|NCT01716234|452869019|FG004|Overall Study|Protocol Violation|1|||
126285473|NCT01625988|454332959|FG000|Overall Study|Adverse Event|0|||
126285474|NCT01625988|454332960|FG001|Overall Study|Adverse Event|1|||
126285475|NCT01625988|454332959|FG000|Overall Study|Lack of Efficacy|0|||
126285476|NCT01625988|454332960|FG001|Overall Study|Lack of Efficacy|1|||
126285477|NCT01625988|454332959|FG000|Overall Study|Randomized Inappropriately|1|||
126285478|NCT01625988|454332960|FG001|Overall Study|Randomized Inappropriately|0|||
125882636|NCT01716234|452869020|FG005|Overall Study|Protocol Violation|1|||
125882637|NCT01716234|452869021|FG006|Overall Study|Protocol Violation|0|||
125882638|NCT01716234|452869015|FG000|Overall Study|Lack of Efficacy|0|||
125882639|NCT01716234|452869016|FG001|Overall Study|Lack of Efficacy|0|||
125882640|NCT01716234|452869017|FG002|Overall Study|Lack of Efficacy|0|||
125882641|NCT01716234|452869018|FG003|Overall Study|Lack of Efficacy|1|||
125882642|NCT01716234|452869019|FG004|Overall Study|Lack of Efficacy|0|||
125882643|NCT01716234|452869020|FG005|Overall Study|Lack of Efficacy|0|||
125882644|NCT01716234|452869021|FG006|Overall Study|Lack of Efficacy|0|||
125882645|NCT01716234|452869015|FG000|Overall Study|Did not meet protocol eligibility|0|||
125882646|NCT01716234|452869016|FG001|Overall Study|Did not meet protocol eligibility|0|||
125882647|NCT01716234|452869017|FG002|Overall Study|Did not meet protocol eligibility|1|||
125882648|NCT01716234|452869018|FG003|Overall Study|Did not meet protocol eligibility|0|||
125882649|NCT01716234|452869019|FG004|Overall Study|Did not meet protocol eligibility|0|||
125882650|NCT01716234|452869020|FG005|Overall Study|Did not meet protocol eligibility|4|||
125882651|NCT01716234|452869021|FG006|Overall Study|Did not meet protocol eligibility|0|||
125882652|NCT01716234|452869015|FG000|Overall Study|Adverse Event|7|||
125882653|NCT01716234|452869016|FG001|Overall Study|Adverse Event|10|||
125882654|NCT01716234|452869017|FG002|Overall Study|Adverse Event|2|||
125882655|NCT01716234|452869018|FG003|Overall Study|Adverse Event|8|||
125882656|NCT01716234|452869019|FG004|Overall Study|Adverse Event|3|||
125882657|NCT01716234|452869020|FG005|Overall Study|Adverse Event|6|||
125882658|NCT01716234|452869021|FG006|Overall Study|Adverse Event|0|||
125882659|NCT01716234|452869015|FG000|Overall Study|Withdrawal by Subject|3|||
125882660|NCT01716234|452869016|FG001|Overall Study|Withdrawal by Subject|0|||
125882661|NCT01716234|452869017|FG002|Overall Study|Withdrawal by Subject|2|||
125882662|NCT01716234|452869018|FG003|Overall Study|Withdrawal by Subject|2|||
125882663|NCT01716234|452869019|FG004|Overall Study|Withdrawal by Subject|1|||
125882664|NCT01716234|452869020|FG005|Overall Study|Withdrawal by Subject|3|||
125882665|NCT01716234|452869021|FG006|Overall Study|Withdrawal by Subject|0|||
125882666|NCT01523756|452869023|FG000|Baseline Period|Adverse Event|0|||
125882667|NCT01523756|452869024|FG001|Baseline Period|Adverse Event|1|||
125882668|NCT01523756|452869023|FG000|Test Period 1|Adverse Event|1|||
125882669|NCT01523756|452869024|FG001|Test Period 1|Adverse Event|0|||
125882670|NCT01523756|452869023|FG000|Test Period 2|Withdrawal by Subject|0|||
125882671|NCT01523756|452869024|FG001|Test Period 2|Withdrawal by Subject|1|||
125882672|NCT00993967|452869025|FG000|Overall Study|Adverse Event|8|||
125882673|NCT00993967|452869025|FG000|Overall Study|Death|1|||
125882674|NCT00993967|452869025|FG000|Overall Study|Lost to Follow-up|14|||
125882675|NCT00993967|452869025|FG000|Overall Study|Withdrawal by Subject|36|||
125882676|NCT00993967|452869025|FG000|Overall Study|Protocol Violation|2|||
125882677|NCT00515619|452869026|FG000|Overall Study|Adverse Event|34|||
125882678|NCT00515619|452869026|FG000|Overall Study|Lack of Efficacy|92|||
126285479|NCT01625988|454332959|FG000|Overall Study|Protocol Violation|0|||
126285480|NCT01625988|454332960|FG001|Overall Study|Protocol Violation|2|||
126285481|NCT01121562|454332961|FG000|Overall Study|Objective progression or relapse|8|||
126285482|NCT01121562|454332961|FG000|Overall Study|Withdrawal by Subject|1|||
126285483|NCT01121562|454332961|FG000|Overall Study|Adverse Event|1|||
126285484|NCT01121562|454332961|FG000|Overall Study|Sponsor Decision|1|||
126285485|NCT01121562|454332961|FG000|Overall Study|Met study discontinuation criteria|1|||
126285486|NCT01495702|454332962|FG000|Randomized Phase|Randomized But Not Treated|1|||
126285487|NCT01495702|454332963|FG001|Randomized Phase|Randomized But Not Treated|4|||
126285488|NCT01495702|454332962|FG000|Randomized Phase|Adverse Event|2|||
126285489|NCT01495702|454332963|FG001|Randomized Phase|Adverse Event|2|||
126285490|NCT01495702|454332962|FG000|Randomized Phase|Death|1|||
126285491|NCT01495702|454332963|FG001|Randomized Phase|Death|0|||
126285492|NCT01495702|454332962|FG000|Randomized Phase|Lack of Efficacy|2|||
126285493|NCT01495702|454332963|FG001|Randomized Phase|Lack of Efficacy|0|||
126285494|NCT01495702|454332962|FG000|Randomized Phase|Investigators Discretion|2|||
126285495|NCT01495702|454332963|FG001|Randomized Phase|Investigators Discretion|0|||
126285496|NCT01495702|454332962|FG000|Randomized Phase|Withdrew Consent|10|||
126285497|NCT01495702|454332963|FG001|Randomized Phase|Withdrew Consent|18|||
126285498|NCT01495702|454332962|FG000|Randomized Phase|Lost to Follow-up|4|||
126285499|NCT01495702|454332963|FG001|Randomized Phase|Lost to Follow-up|3|||
126285500|NCT01495702|454332962|FG000|Randomized Phase|Participant Noncompliance|1|||
126285501|NCT01495702|454332963|FG001|Randomized Phase|Participant Noncompliance|0|||
126285502|NCT01495702|454332962|FG000|Randomized Phase|Protocol Violation|3|||
125882679|NCT00515619|452869026|FG000|Overall Study|Withdrawal by Subject|66|||
125882680|NCT00515619|452869026|FG000|Overall Study|Protocol Violation|3|||
125882681|NCT00515619|452869026|FG000|Overall Study|Lost to Follow-up|4|||
125882682|NCT00515619|452869026|FG000|Overall Study|Unsatisfactory compliance|6|||
125882683|NCT00515619|452869026|FG000|Overall Study|Other: Site discontinuing trials|2|||
125882684|NCT00515619|452869026|FG000|Overall Study|Other: Subject cannot attend visits|2|||
125882685|NCT00515619|452869026|FG000|Overall Study|Other: Subject required surgery|1|||
125882686|NCT00515619|452869026|FG000|Overall Study|Other: Subject moved to another country|1|||
125882687|NCT00515619|452869026|FG000|Overall Study|Other: Investigator decision|1|||
125882688|NCT00515619|452869026|FG000|Overall Study|Other: Subject became pregnant|1|||
126040834|NCT02240238|453447171|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126040835|NCT02240238|453447172|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126285503|NCT01495702|454332963|FG001|Randomized Phase|Protocol Violation|1|||
126285504|NCT04152863|454332964|FG000|Overall Study|Death|13|||
126285505|NCT04152863|454332965|FG001|Overall Study|Death|12|||
126285506|NCT04152863|454332966|FG002|Overall Study|Death|7|||
126285507|NCT04152863|454332964|FG000|Overall Study|Physician Decision|1|||
126285508|NCT04152863|454332965|FG001|Overall Study|Physician Decision|1|||
126285509|NCT04152863|454332966|FG002|Overall Study|Physician Decision|1|||
126285510|NCT04152863|454332964|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
126285511|NCT04152863|454332965|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
126285512|NCT04152863|454332966|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
126285513|NCT04152863|454332964|FG000|Overall Study|Withdrawal by Subject|2|||
126285514|NCT04152863|454332965|FG001|Overall Study|Withdrawal by Subject|1|||
126285515|NCT04152863|454332966|FG002|Overall Study|Withdrawal by Subject|3|||
126285516|NCT01644617|454332967|FG000|Overall Study|Withdrawal by Subject|3|||
126285517|NCT01644617|454332968|FG001|Overall Study|Withdrawal by Subject|4|||
126285518|NCT01644617|454332969|FG002|Overall Study|Withdrawal by Subject|1|||
126285519|NCT01644617|454332967|FG000|Overall Study|Lost to Follow-up|0|||
126285520|NCT01644617|454332968|FG001|Overall Study|Lost to Follow-up|1|||
126285521|NCT01644617|454332969|FG002|Overall Study|Lost to Follow-up|0|||
126285522|NCT01644617|454332967|FG000|Overall Study|Adverse Event|3|||
126285523|NCT01644617|454332968|FG001|Overall Study|Adverse Event|0|||
126285524|NCT01644617|454332969|FG002|Overall Study|Adverse Event|6|||
126285525|NCT02075515|454332970|FG000|Overall Study|Serious Adverse Event|1|||
126285526|NCT02075515|454332971|FG001|Overall Study|Serious Adverse Event|1|||
126285527|NCT02075515|454332972|FG002|Overall Study|Serious Adverse Event|1|||
126285528|NCT02075515|454332970|FG000|Overall Study|Non-Serious Adverse Event|0|||
126285529|NCT02075515|454332971|FG001|Overall Study|Non-Serious Adverse Event|1|||
126285530|NCT02075515|454332972|FG002|Overall Study|Non-Serious Adverse Event|0|||
126285531|NCT02075515|454332970|FG000|Overall Study|Withdrawal by Subject|2|||
126285532|NCT02075515|454332971|FG001|Overall Study|Withdrawal by Subject|0|||
126285533|NCT02075515|454332972|FG002|Overall Study|Withdrawal by Subject|1|||
126285534|NCT02075515|454332970|FG000|Overall Study|Lost to Follow-up|1|||
126285535|NCT02075515|454332971|FG001|Overall Study|Lost to Follow-up|3|||
126285536|NCT02075515|454332972|FG002|Overall Study|Lost to Follow-up|6|||
126285537|NCT00378573|454332975|FG000|Treatment Period|Adverse Event|9|||
126285538|NCT00378573|454332975|FG000|Treatment Period|Physician Decision|1|||
126285539|NCT00378573|454332975|FG000|Treatment Period|Withdrawal by Subject|2|||
126285540|NCT00378573|454332975|FG000|Treatment Period|Disease Progression|4|||
126285541|NCT00378573|454332975|FG000|Treatment Period|Sponsor decision to close study|1|||
126285542|NCT00378573|454332975|FG000|Follow-up|Death|12|||
126285543|NCT00378573|454332975|FG000|Follow-up|Lost to Follow-up|1|||
126285544|NCT00378573|454332975|FG000|Follow-up|Withdrawal by Subject|1|||
126285545|NCT02797171|454332979|FG000|Overall Study|Lost to Follow-up|2|||
126285546|NCT02797171|454332980|FG001|Overall Study|Lost to Follow-up|0|||
126285547|NCT02797171|454332981|FG002|Overall Study|Lost to Follow-up|2|||
126285548|NCT02797171|454332982|FG003|Overall Study|Lost to Follow-up|1|||
126285549|NCT02797171|454332983|FG004|Overall Study|Lost to Follow-up|2|||
126285550|NCT02797171|454332984|FG005|Overall Study|Lost to Follow-up|0|||
126285551|NCT02797171|454332979|FG000|Overall Study|Withdrawal by Subject|1|||
126285552|NCT02797171|454332980|FG001|Overall Study|Withdrawal by Subject|1|||
126285553|NCT02797171|454332981|FG002|Overall Study|Withdrawal by Subject|0|||
126285554|NCT02797171|454332982|FG003|Overall Study|Withdrawal by Subject|0|||
126285555|NCT02797171|454332983|FG004|Overall Study|Withdrawal by Subject|0|||
126285556|NCT02797171|454332984|FG005|Overall Study|Withdrawal by Subject|0|||
126285557|NCT02797171|454332979|FG000|Overall Study|Protocol Violation|1|||
126285558|NCT02797171|454332980|FG001|Overall Study|Protocol Violation|0|||
126285559|NCT02797171|454332981|FG002|Overall Study|Protocol Violation|0|||
126285560|NCT02797171|454332982|FG003|Overall Study|Protocol Violation|0|||
126285561|NCT02797171|454332983|FG004|Overall Study|Protocol Violation|0|||
126285562|NCT02797171|454332984|FG005|Overall Study|Protocol Violation|0|||
126285563|NCT02797171|454332979|FG000|Overall Study|Participant unable to adhere|0|||
126285564|NCT02797171|454332980|FG001|Overall Study|Participant unable to adhere|1|||
126285565|NCT02797171|454332981|FG002|Overall Study|Participant unable to adhere|0|||
126285566|NCT02797171|454332982|FG003|Overall Study|Participant unable to adhere|0|||
126285567|NCT02797171|454332983|FG004|Overall Study|Participant unable to adhere|0|||
126285568|NCT02797171|454332984|FG005|Overall Study|Participant unable to adhere|0|||
126285569|NCT02797171|454332979|FG000|Overall Study|Not Randomized|0|||
126285570|NCT02797171|454332980|FG001|Overall Study|Not Randomized|0|||
126285571|NCT02797171|454332981|FG002|Overall Study|Not Randomized|0|||
126285572|NCT02797171|454332982|FG003|Overall Study|Not Randomized|0|||
126285573|NCT02797171|454332983|FG004|Overall Study|Not Randomized|0|||
126285574|NCT02797171|454332984|FG005|Overall Study|Not Randomized|1|||
126285575|NCT01427608|454332985|FG000|Overall Study|Death|1|||
126285576|NCT01427608|454332986|FG001|Overall Study|Death|0|||
126285577|NCT01427608|454332985|FG000|Overall Study|Withdrawal by Subject|7|||
126285578|NCT01427608|454332986|FG001|Overall Study|Withdrawal by Subject|3|||
125882689|NCT00515619|452869026|FG000|Overall Study|Other: Request from sponsor|1|||
125882690|NCT00515619|452869026|FG000|Overall Study|Other: Drug available on license|1|||
125882691|NCT00515619|452869026|FG000|Overall Study|Other: Subject interested in other AED|1|||
125882692|NCT02760498|452869027|FG000|Overall Study|Adverse Event|3|||
125882693|NCT02760498|452869028|FG001|Overall Study|Adverse Event|3|||
125882694|NCT02760498|452869029|FG002|Overall Study|Adverse Event|1|||
125882695|NCT02760498|452869030|FG003|Overall Study|Adverse Event|1|||
125882696|NCT02760498|452869031|FG004|Overall Study|Adverse Event|0|||
125882697|NCT02760498|452869032|FG005|Overall Study|Adverse Event|6|||
125882698|NCT02760498|452869027|FG000|Overall Study|Death|7|||
125882699|NCT02760498|452869028|FG001|Overall Study|Death|5|||
125882700|NCT02760498|452869029|FG002|Overall Study|Death|5|||
125882701|NCT02760498|452869030|FG003|Overall Study|Death|7|||
125882702|NCT02760498|452869031|FG004|Overall Study|Death|0|||
126285579|NCT01427608|454332985|FG000|Overall Study|Relapsed-all cause|13|||
126285580|NCT01427608|454332986|FG001|Overall Study|Relapsed-all cause|34|||
126285581|NCT01427608|454332985|FG000|Overall Study|Events not attributed to study meds|0|||
126285582|NCT01427608|454332986|FG001|Overall Study|Events not attributed to study meds|1|||
126285583|NCT03993379|454332987|FG000|Overall Study|The study was terminated early due to business decision.|0|||
126285584|NCT03993379|454332988|FG001|Overall Study|The study was terminated early due to business decision.|2|||
126285585|NCT03993379|454332989|FG002|Overall Study|The study was terminated early due to business decision.|0|||
126285586|NCT03993379|454332990|FG003|Overall Study|The study was terminated early due to business decision.|0|||
126285587|NCT03993379|454332987|FG000|Overall Study|Withdrawal by Subject|0|||
126285588|NCT03993379|454332988|FG001|Overall Study|Withdrawal by Subject|1|||
126285589|NCT03993379|454332989|FG002|Overall Study|Withdrawal by Subject|0|||
126285590|NCT03993379|454332990|FG003|Overall Study|Withdrawal by Subject|0|||
126285591|NCT02585778|454332995|FG000|Overall Study|Adverse Event|17|||
126285592|NCT02585778|454332996|FG001|Overall Study|Adverse Event|4|||
126285593|NCT02585778|454332995|FG000|Overall Study|Participant did not wish to continue|9|||
126285594|NCT02585778|454332996|FG001|Overall Study|Participant did not wish to continue|4|||
125882703|NCT02760498|452869032|FG005|Overall Study|Death|23|||
125882704|NCT02760498|452869027|FG000|Overall Study|Lost to Follow-up|0|||
126040836|NCT02240238|453447173|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126040837|NCT02240238|453447174|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126040838|NCT02240238|453447175|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126040839|NCT02240238|453447176|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126040840|NCT02240238|453447177|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
126040841|NCT02240238|453447178|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126040842|NCT02240238|453447167|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040843|NCT02240238|453447168|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040844|NCT02240238|453447169|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040845|NCT02240238|453447170|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040846|NCT02240238|453447171|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040847|NCT02240238|453447172|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040848|NCT02240238|453447173|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040849|NCT02240238|453447174|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040850|NCT02240238|453447175|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040851|NCT02240238|453447176|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040852|NCT02240238|453447177|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126040853|NCT02240238|453447178|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
126040854|NCT02315703|453447179|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126040855|NCT02315703|453447180|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126040856|NCT02315703|453447181|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126040857|NCT02315703|453447182|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
126040858|NCT02315703|453447183|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
126040859|NCT02315703|453447184|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126040860|NCT02315703|453447185|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
126040861|NCT02315703|453447186|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126040862|NCT02315703|453447179|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
126040863|NCT02315703|453447180|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
126040864|NCT02315703|453447181|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
126040865|NCT02315703|453447182|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
126040866|NCT02315703|453447183|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
126040867|NCT02315703|453447184|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
125882705|NCT02760498|452869028|FG001|Overall Study|Lost to Follow-up|0|||
125882706|NCT02760498|452869029|FG002|Overall Study|Lost to Follow-up|0|||
125882707|NCT02760498|452869030|FG003|Overall Study|Lost to Follow-up|0|||
125882708|NCT02760498|452869031|FG004|Overall Study|Lost to Follow-up|0|||
125882709|NCT02760498|452869032|FG005|Overall Study|Lost to Follow-up|3|||
125882710|NCT02760498|452869027|FG000|Overall Study|Non-compliance with study drug|0|||
125882711|NCT02760498|452869028|FG001|Overall Study|Non-compliance with study drug|2|||
125882712|NCT02760498|452869029|FG002|Overall Study|Non-compliance with study drug|0|||
125882713|NCT02760498|452869030|FG003|Overall Study|Non-compliance with study drug|0|||
125882714|NCT02760498|452869031|FG004|Overall Study|Non-compliance with study drug|0|||
125882715|NCT02760498|452869032|FG005|Overall Study|Non-compliance with study drug|0|||
126040868|NCT02315703|453447185|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
126040869|NCT02315703|453447186|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
126285595|NCT02585778|454332995|FG000|Overall Study|Poor compliance to study protocol|0|||
126285596|NCT02585778|454332996|FG001|Overall Study|Poor compliance to study protocol|2|||
126285597|NCT02585778|454332995|FG000|Overall Study|Death|0|||
126285598|NCT02585778|454332996|FG001|Overall Study|Death|1|||
126285599|NCT02585778|454332995|FG000|Overall Study|Randomized but not treated|1|||
126285600|NCT02585778|454332996|FG001|Overall Study|Randomized but not treated|2|||
126285601|NCT02585778|454332995|FG000|Overall Study|Other than specified above|6|||
126285602|NCT02585778|454332996|FG001|Overall Study|Other than specified above|2|||
126285603|NCT02789137|454332998|FG000|Overall Study|Dropped out/Died|58|||
126285604|NCT01482312|454332999|FG000|Period 1, 90 Minutes of Wear|Other|1|||
126285605|NCT01482312|454333000|FG001|Period 1, 90 Minutes of Wear|Other|0|||
126285606|NCT01482312|454333001|FG002|Period 1, 90 Minutes of Wear|Other|0|||
126285607|NCT01482312|454332999|FG000|Period 2, 90 Minutes of Wear|Other|1|||
126285608|NCT01482312|454333000|FG001|Period 2, 90 Minutes of Wear|Other|0|||
126285609|NCT01482312|454333001|FG002|Period 2, 90 Minutes of Wear|Other|0|||
126285610|NCT01699815|454333002|FG000|Overall Study|Protocol Violation|4|||
126285611|NCT01699815|454333003|FG001|Overall Study|Protocol Violation|7|||
126285612|NCT01699815|454333002|FG000|Overall Study|record could not be located|1|||
126285613|NCT01699815|454333003|FG001|Overall Study|record could not be located|0|||
126285614|NCT01699815|454333002|FG000|Overall Study|Adverse Event|0|||
126285615|NCT01699815|454333003|FG001|Overall Study|Adverse Event|1|||
126285616|NCT05246670|454333008|FG000|Overall Study|Withdrawal by Subject|2|||
126285617|NCT05246670|454333009|FG001|Overall Study|Withdrawal by Subject|3|||
126285618|NCT05246670|454333010|FG002|Overall Study|Withdrawal by Subject|0|||
126285619|NCT05246670|454333011|FG003|Overall Study|Withdrawal by Subject|1|||
126285620|NCT05246670|454333008|FG000|Overall Study|Adverse Event|0|||
126285621|NCT05246670|454333009|FG001|Overall Study|Adverse Event|0|||
126285622|NCT05246670|454333010|FG002|Overall Study|Adverse Event|1|||
126285623|NCT05246670|454333011|FG003|Overall Study|Adverse Event|0|||
126285624|NCT05246670|454333008|FG000|Overall Study|Physician Decision|1|||
126285625|NCT05246670|454333009|FG001|Overall Study|Physician Decision|0|||
126285626|NCT05246670|454333010|FG002|Overall Study|Physician Decision|0|||
126285627|NCT05246670|454333011|FG003|Overall Study|Physician Decision|0|||
126285628|NCT05246670|454333008|FG000|Overall Study|Protocol Violation|1|||
126285629|NCT05246670|454333009|FG001|Overall Study|Protocol Violation|0|||
126285630|NCT05246670|454333010|FG002|Overall Study|Protocol Violation|0|||
126285631|NCT05246670|454333011|FG003|Overall Study|Protocol Violation|0|||
126285632|NCT00799058|454333017|FG000|Overall Study|Withdrawal by Subject|2|||
126040870|NCT02315703|453447179|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126040871|NCT02315703|453447180|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126040872|NCT02315703|453447181|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126040873|NCT02315703|453447182|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126040874|NCT02315703|453447183|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126040875|NCT02315703|453447184|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
126040876|NCT02315703|453447185|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
126040877|NCT02315703|453447186|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126040878|NCT02315703|453447179|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126040879|NCT02315703|453447180|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126040880|NCT02315703|453447181|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126040881|NCT02315703|453447182|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126285633|NCT00799058|454333018|FG001|Overall Study|Withdrawal by Subject|2|||
126285634|NCT00799058|454333019|FG002|Overall Study|Withdrawal by Subject|2|||
126285635|NCT00799058|454333017|FG000|Overall Study|Lost to Follow-up|1|||
125882716|NCT02760498|452869027|FG000|Overall Study|Participant decision|1|||
126285636|NCT00799058|454333018|FG001|Overall Study|Lost to Follow-up|2|||
126040882|NCT02315703|453447183|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126285637|NCT00799058|454333019|FG002|Overall Study|Lost to Follow-up|1|||
126285638|NCT00799058|454333017|FG000|Overall Study|Adverse Event|0|||
126285639|NCT00799058|454333018|FG001|Overall Study|Adverse Event|2|||
126285640|NCT00799058|454333019|FG002|Overall Study|Adverse Event|0|||
126285641|NCT00799058|454333017|FG000|Overall Study|Pregnancy|1|||
126285642|NCT00799058|454333018|FG001|Overall Study|Pregnancy|0|||
126285643|NCT00799058|454333019|FG002|Overall Study|Pregnancy|0|||
126098976|NCT02480153|453655579|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
126098977|NCT02480153|453655577|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
126098978|NCT02480153|453655578|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
126098979|NCT02480153|453655579|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
126098980|NCT02480153|453655577|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
126098981|NCT02480153|453655578|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
126098982|NCT02480153|453655579|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
126098983|NCT02480153|453655577|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
126098984|NCT02480153|453655578|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
126098985|NCT02480153|453655579|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
126098986|NCT02480153|453655577|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
126098987|NCT02480153|453655578|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
126098988|NCT02480153|453655579|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
126098989|NCT02480153|453655577|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
126098990|NCT02480153|453655578|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
126098991|NCT02480153|453655579|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
126098992|NCT02480153|453655577|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
126098993|NCT02480153|453655578|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
126098994|NCT02480153|453655579|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
126098995|NCT02480153|453655577|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
126098996|NCT02480153|453655578|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
126098997|NCT02480153|453655579|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
126098998|NCT02480153|453655577|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
126098999|NCT02480153|453655578|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
126099000|NCT02480153|453655579|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
126099001|NCT02480153|453655577|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
126099002|NCT02480153|453655578|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
126099003|NCT02480153|453655579|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
126099004|NCT02480153|453655577|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
126099005|NCT02480153|453655578|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
126099006|NCT02480153|453655579|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
126099007|NCT00512317|453655580|FG000|Overall Study|Insufficient clinical response|36|||
126099008|NCT00512317|453655580|FG000|Overall Study|Withdrawal by Subject|23|||
126099009|NCT00512317|453655580|FG000|Overall Study|Sponsor closure of study|21|||
126099010|NCT00512317|453655580|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
126099011|NCT00512317|453655580|FG000|Overall Study|Adverse Event|13|||
126099012|NCT00512317|453655580|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
126099013|NCT00512317|453655580|FG000|Overall Study|Lost to Follow-up|2|||
126099014|NCT00512317|453655580|FG000|Overall Study|Other|2|||
126099015|NCT00007345|453655581|FG000|Overall Study|Refused further treatment|0|||
126099016|NCT00007345|453655582|FG001|Overall Study|Refused further treatment|7|||
126099017|NCT00007345|453655581|FG000|Overall Study|Switched to alternative treatment|0|||
126099018|NCT00007345|453655582|FG001|Overall Study|Switched to alternative treatment|3|||
126099019|NCT00007345|453655581|FG000|Overall Study|Intercurrent illness|1|||
126099020|NCT00007345|453655582|FG001|Overall Study|Intercurrent illness|0|||
126099021|NCT00007345|453655581|FG000|Overall Study|Death on study|1|||
126099022|NCT00007345|453655582|FG001|Overall Study|Death on study|1|||
126040883|NCT02315703|453447184|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126040884|NCT02315703|453447185|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126040885|NCT02315703|453447186|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
126040886|NCT02315703|453447179|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
126040887|NCT02315703|453447180|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
126040888|NCT02315703|453447181|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
126099023|NCT04433585|453655583|FG000|Overall Study|Withdrawal by Subject|15|||
126285644|NCT00799058|454333017|FG000|Overall Study|Not adherent|3|||
126099024|NCT04433585|453655584|FG001|Overall Study|Withdrawal by Subject|3|||
126099025|NCT04433585|453655585|FG002|Overall Study|Withdrawal by Subject|15|||
126099026|NCT04433585|453655586|FG003|Overall Study|Withdrawal by Subject|6|||
126285645|NCT00799058|454333018|FG001|Overall Study|Not adherent|2|||
126285646|NCT00799058|454333019|FG002|Overall Study|Not adherent|1|||
126285647|NCT00799058|454333017|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
126285648|NCT00799058|454333018|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
126285649|NCT00799058|454333019|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
126285650|NCT00799058|454333017|FG000|Overall Study|IP dispensing error|1|||
126285651|NCT00799058|454333018|FG001|Overall Study|IP dispensing error|0|||
126285652|NCT00799058|454333019|FG002|Overall Study|IP dispensing error|0|||
126285653|NCT00799058|454333017|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
126285654|NCT00799058|454333018|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
125882717|NCT02760498|452869028|FG001|Overall Study|Participant decision|4|||
125882718|NCT02760498|452869029|FG002|Overall Study|Participant decision|2|||
125882719|NCT02760498|452869030|FG003|Overall Study|Participant decision|2|||
125882720|NCT02760498|452869031|FG004|Overall Study|Participant decision|1|||
125882721|NCT02760498|452869032|FG005|Overall Study|Participant decision|6|||
125882722|NCT02760498|452869027|FG000|Overall Study|Sponsor decision|0|||
125882723|NCT02760498|452869028|FG001|Overall Study|Sponsor decision|0|||
125882724|NCT02760498|452869029|FG002|Overall Study|Sponsor decision|0|||
125882725|NCT02760498|452869030|FG003|Overall Study|Sponsor decision|3|||
125882726|NCT02760498|452869031|FG004|Overall Study|Sponsor decision|0|||
125882727|NCT02760498|452869032|FG005|Overall Study|Sponsor decision|0|||
125882728|NCT02760498|452869027|FG000|Overall Study|Physician Decision|3|||
125882729|NCT02760498|452869028|FG001|Overall Study|Physician Decision|4|||
125882730|NCT02760498|452869029|FG002|Overall Study|Physician Decision|1|||
125882731|NCT02760498|452869030|FG003|Overall Study|Physician Decision|4|||
125882732|NCT02760498|452869031|FG004|Overall Study|Physician Decision|0|||
125882733|NCT02760498|452869032|FG005|Overall Study|Physician Decision|2|||
125882734|NCT02760498|452869027|FG000|Overall Study|Disease progression|21|||
125882735|NCT02760498|452869028|FG001|Overall Study|Disease progression|19|||
125882736|NCT02760498|452869029|FG002|Overall Study|Disease progression|20|||
125882737|NCT02760498|452869030|FG003|Overall Study|Disease progression|18|||
125882738|NCT02760498|452869031|FG004|Overall Study|Disease progression|4|||
125882739|NCT02760498|452869032|FG005|Overall Study|Disease progression|55|||
125882740|NCT02760498|452869027|FG000|Overall Study|Withdrawal by Subject|4|||
125882741|NCT02760498|452869028|FG001|Overall Study|Withdrawal by Subject|7|||
125882742|NCT02760498|452869029|FG002|Overall Study|Withdrawal by Subject|5|||
125882743|NCT02760498|452869030|FG003|Overall Study|Withdrawal by Subject|1|||
125882744|NCT02760498|452869031|FG004|Overall Study|Withdrawal by Subject|0|||
125882745|NCT02760498|452869032|FG005|Overall Study|Withdrawal by Subject|6|||
125882746|NCT02760498|452869027|FG000|Overall Study|Other than specified|1|||
125882747|NCT02760498|452869028|FG001|Overall Study|Other than specified|6|||
125882748|NCT02760498|452869029|FG002|Overall Study|Other than specified|0|||
125882749|NCT02760498|452869030|FG003|Overall Study|Other than specified|3|||
125882750|NCT02760498|452869031|FG004|Overall Study|Other than specified|1|||
125882751|NCT02760498|452869032|FG005|Overall Study|Other than specified|0|||
125882752|NCT02760498|452869027|FG000|Overall Study|Not treated|0|||
125882753|NCT02760498|452869028|FG001|Overall Study|Not treated|0|||
125882754|NCT02760498|452869029|FG002|Overall Study|Not treated|0|||
126040889|NCT02315703|453447182|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
126040890|NCT02315703|453447183|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
126040891|NCT02315703|453447184|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
126040892|NCT02315703|453447185|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
126040893|NCT02315703|453447186|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
126040894|NCT02315703|453447179|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
126040895|NCT02315703|453447180|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
126040896|NCT02315703|453447181|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
126040897|NCT02315703|453447182|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
126040898|NCT02315703|453447183|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
126040899|NCT02315703|453447184|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
126040900|NCT02315703|453447185|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
126040901|NCT02315703|453447186|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
126040902|NCT02315703|453447179|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
126040903|NCT02315703|453447180|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
126040904|NCT02315703|453447181|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126040905|NCT02315703|453447182|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126040906|NCT02315703|453447183|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126040907|NCT02315703|453447184|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126040908|NCT02315703|453447185|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126040909|NCT02315703|453447186|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126040910|NCT02315703|453447179|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126040911|NCT02315703|453447180|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
126099027|NCT04433585|453655583|FG000|Overall Study|Adverse Event|10|||
125882755|NCT02760498|452869030|FG003|Overall Study|Not treated|0|||
125882756|NCT02760498|452869031|FG004|Overall Study|Not treated|0|||
125882757|NCT02760498|452869032|FG005|Overall Study|Not treated|2|||
125882758|NCT01467960|452869033|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
125882759|NCT01467960|452869034|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
126285655|NCT00799058|454333019|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
126285656|NCT00799058|454333017|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
126285657|NCT00799058|454333018|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
126285658|NCT00799058|454333019|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
126285659|NCT00799058|454333017|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
126285660|NCT00799058|454333018|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
126285661|NCT00799058|454333019|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
126285662|NCT00799058|454333017|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
126285663|NCT00799058|454333018|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
126285664|NCT00799058|454333019|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
126285665|NCT03639779|454333020|FG000|Overall Study|Lost to Follow-up|1|||
126285666|NCT00810511|454333021|FG000|Overall Study|Protocol Violation|0|||
126285667|NCT00810511|454333022|FG001|Overall Study|Protocol Violation|1|||
126285668|NCT00810511|454333021|FG000|Overall Study|Lack of Efficacy|9|||
126285669|NCT00810511|454333022|FG001|Overall Study|Lack of Efficacy|1|||
126285670|NCT00810511|454333021|FG000|Overall Study|death in the family|0|||
126285671|NCT00810511|454333022|FG001|Overall Study|death in the family|1|||
126285672|NCT00810511|454333021|FG000|Overall Study|Lost to Follow-up|1|||
126285673|NCT00810511|454333022|FG001|Overall Study|Lost to Follow-up|0|||
126285674|NCT00810511|454333021|FG000|Overall Study|deposits on contact lens|0|||
126285675|NCT00810511|454333022|FG001|Overall Study|deposits on contact lens|1|||
126285676|NCT02088697|454333023|FG000|Period I|Physician Decision|1|||
126285677|NCT02088697|454333024|FG001|Period I|Physician Decision|4|||
126285678|NCT02088697|454333023|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
126285679|NCT02088697|454333024|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
126285680|NCT00911300|454333028|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
126285681|NCT00911300|454333029|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
126285682|NCT00911300|454333028|FG000|Overall Study|Death|1|||
126285683|NCT00911300|454333029|FG001|Overall Study|Death|0|||
126285684|NCT00911300|454333028|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
126285685|NCT00911300|454333029|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
126285686|NCT00911300|454333028|FG000|Overall Study|Adverse Event|14|||
126285687|NCT00911300|454333029|FG001|Overall Study|Adverse Event|6|||
126285688|NCT00911300|454333028|FG000|Overall Study|Protocol Violation|3|||
126285689|NCT00911300|454333029|FG001|Overall Study|Protocol Violation|2|||
126285690|NCT00911300|454333028|FG000|Overall Study|Consent Withdrawn|4|||
126285691|NCT00911300|454333029|FG001|Overall Study|Consent Withdrawn|12|||
126285692|NCT00911300|454333028|FG000|Overall Study|Coronary Angiography Performed|1|||
126285693|NCT00911300|454333029|FG001|Overall Study|Coronary Angiography Performed|0|||
126285694|NCT00911300|454333028|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
126285695|NCT00911300|454333029|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
126285696|NCT00911300|454333028|FG000|Overall Study|Received Commercial Treatment|1|||
126285697|NCT00911300|454333029|FG001|Overall Study|Received Commercial Treatment|0|||
126285698|NCT00911300|454333028|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
126285699|NCT00911300|454333029|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
126285700|NCT00911300|454333028|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
126285701|NCT00911300|454333029|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
126285702|NCT00911300|454333028|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
126285703|NCT00911300|454333029|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
126285704|NCT00911300|454333028|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
126285705|NCT00911300|454333029|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
126285706|NCT00911300|454333028|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
126285707|NCT00911300|454333029|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
126285708|NCT00911300|454333028|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
126285709|NCT00911300|454333029|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
125882760|NCT01467960|452869035|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
125882761|NCT01467960|452869036|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
125882762|NCT01467960|452869037|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
126285710|NCT00911300|454333028|FG000|Overall Study|International Normalized Ratio Too High|0|||
126285711|NCT00911300|454333029|FG001|Overall Study|International Normalized Ratio Too High|1|||
126285712|NCT00911300|454333028|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
126285713|NCT00911300|454333029|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
126285714|NCT00911300|454333028|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
126365098|NCT02613507|454630432|FG001|Treatment|Participant withdrew consent|2|||
125882763|NCT01467960|452869038|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
125882764|NCT00771758|452869039|FG000|Overall Study|Adverse Event|2|||
126285715|NCT00911300|454333029|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
126285716|NCT00911300|454333028|FG000|Overall Study|Physician Decision|0|||
126285717|NCT00911300|454333029|FG001|Overall Study|Physician Decision|1|||
126285718|NCT00911300|454333028|FG000|Overall Study|Treatment Stopped by Mistake|0|||
126285719|NCT00911300|454333029|FG001|Overall Study|Treatment Stopped by Mistake|1|||
126285720|NCT00911300|454333028|FG000|Overall Study|Randomized; No Study Medication Received|0|||
126285721|NCT00911300|454333029|FG001|Overall Study|Randomized; No Study Medication Received|2|||
126285722|NCT04152291|454333032|FG000|Overall Study|Covid-19 restrictions|27|||
126285723|NCT04152291|454333032|FG000|Overall Study|Withdrawal by Subject|3|||
126285724|NCT01685840|454333033|FG000|Overall Study|Death|77|||
126285725|NCT01685840|454333034|FG001|Overall Study|Death|66|||
126285726|NCT01685840|454333033|FG000|Overall Study|Lost to Follow-up|27|||
126285727|NCT01685840|454333034|FG001|Overall Study|Lost to Follow-up|25|||
126285728|NCT01685840|454333033|FG000|Overall Study|Physician Decision|3|||
126285729|NCT01685840|454333034|FG001|Overall Study|Physician Decision|7|||
126285730|NCT01685840|454333033|FG000|Overall Study|Withdrawal by Subject|14|||
126285731|NCT01685840|454333034|FG001|Overall Study|Withdrawal by Subject|17|||
126285732|NCT01685840|454333033|FG000|Overall Study|Futility|197|||
126285733|NCT01685840|454333034|FG001|Overall Study|Futility|200|||
126285734|NCT01685840|454333033|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
126285735|NCT01685840|454333034|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
126285736|NCT02211417|454333039|FG000|Overall Study|Withdrawal by Subject|11|||
126285737|NCT02211417|454333040|FG001|Overall Study|Withdrawal by Subject|8|||
126285738|NCT02211417|454333039|FG000|Overall Study|Protocol Violation|1|||
126285739|NCT02211417|454333040|FG001|Overall Study|Protocol Violation|0|||
126285740|NCT02211417|454333039|FG000|Overall Study|Pregnancy|0|||
126285741|NCT02211417|454333040|FG001|Overall Study|Pregnancy|1|||
126040912|NCT02315703|453447181|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126285742|NCT02211417|454333039|FG000|Overall Study|Lost to Follow-up|2|||
126285743|NCT02211417|454333040|FG001|Overall Study|Lost to Follow-up|3|||
126285744|NCT02211417|454333039|FG000|Overall Study|Adverse Event|1|||
126285745|NCT02211417|454333040|FG001|Overall Study|Adverse Event|4|||
126285746|NCT00447993|454333041|FG000|Overall Study|Lost to Follow-up|0|||
126285747|NCT00447993|454333042|FG001|Overall Study|Lost to Follow-up|0|||
126285748|NCT00447993|454333043|FG002|Overall Study|Lost to Follow-up|2|||
126285749|NCT00447993|454333044|FG003|Overall Study|Lost to Follow-up|2|||
126285750|NCT00447993|454333041|FG000|Overall Study|Withdrawal by Subject|0|||
126285751|NCT00447993|454333042|FG001|Overall Study|Withdrawal by Subject|0|||
126285752|NCT00447993|454333043|FG002|Overall Study|Withdrawal by Subject|2|||
126285753|NCT00447993|454333044|FG003|Overall Study|Withdrawal by Subject|2|||
126285754|NCT04700137|454333049|FG000|Overall Study|Lost to Follow-up|1|||
126285755|NCT04700137|454333050|FG001|Overall Study|Lost to Follow-up|6|||
126285756|NCT04700137|454333051|FG002|Overall Study|Lost to Follow-up|1|||
126285757|NCT04700137|454333052|FG003|Overall Study|Lost to Follow-up|1|||
126285758|NCT04700137|454333049|FG000|Overall Study|Withdrawal by Subject|0|||
126285759|NCT04700137|454333050|FG001|Overall Study|Withdrawal by Subject|0|||
126285760|NCT04700137|454333051|FG002|Overall Study|Withdrawal by Subject|1|||
126285761|NCT04700137|454333052|FG003|Overall Study|Withdrawal by Subject|0|||
126285762|NCT04700137|454333049|FG000|Overall Study|Death|0|||
126285763|NCT04700137|454333050|FG001|Overall Study|Death|0|||
126285764|NCT04700137|454333051|FG002|Overall Study|Death|1|||
126285765|NCT04700137|454333052|FG003|Overall Study|Death|0|||
126285766|NCT00548093|454333053|FG000|Overall Study|Death|33|||
126285767|NCT00548093|454333054|FG001|Overall Study|Death|13|||
126285768|NCT00548093|454333053|FG000|Overall Study|Lost to Follow-up|3|||
126285769|NCT00548093|454333054|FG001|Overall Study|Lost to Follow-up|1|||
126285770|NCT00548093|454333053|FG000|Overall Study|Objective progression or relapse|1|||
126285771|NCT00548093|454333054|FG001|Overall Study|Objective progression or relapse|1|||
126285772|NCT00548093|454333053|FG000|Overall Study|Other|11|||
126285773|NCT00548093|454333054|FG001|Overall Study|Other|1|||
126285774|NCT00548093|454333053|FG000|Overall Study|Withdrawal by Subject|1|||
126285775|NCT00548093|454333054|FG001|Overall Study|Withdrawal by Subject|0|||
126285776|NCT00548093|454333053|FG000|Overall Study|Completed post-treatment follow-up|1|||
126285777|NCT00548093|454333054|FG001|Overall Study|Completed post-treatment follow-up|0|||
126285778|NCT02296931|454333060|FG000|Overall Study|Protocol Violation|0|||
126285779|NCT02296931|454333061|FG001|Overall Study|Protocol Violation|2|||
126285780|NCT01590277|454333062|FG000|Overall Study|Withdrawal by Subject|3|||
126285781|NCT01590277|454333062|FG000|Overall Study|Withdrawal by Subject|2|||
126285782|NCT01590277|454333062|FG000|Overall Study|Withdrawal by Subject|1|||
126285783|NCT01590277|454333062|FG000|Overall Study|Withdrawal by Subject|1|||
126285784|NCT04386616|454333063|FG000|Overall Study|Death|22|||
126285785|NCT04386616|454333064|FG001|Overall Study|Death|22|||
126285786|NCT04386616|454333065|FG002|Overall Study|Death|21|||
126285787|NCT04386616|454333063|FG000|Overall Study|Lost to Follow-up|5|||
126285788|NCT04386616|454333064|FG001|Overall Study|Lost to Follow-up|8|||
126285789|NCT04386616|454333065|FG002|Overall Study|Lost to Follow-up|6|||
126285790|NCT04386616|454333063|FG000|Overall Study|Withdrawal by Subject|2|||
126285791|NCT04386616|454333064|FG001|Overall Study|Withdrawal by Subject|4|||
126285792|NCT04386616|454333065|FG002|Overall Study|Withdrawal by Subject|1|||
126040913|NCT02315703|453447182|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126040914|NCT02315703|453447183|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126040915|NCT02315703|453447184|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126040916|NCT02315703|453447185|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126040917|NCT02315703|453447186|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126285793|NCT04386616|454333063|FG000|Overall Study|Adverse Event|1|||
126285794|NCT04386616|454333064|FG001|Overall Study|Adverse Event|1|||
126285795|NCT04386616|454333065|FG002|Overall Study|Adverse Event|0|||
126285796|NCT00805961|454333068|FG000|Modality Therapy|Withdrawal by Subject|1|||
126040918|NCT02315703|453447179|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
126285797|NCT00805961|454333068|FG000|Modality Therapy|Adverse Event|1|||
126285798|NCT00805961|454333068|FG000|Modality Therapy|Disease Progression|2|||
126285799|NCT00805961|454333068|FG000|Treatment-Free Interval|Adverse Event|3|||
126365099|NCT02613507|454630431|FG000|Treatment|Participant request to discontinue study treatment|13|||
126365100|NCT02613507|454630432|FG001|Treatment|Participant request to discontinue study treatment|17|||
126365101|NCT02613507|454630431|FG000|Treatment|Adverse event unrelated to study drug|20|||
126365102|NCT02613507|454630432|FG001|Treatment|Adverse event unrelated to study drug|3|||
126365103|NCT02613507|454630431|FG000|Treatment|Death|2|||
126365104|NCT02613507|454630432|FG001|Treatment|Death|0|||
126365105|NCT02613507|454630431|FG000|Treatment|Study drug toxicity|19|||
126365106|NCT02613507|454630432|FG001|Treatment|Study drug toxicity|14|||
126365107|NCT02613507|454630431|FG000|Treatment|Disease progression|263|||
126365108|NCT02613507|454630432|FG001|Treatment|Disease progression|110|||
126365109|NCT03941093|454630433|FG000|Overall Study|Protocol Violation|0|||
126365110|NCT03941093|454630434|FG001|Overall Study|Protocol Violation|1|||
126365111|NCT03941093|454630433|FG000|Overall Study|Withdrawal by Subject|9|||
126365112|NCT03941093|454630434|FG001|Overall Study|Withdrawal by Subject|6|||
126365113|NCT00590317|454631681|FG000|Overall Study|Lack of Efficacy|1|||
126365114|NCT00590317|454631682|FG001|Overall Study|Lack of Efficacy|5|||
126365115|NCT00003907|454631689|FG000|Overall Study|Adverse Event|2|||
126365116|NCT00003907|454631690|FG001|Overall Study|Adverse Event|11|||
126365117|NCT00003907|454631689|FG000|Overall Study|Death|2|||
126365118|NCT00003907|454631690|FG001|Overall Study|Death|0|||
126365119|NCT00003907|454631689|FG000|Overall Study|Withdrawal by Subject|1|||
126365120|NCT00003907|454631690|FG001|Overall Study|Withdrawal by Subject|3|||
126365121|NCT00003907|454631689|FG000|Overall Study|Progressive disease|4|||
126365122|NCT00003907|454631690|FG001|Overall Study|Progressive disease|4|||
126365123|NCT00003907|454631689|FG000|Overall Study|Complicating disease|1|||
126365124|NCT00003907|454631690|FG001|Overall Study|Complicating disease|0|||
126365125|NCT00003907|454631689|FG000|Overall Study|Other|1|||
126365126|NCT00003907|454631690|FG001|Overall Study|Other|3|||
126365127|NCT00003907|454631689|FG000|Overall Study|ineligible or not treated|2|||
126365128|NCT00003907|454631690|FG001|Overall Study|ineligible or not treated|2|||
126365129|NCT01517178|454631691|FG000|Period 1|Adverse Event|1|||
126365130|NCT01517178|454631692|FG001|Period 1|Adverse Event|2|||
126365131|NCT01517178|454631691|FG000|Period 1|Lack of Efficacy|0|||
126365132|NCT01517178|454631692|FG001|Period 1|Lack of Efficacy|1|||
126365133|NCT01517178|454631691|FG000|Period 1|E.g. study termination|3|||
126365134|NCT01517178|454631692|FG001|Period 1|E.g. study termination|1|||
126365135|NCT01517178|454631691|FG000|Period 1|Withdrawal by Subject|0|||
126365136|NCT01517178|454631692|FG001|Period 1|Withdrawal by Subject|1|||
126365137|NCT01517178|454631691|FG000|Period 2|Adverse Event|1|||
126365138|NCT01517178|454631692|FG001|Period 2|Adverse Event|0|||
126365139|NCT01517178|454631691|FG000|Period 2|Withdrawal by Subject|3|||
126365140|NCT01517178|454631692|FG001|Period 2|Withdrawal by Subject|0|||
126365141|NCT01517178|454631691|FG000|Period 2|E.g. study termination|2|||
126365142|NCT01517178|454631692|FG001|Period 2|E.g. study termination|2|||
126365143|NCT01050218|454631699|FG000|Overall Study|Adverse Event|37|||
126365144|NCT01050218|454631699|FG000|Overall Study|Lack of Efficacy|8|||
126365145|NCT01050218|454631699|FG000|Overall Study|Protocol Violation|3|||
126365146|NCT01050218|454631699|FG000|Overall Study|Withdrawal by Subject|18|||
126365147|NCT01050218|454631699|FG000|Overall Study|Discontinued by sponsor|18|||
126365148|NCT01050218|454631699|FG000|Overall Study|Compliance|2|||
126365149|NCT01050218|454631699|FG000|Overall Study|Failed to return|7|||
126365150|NCT01050218|454631699|FG000|Overall Study|Serious Adverse Event|1|||
126365151|NCT01050218|454631699|FG000|Overall Study|Family emergency|1|||
126365152|NCT01149460|454631700|FG000|Overall Study|Withdrawal by Subject|0|||
126365153|NCT01149460|454631701|FG001|Overall Study|Withdrawal by Subject|2|||
126365154|NCT02272985|454631704|FG000|Overall Study|Withdrawal by Subject|1|||
126365155|NCT02272985|454631704|FG000|Overall Study|hip fracture|1|||
126365156|NCT02272985|454631704|FG000|Overall Study|kidney transplantation|1|||
126365157|NCT00266032|454631705|FG000|Treatment|Adverse Event|42|||
126365158|NCT00266032|454631706|FG001|Treatment|Adverse Event|26|||
126365159|NCT00266032|454631707|FG002|Treatment|Adverse Event|10|||
126365160|NCT00266032|454631705|FG000|Treatment|Lost to Follow-up|19|||
126365161|NCT00266032|454631706|FG001|Treatment|Lost to Follow-up|4|||
126365162|NCT00266032|454631707|FG002|Treatment|Lost to Follow-up|2|||
126365163|NCT00266032|454631705|FG000|Treatment|Pregnancy|3|||
126365164|NCT00266032|454631706|FG001|Treatment|Pregnancy|2|||
126365165|NCT00266032|454631707|FG002|Treatment|Pregnancy|2|||
126365166|NCT00266032|454631705|FG000|Treatment|Protocol Violation|6|||
126365167|NCT00266032|454631706|FG001|Treatment|Protocol Violation|14|||
126365168|NCT00266032|454631707|FG002|Treatment|Protocol Violation|13|||
126365169|NCT00266032|454631705|FG000|Treatment|Withdrawal by Subject|28|||
126365170|NCT00266032|454631706|FG001|Treatment|Withdrawal by Subject|13|||
126365171|NCT00266032|454631707|FG002|Treatment|Withdrawal by Subject|12|||
126365172|NCT00266032|454631705|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
126365173|NCT00266032|454631706|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
126365174|NCT00266032|454631707|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
126040919|NCT02315703|453447180|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
126040920|NCT02315703|453447181|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
126040921|NCT02315703|453447182|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
126040922|NCT02315703|453447183|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
126040923|NCT02315703|453447184|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
126040924|NCT02315703|453447185|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
126040925|NCT02315703|453447186|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
126285800|NCT00805961|454333068|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
126285801|NCT00805961|454333068|FG000|Treatment-Free Interval|Physician Decision|1|||
126285802|NCT00805961|454333068|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
126285803|NCT00805961|454333068|FG000|Maintenance Treatment|Lack of Efficacy|13|||
126285804|NCT00805961|454333068|FG000|Maintenance Treatment|Intercurrent Illness|7|||
126285805|NCT00805961|454333068|FG000|Maintenance Treatment|Adverse Event|6|||
126285806|NCT00805961|454333068|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
126285807|NCT00805961|454333068|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
126285808|NCT00805961|454333068|FG000|Maintenance Treatment|Withdrawn Consent|1|||
126285809|NCT01862484|454333069|FG000|Overall Study|Lack of Efficacy|1|||
126285810|NCT01862484|454333070|FG001|Overall Study|Lack of Efficacy|1|||
126285811|NCT01862484|454333069|FG000|Overall Study|Lost to Follow-up|1|||
126285812|NCT01862484|454333070|FG001|Overall Study|Lost to Follow-up|2|||
126285813|NCT01862484|454333069|FG000|Overall Study|Protocol Violation|0|||
126285814|NCT01862484|454333070|FG001|Overall Study|Protocol Violation|2|||
126285815|NCT01862484|454333069|FG000|Overall Study|Withdrawal by Subject|0|||
126285816|NCT01862484|454333070|FG001|Overall Study|Withdrawal by Subject|3|||
126285817|NCT01632280|454333071|FG000|Overall Study|Withdrawal by Subject|1|||
126285818|NCT01632280|454333072|FG001|Overall Study|Withdrawal by Subject|0|||
126285819|NCT00993421|454333073|FG000|Overall Study|Adverse Event|2|||
126285820|NCT00993421|454333074|FG001|Overall Study|Adverse Event|7|||
126285821|NCT00993421|454333075|FG002|Overall Study|Adverse Event|6|||
126285822|NCT00993421|454333076|FG003|Overall Study|Adverse Event|9|||
126285823|NCT00993421|454333077|FG004|Overall Study|Adverse Event|5|||
126285824|NCT00993421|454333078|FG005|Overall Study|Adverse Event|7|||
126285825|NCT00993421|454333079|FG006|Overall Study|Adverse Event|1|||
126285826|NCT00993421|454333073|FG000|Overall Study|Sponsor Decision|36|||
126285827|NCT00993421|454333074|FG001|Overall Study|Sponsor Decision|31|||
126285828|NCT00993421|454333075|FG002|Overall Study|Sponsor Decision|28|||
126285829|NCT00993421|454333076|FG003|Overall Study|Sponsor Decision|30|||
126285830|NCT00993421|454333077|FG004|Overall Study|Sponsor Decision|38|||
126285831|NCT00993421|454333078|FG005|Overall Study|Sponsor Decision|30|||
126285832|NCT00993421|454333079|FG006|Overall Study|Sponsor Decision|29|||
126285833|NCT00993421|454333073|FG000|Overall Study|Lost to Follow-up|3|||
126285834|NCT00993421|454333074|FG001|Overall Study|Lost to Follow-up|5|||
126285835|NCT00993421|454333075|FG002|Overall Study|Lost to Follow-up|5|||
126285836|NCT00993421|454333076|FG003|Overall Study|Lost to Follow-up|0|||
126285837|NCT00993421|454333077|FG004|Overall Study|Lost to Follow-up|0|||
126040926|NCT05863156|453447196|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
126040927|NCT05863156|453447197|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
126040928|NCT05863156|453447198|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
126040929|NCT05216406|453447201|FG000|Overall Study|Lost to Follow-up|8|||
126040930|NCT05216406|453447202|FG001|Overall Study|Lost to Follow-up|9|||
126040931|NCT03711474|453447203|FG000|Overall Study|Physician Decision|2|||
126040932|NCT03711474|453447204|FG001|Overall Study|Physician Decision|0|||
126040933|NCT04690582|453447205|FG000|Overall Study|Withdrawal by Subject|6|||
126040934|NCT04690582|453447206|FG001|Overall Study|Withdrawal by Subject|4|||
126040935|NCT03625115|453447209|FG000|Overall Study|Withdrawal by Subject|4|||
126040936|NCT03625115|453447210|FG001|Overall Study|Withdrawal by Subject|7|||
126040937|NCT03625115|453447209|FG000|Overall Study|Lost to Follow-up|17|||
126040938|NCT03625115|453447210|FG001|Overall Study|Lost to Follow-up|24|||
126040939|NCT04101357|453447212|FG000|Overall Study|Death|1|||
126040940|NCT04101357|453447213|FG001|Overall Study|Death|1|||
126040941|NCT04101357|453447214|FG002|Overall Study|Death|1|||
126040942|NCT04101357|453447215|FG003|Overall Study|Death|2|||
126040943|NCT04101357|453447216|FG004|Overall Study|Death|4|||
126040944|NCT04101357|453447217|FG005|Overall Study|Death|11|||
126040945|NCT04101357|453447218|FG006|Overall Study|Death|4|||
126040946|NCT04101357|453447219|FG007|Overall Study|Death|4|||
126040947|NCT04101357|453447220|FG008|Overall Study|Death|5|||
126040948|NCT04101357|453447221|FG009|Overall Study|Death|2|||
126040949|NCT04101357|453447222|FG010|Overall Study|Death|3|||
126040950|NCT04101357|453447212|FG000|Overall Study|Trial closure|0|||
126040951|NCT04101357|453447213|FG001|Overall Study|Trial closure|0|||
126040952|NCT04101357|453447214|FG002|Overall Study|Trial closure|0|||
126040953|NCT04101357|453447215|FG003|Overall Study|Trial closure|0|||
126040954|NCT04101357|453447216|FG004|Overall Study|Trial closure|0|||
126040955|NCT04101357|453447217|FG005|Overall Study|Trial closure|2|||
126040956|NCT04101357|453447218|FG006|Overall Study|Trial closure|2|||
126040957|NCT04101357|453447219|FG007|Overall Study|Trial closure|0|||
126040958|NCT04101357|453447220|FG008|Overall Study|Trial closure|0|||
126099028|NCT04433585|453655584|FG001|Overall Study|Adverse Event|4|||
126099029|NCT04433585|453655585|FG002|Overall Study|Adverse Event|1|||
126099030|NCT04433585|453655586|FG003|Overall Study|Adverse Event|0|||
126099031|NCT04433585|453655583|FG000|Overall Study|Due to the conflict in Ukraine|2|||
126099032|NCT04433585|453655584|FG001|Overall Study|Due to the conflict in Ukraine|1|||
126099033|NCT04433585|453655585|FG002|Overall Study|Due to the conflict in Ukraine|1|||
126099034|NCT04433585|453655586|FG003|Overall Study|Due to the conflict in Ukraine|2|||
126099035|NCT04433585|453655583|FG000|Overall Study|Physician Decision|1|||
126099036|NCT04433585|453655584|FG001|Overall Study|Physician Decision|2|||
126099037|NCT04433585|453655585|FG002|Overall Study|Physician Decision|0|||
126099038|NCT04433585|453655586|FG003|Overall Study|Physician Decision|0|||
126099039|NCT04433585|453655583|FG000|Overall Study|Lost to Follow-up|1|||
126099040|NCT04433585|453655584|FG001|Overall Study|Lost to Follow-up|1|||
126099041|NCT04433585|453655585|FG002|Overall Study|Lost to Follow-up|1|||
126099042|NCT04433585|453655586|FG003|Overall Study|Lost to Follow-up|0|||
126099043|NCT04433585|453655583|FG000|Overall Study|Lack of Efficacy|0|||
126099044|NCT04433585|453655584|FG001|Overall Study|Lack of Efficacy|1|||
126099045|NCT04433585|453655585|FG002|Overall Study|Lack of Efficacy|1|||
126099046|NCT04433585|453655586|FG003|Overall Study|Lack of Efficacy|1|||
126099047|NCT04433585|453655583|FG000|Overall Study|Death|0|||
126099048|NCT04433585|453655584|FG001|Overall Study|Death|1|||
126099049|NCT04433585|453655585|FG002|Overall Study|Death|0|||
126099050|NCT04433585|453655586|FG003|Overall Study|Death|0|||
126099051|NCT02342743|453655587|FG000|Baseline Period|Withdrawal by Subject|3|||
126099052|NCT02342743|453655587|FG000|Baseline Period|Lost to Follow-up|2|||
126099053|NCT02342743|453655587|FG000|Baseline Period|Change in prophylactic medication|3|||
126099054|NCT02342743|453655587|FG000|Baseline Period|Screening failure regarding baseline|7|||
126099055|NCT02342743|453655587|FG000|Treatment Period|Withdrawal by Subject|2|||
126099056|NCT02342743|453655587|FG000|Treatment Period|Lost to Follow-up|8|||
126099057|NCT02342743|453655587|FG000|Treatment Period|Change in prophylactic medication|1|||
126099058|NCT04875676|453655588|FG000|Overall Study|Lost to Follow-up|1|||
126099059|NCT04875676|453655589|FG001|Overall Study|Lost to Follow-up|0|||
126099060|NCT04875676|453655590|FG002|Overall Study|Lost to Follow-up|0|||
126099061|NCT02937454|453655595|FG000|Overall Study|Adverse Event|0|||
126099062|NCT02937454|453655596|FG001|Overall Study|Adverse Event|1|||
126099063|NCT02937454|453655595|FG000|Overall Study|Death|98|||
126099064|NCT02937454|453655596|FG001|Overall Study|Death|95|||
126099065|NCT02937454|453655595|FG000|Overall Study|Lost to Follow-up|1|||
126099066|NCT02937454|453655596|FG001|Overall Study|Lost to Follow-up|1|||
126099067|NCT02937454|453655595|FG000|Overall Study|Physician Decision|0|||
126099068|NCT02937454|453655596|FG001|Overall Study|Physician Decision|1|||
126099069|NCT02937454|453655595|FG000|Overall Study|Protocol Violation|6|||
126099070|NCT02937454|453655596|FG001|Overall Study|Protocol Violation|10|||
126099071|NCT02937454|453655595|FG000|Overall Study|Withdrawal by Subject|27|||
126099072|NCT02937454|453655596|FG001|Overall Study|Withdrawal by Subject|15|||
126099073|NCT02937454|453655595|FG000|Overall Study|Other|8|||
126099074|NCT02937454|453655596|FG001|Overall Study|Other|5|||
126099075|NCT02630693|453655597|FG000|Overall Study|No receive treatment|0|||
126099076|NCT02630693|453655598|FG001|Overall Study|No receive treatment|1|||
126099077|NCT00993668|453655599|FG000|Single-Blind Period|Adverse Event|1|||
126099078|NCT00993668|453655600|FG001|Single-Blind Period|Adverse Event|1|||
126099079|NCT00993668|453655599|FG000|Single-Blind Period|Lack of Efficacy|0|||
126099080|NCT00993668|453655600|FG001|Single-Blind Period|Lack of Efficacy|1|||
126099081|NCT00993668|453655599|FG000|Single-Blind Period|Lost to Follow-up|3|||
126099082|NCT00993668|453655600|FG001|Single-Blind Period|Lost to Follow-up|1|||
126099083|NCT00993668|453655599|FG000|Open-Label Period|Adverse Event|9|||
126099084|NCT00993668|453655600|FG001|Open-Label Period|Adverse Event|8|||
126099085|NCT00993668|453655599|FG000|Open-Label Period|Lack of Efficacy|4|||
126099086|NCT00993668|453655600|FG001|Open-Label Period|Lack of Efficacy|3|||
126099087|NCT00993668|453655599|FG000|Open-Label Period|Withdrawal by Subject|4|||
126099088|NCT00993668|453655600|FG001|Open-Label Period|Withdrawal by Subject|3|||
126285838|NCT00993421|454333078|FG005|Overall Study|Lost to Follow-up|0|||
126285839|NCT00993421|454333079|FG006|Overall Study|Lost to Follow-up|6|||
126099089|NCT00993668|453655599|FG000|Open-Label Period|Lost to Follow-up|6|||
126099090|NCT00993668|453655600|FG001|Open-Label Period|Lost to Follow-up|1|||
126099091|NCT03606668|453655603|FG000|Overall Study|Screen Failure|1|||
126099092|NCT03606668|453655603|FG000|Overall Study|Lost to Follow-up|1|||
126285840|NCT00993421|454333073|FG000|Overall Study|Withdrawal by Subject|3|||
126099093|NCT02057523|453655607|FG000|Overall Study|Withdrawal by Subject|1|||
126099094|NCT02057523|453655607|FG000|Overall Study|Lack of Efficacy|1|||
126099095|NCT03618823|453655611|FG000|Overall Study|Lost to Follow-up|63|||
126099096|NCT03618823|453655612|FG001|Overall Study|Lost to Follow-up|61|||
125882765|NCT00771758|452869040|FG001|Overall Study|Adverse Event|8|||
126099097|NCT00523640|453655613|FG000|Overall Study|Death|1|||
126099098|NCT02399254|453655615|FG000|Overall Study|Physician Decision|2|||
126099099|NCT00564889|453655616|FG000|Overall Study|Death|7|||
126099100|NCT00564889|453655616|FG000|Overall Study|Adverse Event|12|||
126285841|NCT00993421|454333074|FG001|Overall Study|Withdrawal by Subject|2|||
126285842|NCT00993421|454333075|FG002|Overall Study|Withdrawal by Subject|3|||
126285843|NCT00993421|454333076|FG003|Overall Study|Withdrawal by Subject|3|||
126285844|NCT00993421|454333077|FG004|Overall Study|Withdrawal by Subject|3|||
126285845|NCT00993421|454333078|FG005|Overall Study|Withdrawal by Subject|5|||
126285846|NCT00993421|454333079|FG006|Overall Study|Withdrawal by Subject|3|||
126285847|NCT00993421|454333073|FG000|Overall Study|Death|0|||
126099101|NCT00564889|453655616|FG000|Overall Study|Alternative treatment|3|||
126099102|NCT00564889|453655616|FG000|Overall Study|Disease progression|3|||
126099103|NCT00564889|453655616|FG000|Overall Study|Other, not specified|4|||
126099104|NCT03500159|453655617|FG000|Overall Study|Study Terminated|2|||
126099105|NCT03500159|453655618|FG001|Overall Study|Study Terminated|1|||
126099106|NCT02292927|453655619|FG000|Overall Study|Protocol Violation|13|||
126099107|NCT02292927|453655620|FG001|Overall Study|Protocol Violation|7|||
126099108|NCT01605916|453655622|FG000|Overall Study|Adverse Event|1|||
126099109|NCT01605916|453655623|FG001|Overall Study|Adverse Event|0|||
126099110|NCT01605916|453655624|FG002|Overall Study|Adverse Event|0|||
126099111|NCT01605916|453655625|FG003|Overall Study|Adverse Event|1|||
126099112|NCT01605916|453655626|FG004|Overall Study|Adverse Event|0|||
126099113|NCT01605916|453655622|FG000|Overall Study|Lack of Efficacy|2|||
126099114|NCT01605916|453655623|FG001|Overall Study|Lack of Efficacy|3|||
126099115|NCT01605916|453655624|FG002|Overall Study|Lack of Efficacy|3|||
126099116|NCT01605916|453655625|FG003|Overall Study|Lack of Efficacy|5|||
126099117|NCT01605916|453655626|FG004|Overall Study|Lack of Efficacy|4|||
126099118|NCT01605916|453655622|FG000|Overall Study|Withdrawal by Subject|1|||
126099119|NCT01605916|453655623|FG001|Overall Study|Withdrawal by Subject|1|||
126099120|NCT01605916|453655624|FG002|Overall Study|Withdrawal by Subject|0|||
126099121|NCT01605916|453655625|FG003|Overall Study|Withdrawal by Subject|0|||
126099122|NCT01605916|453655626|FG004|Overall Study|Withdrawal by Subject|2|||
126099123|NCT01021215|453655636|FG000|Overall Study|Lost to Follow-up|3|||
126099124|NCT01021215|453655637|FG001|Overall Study|Lost to Follow-up|0|||
126099125|NCT01011387|453655643|FG000|Overall Study|Withdrawal by Subject|3|||
126099126|NCT01011387|453655643|FG000|Overall Study|Adverse Event|2|||
126099127|NCT01011387|453655643|FG000|Overall Study|Protocol Violation|1|||
126099128|NCT02433340|453655644|FG000|Overall Study|Adverse Event|0|||
126099129|NCT02433340|453655645|FG001|Overall Study|Adverse Event|0|||
126099130|NCT02433340|453655646|FG002|Overall Study|Adverse Event|1|||
126099131|NCT02433340|453655647|FG003|Overall Study|Adverse Event|0|||
126099132|NCT02433340|453655644|FG000|Overall Study|Withdrawal by Subject|1|||
126099133|NCT02433340|453655645|FG001|Overall Study|Withdrawal by Subject|0|||
126099134|NCT02433340|453655646|FG002|Overall Study|Withdrawal by Subject|1|||
126099135|NCT02433340|453655647|FG003|Overall Study|Withdrawal by Subject|2|||
126099136|NCT02433340|453655644|FG000|Overall Study|Lost to Follow-up|0|||
126099137|NCT02433340|453655645|FG001|Overall Study|Lost to Follow-up|1|||
126099138|NCT02433340|453655646|FG002|Overall Study|Lost to Follow-up|0|||
126099139|NCT02433340|453655647|FG003|Overall Study|Lost to Follow-up|0|||
126099140|NCT02433340|453655644|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
126099141|NCT02433340|453655645|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
126099142|NCT02433340|453655646|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
126099143|NCT02433340|453655647|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
126099144|NCT02433340|453655644|FG000|Overall Study|Other|0|||
126099145|NCT02433340|453655645|FG001|Overall Study|Other|1|||
126099146|NCT02433340|453655646|FG002|Overall Study|Other|0|||
126099147|NCT02433340|453655647|FG003|Overall Study|Other|0|||
126099148|NCT01178385|453655648|FG000|Overall Study|Withdrawal by Subject|2|||
126099149|NCT01178385|453655649|FG001|Overall Study|Withdrawal by Subject|0|||
126099150|NCT01226095|453655650|FG000|Overall Study|Poor compliance|1|||
126099151|NCT01688830|453655653|FG000|Overall Study|Lost to Follow-up|0|||
126099152|NCT01688830|453655654|FG001|Overall Study|Lost to Follow-up|0|||
126285848|NCT00993421|454333074|FG001|Overall Study|Death|0|||
126365175|NCT00266032|454631705|FG000|Open-label Safety Extension|Adverse Event|5|||
126365176|NCT00266032|454631706|FG001|Open-label Safety Extension|Adverse Event|0|||
126365177|NCT00266032|454631707|FG002|Open-label Safety Extension|Adverse Event|4|||
126365178|NCT00266032|454631705|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
126365179|NCT00266032|454631706|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
126365180|NCT00266032|454631707|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
126365181|NCT00266032|454631705|FG000|Open-label Safety Extension|Pregnancy|4|||
126365182|NCT00266032|454631706|FG001|Open-label Safety Extension|Pregnancy|1|||
126365183|NCT00266032|454631707|FG002|Open-label Safety Extension|Pregnancy|2|||
126365184|NCT00266032|454631705|FG000|Open-label Safety Extension|Protocol Violation|1|||
126365185|NCT00266032|454631706|FG001|Open-label Safety Extension|Protocol Violation|3|||
126365186|NCT00266032|454631707|FG002|Open-label Safety Extension|Protocol Violation|2|||
126285849|NCT00993421|454333075|FG002|Overall Study|Death|0|||
126099153|NCT01688830|453655655|FG002|Overall Study|Lost to Follow-up|0|||
126099154|NCT01688830|453655656|FG003|Overall Study|Lost to Follow-up|0|||
126099155|NCT01688830|453655657|FG004|Overall Study|Lost to Follow-up|0|||
126099156|NCT01688830|453655658|FG005|Overall Study|Lost to Follow-up|0|||
126099157|NCT01688830|453655659|FG006|Overall Study|Lost to Follow-up|0|||
126099158|NCT01688830|453655660|FG007|Overall Study|Lost to Follow-up|0|||
126099159|NCT01688830|453655661|FG008|Overall Study|Lost to Follow-up|0|||
126099160|NCT01688830|453655662|FG009|Overall Study|Lost to Follow-up|0|||
126099161|NCT01688830|453655663|FG010|Overall Study|Lost to Follow-up|1|||
126099162|NCT01688830|453655664|FG011|Overall Study|Lost to Follow-up|0|||
126099163|NCT01688830|453655665|FG012|Overall Study|Lost to Follow-up|0|||
126099164|NCT01688830|453655666|FG013|Overall Study|Lost to Follow-up|0|||
126099165|NCT01688830|453655667|FG014|Overall Study|Lost to Follow-up|0|||
126099166|NCT01688830|453655668|FG015|Overall Study|Lost to Follow-up|0|||
126099167|NCT01688830|453655669|FG016|Overall Study|Lost to Follow-up|0|||
126099168|NCT01688830|453655670|FG017|Overall Study|Lost to Follow-up|0|||
126099169|NCT01688830|453655671|FG018|Overall Study|Lost to Follow-up|0|||
126099170|NCT01688830|453655672|FG019|Overall Study|Lost to Follow-up|0|||
126099171|NCT01688830|453655673|FG020|Overall Study|Lost to Follow-up|0|||
126099172|NCT01285609|453655674|FG000|Randomized|Progressive Disease|41|||
126099173|NCT01285609|453655675|FG001|Randomized|Progressive Disease|61|||
126099174|NCT01285609|453655674|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
126099175|NCT01285609|453655675|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
126099176|NCT01285609|453655674|FG000|Randomized|Study Drug Toxicity|13|||
126099177|NCT01285609|453655675|FG001|Randomized|Study Drug Toxicity|14|||
126099178|NCT01285609|453655674|FG000|Randomized|Death|5|||
126099179|NCT01285609|453655675|FG001|Randomized|Death|7|||
126099180|NCT01285609|453655674|FG000|Randomized|Withdrawal by Subject|8|||
126099181|NCT01285609|453655675|FG001|Randomized|Withdrawal by Subject|11|||
126099182|NCT01285609|453655674|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
126099183|NCT01285609|453655675|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
126099184|NCT01285609|453655674|FG000|Randomized|Undisclosed Reasons|1|||
126099185|NCT01285609|453655675|FG001|Randomized|Undisclosed Reasons|0|||
126099186|NCT01285609|453655674|FG000|Randomized|Randomized but not Treated|4|||
126099187|NCT01285609|453655675|FG001|Randomized|Randomized but not Treated|4|||
126099188|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
126099189|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
126099190|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
126099191|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
126099192|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
126099193|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
126099194|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
126099195|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
126099196|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Death|11|||
126099197|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Death|3|||
126099198|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
126099199|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
125882766|NCT00771758|452869041|FG002|Overall Study|Adverse Event|1|||
125882767|NCT00771758|452869039|FG000|Overall Study|Lack of Efficacy|0|||
126099200|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Not Reported|0|||
126099201|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Not Reported|2|||
126099202|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
126099203|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
126099204|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
126099205|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
126099206|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
126365187|NCT00266032|454631705|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
126365188|NCT00266032|454631706|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
126365189|NCT00266032|454631707|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
126365190|NCT00266032|454631705|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
126365191|NCT00266032|454631706|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
126365192|NCT00266032|454631707|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
126365193|NCT01514357|454631711|FG000|Overall Study|Screen failure|2|||
126365194|NCT01514357|454631712|FG001|Overall Study|Screen failure|0|||
126365195|NCT01514357|454631711|FG000|Overall Study|Withdrawal by Subject|2|||
126365196|NCT01514357|454631712|FG001|Overall Study|Withdrawal by Subject|0|||
126365197|NCT00752219|454631713|FG000|Overall Study|Clinical failure|0|||
126365198|NCT00752219|454631714|FG001|Overall Study|Clinical failure|1|||
126365199|NCT00752219|454631713|FG000|Overall Study|Adverse Event|5|||
126365200|NCT00752219|454631714|FG001|Overall Study|Adverse Event|3|||
126365201|NCT00752219|454631713|FG000|Overall Study|Protocol deviation|1|||
126365202|NCT00752219|454631714|FG001|Overall Study|Protocol deviation|0|||
126365203|NCT00752219|454631713|FG000|Overall Study|Lost to Follow-up|1|||
126365204|NCT00752219|454631714|FG001|Overall Study|Lost to Follow-up|2|||
126365205|NCT00752219|454631713|FG000|Overall Study|Randomized but not treated|1|||
126365206|NCT00752219|454631714|FG001|Overall Study|Randomized but not treated|0|||
126365207|NCT00752219|454631713|FG000|Overall Study|Other|3|||
126365208|NCT00752219|454631714|FG001|Overall Study|Other|0|||
126365209|NCT04691115|454631717|FG000|Overall Study|Withdrawal by Subject|0|||
126365210|NCT04691115|454631718|FG001|Overall Study|Withdrawal by Subject|0|||
126365211|NCT04691115|454631719|FG002|Overall Study|Withdrawal by Subject|0|||
126365212|NCT04691115|454631720|FG003|Overall Study|Withdrawal by Subject|0|||
126365213|NCT04691115|454631721|FG004|Overall Study|Withdrawal by Subject|0|||
126365214|NCT04691115|454631722|FG005|Overall Study|Withdrawal by Subject|1|||
126365215|NCT04691115|454631723|FG006|Overall Study|Withdrawal by Subject|0|||
126365216|NCT04691115|454631724|FG007|Overall Study|Withdrawal by Subject|0|||
126365217|NCT04691115|454631725|FG008|Overall Study|Withdrawal by Subject|0|||
126365218|NCT04691115|454631726|FG009|Overall Study|Withdrawal by Subject|0|||
126365219|NCT04691115|454631727|FG010|Overall Study|Withdrawal by Subject|0|||
126365220|NCT04691115|454631728|FG011|Overall Study|Withdrawal by Subject|0|||
126365221|NCT04691115|454631729|FG012|Overall Study|Withdrawal by Subject|0|||
126365222|NCT04691115|454631730|FG013|Overall Study|Withdrawal by Subject|0|||
126040959|NCT04101357|453447221|FG009|Overall Study|Trial closure|0|||
126040960|NCT04101357|453447222|FG010|Overall Study|Trial closure|1|||
126040961|NCT04101357|453447212|FG000|Overall Study|Lost to Follow-up|0|||
126040962|NCT04101357|453447213|FG001|Overall Study|Lost to Follow-up|0|||
126040963|NCT04101357|453447214|FG002|Overall Study|Lost to Follow-up|0|||
126040964|NCT04101357|453447215|FG003|Overall Study|Lost to Follow-up|1|||
126040965|NCT04101357|453447216|FG004|Overall Study|Lost to Follow-up|0|||
126040966|NCT04101357|453447217|FG005|Overall Study|Lost to Follow-up|0|||
126040967|NCT04101357|453447218|FG006|Overall Study|Lost to Follow-up|0|||
126040968|NCT04101357|453447219|FG007|Overall Study|Lost to Follow-up|1|||
126040969|NCT04101357|453447220|FG008|Overall Study|Lost to Follow-up|0|||
126040970|NCT04101357|453447221|FG009|Overall Study|Lost to Follow-up|0|||
126099207|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
126099208|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
126099209|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
126099210|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
126099211|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
126099212|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
126099213|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
126099214|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
126099215|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
126099216|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
126099217|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
126099218|NCT01285609|453655674|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
126099219|NCT01285609|453655675|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
126099220|NCT01285609|453655674|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
126099221|NCT01285609|453655675|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
126099222|NCT04822597|453655676|FG000|Overall Study|Withdrawal by Subject|0|||
126099223|NCT04822597|453655677|FG001|Overall Study|Withdrawal by Subject|1|||
126099224|NCT04822597|453655678|FG002|Overall Study|Withdrawal by Subject|1|||
126099225|NCT04822597|453655679|FG003|Overall Study|Withdrawal by Subject|0|||
126099226|NCT04822597|453655676|FG000|Overall Study|Physician Decision|0|||
126099227|NCT04822597|453655677|FG001|Overall Study|Physician Decision|0|||
126099228|NCT04822597|453655678|FG002|Overall Study|Physician Decision|1|||
126099229|NCT04822597|453655679|FG003|Overall Study|Physician Decision|1|||
126099230|NCT04822597|453655676|FG000|Overall Study|Subject withdrawn after enrollment|0|||
126099231|NCT04822597|453655677|FG001|Overall Study|Subject withdrawn after enrollment|1|||
126099232|NCT04822597|453655678|FG002|Overall Study|Subject withdrawn after enrollment|0|||
126099233|NCT04822597|453655679|FG003|Overall Study|Subject withdrawn after enrollment|1|||
126099234|NCT04822597|453655676|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
126099235|NCT04822597|453655677|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
126099236|NCT04822597|453655678|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
126099237|NCT04822597|453655679|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
126099238|NCT03265938|453655689|FG000|Overall Study|Withdrawal by Subject|1|||
126099239|NCT03265938|453655689|FG000|Overall Study|Physician Decision|1|||
126099240|NCT03265938|453655689|FG000|Overall Study|friable mass|6|||
126099241|NCT02412371|453655692|FG000|Overall Study|Withdrawal by Subject|0|||
126099242|NCT02412371|453655693|FG001|Overall Study|Withdrawal by Subject|2|||
126099243|NCT02412371|453655694|FG002|Overall Study|Withdrawal by Subject|0|||
126099244|NCT02412371|453655695|FG003|Overall Study|Withdrawal by Subject|1|||
126099245|NCT02412371|453655696|FG004|Overall Study|Withdrawal by Subject|1|||
126365223|NCT00835042|454631735|FG000|First Intervention|Withdrawal by Subject|3|||
126365224|NCT00835042|454631736|FG001|First Intervention|Withdrawal by Subject|0|||
126040971|NCT04101357|453447222|FG010|Overall Study|Lost to Follow-up|0|||
126040972|NCT04101357|453447212|FG000|Overall Study|Withdrawal by Subject|1|||
126040973|NCT04101357|453447213|FG001|Overall Study|Withdrawal by Subject|0|||
126099246|NCT02412371|453655697|FG005|Overall Study|Withdrawal by Subject|0|||
126099247|NCT02412371|453655692|FG000|Overall Study|Sponsor Discontinued Study|1|||
126099248|NCT02412371|453655693|FG001|Overall Study|Sponsor Discontinued Study|4|||
126099249|NCT02412371|453655694|FG002|Overall Study|Sponsor Discontinued Study|6|||
126099250|NCT02412371|453655695|FG003|Overall Study|Sponsor Discontinued Study|4|||
126099251|NCT02412371|453655696|FG004|Overall Study|Sponsor Discontinued Study|5|||
126099252|NCT02412371|453655697|FG005|Overall Study|Sponsor Discontinued Study|0|||
126099253|NCT02412371|453655692|FG000|Overall Study|Death|4|||
126099254|NCT02412371|453655693|FG001|Overall Study|Death|2|||
126099255|NCT02412371|453655694|FG002|Overall Study|Death|1|||
126099256|NCT02412371|453655695|FG003|Overall Study|Death|3|||
126099257|NCT02412371|453655696|FG004|Overall Study|Death|5|||
126099258|NCT02412371|453655697|FG005|Overall Study|Death|2|||
126099259|NCT02412371|453655692|FG000|Overall Study|Other|2|||
126099260|NCT02412371|453655693|FG001|Overall Study|Other|1|||
126099261|NCT02412371|453655694|FG002|Overall Study|Other|0|||
126099262|NCT02412371|453655695|FG003|Overall Study|Other|0|||
126099263|NCT02412371|453655696|FG004|Overall Study|Other|1|||
126099264|NCT02412371|453655697|FG005|Overall Study|Other|3|||
126099265|NCT02053792|453655698|FG000|Overall Study|Physician Decision|0|||
126099266|NCT02053792|453655699|FG001|Overall Study|Physician Decision|1|||
126099267|NCT02053792|453655698|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
126099268|NCT02053792|453655699|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
126099269|NCT02053792|453655698|FG000|Overall Study|Lack of Efficacy|1|||
126099270|NCT02053792|453655699|FG001|Overall Study|Lack of Efficacy|0|||
126099271|NCT02053792|453655698|FG000|Overall Study|Adverse Event|1|||
126099272|NCT02053792|453655699|FG001|Overall Study|Adverse Event|0|||
126099273|NCT02053792|453655698|FG000|Overall Study|Withdrawal by Subject|2|||
126099274|NCT02053792|453655699|FG001|Overall Study|Withdrawal by Subject|2|||
126099275|NCT02053792|453655698|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
126099276|NCT02053792|453655699|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
126099277|NCT02053792|453655698|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
126285850|NCT00993421|454333076|FG003|Overall Study|Death|0|||
126099278|NCT02053792|453655699|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
126099279|NCT01028027|453655700|FG000|Overall Study|Lost to Follow-up|4|||
126099280|NCT01028027|453655701|FG001|Overall Study|Lost to Follow-up|1|||
126099281|NCT01028027|453655700|FG000|Overall Study|Withdrawal by Subject|5|||
126099282|NCT01028027|453655701|FG001|Overall Study|Withdrawal by Subject|3|||
126099283|NCT01028027|453655700|FG000|Overall Study|Adverse Event|4|||
126099284|NCT01028027|453655701|FG001|Overall Study|Adverse Event|7|||
126099285|NCT01028027|453655700|FG000|Overall Study|Protocol Violation|3|||
126099286|NCT01028027|453655701|FG001|Overall Study|Protocol Violation|1|||
126099287|NCT01028027|453655700|FG000|Overall Study|Lack of Efficacy|0|||
126099288|NCT01028027|453655701|FG001|Overall Study|Lack of Efficacy|1|||
126099289|NCT03149549|453655710|FG000|Study Discontinuation--Treatment Period|Death|0|||
126099290|NCT03149549|453655711|FG001|Study Discontinuation--Treatment Period|Death|0|||
126099291|NCT03149549|453655712|FG002|Study Discontinuation--Treatment Period|Death|0|||
126099292|NCT03149549|453655713|FG003|Study Discontinuation--Treatment Period|Death|1|||
126099293|NCT03149549|453655714|FG004|Study Discontinuation--Treatment Period|Death|2|||
126099294|NCT03149549|453655715|FG005|Study Discontinuation--Treatment Period|Death|1|||
126099295|NCT03149549|453655716|FG006|Study Discontinuation--Treatment Period|Death|1|||
126099296|NCT03149549|453655717|FG007|Study Discontinuation--Treatment Period|Death|2|||
126099297|NCT03149549|453655718|FG008|Study Discontinuation--Treatment Period|Death|4|||
126099298|NCT03149549|453655719|FG009|Study Discontinuation--Treatment Period|Death|1|||
126099299|NCT03149549|453655720|FG010|Study Discontinuation--Treatment Period|Death|0|||
126099300|NCT03149549|453655721|FG011|Study Discontinuation--Treatment Period|Death|0|||
126099301|NCT03149549|453655722|FG012|Study Discontinuation--Treatment Period|Death|1|||
126099302|NCT03149549|453655710|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099303|NCT03149549|453655711|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126285851|NCT00993421|454333077|FG004|Overall Study|Death|0|||
126099304|NCT03149549|453655712|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099305|NCT03149549|453655713|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099306|NCT03149549|453655714|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099307|NCT03149549|453655715|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099308|NCT03149549|453655716|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099309|NCT03149549|453655717|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
126099310|NCT03149549|453655718|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099311|NCT03149549|453655719|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099312|NCT03149549|453655720|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099313|NCT03149549|453655721|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126099314|NCT03149549|453655722|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
126099315|NCT03149549|453655710|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125882768|NCT00771758|452869040|FG001|Overall Study|Lack of Efficacy|2|||
125882769|NCT00771758|452869041|FG002|Overall Study|Lack of Efficacy|1|||
125882770|NCT00771758|452869039|FG000|Overall Study|Lost to Follow-up|1|||
126040974|NCT04101357|453447214|FG002|Overall Study|Withdrawal by Subject|0|||
126040975|NCT04101357|453447215|FG003|Overall Study|Withdrawal by Subject|0|||
126040976|NCT04101357|453447216|FG004|Overall Study|Withdrawal by Subject|0|||
126040977|NCT04101357|453447217|FG005|Overall Study|Withdrawal by Subject|0|||
126040978|NCT04101357|453447218|FG006|Overall Study|Withdrawal by Subject|0|||
126040979|NCT04101357|453447219|FG007|Overall Study|Withdrawal by Subject|0|||
126040980|NCT04101357|453447220|FG008|Overall Study|Withdrawal by Subject|1|||
126040981|NCT04101357|453447221|FG009|Overall Study|Withdrawal by Subject|1|||
126040982|NCT04101357|453447222|FG010|Overall Study|Withdrawal by Subject|0|||
126040983|NCT04101357|453447212|FG000|Overall Study|Other|0|||
126040984|NCT04101357|453447213|FG001|Overall Study|Other|0|||
126040985|NCT04101357|453447214|FG002|Overall Study|Other|0|||
126040986|NCT04101357|453447215|FG003|Overall Study|Other|0|||
126040987|NCT04101357|453447216|FG004|Overall Study|Other|0|||
126040988|NCT04101357|453447217|FG005|Overall Study|Other|1|||
126040989|NCT04101357|453447218|FG006|Overall Study|Other|2|||
126040990|NCT04101357|453447219|FG007|Overall Study|Other|1|||
126040991|NCT04101357|453447220|FG008|Overall Study|Other|0|||
126040992|NCT04101357|453447221|FG009|Overall Study|Other|0|||
126040993|NCT04101357|453447222|FG010|Overall Study|Other|0|||
126040994|NCT04101357|453447212|FG000|Overall Study|Enrolled but not treated|0|||
126040995|NCT04101357|453447213|FG001|Overall Study|Enrolled but not treated|0|||
126040996|NCT04101357|453447214|FG002|Overall Study|Enrolled but not treated|0|||
126040997|NCT04101357|453447215|FG003|Overall Study|Enrolled but not treated|0|||
126040998|NCT04101357|453447216|FG004|Overall Study|Enrolled but not treated|0|||
126040999|NCT04101357|453447217|FG005|Overall Study|Enrolled but not treated|1|||
126041000|NCT04101357|453447218|FG006|Overall Study|Enrolled but not treated|1|||
126041001|NCT04101357|453447219|FG007|Overall Study|Enrolled but not treated|0|||
126041002|NCT04101357|453447220|FG008|Overall Study|Enrolled but not treated|0|||
126041003|NCT04101357|453447221|FG009|Overall Study|Enrolled but not treated|0|||
126041004|NCT04101357|453447222|FG010|Overall Study|Enrolled but not treated|0|||
126041005|NCT05868382|453447223|FG000|Overall Study|Lost to Follow-up|5|||
126041006|NCT05868382|453447224|FG001|Overall Study|Lost to Follow-up|0|||
126041007|NCT05868382|453447225|FG002|Overall Study|Lost to Follow-up|6|||
126041008|NCT05868382|453447226|FG003|Overall Study|Lost to Follow-up|4|||
126041009|NCT05868382|453447227|FG004|Overall Study|Lost to Follow-up|2|||
126041010|NCT05868382|453447228|FG005|Overall Study|Lost to Follow-up|6|||
126041011|NCT05868382|453447223|FG000|Overall Study|Withdrawal by Subject|1|||
126099316|NCT03149549|453655711|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125882771|NCT00771758|452869040|FG001|Overall Study|Lost to Follow-up|0|||
126041012|NCT05868382|453447224|FG001|Overall Study|Withdrawal by Subject|0|||
126041013|NCT05868382|453447225|FG002|Overall Study|Withdrawal by Subject|0|||
126041014|NCT05868382|453447226|FG003|Overall Study|Withdrawal by Subject|0|||
126041015|NCT05868382|453447227|FG004|Overall Study|Withdrawal by Subject|1|||
126041016|NCT05868382|453447228|FG005|Overall Study|Withdrawal by Subject|0|||
126041017|NCT02497950|453447229|FG000|Overall Study|Death|209|||
126041018|NCT02497950|453447229|FG000|Overall Study|Transplanted|85|||
126041019|NCT02497950|453447229|FG000|Overall Study|Explanted|8|||
126041020|NCT02497950|453447229|FG000|Overall Study|Device Permanently Deactivated|4|||
126041021|NCT02497950|453447229|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
126041022|NCT02497950|453447229|FG000|Overall Study|Lost to Follow-up|6|||
126041023|NCT02497950|453447229|FG000|Overall Study|Withdrawal by Subject|2|||
126041024|NCT02497950|453447229|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
126041025|NCT02497950|453447229|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
126041026|NCT01236781|453447230|FG000|Overall Study|Ineligible|2|||
126041027|NCT01236781|453447231|FG001|Overall Study|Ineligible|1|||
126041028|NCT01236781|453447230|FG000|Overall Study|Did not complete study imaging|5|||
126041029|NCT01236781|453447231|FG001|Overall Study|Did not complete study imaging|0|||
126041030|NCT01009788|453447244|FG000|Overall Study|Withdrawal by Subject|1|||
126041031|NCT01009788|453447245|FG001|Overall Study|Withdrawal by Subject|0|||
126041032|NCT04308681|453447246|FG000|Pre-Treatment|Not reported|1|||
126041033|NCT04308681|453447247|FG001|Pre-Treatment|Not reported|1|||
126041034|NCT04308681|453447248|FG002|Pre-Treatment|Not reported|0|||
126041035|NCT04308681|453447249|FG003|Pre-Treatment|Not reported|0|||
126041036|NCT04308681|453447250|FG004|Pre-Treatment|Not reported|0|||
126041037|NCT04308681|453447251|FG005|Pre-Treatment|Not reported|2|||
126041038|NCT04308681|453447252|FG006|Pre-Treatment|Not reported|0|||
126041039|NCT04308681|453447253|FG007|Pre-Treatment|Not reported|0|||
126041040|NCT04308681|453447246|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
126041041|NCT04308681|453447247|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
126041042|NCT04308681|453447248|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
126041043|NCT04308681|453447249|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
126041044|NCT04308681|453447250|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
126041045|NCT04308681|453447251|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
126041046|NCT04308681|453447252|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
126041047|NCT04308681|453447253|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
126041048|NCT04308681|453447246|FG000|Treatment up to Week 26|Other reasons|2|||
126041049|NCT04308681|453447247|FG001|Treatment up to Week 26|Other reasons|0|||
126041050|NCT04308681|453447248|FG002|Treatment up to Week 26|Other reasons|0|||
126041051|NCT04308681|453447249|FG003|Treatment up to Week 26|Other reasons|0|||
126041052|NCT04308681|453447250|FG004|Treatment up to Week 26|Other reasons|1|||
126041053|NCT04308681|453447251|FG005|Treatment up to Week 26|Other reasons|1|||
126041054|NCT04308681|453447252|FG006|Treatment up to Week 26|Other reasons|0|||
126041055|NCT04308681|453447253|FG007|Treatment up to Week 26|Other reasons|0|||
126041056|NCT04308681|453447246|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
126041057|NCT04308681|453447247|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
126041058|NCT04308681|453447248|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
126041059|NCT04308681|453447249|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
126041060|NCT04308681|453447250|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
126041061|NCT04308681|453447251|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
126285852|NCT00993421|454333078|FG005|Overall Study|Death|0|||
126099317|NCT03149549|453655712|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126099318|NCT03149549|453655713|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
126099319|NCT03149549|453655714|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
126099320|NCT03149549|453655715|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
126099321|NCT03149549|453655716|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
126099322|NCT03149549|453655717|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126099323|NCT03149549|453655718|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
126099324|NCT03149549|453655719|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126099325|NCT03149549|453655720|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126099326|NCT03149549|453655721|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126099327|NCT03149549|453655722|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126099328|NCT03149549|453655710|FG000|Study Discontinuation--Treatment Period|Other|0|||
126285853|NCT00993421|454333079|FG006|Overall Study|Death|1|||
126285854|NCT00993421|454333073|FG000|Overall Study|Entry Criteria Exclusion|0|||
126041062|NCT04308681|453447252|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
126041063|NCT04308681|453447253|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
126041064|NCT04308681|453447246|FG000|Treatment up to Week 26|Adverse Event|6|||
126041065|NCT04308681|453447247|FG001|Treatment up to Week 26|Adverse Event|5|||
126041066|NCT04308681|453447248|FG002|Treatment up to Week 26|Adverse Event|5|||
126041067|NCT04308681|453447249|FG003|Treatment up to Week 26|Adverse Event|0|||
126041068|NCT04308681|453447250|FG004|Treatment up to Week 26|Adverse Event|6|||
126041069|NCT04308681|453447251|FG005|Treatment up to Week 26|Adverse Event|1|||
126041070|NCT04308681|453447252|FG006|Treatment up to Week 26|Adverse Event|0|||
126041071|NCT04308681|453447253|FG007|Treatment up to Week 26|Adverse Event|0|||
126041072|NCT04308681|453447246|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126041073|NCT04308681|453447247|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
126041074|NCT04308681|453447248|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
126041075|NCT04308681|453447249|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126041076|NCT04308681|453447250|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126041077|NCT04308681|453447251|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126041078|NCT04308681|453447252|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126041079|NCT04308681|453447253|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126041080|NCT04308681|453447246|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
126041081|NCT04308681|453447247|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
126041082|NCT04308681|453447248|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
126041083|NCT04308681|453447249|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
126041084|NCT04308681|453447250|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
126041085|NCT04308681|453447251|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
126041086|NCT04308681|453447252|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
126041087|NCT04308681|453447253|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
126041088|NCT04308681|453447246|FG000|OTE - 26 Weeks|Death|0|||
126041089|NCT04308681|453447247|FG001|OTE - 26 Weeks|Death|1|||
126041090|NCT04308681|453447248|FG002|OTE - 26 Weeks|Death|0|||
126041091|NCT04308681|453447249|FG003|OTE - 26 Weeks|Death|0|||
126041092|NCT04308681|453447250|FG004|OTE - 26 Weeks|Death|0|||
126041093|NCT04308681|453447251|FG005|OTE - 26 Weeks|Death|0|||
126041094|NCT04308681|453447252|FG006|OTE - 26 Weeks|Death|1|||
126041095|NCT04308681|453447253|FG007|OTE - 26 Weeks|Death|0|||
126041096|NCT04308681|453447246|FG000|OTE - 26 Weeks|Adverse Event|0|||
126041097|NCT04308681|453447247|FG001|OTE - 26 Weeks|Adverse Event|2|||
126041098|NCT04308681|453447248|FG002|OTE - 26 Weeks|Adverse Event|8|||
126041099|NCT04308681|453447249|FG003|OTE - 26 Weeks|Adverse Event|3|||
126041100|NCT04308681|453447250|FG004|OTE - 26 Weeks|Adverse Event|0|||
126041101|NCT04308681|453447251|FG005|OTE - 26 Weeks|Adverse Event|1|||
126041102|NCT04308681|453447252|FG006|OTE - 26 Weeks|Adverse Event|2|||
126099329|NCT03149549|453655711|FG001|Study Discontinuation--Treatment Period|Other|0|||
126099330|NCT03149549|453655712|FG002|Study Discontinuation--Treatment Period|Other|0|||
126099331|NCT03149549|453655713|FG003|Study Discontinuation--Treatment Period|Other|0|||
126099332|NCT03149549|453655714|FG004|Study Discontinuation--Treatment Period|Other|0|||
126099333|NCT03149549|453655715|FG005|Study Discontinuation--Treatment Period|Other|0|||
126099334|NCT03149549|453655716|FG006|Study Discontinuation--Treatment Period|Other|0|||
126099335|NCT03149549|453655717|FG007|Study Discontinuation--Treatment Period|Other|1|||
126099336|NCT03149549|453655718|FG008|Study Discontinuation--Treatment Period|Other|0|||
126099337|NCT03149549|453655719|FG009|Study Discontinuation--Treatment Period|Other|1|||
126099338|NCT03149549|453655720|FG010|Study Discontinuation--Treatment Period|Other|0|||
126099339|NCT03149549|453655721|FG011|Study Discontinuation--Treatment Period|Other|0|||
126099340|NCT03149549|453655722|FG012|Study Discontinuation--Treatment Period|Other|0|||
126099341|NCT03149549|453655710|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126099342|NCT03149549|453655711|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126099343|NCT03149549|453655712|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126099344|NCT03149549|453655713|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126099345|NCT03149549|453655714|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126099346|NCT03149549|453655715|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
126099347|NCT03149549|453655716|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
126099348|NCT03149549|453655717|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126041103|NCT04308681|453447253|FG007|OTE - 26 Weeks|Adverse Event|0|||
126041104|NCT04308681|453447246|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126041105|NCT04308681|453447247|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
126041106|NCT04308681|453447248|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
126099349|NCT03149549|453655718|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
126099350|NCT03149549|453655719|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125882772|NCT00771758|452869041|FG002|Overall Study|Lost to Follow-up|0|||
126041107|NCT04308681|453447249|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126041108|NCT04308681|453447250|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126041109|NCT04308681|453447251|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
126099351|NCT03149549|453655720|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126099352|NCT03149549|453655721|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126099353|NCT03149549|453655722|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126099354|NCT03149549|453655710|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126099355|NCT03149549|453655711|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126099356|NCT03149549|453655712|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126099357|NCT03149549|453655713|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126099358|NCT03149549|453655714|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
126099359|NCT03149549|453655715|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126099360|NCT03149549|453655716|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126099361|NCT03149549|453655717|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
126099362|NCT03149549|453655718|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
126099363|NCT03149549|453655719|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126099364|NCT03149549|453655720|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126099365|NCT03149549|453655721|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
126099366|NCT03149549|453655722|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
126099367|NCT03149549|453655710|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126099368|NCT03149549|453655711|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126099369|NCT03149549|453655712|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126099370|NCT03149549|453655713|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126099371|NCT03149549|453655714|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
126099372|NCT03149549|453655715|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126099373|NCT03149549|453655716|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126099374|NCT03149549|453655717|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
126099375|NCT03149549|453655718|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
126099376|NCT03149549|453655719|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
126099377|NCT03149549|453655720|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
126099378|NCT03149549|453655721|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126099379|NCT03149549|453655722|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
126099380|NCT03149549|453655710|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
126099381|NCT03149549|453655711|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
126099382|NCT03149549|453655712|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
126365225|NCT00835042|454631735|FG000|First Intervention|Adverse Event|1|||
126365226|NCT00835042|454631736|FG001|First Intervention|Adverse Event|2|||
126041110|NCT04308681|453447252|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126041111|NCT04308681|453447253|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126041112|NCT05565820|453447254|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
126041113|NCT05565820|453447255|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
126041114|NCT05565820|453447254|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
126041115|NCT05565820|453447255|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
126041116|NCT00429364|453447257|FG000|Overall Study|Withdrawal by Subject|11|||
126041117|NCT00429364|453447258|FG001|Overall Study|Withdrawal by Subject|5|||
126041118|NCT00429364|453447257|FG000|Overall Study|Physician Decision|4|||
126041119|NCT00429364|453447258|FG001|Overall Study|Physician Decision|2|||
126041120|NCT00429364|453447257|FG000|Overall Study|Lost to Follow-up|7|||
126365227|NCT00835042|454631735|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
126365228|NCT00835042|454631736|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
126365229|NCT02096354|454631737|FG000|Overall Study|Physician Decision|4|||
126365230|NCT02096354|454631738|FG001|Overall Study|Physician Decision|5|||
126365231|NCT02096354|454631739|FG002|Overall Study|Physician Decision|0|||
126365232|NCT02096354|454631737|FG000|Overall Study|Withdrawal by Subject|3|||
126365233|NCT02096354|454631738|FG001|Overall Study|Withdrawal by Subject|1|||
126365234|NCT02096354|454631739|FG002|Overall Study|Withdrawal by Subject|0|||
126365235|NCT02096354|454631737|FG000|Overall Study|Adverse Event|7|||
126365236|NCT02096354|454631738|FG001|Overall Study|Adverse Event|4|||
126365237|NCT02096354|454631739|FG002|Overall Study|Adverse Event|0|||
126365238|NCT02096354|454631737|FG000|Overall Study|Ineligible|0|||
126365239|NCT02096354|454631738|FG001|Overall Study|Ineligible|0|||
126365240|NCT02096354|454631739|FG002|Overall Study|Ineligible|11|||
126365241|NCT03715829|454631740|FG000|Dose Ranging Period|Adverse Event|2|||
126365242|NCT03715829|454631741|FG001|Dose Ranging Period|Adverse Event|4|||
126365243|NCT03715829|454631742|FG002|Dose Ranging Period|Adverse Event|5|||
126365244|NCT03715829|454631743|FG003|Dose Ranging Period|Adverse Event|2|||
126365245|NCT03715829|454631744|FG004|Dose Ranging Period|Adverse Event|3|||
126365246|NCT03715829|454631745|FG005|Dose Ranging Period|Adverse Event|3|||
126365247|NCT03715829|454631746|FG006|Dose Ranging Period|Adverse Event|0|||
126365248|NCT03715829|454631747|FG007|Dose Ranging Period|Adverse Event|0|||
126365249|NCT03715829|454631748|FG008|Dose Ranging Period|Adverse Event|0|||
126365250|NCT03715829|454631749|FG009|Dose Ranging Period|Adverse Event|0|||
126365251|NCT03715829|454631750|FG010|Dose Ranging Period|Adverse Event|0|||
126365252|NCT03715829|454631740|FG000|Dose Ranging Period|Lack of Efficacy|0|||
126041121|NCT00429364|453447258|FG001|Overall Study|Lost to Follow-up|6|||
126041122|NCT00429364|453447257|FG000|Overall Study|Death|0|||
126041123|NCT00429364|453447258|FG001|Overall Study|Death|1|||
126041124|NCT00429364|453447257|FG000|Overall Study|Underwent aortic root surgery|10|||
126041125|NCT00429364|453447258|FG001|Overall Study|Underwent aortic root surgery|18|||
126041126|NCT00429364|453447257|FG000|Overall Study|Pregnancy|0|||
126041127|NCT00429364|453447258|FG001|Overall Study|Pregnancy|1|||
126041128|NCT04871529|453447259|FG000|Overall Study|Withdrawal by Subject|0|||
126041129|NCT04871529|453447260|FG001|Overall Study|Withdrawal by Subject|1|||
126041130|NCT04871529|453447259|FG000|Overall Study|Death|0|||
126041131|NCT04871529|453447260|FG001|Overall Study|Death|1|||
126041132|NCT04871529|453447259|FG000|Overall Study|Not protocol specified|0|||
126041133|NCT04871529|453447260|FG001|Overall Study|Not protocol specified|1|||
126041134|NCT05012163|453447267|FG000|Overall Study|Protocol Violation|0|||
126041135|NCT05012163|453447268|FG001|Overall Study|Protocol Violation|0|||
126041136|NCT05012163|453447269|FG002|Overall Study|Protocol Violation|1|||
126041137|NCT05012163|453447270|FG003|Overall Study|Protocol Violation|1|||
126041138|NCT04003246|453447273|FG000|Overall Study|Death|9|||
126041139|NCT04132518|453447281|FG000|Overall Study|Prematurely withdrawn from the study|0|||
126041140|NCT04132518|453447282|FG001|Overall Study|Prematurely withdrawn from the study|9|||
126041141|NCT04132518|453447283|FG002|Overall Study|Prematurely withdrawn from the study|1|||
126041142|NCT05524402|453447285|FG000|Overall Study|Withdrawal by Subject|3|||
126041143|NCT05524402|453447286|FG001|Overall Study|Withdrawal by Subject|1|||
126041144|NCT05524402|453447285|FG000|Overall Study|Lost to Follow-up|2|||
126041145|NCT05524402|453447286|FG001|Overall Study|Lost to Follow-up|1|||
126041146|NCT04428203|453447287|FG000|Overall Study|Adverse Event|1|||
126041147|NCT04428203|453447288|FG001|Overall Study|Adverse Event|0|||
126041148|NCT04428203|453447289|FG002|Overall Study|Adverse Event|0|||
126041149|NCT04428203|453447287|FG000|Overall Study|Withdrawal by Subject|1|||
126041150|NCT04428203|453447288|FG001|Overall Study|Withdrawal by Subject|0|||
126041151|NCT04428203|453447289|FG002|Overall Study|Withdrawal by Subject|1|||
126041152|NCT05237284|453447292|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
126041153|NCT05237284|453447293|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
126041154|NCT05237284|453447294|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
126041155|NCT05237284|453447295|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
126041156|NCT05237284|453447292|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
126041157|NCT05237284|453447293|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
126041158|NCT05237284|453447294|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
126041159|NCT05237284|453447295|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
126041160|NCT05237284|453447292|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
126041161|NCT05237284|453447293|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
126041162|NCT05237284|453447294|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
126041163|NCT05237284|453447295|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
126041164|NCT05237284|453447292|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
126041165|NCT05237284|453447293|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
126041166|NCT05237284|453447294|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
126041167|NCT05237284|453447295|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
126041168|NCT05237284|453447292|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
126041169|NCT05237284|453447293|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
126041170|NCT05237284|453447294|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
126041171|NCT05237284|453447295|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
126041172|NCT05237284|453447292|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
126365253|NCT03715829|454631741|FG001|Dose Ranging Period|Lack of Efficacy|1|||
126365254|NCT03715829|454631742|FG002|Dose Ranging Period|Lack of Efficacy|0|||
126365255|NCT03715829|454631743|FG003|Dose Ranging Period|Lack of Efficacy|1|||
126365256|NCT03715829|454631744|FG004|Dose Ranging Period|Lack of Efficacy|0|||
126365257|NCT03715829|454631745|FG005|Dose Ranging Period|Lack of Efficacy|0|||
126365258|NCT03715829|454631746|FG006|Dose Ranging Period|Lack of Efficacy|0|||
126365259|NCT03715829|454631747|FG007|Dose Ranging Period|Lack of Efficacy|0|||
126365260|NCT03715829|454631748|FG008|Dose Ranging Period|Lack of Efficacy|0|||
126365261|NCT03715829|454631749|FG009|Dose Ranging Period|Lack of Efficacy|0|||
126365262|NCT03715829|454631750|FG010|Dose Ranging Period|Lack of Efficacy|0|||
126365263|NCT03715829|454631740|FG000|Dose Ranging Period|Lost to Follow-up|2|||
126365264|NCT03715829|454631741|FG001|Dose Ranging Period|Lost to Follow-up|0|||
126365265|NCT03715829|454631742|FG002|Dose Ranging Period|Lost to Follow-up|1|||
126365266|NCT03715829|454631743|FG003|Dose Ranging Period|Lost to Follow-up|1|||
126041173|NCT05237284|453447293|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
126041174|NCT05237284|453447294|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
126365267|NCT03715829|454631744|FG004|Dose Ranging Period|Lost to Follow-up|1|||
126365268|NCT03715829|454631745|FG005|Dose Ranging Period|Lost to Follow-up|2|||
126365269|NCT03715829|454631746|FG006|Dose Ranging Period|Lost to Follow-up|0|||
126041175|NCT05237284|453447295|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
126041176|NCT05237284|453447292|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
126041177|NCT05237284|453447293|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
126041178|NCT05237284|453447294|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
126041179|NCT05237284|453447295|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
126041180|NCT05237284|453447292|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
126041181|NCT05237284|453447293|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
126041182|NCT05237284|453447294|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
126041183|NCT05237284|453447295|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
126041184|NCT05237284|453447292|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
126041185|NCT05237284|453447293|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
126041186|NCT05237284|453447294|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
126041187|NCT05237284|453447295|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
126041188|NCT03733925|453447299|FG000|Overall Study|Lost to Follow-up|1|||
126041189|NCT03733925|453447299|FG000|Overall Study|Withdrawal by Subject|2|||
126041190|NCT03733925|453447299|FG000|Overall Study|Adverse Event|2|||
126041191|NCT03733925|453447299|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126041192|NCT03209973|453448350|FG000|Overall Study|Withdrawal by Subject|7|||
126041193|NCT03209973|453448350|FG000|Overall Study|Lost to Follow-up|2|||
126041194|NCT03209973|453448350|FG000|Overall Study|Death|8|||
126041195|NCT03209973|453448350|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
126041196|NCT03209973|453448350|FG000|Overall Study|Sponsor Decision|18|||
126041197|NCT03209973|453448350|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
126041198|NCT03209973|453448350|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
126041199|NCT05218096|453448351|FG000|Primary Evaluation|Withdrawal by Subject|0|||
126041200|NCT05218096|453448352|FG001|Primary Evaluation|Withdrawal by Subject|0|||
126041201|NCT05218096|453448353|FG002|Primary Evaluation|Withdrawal by Subject|2|||
126041202|NCT05218096|453448354|FG003|Primary Evaluation|Withdrawal by Subject|0|||
126041203|NCT05218096|453448355|FG004|Primary Evaluation|Withdrawal by Subject|0|||
126041204|NCT05218096|453448351|FG000|Primary Evaluation|Physician Decision|1|||
126041205|NCT05218096|453448352|FG001|Primary Evaluation|Physician Decision|0|||
126041206|NCT05218096|453448353|FG002|Primary Evaluation|Physician Decision|0|||
126041207|NCT05218096|453448354|FG003|Primary Evaluation|Physician Decision|0|||
126041208|NCT05218096|453448355|FG004|Primary Evaluation|Physician Decision|0|||
126041209|NCT05218096|453448351|FG000|Extended Treatment|Clinical Deterioration|1|||
126041210|NCT05218096|453448352|FG001|Extended Treatment|Clinical Deterioration|1|||
126041211|NCT05218096|453448353|FG002|Extended Treatment|Clinical Deterioration|0|||
126041212|NCT05218096|453448354|FG003|Extended Treatment|Clinical Deterioration|0|||
126041213|NCT05218096|453448355|FG004|Extended Treatment|Clinical Deterioration|0|||
126041214|NCT05218096|453448351|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
126041215|NCT05218096|453448352|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
126041216|NCT05218096|453448353|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
126041217|NCT05218096|453448354|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
126041218|NCT05218096|453448355|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
126041219|NCT05218096|453448351|FG000|Extended Treatment|Withdrawal by Subject|1|||
126041220|NCT05218096|453448352|FG001|Extended Treatment|Withdrawal by Subject|3|||
126041221|NCT05218096|453448353|FG002|Extended Treatment|Withdrawal by Subject|0|||
126041222|NCT05218096|453448354|FG003|Extended Treatment|Withdrawal by Subject|2|||
126041223|NCT05218096|453448355|FG004|Extended Treatment|Withdrawal by Subject|2|||
126041224|NCT05218096|453448351|FG000|Extended Treatment|Lack of Efficacy|3|||
126041225|NCT05218096|453448352|FG001|Extended Treatment|Lack of Efficacy|0|||
126041226|NCT05218096|453448353|FG002|Extended Treatment|Lack of Efficacy|0|||
126041227|NCT05218096|453448354|FG003|Extended Treatment|Lack of Efficacy|0|||
126041228|NCT05218096|453448355|FG004|Extended Treatment|Lack of Efficacy|0|||
126041229|NCT05218096|453448351|FG000|Extended Treatment|Physician Decision|0|||
126041230|NCT05218096|453448352|FG001|Extended Treatment|Physician Decision|1|||
126041231|NCT05218096|453448353|FG002|Extended Treatment|Physician Decision|0|||
126041232|NCT05218096|453448354|FG003|Extended Treatment|Physician Decision|0|||
126041233|NCT05218096|453448355|FG004|Extended Treatment|Physician Decision|0|||
126041234|NCT05218096|453448351|FG000|Open-label Extension|Adverse Event|1|||
126041235|NCT05218096|453448352|FG001|Open-label Extension|Adverse Event|0|||
126041236|NCT05218096|453448353|FG002|Open-label Extension|Adverse Event|0|||
126041237|NCT05218096|453448354|FG003|Open-label Extension|Adverse Event|0|||
126285855|NCT00993421|454333074|FG001|Overall Study|Entry Criteria Exclusion|0|||
126041238|NCT05218096|453448355|FG004|Open-label Extension|Adverse Event|1|||
126041239|NCT05218096|453448351|FG000|Open-label Extension|Pregnancy|0|||
126041240|NCT05218096|453448352|FG001|Open-label Extension|Pregnancy|0|||
126041241|NCT05218096|453448353|FG002|Open-label Extension|Pregnancy|0|||
126041242|NCT05218096|453448354|FG003|Open-label Extension|Pregnancy|0|||
126041243|NCT05218096|453448355|FG004|Open-label Extension|Pregnancy|1|||
126041244|NCT05218096|453448351|FG000|Open-label Extension|Lack of Efficacy|1|||
126041245|NCT05218096|453448352|FG001|Open-label Extension|Lack of Efficacy|2|||
126041246|NCT05218096|453448353|FG002|Open-label Extension|Lack of Efficacy|0|||
126041247|NCT05218096|453448354|FG003|Open-label Extension|Lack of Efficacy|0|||
126041248|NCT05218096|453448355|FG004|Open-label Extension|Lack of Efficacy|0|||
126041249|NCT05218096|453448351|FG000|Open-label Extension|Lost to Follow-up|1|||
126041250|NCT05218096|453448352|FG001|Open-label Extension|Lost to Follow-up|0|||
126041251|NCT05218096|453448353|FG002|Open-label Extension|Lost to Follow-up|0|||
126041252|NCT05218096|453448354|FG003|Open-label Extension|Lost to Follow-up|0|||
126041253|NCT05218096|453448355|FG004|Open-label Extension|Lost to Follow-up|0|||
126041254|NCT05218096|453448351|FG000|Open-label Extension|Death|0|||
126041255|NCT05218096|453448352|FG001|Open-label Extension|Death|0|||
126041256|NCT05218096|453448353|FG002|Open-label Extension|Death|0|||
126041257|NCT05218096|453448354|FG003|Open-label Extension|Death|1|||
126041258|NCT05218096|453448355|FG004|Open-label Extension|Death|0|||
126041259|NCT05218096|453448351|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
126041260|NCT05218096|453448352|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
126041261|NCT05218096|453448353|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
126041262|NCT05218096|453448354|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
126041263|NCT05218096|453448355|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
126041264|NCT04797195|453448364|FG000|Overall Study|Death|8|||
126041265|NCT04797195|453448365|FG001|Overall Study|Death|15|||
126041266|NCT04797195|453448364|FG000|Overall Study|Change from PD|15|||
126041267|NCT04797195|453448365|FG001|Overall Study|Change from PD|15|||
126041268|NCT04797195|453448364|FG000|Overall Study|Withdrawal by Subject|3|||
126041269|NCT04797195|453448365|FG001|Overall Study|Withdrawal by Subject|2|||
126041270|NCT04660539|453448366|FG000|Overall Study|Adverse Event|10|||
126041271|NCT04660539|453448366|FG000|Overall Study|Lack of Efficacy|4|||
126099383|NCT03149549|453655713|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
126099384|NCT03149549|453655714|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
126099385|NCT03149549|453655715|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
126099386|NCT03149549|453655716|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
126099387|NCT03149549|453655717|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
126099388|NCT03149549|453655718|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
126099389|NCT03149549|453655719|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
126099390|NCT03149549|453655720|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
126099391|NCT03149549|453655721|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
126099392|NCT03149549|453655722|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
126099393|NCT03149549|453655710|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
126099394|NCT03149549|453655711|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
126099395|NCT03149549|453655712|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
126099396|NCT03149549|453655713|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
126099397|NCT03149549|453655714|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
126099398|NCT03149549|453655715|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
126099399|NCT03149549|453655716|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
126099400|NCT03149549|453655717|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
126099401|NCT03149549|453655718|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
126099402|NCT03149549|453655719|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
126099403|NCT03149549|453655720|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
126099404|NCT03149549|453655721|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
126099405|NCT03149549|453655722|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
126099406|NCT01034176|453657564|FG000|Overall Study|Physician Decision|2|||
126099407|NCT01034176|453657565|FG001|Overall Study|Physician Decision|0|||
126099408|NCT01034176|453657564|FG000|Overall Study|Withdrawal by Subject|0|||
126099409|NCT01034176|453657565|FG001|Overall Study|Withdrawal by Subject|1|||
126099410|NCT01034176|453657564|FG000|Overall Study|Lost to Follow-up|0|||
126099411|NCT01034176|453657565|FG001|Overall Study|Lost to Follow-up|1|||
126099412|NCT03207009|453657568|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
126099413|NCT03241225|453657569|FG000|Overall Study|Lost to Follow-up|2|||
126099414|NCT03241225|453657570|FG001|Overall Study|Lost to Follow-up|1|||
126099415|NCT03241225|453657569|FG000|Overall Study|Protocol Violation|4|||
126099416|NCT03241225|453657570|FG001|Overall Study|Protocol Violation|1|||
126099417|NCT03241225|453657569|FG000|Overall Study|Withdrawal by Subject|1|||
126099418|NCT03241225|453657570|FG001|Overall Study|Withdrawal by Subject|0|||
126099419|NCT01635920|453657575|FG000|Overall Study|Adverse Event|1|||
126099420|NCT01635920|453657576|FG001|Overall Study|Adverse Event|0|||
126099421|NCT01635920|453657575|FG000|Overall Study|Lost to Follow-up|0|||
125882773|NCT00771758|452869039|FG000|Overall Study|Protocol Violation|1|||
126099422|NCT01635920|453657576|FG001|Overall Study|Lost to Follow-up|1|||
126099423|NCT01635920|453657575|FG000|Overall Study|Subject decision|2|||
126099424|NCT01635920|453657576|FG001|Overall Study|Subject decision|0|||
126099425|NCT02074553|453657577|FG000|Intervention Period 1|Family Emergency|0|||
126099426|NCT02074553|453657578|FG001|Intervention Period 1|Family Emergency|0|||
126285856|NCT00993421|454333075|FG002|Overall Study|Entry Criteria Exclusion|1|||
126285857|NCT00993421|454333076|FG003|Overall Study|Entry Criteria Exclusion|3|||
126285858|NCT00993421|454333077|FG004|Overall Study|Entry Criteria Exclusion|0|||
126285859|NCT00993421|454333078|FG005|Overall Study|Entry Criteria Exclusion|1|||
126285860|NCT00993421|454333079|FG006|Overall Study|Entry Criteria Exclusion|0|||
126285861|NCT00993421|454333073|FG000|Overall Study|Physician Decision|0|||
126285862|NCT00993421|454333074|FG001|Overall Study|Physician Decision|0|||
126285863|NCT00993421|454333075|FG002|Overall Study|Physician Decision|0|||
126285864|NCT00993421|454333076|FG003|Overall Study|Physician Decision|0|||
126285865|NCT00993421|454333077|FG004|Overall Study|Physician Decision|0|||
126285866|NCT00993421|454333078|FG005|Overall Study|Physician Decision|1|||
126285867|NCT00993421|454333079|FG006|Overall Study|Physician Decision|1|||
126285868|NCT00993421|454333073|FG000|Overall Study|Protocol Violation|0|||
126285869|NCT00993421|454333074|FG001|Overall Study|Protocol Violation|0|||
126285870|NCT00993421|454333075|FG002|Overall Study|Protocol Violation|0|||
126285871|NCT00993421|454333076|FG003|Overall Study|Protocol Violation|0|||
126285872|NCT00993421|454333077|FG004|Overall Study|Protocol Violation|0|||
126285873|NCT00993421|454333078|FG005|Overall Study|Protocol Violation|2|||
126285874|NCT00993421|454333079|FG006|Overall Study|Protocol Violation|1|||
126285875|NCT02215967|454333080|FG000|Overall Study|Patient became ineligible for treatment|0|||
126285876|NCT02215967|454333081|FG001|Overall Study|Patient became ineligible for treatment|0|||
126285877|NCT02215967|454333082|FG002|Overall Study|Patient became ineligible for treatment|0|||
126285878|NCT02215967|454333083|FG003|Overall Study|Patient became ineligible for treatment|3|||
126285879|NCT02215967|454333080|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
126285880|NCT02215967|454333081|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
126285881|NCT02215967|454333082|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
126285882|NCT02215967|454333083|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
126099427|NCT02074553|453657579|FG002|Intervention Period 1|Family Emergency|0|||
126099428|NCT02074553|453657580|FG003|Intervention Period 1|Family Emergency|1|||
126099429|NCT02074553|453657581|FG004|Intervention Period 1|Family Emergency|0|||
126099430|NCT02074553|453657582|FG005|Intervention Period 1|Family Emergency|0|||
126099431|NCT02074553|453657583|FG006|Intervention Period 1|Family Emergency|0|||
126099432|NCT02074553|453657584|FG007|Intervention Period 1|Family Emergency|0|||
126099433|NCT02074553|453657577|FG000|Washout Period 1|Adverse Event|1|||
126099434|NCT02074553|453657578|FG001|Washout Period 1|Adverse Event|0|||
126099435|NCT02074553|453657579|FG002|Washout Period 1|Adverse Event|0|||
126099436|NCT02074553|453657580|FG003|Washout Period 1|Adverse Event|0|||
126099437|NCT02074553|453657581|FG004|Washout Period 1|Adverse Event|0|||
126285883|NCT01954745|454333087|FG000|Overall Study|Radiological Progression|11|||
126285884|NCT01954745|454333087|FG000|Overall Study|Clinical Progression|5|||
126285885|NCT01954745|454333087|FG000|Overall Study|Adverse Event|2|||
126285886|NCT01954745|454333087|FG000|Overall Study|Death|1|||
126285887|NCT00352417|454333088|FG000|Overall Study|Adverse Event|1|||
126285888|NCT00352417|454333089|FG001|Overall Study|Adverse Event|0|||
126285889|NCT00352417|454333088|FG000|Overall Study|Protocol Violation|0|||
126285890|NCT00352417|454333089|FG001|Overall Study|Protocol Violation|2|||
126285891|NCT00352417|454333088|FG000|Overall Study|Withdrawal by Subject|1|||
126285892|NCT00352417|454333089|FG001|Overall Study|Withdrawal by Subject|2|||
126285893|NCT00352417|454333088|FG000|Overall Study|Lost to Follow-up|1|||
126285894|NCT00352417|454333089|FG001|Overall Study|Lost to Follow-up|0|||
126285895|NCT00352417|454333088|FG000|Overall Study|Schedule Change|2|||
126285896|NCT00352417|454333089|FG001|Overall Study|Schedule Change|1|||
126285897|NCT01496976|454334916|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
126285898|NCT05938621|454334917|FG000|Overall Study|Lost to Follow-up|1|||
126285899|NCT05938621|454334918|FG001|Overall Study|Lost to Follow-up|5|||
126285900|NCT05938621|454334919|FG002|Overall Study|Lost to Follow-up|2|||
126285901|NCT05938621|454334920|FG003|Overall Study|Lost to Follow-up|2|||
126285902|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
126285903|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
126285904|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
126285905|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
126285906|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
126285907|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
126285908|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
126285909|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
126285910|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
126285911|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
126285912|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
126285913|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
126285914|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285915|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285916|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285917|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
126285918|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285919|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285920|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
126285921|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
126285922|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
126285923|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285924|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285925|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285926|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285927|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126099438|NCT02074553|453657582|FG005|Washout Period 1|Adverse Event|0|||
126099439|NCT02074553|453657583|FG006|Washout Period 1|Adverse Event|0|||
126099440|NCT02074553|453657584|FG007|Washout Period 1|Adverse Event|0|||
126099441|NCT02074553|453657577|FG000|Washout Period 1|Physician Decision|0|||
126099442|NCT02074553|453657578|FG001|Washout Period 1|Physician Decision|0|||
126099443|NCT02074553|453657579|FG002|Washout Period 1|Physician Decision|0|||
126099444|NCT02074553|453657580|FG003|Washout Period 1|Physician Decision|1|||
126099445|NCT02074553|453657581|FG004|Washout Period 1|Physician Decision|0|||
126099446|NCT02074553|453657582|FG005|Washout Period 1|Physician Decision|0|||
126099447|NCT02074553|453657583|FG006|Washout Period 1|Physician Decision|0|||
126099448|NCT02074553|453657584|FG007|Washout Period 1|Physician Decision|0|||
126099449|NCT02074553|453657577|FG000|Washout Period 1|Other|0|||
126099450|NCT02074553|453657578|FG001|Washout Period 1|Other|0|||
126099451|NCT02074553|453657579|FG002|Washout Period 1|Other|0|||
126099452|NCT02074553|453657580|FG003|Washout Period 1|Other|0|||
126099453|NCT02074553|453657581|FG004|Washout Period 1|Other|0|||
126099454|NCT02074553|453657582|FG005|Washout Period 1|Other|1|||
126099455|NCT02074553|453657583|FG006|Washout Period 1|Other|0|||
126099456|NCT02074553|453657584|FG007|Washout Period 1|Other|0|||
126285928|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285929|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
126285930|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
126285931|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
126285932|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285933|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126041272|NCT04660539|453448366|FG000|Overall Study|Lost to Follow-up|5|||
126041273|NCT04660539|453448366|FG000|Overall Study|Non-Compliance With Study Drug|3|||
126041274|NCT04660539|453448366|FG000|Overall Study|Reason not Specified|12|||
126041275|NCT04660539|453448366|FG000|Overall Study|Pregnancy|2|||
126041276|NCT04660539|453448366|FG000|Overall Study|Protocol Violation|2|||
126041277|NCT04660539|453448366|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
126041278|NCT04660539|453448366|FG000|Overall Study|Withdrawal by Subject|21|||
126041279|NCT03852550|453448369|FG000|Overall Study|Lost to Follow-up|4|||
126041280|NCT03852550|453448370|FG001|Overall Study|Lost to Follow-up|3|||
126041281|NCT03852550|453448369|FG000|Overall Study|Only parent outcomes completed|0|||
126041282|NCT03852550|453448370|FG001|Overall Study|Only parent outcomes completed|1|||
126041283|NCT03852550|453448369|FG000|Overall Study|Withdrawal by Subject|1|||
126041284|NCT03852550|453448370|FG001|Overall Study|Withdrawal by Subject|0|||
126041285|NCT05207956|453448380|FG000|Overall Study|Lost to follow up|1|||
126041286|NCT05207956|453448381|FG001|Overall Study|Lost to follow up|2|||
126041287|NCT02296684|453448382|FG000|Overall Study|Withdrawal by Subject|0|||
126041288|NCT02296684|453448383|FG001|Overall Study|Withdrawal by Subject|1|||
126041289|NCT02296684|453448384|FG002|Overall Study|Withdrawal by Subject|1|||
126041290|NCT02296684|453448382|FG000|Overall Study|Death|2|||
126041291|NCT02296684|453448383|FG001|Overall Study|Death|0|||
126041292|NCT02296684|453448384|FG002|Overall Study|Death|0|||
126041293|NCT01828112|453448389|FG000|Treatment Phase|Adverse Event|7|||
126041294|NCT01828112|453448390|FG001|Treatment Phase|Adverse Event|8|||
126041295|NCT01828112|453448391|FG002|Treatment Phase|Adverse Event|0|||
126041296|NCT01828112|453448389|FG000|Treatment Phase|Death|9|||
126041297|NCT01828112|453448390|FG001|Treatment Phase|Death|5|||
126041298|NCT01828112|453448391|FG002|Treatment Phase|Death|0|||
126041299|NCT01828112|453448389|FG000|Treatment Phase|No longer required treatment|0|||
126041300|NCT01828112|453448390|FG001|Treatment Phase|No longer required treatment|1|||
126041301|NCT01828112|453448391|FG002|Treatment Phase|No longer required treatment|0|||
126041302|NCT01828112|453448389|FG000|Treatment Phase|Physician Decision|6|||
126041303|NCT01828112|453448390|FG001|Treatment Phase|Physician Decision|7|||
126041304|NCT01828112|453448391|FG002|Treatment Phase|Physician Decision|0|||
126041305|NCT01828112|453448389|FG000|Treatment Phase|Pregnancy|1|||
126041306|NCT01828112|453448390|FG001|Treatment Phase|Pregnancy|0|||
126041307|NCT01828112|453448391|FG002|Treatment Phase|Pregnancy|0|||
126041308|NCT01828112|453448389|FG000|Treatment Phase|Progressive disease|79|||
126041309|NCT01828112|453448390|FG001|Treatment Phase|Progressive disease|87|||
126041310|NCT01828112|453448391|FG002|Treatment Phase|Progressive disease|0|||
126041311|NCT01828112|453448389|FG000|Treatment Phase|Study terminated by sponsor|1|||
126041312|NCT01828112|453448390|FG001|Treatment Phase|Study terminated by sponsor|0|||
126041313|NCT01828112|453448391|FG002|Treatment Phase|Study terminated by sponsor|0|||
126041314|NCT01828112|453448389|FG000|Treatment Phase|Subject/guardian decision|12|||
126041315|NCT01828112|453448390|FG001|Treatment Phase|Subject/guardian decision|8|||
126041316|NCT01828112|453448391|FG002|Treatment Phase|Subject/guardian decision|0|||
125882774|NCT00771758|452869040|FG001|Overall Study|Protocol Violation|0|||
126041317|NCT01828112|453448389|FG000|Extension Treatment Phase|Adverse Event|0|||
126041318|NCT01828112|453448390|FG001|Extension Treatment Phase|Adverse Event|0|||
126041319|NCT01828112|453448391|FG002|Extension Treatment Phase|Adverse Event|6|||
126041320|NCT01828112|453448389|FG000|Extension Treatment Phase|Death|0|||
126041321|NCT01828112|453448390|FG001|Extension Treatment Phase|Death|0|||
126041322|NCT01828112|453448391|FG002|Extension Treatment Phase|Death|17|||
126041323|NCT01828112|453448389|FG000|Extension Treatment Phase|Physician Decision|0|||
126041324|NCT01828112|453448390|FG001|Extension Treatment Phase|Physician Decision|0|||
126041325|NCT01828112|453448391|FG002|Extension Treatment Phase|Physician Decision|5|||
126041326|NCT01828112|453448389|FG000|Extension Treatment Phase|Progressive disease|0|||
126285934|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285935|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285936|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285937|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285938|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
126285939|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
126285940|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
126285941|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126285942|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126285943|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126285944|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
126365270|NCT03715829|454631747|FG007|Dose Ranging Period|Lost to Follow-up|0|||
126365271|NCT03715829|454631748|FG008|Dose Ranging Period|Lost to Follow-up|0|||
126285945|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126365272|NCT03715829|454631749|FG009|Dose Ranging Period|Lost to Follow-up|0|||
126365273|NCT03715829|454631750|FG010|Dose Ranging Period|Lost to Follow-up|0|||
126365274|NCT03715829|454631740|FG000|Dose Ranging Period|Protocol Violation|0|||
126365275|NCT03715829|454631741|FG001|Dose Ranging Period|Protocol Violation|0|||
126365276|NCT03715829|454631742|FG002|Dose Ranging Period|Protocol Violation|0|||
126365277|NCT03715829|454631743|FG003|Dose Ranging Period|Protocol Violation|1|||
126365278|NCT03715829|454631744|FG004|Dose Ranging Period|Protocol Violation|0|||
126365279|NCT03715829|454631745|FG005|Dose Ranging Period|Protocol Violation|0|||
126365280|NCT03715829|454631746|FG006|Dose Ranging Period|Protocol Violation|0|||
126365281|NCT03715829|454631747|FG007|Dose Ranging Period|Protocol Violation|0|||
126365282|NCT03715829|454631748|FG008|Dose Ranging Period|Protocol Violation|0|||
126365283|NCT03715829|454631749|FG009|Dose Ranging Period|Protocol Violation|0|||
126365284|NCT03715829|454631750|FG010|Dose Ranging Period|Protocol Violation|0|||
126365285|NCT03715829|454631740|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
126365286|NCT03715829|454631741|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
126365287|NCT03715829|454631742|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
126041327|NCT01828112|453448390|FG001|Extension Treatment Phase|Progressive disease|0|||
126041328|NCT01828112|453448391|FG002|Extension Treatment Phase|Progressive disease|46|||
126041329|NCT01828112|453448389|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
126041330|NCT01828112|453448390|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
126041331|NCT01828112|453448391|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
126041332|NCT01828112|453448389|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
126365288|NCT03715829|454631743|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
126365289|NCT03715829|454631744|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
126365290|NCT03715829|454631745|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
126365291|NCT03715829|454631746|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
126365292|NCT03715829|454631747|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
126365293|NCT03715829|454631748|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
126365294|NCT03715829|454631749|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
126365295|NCT03715829|454631750|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
126365296|NCT03715829|454631740|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365297|NCT03715829|454631741|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126041333|NCT01828112|453448390|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
126041334|NCT01828112|453448391|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
126041335|NCT02446236|453448401|FG000|Overall Study|Screen Failure|1|||
126041336|NCT02446236|453448402|FG001|Overall Study|Screen Failure|0|||
126041337|NCT02446236|453448403|FG002|Overall Study|Screen Failure|1|||
126041338|NCT02446236|453448401|FG000|Overall Study|Actively Receiving Therapy|0|||
126041339|NCT02446236|453448402|FG001|Overall Study|Actively Receiving Therapy|0|||
126041340|NCT02446236|453448403|FG002|Overall Study|Actively Receiving Therapy|1|||
126041341|NCT04786119|453448404|FG000|Overall Study|Withdrawal by Subject|2|||
126041342|NCT05076266|453448405|FG000|Overall Study|Survey not complete - Participant refusal|2|||
126041343|NCT05076266|453448406|FG001|Overall Study|Survey not complete - Participant refusal|0|||
126041344|NCT03213873|453448409|FG000|Overall Study|Withdrawal by Subject|8|||
126041345|NCT03213873|453448410|FG001|Overall Study|Withdrawal by Subject|9|||
126041346|NCT03213873|453448409|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
126041347|NCT03213873|453448410|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
126041348|NCT03213873|453448409|FG000|Overall Study|Lost to Follow-up|0|||
126041349|NCT03213873|453448410|FG001|Overall Study|Lost to Follow-up|2|||
126041350|NCT02361216|453448416|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
126041351|NCT02361216|453448417|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
126365298|NCT03715829|454631742|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
126041352|NCT02361216|453448416|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
126041353|NCT02361216|453448417|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
126099457|NCT02074553|453657577|FG000|Washout Period 2|Adverse Event|0|||
126099458|NCT02074553|453657578|FG001|Washout Period 2|Adverse Event|0|||
126099459|NCT02074553|453657579|FG002|Washout Period 2|Adverse Event|0|||
126099460|NCT02074553|453657580|FG003|Washout Period 2|Adverse Event|0|||
126099461|NCT02074553|453657581|FG004|Washout Period 2|Adverse Event|0|||
126099462|NCT02074553|453657582|FG005|Washout Period 2|Adverse Event|0|||
126099463|NCT02074553|453657583|FG006|Washout Period 2|Adverse Event|1|||
126285946|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126285947|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
126285948|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285949|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285950|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285951|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285952|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285953|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285954|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285955|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285956|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285957|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
126285958|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126041354|NCT02361216|453448416|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
126041355|NCT02361216|453448417|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
126041356|NCT02361216|453448416|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
126041357|NCT02361216|453448417|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
126041358|NCT02361216|453448416|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
126041359|NCT02361216|453448417|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
126041360|NCT02361216|453448416|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
126041361|NCT02361216|453448417|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
126285959|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285960|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285961|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285962|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285963|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285964|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126365299|NCT03715829|454631743|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365300|NCT03715829|454631744|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365301|NCT03715829|454631745|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365302|NCT03715829|454631746|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365303|NCT03715829|454631747|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365304|NCT03715829|454631748|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365305|NCT03715829|454631749|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365306|NCT03715829|454631750|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365307|NCT03715829|454631740|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365308|NCT03715829|454631741|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365309|NCT03715829|454631742|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
126365310|NCT03715829|454631743|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365311|NCT03715829|454631744|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
126365312|NCT03715829|454631745|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365313|NCT03715829|454631746|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365314|NCT03715829|454631747|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365315|NCT03715829|454631748|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365316|NCT03715829|454631749|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365317|NCT03715829|454631750|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365318|NCT03715829|454631740|FG000|Dose Ranging Period|Other|0|||
126365319|NCT03715829|454631741|FG001|Dose Ranging Period|Other|0|||
126365320|NCT03715829|454631742|FG002|Dose Ranging Period|Other|2|||
126365321|NCT03715829|454631743|FG003|Dose Ranging Period|Other|0|||
126365322|NCT03715829|454631744|FG004|Dose Ranging Period|Other|0|||
126365323|NCT03715829|454631745|FG005|Dose Ranging Period|Other|3|||
126365324|NCT03715829|454631746|FG006|Dose Ranging Period|Other|0|||
126365325|NCT03715829|454631747|FG007|Dose Ranging Period|Other|0|||
126365326|NCT03715829|454631748|FG008|Dose Ranging Period|Other|0|||
126365327|NCT03715829|454631749|FG009|Dose Ranging Period|Other|0|||
126365328|NCT03715829|454631750|FG010|Dose Ranging Period|Other|0|||
126365329|NCT03715829|454631740|FG000|Extension Period|Adverse Event|0|||
126365330|NCT03715829|454631741|FG001|Extension Period|Adverse Event|0|||
126365331|NCT03715829|454631742|FG002|Extension Period|Adverse Event|0|||
126365332|NCT03715829|454631743|FG003|Extension Period|Adverse Event|0|||
126099464|NCT02074553|453657584|FG007|Washout Period 2|Adverse Event|0|||
126099465|NCT02074553|453657577|FG000|Washout Period 2|Physician Decision|0|||
126099466|NCT02074553|453657578|FG001|Washout Period 2|Physician Decision|0|||
126099467|NCT02074553|453657579|FG002|Washout Period 2|Physician Decision|0|||
126099468|NCT02074553|453657580|FG003|Washout Period 2|Physician Decision|0|||
126099469|NCT02074553|453657581|FG004|Washout Period 2|Physician Decision|0|||
126099470|NCT02074553|453657582|FG005|Washout Period 2|Physician Decision|1|||
126099471|NCT02074553|453657583|FG006|Washout Period 2|Physician Decision|0|||
126099472|NCT02074553|453657584|FG007|Washout Period 2|Physician Decision|0|||
126099473|NCT02074553|453657577|FG000|Washout Period 2|Lost to Follow-up|0|||
126099474|NCT02074553|453657578|FG001|Washout Period 2|Lost to Follow-up|0|||
126099475|NCT02074553|453657579|FG002|Washout Period 2|Lost to Follow-up|1|||
126099476|NCT02074553|453657580|FG003|Washout Period 2|Lost to Follow-up|0|||
126099477|NCT02074553|453657581|FG004|Washout Period 2|Lost to Follow-up|0|||
126099478|NCT02074553|453657582|FG005|Washout Period 2|Lost to Follow-up|0|||
126099479|NCT02074553|453657583|FG006|Washout Period 2|Lost to Follow-up|0|||
126099480|NCT02074553|453657584|FG007|Washout Period 2|Lost to Follow-up|0|||
126099481|NCT02074553|453657577|FG000|Washout Period 3|Physician Decision|0|||
126099482|NCT02074553|453657578|FG001|Washout Period 3|Physician Decision|0|||
126099483|NCT02074553|453657579|FG002|Washout Period 3|Physician Decision|0|||
126099484|NCT02074553|453657580|FG003|Washout Period 3|Physician Decision|0|||
126099485|NCT02074553|453657581|FG004|Washout Period 3|Physician Decision|0|||
126099486|NCT02074553|453657582|FG005|Washout Period 3|Physician Decision|0|||
126099487|NCT02074553|453657583|FG006|Washout Period 3|Physician Decision|0|||
126099488|NCT02074553|453657584|FG007|Washout Period 3|Physician Decision|1|||
126099489|NCT00194987|453657585|FG000|Overall Study|Withdrawal by Subject|0|||
126099490|NCT00194987|453657586|FG001|Overall Study|Withdrawal by Subject|3|||
126099491|NCT01664598|453657587|FG000|Overall Study|Sponsor Decision|1|||
126285965|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285966|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285967|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
126285968|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126099492|NCT01664598|453657587|FG000|Overall Study|Withdrawal of Informed Consent|4|||
126099493|NCT01664598|453657587|FG000|Overall Study|Adverse Event|1|||
126099494|NCT01658150|453657588|FG000|Overall Study|Withdrawal by Subject|1|||
126099495|NCT04187989|453657589|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
126099496|NCT04187989|453657590|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
126099497|NCT04187989|453657589|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
126285969|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285970|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285971|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285972|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285973|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285974|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
126285975|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285976|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285977|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285978|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285979|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285980|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285981|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285982|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285983|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
126285984|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285985|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126365333|NCT03715829|454631744|FG004|Extension Period|Adverse Event|0|||
125882775|NCT00771758|452869041|FG002|Overall Study|Protocol Violation|0|||
125882776|NCT00771758|452869039|FG000|Overall Study|Withdrawal by Subject|1|||
125882777|NCT00771758|452869040|FG001|Overall Study|Withdrawal by Subject|0|||
126099498|NCT04187989|453657590|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
126099499|NCT03646656|453657591|FG000|Overall Study|Lost to Follow-up|1|||
126099500|NCT03646656|453657592|FG001|Overall Study|Lost to Follow-up|0|||
126099501|NCT03646656|453657591|FG000|Overall Study|Withdrawal by Subject|2|||
126099502|NCT03646656|453657592|FG001|Overall Study|Withdrawal by Subject|0|||
126099503|NCT03602066|453657593|FG000|Overall Study|Withdrawal by Subject|2|||
126099504|NCT03602066|453657594|FG001|Overall Study|Withdrawal by Subject|0|||
126099505|NCT03602066|453657593|FG000|Overall Study|Physician Decision|1|||
126365334|NCT03715829|454631745|FG005|Extension Period|Adverse Event|0|||
126365335|NCT03715829|454631746|FG006|Extension Period|Adverse Event|3|||
126099506|NCT03602066|453657594|FG001|Overall Study|Physician Decision|0|||
126099507|NCT00092495|453657595|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
125882778|NCT00771758|452869041|FG002|Overall Study|Withdrawal by Subject|0|||
125882779|NCT00771758|452869039|FG000|Overall Study|Other|3|||
125882780|NCT00771758|452869040|FG001|Overall Study|Other|2|||
125882781|NCT00771758|452869041|FG002|Overall Study|Other|0|||
125882782|NCT03067077|452869042|FG000|Overall Study|Did not receive surgery|4|||
125882783|NCT03067077|452869043|FG001|Overall Study|Did not receive surgery|5|||
125882784|NCT03067077|452869042|FG000|Overall Study|Lost to Follow-up|3|||
125882785|NCT03067077|452869043|FG001|Overall Study|Lost to Follow-up|2|||
125882786|NCT00935584|452869046|FG000|Overall Study|Withdrawal by Subject|9|||
125882787|NCT00935584|452869047|FG001|Overall Study|Withdrawal by Subject|0|||
125882788|NCT00935584|452869046|FG000|Overall Study|Death|3|||
125882789|NCT00935584|452869047|FG001|Overall Study|Death|0|||
125882790|NCT00935584|452869046|FG000|Overall Study|Lost to Follow-up|8|||
125882791|NCT00935584|452869047|FG001|Overall Study|Lost to Follow-up|0|||
125882792|NCT00935584|452869046|FG000|Overall Study|No show|9|||
125882793|NCT00935584|452869047|FG001|Overall Study|No show|0|||
125882794|NCT00935584|452869046|FG000|Overall Study|Relocated|3|||
125882795|NCT00935584|452869047|FG001|Overall Study|Relocated|0|||
125882796|NCT00935584|452869046|FG000|Overall Study|Patient changed provider|3|||
125882797|NCT00935584|452869047|FG001|Overall Study|Patient changed provider|0|||
125882798|NCT00935584|452869046|FG000|Overall Study|Provider dropped out of study|14|||
125882799|NCT00935584|452869047|FG001|Overall Study|Provider dropped out of study|4|||
125882800|NCT00687193|452869049|FG000|Overall Study|Adverse Event|0|||
125882801|NCT00687193|452869050|FG001|Overall Study|Adverse Event|1|||
125882802|NCT00687193|452869051|FG002|Overall Study|Adverse Event|2|||
125882803|NCT00687193|452869052|FG003|Overall Study|Adverse Event|3|||
125882804|NCT00687193|452869053|FG004|Overall Study|Adverse Event|0|||
125882805|NCT00687193|452869054|FG005|Overall Study|Adverse Event|2|||
125882806|NCT00687193|452869049|FG000|Overall Study|Lack of Efficacy|1|||
125882807|NCT00687193|452869050|FG001|Overall Study|Lack of Efficacy|1|||
125882808|NCT00687193|452869051|FG002|Overall Study|Lack of Efficacy|0|||
125882809|NCT00687193|452869052|FG003|Overall Study|Lack of Efficacy|0|||
125882810|NCT00687193|452869053|FG004|Overall Study|Lack of Efficacy|0|||
125882811|NCT00687193|452869054|FG005|Overall Study|Lack of Efficacy|2|||
125882812|NCT00687193|452869049|FG000|Overall Study|Protocol Violation|1|||
125882813|NCT00687193|452869050|FG001|Overall Study|Protocol Violation|2|||
125882814|NCT00687193|452869051|FG002|Overall Study|Protocol Violation|0|||
125882815|NCT00687193|452869052|FG003|Overall Study|Protocol Violation|1|||
125882816|NCT00687193|452869053|FG004|Overall Study|Protocol Violation|2|||
125882817|NCT00687193|452869054|FG005|Overall Study|Protocol Violation|0|||
125882818|NCT01394016|452869055|FG000|Overall Study|Progressive Disease|2|||
125882819|NCT01394016|452869056|FG001|Overall Study|Progressive Disease|0|||
126041362|NCT02852655|453448426|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
126041363|NCT02852655|453448427|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
126041364|NCT02852655|453448428|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
126041365|NCT02852655|453448426|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
126041366|NCT02852655|453448427|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
126041367|NCT02852655|453448428|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
126041368|NCT02852655|453448426|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
126041369|NCT02852655|453448427|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
126041370|NCT02852655|453448428|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
126041371|NCT02852655|453448426|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
126041372|NCT02852655|453448427|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
126041373|NCT02852655|453448428|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
126041374|NCT02852655|453448426|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
126041375|NCT02852655|453448427|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
126041376|NCT02852655|453448428|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
126041377|NCT02852655|453448426|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
126041378|NCT02852655|453448427|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
126041379|NCT02852655|453448428|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
126041380|NCT02852655|453448426|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
126041381|NCT02852655|453448427|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
126041382|NCT02852655|453448428|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
126041383|NCT02852655|453448426|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
126041384|NCT02852655|453448427|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
126285986|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125882820|NCT01394016|452869057|FG002|Overall Study|Progressive Disease|0|||
125882821|NCT01394016|452869058|FG003|Overall Study|Progressive Disease|0|||
125882822|NCT01394016|452869059|FG004|Overall Study|Progressive Disease|0|||
125882823|NCT01394016|452869060|FG005|Overall Study|Progressive Disease|0|||
125882824|NCT01394016|452869061|FG006|Overall Study|Progressive Disease|0|||
125882825|NCT01394016|452869062|FG007|Overall Study|Progressive Disease|0|||
125882826|NCT01394016|452869063|FG008|Overall Study|Progressive Disease|0|||
126041385|NCT02852655|453448428|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
126099508|NCT00092495|453657596|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
126099509|NCT00092495|453657597|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126099510|NCT00092495|453657598|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
126099511|NCT00092495|453657599|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126099512|NCT00092495|453657595|FG000|Base Study Vaccination Period|Extended|0|||
126099513|NCT00092495|453657596|FG001|Base Study Vaccination Period|Extended|0|||
126099514|NCT00092495|453657597|FG002|Base Study Vaccination Period|Extended|0|||
126099515|NCT00092495|453657598|FG003|Base Study Vaccination Period|Extended|1|||
126099516|NCT00092495|453657599|FG004|Base Study Vaccination Period|Extended|0|||
126099517|NCT00092495|453657595|FG000|Base Study Vaccination Period|*Clinical AE|1|||
126099518|NCT00092495|453657596|FG001|Base Study Vaccination Period|*Clinical AE|0|||
126099519|NCT00092495|453657597|FG002|Base Study Vaccination Period|*Clinical AE|1|||
126099520|NCT00092495|453657598|FG003|Base Study Vaccination Period|*Clinical AE|2|||
126285987|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285988|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285989|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285990|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285991|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285992|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
125882827|NCT01394016|452869064|FG009|Overall Study|Progressive Disease|0|||
126041386|NCT02852655|453448426|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
126041387|NCT02852655|453448427|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
126041388|NCT02852655|453448428|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
126041389|NCT02834390|453448436|FG000|Induction Phase|Progressive disease|0|||
126041390|NCT02834390|453448437|FG001|Induction Phase|Progressive disease|1|||
126041391|NCT02834390|453448436|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
126041392|NCT02834390|453448437|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
126041393|NCT02834390|453448436|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
126041394|NCT02834390|453448437|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
126041395|NCT02834390|453448436|FG000|Consolidation Phase|Physician Decision|1|||
126041396|NCT02834390|453448437|FG001|Consolidation Phase|Physician Decision|1|||
126041397|NCT04544007|453448438|FG000|Overall Study|Withdrawal by Subject|1|||
126041398|NCT04544007|453448438|FG000|Overall Study|Confirmed Progressive Disease|1|||
126041399|NCT02998528|453448439|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
126041400|NCT02998528|453448440|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
126041401|NCT02998528|453448441|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
126041402|NCT02998528|453448439|FG000|Randomization Period|Participant withdrew consent|0|||
126041403|NCT02998528|453448440|FG001|Randomization Period|Participant withdrew consent|3|||
126041404|NCT02998528|453448441|FG002|Randomization Period|Participant withdrew consent|0|||
126041405|NCT02998528|453448439|FG000|Randomization Period|Participant no longer meets study criteria|1|||
126041406|NCT02998528|453448440|FG001|Randomization Period|Participant no longer meets study criteria|3|||
126041407|NCT02998528|453448441|FG002|Randomization Period|Participant no longer meets study criteria|2|||
126041408|NCT02998528|453448439|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
126041409|NCT02998528|453448440|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
126041410|NCT02998528|453448441|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
126041411|NCT02998528|453448439|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
126041412|NCT02998528|453448440|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
126041413|NCT02998528|453448441|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
126041414|NCT02998528|453448439|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
126041415|NCT02998528|453448440|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
126041416|NCT02998528|453448441|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
126041417|NCT02998528|453448439|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
126041418|NCT02998528|453448440|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
126041419|NCT02998528|453448441|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
126041420|NCT02998528|453448439|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
126041421|NCT02998528|453448440|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
126041422|NCT02998528|453448441|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
126041423|NCT02998528|453448439|FG000|Neoadjuvant Treatment Period|Death|1|||
126041424|NCT02998528|453448440|FG001|Neoadjuvant Treatment Period|Death|0|||
126041425|NCT02998528|453448441|FG002|Neoadjuvant Treatment Period|Death|0|||
126041426|NCT02998528|453448439|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
126041427|NCT02998528|453448440|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
126041428|NCT02998528|453448441|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
126041429|NCT02998528|453448439|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
126099521|NCT00092495|453657599|FG004|Base Study Vaccination Period|*Clinical AE|0|||
126365336|NCT03715829|454631747|FG007|Extension Period|Adverse Event|1|||
126099522|NCT00092495|453657595|FG000|Base Study Vaccination Period|*Other reasons|1|||
126099523|NCT00092495|453657596|FG001|Base Study Vaccination Period|*Other reasons|0|||
126099524|NCT00092495|453657597|FG002|Base Study Vaccination Period|*Other reasons|0|||
126285993|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285994|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126099525|NCT00092495|453657598|FG003|Base Study Vaccination Period|*Other reasons|1|||
126099526|NCT00092495|453657599|FG004|Base Study Vaccination Period|*Other reasons|0|||
126285995|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285996|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285997|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285998|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285999|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126286000|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126099527|NCT00092495|453657595|FG000|Base Study Vaccination Period|*Pregnancy|0|||
126099528|NCT00092495|453657596|FG001|Base Study Vaccination Period|*Pregnancy|2|||
126099529|NCT00092495|453657597|FG002|Base Study Vaccination Period|*Pregnancy|5|||
126099530|NCT00092495|453657598|FG003|Base Study Vaccination Period|*Pregnancy|7|||
126099531|NCT00092495|453657599|FG004|Base Study Vaccination Period|*Pregnancy|0|||
126099532|NCT00092495|453657595|FG000|Base Study Vaccination Period|Adverse Event|1|||
126099533|NCT00092495|453657596|FG001|Base Study Vaccination Period|Adverse Event|0|||
126099534|NCT00092495|453657597|FG002|Base Study Vaccination Period|Adverse Event|0|||
126099535|NCT00092495|453657598|FG003|Base Study Vaccination Period|Adverse Event|3|||
126099536|NCT00092495|453657599|FG004|Base Study Vaccination Period|Adverse Event|0|||
126099537|NCT00092495|453657595|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
126286001|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286002|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
126099538|NCT00092495|453657596|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
126099539|NCT00092495|453657597|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
126099540|NCT00092495|453657598|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
126099541|NCT00092495|453657599|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
126099542|NCT00092495|453657595|FG000|Base Study Vaccination Period|Moved|3|||
126099543|NCT00092495|453657596|FG001|Base Study Vaccination Period|Moved|1|||
126099544|NCT00092495|453657597|FG002|Base Study Vaccination Period|Moved|2|||
126099545|NCT00092495|453657598|FG003|Base Study Vaccination Period|Moved|2|||
126099546|NCT00092495|453657599|FG004|Base Study Vaccination Period|Moved|0|||
126099547|NCT00092495|453657595|FG000|Base Study Vaccination Period|Other|1|||
126099548|NCT00092495|453657596|FG001|Base Study Vaccination Period|Other|1|||
126099549|NCT00092495|453657597|FG002|Base Study Vaccination Period|Other|0|||
126099550|NCT00092495|453657598|FG003|Base Study Vaccination Period|Other|2|||
126099551|NCT00092495|453657599|FG004|Base Study Vaccination Period|Other|0|||
126286003|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
126286004|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286005|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286006|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286007|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286008|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286009|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286010|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
126286011|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
126286012|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286013|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286014|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286015|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286016|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286017|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286018|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286019|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286020|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
126286021|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125882828|NCT01394016|452869065|FG010|Overall Study|Progressive Disease|0|||
125882829|NCT01394016|452869066|FG011|Overall Study|Progressive Disease|0|||
126286022|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286023|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286024|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286025|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125882830|NCT01394016|452869067|FG012|Overall Study|Progressive Disease|0|||
126041430|NCT02998528|453448440|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
126041431|NCT02998528|453448441|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
126041432|NCT02998528|453448439|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
126286026|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286027|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286028|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286029|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
126286030|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286031|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286032|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286033|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286034|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286035|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286036|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286037|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286038|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286039|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
126286040|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286041|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286042|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286043|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286044|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286045|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286046|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286047|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286048|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
126286049|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286050|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286051|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286052|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286053|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286054|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286055|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286056|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286057|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
126286058|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286059|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286060|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126041433|NCT02998528|453448440|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
126286061|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125882831|NCT01394016|452869068|FG013|Overall Study|Progressive Disease|0|||
125882832|NCT01394016|452869069|FG014|Overall Study|Progressive Disease|0|||
125882833|NCT01394016|452869070|FG015|Overall Study|Progressive Disease|0|||
126286062|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286063|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286064|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286065|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286066|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286067|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286068|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286069|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286070|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
126286071|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286072|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286073|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
126286074|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
126286075|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286076|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286077|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286078|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286079|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286080|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286081|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286082|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286083|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286084|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
126286085|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286086|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286087|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286088|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286089|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286090|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286091|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286092|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286093|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286094|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
126286095|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
126286096|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
126286097|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286098|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286099|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286100|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286101|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286102|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286103|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
126286104|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286105|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286106|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286107|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286108|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286109|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286110|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286111|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125882834|NCT01394016|452869071|FG016|Overall Study|Progressive Disease|0|||
125882835|NCT01394016|452869072|FG017|Overall Study|Progressive Disease|0|||
125882836|NCT01394016|452869073|FG018|Overall Study|Progressive Disease|0|||
126099552|NCT00092495|453657595|FG000|Base Study Vaccination Period|Pregnancy|2|||
125882837|NCT01394016|452869055|FG000|Overall Study|Withdrawal by Subject|0|||
125882838|NCT01394016|452869056|FG001|Overall Study|Withdrawal by Subject|0|||
125882839|NCT01394016|452869057|FG002|Overall Study|Withdrawal by Subject|0|||
125882840|NCT01394016|452869058|FG003|Overall Study|Withdrawal by Subject|0|||
126286112|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
126286113|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286114|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286115|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126099553|NCT00092495|453657596|FG001|Base Study Vaccination Period|Pregnancy|0|||
126099554|NCT00092495|453657597|FG002|Base Study Vaccination Period|Pregnancy|0|||
126099555|NCT00092495|453657598|FG003|Base Study Vaccination Period|Pregnancy|0|||
126099556|NCT00092495|453657599|FG004|Base Study Vaccination Period|Pregnancy|0|||
126099557|NCT00092495|453657595|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
126099558|NCT00092495|453657596|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
126099559|NCT00092495|453657597|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
126099560|NCT00092495|453657598|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
126099561|NCT00092495|453657599|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
126099562|NCT00092495|453657595|FG000|Base Study Vaccination Period|Protocol Violation|1|||
126099563|NCT00092495|453657596|FG001|Base Study Vaccination Period|Protocol Violation|0|||
126099564|NCT00092495|453657597|FG002|Base Study Vaccination Period|Protocol Violation|0|||
126099565|NCT00092495|453657598|FG003|Base Study Vaccination Period|Protocol Violation|0|||
126099566|NCT00092495|453657599|FG004|Base Study Vaccination Period|Protocol Violation|0|||
126099567|NCT00092495|453657595|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
126099568|NCT00092495|453657596|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
126099569|NCT00092495|453657597|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
126099570|NCT00092495|453657598|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
126099571|NCT00092495|453657599|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
126099572|NCT00092495|453657595|FG000|Base Study Follow-up Period|Extended|0|||
126099573|NCT00092495|453657596|FG001|Base Study Follow-up Period|Extended|0|||
126099574|NCT00092495|453657597|FG002|Base Study Follow-up Period|Extended|1|||
126099575|NCT00092495|453657598|FG003|Base Study Follow-up Period|Extended|2|||
126099576|NCT00092495|453657599|FG004|Base Study Follow-up Period|Extended|0|||
126099577|NCT00092495|453657595|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
126099578|NCT00092495|453657596|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
126099579|NCT00092495|453657597|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
126099580|NCT00092495|453657598|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
126099581|NCT00092495|453657599|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
126099582|NCT00092495|453657595|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
126099583|NCT00092495|453657596|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
126099584|NCT00092495|453657597|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
126099585|NCT00092495|453657598|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
126099586|NCT00092495|453657599|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
126099587|NCT01888900|453657608|FG000|Overall Study|failed treatment|0|||
126099588|NCT01888900|453657609|FG001|Overall Study|failed treatment|2|||
126099589|NCT03932812|453657610|FG000|Overall Study|Lost to Follow-up|12|||
126099590|NCT03932812|453657611|FG001|Overall Study|Lost to Follow-up|14|||
126099591|NCT03932812|453657610|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
126099592|NCT03932812|453657611|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
126099593|NCT02585232|453657612|FG000|Overall Study|Lost to Follow-up|8|||
126099594|NCT02585232|453657613|FG001|Overall Study|Lost to Follow-up|8|||
126099595|NCT02585232|453657612|FG000|Overall Study|Withdrawal by Subject|4|||
126099596|NCT02585232|453657613|FG001|Overall Study|Withdrawal by Subject|8|||
126099597|NCT02313233|453657614|FG000|Overall Study|Withdrawal by Subject|1|||
126099598|NCT02313233|453657615|FG001|Overall Study|Withdrawal by Subject|2|||
125882841|NCT01394016|452869059|FG004|Overall Study|Withdrawal by Subject|0|||
126099599|NCT02313233|453657614|FG000|Overall Study|Administrative reason|1|||
126099600|NCT02313233|453657615|FG001|Overall Study|Administrative reason|1|||
126099601|NCT02679573|453657627|FG000|Overall Study|Adverse Event|13|||
126099602|NCT02679573|453657628|FG001|Overall Study|Adverse Event|6|||
126099603|NCT02679573|453657627|FG000|Overall Study|Lack of Efficacy|12|||
126099604|NCT02679573|453657628|FG001|Overall Study|Lack of Efficacy|15|||
126286116|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286117|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286118|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286119|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286120|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286121|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
126286122|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
126286123|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286124|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286125|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286126|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286127|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286128|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126099605|NCT02679573|453657627|FG000|Overall Study|Could not complete required study visits|6|||
126099606|NCT02679573|453657628|FG001|Overall Study|Could not complete required study visits|2|||
126099607|NCT02679573|453657627|FG000|Overall Study|Withdrawal by Subject|2|||
126099608|NCT02679573|453657628|FG001|Overall Study|Withdrawal by Subject|9|||
126099609|NCT02679573|453657627|FG000|Overall Study|Death|2|||
126099610|NCT02679573|453657628|FG001|Overall Study|Death|0|||
126099611|NCT02679573|453657627|FG000|Overall Study|Physician Decision|2|||
126099612|NCT02679573|453657628|FG001|Overall Study|Physician Decision|4|||
126099613|NCT02679573|453657627|FG000|Overall Study|Lost to Follow-up|0|||
126099614|NCT02679573|453657628|FG001|Overall Study|Lost to Follow-up|3|||
126099615|NCT00682890|453657629|FG000|Overall Study|Lost to Follow-up|1|||
126099616|NCT00682890|453657630|FG001|Overall Study|Lost to Follow-up|1|||
126099617|NCT00682890|453657629|FG000|Overall Study|subject moved away|0|||
126099618|NCT00682890|453657630|FG001|Overall Study|subject moved away|1|||
126099619|NCT00682890|453657629|FG000|Overall Study|heavy menstrual bleeding|1|||
126099620|NCT00682890|453657630|FG001|Overall Study|heavy menstrual bleeding|0|||
126099621|NCT03545503|453657631|FG000|Overall Study|Protocol Violation|14|||
126099622|NCT03545503|453657632|FG001|Overall Study|Protocol Violation|16|||
126099623|NCT02884908|453657635|FG000|Overall Study|Lost to Follow-up|13|||
126099624|NCT02884908|453657636|FG001|Overall Study|Lost to Follow-up|18|||
126099625|NCT01605019|453657639|FG000|Overall Study|pt did not meet transplant endpoint|3|||
126099626|NCT01605019|453657640|FG001|Overall Study|pt did not meet transplant endpoint|0|||
126099627|NCT00862719|453657641|FG000|Overall Study|Disease Progression|5|||
126099628|NCT00862719|453657642|FG001|Overall Study|Disease Progression|0|||
126099629|NCT00862719|453657643|FG002|Overall Study|Disease Progression|1|||
126099630|NCT00862719|453657644|FG003|Overall Study|Disease Progression|0|||
126099631|NCT00862719|453657641|FG000|Overall Study|Death|5|||
126099632|NCT00862719|453657642|FG001|Overall Study|Death|6|||
126099633|NCT00862719|453657643|FG002|Overall Study|Death|1|||
126099634|NCT00862719|453657644|FG003|Overall Study|Death|1|||
126099635|NCT00862719|453657641|FG000|Overall Study|Engraftment failure|0|||
126099636|NCT00862719|453657642|FG001|Overall Study|Engraftment failure|0|||
126099637|NCT00862719|453657643|FG002|Overall Study|Engraftment failure|1|||
126099638|NCT00862719|453657644|FG003|Overall Study|Engraftment failure|0|||
126099639|NCT00862719|453657641|FG000|Overall Study|Veno-Occlusive Disease|0|||
126099640|NCT00862719|453657642|FG001|Overall Study|Veno-Occlusive Disease|0|||
126099641|NCT00862719|453657643|FG002|Overall Study|Veno-Occlusive Disease|1|||
126099642|NCT00862719|453657644|FG003|Overall Study|Veno-Occlusive Disease|0|||
126099643|NCT00324116|453657645|FG000|Overall Study|Adverse Event|5|||
126099644|NCT00324116|453657645|FG000|Overall Study|Lack of Efficacy|17|||
126099645|NCT00324116|453657645|FG000|Overall Study|Withdrawal by Subject|5|||
126099646|NCT00324116|453657645|FG000|Overall Study|Other|5|||
126099647|NCT01806623|453657646|FG000|Overall Study|Withdrawal by Subject|1|||
126099648|NCT01806623|453657646|FG000|Overall Study|Adverse Event|1|||
126099649|NCT01806623|453657646|FG000|Overall Study|Did not meet the inclusion criteria|56|||
126099650|NCT01737827|453657647|FG000|Overall Study|Adverse Event|3|||
126099651|NCT01737827|453657648|FG001|Overall Study|Adverse Event|6|||
126099652|NCT01737827|453657649|FG002|Overall Study|Adverse Event|0|||
126041434|NCT02998528|453448441|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
126041435|NCT02998528|453448439|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
126041436|NCT02998528|453448440|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
126041437|NCT02998528|453448441|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
126041438|NCT02998528|453448439|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
126041439|NCT02998528|453448440|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
126041440|NCT02998528|453448441|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
126041441|NCT02998528|453448439|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
126099653|NCT01737827|453657647|FG000|Overall Study|Lost to Follow-up|0|||
126099654|NCT01737827|453657648|FG001|Overall Study|Lost to Follow-up|1|||
126099655|NCT01737827|453657649|FG002|Overall Study|Lost to Follow-up|0|||
126099656|NCT01737827|453657647|FG000|Overall Study|Physician Decision|0|||
126099657|NCT01737827|453657648|FG001|Overall Study|Physician Decision|2|||
126099658|NCT01737827|453657649|FG002|Overall Study|Physician Decision|0|||
126099659|NCT01737827|453657647|FG000|Overall Study|Progressive Disease|5|||
126099660|NCT01737827|453657648|FG001|Overall Study|Progressive Disease|16|||
126099661|NCT01737827|453657649|FG002|Overall Study|Progressive Disease|2|||
126099662|NCT01737827|453657647|FG000|Overall Study|Study Terminated by Sponsor|0|||
126099663|NCT01737827|453657648|FG001|Overall Study|Study Terminated by Sponsor|1|||
126099664|NCT01737827|453657649|FG002|Overall Study|Study Terminated by Sponsor|0|||
126099665|NCT01737827|453657647|FG000|Overall Study|Subject/Guardian Decision|0|||
126099666|NCT01737827|453657648|FG001|Overall Study|Subject/Guardian Decision|2|||
126099667|NCT01737827|453657649|FG002|Overall Study|Subject/Guardian Decision|0|||
126099668|NCT01451827|453657650|FG000|Overall Study|Adverse Event|2|||
126099669|NCT01451827|453657651|FG001|Overall Study|Adverse Event|0|||
126099670|NCT01451827|453657652|FG002|Overall Study|Adverse Event|1|||
126099671|NCT01451827|453657653|FG003|Overall Study|Adverse Event|1|||
126099672|NCT01451827|453657650|FG000|Overall Study|Protocol deviation|1|||
126099673|NCT01451827|453657651|FG001|Overall Study|Protocol deviation|0|||
126099674|NCT01451827|453657652|FG002|Overall Study|Protocol deviation|0|||
126099675|NCT01451827|453657653|FG003|Overall Study|Protocol deviation|0|||
126099676|NCT01451827|453657650|FG000|Overall Study|Lost to Follow-up|0|||
126099677|NCT01451827|453657651|FG001|Overall Study|Lost to Follow-up|3|||
126099678|NCT01451827|453657652|FG002|Overall Study|Lost to Follow-up|0|||
126099679|NCT01451827|453657653|FG003|Overall Study|Lost to Follow-up|2|||
126099680|NCT01451827|453657650|FG000|Overall Study|Participant met withdrawal criteria|0|||
126099681|NCT01451827|453657651|FG001|Overall Study|Participant met withdrawal criteria|2|||
126099682|NCT01451827|453657652|FG002|Overall Study|Participant met withdrawal criteria|0|||
126099683|NCT01451827|453657653|FG003|Overall Study|Participant met withdrawal criteria|0|||
126099684|NCT01451827|453657650|FG000|Overall Study|Withdrawal by Subject|0|||
126099685|NCT01451827|453657651|FG001|Overall Study|Withdrawal by Subject|0|||
126099686|NCT01451827|453657652|FG002|Overall Study|Withdrawal by Subject|1|||
126099687|NCT01451827|453657653|FG003|Overall Study|Withdrawal by Subject|1|||
126099688|NCT01034163|453657656|FG000|Overall Study|Treatment completed as per protocol|8|||
126099689|NCT01034163|453657657|FG001|Overall Study|Treatment completed as per protocol|7|||
126099690|NCT01034163|453657656|FG000|Overall Study|Withdrawal by Subject|8|||
126099691|NCT01034163|453657657|FG001|Overall Study|Withdrawal by Subject|2|||
126099692|NCT01034163|453657656|FG000|Overall Study|Protocol deviation|1|||
126099693|NCT01034163|453657657|FG001|Overall Study|Protocol deviation|0|||
126099694|NCT01034163|453657656|FG000|Overall Study|Disease progression|3|||
126099695|NCT01034163|453657657|FG001|Overall Study|Disease progression|4|||
126099696|NCT01034163|453657656|FG000|Overall Study|Adverse Event|6|||
126099697|NCT01034163|453657657|FG001|Overall Study|Adverse Event|0|||
126286129|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286130|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
126286131|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286132|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286133|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286134|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286135|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286136|NCT05292183|454334942|FG000|Overall Study|Adverse Event|1|||
126099698|NCT01034163|453657656|FG000|Overall Study|Administrative problems|0|||
126099699|NCT01034163|453657657|FG001|Overall Study|Administrative problems|1|||
126099700|NCT01034163|453657656|FG000|Overall Study|Abnormal laboratory value|1|||
126099701|NCT01034163|453657657|FG001|Overall Study|Abnormal laboratory value|0|||
126099702|NCT02424734|453657658|FG000|Overall Study|Treatment stopped to be discharged home|2|||
126099703|NCT02424734|453657659|FG001|Overall Study|Treatment stopped to be discharged home|2|||
126099704|NCT02424734|453657660|FG002|Overall Study|Treatment stopped to be discharged home|0|||
126099705|NCT00528645|453657661|FG000|Overall Study|Adverse Event|3|||
126099706|NCT00116753|453657662|FG000|Overall Study|Adverse Event|16|||
126099707|NCT00116753|453657663|FG001|Overall Study|Adverse Event|10|||
126099708|NCT00116753|453657664|FG002|Overall Study|Adverse Event|7|||
126365337|NCT03715829|454631748|FG008|Extension Period|Adverse Event|6|||
126286137|NCT02506153|454334945|FG000|Overall Study|Adverse Event|359|||
126286138|NCT02506153|454334946|FG001|Overall Study|Adverse Event|114|||
126286139|NCT02506153|454334945|FG000|Overall Study|Refused unrelated to adverse event|127|||
126286140|NCT02506153|454334946|FG001|Overall Study|Refused unrelated to adverse event|18|||
126286141|NCT02506153|454334945|FG000|Overall Study|Progression/relapse|91|||
126286142|NCT02506153|454334946|FG001|Overall Study|Progression/relapse|136|||
126286143|NCT02506153|454334945|FG000|Overall Study|Death|2|||
126286144|NCT02506153|454334946|FG001|Overall Study|Death|1|||
126286145|NCT02506153|454334945|FG000|Overall Study|Other - not protocol specified|23|||
126286146|NCT02506153|454334946|FG001|Overall Study|Other - not protocol specified|12|||
126286147|NCT06400238|454334951|FG000|Overall Study|Started Protocol Therapy|2|||
126286148|NCT06400238|454334951|FG000|Overall Study|Adverse Event|1|||
126286149|NCT06400238|454334951|FG000|Overall Study|Death|1|||
126286150|NCT06400238|454334951|FG000|Overall Study|Disease Progression|27|||
126286151|NCT06400238|454334951|FG000|Overall Study|Withdrawal by Subject|2|||
126286152|NCT06400238|454334951|FG000|Overall Study|Physician Decision|2|||
126286153|NCT04034927|454334952|FG000|Overall Study|Adverse Event|4|||
126286154|NCT04034927|454334953|FG001|Overall Study|Adverse Event|9|||
126286155|NCT04034927|454334952|FG000|Overall Study|Death|0|||
126286156|NCT04034927|454334953|FG001|Overall Study|Death|1|||
126286157|NCT04034927|454334952|FG000|Overall Study|Withdrawal by Subject|0|||
126286158|NCT04034927|454334953|FG001|Overall Study|Withdrawal by Subject|3|||
126286159|NCT04034927|454334952|FG000|Overall Study|Still on Treatment|2|||
126099709|NCT00116753|453657662|FG000|Overall Study|Withdrawal by Subject|11|||
126286160|NCT04034927|454334953|FG001|Overall Study|Still on Treatment|1|||
126286161|NCT04034927|454334952|FG000|Overall Study|Other|1|||
126286162|NCT04034927|454334953|FG001|Overall Study|Other|1|||
126286163|NCT03996447|454334956|FG000|First MRI Examination|Adverse Event|2|||
126286164|NCT03996447|454334957|FG001|First MRI Examination|Adverse Event|0|||
126286165|NCT03996447|454334956|FG000|First MRI Examination|Withdrawal by Subject|1|||
126286166|NCT03996447|454334957|FG001|First MRI Examination|Withdrawal by Subject|2|||
126286167|NCT03996447|454334956|FG000|First MRI Examination|Protocol Violation|0|||
126286168|NCT03996447|454334957|FG001|First MRI Examination|Protocol Violation|1|||
126365338|NCT03715829|454631749|FG009|Extension Period|Adverse Event|0|||
126365339|NCT03715829|454631750|FG010|Extension Period|Adverse Event|0|||
126365340|NCT03715829|454631740|FG000|Extension Period|Lack of Efficacy|0|||
126365341|NCT03715829|454631741|FG001|Extension Period|Lack of Efficacy|0|||
126365342|NCT03715829|454631742|FG002|Extension Period|Lack of Efficacy|0|||
126365343|NCT03715829|454631743|FG003|Extension Period|Lack of Efficacy|0|||
126041442|NCT02998528|453448440|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
126041443|NCT02998528|453448441|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
126041444|NCT02988661|453448444|FG000|Overall Study|Death|2|||
126041445|NCT02988661|453448445|FG001|Overall Study|Death|18|||
126041446|NCT02988661|453448444|FG000|Overall Study|Lost to Follow-up|0|||
126041447|NCT02988661|453448445|FG001|Overall Study|Lost to Follow-up|33|||
126041448|NCT02988661|453448444|FG000|Overall Study|Withdrawal by Subject|0|||
126041449|NCT02988661|453448445|FG001|Overall Study|Withdrawal by Subject|6|||
126041450|NCT02988661|453448444|FG000|Overall Study|Unable to complete the 18-month survey|1|||
126041451|NCT02988661|453448445|FG001|Overall Study|Unable to complete the 18-month survey|27|||
126041452|NCT03213678|453448451|FG000|Overall Study|Death|1|||
126041453|NCT03213678|453448451|FG000|Overall Study|Physician Decision|1|||
126041454|NCT03213678|453448451|FG000|Overall Study|Progressive disease|16|||
126041455|NCT04218851|453448452|FG000|Overall Study|Death|1|||
126041456|NCT04218851|453448453|FG001|Overall Study|Death|3|||
126041457|NCT02413489|453448468|FG000|Overall Study|Death|11|||
126041458|NCT02413489|453448469|FG001|Overall Study|Death|3|||
126041459|NCT02413489|453448470|FG002|Overall Study|Death|4|||
126041460|NCT02413489|453448468|FG000|Overall Study|Withdrawal by Subject|2|||
126041461|NCT02413489|453448469|FG001|Overall Study|Withdrawal by Subject|0|||
126041462|NCT02413489|453448470|FG002|Overall Study|Withdrawal by Subject|0|||
126041463|NCT02413489|453448468|FG000|Overall Study|Study Terminated By Sponsor|2|||
126041464|NCT02413489|453448469|FG001|Overall Study|Study Terminated By Sponsor|13|||
126041465|NCT02413489|453448470|FG002|Overall Study|Study Terminated By Sponsor|1|||
126041466|NCT04247802|453448471|FG000|Overall Study|Withdrawal by Subject|1|||
126041467|NCT04247802|453448472|FG001|Overall Study|Withdrawal by Subject|3|||
126286169|NCT03996447|454334956|FG000|Washout|Adverse Event|2|||
126286170|NCT03996447|454334957|FG001|Washout|Adverse Event|0|||
126286171|NCT03996447|454334956|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
126286172|NCT03996447|454334957|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
126286173|NCT03996447|454334956|FG000|Washout|Withdrawal by Subject|0|||
126286174|NCT03996447|454334957|FG001|Washout|Withdrawal by Subject|1|||
126365344|NCT03715829|454631744|FG004|Extension Period|Lack of Efficacy|0|||
126041468|NCT04247802|453448471|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
126041469|NCT04247802|453448472|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
126041470|NCT02575950|453448473|FG000|Overall Study|Withdrawal by Subject|0|||
126041471|NCT02575950|453448474|FG001|Overall Study|Withdrawal by Subject|0|||
126099710|NCT00116753|453657663|FG001|Overall Study|Withdrawal by Subject|12|||
126099711|NCT00116753|453657664|FG002|Overall Study|Withdrawal by Subject|8|||
126099712|NCT00116753|453657662|FG000|Overall Study|Lost to Follow-up|0|||
126099713|NCT00116753|453657663|FG001|Overall Study|Lost to Follow-up|2|||
126099714|NCT00116753|453657664|FG002|Overall Study|Lost to Follow-up|1|||
126099715|NCT00116753|453657662|FG000|Overall Study|Protocol Violation|0|||
126099716|NCT00116753|453657663|FG001|Overall Study|Protocol Violation|0|||
126099717|NCT00116753|453657664|FG002|Overall Study|Protocol Violation|1|||
126099718|NCT00116753|453657662|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
126099719|NCT00116753|453657663|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
126099720|NCT00116753|453657664|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
126099721|NCT00116753|453657662|FG000|Overall Study|Disease Progression|3|||
126099722|NCT00116753|453657663|FG001|Overall Study|Disease Progression|4|||
126099723|NCT00116753|453657664|FG002|Overall Study|Disease Progression|3|||
126099724|NCT00116753|453657662|FG000|Overall Study|Abnormal Echocardiogram|0|||
126099725|NCT00116753|453657663|FG001|Overall Study|Abnormal Echocardiogram|0|||
126099726|NCT00116753|453657664|FG002|Overall Study|Abnormal Echocardiogram|1|||
126099727|NCT00116753|453657662|FG000|Overall Study|Progressive Parkinson's Disease|1|||
126099728|NCT00116753|453657663|FG001|Overall Study|Progressive Parkinson's Disease|0|||
126099729|NCT00116753|453657664|FG002|Overall Study|Progressive Parkinson's Disease|0|||
126099730|NCT00116753|453657662|FG000|Overall Study|Dosing Error|0|||
126099731|NCT00116753|453657663|FG001|Overall Study|Dosing Error|1|||
126099732|NCT00116753|453657664|FG002|Overall Study|Dosing Error|0|||
126099733|NCT01642251|453657665|FG000|Overall Study|Progressive disease|0|||
126099734|NCT01642251|453657666|FG001|Overall Study|Progressive disease|0|||
126286175|NCT03996447|454334956|FG000|Washout|Other reason|1|||
126286176|NCT03996447|454334957|FG001|Washout|Other reason|1|||
126286177|NCT03355469|454334958|FG000|Overall Study|COVID-19|3|||
126286178|NCT03355469|454334959|FG001|Overall Study|COVID-19|2|||
126286179|NCT03355469|454334960|FG002|Overall Study|COVID-19|3|||
126286180|NCT03355469|454334961|FG003|Overall Study|COVID-19|3|||
126286181|NCT03355469|454334958|FG000|Overall Study|Lost to Follow-up|1|||
126286182|NCT03355469|454334959|FG001|Overall Study|Lost to Follow-up|0|||
126286183|NCT03355469|454334960|FG002|Overall Study|Lost to Follow-up|1|||
126286184|NCT03355469|454334961|FG003|Overall Study|Lost to Follow-up|0|||
126286185|NCT03355469|454334958|FG000|Overall Study|Withdrawal by Subject|2|||
126286186|NCT03355469|454334959|FG001|Overall Study|Withdrawal by Subject|1|||
126286187|NCT03355469|454334960|FG002|Overall Study|Withdrawal by Subject|0|||
126286188|NCT03355469|454334961|FG003|Overall Study|Withdrawal by Subject|3|||
126099735|NCT01642251|453657667|FG002|Overall Study|Progressive disease|3|||
126099736|NCT01642251|453657668|FG003|Overall Study|Progressive disease|3|||
126099737|NCT01642251|453657665|FG000|Overall Study|Adverse Event|0|||
126099738|NCT01642251|453657666|FG001|Overall Study|Adverse Event|0|||
126099739|NCT01642251|453657667|FG002|Overall Study|Adverse Event|5|||
126099740|NCT01642251|453657668|FG003|Overall Study|Adverse Event|4|||
126099741|NCT01642251|453657665|FG000|Overall Study|Death|0|||
126099742|NCT01642251|453657666|FG001|Overall Study|Death|0|||
126099743|NCT01642251|453657667|FG002|Overall Study|Death|1|||
126099744|NCT01642251|453657668|FG003|Overall Study|Death|3|||
126099745|NCT01642251|453657665|FG000|Overall Study|Withdrawal by Subject|0|||
126099746|NCT01642251|453657666|FG001|Overall Study|Withdrawal by Subject|0|||
126099747|NCT01642251|453657667|FG002|Overall Study|Withdrawal by Subject|1|||
126099748|NCT01642251|453657668|FG003|Overall Study|Withdrawal by Subject|3|||
126099749|NCT01642251|453657665|FG000|Overall Study|Alternative therapy|0|||
126099750|NCT01642251|453657666|FG001|Overall Study|Alternative therapy|0|||
126099751|NCT01642251|453657667|FG002|Overall Study|Alternative therapy|0|||
126099752|NCT01642251|453657668|FG003|Overall Study|Alternative therapy|2|||
126099753|NCT01642251|453657665|FG000|Overall Study|Other complicating disease|0|||
126286189|NCT01708941|454334962|FG000|Overall Study|Adverse Event|4|||
126286190|NCT01708941|454334963|FG001|Overall Study|Adverse Event|6|||
126286191|NCT01708941|454334964|FG002|Overall Study|Adverse Event|1|||
126286192|NCT01708941|454334965|FG003|Overall Study|Adverse Event|0|||
126286193|NCT01708941|454334962|FG000|Overall Study|Death|1|||
126099754|NCT01642251|453657666|FG001|Overall Study|Other complicating disease|0|||
126099755|NCT01642251|453657667|FG002|Overall Study|Other complicating disease|1|||
126099756|NCT01642251|453657668|FG003|Overall Study|Other complicating disease|0|||
126286194|NCT01708941|454334963|FG001|Overall Study|Death|1|||
126286195|NCT01708941|454334964|FG002|Overall Study|Death|2|||
126286196|NCT01708941|454334965|FG003|Overall Study|Death|14|||
126099757|NCT01642251|453657665|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
126099758|NCT01642251|453657666|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
126099759|NCT01642251|453657667|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
126286197|NCT01708941|454334962|FG000|Overall Study|Withdrawal by Subject|1|||
126286198|NCT01708941|454334963|FG001|Overall Study|Withdrawal by Subject|0|||
126099760|NCT01642251|453657668|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
126099761|NCT01445301|453657669|FG000|Overall Study|Adverse Event|15|||
126099762|NCT01445301|453657670|FG001|Overall Study|Adverse Event|25|||
126099763|NCT01445301|453657671|FG002|Overall Study|Adverse Event|4|||
126099764|NCT01445301|453657669|FG000|Overall Study|Lack of Efficacy|0|||
126099765|NCT01445301|453657670|FG001|Overall Study|Lack of Efficacy|1|||
126099766|NCT01445301|453657671|FG002|Overall Study|Lack of Efficacy|0|||
126099767|NCT01445301|453657669|FG000|Overall Study|Protocol Violation|1|||
126099768|NCT01445301|453657670|FG001|Overall Study|Protocol Violation|0|||
126099769|NCT01445301|453657671|FG002|Overall Study|Protocol Violation|0|||
126099770|NCT01445301|453657669|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
126099771|NCT01445301|453657670|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
126099772|NCT01445301|453657671|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
126099773|NCT01445301|453657669|FG000|Overall Study|Physician Decision|0|||
126099774|NCT01445301|453657670|FG001|Overall Study|Physician Decision|2|||
126099775|NCT01445301|453657671|FG002|Overall Study|Physician Decision|0|||
126099776|NCT01445301|453657669|FG000|Overall Study|Withdrawal by Subject|5|||
126099777|NCT01445301|453657670|FG001|Overall Study|Withdrawal by Subject|6|||
126041472|NCT02575950|453448475|FG002|Overall Study|Withdrawal by Subject|0|||
126041473|NCT02575950|453448476|FG003|Overall Study|Withdrawal by Subject|2|||
126041474|NCT02575950|453448473|FG000|Overall Study|Lost to Follow-up|0|||
126041475|NCT02575950|453448474|FG001|Overall Study|Lost to Follow-up|1|||
126041476|NCT02575950|453448475|FG002|Overall Study|Lost to Follow-up|0|||
126041477|NCT02575950|453448476|FG003|Overall Study|Lost to Follow-up|3|||
126041478|NCT05645757|453451003|FG000|Overall Study|Enrolled but treatment not administered|0|||
126041479|NCT05645757|453451004|FG001|Overall Study|Enrolled but treatment not administered|0|||
126041480|NCT05645757|453451005|FG002|Overall Study|Enrolled but treatment not administered|0|||
126041481|NCT05645757|453451006|FG003|Overall Study|Enrolled but treatment not administered|0|||
126099778|NCT01445301|453657671|FG002|Overall Study|Withdrawal by Subject|4|||
126099779|NCT00752557|453657672|FG000|Overall Study|Withdrawal by Subject|4|||
126099780|NCT00752557|453657673|FG001|Overall Study|Withdrawal by Subject|3|||
126099781|NCT00752557|453657674|FG002|Overall Study|Withdrawal by Subject|3|||
126099782|NCT00752557|453657672|FG000|Overall Study|Unspecified resaons|0|||
126099783|NCT00752557|453657673|FG001|Overall Study|Unspecified resaons|2|||
126099784|NCT00752557|453657674|FG002|Overall Study|Unspecified resaons|2|||
126099785|NCT00752557|453657672|FG000|Overall Study|Lost to Follow-up|1|||
126099786|NCT00752557|453657673|FG001|Overall Study|Lost to Follow-up|0|||
126099787|NCT00752557|453657674|FG002|Overall Study|Lost to Follow-up|1|||
126286199|NCT01708941|454334964|FG002|Overall Study|Withdrawal by Subject|3|||
126286200|NCT01708941|454334965|FG003|Overall Study|Withdrawal by Subject|4|||
126286201|NCT01708941|454334962|FG000|Overall Study|Disease progression|9|||
126286202|NCT01708941|454334963|FG001|Overall Study|Disease progression|10|||
126286203|NCT01708941|454334964|FG002|Overall Study|Disease progression|8|||
126286204|NCT01708941|454334965|FG003|Overall Study|Disease progression|0|||
126286205|NCT01708941|454334962|FG000|Overall Study|Alternative therapy|0|||
126286206|NCT01708941|454334963|FG001|Overall Study|Alternative therapy|0|||
126286207|NCT01708941|454334964|FG002|Overall Study|Alternative therapy|2|||
126286208|NCT01708941|454334965|FG003|Overall Study|Alternative therapy|0|||
126286209|NCT01708941|454334962|FG000|Overall Study|Ineligible and never started treatment|1|||
126286210|NCT01708941|454334963|FG001|Overall Study|Ineligible and never started treatment|0|||
126286211|NCT01708941|454334964|FG002|Overall Study|Ineligible and never started treatment|1|||
126286212|NCT01708941|454334965|FG003|Overall Study|Ineligible and never started treatment|0|||
126286213|NCT01708941|454334962|FG000|Overall Study|Never started treatment|2|||
126286214|NCT01708941|454334963|FG001|Overall Study|Never started treatment|1|||
126365345|NCT03715829|454631745|FG005|Extension Period|Lack of Efficacy|0|||
126365346|NCT03715829|454631746|FG006|Extension Period|Lack of Efficacy|1|||
126365347|NCT03715829|454631747|FG007|Extension Period|Lack of Efficacy|9|||
126365348|NCT03715829|454631748|FG008|Extension Period|Lack of Efficacy|2|||
126365349|NCT03715829|454631749|FG009|Extension Period|Lack of Efficacy|0|||
126365350|NCT03715829|454631750|FG010|Extension Period|Lack of Efficacy|0|||
126365351|NCT03715829|454631740|FG000|Extension Period|Lost to Follow-up|0|||
126365352|NCT03715829|454631741|FG001|Extension Period|Lost to Follow-up|0|||
126365353|NCT03715829|454631742|FG002|Extension Period|Lost to Follow-up|0|||
126041482|NCT05645757|453451007|FG004|Overall Study|Enrolled but treatment not administered|1|||
126365354|NCT03715829|454631743|FG003|Extension Period|Lost to Follow-up|0|||
126041483|NCT05645757|453451008|FG005|Overall Study|Enrolled but treatment not administered|1|||
126041484|NCT05645757|453451009|FG006|Overall Study|Enrolled but treatment not administered|0|||
126099788|NCT02413333|453657679|FG000|Period 1|Adverse Event|1|||
126099789|NCT02413333|453657680|FG001|Period 1|Adverse Event|0|||
126099790|NCT02413333|453657679|FG000|Period 1|Reason Not Specified|0|||
126099791|NCT02413333|453657680|FG001|Period 1|Reason Not Specified|1|||
126099792|NCT02413333|453657679|FG000|Period 2|Protocol Deviation|1|||
126099793|NCT02413333|453657680|FG001|Period 2|Protocol Deviation|0|||
126099794|NCT00470366|453657681|FG000|Overall Study|Adverse Event|3|||
126286215|NCT01708941|454334964|FG002|Overall Study|Never started treatment|0|||
126286216|NCT01708941|454334965|FG003|Overall Study|Never started treatment|0|||
126099795|NCT00470366|453657681|FG000|Overall Study|Poor compliance|1|||
126099796|NCT02996474|453657682|FG000|Overall Study|Physician Decision|5|||
126099797|NCT04493502|453657683|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
126099798|NCT04493502|453657684|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
126099799|NCT04493502|453657683|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
126099800|NCT04493502|453657684|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
126286217|NCT01708941|454334962|FG000|Overall Study|Ineligible|0|||
126286218|NCT01708941|454334963|FG001|Overall Study|Ineligible|0|||
125882842|NCT01394016|452869060|FG005|Overall Study|Withdrawal by Subject|0|||
125882843|NCT01394016|452869061|FG006|Overall Study|Withdrawal by Subject|0|||
126286219|NCT01708941|454334964|FG002|Overall Study|Ineligible|2|||
126286220|NCT01708941|454334965|FG003|Overall Study|Ineligible|0|||
126286221|NCT01575548|454334966|FG000|Overall Study|Adverse Event|15|||
126286222|NCT01575548|454334967|FG001|Overall Study|Adverse Event|2|||
126286223|NCT01575548|454334966|FG000|Overall Study|Disease progression|12|||
126286224|NCT01575548|454334967|FG001|Overall Study|Disease progression|25|||
126286225|NCT01575548|454334966|FG000|Overall Study|Death|1|||
126286226|NCT01575548|454334967|FG001|Overall Study|Death|0|||
126286227|NCT01575548|454334966|FG000|Overall Study|Other complicating disease|1|||
126286228|NCT01575548|454334967|FG001|Overall Study|Other complicating disease|0|||
126286229|NCT01575548|454334966|FG000|Overall Study|Withdrawal by Subject|7|||
126286230|NCT01575548|454334967|FG001|Overall Study|Withdrawal by Subject|3|||
126286231|NCT01575548|454334966|FG000|Overall Study|Noncompliance|1|||
126286232|NCT01575548|454334967|FG001|Overall Study|Noncompliance|0|||
126286233|NCT01575548|454334966|FG000|Overall Study|Anticipated surgery|0|||
126286234|NCT01575548|454334967|FG001|Overall Study|Anticipated surgery|1|||
126286235|NCT01575548|454334966|FG000|Overall Study|Never started protocol therapy|3|||
126286236|NCT01575548|454334967|FG001|Overall Study|Never started protocol therapy|2|||
126286237|NCT04175912|454334968|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
126286238|NCT04175912|454334969|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
126286239|NCT04175912|454334968|FG000|Overall Study|Adverse Event|0|||
126286240|NCT04175912|454334969|FG001|Overall Study|Adverse Event|3|||
125882844|NCT01394016|452869062|FG007|Overall Study|Withdrawal by Subject|1|||
126099801|NCT04493502|453657683|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
126099802|NCT04493502|453657684|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
126286241|NCT04175912|454334968|FG000|Overall Study|Never started treatment|3|||
126286242|NCT04175912|454334969|FG001|Overall Study|Never started treatment|3|||
126286243|NCT04175912|454334968|FG000|Overall Study|Death|0|||
126286244|NCT04175912|454334969|FG001|Overall Study|Death|1|||
126286245|NCT02048813|454334973|FG000|Overall Study|Still on treatment|279|||
126286246|NCT02048813|454334974|FG001|Overall Study|Still on treatment|0|||
126286247|NCT02048813|454334973|FG000|Overall Study|Adverse Event|40|||
125882845|NCT01394016|452869063|FG008|Overall Study|Withdrawal by Subject|1|||
126041485|NCT05645757|453451010|FG007|Overall Study|Enrolled but treatment not administered|0|||
126041486|NCT03924635|453451011|FG000|Overall Study|Withdrawal by Subject|2|||
126041487|NCT03924635|453451012|FG001|Overall Study|Withdrawal by Subject|4|||
126041488|NCT00539591|453451013|FG000|Overall Study|Toxicity|3|||
126041489|NCT00539591|453451014|FG001|Overall Study|Toxicity|0|||
126041490|NCT00539591|453451015|FG002|Overall Study|Toxicity|0|||
126041491|NCT00539591|453451013|FG000|Overall Study|Disease progression|2|||
126041492|NCT00539591|453451014|FG001|Overall Study|Disease progression|2|||
126041493|NCT00539591|453451015|FG002|Overall Study|Disease progression|3|||
126099803|NCT04493502|453657683|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
126099804|NCT04493502|453657684|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
126099805|NCT04493502|453657683|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
126099806|NCT04493502|453657684|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
126099807|NCT04493502|453657683|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
126099808|NCT04493502|453657684|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
126099809|NCT04493502|453657683|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
126099810|NCT04493502|453657684|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
126099811|NCT04493502|453657683|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
126099812|NCT04493502|453657684|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
126099813|NCT04493502|453657683|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
126099814|NCT04493502|453657684|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
126099815|NCT04493502|453657683|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
126099816|NCT04493502|453657684|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
126286248|NCT02048813|454334974|FG001|Overall Study|Adverse Event|38|||
126286249|NCT02048813|454334973|FG000|Overall Study|Disease progression|13|||
126286250|NCT02048813|454334974|FG001|Overall Study|Disease progression|3|||
126286251|NCT02048813|454334973|FG000|Overall Study|Withdrawal by Subject|7|||
126286252|NCT02048813|454334974|FG001|Overall Study|Withdrawal by Subject|8|||
126286253|NCT02048813|454334973|FG000|Overall Study|Death|2|||
126286254|NCT02048813|454334974|FG001|Overall Study|Death|1|||
126286255|NCT02048813|454334973|FG000|Overall Study|Complication|2|||
126286256|NCT02048813|454334974|FG001|Overall Study|Complication|2|||
126286257|NCT02048813|454334973|FG000|Overall Study|Non-protocol therapy|0|||
126286258|NCT02048813|454334974|FG001|Overall Study|Non-protocol therapy|1|||
126286259|NCT02048813|454334973|FG000|Overall Study|Second primary cancer|2|||
126286260|NCT02048813|454334974|FG001|Overall Study|Second primary cancer|0|||
126286261|NCT02048813|454334973|FG000|Overall Study|Insurance|2|||
126286262|NCT02048813|454334974|FG001|Overall Study|Insurance|0|||
126286263|NCT02048813|454334973|FG000|Overall Study|Wound infection/healing|2|||
126286264|NCT02048813|454334974|FG001|Overall Study|Wound infection/healing|0|||
126286265|NCT02048813|454334973|FG000|Overall Study|Missed appointment|3|||
126286266|NCT02048813|454334974|FG001|Overall Study|Missed appointment|0|||
126041494|NCT01960452|453451016|FG000|Overall Study|Withdrawal by Subject|2|||
126041495|NCT01960452|453451017|FG001|Overall Study|Withdrawal by Subject|1|||
126365355|NCT03715829|454631744|FG004|Extension Period|Lost to Follow-up|0|||
126365356|NCT03715829|454631745|FG005|Extension Period|Lost to Follow-up|0|||
126365357|NCT03715829|454631746|FG006|Extension Period|Lost to Follow-up|0|||
126365358|NCT03715829|454631747|FG007|Extension Period|Lost to Follow-up|0|||
126365359|NCT03715829|454631748|FG008|Extension Period|Lost to Follow-up|2|||
126365360|NCT03715829|454631749|FG009|Extension Period|Lost to Follow-up|0|||
126365361|NCT03715829|454631750|FG010|Extension Period|Lost to Follow-up|0|||
126365362|NCT03715829|454631740|FG000|Extension Period|Protocol Violation|0|||
126365363|NCT03715829|454631741|FG001|Extension Period|Protocol Violation|0|||
126365364|NCT03715829|454631742|FG002|Extension Period|Protocol Violation|0|||
126365365|NCT03715829|454631743|FG003|Extension Period|Protocol Violation|0|||
126365366|NCT03715829|454631744|FG004|Extension Period|Protocol Violation|0|||
126365367|NCT03715829|454631745|FG005|Extension Period|Protocol Violation|0|||
126365368|NCT03715829|454631746|FG006|Extension Period|Protocol Violation|0|||
126365369|NCT03715829|454631747|FG007|Extension Period|Protocol Violation|0|||
126365370|NCT03715829|454631748|FG008|Extension Period|Protocol Violation|1|||
126365371|NCT03715829|454631749|FG009|Extension Period|Protocol Violation|0|||
126365372|NCT03715829|454631750|FG010|Extension Period|Protocol Violation|0|||
126365373|NCT03715829|454631740|FG000|Extension Period|Withdrawal by Subject|0|||
126365374|NCT03715829|454631741|FG001|Extension Period|Withdrawal by Subject|0|||
126365375|NCT03715829|454631742|FG002|Extension Period|Withdrawal by Subject|0|||
126365376|NCT03715829|454631743|FG003|Extension Period|Withdrawal by Subject|0|||
126365377|NCT03715829|454631744|FG004|Extension Period|Withdrawal by Subject|0|||
126365378|NCT03715829|454631745|FG005|Extension Period|Withdrawal by Subject|0|||
126365379|NCT03715829|454631746|FG006|Extension Period|Withdrawal by Subject|3|||
126365380|NCT03715829|454631747|FG007|Extension Period|Withdrawal by Subject|3|||
126365381|NCT03715829|454631748|FG008|Extension Period|Withdrawal by Subject|12|||
126365382|NCT03715829|454631749|FG009|Extension Period|Withdrawal by Subject|3|||
126365383|NCT03715829|454631750|FG010|Extension Period|Withdrawal by Subject|0|||
126365384|NCT03715829|454631740|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365385|NCT03715829|454631741|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365386|NCT03715829|454631742|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365387|NCT03715829|454631743|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365388|NCT03715829|454631744|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365389|NCT03715829|454631745|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365390|NCT03715829|454631746|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365391|NCT03715829|454631747|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
126365392|NCT03715829|454631748|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
126365393|NCT03715829|454631749|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365394|NCT03715829|454631750|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365395|NCT03715829|454631740|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365396|NCT03715829|454631741|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365397|NCT03715829|454631742|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365398|NCT03715829|454631743|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365399|NCT03715829|454631744|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365400|NCT03715829|454631745|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365401|NCT03715829|454631746|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365402|NCT03715829|454631747|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
125882846|NCT01394016|452869064|FG009|Overall Study|Withdrawal by Subject|1|||
126041496|NCT01960452|453451016|FG000|Overall Study|Sleep apnea in Night 1|1|||
126041497|NCT01960452|453451017|FG001|Overall Study|Sleep apnea in Night 1|0|||
126365403|NCT03715829|454631748|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
126365404|NCT03715829|454631749|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365405|NCT03715829|454631750|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365406|NCT03715829|454631740|FG000|Extension Period|Other|0|||
126365407|NCT03715829|454631741|FG001|Extension Period|Other|0|||
126041498|NCT01960452|453451016|FG000|Overall Study|Poor Sleep in Night 1|0|||
126041499|NCT01960452|453451017|FG001|Overall Study|Poor Sleep in Night 1|2|||
126041500|NCT01960452|453451016|FG000|Overall Study|No Sex/Age Match Night 1|1|||
126041501|NCT01960452|453451017|FG001|Overall Study|No Sex/Age Match Night 1|0|||
126041502|NCT01960452|453451016|FG000|Overall Study|No Sex/Age Match Night 2|0|||
126041503|NCT01960452|453451017|FG001|Overall Study|No Sex/Age Match Night 2|2|||
126041504|NCT01960452|453451016|FG000|Overall Study|Technical Difficulties Night 2|2|||
126041505|NCT01960452|453451017|FG001|Overall Study|Technical Difficulties Night 2|0|||
126041506|NCT04414722|453451018|FG000|Overall Study|Lost to Follow-up|3|||
126041507|NCT04414722|453451019|FG001|Overall Study|Lost to Follow-up|4|||
126041508|NCT04414722|453451020|FG002|Overall Study|Lost to Follow-up|3|||
126041509|NCT04414722|453451021|FG003|Overall Study|Lost to Follow-up|2|||
126041510|NCT04414722|453451022|FG004|Overall Study|Lost to Follow-up|3|||
126041511|NCT04414722|453451018|FG000|Overall Study|Withdrawal by Subject|6|||
126041512|NCT04414722|453451019|FG001|Overall Study|Withdrawal by Subject|3|||
126041513|NCT04414722|453451020|FG002|Overall Study|Withdrawal by Subject|1|||
126041514|NCT04414722|453451021|FG003|Overall Study|Withdrawal by Subject|5|||
126041515|NCT04414722|453451022|FG004|Overall Study|Withdrawal by Subject|1|||
126041516|NCT04414722|453451018|FG000|Overall Study|Physician Decision|0|||
126041517|NCT04414722|453451019|FG001|Overall Study|Physician Decision|1|||
126041518|NCT04414722|453451020|FG002|Overall Study|Physician Decision|2|||
126041519|NCT04414722|453451021|FG003|Overall Study|Physician Decision|0|||
126041520|NCT04414722|453451022|FG004|Overall Study|Physician Decision|0|||
126041521|NCT04414722|453451018|FG000|Overall Study|Non-participatory|0|||
126041522|NCT04414722|453451019|FG001|Overall Study|Non-participatory|1|||
126041523|NCT04414722|453451020|FG002|Overall Study|Non-participatory|1|||
126041524|NCT04414722|453451021|FG003|Overall Study|Non-participatory|0|||
126041525|NCT04414722|453451022|FG004|Overall Study|Non-participatory|0|||
126041526|NCT03655028|453451027|FG000|12-weeks Follow up|Death|1|||
126041527|NCT03655028|453451028|FG001|12-weeks Follow up|Death|0|||
126041528|NCT03655028|453451027|FG000|12-weeks Follow up|Physician Decision|3|||
126041529|NCT03655028|453451028|FG001|12-weeks Follow up|Physician Decision|3|||
126041530|NCT03655028|453451027|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
126041531|NCT03655028|453451028|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
126041532|NCT03655028|453451027|FG000|12-weeks Follow up|Lost to Follow-up|4|||
126041533|NCT03655028|453451028|FG001|12-weeks Follow up|Lost to Follow-up|4|||
126041534|NCT03655028|453451027|FG000|24-weeks|Lost to Follow-up|1|||
126041535|NCT03655028|453451028|FG001|24-weeks|Lost to Follow-up|1|||
126041536|NCT03655028|453451027|FG000|24-weeks|Death|0|||
126041537|NCT03655028|453451028|FG001|24-weeks|Death|1|||
126041538|NCT03513302|453451029|FG000|First Intervention (14 Days)|Screen failure|15|||
126041539|NCT03513302|453451030|FG001|First Intervention (14 Days)|Screen failure|16|||
125882847|NCT01394016|452869065|FG010|Overall Study|Withdrawal by Subject|4|||
126041540|NCT05256654|453451031|FG000|Overall Study|Adverse Event|0|||
126041541|NCT05256654|453451032|FG001|Overall Study|Adverse Event|0|||
126041542|NCT05256654|453451033|FG002|Overall Study|Adverse Event|1|||
126041543|NCT05256654|453451034|FG003|Overall Study|Adverse Event|0|||
126041544|NCT05256654|453451031|FG000|Overall Study|Lost to Follow-up|0|||
126041545|NCT05256654|453451032|FG001|Overall Study|Lost to Follow-up|0|||
126041546|NCT05256654|453451033|FG002|Overall Study|Lost to Follow-up|0|||
126041547|NCT05256654|453451034|FG003|Overall Study|Lost to Follow-up|1|||
126041548|NCT05256654|453451031|FG000|Overall Study|Withdrawal by Subject|1|||
126041549|NCT05256654|453451032|FG001|Overall Study|Withdrawal by Subject|2|||
126041550|NCT05256654|453451033|FG002|Overall Study|Withdrawal by Subject|1|||
126041551|NCT05256654|453451034|FG003|Overall Study|Withdrawal by Subject|3|||
126041552|NCT05256654|453451031|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
126041553|NCT05256654|453451032|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
126041554|NCT05256654|453451033|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
126041555|NCT05256654|453451034|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
126041556|NCT05256654|453451031|FG000|Overall Study|Other|0|||
126041557|NCT05256654|453451032|FG001|Overall Study|Other|0|||
126041558|NCT05256654|453451033|FG002|Overall Study|Other|0|||
126041559|NCT05256654|453451034|FG003|Overall Study|Other|1|||
126041560|NCT05618587|453451035|FG000|Overall Study|Lost to Follow-up|2|||
126099817|NCT04493502|453657683|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
126099818|NCT04493502|453657684|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
126099819|NCT04493502|453657683|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
126099820|NCT04493502|453657684|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
126099821|NCT04493502|453657683|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
126099822|NCT04493502|453657684|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
126099823|NCT00540046|453657685|FG000|Overall Study|Lost to Follow-up|33|||
126099824|NCT00540046|453657686|FG001|Overall Study|Lost to Follow-up|23|||
126099825|NCT02891837|453657687|FG000|Overall Study|Lost to Follow-up|2|||
126099826|NCT02891837|453657688|FG001|Overall Study|Lost to Follow-up|0|||
126099827|NCT02891837|453657687|FG000|Overall Study|Withdrawal by Subject|1|||
126099828|NCT02891837|453657688|FG001|Overall Study|Withdrawal by Subject|0|||
126099829|NCT02751320|453657689|FG000|Overall Study|Adverse Event|2|||
126099830|NCT02751320|453657689|FG000|Overall Study|Withdrawal by Subject|1|||
126099831|NCT00185965|453657690|FG000|Overall Study|Adverse Event|0|||
126099832|NCT00185965|453657691|FG001|Overall Study|Adverse Event|1|||
126099833|NCT02533531|453657692|FG000|Overall Study|Device did not turn on|1|||
126099834|NCT02047903|453657693|FG000|Overall Study|Adverse Event|14|||
126099835|NCT02047903|453657693|FG000|Overall Study|Serious adverse event|10|||
126286267|NCT02048813|454334973|FG000|Overall Study|Never started treatment|2|||
126286268|NCT02048813|454334974|FG001|Overall Study|Never started treatment|17|||
126286269|NCT01708954|454334975|FG000|Step 1|Disease progression|26|||
126286270|NCT01708954|454334976|FG001|Step 1|Disease progression|17|||
126286271|NCT01708954|454334977|FG002|Step 1|Disease progression|14|||
126286272|NCT01708954|454334975|FG000|Step 1|Adverse Event|3|||
126286273|NCT01708954|454334976|FG001|Step 1|Adverse Event|11|||
126286274|NCT01708954|454334977|FG002|Step 1|Adverse Event|13|||
126286275|NCT01708954|454334975|FG000|Step 1|Death|3|||
126286276|NCT01708954|454334976|FG001|Step 1|Death|2|||
126286277|NCT01708954|454334977|FG002|Step 1|Death|3|||
126286278|NCT01708954|454334975|FG000|Step 1|Withdrawal by Subject|2|||
126286279|NCT01708954|454334976|FG001|Step 1|Withdrawal by Subject|5|||
126286280|NCT01708954|454334977|FG002|Step 1|Withdrawal by Subject|3|||
126286281|NCT01708954|454334975|FG000|Step 1|Other complicating disease|0|||
126286282|NCT01708954|454334976|FG001|Step 1|Other complicating disease|2|||
126041561|NCT05618587|453451036|FG001|Overall Study|Lost to Follow-up|0|||
126099836|NCT02047903|453657693|FG000|Overall Study|Withdrawal by Subject|16|||
126099837|NCT02047903|453657693|FG000|Overall Study|Lost to Follow-up|4|||
126099838|NCT02047903|453657693|FG000|Overall Study|Reason not listed|6|||
126099839|NCT02047903|453657693|FG000|Overall Study|Not Treated|9|||
126099840|NCT01014533|453657694|FG000|Overall Study|Protocol Violation|3|||
126099841|NCT01014533|453657695|FG001|Overall Study|Protocol Violation|2|||
126099842|NCT01014533|453657694|FG000|Overall Study|Withdrawal by Subject|2|||
126041562|NCT05167864|453451041|FG000|Overall Study|Lost to Follow-up|7|||
126041563|NCT05167864|453451042|FG001|Overall Study|Lost to Follow-up|6|||
126041564|NCT05167864|453451043|FG002|Overall Study|Lost to Follow-up|7|||
126041565|NCT05167864|453451044|FG003|Overall Study|Lost to Follow-up|9|||
126041566|NCT04862416|453451045|FG000|Overall Study|Withdrawal by Subject|0|||
126099843|NCT01014533|453657695|FG001|Overall Study|Withdrawal by Subject|0|||
126099844|NCT01014533|453657694|FG000|Overall Study|unable to come to appointment|0|||
126099845|NCT01014533|453657695|FG001|Overall Study|unable to come to appointment|3|||
126099846|NCT00296400|453657699|FG000|Overall Study|Adverse Event|7|||
126099847|NCT00296400|453657700|FG001|Overall Study|Adverse Event|7|||
126099848|NCT00296400|453657701|FG002|Overall Study|Adverse Event|7|||
126286283|NCT01708954|454334977|FG002|Step 1|Other complicating disease|0|||
126286284|NCT01708954|454334975|FG000|Step 1|Crossed over to Step 2|2|||
126286285|NCT01708954|454334976|FG001|Step 1|Crossed over to Step 2|0|||
126099849|NCT00296400|453657699|FG000|Overall Study|Withdrawal by Subject|5|||
126099850|NCT00296400|453657700|FG001|Overall Study|Withdrawal by Subject|6|||
126099851|NCT00296400|453657701|FG002|Overall Study|Withdrawal by Subject|2|||
126286286|NCT01708954|454334977|FG002|Step 1|Crossed over to Step 2|0|||
126286287|NCT01708954|454334975|FG000|Step 1|Symptomatic deterioration|1|||
126099852|NCT00296400|453657699|FG000|Overall Study|Incorrect enrollment|2|||
126099853|NCT00296400|453657700|FG001|Overall Study|Incorrect enrollment|0|||
126099854|NCT00296400|453657701|FG002|Overall Study|Incorrect enrollment|0|||
126099855|NCT00296400|453657699|FG000|Overall Study|Protocol Violation|1|||
126099856|NCT00296400|453657700|FG001|Overall Study|Protocol Violation|1|||
126099857|NCT00296400|453657701|FG002|Overall Study|Protocol Violation|1|||
126099858|NCT00296400|453657699|FG000|Overall Study|Lost to Follow-up|1|||
126099859|NCT00296400|453657700|FG001|Overall Study|Lost to Follow-up|1|||
126099860|NCT00296400|453657701|FG002|Overall Study|Lost to Follow-up|2|||
126099861|NCT00296400|453657699|FG000|Overall Study|Study specific discontinuation criteria|0|||
126099862|NCT00296400|453657700|FG001|Overall Study|Study specific discontinuation criteria|0|||
126099863|NCT00296400|453657701|FG002|Overall Study|Study specific discontinuation criteria|1|||
126099864|NCT00296400|453657699|FG000|Overall Study|Visit 10 was performed earlier|0|||
126099865|NCT00296400|453657700|FG001|Overall Study|Visit 10 was performed earlier|1|||
126099866|NCT00296400|453657701|FG002|Overall Study|Visit 10 was performed earlier|0|||
126099867|NCT00296400|453657699|FG000|Overall Study|Pregnancy|1|||
126099868|NCT00296400|453657700|FG001|Overall Study|Pregnancy|2|||
126099869|NCT00296400|453657701|FG002|Overall Study|Pregnancy|0|||
126099870|NCT00412061|453657703|FG000|Double Blind Phase|Disease Progression|101|||
126286288|NCT01708954|454334976|FG001|Step 1|Symptomatic deterioration|0|||
126099871|NCT00412061|453657704|FG001|Double Blind Phase|Disease Progression|154|||
126099872|NCT00412061|453657703|FG000|Double Blind Phase|Adverse Event|61|||
126099873|NCT00412061|453657704|FG001|Double Blind Phase|Adverse Event|16|||
125882848|NCT01394016|452869066|FG011|Overall Study|Withdrawal by Subject|0|||
126099874|NCT00412061|453657703|FG000|Double Blind Phase|Final Primary Analysis|26|||
126099875|NCT00412061|453657704|FG001|Double Blind Phase|Final Primary Analysis|14|||
126099876|NCT00412061|453657703|FG000|Double Blind Phase|Withdrawal by Subject|18|||
126099877|NCT00412061|453657704|FG001|Double Blind Phase|Withdrawal by Subject|20|||
126099878|NCT00412061|453657703|FG000|Double Blind Phase|Death|6|||
126099879|NCT00412061|453657704|FG001|Double Blind Phase|Death|3|||
126099880|NCT00412061|453657703|FG000|Double Blind Phase|Protocol Violation|3|||
126099881|NCT00412061|453657704|FG001|Double Blind Phase|Protocol Violation|4|||
126099882|NCT00412061|453657703|FG000|Double Blind Phase|New Cander Therapy|1|||
126099883|NCT00412061|453657704|FG001|Double Blind Phase|New Cander Therapy|1|||
126099884|NCT00412061|453657703|FG000|Double Blind Phase|Lost to Follow-up|0|||
126099885|NCT00412061|453657704|FG001|Double Blind Phase|Lost to Follow-up|1|||
126099886|NCT00412061|453657703|FG000|Open Label Phase|Disease Progression|0|||
126099887|NCT00412061|453657704|FG001|Open Label Phase|Disease Progression|86|||
126099888|NCT00412061|453657703|FG000|Open Label Phase|Adverse Event|0|||
126099889|NCT00412061|453657704|FG001|Open Label Phase|Adverse Event|46|||
126099890|NCT00412061|453657703|FG000|Open Label Phase|Withdrawal by Subject|0|||
126099891|NCT00412061|453657704|FG001|Open Label Phase|Withdrawal by Subject|15|||
126286289|NCT01708954|454334977|FG002|Step 1|Symptomatic deterioration|1|||
126286290|NCT01708954|454334975|FG000|Step 1|Off-treatment reason not submitted|1|||
126286291|NCT01708954|454334976|FG001|Step 1|Off-treatment reason not submitted|1|||
126365408|NCT03715829|454631742|FG002|Extension Period|Other|0|||
126041567|NCT04862416|453451046|FG001|Overall Study|Withdrawal by Subject|1|||
126041568|NCT04862416|453451047|FG002|Overall Study|Withdrawal by Subject|0|||
126041569|NCT04862416|453451048|FG003|Overall Study|Withdrawal by Subject|1|||
126041570|NCT04862416|453451049|FG004|Overall Study|Withdrawal by Subject|0|||
126041571|NCT04862416|453451050|FG005|Overall Study|Withdrawal by Subject|0|||
126041572|NCT04862416|453451051|FG006|Overall Study|Withdrawal by Subject|0|||
126041573|NCT04862416|453451052|FG007|Overall Study|Withdrawal by Subject|0|||
126041574|NCT03442309|453451053|FG000|Overall Study|Lost to Follow-up|1676|||
126041575|NCT03442309|453451054|FG001|Overall Study|Lost to Follow-up|1642|||
126041576|NCT05204654|453451055|FG000|Overall Study|Study terminated due to time restraint|2|||
126041577|NCT05204654|453451056|FG001|Overall Study|Study terminated due to time restraint|2|||
126041578|NCT01254864|453451062|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
126041579|NCT01254864|453451063|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
126041580|NCT01254864|453451064|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
126041581|NCT01254864|453451062|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
126041582|NCT01254864|453451063|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
126041583|NCT01254864|453451064|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
126041584|NCT01254864|453451062|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
126041585|NCT01254864|453451063|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
126041586|NCT01254864|453451064|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
126041587|NCT01254864|453451062|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
126041588|NCT01254864|453451063|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
126041589|NCT01254864|453451064|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
126041590|NCT01254864|453451062|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
126041591|NCT01254864|453451063|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
126041592|NCT01254864|453451064|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
126041593|NCT01254864|453451062|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
126041594|NCT01254864|453451063|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
126041595|NCT01254864|453451064|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
126041596|NCT01254864|453451062|FG000|Randomization Phase|Adverse Event|0|||
126041597|NCT01254864|453451063|FG001|Randomization Phase|Adverse Event|5|||
126041598|NCT01254864|453451064|FG002|Randomization Phase|Adverse Event|17|||
126041599|NCT01254864|453451062|FG000|Randomization Phase|Death|0|||
126041600|NCT01254864|453451063|FG001|Randomization Phase|Death|1|||
126041601|NCT01254864|453451064|FG002|Randomization Phase|Death|0|||
126041602|NCT01254864|453451062|FG000|Randomization Phase|Lost to Follow-up|0|||
126041603|NCT01254864|453451063|FG001|Randomization Phase|Lost to Follow-up|0|||
126041604|NCT01254864|453451064|FG002|Randomization Phase|Lost to Follow-up|1|||
126041605|NCT01254864|453451062|FG000|Randomization Phase|Physician Decision|0|||
126041606|NCT01254864|453451063|FG001|Randomization Phase|Physician Decision|20|||
126041607|NCT01254864|453451064|FG002|Randomization Phase|Physician Decision|25|||
126041608|NCT01254864|453451062|FG000|Randomization Phase|Withdrawal by Subject|0|||
126041609|NCT01254864|453451063|FG001|Randomization Phase|Withdrawal by Subject|4|||
126041610|NCT01254864|453451064|FG002|Randomization Phase|Withdrawal by Subject|2|||
126041611|NCT01254864|453451062|FG000|Randomization Phase|Non-Compliance|0|||
126041612|NCT01254864|453451063|FG001|Randomization Phase|Non-Compliance|1|||
126041613|NCT01254864|453451064|FG002|Randomization Phase|Non-Compliance|0|||
126041614|NCT01254864|453451062|FG000|Randomization Phase|Comorbidities|0|||
126041615|NCT01254864|453451063|FG001|Randomization Phase|Comorbidities|2|||
126041616|NCT01254864|453451064|FG002|Randomization Phase|Comorbidities|1|||
126041617|NCT05184452|453451065|FG000|Overall Study|Lost to Follow-up|0|||
126041618|NCT05184452|453451066|FG001|Overall Study|Lost to Follow-up|0|||
126041619|NCT05184452|453451067|FG002|Overall Study|Lost to Follow-up|0|||
126041620|NCT05184452|453451068|FG003|Overall Study|Lost to Follow-up|0|||
126041621|NCT05184452|453451069|FG004|Overall Study|Lost to Follow-up|0|||
126041622|NCT05184452|453451070|FG005|Overall Study|Lost to Follow-up|2|||
126041623|NCT05184452|453451071|FG006|Overall Study|Lost to Follow-up|0|||
126041624|NCT05184452|453451072|FG007|Overall Study|Lost to Follow-up|0|||
126041625|NCT05184452|453451073|FG008|Overall Study|Lost to Follow-up|0|||
126041626|NCT05184452|453451074|FG009|Overall Study|Lost to Follow-up|1|||
126041627|NCT05184452|453451065|FG000|Overall Study|Withdrawal by Subject|0|||
126041628|NCT05184452|453451066|FG001|Overall Study|Withdrawal by Subject|0|||
126041629|NCT05184452|453451067|FG002|Overall Study|Withdrawal by Subject|0|||
126365409|NCT03715829|454631743|FG003|Extension Period|Other|0|||
126365410|NCT03715829|454631744|FG004|Extension Period|Other|0|||
126365411|NCT03715829|454631745|FG005|Extension Period|Other|0|||
126041630|NCT05184452|453451068|FG003|Overall Study|Withdrawal by Subject|0|||
126041631|NCT05184452|453451069|FG004|Overall Study|Withdrawal by Subject|0|||
126041632|NCT05184452|453451070|FG005|Overall Study|Withdrawal by Subject|1|||
126041633|NCT05184452|453451071|FG006|Overall Study|Withdrawal by Subject|0|||
126041634|NCT05184452|453451072|FG007|Overall Study|Withdrawal by Subject|0|||
126365412|NCT03715829|454631746|FG006|Extension Period|Other|1|||
126365413|NCT03715829|454631747|FG007|Extension Period|Other|2|||
126099892|NCT00412061|453657703|FG000|Open Label Phase|Administrative Problems|0|||
126099893|NCT00412061|453657704|FG001|Open Label Phase|Administrative Problems|13|||
126099894|NCT00412061|453657703|FG000|Open Label Phase|Death|0|||
126099895|NCT00412061|453657704|FG001|Open Label Phase|Death|7|||
126099896|NCT00412061|453657703|FG000|Open Label Phase|Lost to Follow-up|0|||
126099897|NCT00412061|453657704|FG001|Open Label Phase|Lost to Follow-up|2|||
126099898|NCT00412061|453657703|FG000|Open Label Phase|New Cancer Therapy|0|||
126099899|NCT00412061|453657704|FG001|Open Label Phase|New Cancer Therapy|1|||
126099900|NCT01942590|453657705|FG000|Overall Study|Withdrawal by Subject|0|||
126099901|NCT01942590|453657706|FG001|Overall Study|Withdrawal by Subject|1|||
126099902|NCT01942590|453657705|FG000|Overall Study|Adverse Event|1|||
126099903|NCT01942590|453657706|FG001|Overall Study|Adverse Event|0|||
126099904|NCT03616977|453657708|FG000|Period 1|Physician Decision|0|||
126286292|NCT01708954|454334977|FG002|Step 1|Off-treatment reason not submitted|1|||
126286293|NCT01708954|454334975|FG000|Step 1|Ineligible or never received treatment|4|||
126286294|NCT01708954|454334976|FG001|Step 1|Ineligible or never received treatment|2|||
126286295|NCT01708954|454334977|FG002|Step 1|Ineligible or never received treatment|8|||
126286296|NCT01708954|454334975|FG000|Step 2|Disease progression|9|||
126286297|NCT01708954|454334976|FG001|Step 2|Disease progression|4|||
126286298|NCT01708954|454334977|FG002|Step 2|Disease progression|0|||
126286299|NCT01708954|454334975|FG000|Step 2|Adverse Event|3|||
126286300|NCT01708954|454334976|FG001|Step 2|Adverse Event|2|||
126286301|NCT01708954|454334977|FG002|Step 2|Adverse Event|0|||
126286302|NCT01708954|454334975|FG000|Step 2|Withdrawal by Subject|1|||
126286303|NCT01708954|454334976|FG001|Step 2|Withdrawal by Subject|1|||
126286304|NCT01708954|454334977|FG002|Step 2|Withdrawal by Subject|0|||
126286305|NCT06400251|454334978|FG000|Overall Study|Never Start Protocol Therapy|1|||
126286306|NCT06400251|454334978|FG000|Overall Study|Ineligible|2|||
126286307|NCT06400251|454334978|FG000|Overall Study|Mutation Status Not Confirmed|3|||
126286308|NCT06400251|454334978|FG000|Overall Study|Disease Progression|25|||
126286309|NCT06400251|454334978|FG000|Overall Study|Adverse Event|1|||
126286310|NCT06400251|454334978|FG000|Overall Study|Complicating Disease|1|||
126286311|NCT06400251|454334978|FG000|Overall Study|Physician Decision|2|||
126286312|NCT03631199|454334979|FG000|Overall Study|Progressive disease|9|||
126286313|NCT03631199|454334980|FG001|Overall Study|Progressive disease|5|||
126286314|NCT03631199|454334981|FG002|Overall Study|Progressive disease|5|||
126286315|NCT03631199|454334982|FG003|Overall Study|Progressive disease|149|||
126099905|NCT03616977|453657709|FG001|Period 1|Physician Decision|1|||
126099906|NCT03616977|453657708|FG000|Period 3|Adverse Event|1|||
126099907|NCT03616977|453657709|FG001|Period 3|Adverse Event|1|||
126099908|NCT03683823|453657710|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
126099909|NCT03683823|453657711|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
126099910|NCT03683823|453657710|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
126099911|NCT03683823|453657711|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
126099912|NCT03683823|453657710|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
126099913|NCT03683823|453657711|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
126099914|NCT01323972|453657713|FG000|Overall Study|Withdrawal by Subject|1|||
126099915|NCT01323972|453657714|FG001|Overall Study|Withdrawal by Subject|0|||
126099916|NCT01323972|453657715|FG002|Overall Study|Withdrawal by Subject|1|||
126099917|NCT01323972|453657716|FG003|Overall Study|Withdrawal by Subject|0|||
126365414|NCT03715829|454631748|FG008|Extension Period|Other|4|||
126365415|NCT03715829|454631749|FG009|Extension Period|Other|0|||
126365416|NCT03715829|454631750|FG010|Extension Period|Other|0|||
126365417|NCT03579719|454631751|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
126365418|NCT03253627|454631754|FG000|Overall Study|Lost to Follow-up|1|||
126365419|NCT03253627|454631755|FG001|Overall Study|Lost to Follow-up|2|||
126365420|NCT03253627|454631754|FG000|Overall Study|Withdrawal by Subject|0|||
126365421|NCT03253627|454631755|FG001|Overall Study|Withdrawal by Subject|2|||
126365422|NCT03253627|454631754|FG000|Overall Study|Inability to complete MRI|1|||
126365423|NCT03253627|454631755|FG001|Overall Study|Inability to complete MRI|0|||
126365424|NCT02940223|454631759|FG000|Overall Study|Failed Requirement|2|||
126365425|NCT02940223|454631760|FG001|Overall Study|Failed Requirement|0|||
126286316|NCT03631199|454334983|FG004|Overall Study|Progressive disease|148|||
126365426|NCT01813357|454631761|FG000|Overall Study|Lost to Follow-up|5|||
126365427|NCT01813357|454631762|FG001|Overall Study|Lost to Follow-up|6|||
126286317|NCT03631199|454334979|FG000|Overall Study|Physician Decision|0|||
126286318|NCT03631199|454334980|FG001|Overall Study|Physician Decision|2|||
126286319|NCT03631199|454334981|FG002|Overall Study|Physician Decision|3|||
126286320|NCT03631199|454334982|FG003|Overall Study|Physician Decision|19|||
126286321|NCT03631199|454334983|FG004|Overall Study|Physician Decision|13|||
126286322|NCT03631199|454334979|FG000|Overall Study|Adverse Event|1|||
126365428|NCT03773562|454631763|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
126365429|NCT03773562|454631763|FG000|Overall Study|Lost to Follow-up|10|||
126365430|NCT03773562|454631763|FG000|Overall Study|Withdrawal by Subject|1|||
126365431|NCT04806373|454631767|FG000|Overall Study|Withdrawal by Subject|1|||
126365432|NCT04806373|454631768|FG001|Overall Study|Withdrawal by Subject|1|||
126365433|NCT03301415|454631771|FG000|Overall Study|Lost to Follow-up|2|||
126365434|NCT03301415|454631771|FG000|Overall Study|Unable to comply with visit schedule|2|||
126099918|NCT01323972|453657713|FG000|Overall Study|Migrated/moved from study area|1|||
126099919|NCT01323972|453657714|FG001|Overall Study|Migrated/moved from study area|2|||
126099920|NCT01323972|453657715|FG002|Overall Study|Migrated/moved from study area|0|||
126099921|NCT01323972|453657716|FG003|Overall Study|Migrated/moved from study area|0|||
126099922|NCT01323972|453657713|FG000|Overall Study|Lost to Follow-up|0|||
126099923|NCT01323972|453657714|FG001|Overall Study|Lost to Follow-up|1|||
126099924|NCT01323972|453657715|FG002|Overall Study|Lost to Follow-up|1|||
126099925|NCT01323972|453657716|FG003|Overall Study|Lost to Follow-up|1|||
126099926|NCT02008877|453657717|FG000|Overall Study|Inevaluable|0|||
126099927|NCT02008877|453657718|FG001|Overall Study|Inevaluable|1|||
126099928|NCT02008877|453657719|FG002|Overall Study|Inevaluable|0|||
126099929|NCT01049217|453657720|FG000|Overall Study|Adverse Event|2|||
126099930|NCT01049217|453657721|FG001|Overall Study|Adverse Event|1|||
126099931|NCT01049217|453657720|FG000|Overall Study|Lack of Efficacy|1|||
126099932|NCT01049217|453657721|FG001|Overall Study|Lack of Efficacy|1|||
126099933|NCT01049217|453657720|FG000|Overall Study|Lost to Follow-up|3|||
126099934|NCT01049217|453657721|FG001|Overall Study|Lost to Follow-up|8|||
126099935|NCT01049217|453657720|FG000|Overall Study|Withdrawal by Subject|4|||
126099936|NCT01049217|453657721|FG001|Overall Study|Withdrawal by Subject|3|||
126099937|NCT01049217|453657720|FG000|Overall Study|Protocol Violation|1|||
126099938|NCT01049217|453657721|FG001|Overall Study|Protocol Violation|3|||
126099939|NCT01049217|453657720|FG000|Overall Study|Pregnancy|1|||
126099940|NCT01049217|453657721|FG001|Overall Study|Pregnancy|0|||
126099941|NCT01049217|453657720|FG000|Overall Study|Study Terminated by Sponsor|43|||
126099942|NCT01049217|453657721|FG001|Overall Study|Study Terminated by Sponsor|43|||
126099943|NCT01049217|453657720|FG000|Overall Study|Other|1|||
126099944|NCT01049217|453657721|FG001|Overall Study|Other|2|||
126099945|NCT01049217|453657720|FG000|Overall Study|Randomized but not Treated|0|||
126286323|NCT03631199|454334980|FG001|Overall Study|Adverse Event|1|||
126286324|NCT03631199|454334981|FG002|Overall Study|Adverse Event|0|||
126286325|NCT03631199|454334982|FG003|Overall Study|Adverse Event|28|||
126286326|NCT03631199|454334983|FG004|Overall Study|Adverse Event|29|||
126286327|NCT03631199|454334979|FG000|Overall Study|Death|0|||
126286328|NCT03631199|454334980|FG001|Overall Study|Death|1|||
126286329|NCT03631199|454334981|FG002|Overall Study|Death|0|||
126286330|NCT03631199|454334982|FG003|Overall Study|Death|35|||
126286331|NCT03631199|454334983|FG004|Overall Study|Death|48|||
126286332|NCT03631199|454334979|FG000|Overall Study|Subject decision|0|||
126286333|NCT03631199|454334980|FG001|Overall Study|Subject decision|1|||
126286334|NCT03631199|454334981|FG002|Overall Study|Subject decision|0|||
126286335|NCT03631199|454334982|FG003|Overall Study|Subject decision|12|||
126286336|NCT03631199|454334983|FG004|Overall Study|Subject decision|12|||
126286337|NCT03631199|454334979|FG000|Overall Study|No treated|0|||
126286338|NCT03631199|454334980|FG001|Overall Study|No treated|0|||
126286339|NCT03631199|454334981|FG002|Overall Study|No treated|0|||
126286340|NCT03631199|454334982|FG003|Overall Study|No treated|0|||
126286341|NCT03631199|454334983|FG004|Overall Study|No treated|1|||
126286342|NCT03631199|454334979|FG000|Overall Study|Treatment ongoing|0|||
126286343|NCT03631199|454334980|FG001|Overall Study|Treatment ongoing|1|||
126286344|NCT03631199|454334981|FG002|Overall Study|Treatment ongoing|1|||
126286345|NCT03631199|454334982|FG003|Overall Study|Treatment ongoing|76|||
126286346|NCT03631199|454334983|FG004|Overall Study|Treatment ongoing|71|||
126286347|NCT03631199|454334979|FG000|Overall Study|Guardian decision|0|||
126286348|NCT03631199|454334980|FG001|Overall Study|Guardian decision|0|||
126286349|NCT03631199|454334981|FG002|Overall Study|Guardian decision|0|||
126286350|NCT03631199|454334982|FG003|Overall Study|Guardian decision|1|||
126286351|NCT03631199|454334983|FG004|Overall Study|Guardian decision|1|||
126286352|NCT03651700|454334985|FG000|Overall Study|Withdrawal by Subject|1|||
126286353|NCT03651700|454334986|FG001|Overall Study|Withdrawal by Subject|0|||
126286354|NCT05124691|454334987|FG000|Phase II|Eligibility criteria|0|||
126286355|NCT05124691|454334988|FG001|Phase II|Eligibility criteria|1|||
126286356|NCT05124691|454334989|FG002|Phase II|Eligibility criteria|0|||
126286357|NCT05124691|454334987|FG000|Phase II|Withdrawal by Subject|6|||
126099946|NCT01049217|453657721|FG001|Overall Study|Randomized but not Treated|2|||
126286358|NCT05124691|454334988|FG001|Phase II|Withdrawal by Subject|2|||
126286359|NCT05124691|454334989|FG002|Phase II|Withdrawal by Subject|3|||
126286360|NCT05124691|454334987|FG000|Phase III|Withdrawal by Subject|6|||
126286361|NCT05124691|454334988|FG001|Phase III|Withdrawal by Subject|4|||
126286362|NCT05124691|454334989|FG002|Phase III|Withdrawal by Subject|4|||
126286363|NCT05124691|454334987|FG000|Phase III|Lost to Follow-up|1|||
126286364|NCT05124691|454334988|FG001|Phase III|Lost to Follow-up|0|||
126286365|NCT05124691|454334989|FG002|Phase III|Lost to Follow-up|0|||
126099947|NCT00903682|453657722|FG000|Overall Study|Adverse Event|6|||
126099948|NCT00903682|453657723|FG001|Overall Study|Adverse Event|13|||
126099949|NCT00903682|453657722|FG000|Overall Study|Lost to Follow-up|1|||
126099950|NCT00903682|453657723|FG001|Overall Study|Lost to Follow-up|0|||
126286366|NCT03509467|454334990|FG000|Overall Study|Withdrawal by Subject|5|||
126286367|NCT03509467|454334991|FG001|Overall Study|Withdrawal by Subject|1|||
126286368|NCT03509467|454334992|FG002|Overall Study|Withdrawal by Subject|6|||
126286369|NCT03509467|454334993|FG003|Overall Study|Withdrawal by Subject|7|||
126286370|NCT03509467|454334994|FG004|Overall Study|Withdrawal by Subject|10|||
126286371|NCT03509467|454334995|FG005|Overall Study|Withdrawal by Subject|10|||
126286372|NCT03509467|454334996|FG006|Overall Study|Withdrawal by Subject|10|||
126286373|NCT03509467|454334997|FG007|Overall Study|Withdrawal by Subject|10|||
126286374|NCT03509467|454334990|FG000|Overall Study|Death|0|||
126286375|NCT03509467|454334991|FG001|Overall Study|Death|0|||
126286376|NCT03509467|454334992|FG002|Overall Study|Death|2|||
126286377|NCT03509467|454334993|FG003|Overall Study|Death|2|||
126286378|NCT03509467|454334994|FG004|Overall Study|Death|1|||
126286379|NCT03509467|454334995|FG005|Overall Study|Death|0|||
126286380|NCT03509467|454334996|FG006|Overall Study|Death|1|||
126286381|NCT03509467|454334997|FG007|Overall Study|Death|0|||
126286382|NCT03509467|454334990|FG000|Overall Study|Proxy Withdrawal|0|||
126286383|NCT03509467|454334991|FG001|Overall Study|Proxy Withdrawal|0|||
126286384|NCT03509467|454334992|FG002|Overall Study|Proxy Withdrawal|0|||
126286385|NCT03509467|454334993|FG003|Overall Study|Proxy Withdrawal|0|||
126286386|NCT03509467|454334994|FG004|Overall Study|Proxy Withdrawal|0|||
125882849|NCT01394016|452869067|FG012|Overall Study|Withdrawal by Subject|0|||
125882850|NCT01394016|452869068|FG013|Overall Study|Withdrawal by Subject|3|||
125882851|NCT01394016|452869069|FG014|Overall Study|Withdrawal by Subject|1|||
125882852|NCT01394016|452869070|FG015|Overall Study|Withdrawal by Subject|3|||
125882853|NCT01394016|452869071|FG016|Overall Study|Withdrawal by Subject|1|||
125882854|NCT01394016|452869072|FG017|Overall Study|Withdrawal by Subject|1|||
125882855|NCT01394016|452869073|FG018|Overall Study|Withdrawal by Subject|2|||
125882856|NCT01394016|452869055|FG000|Overall Study|Adverse Event|0|||
125882857|NCT01394016|452869056|FG001|Overall Study|Adverse Event|0|||
126286387|NCT03509467|454334995|FG005|Overall Study|Proxy Withdrawal|0|||
126286388|NCT03509467|454334996|FG006|Overall Study|Proxy Withdrawal|0|||
125882858|NCT01394016|452869057|FG002|Overall Study|Adverse Event|0|||
126041635|NCT05184452|453451073|FG008|Overall Study|Withdrawal by Subject|0|||
126041636|NCT05184452|453451074|FG009|Overall Study|Withdrawal by Subject|1|||
126041637|NCT05586490|453451075|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
126041638|NCT05586490|453451076|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
126041639|NCT05586490|453451077|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
126041640|NCT05586490|453451078|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
126041641|NCT05586490|453451079|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
126041642|NCT05586490|453451075|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
126041643|NCT05586490|453451076|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
126041644|NCT05586490|453451077|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
126041645|NCT05586490|453451078|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
126041646|NCT05586490|453451079|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
126041647|NCT05586490|453451075|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
126041648|NCT05586490|453451076|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
126041649|NCT05586490|453451077|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
126041650|NCT05586490|453451078|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
126041651|NCT05586490|453451079|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
126041652|NCT04862234|453451085|FG000|Overall Study|Surgery cancellation|1|||
126041653|NCT04862234|453451086|FG001|Overall Study|Surgery cancellation|2|||
126041654|NCT04862234|453451085|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
126041655|NCT04862234|453451086|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
126041656|NCT04862234|453451085|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
126041657|NCT04862234|453451086|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
126041658|NCT03292484|453451087|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
126041659|NCT03292484|453451087|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
126041660|NCT03292484|453451087|FG000|Overall Study|Protocol Violation|2|||
126041661|NCT03292484|453451087|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
126041662|NCT03292484|453451087|FG000|Overall Study|Sponsor decision|349|||
126041663|NCT03292484|453451087|FG000|Overall Study|Lost to Follow-up|7|||
126041664|NCT03292484|453451087|FG000|Overall Study|Coronavirus Disease 2019|1|||
126041665|NCT03292484|453451087|FG000|Overall Study|Other|20|||
126041666|NCT05290493|453451088|FG000|Overall Study|Withdrawal by Subject|2|||
126041667|NCT05290493|453451089|FG001|Overall Study|Withdrawal by Subject|2|||
126286389|NCT03509467|454334997|FG007|Overall Study|Proxy Withdrawal|1|||
126286390|NCT02829918|454334998|FG000|Overall Study|Death|2|||
126286391|NCT02829918|454334998|FG000|Overall Study|Withdrawal by Subject|4|||
126286392|NCT02829918|454334998|FG000|Overall Study|Adverse Event|1|||
126286393|NCT02829918|454334998|FG000|Overall Study|Progression|1|||
125882859|NCT01394016|452869058|FG003|Overall Study|Adverse Event|0|||
125882860|NCT01394016|452869059|FG004|Overall Study|Adverse Event|0|||
126286394|NCT04223752|454335004|FG000|Overall Study|Participant enrolled in error|0|||
126041668|NCT05290493|453451088|FG000|Overall Study|Adverse Event|1|||
126041669|NCT05290493|453451089|FG001|Overall Study|Adverse Event|0|||
126286395|NCT04223752|454335005|FG001|Overall Study|Participant enrolled in error|0|||
126286396|NCT04223752|454335006|FG002|Overall Study|Participant enrolled in error|0|||
126286397|NCT04223752|454335007|FG003|Overall Study|Participant enrolled in error|0|||
126286398|NCT04223752|454335008|FG004|Overall Study|Participant enrolled in error|1|||
126286399|NCT04223752|454335004|FG000|Overall Study|Death|0|||
126286400|NCT04223752|454335005|FG001|Overall Study|Death|0|||
126286401|NCT04223752|454335006|FG002|Overall Study|Death|0|||
126286402|NCT04223752|454335007|FG003|Overall Study|Death|2|||
126041670|NCT03677141|453451093|FG000|Overall Study|Death|2|||
126041671|NCT03677141|453451094|FG001|Overall Study|Death|1|||
126041672|NCT03677141|453451095|FG002|Overall Study|Death|6|||
126041673|NCT03677141|453451096|FG003|Overall Study|Death|9|||
126041674|NCT03677141|453451097|FG004|Overall Study|Death|5|||
126041675|NCT03677141|453451098|FG005|Overall Study|Death|3|||
126041676|NCT03677141|453451093|FG000|Overall Study|Lost to Follow-up|0|||
126041677|NCT03677141|453451094|FG001|Overall Study|Lost to Follow-up|0|||
126041678|NCT03677141|453451095|FG002|Overall Study|Lost to Follow-up|0|||
126041679|NCT03677141|453451096|FG003|Overall Study|Lost to Follow-up|2|||
126041680|NCT03677141|453451097|FG004|Overall Study|Lost to Follow-up|0|||
126041681|NCT03677141|453451098|FG005|Overall Study|Lost to Follow-up|0|||
126041682|NCT03677141|453451093|FG000|Overall Study|Screen failure or enrolled in error|0|||
126041683|NCT03677141|453451094|FG001|Overall Study|Screen failure or enrolled in error|0|||
126041684|NCT03677141|453451095|FG002|Overall Study|Screen failure or enrolled in error|0|||
126041685|NCT03677141|453451096|FG003|Overall Study|Screen failure or enrolled in error|0|||
126041686|NCT03677141|453451097|FG004|Overall Study|Screen failure or enrolled in error|2|||
126041687|NCT03677141|453451098|FG005|Overall Study|Screen failure or enrolled in error|0|||
126041688|NCT03677141|453451093|FG000|Overall Study|Physician Decision|0|||
126041689|NCT03677141|453451094|FG001|Overall Study|Physician Decision|0|||
126041690|NCT03677141|453451095|FG002|Overall Study|Physician Decision|0|||
126041691|NCT03677141|453451096|FG003|Overall Study|Physician Decision|0|||
126041692|NCT03677141|453451097|FG004|Overall Study|Physician Decision|1|||
126041693|NCT03677141|453451098|FG005|Overall Study|Physician Decision|0|||
126041694|NCT03677141|453451093|FG000|Overall Study|Withdrawal by Subject|0|||
126041695|NCT03677141|453451094|FG001|Overall Study|Withdrawal by Subject|0|||
126041696|NCT03677141|453451095|FG002|Overall Study|Withdrawal by Subject|1|||
126041697|NCT03677141|453451096|FG003|Overall Study|Withdrawal by Subject|1|||
126041698|NCT03677141|453451097|FG004|Overall Study|Withdrawal by Subject|1|||
126041699|NCT03677141|453451098|FG005|Overall Study|Withdrawal by Subject|0|||
126041700|NCT05425420|453451099|FG000|Overall Study|Physician Decision|1|||
126041701|NCT05425420|453451099|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
126041702|NCT05280574|453451100|FG000|Overall Study|Withdrawal by Subject|0|||
126041703|NCT05280574|453451101|FG001|Overall Study|Withdrawal by Subject|2|||
126041704|NCT05280574|453451102|FG002|Overall Study|Withdrawal by Subject|0|||
126041705|NCT05838027|453451103|FG000|Overall Study|Lost to Follow-up|5|||
126041706|NCT05838027|453451104|FG001|Overall Study|Lost to Follow-up|1|||
126041707|NCT05838027|453451103|FG000|Overall Study|Withdrawal by Subject|1|||
126041708|NCT05838027|453451104|FG001|Overall Study|Withdrawal by Subject|0|||
126041709|NCT04056611|453451108|FG000|Overall Study|Physician Decision|1|||
126041710|NCT02631746|453451111|FG000|Overall Study|Lack of Efficacy|3|||
126041711|NCT04571619|453451112|FG000|Phase 1|Death|22|||
126041712|NCT04571619|453451113|FG001|Phase 1|Death|18|||
126041713|NCT04571619|453451112|FG000|Phase 1|Withdrawal by Subject|7|||
126286403|NCT04223752|454335008|FG004|Overall Study|Death|1|||
126041714|NCT04571619|453451113|FG001|Phase 1|Withdrawal by Subject|2|||
126041715|NCT04571619|453451112|FG000|Phase 2|Death|13|||
126041716|NCT04571619|453451113|FG001|Phase 2|Death|16|||
126286404|NCT04759703|454335009|FG000|Overall Study|Withdrawal by Subject|4|||
126286405|NCT04759703|454335010|FG001|Overall Study|Withdrawal by Subject|9|||
126286406|NCT04759703|454335009|FG000|Overall Study|Adverse Event|1|||
126286407|NCT04759703|454335010|FG001|Overall Study|Adverse Event|0|||
126286408|NCT04759703|454335009|FG000|Overall Study|Lost to Follow-up|2|||
126286409|NCT04759703|454335010|FG001|Overall Study|Lost to Follow-up|0|||
126286410|NCT01128543|454335023|FG000|Overall Study|Withdrawal by Subject|3|||
126286411|NCT01128543|454335023|FG000|Overall Study|Protocol Violation|1|||
126286412|NCT01941498|454335027|FG000|Overall Study|Relocated out of state|1|||
126286413|NCT04487067|454335028|FG000|Overall Study|Adverse Event|3|||
126041717|NCT04571619|453451112|FG000|Phase 2|Withdrawal by Subject|6|||
126041718|NCT04571619|453451113|FG001|Phase 2|Withdrawal by Subject|4|||
126041719|NCT04709419|453451115|FG000|Overall Study|Physician Decision|1|||
126041720|NCT04709419|453451116|FG001|Overall Study|Physician Decision|0|||
126041721|NCT05683340|453451117|FG000|Overall Study|Adverse Event|1|||
126041722|NCT05683340|453451118|FG001|Overall Study|Adverse Event|1|||
126041723|NCT05683340|453451117|FG000|Overall Study|Protocol Violation|1|||
126041724|NCT05683340|453451118|FG001|Overall Study|Protocol Violation|0|||
126041725|NCT05683340|453451117|FG000|Overall Study|Withdrawal by Subject|0|||
126041726|NCT05683340|453451118|FG001|Overall Study|Withdrawal by Subject|2|||
126041727|NCT02224144|453451119|FG000|Overall Study|Lost to Follow-up|3|||
126041728|NCT02224144|453451120|FG001|Overall Study|Lost to Follow-up|1|||
126041729|NCT02224144|453451119|FG000|Overall Study|Death|2|||
126041730|NCT02224144|453451120|FG001|Overall Study|Death|0|||
126041731|NCT02224144|453451119|FG000|Overall Study|Withdrawal by Subject|0|||
126041732|NCT02224144|453451120|FG001|Overall Study|Withdrawal by Subject|1|||
126041733|NCT03505008|453451121|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
126041734|NCT03505008|453451122|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
126041735|NCT03505008|453451123|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
126041736|NCT03505008|453451124|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
126041737|NCT03505008|453451121|FG000|Before Week 24 Randomization|Adverse Event|10|||
126041738|NCT03505008|453451122|FG001|Before Week 24 Randomization|Adverse Event|0|||
126041739|NCT03505008|453451123|FG002|Before Week 24 Randomization|Adverse Event|0|||
126041740|NCT03505008|453451124|FG003|Before Week 24 Randomization|Adverse Event|0|||
126041741|NCT03505008|453451121|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
126041742|NCT03505008|453451122|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
126041743|NCT03505008|453451123|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
126041744|NCT03505008|453451124|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
126041745|NCT03505008|453451121|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
126041746|NCT03505008|453451122|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
126041747|NCT03505008|453451123|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
126041748|NCT03505008|453451124|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
126041749|NCT03505008|453451121|FG000|Before Week 24 Randomization|Physician Decision|2|||
126041750|NCT03505008|453451122|FG001|Before Week 24 Randomization|Physician Decision|0|||
126041751|NCT03505008|453451123|FG002|Before Week 24 Randomization|Physician Decision|0|||
126041752|NCT03505008|453451124|FG003|Before Week 24 Randomization|Physician Decision|0|||
126041753|NCT03505008|453451121|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
126041754|NCT03505008|453451122|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
126041755|NCT03505008|453451123|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
126041756|NCT03505008|453451124|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
126041757|NCT03505008|453451121|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
126041758|NCT03505008|453451122|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
126041759|NCT03505008|453451123|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
126286414|NCT04487067|454335028|FG000|Overall Study|Death Other Than Progressive Disease|60|||
126286415|NCT04487067|454335028|FG000|Overall Study|Death Due To Progressive Disease|40|||
126286416|NCT04487067|454335028|FG000|Overall Study|Lost to Follow-up|3|||
126286417|NCT04487067|454335028|FG000|Overall Study|Progressive Disease|1|||
126286418|NCT04487067|454335028|FG000|Overall Study|Protocol Violation|3|||
126286419|NCT04487067|454335028|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
126286420|NCT04487067|454335028|FG000|Overall Study|Withdrawal by Subject|15|||
126286421|NCT01755091|454335029|FG000|Overall Study|Withdrawal by Subject|6|||
126286422|NCT01755091|454335030|FG001|Overall Study|Withdrawal by Subject|1|||
126286423|NCT01755091|454335031|FG002|Overall Study|Withdrawal by Subject|3|||
126286424|NCT01755091|454335029|FG000|Overall Study|Adverse Event|1|||
126286425|NCT01755091|454335030|FG001|Overall Study|Adverse Event|1|||
126286426|NCT01755091|454335031|FG002|Overall Study|Adverse Event|1|||
126286427|NCT01755091|454335029|FG000|Overall Study|Lost to Follow-up|1|||
126286428|NCT01755091|454335030|FG001|Overall Study|Lost to Follow-up|0|||
126286429|NCT01755091|454335031|FG002|Overall Study|Lost to Follow-up|1|||
126286430|NCT01755091|454335029|FG000|Overall Study|Physician Decision|1|||
126286431|NCT01755091|454335030|FG001|Overall Study|Physician Decision|1|||
126286432|NCT01755091|454335031|FG002|Overall Study|Physician Decision|2|||
126286433|NCT00490841|454335032|FG000|Overall Study|Death|5|||
126286434|NCT00490841|454335032|FG000|Overall Study|Withdrawal by Subject|4|||
126286435|NCT00490841|454335032|FG000|Overall Study|Lost to Follow-up|1|||
126286436|NCT00490841|454335032|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
126286437|NCT06385483|454335035|FG000|Overall Study|Withdrawal by Subject|2|||
126286438|NCT06385483|454335035|FG000|Overall Study|Never start protocol therapy|2|||
126286439|NCT06385483|454335035|FG000|Overall Study|Disease progression|15|||
126286440|NCT02503787|454335036|FG000|Enrollment|Withdrawal by Subject|6|||
126286441|NCT02503787|454335036|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
126286442|NCT02503787|454335036|FG000|Enrollment|Physician Decision|2|||
126286443|NCT02503787|454335036|FG000|Enrollment|Insurance issue|2|||
126286444|NCT02503787|454335036|FG000|Enrollment|Lost to Follow-up|1|||
126286445|NCT02503787|454335036|FG000|Enrollment|Study closure|1|||
126286446|NCT02503787|454335036|FG000|Enrollment|Adverse Event|1|||
126286447|NCT02503787|454335036|FG000|Enrollment|Protocol Violation|1|||
126286448|NCT02503787|454335036|FG000|Enrollment|Inability to implant system|1|||
126286449|NCT02503787|454335036|FG000|Enrollment|Unable to be programmed|1|||
126286450|NCT02503787|454335036|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
126286451|NCT02503787|454335036|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
126286452|NCT02503787|454335036|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
126286453|NCT02503787|454335036|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
126286454|NCT02503787|454335036|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
126286455|NCT02503787|454335036|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
126286456|NCT04787627|454335037|FG000|Overall Study|Withdrawal by Subject|3|||
126286457|NCT04787627|454335038|FG001|Overall Study|Withdrawal by Subject|0|||
126286458|NCT04787627|454335037|FG000|Overall Study|Physician Decision|2|||
126286459|NCT04787627|454335038|FG001|Overall Study|Physician Decision|0|||
126286460|NCT04787627|454335037|FG000|Overall Study|Excluded|0|||
126286461|NCT04787627|454335038|FG001|Overall Study|Excluded|1|||
126286462|NCT00174954|454335039|FG000|Overall Study|Adverse Event|2|||
126286463|NCT00174954|454335039|FG000|Overall Study|No tophi found in MRI|1|||
126286464|NCT00174954|454335039|FG000|Overall Study|Physician Decision|1|||
126365435|NCT04091438|454631775|FG000|Treatment Period 1 (1 Day)|Other|1|||
126365436|NCT04091438|454631776|FG001|Treatment Period 1 (1 Day)|Other|0|||
126365437|NCT04091438|454631775|FG000|Washout Period (1 Day)|Protocol deviation|0|||
126365438|NCT04091438|454631776|FG001|Washout Period (1 Day)|Protocol deviation|1|||
126365439|NCT04091438|454631775|FG000|Washout Period (1 Day)|Other|0|||
126365440|NCT04091438|454631776|FG001|Washout Period (1 Day)|Other|1|||
126286465|NCT00839254|454335040|FG000|Overall Study|Protocol Violation|0|||
126365441|NCT00421408|454631777|FG000|Overall Study|Lost to Follow-up|30|||
126365442|NCT00421408|454631778|FG001|Overall Study|Lost to Follow-up|20|||
126365443|NCT00421408|454631777|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
126365444|NCT00421408|454631778|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
126365445|NCT00787800|454631782|FG000|Overall Study|Withdrawal by Subject|3|||
126365446|NCT00787800|454631783|FG001|Overall Study|Withdrawal by Subject|5|||
126286466|NCT00839254|454335041|FG001|Overall Study|Protocol Violation|1|||
126286467|NCT00839254|454335042|FG002|Overall Study|Protocol Violation|1|||
126286468|NCT00839254|454335043|FG003|Overall Study|Protocol Violation|1|||
126365447|NCT00787800|454631782|FG000|Overall Study|Death|0|||
126286469|NCT00839254|454335044|FG004|Overall Study|Protocol Violation|0|||
126286470|NCT00839254|454335045|FG005|Overall Study|Protocol Violation|0|||
126286471|NCT00839254|454335046|FG006|Overall Study|Protocol Violation|1|||
126286472|NCT00839254|454335047|FG007|Overall Study|Protocol Violation|2|||
126286473|NCT00839254|454335040|FG000|Overall Study|Physician Decision|0|||
126286474|NCT00839254|454335041|FG001|Overall Study|Physician Decision|1|||
126286475|NCT00839254|454335042|FG002|Overall Study|Physician Decision|0|||
126365448|NCT00787800|454631783|FG001|Overall Study|Death|2|||
126286476|NCT00839254|454335043|FG003|Overall Study|Physician Decision|0|||
126286477|NCT00839254|454335044|FG004|Overall Study|Physician Decision|0|||
126286478|NCT00839254|454335045|FG005|Overall Study|Physician Decision|0|||
126286479|NCT00839254|454335046|FG006|Overall Study|Physician Decision|0|||
126286480|NCT00839254|454335047|FG007|Overall Study|Physician Decision|1|||
126286481|NCT00839254|454335040|FG000|Overall Study|Wrong treatment number allocation|0|||
126286482|NCT00839254|454335041|FG001|Overall Study|Wrong treatment number allocation|1|||
126286483|NCT00839254|454335042|FG002|Overall Study|Wrong treatment number allocation|0|||
126286484|NCT00839254|454335043|FG003|Overall Study|Wrong treatment number allocation|0|||
126286485|NCT00839254|454335044|FG004|Overall Study|Wrong treatment number allocation|0|||
126286486|NCT00839254|454335045|FG005|Overall Study|Wrong treatment number allocation|1|||
126286487|NCT00839254|454335046|FG006|Overall Study|Wrong treatment number allocation|0|||
126286488|NCT00839254|454335047|FG007|Overall Study|Wrong treatment number allocation|0|||
126286489|NCT00839254|454335040|FG000|Overall Study|Adverse Event|12|||
126286490|NCT00839254|454335041|FG001|Overall Study|Adverse Event|6|||
126286491|NCT00839254|454335042|FG002|Overall Study|Adverse Event|3|||
126286492|NCT00839254|454335043|FG003|Overall Study|Adverse Event|5|||
126286493|NCT00839254|454335044|FG004|Overall Study|Adverse Event|2|||
126286494|NCT00839254|454335045|FG005|Overall Study|Adverse Event|1|||
126286495|NCT00839254|454335046|FG006|Overall Study|Adverse Event|0|||
126286496|NCT00839254|454335047|FG007|Overall Study|Adverse Event|1|||
126286497|NCT00839254|454335040|FG000|Overall Study|Withdrawal by Subject|87|||
126286498|NCT00839254|454335041|FG001|Overall Study|Withdrawal by Subject|53|||
126286499|NCT00839254|454335042|FG002|Overall Study|Withdrawal by Subject|54|||
126286500|NCT00839254|454335043|FG003|Overall Study|Withdrawal by Subject|32|||
126286501|NCT00839254|454335044|FG004|Overall Study|Withdrawal by Subject|27|||
126286502|NCT00839254|454335045|FG005|Overall Study|Withdrawal by Subject|15|||
126286503|NCT00839254|454335046|FG006|Overall Study|Withdrawal by Subject|22|||
126286504|NCT00839254|454335047|FG007|Overall Study|Withdrawal by Subject|9|||
126286505|NCT00839254|454335040|FG000|Overall Study|Wrong group allocation|0|||
126286506|NCT00839254|454335041|FG001|Overall Study|Wrong group allocation|0|||
126286507|NCT00839254|454335042|FG002|Overall Study|Wrong group allocation|0|||
126286508|NCT00839254|454335043|FG003|Overall Study|Wrong group allocation|0|||
126286509|NCT00839254|454335044|FG004|Overall Study|Wrong group allocation|0|||
126286510|NCT00839254|454335045|FG005|Overall Study|Wrong group allocation|0|||
126286511|NCT00839254|454335046|FG006|Overall Study|Wrong group allocation|1|||
126286512|NCT00839254|454335047|FG007|Overall Study|Wrong group allocation|0|||
126286513|NCT00839254|454335040|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
126286514|NCT00839254|454335041|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286515|NCT00839254|454335042|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286516|NCT00839254|454335043|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286517|NCT00839254|454335044|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286518|NCT00839254|454335045|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
126286519|NCT00839254|454335046|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286520|NCT00839254|454335047|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286521|NCT00839254|454335040|FG000|Overall Study|Withdrawn due to non-compliance|2|||
126286522|NCT00839254|454335041|FG001|Overall Study|Withdrawn due to non-compliance|0|||
126286523|NCT00839254|454335042|FG002|Overall Study|Withdrawn due to non-compliance|0|||
126286524|NCT00839254|454335043|FG003|Overall Study|Withdrawn due to non-compliance|0|||
126286525|NCT00839254|454335044|FG004|Overall Study|Withdrawn due to non-compliance|0|||
126286526|NCT00839254|454335045|FG005|Overall Study|Withdrawn due to non-compliance|0|||
126286527|NCT00839254|454335046|FG006|Overall Study|Withdrawn due to non-compliance|0|||
126286528|NCT00839254|454335047|FG007|Overall Study|Withdrawn due to non-compliance|0|||
126286529|NCT00839254|454335040|FG000|Overall Study|Lost to Follow-up|51|||
126286530|NCT00839254|454335041|FG001|Overall Study|Lost to Follow-up|30|||
126286531|NCT00839254|454335042|FG002|Overall Study|Lost to Follow-up|32|||
126286532|NCT00839254|454335043|FG003|Overall Study|Lost to Follow-up|24|||
126286533|NCT00839254|454335044|FG004|Overall Study|Lost to Follow-up|8|||
126286534|NCT00839254|454335045|FG005|Overall Study|Lost to Follow-up|8|||
126286535|NCT00839254|454335046|FG006|Overall Study|Lost to Follow-up|4|||
126286536|NCT00839254|454335047|FG007|Overall Study|Lost to Follow-up|2|||
126286537|NCT01320150|454335049|FG000|Overall Study|Protocol Violation|15|||
126286538|NCT01320150|454335049|FG000|Overall Study|Withdrawal by Subject|5|||
126286539|NCT01320150|454335049|FG000|Overall Study|Death|2|||
126286540|NCT01320150|454335049|FG000|Overall Study|Lost to Follow-up|44|||
126286541|NCT00919854|454335052|FG000|Overall Study|Adverse Event|1|||
126286542|NCT00985491|454335053|FG000|Overall Study|Adverse Event|8|||
126286543|NCT00985491|454335053|FG000|Overall Study|device migration|7|||
126286544|NCT00985491|454335053|FG000|Overall Study|Withdrawal by Subject|1|||
125882861|NCT01394016|452869060|FG005|Overall Study|Adverse Event|0|||
126286545|NCT00985491|454335053|FG000|Overall Study|implant failure|3|||
126286546|NCT00489827|454335058|FG000|Overall Study|Intraoperative exclusion criteria|1|||
126286547|NCT00489827|454335059|FG001|Overall Study|Intraoperative exclusion criteria|1|||
126286548|NCT00489827|454335058|FG000|Overall Study|Intraoperative exclusion criteria|1|||
126286549|NCT00489827|454335059|FG001|Overall Study|Intraoperative exclusion criteria|1|||
126286550|NCT01377012|454335060|FG000|Core Study|Study terminated by Sponsor|47|||
126286551|NCT01377012|454335061|FG001|Core Study|Study terminated by Sponsor|54|||
126286552|NCT01377012|454335062|FG002|Core Study|Study terminated by Sponsor|46|||
126286553|NCT01377012|454335060|FG000|Core Study|Technical problems|1|||
126286554|NCT01377012|454335061|FG001|Core Study|Technical problems|0|||
126286555|NCT01377012|454335062|FG002|Core Study|Technical problems|0|||
126286556|NCT01377012|454335060|FG000|Core Study|Withdrawal by Subject|15|||
126286557|NCT01377012|454335061|FG001|Core Study|Withdrawal by Subject|23|||
126286558|NCT01377012|454335062|FG002|Core Study|Withdrawal by Subject|18|||
126286559|NCT01377012|454335060|FG000|Core Study|Protocol Violation|7|||
126286560|NCT01377012|454335061|FG001|Core Study|Protocol Violation|3|||
126286561|NCT01377012|454335062|FG002|Core Study|Protocol Violation|2|||
126286562|NCT01377012|454335060|FG000|Core Study|Pregnancy|0|||
126286563|NCT01377012|454335061|FG001|Core Study|Pregnancy|0|||
126286564|NCT01377012|454335062|FG002|Core Study|Pregnancy|1|||
126286565|NCT01377012|454335060|FG000|Core Study|Physician Decision|5|||
126286566|NCT01377012|454335061|FG001|Core Study|Physician Decision|4|||
126286567|NCT01377012|454335062|FG002|Core Study|Physician Decision|10|||
126286568|NCT01377012|454335060|FG000|Core Study|Non-Compliant with study treatment|0|||
126286569|NCT01377012|454335061|FG001|Core Study|Non-Compliant with study treatment|0|||
126286570|NCT01377012|454335062|FG002|Core Study|Non-Compliant with study treatment|1|||
126286571|NCT01377012|454335060|FG000|Core Study|No Longer require treatment|0|||
126286572|NCT01377012|454335061|FG001|Core Study|No Longer require treatment|0|||
126286573|NCT01377012|454335062|FG002|Core Study|No Longer require treatment|1|||
126286574|NCT01377012|454335060|FG000|Core Study|Lost to Follow-up|7|||
126286575|NCT01377012|454335061|FG001|Core Study|Lost to Follow-up|5|||
126286576|NCT01377012|454335062|FG002|Core Study|Lost to Follow-up|4|||
126286577|NCT01377012|454335060|FG000|Core Study|Lack of Efficacy|41|||
126286578|NCT01377012|454335061|FG001|Core Study|Lack of Efficacy|28|||
126286579|NCT01377012|454335062|FG002|Core Study|Lack of Efficacy|37|||
126286580|NCT01377012|454335060|FG000|Core Study|Death|1|||
126286581|NCT01377012|454335061|FG001|Core Study|Death|1|||
126286582|NCT01377012|454335062|FG002|Core Study|Death|1|||
126286583|NCT01377012|454335060|FG000|Core Study|Adverse Event|10|||
126286584|NCT01377012|454335061|FG001|Core Study|Adverse Event|14|||
126286585|NCT01377012|454335062|FG002|Core Study|Adverse Event|13|||
126286586|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
126286587|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
126286588|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
126286589|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
126286590|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
126286591|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
126286592|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
126286593|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
126286594|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
126286595|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
126286596|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
126286597|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
126286598|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
126286599|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
126286600|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
126286601|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
126365449|NCT04309500|454631786|FG000|Overall Study|Lost to Follow-up|1|||
126365450|NCT04309500|454631787|FG001|Overall Study|Lost to Follow-up|0|||
126365451|NCT04309500|454631788|FG002|Overall Study|Lost to Follow-up|0|||
126365452|NCT04309500|454631789|FG003|Overall Study|Lost to Follow-up|0|||
126365453|NCT00913835|454631790|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
126365454|NCT00913835|454631791|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
126365455|NCT00913835|454631790|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
126365456|NCT00913835|454631791|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
126365457|NCT00913835|454631790|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
126365458|NCT00913835|454631791|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
126286602|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
126286603|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
126286604|NCT04380961|454335063|FG000|Overall Study|Lost to Follow-up|17|||
126286605|NCT04380961|454335064|FG001|Overall Study|Lost to Follow-up|11|||
126286606|NCT04380961|454335063|FG000|Overall Study|Withdrawal by Subject|3|||
126286607|NCT04380961|454335064|FG001|Overall Study|Withdrawal by Subject|0|||
126286608|NCT04380961|454335063|FG000|Overall Study|Death|22|||
126286609|NCT04380961|454335064|FG001|Overall Study|Death|16|||
126286610|NCT04380961|454335063|FG000|Overall Study|Other|1|||
126286611|NCT04380961|454335064|FG001|Overall Study|Other|0|||
126286612|NCT04380961|454335063|FG000|Overall Study|Randomized but Not Treated|1|||
126286613|NCT04380961|454335064|FG001|Overall Study|Randomized but Not Treated|2|||
125882862|NCT01394016|452869061|FG006|Overall Study|Adverse Event|0|||
125882863|NCT01394016|452869062|FG007|Overall Study|Adverse Event|0|||
125882864|NCT01394016|452869063|FG008|Overall Study|Adverse Event|0|||
126286614|NCT03736031|454335066|FG000|Overall Study|Death|2|||
126286615|NCT03736031|454335067|FG001|Overall Study|Death|4|||
126286616|NCT03736031|454335066|FG000|Overall Study|Lost to Follow-up|21|||
126286617|NCT03736031|454335067|FG001|Overall Study|Lost to Follow-up|2|||
126286618|NCT03736031|454335066|FG000|Overall Study|Withdrawal by Subject|9|||
126286619|NCT03736031|454335067|FG001|Overall Study|Withdrawal by Subject|0|||
126286620|NCT06419907|454336122|FG000|Overall Study|Protocol Violation|0|||
126286621|NCT06419907|454336123|FG001|Overall Study|Protocol Violation|3|||
126286622|NCT06419907|454336124|FG002|Overall Study|Protocol Violation|0|||
126286623|NCT06419907|454336125|FG003|Overall Study|Protocol Violation|1|||
126286624|NCT06419907|454336122|FG000|Overall Study|Lost to Follow-up|0|||
126286625|NCT06419907|454336123|FG001|Overall Study|Lost to Follow-up|0|||
126286626|NCT06419907|454336124|FG002|Overall Study|Lost to Follow-up|2|||
126286627|NCT06419907|454336125|FG003|Overall Study|Lost to Follow-up|1|||
126286628|NCT05929651|454336128|FG000|Overall Study|Protocol Deviation|1|||
126286629|NCT05929651|454336128|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
126286630|NCT02260570|454336129|FG000|Overall Study|Withdrawal by Subject|2|||
126286631|NCT02260570|454336130|FG001|Overall Study|Withdrawal by Subject|1|||
126286632|NCT02260570|454336129|FG000|Overall Study|Physician Decision|1|||
126286633|NCT02260570|454336130|FG001|Overall Study|Physician Decision|1|||
126286634|NCT05026177|454336131|FG000|Overall Study|Adverse Event|33|||
126286635|NCT05026177|454336132|FG001|Overall Study|Adverse Event|33|||
126286636|NCT05026177|454336133|FG002|Overall Study|Adverse Event|17|||
126286637|NCT05026177|454336131|FG000|Overall Study|Lost to Follow-up|7|||
126286638|NCT05026177|454336132|FG001|Overall Study|Lost to Follow-up|6|||
126286639|NCT05026177|454336133|FG002|Overall Study|Lost to Follow-up|8|||
126286640|NCT05026177|454336131|FG000|Overall Study|Noncompliance with study drug|6|||
126286641|NCT05026177|454336132|FG001|Overall Study|Noncompliance with study drug|2|||
126286642|NCT05026177|454336133|FG002|Overall Study|Noncompliance with study drug|1|||
126286643|NCT05026177|454336131|FG000|Overall Study|Physician Decision|4|||
126286644|NCT05026177|454336132|FG001|Overall Study|Physician Decision|1|||
126286645|NCT05026177|454336133|FG002|Overall Study|Physician Decision|0|||
126286646|NCT05026177|454336131|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
126286647|NCT05026177|454336132|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
126286648|NCT05026177|454336133|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
126286649|NCT05026177|454336131|FG000|Overall Study|Withdrawal by Subject|53|||
126286650|NCT05026177|454336132|FG001|Overall Study|Withdrawal by Subject|51|||
126286651|NCT05026177|454336133|FG002|Overall Study|Withdrawal by Subject|55|||
126286652|NCT05026177|454336131|FG000|Overall Study|Protocol Violation|0|||
126286653|NCT05026177|454336132|FG001|Overall Study|Protocol Violation|1|||
126286654|NCT05026177|454336133|FG002|Overall Study|Protocol Violation|0|||
126286655|NCT05026177|454336131|FG000|Overall Study|Study terminated by sponsor|70|||
125882865|NCT01394016|452869064|FG009|Overall Study|Adverse Event|1|||
125882866|NCT01394016|452869065|FG010|Overall Study|Adverse Event|0|||
125882867|NCT01394016|452869066|FG011|Overall Study|Adverse Event|0|||
125882868|NCT01394016|452869067|FG012|Overall Study|Adverse Event|0|||
125882869|NCT01394016|452869068|FG013|Overall Study|Adverse Event|0|||
125882870|NCT01394016|452869069|FG014|Overall Study|Adverse Event|0|||
125882871|NCT01394016|452869070|FG015|Overall Study|Adverse Event|0|||
125882872|NCT01394016|452869071|FG016|Overall Study|Adverse Event|1|||
125882873|NCT01394016|452869072|FG017|Overall Study|Adverse Event|1|||
125882874|NCT01394016|452869073|FG018|Overall Study|Adverse Event|0|||
126286656|NCT05026177|454336132|FG001|Overall Study|Study terminated by sponsor|74|||
126286657|NCT05026177|454336133|FG002|Overall Study|Study terminated by sponsor|67|||
126365459|NCT00913835|454631790|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
126365460|NCT00913835|454631791|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
126286658|NCT05026177|454336131|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
126286659|NCT05026177|454336132|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
126286660|NCT05026177|454336133|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
126286661|NCT05026177|454336131|FG000|Overall Study|Starting alternative treatment|0|||
126286662|NCT05026177|454336132|FG001|Overall Study|Starting alternative treatment|1|||
126286663|NCT05026177|454336133|FG002|Overall Study|Starting alternative treatment|1|||
126286664|NCT05026177|454336131|FG000|Overall Study|Noncompliance with study procedures|0|||
126286665|NCT05026177|454336132|FG001|Overall Study|Noncompliance with study procedures|1|||
126286666|NCT05026177|454336133|FG002|Overall Study|Noncompliance with study procedures|1|||
126286667|NCT05026177|454336131|FG000|Overall Study|Met stopping criteria|0|||
125882875|NCT01394016|452869055|FG000|Overall Study|Sponsor Decision|0|||
125882876|NCT01394016|452869056|FG001|Overall Study|Sponsor Decision|0|||
125882877|NCT01394016|452869057|FG002|Overall Study|Sponsor Decision|0|||
126365461|NCT00913835|454631790|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
126365462|NCT00913835|454631791|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
126365463|NCT01308788|454631792|FG000|2-year Treatment|medication change by treating physician|4|||
126365464|NCT01308788|454631793|FG001|2-year Treatment|medication change by treating physician|11|||
126365465|NCT02414841|454631794|FG000|Overall Study|Withdrawal by Subject|7|||
126365466|NCT02414841|454631795|FG001|Overall Study|Withdrawal by Subject|5|||
126365467|NCT02414841|454631794|FG000|Overall Study|Lost to Follow-up|13|||
126365468|NCT02414841|454631795|FG001|Overall Study|Lost to Follow-up|6|||
126365469|NCT02414841|454631794|FG000|Overall Study|Death|17|||
126365470|NCT02414841|454631795|FG001|Overall Study|Death|14|||
126365471|NCT02414841|454631794|FG000|Overall Study|Received a Kidney Transplant|13|||
126365472|NCT02414841|454631795|FG001|Overall Study|Received a Kidney Transplant|4|||
126365473|NCT02414841|454631794|FG000|Overall Study|Randomized But Not Treated|6|||
126365474|NCT02414841|454631795|FG001|Overall Study|Randomized But Not Treated|4|||
126365475|NCT03249558|454631798|FG000|Overall Study|Lost to Follow-up|2|||
126365476|NCT03249558|454631799|FG001|Overall Study|Lost to Follow-up|1|||
126365477|NCT03249558|454631800|FG002|Overall Study|Lost to Follow-up|4|||
126365478|NCT03249558|454631798|FG000|Overall Study|Physician Decision|1|||
126365479|NCT03249558|454631799|FG001|Overall Study|Physician Decision|0|||
126365480|NCT03249558|454631800|FG002|Overall Study|Physician Decision|0|||
126365481|NCT03249558|454631798|FG000|Overall Study|Withdrawal by Subject|6|||
126365482|NCT03249558|454631799|FG001|Overall Study|Withdrawal by Subject|5|||
126365483|NCT03249558|454631800|FG002|Overall Study|Withdrawal by Subject|7|||
126365484|NCT03249558|454631798|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
126365485|NCT03249558|454631799|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
126365486|NCT03249558|454631800|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
126365487|NCT03249558|454631798|FG000|Overall Study|Protocol Violation|1|||
126365488|NCT03249558|454631799|FG001|Overall Study|Protocol Violation|1|||
126365489|NCT03249558|454631800|FG002|Overall Study|Protocol Violation|2|||
126365490|NCT05943990|454631802|FG000|Overall Study|Study Terminated by Sponsor|0|||
126365491|NCT05943990|454631803|FG001|Overall Study|Study Terminated by Sponsor|0|||
126041760|NCT03505008|453451124|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
126365492|NCT05943990|454631804|FG002|Overall Study|Study Terminated by Sponsor|1|||
126365493|NCT02657356|454632786|FG000|Overall Study|Death|1|||
126365494|NCT02657356|454632787|FG001|Overall Study|Death|0|||
126365495|NCT02657356|454632786|FG000|Overall Study|Withdrawal by Subject|5|||
126041761|NCT03505008|453451121|FG000|Before Week 24 Randomization|Complication|1|||
126365496|NCT02657356|454632787|FG001|Overall Study|Withdrawal by Subject|6|||
126365497|NCT02657356|454632786|FG000|Overall Study|Terminated by Sponsor|8|||
126365498|NCT02657356|454632787|FG001|Overall Study|Terminated by Sponsor|5|||
126365499|NCT02657356|454632786|FG000|Overall Study|Rolled over to EAP study|6|||
126365500|NCT02657356|454632787|FG001|Overall Study|Rolled over to EAP study|4|||
126365501|NCT03379870|454632788|FG000|Overall Study|Lost to Follow-up|1|||
126365502|NCT03379870|454632789|FG001|Overall Study|Lost to Follow-up|0|||
126365503|NCT03379870|454632788|FG000|Overall Study|Protocol Violation|1|||
126365504|NCT03379870|454632789|FG001|Overall Study|Protocol Violation|1|||
126365505|NCT01394185|454632790|FG000|Overall Study|Withdrawal by Subject|2|||
126365506|NCT01394185|454632791|FG001|Overall Study|Withdrawal by Subject|0|||
126365507|NCT01394185|454632792|FG002|Overall Study|Withdrawal by Subject|0|||
126365508|NCT01394185|454632793|FG003|Overall Study|Withdrawal by Subject|0|||
126365509|NCT01394185|454632794|FG004|Overall Study|Withdrawal by Subject|1|||
126365510|NCT01394185|454632795|FG005|Overall Study|Withdrawal by Subject|0|||
126365511|NCT01394185|454632790|FG000|Overall Study|Change in protocol|3|||
126365512|NCT01394185|454632791|FG001|Overall Study|Change in protocol|0|||
126365513|NCT01394185|454632792|FG002|Overall Study|Change in protocol|0|||
126365514|NCT01394185|454632793|FG003|Overall Study|Change in protocol|0|||
126365515|NCT01394185|454632794|FG004|Overall Study|Change in protocol|3|||
126365516|NCT01394185|454632795|FG005|Overall Study|Change in protocol|0|||
126365517|NCT01394185|454632790|FG000|Overall Study|Protocol Violation|1|||
126365518|NCT01394185|454632791|FG001|Overall Study|Protocol Violation|0|||
126365519|NCT01394185|454632792|FG002|Overall Study|Protocol Violation|0|||
126365520|NCT01394185|454632793|FG003|Overall Study|Protocol Violation|1|||
126365521|NCT01394185|454632794|FG004|Overall Study|Protocol Violation|0|||
126365522|NCT01394185|454632795|FG005|Overall Study|Protocol Violation|1|||
126365523|NCT01817777|454632801|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
126365524|NCT01817777|454632802|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
126365525|NCT01817777|454632803|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
126365526|NCT01817777|454632801|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
126365527|NCT01817777|454632802|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
126365528|NCT01817777|454632803|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
126365529|NCT01817777|454632801|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
126365530|NCT01817777|454632802|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
126365531|NCT01817777|454632803|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
126365532|NCT01817777|454632801|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
126286668|NCT05026177|454336132|FG001|Overall Study|Met stopping criteria|0|||
126286669|NCT05026177|454336133|FG002|Overall Study|Met stopping criteria|1|||
126286670|NCT05026177|454336131|FG000|Overall Study|Health issues preventing continuation|0|||
126286671|NCT05026177|454336132|FG001|Overall Study|Health issues preventing continuation|0|||
126286672|NCT05026177|454336133|FG002|Overall Study|Health issues preventing continuation|1|||
126286673|NCT05026177|454336131|FG000|Overall Study|Randomized in error, not treated|0|||
126286674|NCT05026177|454336132|FG001|Overall Study|Randomized in error, not treated|0|||
126286675|NCT05026177|454336133|FG002|Overall Study|Randomized in error, not treated|2|||
126286676|NCT04856917|454336134|FG000|Overall Study|Withdrawal by Subject|4|||
126286677|NCT04856917|454336135|FG001|Overall Study|Withdrawal by Subject|3|||
126286678|NCT04856917|454336136|FG002|Overall Study|Withdrawal by Subject|1|||
126286679|NCT04856917|454336134|FG000|Overall Study|Lost to Follow-up|3|||
126286680|NCT04856917|454336135|FG001|Overall Study|Lost to Follow-up|1|||
126286681|NCT04856917|454336136|FG002|Overall Study|Lost to Follow-up|1|||
126286682|NCT04856917|454336134|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
126286683|NCT04856917|454336135|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
126286684|NCT04856917|454336136|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
126286685|NCT04856917|454336134|FG000|Overall Study|Other|1|||
126286686|NCT04856917|454336135|FG001|Overall Study|Other|1|||
126286687|NCT04856917|454336136|FG002|Overall Study|Other|0|||
126286688|NCT01169337|454336137|FG000|Overall Study|Lack of Efficacy|5|||
126286689|NCT01169337|454336138|FG001|Overall Study|Lack of Efficacy|7|||
126286690|NCT01169337|454336139|FG002|Overall Study|Lack of Efficacy|0|||
126286691|NCT01169337|454336137|FG000|Overall Study|Adverse Event|12|||
126286692|NCT01169337|454336138|FG001|Overall Study|Adverse Event|18|||
126286693|NCT01169337|454336139|FG002|Overall Study|Adverse Event|0|||
126286694|NCT01169337|454336137|FG000|Overall Study|Death|2|||
126286695|NCT01169337|454336138|FG001|Overall Study|Death|0|||
126286696|NCT01169337|454336139|FG002|Overall Study|Death|0|||
126286697|NCT01169337|454336137|FG000|Overall Study|Withdrawal by Subject|11|||
126286698|NCT01169337|454336138|FG001|Overall Study|Withdrawal by Subject|11|||
126286699|NCT01169337|454336139|FG002|Overall Study|Withdrawal by Subject|6|||
126286700|NCT01169337|454336137|FG000|Overall Study|Noncompliance|2|||
126286701|NCT01169337|454336138|FG001|Overall Study|Noncompliance|0|||
126286702|NCT01169337|454336139|FG002|Overall Study|Noncompliance|0|||
126286703|NCT01169337|454336137|FG000|Overall Study|Other complicating disease|1|||
126286704|NCT01169337|454336138|FG001|Overall Study|Other complicating disease|1|||
126286705|NCT01169337|454336139|FG002|Overall Study|Other complicating disease|0|||
126286706|NCT01169337|454336137|FG000|Overall Study|Physician Decision|1|||
126286707|NCT01169337|454336138|FG001|Overall Study|Physician Decision|5|||
126286708|NCT01169337|454336139|FG002|Overall Study|Physician Decision|0|||
126286709|NCT01169337|454336137|FG000|Overall Study|Alternative therapy|0|||
126286710|NCT01169337|454336138|FG001|Overall Study|Alternative therapy|2|||
126286711|NCT01169337|454336139|FG002|Overall Study|Alternative therapy|0|||
126286712|NCT01169337|454336137|FG000|Overall Study|Changed hospital|0|||
126286713|NCT01169337|454336138|FG001|Overall Study|Changed hospital|1|||
126286714|NCT01169337|454336139|FG002|Overall Study|Changed hospital|0|||
126286715|NCT01169337|454336137|FG000|Overall Study|Never started treatment|0|||
126286716|NCT01169337|454336138|FG001|Overall Study|Never started treatment|2|||
126286717|NCT01169337|454336139|FG002|Overall Study|Never started treatment|0|||
126286718|NCT01169337|454336137|FG000|Overall Study|Reason not reported|1|||
126286719|NCT01169337|454336138|FG001|Overall Study|Reason not reported|0|||
126286720|NCT01169337|454336139|FG002|Overall Study|Reason not reported|0|||
126286721|NCT01169337|454336137|FG000|Overall Study|Continuing lenalidomide|9|||
126286722|NCT01169337|454336138|FG001|Overall Study|Continuing lenalidomide|43|||
126286723|NCT01169337|454336139|FG002|Overall Study|Continuing lenalidomide|0|||
126286724|NCT03560037|454336140|FG000|Overall Study|Protocol Violation|1|||
126286725|NCT03560037|454336141|FG001|Overall Study|Protocol Violation|0|||
126286726|NCT03560037|454336140|FG000|Overall Study|Physician Decision|0|||
126286727|NCT03560037|454336141|FG001|Overall Study|Physician Decision|1|||
126286728|NCT03816878|454336142|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
126286729|NCT03816878|454336143|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
126286730|NCT03816878|454336142|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
126286731|NCT03816878|454336143|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
125882878|NCT01394016|452869058|FG003|Overall Study|Sponsor Decision|0|||
126286732|NCT00588770|454336144|FG000|Overall Study|Disease progression|85|||
126286733|NCT00588770|454336145|FG001|Overall Study|Disease progression|68|||
126286734|NCT00588770|454336144|FG000|Overall Study|Adverse Event|29|||
126286735|NCT00588770|454336145|FG001|Overall Study|Adverse Event|58|||
126286736|NCT00588770|454336144|FG000|Overall Study|Death|13|||
126286737|NCT00588770|454336145|FG001|Overall Study|Death|22|||
126286738|NCT00588770|454336144|FG000|Overall Study|Withdrawal by Subject|15|||
126286739|NCT00588770|454336145|FG001|Overall Study|Withdrawal by Subject|25|||
126286740|NCT00588770|454336144|FG000|Overall Study|Alternative therapy|2|||
126286741|NCT00588770|454336145|FG001|Overall Study|Alternative therapy|4|||
126286742|NCT00588770|454336144|FG000|Overall Study|Other complicating disease|3|||
126286743|NCT00588770|454336145|FG001|Overall Study|Other complicating disease|2|||
126286744|NCT00588770|454336144|FG000|Overall Study|Not start protocol therapy|0|||
126286745|NCT00588770|454336145|FG001|Overall Study|Not start protocol therapy|9|||
126286746|NCT00588770|454336144|FG000|Overall Study|Lack of Efficacy|8|||
126286747|NCT00588770|454336145|FG001|Overall Study|Lack of Efficacy|10|||
126286748|NCT00588770|454336144|FG000|Overall Study|Physician discretion|2|||
126286749|NCT00588770|454336145|FG001|Overall Study|Physician discretion|0|||
126286750|NCT00588770|454336144|FG000|Overall Study|Patient non-compliance|2|||
126286751|NCT00588770|454336145|FG001|Overall Study|Patient non-compliance|2|||
126286752|NCT03698019|454336146|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
126286753|NCT03698019|454336147|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
126286754|NCT03698019|454336146|FG000|Step 1: Registration|Withdrawal by Subject|7|||
126286755|NCT03698019|454336147|FG001|Step 1: Registration|Withdrawal by Subject|2|||
126286756|NCT03698019|454336146|FG000|Step 1: Registration|Toxicity|0|||
126286757|NCT03698019|454336147|FG001|Step 1: Registration|Toxicity|1|||
126286758|NCT03698019|454336146|FG000|Step 1: Registration|Disease Progression|0|||
126286759|NCT03698019|454336147|FG001|Step 1: Registration|Disease Progression|12|||
126286760|NCT03698019|454336146|FG000|Step 1: Registration|Co-morbidities|0|||
126286761|NCT03698019|454336147|FG001|Step 1: Registration|Co-morbidities|1|||
126286762|NCT03698019|454336146|FG000|Step 1: Registration|Scheduling Issues|1|||
126286763|NCT03698019|454336147|FG001|Step 1: Registration|Scheduling Issues|0|||
126286764|NCT03698019|454336146|FG000|Step 1: Registration|Participant Refusal|0|||
126286765|NCT03698019|454336147|FG001|Step 1: Registration|Participant Refusal|1|||
126286766|NCT03698019|454336146|FG000|Step 2: Surgery|Participant Refusal|2|||
126286767|NCT03698019|454336147|FG001|Step 2: Surgery|Participant Refusal|1|||
126286768|NCT03698019|454336146|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
126286769|NCT03698019|454336147|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
126286770|NCT03698019|454336146|FG000|Step 2: Surgery|Metastatic Disease|16|||
126286771|NCT03698019|454336147|FG001|Step 2: Surgery|Metastatic Disease|9|||
126286772|NCT03698019|454336146|FG000|Step 2: Surgery|Residual Disease|2|||
126286773|NCT03698019|454336147|FG001|Step 2: Surgery|Residual Disease|1|||
126286774|NCT03698019|454336146|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
126286775|NCT03698019|454336147|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
126286776|NCT03698019|454336146|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
126286777|NCT03698019|454336147|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
126286778|NCT03698019|454336146|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
126286779|NCT03698019|454336147|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
126286780|NCT03698019|454336146|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
126286781|NCT03698019|454336147|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
126286782|NCT03698019|454336146|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
126286783|NCT03698019|454336147|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
126286784|NCT03698019|454336146|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
126286785|NCT03698019|454336147|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
126286786|NCT03698019|454336146|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
126286787|NCT03698019|454336147|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
126286788|NCT03698019|454336146|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
126286789|NCT03698019|454336147|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
126286790|NCT01856192|454336148|FG000|Overall Study|Adverse Event|12|||
126286791|NCT01856192|454336149|FG001|Overall Study|Adverse Event|4|||
126286792|NCT01856192|454336148|FG000|Overall Study|Alternative therapy|0|||
126286793|NCT01856192|454336149|FG001|Overall Study|Alternative therapy|3|||
126286794|NCT01856192|454336148|FG000|Overall Study|Death|3|||
126286795|NCT01856192|454336149|FG001|Overall Study|Death|5|||
126286796|NCT01856192|454336148|FG000|Overall Study|Lack of Efficacy|0|||
126286797|NCT01856192|454336149|FG001|Overall Study|Lack of Efficacy|5|||
126286798|NCT01856192|454336148|FG000|Overall Study|Withdrawal by Subject|1|||
126286799|NCT01856192|454336149|FG001|Overall Study|Withdrawal by Subject|1|||
126286800|NCT01856192|454336148|FG000|Overall Study|Other diseases|1|||
126286801|NCT01856192|454336149|FG001|Overall Study|Other diseases|0|||
126286802|NCT01856192|454336148|FG000|Overall Study|Never started treatment|7|||
126286803|NCT01856192|454336149|FG001|Overall Study|Never started treatment|5|||
126286804|NCT01856192|454336148|FG000|Overall Study|Path ineligible|20|||
126286805|NCT01856192|454336149|FG001|Overall Study|Path ineligible|34|||
126286806|NCT01856192|454336148|FG000|Overall Study|Non-path ineligible|2|||
126286807|NCT01856192|454336149|FG001|Overall Study|Non-path ineligible|2|||
126286808|NCT01856192|454336148|FG000|Overall Study|Physician Decision|1|||
126286809|NCT01856192|454336149|FG001|Overall Study|Physician Decision|1|||
126286810|NCT01856192|454336148|FG000|Overall Study|Suspicion of progressive disease|1|||
126286811|NCT01856192|454336149|FG001|Overall Study|Suspicion of progressive disease|0|||
126286812|NCT01856192|454336148|FG000|Overall Study|Non-compliance|1|||
126286813|NCT01856192|454336149|FG001|Overall Study|Non-compliance|0|||
126286814|NCT02642042|454336150|FG000|Overall Study|Adverse Event|22|||
126286815|NCT02642042|454336150|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126286816|NCT02642042|454336150|FG000|Overall Study|Progression/Relapse|28|||
126286817|NCT02642042|454336150|FG000|Overall Study|Death|1|||
126286818|NCT02642042|454336150|FG000|Overall Study|Not Protocol Specified|2|||
126286819|NCT04976621|454336151|FG000|Overall Study|Lost to Follow-up|2|||
126286820|NCT04976621|454336152|FG001|Overall Study|Lost to Follow-up|1|||
126286821|NCT04976621|454336151|FG000|Overall Study|Withdrawal by Subject|1|||
126286822|NCT04976621|454336152|FG001|Overall Study|Withdrawal by Subject|0|||
126286823|NCT03348631|454336155|FG000|Overall Study|Not Eligible, No treatment|0|||
126286824|NCT03348631|454336156|FG001|Overall Study|Not Eligible, No treatment|1|||
126286825|NCT03348631|454336155|FG000|Overall Study|Not Eligible, Treated|2|||
126286826|NCT03348631|454336156|FG001|Overall Study|Not Eligible, Treated|0|||
126286827|NCT03348631|454336155|FG000|Overall Study|Eligible, No Treatment|1|||
126286828|NCT03348631|454336156|FG001|Overall Study|Eligible, No Treatment|0|||
126286829|NCT05223920|454336164|FG000|Overall Study|Adverse Event|6|||
126286830|NCT05223920|454336165|FG001|Overall Study|Adverse Event|3|||
126286831|NCT05223920|454336164|FG000|Overall Study|Death|2|||
126286832|NCT05223920|454336165|FG001|Overall Study|Death|0|||
126286833|NCT05223920|454336164|FG000|Overall Study|Disease Progression|1|||
126286834|NCT05223920|454336165|FG001|Overall Study|Disease Progression|2|||
126286835|NCT05223920|454336164|FG000|Overall Study|Physician Decision|1|||
126286836|NCT05223920|454336165|FG001|Overall Study|Physician Decision|2|||
126286837|NCT05223920|454336164|FG000|Overall Study|Sponsor decision|11|||
126286838|NCT05223920|454336165|FG001|Overall Study|Sponsor decision|9|||
126286839|NCT05223920|454336164|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
126286840|NCT05223920|454336165|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
126286841|NCT05223920|454336164|FG000|Overall Study|Subject decision|1|||
126286842|NCT05223920|454336165|FG001|Overall Study|Subject decision|0|||
126286843|NCT05223920|454336164|FG000|Overall Study|Withdrawal by Subject|1|||
126286844|NCT05223920|454336165|FG001|Overall Study|Withdrawal by Subject|6|||
126286845|NCT03790657|454336166|FG000|Overall Study|Adverse Event|1|||
126286846|NCT03790657|454336167|FG001|Overall Study|Adverse Event|1|||
126286847|NCT03790657|454336166|FG000|Overall Study|Withdrawal by Subject|1|||
126286848|NCT03790657|454336167|FG001|Overall Study|Withdrawal by Subject|1|||
126286849|NCT03154125|454336168|FG000|Overall Study|Lost to Follow-up|11|||
126286850|NCT03154125|454336169|FG001|Overall Study|Lost to Follow-up|11|||
126286851|NCT03154125|454336170|FG002|Overall Study|Lost to Follow-up|0|||
126286852|NCT03154125|454336168|FG000|Overall Study|Withdrawal by Subject|49|||
126286853|NCT03154125|454336169|FG001|Overall Study|Withdrawal by Subject|55|||
126286854|NCT03154125|454336170|FG002|Overall Study|Withdrawal by Subject|8|||
126286855|NCT03154125|454336168|FG000|Overall Study|Physician Decision|13|||
126286856|NCT03154125|454336169|FG001|Overall Study|Physician Decision|6|||
126286857|NCT03154125|454336170|FG002|Overall Study|Physician Decision|0|||
126286858|NCT03154125|454336168|FG000|Overall Study|Protocol Violation|3|||
126286859|NCT03154125|454336169|FG001|Overall Study|Protocol Violation|5|||
126286860|NCT03154125|454336170|FG002|Overall Study|Protocol Violation|0|||
126286861|NCT05219448|454336171|FG000|Overall Study|Lost to Follow-up|9|||
126286862|NCT05219448|454336172|FG001|Overall Study|Lost to Follow-up|0|||
126286863|NCT02287922|454336173|FG000|Overall Study|Adverse Event|1|||
126286864|NCT02287922|454336174|FG001|Overall Study|Adverse Event|1|||
126286865|NCT02287922|454336175|FG002|Overall Study|Adverse Event|3|||
126286866|NCT02287922|454336176|FG003|Overall Study|Adverse Event|4|||
126286867|NCT02287922|454336173|FG000|Overall Study|Withdrawal by Subject|1|||
126286868|NCT02287922|454336174|FG001|Overall Study|Withdrawal by Subject|1|||
126286869|NCT02287922|454336175|FG002|Overall Study|Withdrawal by Subject|1|||
125882879|NCT01394016|452869059|FG004|Overall Study|Sponsor Decision|0|||
125882880|NCT01394016|452869060|FG005|Overall Study|Sponsor Decision|0|||
126286870|NCT02287922|454336176|FG003|Overall Study|Withdrawal by Subject|2|||
126286871|NCT02287922|454336173|FG000|Overall Study|Lost to Follow-up|0|||
126286872|NCT02287922|454336174|FG001|Overall Study|Lost to Follow-up|0|||
126286873|NCT02287922|454336175|FG002|Overall Study|Lost to Follow-up|1|||
126286874|NCT02287922|454336176|FG003|Overall Study|Lost to Follow-up|0|||
126286875|NCT02287922|454336173|FG000|Overall Study|Sponsor's decision|0|||
126286876|NCT02287922|454336174|FG001|Overall Study|Sponsor's decision|0|||
126286877|NCT02287922|454336175|FG002|Overall Study|Sponsor's decision|0|||
126286878|NCT02287922|454336176|FG003|Overall Study|Sponsor's decision|1|||
126286879|NCT02287922|454336173|FG000|Overall Study|Other|1|||
126286880|NCT02287922|454336174|FG001|Overall Study|Other|0|||
126286881|NCT02287922|454336175|FG002|Overall Study|Other|2|||
126286882|NCT02287922|454336176|FG003|Overall Study|Other|0|||
126286883|NCT00668317|454336177|FG000|Overall Study|Adverse Event|2|||
126286884|NCT04186845|454336196|FG000|Overall Study|Death|2|||
126286885|NCT04186845|454336196|FG000|Overall Study|Lost to Follow-up|1|||
126286886|NCT04186845|454336196|FG000|Overall Study|Physician Decision|1|||
126286887|NCT04186845|454336196|FG000|Overall Study|Protocol Violation|1|||
126286888|NCT04186845|454336196|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
126286889|NCT04186845|454336196|FG000|Overall Study|Biopsy ordered but not done|1|||
126286890|NCT04186845|454336196|FG000|Overall Study|It was previously confirmed|1|||
126286891|NCT04186845|454336196|FG000|Overall Study|Patient cancelled scheduled scans|2|||
126286892|NCT04186845|454336196|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
126286893|NCT04186845|454336196|FG000|Overall Study|Subject refused confirmatory imaging|1|||
126286894|NCT04186845|454336196|FG000|Overall Study|Too small to biopsy|1|||
126286895|NCT05061420|454336199|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
126286896|NCT05061420|454336200|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
126286897|NCT05061420|454336201|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
126286898|NCT05061420|454336199|FG000|Overall Study|Progressive disease|11|||
126286899|NCT05061420|454336200|FG001|Overall Study|Progressive disease|15|||
126286900|NCT05061420|454336201|FG002|Overall Study|Progressive disease|14|||
126286901|NCT05061420|454336199|FG000|Overall Study|Withdrawal by Subject|2|||
126286902|NCT05061420|454336200|FG001|Overall Study|Withdrawal by Subject|0|||
126286903|NCT05061420|454336201|FG002|Overall Study|Withdrawal by Subject|1|||
126286904|NCT05061420|454336199|FG000|Overall Study|Not related to COVID-19|2|||
126286905|NCT05061420|454336200|FG001|Overall Study|Not related to COVID-19|0|||
126286906|NCT05061420|454336201|FG002|Overall Study|Not related to COVID-19|0|||
126286907|NCT01814553|454336202|FG000|Overall Study|PD per clinical progression|6|||
126286908|NCT01814553|454336203|FG001|Overall Study|PD per clinical progression|8|||
126286909|NCT01814553|454336202|FG000|Overall Study|Other Adverse Event|4|||
126286910|NCT01814553|454336203|FG001|Overall Study|Other Adverse Event|5|||
126286911|NCT01814553|454336202|FG000|Overall Study|Withdrawal by Subject|1|||
126286912|NCT01814553|454336203|FG001|Overall Study|Withdrawal by Subject|1|||
126286913|NCT01814553|454336202|FG000|Overall Study|Other than stated|7|||
126286914|NCT01814553|454336203|FG001|Overall Study|Other than stated|8|||
126286915|NCT04138823|454336204|FG000|Overall Study|Clinical disease progression|0|||
126286916|NCT04138823|454336205|FG001|Overall Study|Clinical disease progression|0|||
126286917|NCT04138823|454336206|FG002|Overall Study|Clinical disease progression|1|||
126286918|NCT04138823|454336204|FG000|Overall Study|Objective disease progression|3|||
126286919|NCT04138823|454336205|FG001|Overall Study|Objective disease progression|2|||
126286920|NCT04138823|454336206|FG002|Overall Study|Objective disease progression|5|||
126286921|NCT02859142|454336207|FG000|Overall Study|Adverse Event|1|||
126286922|NCT02859142|454336208|FG001|Overall Study|Adverse Event|2|||
126286923|NCT02859142|454336207|FG000|Overall Study|Lost to Follow-up|1|||
126286924|NCT02859142|454336208|FG001|Overall Study|Lost to Follow-up|4|||
126286925|NCT02859142|454336207|FG000|Overall Study|Withdrawal by Subject|2|||
126286926|NCT02859142|454336208|FG001|Overall Study|Withdrawal by Subject|0|||
126286927|NCT02859142|454336207|FG000|Overall Study|Scheduling difficulties|0|||
126286928|NCT02859142|454336208|FG001|Overall Study|Scheduling difficulties|3|||
126286929|NCT03290079|454336209|FG000|Overall Study|Death|2|||
126286930|NCT02466685|454336210|FG000|Overall Study|Adverse Event|5|||
126286931|NCT02466685|454336211|FG001|Overall Study|Adverse Event|2|||
126286932|NCT02466685|454336210|FG000|Overall Study|Lost to Follow-up|1|||
126286933|NCT02466685|454336211|FG001|Overall Study|Lost to Follow-up|1|||
126286934|NCT02466685|454336210|FG000|Overall Study|Withdrawal by Subject|1|||
126286935|NCT02466685|454336211|FG001|Overall Study|Withdrawal by Subject|0|||
126286936|NCT02466685|454336210|FG000|Overall Study|Physician Decision|1|||
126286937|NCT02466685|454336211|FG001|Overall Study|Physician Decision|1|||
126286938|NCT03340974|454336212|FG000|Completion of Study -Long Term Follow up|Death|8|||
126286939|NCT03340974|454336213|FG001|Completion of Study -Long Term Follow up|Death|5|||
126286940|NCT03340974|454336214|FG002|Completion of Study -Long Term Follow up|Death|5|||
126286941|NCT03340974|454336215|FG003|Completion of Study -Long Term Follow up|Death|7|||
126286942|NCT03340974|454336212|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
126286943|NCT03340974|454336213|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
126286944|NCT03340974|454336214|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
126286945|NCT03340974|454336215|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
126286946|NCT03340974|454336212|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
126286947|NCT03340974|454336213|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
126286948|NCT03340974|454336214|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
126286949|NCT03340974|454336215|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
126286950|NCT03340974|454336212|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
126286951|NCT03340974|454336213|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
126286952|NCT03340974|454336214|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
126286953|NCT03340974|454336215|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
126286954|NCT04877457|454336220|FG000|Overall Study|Early termination of study due to low enrollment|2|||
126286955|NCT04877457|454336221|FG001|Overall Study|Early termination of study due to low enrollment|1|||
126286956|NCT04697069|454336222|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
126286957|NCT04697069|454336223|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
126286958|NCT04697069|454336222|FG000|Overall Study|Study termination|2|||
126286959|NCT04697069|454336223|FG001|Overall Study|Study termination|1|||
126286960|NCT05180227|454336224|FG000|Overall Study|Hypertension at screening|1|||
126286961|NCT05180227|454336224|FG000|Overall Study|Lost to Follow-up|1|||
126286962|NCT04739800|454336225|FG000|Overall Study|Adverse Event|2|||
126286963|NCT04739800|454336226|FG001|Overall Study|Adverse Event|1|||
126286964|NCT04739800|454336227|FG002|Overall Study|Adverse Event|4|||
126286965|NCT04739800|454336228|FG003|Overall Study|Adverse Event|5|||
126286966|NCT04739800|454336225|FG000|Overall Study|Never Treated|2|||
126286967|NCT04739800|454336226|FG001|Overall Study|Never Treated|0|||
126286968|NCT04739800|454336227|FG002|Overall Study|Never Treated|1|||
126286969|NCT04739800|454336228|FG003|Overall Study|Never Treated|1|||
126286970|NCT04739800|454336225|FG000|Overall Study|On Treatment|5|||
126286971|NCT04739800|454336226|FG001|Overall Study|On Treatment|9|||
126286972|NCT04739800|454336227|FG002|Overall Study|On Treatment|9|||
126286973|NCT04739800|454336228|FG003|Overall Study|On Treatment|9|||
126286974|NCT04739800|454336225|FG000|Overall Study|Symptomatic Deterioration|1|||
126286975|NCT04739800|454336226|FG001|Overall Study|Symptomatic Deterioration|1|||
126286976|NCT04739800|454336227|FG002|Overall Study|Symptomatic Deterioration|3|||
126286977|NCT04739800|454336228|FG003|Overall Study|Symptomatic Deterioration|0|||
126286978|NCT04739800|454336225|FG000|Overall Study|Withdrawal by Subject|1|||
126286979|NCT04739800|454336226|FG001|Overall Study|Withdrawal by Subject|2|||
126286980|NCT04739800|454336227|FG002|Overall Study|Withdrawal by Subject|1|||
126286981|NCT04739800|454336228|FG003|Overall Study|Withdrawal by Subject|3|||
126286982|NCT04739800|454336225|FG000|Overall Study|Other Reason|1|||
126286983|NCT04739800|454336226|FG001|Overall Study|Other Reason|3|||
126286984|NCT04739800|454336227|FG002|Overall Study|Other Reason|5|||
126286985|NCT04739800|454336228|FG003|Overall Study|Other Reason|4|||
126286986|NCT02779855|454336229|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
126286987|NCT02779855|454336230|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
126286988|NCT02779855|454336231|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
126286989|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
126286990|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Off-label use|283|||
126286991|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
126286992|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
126286993|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
126365533|NCT01817777|454632802|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
126365534|NCT01817777|454632803|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
126365535|NCT01817777|454632801|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
126365536|NCT01817777|454632802|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
126365537|NCT01817777|454632803|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
126286994|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
125882881|NCT01394016|452869061|FG006|Overall Study|Sponsor Decision|0|||
126041762|NCT03505008|453451122|FG001|Before Week 24 Randomization|Complication|0|||
126041763|NCT03505008|453451123|FG002|Before Week 24 Randomization|Complication|0|||
126041764|NCT03505008|453451124|FG003|Before Week 24 Randomization|Complication|0|||
126041765|NCT03505008|453451121|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
126286995|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
126286996|NCT01070953|454336234|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
126286997|NCT01070953|454336234|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
126286998|NCT01070953|454336234|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
126286999|NCT03514017|454336236|FG000|Overall Study|Death|1|||
126287000|NCT03514017|454336236|FG000|Overall Study|Adverse Event|1|||
126287001|NCT01290302|454337609|FG000|Overall Study|Adverse Event|2|||
126287002|NCT01290302|454337610|FG001|Overall Study|Adverse Event|0|||
126287003|NCT01290302|454337609|FG000|Overall Study|Withdrawal by Subject|1|||
126287004|NCT01290302|454337610|FG001|Overall Study|Withdrawal by Subject|0|||
126287005|NCT01290302|454337609|FG000|Overall Study|Physician Decision|0|||
126287006|NCT01290302|454337610|FG001|Overall Study|Physician Decision|2|||
126287007|NCT01290302|454337609|FG000|Overall Study|Expiration of time for screening window|1|||
126287008|NCT01290302|454337610|FG001|Overall Study|Expiration of time for screening window|0|||
126287009|NCT01059786|454337611|FG000|Overall Study|Did not receive 6 cycles.|0|||
126287010|NCT01059786|454337612|FG001|Overall Study|Did not receive 6 cycles.|0|||
126287011|NCT01059786|454337613|FG002|Overall Study|Did not receive 6 cycles.|4|||
126287012|NCT01059786|454337614|FG003|Overall Study|Did not receive 6 cycles.|1|||
126287013|NCT01059786|454337615|FG004|Overall Study|Did not receive 6 cycles.|0|||
126287014|NCT02586688|454337618|FG000|Overall Study|Lost to Follow-up|2|||
126287015|NCT02586688|454337619|FG001|Overall Study|Lost to Follow-up|1|||
126287016|NCT02586688|454337618|FG000|Overall Study|Withdrawal by Subject|1|||
126287017|NCT02586688|454337619|FG001|Overall Study|Withdrawal by Subject|1|||
126287018|NCT02586688|454337618|FG000|Overall Study|Adverse Event|3|||
126041766|NCT03505008|453451122|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
126287019|NCT02586688|454337619|FG001|Overall Study|Adverse Event|1|||
126287020|NCT02454608|454337620|FG000|Double-Blind Period|Lack of Efficacy|0|||
126099951|NCT00903682|453657722|FG000|Overall Study|Withdrawal by Subject|5|||
126287021|NCT02454608|454337621|FG001|Double-Blind Period|Lack of Efficacy|2|||
126287022|NCT02454608|454337622|FG002|Double-Blind Period|Lack of Efficacy|0|||
126287023|NCT02454608|454337620|FG000|Open Label Period|Lost to Follow-up|0|||
126287024|NCT02454608|454337621|FG001|Open Label Period|Lost to Follow-up|0|||
126287025|NCT02454608|454337622|FG002|Open Label Period|Lost to Follow-up|11|||
126287026|NCT02454608|454337620|FG000|Open Label Period|Withdrawal by Subject|0|||
126287027|NCT02454608|454337621|FG001|Open Label Period|Withdrawal by Subject|0|||
126287028|NCT02454608|454337622|FG002|Open Label Period|Withdrawal by Subject|8|||
126287029|NCT01433055|454337623|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
126287030|NCT01433055|454337624|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
126287031|NCT01433055|454337623|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
126287032|NCT01433055|454337624|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
126287033|NCT03573830|454337628|FG000|Overall Study|Dropped without completing treatment|0|||
126287034|NCT03573830|454337629|FG001|Overall Study|Dropped without completing treatment|7|||
126287035|NCT03573830|454337628|FG000|Overall Study|Lost to Follow-up|4|||
126287036|NCT03573830|454337629|FG001|Overall Study|Lost to Follow-up|0|||
126287037|NCT01769456|454337630|FG000|Overall Study|Lost to Follow-up|19|||
126287038|NCT01769456|454337630|FG000|Overall Study|Withdrawal by Subject|3|||
126287039|NCT01769456|454337630|FG000|Overall Study|Did not receive PCC intervention|6|||
126287040|NCT01769456|454337630|FG000|Overall Study|Moved out of the area|3|||
126287041|NCT01769456|454337630|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
126287042|NCT01769456|454337630|FG000|Overall Study|Parental request to youth to withdraw|1|||
126287043|NCT02847260|454337637|FG000|Overall Study|Adverse Event|3|||
126287044|NCT02847260|454337637|FG000|Overall Study|Withdrawal by Subject|2|||
126287045|NCT02847260|454337637|FG000|Overall Study|Clinical Deterioration|1|||
126287046|NCT02847260|454337637|FG000|Overall Study|Physician Decision|1|||
126287047|NCT01692626|454337639|FG000|Overall Study|Death|0|||
126287048|NCT01692626|454337640|FG001|Overall Study|Death|1|||
126287049|NCT01692626|454337639|FG000|Overall Study|Adverse Event|2|||
126287050|NCT01692626|454337640|FG001|Overall Study|Adverse Event|3|||
126287051|NCT01692626|454337639|FG000|Overall Study|Protocol Violation|1|||
126287052|NCT01692626|454337640|FG001|Overall Study|Protocol Violation|2|||
126287053|NCT01692626|454337639|FG000|Overall Study|Withdrawal by Subject|1|||
126287054|NCT01692626|454337640|FG001|Overall Study|Withdrawal by Subject|0|||
126287055|NCT05490771|454337641|FG000|Overall Study|Disease progression|18|||
126287056|NCT05490771|454337641|FG000|Overall Study|Adverse Event|3|||
126287057|NCT05490771|454337641|FG000|Overall Study|Other complicating disease|1|||
126287058|NCT05490771|454337641|FG000|Overall Study|Withdrawal by Subject|3|||
126287059|NCT05490771|454337641|FG000|Overall Study|Physician Decision|1|||
126287060|NCT05490771|454337641|FG000|Overall Study|Still on treatment|2|||
126287061|NCT05490771|454337641|FG000|Overall Study|Never start protocol therapy|5|||
126287062|NCT05490771|454337641|FG000|Overall Study|Ineligible|2|||
126365538|NCT00557440|454632804|FG000|Treatment Period 1|Adverse Event|0|||
126365539|NCT00557440|454632805|FG001|Treatment Period 1|Adverse Event|0|||
126365540|NCT00557440|454632806|FG002|Treatment Period 1|Adverse Event|1|||
126365541|NCT03524157|454632807|FG000|Overall Study|cytology not readable|0|||
126365542|NCT03524157|454632808|FG001|Overall Study|cytology not readable|0|||
126365543|NCT03524157|454632809|FG002|Overall Study|cytology not readable|1|||
126365544|NCT01592747|454632810|FG000|Overall Study|Loss of Therapeutic Response|107|||
126365545|NCT01592747|454632811|FG001|Overall Study|Loss of Therapeutic Response|108|||
126365546|NCT01592747|454632812|FG002|Overall Study|Loss of Therapeutic Response|100|||
126365547|NCT01592747|454632810|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
126365548|NCT01592747|454632811|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
126365549|NCT01592747|454632812|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
126365550|NCT01592747|454632810|FG000|Overall Study|Adverse Event|1|||
126365551|NCT01592747|454632811|FG001|Overall Study|Adverse Event|0|||
126365552|NCT01592747|454632812|FG002|Overall Study|Adverse Event|0|||
126365553|NCT01592747|454632810|FG000|Overall Study|Protocol Violation|4|||
126365554|NCT01592747|454632811|FG001|Overall Study|Protocol Violation|0|||
126365555|NCT01592747|454632812|FG002|Overall Study|Protocol Violation|4|||
126365556|NCT01592747|454632810|FG000|Overall Study|Lack of Efficacy|0|||
126365557|NCT01592747|454632811|FG001|Overall Study|Lack of Efficacy|1|||
126287063|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
126365558|NCT01592747|454632812|FG002|Overall Study|Lack of Efficacy|0|||
126365559|NCT01592747|454632810|FG000|Overall Study|Withdrawal by Subject|2|||
126365560|NCT01592747|454632811|FG001|Overall Study|Withdrawal by Subject|0|||
126365561|NCT01592747|454632812|FG002|Overall Study|Withdrawal by Subject|2|||
126365562|NCT01592747|454632810|FG000|Overall Study|Lost to Follow-up|1|||
126365563|NCT01592747|454632811|FG001|Overall Study|Lost to Follow-up|0|||
126365564|NCT01592747|454632812|FG002|Overall Study|Lost to Follow-up|1|||
126287064|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
126365565|NCT01592747|454632810|FG000|Overall Study|Other Reasons|1|||
126365566|NCT01592747|454632811|FG001|Overall Study|Other Reasons|1|||
126365567|NCT01592747|454632812|FG002|Overall Study|Other Reasons|0|||
126287065|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
126365568|NCT02853136|454632813|FG000|Wash-out|Adverse Event|0|||
126365569|NCT02853136|454632814|FG001|Wash-out|Adverse Event|0|||
126365570|NCT02853136|454632815|FG002|Wash-out|Adverse Event|0|||
126365571|NCT02853136|454632816|FG003|Wash-out|Adverse Event|1|||
126365572|NCT00867334|454632817|FG000|Overall Study|Withdrawal by Subject|0|||
126287066|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
126365573|NCT00867334|454632818|FG001|Overall Study|Withdrawal by Subject|1|||
126365574|NCT00867334|454632817|FG000|Overall Study|Withdrawal by Subject|1|||
126365575|NCT00867334|454632818|FG001|Overall Study|Withdrawal by Subject|0|||
126365576|NCT00867334|454632817|FG000|Overall Study|Withdrawal by Subject|1|||
126365577|NCT00867334|454632818|FG001|Overall Study|Withdrawal by Subject|0|||
126365578|NCT05418426|454632820|FG000|Overall Study|Adverse Event|0|||
126365579|NCT05418426|454632821|FG001|Overall Study|Adverse Event|1|||
126365580|NCT05418426|454632822|FG002|Overall Study|Adverse Event|0|||
126365581|NCT05418426|454632820|FG000|Overall Study|Withdrawal by Subject|0|||
126365582|NCT05418426|454632821|FG001|Overall Study|Withdrawal by Subject|1|||
126365583|NCT05418426|454632822|FG002|Overall Study|Withdrawal by Subject|0|||
126365584|NCT05418426|454632820|FG000|Overall Study|Protocol Violation|0|||
126365585|NCT05418426|454632821|FG001|Overall Study|Protocol Violation|0|||
126365586|NCT05418426|454632822|FG002|Overall Study|Protocol Violation|1|||
126365587|NCT04620668|454632823|FG000|Overall Study|Withdrawal by Subject|2|||
126365588|NCT04620668|454632824|FG001|Overall Study|Withdrawal by Subject|0|||
126365589|NCT04620668|454632823|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
126365590|NCT04620668|454632824|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
126365591|NCT04620668|454632823|FG000|Overall Study|Removed before analysis: missing data|2|||
126365592|NCT04620668|454632824|FG001|Overall Study|Removed before analysis: missing data|0|||
126365593|NCT04620668|454632823|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
126365594|NCT04620668|454632824|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
126365595|NCT04620668|454632823|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
126365596|NCT04620668|454632824|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
126365597|NCT02951819|454632829|FG000|Overall Study|Death|9|||
126365598|NCT02951819|454632830|FG001|Overall Study|Death|7|||
126365599|NCT02951819|454632829|FG000|Overall Study|Withdrawal by Subject|3|||
126365600|NCT02951819|454632830|FG001|Overall Study|Withdrawal by Subject|0|||
126365601|NCT02951819|454632829|FG000|Overall Study|Adverse Event|1|||
126365602|NCT02951819|454632830|FG001|Overall Study|Adverse Event|0|||
126365603|NCT02951819|454632829|FG000|Overall Study|Lack of Efficacy|4|||
126365604|NCT02951819|454632830|FG001|Overall Study|Lack of Efficacy|0|||
126365605|NCT02951819|454632829|FG000|Overall Study|Lost to Follow-up|1|||
126365606|NCT02951819|454632830|FG001|Overall Study|Lost to Follow-up|0|||
126365607|NCT02951819|454632829|FG000|Overall Study|Progressive Disease|1|||
126365608|NCT02951819|454632830|FG001|Overall Study|Progressive Disease|0|||
126365609|NCT02951819|454632829|FG000|Overall Study|Other|9|||
126365610|NCT02951819|454632830|FG001|Overall Study|Other|0|||
126365611|NCT01922895|454632835|FG000|Overall Study|Death|0|||
126287067|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
126287068|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
126365612|NCT01922895|454632836|FG001|Overall Study|Death|1|||
126365613|NCT01922895|454632835|FG000|Overall Study|Withdrawal by Subject|1|||
126365614|NCT01922895|454632836|FG001|Overall Study|Withdrawal by Subject|2|||
126365615|NCT01922895|454632835|FG000|Overall Study|Lost to Follow-up|5|||
126287069|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
126287070|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
126287071|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
126287072|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
126287073|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
126287074|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
126287075|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
126287076|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
125882882|NCT01394016|452869062|FG007|Overall Study|Sponsor Decision|0|||
125882883|NCT01394016|452869063|FG008|Overall Study|Sponsor Decision|0|||
126287077|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
126287078|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
126287079|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
126287080|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
126365616|NCT01922895|454632836|FG001|Overall Study|Lost to Follow-up|11|||
126365617|NCT01916226|454632837|FG000|Overall Study|Adverse Event|1|||
126365618|NCT01916226|454632838|FG001|Overall Study|Adverse Event|0|||
126365619|NCT01916226|454632839|FG002|Overall Study|Adverse Event|1|||
126365620|NCT01916226|454632840|FG003|Overall Study|Adverse Event|1|||
126365621|NCT01916226|454632837|FG000|Overall Study|Lack of Efficacy|0|||
126365622|NCT01916226|454632838|FG001|Overall Study|Lack of Efficacy|0|||
126365623|NCT01916226|454632839|FG002|Overall Study|Lack of Efficacy|2|||
126365624|NCT01916226|454632840|FG003|Overall Study|Lack of Efficacy|1|||
125882884|NCT01394016|452869064|FG009|Overall Study|Sponsor Decision|0|||
125882885|NCT01394016|452869065|FG010|Overall Study|Sponsor Decision|0|||
125882886|NCT01394016|452869066|FG011|Overall Study|Sponsor Decision|0|||
125882887|NCT01394016|452869067|FG012|Overall Study|Sponsor Decision|1|||
125882888|NCT01394016|452869068|FG013|Overall Study|Sponsor Decision|0|||
125882889|NCT01394016|452869069|FG014|Overall Study|Sponsor Decision|0|||
125882890|NCT01394016|452869070|FG015|Overall Study|Sponsor Decision|0|||
125882891|NCT01394016|452869071|FG016|Overall Study|Sponsor Decision|0|||
125882892|NCT01394016|452869072|FG017|Overall Study|Sponsor Decision|0|||
125882893|NCT01394016|452869073|FG018|Overall Study|Sponsor Decision|0|||
125882894|NCT01394016|452869055|FG000|Overall Study|Lost to Follow-up|0|||
125882895|NCT01394016|452869056|FG001|Overall Study|Lost to Follow-up|0|||
125882896|NCT01394016|452869057|FG002|Overall Study|Lost to Follow-up|0|||
125882897|NCT01394016|452869058|FG003|Overall Study|Lost to Follow-up|0|||
125882898|NCT01394016|452869059|FG004|Overall Study|Lost to Follow-up|0|||
125882899|NCT01394016|452869060|FG005|Overall Study|Lost to Follow-up|0|||
125882900|NCT01394016|452869061|FG006|Overall Study|Lost to Follow-up|0|||
125882901|NCT01394016|452869062|FG007|Overall Study|Lost to Follow-up|0|||
125882902|NCT01394016|452869063|FG008|Overall Study|Lost to Follow-up|0|||
125882903|NCT01394016|452869064|FG009|Overall Study|Lost to Follow-up|0|||
125882904|NCT01394016|452869065|FG010|Overall Study|Lost to Follow-up|0|||
125882905|NCT01394016|452869066|FG011|Overall Study|Lost to Follow-up|0|||
125882906|NCT01394016|452869067|FG012|Overall Study|Lost to Follow-up|0|||
125882907|NCT01394016|452869068|FG013|Overall Study|Lost to Follow-up|0|||
125882908|NCT01394016|452869069|FG014|Overall Study|Lost to Follow-up|0|||
125882909|NCT01394016|452869070|FG015|Overall Study|Lost to Follow-up|0|||
125882910|NCT01394016|452869071|FG016|Overall Study|Lost to Follow-up|0|||
125882911|NCT01394016|452869072|FG017|Overall Study|Lost to Follow-up|0|||
125882912|NCT01394016|452869073|FG018|Overall Study|Lost to Follow-up|1|||
126287081|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
126287082|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
126287083|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
126287084|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
126287085|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
126287086|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
126287087|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
126287088|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
126287089|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
126287090|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
126287091|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
126287092|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
126287093|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
126287094|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
126287095|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
126287096|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
126287097|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
126287098|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
126287099|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
126287100|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
126287101|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
126287102|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
126287103|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
126287104|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
126287105|NCT03126435|454337644|FG000|Overall Study|Death|90|||
126287106|NCT03126435|454337645|FG001|Overall Study|Death|84|||
126287107|NCT03126435|454337644|FG000|Overall Study|Lost to Follow-up|4|||
126287108|NCT03126435|454337645|FG001|Overall Study|Lost to Follow-up|3|||
126287109|NCT03126435|454337644|FG000|Overall Study|Physician Decision|0|||
126287110|NCT03126435|454337645|FG001|Overall Study|Physician Decision|1|||
126287111|NCT03126435|454337644|FG000|Overall Study|Withdrawal by Subject|6|||
126287112|NCT03126435|454337645|FG001|Overall Study|Withdrawal by Subject|12|||
125882913|NCT03534804|452869074|FG000|Overall Study|Withdrawal by Subject|1|||
126041767|NCT03505008|453451123|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
126041768|NCT03505008|453451124|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
126365625|NCT01916226|454632837|FG000|Overall Study|Protocol Violation|0|||
125882914|NCT04986904|452869075|FG000|Overall Study|Lost to Follow-up|11|||
125882915|NCT04986904|452869075|FG000|Overall Study|Withdrawal by Subject|1|||
125882916|NCT00174187|452869076|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
125882917|NCT00174187|452869077|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
125882918|NCT00174187|452869078|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
125882919|NCT00174187|452869076|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
125882920|NCT00174187|452869077|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
125882921|NCT00174187|452869078|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
125882922|NCT00174187|452869076|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
125882923|NCT00174187|452869077|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
125882924|NCT00174187|452869078|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
125882925|NCT00174187|452869076|FG000|Period 1 (up to 3 Years)|Other|0|||
125882926|NCT00174187|452869077|FG001|Period 1 (up to 3 Years)|Other|1|||
125882927|NCT00174187|452869078|FG002|Period 1 (up to 3 Years)|Other|0|||
125882928|NCT00174187|452869076|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
126287113|NCT03126435|454337644|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
126287114|NCT03126435|454337645|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
126287115|NCT02276807|454337648|FG000|Overall Study|Withdrawal by Subject|8|||
126287116|NCT02276807|454337649|FG001|Overall Study|Withdrawal by Subject|7|||
126287117|NCT02276807|454337648|FG000|Overall Study|Lost to Follow-up|10|||
126287118|NCT02276807|454337649|FG001|Overall Study|Lost to Follow-up|10|||
126287119|NCT03971474|454337650|FG000|Overall Study|Adverse Event|11|||
126287120|NCT03971474|454337651|FG001|Overall Study|Adverse Event|7|||
126287121|NCT03971474|454337650|FG000|Overall Study|Refusal unrelated to adverse event|5|||
126287122|NCT03971474|454337651|FG001|Overall Study|Refusal unrelated to adverse event|1|||
126287123|NCT03971474|454337650|FG000|Overall Study|Progression/relapse|40|||
126287124|NCT03971474|454337651|FG001|Overall Study|Progression/relapse|47|||
126287125|NCT03971474|454337650|FG000|Overall Study|Death|6|||
126287126|NCT03971474|454337651|FG001|Overall Study|Death|3|||
126287127|NCT03971474|454337650|FG000|Overall Study|Other - not protocol specified|5|||
126287128|NCT03971474|454337651|FG001|Overall Study|Other - not protocol specified|4|||
126287129|NCT03971474|454337650|FG000|Overall Study|On treatment|0|||
126287130|NCT03971474|454337651|FG001|Overall Study|On treatment|7|||
126287131|NCT00261950|454337652|FG000|Overall Study|Lost to Follow-up|2|||
126287132|NCT00261950|454337652|FG000|Overall Study|Death|6|||
126287133|NCT00261950|454337652|FG000|Overall Study|Withdrawal by Subject|5|||
126287134|NCT00261950|454337652|FG000|Overall Study|Other|1|||
126287135|NCT00261950|454337652|FG000|Overall Study|Physician Decision|1|||
126287136|NCT00261950|454337652|FG000|Overall Study|Protocol specified Criteria|11|||
126287137|NCT01937871|454337659|FG000|Overall Study|Adverse Event|6|||
126287138|NCT01937871|454337660|FG001|Overall Study|Adverse Event|6|||
126287139|NCT01937871|454337661|FG002|Overall Study|Adverse Event|2|||
126287140|NCT01937871|454337659|FG000|Overall Study|Lost to Follow-up|8|||
126287141|NCT01937871|454337660|FG001|Overall Study|Lost to Follow-up|2|||
126287142|NCT01937871|454337661|FG002|Overall Study|Lost to Follow-up|4|||
126287143|NCT01937871|454337659|FG000|Overall Study|Withdrawal by Subject|9|||
125882929|NCT00174187|452869077|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
126041769|NCT03505008|453451121|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
126041770|NCT03505008|453451122|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
126041771|NCT03505008|453451123|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
126041772|NCT03505008|453451124|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
126041773|NCT03505008|453451121|FG000|After Week 24 Randomization|Adverse Event|0|||
126041774|NCT03505008|453451122|FG001|After Week 24 Randomization|Adverse Event|1|||
126041775|NCT03505008|453451123|FG002|After Week 24 Randomization|Adverse Event|2|||
126041776|NCT03505008|453451124|FG003|After Week 24 Randomization|Adverse Event|2|||
126041777|NCT03505008|453451121|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
126041778|NCT03505008|453451122|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
126041779|NCT03505008|453451123|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
126041780|NCT03505008|453451124|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
126041781|NCT03505008|453451121|FG000|After Week 24 Randomization|Protocol Violation|0|||
126041782|NCT03505008|453451122|FG001|After Week 24 Randomization|Protocol Violation|0|||
126041783|NCT03505008|453451123|FG002|After Week 24 Randomization|Protocol Violation|1|||
126041784|NCT03505008|453451124|FG003|After Week 24 Randomization|Protocol Violation|0|||
126287144|NCT01937871|454337660|FG001|Overall Study|Withdrawal by Subject|6|||
126287145|NCT01937871|454337661|FG002|Overall Study|Withdrawal by Subject|4|||
126287146|NCT01937871|454337659|FG000|Overall Study|Physician Decision|0|||
126287147|NCT01937871|454337660|FG001|Overall Study|Physician Decision|1|||
126287148|NCT01937871|454337661|FG002|Overall Study|Physician Decision|0|||
126287149|NCT01937871|454337659|FG000|Overall Study|Entry Criteria Not Met|1|||
126287150|NCT01937871|454337660|FG001|Overall Study|Entry Criteria Not Met|2|||
126041785|NCT02962076|453451127|FG000|Overall Study|MHED tracer not available|5|||
126041786|NCT02962076|453451127|FG000|Overall Study|Protocol Violation|1|||
126287151|NCT01937871|454337661|FG002|Overall Study|Entry Criteria Not Met|1|||
126287152|NCT00577863|454337668|FG000|Overall Study|Adverse Event|4|||
126287153|NCT00577863|454337669|FG001|Overall Study|Adverse Event|2|||
126287154|NCT00577863|454337668|FG000|Overall Study|Death|1|||
126287155|NCT00577863|454337669|FG001|Overall Study|Death|0|||
126287156|NCT00577863|454337668|FG000|Overall Study|Lost to Follow-up|2|||
126287157|NCT00577863|454337669|FG001|Overall Study|Lost to Follow-up|2|||
126287158|NCT00577863|454337668|FG000|Overall Study|Entry Criteria Exclusion|1|||
126287159|NCT00577863|454337669|FG001|Overall Study|Entry Criteria Exclusion|0|||
125882930|NCT00174187|452869078|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
126287160|NCT00577863|454337668|FG000|Overall Study|Withdrawal by Subject|0|||
126287161|NCT00577863|454337669|FG001|Overall Study|Withdrawal by Subject|2|||
126287162|NCT00577863|454337668|FG000|Overall Study|Sponsor Decision|2|||
126287163|NCT00577863|454337669|FG001|Overall Study|Sponsor Decision|7|||
126287164|NCT00577863|454337668|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
126287165|NCT00577863|454337669|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
126287166|NCT04868500|454337670|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
126287167|NCT04868500|454337671|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
126287168|NCT04868500|454337670|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
126287169|NCT04868500|454337671|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
126287170|NCT02676765|454337672|FG000|Overall Study|Lost to Follow-up|0|||
126287171|NCT02676765|454337673|FG001|Overall Study|Lost to Follow-up|1|||
126287172|NCT05299528|454337678|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287173|NCT05299528|454337679|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
126287174|NCT05299528|454337680|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287175|NCT05299528|454337681|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287176|NCT05299528|454337682|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287177|NCT05299528|454337683|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287178|NCT05299528|454337684|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287179|NCT05299528|454337678|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287180|NCT05299528|454337679|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287181|NCT05299528|454337680|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287182|NCT05299528|454337681|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287183|NCT05299528|454337682|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287184|NCT05299528|454337683|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
126287185|NCT05299528|454337684|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287186|NCT05299528|454337678|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
126287187|NCT05299528|454337679|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
126287188|NCT05299528|454337680|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
126287189|NCT05299528|454337681|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
126287190|NCT05299528|454337682|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
126287191|NCT05299528|454337683|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
126365626|NCT01916226|454632838|FG001|Overall Study|Protocol Violation|1|||
126365627|NCT01916226|454632839|FG002|Overall Study|Protocol Violation|0|||
126365628|NCT01916226|454632840|FG003|Overall Study|Protocol Violation|1|||
126365629|NCT01916226|454632837|FG000|Overall Study|Physician Decision|0|||
126365630|NCT01916226|454632838|FG001|Overall Study|Physician Decision|0|||
126365631|NCT01916226|454632839|FG002|Overall Study|Physician Decision|0|||
126365632|NCT01916226|454632840|FG003|Overall Study|Physician Decision|1|||
126365633|NCT03163667|454632841|FG000|Overall Study|Death|15|||
126365634|NCT03163667|454632842|FG001|Overall Study|Death|27|||
126365635|NCT03163667|454632841|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
126365636|NCT03163667|454632842|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
126365637|NCT01422382|454632847|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
126365638|NCT05810597|454632850|FG000|Period 1|Adverse Event|2|||
126365639|NCT05810597|454632851|FG001|Period 1|Adverse Event|0|||
126365640|NCT05810597|454632850|FG000|Period 1|Physician Decision|1|||
126365641|NCT05810597|454632851|FG001|Period 1|Physician Decision|0|||
126365642|NCT05021224|454632852|FG000|Overall Study|Did not complete all survey items|4|||
126365643|NCT05021224|454632853|FG001|Overall Study|Did not complete all survey items|1|||
126365644|NCT05021224|454632854|FG002|Overall Study|Did not complete all survey items|0|||
126365645|NCT05021224|454632855|FG003|Overall Study|Did not complete all survey items|2|||
126365646|NCT02412436|454632856|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
126365647|NCT02412436|454632856|FG000|Overall Study|Lost to Follow-up|6|||
126365648|NCT02412436|454632856|FG000|Overall Study|Unable to get to clinic|3|||
126365649|NCT02412436|454632856|FG000|Overall Study|Death|1|||
126365650|NCT02412436|454632856|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
126365651|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
126365652|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126365653|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126365654|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126365655|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126365656|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
126365657|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126099952|NCT00903682|453657723|FG001|Overall Study|Withdrawal by Subject|0|||
126365658|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126365659|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126287192|NCT05299528|454337684|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
126287193|NCT02445963|454337690|FG000|Overall Study|Lost to Follow-up|1|||
126287194|NCT02445963|454337691|FG001|Overall Study|Lost to Follow-up|0|||
126287195|NCT02445963|454337692|FG002|Overall Study|Lost to Follow-up|0|||
126287196|NCT02445963|454337693|FG003|Overall Study|Lost to Follow-up|0|||
126287197|NCT02445963|454337690|FG000|Overall Study|Change in employment|1|||
126287198|NCT02445963|454337691|FG001|Overall Study|Change in employment|0|||
126287199|NCT02445963|454337692|FG002|Overall Study|Change in employment|0|||
126287200|NCT02445963|454337693|FG003|Overall Study|Change in employment|0|||
126287201|NCT02445963|454337690|FG000|Overall Study|Symptoms post-vaccination|0|||
126287202|NCT02445963|454337691|FG001|Overall Study|Symptoms post-vaccination|0|||
126287203|NCT02445963|454337692|FG002|Overall Study|Symptoms post-vaccination|1|||
126287204|NCT02445963|454337693|FG003|Overall Study|Symptoms post-vaccination|0|||
126287205|NCT01957176|454337694|FG000|Overall Study|Adverse Event|2|||
126287206|NCT01957176|454337695|FG001|Overall Study|Adverse Event|0|||
126287207|NCT01957176|454337694|FG000|Overall Study|Physician Decision|2|||
126287208|NCT01957176|454337695|FG001|Overall Study|Physician Decision|1|||
126287209|NCT01957176|454337694|FG000|Overall Study|Withdrawal by Subject|1|||
126287210|NCT01957176|454337695|FG001|Overall Study|Withdrawal by Subject|0|||
126287211|NCT02359994|454337698|FG000|Overall Population Study|Adverse Event|1|||
126287212|NCT02359994|454337699|FG001|Overall Population Study|Adverse Event|1|||
126287213|NCT02359994|454337698|FG000|Overall Population Study|Death|1|||
126287214|NCT02359994|454337699|FG001|Overall Population Study|Death|5|||
126287215|NCT02359994|454337698|FG000|Overall Population Study|Lost to Follow-up|1|||
126287216|NCT02359994|454337699|FG001|Overall Population Study|Lost to Follow-up|1|||
126287217|NCT02359994|454337698|FG000|Overall Population Study|Withdrawal by Subject|1|||
126287218|NCT02359994|454337699|FG001|Overall Population Study|Withdrawal by Subject|0|||
126287219|NCT02359994|454337698|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
126287220|NCT02359994|454337699|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
126287221|NCT02359994|454337698|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
126287222|NCT02359994|454337699|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
126287223|NCT02359994|454337698|FG000|Extended Oncology 24-Month Survival|Death|19|||
126287224|NCT02359994|454337699|FG001|Extended Oncology 24-Month Survival|Death|21|||
126287225|NCT02359994|454337698|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
126287226|NCT02359994|454337699|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
126287227|NCT04597632|454337700|FG000|Overall Study|Withdrawal by Subject|10|||
126287228|NCT04597632|454337700|FG000|Overall Study|Lost to Follow-up|1|||
126287229|NCT04597632|454337700|FG000|Overall Study|Death|1|||
126287230|NCT04597632|454337700|FG000|Overall Study|Adverse Event|5|||
126287231|NCT01823835|454337701|FG000|Overall Study|Adverse Event|0|||
126287232|NCT01823835|454337702|FG001|Overall Study|Adverse Event|0|||
126287233|NCT01823835|454337703|FG002|Overall Study|Adverse Event|0|||
126287234|NCT01823835|454337704|FG003|Overall Study|Adverse Event|0|||
126287235|NCT01823835|454337705|FG004|Overall Study|Adverse Event|1|||
126287236|NCT01823835|454337706|FG005|Overall Study|Adverse Event|0|||
126287237|NCT01823835|454337707|FG006|Overall Study|Adverse Event|1|||
126287238|NCT01823835|454337708|FG007|Overall Study|Adverse Event|0|||
126287239|NCT01823835|454337709|FG008|Overall Study|Adverse Event|0|||
126287240|NCT01823835|454337710|FG009|Overall Study|Adverse Event|0|||
126287241|NCT01823835|454337711|FG010|Overall Study|Adverse Event|1|||
126099953|NCT00903682|453657722|FG000|Overall Study|Pregnancy|0|||
126099954|NCT00903682|453657723|FG001|Overall Study|Pregnancy|1|||
126099955|NCT00903682|453657722|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
126287242|NCT01823835|454337712|FG011|Overall Study|Adverse Event|2|||
126287243|NCT01823835|454337713|FG012|Overall Study|Adverse Event|0|||
126287244|NCT01823835|454337714|FG013|Overall Study|Adverse Event|0|||
126287245|NCT01823835|454337715|FG014|Overall Study|Adverse Event|0|||
126287246|NCT01823835|454337701|FG000|Overall Study|Physician Decision|0|||
126287247|NCT01823835|454337702|FG001|Overall Study|Physician Decision|0|||
126287248|NCT01823835|454337703|FG002|Overall Study|Physician Decision|0|||
126287249|NCT01823835|454337704|FG003|Overall Study|Physician Decision|0|||
126287250|NCT01823835|454337705|FG004|Overall Study|Physician Decision|0|||
126287251|NCT01823835|454337706|FG005|Overall Study|Physician Decision|0|||
126287252|NCT01823835|454337707|FG006|Overall Study|Physician Decision|0|||
126287253|NCT01823835|454337708|FG007|Overall Study|Physician Decision|0|||
126287254|NCT01823835|454337709|FG008|Overall Study|Physician Decision|0|||
126287255|NCT01823835|454337710|FG009|Overall Study|Physician Decision|0|||
126287256|NCT01823835|454337711|FG010|Overall Study|Physician Decision|0|||
126287257|NCT01823835|454337712|FG011|Overall Study|Physician Decision|2|||
126287258|NCT01823835|454337713|FG012|Overall Study|Physician Decision|0|||
126287259|NCT01823835|454337714|FG013|Overall Study|Physician Decision|0|||
126287260|NCT01823835|454337715|FG014|Overall Study|Physician Decision|0|||
126287261|NCT01823835|454337701|FG000|Overall Study|Progressive Disease|3|||
126287262|NCT01823835|454337702|FG001|Overall Study|Progressive Disease|4|||
126287263|NCT01823835|454337703|FG002|Overall Study|Progressive Disease|3|||
126287264|NCT01823835|454337704|FG003|Overall Study|Progressive Disease|6|||
126287265|NCT01823835|454337705|FG004|Overall Study|Progressive Disease|4|||
126287266|NCT01823835|454337706|FG005|Overall Study|Progressive Disease|6|||
126041787|NCT02962076|453451127|FG000|Overall Study|Physician Decision|1|||
126041788|NCT04741776|453451128|FG000|Overall Study|Withdrawal by Subject|7|||
126287267|NCT01823835|454337707|FG006|Overall Study|Progressive Disease|5|||
126287268|NCT01823835|454337708|FG007|Overall Study|Progressive Disease|3|||
126287269|NCT01823835|454337709|FG008|Overall Study|Progressive Disease|3|||
126287270|NCT01823835|454337710|FG009|Overall Study|Progressive Disease|18|||
126287271|NCT01823835|454337711|FG010|Overall Study|Progressive Disease|8|||
126287272|NCT01823835|454337712|FG011|Overall Study|Progressive Disease|46|||
126287273|NCT01823835|454337713|FG012|Overall Study|Progressive Disease|18|||
126287274|NCT01823835|454337714|FG013|Overall Study|Progressive Disease|4|||
126287275|NCT01823835|454337715|FG014|Overall Study|Progressive Disease|6|||
126287276|NCT01823835|454337701|FG000|Overall Study|Study Termination|0|||
126287277|NCT01823835|454337702|FG001|Overall Study|Study Termination|0|||
126287278|NCT01823835|454337703|FG002|Overall Study|Study Termination|0|||
126287279|NCT01823835|454337704|FG003|Overall Study|Study Termination|0|||
126287280|NCT01823835|454337705|FG004|Overall Study|Study Termination|1|||
126287281|NCT01823835|454337706|FG005|Overall Study|Study Termination|0|||
126287282|NCT01823835|454337707|FG006|Overall Study|Study Termination|0|||
126287283|NCT01823835|454337708|FG007|Overall Study|Study Termination|0|||
126287284|NCT01823835|454337709|FG008|Overall Study|Study Termination|0|||
126287285|NCT01823835|454337710|FG009|Overall Study|Study Termination|0|||
126287286|NCT01823835|454337711|FG010|Overall Study|Study Termination|0|||
126287287|NCT01823835|454337712|FG011|Overall Study|Study Termination|1|||
126287288|NCT01823835|454337713|FG012|Overall Study|Study Termination|0|||
126287289|NCT01823835|454337714|FG013|Overall Study|Study Termination|0|||
126287290|NCT01823835|454337715|FG014|Overall Study|Study Termination|0|||
126287291|NCT01823835|454337701|FG000|Overall Study|Withdrawal by Subject|0|||
126287292|NCT01823835|454337702|FG001|Overall Study|Withdrawal by Subject|0|||
126287293|NCT01823835|454337703|FG002|Overall Study|Withdrawal by Subject|1|||
126287294|NCT01823835|454337704|FG003|Overall Study|Withdrawal by Subject|0|||
126287295|NCT01823835|454337705|FG004|Overall Study|Withdrawal by Subject|0|||
126287296|NCT01823835|454337706|FG005|Overall Study|Withdrawal by Subject|0|||
126287297|NCT01823835|454337707|FG006|Overall Study|Withdrawal by Subject|0|||
126287298|NCT01823835|454337708|FG007|Overall Study|Withdrawal by Subject|0|||
126287299|NCT01823835|454337709|FG008|Overall Study|Withdrawal by Subject|0|||
126287300|NCT01823835|454337710|FG009|Overall Study|Withdrawal by Subject|1|||
126287301|NCT01823835|454337711|FG010|Overall Study|Withdrawal by Subject|1|||
126287302|NCT01823835|454337712|FG011|Overall Study|Withdrawal by Subject|2|||
125885162|NCT03847896|452876789|FG000|Overall Study|Withdrawal by Subject|2|||
126041789|NCT04741776|453451129|FG001|Overall Study|Withdrawal by Subject|10|||
126041790|NCT04741776|453451130|FG002|Overall Study|Withdrawal by Subject|10|||
126287303|NCT01823835|454337713|FG012|Overall Study|Withdrawal by Subject|1|||
126287304|NCT01823835|454337714|FG013|Overall Study|Withdrawal by Subject|0|||
126287305|NCT01823835|454337715|FG014|Overall Study|Withdrawal by Subject|0|||
126287306|NCT03017612|454337716|FG000|Overall Study|Adverse Event|2|||
126287307|NCT04895982|454337717|FG000|Overall Study|Withdrawal by Subject|0|||
126041791|NCT04741776|453451131|FG003|Overall Study|Withdrawal by Subject|17|||
126287308|NCT04895982|454337718|FG001|Overall Study|Withdrawal by Subject|0|||
126287309|NCT04895982|454337719|FG002|Overall Study|Withdrawal by Subject|0|||
126287310|NCT04895982|454337720|FG003|Overall Study|Withdrawal by Subject|0|||
126287311|NCT04895982|454337721|FG004|Overall Study|Withdrawal by Subject|0|||
126287312|NCT04895982|454337722|FG005|Overall Study|Withdrawal by Subject|1|||
125882931|NCT00174187|452869076|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
125882932|NCT00174187|452869077|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
125882933|NCT00174187|452869078|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
125882934|NCT00174187|452869076|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
125882935|NCT00174187|452869077|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
125882936|NCT00174187|452869078|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
125882937|NCT00174187|452869076|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
125882938|NCT00174187|452869077|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
125882939|NCT00174187|452869078|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
126287313|NCT04895982|454337723|FG006|Overall Study|Withdrawal by Subject|1|||
126287314|NCT04895982|454337724|FG007|Overall Study|Withdrawal by Subject|0|||
126287315|NCT04895982|454337725|FG008|Overall Study|Withdrawal by Subject|0|||
126287316|NCT04895982|454337726|FG009|Overall Study|Withdrawal by Subject|1|||
126287317|NCT04895982|454337727|FG010|Overall Study|Withdrawal by Subject|0|||
126287318|NCT04895982|454337728|FG011|Overall Study|Withdrawal by Subject|1|||
126287319|NCT04895982|454337717|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126287320|NCT04895982|454337718|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126287321|NCT04895982|454337719|FG002|Overall Study|Withdrawal by parent/guardian|3|||
126287322|NCT04895982|454337720|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126287323|NCT04895982|454337721|FG004|Overall Study|Withdrawal by parent/guardian|3|||
126287324|NCT04895982|454337722|FG005|Overall Study|Withdrawal by parent/guardian|2|||
126287325|NCT04895982|454337723|FG006|Overall Study|Withdrawal by parent/guardian|1|||
126287326|NCT04895982|454337724|FG007|Overall Study|Withdrawal by parent/guardian|0|||
126287327|NCT04895982|454337725|FG008|Overall Study|Withdrawal by parent/guardian|3|||
126287328|NCT04895982|454337726|FG009|Overall Study|Withdrawal by parent/guardian|0|||
126287329|NCT04895982|454337727|FG010|Overall Study|Withdrawal by parent/guardian|0|||
126287330|NCT04895982|454337728|FG011|Overall Study|Withdrawal by parent/guardian|0|||
126287331|NCT04895982|454337717|FG000|Overall Study|Other|0|||
126287332|NCT04895982|454337718|FG001|Overall Study|Other|0|||
126287333|NCT04895982|454337719|FG002|Overall Study|Other|1|||
126287334|NCT04895982|454337720|FG003|Overall Study|Other|1|||
126287335|NCT04895982|454337721|FG004|Overall Study|Other|0|||
126287336|NCT04895982|454337722|FG005|Overall Study|Other|0|||
126287337|NCT04895982|454337723|FG006|Overall Study|Other|0|||
126287338|NCT04895982|454337724|FG007|Overall Study|Other|0|||
126287339|NCT04895982|454337725|FG008|Overall Study|Other|0|||
126287340|NCT04895982|454337726|FG009|Overall Study|Other|1|||
126287341|NCT04895982|454337727|FG010|Overall Study|Other|0|||
126287342|NCT04895982|454337728|FG011|Overall Study|Other|0|||
126287343|NCT04895982|454337717|FG000|Overall Study|Protocol Violation|0|||
126287344|NCT04895982|454337718|FG001|Overall Study|Protocol Violation|0|||
126287345|NCT04895982|454337719|FG002|Overall Study|Protocol Violation|1|||
126287346|NCT04895982|454337720|FG003|Overall Study|Protocol Violation|1|||
126287347|NCT04895982|454337721|FG004|Overall Study|Protocol Violation|1|||
126287348|NCT04895982|454337722|FG005|Overall Study|Protocol Violation|0|||
126287349|NCT04895982|454337723|FG006|Overall Study|Protocol Violation|0|||
126287350|NCT04895982|454337724|FG007|Overall Study|Protocol Violation|1|||
126287351|NCT04895982|454337725|FG008|Overall Study|Protocol Violation|0|||
126287352|NCT04895982|454337726|FG009|Overall Study|Protocol Violation|0|||
126287353|NCT04895982|454337727|FG010|Overall Study|Protocol Violation|0|||
126287354|NCT04895982|454337728|FG011|Overall Study|Protocol Violation|0|||
126287355|NCT04895982|454337717|FG000|Overall Study|Lost to Follow-up|0|||
125882940|NCT00174187|452869076|FG000|Period 2 (After 3 Years)|Other|0|||
125882941|NCT00174187|452869077|FG001|Period 2 (After 3 Years)|Other|0|||
126099956|NCT00903682|453657723|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
126099957|NCT00903682|453657722|FG000|Overall Study|Subject Non-Compliant|1|||
126287356|NCT04895982|454337718|FG001|Overall Study|Lost to Follow-up|0|||
126287357|NCT04895982|454337719|FG002|Overall Study|Lost to Follow-up|1|||
126287358|NCT04895982|454337720|FG003|Overall Study|Lost to Follow-up|0|||
126287359|NCT04895982|454337721|FG004|Overall Study|Lost to Follow-up|0|||
126287360|NCT04895982|454337722|FG005|Overall Study|Lost to Follow-up|1|||
126287361|NCT04895982|454337723|FG006|Overall Study|Lost to Follow-up|0|||
126287362|NCT04895982|454337724|FG007|Overall Study|Lost to Follow-up|0|||
126287363|NCT04895982|454337725|FG008|Overall Study|Lost to Follow-up|1|||
126287364|NCT04895982|454337726|FG009|Overall Study|Lost to Follow-up|0|||
126287365|NCT04895982|454337727|FG010|Overall Study|Lost to Follow-up|0|||
126287366|NCT04895982|454337728|FG011|Overall Study|Lost to Follow-up|0|||
126287367|NCT04895982|454337717|FG000|Overall Study|Refused further study procedures|0|||
126287368|NCT04895982|454337718|FG001|Overall Study|Refused further study procedures|0|||
126287369|NCT04895982|454337719|FG002|Overall Study|Refused further study procedures|1|||
126287370|NCT04895982|454337720|FG003|Overall Study|Refused further study procedures|0|||
126287371|NCT04895982|454337721|FG004|Overall Study|Refused further study procedures|0|||
126287372|NCT04895982|454337722|FG005|Overall Study|Refused further study procedures|0|||
126287373|NCT04895982|454337723|FG006|Overall Study|Refused further study procedures|0|||
125882942|NCT00174187|452869078|FG002|Period 2 (After 3 Years)|Other|5|||
126287374|NCT04895982|454337724|FG007|Overall Study|Refused further study procedures|0|||
126041792|NCT04741776|453451128|FG000|Overall Study|Death|0|||
126041793|NCT04741776|453451129|FG001|Overall Study|Death|0|||
126041794|NCT04741776|453451130|FG002|Overall Study|Death|1|||
126041795|NCT04741776|453451131|FG003|Overall Study|Death|0|||
126287375|NCT04895982|454337725|FG008|Overall Study|Refused further study procedures|0|||
126287376|NCT04895982|454337726|FG009|Overall Study|Refused further study procedures|0|||
126287377|NCT04895982|454337727|FG010|Overall Study|Refused further study procedures|0|||
126287378|NCT04895982|454337728|FG011|Overall Study|Refused further study procedures|0|||
126287379|NCT01893346|454337729|FG000|Overall Study|Lost to Follow-up|0|||
126287380|NCT01893346|454337730|FG001|Overall Study|Lost to Follow-up|1|||
126287381|NCT01893346|454337731|FG002|Overall Study|Lost to Follow-up|0|||
126287382|NCT01893346|454337732|FG003|Overall Study|Lost to Follow-up|0|||
126287383|NCT01893346|454337729|FG000|Overall Study|Protocol Violation|1|||
126287384|NCT01893346|454337730|FG001|Overall Study|Protocol Violation|0|||
126287385|NCT01893346|454337731|FG002|Overall Study|Protocol Violation|0|||
126287386|NCT01893346|454337732|FG003|Overall Study|Protocol Violation|0|||
126041796|NCT04089865|453451132|FG000|Overall Study|Withdrawal by Subject|2|||
126041797|NCT04089865|453451133|FG001|Overall Study|Withdrawal by Subject|2|||
126041798|NCT04089865|453451134|FG002|Overall Study|Withdrawal by Subject|7|||
126041799|NCT04089865|453451135|FG003|Overall Study|Withdrawal by Subject|2|||
126287387|NCT01893346|454337729|FG000|Overall Study|Withdrawal by Subject|2|||
126287388|NCT01893346|454337730|FG001|Overall Study|Withdrawal by Subject|0|||
126041800|NCT02780700|453451145|FG000|Overall Study|Progressive disease|1|||
126041801|NCT03824366|453451146|FG000|Overall Study|Death|1|||
126287389|NCT01893346|454337731|FG002|Overall Study|Withdrawal by Subject|0|||
126287390|NCT01893346|454337732|FG003|Overall Study|Withdrawal by Subject|0|||
126287391|NCT01449812|454337733|FG000|Overall Study|Migrated/moved from study area|1|||
126287392|NCT01449812|454337734|FG001|Overall Study|Migrated/moved from study area|0|||
126287393|NCT01449812|454337735|FG002|Overall Study|Migrated/moved from study area|0|||
126287394|NCT01449812|454337733|FG000|Overall Study|Withdrawal by Subject|0|||
126287395|NCT01449812|454337734|FG001|Overall Study|Withdrawal by Subject|0|||
126287396|NCT01449812|454337735|FG002|Overall Study|Withdrawal by Subject|1|||
126287397|NCT01449812|454337733|FG000|Overall Study|Lost to Follow-up|1|||
126287398|NCT01449812|454337734|FG001|Overall Study|Lost to Follow-up|0|||
126287399|NCT01449812|454337735|FG002|Overall Study|Lost to Follow-up|0|||
126287400|NCT04239027|454337738|FG000|Overall Study|Adverse Event|4|||
126287401|NCT04239027|454337738|FG000|Overall Study|Withdrawal by Subject|9|||
126287402|NCT04239027|454337738|FG000|Overall Study|Death|1|||
126287403|NCT04239027|454337738|FG000|Overall Study|Physician Decision|9|||
126287404|NCT04239027|454337738|FG000|Overall Study|Lost to Follow-up|2|||
126287405|NCT04239027|454337738|FG000|Overall Study|Lack of Efficacy|1|||
126287406|NCT02839707|454337745|FG000|Phase I|Not eligible for analysis|9|||
126287407|NCT02839707|454337746|FG001|Phase I|Not eligible for analysis|0|||
126287408|NCT02839707|454337747|FG002|Phase I|Not eligible for analysis|0|||
126287409|NCT02839707|454337745|FG000|Phase II|Not treated according to protocol|4|||
126287410|NCT02839707|454337746|FG001|Phase II|Not treated according to protocol|0|||
126287411|NCT02839707|454337747|FG002|Phase II|Not treated according to protocol|2|||
126287412|NCT02839707|454337745|FG000|Phase III|Not treated according to protocol|0|||
126287413|NCT02839707|454337746|FG001|Phase III|Not treated according to protocol|0|||
126287414|NCT02839707|454337747|FG002|Phase III|Not treated according to protocol|4|||
125882943|NCT03435211|452869079|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
125882944|NCT00759941|452869080|FG000|Overall Study|Use of medication|1|||
125882945|NCT00759941|452869081|FG001|Overall Study|Use of medication|0|||
126287415|NCT01950390|454337748|FG000|Overall Study|Never started treatment|3|||
126287416|NCT01950390|454337749|FG001|Overall Study|Never started treatment|2|||
126287417|NCT01950390|454337748|FG000|Overall Study|Disease progression|45|||
126287418|NCT01950390|454337749|FG001|Overall Study|Disease progression|52|||
126287419|NCT01950390|454337748|FG000|Overall Study|Adverse Event|22|||
126287420|NCT01950390|454337749|FG001|Overall Study|Adverse Event|16|||
126287421|NCT01950390|454337748|FG000|Overall Study|Death|5|||
126365660|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126365661|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
126365662|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126365663|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126365664|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126365665|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126365666|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
126365667|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
126365668|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
126365669|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
126365670|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
126365671|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
126365672|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
126365673|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
126287422|NCT01950390|454337749|FG001|Overall Study|Death|3|||
126287423|NCT01950390|454337748|FG000|Overall Study|Withdrawal by Subject|5|||
126287424|NCT01950390|454337749|FG001|Overall Study|Withdrawal by Subject|1|||
126287425|NCT01950390|454337748|FG000|Overall Study|Alternative therapy|0|||
126287426|NCT01950390|454337749|FG001|Overall Study|Alternative therapy|3|||
126287427|NCT01950390|454337748|FG000|Overall Study|Complicating disease|1|||
126287428|NCT01950390|454337749|FG001|Overall Study|Complicating disease|0|||
126287429|NCT01950390|454337748|FG000|Overall Study|On treatment|1|||
126287430|NCT01950390|454337749|FG001|Overall Study|On treatment|0|||
126287431|NCT01950390|454337748|FG000|Overall Study|Symptomatic deterioration|2|||
126287432|NCT01950390|454337749|FG001|Overall Study|Symptomatic deterioration|1|||
126287433|NCT01950390|454337748|FG000|Overall Study|Physician Decision|0|||
126287434|NCT01950390|454337749|FG001|Overall Study|Physician Decision|4|||
126287435|NCT01950390|454337748|FG000|Overall Study|Lack of clinical benefit|0|||
126287436|NCT01950390|454337749|FG001|Overall Study|Lack of clinical benefit|1|||
126287437|NCT01950390|454337748|FG000|Overall Study|Maintained PR and moved to observation only|0|||
126287438|NCT01950390|454337749|FG001|Overall Study|Maintained PR and moved to observation only|1|||
126287439|NCT05192889|454337751|FG000|Block 1: All Eligible Patients|Death|2|||
126287440|NCT05192889|454337752|FG001|Block 1: All Eligible Patients|Death|0|||
126287441|NCT05192889|454337753|FG002|Block 1: All Eligible Patients|Death|0|||
126287442|NCT05192889|454337751|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
126287443|NCT05192889|454337752|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
126287444|NCT05192889|454337753|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
126287445|NCT05192889|454337751|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
126287446|NCT05192889|454337752|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
126287447|NCT05192889|454337753|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
126287448|NCT02717455|454339790|FG000|Overall Study|Adverse Event|1|||
126287449|NCT02717455|454339791|FG001|Overall Study|Adverse Event|0|||
126287450|NCT02717455|454339792|FG002|Overall Study|Adverse Event|0|||
126287451|NCT02717455|454339793|FG003|Overall Study|Adverse Event|2|||
126287452|NCT02717455|454339794|FG004|Overall Study|Adverse Event|2|||
126287453|NCT02717455|454339795|FG005|Overall Study|Adverse Event|2|||
126287454|NCT02717455|454339790|FG000|Overall Study|Withdrawal by Subject|1|||
126287455|NCT02717455|454339791|FG001|Overall Study|Withdrawal by Subject|1|||
126287456|NCT02717455|454339792|FG002|Overall Study|Withdrawal by Subject|0|||
126287457|NCT02717455|454339793|FG003|Overall Study|Withdrawal by Subject|2|||
126287458|NCT02717455|454339794|FG004|Overall Study|Withdrawal by Subject|2|||
126287459|NCT02717455|454339795|FG005|Overall Study|Withdrawal by Subject|1|||
126287460|NCT02717455|454339790|FG000|Overall Study|Death|1|||
126287461|NCT02717455|454339791|FG001|Overall Study|Death|0|||
126287462|NCT02717455|454339792|FG002|Overall Study|Death|0|||
126287463|NCT02717455|454339793|FG003|Overall Study|Death|0|||
126287464|NCT02717455|454339794|FG004|Overall Study|Death|1|||
126287465|NCT02717455|454339795|FG005|Overall Study|Death|0|||
126287466|NCT02717455|454339790|FG000|Overall Study|Did not receive study drug|0|||
126287467|NCT02717455|454339791|FG001|Overall Study|Did not receive study drug|0|||
126287468|NCT02717455|454339792|FG002|Overall Study|Did not receive study drug|0|||
126287469|NCT02717455|454339793|FG003|Overall Study|Did not receive study drug|1|||
126287470|NCT02717455|454339794|FG004|Overall Study|Did not receive study drug|0|||
126287471|NCT02717455|454339795|FG005|Overall Study|Did not receive study drug|1|||
126287472|NCT02717455|454339790|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287473|NCT02717455|454339791|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287474|NCT02717455|454339792|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287475|NCT02717455|454339793|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287476|NCT02717455|454339794|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287477|NCT02717455|454339795|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
126287478|NCT02717455|454339790|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
126287479|NCT02717455|454339791|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
126287480|NCT02717455|454339792|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
126287481|NCT02717455|454339793|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
126287482|NCT02717455|454339794|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
126287483|NCT02717455|454339795|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
126099958|NCT00903682|453657723|FG001|Overall Study|Subject Non-Compliant|0|||
126287484|NCT00233948|454339798|FG000|Overall Study|Adverse Event|1|||
126287485|NCT00233948|454339799|FG001|Overall Study|Adverse Event|0|||
126287486|NCT00233948|454339800|FG002|Overall Study|Adverse Event|0|||
126287487|NCT00233948|454339801|FG003|Overall Study|Adverse Event|0|||
126287488|NCT00233948|454339802|FG004|Overall Study|Adverse Event|0|||
126287489|NCT00233948|454339803|FG005|Overall Study|Adverse Event|0|||
126287490|NCT02465398|454339808|FG000|Overall Study|Death|7|||
126287491|NCT02465398|454339808|FG000|Overall Study|Revision|7|||
126287492|NCT02465398|454339808|FG000|Overall Study|did not receive study device|1|||
126287493|NCT02465398|454339808|FG000|Overall Study|Withdrawal by Subject|1|||
126099959|NCT00903682|453657722|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
126287494|NCT02465398|454339808|FG000|Overall Study|Lost to Follow-up|14|||
126287495|NCT05244122|454339813|FG000|Overall Study|Withdrawal by Subject|318|||
126287496|NCT02969382|454339818|FG000|Overall Study|Adverse Event|8|||
126287497|NCT02969382|454339819|FG001|Overall Study|Adverse Event|10|||
126287498|NCT02969382|454339818|FG000|Overall Study|Lack of Efficacy|4|||
126287499|NCT02969382|454339819|FG001|Overall Study|Lack of Efficacy|5|||
126287500|NCT02969382|454339818|FG000|Overall Study|Death|0|||
126287501|NCT02969382|454339819|FG001|Overall Study|Death|1|||
126287502|NCT02969382|454339818|FG000|Overall Study|PROTOCOL DEVIATION|0|||
126287503|NCT02969382|454339819|FG001|Overall Study|PROTOCOL DEVIATION|1|||
126287504|NCT02969382|454339818|FG000|Overall Study|Withdrawal by Subject|14|||
126287505|NCT02969382|454339819|FG001|Overall Study|Withdrawal by Subject|9|||
126287506|NCT00886015|454339822|FG000|Overall Study|Death|0|||
126287507|NCT00886015|454339823|FG001|Overall Study|Death|2|||
126287508|NCT00855894|454339824|FG000|Overall Study|Death|31|||
126287509|NCT00855894|454339824|FG000|Overall Study|Patient's decision|1|||
126287510|NCT00855894|454339824|FG000|Overall Study|Disease progression|1|||
126287511|NCT01473407|454339836|FG000|Overall Study|Physician Decision|1|||
126287512|NCT01473407|454339837|FG001|Overall Study|Physician Decision|4|||
126287513|NCT01473407|454339836|FG000|Overall Study|Lost to Follow-up|10|||
126287514|NCT01473407|454339837|FG001|Overall Study|Lost to Follow-up|4|||
126287515|NCT01473407|454339836|FG000|Overall Study|Adverse Event|8|||
126287516|NCT01473407|454339837|FG001|Overall Study|Adverse Event|8|||
126287517|NCT01473407|454339836|FG000|Overall Study|Randomization Error|3|||
126287518|NCT01473407|454339837|FG001|Overall Study|Randomization Error|1|||
126287519|NCT01473407|454339836|FG000|Overall Study|Withdrawal by Subject|4|||
126287520|NCT01473407|454339837|FG001|Overall Study|Withdrawal by Subject|7|||
126287521|NCT01473407|454339836|FG000|Overall Study|Kidney Transplant|7|||
126287522|NCT01473407|454339837|FG001|Overall Study|Kidney Transplant|6|||
126287523|NCT01473407|454339836|FG000|Overall Study|Vacation/Travel|1|||
126287524|NCT01473407|454339837|FG001|Overall Study|Vacation/Travel|1|||
126287525|NCT01473407|454339836|FG000|Overall Study|Elevated Hemoglobin|1|||
126287526|NCT01473407|454339837|FG001|Overall Study|Elevated Hemoglobin|0|||
126041802|NCT03824366|453451146|FG000|Overall Study|Previously unidentified metal artifact|1|||
126041803|NCT03824366|453451146|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
126041804|NCT03824366|453451146|FG000|Overall Study|Withdrawal by Subject|1|||
126041805|NCT05069896|453451151|FG000|Overall Study|Adverse Event|0|||
126041806|NCT05069896|453451152|FG001|Overall Study|Adverse Event|1|||
126041807|NCT05069896|453451153|FG002|Overall Study|Adverse Event|1|||
126041808|NCT05069896|453451154|FG003|Overall Study|Adverse Event|0|||
126041809|NCT05069896|453451155|FG004|Overall Study|Adverse Event|0|||
126041810|NCT05069896|453451156|FG005|Overall Study|Adverse Event|0|||
126041811|NCT05069896|453451151|FG000|Overall Study|Lost to Follow-up|0|||
126041812|NCT05069896|453451152|FG001|Overall Study|Lost to Follow-up|0|||
126041813|NCT05069896|453451153|FG002|Overall Study|Lost to Follow-up|1|||
126041814|NCT05069896|453451154|FG003|Overall Study|Lost to Follow-up|0|||
126041815|NCT05069896|453451155|FG004|Overall Study|Lost to Follow-up|1|||
126041816|NCT05069896|453451156|FG005|Overall Study|Lost to Follow-up|2|||
126041817|NCT04820322|453451157|FG000|Overall Study|Adverse Event|1|||
126041818|NCT04820322|453451158|FG001|Overall Study|Adverse Event|0|||
126041819|NCT00323856|453451162|FG000|Overall Study|Withdrawal by Subject|1|||
126041820|NCT00323856|453451162|FG000|Overall Study|Was uncooperative and noncompliant|1|||
126041821|NCT00323856|453451162|FG000|Overall Study|Reason not specified|1|||
126041822|NCT00323856|453451162|FG000|Overall Study|Missing|2|||
126041823|NCT03156465|453451168|FG000|Overall Study|Withdrawal by Subject|2|||
126041824|NCT05715528|453451178|FG000|Overall Study|Randomized but never treated|11|||
126287527|NCT01473407|454339836|FG000|Overall Study|Patient Received Aranesp|1|||
126287528|NCT01473407|454339837|FG001|Overall Study|Patient Received Aranesp|0|||
126041825|NCT05715528|453451179|FG001|Overall Study|Randomized but never treated|13|||
126041826|NCT05715528|453451178|FG000|Overall Study|Withdrew consent|7|||
126041827|NCT05715528|453451179|FG001|Overall Study|Withdrew consent|15|||
126041828|NCT05715528|453451178|FG000|Overall Study|Lost to Follow-up|5|||
126041829|NCT05715528|453451179|FG001|Overall Study|Lost to Follow-up|13|||
126041830|NCT05715528|453451178|FG000|Overall Study|Investigator's discretion|3|||
126041831|NCT05715528|453451179|FG001|Overall Study|Investigator's discretion|1|||
126287529|NCT01473407|454339836|FG000|Overall Study|Patient Lost Green Card Status|1|||
126287530|NCT01473407|454339837|FG001|Overall Study|Patient Lost Green Card Status|0|||
126287531|NCT01473407|454339836|FG000|Overall Study|Temperature Excursion|2|||
126287532|NCT01473407|454339837|FG001|Overall Study|Temperature Excursion|3|||
126287533|NCT01473407|454339836|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
126287534|NCT01473407|454339837|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
126287535|NCT01473407|454339836|FG000|Overall Study|Sponsor's Decision|10|||
126287536|NCT01473407|454339837|FG001|Overall Study|Sponsor's Decision|10|||
126287537|NCT01473407|454339836|FG000|Overall Study|Site Closure|1|||
126287538|NCT01473407|454339837|FG001|Overall Study|Site Closure|0|||
126287539|NCT04071405|454339838|FG000|Overall Study|Protocol Violation|3|||
126287540|NCT00369941|454339839|FG000|Overall Study|Never Treated|1|||
126287541|NCT00369941|454339840|FG001|Overall Study|Never Treated|2|||
126287542|NCT00369941|454339839|FG000|Overall Study|Adverse Event|14|||
126287543|NCT00369941|454339840|FG001|Overall Study|Adverse Event|28|||
126287544|NCT00369941|454339839|FG000|Overall Study|Lack of Efficacy|6|||
126287545|NCT00369941|454339840|FG001|Overall Study|Lack of Efficacy|10|||
126287546|NCT00369941|454339839|FG000|Overall Study|Lost to Follow-up|12|||
126287547|NCT00369941|454339840|FG001|Overall Study|Lost to Follow-up|22|||
126287548|NCT00369941|454339839|FG000|Overall Study|Protocol Violation|5|||
126287549|NCT00369941|454339840|FG001|Overall Study|Protocol Violation|3|||
126287550|NCT00369941|454339839|FG000|Overall Study|Withdrawal by Subject|5|||
126287551|NCT00369941|454339840|FG001|Overall Study|Withdrawal by Subject|18|||
126287552|NCT00369941|454339839|FG000|Overall Study|Pregnancy|4|||
126287553|NCT00369941|454339840|FG001|Overall Study|Pregnancy|2|||
126287554|NCT00369941|454339839|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
126287555|NCT00369941|454339840|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
126287556|NCT00369941|454339839|FG000|Overall Study|Moved|11|||
126287557|NCT00369941|454339840|FG001|Overall Study|Moved|5|||
126287558|NCT00369941|454339839|FG000|Overall Study|Treatment with Prohibited Medication|3|||
126287559|NCT00369941|454339840|FG001|Overall Study|Treatment with Prohibited Medication|1|||
126287560|NCT00369941|454339839|FG000|Overall Study|Employment Interfered with Study Visits|1|||
126287561|NCT00369941|454339840|FG001|Overall Study|Employment Interfered with Study Visits|0|||
126287562|NCT00369941|454339839|FG000|Overall Study|Study Site Terminated|2|||
126287563|NCT00369941|454339840|FG001|Overall Study|Study Site Terminated|0|||
126287564|NCT00369941|454339839|FG000|Overall Study|Miscellaneous|3|||
126287565|NCT00369941|454339840|FG001|Overall Study|Miscellaneous|3|||
126287566|NCT01027702|454339841|FG000|Overall Study|Received subsequent therapy|1|||
126287567|NCT01027702|454339842|FG001|Overall Study|Received subsequent therapy|2|||
126287568|NCT01027702|454339843|FG002|Overall Study|Received subsequent therapy|0|||
126287569|NCT01027702|454339844|FG003|Overall Study|Received subsequent therapy|4|||
126287570|NCT01027702|454339845|FG004|Overall Study|Received subsequent therapy|1|||
126287571|NCT01027702|454339846|FG005|Overall Study|Received subsequent therapy|0|||
126287572|NCT01027702|454339847|FG006|Overall Study|Received subsequent therapy|1|||
126287573|NCT01027702|454339841|FG000|Overall Study|Death|0|||
126287574|NCT01027702|454339842|FG001|Overall Study|Death|0|||
126287575|NCT01027702|454339843|FG002|Overall Study|Death|1|||
126287576|NCT01027702|454339844|FG003|Overall Study|Death|0|||
126287577|NCT01027702|454339845|FG004|Overall Study|Death|0|||
126287578|NCT01027702|454339846|FG005|Overall Study|Death|0|||
126287579|NCT01027702|454339847|FG006|Overall Study|Death|0|||
126287580|NCT00403585|454339851|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
126287581|NCT00403585|454339851|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
126287582|NCT00403585|454339851|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
126287583|NCT00661193|454339852|FG000|Overall Study|Adverse Event|2|||
126287584|NCT00661193|454339853|FG001|Overall Study|Adverse Event|1|||
126287585|NCT00661193|454339852|FG000|Overall Study|Withdrawal by Subject|3|||
126287586|NCT00661193|454339853|FG001|Overall Study|Withdrawal by Subject|1|||
126287587|NCT00661193|454339852|FG000|Overall Study|Progression|27|||
126287588|NCT00661193|454339853|FG001|Overall Study|Progression|24|||
126287589|NCT00661193|454339852|FG000|Overall Study|Not protocol specified|1|||
126287590|NCT00661193|454339853|FG001|Overall Study|Not protocol specified|0|||
126287591|NCT02964312|454339860|FG000|Overall Study|Lost to Follow-up|28|||
126287592|NCT02964312|454339860|FG000|Overall Study|Withdrawal by Subject|11|||
126287593|NCT02964312|454339860|FG000|Overall Study|Lack of Efficacy|10|||
126287594|NCT02964312|454339860|FG000|Overall Study|Did not consent to long-term FU|14|||
126287595|NCT02964312|454339860|FG000|Overall Study|Death|1|||
126287596|NCT02862730|454339865|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287597|NCT02862730|454339866|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287598|NCT02862730|454339867|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
126099960|NCT00903682|453657723|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
126365674|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
126365675|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
126287599|NCT02862730|454339868|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287600|NCT02862730|454339869|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287601|NCT02862730|454339870|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287602|NCT02862730|454339871|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287603|NCT02862730|454339865|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
126287604|NCT02862730|454339866|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287605|NCT02862730|454339867|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287606|NCT02862730|454339868|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287607|NCT02862730|454339869|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287608|NCT02862730|454339870|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287609|NCT02862730|454339871|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287610|NCT02862730|454339865|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287611|NCT02862730|454339866|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287612|NCT02862730|454339867|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
126287613|NCT02862730|454339868|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287614|NCT02862730|454339869|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
126287615|NCT02862730|454339870|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287616|NCT02862730|454339871|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287617|NCT02862730|454339865|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287618|NCT02862730|454339866|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287619|NCT02862730|454339867|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287620|NCT02862730|454339868|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
126287621|NCT02862730|454339869|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287622|NCT02862730|454339870|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287623|NCT02862730|454339871|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287624|NCT03685344|454339872|FG000|Overall Study|Withdrawal by Subject|1|||
126287625|NCT03685344|454339873|FG001|Overall Study|Withdrawal by Subject|1|||
126287626|NCT03685344|454339874|FG002|Overall Study|Withdrawal by Subject|2|||
126287627|NCT03685344|454339875|FG003|Overall Study|Withdrawal by Subject|0|||
126287628|NCT03685344|454339872|FG000|Overall Study|Physician Decision|1|||
126287629|NCT03685344|454339873|FG001|Overall Study|Physician Decision|1|||
126287630|NCT03685344|454339874|FG002|Overall Study|Physician Decision|5|||
126287631|NCT03685344|454339875|FG003|Overall Study|Physician Decision|0|||
126287632|NCT03685344|454339872|FG000|Overall Study|Death|1|||
126287633|NCT03685344|454339873|FG001|Overall Study|Death|1|||
126287634|NCT03685344|454339874|FG002|Overall Study|Death|0|||
126287635|NCT03685344|454339875|FG003|Overall Study|Death|0|||
126287636|NCT01023035|454339878|FG000|Treatment Period|Adverse Event|27|||
126287637|NCT01023035|454339879|FG001|Treatment Period|Adverse Event|32|||
126287638|NCT01023035|454339880|FG002|Treatment Period|Adverse Event|50|||
126287639|NCT01023035|454339878|FG000|Treatment Period|Non-Medical Reasons|19|||
126287640|NCT01023035|454339879|FG001|Treatment Period|Non-Medical Reasons|22|||
126287641|NCT01023035|454339880|FG002|Treatment Period|Non-Medical Reasons|44|||
126287642|NCT01023035|454339878|FG000|Treatment Period|Treatment Failure|26|||
126287643|NCT01023035|454339879|FG001|Treatment Period|Treatment Failure|31|||
126287644|NCT01023035|454339880|FG002|Treatment Period|Treatment Failure|24|||
126287645|NCT01023035|454339878|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
126287646|NCT01023035|454339879|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
126287647|NCT01023035|454339880|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
126287648|NCT01023035|454339878|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
126287649|NCT01023035|454339879|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
126287650|NCT01023035|454339880|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
126287651|NCT00524420|454339881|FG000|Overall Study|Lack of Efficacy|1|||
126287652|NCT00524420|454339882|FG001|Overall Study|Lack of Efficacy|0|||
126287653|NCT01090414|454339883|FG000|Study 101-99|Progressive Disease|28|||
126287654|NCT01090414|454339884|FG001|Study 101-99|Progressive Disease|48|||
126287655|NCT01090414|454339885|FG002|Study 101-99|Progressive Disease|10|||
126287656|NCT01090414|454339886|FG003|Study 101-99|Progressive Disease|4|||
126287657|NCT01090414|454339883|FG000|Study 101-99|Adverse Event|10|||
126287658|NCT01090414|454339884|FG001|Study 101-99|Adverse Event|28|||
126287659|NCT01090414|454339885|FG002|Study 101-99|Adverse Event|18|||
126287660|NCT01090414|454339886|FG003|Study 101-99|Adverse Event|0|||
126287661|NCT01090414|454339883|FG000|Study 101-99|Investigator Request|1|||
125882946|NCT00759941|452869080|FG000|Overall Study|Adverse Event|1|||
125882947|NCT00759941|452869081|FG001|Overall Study|Adverse Event|0|||
125882948|NCT00759941|452869080|FG000|Overall Study|Exited in error by site|1|||
125882949|NCT00759941|452869081|FG001|Overall Study|Exited in error by site|1|||
125882950|NCT03863080|452869082|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
125882951|NCT03863080|452869083|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
126287662|NCT01090414|454339884|FG001|Study 101-99|Investigator Request|11|||
125882952|NCT03863080|452869084|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
126287663|NCT01090414|454339885|FG002|Study 101-99|Investigator Request|4|||
126287664|NCT01090414|454339886|FG003|Study 101-99|Investigator Request|0|||
126287665|NCT01090414|454339883|FG000|Study 101-99|Death|3|||
126365676|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
126365677|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
126041832|NCT05715528|453451178|FG000|Overall Study|Protocol Violation|2|||
126287666|NCT01090414|454339884|FG001|Study 101-99|Death|8|||
126287667|NCT01090414|454339885|FG002|Study 101-99|Death|1|||
126287668|NCT01090414|454339886|FG003|Study 101-99|Death|0|||
126287669|NCT01090414|454339883|FG000|Study 101-99|Sponsor Discontinued Study|0|||
126287670|NCT01090414|454339884|FG001|Study 101-99|Sponsor Discontinued Study|7|||
126287671|NCT01090414|454339885|FG002|Study 101-99|Sponsor Discontinued Study|5|||
126287672|NCT01090414|454339886|FG003|Study 101-99|Sponsor Discontinued Study|0|||
126287673|NCT01090414|454339883|FG000|Study 101-99|Other (Unknown Reasons)|3|||
126287674|NCT01090414|454339884|FG001|Study 101-99|Other (Unknown Reasons)|3|||
126287675|NCT01090414|454339885|FG002|Study 101-99|Other (Unknown Reasons)|0|||
126287676|NCT01090414|454339886|FG003|Study 101-99|Other (Unknown Reasons)|0|||
126287677|NCT01090414|454339883|FG000|Study 101-99|Withdrew Consent|0|||
126041833|NCT05715528|453451179|FG001|Overall Study|Protocol Violation|0|||
126041834|NCT05715528|453451178|FG000|Overall Study|Non-compliance with study drug|0|||
126041835|NCT05715528|453451179|FG001|Overall Study|Non-compliance with study drug|1|||
126041836|NCT03485729|453451183|FG000|Overall Study|Withdrawal by Subject|0|||
126041837|NCT03485729|453451184|FG001|Overall Study|Withdrawal by Subject|0|||
126041838|NCT03485729|453451185|FG002|Overall Study|Withdrawal by Subject|1|||
126041839|NCT03485729|453451183|FG000|Overall Study|Disease progression|8|||
126041840|NCT03485729|453451184|FG001|Overall Study|Disease progression|13|||
126041841|NCT03485729|453451185|FG002|Overall Study|Disease progression|1|||
126041842|NCT03485729|453451183|FG000|Overall Study|Hospice care|1|||
126041843|NCT03485729|453451184|FG001|Overall Study|Hospice care|0|||
126041844|NCT03485729|453451185|FG002|Overall Study|Hospice care|0|||
126041845|NCT03485729|453451183|FG000|Overall Study|Poor performance status|1|||
126041846|NCT03485729|453451184|FG001|Overall Study|Poor performance status|0|||
126041847|NCT03485729|453451185|FG002|Overall Study|Poor performance status|0|||
126041848|NCT03485729|453451183|FG000|Overall Study|Illness|0|||
126041849|NCT03485729|453451184|FG001|Overall Study|Illness|1|||
126041850|NCT03485729|453451185|FG002|Overall Study|Illness|0|||
126041851|NCT05035654|453451187|FG000|Overall Study|Physician Decision|0|||
126041852|NCT05035654|453451188|FG001|Overall Study|Physician Decision|1|||
126041853|NCT05035654|453451189|FG002|Overall Study|Physician Decision|0|||
126041854|NCT05035654|453451187|FG000|Overall Study|Adverse Event|0|||
126041855|NCT05035654|453451188|FG001|Overall Study|Adverse Event|1|||
126041856|NCT05035654|453451189|FG002|Overall Study|Adverse Event|0|||
126287678|NCT01090414|454339884|FG001|Study 101-99|Withdrew Consent|2|||
126287679|NCT01090414|454339885|FG002|Study 101-99|Withdrew Consent|3|||
126287680|NCT01090414|454339886|FG003|Study 101-99|Withdrew Consent|1|||
126287681|NCT01090414|454339883|FG000|Study 101-99|Participant Request|3|||
126287682|NCT01090414|454339884|FG001|Study 101-99|Participant Request|1|||
126041857|NCT05035654|453451187|FG000|Overall Study|Withdrawal by Subject|0|||
126041858|NCT05035654|453451188|FG001|Overall Study|Withdrawal by Subject|0|||
126041859|NCT05035654|453451189|FG002|Overall Study|Withdrawal by Subject|4|||
126041860|NCT05035654|453451187|FG000|Overall Study|Bilateral Dislodgement|1|||
126041861|NCT05035654|453451188|FG001|Overall Study|Bilateral Dislodgement|0|||
126041862|NCT05035654|453451189|FG002|Overall Study|Bilateral Dislodgement|0|||
126041863|NCT04880733|453451190|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
126287683|NCT01090414|454339885|FG002|Study 101-99|Participant Request|0|||
126041864|NCT04880733|453451191|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
126287684|NCT01090414|454339886|FG003|Study 101-99|Participant Request|0|||
126287685|NCT02413229|454339893|FG000|Overall Study|Adverse Event|0|||
126287686|NCT02413229|454339894|FG001|Overall Study|Adverse Event|0|||
126287687|NCT02413229|454339895|FG002|Overall Study|Adverse Event|0|||
126287688|NCT02413229|454339896|FG003|Overall Study|Adverse Event|1|||
126287689|NCT02413229|454339897|FG004|Overall Study|Adverse Event|0|||
126287690|NCT02413229|454339898|FG005|Overall Study|Adverse Event|0|||
126287691|NCT02413229|454339899|FG006|Overall Study|Adverse Event|0|||
126287692|NCT02413229|454339900|FG007|Overall Study|Adverse Event|1|||
126287693|NCT02413229|454339893|FG000|Overall Study|Lost to Follow-up|0|||
126287694|NCT02413229|454339894|FG001|Overall Study|Lost to Follow-up|0|||
126287695|NCT02413229|454339895|FG002|Overall Study|Lost to Follow-up|1|||
126287696|NCT02413229|454339896|FG003|Overall Study|Lost to Follow-up|0|||
126287697|NCT02413229|454339897|FG004|Overall Study|Lost to Follow-up|2|||
126287698|NCT02413229|454339898|FG005|Overall Study|Lost to Follow-up|0|||
126287699|NCT02413229|454339899|FG006|Overall Study|Lost to Follow-up|0|||
126287700|NCT02413229|454339900|FG007|Overall Study|Lost to Follow-up|0|||
126287701|NCT02413229|454339893|FG000|Overall Study|Withdrawal by Subject|1|||
126287702|NCT02413229|454339894|FG001|Overall Study|Withdrawal by Subject|1|||
126287703|NCT02413229|454339895|FG002|Overall Study|Withdrawal by Subject|0|||
126287704|NCT02413229|454339896|FG003|Overall Study|Withdrawal by Subject|0|||
126287705|NCT02413229|454339897|FG004|Overall Study|Withdrawal by Subject|1|||
126287706|NCT02413229|454339898|FG005|Overall Study|Withdrawal by Subject|0|||
126287707|NCT02413229|454339899|FG006|Overall Study|Withdrawal by Subject|0|||
126287708|NCT02413229|454339900|FG007|Overall Study|Withdrawal by Subject|2|||
126287709|NCT02413229|454339893|FG000|Overall Study|Progressive Disease|0|||
126287710|NCT02413229|454339894|FG001|Overall Study|Progressive Disease|0|||
126287711|NCT02413229|454339895|FG002|Overall Study|Progressive Disease|0|||
126287712|NCT02413229|454339896|FG003|Overall Study|Progressive Disease|0|||
126287713|NCT02413229|454339897|FG004|Overall Study|Progressive Disease|0|||
126287714|NCT02413229|454339898|FG005|Overall Study|Progressive Disease|0|||
126287715|NCT02413229|454339899|FG006|Overall Study|Progressive Disease|0|||
126287716|NCT02413229|454339900|FG007|Overall Study|Progressive Disease|1|||
126287717|NCT02932462|454339901|FG000|Overall Study|Adverse Event|1|||
126287718|NCT02932462|454339902|FG001|Overall Study|Adverse Event|2|||
126287719|NCT02932462|454339901|FG000|Overall Study|Lost to Follow-up|4|||
126287720|NCT02932462|454339902|FG001|Overall Study|Lost to Follow-up|1|||
126287721|NCT02932462|454339901|FG000|Overall Study|Protocol Violation|0|||
126287722|NCT02932462|454339902|FG001|Overall Study|Protocol Violation|5|||
126287723|NCT02932462|454339901|FG000|Overall Study|Withdrawal by Subject|1|||
126287724|NCT02932462|454339902|FG001|Overall Study|Withdrawal by Subject|4|||
126287725|NCT02932462|454339901|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126287726|NCT02932462|454339902|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126287727|NCT02932462|454339901|FG000|Overall Study|Progressive Disease|1|||
126287728|NCT02932462|454339902|FG001|Overall Study|Progressive Disease|0|||
126287729|NCT02652949|454339903|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
126287730|NCT02652949|454339903|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
126287731|NCT02652949|454339903|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
126287732|NCT02652949|454339903|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
126287733|NCT02652949|454339903|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
126287734|NCT02652949|454339903|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
126287735|NCT02652949|454339903|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
126287736|NCT02652949|454339903|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
126287737|NCT02652949|454339903|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
126287738|NCT02652949|454339903|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
126287739|NCT02652949|454339903|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
126287740|NCT02652949|454339903|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
126287741|NCT02652949|454339903|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
126287742|NCT02652949|454339903|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
126287743|NCT02652949|454339903|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
126287744|NCT02652949|454339903|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
126287745|NCT02652949|454339903|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
126041865|NCT04880733|453451192|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
126365678|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
126365679|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
126365680|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
126365681|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
126365682|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126287746|NCT03022370|454339904|FG000|Overall Study|Death|6|||
126287747|NCT03022370|454339905|FG001|Overall Study|Death|12|||
126287748|NCT03022370|454339904|FG000|Overall Study|Lost to Follow-up|174|||
126287749|NCT03022370|454339905|FG001|Overall Study|Lost to Follow-up|109|||
126287750|NCT00699816|454339906|FG000|Overall Study|Protocol Violation|1|||
126287751|NCT00699816|454339907|FG001|Overall Study|Protocol Violation|3|||
126287752|NCT02454933|454339912|FG000|Overall Study|Progressive disease|10|||
126287753|NCT02454933|454339913|FG001|Overall Study|Progressive disease|7|||
126287754|NCT02454933|454339912|FG000|Overall Study|Adverse Event|1|||
126287755|NCT02454933|454339913|FG001|Overall Study|Adverse Event|1|||
126287756|NCT02454933|454339912|FG000|Overall Study|Withdrawal by Subject|0|||
126287757|NCT02454933|454339913|FG001|Overall Study|Withdrawal by Subject|3|||
126287758|NCT02454933|454339912|FG000|Overall Study|Lost to Follow-up|1|||
126287759|NCT02454933|454339913|FG001|Overall Study|Lost to Follow-up|0|||
126287760|NCT01526655|454339914|FG000|Overall Study|Withdrawal by Subject|0|||
126287761|NCT01526655|454339915|FG001|Overall Study|Withdrawal by Subject|1|||
126287762|NCT04753216|454339916|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
126287763|NCT04753216|454339916|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
126287764|NCT04753216|454339916|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
126287765|NCT05211726|454339925|FG000|Overall Study|Withdrawal by Subject|2|||
126287766|NCT05211726|454339926|FG001|Overall Study|Withdrawal by Subject|3|||
126287767|NCT05211726|454339925|FG000|Overall Study|Protocol Violation|0|||
126287768|NCT05211726|454339926|FG001|Overall Study|Protocol Violation|1|||
126287769|NCT02374346|454339932|FG000|Overall Study|operated or discharged during weekend|48|||
126287770|NCT04807400|454339933|FG000|Overall Study|Adverse Event|2|||
126287771|NCT04807400|454339934|FG001|Overall Study|Adverse Event|3|||
126287772|NCT04807400|454339935|FG002|Overall Study|Adverse Event|3|||
126287773|NCT04807400|454339933|FG000|Overall Study|Death|2|||
126287774|NCT04807400|454339934|FG001|Overall Study|Death|0|||
126287775|NCT04807400|454339935|FG002|Overall Study|Death|0|||
126287776|NCT04807400|454339933|FG000|Overall Study|Lost to Follow-up|8|||
126287777|NCT04807400|454339934|FG001|Overall Study|Lost to Follow-up|6|||
126287778|NCT04807400|454339935|FG002|Overall Study|Lost to Follow-up|6|||
126287779|NCT04807400|454339933|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126287780|NCT04807400|454339934|FG001|Overall Study|Non-Compliance With Study Drug|4|||
126287781|NCT04807400|454339935|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126287782|NCT04807400|454339933|FG000|Overall Study|Participant Decision|20|||
126287783|NCT04807400|454339934|FG001|Overall Study|Participant Decision|19|||
126287784|NCT04807400|454339935|FG002|Overall Study|Participant Decision|26|||
126287785|NCT04807400|454339933|FG000|Overall Study|Physician Decision|0|||
126287786|NCT04807400|454339934|FG001|Overall Study|Physician Decision|1|||
126287787|NCT04807400|454339935|FG002|Overall Study|Physician Decision|0|||
126287788|NCT04807400|454339933|FG000|Overall Study|Protocol Violation|4|||
126287789|NCT04807400|454339934|FG001|Overall Study|Protocol Violation|3|||
126287790|NCT04807400|454339935|FG002|Overall Study|Protocol Violation|7|||
126287791|NCT04807400|454339933|FG000|Overall Study|Withdrawal by Subject|13|||
126287792|NCT04807400|454339934|FG001|Overall Study|Withdrawal by Subject|9|||
126287793|NCT04807400|454339935|FG002|Overall Study|Withdrawal by Subject|20|||
126287794|NCT04807400|454339933|FG000|Overall Study|Mis-randomized|1|||
126287795|NCT04807400|454339934|FG001|Overall Study|Mis-randomized|0|||
126287796|NCT04807400|454339935|FG002|Overall Study|Mis-randomized|0|||
126287797|NCT03656744|454339938|FG000|Overall Study|Adverse Event|1|||
126287798|NCT03656744|454339939|FG001|Overall Study|Adverse Event|4|||
126287799|NCT03656744|454339940|FG002|Overall Study|Adverse Event|1|||
126287800|NCT03656744|454339938|FG000|Overall Study|Protocol Violation|1|||
126287801|NCT03656744|454339939|FG001|Overall Study|Protocol Violation|0|||
126287802|NCT03656744|454339940|FG002|Overall Study|Protocol Violation|0|||
126287803|NCT03656744|454339938|FG000|Overall Study|Lost to Follow-up|2|||
126287804|NCT03656744|454339939|FG001|Overall Study|Lost to Follow-up|2|||
126287805|NCT03656744|454339940|FG002|Overall Study|Lost to Follow-up|0|||
126287806|NCT03656744|454339938|FG000|Overall Study|Withdrawal by Subject|0|||
126287807|NCT03656744|454339939|FG001|Overall Study|Withdrawal by Subject|1|||
126287808|NCT03656744|454339940|FG002|Overall Study|Withdrawal by Subject|0|||
126287809|NCT03656744|454339938|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
126287810|NCT03656744|454339939|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
126287811|NCT03656744|454339940|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
126287812|NCT01332292|454339943|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
126287813|NCT01332292|454339944|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
126287814|NCT01332292|454339943|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
126287815|NCT01332292|454339944|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
126287816|NCT01332292|454339943|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
126287817|NCT01332292|454339944|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
126287818|NCT03910673|454339946|FG000|Overall Study|Adverse Event|0|||
126287819|NCT03910673|454339947|FG001|Overall Study|Adverse Event|0|||
126287820|NCT03910673|454339948|FG002|Overall Study|Adverse Event|0|||
126287821|NCT03910673|454339949|FG003|Overall Study|Adverse Event|2|||
126287822|NCT03910673|454339950|FG004|Overall Study|Adverse Event|0|||
126287823|NCT01487525|454339951|FG000|Overall Study|Withdrawal by Subject|0|||
126287824|NCT01487525|454339952|FG001|Overall Study|Withdrawal by Subject|1|||
126287825|NCT04650204|454339953|FG000|Overall Study|Study was Terminated|2|||
126287826|NCT04650204|454339954|FG001|Overall Study|Study was Terminated|1|||
126287827|NCT01330303|454339955|FG000|Period 1|Adverse Event|1|||
126287828|NCT01330303|454339956|FG001|Period 1|Adverse Event|0|||
126287829|NCT01330303|454339955|FG000|Period 1|Protocol Violation|0|||
126287830|NCT01330303|454339956|FG001|Period 1|Protocol Violation|1|||
126287831|NCT01330303|454339955|FG000|Period 1|Withdrawal by Subject|0|||
126287832|NCT01330303|454339956|FG001|Period 1|Withdrawal by Subject|1|||
126287833|NCT01107197|454339957|FG000|Overall Study|Death|12|||
126287834|NCT01107197|454339958|FG001|Overall Study|Death|10|||
126287835|NCT01107197|454339957|FG000|Overall Study|Lost to Follow-up|5|||
126287836|NCT01107197|454339958|FG001|Overall Study|Lost to Follow-up|8|||
126287837|NCT01107197|454339957|FG000|Overall Study|Withdrawal by Subject|3|||
126287838|NCT01107197|454339958|FG001|Overall Study|Withdrawal by Subject|5|||
126287839|NCT03548337|454339959|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
126287840|NCT03548337|454339960|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
126287841|NCT03548337|454339959|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
126287842|NCT03548337|454339960|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
126287843|NCT03548337|454339959|FG000|Infant Series|Lost to Follow-up|2|||
126287844|NCT03548337|454339960|FG001|Infant Series|Lost to Follow-up|1|||
126287845|NCT03548337|454339959|FG000|Infant Series|Adverse Event|0|||
126287846|NCT03548337|454339960|FG001|Infant Series|Adverse Event|2|||
126287847|NCT03548337|454339959|FG000|Infant Series|Randomized but Not Vaccinated|1|||
126287848|NCT03548337|454339960|FG001|Infant Series|Randomized but Not Vaccinated|0|||
126287849|NCT03548337|454339959|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
126287850|NCT03548337|454339960|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
126287851|NCT01911273|454339962|FG000|Overall Study|Progression of Disease|1|||
126287852|NCT01911273|454339963|FG001|Overall Study|Progression of Disease|0|||
126287853|NCT01911273|454339962|FG000|Overall Study|Withdrawal by Subject|0|||
126287854|NCT01911273|454339963|FG001|Overall Study|Withdrawal by Subject|2|||
126287855|NCT01855828|454339967|FG000|Overall Study|Adverse Event|1|||
126287856|NCT01855828|454339967|FG000|Overall Study|Withdrawal by Subject|1|||
126287857|NCT01866098|454339972|FG000|Overall Study|Lost to Follow-up|11|||
126287858|NCT01866098|454339973|FG001|Overall Study|Lost to Follow-up|18|||
126287859|NCT01866098|454339974|FG002|Overall Study|Lost to Follow-up|13|||
126287860|NCT01866098|454339972|FG000|Overall Study|Physician Decision|0|||
126287861|NCT01866098|454339973|FG001|Overall Study|Physician Decision|1|||
126287862|NCT01866098|454339974|FG002|Overall Study|Physician Decision|2|||
126287863|NCT01866098|454339972|FG000|Overall Study|Adverse Event|1|||
126287864|NCT01866098|454339973|FG001|Overall Study|Adverse Event|5|||
126287865|NCT01866098|454339974|FG002|Overall Study|Adverse Event|4|||
126287866|NCT01866098|454339972|FG000|Overall Study|Protocol Violation|1|||
126287867|NCT01866098|454339973|FG001|Overall Study|Protocol Violation|0|||
126287868|NCT01866098|454339974|FG002|Overall Study|Protocol Violation|0|||
126287869|NCT01866098|454339972|FG000|Overall Study|Withdrawal by Subject|1|||
126287870|NCT01866098|454339973|FG001|Overall Study|Withdrawal by Subject|2|||
126287871|NCT01866098|454339974|FG002|Overall Study|Withdrawal by Subject|0|||
126287872|NCT01866098|454339972|FG000|Overall Study|Unrelated Hospitalization|2|||
126287873|NCT01866098|454339973|FG001|Overall Study|Unrelated Hospitalization|0|||
126287874|NCT01866098|454339974|FG002|Overall Study|Unrelated Hospitalization|1|||
126287875|NCT01866098|454339972|FG000|Overall Study|Non-compliance|1|||
126287876|NCT01866098|454339973|FG001|Overall Study|Non-compliance|0|||
126287877|NCT01866098|454339974|FG002|Overall Study|Non-compliance|1|||
126287878|NCT01866098|454339972|FG000|Overall Study|Pregnancy|2|||
126287879|NCT01866098|454339973|FG001|Overall Study|Pregnancy|0|||
126287880|NCT01866098|454339974|FG002|Overall Study|Pregnancy|0|||
126287881|NCT01866098|454339972|FG000|Overall Study|Death|0|||
126287882|NCT01866098|454339973|FG001|Overall Study|Death|1|||
126287883|NCT01866098|454339974|FG002|Overall Study|Death|0|||
126287884|NCT02517463|454339982|FG000|Overall Study|Lost to Follow-up|5|||
126287885|NCT02517463|454339983|FG001|Overall Study|Lost to Follow-up|2|||
126287886|NCT03449446|454339984|FG000|Overall Study|Randomized but Never Treated|0|||
126287887|NCT03449446|454339985|FG001|Overall Study|Randomized but Never Treated|0|||
126287888|NCT03449446|454339986|FG002|Overall Study|Randomized but Never Treated|1|||
126287889|NCT03449446|454339987|FG003|Overall Study|Randomized but Never Treated|1|||
126099961|NCT00903682|453657722|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
126099962|NCT00903682|453657723|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
126099963|NCT02495792|453657724|FG000|Overall Study|Lost to Follow-up|5|||
126099964|NCT02495792|453657725|FG001|Overall Study|Lost to Follow-up|9|||
126287890|NCT03449446|454339988|FG004|Overall Study|Randomized but Never Treated|1|||
126287891|NCT03449446|454339989|FG005|Overall Study|Randomized but Never Treated|0|||
126287892|NCT03449446|454339990|FG006|Overall Study|Randomized but Never Treated|0|||
126365683|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126365684|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126099965|NCT02495792|453657724|FG000|Overall Study|Protocol Violation|32|||
126287893|NCT03449446|454339984|FG000|Overall Study|Unknown Reason|33|||
126287894|NCT03449446|454339985|FG001|Overall Study|Unknown Reason|1|||
126287895|NCT03449446|454339986|FG002|Overall Study|Unknown Reason|1|||
126287896|NCT03449446|454339987|FG003|Overall Study|Unknown Reason|1|||
126287897|NCT03449446|454339988|FG004|Overall Study|Unknown Reason|2|||
126287898|NCT03449446|454339989|FG005|Overall Study|Unknown Reason|2|||
126287899|NCT03449446|454339990|FG006|Overall Study|Unknown Reason|0|||
126287900|NCT03449446|454339984|FG000|Overall Study|Withdrew Consent|1|||
126287901|NCT03449446|454339985|FG001|Overall Study|Withdrew Consent|3|||
126099966|NCT02495792|453657725|FG001|Overall Study|Protocol Violation|31|||
126099967|NCT03141905|453657728|FG000|Overall Study|Death|3|||
126099968|NCT03141905|453657729|FG001|Overall Study|Death|2|||
126099969|NCT03141905|453657728|FG000|Overall Study|Withdrawal by Subject|1|||
126099970|NCT03141905|453657729|FG001|Overall Study|Withdrawal by Subject|0|||
126099971|NCT03141905|453657728|FG000|Overall Study|Lost to Follow-up|3|||
126099972|NCT03141905|453657729|FG001|Overall Study|Lost to Follow-up|7|||
126099973|NCT03141905|453657728|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
126099974|NCT03141905|453657729|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
126099975|NCT02502799|453659777|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
126099976|NCT02502799|453659778|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
126099977|NCT02502799|453659779|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
126099978|NCT02502799|453659780|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
126099979|NCT02502799|453659777|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
126099980|NCT02502799|453659778|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
126099981|NCT02502799|453659779|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
126099982|NCT02502799|453659780|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
126099983|NCT02502799|453659777|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
126099984|NCT02502799|453659778|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
126099985|NCT02502799|453659779|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
126099986|NCT02502799|453659780|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
126287902|NCT03449446|454339986|FG002|Overall Study|Withdrew Consent|1|||
126287903|NCT03449446|454339987|FG003|Overall Study|Withdrew Consent|4|||
126287904|NCT03449446|454339988|FG004|Overall Study|Withdrew Consent|4|||
126287905|NCT03449446|454339989|FG005|Overall Study|Withdrew Consent|4|||
126287906|NCT03449446|454339990|FG006|Overall Study|Withdrew Consent|1|||
126287907|NCT03449446|454339984|FG000|Overall Study|Adverse Event|1|||
126287908|NCT03449446|454339985|FG001|Overall Study|Adverse Event|2|||
126287909|NCT03449446|454339986|FG002|Overall Study|Adverse Event|1|||
126287910|NCT03449446|454339987|FG003|Overall Study|Adverse Event|0|||
126287911|NCT03449446|454339988|FG004|Overall Study|Adverse Event|0|||
126287912|NCT03449446|454339989|FG005|Overall Study|Adverse Event|2|||
126287913|NCT03449446|454339990|FG006|Overall Study|Adverse Event|0|||
126287914|NCT03449446|454339984|FG000|Overall Study|Lost to Follow-up|0|||
126287915|NCT03449446|454339985|FG001|Overall Study|Lost to Follow-up|0|||
126287916|NCT03449446|454339986|FG002|Overall Study|Lost to Follow-up|2|||
126287917|NCT03449446|454339987|FG003|Overall Study|Lost to Follow-up|1|||
126287918|NCT03449446|454339988|FG004|Overall Study|Lost to Follow-up|3|||
126287919|NCT03449446|454339989|FG005|Overall Study|Lost to Follow-up|0|||
126287920|NCT03449446|454339990|FG006|Overall Study|Lost to Follow-up|0|||
126287921|NCT03449446|454339984|FG000|Overall Study|Investigator's Discretion|0|||
126287922|NCT03449446|454339985|FG001|Overall Study|Investigator's Discretion|1|||
126287923|NCT03449446|454339986|FG002|Overall Study|Investigator's Discretion|1|||
126287924|NCT03449446|454339987|FG003|Overall Study|Investigator's Discretion|2|||
126287925|NCT03449446|454339988|FG004|Overall Study|Investigator's Discretion|0|||
126287926|NCT03449446|454339989|FG005|Overall Study|Investigator's Discretion|0|||
126287927|NCT03449446|454339990|FG006|Overall Study|Investigator's Discretion|0|||
126287928|NCT03449446|454339984|FG000|Overall Study|Non Compliance with Study Drug|1|||
126287929|NCT03449446|454339985|FG001|Overall Study|Non Compliance with Study Drug|0|||
126287930|NCT03449446|454339986|FG002|Overall Study|Non Compliance with Study Drug|0|||
126287931|NCT03449446|454339987|FG003|Overall Study|Non Compliance with Study Drug|0|||
126287932|NCT03449446|454339988|FG004|Overall Study|Non Compliance with Study Drug|0|||
126287933|NCT03449446|454339989|FG005|Overall Study|Non Compliance with Study Drug|0|||
126287934|NCT03449446|454339990|FG006|Overall Study|Non Compliance with Study Drug|0|||
126287935|NCT03449446|454339984|FG000|Overall Study|Protocol Violation|0|||
126287936|NCT03449446|454339985|FG001|Overall Study|Protocol Violation|0|||
126287937|NCT03449446|454339986|FG002|Overall Study|Protocol Violation|0|||
126287938|NCT03449446|454339987|FG003|Overall Study|Protocol Violation|0|||
126287939|NCT03449446|454339988|FG004|Overall Study|Protocol Violation|1|||
126287940|NCT03449446|454339989|FG005|Overall Study|Protocol Violation|1|||
126287941|NCT03449446|454339990|FG006|Overall Study|Protocol Violation|0|||
126287942|NCT03449446|454339984|FG000|Overall Study|Death|0|||
126099987|NCT02502799|453659777|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
126287943|NCT03449446|454339985|FG001|Overall Study|Death|0|||
126287944|NCT03449446|454339986|FG002|Overall Study|Death|0|||
126287945|NCT03449446|454339987|FG003|Overall Study|Death|0|||
126287946|NCT03449446|454339988|FG004|Overall Study|Death|1|||
126287947|NCT03449446|454339989|FG005|Overall Study|Death|0|||
126287948|NCT03449446|454339990|FG006|Overall Study|Death|0|||
126287949|NCT04460885|454342097|FG000|Overall Study|Withdrawal by Subject|6|||
126287950|NCT04460885|454342098|FG001|Overall Study|Withdrawal by Subject|8|||
126287951|NCT04460885|454342097|FG000|Overall Study|Site closure|1|||
126287952|NCT04460885|454342098|FG001|Overall Study|Site closure|0|||
126287953|NCT04460885|454342097|FG000|Overall Study|Death|5|||
126287954|NCT04460885|454342098|FG001|Overall Study|Death|4|||
126287955|NCT04460885|454342097|FG000|Overall Study|Physician Decision|2|||
126287956|NCT04460885|454342098|FG001|Overall Study|Physician Decision|1|||
126287957|NCT04460885|454342097|FG000|Overall Study|Lost to Follow-up|4|||
126287958|NCT04460885|454342098|FG001|Overall Study|Lost to Follow-up|4|||
126287959|NCT04559347|454342099|FG000|Overall Study|Death|1|||
126287960|NCT04559347|454342100|FG001|Overall Study|Death|0|||
126287961|NCT04559347|454342099|FG000|Overall Study|Thoracotomy conversion|1|||
126287962|NCT04559347|454342100|FG001|Overall Study|Thoracotomy conversion|1|||
126287963|NCT04559347|454342099|FG000|Overall Study|Provider unavailable|2|||
126287964|NCT04559347|454342100|FG001|Overall Study|Provider unavailable|1|||
126287965|NCT04559347|454342099|FG000|Overall Study|Other|2|||
126287966|NCT04559347|454342100|FG001|Overall Study|Other|1|||
126287967|NCT03999996|454342105|FG000|Prior to Booster|Adverse Event|2|||
126287968|NCT03999996|454342106|FG001|Prior to Booster|Adverse Event|0|||
126287969|NCT03999996|454342107|FG002|Prior to Booster|Adverse Event|0|||
126287970|NCT03999996|454342108|FG003|Prior to Booster|Adverse Event|0|||
126287971|NCT03999996|454342105|FG000|Prior to Booster|Lost to Follow-up|17|||
126287972|NCT03999996|454342106|FG001|Prior to Booster|Lost to Follow-up|22|||
126287973|NCT03999996|454342107|FG002|Prior to Booster|Lost to Follow-up|0|||
126287974|NCT03999996|454342108|FG003|Prior to Booster|Lost to Follow-up|0|||
126287975|NCT03999996|454342105|FG000|Prior to Booster|Withdrawal of Consent|51|||
126287976|NCT03999996|454342106|FG001|Prior to Booster|Withdrawal of Consent|8|||
126287977|NCT03999996|454342107|FG002|Prior to Booster|Withdrawal of Consent|0|||
126287978|NCT03999996|454342108|FG003|Prior to Booster|Withdrawal of Consent|0|||
126287979|NCT03999996|454342105|FG000|Prior to Booster|Death|0|||
126287980|NCT03999996|454342106|FG001|Prior to Booster|Death|1|||
126287981|NCT03999996|454342107|FG002|Prior to Booster|Death|0|||
126287982|NCT03999996|454342108|FG003|Prior to Booster|Death|0|||
126287983|NCT03999996|454342105|FG000|Prior to Booster|Reason Not Specified|27|||
126287984|NCT03999996|454342106|FG001|Prior to Booster|Reason Not Specified|4|||
126287985|NCT03999996|454342107|FG002|Prior to Booster|Reason Not Specified|0|||
126287986|NCT03999996|454342108|FG003|Prior to Booster|Reason Not Specified|0|||
126287987|NCT03999996|454342105|FG000|Booster Phase|Lost to Follow-up|0|||
126287988|NCT03999996|454342106|FG001|Booster Phase|Lost to Follow-up|0|||
126287989|NCT03999996|454342107|FG002|Booster Phase|Lost to Follow-up|3|||
126287990|NCT03999996|454342108|FG003|Booster Phase|Lost to Follow-up|3|||
126287991|NCT03999996|454342105|FG000|Booster Phase|Withdrawal of Consent|0|||
126287992|NCT03999996|454342106|FG001|Booster Phase|Withdrawal of Consent|0|||
126287993|NCT03999996|454342107|FG002|Booster Phase|Withdrawal of Consent|0|||
126287994|NCT03999996|454342108|FG003|Booster Phase|Withdrawal of Consent|1|||
126287995|NCT03999996|454342105|FG000|Booster Phase|Reason Not Specified|0|||
126287996|NCT03999996|454342106|FG001|Booster Phase|Reason Not Specified|0|||
126287997|NCT03999996|454342107|FG002|Booster Phase|Reason Not Specified|0|||
126287998|NCT03999996|454342108|FG003|Booster Phase|Reason Not Specified|1|||
126287999|NCT00733005|454342109|FG000|Overall Study|Adverse Event|0|||
126288000|NCT00733005|454342110|FG001|Overall Study|Adverse Event|1|||
126288001|NCT00733005|454342109|FG000|Overall Study|Treatment Failure|0|||
126288002|NCT00733005|454342110|FG001|Overall Study|Treatment Failure|1|||
126288003|NCT00733005|454342109|FG000|Overall Study|Withdrawal by Subject|0|||
126288004|NCT00733005|454342110|FG001|Overall Study|Withdrawal by Subject|1|||
126288005|NCT00733005|454342109|FG000|Overall Study|Protocol Violation|2|||
126365685|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126365686|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
126365687|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
126365688|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
126365689|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
126365690|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
126365691|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126365692|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126365693|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126365694|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
126365695|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126365696|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
126365697|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
126365698|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
126288006|NCT00733005|454342110|FG001|Overall Study|Protocol Violation|0|||
126288007|NCT00266630|454342111|FG000|Overall Study|Adverse Event|8|||
126288008|NCT00266630|454342112|FG001|Overall Study|Adverse Event|6|||
126288009|NCT00266630|454342111|FG000|Overall Study|Lack of Efficacy|1|||
126288010|NCT00266630|454342112|FG001|Overall Study|Lack of Efficacy|4|||
126288011|NCT00266630|454342111|FG000|Overall Study|Entry Criteria not met|1|||
126288012|NCT00266630|454342112|FG001|Overall Study|Entry Criteria not met|0|||
126288013|NCT00266630|454342111|FG000|Overall Study|Protocol Violation|1|||
126288014|NCT00266630|454342112|FG001|Overall Study|Protocol Violation|3|||
126288015|NCT00266630|454342111|FG000|Overall Study|Physician Decision|1|||
126288016|NCT00266630|454342112|FG001|Overall Study|Physician Decision|2|||
126288017|NCT00266630|454342111|FG000|Overall Study|Withdrawal by Subject|10|||
125882953|NCT03863080|452869085|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
125882954|NCT03863080|452869082|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125882955|NCT03863080|452869083|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125882956|NCT03863080|452869084|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125882957|NCT03863080|452869085|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
125882958|NCT03863080|452869082|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
125882959|NCT03863080|452869083|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
125882960|NCT03863080|452869084|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
126041866|NCT04880733|453451190|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
126041867|NCT04880733|453451191|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
126041868|NCT04880733|453451192|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
126288018|NCT00266630|454342112|FG001|Overall Study|Withdrawal by Subject|2|||
126288019|NCT00266630|454342111|FG000|Overall Study|Lost to Follow-up|1|||
126288020|NCT00266630|454342112|FG001|Overall Study|Lost to Follow-up|0|||
126288021|NCT00266630|454342111|FG000|Overall Study|Other|19|||
126288022|NCT00266630|454342112|FG001|Overall Study|Other|11|||
126288023|NCT03410056|454342113|FG000|Overall Study|Decision by Sponsor|0|||
126288024|NCT03410056|454342114|FG001|Overall Study|Decision by Sponsor|0|||
126288025|NCT03410056|454342115|FG002|Overall Study|Decision by Sponsor|3|||
126288026|NCT03410056|454342116|FG003|Overall Study|Decision by Sponsor|0|||
126288027|NCT03410056|454342117|FG004|Overall Study|Decision by Sponsor|0|||
126288028|NCT03410056|454342118|FG005|Overall Study|Decision by Sponsor|0|||
126288029|NCT03410056|454342119|FG006|Overall Study|Decision by Sponsor|0|||
126288030|NCT03410056|454342113|FG000|Overall Study|Withdrawal by Subject|0|||
126288031|NCT03410056|454342114|FG001|Overall Study|Withdrawal by Subject|2|||
126288032|NCT03410056|454342115|FG002|Overall Study|Withdrawal by Subject|5|||
126288033|NCT03410056|454342116|FG003|Overall Study|Withdrawal by Subject|5|||
126288034|NCT03410056|454342117|FG004|Overall Study|Withdrawal by Subject|0|||
126288035|NCT03410056|454342118|FG005|Overall Study|Withdrawal by Subject|0|||
126288036|NCT03410056|454342119|FG006|Overall Study|Withdrawal by Subject|0|||
126288037|NCT03284723|454342120|FG000|Overall Study|Death|0|||
126288038|NCT03284723|454342121|FG001|Overall Study|Death|0|||
126288039|NCT03284723|454342122|FG002|Overall Study|Death|0|||
126288040|NCT03284723|454342123|FG003|Overall Study|Death|1|||
126288041|NCT03284723|454342124|FG004|Overall Study|Death|0|||
126288042|NCT03284723|454342125|FG005|Overall Study|Death|0|||
126288043|NCT03284723|454342126|FG006|Overall Study|Death|1|||
126041869|NCT04880733|453451190|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
126041870|NCT04880733|453451191|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
126041871|NCT04880733|453451192|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
126041872|NCT04880733|453451190|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
126041873|NCT04880733|453451191|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
126099988|NCT02502799|453659778|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
126099989|NCT02502799|453659779|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
126288044|NCT03284723|454342127|FG007|Overall Study|Death|0|||
126288045|NCT03284723|454342128|FG008|Overall Study|Death|0|||
126288046|NCT03284723|454342129|FG009|Overall Study|Death|2|||
126099990|NCT02502799|453659780|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
126099991|NCT02502799|453659777|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
126288047|NCT03284723|454342130|FG010|Overall Study|Death|1|||
126288048|NCT03284723|454342131|FG011|Overall Study|Death|0|||
126288049|NCT03284723|454342120|FG000|Overall Study|Lost to Follow-up|0|||
126288050|NCT03284723|454342121|FG001|Overall Study|Lost to Follow-up|0|||
126288051|NCT03284723|454342122|FG002|Overall Study|Lost to Follow-up|0|||
126288052|NCT03284723|454342123|FG003|Overall Study|Lost to Follow-up|0|||
126288053|NCT03284723|454342124|FG004|Overall Study|Lost to Follow-up|0|||
126288054|NCT03284723|454342125|FG005|Overall Study|Lost to Follow-up|2|||
126288055|NCT03284723|454342126|FG006|Overall Study|Lost to Follow-up|1|||
126288056|NCT03284723|454342127|FG007|Overall Study|Lost to Follow-up|0|||
126288057|NCT03284723|454342128|FG008|Overall Study|Lost to Follow-up|0|||
126288058|NCT03284723|454342129|FG009|Overall Study|Lost to Follow-up|2|||
126288059|NCT03284723|454342130|FG010|Overall Study|Lost to Follow-up|0|||
126288060|NCT03284723|454342131|FG011|Overall Study|Lost to Follow-up|0|||
126288061|NCT03284723|454342120|FG000|Overall Study|Study Terminated By Sponsor|0|||
126288062|NCT03284723|454342121|FG001|Overall Study|Study Terminated By Sponsor|0|||
126288063|NCT03284723|454342122|FG002|Overall Study|Study Terminated By Sponsor|0|||
126288064|NCT03284723|454342123|FG003|Overall Study|Study Terminated By Sponsor|0|||
126288065|NCT03284723|454342124|FG004|Overall Study|Study Terminated By Sponsor|1|||
126288066|NCT03284723|454342125|FG005|Overall Study|Study Terminated By Sponsor|0|||
126288067|NCT03284723|454342126|FG006|Overall Study|Study Terminated By Sponsor|0|||
126288068|NCT03284723|454342127|FG007|Overall Study|Study Terminated By Sponsor|0|||
126288069|NCT03284723|454342128|FG008|Overall Study|Study Terminated By Sponsor|1|||
126288070|NCT03284723|454342129|FG009|Overall Study|Study Terminated By Sponsor|1|||
126288071|NCT03284723|454342130|FG010|Overall Study|Study Terminated By Sponsor|1|||
126288072|NCT03284723|454342131|FG011|Overall Study|Study Terminated By Sponsor|1|||
126288073|NCT03284723|454342120|FG000|Overall Study|Withdrawal by Subject|0|||
126288074|NCT03284723|454342121|FG001|Overall Study|Withdrawal by Subject|0|||
126288075|NCT03284723|454342122|FG002|Overall Study|Withdrawal by Subject|0|||
126041874|NCT04880733|453451192|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
126288076|NCT03284723|454342123|FG003|Overall Study|Withdrawal by Subject|0|||
126288077|NCT03284723|454342124|FG004|Overall Study|Withdrawal by Subject|5|||
126288078|NCT03284723|454342125|FG005|Overall Study|Withdrawal by Subject|3|||
126288079|NCT03284723|454342126|FG006|Overall Study|Withdrawal by Subject|1|||
126288080|NCT03284723|454342127|FG007|Overall Study|Withdrawal by Subject|0|||
126288081|NCT03284723|454342128|FG008|Overall Study|Withdrawal by Subject|6|||
126288082|NCT03284723|454342129|FG009|Overall Study|Withdrawal by Subject|0|||
126288083|NCT03284723|454342130|FG010|Overall Study|Withdrawal by Subject|3|||
126288084|NCT03284723|454342131|FG011|Overall Study|Withdrawal by Subject|1|||
126288085|NCT03284723|454342120|FG000|Overall Study|Other|1|||
125882961|NCT03863080|452869085|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
125882962|NCT01342211|452869086|FG000|Overall Study|Lost to Follow-up|0|||
125882963|NCT01342211|452869087|FG001|Overall Study|Lost to Follow-up|0|||
125882964|NCT01342211|452869088|FG002|Overall Study|Lost to Follow-up|0|||
125882965|NCT01342211|452869089|FG003|Overall Study|Lost to Follow-up|1|||
125882966|NCT01342211|452869090|FG004|Overall Study|Lost to Follow-up|0|||
125882967|NCT01342211|452869086|FG000|Overall Study|Adverse Event|0|||
125882968|NCT01342211|452869087|FG001|Overall Study|Adverse Event|0|||
125882969|NCT01342211|452869088|FG002|Overall Study|Adverse Event|0|||
125882970|NCT01342211|452869089|FG003|Overall Study|Adverse Event|0|||
125882971|NCT01342211|452869090|FG004|Overall Study|Adverse Event|1|||
125882972|NCT01342211|452869086|FG000|Overall Study|Withdrawal by Subject|0|||
125882973|NCT01342211|452869087|FG001|Overall Study|Withdrawal by Subject|0|||
125882974|NCT01342211|452869088|FG002|Overall Study|Withdrawal by Subject|0|||
125882975|NCT01342211|452869089|FG003|Overall Study|Withdrawal by Subject|1|||
126099992|NCT02502799|453659778|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
126288086|NCT03284723|454342121|FG001|Overall Study|Other|0|||
125882976|NCT01342211|452869090|FG004|Overall Study|Withdrawal by Subject|0|||
126288087|NCT03284723|454342122|FG002|Overall Study|Other|1|||
126288088|NCT03284723|454342123|FG003|Overall Study|Other|0|||
126288089|NCT03284723|454342124|FG004|Overall Study|Other|1|||
126288090|NCT03284723|454342125|FG005|Overall Study|Other|0|||
126288091|NCT03284723|454342126|FG006|Overall Study|Other|0|||
126288092|NCT03284723|454342127|FG007|Overall Study|Other|0|||
126288093|NCT03284723|454342128|FG008|Overall Study|Other|0|||
126288094|NCT03284723|454342129|FG009|Overall Study|Other|0|||
126288095|NCT03284723|454342130|FG010|Overall Study|Other|1|||
126288096|NCT03284723|454342131|FG011|Overall Study|Other|0|||
126288097|NCT03284723|454342120|FG000|Overall Study|Adverse Event|0|||
126288098|NCT03284723|454342121|FG001|Overall Study|Adverse Event|0|||
126288099|NCT03284723|454342122|FG002|Overall Study|Adverse Event|0|||
126288100|NCT03284723|454342123|FG003|Overall Study|Adverse Event|0|||
126288101|NCT03284723|454342124|FG004|Overall Study|Adverse Event|0|||
126288102|NCT03284723|454342125|FG005|Overall Study|Adverse Event|0|||
126288103|NCT03284723|454342126|FG006|Overall Study|Adverse Event|0|||
126288104|NCT03284723|454342127|FG007|Overall Study|Adverse Event|0|||
126288105|NCT03284723|454342128|FG008|Overall Study|Adverse Event|1|||
126288106|NCT03284723|454342129|FG009|Overall Study|Adverse Event|0|||
126288107|NCT03284723|454342130|FG010|Overall Study|Adverse Event|0|||
126288108|NCT03284723|454342131|FG011|Overall Study|Adverse Event|0|||
126288109|NCT00615199|454342132|FG000|Overall Study|Adverse Event|3|||
126288110|NCT00615199|454342133|FG001|Overall Study|Adverse Event|1|||
126288111|NCT00615199|454342134|FG002|Overall Study|Adverse Event|1|||
126288112|NCT00615199|454342135|FG003|Overall Study|Adverse Event|0|||
126288113|NCT00615199|454342132|FG000|Overall Study|Lack of Efficacy|2|||
126288114|NCT00615199|454342133|FG001|Overall Study|Lack of Efficacy|0|||
126288115|NCT00615199|454342134|FG002|Overall Study|Lack of Efficacy|0|||
126288116|NCT00615199|454342135|FG003|Overall Study|Lack of Efficacy|1|||
126288117|NCT00615199|454342132|FG000|Overall Study|Lost to Follow-up|1|||
126288118|NCT00615199|454342133|FG001|Overall Study|Lost to Follow-up|0|||
126288119|NCT00615199|454342134|FG002|Overall Study|Lost to Follow-up|0|||
126288120|NCT00615199|454342135|FG003|Overall Study|Lost to Follow-up|0|||
126288121|NCT00615199|454342132|FG000|Overall Study|Other|0|||
126288122|NCT00615199|454342133|FG001|Overall Study|Other|0|||
126288123|NCT00615199|454342134|FG002|Overall Study|Other|0|||
126288124|NCT00615199|454342135|FG003|Overall Study|Other|1|||
126288125|NCT00615199|454342132|FG000|Overall Study|Withdrawal by Subject|2|||
126288126|NCT00615199|454342133|FG001|Overall Study|Withdrawal by Subject|1|||
126288127|NCT00615199|454342134|FG002|Overall Study|Withdrawal by Subject|0|||
126288128|NCT00615199|454342135|FG003|Overall Study|Withdrawal by Subject|0|||
126288129|NCT00064987|454342140|FG000|Overall Study|Physician Decision|3|||
126288130|NCT00064987|454342141|FG001|Overall Study|Physician Decision|0|||
126288131|NCT00764881|454342142|FG000|Overall Study|Adverse Event|5|||
126288132|NCT00764881|454342143|FG001|Overall Study|Adverse Event|1|||
126288133|NCT00764881|454342142|FG000|Overall Study|Withdrawal by Subject|1|||
126288134|NCT00764881|454342143|FG001|Overall Study|Withdrawal by Subject|3|||
125882977|NCT01342211|452869086|FG000|Overall Study|Randomized, but not Treated|0|||
125882978|NCT01342211|452869087|FG001|Overall Study|Randomized, but not Treated|2|||
125882979|NCT01342211|452869088|FG002|Overall Study|Randomized, but not Treated|0|||
125882980|NCT01342211|452869089|FG003|Overall Study|Randomized, but not Treated|0|||
125882981|NCT01342211|452869090|FG004|Overall Study|Randomized, but not Treated|1|||
125882982|NCT01588522|452869106|FG000|Overall Study|Withdrawal by Subject|1|||
125882983|NCT01588522|452869107|FG001|Overall Study|Withdrawal by Subject|5|||
125882984|NCT01588522|452869108|FG002|Overall Study|Withdrawal by Subject|3|||
125882985|NCT01588522|452869109|FG003|Overall Study|Withdrawal by Subject|1|||
125882986|NCT01588522|452869110|FG004|Overall Study|Withdrawal by Subject|2|||
125882987|NCT01588522|452869111|FG005|Overall Study|Withdrawal by Subject|0|||
125882988|NCT01588522|452869106|FG000|Overall Study|Lack of Efficacy|0|||
125882989|NCT01588522|452869107|FG001|Overall Study|Lack of Efficacy|0|||
125882990|NCT01588522|452869108|FG002|Overall Study|Lack of Efficacy|0|||
125882991|NCT01588522|452869109|FG003|Overall Study|Lack of Efficacy|0|||
125882992|NCT01588522|452869110|FG004|Overall Study|Lack of Efficacy|1|||
125882993|NCT01588522|452869111|FG005|Overall Study|Lack of Efficacy|0|||
125882994|NCT01588522|452869106|FG000|Overall Study|Adverse Event|0|||
125882995|NCT01588522|452869107|FG001|Overall Study|Adverse Event|0|||
125882996|NCT01588522|452869108|FG002|Overall Study|Adverse Event|0|||
125882997|NCT01588522|452869109|FG003|Overall Study|Adverse Event|1|||
125882998|NCT01588522|452869110|FG004|Overall Study|Adverse Event|0|||
125882999|NCT01588522|452869111|FG005|Overall Study|Adverse Event|0|||
125883000|NCT01588522|452869106|FG000|Overall Study|Grade 2 alopecia|1|||
125883001|NCT01588522|452869107|FG001|Overall Study|Grade 2 alopecia|0|||
125883002|NCT01588522|452869108|FG002|Overall Study|Grade 2 alopecia|0|||
125883003|NCT01588522|452869109|FG003|Overall Study|Grade 2 alopecia|0|||
125883004|NCT01588522|452869110|FG004|Overall Study|Grade 2 alopecia|0|||
125883005|NCT01588522|452869111|FG005|Overall Study|Grade 2 alopecia|0|||
126288135|NCT00764881|454342142|FG000|Overall Study|Protocol Violation|2|||
126288136|NCT00764881|454342143|FG001|Overall Study|Protocol Violation|2|||
126288137|NCT00764881|454342142|FG000|Overall Study|Lost to Follow-up|2|||
126288138|NCT00764881|454342143|FG001|Overall Study|Lost to Follow-up|0|||
126288139|NCT00764881|454342142|FG000|Overall Study|Noncompliant|1|||
126288140|NCT00764881|454342143|FG001|Overall Study|Noncompliant|0|||
126288141|NCT00764881|454342142|FG000|Overall Study|Accidentally discontinued study drug|1|||
126288142|NCT00764881|454342143|FG001|Overall Study|Accidentally discontinued study drug|0|||
126288143|NCT00764881|454342142|FG000|Overall Study|Wished to become pregnant|1|||
126288144|NCT00764881|454342143|FG001|Overall Study|Wished to become pregnant|0|||
126288145|NCT00764881|454342142|FG000|Overall Study|Carcinoma detected|1|||
126288146|NCT00764881|454342143|FG001|Overall Study|Carcinoma detected|0|||
126288147|NCT00764881|454342142|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
126288148|NCT00764881|454342143|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
126288149|NCT00764881|454342142|FG000|Overall Study|no treatment or no observation|2|||
126288150|NCT00764881|454342143|FG001|Overall Study|no treatment or no observation|2|||
126288151|NCT01214655|454342147|FG000|Part A|Progressive Disease|7|||
126288152|NCT01214655|454342148|FG001|Part A|Progressive Disease|0|||
126288153|NCT01214655|454342149|FG002|Part A|Progressive Disease|0|||
126288154|NCT01214655|454342147|FG000|Part A|Physician Decision|1|||
126288155|NCT01214655|454342148|FG001|Part A|Physician Decision|0|||
126288156|NCT01214655|454342149|FG002|Part A|Physician Decision|0|||
126288157|NCT01214655|454342147|FG000|Part B|Progressive disease|0|||
126288158|NCT01214655|454342148|FG001|Part B|Progressive disease|10|||
126288159|NCT01214655|454342149|FG002|Part B|Progressive disease|0|||
126288160|NCT01214655|454342147|FG000|Part B|Death|0|||
126288161|NCT01214655|454342148|FG001|Part B|Death|1|||
126288162|NCT01214655|454342149|FG002|Part B|Death|0|||
126288163|NCT01214655|454342147|FG000|Part B|Withdrawal by Subject|0|||
126288164|NCT01214655|454342148|FG001|Part B|Withdrawal by Subject|2|||
126288165|NCT01214655|454342149|FG002|Part B|Withdrawal by Subject|0|||
126288166|NCT01214655|454342147|FG000|Part C|Progressive Disease|0|||
126288167|NCT01214655|454342148|FG001|Part C|Progressive Disease|0|||
126288168|NCT01214655|454342149|FG002|Part C|Progressive Disease|5|||
126288169|NCT01214655|454342147|FG000|Part C|Death|0|||
125883006|NCT01588522|452869106|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
125883007|NCT01588522|452869107|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
125883008|NCT01588522|452869108|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
125883009|NCT01588522|452869109|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
125883010|NCT01588522|452869110|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
125883011|NCT01588522|452869111|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
125883012|NCT01588522|452869106|FG000|Overall Study|Taken off taxane-based regimen|0|||
126288170|NCT01214655|454342148|FG001|Part C|Death|0|||
126288171|NCT01214655|454342149|FG002|Part C|Death|1|||
126288172|NCT01214655|454342147|FG000|Part C|Physician Decision|0|||
126288173|NCT01214655|454342148|FG001|Part C|Physician Decision|0|||
126288174|NCT01214655|454342149|FG002|Part C|Physician Decision|1|||
126288175|NCT05256134|454342150|FG000|Overall Study|Study Terminated by Sponsor|11|||
126288176|NCT05256134|454342151|FG001|Overall Study|Study Terminated by Sponsor|10|||
126288177|NCT05256134|454342150|FG000|Overall Study|Withdrawal by Subject|1|||
126288178|NCT05256134|454342151|FG001|Overall Study|Withdrawal by Subject|3|||
126288179|NCT01567462|454342152|FG000|Overall Study|Withdrawal by Subject|4|||
126288180|NCT01567462|454342153|FG001|Overall Study|Withdrawal by Subject|7|||
126288181|NCT01977417|454342160|FG000|Overall Study|Adverse Event|1|||
126288182|NCT01977417|454342161|FG001|Overall Study|Adverse Event|0|||
126288183|NCT01977417|454342160|FG000|Overall Study|Withdrawal by Subject|2|||
126288184|NCT01977417|454342161|FG001|Overall Study|Withdrawal by Subject|4|||
126288185|NCT01977417|454342160|FG000|Overall Study|Female enrollment goal met|0|||
126288186|NCT01977417|454342161|FG001|Overall Study|Female enrollment goal met|2|||
126288187|NCT02548156|454342167|FG000|Washout Period 1|Lost to Follow-up|0|||
126288188|NCT02548156|454342168|FG001|Washout Period 1|Lost to Follow-up|0|||
126288189|NCT02548156|454342169|FG002|Washout Period 1|Lost to Follow-up|0|||
126288190|NCT02548156|454342170|FG003|Washout Period 1|Lost to Follow-up|0|||
126288191|NCT02548156|454342171|FG004|Washout Period 1|Lost to Follow-up|1|||
126288192|NCT02548156|454342172|FG005|Washout Period 1|Lost to Follow-up|0|||
126288193|NCT01068262|454342173|FG000|Overall Study|Adverse Event|2|||
126288194|NCT01068262|454342174|FG001|Overall Study|Adverse Event|0|||
126288195|NCT01068262|454342175|FG002|Overall Study|Adverse Event|1|||
126288196|NCT01068262|454342176|FG003|Overall Study|Adverse Event|0|||
126288197|NCT01068262|454342173|FG000|Overall Study|Protocol Violation|1|||
126288198|NCT01068262|454342174|FG001|Overall Study|Protocol Violation|0|||
126288199|NCT01068262|454342175|FG002|Overall Study|Protocol Violation|0|||
126288200|NCT01068262|454342176|FG003|Overall Study|Protocol Violation|0|||
126288201|NCT01068262|454342173|FG000|Overall Study|Withdrawal by Subject|0|||
126288202|NCT01068262|454342174|FG001|Overall Study|Withdrawal by Subject|1|||
126288203|NCT01068262|454342175|FG002|Overall Study|Withdrawal by Subject|0|||
126288204|NCT01068262|454342176|FG003|Overall Study|Withdrawal by Subject|0|||
126288205|NCT00444587|454342177|FG000|Overall Study|Death|2|||
126288206|NCT00444587|454342178|FG001|Overall Study|Death|1|||
126288207|NCT00444587|454342177|FG000|Overall Study|Progression of the disease|73|||
126288208|NCT00444587|454342178|FG001|Overall Study|Progression of the disease|8|||
126288209|NCT00444587|454342177|FG000|Overall Study|Refused treatment/did not cooperate|4|||
126288210|NCT00444587|454342178|FG001|Overall Study|Refused treatment/did not cooperate|1|||
126288211|NCT00444587|454342177|FG000|Overall Study|Investigator decision|3|||
126365699|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
126365700|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
126099993|NCT02502799|453659779|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
126099994|NCT02502799|453659780|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
126288212|NCT00444587|454342178|FG001|Overall Study|Investigator decision|0|||
126288213|NCT00444587|454342177|FG000|Overall Study|Protocol Violation|1|||
126288214|NCT00444587|454342178|FG001|Overall Study|Protocol Violation|0|||
126288215|NCT00444587|454342177|FG000|Overall Study|Missing|0|||
126288216|NCT00444587|454342178|FG001|Overall Study|Missing|5|||
126288217|NCT01720225|454342185|FG000|Overall Study|Withdrawal by Subject|0|||
126288218|NCT01720225|454342186|FG001|Overall Study|Withdrawal by Subject|1|||
126288219|NCT01720225|454342185|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
126288220|NCT01720225|454342186|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
126288221|NCT02301390|454342187|FG000|Overall Study|Withdrawal by Subject|3|||
126288222|NCT02301390|454342188|FG001|Overall Study|Withdrawal by Subject|5|||
126288223|NCT02301390|454342187|FG000|Overall Study|Protocol Violation|1|||
126288224|NCT02301390|454342188|FG001|Overall Study|Protocol Violation|0|||
126288225|NCT02301390|454342187|FG000|Overall Study|Physician Decision|1|||
126288226|NCT02301390|454342188|FG001|Overall Study|Physician Decision|0|||
126288227|NCT02301390|454342187|FG000|Overall Study|Lost to Follow-up|0|||
126288228|NCT02301390|454342188|FG001|Overall Study|Lost to Follow-up|1|||
126288229|NCT02301390|454342187|FG000|Overall Study|Death|2|||
126288230|NCT02301390|454342188|FG001|Overall Study|Death|2|||
126288231|NCT02301390|454342187|FG000|Overall Study|Procedure not completed|0|||
126288232|NCT02301390|454342188|FG001|Overall Study|Procedure not completed|4|||
126288233|NCT02301390|454342187|FG000|Overall Study|Missed multiple visits|1|||
126288234|NCT02301390|454342188|FG001|Overall Study|Missed multiple visits|1|||
126288235|NCT02301390|454342187|FG000|Overall Study|study terminated|2|||
126288236|NCT02301390|454342188|FG001|Overall Study|study terminated|0|||
126288237|NCT01153425|454342190|FG000|Overall Study|Withdrawal by Subject|3|||
126288238|NCT01153425|454342191|FG001|Overall Study|Withdrawal by Subject|3|||
126288239|NCT01232452|454342197|FG000|Overall Study|Adverse Event|17|||
126288240|NCT01232452|454342198|FG001|Overall Study|Adverse Event|15|||
126288241|NCT01232452|454342197|FG000|Overall Study|Withdrawal by Subject|11|||
126288242|NCT01232452|454342198|FG001|Overall Study|Withdrawal by Subject|8|||
126288243|NCT01232452|454342197|FG000|Overall Study|Physician Decision|8|||
126288244|NCT01232452|454342198|FG001|Overall Study|Physician Decision|12|||
126288245|NCT01232452|454342197|FG000|Overall Study|Protocol entry criterion not met|0|||
126288246|NCT01232452|454342198|FG001|Overall Study|Protocol entry criterion not met|2|||
126288247|NCT01232452|454342197|FG000|Overall Study|Sponsor Decision|3|||
126288248|NCT01232452|454342198|FG001|Overall Study|Sponsor Decision|1|||
126288249|NCT01232452|454342197|FG000|Overall Study|Protocol Violation|0|||
126288250|NCT01232452|454342198|FG001|Overall Study|Protocol Violation|1|||
126288251|NCT05024747|454342199|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
126288252|NCT05024747|454342200|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
126288253|NCT05024747|454342199|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
126288254|NCT05024747|454342200|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
126288255|NCT05024747|454342199|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
126288256|NCT05024747|454342200|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
126288257|NCT00662649|454342201|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
126288258|NCT00662649|454342202|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
126288259|NCT00662649|454342203|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
126288260|NCT00662649|454342204|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
126288261|NCT00662649|454342205|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
126288262|NCT00662649|454342201|FG000|Core Study (24 Months)|Adverse Event|22|||
126288263|NCT00662649|454342202|FG001|Core Study (24 Months)|Adverse Event|13|||
126288264|NCT00662649|454342203|FG002|Core Study (24 Months)|Adverse Event|18|||
126288265|NCT00662649|454342204|FG003|Core Study (24 Months)|Adverse Event|0|||
126288266|NCT00662649|454342205|FG004|Core Study (24 Months)|Adverse Event|0|||
126288267|NCT00662649|454342201|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
126288268|NCT00662649|454342202|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
126288269|NCT00662649|454342203|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
126288270|NCT00662649|454342204|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
126288271|NCT00662649|454342205|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
126288272|NCT00662649|454342201|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
126288273|NCT00662649|454342202|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
126288274|NCT00662649|454342203|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
126288275|NCT00662649|454342204|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
126288276|NCT00662649|454342205|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
126288277|NCT00662649|454342201|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
126288278|NCT00662649|454342202|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
126288279|NCT00662649|454342203|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
126288280|NCT00662649|454342204|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
126288281|NCT00662649|454342205|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
126288282|NCT00662649|454342201|FG000|Core Study (24 Months)|Protocol Violation|5|||
126288283|NCT00662649|454342202|FG001|Core Study (24 Months)|Protocol Violation|5|||
126288284|NCT00662649|454342203|FG002|Core Study (24 Months)|Protocol Violation|4|||
126288285|NCT00662649|454342204|FG003|Core Study (24 Months)|Protocol Violation|0|||
126288286|NCT00662649|454342205|FG004|Core Study (24 Months)|Protocol Violation|0|||
126099995|NCT01076192|453659794|FG000|Overall Study|Other|197|||
126288287|NCT00662649|454342201|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
126288288|NCT00662649|454342202|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
126041875|NCT04880733|453451190|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
126041876|NCT04880733|453451191|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
126041877|NCT04880733|453451192|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
126041878|NCT04934072|453451195|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
126288289|NCT00662649|454342203|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
126288290|NCT00662649|454342204|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
126288291|NCT00662649|454342205|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
126288292|NCT00662649|454342201|FG000|Core Study (24 Months)|Death|1|||
126288293|NCT00662649|454342202|FG001|Core Study (24 Months)|Death|0|||
126288294|NCT00662649|454342203|FG002|Core Study (24 Months)|Death|2|||
126288295|NCT00662649|454342204|FG003|Core Study (24 Months)|Death|0|||
126288296|NCT00662649|454342205|FG004|Core Study (24 Months)|Death|0|||
126288297|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
126288298|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
126288299|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
126288300|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
126288301|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
126288302|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
126288303|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
126288304|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
126288305|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
126288306|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
126288307|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
126288308|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
126288309|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
126288310|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
126288311|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
126288312|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
126288313|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
126288314|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
126288315|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
126288316|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
126365701|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
126365702|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
126041879|NCT04934072|453451196|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
126041880|NCT04934072|453451197|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
126288317|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
126365703|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
126365704|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
126365705|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
126365706|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
126365707|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
126365708|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
126365709|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
126365710|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
126365711|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
126365712|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
126365713|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
126365714|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
126365715|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
126365716|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126365717|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126365718|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
126365719|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126365720|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126365721|NCT04090749|454632862|FG000|Open Label Pilot|Lost to Follow-up|1|||
126365722|NCT04090749|454632863|FG001|Open Label Pilot|Lost to Follow-up|0|||
126365723|NCT04090749|454632864|FG002|Open Label Pilot|Lost to Follow-up|0|||
126365724|NCT04090749|454632862|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
126365725|NCT04090749|454632863|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
126041881|NCT04934072|453451198|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
126041882|NCT04934072|453451199|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
126365726|NCT04090749|454632864|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
126365727|NCT04090749|454632862|FG000|Pilot Trial|Lost to Follow-up|0|||
126365728|NCT04090749|454632863|FG001|Pilot Trial|Lost to Follow-up|1|||
126365729|NCT04090749|454632864|FG002|Pilot Trial|Lost to Follow-up|1|||
126041883|NCT04934072|453451195|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
126041884|NCT04934072|453451196|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
126288318|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
126288319|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
126288320|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
126288321|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
126288322|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
126288323|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
126288324|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
126288325|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
126288326|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
126288327|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
126288328|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
126288329|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
126288330|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
126288331|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
126288332|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
126288333|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
126288334|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
126288335|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
126288336|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
126288337|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
126288338|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
126288339|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
126288340|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
126288341|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
126288342|NCT03594071|454342206|FG000|Overall Study|Re-operation|3|||
126288343|NCT03594071|454342206|FG000|Overall Study|Missed visit|2|||
126288344|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
126288345|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Death|1|||
126288346|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
126288347|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
126288348|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
126288349|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
126288350|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
126288351|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
126288352|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
126288353|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
126288354|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
126288355|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Other|3|||
126288356|NCT01965860|454342211|FG000|Overall Study|Pregnancy|1|||
126288357|NCT01965860|454342212|FG001|Overall Study|Pregnancy|0|||
126288358|NCT01965860|454342213|FG002|Overall Study|Pregnancy|1|||
126288359|NCT01965860|454342211|FG000|Overall Study|Logistics|1|||
126288360|NCT01965860|454342212|FG001|Overall Study|Logistics|0|||
126288361|NCT01965860|454342213|FG002|Overall Study|Logistics|0|||
126288362|NCT02288325|454342220|FG000|Run-in Period|Adverse Event|48|||
126288363|NCT02288325|454342221|FG001|Run-in Period|Adverse Event|0|||
126288364|NCT02288325|454342222|FG002|Run-in Period|Adverse Event|0|||
126288365|NCT02288325|454342220|FG000|Run-in Period|Lack of Efficacy|16|||
126288366|NCT02288325|454342221|FG001|Run-in Period|Lack of Efficacy|0|||
126288367|NCT02288325|454342222|FG002|Run-in Period|Lack of Efficacy|0|||
126288368|NCT02288325|454342220|FG000|Run-in Period|Withdrawal of Consent|28|||
126288369|NCT02288325|454342221|FG001|Run-in Period|Withdrawal of Consent|0|||
126288370|NCT02288325|454342222|FG002|Run-in Period|Withdrawal of Consent|0|||
125883013|NCT01588522|452869107|FG001|Overall Study|Taken off taxane-based regimen|0|||
126288371|NCT02288325|454342220|FG000|Run-in Period|Lost to Follow-up|25|||
126288372|NCT02288325|454342221|FG001|Run-in Period|Lost to Follow-up|0|||
126288373|NCT02288325|454342222|FG002|Run-in Period|Lost to Follow-up|0|||
126288374|NCT02288325|454342220|FG000|Run-in Period|Protocol Violation|17|||
126288375|NCT02288325|454342221|FG001|Run-in Period|Protocol Violation|0|||
126288376|NCT02288325|454342222|FG002|Run-in Period|Protocol Violation|0|||
126288377|NCT02288325|454342220|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
126288378|NCT02288325|454342221|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
126288379|NCT02288325|454342222|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
126288380|NCT02288325|454342220|FG000|Run-in Period|Reason not Specified|8|||
126288381|NCT02288325|454342221|FG001|Run-in Period|Reason not Specified|0|||
126288382|NCT02288325|454342222|FG002|Run-in Period|Reason not Specified|0|||
126288383|NCT02288325|454342220|FG000|Stabilization Period|Adverse Event|13|||
126288384|NCT02288325|454342221|FG001|Stabilization Period|Adverse Event|0|||
126288385|NCT02288325|454342222|FG002|Stabilization Period|Adverse Event|0|||
126288386|NCT02288325|454342220|FG000|Stabilization Period|Lack of Efficacy|22|||
126288387|NCT02288325|454342221|FG001|Stabilization Period|Lack of Efficacy|0|||
126288388|NCT02288325|454342222|FG002|Stabilization Period|Lack of Efficacy|0|||
126288389|NCT02288325|454342220|FG000|Stabilization Period|Withdrawal of Consent|23|||
126288390|NCT02288325|454342221|FG001|Stabilization Period|Withdrawal of Consent|0|||
126288391|NCT02288325|454342222|FG002|Stabilization Period|Withdrawal of Consent|0|||
126288392|NCT02288325|454342220|FG000|Stabilization Period|Lost to Follow-up|12|||
126288393|NCT02288325|454342221|FG001|Stabilization Period|Lost to Follow-up|0|||
126288394|NCT02288325|454342222|FG002|Stabilization Period|Lost to Follow-up|0|||
126288395|NCT02288325|454342220|FG000|Stabilization Period|Protocol Violation|8|||
126288396|NCT02288325|454342221|FG001|Stabilization Period|Protocol Violation|0|||
126288397|NCT02288325|454342222|FG002|Stabilization Period|Protocol Violation|0|||
126288398|NCT02288325|454342220|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
126288399|NCT02288325|454342221|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
126288400|NCT02288325|454342222|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
126288401|NCT02288325|454342220|FG000|Stabilization Period|Reason not Specified|15|||
126288402|NCT02288325|454342221|FG001|Stabilization Period|Reason not Specified|0|||
126288403|NCT02288325|454342222|FG002|Stabilization Period|Reason not Specified|0|||
126288404|NCT02288325|454342220|FG000|Double-blind Treatment Period|Adverse Event|0|||
126288405|NCT02288325|454342221|FG001|Double-blind Treatment Period|Adverse Event|2|||
126288406|NCT02288325|454342222|FG002|Double-blind Treatment Period|Adverse Event|5|||
126288407|NCT02288325|454342220|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
126288408|NCT02288325|454342221|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
126288409|NCT02288325|454342222|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
126288410|NCT02288325|454342220|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126288411|NCT02288325|454342221|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
126288412|NCT02288325|454342222|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
126288413|NCT02288325|454342220|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126288414|NCT02288325|454342221|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126288415|NCT02288325|454342222|FG002|Double-blind Treatment Period|Protocol Violation|2|||
126288416|NCT02288325|454342220|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
126288417|NCT02288325|454342221|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
126288418|NCT02288325|454342222|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
126288419|NCT02288325|454342220|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
126288420|NCT02288325|454342221|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
126288421|NCT02288325|454342222|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
126288422|NCT03735121|454342225|FG000|Overall Study|Death|3|||
126288423|NCT03735121|454342226|FG001|Overall Study|Death|6|||
126288424|NCT03735121|454342227|FG002|Overall Study|Death|8|||
126288425|NCT03735121|454342228|FG003|Overall Study|Death|37|||
126288426|NCT03735121|454342229|FG004|Overall Study|Death|86|||
126288427|NCT03735121|454342225|FG000|Overall Study|Withdrawal by Subject|1|||
126288428|NCT03735121|454342226|FG001|Overall Study|Withdrawal by Subject|1|||
126288429|NCT03735121|454342227|FG002|Overall Study|Withdrawal by Subject|3|||
126288430|NCT03735121|454342228|FG003|Overall Study|Withdrawal by Subject|4|||
126288431|NCT03735121|454342229|FG004|Overall Study|Withdrawal by Subject|2|||
126288432|NCT03735121|454342225|FG000|Overall Study|Progressive Disease|0|||
126288433|NCT03735121|454342226|FG001|Overall Study|Progressive Disease|0|||
126288434|NCT03735121|454342227|FG002|Overall Study|Progressive Disease|1|||
125883014|NCT01588522|452869108|FG002|Overall Study|Taken off taxane-based regimen|0|||
125883015|NCT01588522|452869109|FG003|Overall Study|Taken off taxane-based regimen|1|||
125883016|NCT01588522|452869110|FG004|Overall Study|Taken off taxane-based regimen|0|||
125883017|NCT01588522|452869111|FG005|Overall Study|Taken off taxane-based regimen|0|||
125883018|NCT01588522|452869106|FG000|Overall Study|Did not initiate chemotherapy|0|||
125883019|NCT01588522|452869107|FG001|Overall Study|Did not initiate chemotherapy|0|||
125883020|NCT01588522|452869108|FG002|Overall Study|Did not initiate chemotherapy|0|||
125883021|NCT01588522|452869109|FG003|Overall Study|Did not initiate chemotherapy|0|||
125883022|NCT01588522|452869110|FG004|Overall Study|Did not initiate chemotherapy|1|||
125883023|NCT01588522|452869111|FG005|Overall Study|Did not initiate chemotherapy|0|||
125883024|NCT03205423|452869114|FG000|Overall Study|Personal|1|||
126288435|NCT03735121|454342228|FG003|Overall Study|Progressive Disease|0|||
126288436|NCT03735121|454342229|FG004|Overall Study|Progressive Disease|0|||
126288437|NCT03735121|454342225|FG000|Overall Study|Lost to Follow-up|0|||
126288438|NCT03735121|454342226|FG001|Overall Study|Lost to Follow-up|0|||
126288439|NCT03735121|454342227|FG002|Overall Study|Lost to Follow-up|0|||
126288440|NCT03735121|454342228|FG003|Overall Study|Lost to Follow-up|0|||
126288441|NCT03735121|454342229|FG004|Overall Study|Lost to Follow-up|1|||
126288442|NCT03735121|454342225|FG000|Overall Study|Ongoing|3|||
126288443|NCT03735121|454342226|FG001|Overall Study|Ongoing|3|||
126288444|NCT03735121|454342227|FG002|Overall Study|Ongoing|26|||
126288445|NCT03735121|454342228|FG003|Overall Study|Ongoing|83|||
126288446|NCT03735121|454342229|FG004|Overall Study|Ongoing|158|||
126288447|NCT00344448|454342233|FG000|Screening|Withdrawal by Subject|0|||
126288448|NCT00344448|454342234|FG001|Screening|Withdrawal by Subject|1|||
126288449|NCT00344448|454342233|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
126288450|NCT00344448|454342234|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
125883025|NCT03205423|452869115|FG001|Overall Study|Personal|1|||
125883026|NCT03205423|452869114|FG000|Overall Study|Physician Decision|0|||
125883027|NCT03205423|452869115|FG001|Overall Study|Physician Decision|2|||
125883028|NCT05786651|452869118|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
125883029|NCT04390763|452869119|FG000|Safety run-in Part|Adverse Event|4|||
125883030|NCT04390763|452869120|FG001|Safety run-in Part|Adverse Event|0|||
125883031|NCT04390763|452869121|FG002|Safety run-in Part|Adverse Event|0|||
125883032|NCT04390763|452869122|FG003|Safety run-in Part|Adverse Event|0|||
125883033|NCT04390763|452869119|FG000|Safety run-in Part|Physician Decision|1|||
125883034|NCT04390763|452869120|FG001|Safety run-in Part|Physician Decision|0|||
125883035|NCT04390763|452869121|FG002|Safety run-in Part|Physician Decision|0|||
125883036|NCT04390763|452869122|FG003|Safety run-in Part|Physician Decision|0|||
125883037|NCT04390763|452869119|FG000|Safety run-in Part|Progressive Disease|6|||
125883038|NCT04390763|452869120|FG001|Safety run-in Part|Progressive Disease|0|||
125883039|NCT04390763|452869121|FG002|Safety run-in Part|Progressive Disease|0|||
126041885|NCT04934072|453451197|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
126041886|NCT04934072|453451198|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
126041887|NCT04934072|453451199|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
126041888|NCT04934072|453451195|FG000|Day 0 to Week 52|Other|3|||
126041889|NCT04934072|453451196|FG001|Day 0 to Week 52|Other|1|||
126041890|NCT04934072|453451197|FG002|Day 0 to Week 52|Other|0|||
126041891|NCT04934072|453451198|FG003|Day 0 to Week 52|Other|0|||
126041892|NCT04934072|453451199|FG004|Day 0 to Week 52|Other|0|||
126041893|NCT04934072|453451195|FG000|Day 0 to Week 52|Adverse Event|1|||
126288451|NCT00344448|454342233|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
125883040|NCT04390763|452869122|FG003|Safety run-in Part|Progressive Disease|0|||
125883041|NCT04390763|452869119|FG000|Randomized Part|Adverse Event|0|||
125883042|NCT04390763|452869120|FG001|Randomized Part|Adverse Event|11|||
126041894|NCT04934072|453451196|FG001|Day 0 to Week 52|Adverse Event|3|||
126041895|NCT04934072|453451197|FG002|Day 0 to Week 52|Adverse Event|0|||
126041896|NCT04934072|453451198|FG003|Day 0 to Week 52|Adverse Event|0|||
126288452|NCT00344448|454342234|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
126288453|NCT00344448|454342233|FG000|Open Label|Withdrawal by Subject|1|||
126288454|NCT00344448|454342234|FG001|Open Label|Withdrawal by Subject|1|||
126288455|NCT00344448|454342233|FG000|Open Label|Study terminated|1|||
126288456|NCT00344448|454342234|FG001|Open Label|Study terminated|0|||
126288457|NCT03138655|454342236|FG000|Overall Study|Adverse Event|2|||
126288458|NCT03138655|454342237|FG001|Overall Study|Adverse Event|1|||
126288459|NCT03138655|454342238|FG002|Overall Study|Adverse Event|2|||
126041897|NCT04934072|453451199|FG004|Day 0 to Week 52|Adverse Event|0|||
126041898|NCT04934072|453451195|FG000|Week 52 to Week 78|Adverse Event|0|||
126041899|NCT04934072|453451196|FG001|Week 52 to Week 78|Adverse Event|0|||
126288460|NCT03138655|454342239|FG003|Overall Study|Adverse Event|1|||
126288461|NCT03138655|454342240|FG004|Overall Study|Adverse Event|1|||
126288462|NCT03138655|454342241|FG005|Overall Study|Adverse Event|4|||
126288463|NCT03138655|454342242|FG006|Overall Study|Adverse Event|2|||
126288464|NCT03138655|454342243|FG007|Overall Study|Adverse Event|2|||
126288465|NCT03138655|454342236|FG000|Overall Study|Withdrawal by Subject|0|||
126288466|NCT03138655|454342237|FG001|Overall Study|Withdrawal by Subject|1|||
126288467|NCT03138655|454342238|FG002|Overall Study|Withdrawal by Subject|0|||
126288468|NCT03138655|454342239|FG003|Overall Study|Withdrawal by Subject|0|||
126288469|NCT03138655|454342240|FG004|Overall Study|Withdrawal by Subject|0|||
126288470|NCT03138655|454342241|FG005|Overall Study|Withdrawal by Subject|0|||
126288471|NCT03138655|454342242|FG006|Overall Study|Withdrawal by Subject|1|||
126288472|NCT03138655|454342243|FG007|Overall Study|Withdrawal by Subject|0|||
126288473|NCT03138655|454342236|FG000|Overall Study|Reason not Specified|1|||
126288474|NCT03138655|454342237|FG001|Overall Study|Reason not Specified|0|||
126288475|NCT03138655|454342238|FG002|Overall Study|Reason not Specified|0|||
126288476|NCT03138655|454342239|FG003|Overall Study|Reason not Specified|2|||
126288477|NCT03138655|454342240|FG004|Overall Study|Reason not Specified|1|||
126288478|NCT03138655|454342241|FG005|Overall Study|Reason not Specified|1|||
126288479|NCT03138655|454342242|FG006|Overall Study|Reason not Specified|0|||
126288480|NCT03138655|454342243|FG007|Overall Study|Reason not Specified|0|||
126288481|NCT02565511|454342244|FG000|Overall Study|Study terminated by Sponsor|35|||
126288482|NCT02565511|454342245|FG001|Overall Study|Study terminated by Sponsor|22|||
126288483|NCT02565511|454342246|FG002|Overall Study|Study terminated by Sponsor|235|||
126288484|NCT02565511|454342247|FG003|Overall Study|Study terminated by Sponsor|156|||
126288485|NCT02565511|454342244|FG000|Overall Study|Withdrawal by Subject|3|||
126288486|NCT02565511|454342245|FG001|Overall Study|Withdrawal by Subject|0|||
126288487|NCT02565511|454342246|FG002|Overall Study|Withdrawal by Subject|12|||
126288488|NCT02565511|454342247|FG003|Overall Study|Withdrawal by Subject|5|||
126288489|NCT02565511|454342244|FG000|Overall Study|Adverse Event|0|||
126288490|NCT02565511|454342245|FG001|Overall Study|Adverse Event|0|||
126288491|NCT02565511|454342246|FG002|Overall Study|Adverse Event|1|||
126288492|NCT02565511|454342247|FG003|Overall Study|Adverse Event|1|||
126288493|NCT02565511|454342244|FG000|Overall Study|Lost to Follow-up|4|||
126288494|NCT02565511|454342245|FG001|Overall Study|Lost to Follow-up|1|||
126288495|NCT02565511|454342246|FG002|Overall Study|Lost to Follow-up|0|||
126288496|NCT02565511|454342247|FG003|Overall Study|Lost to Follow-up|1|||
126288497|NCT02565511|454342244|FG000|Overall Study|Physician Decision|0|||
126288498|NCT02565511|454342245|FG001|Overall Study|Physician Decision|0|||
126288499|NCT02565511|454342246|FG002|Overall Study|Physician Decision|0|||
126288500|NCT02565511|454342247|FG003|Overall Study|Physician Decision|1|||
126288501|NCT02565511|454342244|FG000|Overall Study|Protocol deviation|0|||
126288502|NCT02565511|454342245|FG001|Overall Study|Protocol deviation|0|||
126288503|NCT02565511|454342246|FG002|Overall Study|Protocol deviation|3|||
126288504|NCT02565511|454342247|FG003|Overall Study|Protocol deviation|0|||
126288505|NCT03076775|454342250|FG000|Overall Study|Lost to Follow-up|1|||
126288506|NCT03076775|454342251|FG001|Overall Study|Lost to Follow-up|0|||
126041900|NCT04934072|453451197|FG002|Week 52 to Week 78|Adverse Event|0|||
126041901|NCT04934072|453451198|FG003|Week 52 to Week 78|Adverse Event|1|||
126288507|NCT00098774|454342255|FG000|Overall Study|Adverse Event|2|||
126288508|NCT00098774|454342255|FG000|Overall Study|Disease Progression|9|||
126288509|NCT00098774|454342255|FG000|Overall Study|Withdrawal by Subject|1|||
126288510|NCT00098774|454342255|FG000|Overall Study|Failed (to respond) during induction|4|||
126288511|NCT00098774|454342255|FG000|Overall Study|Physician Decision|2|||
126288512|NCT00796757|454342256|FG000|Overall Study|Withdrawal by Subject|14|||
126365730|NCT02528305|454632865|FG000|Overall Study|Withdrawal by Subject|1|||
126365731|NCT02528305|454632865|FG000|Overall Study|Adverse Event|1|||
126365732|NCT02528305|454632865|FG000|Overall Study|Physician Decision|1|||
126365733|NCT02184442|454632866|FG000|Overall Study|Death|61|||
126365734|NCT02184442|454632867|FG001|Overall Study|Death|65|||
126365735|NCT02184442|454632866|FG000|Overall Study|Withdrawal by Subject|3|||
126365736|NCT02184442|454632867|FG001|Overall Study|Withdrawal by Subject|11|||
126365737|NCT01852214|454632868|FG000|Period 1|Adverse Event|1|||
126365738|NCT01852214|454632869|FG001|Period 1|Adverse Event|2|||
126365739|NCT01852214|454632868|FG000|Period 1|Withdrawal by Subject|0|||
126365740|NCT01852214|454632869|FG001|Period 1|Withdrawal by Subject|1|||
126365741|NCT01852214|454632868|FG000|Washout Period|Withdrawal by Subject|0|||
126365742|NCT01852214|454632869|FG001|Washout Period|Withdrawal by Subject|1|||
126365743|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
126365744|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
126365745|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
126365746|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
126365747|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
126365748|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
126365749|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Other|2|||
126365750|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Other|1|||
126365751|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Other|1|||
126365752|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
126365753|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
126365754|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
126365755|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
126365756|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
126365757|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
126365758|NCT00637156|454632875|FG000|Overall Study|Withdrawal by Subject|0|||
126365759|NCT00637156|454632876|FG001|Overall Study|Withdrawal by Subject|7|||
126365760|NCT00637156|454632875|FG000|Overall Study|Death|0|||
126365761|NCT00637156|454632876|FG001|Overall Study|Death|1|||
126365762|NCT00637156|454632875|FG000|Overall Study|Lost to Follow-up|10|||
126365763|NCT00637156|454632876|FG001|Overall Study|Lost to Follow-up|16|||
126365764|NCT00461812|454632877|FG000|Overall Study|study terminated|10|||
126365765|NCT03193437|454632878|FG000|Overall Study|Adverse Event|4|||
126365766|NCT03193437|454632878|FG000|Overall Study|Withdrawal by Subject|2|||
126365767|NCT03193437|454632878|FG000|Overall Study|Disease Progression|2|||
126365768|NCT05487378|454632879|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
126365769|NCT05487378|454632880|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
126365770|NCT05487378|454632879|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
126365771|NCT05487378|454632880|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
126365772|NCT03359395|454632896|FG000|First Intervention A / B|Withdrawal by Subject|1|||
126365773|NCT03359395|454632897|FG001|First Intervention A / B|Withdrawal by Subject|0|||
126365774|NCT03359395|454632896|FG000|First Intervention A / B|Lost to Follow-up|2|||
126365775|NCT03359395|454632897|FG001|First Intervention A / B|Lost to Follow-up|3|||
126365776|NCT03359395|454632896|FG000|Second Intervention B/A|Exclusion criteria|0|||
126365777|NCT03359395|454632897|FG001|Second Intervention B/A|Exclusion criteria|1|||
126365778|NCT03359395|454632896|FG000|Second Intervention B/A|Lost to Follow-up|3|||
126365779|NCT03359395|454632897|FG001|Second Intervention B/A|Lost to Follow-up|2|||
126365780|NCT03164356|454632898|FG000|Overall Study|Lost to Follow-up|1|||
126365781|NCT03164356|454632899|FG001|Overall Study|Lost to Follow-up|1|||
126365782|NCT03164356|454632900|FG002|Overall Study|Lost to Follow-up|2|||
126365783|NCT03164356|454632901|FG003|Overall Study|Lost to Follow-up|1|||
126365784|NCT03164356|454632898|FG000|Overall Study|Physician Decision|0|||
125883043|NCT04390763|452869121|FG002|Randomized Part|Adverse Event|5|||
125883044|NCT04390763|452869122|FG003|Randomized Part|Adverse Event|5|||
125883045|NCT04390763|452869119|FG000|Randomized Part|Death|0|||
125883046|NCT04390763|452869120|FG001|Randomized Part|Death|3|||
125883047|NCT04390763|452869121|FG002|Randomized Part|Death|4|||
125883048|NCT04390763|452869122|FG003|Randomized Part|Death|2|||
125883049|NCT04390763|452869119|FG000|Randomized Part|Physician Decision|0|||
126365785|NCT03164356|454632899|FG001|Overall Study|Physician Decision|0|||
125883050|NCT04390763|452869120|FG001|Randomized Part|Physician Decision|2|||
126365786|NCT03164356|454632900|FG002|Overall Study|Physician Decision|3|||
126365787|NCT03164356|454632901|FG003|Overall Study|Physician Decision|0|||
126365788|NCT03164356|454632898|FG000|Overall Study|Protocol Violation|2|||
126365789|NCT03164356|454632899|FG001|Overall Study|Protocol Violation|1|||
126365790|NCT03164356|454632900|FG002|Overall Study|Protocol Violation|0|||
126365791|NCT03164356|454632901|FG003|Overall Study|Protocol Violation|0|||
126365792|NCT03164356|454632898|FG000|Overall Study|Withdrawal by Subject|1|||
126365793|NCT03164356|454632899|FG001|Overall Study|Withdrawal by Subject|0|||
126365794|NCT03164356|454632900|FG002|Overall Study|Withdrawal by Subject|0|||
126365795|NCT03164356|454632901|FG003|Overall Study|Withdrawal by Subject|0|||
126041902|NCT04934072|453451199|FG004|Week 52 to Week 78|Adverse Event|1|||
126041903|NCT04934072|453451195|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
126288513|NCT00796757|454342256|FG000|Overall Study|Death|61|||
126288514|NCT00796757|454342256|FG000|Overall Study|Protocol Violation|1|||
126288515|NCT00796757|454342256|FG000|Overall Study|Participant noncompliance|1|||
126288516|NCT00796757|454342256|FG000|Overall Study|Investigator's decision|2|||
126288517|NCT00796757|454342256|FG000|Overall Study|Other|7|||
126288518|NCT02324582|454342257|FG000|Overall Study|Screen Failures|0|||
126288519|NCT02324582|454342258|FG001|Overall Study|Screen Failures|5|||
126288520|NCT02890355|454342261|FG000|Overall Study|Adverse Event|5|||
126288521|NCT02890355|454342262|FG001|Overall Study|Adverse Event|5|||
126288522|NCT02890355|454342261|FG000|Overall Study|Refusal unrelated to adverse event|5|||
126288523|NCT02890355|454342262|FG001|Overall Study|Refusal unrelated to adverse event|10|||
126288524|NCT02890355|454342261|FG000|Overall Study|Progression/relapse|46|||
126288525|NCT02890355|454342262|FG001|Overall Study|Progression/relapse|39|||
126288526|NCT02890355|454342261|FG000|Overall Study|Not protocol specified|3|||
126288527|NCT02890355|454342262|FG001|Overall Study|Not protocol specified|4|||
126288528|NCT01128179|454342263|FG000|Overall Study|Death|1|||
126288529|NCT01128179|454342264|FG001|Overall Study|Death|0|||
126288530|NCT01128179|454342263|FG000|Overall Study|Protocol Violation|1|||
126288531|NCT01128179|454342264|FG001|Overall Study|Protocol Violation|0|||
126288532|NCT00720382|454342265|FG000|Overall Study|Adverse Event|54|||
126288533|NCT00720382|454342266|FG001|Overall Study|Adverse Event|17|||
126288534|NCT00720382|454342265|FG000|Overall Study|Lack of Efficacy|18|||
126288535|NCT00720382|454342266|FG001|Overall Study|Lack of Efficacy|7|||
126288536|NCT00720382|454342265|FG000|Overall Study|Non-Compliance|15|||
126041904|NCT04934072|453451196|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
126288537|NCT00720382|454342266|FG001|Overall Study|Non-Compliance|5|||
126288538|NCT00720382|454342265|FG000|Overall Study|Withdrawal by Subject|47|||
126288539|NCT00720382|454342266|FG001|Overall Study|Withdrawal by Subject|11|||
126288540|NCT00720382|454342265|FG000|Overall Study|Lost to Follow-up|28|||
126288541|NCT00720382|454342266|FG001|Overall Study|Lost to Follow-up|14|||
126288542|NCT00720382|454342265|FG000|Overall Study|administrative|14|||
126288543|NCT00720382|454342266|FG001|Overall Study|administrative|5|||
126288544|NCT05377749|454343976|FG000|3 Weeks|Lost to Follow-up|2|||
126288545|NCT05377749|454343977|FG001|3 Weeks|Lost to Follow-up|4|||
126288546|NCT05377749|454343976|FG000|3 Weeks|Withdrawal by Subject|1|||
126288547|NCT05377749|454343977|FG001|3 Weeks|Withdrawal by Subject|1|||
126288548|NCT02121652|454343980|FG000|Overall Study|Lost to Follow-up|2|||
126288549|NCT02121652|454343981|FG001|Overall Study|Lost to Follow-up|1|||
126288550|NCT02121652|454343980|FG000|Overall Study|Death|1|||
126288551|NCT02121652|454343981|FG001|Overall Study|Death|0|||
126288552|NCT02121652|454343980|FG000|Overall Study|Withdrawal by Subject|3|||
126288553|NCT02121652|454343981|FG001|Overall Study|Withdrawal by Subject|3|||
126288554|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Other|34|||
126041905|NCT04934072|453451197|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
126288555|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Other|0|||
126288556|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Other|0|||
126288557|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Other|0|||
126288558|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Death|14|||
126288559|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Death|0|||
126288560|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Death|0|||
126288561|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Death|0|||
126288562|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
126288563|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
126288564|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
126288565|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
126288566|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
126288567|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
126288568|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
126288569|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
126288570|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
126288571|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
126288572|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
126288573|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
126288574|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
126288575|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
126288576|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
126288577|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
126288578|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
126288579|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
126288580|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
126288581|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
126288582|NCT01995513|454343982|FG000|Period 1: Second Open Label Treatment|Other|0|||
126288583|NCT01995513|454343983|FG001|Period 1: Second Open Label Treatment|Other|2|||
126288584|NCT01995513|454343984|FG002|Period 1: Second Open Label Treatment|Other|0|||
126288585|NCT01995513|454343985|FG003|Period 1: Second Open Label Treatment|Other|0|||
126288586|NCT01995513|454343982|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
126288587|NCT01995513|454343983|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
126288588|NCT01995513|454343984|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
126288589|NCT01995513|454343985|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
126288590|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Death|0|||
126288591|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Death|0|||
126288592|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Death|0|||
126288593|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Death|1|||
126288594|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Other|0|||
126288595|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Other|0|||
126288596|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Other|3|||
126288597|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Other|3|||
126288598|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
126288599|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
126288600|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
126288601|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
126288602|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
126288603|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
126288604|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
126288605|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
126288606|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
126288607|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
126288608|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
126288609|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
126288610|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
126288611|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
126288612|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
126288613|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
126288614|NCT04108299|454343990|FG000|Overall Study|Not interested in participating|2|||
126288615|NCT04108299|454343991|FG001|Overall Study|Not interested in participating|1|||
125883051|NCT04390763|452869121|FG002|Randomized Part|Physician Decision|2|||
125883052|NCT04390763|452869122|FG003|Randomized Part|Physician Decision|9|||
125883053|NCT04390763|452869119|FG000|Randomized Part|Progressive Disease|0|||
125883054|NCT04390763|452869120|FG001|Randomized Part|Progressive Disease|24|||
125883055|NCT04390763|452869121|FG002|Randomized Part|Progressive Disease|31|||
126288616|NCT04108299|454343992|FG002|Overall Study|Not interested in participating|2|||
126288617|NCT04108299|454343993|FG003|Overall Study|Not interested in participating|1|||
126288618|NCT04123405|454343994|FG000|Overall Study|Adverse Event|1|||
126288619|NCT04123405|454343995|FG001|Overall Study|Adverse Event|2|||
126288620|NCT04123405|454343996|FG002|Overall Study|Adverse Event|3|||
126288621|NCT04123405|454343997|FG003|Overall Study|Adverse Event|3|||
126288622|NCT04123405|454343994|FG000|Overall Study|Exclusion criteria met|1|||
126288623|NCT04123405|454343995|FG001|Overall Study|Exclusion criteria met|2|||
126288624|NCT04123405|454343996|FG002|Overall Study|Exclusion criteria met|0|||
126288625|NCT04123405|454343997|FG003|Overall Study|Exclusion criteria met|2|||
126288626|NCT04123405|454343994|FG000|Overall Study|Withdrawal by Subject|1|||
126288627|NCT04123405|454343995|FG001|Overall Study|Withdrawal by Subject|3|||
126288628|NCT04123405|454343996|FG002|Overall Study|Withdrawal by Subject|0|||
126288629|NCT04123405|454343997|FG003|Overall Study|Withdrawal by Subject|2|||
126288630|NCT04123405|454343994|FG000|Overall Study|Contact to subject lost|0|||
126288631|NCT04123405|454343995|FG001|Overall Study|Contact to subject lost|0|||
126288632|NCT04123405|454343996|FG002|Overall Study|Contact to subject lost|0|||
126288633|NCT04123405|454343997|FG003|Overall Study|Contact to subject lost|1|||
126288634|NCT04123405|454343994|FG000|Overall Study|screening failure|1|||
126288635|NCT04123405|454343995|FG001|Overall Study|screening failure|0|||
126288636|NCT04123405|454343996|FG002|Overall Study|screening failure|0|||
126288637|NCT04123405|454343997|FG003|Overall Study|screening failure|0|||
126288638|NCT00247676|454343998|FG000|Overall Study|Death|5|||
126288639|NCT00247676|454343998|FG000|Overall Study|Adverse Event|11|||
126288640|NCT00247676|454343998|FG000|Overall Study|Lack of Efficacy|15|||
126288641|NCT00247676|454343998|FG000|Overall Study|Other|3|||
126288642|NCT00247676|454343998|FG000|Overall Study|Withdrawal by Subject|2|||
126288643|NCT01026194|454343999|FG000|Period 1：Double Blind Period|Adverse Event|2|||
126288644|NCT01026194|454344000|FG001|Period 1：Double Blind Period|Adverse Event|1|||
126288645|NCT01026194|454343999|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
126288646|NCT01026194|454344000|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
126288647|NCT01026194|454343999|FG000|Period 1：Double Blind Period|Physician Decision|0|||
126288648|NCT01026194|454344000|FG001|Period 1：Double Blind Period|Physician Decision|4|||
126288649|NCT01026194|454343999|FG000|Period 2：Open-label Period|Adverse Event|4|||
126288650|NCT01026194|454344000|FG001|Period 2：Open-label Period|Adverse Event|5|||
126288651|NCT01026194|454343999|FG000|Period 2：Open-label Period|Physician Decision|3|||
126288652|NCT01026194|454344000|FG001|Period 2：Open-label Period|Physician Decision|1|||
125883056|NCT04390763|452869122|FG003|Randomized Part|Progressive Disease|23|||
125883057|NCT04390763|452869119|FG000|Randomized Part|Study terminated by sponsor|0|||
125883058|NCT04390763|452869120|FG001|Randomized Part|Study terminated by sponsor|1|||
125883059|NCT04390763|452869121|FG002|Randomized Part|Study terminated by sponsor|0|||
126288653|NCT01026194|454343999|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
126288654|NCT01026194|454344000|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
126288655|NCT01750190|454344001|FG000|Overall Study|Adverse Event|47|||
126288656|NCT01750190|454344002|FG001|Overall Study|Adverse Event|19|||
126288657|NCT01750190|454344001|FG000|Overall Study|Death|38|||
126288658|NCT01750190|454344002|FG001|Overall Study|Death|11|||
125883060|NCT04390763|452869122|FG003|Randomized Part|Study terminated by sponsor|0|||
126041906|NCT04934072|453451198|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
126288659|NCT01750190|454344001|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
126288660|NCT01750190|454344002|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
126288661|NCT01750190|454344001|FG000|Overall Study|Lost to Follow-up|28|||
126288662|NCT01750190|454344002|FG001|Overall Study|Lost to Follow-up|7|||
126288663|NCT01750190|454344001|FG000|Overall Study|Physician Decision|16|||
126288664|NCT01750190|454344002|FG001|Overall Study|Physician Decision|17|||
126288665|NCT01750190|454344001|FG000|Overall Study|Protocol Violation|6|||
126288666|NCT01750190|454344002|FG001|Overall Study|Protocol Violation|5|||
126288667|NCT01750190|454344001|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
126288668|NCT01750190|454344002|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
126288669|NCT01750190|454344001|FG000|Overall Study|Withdrawal by Subject|83|||
126288670|NCT01750190|454344002|FG001|Overall Study|Withdrawal by Subject|89|||
126288671|NCT01750190|454344001|FG000|Overall Study|Kidney Transplant|8|||
126288672|NCT01750190|454344002|FG001|Overall Study|Kidney Transplant|4|||
126288673|NCT01750190|454344001|FG000|Overall Study|Dialysis|22|||
126288674|NCT01750190|454344002|FG001|Overall Study|Dialysis|8|||
126288675|NCT01750190|454344001|FG000|Overall Study|Other than Specified|13|||
126288676|NCT01750190|454344002|FG001|Overall Study|Other than Specified|4|||
126288677|NCT02009722|454344009|FG000|Overall Study|Protocol Violation|1|||
126288678|NCT02009722|454344010|FG001|Overall Study|Protocol Violation|2|||
126288679|NCT02009722|454344009|FG000|Overall Study|Did not receive intervention|0|||
126288680|NCT02009722|454344010|FG001|Overall Study|Did not receive intervention|1|||
126288681|NCT02955212|454344011|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
126288682|NCT02955212|454344012|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
126288683|NCT02955212|454344011|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
126288684|NCT02955212|454344012|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
126288685|NCT02955212|454344011|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
126288686|NCT02955212|454344012|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
126288687|NCT02955212|454344011|FG000|Period 1: Double-blind Treatment Period|Other|3|||
126288688|NCT02955212|454344012|FG001|Period 1: Double-blind Treatment Period|Other|2|||
126288689|NCT02955212|454344011|FG000|Period 2: Open-label Extension|Adverse Event|11|||
126288690|NCT02955212|454344012|FG001|Period 2: Open-label Extension|Adverse Event|7|||
126288691|NCT02955212|454344011|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
126288692|NCT02955212|454344012|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
126288693|NCT02955212|454344011|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
126288694|NCT02955212|454344012|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
126288695|NCT02955212|454344011|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
126288696|NCT02955212|454344012|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
126288697|NCT02955212|454344011|FG000|Period 2: Open-label Extension|Other|2|||
126288698|NCT02955212|454344012|FG001|Period 2: Open-label Extension|Other|4|||
126288699|NCT00545714|454344015|FG000|Induction Phase (6 Months)|Physician Decision|3|||
126288700|NCT00545714|454344015|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
126288701|NCT00545714|454344015|FG000|Induction Phase (6 Months)|Disease Progression|1|||
126288702|NCT00545714|454344015|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
126288703|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
126288704|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
126288705|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
126288706|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
126288707|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
126288708|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Death|2|||
126288709|NCT04428034|454344020|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
126288710|NCT00560391|454344023|FG000|Overall Study|Still on treatment|0|||
126288711|NCT00560391|454344024|FG001|Overall Study|Still on treatment|0|||
126288712|NCT00560391|454344025|FG002|Overall Study|Still on treatment|0|||
126288713|NCT00560391|454344026|FG003|Overall Study|Still on treatment|1|||
126288714|NCT00560391|454344027|FG004|Overall Study|Still on treatment|2|||
126288715|NCT02556801|454344028|FG000|Overall Study|Lost to Follow-up|1|||
126288716|NCT02556801|454344029|FG001|Overall Study|Lost to Follow-up|0|||
126288717|NCT02556801|454344030|FG002|Overall Study|Lost to Follow-up|2|||
126288718|NCT02556801|454344031|FG003|Overall Study|Lost to Follow-up|0|||
126288719|NCT02556801|454344028|FG000|Overall Study|Withdrawal by Subject|1|||
126288720|NCT02556801|454344029|FG001|Overall Study|Withdrawal by Subject|1|||
126288721|NCT02556801|454344030|FG002|Overall Study|Withdrawal by Subject|1|||
126288722|NCT02556801|454344031|FG003|Overall Study|Withdrawal by Subject|0|||
126288723|NCT02556801|454344028|FG000|Overall Study|Protocol Violation|0|||
126288724|NCT02556801|454344029|FG001|Overall Study|Protocol Violation|3|||
126288725|NCT02556801|454344030|FG002|Overall Study|Protocol Violation|1|||
126288726|NCT02556801|454344031|FG003|Overall Study|Protocol Violation|1|||
126288727|NCT02556801|454344028|FG000|Overall Study|Adverse Event|0|||
126288728|NCT02556801|454344029|FG001|Overall Study|Adverse Event|2|||
126288729|NCT02556801|454344030|FG002|Overall Study|Adverse Event|0|||
126288730|NCT02556801|454344031|FG003|Overall Study|Adverse Event|3|||
126041907|NCT04934072|453451199|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
126041908|NCT04934072|453451195|FG000|Week 52 to Week 78|Other|0|||
126041909|NCT04934072|453451196|FG001|Week 52 to Week 78|Other|0|||
126288731|NCT02556801|454344028|FG000|Overall Study|Pregnancy|0|||
126288732|NCT02556801|454344029|FG001|Overall Study|Pregnancy|1|||
126288733|NCT02556801|454344030|FG002|Overall Study|Pregnancy|0|||
126288734|NCT02556801|454344031|FG003|Overall Study|Pregnancy|0|||
126288735|NCT02556801|454344028|FG000|Overall Study|Personal reasons patient|0|||
126288736|NCT02556801|454344029|FG001|Overall Study|Personal reasons patient|0|||
126288737|NCT02556801|454344030|FG002|Overall Study|Personal reasons patient|0|||
126288738|NCT02556801|454344031|FG003|Overall Study|Personal reasons patient|1|||
126288739|NCT03668808|454344032|FG000|First Intervention|Withdrawal by Subject|2|||
126288740|NCT03668808|454344033|FG001|First Intervention|Withdrawal by Subject|2|||
126288741|NCT00280735|454344041|FG000|Overall Study|Adverse Event|5|||
126288742|NCT00280735|454344041|FG000|Overall Study|Lack of Efficacy|3|||
126288743|NCT00280735|454344041|FG000|Overall Study|Withdrawal by Subject|8|||
126288744|NCT00280735|454344041|FG000|Overall Study|Intercurrent Illness|2|||
126288745|NCT01895777|454344042|FG000|Overall Study|Adverse Event|1|||
126288746|NCT01895777|454344043|FG001|Overall Study|Adverse Event|2|||
126288747|NCT01895777|454344042|FG000|Overall Study|Lost to Follow-up|2|||
126288748|NCT01895777|454344043|FG001|Overall Study|Lost to Follow-up|0|||
126288749|NCT01895777|454344042|FG000|Overall Study|Not treated|1|||
126288750|NCT01895777|454344043|FG001|Overall Study|Not treated|0|||
126288751|NCT01895777|454344042|FG000|Overall Study|Other reasons|3|||
126288752|NCT01895777|454344043|FG001|Overall Study|Other reasons|2|||
126288753|NCT01895777|454344042|FG000|Overall Study|Non-compliance with the CTP|2|||
126288754|NCT01895777|454344043|FG001|Overall Study|Non-compliance with the CTP|1|||
126288755|NCT04542057|454344047|FG000|Overall Study|Death|3|||
126288756|NCT04542057|454344048|FG001|Overall Study|Death|1|||
126288757|NCT04542057|454344047|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
126288758|NCT04542057|454344048|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
126288759|NCT04542057|454344047|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
126288760|NCT04542057|454344048|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
126288761|NCT04542057|454344047|FG000|Overall Study|Adverse Event|15|||
126288762|NCT04542057|454344048|FG001|Overall Study|Adverse Event|6|||
126288763|NCT04542057|454344047|FG000|Overall Study|COVID-19 adverse event|6|||
126288764|NCT04542057|454344048|FG001|Overall Study|COVID-19 adverse event|4|||
126288765|NCT04542057|454344047|FG000|Overall Study|Lack of Efficacy|2|||
126288766|NCT04542057|454344048|FG001|Overall Study|Lack of Efficacy|5|||
125883061|NCT04390763|452869119|FG000|Randomized Part|Participant Decision|0|||
126288767|NCT04542057|454344047|FG000|Overall Study|Study terminated by sponsor|1|||
126288768|NCT04542057|454344048|FG001|Overall Study|Study terminated by sponsor|0|||
125883062|NCT04390763|452869120|FG001|Randomized Part|Participant Decision|5|||
126041910|NCT04934072|453451197|FG002|Week 52 to Week 78|Other|1|||
126041911|NCT04934072|453451198|FG003|Week 52 to Week 78|Other|0|||
126288769|NCT04542057|454344047|FG000|Overall Study|Investigator discretion|2|||
126288770|NCT04542057|454344048|FG001|Overall Study|Investigator discretion|1|||
126288771|NCT04542057|454344047|FG000|Overall Study|Withdrawal by Subject|52|||
126288772|NCT04542057|454344048|FG001|Overall Study|Withdrawal by Subject|30|||
126288773|NCT04542057|454344047|FG000|Overall Study|Lost to Follow-up|8|||
126288774|NCT04542057|454344048|FG001|Overall Study|Lost to Follow-up|11|||
126288775|NCT04542057|454344047|FG000|Overall Study|Other|2|||
126288776|NCT04542057|454344048|FG001|Overall Study|Other|2|||
126288777|NCT01277211|454344051|FG000|Overall Study|Adverse Event|60|||
126288778|NCT01277211|454344052|FG001|Overall Study|Adverse Event|22|||
126288779|NCT01277211|454344051|FG000|Overall Study|Pregnancy|9|||
126288780|NCT01277211|454344052|FG001|Overall Study|Pregnancy|4|||
126288781|NCT01277211|454344051|FG000|Overall Study|Lost to Follow-up|14|||
126288782|NCT01277211|454344052|FG001|Overall Study|Lost to Follow-up|9|||
126288783|NCT01277211|454344051|FG000|Overall Study|Did not wish to continue|17|||
126288784|NCT01277211|454344052|FG001|Overall Study|Did not wish to continue|0|||
126288785|NCT01277211|454344051|FG000|Overall Study|Withdrew Consent|9|||
126288786|NCT01277211|454344052|FG001|Overall Study|Withdrew Consent|9|||
126288787|NCT01277211|454344051|FG000|Overall Study|Non-compliance with protocol|13|||
126288788|NCT01277211|454344052|FG001|Overall Study|Non-compliance with protocol|4|||
126288789|NCT01277211|454344051|FG000|Overall Study|Did not meet protocol eligibility|1|||
126288790|NCT01277211|454344052|FG001|Overall Study|Did not meet protocol eligibility|0|||
126288791|NCT01277211|454344051|FG000|Overall Study|Administrative|3|||
126288792|NCT01277211|454344052|FG001|Overall Study|Administrative|0|||
126288793|NCT01277211|454344051|FG000|Overall Study|Pregnancy wish|0|||
126288794|NCT01277211|454344052|FG001|Overall Study|Pregnancy wish|2|||
126288795|NCT01277211|454344051|FG000|Overall Study|Discontinued prior to treatment|24|||
126288796|NCT01277211|454344052|FG001|Overall Study|Discontinued prior to treatment|13|||
126288797|NCT03452943|454344053|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
126288798|NCT03452943|454344054|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
126288799|NCT03452943|454344053|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
126288800|NCT03452943|454344054|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
126288801|NCT03452943|454344053|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
126288802|NCT03452943|454344054|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
126288803|NCT03452943|454344053|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
126288804|NCT03452943|454344054|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
126288805|NCT03452943|454344053|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
126288806|NCT03452943|454344054|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
126288807|NCT03452943|454344053|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
126288808|NCT03452943|454344054|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
126288809|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
126288810|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
126288811|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
126288812|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
126288813|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
126288814|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
126288815|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
126288816|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
126288817|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
126288818|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
126288819|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
126288820|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
126288821|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
126288822|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
126288823|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
126288824|NCT01130493|454344055|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
126288825|NCT01130493|454344056|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
126288826|NCT01130493|454344057|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
126288827|NCT01130493|454344055|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
126288828|NCT01130493|454344056|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
126288829|NCT01130493|454344057|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
126365796|NCT03164356|454632898|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
126288830|NCT01130493|454344055|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
126288831|NCT01130493|454344056|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
126288832|NCT01130493|454344057|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
126288833|NCT01130493|454344055|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
126365797|NCT03164356|454632899|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
126365798|NCT03164356|454632900|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
126365799|NCT03164356|454632901|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
126365800|NCT03164356|454632898|FG000|Overall Study|Subject Incarcerated|0|||
126365801|NCT03164356|454632899|FG001|Overall Study|Subject Incarcerated|1|||
126365802|NCT03164356|454632900|FG002|Overall Study|Subject Incarcerated|0|||
126365803|NCT03164356|454632901|FG003|Overall Study|Subject Incarcerated|0|||
126288834|NCT01130493|454344056|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
126288835|NCT01130493|454344057|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
126288836|NCT01130493|454344055|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
126288837|NCT01130493|454344056|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
126288838|NCT01130493|454344057|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
126288839|NCT01130493|454344055|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
126288840|NCT01130493|454344056|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
126288841|NCT01130493|454344057|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
126288842|NCT01130493|454344055|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
126288843|NCT01130493|454344056|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
126288844|NCT01130493|454344057|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
126288845|NCT01130493|454344055|FG000|Part 2: OLE|Adverse Event|0|||
126288846|NCT01130493|454344056|FG001|Part 2: OLE|Adverse Event|2|||
126288847|NCT01130493|454344057|FG002|Part 2: OLE|Adverse Event|1|||
126288848|NCT01130493|454344055|FG000|Part 2: OLE|Withdrawal by Subject|0|||
126288849|NCT01130493|454344056|FG001|Part 2: OLE|Withdrawal by Subject|1|||
126288850|NCT01130493|454344057|FG002|Part 2: OLE|Withdrawal by Subject|4|||
126288851|NCT03541317|454344060|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
126288852|NCT03541317|454344061|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288853|NCT03541317|454344062|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288854|NCT03541317|454344063|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288855|NCT03541317|454344064|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288856|NCT03541317|454344065|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288857|NCT00879086|454344066|FG000|Overall Study|Adverse Event|3|||
126288858|NCT00879086|454344067|FG001|Overall Study|Adverse Event|15|||
126288859|NCT00879086|454344066|FG000|Overall Study|Participant choice|2|||
126288860|NCT00879086|454344067|FG001|Overall Study|Participant choice|2|||
126288861|NCT00879086|454344066|FG000|Overall Study|Progression of disease|40|||
126288862|NCT00879086|454344067|FG001|Overall Study|Progression of disease|26|||
126288863|NCT00879086|454344066|FG000|Overall Study|Withdrawal of consent|2|||
126288864|NCT00879086|454344067|FG001|Overall Study|Withdrawal of consent|1|||
126288865|NCT00879086|454344066|FG000|Overall Study|Other|4|||
126288866|NCT00879086|454344067|FG001|Overall Study|Other|6|||
126288867|NCT00879086|454344066|FG000|Overall Study|Death|1|||
126288868|NCT00879086|454344067|FG001|Overall Study|Death|2|||
126288869|NCT02536846|454344068|FG000|Overall Study|Withdrawal by Subject|1|||
126288870|NCT02123446|454344069|FG000|Washout Period (1 Day)|Physician Decision|1|||
126288871|NCT02123446|454344070|FG001|Washout Period (1 Day)|Physician Decision|0|||
126288872|NCT04388553|454344071|FG000|Overall Study|Protocol Violation|1|||
126288873|NCT04388553|454344072|FG001|Overall Study|Protocol Violation|0|||
126288874|NCT04604795|454344073|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
126288875|NCT04604795|454344074|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
126288876|NCT04604795|454344075|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288877|NCT04604795|454344076|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288878|NCT04604795|454344077|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288879|NCT04604795|454344078|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288880|NCT04604795|454344079|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288881|NCT04604795|454344080|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288882|NCT04604795|454344081|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288883|NCT04604795|454344082|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288884|NCT04604795|454344073|FG000|Part B: Up to Day 14|Adverse Event|0|||
126288885|NCT04604795|454344074|FG001|Part B: Up to Day 14|Adverse Event|0|||
126288886|NCT04604795|454344075|FG002|Part B: Up to Day 14|Adverse Event|0|||
126288887|NCT04604795|454344076|FG003|Part B: Up to Day 14|Adverse Event|0|||
126041912|NCT04934072|453451199|FG004|Week 52 to Week 78|Other|0|||
126041913|NCT03174275|453451203|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
126041914|NCT03174275|453451203|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
126041915|NCT03174275|453451203|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
126288888|NCT04604795|454344077|FG004|Part B: Up to Day 14|Adverse Event|2|||
126288889|NCT04604795|454344078|FG005|Part B: Up to Day 14|Adverse Event|1|||
126288890|NCT04604795|454344079|FG006|Part B: Up to Day 14|Adverse Event|0|||
126288891|NCT04604795|454344080|FG007|Part B: Up to Day 14|Adverse Event|0|||
126288892|NCT04604795|454344081|FG008|Part B: Up to Day 14|Adverse Event|0|||
126288893|NCT04604795|454344082|FG009|Part B: Up to Day 14|Adverse Event|0|||
126288894|NCT04604795|454344073|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288895|NCT04604795|454344074|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288896|NCT04604795|454344075|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288897|NCT04604795|454344076|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288898|NCT04604795|454344077|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288899|NCT04604795|454344078|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288900|NCT04604795|454344079|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288901|NCT04604795|454344080|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288902|NCT04604795|454344081|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288903|NCT04604795|454344082|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
126288904|NCT04604795|454344073|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288905|NCT04604795|454344074|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288906|NCT04604795|454344075|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288907|NCT04604795|454344076|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288908|NCT04604795|454344077|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288909|NCT04604795|454344078|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288910|NCT04604795|454344079|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288911|NCT04604795|454344080|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288912|NCT04604795|454344081|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
126288913|NCT04604795|454344082|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288914|NCT04604795|454344073|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288915|NCT04604795|454344074|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288916|NCT04604795|454344075|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288917|NCT04604795|454344076|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288918|NCT04604795|454344077|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288919|NCT04604795|454344078|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288920|NCT04604795|454344079|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288921|NCT04604795|454344080|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288922|NCT04604795|454344081|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
126288923|NCT04604795|454344082|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288924|NCT04604795|454344073|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288925|NCT04604795|454344074|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288926|NCT04604795|454344075|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288927|NCT04604795|454344076|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288928|NCT04604795|454344077|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288929|NCT04604795|454344078|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288930|NCT04604795|454344079|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288931|NCT04604795|454344080|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288932|NCT04604795|454344081|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
126288933|NCT04604795|454344082|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288934|NCT00111241|454344092|FG000|Overall Study|Lost to Follow-up|1|||
126288935|NCT00111241|454344093|FG001|Overall Study|Lost to Follow-up|0|||
126288936|NCT00111241|454344092|FG000|Overall Study|Withdrawal by Subject|4|||
126288937|NCT00111241|454344093|FG001|Overall Study|Withdrawal by Subject|0|||
126288938|NCT00111241|454344092|FG000|Overall Study|Protocol Violation|9|||
126288939|NCT00111241|454344093|FG001|Overall Study|Protocol Violation|8|||
126288940|NCT00111241|454344092|FG000|Overall Study|Adverse Event|1|||
126288941|NCT00111241|454344093|FG001|Overall Study|Adverse Event|0|||
126288942|NCT04502212|454344094|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
126288943|NCT04502212|454344094|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
126288944|NCT02096744|454344095|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
126288945|NCT02096744|454344096|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
126288946|NCT02096744|454344095|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
126288947|NCT02096744|454344096|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
126288948|NCT02096744|454344095|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
126288949|NCT02096744|454344096|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
126288950|NCT00952731|454344098|FG000|Overall Study|Drug supply expired|1|||
126288951|NCT00952731|454344099|FG001|Overall Study|Drug supply expired|0|||
126288952|NCT01450683|454344111|FG000|Overall Study|Adverse Event|2|||
126288953|NCT02108912|454344113|FG000|Overall Study|Lost to Follow-up|1|||
126288954|NCT02108912|454344114|FG001|Overall Study|Lost to Follow-up|1|||
126288955|NCT02108912|454344113|FG000|Overall Study|lack of transportation|1|||
126288956|NCT02108912|454344114|FG001|Overall Study|lack of transportation|0|||
126288957|NCT02108912|454344113|FG000|Overall Study|high blood pressure|1|||
126288958|NCT02108912|454344114|FG001|Overall Study|high blood pressure|0|||
126288959|NCT00625872|454344119|FG000|Overall Study|Withdrawal by Subject|1|||
126288960|NCT00625872|454344120|FG001|Overall Study|Withdrawal by Subject|0|||
126288961|NCT00625872|454344119|FG000|Overall Study|Does not meet inclusion criteria|1|||
126288962|NCT00625872|454344120|FG001|Overall Study|Does not meet inclusion criteria|0|||
126288963|NCT00625872|454344119|FG000|Overall Study|Terminated by sponsor|2|||
126288964|NCT00625872|454344120|FG001|Overall Study|Terminated by sponsor|5|||
126288965|NCT00625872|454344119|FG000|Overall Study|Randomized but not treated|0|||
126288966|NCT00625872|454344120|FG001|Overall Study|Randomized but not treated|1|||
126288967|NCT04208750|454344121|FG000|Overall Study|Lost to Follow-up|16|||
126288968|NCT04208750|454344122|FG001|Overall Study|Lost to Follow-up|15|||
126288969|NCT03485352|454344126|FG000|Overall Study|Lost to Follow-up|9|||
126288970|NCT00852202|454344127|FG000|Overall Study|Adverse Event|2|||
126288971|NCT00852202|454344128|FG001|Overall Study|Adverse Event|3|||
126288972|NCT00852202|454344129|FG002|Overall Study|Adverse Event|7|||
126288973|NCT00852202|454344127|FG000|Overall Study|Lack of Efficacy|4|||
126288974|NCT00852202|454344128|FG001|Overall Study|Lack of Efficacy|1|||
125883063|NCT04390763|452869121|FG002|Randomized Part|Participant Decision|7|||
125883064|NCT04390763|452869122|FG003|Randomized Part|Participant Decision|6|||
125883065|NCT04390763|452869119|FG000|Randomized Part|Not treated|0|||
125883066|NCT04390763|452869120|FG001|Randomized Part|Not treated|4|||
125883067|NCT04390763|452869121|FG002|Randomized Part|Not treated|2|||
125883068|NCT04390763|452869122|FG003|Randomized Part|Not treated|7|||
125883069|NCT04949490|452869123|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125883070|NCT04949490|452869124|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125883071|NCT04949490|452869125|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125883072|NCT04949490|452869126|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
125883073|NCT04949490|452869127|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
126041916|NCT03174275|453451203|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
126041917|NCT03174275|453451203|FG000|Adjuvant Chemotherapy|Progression|1|||
126041918|NCT03174275|453451203|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
126041919|NCT03174275|453451203|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
126041920|NCT03174275|453451203|FG000|Adjuvant Durvalumab|Progression|1|||
126041921|NCT03174275|453451203|FG000|Adjuvant Durvalumab|Adverse Event|3|||
126041922|NCT03174275|453451203|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
126041923|NCT03174275|453451203|FG000|Adjuvant Radiotherapy|Progression|1|||
126041924|NCT03174275|453451203|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
126041925|NCT04456296|453451204|FG000|Overall Study|Withdrawal by Subject|14|||
126041926|NCT04456296|453451205|FG001|Overall Study|Withdrawal by Subject|21|||
126041927|NCT04456296|453451206|FG002|Overall Study|Withdrawal by Subject|21|||
126041928|NCT04456296|453451204|FG000|Overall Study|Adverse Event|2|||
126041929|NCT04456296|453451205|FG001|Overall Study|Adverse Event|2|||
126041930|NCT04456296|453451206|FG002|Overall Study|Adverse Event|2|||
126041931|NCT04456296|453451204|FG000|Overall Study|Death|1|||
126041932|NCT04456296|453451205|FG001|Overall Study|Death|0|||
126041933|NCT04456296|453451206|FG002|Overall Study|Death|0|||
126041934|NCT04456296|453451204|FG000|Overall Study|Lost to Follow-up|3|||
126041935|NCT04456296|453451205|FG001|Overall Study|Lost to Follow-up|5|||
126041936|NCT04456296|453451206|FG002|Overall Study|Lost to Follow-up|6|||
126041937|NCT04456296|453451204|FG000|Overall Study|Other than specified|0|||
126041938|NCT04456296|453451205|FG001|Overall Study|Other than specified|1|||
126041939|NCT04456296|453451206|FG002|Overall Study|Other than specified|4|||
126041940|NCT04456296|453451204|FG000|Overall Study|Randomized, not treated|2|||
126041941|NCT04456296|453451205|FG001|Overall Study|Randomized, not treated|1|||
126288975|NCT00852202|454344129|FG002|Overall Study|Lack of Efficacy|2|||
126288976|NCT00852202|454344127|FG000|Overall Study|Protocol Violation|2|||
126288977|NCT00852202|454344128|FG001|Overall Study|Protocol Violation|2|||
126288978|NCT00852202|454344129|FG002|Overall Study|Protocol Violation|7|||
126288979|NCT00852202|454344127|FG000|Overall Study|Withdrawal by Subject|3|||
126288980|NCT00852202|454344128|FG001|Overall Study|Withdrawal by Subject|1|||
126288981|NCT00852202|454344129|FG002|Overall Study|Withdrawal by Subject|2|||
126288982|NCT00852202|454344127|FG000|Overall Study|Lost to Follow-up|5|||
126288983|NCT00852202|454344128|FG001|Overall Study|Lost to Follow-up|5|||
126288984|NCT00852202|454344129|FG002|Overall Study|Lost to Follow-up|6|||
126288985|NCT00852202|454344127|FG000|Overall Study|pregnancy,moving away and surgery|1|||
126288986|NCT00852202|454344128|FG001|Overall Study|pregnancy,moving away and surgery|0|||
126288987|NCT00852202|454344129|FG002|Overall Study|pregnancy,moving away and surgery|2|||
126288988|NCT05022212|454344132|FG000|Overall Study|Lost to Follow-up|0|||
126288989|NCT05022212|454344133|FG001|Overall Study|Lost to Follow-up|2|||
126288990|NCT01682811|454344134|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288991|NCT01682811|454344135|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288992|NCT01682811|454344136|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288993|NCT01682811|454344137|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126041942|NCT04456296|453451206|FG002|Overall Study|Randomized, not treated|0|||
126041943|NCT02997202|453451207|FG000|Overall Study|Miscellaneous|2|||
126288994|NCT01682811|454344138|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
126288995|NCT01682811|454344139|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288996|NCT01682811|454344140|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288997|NCT01682811|454344134|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
126288998|NCT01682811|454344135|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
126288999|NCT01682811|454344136|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
126289000|NCT01682811|454344137|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
126289001|NCT01682811|454344138|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
126289002|NCT01682811|454344139|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
125883074|NCT04949490|452869128|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125883075|NCT04949490|452869123|FG000|Group A and Group B|Withdrawal by Subject|0|||
125883076|NCT04949490|452869124|FG001|Group A and Group B|Withdrawal by Subject|0|||
125883077|NCT04949490|452869125|FG002|Group A and Group B|Withdrawal by Subject|1|||
126041944|NCT02997202|453451208|FG001|Overall Study|Miscellaneous|2|||
126041945|NCT02997202|453451207|FG000|Overall Study|Withdrawal by Subject|8|||
126041946|NCT02997202|453451208|FG001|Overall Study|Withdrawal by Subject|12|||
126041947|NCT02997202|453451207|FG000|Overall Study|Lost to Follow-up|5|||
126289003|NCT01682811|454344140|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
126041948|NCT02997202|453451208|FG001|Overall Study|Lost to Follow-up|3|||
126289004|NCT01682811|454344134|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289005|NCT01682811|454344135|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289006|NCT01682811|454344136|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289007|NCT01682811|454344137|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289008|NCT01682811|454344138|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
126289009|NCT01682811|454344139|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289010|NCT01682811|454344140|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289011|NCT01682811|454344134|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289012|NCT01682811|454344135|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289013|NCT01682811|454344136|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289014|NCT01682811|454344137|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289015|NCT01682811|454344138|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289016|NCT01682811|454344139|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
126289017|NCT01682811|454344140|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289018|NCT02694328|454344141|FG000|Overall Study|Adverse Event|27|||
126289019|NCT02694328|454344142|FG001|Overall Study|Adverse Event|33|||
126289020|NCT02694328|454344141|FG000|Overall Study|Withdrawal by Subject|27|||
126289021|NCT02694328|454344142|FG001|Overall Study|Withdrawal by Subject|23|||
126289022|NCT02694328|454344141|FG000|Overall Study|Lost to Follow-up|26|||
126289023|NCT02694328|454344142|FG001|Overall Study|Lost to Follow-up|22|||
126289024|NCT02694328|454344141|FG000|Overall Study|Noncompliant with study drug|11|||
126289025|NCT02694328|454344142|FG001|Overall Study|Noncompliant with study drug|8|||
126289026|NCT02694328|454344141|FG000|Overall Study|Incarceration|1|||
126289027|NCT02694328|454344142|FG001|Overall Study|Incarceration|1|||
126289028|NCT02694328|454344141|FG000|Overall Study|Lack of Efficacy|1|||
126289029|NCT02694328|454344142|FG001|Overall Study|Lack of Efficacy|2|||
126289030|NCT02694328|454344141|FG000|Overall Study|Pregnancy|1|||
126289031|NCT02694328|454344142|FG001|Overall Study|Pregnancy|1|||
126289032|NCT02694328|454344141|FG000|Overall Study|Protocol Violation|6|||
126289033|NCT02694328|454344142|FG001|Overall Study|Protocol Violation|5|||
126289034|NCT02694328|454344141|FG000|Overall Study|Abnormal Laboratory Value|0|||
126289035|NCT02694328|454344142|FG001|Overall Study|Abnormal Laboratory Value|3|||
126289036|NCT01260701|454344143|FG000|Overall Study|Adverse Event|9|||
126289037|NCT01260701|454344143|FG000|Overall Study|Withdrawal by Subject|2|||
126289038|NCT01260701|454344143|FG000|Overall Study|Progression|53|||
126289039|NCT01260701|454344143|FG000|Overall Study|Death|2|||
126289040|NCT01260701|454344143|FG000|Overall Study|Not protocol specified|3|||
126289041|NCT01260701|454344143|FG000|Overall Study|Under review|1|||
126289042|NCT01260701|454344143|FG000|Overall Study|Ineligible|4|||
126289043|NCT01260701|454344143|FG000|Overall Study|Did not begin protocol therapy|1|||
126289044|NCT02731638|454345910|FG000|Overall Study|Lost to Follow-up|6|||
126289045|NCT02731638|454345911|FG001|Overall Study|Lost to Follow-up|9|||
126289046|NCT06195930|454345912|FG000|Overall Study|Adverse Event|4|||
126289047|NCT05878093|454345913|FG000|Overall Study|Withdrawal by Subject|3|||
126289048|NCT05878093|454345914|FG001|Overall Study|Withdrawal by Subject|1|||
126289049|NCT04100018|454345917|FG000|Pre-Treatment Period|Not Reported|0|||
126289050|NCT04100018|454345918|FG001|Pre-Treatment Period|Not Reported|4|||
126289051|NCT04100018|454345917|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
126289052|NCT04100018|454345918|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
126289053|NCT04100018|454345917|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
126289054|NCT04100018|454345918|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
126289055|NCT04100018|454345917|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
126289056|NCT04100018|454345918|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126289057|NCT04100018|454345917|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
126289058|NCT04100018|454345918|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
126289059|NCT04100018|454345917|FG000|Treatment Period|Ongoing Treatment|1|||
126289060|NCT04100018|454345918|FG001|Treatment Period|Ongoing Treatment|0|||
126289061|NCT04100018|454345917|FG000|Treatment Period|Other Reason|26|||
126289062|NCT04100018|454345918|FG001|Treatment Period|Other Reason|37|||
126289063|NCT04100018|454345917|FG000|Treatment Period|Completed treatment as per protocol|1|||
126041949|NCT02997202|453451207|FG000|Overall Study|Death|41|||
126041950|NCT02997202|453451208|FG001|Overall Study|Death|45|||
126041951|NCT04271046|453451209|FG000|Overall Study|Death|0|||
126041952|NCT04271046|453451210|FG001|Overall Study|Death|2|||
126289064|NCT04100018|454345918|FG001|Treatment Period|Completed treatment as per protocol|2|||
126041953|NCT04271046|453451211|FG002|Overall Study|Death|0|||
126041954|NCT04271046|453451212|FG003|Overall Study|Death|2|||
126289065|NCT04100018|454345917|FG000|Treatment Period|Maximum clinical benefit|3|||
126289066|NCT04100018|454345918|FG001|Treatment Period|Maximum clinical benefit|0|||
126289067|NCT04100018|454345917|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
126289068|NCT04100018|454345918|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
126289069|NCT04100018|454345917|FG000|Treatment Period|Study drug toxicity|67|||
126289070|NCT04100018|454345918|FG001|Treatment Period|Study drug toxicity|28|||
126041955|NCT04271046|453451209|FG000|Overall Study|Lost to Follow-up|12|||
126041956|NCT04271046|453451210|FG001|Overall Study|Lost to Follow-up|12|||
125883078|NCT04949490|452869126|FG003|Group A and Group B|Withdrawal by Subject|0|||
125883079|NCT04949490|452869127|FG004|Group A and Group B|Withdrawal by Subject|0|||
125883080|NCT04949490|452869128|FG005|Group A and Group B|Withdrawal by Subject|0|||
125883081|NCT04949490|452869123|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125883082|NCT04949490|452869124|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125883083|NCT04949490|452869125|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125883084|NCT04949490|452869126|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125883085|NCT04949490|452869127|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125883086|NCT04949490|452869128|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
125883087|NCT04949490|452869123|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125883088|NCT04949490|452869124|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125883089|NCT04949490|452869125|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125883090|NCT04949490|452869126|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125883091|NCT04949490|452869127|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
125883092|NCT04949490|452869128|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125883093|NCT02017405|452869129|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125883094|NCT02017405|452869130|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125883095|NCT02017405|452869131|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125883096|NCT02017405|452869132|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125883097|NCT02017405|452869133|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125883098|NCT02017405|452869134|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
125883099|NCT02017405|452869129|FG000|Open-label Phase|Adverse Event|1|||
126289071|NCT04100018|454345917|FG000|Treatment Period|Disease Progression|284|||
126289072|NCT04100018|454345918|FG001|Treatment Period|Disease Progression|327|||
126289073|NCT04100018|454345917|FG000|Treatment Period|Administrative reasons by sponsor|16|||
126289074|NCT04100018|454345918|FG001|Treatment Period|Administrative reasons by sponsor|30|||
126289075|NCT04100018|454345917|FG000|Treatment Period|Poor/Non-Compliance|1|||
126289076|NCT04100018|454345918|FG001|Treatment Period|Poor/Non-Compliance|0|||
126289077|NCT04100018|454345917|FG000|Treatment Period|Lost to Follow-up|2|||
126289078|NCT04100018|454345918|FG001|Treatment Period|Lost to Follow-up|2|||
126289079|NCT04100018|454345917|FG000|Treatment Period|Death|16|||
126289080|NCT04100018|454345918|FG001|Treatment Period|Death|11|||
126289081|NCT04100018|454345917|FG000|Treatment Period|Participant withdrew consent|10|||
126289082|NCT04100018|454345918|FG001|Treatment Period|Participant withdrew consent|10|||
126289083|NCT04100018|454345917|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
126289084|NCT04100018|454345918|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
126289085|NCT04100018|454345917|FG000|Treatment Period|Adverse Event|14|||
126289086|NCT04100018|454345918|FG001|Treatment Period|Adverse Event|6|||
126289087|NCT04100018|454345917|FG000|Treatment Period|Lack of Efficacy|4|||
126289088|NCT04100018|454345918|FG001|Treatment Period|Lack of Efficacy|2|||
126289089|NCT02653625|454345923|FG000|Overall Study|Adverse Event|1|||
126289090|NCT02653625|454345923|FG000|Overall Study|Non-compliance with Study Drug|1|||
126289091|NCT02653625|454345923|FG000|Overall Study|Protocol Violation|1|||
126289092|NCT02653625|454345923|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
126289093|NCT02090725|454345926|FG000|Overall Study|Withdrawal by Subject|1|||
126289094|NCT02090725|454345926|FG000|Overall Study|participants moved from area|3|||
126289095|NCT01499095|454345927|FG000|Overall Study|Randomized But Not Treated|1|||
126289096|NCT01499095|454345928|FG001|Overall Study|Randomized But Not Treated|1|||
126289097|NCT01499095|454345927|FG000|Overall Study|Adverse Event|12|||
126289098|NCT01499095|454345928|FG001|Overall Study|Adverse Event|7|||
126289099|NCT01499095|454345927|FG000|Overall Study|Lack of Efficacy|2|||
126289100|NCT01499095|454345928|FG001|Overall Study|Lack of Efficacy|1|||
126289101|NCT01499095|454345927|FG000|Overall Study|Protocol Violation|6|||
126289102|NCT01499095|454345928|FG001|Overall Study|Protocol Violation|7|||
126289103|NCT01499095|454345927|FG000|Overall Study|Received Rescue Therapy|32|||
126289104|NCT01499095|454345928|FG001|Overall Study|Received Rescue Therapy|40|||
126289105|NCT01499095|454345927|FG000|Overall Study|Diverse Reasons|22|||
126289106|NCT01499095|454345928|FG001|Overall Study|Diverse Reasons|25|||
126289107|NCT01499095|454345927|FG000|Overall Study|Lost to Follow-up|6|||
125883100|NCT02017405|452869130|FG001|Open-label Phase|Adverse Event|1|||
126289108|NCT01499095|454345928|FG001|Overall Study|Lost to Follow-up|4|||
126289109|NCT01499095|454345927|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
126289110|NCT01499095|454345928|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
126289111|NCT01499095|454345927|FG000|Overall Study|Hypoglycemia|3|||
126289112|NCT01499095|454345928|FG001|Overall Study|Hypoglycemia|1|||
126289113|NCT01499095|454345927|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
126289114|NCT01499095|454345928|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
126289115|NCT01499095|454345927|FG000|Overall Study|Change in Injection Schedule|2|||
126289116|NCT01499095|454345928|FG001|Overall Study|Change in Injection Schedule|0|||
126289117|NCT01499095|454345927|FG000|Overall Study|Perceived Lack of Efficacy|1|||
126289118|NCT01499095|454345928|FG001|Overall Study|Perceived Lack of Efficacy|1|||
126289119|NCT04358081|454345930|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
126289120|NCT04358081|454345931|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
126289121|NCT04358081|454345932|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
126289122|NCT04358081|454345930|FG000|Treatment Phase of Study|Adverse Event|1|||
126289123|NCT04358081|454345931|FG001|Treatment Phase of Study|Adverse Event|0|||
126289124|NCT04358081|454345932|FG002|Treatment Phase of Study|Adverse Event|1|||
126289125|NCT04358081|454345930|FG000|Treatment Phase of Study|Physician Decision|2|||
126289126|NCT04358081|454345931|FG001|Treatment Phase of Study|Physician Decision|0|||
126289127|NCT04358081|454345932|FG002|Treatment Phase of Study|Physician Decision|1|||
126289128|NCT04358081|454345930|FG000|Treatment Phase of Study|Protocol Violation|1|||
126289129|NCT04358081|454345931|FG001|Treatment Phase of Study|Protocol Violation|0|||
126289130|NCT04358081|454345932|FG002|Treatment Phase of Study|Protocol Violation|0|||
126289131|NCT04358081|454345930|FG000|Study Completion Phase|Death|0|||
126289132|NCT04358081|454345931|FG001|Study Completion Phase|Death|0|||
126289133|NCT04358081|454345932|FG002|Study Completion Phase|Death|1|||
126289134|NCT04358081|454345930|FG000|Study Completion Phase|Lost to Follow-up|1|||
126289135|NCT04358081|454345931|FG001|Study Completion Phase|Lost to Follow-up|0|||
126289136|NCT04358081|454345932|FG002|Study Completion Phase|Lost to Follow-up|1|||
126289137|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
126289138|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
126289139|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
126289140|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
126289141|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
126289142|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
126289143|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
126289144|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
126289145|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
126289146|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
126289147|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
126289148|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
126289149|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
126289150|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
126289151|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
126289152|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
126289153|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
126289154|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
126289155|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
126289156|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
126289157|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
126289158|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
126289159|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
126289160|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
126289161|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
126289162|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
126289163|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
126289164|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
126289165|NCT01130532|454345933|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
126289166|NCT01130532|454345934|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
126289167|NCT01130532|454345935|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
126289168|NCT01130532|454345936|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
126289169|NCT01130532|454345933|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
126289170|NCT01130532|454345934|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
126289171|NCT01130532|454345935|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
126289172|NCT01130532|454345936|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
126289173|NCT01130532|454345933|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
126289174|NCT01130532|454345934|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
126289175|NCT01130532|454345935|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
126289176|NCT01130532|454345936|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
126289177|NCT01130532|454345933|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
126289178|NCT01130532|454345934|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
126289179|NCT01130532|454345935|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
126289180|NCT01130532|454345936|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
126289181|NCT02762929|454345937|FG000|Overall Study|Adverse Event|0|||
126289182|NCT02762929|454345938|FG001|Overall Study|Adverse Event|0|||
126289183|NCT02762929|454345939|FG002|Overall Study|Adverse Event|0|||
126289184|NCT02762929|454345940|FG003|Overall Study|Adverse Event|1|||
126289185|NCT02762929|454345941|FG004|Overall Study|Adverse Event|0|||
126289186|NCT02762929|454345942|FG005|Overall Study|Adverse Event|0|||
126289187|NCT02762929|454345937|FG000|Overall Study|Lost to Follow-up|1|||
126289188|NCT02762929|454345938|FG001|Overall Study|Lost to Follow-up|2|||
126289189|NCT02762929|454345939|FG002|Overall Study|Lost to Follow-up|0|||
126041957|NCT04271046|453451211|FG002|Overall Study|Lost to Follow-up|11|||
126289190|NCT02762929|454345940|FG003|Overall Study|Lost to Follow-up|1|||
126041958|NCT04271046|453451212|FG003|Overall Study|Lost to Follow-up|11|||
126289191|NCT02762929|454345941|FG004|Overall Study|Lost to Follow-up|0|||
126289192|NCT02762929|454345942|FG005|Overall Study|Lost to Follow-up|0|||
126041959|NCT04271046|453451209|FG000|Overall Study|Patient with Dementia Died|2|||
126289193|NCT02762929|454345937|FG000|Overall Study|Withdrawal by Subject|0|||
126289194|NCT02762929|454345938|FG001|Overall Study|Withdrawal by Subject|1|||
126289195|NCT02762929|454345939|FG002|Overall Study|Withdrawal by Subject|0|||
126289196|NCT02762929|454345940|FG003|Overall Study|Withdrawal by Subject|0|||
126289197|NCT02762929|454345941|FG004|Overall Study|Withdrawal by Subject|0|||
126289198|NCT02762929|454345942|FG005|Overall Study|Withdrawal by Subject|0|||
126289199|NCT02762929|454345937|FG000|Overall Study|exclusionary medication disclosed late|0|||
126289200|NCT02762929|454345938|FG001|Overall Study|exclusionary medication disclosed late|0|||
126289201|NCT02762929|454345939|FG002|Overall Study|exclusionary medication disclosed late|0|||
126289202|NCT02762929|454345940|FG003|Overall Study|exclusionary medication disclosed late|1|||
126289203|NCT02762929|454345941|FG004|Overall Study|exclusionary medication disclosed late|0|||
126289204|NCT02762929|454345942|FG005|Overall Study|exclusionary medication disclosed late|0|||
126289205|NCT02656303|454345943|FG000|Overall Study|Adverse Event|3|||
126289206|NCT02656303|454345944|FG001|Overall Study|Adverse Event|2|||
126289207|NCT02656303|454345945|FG002|Overall Study|Adverse Event|0|||
126289208|NCT02656303|454345943|FG000|Overall Study|Death|12|||
126289209|NCT02656303|454345944|FG001|Overall Study|Death|4|||
126289210|NCT02656303|454345945|FG002|Overall Study|Death|1|||
126289211|NCT02656303|454345943|FG000|Overall Study|Lack of Efficacy|1|||
126289212|NCT02656303|454345944|FG001|Overall Study|Lack of Efficacy|0|||
126289213|NCT02656303|454345945|FG002|Overall Study|Lack of Efficacy|0|||
126289214|NCT02656303|454345943|FG000|Overall Study|Non-Compliance with Study|1|||
126289215|NCT02656303|454345944|FG001|Overall Study|Non-Compliance with Study|1|||
126289216|NCT02656303|454345945|FG002|Overall Study|Non-Compliance with Study|0|||
126289217|NCT02656303|454345943|FG000|Overall Study|Investigator Decision|2|||
126289218|NCT02656303|454345944|FG001|Overall Study|Investigator Decision|1|||
126289219|NCT02656303|454345945|FG002|Overall Study|Investigator Decision|0|||
126289220|NCT02656303|454345943|FG000|Overall Study|Progressive Disease|25|||
126289221|NCT02656303|454345944|FG001|Overall Study|Progressive Disease|14|||
126289222|NCT02656303|454345945|FG002|Overall Study|Progressive Disease|10|||
126289223|NCT02656303|454345943|FG000|Overall Study|Study Terminated by Sponsor|20|||
126289224|NCT02656303|454345944|FG001|Overall Study|Study Terminated by Sponsor|7|||
126289225|NCT02656303|454345945|FG002|Overall Study|Study Terminated by Sponsor|5|||
126289226|NCT02656303|454345943|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
126289227|NCT02656303|454345944|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
126289228|NCT02656303|454345945|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
126289229|NCT02656303|454345943|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
126289230|NCT02656303|454345944|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
126289231|NCT02656303|454345945|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
126289232|NCT02656303|454345943|FG000|Overall Study|Reason not Specified|1|||
126289233|NCT02656303|454345944|FG001|Overall Study|Reason not Specified|1|||
126289234|NCT02656303|454345945|FG002|Overall Study|Reason not Specified|2|||
126289235|NCT03041311|454345948|FG000|Overall Study|Death|39|||
126289236|NCT03041311|454345949|FG001|Overall Study|Death|42|||
126289237|NCT03041311|454345948|FG000|Overall Study|Lost to Follow-up|0|||
126289238|NCT03041311|454345949|FG001|Overall Study|Lost to Follow-up|1|||
126289239|NCT03041311|454345948|FG000|Overall Study|Withdrawal by Subject|8|||
126289240|NCT03041311|454345949|FG001|Overall Study|Withdrawal by Subject|5|||
126289241|NCT03041311|454345948|FG000|Overall Study|Sponsor Terminated Study|2|||
126289242|NCT03041311|454345949|FG001|Overall Study|Sponsor Terminated Study|4|||
126289243|NCT03041311|454345948|FG000|Overall Study|Disease Progression|3|||
125883101|NCT02017405|452869131|FG002|Open-label Phase|Adverse Event|0|||
125883102|NCT02017405|452869132|FG003|Open-label Phase|Adverse Event|0|||
125883103|NCT02017405|452869133|FG004|Open-label Phase|Adverse Event|0|||
125883104|NCT02017405|452869134|FG005|Open-label Phase|Adverse Event|0|||
125883105|NCT00463567|452871415|FG000|Overall Study|Adverse Event|29|||
125883106|NCT00463567|452871416|FG001|Overall Study|Adverse Event|26|||
125883107|NCT00463567|452871417|FG002|Overall Study|Adverse Event|17|||
125883108|NCT00463567|452871418|FG003|Overall Study|Adverse Event|46|||
125883109|NCT00463567|452871419|FG004|Overall Study|Adverse Event|10|||
125883110|NCT00463567|452871420|FG005|Overall Study|Adverse Event|10|||
125883111|NCT00463567|452871421|FG006|Overall Study|Adverse Event|4|||
125883112|NCT00463567|452871415|FG000|Overall Study|Withdrawal by Subject|29|||
125883113|NCT00463567|452871416|FG001|Overall Study|Withdrawal by Subject|22|||
125883114|NCT00463567|452871417|FG002|Overall Study|Withdrawal by Subject|20|||
126041960|NCT04271046|453451210|FG001|Overall Study|Patient with Dementia Died|0|||
126041961|NCT04271046|453451211|FG002|Overall Study|Patient with Dementia Died|2|||
126041962|NCT04271046|453451212|FG003|Overall Study|Patient with Dementia Died|0|||
126041963|NCT04271046|453451209|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
126041964|NCT04271046|453451210|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
126041965|NCT04271046|453451211|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
126041966|NCT04271046|453451212|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
126041967|NCT01570361|453451213|FG000|Overall Study|Subject discontinued|1|||
126041968|NCT01570361|453451214|FG001|Overall Study|Subject discontinued|2|||
126041969|NCT01570361|453451213|FG000|Overall Study|Sponsor closing the study|51|||
125883115|NCT00463567|452871418|FG003|Overall Study|Withdrawal by Subject|37|||
125883116|NCT00463567|452871419|FG004|Overall Study|Withdrawal by Subject|6|||
125883117|NCT00463567|452871420|FG005|Overall Study|Withdrawal by Subject|5|||
126041970|NCT01570361|453451214|FG001|Overall Study|Sponsor closing the study|50|||
126041971|NCT01570361|453451213|FG000|Overall Study|Subject excluded|5|||
126041972|NCT01570361|453451214|FG001|Overall Study|Subject excluded|3|||
126041973|NCT01570361|453451213|FG000|Overall Study|Subject withdrew consent|14|||
126041974|NCT01570361|453451214|FG001|Overall Study|Subject withdrew consent|9|||
126041975|NCT01570361|453451213|FG000|Overall Study|Adverse Event|2|||
126041976|NCT01570361|453451214|FG001|Overall Study|Adverse Event|1|||
126041977|NCT01570361|453451213|FG000|Overall Study|Lost to Follow-up|4|||
126041978|NCT01570361|453451214|FG001|Overall Study|Lost to Follow-up|4|||
126041979|NCT01570361|453451213|FG000|Overall Study|Death|5|||
126041980|NCT01570361|453451214|FG001|Overall Study|Death|4|||
126041981|NCT01570361|453451213|FG000|Overall Study|Other|0|||
126289244|NCT03041311|454345949|FG001|Overall Study|Disease Progression|1|||
126289245|NCT03041311|454345948|FG000|Overall Study|Randomized in error, did not receive drug|2|||
126289246|NCT03041311|454345949|FG001|Overall Study|Randomized in error, did not receive drug|0|||
126289247|NCT00782626|454345953|FG000|Overall Study|Adverse Event|1|||
126289248|NCT00782626|454345953|FG000|Overall Study|Progressive Disease|5|||
126289249|NCT00782626|454345953|FG000|Overall Study|Other Complicating Disease|1|||
126289250|NCT04182490|454345957|FG000|Overall Study|Withdrawal by Subject|3|||
126289251|NCT04182490|454345958|FG001|Overall Study|Withdrawal by Subject|3|||
126289252|NCT04182490|454345957|FG000|Overall Study|Lost to Follow-up|0|||
126289253|NCT04182490|454345958|FG001|Overall Study|Lost to Follow-up|1|||
126289254|NCT04182490|454345957|FG000|Overall Study|Physician Decision|0|||
126289255|NCT04182490|454345958|FG001|Overall Study|Physician Decision|1|||
126289256|NCT00853099|454345959|FG000|Double-blind Period|Adverse Event|7|||
126289257|NCT00853099|454345960|FG001|Double-blind Period|Adverse Event|9|||
126289258|NCT00853099|454345961|FG002|Double-blind Period|Adverse Event|13|||
126289259|NCT00853099|454345962|FG003|Double-blind Period|Adverse Event|0|||
126289260|NCT00853099|454345959|FG000|Double-blind Period|Withdrawal by Subject|2|||
126289261|NCT00853099|454345960|FG001|Double-blind Period|Withdrawal by Subject|3|||
126289262|NCT00853099|454345961|FG002|Double-blind Period|Withdrawal by Subject|0|||
126289263|NCT00853099|454345962|FG003|Double-blind Period|Withdrawal by Subject|0|||
126289264|NCT00853099|454345959|FG000|Double-blind Period|Lack of Efficacy|14|||
126289265|NCT00853099|454345960|FG001|Double-blind Period|Lack of Efficacy|17|||
126289266|NCT00853099|454345961|FG002|Double-blind Period|Lack of Efficacy|16|||
126289267|NCT00853099|454345962|FG003|Double-blind Period|Lack of Efficacy|0|||
126289268|NCT00853099|454345959|FG000|Double-blind Period|Other|0|||
126289269|NCT00853099|454345960|FG001|Double-blind Period|Other|0|||
126289270|NCT00853099|454345961|FG002|Double-blind Period|Other|1|||
126289271|NCT00853099|454345962|FG003|Double-blind Period|Other|0|||
126289272|NCT00853099|454345959|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
125883118|NCT00463567|452871421|FG006|Overall Study|Withdrawal by Subject|1|||
125883119|NCT00463567|452871415|FG000|Overall Study|Protocol Deviation|13|||
126041982|NCT01570361|453451214|FG001|Overall Study|Other|2|||
126041983|NCT04826471|453453036|FG000|Overall Study|Lost to Follow-up|2|||
126041984|NCT04826471|453453036|FG000|Overall Study|Protocol Violation|3|||
126289273|NCT00853099|454345960|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
126289274|NCT00853099|454345961|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
126289275|NCT00853099|454345962|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
126289276|NCT00853099|454345959|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
126289277|NCT00853099|454345960|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
126289278|NCT00853099|454345961|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
126289279|NCT00853099|454345962|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
126289280|NCT00853099|454345959|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
126289281|NCT00853099|454345960|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
126289282|NCT00853099|454345961|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
126289283|NCT00853099|454345962|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
126289284|NCT00853099|454345959|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
126289285|NCT00853099|454345960|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
126289286|NCT00853099|454345961|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
126289287|NCT00853099|454345962|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
126289288|NCT00853099|454345959|FG000|Double-blind + Open-label Periods|Other|0|||
126289289|NCT00853099|454345960|FG001|Double-blind + Open-label Periods|Other|0|||
126289290|NCT00853099|454345961|FG002|Double-blind + Open-label Periods|Other|0|||
126289291|NCT00853099|454345962|FG003|Double-blind + Open-label Periods|Other|6|||
126289292|NCT01811472|454345963|FG000|Overall Study|Adverse Event|1|||
126289293|NCT01811472|454345964|FG001|Overall Study|Adverse Event|0|||
126289294|NCT01811472|454345965|FG002|Overall Study|Adverse Event|4|||
126289295|NCT01811472|454345963|FG000|Overall Study|Lost to Follow-up|0|||
126289296|NCT01811472|454345964|FG001|Overall Study|Lost to Follow-up|0|||
126289297|NCT01811472|454345965|FG002|Overall Study|Lost to Follow-up|1|||
126289298|NCT01811472|454345963|FG000|Overall Study|Subject/guardian decision|1|||
126289299|NCT01811472|454345964|FG001|Overall Study|Subject/guardian decision|0|||
126289300|NCT01811472|454345965|FG002|Overall Study|Subject/guardian decision|0|||
126289301|NCT03280264|454345966|FG000|Overall Study|Adverse Event|1|||
126289302|NCT03280264|454345966|FG000|Overall Study|Physician Decision|1|||
126289303|NCT03280264|454345966|FG000|Overall Study|Withdrawal by Subject|1|||
126289304|NCT02738138|454345968|FG000|Overall Study|Adverse Event|0|||
126289305|NCT02738138|454345969|FG001|Overall Study|Adverse Event|1|||
126289306|NCT02738138|454345968|FG000|Overall Study|Lost to Follow-up|2|||
126289307|NCT02738138|454345969|FG001|Overall Study|Lost to Follow-up|0|||
126289308|NCT02738138|454345968|FG000|Overall Study|Other - not further specified|1|||
126289309|NCT02738138|454345969|FG001|Overall Study|Other - not further specified|0|||
126289310|NCT02071225|454345980|FG000|Overall Study|Withdrawal of Consent|2|||
126289311|NCT02071225|454345980|FG000|Overall Study|Protocol Deviation|1|||
126289312|NCT02071225|454345980|FG000|Overall Study|Lost to Follow-up|2|||
126289313|NCT02071225|454345980|FG000|Overall Study|Death|25|||
126289314|NCT02064296|454345985|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
126289315|NCT02064296|454345986|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
126289316|NCT02064296|454345987|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
126289317|NCT02064296|454345985|FG000|Intervention|Withdrawal by Subject|0|||
126289318|NCT02064296|454345986|FG001|Intervention|Withdrawal by Subject|1|||
126289319|NCT02064296|454345987|FG002|Intervention|Withdrawal by Subject|2|||
126289320|NCT03885661|454345996|FG000|Overall Study|Withdrawal by Subject|0|||
126289321|NCT03885661|454345997|FG001|Overall Study|Withdrawal by Subject|1|||
126289322|NCT03885661|454345996|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
126289323|NCT03885661|454345997|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
126289324|NCT03934541|454346002|FG000|Overall Study|Study Terminated by Sponsor|0|||
126289325|NCT03934541|454346003|FG001|Overall Study|Study Terminated by Sponsor|1|||
126289326|NCT03934541|454346004|FG002|Overall Study|Study Terminated by Sponsor|0|||
126289327|NCT03934541|454346005|FG003|Overall Study|Study Terminated by Sponsor|0|||
126289328|NCT02673775|454346006|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
126289329|NCT02673775|454346007|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
126289330|NCT02673775|454346006|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
126289331|NCT02673775|454346007|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
126289332|NCT02673775|454346006|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
126289333|NCT02673775|454346007|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
126289334|NCT02673775|454346006|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
125883120|NCT00463567|452871416|FG001|Overall Study|Protocol Deviation|9|||
126289335|NCT02673775|454346007|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
126289336|NCT02441686|454346008|FG000|Induction|Adverse Event|4|||
126289337|NCT02441686|454346008|FG000|Induction|Complicating disease|1|||
126289338|NCT02441686|454346008|FG000|Induction|Physician Decision|1|||
126289339|NCT02441686|454346008|FG000|Induction|Withdrawal by Subject|1|||
126289340|NCT02441686|454346008|FG000|Induction|Did not receive treatment|1|||
126289341|NCT02441686|454346008|FG000|Maintenance|Remaining on Treatment|23|||
126289342|NCT02441686|454346008|FG000|Maintenance|Physician Decision|1|||
126289343|NCT02441686|454346008|FG000|Maintenance|Adverse Event|3|||
126289344|NCT02441686|454346008|FG000|Maintenance|Progressive Disease|10|||
126289345|NCT02441686|454346008|FG000|Maintenance|Withdrawal by Subject|1|||
126289346|NCT03151304|454346009|FG000|Overall Study|Termination of study by Sponsor|23|||
126289347|NCT03151304|454346009|FG000|Overall Study|missing|3|||
126289348|NCT03151304|454346009|FG000|Overall Study|Withdrawal by Subject|8|||
126289349|NCT03151304|454346009|FG000|Overall Study|multiple reasons|30|||
126289350|NCT03519087|454346010|FG000|Clinic Evaluation|Physician Decision|15|||
126289351|NCT03519087|454346011|FG001|Clinic Evaluation|Physician Decision|18|||
126289352|NCT03519087|454346012|FG002|Clinic Evaluation|Physician Decision|0|||
126289353|NCT03519087|454346013|FG003|Clinic Evaluation|Physician Decision|0|||
126289354|NCT03519087|454346014|FG004|Clinic Evaluation|Physician Decision|0|||
126289355|NCT03519087|454346010|FG000|Clinic Evaluation|Protocol Violation|1|||
126289356|NCT03519087|454346011|FG001|Clinic Evaluation|Protocol Violation|0|||
126289357|NCT03519087|454346012|FG002|Clinic Evaluation|Protocol Violation|0|||
126289358|NCT03519087|454346013|FG003|Clinic Evaluation|Protocol Violation|0|||
126289359|NCT03519087|454346014|FG004|Clinic Evaluation|Protocol Violation|0|||
126289360|NCT03519087|454346010|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
126289361|NCT03519087|454346011|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
126289362|NCT03519087|454346012|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
126289363|NCT03519087|454346013|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
126289364|NCT03519087|454346014|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
126289365|NCT03519087|454346010|FG000|Re-randomization for Treatment|Not appropriate|2|||
126289366|NCT03519087|454346011|FG001|Re-randomization for Treatment|Not appropriate|3|||
126289367|NCT03519087|454346012|FG002|Re-randomization for Treatment|Not appropriate|0|||
126289368|NCT03519087|454346013|FG003|Re-randomization for Treatment|Not appropriate|0|||
126289369|NCT03519087|454346014|FG004|Re-randomization for Treatment|Not appropriate|0|||
126289370|NCT03519087|454346010|FG000|Laboratory Testing|Lost to Follow-up|0|||
126289371|NCT03519087|454346011|FG001|Laboratory Testing|Lost to Follow-up|0|||
126289372|NCT03519087|454346012|FG002|Laboratory Testing|Lost to Follow-up|2|||
126289373|NCT03519087|454346013|FG003|Laboratory Testing|Lost to Follow-up|3|||
126289374|NCT03519087|454346014|FG004|Laboratory Testing|Lost to Follow-up|6|||
126289375|NCT03519087|454346010|FG000|Laboratory Testing|Protocol Violation|0|||
126289376|NCT03519087|454346011|FG001|Laboratory Testing|Protocol Violation|0|||
126289377|NCT03519087|454346012|FG002|Laboratory Testing|Protocol Violation|0|||
126289378|NCT03519087|454346013|FG003|Laboratory Testing|Protocol Violation|1|||
126289379|NCT03519087|454346014|FG004|Laboratory Testing|Protocol Violation|0|||
126289380|NCT01137071|454346015|FG000|Overall Study|Disease Progression|11|||
126289381|NCT01137071|454346015|FG000|Overall Study|Withdrawal by Subject|2|||
126289382|NCT01137071|454346015|FG000|Overall Study|Wrongly Included|1|||
126289383|NCT04194645|454346016|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289384|NCT04194645|454346017|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289385|NCT04194645|454346018|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126365804|NCT03164356|454632898|FG000|Overall Study|Prosthetist unable to participate|0|||
126365805|NCT03164356|454632899|FG001|Overall Study|Prosthetist unable to participate|2|||
126365806|NCT03164356|454632900|FG002|Overall Study|Prosthetist unable to participate|1|||
126365807|NCT03164356|454632901|FG003|Overall Study|Prosthetist unable to participate|0|||
126365808|NCT00561821|454632902|FG000|Overall Study|Not treated|0|||
126365809|NCT00561821|454632903|FG001|Overall Study|Not treated|0|||
126365810|NCT00561821|454632904|FG002|Overall Study|Not treated|1|||
126365811|NCT00561821|454632905|FG003|Overall Study|Not treated|0|||
126365812|NCT00561821|454632902|FG000|Overall Study|Withdrawal by Subject|0|||
126365813|NCT00561821|454632903|FG001|Overall Study|Withdrawal by Subject|1|||
126365814|NCT00561821|454632904|FG002|Overall Study|Withdrawal by Subject|0|||
126365815|NCT00561821|454632905|FG003|Overall Study|Withdrawal by Subject|2|||
126365816|NCT00561821|454632902|FG000|Overall Study|Reasons not related to trial|2|||
126365817|NCT00561821|454632903|FG001|Overall Study|Reasons not related to trial|1|||
126365818|NCT00561821|454632904|FG002|Overall Study|Reasons not related to trial|0|||
126365819|NCT00561821|454632905|FG003|Overall Study|Reasons not related to trial|0|||
126365820|NCT00561821|454632902|FG000|Overall Study|Other (reason not specified)|1|||
126365821|NCT00561821|454632903|FG001|Overall Study|Other (reason not specified)|1|||
126365822|NCT00561821|454632904|FG002|Overall Study|Other (reason not specified)|0|||
126365823|NCT00561821|454632905|FG003|Overall Study|Other (reason not specified)|0|||
126365824|NCT00561821|454632902|FG000|Overall Study|Adverse Event|2|||
126365825|NCT00561821|454632903|FG001|Overall Study|Adverse Event|3|||
126365826|NCT00561821|454632904|FG002|Overall Study|Adverse Event|1|||
126289386|NCT04194645|454346019|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289387|NCT04194645|454346020|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289388|NCT04194645|454346021|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289389|NCT04194645|454346022|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289390|NCT04194645|454346023|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289391|NCT04194645|454346024|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289392|NCT04194645|454346025|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
126289393|NCT04194645|454346026|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289394|NCT04194645|454346027|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289395|NCT04194645|454346028|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289396|NCT04194645|454346029|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289397|NCT04194645|454346030|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289398|NCT01783886|454346031|FG000|Overall Study|Lost to Follow-up|0|||
126289399|NCT01783886|454346032|FG001|Overall Study|Lost to Follow-up|3|||
126289400|NCT01783886|454346033|FG002|Overall Study|Lost to Follow-up|0|||
126289401|NCT01783886|454346031|FG000|Overall Study|Protocol deviation|0|||
126289402|NCT01783886|454346032|FG001|Overall Study|Protocol deviation|0|||
126289403|NCT01783886|454346033|FG002|Overall Study|Protocol deviation|2|||
126289404|NCT01783886|454346031|FG000|Overall Study|Withdrawal of consent by participant|1|||
126289405|NCT01783886|454346032|FG001|Overall Study|Withdrawal of consent by participant|3|||
126289406|NCT01783886|454346033|FG002|Overall Study|Withdrawal of consent by participant|4|||
126289407|NCT01783886|454346031|FG000|Overall Study|Adverse Event|4|||
126289408|NCT01783886|454346032|FG001|Overall Study|Adverse Event|5|||
126289409|NCT01783886|454346033|FG002|Overall Study|Adverse Event|4|||
126289410|NCT00104572|454346034|FG000|Overall Study|Withdrawal by Subject|3|||
126289411|NCT00104572|454346035|FG001|Overall Study|Withdrawal by Subject|3|||
126289412|NCT00104572|454346036|FG002|Overall Study|Withdrawal by Subject|0|||
126289413|NCT00940316|454346037|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
126289414|NCT00940316|454346038|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
126289415|NCT00940316|454346039|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
126289416|NCT00940316|454346037|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
126289417|NCT00940316|454346038|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
126289418|NCT00940316|454346039|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
126289419|NCT00940316|454346037|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
126289420|NCT00940316|454346038|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
126289421|NCT00940316|454346039|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
126289422|NCT00940316|454346037|FG000|Treated After Cycle 5|Adverse Event|0|||
126289423|NCT00940316|454346038|FG001|Treated After Cycle 5|Adverse Event|0|||
126289424|NCT00940316|454346039|FG002|Treated After Cycle 5|Adverse Event|1|||
126289425|NCT00940316|454346037|FG000|Treated After Cycle 5|Progressive disease|0|||
126289426|NCT00940316|454346038|FG001|Treated After Cycle 5|Progressive disease|1|||
126289427|NCT00940316|454346039|FG002|Treated After Cycle 5|Progressive disease|0|||
126289428|NCT02290405|454346040|FG000|Overall Study|Withdrawal by Subject|1|||
126289429|NCT02290405|454346041|FG001|Overall Study|Withdrawal by Subject|0|||
126289430|NCT02016183|454346042|FG000|Overall Study|Case Report Forms Uncollected|13|||
126289431|NCT02016183|454346042|FG000|Overall Study|Protocol Violation|52|||
126289432|NCT00996489|454346043|FG000|Overall Study|Device failure|45|||
126289433|NCT00996489|454346043|FG000|Overall Study|Discontinued|116|||
126289434|NCT03142191|454346044|FG000|Placebo Controlled Period|Death|0|||
126289435|NCT03142191|454346045|FG001|Placebo Controlled Period|Death|1|||
126289436|NCT03142191|454346046|FG002|Placebo Controlled Period|Death|1|||
126289437|NCT03142191|454346047|FG003|Placebo Controlled Period|Death|0|||
126289438|NCT03142191|454346048|FG004|Placebo Controlled Period|Death|0|||
126289439|NCT03142191|454346044|FG000|Placebo Controlled Period|Adverse Event|4|||
126289440|NCT03142191|454346045|FG001|Placebo Controlled Period|Adverse Event|5|||
126289441|NCT03142191|454346046|FG002|Placebo Controlled Period|Adverse Event|1|||
126289442|NCT03142191|454346047|FG003|Placebo Controlled Period|Adverse Event|0|||
126289443|NCT03142191|454346048|FG004|Placebo Controlled Period|Adverse Event|0|||
126289444|NCT03142191|454346044|FG000|Placebo Controlled Period|Progressive Disease|1|||
126289445|NCT03142191|454346045|FG001|Placebo Controlled Period|Progressive Disease|0|||
126289446|NCT03142191|454346046|FG002|Placebo Controlled Period|Progressive Disease|1|||
126365827|NCT00561821|454632905|FG003|Overall Study|Adverse Event|1|||
126365828|NCT02520154|454632907|FG000|Overall Study|Death|1|||
126365829|NCT02520154|454632907|FG000|Overall Study|Withdrawal by Subject|2|||
126365830|NCT02520154|454632907|FG000|Overall Study|Physician Decision|2|||
126365831|NCT03443401|454634231|FG000|Overall Study|Lost to Follow-up|13|||
126365832|NCT03443401|454634231|FG000|Overall Study|Influential outlier|1|||
126365833|NCT02904265|454634232|FG000|Overall Study|Physician Decision|1|||
126365834|NCT02904265|454634233|FG001|Overall Study|Physician Decision|2|||
126365835|NCT00267488|454634237|FG000|Overall Study|Sponsor Terminated Study|9|||
126365836|NCT00267488|454634237|FG000|Overall Study|Protocol Violation|1|||
126365837|NCT00267488|454634237|FG000|Overall Study|Other (Disease Progression)|1|||
126365838|NCT01557569|454634238|FG000|Overall Study|Adverse Event|2|||
126365839|NCT01557569|454634239|FG001|Overall Study|Adverse Event|0|||
126365840|NCT01557569|454634238|FG000|Overall Study|high blood pressure|0|||
126289447|NCT03142191|454346047|FG003|Placebo Controlled Period|Progressive Disease|0|||
126289448|NCT03142191|454346048|FG004|Placebo Controlled Period|Progressive Disease|0|||
126289449|NCT03142191|454346044|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
126289450|NCT03142191|454346045|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
126289451|NCT03142191|454346046|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
126289452|NCT03142191|454346047|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
126289453|NCT03142191|454346048|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
126289454|NCT03142191|454346044|FG000|Placebo Controlled Period|Other Reasons|1|||
126289455|NCT03142191|454346045|FG001|Placebo Controlled Period|Other Reasons|0|||
126289456|NCT03142191|454346046|FG002|Placebo Controlled Period|Other Reasons|0|||
126289457|NCT03142191|454346047|FG003|Placebo Controlled Period|Other Reasons|0|||
126289458|NCT03142191|454346048|FG004|Placebo Controlled Period|Other Reasons|0|||
126289459|NCT03142191|454346044|FG000|Active Treatment Extension Period|Death|2|||
126289460|NCT03142191|454346045|FG001|Active Treatment Extension Period|Death|1|||
126289461|NCT03142191|454346046|FG002|Active Treatment Extension Period|Death|1|||
126289462|NCT03142191|454346047|FG003|Active Treatment Extension Period|Death|1|||
126289463|NCT03142191|454346048|FG004|Active Treatment Extension Period|Death|0|||
126289464|NCT03142191|454346044|FG000|Active Treatment Extension Period|Adverse Event|6|||
126289465|NCT03142191|454346045|FG001|Active Treatment Extension Period|Adverse Event|5|||
126289466|NCT03142191|454346046|FG002|Active Treatment Extension Period|Adverse Event|4|||
126289467|NCT03142191|454346047|FG003|Active Treatment Extension Period|Adverse Event|1|||
126289468|NCT03142191|454346048|FG004|Active Treatment Extension Period|Adverse Event|0|||
126289469|NCT03142191|454346044|FG000|Active Treatment Extension Period|Progressive Disease|10|||
126289470|NCT03142191|454346045|FG001|Active Treatment Extension Period|Progressive Disease|5|||
126289471|NCT03142191|454346046|FG002|Active Treatment Extension Period|Progressive Disease|4|||
126289472|NCT03142191|454346047|FG003|Active Treatment Extension Period|Progressive Disease|1|||
126289473|NCT03142191|454346048|FG004|Active Treatment Extension Period|Progressive Disease|2|||
126289474|NCT03142191|454346044|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
126289475|NCT03142191|454346045|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
126289476|NCT03142191|454346046|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
126289477|NCT03142191|454346047|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
126289478|NCT03142191|454346048|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
126289479|NCT03142191|454346044|FG000|Active Treatment Extension Period|Physician Decision|2|||
126289480|NCT03142191|454346045|FG001|Active Treatment Extension Period|Physician Decision|0|||
126289481|NCT03142191|454346046|FG002|Active Treatment Extension Period|Physician Decision|0|||
126289482|NCT03142191|454346047|FG003|Active Treatment Extension Period|Physician Decision|0|||
126289483|NCT03142191|454346048|FG004|Active Treatment Extension Period|Physician Decision|0|||
126289484|NCT03142191|454346044|FG000|Active Treatment Extension Period|Other Reasons|3|||
126289485|NCT03142191|454346045|FG001|Active Treatment Extension Period|Other Reasons|3|||
126289486|NCT03142191|454346046|FG002|Active Treatment Extension Period|Other Reasons|3|||
126289487|NCT03142191|454346047|FG003|Active Treatment Extension Period|Other Reasons|8|||
126289488|NCT03142191|454346048|FG004|Active Treatment Extension Period|Other Reasons|3|||
126289489|NCT03142191|454346044|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
126289490|NCT03142191|454346045|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
126289491|NCT03142191|454346046|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
126289492|NCT03142191|454346047|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
126289493|NCT03142191|454346048|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
126289494|NCT00770328|454346051|FG000|Overall Study|Adverse Event|11|||
126289495|NCT00770328|454346052|FG001|Overall Study|Adverse Event|2|||
126289496|NCT00770328|454346051|FG000|Overall Study|Lost to Follow-up|2|||
126289497|NCT00770328|454346052|FG001|Overall Study|Lost to Follow-up|2|||
126289498|NCT02286843|454346053|FG000|Overall Study|Not Treated|4|||
126289499|NCT02286843|454346053|FG000|Overall Study|Protocol Violation|1|||
126289500|NCT02286843|454346053|FG000|Overall Study|Withdrawal by Subject|1|||
126289501|NCT02593110|454346054|FG000|Overall Study|Withdrawal by Subject|0|||
126289502|NCT02593110|454346055|FG001|Overall Study|Withdrawal by Subject|3|||
126289503|NCT02593110|454346056|FG002|Overall Study|Withdrawal by Subject|3|||
126365841|NCT01557569|454634239|FG001|Overall Study|high blood pressure|1|||
126365842|NCT01557569|454634238|FG000|Overall Study|Withdrawal by Subject|3|||
126365843|NCT01557569|454634239|FG001|Overall Study|Withdrawal by Subject|5|||
126365844|NCT01557569|454634238|FG000|Overall Study|noncompliance with rules of residential|0|||
126365845|NCT01557569|454634239|FG001|Overall Study|noncompliance with rules of residential|1|||
126365846|NCT02254460|454634240|FG000|Overall Study|Adverse Event|1|||
126365847|NCT02254460|454634241|FG001|Overall Study|Adverse Event|0|||
126365848|NCT00137449|454634242|FG000|Overall Study|Disease Progression|8|||
126289504|NCT02593110|454346057|FG003|Overall Study|Withdrawal by Subject|2|||
126289505|NCT02593110|454346054|FG000|Overall Study|Death|0|||
126365849|NCT00137449|454634243|FG001|Overall Study|Disease Progression|13|||
126365850|NCT00137449|454634242|FG000|Overall Study|Death|4|||
126041985|NCT04826471|453453036|FG000|Overall Study|Withdrawal by Subject|1|||
126289506|NCT02593110|454346055|FG001|Overall Study|Death|0|||
126289507|NCT02593110|454346056|FG002|Overall Study|Death|1|||
126289508|NCT02593110|454346057|FG003|Overall Study|Death|0|||
126289509|NCT03172494|454346062|FG000|Overall Study|Adverse Event|5|||
126289510|NCT03172494|454346063|FG001|Overall Study|Adverse Event|1|||
126289511|NCT03172494|454346064|FG002|Overall Study|Adverse Event|15|||
126289512|NCT03172494|454346062|FG000|Overall Study|Protocol Violation|3|||
126289513|NCT03172494|454346063|FG001|Overall Study|Protocol Violation|2|||
126289514|NCT03172494|454346064|FG002|Overall Study|Protocol Violation|1|||
126289515|NCT03172494|454346062|FG000|Overall Study|Lack of Efficacy|0|||
126289516|NCT03172494|454346063|FG001|Overall Study|Lack of Efficacy|0|||
126289517|NCT03172494|454346064|FG002|Overall Study|Lack of Efficacy|4|||
126289518|NCT03172494|454346062|FG000|Overall Study|Pregnancy|0|||
126289519|NCT03172494|454346063|FG001|Overall Study|Pregnancy|1|||
126289520|NCT03172494|454346064|FG002|Overall Study|Pregnancy|0|||
126289521|NCT03172494|454346062|FG000|Overall Study|Withdrawal by Subject|10|||
126289522|NCT03172494|454346063|FG001|Overall Study|Withdrawal by Subject|8|||
126289523|NCT03172494|454346064|FG002|Overall Study|Withdrawal by Subject|8|||
126289524|NCT03172494|454346062|FG000|Overall Study|Severe hypoglycaemic episode|0|||
126289525|NCT03172494|454346063|FG001|Overall Study|Severe hypoglycaemic episode|0|||
126289526|NCT03172494|454346064|FG002|Overall Study|Severe hypoglycaemic episode|1|||
126289527|NCT03172494|454346062|FG000|Overall Study|Non-compliance towards treatment|2|||
126289528|NCT03172494|454346063|FG001|Overall Study|Non-compliance towards treatment|0|||
126289529|NCT03172494|454346064|FG002|Overall Study|Non-compliance towards treatment|0|||
126289530|NCT02764151|454346065|FG000|Overall Study|Subject refused further follow-up|0|||
126289531|NCT02764151|454346066|FG001|Overall Study|Subject refused further follow-up|0|||
126289532|NCT02764151|454346067|FG002|Overall Study|Subject refused further follow-up|0|||
126289533|NCT02764151|454346068|FG003|Overall Study|Subject refused further follow-up|1|||
126289534|NCT02764151|454346065|FG000|Overall Study|Other|0|||
126289535|NCT02764151|454346066|FG001|Overall Study|Other|0|||
126289536|NCT02764151|454346067|FG002|Overall Study|Other|0|||
126289537|NCT02764151|454346068|FG003|Overall Study|Other|2|||
126289538|NCT03086551|454346069|FG000|First Intervention|Failure to meet inclusion criterion|1|||
126289539|NCT03086551|454346070|FG001|First Intervention|Failure to meet inclusion criterion|0|||
126289540|NCT03086551|454346069|FG000|First Intervention|Lost to Follow-up|0|||
126289541|NCT03086551|454346070|FG001|First Intervention|Lost to Follow-up|1|||
126289542|NCT03086551|454346069|FG000|Washout|Lost to Follow-up|1|||
126289543|NCT03086551|454346070|FG001|Washout|Lost to Follow-up|2|||
126289544|NCT03086551|454346069|FG000|Washout|Withdrawal by Subject|2|||
126289545|NCT03086551|454346070|FG001|Washout|Withdrawal by Subject|1|||
126289546|NCT02201277|454346071|FG000|Overall Study|Death|3|||
126289547|NCT02201277|454346072|FG001|Overall Study|Death|4|||
126289548|NCT02201277|454346071|FG000|Overall Study|Lost to Follow-up|2|||
126289549|NCT02201277|454346072|FG001|Overall Study|Lost to Follow-up|1|||
126289550|NCT02201277|454346071|FG000|Overall Study|Failed retrieval|1|||
126289551|NCT02201277|454346072|FG001|Overall Study|Failed retrieval|0|||
126289552|NCT02201277|454346071|FG000|Overall Study|Physician Decision|1|||
126289553|NCT02201277|454346072|FG001|Overall Study|Physician Decision|0|||
126289554|NCT01512160|454346073|FG000|Overall Study|Lost to Follow-up|1|||
126289555|NCT01512160|454346074|FG001|Overall Study|Lost to Follow-up|0|||
126289556|NCT01512160|454346075|FG002|Overall Study|Lost to Follow-up|0|||
126289557|NCT01512160|454346076|FG003|Overall Study|Lost to Follow-up|0|||
126289558|NCT01512160|454346073|FG000|Overall Study|Withdrawal by Subject|1|||
126289559|NCT01512160|454346074|FG001|Overall Study|Withdrawal by Subject|0|||
126289560|NCT01512160|454346075|FG002|Overall Study|Withdrawal by Subject|0|||
126289561|NCT01512160|454346076|FG003|Overall Study|Withdrawal by Subject|1|||
126289562|NCT04205812|454347685|FG000|Randomized Treatment Period|Ongoing|28|||
126289563|NCT04205812|454347686|FG001|Randomized Treatment Period|Ongoing|138|||
126041986|NCT04304144|453453038|FG000|DLT Observation Period|Physician Decision|0|||
126289564|NCT04205812|454347685|FG000|Randomized Treatment Period|Death|94|||
126289565|NCT04205812|454347686|FG001|Randomized Treatment Period|Death|226|||
126289566|NCT04205812|454347685|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
126289567|NCT04205812|454347686|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
126289568|NCT04205812|454347685|FG000|Randomized Treatment Period|Physician Decision|1|||
126289569|NCT04205812|454347686|FG001|Randomized Treatment Period|Physician Decision|4|||
126289570|NCT04205812|454347685|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
126289571|NCT04205812|454347686|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
126289572|NCT04205812|454347685|FG000|Randomized Treatment Period|Progressive Disease|0|||
126289573|NCT04205812|454347686|FG001|Randomized Treatment Period|Progressive Disease|1|||
126289574|NCT04205812|454347685|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
126289575|NCT04205812|454347686|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
126289576|NCT04205812|454347685|FG000|Monotherapy Treatment Period|Ongoing|17|||
126365851|NCT00137449|454634243|FG001|Overall Study|Death|3|||
126365852|NCT00137449|454634242|FG000|Overall Study|Adverse Event|3|||
126365853|NCT00137449|454634243|FG001|Overall Study|Adverse Event|1|||
126365854|NCT00137449|454634242|FG000|Overall Study|Withdrawal by Subject|1|||
126365855|NCT00137449|454634243|FG001|Overall Study|Withdrawal by Subject|1|||
126365856|NCT01356940|454634244|FG000|First Intervention (28 Days)|Adverse Event|1|||
126365857|NCT01356940|454634245|FG001|First Intervention (28 Days)|Adverse Event|0|||
126365858|NCT01356940|454634244|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
126365859|NCT01356940|454634245|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
126365860|NCT00505687|454634248|FG000|Overall Study|Important protocol violation|2|||
126365861|NCT00505687|454634248|FG000|Overall Study|Lack of Efficacy|15|||
126365862|NCT00505687|454634248|FG000|Overall Study|Adverse Event|48|||
126365863|NCT00505687|454634248|FG000|Overall Study|Subject withdrew consent|15|||
126365864|NCT00505687|454634248|FG000|Overall Study|Lost to Follow-up|1|||
126365865|NCT00505687|454634248|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
126365866|NCT00505687|454634248|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
126365867|NCT00505687|454634248|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
126365868|NCT00505687|454634248|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
126365869|NCT00505687|454634248|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
126365870|NCT00505687|454634248|FG000|Overall Study|Other: Disease Progression|1|||
126365871|NCT00505687|454634248|FG000|Overall Study|Other: As Per Sponsor|8|||
126365872|NCT00278161|454634249|FG000|Overall Study|Death|11|||
126365873|NCT00443456|454634250|FG000|Overall Study|Adverse Event|16|||
126365874|NCT00443456|454634250|FG000|Overall Study|Move|1|||
126365875|NCT00443456|454634250|FG000|Overall Study|Withdrawal by Subject|1|||
126365876|NCT02157610|454634251|FG000|Overall Study|Death|4|||
126365877|NCT02157610|454634252|FG001|Overall Study|Death|4|||
126365878|NCT01935947|454634253|FG000|Overall Study|Adverse Event|0|||
126365879|NCT01935947|454634254|FG001|Overall Study|Adverse Event|2|||
126365880|NCT01935947|454634255|FG002|Overall Study|Adverse Event|0|||
126365881|NCT01935947|454634253|FG000|Overall Study|Diease Progression|2|||
126041987|NCT04304144|453453039|FG001|DLT Observation Period|Physician Decision|1|||
126041988|NCT04304144|453453040|FG002|DLT Observation Period|Physician Decision|0|||
126041989|NCT04304144|453453041|FG003|DLT Observation Period|Physician Decision|0|||
126365882|NCT01935947|454634254|FG001|Overall Study|Diease Progression|2|||
126365883|NCT01935947|454634255|FG002|Overall Study|Diease Progression|2|||
126365884|NCT01935947|454634253|FG000|Overall Study|Death|1|||
126365885|NCT01935947|454634254|FG001|Overall Study|Death|0|||
126365886|NCT01935947|454634255|FG002|Overall Study|Death|0|||
126365887|NCT04507763|454634256|FG000|Overall Study|Participants did not meet entrance criteria|201|||
126365888|NCT03427619|454634257|FG000|Overall Study|Physician Decision|3|||
126365889|NCT03427619|454634257|FG000|Overall Study|Withdrawal by Subject|4|||
126365890|NCT03427619|454634257|FG000|Overall Study|Lost to Follow-up|5|||
126365891|NCT03427619|454634257|FG000|Overall Study|Administrative|4|||
126365892|NCT03427619|454634257|FG000|Overall Study|Other|2|||
126365893|NCT03427619|454634257|FG000|Overall Study|Unknown or Missing Completion Status|48|||
126365894|NCT00425555|454634258|FG000|Overall Study|Withdrawal by Subject|11|||
126365895|NCT00425555|454634259|FG001|Overall Study|Withdrawal by Subject|8|||
126289577|NCT04205812|454347686|FG001|Monotherapy Treatment Period|Ongoing|0|||
126289578|NCT04205812|454347685|FG000|Monotherapy Treatment Period|Death|39|||
126289579|NCT04205812|454347686|FG001|Monotherapy Treatment Period|Death|0|||
126289580|NCT04205812|454347685|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
126289581|NCT04205812|454347686|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
126289582|NCT04205812|454347685|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
126289583|NCT04205812|454347686|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
126289584|NCT05221320|454347687|FG000|Overall Study|Lack of Efficacy|3|||
126041990|NCT04304144|453453038|FG000|Continued Treatment Period|Adverse Event|0|||
126041991|NCT04304144|453453039|FG001|Continued Treatment Period|Adverse Event|1|||
126041992|NCT04304144|453453040|FG002|Continued Treatment Period|Adverse Event|0|||
126041993|NCT04304144|453453041|FG003|Continued Treatment Period|Adverse Event|0|||
126289585|NCT05221320|454347688|FG001|Overall Study|Lack of Efficacy|7|||
126289586|NCT05221320|454347689|FG002|Overall Study|Lack of Efficacy|10|||
126289587|NCT05221320|454347690|FG003|Overall Study|Lack of Efficacy|1|||
126289588|NCT05221320|454347691|FG004|Overall Study|Lack of Efficacy|0|||
126289589|NCT05221320|454347692|FG005|Overall Study|Lack of Efficacy|0|||
126289590|NCT05221320|454347687|FG000|Overall Study|Physician Decision|1|||
126289591|NCT05221320|454347688|FG001|Overall Study|Physician Decision|0|||
126289592|NCT05221320|454347689|FG002|Overall Study|Physician Decision|3|||
126289593|NCT05221320|454347690|FG003|Overall Study|Physician Decision|1|||
126041994|NCT04304144|453453038|FG000|Continued Treatment Period|Death|0|||
126041995|NCT04304144|453453039|FG001|Continued Treatment Period|Death|0|||
126041996|NCT04304144|453453040|FG002|Continued Treatment Period|Death|1|||
126041997|NCT04304144|453453041|FG003|Continued Treatment Period|Death|2|||
126289594|NCT05221320|454347691|FG004|Overall Study|Physician Decision|0|||
126289595|NCT05221320|454347692|FG005|Overall Study|Physician Decision|0|||
126289596|NCT05221320|454347687|FG000|Overall Study|Withdrawal by Subject|0|||
126289597|NCT05221320|454347688|FG001|Overall Study|Withdrawal by Subject|3|||
126289598|NCT05221320|454347689|FG002|Overall Study|Withdrawal by Subject|1|||
126289599|NCT05221320|454347690|FG003|Overall Study|Withdrawal by Subject|0|||
126289600|NCT05221320|454347691|FG004|Overall Study|Withdrawal by Subject|0|||
126289601|NCT05221320|454347692|FG005|Overall Study|Withdrawal by Subject|0|||
126289602|NCT05221320|454347687|FG000|Overall Study|Death|0|||
126289603|NCT05221320|454347688|FG001|Overall Study|Death|5|||
126289604|NCT05221320|454347689|FG002|Overall Study|Death|6|||
126289605|NCT05221320|454347690|FG003|Overall Study|Death|0|||
126289606|NCT05221320|454347691|FG004|Overall Study|Death|1|||
126289607|NCT05221320|454347692|FG005|Overall Study|Death|0|||
126289608|NCT06473519|454347693|FG000|Overall Study|Lost to Follow-up|2|||
126289609|NCT06473519|454347694|FG001|Overall Study|Lost to Follow-up|5|||
126289610|NCT06473519|454347693|FG000|Overall Study|Withdrawal by Subject|1|||
126289611|NCT06473519|454347694|FG001|Overall Study|Withdrawal by Subject|4|||
126289612|NCT06473519|454347693|FG000|Overall Study|Randomized but not vaccinated|1|||
126289613|NCT06473519|454347694|FG001|Overall Study|Randomized but not vaccinated|2|||
126289614|NCT02514447|454347699|FG000|Overall Study|Withdrawal by Subject|3|||
126289615|NCT02514447|454347700|FG001|Overall Study|Withdrawal by Subject|1|||
126289616|NCT02514447|454347701|FG002|Overall Study|Withdrawal by Subject|1|||
126289617|NCT02514447|454347702|FG003|Overall Study|Withdrawal by Subject|0|||
126289618|NCT02514447|454347703|FG004|Overall Study|Withdrawal by Subject|0|||
126289619|NCT02514447|454347704|FG005|Overall Study|Withdrawal by Subject|0|||
126289620|NCT02514447|454347705|FG006|Overall Study|Withdrawal by Subject|0|||
126289621|NCT02514447|454347706|FG007|Overall Study|Withdrawal by Subject|1|||
126289622|NCT02514447|454347707|FG008|Overall Study|Withdrawal by Subject|1|||
126289623|NCT02514447|454347699|FG000|Overall Study|Death|24|||
126289624|NCT02514447|454347700|FG001|Overall Study|Death|28|||
126289625|NCT02514447|454347701|FG002|Overall Study|Death|29|||
126289626|NCT02514447|454347702|FG003|Overall Study|Death|0|||
126289627|NCT02514447|454347703|FG004|Overall Study|Death|3|||
126289628|NCT02514447|454347704|FG005|Overall Study|Death|4|||
126289629|NCT02514447|454347705|FG006|Overall Study|Death|8|||
126289630|NCT02514447|454347706|FG007|Overall Study|Death|6|||
126289631|NCT02514447|454347707|FG008|Overall Study|Death|5|||
126289632|NCT02514447|454347699|FG000|Overall Study|Lost to Follow-up|1|||
126041998|NCT04304144|453453038|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
126041999|NCT04304144|453453039|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
126289633|NCT02514447|454347700|FG001|Overall Study|Lost to Follow-up|0|||
126289634|NCT02514447|454347701|FG002|Overall Study|Lost to Follow-up|0|||
126289635|NCT02514447|454347702|FG003|Overall Study|Lost to Follow-up|0|||
126289636|NCT02514447|454347703|FG004|Overall Study|Lost to Follow-up|0|||
126289637|NCT02514447|454347704|FG005|Overall Study|Lost to Follow-up|0|||
126289638|NCT02514447|454347705|FG006|Overall Study|Lost to Follow-up|0|||
126289639|NCT02514447|454347706|FG007|Overall Study|Lost to Follow-up|0|||
126289640|NCT02514447|454347707|FG008|Overall Study|Lost to Follow-up|1|||
126289641|NCT02514447|454347699|FG000|Overall Study|Sponsor Termination of Study|0|||
126289642|NCT02514447|454347700|FG001|Overall Study|Sponsor Termination of Study|1|||
126289643|NCT02514447|454347701|FG002|Overall Study|Sponsor Termination of Study|1|||
126289644|NCT02514447|454347702|FG003|Overall Study|Sponsor Termination of Study|0|||
126042000|NCT04304144|453453040|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
126042001|NCT04304144|453453041|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
126042002|NCT04304144|453453038|FG000|Continued Treatment Period|Other than specified|2|||
126042003|NCT04304144|453453039|FG001|Continued Treatment Period|Other than specified|0|||
126042004|NCT04304144|453453040|FG002|Continued Treatment Period|Other than specified|1|||
126042005|NCT04304144|453453041|FG003|Continued Treatment Period|Other than specified|1|||
126042006|NCT04615273|453453044|FG000|Overall Study|Withdrawal by Subject|3|||
126042007|NCT04615273|453453045|FG001|Overall Study|Withdrawal by Subject|1|||
126042008|NCT04615273|453453046|FG002|Overall Study|Withdrawal by Subject|2|||
126042009|NCT04615273|453453044|FG000|Overall Study|Adverse Event|1|||
126042010|NCT04615273|453453045|FG001|Overall Study|Adverse Event|0|||
126042011|NCT04615273|453453046|FG002|Overall Study|Adverse Event|1|||
126042012|NCT04615273|453453044|FG000|Overall Study|Lost to Follow-up|0|||
126042013|NCT04615273|453453045|FG001|Overall Study|Lost to Follow-up|1|||
126042014|NCT04615273|453453046|FG002|Overall Study|Lost to Follow-up|0|||
126042015|NCT04615273|453453044|FG000|Overall Study|Physician Decision|0|||
126042016|NCT04615273|453453045|FG001|Overall Study|Physician Decision|0|||
126289645|NCT02514447|454347703|FG004|Overall Study|Sponsor Termination of Study|0|||
126289646|NCT02514447|454347704|FG005|Overall Study|Sponsor Termination of Study|0|||
126289647|NCT02514447|454347705|FG006|Overall Study|Sponsor Termination of Study|0|||
126289648|NCT02514447|454347706|FG007|Overall Study|Sponsor Termination of Study|0|||
126289649|NCT02514447|454347707|FG008|Overall Study|Sponsor Termination of Study|0|||
126289650|NCT02514447|454347699|FG000|Overall Study|Study completion per Investigator|1|||
126289651|NCT02514447|454347700|FG001|Overall Study|Study completion per Investigator|0|||
126289652|NCT02514447|454347701|FG002|Overall Study|Study completion per Investigator|1|||
126289653|NCT02514447|454347702|FG003|Overall Study|Study completion per Investigator|2|||
126289654|NCT02514447|454347703|FG004|Overall Study|Study completion per Investigator|0|||
126289655|NCT02514447|454347704|FG005|Overall Study|Study completion per Investigator|0|||
126289656|NCT02514447|454347705|FG006|Overall Study|Study completion per Investigator|0|||
126289657|NCT02514447|454347706|FG007|Overall Study|Study completion per Investigator|0|||
126289658|NCT02514447|454347707|FG008|Overall Study|Study completion per Investigator|1|||
126289659|NCT04903288|454347708|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
126289660|NCT04903288|454347708|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
126289661|NCT04903288|454347708|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
126289662|NCT04903288|454347708|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
126289663|NCT04776148|454347709|FG000|Overall Study|Death|249|||
126289664|NCT04776148|454347710|FG001|Overall Study|Death|260|||
126289665|NCT04776148|454347709|FG000|Overall Study|Lost to Follow-up|0|||
126289666|NCT04776148|454347710|FG001|Overall Study|Lost to Follow-up|1|||
126289667|NCT04776148|454347709|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126289668|NCT04776148|454347710|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126289669|NCT04776148|454347709|FG000|Overall Study|Withdrawal by Subject|3|||
126289670|NCT04776148|454347710|FG001|Overall Study|Withdrawal by Subject|4|||
126289671|NCT04776148|454347709|FG000|Overall Study|Sponsor Decision|30|||
126289672|NCT04776148|454347710|FG001|Overall Study|Sponsor Decision|15|||
126289673|NCT05109611|454347715|FG000|Overall Study|Adverse Event|13|||
126289674|NCT05109611|454347716|FG001|Overall Study|Adverse Event|10|||
126289675|NCT05109611|454347715|FG000|Overall Study|Withdrawal by Subject|1|||
126289676|NCT05109611|454347716|FG001|Overall Study|Withdrawal by Subject|0|||
126289677|NCT05109611|454347715|FG000|Overall Study|Lost to Follow-up|1|||
126289678|NCT05109611|454347716|FG001|Overall Study|Lost to Follow-up|2|||
126289679|NCT05109611|454347715|FG000|Overall Study|Protocol Violation|0|||
126289680|NCT05109611|454347716|FG001|Overall Study|Protocol Violation|4|||
126289681|NCT05109611|454347715|FG000|Overall Study|Information unavailable|1|||
126289682|NCT05109611|454347716|FG001|Overall Study|Information unavailable|1|||
126289683|NCT05626231|454347717|FG000|Provider Enrollment|Worked part-time|4|||
126289684|NCT05626231|454347717|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
126289685|NCT05626231|454347717|FG000|Provider Enrollment|Non-clinical employee|1|||
126289686|NCT05626231|454347717|FG000|Provider Enrollment|Provider does not see clients|3|||
126289687|NCT05626231|454347717|FG000|Provider Enrollment|Other|5|||
126289688|NCT04995029|454347718|FG000|Induction Phase|Did not meet eligibility criteria|5|||
126289689|NCT04995029|454347719|FG001|Induction Phase|Did not meet eligibility criteria|2|||
126042017|NCT04615273|453453046|FG002|Overall Study|Physician Decision|1|||
126289690|NCT04995029|454347720|FG002|Induction Phase|Did not meet eligibility criteria|0|||
126289691|NCT04995029|454347721|FG003|Induction Phase|Did not meet eligibility criteria|0|||
126289692|NCT04995029|454347718|FG000|Induction Phase|Withdrawal by Subject|85|||
126289693|NCT04995029|454347719|FG001|Induction Phase|Withdrawal by Subject|42|||
126289694|NCT04995029|454347720|FG002|Induction Phase|Withdrawal by Subject|0|||
126042018|NCT04615273|453453044|FG000|Overall Study|Other|0|||
126042019|NCT04615273|453453045|FG001|Overall Study|Other|1|||
126042020|NCT04615273|453453046|FG002|Overall Study|Other|0|||
126289695|NCT04995029|454347721|FG003|Induction Phase|Withdrawal by Subject|0|||
126289696|NCT04995029|454347718|FG000|Induction Phase|Lost to Follow-up|103|||
126289697|NCT04995029|454347719|FG001|Induction Phase|Lost to Follow-up|67|||
126289698|NCT04995029|454347720|FG002|Induction Phase|Lost to Follow-up|0|||
126289699|NCT04995029|454347721|FG003|Induction Phase|Lost to Follow-up|0|||
126289700|NCT04995029|454347718|FG000|Induction Phase|Adverse Event|5|||
126289701|NCT04995029|454347719|FG001|Induction Phase|Adverse Event|3|||
126289702|NCT04995029|454347720|FG002|Induction Phase|Adverse Event|0|||
126289703|NCT04995029|454347721|FG003|Induction Phase|Adverse Event|0|||
126289704|NCT04995029|454347718|FG000|Induction Phase|Physician Decision|11|||
126289705|NCT04995029|454347719|FG001|Induction Phase|Physician Decision|8|||
126289706|NCT04995029|454347720|FG002|Induction Phase|Physician Decision|0|||
126289707|NCT04995029|454347721|FG003|Induction Phase|Physician Decision|0|||
126289708|NCT04995029|454347718|FG000|Induction Phase|Incarceration|6|||
126289709|NCT04995029|454347719|FG001|Induction Phase|Incarceration|3|||
126289710|NCT04995029|454347720|FG002|Induction Phase|Incarceration|0|||
126289711|NCT04995029|454347721|FG003|Induction Phase|Incarceration|0|||
126289712|NCT04995029|454347718|FG000|Induction Phase|Not otherwise described|5|||
126042021|NCT04615273|453453044|FG000|Overall Study|Randomized but not treated|1|||
126042022|NCT04615273|453453045|FG001|Overall Study|Randomized but not treated|3|||
126289713|NCT04995029|454347719|FG001|Induction Phase|Not otherwise described|5|||
126289714|NCT04995029|454347720|FG002|Induction Phase|Not otherwise described|0|||
126289715|NCT04995029|454347721|FG003|Induction Phase|Not otherwise described|0|||
126289716|NCT04995029|454347718|FG000|Maintenance Phase|Lost to Follow-up|0|||
126289717|NCT04995029|454347719|FG001|Maintenance Phase|Lost to Follow-up|0|||
126289718|NCT04995029|454347720|FG002|Maintenance Phase|Lost to Follow-up|51|||
126289719|NCT04995029|454347721|FG003|Maintenance Phase|Lost to Follow-up|44|||
126289720|NCT04995029|454347718|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
126289721|NCT04995029|454347719|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
126289722|NCT04995029|454347720|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
126289723|NCT04995029|454347721|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
126289724|NCT04995029|454347718|FG000|Maintenance Phase|Adverse Event|0|||
126289725|NCT04995029|454347719|FG001|Maintenance Phase|Adverse Event|0|||
126289726|NCT04995029|454347720|FG002|Maintenance Phase|Adverse Event|0|||
126289727|NCT04995029|454347721|FG003|Maintenance Phase|Adverse Event|1|||
126289728|NCT04995029|454347718|FG000|Maintenance Phase|Physician Decision|0|||
126289729|NCT04995029|454347719|FG001|Maintenance Phase|Physician Decision|0|||
126289730|NCT04995029|454347720|FG002|Maintenance Phase|Physician Decision|8|||
126289731|NCT04995029|454347721|FG003|Maintenance Phase|Physician Decision|4|||
126289732|NCT04995029|454347718|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126289733|NCT04995029|454347719|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126289734|NCT04995029|454347720|FG002|Maintenance Phase|Withdrawal by Subject|17|||
126289735|NCT04995029|454347721|FG003|Maintenance Phase|Withdrawal by Subject|31|||
126289736|NCT04995029|454347718|FG000|Maintenance Phase|Incarceration|0|||
126289737|NCT04995029|454347719|FG001|Maintenance Phase|Incarceration|0|||
126289738|NCT04995029|454347720|FG002|Maintenance Phase|Incarceration|4|||
126042023|NCT04615273|453453046|FG002|Overall Study|Randomized but not treated|1|||
126042024|NCT03673501|453453052|FG000|Overall Study|Participants ongoing.|36|||
126042025|NCT03673501|453453053|FG001|Overall Study|Participants ongoing.|24|||
126042026|NCT04599634|453453054|FG000|Overall Study|Dose limiting toxicity|0|||
126042027|NCT04599634|453453055|FG001|Overall Study|Dose limiting toxicity|0|||
126042028|NCT04599634|453453056|FG002|Overall Study|Dose limiting toxicity|2|||
126042029|NCT04599634|453453057|FG003|Overall Study|Dose limiting toxicity|0|||
126042030|NCT03714815|453453058|FG000|Overall Study|Physician Decision|2|||
126042031|NCT03714815|453453058|FG000|Overall Study|Withdrawal by Subject|2|||
126042032|NCT03714815|453453058|FG000|Overall Study|Death|11|||
126042033|NCT01314105|453453062|FG000|Overall Study|Progressive Disease|6|||
126042034|NCT01314105|453453063|FG001|Overall Study|Progressive Disease|10|||
126042035|NCT01314105|453453062|FG000|Overall Study|Refused to continue taking medication|0|||
126042036|NCT01314105|453453063|FG001|Overall Study|Refused to continue taking medication|1|||
126289739|NCT04995029|454347721|FG003|Maintenance Phase|Incarceration|3|||
126289740|NCT04995029|454347718|FG000|Maintenance Phase|Not otherwise described|0|||
126289741|NCT04995029|454347719|FG001|Maintenance Phase|Not otherwise described|0|||
126289742|NCT04995029|454347720|FG002|Maintenance Phase|Not otherwise described|2|||
126289743|NCT04995029|454347721|FG003|Maintenance Phase|Not otherwise described|3|||
126289744|NCT04995029|454347718|FG000|Maintenance Phase|Pregnancy|0|||
126289745|NCT04995029|454347719|FG001|Maintenance Phase|Pregnancy|0|||
126289746|NCT04995029|454347720|FG002|Maintenance Phase|Pregnancy|2|||
126289747|NCT04995029|454347721|FG003|Maintenance Phase|Pregnancy|2|||
126289748|NCT03690388|454347722|FG000|Overall Study|Adverse Event|8|||
126289749|NCT03690388|454347723|FG001|Overall Study|Adverse Event|1|||
126289750|NCT03690388|454347722|FG000|Overall Study|Radiographic Progression|14|||
126289751|NCT03690388|454347723|FG001|Overall Study|Radiographic Progression|29|||
126365896|NCT00425555|454634258|FG000|Overall Study|Lost to Follow-up|0|||
126042037|NCT01314105|453453062|FG000|Overall Study|Other Adverse Event|1|||
126042038|NCT01314105|453453063|FG001|Overall Study|Other Adverse Event|1|||
126042039|NCT06106022|453453064|FG000|Overall Study|Lost to Follow-up|1|||
126099996|NCT05087979|453659795|FG000|Overall Study|Converted to general anesthesia|1|||
126289752|NCT03690388|454347722|FG000|Overall Study|Clinical deterioration|10|||
126289753|NCT03690388|454347723|FG001|Overall Study|Clinical deterioration|6|||
126365897|NCT00425555|454634259|FG001|Overall Study|Lost to Follow-up|1|||
125883121|NCT00463567|452871417|FG002|Overall Study|Protocol Deviation|14|||
125883122|NCT00463567|452871418|FG003|Overall Study|Protocol Deviation|11|||
125883123|NCT00463567|452871419|FG004|Overall Study|Protocol Deviation|1|||
125883124|NCT00463567|452871420|FG005|Overall Study|Protocol Deviation|1|||
125883125|NCT00463567|452871421|FG006|Overall Study|Protocol Deviation|2|||
125883126|NCT00463567|452871415|FG000|Overall Study|Lost to Follow-up|12|||
125883127|NCT00463567|452871416|FG001|Overall Study|Lost to Follow-up|6|||
125883128|NCT00463567|452871417|FG002|Overall Study|Lost to Follow-up|13|||
126289754|NCT03690388|454347722|FG000|Overall Study|Withdrawal by Subject|2|||
126289755|NCT03690388|454347723|FG001|Overall Study|Withdrawal by Subject|0|||
126289756|NCT03690388|454347722|FG000|Overall Study|Lack of Efficacy|1|||
126289757|NCT03690388|454347723|FG001|Overall Study|Lack of Efficacy|0|||
126289758|NCT03690388|454347722|FG000|Overall Study|Lost to Follow-up|1|||
126289759|NCT03690388|454347723|FG001|Overall Study|Lost to Follow-up|0|||
126289760|NCT01842438|454347729|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
126289761|NCT01842438|454347730|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
126289762|NCT01842438|454347729|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
126289763|NCT01842438|454347730|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
126289764|NCT01842438|454347729|FG000|T2: 6month Follow-up|Death|0|||
126289765|NCT01842438|454347730|FG001|T2: 6month Follow-up|Death|1|||
126289766|NCT04909853|454347731|FG000|Part 1|Assigned but not treated|0|||
126289767|NCT04909853|454347732|FG001|Part 1|Assigned but not treated|0|||
126289768|NCT04909853|454347733|FG002|Part 1|Assigned but not treated|1|||
126289769|NCT04909853|454347734|FG003|Part 1|Assigned but not treated|0|||
126289770|NCT04909853|454347731|FG000|Part 2|Adverse Event|0|||
126289771|NCT04909853|454347732|FG001|Part 2|Adverse Event|0|||
126289772|NCT04909853|454347733|FG002|Part 2|Adverse Event|0|||
126289773|NCT04909853|454347734|FG003|Part 2|Adverse Event|1|||
126289774|NCT04054765|454347735|FG000|Baseline|Withdrawal by Subject|5|||
126289775|NCT04054765|454347736|FG001|Baseline|Withdrawal by Subject|3|||
126289776|NCT04054765|454347735|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
126289777|NCT04054765|454347736|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
126289778|NCT04054765|454347735|FG000|3-month Follow up|Withdrawal by Subject|0|||
126289779|NCT04054765|454347736|FG001|3-month Follow up|Withdrawal by Subject|3|||
126365898|NCT00425555|454634258|FG000|Overall Study|Administrative problems|3|||
126365899|NCT00425555|454634259|FG001|Overall Study|Administrative problems|0|||
126365900|NCT00425555|454634258|FG000|Overall Study|Death|1|||
126365901|NCT00425555|454634259|FG001|Overall Study|Death|2|||
126365902|NCT00425555|454634258|FG000|Overall Study|New cancer therapy|2|||
126365903|NCT00425555|454634259|FG001|Overall Study|New cancer therapy|1|||
126365904|NCT00425555|454634258|FG000|Overall Study|Disease progression|36|||
126365905|NCT00425555|454634259|FG001|Overall Study|Disease progression|33|||
126365906|NCT00425555|454634258|FG000|Overall Study|Adverse Event|25|||
126365907|NCT00425555|454634259|FG001|Overall Study|Adverse Event|15|||
126365908|NCT00425555|454634258|FG000|Overall Study|Protocol Violation|1|||
126365909|NCT00425555|454634259|FG001|Overall Study|Protocol Violation|0|||
126365910|NCT05763381|454634260|FG000|Overall Study|Lost to Follow-up|2|||
126365911|NCT05763381|454634261|FG001|Overall Study|Lost to Follow-up|3|||
126365912|NCT05763381|454634260|FG000|Overall Study|Withdrawal by Subject|1|||
126365913|NCT05763381|454634261|FG001|Overall Study|Withdrawal by Subject|2|||
126365914|NCT01674062|454634262|FG000|Overall Study|Insufficient Therapeutic Response|56|||
126365915|NCT01674062|454634263|FG001|Overall Study|Insufficient Therapeutic Response|26|||
126365916|NCT01674062|454634262|FG000|Overall Study|Other|8|||
126365917|NCT01674062|454634263|FG001|Overall Study|Other|1|||
126365918|NCT01674062|454634262|FG000|Overall Study|Adverse Event|1|||
126365919|NCT01674062|454634263|FG001|Overall Study|Adverse Event|1|||
126365920|NCT01674062|454634262|FG000|Overall Study|Death|0|||
126365921|NCT01674062|454634263|FG001|Overall Study|Death|1|||
126365922|NCT01674062|454634262|FG000|Overall Study|Programming Error|1|||
126365923|NCT01674062|454634263|FG001|Overall Study|Programming Error|0|||
126365924|NCT01443026|454634267|FG000|Overall Study|Physician Decision|1|||
126365925|NCT01443026|454634268|FG001|Overall Study|Physician Decision|0|||
126365926|NCT01443026|454634267|FG000|Overall Study|Death|0|||
126365927|NCT01443026|454634268|FG001|Overall Study|Death|1|||
126365928|NCT01443026|454634267|FG000|Overall Study|Withdrawal by Subject|0|||
126365929|NCT01443026|454634268|FG001|Overall Study|Withdrawal by Subject|3|||
126289780|NCT04054765|454347735|FG000|6-month Follow up|Lost to Follow-up|32|||
126289781|NCT04054765|454347736|FG001|6-month Follow up|Lost to Follow-up|32|||
126289782|NCT00077207|454347737|FG000|Overall Study|Adverse Event|5|||
126289783|NCT00077207|454347737|FG000|Overall Study|Lack of Efficacy|12|||
126289784|NCT00077207|454347737|FG000|Overall Study|Physician Decision|6|||
126365930|NCT01443026|454634267|FG000|Overall Study|Lost to Follow-up|2|||
126365931|NCT01443026|454634268|FG001|Overall Study|Lost to Follow-up|1|||
125883129|NCT00463567|452871418|FG003|Overall Study|Lost to Follow-up|8|||
126289785|NCT00077207|454347737|FG000|Overall Study|Withdrawal by Subject|6|||
125883130|NCT00463567|452871419|FG004|Overall Study|Lost to Follow-up|1|||
126289786|NCT00077207|454347737|FG000|Overall Study|Ineligible|1|||
126365932|NCT00581919|454634269|FG000|Overall Study|Adverse Event|8|||
126365933|NCT00581919|454634269|FG000|Overall Study|Death|1|||
126365934|NCT00581919|454634269|FG000|Overall Study|Disease Progression|10|||
126042040|NCT06106022|453453065|FG001|Overall Study|Lost to Follow-up|0|||
126042041|NCT06106022|453453064|FG000|Overall Study|Voluntary Withdrawal|0|||
126042042|NCT06106022|453453065|FG001|Overall Study|Voluntary Withdrawal|2|||
126289787|NCT00666328|454347738|FG000|Overall Study|Death|2|||
126289788|NCT00666328|454347738|FG000|Overall Study|Lost to Follow-up|2|||
126289789|NCT00666328|454347738|FG000|Overall Study|No longer met eligibility criteria|1|||
126289790|NCT05064397|454347739|FG000|Overall Study|Adverse Event|4|||
126289791|NCT05064397|454347739|FG000|Overall Study|Lack of Efficacy|12|||
126289792|NCT05064397|454347739|FG000|Overall Study|Withdrawal by Subject|3|||
126289793|NCT05064397|454347739|FG000|Overall Study|Lost to Follow-up|1|||
126289794|NCT05064397|454347739|FG000|Overall Study|Other reasons|3|||
126289795|NCT02232984|454347740|FG000|Overall Study|Withdrawal by Subject|5|||
126289796|NCT02232984|454347740|FG000|Overall Study|Death|1|||
126289797|NCT02232984|454347740|FG000|Overall Study|Investigator withdrawal|10|||
126289798|NCT02232984|454347740|FG000|Overall Study|Device implant unsuccessful|53|||
126289799|NCT02232984|454347740|FG000|Overall Study|not disclosed by site|7|||
126289800|NCT02232984|454347740|FG000|Overall Study|Protocol Violation|1|||
126289801|NCT00535405|454347743|FG000|Overall Study|Adverse Event|6|||
126289802|NCT00535405|454347744|FG001|Overall Study|Adverse Event|8|||
126289803|NCT00535405|454347745|FG002|Overall Study|Adverse Event|3|||
126289804|NCT00535405|454347746|FG003|Overall Study|Adverse Event|8|||
126289805|NCT00535405|454347747|FG004|Overall Study|Adverse Event|6|||
126289806|NCT00535405|454347743|FG000|Overall Study|Lost to Follow-up|1|||
126289807|NCT00535405|454347744|FG001|Overall Study|Lost to Follow-up|3|||
126289808|NCT00535405|454347745|FG002|Overall Study|Lost to Follow-up|3|||
126289809|NCT00535405|454347746|FG003|Overall Study|Lost to Follow-up|2|||
126289810|NCT00535405|454347747|FG004|Overall Study|Lost to Follow-up|1|||
126289811|NCT00535405|454347743|FG000|Overall Study|Physician Decision|3|||
126289812|NCT00535405|454347744|FG001|Overall Study|Physician Decision|2|||
126289813|NCT00535405|454347745|FG002|Overall Study|Physician Decision|0|||
126289814|NCT00535405|454347746|FG003|Overall Study|Physician Decision|1|||
126289815|NCT00535405|454347747|FG004|Overall Study|Physician Decision|1|||
126289816|NCT00535405|454347743|FG000|Overall Study|Protocol Violation|2|||
126289817|NCT00535405|454347744|FG001|Overall Study|Protocol Violation|2|||
126289818|NCT00535405|454347745|FG002|Overall Study|Protocol Violation|2|||
126289819|NCT00535405|454347746|FG003|Overall Study|Protocol Violation|1|||
126289820|NCT00535405|454347747|FG004|Overall Study|Protocol Violation|0|||
126289821|NCT00535405|454347743|FG000|Overall Study|Withdrawal by Subject|5|||
126289822|NCT00535405|454347744|FG001|Overall Study|Withdrawal by Subject|11|||
126289823|NCT00535405|454347745|FG002|Overall Study|Withdrawal by Subject|10|||
126289824|NCT00535405|454347746|FG003|Overall Study|Withdrawal by Subject|10|||
126289825|NCT00535405|454347747|FG004|Overall Study|Withdrawal by Subject|8|||
126289826|NCT03404674|454347748|FG000|Overall Study|Inability to Attend Future Visits|0|||
126289827|NCT03404674|454347749|FG001|Overall Study|Inability to Attend Future Visits|1|||
126289828|NCT03404674|454347750|FG002|Overall Study|Inability to Attend Future Visits|1|||
126289829|NCT03404674|454347751|FG003|Overall Study|Inability to Attend Future Visits|0|||
126289830|NCT03404674|454347752|FG004|Overall Study|Inability to Attend Future Visits|0|||
126289831|NCT03404674|454347753|FG005|Overall Study|Inability to Attend Future Visits|0|||
126289832|NCT03404674|454347748|FG000|Overall Study|Behavioral Problems|0|||
126289833|NCT03404674|454347749|FG001|Overall Study|Behavioral Problems|0|||
126289834|NCT03404674|454347750|FG002|Overall Study|Behavioral Problems|1|||
126289835|NCT03404674|454347751|FG003|Overall Study|Behavioral Problems|0|||
126365935|NCT00581919|454634269|FG000|Overall Study|Physician Decision|1|||
126365936|NCT00581919|454634269|FG000|Overall Study|Other Complicating Disease|1|||
126365937|NCT00581919|454634269|FG000|Overall Study|Started Non-Protocol Therapy|2|||
126365938|NCT00581919|454634269|FG000|Overall Study|Withdrawal by Subject|1|||
126365939|NCT02655601|454634270|FG000|Overall Study|Adverse Event|0|||
126365940|NCT02655601|454634271|FG001|Overall Study|Adverse Event|0|||
126365941|NCT02655601|454634272|FG002|Overall Study|Adverse Event|0|||
126365942|NCT02655601|454634273|FG003|Overall Study|Adverse Event|1|||
126365943|NCT02655601|454634274|FG004|Overall Study|Adverse Event|1|||
126365944|NCT02655601|454634275|FG005|Overall Study|Adverse Event|0|||
126365945|NCT02655601|454634270|FG000|Overall Study|Physician Decision|0|||
126365946|NCT02655601|454634271|FG001|Overall Study|Physician Decision|0|||
126365947|NCT02655601|454634272|FG002|Overall Study|Physician Decision|0|||
126365948|NCT02655601|454634273|FG003|Overall Study|Physician Decision|0|||
126365949|NCT02655601|454634274|FG004|Overall Study|Physician Decision|1|||
126365950|NCT02655601|454634275|FG005|Overall Study|Physician Decision|1|||
126365951|NCT02655601|454634270|FG000|Overall Study|Withdrawal by Subject|0|||
126365952|NCT02655601|454634271|FG001|Overall Study|Withdrawal by Subject|0|||
126365953|NCT02655601|454634272|FG002|Overall Study|Withdrawal by Subject|0|||
126365954|NCT02655601|454634273|FG003|Overall Study|Withdrawal by Subject|0|||
126365955|NCT02655601|454634274|FG004|Overall Study|Withdrawal by Subject|4|||
126365956|NCT02655601|454634275|FG005|Overall Study|Withdrawal by Subject|8|||
126365957|NCT02655601|454634270|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
126365958|NCT02655601|454634271|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365959|NCT02655601|454634272|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365960|NCT02655601|454634273|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365961|NCT02655601|454634274|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365962|NCT02655601|454634275|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365963|NCT03829683|454634280|FG000|Overall Study|Lost to Follow-up|1|||
126365964|NCT03829683|454634281|FG001|Overall Study|Lost to Follow-up|0|||
126365965|NCT03829683|454634280|FG000|Overall Study|Physician Decision|3|||
126365966|NCT03829683|454634281|FG001|Overall Study|Physician Decision|1|||
126365967|NCT03829683|454634280|FG000|Overall Study|Withdrawal by Subject|0|||
126365968|NCT03829683|454634281|FG001|Overall Study|Withdrawal by Subject|1|||
126365969|NCT03829683|454634280|FG000|Overall Study|Discharge from hospital|1|||
126365970|NCT03829683|454634281|FG001|Overall Study|Discharge from hospital|0|||
126365971|NCT02796651|454634285|FG000|Overall Study|Adverse Event|6|||
126365972|NCT02796651|454634285|FG000|Overall Study|Lost to Follow-up|1|||
126365973|NCT02796651|454634285|FG000|Overall Study|Withdrawal by Subject|4|||
126365974|NCT02796651|454634285|FG000|Overall Study|Protocol Violation|4|||
126365975|NCT02796651|454634285|FG000|Overall Study|Lack of Efficacy|1|||
126365976|NCT02796651|454634285|FG000|Overall Study|Other|10|||
126365977|NCT05430919|454634289|FG000|Overall Study|Protocol Violation|0|||
126365978|NCT05430919|454634290|FG001|Overall Study|Protocol Violation|0|||
126365979|NCT05430919|454634291|FG002|Overall Study|Protocol Violation|1|||
126365980|NCT05430919|454634292|FG003|Overall Study|Protocol Violation|0|||
126365981|NCT05430919|454634289|FG000|Overall Study|Lost to Follow-up|0|||
126365982|NCT05430919|454634290|FG001|Overall Study|Lost to Follow-up|1|||
126365983|NCT05430919|454634291|FG002|Overall Study|Lost to Follow-up|0|||
126365984|NCT05430919|454634292|FG003|Overall Study|Lost to Follow-up|0|||
126365985|NCT05430919|454634289|FG000|Overall Study|Withdrawal by Subject|3|||
126365986|NCT05430919|454634290|FG001|Overall Study|Withdrawal by Subject|0|||
126365987|NCT05430919|454634291|FG002|Overall Study|Withdrawal by Subject|0|||
126365988|NCT05430919|454634292|FG003|Overall Study|Withdrawal by Subject|1|||
126365989|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
126365990|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
126365991|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
126365992|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
126365993|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
126365994|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
126365995|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
126365996|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
126365997|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
126365998|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
126365999|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
126366000|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
126366001|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
126366002|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
126366003|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
126289836|NCT03404674|454347752|FG004|Overall Study|Behavioral Problems|0|||
126289837|NCT03404674|454347753|FG005|Overall Study|Behavioral Problems|0|||
126289838|NCT03404674|454347748|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
126289839|NCT03404674|454347749|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
126289840|NCT03404674|454347750|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
126289841|NCT03404674|454347751|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
126289842|NCT03404674|454347752|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
126289843|NCT03404674|454347753|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
126366004|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
126366005|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
126366006|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
126366007|NCT05014919|454634293|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
126366008|NCT05014919|454634294|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
126366009|NCT05014919|454634295|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
126366010|NCT05014919|454634293|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
126366011|NCT05014919|454634294|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
126366012|NCT05014919|454634295|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
126366013|NCT02971163|454634298|FG000|Overall Study|Lost to Follow-up|4|||
126366014|NCT02971163|454634299|FG001|Overall Study|Lost to Follow-up|2|||
126366015|NCT01491919|454634300|FG000|Overall Study|Insufficient PK sampling|1|||
126289844|NCT04728802|454347758|FG000|Overall Study|Withdrawal by Subject|4|||
126289845|NCT04728802|454347759|FG001|Overall Study|Withdrawal by Subject|20|||
126289846|NCT04728802|454347758|FG000|Overall Study|Physician Decision|7|||
126289847|NCT04728802|454347759|FG001|Overall Study|Physician Decision|7|||
126289848|NCT04728802|454347758|FG000|Overall Study|Protocol Violation|10|||
126289849|NCT04728802|454347759|FG001|Overall Study|Protocol Violation|4|||
126289850|NCT04728802|454347758|FG000|Overall Study|Transfer|1|||
126289851|NCT04728802|454347759|FG001|Overall Study|Transfer|0|||
126289852|NCT04728802|454347758|FG000|Overall Study|Death|4|||
126289853|NCT04728802|454347759|FG001|Overall Study|Death|5|||
126289854|NCT04728802|454347758|FG000|Overall Study|Other|3|||
126289855|NCT04728802|454347759|FG001|Overall Study|Other|0|||
126289856|NCT01176513|454347760|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
126289857|NCT03164616|454347764|FG000|Overall Study|Death|250|||
126289858|NCT03164616|454347765|FG001|Overall Study|Death|264|||
126289859|NCT03164616|454347766|FG002|Overall Study|Death|279|||
126289860|NCT03164616|454347764|FG000|Overall Study|Lost to Follow-up|2|||
126289861|NCT03164616|454347765|FG001|Overall Study|Lost to Follow-up|2|||
126289862|NCT03164616|454347766|FG002|Overall Study|Lost to Follow-up|2|||
126289863|NCT03164616|454347764|FG000|Overall Study|Withdrawal by Subject|6|||
126289864|NCT03164616|454347765|FG001|Overall Study|Withdrawal by Subject|7|||
126289865|NCT03164616|454347766|FG002|Overall Study|Withdrawal by Subject|16|||
126289866|NCT00489255|454347778|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
126289867|NCT00489255|454347779|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
126289868|NCT00489255|454347778|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
126289869|NCT00489255|454347779|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
126289870|NCT00489255|454347778|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
126289871|NCT00489255|454347779|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
126289872|NCT00489255|454347778|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
126289873|NCT00489255|454347779|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
126289874|NCT00489255|454347778|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
126289875|NCT00489255|454347779|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
126289876|NCT00489255|454347778|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
126289877|NCT00489255|454347779|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
126289878|NCT00489255|454347778|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
126289879|NCT00489255|454347779|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
126289880|NCT00489255|454347778|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
126289881|NCT00489255|454347779|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
126289882|NCT00489255|454347778|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
126289883|NCT00489255|454347779|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
126289884|NCT00489255|454347778|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
126289885|NCT00489255|454347779|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
126289886|NCT06018129|454347782|FG000|Overall Study|Death|1|||
126289887|NCT06018129|454347783|FG001|Overall Study|Death|1|||
126289888|NCT06018129|454347784|FG002|Overall Study|Death|2|||
126289889|NCT06018129|454347782|FG000|Overall Study|Sponsor Decision|2|||
126289890|NCT06018129|454347783|FG001|Overall Study|Sponsor Decision|2|||
126289891|NCT06018129|454347784|FG002|Overall Study|Sponsor Decision|1|||
126289892|NCT01959295|454347785|FG000|Overall Study|Adverse Event|2|||
126289893|NCT01959295|454347786|FG001|Overall Study|Adverse Event|0|||
126289894|NCT01959295|454347785|FG000|Overall Study|Lost to Follow-up|0|||
126289895|NCT01959295|454347786|FG001|Overall Study|Lost to Follow-up|2|||
126289896|NCT01959295|454347785|FG000|Overall Study|Physician Decision|2|||
126289897|NCT01959295|454347786|FG001|Overall Study|Physician Decision|3|||
126289898|NCT01959295|454347785|FG000|Overall Study|Protocol Violation|16|||
126289899|NCT01959295|454347786|FG001|Overall Study|Protocol Violation|5|||
126289900|NCT01959295|454347785|FG000|Overall Study|Withdrawal by Subject|3|||
126289901|NCT01959295|454347786|FG001|Overall Study|Withdrawal by Subject|1|||
126289902|NCT01959295|454347785|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
126289903|NCT01959295|454347786|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
126289904|NCT04917861|454347788|FG000|Main Study (196 Days)|Adverse Event|0|||
126289905|NCT04917861|454347789|FG001|Main Study (196 Days)|Adverse Event|1|||
126289906|NCT04917861|454347790|FG002|Main Study (196 Days)|Adverse Event|0|||
126289907|NCT04917861|454347791|FG003|Main Study (196 Days)|Adverse Event|0|||
126289908|NCT04917861|454347788|FG000|Main Study (196 Days)|Death|0|||
126289909|NCT04917861|454347789|FG001|Main Study (196 Days)|Death|0|||
126289910|NCT04917861|454347790|FG002|Main Study (196 Days)|Death|0|||
126289911|NCT04917861|454347791|FG003|Main Study (196 Days)|Death|1|||
126289912|NCT04917861|454347788|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
126289913|NCT04917861|454347789|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
126289914|NCT04917861|454347790|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
126289915|NCT04917861|454347791|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
126289916|NCT04917861|454347788|FG000|Main Study (196 Days)|Physician Decision|0|||
126289917|NCT04917861|454347789|FG001|Main Study (196 Days)|Physician Decision|0|||
126289918|NCT04917861|454347790|FG002|Main Study (196 Days)|Physician Decision|0|||
126289919|NCT04917861|454347791|FG003|Main Study (196 Days)|Physician Decision|1|||
126289920|NCT04917861|454347788|FG000|Main Study (196 Days)|Pregnancy|1|||
126289921|NCT04917861|454347789|FG001|Main Study (196 Days)|Pregnancy|1|||
126289922|NCT04917861|454347790|FG002|Main Study (196 Days)|Pregnancy|0|||
126289923|NCT04917861|454347791|FG003|Main Study (196 Days)|Pregnancy|0|||
126289924|NCT04917861|454347788|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
126289925|NCT04917861|454347789|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
126289926|NCT04917861|454347790|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
126289927|NCT04917861|454347791|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
126289928|NCT04917861|454347788|FG000|Main Study (196 Days)|Other Than Specified|1|||
126289929|NCT04917861|454347789|FG001|Main Study (196 Days)|Other Than Specified|0|||
126289930|NCT04917861|454347790|FG002|Main Study (196 Days)|Other Than Specified|1|||
126289931|NCT04917861|454347791|FG003|Main Study (196 Days)|Other Than Specified|2|||
126289932|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
126289933|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
126289934|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
126289935|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
126289936|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
126289937|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
126289938|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
126289939|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
126289940|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
126289941|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
126289942|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
126289943|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
126289944|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
126289945|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
126289946|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
126289947|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
126289948|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
126289949|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
126289950|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
126289951|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
126289952|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
126289953|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
126289954|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
126289955|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
126289956|NCT06389487|454347792|FG000|Overall Study|Lost to Follow-up|9|||
126289957|NCT06389487|454347793|FG001|Overall Study|Lost to Follow-up|5|||
126289958|NCT06389487|454347794|FG002|Overall Study|Lost to Follow-up|13|||
126289959|NCT06389487|454347792|FG000|Overall Study|Protocol Violation|0|||
126289960|NCT06389487|454347793|FG001|Overall Study|Protocol Violation|0|||
126289961|NCT06389487|454347794|FG002|Overall Study|Protocol Violation|2|||
126289962|NCT06389487|454347792|FG000|Overall Study|Withdrawal by Subject|2|||
126289963|NCT06389487|454347793|FG001|Overall Study|Withdrawal by Subject|2|||
126289964|NCT06389487|454347794|FG002|Overall Study|Withdrawal by Subject|1|||
126289965|NCT06389487|454347792|FG000|Overall Study|Other|1|||
126289966|NCT06389487|454347793|FG001|Overall Study|Other|0|||
126289967|NCT06389487|454347794|FG002|Overall Study|Other|1|||
126289968|NCT03713593|454348782|FG000|Overall Study|Sponsor Decision|73|||
126289969|NCT03713593|454348783|FG001|Overall Study|Sponsor Decision|41|||
126289970|NCT03713593|454348782|FG000|Overall Study|Lost to Follow-up|2|||
126289971|NCT03713593|454348783|FG001|Overall Study|Lost to Follow-up|1|||
126289972|NCT03713593|454348782|FG000|Overall Study|Death|314|||
126289973|NCT03713593|454348783|FG001|Overall Study|Death|349|||
126289974|NCT03713593|454348782|FG000|Overall Study|Withdrawal by Subject|6|||
126289975|NCT03713593|454348783|FG001|Overall Study|Withdrawal by Subject|8|||
126289976|NCT03130777|454348784|FG000|Overall Study|Death|0|||
126289977|NCT03130777|454348785|FG001|Overall Study|Death|1|||
126289978|NCT03130777|454348784|FG000|Overall Study|Did not meet eligibility criteria|1|||
126289979|NCT03130777|454348785|FG001|Overall Study|Did not meet eligibility criteria|0|||
126289980|NCT02498613|454348786|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
126289981|NCT02498613|454348787|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
126289982|NCT02498613|454348788|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
126289983|NCT02498613|454348789|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
126289984|NCT02498613|454348786|FG000|Overall Study|Withdrawal by Subject|3|||
126289985|NCT02498613|454348787|FG001|Overall Study|Withdrawal by Subject|1|||
126289986|NCT02498613|454348788|FG002|Overall Study|Withdrawal by Subject|0|||
126289987|NCT02498613|454348789|FG003|Overall Study|Withdrawal by Subject|0|||
126289988|NCT05168202|454348790|FG000|Overall Study|Progressive Disease|4|||
126289989|NCT05168202|454348791|FG001|Overall Study|Progressive Disease|4|||
126289990|NCT05168202|454348792|FG002|Overall Study|Progressive Disease|2|||
126289991|NCT05168202|454348793|FG003|Overall Study|Progressive Disease|3|||
126289992|NCT05168202|454348794|FG004|Overall Study|Progressive Disease|2|||
126099997|NCT05087979|453659796|FG001|Overall Study|Converted to general anesthesia|0|||
126042043|NCT03276676|453453067|FG000|Overall Study|Withdrawal by Subject|2|||
126042044|NCT03276676|453453068|FG001|Overall Study|Withdrawal by Subject|1|||
126289993|NCT05168202|454348795|FG005|Overall Study|Progressive Disease|3|||
126289994|NCT05168202|454348796|FG006|Overall Study|Progressive Disease|2|||
126289995|NCT05168202|454348790|FG000|Overall Study|Adverse Event|2|||
126289996|NCT05168202|454348791|FG001|Overall Study|Adverse Event|1|||
126289997|NCT05168202|454348792|FG002|Overall Study|Adverse Event|4|||
126289998|NCT05168202|454348793|FG003|Overall Study|Adverse Event|4|||
126289999|NCT05168202|454348794|FG004|Overall Study|Adverse Event|3|||
126290000|NCT05168202|454348795|FG005|Overall Study|Adverse Event|2|||
126290001|NCT05168202|454348796|FG006|Overall Study|Adverse Event|0|||
126290002|NCT05168202|454348790|FG000|Overall Study|Lack of Efficacy|0|||
126290003|NCT05168202|454348791|FG001|Overall Study|Lack of Efficacy|1|||
126290004|NCT05168202|454348792|FG002|Overall Study|Lack of Efficacy|1|||
126290005|NCT05168202|454348793|FG003|Overall Study|Lack of Efficacy|0|||
126290006|NCT05168202|454348794|FG004|Overall Study|Lack of Efficacy|1|||
126290007|NCT05168202|454348795|FG005|Overall Study|Lack of Efficacy|2|||
126290008|NCT05168202|454348796|FG006|Overall Study|Lack of Efficacy|2|||
126290009|NCT05168202|454348790|FG000|Overall Study|Withdrawal by Subject|0|||
126290010|NCT05168202|454348791|FG001|Overall Study|Withdrawal by Subject|0|||
126290011|NCT05168202|454348792|FG002|Overall Study|Withdrawal by Subject|1|||
126290012|NCT05168202|454348793|FG003|Overall Study|Withdrawal by Subject|1|||
126290013|NCT05168202|454348794|FG004|Overall Study|Withdrawal by Subject|1|||
126290014|NCT05168202|454348795|FG005|Overall Study|Withdrawal by Subject|1|||
126290015|NCT05168202|454348796|FG006|Overall Study|Withdrawal by Subject|0|||
126290016|NCT05168202|454348790|FG000|Overall Study|Disease Relapse|0|||
126290017|NCT05168202|454348791|FG001|Overall Study|Disease Relapse|1|||
126290018|NCT05168202|454348792|FG002|Overall Study|Disease Relapse|0|||
126290019|NCT05168202|454348793|FG003|Overall Study|Disease Relapse|1|||
126290020|NCT05168202|454348794|FG004|Overall Study|Disease Relapse|1|||
126290021|NCT05168202|454348795|FG005|Overall Study|Disease Relapse|0|||
126290022|NCT05168202|454348796|FG006|Overall Study|Disease Relapse|0|||
126290023|NCT05168202|454348790|FG000|Overall Study|Other Reasons|0|||
126290024|NCT05168202|454348791|FG001|Overall Study|Other Reasons|0|||
126290025|NCT05168202|454348792|FG002|Overall Study|Other Reasons|0|||
126290026|NCT05168202|454348793|FG003|Overall Study|Other Reasons|0|||
126290027|NCT05168202|454348794|FG004|Overall Study|Other Reasons|0|||
126290028|NCT05168202|454348795|FG005|Overall Study|Other Reasons|2|||
126290029|NCT05168202|454348796|FG006|Overall Study|Other Reasons|1|||
126290030|NCT05168202|454348790|FG000|Overall Study|Physician Decision|0|||
126290031|NCT05168202|454348791|FG001|Overall Study|Physician Decision|1|||
126290032|NCT05168202|454348792|FG002|Overall Study|Physician Decision|1|||
126290033|NCT05168202|454348793|FG003|Overall Study|Physician Decision|0|||
126290034|NCT05168202|454348794|FG004|Overall Study|Physician Decision|0|||
126290035|NCT05168202|454348795|FG005|Overall Study|Physician Decision|0|||
126290036|NCT05168202|454348796|FG006|Overall Study|Physician Decision|0|||
126290037|NCT05168202|454348790|FG000|Overall Study|Study Terminated by Sponsor|0|||
126290038|NCT05168202|454348791|FG001|Overall Study|Study Terminated by Sponsor|0|||
126290039|NCT05168202|454348792|FG002|Overall Study|Study Terminated by Sponsor|0|||
126290040|NCT05168202|454348793|FG003|Overall Study|Study Terminated by Sponsor|1|||
126290041|NCT05168202|454348794|FG004|Overall Study|Study Terminated by Sponsor|0|||
126290042|NCT05168202|454348795|FG005|Overall Study|Study Terminated by Sponsor|0|||
126290043|NCT05168202|454348796|FG006|Overall Study|Study Terminated by Sponsor|0|||
126290044|NCT00001521|454348801|FG000|Overall Study|Withdrawal by Subject|3|||
126290045|NCT00001521|454348802|FG001|Overall Study|Withdrawal by Subject|3|||
126290046|NCT00001521|454348801|FG000|Overall Study|Physician Decision|1|||
126042045|NCT01730937|453453071|FG000|Overall Study|Protocol Violation|5|||
126290047|NCT00001521|454348802|FG001|Overall Study|Physician Decision|1|||
126290048|NCT00001521|454348801|FG000|Overall Study|Noncompliant|6|||
126290049|NCT00001521|454348802|FG001|Overall Study|Noncompliant|3|||
126290050|NCT00970593|454348810|FG000|Overall Study|Adverse Event|1|||
126290051|NCT00970593|454348811|FG001|Overall Study|Adverse Event|1|||
126290052|NCT00970593|454348812|FG002|Overall Study|Adverse Event|0|||
126290053|NCT00970593|454348813|FG003|Overall Study|Adverse Event|0|||
126290054|NCT00970593|454348814|FG004|Overall Study|Adverse Event|0|||
126290055|NCT00970593|454348815|FG005|Overall Study|Adverse Event|0|||
126290056|NCT00970593|454348816|FG006|Overall Study|Adverse Event|0|||
126290057|NCT00970593|454348810|FG000|Overall Study|Discontinuation of study by sponsor|0|||
126290058|NCT00970593|454348811|FG001|Overall Study|Discontinuation of study by sponsor|0|||
126290059|NCT00970593|454348812|FG002|Overall Study|Discontinuation of study by sponsor|5|||
126290060|NCT00970593|454348813|FG003|Overall Study|Discontinuation of study by sponsor|0|||
126290061|NCT00970593|454348814|FG004|Overall Study|Discontinuation of study by sponsor|0|||
126290062|NCT00970593|454348815|FG005|Overall Study|Discontinuation of study by sponsor|0|||
126290063|NCT00970593|454348816|FG006|Overall Study|Discontinuation of study by sponsor|2|||
126290064|NCT00970593|454348810|FG000|Overall Study|Withdrawal by Subject|0|||
126290065|NCT00970593|454348811|FG001|Overall Study|Withdrawal by Subject|0|||
126290066|NCT00970593|454348812|FG002|Overall Study|Withdrawal by Subject|1|||
126290067|NCT00970593|454348813|FG003|Overall Study|Withdrawal by Subject|0|||
126290068|NCT00970593|454348814|FG004|Overall Study|Withdrawal by Subject|0|||
126290069|NCT00970593|454348815|FG005|Overall Study|Withdrawal by Subject|0|||
126290070|NCT00970593|454348816|FG006|Overall Study|Withdrawal by Subject|0|||
126290071|NCT01342081|454348830|FG000|Overall Study|Did not receive allocated intervention|0|||
126290072|NCT01342081|454348831|FG001|Overall Study|Did not receive allocated intervention|0|||
126290073|NCT01342081|454348832|FG002|Overall Study|Did not receive allocated intervention|1|||
126290074|NCT01342081|454348830|FG000|Overall Study|Adverse Event|1|||
126290075|NCT01342081|454348831|FG001|Overall Study|Adverse Event|0|||
126290076|NCT01342081|454348832|FG002|Overall Study|Adverse Event|0|||
126290077|NCT01342081|454348830|FG000|Overall Study|Physician Decision|0|||
126290078|NCT01342081|454348831|FG001|Overall Study|Physician Decision|1|||
126290079|NCT01342081|454348832|FG002|Overall Study|Physician Decision|0|||
126290080|NCT01342081|454348830|FG000|Overall Study|Withdrawal by Subject|1|||
126290081|NCT01342081|454348831|FG001|Overall Study|Withdrawal by Subject|1|||
126290082|NCT01342081|454348832|FG002|Overall Study|Withdrawal by Subject|0|||
126290083|NCT01202175|454348833|FG000|Overall Study|Lost to Follow-up|2|||
126290084|NCT01202175|454348833|FG000|Overall Study|Withdrawal by Subject|1|||
126290085|NCT01202175|454348833|FG000|Overall Study|Adverse Event|2|||
126290086|NCT02790437|454348834|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
126290087|NCT02790437|454348835|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
126290088|NCT02790437|454348834|FG000|Overall Study|Adverse Event|1|||
126290089|NCT02790437|454348835|FG001|Overall Study|Adverse Event|0|||
126290090|NCT02790437|454348834|FG000|Overall Study|Withdrawal by Subject|1|||
126290091|NCT02790437|454348835|FG001|Overall Study|Withdrawal by Subject|0|||
126290092|NCT04720053|454348840|FG000|Overall Study|Lost to Follow-up|12|||
126290093|NCT01942993|454348841|FG000|Overall Study|Lost to Follow-up|1|||
126290094|NCT01942993|454348841|FG000|Overall Study|Physician Decision|1|||
126290095|NCT01350271|454348842|FG000|Overall Study|Lost to Follow-up|21|||
126290096|NCT01350271|454348843|FG001|Overall Study|Lost to Follow-up|17|||
126290097|NCT01350271|454348844|FG002|Overall Study|Lost to Follow-up|26|||
126290098|NCT02906670|454348848|FG000|Cohort 1, QW|Radiological Progression|1|||
126290099|NCT02906670|454348849|FG001|Cohort 1, QW|Radiological Progression|0|||
126290100|NCT02906670|454348850|FG002|Cohort 1, QW|Radiological Progression|0|||
126290101|NCT02906670|454348851|FG003|Cohort 1, QW|Radiological Progression|0|||
126290102|NCT02906670|454348852|FG004|Cohort 1, QW|Radiological Progression|0|||
126290103|NCT02906670|454348853|FG005|Cohort 1, QW|Radiological Progression|0|||
126290104|NCT02906670|454348854|FG006|Cohort 1, QW|Radiological Progression|0|||
126290105|NCT02906670|454348855|FG007|Cohort 1, QW|Radiological Progression|0|||
126290106|NCT02906670|454348856|FG008|Cohort 1, QW|Radiological Progression|0|||
126290107|NCT02906670|454348857|FG009|Cohort 1, QW|Radiological Progression|0|||
126290108|NCT02906670|454348848|FG000|Cohort 2, QW|Radiological Progression|0|||
126290109|NCT02906670|454348849|FG001|Cohort 2, QW|Radiological Progression|1|||
126290110|NCT02906670|454348850|FG002|Cohort 2, QW|Radiological Progression|0|||
126290111|NCT02906670|454348851|FG003|Cohort 2, QW|Radiological Progression|0|||
126290112|NCT02906670|454348852|FG004|Cohort 2, QW|Radiological Progression|0|||
126290113|NCT02906670|454348853|FG005|Cohort 2, QW|Radiological Progression|0|||
126290114|NCT02906670|454348854|FG006|Cohort 2, QW|Radiological Progression|0|||
126290115|NCT02906670|454348855|FG007|Cohort 2, QW|Radiological Progression|0|||
126290116|NCT02906670|454348856|FG008|Cohort 2, QW|Radiological Progression|0|||
126290117|NCT02906670|454348857|FG009|Cohort 2, QW|Radiological Progression|0|||
126290118|NCT02906670|454348848|FG000|Cohort 3, QW|Radiological Progression|0|||
126290119|NCT02906670|454348849|FG001|Cohort 3, QW|Radiological Progression|0|||
126290120|NCT02906670|454348850|FG002|Cohort 3, QW|Radiological Progression|2|||
126290121|NCT02906670|454348851|FG003|Cohort 3, QW|Radiological Progression|0|||
126290122|NCT02906670|454348852|FG004|Cohort 3, QW|Radiological Progression|0|||
126290123|NCT02906670|454348853|FG005|Cohort 3, QW|Radiological Progression|0|||
126290124|NCT02906670|454348854|FG006|Cohort 3, QW|Radiological Progression|0|||
126290125|NCT02906670|454348855|FG007|Cohort 3, QW|Radiological Progression|0|||
126290126|NCT02906670|454348856|FG008|Cohort 3, QW|Radiological Progression|0|||
126290127|NCT02906670|454348857|FG009|Cohort 3, QW|Radiological Progression|0|||
126290128|NCT02906670|454348848|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290129|NCT02906670|454348849|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290130|NCT02906670|454348850|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
126290131|NCT02906670|454348851|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290132|NCT02906670|454348852|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290133|NCT02906670|454348853|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290134|NCT02906670|454348854|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290135|NCT02906670|454348855|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290136|NCT02906670|454348856|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290137|NCT02906670|454348857|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290138|NCT02906670|454348848|FG000|Cohort 4, Q2W|Radiological Progression|0|||
126290139|NCT02906670|454348849|FG001|Cohort 4, Q2W|Radiological Progression|0|||
126290140|NCT02906670|454348850|FG002|Cohort 4, Q2W|Radiological Progression|0|||
126290141|NCT02906670|454348851|FG003|Cohort 4, Q2W|Radiological Progression|0|||
126290142|NCT02906670|454348852|FG004|Cohort 4, Q2W|Radiological Progression|0|||
126290143|NCT02906670|454348853|FG005|Cohort 4, Q2W|Radiological Progression|1|||
126290144|NCT02906670|454348854|FG006|Cohort 4, Q2W|Radiological Progression|0|||
126290145|NCT02906670|454348855|FG007|Cohort 4, Q2W|Radiological Progression|0|||
126290146|NCT02906670|454348856|FG008|Cohort 4, Q2W|Radiological Progression|0|||
126290147|NCT02906670|454348857|FG009|Cohort 4, Q2W|Radiological Progression|0|||
126290148|NCT02906670|454348848|FG000|Cohort 4, Q2W|Clinical Progression|0|||
126290149|NCT02906670|454348849|FG001|Cohort 4, Q2W|Clinical Progression|0|||
126290150|NCT02906670|454348850|FG002|Cohort 4, Q2W|Clinical Progression|0|||
126290151|NCT02906670|454348851|FG003|Cohort 4, Q2W|Clinical Progression|0|||
126290152|NCT02906670|454348852|FG004|Cohort 4, Q2W|Clinical Progression|0|||
126290153|NCT02906670|454348853|FG005|Cohort 4, Q2W|Clinical Progression|2|||
126366016|NCT01491919|454634301|FG001|Overall Study|Insufficient PK sampling|2|||
126366017|NCT01491919|454634302|FG002|Overall Study|Insufficient PK sampling|1|||
126366018|NCT02871219|454634303|FG000|Overall Study|Adverse Event|15|||
126366019|NCT02871219|454634303|FG000|Overall Study|Death|3|||
126366020|NCT02871219|454634303|FG000|Overall Study|Progression|3|||
126366021|NCT02871219|454634303|FG000|Overall Study|Infections|7|||
126366022|NCT02871219|454634303|FG000|Overall Study|Infusion Related|4|||
126366023|NCT02298946|454634307|FG000|Overall Study|Did not receive treatment|2|||
126366024|NCT02298946|454634308|FG001|Overall Study|Did not receive treatment|0|||
126366025|NCT02298946|454634307|FG000|Overall Study|Unevaluable|2|||
126366026|NCT02298946|454634308|FG001|Overall Study|Unevaluable|1|||
126366027|NCT05375929|454634316|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
126366028|NCT05375929|454634317|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
126366029|NCT05375929|454634318|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
126366030|NCT05375929|454634319|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
126366031|NCT05375929|454634316|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
126366032|NCT05375929|454634317|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
126366033|NCT05375929|454634318|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
126366034|NCT05375929|454634319|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
126366035|NCT05375929|454634316|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
126366036|NCT05375929|454634317|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
126366037|NCT05375929|454634318|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
126366038|NCT05375929|454634319|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
126366039|NCT05375929|454634316|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
126366040|NCT05375929|454634317|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
126366041|NCT05375929|454634318|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
126366042|NCT05375929|454634319|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
126366043|NCT05375929|454634316|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
126366044|NCT05375929|454634317|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
126366045|NCT05375929|454634318|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
126366046|NCT05375929|454634319|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
126366047|NCT05375929|454634316|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
126366048|NCT05375929|454634317|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
126366049|NCT05375929|454634318|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
126366050|NCT05375929|454634319|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
126366051|NCT05375929|454634316|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
126366052|NCT05375929|454634317|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
126366053|NCT05375929|454634318|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
126366054|NCT05375929|454634319|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
126366055|NCT05375929|454634316|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
125883131|NCT00463567|452871420|FG005|Overall Study|Lost to Follow-up|1|||
125883132|NCT00463567|452871421|FG006|Overall Study|Lost to Follow-up|1|||
126290154|NCT02906670|454348854|FG006|Cohort 4, Q2W|Clinical Progression|0|||
126290155|NCT02906670|454348855|FG007|Cohort 4, Q2W|Clinical Progression|0|||
126290156|NCT02906670|454348856|FG008|Cohort 4, Q2W|Clinical Progression|0|||
126290157|NCT02906670|454348857|FG009|Cohort 4, Q2W|Clinical Progression|0|||
126290158|NCT02906670|454348848|FG000|Cohort 5, Q2W|Radiological Progression|0|||
126290159|NCT02906670|454348849|FG001|Cohort 5, Q2W|Radiological Progression|0|||
126290160|NCT02906670|454348850|FG002|Cohort 5, Q2W|Radiological Progression|0|||
126290161|NCT02906670|454348851|FG003|Cohort 5, Q2W|Radiological Progression|0|||
126290162|NCT02906670|454348852|FG004|Cohort 5, Q2W|Radiological Progression|0|||
126290163|NCT02906670|454348853|FG005|Cohort 5, Q2W|Radiological Progression|0|||
126290164|NCT02906670|454348854|FG006|Cohort 5, Q2W|Radiological Progression|4|||
126290165|NCT02906670|454348855|FG007|Cohort 5, Q2W|Radiological Progression|0|||
126290166|NCT02906670|454348856|FG008|Cohort 5, Q2W|Radiological Progression|0|||
126290167|NCT02906670|454348857|FG009|Cohort 5, Q2W|Radiological Progression|0|||
126290168|NCT02906670|454348848|FG000|Cohort 5, Q2W|Clinical Progression|0|||
126290169|NCT02906670|454348849|FG001|Cohort 5, Q2W|Clinical Progression|0|||
126290170|NCT02906670|454348850|FG002|Cohort 5, Q2W|Clinical Progression|0|||
126290171|NCT02906670|454348851|FG003|Cohort 5, Q2W|Clinical Progression|0|||
126290172|NCT02906670|454348852|FG004|Cohort 5, Q2W|Clinical Progression|0|||
126290173|NCT02906670|454348853|FG005|Cohort 5, Q2W|Clinical Progression|0|||
126290174|NCT02906670|454348854|FG006|Cohort 5, Q2W|Clinical Progression|1|||
126290175|NCT02906670|454348855|FG007|Cohort 5, Q2W|Clinical Progression|0|||
126290176|NCT02906670|454348856|FG008|Cohort 5, Q2W|Clinical Progression|0|||
126290177|NCT02906670|454348857|FG009|Cohort 5, Q2W|Clinical Progression|0|||
126290178|NCT02906670|454348848|FG000|Cohort 5, Q2W|Adverse Event|0|||
126290179|NCT02906670|454348849|FG001|Cohort 5, Q2W|Adverse Event|0|||
126290180|NCT02906670|454348850|FG002|Cohort 5, Q2W|Adverse Event|0|||
126290181|NCT02906670|454348851|FG003|Cohort 5, Q2W|Adverse Event|0|||
126290182|NCT02906670|454348852|FG004|Cohort 5, Q2W|Adverse Event|0|||
126290183|NCT02906670|454348853|FG005|Cohort 5, Q2W|Adverse Event|0|||
126290184|NCT02906670|454348854|FG006|Cohort 5, Q2W|Adverse Event|1|||
126290185|NCT02906670|454348855|FG007|Cohort 5, Q2W|Adverse Event|0|||
126290186|NCT02906670|454348856|FG008|Cohort 5, Q2W|Adverse Event|0|||
126290187|NCT02906670|454348857|FG009|Cohort 5, Q2W|Adverse Event|0|||
126290188|NCT02906670|454348848|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290189|NCT02906670|454348849|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290190|NCT02906670|454348850|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290191|NCT02906670|454348851|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290192|NCT02906670|454348852|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126366056|NCT05375929|454634317|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
126366057|NCT05375929|454634318|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
126366058|NCT05375929|454634319|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
126366059|NCT05375929|454634316|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
126366060|NCT05375929|454634317|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
126366061|NCT05375929|454634318|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
126366062|NCT05375929|454634319|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
126366063|NCT05375929|454634316|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
126366064|NCT05375929|454634317|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
126366065|NCT05375929|454634318|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
126366066|NCT05375929|454634319|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
126366067|NCT00773461|454634324|FG000|Overall Study|Adverse Event|1|||
126366068|NCT00773461|454634325|FG001|Overall Study|Adverse Event|3|||
126366069|NCT00773461|454634324|FG000|Overall Study|Withdrawal by Subject|4|||
126366070|NCT00773461|454634325|FG001|Overall Study|Withdrawal by Subject|1|||
126366071|NCT00322218|454634328|FG000|Overall Study|Death|3|||
126366072|NCT00322218|454634329|FG001|Overall Study|Death|6|||
126366073|NCT01385995|454634331|FG000|Period 1, 2 Months|Physician Decision|1|||
126366074|NCT01385995|454634332|FG001|Period 1, 2 Months|Physician Decision|0|||
126366075|NCT00112385|454634333|FG000|Overall Study|Lost to Follow-up|1|||
126366076|NCT00112385|454634334|FG001|Overall Study|Lost to Follow-up|0|||
126366077|NCT00112385|454634333|FG000|Overall Study|Withdrawal by Subject|0|||
126366078|NCT00112385|454634334|FG001|Overall Study|Withdrawal by Subject|1|||
126366079|NCT00964678|454634345|FG000|Overall Study|Physician Decision|4|||
126366080|NCT00908141|454634346|FG000|Overall Study|Withdrawal by Subject|0|||
126366081|NCT00908141|454634347|FG001|Overall Study|Withdrawal by Subject|1|||
126366082|NCT00980044|454635698|FG000|Overall Study|Withdrawal by Subject|5|||
126366083|NCT00980044|454635699|FG001|Overall Study|Withdrawal by Subject|7|||
126366084|NCT00980044|454635700|FG002|Overall Study|Withdrawal by Subject|3|||
126366085|NCT00980044|454635698|FG000|Overall Study|Protocol Violation|0|||
126366086|NCT00980044|454635699|FG001|Overall Study|Protocol Violation|0|||
126366087|NCT00980044|454635700|FG002|Overall Study|Protocol Violation|2|||
126366088|NCT02254291|454635701|FG000|Overall Study|Withdrawal by Subject|0|||
126290193|NCT02906670|454348853|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290194|NCT02906670|454348854|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
126290195|NCT02906670|454348855|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290196|NCT02906670|454348856|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290197|NCT02906670|454348857|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290198|NCT02906670|454348848|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
126290199|NCT02906670|454348849|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
125883133|NCT00463567|452871415|FG000|Overall Study|Administrative problems|5|||
126042046|NCT01730937|453453072|FG001|Overall Study|Protocol Violation|11|||
126042047|NCT04068831|453453088|FG000|Overall Study|Disease Progression|10|||
126042048|NCT04068831|453453089|FG001|Overall Study|Disease Progression|8|||
126042049|NCT04086121|453453090|FG000|Overall Study|Other than listed|8|||
126042050|NCT04086121|453453090|FG000|Overall Study|Withdrawal by Subject|3|||
126042051|NCT04086121|453453090|FG000|Overall Study|Lost to Follow-up|2|||
126042052|NCT04086121|453453090|FG000|Overall Study|Adverse Event|1|||
126042053|NCT04580914|453453093|FG000|Overall Study|Withdrawal by Subject|6|||
126042054|NCT04580914|453453093|FG000|Overall Study|Lost to Follow-up|2|||
126042055|NCT03580356|453453095|FG000|Treatment Period|Withdrawal by Subject|13|||
126042056|NCT03580356|453453096|FG001|Treatment Period|Withdrawal by Subject|0|||
126042057|NCT03580356|453453097|FG002|Treatment Period|Withdrawal by Subject|13|||
126042058|NCT03580356|453453098|FG003|Treatment Period|Withdrawal by Subject|1|||
126042059|NCT03580356|453453099|FG004|Treatment Period|Withdrawal by Subject|17|||
126042060|NCT03580356|453453100|FG005|Treatment Period|Withdrawal by Subject|0|||
126290200|NCT02906670|454348850|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
126290201|NCT02906670|454348851|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
126290202|NCT02906670|454348852|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
126290203|NCT02906670|454348853|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
126290204|NCT02906670|454348854|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
126290205|NCT02906670|454348855|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
126290206|NCT02906670|454348856|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
126290207|NCT02906670|454348857|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
126290208|NCT02906670|454348848|FG000|Cohort 5P, Q2W|Adverse Event|0|||
126290209|NCT02906670|454348849|FG001|Cohort 5P, Q2W|Adverse Event|0|||
126290210|NCT02906670|454348850|FG002|Cohort 5P, Q2W|Adverse Event|0|||
126290211|NCT02906670|454348851|FG003|Cohort 5P, Q2W|Adverse Event|0|||
126290212|NCT02906670|454348852|FG004|Cohort 5P, Q2W|Adverse Event|0|||
126290213|NCT02906670|454348853|FG005|Cohort 5P, Q2W|Adverse Event|0|||
126290214|NCT02906670|454348854|FG006|Cohort 5P, Q2W|Adverse Event|0|||
126290215|NCT02906670|454348855|FG007|Cohort 5P, Q2W|Adverse Event|1|||
126290216|NCT02906670|454348856|FG008|Cohort 5P, Q2W|Adverse Event|0|||
126290217|NCT02906670|454348857|FG009|Cohort 5P, Q2W|Adverse Event|0|||
126290218|NCT02906670|454348848|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
126290219|NCT02906670|454348849|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
126290220|NCT02906670|454348850|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
126290221|NCT02906670|454348851|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
126290222|NCT02906670|454348852|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
126290223|NCT02906670|454348853|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
126290224|NCT02906670|454348854|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
126290225|NCT02906670|454348855|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
126290226|NCT02906670|454348856|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
126290227|NCT02906670|454348857|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
126290228|NCT02906670|454348848|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
126290229|NCT02906670|454348849|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
126290230|NCT02906670|454348850|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
126290231|NCT02906670|454348851|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
126290232|NCT02906670|454348852|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
126290233|NCT02906670|454348853|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
126290234|NCT02906670|454348854|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
126290235|NCT02906670|454348855|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
126290236|NCT02906670|454348856|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
126290237|NCT02906670|454348857|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
126290238|NCT02906670|454348848|FG000|Cohort 4P, QW|Radiological Progression|0|||
126290239|NCT02906670|454348849|FG001|Cohort 4P, QW|Radiological Progression|0|||
126290240|NCT02906670|454348850|FG002|Cohort 4P, QW|Radiological Progression|0|||
126290241|NCT02906670|454348851|FG003|Cohort 4P, QW|Radiological Progression|3|||
126290242|NCT02906670|454348852|FG004|Cohort 4P, QW|Radiological Progression|0|||
126290243|NCT02906670|454348853|FG005|Cohort 4P, QW|Radiological Progression|0|||
126290244|NCT02906670|454348854|FG006|Cohort 4P, QW|Radiological Progression|0|||
126290245|NCT02906670|454348855|FG007|Cohort 4P, QW|Radiological Progression|0|||
126290246|NCT02906670|454348856|FG008|Cohort 4P, QW|Radiological Progression|0|||
126290247|NCT02906670|454348857|FG009|Cohort 4P, QW|Radiological Progression|0|||
126290248|NCT02906670|454348848|FG000|Cohort 7P, Q2W|Adverse Event|0|||
126290249|NCT02906670|454348849|FG001|Cohort 7P, Q2W|Adverse Event|0|||
126290250|NCT02906670|454348850|FG002|Cohort 7P, Q2W|Adverse Event|0|||
126290251|NCT02906670|454348851|FG003|Cohort 7P, Q2W|Adverse Event|0|||
126042061|NCT03580356|453453101|FG006|Treatment Period|Withdrawal by Subject|5|||
126042062|NCT03580356|453453102|FG007|Treatment Period|Withdrawal by Subject|0|||
126042063|NCT03580356|453453095|FG000|Treatment Period|Adverse Event|10|||
126290252|NCT02906670|454348852|FG004|Cohort 7P, Q2W|Adverse Event|0|||
126042064|NCT03580356|453453096|FG001|Treatment Period|Adverse Event|0|||
126042065|NCT03580356|453453097|FG002|Treatment Period|Adverse Event|13|||
126042066|NCT03580356|453453098|FG003|Treatment Period|Adverse Event|0|||
126290253|NCT02906670|454348853|FG005|Cohort 7P, Q2W|Adverse Event|0|||
126290254|NCT02906670|454348854|FG006|Cohort 7P, Q2W|Adverse Event|0|||
126290255|NCT02906670|454348855|FG007|Cohort 7P, Q2W|Adverse Event|0|||
126290256|NCT02906670|454348856|FG008|Cohort 7P, Q2W|Adverse Event|0|||
126290257|NCT02906670|454348857|FG009|Cohort 7P, Q2W|Adverse Event|1|||
126290258|NCT02906670|454348848|FG000|Cohort 7P, Q2W|Physician Decision|0|||
126290259|NCT02906670|454348849|FG001|Cohort 7P, Q2W|Physician Decision|0|||
126290260|NCT02906670|454348850|FG002|Cohort 7P, Q2W|Physician Decision|0|||
126290261|NCT02906670|454348851|FG003|Cohort 7P, Q2W|Physician Decision|0|||
126290262|NCT02906670|454348852|FG004|Cohort 7P, Q2W|Physician Decision|0|||
126290263|NCT02906670|454348853|FG005|Cohort 7P, Q2W|Physician Decision|0|||
126290264|NCT02906670|454348854|FG006|Cohort 7P, Q2W|Physician Decision|0|||
126290265|NCT02906670|454348855|FG007|Cohort 7P, Q2W|Physician Decision|0|||
126290266|NCT02906670|454348856|FG008|Cohort 7P, Q2W|Physician Decision|0|||
126290267|NCT02906670|454348857|FG009|Cohort 7P, Q2W|Physician Decision|1|||
126290268|NCT02906670|454348848|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290269|NCT02906670|454348849|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290270|NCT02906670|454348850|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290271|NCT02906670|454348851|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290272|NCT02906670|454348852|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290273|NCT02906670|454348853|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290274|NCT02906670|454348854|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290275|NCT02906670|454348855|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290276|NCT02906670|454348856|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290277|NCT02906670|454348857|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
126290278|NCT02906670|454348848|FG000|Cohort 5P, QW|Radiological Progression|0|||
126290279|NCT02906670|454348849|FG001|Cohort 5P, QW|Radiological Progression|0|||
126290280|NCT02906670|454348850|FG002|Cohort 5P, QW|Radiological Progression|0|||
126290281|NCT02906670|454348851|FG003|Cohort 5P, QW|Radiological Progression|0|||
126290282|NCT02906670|454348852|FG004|Cohort 5P, QW|Radiological Progression|3|||
126290283|NCT02906670|454348853|FG005|Cohort 5P, QW|Radiological Progression|0|||
126290284|NCT02906670|454348854|FG006|Cohort 5P, QW|Radiological Progression|0|||
126290285|NCT02906670|454348855|FG007|Cohort 5P, QW|Radiological Progression|0|||
126290286|NCT02906670|454348856|FG008|Cohort 5P, QW|Radiological Progression|0|||
126290287|NCT02906670|454348857|FG009|Cohort 5P, QW|Radiological Progression|0|||
126290288|NCT01349192|454348858|FG000|Overall Study|Protocol Violation|0|||
126290289|NCT01349192|454348859|FG001|Overall Study|Protocol Violation|1|||
126290290|NCT01349192|454348858|FG000|Overall Study|Withdrawal by Subject|0|||
126290291|NCT01349192|454348859|FG001|Overall Study|Withdrawal by Subject|2|||
126290292|NCT01349192|454348858|FG000|Overall Study|Lost to Follow-up|1|||
126290293|NCT01349192|454348859|FG001|Overall Study|Lost to Follow-up|3|||
126290294|NCT01349192|454348858|FG000|Overall Study|Failure to adhere to Protocol|2|||
126290295|NCT01349192|454348859|FG001|Overall Study|Failure to adhere to Protocol|0|||
126290296|NCT03749330|454348860|FG000|Overall Study|Clinicians left work in the CICU|0|||
126290297|NCT03749330|454348861|FG001|Overall Study|Clinicians left work in the CICU|2|||
126290298|NCT03749330|454348862|FG002|Overall Study|Clinicians left work in the CICU|0|||
126290299|NCT03749330|454348863|FG003|Overall Study|Clinicians left work in the CICU|0|||
126290300|NCT03749330|454348864|FG004|Overall Study|Clinicians left work in the CICU|0|||
126290301|NCT03749330|454348865|FG005|Overall Study|Clinicians left work in the CICU|0|||
126290302|NCT03908125|454348871|FG000|Overall Study|Withdrawal by Subject|92|||
126290303|NCT03908125|454348871|FG000|Overall Study|Lost to Follow-up|8|||
126290304|NCT02262325|454348872|FG000|Overall Study|Death|16|||
126290305|NCT02262325|454348872|FG000|Overall Study|Lost to Follow-up|1|||
125883134|NCT00463567|452871416|FG001|Overall Study|Administrative problems|3|||
126290306|NCT01071915|454348873|FG000|Overall Study|Adverse Event|3|||
126290307|NCT01071915|454348873|FG000|Overall Study|Physician Decision|2|||
126290308|NCT01071915|454348873|FG000|Overall Study|Withdrawal by Subject|2|||
126290309|NCT01071915|454348873|FG000|Overall Study|Miscellaneous Reasons|2|||
126290310|NCT00114140|454348874|FG000|Overall Study|Protocol Violation|7|||
126290311|NCT04011722|454350529|FG000|30 Days|Death|5|||
126290312|NCT04011722|454350530|FG001|30 Days|Death|1|||
126290313|NCT04011722|454350529|FG000|1 Year|Death|13|||
126290314|NCT04011722|454350530|FG001|1 Year|Death|5|||
126290315|NCT04011722|454350529|FG000|1 Year|Withdrawal by Subject|8|||
126290316|NCT04011722|454350530|FG001|1 Year|Withdrawal by Subject|2|||
126290317|NCT04011722|454350529|FG000|1 Year|Missed Visit|6|||
126290318|NCT04011722|454350530|FG001|1 Year|Missed Visit|1|||
126290319|NCT04011722|454350529|FG000|1 Year|Pending Visit|0|||
126290320|NCT04011722|454350530|FG001|1 Year|Pending Visit|11|||
126290321|NCT04011722|454350529|FG000|1 Year|Not Yet Due|0|||
126290322|NCT04011722|454350530|FG001|1 Year|Not Yet Due|9|||
126290323|NCT04011722|454350529|FG000|2 Year|Death|16|||
126290324|NCT04011722|454350530|FG001|2 Year|Death|1|||
126290325|NCT04011722|454350529|FG000|2 Year|Withdrawal by Subject|10|||
126290326|NCT04011722|454350530|FG001|2 Year|Withdrawal by Subject|1|||
126290327|NCT04011722|454350529|FG000|2 Year|Missed Visit|9|||
126290328|NCT04011722|454350530|FG001|2 Year|Missed Visit|0|||
126290329|NCT04011722|454350529|FG000|2 Year|Visit Pending|1|||
126290330|NCT04011722|454350530|FG001|2 Year|Visit Pending|3|||
126290331|NCT04011722|454350529|FG000|2 Year|Not Yet Due|43|||
126290332|NCT04011722|454350530|FG001|2 Year|Not Yet Due|54|||
126290333|NCT04011722|454350529|FG000|3 Year|Death|10|||
126290334|NCT04011722|454350530|FG001|3 Year|Death|0|||
126290335|NCT04011722|454350529|FG000|3 Year|Withdrawal by Subject|2|||
126290336|NCT04011722|454350530|FG001|3 Year|Withdrawal by Subject|0|||
126290337|NCT04011722|454350529|FG000|3 Year|Missed Visit|2|||
126290338|NCT04011722|454350530|FG001|3 Year|Missed Visit|0|||
126290339|NCT04011722|454350529|FG000|3 Year|Pending Visit|34|||
126290340|NCT04011722|454350530|FG001|3 Year|Pending Visit|0|||
126290341|NCT04011722|454350529|FG000|3 Year|Not Yet Due|99|||
126290342|NCT04011722|454350530|FG001|3 Year|Not Yet Due|0|||
126290343|NCT05061134|454350531|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
126290344|NCT05061134|454350532|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
126290345|NCT05061134|454350533|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
126290346|NCT05061134|454350531|FG000|Overall Study|Subject not treated|0|||
126290347|NCT05061134|454350532|FG001|Overall Study|Subject not treated|0|||
126290348|NCT05061134|454350533|FG002|Overall Study|Subject not treated|2|||
126290349|NCT05061134|454350531|FG000|Overall Study|Other|0|||
126290350|NCT05061134|454350532|FG001|Overall Study|Other|0|||
126290351|NCT05061134|454350533|FG002|Overall Study|Other|9|||
126290352|NCT05061134|454350531|FG000|Overall Study|Withdrawal by Subject|9|||
126290353|NCT05061134|454350532|FG001|Overall Study|Withdrawal by Subject|8|||
126290354|NCT05061134|454350533|FG002|Overall Study|Withdrawal by Subject|5|||
126290355|NCT05061134|454350531|FG000|Overall Study|Study Terminated by Sponsor|22|||
126290356|NCT05061134|454350532|FG001|Overall Study|Study Terminated by Sponsor|14|||
126290357|NCT05061134|454350533|FG002|Overall Study|Study Terminated by Sponsor|7|||
126290358|NCT05061134|454350531|FG000|Overall Study|Progressive Disease|1|||
126290359|NCT05061134|454350532|FG001|Overall Study|Progressive Disease|2|||
126290360|NCT05061134|454350533|FG002|Overall Study|Progressive Disease|0|||
126290361|NCT05061134|454350531|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
126290362|NCT05061134|454350532|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
126290363|NCT05061134|454350533|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
126290364|NCT05061134|454350531|FG000|Overall Study|Lost to Follow-up|1|||
126290365|NCT05061134|454350532|FG001|Overall Study|Lost to Follow-up|0|||
126290366|NCT05061134|454350533|FG002|Overall Study|Lost to Follow-up|0|||
126290367|NCT05061134|454350531|FG000|Overall Study|Physician Decision|1|||
126290368|NCT05061134|454350532|FG001|Overall Study|Physician Decision|1|||
126290369|NCT05061134|454350533|FG002|Overall Study|Physician Decision|0|||
126290370|NCT05061134|454350531|FG000|Overall Study|Disease progression|1|||
126290371|NCT05061134|454350532|FG001|Overall Study|Disease progression|0|||
126290372|NCT05061134|454350533|FG002|Overall Study|Disease progression|0|||
126290373|NCT05061134|454350531|FG000|Overall Study|Death|43|||
126290374|NCT05061134|454350532|FG001|Overall Study|Death|23|||
126290375|NCT05061134|454350533|FG002|Overall Study|Death|14|||
126290376|NCT05061134|454350531|FG000|Overall Study|Database lock|2|||
126290377|NCT05061134|454350532|FG001|Overall Study|Database lock|0|||
126290378|NCT05061134|454350533|FG002|Overall Study|Database lock|0|||
126290379|NCT04848480|454350539|FG000|Main Phase (26 Weeks)|Death|1|||
126290380|NCT04848480|454350540|FG001|Main Phase (26 Weeks)|Death|0|||
126290381|NCT04848480|454350539|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
126290382|NCT04848480|454350540|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
126290383|NCT04848480|454350539|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
126290384|NCT04848480|454350540|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
126290385|NCT04848480|454350539|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
126290386|NCT04848480|454350540|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
126290387|NCT04848480|454350539|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
126290388|NCT04848480|454350540|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
126290389|NCT04848480|454350539|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
126290390|NCT04848480|454350540|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
126290391|NCT01368497|454350541|FG000|Overall Study|Lost to Follow-up|2|||
126290392|NCT02366689|454350543|FG000|Overall Study|Withdrawal by Subject|1|||
126042067|NCT03580356|453453099|FG004|Treatment Period|Adverse Event|5|||
126042068|NCT03580356|453453100|FG005|Treatment Period|Adverse Event|0|||
126042069|NCT03580356|453453101|FG006|Treatment Period|Adverse Event|8|||
126042070|NCT03580356|453453102|FG007|Treatment Period|Adverse Event|0|||
126042071|NCT03580356|453453095|FG000|Treatment Period|Protocol Violation|5|||
126042072|NCT03580356|453453096|FG001|Treatment Period|Protocol Violation|0|||
126042073|NCT03580356|453453097|FG002|Treatment Period|Protocol Violation|6|||
126042074|NCT03580356|453453098|FG003|Treatment Period|Protocol Violation|1|||
126042075|NCT03580356|453453099|FG004|Treatment Period|Protocol Violation|9|||
126042076|NCT03580356|453453100|FG005|Treatment Period|Protocol Violation|1|||
126042077|NCT03580356|453453101|FG006|Treatment Period|Protocol Violation|1|||
126042078|NCT03580356|453453102|FG007|Treatment Period|Protocol Violation|0|||
126042079|NCT03580356|453453095|FG000|Treatment Period|Lack of Efficacy|6|||
126042080|NCT03580356|453453096|FG001|Treatment Period|Lack of Efficacy|0|||
126042081|NCT03580356|453453097|FG002|Treatment Period|Lack of Efficacy|2|||
126290393|NCT02366689|454350544|FG001|Overall Study|Withdrawal by Subject|0|||
126290394|NCT02366689|454350545|FG002|Overall Study|Withdrawal by Subject|1|||
126290395|NCT02366689|454350543|FG000|Overall Study|Lost to Follow-up|3|||
126290396|NCT02366689|454350544|FG001|Overall Study|Lost to Follow-up|2|||
126290397|NCT02366689|454350545|FG002|Overall Study|Lost to Follow-up|0|||
126290398|NCT02366689|454350543|FG000|Overall Study|Pregnancy|0|||
126290399|NCT02366689|454350544|FG001|Overall Study|Pregnancy|1|||
126290400|NCT02366689|454350545|FG002|Overall Study|Pregnancy|1|||
126290401|NCT03283566|454350546|FG000|Overall Study|Lost to Follow-up|1|||
126290402|NCT03283566|454350547|FG001|Overall Study|Lost to Follow-up|2|||
126290403|NCT04882241|454350550|FG000|Overall Study|Ongoing in study|46|||
126290404|NCT04882241|454350551|FG001|Overall Study|Ongoing in study|48|||
126290405|NCT04882241|454350552|FG002|Overall Study|Ongoing in study|0|||
126290406|NCT04882241|454350553|FG003|Overall Study|Ongoing in study|0|||
126290407|NCT04882241|454350550|FG000|Overall Study|Death|13|||
126290408|NCT04882241|454350551|FG001|Overall Study|Death|13|||
126290409|NCT04882241|454350552|FG002|Overall Study|Death|0|||
126290410|NCT04882241|454350553|FG003|Overall Study|Death|0|||
126290411|NCT00470535|454350562|FG000|Overall Study|Disease Progression|13|||
126290412|NCT00470535|454350562|FG000|Overall Study|Withdrawal by Subject|1|||
126290413|NCT00470535|454350562|FG000|Overall Study|Adverse Event|1|||
126290414|NCT00470535|454350562|FG000|Overall Study|Death|1|||
126290415|NCT00470535|454350562|FG000|Overall Study|Other|2|||
126290416|NCT02070965|454350567|FG000|Overall Study|Lost to Follow-up|0|||
126290417|NCT02070965|454350568|FG001|Overall Study|Lost to Follow-up|1|||
126290418|NCT02070965|454350569|FG002|Overall Study|Lost to Follow-up|0|||
126290419|NCT02070965|454350567|FG000|Overall Study|Withdrawal by Subject|1|||
126290420|NCT02070965|454350568|FG001|Overall Study|Withdrawal by Subject|1|||
126290421|NCT02070965|454350569|FG002|Overall Study|Withdrawal by Subject|1|||
126290422|NCT02070965|454350567|FG000|Overall Study|Subject moved|1|||
126290423|NCT02070965|454350568|FG001|Overall Study|Subject moved|0|||
126290424|NCT02070965|454350569|FG002|Overall Study|Subject moved|0|||
126290425|NCT02515331|454350570|FG000|Overall Study|Withdrawal by Subject|0|||
126290426|NCT02515331|454350571|FG001|Overall Study|Withdrawal by Subject|0|||
126290427|NCT02515331|454350572|FG002|Overall Study|Withdrawal by Subject|1|||
126290428|NCT02515331|454350570|FG000|Overall Study|Protocol deviation|0|||
126290429|NCT02515331|454350571|FG001|Overall Study|Protocol deviation|0|||
126290430|NCT02515331|454350572|FG002|Overall Study|Protocol deviation|3|||
126290431|NCT02515331|454350570|FG000|Overall Study|Adverse Event|2|||
126290432|NCT02515331|454350571|FG001|Overall Study|Adverse Event|0|||
126290433|NCT02515331|454350572|FG002|Overall Study|Adverse Event|0|||
126290434|NCT00124748|454350573|FG000|Overall Study|Adverse Event|8|||
126290435|NCT00124748|454350574|FG001|Overall Study|Adverse Event|39|||
126042082|NCT03580356|453453098|FG003|Treatment Period|Lack of Efficacy|0|||
126042083|NCT03580356|453453099|FG004|Treatment Period|Lack of Efficacy|3|||
126042084|NCT03580356|453453100|FG005|Treatment Period|Lack of Efficacy|0|||
126042085|NCT03580356|453453101|FG006|Treatment Period|Lack of Efficacy|3|||
126042086|NCT03580356|453453102|FG007|Treatment Period|Lack of Efficacy|0|||
126290436|NCT00124748|454350573|FG000|Overall Study|Abnormal laboratory Value|2|||
125883135|NCT00463567|452871417|FG002|Overall Study|Administrative problems|6|||
126290437|NCT00124748|454350574|FG001|Overall Study|Abnormal laboratory Value|2|||
125883136|NCT00463567|452871418|FG003|Overall Study|Administrative problems|9|||
126042087|NCT03580356|453453095|FG000|Treatment Period|Pregnancy|1|||
126042088|NCT03580356|453453096|FG001|Treatment Period|Pregnancy|0|||
126290438|NCT00124748|454350573|FG000|Overall Study|Abnormal Procedure|0|||
126290439|NCT00124748|454350574|FG001|Overall Study|Abnormal Procedure|1|||
126290440|NCT00124748|454350573|FG000|Overall Study|Lack of Efficacy|20|||
126290441|NCT00124748|454350574|FG001|Overall Study|Lack of Efficacy|41|||
126290442|NCT00124748|454350573|FG000|Overall Study|No longer requires study drug|1|||
126290443|NCT00124748|454350574|FG001|Overall Study|No longer requires study drug|1|||
126290444|NCT00124748|454350573|FG000|Overall Study|Protocol Violation|3|||
126290445|NCT00124748|454350574|FG001|Overall Study|Protocol Violation|1|||
126290446|NCT00124748|454350573|FG000|Overall Study|Withdrawal by Subject|5|||
126290447|NCT00124748|454350574|FG001|Overall Study|Withdrawal by Subject|15|||
126042089|NCT03580356|453453097|FG002|Treatment Period|Pregnancy|7|||
126042090|NCT03580356|453453098|FG003|Treatment Period|Pregnancy|0|||
126042091|NCT03580356|453453099|FG004|Treatment Period|Pregnancy|2|||
126290448|NCT00124748|454350573|FG000|Overall Study|Lost to Follow-up|2|||
126290449|NCT00124748|454350574|FG001|Overall Study|Lost to Follow-up|7|||
126290450|NCT00124748|454350573|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
126290451|NCT00124748|454350574|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
126290452|NCT00124748|454350573|FG000|Overall Study|Death|1|||
126290453|NCT00124748|454350574|FG001|Overall Study|Death|3|||
126290454|NCT00322712|454350575|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
126290455|NCT03889886|454350576|FG000|Overall Study|Other|0|||
126290456|NCT03889886|454350577|FG001|Overall Study|Other|1|||
126290457|NCT03889886|454350578|FG002|Overall Study|Other|0|||
126290458|NCT03889886|454350579|FG003|Overall Study|Other|1|||
126290459|NCT03889886|454350576|FG000|Overall Study|Withdrawal by Subject|0|||
126290460|NCT03889886|454350577|FG001|Overall Study|Withdrawal by Subject|0|||
126290461|NCT03889886|454350578|FG002|Overall Study|Withdrawal by Subject|1|||
126290462|NCT03889886|454350579|FG003|Overall Study|Withdrawal by Subject|0|||
126290463|NCT03889886|454350576|FG000|Overall Study|Adverse Event|0|||
126290464|NCT03889886|454350577|FG001|Overall Study|Adverse Event|0|||
126290465|NCT03889886|454350578|FG002|Overall Study|Adverse Event|0|||
126290466|NCT03889886|454350579|FG003|Overall Study|Adverse Event|6|||
126290467|NCT04176250|454350580|FG000|Overall Study|Adverse Event|0|||
126290468|NCT04176250|454350581|FG001|Overall Study|Adverse Event|1|||
126290469|NCT04176250|454350582|FG002|Overall Study|Adverse Event|0|||
126290470|NCT04176250|454350583|FG003|Overall Study|Adverse Event|1|||
126290471|NCT04176250|454350584|FG004|Overall Study|Adverse Event|0|||
126290472|NCT04176250|454350585|FG005|Overall Study|Adverse Event|1|||
126290473|NCT04176250|454350580|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
126290474|NCT04176250|454350581|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
126290475|NCT04176250|454350582|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
126290476|NCT04176250|454350583|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
126290477|NCT04176250|454350584|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
126290478|NCT04176250|454350585|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
126290479|NCT04176250|454350580|FG000|Overall Study|Withdrawal by Subject|0|||
126290480|NCT04176250|454350581|FG001|Overall Study|Withdrawal by Subject|0|||
126290481|NCT04176250|454350582|FG002|Overall Study|Withdrawal by Subject|0|||
126290482|NCT04176250|454350583|FG003|Overall Study|Withdrawal by Subject|0|||
126290483|NCT04176250|454350584|FG004|Overall Study|Withdrawal by Subject|0|||
126290484|NCT04176250|454350585|FG005|Overall Study|Withdrawal by Subject|1|||
126290485|NCT04176250|454350580|FG000|Overall Study|Randomized in error|0|||
126290486|NCT04176250|454350581|FG001|Overall Study|Randomized in error|0|||
126290487|NCT04176250|454350582|FG002|Overall Study|Randomized in error|0|||
126290488|NCT04176250|454350583|FG003|Overall Study|Randomized in error|0|||
126290489|NCT04176250|454350584|FG004|Overall Study|Randomized in error|1|||
126290490|NCT04176250|454350585|FG005|Overall Study|Randomized in error|0|||
126290491|NCT04747470|454350597|FG000|Overall Study|Death|0|||
126290492|NCT04747470|454350598|FG001|Overall Study|Death|3|||
126290493|NCT04747470|454350599|FG002|Overall Study|Death|2|||
126290494|NCT04747470|454350600|FG003|Overall Study|Death|2|||
126290495|NCT04747470|454350601|FG004|Overall Study|Death|2|||
126290496|NCT04747470|454350602|FG005|Overall Study|Death|0|||
126290497|NCT04747470|454350603|FG006|Overall Study|Death|0|||
126290498|NCT04747470|454350604|FG007|Overall Study|Death|0|||
126290499|NCT04747470|454350605|FG008|Overall Study|Death|0|||
126290500|NCT04747470|454350606|FG009|Overall Study|Death|0|||
126290501|NCT04747470|454350607|FG010|Overall Study|Death|0|||
126290502|NCT04747470|454350597|FG000|Overall Study|Withdrew Consent|0|||
126290503|NCT04747470|454350598|FG001|Overall Study|Withdrew Consent|0|||
126290504|NCT04747470|454350599|FG002|Overall Study|Withdrew Consent|0|||
126290505|NCT04747470|454350600|FG003|Overall Study|Withdrew Consent|1|||
126042092|NCT03580356|453453100|FG005|Treatment Period|Pregnancy|0|||
126042093|NCT03580356|453453101|FG006|Treatment Period|Pregnancy|1|||
126042094|NCT03580356|453453102|FG007|Treatment Period|Pregnancy|0|||
126042095|NCT03580356|453453095|FG000|Treatment Period|Physician Decision|2|||
126042096|NCT03580356|453453096|FG001|Treatment Period|Physician Decision|0|||
126042097|NCT03580356|453453097|FG002|Treatment Period|Physician Decision|1|||
126290506|NCT04747470|454350601|FG004|Overall Study|Withdrew Consent|0|||
126290507|NCT04747470|454350602|FG005|Overall Study|Withdrew Consent|0|||
126290508|NCT04747470|454350603|FG006|Overall Study|Withdrew Consent|0|||
126042098|NCT03580356|453453098|FG003|Treatment Period|Physician Decision|0|||
126042099|NCT03580356|453453099|FG004|Treatment Period|Physician Decision|4|||
126099998|NCT02924428|453659797|FG000|Overall Study|Adverse Event|1|||
126290509|NCT04747470|454350604|FG007|Overall Study|Withdrew Consent|0|||
126290510|NCT04747470|454350605|FG008|Overall Study|Withdrew Consent|0|||
126290511|NCT04747470|454350606|FG009|Overall Study|Withdrew Consent|0|||
126290512|NCT04747470|454350607|FG010|Overall Study|Withdrew Consent|0|||
126290513|NCT04747470|454350597|FG000|Overall Study|Study Terminated by Sponsor|0|||
126290514|NCT04747470|454350598|FG001|Overall Study|Study Terminated by Sponsor|0|||
126290515|NCT04747470|454350599|FG002|Overall Study|Study Terminated by Sponsor|1|||
126290516|NCT04747470|454350600|FG003|Overall Study|Study Terminated by Sponsor|0|||
126290517|NCT04747470|454350601|FG004|Overall Study|Study Terminated by Sponsor|2|||
126290518|NCT04747470|454350602|FG005|Overall Study|Study Terminated by Sponsor|0|||
126290519|NCT04747470|454350603|FG006|Overall Study|Study Terminated by Sponsor|0|||
126290520|NCT04747470|454350604|FG007|Overall Study|Study Terminated by Sponsor|0|||
126290521|NCT04747470|454350605|FG008|Overall Study|Study Terminated by Sponsor|0|||
126290522|NCT04747470|454350606|FG009|Overall Study|Study Terminated by Sponsor|0|||
126290523|NCT04747470|454350607|FG010|Overall Study|Study Terminated by Sponsor|0|||
126290524|NCT01269918|454350610|FG000|Overall Study|Did not receive study drug|0|||
126290525|NCT01269918|454350611|FG001|Overall Study|Did not receive study drug|3|||
126290526|NCT00769379|454350612|FG000|Overall Study|No follow up data mapped to Other.|3|||
126290527|NCT00769379|454350613|FG001|Overall Study|No follow up data mapped to Other.|13|||
126290528|NCT01928472|454350614|FG000|Overall Study|Death|0|||
126290529|NCT01928472|454350615|FG001|Overall Study|Death|0|||
126290530|NCT01928472|454350616|FG002|Overall Study|Death|1|||
126290531|NCT01928472|454350617|FG003|Overall Study|Death|0|||
126290532|NCT01928472|454350614|FG000|Overall Study|Withdrawal by Subject|4|||
126290533|NCT01928472|454350615|FG001|Overall Study|Withdrawal by Subject|4|||
126290534|NCT01928472|454350616|FG002|Overall Study|Withdrawal by Subject|1|||
126290535|NCT01928472|454350617|FG003|Overall Study|Withdrawal by Subject|2|||
126290536|NCT01928472|454350614|FG000|Overall Study|Lost to Follow-up|2|||
126290537|NCT01928472|454350615|FG001|Overall Study|Lost to Follow-up|3|||
126290538|NCT01928472|454350616|FG002|Overall Study|Lost to Follow-up|4|||
126290539|NCT01928472|454350617|FG003|Overall Study|Lost to Follow-up|0|||
126290540|NCT01928472|454350614|FG000|Overall Study|Administrative Reason|2|||
126290541|NCT01928472|454350615|FG001|Overall Study|Administrative Reason|1|||
126290542|NCT01928472|454350616|FG002|Overall Study|Administrative Reason|0|||
126290543|NCT01928472|454350617|FG003|Overall Study|Administrative Reason|0|||
126290544|NCT01928472|454350614|FG000|Overall Study|Unclassified|0|||
126290545|NCT01928472|454350615|FG001|Overall Study|Unclassified|0|||
126290546|NCT01928472|454350616|FG002|Overall Study|Unclassified|1|||
126290547|NCT01928472|454350617|FG003|Overall Study|Unclassified|0|||
126290548|NCT01308424|454350618|FG000|Baseline Eligibility|Screen Failures|71|||
126290549|NCT01308424|454350619|FG001|Baseline Eligibility|Screen Failures|0|||
126290550|NCT01308424|454350620|FG002|Baseline Eligibility|Screen Failures|0|||
126290551|NCT01308424|454350618|FG000|Randomization|Adverse Event|0|||
126042100|NCT03580356|453453100|FG005|Treatment Period|Physician Decision|0|||
126042101|NCT03580356|453453101|FG006|Treatment Period|Physician Decision|2|||
126042102|NCT03580356|453453102|FG007|Treatment Period|Physician Decision|0|||
126290552|NCT01308424|454350619|FG001|Randomization|Adverse Event|1|||
126290553|NCT01308424|454350620|FG002|Randomization|Adverse Event|1|||
126290554|NCT01308424|454350618|FG000|Randomization|Lost to Follow-up|0|||
126290555|NCT01308424|454350619|FG001|Randomization|Lost to Follow-up|1|||
126290556|NCT01308424|454350620|FG002|Randomization|Lost to Follow-up|0|||
126290557|NCT01308424|454350618|FG000|Randomization|Physician Decision|0|||
126290558|NCT01308424|454350619|FG001|Randomization|Physician Decision|1|||
126290559|NCT01308424|454350620|FG002|Randomization|Physician Decision|1|||
126290560|NCT04471428|454350624|FG000|Overall Study|Withdrawal by Subject|29|||
126290561|NCT04471428|454350625|FG001|Overall Study|Withdrawal by Subject|1|||
126290562|NCT04471428|454350624|FG000|Overall Study|Physician Decision|0|||
126290563|NCT04471428|454350625|FG001|Overall Study|Physician Decision|1|||
126290564|NCT04471428|454350624|FG000|Overall Study|Reason Not Specified|0|||
126290565|NCT04471428|454350625|FG001|Overall Study|Reason Not Specified|2|||
126290566|NCT04471428|454350624|FG000|Overall Study|Death|106|||
126042103|NCT03580356|453453095|FG000|Treatment Period|Lost to Follow-up|1|||
126290567|NCT04471428|454350625|FG001|Overall Study|Death|114|||
126290568|NCT04471428|454350624|FG000|Overall Study|Ongoing in the study|45|||
126290569|NCT04471428|454350625|FG001|Overall Study|Ongoing in the study|68|||
126290570|NCT00129545|454350628|FG000|Overall Study|Death|5|||
126290571|NCT00129545|454350629|FG001|Overall Study|Death|60|||
126290572|NCT00129545|454350630|FG002|Overall Study|Death|44|||
126290573|NCT00129545|454350628|FG000|Overall Study|Withdrawal by Subject|3|||
126290574|NCT00129545|454350629|FG001|Overall Study|Withdrawal by Subject|18|||
126290575|NCT00129545|454350630|FG002|Overall Study|Withdrawal by Subject|44|||
126042104|NCT03580356|453453096|FG001|Treatment Period|Lost to Follow-up|1|||
125883137|NCT00463567|452871419|FG004|Overall Study|Administrative problems|3|||
126042105|NCT03580356|453453097|FG002|Treatment Period|Lost to Follow-up|1|||
126042106|NCT03580356|453453098|FG003|Treatment Period|Lost to Follow-up|0|||
126290576|NCT00129545|454350628|FG000|Overall Study|Lost to Follow-up|2|||
126290577|NCT00129545|454350629|FG001|Overall Study|Lost to Follow-up|22|||
126290578|NCT00129545|454350630|FG002|Overall Study|Lost to Follow-up|13|||
126290579|NCT00129545|454350628|FG000|Overall Study|Physician Decision|0|||
126290580|NCT00129545|454350629|FG001|Overall Study|Physician Decision|3|||
126290581|NCT00129545|454350630|FG002|Overall Study|Physician Decision|10|||
126290582|NCT00129545|454350628|FG000|Overall Study|Device not implanted|16|||
126290583|NCT00129545|454350629|FG001|Overall Study|Device not implanted|61|||
126290584|NCT00129545|454350630|FG002|Overall Study|Device not implanted|0|||
126290585|NCT01841593|454350631|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
126290586|NCT01841593|454350632|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
126290587|NCT01841593|454350631|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
126290588|NCT01841593|454350632|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
126290589|NCT00307086|454350635|FG000|Overall Study|ineligible|5|||
126290590|NCT02969044|454350636|FG000|Overall Study|Withdrawal by Subject|2|||
126290591|NCT02969044|454350637|FG001|Overall Study|Withdrawal by Subject|6|||
126290592|NCT02969044|454350636|FG000|Overall Study|Adverse Event|3|||
126290593|NCT02969044|454350637|FG001|Overall Study|Adverse Event|0|||
126290594|NCT00312338|454350641|FG000|Overall Study|Adverse Event|7|||
126290595|NCT00312338|454350642|FG001|Overall Study|Adverse Event|2|||
126290596|NCT00312338|454350641|FG000|Overall Study|Lost to Follow-up|9|||
126290597|NCT00312338|454350642|FG001|Overall Study|Lost to Follow-up|1|||
126290598|NCT00312338|454350641|FG000|Overall Study|Withdrawal by Subject|4|||
126290599|NCT00312338|454350642|FG001|Overall Study|Withdrawal by Subject|0|||
126290600|NCT00312338|454350641|FG000|Overall Study|Subsequent infection|2|||
126290601|NCT00312338|454350642|FG001|Overall Study|Subsequent infection|0|||
126290602|NCT00262028|454350643|FG000|Overall Study|Withdrawal by Subject|6|||
126290603|NCT00262028|454350644|FG001|Overall Study|Withdrawal by Subject|3|||
126290604|NCT00262028|454350645|FG002|Overall Study|Withdrawal by Subject|6|||
126290605|NCT00262028|454350646|FG003|Overall Study|Withdrawal by Subject|5|||
126290606|NCT00262028|454350647|FG004|Overall Study|Withdrawal by Subject|2|||
126290607|NCT00262028|454350648|FG005|Overall Study|Withdrawal by Subject|3|||
126290608|NCT00262028|454350649|FG006|Overall Study|Withdrawal by Subject|5|||
126290609|NCT00262028|454350650|FG007|Overall Study|Withdrawal by Subject|7|||
126290610|NCT00262028|454350651|FG008|Overall Study|Withdrawal by Subject|2|||
126290611|NCT00262028|454350643|FG000|Overall Study|Lost to Follow-up|7|||
126290612|NCT00262028|454350644|FG001|Overall Study|Lost to Follow-up|7|||
126290613|NCT00262028|454350645|FG002|Overall Study|Lost to Follow-up|5|||
126290614|NCT00262028|454350646|FG003|Overall Study|Lost to Follow-up|5|||
126290615|NCT00262028|454350647|FG004|Overall Study|Lost to Follow-up|4|||
126290616|NCT00262028|454350648|FG005|Overall Study|Lost to Follow-up|3|||
126290617|NCT00262028|454350649|FG006|Overall Study|Lost to Follow-up|3|||
126290618|NCT00262028|454350650|FG007|Overall Study|Lost to Follow-up|5|||
126290619|NCT00262028|454350651|FG008|Overall Study|Lost to Follow-up|6|||
126290620|NCT00262028|454350643|FG000|Overall Study|Administrative Reason|11|||
126290621|NCT00262028|454350644|FG001|Overall Study|Administrative Reason|14|||
126290622|NCT00262028|454350645|FG002|Overall Study|Administrative Reason|9|||
126290623|NCT00262028|454350646|FG003|Overall Study|Administrative Reason|12|||
126290624|NCT00262028|454350647|FG004|Overall Study|Administrative Reason|6|||
126290625|NCT00262028|454350648|FG005|Overall Study|Administrative Reason|7|||
126290626|NCT00262028|454350649|FG006|Overall Study|Administrative Reason|4|||
126290627|NCT00262028|454350650|FG007|Overall Study|Administrative Reason|6|||
126290628|NCT00262028|454350651|FG008|Overall Study|Administrative Reason|10|||
126290629|NCT00262028|454350643|FG000|Overall Study|Protocol Violation|0|||
126290630|NCT00262028|454350644|FG001|Overall Study|Protocol Violation|0|||
126290631|NCT00262028|454350645|FG002|Overall Study|Protocol Violation|0|||
126290632|NCT00262028|454350646|FG003|Overall Study|Protocol Violation|1|||
126290633|NCT00262028|454350647|FG004|Overall Study|Protocol Violation|0|||
126290634|NCT00262028|454350648|FG005|Overall Study|Protocol Violation|0|||
126290635|NCT00262028|454350649|FG006|Overall Study|Protocol Violation|0|||
126290636|NCT00262028|454350650|FG007|Overall Study|Protocol Violation|0|||
126366089|NCT02254291|454635702|FG001|Overall Study|Withdrawal by Subject|3|||
126366090|NCT02254291|454635703|FG002|Overall Study|Withdrawal by Subject|1|||
126366091|NCT02254291|454635701|FG000|Overall Study|Missing follow-up information|0|||
126366092|NCT02254291|454635702|FG001|Overall Study|Missing follow-up information|0|||
126366093|NCT02254291|454635703|FG002|Overall Study|Missing follow-up information|1|||
126366094|NCT00833703|454635713|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
126366095|NCT00833703|454635714|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
126366096|NCT01904279|454635715|FG000|Overall Study|Lack of Efficacy|2|||
126366097|NCT01904279|454635716|FG001|Overall Study|Lack of Efficacy|3|||
126366098|NCT01904279|454635715|FG000|Overall Study|Withdrawal by Subject|1|||
126042107|NCT03580356|453453099|FG004|Treatment Period|Lost to Follow-up|3|||
126290637|NCT00262028|454350651|FG008|Overall Study|Protocol Violation|0|||
126290638|NCT00262028|454350643|FG000|Overall Study|Unable to classify|0|||
126366099|NCT01904279|454635716|FG001|Overall Study|Withdrawal by Subject|0|||
126366100|NCT02489279|454635719|FG000|Overall Study|Lost to Follow-up|12|||
126366101|NCT02489279|454635720|FG001|Overall Study|Lost to Follow-up|10|||
126366102|NCT02263547|454635721|FG000|Overall Study|Adverse Event|1|||
126366103|NCT02263547|454635721|FG000|Overall Study|Lost to Follow-up|2|||
126366104|NCT01344356|454635722|FG000|Overall Study|Physician Decision|0|||
126366105|NCT01344356|454635723|FG001|Overall Study|Physician Decision|3|||
126366106|NCT01344356|454635722|FG000|Overall Study|Lost to Follow-up|0|||
126366107|NCT01344356|454635723|FG001|Overall Study|Lost to Follow-up|6|||
126366108|NCT00095576|454635724|FG000|Overall Study|Adverse Event|5|||
126366109|NCT00095576|454635725|FG001|Overall Study|Adverse Event|3|||
126366110|NCT00095576|454635724|FG000|Overall Study|Lost to Follow-up|233|||
126366111|NCT00095576|454635725|FG001|Overall Study|Lost to Follow-up|229|||
126366112|NCT00095576|454635724|FG000|Overall Study|Protocol Violation|1|||
126366113|NCT00095576|454635725|FG001|Overall Study|Protocol Violation|0|||
126366114|NCT00095576|454635724|FG000|Overall Study|Withdrawal by Subject|34|||
126366115|NCT00095576|454635725|FG001|Overall Study|Withdrawal by Subject|47|||
126366116|NCT00095576|454635724|FG000|Overall Study|Option to switch to a rollover study|1097|||
126366117|NCT00095576|454635725|FG001|Overall Study|Option to switch to a rollover study|1099|||
126366118|NCT00095576|454635724|FG000|Overall Study|Site terminated|75|||
126366119|NCT00095576|454635725|FG001|Overall Study|Site terminated|67|||
126366120|NCT00095576|454635724|FG000|Overall Study|Subject moved|30|||
126366121|NCT00095576|454635725|FG001|Overall Study|Subject moved|36|||
126290639|NCT00262028|454350644|FG001|Overall Study|Unable to classify|3|||
126290640|NCT00262028|454350645|FG002|Overall Study|Unable to classify|0|||
126290641|NCT00262028|454350646|FG003|Overall Study|Unable to classify|0|||
126290642|NCT00262028|454350647|FG004|Overall Study|Unable to classify|0|||
126290643|NCT00262028|454350648|FG005|Overall Study|Unable to classify|0|||
126290644|NCT00262028|454350649|FG006|Overall Study|Unable to classify|0|||
126290645|NCT00262028|454350650|FG007|Overall Study|Unable to classify|0|||
126290646|NCT00262028|454350651|FG008|Overall Study|Unable to classify|1|||
126290647|NCT02308124|454350652|FG000|Overall Study|Lost to Follow-up|6|||
126290648|NCT02308124|454350653|FG001|Overall Study|Lost to Follow-up|6|||
126290649|NCT02308124|454350654|FG002|Overall Study|Lost to Follow-up|6|||
126290650|NCT02308124|454350652|FG000|Overall Study|Adverse Event|0|||
126290651|NCT02308124|454350653|FG001|Overall Study|Adverse Event|2|||
126290652|NCT02308124|454350654|FG002|Overall Study|Adverse Event|2|||
126290653|NCT02553772|454350655|FG000|Overall Study|Adverse Event|2|||
126290654|NCT02553772|454350656|FG001|Overall Study|Adverse Event|3|||
126290655|NCT02553772|454350655|FG000|Overall Study|Lost to Follow-up|2|||
126290656|NCT02553772|454350656|FG001|Overall Study|Lost to Follow-up|1|||
126290657|NCT02553772|454350655|FG000|Overall Study|Withdrawal of Consent|1|||
126290658|NCT02553772|454350656|FG001|Overall Study|Withdrawal of Consent|1|||
126290659|NCT02553772|454350655|FG000|Overall Study|Lack of Efficacy|1|||
126290660|NCT02553772|454350656|FG001|Overall Study|Lack of Efficacy|0|||
126290661|NCT02553772|454350655|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126290662|NCT02553772|454350656|FG001|Overall Study|Other Miscellaneous Reasons|1|||
126290663|NCT01329900|454350657|FG000|Overall Study|Elevated creatinine/renal function|1|||
126290664|NCT01184079|454350661|FG000|Overall Study|Lost to Follow-up|14|||
126290665|NCT01184079|454350662|FG001|Overall Study|Lost to Follow-up|2|||
126290666|NCT04233073|454350667|FG000|Overall Study|Death|5|||
126290667|NCT00143390|454350668|FG000|Overall Study|Death|2|||
126290668|NCT00143390|454350669|FG001|Overall Study|Death|0|||
126290669|NCT00143390|454350668|FG000|Overall Study|Not meeting entry criteria|2|||
126290670|NCT00143390|454350669|FG001|Overall Study|Not meeting entry criteria|5|||
126290671|NCT00143390|454350668|FG000|Overall Study|Withdrawal by Subject|4|||
126290672|NCT00143390|454350669|FG001|Overall Study|Withdrawal by Subject|4|||
126290673|NCT00143390|454350668|FG000|Overall Study|Progressive disease|119|||
126290674|NCT00143390|454350669|FG001|Overall Study|Progressive disease|115|||
126290675|NCT00143390|454350668|FG000|Overall Study|Protocol Violation|2|||
126366122|NCT02014467|454635728|FG000|Overall Study|Adverse Event|4|||
126366123|NCT02014467|454635729|FG001|Overall Study|Adverse Event|0|||
126366124|NCT02014467|454635728|FG000|Overall Study|Protocol Violation|3|||
126290676|NCT00143390|454350669|FG001|Overall Study|Protocol Violation|0|||
126366125|NCT02014467|454635729|FG001|Overall Study|Protocol Violation|0|||
126366126|NCT02014467|454635728|FG000|Overall Study|Physician Decision|2|||
126366127|NCT02014467|454635729|FG001|Overall Study|Physician Decision|3|||
126042108|NCT03580356|453453100|FG005|Treatment Period|Lost to Follow-up|0|||
126042109|NCT03580356|453453101|FG006|Treatment Period|Lost to Follow-up|1|||
126042110|NCT03580356|453453102|FG007|Treatment Period|Lost to Follow-up|0|||
126290677|NCT00143390|454350668|FG000|Overall Study|Study termination|10|||
126290678|NCT00143390|454350669|FG001|Overall Study|Study termination|15|||
126290679|NCT00143390|454350668|FG000|Overall Study|Adverse Event|9|||
126290680|NCT00143390|454350669|FG001|Overall Study|Adverse Event|8|||
126290681|NCT00143390|454350668|FG000|Overall Study|Other|1|||
126290682|NCT00143390|454350669|FG001|Overall Study|Other|2|||
126290683|NCT00041132|454350672|FG000|Overall Study|Adverse Event|19|||
126290684|NCT00041132|454350672|FG000|Overall Study|Death|1|||
126290685|NCT00041132|454350672|FG000|Overall Study|Not Eligible|7|||
126290686|NCT00041132|454350672|FG000|Overall Study|Withdrawal by Subject|1|||
126290687|NCT00041132|454350672|FG000|Overall Study|Physician Decision|2|||
126290688|NCT03200717|454350678|FG000|Overall Study|Progressive disease|24|||
126290689|NCT03200717|454350679|FG001|Overall Study|Progressive disease|5|||
126290690|NCT03200717|454350678|FG000|Overall Study|Adverse Event|11|||
126290691|NCT03200717|454350679|FG001|Overall Study|Adverse Event|8|||
126290692|NCT03200717|454350678|FG000|Overall Study|Physician Decision|3|||
126290693|NCT03200717|454350679|FG001|Overall Study|Physician Decision|2|||
126290694|NCT03200717|454350678|FG000|Overall Study|Death|2|||
126290695|NCT03200717|454350679|FG001|Overall Study|Death|0|||
126290696|NCT03200717|454350678|FG000|Overall Study|Subject/Guardian Decision|1|||
126290697|NCT03200717|454350679|FG001|Overall Study|Subject/Guardian Decision|0|||
126290698|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
126290699|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
126290700|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
126290701|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
126290702|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
126290703|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
126290704|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
126290705|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
126290706|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
126290707|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
126290708|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
126290709|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
126290710|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
126290711|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
126290712|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
126290713|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
126290714|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
126290715|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
126290716|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
126290717|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
126290718|NCT00866359|454350680|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
126290719|NCT00866359|454350681|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
126290720|NCT00866359|454350682|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
126290721|NCT00866359|454350683|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
126290722|NCT01625091|454350684|FG000|Intervention|Death|1|||
126290723|NCT01625091|454350685|FG001|Intervention|Death|1|||
126290724|NCT01625091|454350684|FG000|Intervention|Withdrawal by Subject|4|||
126290725|NCT01625091|454350685|FG001|Intervention|Withdrawal by Subject|1|||
126290726|NCT01625091|454350684|FG000|Intervention|Adverse Event|0|||
126290727|NCT01625091|454350685|FG001|Intervention|Adverse Event|2|||
126290728|NCT01625091|454350684|FG000|Intervention|Lost to Follow-up|4|||
126290729|NCT01625091|454350685|FG001|Intervention|Lost to Follow-up|4|||
126290730|NCT01625091|454350684|FG000|Intervention|Study termination|2|||
126290731|NCT01625091|454350685|FG001|Intervention|Study termination|3|||
126290732|NCT01625091|454350684|FG000|Post-intervention|Death|0|||
126290733|NCT01625091|454350685|FG001|Post-intervention|Death|1|||
126290734|NCT01625091|454350684|FG000|Post-intervention|Lost to Follow-up|2|||
126042111|NCT03580356|453453095|FG000|Treatment Period|Death|0|||
126042112|NCT03580356|453453096|FG001|Treatment Period|Death|0|||
126042113|NCT03580356|453453097|FG002|Treatment Period|Death|1|||
126042114|NCT03580356|453453098|FG003|Treatment Period|Death|0|||
126042115|NCT03580356|453453099|FG004|Treatment Period|Death|0|||
126099999|NCT02924428|453659798|FG001|Overall Study|Adverse Event|0|||
126290735|NCT01625091|454350685|FG001|Post-intervention|Lost to Follow-up|0|||
126290736|NCT01625091|454350684|FG000|Post-intervention|Study termination|2|||
126290737|NCT01625091|454350685|FG001|Post-intervention|Study termination|1|||
126290738|NCT02163057|454350686|FG000|Overall Study|Participant Refusal to Continue|2|||
126290739|NCT02163057|454350687|FG001|Overall Study|Participant Refusal to Continue|2|||
126290740|NCT02163057|454350686|FG000|Overall Study|Participant Significant Noncompliance|0|||
126290741|NCT02163057|454350687|FG001|Overall Study|Participant Significant Noncompliance|1|||
126290742|NCT02163057|454350686|FG000|Overall Study|Progression of Disease|1|||
126042116|NCT03580356|453453100|FG005|Treatment Period|Death|0|||
126290743|NCT02163057|454350687|FG001|Overall Study|Progression of Disease|2|||
126290744|NCT00768248|454350688|FG000|Overall Study|Research coordinator didn't collect data|1|||
126290745|NCT00768248|454350689|FG001|Overall Study|Research coordinator didn't collect data|1|||
126290746|NCT01547390|454350694|FG000|Overall Study|Withdrawal by Subject|10|||
126290747|NCT01547390|454350695|FG001|Overall Study|Withdrawal by Subject|7|||
126290748|NCT01547390|454350694|FG000|Overall Study|termination of pregnancy|0|||
126290749|NCT01547390|454350695|FG001|Overall Study|termination of pregnancy|1|||
126290750|NCT01547390|454350694|FG000|Overall Study|Lost to Follow-up|0|||
126290751|NCT01547390|454350695|FG001|Overall Study|Lost to Follow-up|2|||
126290752|NCT01547390|454350694|FG000|Overall Study|Adverse Event|3|||
126290753|NCT01547390|454350695|FG001|Overall Study|Adverse Event|0|||
126290754|NCT01459783|454350696|FG000|Baseline to 6 Months|Death|1|||
126290755|NCT01459783|454350697|FG001|Baseline to 6 Months|Death|0|||
126290756|NCT01459783|454350696|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
126290757|NCT01459783|454350697|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
126290758|NCT01459783|454350696|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
126290759|NCT01459783|454350697|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
126290760|NCT01459783|454350696|FG000|6 Months to 12 Months|Death|0|||
126290761|NCT01459783|454350697|FG001|6 Months to 12 Months|Death|1|||
126290762|NCT01459783|454350696|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
126290763|NCT01459783|454350697|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
126290764|NCT01459783|454350696|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
126290765|NCT01459783|454350697|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
126290766|NCT01459783|454350696|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
126290767|NCT01459783|454350697|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
126290768|NCT04211831|454350698|FG000|Overall Study|Withdrawal by Subject|4|||
126290769|NCT04211831|454350699|FG001|Overall Study|Withdrawal by Subject|1|||
126290770|NCT04211831|454350700|FG002|Overall Study|Withdrawal by Subject|1|||
126290771|NCT04211831|454350698|FG000|Overall Study|Protocol Violation|0|||
126290772|NCT04211831|454350699|FG001|Overall Study|Protocol Violation|0|||
126290773|NCT04211831|454350700|FG002|Overall Study|Protocol Violation|1|||
126290774|NCT04211831|454350698|FG000|Overall Study|Adverse Event|0|||
126290775|NCT04211831|454350699|FG001|Overall Study|Adverse Event|1|||
126290776|NCT04211831|454350700|FG002|Overall Study|Adverse Event|0|||
126290777|NCT04211831|454350698|FG000|Overall Study|Lack of Efficacy|0|||
126290778|NCT04211831|454350699|FG001|Overall Study|Lack of Efficacy|0|||
126290779|NCT04211831|454350700|FG002|Overall Study|Lack of Efficacy|1|||
126290780|NCT04211831|454350698|FG000|Overall Study|Lost to Follow-up|0|||
126290781|NCT04211831|454350699|FG001|Overall Study|Lost to Follow-up|0|||
126290782|NCT04211831|454350700|FG002|Overall Study|Lost to Follow-up|2|||
126290783|NCT04211831|454350698|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
126290784|NCT04211831|454350699|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
126290785|NCT04211831|454350700|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
126290786|NCT04211831|454350698|FG000|Overall Study|Other|0|||
126290787|NCT04211831|454350699|FG001|Overall Study|Other|1|||
126290788|NCT04211831|454350700|FG002|Overall Study|Other|0|||
126290789|NCT01256879|454350701|FG000|Overall Study|Withdrawal by Subject|1|||
126290790|NCT00640315|454350702|FG000|Overall Study|Withdrawal by Subject|0|||
126290791|NCT00640315|454350703|FG001|Overall Study|Withdrawal by Subject|1|||
126290792|NCT00397514|454350704|FG000|Overall Study|Withdrawal by Subject|1|||
126290793|NCT00397514|454350704|FG000|Overall Study|Pacing wire malfunction|1|||
126290794|NCT00397514|454350704|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
126290795|NCT00397514|454350704|FG000|Overall Study|early extubation|2|||
126290796|NCT00397514|454350704|FG000|Overall Study|poor echocardiographic windows|1|||
126290797|NCT03493685|454352791|FG000|Overall Study|Death|4|||
126290798|NCT03493685|454352792|FG001|Overall Study|Death|3|||
126290799|NCT03493685|454352791|FG000|Overall Study|Lost to Follow-up|3|||
126290800|NCT03493685|454352792|FG001|Overall Study|Lost to Follow-up|2|||
126290801|NCT03493685|454352791|FG000|Overall Study|Physician Decision|2|||
126290802|NCT03493685|454352792|FG001|Overall Study|Physician Decision|0|||
126290803|NCT03493685|454352791|FG000|Overall Study|Withdrawal by Subject|7|||
126290804|NCT03493685|454352792|FG001|Overall Study|Withdrawal by Subject|11|||
126290805|NCT04452669|454352793|FG000|Overall Study|Death|1|||
126290806|NCT04452669|454352794|FG001|Overall Study|Death|4|||
126290807|NCT03300817|454352795|FG000|Overall Study|Withdrawal by Subject|1|||
126290808|NCT03300817|454352795|FG000|Overall Study|Adverse Event|1|||
126290809|NCT03300817|454352795|FG000|Overall Study|Subject Found to be Ineligible|2|||
126290810|NCT00265759|454352796|FG000|Overall Study|Withdrawal by Subject|0|||
126290811|NCT00265759|454352797|FG001|Overall Study|Withdrawal by Subject|1|||
126290812|NCT00265759|454352798|FG002|Overall Study|Withdrawal by Subject|2|||
126290813|NCT00265759|454352799|FG003|Overall Study|Withdrawal by Subject|2|||
126290814|NCT00265759|454352796|FG000|Overall Study|Cancel|0|||
126290815|NCT00265759|454352797|FG001|Overall Study|Cancel|0|||
126366128|NCT02014467|454635728|FG000|Overall Study|Withdrawal by Subject|16|||
126366129|NCT02014467|454635729|FG001|Overall Study|Withdrawal by Subject|4|||
126366130|NCT00831389|454635732|FG000|Overall Study|Withdrawal by Subject|0|||
126366131|NCT00831389|454635733|FG001|Overall Study|Withdrawal by Subject|1|||
126366132|NCT00124657|454635735|FG000|Overall Study|Toxicity|0|||
126366133|NCT00124657|454635736|FG001|Overall Study|Toxicity|0|||
126366134|NCT00124657|454635737|FG002|Overall Study|Toxicity|1|||
126366135|NCT00124657|454635735|FG000|Overall Study|Non-compliance|1|||
126366136|NCT00124657|454635736|FG001|Overall Study|Non-compliance|0|||
126366137|NCT00124657|454635737|FG002|Overall Study|Non-compliance|4|||
126366138|NCT00124657|454635735|FG000|Overall Study|Progressive disease|14|||
126366139|NCT00124657|454635736|FG001|Overall Study|Progressive disease|5|||
126366140|NCT00124657|454635737|FG002|Overall Study|Progressive disease|27|||
126366141|NCT00124657|454635735|FG000|Overall Study|Intercurrent illness|1|||
126366142|NCT00124657|454635736|FG001|Overall Study|Intercurrent illness|0|||
126366143|NCT00124657|454635737|FG002|Overall Study|Intercurrent illness|0|||
126366144|NCT01378195|454635738|FG000|Overall Study|Lost to Follow-up|29|||
126366145|NCT01378195|454635739|FG001|Overall Study|Lost to Follow-up|18|||
126366146|NCT00841815|454635746|FG000|Washout|Withdrawal by Subject|0|||
126366147|NCT00841815|454635747|FG001|Washout|Withdrawal by Subject|1|||
126366148|NCT01148771|454635749|FG000|Washout Period|Withdrawal by Subject|0|||
126366149|NCT01148771|454635750|FG001|Washout Period|Withdrawal by Subject|1|||
126366150|NCT03787615|454635751|FG000|Overall Study|Withdrawal by Subject|2|||
126366151|NCT03787615|454635751|FG000|Overall Study|Lost to Follow-up|2|||
126366152|NCT03464461|454635752|FG000|Overall Study|exclusionary medication given ,|1|||
126366153|NCT03464461|454635753|FG001|Overall Study|exclusionary medication given ,|2|||
126366154|NCT03464461|454635754|FG002|Overall Study|exclusionary medication given ,|0|||
126366155|NCT03464461|454635752|FG000|Overall Study|Physician Decision|0|||
126366156|NCT03464461|454635753|FG001|Overall Study|Physician Decision|1|||
126366157|NCT03464461|454635754|FG002|Overall Study|Physician Decision|0|||
126366158|NCT03685149|454635756|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
126366159|NCT03685149|454635757|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
126366160|NCT03685149|454635756|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126366161|NCT03685149|454635757|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126366162|NCT03685149|454635756|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
126366163|NCT03685149|454635757|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
126366164|NCT02609503|454635758|FG000|Overall Study|Adverse Event|1|||
126366165|NCT02609503|454635758|FG000|Overall Study|Death|1|||
126366166|NCT02609503|454635758|FG000|Overall Study|Withdrawal by Subject|1|||
126366167|NCT02609503|454635758|FG000|Overall Study|Disease progression|1|||
126366168|NCT03647137|454635759|FG000|Overall Study|Scan Limitation|2|||
126366169|NCT03647137|454635760|FG001|Overall Study|Scan Limitation|1|||
126366170|NCT03647137|454635761|FG002|Overall Study|Scan Limitation|1|||
126366171|NCT03647137|454635762|FG003|Overall Study|Scan Limitation|2|||
126366172|NCT02226653|454635763|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
126366173|NCT02226653|454635764|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
126366174|NCT02226653|454635763|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
126366175|NCT02226653|454635764|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
126366176|NCT04876391|454635766|FG000|Overall Study|Withdrawal by Subject|1|||
126366177|NCT04876391|454635767|FG001|Overall Study|Withdrawal by Subject|10|||
126366178|NCT04876391|454635766|FG000|Overall Study|Lost to Follow-up|2|||
126366179|NCT04876391|454635767|FG001|Overall Study|Lost to Follow-up|4|||
126366180|NCT04876391|454635766|FG000|Overall Study|Lack of Efficacy|0|||
126366181|NCT04876391|454635767|FG001|Overall Study|Lack of Efficacy|2|||
126366182|NCT04876391|454635766|FG000|Overall Study|Adverse Event|3|||
126366183|NCT04876391|454635767|FG001|Overall Study|Adverse Event|1|||
126366184|NCT04876391|454635766|FG000|Overall Study|Patient non-compliance|0|||
126366185|NCT04876391|454635767|FG001|Overall Study|Patient non-compliance|1|||
126366186|NCT04876391|454635766|FG000|Overall Study|Personal reasons|0|||
126366187|NCT04876391|454635767|FG001|Overall Study|Personal reasons|1|||
126366188|NCT04876391|454635766|FG000|Overall Study|Withdrawn as per protocol|2|||
126366189|NCT04876391|454635767|FG001|Overall Study|Withdrawn as per protocol|2|||
126366190|NCT00209131|454635773|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
126366191|NCT00209131|454635774|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
125883138|NCT00463567|452871420|FG005|Overall Study|Administrative problems|2|||
126366192|NCT05360784|454635775|FG000|Overall Study|Discontinued|25|||
125883139|NCT00463567|452871421|FG006|Overall Study|Administrative problems|2|||
126100000|NCT02924428|453659797|FG000|Overall Study|Physician Decision|1|||
126366193|NCT05360784|454635776|FG001|Overall Study|Discontinued|11|||
126366194|NCT05142306|454635777|FG000|Overall Study|Withdrawal by Subject|0|||
126366195|NCT05142306|454635778|FG001|Overall Study|Withdrawal by Subject|0|||
126366196|NCT05142306|454635779|FG002|Overall Study|Withdrawal by Subject|1|||
126366197|NCT02251041|454635780|FG000|Overall Study|Did not receive intervention|15|||
126366198|NCT02251041|454635781|FG001|Overall Study|Did not receive intervention|4|||
126366199|NCT04079920|454635782|FG000|Overall Study|Adverse event, not related to study drug|2|||
126366200|NCT04079920|454635782|FG000|Overall Study|Adverse event related to study drug|10|||
126366201|NCT04079920|454635782|FG000|Overall Study|Death|2|||
126290816|NCT00265759|454352798|FG002|Overall Study|Cancel|0|||
126290817|NCT00265759|454352799|FG003|Overall Study|Cancel|3|||
126290818|NCT00265759|454352796|FG000|Overall Study|Ineligible|0|||
126290819|NCT00265759|454352797|FG001|Overall Study|Ineligible|0|||
126290820|NCT00265759|454352798|FG002|Overall Study|Ineligible|0|||
126290821|NCT00265759|454352799|FG003|Overall Study|Ineligible|1|||
126290822|NCT00265759|454352796|FG000|Overall Study|Bilateral disease|0|||
126290823|NCT00265759|454352797|FG001|Overall Study|Bilateral disease|0|||
126290824|NCT00265759|454352798|FG002|Overall Study|Bilateral disease|0|||
126290825|NCT00265759|454352799|FG003|Overall Study|Bilateral disease|2|||
126290826|NCT00265759|454352796|FG000|Overall Study|Discontinued due to intolerability|0|||
126290827|NCT00265759|454352797|FG001|Overall Study|Discontinued due to intolerability|0|||
126290828|NCT00265759|454352798|FG002|Overall Study|Discontinued due to intolerability|0|||
126290829|NCT00265759|454352799|FG003|Overall Study|Discontinued due to intolerability|1|||
126290830|NCT03729596|454352802|FG000|Overall Study|Death|3|||
126290831|NCT03729596|454352803|FG001|Overall Study|Death|5|||
126290832|NCT03729596|454352804|FG002|Overall Study|Death|4|||
126290833|NCT03729596|454352805|FG003|Overall Study|Death|1|||
126290834|NCT03729596|454352806|FG004|Overall Study|Death|0|||
126290835|NCT03729596|454352807|FG005|Overall Study|Death|34|||
126290836|NCT03729596|454352808|FG006|Overall Study|Death|18|||
126290837|NCT03729596|454352809|FG007|Overall Study|Death|14|||
126290838|NCT03729596|454352810|FG008|Overall Study|Death|19|||
126290839|NCT03729596|454352811|FG009|Overall Study|Death|9|||
126290840|NCT03729596|454352802|FG000|Overall Study|Lost to Follow-up|0|||
126290841|NCT03729596|454352803|FG001|Overall Study|Lost to Follow-up|0|||
126290842|NCT03729596|454352804|FG002|Overall Study|Lost to Follow-up|0|||
126290843|NCT03729596|454352805|FG003|Overall Study|Lost to Follow-up|0|||
126290844|NCT03729596|454352806|FG004|Overall Study|Lost to Follow-up|0|||
126290845|NCT03729596|454352807|FG005|Overall Study|Lost to Follow-up|0|||
126290846|NCT03729596|454352808|FG006|Overall Study|Lost to Follow-up|1|||
126290847|NCT03729596|454352809|FG007|Overall Study|Lost to Follow-up|0|||
126290848|NCT03729596|454352810|FG008|Overall Study|Lost to Follow-up|0|||
126290849|NCT03729596|454352811|FG009|Overall Study|Lost to Follow-up|1|||
126290850|NCT03729596|454352802|FG000|Overall Study|protocol amendment|0|||
126290851|NCT03729596|454352803|FG001|Overall Study|protocol amendment|1|||
126290852|NCT03729596|454352804|FG002|Overall Study|protocol amendment|3|||
126290853|NCT03729596|454352805|FG003|Overall Study|protocol amendment|6|||
126290854|NCT03729596|454352806|FG004|Overall Study|protocol amendment|5|||
126290855|NCT03729596|454352807|FG005|Overall Study|protocol amendment|0|||
126290856|NCT03729596|454352808|FG006|Overall Study|protocol amendment|0|||
126290857|NCT03729596|454352809|FG007|Overall Study|protocol amendment|0|||
126290858|NCT03729596|454352810|FG008|Overall Study|protocol amendment|0|||
126290859|NCT03729596|454352811|FG009|Overall Study|protocol amendment|0|||
126290860|NCT03729596|454352802|FG000|Overall Study|Withdrawal by Subject|0|||
126290861|NCT03729596|454352803|FG001|Overall Study|Withdrawal by Subject|0|||
126290862|NCT03729596|454352804|FG002|Overall Study|Withdrawal by Subject|0|||
126290863|NCT03729596|454352805|FG003|Overall Study|Withdrawal by Subject|0|||
126290864|NCT03729596|454352806|FG004|Overall Study|Withdrawal by Subject|0|||
126290865|NCT03729596|454352807|FG005|Overall Study|Withdrawal by Subject|4|||
126290866|NCT03729596|454352808|FG006|Overall Study|Withdrawal by Subject|2|||
126290867|NCT03729596|454352809|FG007|Overall Study|Withdrawal by Subject|3|||
126290868|NCT03729596|454352810|FG008|Overall Study|Withdrawal by Subject|2|||
126290869|NCT03729596|454352811|FG009|Overall Study|Withdrawal by Subject|3|||
126290870|NCT03729596|454352802|FG000|Overall Study|study terminated by sponsor|0|||
126290871|NCT03729596|454352803|FG001|Overall Study|study terminated by sponsor|0|||
126290872|NCT03729596|454352804|FG002|Overall Study|study terminated by sponsor|0|||
126290873|NCT03729596|454352805|FG003|Overall Study|study terminated by sponsor|0|||
126290874|NCT03729596|454352806|FG004|Overall Study|study terminated by sponsor|1|||
126290875|NCT03729596|454352807|FG005|Overall Study|study terminated by sponsor|3|||
126290876|NCT03729596|454352808|FG006|Overall Study|study terminated by sponsor|0|||
126290877|NCT03729596|454352809|FG007|Overall Study|study terminated by sponsor|1|||
126290878|NCT03729596|454352810|FG008|Overall Study|study terminated by sponsor|0|||
126290879|NCT03729596|454352811|FG009|Overall Study|study terminated by sponsor|0|||
126290880|NCT04467840|454352812|FG000|Overall Study|Death|35|||
126290881|NCT04467840|454352813|FG001|Overall Study|Death|39|||
126290882|NCT04467840|454352812|FG000|Overall Study|Withdrawal by Subject|8|||
126290883|NCT04467840|454352813|FG001|Overall Study|Withdrawal by Subject|4|||
126290884|NCT04467840|454352812|FG000|Overall Study|Adverse Event|2|||
126290885|NCT04467840|454352813|FG001|Overall Study|Adverse Event|0|||
126290886|NCT04467840|454352812|FG000|Overall Study|Lost to Follow-up|1|||
126290887|NCT04467840|454352813|FG001|Overall Study|Lost to Follow-up|3|||
126290888|NCT04467840|454352812|FG000|Overall Study|Physician Decision|1|||
126290889|NCT04467840|454352813|FG001|Overall Study|Physician Decision|0|||
126290890|NCT04467840|454352812|FG000|Overall Study|Other|1|||
126290891|NCT04467840|454352813|FG001|Overall Study|Other|5|||
126290892|NCT04467840|454352812|FG000|Overall Study|Missing study completion status|3|||
126290893|NCT04467840|454352813|FG001|Overall Study|Missing study completion status|1|||
126290894|NCT05201794|454352816|FG000|Overall Study|Withdrawal by Subject|13|||
126290895|NCT05201794|454352817|FG001|Overall Study|Withdrawal by Subject|12|||
126290896|NCT05201794|454352818|FG002|Overall Study|Withdrawal by Subject|14|||
126290897|NCT05201794|454352819|FG003|Overall Study|Withdrawal by Subject|0|||
126290898|NCT05201794|454352816|FG000|Overall Study|Adverse Event|5|||
126290899|NCT05201794|454352817|FG001|Overall Study|Adverse Event|5|||
126290900|NCT05201794|454352818|FG002|Overall Study|Adverse Event|4|||
126290901|NCT05201794|454352819|FG003|Overall Study|Adverse Event|0|||
126290902|NCT05201794|454352816|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
126290903|NCT05201794|454352817|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126290904|NCT05201794|454352818|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
126290905|NCT05201794|454352819|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126290906|NCT05201794|454352816|FG000|Overall Study|Non-Compliance With Study Drug|2|||
126290907|NCT05201794|454352817|FG001|Overall Study|Non-Compliance With Study Drug|3|||
126290908|NCT05201794|454352818|FG002|Overall Study|Non-Compliance With Study Drug|3|||
126290909|NCT05201794|454352819|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126290910|NCT05201794|454352816|FG000|Overall Study|Physician Decision|1|||
126290911|NCT05201794|454352817|FG001|Overall Study|Physician Decision|3|||
126290912|NCT05201794|454352818|FG002|Overall Study|Physician Decision|2|||
126290913|NCT05201794|454352819|FG003|Overall Study|Physician Decision|0|||
126290914|NCT05201794|454352816|FG000|Overall Study|Lost to Follow-up|2|||
126290915|NCT05201794|454352817|FG001|Overall Study|Lost to Follow-up|2|||
126290916|NCT05201794|454352818|FG002|Overall Study|Lost to Follow-up|0|||
126290917|NCT05201794|454352819|FG003|Overall Study|Lost to Follow-up|0|||
126290918|NCT05201794|454352816|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
126290919|NCT05201794|454352817|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
126290920|NCT05201794|454352818|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
126290921|NCT05201794|454352819|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
126290922|NCT05201794|454352816|FG000|Overall Study|Protocol Violation|2|||
126290923|NCT05201794|454352817|FG001|Overall Study|Protocol Violation|0|||
126290924|NCT05201794|454352818|FG002|Overall Study|Protocol Violation|1|||
126290925|NCT05201794|454352819|FG003|Overall Study|Protocol Violation|0|||
126290926|NCT05201794|454352816|FG000|Overall Study|Death|1|||
126290927|NCT05201794|454352817|FG001|Overall Study|Death|0|||
126290928|NCT05201794|454352818|FG002|Overall Study|Death|0|||
126290929|NCT05201794|454352819|FG003|Overall Study|Death|0|||
126290930|NCT05201794|454352816|FG000|Overall Study|Site Terminated By Sponsor|0|||
126290931|NCT05201794|454352817|FG001|Overall Study|Site Terminated By Sponsor|1|||
126290932|NCT05201794|454352818|FG002|Overall Study|Site Terminated By Sponsor|0|||
126290933|NCT05201794|454352819|FG003|Overall Study|Site Terminated By Sponsor|0|||
126290934|NCT05201794|454352816|FG000|Overall Study|Other|3|||
126290935|NCT05201794|454352817|FG001|Overall Study|Other|3|||
126290936|NCT05201794|454352818|FG002|Overall Study|Other|3|||
126290937|NCT05201794|454352819|FG003|Overall Study|Other|0|||
126290938|NCT05201794|454352816|FG000|Overall Study|Randomized But Not Treated|1|||
126290939|NCT05201794|454352817|FG001|Overall Study|Randomized But Not Treated|2|||
126290940|NCT05201794|454352818|FG002|Overall Study|Randomized But Not Treated|1|||
126290941|NCT05201794|454352819|FG003|Overall Study|Randomized But Not Treated|0|||
126290942|NCT04653454|454352824|FG000|Overall Study|Withdrawal by Subject|1|||
126290943|NCT04653454|454352824|FG000|Overall Study|Physician Decision|40|||
126290944|NCT03620708|454352825|FG000|Overall Study|Lost to Follow-up|1|||
126290945|NCT03620708|454352826|FG001|Overall Study|Lost to Follow-up|1|||
126290946|NCT03620708|454352827|FG002|Overall Study|Lost to Follow-up|2|||
126290947|NCT03620708|454352825|FG000|Overall Study|Withdrawal by Subject|0|||
126290948|NCT03620708|454352826|FG001|Overall Study|Withdrawal by Subject|0|||
126100001|NCT02924428|453659798|FG001|Overall Study|Physician Decision|0|||
126290949|NCT03620708|454352827|FG002|Overall Study|Withdrawal by Subject|1|||
126290950|NCT05126693|454352828|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
126290951|NCT05126693|454352829|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
126290952|NCT05126693|454352828|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
126290953|NCT05126693|454352829|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
126290954|NCT05126693|454352828|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
126290955|NCT05126693|454352829|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
126290956|NCT06082843|454352834|FG000|Overall Study|Withdrawal by Subject|0|||
126290957|NCT06082843|454352835|FG001|Overall Study|Withdrawal by Subject|2|||
126290958|NCT06082843|454352834|FG000|Overall Study|Study terminated by sponsor|12|||
126290959|NCT06082843|454352835|FG001|Overall Study|Study terminated by sponsor|8|||
126290960|NCT05525520|454352837|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
126290961|NCT05525520|454352838|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
126290962|NCT05525520|454352837|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
126290963|NCT05525520|454352838|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
126290964|NCT03176134|454352839|FG000|Overall Study|Lost to Follow-up|0|||
126290965|NCT03176134|454352840|FG001|Overall Study|Lost to Follow-up|2|||
126290966|NCT03176134|454352841|FG002|Overall Study|Lost to Follow-up|0|||
126290967|NCT03176134|454352842|FG003|Overall Study|Lost to Follow-up|0|||
126290968|NCT03176134|454352843|FG004|Overall Study|Lost to Follow-up|0|||
126290969|NCT03176134|454352844|FG005|Overall Study|Lost to Follow-up|0|||
126290970|NCT03176134|454352845|FG006|Overall Study|Lost to Follow-up|0|||
126290971|NCT03176134|454352846|FG007|Overall Study|Lost to Follow-up|0|||
126290972|NCT03176134|454352839|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126290973|NCT03176134|454352840|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126290974|NCT03176134|454352841|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
126290975|NCT03176134|454352842|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126290976|NCT03176134|454352843|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126290977|NCT03176134|454352844|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126290978|NCT03176134|454352845|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
126290979|NCT03176134|454352846|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
126290980|NCT05989672|454352847|FG000|Overall Study|Adverse Event|3|||
126290981|NCT05989672|454352848|FG001|Overall Study|Adverse Event|0|||
126290982|NCT05989672|454352849|FG002|Overall Study|Adverse Event|0|||
126290983|NCT00443729|454352850|FG000|Overall Study|Never Treated|0|||
126290984|NCT00443729|454352851|FG001|Overall Study|Never Treated|1|||
126290985|NCT00443729|454352850|FG000|Overall Study|Lack of Efficacy|4|||
126290986|NCT00443729|454352851|FG001|Overall Study|Lack of Efficacy|2|||
126290987|NCT00443729|454352850|FG000|Overall Study|Lost to Follow-up|0|||
126290988|NCT00443729|454352851|FG001|Overall Study|Lost to Follow-up|1|||
126290989|NCT00443729|454352850|FG000|Overall Study|Physician Decision|2|||
126290990|NCT00443729|454352851|FG001|Overall Study|Physician Decision|1|||
126290991|NCT00443729|454352850|FG000|Overall Study|Protocol Violation|1|||
126290992|NCT00443729|454352851|FG001|Overall Study|Protocol Violation|1|||
126290993|NCT00443729|454352850|FG000|Overall Study|Withdrawal by Subject|3|||
126290994|NCT00443729|454352851|FG001|Overall Study|Withdrawal by Subject|1|||
126290995|NCT03642262|454352852|FG000|Period 1|Withdrawal by Subject|1|||
126290996|NCT03642262|454352853|FG001|Period 1|Withdrawal by Subject|1|||
126290997|NCT03642262|454352852|FG000|Period 1|Adverse Event|0|||
126290998|NCT03642262|454352853|FG001|Period 1|Adverse Event|1|||
126290999|NCT03718832|454352860|FG000|Analysis Sample|Withdrawal by Subject|18|||
126291000|NCT03718832|454352861|FG001|Analysis Sample|Withdrawal by Subject|15|||
126291001|NCT03718832|454352860|FG000|Analysis Sample|Legal hold on data|1|||
126291002|NCT03718832|454352861|FG001|Analysis Sample|Legal hold on data|0|||
126291003|NCT03718832|454352860|FG000|Analysis Sample|Participant from treated household|0|||
126291004|NCT03718832|454352861|FG001|Analysis Sample|Participant from treated household|1|||
126291005|NCT03718832|454352860|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
126291006|NCT03718832|454352861|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
126291007|NCT02760004|454352865|FG000|Overall Study|Lost to Follow-up|13|||
126291008|NCT02760004|454352866|FG001|Overall Study|Lost to Follow-up|22|||
126366202|NCT04079920|454635782|FG000|Overall Study|Lost to Follow-up|22|||
126366203|NCT04079920|454635782|FG000|Overall Study|Physician Decision|1|||
126366204|NCT04079920|454635782|FG000|Overall Study|Withdrawal by Subject|11|||
126366205|NCT04918771|454635783|FG000|Overall Study|Withdrawal by Subject|4|||
126366206|NCT04918771|454635784|FG001|Overall Study|Withdrawal by Subject|5|||
126366207|NCT04918771|454635783|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
126366208|NCT04918771|454635784|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
126366209|NCT00680914|454635789|FG000|Overall Study|Consent withdrawal|6|||
126042117|NCT03580356|453453101|FG006|Treatment Period|Death|0|||
126042118|NCT03580356|453453102|FG007|Treatment Period|Death|0|||
126042119|NCT03580356|453453095|FG000|Treatment Period|Technical problems|0|||
126042120|NCT03580356|453453096|FG001|Treatment Period|Technical problems|0|||
126291009|NCT03288714|454352869|FG000|Overall Study|Lost to Follow-up|2|||
126291010|NCT03288714|454352870|FG001|Overall Study|Lost to Follow-up|1|||
126291011|NCT03288714|454352869|FG000|Overall Study|Non-compliance with study schedule|2|||
126291012|NCT03288714|454352870|FG001|Overall Study|Non-compliance with study schedule|0|||
126291013|NCT03288714|454352869|FG000|Overall Study|Withdrawal by Subject|3|||
126291014|NCT03288714|454352870|FG001|Overall Study|Withdrawal by Subject|1|||
126291015|NCT03288714|454352869|FG000|Overall Study|Clinical Worsening|2|||
126366210|NCT00680914|454635790|FG001|Overall Study|Consent withdrawal|3|||
126366211|NCT00680914|454635789|FG000|Overall Study|Lost to Follow-up|4|||
126291016|NCT03288714|454352870|FG001|Overall Study|Clinical Worsening|1|||
126366212|NCT00680914|454635790|FG001|Overall Study|Lost to Follow-up|0|||
126291017|NCT03288714|454352869|FG000|Overall Study|Adverse Event|1|||
126042121|NCT03580356|453453097|FG002|Treatment Period|Technical problems|0|||
126291018|NCT03288714|454352870|FG001|Overall Study|Adverse Event|0|||
126291019|NCT02203357|454352873|FG000|Overall Study|Lost to Follow-up|58|||
126291020|NCT02203357|454352874|FG001|Overall Study|Lost to Follow-up|66|||
126291021|NCT02203357|454352875|FG002|Overall Study|Lost to Follow-up|70|||
126291022|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
126291023|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
126291024|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
126291025|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291026|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
126291027|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
126291028|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291029|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291030|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291031|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291032|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291033|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291034|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291035|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291036|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291037|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291038|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291039|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
126291040|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291041|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
126291042|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
126291043|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
126291044|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
126291045|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291046|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291047|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291048|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291049|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291050|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291051|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291052|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291053|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291054|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291055|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291056|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
126291057|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
126291058|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
126291059|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
126291060|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
126291061|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
126291062|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291063|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291064|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291065|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291066|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291067|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291068|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291069|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291070|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291071|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291072|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291073|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291074|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
126366213|NCT00680914|454635789|FG000|Overall Study|serious adverse event (SAE)|0|||
126291075|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
126291076|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291077|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
126291078|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
126291079|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291080|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126366214|NCT00680914|454635790|FG001|Overall Study|serious adverse event (SAE)|1|||
126366215|NCT00539500|454635791|FG000|Overall Study|Disease Progression|1|||
126366216|NCT00539500|454635791|FG000|Overall Study|Lost to Follow-up|2|||
126366217|NCT01299961|454635794|FG000|Overall Study|Adverse Event|3|||
126291081|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291082|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126100002|NCT02924428|453659797|FG000|Overall Study|Lost to Follow-up|2|||
126100003|NCT02924428|453659798|FG001|Overall Study|Lost to Follow-up|4|||
126100004|NCT02924428|453659797|FG000|Overall Study|Pregnancy|0|||
126100005|NCT02924428|453659798|FG001|Overall Study|Pregnancy|1|||
126100006|NCT01850446|453659799|FG000|Overall Study|Lack of Efficacy|1|||
126100007|NCT01850446|453659800|FG001|Overall Study|Lack of Efficacy|0|||
126100008|NCT01850446|453659799|FG000|Overall Study|Withdrawal by Subject|4|||
126100009|NCT01850446|453659800|FG001|Overall Study|Withdrawal by Subject|0|||
126100010|NCT01850446|453659799|FG000|Overall Study|Protocol Violation|0|||
126100011|NCT01850446|453659800|FG001|Overall Study|Protocol Violation|2|||
126100012|NCT02680002|453659801|FG000|Overall Study|Lost to Follow-up|5|||
126100013|NCT02680002|453659802|FG001|Overall Study|Lost to Follow-up|1|||
126100014|NCT02680002|453659803|FG002|Overall Study|Lost to Follow-up|4|||
126100015|NCT02680002|453659804|FG003|Overall Study|Lost to Follow-up|2|||
126100016|NCT02680002|453659805|FG004|Overall Study|Lost to Follow-up|0|||
126100017|NCT02680002|453659806|FG005|Overall Study|Lost to Follow-up|2|||
126100018|NCT02680002|453659801|FG000|Overall Study|Physician Decision|5|||
126100019|NCT02680002|453659802|FG001|Overall Study|Physician Decision|1|||
126100020|NCT02680002|453659803|FG002|Overall Study|Physician Decision|1|||
126100021|NCT02680002|453659804|FG003|Overall Study|Physician Decision|1|||
126100022|NCT02680002|453659805|FG004|Overall Study|Physician Decision|1|||
126100023|NCT02680002|453659806|FG005|Overall Study|Physician Decision|1|||
126100024|NCT02680002|453659801|FG000|Overall Study|Protocol Violation|1|||
126291083|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291084|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291085|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291086|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291087|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291088|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291089|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291090|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291091|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291092|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
126291093|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
126291094|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291095|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291096|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291097|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291098|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291099|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291100|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291101|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291102|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291103|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291104|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291105|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291106|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291107|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291108|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291109|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291110|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291111|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
126291112|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291113|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291114|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291115|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291116|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291117|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291118|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291119|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291120|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291121|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291122|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126100025|NCT02680002|453659802|FG001|Overall Study|Protocol Violation|0|||
126100026|NCT02680002|453659803|FG002|Overall Study|Protocol Violation|1|||
126100027|NCT02680002|453659804|FG003|Overall Study|Protocol Violation|0|||
126100028|NCT02680002|453659805|FG004|Overall Study|Protocol Violation|1|||
126100029|NCT02680002|453659806|FG005|Overall Study|Protocol Violation|2|||
126100030|NCT02680002|453659801|FG000|Overall Study|Withdrawal by Subject|0|||
126100031|NCT02680002|453659802|FG001|Overall Study|Withdrawal by Subject|0|||
126291123|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126366218|NCT01299961|454635794|FG000|Overall Study|Lack of Efficacy|2|||
126291124|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291125|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
126291126|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291127|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291128|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291129|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291130|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291131|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291132|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291133|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291134|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291135|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291136|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291137|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291138|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291139|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291140|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291141|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291142|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
126291143|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291144|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291145|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291146|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291147|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291148|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291149|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291150|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291151|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291152|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291153|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291154|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291155|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291156|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291157|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291158|NCT00758524|454352877|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291159|NCT00758524|454352878|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291160|NCT00758524|454352879|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291161|NCT00758524|454352880|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291162|NCT00758524|454352881|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291163|NCT00758524|454352882|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291164|NCT00758524|454352883|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291165|NCT00758524|454352884|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291166|NCT00758524|454352885|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
126291167|NCT00758524|454352886|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291168|NCT00758524|454352887|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291169|NCT00758524|454352888|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291170|NCT00758524|454352889|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291171|NCT00758524|454352890|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291172|NCT00758524|454352891|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291173|NCT00758524|454352892|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291174|NCT00758524|454352893|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291175|NCT00758524|454352877|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291176|NCT00758524|454352878|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291177|NCT00758524|454352879|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291178|NCT00758524|454352880|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291179|NCT00758524|454352881|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291180|NCT00758524|454352882|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291181|NCT00758524|454352883|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
126291182|NCT00758524|454352884|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291183|NCT00758524|454352885|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126366219|NCT01299961|454635794|FG000|Overall Study|Lost to Follow-up|1|||
126366220|NCT02904096|454635795|FG000|Overall Study|Adverse Event|1|||
126366221|NCT02904096|454635796|FG001|Overall Study|Adverse Event|0|||
126291184|NCT00758524|454352886|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291185|NCT00758524|454352887|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291186|NCT00758524|454352888|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291187|NCT00758524|454352889|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291188|NCT00758524|454352890|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291189|NCT00758524|454352891|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291190|NCT00758524|454352892|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291191|NCT00758524|454352893|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291192|NCT01973439|454352897|FG000|Overall Study|Lost samples from one PK Day|2|||
126291193|NCT01973439|454352897|FG000|Overall Study|Vomiting after commencing once daily|1|||
126291194|NCT01973439|454352897|FG000|Overall Study|PK curve incomplete|2|||
126291195|NCT02038010|454352898|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
126291196|NCT02038010|454352899|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
126291197|NCT02038010|454352900|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
126291198|NCT02038010|454352901|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
126291199|NCT02038010|454352898|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
126291200|NCT02038010|454352899|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
126291201|NCT02038010|454352900|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
126291202|NCT02038010|454352901|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
126291203|NCT02038010|454352898|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
126291204|NCT02038010|454352899|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
126291205|NCT02038010|454352900|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
126291206|NCT02038010|454352901|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
126291207|NCT02038010|454352898|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
126291208|NCT02038010|454352899|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
126291209|NCT02038010|454352900|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
126291210|NCT02038010|454352901|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
126291211|NCT02038010|454352898|FG000|Follow Up|Death|4|||
126291212|NCT02038010|454352899|FG001|Follow Up|Death|3|||
126291213|NCT02038010|454352900|FG002|Follow Up|Death|0|||
126291214|NCT02038010|454352901|FG003|Follow Up|Death|0|||
126291215|NCT02038010|454352898|FG000|Follow Up|Other|3|||
126291216|NCT02038010|454352899|FG001|Follow Up|Other|0|||
126291217|NCT02038010|454352900|FG002|Follow Up|Other|0|||
126291218|NCT02038010|454352901|FG003|Follow Up|Other|0|||
126291219|NCT02815995|454352902|FG000|Overall Study|Disease Progression|3|||
126291220|NCT02815995|454352903|FG001|Overall Study|Disease Progression|7|||
126291221|NCT02815995|454352904|FG002|Overall Study|Disease Progression|2|||
126291222|NCT02815995|454352905|FG003|Overall Study|Disease Progression|4|||
126291223|NCT02815995|454352906|FG004|Overall Study|Disease Progression|3|||
126291224|NCT02815995|454352907|FG005|Overall Study|Disease Progression|9|||
126291225|NCT02815995|454352908|FG006|Overall Study|Disease Progression|3|||
126291226|NCT02815995|454352909|FG007|Overall Study|Disease Progression|1|||
126291227|NCT02815995|454352902|FG000|Overall Study|Adverse Event|1|||
126291228|NCT02815995|454352903|FG001|Overall Study|Adverse Event|2|||
126291229|NCT02815995|454352904|FG002|Overall Study|Adverse Event|2|||
126291230|NCT02815995|454352905|FG003|Overall Study|Adverse Event|0|||
125883140|NCT00463567|452871415|FG000|Overall Study|Lack of Efficacy|4|||
126291231|NCT02815995|454352906|FG004|Overall Study|Adverse Event|0|||
126291232|NCT02815995|454352907|FG005|Overall Study|Adverse Event|1|||
126291233|NCT02815995|454352908|FG006|Overall Study|Adverse Event|0|||
126291234|NCT02815995|454352909|FG007|Overall Study|Adverse Event|0|||
126291235|NCT02815995|454352902|FG000|Overall Study|Pregnancy|0|||
126291236|NCT02815995|454352903|FG001|Overall Study|Pregnancy|0|||
126291237|NCT02815995|454352904|FG002|Overall Study|Pregnancy|0|||
126291238|NCT02815995|454352905|FG003|Overall Study|Pregnancy|0|||
126291239|NCT02815995|454352906|FG004|Overall Study|Pregnancy|0|||
126291240|NCT02815995|454352907|FG005|Overall Study|Pregnancy|0|||
126291241|NCT02815995|454352908|FG006|Overall Study|Pregnancy|1|||
126291242|NCT02815995|454352909|FG007|Overall Study|Pregnancy|0|||
126291243|NCT03571828|454352910|FG000|Overall Study|Withdrawal by Subject|1|||
126291244|NCT03571828|454352911|FG001|Overall Study|Withdrawal by Subject|0|||
126291245|NCT03571828|454352910|FG000|Overall Study|Decision by sponsor|5|||
126291246|NCT03571828|454352911|FG001|Overall Study|Decision by sponsor|1|||
126291247|NCT03571828|454352910|FG000|Overall Study|Death|2|||
126291248|NCT03571828|454352911|FG001|Overall Study|Death|0|||
126291249|NCT01870778|454352912|FG000|Overall Study|Withdrawal by Subject|8|||
126291250|NCT01870778|454352913|FG001|Overall Study|Withdrawal by Subject|7|||
126291251|NCT01870778|454352912|FG000|Overall Study|Lost to Follow-up|0|||
126291252|NCT01870778|454352913|FG001|Overall Study|Lost to Follow-up|2|||
126291253|NCT00786409|454352917|FG000|Overall Study|Withdrawal by Subject|2|||
126291254|NCT00786409|454352917|FG000|Overall Study|Adverse Event|2|||
126291255|NCT00786409|454352917|FG000|Overall Study|Pregnancy|2|||
126291256|NCT00786409|454352917|FG000|Overall Study|Lost to Follow-up|1|||
126291257|NCT00610129|454352918|FG000|Overall Study|Not treated since patients ineligible|3|||
126291258|NCT02198963|454352924|FG000|Overall Study|Adverse Event|1|||
126291259|NCT02198963|454352924|FG000|Overall Study|Withdrawal by Subject|6|||
126291260|NCT00281957|454352929|FG000|Overall Study|Adverse Event|7|||
126291261|NCT00281957|454352930|FG001|Overall Study|Adverse Event|2|||
126291262|NCT00281957|454352929|FG000|Overall Study|Death|1|||
126291263|NCT00281957|454352930|FG001|Overall Study|Death|0|||
126291264|NCT00281957|454352929|FG000|Overall Study|Progression/relapse|47|||
126291265|NCT00281957|454352930|FG001|Overall Study|Progression/relapse|35|||
126291266|NCT00281957|454352929|FG000|Overall Study|Not protocol specified|8|||
126291267|NCT00281957|454352930|FG001|Overall Study|Not protocol specified|1|||
126291268|NCT00281957|454352929|FG000|Overall Study|Not eligible|1|||
126291269|NCT00281957|454352930|FG001|Overall Study|Not eligible|2|||
126291270|NCT00281957|454352929|FG000|Overall Study|Did not start treatment|3|||
126291271|NCT00281957|454352930|FG001|Overall Study|Did not start treatment|1|||
126291272|NCT00281957|454352929|FG000|Overall Study|Refusal unrelated to adverse events|0|||
126291273|NCT00281957|454352930|FG001|Overall Study|Refusal unrelated to adverse events|1|||
126291274|NCT01876446|454352931|FG000|Overall Study|Death|0|||
126291275|NCT01876446|454352932|FG001|Overall Study|Death|1|||
126291276|NCT01876446|454352931|FG000|Overall Study|Withdrawal by Subject|1|||
126291277|NCT01876446|454352932|FG001|Overall Study|Withdrawal by Subject|2|||
126291278|NCT01876446|454352931|FG000|Overall Study|Physician Decision|1|||
126291279|NCT01876446|454352932|FG001|Overall Study|Physician Decision|3|||
126291280|NCT03180645|454352934|FG000|Overall Study|Adverse Event|0|||
126291281|NCT03180645|454352935|FG001|Overall Study|Adverse Event|1|||
126291282|NCT03180645|454352936|FG002|Overall Study|Adverse Event|2|||
126291283|NCT01808573|454352937|FG000|Overall Study|Death|212|||
126291284|NCT01808573|454352938|FG001|Overall Study|Death|240|||
126291285|NCT01808573|454352937|FG000|Overall Study|Withdrawal by Subject|12|||
126291286|NCT01808573|454352938|FG001|Overall Study|Withdrawal by Subject|10|||
126291287|NCT01808573|454352937|FG000|Overall Study|Lost to Follow-up|3|||
126291288|NCT01808573|454352938|FG001|Overall Study|Lost to Follow-up|0|||
126291289|NCT01808573|454352937|FG000|Overall Study|Discontinuation of study by sponsor|79|||
126291290|NCT01808573|454352938|FG001|Overall Study|Discontinuation of study by sponsor|64|||
126291291|NCT01808573|454352937|FG000|Overall Study|Randomized in Error|1|||
126291292|NCT01808573|454352938|FG001|Overall Study|Randomized in Error|0|||
126291293|NCT00995774|454352939|FG000|Training Period 2|Withdrawal by Subject|2|||
126291294|NCT00995774|454352940|FG001|Training Period 2|Withdrawal by Subject|0|||
126291295|NCT03953612|454352941|FG000|Overall Study|Randomized but did not start|1|||
126291296|NCT03953612|454352942|FG001|Overall Study|Randomized but did not start|1|||
126291297|NCT03953612|454352943|FG002|Overall Study|Randomized but did not start|1|||
126291298|NCT03953612|454352941|FG000|Overall Study|Withdrawal by Subject|2|||
126291299|NCT03953612|454352942|FG001|Overall Study|Withdrawal by Subject|1|||
126291300|NCT03953612|454352943|FG002|Overall Study|Withdrawal by Subject|0|||
126291301|NCT01461538|454352959|FG000|Overall Study|Death|15|||
126291302|NCT01461538|454352960|FG001|Overall Study|Death|6|||
126291303|NCT01461538|454352961|FG002|Overall Study|Death|2|||
126291304|NCT01461538|454352959|FG000|Overall Study|Study Stopped by Sponsor|2|||
126291305|NCT01461538|454352960|FG001|Overall Study|Study Stopped by Sponsor|1|||
126291306|NCT01461538|454352961|FG002|Overall Study|Study Stopped by Sponsor|0|||
126291307|NCT01461538|454352959|FG000|Overall Study|Withdrawal by Subject|1|||
126291308|NCT01461538|454352960|FG001|Overall Study|Withdrawal by Subject|1|||
126366222|NCT02904096|454635795|FG000|Overall Study|Withdrawal by Subject|4|||
126291309|NCT01461538|454352961|FG002|Overall Study|Withdrawal by Subject|0|||
126291310|NCT00141778|454352962|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
126291311|NCT00141778|454352963|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
126291312|NCT00141778|454352964|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
126291313|NCT00141778|454352962|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
126291314|NCT00141778|454352963|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
126291315|NCT00141778|454352964|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
126291316|NCT00141778|454352962|FG000|Started Study Medication|Withdrawal by Subject|0|||
126291317|NCT00141778|454352963|FG001|Started Study Medication|Withdrawal by Subject|2|||
126291318|NCT00141778|454352964|FG002|Started Study Medication|Withdrawal by Subject|0|||
126291319|NCT00141778|454352962|FG000|Started Study Medication|Difficulty Swallowing|0|||
126291320|NCT00141778|454352963|FG001|Started Study Medication|Difficulty Swallowing|1|||
126291321|NCT00141778|454352964|FG002|Started Study Medication|Difficulty Swallowing|0|||
126291322|NCT00141778|454352962|FG000|Started Study Medication|Chest Discomfort|0|||
126291323|NCT00141778|454352963|FG001|Started Study Medication|Chest Discomfort|0|||
126291324|NCT00141778|454352964|FG002|Started Study Medication|Chest Discomfort|1|||
126291325|NCT02729909|454352965|FG000|Overall Study|Lost to Follow-up|0|||
126291326|NCT02729909|454352966|FG001|Overall Study|Lost to Follow-up|1|||
126291327|NCT02729909|454352965|FG000|Overall Study|Lack of Efficacy|0|||
126291328|NCT02729909|454352966|FG001|Overall Study|Lack of Efficacy|2|||
126291329|NCT02729909|454352965|FG000|Overall Study|Significant Protocol Deviation|0|||
126291330|NCT02729909|454352966|FG001|Overall Study|Significant Protocol Deviation|2|||
126291331|NCT02729909|454352965|FG000|Overall Study|Voluntary Withdrawal|1|||
126291332|NCT02729909|454352966|FG001|Overall Study|Voluntary Withdrawal|0|||
126291333|NCT01245283|454352971|FG000|Overall Study|Lost to Follow-up|14|||
126291334|NCT01245283|454352972|FG001|Overall Study|Lost to Follow-up|11|||
126291335|NCT01245283|454352973|FG002|Overall Study|Lost to Follow-up|11|||
126291336|NCT01610492|454352976|FG000|Overall Study|Adverse Event|1|||
126291337|NCT01610492|454352976|FG000|Overall Study|Lack of Efficacy|3|||
126291338|NCT01610492|454352976|FG000|Overall Study|Other: Reached stopping criteria|1|||
126291339|NCT01610492|454352976|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
126291340|NCT01982955|454352977|FG000|Overall Study|Randomized but not treated|0|||
126291341|NCT01982955|454352978|FG001|Overall Study|Randomized but not treated|0|||
126291342|NCT01982955|454352979|FG002|Overall Study|Randomized but not treated|0|||
126291343|NCT01982955|454352980|FG003|Overall Study|Randomized but not treated|1|||
126291344|NCT01982955|454352981|FG004|Overall Study|Randomized but not treated|0|||
126291345|NCT03657797|454355104|FG000|Overall Study|Lost to Follow-up|0|||
126291346|NCT03657797|454355105|FG001|Overall Study|Lost to Follow-up|1|||
126291347|NCT03657797|454355106|FG002|Overall Study|Lost to Follow-up|1|||
126291348|NCT03657797|454355107|FG003|Overall Study|Lost to Follow-up|0|||
126291349|NCT03657797|454355104|FG000|Overall Study|Physician Decision|0|||
126291350|NCT03657797|454355105|FG001|Overall Study|Physician Decision|1|||
126291351|NCT03657797|454355106|FG002|Overall Study|Physician Decision|0|||
126291352|NCT03657797|454355107|FG003|Overall Study|Physician Decision|0|||
126291353|NCT03657797|454355104|FG000|Overall Study|Withdrawal by Subject|0|||
126291354|NCT03657797|454355105|FG001|Overall Study|Withdrawal by Subject|1|||
126291355|NCT03657797|454355106|FG002|Overall Study|Withdrawal by Subject|2|||
126291356|NCT03657797|454355107|FG003|Overall Study|Withdrawal by Subject|0|||
126291357|NCT03657797|454355104|FG000|Overall Study|Adverse Event|0|||
126291358|NCT03657797|454355105|FG001|Overall Study|Adverse Event|0|||
126291359|NCT03657797|454355106|FG002|Overall Study|Adverse Event|2|||
126291360|NCT03657797|454355107|FG003|Overall Study|Adverse Event|0|||
126291361|NCT00118157|454355108|FG000|Overall Study|Adverse Event|2|||
126291362|NCT00118157|454355108|FG000|Overall Study|Death|8|||
126291363|NCT00118157|454355108|FG000|Overall Study|Withdrawal by Subject|2|||
126291364|NCT00696423|454355109|FG000|Overall Study|Lost to Follow-up|0|||
126291365|NCT00696423|454355110|FG001|Overall Study|Lost to Follow-up|5|||
126291366|NCT03989102|454355111|FG000|Year 1|Withdrawal by Subject|6|||
126291367|NCT03989102|454355112|FG001|Year 1|Withdrawal by Subject|2|||
126291368|NCT03989102|454355113|FG002|Year 1|Withdrawal by Subject|7|||
126291369|NCT03989102|454355111|FG000|Year 1|Lost to Follow-up|5|||
126291370|NCT03989102|454355112|FG001|Year 1|Lost to Follow-up|2|||
125883141|NCT00463567|452871416|FG001|Overall Study|Lack of Efficacy|9|||
125883142|NCT00463567|452871417|FG002|Overall Study|Lack of Efficacy|9|||
126291371|NCT03989102|454355113|FG002|Year 1|Lost to Follow-up|5|||
126291372|NCT03989102|454355111|FG000|Year 1|Subject met withdrawal criteria|1|||
126291373|NCT03989102|454355112|FG001|Year 1|Subject met withdrawal criteria|0|||
126291374|NCT03989102|454355113|FG002|Year 1|Subject met withdrawal criteria|1|||
126291375|NCT03989102|454355111|FG000|Year 2|Lost to Follow-up|7|||
126291376|NCT03989102|454355112|FG001|Year 2|Lost to Follow-up|3|||
126291377|NCT03989102|454355113|FG002|Year 2|Lost to Follow-up|4|||
126291378|NCT03989102|454355111|FG000|Year 2|Withdrawal by Subject|3|||
126291379|NCT03989102|454355112|FG001|Year 2|Withdrawal by Subject|1|||
126291380|NCT03989102|454355113|FG002|Year 2|Withdrawal by Subject|2|||
126291381|NCT03989102|454355111|FG000|Year 2|Subject non-compliant|3|||
126291382|NCT03989102|454355112|FG001|Year 2|Subject non-compliant|2|||
126291383|NCT03989102|454355113|FG002|Year 2|Subject non-compliant|0|||
126291384|NCT03989102|454355111|FG000|Year 2|Travel|1|||
126291385|NCT03989102|454355112|FG001|Year 2|Travel|0|||
126291386|NCT03989102|454355113|FG002|Year 2|Travel|1|||
126291387|NCT03989102|454355111|FG000|Year 2|P16 missing|4|||
126291388|NCT03989102|454355112|FG001|Year 2|P16 missing|2|||
126291389|NCT03989102|454355113|FG002|Year 2|P16 missing|1|||
126291390|NCT03989102|454355111|FG000|Year 2|P11 missing|1|||
126291391|NCT03989102|454355112|FG001|Year 2|P11 missing|3|||
126291392|NCT03989102|454355113|FG002|Year 2|P11 missing|7|||
126291393|NCT03989102|454355111|FG000|Year 2|Definitive displacement outside the study site|0|||
126291394|NCT03989102|454355112|FG001|Year 2|Definitive displacement outside the study site|1|||
126291395|NCT03989102|454355113|FG002|Year 2|Definitive displacement outside the study site|0|||
126291396|NCT03989102|454355111|FG000|Year 2|Subject missed last study visit|0|||
126291397|NCT03989102|454355112|FG001|Year 2|Subject missed last study visit|1|||
126291398|NCT03989102|454355113|FG002|Year 2|Subject missed last study visit|0|||
126291399|NCT03989102|454355111|FG000|Year 2|Death|0|||
126291400|NCT03989102|454355112|FG001|Year 2|Death|1|||
126291401|NCT03989102|454355113|FG002|Year 2|Death|0|||
126291402|NCT03989102|454355111|FG000|Year 2|Subject not reachable|0|||
126291403|NCT03989102|454355112|FG001|Year 2|Subject not reachable|0|||
126291404|NCT03989102|454355113|FG002|Year 2|Subject not reachable|1|||
126291405|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
126291406|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
126291407|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
126291408|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
126291409|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
126291410|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
126291411|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
126291412|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
126291413|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
126291414|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
126291415|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
126291416|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
126291417|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
126291418|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
126291419|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
126291420|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
126291421|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
126291422|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
126291423|NCT01050530|454355114|FG000|Overall Study|Adverse Event|6|||
126291424|NCT01050530|454355115|FG001|Overall Study|Adverse Event|3|||
126291425|NCT01050530|454355114|FG000|Overall Study|Lack of Efficacy|1|||
126291426|NCT01050530|454355115|FG001|Overall Study|Lack of Efficacy|4|||
126291427|NCT01050530|454355114|FG000|Overall Study|Withdrawal by Subject|0|||
126291428|NCT01050530|454355115|FG001|Overall Study|Withdrawal by Subject|3|||
126291429|NCT01050530|454355114|FG000|Overall Study|Protocol Violation|1|||
126291430|NCT01050530|454355115|FG001|Overall Study|Protocol Violation|0|||
126291431|NCT02288312|454355116|FG000|Overall Study|Pregnancy|1|||
126291432|NCT02288312|454355117|FG001|Overall Study|Pregnancy|0|||
126291433|NCT02288312|454355118|FG002|Overall Study|Pregnancy|0|||
126291434|NCT01276041|454355119|FG000|Overall Study|Adverse Event|2|||
126291435|NCT01276041|454355119|FG000|Overall Study|Protocol Violation|1|||
126291436|NCT00485264|454355120|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
126291437|NCT00485264|454355121|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
126291438|NCT00485264|454355122|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
126291439|NCT00485264|454355123|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
126291440|NCT00485264|454355124|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
126291441|NCT00485264|454355125|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
126291442|NCT00485264|454355120|FG000|Overall Study|Death|1|||
126291443|NCT00485264|454355121|FG001|Overall Study|Death|0|||
126291444|NCT00485264|454355122|FG002|Overall Study|Death|0|||
126291445|NCT00485264|454355123|FG003|Overall Study|Death|0|||
126291446|NCT00485264|454355124|FG004|Overall Study|Death|1|||
126291447|NCT00485264|454355125|FG005|Overall Study|Death|0|||
126291448|NCT00485264|454355120|FG000|Overall Study|Adverse Event|1|||
126291449|NCT00485264|454355121|FG001|Overall Study|Adverse Event|0|||
126291450|NCT00485264|454355122|FG002|Overall Study|Adverse Event|2|||
126291451|NCT00485264|454355123|FG003|Overall Study|Adverse Event|3|||
126291452|NCT00485264|454355124|FG004|Overall Study|Adverse Event|1|||
125883143|NCT00463567|452871418|FG003|Overall Study|Lack of Efficacy|17|||
125883144|NCT00463567|452871419|FG004|Overall Study|Lack of Efficacy|1|||
126291453|NCT00485264|454355125|FG005|Overall Study|Adverse Event|3|||
126291454|NCT00485264|454355120|FG000|Overall Study|Pregnancy|4|||
125883145|NCT00463567|452871420|FG005|Overall Study|Lack of Efficacy|0|||
126291455|NCT00485264|454355121|FG001|Overall Study|Pregnancy|0|||
126291456|NCT00485264|454355122|FG002|Overall Study|Pregnancy|0|||
126291457|NCT00485264|454355123|FG003|Overall Study|Pregnancy|0|||
126291458|NCT00485264|454355124|FG004|Overall Study|Pregnancy|0|||
126042122|NCT03580356|453453098|FG003|Treatment Period|Technical problems|0|||
126042123|NCT03580356|453453099|FG004|Treatment Period|Technical problems|1|||
126042124|NCT03580356|453453100|FG005|Treatment Period|Technical problems|0|||
126291459|NCT00485264|454355125|FG005|Overall Study|Pregnancy|0|||
126291460|NCT00485264|454355120|FG000|Overall Study|Disallowed Medication|0|||
126291461|NCT00485264|454355121|FG001|Overall Study|Disallowed Medication|0|||
126291462|NCT00485264|454355122|FG002|Overall Study|Disallowed Medication|0|||
126291463|NCT00485264|454355123|FG003|Overall Study|Disallowed Medication|0|||
126291464|NCT00485264|454355124|FG004|Overall Study|Disallowed Medication|0|||
126291465|NCT00485264|454355125|FG005|Overall Study|Disallowed Medication|1|||
126291466|NCT00485264|454355120|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
126291467|NCT00485264|454355121|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
126291468|NCT00485264|454355122|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
126291469|NCT00485264|454355123|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
126291470|NCT00485264|454355124|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
126291471|NCT00485264|454355125|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
126291472|NCT00485264|454355120|FG000|Overall Study|Lack of Efficacy|0|||
126291473|NCT00485264|454355121|FG001|Overall Study|Lack of Efficacy|1|||
126291474|NCT00485264|454355122|FG002|Overall Study|Lack of Efficacy|0|||
126291475|NCT00485264|454355123|FG003|Overall Study|Lack of Efficacy|0|||
126291476|NCT00485264|454355124|FG004|Overall Study|Lack of Efficacy|0|||
126291477|NCT00485264|454355125|FG005|Overall Study|Lack of Efficacy|0|||
126291478|NCT00485264|454355120|FG000|Overall Study|Guardian Consent Withdrawn|1|||
126291479|NCT00485264|454355121|FG001|Overall Study|Guardian Consent Withdrawn|0|||
126291480|NCT00485264|454355122|FG002|Overall Study|Guardian Consent Withdrawn|0|||
126291481|NCT00485264|454355123|FG003|Overall Study|Guardian Consent Withdrawn|0|||
126291482|NCT00485264|454355124|FG004|Overall Study|Guardian Consent Withdrawn|1|||
126291483|NCT00485264|454355125|FG005|Overall Study|Guardian Consent Withdrawn|0|||
126291484|NCT00485264|454355120|FG000|Overall Study|Physician Decision|0|||
126291485|NCT00485264|454355121|FG001|Overall Study|Physician Decision|2|||
126291486|NCT00485264|454355122|FG002|Overall Study|Physician Decision|0|||
126291487|NCT00485264|454355123|FG003|Overall Study|Physician Decision|0|||
126291488|NCT00485264|454355124|FG004|Overall Study|Physician Decision|0|||
126291489|NCT00485264|454355125|FG005|Overall Study|Physician Decision|0|||
126291490|NCT00485264|454355120|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291491|NCT00485264|454355121|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291492|NCT00485264|454355122|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
126291493|NCT00485264|454355123|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291494|NCT00485264|454355124|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291495|NCT00485264|454355125|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291496|NCT00485264|454355120|FG000|Overall Study|Not Able to Attend Clinic|5|||
126291497|NCT00485264|454355121|FG001|Overall Study|Not Able to Attend Clinic|0|||
126291498|NCT00485264|454355122|FG002|Overall Study|Not Able to Attend Clinic|0|||
126291499|NCT00485264|454355123|FG003|Overall Study|Not Able to Attend Clinic|1|||
126291500|NCT00485264|454355124|FG004|Overall Study|Not Able to Attend Clinic|1|||
126291501|NCT00485264|454355125|FG005|Overall Study|Not Able to Attend Clinic|2|||
126291502|NCT00485264|454355120|FG000|Overall Study|Non-Compliant|17|||
126291503|NCT00485264|454355121|FG001|Overall Study|Non-Compliant|2|||
126291504|NCT00485264|454355122|FG002|Overall Study|Non-Compliant|1|||
126291505|NCT00485264|454355123|FG003|Overall Study|Non-Compliant|0|||
126291506|NCT00485264|454355124|FG004|Overall Study|Non-Compliant|1|||
126291507|NCT00485264|454355125|FG005|Overall Study|Non-Compliant|0|||
126291508|NCT00485264|454355120|FG000|Overall Study|Lost to Follow-up|2|||
126291509|NCT00485264|454355121|FG001|Overall Study|Lost to Follow-up|1|||
126291510|NCT00485264|454355122|FG002|Overall Study|Lost to Follow-up|1|||
126291511|NCT00485264|454355123|FG003|Overall Study|Lost to Follow-up|0|||
126291512|NCT00485264|454355124|FG004|Overall Study|Lost to Follow-up|0|||
126291513|NCT00485264|454355125|FG005|Overall Study|Lost to Follow-up|1|||
126291514|NCT00485264|454355120|FG000|Overall Study|Other Reason|3|||
126291515|NCT00485264|454355121|FG001|Overall Study|Other Reason|0|||
126291516|NCT00485264|454355122|FG002|Overall Study|Other Reason|0|||
126291517|NCT00485264|454355123|FG003|Overall Study|Other Reason|0|||
126291518|NCT00485264|454355124|FG004|Overall Study|Other Reason|0|||
126291519|NCT00485264|454355125|FG005|Overall Study|Other Reason|0|||
126291520|NCT00276484|454355126|FG000|Overall Study|Adverse Event|4|||
126291521|NCT00276484|454355127|FG001|Overall Study|Adverse Event|7|||
126291522|NCT00276484|454355126|FG000|Overall Study|Lost to Follow-up|1|||
126291523|NCT00276484|454355127|FG001|Overall Study|Lost to Follow-up|1|||
126291524|NCT00276484|454355126|FG000|Overall Study|Protocol Violation|0|||
126291525|NCT00276484|454355127|FG001|Overall Study|Protocol Violation|1|||
126291526|NCT00276484|454355126|FG000|Overall Study|Withdrawal by Subject|4|||
126291527|NCT00276484|454355127|FG001|Overall Study|Withdrawal by Subject|3|||
126291528|NCT00276484|454355126|FG000|Overall Study|Could not take time off work|0|||
126291529|NCT00276484|454355127|FG001|Overall Study|Could not take time off work|1|||
126291530|NCT02440464|454355128|FG000|Overall Study|Withdrawal by Subject|3|||
126291531|NCT02440464|454355129|FG001|Overall Study|Withdrawal by Subject|2|||
126291532|NCT01626690|454355130|FG000|Overall Study|Protocol Violation|1|||
126291533|NCT01626690|454355131|FG001|Overall Study|Protocol Violation|0|||
126291534|NCT01626690|454355130|FG000|Overall Study|Adverse Event|1|||
126291535|NCT01626690|454355131|FG001|Overall Study|Adverse Event|0|||
126291536|NCT04688671|454355132|FG000|Overall Study|Adverse Event|3|||
126291537|NCT04688671|454355133|FG001|Overall Study|Adverse Event|1|||
126291538|NCT04688671|454355132|FG000|Overall Study|Withdrawal by Subject|3|||
126291539|NCT04688671|454355133|FG001|Overall Study|Withdrawal by Subject|1|||
126291540|NCT04688671|454355132|FG000|Overall Study|Lack of Efficacy|1|||
126291541|NCT04688671|454355133|FG001|Overall Study|Lack of Efficacy|1|||
126291542|NCT04688671|454355132|FG000|Overall Study|Protocol Violation|1|||
126291543|NCT04688671|454355133|FG001|Overall Study|Protocol Violation|0|||
126291544|NCT04688671|454355132|FG000|Overall Study|Lost to Follow-up|0|||
126291545|NCT04688671|454355133|FG001|Overall Study|Lost to Follow-up|1|||
126291546|NCT02414958|454355137|FG000|Overall Study|Adverse Event|6|||
126291547|NCT02414958|454355138|FG001|Overall Study|Adverse Event|6|||
126291548|NCT02414958|454355139|FG002|Overall Study|Adverse Event|3|||
126291549|NCT02414958|454355137|FG000|Overall Study|Protocol Violation|10|||
126291550|NCT02414958|454355138|FG001|Overall Study|Protocol Violation|3|||
126291551|NCT02414958|454355139|FG002|Overall Study|Protocol Violation|1|||
126291552|NCT02414958|454355137|FG000|Overall Study|Lost to Follow-up|7|||
126291553|NCT02414958|454355138|FG001|Overall Study|Lost to Follow-up|4|||
126291554|NCT02414958|454355139|FG002|Overall Study|Lost to Follow-up|0|||
126291555|NCT02414958|454355137|FG000|Overall Study|Withdrawal by Subject|5|||
126291556|NCT02414958|454355138|FG001|Overall Study|Withdrawal by Subject|3|||
126291557|NCT02414958|454355139|FG002|Overall Study|Withdrawal by Subject|5|||
126291558|NCT02414958|454355137|FG000|Overall Study|Other than specified|4|||
126291559|NCT02414958|454355138|FG001|Overall Study|Other than specified|4|||
126291560|NCT02414958|454355139|FG002|Overall Study|Other than specified|5|||
126291561|NCT05767905|454355142|FG000|Overall Study|Adverse Event|0|||
126291562|NCT05767905|454355143|FG001|Overall Study|Adverse Event|0|||
126291563|NCT05767905|454355144|FG002|Overall Study|Adverse Event|1|||
126291564|NCT03762239|454355145|FG000|Overall Study|Appointment to the doctor|1|||
126291565|NCT03762239|454355146|FG001|Overall Study|Appointment to the doctor|1|||
126291566|NCT03645863|454355147|FG000|Overall Study|Withdrawal by Subject|1|||
126291567|NCT03645863|454355148|FG001|Overall Study|Withdrawal by Subject|0|||
126291568|NCT03645863|454355149|FG002|Overall Study|Withdrawal by Subject|0|||
126291569|NCT03624192|454355163|FG000|Overall Study|Lost to Follow-up|1|||
126291570|NCT03624192|454355164|FG001|Overall Study|Lost to Follow-up|1|||
126291571|NCT04660331|454355165|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
126291572|NCT04660331|454355166|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
126291573|NCT04660331|454355167|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
126291574|NCT02635984|454355168|FG000|Overall Study|Lost to Follow-up|2|||
126291575|NCT02635984|454355169|FG001|Overall Study|Lost to Follow-up|4|||
126291576|NCT02635984|454355168|FG000|Overall Study|Study Arm Closed|1|||
126291577|NCT02635984|454355169|FG001|Overall Study|Study Arm Closed|0|||
126291578|NCT01640249|454355171|FG000|Period 1|Withdrawal by Subject|1|||
126291579|NCT01640249|454355172|FG001|Period 1|Withdrawal by Subject|0|||
126291580|NCT01640249|454355173|FG002|Period 1|Withdrawal by Subject|0|||
126291581|NCT01640249|454355174|FG003|Period 1|Withdrawal by Subject|0|||
126291582|NCT01640249|454355175|FG004|Period 1|Withdrawal by Subject|0|||
126291583|NCT01640249|454355176|FG005|Period 1|Withdrawal by Subject|1|||
126291584|NCT01640249|454355177|FG006|Period 1|Withdrawal by Subject|0|||
126291585|NCT01215136|454355180|FG000|Overall Study|Adverse Event|2|||
126291586|NCT01215136|454355181|FG001|Overall Study|Adverse Event|9|||
126291587|NCT01215136|454355180|FG000|Overall Study|Disease Progression|3|||
126291588|NCT01215136|454355181|FG001|Overall Study|Disease Progression|14|||
126291589|NCT01215136|454355180|FG000|Overall Study|Symptomatic Deterioration|1|||
126291590|NCT01215136|454355181|FG001|Overall Study|Symptomatic Deterioration|1|||
126291591|NCT01215136|454355180|FG000|Overall Study|Death|0|||
126291592|NCT01215136|454355181|FG001|Overall Study|Death|2|||
126291593|NCT01215136|454355180|FG000|Overall Study|Withdrawal by Subject|0|||
126291594|NCT01215136|454355181|FG001|Overall Study|Withdrawal by Subject|1|||
126291595|NCT00613171|454355186|FG000|Overall Study|Adverse Event|7|||
126291596|NCT00613171|454355186|FG000|Overall Study|Withdrawal by Subject|3|||
126291597|NCT00613171|454355186|FG000|Overall Study|Reason not Specified|4|||
126291598|NCT00951496|454355187|FG000|Overall Study|Did not initiate study treatment|10|||
126042125|NCT03580356|453453101|FG006|Treatment Period|Technical problems|0|||
126291599|NCT00951496|454355188|FG001|Overall Study|Did not initiate study treatment|8|||
126291600|NCT00951496|454355189|FG002|Overall Study|Did not initiate study treatment|13|||
126291601|NCT01526057|454355190|FG000|Overall Study|Withdrawal by Subject|3|||
126291602|NCT01526057|454355191|FG001|Overall Study|Withdrawal by Subject|2|||
126291603|NCT01526057|454355192|FG002|Overall Study|Withdrawal by Subject|2|||
126042126|NCT03580356|453453102|FG007|Treatment Period|Technical problems|0|||
126291604|NCT01526057|454355190|FG000|Overall Study|Adverse Event|3|||
126291605|NCT01526057|454355191|FG001|Overall Study|Adverse Event|1|||
126291606|NCT01526057|454355192|FG002|Overall Study|Adverse Event|1|||
126291607|NCT01526057|454355190|FG000|Overall Study|Death|1|||
126291608|NCT01526057|454355191|FG001|Overall Study|Death|0|||
126291609|NCT01526057|454355192|FG002|Overall Study|Death|0|||
126291610|NCT01526057|454355190|FG000|Overall Study|Lost to Follow-up|1|||
126291611|NCT01526057|454355191|FG001|Overall Study|Lost to Follow-up|0|||
126291612|NCT01526057|454355192|FG002|Overall Study|Lost to Follow-up|1|||
126291613|NCT01526057|454355190|FG000|Overall Study|Other|1|||
126291614|NCT01526057|454355191|FG001|Overall Study|Other|0|||
126291615|NCT01526057|454355192|FG002|Overall Study|Other|1|||
126291616|NCT01526057|454355190|FG000|Overall Study|Protocol Violation|0|||
126291617|NCT01526057|454355191|FG001|Overall Study|Protocol Violation|0|||
126291618|NCT01526057|454355192|FG002|Overall Study|Protocol Violation|1|||
126291619|NCT02289729|454355203|FG000|Overall Study|Lack of Efficacy|3|||
126291620|NCT02289729|454355203|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
126291621|NCT02289729|454355203|FG000|Overall Study|Withdrawal by Subject|1|||
126291622|NCT02289729|454355203|FG000|Overall Study|Death|1|||
126291623|NCT04870710|454355209|FG000|Overall Study|Lost to Follow-up|3|||
126291624|NCT00476190|454355210|FG000|Overall Study|Ineligible|1|||
126291625|NCT00476190|454355211|FG001|Overall Study|Ineligible|1|||
126291626|NCT00476190|454355210|FG000|Overall Study|Induction Death|2|||
126291627|NCT00476190|454355211|FG001|Overall Study|Induction Death|0|||
126291628|NCT00476190|454355210|FG000|Overall Study|Induction Failure|2|||
126291629|NCT00476190|454355211|FG001|Overall Study|Induction Failure|4|||
126291630|NCT00476190|454355210|FG000|Overall Study|Lost to Follow-up|1|||
126291631|NCT00476190|454355211|FG001|Overall Study|Lost to Follow-up|0|||
126291632|NCT00476190|454355210|FG000|Overall Study|Relapse/Progression|5|||
126291633|NCT00476190|454355211|FG001|Overall Study|Relapse/Progression|2|||
126291634|NCT00476190|454355210|FG000|Overall Study|Remission Death|0|||
126291635|NCT00476190|454355211|FG001|Overall Study|Remission Death|1|||
126291636|NCT00476190|454355210|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
126291637|NCT00476190|454355211|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
126291638|NCT00476190|454355210|FG000|Overall Study|Withdrawal by Subject|6|||
126291639|NCT00476190|454355211|FG001|Overall Study|Withdrawal by Subject|2|||
126291640|NCT00476190|454355210|FG000|Overall Study|Other|9|||
126291641|NCT00476190|454355211|FG001|Overall Study|Other|10|||
126291642|NCT05724589|454355212|FG000|Overall Study|Lost to Follow-up|1|||
126291643|NCT02273388|454355221|FG000|Overall Study|Adverse Event|0|||
126291644|NCT02273388|454355222|FG001|Overall Study|Adverse Event|0|||
126291645|NCT02273388|454355223|FG002|Overall Study|Adverse Event|0|||
126291646|NCT02273388|454355224|FG003|Overall Study|Adverse Event|0|||
126291647|NCT02273388|454355225|FG004|Overall Study|Adverse Event|0|||
126291648|NCT02273388|454355226|FG005|Overall Study|Adverse Event|0|||
126291649|NCT02273388|454355227|FG006|Overall Study|Adverse Event|1|||
126291650|NCT02273388|454355228|FG007|Overall Study|Adverse Event|2|||
126291651|NCT02273388|454355229|FG008|Overall Study|Adverse Event|0|||
126291652|NCT02273388|454355230|FG009|Overall Study|Adverse Event|0|||
126291653|NCT02273388|454355231|FG010|Overall Study|Adverse Event|0|||
126291654|NCT02273388|454355232|FG011|Overall Study|Adverse Event|0|||
126291655|NCT02273388|454355221|FG000|Overall Study|Adverse Event study disease worse|4|||
126291656|NCT02273388|454355222|FG001|Overall Study|Adverse Event study disease worse|3|||
126291657|NCT02273388|454355223|FG002|Overall Study|Adverse Event study disease worse|3|||
126291658|NCT02273388|454355224|FG003|Overall Study|Adverse Event study disease worse|2|||
126291659|NCT02273388|454355225|FG004|Overall Study|Adverse Event study disease worse|4|||
126291660|NCT02273388|454355226|FG005|Overall Study|Adverse Event study disease worse|3|||
126291661|NCT02273388|454355227|FG006|Overall Study|Adverse Event study disease worse|14|||
126291662|NCT02273388|454355228|FG007|Overall Study|Adverse Event study disease worse|6|||
126291663|NCT02273388|454355229|FG008|Overall Study|Adverse Event study disease worse|6|||
126291664|NCT02273388|454355230|FG009|Overall Study|Adverse Event study disease worse|5|||
126291665|NCT02273388|454355231|FG010|Overall Study|Adverse Event study disease worse|10|||
126291666|NCT02273388|454355232|FG011|Overall Study|Adverse Event study disease worse|1|||
126291667|NCT02273388|454355221|FG000|Overall Study|Sponsor decision|0|||
126291668|NCT02273388|454355222|FG001|Overall Study|Sponsor decision|0|||
126291669|NCT02273388|454355223|FG002|Overall Study|Sponsor decision|0|||
126291670|NCT02273388|454355224|FG003|Overall Study|Sponsor decision|0|||
126291671|NCT02273388|454355225|FG004|Overall Study|Sponsor decision|0|||
126291672|NCT02273388|454355226|FG005|Overall Study|Sponsor decision|0|||
126291673|NCT02273388|454355227|FG006|Overall Study|Sponsor decision|0|||
126291674|NCT02273388|454355228|FG007|Overall Study|Sponsor decision|0|||
126291675|NCT02273388|454355229|FG008|Overall Study|Sponsor decision|0|||
126291676|NCT02273388|454355230|FG009|Overall Study|Sponsor decision|0|||
126291677|NCT02273388|454355231|FG010|Overall Study|Sponsor decision|0|||
126366223|NCT02904096|454635796|FG001|Overall Study|Withdrawal by Subject|3|||
126366224|NCT02904096|454635795|FG000|Overall Study|Lost to Follow-up|10|||
126291678|NCT02273388|454355232|FG011|Overall Study|Sponsor decision|1|||
126366225|NCT02904096|454635796|FG001|Overall Study|Lost to Follow-up|17|||
126291679|NCT01042093|454355233|FG000|Overall Study|Protocol Violation|2|||
126291680|NCT01042093|454355234|FG001|Overall Study|Protocol Violation|2|||
126291681|NCT01042093|454355235|FG002|Overall Study|Protocol Violation|2|||
126291682|NCT01042093|454355236|FG003|Overall Study|Protocol Violation|3|||
126291683|NCT01042093|454355233|FG000|Overall Study|Withdrawal by Subject|0|||
126291684|NCT01042093|454355234|FG001|Overall Study|Withdrawal by Subject|0|||
126291685|NCT01042093|454355235|FG002|Overall Study|Withdrawal by Subject|0|||
126291686|NCT01042093|454355236|FG003|Overall Study|Withdrawal by Subject|1|||
126291687|NCT04331808|454355237|FG000|Overall Study|Withdrew consent|1|||
126291688|NCT04331808|454355238|FG001|Overall Study|Withdrew consent|0|||
126291689|NCT04331808|454355239|FG002|Overall Study|Withdrew consent|2|||
126291690|NCT04331808|454355240|FG003|Overall Study|Withdrew consent|3|||
126291691|NCT02189837|454355244|FG000|Overall Study|Withdrawal by Subject|2|||
126291692|NCT02189837|454355245|FG001|Overall Study|Withdrawal by Subject|1|||
126291693|NCT02189837|454355246|FG002|Overall Study|Withdrawal by Subject|3|||
126291694|NCT02189837|454355247|FG003|Overall Study|Withdrawal by Subject|1|||
126291695|NCT02189837|454355244|FG000|Overall Study|Sponsor Decision|0|||
126291696|NCT02189837|454355245|FG001|Overall Study|Sponsor Decision|0|||
126291697|NCT02189837|454355246|FG002|Overall Study|Sponsor Decision|0|||
126291698|NCT02189837|454355247|FG003|Overall Study|Sponsor Decision|1|||
126291699|NCT00822692|454355253|FG000|Overall Study|Lost to Follow-up|17|||
126291700|NCT00822692|454355254|FG001|Overall Study|Lost to Follow-up|25|||
126291701|NCT01256502|454355257|FG000|Overall Study|Had scaffold removed|4|||
126291702|NCT01256502|454355257|FG000|Overall Study|Personal reasons|5|||
126291703|NCT01256502|454355257|FG000|Overall Study|Protocol deviation|1|||
126291704|NCT01523002|454355258|FG000|Period 1|Withdrawal by Subject|1|||
126291705|NCT01523002|454355259|FG001|Period 1|Withdrawal by Subject|3|||
126291706|NCT01523002|454355258|FG000|Period 1|Lost to Follow-up|1|||
126291707|NCT01523002|454355259|FG001|Period 1|Lost to Follow-up|0|||
126291708|NCT01523002|454355258|FG000|Period 1|Adverse Event|0|||
126291709|NCT01523002|454355259|FG001|Period 1|Adverse Event|8|||
126291710|NCT01523002|454355258|FG000|Period 2|Withdrawal by Subject|4|||
126291711|NCT01523002|454355259|FG001|Period 2|Withdrawal by Subject|1|||
126291712|NCT01523002|454355258|FG000|Period 2|Adverse Event|2|||
126291713|NCT01523002|454355259|FG001|Period 2|Adverse Event|5|||
126291714|NCT01523002|454355258|FG000|Period 3|Withdrawal by Subject|1|||
126291715|NCT01523002|454355259|FG001|Period 3|Withdrawal by Subject|0|||
126291716|NCT01523002|454355258|FG000|Period 3|Adverse Event|3|||
126291717|NCT01523002|454355259|FG001|Period 3|Adverse Event|0|||
126291718|NCT03281876|454355260|FG000|Overall Study|Adverse Event|4|||
126291719|NCT03281876|454355261|FG001|Overall Study|Adverse Event|15|||
126291720|NCT03281876|454355260|FG000|Overall Study|Lost to Follow-up|1|||
126291721|NCT03281876|454355261|FG001|Overall Study|Lost to Follow-up|4|||
126291722|NCT03281876|454355260|FG000|Overall Study|Withdrawal by Subject|11|||
126291723|NCT03281876|454355261|FG001|Overall Study|Withdrawal by Subject|15|||
126291724|NCT03281876|454355260|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126291725|NCT03281876|454355261|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126291726|NCT03281876|454355260|FG000|Overall Study|OTHER|5|||
126291727|NCT03281876|454355261|FG001|Overall Study|OTHER|5|||
126291728|NCT02208089|454355262|FG000|Overall Study|Withdrawal by Subject|1|||
126291729|NCT02208089|454355263|FG001|Overall Study|Withdrawal by Subject|0|||
126291730|NCT02208089|454355262|FG000|Overall Study|Lost to Follow-up|6|||
126291731|NCT02208089|454355263|FG001|Overall Study|Lost to Follow-up|0|||
126291732|NCT00972595|454355264|FG000|Period 1|Adverse Event|1|||
126291733|NCT00972595|454355265|FG001|Period 1|Adverse Event|0|||
126291734|NCT03629184|454355266|FG000|Overall Study|Withdrawal by Subject|2|||
126291735|NCT03629184|454355267|FG001|Overall Study|Withdrawal by Subject|1|||
126291736|NCT03629184|454355266|FG000|Overall Study|Physician Decision|1|||
126291737|NCT03629184|454355267|FG001|Overall Study|Physician Decision|0|||
126291738|NCT05101343|454355270|FG000|Overall Study|Withdrawal by Subject|2|||
126291739|NCT05101343|454355271|FG001|Overall Study|Withdrawal by Subject|1|||
126291740|NCT02046603|454355272|FG000|Overall Study|Other|11|||
126291741|NCT02046603|454355273|FG001|Overall Study|Other|66|||
126291742|NCT02046603|454355272|FG000|Overall Study|Protocol Violation|0|||
126291743|NCT02046603|454355273|FG001|Overall Study|Protocol Violation|1|||
126291744|NCT02046603|454355272|FG000|Overall Study|Participant/legal guardian decision|1|||
126291745|NCT02046603|454355273|FG001|Overall Study|Participant/legal guardian decision|3|||
126291746|NCT02046603|454355272|FG000|Overall Study|Physician Decision|2|||
126291747|NCT02046603|454355273|FG001|Overall Study|Physician Decision|1|||
126291748|NCT02046603|454355272|FG000|Overall Study|Lost to Follow-up|1|||
126291749|NCT02046603|454355273|FG001|Overall Study|Lost to Follow-up|2|||
126291750|NCT02046603|454355272|FG000|Overall Study|Death|0|||
126291751|NCT02046603|454355273|FG001|Overall Study|Death|1|||
126291752|NCT02046603|454355272|FG000|Overall Study|Adverse Event|0|||
126291753|NCT02046603|454355273|FG001|Overall Study|Adverse Event|1|||
126042127|NCT03580356|453453095|FG000|Treatment Period|Misrandomized, no treatment|0|||
126291754|NCT02461160|454355274|FG000|Overall Study|Lost to Follow-up|0|||
126291755|NCT02461160|454355275|FG001|Overall Study|Lost to Follow-up|0|||
126291756|NCT02461160|454355276|FG002|Overall Study|Lost to Follow-up|0|||
126291757|NCT02461160|454355277|FG003|Overall Study|Lost to Follow-up|0|||
126291758|NCT02461160|454355278|FG004|Overall Study|Lost to Follow-up|0|||
126291759|NCT02461160|454355279|FG005|Overall Study|Lost to Follow-up|0|||
126291760|NCT02461160|454355280|FG006|Overall Study|Lost to Follow-up|0|||
126291761|NCT02461160|454355281|FG007|Overall Study|Lost to Follow-up|1|||
126291762|NCT02461160|454355282|FG008|Overall Study|Lost to Follow-up|0|||
126291763|NCT02461160|454355283|FG009|Overall Study|Lost to Follow-up|0|||
126291764|NCT02461160|454355284|FG010|Overall Study|Lost to Follow-up|0|||
126291765|NCT02461160|454355285|FG011|Overall Study|Lost to Follow-up|0|||
126291766|NCT02461160|454355286|FG012|Overall Study|Lost to Follow-up|0|||
126291767|NCT00193050|454355287|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
126291768|NCT00193050|454355287|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
126291769|NCT00193050|454355287|FG000|Neoadjuvant Treatment|Physician Decision|2|||
126291770|NCT00193050|454355287|FG000|Neoadjuvant Treatment|Adverse Event|2|||
126291771|NCT00193050|454355287|FG000|Adjuvant|Physician Decision|5|||
126291772|NCT00193050|454355287|FG000|Adjuvant|Intercurrent Hospitalization|3|||
126291773|NCT00193050|454355287|FG000|Adjuvant|Lack of Efficacy|2|||
126291774|NCT00061932|454355288|FG000|Overall Study|Withdrawal by Subject|13|||
126291775|NCT00061932|454355289|FG001|Overall Study|Withdrawal by Subject|4|||
126291776|NCT02899962|454355290|FG000|Open-label Phase|Adverse Event|2|||
126291777|NCT02899962|454355291|FG001|Open-label Phase|Adverse Event|0|||
126291778|NCT02899962|454355292|FG002|Open-label Phase|Adverse Event|0|||
126291779|NCT02899962|454355290|FG000|Open-label Phase|Lost to Follow-up|9|||
126291780|NCT02899962|454355291|FG001|Open-label Phase|Lost to Follow-up|0|||
126291781|NCT02899962|454355292|FG002|Open-label Phase|Lost to Follow-up|0|||
126291782|NCT02899962|454355290|FG000|Open-label Phase|Other reasons|9|||
126291783|NCT02899962|454355291|FG001|Open-label Phase|Other reasons|0|||
126291784|NCT02899962|454355292|FG002|Open-label Phase|Other reasons|0|||
126291785|NCT02899962|454355290|FG000|Open-label Phase|Withdrawal by Subject|7|||
126291786|NCT02899962|454355291|FG001|Open-label Phase|Withdrawal by Subject|0|||
126291787|NCT02899962|454355292|FG002|Open-label Phase|Withdrawal by Subject|0|||
126291788|NCT02899962|454355290|FG000|Maintenance Phase|Adverse Event|0|||
126291789|NCT02899962|454355291|FG001|Maintenance Phase|Adverse Event|2|||
126291790|NCT02899962|454355292|FG002|Maintenance Phase|Adverse Event|1|||
126291791|NCT02899962|454355290|FG000|Maintenance Phase|Death|0|||
126291792|NCT02899962|454355291|FG001|Maintenance Phase|Death|0|||
126291793|NCT02899962|454355292|FG002|Maintenance Phase|Death|1|||
126291794|NCT02899962|454355290|FG000|Maintenance Phase|Lack of Efficacy|0|||
126291795|NCT02899962|454355291|FG001|Maintenance Phase|Lack of Efficacy|20|||
126291796|NCT02899962|454355292|FG002|Maintenance Phase|Lack of Efficacy|16|||
126291797|NCT02899962|454355290|FG000|Maintenance Phase|Lost to Follow-up|0|||
126291798|NCT02899962|454355291|FG001|Maintenance Phase|Lost to Follow-up|12|||
126291799|NCT02899962|454355292|FG002|Maintenance Phase|Lost to Follow-up|14|||
126291800|NCT02899962|454355290|FG000|Maintenance Phase|Other reasons|0|||
126291801|NCT02899962|454355291|FG001|Maintenance Phase|Other reasons|9|||
126291802|NCT02899962|454355292|FG002|Maintenance Phase|Other reasons|13|||
126291803|NCT02899962|454355290|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
126291804|NCT02899962|454355291|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
126291805|NCT02899962|454355292|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
126291806|NCT02899962|454355290|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
126291807|NCT02899962|454355291|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
126291808|NCT02899962|454355292|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
126291809|NCT02899962|454355290|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126291810|NCT02899962|454355291|FG001|Maintenance Phase|Withdrawal by Subject|30|||
126291811|NCT02899962|454355292|FG002|Maintenance Phase|Withdrawal by Subject|36|||
126291812|NCT02603146|454357366|FG000|Overall Study|Lost to Follow-up|5|||
126291813|NCT02603146|454357367|FG001|Overall Study|Lost to Follow-up|6|||
126291814|NCT02603146|454357366|FG000|Overall Study|Withdrawal by Subject|8|||
126291815|NCT02603146|454357367|FG001|Overall Study|Withdrawal by Subject|10|||
126291816|NCT02603146|454357366|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
126291817|NCT02603146|454357367|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
126291818|NCT02603146|454357366|FG000|Overall Study|Participant moved|2|||
126291819|NCT02603146|454357367|FG001|Overall Study|Participant moved|0|||
126291820|NCT02603146|454357366|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
126291821|NCT02603146|454357367|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
126291822|NCT00654095|454357376|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
126291823|NCT00654095|454357376|FG000|Overall Study|Elevated triglyceride level (2)|1|||
126291824|NCT00654095|454357376|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
126291825|NCT00654095|454357376|FG000|Overall Study|Adverse Event|11|||
126291826|NCT00654095|454357376|FG000|Overall Study|Withdrawal by Subject|5|||
126291827|NCT00654095|454357376|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
126291828|NCT00654095|454357376|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
126291829|NCT00654095|454357376|FG000|Overall Study|Did not meet inclusion criteria|1|||
126291830|NCT01431079|454357377|FG000|Overall Study|Lost to Follow-up|35|||
126291831|NCT01431079|454357378|FG001|Overall Study|Lost to Follow-up|39|||
126291832|NCT03347110|454357383|FG000|Overall Study|Other (Participant is incarcerated)|1|||
126291833|NCT03347110|454357383|FG000|Overall Study|Withdrawal by Subject|9|||
126291834|NCT03347110|454357383|FG000|Overall Study|Lost to Follow-up|1|||
126291835|NCT03347110|454357383|FG000|Overall Study|Lack of Efficacy|2|||
126291836|NCT03347110|454357383|FG000|Overall Study|Adverse Event, non-fatal|9|||
126291837|NCT00110396|454357384|FG000|Overall Study|Adverse Event|15|||
126291838|NCT00110396|454357384|FG000|Overall Study|Lost to Follow-up|1|||
126042128|NCT03580356|453453096|FG001|Treatment Period|Misrandomized, no treatment|0|||
126291839|NCT00110396|454357384|FG000|Overall Study|Administration of plasmapheresis|1|||
126291840|NCT00110396|454357384|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
126291841|NCT00110396|454357384|FG000|Overall Study|Lack of Efficacy|1|||
126291842|NCT00110396|454357384|FG000|Overall Study|Decided not to continue treatment|1|||
126291843|NCT00110396|454357384|FG000|Overall Study|Patient non-compliance|1|||
126291844|NCT00110396|454357384|FG000|Overall Study|Patient refused to continue|1|||
126291845|NCT00110396|454357384|FG000|Overall Study|Patient refused to participate|1|||
126291846|NCT00110396|454357384|FG000|Overall Study|Patient will|1|||
126291847|NCT00110396|454357384|FG000|Overall Study|Patient's decision|1|||
126291848|NCT00110396|454357384|FG000|Overall Study|Participation in MS vaccine study|1|||
126291849|NCT00110396|454357384|FG000|Overall Study|Pregnancy|1|||
126291850|NCT00110396|454357384|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
126291851|NCT00110396|454357384|FG000|Overall Study|Protocol Violation|2|||
126291852|NCT00110396|454357384|FG000|Overall Study|Patient refused to come back|1|||
126291853|NCT00110396|454357384|FG000|Overall Study|The patient has refused|2|||
126291854|NCT00110396|454357384|FG000|Overall Study|The patient has refused to visit site|1|||
126291855|NCT00110396|454357384|FG000|Overall Study|Patient is to be administered copaxone|1|||
126042129|NCT03580356|453453097|FG002|Treatment Period|Misrandomized, no treatment|1|||
126042130|NCT03580356|453453098|FG003|Treatment Period|Misrandomized, no treatment|0|||
126042131|NCT03580356|453453099|FG004|Treatment Period|Misrandomized, no treatment|2|||
126042132|NCT03580356|453453100|FG005|Treatment Period|Misrandomized, no treatment|0|||
126042133|NCT03580356|453453101|FG006|Treatment Period|Misrandomized, no treatment|0|||
126042134|NCT03580356|453453102|FG007|Treatment Period|Misrandomized, no treatment|0|||
126042135|NCT03580356|453453095|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
126291856|NCT00882518|454357385|FG000|Overall Study|Adverse Event|9|||
126291857|NCT00882518|454357386|FG001|Overall Study|Adverse Event|18|||
126291858|NCT00882518|454357385|FG000|Overall Study|Withdrawal by Subject|9|||
126291859|NCT00882518|454357386|FG001|Overall Study|Withdrawal by Subject|13|||
126291860|NCT00882518|454357385|FG000|Overall Study|Lack of Efficacy|12|||
126291861|NCT00882518|454357386|FG001|Overall Study|Lack of Efficacy|9|||
126291862|NCT00882518|454357385|FG000|Overall Study|Severe non-compliance to protocol|3|||
126291863|NCT00882518|454357386|FG001|Overall Study|Severe non-compliance to protocol|1|||
126291864|NCT00882518|454357385|FG000|Overall Study|Incorrect enrolment|4|||
126291865|NCT00882518|454357386|FG001|Overall Study|Incorrect enrolment|2|||
126291866|NCT00882518|454357385|FG000|Overall Study|Central lab closure for National day|1|||
126291867|NCT00882518|454357386|FG001|Overall Study|Central lab closure for National day|0|||
126291868|NCT00882518|454357385|FG000|Overall Study|Allocating random number by mistake|0|||
126291869|NCT00882518|454357386|FG001|Overall Study|Allocating random number by mistake|1|||
126291870|NCT02137252|454357388|FG000|Overall Study|trial terminated early|2|||
126291871|NCT02137252|454357389|FG001|Overall Study|trial terminated early|1|||
126291872|NCT00245466|454357390|FG000|Overall Study|Adverse Event|2|||
126291873|NCT00245466|454357391|FG001|Overall Study|Adverse Event|8|||
126291874|NCT00245466|454357392|FG002|Overall Study|Adverse Event|4|||
126291875|NCT00245466|454357390|FG000|Overall Study|Low prostate specific antigen suppr|16|||
126291876|NCT00245466|454357391|FG001|Overall Study|Low prostate specific antigen suppr|14|||
126291877|NCT00245466|454357392|FG002|Overall Study|Low prostate specific antigen suppr|5|||
126291878|NCT00245466|454357390|FG000|Overall Study|Insufficient testosterone suppr|12|||
126291879|NCT00245466|454357391|FG001|Overall Study|Insufficient testosterone suppr|12|||
126291880|NCT00245466|454357392|FG002|Overall Study|Insufficient testosterone suppr|21|||
126291881|NCT00245466|454357390|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
126291882|NCT00245466|454357391|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
126291883|NCT00245466|454357392|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
126291884|NCT00245466|454357390|FG000|Overall Study|Withdrawal by Subject|2|||
126291885|NCT00245466|454357391|FG001|Overall Study|Withdrawal by Subject|2|||
126291886|NCT00245466|454357392|FG002|Overall Study|Withdrawal by Subject|1|||
126291887|NCT00245466|454357390|FG000|Overall Study|Lost to Follow-up|3|||
126291888|NCT00245466|454357391|FG001|Overall Study|Lost to Follow-up|0|||
126291889|NCT00245466|454357392|FG002|Overall Study|Lost to Follow-up|0|||
126366226|NCT02904096|454635795|FG000|Overall Study|Non-compliant|3|||
126366227|NCT02904096|454635796|FG001|Overall Study|Non-compliant|1|||
126042136|NCT03580356|453453096|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
126291890|NCT00245466|454357390|FG000|Overall Study|Disease progression|0|||
126291891|NCT00245466|454357391|FG001|Overall Study|Disease progression|3|||
126291892|NCT00245466|454357392|FG002|Overall Study|Disease progression|1|||
126291893|NCT00245466|454357390|FG000|Overall Study|Protocol Violation|1|||
126291894|NCT00245466|454357391|FG001|Overall Study|Protocol Violation|2|||
126291895|NCT00245466|454357392|FG002|Overall Study|Protocol Violation|2|||
126291896|NCT00245466|454357390|FG000|Overall Study|Death|0|||
126291897|NCT00245466|454357391|FG001|Overall Study|Death|2|||
126291898|NCT00245466|454357392|FG002|Overall Study|Death|0|||
126291899|NCT00245466|454357390|FG000|Overall Study|Administrative reasons|0|||
126291900|NCT00245466|454357391|FG001|Overall Study|Administrative reasons|1|||
126366228|NCT02904096|454635795|FG000|Overall Study|Sponsor instructed|1|||
126366229|NCT02904096|454635796|FG001|Overall Study|Sponsor instructed|0|||
126291901|NCT00245466|454357392|FG002|Overall Study|Administrative reasons|0|||
126291902|NCT01958437|454357393|FG000|Overall Study|Incidental MRI findings|0|||
126291903|NCT01958437|454357394|FG001|Overall Study|Incidental MRI findings|0|||
126291904|NCT01958437|454357395|FG002|Overall Study|Incidental MRI findings|1|||
126291905|NCT01958437|454357396|FG003|Overall Study|Incidental MRI findings|1|||
126291906|NCT04886596|454357399|FG000|Overall Study|Adverse Event|442|||
126291907|NCT04886596|454357400|FG001|Overall Study|Adverse Event|441|||
126291908|NCT04886596|454357399|FG000|Overall Study|Lost to Follow-up|448|||
126291909|NCT04886596|454357400|FG001|Overall Study|Lost to Follow-up|465|||
126291910|NCT04886596|454357399|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
126291911|NCT04886596|454357400|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
126291912|NCT04886596|454357399|FG000|Overall Study|Migrated/moved from the study area|201|||
126291913|NCT04886596|454357400|FG001|Overall Study|Migrated/moved from the study area|184|||
126291914|NCT04886596|454357399|FG000|Overall Study|Other|298|||
126291915|NCT04886596|454357400|FG001|Overall Study|Other|326|||
126291916|NCT00948155|454357402|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
126291917|NCT00948155|454357403|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
126291918|NCT00948155|454357402|FG000|Washout 14 Days|Lost to Follow-up|1|||
126291919|NCT00948155|454357403|FG001|Washout 14 Days|Lost to Follow-up|2|||
126291920|NCT04620746|454357404|FG000|Overall Study|Adverse Event|2|||
126291921|NCT04620746|454357405|FG001|Overall Study|Adverse Event|0|||
126291922|NCT04620746|454357404|FG000|Overall Study|Uniterpretable skin test|1|||
126291923|NCT04620746|454357405|FG001|Overall Study|Uniterpretable skin test|0|||
126291924|NCT04620746|454357404|FG000|Overall Study|Withdrawal by Subject|0|||
126291925|NCT04620746|454357405|FG001|Overall Study|Withdrawal by Subject|1|||
126291926|NCT03473925|454357406|FG000|Overall Study|Death|48|||
126291927|NCT03473925|454357407|FG001|Overall Study|Death|44|||
126291928|NCT03473925|454357406|FG000|Overall Study|Sponsor Decision|2|||
126291929|NCT03473925|454357407|FG001|Overall Study|Sponsor Decision|7|||
126291930|NCT03473925|454357406|FG000|Overall Study|Withdrawal by Subject|1|||
126291931|NCT03473925|454357407|FG001|Overall Study|Withdrawal by Subject|3|||
126291932|NCT03473925|454357406|FG000|Overall Study|Not Treated|1|||
126291933|NCT03473925|454357407|FG001|Overall Study|Not Treated|1|||
126291934|NCT03411863|454357408|FG000|Overall Study|Withdrawal by Subject|3|||
126291935|NCT03411863|454357409|FG001|Overall Study|Withdrawal by Subject|1|||
126291936|NCT03411863|454357408|FG000|Overall Study|Physician Decision|0|||
126291937|NCT03411863|454357409|FG001|Overall Study|Physician Decision|1|||
126291938|NCT04661150|454357414|FG000|Overall Study|Ongoing in study|19|||
126366230|NCT05305651|454635797|FG000|Overall Study|Death|1|||
126366231|NCT05305651|454635797|FG000|Overall Study|Withdrawal by Subject|4|||
126366232|NCT05305651|454635797|FG000|Overall Study|Lost to Follow-up|4|||
126366233|NCT00526799|454635798|FG000|Overall Study|Withdrawal by Subject|1|||
126366234|NCT00526799|454635799|FG001|Overall Study|Withdrawal by Subject|0|||
126366235|NCT00526799|454635798|FG000|Overall Study|Intercurrent Complicating Disease|0|||
126366236|NCT00526799|454635799|FG001|Overall Study|Intercurrent Complicating Disease|1|||
126366237|NCT04003389|454635800|FG000|Overall Study|Adverse Event|27|||
126366238|NCT04003389|454635801|FG001|Overall Study|Adverse Event|34|||
126366239|NCT04003389|454635802|FG002|Overall Study|Adverse Event|28|||
126366240|NCT04003389|454635800|FG000|Overall Study|Lost to Follow-up|39|||
126366241|NCT04003389|454635801|FG001|Overall Study|Lost to Follow-up|30|||
126366242|NCT04003389|454635802|FG002|Overall Study|Lost to Follow-up|33|||
126366243|NCT04003389|454635800|FG000|Overall Study|Protocol Violation|1|||
126366244|NCT04003389|454635801|FG001|Overall Study|Protocol Violation|6|||
126366245|NCT04003389|454635802|FG002|Overall Study|Protocol Violation|5|||
126366246|NCT04003389|454635800|FG000|Overall Study|Withdrawal by Subject|119|||
126366247|NCT04003389|454635801|FG001|Overall Study|Withdrawal by Subject|79|||
126291939|NCT04661150|454357415|FG001|Overall Study|Ongoing in study|20|||
126291940|NCT04661150|454357414|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
126291941|NCT04661150|454357415|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
126366248|NCT04003389|454635802|FG002|Overall Study|Withdrawal by Subject|85|||
126366249|NCT04003389|454635800|FG000|Overall Study|Miscellaneous|14|||
126291942|NCT04661150|454357414|FG000|Overall Study|Death|2|||
126366250|NCT04003389|454635801|FG001|Overall Study|Miscellaneous|11|||
126291943|NCT04661150|454357415|FG001|Overall Study|Death|0|||
126291944|NCT03535740|454357416|FG000|Overall Study|Death|44|||
126291945|NCT03535740|454357416|FG000|Overall Study|Lost to Follow-up|1|||
126291946|NCT03535740|454357416|FG000|Overall Study|Withdrawal by Subject|13|||
126291947|NCT03535740|454357416|FG000|Overall Study|Site terminated by Sponsor|45|||
126366251|NCT04003389|454635802|FG002|Overall Study|Miscellaneous|14|||
126291948|NCT05198518|454357421|FG000|Screening Visit|Deemed unable to participate|58|||
126291949|NCT05198518|454357422|FG001|Screening Visit|Deemed unable to participate|0|||
126366252|NCT04003389|454635800|FG000|Overall Study|Participant did not receive study drug|1|||
126366253|NCT04003389|454635801|FG001|Overall Study|Participant did not receive study drug|0|||
126291950|NCT05198518|454357423|FG002|Screening Visit|Deemed unable to participate|0|||
126291951|NCT02756611|454357427|FG000|Overall Study|Death|70|||
126291952|NCT02756611|454357427|FG000|Overall Study|Withdrawal by Subject|2|||
126291953|NCT02756611|454357427|FG000|Overall Study|Lost to Follow-up|3|||
126291954|NCT02756611|454357427|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
126291955|NCT02756611|454357427|FG000|Overall Study|Other|10|||
126291956|NCT03125798|454357428|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
126291957|NCT03125798|454357429|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
126291958|NCT03125798|454357428|FG000|Overall Study|Conversion to thoracotomy|7|||
126291959|NCT03125798|454357429|FG001|Overall Study|Conversion to thoracotomy|7|||
126291960|NCT00065156|454357433|FG000|Overall Study|Adverse Event|37|||
126291961|NCT00065156|454357433|FG000|Overall Study|Lack of Efficacy|52|||
126291962|NCT00065156|454357433|FG000|Overall Study|Withdrawal by Subject|8|||
126291963|NCT00065156|454357433|FG000|Overall Study|Lost to Follow-up|1|||
126291964|NCT00065156|454357433|FG000|Overall Study|Death|11|||
126291965|NCT00065156|454357433|FG000|Overall Study|Study Closed by Sponsor|2|||
126291966|NCT00065156|454357433|FG000|Overall Study|Disease Progression|7|||
126291967|NCT00065156|454357433|FG000|Overall Study|Investigator Decision|2|||
126291968|NCT00065156|454357433|FG000|Overall Study|Non-Compliance|2|||
126291969|NCT00065156|454357433|FG000|Overall Study|Loss of Response|1|||
126291970|NCT00065156|454357433|FG000|Overall Study|Secondary Malign Disease|1|||
126291971|NCT00100828|454357434|FG000|Overall Study|Physician Decision|6|||
126291972|NCT01197911|454357435|FG000|Overall Study|Adverse Event|0|||
126291973|NCT01197911|454357436|FG001|Overall Study|Adverse Event|0|||
126291974|NCT01197911|454357437|FG002|Overall Study|Adverse Event|1|||
126291975|NCT02443740|454357439|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291976|NCT02443740|454357440|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291977|NCT02443740|454357441|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291978|NCT02443740|454357442|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291979|NCT02443740|454357443|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291980|NCT02443740|454357444|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
126291981|NCT02443740|454357445|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291982|NCT02443740|454357446|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291983|NCT02443740|454357447|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291984|NCT02443740|454357448|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291985|NCT02443740|454357449|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291986|NCT02443740|454357439|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
126291987|NCT02443740|454357440|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291988|NCT02443740|454357441|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291989|NCT02443740|454357442|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291990|NCT02443740|454357443|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291991|NCT02443740|454357444|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291992|NCT02443740|454357445|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
126291993|NCT02443740|454357446|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291994|NCT02443740|454357447|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291995|NCT02443740|454357448|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291996|NCT02443740|454357449|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291997|NCT02443740|454357439|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126291998|NCT02443740|454357440|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126291999|NCT02443740|454357441|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292000|NCT02443740|454357442|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292001|NCT02443740|454357443|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292002|NCT02443740|454357444|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
126292003|NCT02443740|454357445|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292004|NCT02443740|454357446|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292005|NCT02443740|454357447|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292006|NCT02443740|454357448|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292007|NCT02443740|454357449|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292008|NCT00456300|454357450|FG000|Overall Study|Adverse Event|1|||
126292009|NCT00456300|454357451|FG001|Overall Study|Adverse Event|0|||
126292010|NCT01478373|454357453|FG000|Treatment Phase|Protocol Violation|1|||
126292011|NCT01478373|454357453|FG000|Survival Phase|Adverse Event|8|||
126292012|NCT01478373|454357453|FG000|Survival Phase|Protocol Violation|1|||
126292013|NCT01478373|454357453|FG000|Survival Phase|crossover to another study|2|||
126292014|NCT01478373|454357453|FG000|Survival Phase|Progressive Disease|27|||
126292015|NCT01074944|454357456|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
126292016|NCT01074944|454357457|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
126292017|NCT01074944|454357458|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
126292018|NCT01074944|454357459|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
126292019|NCT01074944|454357460|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
126292020|NCT01074944|454357456|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
126292021|NCT01074944|454357457|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
126292022|NCT01074944|454357458|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
126292023|NCT01074944|454357459|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
126292024|NCT01074944|454357460|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
126366254|NCT04003389|454635802|FG002|Overall Study|Participant did not receive study drug|0|||
126366255|NCT04629196|454635803|FG000|Overall Study|Subject discontinued study drug|1|||
126366256|NCT04629196|454635804|FG001|Overall Study|Subject discontinued study drug|0|||
126366257|NCT04629196|454635803|FG000|Overall Study|Subject study drug dosing increased|1|||
126366258|NCT04629196|454635804|FG001|Overall Study|Subject study drug dosing increased|1|||
126366259|NCT04629196|454635803|FG000|Overall Study|Withdrawal by Subject|1|||
126366260|NCT04629196|454635804|FG001|Overall Study|Withdrawal by Subject|2|||
126366261|NCT01450631|454635808|FG000|Overall Study|Lost to Follow-up|2|||
126366262|NCT01450631|454635809|FG001|Overall Study|Lost to Follow-up|4|||
126292025|NCT01074944|454357456|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
126292026|NCT01074944|454357457|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
126292027|NCT01074944|454357458|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
126292028|NCT01074944|454357459|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
126292029|NCT01074944|454357460|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
126292030|NCT01074944|454357456|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
126292031|NCT01074944|454357457|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
126292032|NCT01074944|454357458|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
126292033|NCT01074944|454357459|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
126292034|NCT01074944|454357460|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
126042137|NCT03580356|453453097|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
126042138|NCT03580356|453453098|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
126366263|NCT01450631|454635808|FG000|Overall Study|Withdrawal by Subject|1|||
126366264|NCT01450631|454635809|FG001|Overall Study|Withdrawal by Subject|0|||
126366265|NCT00835354|454635810|FG000|First Intervention|Adverse Event|0|||
126366266|NCT00835354|454635811|FG001|First Intervention|Adverse Event|1|||
126366267|NCT03204812|454635812|FG000|Overall Study|Adverse Event|3|||
126366268|NCT03648372|454635814|FG000|Overall Study|Withdrawal by Subject|2|||
126366269|NCT03648372|454635815|FG001|Overall Study|Withdrawal by Subject|0|||
126366270|NCT03648372|454635816|FG002|Overall Study|Withdrawal by Subject|0|||
126366271|NCT03648372|454635817|FG003|Overall Study|Withdrawal by Subject|0|||
126366272|NCT03648372|454635818|FG004|Overall Study|Withdrawal by Subject|0|||
126366273|NCT03648372|454635819|FG005|Overall Study|Withdrawal by Subject|1|||
126366274|NCT03648372|454635820|FG006|Overall Study|Withdrawal by Subject|2|||
126366275|NCT03648372|454635821|FG007|Overall Study|Withdrawal by Subject|0|||
126366276|NCT03648372|454635822|FG008|Overall Study|Withdrawal by Subject|0|||
126366277|NCT03648372|454635823|FG009|Overall Study|Withdrawal by Subject|0|||
126366278|NCT03648372|454635824|FG010|Overall Study|Withdrawal by Subject|2|||
126366279|NCT03648372|454635825|FG011|Overall Study|Withdrawal by Subject|0|||
126366280|NCT03648372|454635826|FG012|Overall Study|Withdrawal by Subject|2|||
126366281|NCT03648372|454635827|FG013|Overall Study|Withdrawal by Subject|0|||
126366282|NCT03648372|454635828|FG014|Overall Study|Withdrawal by Subject|0|||
126366283|NCT03648372|454635829|FG015|Overall Study|Withdrawal by Subject|0|||
126366284|NCT03648372|454635830|FG016|Overall Study|Withdrawal by Subject|1|||
126366285|NCT03648372|454635831|FG017|Overall Study|Withdrawal by Subject|0|||
126366286|NCT03648372|454635832|FG018|Overall Study|Withdrawal by Subject|0|||
126366287|NCT03648372|454635833|FG019|Overall Study|Withdrawal by Subject|0|||
126366288|NCT03648372|454635834|FG020|Overall Study|Withdrawal by Subject|0|||
126366289|NCT03648372|454635814|FG000|Overall Study|Progressive Disease|2|||
126042139|NCT03580356|453453099|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
126292035|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
126366290|NCT03648372|454635815|FG001|Overall Study|Progressive Disease|3|||
126366291|NCT03648372|454635816|FG002|Overall Study|Progressive Disease|4|||
126366292|NCT03648372|454635817|FG003|Overall Study|Progressive Disease|3|||
126366293|NCT03648372|454635818|FG004|Overall Study|Progressive Disease|2|||
126366294|NCT03648372|454635819|FG005|Overall Study|Progressive Disease|2|||
126292036|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
126292037|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
126292038|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
126366295|NCT03648372|454635820|FG006|Overall Study|Progressive Disease|3|||
126366296|NCT03648372|454635821|FG007|Overall Study|Progressive Disease|3|||
126366297|NCT03648372|454635822|FG008|Overall Study|Progressive Disease|5|||
126366298|NCT03648372|454635823|FG009|Overall Study|Progressive Disease|5|||
126366299|NCT03648372|454635824|FG010|Overall Study|Progressive Disease|2|||
126366300|NCT03648372|454635825|FG011|Overall Study|Progressive Disease|3|||
126366301|NCT03648372|454635826|FG012|Overall Study|Progressive Disease|3|||
126366302|NCT03648372|454635827|FG013|Overall Study|Progressive Disease|3|||
126366303|NCT03648372|454635828|FG014|Overall Study|Progressive Disease|6|||
126292039|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
126292040|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
126292041|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
126292042|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
126292043|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
126292044|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
126292045|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
126292046|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
126292047|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
126292048|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
126292049|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
126292050|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
126292051|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
126292052|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
126292053|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
126292054|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
126292055|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
126292056|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
126292057|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
126292058|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
126292059|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
126292060|NCT01074944|454357456|FG000|Long Term Treatment|Adverse Event|0|||
126292061|NCT01074944|454357457|FG001|Long Term Treatment|Adverse Event|0|||
126292062|NCT01074944|454357458|FG002|Long Term Treatment|Adverse Event|0|||
126292063|NCT01074944|454357459|FG003|Long Term Treatment|Adverse Event|3|||
126292064|NCT01074944|454357460|FG004|Long Term Treatment|Adverse Event|0|||
126292065|NCT01074944|454357456|FG000|Long Term Treatment|Lost to Follow-up|0|||
126292066|NCT01074944|454357457|FG001|Long Term Treatment|Lost to Follow-up|0|||
126292067|NCT01074944|454357458|FG002|Long Term Treatment|Lost to Follow-up|0|||
126292068|NCT01074944|454357459|FG003|Long Term Treatment|Lost to Follow-up|2|||
126292069|NCT01074944|454357460|FG004|Long Term Treatment|Lost to Follow-up|0|||
126292070|NCT01074944|454357456|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
126292071|NCT01074944|454357457|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
126292072|NCT01074944|454357458|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
126292073|NCT01074944|454357459|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
126292074|NCT01074944|454357460|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
126292075|NCT01074944|454357456|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
126292076|NCT01074944|454357457|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
126292077|NCT01074944|454357458|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
126292078|NCT01074944|454357459|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
126292079|NCT01074944|454357460|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
126292080|NCT01074944|454357456|FG000|Long Term Treatment|Withdrawal by Subject|0|||
126292081|NCT01074944|454357457|FG001|Long Term Treatment|Withdrawal by Subject|0|||
126292082|NCT01074944|454357458|FG002|Long Term Treatment|Withdrawal by Subject|0|||
126292083|NCT01074944|454357459|FG003|Long Term Treatment|Withdrawal by Subject|2|||
126292084|NCT01074944|454357460|FG004|Long Term Treatment|Withdrawal by Subject|0|||
126292085|NCT01074944|454357456|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
126292086|NCT01074944|454357457|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
126292087|NCT01074944|454357458|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
126292088|NCT01074944|454357459|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
126292089|NCT01074944|454357460|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
126292090|NCT01074944|454357456|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
126292091|NCT01074944|454357457|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
126292092|NCT01074944|454357458|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
126292093|NCT01074944|454357459|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
126292094|NCT01074944|454357460|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
126292095|NCT02348112|454357462|FG000|Overall Study|Withdrawal by Subject|32|||
126292096|NCT02348112|454357463|FG001|Overall Study|Withdrawal by Subject|29|||
126292097|NCT02348112|454357462|FG000|Overall Study|Lost to Follow-up|24|||
126292098|NCT02348112|454357463|FG001|Overall Study|Lost to Follow-up|20|||
126292099|NCT02348112|454357462|FG000|Overall Study|Physician Decision|17|||
126292100|NCT02348112|454357463|FG001|Overall Study|Physician Decision|15|||
126292101|NCT02348112|454357462|FG000|Overall Study|Site closed due to PI leaving|0|||
126292102|NCT02348112|454357463|FG001|Overall Study|Site closed due to PI leaving|30|||
126292103|NCT02348112|454357462|FG000|Overall Study|Sponsor withdrawal|0|||
126292104|NCT02348112|454357463|FG001|Overall Study|Sponsor withdrawal|7|||
125883146|NCT00463567|452871421|FG006|Overall Study|Lack of Efficacy|1|||
126100032|NCT02680002|453659803|FG002|Overall Study|Withdrawal by Subject|1|||
125883147|NCT00463567|452871415|FG000|Overall Study|Abnormal lab value(s)|1|||
125883148|NCT00463567|452871416|FG001|Overall Study|Abnormal lab value(s)|1|||
125883149|NCT00463567|452871417|FG002|Overall Study|Abnormal lab value(s)|2|||
125883150|NCT00463567|452871418|FG003|Overall Study|Abnormal lab value(s)|1|||
125883151|NCT00463567|452871419|FG004|Overall Study|Abnormal lab value(s)|1|||
126100033|NCT02680002|453659804|FG003|Overall Study|Withdrawal by Subject|0|||
126100034|NCT02680002|453659805|FG004|Overall Study|Withdrawal by Subject|2|||
126292105|NCT02348112|454357462|FG000|Overall Study|Death|0|||
126292106|NCT02348112|454357463|FG001|Overall Study|Death|1|||
126292107|NCT01998841|454357471|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
126292108|NCT01998841|454357472|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
126292109|NCT01998841|454357473|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
126292110|NCT01998841|454357474|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292111|NCT01998841|454357475|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292112|NCT01998841|454357471|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292113|NCT01998841|454357472|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292114|NCT01998841|454357473|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292115|NCT01998841|454357474|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
126292116|NCT01998841|454357475|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
126292117|NCT02552121|454357476|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
126292118|NCT02552121|454357477|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292119|NCT02552121|454357478|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292120|NCT02552121|454357479|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292121|NCT02552121|454357480|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292122|NCT02552121|454357481|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292123|NCT02552121|454357482|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292124|NCT02552121|454357483|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292125|NCT02552121|454357476|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
126292126|NCT02552121|454357477|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292127|NCT02552121|454357478|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292128|NCT02552121|454357479|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292129|NCT02552121|454357480|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292130|NCT02552121|454357481|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292131|NCT02552121|454357482|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292132|NCT02552121|454357483|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292133|NCT02552121|454357476|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292134|NCT02552121|454357477|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
126292135|NCT02552121|454357478|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292136|NCT02552121|454357479|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292137|NCT02552121|454357480|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292138|NCT02552121|454357481|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292139|NCT02552121|454357482|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292140|NCT02552121|454357483|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292141|NCT02552121|454357476|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292142|NCT02552121|454357477|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
126292143|NCT02552121|454357478|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292144|NCT02552121|454357479|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292145|NCT02552121|454357480|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292146|NCT02552121|454357481|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292147|NCT02552121|454357482|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292148|NCT02552121|454357483|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292149|NCT02552121|454357476|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126366304|NCT03648372|454635829|FG015|Overall Study|Progressive Disease|0|||
126366305|NCT03648372|454635830|FG016|Overall Study|Progressive Disease|0|||
126366306|NCT03648372|454635831|FG017|Overall Study|Progressive Disease|0|||
126366307|NCT03648372|454635832|FG018|Overall Study|Progressive Disease|0|||
126366308|NCT03648372|454635833|FG019|Overall Study|Progressive Disease|0|||
126366309|NCT03648372|454635834|FG020|Overall Study|Progressive Disease|0|||
126366310|NCT03648372|454635814|FG000|Overall Study|Other|0|||
126366311|NCT03648372|454635815|FG001|Overall Study|Other|0|||
126366312|NCT03648372|454635816|FG002|Overall Study|Other|0|||
126366313|NCT03648372|454635817|FG003|Overall Study|Other|0|||
126366314|NCT03648372|454635818|FG004|Overall Study|Other|1|||
126366315|NCT03648372|454635819|FG005|Overall Study|Other|0|||
126366316|NCT03648372|454635820|FG006|Overall Study|Other|0|||
126366317|NCT03648372|454635821|FG007|Overall Study|Other|0|||
126366318|NCT03648372|454635822|FG008|Overall Study|Other|0|||
126366319|NCT03648372|454635823|FG009|Overall Study|Other|0|||
126366320|NCT03648372|454635824|FG010|Overall Study|Other|1|||
126366321|NCT03648372|454635825|FG011|Overall Study|Other|2|||
126366322|NCT03648372|454635826|FG012|Overall Study|Other|1|||
126366323|NCT03648372|454635827|FG013|Overall Study|Other|3|||
126292150|NCT02552121|454357477|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
126292151|NCT02552121|454357478|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292152|NCT02552121|454357479|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292153|NCT02552121|454357480|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292154|NCT02552121|454357481|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292155|NCT02552121|454357482|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292156|NCT02552121|454357483|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292157|NCT02552121|454357476|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292158|NCT02552121|454357477|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
126292159|NCT02552121|454357478|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292160|NCT02552121|454357479|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292161|NCT02552121|454357480|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292162|NCT02552121|454357481|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292163|NCT02552121|454357482|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292164|NCT02552121|454357483|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292165|NCT02552121|454357476|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
126292166|NCT02552121|454357477|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
126292167|NCT02552121|454357478|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
126292168|NCT02552121|454357479|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
126292169|NCT02552121|454357480|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
126292170|NCT02552121|454357481|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
126292171|NCT02552121|454357482|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
126292172|NCT02552121|454357483|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
126292173|NCT02552121|454357476|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
126292174|NCT02552121|454357477|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
126292175|NCT02552121|454357478|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
126292176|NCT02552121|454357479|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
126292177|NCT02552121|454357480|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
126292178|NCT02552121|454357481|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
126292179|NCT02552121|454357482|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
126292180|NCT02552121|454357483|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
126292181|NCT02552121|454357476|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
126292182|NCT02552121|454357477|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
126292183|NCT02552121|454357478|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
126292184|NCT02552121|454357479|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
126292185|NCT02552121|454357480|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
126292186|NCT02552121|454357481|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
126292187|NCT02552121|454357482|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
126292188|NCT02552121|454357483|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
126292189|NCT02552121|454357476|FG000|Part 2: Cohort Expansion|Death|0|||
126292190|NCT02552121|454357477|FG001|Part 2: Cohort Expansion|Death|0|||
126292191|NCT02552121|454357478|FG002|Part 2: Cohort Expansion|Death|1|||
126292192|NCT02552121|454357479|FG003|Part 2: Cohort Expansion|Death|0|||
126292193|NCT02552121|454357480|FG004|Part 2: Cohort Expansion|Death|0|||
126292194|NCT02552121|454357481|FG005|Part 2: Cohort Expansion|Death|0|||
126292195|NCT02552121|454357482|FG006|Part 2: Cohort Expansion|Death|0|||
126292196|NCT02552121|454357483|FG007|Part 2: Cohort Expansion|Death|0|||
126292197|NCT02905032|454357485|FG000|Overall Study|Withdrawal by Subject|2|||
126292198|NCT02905032|454357486|FG001|Overall Study|Withdrawal by Subject|0|||
126292199|NCT02905032|454357487|FG002|Overall Study|Withdrawal by Subject|0|||
126292200|NCT02905032|454357485|FG000|Overall Study|Protocol Violation|6|||
126292201|NCT02905032|454357486|FG001|Overall Study|Protocol Violation|12|||
126292202|NCT02905032|454357487|FG002|Overall Study|Protocol Violation|0|||
126292203|NCT03447743|454357488|FG000|Overall Study|Withdrawal by Subject|2|||
126292204|NCT03447743|454357488|FG000|Overall Study|Lost to Follow-up|3|||
126292205|NCT03447743|454357488|FG000|Overall Study|Adverse Event|1|||
125883152|NCT00463567|452871420|FG005|Overall Study|Abnormal lab value(s)|0|||
126292206|NCT03447743|454357488|FG000|Overall Study|Did not meet criteria to continue|1|||
126292207|NCT02854527|454357489|FG000|Overall Study|Adverse Event|0|||
126292208|NCT02854527|454357490|FG001|Overall Study|Adverse Event|0|||
126292209|NCT02854527|454357491|FG002|Overall Study|Adverse Event|0|||
126292210|NCT02854527|454357492|FG003|Overall Study|Adverse Event|0|||
126292211|NCT02854527|454357493|FG004|Overall Study|Adverse Event|1|||
125883153|NCT00463567|452871421|FG006|Overall Study|Abnormal lab value(s)|0|||
126292212|NCT02854527|454357494|FG005|Overall Study|Adverse Event|0|||
126292213|NCT02854527|454357495|FG006|Overall Study|Adverse Event|0|||
126292214|NCT02854527|454357496|FG007|Overall Study|Adverse Event|0|||
126292215|NCT02854527|454357497|FG008|Overall Study|Adverse Event|0|||
126292216|NCT02854527|454357498|FG009|Overall Study|Adverse Event|0|||
126292217|NCT02854527|454357489|FG000|Overall Study|Lost to Follow-up|0|||
126292218|NCT02854527|454357490|FG001|Overall Study|Lost to Follow-up|0|||
126292219|NCT02854527|454357491|FG002|Overall Study|Lost to Follow-up|0|||
126292220|NCT02854527|454357492|FG003|Overall Study|Lost to Follow-up|1|||
126292221|NCT02854527|454357493|FG004|Overall Study|Lost to Follow-up|0|||
126292222|NCT02854527|454357494|FG005|Overall Study|Lost to Follow-up|0|||
126292223|NCT02854527|454357495|FG006|Overall Study|Lost to Follow-up|0|||
126292224|NCT02854527|454357496|FG007|Overall Study|Lost to Follow-up|0|||
126292225|NCT02854527|454357497|FG008|Overall Study|Lost to Follow-up|0|||
126292226|NCT02854527|454357498|FG009|Overall Study|Lost to Follow-up|0|||
126292227|NCT03567980|454357499|FG000|Overall Study|Adverse Event|1|||
126292228|NCT03093259|454357501|FG000|Overall Study|Adverse Event|1|||
126292229|NCT03093259|454357502|FG001|Overall Study|Adverse Event|0|||
126292230|NCT03093259|454357501|FG000|Overall Study|Withdrawal by Subject|1|||
126292231|NCT03093259|454357502|FG001|Overall Study|Withdrawal by Subject|0|||
126292232|NCT02575833|454357503|FG000|Overall Study|Withdrawal by Subject|0|||
126292233|NCT02575833|454357504|FG001|Overall Study|Withdrawal by Subject|1|||
126292234|NCT02575833|454357503|FG000|Overall Study|Lost to Follow-up|1|||
126292235|NCT02575833|454357504|FG001|Overall Study|Lost to Follow-up|0|||
126292236|NCT01821807|454357505|FG000|Overall Study|Lost to Follow-up|3|||
126292237|NCT01821807|454357506|FG001|Overall Study|Lost to Follow-up|1|||
126292238|NCT00550459|454357508|FG000|Overall Study|Adverse Event|0|||
126292239|NCT00550459|454357509|FG001|Overall Study|Adverse Event|2|||
126292240|NCT00550459|454357508|FG000|Overall Study|Withdrawal by Subject|1|||
126292241|NCT00550459|454357509|FG001|Overall Study|Withdrawal by Subject|1|||
126292242|NCT02404805|454357510|FG000|Overall Study|Withdrawal by Subject|1|||
126292243|NCT02404805|454357511|FG001|Overall Study|Withdrawal by Subject|0|||
126292244|NCT02404805|454357512|FG002|Overall Study|Withdrawal by Subject|0|||
126292245|NCT02404805|454357513|FG003|Overall Study|Withdrawal by Subject|0|||
126292246|NCT02404805|454357514|FG004|Overall Study|Withdrawal by Subject|0|||
126292247|NCT02404805|454357515|FG005|Overall Study|Withdrawal by Subject|0|||
126292248|NCT00445146|454357516|FG000|Overall Study|Withdrew Consent|29|||
126292249|NCT00445146|454357516|FG000|Overall Study|Lack of Efficacy|28|||
126292250|NCT00445146|454357516|FG000|Overall Study|Investigator's Discretion|22|||
126292251|NCT00445146|454357516|FG000|Overall Study|Adverse Event|13|||
126292252|NCT00445146|454357516|FG000|Overall Study|Lost to Follow-up|13|||
126292253|NCT00445146|454357516|FG000|Overall Study|Death|9|||
126292254|NCT00445146|454357516|FG000|Overall Study|Protocol Violation|4|||
126292255|NCT00445146|454357516|FG000|Overall Study|Pregnancy|1|||
126292256|NCT00625820|454357517|FG000|Overall Study|Withdrawal by Subject|1|||
126292257|NCT02623725|454357518|FG000|Overall Study|Non compliance with protocol|9|||
126292258|NCT02623725|454357519|FG001|Overall Study|Non compliance with protocol|3|||
126292259|NCT02623725|454357518|FG000|Overall Study|Serious adverse event|0|||
126292260|NCT02623725|454357519|FG001|Overall Study|Serious adverse event|2|||
126292261|NCT02623725|454357518|FG000|Overall Study|Withdrawal by Subject|7|||
126292262|NCT02623725|454357519|FG001|Overall Study|Withdrawal by Subject|1|||
126292263|NCT00967330|454357520|FG000|Overall Study|Protocol Violation|3|||
126292264|NCT00967330|454357521|FG001|Overall Study|Protocol Violation|4|||
126292265|NCT00967330|454357520|FG000|Overall Study|Regular|10|||
126292266|NCT00967330|454357521|FG001|Overall Study|Regular|3|||
126292267|NCT00967330|454357520|FG000|Overall Study|Withdrawal by Subject|6|||
126292268|NCT00967330|454357521|FG001|Overall Study|Withdrawal by Subject|0|||
126292269|NCT00967330|454357520|FG000|Overall Study|Lost to Follow-up|1|||
126292270|NCT00967330|454357521|FG001|Overall Study|Lost to Follow-up|1|||
126292271|NCT00967330|454357520|FG000|Overall Study|Death|102|||
126292272|NCT00967330|454357521|FG001|Overall Study|Death|51|||
126292273|NCT00967330|454357520|FG000|Overall Study|Severe protocol deviation|0|||
126292274|NCT00967330|454357521|FG001|Overall Study|Severe protocol deviation|1|||
126292275|NCT03759392|454357523|FG000|Overall Study|Adverse Event|12|||
126292276|NCT03759392|454357524|FG001|Overall Study|Adverse Event|4|||
126292277|NCT03759392|454357523|FG000|Overall Study|Death|2|||
126292278|NCT03759392|454357524|FG001|Overall Study|Death|1|||
126292279|NCT03759392|454357523|FG000|Overall Study|Withdrawal by Subject|2|||
126292280|NCT03759392|454357524|FG001|Overall Study|Withdrawal by Subject|0|||
126292281|NCT03759392|454357523|FG000|Overall Study|Protocol Violation|2|||
126292282|NCT03759392|454357524|FG001|Overall Study|Protocol Violation|0|||
126292283|NCT03759392|454357523|FG000|Overall Study|Physician Decision|0|||
126292284|NCT03759392|454357524|FG001|Overall Study|Physician Decision|1|||
126292285|NCT03759392|454357523|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
126292286|NCT03759392|454357524|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
126292287|NCT03759392|454357523|FG000|Overall Study|No longer able to take medicines|1|||
126292288|NCT03759392|454357524|FG001|Overall Study|No longer able to take medicines|0|||
126292289|NCT03759392|454357523|FG000|Overall Study|Stopped taking study drug|1|||
126292290|NCT03759392|454357524|FG001|Overall Study|Stopped taking study drug|0|||
126292291|NCT02548143|454357525|FG000|Overall Study|Adverse Event|1|||
126292292|NCT02548143|454357526|FG001|Overall Study|Adverse Event|0|||
126292293|NCT02548143|454357525|FG000|Overall Study|Withdrawal by Subject|0|||
126292294|NCT02548143|454357526|FG001|Overall Study|Withdrawal by Subject|1|||
126292295|NCT04871776|454357527|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
126292296|NCT04871776|454357528|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
126292297|NCT04871776|454357529|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
126292298|NCT04871776|454357527|FG000|Overall Study|Did not meet eligibility criteria|1|||
126292299|NCT04871776|454357528|FG001|Overall Study|Did not meet eligibility criteria|1|||
126292300|NCT04871776|454357529|FG002|Overall Study|Did not meet eligibility criteria|1|||
126292301|NCT05620082|454357532|FG000|Overall Study|Discharged before study end|1|||
126292302|NCT05620082|454357533|FG001|Overall Study|Discharged before study end|4|||
126292303|NCT05620082|454357534|FG002|Overall Study|Discharged before study end|0|||
126292304|NCT05620082|454357532|FG000|Overall Study|Moved to a different ward|1|||
126292305|NCT05620082|454357533|FG001|Overall Study|Moved to a different ward|0|||
126292306|NCT05620082|454357534|FG002|Overall Study|Moved to a different ward|0|||
126292307|NCT05620082|454357532|FG000|Overall Study|Feeling too unwell|1|||
126292308|NCT05620082|454357533|FG001|Overall Study|Feeling too unwell|0|||
126292309|NCT05620082|454357534|FG002|Overall Study|Feeling too unwell|0|||
126292310|NCT04075487|454359249|FG000|Overall Study|Withdrawal by Subject|1|||
126292311|NCT00711243|454359252|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
126292312|NCT00711243|454359253|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
126292313|NCT00711243|454359254|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
126292314|NCT00711243|454359255|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
126292315|NCT00711243|454359256|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
126292316|NCT00711243|454359257|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
126292317|NCT00711243|454359252|FG000|Reached First Response/4 Cycles|Death|0|||
126292318|NCT00711243|454359253|FG001|Reached First Response/4 Cycles|Death|0|||
126292319|NCT00711243|454359254|FG002|Reached First Response/4 Cycles|Death|0|||
126292320|NCT00711243|454359255|FG003|Reached First Response/4 Cycles|Death|0|||
126292321|NCT00711243|454359256|FG004|Reached First Response/4 Cycles|Death|0|||
126292322|NCT00711243|454359257|FG005|Reached First Response/4 Cycles|Death|2|||
126292323|NCT00711243|454359252|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
126292324|NCT00711243|454359253|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
126292325|NCT00711243|454359254|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
126292326|NCT00711243|454359255|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
126292327|NCT00711243|454359256|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
126292328|NCT00711243|454359257|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
126292329|NCT00711243|454359252|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
126292330|NCT00711243|454359253|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
126292331|NCT00711243|454359254|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
126292332|NCT00711243|454359255|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
126292333|NCT00711243|454359256|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
126292334|NCT00711243|454359257|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
126292335|NCT00711243|454359252|FG000|Treated Cycle 5 After First Response|Death|0|||
126292336|NCT00711243|454359253|FG001|Treated Cycle 5 After First Response|Death|0|||
126292337|NCT00711243|454359254|FG002|Treated Cycle 5 After First Response|Death|0|||
126292338|NCT00711243|454359255|FG003|Treated Cycle 5 After First Response|Death|0|||
126292339|NCT00711243|454359256|FG004|Treated Cycle 5 After First Response|Death|0|||
126292340|NCT00711243|454359257|FG005|Treated Cycle 5 After First Response|Death|2|||
126292341|NCT00711243|454359252|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292342|NCT00711243|454359253|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292343|NCT00711243|454359254|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292344|NCT00711243|454359255|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292345|NCT00711243|454359256|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292346|NCT00711243|454359257|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
126292347|NCT00711243|454359252|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292348|NCT00711243|454359253|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292349|NCT00711243|454359254|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292350|NCT00711243|454359255|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292351|NCT00711243|454359256|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292352|NCT00711243|454359257|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
126292353|NCT01402570|454359258|FG000|Overall Study|Adverse Event|1|||
126292354|NCT04179838|454359262|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
126292355|NCT04179838|454359263|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
126292356|NCT04179838|454359262|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
126292357|NCT04179838|454359263|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
126292358|NCT01290068|454359268|FG000|Overall Study|Adverse Event|1|||
126292359|NCT01290068|454359269|FG001|Overall Study|Adverse Event|3|||
126292360|NCT01290068|454359268|FG000|Overall Study|Lost to Follow-up|3|||
126292361|NCT01290068|454359269|FG001|Overall Study|Lost to Follow-up|0|||
126292362|NCT01290068|454359268|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
126292363|NCT01290068|454359269|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
126292364|NCT01290068|454359268|FG000|Overall Study|Other|3|||
126292365|NCT01290068|454359269|FG001|Overall Study|Other|1|||
126292366|NCT01417156|454359274|FG000|Overall Study|Adverse Event|12|||
126292367|NCT01417156|454359274|FG000|Overall Study|Protocol Violation|2|||
126292368|NCT00818766|454359275|FG000|Overall Study|Could not be Contacted on Day 28|11|||
126292369|NCT00818766|454359276|FG001|Overall Study|Could not be Contacted on Day 28|10|||
126292370|NCT00818766|454359275|FG000|Overall Study|Death|1|||
126292371|NCT00818766|454359276|FG001|Overall Study|Death|0|||
126292372|NCT00818766|454359275|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
126292373|NCT00818766|454359276|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
126292374|NCT00086684|454359277|FG000|Overall Study|Adverse Event|12|||
126292375|NCT00086684|454359278|FG001|Overall Study|Adverse Event|17|||
126292376|NCT00086684|454359279|FG002|Overall Study|Adverse Event|14|||
126292377|NCT00086684|454359277|FG000|Overall Study|Lack of Efficacy|6|||
126292378|NCT00086684|454359278|FG001|Overall Study|Lack of Efficacy|6|||
126292379|NCT00086684|454359279|FG002|Overall Study|Lack of Efficacy|5|||
126292380|NCT00086684|454359277|FG000|Overall Study|Lost to Follow-up|15|||
126292381|NCT00086684|454359278|FG001|Overall Study|Lost to Follow-up|8|||
126292382|NCT00086684|454359279|FG002|Overall Study|Lost to Follow-up|10|||
126292383|NCT00086684|454359277|FG000|Overall Study|Protocol Violation|8|||
126292384|NCT00086684|454359278|FG001|Overall Study|Protocol Violation|3|||
126292385|NCT00086684|454359279|FG002|Overall Study|Protocol Violation|0|||
126292386|NCT00086684|454359277|FG000|Overall Study|Withdrawal by Subject|0|||
126292387|NCT00086684|454359278|FG001|Overall Study|Withdrawal by Subject|4|||
126292388|NCT00086684|454359279|FG002|Overall Study|Withdrawal by Subject|10|||
126292389|NCT00086684|454359277|FG000|Overall Study|NONCOMPLIANCE|5|||
126292390|NCT00086684|454359278|FG001|Overall Study|NONCOMPLIANCE|7|||
126292391|NCT00086684|454359279|FG002|Overall Study|NONCOMPLIANCE|6|||
126292392|NCT00086684|454359277|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126292393|NCT00086684|454359278|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
126292394|NCT00086684|454359279|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126292395|NCT00086684|454359277|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
126292396|NCT00086684|454359278|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
126292397|NCT00086684|454359279|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
126292398|NCT00086684|454359277|FG000|Overall Study|Other|4|||
126292399|NCT00086684|454359278|FG001|Overall Study|Other|2|||
126292400|NCT00086684|454359279|FG002|Overall Study|Other|3|||
126292401|NCT01996241|454359281|FG000|Overall Study|Lost to Follow-up|252|||
126292402|NCT01996241|454359282|FG001|Overall Study|Lost to Follow-up|235|||
126292403|NCT04515147|454359283|FG000|Overall Study|Withdrawal by Subject|1|||
126292404|NCT04515147|454359284|FG001|Overall Study|Withdrawal by Subject|0|||
126292405|NCT04515147|454359285|FG002|Overall Study|Withdrawal by Subject|10|||
126292406|NCT04515147|454359286|FG003|Overall Study|Withdrawal by Subject|18|||
126292407|NCT04515147|454359287|FG004|Overall Study|Withdrawal by Subject|1|||
126292408|NCT04515147|454359288|FG005|Overall Study|Withdrawal by Subject|8|||
126292409|NCT04515147|454359283|FG000|Overall Study|Lost to Follow-up|0|||
126292410|NCT04515147|454359284|FG001|Overall Study|Lost to Follow-up|1|||
126292411|NCT04515147|454359285|FG002|Overall Study|Lost to Follow-up|5|||
126292412|NCT04515147|454359286|FG003|Overall Study|Lost to Follow-up|6|||
126292413|NCT04515147|454359287|FG004|Overall Study|Lost to Follow-up|2|||
126292414|NCT04515147|454359288|FG005|Overall Study|Lost to Follow-up|1|||
126292415|NCT04515147|454359283|FG000|Overall Study|Adverse Event|0|||
126292416|NCT04515147|454359284|FG001|Overall Study|Adverse Event|0|||
126292417|NCT04515147|454359285|FG002|Overall Study|Adverse Event|0|||
126292418|NCT04515147|454359286|FG003|Overall Study|Adverse Event|2|||
126292419|NCT04515147|454359287|FG004|Overall Study|Adverse Event|0|||
126292420|NCT04515147|454359288|FG005|Overall Study|Adverse Event|0|||
126292421|NCT04515147|454359283|FG000|Overall Study|Miscellaneous|0|||
126292422|NCT04515147|454359284|FG001|Overall Study|Miscellaneous|0|||
126292423|NCT04515147|454359285|FG002|Overall Study|Miscellaneous|0|||
126292424|NCT04515147|454359286|FG003|Overall Study|Miscellaneous|1|||
126292425|NCT04515147|454359287|FG004|Overall Study|Miscellaneous|0|||
126292426|NCT04515147|454359288|FG005|Overall Study|Miscellaneous|1|||
126292427|NCT02094300|454359293|FG000|Overall Study|Death|7|||
126292428|NCT02094300|454359293|FG000|Overall Study|Lost to Follow-up|10|||
126292429|NCT02094300|454359293|FG000|Overall Study|Still be eligible for follow-up|3|||
126292430|NCT03565900|454359299|FG000|Overall Study|Disposition Unknown|4|||
126292431|NCT03565900|454359300|FG001|Overall Study|Disposition Unknown|1|||
126292432|NCT03565900|454359299|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126292433|NCT03565900|454359300|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
126292434|NCT03565900|454359299|FG000|Overall Study|Withdrawal by Subject|4|||
126292435|NCT03565900|454359300|FG001|Overall Study|Withdrawal by Subject|5|||
126292436|NCT03565900|454359299|FG000|Overall Study|Randomized By Mistake|0|||
126292437|NCT03565900|454359300|FG001|Overall Study|Randomized By Mistake|2|||
126292438|NCT03565900|454359299|FG000|Overall Study|Physician Decision|7|||
126292439|NCT03565900|454359300|FG001|Overall Study|Physician Decision|11|||
126292440|NCT03565900|454359299|FG000|Overall Study|Death|9|||
126292441|NCT03565900|454359300|FG001|Overall Study|Death|7|||
126292442|NCT00942357|454359313|FG000|Overall Study|Ineligible|37|||
126292443|NCT00942357|454359314|FG001|Overall Study|Ineligible|40|||
126292444|NCT01960257|454359315|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
126292445|NCT01960257|454359316|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
126292446|NCT01960257|454359317|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
126292447|NCT01960257|454359315|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
126292448|NCT01960257|454359316|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
126292449|NCT01960257|454359317|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
126292450|NCT01960257|454359315|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
126292451|NCT01960257|454359316|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
126292452|NCT01960257|454359317|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
126292453|NCT02002221|454359318|FG000|Overall Study|Adverse Event|2|||
126292454|NCT02002221|454359319|FG001|Overall Study|Adverse Event|1|||
126292455|NCT02002221|454359318|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126292456|NCT02002221|454359319|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126292457|NCT02002221|454359318|FG000|Overall Study|Patient withdrew consent|0|||
126292458|NCT02002221|454359319|FG001|Overall Study|Patient withdrew consent|1|||
126292459|NCT01518322|454359320|FG000|Overall Study|FeNO measurement was missing|13|||
126292460|NCT03518008|454359325|FG000|Period 2, Second Week of Wear|Family emergency|0|||
126292461|NCT03518008|454359326|FG001|Period 2, Second Week of Wear|Family emergency|1|||
126292462|NCT01169350|454359327|FG000|Overall Study|Physician Decision|3|||
126292463|NCT01169350|454359327|FG000|Overall Study|Lost to Follow-up|2|||
126292464|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
126292465|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
126292466|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
126292467|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
126292468|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
126292469|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
126292470|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
126292471|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
126292472|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
126292473|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
126292474|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
126292475|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
126292476|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
126292477|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
126292478|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
126292479|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
126292480|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
126292481|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
126292482|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
126292483|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
126292484|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
126292485|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
126292486|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
126292487|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
126292488|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
126292489|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
126292490|NCT04338022|454359328|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
126292491|NCT04338022|454359329|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
126292492|NCT02860546|454359331|FG000|Overall Study|Clinical Progression|6|||
126292493|NCT02860546|454359331|FG000|Overall Study|Radiological Progression|12|||
126292494|NCT02466321|454359332|FG000|Overall Study|Death|26|||
126292495|NCT02466321|454359332|FG000|Overall Study|Revision|6|||
126292496|NCT02466321|454359332|FG000|Overall Study|Lost to Follow-up|60|||
126292497|NCT02466321|454359332|FG000|Overall Study|Did not receive study device|1|||
126292498|NCT06071754|454359333|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
126292499|NCT00729937|454359334|FG000|Overall Study|Lost to Follow-up|49|||
126292500|NCT00729937|454359335|FG001|Overall Study|Lost to Follow-up|58|||
126292501|NCT00729937|454359336|FG002|Overall Study|Lost to Follow-up|18|||
126292502|NCT00729937|454359337|FG003|Overall Study|Lost to Follow-up|33|||
126292503|NCT00729937|454359338|FG004|Overall Study|Lost to Follow-up|18|||
126292504|NCT00729937|454359339|FG005|Overall Study|Lost to Follow-up|23|||
126292505|NCT00729937|454359334|FG000|Overall Study|Physician Decision|7|||
126292506|NCT00729937|454359335|FG001|Overall Study|Physician Decision|16|||
126292507|NCT00729937|454359336|FG002|Overall Study|Physician Decision|2|||
126292508|NCT00729937|454359337|FG003|Overall Study|Physician Decision|0|||
126292509|NCT00729937|454359338|FG004|Overall Study|Physician Decision|5|||
126292510|NCT00729937|454359339|FG005|Overall Study|Physician Decision|8|||
126292511|NCT00729937|454359334|FG000|Overall Study|Death|1|||
126292512|NCT00729937|454359335|FG001|Overall Study|Death|0|||
126292513|NCT00729937|454359336|FG002|Overall Study|Death|1|||
126292514|NCT00729937|454359337|FG003|Overall Study|Death|0|||
126292515|NCT00729937|454359338|FG004|Overall Study|Death|0|||
126292516|NCT00729937|454359339|FG005|Overall Study|Death|1|||
126292517|NCT00729937|454359334|FG000|Overall Study|Withdrawal by Subject|3|||
126292518|NCT00729937|454359335|FG001|Overall Study|Withdrawal by Subject|5|||
126292519|NCT00729937|454359336|FG002|Overall Study|Withdrawal by Subject|6|||
126292520|NCT00729937|454359337|FG003|Overall Study|Withdrawal by Subject|0|||
126292521|NCT00729937|454359338|FG004|Overall Study|Withdrawal by Subject|4|||
126292522|NCT00729937|454359339|FG005|Overall Study|Withdrawal by Subject|2|||
126292523|NCT00729937|454359334|FG000|Overall Study|Randomized but not treated|12|||
126292524|NCT00729937|454359335|FG001|Overall Study|Randomized but not treated|6|||
126366324|NCT03648372|454635828|FG014|Overall Study|Other|0|||
126366325|NCT03648372|454635829|FG015|Overall Study|Other|5|||
126366326|NCT03648372|454635830|FG016|Overall Study|Other|1|||
126366327|NCT03648372|454635831|FG017|Overall Study|Other|5|||
126366328|NCT03648372|454635832|FG018|Overall Study|Other|0|||
126366329|NCT03648372|454635833|FG019|Overall Study|Other|1|||
126366330|NCT03648372|454635834|FG020|Overall Study|Other|0|||
126366331|NCT03648372|454635814|FG000|Overall Study|Lost to Follow-up|0|||
126366332|NCT03648372|454635815|FG001|Overall Study|Lost to Follow-up|0|||
126366333|NCT03648372|454635816|FG002|Overall Study|Lost to Follow-up|0|||
126366334|NCT03648372|454635817|FG003|Overall Study|Lost to Follow-up|0|||
126366335|NCT03648372|454635818|FG004|Overall Study|Lost to Follow-up|0|||
126292525|NCT00729937|454359336|FG002|Overall Study|Randomized but not treated|1|||
126292526|NCT00729937|454359337|FG003|Overall Study|Randomized but not treated|0|||
126292527|NCT00729937|454359338|FG004|Overall Study|Randomized but not treated|1|||
126292528|NCT00729937|454359339|FG005|Overall Study|Randomized but not treated|3|||
126292529|NCT00729937|454359334|FG000|Overall Study|Did not meet eligibility criteria|2|||
126292530|NCT00729937|454359335|FG001|Overall Study|Did not meet eligibility criteria|1|||
126292531|NCT00729937|454359336|FG002|Overall Study|Did not meet eligibility criteria|0|||
126292532|NCT00729937|454359337|FG003|Overall Study|Did not meet eligibility criteria|0|||
126292533|NCT00729937|454359338|FG004|Overall Study|Did not meet eligibility criteria|0|||
126292534|NCT00729937|454359339|FG005|Overall Study|Did not meet eligibility criteria|0|||
126292535|NCT00729937|454359334|FG000|Overall Study|Incarcerated|0|||
126292536|NCT00729937|454359335|FG001|Overall Study|Incarcerated|2|||
126292537|NCT00729937|454359336|FG002|Overall Study|Incarcerated|1|||
126292538|NCT00729937|454359337|FG003|Overall Study|Incarcerated|1|||
126292539|NCT00729937|454359338|FG004|Overall Study|Incarcerated|0|||
126292540|NCT00729937|454359339|FG005|Overall Study|Incarcerated|0|||
126292541|NCT00243412|454359341|FG000|Overall Study|Death|0|||
126292542|NCT00243412|454359342|FG001|Overall Study|Death|1|||
126292543|NCT00243412|454359341|FG000|Overall Study|Adverse Event|4|||
126292544|NCT00243412|454359342|FG001|Overall Study|Adverse Event|2|||
126292545|NCT00243412|454359341|FG000|Overall Study|Lost to Follow-up|0|||
126292546|NCT00243412|454359342|FG001|Overall Study|Lost to Follow-up|1|||
126292547|NCT00243412|454359341|FG000|Overall Study|Physician Decision|1|||
126292548|NCT00243412|454359342|FG001|Overall Study|Physician Decision|1|||
126292549|NCT00243412|454359341|FG000|Overall Study|Withdrawal by Subject|4|||
126292550|NCT00243412|454359342|FG001|Overall Study|Withdrawal by Subject|5|||
126292551|NCT00243412|454359341|FG000|Overall Study|Other|1|||
126292552|NCT00243412|454359342|FG001|Overall Study|Other|1|||
126292553|NCT00683657|454359353|FG000|Overall Study|Adverse Event|0|||
126292554|NCT00683657|454359354|FG001|Overall Study|Adverse Event|1|||
126292555|NCT00683657|454359353|FG000|Overall Study|Subject Withdrew Consent|1|||
126292556|NCT00683657|454359354|FG001|Overall Study|Subject Withdrew Consent|0|||
126292557|NCT01408043|454359359|FG000|Overall Study|unable to collect cells|1|||
126292558|NCT02586155|454359360|FG000|Overall Study|Adverse Event|2|||
126292559|NCT02586155|454359361|FG001|Overall Study|Adverse Event|3|||
126292560|NCT02586155|454359360|FG000|Overall Study|Withdrawal by Subject|31|||
126292561|NCT02586155|454359361|FG001|Overall Study|Withdrawal by Subject|24|||
126292562|NCT02586155|454359360|FG000|Overall Study|Lost to Follow-up|7|||
126292563|NCT02586155|454359361|FG001|Overall Study|Lost to Follow-up|13|||
126292564|NCT02586155|454359360|FG000|Overall Study|Death|61|||
126292565|NCT02586155|454359361|FG001|Overall Study|Death|72|||
126292566|NCT02586155|454359360|FG000|Overall Study|Other reasons|26|||
126292567|NCT02586155|454359361|FG001|Overall Study|Other reasons|15|||
126292568|NCT00739063|454359362|FG000|Overall Study|Screen failures|8|||
126292569|NCT04779879|454359363|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126292570|NCT04779879|454359364|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126292571|NCT04779879|454359365|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126292572|NCT04779879|454359366|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
126292573|NCT04779879|454359367|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126292574|NCT04779879|454359368|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126366336|NCT03648372|454635819|FG005|Overall Study|Lost to Follow-up|0|||
126366337|NCT03648372|454635820|FG006|Overall Study|Lost to Follow-up|0|||
126366338|NCT03648372|454635821|FG007|Overall Study|Lost to Follow-up|0|||
126366339|NCT03648372|454635822|FG008|Overall Study|Lost to Follow-up|0|||
126366340|NCT03648372|454635823|FG009|Overall Study|Lost to Follow-up|0|||
126366341|NCT03648372|454635824|FG010|Overall Study|Lost to Follow-up|0|||
126366342|NCT03648372|454635825|FG011|Overall Study|Lost to Follow-up|0|||
126366343|NCT03648372|454635826|FG012|Overall Study|Lost to Follow-up|0|||
126366344|NCT03648372|454635827|FG013|Overall Study|Lost to Follow-up|1|||
126366345|NCT03648372|454635828|FG014|Overall Study|Lost to Follow-up|0|||
126292575|NCT04779879|454359363|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292576|NCT04779879|454359364|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292577|NCT04779879|454359365|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292578|NCT04779879|454359366|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
126292579|NCT04779879|454359367|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292580|NCT04779879|454359368|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292581|NCT04779879|454359363|FG000|Part C: Up to Week 36|Death|0|||
126292582|NCT04779879|454359364|FG001|Part C: Up to Week 36|Death|0|||
126292583|NCT04779879|454359365|FG002|Part C: Up to Week 36|Death|0|||
126292584|NCT04779879|454359366|FG003|Part C: Up to Week 36|Death|0|||
126292585|NCT04779879|454359367|FG004|Part C: Up to Week 36|Death|0|||
126292586|NCT04779879|454359368|FG005|Part C: Up to Week 36|Death|1|||
126366346|NCT03648372|454635829|FG015|Overall Study|Lost to Follow-up|1|||
126366347|NCT03648372|454635830|FG016|Overall Study|Lost to Follow-up|0|||
126292587|NCT04779879|454359363|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
126292588|NCT04779879|454359364|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
126292589|NCT04779879|454359365|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
126292590|NCT04779879|454359366|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
126292591|NCT04779879|454359367|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
126292592|NCT04779879|454359368|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
126292593|NCT02072980|454359369|FG000|Period 2, Second Wear|Adverse Event|0|||
126292594|NCT02072980|454359370|FG001|Period 2, Second Wear|Adverse Event|1|||
126292595|NCT02633787|454359371|FG000|Overall Study|Withdrawal by Subject|1|||
126292596|NCT01742897|454359372|FG000|Overall Study|Adverse Event|3|||
126292597|NCT01742897|454359372|FG000|Overall Study|Withdrawal by Subject|1|||
126292598|NCT01742897|454359372|FG000|Overall Study|Other|1|||
126292599|NCT02601014|454359374|FG000|Overall Study|Adverse Event|3|||
126292600|NCT02601014|454359375|FG001|Overall Study|Adverse Event|3|||
126292601|NCT02601014|454359374|FG000|Overall Study|Death|3|||
126292602|NCT02601014|454359375|FG001|Overall Study|Death|1|||
126292603|NCT02601014|454359374|FG000|Overall Study|Disease progression|4|||
126292604|NCT02601014|454359375|FG001|Overall Study|Disease progression|8|||
126292605|NCT01168427|454359376|FG000|Overall Study|Patient exited prior to implant|1|||
126292606|NCT02456740|454359380|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
126292607|NCT02456740|454359381|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
126292608|NCT02456740|454359382|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
126292609|NCT02456740|454359383|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292610|NCT02456740|454359384|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292611|NCT02456740|454359385|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292612|NCT02456740|454359386|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292613|NCT02456740|454359387|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292614|NCT02456740|454359388|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292615|NCT02456740|454359380|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
126292616|NCT02456740|454359381|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
126292617|NCT02456740|454359382|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
126292618|NCT02456740|454359383|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292619|NCT02456740|454359384|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292620|NCT02456740|454359385|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292621|NCT02456740|454359386|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292622|NCT02456740|454359387|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292623|NCT02456740|454359388|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292624|NCT02456740|454359380|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
126292625|NCT02456740|454359381|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
126292626|NCT02456740|454359382|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
126292627|NCT02456740|454359383|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292628|NCT02456740|454359384|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292629|NCT02456740|454359385|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292630|NCT02456740|454359386|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292631|NCT02456740|454359387|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292632|NCT02456740|454359388|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292633|NCT02456740|454359380|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292634|NCT02456740|454359381|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292635|NCT02456740|454359382|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292636|NCT02456740|454359383|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
126292637|NCT02456740|454359384|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
126292638|NCT02456740|454359385|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292639|NCT02456740|454359386|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292640|NCT02456740|454359387|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292641|NCT02456740|454359388|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
126292642|NCT02456740|454359380|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126292643|NCT02456740|454359381|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126292644|NCT02456740|454359382|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126292645|NCT02456740|454359383|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
126366348|NCT03648372|454635831|FG017|Overall Study|Lost to Follow-up|1|||
125883154|NCT00463567|452871415|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125883155|NCT00463567|452871416|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126292646|NCT02456740|454359384|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
126292647|NCT02456740|454359385|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
126292648|NCT02456740|454359386|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
126366349|NCT03648372|454635832|FG018|Overall Study|Lost to Follow-up|0|||
126292649|NCT02456740|454359387|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
126292650|NCT02456740|454359388|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
126292651|NCT02456740|454359380|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292652|NCT02456740|454359381|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292653|NCT02456740|454359382|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292654|NCT02456740|454359383|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292655|NCT02456740|454359384|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292656|NCT02456740|454359385|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292657|NCT02456740|454359386|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292658|NCT02456740|454359387|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
126292659|NCT02456740|454359388|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292660|NCT02456740|454359380|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126292661|NCT02456740|454359381|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126292662|NCT02456740|454359382|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126292663|NCT02456740|454359383|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
126292664|NCT02456740|454359384|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
126292665|NCT02456740|454359385|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
126292666|NCT02456740|454359386|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
126292667|NCT02456740|454359387|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
126292668|NCT02456740|454359388|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
126292669|NCT00955617|454359397|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
126292670|NCT00955617|454359398|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
126292671|NCT00955617|454359397|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
126292672|NCT00955617|454359398|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
126292673|NCT00955617|454359397|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
126042140|NCT03580356|453453100|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
126042141|NCT03580356|453453101|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
126042142|NCT03580356|453453102|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
126292674|NCT00955617|454359398|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
126292675|NCT00955617|454359397|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
126292676|NCT00955617|454359398|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
126292677|NCT00931528|454361438|FG000|Overall Study|Protocol Violation|9|||
126292678|NCT00931528|454361439|FG001|Overall Study|Protocol Violation|12|||
126292679|NCT00931528|454361438|FG000|Overall Study|Withdrawal by Subject|4|||
126292680|NCT00931528|454361439|FG001|Overall Study|Withdrawal by Subject|12|||
126292681|NCT00931528|454361438|FG000|Overall Study|Lost to Follow-up|6|||
126292682|NCT00931528|454361439|FG001|Overall Study|Lost to Follow-up|13|||
126292683|NCT00931528|454361438|FG000|Overall Study|Assessment outside of Time Frame|22|||
126292684|NCT00931528|454361439|FG001|Overall Study|Assessment outside of Time Frame|23|||
126292685|NCT02721732|454361440|FG000|Overall Study|Adverse Event|2|||
126292686|NCT02721732|454361441|FG001|Overall Study|Adverse Event|0|||
126292687|NCT02721732|454361442|FG002|Overall Study|Adverse Event|2|||
126292688|NCT02721732|454361443|FG003|Overall Study|Adverse Event|0|||
126292689|NCT02721732|454361444|FG004|Overall Study|Adverse Event|1|||
126292690|NCT02721732|454361445|FG005|Overall Study|Adverse Event|0|||
126292691|NCT02721732|454361446|FG006|Overall Study|Adverse Event|1|||
126292692|NCT02721732|454361447|FG007|Overall Study|Adverse Event|0|||
126292693|NCT02721732|454361448|FG008|Overall Study|Adverse Event|1|||
126292694|NCT02721732|454361449|FG009|Overall Study|Adverse Event|1|||
126292695|NCT02721732|454361440|FG000|Overall Study|Death|0|||
126292696|NCT02721732|454361441|FG001|Overall Study|Death|0|||
126292697|NCT02721732|454361442|FG002|Overall Study|Death|0|||
126292698|NCT02721732|454361443|FG003|Overall Study|Death|0|||
126292699|NCT02721732|454361444|FG004|Overall Study|Death|1|||
126292700|NCT02721732|454361445|FG005|Overall Study|Death|0|||
126292701|NCT02721732|454361446|FG006|Overall Study|Death|1|||
126292702|NCT02721732|454361447|FG007|Overall Study|Death|0|||
126292703|NCT02721732|454361448|FG008|Overall Study|Death|0|||
126292704|NCT02721732|454361449|FG009|Overall Study|Death|1|||
126292705|NCT02721732|454361440|FG000|Overall Study|Lack of Efficacy|12|||
126292706|NCT02721732|454361441|FG001|Overall Study|Lack of Efficacy|11|||
126292707|NCT02721732|454361442|FG002|Overall Study|Lack of Efficacy|18|||
126292708|NCT02721732|454361443|FG003|Overall Study|Lack of Efficacy|5|||
126292709|NCT02721732|454361444|FG004|Overall Study|Lack of Efficacy|21|||
126292710|NCT02721732|454361445|FG005|Overall Study|Lack of Efficacy|2|||
126292711|NCT02721732|454361446|FG006|Overall Study|Lack of Efficacy|8|||
126292712|NCT02721732|454361447|FG007|Overall Study|Lack of Efficacy|11|||
126292713|NCT02721732|454361448|FG008|Overall Study|Lack of Efficacy|10|||
126292714|NCT02721732|454361449|FG009|Overall Study|Lack of Efficacy|20|||
126292715|NCT02721732|454361440|FG000|Overall Study|Physician Decision|0|||
126292716|NCT02721732|454361441|FG001|Overall Study|Physician Decision|0|||
126292717|NCT02721732|454361442|FG002|Overall Study|Physician Decision|1|||
126292718|NCT02721732|454361443|FG003|Overall Study|Physician Decision|0|||
126292719|NCT02721732|454361444|FG004|Overall Study|Physician Decision|0|||
125883156|NCT00463567|452871417|FG002|Overall Study|Abnormal test procedure result(s)|6|||
125883157|NCT00463567|452871418|FG003|Overall Study|Abnormal test procedure result(s)|2|||
126292720|NCT02721732|454361445|FG005|Overall Study|Physician Decision|0|||
126292721|NCT02721732|454361446|FG006|Overall Study|Physician Decision|0|||
126292722|NCT02721732|454361447|FG007|Overall Study|Physician Decision|0|||
126292723|NCT02721732|454361448|FG008|Overall Study|Physician Decision|0|||
126292724|NCT02721732|454361449|FG009|Overall Study|Physician Decision|0|||
126292725|NCT02721732|454361440|FG000|Overall Study|Withdrawal by Subject|1|||
126292726|NCT02721732|454361441|FG001|Overall Study|Withdrawal by Subject|0|||
126292727|NCT02721732|454361442|FG002|Overall Study|Withdrawal by Subject|0|||
126292728|NCT02721732|454361443|FG003|Overall Study|Withdrawal by Subject|0|||
126292729|NCT02721732|454361444|FG004|Overall Study|Withdrawal by Subject|3|||
126292730|NCT02721732|454361445|FG005|Overall Study|Withdrawal by Subject|0|||
126292731|NCT02721732|454361446|FG006|Overall Study|Withdrawal by Subject|1|||
126292732|NCT02721732|454361447|FG007|Overall Study|Withdrawal by Subject|1|||
126292733|NCT02721732|454361448|FG008|Overall Study|Withdrawal by Subject|0|||
126292734|NCT02721732|454361449|FG009|Overall Study|Withdrawal by Subject|1|||
126292735|NCT02721732|454361440|FG000|Overall Study|Participant Choice|1|||
126292736|NCT02721732|454361441|FG001|Overall Study|Participant Choice|0|||
126292737|NCT02721732|454361442|FG002|Overall Study|Participant Choice|0|||
126292738|NCT02721732|454361443|FG003|Overall Study|Participant Choice|0|||
126292739|NCT02721732|454361444|FG004|Overall Study|Participant Choice|0|||
126292740|NCT02721732|454361445|FG005|Overall Study|Participant Choice|0|||
126292741|NCT02721732|454361446|FG006|Overall Study|Participant Choice|0|||
126292742|NCT02721732|454361447|FG007|Overall Study|Participant Choice|0|||
126292743|NCT02721732|454361448|FG008|Overall Study|Participant Choice|0|||
126292744|NCT02721732|454361449|FG009|Overall Study|Participant Choice|1|||
126292745|NCT02721732|454361440|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292746|NCT02721732|454361441|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292747|NCT02721732|454361442|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
126292748|NCT02721732|454361443|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292749|NCT02721732|454361444|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292750|NCT02721732|454361445|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292751|NCT02721732|454361446|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292752|NCT02721732|454361447|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292753|NCT02721732|454361448|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292754|NCT02721732|454361449|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292755|NCT02721732|454361440|FG000|Overall Study|Progression and withdrew consent|1|||
126292756|NCT02721732|454361441|FG001|Overall Study|Progression and withdrew consent|1|||
126292757|NCT02721732|454361442|FG002|Overall Study|Progression and withdrew consent|0|||
126292758|NCT02721732|454361443|FG003|Overall Study|Progression and withdrew consent|0|||
126292759|NCT02721732|454361444|FG004|Overall Study|Progression and withdrew consent|0|||
126292760|NCT02721732|454361445|FG005|Overall Study|Progression and withdrew consent|0|||
126292761|NCT02721732|454361446|FG006|Overall Study|Progression and withdrew consent|0|||
126292762|NCT02721732|454361447|FG007|Overall Study|Progression and withdrew consent|0|||
126292763|NCT02721732|454361448|FG008|Overall Study|Progression and withdrew consent|0|||
126292764|NCT02721732|454361449|FG009|Overall Study|Progression and withdrew consent|1|||
126292765|NCT02721732|454361440|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
126292766|NCT02721732|454361441|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
126292767|NCT02721732|454361442|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
126292768|NCT02721732|454361443|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
126292769|NCT02721732|454361444|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
126292770|NCT02721732|454361445|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
126292771|NCT02721732|454361446|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
126292772|NCT02721732|454361447|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
126292773|NCT02721732|454361448|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
126366350|NCT03648372|454635833|FG019|Overall Study|Lost to Follow-up|0|||
126366351|NCT03648372|454635834|FG020|Overall Study|Lost to Follow-up|0|||
126366352|NCT03648372|454635814|FG000|Overall Study|Start of a New Systemic Treatment|0|||
126366353|NCT03648372|454635815|FG001|Overall Study|Start of a New Systemic Treatment|0|||
126366354|NCT03648372|454635816|FG002|Overall Study|Start of a New Systemic Treatment|0|||
126366355|NCT03648372|454635817|FG003|Overall Study|Start of a New Systemic Treatment|0|||
126366356|NCT03648372|454635818|FG004|Overall Study|Start of a New Systemic Treatment|0|||
126366357|NCT03648372|454635819|FG005|Overall Study|Start of a New Systemic Treatment|0|||
126366358|NCT03648372|454635820|FG006|Overall Study|Start of a New Systemic Treatment|0|||
126366359|NCT03648372|454635821|FG007|Overall Study|Start of a New Systemic Treatment|2|||
126292774|NCT02721732|454361449|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
126292775|NCT02848001|454361450|FG000|Overall Study|other reasons|0|||
126366360|NCT03648372|454635822|FG008|Overall Study|Start of a New Systemic Treatment|0|||
126292776|NCT02848001|454361451|FG001|Overall Study|other reasons|0|||
126292777|NCT02848001|454361452|FG002|Overall Study|other reasons|1|||
126292778|NCT02848001|454361453|FG003|Overall Study|other reasons|0|||
126292779|NCT02848001|454361454|FG004|Overall Study|other reasons|4|||
126292780|NCT02848001|454361455|FG005|Overall Study|other reasons|1|||
126292781|NCT02848001|454361456|FG006|Overall Study|other reasons|0|||
126292782|NCT02848001|454361457|FG007|Overall Study|other reasons|2|||
126292783|NCT02848001|454361458|FG008|Overall Study|other reasons|2|||
126292784|NCT02848001|454361459|FG009|Overall Study|other reasons|3|||
126292785|NCT02848001|454361460|FG010|Overall Study|other reasons|0|||
126292786|NCT02848001|454361461|FG011|Overall Study|other reasons|1|||
126292787|NCT02848001|454361462|FG012|Overall Study|other reasons|1|||
126292788|NCT02848001|454361463|FG013|Overall Study|other reasons|0|||
126292789|NCT02848001|454361464|FG014|Overall Study|other reasons|0|||
126292790|NCT02848001|454361465|FG015|Overall Study|other reasons|2|||
126292791|NCT02848001|454361466|FG016|Overall Study|other reasons|1|||
126292792|NCT02848001|454361450|FG000|Overall Study|Lack of Efficacy|0|||
126292793|NCT02848001|454361451|FG001|Overall Study|Lack of Efficacy|1|||
126292794|NCT02848001|454361452|FG002|Overall Study|Lack of Efficacy|1|||
126292795|NCT02848001|454361453|FG003|Overall Study|Lack of Efficacy|2|||
126292796|NCT02848001|454361454|FG004|Overall Study|Lack of Efficacy|3|||
126292797|NCT02848001|454361455|FG005|Overall Study|Lack of Efficacy|0|||
126292798|NCT02848001|454361456|FG006|Overall Study|Lack of Efficacy|1|||
126292799|NCT02848001|454361457|FG007|Overall Study|Lack of Efficacy|0|||
126292800|NCT02848001|454361458|FG008|Overall Study|Lack of Efficacy|0|||
126292801|NCT02848001|454361459|FG009|Overall Study|Lack of Efficacy|1|||
126292802|NCT02848001|454361460|FG010|Overall Study|Lack of Efficacy|0|||
126292803|NCT02848001|454361461|FG011|Overall Study|Lack of Efficacy|2|||
126292804|NCT02848001|454361462|FG012|Overall Study|Lack of Efficacy|0|||
126292805|NCT02848001|454361463|FG013|Overall Study|Lack of Efficacy|2|||
126292806|NCT02848001|454361464|FG014|Overall Study|Lack of Efficacy|2|||
126292807|NCT02848001|454361465|FG015|Overall Study|Lack of Efficacy|0|||
126292808|NCT02848001|454361466|FG016|Overall Study|Lack of Efficacy|0|||
126292809|NCT02848001|454361450|FG000|Overall Study|Progressive Disease|2|||
126292810|NCT02848001|454361451|FG001|Overall Study|Progressive Disease|1|||
126292811|NCT02848001|454361452|FG002|Overall Study|Progressive Disease|0|||
126292812|NCT02848001|454361453|FG003|Overall Study|Progressive Disease|4|||
126292813|NCT02848001|454361454|FG004|Overall Study|Progressive Disease|3|||
126292814|NCT02848001|454361455|FG005|Overall Study|Progressive Disease|0|||
126292815|NCT02848001|454361456|FG006|Overall Study|Progressive Disease|4|||
126292816|NCT02848001|454361457|FG007|Overall Study|Progressive Disease|1|||
126292817|NCT02848001|454361458|FG008|Overall Study|Progressive Disease|0|||
126292818|NCT02848001|454361459|FG009|Overall Study|Progressive Disease|2|||
126292819|NCT02848001|454361460|FG010|Overall Study|Progressive Disease|3|||
126292820|NCT02848001|454361461|FG011|Overall Study|Progressive Disease|2|||
126292821|NCT02848001|454361462|FG012|Overall Study|Progressive Disease|1|||
126292822|NCT02848001|454361463|FG013|Overall Study|Progressive Disease|0|||
126292823|NCT02848001|454361464|FG014|Overall Study|Progressive Disease|2|||
126292824|NCT02848001|454361465|FG015|Overall Study|Progressive Disease|4|||
126292825|NCT02848001|454361466|FG016|Overall Study|Progressive Disease|0|||
126292826|NCT02848001|454361450|FG000|Overall Study|Adverse Event|0|||
126292827|NCT02848001|454361451|FG001|Overall Study|Adverse Event|0|||
126366361|NCT03648372|454635823|FG009|Overall Study|Start of a New Systemic Treatment|0|||
126366362|NCT03648372|454635824|FG010|Overall Study|Start of a New Systemic Treatment|1|||
126366363|NCT03648372|454635825|FG011|Overall Study|Start of a New Systemic Treatment|0|||
126366364|NCT03648372|454635826|FG012|Overall Study|Start of a New Systemic Treatment|0|||
126366365|NCT03648372|454635827|FG013|Overall Study|Start of a New Systemic Treatment|0|||
126366366|NCT03648372|454635828|FG014|Overall Study|Start of a New Systemic Treatment|0|||
126366367|NCT03648372|454635829|FG015|Overall Study|Start of a New Systemic Treatment|0|||
126366368|NCT03648372|454635830|FG016|Overall Study|Start of a New Systemic Treatment|0|||
126366369|NCT03648372|454635831|FG017|Overall Study|Start of a New Systemic Treatment|0|||
126366370|NCT03648372|454635832|FG018|Overall Study|Start of a New Systemic Treatment|0|||
126366371|NCT03648372|454635833|FG019|Overall Study|Start of a New Systemic Treatment|0|||
126366372|NCT03648372|454635834|FG020|Overall Study|Start of a New Systemic Treatment|0|||
126366373|NCT04280783|454636969|FG000|Overall Study|Family issues unrelated to the study.|1|||
126366374|NCT04280783|454636970|FG001|Overall Study|Family issues unrelated to the study.|0|||
126366375|NCT04280783|454636969|FG000|Overall Study|Withdrawal by Subject|0|||
126366376|NCT04280783|454636970|FG001|Overall Study|Withdrawal by Subject|1|||
126366377|NCT05654181|454636971|FG000|Overall Study|Adverse Event|1|||
126292828|NCT02848001|454361452|FG002|Overall Study|Adverse Event|0|||
126292829|NCT02848001|454361453|FG003|Overall Study|Adverse Event|0|||
126366378|NCT05654181|454636972|FG001|Overall Study|Adverse Event|0|||
126366379|NCT05654181|454636973|FG002|Overall Study|Adverse Event|0|||
126366380|NCT05654181|454636974|FG003|Overall Study|Adverse Event|0|||
126292830|NCT02848001|454361454|FG004|Overall Study|Adverse Event|2|||
126292831|NCT02848001|454361455|FG005|Overall Study|Adverse Event|0|||
126292832|NCT02848001|454361456|FG006|Overall Study|Adverse Event|0|||
126292833|NCT02848001|454361457|FG007|Overall Study|Adverse Event|0|||
126366381|NCT05654181|454636975|FG004|Overall Study|Adverse Event|0|||
126292834|NCT02848001|454361458|FG008|Overall Study|Adverse Event|0|||
126292835|NCT02848001|454361459|FG009|Overall Study|Adverse Event|1|||
126292836|NCT02848001|454361460|FG010|Overall Study|Adverse Event|0|||
126292837|NCT02848001|454361461|FG011|Overall Study|Adverse Event|1|||
126292838|NCT02848001|454361462|FG012|Overall Study|Adverse Event|1|||
126292839|NCT02848001|454361463|FG013|Overall Study|Adverse Event|0|||
126292840|NCT02848001|454361464|FG014|Overall Study|Adverse Event|2|||
126292841|NCT02848001|454361465|FG015|Overall Study|Adverse Event|0|||
126292842|NCT02848001|454361466|FG016|Overall Study|Adverse Event|0|||
126292843|NCT02848001|454361450|FG000|Overall Study|Death|0|||
126292844|NCT02848001|454361451|FG001|Overall Study|Death|0|||
126292845|NCT02848001|454361452|FG002|Overall Study|Death|0|||
126292846|NCT02848001|454361453|FG003|Overall Study|Death|1|||
126292847|NCT02848001|454361454|FG004|Overall Study|Death|3|||
126292848|NCT02848001|454361455|FG005|Overall Study|Death|1|||
126292849|NCT02848001|454361456|FG006|Overall Study|Death|2|||
126292850|NCT02848001|454361457|FG007|Overall Study|Death|3|||
126292851|NCT02848001|454361458|FG008|Overall Study|Death|4|||
126292852|NCT02848001|454361459|FG009|Overall Study|Death|1|||
126292853|NCT02848001|454361460|FG010|Overall Study|Death|0|||
126292854|NCT02848001|454361461|FG011|Overall Study|Death|1|||
126292855|NCT02848001|454361462|FG012|Overall Study|Death|3|||
126292856|NCT02848001|454361463|FG013|Overall Study|Death|0|||
126292857|NCT02848001|454361464|FG014|Overall Study|Death|2|||
126292858|NCT02848001|454361465|FG015|Overall Study|Death|3|||
126292859|NCT02848001|454361466|FG016|Overall Study|Death|0|||
126292860|NCT02848001|454361450|FG000|Overall Study|Physician Decision|0|||
126292861|NCT02848001|454361451|FG001|Overall Study|Physician Decision|0|||
126292862|NCT02848001|454361452|FG002|Overall Study|Physician Decision|0|||
126292863|NCT02848001|454361453|FG003|Overall Study|Physician Decision|0|||
126292864|NCT02848001|454361454|FG004|Overall Study|Physician Decision|0|||
126292865|NCT02848001|454361455|FG005|Overall Study|Physician Decision|0|||
126292866|NCT02848001|454361456|FG006|Overall Study|Physician Decision|0|||
126292867|NCT02848001|454361457|FG007|Overall Study|Physician Decision|0|||
126292868|NCT02848001|454361458|FG008|Overall Study|Physician Decision|1|||
126292869|NCT02848001|454361459|FG009|Overall Study|Physician Decision|1|||
126292870|NCT02848001|454361460|FG010|Overall Study|Physician Decision|0|||
126292871|NCT02848001|454361461|FG011|Overall Study|Physician Decision|0|||
126292872|NCT02848001|454361462|FG012|Overall Study|Physician Decision|2|||
126292873|NCT02848001|454361463|FG013|Overall Study|Physician Decision|0|||
126292874|NCT02848001|454361464|FG014|Overall Study|Physician Decision|0|||
126292875|NCT02848001|454361465|FG015|Overall Study|Physician Decision|0|||
126292876|NCT02848001|454361466|FG016|Overall Study|Physician Decision|0|||
126292877|NCT02848001|454361450|FG000|Overall Study|Withdrawal by Subject|0|||
126292878|NCT02848001|454361451|FG001|Overall Study|Withdrawal by Subject|0|||
126292879|NCT02848001|454361452|FG002|Overall Study|Withdrawal by Subject|0|||
126292880|NCT02848001|454361453|FG003|Overall Study|Withdrawal by Subject|0|||
126292881|NCT02848001|454361454|FG004|Overall Study|Withdrawal by Subject|0|||
126292882|NCT02848001|454361455|FG005|Overall Study|Withdrawal by Subject|1|||
126292883|NCT02848001|454361456|FG006|Overall Study|Withdrawal by Subject|1|||
126292884|NCT02848001|454361457|FG007|Overall Study|Withdrawal by Subject|1|||
126292885|NCT02848001|454361458|FG008|Overall Study|Withdrawal by Subject|0|||
126292886|NCT02848001|454361459|FG009|Overall Study|Withdrawal by Subject|0|||
126292887|NCT02848001|454361460|FG010|Overall Study|Withdrawal by Subject|0|||
126292888|NCT02848001|454361461|FG011|Overall Study|Withdrawal by Subject|0|||
126292889|NCT02848001|454361462|FG012|Overall Study|Withdrawal by Subject|0|||
126292890|NCT02848001|454361463|FG013|Overall Study|Withdrawal by Subject|0|||
126292891|NCT02848001|454361464|FG014|Overall Study|Withdrawal by Subject|0|||
126292892|NCT02848001|454361465|FG015|Overall Study|Withdrawal by Subject|0|||
126292893|NCT02848001|454361466|FG016|Overall Study|Withdrawal by Subject|0|||
126292894|NCT00725283|454361472|FG000|Overall Study|Missing Code|3|||
126292895|NCT00725283|454361472|FG000|Overall Study|Death|5|||
126292896|NCT00725283|454361472|FG000|Overall Study|Other|6|||
126292897|NCT00725283|454361472|FG000|Overall Study|Withdrawal by Subject|10|||
126292898|NCT02115269|454361473|FG000|Overall Study|Lost to Follow-up|43|||
126292899|NCT02115269|454361473|FG000|Overall Study|Did not complete patient diary|3|||
126292900|NCT02115269|454361473|FG000|Overall Study|Moved to another city|7|||
126292901|NCT02115269|454361473|FG000|Overall Study|Withdrawal by Subject|2|||
126292902|NCT02115269|454361473|FG000|Overall Study|Didn't take study drug|2|||
126292903|NCT01557504|454361476|FG000|Overall Study|Physician Decision|1|||
126292904|NCT01557504|454361477|FG001|Overall Study|Physician Decision|0|||
126292905|NCT01962103|454361478|FG000|Phase 1|Adverse Event|4|||
126292906|NCT01962103|454361479|FG001|Phase 1|Adverse Event|0|||
126292907|NCT01962103|454361480|FG002|Phase 1|Adverse Event|2|||
126292908|NCT01962103|454361481|FG003|Phase 1|Adverse Event|1|||
126292909|NCT01962103|454361482|FG004|Phase 1|Adverse Event|2|||
126292910|NCT01962103|454361483|FG005|Phase 1|Adverse Event|2|||
126292911|NCT01962103|454361484|FG006|Phase 1|Adverse Event|0|||
126292912|NCT01962103|454361485|FG007|Phase 1|Adverse Event|0|||
126292913|NCT01962103|454361486|FG008|Phase 1|Adverse Event|0|||
126292914|NCT01962103|454361478|FG000|Phase 1|Progressive Disease|8|||
126292915|NCT01962103|454361479|FG001|Phase 1|Progressive Disease|6|||
126292916|NCT01962103|454361480|FG002|Phase 1|Progressive Disease|8|||
126292917|NCT01962103|454361481|FG003|Phase 1|Progressive Disease|4|||
126292918|NCT01962103|454361482|FG004|Phase 1|Progressive Disease|5|||
126292919|NCT01962103|454361483|FG005|Phase 1|Progressive Disease|4|||
126292920|NCT01962103|454361484|FG006|Phase 1|Progressive Disease|0|||
126292921|NCT01962103|454361485|FG007|Phase 1|Progressive Disease|0|||
126292922|NCT01962103|454361486|FG008|Phase 1|Progressive Disease|0|||
126292923|NCT01962103|454361478|FG000|Phase 1|Withdrawal by Subject|0|||
126292924|NCT01962103|454361479|FG001|Phase 1|Withdrawal by Subject|0|||
126292925|NCT01962103|454361480|FG002|Phase 1|Withdrawal by Subject|0|||
126292926|NCT01962103|454361481|FG003|Phase 1|Withdrawal by Subject|2|||
126292927|NCT01962103|454361482|FG004|Phase 1|Withdrawal by Subject|0|||
126292928|NCT01962103|454361483|FG005|Phase 1|Withdrawal by Subject|0|||
126292929|NCT01962103|454361484|FG006|Phase 1|Withdrawal by Subject|0|||
126292930|NCT01962103|454361485|FG007|Phase 1|Withdrawal by Subject|0|||
126292931|NCT01962103|454361486|FG008|Phase 1|Withdrawal by Subject|0|||
126292932|NCT01962103|454361478|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
126292933|NCT01962103|454361479|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
126292934|NCT01962103|454361480|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
126292935|NCT01962103|454361481|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
126292936|NCT01962103|454361482|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
126292937|NCT01962103|454361483|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
126292938|NCT01962103|454361484|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
126292939|NCT01962103|454361485|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
126292940|NCT01962103|454361486|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
126292941|NCT01962103|454361478|FG000|Phase 1|Physician Decision|0|||
126292942|NCT01962103|454361479|FG001|Phase 1|Physician Decision|0|||
126292943|NCT01962103|454361480|FG002|Phase 1|Physician Decision|0|||
126292944|NCT01962103|454361481|FG003|Phase 1|Physician Decision|1|||
126292945|NCT01962103|454361482|FG004|Phase 1|Physician Decision|0|||
126292946|NCT01962103|454361483|FG005|Phase 1|Physician Decision|0|||
126292947|NCT01962103|454361484|FG006|Phase 1|Physician Decision|0|||
126292948|NCT01962103|454361485|FG007|Phase 1|Physician Decision|0|||
126292949|NCT01962103|454361486|FG008|Phase 1|Physician Decision|0|||
126292950|NCT01962103|454361478|FG000|Phase 1|Symptomatic Deterioration|3|||
126292951|NCT01962103|454361479|FG001|Phase 1|Symptomatic Deterioration|2|||
126292952|NCT01962103|454361480|FG002|Phase 1|Symptomatic Deterioration|2|||
126292953|NCT01962103|454361481|FG003|Phase 1|Symptomatic Deterioration|2|||
126292954|NCT01962103|454361482|FG004|Phase 1|Symptomatic Deterioration|1|||
126292955|NCT01962103|454361483|FG005|Phase 1|Symptomatic Deterioration|1|||
126292956|NCT01962103|454361484|FG006|Phase 1|Symptomatic Deterioration|0|||
126292957|NCT01962103|454361485|FG007|Phase 1|Symptomatic Deterioration|0|||
126292958|NCT01962103|454361486|FG008|Phase 1|Symptomatic Deterioration|0|||
126292959|NCT01962103|454361478|FG000|Phase 1|Miscellaneous|1|||
126292960|NCT01962103|454361479|FG001|Phase 1|Miscellaneous|0|||
126292961|NCT01962103|454361480|FG002|Phase 1|Miscellaneous|0|||
126292962|NCT01962103|454361481|FG003|Phase 1|Miscellaneous|0|||
126292963|NCT01962103|454361482|FG004|Phase 1|Miscellaneous|0|||
126292964|NCT01962103|454361483|FG005|Phase 1|Miscellaneous|0|||
126292965|NCT01962103|454361484|FG006|Phase 1|Miscellaneous|0|||
126292966|NCT01962103|454361485|FG007|Phase 1|Miscellaneous|0|||
126292967|NCT01962103|454361486|FG008|Phase 1|Miscellaneous|0|||
126292968|NCT01962103|454361478|FG000|Phase 2|Adverse Event|0|||
126292969|NCT01962103|454361479|FG001|Phase 2|Adverse Event|0|||
126292970|NCT01962103|454361480|FG002|Phase 2|Adverse Event|0|||
126292971|NCT01962103|454361481|FG003|Phase 2|Adverse Event|0|||
126292972|NCT01962103|454361482|FG004|Phase 2|Adverse Event|0|||
126292973|NCT01962103|454361483|FG005|Phase 2|Adverse Event|0|||
126292974|NCT01962103|454361484|FG006|Phase 2|Adverse Event|1|||
126292975|NCT01962103|454361485|FG007|Phase 2|Adverse Event|0|||
126292976|NCT01962103|454361486|FG008|Phase 2|Adverse Event|3|||
126292977|NCT01962103|454361478|FG000|Phase 2|Progressive Disease|0|||
126292978|NCT01962103|454361479|FG001|Phase 2|Progressive Disease|0|||
126292979|NCT01962103|454361480|FG002|Phase 2|Progressive Disease|0|||
126292980|NCT01962103|454361481|FG003|Phase 2|Progressive Disease|0|||
126292981|NCT01962103|454361482|FG004|Phase 2|Progressive Disease|0|||
126292982|NCT01962103|454361483|FG005|Phase 2|Progressive Disease|0|||
126292983|NCT01962103|454361484|FG006|Phase 2|Progressive Disease|11|||
126292984|NCT01962103|454361485|FG007|Phase 2|Progressive Disease|12|||
126292985|NCT01962103|454361486|FG008|Phase 2|Progressive Disease|11|||
126292986|NCT01962103|454361478|FG000|Phase 2|Symptomatic Deterioration|0|||
126292987|NCT01962103|454361479|FG001|Phase 2|Symptomatic Deterioration|0|||
126292988|NCT01962103|454361480|FG002|Phase 2|Symptomatic Deterioration|0|||
126292989|NCT01962103|454361481|FG003|Phase 2|Symptomatic Deterioration|0|||
126292990|NCT01962103|454361482|FG004|Phase 2|Symptomatic Deterioration|0|||
126292991|NCT01962103|454361483|FG005|Phase 2|Symptomatic Deterioration|0|||
126292992|NCT01962103|454361484|FG006|Phase 2|Symptomatic Deterioration|2|||
126292993|NCT01962103|454361485|FG007|Phase 2|Symptomatic Deterioration|2|||
126292994|NCT01962103|454361486|FG008|Phase 2|Symptomatic Deterioration|0|||
126292995|NCT01321749|454361487|FG000|Overall Study|Lost to Follow-up|4|||
126292996|NCT01321749|454361488|FG001|Overall Study|Lost to Follow-up|11|||
126292997|NCT01321749|454361487|FG000|Overall Study|Protocol Violation|4|||
126292998|NCT01321749|454361488|FG001|Overall Study|Protocol Violation|7|||
126292999|NCT01321749|454361487|FG000|Overall Study|Withdrawal by Subject|5|||
126293000|NCT01321749|454361488|FG001|Overall Study|Withdrawal by Subject|4|||
126293001|NCT02750618|454361492|FG000|Overall Study|Withdrawal by Subject|1|||
126293002|NCT02572570|454361498|FG000|Overall Study|Study Terminated|27|||
126293003|NCT02763046|454361499|FG000|Overall Study|Adverse Event|5|||
126293004|NCT02763046|454361500|FG001|Overall Study|Adverse Event|4|||
126293005|NCT02763046|454361501|FG002|Overall Study|Adverse Event|0|||
126293006|NCT02763046|454361499|FG000|Overall Study|Lack of Efficacy|1|||
126293007|NCT02763046|454361500|FG001|Overall Study|Lack of Efficacy|1|||
126293008|NCT02763046|454361501|FG002|Overall Study|Lack of Efficacy|3|||
126293009|NCT02763046|454361499|FG000|Overall Study|Physician Decision|1|||
126293010|NCT02763046|454361500|FG001|Overall Study|Physician Decision|0|||
126293011|NCT02763046|454361501|FG002|Overall Study|Physician Decision|1|||
126293012|NCT02763046|454361499|FG000|Overall Study|Subject/guardian decision|2|||
126293013|NCT02763046|454361500|FG001|Overall Study|Subject/guardian decision|0|||
126293014|NCT02763046|454361501|FG002|Overall Study|Subject/guardian decision|4|||
126293015|NCT00513695|454361502|FG000|Overall Study|Discontinued therapy|2|||
126293016|NCT00513695|454361502|FG000|Overall Study|Progression prior to surgery|3|||
126293017|NCT03052751|454361509|FG000|Dosing Period 1|Adverse Event|0|||
126293018|NCT03052751|454361510|FG001|Dosing Period 1|Adverse Event|1|||
126293019|NCT03052751|454361511|FG002|Dosing Period 1|Adverse Event|0|||
126293020|NCT03052751|454361512|FG003|Dosing Period 1|Adverse Event|0|||
126293021|NCT03052751|454361513|FG004|Dosing Period 1|Adverse Event|0|||
126293022|NCT03052751|454361514|FG005|Dosing Period 1|Adverse Event|0|||
126293023|NCT03052751|454361509|FG000|Dosing Period 2|Adverse Event|0|||
126293024|NCT03052751|454361510|FG001|Dosing Period 2|Adverse Event|0|||
126293025|NCT03052751|454361511|FG002|Dosing Period 2|Adverse Event|3|||
126293026|NCT03052751|454361512|FG003|Dosing Period 2|Adverse Event|0|||
126293027|NCT03052751|454361513|FG004|Dosing Period 2|Adverse Event|0|||
126293028|NCT03052751|454361514|FG005|Dosing Period 2|Adverse Event|0|||
126293029|NCT03052751|454361509|FG000|Observation Period|Adverse Event|0|||
126293030|NCT03052751|454361510|FG001|Observation Period|Adverse Event|0|||
126293031|NCT03052751|454361511|FG002|Observation Period|Adverse Event|0|||
126293032|NCT03052751|454361512|FG003|Observation Period|Adverse Event|0|||
126293033|NCT03052751|454361513|FG004|Observation Period|Adverse Event|1|||
126293034|NCT03052751|454361514|FG005|Observation Period|Adverse Event|0|||
126293035|NCT01067105|454361515|FG000|Overall Study|Adverse Event|14|||
125883158|NCT00463567|452871419|FG004|Overall Study|Abnormal test procedure result(s)|0|||
125883159|NCT00463567|452871420|FG005|Overall Study|Abnormal test procedure result(s)|2|||
125883160|NCT00463567|452871421|FG006|Overall Study|Abnormal test procedure result(s)|0|||
125883161|NCT00463567|452871415|FG000|Overall Study|Death|1|||
125883162|NCT00463567|452871416|FG001|Overall Study|Death|0|||
125883163|NCT00463567|452871417|FG002|Overall Study|Death|2|||
125883164|NCT00463567|452871418|FG003|Overall Study|Death|0|||
125883165|NCT00463567|452871419|FG004|Overall Study|Death|0|||
125883166|NCT00463567|452871420|FG005|Overall Study|Death|0|||
125883167|NCT00463567|452871421|FG006|Overall Study|Death|0|||
125883168|NCT01803607|452871426|FG000|Overall Study|Adverse Event|5|||
125883169|NCT01803607|452871427|FG001|Overall Study|Adverse Event|3|||
126293036|NCT01067105|454361515|FG000|Overall Study|Protocol Violation|48|||
125883170|NCT01803607|452871426|FG000|Overall Study|Lack of Efficacy|0|||
126293037|NCT01067105|454361515|FG000|Overall Study|Withdrawal by Subject|36|||
126293038|NCT01067105|454361515|FG000|Overall Study|Lost to Follow-up|6|||
125883171|NCT01803607|452871427|FG001|Overall Study|Lack of Efficacy|1|||
125883172|NCT01803607|452871426|FG000|Overall Study|Protocol Violation|3|||
126293039|NCT01067105|454361515|FG000|Overall Study|Physician Decision|6|||
126293040|NCT01067105|454361515|FG000|Overall Study|Other|31|||
126293041|NCT02302833|454361518|FG000|Overall Study|Lost to Follow-up|3|||
126293042|NCT04878432|454361519|FG000|Overall Study|Adverse Event|1|||
126293043|NCT04878432|454361519|FG000|Overall Study|Death|2|||
126293044|NCT04878432|454361519|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126293045|NCT04878432|454361519|FG000|Overall Study|Withdrawal by Subject|6|||
126042143|NCT03580356|453453095|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
126042144|NCT03580356|453453096|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126042145|NCT03580356|453453097|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
126042146|NCT03580356|453453098|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126042147|NCT03580356|453453099|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
126042148|NCT03580356|453453100|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126042149|NCT03580356|453453101|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126042150|NCT03580356|453453102|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126293046|NCT04878432|454361519|FG000|Overall Study|Progressive Disease|7|||
126293047|NCT04878432|454361519|FG000|Overall Study|New Therapy for Study Indication|7|||
126293048|NCT04878432|454361519|FG000|Overall Study|Physician Decision|11|||
126293049|NCT02719184|454361522|FG000|Overall Study|Other than listed|1|||
126293050|NCT02719184|454361523|FG001|Overall Study|Other than listed|12|||
126293051|NCT02719184|454361524|FG002|Overall Study|Other than listed|13|||
126293052|NCT02719184|454361525|FG003|Overall Study|Other than listed|22|||
126293053|NCT02719184|454361526|FG004|Overall Study|Other than listed|9|||
126293054|NCT02719184|454361522|FG000|Overall Study|Withdrawal by Subject|5|||
126293055|NCT02719184|454361523|FG001|Overall Study|Withdrawal by Subject|3|||
126293056|NCT02719184|454361524|FG002|Overall Study|Withdrawal by Subject|6|||
126293057|NCT02719184|454361525|FG003|Overall Study|Withdrawal by Subject|6|||
126293058|NCT02719184|454361526|FG004|Overall Study|Withdrawal by Subject|0|||
126293059|NCT02719184|454361522|FG000|Overall Study|Lost to Follow-up|0|||
126293060|NCT02719184|454361523|FG001|Overall Study|Lost to Follow-up|4|||
126293061|NCT02719184|454361524|FG002|Overall Study|Lost to Follow-up|1|||
126293062|NCT02719184|454361525|FG003|Overall Study|Lost to Follow-up|3|||
126293063|NCT02719184|454361526|FG004|Overall Study|Lost to Follow-up|0|||
126293064|NCT02719184|454361522|FG000|Overall Study|Protocol Violation|0|||
126293065|NCT02719184|454361523|FG001|Overall Study|Protocol Violation|3|||
126293066|NCT02719184|454361524|FG002|Overall Study|Protocol Violation|0|||
126293067|NCT02719184|454361525|FG003|Overall Study|Protocol Violation|2|||
126293068|NCT02719184|454361526|FG004|Overall Study|Protocol Violation|0|||
126293069|NCT02719184|454361522|FG000|Overall Study|Adverse Event|0|||
126293070|NCT02719184|454361523|FG001|Overall Study|Adverse Event|0|||
126293071|NCT02719184|454361524|FG002|Overall Study|Adverse Event|0|||
126293072|NCT02719184|454361525|FG003|Overall Study|Adverse Event|3|||
126293073|NCT02719184|454361526|FG004|Overall Study|Adverse Event|0|||
126293074|NCT02439216|454361527|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
126293075|NCT02439216|454361528|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126042151|NCT03580356|453453095|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
126293076|NCT02439216|454361529|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293077|NCT02439216|454361530|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293078|NCT02439216|454361531|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293079|NCT02439216|454361532|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293080|NCT02439216|454361533|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293081|NCT02439216|454361534|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293082|NCT02439216|454361535|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293083|NCT02439216|454361527|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293084|NCT02439216|454361528|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293085|NCT02439216|454361529|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126042152|NCT03580356|453453096|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
126042153|NCT03580356|453453097|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
126042154|NCT03580356|453453098|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
126042155|NCT03580356|453453099|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
126042156|NCT03580356|453453100|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
126042157|NCT03580356|453453101|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
126042158|NCT03580356|453453102|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
126042159|NCT03580356|453453095|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126042160|NCT03580356|453453096|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126293086|NCT02439216|454361530|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293087|NCT02439216|454361531|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293088|NCT02439216|454361532|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125883173|NCT01803607|452871427|FG001|Overall Study|Protocol Violation|2|||
126366382|NCT05654181|454636976|FG005|Overall Study|Adverse Event|0|||
126366383|NCT05654181|454636977|FG006|Overall Study|Adverse Event|0|||
126366384|NCT05654181|454636978|FG007|Overall Study|Adverse Event|1|||
126366385|NCT05654181|454636979|FG008|Overall Study|Adverse Event|0|||
126366386|NCT05654181|454636980|FG009|Overall Study|Adverse Event|0|||
126366387|NCT05654181|454636971|FG000|Overall Study|Withdrawal by Subject|0|||
126366388|NCT05654181|454636972|FG001|Overall Study|Withdrawal by Subject|0|||
125883174|NCT01803607|452871426|FG000|Overall Study|Study terminated by sponsor|54|||
125883175|NCT01803607|452871427|FG001|Overall Study|Study terminated by sponsor|56|||
125883176|NCT01803607|452871426|FG000|Overall Study|Withdrawal by Subject|6|||
125883177|NCT01803607|452871427|FG001|Overall Study|Withdrawal by Subject|5|||
125883178|NCT03077412|452871428|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
125883179|NCT03077412|452871429|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
125883180|NCT03077412|452871430|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
125883181|NCT03077412|452871428|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
125883182|NCT03077412|452871429|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
125883183|NCT03077412|452871430|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
125883184|NCT03077412|452871428|FG000|Overall Study|Adverse Event|1|||
125883185|NCT03077412|452871429|FG001|Overall Study|Adverse Event|2|||
125883186|NCT03077412|452871430|FG002|Overall Study|Adverse Event|2|||
125883187|NCT03077412|452871428|FG000|Overall Study|Investigator's Discretion|0|||
125883188|NCT03077412|452871429|FG001|Overall Study|Investigator's Discretion|1|||
125883189|NCT03077412|452871430|FG002|Overall Study|Investigator's Discretion|1|||
125883190|NCT03077412|452871428|FG000|Overall Study|Withdrew Consent|0|||
125883191|NCT03077412|452871429|FG001|Overall Study|Withdrew Consent|2|||
125883192|NCT03077412|452871430|FG002|Overall Study|Withdrew Consent|0|||
125883193|NCT02266888|452871434|FG000|Overall Study|Death|2|||
125883194|NCT02266888|452871435|FG001|Overall Study|Death|2|||
125883195|NCT02266888|452871436|FG002|Overall Study|Death|4|||
125883196|NCT02266888|452871437|FG003|Overall Study|Death|2|||
125883197|NCT02266888|452871434|FG000|Overall Study|Physician Decision|0|||
125883198|NCT02266888|452871435|FG001|Overall Study|Physician Decision|1|||
125883199|NCT02266888|452871436|FG002|Overall Study|Physician Decision|2|||
125883200|NCT02266888|452871437|FG003|Overall Study|Physician Decision|2|||
125883201|NCT02266888|452871434|FG000|Overall Study|Study Terminated|5|||
125883202|NCT02266888|452871435|FG001|Overall Study|Study Terminated|1|||
125883203|NCT02266888|452871436|FG002|Overall Study|Study Terminated|0|||
125883204|NCT02266888|452871437|FG003|Overall Study|Study Terminated|0|||
126293089|NCT02439216|454361533|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293090|NCT02439216|454361534|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
126293091|NCT02439216|454361535|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293092|NCT02439216|454361527|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293093|NCT02439216|454361528|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293094|NCT02439216|454361529|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293095|NCT02439216|454361530|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293096|NCT02439216|454361531|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293097|NCT02439216|454361532|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293098|NCT02439216|454361533|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293099|NCT02439216|454361534|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
126293100|NCT02439216|454361535|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
126293101|NCT02439216|454361527|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293102|NCT02439216|454361528|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293103|NCT02439216|454361529|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293104|NCT02439216|454361530|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293105|NCT02439216|454361531|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293106|NCT02439216|454361532|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293107|NCT02439216|454361533|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293108|NCT02439216|454361534|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293109|NCT02439216|454361535|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
126293110|NCT02439216|454361527|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293111|NCT02439216|454361528|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293112|NCT02439216|454361529|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293113|NCT02439216|454361530|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293114|NCT02439216|454361531|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293115|NCT02439216|454361532|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126366389|NCT05654181|454636973|FG002|Overall Study|Withdrawal by Subject|0|||
126366390|NCT05654181|454636974|FG003|Overall Study|Withdrawal by Subject|0|||
126366391|NCT05654181|454636975|FG004|Overall Study|Withdrawal by Subject|0|||
125883205|NCT02266888|452871434|FG000|Overall Study|No Longer Eligible|0|||
126293116|NCT02439216|454361533|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293117|NCT02439216|454361534|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
126293118|NCT02439216|454361535|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
126293119|NCT00725491|454361537|FG000|Overall Study|Adverse Event|3|||
126293120|NCT00725491|454361538|FG001|Overall Study|Adverse Event|2|||
126293121|NCT00725491|454361537|FG000|Overall Study|Pregnancy|0|||
126293122|NCT00725491|454361538|FG001|Overall Study|Pregnancy|3|||
126293123|NCT00725491|454361537|FG000|Overall Study|Risk for hyperstimulation|2|||
126293124|NCT00725491|454361538|FG001|Overall Study|Risk for hyperstimulation|9|||
126293125|NCT00725491|454361537|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
126293126|NCT00725491|454361538|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
126293127|NCT00725491|454361537|FG000|Overall Study|Fertilization failure|0|||
126293128|NCT00725491|454361538|FG001|Overall Study|Fertilization failure|1|||
126293129|NCT00725491|454361537|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
126293130|NCT00725491|454361538|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
126293131|NCT01495000|454361539|FG000|Overall Study|Lost to Follow-up|2|||
126293132|NCT01495000|454361540|FG001|Overall Study|Lost to Follow-up|2|||
126293133|NCT01495000|454361539|FG000|Overall Study|Protocol Violation|1|||
126293134|NCT01495000|454361540|FG001|Overall Study|Protocol Violation|0|||
126293135|NCT01495000|454361539|FG000|Overall Study|Withdrawal by Subject|10|||
126293136|NCT01495000|454361540|FG001|Overall Study|Withdrawal by Subject|10|||
126293137|NCT01514461|454361541|FG000|Overall Study|Adverse Event|2|||
126293138|NCT01514461|454361542|FG001|Overall Study|Adverse Event|1|||
126293139|NCT01514461|454361543|FG002|Overall Study|Adverse Event|3|||
126293140|NCT01514461|454361541|FG000|Overall Study|Physician Decision|1|||
126293141|NCT01514461|454361542|FG001|Overall Study|Physician Decision|1|||
126293142|NCT01514461|454361543|FG002|Overall Study|Physician Decision|0|||
126293143|NCT01514461|454361541|FG000|Overall Study|Patient/guardian decision|1|||
126293144|NCT01514461|454361542|FG001|Overall Study|Patient/guardian decision|1|||
126293145|NCT01514461|454361543|FG002|Overall Study|Patient/guardian decision|1|||
126293146|NCT01514461|454361541|FG000|Overall Study|Death|1|||
126293147|NCT01514461|454361542|FG001|Overall Study|Death|0|||
126293148|NCT01514461|454361543|FG002|Overall Study|Death|0|||
126293149|NCT03499067|454361544|FG000|First Intervention|Physician Decision|2|||
126293150|NCT03499067|454361545|FG001|First Intervention|Physician Decision|1|||
126293151|NCT03499067|454361544|FG000|First Intervention|Withdrawal by Subject|3|||
126293152|NCT03499067|454361545|FG001|First Intervention|Withdrawal by Subject|6|||
126293153|NCT02548832|454361546|FG000|Overall Study|Lost to Follow-up|2|||
126293154|NCT02548832|454361547|FG001|Overall Study|Lost to Follow-up|2|||
126293155|NCT02548832|454361548|FG002|Overall Study|Lost to Follow-up|2|||
126293156|NCT03472014|454361563|FG000|Overall Study|Lost to Follow-up|4|||
126293157|NCT02792517|454361564|FG000|Overall Study|Withdrawal by Subject|10|||
126293158|NCT02792517|454361564|FG000|Overall Study|Decision by Sponsor|7|||
126293159|NCT02792517|454361564|FG000|Overall Study|Lost to Follow-up|3|||
126293160|NCT03743051|454361567|FG000|Overall Study|Adverse Event|5|||
126293161|NCT03743051|454361568|FG001|Overall Study|Adverse Event|9|||
126293162|NCT03743051|454361567|FG000|Overall Study|Death|27|||
126293163|NCT03743051|454361568|FG001|Overall Study|Death|26|||
126293164|NCT03743051|454361567|FG000|Overall Study|Lost to Follow-up|4|||
126293165|NCT03743051|454361568|FG001|Overall Study|Lost to Follow-up|8|||
126293166|NCT03743051|454361567|FG000|Overall Study|Withdrawal by Subject|32|||
126293167|NCT03743051|454361568|FG001|Overall Study|Withdrawal by Subject|19|||
126293168|NCT03743051|454361567|FG000|Overall Study|Physician Decision|10|||
126293169|NCT03743051|454361568|FG001|Overall Study|Physician Decision|15|||
126293170|NCT03743051|454361567|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
126293171|NCT03743051|454361568|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
126293172|NCT00711087|454361569|FG000|Overall Study|Lost to Follow-up|1|||
126366392|NCT05654181|454636976|FG005|Overall Study|Withdrawal by Subject|0|||
126366393|NCT05654181|454636977|FG006|Overall Study|Withdrawal by Subject|0|||
126042161|NCT03580356|453453097|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
126042162|NCT03580356|453453098|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126042163|NCT03580356|453453099|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
126042164|NCT03580356|453453100|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126042165|NCT03580356|453453101|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126042166|NCT03580356|453453102|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126042167|NCT03580356|453453095|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
126042168|NCT03580356|453453096|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
126293173|NCT00711087|454361570|FG001|Overall Study|Lost to Follow-up|0|||
126293174|NCT00811733|454361573|FG000|Overall Study|Investigator Discretion|10|||
126293175|NCT00811733|454361574|FG001|Overall Study|Investigator Discretion|8|||
126293176|NCT00811733|454361573|FG000|Overall Study|Withdrawal by Subject|1|||
126293177|NCT00811733|454361574|FG001|Overall Study|Withdrawal by Subject|2|||
126293178|NCT00793871|454361575|FG000|Overall Study|Death|50|||
126293179|NCT00793871|454361575|FG000|Overall Study|Lost to Follow-up|3|||
126366394|NCT05654181|454636978|FG007|Overall Study|Withdrawal by Subject|1|||
125883206|NCT02266888|452871435|FG001|Overall Study|No Longer Eligible|0|||
126293180|NCT00793871|454361575|FG000|Overall Study|Study terminated by the Sponsor|7|||
126293181|NCT00856193|454361576|FG000|Period 2|Abnormal test procedure results|0|||
126293182|NCT00856193|454361577|FG001|Period 2|Abnormal test procedure results|1|||
126293183|NCT00856193|454361576|FG000|Period 2|Lost to Follow-up|0|||
126293184|NCT00856193|454361577|FG001|Period 2|Lost to Follow-up|1|||
126293185|NCT02569801|454361578|FG000|Overall Study|Withdrawal by Subject|9|||
126293186|NCT02569801|454361579|FG001|Overall Study|Withdrawal by Subject|9|||
126293187|NCT02569801|454361578|FG000|Overall Study|Sponsor Decision|13|||
126293188|NCT02569801|454361579|FG001|Overall Study|Sponsor Decision|14|||
126293189|NCT02569801|454361578|FG000|Overall Study|Progressive Disease|2|||
126293190|NCT02569801|454361579|FG001|Overall Study|Progressive Disease|7|||
126293191|NCT02569801|454361578|FG000|Overall Study|Lost to Follow-up|0|||
126293192|NCT02569801|454361579|FG001|Overall Study|Lost to Follow-up|1|||
126293193|NCT02569801|454361578|FG000|Overall Study|Death|12|||
126293194|NCT02569801|454361579|FG001|Overall Study|Death|4|||
126293195|NCT00428246|454361580|FG000|Overall Study|Withdrawal by Subject|0|||
126293196|NCT00428246|454361581|FG001|Overall Study|Withdrawal by Subject|0|||
126293197|NCT00428246|454361582|FG002|Overall Study|Withdrawal by Subject|1|||
126293198|NCT00428246|454361580|FG000|Overall Study|Adverse Event|1|||
126293199|NCT00428246|454361581|FG001|Overall Study|Adverse Event|0|||
126293200|NCT00428246|454361582|FG002|Overall Study|Adverse Event|0|||
126293201|NCT03442751|454361583|FG000|Overall Study|Withdrawal by Subject|3|||
126293202|NCT03442751|454361584|FG001|Overall Study|Withdrawal by Subject|1|||
126293203|NCT03442751|454361583|FG000|Overall Study|Lost to Follow-up|3|||
126293204|NCT03442751|454361584|FG001|Overall Study|Lost to Follow-up|0|||
126293205|NCT02766335|454361586|FG000|Initial Registration|Adverse Event|6|||
126293206|NCT02766335|454361587|FG001|Initial Registration|Adverse Event|3|||
126293207|NCT02766335|454361588|FG002|Initial Registration|Adverse Event|0|||
126293208|NCT02766335|454361586|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
126293209|NCT02766335|454361587|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
126293210|NCT02766335|454361588|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
126293211|NCT02766335|454361586|FG000|Initial Registration|Progression/relapse|49|||
126293212|NCT02766335|454361587|FG001|Initial Registration|Progression/relapse|15|||
126293213|NCT02766335|454361588|FG002|Initial Registration|Progression/relapse|0|||
126293214|NCT02766335|454361586|FG000|Initial Registration|Death|1|||
126293215|NCT02766335|454361587|FG001|Initial Registration|Death|3|||
126293216|NCT02766335|454361588|FG002|Initial Registration|Death|0|||
126293217|NCT02766335|454361586|FG000|Initial Registration|not protocol specified|1|||
126293218|NCT02766335|454361587|FG001|Initial Registration|not protocol specified|9|||
126293219|NCT02766335|454361588|FG002|Initial Registration|not protocol specified|0|||
126293220|NCT02766335|454361586|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
126293221|NCT02766335|454361587|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
126293222|NCT02766335|454361588|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
126293223|NCT02766335|454361586|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
126293224|NCT02766335|454361587|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
126293225|NCT02766335|454361588|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
126293226|NCT04583735|454361595|FG000|Double-masked Treatment Period|Adverse Event|0|||
126100035|NCT02680002|453659806|FG005|Overall Study|Withdrawal by Subject|2|||
126293227|NCT04583735|454361596|FG001|Double-masked Treatment Period|Adverse Event|1|||
126100036|NCT02680002|453659801|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
126100037|NCT02680002|453659802|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
126100038|NCT02680002|453659803|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
126100039|NCT02680002|453659804|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
126100040|NCT02680002|453659805|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
126100041|NCT02680002|453659806|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
126100042|NCT02680002|453659801|FG000|Overall Study|Other|0|||
126100043|NCT02680002|453659802|FG001|Overall Study|Other|1|||
126100044|NCT02680002|453659803|FG002|Overall Study|Other|0|||
126100045|NCT02680002|453659804|FG003|Overall Study|Other|0|||
126293228|NCT04583735|454361595|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
126293229|NCT04583735|454361596|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
126042169|NCT03580356|453453097|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
126042170|NCT03580356|453453098|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
126042171|NCT03580356|453453099|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
126042172|NCT03580356|453453100|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
126293230|NCT04583735|454361595|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
126293231|NCT04583735|454361596|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
126293232|NCT04583735|454361595|FG000|Open-label Treatment Period|Adverse Event|1|||
126293233|NCT04583735|454361596|FG001|Open-label Treatment Period|Adverse Event|1|||
126293234|NCT04583735|454361595|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
126293235|NCT04583735|454361596|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126293236|NCT04583735|454361595|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126293237|NCT04583735|454361596|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
126293238|NCT00124917|454361597|FG000|Overall Study|Physician Decision|3|||
126293239|NCT01515423|454361598|FG000|Open Label Phase|Adverse Event|57|||
126293240|NCT01515423|454361599|FG001|Open Label Phase|Adverse Event|0|||
126293241|NCT01515423|454361600|FG002|Open Label Phase|Adverse Event|0|||
126293242|NCT01515423|454361598|FG000|Open Label Phase|Death|2|||
126293243|NCT01515423|454361599|FG001|Open Label Phase|Death|0|||
126293244|NCT01515423|454361600|FG002|Open Label Phase|Death|0|||
126293245|NCT01515423|454361598|FG000|Open Label Phase|Lack of Efficacy|117|||
126293246|NCT01515423|454361599|FG001|Open Label Phase|Lack of Efficacy|0|||
126293247|NCT01515423|454361600|FG002|Open Label Phase|Lack of Efficacy|0|||
126293248|NCT01515423|454361598|FG000|Open Label Phase|Lost to Follow-up|21|||
126293249|NCT01515423|454361599|FG001|Open Label Phase|Lost to Follow-up|0|||
126293250|NCT01515423|454361600|FG002|Open Label Phase|Lost to Follow-up|0|||
126293251|NCT01515423|454361598|FG000|Open Label Phase|Withdrawal by Subject|118|||
126293252|NCT01515423|454361599|FG001|Open Label Phase|Withdrawal by Subject|0|||
126293253|NCT01515423|454361600|FG002|Open Label Phase|Withdrawal by Subject|0|||
126293254|NCT01515423|454361598|FG000|Open Label Phase|excluded from DB Phase|70|||
126293255|NCT01515423|454361599|FG001|Open Label Phase|excluded from DB Phase|0|||
126293256|NCT01515423|454361600|FG002|Open Label Phase|excluded from DB Phase|0|||
126293257|NCT01515423|454361598|FG000|Open Label Phase|Other|28|||
126293258|NCT01515423|454361599|FG001|Open Label Phase|Other|0|||
126293259|NCT01515423|454361600|FG002|Open Label Phase|Other|0|||
126293260|NCT01515423|454361598|FG000|DOUBLE BLIND|Adverse Event|0|||
126293261|NCT01515423|454361599|FG001|DOUBLE BLIND|Adverse Event|15|||
126293262|NCT01515423|454361600|FG002|DOUBLE BLIND|Adverse Event|13|||
126293263|NCT01515423|454361598|FG000|DOUBLE BLIND|Death|0|||
126293264|NCT01515423|454361599|FG001|DOUBLE BLIND|Death|1|||
126293265|NCT01515423|454361600|FG002|DOUBLE BLIND|Death|2|||
126293266|NCT01515423|454361598|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
126293267|NCT01515423|454361599|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
126293268|NCT01515423|454361600|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
126293269|NCT01515423|454361598|FG000|DOUBLE BLIND|Pregnancy|0|||
126293270|NCT01515423|454361599|FG001|DOUBLE BLIND|Pregnancy|2|||
126293271|NCT01515423|454361600|FG002|DOUBLE BLIND|Pregnancy|0|||
126293272|NCT01515423|454361598|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
126293273|NCT01515423|454361599|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
126293274|NCT01515423|454361600|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
126293275|NCT01515423|454361598|FG000|DOUBLE BLIND|Other|0|||
126293276|NCT01515423|454361599|FG001|DOUBLE BLIND|Other|6|||
126293277|NCT01515423|454361600|FG002|DOUBLE BLIND|Other|12|||
126293278|NCT01515423|454361598|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
126042173|NCT03580356|453453101|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
126293279|NCT01515423|454361599|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
126293280|NCT01515423|454361600|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
126293281|NCT01125917|454361601|FG000|Overall Study|Adverse Event|43|||
126293282|NCT01125917|454361601|FG000|Overall Study|Lost to Follow-up|23|||
126293283|NCT01125917|454361601|FG000|Overall Study|Withdrawal by Subject|31|||
126293284|NCT01125917|454361601|FG000|Overall Study|Administrative|223|||
126293285|NCT01125917|454361601|FG000|Overall Study|Lack of Efficacy|19|||
126293286|NCT04421131|454361602|FG000|Overall Study|Lost to Follow-up|1|||
126293287|NCT04421131|454361602|FG000|Overall Study|Protocol Violation|2|||
126293288|NCT04421131|454361602|FG000|Overall Study|App crashed|5|||
126293289|NCT02501928|454361605|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126293290|NCT02501928|454361606|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
126042174|NCT03580356|453453102|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
126042175|NCT03580356|453453095|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
126042176|NCT03580356|453453096|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
126042177|NCT03580356|453453097|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
126042178|NCT03580356|453453098|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
126042179|NCT03580356|453453099|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
126042180|NCT03580356|453453100|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
126042181|NCT03580356|453453101|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
126042182|NCT03580356|453453102|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
126042183|NCT03580356|453453095|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
126042184|NCT03580356|453453096|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
126042185|NCT03580356|453453097|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
126042186|NCT03580356|453453098|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
126042187|NCT03580356|453453099|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
126042188|NCT03580356|453453100|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
126042189|NCT03580356|453453101|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
126042190|NCT03580356|453453102|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
126042191|NCT03118518|453453103|FG000|Overall Study|Early Exit after treatment|2|||
126042192|NCT03118518|453453104|FG001|Overall Study|Early Exit after treatment|8|||
126042193|NCT03118518|453453103|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
126042194|NCT03118518|453453104|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
126042195|NCT03536884|453453110|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
126042196|NCT03536884|453453111|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
126042197|NCT03536884|453453112|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042198|NCT03536884|453453113|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042199|NCT03536884|453453114|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042200|NCT03536884|453453115|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042201|NCT03536884|453453116|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042202|NCT03536884|453453117|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042203|NCT03536884|453453118|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042204|NCT03536884|453453119|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042205|NCT03536884|453453120|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042206|NCT03536884|453453121|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126042207|NCT03536884|453453110|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042208|NCT03536884|453453111|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
126042209|NCT03536884|453453112|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042210|NCT03536884|453453113|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042211|NCT03536884|453453114|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042212|NCT03536884|453453115|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042213|NCT03536884|453453116|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042214|NCT03536884|453453117|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042215|NCT03536884|453453118|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042216|NCT03536884|453453119|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042217|NCT03536884|453453120|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042218|NCT03536884|453453121|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126042219|NCT03536884|453453110|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
126042220|NCT03536884|453453111|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
126042221|NCT03536884|453453112|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042222|NCT03536884|453453113|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042223|NCT03536884|453453114|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042224|NCT03536884|453453115|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042225|NCT03536884|453453116|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042226|NCT03536884|453453117|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042227|NCT03536884|453453118|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042228|NCT03536884|453453119|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042229|NCT03536884|453453120|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126042230|NCT03536884|453453121|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126100046|NCT02680002|453659805|FG004|Overall Study|Other|1|||
126100047|NCT02680002|453659806|FG005|Overall Study|Other|0|||
126293291|NCT02501928|454361607|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
126293292|NCT02501928|454361608|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
126293293|NCT02501928|454361609|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
126293294|NCT02501928|454361610|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
126293295|NCT00838526|454361618|FG000|Overall Study|Adverse Event|3|||
126293296|NCT00838526|454361619|FG001|Overall Study|Adverse Event|12|||
126293297|NCT00838526|454361618|FG000|Overall Study|Lost to Follow-up|4|||
126293298|NCT00838526|454361619|FG001|Overall Study|Lost to Follow-up|12|||
125883207|NCT02266888|452871436|FG002|Overall Study|No Longer Eligible|0|||
126293299|NCT00838526|454361618|FG000|Overall Study|Withdrawal by Subject|4|||
126293300|NCT00838526|454361619|FG001|Overall Study|Withdrawal by Subject|5|||
126293301|NCT00838526|454361618|FG000|Overall Study|Lack of Efficacy|2|||
126293302|NCT00838526|454361619|FG001|Overall Study|Lack of Efficacy|3|||
126293303|NCT00838526|454361618|FG000|Overall Study|Other|11|||
126293304|NCT00838526|454361619|FG001|Overall Study|Other|7|||
126293305|NCT01320293|454361620|FG000|Overall Study|Lack of Efficacy|1|||
126293306|NCT01320293|454361620|FG000|Overall Study|Adverse Event|1|||
126293307|NCT00931411|454361621|FG000|First Intervention - 42 Days|Adverse Event|2|||
126293308|NCT00931411|454361622|FG001|First Intervention - 42 Days|Adverse Event|3|||
126293309|NCT00931411|454361621|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
126293310|NCT00931411|454361622|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
126293311|NCT00931411|454361621|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
126293312|NCT00931411|454361622|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
126293313|NCT03483012|454361625|FG000|Overall Study|Lack of Efficacy|6|||
126293314|NCT00070564|454362603|FG000|Overall Study|Progression|2|||
126293315|NCT00070564|454362604|FG001|Overall Study|Progression|4|||
126293316|NCT00070564|454362605|FG002|Overall Study|Progression|7|||
126293317|NCT00070564|454362606|FG003|Overall Study|Progression|7|||
126293318|NCT00070564|454362607|FG004|Overall Study|Progression|1|||
126293319|NCT00070564|454362608|FG005|Overall Study|Progression|0|||
126293320|NCT00070564|454362603|FG000|Overall Study|Delinquent|1|||
126293321|NCT00070564|454362604|FG001|Overall Study|Delinquent|4|||
126293322|NCT00070564|454362605|FG002|Overall Study|Delinquent|2|||
126293323|NCT00070564|454362606|FG003|Overall Study|Delinquent|0|||
126293324|NCT00070564|454362607|FG004|Overall Study|Delinquent|0|||
126293325|NCT00070564|454362608|FG005|Overall Study|Delinquent|0|||
126293326|NCT00070564|454362603|FG000|Overall Study|Adverse Event|150|||
126293327|NCT00070564|454362604|FG001|Overall Study|Adverse Event|142|||
126293328|NCT00070564|454362605|FG002|Overall Study|Adverse Event|120|||
126293329|NCT00070564|454362606|FG003|Overall Study|Adverse Event|108|||
126293330|NCT00070564|454362607|FG004|Overall Study|Adverse Event|63|||
126293331|NCT00070564|454362608|FG005|Overall Study|Adverse Event|36|||
126293332|NCT00070564|454362603|FG000|Overall Study|Death|4|||
126293333|NCT00070564|454362604|FG001|Overall Study|Death|1|||
126293334|NCT00070564|454362605|FG002|Overall Study|Death|5|||
126293335|NCT00070564|454362606|FG003|Overall Study|Death|3|||
126293336|NCT00070564|454362607|FG004|Overall Study|Death|0|||
126293337|NCT00070564|454362608|FG005|Overall Study|Death|1|||
126293338|NCT00070564|454362603|FG000|Overall Study|Other, not protocol specified|17|||
126293339|NCT00070564|454362604|FG001|Overall Study|Other, not protocol specified|15|||
126293340|NCT00070564|454362605|FG002|Overall Study|Other, not protocol specified|14|||
126293341|NCT00070564|454362606|FG003|Overall Study|Other, not protocol specified|19|||
126293342|NCT00070564|454362607|FG004|Overall Study|Other, not protocol specified|6|||
126293343|NCT00070564|454362608|FG005|Overall Study|Other, not protocol specified|7|||
126293344|NCT00070564|454362603|FG000|Overall Study|Withdrawal by Subject|26|||
126293345|NCT00070564|454362604|FG001|Overall Study|Withdrawal by Subject|37|||
126293346|NCT00070564|454362605|FG002|Overall Study|Withdrawal by Subject|23|||
126293347|NCT00070564|454362606|FG003|Overall Study|Withdrawal by Subject|30|||
126293348|NCT00070564|454362607|FG004|Overall Study|Withdrawal by Subject|8|||
126293349|NCT00070564|454362608|FG005|Overall Study|Withdrawal by Subject|8|||
125883208|NCT02266888|452871437|FG003|Overall Study|No Longer Eligible|2|||
126293350|NCT00070564|454362603|FG000|Overall Study|Not reported|0|||
126293351|NCT00070564|454362604|FG001|Overall Study|Not reported|0|||
126293352|NCT00070564|454362605|FG002|Overall Study|Not reported|0|||
126293353|NCT00070564|454362606|FG003|Overall Study|Not reported|0|||
126293354|NCT00070564|454362607|FG004|Overall Study|Not reported|1|||
126293355|NCT00070564|454362608|FG005|Overall Study|Not reported|0|||
126293356|NCT05017246|454362612|FG000|Overall Study|Withdrawal by Subject|5|||
126293357|NCT05017246|454362613|FG001|Overall Study|Withdrawal by Subject|3|||
126293358|NCT05017246|454362612|FG000|Overall Study|Determined to be ineligible|0|||
126293359|NCT05017246|454362613|FG001|Overall Study|Determined to be ineligible|1|||
126293360|NCT05017246|454362612|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
126293361|NCT05017246|454362613|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
126293362|NCT05017246|454362612|FG000|Overall Study|Technical failure|1|||
126293363|NCT05017246|454362613|FG001|Overall Study|Technical failure|3|||
126293364|NCT02058069|454362614|FG000|Overall Study|Exclusion due to implant size|5|||
126293365|NCT02058069|454362614|FG000|Overall Study|Withdrawal by Subject|6|||
126293366|NCT02500589|454362628|FG000|Overall Study|Withdrawal by Subject|11|||
126293367|NCT02500589|454362629|FG001|Overall Study|Withdrawal by Subject|14|||
126293368|NCT02500589|454362628|FG000|Overall Study|Lost to Follow-up|10|||
126293369|NCT02500589|454362629|FG001|Overall Study|Lost to Follow-up|12|||
126293370|NCT02500589|454362628|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
126293371|NCT02500589|454362629|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
126293372|NCT02500589|454362628|FG000|Overall Study|Death|7|||
126293373|NCT02500589|454362629|FG001|Overall Study|Death|5|||
126293374|NCT03652051|454362630|FG000|Stage 1|Adverse Event|0|||
126293375|NCT03652051|454362631|FG001|Stage 1|Adverse Event|5|||
126293376|NCT03652051|454362632|FG002|Stage 1|Adverse Event|7|||
126293377|NCT03652051|454362633|FG003|Stage 1|Adverse Event|1|||
126293378|NCT03652051|454362630|FG000|Stage 1|Withdrawal by Subject|0|||
126293379|NCT03652051|454362631|FG001|Stage 1|Withdrawal by Subject|0|||
126293380|NCT03652051|454362632|FG002|Stage 1|Withdrawal by Subject|1|||
126293381|NCT03652051|454362633|FG003|Stage 1|Withdrawal by Subject|0|||
126293382|NCT03652051|454362630|FG000|Stage 2|Adverse Event|0|||
126293383|NCT03652051|454362631|FG001|Stage 2|Adverse Event|2|||
126293384|NCT03652051|454362632|FG002|Stage 2|Adverse Event|1|||
126293385|NCT03652051|454362633|FG003|Stage 2|Adverse Event|0|||
126293386|NCT03652051|454362630|FG000|Stage 2|Protocol Violation|0|||
126293387|NCT03652051|454362631|FG001|Stage 2|Protocol Violation|1|||
126293388|NCT03652051|454362632|FG002|Stage 2|Protocol Violation|6|||
126293389|NCT03652051|454362633|FG003|Stage 2|Protocol Violation|0|||
126293390|NCT03652051|454362630|FG000|Stage 2|Lost to Follow-up|0|||
126293391|NCT03652051|454362631|FG001|Stage 2|Lost to Follow-up|2|||
126293392|NCT03652051|454362632|FG002|Stage 2|Lost to Follow-up|0|||
126293393|NCT03652051|454362633|FG003|Stage 2|Lost to Follow-up|3|||
126293394|NCT03652051|454362630|FG000|Stage 2|Withdrawal by Subject|0|||
125883209|NCT02266888|452871434|FG000|Overall Study|Randomization Closed|0|||
125883210|NCT02266888|452871435|FG001|Overall Study|Randomization Closed|0|||
126042231|NCT03536884|453453110|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042232|NCT03536884|453453111|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
126042233|NCT03536884|453453112|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042234|NCT03536884|453453113|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042235|NCT03536884|453453114|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042236|NCT03536884|453453115|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042237|NCT03536884|453453116|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042238|NCT03536884|453453117|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042239|NCT03536884|453453118|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042240|NCT03536884|453453119|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042241|NCT03536884|453453120|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042242|NCT03536884|453453121|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126042243|NCT03536884|453453110|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042244|NCT03536884|453453111|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
126042245|NCT03536884|453453112|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042246|NCT03536884|453453113|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042247|NCT03536884|453453114|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042248|NCT03536884|453453115|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042249|NCT03536884|453453116|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042250|NCT03536884|453453117|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126293395|NCT03652051|454362631|FG001|Stage 2|Withdrawal by Subject|11|||
126293396|NCT03652051|454362632|FG002|Stage 2|Withdrawal by Subject|9|||
126293397|NCT03652051|454362633|FG003|Stage 2|Withdrawal by Subject|3|||
126293398|NCT01113892|454362640|FG000|Overall Study|Lost to Follow-up|2|||
126293399|NCT01113892|454362641|FG001|Overall Study|Lost to Follow-up|2|||
126293400|NCT01113892|454362640|FG000|Overall Study|Withdrawal by Subject|1|||
126293401|NCT01113892|454362641|FG001|Overall Study|Withdrawal by Subject|1|||
126293402|NCT01113892|454362640|FG000|Overall Study|Death|2|||
126293403|NCT01113892|454362641|FG001|Overall Study|Death|4|||
126293404|NCT01113892|454362640|FG000|Overall Study|Graft no longer evaluable|9|||
126293405|NCT01113892|454362641|FG001|Overall Study|Graft no longer evaluable|9|||
126293406|NCT02603887|454362644|FG000|Stage 1|Adverse Event|4|||
126293407|NCT02603887|454362644|FG000|Stage 1|Disease progression|1|||
126293408|NCT02603887|454362644|FG000|Stage 2|FDA guidance|1|||
126293409|NCT00470470|454362654|FG000|Overall Study|Adverse Event|2|||
126293410|NCT00470470|454362654|FG000|Overall Study|Death|2|||
126293411|NCT00470470|454362654|FG000|Overall Study|Not treated|1|||
126293412|NCT04782076|454362659|FG000|Overall Study|Family Emergency|1|||
126293413|NCT01949662|454362664|FG000|Overall Study|Death|9|||
126293414|NCT01949662|454362665|FG001|Overall Study|Death|7|||
126293415|NCT01949662|454362664|FG000|Overall Study|Discharged before an agitation event|8|||
126293416|NCT01949662|454362665|FG001|Overall Study|Discharged before an agitation event|3|||
126293417|NCT01949662|454362664|FG000|Overall Study|Dropped out|1|||
126293418|NCT01949662|454362665|FG001|Overall Study|Dropped out|3|||
126293419|NCT01949662|454362664|FG000|Overall Study|Ineligible|0|||
126293420|NCT01949662|454362665|FG001|Overall Study|Ineligible|1|||
126366395|NCT05654181|454636979|FG008|Overall Study|Withdrawal by Subject|0|||
126293421|NCT02452476|454362670|FG000|Overall Study|Death|4|||
126293422|NCT02452476|454362671|FG001|Overall Study|Death|7|||
126293423|NCT02452476|454362670|FG000|Overall Study|Lost to Follow-up|1|||
126293424|NCT02452476|454362671|FG001|Overall Study|Lost to Follow-up|1|||
126366396|NCT05654181|454636980|FG009|Overall Study|Withdrawal by Subject|0|||
126366397|NCT05654181|454636971|FG000|Overall Study|Other|0|||
126366398|NCT05654181|454636972|FG001|Overall Study|Other|0|||
126366399|NCT05654181|454636973|FG002|Overall Study|Other|0|||
126366400|NCT05654181|454636974|FG003|Overall Study|Other|0|||
126366401|NCT05654181|454636975|FG004|Overall Study|Other|1|||
126366402|NCT05654181|454636976|FG005|Overall Study|Other|1|||
126293425|NCT02452476|454362670|FG000|Overall Study|Physician Decision|1|||
126293426|NCT02452476|454362671|FG001|Overall Study|Physician Decision|1|||
126293427|NCT02452476|454362670|FG000|Overall Study|Not treated|5|||
126293428|NCT02452476|454362671|FG001|Overall Study|Not treated|1|||
126293429|NCT02201784|454362672|FG000|Overall Study|Failure to achieve adequate block|2|||
126293430|NCT02201784|454362673|FG001|Overall Study|Failure to achieve adequate block|0|||
126293431|NCT01757275|454362674|FG000|Overall Study|Lost to Follow-up|1|||
126366403|NCT05654181|454636977|FG006|Overall Study|Other|0|||
126366404|NCT05654181|454636978|FG007|Overall Study|Other|0|||
126366405|NCT05654181|454636979|FG008|Overall Study|Other|0|||
126293432|NCT01757275|454362675|FG001|Overall Study|Lost to Follow-up|2|||
126366406|NCT05654181|454636980|FG009|Overall Study|Other|0|||
126366407|NCT04101331|454636981|FG000|Overall Study|Adverse Event|9|||
126293433|NCT01757275|454362674|FG000|Overall Study|Adverse Event|3|||
126293434|NCT01757275|454362675|FG001|Overall Study|Adverse Event|3|||
126293435|NCT01757275|454362674|FG000|Overall Study|Withdrawal by Subject|2|||
126293436|NCT01757275|454362675|FG001|Overall Study|Withdrawal by Subject|4|||
126293437|NCT01757275|454362674|FG000|Overall Study|Not treated|3|||
126293438|NCT01757275|454362675|FG001|Overall Study|Not treated|4|||
126293439|NCT01401452|454362678|FG000|Overall Study|Adverse reaction|9|||
126293440|NCT01401452|454362678|FG000|Overall Study|Lost to Follow-up|12|||
126293441|NCT01401452|454362678|FG000|Overall Study|Lack of Efficacy|30|||
126293442|NCT01401452|454362678|FG000|Overall Study|Participant developed breast cancer|1|||
126293443|NCT01401452|454362678|FG000|Overall Study|Tx stopped due to financial reasons|1|||
126293444|NCT01401452|454362678|FG000|Overall Study|Tx stopped by psychiatrist|1|||
126293445|NCT01401452|454362678|FG000|Overall Study|No more visits within the 36 wk followup|4|||
126293446|NCT01401452|454362678|FG000|Overall Study|Subject did not come to follow up visits|2|||
126293447|NCT01401452|454362678|FG000|Overall Study|Subject didn't return for routine visits|1|||
126293448|NCT01401452|454362678|FG000|Overall Study|Subject moved to another city|1|||
126293449|NCT01401452|454362678|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
126293450|NCT01401452|454362678|FG000|Overall Study|Psoriatic arthritis|1|||
126293451|NCT01401452|454362678|FG000|Overall Study|Participant stopped Tx|2|||
126293452|NCT01401452|454362678|FG000|Overall Study|Discontinuation for personal reasons|1|||
126293453|NCT01401452|454362678|FG000|Overall Study|Treatment failure|1|||
126293454|NCT01401452|454362678|FG000|Overall Study|Unsatisfactory output|1|||
126293455|NCT01401452|454362678|FG000|Overall Study|Subject withdrew because of Tx success|1|||
126293456|NCT01401452|454362678|FG000|Overall Study|Subject chose to discontinue treatment|1|||
126293457|NCT01401452|454362678|FG000|Overall Study|Participant withdrew consent|1|||
126293458|NCT04720105|454362679|FG000|Overall Study|Lack of Efficacy|1|||
126293459|NCT04720105|454362679|FG000|Overall Study|Lost to Follow-up|1|||
126293460|NCT04720105|454362679|FG000|Overall Study|Withdrawal by Subject|3|||
126293461|NCT01133067|454362682|FG000|Overall Study|Death|136|||
126293462|NCT01133067|454362682|FG000|Overall Study|Lost to Follow-up|3|||
126293463|NCT04135937|454362686|FG000|Overall Study|Lost to Follow-up|2|||
126293464|NCT04135937|454362686|FG000|Overall Study|Withdrawal by Subject|1|||
126293465|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
126293466|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
126293467|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
126293468|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
126293469|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126293470|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
126293471|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
126293472|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
126293473|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
126293474|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Other|1|||
126293475|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Other|0|||
126293476|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Other|4|||
126293477|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
126293478|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
126293479|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
126293480|NCT00273182|454362694|FG000|Overall Study|Death|450|||
126293481|NCT00273182|454362694|FG000|Overall Study|Lost to Follow-up|88|||
126042251|NCT03536884|453453118|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042252|NCT03536884|453453119|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042253|NCT03536884|453453120|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042254|NCT03536884|453453121|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126042255|NCT03536884|453453110|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042256|NCT03536884|453453111|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
126042257|NCT03536884|453453112|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042258|NCT03536884|453453113|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042259|NCT03536884|453453114|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042260|NCT03536884|453453115|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042261|NCT03536884|453453116|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042262|NCT03536884|453453117|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042263|NCT03536884|453453118|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042264|NCT03536884|453453119|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042265|NCT03536884|453453120|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042266|NCT03536884|453453121|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126042267|NCT03536884|453453110|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
126042268|NCT03536884|453453111|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
126042269|NCT03536884|453453112|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
126042270|NCT03536884|453453113|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
126042271|NCT03536884|453453114|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
126042272|NCT03536884|453453115|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
126293482|NCT00273182|454362694|FG000|Overall Study|Withdrawal by Subject|257|||
126293483|NCT00273182|454362694|FG000|Overall Study|Device/System Explant|154|||
126042273|NCT03536884|453453116|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
126042274|NCT03536884|453453117|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
126042275|NCT03536884|453453118|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
126042276|NCT03536884|453453119|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
126042277|NCT03536884|453453120|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
126042278|NCT03536884|453453121|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
126100048|NCT02680002|453659801|FG000|Overall Study|Adverse Event|0|||
125883211|NCT02266888|452871436|FG002|Overall Study|Randomization Closed|4|||
125883212|NCT02266888|452871437|FG003|Overall Study|Randomization Closed|0|||
125883213|NCT02266888|452871434|FG000|Overall Study|Personnel unavailable at transplant|0|||
125883214|NCT02266888|452871435|FG001|Overall Study|Personnel unavailable at transplant|0|||
125883215|NCT02266888|452871436|FG002|Overall Study|Personnel unavailable at transplant|0|||
125883216|NCT02266888|452871437|FG003|Overall Study|Personnel unavailable at transplant|1|||
125883217|NCT02266888|452871434|FG000|Overall Study|Transfer of care|0|||
126293484|NCT00273182|454362694|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
126293485|NCT00420420|454362695|FG000|Overall Study|Adverse Event|5|||
126293486|NCT00420420|454362696|FG001|Overall Study|Adverse Event|3|||
126293487|NCT00420420|454362695|FG000|Overall Study|Protocol Violation|1|||
126293488|NCT00420420|454362696|FG001|Overall Study|Protocol Violation|1|||
126293489|NCT00420420|454362695|FG000|Overall Study|Withdrawal by Subject|1|||
126293490|NCT00420420|454362696|FG001|Overall Study|Withdrawal by Subject|0|||
126293491|NCT00420420|454362695|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
126293492|NCT00420420|454362696|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
126293493|NCT00856492|454362697|FG000|Overall Study|Ineligible or withdrew consent|1|||
126293494|NCT00856492|454362698|FG001|Overall Study|Ineligible or withdrew consent|1|||
126293495|NCT00856492|454362699|FG002|Overall Study|Ineligible or withdrew consent|2|||
126293496|NCT00868530|454362703|FG000|Overall Study|Adverse Event|3|||
126293497|NCT00868530|454362703|FG000|Overall Study|Lost to Follow-up|1|||
126293498|NCT04576507|454364697|FG000|Overall Study|Adverse Event|4|||
126293499|NCT04576507|454364697|FG000|Overall Study|Withdrawal by Subject|1|||
126293500|NCT01749826|454364702|FG000|Overall Study|Study Terminated|20|||
125883218|NCT02266888|452871435|FG001|Overall Study|Transfer of care|0|||
125883219|NCT02266888|452871436|FG002|Overall Study|Transfer of care|1|||
125883220|NCT02266888|452871437|FG003|Overall Study|Transfer of care|0|||
126042279|NCT03536884|453453110|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125883221|NCT02351856|452871438|FG000|Overall Study|Adverse Event|2|||
126293501|NCT01749826|454364703|FG001|Overall Study|Study Terminated|0|||
126293502|NCT05842967|454364704|FG000|Period 1: SSA|Adverse Event|1|||
126293503|NCT05842967|454364705|FG001|Period 1: SSA|Adverse Event|1|||
126293504|NCT05842967|454364706|FG002|Period 1: SSA|Adverse Event|0|||
126293505|NCT05842967|454364707|FG003|Period 1: SSA|Adverse Event|0|||
126293506|NCT05842967|454364704|FG000|Period 1: SSA|Death|1|||
126293507|NCT05842967|454364705|FG001|Period 1: SSA|Death|0|||
126293508|NCT05842967|454364706|FG002|Period 1: SSA|Death|0|||
126293509|NCT05842967|454364707|FG003|Period 1: SSA|Death|0|||
126293510|NCT05842967|454364704|FG000|Period 1: SSA|Lost to Follow-up|16|||
126293511|NCT05842967|454364705|FG001|Period 1: SSA|Lost to Follow-up|4|||
126293512|NCT05842967|454364706|FG002|Period 1: SSA|Lost to Follow-up|0|||
126293513|NCT05842967|454364707|FG003|Period 1: SSA|Lost to Follow-up|0|||
126293514|NCT05842967|454364704|FG000|Period 1: SSA|Physician Decision|1|||
126293515|NCT05842967|454364705|FG001|Period 1: SSA|Physician Decision|0|||
126293516|NCT05842967|454364706|FG002|Period 1: SSA|Physician Decision|0|||
126293517|NCT05842967|454364707|FG003|Period 1: SSA|Physician Decision|0|||
126293518|NCT05842967|454364704|FG000|Period 1: SSA|Withdrawal by Subject|2|||
126100049|NCT02680002|453659802|FG001|Overall Study|Adverse Event|0|||
126293519|NCT05842967|454364705|FG001|Period 1: SSA|Withdrawal by Subject|2|||
126293520|NCT05842967|454364706|FG002|Period 1: SSA|Withdrawal by Subject|0|||
126293521|NCT05842967|454364707|FG003|Period 1: SSA|Withdrawal by Subject|0|||
126293522|NCT05842967|454364704|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
126293523|NCT05842967|454364705|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
126293524|NCT05842967|454364706|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
126293525|NCT05842967|454364707|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
126293526|NCT05842967|454364704|FG000|Period 2: SSB|Adverse Event|0|||
126293527|NCT05842967|454364705|FG001|Period 2: SSB|Adverse Event|0|||
126293528|NCT05842967|454364706|FG002|Period 2: SSB|Adverse Event|2|||
126293529|NCT05842967|454364707|FG003|Period 2: SSB|Adverse Event|0|||
125883222|NCT02351856|452871438|FG000|Overall Study|Physician Decision|5|||
125883223|NCT02351856|452871438|FG000|Overall Study|Study terminated by sponsor|1|||
125883224|NCT01281124|452871441|FG000|Overall Study|Death|1|||
125883225|NCT03038100|452871442|FG000|Overall Study|Death|289|||
125883226|NCT03038100|452871443|FG001|Overall Study|Death|272|||
125883227|NCT03038100|452871442|FG000|Overall Study|Lost to Follow-up|9|||
125883228|NCT03038100|452871443|FG001|Overall Study|Lost to Follow-up|10|||
125883229|NCT03038100|452871442|FG000|Overall Study|Protocol Deviation|1|||
125883230|NCT03038100|452871443|FG001|Overall Study|Protocol Deviation|4|||
125883231|NCT03038100|452871442|FG000|Overall Study|Withdrawal by Subject|45|||
125883232|NCT03038100|452871443|FG001|Overall Study|Withdrawal by Subject|51|||
125883233|NCT03038100|452871442|FG000|Overall Study|Study Terminated By Sponsor|305|||
125883234|NCT03038100|452871443|FG001|Overall Study|Study Terminated By Sponsor|311|||
125883235|NCT03038100|452871442|FG000|Overall Study|Physician Decision|1|||
125883236|NCT03038100|452871443|FG001|Overall Study|Physician Decision|3|||
125883237|NCT00918255|452871444|FG000|Overall Study|Adverse Event|1|||
125883238|NCT00918255|452871445|FG001|Overall Study|Adverse Event|0|||
125883239|NCT00918255|452871446|FG002|Overall Study|Adverse Event|0|||
125883240|NCT00918255|452871444|FG000|Overall Study|Withdrawal by Subject|1|||
125883241|NCT00918255|452871445|FG001|Overall Study|Withdrawal by Subject|0|||
125883242|NCT00918255|452871446|FG002|Overall Study|Withdrawal by Subject|2|||
125883243|NCT00918255|452871444|FG000|Overall Study|Lack of Efficacy|1|||
125883244|NCT00918255|452871445|FG001|Overall Study|Lack of Efficacy|0|||
125883245|NCT00918255|452871446|FG002|Overall Study|Lack of Efficacy|0|||
125883246|NCT00918255|452871444|FG000|Overall Study|Lost to Follow-up|1|||
125883247|NCT00918255|452871445|FG001|Overall Study|Lost to Follow-up|0|||
125883248|NCT00918255|452871446|FG002|Overall Study|Lost to Follow-up|2|||
125883249|NCT00918255|452871444|FG000|Overall Study|Exceeded allowed number of interventions|0|||
126100050|NCT02680002|453659803|FG002|Overall Study|Adverse Event|0|||
126293530|NCT05842967|454364704|FG000|Period 2: SSB|Lost to Follow-up|0|||
126293531|NCT05842967|454364705|FG001|Period 2: SSB|Lost to Follow-up|0|||
126366408|NCT04101331|454636981|FG000|Overall Study|Disease progression|82|||
126366409|NCT04101331|454636981|FG000|Overall Study|Withdrawal by Subject|1|||
126366410|NCT04101331|454636981|FG000|Overall Study|Investigator decision|6|||
126366411|NCT04101331|454636981|FG000|Overall Study|Death|6|||
126366412|NCT04101331|454636981|FG000|Overall Study|Allogenic transplant|1|||
126366413|NCT04110145|454636982|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
126366414|NCT04110145|454636983|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
126366415|NCT04110145|454636984|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
126366416|NCT04110145|454636985|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
126366417|NCT04110145|454636986|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
126366418|NCT00488293|454636990|FG000|Overall Study|Lost to Follow-up|28|||
126366419|NCT00488293|454636991|FG001|Overall Study|Lost to Follow-up|25|||
126366420|NCT00488293|454636990|FG000|Overall Study|Withdrawal by Subject|5|||
126366421|NCT00488293|454636991|FG001|Overall Study|Withdrawal by Subject|3|||
126366422|NCT00488293|454636990|FG000|Overall Study|Death|2|||
126366423|NCT00488293|454636991|FG001|Overall Study|Death|1|||
126366424|NCT00488293|454636990|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
126366425|NCT00488293|454636991|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
126366426|NCT00500331|454636992|FG000|Overall Study|Adverse Event|0|||
126366427|NCT00500331|454636993|FG001|Overall Study|Adverse Event|2|||
126366428|NCT00500331|454636994|FG002|Overall Study|Adverse Event|0|||
126366429|NCT00500331|454636995|FG003|Overall Study|Adverse Event|1|||
126366430|NCT00500331|454636996|FG004|Overall Study|Adverse Event|2|||
126366431|NCT00500331|454636997|FG005|Overall Study|Adverse Event|2|||
126366432|NCT00500331|454636998|FG006|Overall Study|Adverse Event|0|||
126366433|NCT00500331|454636992|FG000|Overall Study|Lost to Follow-up|1|||
126366434|NCT00500331|454636993|FG001|Overall Study|Lost to Follow-up|1|||
125883250|NCT00918255|452871445|FG001|Overall Study|Exceeded allowed number of interventions|0|||
126293532|NCT05842967|454364706|FG002|Period 2: SSB|Lost to Follow-up|4|||
126366435|NCT00500331|454636994|FG002|Overall Study|Lost to Follow-up|1|||
126366436|NCT00500331|454636995|FG003|Overall Study|Lost to Follow-up|2|||
126366437|NCT00500331|454636996|FG004|Overall Study|Lost to Follow-up|1|||
126366438|NCT00500331|454636997|FG005|Overall Study|Lost to Follow-up|0|||
126366439|NCT00500331|454636998|FG006|Overall Study|Lost to Follow-up|0|||
125883251|NCT00918255|452871446|FG002|Overall Study|Exceeded allowed number of interventions|1|||
126293533|NCT05842967|454364707|FG003|Period 2: SSB|Lost to Follow-up|3|||
125883252|NCT00918255|452871444|FG000|Overall Study|Non-compliance|1|||
125883253|NCT00918255|452871445|FG001|Overall Study|Non-compliance|0|||
125883254|NCT00918255|452871446|FG002|Overall Study|Non-compliance|0|||
125883255|NCT00918255|452871444|FG000|Overall Study|Investigator discretion|1|||
126293534|NCT05842967|454364704|FG000|Period 2: SSB|Withdrawal by Subject|0|||
126293535|NCT05842967|454364705|FG001|Period 2: SSB|Withdrawal by Subject|0|||
126293536|NCT05842967|454364706|FG002|Period 2: SSB|Withdrawal by Subject|1|||
126293537|NCT05842967|454364707|FG003|Period 2: SSB|Withdrawal by Subject|0|||
126293538|NCT05842967|454364704|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
126293539|NCT05842967|454364705|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
126293540|NCT05842967|454364706|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
126293541|NCT05842967|454364707|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
126293542|NCT05842967|454364704|FG000|Period 2: SSB|Protocol Violation|0|||
126293543|NCT05842967|454364705|FG001|Period 2: SSB|Protocol Violation|0|||
126293544|NCT05842967|454364706|FG002|Period 2: SSB|Protocol Violation|0|||
126293545|NCT05842967|454364707|FG003|Period 2: SSB|Protocol Violation|1|||
126293546|NCT01103180|454364709|FG000|Overall Study|Withdrawal by Subject|8|||
126293547|NCT01103180|454364710|FG001|Overall Study|Withdrawal by Subject|13|||
126293548|NCT01103180|454364709|FG000|Overall Study|Lost to Follow-up|13|||
126293549|NCT01103180|454364710|FG001|Overall Study|Lost to Follow-up|7|||
126293550|NCT01103180|454364709|FG000|Overall Study|Physician Decision|1|||
126293551|NCT01103180|454364710|FG001|Overall Study|Physician Decision|0|||
126293552|NCT01103180|454364709|FG000|Overall Study|Protocol Violation|0|||
126293553|NCT01103180|454364710|FG001|Overall Study|Protocol Violation|1|||
126293554|NCT01173523|454364711|FG000|Overall Study|Clinical Progression|1|||
126293555|NCT01173523|454364712|FG001|Overall Study|Clinical Progression|1|||
126293556|NCT01173523|454364711|FG000|Overall Study|Progressive Disease|10|||
126293557|NCT01173523|454364712|FG001|Overall Study|Progressive Disease|8|||
126293558|NCT01173523|454364711|FG000|Overall Study|Other|2|||
126293559|NCT01173523|454364712|FG001|Overall Study|Other|3|||
126293560|NCT01439802|454364717|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
126293561|NCT01439802|454364717|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
126293562|NCT01866826|454364718|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
126293563|NCT01866826|454364719|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
126293564|NCT01866826|454364718|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
126293565|NCT01866826|454364719|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
126293566|NCT01866826|454364718|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
126293567|NCT01866826|454364719|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
126293568|NCT02493660|454364722|FG000|Overall Study|Physician Decision|0|||
126293569|NCT02493660|454364723|FG001|Overall Study|Physician Decision|1|||
126293570|NCT02493660|454364722|FG000|Overall Study|Adverse Event|4|||
126293571|NCT02493660|454364723|FG001|Overall Study|Adverse Event|2|||
126293572|NCT02493660|454364722|FG000|Overall Study|Withdrawal by Subject|2|||
126293573|NCT02493660|454364723|FG001|Overall Study|Withdrawal by Subject|3|||
126293574|NCT02493660|454364722|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
126293575|NCT02493660|454364723|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
126293576|NCT02493660|454364722|FG000|Overall Study|Protocol Violation|0|||
126293577|NCT02493660|454364723|FG001|Overall Study|Protocol Violation|1|||
126293578|NCT02493660|454364722|FG000|Overall Study|Death|0|||
126042280|NCT03536884|453453111|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126042281|NCT03536884|453453112|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
126293579|NCT02493660|454364723|FG001|Overall Study|Death|1|||
126293580|NCT02493660|454364722|FG000|Overall Study|Lost to Follow-up|2|||
126293581|NCT02493660|454364723|FG001|Overall Study|Lost to Follow-up|4|||
126293582|NCT00595621|454364725|FG000|Open Label Run in|Adverse Event|1|||
126293583|NCT00595621|454364726|FG001|Open Label Run in|Adverse Event|0|||
126293584|NCT00595621|454364725|FG000|Open Label Run in|Physician Decision|1|||
126293585|NCT00595621|454364726|FG001|Open Label Run in|Physician Decision|0|||
126293586|NCT00595621|454364725|FG000|Open Label Run in|Withdrawal by Subject|1|||
126293587|NCT00595621|454364726|FG001|Open Label Run in|Withdrawal by Subject|0|||
126293588|NCT00595621|454364725|FG000|Randomization and Study|Adverse Event|2|||
126293589|NCT00595621|454364726|FG001|Randomization and Study|Adverse Event|0|||
126366440|NCT00500331|454636992|FG000|Overall Study|Protocol Violation|3|||
126042282|NCT03536884|453453113|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
126042283|NCT03536884|453453114|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
126042284|NCT03536884|453453115|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126042285|NCT03536884|453453116|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126042286|NCT03536884|453453117|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126042287|NCT03536884|453453118|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126042288|NCT03536884|453453119|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126042289|NCT03536884|453453120|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126042290|NCT03536884|453453121|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126042291|NCT03536884|453453110|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042292|NCT03536884|453453111|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042293|NCT03536884|453453112|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042294|NCT03536884|453453113|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
126042295|NCT03536884|453453114|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
126042296|NCT03536884|453453115|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042297|NCT03536884|453453116|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042298|NCT03536884|453453117|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042299|NCT03536884|453453118|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042300|NCT03536884|453453119|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042301|NCT03536884|453453120|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042302|NCT03536884|453453121|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126042303|NCT03536884|453453110|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126042304|NCT03536884|453453111|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126042305|NCT03536884|453453112|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
126042306|NCT03536884|453453113|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
126042307|NCT03536884|453453114|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
126042308|NCT03536884|453453115|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126042309|NCT03536884|453453116|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126042310|NCT03536884|453453117|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126042311|NCT03536884|453453118|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126042312|NCT03536884|453453119|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126366441|NCT00500331|454636993|FG001|Overall Study|Protocol Violation|1|||
126366442|NCT00500331|454636994|FG002|Overall Study|Protocol Violation|1|||
126366443|NCT00500331|454636995|FG003|Overall Study|Protocol Violation|0|||
126366444|NCT00500331|454636996|FG004|Overall Study|Protocol Violation|1|||
126366445|NCT00500331|454636997|FG005|Overall Study|Protocol Violation|1|||
126366446|NCT00500331|454636998|FG006|Overall Study|Protocol Violation|1|||
126366447|NCT00500331|454636992|FG000|Overall Study|Withdrawal by Subject|4|||
126366448|NCT00500331|454636993|FG001|Overall Study|Withdrawal by Subject|0|||
126366449|NCT00500331|454636994|FG002|Overall Study|Withdrawal by Subject|1|||
126366450|NCT00500331|454636995|FG003|Overall Study|Withdrawal by Subject|5|||
126366451|NCT00500331|454636996|FG004|Overall Study|Withdrawal by Subject|0|||
126366452|NCT00500331|454636997|FG005|Overall Study|Withdrawal by Subject|1|||
126366453|NCT00500331|454636998|FG006|Overall Study|Withdrawal by Subject|1|||
126366454|NCT00500331|454636992|FG000|Overall Study|Lack of Efficacy|3|||
126366455|NCT00500331|454636993|FG001|Overall Study|Lack of Efficacy|1|||
126366456|NCT00500331|454636994|FG002|Overall Study|Lack of Efficacy|0|||
126366457|NCT00500331|454636995|FG003|Overall Study|Lack of Efficacy|0|||
126366458|NCT00500331|454636996|FG004|Overall Study|Lack of Efficacy|0|||
126366459|NCT00500331|454636997|FG005|Overall Study|Lack of Efficacy|0|||
126366460|NCT00500331|454636998|FG006|Overall Study|Lack of Efficacy|0|||
126366461|NCT00500331|454636992|FG000|Overall Study|Liver function test abnormality|0|||
126366462|NCT00500331|454636993|FG001|Overall Study|Liver function test abnormality|0|||
126366463|NCT00500331|454636994|FG002|Overall Study|Liver function test abnormality|1|||
126366464|NCT00500331|454636995|FG003|Overall Study|Liver function test abnormality|0|||
126366465|NCT00500331|454636996|FG004|Overall Study|Liver function test abnormality|0|||
126366466|NCT00500331|454636997|FG005|Overall Study|Liver function test abnormality|0|||
126366467|NCT00500331|454636998|FG006|Overall Study|Liver function test abnormality|0|||
126366468|NCT00500331|454636992|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
126366469|NCT00500331|454636993|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
126366470|NCT00500331|454636994|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
126366471|NCT00500331|454636995|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
126366472|NCT00500331|454636996|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
126366473|NCT00500331|454636997|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
126366474|NCT00500331|454636998|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
125883256|NCT00918255|452871445|FG001|Overall Study|Investigator discretion|0|||
126293590|NCT00595621|454364725|FG000|Randomization and Study|Withdrawal by Subject|0|||
126293591|NCT00595621|454364726|FG001|Randomization and Study|Withdrawal by Subject|1|||
126293592|NCT00324987|454364727|FG000|Overall Study|Adverse Event|2|||
126293593|NCT00324987|454364728|FG001|Overall Study|Adverse Event|1|||
126293594|NCT00324987|454364727|FG000|Overall Study|Withdrawal by Subject|1|||
126293595|NCT00324987|454364728|FG001|Overall Study|Withdrawal by Subject|1|||
126293596|NCT00324987|454364727|FG000|Overall Study|Progression|1|||
126293597|NCT00324987|454364728|FG001|Overall Study|Progression|1|||
126293598|NCT00324987|454364727|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
126293599|NCT00324987|454364728|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
126293600|NCT02392481|454364729|FG000|Overall Study|Adverse Event|0|||
126293601|NCT02392481|454364730|FG001|Overall Study|Adverse Event|0|||
126293602|NCT02392481|454364731|FG002|Overall Study|Adverse Event|1|||
126100051|NCT02680002|453659804|FG003|Overall Study|Adverse Event|0|||
126100052|NCT02680002|453659805|FG004|Overall Study|Adverse Event|1|||
126100053|NCT02680002|453659806|FG005|Overall Study|Adverse Event|2|||
126100054|NCT00759915|453659807|FG000|Overall Study|Withdrawal by Subject|1|||
126100055|NCT00759915|453659808|FG001|Overall Study|Withdrawal by Subject|0|||
126100056|NCT00759915|453659807|FG000|Overall Study|Adverse Event|0|||
126100057|NCT00759915|453659808|FG001|Overall Study|Adverse Event|1|||
126293603|NCT02392481|454364732|FG003|Overall Study|Adverse Event|2|||
126293604|NCT02392481|454364729|FG000|Overall Study|Withdrawal by Subject|0|||
126293605|NCT02392481|454364730|FG001|Overall Study|Withdrawal by Subject|0|||
126293606|NCT02392481|454364731|FG002|Overall Study|Withdrawal by Subject|1|||
126100058|NCT03527173|453659811|FG000|Overall Study|Lost to Follow-up|4|||
126100059|NCT03527173|453659812|FG001|Overall Study|Lost to Follow-up|2|||
126100060|NCT03527173|453659811|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
126100061|NCT03527173|453659812|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
126100062|NCT03527173|453659811|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
126100063|NCT03527173|453659812|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
126100064|NCT03527173|453659811|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
126100065|NCT03527173|453659812|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126100066|NCT01248780|453659817|FG000|Overall Study|Lack of Efficacy|2|||
126100067|NCT01248780|453659818|FG001|Overall Study|Lack of Efficacy|0|||
126100068|NCT01248780|453659817|FG000|Overall Study|Lost to Follow-up|0|||
126100069|NCT01248780|453659818|FG001|Overall Study|Lost to Follow-up|1|||
126100070|NCT01248780|453659817|FG000|Overall Study|Death|0|||
126100071|NCT01248780|453659818|FG001|Overall Study|Death|1|||
126100072|NCT01248780|453659817|FG000|Overall Study|Adverse Event|2|||
126100073|NCT01248780|453659818|FG001|Overall Study|Adverse Event|7|||
126293607|NCT02392481|454364732|FG003|Overall Study|Withdrawal by Subject|0|||
126293608|NCT02502149|454364734|FG000|Intermediate|Discontinued prematurely|1|||
126293609|NCT02502149|454364735|FG001|Intermediate|Discontinued prematurely|0|||
126293610|NCT02502149|454364736|FG002|Intermediate|Discontinued prematurely|0|||
126293611|NCT02502149|454364737|FG003|Intermediate|Discontinued prematurely|0|||
126100074|NCT01248780|453659817|FG000|Overall Study|Protocol Violation|1|||
126293612|NCT02502149|454364738|FG004|Intermediate|Discontinued prematurely|0|||
126293613|NCT02968576|454364739|FG000|Overall Study|Pregnancy|0|||
126293614|NCT02968576|454364740|FG001|Overall Study|Pregnancy|1|||
126100075|NCT01248780|453659818|FG001|Overall Study|Protocol Violation|1|||
126293615|NCT02222922|454364741|FG000|Overall Study|Death|0|||
126100076|NCT01248780|453659817|FG000|Overall Study|Withdrawal by Subject|4|||
126100077|NCT01248780|453659818|FG001|Overall Study|Withdrawal by Subject|4|||
126100078|NCT01248780|453659817|FG000|Overall Study|Not treated|0|||
126293616|NCT02222922|454364742|FG001|Overall Study|Death|0|||
126293617|NCT02222922|454364743|FG002|Overall Study|Death|0|||
126293618|NCT02222922|454364744|FG003|Overall Study|Death|0|||
126293619|NCT02222922|454364745|FG004|Overall Study|Death|13|||
126293620|NCT02222922|454364746|FG005|Overall Study|Death|0|||
126293621|NCT02222922|454364747|FG006|Overall Study|Death|0|||
126293622|NCT02222922|454364748|FG007|Overall Study|Death|0|||
126293623|NCT02222922|454364749|FG008|Overall Study|Death|2|||
126293624|NCT02222922|454364741|FG000|Overall Study|Lost to Follow-up|0|||
126293625|NCT02222922|454364742|FG001|Overall Study|Lost to Follow-up|0|||
126293626|NCT02222922|454364743|FG002|Overall Study|Lost to Follow-up|1|||
126293627|NCT02222922|454364744|FG003|Overall Study|Lost to Follow-up|0|||
126293628|NCT02222922|454364745|FG004|Overall Study|Lost to Follow-up|9|||
126293629|NCT02222922|454364746|FG005|Overall Study|Lost to Follow-up|1|||
126293630|NCT02222922|454364747|FG006|Overall Study|Lost to Follow-up|0|||
126293631|NCT02222922|454364748|FG007|Overall Study|Lost to Follow-up|0|||
126293632|NCT02222922|454364749|FG008|Overall Study|Lost to Follow-up|0|||
126293633|NCT02222922|454364741|FG000|Overall Study|Other|0|||
126042313|NCT03536884|453453120|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126042314|NCT03536884|453453121|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126042315|NCT03536884|453453110|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042316|NCT03536884|453453111|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042317|NCT03536884|453453112|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
126042318|NCT03536884|453453113|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
126042319|NCT03536884|453453114|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
126042320|NCT03536884|453453115|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042321|NCT03536884|453453116|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042322|NCT03536884|453453117|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042323|NCT03536884|453453118|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042324|NCT03536884|453453119|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042325|NCT03536884|453453120|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042326|NCT03536884|453453121|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126042327|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
126042328|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
126042329|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
126042330|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
126042331|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
126042332|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
126042333|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
126042334|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
126042335|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
126042336|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
126042337|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
126293634|NCT02222922|454364742|FG001|Overall Study|Other|0|||
126293635|NCT02222922|454364743|FG002|Overall Study|Other|0|||
126293636|NCT02222922|454364744|FG003|Overall Study|Other|2|||
126293637|NCT02222922|454364745|FG004|Overall Study|Other|10|||
126293638|NCT02222922|454364746|FG005|Overall Study|Other|2|||
126293639|NCT02222922|454364747|FG006|Overall Study|Other|2|||
126100079|NCT01248780|453659818|FG001|Overall Study|Not treated|1|||
126100080|NCT04097301|453659819|FG000|Overall Study|Death|1|||
126100081|NCT04097301|453659819|FG000|Overall Study|Withdrawal by Subject|1|||
126100082|NCT04097301|453659819|FG000|Overall Study|Screening Failure|5|||
126100083|NCT00203476|453659820|FG000|Overall Study|Lost to Follow-up|1|||
126100084|NCT00203476|453659821|FG001|Overall Study|Lost to Follow-up|0|||
126100085|NCT00203476|453659822|FG002|Overall Study|Lost to Follow-up|0|||
126100086|NCT00203476|453659820|FG000|Overall Study|Withdrawal by Subject|0|||
126100087|NCT00203476|453659821|FG001|Overall Study|Withdrawal by Subject|1|||
125883257|NCT00918255|452871446|FG002|Overall Study|Investigator discretion|0|||
125883258|NCT02392624|452871447|FG000|Overall Study|Withdrawal by Subject|15|||
125883259|NCT02392624|452871448|FG001|Overall Study|Withdrawal by Subject|12|||
125883260|NCT02392624|452871449|FG002|Overall Study|Withdrawal by Subject|9|||
126100088|NCT00203476|453659822|FG002|Overall Study|Withdrawal by Subject|0|||
126100089|NCT01190514|453659823|FG000|First Intervention (Period 1)|Adverse Event|1|||
126100090|NCT01190514|453659824|FG001|First Intervention (Period 1)|Adverse Event|0|||
126100091|NCT01190514|453659825|FG002|First Intervention (Period 1)|Adverse Event|0|||
126293640|NCT02222922|454364748|FG007|Overall Study|Other|4|||
126293641|NCT02222922|454364749|FG008|Overall Study|Other|1|||
126293642|NCT02222922|454364741|FG000|Overall Study|Participant refused further follow-up|1|||
126293643|NCT02222922|454364742|FG001|Overall Study|Participant refused further follow-up|0|||
126293644|NCT02222922|454364743|FG002|Overall Study|Participant refused further follow-up|0|||
126293645|NCT02222922|454364744|FG003|Overall Study|Participant refused further follow-up|1|||
126100092|NCT01190514|453659826|FG003|First Intervention (Period 1)|Adverse Event|0|||
126293646|NCT02222922|454364745|FG004|Overall Study|Participant refused further follow-up|6|||
126293647|NCT02222922|454364746|FG005|Overall Study|Participant refused further follow-up|0|||
126293648|NCT02222922|454364747|FG006|Overall Study|Participant refused further follow-up|0|||
126293649|NCT02222922|454364748|FG007|Overall Study|Participant refused further follow-up|0|||
126293650|NCT02222922|454364749|FG008|Overall Study|Participant refused further follow-up|3|||
125883261|NCT02392624|452871447|FG000|Overall Study|Adverse Event|4|||
125883262|NCT02392624|452871448|FG001|Overall Study|Adverse Event|1|||
125883263|NCT02392624|452871449|FG002|Overall Study|Adverse Event|2|||
125883264|NCT02392624|452871447|FG000|Overall Study|Pregnancy|1|||
125883265|NCT02392624|452871448|FG001|Overall Study|Pregnancy|0|||
125883266|NCT02392624|452871449|FG002|Overall Study|Pregnancy|0|||
125883267|NCT02392624|452871447|FG000|Overall Study|Protocol Violation|0|||
125883268|NCT02392624|452871448|FG001|Overall Study|Protocol Violation|0|||
125883269|NCT02392624|452871449|FG002|Overall Study|Protocol Violation|1|||
125883270|NCT02392624|452871447|FG000|Overall Study|Sponsor/Investigator Decision|2|||
125883271|NCT02392624|452871448|FG001|Overall Study|Sponsor/Investigator Decision|1|||
125883272|NCT02392624|452871449|FG002|Overall Study|Sponsor/Investigator Decision|0|||
125883273|NCT02392624|452871447|FG000|Overall Study|Other|49|||
125883274|NCT02392624|452871448|FG001|Overall Study|Other|1|||
125883275|NCT02392624|452871449|FG002|Overall Study|Other|1|||
125883276|NCT00706238|452871450|FG000|Overall Study|Disease progression|4|||
125883277|NCT00706238|452871450|FG000|Overall Study|Other|1|||
125883278|NCT01193244|452871453|FG000|Overall Study|Withdrawal by Subject|79|||
125883279|NCT01193244|452871454|FG001|Overall Study|Withdrawal by Subject|97|||
125883280|NCT01193244|452871453|FG000|Overall Study|Other|303|||
125883281|NCT01193244|452871454|FG001|Overall Study|Other|278|||
125883282|NCT01193244|452871453|FG000|Overall Study|Lost to Follow-up|6|||
125883283|NCT01193244|452871454|FG001|Overall Study|Lost to Follow-up|15|||
125883284|NCT03763877|452871456|FG000|Overall Study|Withdrawal by Subject|3|||
125883285|NCT03763877|452871457|FG001|Overall Study|Withdrawal by Subject|1|||
125883286|NCT03763877|452871458|FG002|Overall Study|Withdrawal by Subject|3|||
125883287|NCT03763877|452871459|FG003|Overall Study|Withdrawal by Subject|4|||
125883288|NCT03763877|452871456|FG000|Overall Study|Adverse Event|1|||
125883289|NCT03763877|452871457|FG001|Overall Study|Adverse Event|1|||
125883290|NCT03763877|452871458|FG002|Overall Study|Adverse Event|3|||
126293651|NCT01254643|454364750|FG000|Overall Study|Withdrawal by Subject|1|||
126293652|NCT03359850|454364753|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
126293653|NCT03359850|454364754|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
126293654|NCT03359850|454364753|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
126293655|NCT03359850|454364754|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
126293656|NCT03359850|454364753|FG000|Extension Phase (Up to 28 Months)|Death|2|||
126293657|NCT03359850|454364754|FG001|Extension Phase (Up to 28 Months)|Death|4|||
126293658|NCT03359850|454364753|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
126293659|NCT03359850|454364754|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
126042338|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
126293660|NCT03359850|454364753|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
126293661|NCT03359850|454364754|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
126293662|NCT00116779|454364756|FG000|Overall Study|Adverse Event|4|||
126293663|NCT00116779|454364757|FG001|Overall Study|Adverse Event|2|||
126293664|NCT00116779|454364756|FG000|Overall Study|Protocol Violation|1|||
126293665|NCT00116779|454364757|FG001|Overall Study|Protocol Violation|4|||
126042339|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126042340|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125883291|NCT03763877|452871459|FG003|Overall Study|Adverse Event|1|||
125883292|NCT03763877|452871456|FG000|Overall Study|Protocol Violation|1|||
125883293|NCT03763877|452871457|FG001|Overall Study|Protocol Violation|1|||
126042341|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126293666|NCT00116779|454364756|FG000|Overall Study|Withdrawal by Subject|4|||
126293667|NCT00116779|454364757|FG001|Overall Study|Withdrawal by Subject|1|||
126293668|NCT00116779|454364756|FG000|Overall Study|Inadequate testosterone suppression|7|||
125883294|NCT03763877|452871458|FG002|Overall Study|Protocol Violation|0|||
125883295|NCT03763877|452871459|FG003|Overall Study|Protocol Violation|0|||
125883296|NCT03763877|452871456|FG000|Overall Study|Lost to Follow-up|0|||
126366475|NCT00500331|454636992|FG000|Overall Study|Didn't return for continuation of study|1|||
126366476|NCT00500331|454636993|FG001|Overall Study|Didn't return for continuation of study|0|||
126366477|NCT00500331|454636994|FG002|Overall Study|Didn't return for continuation of study|0|||
126366478|NCT00500331|454636995|FG003|Overall Study|Didn't return for continuation of study|0|||
126366479|NCT00500331|454636996|FG004|Overall Study|Didn't return for continuation of study|0|||
126366480|NCT00500331|454636997|FG005|Overall Study|Didn't return for continuation of study|0|||
126366481|NCT00500331|454636998|FG006|Overall Study|Didn't return for continuation of study|0|||
126366482|NCT00500331|454636992|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
126366483|NCT00500331|454636993|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366484|NCT00500331|454636994|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366485|NCT00500331|454636995|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366486|NCT00500331|454636996|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366487|NCT00500331|454636997|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366488|NCT00500331|454636998|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366489|NCT00500331|454636992|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
126366490|NCT00500331|454636993|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
126366491|NCT00500331|454636994|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
126366492|NCT00500331|454636995|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
126366493|NCT00500331|454636996|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
126293669|NCT00116779|454364757|FG001|Overall Study|Inadequate testosterone suppression|9|||
126293670|NCT00116779|454364756|FG000|Overall Study|Physician Decision|3|||
126293671|NCT00116779|454364757|FG001|Overall Study|Physician Decision|1|||
126293672|NCT00116779|454364756|FG000|Overall Study|Elevated PSA levels|2|||
126293673|NCT00116779|454364757|FG001|Overall Study|Elevated PSA levels|2|||
126293674|NCT02105467|454364758|FG000|Period 1|Lost to Follow-up|1|||
126293675|NCT02105467|454364759|FG001|Period 1|Lost to Follow-up|0|||
126293676|NCT02105467|454364758|FG000|Period 1|Death|1|||
126293677|NCT02105467|454364759|FG001|Period 1|Death|0|||
126293678|NCT02105467|454364758|FG000|Period 2|Lost to Follow-up|1|||
126293679|NCT02105467|454364759|FG001|Period 2|Lost to Follow-up|0|||
126293680|NCT02105467|454364758|FG000|Period 2|Death|1|||
126293681|NCT02105467|454364759|FG001|Period 2|Death|0|||
126293682|NCT02105467|454364758|FG000|Period 2|Withdrawal by Subject|0|||
126293683|NCT02105467|454364759|FG001|Period 2|Withdrawal by Subject|2|||
126293684|NCT02105467|454364758|FG000|Period 3|Lost to Follow-up|0|||
126293685|NCT02105467|454364759|FG001|Period 3|Lost to Follow-up|1|||
126293686|NCT01037218|454364760|FG000|Overall Study|Adverse Event|4|||
126293687|NCT01037218|454364761|FG001|Overall Study|Adverse Event|2|||
126293688|NCT01037218|454364762|FG002|Overall Study|Adverse Event|2|||
126293689|NCT01037218|454364763|FG003|Overall Study|Adverse Event|1|||
126293690|NCT01037218|454364760|FG000|Overall Study|Lack of Efficacy|0|||
126293691|NCT01037218|454364761|FG001|Overall Study|Lack of Efficacy|2|||
126293692|NCT01037218|454364762|FG002|Overall Study|Lack of Efficacy|1|||
126100093|NCT01190514|453659823|FG000|Third Intervention (Period 3)|Adverse Event|1|||
126100094|NCT01190514|453659824|FG001|Third Intervention (Period 3)|Adverse Event|0|||
126100095|NCT01190514|453659825|FG002|Third Intervention (Period 3)|Adverse Event|0|||
126293693|NCT01037218|454364763|FG003|Overall Study|Lack of Efficacy|5|||
126293694|NCT01037218|454364760|FG000|Overall Study|Lost to Follow-up|3|||
126293695|NCT01037218|454364761|FG001|Overall Study|Lost to Follow-up|5|||
126293696|NCT01037218|454364762|FG002|Overall Study|Lost to Follow-up|4|||
126293697|NCT01037218|454364763|FG003|Overall Study|Lost to Follow-up|2|||
126293698|NCT01037218|454364760|FG000|Overall Study|Withdrawal by Subject|6|||
126293699|NCT01037218|454364761|FG001|Overall Study|Withdrawal by Subject|7|||
126293700|NCT01037218|454364762|FG002|Overall Study|Withdrawal by Subject|7|||
126293701|NCT01037218|454364763|FG003|Overall Study|Withdrawal by Subject|4|||
126293702|NCT01037218|454364760|FG000|Overall Study|Partner Withdrew Consent|0|||
126293703|NCT01037218|454364761|FG001|Overall Study|Partner Withdrew Consent|3|||
126293704|NCT01037218|454364762|FG002|Overall Study|Partner Withdrew Consent|2|||
126293705|NCT01037218|454364763|FG003|Overall Study|Partner Withdrew Consent|1|||
126293706|NCT01037218|454364760|FG000|Overall Study|Protocol Violation|0|||
126293707|NCT01037218|454364761|FG001|Overall Study|Protocol Violation|0|||
126293708|NCT01037218|454364762|FG002|Overall Study|Protocol Violation|2|||
126293709|NCT01037218|454364763|FG003|Overall Study|Protocol Violation|2|||
126293710|NCT01037218|454364760|FG000|Overall Study|Various|3|||
126293711|NCT01037218|454364761|FG001|Overall Study|Various|2|||
126293712|NCT01037218|454364762|FG002|Overall Study|Various|3|||
126293713|NCT01037218|454364763|FG003|Overall Study|Various|1|||
126293714|NCT02676882|454364764|FG000|Overall Study|Adverse Event|1|||
126293715|NCT02676882|454364765|FG001|Overall Study|Adverse Event|0|||
126293716|NCT02676882|454364764|FG000|Overall Study|Lost to Follow-up|1|||
126293717|NCT02676882|454364765|FG001|Overall Study|Lost to Follow-up|0|||
126293718|NCT02676882|454364764|FG000|Overall Study|Withdrawal by Subject|1|||
126293719|NCT02676882|454364765|FG001|Overall Study|Withdrawal by Subject|2|||
126293720|NCT02568072|454364766|FG000|Overall Study|Unavailable for appointment|23|||
126293721|NCT02568072|454364766|FG000|Overall Study|Unable to contact|3|||
126293722|NCT02568072|454364766|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
126293723|NCT02568072|454364766|FG000|Overall Study|Withdrawal by Subject|1|||
126293724|NCT02568072|454364766|FG000|Overall Study|Sustained injury, marathon not run|24|||
126293725|NCT00958828|454364767|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
126293726|NCT00958828|454364768|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
126293727|NCT00958828|454364767|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
126293728|NCT00958828|454364768|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
126293729|NCT02687451|454364770|FG000|Overall Study|Withdrawal by Subject|1|||
126293730|NCT02687451|454364771|FG001|Overall Study|Withdrawal by Subject|0|||
126293731|NCT02687451|454364772|FG002|Overall Study|Withdrawal by Subject|0|||
126293732|NCT02687451|454364773|FG003|Overall Study|Withdrawal by Subject|0|||
126293733|NCT02687451|454364774|FG004|Overall Study|Withdrawal by Subject|0|||
126293734|NCT02687451|454364775|FG005|Overall Study|Withdrawal by Subject|1|||
126293735|NCT01125189|454364776|FG000|Treatment Period|Lack of Efficacy|15|||
126042342|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126042343|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126042344|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
126042345|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
126042346|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
126042347|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
126042348|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126042349|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126100096|NCT01190514|453659826|FG003|Third Intervention (Period 3)|Adverse Event|0|||
126100097|NCT01813929|453659827|FG000|Overall Study|Withdrawal by Subject|0|||
126100098|NCT01813929|453659828|FG001|Overall Study|Withdrawal by Subject|1|||
126042350|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126042351|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126042352|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126042353|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125883297|NCT03763877|452871457|FG001|Overall Study|Lost to Follow-up|1|||
126293736|NCT01125189|454364777|FG001|Treatment Period|Lack of Efficacy|18|||
126293737|NCT01125189|454364778|FG002|Treatment Period|Lack of Efficacy|25|||
126293738|NCT01125189|454364776|FG000|Treatment Period|Adverse Event|7|||
126100099|NCT00938470|453659831|FG000|Overall Study|Disease Progression|3|||
126293739|NCT01125189|454364777|FG001|Treatment Period|Adverse Event|8|||
125883298|NCT03763877|452871458|FG002|Overall Study|Lost to Follow-up|1|||
125883299|NCT03763877|452871459|FG003|Overall Study|Lost to Follow-up|0|||
125883300|NCT03040336|452871460|FG000|Overall Study|Death|1|||
125883301|NCT03040336|452871461|FG001|Overall Study|Death|0|||
125883302|NCT03040336|452871460|FG000|Overall Study|Withdrawal by Subject|2|||
125883303|NCT03040336|452871461|FG001|Overall Study|Withdrawal by Subject|3|||
125883304|NCT00068692|452871466|FG000|Step 1: Registration|Disese progression/relapse|5|||
125883305|NCT00068692|452871467|FG001|Step 1: Registration|Disese progression/relapse|0|||
125883306|NCT00068692|452871468|FG002|Step 1: Registration|Disese progression/relapse|0|||
126366494|NCT00500331|454636997|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
126366495|NCT00500331|454636998|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
126366496|NCT00500331|454636992|FG000|Overall Study|Participant was randomized by mistake|1|||
126366497|NCT00500331|454636993|FG001|Overall Study|Participant was randomized by mistake|0|||
125883307|NCT00068692|452871469|FG003|Step 1: Registration|Disese progression/relapse|0|||
125883308|NCT00068692|452871470|FG004|Step 1: Registration|Disese progression/relapse|0|||
125883309|NCT00068692|452871471|FG005|Step 1: Registration|Disese progression/relapse|0|||
125883310|NCT00068692|452871472|FG006|Step 1: Registration|Disese progression/relapse|0|||
125883311|NCT00068692|452871473|FG007|Step 1: Registration|Disese progression/relapse|0|||
125883312|NCT00068692|452871466|FG000|Step 1: Registration|Adverse Event|7|||
125883313|NCT00068692|452871467|FG001|Step 1: Registration|Adverse Event|0|||
125883314|NCT00068692|452871468|FG002|Step 1: Registration|Adverse Event|0|||
125883315|NCT00068692|452871469|FG003|Step 1: Registration|Adverse Event|0|||
125883316|NCT00068692|452871470|FG004|Step 1: Registration|Adverse Event|0|||
125883317|NCT00068692|452871471|FG005|Step 1: Registration|Adverse Event|0|||
125883318|NCT00068692|452871472|FG006|Step 1: Registration|Adverse Event|0|||
125883319|NCT00068692|452871473|FG007|Step 1: Registration|Adverse Event|0|||
125883320|NCT00068692|452871466|FG000|Step 1: Registration|Death|1|||
125883321|NCT00068692|452871467|FG001|Step 1: Registration|Death|0|||
125883322|NCT00068692|452871468|FG002|Step 1: Registration|Death|0|||
125883323|NCT00068692|452871469|FG003|Step 1: Registration|Death|0|||
125883324|NCT00068692|452871470|FG004|Step 1: Registration|Death|0|||
125883325|NCT00068692|452871471|FG005|Step 1: Registration|Death|0|||
125883326|NCT00068692|452871472|FG006|Step 1: Registration|Death|0|||
125883327|NCT00068692|452871473|FG007|Step 1: Registration|Death|0|||
125883328|NCT00068692|452871466|FG000|Step 1: Registration|Withdrawal by Subject|11|||
125883329|NCT00068692|452871467|FG001|Step 1: Registration|Withdrawal by Subject|0|||
125883330|NCT00068692|452871468|FG002|Step 1: Registration|Withdrawal by Subject|0|||
125883331|NCT00068692|452871469|FG003|Step 1: Registration|Withdrawal by Subject|0|||
125883332|NCT00068692|452871470|FG004|Step 1: Registration|Withdrawal by Subject|0|||
125883333|NCT00068692|452871471|FG005|Step 1: Registration|Withdrawal by Subject|0|||
125883334|NCT00068692|452871472|FG006|Step 1: Registration|Withdrawal by Subject|0|||
125883335|NCT00068692|452871473|FG007|Step 1: Registration|Withdrawal by Subject|0|||
125883336|NCT00068692|452871466|FG000|Step 1: Registration|Alternative therapy|2|||
125883337|NCT00068692|452871467|FG001|Step 1: Registration|Alternative therapy|0|||
125883338|NCT00068692|452871468|FG002|Step 1: Registration|Alternative therapy|0|||
125883339|NCT00068692|452871469|FG003|Step 1: Registration|Alternative therapy|0|||
125883340|NCT00068692|452871470|FG004|Step 1: Registration|Alternative therapy|0|||
125883341|NCT00068692|452871471|FG005|Step 1: Registration|Alternative therapy|0|||
125883342|NCT00068692|452871472|FG006|Step 1: Registration|Alternative therapy|0|||
125883343|NCT00068692|452871473|FG007|Step 1: Registration|Alternative therapy|0|||
125883344|NCT00068692|452871466|FG000|Step 1: Registration|Complicating disease|2|||
126042354|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126042355|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126042356|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
126366498|NCT00500331|454636994|FG002|Overall Study|Participant was randomized by mistake|0|||
126366499|NCT00500331|454636995|FG003|Overall Study|Participant was randomized by mistake|0|||
126366500|NCT00500331|454636996|FG004|Overall Study|Participant was randomized by mistake|0|||
126366501|NCT00500331|454636997|FG005|Overall Study|Participant was randomized by mistake|0|||
126366502|NCT00500331|454636998|FG006|Overall Study|Participant was randomized by mistake|0|||
126366503|NCT00500331|454636992|FG000|Overall Study|Diabetologist nurse in the study|0|||
126366504|NCT00500331|454636993|FG001|Overall Study|Diabetologist nurse in the study|0|||
126366505|NCT00500331|454636994|FG002|Overall Study|Diabetologist nurse in the study|1|||
126366506|NCT00500331|454636995|FG003|Overall Study|Diabetologist nurse in the study|0|||
126366507|NCT00500331|454636996|FG004|Overall Study|Diabetologist nurse in the study|0|||
126366508|NCT00500331|454636997|FG005|Overall Study|Diabetologist nurse in the study|0|||
126366509|NCT00500331|454636998|FG006|Overall Study|Diabetologist nurse in the study|0|||
126366510|NCT00500331|454636992|FG000|Overall Study|State ban of biological samples export|0|||
126366511|NCT00500331|454636993|FG001|Overall Study|State ban of biological samples export|0|||
126366512|NCT00500331|454636994|FG002|Overall Study|State ban of biological samples export|0|||
126100100|NCT00938470|453659832|FG001|Overall Study|Disease Progression|0|||
125883345|NCT00068692|452871467|FG001|Step 1: Registration|Complicating disease|0|||
125883346|NCT00068692|452871468|FG002|Step 1: Registration|Complicating disease|0|||
125883347|NCT00068692|452871469|FG003|Step 1: Registration|Complicating disease|0|||
126042357|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126042358|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
126042359|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126042360|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126042361|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126042362|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126100101|NCT00938470|453659831|FG000|Overall Study|Alternate Treatment|1|||
126042363|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126042364|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126042365|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126042366|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126042367|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126042368|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
126042369|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126293740|NCT01125189|454364778|FG002|Treatment Period|Adverse Event|8|||
126293741|NCT01125189|454364776|FG000|Treatment Period|Withdrawal by Subject|3|||
126293742|NCT01125189|454364777|FG001|Treatment Period|Withdrawal by Subject|1|||
126293743|NCT01125189|454364778|FG002|Treatment Period|Withdrawal by Subject|1|||
126293744|NCT01125189|454364776|FG000|Treatment Period|Death|1|||
126293745|NCT01125189|454364777|FG001|Treatment Period|Death|0|||
126293746|NCT01125189|454364778|FG002|Treatment Period|Death|0|||
126293747|NCT01125189|454364776|FG000|Treatment Period|Lost to Follow-up|1|||
126293748|NCT01125189|454364777|FG001|Treatment Period|Lost to Follow-up|2|||
126293749|NCT01125189|454364778|FG002|Treatment Period|Lost to Follow-up|1|||
126293750|NCT01125189|454364776|FG000|Treatment Period|Poor compliance/noncompliance|0|||
126293751|NCT01125189|454364777|FG001|Treatment Period|Poor compliance/noncompliance|1|||
126293752|NCT01125189|454364778|FG002|Treatment Period|Poor compliance/noncompliance|0|||
126293753|NCT01125189|454364776|FG000|Treatment Period|Participants requested to discontinue|1|||
126293754|NCT01125189|454364777|FG001|Treatment Period|Participants requested to discontinue|3|||
126293755|NCT01125189|454364778|FG002|Treatment Period|Participants requested to discontinue|4|||
126293756|NCT01125189|454364776|FG000|Treatment Period|Other reasons|1|||
126293757|NCT01125189|454364777|FG001|Treatment Period|Other reasons|1|||
126293758|NCT01125189|454364778|FG002|Treatment Period|Other reasons|0|||
126293759|NCT01125189|454364776|FG000|Treatment Period|Completed 24 week treatment period only|2|||
126293760|NCT01125189|454364777|FG001|Treatment Period|Completed 24 week treatment period only|1|||
126293761|NCT01125189|454364778|FG002|Treatment Period|Completed 24 week treatment period only|2|||
126293762|NCT01125189|454364776|FG000|Follow up Period|Withdrawal by Subject|3|||
126293763|NCT01125189|454364777|FG001|Follow up Period|Withdrawal by Subject|2|||
126293764|NCT01125189|454364778|FG002|Follow up Period|Withdrawal by Subject|5|||
126293765|NCT01125189|454364776|FG000|Follow up Period|Death|1|||
126293766|NCT01125189|454364777|FG001|Follow up Period|Death|0|||
126366513|NCT00500331|454636995|FG003|Overall Study|State ban of biological samples export|1|||
126366514|NCT00500331|454636996|FG004|Overall Study|State ban of biological samples export|0|||
126366515|NCT00500331|454636997|FG005|Overall Study|State ban of biological samples export|0|||
126366516|NCT00500331|454636998|FG006|Overall Study|State ban of biological samples export|0|||
126366517|NCT00500331|454636992|FG000|Overall Study|Protocol violated|0|||
126366518|NCT00500331|454636993|FG001|Overall Study|Protocol violated|0|||
126366519|NCT00500331|454636994|FG002|Overall Study|Protocol violated|0|||
126366520|NCT00500331|454636995|FG003|Overall Study|Protocol violated|1|||
126366521|NCT00500331|454636996|FG004|Overall Study|Protocol violated|0|||
126366522|NCT00500331|454636997|FG005|Overall Study|Protocol violated|0|||
126366523|NCT00500331|454636998|FG006|Overall Study|Protocol violated|0|||
126366524|NCT03436732|454636999|FG000|Overall Study|Not treated-enrolled in different study|1|||
126366525|NCT03436732|454637000|FG001|Overall Study|Not treated-enrolled in different study|0|||
126366526|NCT03436732|454636999|FG000|Overall Study|Off study after cycle 1|1|||
126366527|NCT03436732|454637000|FG001|Overall Study|Off study after cycle 1|0|||
126366528|NCT03436732|454636999|FG000|Overall Study|Adverse Event|2|||
126366529|NCT03436732|454637000|FG001|Overall Study|Adverse Event|0|||
126366530|NCT03436732|454636999|FG000|Overall Study|Death|0|||
126366531|NCT03436732|454637000|FG001|Overall Study|Death|1|||
126366532|NCT03345550|454637001|FG000|Overall Study|Withdrawal by Subject|1|||
126366533|NCT03345550|454637002|FG001|Overall Study|Withdrawal by Subject|0|||
126366534|NCT03345550|454637001|FG000|Overall Study|Lost to Follow-up|4|||
126366535|NCT03345550|454637002|FG001|Overall Study|Lost to Follow-up|5|||
126366536|NCT05538728|454637003|FG000|Overall Study|Withdrawal by Subject|1|||
126366537|NCT05538728|454637004|FG001|Overall Study|Withdrawal by Subject|1|||
126366538|NCT00959049|454637005|FG000|Overall Study|Adverse Event|1|||
126366539|NCT00959049|454637006|FG001|Overall Study|Adverse Event|0|||
126366540|NCT00959049|454637007|FG002|Overall Study|Adverse Event|0|||
126366541|NCT00959049|454637008|FG003|Overall Study|Adverse Event|0|||
126366542|NCT00959049|454637009|FG004|Overall Study|Adverse Event|0|||
126366543|NCT00959049|454637010|FG005|Overall Study|Adverse Event|0|||
126366544|NCT00959049|454637005|FG000|Overall Study|Lost to Follow-up|17|||
126366545|NCT00959049|454637006|FG001|Overall Study|Lost to Follow-up|5|||
126366546|NCT00959049|454637007|FG002|Overall Study|Lost to Follow-up|1|||
126366547|NCT00959049|454637008|FG003|Overall Study|Lost to Follow-up|10|||
126293767|NCT01125189|454364778|FG002|Follow up Period|Death|0|||
126293768|NCT01125189|454364776|FG000|Follow up Period|Lost to Follow-up|12|||
126293769|NCT01125189|454364777|FG001|Follow up Period|Lost to Follow-up|9|||
126293770|NCT01125189|454364778|FG002|Follow up Period|Lost to Follow-up|6|||
126366548|NCT00959049|454637009|FG004|Overall Study|Lost to Follow-up|9|||
126366549|NCT00959049|454637010|FG005|Overall Study|Lost to Follow-up|1|||
126366550|NCT00959049|454637005|FG000|Overall Study|Contraindicated medication|0|||
126366551|NCT00959049|454637006|FG001|Overall Study|Contraindicated medication|0|||
126366552|NCT00959049|454637007|FG002|Overall Study|Contraindicated medication|0|||
126293771|NCT01125189|454364776|FG000|Follow up Period|Other reasons|4|||
126293772|NCT01125189|454364777|FG001|Follow up Period|Other reasons|4|||
126293773|NCT01125189|454364778|FG002|Follow up Period|Other reasons|5|||
126366553|NCT00959049|454637008|FG003|Overall Study|Contraindicated medication|1|||
126366554|NCT00959049|454637009|FG004|Overall Study|Contraindicated medication|0|||
126366555|NCT00959049|454637010|FG005|Overall Study|Contraindicated medication|0|||
126293774|NCT00927589|454364779|FG000|Overall Study|Death|1|||
126293775|NCT00927589|454364779|FG000|Overall Study|Physician Decision|1|||
126293776|NCT00927589|454364779|FG000|Overall Study|Withdrawal by Subject|3|||
126293777|NCT00927589|454364779|FG000|Overall Study|Adverse Event|2|||
126293778|NCT00927589|454364779|FG000|Overall Study|Disease Progression|8|||
126293779|NCT00927589|454364779|FG000|Overall Study|Non-compliance|1|||
126293780|NCT00707239|454364780|FG000|Overall Study|Adverse Event|5|||
126293781|NCT00707239|454364781|FG001|Overall Study|Adverse Event|3|||
126293782|NCT00707239|454364782|FG002|Overall Study|Adverse Event|2|||
126293783|NCT00707239|454364780|FG000|Overall Study|Death|3|||
126293784|NCT00707239|454364781|FG001|Overall Study|Death|1|||
126293785|NCT00707239|454364782|FG002|Overall Study|Death|3|||
126293786|NCT00707239|454364780|FG000|Overall Study|Physician Decision|1|||
126293787|NCT00707239|454364781|FG001|Overall Study|Physician Decision|1|||
126293788|NCT00707239|454364782|FG002|Overall Study|Physician Decision|2|||
126293789|NCT00707239|454364780|FG000|Overall Study|Protocol Violation|0|||
126293790|NCT00707239|454364781|FG001|Overall Study|Protocol Violation|0|||
126293791|NCT00707239|454364782|FG002|Overall Study|Protocol Violation|1|||
126293792|NCT00707239|454364780|FG000|Overall Study|Lack of Efficacy|1|||
126100102|NCT00938470|453659832|FG001|Overall Study|Alternate Treatment|0|||
126293793|NCT00707239|454364781|FG001|Overall Study|Lack of Efficacy|2|||
126293794|NCT00707239|454364782|FG002|Overall Study|Lack of Efficacy|0|||
126293795|NCT00707239|454364780|FG000|Overall Study|Randomized, but not treated|1|||
126293796|NCT00707239|454364781|FG001|Overall Study|Randomized, but not treated|1|||
126293797|NCT00707239|454364782|FG002|Overall Study|Randomized, but not treated|1|||
126293798|NCT00707239|454364780|FG000|Overall Study|Other|8|||
126293799|NCT00707239|454364781|FG001|Overall Study|Other|3|||
126293800|NCT00707239|454364782|FG002|Overall Study|Other|5|||
126293801|NCT01651117|454364785|FG000|Overall Study|Death|2|||
126293802|NCT01651117|454364786|FG001|Overall Study|Death|3|||
126042370|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
126293803|NCT01651117|454364787|FG002|Overall Study|Death|2|||
126042371|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
126293804|NCT01651117|454364788|FG003|Overall Study|Death|2|||
126293805|NCT02714218|454364789|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126293806|NCT02714218|454364790|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126293807|NCT02714218|454364791|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126293808|NCT02714218|454364789|FG000|Pre-Treatment Period|Other reasons|0|||
126293809|NCT02714218|454364790|FG001|Pre-Treatment Period|Other reasons|1|||
126293810|NCT02714218|454364791|FG002|Pre-Treatment Period|Other reasons|0|||
126293811|NCT02714218|454364789|FG000|Treatment Period|Disease Progression|55|||
126293812|NCT02714218|454364790|FG001|Treatment Period|Disease Progression|52|||
126293813|NCT02714218|454364791|FG002|Treatment Period|Disease Progression|14|||
126293814|NCT02714218|454364789|FG000|Treatment Period|Study drug toxicity|46|||
126293815|NCT02714218|454364790|FG001|Treatment Period|Study drug toxicity|70|||
126293816|NCT02714218|454364791|FG002|Treatment Period|Study drug toxicity|6|||
126293817|NCT02714218|454364789|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
126293818|NCT02714218|454364790|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
126293819|NCT02714218|454364791|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
126293820|NCT02714218|454364789|FG000|Treatment Period|Request to discontinue treatment|1|||
126293821|NCT02714218|454364790|FG001|Treatment Period|Request to discontinue treatment|4|||
126293822|NCT02714218|454364791|FG002|Treatment Period|Request to discontinue treatment|1|||
126293823|NCT02714218|454364789|FG000|Treatment Period|Participant withdrew consent|2|||
126293824|NCT02714218|454364790|FG001|Treatment Period|Participant withdrew consent|2|||
126293825|NCT02714218|454364791|FG002|Treatment Period|Participant withdrew consent|0|||
126293826|NCT02714218|454364789|FG000|Treatment Period|Maximum clinical benefit|4|||
126293827|NCT02714218|454364790|FG001|Treatment Period|Maximum clinical benefit|2|||
126293828|NCT02714218|454364791|FG002|Treatment Period|Maximum clinical benefit|0|||
126293829|NCT02714218|454364789|FG000|Treatment Period|Administrative reason by sponsor|2|||
126293830|NCT02714218|454364790|FG001|Treatment Period|Administrative reason by sponsor|1|||
126293831|NCT02714218|454364791|FG002|Treatment Period|Administrative reason by sponsor|0|||
126293832|NCT02714218|454364789|FG000|Treatment Period|Other reasons|6|||
126293833|NCT02714218|454364790|FG001|Treatment Period|Other reasons|6|||
126293834|NCT02714218|454364791|FG002|Treatment Period|Other reasons|0|||
126293835|NCT02714218|454364789|FG000|Treatment Period|Completed treatment as per protocol|36|||
126293836|NCT02714218|454364790|FG001|Treatment Period|Completed treatment as per protocol|27|||
126293837|NCT02714218|454364791|FG002|Treatment Period|Completed treatment as per protocol|3|||
126293838|NCT02714218|454364789|FG000|Treatment Period|Not reported|9|||
126293839|NCT02714218|454364790|FG001|Treatment Period|Not reported|6|||
126293840|NCT02714218|454364791|FG002|Treatment Period|Not reported|0|||
126293841|NCT02088177|454364794|FG000|Overall Study|Lost to Follow-up|3|||
126293842|NCT01778530|454364796|FG000|Overall Study|Progression on study|1|||
126293843|NCT01778530|454364796|FG000|Overall Study|Adverse event/side effect|1|||
126293844|NCT01894919|454364797|FG000|Overall Study|Withdrawal by Subject|1|||
126293845|NCT01894919|454364798|FG001|Overall Study|Withdrawal by Subject|0|||
126293846|NCT01894919|454364799|FG002|Overall Study|Withdrawal by Subject|0|||
126293847|NCT01894919|454364800|FG003|Overall Study|Withdrawal by Subject|0|||
126293848|NCT01894919|454364801|FG004|Overall Study|Withdrawal by Subject|1|||
126293849|NCT01894919|454364802|FG005|Overall Study|Withdrawal by Subject|0|||
126293850|NCT01894919|454364803|FG006|Overall Study|Withdrawal by Subject|0|||
126293851|NCT01894919|454364804|FG007|Overall Study|Withdrawal by Subject|0|||
126293852|NCT01894919|454364805|FG008|Overall Study|Withdrawal by Subject|0|||
126293853|NCT01894919|454364806|FG009|Overall Study|Withdrawal by Subject|1|||
126293854|NCT01894919|454364807|FG010|Overall Study|Withdrawal by Subject|1|||
126293855|NCT01894919|454364808|FG011|Overall Study|Withdrawal by Subject|0|||
126293856|NCT01894919|454364809|FG012|Overall Study|Withdrawal by Subject|0|||
126293857|NCT01894919|454364797|FG000|Overall Study|Adverse Event|0|||
126293858|NCT01894919|454364798|FG001|Overall Study|Adverse Event|0|||
126293859|NCT01894919|454364799|FG002|Overall Study|Adverse Event|0|||
126293860|NCT01894919|454364800|FG003|Overall Study|Adverse Event|0|||
126293861|NCT01894919|454364801|FG004|Overall Study|Adverse Event|0|||
126293862|NCT01894919|454364802|FG005|Overall Study|Adverse Event|0|||
126293863|NCT01894919|454364803|FG006|Overall Study|Adverse Event|0|||
126293864|NCT01894919|454364804|FG007|Overall Study|Adverse Event|0|||
126293865|NCT01894919|454364805|FG008|Overall Study|Adverse Event|0|||
126293866|NCT01894919|454364806|FG009|Overall Study|Adverse Event|0|||
126293867|NCT01894919|454364807|FG010|Overall Study|Adverse Event|1|||
126293868|NCT01894919|454364808|FG011|Overall Study|Adverse Event|0|||
126293869|NCT01894919|454364809|FG012|Overall Study|Adverse Event|0|||
126293870|NCT01894919|454364797|FG000|Overall Study|Other-Unspecified|1|||
126293871|NCT01894919|454364798|FG001|Overall Study|Other-Unspecified|0|||
126293872|NCT01894919|454364799|FG002|Overall Study|Other-Unspecified|0|||
126293873|NCT01894919|454364800|FG003|Overall Study|Other-Unspecified|0|||
126293874|NCT01894919|454364801|FG004|Overall Study|Other-Unspecified|0|||
126293875|NCT01894919|454364802|FG005|Overall Study|Other-Unspecified|0|||
126293876|NCT01894919|454364803|FG006|Overall Study|Other-Unspecified|0|||
126293877|NCT01894919|454364804|FG007|Overall Study|Other-Unspecified|0|||
126293878|NCT01894919|454364805|FG008|Overall Study|Other-Unspecified|0|||
126293879|NCT01894919|454364806|FG009|Overall Study|Other-Unspecified|0|||
126293880|NCT01894919|454364807|FG010|Overall Study|Other-Unspecified|0|||
126293881|NCT01894919|454364808|FG011|Overall Study|Other-Unspecified|0|||
126293882|NCT01894919|454364809|FG012|Overall Study|Other-Unspecified|0|||
126293883|NCT01894919|454364797|FG000|Overall Study|Lost to Follow-up|0|||
126293884|NCT01894919|454364798|FG001|Overall Study|Lost to Follow-up|0|||
126293885|NCT01894919|454364799|FG002|Overall Study|Lost to Follow-up|0|||
126293886|NCT01894919|454364800|FG003|Overall Study|Lost to Follow-up|0|||
126293887|NCT01894919|454364801|FG004|Overall Study|Lost to Follow-up|2|||
126293888|NCT01894919|454364802|FG005|Overall Study|Lost to Follow-up|0|||
126293889|NCT01894919|454364803|FG006|Overall Study|Lost to Follow-up|0|||
125883348|NCT00068692|452871470|FG004|Step 1: Registration|Complicating disease|0|||
125883349|NCT00068692|452871471|FG005|Step 1: Registration|Complicating disease|0|||
125883350|NCT00068692|452871472|FG006|Step 1: Registration|Complicating disease|0|||
125883351|NCT00068692|452871473|FG007|Step 1: Registration|Complicating disease|0|||
125883352|NCT00068692|452871466|FG000|Step 1: Registration|Protocol Violation|1|||
125883353|NCT00068692|452871467|FG001|Step 1: Registration|Protocol Violation|0|||
126293890|NCT01894919|454364804|FG007|Overall Study|Lost to Follow-up|0|||
126293891|NCT01894919|454364805|FG008|Overall Study|Lost to Follow-up|0|||
126293892|NCT01894919|454364806|FG009|Overall Study|Lost to Follow-up|0|||
126293893|NCT01894919|454364807|FG010|Overall Study|Lost to Follow-up|0|||
126293894|NCT01894919|454364808|FG011|Overall Study|Lost to Follow-up|0|||
126293895|NCT01894919|454364809|FG012|Overall Study|Lost to Follow-up|0|||
126293896|NCT03711188|454364812|FG000|Overall Study|Disease progression|11|||
126293897|NCT03711188|454364812|FG000|Overall Study|Adverse Event|1|||
125883354|NCT00068692|452871468|FG002|Step 1: Registration|Protocol Violation|0|||
125883355|NCT00068692|452871469|FG003|Step 1: Registration|Protocol Violation|0|||
125883356|NCT00068692|452871470|FG004|Step 1: Registration|Protocol Violation|0|||
126293898|NCT01433471|454364815|FG000|Overall Study|Withdrawal by Subject|0|||
126293899|NCT01433471|454364816|FG001|Overall Study|Withdrawal by Subject|1|||
126293900|NCT03238651|454364817|FG000|Overall Study|Other|0|||
126293901|NCT03238651|454364818|FG001|Overall Study|Other|0|||
126293902|NCT03238651|454364819|FG002|Overall Study|Other|0|||
126293903|NCT03238651|454364820|FG003|Overall Study|Other|0|||
126293904|NCT03238651|454364821|FG004|Overall Study|Other|1|||
126293905|NCT03238651|454364817|FG000|Overall Study|Progressive Disease|2|||
126293906|NCT03238651|454364818|FG001|Overall Study|Progressive Disease|2|||
126293907|NCT03238651|454364819|FG002|Overall Study|Progressive Disease|2|||
126293908|NCT03238651|454364820|FG003|Overall Study|Progressive Disease|2|||
126293909|NCT03238651|454364821|FG004|Overall Study|Progressive Disease|0|||
126293910|NCT03238651|454364817|FG000|Overall Study|Withdrawal by Subject|0|||
126293911|NCT03238651|454364818|FG001|Overall Study|Withdrawal by Subject|1|||
126293912|NCT03238651|454364819|FG002|Overall Study|Withdrawal by Subject|0|||
126293913|NCT03238651|454364820|FG003|Overall Study|Withdrawal by Subject|1|||
126293914|NCT03238651|454364821|FG004|Overall Study|Withdrawal by Subject|0|||
126293915|NCT03238651|454364817|FG000|Overall Study|Adverse Event|1|||
126293916|NCT03238651|454364818|FG001|Overall Study|Adverse Event|3|||
126293917|NCT03238651|454364819|FG002|Overall Study|Adverse Event|2|||
126293918|NCT03238651|454364820|FG003|Overall Study|Adverse Event|0|||
126293919|NCT03238651|454364821|FG004|Overall Study|Adverse Event|0|||
126293920|NCT03875508|454364822|FG000|Overall Study|Adverse Event|1|||
126293921|NCT03875508|454364822|FG000|Overall Study|Lost to Follow-up|8|||
126293922|NCT03875508|454364822|FG000|Overall Study|Lack of Efficacy|1|||
126293923|NCT03875508|454364822|FG000|Overall Study|Other, not specified|2|||
126293924|NCT03164551|454364826|FG000|Overall Study|Imaging discontinued prior completion|8|||
126293925|NCT03164551|454364827|FG001|Overall Study|Imaging discontinued prior completion|0|||
126293926|NCT03164551|454364826|FG000|Overall Study|Participant was non-compliant|1|||
126293927|NCT03164551|454364827|FG001|Overall Study|Participant was non-compliant|0|||
126293928|NCT03164551|454364826|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
126293929|NCT03164551|454364827|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
126293930|NCT03164551|454364826|FG000|Overall Study|Other|8|||
126293931|NCT03164551|454364827|FG001|Overall Study|Other|2|||
126293932|NCT01149863|454364836|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
126293933|NCT04052620|454364837|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
126293934|NCT04052620|454364838|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
126293935|NCT04052620|454364837|FG000|Overall Study|Withdrawal by Subject|1|||
126293936|NCT04052620|454364838|FG001|Overall Study|Withdrawal by Subject|0|||
126293937|NCT04052620|454364837|FG000|Overall Study|Lost to Follow-up|1|||
126293938|NCT04052620|454364838|FG001|Overall Study|Lost to Follow-up|1|||
126293939|NCT04052620|454364837|FG000|Overall Study|Adverse Event|1|||
126293940|NCT04052620|454364838|FG001|Overall Study|Adverse Event|0|||
126293941|NCT04052620|454364837|FG000|Overall Study|Subject did not meet study Criteria|0|||
126293942|NCT04052620|454364838|FG001|Overall Study|Subject did not meet study Criteria|1|||
126293943|NCT04052620|454364837|FG000|Overall Study|Screened failure, randomized by mistake|0|||
126293944|NCT04052620|454364838|FG001|Overall Study|Screened failure, randomized by mistake|1|||
126293945|NCT04052620|454364837|FG000|Overall Study|Personal reasons|2|||
126293946|NCT04052620|454364838|FG001|Overall Study|Personal reasons|4|||
126293947|NCT04052620|454364837|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
126293948|NCT04052620|454364838|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
126293949|NCT01406574|454364839|FG000|Overall Study|Adverse Event|0|||
126293950|NCT01406574|454364840|FG001|Overall Study|Adverse Event|0|||
126293951|NCT01406574|454364841|FG002|Overall Study|Adverse Event|1|||
126293952|NCT01406574|454364842|FG003|Overall Study|Adverse Event|3|||
126293953|NCT01406574|454364839|FG000|Overall Study|Physician Decision|0|||
126293954|NCT01406574|454364840|FG001|Overall Study|Physician Decision|0|||
126293955|NCT01406574|454364841|FG002|Overall Study|Physician Decision|0|||
126293956|NCT01406574|454364842|FG003|Overall Study|Physician Decision|1|||
126293957|NCT01406574|454364839|FG000|Overall Study|Withdrawal by Subject|0|||
126293958|NCT01406574|454364840|FG001|Overall Study|Withdrawal by Subject|1|||
126293959|NCT01406574|454364841|FG002|Overall Study|Withdrawal by Subject|0|||
126293960|NCT01406574|454364842|FG003|Overall Study|Withdrawal by Subject|0|||
126293961|NCT01406574|454364839|FG000|Overall Study|Definite progression of primary disease|1|||
126293962|NCT01406574|454364840|FG001|Overall Study|Definite progression of primary disease|0|||
126293963|NCT01406574|454364841|FG002|Overall Study|Definite progression of primary disease|0|||
126293964|NCT01406574|454364842|FG003|Overall Study|Definite progression of primary disease|0|||
126293965|NCT03552380|454364843|FG000|Study Treatment|Disease Progression|3|||
126293966|NCT03552380|454364844|FG001|Study Treatment|Disease Progression|4|||
126293967|NCT03552380|454364843|FG000|Study Treatment|Adverse Event|2|||
126293968|NCT03552380|454364844|FG001|Study Treatment|Adverse Event|2|||
126293969|NCT03552380|454364843|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
126293970|NCT03552380|454364844|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
126293971|NCT03552380|454364843|FG000|Follow up|Death|3|||
126293972|NCT03552380|454364844|FG001|Follow up|Death|4|||
126293973|NCT03552380|454364843|FG000|Follow up|Site IRB terminated|0|||
126293974|NCT03552380|454364844|FG001|Follow up|Site IRB terminated|1|||
126293975|NCT02431364|454364845|FG000|Overall Study|Adverse Event|0|||
126293976|NCT02431364|454364846|FG001|Overall Study|Adverse Event|1|||
126293977|NCT02431364|454364847|FG002|Overall Study|Adverse Event|0|||
126293978|NCT02431364|454364848|FG003|Overall Study|Adverse Event|0|||
126293979|NCT02431364|454364849|FG004|Overall Study|Adverse Event|0|||
126293980|NCT02431364|454364845|FG000|Overall Study|Randomized but never treated|0|||
126293981|NCT02431364|454364846|FG001|Overall Study|Randomized but never treated|0|||
126293982|NCT02431364|454364847|FG002|Overall Study|Randomized but never treated|0|||
126293983|NCT02431364|454364848|FG003|Overall Study|Randomized but never treated|1|||
126293984|NCT02431364|454364849|FG004|Overall Study|Randomized but never treated|0|||
126293985|NCT00916383|454364850|FG000|Overall Study|Adverse Event|1|||
126293986|NCT00916383|454364850|FG000|Overall Study|Death|1|||
126293987|NCT00916383|454364850|FG000|Overall Study|Protocol Violation|1|||
126293988|NCT00258960|454364851|FG000|Overall Study|Death|2|||
126293989|NCT00258960|454364851|FG000|Overall Study|Disease Progression|7|||
126293990|NCT00258960|454364851|FG000|Overall Study|Adverse Event|4|||
126293991|NCT00258960|454364851|FG000|Overall Study|Physician Decision|1|||
126293992|NCT00258960|454364851|FG000|Overall Study|Withdrawal by Subject|1|||
126293993|NCT00258960|454364851|FG000|Overall Study|Mistake|2|||
126293994|NCT00473590|454364852|FG000|Overall Study|Adverse Event|3|||
126293995|NCT00473590|454364853|FG001|Overall Study|Adverse Event|3|||
126293996|NCT00473590|454364852|FG000|Overall Study|Death|4|||
126293997|NCT00473590|454364853|FG001|Overall Study|Death|2|||
126293998|NCT00473590|454364852|FG000|Overall Study|Progression not resulting in death|24|||
126293999|NCT00473590|454364853|FG001|Overall Study|Progression not resulting in death|20|||
126294000|NCT00473590|454364852|FG000|Overall Study|Non-protocol-specified therapy|7|||
126294001|NCT00473590|454364853|FG001|Overall Study|Non-protocol-specified therapy|5|||
126366556|NCT00959049|454637005|FG000|Overall Study|Withdrawal by Subject|0|||
126366557|NCT00959049|454637006|FG001|Overall Study|Withdrawal by Subject|2|||
126366558|NCT00959049|454637007|FG002|Overall Study|Withdrawal by Subject|0|||
126366559|NCT00959049|454637008|FG003|Overall Study|Withdrawal by Subject|0|||
126366560|NCT00959049|454637009|FG004|Overall Study|Withdrawal by Subject|0|||
126366561|NCT00959049|454637010|FG005|Overall Study|Withdrawal by Subject|0|||
126366562|NCT00567502|454637011|FG000|Overall Study|Lost to Follow-up|91|||
126366563|NCT00567502|454637012|FG001|Overall Study|Lost to Follow-up|14|||
126366564|NCT00567502|454637013|FG002|Overall Study|Lost to Follow-up|351|||
126366565|NCT00567502|454637014|FG003|Overall Study|Lost to Follow-up|2|||
126366566|NCT00567502|454637011|FG000|Overall Study|Death|65|||
126366567|NCT00567502|454637012|FG001|Overall Study|Death|16|||
126366568|NCT00567502|454637013|FG002|Overall Study|Death|360|||
126366569|NCT00567502|454637014|FG003|Overall Study|Death|5|||
126366570|NCT00567502|454637011|FG000|Overall Study|Other|64|||
126366571|NCT00567502|454637012|FG001|Overall Study|Other|2|||
126366572|NCT00567502|454637013|FG002|Overall Study|Other|134|||
126366573|NCT00567502|454637014|FG003|Overall Study|Other|6|||
126366574|NCT00567502|454637011|FG000|Overall Study|Participant request|12|||
126366575|NCT00567502|454637012|FG001|Overall Study|Participant request|1|||
126366576|NCT00567502|454637013|FG002|Overall Study|Participant request|33|||
126366577|NCT00567502|454637014|FG003|Overall Study|Participant request|1|||
126366578|NCT00567502|454637011|FG000|Overall Study|Sponsor request|9|||
126366579|NCT00567502|454637012|FG001|Overall Study|Sponsor request|0|||
126366580|NCT00567502|454637013|FG002|Overall Study|Sponsor request|30|||
126366581|NCT00567502|454637014|FG003|Overall Study|Sponsor request|1|||
126366582|NCT00567502|454637011|FG000|Overall Study|Never Initiated Treatment|0|||
126366583|NCT00567502|454637012|FG001|Overall Study|Never Initiated Treatment|0|||
126366584|NCT00567502|454637013|FG002|Overall Study|Never Initiated Treatment|0|||
126366585|NCT00567502|454637014|FG003|Overall Study|Never Initiated Treatment|72|||
126366586|NCT00337168|454637015|FG000|Overall Study|Death|5|||
126366587|NCT00337168|454637015|FG000|Overall Study|Not protocol specified|2|||
126366588|NCT00337168|454637015|FG000|Overall Study|Did not start therapy|1|||
126366589|NCT00586157|454637018|FG000|First Intervention|Worsening behavior|1|||
126366590|NCT00586157|454637019|FG001|First Intervention|Worsening behavior|0|||
126366591|NCT00586157|454637018|FG000|Second Intervention|Withdrawal by Subject|1|||
126366592|NCT00586157|454637019|FG001|Second Intervention|Withdrawal by Subject|0|||
126366593|NCT00586157|454637018|FG000|Second Intervention|Worsening behavior|1|||
126366594|NCT00586157|454637019|FG001|Second Intervention|Worsening behavior|0|||
126366595|NCT00586157|454637018|FG000|Second Intervention|Adverse Event|0|||
126366596|NCT00586157|454637019|FG001|Second Intervention|Adverse Event|1|||
126366597|NCT01230060|454637023|FG000|Overall Study|Withdrawal by Subject|1|||
126366598|NCT03663582|454637026|FG000|Overall Study|Physician Decision|1|||
126366599|NCT00480532|454637027|FG000|Overall Study|Withdrawal by Subject|2|||
126366600|NCT00480532|454637028|FG001|Overall Study|Withdrawal by Subject|4|||
126366601|NCT00480532|454637029|FG002|Overall Study|Withdrawal by Subject|3|||
126366602|NCT00480532|454637030|FG003|Overall Study|Withdrawal by Subject|1|||
126100103|NCT00938470|453659831|FG000|Overall Study|Death|3|||
126294002|NCT00473590|454364852|FG000|Overall Study|Physician Decision|2|||
126294003|NCT00473590|454364853|FG001|Overall Study|Physician Decision|4|||
126294004|NCT00473590|454364852|FG000|Overall Study|Withdrawal by Subject|5|||
126366603|NCT00480532|454637027|FG000|Overall Study|Protocol Violation|0|||
126366604|NCT00480532|454637028|FG001|Overall Study|Protocol Violation|0|||
126366605|NCT00480532|454637029|FG002|Overall Study|Protocol Violation|1|||
126366606|NCT00480532|454637030|FG003|Overall Study|Protocol Violation|0|||
126366607|NCT03242434|454637040|FG000|Overall Study|Death|0|||
126366608|NCT03242434|454637041|FG001|Overall Study|Death|2|||
126294005|NCT00473590|454364853|FG001|Overall Study|Withdrawal by Subject|3|||
126366609|NCT01602484|454637042|FG000|Overall Study|Airway issues unrelated to study|0|||
126366610|NCT01602484|454637043|FG001|Overall Study|Airway issues unrelated to study|1|||
126294006|NCT00473590|454364852|FG000|Overall Study|Other|0|||
126294007|NCT00473590|454364853|FG001|Overall Study|Other|1|||
126294008|NCT01112059|454364856|FG000|Overall Study|Withdrawal by Subject|1|||
126294009|NCT01112059|454364857|FG001|Overall Study|Withdrawal by Subject|0|||
126294010|NCT00858273|454364860|FG000|Overall Study|Protocol Violation|3|||
126294011|NCT00858273|454364861|FG001|Overall Study|Protocol Violation|5|||
126294012|NCT04199104|454366543|FG000|Overall Study|Death|148|||
126294013|NCT04199104|454366544|FG001|Overall Study|Death|134|||
126294014|NCT04199104|454366543|FG000|Overall Study|Lost to Follow-up|1|||
126294015|NCT04199104|454366544|FG001|Overall Study|Lost to Follow-up|1|||
126294016|NCT04199104|454366543|FG000|Overall Study|Withdrawal by Subject|4|||
126294017|NCT04199104|454366544|FG001|Overall Study|Withdrawal by Subject|4|||
126294018|NCT04199104|454366543|FG000|Overall Study|Participants Ongoing|103|||
126294019|NCT04199104|454366544|FG001|Overall Study|Participants Ongoing|116|||
126294020|NCT02325973|454366545|FG000|Overall Study|Death|5|||
126294021|NCT02325973|454366545|FG000|Overall Study|Withdrawal by subject or investigator|16|||
126294022|NCT05655546|454366546|FG000|Overall Study|Withdrawal by Subject|2|||
126294023|NCT05655546|454366547|FG001|Overall Study|Withdrawal by Subject|4|||
126294024|NCT01168232|454366548|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
126294025|NCT01168232|454366548|FG000|Overall Study|Ineligible- Wrong cell type|6|||
126294026|NCT01168232|454366548|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
126294027|NCT05012098|454366551|FG000|Overall Study|Disease progression|5|||
126294028|NCT05012098|454366552|FG001|Overall Study|Disease progression|2|||
126294029|NCT05012098|454366551|FG000|Overall Study|Adverse Event|1|||
126294030|NCT05012098|454366552|FG001|Overall Study|Adverse Event|0|||
126294031|NCT05012098|454366551|FG000|Overall Study|Withdrawal by Subject|1|||
126294032|NCT05012098|454366552|FG001|Overall Study|Withdrawal by Subject|0|||
126294033|NCT05012098|454366551|FG000|Overall Study|Discontinuation per protocol|1|||
126294034|NCT05012098|454366552|FG001|Overall Study|Discontinuation per protocol|0|||
126294035|NCT05258773|454366553|FG000|Overall Study|Screen Failure|1|||
126294036|NCT05258773|454366554|FG001|Overall Study|Screen Failure|1|||
126294037|NCT05258773|454366553|FG000|Overall Study|Adverse Event|1|||
126294038|NCT05258773|454366554|FG001|Overall Study|Adverse Event|0|||
126294039|NCT05258773|454366553|FG000|Overall Study|Withdrawal by Subject|0|||
126294040|NCT05258773|454366554|FG001|Overall Study|Withdrawal by Subject|1|||
126294041|NCT03018288|454366557|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
126294042|NCT03018288|454366558|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
126294043|NCT03018288|454366559|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
126294044|NCT03018288|454366560|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
126294045|NCT03018288|454366557|FG000|Overall Study|Participant withdrew consent.|0|||
126294046|NCT03018288|454366558|FG001|Overall Study|Participant withdrew consent.|0|||
126294047|NCT03018288|454366559|FG002|Overall Study|Participant withdrew consent.|1|||
126294048|NCT03018288|454366560|FG003|Overall Study|Participant withdrew consent.|0|||
126294049|NCT03018288|454366557|FG000|Overall Study|Switched to alternative treatment.|0|||
126294050|NCT03018288|454366558|FG001|Overall Study|Switched to alternative treatment.|0|||
126294051|NCT03018288|454366559|FG002|Overall Study|Switched to alternative treatment.|1|||
126294052|NCT03018288|454366560|FG003|Overall Study|Switched to alternative treatment.|0|||
126294053|NCT03018288|454366557|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
126294054|NCT03018288|454366558|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
126294055|NCT03018288|454366559|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
126294056|NCT03018288|454366560|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
126294057|NCT03018288|454366557|FG000|Overall Study|Screen failures|0|||
126294058|NCT03018288|454366558|FG001|Overall Study|Screen failures|0|||
126294059|NCT03018288|454366559|FG002|Overall Study|Screen failures|0|||
126294060|NCT03018288|454366560|FG003|Overall Study|Screen failures|51|||
126294061|NCT03018288|454366557|FG000|Overall Study|Chose treatment outside of UNC|0|||
126294062|NCT03018288|454366558|FG001|Overall Study|Chose treatment outside of UNC|0|||
126294063|NCT03018288|454366559|FG002|Overall Study|Chose treatment outside of UNC|0|||
126294064|NCT03018288|454366560|FG003|Overall Study|Chose treatment outside of UNC|1|||
126294065|NCT03018288|454366557|FG000|Overall Study|Unable to comply with protocol requirements|1|||
126294066|NCT03018288|454366558|FG001|Overall Study|Unable to comply with protocol requirements|1|||
126294067|NCT03018288|454366559|FG002|Overall Study|Unable to comply with protocol requirements|0|||
126294068|NCT03018288|454366560|FG003|Overall Study|Unable to comply with protocol requirements|1|||
126294069|NCT03018288|454366557|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
126294070|NCT03018288|454366558|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
126294071|NCT03018288|454366559|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
126294072|NCT03018288|454366560|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
126100104|NCT00938470|453659832|FG001|Overall Study|Death|2|||
126100105|NCT00938470|453659831|FG000|Overall Study|Other Reason|0|||
126100106|NCT00938470|453659832|FG001|Overall Study|Other Reason|1|||
126100107|NCT04279392|453659833|FG000|Overall Study|Physician Decision|1|||
125883357|NCT00068692|452871471|FG005|Step 1: Registration|Protocol Violation|0|||
125883358|NCT00068692|452871472|FG006|Step 1: Registration|Protocol Violation|0|||
125883359|NCT00068692|452871473|FG007|Step 1: Registration|Protocol Violation|0|||
125883360|NCT00068692|452871466|FG000|Step 1: Registration|Not eligible|6|||
125883361|NCT00068692|452871467|FG001|Step 1: Registration|Not eligible|0|||
125883362|NCT00068692|452871468|FG002|Step 1: Registration|Not eligible|0|||
125883363|NCT00068692|452871469|FG003|Step 1: Registration|Not eligible|0|||
125883364|NCT00068692|452871470|FG004|Step 1: Registration|Not eligible|0|||
126100108|NCT04279392|453659834|FG001|Overall Study|Physician Decision|0|||
126100109|NCT01171807|453659835|FG000|Overall Study|Treatment failure|2|||
126100110|NCT01171807|453659836|FG001|Overall Study|Treatment failure|4|||
126100111|NCT01171807|453659835|FG000|Overall Study|Non compliance|1|||
126100112|NCT01171807|453659836|FG001|Overall Study|Non compliance|0|||
126294073|NCT03018288|454366557|FG000|Overall Study|Physician Decision|0|||
126294074|NCT03018288|454366558|FG001|Overall Study|Physician Decision|0|||
126294075|NCT03018288|454366559|FG002|Overall Study|Physician Decision|0|||
126294076|NCT03018288|454366560|FG003|Overall Study|Physician Decision|1|||
126294077|NCT01490086|454366562|FG000|Overall Study|Consent withdrawn|4|||
126294078|NCT01490086|454366563|FG001|Overall Study|Consent withdrawn|4|||
126294079|NCT01490086|454366564|FG002|Overall Study|Consent withdrawn|3|||
126294080|NCT01490086|454366565|FG003|Overall Study|Consent withdrawn|0|||
126294081|NCT01490086|454366566|FG004|Overall Study|Consent withdrawn|1|||
126294082|NCT01490086|454366562|FG000|Overall Study|Non-compliance|0|||
126294083|NCT01490086|454366563|FG001|Overall Study|Non-compliance|1|||
126294084|NCT01490086|454366564|FG002|Overall Study|Non-compliance|0|||
126100113|NCT01171807|453659835|FG000|Overall Study|Lost to Follow-up|3|||
126366611|NCT03729609|454637044|FG000|Overall Study|Protocol Violation|1|||
126366612|NCT00605189|454637051|FG000|Overall Study|Adverse Event|1|||
126366613|NCT00605189|454637052|FG001|Overall Study|Adverse Event|0|||
126366614|NCT00605189|454637053|FG002|Overall Study|Adverse Event|0|||
126366615|NCT00605189|454637051|FG000|Overall Study|Other|2|||
126366616|NCT00605189|454637052|FG001|Overall Study|Other|2|||
126366617|NCT00605189|454637053|FG002|Overall Study|Other|0|||
126366618|NCT02697448|454637054|FG000|Overall Study|Protocol Violation|2|||
126366619|NCT02697448|454637055|FG001|Overall Study|Protocol Violation|4|||
126366620|NCT02697448|454637054|FG000|Overall Study|Clinical concerns during ablation|1|||
126366621|NCT02697448|454637055|FG001|Overall Study|Clinical concerns during ablation|1|||
126366622|NCT02697448|454637054|FG000|Overall Study|No data collected|2|||
126366623|NCT02697448|454637055|FG001|Overall Study|No data collected|0|||
126366624|NCT05473715|454637056|FG000|Overall Study|Trial terminate|2|||
126366625|NCT05473715|454637057|FG001|Overall Study|Trial terminate|1|||
126366626|NCT02919618|454637061|FG000|Overall Study|Death|1|||
126366627|NCT02592863|454637062|FG000|Overall Study|Withdrawal by Subject|2|||
126366628|NCT02592863|454637063|FG001|Overall Study|Withdrawal by Subject|2|||
126366629|NCT02592863|454637062|FG000|Overall Study|Lost to Follow-up|1|||
126366630|NCT02592863|454637063|FG001|Overall Study|Lost to Follow-up|1|||
126366631|NCT02743221|454637064|FG000|Overall Study|Progressive disease|29|||
126366632|NCT02743221|454637065|FG001|Overall Study|Progressive disease|38|||
126366633|NCT02743221|454637064|FG000|Overall Study|Adverse Event|17|||
126366634|NCT02743221|454637065|FG001|Overall Study|Adverse Event|14|||
126366635|NCT02743221|454637064|FG000|Overall Study|non medical reason|8|||
126366636|NCT02743221|454637065|FG001|Overall Study|non medical reason|2|||
126366637|NCT02743221|454637064|FG000|Overall Study|Physician Decision|2|||
126366638|NCT02743221|454637065|FG001|Overall Study|Physician Decision|5|||
126366639|NCT02743221|454637064|FG000|Overall Study|Patient not eligible, not treated|0|||
126366640|NCT02743221|454637065|FG001|Overall Study|Patient not eligible, not treated|1|||
126366641|NCT04770285|454637067|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
126366642|NCT04770285|454637068|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
126366643|NCT04770285|454637067|FG000|Overall Study|Lack of Efficacy|0|||
125883365|NCT00068692|452871471|FG005|Step 1: Registration|Not eligible|0|||
125883366|NCT00068692|452871472|FG006|Step 1: Registration|Not eligible|0|||
126100114|NCT01171807|453659836|FG001|Overall Study|Lost to Follow-up|0|||
126294085|NCT01490086|454366565|FG003|Overall Study|Non-compliance|0|||
126294086|NCT01490086|454366566|FG004|Overall Study|Non-compliance|0|||
126294087|NCT01490086|454366562|FG000|Overall Study|Abnormal laboratory findings|1|||
126294088|NCT01490086|454366563|FG001|Overall Study|Abnormal laboratory findings|0|||
126294089|NCT01490086|454366564|FG002|Overall Study|Abnormal laboratory findings|0|||
126366644|NCT04770285|454637068|FG001|Overall Study|Lack of Efficacy|1|||
126366645|NCT04770285|454637067|FG000|Overall Study|Lost to Follow-up|11|||
126366646|NCT04770285|454637068|FG001|Overall Study|Lost to Follow-up|8|||
126366647|NCT04770285|454637067|FG000|Overall Study|Protocol Deviation|6|||
126366648|NCT04770285|454637068|FG001|Overall Study|Protocol Deviation|6|||
126366649|NCT04770285|454637067|FG000|Overall Study|Technical Problem|0|||
126366650|NCT04770285|454637068|FG001|Overall Study|Technical Problem|1|||
126366651|NCT04770285|454637067|FG000|Overall Study|Withdrawal by Subject|9|||
126366652|NCT04770285|454637068|FG001|Overall Study|Withdrawal by Subject|8|||
125883367|NCT00068692|452871473|FG007|Step 1: Registration|Not eligible|0|||
125883368|NCT00068692|452871466|FG000|Step 1: Registration|Other|2|||
125883369|NCT00068692|452871467|FG001|Step 1: Registration|Other|0|||
126294090|NCT01490086|454366565|FG003|Overall Study|Abnormal laboratory findings|0|||
126294091|NCT01490086|454366566|FG004|Overall Study|Abnormal laboratory findings|0|||
126294092|NCT01490086|454366562|FG000|Overall Study|Lost to Follow-up|0|||
126294093|NCT01490086|454366563|FG001|Overall Study|Lost to Follow-up|0|||
126294094|NCT01490086|454366564|FG002|Overall Study|Lost to Follow-up|0|||
126294095|NCT01490086|454366565|FG003|Overall Study|Lost to Follow-up|0|||
126294096|NCT01490086|454366566|FG004|Overall Study|Lost to Follow-up|1|||
126294097|NCT01490086|454366562|FG000|Overall Study|Physician Decision|3|||
126294098|NCT01490086|454366563|FG001|Overall Study|Physician Decision|4|||
126294099|NCT01490086|454366564|FG002|Overall Study|Physician Decision|2|||
126294100|NCT01490086|454366565|FG003|Overall Study|Physician Decision|3|||
126294101|NCT01490086|454366566|FG004|Overall Study|Physician Decision|1|||
126294102|NCT01490086|454366562|FG000|Overall Study|Adverse Event|0|||
126294103|NCT01490086|454366563|FG001|Overall Study|Adverse Event|0|||
126294104|NCT01490086|454366564|FG002|Overall Study|Adverse Event|1|||
126366653|NCT04770285|454637067|FG000|Overall Study|Reason Not Specified|0|||
126366654|NCT04770285|454637068|FG001|Overall Study|Reason Not Specified|1|||
126366655|NCT03411044|454637069|FG000|Overall Study|Death|30|||
126366656|NCT03411044|454637069|FG000|Overall Study|Withdrawal by Subject|48|||
126366657|NCT03411044|454637069|FG000|Overall Study|Lost to Follow-up|78|||
126366658|NCT03411044|454637069|FG000|Overall Study|Adverse Event|30|||
126366659|NCT03411044|454637069|FG000|Overall Study|Missing status|4|||
126366660|NCT01969409|454637070|FG000|Overall Study|Death|2|||
126366661|NCT01969409|454637071|FG001|Overall Study|Death|2|||
126366662|NCT01969409|454637070|FG000|Overall Study|Transplant|1|||
126366663|NCT01969409|454637071|FG001|Overall Study|Transplant|1|||
126366664|NCT01969409|454637070|FG000|Overall Study|Withdrawal by Subject|0|||
126366665|NCT01969409|454637071|FG001|Overall Study|Withdrawal by Subject|1|||
126366666|NCT03078868|454637074|FG000|Overall Study|Physician Decision|3|||
126366667|NCT01435356|454637075|FG000|Overall Study|Adverse Event|2|||
126366668|NCT01435356|454637076|FG001|Overall Study|Adverse Event|0|||
126366669|NCT01435356|454637075|FG000|Overall Study|Disease progression/recurrence|17|||
126366670|NCT01435356|454637076|FG001|Overall Study|Disease progression/recurrence|10|||
126366671|NCT01435356|454637075|FG000|Overall Study|Protocol Violation|0|||
126366672|NCT01435356|454637076|FG001|Overall Study|Protocol Violation|1|||
126366673|NCT01435356|454637075|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
126366674|NCT01435356|454637076|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
126366675|NCT01435356|454637075|FG000|Overall Study|Withdrawal by Subject|1|||
126366676|NCT01435356|454637076|FG001|Overall Study|Withdrawal by Subject|1|||
126366677|NCT01435356|454637075|FG000|Overall Study|Facial palsy|1|||
126366678|NCT01435356|454637076|FG001|Overall Study|Facial palsy|0|||
126366679|NCT01435356|454637075|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
126366680|NCT01435356|454637076|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
126366681|NCT01435356|454637075|FG000|Overall Study|Physician Decision|1|||
126366682|NCT01435356|454637076|FG001|Overall Study|Physician Decision|0|||
126366683|NCT01435356|454637075|FG000|Overall Study|Patient decision|3|||
126366684|NCT01435356|454637076|FG001|Overall Study|Patient decision|0|||
126366685|NCT01435356|454637075|FG000|Overall Study|Patient moved to another city|1|||
126366686|NCT01435356|454637076|FG001|Overall Study|Patient moved to another city|1|||
126366687|NCT00437073|454637077|FG000|Overall Study|Sponsor Terminated Study|1|||
126366688|NCT00437073|454637078|FG001|Overall Study|Sponsor Terminated Study|0|||
126366689|NCT00437073|454637077|FG000|Overall Study|Physician Decision|0|||
126366690|NCT00437073|454637078|FG001|Overall Study|Physician Decision|1|||
126366691|NCT04221438|454637081|FG000|Overall Study|Adverse Event|1|||
126366692|NCT04221438|454637081|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
126366693|NCT03673176|454639278|FG000|Overall Study|Death prior to intervention|1|||
126366694|NCT03673176|454639278|FG000|Overall Study|Death following intervention|3|||
126366695|NCT03673176|454639278|FG000|Overall Study|Withdrawal by Subject|1|||
126366696|NCT03283241|454639279|FG000|Overall Study|Adverse Event|4|||
126366697|NCT03283241|454639280|FG001|Overall Study|Adverse Event|1|||
126366698|NCT03283241|454639279|FG000|Overall Study|Withdrawal by Subject|0|||
126366699|NCT03283241|454639280|FG001|Overall Study|Withdrawal by Subject|1|||
126366700|NCT03283241|454639279|FG000|Overall Study|Subject relocated to Finland|0|||
126366701|NCT03283241|454639280|FG001|Overall Study|Subject relocated to Finland|1|||
126366702|NCT00666263|454639281|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
126366703|NCT00666263|454639282|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
126294105|NCT01490086|454366565|FG003|Overall Study|Adverse Event|2|||
126294106|NCT01490086|454366566|FG004|Overall Study|Adverse Event|0|||
126366704|NCT00666263|454639281|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
126366705|NCT00666263|454639282|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
126366706|NCT00666263|454639281|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
126366707|NCT00666263|454639282|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
126366708|NCT01225952|454639284|FG000|Overall Study|Lost to Follow-up|1|||
126366709|NCT01225952|454639285|FG001|Overall Study|Lost to Follow-up|0|||
126366710|NCT01225952|454639286|FG002|Overall Study|Lost to Follow-up|0|||
126294107|NCT01490086|454366562|FG000|Overall Study|Lack of Efficacy|0|||
125883370|NCT00068692|452871468|FG002|Step 1: Registration|Other|0|||
125883371|NCT00068692|452871469|FG003|Step 1: Registration|Other|0|||
125883372|NCT00068692|452871470|FG004|Step 1: Registration|Other|0|||
125883373|NCT00068692|452871471|FG005|Step 1: Registration|Other|0|||
125883374|NCT00068692|452871472|FG006|Step 1: Registration|Other|0|||
125883375|NCT00068692|452871473|FG007|Step 1: Registration|Other|0|||
125883376|NCT00068692|452871466|FG000|Step 1: Registration|Not start protocol therapy|3|||
125883377|NCT00068692|452871467|FG001|Step 1: Registration|Not start protocol therapy|0|||
125883378|NCT00068692|452871468|FG002|Step 1: Registration|Not start protocol therapy|0|||
125883379|NCT00068692|452871469|FG003|Step 1: Registration|Not start protocol therapy|0|||
125883380|NCT00068692|452871470|FG004|Step 1: Registration|Not start protocol therapy|0|||
125883381|NCT00068692|452871471|FG005|Step 1: Registration|Not start protocol therapy|0|||
125883382|NCT00068692|452871472|FG006|Step 1: Registration|Not start protocol therapy|0|||
125883383|NCT00068692|452871473|FG007|Step 1: Registration|Not start protocol therapy|0|||
125883384|NCT00068692|452871466|FG000|Step 1: Registration|Registered but not randomized|0|||
125883385|NCT00068692|452871467|FG001|Step 1: Registration|Registered but not randomized|1|||
125883386|NCT00068692|452871468|FG002|Step 1: Registration|Registered but not randomized|0|||
125883387|NCT00068692|452871469|FG003|Step 1: Registration|Registered but not randomized|0|||
125883388|NCT00068692|452871470|FG004|Step 1: Registration|Registered but not randomized|0|||
125883389|NCT00068692|452871471|FG005|Step 1: Registration|Registered but not randomized|0|||
125883390|NCT00068692|452871472|FG006|Step 1: Registration|Registered but not randomized|0|||
125883391|NCT00068692|452871473|FG007|Step 1: Registration|Registered but not randomized|0|||
125883392|NCT00068692|452871466|FG000|Step 2: Randomization|Disesae progression/replase|0|||
125883393|NCT00068692|452871467|FG001|Step 2: Randomization|Disesae progression/replase|0|||
125883394|NCT00068692|452871468|FG002|Step 2: Randomization|Disesae progression/replase|1|||
125883395|NCT00068692|452871469|FG003|Step 2: Randomization|Disesae progression/replase|1|||
125883396|NCT00068692|452871470|FG004|Step 2: Randomization|Disesae progression/replase|0|||
125883397|NCT00068692|452871471|FG005|Step 2: Randomization|Disesae progression/replase|0|||
125883398|NCT00068692|452871472|FG006|Step 2: Randomization|Disesae progression/replase|0|||
125883399|NCT00068692|452871473|FG007|Step 2: Randomization|Disesae progression/replase|0|||
125883400|NCT00068692|452871466|FG000|Step 2: Randomization|Adverse Event|0|||
125883401|NCT00068692|452871467|FG001|Step 2: Randomization|Adverse Event|0|||
125883402|NCT00068692|452871468|FG002|Step 2: Randomization|Adverse Event|4|||
125883403|NCT00068692|452871469|FG003|Step 2: Randomization|Adverse Event|2|||
125883404|NCT00068692|452871470|FG004|Step 2: Randomization|Adverse Event|2|||
125883405|NCT00068692|452871471|FG005|Step 2: Randomization|Adverse Event|3|||
126294108|NCT01490086|454366563|FG001|Overall Study|Lack of Efficacy|3|||
126042372|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126042373|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126042374|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126042375|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126042376|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126042377|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126042378|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126294109|NCT01490086|454366564|FG002|Overall Study|Lack of Efficacy|1|||
126294110|NCT01490086|454366565|FG003|Overall Study|Lack of Efficacy|0|||
126294111|NCT01490086|454366566|FG004|Overall Study|Lack of Efficacy|8|||
126294112|NCT01490086|454366562|FG000|Overall Study|Worsening of symptoms|0|||
126294113|NCT01490086|454366563|FG001|Overall Study|Worsening of symptoms|1|||
126294114|NCT01490086|454366564|FG002|Overall Study|Worsening of symptoms|0|||
126294115|NCT01490086|454366565|FG003|Overall Study|Worsening of symptoms|1|||
126294116|NCT01490086|454366566|FG004|Overall Study|Worsening of symptoms|0|||
126294117|NCT01490086|454366562|FG000|Overall Study|Subject uncontrollable and abusive|0|||
126294118|NCT01490086|454366563|FG001|Overall Study|Subject uncontrollable and abusive|1|||
126294119|NCT01490086|454366564|FG002|Overall Study|Subject uncontrollable and abusive|0|||
126294120|NCT01490086|454366565|FG003|Overall Study|Subject uncontrollable and abusive|0|||
126294121|NCT01490086|454366566|FG004|Overall Study|Subject uncontrollable and abusive|0|||
126294122|NCT01490086|454366562|FG000|Overall Study|Subject left hospital|0|||
126294123|NCT01490086|454366563|FG001|Overall Study|Subject left hospital|1|||
126294124|NCT01490086|454366564|FG002|Overall Study|Subject left hospital|0|||
126294125|NCT01490086|454366565|FG003|Overall Study|Subject left hospital|1|||
126294126|NCT01490086|454366566|FG004|Overall Study|Subject left hospital|0|||
126294127|NCT06025721|454366567|FG000|Overall Study|Physician Decision|1|||
126294128|NCT06025721|454366567|FG000|Overall Study|Protocol Violation|1|||
126294129|NCT06025721|454366567|FG000|Overall Study|Incarceration|1|||
126294130|NCT04510090|454366568|FG000|FE-HS|Withdrawal by Subject|0|||
126294131|NCT04510090|454366569|FG001|FE-HS|Withdrawal by Subject|0|||
126294132|NCT04510090|454366570|FG002|FE-HS|Withdrawal by Subject|0|||
126294133|NCT04510090|454366571|FG003|FE-HS|Withdrawal by Subject|0|||
126294134|NCT04510090|454366572|FG004|FE-HS|Withdrawal by Subject|1|||
126294135|NCT04510090|454366573|FG005|FE-HS|Withdrawal by Subject|0|||
126294136|NCT04510090|454366574|FG006|FE-HS|Withdrawal by Subject|0|||
126294137|NCT04510090|454366575|FG007|FE-HS|Withdrawal by Subject|0|||
126294138|NCT05825404|454366576|FG000|First Intervention (Weeks 2-5)|Death|0|||
126294139|NCT05825404|454366577|FG001|First Intervention (Weeks 2-5)|Death|1|||
125883406|NCT00068692|452871472|FG006|Step 2: Randomization|Adverse Event|4|||
125883407|NCT00068692|452871473|FG007|Step 2: Randomization|Adverse Event|4|||
126042379|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126042380|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
126042381|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
126042382|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
126042383|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
126042384|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126042385|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126042386|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126042387|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042388|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042389|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042390|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042391|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042392|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
126042393|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042394|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042395|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042396|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042397|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042398|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126042399|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042400|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042401|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126100115|NCT04101318|453659841|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
126366711|NCT01225952|454639284|FG000|Overall Study|Study Eye Explanted|0|||
126366712|NCT01225952|454639285|FG001|Overall Study|Study Eye Explanted|0|||
126366713|NCT01225952|454639286|FG002|Overall Study|Study Eye Explanted|1|||
126366714|NCT01225952|454639284|FG000|Overall Study|Withdrawal by Subject|4|||
126366715|NCT01225952|454639285|FG001|Overall Study|Withdrawal by Subject|4|||
126366716|NCT01225952|454639286|FG002|Overall Study|Withdrawal by Subject|5|||
126366717|NCT01225952|454639284|FG000|Overall Study|Surgical complications|1|||
126366718|NCT01225952|454639285|FG001|Overall Study|Surgical complications|0|||
126366719|NCT01225952|454639286|FG002|Overall Study|Surgical complications|0|||
126366720|NCT02378480|454639287|FG000|Overall Study|Physician Decision|1|||
126366721|NCT02378480|454639288|FG001|Overall Study|Physician Decision|1|||
126366722|NCT02378480|454639287|FG000|Overall Study|Death|1|||
126366723|NCT02378480|454639288|FG001|Overall Study|Death|2|||
126366724|NCT02378480|454639287|FG000|Overall Study|Randomized, but Not Treated|6|||
126366725|NCT02378480|454639288|FG001|Overall Study|Randomized, but Not Treated|4|||
126366726|NCT02378480|454639287|FG000|Overall Study|Adverse Event|0|||
126366727|NCT02378480|454639288|FG001|Overall Study|Adverse Event|1|||
126366728|NCT02378480|454639287|FG000|Overall Study|Missed EOT/PTE Visit|1|||
126366729|NCT02378480|454639288|FG001|Overall Study|Missed EOT/PTE Visit|2|||
126366730|NCT02378480|454639287|FG000|Overall Study|Withdrawal by Subject|9|||
126366731|NCT02378480|454639288|FG001|Overall Study|Withdrawal by Subject|4|||
126366732|NCT02378480|454639287|FG000|Overall Study|Lost to Follow-up|10|||
126366733|NCT02378480|454639288|FG001|Overall Study|Lost to Follow-up|18|||
126366734|NCT01217892|454639289|FG000|Overall Study|Adverse Event|1|||
126366735|NCT01217892|454639290|FG001|Overall Study|Adverse Event|1|||
126366736|NCT01217892|454639291|FG002|Overall Study|Adverse Event|1|||
126366737|NCT01217892|454639292|FG003|Overall Study|Adverse Event|0|||
126366738|NCT01217892|454639289|FG000|Overall Study|Withdrawal by Subject|0|||
126366739|NCT01217892|454639290|FG001|Overall Study|Withdrawal by Subject|2|||
126366740|NCT01217892|454639291|FG002|Overall Study|Withdrawal by Subject|1|||
126366741|NCT01217892|454639292|FG003|Overall Study|Withdrawal by Subject|0|||
126366742|NCT01217892|454639289|FG000|Overall Study|Lab value|1|||
126366743|NCT01217892|454639290|FG001|Overall Study|Lab value|0|||
126366744|NCT01217892|454639291|FG002|Overall Study|Lab value|1|||
126366745|NCT01217892|454639292|FG003|Overall Study|Lab value|0|||
126366746|NCT01217892|454639289|FG000|Overall Study|Subject no longer meets study criteria|5|||
126366747|NCT01217892|454639290|FG001|Overall Study|Subject no longer meets study criteria|2|||
126366748|NCT01217892|454639291|FG002|Overall Study|Subject no longer meets study criteria|4|||
126366749|NCT01217892|454639292|FG003|Overall Study|Subject no longer meets study criteria|8|||
126366750|NCT01217892|454639289|FG000|Overall Study|Incorrect enrollment|0|||
126366751|NCT01217892|454639290|FG001|Overall Study|Incorrect enrollment|1|||
126366752|NCT01217892|454639291|FG002|Overall Study|Incorrect enrollment|1|||
126294140|NCT05825404|454366576|FG000|Second Intervention (Weeks 8-11)|Death|0|||
126294141|NCT05825404|454366577|FG001|Second Intervention (Weeks 8-11)|Death|1|||
126294142|NCT01127256|454366578|FG000|Overall Study|Adverse Event|13|||
126294143|NCT01127256|454366579|FG001|Overall Study|Adverse Event|13|||
126294144|NCT01127256|454366578|FG000|Overall Study|Lack of Efficacy|4|||
126294145|NCT01127256|454366579|FG001|Overall Study|Lack of Efficacy|0|||
126294146|NCT01127256|454366578|FG000|Overall Study|Lost to Follow-up|16|||
126294147|NCT01127256|454366579|FG001|Overall Study|Lost to Follow-up|17|||
126294148|NCT01127256|454366578|FG000|Overall Study|Withdrawal by Subject|5|||
126100116|NCT04101318|453659842|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
126100117|NCT04101318|453659841|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
126100118|NCT04101318|453659842|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
126100119|NCT04101318|453659841|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
126100120|NCT04101318|453659842|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
126100121|NCT04289051|453659843|FG000|Overall Study|Lost to Follow-up|0|||
126100122|NCT04289051|453659844|FG001|Overall Study|Lost to Follow-up|0|||
126100123|NCT04289051|453659845|FG002|Overall Study|Lost to Follow-up|2|||
126100124|NCT01901341|453659846|FG000|Overall Study|Adverse Event|4|||
126100125|NCT01901341|453659847|FG001|Overall Study|Adverse Event|2|||
126100126|NCT01901341|453659846|FG000|Overall Study|Lack of Efficacy|0|||
126100127|NCT01901341|453659847|FG001|Overall Study|Lack of Efficacy|2|||
126100128|NCT01901341|453659846|FG000|Overall Study|Lost to Follow-up|0|||
126100129|NCT01901341|453659847|FG001|Overall Study|Lost to Follow-up|1|||
126100130|NCT01901341|453659846|FG000|Overall Study|Protocol Violation|2|||
126100131|NCT01901341|453659847|FG001|Overall Study|Protocol Violation|0|||
126100132|NCT01901341|453659846|FG000|Overall Study|Study Terminated by Sponsor|13|||
126100133|NCT01901341|453659847|FG001|Overall Study|Study Terminated by Sponsor|15|||
126100134|NCT01901341|453659846|FG000|Overall Study|Withdrawal by Subject|1|||
126100135|NCT01901341|453659847|FG001|Overall Study|Withdrawal by Subject|1|||
126100136|NCT00822172|453659851|FG000|Overall Study|Adverse Event|10|||
126100137|NCT00822172|453659852|FG001|Overall Study|Adverse Event|12|||
126100138|NCT00822172|453659851|FG000|Overall Study|Death|1|||
126100139|NCT00822172|453659852|FG001|Overall Study|Death|0|||
126100140|NCT00822172|453659851|FG000|Overall Study|Lost to Follow-up|3|||
126100141|NCT00822172|453659852|FG001|Overall Study|Lost to Follow-up|1|||
126100142|NCT00822172|453659851|FG000|Overall Study|Withdrawal by Subject|1|||
126100143|NCT00822172|453659852|FG001|Overall Study|Withdrawal by Subject|4|||
126100144|NCT00822172|453659851|FG000|Overall Study|site closed|0|||
126100145|NCT00822172|453659852|FG001|Overall Study|site closed|1|||
126100146|NCT00822172|453659851|FG000|Overall Study|Other|0|||
126100147|NCT00822172|453659852|FG001|Overall Study|Other|1|||
126100148|NCT01981473|453659853|FG000|Overall Study|Incorrect diagnosis of RA|0|||
126100149|NCT01981473|453659854|FG001|Overall Study|Incorrect diagnosis of RA|0|||
126100150|NCT01981473|453659855|FG002|Overall Study|Incorrect diagnosis of RA|1|||
126294149|NCT01127256|454366579|FG001|Overall Study|Withdrawal by Subject|9|||
126294150|NCT01127256|454366578|FG000|Overall Study|Protocol Violation|1|||
126294151|NCT01127256|454366579|FG001|Overall Study|Protocol Violation|0|||
125883408|NCT00068692|452871466|FG000|Step 2: Randomization|Death|0|||
125883409|NCT00068692|452871467|FG001|Step 2: Randomization|Death|0|||
126294152|NCT01415518|454366580|FG000|Overall Study|Withdrawal by Subject|2|||
126100151|NCT01981473|453659853|FG000|Overall Study|Received treatment for < 6 months|0|||
126100152|NCT01981473|453659854|FG001|Overall Study|Received treatment for < 6 months|0|||
126100153|NCT01981473|453659855|FG002|Overall Study|Received treatment for < 6 months|1|||
126294153|NCT01415518|454366581|FG001|Overall Study|Withdrawal by Subject|12|||
126294154|NCT01415518|454366580|FG000|Overall Study|Protocol Violation|6|||
126100154|NCT01981473|453659853|FG000|Overall Study|Received treatment for >24 months|2|||
126100155|NCT01981473|453659854|FG001|Overall Study|Received treatment for >24 months|0|||
126042402|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042403|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042404|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042405|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
126042406|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126294155|NCT01415518|454366581|FG001|Overall Study|Protocol Violation|8|||
126294156|NCT01415518|454366580|FG000|Overall Study|Lost to Follow-up|3|||
126294157|NCT01415518|454366581|FG001|Overall Study|Lost to Follow-up|5|||
126294158|NCT01415518|454366580|FG000|Overall Study|Adverse Event|3|||
126294159|NCT01415518|454366581|FG001|Overall Study|Adverse Event|4|||
126294160|NCT01415518|454366580|FG000|Overall Study|Death|1|||
126294161|NCT01415518|454366581|FG001|Overall Study|Death|1|||
126294162|NCT01415518|454366580|FG000|Overall Study|Condition under Investigation Worsened|1|||
126294163|NCT01415518|454366581|FG001|Overall Study|Condition under Investigation Worsened|1|||
126294164|NCT00679211|454366582|FG000|Overall Study|Progressive disease|82|||
126366753|NCT01217892|454639292|FG003|Overall Study|Incorrect enrollment|0|||
126366754|NCT01217892|454639289|FG000|Overall Study|Poor/Non-Compliance|0|||
126366755|NCT01217892|454639290|FG001|Overall Study|Poor/Non-Compliance|0|||
126366756|NCT01217892|454639291|FG002|Overall Study|Poor/Non-Compliance|1|||
126366757|NCT01217892|454639292|FG003|Overall Study|Poor/Non-Compliance|0|||
126366758|NCT01052779|454639293|FG000|Overall Study|Adverse Event|1|||
126366759|NCT01052779|454639294|FG001|Overall Study|Adverse Event|4|||
126366760|NCT01052779|454639293|FG000|Overall Study|Withdrawal by Subject|1|||
126366761|NCT01052779|454639294|FG001|Overall Study|Withdrawal by Subject|2|||
126366762|NCT01052779|454639293|FG000|Overall Study|Other-Protocol Violation|1|||
126366763|NCT01052779|454639294|FG001|Overall Study|Other-Protocol Violation|1|||
126366764|NCT01052779|454639293|FG000|Overall Study|Other-Surgery|0|||
126366765|NCT01052779|454639294|FG001|Overall Study|Other-Surgery|2|||
126366766|NCT01052779|454639293|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
126366767|NCT01052779|454639294|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
126366768|NCT03802916|454639295|FG000|Overall Study|Adverse Event|0|||
126366769|NCT03802916|454639296|FG001|Overall Study|Adverse Event|1|||
126366770|NCT03802916|454639295|FG000|Overall Study|Withdrawal by Subject|0|||
126366771|NCT03802916|454639296|FG001|Overall Study|Withdrawal by Subject|1|||
126366772|NCT01285102|454639297|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
126366773|NCT01905540|454639298|FG000|Period 3|Other|1|||
126366774|NCT01905540|454639299|FG001|Period 3|Other|0|||
126366775|NCT01905540|454639300|FG002|Period 3|Other|1|||
126366776|NCT01905540|454639301|FG003|Period 3|Other|1|||
126366777|NCT02367885|454639302|FG000|Overall Study|Lost to Follow-up|1|||
126366778|NCT02367885|454639303|FG001|Overall Study|Lost to Follow-up|0|||
126366779|NCT02367885|454639304|FG002|Overall Study|Lost to Follow-up|0|||
126366780|NCT02367885|454639302|FG000|Overall Study|Withdrawal by Subject|1|||
126366781|NCT02367885|454639303|FG001|Overall Study|Withdrawal by Subject|0|||
126366782|NCT02367885|454639304|FG002|Overall Study|Withdrawal by Subject|0|||
126366783|NCT02743962|454639307|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
126366784|NCT02743962|454639308|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
126366785|NCT02327169|454639312|FG000|Overall Study|Progressive Disease|1|||
126366786|NCT02327169|454639313|FG001|Overall Study|Progressive Disease|3|||
126366787|NCT02327169|454639314|FG002|Overall Study|Progressive Disease|4|||
126366788|NCT02327169|454639315|FG003|Overall Study|Progressive Disease|3|||
126366789|NCT02327169|454639316|FG004|Overall Study|Progressive Disease|4|||
126366790|NCT02327169|454639317|FG005|Overall Study|Progressive Disease|3|||
126366791|NCT02327169|454639318|FG006|Overall Study|Progressive Disease|3|||
126366792|NCT02327169|454639319|FG007|Overall Study|Progressive Disease|3|||
126366793|NCT02327169|454639320|FG008|Overall Study|Progressive Disease|4|||
126366794|NCT02327169|454639321|FG009|Overall Study|Progressive Disease|4|||
126366795|NCT02327169|454639322|FG010|Overall Study|Progressive Disease|4|||
126366796|NCT02327169|454639323|FG011|Overall Study|Progressive Disease|3|||
126366797|NCT02327169|454639324|FG012|Overall Study|Progressive Disease|1|||
126366798|NCT02327169|454639325|FG013|Overall Study|Progressive Disease|3|||
126366799|NCT02327169|454639326|FG014|Overall Study|Progressive Disease|3|||
126366800|NCT02327169|454639312|FG000|Overall Study|Adverse Event|2|||
126366801|NCT02327169|454639313|FG001|Overall Study|Adverse Event|0|||
126366802|NCT02327169|454639314|FG002|Overall Study|Adverse Event|1|||
126366803|NCT02327169|454639315|FG003|Overall Study|Adverse Event|0|||
126366804|NCT02327169|454639316|FG004|Overall Study|Adverse Event|1|||
126366805|NCT02327169|454639317|FG005|Overall Study|Adverse Event|0|||
126366806|NCT02327169|454639318|FG006|Overall Study|Adverse Event|0|||
126366807|NCT02327169|454639319|FG007|Overall Study|Adverse Event|0|||
126366808|NCT02327169|454639320|FG008|Overall Study|Adverse Event|0|||
126366809|NCT02327169|454639321|FG009|Overall Study|Adverse Event|2|||
126366810|NCT02327169|454639322|FG010|Overall Study|Adverse Event|0|||
126366811|NCT02327169|454639323|FG011|Overall Study|Adverse Event|3|||
126366812|NCT02327169|454639324|FG012|Overall Study|Adverse Event|0|||
126366813|NCT02327169|454639325|FG013|Overall Study|Adverse Event|2|||
126366814|NCT02327169|454639326|FG014|Overall Study|Adverse Event|1|||
126366815|NCT02327169|454639312|FG000|Overall Study|Symptomatic Deterioration|0|||
126294165|NCT00679211|454366582|FG000|Overall Study|Adverse Event|7|||
125883410|NCT00068692|452871468|FG002|Step 2: Randomization|Death|0|||
126042407|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042408|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042409|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042410|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126042411|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042412|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042413|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042414|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042415|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042416|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126294166|NCT00679211|454366582|FG000|Overall Study|Withdrawal by Subject|2|||
126294167|NCT00679211|454366582|FG000|Overall Study|Physician Decision|5|||
126100156|NCT01981473|453659855|FG002|Overall Study|Received treatment for >24 months|6|||
126100157|NCT02257567|453659863|FG000|Overall Study|Adverse Event|0|||
126100158|NCT02257567|453659864|FG001|Overall Study|Adverse Event|0|||
126100159|NCT02257567|453659865|FG002|Overall Study|Adverse Event|0|||
126100160|NCT02257567|453659866|FG003|Overall Study|Adverse Event|1|||
126100161|NCT02257567|453659867|FG004|Overall Study|Adverse Event|1|||
126100162|NCT02257567|453659868|FG005|Overall Study|Adverse Event|0|||
126100163|NCT02257567|453659869|FG006|Overall Study|Adverse Event|0|||
126100164|NCT02257567|453659870|FG007|Overall Study|Adverse Event|0|||
125883411|NCT00068692|452871469|FG003|Step 2: Randomization|Death|0|||
125883412|NCT00068692|452871470|FG004|Step 2: Randomization|Death|1|||
125883413|NCT00068692|452871471|FG005|Step 2: Randomization|Death|0|||
125883414|NCT00068692|452871472|FG006|Step 2: Randomization|Death|0|||
126100165|NCT02257567|453659871|FG008|Overall Study|Adverse Event|1|||
126294168|NCT00679211|454366582|FG000|Overall Study|Refused to undergo protocol procedures|1|||
126294169|NCT00679211|454366582|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
125883415|NCT00068692|452871473|FG007|Step 2: Randomization|Death|1|||
125883416|NCT00068692|452871466|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
126100166|NCT02257567|453659872|FG009|Overall Study|Adverse Event|0|||
126100167|NCT02257567|453659873|FG010|Overall Study|Adverse Event|0|||
126100168|NCT02257567|453659863|FG000|Overall Study|Death|2|||
126294170|NCT00679211|454366582|FG000|Overall Study|Other|1|||
126294171|NCT01730053|454366583|FG000|Overall Study|Participant moved|0|||
126294172|NCT01730053|454366584|FG001|Overall Study|Participant moved|0|||
126294173|NCT01730053|454366585|FG002|Overall Study|Participant moved|1|||
126294174|NCT01730053|454366586|FG003|Overall Study|Participant moved|0|||
126294175|NCT01730053|454366587|FG004|Overall Study|Participant moved|0|||
126294176|NCT01730053|454366588|FG005|Overall Study|Participant moved|0|||
126294177|NCT01730053|454366583|FG000|Overall Study|Physician Decision|0|||
126294178|NCT01730053|454366584|FG001|Overall Study|Physician Decision|0|||
126294179|NCT01730053|454366585|FG002|Overall Study|Physician Decision|0|||
126294180|NCT01730053|454366586|FG003|Overall Study|Physician Decision|1|||
126294181|NCT01730053|454366587|FG004|Overall Study|Physician Decision|0|||
126294182|NCT01730053|454366588|FG005|Overall Study|Physician Decision|0|||
126294183|NCT01730053|454366583|FG000|Overall Study|Adverse Event|2|||
126294184|NCT01730053|454366584|FG001|Overall Study|Adverse Event|6|||
126294185|NCT01730053|454366585|FG002|Overall Study|Adverse Event|3|||
126294186|NCT01730053|454366586|FG003|Overall Study|Adverse Event|3|||
126294187|NCT01730053|454366587|FG004|Overall Study|Adverse Event|2|||
126294188|NCT01730053|454366588|FG005|Overall Study|Adverse Event|2|||
126294189|NCT01730053|454366583|FG000|Overall Study|Poor compliance to protocol|1|||
126294190|NCT01730053|454366584|FG001|Overall Study|Poor compliance to protocol|2|||
126294191|NCT01730053|454366585|FG002|Overall Study|Poor compliance to protocol|2|||
126294192|NCT01730053|454366586|FG003|Overall Study|Poor compliance to protocol|0|||
126294193|NCT01730053|454366587|FG004|Overall Study|Poor compliance to protocol|0|||
126294194|NCT01730053|454366588|FG005|Overall Study|Poor compliance to protocol|2|||
126294195|NCT01730053|454366583|FG000|Overall Study|Other than specified|2|||
126294196|NCT01730053|454366584|FG001|Overall Study|Other than specified|6|||
126294197|NCT01730053|454366585|FG002|Overall Study|Other than specified|5|||
126294198|NCT01730053|454366586|FG003|Overall Study|Other than specified|4|||
126294199|NCT01730053|454366587|FG004|Overall Study|Other than specified|7|||
126294200|NCT01730053|454366588|FG005|Overall Study|Other than specified|9|||
126294201|NCT01470248|454366589|FG000|Overall Study|Withdrawal by Subject|1|||
126294202|NCT05085834|454366590|FG000|Overall Study|Lost to Follow-up|9|||
126294203|NCT05085834|454366591|FG001|Overall Study|Lost to Follow-up|2|||
126294204|NCT05085834|454366590|FG000|Overall Study|Adverse Event|6|||
126294205|NCT05085834|454366591|FG001|Overall Study|Adverse Event|0|||
126042417|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
126042418|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042419|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126294206|NCT05085834|454366590|FG000|Overall Study|Death|1|||
126294207|NCT05085834|454366591|FG001|Overall Study|Death|0|||
126294208|NCT05085834|454366590|FG000|Overall Study|Inability to swallow the pill|0|||
126046520|NCT03868930|453468247|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
126294209|NCT05085834|454366591|FG001|Overall Study|Inability to swallow the pill|1|||
126294210|NCT02243605|454366592|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
126294211|NCT02243605|454366593|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
126294212|NCT02243605|454366592|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
126294213|NCT02243605|454366593|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
126294214|NCT02243605|454366592|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
126294215|NCT02243605|454366593|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
126294216|NCT02243605|454366592|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
126294217|NCT02243605|454366593|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
126294218|NCT02243605|454366592|FG000|Stage 2 - Final Analysis Population|Progression|0|||
126294219|NCT02243605|454366593|FG001|Stage 2 - Final Analysis Population|Progression|1|||
126294220|NCT01823328|454366594|FG000|Overall Study|Withdrawal by Subject|8|||
126294221|NCT01823328|454366595|FG001|Overall Study|Withdrawal by Subject|6|||
126294222|NCT00742209|454366602|FG000|Overall Study|Adverse Event|11|||
126294223|NCT00742209|454366603|FG001|Overall Study|Adverse Event|4|||
126294224|NCT00742209|454366604|FG002|Overall Study|Adverse Event|17|||
126294225|NCT00742209|454366605|FG003|Overall Study|Adverse Event|16|||
126294226|NCT00742209|454366606|FG004|Overall Study|Adverse Event|13|||
126294227|NCT00742209|454366602|FG000|Overall Study|Participant Withdrew Consent|8|||
126294228|NCT00742209|454366603|FG001|Overall Study|Participant Withdrew Consent|4|||
126294229|NCT00742209|454366604|FG002|Overall Study|Participant Withdrew Consent|14|||
126294230|NCT00742209|454366605|FG003|Overall Study|Participant Withdrew Consent|7|||
126294231|NCT00742209|454366606|FG004|Overall Study|Participant Withdrew Consent|4|||
126294232|NCT00742209|454366602|FG000|Overall Study|Protocol Violation|6|||
126294233|NCT00742209|454366603|FG001|Overall Study|Protocol Violation|5|||
126294234|NCT00742209|454366604|FG002|Overall Study|Protocol Violation|4|||
126294235|NCT00742209|454366605|FG003|Overall Study|Protocol Violation|5|||
126294236|NCT00742209|454366606|FG004|Overall Study|Protocol Violation|3|||
126294237|NCT00742209|454366602|FG000|Overall Study|Lost to Follow-up|3|||
126294238|NCT00742209|454366603|FG001|Overall Study|Lost to Follow-up|4|||
126294239|NCT00742209|454366604|FG002|Overall Study|Lost to Follow-up|5|||
126294240|NCT00742209|454366605|FG003|Overall Study|Lost to Follow-up|5|||
126294241|NCT00742209|454366606|FG004|Overall Study|Lost to Follow-up|3|||
126294242|NCT00742209|454366602|FG000|Overall Study|Lack of Efficacy|6|||
126294243|NCT00742209|454366603|FG001|Overall Study|Lack of Efficacy|1|||
126294244|NCT00742209|454366604|FG002|Overall Study|Lack of Efficacy|1|||
126294245|NCT00742209|454366605|FG003|Overall Study|Lack of Efficacy|3|||
126294246|NCT00742209|454366606|FG004|Overall Study|Lack of Efficacy|1|||
126294247|NCT00742209|454366602|FG000|Overall Study|Investigator Discretion|0|||
126294248|NCT00742209|454366603|FG001|Overall Study|Investigator Discretion|0|||
126294249|NCT00742209|454366604|FG002|Overall Study|Investigator Discretion|5|||
126294250|NCT00742209|454366605|FG003|Overall Study|Investigator Discretion|1|||
126294251|NCT00742209|454366606|FG004|Overall Study|Investigator Discretion|1|||
126294252|NCT03817125|454366610|FG000|Overall Study|Adverse Event|1|||
126294253|NCT03817125|454366611|FG001|Overall Study|Adverse Event|0|||
126294254|NCT03817125|454366610|FG000|Overall Study|Physician Decision|0|||
126294255|NCT03817125|454366611|FG001|Overall Study|Physician Decision|1|||
126294256|NCT03817125|454366610|FG000|Overall Study|Lack of Efficacy|1|||
126294257|NCT03817125|454366611|FG001|Overall Study|Lack of Efficacy|5|||
126294258|NCT01998919|454366612|FG000|Overall Study|Death|2|||
126294259|NCT01998919|454366613|FG001|Overall Study|Death|2|||
126294260|NCT01998919|454366612|FG000|Overall Study|Adverse Event|0|||
126294261|NCT01998919|454366613|FG001|Overall Study|Adverse Event|5|||
126294262|NCT01998919|454366612|FG000|Overall Study|Disease progression|31|||
126294263|NCT01998919|454366613|FG001|Overall Study|Disease progression|22|||
126294264|NCT01998919|454366612|FG000|Overall Study|Withdrawal by Subject|2|||
126294265|NCT01998919|454366613|FG001|Overall Study|Withdrawal by Subject|4|||
126294266|NCT01998919|454366612|FG000|Overall Study|Lost to Follow-up|2|||
126294267|NCT01998919|454366613|FG001|Overall Study|Lost to Follow-up|0|||
126294268|NCT01998919|454366612|FG000|Overall Study|Other|5|||
126294269|NCT01998919|454366613|FG001|Overall Study|Other|2|||
126294270|NCT01321879|454366617|FG000|Overall Study|Lack of Efficacy|5|||
126294271|NCT01321879|454366617|FG000|Overall Study|Adverse Event|5|||
126294272|NCT01321879|454366617|FG000|Overall Study|Death|3|||
126294273|NCT01321879|454366617|FG000|Overall Study|Withdrawal by Subject|1|||
126294274|NCT00897715|454366618|FG000|Overall Study|Lost to Follow-up|0|||
126294275|NCT00897715|454366619|FG001|Overall Study|Lost to Follow-up|1|||
126294276|NCT00897715|454366618|FG000|Overall Study|Physician Decision|1|||
126294277|NCT00897715|454366619|FG001|Overall Study|Physician Decision|0|||
126294278|NCT00897715|454366618|FG000|Overall Study|increased risk of infection|1|||
126294279|NCT00897715|454366619|FG001|Overall Study|increased risk of infection|0|||
126294280|NCT01199939|454366626|FG000|Overall Study|Adverse Event|4|||
126294281|NCT01199939|454366626|FG000|Overall Study|Protocol Violation|3|||
126294282|NCT01199939|454366626|FG000|Overall Study|Lost to Follow-up|2|||
126294283|NCT01199939|454366626|FG000|Overall Study|Reached a virologic endpoint|4|||
126294284|NCT02550561|454366627|FG000|Overall Study|Lost to Follow-up|5|||
126294285|NCT02550561|454366627|FG000|Overall Study|Withdrawal by Subject|1|||
126294286|NCT02394600|454366628|FG000|Overall Study|Adverse Event|3|||
126294287|NCT02394600|454366629|FG001|Overall Study|Adverse Event|0|||
126294288|NCT02394600|454366628|FG000|Overall Study|Lost to Follow-up|0|||
126294289|NCT02394600|454366629|FG001|Overall Study|Lost to Follow-up|1|||
126294290|NCT02394600|454366628|FG000|Overall Study|Withdrawal by Subject|0|||
126294291|NCT02394600|454366629|FG001|Overall Study|Withdrawal by Subject|1|||
126294292|NCT02394600|454366628|FG000|Overall Study|Protocol Violation|1|||
126294293|NCT02394600|454366629|FG001|Overall Study|Protocol Violation|0|||
126294294|NCT01686373|454366630|FG000|Overall Study|Lost to Follow-up|3|||
126294295|NCT01686373|454366631|FG001|Overall Study|Lost to Follow-up|0|||
126294296|NCT01686373|454366630|FG000|Overall Study|Withdrawal by Subject|0|||
126294297|NCT01686373|454366631|FG001|Overall Study|Withdrawal by Subject|1|||
126294298|NCT01686373|454366630|FG000|Overall Study|Adverse Event|0|||
126294299|NCT01686373|454366631|FG001|Overall Study|Adverse Event|1|||
126294300|NCT00791778|454366632|FG000|Double-blind Treatment|Adverse Event|49|||
126294301|NCT00791778|454366633|FG001|Double-blind Treatment|Adverse Event|9|||
126294302|NCT00791778|454366632|FG000|Double-blind Treatment|Physician Decision|6|||
126294303|NCT00791778|454366633|FG001|Double-blind Treatment|Physician Decision|26|||
126294304|NCT00791778|454366632|FG000|Double-blind Treatment|Protocol Violation|0|||
126294305|NCT00791778|454366633|FG001|Double-blind Treatment|Protocol Violation|4|||
126294306|NCT00791778|454366632|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
126294307|NCT00791778|454366633|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
126294308|NCT00791778|454366632|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
126294309|NCT00791778|454366633|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
126294310|NCT00791778|454366632|FG000|Follow-up|Withdrawal by Subject|3|||
126294311|NCT00791778|454366633|FG001|Follow-up|Withdrawal by Subject|0|||
126294312|NCT00791778|454366632|FG000|Follow-up|Lost to Follow-up|2|||
126100169|NCT02257567|453659864|FG001|Overall Study|Death|2|||
126100170|NCT02257567|453659865|FG002|Overall Study|Death|2|||
126294313|NCT00791778|454366633|FG001|Follow-up|Lost to Follow-up|1|||
126294314|NCT00235755|454366636|FG000|4-Week Titration Phase|Adverse Event|6|||
126294315|NCT00235755|454366637|FG001|4-Week Titration Phase|Adverse Event|14|||
126294316|NCT00235755|454366638|FG002|4-Week Titration Phase|Adverse Event|20|||
126294317|NCT00235755|454366636|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
126294318|NCT00235755|454366637|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
126294319|NCT00235755|454366638|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
126294320|NCT00235755|454366636|FG000|4-Week Titration Phase|Protocol Violation|2|||
126100171|NCT02257567|453659866|FG003|Overall Study|Death|4|||
126100172|NCT02257567|453659867|FG004|Overall Study|Death|15|||
126294321|NCT00235755|454366637|FG001|4-Week Titration Phase|Protocol Violation|2|||
126294322|NCT00235755|454366638|FG002|4-Week Titration Phase|Protocol Violation|1|||
126294323|NCT00235755|454366636|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
126294324|NCT00235755|454366637|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
126294325|NCT00235755|454366638|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
126294326|NCT00235755|454366636|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
126294327|NCT00235755|454366637|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
126294328|NCT00235755|454366638|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
126294329|NCT00235755|454366636|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
126294330|NCT00235755|454366637|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
126294331|NCT00235755|454366638|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
126294332|NCT00235755|454366636|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
126294333|NCT00235755|454366637|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
125883417|NCT00068692|452871467|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
126100173|NCT02257567|453659868|FG005|Overall Study|Death|11|||
126100174|NCT02257567|453659869|FG006|Overall Study|Death|26|||
126100175|NCT02257567|453659870|FG007|Overall Study|Death|30|||
126294334|NCT00235755|454366638|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
126294335|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Adverse Event|8|||
126294336|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Adverse Event|12|||
126294337|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Adverse Event|26|||
126294338|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
126294339|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
126294340|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
126294341|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
126294342|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
126294343|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
126294344|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
126294345|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
126294346|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
126294347|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
126294348|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
126294349|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
126294350|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
126294351|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
126294352|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
126294353|NCT02314026|454366639|FG000|Overall Study|Protocol Violation|28|||
126294354|NCT01532934|454366642|FG000|Overall Study|Lost to Follow-up|11|||
126294355|NCT01532934|454366643|FG001|Overall Study|Lost to Follow-up|11|||
126294356|NCT01532934|454366642|FG000|Overall Study|In controlled environment|3|||
126294357|NCT01532934|454366643|FG001|Overall Study|In controlled environment|2|||
126294358|NCT01147068|454366644|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
126294359|NCT01147068|454366645|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294360|NCT01147068|454366646|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294361|NCT01147068|454366647|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294362|NCT01147068|454366648|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294363|NCT01147068|454366649|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
126294364|NCT01147068|454366650|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294365|NCT01147068|454366644|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
126294366|NCT01147068|454366645|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
126294367|NCT01147068|454366646|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
126294368|NCT01147068|454366647|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
126294369|NCT01147068|454366648|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
126294370|NCT01147068|454366649|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
126294371|NCT01147068|454366650|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
126042420|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042421|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042422|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126042423|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
126294372|NCT01147068|454366644|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
126294373|NCT01147068|454366645|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
126100176|NCT02257567|453659871|FG008|Overall Study|Death|2|||
126100177|NCT02257567|453659872|FG009|Overall Study|Death|18|||
126100178|NCT02257567|453659873|FG010|Overall Study|Death|65|||
126100179|NCT02257567|453659863|FG000|Overall Study|Lost to Follow-up|0|||
126100180|NCT02257567|453659864|FG001|Overall Study|Lost to Follow-up|0|||
126100181|NCT02257567|453659865|FG002|Overall Study|Lost to Follow-up|0|||
126100182|NCT02257567|453659866|FG003|Overall Study|Lost to Follow-up|0|||
126100183|NCT02257567|453659867|FG004|Overall Study|Lost to Follow-up|2|||
126100184|NCT02257567|453659868|FG005|Overall Study|Lost to Follow-up|2|||
126100185|NCT02257567|453659869|FG006|Overall Study|Lost to Follow-up|0|||
126100186|NCT02257567|453659870|FG007|Overall Study|Lost to Follow-up|0|||
126100187|NCT02257567|453659871|FG008|Overall Study|Lost to Follow-up|0|||
126100188|NCT02257567|453659872|FG009|Overall Study|Lost to Follow-up|1|||
126100189|NCT02257567|453659873|FG010|Overall Study|Lost to Follow-up|1|||
126100190|NCT02257567|453659863|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100191|NCT02257567|453659864|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100192|NCT02257567|453659865|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100193|NCT02257567|453659866|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100194|NCT02257567|453659867|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
126100195|NCT02257567|453659868|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100196|NCT02257567|453659869|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
126100197|NCT02257567|453659870|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100198|NCT02257567|453659871|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100199|NCT02257567|453659872|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100200|NCT02257567|453659873|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126100201|NCT02257567|453659863|FG000|Overall Study|Physician Decision|0|||
126100202|NCT02257567|453659864|FG001|Overall Study|Physician Decision|0|||
126100203|NCT02257567|453659865|FG002|Overall Study|Physician Decision|0|||
125883418|NCT00068692|452871468|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
125883419|NCT00068692|452871469|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
125883420|NCT00068692|452871470|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
125883421|NCT00068692|452871471|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
125883422|NCT00068692|452871472|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
125883423|NCT00068692|452871473|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
125883424|NCT00068692|452871466|FG000|Step 2: Randomization|alternative therapy|0|||
125883425|NCT00068692|452871467|FG001|Step 2: Randomization|alternative therapy|0|||
126042424|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
126042425|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
126294374|NCT01147068|454366646|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
126294375|NCT01147068|454366647|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
126294376|NCT01147068|454366648|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
126042426|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
126294377|NCT01147068|454366649|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
126294378|NCT01147068|454366650|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
126294379|NCT01147068|454366644|FG000|Subjects That Received 2nd Dose|Other|0|||
126294380|NCT01147068|454366645|FG001|Subjects That Received 2nd Dose|Other|3|||
126294381|NCT01147068|454366646|FG002|Subjects That Received 2nd Dose|Other|3|||
126294382|NCT01147068|454366647|FG003|Subjects That Received 2nd Dose|Other|0|||
126294383|NCT01147068|454366648|FG004|Subjects That Received 2nd Dose|Other|1|||
126294384|NCT01147068|454366649|FG005|Subjects That Received 2nd Dose|Other|0|||
126294385|NCT01147068|454366650|FG006|Subjects That Received 2nd Dose|Other|0|||
126294386|NCT01147068|454366644|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
126294387|NCT01147068|454366645|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
126294388|NCT01147068|454366646|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
126294389|NCT01147068|454366647|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
126294390|NCT01147068|454366648|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
126294391|NCT01147068|454366649|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
126294392|NCT01147068|454366650|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
126294393|NCT01147068|454366644|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294394|NCT01147068|454366645|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294395|NCT01147068|454366646|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294396|NCT01147068|454366647|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
126294397|NCT01147068|454366648|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294398|NCT01147068|454366649|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294399|NCT01147068|454366650|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294400|NCT01147068|454366644|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294401|NCT01147068|454366645|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
126294402|NCT01147068|454366646|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294403|NCT01147068|454366647|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294404|NCT01147068|454366648|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294405|NCT01147068|454366649|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294406|NCT01147068|454366650|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294407|NCT02291237|454366651|FG000|Overall Study|Study Terminated by Sponsor|72|||
126294408|NCT02291237|454366652|FG001|Overall Study|Study Terminated by Sponsor|67|||
126294409|NCT02291237|454366651|FG000|Overall Study|Adverse Event|1|||
126294410|NCT02291237|454366652|FG001|Overall Study|Adverse Event|3|||
126294411|NCT02291237|454366651|FG000|Overall Study|Investigator's Discretion|0|||
126294412|NCT02291237|454366652|FG001|Overall Study|Investigator's Discretion|3|||
126294413|NCT02291237|454366651|FG000|Overall Study|Withdrew Consent|11|||
126294414|NCT02291237|454366652|FG001|Overall Study|Withdrew Consent|11|||
126294415|NCT02291237|454366651|FG000|Overall Study|Lost to Follow-up|0|||
126294416|NCT02291237|454366652|FG001|Overall Study|Lost to Follow-up|2|||
126294417|NCT02291237|454366651|FG000|Overall Study|Subject Required Prohibited Medication|2|||
126294418|NCT02291237|454366652|FG001|Overall Study|Subject Required Prohibited Medication|0|||
126294419|NCT01306305|454366653|FG000|Overall Study|Lost to Follow-up|1|||
126294420|NCT01306305|454366654|FG001|Overall Study|Lost to Follow-up|0|||
126294421|NCT01306305|454366653|FG000|Overall Study|Withdrew consent|1|||
126294422|NCT01306305|454366654|FG001|Overall Study|Withdrew consent|0|||
126294423|NCT03326193|454366655|FG000|Overall Study|Sponsor decision|35|||
126294424|NCT00699998|454366657|FG000|Overall Study|Withdrawal by Subject|194|||
126294425|NCT00699998|454366658|FG001|Overall Study|Withdrawal by Subject|83|||
126294426|NCT00699998|454366659|FG002|Overall Study|Withdrawal by Subject|202|||
126294427|NCT00699998|454366660|FG003|Overall Study|Withdrawal by Subject|80|||
126294428|NCT00699998|454366657|FG000|Overall Study|Physician Decision|3|||
126294429|NCT00699998|454366658|FG001|Overall Study|Physician Decision|2|||
126294430|NCT00699998|454366659|FG002|Overall Study|Physician Decision|1|||
126294431|NCT00699998|454366660|FG003|Overall Study|Physician Decision|1|||
126294432|NCT00699998|454366657|FG000|Overall Study|Lost to Follow-up|2|||
126294433|NCT00699998|454366658|FG001|Overall Study|Lost to Follow-up|1|||
126294434|NCT00699998|454366659|FG002|Overall Study|Lost to Follow-up|3|||
126294435|NCT00699998|454366660|FG003|Overall Study|Lost to Follow-up|1|||
126294436|NCT03367819|454366665|FG000|Overall Study|Adverse Event|4|||
126294437|NCT03367819|454366666|FG001|Overall Study|Adverse Event|4|||
126294438|NCT03367819|454366665|FG000|Overall Study|Progressive Disease|15|||
126294439|NCT03367819|454366666|FG001|Overall Study|Progressive Disease|13|||
126294440|NCT03367819|454366665|FG000|Overall Study|Withdrawal by Subject|1|||
126294441|NCT03367819|454366666|FG001|Overall Study|Withdrawal by Subject|0|||
126294442|NCT03367819|454366665|FG000|Overall Study|Other|4|||
126294443|NCT03367819|454366666|FG001|Overall Study|Other|2|||
126294444|NCT00584454|454366667|FG000|Overall Study|Adverse Event|1|||
126294445|NCT00584454|454366667|FG000|Overall Study|Relocation|1|||
126294446|NCT00584454|454366667|FG000|Overall Study|Clinical Hold|2|||
126294447|NCT01565889|454366668|FG000|Part A|Withdrawal by Subject|1|||
126294448|NCT01565889|454366669|FG001|Part A|Withdrawal by Subject|0|||
126294449|NCT01565889|454366670|FG002|Part A|Withdrawal by Subject|0|||
126294450|NCT01565889|454366671|FG003|Part A|Withdrawal by Subject|0|||
126294451|NCT01565889|454366672|FG004|Part A|Withdrawal by Subject|0|||
126294452|NCT01565889|454366673|FG005|Part A|Withdrawal by Subject|0|||
126294453|NCT01565889|454366668|FG000|Part B|Withdrawal by Subject|0|||
126294454|NCT01565889|454366669|FG001|Part B|Withdrawal by Subject|0|||
126294455|NCT01565889|454366670|FG002|Part B|Withdrawal by Subject|0|||
126294456|NCT01565889|454366671|FG003|Part B|Withdrawal by Subject|0|||
126294457|NCT01565889|454366672|FG004|Part B|Withdrawal by Subject|0|||
126294458|NCT01565889|454366673|FG005|Part B|Withdrawal by Subject|1|||
126294459|NCT01565889|454366668|FG000|Part B|Lack of Efficacy|0|||
126294460|NCT01565889|454366669|FG001|Part B|Lack of Efficacy|0|||
126294461|NCT01565889|454366670|FG002|Part B|Lack of Efficacy|0|||
126294462|NCT01565889|454366671|FG003|Part B|Lack of Efficacy|0|||
126294463|NCT01565889|454366672|FG004|Part B|Lack of Efficacy|0|||
126294464|NCT01565889|454366673|FG005|Part B|Lack of Efficacy|2|||
126294465|NCT01565889|454366668|FG000|Part B|Lost to Follow-up|0|||
126294466|NCT01565889|454366669|FG001|Part B|Lost to Follow-up|0|||
126294467|NCT01565889|454366670|FG002|Part B|Lost to Follow-up|0|||
126294468|NCT01565889|454366671|FG003|Part B|Lost to Follow-up|0|||
126294469|NCT01565889|454366672|FG004|Part B|Lost to Follow-up|0|||
126294470|NCT01565889|454366673|FG005|Part B|Lost to Follow-up|1|||
126294471|NCT01326845|454366674|FG000|Overall Study|Administrative Problems|5|||
126294472|NCT01326845|454366675|FG001|Overall Study|Administrative Problems|2|||
126294473|NCT01326845|454366674|FG000|Overall Study|Adverse Event|1|||
126294474|NCT01326845|454366675|FG001|Overall Study|Adverse Event|0|||
126294475|NCT01326845|454366674|FG000|Overall Study|Misisng|1|||
126294476|NCT01326845|454366675|FG001|Overall Study|Misisng|3|||
126294477|NCT00982657|454366676|FG000|Overall Study|Death|1|||
126294478|NCT00982657|454366677|FG001|Overall Study|Death|0|||
126294479|NCT00982657|454366678|FG002|Overall Study|Death|1|||
126294480|NCT00982657|454366679|FG003|Overall Study|Death|1|||
126294481|NCT00982657|454366676|FG000|Overall Study|Withdrawal by Subject|0|||
126294482|NCT00982657|454366677|FG001|Overall Study|Withdrawal by Subject|0|||
126294483|NCT00982657|454366678|FG002|Overall Study|Withdrawal by Subject|1|||
126294484|NCT00982657|454366679|FG003|Overall Study|Withdrawal by Subject|3|||
126294485|NCT00982657|454366676|FG000|Overall Study|Other|0|||
126294486|NCT00982657|454366677|FG001|Overall Study|Other|0|||
126294487|NCT00982657|454366678|FG002|Overall Study|Other|0|||
126294488|NCT00982657|454366679|FG003|Overall Study|Other|4|||
126294489|NCT00982657|454366676|FG000|Overall Study|On going at date of cut-off|0|||
126294490|NCT00982657|454366677|FG001|Overall Study|On going at date of cut-off|0|||
126294491|NCT00982657|454366678|FG002|Overall Study|On going at date of cut-off|0|||
126294492|NCT00982657|454366679|FG003|Overall Study|On going at date of cut-off|1|||
126294493|NCT00725920|454366680|FG000|Overall Study|Lack of Efficacy|3|||
126294494|NCT00725920|454366681|FG001|Overall Study|Lack of Efficacy|6|||
126294495|NCT03918629|454366682|FG000|Overall Study|Adverse Event|19|||
126294496|NCT03918629|454366683|FG001|Overall Study|Adverse Event|20|||
126294497|NCT03918629|454366682|FG000|Overall Study|Death|14|||
126294498|NCT03918629|454366683|FG001|Overall Study|Death|7|||
126294499|NCT03918629|454366682|FG000|Overall Study|Lost to Follow-up|36|||
126294500|NCT03918629|454366683|FG001|Overall Study|Lost to Follow-up|28|||
126294501|NCT03918629|454366682|FG000|Overall Study|Physician Decision|1|||
126294502|NCT03918629|454366683|FG001|Overall Study|Physician Decision|0|||
126294503|NCT03918629|454366682|FG000|Overall Study|Protocol Violation|7|||
126294504|NCT03918629|454366683|FG001|Overall Study|Protocol Violation|4|||
126294505|NCT03918629|454366682|FG000|Overall Study|Withdrawal by Subject|47|||
126294506|NCT03918629|454366683|FG001|Overall Study|Withdrawal by Subject|47|||
126294507|NCT03918629|454366682|FG000|Overall Study|Other|7|||
126294508|NCT03918629|454366683|FG001|Overall Study|Other|11|||
126294509|NCT03918629|454366682|FG000|Overall Study|Randomized but not vaccinated|2|||
126294510|NCT03918629|454366683|FG001|Overall Study|Randomized but not vaccinated|1|||
126294511|NCT01891864|454366686|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
126294512|NCT01891864|454366687|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
126294513|NCT01891864|454366688|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
126294514|NCT01891864|454366689|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
126294515|NCT01891864|454366690|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
126294516|NCT01891864|454366691|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
126294517|NCT01891864|454366686|FG000|Treatment Period 1|Physician Decision|0|||
126294518|NCT01891864|454366687|FG001|Treatment Period 1|Physician Decision|1|||
126294519|NCT01891864|454366688|FG002|Treatment Period 1|Physician Decision|0|||
126294520|NCT01891864|454366689|FG003|Treatment Period 1|Physician Decision|0|||
126294521|NCT01891864|454366690|FG004|Treatment Period 1|Physician Decision|0|||
126294522|NCT01891864|454366691|FG005|Treatment Period 1|Physician Decision|0|||
126294523|NCT01891864|454366686|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294524|NCT01891864|454366687|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
126294525|NCT01891864|454366688|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294526|NCT01891864|454366689|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294527|NCT01891864|454366690|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294528|NCT01891864|454366691|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294529|NCT01891864|454366686|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
126294530|NCT01891864|454366687|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
126294531|NCT01891864|454366688|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
126294532|NCT01891864|454366689|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
126294533|NCT01891864|454366690|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
126294534|NCT01891864|454366691|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
126294535|NCT01891864|454366686|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126294536|NCT01891864|454366687|FG001|Treatment Period 1|Withdrawal by Subject|5|||
126294537|NCT01891864|454366688|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126294538|NCT01891864|454366689|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126294539|NCT01891864|454366690|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126294540|NCT01891864|454366691|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126294541|NCT01891864|454366686|FG000|Treatment Period 1|Lost to Follow-up|1|||
126294542|NCT01891864|454366687|FG001|Treatment Period 1|Lost to Follow-up|0|||
126294543|NCT01891864|454366688|FG002|Treatment Period 1|Lost to Follow-up|0|||
126294544|NCT01891864|454366689|FG003|Treatment Period 1|Lost to Follow-up|0|||
126294545|NCT01891864|454366690|FG004|Treatment Period 1|Lost to Follow-up|0|||
126294546|NCT01891864|454366691|FG005|Treatment Period 1|Lost to Follow-up|0|||
126294547|NCT01891864|454366686|FG000|Treatment Period 2|Protocol Violation|0|||
126294548|NCT01891864|454366687|FG001|Treatment Period 2|Protocol Violation|0|||
126294549|NCT01891864|454366688|FG002|Treatment Period 2|Protocol Violation|0|||
126294550|NCT01891864|454366689|FG003|Treatment Period 2|Protocol Violation|1|||
125883426|NCT00068692|452871468|FG002|Step 2: Randomization|alternative therapy|0|||
126294551|NCT01891864|454366690|FG004|Treatment Period 2|Protocol Violation|0|||
125883427|NCT00068692|452871469|FG003|Step 2: Randomization|alternative therapy|1|||
126042427|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
126294552|NCT01891864|454366691|FG005|Treatment Period 2|Protocol Violation|0|||
126294553|NCT01891864|454366686|FG000|Treatment Period 2|Physician Decision|0|||
126294554|NCT01891864|454366687|FG001|Treatment Period 2|Physician Decision|0|||
126294555|NCT01891864|454366688|FG002|Treatment Period 2|Physician Decision|1|||
126294556|NCT01891864|454366689|FG003|Treatment Period 2|Physician Decision|0|||
126294557|NCT01891864|454366690|FG004|Treatment Period 2|Physician Decision|0|||
126294558|NCT01891864|454366691|FG005|Treatment Period 2|Physician Decision|0|||
126294559|NCT01891864|454366686|FG000|Treatment Period 2|Site Termination|0|||
126294560|NCT01891864|454366687|FG001|Treatment Period 2|Site Termination|0|||
126294561|NCT01891864|454366688|FG002|Treatment Period 2|Site Termination|1|||
126294562|NCT01891864|454366689|FG003|Treatment Period 2|Site Termination|2|||
126294563|NCT01891864|454366690|FG004|Treatment Period 2|Site Termination|0|||
126294564|NCT01891864|454366691|FG005|Treatment Period 2|Site Termination|0|||
126294565|NCT01891864|454366686|FG000|Treatment Period 2|Lack of Efficacy|0|||
126294566|NCT01891864|454366687|FG001|Treatment Period 2|Lack of Efficacy|0|||
126294567|NCT01891864|454366688|FG002|Treatment Period 2|Lack of Efficacy|1|||
126294568|NCT01891864|454366689|FG003|Treatment Period 2|Lack of Efficacy|0|||
126294569|NCT01891864|454366690|FG004|Treatment Period 2|Lack of Efficacy|1|||
126294570|NCT01891864|454366691|FG005|Treatment Period 2|Lack of Efficacy|0|||
126294571|NCT01891864|454366686|FG000|Treatment Period 2|Adverse Event|0|||
126294572|NCT01891864|454366687|FG001|Treatment Period 2|Adverse Event|0|||
126294573|NCT01891864|454366688|FG002|Treatment Period 2|Adverse Event|1|||
126294574|NCT01891864|454366689|FG003|Treatment Period 2|Adverse Event|2|||
126294575|NCT01891864|454366690|FG004|Treatment Period 2|Adverse Event|0|||
126294576|NCT01891864|454366691|FG005|Treatment Period 2|Adverse Event|4|||
126294577|NCT01891864|454366686|FG000|Treatment Period 2|Termination of Site|0|||
126294578|NCT01891864|454366687|FG001|Treatment Period 2|Termination of Site|0|||
126294579|NCT01891864|454366688|FG002|Treatment Period 2|Termination of Site|0|||
126294580|NCT01891864|454366689|FG003|Treatment Period 2|Termination of Site|0|||
126294581|NCT01891864|454366690|FG004|Treatment Period 2|Termination of Site|2|||
126294582|NCT01891864|454366691|FG005|Treatment Period 2|Termination of Site|0|||
126294583|NCT01891864|454366686|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126294584|NCT01891864|454366687|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126294585|NCT01891864|454366688|FG002|Treatment Period 2|Withdrawal by Subject|3|||
126294586|NCT01891864|454366689|FG003|Treatment Period 2|Withdrawal by Subject|4|||
126294587|NCT01891864|454366690|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126294588|NCT01891864|454366691|FG005|Treatment Period 2|Withdrawal by Subject|1|||
126294589|NCT01891864|454366686|FG000|Extension Period|Lack of Efficacy|0|||
126294590|NCT01891864|454366687|FG001|Extension Period|Lack of Efficacy|0|||
126294591|NCT01891864|454366688|FG002|Extension Period|Lack of Efficacy|0|||
126294592|NCT01891864|454366689|FG003|Extension Period|Lack of Efficacy|1|||
126294593|NCT01891864|454366690|FG004|Extension Period|Lack of Efficacy|1|||
126294594|NCT01891864|454366691|FG005|Extension Period|Lack of Efficacy|0|||
126294595|NCT01891864|454366686|FG000|Extension Period|Pregnancy|0|||
126294596|NCT01891864|454366687|FG001|Extension Period|Pregnancy|0|||
126294597|NCT01891864|454366688|FG002|Extension Period|Pregnancy|1|||
126294598|NCT01891864|454366689|FG003|Extension Period|Pregnancy|0|||
126294599|NCT01891864|454366690|FG004|Extension Period|Pregnancy|0|||
126294600|NCT01891864|454366691|FG005|Extension Period|Pregnancy|0|||
126294601|NCT01891864|454366686|FG000|Extension Period|Adverse Event|0|||
126294602|NCT01891864|454366687|FG001|Extension Period|Adverse Event|0|||
126294603|NCT01891864|454366688|FG002|Extension Period|Adverse Event|4|||
126294604|NCT01891864|454366689|FG003|Extension Period|Adverse Event|2|||
126294605|NCT01891864|454366690|FG004|Extension Period|Adverse Event|2|||
126294606|NCT01891864|454366691|FG005|Extension Period|Adverse Event|0|||
126294607|NCT01891864|454366686|FG000|Extension Period|Withdrawal by Subject|0|||
126294608|NCT01891864|454366687|FG001|Extension Period|Withdrawal by Subject|0|||
126294609|NCT01891864|454366688|FG002|Extension Period|Withdrawal by Subject|1|||
126294610|NCT01891864|454366689|FG003|Extension Period|Withdrawal by Subject|2|||
126294611|NCT01891864|454366690|FG004|Extension Period|Withdrawal by Subject|4|||
126294612|NCT01891864|454366691|FG005|Extension Period|Withdrawal by Subject|0|||
126294613|NCT01891864|454366686|FG000|Extension Period|Lost to Follow-up|0|||
126294614|NCT01891864|454366687|FG001|Extension Period|Lost to Follow-up|0|||
126294615|NCT01891864|454366688|FG002|Extension Period|Lost to Follow-up|2|||
126294616|NCT01891864|454366689|FG003|Extension Period|Lost to Follow-up|0|||
126294617|NCT01891864|454366690|FG004|Extension Period|Lost to Follow-up|0|||
126294618|NCT01891864|454366691|FG005|Extension Period|Lost to Follow-up|0|||
126294619|NCT02698163|454366692|FG000|Overall Study|Lost to Follow-up|0|||
126294620|NCT02698163|454366693|FG001|Overall Study|Lost to Follow-up|1|||
126294621|NCT05373108|454366694|FG000|Overall Study|Withdrawal by Subject|2|||
126294622|NCT02892331|454366695|FG000|Overall Study|Withdrawal by Subject|0|||
126294623|NCT02892331|454366696|FG001|Overall Study|Withdrawal by Subject|1|||
126294624|NCT02892331|454366697|FG002|Overall Study|Withdrawal by Subject|1|||
126294625|NCT02892331|454366695|FG000|Overall Study|Sick family member|0|||
126294626|NCT02892331|454366696|FG001|Overall Study|Sick family member|0|||
126294627|NCT02892331|454366697|FG002|Overall Study|Sick family member|1|||
126294628|NCT02892331|454366695|FG000|Overall Study|Corona virus pandemic|1|||
126294629|NCT02892331|454366696|FG001|Overall Study|Corona virus pandemic|0|||
126294630|NCT02892331|454366697|FG002|Overall Study|Corona virus pandemic|1|||
126294631|NCT02892331|454366695|FG000|Overall Study|Lost to Follow-up|1|||
126294632|NCT02892331|454366696|FG001|Overall Study|Lost to Follow-up|0|||
126294633|NCT02892331|454366697|FG002|Overall Study|Lost to Follow-up|1|||
126294634|NCT02892331|454366695|FG000|Overall Study|Blood pressure was too elevated|0|||
126294635|NCT02892331|454366696|FG001|Overall Study|Blood pressure was too elevated|1|||
126294636|NCT02892331|454366697|FG002|Overall Study|Blood pressure was too elevated|0|||
126294637|NCT02892331|454366695|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
126294638|NCT02892331|454366696|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
126294639|NCT02892331|454366697|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
126294640|NCT00752128|454366701|FG000|Overall Study|Withdrawal by Subject|4|||
126294641|NCT00349973|454366702|FG000|Overall Study|Adverse Event|3|||
126294642|NCT00349973|454366703|FG001|Overall Study|Adverse Event|3|||
126294643|NCT00349973|454366702|FG000|Overall Study|Withdrawal by Subject|1|||
126294644|NCT00349973|454366703|FG001|Overall Study|Withdrawal by Subject|0|||
126294645|NCT04314037|454366704|FG000|Treatment Period 2|Adverse Event|1|||
126294646|NCT04314037|454366705|FG001|Treatment Period 2|Adverse Event|0|||
126294647|NCT04314037|454366704|FG000|Treatment Period 3|Protocol Violation|1|||
126294648|NCT04314037|454366705|FG001|Treatment Period 3|Protocol Violation|0|||
126294649|NCT04314037|454366704|FG000|Treatment Period 3|Adverse Event|0|||
126294650|NCT04314037|454366705|FG001|Treatment Period 3|Adverse Event|1|||
126294651|NCT02235454|454366708|FG000|Overall Study|Withdrawal by Subject|2|||
126294652|NCT03323398|454366709|FG000|Overall Study|Other than Specified|0|||
126294653|NCT03323398|454366710|FG001|Overall Study|Other than Specified|1|||
126294654|NCT03323398|454366711|FG002|Overall Study|Other than Specified|2|||
126294655|NCT03323398|454366712|FG003|Overall Study|Other than Specified|0|||
126294656|NCT03323398|454366713|FG004|Overall Study|Other than Specified|0|||
126294657|NCT03323398|454366714|FG005|Overall Study|Other than Specified|0|||
126294658|NCT03323398|454366715|FG006|Overall Study|Other than Specified|1|||
126294659|NCT03323398|454366716|FG007|Overall Study|Other than Specified|0|||
126294660|NCT03323398|454366717|FG008|Overall Study|Other than Specified|2|||
126294661|NCT03323398|454366709|FG000|Overall Study|Lost to Follow-up|1|||
126294662|NCT03323398|454366710|FG001|Overall Study|Lost to Follow-up|2|||
126294663|NCT03323398|454366711|FG002|Overall Study|Lost to Follow-up|1|||
126294664|NCT03323398|454366712|FG003|Overall Study|Lost to Follow-up|0|||
126294665|NCT03323398|454366713|FG004|Overall Study|Lost to Follow-up|0|||
126294666|NCT03323398|454366714|FG005|Overall Study|Lost to Follow-up|0|||
126294667|NCT03323398|454366715|FG006|Overall Study|Lost to Follow-up|0|||
126294668|NCT03323398|454366716|FG007|Overall Study|Lost to Follow-up|0|||
126294669|NCT03323398|454366717|FG008|Overall Study|Lost to Follow-up|0|||
126294670|NCT03323398|454366709|FG000|Overall Study|Death|4|||
126294671|NCT03323398|454366710|FG001|Overall Study|Death|6|||
126294672|NCT03323398|454366711|FG002|Overall Study|Death|2|||
126294673|NCT03323398|454366712|FG003|Overall Study|Death|2|||
126294674|NCT03323398|454366713|FG004|Overall Study|Death|1|||
126294675|NCT03323398|454366714|FG005|Overall Study|Death|2|||
126294676|NCT03323398|454366715|FG006|Overall Study|Death|0|||
126294677|NCT03323398|454366716|FG007|Overall Study|Death|0|||
126294678|NCT03323398|454366717|FG008|Overall Study|Death|6|||
126294679|NCT03323398|454366709|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
126294680|NCT03323398|454366710|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
126294681|NCT03323398|454366711|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
126294682|NCT03323398|454366712|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
126294683|NCT03323398|454366713|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
126294684|NCT03323398|454366714|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
126294685|NCT03323398|454366715|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
126294686|NCT03323398|454366716|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
126294687|NCT03323398|454366717|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
126294688|NCT03323398|454366709|FG000|Overall Study|Withdrawal by Subject|2|||
126294689|NCT03323398|454366710|FG001|Overall Study|Withdrawal by Subject|1|||
126294690|NCT03323398|454366711|FG002|Overall Study|Withdrawal by Subject|3|||
126294691|NCT03323398|454366712|FG003|Overall Study|Withdrawal by Subject|0|||
126294692|NCT03323398|454366713|FG004|Overall Study|Withdrawal by Subject|0|||
126294693|NCT03323398|454366714|FG005|Overall Study|Withdrawal by Subject|1|||
126294694|NCT03323398|454366715|FG006|Overall Study|Withdrawal by Subject|0|||
126294695|NCT03323398|454366716|FG007|Overall Study|Withdrawal by Subject|0|||
126294696|NCT03323398|454366717|FG008|Overall Study|Withdrawal by Subject|0|||
126294697|NCT03323398|454366709|FG000|Overall Study|Participant was Put on Hospice|0|||
126294698|NCT03323398|454366710|FG001|Overall Study|Participant was Put on Hospice|0|||
126294699|NCT03323398|454366711|FG002|Overall Study|Participant was Put on Hospice|0|||
126294700|NCT03323398|454366712|FG003|Overall Study|Participant was Put on Hospice|0|||
126294701|NCT03323398|454366713|FG004|Overall Study|Participant was Put on Hospice|0|||
126294702|NCT03323398|454366714|FG005|Overall Study|Participant was Put on Hospice|0|||
126294703|NCT03323398|454366715|FG006|Overall Study|Participant was Put on Hospice|1|||
126294704|NCT03323398|454366716|FG007|Overall Study|Participant was Put on Hospice|0|||
126294705|NCT03323398|454366717|FG008|Overall Study|Participant was Put on Hospice|0|||
126294706|NCT03323398|454366709|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
126294707|NCT03323398|454366710|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
126294708|NCT03323398|454366711|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
126294709|NCT03323398|454366712|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
126100204|NCT02257567|453659866|FG003|Overall Study|Physician Decision|0|||
126100205|NCT02257567|453659867|FG004|Overall Study|Physician Decision|0|||
126100206|NCT02257567|453659868|FG005|Overall Study|Physician Decision|0|||
126100207|NCT02257567|453659869|FG006|Overall Study|Physician Decision|0|||
126100208|NCT02257567|453659870|FG007|Overall Study|Physician Decision|2|||
126100209|NCT02257567|453659871|FG008|Overall Study|Physician Decision|0|||
126100210|NCT02257567|453659872|FG009|Overall Study|Physician Decision|1|||
126100211|NCT02257567|453659873|FG010|Overall Study|Physician Decision|0|||
126294710|NCT03323398|454366713|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
126294711|NCT03323398|454366714|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
126294712|NCT03323398|454366715|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
126294713|NCT03323398|454366716|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
126294714|NCT03323398|454366717|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
126294715|NCT03641469|454366718|FG000|Overall Study|Ineligible|2|||
126100212|NCT02257567|453659863|FG000|Overall Study|Withdrawal by Subject|0|||
126100213|NCT02257567|453659864|FG001|Overall Study|Withdrawal by Subject|0|||
126100214|NCT02257567|453659865|FG002|Overall Study|Withdrawal by Subject|2|||
126100215|NCT02257567|453659866|FG003|Overall Study|Withdrawal by Subject|0|||
126100216|NCT02257567|453659867|FG004|Overall Study|Withdrawal by Subject|0|||
126294716|NCT03641469|454366718|FG000|Overall Study|Withdrawal by Subject|5|||
126294717|NCT03641469|454366718|FG000|Overall Study|Physician Decision|1|||
126294718|NCT03641469|454366718|FG000|Overall Study|Protocol Violation|1|||
126294719|NCT03641469|454366718|FG000|Overall Study|Lost to Follow-up|2|||
126294720|NCT02562235|454368423|FG000|Overall Study|Adverse Event|3|||
126294721|NCT02546986|454368424|FG000|Treatment Period|Progressive Disease|20|||
126294722|NCT02546986|454368425|FG001|Treatment Period|Progressive Disease|22|||
126294723|NCT02546986|454368424|FG000|Treatment Period|Adverse Event|14|||
126294724|NCT02546986|454368425|FG001|Treatment Period|Adverse Event|6|||
126294725|NCT02546986|454368424|FG000|Treatment Period|Symptomatic Deterioration|4|||
126294726|NCT02546986|454368425|FG001|Treatment Period|Symptomatic Deterioration|3|||
126294727|NCT02546986|454368424|FG000|Treatment Period|Death|3|||
126294728|NCT02546986|454368425|FG001|Treatment Period|Death|4|||
126294729|NCT02546986|454368424|FG000|Treatment Period|Physician Decision|1|||
126294730|NCT02546986|454368425|FG001|Treatment Period|Physician Decision|2|||
126294731|NCT02546986|454368424|FG000|Treatment Period|Protocol Violation|1|||
126294732|NCT02546986|454368425|FG001|Treatment Period|Protocol Violation|0|||
126294733|NCT02546986|454368424|FG000|Treatment Period|Withdrawal by Subject|1|||
126294734|NCT02546986|454368425|FG001|Treatment Period|Withdrawal by Subject|1|||
126294735|NCT02546986|454368424|FG000|Treatment Period|Non-compliance with Study Drug|0|||
126294736|NCT02546986|454368425|FG001|Treatment Period|Non-compliance with Study Drug|1|||
126294737|NCT02546986|454368424|FG000|Treatment Period|Study Terminated by Sponsor|0|||
126294738|NCT02546986|454368425|FG001|Treatment Period|Study Terminated by Sponsor|1|||
126294739|NCT02546986|454368424|FG000|Treatment Period|Miscellaneous|7|||
126294740|NCT02546986|454368425|FG001|Treatment Period|Miscellaneous|9|||
126294741|NCT02546986|454368424|FG000|Survival Follow-Up Phase|Missing Status|3|||
126294742|NCT02546986|454368425|FG001|Survival Follow-Up Phase|Missing Status|5|||
126294743|NCT02546986|454368424|FG000|Survival Follow-Up Phase|Death|18|||
126294744|NCT02546986|454368425|FG001|Survival Follow-Up Phase|Death|12|||
126294745|NCT02546986|454368424|FG000|Survival Follow-Up Phase|Alive|13|||
126294746|NCT02546986|454368425|FG001|Survival Follow-Up Phase|Alive|16|||
126294747|NCT02546986|454368424|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
126294748|NCT02546986|454368425|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
126294749|NCT05016960|454368426|FG000|Overall Study|Withdrawal by Subject|1|||
126294750|NCT05016960|454368427|FG001|Overall Study|Withdrawal by Subject|9|||
126294751|NCT04796961|454368428|FG000|Overall Study|Lost to Follow-up|10|||
126294752|NCT04796961|454368428|FG000|Overall Study|Withdrawal by Subject|3|||
126294753|NCT04796961|454368428|FG000|Overall Study|Left Organization|10|||
126100217|NCT02257567|453659868|FG005|Overall Study|Withdrawal by Subject|6|||
126100218|NCT02257567|453659869|FG006|Overall Study|Withdrawal by Subject|6|||
126100219|NCT02257567|453659870|FG007|Overall Study|Withdrawal by Subject|6|||
126100220|NCT02257567|453659871|FG008|Overall Study|Withdrawal by Subject|1|||
126100221|NCT02257567|453659872|FG009|Overall Study|Withdrawal by Subject|1|||
126100222|NCT02257567|453659873|FG010|Overall Study|Withdrawal by Subject|10|||
126294754|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
126294755|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
126294756|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
126294757|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
126294758|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
126294759|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
126294760|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
126294761|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
126294762|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
126294763|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
126294764|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
126294765|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
126294766|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
126294767|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
126294768|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
126294769|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
126294770|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
126294771|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
126294772|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
126294773|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
126294774|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
126294775|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
126294776|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
126294777|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
126294778|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
126294779|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
126294780|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
126294781|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
126294782|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
126294783|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
126294784|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
126294785|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
126294786|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
126294787|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
126294788|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
126294789|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
126294790|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
126294791|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
126294792|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
126294793|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
126294794|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
126294795|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
126294796|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
126294797|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
126294798|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
126294799|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
126294800|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
126294801|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
126294802|NCT02068508|454368441|FG000|Overall Study|Case report forms uncollected|27|||
126294803|NCT02068508|454368441|FG000|Overall Study|Patient did not visit the study site|1|||
126294804|NCT02068508|454368441|FG000|Overall Study|Protocol Violation|4|||
126294805|NCT04173507|454368442|FG000|Overall Study|On Treatment|3|||
126294806|NCT04173507|454368442|FG000|Overall Study|Adverse Event|3|||
126294807|NCT04173507|454368442|FG000|Overall Study|Progression/Relapse|34|||
126294808|NCT04173507|454368442|FG000|Overall Study|Death|2|||
126294809|NCT02157935|454368443|FG000|Overall Study|Withdrawal by Subject|25|||
126294810|NCT02157935|454368444|FG001|Overall Study|Withdrawal by Subject|39|||
126042428|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
126294811|NCT02157935|454368443|FG000|Overall Study|Screen failure|1|||
126294812|NCT02157935|454368444|FG001|Overall Study|Screen failure|2|||
126294813|NCT02157935|454368443|FG000|Overall Study|Protocol Violation|1|||
126294814|NCT02157935|454368444|FG001|Overall Study|Protocol Violation|0|||
126294815|NCT02157935|454368443|FG000|Overall Study|Progressive disease|0|||
126294816|NCT02157935|454368444|FG001|Overall Study|Progressive disease|2|||
126294817|NCT02157935|454368443|FG000|Overall Study|Other|5|||
126294818|NCT02157935|454368444|FG001|Overall Study|Other|12|||
126294819|NCT02157935|454368443|FG000|Overall Study|Lack of Efficacy|0|||
126042429|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
126294820|NCT02157935|454368444|FG001|Overall Study|Lack of Efficacy|1|||
126294821|NCT02157935|454368443|FG000|Overall Study|Death|4|||
126366816|NCT02327169|454639313|FG001|Overall Study|Symptomatic Deterioration|0|||
126366817|NCT02327169|454639314|FG002|Overall Study|Symptomatic Deterioration|1|||
126366818|NCT02327169|454639315|FG003|Overall Study|Symptomatic Deterioration|0|||
126366819|NCT02327169|454639316|FG004|Overall Study|Symptomatic Deterioration|1|||
126366820|NCT02327169|454639317|FG005|Overall Study|Symptomatic Deterioration|1|||
126366821|NCT02327169|454639318|FG006|Overall Study|Symptomatic Deterioration|0|||
126366822|NCT02327169|454639319|FG007|Overall Study|Symptomatic Deterioration|0|||
126366823|NCT02327169|454639320|FG008|Overall Study|Symptomatic Deterioration|2|||
126366824|NCT02327169|454639321|FG009|Overall Study|Symptomatic Deterioration|1|||
126366825|NCT02327169|454639322|FG010|Overall Study|Symptomatic Deterioration|0|||
126366826|NCT02327169|454639323|FG011|Overall Study|Symptomatic Deterioration|0|||
126366827|NCT02327169|454639324|FG012|Overall Study|Symptomatic Deterioration|0|||
126366828|NCT02327169|454639325|FG013|Overall Study|Symptomatic Deterioration|2|||
126366829|NCT02327169|454639326|FG014|Overall Study|Symptomatic Deterioration|1|||
126366830|NCT02327169|454639312|FG000|Overall Study|Reason Not Specified|0|||
126366831|NCT02327169|454639313|FG001|Overall Study|Reason Not Specified|0|||
126366832|NCT02327169|454639314|FG002|Overall Study|Reason Not Specified|1|||
126366833|NCT02327169|454639315|FG003|Overall Study|Reason Not Specified|0|||
126366834|NCT02327169|454639316|FG004|Overall Study|Reason Not Specified|0|||
126366835|NCT02327169|454639317|FG005|Overall Study|Reason Not Specified|0|||
126366836|NCT02327169|454639318|FG006|Overall Study|Reason Not Specified|0|||
126366837|NCT02327169|454639319|FG007|Overall Study|Reason Not Specified|0|||
126366838|NCT02327169|454639320|FG008|Overall Study|Reason Not Specified|0|||
126366839|NCT02327169|454639321|FG009|Overall Study|Reason Not Specified|1|||
126042430|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
126042431|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
126042432|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
126294822|NCT02157935|454368444|FG001|Overall Study|Death|4|||
126294823|NCT02157935|454368443|FG000|Overall Study|Adverse Event|3|||
126294824|NCT02157935|454368444|FG001|Overall Study|Adverse Event|5|||
126294825|NCT02764762|454368445|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
126294826|NCT02764762|454368445|FG000|Overall Study|Lost to Follow-up|4|||
126294827|NCT02764762|454368445|FG000|Overall Study|Voluntary Withdrawal|8|||
126294828|NCT02764762|454368445|FG000|Overall Study|Site Termination|1|||
126294829|NCT02764762|454368445|FG000|Overall Study|Lack of Efficacy|16|||
126294830|NCT02764762|454368445|FG000|Overall Study|Reason not Specified|1|||
126294831|NCT02547428|454368452|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
126294832|NCT02547428|454368453|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
126294833|NCT02547428|454368452|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
126294834|NCT02547428|454368453|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
126294835|NCT02547428|454368452|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
126042433|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
126042434|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
126042435|NCT03536884|453453110|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042436|NCT03536884|453453111|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042437|NCT03536884|453453112|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042438|NCT03536884|453453113|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042439|NCT03536884|453453114|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042440|NCT03536884|453453115|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042441|NCT03536884|453453116|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042442|NCT03536884|453453117|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042443|NCT03536884|453453118|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
126042444|NCT03536884|453453119|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042445|NCT03536884|453453120|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042446|NCT03536884|453453121|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126042447|NCT03536884|453453110|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126042448|NCT03536884|453453111|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126042449|NCT03536884|453453112|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126042450|NCT03536884|453453113|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126100223|NCT03215810|453659876|FG000|Overall Study|Still responding to nivolumab|1|||
126100224|NCT03215810|453659876|FG000|Overall Study|Insufficient TIL growth|1|||
126100225|NCT03215810|453659876|FG000|Overall Study|Decline in performance status|1|||
126100226|NCT03215810|453659876|FG000|Overall Study|Withdrawal by Subject|1|||
126294836|NCT02547428|454368453|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
126294837|NCT02547428|454368452|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
126366840|NCT02327169|454639322|FG010|Overall Study|Reason Not Specified|2|||
126366841|NCT02327169|454639323|FG011|Overall Study|Reason Not Specified|1|||
126366842|NCT02327169|454639324|FG012|Overall Study|Reason Not Specified|0|||
126366843|NCT02327169|454639325|FG013|Overall Study|Reason Not Specified|0|||
126366844|NCT02327169|454639326|FG014|Overall Study|Reason Not Specified|2|||
126042451|NCT03536884|453453114|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126366845|NCT02327169|454639312|FG000|Overall Study|Withdrawal by Subject|1|||
126366846|NCT02327169|454639313|FG001|Overall Study|Withdrawal by Subject|0|||
126366847|NCT02327169|454639314|FG002|Overall Study|Withdrawal by Subject|0|||
126366848|NCT02327169|454639315|FG003|Overall Study|Withdrawal by Subject|0|||
126366849|NCT02327169|454639316|FG004|Overall Study|Withdrawal by Subject|1|||
126366850|NCT02327169|454639317|FG005|Overall Study|Withdrawal by Subject|0|||
126366851|NCT02327169|454639318|FG006|Overall Study|Withdrawal by Subject|0|||
126366852|NCT02327169|454639319|FG007|Overall Study|Withdrawal by Subject|1|||
126366853|NCT02327169|454639320|FG008|Overall Study|Withdrawal by Subject|0|||
126366854|NCT02327169|454639321|FG009|Overall Study|Withdrawal by Subject|0|||
126366855|NCT02327169|454639322|FG010|Overall Study|Withdrawal by Subject|0|||
126366856|NCT02327169|454639323|FG011|Overall Study|Withdrawal by Subject|0|||
126366857|NCT02327169|454639324|FG012|Overall Study|Withdrawal by Subject|0|||
126366858|NCT02327169|454639325|FG013|Overall Study|Withdrawal by Subject|0|||
126366859|NCT02327169|454639326|FG014|Overall Study|Withdrawal by Subject|3|||
126366860|NCT02327169|454639312|FG000|Overall Study|Lost to Follow-up|0|||
126366861|NCT02327169|454639313|FG001|Overall Study|Lost to Follow-up|0|||
126366862|NCT02327169|454639314|FG002|Overall Study|Lost to Follow-up|0|||
126366863|NCT02327169|454639315|FG003|Overall Study|Lost to Follow-up|0|||
126366864|NCT02327169|454639316|FG004|Overall Study|Lost to Follow-up|1|||
126366865|NCT02327169|454639317|FG005|Overall Study|Lost to Follow-up|0|||
126366866|NCT02327169|454639318|FG006|Overall Study|Lost to Follow-up|0|||
126366867|NCT02327169|454639319|FG007|Overall Study|Lost to Follow-up|0|||
126366868|NCT02327169|454639320|FG008|Overall Study|Lost to Follow-up|0|||
126366869|NCT02327169|454639321|FG009|Overall Study|Lost to Follow-up|0|||
126366870|NCT02327169|454639322|FG010|Overall Study|Lost to Follow-up|0|||
126366871|NCT02327169|454639323|FG011|Overall Study|Lost to Follow-up|0|||
126366872|NCT02327169|454639324|FG012|Overall Study|Lost to Follow-up|0|||
126366873|NCT02327169|454639325|FG013|Overall Study|Lost to Follow-up|0|||
126366874|NCT02327169|454639326|FG014|Overall Study|Lost to Follow-up|0|||
126366875|NCT01381679|454639330|FG000|Overall Study|Adverse Event|3|||
126366876|NCT01381679|454639330|FG000|Overall Study|Lost to Follow-up|885|||
126366877|NCT04023487|454639331|FG000|Overall Study|Lost to Follow-up|5|||
126366878|NCT04023487|454639332|FG001|Overall Study|Lost to Follow-up|4|||
126366879|NCT04023487|454639331|FG000|Overall Study|Pregnancy|1|||
126366880|NCT04023487|454639332|FG001|Overall Study|Pregnancy|2|||
126366881|NCT04023487|454639331|FG000|Overall Study|Withdrawal by Subject|4|||
126366882|NCT04023487|454639332|FG001|Overall Study|Withdrawal by Subject|5|||
126366883|NCT04023487|454639331|FG000|Overall Study|Partially completed testing|8|||
126366884|NCT04023487|454639332|FG001|Overall Study|Partially completed testing|4|||
126366885|NCT03766399|454639335|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366886|NCT03766399|454639336|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366887|NCT03766399|454639337|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366888|NCT03766399|454639338|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126294838|NCT02547428|454368453|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
126294839|NCT02547428|454368452|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
126294840|NCT02547428|454368453|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
126294841|NCT02547428|454368452|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
126294842|NCT02547428|454368453|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
126294843|NCT02547428|454368452|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
126294844|NCT02547428|454368453|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
126294845|NCT02547428|454368452|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
126294846|NCT02547428|454368453|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
126294847|NCT01479465|454368454|FG000|Overall Study|Disease Progression|9|||
126294848|NCT01479465|454368455|FG001|Overall Study|Disease Progression|61|||
126294849|NCT01479465|454368456|FG002|Overall Study|Disease Progression|65|||
126294850|NCT01479465|454368457|FG003|Overall Study|Disease Progression|70|||
126294851|NCT01479465|454368454|FG000|Overall Study|Study Discontinued by Sponsor|0|||
126294852|NCT01479465|454368455|FG001|Overall Study|Study Discontinued by Sponsor|7|||
126294853|NCT01479465|454368456|FG002|Overall Study|Study Discontinued by Sponsor|5|||
126294854|NCT01479465|454368457|FG003|Overall Study|Study Discontinued by Sponsor|3|||
126366889|NCT03766399|454639339|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366890|NCT03766399|454639340|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366891|NCT03766399|454639341|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366892|NCT03766399|454639342|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366893|NCT03766399|454639343|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366894|NCT03766399|454639344|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366895|NCT03766399|454639345|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366896|NCT03766399|454639346|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366897|NCT03766399|454639347|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126294855|NCT01479465|454368454|FG000|Overall Study|Adverse Event|0|||
126294856|NCT01479465|454368455|FG001|Overall Study|Adverse Event|3|||
126294857|NCT01479465|454368456|FG002|Overall Study|Adverse Event|6|||
126294858|NCT01479465|454368457|FG003|Overall Study|Adverse Event|4|||
126294859|NCT01479465|454368454|FG000|Overall Study|Investigator Discretion|1|||
126294860|NCT01479465|454368455|FG001|Overall Study|Investigator Discretion|4|||
126294861|NCT01479465|454368456|FG002|Overall Study|Investigator Discretion|2|||
126294862|NCT01479465|454368457|FG003|Overall Study|Investigator Discretion|4|||
126294863|NCT01479465|454368454|FG000|Overall Study|Subject Request|1|||
126294864|NCT01479465|454368455|FG001|Overall Study|Subject Request|3|||
126294865|NCT01479465|454368456|FG002|Overall Study|Subject Request|4|||
126294866|NCT01479465|454368457|FG003|Overall Study|Subject Request|2|||
126294867|NCT01479465|454368454|FG000|Overall Study|Subject Withdrew Consent|0|||
126294868|NCT01479465|454368455|FG001|Overall Study|Subject Withdrew Consent|5|||
126294869|NCT01479465|454368456|FG002|Overall Study|Subject Withdrew Consent|2|||
126294870|NCT01479465|454368457|FG003|Overall Study|Subject Withdrew Consent|1|||
126294871|NCT01479465|454368454|FG000|Overall Study|Protocol Violation|0|||
126042452|NCT03536884|453453115|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126042453|NCT03536884|453453116|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126294872|NCT01479465|454368455|FG001|Overall Study|Protocol Violation|1|||
126294873|NCT01479465|454368456|FG002|Overall Study|Protocol Violation|1|||
126294874|NCT01479465|454368457|FG003|Overall Study|Protocol Violation|0|||
126294875|NCT01479465|454368454|FG000|Overall Study|Death|0|||
126294876|NCT01479465|454368455|FG001|Overall Study|Death|0|||
126294877|NCT01479465|454368456|FG002|Overall Study|Death|0|||
126294878|NCT01479465|454368457|FG003|Overall Study|Death|1|||
126294879|NCT01479465|454368454|FG000|Overall Study|Lost to Follow-up|0|||
126294880|NCT01479465|454368455|FG001|Overall Study|Lost to Follow-up|0|||
126294881|NCT01479465|454368456|FG002|Overall Study|Lost to Follow-up|1|||
126294882|NCT01479465|454368457|FG003|Overall Study|Lost to Follow-up|0|||
126294883|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
126294884|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
126294885|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
126294886|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
126294887|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
126294888|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
126294889|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
126294890|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
126294891|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
126294892|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
126294893|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
126294894|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
126294895|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
126294896|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
126294897|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
126294898|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
126294899|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
126294900|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
126294901|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
126294902|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
126294903|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
126294904|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
126294905|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
126294906|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
126294907|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
126294908|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
126294909|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
126294910|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
126294911|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
126294912|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
126294913|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Death|9|||
126294914|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Death|18|||
126294915|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Death|5|||
126042454|NCT03536884|453453117|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126042455|NCT03536884|453453118|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126294916|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Death|0|||
126294917|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Death|0|||
126294918|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Death|0|||
126294919|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294920|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294921|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294922|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
126294923|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294924|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294925|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
126294926|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
126294927|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
126294928|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
126294929|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
126294930|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
126294931|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
126294932|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
126294933|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
126294934|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
126294935|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
126294936|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
126294937|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
126294938|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
126294939|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
126294940|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
126294941|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
126294942|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
126294943|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
126294944|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
126294945|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
126294946|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
126294947|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
126294948|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
126294949|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
126294950|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
126294951|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
126294952|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
126294953|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
126294954|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
126294955|NCT05516108|454368468|FG000|Overall Study|Time Commitment|3|||
126294956|NCT05516108|454368469|FG001|Overall Study|Time Commitment|1|||
126294957|NCT05516108|454368468|FG000|Overall Study|Reason Unknown|2|||
126294958|NCT05516108|454368469|FG001|Overall Study|Reason Unknown|4|||
126294959|NCT02717507|454368470|FG000|Overall Study|Lost to Follow-up|5|||
126294960|NCT02717507|454368471|FG001|Overall Study|Lost to Follow-up|8|||
126294961|NCT02717507|454368470|FG000|Overall Study|Pregnancy|1|||
126294962|NCT02717507|454368471|FG001|Overall Study|Pregnancy|1|||
126294963|NCT02717507|454368470|FG000|Overall Study|Protocol Violation|2|||
126294964|NCT02717507|454368471|FG001|Overall Study|Protocol Violation|2|||
126294965|NCT02717507|454368470|FG000|Overall Study|Withdrawal by Subject|20|||
126294966|NCT02717507|454368471|FG001|Overall Study|Withdrawal by Subject|20|||
126294967|NCT02717507|454368470|FG000|Overall Study|Relapse|1|||
126294968|NCT02717507|454368471|FG001|Overall Study|Relapse|1|||
126294969|NCT02717507|454368470|FG000|Overall Study|Cardiac Event|2|||
126294970|NCT02717507|454368471|FG001|Overall Study|Cardiac Event|6|||
126294971|NCT00709995|454368472|FG000|Overall Study|Adverse Event|4|||
126294972|NCT00709995|454368473|FG001|Overall Study|Adverse Event|2|||
126042456|NCT03536884|453453119|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
126042457|NCT03536884|453453120|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
126042458|NCT03536884|453453121|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
126042459|NCT03536884|453453110|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126042460|NCT03536884|453453111|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126042461|NCT03536884|453453112|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126042462|NCT03536884|453453113|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126294973|NCT00709995|454368472|FG000|Overall Study|Withdrawal by Subject|1|||
126294974|NCT00709995|454368473|FG001|Overall Study|Withdrawal by Subject|3|||
126294975|NCT02003209|454368474|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
126294976|NCT02003209|454368475|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
126294977|NCT00638508|454368476|FG000|Overall Study|Physician Decision|5|||
126294978|NCT00638508|454368477|FG001|Overall Study|Physician Decision|2|||
126294979|NCT00370552|454368478|FG000|Overall Study|Adverse Event|2|||
126294980|NCT00370552|454368479|FG001|Overall Study|Adverse Event|2|||
126294981|NCT00370552|454368480|FG002|Overall Study|Adverse Event|2|||
126294982|NCT00370552|454368478|FG000|Overall Study|Disease progression|23|||
126294983|NCT00370552|454368479|FG001|Overall Study|Disease progression|23|||
126294984|NCT00370552|454368480|FG002|Overall Study|Disease progression|15|||
126294985|NCT00370552|454368478|FG000|Overall Study|Maximum clinical benefit|3|||
126366898|NCT03766399|454639348|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
126294986|NCT00370552|454368479|FG001|Overall Study|Maximum clinical benefit|5|||
126294987|NCT00370552|454368480|FG002|Overall Study|Maximum clinical benefit|5|||
126294988|NCT00370552|454368478|FG000|Overall Study|Poor or noncompliance|0|||
126294989|NCT00370552|454368479|FG001|Overall Study|Poor or noncompliance|0|||
126294990|NCT00370552|454368480|FG002|Overall Study|Poor or noncompliance|1|||
126294991|NCT00370552|454368478|FG000|Overall Study|Study drug toxicity|11|||
126294992|NCT00370552|454368479|FG001|Overall Study|Study drug toxicity|8|||
126294993|NCT00370552|454368480|FG002|Overall Study|Study drug toxicity|6|||
126294994|NCT00370552|454368478|FG000|Overall Study|Withdrawal by Subject|2|||
126294995|NCT00370552|454368479|FG001|Overall Study|Withdrawal by Subject|0|||
126294996|NCT00370552|454368480|FG002|Overall Study|Withdrawal by Subject|1|||
126294997|NCT00370552|454368478|FG000|Overall Study|Still on treatment|1|||
126294998|NCT00370552|454368479|FG001|Overall Study|Still on treatment|3|||
126294999|NCT00370552|454368480|FG002|Overall Study|Still on treatment|2|||
126295000|NCT00370552|454368478|FG000|Overall Study|Never treated|1|||
126295001|NCT00370552|454368479|FG001|Overall Study|Never treated|0|||
126295002|NCT00370552|454368480|FG002|Overall Study|Never treated|0|||
126295003|NCT00370552|454368478|FG000|Overall Study|Physician Decision|1|||
126295004|NCT00370552|454368479|FG001|Overall Study|Physician Decision|1|||
126295005|NCT00370552|454368480|FG002|Overall Study|Physician Decision|0|||
126295006|NCT00370552|454368478|FG000|Overall Study|Investigator decision|2|||
126295007|NCT00370552|454368479|FG001|Overall Study|Investigator decision|1|||
126295008|NCT00370552|454368480|FG002|Overall Study|Investigator decision|0|||
126295009|NCT00370552|454368478|FG000|Overall Study|High risk of allergic reaction|0|||
126295010|NCT00370552|454368479|FG001|Overall Study|High risk of allergic reaction|1|||
126295011|NCT00370552|454368480|FG002|Overall Study|High risk of allergic reaction|0|||
126295012|NCT00370552|454368478|FG000|Overall Study|Planned radiation for palliation|0|||
126295013|NCT00370552|454368479|FG001|Overall Study|Planned radiation for palliation|1|||
126295014|NCT00370552|454368480|FG002|Overall Study|Planned radiation for palliation|0|||
126295015|NCT03500198|454368481|FG000|Overall Study|Lost to Follow-up|0|||
126295016|NCT03500198|454368482|FG001|Overall Study|Lost to Follow-up|1|||
126295017|NCT00942084|454368494|FG000|Overall Study|Death|2|||
126295018|NCT01641640|454368495|FG000|Overall Study|Enrolled but not treated|1|||
126295019|NCT01641640|454368495|FG000|Overall Study|Efficacy failure|29|||
126295020|NCT01641640|454368495|FG000|Overall Study|Lost to Follow-up|3|||
126295021|NCT01641640|454368495|FG000|Overall Study|Withdrawal by Subject|2|||
126295022|NCT01641640|454368495|FG000|Overall Study|Adverse Event|1|||
126295023|NCT01234350|454368496|FG000|Overall Study|Adverse Event|277|||
126295024|NCT01234350|454368497|FG001|Overall Study|Adverse Event|92|||
126295025|NCT01234350|454368496|FG000|Overall Study|Withdrawal by Subject|61|||
126295026|NCT01234350|454368497|FG001|Overall Study|Withdrawal by Subject|36|||
126295027|NCT01234350|454368496|FG000|Overall Study|Lost to Follow-up|115|||
126295028|NCT01234350|454368497|FG001|Overall Study|Lost to Follow-up|47|||
126295029|NCT01234350|454368496|FG000|Overall Study|Covers a diverse set of reasons|234|||
126295030|NCT01234350|454368497|FG001|Overall Study|Covers a diverse set of reasons|92|||
126295031|NCT03534687|454368498|FG000|Overall Study|Lost to Follow-up|7|||
126295032|NCT03534687|454368499|FG001|Overall Study|Lost to Follow-up|2|||
126295033|NCT01051960|454368500|FG000|Overall Study|Adverse Event|1|||
126295034|NCT01960413|454368509|FG000|Overall Study|Withdrawal by Subject|1|||
126295035|NCT01960413|454368510|FG001|Overall Study|Withdrawal by Subject|1|||
126295036|NCT01960413|454368509|FG000|Overall Study|Physician Decision|1|||
126295037|NCT01960413|454368510|FG001|Overall Study|Physician Decision|0|||
126295038|NCT01960413|454368509|FG000|Overall Study|Lost to Follow-up|2|||
126295039|NCT01960413|454368510|FG001|Overall Study|Lost to Follow-up|0|||
126295040|NCT01082328|454368514|FG000|Overall Study|Adverse Event|1|||
126295041|NCT02285361|454368515|FG000|Overall Study|Protocol Violation|43|||
126295042|NCT02285361|454368515|FG000|Overall Study|Lost to Follow-up|5|||
126295043|NCT02285361|454368515|FG000|Overall Study|Not taken GIOTRIF|2|||
126295044|NCT02285361|454368515|FG000|Overall Study|Consented prior to the contract date|1|||
126295045|NCT05506046|454368518|FG000|Overall Study|Lost to Follow-up|89|||
126295046|NCT05506046|454368519|FG001|Overall Study|Lost to Follow-up|101|||
126295047|NCT05506046|454368520|FG002|Overall Study|Lost to Follow-up|102|||
126295048|NCT05506046|454368521|FG003|Overall Study|Lost to Follow-up|99|||
126295049|NCT03335475|454368522|FG000|Overall Study|Did not wear accelerometer|4|||
126295050|NCT03335475|454368523|FG001|Overall Study|Did not wear accelerometer|0|||
126295051|NCT03335475|454368522|FG000|Overall Study|Withdrawal by Subject|0|||
126295052|NCT03335475|454368523|FG001|Overall Study|Withdrawal by Subject|1|||
126295053|NCT02755103|454368524|FG000|Overall Study|Lost to Follow-up|17|||
126295054|NCT02755103|454368525|FG001|Overall Study|Lost to Follow-up|15|||
126295055|NCT02755103|454368524|FG000|Overall Study|Death|0|||
126295056|NCT02755103|454368525|FG001|Overall Study|Death|1|||
126295057|NCT02755103|454368524|FG000|Overall Study|Physician Decision|0|||
126295058|NCT02755103|454368525|FG001|Overall Study|Physician Decision|1|||
126295059|NCT02755103|454368524|FG000|Overall Study|Pregnancy|0|||
126295060|NCT02755103|454368525|FG001|Overall Study|Pregnancy|1|||
126295061|NCT02755103|454368524|FG000|Overall Study|Withdrawal by Subject|3|||
126295062|NCT02755103|454368525|FG001|Overall Study|Withdrawal by Subject|0|||
126295063|NCT05366010|454368528|FG000|Overall Study|Withdrawal by Subject|1|||
126295064|NCT05366010|454368528|FG000|Overall Study|Protocol Violation|1|||
126295065|NCT05366010|454368528|FG000|Overall Study|Lost to Follow-up|2|||
126295066|NCT05366010|454368528|FG000|Overall Study|Screen Failure|2|||
126295067|NCT02224157|454368529|FG000|Overall Study|Severe non-compliance to protocol|2|||
126295068|NCT02224157|454368530|FG001|Overall Study|Severe non-compliance to protocol|2|||
126295069|NCT02224157|454368529|FG000|Overall Study|Other|13|||
126295070|NCT02224157|454368530|FG001|Overall Study|Other|10|||
126295071|NCT02224157|454368529|FG000|Overall Study|Subject decision|58|||
126295072|NCT02224157|454368530|FG001|Overall Study|Subject decision|50|||
126295073|NCT02224157|454368529|FG000|Overall Study|Prematurely closed site|4|||
126295074|NCT02224157|454368530|FG001|Overall Study|Prematurely closed site|2|||
126295075|NCT02224157|454368529|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
126295076|NCT02224157|454368530|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
126295077|NCT02224157|454368529|FG000|Overall Study|Lost to Follow-up|27|||
126295078|NCT02224157|454368530|FG001|Overall Study|Lost to Follow-up|35|||
126295079|NCT02224157|454368529|FG000|Overall Study|Death|1|||
126295080|NCT02224157|454368530|FG001|Overall Study|Death|1|||
126295081|NCT02224157|454368529|FG000|Overall Study|Adverse Event|1|||
126295082|NCT02224157|454368530|FG001|Overall Study|Adverse Event|3|||
126295083|NCT05906628|454368533|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
126295084|NCT05906628|454368534|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
126295085|NCT05906628|454368533|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
126295086|NCT05906628|454368534|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
126295087|NCT05906628|454368533|FG000|16-Week DBVC Period|Protocol Violation|4|||
126295088|NCT05906628|454368534|FG001|16-Week DBVC Period|Protocol Violation|2|||
126295089|NCT05906628|454368533|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
126295090|NCT05906628|454368534|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
126295091|NCT05906628|454368533|FG000|16-Week OLE Period|Death|1|||
126295092|NCT05906628|454368534|FG001|16-Week OLE Period|Death|0|||
126295093|NCT05906628|454368533|FG000|16-Week OLE Period|Lost to Follow-up|1|||
126295094|NCT05906628|454368534|FG001|16-Week OLE Period|Lost to Follow-up|1|||
126295095|NCT05906628|454368533|FG000|16-Week OLE Period|Protocol Violation|0|||
126295096|NCT05906628|454368534|FG001|16-Week OLE Period|Protocol Violation|1|||
126295097|NCT05906628|454368533|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
126295098|NCT05906628|454368534|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
126295099|NCT04578535|454368535|FG000|Overall Study|Lost to Follow-up|1|||
126295100|NCT04578535|454368536|FG001|Overall Study|Lost to Follow-up|0|||
126295101|NCT04578535|454368537|FG002|Overall Study|Lost to Follow-up|0|||
126295102|NCT04578535|454368538|FG003|Overall Study|Lost to Follow-up|1|||
126295103|NCT04578535|454368539|FG004|Overall Study|Lost to Follow-up|0|||
126295104|NCT04578535|454368540|FG005|Overall Study|Lost to Follow-up|2|||
126295105|NCT04578535|454368535|FG000|Overall Study|Pregnancy|1|||
126295106|NCT04578535|454368536|FG001|Overall Study|Pregnancy|0|||
126295107|NCT04578535|454368537|FG002|Overall Study|Pregnancy|0|||
126295108|NCT04578535|454368538|FG003|Overall Study|Pregnancy|0|||
126295109|NCT04578535|454368539|FG004|Overall Study|Pregnancy|0|||
126295110|NCT04578535|454368540|FG005|Overall Study|Pregnancy|0|||
126295111|NCT04578535|454368535|FG000|Overall Study|Withdrawal by Subject|0|||
126295112|NCT04578535|454368536|FG001|Overall Study|Withdrawal by Subject|0|||
126295113|NCT04578535|454368537|FG002|Overall Study|Withdrawal by Subject|0|||
126295114|NCT04578535|454368538|FG003|Overall Study|Withdrawal by Subject|1|||
126295115|NCT04578535|454368539|FG004|Overall Study|Withdrawal by Subject|1|||
126295116|NCT04578535|454368540|FG005|Overall Study|Withdrawal by Subject|5|||
126295117|NCT04578535|454368535|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
126295118|NCT04578535|454368536|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
126295119|NCT04578535|454368537|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
126295120|NCT04578535|454368538|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
126295121|NCT04578535|454368539|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
126295122|NCT04578535|454368540|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
126295123|NCT05317312|454368541|FG000|Overall Study|Withdrawal by Subject|0|||
126295124|NCT05317312|454368542|FG001|Overall Study|Withdrawal by Subject|1|||
126295125|NCT05317312|454368543|FG002|Overall Study|Withdrawal by Subject|0|||
126295126|NCT05317312|454368544|FG003|Overall Study|Withdrawal by Subject|0|||
126295127|NCT05317312|454368541|FG000|Overall Study|Lost to Follow-up|0|||
126295128|NCT05317312|454368542|FG001|Overall Study|Lost to Follow-up|0|||
126295129|NCT05317312|454368543|FG002|Overall Study|Lost to Follow-up|0|||
126295130|NCT05317312|454368544|FG003|Overall Study|Lost to Follow-up|1|||
126295131|NCT05317312|454368541|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
126295132|NCT05317312|454368542|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
126295133|NCT05317312|454368543|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
126295134|NCT05317312|454368544|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
126295135|NCT01060072|454368545|FG000|Overall Study|Adverse Event|1|||
126295136|NCT01060072|454368546|FG001|Overall Study|Adverse Event|1|||
126295137|NCT01060072|454368545|FG000|Overall Study|Physician Decision|0|||
126295138|NCT01060072|454368546|FG001|Overall Study|Physician Decision|2|||
126295139|NCT01060072|454368545|FG000|Overall Study|Protocol Violation|0|||
126295140|NCT01060072|454368546|FG001|Overall Study|Protocol Violation|1|||
126295141|NCT01060072|454368545|FG000|Overall Study|Acute cholecystitis|1|||
126295142|NCT01060072|454368546|FG001|Overall Study|Acute cholecystitis|0|||
126295143|NCT01060072|454368545|FG000|Overall Study|Excluded Medications|0|||
126295144|NCT01060072|454368546|FG001|Overall Study|Excluded Medications|1|||
126295145|NCT00837148|454368547|FG000|Overall Study|Adverse Event|1|||
126295146|NCT00837148|454368547|FG000|Overall Study|Death|1|||
126295147|NCT00380874|454368548|FG000|Overall Study|Adverse Event|7|||
126295148|NCT00380874|454368549|FG001|Overall Study|Adverse Event|7|||
126295149|NCT00380874|454368548|FG000|Overall Study|Death|1|||
126295150|NCT00380874|454368549|FG001|Overall Study|Death|0|||
126295151|NCT00380874|454368548|FG000|Overall Study|Withdrawal by Subject|2|||
126295152|NCT00380874|454368549|FG001|Overall Study|Withdrawal by Subject|1|||
126295153|NCT00380874|454368548|FG000|Overall Study|Not related to study drug|3|||
126295154|NCT00380874|454368549|FG001|Overall Study|Not related to study drug|2|||
126295155|NCT03839628|454368550|FG000|Overall Study|Withdrawal by Subject|1|||
126295156|NCT01707290|454368551|FG000|Overall Study|Adverse event (AE)|1|||
126295157|NCT01707290|454368552|FG001|Overall Study|Adverse event (AE)|0|||
126295158|NCT01707290|454368551|FG000|Overall Study|Physician Decision|1|||
126295159|NCT01707290|454368552|FG001|Overall Study|Physician Decision|0|||
126295160|NCT01707290|454368551|FG000|Overall Study|Lost to Follow-up|3|||
126295161|NCT01707290|454368552|FG001|Overall Study|Lost to Follow-up|0|||
126295162|NCT01707290|454368551|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
126295163|NCT01707290|454368552|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
126295164|NCT01707290|454368551|FG000|Overall Study|Commercial drug available|60|||
126295165|NCT01707290|454368552|FG001|Overall Study|Commercial drug available|1|||
126295166|NCT01707290|454368551|FG000|Overall Study|Other unspecified|17|||
126295167|NCT01707290|454368552|FG001|Overall Study|Other unspecified|0|||
126295168|NCT01964976|454368553|FG000|Overall Study|Protocol Violation|31|||
126295169|NCT02286713|454368559|FG000|One Week Follow-Up|Death|1|||
126295170|NCT02286713|454368560|FG001|One Week Follow-Up|Death|0|||
126295171|NCT02286713|454368559|FG000|One Week Follow-Up|Lost to Follow-up|17|||
126295172|NCT02286713|454368560|FG001|One Week Follow-Up|Lost to Follow-up|21|||
126295173|NCT02286713|454368559|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
126295174|NCT02286713|454368560|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
126295175|NCT02286713|454368559|FG000|Three Month Follow-Up|Death|1|||
126295176|NCT02286713|454368560|FG001|Three Month Follow-Up|Death|1|||
126295177|NCT02286713|454368559|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
126295178|NCT02286713|454368560|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
126295179|NCT02286713|454368559|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
126295180|NCT02286713|454368560|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
126295181|NCT02286713|454368559|FG000|Six Month Follow-Up|Death|2|||
126295182|NCT02286713|454368560|FG001|Six Month Follow-Up|Death|0|||
126295183|NCT02286713|454368559|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
126295184|NCT02286713|454368560|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
126295185|NCT05479435|454368561|FG000|Overall Study|Withdrawal by Subject|1|||
126295186|NCT05479435|454368562|FG001|Overall Study|Withdrawal by Subject|0|||
126295187|NCT05479435|454368563|FG002|Overall Study|Withdrawal by Subject|0|||
126295188|NCT05479435|454368561|FG000|Overall Study|Covid 19|0|||
126295189|NCT05479435|454368562|FG001|Overall Study|Covid 19|0|||
126295190|NCT05479435|454368563|FG002|Overall Study|Covid 19|2|||
126295191|NCT03428958|454370575|FG000|Overall Study|Adverse Event|0|||
126295192|NCT03428958|454370576|FG001|Overall Study|Adverse Event|0|||
126295193|NCT03428958|454370577|FG002|Overall Study|Adverse Event|0|||
126295194|NCT03428958|454370578|FG003|Overall Study|Adverse Event|1|||
126295195|NCT03428958|454370579|FG004|Overall Study|Adverse Event|0|||
126295196|NCT03428958|454370580|FG005|Overall Study|Adverse Event|2|||
126295197|NCT03428958|454370581|FG006|Overall Study|Adverse Event|1|||
126295198|NCT03428958|454370582|FG007|Overall Study|Adverse Event|0|||
126295199|NCT03428958|454370583|FG008|Overall Study|Adverse Event|0|||
126295200|NCT03428958|454370584|FG009|Overall Study|Adverse Event|0|||
126295201|NCT03428958|454370585|FG010|Overall Study|Adverse Event|0|||
126295202|NCT03428958|454370586|FG011|Overall Study|Adverse Event|0|||
126295203|NCT03428958|454370587|FG012|Overall Study|Adverse Event|0|||
126295204|NCT03428958|454370588|FG013|Overall Study|Adverse Event|0|||
126295205|NCT03428958|454370589|FG014|Overall Study|Adverse Event|0|||
126295206|NCT03428958|454370590|FG015|Overall Study|Adverse Event|0|||
126295207|NCT03428958|454370591|FG016|Overall Study|Adverse Event|0|||
126295208|NCT03428958|454370575|FG000|Overall Study|Clinical Progression|2|||
126295209|NCT03428958|454370576|FG001|Overall Study|Clinical Progression|3|||
126295210|NCT03428958|454370577|FG002|Overall Study|Clinical Progression|2|||
126295211|NCT03428958|454370578|FG003|Overall Study|Clinical Progression|1|||
126295212|NCT03428958|454370579|FG004|Overall Study|Clinical Progression|0|||
126295213|NCT03428958|454370580|FG005|Overall Study|Clinical Progression|2|||
126295214|NCT03428958|454370581|FG006|Overall Study|Clinical Progression|0|||
126295215|NCT03428958|454370582|FG007|Overall Study|Clinical Progression|0|||
126295216|NCT03428958|454370583|FG008|Overall Study|Clinical Progression|0|||
126295217|NCT03428958|454370584|FG009|Overall Study|Clinical Progression|0|||
126295218|NCT03428958|454370585|FG010|Overall Study|Clinical Progression|0|||
126295219|NCT03428958|454370586|FG011|Overall Study|Clinical Progression|0|||
126295220|NCT03428958|454370587|FG012|Overall Study|Clinical Progression|0|||
126295221|NCT03428958|454370588|FG013|Overall Study|Clinical Progression|0|||
126295222|NCT03428958|454370589|FG014|Overall Study|Clinical Progression|0|||
126295223|NCT03428958|454370590|FG015|Overall Study|Clinical Progression|0|||
126295224|NCT03428958|454370591|FG016|Overall Study|Clinical Progression|0|||
126295225|NCT03428958|454370575|FG000|Overall Study|Progression per RECIST|6|||
126295226|NCT03428958|454370576|FG001|Overall Study|Progression per RECIST|6|||
126295227|NCT03428958|454370577|FG002|Overall Study|Progression per RECIST|7|||
126295228|NCT03428958|454370578|FG003|Overall Study|Progression per RECIST|4|||
126295229|NCT03428958|454370579|FG004|Overall Study|Progression per RECIST|0|||
126295230|NCT03428958|454370580|FG005|Overall Study|Progression per RECIST|7|||
126295231|NCT03428958|454370581|FG006|Overall Study|Progression per RECIST|8|||
126295232|NCT03428958|454370582|FG007|Overall Study|Progression per RECIST|0|||
126295233|NCT03428958|454370583|FG008|Overall Study|Progression per RECIST|0|||
126295234|NCT03428958|454370584|FG009|Overall Study|Progression per RECIST|0|||
126295235|NCT03428958|454370585|FG010|Overall Study|Progression per RECIST|0|||
126295236|NCT03428958|454370586|FG011|Overall Study|Progression per RECIST|0|||
126295237|NCT03428958|454370587|FG012|Overall Study|Progression per RECIST|1|||
126295238|NCT03428958|454370588|FG013|Overall Study|Progression per RECIST|0|||
126295239|NCT03428958|454370589|FG014|Overall Study|Progression per RECIST|0|||
126295240|NCT03428958|454370590|FG015|Overall Study|Progression per RECIST|0|||
126295241|NCT03428958|454370591|FG016|Overall Study|Progression per RECIST|0|||
126295242|NCT03428958|454370575|FG000|Overall Study|Death|2|||
126295243|NCT03428958|454370576|FG001|Overall Study|Death|2|||
126295244|NCT03428958|454370577|FG002|Overall Study|Death|0|||
126295245|NCT03428958|454370578|FG003|Overall Study|Death|0|||
126295246|NCT03428958|454370579|FG004|Overall Study|Death|0|||
126295247|NCT03428958|454370580|FG005|Overall Study|Death|7|||
126295248|NCT03428958|454370581|FG006|Overall Study|Death|9|||
126295249|NCT03428958|454370582|FG007|Overall Study|Death|6|||
126295250|NCT03428958|454370583|FG008|Overall Study|Death|0|||
126295251|NCT03428958|454370584|FG009|Overall Study|Death|0|||
126295252|NCT03428958|454370585|FG010|Overall Study|Death|3|||
126295253|NCT03428958|454370586|FG011|Overall Study|Death|0|||
126295254|NCT03428958|454370587|FG012|Overall Study|Death|4|||
126295255|NCT03428958|454370588|FG013|Overall Study|Death|0|||
126295256|NCT03428958|454370589|FG014|Overall Study|Death|0|||
126295257|NCT03428958|454370590|FG015|Overall Study|Death|0|||
126295258|NCT03428958|454370591|FG016|Overall Study|Death|0|||
126295259|NCT03428958|454370575|FG000|Overall Study|Lost to Follow-up|0|||
126295260|NCT03428958|454370576|FG001|Overall Study|Lost to Follow-up|0|||
126295261|NCT03428958|454370577|FG002|Overall Study|Lost to Follow-up|0|||
126295262|NCT03428958|454370578|FG003|Overall Study|Lost to Follow-up|0|||
126295263|NCT03428958|454370579|FG004|Overall Study|Lost to Follow-up|0|||
126295264|NCT03428958|454370580|FG005|Overall Study|Lost to Follow-up|1|||
126295265|NCT03428958|454370581|FG006|Overall Study|Lost to Follow-up|1|||
126295266|NCT03428958|454370582|FG007|Overall Study|Lost to Follow-up|0|||
126295267|NCT03428958|454370583|FG008|Overall Study|Lost to Follow-up|0|||
126295268|NCT03428958|454370584|FG009|Overall Study|Lost to Follow-up|0|||
126295269|NCT03428958|454370585|FG010|Overall Study|Lost to Follow-up|0|||
126295270|NCT03428958|454370586|FG011|Overall Study|Lost to Follow-up|0|||
126295271|NCT03428958|454370587|FG012|Overall Study|Lost to Follow-up|0|||
126295272|NCT03428958|454370588|FG013|Overall Study|Lost to Follow-up|0|||
126295273|NCT03428958|454370589|FG014|Overall Study|Lost to Follow-up|0|||
126295274|NCT03428958|454370590|FG015|Overall Study|Lost to Follow-up|0|||
126295275|NCT03428958|454370591|FG016|Overall Study|Lost to Follow-up|0|||
126295276|NCT03428958|454370575|FG000|Overall Study|Physician/Sponsor Decision|1|||
126295277|NCT03428958|454370576|FG001|Overall Study|Physician/Sponsor Decision|0|||
126295278|NCT03428958|454370577|FG002|Overall Study|Physician/Sponsor Decision|1|||
126295279|NCT03428958|454370578|FG003|Overall Study|Physician/Sponsor Decision|0|||
126295280|NCT03428958|454370579|FG004|Overall Study|Physician/Sponsor Decision|0|||
126295281|NCT03428958|454370580|FG005|Overall Study|Physician/Sponsor Decision|2|||
126295282|NCT03428958|454370581|FG006|Overall Study|Physician/Sponsor Decision|2|||
126295283|NCT03428958|454370582|FG007|Overall Study|Physician/Sponsor Decision|2|||
126295284|NCT03428958|454370583|FG008|Overall Study|Physician/Sponsor Decision|0|||
126295285|NCT03428958|454370584|FG009|Overall Study|Physician/Sponsor Decision|0|||
126295286|NCT03428958|454370585|FG010|Overall Study|Physician/Sponsor Decision|2|||
126295287|NCT03428958|454370586|FG011|Overall Study|Physician/Sponsor Decision|0|||
126295288|NCT03428958|454370587|FG012|Overall Study|Physician/Sponsor Decision|4|||
126295289|NCT03428958|454370588|FG013|Overall Study|Physician/Sponsor Decision|0|||
126366899|NCT03766399|454639349|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366900|NCT03766399|454639350|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366901|NCT03766399|454639351|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366902|NCT03766399|454639352|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366903|NCT02014376|454639353|FG000|Overall Study|Adverse Event|1|||
126366904|NCT02014376|454639354|FG001|Overall Study|Adverse Event|1|||
126366905|NCT02014376|454639355|FG002|Overall Study|Adverse Event|0|||
126366906|NCT02014376|454639353|FG000|Overall Study|Lost to Follow-up|2|||
126295290|NCT03428958|454370589|FG014|Overall Study|Physician/Sponsor Decision|0|||
126295291|NCT03428958|454370590|FG015|Overall Study|Physician/Sponsor Decision|0|||
126295292|NCT03428958|454370591|FG016|Overall Study|Physician/Sponsor Decision|0|||
126295293|NCT03428958|454370575|FG000|Overall Study|Withdrawal by Subject|0|||
126295294|NCT03428958|454370576|FG001|Overall Study|Withdrawal by Subject|0|||
126295295|NCT03428958|454370577|FG002|Overall Study|Withdrawal by Subject|2|||
126295296|NCT03428958|454370578|FG003|Overall Study|Withdrawal by Subject|0|||
126295297|NCT03428958|454370579|FG004|Overall Study|Withdrawal by Subject|0|||
126295298|NCT03428958|454370580|FG005|Overall Study|Withdrawal by Subject|2|||
126295299|NCT03428958|454370581|FG006|Overall Study|Withdrawal by Subject|4|||
126295300|NCT03428958|454370582|FG007|Overall Study|Withdrawal by Subject|1|||
126366907|NCT02014376|454639354|FG001|Overall Study|Lost to Follow-up|0|||
126295301|NCT03428958|454370583|FG008|Overall Study|Withdrawal by Subject|0|||
126295302|NCT03428958|454370584|FG009|Overall Study|Withdrawal by Subject|0|||
126295303|NCT03428958|454370585|FG010|Overall Study|Withdrawal by Subject|0|||
126295304|NCT03428958|454370586|FG011|Overall Study|Withdrawal by Subject|0|||
126295305|NCT03428958|454370587|FG012|Overall Study|Withdrawal by Subject|0|||
126295306|NCT03428958|454370588|FG013|Overall Study|Withdrawal by Subject|0|||
126295307|NCT03428958|454370589|FG014|Overall Study|Withdrawal by Subject|0|||
126295308|NCT03428958|454370590|FG015|Overall Study|Withdrawal by Subject|0|||
126295309|NCT03428958|454370591|FG016|Overall Study|Withdrawal by Subject|0|||
126295310|NCT03874117|454370592|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
126295311|NCT03874117|454370593|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
126295312|NCT03874117|454370592|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
126295313|NCT03874117|454370593|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
126366908|NCT02014376|454639355|FG002|Overall Study|Lost to Follow-up|0|||
126366909|NCT01051661|454639361|FG000|Overall Study|Adverse Event|1|||
126366910|NCT01051661|454639362|FG001|Overall Study|Adverse Event|1|||
126366911|NCT01051661|454639363|FG002|Overall Study|Adverse Event|1|||
126366912|NCT01051661|454639364|FG003|Overall Study|Adverse Event|1|||
126366913|NCT01051661|454639365|FG004|Overall Study|Adverse Event|0|||
126366914|NCT01051661|454639366|FG005|Overall Study|Adverse Event|0|||
126366915|NCT01051661|454639361|FG000|Overall Study|Lost to Follow-up|13|||
126366916|NCT01051661|454639362|FG001|Overall Study|Lost to Follow-up|22|||
126366917|NCT01051661|454639363|FG002|Overall Study|Lost to Follow-up|15|||
126366918|NCT01051661|454639364|FG003|Overall Study|Lost to Follow-up|17|||
125883428|NCT00068692|452871470|FG004|Step 2: Randomization|alternative therapy|1|||
125883429|NCT00068692|452871471|FG005|Step 2: Randomization|alternative therapy|0|||
126042463|NCT03536884|453453114|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126295314|NCT03874117|454370592|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126295315|NCT03874117|454370593|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126295316|NCT03874117|454370592|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
126295317|NCT03874117|454370593|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
126295318|NCT03874117|454370592|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126295319|NCT03874117|454370593|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126295320|NCT01922037|454370594|FG000|Overall Study|Withdrawal by Subject|2|||
126295321|NCT01922037|454370595|FG001|Overall Study|Withdrawal by Subject|44|||
126295322|NCT01922037|454370594|FG000|Overall Study|Adverse Event|1|||
126295323|NCT01922037|454370595|FG001|Overall Study|Adverse Event|7|||
126295324|NCT01922037|454370594|FG000|Overall Study|Death|0|||
126295325|NCT01922037|454370595|FG001|Overall Study|Death|5|||
126295326|NCT01922037|454370594|FG000|Overall Study|Pregnancy|0|||
126295327|NCT01922037|454370595|FG001|Overall Study|Pregnancy|2|||
126042464|NCT03536884|453453115|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126042465|NCT03536884|453453116|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126295328|NCT01922037|454370594|FG000|Overall Study|Participant non-compliance|4|||
126295329|NCT01922037|454370595|FG001|Overall Study|Participant non-compliance|46|||
125883430|NCT00068692|452871472|FG006|Step 2: Randomization|alternative therapy|0|||
126042466|NCT03536884|453453117|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126295330|NCT01922037|454370594|FG000|Overall Study|Investigator/Sponsor decision|1|||
126295331|NCT01922037|454370595|FG001|Overall Study|Investigator/Sponsor decision|4|||
126366919|NCT01051661|454639365|FG004|Overall Study|Lost to Follow-up|10|||
126366920|NCT01051661|454639366|FG005|Overall Study|Lost to Follow-up|24|||
126366921|NCT01051661|454639361|FG000|Overall Study|Migrated/moved from study area|1|||
126366922|NCT01051661|454639362|FG001|Overall Study|Migrated/moved from study area|6|||
126295332|NCT01922037|454370594|FG000|Overall Study|Other unspecified|2|||
126295333|NCT01922037|454370595|FG001|Overall Study|Other unspecified|66|||
126295334|NCT00413699|454370601|FG000|Initial Period|Death|25|||
126295335|NCT00413699|454370602|FG001|Initial Period|Death|30|||
126295336|NCT00413699|454370603|FG002|Initial Period|Death|0|||
126295337|NCT00413699|454370601|FG000|Initial Period|Lack of Efficacy|59|||
126295338|NCT00413699|454370602|FG001|Initial Period|Lack of Efficacy|115|||
126295339|NCT00413699|454370603|FG002|Initial Period|Lack of Efficacy|0|||
126295340|NCT00413699|454370601|FG000|Initial Period|Lost to Follow-up|31|||
126295341|NCT00413699|454370602|FG001|Initial Period|Lost to Follow-up|101|||
126295342|NCT00413699|454370603|FG002|Initial Period|Lost to Follow-up|0|||
126295343|NCT00413699|454370601|FG000|Initial Period|Protocol Violation|38|||
126295344|NCT00413699|454370602|FG001|Initial Period|Protocol Violation|89|||
126295345|NCT00413699|454370603|FG002|Initial Period|Protocol Violation|0|||
126295346|NCT00413699|454370601|FG000|Initial Period|Pregnancy|10|||
126295347|NCT00413699|454370602|FG001|Initial Period|Pregnancy|8|||
126295348|NCT00413699|454370603|FG002|Initial Period|Pregnancy|0|||
126295349|NCT00413699|454370601|FG000|Initial Period|Did not meet entrance criteria|2|||
126295350|NCT00413699|454370602|FG001|Initial Period|Did not meet entrance criteria|2|||
126295351|NCT00413699|454370603|FG002|Initial Period|Did not meet entrance criteria|0|||
126295352|NCT00413699|454370601|FG000|Initial Period|Medication error without adverse event|0|||
126295353|NCT00413699|454370602|FG001|Initial Period|Medication error without adverse event|1|||
126295354|NCT00413699|454370603|FG002|Initial Period|Medication error without adverse event|0|||
126295355|NCT00413699|454370601|FG000|Initial Period|Study terminated by Sponsor|0|||
126295356|NCT00413699|454370602|FG001|Initial Period|Study terminated by Sponsor|1|||
126295357|NCT00413699|454370603|FG002|Initial Period|Study terminated by Sponsor|0|||
126295358|NCT00413699|454370601|FG000|Initial Period|Other|67|||
126295359|NCT00413699|454370602|FG001|Initial Period|Other|211|||
126295360|NCT00413699|454370603|FG002|Initial Period|Other|0|||
126295361|NCT00413699|454370601|FG000|Initial Period|Adverse event related to study drug|178|||
126295362|NCT00413699|454370602|FG001|Initial Period|Adverse event related to study drug|527|||
126295363|NCT00413699|454370603|FG002|Initial Period|Adverse event related to study drug|0|||
126295364|NCT00413699|454370601|FG000|Initial Period|Adverse event not related to study drug|113|||
126295365|NCT00413699|454370602|FG001|Initial Period|Adverse event not related to study drug|248|||
126295366|NCT00413699|454370603|FG002|Initial Period|Adverse event not related to study drug|0|||
126295367|NCT00413699|454370601|FG000|Initial Period|Missing end of study page|0|||
126295368|NCT00413699|454370602|FG001|Initial Period|Missing end of study page|4|||
126295369|NCT00413699|454370603|FG002|Initial Period|Missing end of study page|0|||
126295370|NCT00413699|454370601|FG000|Initial Period|No longer willing to participate|116|||
126295371|NCT00413699|454370602|FG001|Initial Period|No longer willing to participate|368|||
126295372|NCT00413699|454370603|FG002|Initial Period|No longer willing to participate|0|||
126295373|NCT00413699|454370601|FG000|Extension Period|No Longer Willing to Participate|0|||
126295374|NCT00413699|454370602|FG001|Extension Period|No Longer Willing to Participate|0|||
126295375|NCT00413699|454370603|FG002|Extension Period|No Longer Willing to Participate|2|||
126295376|NCT00413699|454370601|FG000|Extension Period|Protocol Violation|0|||
126295377|NCT00413699|454370602|FG001|Extension Period|Protocol Violation|0|||
126295378|NCT00413699|454370603|FG002|Extension Period|Protocol Violation|1|||
126295379|NCT00413699|454370601|FG000|Extension Period|Adverse Event|0|||
126295380|NCT00413699|454370602|FG001|Extension Period|Adverse Event|0|||
126295381|NCT00413699|454370603|FG002|Extension Period|Adverse Event|2|||
126295382|NCT03511105|454370604|FG000|Overall Study|Adverse Event|1|||
126295383|NCT03511105|454370605|FG001|Overall Study|Adverse Event|0|||
126295384|NCT03511105|454370604|FG000|Overall Study|Withdrew consent|1|||
126295385|NCT03511105|454370605|FG001|Overall Study|Withdrew consent|0|||
126295386|NCT02810457|454370606|FG000|Overall Study|Randomised but no treatment received|2|||
126295387|NCT02810457|454370607|FG001|Overall Study|Randomised but no treatment received|1|||
126295388|NCT02810457|454370606|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
126295389|NCT02810457|454370607|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
126295390|NCT02810457|454370606|FG000|Overall Study|Adverse Event|37|||
126295391|NCT02810457|454370607|FG001|Overall Study|Adverse Event|43|||
126295392|NCT02810457|454370606|FG000|Overall Study|Patient decision|31|||
126295393|NCT02810457|454370607|FG001|Overall Study|Patient decision|35|||
126295394|NCT02810457|454370606|FG000|Overall Study|Patient lost to follow-up|2|||
126295395|NCT02810457|454370607|FG001|Overall Study|Patient lost to follow-up|2|||
126295396|NCT02810457|454370606|FG000|Overall Study|Death|39|||
126295397|NCT02810457|454370607|FG001|Overall Study|Death|28|||
126295398|NCT02810457|454370606|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
126295399|NCT02810457|454370607|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
126295400|NCT02810457|454370606|FG000|Overall Study|Clinical progression|15|||
126295401|NCT02810457|454370607|FG001|Overall Study|Clinical progression|16|||
126295402|NCT02810457|454370606|FG000|Overall Study|Investigator decision|3|||
126295403|NCT02810457|454370607|FG001|Overall Study|Investigator decision|2|||
126295404|NCT02810457|454370606|FG000|Overall Study|Patient ineligibility|3|||
126295405|NCT02810457|454370607|FG001|Overall Study|Patient ineligibility|0|||
126366923|NCT01051661|454639363|FG002|Overall Study|Migrated/moved from study area|6|||
126100227|NCT01656733|453659877|FG000|Overall Study|No permission to collect birth outcomes|0|||
126100228|NCT01656733|453659878|FG001|Overall Study|No permission to collect birth outcomes|1|||
126100229|NCT01656733|453659877|FG000|Overall Study|Delivery at another hospital|0|||
126295406|NCT02810457|454370606|FG000|Overall Study|Miscalculated PD|1|||
126295407|NCT02810457|454370607|FG001|Overall Study|Miscalculated PD|0|||
126295408|NCT02810457|454370606|FG000|Overall Study|Physician Decision|0|||
126295409|NCT02810457|454370607|FG001|Overall Study|Physician Decision|1|||
126295410|NCT02832687|454370608|FG000|Overall Study|Adverse Event|0|||
126295411|NCT02832687|454370609|FG001|Overall Study|Adverse Event|2|||
126295412|NCT04231825|454370610|FG000|Overall Study|Protocol Violation|3|||
126295413|NCT04231825|454370611|FG001|Overall Study|Protocol Violation|3|||
126295414|NCT04231825|454370610|FG000|Overall Study|Lost to Follow-up|0|||
126295415|NCT04231825|454370611|FG001|Overall Study|Lost to Follow-up|1|||
126295416|NCT02019472|454370612|FG000|Overall Study|Adverse Event|14|||
126295417|NCT02019472|454370613|FG001|Overall Study|Adverse Event|23|||
126295418|NCT02019472|454370614|FG002|Overall Study|Adverse Event|17|||
126295419|NCT02019472|454370612|FG000|Overall Study|Death|0|||
126295420|NCT02019472|454370613|FG001|Overall Study|Death|1|||
126295421|NCT02019472|454370614|FG002|Overall Study|Death|1|||
126295422|NCT02019472|454370612|FG000|Overall Study|Lack of Efficacy|7|||
126295423|NCT02019472|454370613|FG001|Overall Study|Lack of Efficacy|4|||
126295424|NCT02019472|454370614|FG002|Overall Study|Lack of Efficacy|4|||
126295425|NCT02019472|454370612|FG000|Overall Study|Lost to Follow-up|0|||
126295426|NCT02019472|454370613|FG001|Overall Study|Lost to Follow-up|2|||
126295427|NCT02019472|454370614|FG002|Overall Study|Lost to Follow-up|1|||
126295428|NCT02019472|454370612|FG000|Overall Study|Physician Decision|1|||
126295429|NCT02019472|454370613|FG001|Overall Study|Physician Decision|2|||
126295430|NCT02019472|454370614|FG002|Overall Study|Physician Decision|0|||
126295431|NCT02019472|454370612|FG000|Overall Study|Pregnancy|1|||
126295432|NCT02019472|454370613|FG001|Overall Study|Pregnancy|2|||
126295433|NCT02019472|454370614|FG002|Overall Study|Pregnancy|2|||
126295434|NCT02019472|454370612|FG000|Overall Study|Withdrawal by Subject|11|||
126295435|NCT02019472|454370613|FG001|Overall Study|Withdrawal by Subject|10|||
126295436|NCT02019472|454370614|FG002|Overall Study|Withdrawal by Subject|11|||
126295437|NCT02019472|454370612|FG000|Overall Study|Other|3|||
126295438|NCT02019472|454370613|FG001|Overall Study|Other|8|||
126295439|NCT02019472|454370614|FG002|Overall Study|Other|6|||
126295440|NCT01217112|454370617|FG000|Overall Study|Adverse Event|0|||
126295441|NCT01217112|454370618|FG001|Overall Study|Adverse Event|2|||
126295442|NCT01217112|454370619|FG002|Overall Study|Adverse Event|0|||
126295443|NCT01217112|454370620|FG003|Overall Study|Adverse Event|2|||
126295444|NCT01217112|454370621|FG004|Overall Study|Adverse Event|0|||
126295445|NCT01217112|454370617|FG000|Overall Study|Withdrawal by Subject|0|||
126295446|NCT01217112|454370618|FG001|Overall Study|Withdrawal by Subject|0|||
126295447|NCT01217112|454370619|FG002|Overall Study|Withdrawal by Subject|1|||
126295448|NCT01217112|454370620|FG003|Overall Study|Withdrawal by Subject|0|||
126295449|NCT01217112|454370621|FG004|Overall Study|Withdrawal by Subject|0|||
126295450|NCT01217112|454370617|FG000|Overall Study|Physician Decision|0|||
126295451|NCT01217112|454370618|FG001|Overall Study|Physician Decision|0|||
126295452|NCT01217112|454370619|FG002|Overall Study|Physician Decision|0|||
126295453|NCT01217112|454370620|FG003|Overall Study|Physician Decision|0|||
126295454|NCT01217112|454370621|FG004|Overall Study|Physician Decision|1|||
126295455|NCT03192488|454370622|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
126295456|NCT03192488|454370623|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
126295457|NCT03192488|454370624|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
126295458|NCT03192488|454370625|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
126295459|NCT03192488|454370626|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
126295460|NCT03192488|454370627|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
126295461|NCT03192488|454370622|FG000|Third Intervention (d1)|Adverse Event|0|||
126295462|NCT03192488|454370623|FG001|Third Intervention (d1)|Adverse Event|0|||
126295463|NCT03192488|454370624|FG002|Third Intervention (d1)|Adverse Event|0|||
126295464|NCT03192488|454370625|FG003|Third Intervention (d1)|Adverse Event|0|||
126295465|NCT03192488|454370626|FG004|Third Intervention (d1)|Adverse Event|1|||
126295466|NCT03192488|454370627|FG005|Third Intervention (d1)|Adverse Event|0|||
126295467|NCT01401361|454370628|FG000|Overall Study|Withdrawal by Subject|16|||
126295468|NCT01401361|454370628|FG000|Overall Study|Lack of Efficacy|6|||
126295469|NCT01401361|454370628|FG000|Overall Study|Physician Decision|1|||
126295470|NCT01401361|454370628|FG000|Overall Study|Lost to Follow-up|3|||
126295471|NCT01401361|454370628|FG000|Overall Study|Subject/family decision post procedure|2|||
126295472|NCT02512302|454370630|FG000|Period 1|Adverse Event|0|||
126295473|NCT02512302|454370631|FG001|Period 1|Adverse Event|1|||
126295474|NCT02512302|454370632|FG002|Period 1|Adverse Event|0|||
126100230|NCT01656733|453659878|FG001|Overall Study|Delivery at another hospital|2|||
126295475|NCT02512302|454370633|FG003|Period 1|Adverse Event|0|||
126295476|NCT02512302|454370634|FG004|Period 1|Adverse Event|0|||
126295477|NCT02512302|454370635|FG005|Period 1|Adverse Event|0|||
126295478|NCT02512302|454370636|FG006|Period 1|Adverse Event|0|||
126295479|NCT02512302|454370637|FG007|Period 1|Adverse Event|0|||
126295480|NCT02512302|454370638|FG008|Period 1|Adverse Event|0|||
126295481|NCT02512302|454370639|FG009|Period 1|Adverse Event|0|||
126295482|NCT02512302|454370630|FG000|Period 2|Adverse Event|0|||
126295483|NCT02512302|454370631|FG001|Period 2|Adverse Event|0|||
126295484|NCT02512302|454370632|FG002|Period 2|Adverse Event|0|||
126295485|NCT02512302|454370633|FG003|Period 2|Adverse Event|0|||
126295486|NCT02512302|454370634|FG004|Period 2|Adverse Event|0|||
126295487|NCT02512302|454370635|FG005|Period 2|Adverse Event|0|||
126295488|NCT02512302|454370636|FG006|Period 2|Adverse Event|0|||
126295489|NCT02512302|454370637|FG007|Period 2|Adverse Event|0|||
126295490|NCT02512302|454370638|FG008|Period 2|Adverse Event|0|||
126295491|NCT02512302|454370639|FG009|Period 2|Adverse Event|1|||
126295492|NCT02512302|454370630|FG000|Period 3|Lost to Follow-up|0|||
126295493|NCT02512302|454370631|FG001|Period 3|Lost to Follow-up|0|||
126295494|NCT02512302|454370632|FG002|Period 3|Lost to Follow-up|1|||
126295495|NCT02512302|454370633|FG003|Period 3|Lost to Follow-up|0|||
126295496|NCT02512302|454370634|FG004|Period 3|Lost to Follow-up|0|||
126295497|NCT02512302|454370635|FG005|Period 3|Lost to Follow-up|0|||
126295498|NCT02512302|454370636|FG006|Period 3|Lost to Follow-up|0|||
126295499|NCT02512302|454370637|FG007|Period 3|Lost to Follow-up|0|||
126295500|NCT02512302|454370638|FG008|Period 3|Lost to Follow-up|0|||
126295501|NCT02512302|454370639|FG009|Period 3|Lost to Follow-up|0|||
126295502|NCT02512302|454370630|FG000|Period 4|Adverse Event|0|||
126295503|NCT02512302|454370631|FG001|Period 4|Adverse Event|0|||
126295504|NCT02512302|454370632|FG002|Period 4|Adverse Event|0|||
126295505|NCT02512302|454370633|FG003|Period 4|Adverse Event|0|||
126295506|NCT02512302|454370634|FG004|Period 4|Adverse Event|0|||
126295507|NCT02512302|454370635|FG005|Period 4|Adverse Event|0|||
126295508|NCT02512302|454370636|FG006|Period 4|Adverse Event|1|||
126295509|NCT02512302|454370637|FG007|Period 4|Adverse Event|0|||
126295510|NCT02512302|454370638|FG008|Period 4|Adverse Event|0|||
126295511|NCT02512302|454370639|FG009|Period 4|Adverse Event|0|||
126295512|NCT01002989|454370643|FG000|Overall Study|exclusion criteria, no consent|5|||
126295513|NCT01892501|454370644|FG000|Overall Study|Protocol Violation|2|||
126295514|NCT01892501|454370644|FG000|Overall Study|Puncture not carried out|9|||
126295515|NCT01892501|454370644|FG000|Overall Study|Radiological monitoring not carried out|5|||
126295516|NCT01892501|454370644|FG000|Overall Study|Non-contributory histological result|12|||
126295517|NCT00063934|454370648|FG000|Overall Study|Ineligible|1|||
126295518|NCT04341363|454370649|FG000|Overall Study|Adverse Event|1|||
126295519|NCT04341363|454370649|FG000|Overall Study|Withdrawal by Subject|1|||
126295520|NCT00840749|454370653|FG000|Overall Study|Death|1|||
126295521|NCT00840749|454370654|FG001|Overall Study|Death|2|||
126295522|NCT00840749|454370653|FG000|Overall Study|not treated on study arm|11|||
126295523|NCT00840749|454370654|FG001|Overall Study|not treated on study arm|11|||
126295524|NCT00840749|454370653|FG000|Overall Study|study closed|19|||
126295525|NCT00840749|454370654|FG001|Overall Study|study closed|14|||
126295526|NCT00395629|454370655|FG000|Core Study|Adverse Event|0|||
126295527|NCT00395629|454370656|FG001|Core Study|Adverse Event|3|||
126295528|NCT00395629|454370657|FG002|Core Study|Adverse Event|4|||
126295529|NCT00395629|454370655|FG000|Core Study|Abnormal laboratory value(s)|0|||
126295530|NCT00395629|454370656|FG001|Core Study|Abnormal laboratory value(s)|0|||
126295531|NCT00395629|454370657|FG002|Core Study|Abnormal laboratory value(s)|1|||
126295532|NCT00395629|454370655|FG000|Core Study|Protocol Violation|1|||
126295533|NCT00395629|454370656|FG001|Core Study|Protocol Violation|0|||
126295534|NCT00395629|454370657|FG002|Core Study|Protocol Violation|0|||
126295535|NCT00395629|454370655|FG000|Core Study|Withdrawal by Subject|0|||
126295536|NCT00395629|454370656|FG001|Core Study|Withdrawal by Subject|1|||
126295537|NCT00395629|454370657|FG002|Core Study|Withdrawal by Subject|1|||
126295538|NCT00395629|454370655|FG000|Core Study|Lost to Follow-up|0|||
126295539|NCT00395629|454370656|FG001|Core Study|Lost to Follow-up|0|||
126295540|NCT00395629|454370657|FG002|Core Study|Lost to Follow-up|1|||
126295541|NCT00395629|454370655|FG000|Extension Study|Adverse Event|0|||
126295542|NCT00395629|454370656|FG001|Extension Study|Adverse Event|0|||
126295543|NCT00395629|454370657|FG002|Extension Study|Adverse Event|2|||
126295544|NCT00395629|454370655|FG000|Extension Study|Administrative problems|0|||
126295545|NCT00395629|454370656|FG001|Extension Study|Administrative problems|0|||
126295546|NCT00395629|454370657|FG002|Extension Study|Administrative problems|1|||
126295547|NCT01836471|454370660|FG000|Overall Study|Pregnancy|1|||
126295548|NCT01836471|454370661|FG001|Overall Study|Pregnancy|0|||
126295549|NCT01836471|454370662|FG002|Overall Study|Pregnancy|0|||
126295550|NCT01836471|454370663|FG003|Overall Study|Pregnancy|0|||
126295551|NCT01836471|454370664|FG004|Overall Study|Pregnancy|0|||
126295552|NCT01836471|454370660|FG000|Overall Study|Withdrawal by Subject|3|||
126295553|NCT01836471|454370661|FG001|Overall Study|Withdrawal by Subject|4|||
126295554|NCT01836471|454370662|FG002|Overall Study|Withdrawal by Subject|1|||
126295555|NCT01836471|454370663|FG003|Overall Study|Withdrawal by Subject|0|||
126295556|NCT01836471|454370664|FG004|Overall Study|Withdrawal by Subject|2|||
126295557|NCT01836471|454370660|FG000|Overall Study|Physician Decision|0|||
126295558|NCT01836471|454370661|FG001|Overall Study|Physician Decision|1|||
126295559|NCT01836471|454370662|FG002|Overall Study|Physician Decision|0|||
126295560|NCT01836471|454370663|FG003|Overall Study|Physician Decision|0|||
126295561|NCT01836471|454370664|FG004|Overall Study|Physician Decision|0|||
126295562|NCT01836471|454370660|FG000|Overall Study|Lost to Follow-up|0|||
126295563|NCT01836471|454370661|FG001|Overall Study|Lost to Follow-up|0|||
126295564|NCT01836471|454370662|FG002|Overall Study|Lost to Follow-up|0|||
126295565|NCT01836471|454370663|FG003|Overall Study|Lost to Follow-up|1|||
126295566|NCT01836471|454370664|FG004|Overall Study|Lost to Follow-up|1|||
126295567|NCT01836471|454370660|FG000|Overall Study|Adverse Event|6|||
126295568|NCT01836471|454370661|FG001|Overall Study|Adverse Event|3|||
126295569|NCT01836471|454370662|FG002|Overall Study|Adverse Event|1|||
126295570|NCT01836471|454370663|FG003|Overall Study|Adverse Event|1|||
126295571|NCT01836471|454370664|FG004|Overall Study|Adverse Event|2|||
126295572|NCT01836471|454370660|FG000|Overall Study|Non compliance with tx|1|||
126295573|NCT01836471|454370661|FG001|Overall Study|Non compliance with tx|1|||
126295574|NCT01836471|454370662|FG002|Overall Study|Non compliance with tx|0|||
126295575|NCT01836471|454370663|FG003|Overall Study|Non compliance with tx|0|||
126295576|NCT01836471|454370664|FG004|Overall Study|Non compliance with tx|0|||
126295577|NCT03051100|454370666|FG000|Overall Study|Withdrawal by Subject|1|||
126295578|NCT03051100|454370667|FG001|Overall Study|Withdrawal by Subject|0|||
126295579|NCT02059135|454370668|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
126295580|NCT02059135|454370669|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
126295581|NCT02059135|454370668|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
126295582|NCT02059135|454370669|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
126295583|NCT02059135|454370668|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
126295584|NCT02059135|454370669|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
126295585|NCT02059135|454370668|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
126295586|NCT02059135|454370669|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
126295587|NCT02059135|454370668|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
126295588|NCT02059135|454370669|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
126295589|NCT02059135|454370668|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
126295590|NCT02059135|454370669|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
126295591|NCT02059135|454370668|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
126295592|NCT02059135|454370669|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
126295593|NCT02059135|454370668|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
126295594|NCT02059135|454370669|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
126295595|NCT03776357|454370671|FG000|Overall Study|Lost to Follow-up|3|||
126295596|NCT00658723|454370677|FG000|Overall Study|Lost to Follow-up|0|||
126295597|NCT00658723|454370678|FG001|Overall Study|Lost to Follow-up|2|||
126295598|NCT00658723|454370679|FG002|Overall Study|Lost to Follow-up|2|||
126295599|NCT00658723|454370677|FG000|Overall Study|Death|2|||
126295600|NCT00658723|454370678|FG001|Overall Study|Death|1|||
126295601|NCT00658723|454370679|FG002|Overall Study|Death|4|||
126295602|NCT00658723|454370677|FG000|Overall Study|Scheduling Issue|1|||
126295603|NCT00658723|454370678|FG001|Overall Study|Scheduling Issue|1|||
126295604|NCT00658723|454370679|FG002|Overall Study|Scheduling Issue|0|||
126295605|NCT00658723|454370677|FG000|Overall Study|Withdrawal by Subject|1|||
126295606|NCT00658723|454370678|FG001|Overall Study|Withdrawal by Subject|0|||
126295607|NCT00658723|454370679|FG002|Overall Study|Withdrawal by Subject|1|||
126295608|NCT02411656|454370680|FG000|Overall Study|Adverse Event|4|||
126295609|NCT02411656|454370680|FG000|Overall Study|Clinical Progression|33|||
126295610|NCT06481709|454370681|FG000|Overall Study|Withdrawal by Subject|0|||
126295611|NCT06481709|454370682|FG001|Overall Study|Withdrawal by Subject|0|||
126295612|NCT06481709|454370683|FG002|Overall Study|Withdrawal by Subject|2|||
126295613|NCT06481709|454370684|FG003|Overall Study|Withdrawal by Subject|0|||
126295614|NCT05921903|454370685|FG000|Overall Study|Unsolicited non-SAE|0|||
126295615|NCT05921903|454370686|FG001|Overall Study|Unsolicited non-SAE|1|||
126295616|NCT05921903|454370687|FG002|Overall Study|Unsolicited non-SAE|0|||
126295617|NCT05921903|454370685|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
126295618|NCT05921903|454370686|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
126295619|NCT05921903|454370687|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
126295620|NCT05921903|454370685|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
126295621|NCT05921903|454370686|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
126295622|NCT05921903|454370687|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
126295623|NCT03305848|454370688|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
126295624|NCT03305848|454370688|FG000|Overall Study|Physician Decision|2|||
126042467|NCT03536884|453453118|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126042468|NCT03536884|453453119|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
126295625|NCT00789854|454370691|FG000|Overall Study|Adverse Event|28|||
126295626|NCT00789854|454370692|FG001|Overall Study|Adverse Event|23|||
126295627|NCT00789854|454370693|FG002|Overall Study|Adverse Event|18|||
126295628|NCT00789854|454370691|FG000|Overall Study|Lost to Follow-up|1|||
126042469|NCT03536884|453453120|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
126042470|NCT03536884|453453121|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
126295629|NCT00789854|454370692|FG001|Overall Study|Lost to Follow-up|1|||
126295630|NCT00789854|454370693|FG002|Overall Study|Lost to Follow-up|4|||
126295631|NCT00789854|454370691|FG000|Overall Study|Withdrawal by Subject|9|||
126295632|NCT00789854|454370692|FG001|Overall Study|Withdrawal by Subject|6|||
126295633|NCT00789854|454370693|FG002|Overall Study|Withdrawal by Subject|17|||
126295634|NCT00789854|454370691|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126295635|NCT00789854|454370692|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
126295636|NCT00789854|454370693|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126295637|NCT00789854|454370691|FG000|Overall Study|Severe non-compliance to the protocol|3|||
126295638|NCT00789854|454370692|FG001|Overall Study|Severe non-compliance to the protocol|0|||
126295639|NCT00789854|454370693|FG002|Overall Study|Severe non-compliance to the protocol|0|||
126295640|NCT00789854|454370691|FG000|Overall Study|Safety reasons|0|||
126295641|NCT00789854|454370692|FG001|Overall Study|Safety reasons|0|||
126295642|NCT00789854|454370693|FG002|Overall Study|Safety reasons|2|||
125883431|NCT00068692|452871473|FG007|Step 2: Randomization|alternative therapy|0|||
126295643|NCT00789854|454370691|FG000|Overall Study|Other|6|||
126295644|NCT00789854|454370692|FG001|Overall Study|Other|0|||
126295645|NCT00789854|454370693|FG002|Overall Study|Other|5|||
126295646|NCT00923013|454370694|FG000|Overall Study|Refused further treatment|0|||
126295647|NCT00923013|454370695|FG001|Overall Study|Refused further treatment|1|||
126295648|NCT00923013|454370696|FG002|Overall Study|Refused further treatment|2|||
126295649|NCT00923013|454370697|FG003|Overall Study|Refused further treatment|0|||
126295650|NCT00923013|454370698|FG004|Overall Study|Refused further treatment|0|||
126295651|NCT00923013|454370699|FG005|Overall Study|Refused further treatment|0|||
126295652|NCT00923013|454370694|FG000|Overall Study|Switched to alternative treatment|0|||
126295653|NCT00923013|454370695|FG001|Overall Study|Switched to alternative treatment|1|||
126295654|NCT00923013|454370696|FG002|Overall Study|Switched to alternative treatment|0|||
126295655|NCT00923013|454370697|FG003|Overall Study|Switched to alternative treatment|0|||
126295656|NCT00923013|454370698|FG004|Overall Study|Switched to alternative treatment|0|||
126295657|NCT00923013|454370699|FG005|Overall Study|Switched to alternative treatment|0|||
126295658|NCT00923013|454370694|FG000|Overall Study|Death on study|2|||
126295659|NCT00923013|454370695|FG001|Overall Study|Death on study|2|||
126295660|NCT00923013|454370696|FG002|Overall Study|Death on study|0|||
126295661|NCT00923013|454370697|FG003|Overall Study|Death on study|1|||
126295662|NCT00923013|454370698|FG004|Overall Study|Death on study|0|||
126295663|NCT00923013|454370699|FG005|Overall Study|Death on study|0|||
126295664|NCT02301169|454370702|FG000|Overall Study|Adverse Event|1|||
126295665|NCT02301169|454370703|FG001|Overall Study|Adverse Event|0|||
126295666|NCT01198470|454370708|FG000|Overall Study|Adverse Event|2|||
126295667|NCT02949973|454370709|FG000|Overall Study|Physician Decision|1|||
126295668|NCT01422213|454370710|FG000|Overall Study|Adverse Event|8|||
126295669|NCT01422213|454370711|FG001|Overall Study|Adverse Event|7|||
126295670|NCT01422213|454370712|FG002|Overall Study|Adverse Event|11|||
126295671|NCT01422213|454370710|FG000|Overall Study|Lack of Efficacy|10|||
126295672|NCT01422213|454370711|FG001|Overall Study|Lack of Efficacy|2|||
126295673|NCT01422213|454370712|FG002|Overall Study|Lack of Efficacy|2|||
126295674|NCT01422213|454370710|FG000|Overall Study|Non-compliance with study drug|0|||
126295675|NCT01422213|454370711|FG001|Overall Study|Non-compliance with study drug|1|||
126295676|NCT01422213|454370712|FG002|Overall Study|Non-compliance with study drug|0|||
126295677|NCT01422213|454370710|FG000|Overall Study|Protocol Violation|0|||
126295678|NCT01422213|454370711|FG001|Overall Study|Protocol Violation|2|||
126295679|NCT01422213|454370712|FG002|Overall Study|Protocol Violation|4|||
126295680|NCT01422213|454370710|FG000|Overall Study|Withdrawal of Consent|7|||
126295681|NCT01422213|454370711|FG001|Overall Study|Withdrawal of Consent|3|||
126295682|NCT01422213|454370712|FG002|Overall Study|Withdrawal of Consent|5|||
126295683|NCT01422213|454370710|FG000|Overall Study|Lost to Follow-up|3|||
126295684|NCT01422213|454370711|FG001|Overall Study|Lost to Follow-up|3|||
126042471|NCT03536884|453453110|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126042472|NCT03536884|453453111|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126295685|NCT01422213|454370712|FG002|Overall Study|Lost to Follow-up|5|||
126295686|NCT01422213|454370710|FG000|Overall Study|Administrative or Other Reason(s)|5|||
126295687|NCT01422213|454370711|FG001|Overall Study|Administrative or Other Reason(s)|4|||
126295688|NCT01422213|454370712|FG002|Overall Study|Administrative or Other Reason(s)|2|||
126295689|NCT04129125|454370719|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
126295690|NCT04129125|454370719|FG000|Overall Study|Study device was not used|3|||
126295691|NCT04484142|454370720|FG000|Overall Study|Adverse Event|13|||
126295692|NCT04484142|454370720|FG000|Overall Study|Progressive Disease|87|||
126295693|NCT04484142|454370720|FG000|Overall Study|Clinical Progression|10|||
126295694|NCT04484142|454370720|FG000|Overall Study|Withdrawal by Subject|6|||
125883432|NCT00068692|452871466|FG000|Step 2: Randomization|Physician Decision|0|||
126042473|NCT03536884|453453112|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126295695|NCT04484142|454370720|FG000|Overall Study|Physician Decision|1|||
126295696|NCT03181633|454370721|FG000|Overall Study|Withdrawal by Subject|1|||
126295697|NCT03181633|454370721|FG000|Overall Study|Missing follow-up visit|1|||
126295698|NCT05303194|454370722|FG000|Overall Study|Lost to Follow-up|1|||
126295699|NCT05303194|454370723|FG001|Overall Study|Lost to Follow-up|1|||
126295700|NCT05303194|454370722|FG000|Overall Study|Withdrawal by Subject|0|||
126295701|NCT05303194|454370723|FG001|Overall Study|Withdrawal by Subject|1|||
126295702|NCT04837196|454370733|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
126295703|NCT04837196|454370734|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
126295704|NCT04837196|454370735|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
126295705|NCT04837196|454370736|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
126295706|NCT04837196|454370737|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
126295707|NCT04837196|454370733|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
126295708|NCT04837196|454370734|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
126295709|NCT04837196|454370735|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
126295710|NCT04837196|454370736|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
126295711|NCT04837196|454370737|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
126295712|NCT04837196|454370733|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
126295713|NCT04837196|454370734|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
126295714|NCT04837196|454370735|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
126295715|NCT04837196|454370736|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
126295716|NCT04837196|454370737|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
126295717|NCT04837196|454370733|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
126295718|NCT04837196|454370734|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
126295719|NCT04837196|454370735|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
126295720|NCT04837196|454370736|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
126295721|NCT04837196|454370737|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
126295722|NCT04837196|454370733|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
126295723|NCT04837196|454370734|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
126295724|NCT04837196|454370735|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
126295725|NCT04837196|454370736|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
126295726|NCT04837196|454370737|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
126295727|NCT05271175|454370738|FG000|One Week Follow up|Lost to Follow-up|10|||
126295728|NCT05271175|454370739|FG001|One Week Follow up|Lost to Follow-up|7|||
126295729|NCT05271175|454370740|FG002|One Week Follow up|Lost to Follow-up|5|||
126295730|NCT05271175|454370738|FG000|One Month Follow up|Lost to Follow-up|12|||
126100231|NCT01656733|453659877|FG000|Overall Study|Spontaneous abortion|0|||
126100232|NCT01656733|453659878|FG001|Overall Study|Spontaneous abortion|1|||
126295731|NCT05271175|454370739|FG001|One Month Follow up|Lost to Follow-up|7|||
126295732|NCT05271175|454370740|FG002|One Month Follow up|Lost to Follow-up|9|||
126295733|NCT05271175|454370738|FG000|Six Months Follow up|Lost to Follow-up|8|||
126295734|NCT05271175|454370739|FG001|Six Months Follow up|Lost to Follow-up|2|||
126295735|NCT05271175|454370740|FG002|Six Months Follow up|Lost to Follow-up|2|||
126295736|NCT00991887|454370741|FG000|Overall Study|Lost to Follow-up|2|||
126295737|NCT00991887|454370742|FG001|Overall Study|Lost to Follow-up|1|||
126295738|NCT01522456|454370743|FG000|Overall Study|Adverse Event|2|||
126295739|NCT01522456|454370743|FG000|Overall Study|Lost to Follow-up|2|||
126295740|NCT01522456|454370743|FG000|Overall Study|Withdrawal by Subject|2|||
126295741|NCT01522456|454370743|FG000|Overall Study|Pregnancy|1|||
126295742|NCT01522456|454370743|FG000|Overall Study|Tolerability Assessment|1|||
126295743|NCT00740636|454370747|FG000|Overall Study|Adverse Event|0|||
126295744|NCT00740636|454370748|FG001|Overall Study|Adverse Event|2|||
126295745|NCT00740636|454370747|FG000|Overall Study|Patient Ineligible|0|||
126295746|NCT00740636|454370748|FG001|Overall Study|Patient Ineligible|1|||
126295747|NCT00740636|454370747|FG000|Overall Study|Patient Not Treated|0|||
126295748|NCT00740636|454370748|FG001|Overall Study|Patient Not Treated|1|||
126295749|NCT00740636|454370747|FG000|Overall Study|Progressive Disease|1|||
126295750|NCT00740636|454370748|FG001|Overall Study|Progressive Disease|0|||
126295751|NCT00740636|454370747|FG000|Overall Study|Death|1|||
126295752|NCT00740636|454370748|FG001|Overall Study|Death|0|||
126295753|NCT03832686|454370749|FG000|Overall Study|Lost to Follow-up|6|||
126295754|NCT03832686|454370750|FG001|Overall Study|Lost to Follow-up|9|||
126295755|NCT03832686|454370749|FG000|Overall Study|Discontinued Intervention|5|||
126295756|NCT03832686|454370750|FG001|Overall Study|Discontinued Intervention|4|||
126295757|NCT02844543|454372502|FG000|Overall Study|Withdrawal by Subject|4|||
126295758|NCT02844543|454372502|FG000|Overall Study|Did not meet eligibility criteria|1|||
126295759|NCT04710576|454372508|FG000|Overall Study|Participants still in the study|73|||
126295760|NCT04710576|454372509|FG001|Overall Study|Participants still in the study|70|||
126295761|NCT04710576|454372510|FG002|Overall Study|Participants still in the study|60|||
126295762|NCT04710576|454372508|FG000|Overall Study|Death|2|||
126295763|NCT04710576|454372509|FG001|Overall Study|Death|7|||
126366924|NCT01051661|454639364|FG003|Overall Study|Migrated/moved from study area|8|||
126366925|NCT01051661|454639365|FG004|Overall Study|Migrated/moved from study area|7|||
126295764|NCT04710576|454372510|FG002|Overall Study|Death|12|||
126295765|NCT04710576|454372508|FG000|Overall Study|Withdrawal by Subject|4|||
126295766|NCT04710576|454372509|FG001|Overall Study|Withdrawal by Subject|3|||
126295767|NCT04710576|454372510|FG002|Overall Study|Withdrawal by Subject|7|||
126295768|NCT04710576|454372508|FG000|Overall Study|Sponsor decision|1|||
126295769|NCT04710576|454372509|FG001|Overall Study|Sponsor decision|0|||
126295770|NCT04710576|454372510|FG002|Overall Study|Sponsor decision|0|||
126295771|NCT04581824|454372511|FG000|Overall Study|Lost to Follow-up|1|||
126295772|NCT04581824|454372512|FG001|Overall Study|Lost to Follow-up|0|||
126295773|NCT04581824|454372511|FG000|Overall Study|Withdrawal by Subject|2|||
126295774|NCT04581824|454372512|FG001|Overall Study|Withdrawal by Subject|7|||
126295775|NCT04581824|454372511|FG000|Overall Study|Study terminated by sponsor|37|||
126295776|NCT04581824|454372512|FG001|Overall Study|Study terminated by sponsor|23|||
126295777|NCT04796909|454372513|FG000|Overall Study|Withdrawal by Subject|1|||
126295778|NCT04796909|454372514|FG001|Overall Study|Withdrawal by Subject|1|||
126295779|NCT03879135|454372515|FG000|Overall Study|Physician Decision|0|||
126295780|NCT03879135|454372516|FG001|Overall Study|Physician Decision|0|||
126295781|NCT03879135|454372517|FG002|Overall Study|Physician Decision|0|||
126295782|NCT03879135|454372518|FG003|Overall Study|Physician Decision|1|||
126295783|NCT03879135|454372519|FG004|Overall Study|Physician Decision|0|||
126295784|NCT03879135|454372520|FG005|Overall Study|Physician Decision|0|||
126295785|NCT03879135|454372515|FG000|Overall Study|Withdrawal by Subject|0|||
126295786|NCT03879135|454372516|FG001|Overall Study|Withdrawal by Subject|0|||
126295787|NCT03879135|454372517|FG002|Overall Study|Withdrawal by Subject|0|||
126295788|NCT03879135|454372518|FG003|Overall Study|Withdrawal by Subject|0|||
126295789|NCT03879135|454372519|FG004|Overall Study|Withdrawal by Subject|0|||
126295790|NCT03879135|454372520|FG005|Overall Study|Withdrawal by Subject|1|||
126295791|NCT03879135|454372515|FG000|Overall Study|Site Closed by Sponsor|0|||
126295792|NCT03879135|454372516|FG001|Overall Study|Site Closed by Sponsor|0|||
126295793|NCT03879135|454372517|FG002|Overall Study|Site Closed by Sponsor|0|||
126295794|NCT03879135|454372518|FG003|Overall Study|Site Closed by Sponsor|1|||
126295795|NCT03879135|454372519|FG004|Overall Study|Site Closed by Sponsor|1|||
126295796|NCT03879135|454372520|FG005|Overall Study|Site Closed by Sponsor|0|||
126295797|NCT04162847|454372521|FG000|Overall Study|Withdrawal by Subject|7|||
126295798|NCT04162847|454372522|FG001|Overall Study|Withdrawal by Subject|1|||
126295799|NCT00813150|454372527|FG000|Treatment Period|Adverse Event|16|||
126295800|NCT00813150|454372528|FG001|Treatment Period|Adverse Event|15|||
126295801|NCT00813150|454372527|FG000|Treatment Period|Death|2|||
126295802|NCT00813150|454372528|FG001|Treatment Period|Death|0|||
126295803|NCT00813150|454372527|FG000|Treatment Period|Progressive disease|1|||
126295804|NCT00813150|454372528|FG001|Treatment Period|Progressive disease|0|||
126295805|NCT00813150|454372527|FG000|Treatment Period|Complete response|0|||
126295806|NCT00813150|454372528|FG001|Treatment Period|Complete response|1|||
126295807|NCT00813150|454372527|FG000|Treatment Period|Stable disease|1|||
126295808|NCT00813150|454372528|FG001|Treatment Period|Stable disease|2|||
126295809|NCT00813150|454372527|FG000|Treatment Period|Protocol Violation|3|||
126295810|NCT00813150|454372528|FG001|Treatment Period|Protocol Violation|4|||
126295811|NCT00813150|454372527|FG000|Treatment Period|Withdrawal by Subject|5|||
126295812|NCT00813150|454372528|FG001|Treatment Period|Withdrawal by Subject|3|||
126295813|NCT00813150|454372527|FG000|Treatment Period|Non compliance|0|||
126295814|NCT00813150|454372528|FG001|Treatment Period|Non compliance|1|||
126295815|NCT00813150|454372527|FG000|Treatment Period|Reason not specified|3|||
126295816|NCT00813150|454372528|FG001|Treatment Period|Reason not specified|4|||
126295817|NCT00813150|454372527|FG000|Treatment Period|Data not available|1|||
126366926|NCT01051661|454639366|FG005|Overall Study|Migrated/moved from study area|3|||
126366927|NCT01051661|454639361|FG000|Overall Study|Refused blood sampling|0|||
126366928|NCT01051661|454639362|FG001|Overall Study|Refused blood sampling|0|||
126366929|NCT01051661|454639363|FG002|Overall Study|Refused blood sampling|0|||
126295818|NCT00813150|454372528|FG001|Treatment Period|Data not available|2|||
126295819|NCT00813150|454372527|FG000|Long Term Follow-up|Death|0|||
126295820|NCT00813150|454372528|FG001|Long Term Follow-up|Death|4|||
126295821|NCT00813150|454372527|FG000|Long Term Follow-up|Other|0|||
126366930|NCT01051661|454639364|FG003|Overall Study|Refused blood sampling|0|||
126366931|NCT01051661|454639365|FG004|Overall Study|Refused blood sampling|0|||
126366932|NCT01051661|454639366|FG005|Overall Study|Refused blood sampling|1|||
126366933|NCT01051661|454639361|FG000|Overall Study|Data not reliable|1|||
126366934|NCT01051661|454639362|FG001|Overall Study|Data not reliable|0|||
125883433|NCT00068692|452871467|FG001|Step 2: Randomization|Physician Decision|0|||
126042474|NCT03536884|453453113|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126295822|NCT00813150|454372528|FG001|Long Term Follow-up|Other|3|||
126366935|NCT01051661|454639363|FG002|Overall Study|Data not reliable|0|||
126366936|NCT01051661|454639364|FG003|Overall Study|Data not reliable|0|||
126295823|NCT00813150|454372527|FG000|Long Term Follow-up|Lost to Follow-up|2|||
126366937|NCT01051661|454639365|FG004|Overall Study|Data not reliable|0|||
125883434|NCT00068692|452871468|FG002|Step 2: Randomization|Physician Decision|0|||
126295824|NCT00813150|454372528|FG001|Long Term Follow-up|Lost to Follow-up|0|||
126295825|NCT00813150|454372527|FG000|Long Term Follow-up|Progression/Relapse|22|||
126295826|NCT00813150|454372528|FG001|Long Term Follow-up|Progression/Relapse|24|||
126295827|NCT03593525|454372540|FG000|Overall Study|Withdrawal by Subject|1|||
126366938|NCT01051661|454639366|FG005|Overall Study|Data not reliable|1|||
126366939|NCT01051661|454639361|FG000|Overall Study|Unable to attend visit(s)|2|||
125883435|NCT00068692|452871469|FG003|Step 2: Randomization|Physician Decision|1|||
126295828|NCT03593525|454372541|FG001|Overall Study|Withdrawal by Subject|0|||
126295829|NCT03593525|454372540|FG000|Overall Study|Lost to Follow-up|7|||
126100233|NCT01065844|453659879|FG000|Overall Study|Adverse Event|5|||
126100234|NCT01502631|453659882|FG000|Overall Study|Adverse Event|5|||
126100235|NCT01502631|453659883|FG001|Overall Study|Adverse Event|8|||
126100236|NCT01502631|453659882|FG000|Overall Study|Lost to Follow-up|2|||
126100237|NCT01502631|453659883|FG001|Overall Study|Lost to Follow-up|2|||
126100238|NCT01502631|453659882|FG000|Overall Study|Participant withdrew consent|2|||
126100239|NCT01502631|453659883|FG001|Overall Study|Participant withdrew consent|4|||
126100240|NCT01502631|453659882|FG000|Overall Study|Participant non-compliant|1|||
126100241|NCT01502631|453659883|FG001|Overall Study|Participant non-compliant|0|||
126100242|NCT01502631|453659882|FG000|Overall Study|Investigator's decision|0|||
126100243|NCT01502631|453659883|FG001|Overall Study|Investigator's decision|1|||
126295830|NCT03593525|454372541|FG001|Overall Study|Lost to Follow-up|5|||
126295831|NCT03103087|454372542|FG000|Overall Study|Did not receive any study drug|1|||
126100244|NCT01502631|453659882|FG000|Overall Study|Other|10|||
126100245|NCT01502631|453659883|FG001|Overall Study|Other|5|||
126100246|NCT02084056|453659884|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
126100247|NCT02084056|453659885|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126100248|NCT02084056|453659886|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126295832|NCT03103087|454372543|FG001|Overall Study|Did not receive any study drug|0|||
126295833|NCT03103087|454372544|FG002|Overall Study|Did not receive any study drug|0|||
126295834|NCT03103087|454372542|FG000|Overall Study|Protocol Violation|1|||
126295835|NCT03103087|454372543|FG001|Overall Study|Protocol Violation|2|||
126295836|NCT03103087|454372544|FG002|Overall Study|Protocol Violation|1|||
126295837|NCT03103087|454372542|FG000|Overall Study|Lack of Efficacy|2|||
126295838|NCT03103087|454372543|FG001|Overall Study|Lack of Efficacy|1|||
126295839|NCT03103087|454372544|FG002|Overall Study|Lack of Efficacy|1|||
126295840|NCT03103087|454372542|FG000|Overall Study|Pregnancy|0|||
126100249|NCT02084056|453659887|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126100250|NCT02084056|453659884|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
126100251|NCT02084056|453659885|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126100252|NCT02084056|453659886|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126100253|NCT02084056|453659887|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126100254|NCT01293487|453659889|FG000|Overall Study|Lost to Follow-up|0|||
126100255|NCT01293487|453659890|FG001|Overall Study|Lost to Follow-up|0|||
126100256|NCT01293487|453659891|FG002|Overall Study|Lost to Follow-up|0|||
126100257|NCT01293487|453659892|FG003|Overall Study|Lost to Follow-up|1|||
126100258|NCT01293487|453659893|FG004|Overall Study|Lost to Follow-up|0|||
126100259|NCT01293487|453659894|FG005|Overall Study|Lost to Follow-up|0|||
126100260|NCT01293487|453659895|FG006|Overall Study|Lost to Follow-up|0|||
126100261|NCT01293487|453659896|FG007|Overall Study|Lost to Follow-up|0|||
126100262|NCT01293487|453659889|FG000|Overall Study|Withdrawal by Subject|0|||
126100263|NCT01293487|453659890|FG001|Overall Study|Withdrawal by Subject|0|||
126100264|NCT01293487|453659891|FG002|Overall Study|Withdrawal by Subject|0|||
126100265|NCT01293487|453659892|FG003|Overall Study|Withdrawal by Subject|0|||
126100266|NCT01293487|453659893|FG004|Overall Study|Withdrawal by Subject|0|||
126295841|NCT03103087|454372543|FG001|Overall Study|Pregnancy|0|||
126295842|NCT03103087|454372544|FG002|Overall Study|Pregnancy|1|||
126295843|NCT03103087|454372542|FG000|Overall Study|Adverse Event|2|||
126295844|NCT03103087|454372543|FG001|Overall Study|Adverse Event|15|||
126295845|NCT03103087|454372544|FG002|Overall Study|Adverse Event|6|||
126295846|NCT03103087|454372542|FG000|Overall Study|Withdrawal by Subject|13|||
126295847|NCT03103087|454372543|FG001|Overall Study|Withdrawal by Subject|6|||
126295848|NCT03103087|454372544|FG002|Overall Study|Withdrawal by Subject|6|||
126295849|NCT03103087|454372542|FG000|Overall Study|Lost to Follow-up|4|||
126295850|NCT03103087|454372543|FG001|Overall Study|Lost to Follow-up|2|||
126295851|NCT03103087|454372544|FG002|Overall Study|Lost to Follow-up|7|||
126295852|NCT03103087|454372542|FG000|Overall Study|Other reason not reported|1|||
126100267|NCT01293487|453659894|FG005|Overall Study|Withdrawal by Subject|0|||
126100268|NCT01293487|453659895|FG006|Overall Study|Withdrawal by Subject|0|||
126100269|NCT01293487|453659896|FG007|Overall Study|Withdrawal by Subject|2|||
126100270|NCT00395460|453659897|FG000|Overall Study|Withdrawal by Subject|1|||
126100271|NCT00395460|453659898|FG001|Overall Study|Withdrawal by Subject|0|||
126100272|NCT04223830|453659905|FG000|Overall Study|Lost to Follow-up|9|||
126100273|NCT04223830|453659905|FG000|Overall Study|Adverse Event|1|||
126295853|NCT03103087|454372543|FG001|Overall Study|Other reason not reported|3|||
126295854|NCT03103087|454372544|FG002|Overall Study|Other reason not reported|5|||
126295855|NCT00075816|454372545|FG000|Overall Study|Did not undergo transplantation|14|||
126100274|NCT01964924|453659906|FG000|Trametinib Monotherapy|Progression|19|||
126100275|NCT01964924|453659907|FG001|Trametinib Monotherapy|Progression|0|||
126100276|NCT00577577|453659909|FG000|Overall Study|Adverse Event|3|||
126100277|NCT00577577|453659910|FG001|Overall Study|Adverse Event|2|||
126100278|NCT00577577|453659909|FG000|Overall Study|Lost to Follow-up|1|||
126100279|NCT00577577|453659910|FG001|Overall Study|Lost to Follow-up|0|||
126100280|NCT00577577|453659909|FG000|Overall Study|Protocol Violation|0|||
126295856|NCT00075816|454372546|FG001|Overall Study|Did not undergo transplantation|11|||
126295857|NCT00471822|454372547|FG000|Overall Study|Protocol Violation|2|||
126295858|NCT02549859|454372548|FG000|Long-term 60 Hz DBS|Study Closed|1|||
126295859|NCT03664232|454372550|FG000|Overall Study|Withdrawal by Subject|0|||
126295860|NCT03664232|454372551|FG001|Overall Study|Withdrawal by Subject|1|||
126295861|NCT03664232|454372552|FG002|Overall Study|Withdrawal by Subject|0|||
126295862|NCT03664232|454372553|FG003|Overall Study|Withdrawal by Subject|1|||
126295863|NCT03664232|454372550|FG000|Overall Study|Adverse Event|0|||
126295864|NCT03664232|454372551|FG001|Overall Study|Adverse Event|0|||
126295865|NCT03664232|454372552|FG002|Overall Study|Adverse Event|1|||
126295866|NCT03664232|454372553|FG003|Overall Study|Adverse Event|0|||
126295867|NCT03664232|454372550|FG000|Overall Study|Other-Non-compliance with study drug|0|||
126295868|NCT03664232|454372551|FG001|Overall Study|Other-Non-compliance with study drug|1|||
126295869|NCT03664232|454372552|FG002|Overall Study|Other-Non-compliance with study drug|0|||
126295870|NCT03664232|454372553|FG003|Overall Study|Other-Non-compliance with study drug|2|||
126295871|NCT03664232|454372550|FG000|Overall Study|Other-Unspecified|0|||
126295872|NCT03664232|454372551|FG001|Overall Study|Other-Unspecified|3|||
126295873|NCT03664232|454372552|FG002|Overall Study|Other-Unspecified|0|||
126295874|NCT03664232|454372553|FG003|Overall Study|Other-Unspecified|1|||
126295875|NCT03664232|454372550|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
126295876|NCT03664232|454372551|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
126295877|NCT03664232|454372552|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
126295878|NCT03664232|454372553|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
126295879|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
126295880|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
126295881|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
126295882|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
126295883|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
126295884|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295885|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295886|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295887|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295888|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295889|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295890|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295891|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295892|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295893|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295894|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
126295895|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
126295896|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
126295897|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
126295898|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
126295899|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295900|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295901|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295902|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295903|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295904|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295905|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295906|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126366940|NCT01051661|454639362|FG001|Overall Study|Unable to attend visit(s)|4|||
126366941|NCT01051661|454639363|FG002|Overall Study|Unable to attend visit(s)|2|||
126366942|NCT01051661|454639364|FG003|Overall Study|Unable to attend visit(s)|1|||
126366943|NCT01051661|454639365|FG004|Overall Study|Unable to attend visit(s)|3|||
126042475|NCT03536884|453453114|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126042476|NCT03536884|453453115|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126042477|NCT03536884|453453116|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126366944|NCT01051661|454639366|FG005|Overall Study|Unable to attend visit(s)|2|||
126366945|NCT01051661|454639361|FG000|Overall Study|Consent not received from both parents|0|||
126295907|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295908|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295909|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
126295910|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
126295911|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
126295912|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
126295913|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
126295914|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295915|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295916|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295917|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295918|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295919|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295920|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295921|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295922|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295923|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295924|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
126295925|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
126295926|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
126295927|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
126295928|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
126295929|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295930|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295931|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295932|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295933|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295934|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295935|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295936|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295937|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295938|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295939|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
126295940|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295941|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
126295942|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
126295943|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
126295944|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295945|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295946|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295947|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295948|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295949|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295950|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295951|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295952|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295953|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295954|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295955|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295956|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295957|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
126295958|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295959|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295960|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295961|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295962|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295963|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295964|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295965|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295966|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295967|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
126366946|NCT01051661|454639362|FG001|Overall Study|Consent not received from both parents|0|||
126366947|NCT01051661|454639363|FG002|Overall Study|Consent not received from both parents|0|||
126366948|NCT01051661|454639364|FG003|Overall Study|Consent not received from both parents|0|||
125883436|NCT00068692|452871470|FG004|Step 2: Randomization|Physician Decision|1|||
126295968|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295969|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295970|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
126295971|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
126295972|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
126295973|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
126295974|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295975|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295976|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295977|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295978|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295979|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295980|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295981|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295982|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295983|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295984|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295985|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295986|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295987|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295988|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295989|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
126295990|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
126295991|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
126295992|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
126295993|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
126295994|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
126295995|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
126295996|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
126295997|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
126295998|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
126295999|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296000|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296001|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296002|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296003|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296004|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
126296005|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
126296006|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
126296007|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
126296008|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
126296009|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
126296010|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
126296011|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
126296012|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
126296013|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
126296014|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296015|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296016|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296017|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296018|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296019|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
126296020|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
126296021|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
126296022|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
126296023|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
126296024|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
126296025|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
126042478|NCT03536884|453453117|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126042479|NCT03536884|453453118|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126042480|NCT03536884|453453119|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126042481|NCT03536884|453453120|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
126296026|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296027|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
126296028|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
126296029|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296030|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296031|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296032|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296033|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296034|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
126296035|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
126296036|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
126100281|NCT00577577|453659910|FG001|Overall Study|Protocol Violation|3|||
126100282|NCT00577577|453659909|FG000|Overall Study|Transportation|1|||
126100283|NCT00577577|453659910|FG001|Overall Study|Transportation|0|||
126100284|NCT01153958|453659911|FG000|Overall Study|Study Terminated|36|||
126100285|NCT01153958|453659912|FG001|Overall Study|Study Terminated|32|||
126100286|NCT02150343|453659915|FG000|Overall Study|Adverse Event|2|||
126296037|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
126296038|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
126296039|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
126296040|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
126296041|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
126296042|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
126296043|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
126296044|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296045|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296046|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126100287|NCT02150343|453659916|FG001|Overall Study|Adverse Event|0|||
126100288|NCT02150343|453659917|FG002|Overall Study|Adverse Event|1|||
126100289|NCT02150343|453659918|FG003|Overall Study|Adverse Event|1|||
126100290|NCT02150343|453659915|FG000|Overall Study|Withdrawal by Subject|13|||
126100291|NCT02150343|453659916|FG001|Overall Study|Withdrawal by Subject|10|||
126100292|NCT02150343|453659917|FG002|Overall Study|Withdrawal by Subject|9|||
126100293|NCT02150343|453659918|FG003|Overall Study|Withdrawal by Subject|4|||
126100294|NCT02150343|453659915|FG000|Overall Study|Lost to Follow-up|4|||
126100295|NCT02150343|453659916|FG001|Overall Study|Lost to Follow-up|4|||
126100296|NCT02150343|453659917|FG002|Overall Study|Lost to Follow-up|2|||
126100297|NCT02150343|453659918|FG003|Overall Study|Lost to Follow-up|3|||
126100298|NCT02150343|453659915|FG000|Overall Study|Other|2|||
126100299|NCT02150343|453659916|FG001|Overall Study|Other|6|||
126100300|NCT02150343|453659917|FG002|Overall Study|Other|0|||
126100301|NCT02150343|453659918|FG003|Overall Study|Other|2|||
126100302|NCT00190749|453659919|FG000|Overall Study|Lost to Follow-up|8|||
126100303|NCT00190749|453659920|FG001|Overall Study|Lost to Follow-up|11|||
126100304|NCT00190749|453659919|FG000|Overall Study|Withdrawal by Subject|10|||
126100305|NCT00190749|453659920|FG001|Overall Study|Withdrawal by Subject|6|||
126100306|NCT00190749|453659919|FG000|Overall Study|Protocol Violation|5|||
126100307|NCT00190749|453659920|FG001|Overall Study|Protocol Violation|4|||
126100308|NCT00190749|453659919|FG000|Overall Study|Adverse Event|0|||
126100309|NCT00190749|453659920|FG001|Overall Study|Adverse Event|5|||
126100310|NCT00190749|453659919|FG000|Overall Study|Lack of Efficacy|2|||
126100311|NCT00190749|453659920|FG001|Overall Study|Lack of Efficacy|3|||
126100312|NCT00190749|453659919|FG000|Overall Study|Reason Not Specified|0|||
126100313|NCT00190749|453659920|FG001|Overall Study|Reason Not Specified|2|||
126100314|NCT00190749|453659919|FG000|Overall Study|Sponsor Decision|1|||
126100315|NCT00190749|453659920|FG001|Overall Study|Sponsor Decision|0|||
126100316|NCT02729753|453659921|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
126100317|NCT02729753|453659922|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
126100318|NCT01200589|453659923|FG000|Overall Study|Withdrawal by Subject|13|||
126100319|NCT01200589|453659924|FG001|Overall Study|Withdrawal by Subject|11|||
126100320|NCT01200589|453659923|FG000|Overall Study|Physician Decision|2|||
126100321|NCT01200589|453659924|FG001|Overall Study|Physician Decision|2|||
126100322|NCT01200589|453659923|FG000|Overall Study|Lost to Follow-up|5|||
126100323|NCT01200589|453659924|FG001|Overall Study|Lost to Follow-up|4|||
126100324|NCT01200589|453659923|FG000|Overall Study|Study terminated|170|||
126100325|NCT01200589|453659924|FG001|Overall Study|Study terminated|172|||
126100326|NCT01090427|453659925|FG000|After Controlled Period|Death|0|||
126100327|NCT01090427|453659926|FG001|After Controlled Period|Death|0|||
126100328|NCT01090427|453659927|FG002|After Controlled Period|Death|0|||
126100329|NCT01090427|453659928|FG003|After Controlled Period|Death|0|||
126100330|NCT01090427|453659929|FG004|After Controlled Period|Death|0|||
126100331|NCT01090427|453659930|FG005|After Controlled Period|Death|1|||
126100332|NCT01090427|453659931|FG006|After Controlled Period|Death|0|||
126100333|NCT01090427|453659925|FG000|After Controlled Period|Lack of Efficacy|0|||
126100334|NCT01090427|453659926|FG001|After Controlled Period|Lack of Efficacy|0|||
126296047|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296048|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296049|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296050|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
126296051|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
126296052|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
126296053|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
126296054|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
126296055|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
126296056|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296057|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
126296058|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
126296059|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296060|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296061|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296062|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296063|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296064|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296065|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296066|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296067|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296068|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296069|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296070|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
126296071|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296072|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
126296073|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296074|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296075|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296076|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296077|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
126042482|NCT03536884|453453121|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126042483|NCT03536884|453453110|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042484|NCT03536884|453453111|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042485|NCT03536884|453453112|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042486|NCT03536884|453453113|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042487|NCT03536884|453453114|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042488|NCT03536884|453453115|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042489|NCT03536884|453453116|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042490|NCT03536884|453453117|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042491|NCT03536884|453453118|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042492|NCT03536884|453453119|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042493|NCT03536884|453453120|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126042494|NCT03536884|453453121|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
126042495|NCT03536884|453453110|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042496|NCT03536884|453453111|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042497|NCT03536884|453453112|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042498|NCT03536884|453453113|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042499|NCT03536884|453453114|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042500|NCT03536884|453453115|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042501|NCT03536884|453453116|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042502|NCT03536884|453453117|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042503|NCT03536884|453453118|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042504|NCT03536884|453453119|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042505|NCT03536884|453453120|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126042506|NCT03536884|453453121|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
126042507|NCT02367040|453453141|FG000|Overall Study|Lost to Follow-up|1|||
126042508|NCT02367040|453453142|FG001|Overall Study|Lost to Follow-up|1|||
126042509|NCT02367040|453453141|FG000|Overall Study|Lack of Efficacy|1|||
126042510|NCT02367040|453453142|FG001|Overall Study|Lack of Efficacy|0|||
126296078|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296079|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
126296080|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296081|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296082|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296083|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296084|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296085|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296086|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296087|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296088|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
126296089|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126042511|NCT02367040|453453141|FG000|Overall Study|Additional primary malignancy|0|||
126042512|NCT02367040|453453142|FG001|Overall Study|Additional primary malignancy|1|||
126042513|NCT02367040|453453141|FG000|Overall Study|AE not associated with clinical disease progression|114|||
126042514|NCT02367040|453453142|FG001|Overall Study|AE not associated with clinical disease progression|11|||
126042515|NCT02367040|453453141|FG000|Overall Study|AE associated with clinical disease progression|1|||
126042516|NCT02367040|453453142|FG001|Overall Study|AE associated with clinical disease progression|3|||
126042517|NCT02367040|453453141|FG000|Overall Study|Physician Decision|2|||
126042518|NCT02367040|453453142|FG001|Overall Study|Physician Decision|8|||
126042519|NCT02367040|453453141|FG000|Overall Study|Non-compliance with study drug|1|||
126042520|NCT02367040|453453142|FG001|Overall Study|Non-compliance with study drug|0|||
126042521|NCT02367040|453453141|FG000|Overall Study|Failure to meet continuation criteria|1|||
126042522|NCT02367040|453453142|FG001|Overall Study|Failure to meet continuation criteria|0|||
126042523|NCT02367040|453453141|FG000|Overall Study|Switching to other therapy|2|||
126042524|NCT02367040|453453142|FG001|Overall Study|Switching to other therapy|0|||
126042525|NCT02367040|453453141|FG000|Overall Study|Withdrawal by Subject|46|||
126042526|NCT02367040|453453142|FG001|Overall Study|Withdrawal by Subject|16|||
126042527|NCT02367040|453453141|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
126042528|NCT02367040|453453142|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126042529|NCT02367040|453453141|FG000|Overall Study|Patient decision|39|||
126042530|NCT02367040|453453142|FG001|Overall Study|Patient decision|14|||
126042531|NCT02367040|453453141|FG000|Overall Study|Required procedure failed|1|||
126042532|NCT02367040|453453142|FG001|Overall Study|Required procedure failed|0|||
126042533|NCT02367040|453453141|FG000|Overall Study|Randomized by mistake with study treatment|1|||
126042534|NCT02367040|453453142|FG001|Overall Study|Randomized by mistake with study treatment|0|||
126042535|NCT02367040|453453141|FG000|Overall Study|Protocol Violation|1|||
126042536|NCT02367040|453453142|FG001|Overall Study|Protocol Violation|0|||
126042537|NCT02367040|453453141|FG000|Overall Study|Progressive disease - radiological progression|51|||
126042538|NCT02367040|453453142|FG001|Overall Study|Progressive disease - radiological progression|78|||
126042539|NCT02367040|453453141|FG000|Overall Study|Progressive disease - clinical progression|6|||
126042540|NCT02367040|453453142|FG001|Overall Study|Progressive disease - clinical progression|6|||
126042541|NCT02367040|453453141|FG000|Overall Study|Drug not administered|3|||
126042542|NCT02367040|453453142|FG001|Overall Study|Drug not administered|2|||
126042543|NCT02367040|453453141|FG000|Overall Study|Progressive disease|0|||
126042544|NCT02367040|453453142|FG001|Overall Study|Progressive disease|1|||
126042545|NCT02367040|453453141|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
126042546|NCT02367040|453453142|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
126042547|NCT02367040|453453141|FG000|Overall Study|Death|2|||
126042548|NCT02367040|453453142|FG001|Overall Study|Death|0|||
126042549|NCT05856435|453453156|FG000|Overall Study|Lost to Follow-up|6|||
126042550|NCT02323880|453453157|FG000|Overall Study|Adverse Event|2|||
126042551|NCT02323880|453453158|FG001|Overall Study|Adverse Event|0|||
126042552|NCT02323880|453453159|FG002|Overall Study|Adverse Event|1|||
126042553|NCT02323880|453453160|FG003|Overall Study|Adverse Event|1|||
126042554|NCT02323880|453453161|FG004|Overall Study|Adverse Event|1|||
126042555|NCT02323880|453453162|FG005|Overall Study|Adverse Event|0|||
126042556|NCT02323880|453453163|FG006|Overall Study|Adverse Event|1|||
126042557|NCT02323880|453453164|FG007|Overall Study|Adverse Event|0|||
126100335|NCT01090427|453659927|FG002|After Controlled Period|Lack of Efficacy|0|||
126042558|NCT02323880|453453157|FG000|Overall Study|Death|0|||
126042559|NCT02323880|453453158|FG001|Overall Study|Death|0|||
126042560|NCT02323880|453453159|FG002|Overall Study|Death|0|||
126042561|NCT02323880|453453160|FG003|Overall Study|Death|0|||
126042562|NCT02323880|453453161|FG004|Overall Study|Death|0|||
126042563|NCT02323880|453453162|FG005|Overall Study|Death|1|||
126042564|NCT02323880|453453163|FG006|Overall Study|Death|0|||
126042565|NCT02323880|453453164|FG007|Overall Study|Death|0|||
126042566|NCT02323880|453453157|FG000|Overall Study|Lack of Efficacy|4|||
126042567|NCT02323880|453453158|FG001|Overall Study|Lack of Efficacy|11|||
126042568|NCT02323880|453453159|FG002|Overall Study|Lack of Efficacy|5|||
126296090|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296091|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296092|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296093|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296094|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296095|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296096|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296097|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296098|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
126296099|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296100|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296101|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296102|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126100336|NCT01090427|453659928|FG003|After Controlled Period|Lack of Efficacy|0|||
126100337|NCT01090427|453659929|FG004|After Controlled Period|Lack of Efficacy|0|||
126100338|NCT01090427|453659930|FG005|After Controlled Period|Lack of Efficacy|3|||
126100339|NCT01090427|453659931|FG006|After Controlled Period|Lack of Efficacy|2|||
126100340|NCT01090427|453659925|FG000|After Controlled Period|Adverse Event|0|||
126100341|NCT01090427|453659926|FG001|After Controlled Period|Adverse Event|0|||
126100342|NCT01090427|453659927|FG002|After Controlled Period|Adverse Event|0|||
126100343|NCT01090427|453659928|FG003|After Controlled Period|Adverse Event|2|||
126100344|NCT01090427|453659929|FG004|After Controlled Period|Adverse Event|0|||
126100345|NCT01090427|453659930|FG005|After Controlled Period|Adverse Event|1|||
126100346|NCT01090427|453659931|FG006|After Controlled Period|Adverse Event|0|||
126100347|NCT01154010|453659932|FG000|Overall Study|Lost to Follow-up|0|||
126100348|NCT01154010|453659933|FG001|Overall Study|Lost to Follow-up|1|||
126100349|NCT00439231|453659934|FG000|Overall Study|Lack of Efficacy|28|||
126100350|NCT01853644|453659935|FG000|Registration and Treatment Start|Did not start treatment|1|||
126100351|NCT01853644|453659935|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
126100352|NCT01853644|453659935|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
126100353|NCT01853644|453659935|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
126100354|NCT01853644|453659935|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
126100355|NCT01853644|453659935|FG000|Continued Treatment After First Response|Adverse Event|2|||
126100356|NCT01853644|453659935|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
126100357|NCT02891408|453659936|FG000|Overall Study|Lost to Follow-up|0|||
126100358|NCT02891408|453659937|FG001|Overall Study|Lost to Follow-up|0|||
126100359|NCT02891408|453659938|FG002|Overall Study|Lost to Follow-up|1|||
126100360|NCT02891408|453659939|FG003|Overall Study|Lost to Follow-up|0|||
126100361|NCT02891408|453659940|FG004|Overall Study|Lost to Follow-up|0|||
126100362|NCT02891408|453659941|FG005|Overall Study|Lost to Follow-up|0|||
126100363|NCT02891408|453659942|FG006|Overall Study|Lost to Follow-up|0|||
126100364|NCT02134977|453662323|FG000|Overall Study|Protocol Deviation|102|||
126100365|NCT01773291|453662324|FG000|Overall Study|Protocol Violation|1|||
126100366|NCT01773291|453662325|FG001|Overall Study|Protocol Violation|0|||
126100367|NCT01773291|453662326|FG002|Overall Study|Protocol Violation|0|||
126100368|NCT01773291|453662324|FG000|Overall Study|Withdrawal by Subject|0|||
126100369|NCT01773291|453662325|FG001|Overall Study|Withdrawal by Subject|0|||
126100370|NCT01773291|453662326|FG002|Overall Study|Withdrawal by Subject|1|||
126100371|NCT00107120|453662328|FG000|Overall Study|Adverse Event|4|||
126100372|NCT00107120|453662329|FG001|Overall Study|Adverse Event|1|||
126100373|NCT00107120|453662328|FG000|Overall Study|Lack of Efficacy|5|||
126100374|NCT00107120|453662329|FG001|Overall Study|Lack of Efficacy|5|||
126100375|NCT00107120|453662328|FG000|Overall Study|Protocol Violation|3|||
126100376|NCT00107120|453662329|FG001|Overall Study|Protocol Violation|0|||
126100377|NCT00107120|453662328|FG000|Overall Study|Withdrawal by Subject|8|||
126100378|NCT00107120|453662329|FG001|Overall Study|Withdrawal by Subject|9|||
126366949|NCT01051661|454639365|FG004|Overall Study|Consent not received from both parents|0|||
126100379|NCT00107120|453662328|FG000|Overall Study|Lost to Follow-up|8|||
126100380|NCT00107120|453662329|FG001|Overall Study|Lost to Follow-up|6|||
126100381|NCT00107120|453662328|FG000|Overall Study|Pregnancy|0|||
126100382|NCT00107120|453662329|FG001|Overall Study|Pregnancy|1|||
126296103|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296104|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296105|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126366950|NCT01051661|454639366|FG005|Overall Study|Consent not received from both parents|1|||
126366951|NCT01051661|454639361|FG000|Overall Study|Failure to comply with protocol|0|||
126100383|NCT00107120|453662328|FG000|Overall Study|moving away from site|1|||
126100384|NCT00107120|453662329|FG001|Overall Study|moving away from site|1|||
126100385|NCT00107120|453662328|FG000|Overall Study|death of parent|0|||
126100386|NCT00107120|453662329|FG001|Overall Study|death of parent|1|||
126100387|NCT00896051|453662333|FG000|Overall Study|Adverse Event|2|||
126100388|NCT00896051|453662334|FG001|Overall Study|Adverse Event|1|||
126100389|NCT00896051|453662333|FG000|Overall Study|Lost to Follow-up|3|||
126296106|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296107|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296108|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296109|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
126296110|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
126296111|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296112|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296113|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296114|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296115|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
126296116|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
126296117|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
126296118|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
126296119|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296120|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296121|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296122|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296123|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296124|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
126296125|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296126|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296127|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296128|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296129|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
126296130|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296131|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296132|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296133|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
126296134|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296135|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296136|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296137|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296138|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296139|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296140|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296141|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
126296142|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
126296143|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296144|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
126296145|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
126296146|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
126296147|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296148|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296149|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296150|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126366952|NCT01051661|454639362|FG001|Overall Study|Failure to comply with protocol|0|||
126366953|NCT01051661|454639363|FG002|Overall Study|Failure to comply with protocol|2|||
126100390|NCT00896051|453662334|FG001|Overall Study|Lost to Follow-up|2|||
126100391|NCT00896051|453662333|FG000|Overall Study|Withdrawal by Subject|3|||
126042569|NCT02323880|453453160|FG003|Overall Study|Lack of Efficacy|5|||
126042570|NCT02323880|453453161|FG004|Overall Study|Lack of Efficacy|4|||
126042571|NCT02323880|453453162|FG005|Overall Study|Lack of Efficacy|8|||
126042572|NCT02323880|453453163|FG006|Overall Study|Lack of Efficacy|4|||
126042573|NCT02323880|453453164|FG007|Overall Study|Lack of Efficacy|6|||
126042574|NCT02323880|453453157|FG000|Overall Study|Physician Decision|0|||
126042575|NCT02323880|453453158|FG001|Overall Study|Physician Decision|0|||
126042576|NCT02323880|453453159|FG002|Overall Study|Physician Decision|0|||
126042577|NCT02323880|453453160|FG003|Overall Study|Physician Decision|0|||
126042578|NCT02323880|453453161|FG004|Overall Study|Physician Decision|1|||
126042579|NCT02323880|453453162|FG005|Overall Study|Physician Decision|1|||
126042580|NCT02323880|453453163|FG006|Overall Study|Physician Decision|1|||
126100392|NCT00896051|453662334|FG001|Overall Study|Withdrawal by Subject|2|||
126042581|NCT02323880|453453164|FG007|Overall Study|Physician Decision|0|||
126042582|NCT02323880|453453157|FG000|Overall Study|Withdrawal by Subject|0|||
126042583|NCT02323880|453453158|FG001|Overall Study|Withdrawal by Subject|2|||
126042584|NCT02323880|453453159|FG002|Overall Study|Withdrawal by Subject|0|||
126042585|NCT02323880|453453160|FG003|Overall Study|Withdrawal by Subject|0|||
126296151|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296152|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296153|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296154|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296155|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296156|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296157|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296158|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296159|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296160|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
126296161|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126100393|NCT00896051|453662333|FG000|Overall Study|Subject noncompliant|1|||
126100394|NCT00896051|453662334|FG001|Overall Study|Subject noncompliant|3|||
126100395|NCT00896051|453662333|FG000|Overall Study|Other|1|||
126100396|NCT00896051|453662334|FG001|Overall Study|Other|1|||
126100397|NCT02935452|453662335|FG000|Overall Study|work and life commintment|3|||
126100398|NCT02935452|453662336|FG001|Overall Study|work and life commintment|1|||
126100399|NCT01346475|453662339|FG000|First Intervention|Lost to Follow-up|4|||
126100400|NCT01346475|453662340|FG001|First Intervention|Lost to Follow-up|3|||
126100401|NCT02029846|453662343|FG000|Overall Study|n=1 each arm|1|||
126100402|NCT02029846|453662344|FG001|Overall Study|n=1 each arm|1|||
126100403|NCT02966301|453662345|FG000|Overall Study|Death|2|||
126100404|NCT02966301|453662345|FG000|Overall Study|Withdrawal by Subject|1|||
126100405|NCT00700258|453662346|FG000|Overall Study|Premature discontinuation of documentation|136|||
126100406|NCT00700258|453662346|FG000|Overall Study|Type of study end not documented|1|||
126100407|NCT00700258|453662346|FG000|Overall Study|Lost to Follow-up|81|||
126100408|NCT00700258|453662346|FG000|Overall Study|Premature discontinuation of therapy|1013|||
126100409|NCT00370331|453662348|FG000|Overall Study|Adverse Event|4|||
126100410|NCT00370331|453662349|FG001|Overall Study|Adverse Event|13|||
126100411|NCT00370331|453662348|FG000|Overall Study|Withdrawal by Subject|2|||
126100412|NCT00370331|453662349|FG001|Overall Study|Withdrawal by Subject|4|||
126100413|NCT00370331|453662348|FG000|Overall Study|Lost to Follow-up|0|||
126100414|NCT00370331|453662349|FG001|Overall Study|Lost to Follow-up|3|||
126100415|NCT00370331|453662348|FG000|Overall Study|Lack of Efficacy|0|||
126100416|NCT00370331|453662349|FG001|Overall Study|Lack of Efficacy|1|||
126100417|NCT00370331|453662348|FG000|Overall Study|Non-compliance|0|||
126100418|NCT00370331|453662349|FG001|Overall Study|Non-compliance|1|||
126100419|NCT00370331|453662348|FG000|Overall Study|Protocol Violation|1|||
126100420|NCT00370331|453662349|FG001|Overall Study|Protocol Violation|1|||
126100421|NCT01874431|453662350|FG000|Overall Study|Physician Decision|0|||
126100422|NCT01874431|453662351|FG001|Overall Study|Physician Decision|0|||
126100423|NCT01874431|453662352|FG002|Overall Study|Physician Decision|1|||
126100424|NCT01874431|453662353|FG003|Overall Study|Physician Decision|0|||
126100425|NCT01874431|453662354|FG004|Overall Study|Physician Decision|0|||
126100426|NCT01874431|453662355|FG005|Overall Study|Physician Decision|0|||
126100427|NCT01874431|453662356|FG006|Overall Study|Physician Decision|0|||
126100428|NCT01874431|453662357|FG007|Overall Study|Physician Decision|0|||
126100429|NCT01874431|453662350|FG000|Overall Study|Adverse Event|5|||
126100430|NCT01874431|453662351|FG001|Overall Study|Adverse Event|4|||
126100431|NCT01874431|453662352|FG002|Overall Study|Adverse Event|6|||
126100432|NCT01874431|453662353|FG003|Overall Study|Adverse Event|5|||
126100433|NCT01874431|453662354|FG004|Overall Study|Adverse Event|2|||
126100434|NCT01874431|453662355|FG005|Overall Study|Adverse Event|8|||
126100435|NCT01874431|453662356|FG006|Overall Study|Adverse Event|2|||
126100436|NCT01874431|453662357|FG007|Overall Study|Adverse Event|3|||
126100437|NCT01874431|453662350|FG000|Overall Study|Protocol Violation|1|||
126100438|NCT01874431|453662351|FG001|Overall Study|Protocol Violation|1|||
126100439|NCT01874431|453662352|FG002|Overall Study|Protocol Violation|1|||
126100440|NCT01874431|453662353|FG003|Overall Study|Protocol Violation|0|||
126100441|NCT01874431|453662354|FG004|Overall Study|Protocol Violation|3|||
126100442|NCT01874431|453662355|FG005|Overall Study|Protocol Violation|2|||
126100443|NCT01874431|453662356|FG006|Overall Study|Protocol Violation|1|||
126100444|NCT01874431|453662357|FG007|Overall Study|Protocol Violation|1|||
126100445|NCT01874431|453662350|FG000|Overall Study|Non-compliance|0|||
126100446|NCT01874431|453662351|FG001|Overall Study|Non-compliance|0|||
126100447|NCT01874431|453662352|FG002|Overall Study|Non-compliance|0|||
126100448|NCT01874431|453662353|FG003|Overall Study|Non-compliance|0|||
126100449|NCT01874431|453662354|FG004|Overall Study|Non-compliance|1|||
126100450|NCT01874431|453662355|FG005|Overall Study|Non-compliance|0|||
126100451|NCT01874431|453662356|FG006|Overall Study|Non-compliance|1|||
126100452|NCT01874431|453662357|FG007|Overall Study|Non-compliance|0|||
126100453|NCT01874431|453662350|FG000|Overall Study|Logistical difficulties|0|||
126100454|NCT01874431|453662351|FG001|Overall Study|Logistical difficulties|0|||
126100455|NCT01874431|453662352|FG002|Overall Study|Logistical difficulties|0|||
126100456|NCT01874431|453662353|FG003|Overall Study|Logistical difficulties|0|||
126100457|NCT01874431|453662354|FG004|Overall Study|Logistical difficulties|0|||
126100458|NCT01874431|453662355|FG005|Overall Study|Logistical difficulties|0|||
126296162|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
126100459|NCT01874431|453662356|FG006|Overall Study|Logistical difficulties|1|||
126100460|NCT01874431|453662357|FG007|Overall Study|Logistical difficulties|0|||
126100461|NCT01874431|453662350|FG000|Overall Study|Withdrawal by Subject|0|||
126100462|NCT01874431|453662351|FG001|Overall Study|Withdrawal by Subject|0|||
126100463|NCT01874431|453662352|FG002|Overall Study|Withdrawal by Subject|1|||
126100464|NCT01874431|453662353|FG003|Overall Study|Withdrawal by Subject|2|||
126100465|NCT01874431|453662354|FG004|Overall Study|Withdrawal by Subject|1|||
126100466|NCT01874431|453662355|FG005|Overall Study|Withdrawal by Subject|1|||
126100467|NCT01874431|453662356|FG006|Overall Study|Withdrawal by Subject|3|||
126100468|NCT01874431|453662357|FG007|Overall Study|Withdrawal by Subject|0|||
126100469|NCT01874431|453662350|FG000|Overall Study|Sponsor decision|0|||
126100470|NCT01874431|453662351|FG001|Overall Study|Sponsor decision|0|||
126100471|NCT01874431|453662352|FG002|Overall Study|Sponsor decision|0|||
126100472|NCT01874431|453662353|FG003|Overall Study|Sponsor decision|0|||
126100473|NCT01874431|453662354|FG004|Overall Study|Sponsor decision|1|||
126100474|NCT01874431|453662355|FG005|Overall Study|Sponsor decision|0|||
126100475|NCT01874431|453662356|FG006|Overall Study|Sponsor decision|0|||
126100476|NCT01874431|453662357|FG007|Overall Study|Sponsor decision|0|||
126100477|NCT01874431|453662350|FG000|Overall Study|Lost to Follow-up|0|||
126100478|NCT01874431|453662351|FG001|Overall Study|Lost to Follow-up|0|||
126100479|NCT01874431|453662352|FG002|Overall Study|Lost to Follow-up|1|||
126100480|NCT01874431|453662353|FG003|Overall Study|Lost to Follow-up|0|||
126100481|NCT01874431|453662354|FG004|Overall Study|Lost to Follow-up|0|||
126100482|NCT01874431|453662355|FG005|Overall Study|Lost to Follow-up|0|||
126100483|NCT01874431|453662356|FG006|Overall Study|Lost to Follow-up|0|||
126100484|NCT01874431|453662357|FG007|Overall Study|Lost to Follow-up|0|||
126100485|NCT00738582|453662360|FG000|Combination Therapy|Completed Combination Therapy|1|||
126100486|NCT00738582|453662361|FG001|Combination Therapy|Completed Combination Therapy|0|||
126100487|NCT00738582|453662360|FG000|Combination Therapy|Physician Decision|1|||
126100488|NCT00738582|453662361|FG001|Combination Therapy|Physician Decision|0|||
126100489|NCT00738582|453662360|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
126100490|NCT00738582|453662361|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
126100491|NCT00738582|453662360|FG000|Combination Therapy|Other|5|||
126100492|NCT00738582|453662361|FG001|Combination Therapy|Other|0|||
126100493|NCT00738582|453662360|FG000|Combination Therapy|Adverse Event|16|||
126100494|NCT00738582|453662361|FG001|Combination Therapy|Adverse Event|0|||
126100495|NCT00738582|453662360|FG000|Combination Therapy|Progressive Disease|9|||
126100496|NCT00738582|453662361|FG001|Combination Therapy|Progressive Disease|0|||
126100497|NCT00738582|453662360|FG000|Maintenance Therapy|Other|0|||
126100498|NCT00738582|453662361|FG001|Maintenance Therapy|Other|2|||
126100499|NCT00738582|453662360|FG000|Maintenance Therapy|Adverse Event|0|||
126100500|NCT00738582|453662361|FG001|Maintenance Therapy|Adverse Event|6|||
126100501|NCT00738582|453662360|FG000|Maintenance Therapy|Progressive Disease|0|||
126100502|NCT00738582|453662361|FG001|Maintenance Therapy|Progressive Disease|47|||
126100503|NCT00738582|453662360|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
126100504|NCT00738582|453662361|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
126100505|NCT00642772|453662362|FG000|Overall Study|Lost to Follow-up|3|||
126100506|NCT00642772|453662362|FG000|Overall Study|Withdrawal by Subject|7|||
126100507|NCT00757588|453662363|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
126100508|NCT00757588|453662364|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
126100509|NCT00757588|453662363|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
126100510|NCT00757588|453662364|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
126100511|NCT00757588|453662363|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
126100512|NCT00757588|453662364|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
126100513|NCT00757588|453662363|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
126100514|NCT00757588|453662364|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
126100515|NCT00757588|453662363|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
126100516|NCT00757588|453662364|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
126100517|NCT00757588|453662363|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
126100518|NCT00757588|453662364|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
126100519|NCT00757588|453662363|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
126100520|NCT00757588|453662364|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
126100521|NCT00757588|453662363|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
126100522|NCT00757588|453662364|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
126100523|NCT00757588|453662363|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
126100524|NCT00757588|453662364|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
126100525|NCT00757588|453662363|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
126100526|NCT00757588|453662364|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
126100527|NCT00757588|453662363|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
126100528|NCT00757588|453662364|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
126100529|NCT00757588|453662363|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
126100530|NCT00757588|453662364|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
126100531|NCT00757588|453662363|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
126100532|NCT00757588|453662364|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
126100533|NCT00757588|453662363|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
126100534|NCT00757588|453662364|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
126100535|NCT00757588|453662363|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
126100536|NCT00757588|453662364|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
126100537|NCT00757588|453662363|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
126100538|NCT00757588|453662364|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
126100539|NCT01052103|453662365|FG000|Overall Study|Adverse Event|10|||
126100540|NCT01052103|453662366|FG001|Overall Study|Adverse Event|6|||
126100541|NCT01052103|453662365|FG000|Overall Study|Entry Criteria Not Met|3|||
126100542|NCT01052103|453662366|FG001|Overall Study|Entry Criteria Not Met|1|||
126100543|NCT01052103|453662365|FG000|Overall Study|Lost to Follow-up|3|||
126100544|NCT01052103|453662366|FG001|Overall Study|Lost to Follow-up|5|||
126100545|NCT01052103|453662365|FG000|Overall Study|Protocol Violation|10|||
126100546|NCT01052103|453662366|FG001|Overall Study|Protocol Violation|4|||
126100547|NCT01052103|453662365|FG000|Overall Study|Scheduling conflict|2|||
126100548|NCT01052103|453662366|FG001|Overall Study|Scheduling conflict|1|||
126100549|NCT01052103|453662365|FG000|Overall Study|Sponsor Decision|2|||
126100550|NCT01052103|453662366|FG001|Overall Study|Sponsor Decision|0|||
126100551|NCT01052103|453662365|FG000|Overall Study|Withdrawal by Subject|3|||
126100552|NCT01052103|453662366|FG001|Overall Study|Withdrawal by Subject|6|||
126100553|NCT01052103|453662365|FG000|Overall Study|Perceived Lack of Efficacy|1|||
126100554|NCT01052103|453662366|FG001|Overall Study|Perceived Lack of Efficacy|0|||
126100555|NCT00545051|453662370|FG000|Overall Study|Adverse Event|7|||
126100556|NCT00545051|453662371|FG001|Overall Study|Adverse Event|3|||
126100557|NCT00545051|453662370|FG000|Overall Study|Death|1|||
126100558|NCT00545051|453662371|FG001|Overall Study|Death|0|||
126100559|NCT00545051|453662370|FG000|Overall Study|Violation of inclusion/exclusion|0|||
126100560|NCT00545051|453662371|FG001|Overall Study|Violation of inclusion/exclusion|2|||
126100561|NCT00545051|453662370|FG000|Overall Study|Protocol Violation|1|||
126100562|NCT00545051|453662371|FG001|Overall Study|Protocol Violation|0|||
126100563|NCT00545051|453662370|FG000|Overall Study|Withdrawal by Subject|0|||
126100564|NCT00545051|453662371|FG001|Overall Study|Withdrawal by Subject|1|||
126100565|NCT00545051|453662370|FG000|Overall Study|Administrative reasons|0|||
126100566|NCT00545051|453662371|FG001|Overall Study|Administrative reasons|1|||
126100567|NCT05398237|453662372|FG000|Overall Study|Withdrawal by Subject|1|||
126100568|NCT00903006|453662375|FG000|Overall Study|Withdrawal by Subject|2|||
126100569|NCT00903006|453662376|FG001|Overall Study|Withdrawal by Subject|0|||
126100570|NCT00903006|453662377|FG002|Overall Study|Withdrawal by Subject|0|||
126100571|NCT00903006|453662378|FG003|Overall Study|Withdrawal by Subject|0|||
126100572|NCT00903006|453662375|FG000|Overall Study|Progressive Disease|0|||
126100573|NCT00903006|453662376|FG001|Overall Study|Progressive Disease|3|||
126100574|NCT00903006|453662377|FG002|Overall Study|Progressive Disease|1|||
126100575|NCT00903006|453662378|FG003|Overall Study|Progressive Disease|0|||
126100576|NCT03271021|453662382|FG000|Overall Study|Adverse Event|3|||
126100577|NCT03271021|453662383|FG001|Overall Study|Adverse Event|2|||
126100578|NCT03271021|453662382|FG000|Overall Study|Withdrawal by Subject|36|||
126100579|NCT03271021|453662383|FG001|Overall Study|Withdrawal by Subject|53|||
126100580|NCT03271021|453662382|FG000|Overall Study|Lost to Follow-up|34|||
126100581|NCT03271021|453662383|FG001|Overall Study|Lost to Follow-up|39|||
126100582|NCT03271021|453662382|FG000|Overall Study|Protocol Violation|6|||
126100583|NCT03271021|453662383|FG001|Overall Study|Protocol Violation|4|||
126100584|NCT03271021|453662382|FG000|Overall Study|Abnormal Lab Results|1|||
126100585|NCT03271021|453662383|FG001|Overall Study|Abnormal Lab Results|0|||
126100586|NCT03271021|453662382|FG000|Overall Study|Miscellaneous|9|||
126100587|NCT03271021|453662383|FG001|Overall Study|Miscellaneous|8|||
126100588|NCT01383499|453662384|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
126100589|NCT01383499|453662385|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126100590|NCT01383499|453662386|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126366954|NCT01051661|454639364|FG003|Overall Study|Failure to comply with protocol|0|||
126100591|NCT01383499|453662387|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126100592|NCT04275089|453662390|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
126100593|NCT01079663|453662391|FG000|Overall Study|Adverse Event|0|||
126100594|NCT01079663|453662392|FG001|Overall Study|Adverse Event|2|||
126100595|NCT01079663|453662391|FG000|Overall Study|Protocol Violation|0|||
126100596|NCT01079663|453662392|FG001|Overall Study|Protocol Violation|2|||
126100597|NCT00297232|453662393|FG000|Overall Study|Lack of Efficacy|7|||
126100598|NCT00297232|453662393|FG000|Overall Study|Lost to Follow-up|10|||
126100599|NCT00297232|453662393|FG000|Overall Study|Adverse Event|63|||
126100600|NCT00297232|453662393|FG000|Overall Study|Voluntary Withdrawal|120|||
126100601|NCT00297232|453662393|FG000|Overall Study|Subject was Noncompliant|9|||
126100602|NCT00297232|453662393|FG000|Overall Study|Death|9|||
126366955|NCT01051661|454639365|FG004|Overall Study|Failure to comply with protocol|0|||
126100603|NCT00297232|453662393|FG000|Overall Study|Anti-natalizumab Positive|8|||
126100604|NCT00297232|453662393|FG000|Overall Study|Switched to Commercial Tysabri|22|||
126100605|NCT00297232|453662393|FG000|Overall Study|Disease Progression|8|||
126042586|NCT02323880|453453161|FG004|Overall Study|Withdrawal by Subject|0|||
126042587|NCT02323880|453453162|FG005|Overall Study|Withdrawal by Subject|0|||
126042588|NCT02323880|453453163|FG006|Overall Study|Withdrawal by Subject|0|||
126042589|NCT02323880|453453164|FG007|Overall Study|Withdrawal by Subject|0|||
126042590|NCT05660434|453453167|FG000|Overall Study|Never obtained study materials|2|||
126042591|NCT05660434|453453168|FG001|Overall Study|Never obtained study materials|1|||
126042592|NCT01820611|453453173|FG000|Overall Study|Death|8|||
126042593|NCT01820611|453453173|FG000|Overall Study|Adverse Event|1|||
126042594|NCT01820611|453453173|FG000|Overall Study|Withdrawal by Subject|9|||
126042595|NCT05736458|453453174|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
126042596|NCT05736458|453453175|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
126042597|NCT05736458|453453176|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
126042598|NCT05736458|453453174|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
126042599|NCT05736458|453453175|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
126042600|NCT05736458|453453176|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
126042601|NCT05736458|453453174|FG000|TMS/fMRI #1|Physician Decision|0|||
126042602|NCT05736458|453453175|FG001|TMS/fMRI #1|Physician Decision|0|||
126042603|NCT05736458|453453176|FG002|TMS/fMRI #1|Physician Decision|2|||
126042604|NCT05736458|453453174|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
126042605|NCT05736458|453453175|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
126042606|NCT05736458|453453176|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
126042607|NCT02990338|453453177|FG000|Overall Study|Randomized and not treated|4|||
126042608|NCT02990338|453453178|FG001|Overall Study|Randomized and not treated|2|||
126042609|NCT02990338|453453177|FG000|Overall Study|Adverse Event|23|||
126042610|NCT02990338|453453178|FG001|Overall Study|Adverse Event|22|||
126042611|NCT02990338|453453177|FG000|Overall Study|Progressive disease|118|||
126042612|NCT02990338|453453178|FG001|Overall Study|Progressive disease|107|||
126042613|NCT02990338|453453177|FG000|Overall Study|Poor compliance to protocol|0|||
126042614|NCT02990338|453453178|FG001|Overall Study|Poor compliance to protocol|1|||
126042615|NCT02990338|453453177|FG000|Overall Study|Withdrawal by Subject|6|||
126042616|NCT02990338|453453178|FG001|Overall Study|Withdrawal by Subject|8|||
126042617|NCT02990338|453453177|FG000|Overall Study|Physician's decision|2|||
126042618|NCT02990338|453453178|FG001|Overall Study|Physician's decision|6|||
126042619|NCT02990338|453453177|FG000|Overall Study|Treatment extension study|0|||
126042620|NCT02990338|453453178|FG001|Overall Study|Treatment extension study|6|||
126042621|NCT02990338|453453177|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
126042622|NCT02990338|453453178|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
126042623|NCT02990338|453453177|FG000|Overall Study|Continue with therapy available commercially|0|||
126042624|NCT02990338|453453178|FG001|Overall Study|Continue with therapy available commercially|1|||
126042625|NCT04479761|453453180|FG000|Overall Study|could not perform the balance tasks|1|||
126042626|NCT04479761|453453181|FG001|Overall Study|could not perform the balance tasks|0|||
126042627|NCT04479761|453453182|FG002|Overall Study|could not perform the balance tasks|0|||
126042628|NCT04479761|453453180|FG000|Overall Study|Adverse Event|1|||
126042629|NCT04479761|453453181|FG001|Overall Study|Adverse Event|0|||
126042630|NCT04479761|453453182|FG002|Overall Study|Adverse Event|0|||
126042631|NCT04479761|453453180|FG000|Overall Study|one control did not meet screening criteria|0|||
126042632|NCT04479761|453453181|FG001|Overall Study|one control did not meet screening criteria|0|||
126042633|NCT04479761|453453182|FG002|Overall Study|one control did not meet screening criteria|1|||
126042634|NCT04479761|453453180|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
126042635|NCT04479761|453453181|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
126042636|NCT04479761|453453182|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
126042637|NCT04186819|453453183|FG000|Overall Study|Adverse Event|1|||
126042638|NCT04186819|453453183|FG000|Overall Study|Lost to Follow-up|1|||
126042639|NCT04186819|453453183|FG000|Overall Study|Opted for EBRT|1|||
126042640|NCT04186819|453453183|FG000|Overall Study|Opted SBRT|1|||
126042641|NCT04186819|453453183|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
126042642|NCT04186819|453453183|FG000|Overall Study|Physician Decision|1|||
126042643|NCT04186819|453453183|FG000|Overall Study|RP Delayed|1|||
126042644|NCT04186819|453453183|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
126042645|NCT04186819|453453183|FG000|Overall Study|Subject declined for financial reasons|1|||
126042646|NCT04186819|453453183|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
126042647|NCT04186819|453453183|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
126042648|NCT04186819|453453183|FG000|Overall Study|The subject opted for other treatment option|2|||
126042649|NCT04186819|453453183|FG000|Overall Study|The subject opted for other treatment options|1|||
126042650|NCT04186819|453453183|FG000|Overall Study|Withdrawal by Subject|3|||
126042651|NCT04186819|453453183|FG000|Overall Study|Reason not specified|1|||
126042652|NCT05900154|453453190|FG000|Follow-Up Period|Lost to Follow-up|1|||
126042653|NCT05900154|453453191|FG001|Follow-Up Period|Lost to Follow-up|2|||
126296163|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
126296164|NCT03922321|454372569|FG000|Overall Study|Participant Moved|1|||
126100606|NCT00297232|453662393|FG000|Overall Study|Fear of PML|10|||
126100607|NCT00297232|453662393|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
126100608|NCT00297232|453662393|FG000|Overall Study|Miscellaneous|5|||
126100609|NCT00297232|453662393|FG000|Overall Study|Sponsor Decision|34|||
126100610|NCT00297232|453662393|FG000|Overall Study|Subject Relocated|7|||
126100611|NCT00297232|453662393|FG000|Overall Study|Subject Withdrew Consent|37|||
126100612|NCT00297232|453662393|FG000|Overall Study|Persistently Positive Antibodies|11|||
126296165|NCT03922321|454372569|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
126296166|NCT04067050|454372577|FG000|One Month|Lost to Follow-up|4|||
126296167|NCT04067050|454372578|FG001|One Month|Lost to Follow-up|0|||
126296168|NCT04067050|454372577|FG000|Two Month|Lost to Follow-up|1|||
126296169|NCT04067050|454372578|FG001|Two Month|Lost to Follow-up|0|||
126296170|NCT04067050|454372577|FG000|Two Month|Adverse Event|1|||
126296171|NCT04067050|454372578|FG001|Two Month|Adverse Event|0|||
126296172|NCT01062425|454372583|FG000|Overall Study|Protocol Violation|3|||
126296173|NCT01062425|454372584|FG001|Overall Study|Protocol Violation|6|||
126296174|NCT02342678|454372585|FG000|Overall Study|Lost to Follow-up|0|||
126296175|NCT02342678|454372586|FG001|Overall Study|Lost to Follow-up|1|||
126296176|NCT02342678|454372585|FG000|Overall Study|Too busy to complete study|0|||
126296177|NCT02342678|454372586|FG001|Overall Study|Too busy to complete study|2|||
126100613|NCT00297232|453662393|FG000|Overall Study|Investigator Withdrew From Program|19|||
126100614|NCT00297232|453662393|FG000|Overall Study|Did Not Enroll to Week 264|34|||
126100615|NCT00297232|453662393|FG000|Overall Study|Did Not Enroll to Week 480|17|||
126100616|NCT00297232|453662393|FG000|Overall Study|No data available after Week 264|161|||
126100617|NCT00297232|453662393|FG000|Overall Study|Other|1|||
126100618|NCT03038438|453662394|FG000|Overall Study|Death|3|||
126100619|NCT03038438|453662394|FG000|Overall Study|Lost to Follow-up|8|||
126100620|NCT03038438|453662394|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
126100621|NCT03038438|453662394|FG000|Overall Study|Withdrawal by Subject|5|||
126100622|NCT03038438|453662394|FG000|Overall Study|No 36-Month Follow-Up|18|||
126100623|NCT03625895|453662397|FG000|Overall Study|Protocol Violation|585|||
126100624|NCT02476279|453662398|FG000|Overall Study|Lost to Follow-up|1|||
126100625|NCT02476279|453662399|FG001|Overall Study|Lost to Follow-up|1|||
126100626|NCT00577473|453662402|FG000|Overall Study|Protocol Violation|1|||
126100627|NCT00577473|453662403|FG001|Overall Study|Protocol Violation|4|||
126100628|NCT00577473|453662402|FG000|Overall Study|Adverse Event|8|||
126100629|NCT00577473|453662403|FG001|Overall Study|Adverse Event|5|||
126100630|NCT00577473|453662402|FG000|Overall Study|Withdrawal by Subject|2|||
126100631|NCT00577473|453662403|FG001|Overall Study|Withdrawal by Subject|6|||
126100632|NCT00577473|453662402|FG000|Overall Study|Physician Decision|2|||
126100633|NCT00577473|453662403|FG001|Overall Study|Physician Decision|2|||
126100634|NCT00577473|453662402|FG000|Overall Study|Lack of Efficacy|8|||
126100635|NCT00577473|453662403|FG001|Overall Study|Lack of Efficacy|7|||
126100636|NCT00938860|453662406|FG000|Overall Study|Adverse Event|2|||
126100637|NCT00938860|453662407|FG001|Overall Study|Adverse Event|1|||
126100638|NCT00938860|453662406|FG000|Overall Study|Abnormal laboratory values|2|||
126100639|NCT00938860|453662407|FG001|Overall Study|Abnormal laboratory values|2|||
126100640|NCT00938860|453662406|FG000|Overall Study|Withdrawal by Subject|11|||
126100641|NCT00938860|453662407|FG001|Overall Study|Withdrawal by Subject|8|||
126100642|NCT00938860|453662406|FG000|Overall Study|Lost to Follow-up|4|||
126100643|NCT00938860|453662407|FG001|Overall Study|Lost to Follow-up|4|||
126100644|NCT00938860|453662406|FG000|Overall Study|Administration problems|2|||
126100645|NCT00938860|453662407|FG001|Overall Study|Administration problems|0|||
126100646|NCT00938860|453662406|FG000|Overall Study|Death|1|||
126100647|NCT00938860|453662407|FG001|Overall Study|Death|1|||
126100648|NCT00938860|453662406|FG000|Overall Study|Protocol Violation|3|||
126100649|NCT00938860|453662407|FG001|Overall Study|Protocol Violation|1|||
126100650|NCT00232544|453662408|FG000|Overall Study|Lost to Follow-up|20|||
126100651|NCT00232544|453662409|FG001|Overall Study|Lost to Follow-up|15|||
126100652|NCT00986973|453662410|FG000|Overall Study|Withdrawn by study team|1|||
126100653|NCT01465347|453662411|FG000|Overall Study|Withdrawal by Subject|1|||
126100654|NCT01465347|453662412|FG001|Overall Study|Withdrawal by Subject|1|||
126100655|NCT01465347|453662411|FG000|Overall Study|Physician Decision|0|||
126100656|NCT01465347|453662412|FG001|Overall Study|Physician Decision|1|||
126100657|NCT01465347|453662411|FG000|Overall Study|Admitted to hospice|0|||
126100658|NCT01465347|453662412|FG001|Overall Study|Admitted to hospice|1|||
126100659|NCT01590082|453662413|FG000|Overall Study|Withdrawal by Subject|1|||
126100660|NCT01590082|453662414|FG001|Overall Study|Withdrawal by Subject|0|||
126100661|NCT01590082|453662413|FG000|Overall Study|Ineligible|1|||
126100662|NCT01590082|453662414|FG001|Overall Study|Ineligible|0|||
126100663|NCT02414932|453662415|FG000|Overall Study|Withdrawal by Subject|2|||
126100664|NCT02414932|453662416|FG001|Overall Study|Withdrawal by Subject|3|||
126100665|NCT02414932|453662415|FG000|Overall Study|Adverse Event|1|||
126296178|NCT02342678|454372585|FG000|Overall Study|Family illness/emergency|0|||
126100666|NCT02414932|453662416|FG001|Overall Study|Adverse Event|0|||
126100667|NCT00906945|453662417|FG000|Overall Study|Found to be not eligible|0|||
126100668|NCT00906945|453662418|FG001|Overall Study|Found to be not eligible|0|||
126100669|NCT00906945|453662419|FG002|Overall Study|Found to be not eligible|0|||
126100670|NCT00906945|453662420|FG003|Overall Study|Found to be not eligible|1|||
126100671|NCT00906945|453662421|FG004|Overall Study|Found to be not eligible|1|||
126100672|NCT00906945|453662422|FG005|Overall Study|Found to be not eligible|1|||
126100673|NCT00906945|453662417|FG000|Overall Study|Physician Decision|0|||
126100674|NCT00906945|453662418|FG001|Overall Study|Physician Decision|0|||
126100675|NCT00906945|453662419|FG002|Overall Study|Physician Decision|0|||
126100676|NCT00906945|453662420|FG003|Overall Study|Physician Decision|0|||
126100677|NCT00906945|453662421|FG004|Overall Study|Physician Decision|0|||
126100678|NCT00906945|453662422|FG005|Overall Study|Physician Decision|1|||
126100679|NCT01210664|453662424|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
126100680|NCT01210664|453662425|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
126100681|NCT01210664|453662426|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
126100682|NCT01210664|453662427|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
126100683|NCT01210664|453662424|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
126100684|NCT01210664|453662425|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
126100685|NCT01210664|453662426|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
126100686|NCT01210664|453662427|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
126100687|NCT01210664|453662424|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
126100688|NCT01210664|453662425|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
126100689|NCT01210664|453662426|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
126100690|NCT01210664|453662427|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
126100691|NCT01054170|453662428|FG000|Overall Study|Protocol Violation|1|||
126100692|NCT01054170|453662429|FG001|Overall Study|Protocol Violation|0|||
126100693|NCT01054170|453662428|FG000|Overall Study|Withdrawal by Subject|3|||
126100694|NCT01054170|453662429|FG001|Overall Study|Withdrawal by Subject|2|||
126100695|NCT01054170|453662428|FG000|Overall Study|Adverse Event|0|||
126100696|NCT01054170|453662429|FG001|Overall Study|Adverse Event|4|||
126100697|NCT02951767|453662430|FG000|Overall Study|Study Terminated By Sponsor|9|||
126100698|NCT02951767|453662430|FG000|Overall Study|Withdrawal by Subject|11|||
126100699|NCT02951767|453662430|FG000|Overall Study|Death|96|||
126100700|NCT02951767|453662430|FG000|Overall Study|Lost to Follow-up|2|||
126100701|NCT02951767|453662430|FG000|Overall Study|Physician Decision|1|||
126100702|NCT00709852|453662431|FG000|Period 1|Adverse Event|2|||
126100703|NCT00709852|453662432|FG001|Period 1|Adverse Event|0|||
126100704|NCT00709852|453662431|FG000|Period 1|Withdrawal by Subject|4|||
126100705|NCT00709852|453662432|FG001|Period 1|Withdrawal by Subject|2|||
126100706|NCT00709852|453662431|FG000|Period 1|Protocol Violation|1|||
126100707|NCT00709852|453662432|FG001|Period 1|Protocol Violation|0|||
126100708|NCT00709852|453662431|FG000|Period 1|Defective scanner|0|||
126100709|NCT00709852|453662432|FG001|Period 1|Defective scanner|1|||
126100710|NCT00709852|453662431|FG000|Period 1|Lost to Follow-up|1|||
126100711|NCT00709852|453662432|FG001|Period 1|Lost to Follow-up|0|||
126100712|NCT00709852|453662431|FG000|Period 2|Protocol Violation|4|||
126100713|NCT00709852|453662432|FG001|Period 2|Protocol Violation|1|||
126100714|NCT00709852|453662431|FG000|Period 2|Adverse Event|1|||
126100715|NCT00709852|453662432|FG001|Period 2|Adverse Event|1|||
126100716|NCT00709852|453662431|FG000|Period 2|Lost to Follow-up|1|||
126100717|NCT00709852|453662432|FG001|Period 2|Lost to Follow-up|0|||
126100718|NCT00709852|453662431|FG000|Period 2|No 72-hour follow-up|3|||
126100719|NCT00709852|453662432|FG001|Period 2|No 72-hour follow-up|0|||
126296179|NCT02342678|454372586|FG001|Overall Study|Family illness/emergency|1|||
126296180|NCT02342678|454372585|FG000|Overall Study|Illness/medical reason|1|||
126296181|NCT02342678|454372586|FG001|Overall Study|Illness/medical reason|1|||
126296182|NCT02383017|454372587|FG000|Overall Study|Injury Sustained Outside Study|1|||
126100720|NCT01442779|453662433|FG000|Overall Study|Withdrawal by Subject|3|||
126100721|NCT01442779|453662433|FG000|Overall Study|Death|3|||
126100722|NCT01442779|453662433|FG000|Overall Study|Non-compliance|1|||
126100723|NCT01048671|453662434|FG000|Overall Study|Protocol Violation|0|||
126100724|NCT01048671|453662435|FG001|Overall Study|Protocol Violation|1|||
126100725|NCT01048671|453662436|FG002|Overall Study|Protocol Violation|1|||
126100726|NCT03814187|453662437|FG000|Overall Study|Sponsor's Administrative Decision|0|||
126100727|NCT03814187|453662438|FG001|Overall Study|Sponsor's Administrative Decision|0|||
126100728|NCT03814187|453662439|FG002|Overall Study|Sponsor's Administrative Decision|272|||
126100729|NCT03814187|453662437|FG000|Overall Study|Death|80|||
126100730|NCT03814187|453662438|FG001|Overall Study|Death|81|||
126100731|NCT03814187|453662439|FG002|Overall Study|Death|4|||
126100732|NCT03814187|453662437|FG000|Overall Study|Withdrew Consent|77|||
126100733|NCT03814187|453662438|FG001|Overall Study|Withdrew Consent|78|||
126100734|NCT03814187|453662439|FG002|Overall Study|Withdrew Consent|2|||
126100735|NCT03814187|453662437|FG000|Overall Study|Lost to Follow-up|47|||
126296183|NCT02383017|454372588|FG001|Overall Study|Injury Sustained Outside Study|0|||
126296184|NCT02383017|454372587|FG000|Overall Study|Compliance|3|||
126296185|NCT02383017|454372588|FG001|Overall Study|Compliance|2|||
126100736|NCT03814187|453662438|FG001|Overall Study|Lost to Follow-up|52|||
126100737|NCT03814187|453662439|FG002|Overall Study|Lost to Follow-up|1|||
126100738|NCT03814187|453662437|FG000|Overall Study|Adverse Event|22|||
126100739|NCT03814187|453662438|FG001|Overall Study|Adverse Event|23|||
126100740|NCT03814187|453662439|FG002|Overall Study|Adverse Event|0|||
126296186|NCT02383017|454372587|FG000|Overall Study|Found to be Hypogonadal|1|||
126042654|NCT05900154|453453192|FG002|Follow-Up Period|Lost to Follow-up|1|||
126042655|NCT05900154|453453193|FG003|Follow-Up Period|Lost to Follow-up|0|||
126042656|NCT05900154|453453194|FG004|Follow-Up Period|Lost to Follow-up|1|||
126042657|NCT05900154|453453195|FG005|Follow-Up Period|Lost to Follow-up|1|||
126042658|NCT00303459|453453196|FG000|Overall Study|Death|33|||
126042659|NCT00303459|453453197|FG001|Overall Study|Death|44|||
126042660|NCT00303459|453453196|FG000|Overall Study|Withdrawal of consent|32|||
126042661|NCT00303459|453453197|FG001|Overall Study|Withdrawal of consent|26|||
126042662|NCT00303459|453453196|FG000|Overall Study|Lost to Follow-up|5|||
126042663|NCT00303459|453453197|FG001|Overall Study|Lost to Follow-up|4|||
126042664|NCT00303459|453453196|FG000|Overall Study|Administrative reason|7|||
126042665|NCT00303459|453453197|FG001|Overall Study|Administrative reason|7|||
126042666|NCT00303459|453453196|FG000|Overall Study|Decision by the investigator|5|||
126042667|NCT00303459|453453197|FG001|Overall Study|Decision by the investigator|7|||
126042668|NCT00303459|453453196|FG000|Overall Study|Lung transplantation|1|||
126042669|NCT00303459|453453197|FG001|Overall Study|Lung transplantation|1|||
126042670|NCT04129554|453453198|FG000|Overall Study|Withdrawal by Subject|4|||
126042671|NCT04129554|453453199|FG001|Overall Study|Withdrawal by Subject|3|||
126042672|NCT04129554|453453198|FG000|Overall Study|Other|0|||
126042673|NCT04129554|453453199|FG001|Overall Study|Other|2|||
126042674|NCT03993392|453453204|FG000|Overall Study|Withdrawal by Subject|3|||
126042675|NCT03993392|453453204|FG000|Overall Study|Lost to Follow-up|2|||
126042676|NCT03993392|453453204|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
126042677|NCT05962814|453453206|FG000|Overall Study|failed eligibility|1|||
126042678|NCT02865538|453453207|FG000|Overall Study|Withdrawal by Subject|0|||
126042679|NCT02865538|453453208|FG001|Overall Study|Withdrawal by Subject|0|||
126042680|NCT02865538|453453209|FG002|Overall Study|Withdrawal by Subject|1|||
126042681|NCT02865538|453453210|FG003|Overall Study|Withdrawal by Subject|0|||
126042682|NCT02865538|453453211|FG004|Overall Study|Withdrawal by Subject|0|||
126042683|NCT02865538|453453207|FG000|Overall Study|Lost to Follow-up|1|||
126042684|NCT02865538|453453208|FG001|Overall Study|Lost to Follow-up|0|||
126042685|NCT02865538|453453209|FG002|Overall Study|Lost to Follow-up|0|||
126042686|NCT02865538|453453210|FG003|Overall Study|Lost to Follow-up|0|||
126042687|NCT02865538|453453211|FG004|Overall Study|Lost to Follow-up|0|||
126042688|NCT03106740|453454679|FG000|Overall Study|Lost to Follow-up|2|||
126042689|NCT03106740|453454680|FG001|Overall Study|Lost to Follow-up|2|||
126042690|NCT03106740|453454679|FG000|Overall Study|Withdrawal by Subject|2|||
126042691|NCT03106740|453454680|FG001|Overall Study|Withdrawal by Subject|4|||
126042692|NCT03106740|453454679|FG000|Overall Study|Physician Decision|0|||
126042693|NCT03106740|453454680|FG001|Overall Study|Physician Decision|1|||
126042694|NCT03106740|453454679|FG000|Overall Study|Partial data|1|||
126042695|NCT03106740|453454680|FG001|Overall Study|Partial data|0|||
126042696|NCT04565990|453454681|FG000|Overall Study|Death|5|||
126042697|NCT04565990|453454681|FG000|Overall Study|Lost to Follow-up|1|||
126042698|NCT04565990|453454681|FG000|Overall Study|Withdrawal by Subject|1|||
126042699|NCT04797858|453454682|FG000|Overall Study|Withdrawal by Subject|0|||
126042700|NCT04797858|453454683|FG001|Overall Study|Withdrawal by Subject|1|||
126042701|NCT04797858|453454682|FG000|Overall Study|Excluded due to administrative error|7|||
126042702|NCT04797858|453454683|FG001|Overall Study|Excluded due to administrative error|8|||
126042703|NCT05363163|453454693|FG000|Overall Study|Withdrawal by Subject|13|||
126042704|NCT04999111|453454694|FG000|Overall Study|Lost to Follow-up|21|||
126042705|NCT04999111|453454695|FG001|Overall Study|Lost to Follow-up|16|||
126042706|NCT04999111|453454696|FG002|Overall Study|Lost to Follow-up|2|||
126042707|NCT04999111|453454697|FG003|Overall Study|Lost to Follow-up|26|||
126042708|NCT04999111|453454698|FG004|Overall Study|Lost to Follow-up|30|||
126042709|NCT04999111|453454699|FG005|Overall Study|Lost to Follow-up|6|||
126042710|NCT04999111|453454694|FG000|Overall Study|Physician Decision|1|||
126042711|NCT04999111|453454695|FG001|Overall Study|Physician Decision|3|||
126042712|NCT04999111|453454696|FG002|Overall Study|Physician Decision|0|||
126042713|NCT04999111|453454697|FG003|Overall Study|Physician Decision|1|||
126042714|NCT04999111|453454698|FG004|Overall Study|Physician Decision|2|||
126042715|NCT04999111|453454699|FG005|Overall Study|Physician Decision|0|||
126042716|NCT04999111|453454694|FG000|Overall Study|Withdrawal by Subject|23|||
126042717|NCT04999111|453454695|FG001|Overall Study|Withdrawal by Subject|29|||
126042718|NCT04999111|453454696|FG002|Overall Study|Withdrawal by Subject|15|||
126042719|NCT04999111|453454697|FG003|Overall Study|Withdrawal by Subject|30|||
126042720|NCT04999111|453454698|FG004|Overall Study|Withdrawal by Subject|35|||
126042721|NCT04999111|453454699|FG005|Overall Study|Withdrawal by Subject|10|||
126042722|NCT04999111|453454694|FG000|Overall Study|Other|6|||
126042723|NCT04999111|453454695|FG001|Overall Study|Other|6|||
126042724|NCT04999111|453454696|FG002|Overall Study|Other|3|||
126042725|NCT04999111|453454697|FG003|Overall Study|Other|8|||
126042726|NCT04999111|453454698|FG004|Overall Study|Other|8|||
126042727|NCT04999111|453454699|FG005|Overall Study|Other|5|||
126042728|NCT04999111|453454694|FG000|Overall Study|Non-compliance with study schedule|1|||
126042729|NCT04999111|453454695|FG001|Overall Study|Non-compliance with study schedule|0|||
126042730|NCT04999111|453454696|FG002|Overall Study|Non-compliance with study schedule|0|||
126100741|NCT03814187|453662437|FG000|Overall Study|Physician Decision|7|||
126100742|NCT03814187|453662438|FG001|Overall Study|Physician Decision|4|||
126100743|NCT03814187|453662439|FG002|Overall Study|Physician Decision|2|||
126100744|NCT03814187|453662437|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
126100745|NCT03814187|453662438|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
126100746|NCT03814187|453662439|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
126100747|NCT03814187|453662437|FG000|Overall Study|Other reasons|34|||
126100748|NCT03814187|453662438|FG001|Overall Study|Other reasons|40|||
126100749|NCT03814187|453662439|FG002|Overall Study|Other reasons|2|||
126100750|NCT00513604|453662440|FG000|Overall Study|Not treated|2|||
126100751|NCT00513604|453662441|FG001|Overall Study|Not treated|0|||
126100752|NCT00513604|453662442|FG002|Overall Study|Not treated|1|||
126100753|NCT00513604|453662443|FG003|Overall Study|Not treated|0|||
126100754|NCT00513604|453662444|FG004|Overall Study|Not treated|0|||
126100755|NCT00513604|453662440|FG000|Overall Study|Death during treatment|0|||
126100756|NCT00513604|453662441|FG001|Overall Study|Death during treatment|3|||
126100757|NCT00513604|453662442|FG002|Overall Study|Death during treatment|2|||
126100758|NCT00513604|453662443|FG003|Overall Study|Death during treatment|0|||
126100759|NCT00513604|453662444|FG004|Overall Study|Death during treatment|0|||
126100760|NCT00196976|453662445|FG000|Primary Study|Migrated from study area|0|||
126100761|NCT00196976|453662446|FG001|Primary Study|Migrated from study area|0|||
126100762|NCT00196976|453662447|FG002|Primary Study|Migrated from study area|0|||
126100763|NCT00196976|453662448|FG003|Primary Study|Migrated from study area|0|||
126100764|NCT00196976|453662449|FG004|Primary Study|Migrated from study area|0|||
126100765|NCT00196976|453662450|FG005|Primary Study|Migrated from study area|0|||
126100766|NCT00196976|453662451|FG006|Primary Study|Migrated from study area|0|||
126100767|NCT00196976|453662452|FG007|Primary Study|Migrated from study area|1|||
126100768|NCT00196976|453662453|FG008|Primary Study|Migrated from study area|0|||
126100769|NCT00196976|453662454|FG009|Primary Study|Migrated from study area|0|||
126100770|NCT00196976|453662455|FG010|Primary Study|Migrated from study area|0|||
126100771|NCT00196976|453662456|FG011|Primary Study|Migrated from study area|0|||
126100772|NCT00196976|453662457|FG012|Primary Study|Migrated from study area|0|||
126100773|NCT00196976|453662458|FG013|Primary Study|Migrated from study area|0|||
126100774|NCT00196976|453662445|FG000|Primary Study|Protocol Violation|0|||
126100775|NCT00196976|453662446|FG001|Primary Study|Protocol Violation|1|||
126100776|NCT00196976|453662447|FG002|Primary Study|Protocol Violation|1|||
126296187|NCT02383017|454372588|FG001|Overall Study|Found to be Hypogonadal|0|||
126100777|NCT00196976|453662448|FG003|Primary Study|Protocol Violation|0|||
126100778|NCT00196976|453662449|FG004|Primary Study|Protocol Violation|0|||
126100779|NCT00196976|453662450|FG005|Primary Study|Protocol Violation|0|||
126100780|NCT00196976|453662451|FG006|Primary Study|Protocol Violation|0|||
126100781|NCT00196976|453662452|FG007|Primary Study|Protocol Violation|0|||
126100782|NCT00196976|453662453|FG008|Primary Study|Protocol Violation|0|||
126100783|NCT00196976|453662454|FG009|Primary Study|Protocol Violation|0|||
126100784|NCT00196976|453662455|FG010|Primary Study|Protocol Violation|0|||
126100785|NCT00196976|453662456|FG011|Primary Study|Protocol Violation|0|||
126100786|NCT00196976|453662457|FG012|Primary Study|Protocol Violation|0|||
126100787|NCT00196976|453662458|FG013|Primary Study|Protocol Violation|0|||
126100788|NCT00196976|453662445|FG000|Primary Study|Withdrawal by Subject|1|||
126100789|NCT00196976|453662446|FG001|Primary Study|Withdrawal by Subject|0|||
126100790|NCT00196976|453662447|FG002|Primary Study|Withdrawal by Subject|1|||
126100791|NCT00196976|453662448|FG003|Primary Study|Withdrawal by Subject|1|||
126100792|NCT00196976|453662449|FG004|Primary Study|Withdrawal by Subject|2|||
126100793|NCT00196976|453662450|FG005|Primary Study|Withdrawal by Subject|1|||
126100794|NCT00196976|453662451|FG006|Primary Study|Withdrawal by Subject|0|||
126100795|NCT00196976|453662452|FG007|Primary Study|Withdrawal by Subject|0|||
126100796|NCT00196976|453662453|FG008|Primary Study|Withdrawal by Subject|0|||
126100797|NCT00196976|453662454|FG009|Primary Study|Withdrawal by Subject|1|||
126100798|NCT00196976|453662455|FG010|Primary Study|Withdrawal by Subject|0|||
126100799|NCT00196976|453662456|FG011|Primary Study|Withdrawal by Subject|0|||
126100800|NCT00196976|453662457|FG012|Primary Study|Withdrawal by Subject|0|||
126100801|NCT00196976|453662458|FG013|Primary Study|Withdrawal by Subject|0|||
126100802|NCT00196976|453662445|FG000|Primary Study|Lost to Follow-up|0|||
126100803|NCT00196976|453662446|FG001|Primary Study|Lost to Follow-up|0|||
126100804|NCT00196976|453662447|FG002|Primary Study|Lost to Follow-up|0|||
126100805|NCT00196976|453662448|FG003|Primary Study|Lost to Follow-up|0|||
126100806|NCT00196976|453662449|FG004|Primary Study|Lost to Follow-up|1|||
126100807|NCT00196976|453662450|FG005|Primary Study|Lost to Follow-up|1|||
126100808|NCT00196976|453662451|FG006|Primary Study|Lost to Follow-up|0|||
126100809|NCT00196976|453662452|FG007|Primary Study|Lost to Follow-up|2|||
126100810|NCT00196976|453662453|FG008|Primary Study|Lost to Follow-up|0|||
126100811|NCT00196976|453662454|FG009|Primary Study|Lost to Follow-up|0|||
126100812|NCT00196976|453662455|FG010|Primary Study|Lost to Follow-up|0|||
126100813|NCT00196976|453662456|FG011|Primary Study|Lost to Follow-up|0|||
126100814|NCT00196976|453662457|FG012|Primary Study|Lost to Follow-up|0|||
126100815|NCT00196976|453662458|FG013|Primary Study|Lost to Follow-up|0|||
126100816|NCT00196976|453662445|FG000|Primary Study|Other|0|||
126100817|NCT00196976|453662446|FG001|Primary Study|Other|0|||
126100818|NCT00196976|453662447|FG002|Primary Study|Other|2|||
126100819|NCT00196976|453662448|FG003|Primary Study|Other|0|||
126100820|NCT00196976|453662449|FG004|Primary Study|Other|0|||
126100821|NCT00196976|453662450|FG005|Primary Study|Other|0|||
126100822|NCT00196976|453662451|FG006|Primary Study|Other|0|||
126100823|NCT00196976|453662452|FG007|Primary Study|Other|0|||
126100824|NCT00196976|453662453|FG008|Primary Study|Other|0|||
126100825|NCT00196976|453662454|FG009|Primary Study|Other|0|||
126100826|NCT00196976|453662455|FG010|Primary Study|Other|0|||
126100827|NCT00196976|453662456|FG011|Primary Study|Other|0|||
126100828|NCT00196976|453662457|FG012|Primary Study|Other|0|||
126100829|NCT00196976|453662458|FG013|Primary Study|Other|0|||
126100830|NCT00196976|453662445|FG000|Booster Study|Withdrawal by Subject|0|||
126100831|NCT00196976|453662446|FG001|Booster Study|Withdrawal by Subject|0|||
126100832|NCT00196976|453662447|FG002|Booster Study|Withdrawal by Subject|0|||
126100833|NCT00196976|453662448|FG003|Booster Study|Withdrawal by Subject|0|||
126100834|NCT00196976|453662449|FG004|Booster Study|Withdrawal by Subject|0|||
126100835|NCT00196976|453662450|FG005|Booster Study|Withdrawal by Subject|0|||
126100836|NCT00196976|453662451|FG006|Booster Study|Withdrawal by Subject|0|||
126100837|NCT00196976|453662452|FG007|Booster Study|Withdrawal by Subject|0|||
126100838|NCT00196976|453662453|FG008|Booster Study|Withdrawal by Subject|0|||
126100839|NCT00196976|453662454|FG009|Booster Study|Withdrawal by Subject|0|||
126100840|NCT00196976|453662455|FG010|Booster Study|Withdrawal by Subject|1|||
126100841|NCT00196976|453662456|FG011|Booster Study|Withdrawal by Subject|0|||
126100842|NCT00196976|453662457|FG012|Booster Study|Withdrawal by Subject|0|||
126100843|NCT00196976|453662458|FG013|Booster Study|Withdrawal by Subject|0|||
126296188|NCT01068860|454372589|FG000|Overall Study|Withdrawal by Subject|0|||
126296189|NCT01068860|454372590|FG001|Overall Study|Withdrawal by Subject|0|||
126100844|NCT00196976|453662445|FG000|Booster Study|Lost to Follow-up|0|||
126100845|NCT00196976|453662446|FG001|Booster Study|Lost to Follow-up|0|||
126100846|NCT00196976|453662447|FG002|Booster Study|Lost to Follow-up|0|||
126100847|NCT00196976|453662448|FG003|Booster Study|Lost to Follow-up|0|||
126100848|NCT00196976|453662449|FG004|Booster Study|Lost to Follow-up|0|||
126100849|NCT00196976|453662450|FG005|Booster Study|Lost to Follow-up|0|||
126100850|NCT00196976|453662451|FG006|Booster Study|Lost to Follow-up|0|||
126100851|NCT00196976|453662452|FG007|Booster Study|Lost to Follow-up|0|||
126100852|NCT00196976|453662453|FG008|Booster Study|Lost to Follow-up|0|||
126100853|NCT00196976|453662454|FG009|Booster Study|Lost to Follow-up|0|||
126100854|NCT00196976|453662455|FG010|Booster Study|Lost to Follow-up|1|||
126100855|NCT00196976|453662456|FG011|Booster Study|Lost to Follow-up|2|||
126100856|NCT00196976|453662457|FG012|Booster Study|Lost to Follow-up|0|||
126100857|NCT00196976|453662458|FG013|Booster Study|Lost to Follow-up|0|||
126100858|NCT02689518|453662459|FG000|Overall Study|Withdrawal by Subject|3|||
126100859|NCT00825825|453662464|FG000|First Medication Period (14 Days)|Adverse Event|1|||
126100860|NCT00825825|453662465|FG001|First Medication Period (14 Days)|Adverse Event|0|||
126100861|NCT00825825|453662466|FG002|First Medication Period (14 Days)|Adverse Event|0|||
126100862|NCT00825825|453662467|FG003|First Medication Period (14 Days)|Adverse Event|0|||
126100863|NCT00825825|453662468|FG004|First Medication Period (14 Days)|Adverse Event|0|||
126100864|NCT00825825|453662469|FG005|First Medication Period (14 Days)|Adverse Event|1|||
126100865|NCT00825825|453662464|FG000|First Medication Period (14 Days)|Physician Decision|2|||
126100866|NCT00825825|453662465|FG001|First Medication Period (14 Days)|Physician Decision|0|||
126100867|NCT00825825|453662466|FG002|First Medication Period (14 Days)|Physician Decision|1|||
126100868|NCT00825825|453662467|FG003|First Medication Period (14 Days)|Physician Decision|0|||
126100869|NCT00825825|453662468|FG004|First Medication Period (14 Days)|Physician Decision|0|||
126100870|NCT00825825|453662469|FG005|First Medication Period (14 Days)|Physician Decision|1|||
126100871|NCT00825825|453662464|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
126100872|NCT00825825|453662465|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
126100873|NCT00825825|453662466|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
126100874|NCT00825825|453662467|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
126100875|NCT00825825|453662468|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
126100876|NCT00825825|453662469|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
126100877|NCT00825825|453662464|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
126100878|NCT00825825|453662465|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
126100879|NCT00825825|453662466|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
126100880|NCT00825825|453662467|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
126100881|NCT00825825|453662468|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
126100882|NCT00825825|453662469|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
126100883|NCT00825825|453662464|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
126100884|NCT00825825|453662465|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
126100885|NCT00825825|453662466|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
126100886|NCT00825825|453662467|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
126100887|NCT00825825|453662468|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
126100888|NCT00825825|453662469|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
126296190|NCT01068860|454372591|FG002|Overall Study|Withdrawal by Subject|0|||
126296191|NCT01068860|454372592|FG003|Overall Study|Withdrawal by Subject|0|||
126296192|NCT01068860|454372593|FG004|Overall Study|Withdrawal by Subject|0|||
126296193|NCT01068860|454372594|FG005|Overall Study|Withdrawal by Subject|2|||
126296194|NCT01068860|454372595|FG006|Overall Study|Withdrawal by Subject|0|||
126296195|NCT01068860|454372596|FG007|Overall Study|Withdrawal by Subject|0|||
126296196|NCT01068860|454372597|FG008|Overall Study|Withdrawal by Subject|0|||
126296197|NCT01068860|454372598|FG009|Overall Study|Withdrawal by Subject|3|||
126296198|NCT01068860|454372589|FG000|Overall Study|Administrative problems; misrandomized|0|||
126296199|NCT01068860|454372590|FG001|Overall Study|Administrative problems; misrandomized|0|||
126296200|NCT01068860|454372591|FG002|Overall Study|Administrative problems; misrandomized|0|||
126296201|NCT01068860|454372592|FG003|Overall Study|Administrative problems; misrandomized|1|||
126296202|NCT01068860|454372593|FG004|Overall Study|Administrative problems; misrandomized|0|||
126296203|NCT01068860|454372594|FG005|Overall Study|Administrative problems; misrandomized|0|||
126296204|NCT01068860|454372595|FG006|Overall Study|Administrative problems; misrandomized|0|||
126296205|NCT01068860|454372596|FG007|Overall Study|Administrative problems; misrandomized|0|||
126296206|NCT01068860|454372597|FG008|Overall Study|Administrative problems; misrandomized|0|||
126296207|NCT01068860|454372598|FG009|Overall Study|Administrative problems; misrandomized|1|||
126296208|NCT01068860|454372589|FG000|Overall Study|Lost to Follow-up|0|||
126296209|NCT01068860|454372590|FG001|Overall Study|Lost to Follow-up|1|||
126296210|NCT01068860|454372591|FG002|Overall Study|Lost to Follow-up|0|||
126296211|NCT01068860|454372592|FG003|Overall Study|Lost to Follow-up|0|||
126296212|NCT01068860|454372593|FG004|Overall Study|Lost to Follow-up|0|||
126296213|NCT01068860|454372594|FG005|Overall Study|Lost to Follow-up|0|||
126296214|NCT01068860|454372595|FG006|Overall Study|Lost to Follow-up|0|||
126296215|NCT01068860|454372596|FG007|Overall Study|Lost to Follow-up|0|||
126100889|NCT00825825|453662464|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
126100890|NCT00825825|453662465|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
126100891|NCT00825825|453662466|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
126100892|NCT00825825|453662467|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
126100893|NCT00825825|453662468|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
126100894|NCT00825825|453662469|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
126100895|NCT00825825|453662464|FG000|Third Medication Period (14 Days)|poor data quality|0|||
126100896|NCT00825825|453662465|FG001|Third Medication Period (14 Days)|poor data quality|1|||
126100897|NCT00825825|453662466|FG002|Third Medication Period (14 Days)|poor data quality|0|||
126100898|NCT00825825|453662467|FG003|Third Medication Period (14 Days)|poor data quality|0|||
126100899|NCT00825825|453662468|FG004|Third Medication Period (14 Days)|poor data quality|0|||
126100900|NCT00825825|453662469|FG005|Third Medication Period (14 Days)|poor data quality|0|||
126100901|NCT01920854|453662473|FG000|Overall Study|Withdrawal by Subject|1|||
126100902|NCT01920854|453662474|FG001|Overall Study|Withdrawal by Subject|0|||
126100903|NCT01920854|453662475|FG002|Overall Study|Withdrawal by Subject|0|||
126100904|NCT01920854|453662476|FG003|Overall Study|Withdrawal by Subject|0|||
126100905|NCT01920854|453662477|FG004|Overall Study|Withdrawal by Subject|1|||
126100906|NCT01920854|453662478|FG005|Overall Study|Withdrawal by Subject|0|||
126100907|NCT01920854|453662479|FG006|Overall Study|Withdrawal by Subject|1|||
126100908|NCT00757783|453662480|FG000|Overall Study|Adverse Event|0|||
126100909|NCT00757783|453662481|FG001|Overall Study|Adverse Event|2|||
126100910|NCT00757783|453662480|FG000|Overall Study|Lost to Follow-up|1|||
126100911|NCT00757783|453662481|FG001|Overall Study|Lost to Follow-up|1|||
126100912|NCT00757783|453662480|FG000|Overall Study|Protocol Violation|1|||
126100913|NCT00757783|453662481|FG001|Overall Study|Protocol Violation|0|||
126100914|NCT00757783|453662480|FG000|Overall Study|Withdrawal by Subject|2|||
126100915|NCT00757783|453662481|FG001|Overall Study|Withdrawal by Subject|1|||
126100916|NCT00757783|453662480|FG000|Overall Study|Other|1|||
126100917|NCT00757783|453662481|FG001|Overall Study|Other|2|||
126100918|NCT02054520|453662482|FG000|Overall Study|Adverse Event|1|||
126100919|NCT02054520|453662483|FG001|Overall Study|Adverse Event|4|||
126100920|NCT02054520|453662484|FG002|Overall Study|Adverse Event|2|||
126100921|NCT02054520|453662485|FG003|Overall Study|Adverse Event|1|||
126100922|NCT02054520|453662486|FG004|Overall Study|Adverse Event|1|||
126100923|NCT02054520|453662487|FG005|Overall Study|Adverse Event|0|||
126100924|NCT02054520|453662482|FG000|Overall Study|Lack of Efficacy|7|||
126100925|NCT02054520|453662483|FG001|Overall Study|Lack of Efficacy|0|||
126100926|NCT02054520|453662484|FG002|Overall Study|Lack of Efficacy|2|||
126100927|NCT02054520|453662485|FG003|Overall Study|Lack of Efficacy|1|||
126100928|NCT02054520|453662486|FG004|Overall Study|Lack of Efficacy|3|||
126100929|NCT02054520|453662487|FG005|Overall Study|Lack of Efficacy|2|||
126100930|NCT02054520|453662482|FG000|Overall Study|Withdrawal by Subject|1|||
126100931|NCT02054520|453662483|FG001|Overall Study|Withdrawal by Subject|0|||
126100932|NCT02054520|453662484|FG002|Overall Study|Withdrawal by Subject|0|||
126100933|NCT02054520|453662485|FG003|Overall Study|Withdrawal by Subject|2|||
126100934|NCT02054520|453662486|FG004|Overall Study|Withdrawal by Subject|1|||
126100935|NCT02054520|453662487|FG005|Overall Study|Withdrawal by Subject|0|||
126100936|NCT02054520|453662482|FG000|Overall Study|Physician Decision|0|||
126100937|NCT02054520|453662483|FG001|Overall Study|Physician Decision|1|||
126100938|NCT02054520|453662484|FG002|Overall Study|Physician Decision|0|||
126100939|NCT02054520|453662485|FG003|Overall Study|Physician Decision|1|||
126100940|NCT02054520|453662486|FG004|Overall Study|Physician Decision|0|||
126100941|NCT02054520|453662487|FG005|Overall Study|Physician Decision|1|||
126100942|NCT02054520|453662482|FG000|Overall Study|Study terminated by Sponsor|0|||
126100943|NCT02054520|453662483|FG001|Overall Study|Study terminated by Sponsor|0|||
126100944|NCT02054520|453662484|FG002|Overall Study|Study terminated by Sponsor|2|||
126100945|NCT02054520|453662485|FG003|Overall Study|Study terminated by Sponsor|1|||
126100946|NCT02054520|453662486|FG004|Overall Study|Study terminated by Sponsor|0|||
126296216|NCT01068860|454372597|FG008|Overall Study|Lost to Follow-up|0|||
126296217|NCT01068860|454372598|FG009|Overall Study|Lost to Follow-up|0|||
126296218|NCT00460603|454372599|FG000|Phase 1|Death|1|||
126296219|NCT00460603|454372600|FG001|Phase 1|Death|0|||
126296220|NCT00460603|454372601|FG002|Phase 1|Death|0|||
126296221|NCT00460603|454372602|FG003|Phase 1|Death|2|||
126296222|NCT00460603|454372603|FG004|Phase 1|Death|0|||
126296223|NCT00460603|454372604|FG005|Phase 1|Death|0|||
126296224|NCT00460603|454372605|FG006|Phase 1|Death|0|||
126296225|NCT00460603|454372606|FG007|Phase 1|Death|0|||
126296226|NCT00460603|454372607|FG008|Phase 1|Death|1|||
126296227|NCT00460603|454372608|FG009|Phase 1|Death|0|||
126296228|NCT00460603|454372609|FG010|Phase 1|Death|0|||
126296229|NCT00460603|454372610|FG011|Phase 1|Death|0|||
126296230|NCT00460603|454372599|FG000|Phase 1|Adverse Event|3|||
126296231|NCT00460603|454372600|FG001|Phase 1|Adverse Event|1|||
126296232|NCT00460603|454372601|FG002|Phase 1|Adverse Event|1|||
126296233|NCT00460603|454372602|FG003|Phase 1|Adverse Event|2|||
126296234|NCT00460603|454372603|FG004|Phase 1|Adverse Event|0|||
126296235|NCT00460603|454372604|FG005|Phase 1|Adverse Event|0|||
126296236|NCT00460603|454372605|FG006|Phase 1|Adverse Event|3|||
126296237|NCT00460603|454372606|FG007|Phase 1|Adverse Event|0|||
126296238|NCT00460603|454372607|FG008|Phase 1|Adverse Event|4|||
126296239|NCT00460603|454372608|FG009|Phase 1|Adverse Event|0|||
126296240|NCT00460603|454372609|FG010|Phase 1|Adverse Event|0|||
126296241|NCT00460603|454372610|FG011|Phase 1|Adverse Event|0|||
126296242|NCT00460603|454372599|FG000|Phase 1|Lack of Efficacy|1|||
126296243|NCT00460603|454372600|FG001|Phase 1|Lack of Efficacy|0|||
126296244|NCT00460603|454372601|FG002|Phase 1|Lack of Efficacy|1|||
126296245|NCT00460603|454372602|FG003|Phase 1|Lack of Efficacy|2|||
126296246|NCT00460603|454372603|FG004|Phase 1|Lack of Efficacy|2|||
126296247|NCT00460603|454372604|FG005|Phase 1|Lack of Efficacy|2|||
126296248|NCT00460603|454372605|FG006|Phase 1|Lack of Efficacy|2|||
126296249|NCT00460603|454372606|FG007|Phase 1|Lack of Efficacy|2|||
126296250|NCT00460603|454372607|FG008|Phase 1|Lack of Efficacy|11|||
126296251|NCT00460603|454372608|FG009|Phase 1|Lack of Efficacy|0|||
126296252|NCT00460603|454372609|FG010|Phase 1|Lack of Efficacy|0|||
126296253|NCT00460603|454372610|FG011|Phase 1|Lack of Efficacy|0|||
126296254|NCT00460603|454372599|FG000|Phase 1|Withdrawal by Subject|1|||
126296255|NCT00460603|454372600|FG001|Phase 1|Withdrawal by Subject|2|||
126296256|NCT00460603|454372601|FG002|Phase 1|Withdrawal by Subject|1|||
126296257|NCT00460603|454372602|FG003|Phase 1|Withdrawal by Subject|1|||
126296258|NCT00460603|454372603|FG004|Phase 1|Withdrawal by Subject|3|||
126296259|NCT00460603|454372604|FG005|Phase 1|Withdrawal by Subject|0|||
126296260|NCT00460603|454372605|FG006|Phase 1|Withdrawal by Subject|1|||
126296261|NCT00460603|454372606|FG007|Phase 1|Withdrawal by Subject|0|||
126296262|NCT00460603|454372607|FG008|Phase 1|Withdrawal by Subject|2|||
126296263|NCT00460603|454372608|FG009|Phase 1|Withdrawal by Subject|0|||
126296264|NCT00460603|454372609|FG010|Phase 1|Withdrawal by Subject|0|||
126296265|NCT00460603|454372610|FG011|Phase 1|Withdrawal by Subject|0|||
126296266|NCT00460603|454372599|FG000|Phase 1|Other|0|||
126296267|NCT00460603|454372600|FG001|Phase 1|Other|3|||
126296268|NCT00460603|454372601|FG002|Phase 1|Other|1|||
126296269|NCT00460603|454372602|FG003|Phase 1|Other|1|||
126296270|NCT00460603|454372603|FG004|Phase 1|Other|1|||
126296271|NCT00460603|454372604|FG005|Phase 1|Other|2|||
126296272|NCT00460603|454372605|FG006|Phase 1|Other|0|||
126296273|NCT00460603|454372606|FG007|Phase 1|Other|1|||
126296274|NCT00460603|454372607|FG008|Phase 1|Other|0|||
126296275|NCT00460603|454372608|FG009|Phase 1|Other|0|||
126296276|NCT00460603|454372609|FG010|Phase 1|Other|0|||
125883437|NCT00068692|452871471|FG005|Step 2: Randomization|Physician Decision|0|||
126100947|NCT02054520|453662487|FG005|Overall Study|Study terminated by Sponsor|0|||
126100948|NCT02372136|453662492|FG000|Overall Study|Death|3|||
126100949|NCT02372136|453662493|FG001|Overall Study|Death|1|||
126100950|NCT00985946|453662494|FG000|Overall Study|Lost to Follow-up|6|||
126100951|NCT00985946|453662494|FG000|Overall Study|Withdrawal by Subject|1|||
126100952|NCT02471833|453662495|FG000|Overall Study|Lost to Follow-up|1|||
126100953|NCT02471833|453662496|FG001|Overall Study|Lost to Follow-up|0|||
126100954|NCT02471833|453662497|FG002|Overall Study|Lost to Follow-up|0|||
126100955|NCT02471833|453662495|FG000|Overall Study|Withdrawal by Subject|2|||
126100956|NCT02471833|453662496|FG001|Overall Study|Withdrawal by Subject|1|||
126100957|NCT02471833|453662497|FG002|Overall Study|Withdrawal by Subject|5|||
126100958|NCT02673515|453662498|FG000|Overall Study|Lack of motivation|2|||
126100959|NCT02673515|453662499|FG001|Overall Study|Lack of motivation|1|||
126100960|NCT03965351|453662501|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
126100961|NCT03965351|453662502|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
126100962|NCT03965351|453662501|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
126100963|NCT03965351|453662502|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
126100964|NCT00490724|453662503|FG000|Period I|Physician Decision|0|||
126100965|NCT00490724|453662504|FG001|Period I|Physician Decision|0|||
126100966|NCT00490724|453662505|FG002|Period I|Physician Decision|1|||
126100967|NCT00490724|453662503|FG000|Period II|Treatment Discontinuation|3|||
126100968|NCT00490724|453662504|FG001|Period II|Treatment Discontinuation|1|||
126100969|NCT00490724|453662505|FG002|Period II|Treatment Discontinuation|3|||
126100970|NCT00994682|453662506|FG000|Double Bilnd|Withdrawal by Subject|5|||
126100971|NCT00994682|453662507|FG001|Double Bilnd|Withdrawal by Subject|6|||
126100972|NCT00994682|453662506|FG000|Double Bilnd|Lost to Follow-up|3|||
126100973|NCT00994682|453662507|FG001|Double Bilnd|Lost to Follow-up|3|||
126100974|NCT00994682|453662506|FG000|Double Bilnd|Adverse Event|1|||
126100975|NCT00994682|453662507|FG001|Double Bilnd|Adverse Event|0|||
126100976|NCT00994682|453662506|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
126100977|NCT00994682|453662507|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
126100978|NCT00994682|453662506|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
126100979|NCT00994682|453662507|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
126100980|NCT00994682|453662506|FG000|Pioglitazone Open Label|Physician Decision|6|||
126100981|NCT00994682|453662507|FG001|Pioglitazone Open Label|Physician Decision|1|||
126100982|NCT02859324|453662510|FG000|Overall Study|Death|4|||
126296277|NCT00460603|454372610|FG011|Phase 1|Other|0|||
126296278|NCT00460603|454372599|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296279|NCT00460603|454372600|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126100983|NCT02859324|453662511|FG001|Overall Study|Death|6|||
126100984|NCT02859324|453662512|FG002|Overall Study|Death|5|||
126100985|NCT02859324|453662510|FG000|Overall Study|Other reasons|3|||
126100986|NCT02859324|453662511|FG001|Overall Study|Other reasons|3|||
126100987|NCT02859324|453662512|FG002|Overall Study|Other reasons|0|||
126100988|NCT04227704|453662516|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
126296280|NCT00460603|454372601|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296281|NCT00460603|454372602|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296282|NCT00460603|454372603|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126100989|NCT04227704|453662517|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
126100990|NCT04227704|453662518|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
126100991|NCT04227704|453662516|FG000|Overall Study|due to C/S being cancelled|1|||
126296283|NCT00460603|454372604|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296284|NCT00460603|454372605|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296285|NCT00460603|454372606|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296286|NCT00460603|454372607|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296287|NCT00460603|454372608|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
126296288|NCT00460603|454372609|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296289|NCT00460603|454372610|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296290|NCT00460603|454372599|FG000|Phase 2|Adverse Event|0|||
126296291|NCT00460603|454372600|FG001|Phase 2|Adverse Event|0|||
126296292|NCT00460603|454372601|FG002|Phase 2|Adverse Event|0|||
126100992|NCT04227704|453662517|FG001|Overall Study|due to C/S being cancelled|0|||
126100993|NCT04227704|453662518|FG002|Overall Study|due to C/S being cancelled|0|||
126100994|NCT00112047|453662519|FG000|Randomized Phase|Lost to Follow-up|26|||
126100995|NCT00112047|453662520|FG001|Randomized Phase|Lost to Follow-up|33|||
126100996|NCT00112047|453662519|FG000|Randomized Phase|Adverse Event|10|||
126100997|NCT00112047|453662520|FG001|Randomized Phase|Adverse Event|10|||
126100998|NCT00112047|453662519|FG000|Randomized Phase|Withrawal of consent|10|||
126100999|NCT00112047|453662520|FG001|Randomized Phase|Withrawal of consent|18|||
126101000|NCT00112047|453662519|FG000|Randomized Phase|Sub-optimal virological response|3|||
126101001|NCT00112047|453662520|FG001|Randomized Phase|Sub-optimal virological response|13|||
126101002|NCT00112047|453662519|FG000|Randomized Phase|Noncompliance|8|||
126101003|NCT00112047|453662520|FG001|Randomized Phase|Noncompliance|4|||
126101004|NCT00112047|453662519|FG000|Randomized Phase|Protocol Violation|2|||
126101005|NCT00112047|453662520|FG001|Randomized Phase|Protocol Violation|0|||
126101006|NCT00112047|453662519|FG000|Randomized Phase|Pregnancy|3|||
126101007|NCT00112047|453662520|FG001|Randomized Phase|Pregnancy|1|||
126101008|NCT00112047|453662519|FG000|Randomized Phase|Death|1|||
126101009|NCT00112047|453662520|FG001|Randomized Phase|Death|3|||
126101010|NCT00112047|453662519|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
126101011|NCT00112047|453662520|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
126101012|NCT00112047|453662519|FG000|Randomized Phase|Inability to swallow pills|0|||
126296293|NCT00460603|454372602|FG003|Phase 2|Adverse Event|0|||
126296294|NCT00460603|454372603|FG004|Phase 2|Adverse Event|0|||
126296295|NCT00460603|454372604|FG005|Phase 2|Adverse Event|0|||
126101013|NCT00112047|453662520|FG001|Randomized Phase|Inability to swallow pills|1|||
126101014|NCT00112047|453662519|FG000|Randomized Phase|Incarceration|3|||
126101015|NCT00112047|453662520|FG001|Randomized Phase|Incarceration|2|||
126101016|NCT00112047|453662519|FG000|Randomized Phase|Moved out of State|0|||
126101017|NCT00112047|453662520|FG001|Randomized Phase|Moved out of State|1|||
126101018|NCT00112047|453662519|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
126101019|NCT00112047|453662520|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
126101020|NCT00112047|453662519|FG000|Randomized Phase|High Hepatitis B DNA|0|||
126101021|NCT00112047|453662520|FG001|Randomized Phase|High Hepatitis B DNA|1|||
126101022|NCT00112047|453662519|FG000|Atripla Phase|Adverse Event|2|||
126101023|NCT00112047|453662520|FG001|Atripla Phase|Adverse Event|1|||
126101024|NCT00112047|453662519|FG000|Atripla Phase|Lost to Follow-up|5|||
126101025|NCT00112047|453662520|FG001|Atripla Phase|Lost to Follow-up|7|||
126101026|NCT00112047|453662519|FG000|Atripla Phase|Pregnancy|0|||
126101027|NCT00112047|453662520|FG001|Atripla Phase|Pregnancy|1|||
126101028|NCT00112047|453662519|FG000|Atripla Phase|Death|0|||
126101029|NCT00112047|453662520|FG001|Atripla Phase|Death|2|||
126101030|NCT00112047|453662519|FG000|Atripla Phase|Withdrew consent|7|||
126101031|NCT00112047|453662520|FG001|Atripla Phase|Withdrew consent|7|||
126101032|NCT00112047|453662519|FG000|Atripla Phase|Sub-optimal virological response|0|||
126101033|NCT00112047|453662520|FG001|Atripla Phase|Sub-optimal virological response|1|||
126101034|NCT00112047|453662519|FG000|Atripla Phase|Non-compliance|1|||
126101035|NCT00112047|453662520|FG001|Atripla Phase|Non-compliance|0|||
126101036|NCT00112047|453662519|FG000|Atripla Phase|Other|3|||
126101037|NCT00112047|453662520|FG001|Atripla Phase|Other|1|||
126101038|NCT01307579|453662521|FG000|Overall Study|Death|3|||
126101039|NCT01307579|453662522|FG001|Overall Study|Death|6|||
126101040|NCT01307579|453662521|FG000|Overall Study|Physician Decision|26|||
126101041|NCT01307579|453662522|FG001|Overall Study|Physician Decision|29|||
126101042|NCT01307579|453662521|FG000|Overall Study|Withdrawal by Subject|7|||
126101043|NCT01307579|453662522|FG001|Overall Study|Withdrawal by Subject|3|||
126101044|NCT01307579|453662521|FG000|Overall Study|Institutional diagnosis of IFD|21|||
126101045|NCT01307579|453662522|FG001|Overall Study|Institutional diagnosis of IFD|36|||
126101046|NCT01307579|453662521|FG000|Overall Study|Begin conditioning for HSCT|42|||
126101047|NCT01307579|453662522|FG001|Overall Study|Begin conditioning for HSCT|44|||
126101048|NCT01307579|453662521|FG000|Overall Study|Refractory or relapsed AML|38|||
126296296|NCT00460603|454372605|FG006|Phase 2|Adverse Event|0|||
126101049|NCT01307579|453662522|FG001|Overall Study|Refractory or relapsed AML|23|||
126101050|NCT01307579|453662521|FG000|Overall Study|Ineligible|3|||
126101051|NCT01307579|453662522|FG001|Overall Study|Ineligible|4|||
126101052|NCT00812331|453664138|FG000|Overall Study|Adverse Event|1|||
126101053|NCT00812331|453664139|FG001|Overall Study|Adverse Event|0|||
126101054|NCT00812331|453664140|FG002|Overall Study|Adverse Event|0|||
126101055|NCT00812331|453664141|FG003|Overall Study|Adverse Event|0|||
126296297|NCT00460603|454372606|FG007|Phase 2|Adverse Event|0|||
126101056|NCT00812331|453664142|FG004|Overall Study|Adverse Event|0|||
126101057|NCT01506453|453664143|FG000|Overall Study|Withdrawal prior to treatment|0|||
126101058|NCT01506453|453664144|FG001|Overall Study|Withdrawal prior to treatment|2|||
126101059|NCT00055601|453664145|FG000|Overall Study|Protocol Violation|1|||
126101060|NCT00055601|453664146|FG001|Overall Study|Protocol Violation|1|||
126101061|NCT00055601|453664145|FG000|Overall Study|No protocol treatment received|1|||
126101062|NCT00055601|453664146|FG001|Overall Study|No protocol treatment received|1|||
126101063|NCT00117845|453664147|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
126101064|NCT00484289|453664148|FG000|Long Term Phase|Adverse Event|1|||
126101065|NCT00484289|453664149|FG001|Long Term Phase|Adverse Event|17|||
126101066|NCT00484289|453664150|FG002|Long Term Phase|Adverse Event|5|||
126101067|NCT00484289|453664148|FG000|Long Term Phase|Withdrawal by Subject|0|||
126101068|NCT00484289|453664149|FG001|Long Term Phase|Withdrawal by Subject|7|||
126101069|NCT00484289|453664150|FG002|Long Term Phase|Withdrawal by Subject|6|||
126101070|NCT00484289|453664148|FG000|Long Term Phase|Inadequate response|2|||
126101071|NCT00484289|453664149|FG001|Long Term Phase|Inadequate response|7|||
126101072|NCT00484289|453664150|FG002|Long Term Phase|Inadequate response|4|||
126296298|NCT00460603|454372607|FG008|Phase 2|Adverse Event|0|||
126296299|NCT00460603|454372608|FG009|Phase 2|Adverse Event|12|||
126296300|NCT00460603|454372609|FG010|Phase 2|Adverse Event|9|||
126296301|NCT00460603|454372610|FG011|Phase 2|Adverse Event|10|||
126296302|NCT00460603|454372599|FG000|Phase 2|Death|0|||
126296303|NCT00460603|454372600|FG001|Phase 2|Death|0|||
126296304|NCT00460603|454372601|FG002|Phase 2|Death|0|||
126296305|NCT00460603|454372602|FG003|Phase 2|Death|0|||
126296306|NCT00460603|454372603|FG004|Phase 2|Death|0|||
126296307|NCT00460603|454372604|FG005|Phase 2|Death|0|||
126296308|NCT00460603|454372605|FG006|Phase 2|Death|0|||
126296309|NCT00460603|454372606|FG007|Phase 2|Death|0|||
126296310|NCT00460603|454372607|FG008|Phase 2|Death|0|||
126296311|NCT00460603|454372608|FG009|Phase 2|Death|4|||
126296312|NCT00460603|454372609|FG010|Phase 2|Death|2|||
126296313|NCT00460603|454372610|FG011|Phase 2|Death|2|||
126296314|NCT00460603|454372599|FG000|Phase 2|Protocol Violation|0|||
126296315|NCT00460603|454372600|FG001|Phase 2|Protocol Violation|0|||
126296316|NCT00460603|454372601|FG002|Phase 2|Protocol Violation|0|||
126296317|NCT00460603|454372602|FG003|Phase 2|Protocol Violation|0|||
126296318|NCT00460603|454372603|FG004|Phase 2|Protocol Violation|0|||
126296319|NCT00460603|454372604|FG005|Phase 2|Protocol Violation|0|||
126296320|NCT00460603|454372605|FG006|Phase 2|Protocol Violation|0|||
126296321|NCT00460603|454372606|FG007|Phase 2|Protocol Violation|0|||
126296322|NCT00460603|454372607|FG008|Phase 2|Protocol Violation|0|||
126296323|NCT00460603|454372608|FG009|Phase 2|Protocol Violation|1|||
126296324|NCT00460603|454372609|FG010|Phase 2|Protocol Violation|1|||
126296325|NCT00460603|454372610|FG011|Phase 2|Protocol Violation|0|||
126296326|NCT00460603|454372599|FG000|Phase 2|Lost to Follow-up|0|||
126296327|NCT00460603|454372600|FG001|Phase 2|Lost to Follow-up|0|||
126296328|NCT00460603|454372601|FG002|Phase 2|Lost to Follow-up|0|||
126296329|NCT00460603|454372602|FG003|Phase 2|Lost to Follow-up|0|||
126296330|NCT00460603|454372603|FG004|Phase 2|Lost to Follow-up|0|||
126296331|NCT00460603|454372604|FG005|Phase 2|Lost to Follow-up|0|||
126296332|NCT00460603|454372605|FG006|Phase 2|Lost to Follow-up|0|||
126296333|NCT00460603|454372606|FG007|Phase 2|Lost to Follow-up|0|||
126296334|NCT00460603|454372607|FG008|Phase 2|Lost to Follow-up|0|||
126296335|NCT00460603|454372608|FG009|Phase 2|Lost to Follow-up|1|||
126296336|NCT00460603|454372609|FG010|Phase 2|Lost to Follow-up|0|||
126296337|NCT00460603|454372610|FG011|Phase 2|Lost to Follow-up|0|||
126296338|NCT00460603|454372599|FG000|Phase 2|Other|0|||
126101073|NCT00484289|453664148|FG000|Long Term Phase|Other Reason|0|||
126101074|NCT00484289|453664149|FG001|Long Term Phase|Other Reason|5|||
126101075|NCT00484289|453664150|FG002|Long Term Phase|Other Reason|1|||
126101076|NCT00484289|453664148|FG000|Post Marketing Phase|Adverse Event|0|||
126101077|NCT00484289|453664149|FG001|Post Marketing Phase|Adverse Event|1|||
126101078|NCT00484289|453664150|FG002|Post Marketing Phase|Adverse Event|0|||
126101079|NCT02349425|453664151|FG000|Period 1|Adverse Event|1|||
126101080|NCT02349425|453664152|FG001|Period 1|Adverse Event|1|||
126101081|NCT02349425|453664153|FG002|Period 1|Adverse Event|0|||
126101082|NCT02349425|453664154|FG003|Period 1|Adverse Event|0|||
126101083|NCT02349425|453664151|FG000|Period 2|Adverse Event|0|||
126101084|NCT02349425|453664152|FG001|Period 2|Adverse Event|1|||
126101085|NCT02349425|453664153|FG002|Period 2|Adverse Event|1|||
126101086|NCT02349425|453664154|FG003|Period 2|Adverse Event|0|||
126101087|NCT01403610|453664155|FG000|Overall Study|Withdrawal by Subject|2|||
126101088|NCT01403610|453664156|FG001|Overall Study|Withdrawal by Subject|0|||
126101089|NCT01403610|453664157|FG002|Overall Study|Withdrawal by Subject|0|||
126101090|NCT01403610|453664158|FG003|Overall Study|Withdrawal by Subject|0|||
126101091|NCT01403610|453664155|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
126101092|NCT01403610|453664156|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
126101093|NCT01403610|453664157|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
126101094|NCT01403610|453664158|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
126101095|NCT00876928|453664159|FG000|Overall Study|Lost to Follow-up|2|||
126101096|NCT00876928|453664160|FG001|Overall Study|Lost to Follow-up|5|||
126101097|NCT00876928|453664159|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
126101098|NCT00876928|453664160|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
126101099|NCT00686725|453664163|FG000|Overall Study|Adverse Event|1|||
126101100|NCT00686725|453664164|FG001|Overall Study|Adverse Event|1|||
126101101|NCT00686725|453664163|FG000|Overall Study|Progressive Disease|17|||
126101102|NCT00686725|453664164|FG001|Overall Study|Progressive Disease|23|||
126101103|NCT00686725|453664163|FG000|Overall Study|Lost to Follow-up|7|||
126101104|NCT00686725|453664164|FG001|Overall Study|Lost to Follow-up|5|||
126101105|NCT00686725|453664163|FG000|Overall Study|Death|6|||
126101106|NCT00686725|453664164|FG001|Overall Study|Death|3|||
126101107|NCT00686725|453664163|FG000|Overall Study|Withdrawal by Subject|13|||
126296339|NCT00460603|454372600|FG001|Phase 2|Other|0|||
126296340|NCT00460603|454372601|FG002|Phase 2|Other|0|||
126296341|NCT00460603|454372602|FG003|Phase 2|Other|0|||
126296342|NCT00460603|454372603|FG004|Phase 2|Other|0|||
126296343|NCT00460603|454372604|FG005|Phase 2|Other|0|||
126296344|NCT00460603|454372605|FG006|Phase 2|Other|0|||
126296345|NCT00460603|454372606|FG007|Phase 2|Other|0|||
126101108|NCT00686725|453664164|FG001|Overall Study|Withdrawal by Subject|4|||
126296346|NCT00460603|454372607|FG008|Phase 2|Other|0|||
126296347|NCT00460603|454372608|FG009|Phase 2|Other|6|||
126296348|NCT00460603|454372609|FG010|Phase 2|Other|16|||
126296349|NCT00460603|454372610|FG011|Phase 2|Other|7|||
126296350|NCT00460603|454372599|FG000|Phase 2|Objective Progression or Relapse|0|||
126296351|NCT00460603|454372600|FG001|Phase 2|Objective Progression or Relapse|0|||
126296352|NCT00460603|454372601|FG002|Phase 2|Objective Progression or Relapse|0|||
126101109|NCT00686725|453664163|FG000|Overall Study|Protocol Violation|1|||
126101110|NCT00686725|453664164|FG001|Overall Study|Protocol Violation|3|||
126101111|NCT00686725|453664163|FG000|Overall Study|Other|1|||
126101112|NCT00686725|453664164|FG001|Overall Study|Other|3|||
126101113|NCT03064035|453664167|FG000|Overall Study|Did not receive allocated intervention|4|||
126101114|NCT03064035|453664168|FG001|Overall Study|Did not receive allocated intervention|2|||
126296353|NCT00460603|454372602|FG003|Phase 2|Objective Progression or Relapse|0|||
126296354|NCT00460603|454372603|FG004|Phase 2|Objective Progression or Relapse|0|||
126296355|NCT00460603|454372604|FG005|Phase 2|Objective Progression or Relapse|0|||
126296356|NCT00460603|454372605|FG006|Phase 2|Objective Progression or Relapse|0|||
126296357|NCT00460603|454372606|FG007|Phase 2|Objective Progression or Relapse|0|||
126296358|NCT00460603|454372607|FG008|Phase 2|Objective Progression or Relapse|0|||
126296359|NCT00460603|454372608|FG009|Phase 2|Objective Progression or Relapse|9|||
126101115|NCT03064035|453664167|FG000|Overall Study|Lost to Follow-up|1|||
126101116|NCT03064035|453664168|FG001|Overall Study|Lost to Follow-up|1|||
126296360|NCT00460603|454372609|FG010|Phase 2|Objective Progression or Relapse|10|||
126296361|NCT00460603|454372610|FG011|Phase 2|Objective Progression or Relapse|17|||
126296362|NCT00460603|454372599|FG000|Phase 2|Global Deterioration of Health Status|0|||
126296363|NCT00460603|454372600|FG001|Phase 2|Global Deterioration of Health Status|0|||
126296364|NCT00460603|454372601|FG002|Phase 2|Global Deterioration of Health Status|0|||
126296365|NCT00460603|454372602|FG003|Phase 2|Global Deterioration of Health Status|0|||
126296366|NCT00460603|454372603|FG004|Phase 2|Global Deterioration of Health Status|0|||
126296367|NCT00460603|454372604|FG005|Phase 2|Global Deterioration of Health Status|0|||
126296368|NCT00460603|454372605|FG006|Phase 2|Global Deterioration of Health Status|0|||
125883438|NCT00068692|452871472|FG006|Step 2: Randomization|Physician Decision|0|||
125883439|NCT00068692|452871473|FG007|Step 2: Randomization|Physician Decision|0|||
126042731|NCT04999111|453454697|FG003|Overall Study|Non-compliance with study schedule|1|||
126042732|NCT04999111|453454698|FG004|Overall Study|Non-compliance with study schedule|1|||
126042733|NCT04999111|453454699|FG005|Overall Study|Non-compliance with study schedule|1|||
126042734|NCT04999111|453454694|FG000|Overall Study|Randomized but not vaccinated|1|||
126042735|NCT04999111|453454695|FG001|Overall Study|Randomized but not vaccinated|2|||
126042736|NCT04999111|453454696|FG002|Overall Study|Randomized but not vaccinated|0|||
126042737|NCT04999111|453454697|FG003|Overall Study|Randomized but not vaccinated|3|||
126042738|NCT04999111|453454698|FG004|Overall Study|Randomized but not vaccinated|3|||
126042739|NCT04999111|453454699|FG005|Overall Study|Randomized but not vaccinated|0|||
126042740|NCT04999111|453454694|FG000|Overall Study|Adverse Event|1|||
126042741|NCT04999111|453454695|FG001|Overall Study|Adverse Event|1|||
126042742|NCT04999111|453454696|FG002|Overall Study|Adverse Event|0|||
126042743|NCT04999111|453454697|FG003|Overall Study|Adverse Event|0|||
126042744|NCT04999111|453454698|FG004|Overall Study|Adverse Event|0|||
126042745|NCT04999111|453454699|FG005|Overall Study|Adverse Event|0|||
126042746|NCT04999111|453454694|FG000|Overall Study|Initiated prohibited medication|0|||
126042747|NCT04999111|453454695|FG001|Overall Study|Initiated prohibited medication|0|||
126042748|NCT04999111|453454696|FG002|Overall Study|Initiated prohibited medication|0|||
126042749|NCT04999111|453454697|FG003|Overall Study|Initiated prohibited medication|0|||
126042750|NCT04999111|453454698|FG004|Overall Study|Initiated prohibited medication|1|||
126042751|NCT04999111|453454699|FG005|Overall Study|Initiated prohibited medication|0|||
126042752|NCT02056834|453454700|FG000|Overall Study|Lost to Follow-up|7|||
126042753|NCT03926130|453454701|FG000|Overall Study|Adverse Event|9|||
126042754|NCT03926130|453454702|FG001|Overall Study|Adverse Event|11|||
126042755|NCT03926130|453454703|FG002|Overall Study|Adverse Event|2|||
126042756|NCT03926130|453454704|FG003|Overall Study|Adverse Event|0|||
126042757|NCT03926130|453454701|FG000|Overall Study|Death|2|||
126042758|NCT03926130|453454702|FG001|Overall Study|Death|0|||
126042759|NCT03926130|453454703|FG002|Overall Study|Death|1|||
126042760|NCT03926130|453454704|FG003|Overall Study|Death|0|||
126042761|NCT03926130|453454701|FG000|Overall Study|Lack of Efficacy|14|||
126042762|NCT03926130|453454702|FG001|Overall Study|Lack of Efficacy|11|||
126042763|NCT03926130|453454703|FG002|Overall Study|Lack of Efficacy|7|||
126042764|NCT03926130|453454704|FG003|Overall Study|Lack of Efficacy|1|||
126042765|NCT03926130|453454701|FG000|Overall Study|Lost to Follow-up|0|||
126042766|NCT03926130|453454702|FG001|Overall Study|Lost to Follow-up|7|||
126042767|NCT03926130|453454703|FG002|Overall Study|Lost to Follow-up|1|||
126042768|NCT03926130|453454704|FG003|Overall Study|Lost to Follow-up|0|||
126042769|NCT03926130|453454701|FG000|Overall Study|As Reported by Investigator|2|||
126042770|NCT03926130|453454702|FG001|Overall Study|As Reported by Investigator|6|||
126042771|NCT03926130|453454703|FG002|Overall Study|As Reported by Investigator|6|||
126042772|NCT03926130|453454704|FG003|Overall Study|As Reported by Investigator|0|||
126042773|NCT03926130|453454701|FG000|Overall Study|Physician Decision|3|||
126042774|NCT03926130|453454702|FG001|Overall Study|Physician Decision|2|||
126042775|NCT03926130|453454703|FG002|Overall Study|Physician Decision|1|||
126042776|NCT03926130|453454704|FG003|Overall Study|Physician Decision|0|||
126042777|NCT03926130|453454701|FG000|Overall Study|Pregnancy|2|||
126042778|NCT03926130|453454702|FG001|Overall Study|Pregnancy|2|||
126042779|NCT03926130|453454703|FG002|Overall Study|Pregnancy|1|||
126042780|NCT03926130|453454704|FG003|Overall Study|Pregnancy|0|||
126042781|NCT03926130|453454701|FG000|Overall Study|Withdrawal by Subject|20|||
126042782|NCT03926130|453454702|FG001|Overall Study|Withdrawal by Subject|28|||
126042783|NCT03926130|453454703|FG002|Overall Study|Withdrawal by Subject|18|||
126042784|NCT03926130|453454704|FG003|Overall Study|Withdrawal by Subject|1|||
126042785|NCT03926130|453454701|FG000|Overall Study|Non-Compliance|1|||
126042786|NCT03926130|453454702|FG001|Overall Study|Non-Compliance|1|||
126042787|NCT03926130|453454703|FG002|Overall Study|Non-Compliance|0|||
126042788|NCT03926130|453454704|FG003|Overall Study|Non-Compliance|0|||
126042789|NCT03926130|453454701|FG000|Overall Study|Disposition Not Captured|0|||
126042790|NCT03926130|453454702|FG001|Overall Study|Disposition Not Captured|2|||
126042791|NCT03926130|453454703|FG002|Overall Study|Disposition Not Captured|1|||
126042792|NCT03926130|453454704|FG003|Overall Study|Disposition Not Captured|0|||
126296369|NCT00460603|454372606|FG007|Phase 2|Global Deterioration of Health Status|0|||
126296370|NCT00460603|454372607|FG008|Phase 2|Global Deterioration of Health Status|0|||
126042793|NCT03583333|453454705|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
126042794|NCT03583333|453454706|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
126101117|NCT03103763|453664169|FG000|Overall Study|Death|15|||
126101118|NCT03103763|453664170|FG001|Overall Study|Death|5|||
126101119|NCT03103763|453664171|FG002|Overall Study|Death|5|||
126101120|NCT03103763|453664169|FG000|Overall Study|Withdrawal by Subject|0|||
126296371|NCT00460603|454372608|FG009|Phase 2|Global Deterioration of Health Status|0|||
126101121|NCT03103763|453664170|FG001|Overall Study|Withdrawal by Subject|3|||
126101122|NCT03103763|453664171|FG002|Overall Study|Withdrawal by Subject|2|||
126101123|NCT01143038|453664172|FG000|Overall Study|Withdrawal by Subject|4|||
126101124|NCT01143038|453664172|FG000|Overall Study|Requirement for alternative therapy|5|||
126101125|NCT01143038|453664172|FG000|Overall Study|Adverse Event|3|||
126101126|NCT01143038|453664172|FG000|Overall Study|Lost to Follow-up|2|||
126296372|NCT00460603|454372609|FG010|Phase 2|Global Deterioration of Health Status|1|||
126296373|NCT00460603|454372610|FG011|Phase 2|Global Deterioration of Health Status|0|||
126296374|NCT00460603|454372599|FG000|Phase 2|Withdrawal by Subject|0|||
126296375|NCT00460603|454372600|FG001|Phase 2|Withdrawal by Subject|0|||
126296376|NCT00460603|454372601|FG002|Phase 2|Withdrawal by Subject|0|||
126296377|NCT00460603|454372602|FG003|Phase 2|Withdrawal by Subject|0|||
126296378|NCT00460603|454372603|FG004|Phase 2|Withdrawal by Subject|0|||
126296379|NCT00460603|454372604|FG005|Phase 2|Withdrawal by Subject|0|||
126296380|NCT00460603|454372605|FG006|Phase 2|Withdrawal by Subject|0|||
126296381|NCT00460603|454372606|FG007|Phase 2|Withdrawal by Subject|0|||
126296382|NCT00460603|454372607|FG008|Phase 2|Withdrawal by Subject|0|||
126296383|NCT00460603|454372608|FG009|Phase 2|Withdrawal by Subject|5|||
126296384|NCT00460603|454372609|FG010|Phase 2|Withdrawal by Subject|4|||
126296385|NCT00460603|454372610|FG011|Phase 2|Withdrawal by Subject|5|||
126296386|NCT00460603|454372599|FG000|Phase 2|Randomized, but not treated|0|||
126296387|NCT00460603|454372600|FG001|Phase 2|Randomized, but not treated|0|||
126296388|NCT00460603|454372601|FG002|Phase 2|Randomized, but not treated|0|||
126296389|NCT00460603|454372602|FG003|Phase 2|Randomized, but not treated|0|||
125883440|NCT00068692|452871466|FG000|Step 2: Randomization|Other|0|||
126101127|NCT01143038|453664172|FG000|Overall Study|Protocol Deviation|1|||
126101128|NCT01143038|453664172|FG000|Overall Study|Death|1|||
126101129|NCT01970345|453664173|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
126101130|NCT01970345|453664174|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
126101131|NCT01970345|453664173|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
126101132|NCT01970345|453664174|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
126101133|NCT00558259|453664179|FG000|Overall Study|Adverse Event|50|||
126101134|NCT00558259|453664180|FG001|Overall Study|Adverse Event|81|||
126101135|NCT00558259|453664179|FG000|Overall Study|Protocol Violation|9|||
126101136|NCT00558259|453664180|FG001|Overall Study|Protocol Violation|5|||
126101137|NCT00558259|453664179|FG000|Overall Study|Withdrawal by Subject|12|||
126101138|NCT00558259|453664180|FG001|Overall Study|Withdrawal by Subject|13|||
126101139|NCT02874924|453664181|FG000|Overall Study|Adverse Event|2|||
126101140|NCT02874924|453664182|FG001|Overall Study|Adverse Event|0|||
126101141|NCT02874924|453664183|FG002|Overall Study|Adverse Event|0|||
126101142|NCT02874924|453664181|FG000|Overall Study|Withdrawal by Subject|1|||
126101143|NCT02874924|453664182|FG001|Overall Study|Withdrawal by Subject|0|||
126101144|NCT02874924|453664183|FG002|Overall Study|Withdrawal by Subject|0|||
126101145|NCT00321373|453664188|FG000|Overall Study|Adverse Event|0|||
126101146|NCT00321373|453664189|FG001|Overall Study|Adverse Event|0|||
126101147|NCT00321373|453664190|FG002|Overall Study|Adverse Event|1|||
126101148|NCT00321373|453664188|FG000|Overall Study|Lost to Follow-up|1|||
126101149|NCT00321373|453664189|FG001|Overall Study|Lost to Follow-up|0|||
126101150|NCT00321373|453664190|FG002|Overall Study|Lost to Follow-up|1|||
126101151|NCT00321373|453664188|FG000|Overall Study|Withdrawal by Subject|1|||
126101152|NCT00321373|453664189|FG001|Overall Study|Withdrawal by Subject|0|||
126101153|NCT00321373|453664190|FG002|Overall Study|Withdrawal by Subject|0|||
126101154|NCT00321373|453664188|FG000|Overall Study|Other|0|||
126101155|NCT00321373|453664189|FG001|Overall Study|Other|0|||
126101156|NCT00321373|453664190|FG002|Overall Study|Other|1|||
126101157|NCT00552240|453664197|FG000|Overall Study|Adverse Event|9|||
126101158|NCT00552240|453664198|FG001|Overall Study|Adverse Event|9|||
126101159|NCT00552240|453664197|FG000|Overall Study|Protocol Violation|1|||
126101160|NCT00552240|453664198|FG001|Overall Study|Protocol Violation|1|||
126101161|NCT00552240|453664197|FG000|Overall Study|Lost to Follow-up|5|||
126101162|NCT00552240|453664198|FG001|Overall Study|Lost to Follow-up|6|||
126101163|NCT00552240|453664197|FG000|Overall Study|Withdrawal by Subject|2|||
126101164|NCT00552240|453664198|FG001|Overall Study|Withdrawal by Subject|2|||
126296390|NCT00460603|454372603|FG004|Phase 2|Randomized, but not treated|0|||
126296391|NCT00460603|454372604|FG005|Phase 2|Randomized, but not treated|0|||
126101165|NCT00552240|453664197|FG000|Overall Study|Lack of Efficacy|6|||
126101166|NCT00552240|453664198|FG001|Overall Study|Lack of Efficacy|0|||
126296392|NCT00460603|454372605|FG006|Phase 2|Randomized, but not treated|0|||
126296393|NCT00460603|454372606|FG007|Phase 2|Randomized, but not treated|0|||
126296394|NCT00460603|454372607|FG008|Phase 2|Randomized, but not treated|0|||
126101167|NCT00552240|453664197|FG000|Overall Study|Other|1|||
126101168|NCT00552240|453664198|FG001|Overall Study|Other|0|||
126101169|NCT02783768|453664199|FG000|Overall Study|Lost to Follow-up|1|||
126101170|NCT02783768|453664200|FG001|Overall Study|Lost to Follow-up|0|||
126101171|NCT01323647|453664201|FG000|Overall Study|Migrated/moved from study area|2|||
126101172|NCT01323647|453664202|FG001|Overall Study|Migrated/moved from study area|0|||
126101173|NCT01323647|453664201|FG000|Overall Study|Withdrawal by Subject|5|||
126101174|NCT01323647|453664202|FG001|Overall Study|Withdrawal by Subject|0|||
126101175|NCT01323647|453664201|FG000|Overall Study|Lost to Follow-up|2|||
126101176|NCT01323647|453664202|FG001|Overall Study|Lost to Follow-up|0|||
126101177|NCT01236339|453664210|FG000|Overall Study|Termination of study by sponsor|11|||
126296395|NCT00460603|454372608|FG009|Phase 2|Randomized, but not treated|3|||
126296396|NCT00460603|454372609|FG010|Phase 2|Randomized, but not treated|0|||
126296397|NCT00460603|454372610|FG011|Phase 2|Randomized, but not treated|0|||
126296398|NCT00513240|454372611|FG000|Overall Study|Did not have intended surgery|3|||
126296399|NCT00513240|454372612|FG001|Overall Study|Did not have intended surgery|0|||
126296400|NCT00513240|454372611|FG000|Overall Study|Death|3|||
126296401|NCT00513240|454372612|FG001|Overall Study|Death|3|||
126296402|NCT00513240|454372611|FG000|Overall Study|Withdrawal by Subject|7|||
126296403|NCT00513240|454372612|FG001|Overall Study|Withdrawal by Subject|4|||
126101178|NCT01236339|453664211|FG001|Overall Study|Termination of study by sponsor|13|||
126101179|NCT02054741|453664212|FG000|Overall Study|Protocol Violation|13|||
126101180|NCT02054741|453664213|FG001|Overall Study|Protocol Violation|2|||
126101181|NCT02054741|453664212|FG000|Overall Study|Withdrawal by Subject|10|||
126101182|NCT02054741|453664213|FG001|Overall Study|Withdrawal by Subject|5|||
126101183|NCT02054741|453664212|FG000|Overall Study|Death|94|||
126101184|NCT02054741|453664213|FG001|Overall Study|Death|90|||
126101185|NCT02054741|453664212|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
126101186|NCT02054741|453664213|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
126296404|NCT05263908|454372613|FG000|Overall Study|No informed consent for publication of study results|397|||
126296405|NCT05263908|454372613|FG000|Overall Study|CRF not collected|1|||
126296406|NCT00289848|454372615|FG000|Overall Study|Adverse Event|6|||
126296407|NCT00289848|454372616|FG001|Overall Study|Adverse Event|4|||
126296408|NCT00289848|454372615|FG000|Overall Study|Death|1|||
126296409|NCT00289848|454372616|FG001|Overall Study|Death|0|||
126296410|NCT00289848|454372615|FG000|Overall Study|Lack of Efficacy|20|||
126296411|NCT00289848|454372616|FG001|Overall Study|Lack of Efficacy|24|||
126296412|NCT00289848|454372615|FG000|Overall Study|Lost to Follow-up|3|||
126296413|NCT00289848|454372616|FG001|Overall Study|Lost to Follow-up|1|||
126296414|NCT00289848|454372615|FG000|Overall Study|Protocol Violation|5|||
126296415|NCT00289848|454372616|FG001|Overall Study|Protocol Violation|2|||
126296416|NCT00289848|454372615|FG000|Overall Study|Withdrawal by Subject|5|||
126296417|NCT00289848|454372616|FG001|Overall Study|Withdrawal by Subject|11|||
126296418|NCT00289848|454372615|FG000|Overall Study|Patient Moved|6|||
126296419|NCT00289848|454372616|FG001|Overall Study|Patient Moved|2|||
126296420|NCT00289848|454372615|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
126296421|NCT00289848|454372616|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
126296422|NCT03871543|454372619|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
126296423|NCT03871543|454372619|FG000|Period 1|Investigator Error|1|||
126296424|NCT03871543|454372619|FG000|Period 1|Protocol Violation|2|||
126296425|NCT03871543|454372619|FG000|Period 1|COVID-19 Related|1|||
126296426|NCT03871543|454372619|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
126296427|NCT03871543|454372619|FG000|Period 1|Withdrawal by Subject|10|||
126296428|NCT03871543|454372619|FG000|Period 2|Adverse Event|1|||
126296429|NCT03871543|454372619|FG000|Period 2|Withdrawal by Subject|1|||
126296430|NCT01930162|454372621|FG000|Overall Study|Abnormal test procedure result(s)|4|||
126296431|NCT01930162|454372621|FG000|Overall Study|Death|1|||
126296432|NCT02069015|454372623|FG000|Overall Study|Lost to Follow-up|39|||
126101187|NCT01945060|453664217|FG000|Overall Study|Lost to follow up|1|||
126101188|NCT01945060|453664218|FG001|Overall Study|Lost to follow up|0|||
126101189|NCT01945060|453664217|FG000|Overall Study|Distress related to IV access|0|||
126101190|NCT01945060|453664218|FG001|Overall Study|Distress related to IV access|1|||
126101191|NCT00402597|453664219|FG000|Overall Study|Death|15|||
126101192|NCT00402597|453664220|FG001|Overall Study|Death|7|||
126101193|NCT00402597|453664221|FG002|Overall Study|Death|6|||
126101194|NCT00402597|453664222|FG003|Overall Study|Death|4|||
126101195|NCT00402597|453664223|FG004|Overall Study|Death|6|||
126101196|NCT00402597|453664219|FG000|Overall Study|Adverse Event|81|||
126101197|NCT00402597|453664220|FG001|Overall Study|Adverse Event|18|||
126296433|NCT02069015|454372624|FG001|Overall Study|Lost to Follow-up|32|||
126296434|NCT02069015|454372623|FG000|Overall Study|Withdrawal by Subject|1|||
126296435|NCT02069015|454372624|FG001|Overall Study|Withdrawal by Subject|1|||
126296436|NCT00031590|454372625|FG000|Overall Study|Adverse Event|1|||
126296437|NCT00031590|454372625|FG000|Overall Study|Withdrawal by parents|2|||
126296438|NCT00586703|454372630|FG000|Overall Study|Death|12|||
126296439|NCT00765102|454372631|FG000|Overall Study|Progressive disease|18|||
126101198|NCT00402597|453664221|FG002|Overall Study|Adverse Event|106|||
126101199|NCT00402597|453664222|FG003|Overall Study|Adverse Event|39|||
126296440|NCT00765102|454372631|FG000|Overall Study|Adverse Event|6|||
126296441|NCT00765102|454372631|FG000|Overall Study|Physician Decision|4|||
126101200|NCT00402597|453664223|FG004|Overall Study|Adverse Event|71|||
126101201|NCT00402597|453664219|FG000|Overall Study|Lost to Follow-up|8|||
126296442|NCT00765102|454372631|FG000|Overall Study|Withdrawal by Subject|2|||
126296443|NCT00765102|454372631|FG000|Overall Study|Protocol Violation|1|||
126296444|NCT02857816|454372632|FG000|Overall Study|Screen Failure|33|||
126296445|NCT02857816|454372632|FG000|Overall Study|Withdrawal by Subject|4|||
126296446|NCT02857816|454372632|FG000|Overall Study|Lost to Follow-up|1|||
126296447|NCT02723344|454372635|FG000|Overall Study|Lost to Follow-up|0|||
126296448|NCT02723344|454372636|FG001|Overall Study|Lost to Follow-up|4|||
126296449|NCT02964247|454372638|FG000|Overall Study|Lost to Follow-up|2|||
126296450|NCT02964247|454372639|FG001|Overall Study|Lost to Follow-up|0|||
126296451|NCT02964247|454372638|FG000|Overall Study|Withdrawal by Subject|1|||
126296452|NCT02964247|454372639|FG001|Overall Study|Withdrawal by Subject|2|||
126296453|NCT01709500|454372640|FG000|Overall Study|Randomized but not treated|0|||
126296454|NCT01709500|454372641|FG001|Overall Study|Randomized but not treated|1|||
126296455|NCT01709500|454372640|FG000|Overall Study|Adverse Event|5|||
126296456|NCT01709500|454372641|FG001|Overall Study|Adverse Event|1|||
126296457|NCT01709500|454372640|FG000|Overall Study|Poor compliance to protocol|2|||
126101202|NCT00402597|453664220|FG001|Overall Study|Lost to Follow-up|1|||
126101203|NCT00402597|453664221|FG002|Overall Study|Lost to Follow-up|8|||
126101204|NCT00402597|453664222|FG003|Overall Study|Lost to Follow-up|2|||
126101205|NCT00402597|453664223|FG004|Overall Study|Lost to Follow-up|3|||
126101206|NCT00402597|453664219|FG000|Overall Study|Withdrawal by Subject|57|||
126101207|NCT00402597|453664220|FG001|Overall Study|Withdrawal by Subject|16|||
126101208|NCT00402597|453664221|FG002|Overall Study|Withdrawal by Subject|65|||
126101209|NCT00402597|453664222|FG003|Overall Study|Withdrawal by Subject|15|||
126101210|NCT00402597|453664223|FG004|Overall Study|Withdrawal by Subject|24|||
126101211|NCT00402597|453664219|FG000|Overall Study|reason not specified|30|||
126101212|NCT00402597|453664220|FG001|Overall Study|reason not specified|4|||
126101213|NCT00402597|453664221|FG002|Overall Study|reason not specified|27|||
126101214|NCT00402597|453664222|FG003|Overall Study|reason not specified|14|||
126101215|NCT00402597|453664223|FG004|Overall Study|reason not specified|20|||
126296458|NCT01709500|454372641|FG001|Overall Study|Poor compliance to protocol|1|||
126296459|NCT01709500|454372640|FG000|Overall Study|Other|3|||
126296460|NCT01709500|454372641|FG001|Overall Study|Other|1|||
126296461|NCT01709500|454372640|FG000|Overall Study|Related to IMP administration|1|||
126296462|NCT01709500|454372641|FG001|Overall Study|Related to IMP administration|0|||
126296463|NCT01709500|454372640|FG000|Overall Study|Treatment ongoing|156|||
126296464|NCT01709500|454372641|FG001|Overall Study|Treatment ongoing|78|||
126296465|NCT01609790|454372642|FG000|Overall Study|Protocol Violation|1|||
126296466|NCT01609790|454372643|FG001|Overall Study|Protocol Violation|7|||
126296467|NCT01609790|454372644|FG002|Overall Study|Protocol Violation|8|||
126296468|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Adverse Event|7|||
126296469|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
126296470|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Non-compliance|3|||
126296471|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Other|17|||
126296472|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Physician Decision|2|||
126296473|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Pregnancy|1|||
126296474|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
126296475|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
126296476|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
126296477|NCT05207865|454373908|FG000|Follow-up Phase|Lost to Follow-up|1|||
126296478|NCT05207865|454373908|FG000|Follow-up Phase|Non-compliance|1|||
126296479|NCT05207865|454373908|FG000|Follow-up Phase|Not reported|2|||
126296480|NCT05207865|454373908|FG000|Follow-up Phase|Not collected|11|||
126296481|NCT00739882|454373911|FG000|Double-blind Period|Adverse Event|1|||
126296482|NCT00739882|454373912|FG001|Double-blind Period|Adverse Event|2|||
126296483|NCT00739882|454373911|FG000|Double-blind Period|Protocol Violation|1|||
126296484|NCT00739882|454373912|FG001|Double-blind Period|Protocol Violation|0|||
126296485|NCT00739882|454373911|FG000|Double-blind Period|Lack of Efficacy|1|||
126296486|NCT00739882|454373912|FG001|Double-blind Period|Lack of Efficacy|1|||
126296487|NCT00739882|454373911|FG000|Double-blind Period|Other|16|||
126296488|NCT00739882|454373912|FG001|Double-blind Period|Other|8|||
126101216|NCT02319525|453664225|FG000|Overall Study|Withdrawal by Subject|2|||
126101217|NCT02319525|453664226|FG001|Overall Study|Withdrawal by Subject|1|||
126101218|NCT00336895|453664227|FG000|Overall Study|diarrhea|1|||
126101219|NCT00336895|453664227|FG000|Overall Study|nausea and upset stomach|1|||
126101220|NCT00336895|453664227|FG000|Overall Study|Physician Decision|1|||
126101221|NCT00336895|453664227|FG000|Overall Study|screen failed|1|||
126101222|NCT00598273|453664231|FG000|Overall Study|Adverse Event|4|||
126101223|NCT00598273|453664232|FG001|Overall Study|Adverse Event|5|||
126101224|NCT00598273|453664233|FG002|Overall Study|Adverse Event|2|||
126101225|NCT00598273|453664231|FG000|Overall Study|Death|6|||
126296489|NCT00739882|454373911|FG000|Open-label Period|Adverse Event|1|||
126296490|NCT00739882|454373912|FG001|Open-label Period|Adverse Event|0|||
126101226|NCT00598273|453664232|FG001|Overall Study|Death|12|||
126296491|NCT00739882|454373911|FG000|Open-label Period|Other|9|||
126296492|NCT00739882|454373912|FG001|Open-label Period|Other|5|||
126101227|NCT00598273|453664233|FG002|Overall Study|Death|8|||
126101228|NCT00598273|453664231|FG000|Overall Study|Lost to Follow-up|8|||
126101229|NCT00598273|453664232|FG001|Overall Study|Lost to Follow-up|3|||
126101230|NCT00598273|453664233|FG002|Overall Study|Lost to Follow-up|5|||
126101231|NCT00598273|453664231|FG000|Overall Study|Physician Decision|0|||
126101232|NCT00598273|453664232|FG001|Overall Study|Physician Decision|0|||
126101233|NCT00598273|453664233|FG002|Overall Study|Physician Decision|1|||
126101234|NCT00598273|453664231|FG000|Overall Study|Withdrawal by Subject|12|||
126101235|NCT00598273|453664232|FG001|Overall Study|Withdrawal by Subject|10|||
126101236|NCT00598273|453664233|FG002|Overall Study|Withdrawal by Subject|10|||
126101237|NCT00598273|453664231|FG000|Overall Study|Noncompliance|3|||
126101238|NCT00598273|453664232|FG001|Overall Study|Noncompliance|2|||
126101239|NCT00598273|453664233|FG002|Overall Study|Noncompliance|3|||
126101240|NCT00598273|453664231|FG000|Overall Study|Relocation|0|||
126101241|NCT00598273|453664232|FG001|Overall Study|Relocation|2|||
126101242|NCT00598273|453664233|FG002|Overall Study|Relocation|4|||
126101243|NCT00598273|453664231|FG000|Overall Study|Renal transplant|1|||
126101244|NCT00598273|453664232|FG001|Overall Study|Renal transplant|0|||
126101245|NCT00598273|453664233|FG002|Overall Study|Renal transplant|1|||
126101246|NCT00598273|453664231|FG000|Overall Study|Site elected to close|1|||
126101247|NCT00598273|453664232|FG001|Overall Study|Site elected to close|0|||
126101248|NCT00598273|453664233|FG002|Overall Study|Site elected to close|0|||
126101249|NCT00598273|453664231|FG000|Overall Study|Started dialysis|6|||
126101250|NCT00598273|453664232|FG001|Overall Study|Started dialysis|4|||
126101251|NCT00598273|453664233|FG002|Overall Study|Started dialysis|5|||
126101252|NCT03426605|453664234|FG000|Overall Study|AML relapse or progression|2|||
126101253|NCT03426605|453664235|FG001|Overall Study|AML relapse or progression|1|||
126101254|NCT03426605|453664236|FG002|Overall Study|AML relapse or progression|2|||
126101255|NCT03426605|453664237|FG003|Overall Study|AML relapse or progression|2|||
126101256|NCT03426605|453664234|FG000|Overall Study|Treatment failure|3|||
126101257|NCT03426605|453664235|FG001|Overall Study|Treatment failure|2|||
126101258|NCT03426605|453664236|FG002|Overall Study|Treatment failure|0|||
126101259|NCT03426605|453664237|FG003|Overall Study|Treatment failure|0|||
126101260|NCT03426605|453664234|FG000|Overall Study|Adverse Event|1|||
126101261|NCT03426605|453664235|FG001|Overall Study|Adverse Event|0|||
126101262|NCT03426605|453664236|FG002|Overall Study|Adverse Event|1|||
126101263|NCT03426605|453664237|FG003|Overall Study|Adverse Event|1|||
126101264|NCT03426605|453664234|FG000|Overall Study|Withdrawal by Subject|0|||
126101265|NCT03426605|453664235|FG001|Overall Study|Withdrawal by Subject|0|||
126101266|NCT03426605|453664236|FG002|Overall Study|Withdrawal by Subject|1|||
126101267|NCT03426605|453664237|FG003|Overall Study|Withdrawal by Subject|1|||
126101268|NCT01535560|453664241|FG000|Overall Study|Adverse Event|12|||
126101269|NCT01535560|453664242|FG001|Overall Study|Adverse Event|7|||
126101270|NCT01535560|453664241|FG000|Overall Study|Lost to Follow-up|1|||
126101271|NCT01535560|453664242|FG001|Overall Study|Lost to Follow-up|3|||
126101272|NCT01535560|453664241|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
126101273|NCT01535560|453664242|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
126101274|NCT01535560|453664241|FG000|Overall Study|Treatment Failure|21|||
126101275|NCT01535560|453664242|FG001|Overall Study|Treatment Failure|83|||
126101276|NCT01535560|453664241|FG000|Overall Study|Other|0|||
126101277|NCT01535560|453664242|FG001|Overall Study|Other|1|||
126101278|NCT01535560|453664241|FG000|Overall Study|Randomized in Error|0|||
126101279|NCT01535560|453664242|FG001|Overall Study|Randomized in Error|1|||
126101280|NCT02009761|453664243|FG000|Overall Study|Adverse Event|4|||
126101281|NCT03218397|453664244|FG000|Overall Study|Prior positive blood culture|8|||
126101282|NCT03218397|453664245|FG001|Overall Study|Prior positive blood culture|13|||
126101283|NCT03218397|453664244|FG000|Overall Study|Comfort care|8|||
126101284|NCT03218397|453664245|FG001|Overall Study|Comfort care|5|||
126101285|NCT03218397|453664244|FG000|Overall Study|Comfort care and positive blood culture|1|||
126101286|NCT03218397|453664245|FG001|Overall Study|Comfort care and positive blood culture|0|||
126101287|NCT03218397|453664244|FG000|Overall Study|Comfort care and mixed culture|0|||
126101288|NCT03218397|453664245|FG001|Overall Study|Comfort care and mixed culture|1|||
126101289|NCT03218397|453664244|FG000|Overall Study|Mixed culture|2|||
126101290|NCT03218397|453664245|FG001|Overall Study|Mixed culture|2|||
126101291|NCT03218397|453664244|FG000|Overall Study|Inaccessible hospital records|2|||
126101292|NCT03218397|453664245|FG001|Overall Study|Inaccessible hospital records|5|||
126101293|NCT03218397|453664244|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
126101294|NCT03218397|453664245|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
126101295|NCT03218397|453664244|FG000|Overall Study|Randomized during laboratory off hours|2|||
126101296|NCT03218397|453664245|FG001|Overall Study|Randomized during laboratory off hours|1|||
126101297|NCT00943111|453664246|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
126101298|NCT00943111|453664247|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
126101299|NCT00943111|453664248|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
126101300|NCT00943111|453664246|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
126101301|NCT00943111|453664247|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
126101302|NCT00943111|453664248|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
126101303|NCT00943111|453664246|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
126101304|NCT00943111|453664247|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
126101305|NCT00943111|453664248|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
126101306|NCT00943111|453664246|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
126101307|NCT00943111|453664247|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
126101308|NCT00943111|453664248|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
126296493|NCT05423093|454373913|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
126296494|NCT05423093|454373913|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
126101309|NCT00943111|453664246|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
126101310|NCT00943111|453664247|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
126101311|NCT00943111|453664248|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
126101312|NCT00943111|453664246|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
126101313|NCT00943111|453664247|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
126101314|NCT00943111|453664248|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
126296495|NCT05423093|454373913|FG000|Attended Intervention Session|Lost to Follow-up|3|||
126296496|NCT05423093|454373913|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
126296497|NCT05423093|454373913|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
126296498|NCT02445248|454373914|FG000|Overall Study|Death|45|||
126296499|NCT02445248|454373915|FG001|Overall Study|Death|12|||
126296500|NCT02445248|454373914|FG000|Overall Study|Progressive disease|13|||
126296501|NCT02445248|454373915|FG001|Overall Study|Progressive disease|1|||
126296502|NCT02445248|454373914|FG000|Overall Study|Subject decision|8|||
126296503|NCT02445248|454373915|FG001|Overall Study|Subject decision|0|||
126296504|NCT02445248|454373914|FG000|Overall Study|Physician Decision|5|||
126296505|NCT02445248|454373915|FG001|Overall Study|Physician Decision|0|||
126296506|NCT02445248|454373914|FG000|Overall Study|Adverse Event|1|||
126296507|NCT02445248|454373915|FG001|Overall Study|Adverse Event|0|||
126296508|NCT02445248|454373914|FG000|Overall Study|Lost to Follow-up|1|||
126296509|NCT02445248|454373915|FG001|Overall Study|Lost to Follow-up|0|||
126296510|NCT02596971|454373916|FG000|Overall Study|Death|5|||
126296511|NCT02596971|454373917|FG001|Overall Study|Death|1|||
126296512|NCT02596971|454373918|FG002|Overall Study|Death|5|||
126296513|NCT02596971|454373916|FG000|Overall Study|Withdrawal by Subject|5|||
126296514|NCT02596971|454373917|FG001|Overall Study|Withdrawal by Subject|1|||
126296515|NCT02596971|454373918|FG002|Overall Study|Withdrawal by Subject|4|||
126296516|NCT00595920|454373921|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
126296517|NCT03588910|454373922|FG000|Overall Study|Withdrawal by Subject|1|||
126296518|NCT03588910|454373923|FG001|Overall Study|Withdrawal by Subject|0|||
126296519|NCT03588910|454373922|FG000|Overall Study|Allergy|2|||
126296520|NCT03588910|454373923|FG001|Overall Study|Allergy|0|||
126296521|NCT03588910|454373922|FG000|Overall Study|Protocol Violation|0|||
126296522|NCT03588910|454373923|FG001|Overall Study|Protocol Violation|3|||
126296523|NCT03588910|454373922|FG000|Overall Study|Did not complete Day 1 Survey|5|||
126296524|NCT03588910|454373923|FG001|Overall Study|Did not complete Day 1 Survey|10|||
126296525|NCT03588910|454373922|FG000|Overall Study|Did not complete Day 7 Survey|5|||
126296526|NCT03588910|454373923|FG001|Overall Study|Did not complete Day 7 Survey|2|||
126296527|NCT04565145|454373924|FG000|Overall Study|Withdrawal by Subject|1|||
126296528|NCT04565145|454373925|FG001|Overall Study|Withdrawal by Subject|1|||
126296529|NCT04570670|454373926|FG000|Overall Study|Withdrawal by Subject|1|||
126296530|NCT04570670|454373927|FG001|Overall Study|Withdrawal by Subject|0|||
126296531|NCT00683618|454373928|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
126296532|NCT00683618|454373929|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
126296533|NCT00683618|454373930|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
126296534|NCT00683618|454373928|FG000|Randomised Treatment Period|Protocol Violation|0|||
126296535|NCT00683618|454373929|FG001|Randomised Treatment Period|Protocol Violation|1|||
126296536|NCT00683618|454373930|FG002|Randomised Treatment Period|Protocol Violation|0|||
126296537|NCT00683618|454373928|FG000|Randomised Treatment Period|Adverse Event|2|||
126296538|NCT00683618|454373929|FG001|Randomised Treatment Period|Adverse Event|0|||
126296539|NCT00683618|454373930|FG002|Randomised Treatment Period|Adverse Event|2|||
126296540|NCT00683618|454373928|FG000|Randomised Treatment Period|Reason not provided|0|||
126101315|NCT00943111|453664246|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
126101316|NCT00943111|453664247|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
126101317|NCT00943111|453664248|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
126101318|NCT00943111|453664246|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
126296541|NCT00683618|454373929|FG001|Randomised Treatment Period|Reason not provided|0|||
126296542|NCT00683618|454373930|FG002|Randomised Treatment Period|Reason not provided|2|||
126296543|NCT00683618|454373928|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
126296544|NCT00683618|454373929|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126296545|NCT00683618|454373930|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
126296546|NCT00683618|454373928|FG000|Extension Treatment Period|Adverse Event|1|||
126296547|NCT00683618|454373929|FG001|Extension Treatment Period|Adverse Event|0|||
126101319|NCT00943111|453664247|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
126101320|NCT00943111|453664248|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
126296548|NCT00683618|454373930|FG002|Extension Treatment Period|Adverse Event|0|||
126296549|NCT00683618|454373928|FG000|Extension Treatment Period|Protocol Violation|1|||
126296550|NCT00683618|454373929|FG001|Extension Treatment Period|Protocol Violation|0|||
126296551|NCT00683618|454373930|FG002|Extension Treatment Period|Protocol Violation|0|||
126296552|NCT03802825|454373932|FG000|Overall Study|Lost to follow-up for intervention|12|||
126296553|NCT03802825|454373933|FG001|Overall Study|Lost to follow-up for intervention|3|||
126296554|NCT03802825|454373932|FG000|Overall Study|Received only 1 component of intervention|0|||
125883441|NCT00068692|452871467|FG001|Step 2: Randomization|Other|0|||
125883442|NCT00068692|452871468|FG002|Step 2: Randomization|Other|0|||
126042795|NCT03583333|453454705|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
126101321|NCT01796548|453664249|FG000|Overall Study|Lost to Follow-up|1|||
126101322|NCT01796548|453664249|FG000|Overall Study|Other|2|||
126101323|NCT03432260|453664264|FG000|Overall Study|Lost to Follow-up|1|||
126101324|NCT03432260|453664265|FG001|Overall Study|Lost to Follow-up|1|||
126101325|NCT03432260|453664266|FG002|Overall Study|Lost to Follow-up|0|||
126101326|NCT03432260|453664267|FG003|Overall Study|Lost to Follow-up|0|||
126101327|NCT03432260|453664268|FG004|Overall Study|Lost to Follow-up|1|||
126101328|NCT01775124|453664270|FG000|Core Period|Disease Progression|0|||
126101329|NCT01775124|453664271|FG001|Core Period|Disease Progression|1|||
126101330|NCT01775124|453664270|FG000|Core Period|Physician Decision|1|||
126101331|NCT01775124|453664271|FG001|Core Period|Physician Decision|1|||
126101332|NCT01775124|453664270|FG000|Core Period|Death|0|||
126101333|NCT01775124|453664271|FG001|Core Period|Death|1|||
126101334|NCT01775124|453664270|FG000|Core Period|Administrative problems|1|||
126101335|NCT01775124|453664271|FG001|Core Period|Administrative problems|0|||
126101336|NCT01775124|453664270|FG000|Core Period|Withdrawal by Subject|4|||
126101337|NCT01775124|453664271|FG001|Core Period|Withdrawal by Subject|2|||
126101338|NCT01775124|453664270|FG000|Core Period|Adverse Event|5|||
126101339|NCT01775124|453664271|FG001|Core Period|Adverse Event|5|||
126101340|NCT01775124|453664270|FG000|Extension Period|Adverse Event|3|||
126101341|NCT01775124|453664271|FG001|Extension Period|Adverse Event|2|||
126101342|NCT01775124|453664270|FG000|Extension Period|Physician Decision|0|||
126042796|NCT03583333|453454706|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
126042797|NCT03583333|453454705|FG000|Overall Study|Withdrawal by Subject|9|||
126042798|NCT03583333|453454706|FG001|Overall Study|Withdrawal by Subject|5|||
126042799|NCT03583333|453454705|FG000|Overall Study|Physician Decision|3|||
126042800|NCT03583333|453454706|FG001|Overall Study|Physician Decision|2|||
126042801|NCT03583333|453454705|FG000|Overall Study|Death|12|||
126042802|NCT03583333|453454706|FG001|Overall Study|Death|7|||
126042803|NCT04469270|453454707|FG000|Overall Study|Adverse Event|2|||
126042804|NCT04469270|453454708|FG001|Overall Study|Adverse Event|0|||
126042805|NCT04469270|453454707|FG000|Overall Study|Lost to Follow-up|4|||
126042806|NCT04469270|453454708|FG001|Overall Study|Lost to Follow-up|3|||
126042807|NCT04469270|453454707|FG000|Overall Study|Withdrawal by Subject|7|||
126042808|NCT04469270|453454708|FG001|Overall Study|Withdrawal by Subject|3|||
126042809|NCT04469270|453454707|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
126042810|NCT04469270|453454708|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
126042811|NCT04469270|453454707|FG000|Overall Study|missing|1|||
126042812|NCT04469270|453454708|FG001|Overall Study|missing|0|||
126042813|NCT02839265|453454715|FG000|Overall Study|Screen Failure|2|||
126042814|NCT02839265|453454715|FG000|Overall Study|Death|1|||
126042815|NCT02839265|453454715|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
126042816|NCT05424380|453454716|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
126042817|NCT05424380|453454717|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126042818|NCT05424380|453454718|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126042819|NCT05424380|453454719|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126042820|NCT05424380|453454720|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126042821|NCT05424380|453454721|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126042822|NCT05424380|453454716|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
126042823|NCT05424380|453454717|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126042824|NCT05424380|453454718|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126101343|NCT01775124|453664271|FG001|Extension Period|Physician Decision|2|||
126042825|NCT05424380|453454719|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126042826|NCT05424380|453454720|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126042827|NCT05424380|453454721|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126042828|NCT05424380|453454716|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
126101344|NCT01775124|453664270|FG000|Extension Period|Administrative problems|0|||
126101345|NCT01775124|453664271|FG001|Extension Period|Administrative problems|1|||
126101346|NCT01775124|453664270|FG000|Extension Period|Lost to Follow-up|0|||
126101347|NCT01775124|453664271|FG001|Extension Period|Lost to Follow-up|1|||
126101348|NCT01775124|453664270|FG000|Extension Period|Withdrawal by Subject|9|||
126101349|NCT01775124|453664271|FG001|Extension Period|Withdrawal by Subject|12|||
126296555|NCT03802825|454373933|FG001|Overall Study|Received only 1 component of intervention|13|||
126101350|NCT01022268|453666107|FG000|Overall Study|Withdrawal by Subject|1|||
126101351|NCT01022268|453666108|FG001|Overall Study|Withdrawal by Subject|0|||
126101352|NCT01022268|453666107|FG000|Overall Study|Withdrawal by Subject|1|||
126101353|NCT01022268|453666108|FG001|Overall Study|Withdrawal by Subject|0|||
126101354|NCT00910689|453666109|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
126101355|NCT00910689|453666110|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
126101356|NCT00910689|453666111|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
126101357|NCT00910689|453666112|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
126101358|NCT00910689|453666109|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
126101359|NCT00910689|453666110|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
126101360|NCT00910689|453666111|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
126101361|NCT00910689|453666112|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
126101362|NCT00910689|453666109|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
126101363|NCT00910689|453666110|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
126101364|NCT00910689|453666111|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
126101365|NCT00910689|453666112|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
126101366|NCT00910689|453666109|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
126101367|NCT00910689|453666110|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
126101368|NCT00910689|453666111|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
126101369|NCT00910689|453666112|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
126101370|NCT00910689|453666109|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
126101371|NCT00910689|453666110|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
126101372|NCT00910689|453666111|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
126101373|NCT00910689|453666112|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
126101374|NCT00910689|453666109|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
126101375|NCT00910689|453666110|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
126101376|NCT00910689|453666111|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
126101377|NCT00910689|453666112|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
126101378|NCT00910689|453666109|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
126101379|NCT00910689|453666110|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
126101380|NCT00910689|453666111|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
126101381|NCT00910689|453666112|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
126101382|NCT00910689|453666109|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
126101383|NCT00910689|453666110|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
126101384|NCT00910689|453666111|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
126101385|NCT00910689|453666112|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
126101386|NCT00910689|453666109|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
126101387|NCT00910689|453666110|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
126101388|NCT00910689|453666111|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
126101389|NCT00910689|453666112|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
126101390|NCT00910689|453666109|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
126101391|NCT00910689|453666110|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
126101392|NCT00910689|453666111|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
126101393|NCT00910689|453666112|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
126101394|NCT00910689|453666109|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
126101395|NCT00910689|453666110|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
126101396|NCT00910689|453666111|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
126101397|NCT00910689|453666112|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
126101398|NCT00910689|453666109|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
126101399|NCT00910689|453666110|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
126101400|NCT00910689|453666111|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
126101401|NCT00910689|453666112|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
126101402|NCT00910689|453666109|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
126101403|NCT00910689|453666110|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
126101404|NCT00910689|453666111|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
126101405|NCT00910689|453666112|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
126101406|NCT00910689|453666109|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
126101407|NCT00910689|453666110|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
126101408|NCT00910689|453666111|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
125883443|NCT00068692|452871469|FG003|Step 2: Randomization|Other|1|||
125883444|NCT00068692|452871470|FG004|Step 2: Randomization|Other|0|||
125883445|NCT00068692|452871471|FG005|Step 2: Randomization|Other|1|||
125883446|NCT00068692|452871472|FG006|Step 2: Randomization|Other|0|||
125883447|NCT00068692|452871473|FG007|Step 2: Randomization|Other|0|||
126101409|NCT00910689|453666112|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
126101410|NCT00910689|453666109|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
126101411|NCT00910689|453666110|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
126101412|NCT00910689|453666111|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
126101413|NCT00910689|453666112|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
126101414|NCT00910689|453666109|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
126101415|NCT00910689|453666110|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
126101416|NCT00910689|453666111|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
126101417|NCT00910689|453666112|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
126101418|NCT00910689|453666109|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
126101419|NCT00910689|453666110|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
126101420|NCT00910689|453666111|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
126101421|NCT00910689|453666112|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
126101422|NCT00910689|453666109|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
126101423|NCT00910689|453666110|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
126101424|NCT00910689|453666111|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
126101425|NCT00910689|453666112|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
126101426|NCT00910689|453666109|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
126101427|NCT00910689|453666110|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
126101428|NCT00910689|453666111|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
126042829|NCT05424380|453454717|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126042830|NCT05424380|453454718|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126042831|NCT05424380|453454719|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126042832|NCT05424380|453454720|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126042833|NCT05424380|453454721|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126042834|NCT05424380|453454716|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126042835|NCT05424380|453454717|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
126042836|NCT05424380|453454718|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126042837|NCT05424380|453454719|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126042838|NCT05424380|453454720|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126042839|NCT05424380|453454721|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126042840|NCT05424380|453454716|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126042841|NCT05424380|453454717|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
126042842|NCT05424380|453454718|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126042843|NCT05424380|453454719|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126042844|NCT05424380|453454720|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126042845|NCT05424380|453454721|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126042846|NCT05424380|453454716|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126042847|NCT05424380|453454717|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126042848|NCT05424380|453454718|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
126042849|NCT05424380|453454719|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126042850|NCT05424380|453454720|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126042851|NCT05424380|453454721|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126042852|NCT05424380|453454716|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126042853|NCT05424380|453454717|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126042854|NCT05424380|453454718|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
126042855|NCT05424380|453454719|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126042856|NCT05424380|453454720|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126042857|NCT05424380|453454721|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126042858|NCT05424380|453454716|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126042859|NCT05424380|453454717|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126042860|NCT05424380|453454718|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
126042861|NCT05424380|453454719|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126042862|NCT05424380|453454720|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126042863|NCT05424380|453454721|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126042864|NCT05424380|453454716|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042865|NCT05424380|453454717|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042866|NCT05424380|453454718|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042867|NCT05424380|453454719|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
126042868|NCT05424380|453454720|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042869|NCT05424380|453454721|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042870|NCT05424380|453454716|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126101429|NCT00910689|453666112|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
126101430|NCT00910689|453666109|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
126101431|NCT00910689|453666110|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
126101432|NCT00910689|453666111|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
126296556|NCT01108718|454373935|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
126296557|NCT01108718|454373936|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
126042871|NCT05424380|453454717|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126042872|NCT05424380|453454718|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126042873|NCT05424380|453454719|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
126042874|NCT05424380|453454720|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126101433|NCT00910689|453666112|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
125883448|NCT00068692|452871466|FG000|Step 2: Randomization|never start protocol therapy|0|||
125883449|NCT00068692|452871467|FG001|Step 2: Randomization|never start protocol therapy|0|||
125883450|NCT00068692|452871468|FG002|Step 2: Randomization|never start protocol therapy|1|||
125883451|NCT00068692|452871469|FG003|Step 2: Randomization|never start protocol therapy|0|||
125883452|NCT00068692|452871470|FG004|Step 2: Randomization|never start protocol therapy|1|||
125883453|NCT00068692|452871471|FG005|Step 2: Randomization|never start protocol therapy|0|||
125883454|NCT00068692|452871472|FG006|Step 2: Randomization|never start protocol therapy|0|||
125883455|NCT00068692|452871473|FG007|Step 2: Randomization|never start protocol therapy|0|||
125883456|NCT00248040|452871478|FG000|Overall Study|transplantectomy|2|||
125883457|NCT00248040|452871479|FG001|Overall Study|transplantectomy|1|||
125883458|NCT00248040|452871480|FG002|Overall Study|transplantectomy|3|||
125883459|NCT00248040|452871478|FG000|Overall Study|transplant cancelled post treat start|1|||
125883460|NCT00248040|452871479|FG001|Overall Study|transplant cancelled post treat start|0|||
125883461|NCT00248040|452871480|FG002|Overall Study|transplant cancelled post treat start|0|||
125883462|NCT00248040|452871478|FG000|Overall Study|Death|0|||
125883463|NCT00248040|452871479|FG001|Overall Study|Death|0|||
125883464|NCT00248040|452871480|FG002|Overall Study|Death|1|||
125883465|NCT00628108|452871489|FG000|Overall Study|Adverse Event|0|||
125883466|NCT00628108|452871490|FG001|Overall Study|Adverse Event|3|||
125883467|NCT00628108|452871489|FG000|Overall Study|Withdrawal by Subject|1|||
125883468|NCT00628108|452871490|FG001|Overall Study|Withdrawal by Subject|0|||
125883469|NCT03848832|452871493|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
125883470|NCT03848832|452871494|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
125883471|NCT03848832|452871495|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
125883472|NCT03848832|452871493|FG000|Overall Study|Withdrawal by Subject|0|||
125883473|NCT03848832|452871494|FG001|Overall Study|Withdrawal by Subject|0|||
125883474|NCT03848832|452871495|FG002|Overall Study|Withdrawal by Subject|1|||
125883475|NCT03848832|452871493|FG000|Overall Study|Withdrawal (Covid-19)|0|||
125883476|NCT03848832|452871494|FG001|Overall Study|Withdrawal (Covid-19)|2|||
125883477|NCT03848832|452871495|FG002|Overall Study|Withdrawal (Covid-19)|0|||
125883478|NCT03848832|452871493|FG000|Overall Study|Physician Decision|2|||
125883479|NCT03848832|452871494|FG001|Overall Study|Physician Decision|1|||
125883480|NCT03848832|452871495|FG002|Overall Study|Physician Decision|3|||
125883481|NCT03848832|452871493|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
125883482|NCT03848832|452871494|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
125883483|NCT03848832|452871495|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
125883484|NCT03848832|452871493|FG000|Overall Study|Adverse Event|1|||
125883485|NCT03848832|452871494|FG001|Overall Study|Adverse Event|0|||
125883486|NCT03848832|452871495|FG002|Overall Study|Adverse Event|0|||
125883487|NCT01760733|452871496|FG000|Waiting List|Death|18|||
125883488|NCT01760733|452871496|FG000|Waiting List|Removed from waiting list|41|||
125883489|NCT01760733|452871496|FG000|Waiting List|Not received a transplant yet|13|||
125883490|NCT01760733|452871496|FG000|Transplanted|Not reached 10 years post transplant|184|||
125883491|NCT01760733|452871496|FG000|Transplanted|Death|26|||
125883492|NCT01760733|452871496|FG000|Transplanted|Graft loss|7|||
125883493|NCT02404025|452871497|FG000|Overall Study|Adverse Event|1|||
126042875|NCT05424380|453454721|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126042876|NCT05424380|453454716|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126042877|NCT05424380|453454717|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126042878|NCT05424380|453454718|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126042879|NCT05424380|453454719|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
126042880|NCT05424380|453454720|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126042881|NCT05424380|453454721|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126042882|NCT05424380|453454716|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126042883|NCT05424380|453454717|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126042884|NCT05424380|453454718|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126042885|NCT05424380|453454719|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126042886|NCT05424380|453454720|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
126042887|NCT05424380|453454721|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126042888|NCT05424380|453454716|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042889|NCT05424380|453454717|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042890|NCT05424380|453454718|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042891|NCT05424380|453454719|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042892|NCT05424380|453454720|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
126042893|NCT05424380|453454721|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126042894|NCT05424380|453454716|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126042895|NCT05424380|453454717|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126042896|NCT05424380|453454718|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126042897|NCT05424380|453454719|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126042898|NCT05424380|453454720|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
126042899|NCT05424380|453454721|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126296558|NCT00806403|454373939|FG000|Overall Study|Death|4|||
126296559|NCT00806403|454373940|FG001|Overall Study|Death|3|||
126296560|NCT01882985|454373941|FG000|Overall Study|Lost to Follow-up|1|||
126296561|NCT01882985|454373941|FG000|Overall Study|Withdrawal by Subject|1|||
126296562|NCT01827111|454373942|FG000|Overall Study|Disease Progression|1|||
126296563|NCT02962648|454373943|FG000|Overall Study|Withdrawal by Subject|3|||
126296564|NCT02962648|454373943|FG000|Overall Study|Lost to Follow-up|3|||
126296565|NCT02962648|454373943|FG000|Overall Study|Physician Decision|1|||
126296566|NCT02962648|454373943|FG000|Overall Study|Subject had problems with transportation|2|||
126296567|NCT01597778|454373944|FG000|Overall Study|Death|7|||
126296568|NCT01597778|454373945|FG001|Overall Study|Death|10|||
126296569|NCT01597778|454373944|FG000|Overall Study|Withdrawal by Subject|3|||
126296570|NCT01597778|454373945|FG001|Overall Study|Withdrawal by Subject|4|||
126296571|NCT01597778|454373944|FG000|Overall Study|Adverse Event|1|||
126296572|NCT01597778|454373945|FG001|Overall Study|Adverse Event|1|||
126296573|NCT01597778|454373944|FG000|Overall Study|Protocol Violation|1|||
126296574|NCT01597778|454373945|FG001|Overall Study|Protocol Violation|11|||
126296575|NCT01597778|454373944|FG000|Overall Study|Transplanted off protocol|2|||
126296576|NCT01597778|454373945|FG001|Overall Study|Transplanted off protocol|3|||
126296577|NCT04383327|454373947|FG000|Overall Study|Lost to Follow-up|112|||
126296578|NCT04383327|454373948|FG001|Overall Study|Lost to Follow-up|14|||
126296579|NCT04383327|454373949|FG002|Overall Study|Lost to Follow-up|78|||
126296580|NCT04383327|454373950|FG003|Overall Study|Lost to Follow-up|13|||
126296581|NCT04383327|454373951|FG004|Overall Study|Lost to Follow-up|110|||
126296582|NCT04383327|454373952|FG005|Overall Study|Lost to Follow-up|13|||
126296583|NCT04383327|454373953|FG006|Overall Study|Lost to Follow-up|74|||
126296584|NCT04383327|454373954|FG007|Overall Study|Lost to Follow-up|13|||
126296585|NCT04383327|454373955|FG008|Overall Study|Lost to Follow-up|78|||
126296586|NCT04383327|454373956|FG009|Overall Study|Lost to Follow-up|10|||
126296587|NCT04383327|454373957|FG010|Overall Study|Lost to Follow-up|160|||
126296588|NCT04383327|454373958|FG011|Overall Study|Lost to Follow-up|13|||
126296589|NCT01289678|454373959|FG000|Overall Study|Physician Decision|6|||
126296590|NCT00468819|454373960|FG000|Overall Study|Withdrawal by Subject|4|||
126296591|NCT00468819|454373961|FG001|Overall Study|Withdrawal by Subject|0|||
126296592|NCT00468819|454373962|FG002|Overall Study|Withdrawal by Subject|1|||
126296593|NCT00468819|454373960|FG000|Overall Study|Lost to Follow-up|0|||
126296594|NCT00468819|454373961|FG001|Overall Study|Lost to Follow-up|0|||
126296595|NCT00468819|454373962|FG002|Overall Study|Lost to Follow-up|1|||
126296596|NCT00468819|454373960|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
126296597|NCT00468819|454373961|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
126296598|NCT00468819|454373962|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
126296599|NCT04030299|454373963|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
126296600|NCT04030299|454373963|FG000|Overall Study|Withdrawal by Subject|3|||
126296601|NCT04740918|454373964|FG000|Overall Study|Study Terminated by Sponsor|41|||
126296602|NCT04740918|454373965|FG001|Overall Study|Study Terminated by Sponsor|32|||
126296603|NCT04740918|454373964|FG000|Overall Study|Death|3|||
126296604|NCT04740918|454373965|FG001|Overall Study|Death|6|||
126296605|NCT04740918|454373964|FG000|Overall Study|Withdrawal by Subject|5|||
126296606|NCT04740918|454373965|FG001|Overall Study|Withdrawal by Subject|4|||
126296607|NCT04740918|454373964|FG000|Overall Study|Lost to Follow-up|1|||
126296608|NCT04740918|454373965|FG001|Overall Study|Lost to Follow-up|3|||
125883494|NCT02404025|452871497|FG000|Overall Study|Lack of Efficacy|3|||
125883495|NCT01524796|452871498|FG000|Overall Study|Adverse Event|13|||
125883496|NCT01524796|452871498|FG000|Overall Study|Lack of Efficacy|3|||
126296609|NCT04740918|454373964|FG000|Overall Study|Progressive disease|0|||
126296610|NCT04740918|454373965|FG001|Overall Study|Progressive disease|1|||
126296611|NCT02524847|454373966|FG000|Overall Study|Adverse Event|4|||
126296612|NCT02524847|454373966|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
126296613|NCT02524847|454373966|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
126042900|NCT02909686|453454722|FG000|Overall Study|Physician Decision|3|||
126296614|NCT02524847|454373966|FG000|Overall Study|Death|1|||
126296615|NCT02524847|454373966|FG000|Overall Study|Reason not Specified|1|||
126296616|NCT04352101|454373967|FG000|Overall Study|Physician Decision|2|||
126296617|NCT04352101|454373968|FG001|Overall Study|Physician Decision|1|||
125883497|NCT01524796|452871498|FG000|Overall Study|Lost to Follow-up|1|||
126042901|NCT02909686|453454722|FG000|Overall Study|Withdrawal by Subject|2|||
126042902|NCT03858517|453454723|FG000|Overall Study|Adverse Event|1|||
126042903|NCT03858517|453454723|FG000|Overall Study|Lost to Follow-up|1|||
126042904|NCT03858517|453454723|FG000|Overall Study|removed for being incarcerated|1|||
126042905|NCT03858517|453454723|FG000|Overall Study|Sponsor Closure|48|||
126042906|NCT06037668|453454724|FG000|Overall Study|Lost to Follow-up|1|||
126042907|NCT06037668|453454725|FG001|Overall Study|Lost to Follow-up|1|||
126042908|NCT06037668|453454724|FG000|Overall Study|Protocol Violation|1|||
126042909|NCT06037668|453454725|FG001|Overall Study|Protocol Violation|0|||
126042910|NCT06037668|453454724|FG000|Overall Study|Withdrawal by Subject|1|||
126042911|NCT06037668|453454725|FG001|Overall Study|Withdrawal by Subject|0|||
126042912|NCT06037668|453454724|FG000|Overall Study|Other Study Discontinuation Reason|1|||
126042913|NCT06037668|453454725|FG001|Overall Study|Other Study Discontinuation Reason|0|||
125883498|NCT01524796|452871498|FG000|Overall Study|The price|1|||
125883499|NCT01524796|452871498|FG000|Overall Study|Withdrawal by Subject|4|||
125883500|NCT01524796|452871498|FG000|Overall Study|Move|1|||
125883501|NCT01524796|452871498|FG000|Overall Study|Deterioration of pains|1|||
125883502|NCT01524796|452871498|FG000|Overall Study|Gall stone surgery|1|||
126296618|NCT01288079|454373976|FG000|Overall Study|Withdrawal by Subject|2|||
126296619|NCT01288079|454373977|FG001|Overall Study|Withdrawal by Subject|4|||
126296620|NCT01288079|454373978|FG002|Overall Study|Withdrawal by Subject|1|||
126296621|NCT01288079|454373979|FG003|Overall Study|Withdrawal by Subject|0|||
126296622|NCT01288079|454373976|FG000|Overall Study|Adverse Event|2|||
126296623|NCT01288079|454373977|FG001|Overall Study|Adverse Event|1|||
126296624|NCT01288079|454373978|FG002|Overall Study|Adverse Event|2|||
126296625|NCT01288079|454373979|FG003|Overall Study|Adverse Event|3|||
126296626|NCT01288079|454373976|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
126296627|NCT01288079|454373977|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
126296628|NCT01288079|454373978|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
126296629|NCT01288079|454373979|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
126296630|NCT01288079|454373976|FG000|Overall Study|Condition under Investigation Worsened|0|||
126296631|NCT01288079|454373977|FG001|Overall Study|Condition under Investigation Worsened|0|||
126296632|NCT01288079|454373978|FG002|Overall Study|Condition under Investigation Worsened|0|||
126366956|NCT01051661|454639366|FG005|Overall Study|Failure to comply with protocol|0|||
125883503|NCT01524796|452871498|FG000|Overall Study|Nervous about confidentiality|1|||
125883504|NCT01524796|452871498|FG000|Overall Study|Switch to carbamazapine|1|||
125883505|NCT01524796|452871498|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
125883506|NCT03938259|452871502|FG000|Overall Study|unable to establish baseline for ventilation|1|||
125883507|NCT03938259|452871503|FG001|Overall Study|unable to establish baseline for ventilation|1|||
125883508|NCT01002339|452871504|FG000|Overall Study|Withdrawal by Subject|0|||
125883509|NCT01002339|452871505|FG001|Overall Study|Withdrawal by Subject|1|||
125883510|NCT01002339|452871506|FG002|Overall Study|Withdrawal by Subject|0|||
125883511|NCT01002339|452871504|FG000|Overall Study|Incorrect treatment assignment|0|||
125883512|NCT01002339|452871505|FG001|Overall Study|Incorrect treatment assignment|0|||
125883513|NCT01002339|452871506|FG002|Overall Study|Incorrect treatment assignment|1|||
125883514|NCT01002339|452871504|FG000|Overall Study|Protocol Violation|0|||
125883515|NCT01002339|452871505|FG001|Overall Study|Protocol Violation|0|||
125883516|NCT01002339|452871506|FG002|Overall Study|Protocol Violation|2|||
125883517|NCT01002339|452871504|FG000|Overall Study|Lung cancer detected before transplant|0|||
125883518|NCT01002339|452871505|FG001|Overall Study|Lung cancer detected before transplant|0|||
125883519|NCT01002339|452871506|FG002|Overall Study|Lung cancer detected before transplant|1|||
125883520|NCT01002339|452871504|FG000|Overall Study|Randomized. Not transplanted|0|||
125883521|NCT01002339|452871505|FG001|Overall Study|Randomized. Not transplanted|0|||
125883522|NCT01002339|452871506|FG002|Overall Study|Randomized. Not transplanted|1|||
125883523|NCT02215252|452871507|FG000|Overall Study|Adverse Event|1|||
125883524|NCT02215252|452871508|FG001|Overall Study|Adverse Event|5|||
125883525|NCT02215252|452871509|FG002|Overall Study|Adverse Event|2|||
125883526|NCT02215252|452871507|FG000|Overall Study|Lost to Follow-up|0|||
125883527|NCT02215252|452871508|FG001|Overall Study|Lost to Follow-up|0|||
125883528|NCT02215252|452871509|FG002|Overall Study|Lost to Follow-up|1|||
125883529|NCT02215252|452871507|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
125883530|NCT02215252|452871508|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
125883531|NCT02215252|452871509|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
125883532|NCT02215252|452871507|FG000|Overall Study|Protocol Violation|0|||
125883533|NCT02215252|452871508|FG001|Overall Study|Protocol Violation|1|||
125883534|NCT02215252|452871509|FG002|Overall Study|Protocol Violation|0|||
125883535|NCT02215252|452871507|FG000|Overall Study|Withdrawal by Subject|1|||
125883536|NCT02215252|452871508|FG001|Overall Study|Withdrawal by Subject|0|||
126042914|NCT05285137|453454727|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
126042915|NCT05285137|453454728|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
126042916|NCT05285137|453454729|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
126042917|NCT05285137|453454730|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
126042918|NCT05285137|453454731|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
126042919|NCT05285137|453454732|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
126042920|NCT05285137|453454733|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
126042921|NCT05285137|453454734|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
126042922|NCT05285137|453454735|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
126042923|NCT05285137|453454727|FG000|Overall Study|Lost to Follow-up|0|||
126042924|NCT05285137|453454728|FG001|Overall Study|Lost to Follow-up|0|||
126042925|NCT05285137|453454729|FG002|Overall Study|Lost to Follow-up|1|||
126042926|NCT05285137|453454730|FG003|Overall Study|Lost to Follow-up|3|||
126042927|NCT05285137|453454731|FG004|Overall Study|Lost to Follow-up|0|||
126296633|NCT01288079|454373979|FG003|Overall Study|Condition under Investigation Worsened|1|||
126296634|NCT01288079|454373976|FG000|Overall Study|Lack of Efficacy|2|||
125883537|NCT02215252|452871509|FG002|Overall Study|Withdrawal by Subject|0|||
125883538|NCT02215252|452871507|FG000|Overall Study|Other|0|||
126296635|NCT01288079|454373977|FG001|Overall Study|Lack of Efficacy|2|||
126296636|NCT01288079|454373978|FG002|Overall Study|Lack of Efficacy|0|||
126296637|NCT01288079|454373979|FG003|Overall Study|Lack of Efficacy|2|||
126296638|NCT01288079|454373976|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
126296639|NCT01288079|454373977|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
126296640|NCT01288079|454373978|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
126296641|NCT01288079|454373979|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
126296642|NCT01288079|454373976|FG000|Overall Study|Lost to Follow-up|1|||
126296643|NCT01288079|454373977|FG001|Overall Study|Lost to Follow-up|1|||
126296644|NCT01288079|454373978|FG002|Overall Study|Lost to Follow-up|1|||
126296645|NCT01288079|454373979|FG003|Overall Study|Lost to Follow-up|0|||
126296646|NCT01288079|454373976|FG000|Overall Study|Other or Study Termination|11|||
126296647|NCT01288079|454373977|FG001|Overall Study|Other or Study Termination|15|||
126296648|NCT01288079|454373978|FG002|Overall Study|Other or Study Termination|14|||
126296649|NCT01288079|454373979|FG003|Overall Study|Other or Study Termination|8|||
126296650|NCT01530464|454373980|FG000|Washout (24h)|Withdrawal by Subject|1|||
126296651|NCT01530464|454373981|FG001|Washout (24h)|Withdrawal by Subject|0|||
126296652|NCT01530464|454373980|FG000|Washout (24h)|Withdrawal by Subject|0|||
126296653|NCT01530464|454373981|FG001|Washout (24h)|Withdrawal by Subject|1|||
126296654|NCT03170544|454373982|FG000|Part 1|Lost to Follow-up|1|||
126296655|NCT03170544|454373983|FG001|Part 1|Lost to Follow-up|0|||
126296656|NCT03170544|454373984|FG002|Part 1|Lost to Follow-up|0|||
126296657|NCT03170544|454373985|FG003|Part 1|Lost to Follow-up|0|||
126296658|NCT03170544|454373986|FG004|Part 1|Lost to Follow-up|0|||
126296659|NCT03170544|454373987|FG005|Part 1|Lost to Follow-up|0|||
126296660|NCT03170544|454373988|FG006|Part 1|Lost to Follow-up|0|||
126296661|NCT03170544|454373989|FG007|Part 1|Lost to Follow-up|0|||
126296662|NCT03170544|454373990|FG008|Part 1|Lost to Follow-up|0|||
126296663|NCT03170544|454373991|FG009|Part 1|Lost to Follow-up|0|||
126296664|NCT03170544|454373992|FG010|Part 1|Lost to Follow-up|0|||
126296665|NCT03170544|454373993|FG011|Part 1|Lost to Follow-up|0|||
126296666|NCT03170544|454373982|FG000|Part 1|Not treated|0|||
126296667|NCT03170544|454373983|FG001|Part 1|Not treated|0|||
126296668|NCT03170544|454373984|FG002|Part 1|Not treated|0|||
126296669|NCT03170544|454373985|FG003|Part 1|Not treated|1|||
126296670|NCT03170544|454373986|FG004|Part 1|Not treated|0|||
126296671|NCT03170544|454373987|FG005|Part 1|Not treated|0|||
126296672|NCT03170544|454373988|FG006|Part 1|Not treated|0|||
126296673|NCT03170544|454373989|FG007|Part 1|Not treated|0|||
126296674|NCT03170544|454373990|FG008|Part 1|Not treated|0|||
126296675|NCT03170544|454373991|FG009|Part 1|Not treated|0|||
126296676|NCT03170544|454373992|FG010|Part 1|Not treated|0|||
126296677|NCT03170544|454373993|FG011|Part 1|Not treated|0|||
126296678|NCT00908544|454373994|FG000|Overall Study|Withdrawal by Subject|2|||
126296679|NCT00908544|454373995|FG001|Overall Study|Withdrawal by Subject|4|||
126296680|NCT00908544|454373994|FG000|Overall Study|Lack of Efficacy|0|||
126296681|NCT00908544|454373995|FG001|Overall Study|Lack of Efficacy|1|||
126296682|NCT00908544|454373994|FG000|Overall Study|Pregnancy|1|||
126296683|NCT00908544|454373995|FG001|Overall Study|Pregnancy|0|||
126296684|NCT00908544|454373994|FG000|Overall Study|Relocation abroad|1|||
126296685|NCT00908544|454373995|FG001|Overall Study|Relocation abroad|1|||
126296686|NCT00908544|454373994|FG000|Overall Study|Unable to visit sutdy center|1|||
126296687|NCT00908544|454373995|FG001|Overall Study|Unable to visit sutdy center|0|||
126296688|NCT02387840|454373996|FG000|Overall Study|Death|0|||
126296689|NCT02387840|454373997|FG001|Overall Study|Death|0|||
126296690|NCT02387840|454373998|FG002|Overall Study|Death|0|||
126296691|NCT02387840|454373999|FG003|Overall Study|Death|0|||
126296692|NCT02387840|454374000|FG004|Overall Study|Death|0|||
126296693|NCT02387840|454374001|FG005|Overall Study|Death|1|||
126296694|NCT03539302|454374009|FG000|Overall Study|Spontaneous cardio version|0|||
126296695|NCT03539302|454374010|FG001|Overall Study|Spontaneous cardio version|0|||
126296696|NCT03539302|454374011|FG002|Overall Study|Spontaneous cardio version|0|||
126296697|NCT03539302|454374012|FG003|Overall Study|Spontaneous cardio version|0|||
126296698|NCT03539302|454374013|FG004|Overall Study|Spontaneous cardio version|0|||
126296699|NCT03539302|454374014|FG005|Overall Study|Spontaneous cardio version|1|||
126296700|NCT03539302|454374015|FG006|Overall Study|Spontaneous cardio version|1|||
126296701|NCT02174627|454374019|FG000|Overall Study|Missing|0|||
126296702|NCT02174627|454374020|FG001|Overall Study|Missing|1|||
126296703|NCT02174627|454374019|FG000|Overall Study|Incorrect enrolment before randomization|0|||
126296704|NCT02174627|454374020|FG001|Overall Study|Incorrect enrolment before randomization|1|||
126296705|NCT02174627|454374019|FG000|Overall Study|Participant decision|84|||
126296706|NCT02174627|454374020|FG001|Overall Study|Participant decision|128|||
126296707|NCT04564092|454374021|FG000|Overall Study|Withdrawal by Subject|1|||
126296708|NCT00071110|454374022|FG000|Overall Study|Protocol Violation|0|||
126296709|NCT00071110|454374023|FG001|Overall Study|Protocol Violation|4|||
126296710|NCT02107131|454374024|FG000|Overall Study|Lost to Follow-up|4|||
126296711|NCT02107131|454374025|FG001|Overall Study|Lost to Follow-up|4|||
126296712|NCT02107131|454374024|FG000|Overall Study|Physician Decision|1|||
126296713|NCT02107131|454374025|FG001|Overall Study|Physician Decision|0|||
126296714|NCT02107131|454374024|FG000|Overall Study|Withdrawal by Subject|2|||
126296715|NCT02107131|454374025|FG001|Overall Study|Withdrawal by Subject|0|||
126296716|NCT02107131|454374024|FG000|Overall Study|mental instability|1|||
126296717|NCT02107131|454374025|FG001|Overall Study|mental instability|0|||
126296718|NCT02107131|454374024|FG000|Overall Study|Death|0|||
126296719|NCT02107131|454374025|FG001|Overall Study|Death|1|||
126296720|NCT02107131|454374024|FG000|Overall Study|Protocol Violation|0|||
126296721|NCT02107131|454374025|FG001|Overall Study|Protocol Violation|4|||
126296722|NCT02389829|454374028|FG000|Overall Study|Lost to Follow-up|0|||
126296723|NCT02389829|454374029|FG001|Overall Study|Lost to Follow-up|1|||
126296724|NCT02362360|454374030|FG000|Period 1|Lack of Efficacy|1|||
126296725|NCT02362360|454374031|FG001|Period 1|Lack of Efficacy|0|||
126296726|NCT02362360|454374030|FG000|Period 1|Withdrawal by Subject|2|||
126296727|NCT02362360|454374031|FG001|Period 1|Withdrawal by Subject|1|||
126296728|NCT03578367|454374032|FG000|Overall Study|Adverse Event|0|||
126296729|NCT03578367|454374033|FG001|Overall Study|Adverse Event|3|||
126296730|NCT03578367|454374034|FG002|Overall Study|Adverse Event|0|||
126296731|NCT03578367|454374035|FG003|Overall Study|Adverse Event|5|||
126296732|NCT03578367|454374032|FG000|Overall Study|Withdrawal by Subject|2|||
126296733|NCT03578367|454374033|FG001|Overall Study|Withdrawal by Subject|2|||
126296734|NCT03578367|454374034|FG002|Overall Study|Withdrawal by Subject|1|||
126296735|NCT03578367|454374035|FG003|Overall Study|Withdrawal by Subject|3|||
126296736|NCT03578367|454374032|FG000|Overall Study|Physician Decision|0|||
126296737|NCT03578367|454374033|FG001|Overall Study|Physician Decision|0|||
126296738|NCT03578367|454374034|FG002|Overall Study|Physician Decision|14|||
126296739|NCT03578367|454374035|FG003|Overall Study|Physician Decision|0|||
126296740|NCT03578367|454374032|FG000|Overall Study|Death|1|||
126296741|NCT03578367|454374033|FG001|Overall Study|Death|0|||
126296742|NCT03578367|454374034|FG002|Overall Study|Death|0|||
126296743|NCT03578367|454374035|FG003|Overall Study|Death|0|||
126296744|NCT03578367|454374032|FG000|Overall Study|Not treated|0|||
126296745|NCT03578367|454374033|FG001|Overall Study|Not treated|0|||
126296746|NCT03578367|454374034|FG002|Overall Study|Not treated|1|||
126296747|NCT03578367|454374035|FG003|Overall Study|Not treated|0|||
126296748|NCT02729025|454374036|FG000|Overall Study|Sponsor Decision|0|||
126296749|NCT02729025|454374037|FG001|Overall Study|Sponsor Decision|1|||
126296750|NCT04815083|454375316|FG000|Overall Study|Physician Decision|1|||
126296751|NCT04815083|454375316|FG000|Overall Study|Study pause|2|||
126296752|NCT04815083|454375316|FG000|Overall Study|Screening failure|4|||
126296753|NCT05364931|454375319|FG000|Overall Study|Adverse Event|0|||
126042928|NCT05285137|453454732|FG005|Overall Study|Lost to Follow-up|0|||
126042929|NCT05285137|453454733|FG006|Overall Study|Lost to Follow-up|1|||
126042930|NCT05285137|453454734|FG007|Overall Study|Lost to Follow-up|0|||
126042931|NCT05285137|453454735|FG008|Overall Study|Lost to Follow-up|0|||
126042932|NCT05285137|453454727|FG000|Overall Study|Physician Decision|0|||
126042933|NCT05285137|453454728|FG001|Overall Study|Physician Decision|1|||
126042934|NCT05285137|453454729|FG002|Overall Study|Physician Decision|0|||
126042935|NCT05285137|453454730|FG003|Overall Study|Physician Decision|0|||
126042936|NCT05285137|453454731|FG004|Overall Study|Physician Decision|0|||
126042937|NCT05285137|453454732|FG005|Overall Study|Physician Decision|0|||
126042938|NCT05285137|453454733|FG006|Overall Study|Physician Decision|0|||
126042939|NCT05285137|453454734|FG007|Overall Study|Physician Decision|0|||
126042940|NCT05285137|453454735|FG008|Overall Study|Physician Decision|0|||
126042941|NCT05285137|453454727|FG000|Overall Study|Pregnancy|0|||
126042942|NCT05285137|453454728|FG001|Overall Study|Pregnancy|0|||
126042943|NCT05285137|453454729|FG002|Overall Study|Pregnancy|0|||
126042944|NCT05285137|453454730|FG003|Overall Study|Pregnancy|0|||
126296754|NCT05364931|454375320|FG001|Overall Study|Adverse Event|2|||
126296755|NCT05364931|454375321|FG002|Overall Study|Adverse Event|1|||
126296756|NCT05364931|454375322|FG003|Overall Study|Adverse Event|0|||
126296757|NCT05364931|454375319|FG000|Overall Study|Lost to Follow-up|1|||
126296758|NCT05364931|454375320|FG001|Overall Study|Lost to Follow-up|0|||
126296759|NCT05364931|454375321|FG002|Overall Study|Lost to Follow-up|0|||
126296760|NCT05364931|454375322|FG003|Overall Study|Lost to Follow-up|0|||
126296761|NCT05364931|454375319|FG000|Overall Study|Withdrawal by Subject|1|||
126296762|NCT05364931|454375320|FG001|Overall Study|Withdrawal by Subject|1|||
126296763|NCT05364931|454375321|FG002|Overall Study|Withdrawal by Subject|3|||
126042945|NCT05285137|453454731|FG004|Overall Study|Pregnancy|0|||
126042946|NCT05285137|453454732|FG005|Overall Study|Pregnancy|0|||
126042947|NCT05285137|453454733|FG006|Overall Study|Pregnancy|1|||
126042948|NCT05285137|453454734|FG007|Overall Study|Pregnancy|0|||
126296764|NCT05364931|454375322|FG003|Overall Study|Withdrawal by Subject|2|||
126296765|NCT05364931|454375319|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
126296766|NCT05364931|454375320|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
126296767|NCT05364931|454375321|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
126042949|NCT05285137|453454735|FG008|Overall Study|Pregnancy|0|||
126296768|NCT05364931|454375322|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
126296769|NCT05364931|454375319|FG000|Overall Study|Discontinued|1|||
126296770|NCT05364931|454375320|FG001|Overall Study|Discontinued|0|||
126296771|NCT05364931|454375321|FG002|Overall Study|Discontinued|0|||
126042950|NCT05285137|453454727|FG000|Overall Study|Withdrawal by Subject|0|||
126296772|NCT05364931|454375322|FG003|Overall Study|Discontinued|0|||
126296773|NCT03504397|454375330|FG000|Overall Study|Progressive Disease|151|||
126296774|NCT03504397|454375331|FG001|Overall Study|Progressive Disease|199|||
126296775|NCT03504397|454375330|FG000|Overall Study|Withdrawal by Subject|29|||
126296776|NCT03504397|454375331|FG001|Overall Study|Withdrawal by Subject|17|||
126296777|NCT03504397|454375330|FG000|Overall Study|Lost to Follow-up|1|||
126296778|NCT03504397|454375331|FG001|Overall Study|Lost to Follow-up|0|||
126296779|NCT03504397|454375330|FG000|Overall Study|Death|14|||
126296780|NCT03504397|454375331|FG001|Overall Study|Death|16|||
126296781|NCT03504397|454375330|FG000|Overall Study|Adverse Event|40|||
126296782|NCT03504397|454375331|FG001|Overall Study|Adverse Event|14|||
126296783|NCT03504397|454375330|FG000|Overall Study|miscellaneous|17|||
126296784|NCT03504397|454375331|FG001|Overall Study|miscellaneous|15|||
126296785|NCT03504397|454375330|FG000|Overall Study|Protocol deviation|1|||
126296786|NCT03504397|454375331|FG001|Overall Study|Protocol deviation|0|||
126296787|NCT03504397|454375330|FG000|Overall Study|Participants who did not take the study drug|4|||
126296788|NCT03504397|454375331|FG001|Overall Study|Participants who did not take the study drug|4|||
126296789|NCT01662635|454375332|FG000|Overall Study|scarce samples for evaluation|30|||
126296790|NCT00351468|454375333|FG000|Overall Study|Adverse Event|42|||
126296791|NCT00351468|454375333|FG000|Overall Study|Withdrawal by Subject|39|||
126296792|NCT00351468|454375333|FG000|Overall Study|Various -follow up w clinical team|39|||
126101434|NCT00910689|453666109|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
126101435|NCT00910689|453666110|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
126101436|NCT00910689|453666111|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
126101437|NCT00910689|453666112|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
126101438|NCT00189488|453666113|FG000|Overall Study|Ineligibility determined|1|||
126101439|NCT00189488|453666114|FG001|Overall Study|Ineligibility determined|0|||
126101440|NCT00189488|453666113|FG000|Overall Study|Protocol deviation|2|||
126101441|NCT00189488|453666114|FG001|Overall Study|Protocol deviation|1|||
126296793|NCT00351468|454375333|FG000|Overall Study|Lack of Efficacy|32|||
125883539|NCT02215252|452871508|FG001|Overall Study|Other|1|||
125883540|NCT02215252|452871509|FG002|Overall Study|Other|1|||
126101442|NCT00189488|453666113|FG000|Overall Study|Adverse Event|2|||
126101443|NCT00189488|453666114|FG001|Overall Study|Adverse Event|1|||
126101444|NCT00189488|453666113|FG000|Overall Study|Withdrawal by Subject|2|||
126101445|NCT00189488|453666114|FG001|Overall Study|Withdrawal by Subject|6|||
126101446|NCT00189488|453666113|FG000|Overall Study|Disease progression|2|||
126101447|NCT00189488|453666114|FG001|Overall Study|Disease progression|4|||
126101448|NCT00189488|453666113|FG000|Overall Study|Administrative Decision|0|||
126101449|NCT00189488|453666114|FG001|Overall Study|Administrative Decision|2|||
126101450|NCT00189488|453666113|FG000|Overall Study|Death|5|||
126101451|NCT00189488|453666114|FG001|Overall Study|Death|8|||
126101452|NCT00189488|453666113|FG000|Overall Study|Other|1|||
126101453|NCT00189488|453666114|FG001|Overall Study|Other|0|||
126101454|NCT00192647|453666120|FG000|Overall Study|Death|1|||
126101455|NCT00192647|453666121|FG001|Overall Study|Death|1|||
126101456|NCT00192647|453666120|FG000|Overall Study|Adverse Event|35|||
126101457|NCT00192647|453666121|FG001|Overall Study|Adverse Event|29|||
126101458|NCT00192647|453666120|FG000|Overall Study|Laboratory Test Abnormality|4|||
126101459|NCT00192647|453666121|FG001|Overall Study|Laboratory Test Abnormality|2|||
126101460|NCT00192647|453666120|FG000|Overall Study|Insufficient Therapeutic Response|53|||
126101461|NCT00192647|453666121|FG001|Overall Study|Insufficient Therapeutic Response|83|||
126101462|NCT00192647|453666120|FG000|Overall Study|Entry Criteria Violation|6|||
126101463|NCT00192647|453666121|FG001|Overall Study|Entry Criteria Violation|6|||
126101464|NCT00192647|453666120|FG000|Overall Study|Protocol Violation|3|||
126101465|NCT00192647|453666121|FG001|Overall Study|Protocol Violation|1|||
126296794|NCT00351468|454375333|FG000|Overall Study|Non-compliance|8|||
126296795|NCT00351468|454375333|FG000|Overall Study|Lost to Follow-up|4|||
126296796|NCT00351468|454375333|FG000|Overall Study|Protocol Violation|3|||
126296797|NCT00611923|454375334|FG000|Overall Study|Withdrawal by Subject|2|||
126296798|NCT00611923|454375335|FG001|Overall Study|Withdrawal by Subject|2|||
126296799|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
126296800|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
126296801|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
126296802|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
126296803|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
126296804|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
126296805|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
125883541|NCT02633306|452871510|FG000|Overall Study|Withdrawal by Subject|3|||
126101466|NCT00192647|453666120|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
126101467|NCT00192647|453666121|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
126101468|NCT00192647|453666120|FG000|Overall Study|Failure to Return|11|||
126101469|NCT00192647|453666121|FG001|Overall Study|Failure to Return|13|||
126296806|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
126101470|NCT00192647|453666120|FG000|Overall Study|Other/Administrative|5|||
126101471|NCT00192647|453666121|FG001|Overall Study|Other/Administrative|3|||
126101472|NCT01828073|453666122|FG000|Overall Study|Lost to Follow-up|1|||
126101473|NCT01828073|453666123|FG001|Overall Study|Lost to Follow-up|2|||
126101474|NCT02915302|453666124|FG000|Overall Study|Adverse Event|3|||
126296807|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
126296808|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
126296809|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
126296810|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
126296811|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
126296812|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
126296813|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
126296814|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
126101475|NCT02915302|453666125|FG001|Overall Study|Adverse Event|0|||
126101476|NCT02915302|453666124|FG000|Overall Study|Protocol Violation|20|||
126101477|NCT02915302|453666125|FG001|Overall Study|Protocol Violation|27|||
126101478|NCT02915302|453666124|FG000|Overall Study|Lost to Follow-up|19|||
126101479|NCT02915302|453666125|FG001|Overall Study|Lost to Follow-up|22|||
126101480|NCT02915302|453666124|FG000|Overall Study|Withdrawal by Subject|22|||
126296815|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
126296816|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
126296817|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
126296818|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
126296819|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
126296820|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
126296821|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
126296822|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
126296823|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
126296824|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
126296825|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
126296826|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
126296827|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
126296828|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
126296829|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
126296830|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
126296831|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
125883542|NCT01746901|452871511|FG000|Naloxone Challenge Phase|Adverse Event|2|||
125883543|NCT01746901|452871512|FG001|Naloxone Challenge Phase|Adverse Event|0|||
125883544|NCT01746901|452871513|FG002|Naloxone Challenge Phase|Adverse Event|0|||
125883545|NCT01746901|452871514|FG003|Naloxone Challenge Phase|Adverse Event|0|||
125883546|NCT01746901|452871515|FG004|Naloxone Challenge Phase|Adverse Event|0|||
125883547|NCT01746901|452871516|FG005|Naloxone Challenge Phase|Adverse Event|0|||
125883548|NCT01746901|452871517|FG006|Naloxone Challenge Phase|Adverse Event|0|||
125883549|NCT01746901|452871518|FG007|Naloxone Challenge Phase|Adverse Event|0|||
125883550|NCT01746901|452871519|FG008|Naloxone Challenge Phase|Adverse Event|0|||
125883551|NCT01746901|452871511|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
126101481|NCT02915302|453666125|FG001|Overall Study|Withdrawal by Subject|29|||
126101482|NCT02915302|453666124|FG000|Overall Study|Other|1|||
126101483|NCT02915302|453666125|FG001|Overall Study|Other|0|||
126101484|NCT00690443|453666126|FG000|Overall Study|Adverse Event|1|||
126101485|NCT00690443|453666127|FG001|Overall Study|Adverse Event|2|||
126101486|NCT01877837|453666128|FG000|Overall Study|Lost to Follow-up|1|||
126101487|NCT01877837|453666128|FG000|Overall Study|Ineligible|4|||
126101488|NCT00645801|453666130|FG000|Overall Study|unclear if patient took all the medication.|1|||
126101489|NCT00645801|453666131|FG001|Overall Study|unclear if patient took all the medication.|0|||
126101490|NCT00645801|453666130|FG000|Overall Study|Lost to Follow-up|19|||
126101491|NCT00645801|453666131|FG001|Overall Study|Lost to Follow-up|15|||
126101492|NCT00705679|453666132|FG000|Overall Study|Adverse Event|1|||
126101493|NCT00705679|453666133|FG001|Overall Study|Adverse Event|1|||
126101494|NCT00705679|453666134|FG002|Overall Study|Adverse Event|0|||
126101495|NCT00705679|453666135|FG003|Overall Study|Adverse Event|0|||
126101496|NCT00705679|453666136|FG004|Overall Study|Adverse Event|0|||
126296832|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
126296833|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
126296834|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
126296835|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
126296836|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
126296837|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
126101497|NCT00705679|453666132|FG000|Overall Study|Death|0|||
126101498|NCT00705679|453666133|FG001|Overall Study|Death|0|||
126101499|NCT00705679|453666134|FG002|Overall Study|Death|3|||
126101500|NCT00705679|453666135|FG003|Overall Study|Death|2|||
126101501|NCT00705679|453666136|FG004|Overall Study|Death|1|||
126101502|NCT00705679|453666132|FG000|Overall Study|Lost to Follow-up|32|||
126101503|NCT00705679|453666133|FG001|Overall Study|Lost to Follow-up|60|||
126101504|NCT00705679|453666134|FG002|Overall Study|Lost to Follow-up|44|||
126101505|NCT00705679|453666135|FG003|Overall Study|Lost to Follow-up|30|||
126101506|NCT00705679|453666136|FG004|Overall Study|Lost to Follow-up|35|||
126101507|NCT00705679|453666132|FG000|Overall Study|Physician Decision|0|||
126101508|NCT00705679|453666133|FG001|Overall Study|Physician Decision|1|||
126101509|NCT00705679|453666134|FG002|Overall Study|Physician Decision|0|||
126101510|NCT00705679|453666135|FG003|Overall Study|Physician Decision|1|||
126101511|NCT00705679|453666136|FG004|Overall Study|Physician Decision|0|||
126101512|NCT00705679|453666132|FG000|Overall Study|Withdrawal by Subject|32|||
126101513|NCT00705679|453666133|FG001|Overall Study|Withdrawal by Subject|77|||
126101514|NCT00705679|453666134|FG002|Overall Study|Withdrawal by Subject|68|||
126101515|NCT00705679|453666135|FG003|Overall Study|Withdrawal by Subject|47|||
126101516|NCT00705679|453666136|FG004|Overall Study|Withdrawal by Subject|33|||
126101517|NCT00932113|453666137|FG000|Overall Study|Lost to Follow-up|1|||
126101518|NCT00932113|453666138|FG001|Overall Study|Lost to Follow-up|0|||
126101519|NCT01776541|453666142|FG000|Overall Study|Administrative Reason|6|||
126101520|NCT01776541|453666143|FG001|Overall Study|Administrative Reason|2|||
126101521|NCT01776541|453666142|FG000|Overall Study|Death|4|||
126296838|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
126296839|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
126296840|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
126296841|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
126296842|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
126296843|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
126101522|NCT01776541|453666143|FG001|Overall Study|Death|0|||
126101523|NCT01776541|453666142|FG000|Overall Study|Lost to Follow-up|27|||
126101524|NCT01776541|453666143|FG001|Overall Study|Lost to Follow-up|48|||
126101525|NCT01776541|453666142|FG000|Overall Study|Unclassified|5|||
126101526|NCT01776541|453666143|FG001|Overall Study|Unclassified|4|||
126101527|NCT01776541|453666142|FG000|Overall Study|Protocol Violation|2|||
126101528|NCT01776541|453666143|FG001|Overall Study|Protocol Violation|1|||
126101529|NCT01776541|453666142|FG000|Overall Study|Withdrawal by Subject|12|||
126101530|NCT01776541|453666143|FG001|Overall Study|Withdrawal by Subject|20|||
126101531|NCT02090959|453666144|FG000|Overall Study|Withdrawal by Subject|10|||
126101532|NCT02090959|453666144|FG000|Overall Study|Adverse Event|1|||
126101533|NCT02090959|453666144|FG000|Overall Study|Investigator decision|2|||
126101534|NCT02090959|453666144|FG000|Overall Study|Study termination|6|||
126101535|NCT02090959|453666144|FG000|Overall Study|Enrolled but not treated|1|||
126101536|NCT02090959|453666144|FG000|Overall Study|Transfer for compassionate use medicine|4|||
126101537|NCT02090959|453666144|FG000|Overall Study|Move to medical need program|3|||
126101538|NCT02090959|453666144|FG000|Overall Study|Entered in to other study|34|||
126101539|NCT02090959|453666144|FG000|Overall Study|Switched to commercial supply|88|||
126101540|NCT02090959|453666144|FG000|Overall Study|Other than specified|2|||
126101541|NCT00522873|453666147|FG000|Overall Study|Adverse Event|41|||
126101542|NCT00522873|453666148|FG001|Overall Study|Adverse Event|26|||
126101543|NCT00522873|453666147|FG000|Overall Study|Withdrawal by Subject|20|||
126101544|NCT00522873|453666148|FG001|Overall Study|Withdrawal by Subject|9|||
126101545|NCT00522873|453666147|FG000|Overall Study|Protocol Violation|14|||
126101546|NCT00522873|453666148|FG001|Overall Study|Protocol Violation|4|||
126101547|NCT00522873|453666147|FG000|Overall Study|Lost to Follow-up|11|||
126101548|NCT00522873|453666148|FG001|Overall Study|Lost to Follow-up|3|||
126101549|NCT00522873|453666147|FG000|Overall Study|Personal Reasons|8|||
126101550|NCT00522873|453666148|FG001|Overall Study|Personal Reasons|1|||
126101551|NCT00522873|453666147|FG000|Overall Study|Medication Errors|1|||
126101552|NCT00522873|453666148|FG001|Overall Study|Medication Errors|1|||
126101553|NCT00522873|453666147|FG000|Overall Study|Never Received Medication|1|||
126101554|NCT00522873|453666148|FG001|Overall Study|Never Received Medication|0|||
126101555|NCT01248065|453666151|FG000|Overall Study|Lost to Follow-up|3|||
126101556|NCT01248065|453666152|FG001|Overall Study|Lost to Follow-up|5|||
126101557|NCT01248065|453666151|FG000|Overall Study|Withdrawal by Subject|14|||
126101558|NCT01248065|453666152|FG001|Overall Study|Withdrawal by Subject|11|||
126101559|NCT01248065|453666151|FG000|Overall Study|Adverse Event|3|||
126101560|NCT01248065|453666152|FG001|Overall Study|Adverse Event|0|||
126101561|NCT01248065|453666151|FG000|Overall Study|Third treatment failure event|3|||
126101562|NCT01248065|453666152|FG001|Overall Study|Third treatment failure event|1|||
126101563|NCT01248065|453666151|FG000|Overall Study|Other|3|||
126101564|NCT01248065|453666152|FG001|Overall Study|Other|5|||
126101565|NCT03010176|453666156|FG000|Overall Study|Death|21|||
126101566|NCT03010176|453666157|FG001|Overall Study|Death|35|||
126101567|NCT03010176|453666158|FG002|Overall Study|Death|19|||
126101568|NCT03010176|453666159|FG003|Overall Study|Death|19|||
126101569|NCT03010176|453666160|FG004|Overall Study|Death|14|||
126101570|NCT03010176|453666161|FG005|Overall Study|Death|0|||
126101571|NCT03010176|453666156|FG000|Overall Study|Lost to Follow-up|0|||
126101572|NCT03010176|453666157|FG001|Overall Study|Lost to Follow-up|0|||
126101573|NCT03010176|453666158|FG002|Overall Study|Lost to Follow-up|0|||
126101574|NCT03010176|453666159|FG003|Overall Study|Lost to Follow-up|0|||
126101575|NCT03010176|453666160|FG004|Overall Study|Lost to Follow-up|1|||
126101576|NCT03010176|453666161|FG005|Overall Study|Lost to Follow-up|0|||
126101577|NCT03010176|453666156|FG000|Overall Study|Physician Decision|0|||
126101578|NCT03010176|453666157|FG001|Overall Study|Physician Decision|4|||
126101579|NCT03010176|453666158|FG002|Overall Study|Physician Decision|0|||
126101580|NCT03010176|453666159|FG003|Overall Study|Physician Decision|1|||
126101581|NCT03010176|453666160|FG004|Overall Study|Physician Decision|0|||
126101582|NCT03010176|453666161|FG005|Overall Study|Physician Decision|0|||
126101583|NCT03010176|453666156|FG000|Overall Study|Sponsor Decision|0|||
126101584|NCT03010176|453666157|FG001|Overall Study|Sponsor Decision|4|||
126101585|NCT03010176|453666158|FG002|Overall Study|Sponsor Decision|4|||
126101586|NCT03010176|453666159|FG003|Overall Study|Sponsor Decision|1|||
126101587|NCT03010176|453666160|FG004|Overall Study|Sponsor Decision|6|||
126101588|NCT03010176|453666161|FG005|Overall Study|Sponsor Decision|0|||
126101589|NCT03010176|453666156|FG000|Overall Study|Withdrawal by Subject|11|||
126101590|NCT03010176|453666157|FG001|Overall Study|Withdrawal by Subject|9|||
126101591|NCT03010176|453666158|FG002|Overall Study|Withdrawal by Subject|3|||
126101592|NCT03010176|453666159|FG003|Overall Study|Withdrawal by Subject|0|||
126101593|NCT03010176|453666160|FG004|Overall Study|Withdrawal by Subject|4|||
126101594|NCT03010176|453666161|FG005|Overall Study|Withdrawal by Subject|0|||
126101595|NCT04256629|453666162|FG000|Overall Study|Adverse Event|0|||
126101596|NCT04256629|453666163|FG001|Overall Study|Adverse Event|0|||
126101597|NCT04256629|453666164|FG002|Overall Study|Adverse Event|0|||
126101598|NCT04256629|453666165|FG003|Overall Study|Adverse Event|0|||
126101599|NCT04256629|453666166|FG004|Overall Study|Adverse Event|0|||
126101600|NCT04256629|453666167|FG005|Overall Study|Adverse Event|1|||
126101601|NCT04256629|453666162|FG000|Overall Study|Protocol Violation|0|||
126101602|NCT04256629|453666163|FG001|Overall Study|Protocol Violation|1|||
126101603|NCT04256629|453666164|FG002|Overall Study|Protocol Violation|0|||
126101604|NCT04256629|453666165|FG003|Overall Study|Protocol Violation|0|||
126101605|NCT04256629|453666166|FG004|Overall Study|Protocol Violation|0|||
126101606|NCT04256629|453666167|FG005|Overall Study|Protocol Violation|0|||
126101607|NCT01774487|453666168|FG000|Overall Study|Did not tolerate taste|4|||
126101608|NCT01774487|453666169|FG001|Overall Study|Did not tolerate taste|4|||
126101609|NCT04447846|453666170|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
126101610|NCT00461032|453666171|FG000|Overall Study|Adverse Event|5|||
126101611|NCT00461032|453666172|FG001|Overall Study|Adverse Event|6|||
126101612|NCT00461032|453666171|FG000|Overall Study|Lack of Efficacy|5|||
126101613|NCT00461032|453666172|FG001|Overall Study|Lack of Efficacy|1|||
126101614|NCT00461032|453666171|FG000|Overall Study|Lost to Follow-up|7|||
126101615|NCT00461032|453666172|FG001|Overall Study|Lost to Follow-up|12|||
126101616|NCT00461032|453666171|FG000|Overall Study|Protocol Violation|4|||
126101617|NCT00461032|453666172|FG001|Overall Study|Protocol Violation|4|||
126101618|NCT00461032|453666171|FG000|Overall Study|Withdrawal by Subject|7|||
126101619|NCT00461032|453666172|FG001|Overall Study|Withdrawal by Subject|15|||
126296844|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
126296845|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
126296846|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
126296847|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
126296848|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
126296849|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
126296850|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
126296851|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Site closed|0|||
126296852|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Site closed|0|||
126296853|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Site closed|1|||
126296854|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Site closed|0|||
126296855|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
126101620|NCT00461032|453666171|FG000|Overall Study|Patient Moved or Relocated|2|||
126101621|NCT00461032|453666172|FG001|Overall Study|Patient Moved or Relocated|1|||
126101622|NCT00461032|453666171|FG000|Overall Study|Other|7|||
126101623|NCT00461032|453666172|FG001|Overall Study|Other|5|||
126101624|NCT01878214|453666173|FG000|Overall Study|Withdrawal by Subject|18|||
126101625|NCT01878214|453666174|FG001|Overall Study|Withdrawal by Subject|7|||
126101626|NCT01878214|453666173|FG000|Overall Study|Death|0|||
126101627|NCT01878214|453666174|FG001|Overall Study|Death|1|||
126101628|NCT01878214|453666173|FG000|Overall Study|Lost to Follow-up|35|||
126101629|NCT01878214|453666174|FG001|Overall Study|Lost to Follow-up|36|||
126296856|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
126296857|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
126101630|NCT00946101|453666175|FG000|Overall Study|Lost to Follow-up|2|||
126101631|NCT00946101|453666176|FG001|Overall Study|Lost to Follow-up|1|||
126101632|NCT00946101|453666175|FG000|Overall Study|Withdrawal of consent|2|||
126101633|NCT00946101|453666176|FG001|Overall Study|Withdrawal of consent|0|||
126101634|NCT00946101|453666175|FG000|Overall Study|Physician Decision|0|||
126101635|NCT00946101|453666176|FG001|Overall Study|Physician Decision|1|||
126101636|NCT02647866|453666179|FG000|Overall Study|Adverse Event|0|||
126101637|NCT02647866|453666180|FG001|Overall Study|Adverse Event|0|||
126101638|NCT02647866|453666181|FG002|Overall Study|Adverse Event|2|||
126101639|NCT02647866|453666182|FG003|Overall Study|Adverse Event|2|||
126101640|NCT02647866|453666183|FG004|Overall Study|Adverse Event|1|||
126101641|NCT02647866|453666179|FG000|Overall Study|Disease Worsening|3|||
126101642|NCT02647866|453666180|FG001|Overall Study|Disease Worsening|1|||
126101643|NCT02647866|453666181|FG002|Overall Study|Disease Worsening|0|||
126101644|NCT02647866|453666182|FG003|Overall Study|Disease Worsening|0|||
126101645|NCT02647866|453666183|FG004|Overall Study|Disease Worsening|1|||
126101646|NCT02647866|453666179|FG000|Overall Study|Withdrawal by Subject|1|||
126101647|NCT02647866|453666180|FG001|Overall Study|Withdrawal by Subject|1|||
126101648|NCT02647866|453666181|FG002|Overall Study|Withdrawal by Subject|2|||
126101649|NCT02647866|453666182|FG003|Overall Study|Withdrawal by Subject|4|||
126101650|NCT02647866|453666183|FG004|Overall Study|Withdrawal by Subject|4|||
126101651|NCT02647866|453666179|FG000|Overall Study|Physician Decision|0|||
126101652|NCT02647866|453666180|FG001|Overall Study|Physician Decision|1|||
126101653|NCT02647866|453666181|FG002|Overall Study|Physician Decision|1|||
126101654|NCT02647866|453666182|FG003|Overall Study|Physician Decision|0|||
126101655|NCT02647866|453666183|FG004|Overall Study|Physician Decision|2|||
126101656|NCT02647866|453666179|FG000|Overall Study|Death|0|||
126101657|NCT02647866|453666180|FG001|Overall Study|Death|1|||
125883552|NCT01746901|452871512|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125883553|NCT01746901|452871513|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125883554|NCT01746901|452871514|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125883555|NCT01746901|452871515|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125883556|NCT01746901|452871516|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125883557|NCT01746901|452871517|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126042951|NCT05285137|453454728|FG001|Overall Study|Withdrawal by Subject|1|||
126042952|NCT05285137|453454729|FG002|Overall Study|Withdrawal by Subject|2|||
126042953|NCT05285137|453454730|FG003|Overall Study|Withdrawal by Subject|1|||
126042954|NCT05285137|453454731|FG004|Overall Study|Withdrawal by Subject|0|||
126042955|NCT05285137|453454732|FG005|Overall Study|Withdrawal by Subject|0|||
126042956|NCT05285137|453454733|FG006|Overall Study|Withdrawal by Subject|0|||
126042957|NCT05285137|453454734|FG007|Overall Study|Withdrawal by Subject|0|||
126042958|NCT05285137|453454735|FG008|Overall Study|Withdrawal by Subject|1|||
126042959|NCT03717935|453454736|FG000|Overall Study|Withdrawal by Subject|0|||
126042960|NCT03717935|453454737|FG001|Overall Study|Withdrawal by Subject|2|||
126042961|NCT03484819|453454742|FG000|Overall Study|Death|2|||
126042962|NCT03484819|453454742|FG000|Overall Study|Adverse Event|2|||
126042963|NCT03484819|453454742|FG000|Overall Study|Physician Decision|1|||
126042964|NCT03484819|453454742|FG000|Overall Study|Withdrawal by Subject|2|||
126042965|NCT03484819|453454742|FG000|Overall Study|Disease Progression|4|||
126042966|NCT03484819|453454742|FG000|Overall Study|Complicating Condition|1|||
126042967|NCT01199133|453454747|FG000|Year 1|Adverse Event|16|||
126042968|NCT01199133|453454748|FG001|Year 1|Adverse Event|4|||
126042969|NCT01199133|453454747|FG000|Year 1|Withdrawal by Subject|8|||
126042970|NCT01199133|453454748|FG001|Year 1|Withdrawal by Subject|4|||
126042971|NCT01199133|453454747|FG000|Year 1|Any other reason not above-mentioned|6|||
126042972|NCT01199133|453454748|FG001|Year 1|Any other reason not above-mentioned|7|||
126042973|NCT01199133|453454747|FG000|Year 2|Adverse Event|1|||
126042974|NCT01199133|453454748|FG001|Year 2|Adverse Event|0|||
126042975|NCT01199133|453454747|FG000|Year 2|Withdrawal by Subject|1|||
126042976|NCT01199133|453454748|FG001|Year 2|Withdrawal by Subject|1|||
126042977|NCT01199133|453454747|FG000|Year 2|Any other reason not above-mentioned|1|||
126042978|NCT01199133|453454748|FG001|Year 2|Any other reason not above-mentioned|2|||
126042979|NCT03988621|453454749|FG000|Overall Study|Lost to Follow-up|16|||
126042980|NCT03988621|453454750|FG001|Overall Study|Lost to Follow-up|17|||
126042981|NCT03988621|453454749|FG000|Overall Study|Withdrawal by Subject|14|||
126042982|NCT03988621|453454750|FG001|Overall Study|Withdrawal by Subject|7|||
126042983|NCT03988621|453454749|FG000|Overall Study|Patient Lost to Follow Up|15|||
126042984|NCT03988621|453454750|FG001|Overall Study|Patient Lost to Follow Up|15|||
126042985|NCT03988621|453454749|FG000|Overall Study|Patient death|1|||
126042986|NCT03988621|453454750|FG001|Overall Study|Patient death|5|||
126042987|NCT05013385|453454751|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
126042988|NCT04629339|453454754|FG000|Overall Study|Death|1|||
126101658|NCT02647866|453666181|FG002|Overall Study|Death|0|||
125883558|NCT01746901|452871518|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126042989|NCT04629339|453454755|FG001|Overall Study|Death|0|||
126042990|NCT04629339|453454756|FG002|Overall Study|Death|2|||
126042991|NCT04629339|453454757|FG003|Overall Study|Death|2|||
126042992|NCT04629339|453454758|FG004|Overall Study|Death|0|||
126101659|NCT02647866|453666182|FG003|Overall Study|Death|0|||
126042993|NCT04629339|453454754|FG000|Overall Study|Disease Progression|0|||
126042994|NCT04629339|453454755|FG001|Overall Study|Disease Progression|0|||
126042995|NCT04629339|453454756|FG002|Overall Study|Disease Progression|1|||
126042996|NCT04629339|453454757|FG003|Overall Study|Disease Progression|1|||
126101660|NCT02647866|453666183|FG004|Overall Study|Death|0|||
126101661|NCT02647866|453666179|FG000|Overall Study|Subject moved to different country|1|||
126101662|NCT02647866|453666180|FG001|Overall Study|Subject moved to different country|0|||
126101663|NCT02647866|453666181|FG002|Overall Study|Subject moved to different country|0|||
126296858|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
126296859|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
126296860|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
126296861|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
126296862|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
126296863|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
126296864|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
126296865|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
126296866|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
126296867|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
126296868|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
126296869|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
126296870|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
126296871|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
126296872|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
126296873|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
126296874|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
126296875|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
126296876|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
126296877|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
126296878|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
126296879|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
126296880|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
126296881|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
126296882|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
126296883|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
126296884|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
126296885|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
126296886|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
126296887|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
126296888|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
126296889|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
126296890|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
126296891|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
126296892|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
126296893|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
126296894|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
126296895|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
126296896|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
126296897|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
126296898|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
126296899|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
126296900|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
126101664|NCT02647866|453666182|FG003|Overall Study|Subject moved to different country|0|||
126101665|NCT02647866|453666183|FG004|Overall Study|Subject moved to different country|0|||
126101666|NCT00069108|453666184|FG000|Overall Study|Withdrawal by Subject|5|||
126101667|NCT00069108|453666185|FG001|Overall Study|Withdrawal by Subject|9|||
126101668|NCT00069108|453666184|FG000|Overall Study|Adverse Event|64|||
126101669|NCT00069108|453666185|FG001|Overall Study|Adverse Event|42|||
126101670|NCT00069108|453666184|FG000|Overall Study|Death|6|||
126101671|NCT00069108|453666185|FG001|Overall Study|Death|6|||
126101672|NCT00069108|453666184|FG000|Overall Study|Administration|15|||
126101673|NCT00069108|453666185|FG001|Overall Study|Administration|4|||
126296901|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
126296902|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
126296903|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
126296904|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
126296905|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
126296906|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
126296907|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Missing|1|||
126296908|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Missing|2|||
126296909|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Missing|1|||
126101674|NCT00069108|453666184|FG000|Overall Study|Insufficient therapy|117|||
126101675|NCT00069108|453666185|FG001|Overall Study|Insufficient therapy|144|||
126101676|NCT00069108|453666184|FG000|Overall Study|Violation criteria|1|||
126101677|NCT00069108|453666185|FG001|Overall Study|Violation criteria|4|||
126101678|NCT00069108|453666184|FG000|Overall Study|Refused treatment|5|||
126101679|NCT00069108|453666185|FG001|Overall Study|Refused treatment|10|||
126101680|NCT01415531|453666187|FG000|Overall Study|Adverse Event|7|||
126101681|NCT01415531|453666188|FG001|Overall Study|Adverse Event|10|||
126101682|NCT01415531|453666187|FG000|Overall Study|Lack of Efficacy|3|||
126101683|NCT01415531|453666188|FG001|Overall Study|Lack of Efficacy|2|||
126101684|NCT01415531|453666187|FG000|Overall Study|Protocol Violation|0|||
126101685|NCT01415531|453666188|FG001|Overall Study|Protocol Violation|1|||
126101686|NCT01415531|453666187|FG000|Overall Study|Withdrawal by Subject|5|||
126101687|NCT01415531|453666188|FG001|Overall Study|Withdrawal by Subject|4|||
126101688|NCT01415531|453666187|FG000|Overall Study|Lost to Follow-up|6|||
126101689|NCT01415531|453666188|FG001|Overall Study|Lost to Follow-up|14|||
126101690|NCT01415531|453666187|FG000|Overall Study|Lack of Compliance|1|||
126101691|NCT01415531|453666188|FG001|Overall Study|Lack of Compliance|4|||
126101692|NCT01415531|453666187|FG000|Overall Study|Other Reasons|3|||
126101693|NCT01415531|453666188|FG001|Overall Study|Other Reasons|2|||
126101694|NCT00394082|453666191|FG000|Overall Study|Unacceptable toxicity|15|||
126101695|NCT00394082|453666191|FG000|Overall Study|Adverse Event|4|||
126101696|NCT00394082|453666191|FG000|Overall Study|Physician Decision|4|||
126101697|NCT00394082|453666191|FG000|Overall Study|Withdrawal by Subject|2|||
126101698|NCT00394082|453666191|FG000|Overall Study|Other|1|||
126101699|NCT02344004|453666193|FG000|Overall Study|Adverse Event|11|||
126101700|NCT02344004|453666194|FG001|Overall Study|Adverse Event|1|||
126101701|NCT02344004|453666193|FG000|Overall Study|Death|9|||
126101702|NCT02344004|453666194|FG001|Overall Study|Death|7|||
126101703|NCT02344004|453666193|FG000|Overall Study|Physician Decision|4|||
126101704|NCT02344004|453666194|FG001|Overall Study|Physician Decision|1|||
126101705|NCT02344004|453666193|FG000|Overall Study|Withdrawal by Subject|22|||
126101706|NCT02344004|453666194|FG001|Overall Study|Withdrawal by Subject|5|||
126101707|NCT02344004|453666193|FG000|Overall Study|Rescue Medication|2|||
126101708|NCT02344004|453666194|FG001|Overall Study|Rescue Medication|0|||
126101709|NCT02344004|453666193|FG000|Overall Study|Other Not Specified|12|||
126101710|NCT02344004|453666194|FG001|Overall Study|Other Not Specified|0|||
126101711|NCT02344004|453666193|FG000|Overall Study|Protocol Violation|1|||
126101712|NCT02344004|453666194|FG001|Overall Study|Protocol Violation|0|||
126101713|NCT02481947|453666198|FG000|Overall Study|Withdrawal by Subject|24|||
126101714|NCT02481947|453666199|FG001|Overall Study|Withdrawal by Subject|10|||
126101715|NCT02481947|453666198|FG000|Overall Study|Lost to Follow-up|11|||
126101716|NCT02481947|453666199|FG001|Overall Study|Lost to Follow-up|5|||
126101717|NCT02481947|453666198|FG000|Overall Study|Adverse Event|6|||
126101718|NCT02481947|453666199|FG001|Overall Study|Adverse Event|11|||
126101719|NCT02481947|453666198|FG000|Overall Study|Physician Decision|4|||
126101720|NCT02481947|453666199|FG001|Overall Study|Physician Decision|5|||
126101721|NCT02481947|453666198|FG000|Overall Study|Protocol Violation|1|||
126101722|NCT02481947|453666199|FG001|Overall Study|Protocol Violation|5|||
126101723|NCT05249829|453666200|FG000|Overall Study|Participant Relocation|0|||
126101724|NCT05249829|453666201|FG001|Overall Study|Participant Relocation|1|||
126101725|NCT05249829|453666202|FG002|Overall Study|Participant Relocation|2|||
126101726|NCT05249829|453666203|FG003|Overall Study|Participant Relocation|2|||
126101727|NCT05249829|453666200|FG000|Overall Study|Withdrawal by Subject|9|||
126101728|NCT05249829|453666201|FG001|Overall Study|Withdrawal by Subject|17|||
126101729|NCT05249829|453666202|FG002|Overall Study|Withdrawal by Subject|40|||
126101730|NCT05249829|453666203|FG003|Overall Study|Withdrawal by Subject|35|||
126101731|NCT05249829|453666200|FG000|Overall Study|Physician Decision|1|||
126101732|NCT05249829|453666201|FG001|Overall Study|Physician Decision|0|||
126101733|NCT05249829|453666202|FG002|Overall Study|Physician Decision|0|||
126101734|NCT05249829|453666203|FG003|Overall Study|Physician Decision|0|||
126101735|NCT05249829|453666200|FG000|Overall Study|Lost to Follow-up|16|||
126101736|NCT05249829|453666201|FG001|Overall Study|Lost to Follow-up|16|||
126101737|NCT05249829|453666202|FG002|Overall Study|Lost to Follow-up|57|||
126101738|NCT05249829|453666203|FG003|Overall Study|Lost to Follow-up|60|||
126101739|NCT05249829|453666200|FG000|Overall Study|Adverse Event|2|||
126101740|NCT05249829|453666201|FG001|Overall Study|Adverse Event|2|||
126101741|NCT05249829|453666202|FG002|Overall Study|Adverse Event|2|||
126101742|NCT05249829|453666203|FG003|Overall Study|Adverse Event|2|||
126101743|NCT05249829|453666200|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
126101744|NCT05249829|453666201|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
126101745|NCT05249829|453666202|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
126101746|NCT05249829|453666203|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
126101747|NCT05249829|453666200|FG000|Overall Study|Protocol Violation|2|||
126101748|NCT05249829|453666201|FG001|Overall Study|Protocol Violation|0|||
126101749|NCT05249829|453666202|FG002|Overall Study|Protocol Violation|5|||
126101750|NCT05249829|453666203|FG003|Overall Study|Protocol Violation|3|||
126101751|NCT05249829|453666200|FG000|Overall Study|Death|0|||
126101752|NCT05249829|453666201|FG001|Overall Study|Death|1|||
126101753|NCT05249829|453666202|FG002|Overall Study|Death|2|||
126101754|NCT05249829|453666203|FG003|Overall Study|Death|4|||
126101755|NCT02842827|453666205|FG000|Overall Study|Adverse Event|0|||
126101756|NCT02842827|453666206|FG001|Overall Study|Adverse Event|1|||
126101757|NCT02842827|453666207|FG002|Overall Study|Adverse Event|0|||
126101758|NCT02842827|453666208|FG003|Overall Study|Adverse Event|1|||
126101759|NCT02842827|453666209|FG004|Overall Study|Adverse Event|0|||
126101760|NCT02842827|453666210|FG005|Overall Study|Adverse Event|1|||
126101761|NCT02842827|453666211|FG006|Overall Study|Adverse Event|0|||
126101762|NCT02842827|453666212|FG007|Overall Study|Adverse Event|0|||
126101763|NCT02842827|453666205|FG000|Overall Study|Death|1|||
126101764|NCT02842827|453666206|FG001|Overall Study|Death|0|||
126101765|NCT02842827|453666207|FG002|Overall Study|Death|2|||
126101766|NCT02842827|453666208|FG003|Overall Study|Death|3|||
126101767|NCT02842827|453666209|FG004|Overall Study|Death|2|||
126101768|NCT02842827|453666210|FG005|Overall Study|Death|1|||
126101769|NCT02842827|453666211|FG006|Overall Study|Death|0|||
126101770|NCT02842827|453666212|FG007|Overall Study|Death|4|||
126101771|NCT02842827|453666205|FG000|Overall Study|Physician Decision|1|||
126101772|NCT02842827|453666206|FG001|Overall Study|Physician Decision|3|||
126101773|NCT02842827|453666207|FG002|Overall Study|Physician Decision|0|||
126101774|NCT02842827|453666208|FG003|Overall Study|Physician Decision|0|||
126101775|NCT02842827|453666209|FG004|Overall Study|Physician Decision|1|||
126101776|NCT02842827|453666210|FG005|Overall Study|Physician Decision|4|||
126101777|NCT02842827|453666211|FG006|Overall Study|Physician Decision|2|||
126101778|NCT02842827|453666212|FG007|Overall Study|Physician Decision|1|||
126101779|NCT02842827|453666205|FG000|Overall Study|Protocol Defined Disease Progression|0|||
126101780|NCT02842827|453666206|FG001|Overall Study|Protocol Defined Disease Progression|0|||
126101781|NCT02842827|453666207|FG002|Overall Study|Protocol Defined Disease Progression|0|||
126101782|NCT02842827|453666208|FG003|Overall Study|Protocol Defined Disease Progression|0|||
126296910|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Missing|1|||
126296911|NCT03096314|454375340|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
126296912|NCT03096314|454375341|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
126296913|NCT03003962|454375342|FG000|Overall Study|Withdrawal by Subject|5|||
126296914|NCT03003962|454375343|FG001|Overall Study|Withdrawal by Subject|17|||
126296915|NCT03003962|454375342|FG000|Overall Study|Death|274|||
126296916|NCT03003962|454375343|FG001|Overall Study|Death|277|||
126296917|NCT03003962|454375342|FG000|Overall Study|Participants ongoing at DCO|55|||
126042997|NCT04629339|453454758|FG004|Overall Study|Disease Progression|0|||
126042998|NCT04629339|453454754|FG000|Overall Study|Lost to Follow-up|0|||
126042999|NCT04629339|453454755|FG001|Overall Study|Lost to Follow-up|0|||
126043000|NCT04629339|453454756|FG002|Overall Study|Lost to Follow-up|0|||
126043001|NCT04629339|453454757|FG003|Overall Study|Lost to Follow-up|1|||
126043002|NCT04629339|453454758|FG004|Overall Study|Lost to Follow-up|0|||
126043003|NCT04629339|453454754|FG000|Overall Study|Physician Decision|0|||
126043004|NCT04629339|453454755|FG001|Overall Study|Physician Decision|1|||
126043005|NCT04629339|453454756|FG002|Overall Study|Physician Decision|0|||
126043006|NCT04629339|453454757|FG003|Overall Study|Physician Decision|0|||
126043007|NCT04629339|453454758|FG004|Overall Study|Physician Decision|0|||
126043008|NCT04629339|453454754|FG000|Overall Study|Study Terminated by Sponsor|0|||
126043009|NCT04629339|453454755|FG001|Overall Study|Study Terminated by Sponsor|0|||
126043010|NCT04629339|453454756|FG002|Overall Study|Study Terminated by Sponsor|0|||
126043011|NCT04629339|453454757|FG003|Overall Study|Study Terminated by Sponsor|1|||
126043012|NCT04629339|453454758|FG004|Overall Study|Study Terminated by Sponsor|0|||
126043013|NCT04629339|453454754|FG000|Overall Study|Withdrawal by Subject|0|||
126043014|NCT04629339|453454755|FG001|Overall Study|Withdrawal by Subject|0|||
126043015|NCT04629339|453454756|FG002|Overall Study|Withdrawal by Subject|2|||
126043016|NCT04629339|453454757|FG003|Overall Study|Withdrawal by Subject|2|||
126043017|NCT04629339|453454758|FG004|Overall Study|Withdrawal by Subject|0|||
126043018|NCT03252288|453454761|FG000|Overall Study|Death|1|||
126043019|NCT03252288|453454762|FG001|Overall Study|Death|0|||
126043020|NCT03252288|453454763|FG002|Overall Study|Death|0|||
126043021|NCT03252288|453454761|FG000|Overall Study|Death|11|||
126043022|NCT03252288|453454762|FG001|Overall Study|Death|0|||
126043023|NCT03252288|453454763|FG002|Overall Study|Death|0|||
126043024|NCT03252288|453454761|FG000|Overall Study|Withdrawal by Subject|2|||
126043025|NCT03252288|453454762|FG001|Overall Study|Withdrawal by Subject|0|||
126043026|NCT03252288|453454763|FG002|Overall Study|Withdrawal by Subject|0|||
126043027|NCT03252288|453454761|FG000|Overall Study|Lost to Follow-up|79|||
126043028|NCT03252288|453454762|FG001|Overall Study|Lost to Follow-up|0|||
126043029|NCT03252288|453454763|FG002|Overall Study|Lost to Follow-up|0|||
126043030|NCT03252288|453454761|FG000|Overall Study|Loss of baseline data on tablets|6|||
126101783|NCT02842827|453666209|FG004|Overall Study|Protocol Defined Disease Progression|0|||
126101784|NCT02842827|453666210|FG005|Overall Study|Protocol Defined Disease Progression|1|||
126296918|NCT03003962|454375343|FG001|Overall Study|Participants ongoing at DCO|40|||
126101785|NCT02842827|453666211|FG006|Overall Study|Protocol Defined Disease Progression|0|||
126101786|NCT02842827|453666212|FG007|Overall Study|Protocol Defined Disease Progression|0|||
126101787|NCT02842827|453666205|FG000|Overall Study|Participant Withdrawal of Consent|1|||
126101788|NCT02842827|453666206|FG001|Overall Study|Participant Withdrawal of Consent|2|||
126043031|NCT03252288|453454762|FG001|Overall Study|Loss of baseline data on tablets|0|||
126101789|NCT02842827|453666207|FG002|Overall Study|Participant Withdrawal of Consent|2|||
126101790|NCT02842827|453666208|FG003|Overall Study|Participant Withdrawal of Consent|2|||
126101791|NCT02842827|453666209|FG004|Overall Study|Participant Withdrawal of Consent|2|||
126101792|NCT02842827|453666210|FG005|Overall Study|Participant Withdrawal of Consent|1|||
126101793|NCT02842827|453666211|FG006|Overall Study|Participant Withdrawal of Consent|2|||
126101794|NCT02842827|453666212|FG007|Overall Study|Participant Withdrawal of Consent|1|||
126101795|NCT01815138|453666215|FG000|Overall Study|Withdrawal by Subject|0|||
126101796|NCT01815138|453666216|FG001|Overall Study|Withdrawal by Subject|1|||
126101797|NCT01815138|453666215|FG000|Overall Study|Physician Decision|8|||
126101798|NCT01815138|453666216|FG001|Overall Study|Physician Decision|5|||
126101799|NCT03426267|453666217|FG000|Overall Study|Physician Decision|1|||
126101800|NCT03426267|453666218|FG001|Overall Study|Physician Decision|4|||
126101801|NCT03426267|453666217|FG000|Overall Study|Lost to Follow-up|1|||
126101802|NCT03426267|453666218|FG001|Overall Study|Lost to Follow-up|0|||
126101803|NCT03426267|453666217|FG000|Overall Study|Withdrawal by Subject|4|||
126296919|NCT03428152|454375351|FG000|Overall Study|Physician Decision|4|||
126043032|NCT03252288|453454763|FG002|Overall Study|Loss of baseline data on tablets|0|||
126101804|NCT03426267|453666218|FG001|Overall Study|Withdrawal by Subject|10|||
126101805|NCT03426267|453666217|FG000|Overall Study|Protocol Violation|1|||
126296920|NCT03428152|454375352|FG001|Overall Study|Physician Decision|2|||
126296921|NCT03428152|454375351|FG000|Overall Study|Protocol Violation|3|||
126296922|NCT03428152|454375352|FG001|Overall Study|Protocol Violation|5|||
126296923|NCT03428152|454375351|FG000|Overall Study|Lack of Efficacy|0|||
126296924|NCT03428152|454375352|FG001|Overall Study|Lack of Efficacy|4|||
126296925|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
126296926|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
126296927|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
126296928|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126043033|NCT01121588|453454767|FG000|Overall Study|Death|5|||
126043034|NCT01121588|453454768|FG001|Overall Study|Death|3|||
126043035|NCT01121588|453454769|FG002|Overall Study|Death|13|||
126043036|NCT01121588|453454767|FG000|Overall Study|Study Terminated by Sponsor|1|||
126043037|NCT01121588|453454768|FG001|Overall Study|Study Terminated by Sponsor|1|||
126043038|NCT01121588|453454769|FG002|Overall Study|Study Terminated by Sponsor|0|||
126043039|NCT01121588|453454767|FG000|Overall Study|Participant Refused Further Followup|2|||
126043040|NCT01121588|453454768|FG001|Overall Study|Participant Refused Further Followup|0|||
126043041|NCT01121588|453454769|FG002|Overall Study|Participant Refused Further Followup|2|||
126043042|NCT01121588|453454767|FG000|Overall Study|Lost to Follow-up|0|||
126043043|NCT01121588|453454768|FG001|Overall Study|Lost to Follow-up|1|||
126043044|NCT01121588|453454769|FG002|Overall Study|Lost to Follow-up|1|||
126043045|NCT01121588|453454767|FG000|Overall Study|Non-Specified Reasons|9|||
126043046|NCT01121588|453454768|FG001|Overall Study|Non-Specified Reasons|4|||
126043047|NCT01121588|453454769|FG002|Overall Study|Non-Specified Reasons|2|||
126043048|NCT02938923|453454777|FG000|Overall Study|Death|1|||
126043049|NCT02938923|453454778|FG001|Overall Study|Death|0|||
126043050|NCT02938923|453454779|FG002|Overall Study|Death|0|||
126043051|NCT02938923|453454777|FG000|Overall Study|Physician Decision|0|||
126043052|NCT02938923|453454778|FG001|Overall Study|Physician Decision|2|||
126043053|NCT02938923|453454779|FG002|Overall Study|Physician Decision|0|||
126043054|NCT02938923|453454777|FG000|Overall Study|Withdrawal by Subject|0|||
126043055|NCT02938923|453454778|FG001|Overall Study|Withdrawal by Subject|1|||
126043056|NCT02938923|453454779|FG002|Overall Study|Withdrawal by Subject|1|||
126043057|NCT02846545|453454783|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
126043058|NCT02846545|453454784|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
126043059|NCT02846545|453454783|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
126043060|NCT02846545|453454784|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
126043061|NCT02846545|453454783|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
126043062|NCT02846545|453454784|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
126043063|NCT02846545|453454783|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
126043064|NCT02846545|453454784|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
126296929|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126043065|NCT02846545|453454783|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
126043066|NCT02846545|453454784|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
126043067|NCT03691298|453454787|FG000|Overall Study|Lost to Follow-up|8|||
126043068|NCT03691298|453454787|FG000|Overall Study|Sponsor terminated study|2|||
126043069|NCT02492711|453454791|FG000|Overall Study|Adverse Event|9|||
126043070|NCT02492711|453454792|FG001|Overall Study|Adverse Event|9|||
126043071|NCT02492711|453454793|FG002|Overall Study|Adverse Event|2|||
126043072|NCT02492711|453454791|FG000|Overall Study|Death|3|||
126101806|NCT03426267|453666218|FG001|Overall Study|Protocol Violation|3|||
126101807|NCT03426267|453666217|FG000|Overall Study|Adverse Event|9|||
126101808|NCT03426267|453666218|FG001|Overall Study|Adverse Event|27|||
126101809|NCT03426267|453666217|FG000|Overall Study|Prohibited Treatment Intake|2|||
126101810|NCT03426267|453666218|FG001|Overall Study|Prohibited Treatment Intake|3|||
126296930|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126101811|NCT03426267|453666217|FG000|Overall Study|Lack of Efficacy|0|||
126101812|NCT03426267|453666218|FG001|Overall Study|Lack of Efficacy|25|||
126101813|NCT03426267|453666217|FG000|Overall Study|other|3|||
126101814|NCT03426267|453666218|FG001|Overall Study|other|0|||
126101815|NCT00609765|453666221|FG000|Overall Study|Study ended prior to 12 months|1|||
126101816|NCT02649946|453666228|FG000|Overall Study|Withdrawal by Subject|1|||
126296931|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126296932|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296933|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296934|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
126296935|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296936|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296937|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296938|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296939|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
126296940|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296941|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
126296942|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296943|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296944|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296945|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296946|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
126296947|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296948|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
126296949|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296950|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296951|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296952|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296953|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
126296954|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
126296955|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
126296956|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126296957|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126101817|NCT02649946|453666229|FG001|Overall Study|Withdrawal by Subject|1|||
126101818|NCT02649946|453666228|FG000|Overall Study|Death|7|||
126101819|NCT02649946|453666229|FG001|Overall Study|Death|9|||
126101820|NCT02649946|453666228|FG000|Overall Study|Physician Decision|1|||
126101821|NCT02649946|453666229|FG001|Overall Study|Physician Decision|0|||
126101822|NCT02649946|453666228|FG000|Overall Study|Lost to Follow-up|2|||
126101823|NCT02649946|453666229|FG001|Overall Study|Lost to Follow-up|1|||
126101824|NCT02649946|453666228|FG000|Overall Study|Erroneously enrolled|1|||
126101825|NCT02649946|453666229|FG001|Overall Study|Erroneously enrolled|0|||
126101826|NCT02649946|453666228|FG000|Overall Study|Missed 6-month follow-up visit|0|||
126296958|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126296959|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126101827|NCT02649946|453666229|FG001|Overall Study|Missed 6-month follow-up visit|4|||
126101828|NCT00950950|453666230|FG000|Overall Study|Adverse Event|1|||
126296960|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126101829|NCT00950950|453666231|FG001|Overall Study|Adverse Event|0|||
126101830|NCT00950950|453666230|FG000|Overall Study|Withdrawal by Subject|0|||
126101831|NCT00950950|453666231|FG001|Overall Study|Withdrawal by Subject|1|||
126101832|NCT01047293|453666232|FG000|Overall Study|DLT criteria not fulfilled|1|||
126101833|NCT01047293|453666233|FG001|Overall Study|DLT criteria not fulfilled|1|||
126101834|NCT01047293|453666234|FG002|Overall Study|DLT criteria not fulfilled|0|||
126101835|NCT01047293|453666235|FG003|Overall Study|DLT criteria not fulfilled|0|||
126101836|NCT01272804|453666241|FG000|Overall Study|Adverse Event|1|||
126101837|NCT01272804|453666242|FG001|Overall Study|Adverse Event|0|||
126101838|NCT01272804|453666243|FG002|Overall Study|Adverse Event|0|||
126101839|NCT01272804|453666244|FG003|Overall Study|Adverse Event|0|||
126101840|NCT01272804|453666245|FG004|Overall Study|Adverse Event|2|||
126101841|NCT01272804|453666246|FG005|Overall Study|Adverse Event|1|||
126101842|NCT02318797|453666247|FG000|Overall Study|Death|3|||
126101843|NCT02318797|453666248|FG001|Overall Study|Death|6|||
126101844|NCT02318797|453666247|FG000|Overall Study|Lost to Follow-up|85|||
126101845|NCT02318797|453666248|FG001|Overall Study|Lost to Follow-up|96|||
126101846|NCT02003573|453666251|FG000|Overall Study|Progressive disease|2|||
126101847|NCT02003573|453666252|FG001|Overall Study|Progressive disease|0|||
126101848|NCT02003573|453666253|FG002|Overall Study|Progressive disease|1|||
126101849|NCT02003573|453666251|FG000|Overall Study|Other Adverse event|0|||
126296961|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126296962|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
126296963|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126296964|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126296965|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126101850|NCT02003573|453666252|FG001|Overall Study|Other Adverse event|1|||
126101851|NCT02003573|453666253|FG002|Overall Study|Other Adverse event|1|||
126101852|NCT02003573|453666251|FG000|Overall Study|Refuse to take trial medication|0|||
126101853|NCT02003573|453666252|FG001|Overall Study|Refuse to take trial medication|1|||
126101854|NCT02003573|453666253|FG002|Overall Study|Refuse to take trial medication|1|||
126101855|NCT02003573|453666251|FG000|Overall Study|Other than specified|1|||
126101856|NCT02003573|453666252|FG001|Overall Study|Other than specified|2|||
126101857|NCT02003573|453666253|FG002|Overall Study|Other than specified|3|||
126101858|NCT02112708|453666256|FG000|Baseline|Physician Decision|16|||
126101859|NCT02112708|453666257|FG001|Baseline|Physician Decision|11|||
126101860|NCT02112708|453666256|FG000|Baseline|Lost to Follow-up|12|||
126101861|NCT02112708|453666257|FG001|Baseline|Lost to Follow-up|0|||
126101862|NCT02112708|453666256|FG000|4 Month|Death|0|||
126306332|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126101863|NCT02112708|453666257|FG001|4 Month|Death|1|||
126101864|NCT02112708|453666256|FG000|4 Month|Withdrawal by Subject|12|||
126101865|NCT02112708|453666257|FG001|4 Month|Withdrawal by Subject|0|||
126101866|NCT02232243|453666262|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
126101867|NCT02232243|453666263|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
126101868|NCT02232243|453666264|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
126101869|NCT00704405|453666265|FG000|Overall Study (NC Population)|Adverse Event|1|||
126101870|NCT00704405|453666266|FG001|Overall Study (NC Population)|Adverse Event|0|||
126101871|NCT00704405|453666267|FG002|Overall Study (NC Population)|Adverse Event|0|||
126101872|NCT00704405|453666268|FG003|Overall Study (NC Population)|Adverse Event|0|||
126101873|NCT00704405|453666269|FG004|Overall Study (NC Population)|Adverse Event|0|||
126101874|NCT00704405|453666265|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
126101875|NCT00704405|453666266|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
126101876|NCT00704405|453666267|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
126101877|NCT00704405|453666268|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
126101878|NCT00704405|453666269|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
126101879|NCT00704405|453666265|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
126101880|NCT00704405|453666266|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
126101881|NCT00704405|453666267|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
126101882|NCT00704405|453666268|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
126101883|NCT00704405|453666269|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
126101884|NCT00704405|453666265|FG000|Overall Study (NC Population)|Other|0|||
126101885|NCT00704405|453666266|FG001|Overall Study (NC Population)|Other|0|||
126101886|NCT00704405|453666267|FG002|Overall Study (NC Population)|Other|0|||
126101887|NCT00704405|453666268|FG003|Overall Study (NC Population)|Other|0|||
126101888|NCT00704405|453666269|FG004|Overall Study (NC Population)|Other|1|||
126101889|NCT00704405|453666265|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
126101890|NCT00704405|453666266|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
126101891|NCT00704405|453666267|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
126101892|NCT00704405|453666268|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
126101893|NCT00704405|453666269|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
126101894|NCT00704405|453666265|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
126101895|NCT00704405|453666266|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
126101896|NCT00704405|453666267|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
126101897|NCT00704405|453666268|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
126101898|NCT00704405|453666269|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
126101899|NCT01395888|453666270|FG000|2-week Run-in Period|Adverse Event|2|||
126101900|NCT01395888|453666271|FG001|2-week Run-in Period|Adverse Event|0|||
126101901|NCT01395888|453666272|FG002|2-week Run-in Period|Adverse Event|0|||
126101902|NCT01395888|453666270|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
126101903|NCT01395888|453666271|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
126101904|NCT01395888|453666272|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
126101905|NCT01395888|453666270|FG000|2-week Run-in Period|Lost to Follow-up|1|||
126101906|NCT01395888|453666271|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126101907|NCT01395888|453666272|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126101908|NCT01395888|453666270|FG000|2-week Run-in Period|Protocol Violation|2|||
126101909|NCT01395888|453666271|FG001|2-week Run-in Period|Protocol Violation|0|||
126101910|NCT01395888|453666272|FG002|2-week Run-in Period|Protocol Violation|0|||
126101911|NCT01395888|453666270|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
126101912|NCT01395888|453666271|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126101913|NCT01395888|453666272|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126101914|NCT01395888|453666270|FG000|Treatment Period (TP)|Adverse Event|0|||
126101915|NCT01395888|453666271|FG001|Treatment Period (TP)|Adverse Event|7|||
126101916|NCT01395888|453666272|FG002|Treatment Period (TP)|Adverse Event|6|||
126101917|NCT01395888|453666270|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
126101918|NCT01395888|453666271|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
126101919|NCT01395888|453666272|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
126101920|NCT01395888|453666270|FG000|Treatment Period (TP)|Protocol Violation|0|||
126101921|NCT01395888|453666271|FG001|Treatment Period (TP)|Protocol Violation|1|||
126101922|NCT01395888|453666272|FG002|Treatment Period (TP)|Protocol Violation|5|||
126101923|NCT01395888|453666270|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
126101924|NCT01395888|453666271|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
126101925|NCT01395888|453666272|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
126101926|NCT01395888|453666270|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
126101927|NCT01395888|453666271|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
126101928|NCT01395888|453666272|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
126101929|NCT00928018|453666273|FG000|Overall Study|Withdrawal by Subject|1|||
126101930|NCT00928018|453666274|FG001|Overall Study|Withdrawal by Subject|0|||
126101931|NCT01946438|453666275|FG000|Overall Study|Adverse Event|0|||
126101932|NCT01946438|453666276|FG001|Overall Study|Adverse Event|0|||
126101933|NCT01946438|453666277|FG002|Overall Study|Adverse Event|0|||
126101934|NCT01946438|453666278|FG003|Overall Study|Adverse Event|1|||
126101935|NCT01946438|453666275|FG000|Overall Study|Serious Adverse event|1|||
126101936|NCT01946438|453666276|FG001|Overall Study|Serious Adverse event|0|||
126101937|NCT01946438|453666277|FG002|Overall Study|Serious Adverse event|0|||
126101938|NCT01946438|453666278|FG003|Overall Study|Serious Adverse event|0|||
126101939|NCT01946438|453666275|FG000|Overall Study|Protocol Violation|0|||
126101940|NCT01946438|453666276|FG001|Overall Study|Protocol Violation|0|||
126101941|NCT01946438|453666277|FG002|Overall Study|Protocol Violation|1|||
126101942|NCT01946438|453666278|FG003|Overall Study|Protocol Violation|0|||
126101943|NCT01946438|453666275|FG000|Overall Study|Withdrawal by Subject|1|||
126101944|NCT01946438|453666276|FG001|Overall Study|Withdrawal by Subject|0|||
126101945|NCT01946438|453666277|FG002|Overall Study|Withdrawal by Subject|0|||
126101946|NCT01946438|453666278|FG003|Overall Study|Withdrawal by Subject|0|||
126101947|NCT02457559|453666279|FG000|Overall Study|Progressive Disease|1|||
126101948|NCT02457559|453666280|FG001|Overall Study|Progressive Disease|2|||
126101949|NCT02457559|453666281|FG002|Overall Study|Progressive Disease|3|||
126101950|NCT02457559|453666282|FG003|Overall Study|Progressive Disease|0|||
126101951|NCT02457559|453666283|FG004|Overall Study|Progressive Disease|0|||
126101952|NCT02457559|453666284|FG005|Overall Study|Progressive Disease|2|||
126101953|NCT02457559|453666285|FG006|Overall Study|Progressive Disease|1|||
126101954|NCT02457559|453666286|FG007|Overall Study|Progressive Disease|0|||
126101955|NCT02457559|453666287|FG008|Overall Study|Progressive Disease|1|||
126101956|NCT02457559|453666288|FG009|Overall Study|Progressive Disease|1|||
126101957|NCT02457559|453666289|FG010|Overall Study|Progressive Disease|1|||
126101958|NCT02457559|453666279|FG000|Overall Study|Investigator's Discretion|0|||
126101959|NCT02457559|453666280|FG001|Overall Study|Investigator's Discretion|0|||
126101960|NCT02457559|453666281|FG002|Overall Study|Investigator's Discretion|2|||
126101961|NCT02457559|453666282|FG003|Overall Study|Investigator's Discretion|0|||
126101962|NCT02457559|453666283|FG004|Overall Study|Investigator's Discretion|1|||
126101963|NCT02457559|453666284|FG005|Overall Study|Investigator's Discretion|0|||
126101964|NCT02457559|453666285|FG006|Overall Study|Investigator's Discretion|1|||
126101965|NCT02457559|453666286|FG007|Overall Study|Investigator's Discretion|0|||
126101966|NCT02457559|453666287|FG008|Overall Study|Investigator's Discretion|1|||
126101967|NCT02457559|453666288|FG009|Overall Study|Investigator's Discretion|0|||
126101968|NCT02457559|453666289|FG010|Overall Study|Investigator's Discretion|1|||
126101969|NCT02457559|453666279|FG000|Overall Study|Adverse Event|0|||
126101970|NCT02457559|453666280|FG001|Overall Study|Adverse Event|1|||
126101971|NCT02457559|453666281|FG002|Overall Study|Adverse Event|2|||
126101972|NCT02457559|453666282|FG003|Overall Study|Adverse Event|0|||
126101973|NCT02457559|453666283|FG004|Overall Study|Adverse Event|0|||
126101974|NCT02457559|453666284|FG005|Overall Study|Adverse Event|0|||
126101975|NCT02457559|453666285|FG006|Overall Study|Adverse Event|0|||
126101976|NCT02457559|453666286|FG007|Overall Study|Adverse Event|0|||
126101977|NCT02457559|453666287|FG008|Overall Study|Adverse Event|0|||
126101978|NCT02457559|453666288|FG009|Overall Study|Adverse Event|0|||
126296966|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126296967|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126101979|NCT02457559|453666289|FG010|Overall Study|Adverse Event|0|||
126101980|NCT02457559|453666279|FG000|Overall Study|Reason not Specified|1|||
126101981|NCT02457559|453666280|FG001|Overall Study|Reason not Specified|0|||
126101982|NCT02457559|453666281|FG002|Overall Study|Reason not Specified|0|||
126101983|NCT02457559|453666282|FG003|Overall Study|Reason not Specified|0|||
126101984|NCT02457559|453666283|FG004|Overall Study|Reason not Specified|0|||
126101985|NCT02457559|453666284|FG005|Overall Study|Reason not Specified|0|||
126101986|NCT02457559|453666285|FG006|Overall Study|Reason not Specified|0|||
126101987|NCT02457559|453666286|FG007|Overall Study|Reason not Specified|0|||
126101988|NCT02457559|453666287|FG008|Overall Study|Reason not Specified|0|||
126101989|NCT02457559|453666288|FG009|Overall Study|Reason not Specified|2|||
126101990|NCT02457559|453666289|FG010|Overall Study|Reason not Specified|0|||
126101991|NCT02457559|453666279|FG000|Overall Study|Death|0|||
126101992|NCT02457559|453666280|FG001|Overall Study|Death|0|||
126101993|NCT02457559|453666281|FG002|Overall Study|Death|0|||
126101994|NCT02457559|453666282|FG003|Overall Study|Death|0|||
126101995|NCT02457559|453666283|FG004|Overall Study|Death|0|||
126101996|NCT02457559|453666284|FG005|Overall Study|Death|0|||
126101997|NCT02457559|453666285|FG006|Overall Study|Death|0|||
126101998|NCT02457559|453666286|FG007|Overall Study|Death|0|||
126101999|NCT02457559|453666287|FG008|Overall Study|Death|1|||
126102000|NCT02457559|453666288|FG009|Overall Study|Death|1|||
126102001|NCT02457559|453666289|FG010|Overall Study|Death|0|||
126102002|NCT00031551|453668159|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
126102003|NCT00031551|453668160|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
126102004|NCT00409773|453668161|FG000|Overall Study|Adverse Event|3|||
126102005|NCT00409773|453668162|FG001|Overall Study|Adverse Event|4|||
126102006|NCT00409773|453668163|FG002|Overall Study|Adverse Event|4|||
126102007|NCT00409773|453668164|FG003|Overall Study|Adverse Event|2|||
126102008|NCT00409773|453668165|FG004|Overall Study|Adverse Event|6|||
126102009|NCT00409773|453668161|FG000|Overall Study|Lost to Follow-up|6|||
126102010|NCT00409773|453668162|FG001|Overall Study|Lost to Follow-up|1|||
126102011|NCT00409773|453668163|FG002|Overall Study|Lost to Follow-up|2|||
126102012|NCT00409773|453668164|FG003|Overall Study|Lost to Follow-up|3|||
126102013|NCT00409773|453668165|FG004|Overall Study|Lost to Follow-up|1|||
126102014|NCT00409773|453668161|FG000|Overall Study|Physician Decision|0|||
126102015|NCT00409773|453668162|FG001|Overall Study|Physician Decision|0|||
126102016|NCT00409773|453668163|FG002|Overall Study|Physician Decision|0|||
126296968|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126296969|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
126296970|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126296971|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126102017|NCT00409773|453668164|FG003|Overall Study|Physician Decision|2|||
126102018|NCT00409773|453668165|FG004|Overall Study|Physician Decision|0|||
126102019|NCT00409773|453668161|FG000|Overall Study|Protocol Violation|0|||
126102020|NCT00409773|453668162|FG001|Overall Study|Protocol Violation|2|||
126102021|NCT00409773|453668163|FG002|Overall Study|Protocol Violation|3|||
126102022|NCT00409773|453668164|FG003|Overall Study|Protocol Violation|3|||
126102023|NCT00409773|453668165|FG004|Overall Study|Protocol Violation|1|||
126102024|NCT00409773|453668161|FG000|Overall Study|Withdrawal by Subject|0|||
126102025|NCT00409773|453668162|FG001|Overall Study|Withdrawal by Subject|0|||
126102026|NCT00409773|453668163|FG002|Overall Study|Withdrawal by Subject|0|||
126102027|NCT00409773|453668164|FG003|Overall Study|Withdrawal by Subject|2|||
126102028|NCT00409773|453668165|FG004|Overall Study|Withdrawal by Subject|1|||
126102029|NCT00409773|453668161|FG000|Overall Study|Lack of Eligibility|0|||
126102030|NCT00409773|453668162|FG001|Overall Study|Lack of Eligibility|0|||
126102031|NCT00409773|453668163|FG002|Overall Study|Lack of Eligibility|0|||
126102032|NCT00409773|453668164|FG003|Overall Study|Lack of Eligibility|0|||
126102033|NCT00409773|453668165|FG004|Overall Study|Lack of Eligibility|1|||
126102034|NCT00153062|453668166|FG000|Overall Study|Death|360|||
126102035|NCT00153062|453668167|FG001|Overall Study|Death|352|||
126102036|NCT00153062|453668168|FG002|Overall Study|Death|369|||
126102037|NCT00153062|453668169|FG003|Overall Study|Death|365|||
126102038|NCT00153062|453668166|FG000|Overall Study|Withdrawal by Subject|14|||
126102039|NCT00153062|453668167|FG001|Overall Study|Withdrawal by Subject|30|||
126102040|NCT00153062|453668168|FG002|Overall Study|Withdrawal by Subject|27|||
126102041|NCT00153062|453668169|FG003|Overall Study|Withdrawal by Subject|28|||
126102042|NCT00153062|453668166|FG000|Overall Study|Lost to Follow-up|12|||
126102043|NCT00153062|453668167|FG001|Overall Study|Lost to Follow-up|20|||
126102044|NCT00153062|453668168|FG002|Overall Study|Lost to Follow-up|15|||
126102045|NCT00153062|453668169|FG003|Overall Study|Lost to Follow-up|16|||
126102046|NCT00153062|453668166|FG000|Overall Study|Adverse Event|0|||
126102047|NCT00153062|453668167|FG001|Overall Study|Adverse Event|1|||
126102048|NCT00153062|453668168|FG002|Overall Study|Adverse Event|1|||
126102049|NCT00153062|453668169|FG003|Overall Study|Adverse Event|0|||
126102050|NCT00153062|453668166|FG000|Overall Study|Protocol Violation|0|||
126102051|NCT00153062|453668167|FG001|Overall Study|Protocol Violation|2|||
126102052|NCT00153062|453668168|FG002|Overall Study|Protocol Violation|1|||
126102053|NCT00153062|453668169|FG003|Overall Study|Protocol Violation|1|||
126102054|NCT00153062|453668166|FG000|Overall Study|No disposition data available|1|||
126102055|NCT00153062|453668167|FG001|Overall Study|No disposition data available|1|||
126102056|NCT00153062|453668168|FG002|Overall Study|No disposition data available|1|||
126102057|NCT00153062|453668169|FG003|Overall Study|No disposition data available|1|||
126102058|NCT00153062|453668166|FG000|Overall Study|Other|0|||
126102059|NCT00153062|453668167|FG001|Overall Study|Other|0|||
126102060|NCT00153062|453668168|FG002|Overall Study|Other|1|||
126102061|NCT00153062|453668169|FG003|Overall Study|Other|0|||
126102062|NCT02359877|453668170|FG000|Overall Study|Withdrawal by Subject|1|||
126102063|NCT02359877|453668171|FG001|Overall Study|Withdrawal by Subject|0|||
126102064|NCT02359877|453668172|FG002|Overall Study|Withdrawal by Subject|0|||
126102065|NCT02359877|453668173|FG003|Overall Study|Withdrawal by Subject|2|||
126102066|NCT02359877|453668170|FG000|Overall Study|Adverse Event|0|||
126102067|NCT02359877|453668171|FG001|Overall Study|Adverse Event|0|||
126102068|NCT02359877|453668172|FG002|Overall Study|Adverse Event|0|||
126102069|NCT02359877|453668173|FG003|Overall Study|Adverse Event|1|||
126102070|NCT01919814|453668180|FG000|Overall Study|Adverse Event|1|||
126102071|NCT01919814|453668181|FG001|Overall Study|Adverse Event|0|||
126102072|NCT01919814|453668180|FG000|Overall Study|Protocol Violation|1|||
126102073|NCT01919814|453668181|FG001|Overall Study|Protocol Violation|0|||
126102074|NCT01919814|453668180|FG000|Overall Study|Withdrawal by Subject|1|||
126102075|NCT01919814|453668181|FG001|Overall Study|Withdrawal by Subject|0|||
126102076|NCT00275262|453668182|FG000|Overall Study|Adverse Event|2|||
126102077|NCT00275262|453668183|FG001|Overall Study|Adverse Event|0|||
126102078|NCT00275262|453668182|FG000|Overall Study|Disease progression|2|||
126102079|NCT00275262|453668183|FG001|Overall Study|Disease progression|5|||
126102080|NCT00275262|453668182|FG000|Overall Study|Lost to Follow-up|0|||
126102081|NCT00275262|453668183|FG001|Overall Study|Lost to Follow-up|2|||
126102082|NCT00275262|453668182|FG000|Overall Study|Protocol Violation|0|||
126102083|NCT00275262|453668183|FG001|Overall Study|Protocol Violation|2|||
126102084|NCT00275262|453668182|FG000|Overall Study|Death|1|||
126102085|NCT00275262|453668183|FG001|Overall Study|Death|0|||
126102086|NCT00275262|453668182|FG000|Overall Study|Started Chemotherapy|1|||
126102087|NCT00275262|453668183|FG001|Overall Study|Started Chemotherapy|0|||
126102088|NCT02164383|453668186|FG000|Overall Study|Lost to Follow-up|1|||
126102089|NCT02164383|453668187|FG001|Overall Study|Lost to Follow-up|0|||
126102090|NCT01589237|453668198|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
126102091|NCT01589237|453668199|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
126102092|NCT01589237|453668200|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
126102093|NCT01589237|453668201|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
126102094|NCT01589237|453668198|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
126102095|NCT01589237|453668199|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
126102096|NCT01589237|453668200|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
126102097|NCT01589237|453668201|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
126102098|NCT01589237|453668198|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
126102099|NCT01589237|453668199|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
126102100|NCT01589237|453668200|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
126102101|NCT01589237|453668201|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
126102102|NCT01589237|453668198|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
126102103|NCT01589237|453668199|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
126102104|NCT01589237|453668200|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
126102105|NCT01589237|453668201|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
126102106|NCT02594163|453668202|FG000|Treatment Period|Progressive disease|2|||
126102107|NCT02594163|453668203|FG001|Treatment Period|Progressive disease|3|||
126102108|NCT02594163|453668202|FG000|Treatment Period|Adverse Event|1|||
126102109|NCT02594163|453668203|FG001|Treatment Period|Adverse Event|5|||
126102110|NCT02594163|453668202|FG000|Treatment Period|Physician Decision|1|||
126102111|NCT02594163|453668203|FG001|Treatment Period|Physician Decision|3|||
126102112|NCT02594163|453668202|FG000|Treatment Period|Study termination by sponsor|2|||
126102113|NCT02594163|453668203|FG001|Treatment Period|Study termination by sponsor|1|||
126102114|NCT02594163|453668202|FG000|Treatment Period|Other, Non-AE|1|||
126102115|NCT02594163|453668203|FG001|Treatment Period|Other, Non-AE|0|||
126102116|NCT02594163|453668202|FG000|Follow-up Period|Withdrawal by Subject|0|||
126102117|NCT02594163|453668203|FG001|Follow-up Period|Withdrawal by Subject|1|||
126102118|NCT02594163|453668202|FG000|Follow-up Period|Study Termination by Sponsor|6|||
126102119|NCT02594163|453668203|FG001|Follow-up Period|Study Termination by Sponsor|4|||
126102120|NCT02594163|453668202|FG000|Follow-up Period|Lost to Follow-up|1|||
126102121|NCT02594163|453668203|FG001|Follow-up Period|Lost to Follow-up|0|||
126102122|NCT02594163|453668202|FG000|Follow-up Period|Death|2|||
126102123|NCT02594163|453668203|FG001|Follow-up Period|Death|5|||
126102124|NCT02594163|453668202|FG000|Follow-up Period|Adverse Event|0|||
126102125|NCT02594163|453668203|FG001|Follow-up Period|Adverse Event|1|||
126102126|NCT02594163|453668202|FG000|Follow-up Period|Progressive Disease|2|||
126102127|NCT02594163|453668203|FG001|Follow-up Period|Progressive Disease|0|||
126102128|NCT02594163|453668202|FG000|Follow-up Period|Physician Decision|0|||
126102129|NCT02594163|453668203|FG001|Follow-up Period|Physician Decision|1|||
126102130|NCT01290029|453668206|FG000|Overall Study|Other|2|||
126102131|NCT02831387|453668207|FG000|Overall Study|Withdrawal by Subject|1|||
126102132|NCT02831387|453668208|FG001|Overall Study|Withdrawal by Subject|1|||
126102133|NCT02831387|453668207|FG000|Overall Study|Discontinued due to stock recovery|0|||
126102134|NCT02831387|453668208|FG001|Overall Study|Discontinued due to stock recovery|1|||
126102135|NCT02336178|453668212|FG000|Overall Study|Lost to Follow-up|1|||
126102136|NCT02336178|453668212|FG000|Overall Study|Protocol Violation|1|||
126102137|NCT02336178|453668212|FG000|Overall Study|Withdrawal by Subject|1|||
126102138|NCT02336178|453668212|FG000|Overall Study|Other|1|||
126102139|NCT00618982|453668213|FG000|Overall Study|Adverse Event|23|||
126102140|NCT00618982|453668213|FG000|Overall Study|Withdrawal by Subject|1|||
126102141|NCT00618982|453668213|FG000|Overall Study|Protocol Violation|1|||
126102142|NCT00618982|453668213|FG000|Overall Study|ongoing, still treated with study med.|25|||
126102143|NCT00156819|453668216|FG000|Overall Study|Lost to Follow-up|1|||
126102144|NCT00156819|453668217|FG001|Overall Study|Lost to Follow-up|1|||
126102145|NCT00156819|453668218|FG002|Overall Study|Lost to Follow-up|3|||
126102146|NCT00799513|453668219|FG000|Overall Study|Physician Decision|1|||
126102147|NCT00799513|453668219|FG000|Overall Study|Adverse Event|1|||
126102148|NCT00666679|453668222|FG000|First Intervention|Lost to Follow-up|1|||
126102149|NCT00666679|453668223|FG001|First Intervention|Lost to Follow-up|0|||
126102150|NCT00666679|453668222|FG000|First Intervention|Protocol Violation|1|||
126102151|NCT00666679|453668223|FG001|First Intervention|Protocol Violation|0|||
126102152|NCT00666679|453668222|FG000|First Intervention|Withdrawal by Subject|1|||
126102153|NCT00666679|453668223|FG001|First Intervention|Withdrawal by Subject|0|||
126102154|NCT00666679|453668222|FG000|First Intervention|Randomized did not start treatment|1|||
126102155|NCT00666679|453668223|FG001|First Intervention|Randomized did not start treatment|1|||
126102156|NCT00666679|453668222|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
126102157|NCT00666679|453668223|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
126102158|NCT00666679|453668222|FG000|Washout Period of 1 Week|Protocol Violation|0|||
126102159|NCT00666679|453668223|FG001|Washout Period of 1 Week|Protocol Violation|1|||
126102160|NCT00666679|453668222|FG000|Second Intervention|Adverse Event|1|||
126102161|NCT00666679|453668223|FG001|Second Intervention|Adverse Event|0|||
126102162|NCT00666679|453668222|FG000|Second Intervention|Death|0|||
126102163|NCT00666679|453668223|FG001|Second Intervention|Death|1|||
126102164|NCT05062759|453668226|FG000|Overall Study|Death|0|||
126102165|NCT05062759|453668227|FG001|Overall Study|Death|1|||
126102166|NCT05062759|453668226|FG000|Overall Study|Lost to Follow-up|1|||
126102167|NCT05062759|453668227|FG001|Overall Study|Lost to Follow-up|0|||
126102168|NCT02781844|453668228|FG000|Treatment Period 1|Adverse Event|0|||
126102169|NCT02781844|453668229|FG001|Treatment Period 1|Adverse Event|0|||
126102170|NCT02781844|453668230|FG002|Treatment Period 1|Adverse Event|0|||
126102171|NCT02781844|453668231|FG003|Treatment Period 1|Adverse Event|0|||
126102172|NCT02781844|453668232|FG004|Treatment Period 1|Adverse Event|0|||
126102173|NCT02781844|453668233|FG005|Treatment Period 1|Adverse Event|1|||
126102174|NCT02781844|453668234|FG006|Treatment Period 1|Adverse Event|0|||
126102175|NCT02781844|453668235|FG007|Treatment Period 1|Adverse Event|0|||
126102176|NCT02518490|453668238|FG000|Overall Study|Withdrawal by Subject|1|||
126102177|NCT02518490|453668239|FG001|Overall Study|Withdrawal by Subject|1|||
126102178|NCT00346632|453668240|FG000|Overall Study|Progressive Disease|2|||
126102179|NCT00346632|453668241|FG001|Overall Study|Progressive Disease|2|||
126102180|NCT00346632|453668242|FG002|Overall Study|Progressive Disease|4|||
126102181|NCT00346632|453668243|FG003|Overall Study|Progressive Disease|3|||
126102182|NCT00346632|453668244|FG004|Overall Study|Progressive Disease|3|||
126102183|NCT00346632|453668245|FG005|Overall Study|Progressive Disease|1|||
126102184|NCT00346632|453668246|FG006|Overall Study|Progressive Disease|2|||
126102185|NCT00346632|453668247|FG007|Overall Study|Progressive Disease|2|||
126102186|NCT00346632|453668248|FG008|Overall Study|Progressive Disease|2|||
126102187|NCT00346632|453668249|FG009|Overall Study|Progressive Disease|2|||
126102188|NCT00346632|453668240|FG000|Overall Study|Adverse Event|0|||
126102189|NCT00346632|453668241|FG001|Overall Study|Adverse Event|0|||
126102190|NCT00346632|453668242|FG002|Overall Study|Adverse Event|0|||
126102191|NCT00346632|453668243|FG003|Overall Study|Adverse Event|0|||
126102192|NCT00346632|453668244|FG004|Overall Study|Adverse Event|1|||
126102193|NCT00346632|453668245|FG005|Overall Study|Adverse Event|1|||
126102194|NCT00346632|453668246|FG006|Overall Study|Adverse Event|1|||
126102195|NCT00346632|453668247|FG007|Overall Study|Adverse Event|0|||
126102196|NCT00346632|453668248|FG008|Overall Study|Adverse Event|0|||
126102197|NCT00346632|453668249|FG009|Overall Study|Adverse Event|0|||
126102198|NCT00346632|453668240|FG000|Overall Study|Death|0|||
126102199|NCT00346632|453668241|FG001|Overall Study|Death|0|||
126102200|NCT00346632|453668242|FG002|Overall Study|Death|1|||
126102201|NCT00346632|453668243|FG003|Overall Study|Death|0|||
126102202|NCT00346632|453668244|FG004|Overall Study|Death|0|||
126102203|NCT00346632|453668245|FG005|Overall Study|Death|0|||
126102204|NCT00346632|453668246|FG006|Overall Study|Death|0|||
126102205|NCT00346632|453668247|FG007|Overall Study|Death|0|||
126102206|NCT00346632|453668248|FG008|Overall Study|Death|0|||
126102207|NCT00346632|453668249|FG009|Overall Study|Death|0|||
126102208|NCT00346632|453668240|FG000|Overall Study|Protocol Violation|0|||
126102209|NCT00346632|453668241|FG001|Overall Study|Protocol Violation|0|||
126102210|NCT00346632|453668242|FG002|Overall Study|Protocol Violation|0|||
126102211|NCT00346632|453668243|FG003|Overall Study|Protocol Violation|0|||
126102212|NCT00346632|453668244|FG004|Overall Study|Protocol Violation|0|||
126102213|NCT00346632|453668245|FG005|Overall Study|Protocol Violation|0|||
126102214|NCT00346632|453668246|FG006|Overall Study|Protocol Violation|1|||
126102215|NCT00346632|453668247|FG007|Overall Study|Protocol Violation|0|||
126102216|NCT00346632|453668248|FG008|Overall Study|Protocol Violation|0|||
126102217|NCT00346632|453668249|FG009|Overall Study|Protocol Violation|0|||
126102218|NCT00346632|453668240|FG000|Overall Study|Withdrawal by Subject|0|||
126102219|NCT00346632|453668241|FG001|Overall Study|Withdrawal by Subject|0|||
126296972|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126296973|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126296974|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296975|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
126296976|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
126296977|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296978|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296979|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296980|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296981|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126296982|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126296983|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126296984|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126296985|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
126296986|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
126296987|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
126296988|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126296989|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126296990|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126296991|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126296992|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
126296993|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
126296994|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
126296995|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126296996|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126296997|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126296998|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126043073|NCT02492711|453454792|FG001|Overall Study|Death|3|||
126043074|NCT02492711|453454793|FG002|Overall Study|Death|0|||
126043075|NCT02492711|453454791|FG000|Overall Study|Withdrawal by Subject|10|||
126043076|NCT02492711|453454792|FG001|Overall Study|Withdrawal by Subject|16|||
126043077|NCT02492711|453454793|FG002|Overall Study|Withdrawal by Subject|5|||
126043078|NCT02492711|453454791|FG000|Overall Study|Physician Decision|10|||
126043079|NCT02492711|453454792|FG001|Overall Study|Physician Decision|6|||
126043080|NCT02492711|453454793|FG002|Overall Study|Physician Decision|4|||
126043081|NCT02492711|453454791|FG000|Overall Study|Lost to Follow-up|0|||
126043082|NCT02492711|453454792|FG001|Overall Study|Lost to Follow-up|0|||
126043083|NCT02492711|453454793|FG002|Overall Study|Lost to Follow-up|1|||
126043084|NCT02492711|453454791|FG000|Overall Study|study treatment delay|2|||
126043085|NCT02492711|453454792|FG001|Overall Study|study treatment delay|1|||
126043086|NCT02492711|453454793|FG002|Overall Study|study treatment delay|0|||
126043087|NCT02492711|453454791|FG000|Overall Study|change in chemotherapy|0|||
126043088|NCT02492711|453454792|FG001|Overall Study|change in chemotherapy|1|||
126043089|NCT02492711|453454793|FG002|Overall Study|change in chemotherapy|0|||
126043090|NCT02492711|453454791|FG000|Overall Study|never treated|2|||
126043091|NCT02492711|453454792|FG001|Overall Study|never treated|4|||
126102220|NCT00346632|453668242|FG002|Overall Study|Withdrawal by Subject|0|||
126102221|NCT00346632|453668243|FG003|Overall Study|Withdrawal by Subject|0|||
126102222|NCT00346632|453668244|FG004|Overall Study|Withdrawal by Subject|0|||
126102223|NCT00346632|453668245|FG005|Overall Study|Withdrawal by Subject|0|||
126102224|NCT00346632|453668246|FG006|Overall Study|Withdrawal by Subject|1|||
126102225|NCT00346632|453668247|FG007|Overall Study|Withdrawal by Subject|0|||
126102226|NCT00346632|453668248|FG008|Overall Study|Withdrawal by Subject|0|||
126102227|NCT00346632|453668249|FG009|Overall Study|Withdrawal by Subject|0|||
126102228|NCT00346632|453668240|FG000|Overall Study|Switched to alternative treatment|0|||
126102229|NCT00346632|453668241|FG001|Overall Study|Switched to alternative treatment|0|||
126102230|NCT00346632|453668242|FG002|Overall Study|Switched to alternative treatment|1|||
126296999|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126297000|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
126297001|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
126297002|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297003|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126043092|NCT02492711|453454793|FG002|Overall Study|never treated|0|||
126043093|NCT02492711|453454791|FG000|Overall Study|Other|0|||
126297004|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297005|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
126297006|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
126297007|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
126297008|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
126297009|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297010|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126102231|NCT00346632|453668243|FG003|Overall Study|Switched to alternative treatment|0|||
126102232|NCT00346632|453668244|FG004|Overall Study|Switched to alternative treatment|0|||
126102233|NCT00346632|453668245|FG005|Overall Study|Switched to alternative treatment|0|||
126102234|NCT00346632|453668246|FG006|Overall Study|Switched to alternative treatment|0|||
126102235|NCT00346632|453668247|FG007|Overall Study|Switched to alternative treatment|0|||
126102236|NCT00346632|453668248|FG008|Overall Study|Switched to alternative treatment|0|||
126102237|NCT00346632|453668249|FG009|Overall Study|Switched to alternative treatment|0|||
126102238|NCT00346632|453668240|FG000|Overall Study|Not Stated|1|||
126102239|NCT00346632|453668241|FG001|Overall Study|Not Stated|1|||
126102240|NCT00346632|453668242|FG002|Overall Study|Not Stated|0|||
126102241|NCT00346632|453668243|FG003|Overall Study|Not Stated|0|||
126102242|NCT00346632|453668244|FG004|Overall Study|Not Stated|0|||
126102243|NCT00346632|453668245|FG005|Overall Study|Not Stated|0|||
126102244|NCT00346632|453668246|FG006|Overall Study|Not Stated|0|||
126102245|NCT00346632|453668247|FG007|Overall Study|Not Stated|2|||
126102246|NCT00346632|453668248|FG008|Overall Study|Not Stated|2|||
126102247|NCT00346632|453668249|FG009|Overall Study|Not Stated|1|||
126102248|NCT00918580|453668250|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
126102249|NCT00918580|453668250|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
126102250|NCT00918580|453668250|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
126102251|NCT00918580|453668250|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
126102252|NCT00918580|453668250|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
126102253|NCT00918580|453668250|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
126102254|NCT00918580|453668250|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
126102255|NCT03486457|453668254|FG000|Up to Month 3|Adverse Event|2|||
126102256|NCT03486457|453668255|FG001|Up to Month 3|Adverse Event|5|||
126102257|NCT03486457|453668254|FG000|Up to Month 3|Lack of Efficacy|1|||
126102258|NCT03486457|453668255|FG001|Up to Month 3|Lack of Efficacy|0|||
126102259|NCT03486457|453668254|FG000|Up to Month 3|Withdrawal by Subject|1|||
126102260|NCT03486457|453668255|FG001|Up to Month 3|Withdrawal by Subject|0|||
126102261|NCT03486457|453668254|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
126102262|NCT03486457|453668255|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
126102263|NCT03486457|453668254|FG000|Up to Month 3|Other|1|||
126102264|NCT03486457|453668255|FG001|Up to Month 3|Other|0|||
126102265|NCT03486457|453668254|FG000|Month 3 to Month 6|Adverse Event|2|||
126102266|NCT03486457|453668255|FG001|Month 3 to Month 6|Adverse Event|0|||
126102267|NCT03486457|453668254|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
126102268|NCT03486457|453668255|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
126102269|NCT03486457|453668254|FG000|Month 3 to Month 6|Pregnancy|0|||
126102270|NCT03486457|453668255|FG001|Month 3 to Month 6|Pregnancy|1|||
126102271|NCT03486457|453668254|FG000|Month 3 to Month 6|Other|1|||
126102272|NCT03486457|453668255|FG001|Month 3 to Month 6|Other|0|||
126102273|NCT00093808|453668256|FG000|Overall Study|Cancel participation before receiving tx|1|||
126102274|NCT00093808|453668256|FG000|Overall Study|Protocol Violation|1|||
126102275|NCT03235284|453668257|FG000|Overall Study|Adverse Event|1|||
126102276|NCT03235284|453668258|FG001|Overall Study|Adverse Event|2|||
126102277|NCT03235284|453668259|FG002|Overall Study|Adverse Event|1|||
126102278|NCT00262951|453668262|FG000|Overall Study|Progressive disease/relapse|3|||
126102279|NCT00262951|453668262|FG000|Overall Study|Adverse Event|7|||
126102280|NCT00262951|453668262|FG000|Overall Study|Death|1|||
126102281|NCT00262951|453668262|FG000|Overall Study|Withdrawal by Subject|1|||
126102282|NCT00262951|453668262|FG000|Overall Study|Alternative treatment|3|||
126102283|NCT00262951|453668262|FG000|Overall Study|Off treatment for other disease|1|||
126102284|NCT02325557|453668263|FG000|Overall Study|Progressive disease|1|||
126102285|NCT02325557|453668264|FG001|Overall Study|Progressive disease|0|||
126297011|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297012|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
126297013|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
126102286|NCT02325557|453668265|FG002|Overall Study|Progressive disease|0|||
126102287|NCT02325557|453668266|FG003|Overall Study|Progressive disease|0|||
126102288|NCT02325557|453668263|FG000|Overall Study|Withdrawal by Subject|4|||
126102289|NCT02325557|453668264|FG001|Overall Study|Withdrawal by Subject|0|||
126102290|NCT02325557|453668265|FG002|Overall Study|Withdrawal by Subject|0|||
126102291|NCT02325557|453668266|FG003|Overall Study|Withdrawal by Subject|15|||
126102292|NCT02325557|453668263|FG000|Overall Study|Death|5|||
126102293|NCT02325557|453668264|FG001|Overall Study|Death|1|||
126102294|NCT02325557|453668265|FG002|Overall Study|Death|1|||
126102295|NCT02325557|453668266|FG003|Overall Study|Death|16|||
126102296|NCT02325557|453668263|FG000|Overall Study|Lost to Follow-up|0|||
126102297|NCT02325557|453668264|FG001|Overall Study|Lost to Follow-up|0|||
126102298|NCT02325557|453668265|FG002|Overall Study|Lost to Follow-up|1|||
126102299|NCT02325557|453668266|FG003|Overall Study|Lost to Follow-up|1|||
126102300|NCT02325557|453668263|FG000|Overall Study|Other|0|||
126102301|NCT02325557|453668264|FG001|Overall Study|Other|0|||
126102302|NCT02325557|453668265|FG002|Overall Study|Other|0|||
126102303|NCT02325557|453668266|FG003|Overall Study|Other|5|||
126102304|NCT01602562|453668269|FG000|Overall Study|Adverse Event|3|||
126102305|NCT01602562|453668270|FG001|Overall Study|Adverse Event|1|||
126102306|NCT01602562|453668269|FG000|Overall Study|Physician Decision|1|||
126102307|NCT01602562|453668270|FG001|Overall Study|Physician Decision|1|||
126102308|NCT01602562|453668269|FG000|Overall Study|Withdrawal by Subject|1|||
126102309|NCT01602562|453668270|FG001|Overall Study|Withdrawal by Subject|1|||
126102310|NCT03881553|453668271|FG000|Overall Study|Discharged prior to participation|1|||
126102311|NCT03881553|453668272|FG001|Overall Study|Discharged prior to participation|1|||
126102312|NCT03881553|453668273|FG002|Overall Study|Discharged prior to participation|0|||
126102313|NCT03881553|453668271|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
126102314|NCT03881553|453668272|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
126102315|NCT03881553|453668273|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
126102316|NCT01959516|453668274|FG000|Epoch 1|Adverse Event|4|||
126102317|NCT01959516|453668275|FG001|Epoch 1|Adverse Event|1|||
126102318|NCT01959516|453668274|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
126102319|NCT01959516|453668275|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
126102320|NCT01959516|453668274|FG000|Epoch 1|Subject withdrew consent|3|||
126102321|NCT01959516|453668275|FG001|Epoch 1|Subject withdrew consent|2|||
126102322|NCT01959516|453668274|FG000|Epoch 1|Administrative problems|1|||
126102323|NCT01959516|453668275|FG001|Epoch 1|Administrative problems|0|||
126102324|NCT01959516|453668274|FG000|Epoch 1|Use of prohibited treatment|1|||
126102325|NCT01959516|453668275|FG001|Epoch 1|Use of prohibited treatment|0|||
126102326|NCT01959516|453668274|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
126102327|NCT01959516|453668275|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
126102328|NCT01959516|453668274|FG000|Epoch 1|Protocol deviation|0|||
126102329|NCT01959516|453668275|FG001|Epoch 1|Protocol deviation|1|||
126102330|NCT01959516|453668274|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
126297014|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
126297015|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
126297016|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297017|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297018|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297019|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297020|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
126297021|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297022|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297023|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297024|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297025|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297026|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297027|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297028|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
126297029|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297030|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126297031|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126297032|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126297033|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126297034|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125883559|NCT01746901|452871519|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126102331|NCT01959516|453668275|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
126102332|NCT01959516|453668274|FG000|Epoch 2|Subject withdrew consent|1|||
126102333|NCT01959516|453668275|FG001|Epoch 2|Subject withdrew consent|0|||
126102334|NCT01959516|453668274|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
126102335|NCT01959516|453668275|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
126102336|NCT01477333|453668276|FG000|Overall Study|Adverse Event|1|||
126102337|NCT01477333|453668276|FG000|Overall Study|Withdrawal by Subject|1|||
126102338|NCT01477333|453668276|FG000|Overall Study|Clinical Deterioration|1|||
126102339|NCT03801915|453668281|FG000|Overall Study|Screen failure|0|||
126297035|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
126297036|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
126297037|NCT04426006|454375360|FG000|Inclusion|Protocol Violation|1|||
125883560|NCT01746901|452871511|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126043094|NCT02492711|453454792|FG001|Overall Study|Other|0|||
126043095|NCT02492711|453454793|FG002|Overall Study|Other|1|||
126043096|NCT04505410|453454797|FG000|Overall Study|Adverse Event|2|||
126043097|NCT04505410|453454798|FG001|Overall Study|Adverse Event|0|||
126043098|NCT04505410|453454797|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
126043099|NCT04505410|453454798|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
126043100|NCT04505410|453454797|FG000|Overall Study|did not want to follow diet|1|||
126043101|NCT04505410|453454798|FG001|Overall Study|did not want to follow diet|0|||
126043102|NCT04505410|453454797|FG000|Overall Study|flare up of ulcerative colitis|0|||
126043103|NCT04505410|453454798|FG001|Overall Study|flare up of ulcerative colitis|1|||
126043104|NCT04505410|453454797|FG000|Overall Study|Lost to Follow-up|0|||
126043105|NCT04505410|453454798|FG001|Overall Study|Lost to Follow-up|2|||
126043106|NCT04505410|453454797|FG000|Overall Study|Lost to Follow-up|1|||
126043107|NCT04505410|453454798|FG001|Overall Study|Lost to Follow-up|0|||
126043108|NCT04505410|453454797|FG000|Overall Study|initiated another diet on their own|0|||
126043109|NCT04505410|453454798|FG001|Overall Study|initiated another diet on their own|2|||
126043110|NCT01586910|453455968|FG000|Overall Study|Death|4|||
126043111|NCT01586910|453455969|FG001|Overall Study|Death|4|||
126043112|NCT01586910|453455968|FG000|Overall Study|Withdrawal by Subject|6|||
126043113|NCT01586910|453455969|FG001|Overall Study|Withdrawal by Subject|43|||
126043114|NCT01586910|453455968|FG000|Overall Study|Physician withdrew Subject|5|||
126043115|NCT01586910|453455969|FG001|Overall Study|Physician withdrew Subject|24|||
126043116|NCT02437136|453455977|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
126043117|NCT02437136|453455978|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126043118|NCT02437136|453455979|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126043119|NCT02437136|453455980|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126043120|NCT02437136|453455981|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126043121|NCT02437136|453455982|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126043122|NCT02437136|453455983|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126043123|NCT02437136|453455977|FG000|Expansion (Phase 2)|Death|0|||
126043124|NCT02437136|453455978|FG001|Expansion (Phase 2)|Death|0|||
126043125|NCT02437136|453455979|FG002|Expansion (Phase 2)|Death|0|||
126043126|NCT02437136|453455980|FG003|Expansion (Phase 2)|Death|6|||
126043127|NCT02437136|453455981|FG004|Expansion (Phase 2)|Death|37|||
126043128|NCT02437136|453455982|FG005|Expansion (Phase 2)|Death|29|||
126043129|NCT02437136|453455983|FG006|Expansion (Phase 2)|Death|24|||
126043130|NCT02437136|453455977|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
126043131|NCT02437136|453455978|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
126043132|NCT02437136|453455979|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
126043133|NCT02437136|453455980|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
126043134|NCT02437136|453455981|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
126043135|NCT02437136|453455982|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
126043136|NCT02437136|453455983|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
126043137|NCT02437136|453455977|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
126043138|NCT02437136|453455978|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
126043139|NCT02437136|453455979|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
126043140|NCT02437136|453455980|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
126043141|NCT02437136|453455981|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
126043142|NCT02437136|453455982|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
126043143|NCT02437136|453455983|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
126043144|NCT03640286|453455991|FG000|Overall Study|Adverse Event|6|||
126043145|NCT03640286|453455992|FG001|Overall Study|Adverse Event|6|||
126043146|NCT03640286|453455991|FG000|Overall Study|Lost to Follow-up|3|||
126043147|NCT03640286|453455992|FG001|Overall Study|Lost to Follow-up|6|||
126043148|NCT03640286|453455991|FG000|Overall Study|Pregnancy|1|||
126043149|NCT03640286|453455992|FG001|Overall Study|Pregnancy|0|||
126043150|NCT03640286|453455991|FG000|Overall Study|Withdrawal by Subject|10|||
126043151|NCT03640286|453455992|FG001|Overall Study|Withdrawal by Subject|10|||
126043152|NCT03640286|453455991|FG000|Overall Study|Non-compliance|4|||
126043153|NCT03640286|453455992|FG001|Overall Study|Non-compliance|10|||
126043154|NCT03640286|453455991|FG000|Overall Study|Medication change|1|||
126043155|NCT03640286|453455992|FG001|Overall Study|Medication change|0|||
126043156|NCT03640286|453455991|FG000|Overall Study|Other|1|||
126043157|NCT03640286|453455992|FG001|Overall Study|Other|2|||
126043158|NCT03640286|453455991|FG000|Overall Study|Joined another lifestyle program|0|||
126043159|NCT03640286|453455992|FG001|Overall Study|Joined another lifestyle program|1|||
126043160|NCT05524116|453455993|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
126043161|NCT05524116|453455994|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
126043162|NCT05524116|453455993|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
126043163|NCT05524116|453455994|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
126043164|NCT05524116|453455993|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
126102340|NCT03801915|453668282|FG001|Overall Study|Screen failure|0|||
126297038|NCT04426006|454375360|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
126297039|NCT04426006|454375360|FG000|Inclusion|Blood sample at inclusion not done|1|||
126297040|NCT04426006|454375360|FG000|3 Months|Lost to Follow-up|17|||
126297041|NCT04426006|454375360|FG000|12 Months|Lost to Follow-up|38|||
126102341|NCT03801915|453668283|FG002|Overall Study|Screen failure|1|||
126102342|NCT03801915|453668281|FG000|Overall Study|Ineligible|1|||
126102343|NCT03801915|453668282|FG001|Overall Study|Ineligible|0|||
126102344|NCT03801915|453668283|FG002|Overall Study|Ineligible|0|||
126102345|NCT03801915|453668281|FG000|Overall Study|Physician Decision|2|||
126102346|NCT03801915|453668282|FG001|Overall Study|Physician Decision|1|||
126297042|NCT03380429|454375363|FG000|Overall Study|Physician Decision|0|||
126297043|NCT03380429|454375364|FG001|Overall Study|Physician Decision|1|||
126297044|NCT03380429|454375365|FG002|Overall Study|Physician Decision|0|||
126297045|NCT03380429|454375366|FG003|Overall Study|Physician Decision|1|||
126297046|NCT03380429|454375367|FG004|Overall Study|Physician Decision|1|||
126297047|NCT03380429|454375363|FG000|Overall Study|Withdrawal by Subject|3|||
126297048|NCT03380429|454375364|FG001|Overall Study|Withdrawal by Subject|3|||
126297049|NCT03380429|454375365|FG002|Overall Study|Withdrawal by Subject|5|||
126297050|NCT03380429|454375366|FG003|Overall Study|Withdrawal by Subject|2|||
126297051|NCT03380429|454375367|FG004|Overall Study|Withdrawal by Subject|1|||
126297052|NCT03380429|454375363|FG000|Overall Study|Lost to Follow-up|0|||
126297053|NCT03380429|454375364|FG001|Overall Study|Lost to Follow-up|2|||
126297054|NCT03380429|454375365|FG002|Overall Study|Lost to Follow-up|4|||
126297055|NCT03380429|454375366|FG003|Overall Study|Lost to Follow-up|3|||
126297056|NCT03380429|454375367|FG004|Overall Study|Lost to Follow-up|1|||
126297057|NCT03380429|454375363|FG000|Overall Study|Protocol Violation|1|||
126297058|NCT03380429|454375364|FG001|Overall Study|Protocol Violation|0|||
126297059|NCT03380429|454375365|FG002|Overall Study|Protocol Violation|1|||
126297060|NCT03380429|454375366|FG003|Overall Study|Protocol Violation|0|||
126297061|NCT03380429|454375367|FG004|Overall Study|Protocol Violation|1|||
126297062|NCT03380429|454375363|FG000|Overall Study|Lack of Efficacy|0|||
126297063|NCT03380429|454375364|FG001|Overall Study|Lack of Efficacy|0|||
126297064|NCT03380429|454375365|FG002|Overall Study|Lack of Efficacy|0|||
126297065|NCT03380429|454375366|FG003|Overall Study|Lack of Efficacy|2|||
126297066|NCT03380429|454375367|FG004|Overall Study|Lack of Efficacy|1|||
126297067|NCT03380429|454375363|FG000|Overall Study|Adverse Event|1|||
126297068|NCT03380429|454375364|FG001|Overall Study|Adverse Event|1|||
126297069|NCT03380429|454375365|FG002|Overall Study|Adverse Event|1|||
126297070|NCT03380429|454375366|FG003|Overall Study|Adverse Event|2|||
126297071|NCT03380429|454375367|FG004|Overall Study|Adverse Event|0|||
126297072|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
126297073|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
126102347|NCT03801915|453668283|FG002|Overall Study|Physician Decision|0|||
126102348|NCT02308020|453668286|FG000|Overall Study|Lost to Follow-up|1|||
126102349|NCT02308020|453668287|FG001|Overall Study|Lost to Follow-up|7|||
126102350|NCT02308020|453668288|FG002|Overall Study|Lost to Follow-up|0|||
126102351|NCT02308020|453668289|FG003|Overall Study|Lost to Follow-up|0|||
126102352|NCT02308020|453668290|FG004|Overall Study|Lost to Follow-up|1|||
126102353|NCT02308020|453668291|FG005|Overall Study|Lost to Follow-up|2|||
126102354|NCT02308020|453668286|FG000|Overall Study|Sponsor Decision|0|||
126102355|NCT02308020|453668287|FG001|Overall Study|Sponsor Decision|8|||
126102356|NCT02308020|453668288|FG002|Overall Study|Sponsor Decision|0|||
126102357|NCT02308020|453668289|FG003|Overall Study|Sponsor Decision|2|||
126102358|NCT02308020|453668290|FG004|Overall Study|Sponsor Decision|2|||
126102359|NCT02308020|453668291|FG005|Overall Study|Sponsor Decision|1|||
126102360|NCT02308020|453668286|FG000|Overall Study|Withdrawal by Subject|3|||
126102361|NCT02308020|453668287|FG001|Overall Study|Withdrawal by Subject|5|||
126102362|NCT02308020|453668288|FG002|Overall Study|Withdrawal by Subject|3|||
126102363|NCT02308020|453668289|FG003|Overall Study|Withdrawal by Subject|2|||
126102364|NCT02308020|453668290|FG004|Overall Study|Withdrawal by Subject|1|||
126102365|NCT02308020|453668291|FG005|Overall Study|Withdrawal by Subject|2|||
126102366|NCT01211288|453668292|FG000|Overall Study|Lost to Follow-up|1|||
126102367|NCT01211288|453668293|FG001|Overall Study|Lost to Follow-up|1|||
126297074|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
126297075|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
126297076|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
126297077|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
126297078|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
126297079|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
126102368|NCT03333837|453668294|FG000|Overall Study|Adverse Event|2|||
126102369|NCT03333837|453668295|FG001|Overall Study|Adverse Event|1|||
126102370|NCT03333837|453668296|FG002|Overall Study|Adverse Event|1|||
126102371|NCT03333837|453668297|FG003|Overall Study|Adverse Event|1|||
126102372|NCT03333837|453668298|FG004|Overall Study|Adverse Event|0|||
126297080|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
126297081|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
126297082|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Other|0|||
126297083|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Other|1|||
126297084|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
126297085|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
126297086|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
126297087|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
126297088|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
126297089|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
126297090|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
126043165|NCT05524116|453455994|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
126043166|NCT05524116|453455993|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
126043167|NCT05524116|453455994|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
126043168|NCT05524116|453455993|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
126043169|NCT05524116|453455994|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
126043170|NCT03181516|453455995|FG000|Overall Study|Withdrawal by Subject|14|||
126043171|NCT03181516|453455996|FG001|Overall Study|Withdrawal by Subject|7|||
126043172|NCT03181516|453455995|FG000|Overall Study|Lost to Follow-up|2|||
126043173|NCT03181516|453455996|FG001|Overall Study|Lost to Follow-up|2|||
126043174|NCT05405985|453455997|FG000|Overall Study|Withdrawal by Subject|1|||
126043175|NCT05405985|453455998|FG001|Overall Study|Withdrawal by Subject|0|||
126043176|NCT03635424|453455999|FG000|Overall Study|Adverse Event|1|||
126043177|NCT03635424|453455999|FG000|Overall Study|Death|1|||
126043178|NCT03635424|453455999|FG000|Overall Study|Device not implanted|1|||
126043179|NCT05533190|453456000|FG000|Overall Study|Lost to Follow-up|19|||
126043180|NCT05533190|453456001|FG001|Overall Study|Lost to Follow-up|7|||
126043181|NCT05533190|453456000|FG000|Overall Study|Failed to download app|1|||
126043182|NCT05533190|453456001|FG001|Overall Study|Failed to download app|0|||
126043183|NCT05533190|453456000|FG000|Overall Study|Thought app was a scam|1|||
126043184|NCT05533190|453456001|FG001|Overall Study|Thought app was a scam|0|||
126043185|NCT05533190|453456000|FG000|Overall Study|Withdrawal by Subject|2|||
126043186|NCT05533190|453456001|FG001|Overall Study|Withdrawal by Subject|0|||
126043187|NCT05552508|453456002|FG000|Overall Study|Adverse Event|3|||
126043188|NCT01917084|453456003|FG000|Overall Study|Withdrawal by Subject|1|||
126043189|NCT04451772|453456011|FG000|Overall Study|Adverse Event|1|||
126043190|NCT04451772|453456012|FG001|Overall Study|Adverse Event|0|||
126043191|NCT04451772|453456013|FG002|Overall Study|Adverse Event|1|||
126043192|NCT04451772|453456014|FG003|Overall Study|Adverse Event|1|||
126043193|NCT04451772|453456015|FG004|Overall Study|Adverse Event|0|||
126043194|NCT04451772|453456016|FG005|Overall Study|Adverse Event|3|||
126043195|NCT04451772|453456011|FG000|Overall Study|Withdrawal by Subject|2|||
126043196|NCT04451772|453456012|FG001|Overall Study|Withdrawal by Subject|7|||
126043197|NCT04451772|453456013|FG002|Overall Study|Withdrawal by Subject|2|||
126043198|NCT04451772|453456014|FG003|Overall Study|Withdrawal by Subject|1|||
126043199|NCT04451772|453456015|FG004|Overall Study|Withdrawal by Subject|1|||
126043200|NCT04451772|453456016|FG005|Overall Study|Withdrawal by Subject|0|||
126043201|NCT04451772|453456011|FG000|Overall Study|Other, not specified|1|||
126043202|NCT04451772|453456012|FG001|Overall Study|Other, not specified|2|||
126043203|NCT04451772|453456013|FG002|Overall Study|Other, not specified|1|||
126043204|NCT04451772|453456014|FG003|Overall Study|Other, not specified|0|||
126043205|NCT04451772|453456015|FG004|Overall Study|Other, not specified|0|||
126043206|NCT04451772|453456016|FG005|Overall Study|Other, not specified|1|||
126043207|NCT04451772|453456011|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
126043208|NCT04451772|453456012|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
126043209|NCT04451772|453456013|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
126043210|NCT04451772|453456014|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
126043211|NCT04451772|453456015|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
126043212|NCT04451772|453456016|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
126043213|NCT04167553|453456017|FG000|Overall Study|Withdrawal by Subject|1|||
126043214|NCT04167553|453456018|FG001|Overall Study|Withdrawal by Subject|0|||
126043215|NCT04167553|453456019|FG002|Overall Study|Withdrawal by Subject|1|||
126043216|NCT04167553|453456020|FG003|Overall Study|Withdrawal by Subject|2|||
126043217|NCT04167553|453456021|FG004|Overall Study|Withdrawal by Subject|1|||
126043218|NCT04167553|453456022|FG005|Overall Study|Withdrawal by Subject|0|||
126043219|NCT04167553|453456023|FG006|Overall Study|Withdrawal by Subject|0|||
126043220|NCT04167553|453456017|FG000|Overall Study|Physician Decision|0|||
126043221|NCT04167553|453456018|FG001|Overall Study|Physician Decision|0|||
126043222|NCT04167553|453456019|FG002|Overall Study|Physician Decision|0|||
126043223|NCT04167553|453456020|FG003|Overall Study|Physician Decision|0|||
126043224|NCT04167553|453456021|FG004|Overall Study|Physician Decision|2|||
126043225|NCT04167553|453456022|FG005|Overall Study|Physician Decision|2|||
126043226|NCT04167553|453456023|FG006|Overall Study|Physician Decision|0|||
126043227|NCT04167553|453456017|FG000|Overall Study|Lost to Follow-up|0|||
126043228|NCT04167553|453456018|FG001|Overall Study|Lost to Follow-up|0|||
126043229|NCT04167553|453456019|FG002|Overall Study|Lost to Follow-up|2|||
126043230|NCT04167553|453456020|FG003|Overall Study|Lost to Follow-up|0|||
126043231|NCT04167553|453456021|FG004|Overall Study|Lost to Follow-up|0|||
126102373|NCT03333837|453668294|FG000|Overall Study|Caregiver withdrew|0|||
126102374|NCT03333837|453668295|FG001|Overall Study|Caregiver withdrew|2|||
126102375|NCT03333837|453668296|FG002|Overall Study|Caregiver withdrew|1|||
126102376|NCT03333837|453668297|FG003|Overall Study|Caregiver withdrew|0|||
126102377|NCT03333837|453668298|FG004|Overall Study|Caregiver withdrew|0|||
126102378|NCT03333837|453668294|FG000|Overall Study|Withdrawal by Subject|0|||
126102379|NCT03333837|453668295|FG001|Overall Study|Withdrawal by Subject|0|||
126102380|NCT03333837|453668296|FG002|Overall Study|Withdrawal by Subject|1|||
126102381|NCT03333837|453668297|FG003|Overall Study|Withdrawal by Subject|1|||
126102382|NCT03333837|453668298|FG004|Overall Study|Withdrawal by Subject|3|||
126102383|NCT03333837|453668294|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
126102384|NCT03333837|453668295|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
126102385|NCT03333837|453668296|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
126102386|NCT03333837|453668297|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
126102387|NCT03333837|453668298|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
126102388|NCT04217590|453668299|FG000|Overall Study|Other|1|||
126102389|NCT04217590|453668300|FG001|Overall Study|Other|1|||
126102390|NCT04217590|453668299|FG000|Overall Study|Withdrawal by Subject|3|||
126102391|NCT04217590|453668300|FG001|Overall Study|Withdrawal by Subject|1|||
126102392|NCT04217590|453668299|FG000|Overall Study|Death|0|||
126102393|NCT04217590|453668300|FG001|Overall Study|Death|1|||
126102394|NCT01242800|453668312|FG000|Overall Study|Patient refusal|0|||
126102395|NCT01242800|453668313|FG001|Overall Study|Patient refusal|10|||
126102396|NCT01242800|453668312|FG000|Overall Study|Physician Decision|0|||
126102397|NCT01242800|453668313|FG001|Overall Study|Physician Decision|1|||
126102398|NCT01242800|453668312|FG000|Overall Study|Disease progression|0|||
126102399|NCT01242800|453668313|FG001|Overall Study|Disease progression|3|||
126102400|NCT01242800|453668312|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
126102401|NCT01242800|453668313|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
126102402|NCT01242800|453668312|FG000|Overall Study|Reasons not reported|0|||
126102403|NCT01242800|453668313|FG001|Overall Study|Reasons not reported|4|||
126102404|NCT00126503|453668316|FG000|Overall Study|disease progression|23|||
126102405|NCT00126503|453668317|FG001|Overall Study|disease progression|14|||
126102406|NCT00126503|453668316|FG000|Overall Study|Withdrawal by Subject|0|||
126102407|NCT00126503|453668317|FG001|Overall Study|Withdrawal by Subject|1|||
126102408|NCT00126503|453668316|FG000|Overall Study|alternative therapy|1|||
126102409|NCT00126503|453668317|FG001|Overall Study|alternative therapy|1|||
126102410|NCT00126503|453668316|FG000|Overall Study|other complicating disease|4|||
126102411|NCT00126503|453668317|FG001|Overall Study|other complicating disease|1|||
126297091|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
126297092|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
126297093|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
126297094|NCT03762265|454375370|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
126297095|NCT03762265|454375371|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
126297096|NCT03762265|454375370|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
126297097|NCT03762265|454375371|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
126297098|NCT03762265|454375370|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
126297099|NCT03762265|454375371|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
126297100|NCT03762265|454375370|FG000|LTE Period: Weeks 61 to 109|Other|1|||
126297101|NCT03762265|454375371|FG001|LTE Period: Weeks 61 to 109|Other|0|||
126297102|NCT01383174|454375374|FG000|3 Month Assessment|Death|0|||
126297103|NCT01383174|454375375|FG001|3 Month Assessment|Death|1|||
126297104|NCT01383174|454375374|FG000|3 Month Assessment|Lost to Follow-up|2|||
126297105|NCT01383174|454375375|FG001|3 Month Assessment|Lost to Follow-up|0|||
126297106|NCT01383174|454375374|FG000|3 Month Assessment|Refused to complete|4|||
126297107|NCT01383174|454375375|FG001|3 Month Assessment|Refused to complete|0|||
126297108|NCT01383174|454375374|FG000|6 Month Assessment|Lost to Follow-up|1|||
126297109|NCT01383174|454375375|FG001|6 Month Assessment|Lost to Follow-up|1|||
126297110|NCT01383174|454375374|FG000|6 Month Assessment|Refused to complete|4|||
126297111|NCT01383174|454375375|FG001|6 Month Assessment|Refused to complete|0|||
126297112|NCT01787292|454375376|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
126297113|NCT01787292|454375377|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
126102412|NCT00126503|453668316|FG000|Overall Study|Death|3|||
126297114|NCT01787292|454375376|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
126297115|NCT01787292|454375377|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
126297116|NCT02169271|454375378|FG000|Overall Study|Protocol Violation|1|||
126297117|NCT02169271|454375379|FG001|Overall Study|Protocol Violation|2|||
126297118|NCT00226499|454375383|FG000|Overall Study|Adverse Event|10|||
126102413|NCT00126503|453668317|FG001|Overall Study|Death|0|||
126102414|NCT00126503|453668316|FG000|Overall Study|Adverse Event|13|||
126102415|NCT00126503|453668317|FG001|Overall Study|Adverse Event|3|||
126102416|NCT00126503|453668316|FG000|Overall Study|non-compliant|1|||
126102417|NCT00126503|453668317|FG001|Overall Study|non-compliant|0|||
126102418|NCT00126503|453668316|FG000|Overall Study|Physician Decision|2|||
126297119|NCT00226499|454375384|FG001|Overall Study|Adverse Event|6|||
126297120|NCT00226499|454375385|FG002|Overall Study|Adverse Event|3|||
126297121|NCT00226499|454375383|FG000|Overall Study|Others|1064|||
126297122|NCT00226499|454375384|FG001|Overall Study|Others|1066|||
126297123|NCT00226499|454375385|FG002|Overall Study|Others|356|||
126297124|NCT00946920|454375388|FG000|Overall Study|Withdrawal by Subject|28|||
126297125|NCT00946920|454375389|FG001|Overall Study|Withdrawal by Subject|15|||
126297126|NCT00946920|454375388|FG000|Overall Study|Lost to Follow-up|2|||
126297127|NCT00946920|454375389|FG001|Overall Study|Lost to Follow-up|2|||
126297128|NCT00946920|454375388|FG000|Overall Study|Physician Decision|5|||
126297129|NCT00946920|454375389|FG001|Overall Study|Physician Decision|2|||
126297130|NCT00946920|454375388|FG000|Overall Study|Adverse Event|41|||
126297131|NCT00946920|454375389|FG001|Overall Study|Adverse Event|14|||
126297132|NCT00946920|454375388|FG000|Overall Study|Protocol Violation|16|||
126297133|NCT00946920|454375389|FG001|Overall Study|Protocol Violation|8|||
126297134|NCT00946920|454375388|FG000|Overall Study|Miscellaneous reasons|18|||
126297135|NCT00946920|454375389|FG001|Overall Study|Miscellaneous reasons|3|||
126297136|NCT04616612|454375390|FG000|Overall Study|Lost to Follow-up|6|||
126297137|NCT04616612|454375391|FG001|Overall Study|Lost to Follow-up|3|||
126297138|NCT01597973|454375392|FG000|Overall Study|Found ineligible before study medication started|4|||
126297139|NCT01597973|454375393|FG001|Overall Study|Found ineligible before study medication started|2|||
126102419|NCT00126503|453668317|FG001|Overall Study|Physician Decision|1|||
126297140|NCT01597973|454375392|FG000|Overall Study|Eligible pathogen not confirmed|14|||
126297141|NCT01597973|454375393|FG001|Overall Study|Eligible pathogen not confirmed|15|||
126297142|NCT01597973|454375392|FG000|Overall Study|LAR not authorized to consent|0|||
126297143|NCT01597973|454375393|FG001|Overall Study|LAR not authorized to consent|1|||
126297144|NCT01597973|454375392|FG000|Overall Study|Ineligible due to early seizures|1|||
126297145|NCT01597973|454375393|FG001|Overall Study|Ineligible due to early seizures|0|||
126297146|NCT01597973|454375392|FG000|Overall Study|Ineligible due to non-target infection|1|||
126297147|NCT01597973|454375393|FG001|Overall Study|Ineligible due to non-target infection|1|||
126297148|NCT00503698|454375399|FG000|Overall Study|Protocol Violation|5|||
126297149|NCT00503698|454375400|FG001|Overall Study|Protocol Violation|6|||
126297150|NCT00503698|454375399|FG000|Overall Study|Adverse Event|52|||
126297151|NCT00503698|454375400|FG001|Overall Study|Adverse Event|41|||
126297152|NCT00503698|454375399|FG000|Overall Study|Death|1|||
126297153|NCT00503698|454375400|FG001|Overall Study|Death|0|||
126297154|NCT00503698|454375399|FG000|Overall Study|Lack of Efficacy|3|||
126297155|NCT00503698|454375400|FG001|Overall Study|Lack of Efficacy|4|||
126297156|NCT00503698|454375399|FG000|Overall Study|Trial terminated|216|||
126297157|NCT00503698|454375400|FG001|Overall Study|Trial terminated|253|||
126297158|NCT00503698|454375399|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
126297159|NCT00503698|454375400|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
126297160|NCT00503698|454375399|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
126297161|NCT00503698|454375400|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
126297162|NCT00503698|454375399|FG000|Overall Study|Any condition in exclusion criteria|4|||
126297163|NCT00503698|454375400|FG001|Overall Study|Any condition in exclusion criteria|6|||
126297164|NCT00503698|454375399|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
126297165|NCT00503698|454375400|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
126297166|NCT00503698|454375399|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
126297167|NCT00503698|454375400|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
126297168|NCT00503698|454375399|FG000|Overall Study|Critically ill|2|||
126297169|NCT00503698|454375400|FG001|Overall Study|Critically ill|0|||
126102420|NCT04677179|453668318|FG000|Induction Treatment Period|Adverse Event|1|||
126102421|NCT04677179|453668319|FG001|Induction Treatment Period|Adverse Event|0|||
126102422|NCT04677179|453668320|FG002|Induction Treatment Period|Adverse Event|0|||
126297170|NCT00503698|454375399|FG000|Overall Study|Unclassified|48|||
126297171|NCT00503698|454375400|FG001|Overall Study|Unclassified|32|||
126297172|NCT00503698|454375399|FG000|Overall Study|Not exposed to trial drug|11|||
126297173|NCT00503698|454375400|FG001|Overall Study|Not exposed to trial drug|6|||
126297174|NCT02259010|454375403|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
126297175|NCT03830333|454375404|FG000|Overall Study|Death|0|||
126297176|NCT03830333|454375405|FG001|Overall Study|Death|1|||
126297177|NCT03830333|454375404|FG000|Overall Study|Withdrawal by Subject|5|||
126297178|NCT03830333|454375405|FG001|Overall Study|Withdrawal by Subject|1|||
126297179|NCT03830333|454375404|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
126297180|NCT03830333|454375405|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
126297181|NCT02208362|454375413|FG000|Overall Study|Participant did not complete treatment|0|||
126297182|NCT02208362|454375414|FG001|Overall Study|Participant did not complete treatment|1|||
126297183|NCT02208362|454375415|FG002|Overall Study|Participant did not complete treatment|0|||
126297184|NCT02208362|454375416|FG003|Overall Study|Participant did not complete treatment|0|||
126297185|NCT02208362|454375417|FG004|Overall Study|Participant did not complete treatment|0|||
126297186|NCT02208362|454375418|FG005|Overall Study|Participant did not complete treatment|0|||
126297187|NCT02208362|454375419|FG006|Overall Study|Participant did not complete treatment|1|||
126102423|NCT04677179|453668321|FG003|Induction Treatment Period|Adverse Event|0|||
126102424|NCT04677179|453668322|FG004|Induction Treatment Period|Adverse Event|0|||
126102425|NCT04677179|453668323|FG005|Induction Treatment Period|Adverse Event|0|||
126102426|NCT04677179|453668324|FG006|Induction Treatment Period|Adverse Event|0|||
126102427|NCT04677179|453668325|FG007|Induction Treatment Period|Adverse Event|0|||
126102428|NCT04677179|453668326|FG008|Induction Treatment Period|Adverse Event|0|||
126102429|NCT04677179|453668327|FG009|Induction Treatment Period|Adverse Event|0|||
126102430|NCT04677179|453668318|FG000|Induction Treatment Period|Physician Decision|1|||
126102431|NCT04677179|453668319|FG001|Induction Treatment Period|Physician Decision|0|||
126102432|NCT04677179|453668320|FG002|Induction Treatment Period|Physician Decision|1|||
126102433|NCT04677179|453668321|FG003|Induction Treatment Period|Physician Decision|0|||
126102434|NCT04677179|453668322|FG004|Induction Treatment Period|Physician Decision|0|||
126102435|NCT04677179|453668323|FG005|Induction Treatment Period|Physician Decision|0|||
126102436|NCT04677179|453668324|FG006|Induction Treatment Period|Physician Decision|0|||
126102437|NCT04677179|453668325|FG007|Induction Treatment Period|Physician Decision|0|||
126102438|NCT04677179|453668326|FG008|Induction Treatment Period|Physician Decision|0|||
126102439|NCT04677179|453668327|FG009|Induction Treatment Period|Physician Decision|0|||
126102440|NCT04677179|453668318|FG000|Induction Treatment Period|Protocol Violation|0|||
126102441|NCT04677179|453668319|FG001|Induction Treatment Period|Protocol Violation|1|||
126102442|NCT04677179|453668320|FG002|Induction Treatment Period|Protocol Violation|0|||
126102443|NCT04677179|453668321|FG003|Induction Treatment Period|Protocol Violation|0|||
126102444|NCT04677179|453668322|FG004|Induction Treatment Period|Protocol Violation|0|||
126102445|NCT04677179|453668323|FG005|Induction Treatment Period|Protocol Violation|0|||
126102446|NCT04677179|453668324|FG006|Induction Treatment Period|Protocol Violation|0|||
126102447|NCT04677179|453668325|FG007|Induction Treatment Period|Protocol Violation|0|||
126102448|NCT04677179|453668326|FG008|Induction Treatment Period|Protocol Violation|0|||
126102449|NCT04677179|453668327|FG009|Induction Treatment Period|Protocol Violation|0|||
126102450|NCT04677179|453668318|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
126102451|NCT04677179|453668319|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
126102452|NCT04677179|453668320|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
126297188|NCT02208362|454375420|FG007|Overall Study|Participant did not complete treatment|1|||
126297189|NCT02208362|454375421|FG008|Overall Study|Participant did not complete treatment|2|||
126297190|NCT02208362|454375422|FG009|Overall Study|Participant did not complete treatment|0|||
126297191|NCT02208362|454375423|FG010|Overall Study|Participant did not complete treatment|1|||
126297192|NCT02208362|454375424|FG011|Overall Study|Participant did not complete treatment|0|||
126297193|NCT02208362|454375413|FG000|Overall Study|Participant received disallowed treatment|0|||
126297194|NCT02208362|454375414|FG001|Overall Study|Participant received disallowed treatment|0|||
126297195|NCT02208362|454375415|FG002|Overall Study|Participant received disallowed treatment|0|||
126297196|NCT02208362|454375416|FG003|Overall Study|Participant received disallowed treatment|0|||
126297197|NCT02208362|454375417|FG004|Overall Study|Participant received disallowed treatment|0|||
126297198|NCT02208362|454375418|FG005|Overall Study|Participant received disallowed treatment|0|||
126297199|NCT02208362|454375419|FG006|Overall Study|Participant received disallowed treatment|0|||
126297200|NCT02208362|454375420|FG007|Overall Study|Participant received disallowed treatment|0|||
126297201|NCT02208362|454375421|FG008|Overall Study|Participant received disallowed treatment|1|||
126297202|NCT02208362|454375422|FG009|Overall Study|Participant received disallowed treatment|0|||
126297203|NCT02208362|454375423|FG010|Overall Study|Participant received disallowed treatment|0|||
126297204|NCT02208362|454375424|FG011|Overall Study|Participant received disallowed treatment|0|||
126297205|NCT01546025|454375425|FG000|Overall Study|Lost to Follow-up|0|||
126297206|NCT01546025|454375426|FG001|Overall Study|Lost to Follow-up|1|||
126297207|NCT05966584|454375433|FG000|Overall Study|Lost to Follow-up|1|||
126297208|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
126297209|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
126297210|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
126297211|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126297212|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126297213|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126297214|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126297215|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297216|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
126297217|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
126297218|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297219|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297220|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297221|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297222|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
125883561|NCT01746901|452871512|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
125883562|NCT01746901|452871513|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125883563|NCT01746901|452871514|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126102453|NCT04677179|453668321|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
126102454|NCT04677179|453668322|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
126297223|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
126297224|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
126297225|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126297226|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126297227|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126297228|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126297229|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
126297230|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
126297231|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
126297232|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126297233|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126297234|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126297235|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126297236|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
126297237|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297238|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297239|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297240|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297241|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297242|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297243|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297244|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297245|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
126297246|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297247|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297248|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297249|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297250|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297251|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297252|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
126297253|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297254|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297255|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297256|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297257|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297258|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
126297259|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
126297260|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297261|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297262|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297263|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297264|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126297265|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126297266|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126297267|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
126297268|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
126297269|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
126297270|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
126297271|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126297272|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126297273|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126297274|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
126297275|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
126297276|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
126297277|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
126297278|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126297279|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126297280|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126297281|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
126297282|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
126297283|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
126297284|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
126297285|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297286|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297287|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297288|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
126297289|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
126297290|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
126297291|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
126297292|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297293|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297294|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297295|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
126297296|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
126297297|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
126297298|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
126297299|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297300|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297301|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297302|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
126297303|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297304|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297305|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297306|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297307|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297308|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297309|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297310|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
126297311|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297312|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297313|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297314|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297315|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297316|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297317|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
126297318|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297319|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297320|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297321|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297322|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297323|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297324|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
126102455|NCT04677179|453668323|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
126102456|NCT04677179|453668324|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
126102457|NCT04677179|453668325|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
126102458|NCT04677179|453668326|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
126102459|NCT04677179|453668327|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
126102460|NCT04677179|453668318|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
126102461|NCT04677179|453668319|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
126102462|NCT04677179|453668320|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
126102463|NCT04677179|453668321|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
126102464|NCT04677179|453668322|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
126102465|NCT04677179|453668323|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
126102466|NCT04677179|453668324|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
126102467|NCT04677179|453668325|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
126102468|NCT04677179|453668326|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
126102469|NCT04677179|453668327|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
126102470|NCT04677179|453668318|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
126102471|NCT04677179|453668319|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
126102472|NCT04677179|453668320|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
126102473|NCT04677179|453668321|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
126102474|NCT04677179|453668322|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
126102475|NCT04677179|453668323|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
126102476|NCT04677179|453668324|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
126102477|NCT04677179|453668325|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
126102478|NCT04677179|453668326|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
126297325|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297326|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297327|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297328|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297329|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297330|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297331|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
126297332|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297333|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297334|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126102479|NCT04677179|453668327|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
126102480|NCT04677179|453668318|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102481|NCT04677179|453668319|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102482|NCT04677179|453668320|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102483|NCT04677179|453668321|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
126102484|NCT04677179|453668322|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102485|NCT04677179|453668323|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102486|NCT04677179|453668324|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102487|NCT04677179|453668325|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102488|NCT04677179|453668326|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102489|NCT04677179|453668327|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
126102490|NCT04677179|453668318|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
126102491|NCT04677179|453668319|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
126102492|NCT04677179|453668320|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
126102493|NCT04677179|453668321|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
126102494|NCT04677179|453668322|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
126102495|NCT04677179|453668323|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
126102496|NCT04677179|453668324|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
126102497|NCT04677179|453668325|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
126102498|NCT04677179|453668326|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
126102499|NCT04677179|453668327|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
126102500|NCT04677179|453668318|FG000|Extension Treatment Period|Lack of Efficacy|0|||
126102501|NCT04677179|453668319|FG001|Extension Treatment Period|Lack of Efficacy|0|||
126102502|NCT04677179|453668320|FG002|Extension Treatment Period|Lack of Efficacy|0|||
126102503|NCT04677179|453668321|FG003|Extension Treatment Period|Lack of Efficacy|0|||
126102504|NCT04677179|453668322|FG004|Extension Treatment Period|Lack of Efficacy|0|||
126102505|NCT04677179|453668323|FG005|Extension Treatment Period|Lack of Efficacy|0|||
126102506|NCT04677179|453668324|FG006|Extension Treatment Period|Lack of Efficacy|6|||
126102507|NCT04677179|453668325|FG007|Extension Treatment Period|Lack of Efficacy|0|||
126102508|NCT04677179|453668326|FG008|Extension Treatment Period|Lack of Efficacy|0|||
126102509|NCT04677179|453668327|FG009|Extension Treatment Period|Lack of Efficacy|0|||
126102510|NCT04677179|453668318|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
126102511|NCT04677179|453668319|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126102512|NCT04677179|453668320|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
126102513|NCT04677179|453668321|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
126102514|NCT04677179|453668322|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
126102515|NCT04677179|453668323|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
126102516|NCT04677179|453668324|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
126102517|NCT04677179|453668325|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
126102518|NCT04677179|453668326|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
126102519|NCT04677179|453668327|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
126102520|NCT04677179|453668318|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
126102521|NCT04677179|453668319|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
126102522|NCT04677179|453668320|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
126297335|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297336|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297337|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297338|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
126297339|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297340|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297341|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297342|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297343|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297344|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297345|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297346|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
126297347|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297348|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297349|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297350|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297351|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297352|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297353|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
126297354|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126102523|NCT04677179|453668321|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
126297355|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297356|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297357|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297358|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297359|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297360|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126102524|NCT04677179|453668322|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
126102525|NCT04677179|453668323|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
126102526|NCT04677179|453668324|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
126297361|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
126297362|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297363|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297364|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297365|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297366|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297367|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297368|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
126297369|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297370|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297371|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297372|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297373|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297374|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297375|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
126297376|NCT04563754|454376973|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
126297377|NCT04563754|454376974|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
126297378|NCT04563754|454376975|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
126297379|NCT04563754|454376973|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
126297380|NCT04563754|454376974|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
126297381|NCT04563754|454376975|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
126297382|NCT04563754|454376973|FG000|Follow up|Lost to Follow-up|61|||
126297383|NCT04563754|454376974|FG001|Follow up|Lost to Follow-up|23|||
126297384|NCT04563754|454376975|FG002|Follow up|Lost to Follow-up|5|||
126297385|NCT04563754|454376973|FG000|Follow up|Death|0|||
126297386|NCT04563754|454376974|FG001|Follow up|Death|2|||
126297387|NCT04563754|454376975|FG002|Follow up|Death|0|||
126102527|NCT04677179|453668325|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
126102528|NCT04677179|453668326|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
126102529|NCT04677179|453668327|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
126297388|NCT04563754|454376973|FG000|Follow up|Ongoing|0|||
126297389|NCT04563754|454376974|FG001|Follow up|Ongoing|28|||
126297390|NCT04563754|454376975|FG002|Follow up|Ongoing|0|||
126297391|NCT04023396|454376976|FG000|Overall Study|Adverse Event|16|||
126297392|NCT04023396|454376976|FG000|Overall Study|Death|1|||
126297393|NCT04023396|454376976|FG000|Overall Study|Lost to Follow-up|1|||
126297394|NCT04023396|454376976|FG000|Overall Study|Withdrawal by Subject|14|||
126297395|NCT04023396|454376976|FG000|Overall Study|Pregnancy|4|||
126297396|NCT04023396|454376976|FG000|Overall Study|Lack of Efficacy|3|||
126297397|NCT04023396|454376976|FG000|Overall Study|Physician Decision|4|||
126297398|NCT04023396|454376976|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
126297399|NCT04075825|454376977|FG000|Overall Study|Withdrawal by Subject|6|||
126297400|NCT04075825|454376978|FG001|Overall Study|Withdrawal by Subject|8|||
126297401|NCT04075825|454376977|FG000|Overall Study|Physician Decision|3|||
126297402|NCT04075825|454376978|FG001|Overall Study|Physician Decision|1|||
126297403|NCT04075825|454376977|FG000|Overall Study|Lost to Follow-up|5|||
126297404|NCT04075825|454376978|FG001|Overall Study|Lost to Follow-up|1|||
126297405|NCT04075825|454376977|FG000|Overall Study|Participation in New Clinical Trial|1|||
126297406|NCT04075825|454376978|FG001|Overall Study|Participation in New Clinical Trial|1|||
126297407|NCT04075825|454376977|FG000|Overall Study|Reason Not Specified|2|||
126297408|NCT04075825|454376978|FG001|Overall Study|Reason Not Specified|2|||
126297409|NCT04021914|454376979|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
126297410|NCT03349060|454376980|FG000|Overall Study|Adverse Event|9|||
126297411|NCT03349060|454376981|FG001|Overall Study|Adverse Event|9|||
126297412|NCT03349060|454376982|FG002|Overall Study|Adverse Event|7|||
126297413|NCT03349060|454376980|FG000|Overall Study|Lack of Efficacy|1|||
126297414|NCT03349060|454376981|FG001|Overall Study|Lack of Efficacy|0|||
126297415|NCT03349060|454376982|FG002|Overall Study|Lack of Efficacy|2|||
126297416|NCT03349060|454376980|FG000|Overall Study|Lost to Follow-up|2|||
126297417|NCT03349060|454376981|FG001|Overall Study|Lost to Follow-up|1|||
126297418|NCT03349060|454376982|FG002|Overall Study|Lost to Follow-up|1|||
126297419|NCT03349060|454376980|FG000|Overall Study|Protocol Violation|2|||
126297420|NCT03349060|454376981|FG001|Overall Study|Protocol Violation|2|||
126297421|NCT03349060|454376982|FG002|Overall Study|Protocol Violation|1|||
126297422|NCT03349060|454376980|FG000|Overall Study|Withdrawal by Subject|5|||
126297423|NCT03349060|454376981|FG001|Overall Study|Withdrawal by Subject|3|||
126297424|NCT03349060|454376982|FG002|Overall Study|Withdrawal by Subject|4|||
126297425|NCT03349060|454376980|FG000|Overall Study|Medication error,no linked adverse event|0|||
126297426|NCT03349060|454376981|FG001|Overall Study|Medication error,no linked adverse event|0|||
126297427|NCT03349060|454376982|FG002|Overall Study|Medication error,no linked adverse event|1|||
126297428|NCT03349060|454376980|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126297429|NCT03349060|454376981|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
126297430|NCT03349060|454376982|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
126297431|NCT03349060|454376980|FG000|Overall Study|Other|2|||
126297432|NCT03349060|454376981|FG001|Overall Study|Other|1|||
126297433|NCT03349060|454376982|FG002|Overall Study|Other|0|||
126297434|NCT02861586|454376983|FG000|Overall Study|Withdrawal by Subject|1|||
126297435|NCT02861586|454376984|FG001|Overall Study|Withdrawal by Subject|2|||
126297436|NCT02861586|454376985|FG002|Overall Study|Withdrawal by Subject|0|||
126297437|NCT02861586|454376986|FG003|Overall Study|Withdrawal by Subject|0|||
126297438|NCT02861586|454376987|FG004|Overall Study|Withdrawal by Subject|0|||
126297439|NCT02861586|454376988|FG005|Overall Study|Withdrawal by Subject|1|||
126297440|NCT02861586|454376989|FG006|Overall Study|Withdrawal by Subject|1|||
126297441|NCT02861586|454376990|FG007|Overall Study|Withdrawal by Subject|0|||
126297442|NCT02861586|454376983|FG000|Overall Study|Lost to Follow-up|3|||
126297443|NCT02861586|454376984|FG001|Overall Study|Lost to Follow-up|1|||
126297444|NCT02861586|454376985|FG002|Overall Study|Lost to Follow-up|1|||
126297445|NCT02861586|454376986|FG003|Overall Study|Lost to Follow-up|0|||
126297446|NCT02861586|454376987|FG004|Overall Study|Lost to Follow-up|0|||
126297447|NCT02861586|454376988|FG005|Overall Study|Lost to Follow-up|3|||
126297448|NCT02861586|454376989|FG006|Overall Study|Lost to Follow-up|0|||
126043232|NCT04167553|453456022|FG005|Overall Study|Lost to Follow-up|0|||
126297449|NCT02861586|454376990|FG007|Overall Study|Lost to Follow-up|0|||
126297450|NCT02861586|454376983|FG000|Overall Study|Adverse Event|0|||
126297451|NCT02861586|454376984|FG001|Overall Study|Adverse Event|0|||
126297452|NCT02861586|454376985|FG002|Overall Study|Adverse Event|0|||
126297453|NCT02861586|454376986|FG003|Overall Study|Adverse Event|0|||
126297454|NCT02861586|454376987|FG004|Overall Study|Adverse Event|0|||
126297455|NCT02861586|454376988|FG005|Overall Study|Adverse Event|1|||
126297456|NCT02861586|454376989|FG006|Overall Study|Adverse Event|0|||
126297457|NCT02861586|454376990|FG007|Overall Study|Adverse Event|0|||
126297458|NCT00955409|454376991|FG000|Overall Study|Lack of Efficacy|1|||
126297459|NCT00955409|454376992|FG001|Overall Study|Lack of Efficacy|0|||
126297460|NCT00955409|454376993|FG002|Overall Study|Lack of Efficacy|0|||
126297461|NCT00955409|454376994|FG003|Overall Study|Lack of Efficacy|0|||
126297462|NCT00955409|454376995|FG004|Overall Study|Lack of Efficacy|0|||
126297463|NCT00955409|454376996|FG005|Overall Study|Lack of Efficacy|0|||
126297464|NCT00955409|454376997|FG006|Overall Study|Lack of Efficacy|0|||
126043233|NCT04167553|453456023|FG006|Overall Study|Lost to Follow-up|0|||
126297465|NCT00955409|454376998|FG007|Overall Study|Lack of Efficacy|0|||
126297466|NCT00955409|454376999|FG008|Overall Study|Lack of Efficacy|0|||
126297467|NCT00955409|454377000|FG009|Overall Study|Lack of Efficacy|0|||
126297468|NCT00955409|454376991|FG000|Overall Study|Withdrawal by Subject|1|||
126297469|NCT00955409|454376992|FG001|Overall Study|Withdrawal by Subject|0|||
126297470|NCT00955409|454376993|FG002|Overall Study|Withdrawal by Subject|5|||
126297471|NCT00955409|454376994|FG003|Overall Study|Withdrawal by Subject|2|||
126297472|NCT00955409|454376995|FG004|Overall Study|Withdrawal by Subject|0|||
126297473|NCT00955409|454376996|FG005|Overall Study|Withdrawal by Subject|0|||
126297474|NCT00955409|454376997|FG006|Overall Study|Withdrawal by Subject|2|||
126297475|NCT00955409|454376998|FG007|Overall Study|Withdrawal by Subject|0|||
126297476|NCT00955409|454376999|FG008|Overall Study|Withdrawal by Subject|1|||
126297477|NCT00955409|454377000|FG009|Overall Study|Withdrawal by Subject|0|||
126297478|NCT00955409|454376991|FG000|Overall Study|Caregiver Request|2|||
126297479|NCT00955409|454376992|FG001|Overall Study|Caregiver Request|0|||
126297480|NCT00955409|454376993|FG002|Overall Study|Caregiver Request|6|||
126297481|NCT00955409|454376994|FG003|Overall Study|Caregiver Request|5|||
126297482|NCT00955409|454376995|FG004|Overall Study|Caregiver Request|0|||
126297483|NCT00955409|454376996|FG005|Overall Study|Caregiver Request|2|||
126297484|NCT00955409|454376997|FG006|Overall Study|Caregiver Request|3|||
126297485|NCT00955409|454376998|FG007|Overall Study|Caregiver Request|1|||
126297486|NCT00955409|454376999|FG008|Overall Study|Caregiver Request|3|||
126297487|NCT00955409|454377000|FG009|Overall Study|Caregiver Request|0|||
126297488|NCT00955409|454376991|FG000|Overall Study|Investigator Request|0|||
126297489|NCT00955409|454376992|FG001|Overall Study|Investigator Request|0|||
126297490|NCT00955409|454376993|FG002|Overall Study|Investigator Request|1|||
126297491|NCT00955409|454376994|FG003|Overall Study|Investigator Request|0|||
126297492|NCT00955409|454376995|FG004|Overall Study|Investigator Request|0|||
125883564|NCT01746901|452871515|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126297493|NCT00955409|454376996|FG005|Overall Study|Investigator Request|0|||
126297494|NCT00955409|454376997|FG006|Overall Study|Investigator Request|0|||
126297495|NCT00955409|454376998|FG007|Overall Study|Investigator Request|0|||
126297496|NCT00955409|454376999|FG008|Overall Study|Investigator Request|0|||
126297497|NCT00955409|454377000|FG009|Overall Study|Investigator Request|0|||
126297498|NCT00955409|454376991|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
125883565|NCT01746901|452871516|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126297499|NCT00955409|454376992|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126043234|NCT02828358|453456029|FG000|Overall Study|Physician Decision|7|||
126043235|NCT02828358|453456030|FG001|Overall Study|Physician Decision|1|||
126043236|NCT02828358|453456029|FG000|Overall Study|Treatment Failure|6|||
126043237|NCT02828358|453456030|FG001|Overall Study|Treatment Failure|0|||
126043238|NCT02828358|453456029|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
126043239|NCT02828358|453456030|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
126043240|NCT02828358|453456029|FG000|Overall Study|Refusal of further protocol therapy|2|||
126043241|NCT02828358|453456030|FG001|Overall Study|Refusal of further protocol therapy|0|||
126043242|NCT02828358|453456029|FG000|Overall Study|Relapse|25|||
126043243|NCT02828358|453456030|FG001|Overall Study|Relapse|0|||
126043244|NCT02828358|453456029|FG000|Overall Study|Still on therapy|5|||
126043245|NCT02828358|453456030|FG001|Overall Study|Still on therapy|0|||
126043246|NCT04804540|453456033|FG000|Overall Study|Adverse Event|26|||
126043247|NCT04804540|453456034|FG001|Overall Study|Adverse Event|13|||
126043248|NCT05172232|453456035|FG000|Overall Study|Lost to Follow-up|3|||
126043249|NCT01828021|453456036|FG000|Overall Study|Adverse Event|5|||
126043250|NCT01828021|453456036|FG000|Overall Study|Lack of Efficacy|17|||
126043251|NCT01828021|453456036|FG000|Overall Study|Withdrawal by Subject|2|||
126043252|NCT01828021|453456036|FG000|Overall Study|Ileal obstruction, unrelated|1|||
126043253|NCT00844415|453456037|FG000|Overall Study|Withdrawal by Subject|1|||
126043254|NCT02473445|453456038|FG000|Overall Study|Withdrawal by Subject|2|||
126043255|NCT02473445|453456038|FG000|Overall Study|Sponsor Decision|20|||
126043256|NCT03015532|453456039|FG000|Overall Study|Adverse Event|0|||
126043257|NCT03015532|453456040|FG001|Overall Study|Adverse Event|0|||
126043258|NCT03015532|453456041|FG002|Overall Study|Adverse Event|0|||
126043259|NCT03015532|453456042|FG003|Overall Study|Adverse Event|0|||
126043260|NCT03015532|453456043|FG004|Overall Study|Adverse Event|0|||
126043261|NCT03015532|453456044|FG005|Overall Study|Adverse Event|2|||
126043262|NCT03015532|453456045|FG006|Overall Study|Adverse Event|1|||
126043263|NCT03015532|453456046|FG007|Overall Study|Adverse Event|0|||
126043264|NCT03015532|453456039|FG000|Overall Study|Withdrawal by Subject|0|||
126043265|NCT03015532|453456040|FG001|Overall Study|Withdrawal by Subject|0|||
126043266|NCT03015532|453456041|FG002|Overall Study|Withdrawal by Subject|0|||
126297500|NCT00955409|454376993|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
126297501|NCT00955409|454376994|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
126297502|NCT00955409|454376995|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
126297503|NCT00955409|454376996|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
126043267|NCT03015532|453456042|FG003|Overall Study|Withdrawal by Subject|0|||
126043268|NCT03015532|453456043|FG004|Overall Study|Withdrawal by Subject|0|||
126297504|NCT00955409|454376997|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
126297505|NCT00955409|454376998|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
126297506|NCT00955409|454376999|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
126297507|NCT00955409|454377000|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
126297508|NCT00955409|454376991|FG000|Overall Study|Lost to Follow-up|0|||
126297509|NCT00955409|454376992|FG001|Overall Study|Lost to Follow-up|0|||
126297510|NCT00955409|454376993|FG002|Overall Study|Lost to Follow-up|1|||
126297511|NCT00955409|454376994|FG003|Overall Study|Lost to Follow-up|0|||
126297512|NCT00955409|454376995|FG004|Overall Study|Lost to Follow-up|0|||
126297513|NCT00955409|454376996|FG005|Overall Study|Lost to Follow-up|0|||
126297514|NCT00955409|454376997|FG006|Overall Study|Lost to Follow-up|1|||
126297515|NCT00955409|454376998|FG007|Overall Study|Lost to Follow-up|0|||
126297516|NCT00955409|454376999|FG008|Overall Study|Lost to Follow-up|0|||
126297517|NCT00955409|454377000|FG009|Overall Study|Lost to Follow-up|0|||
126297518|NCT00955409|454376991|FG000|Overall Study|Failed to Return|2|||
126297519|NCT00955409|454376992|FG001|Overall Study|Failed to Return|0|||
126297520|NCT00955409|454376993|FG002|Overall Study|Failed to Return|0|||
126297521|NCT00955409|454376994|FG003|Overall Study|Failed to Return|0|||
126297522|NCT00955409|454376995|FG004|Overall Study|Failed to Return|0|||
126297523|NCT00955409|454376996|FG005|Overall Study|Failed to Return|0|||
126297524|NCT00955409|454376997|FG006|Overall Study|Failed to Return|0|||
126366957|NCT01051661|454639361|FG000|Overall Study|Subject lost legal representation|0|||
126043269|NCT03015532|453456044|FG005|Overall Study|Withdrawal by Subject|0|||
126043270|NCT03015532|453456045|FG006|Overall Study|Withdrawal by Subject|1|||
126043271|NCT03015532|453456046|FG007|Overall Study|Withdrawal by Subject|0|||
126043272|NCT05970861|453456047|FG000|Overall Study|Physician Decision|4|||
126043273|NCT05970861|453456048|FG001|Overall Study|Physician Decision|4|||
126043274|NCT05970861|453456047|FG000|Overall Study|Lost to Follow-up|4|||
126043275|NCT05970861|453456048|FG001|Overall Study|Lost to Follow-up|3|||
126043276|NCT01447719|453456049|FG000|Overall Study|Image acquisition failure|2|||
126043277|NCT01447719|453456049|FG000|Overall Study|Invalid image or not imaged|3|||
126043278|NCT01447719|453456049|FG000|Overall Study|Subject still living at end of study|79|||
126043279|NCT01447719|453456049|FG000|Overall Study|Withdrawal by Subject|2|||
126043280|NCT01447719|453456049|FG000|Overall Study|Family withdrew autopsy consent|7|||
126043281|NCT05100628|453456050|FG000|Overall Study|Progressive Disease|1|||
126043282|NCT05100628|453456051|FG001|Overall Study|Progressive Disease|0|||
126043283|NCT05100628|453456052|FG002|Overall Study|Progressive Disease|0|||
126043284|NCT05100628|453456053|FG003|Overall Study|Progressive Disease|0|||
126043285|NCT05100628|453456050|FG000|Overall Study|Study Terminated by Sponsor|0|||
126043286|NCT05100628|453456051|FG001|Overall Study|Study Terminated by Sponsor|0|||
126043287|NCT05100628|453456052|FG002|Overall Study|Study Terminated by Sponsor|3|||
126043288|NCT05100628|453456053|FG003|Overall Study|Study Terminated by Sponsor|0|||
126043289|NCT05100628|453456050|FG000|Overall Study|unkown|0|||
126043290|NCT05100628|453456051|FG001|Overall Study|unkown|1|||
126043291|NCT05100628|453456052|FG002|Overall Study|unkown|0|||
126043292|NCT05100628|453456053|FG003|Overall Study|unkown|0|||
126043293|NCT03914469|453456056|FG000|Overall Study|Lost to Follow-up|1|||
126043294|NCT03914469|453456057|FG001|Overall Study|Lost to Follow-up|4|||
126043295|NCT02542631|453456066|FG000|Overall Study|Adverse Event|1|||
126043296|NCT02542631|453456067|FG001|Overall Study|Adverse Event|1|||
126043297|NCT02542631|453456066|FG000|Overall Study|Sponsor Termination|1|||
126043298|NCT02542631|453456067|FG001|Overall Study|Sponsor Termination|0|||
126043299|NCT02542631|453456066|FG000|Overall Study|Withdrawal by Subject|11|||
126043300|NCT02542631|453456067|FG001|Overall Study|Withdrawal by Subject|16|||
126043301|NCT02542631|453456066|FG000|Overall Study|Protocol Violation|1|||
126043302|NCT02542631|453456067|FG001|Overall Study|Protocol Violation|1|||
126043303|NCT02542631|453456066|FG000|Overall Study|Physician Decision|6|||
126043304|NCT02542631|453456067|FG001|Overall Study|Physician Decision|4|||
126043305|NCT02542631|453456066|FG000|Overall Study|Lost to Follow-up|6|||
126043306|NCT02542631|453456067|FG001|Overall Study|Lost to Follow-up|5|||
126043307|NCT02542631|453456066|FG000|Overall Study|Death|1|||
126043308|NCT02542631|453456067|FG001|Overall Study|Death|2|||
126043309|NCT02542631|453456066|FG000|Overall Study|Other|2|||
126043310|NCT02542631|453456067|FG001|Overall Study|Other|1|||
126043311|NCT02542631|453456066|FG000|Overall Study|Used Prohibited Medication|2|||
126043312|NCT02542631|453456067|FG001|Overall Study|Used Prohibited Medication|1|||
126043313|NCT00721149|453456068|FG000|Overall Study|Physician Decision|1|||
126043314|NCT04583280|453456070|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
126043315|NCT04583280|453456071|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
126043316|NCT00631475|453456074|FG000|Overall Study|Death|18|||
126043317|NCT00631475|453456074|FG000|Overall Study|Adverse Event|14|||
126043318|NCT00631475|453456074|FG000|Overall Study|Withdrew consent|5|||
126043319|NCT00631475|453456074|FG000|Overall Study|Preparation for lung transplant|8|||
126043320|NCT05158504|453456075|FG000|Overall Study|Lost to Follow-up|2|||
126043321|NCT05158504|453456076|FG001|Overall Study|Lost to Follow-up|3|||
126043322|NCT03606512|453456077|FG000|Overall Study|Lost to Follow-up|0|||
126043323|NCT03606512|453456078|FG001|Overall Study|Lost to Follow-up|1|||
126043324|NCT03606512|453456077|FG000|Overall Study|'moved from study area|0|||
126043325|NCT03606512|453456078|FG001|Overall Study|'moved from study area|1|||
126297525|NCT00955409|454376998|FG007|Overall Study|Failed to Return|2|||
126297526|NCT00955409|454376999|FG008|Overall Study|Failed to Return|0|||
126297527|NCT00955409|454377000|FG009|Overall Study|Failed to Return|0|||
126297528|NCT00955409|454376991|FG000|Overall Study|Adverse Event (AE)|2|||
126297529|NCT00955409|454376992|FG001|Overall Study|Adverse Event (AE)|0|||
126297530|NCT00955409|454376993|FG002|Overall Study|Adverse Event (AE)|0|||
126297531|NCT00955409|454376994|FG003|Overall Study|Adverse Event (AE)|0|||
126297532|NCT00955409|454376995|FG004|Overall Study|Adverse Event (AE)|0|||
126297533|NCT00955409|454376996|FG005|Overall Study|Adverse Event (AE)|1|||
126297534|NCT00955409|454376997|FG006|Overall Study|Adverse Event (AE)|2|||
126297535|NCT00955409|454376998|FG007|Overall Study|Adverse Event (AE)|0|||
126297536|NCT00955409|454376999|FG008|Overall Study|Adverse Event (AE)|2|||
126297537|NCT00955409|454377000|FG009|Overall Study|Adverse Event (AE)|0|||
126297538|NCT00955409|454376991|FG000|Overall Study|Reason not Specified|2|||
126297539|NCT00955409|454376992|FG001|Overall Study|Reason not Specified|1|||
126297540|NCT00955409|454376993|FG002|Overall Study|Reason not Specified|13|||
126297541|NCT00955409|454376994|FG003|Overall Study|Reason not Specified|1|||
126297542|NCT00955409|454376995|FG004|Overall Study|Reason not Specified|2|||
126297543|NCT00955409|454376996|FG005|Overall Study|Reason not Specified|0|||
126297544|NCT00955409|454376997|FG006|Overall Study|Reason not Specified|16|||
126297545|NCT00955409|454376998|FG007|Overall Study|Reason not Specified|0|||
126297546|NCT00955409|454376999|FG008|Overall Study|Reason not Specified|8|||
126297547|NCT00955409|454377000|FG009|Overall Study|Reason not Specified|1|||
126297548|NCT00485732|454377001|FG000|Overall Study|Protocol Violation|1|||
126297549|NCT00485732|454377002|FG001|Overall Study|Protocol Violation|3|||
126297550|NCT00485732|454377001|FG000|Overall Study|Withdrawal by Subject|5|||
126297551|NCT00485732|454377002|FG001|Overall Study|Withdrawal by Subject|4|||
126297552|NCT00485732|454377001|FG000|Overall Study|Lost to Follow-up|2|||
126102530|NCT04677179|453668318|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
126102531|NCT04677179|453668319|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
126102532|NCT04677179|453668320|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
126102533|NCT04677179|453668321|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
126102534|NCT04677179|453668322|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
126102535|NCT04677179|453668323|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
126102536|NCT04677179|453668324|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
126102537|NCT04677179|453668325|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
126102538|NCT04677179|453668326|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
126102539|NCT04677179|453668327|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
126297553|NCT00485732|454377002|FG001|Overall Study|Lost to Follow-up|2|||
126297554|NCT00803790|454377003|FG000|Period 1|Adverse Event|0|||
126297555|NCT00803790|454377004|FG001|Period 1|Adverse Event|1|||
126297556|NCT00803790|454377005|FG002|Period 1|Adverse Event|0|||
126297557|NCT00803790|454377006|FG003|Period 1|Adverse Event|0|||
126297558|NCT00803790|454377003|FG000|Period 1|Lost to Follow-up|1|||
126297559|NCT00803790|454377004|FG001|Period 1|Lost to Follow-up|2|||
126297560|NCT00803790|454377005|FG002|Period 1|Lost to Follow-up|0|||
126297561|NCT00803790|454377006|FG003|Period 1|Lost to Follow-up|0|||
126297562|NCT00803790|454377003|FG000|Period 1|Withdrawal by Subject|8|||
126297563|NCT00803790|454377004|FG001|Period 1|Withdrawal by Subject|6|||
126297564|NCT00803790|454377005|FG002|Period 1|Withdrawal by Subject|0|||
126297565|NCT00803790|454377006|FG003|Period 1|Withdrawal by Subject|0|||
126297566|NCT00803790|454377003|FG000|Period 1|positive drug screen or personal reasons|0|||
126297567|NCT00803790|454377004|FG001|Period 1|positive drug screen or personal reasons|3|||
126297568|NCT00803790|454377005|FG002|Period 1|positive drug screen or personal reasons|0|||
126297569|NCT00803790|454377006|FG003|Period 1|positive drug screen or personal reasons|4|||
126297570|NCT00803790|454377003|FG000|Period 1|Protocol Violation|0|||
126297571|NCT00803790|454377004|FG001|Period 1|Protocol Violation|0|||
126297572|NCT00803790|454377005|FG002|Period 1|Protocol Violation|1|||
126297573|NCT00803790|454377006|FG003|Period 1|Protocol Violation|0|||
126297574|NCT00803790|454377003|FG000|Period 2|Adverse Event|0|||
126297575|NCT00803790|454377004|FG001|Period 2|Adverse Event|0|||
126297576|NCT00803790|454377005|FG002|Period 2|Adverse Event|1|||
126297577|NCT00803790|454377006|FG003|Period 2|Adverse Event|1|||
125883566|NCT01746901|452871517|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126297578|NCT00803790|454377003|FG000|Period 2|Withdrawal by Subject|1|||
126297579|NCT00803790|454377004|FG001|Period 2|Withdrawal by Subject|0|||
126366958|NCT01051661|454639362|FG001|Overall Study|Subject lost legal representation|0|||
126366959|NCT01051661|454639363|FG002|Overall Study|Subject lost legal representation|0|||
126366960|NCT01051661|454639364|FG003|Overall Study|Subject lost legal representation|0|||
125883567|NCT01746901|452871518|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126297580|NCT00803790|454377005|FG002|Period 2|Withdrawal by Subject|0|||
126297581|NCT00803790|454377006|FG003|Period 2|Withdrawal by Subject|0|||
126297582|NCT00803790|454377003|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
126297583|NCT00803790|454377004|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
126297584|NCT00803790|454377005|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
126297585|NCT00803790|454377006|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
126297586|NCT01880554|454377007|FG000|Overall Study|Protocol Violation|14|||
126366961|NCT01051661|454639365|FG004|Overall Study|Subject lost legal representation|1|||
126297587|NCT01880554|454377007|FG000|Overall Study|Simon's design requirements|2|||
126297588|NCT05161481|454377008|FG000|Overall Study|Withdrawal of consent|0|||
126297589|NCT05161481|454377009|FG001|Overall Study|Withdrawal of consent|1|||
126297590|NCT05161481|454377010|FG002|Overall Study|Withdrawal of consent|1|||
126297591|NCT05161481|454377008|FG000|Overall Study|Study terminated by sponsor|3|||
126297592|NCT05161481|454377009|FG001|Overall Study|Study terminated by sponsor|3|||
126297593|NCT05161481|454377010|FG002|Overall Study|Study terminated by sponsor|2|||
126297594|NCT05161481|454377008|FG000|Overall Study|Adverse Event|3|||
126297595|NCT05161481|454377009|FG001|Overall Study|Adverse Event|0|||
126297596|NCT05161481|454377010|FG002|Overall Study|Adverse Event|6|||
126297597|NCT05161481|454377008|FG000|Overall Study|Randomised in error and was not treated|1|||
126297598|NCT05161481|454377009|FG001|Overall Study|Randomised in error and was not treated|0|||
126297599|NCT05161481|454377010|FG002|Overall Study|Randomised in error and was not treated|0|||
126297600|NCT05161481|454377008|FG000|Overall Study|Subject decision|0|||
126297601|NCT05161481|454377009|FG001|Overall Study|Subject decision|0|||
126297602|NCT05161481|454377010|FG002|Overall Study|Subject decision|1|||
126297603|NCT03985800|454377011|FG000|Overall Study|Death|1|||
126297604|NCT03985800|454377012|FG001|Overall Study|Death|2|||
126297605|NCT03985800|454377011|FG000|Overall Study|Withdrawal by Subject|3|||
126297606|NCT03985800|454377012|FG001|Overall Study|Withdrawal by Subject|6|||
126297607|NCT03985800|454377011|FG000|Overall Study|Protocol Violation|2|||
126297608|NCT03985800|454377012|FG001|Overall Study|Protocol Violation|0|||
126297609|NCT04281485|454377013|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
126297610|NCT04281485|454377014|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
126297611|NCT04281485|454377013|FG000|Overall Study|Ongoing (Safety data collection)|10|||
126297612|NCT04281485|454377014|FG001|Overall Study|Ongoing (Safety data collection)|5|||
126297613|NCT04335123|454377018|FG000|Overall Study|Withdrawal by Subject|2|||
126297614|NCT04335123|454377019|FG001|Overall Study|Withdrawal by Subject|0|||
126297615|NCT04335123|454377018|FG000|Overall Study|Physician Decision|2|||
126297616|NCT04335123|454377019|FG001|Overall Study|Physician Decision|0|||
126297617|NCT01293695|454377028|FG000|Overall Study|Withdrawal by Subject|7|||
126297618|NCT01293695|454377029|FG001|Overall Study|Withdrawal by Subject|1|||
126297619|NCT01293695|454377028|FG000|Overall Study|Lost to Follow-up|8|||
126297620|NCT01293695|454377029|FG001|Overall Study|Lost to Follow-up|6|||
126297621|NCT02570308|454377030|FG000|Overall Study|Death|1|||
126297622|NCT02570308|454377031|FG001|Overall Study|Death|5|||
126297623|NCT02570308|454377032|FG002|Overall Study|Death|4|||
126297624|NCT02570308|454377033|FG003|Overall Study|Death|4|||
126297625|NCT02570308|454377034|FG004|Overall Study|Death|69|||
126297626|NCT02570308|454377030|FG000|Overall Study|Lost to Follow-up|0|||
126297627|NCT02570308|454377031|FG001|Overall Study|Lost to Follow-up|0|||
126297628|NCT02570308|454377032|FG002|Overall Study|Lost to Follow-up|0|||
126297629|NCT02570308|454377033|FG003|Overall Study|Lost to Follow-up|0|||
126297630|NCT02570308|454377034|FG004|Overall Study|Lost to Follow-up|2|||
126297631|NCT02570308|454377030|FG000|Overall Study|Withdrawal by Subject|0|||
126297632|NCT02570308|454377031|FG001|Overall Study|Withdrawal by Subject|0|||
126297633|NCT02570308|454377032|FG002|Overall Study|Withdrawal by Subject|0|||
126297634|NCT02570308|454377033|FG003|Overall Study|Withdrawal by Subject|0|||
126297635|NCT02570308|454377034|FG004|Overall Study|Withdrawal by Subject|1|||
126297636|NCT02570308|454377030|FG000|Overall Study|Other|0|||
126297637|NCT02570308|454377031|FG001|Overall Study|Other|0|||
126297638|NCT02570308|454377032|FG002|Overall Study|Other|0|||
126297639|NCT02570308|454377033|FG003|Overall Study|Other|0|||
126297640|NCT02570308|454377034|FG004|Overall Study|Other|2|||
126297641|NCT00957801|454377035|FG000|Overall Study|Withdrawal by Subject|0|||
126297642|NCT00957801|454377036|FG001|Overall Study|Withdrawal by Subject|0|||
126297643|NCT00957801|454377037|FG002|Overall Study|Withdrawal by Subject|0|||
126297644|NCT00957801|454377038|FG003|Overall Study|Withdrawal by Subject|1|||
126297645|NCT01283464|454377039|FG000|Overall Study|Lost to Follow-up|0|||
126297646|NCT01283464|454377040|FG001|Overall Study|Lost to Follow-up|1|||
126297647|NCT01283464|454377039|FG000|Overall Study|Withdrawal by Subject|1|||
126297648|NCT01283464|454377040|FG001|Overall Study|Withdrawal by Subject|0|||
126297649|NCT01283464|454377039|FG000|Overall Study|Physician Decision|1|||
126297650|NCT01283464|454377040|FG001|Overall Study|Physician Decision|0|||
126297651|NCT02626026|454377041|FG000|Overall Study|Randomized but Never Treated|0|||
126297652|NCT02626026|454377042|FG001|Overall Study|Randomized but Never Treated|0|||
126297653|NCT02626026|454377043|FG002|Overall Study|Randomized but Never Treated|0|||
126297654|NCT02626026|454377044|FG003|Overall Study|Randomized but Never Treated|0|||
126297655|NCT02626026|454377045|FG004|Overall Study|Randomized but Never Treated|1|||
126297656|NCT02626026|454377046|FG005|Overall Study|Randomized but Never Treated|0|||
126297657|NCT01778855|454377047|FG000|Overall Study|Death|0|||
126297658|NCT01778855|454377048|FG001|Overall Study|Death|1|||
126297659|NCT00191477|454377050|FG000|Overall Study|Tumor Recurrence|49|||
126297660|NCT00191477|454377051|FG001|Overall Study|Tumor Recurrence|48|||
126297661|NCT00191477|454377050|FG000|Overall Study|Death, Study Disease|1|||
126297662|NCT00191477|454377051|FG001|Overall Study|Death, Study Disease|1|||
126297663|NCT00191477|454377050|FG000|Overall Study|Death, Other Cause|3|||
126297664|NCT00191477|454377051|FG001|Overall Study|Death, Other Cause|6|||
125883568|NCT01746901|452871519|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126102540|NCT04677179|453668318|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126102541|NCT04677179|453668319|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126102542|NCT04677179|453668320|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126102543|NCT04677179|453668321|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126102544|NCT04677179|453668322|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126102545|NCT04677179|453668323|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126297665|NCT00191477|454377050|FG000|Overall Study|Lost to Follow-up|23|||
126102546|NCT04677179|453668324|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126102547|NCT04677179|453668325|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
126102548|NCT04677179|453668326|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
126102549|NCT04677179|453668327|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126297666|NCT00191477|454377051|FG001|Overall Study|Lost to Follow-up|21|||
126297667|NCT00191477|454377050|FG000|Overall Study|Protocol Violation|1|||
126297668|NCT00191477|454377051|FG001|Overall Study|Protocol Violation|1|||
126297669|NCT00191477|454377050|FG000|Overall Study|Treatment Change|2|||
126297670|NCT00191477|454377051|FG001|Overall Study|Treatment Change|0|||
126102550|NCT04677179|453668318|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126297671|NCT00191477|454377050|FG000|Overall Study|Withdrawal by Subject|2|||
126297672|NCT00191477|454377051|FG001|Overall Study|Withdrawal by Subject|0|||
126297673|NCT00191477|454377050|FG000|Overall Study|Other|2|||
126297674|NCT00191477|454377051|FG001|Overall Study|Other|0|||
126297675|NCT00191477|454377050|FG000|Overall Study|Not Eligible|41|||
126297676|NCT00191477|454377051|FG001|Overall Study|Not Eligible|38|||
126297677|NCT00191477|454377050|FG000|Overall Study|Pathological Specimen Lost|1|||
126297678|NCT00191477|454377051|FG001|Overall Study|Pathological Specimen Lost|0|||
126297679|NCT00191477|454377050|FG000|Overall Study|Discontinued Prior to Instillation|13|||
126297680|NCT00191477|454377051|FG001|Overall Study|Discontinued Prior to Instillation|14|||
126297681|NCT01286467|454377056|FG000|Overall Study|Death|1|||
126297682|NCT01286467|454377057|FG001|Overall Study|Death|1|||
126297683|NCT01286467|454377058|FG002|Overall Study|Death|1|||
126297684|NCT01286467|454377059|FG003|Overall Study|Death|0|||
126297685|NCT01286467|454377056|FG000|Overall Study|Lost to Follow-up|0|||
126297686|NCT01286467|454377057|FG001|Overall Study|Lost to Follow-up|0|||
126297687|NCT01286467|454377058|FG002|Overall Study|Lost to Follow-up|0|||
126297688|NCT01286467|454377059|FG003|Overall Study|Lost to Follow-up|1|||
126297689|NCT01286467|454377056|FG000|Overall Study|Withdrawal by Subject|0|||
126297690|NCT01286467|454377057|FG001|Overall Study|Withdrawal by Subject|0|||
126297691|NCT01286467|454377058|FG002|Overall Study|Withdrawal by Subject|1|||
126297692|NCT01286467|454377059|FG003|Overall Study|Withdrawal by Subject|0|||
126297693|NCT01286467|454377056|FG000|Overall Study|Physician Decision|0|||
126297694|NCT01286467|454377057|FG001|Overall Study|Physician Decision|0|||
126297695|NCT01286467|454377058|FG002|Overall Study|Physician Decision|0|||
126297696|NCT01286467|454377059|FG003|Overall Study|Physician Decision|1|||
126297697|NCT01286467|454377056|FG000|Overall Study|Disease progression|3|||
126297698|NCT01286467|454377057|FG001|Overall Study|Disease progression|2|||
126297699|NCT01286467|454377058|FG002|Overall Study|Disease progression|2|||
126297700|NCT01286467|454377059|FG003|Overall Study|Disease progression|3|||
126297701|NCT01286467|454377056|FG000|Overall Study|Adverse Event|0|||
126297702|NCT01286467|454377057|FG001|Overall Study|Adverse Event|1|||
126297703|NCT01286467|454377058|FG002|Overall Study|Adverse Event|2|||
126297704|NCT01286467|454377059|FG003|Overall Study|Adverse Event|3|||
126297705|NCT01286467|454377056|FG000|Overall Study|Study drug stop longer than 14 days|0|||
126297706|NCT01286467|454377057|FG001|Overall Study|Study drug stop longer than 14 days|0|||
126297707|NCT01286467|454377058|FG002|Overall Study|Study drug stop longer than 14 days|1|||
126297708|NCT01286467|454377059|FG003|Overall Study|Study drug stop longer than 14 days|0|||
126297709|NCT01058642|454377060|FG000|Treatment Period 1|Adverse Event|0|||
126297710|NCT01058642|454377061|FG001|Treatment Period 1|Adverse Event|1|||
126297711|NCT01058642|454377062|FG002|Treatment Period 1|Adverse Event|1|||
126297712|NCT01058642|454377063|FG003|Treatment Period 1|Adverse Event|0|||
126297713|NCT01058642|454377060|FG000|Treatment Period 1|Physician Decision|0|||
126297714|NCT01058642|454377061|FG001|Treatment Period 1|Physician Decision|0|||
126297715|NCT01058642|454377062|FG002|Treatment Period 1|Physician Decision|1|||
126297716|NCT01058642|454377063|FG003|Treatment Period 1|Physician Decision|0|||
126297717|NCT01058642|454377060|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126102551|NCT04677179|453668319|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126297718|NCT01058642|454377061|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126297719|NCT01058642|454377062|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126297720|NCT01058642|454377063|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126297721|NCT01058642|454377060|FG000|Treatment Period 1|Lack of Efficacy|0|||
126297722|NCT01058642|454377061|FG001|Treatment Period 1|Lack of Efficacy|0|||
126297723|NCT01058642|454377062|FG002|Treatment Period 1|Lack of Efficacy|0|||
126297724|NCT01058642|454377063|FG003|Treatment Period 1|Lack of Efficacy|1|||
126297725|NCT01058642|454377060|FG000|Treatment Period 1|Protocol Violation|0|||
126297726|NCT01058642|454377061|FG001|Treatment Period 1|Protocol Violation|0|||
126297727|NCT01058642|454377062|FG002|Treatment Period 1|Protocol Violation|0|||
126297728|NCT01058642|454377063|FG003|Treatment Period 1|Protocol Violation|1|||
126297729|NCT01058642|454377060|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
126297730|NCT01058642|454377061|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
126297731|NCT01058642|454377062|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
126297732|NCT01058642|454377063|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
126297733|NCT01256450|454377064|FG000|Open-label Titration|Adverse Event|39|||
126297734|NCT01256450|454377065|FG001|Open-label Titration|Adverse Event|0|||
126297735|NCT01256450|454377066|FG002|Open-label Titration|Adverse Event|0|||
126297736|NCT01256450|454377064|FG000|Open-label Titration|Lost to Follow-up|7|||
126297737|NCT01256450|454377065|FG001|Open-label Titration|Lost to Follow-up|0|||
126297738|NCT01256450|454377066|FG002|Open-label Titration|Lost to Follow-up|0|||
126297739|NCT01256450|454377064|FG000|Open-label Titration|Lack of analgesic effect|30|||
126297740|NCT01256450|454377065|FG001|Open-label Titration|Lack of analgesic effect|0|||
126297741|NCT01256450|454377066|FG002|Open-label Titration|Lack of analgesic effect|0|||
126297742|NCT01256450|454377064|FG000|Open-label Titration|Non-compliance|9|||
126297743|NCT01256450|454377065|FG001|Open-label Titration|Non-compliance|0|||
126297744|NCT01256450|454377066|FG002|Open-label Titration|Non-compliance|0|||
126297745|NCT01256450|454377064|FG000|Open-label Titration|Screen failure|1|||
126297746|NCT01256450|454377065|FG001|Open-label Titration|Screen failure|0|||
126297747|NCT01256450|454377066|FG002|Open-label Titration|Screen failure|0|||
126297748|NCT01256450|454377064|FG000|Open-label Titration|Other|13|||
126297749|NCT01256450|454377065|FG001|Open-label Titration|Other|0|||
126297750|NCT01256450|454377066|FG002|Open-label Titration|Other|0|||
126297751|NCT01256450|454377064|FG000|Double-blind Treatment|Adverse Event|0|||
126297752|NCT01256450|454377065|FG001|Double-blind Treatment|Adverse Event|8|||
126297753|NCT01256450|454377066|FG002|Double-blind Treatment|Adverse Event|6|||
126297754|NCT01256450|454377064|FG000|Double-blind Treatment|Lost to Follow-up|0|||
126297755|NCT01256450|454377065|FG001|Double-blind Treatment|Lost to Follow-up|1|||
126297756|NCT01256450|454377066|FG002|Double-blind Treatment|Lost to Follow-up|7|||
126297757|NCT01256450|454377064|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
126297758|NCT01256450|454377065|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
126297759|NCT01256450|454377066|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
126297760|NCT01256450|454377064|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
126297761|NCT01256450|454377065|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
126297762|NCT01256450|454377066|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
126297763|NCT01256450|454377064|FG000|Double-blind Treatment|Non-compliance|0|||
126297764|NCT01256450|454377065|FG001|Double-blind Treatment|Non-compliance|5|||
126297765|NCT01256450|454377066|FG002|Double-blind Treatment|Non-compliance|4|||
126297766|NCT01256450|454377064|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
126297767|NCT01256450|454377065|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
126297768|NCT01256450|454377066|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
126297769|NCT01256450|454377064|FG000|Double-blind Treatment|Other|0|||
126297770|NCT01256450|454377065|FG001|Double-blind Treatment|Other|9|||
126297771|NCT01256450|454377066|FG002|Double-blind Treatment|Other|12|||
126297772|NCT03376789|454377067|FG000|Overall Study|Withdrawal by Subject|3|||
126297773|NCT03376789|454377068|FG001|Overall Study|Withdrawal by Subject|5|||
126297774|NCT03376789|454377067|FG000|Overall Study|Protocol Violation|0|||
126297775|NCT03376789|454377068|FG001|Overall Study|Protocol Violation|1|||
126297776|NCT03376789|454377067|FG000|Overall Study|Adverse Event|0|||
126297777|NCT03376789|454377068|FG001|Overall Study|Adverse Event|1|||
126297778|NCT03376789|454377067|FG000|Overall Study|Lost to Follow-up|1|||
126297779|NCT03376789|454377068|FG001|Overall Study|Lost to Follow-up|1|||
126297780|NCT03376789|454377067|FG000|Overall Study|Per sponsor due to noncompliance|1|||
126297781|NCT03376789|454377068|FG001|Overall Study|Per sponsor due to noncompliance|0|||
126297782|NCT03376789|454377067|FG000|Overall Study|Subject off study medication|0|||
126297783|NCT03376789|454377068|FG001|Overall Study|Subject off study medication|1|||
126102552|NCT04677179|453668320|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126102553|NCT04677179|453668321|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126102554|NCT04677179|453668322|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126102555|NCT04677179|453668323|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126102556|NCT04677179|453668324|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126102557|NCT04677179|453668325|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
126102558|NCT04677179|453668326|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126102559|NCT04677179|453668327|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126102560|NCT04677179|453668318|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126102561|NCT04677179|453668319|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126102562|NCT04677179|453668320|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126102563|NCT04677179|453668321|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126102564|NCT04677179|453668322|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126102565|NCT04677179|453668323|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126102566|NCT04677179|453668324|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126102567|NCT04677179|453668325|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
126102568|NCT04677179|453668326|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
126102569|NCT04677179|453668327|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126102570|NCT04677179|453668318|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126102571|NCT04677179|453668319|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126102572|NCT04677179|453668320|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126102573|NCT04677179|453668321|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126102574|NCT04677179|453668322|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126102575|NCT04677179|453668323|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126102576|NCT04677179|453668324|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126102577|NCT04677179|453668325|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
126102578|NCT04677179|453668326|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
126102579|NCT04677179|453668327|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
126102580|NCT00998335|453668329|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
126102581|NCT00998335|453668330|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
126102582|NCT03169101|453668332|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
126102583|NCT03169101|453668333|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
126102584|NCT03169101|453668334|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
126102585|NCT03169101|453668335|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
126102586|NCT02641496|453668336|FG000|Overall Study|Lost to Follow-up|13|||
126102587|NCT02641496|453668337|FG001|Overall Study|Lost to Follow-up|12|||
126102588|NCT02641496|453668336|FG000|Overall Study|Withdrawal by Subject|1|||
126102589|NCT02641496|453668337|FG001|Overall Study|Withdrawal by Subject|0|||
126102590|NCT00790751|453668343|FG000|Overall Study|Protocol non-compliance|16|||
126102591|NCT00790751|453668344|FG001|Overall Study|Protocol non-compliance|16|||
126102592|NCT00790751|453668345|FG002|Overall Study|Protocol non-compliance|10|||
126102593|NCT00790751|453668346|FG003|Overall Study|Protocol non-compliance|11|||
126102594|NCT00790751|453668343|FG000|Overall Study|Lost to Follow-up|4|||
126102595|NCT00790751|453668344|FG001|Overall Study|Lost to Follow-up|9|||
126102596|NCT00790751|453668345|FG002|Overall Study|Lost to Follow-up|4|||
126102597|NCT00790751|453668346|FG003|Overall Study|Lost to Follow-up|5|||
126102598|NCT00790751|453668343|FG000|Overall Study|Adverse Event|5|||
126102599|NCT00790751|453668344|FG001|Overall Study|Adverse Event|3|||
126102600|NCT00790751|453668345|FG002|Overall Study|Adverse Event|5|||
126102601|NCT00790751|453668346|FG003|Overall Study|Adverse Event|4|||
126297784|NCT03876743|454377076|FG000|Overall Study|Lost to Follow-up|6|||
126297785|NCT03876743|454377077|FG001|Overall Study|Lost to Follow-up|4|||
126297786|NCT03876743|454377078|FG002|Overall Study|Lost to Follow-up|4|||
126297787|NCT03876743|454377079|FG003|Overall Study|Lost to Follow-up|7|||
126297788|NCT03889418|454377080|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
126297789|NCT03889418|454377081|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297790|NCT03889418|454377082|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297791|NCT03889418|454377083|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297792|NCT03889418|454377084|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297793|NCT03889418|454377085|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297794|NCT03889418|454377086|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297795|NCT03889418|454377087|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297796|NCT03889418|454377088|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297797|NCT03889418|454377089|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297798|NCT03889418|454377080|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297799|NCT03889418|454377081|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
126297800|NCT03889418|454377082|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
126297801|NCT03889418|454377083|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297802|NCT03889418|454377084|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297803|NCT03889418|454377085|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297804|NCT03889418|454377086|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297805|NCT03889418|454377087|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297806|NCT03889418|454377088|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297807|NCT03889418|454377089|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297808|NCT03889418|454377080|FG000|October-December 2019 (Month 7-9)|Death|0|||
126297809|NCT03889418|454377081|FG001|October-December 2019 (Month 7-9)|Death|0|||
126297810|NCT03889418|454377082|FG002|October-December 2019 (Month 7-9)|Death|0|||
126297811|NCT03889418|454377083|FG003|October-December 2019 (Month 7-9)|Death|0|||
126297812|NCT03889418|454377084|FG004|October-December 2019 (Month 7-9)|Death|0|||
126297813|NCT03889418|454377085|FG005|October-December 2019 (Month 7-9)|Death|0|||
126297814|NCT03889418|454377086|FG006|October-December 2019 (Month 7-9)|Death|0|||
126297815|NCT03889418|454377087|FG007|October-December 2019 (Month 7-9)|Death|0|||
126297816|NCT03889418|454377088|FG008|October-December 2019 (Month 7-9)|Death|1|||
126297817|NCT03889418|454377089|FG009|October-December 2019 (Month 7-9)|Death|0|||
126297818|NCT03889418|454377080|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297819|NCT03889418|454377081|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297820|NCT03889418|454377082|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297821|NCT03889418|454377083|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
126297822|NCT03889418|454377084|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297823|NCT03889418|454377085|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297824|NCT03889418|454377086|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297825|NCT03889418|454377087|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
126297826|NCT03889418|454377088|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297827|NCT03889418|454377089|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297828|NCT03889418|454377080|FG000|April - June 2020 (Month 13-15)|Death|0|||
126297829|NCT03889418|454377081|FG001|April - June 2020 (Month 13-15)|Death|1|||
126297830|NCT03889418|454377082|FG002|April - June 2020 (Month 13-15)|Death|0|||
126297831|NCT03889418|454377083|FG003|April - June 2020 (Month 13-15)|Death|0|||
126297832|NCT03889418|454377084|FG004|April - June 2020 (Month 13-15)|Death|0|||
126297833|NCT03889418|454377085|FG005|April - June 2020 (Month 13-15)|Death|0|||
126297834|NCT03889418|454377086|FG006|April - June 2020 (Month 13-15)|Death|0|||
126297835|NCT03889418|454377087|FG007|April - June 2020 (Month 13-15)|Death|0|||
126297836|NCT03889418|454377088|FG008|April - June 2020 (Month 13-15)|Death|0|||
126297837|NCT03889418|454377089|FG009|April - June 2020 (Month 13-15)|Death|0|||
126297838|NCT03889418|454377080|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297839|NCT03889418|454377081|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297840|NCT03889418|454377082|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297841|NCT03889418|454377083|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
126297842|NCT03889418|454377084|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297843|NCT03889418|454377085|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297844|NCT03889418|454377086|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297845|NCT03889418|454377087|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297846|NCT03889418|454377088|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297847|NCT03889418|454377089|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297848|NCT03889418|454377080|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
126297849|NCT03889418|454377081|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297850|NCT03889418|454377082|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
126297851|NCT03889418|454377083|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
126297852|NCT03889418|454377084|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297853|NCT03889418|454377085|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297854|NCT03889418|454377086|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297855|NCT03889418|454377087|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
126297856|NCT03889418|454377088|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297857|NCT03889418|454377089|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297858|NCT03889418|454377080|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126102602|NCT00790751|453668343|FG000|Overall Study|Requirement for restricted medication|0|||
126102603|NCT00790751|453668344|FG001|Overall Study|Requirement for restricted medication|2|||
126297859|NCT03889418|454377081|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
126297860|NCT03889418|454377082|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
126297861|NCT03889418|454377083|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
126297862|NCT03889418|454377084|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126297863|NCT03889418|454377085|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126297864|NCT03889418|454377086|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126297865|NCT03889418|454377087|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
126297866|NCT03889418|454377088|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126297867|NCT03889418|454377089|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
126297868|NCT00092118|454377090|FG000|Overall Study|Adverse Event|35|||
126297869|NCT00092118|454377091|FG001|Overall Study|Adverse Event|32|||
126297870|NCT00092118|454377090|FG000|Overall Study|Lack of Efficacy|12|||
126297871|NCT00092118|454377091|FG001|Overall Study|Lack of Efficacy|14|||
126297872|NCT00092118|454377090|FG000|Overall Study|Lost to Follow-up|4|||
126297873|NCT00092118|454377091|FG001|Overall Study|Lost to Follow-up|3|||
126297874|NCT00092118|454377090|FG000|Overall Study|Protocol Violation|23|||
126297875|NCT00092118|454377091|FG001|Overall Study|Protocol Violation|25|||
126297876|NCT00092118|454377090|FG000|Overall Study|Withdrawal by Subject|4|||
125883569|NCT01746901|452871511|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125883570|NCT01746901|452871512|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
126297877|NCT00092118|454377091|FG001|Overall Study|Withdrawal by Subject|10|||
126297878|NCT00092118|454377090|FG000|Overall Study|Other|6|||
126297879|NCT00092118|454377091|FG001|Overall Study|Other|5|||
126297880|NCT01139125|454377093|FG000|Overall Study|Withdrawal by Subject|1|||
126297881|NCT03751098|454377094|FG000|Overall Study|Withdrawal by Subject|0|||
126297882|NCT03751098|454377095|FG001|Overall Study|Withdrawal by Subject|1|||
126297883|NCT04760626|454377101|FG000|Overall Study|Withdrawal by Subject|24|||
126297884|NCT04760626|454377102|FG001|Overall Study|Withdrawal by Subject|20|||
126297885|NCT04760626|454377101|FG000|Overall Study|Lost to Follow-up|14|||
126297886|NCT04760626|454377102|FG001|Overall Study|Lost to Follow-up|19|||
126297887|NCT04760626|454377101|FG000|Overall Study|Physician Decision|3|||
126297888|NCT04760626|454377102|FG001|Overall Study|Physician Decision|5|||
126297889|NCT04760626|454377101|FG000|Overall Study|Death|3|||
126297890|NCT04760626|454377102|FG001|Overall Study|Death|6|||
126297891|NCT04760626|454377101|FG000|Overall Study|Site closure|1|||
126297892|NCT04760626|454377102|FG001|Overall Study|Site closure|0|||
126297893|NCT02946463|454377103|FG000|Primary Evaluation Period|Physician Decision|0|||
126297894|NCT02946463|454377104|FG001|Primary Evaluation Period|Physician Decision|1|||
126297895|NCT02946463|454377105|FG002|Primary Evaluation Period|Physician Decision|0|||
126297896|NCT02946463|454377106|FG003|Primary Evaluation Period|Physician Decision|0|||
126297897|NCT02946463|454377103|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
126297898|NCT02946463|454377104|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
126297899|NCT02946463|454377105|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
126297900|NCT02946463|454377106|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
126297901|NCT02946463|454377103|FG000|Extension Period|Death|4|||
126297902|NCT02946463|454377104|FG001|Extension Period|Death|4|||
126297903|NCT02946463|454377105|FG002|Extension Period|Death|0|||
126297904|NCT02946463|454377106|FG003|Extension Period|Death|0|||
126297905|NCT02946463|454377103|FG000|Extension Period|Withdrawal by Subject|4|||
126297906|NCT02946463|454377104|FG001|Extension Period|Withdrawal by Subject|3|||
126297907|NCT02946463|454377105|FG002|Extension Period|Withdrawal by Subject|0|||
126297908|NCT02946463|454377106|FG003|Extension Period|Withdrawal by Subject|0|||
126297909|NCT02946463|454377103|FG000|Extension Period|Other than specified|2|||
126297910|NCT02946463|454377104|FG001|Extension Period|Other than specified|3|||
126297911|NCT02946463|454377105|FG002|Extension Period|Other than specified|2|||
126297912|NCT02946463|454377106|FG003|Extension Period|Other than specified|0|||
126297913|NCT02946463|454377103|FG000|Extension Period|Physician Decision|1|||
126297914|NCT02946463|454377104|FG001|Extension Period|Physician Decision|4|||
126297915|NCT02946463|454377105|FG002|Extension Period|Physician Decision|0|||
126297916|NCT02946463|454377106|FG003|Extension Period|Physician Decision|0|||
126297917|NCT02946463|454377103|FG000|Extension Period|Pregnancy|3|||
126297918|NCT02946463|454377104|FG001|Extension Period|Pregnancy|1|||
126297919|NCT02946463|454377105|FG002|Extension Period|Pregnancy|0|||
126297920|NCT02946463|454377106|FG003|Extension Period|Pregnancy|0|||
126297921|NCT02946463|454377103|FG000|Extension Period|Adverse Event|1|||
126297922|NCT02946463|454377104|FG001|Extension Period|Adverse Event|2|||
126297923|NCT02946463|454377105|FG002|Extension Period|Adverse Event|0|||
126297924|NCT02946463|454377106|FG003|Extension Period|Adverse Event|0|||
126297925|NCT02946463|454377103|FG000|Extension Period|Lost to Follow-up|1|||
126297926|NCT02946463|454377104|FG001|Extension Period|Lost to Follow-up|0|||
126297927|NCT02946463|454377105|FG002|Extension Period|Lost to Follow-up|0|||
126297928|NCT02946463|454377106|FG003|Extension Period|Lost to Follow-up|0|||
126297929|NCT01924689|454377107|FG000|Overall Study|Death|0|||
126297930|NCT01924689|454377108|FG001|Overall Study|Death|1|||
126297931|NCT01924689|454377109|FG002|Overall Study|Death|0|||
126297932|NCT01924689|454377110|FG003|Overall Study|Death|1|||
126297933|NCT01924689|454377111|FG004|Overall Study|Death|0|||
126297934|NCT01924689|454377112|FG005|Overall Study|Death|0|||
126297935|NCT01924689|454377107|FG000|Overall Study|Disease progression|0|||
126297936|NCT01924689|454377108|FG001|Overall Study|Disease progression|0|||
126297937|NCT01924689|454377109|FG002|Overall Study|Disease progression|2|||
126297938|NCT01924689|454377110|FG003|Overall Study|Disease progression|0|||
126297939|NCT01924689|454377111|FG004|Overall Study|Disease progression|3|||
126297940|NCT01924689|454377112|FG005|Overall Study|Disease progression|2|||
126297941|NCT01924689|454377107|FG000|Overall Study|New therapy or study|3|||
126297942|NCT01924689|454377108|FG001|Overall Study|New therapy or study|2|||
126297943|NCT01924689|454377109|FG002|Overall Study|New therapy or study|1|||
126297944|NCT01924689|454377110|FG003|Overall Study|New therapy or study|4|||
126297945|NCT01924689|454377111|FG004|Overall Study|New therapy or study|2|||
126297946|NCT01924689|454377112|FG005|Overall Study|New therapy or study|0|||
126297947|NCT01924689|454377107|FG000|Overall Study|Withdrawal of consent|0|||
126297948|NCT01924689|454377108|FG001|Overall Study|Withdrawal of consent|0|||
126297949|NCT01924689|454377109|FG002|Overall Study|Withdrawal of consent|1|||
126297950|NCT01924689|454377110|FG003|Overall Study|Withdrawal of consent|1|||
126297951|NCT01924689|454377111|FG004|Overall Study|Withdrawal of consent|0|||
126297952|NCT01924689|454377112|FG005|Overall Study|Withdrawal of consent|0|||
126297953|NCT01924689|454377107|FG000|Overall Study|Other|0|||
126043326|NCT05513937|453456079|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
126297954|NCT01924689|454377108|FG001|Overall Study|Other|0|||
126297955|NCT01924689|454377109|FG002|Overall Study|Other|0|||
126297956|NCT01924689|454377110|FG003|Overall Study|Other|0|||
126297957|NCT01924689|454377111|FG004|Overall Study|Other|1|||
126297958|NCT01924689|454377112|FG005|Overall Study|Other|0|||
126297959|NCT03267212|454377113|FG000|First Intervention|Lost to Follow-up|0|||
126297960|NCT03267212|454377114|FG001|First Intervention|Lost to Follow-up|2|||
126297961|NCT03267212|454377113|FG000|First Intervention|Withdrawal by Subject|1|||
126297962|NCT03267212|454377114|FG001|First Intervention|Withdrawal by Subject|1|||
126297963|NCT03267212|454377113|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
126297964|NCT03267212|454377114|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
126297965|NCT05691712|454377116|FG000|Overall Study|Adverse Event|0|||
126297966|NCT05691712|454377117|FG001|Overall Study|Adverse Event|1|||
126297967|NCT05691712|454377118|FG002|Overall Study|Adverse Event|2|||
126297968|NCT05691712|454377119|FG003|Overall Study|Adverse Event|1|||
126297969|NCT05691712|454377116|FG000|Overall Study|Withdrawal by Subject|2|||
126297970|NCT05691712|454377117|FG001|Overall Study|Withdrawal by Subject|3|||
126297971|NCT05691712|454377118|FG002|Overall Study|Withdrawal by Subject|3|||
126297972|NCT05691712|454377119|FG003|Overall Study|Withdrawal by Subject|1|||
126297973|NCT05691712|454377116|FG000|Overall Study|Death|1|||
126297974|NCT05691712|454377117|FG001|Overall Study|Death|0|||
126297975|NCT05691712|454377118|FG002|Overall Study|Death|0|||
126297976|NCT05691712|454377119|FG003|Overall Study|Death|0|||
126043327|NCT05513937|453456080|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
126297977|NCT05691712|454377116|FG000|Overall Study|Pregnancy|0|||
126297978|NCT05691712|454377117|FG001|Overall Study|Pregnancy|1|||
126297979|NCT05691712|454377118|FG002|Overall Study|Pregnancy|0|||
126297980|NCT05691712|454377119|FG003|Overall Study|Pregnancy|0|||
125883571|NCT01746901|452871513|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
126297981|NCT05691712|454377116|FG000|Overall Study|Assigned Treatment by Mistake|1|||
126297982|NCT05691712|454377117|FG001|Overall Study|Assigned Treatment by Mistake|0|||
126297983|NCT05691712|454377118|FG002|Overall Study|Assigned Treatment by Mistake|0|||
126297984|NCT05691712|454377119|FG003|Overall Study|Assigned Treatment by Mistake|1|||
126297985|NCT04225715|454378649|FG000|Overall Study|Reason not Specified|1|||
126297986|NCT04225715|454378650|FG001|Overall Study|Reason not Specified|0|||
126297987|NCT04225715|454378651|FG002|Overall Study|Reason not Specified|0|||
126297988|NCT04225715|454378652|FG003|Overall Study|Reason not Specified|0|||
126297989|NCT04225715|454378653|FG004|Overall Study|Reason not Specified|0|||
126297990|NCT04225715|454378654|FG005|Overall Study|Reason not Specified|0|||
126297991|NCT04225715|454378655|FG006|Overall Study|Reason not Specified|0|||
126297992|NCT04225715|454378656|FG007|Overall Study|Reason not Specified|0|||
126297993|NCT04225715|454378657|FG008|Overall Study|Reason not Specified|0|||
126297994|NCT04225715|454378649|FG000|Overall Study|Protocol Violation|1|||
126297995|NCT04225715|454378650|FG001|Overall Study|Protocol Violation|0|||
126297996|NCT04225715|454378651|FG002|Overall Study|Protocol Violation|0|||
126297997|NCT04225715|454378652|FG003|Overall Study|Protocol Violation|0|||
126297998|NCT04225715|454378653|FG004|Overall Study|Protocol Violation|0|||
126297999|NCT04225715|454378654|FG005|Overall Study|Protocol Violation|9|||
126298000|NCT04225715|454378655|FG006|Overall Study|Protocol Violation|0|||
126298001|NCT04225715|454378656|FG007|Overall Study|Protocol Violation|0|||
126298002|NCT04225715|454378657|FG008|Overall Study|Protocol Violation|0|||
126298003|NCT04225715|454378649|FG000|Overall Study|Withdrawal by Subject|4|||
126298004|NCT04225715|454378650|FG001|Overall Study|Withdrawal by Subject|1|||
126298005|NCT04225715|454378651|FG002|Overall Study|Withdrawal by Subject|1|||
126298006|NCT04225715|454378652|FG003|Overall Study|Withdrawal by Subject|0|||
126298007|NCT04225715|454378653|FG004|Overall Study|Withdrawal by Subject|3|||
126298008|NCT04225715|454378654|FG005|Overall Study|Withdrawal by Subject|1|||
126298009|NCT04225715|454378655|FG006|Overall Study|Withdrawal by Subject|1|||
126298010|NCT04225715|454378656|FG007|Overall Study|Withdrawal by Subject|1|||
126298011|NCT04225715|454378657|FG008|Overall Study|Withdrawal by Subject|0|||
126298012|NCT04225715|454378649|FG000|Overall Study|Adverse Event|0|||
126298013|NCT04225715|454378650|FG001|Overall Study|Adverse Event|0|||
126298014|NCT04225715|454378651|FG002|Overall Study|Adverse Event|0|||
126298015|NCT04225715|454378652|FG003|Overall Study|Adverse Event|0|||
126298016|NCT04225715|454378653|FG004|Overall Study|Adverse Event|0|||
126298017|NCT04225715|454378654|FG005|Overall Study|Adverse Event|0|||
126298018|NCT04225715|454378655|FG006|Overall Study|Adverse Event|0|||
126298019|NCT04225715|454378656|FG007|Overall Study|Adverse Event|0|||
126298020|NCT04225715|454378657|FG008|Overall Study|Adverse Event|1|||
126298021|NCT04225715|454378649|FG000|Overall Study|Arm Terminated By Sponsor|0|||
126298022|NCT04225715|454378650|FG001|Overall Study|Arm Terminated By Sponsor|0|||
126298023|NCT04225715|454378651|FG002|Overall Study|Arm Terminated By Sponsor|0|||
126298024|NCT04225715|454378652|FG003|Overall Study|Arm Terminated By Sponsor|0|||
126298025|NCT04225715|454378653|FG004|Overall Study|Arm Terminated By Sponsor|0|||
126298026|NCT04225715|454378654|FG005|Overall Study|Arm Terminated By Sponsor|0|||
126298027|NCT04225715|454378655|FG006|Overall Study|Arm Terminated By Sponsor|0|||
126298028|NCT04225715|454378656|FG007|Overall Study|Arm Terminated By Sponsor|17|||
126298029|NCT04225715|454378657|FG008|Overall Study|Arm Terminated By Sponsor|18|||
126298030|NCT03318861|454378665|FG000|Overall Study|Death|2|||
126298031|NCT03318861|454378666|FG001|Overall Study|Death|3|||
126298032|NCT03318861|454378667|FG002|Overall Study|Death|3|||
126298033|NCT03318861|454378668|FG003|Overall Study|Death|2|||
126298034|NCT03318861|454378669|FG004|Overall Study|Death|2|||
126298035|NCT03318861|454378665|FG000|Overall Study|Enrolled But Never Treated|0|||
126298036|NCT03318861|454378666|FG001|Overall Study|Enrolled But Never Treated|1|||
126298037|NCT03318861|454378667|FG002|Overall Study|Enrolled But Never Treated|0|||
126298038|NCT03318861|454378668|FG003|Overall Study|Enrolled But Never Treated|1|||
126298039|NCT03318861|454378669|FG004|Overall Study|Enrolled But Never Treated|1|||
126298040|NCT03318861|454378665|FG000|Overall Study|Informed Consent Withdraw|0|||
126298041|NCT03318861|454378666|FG001|Overall Study|Informed Consent Withdraw|0|||
126298042|NCT03318861|454378667|FG002|Overall Study|Informed Consent Withdraw|0|||
126298043|NCT03318861|454378668|FG003|Overall Study|Informed Consent Withdraw|1|||
126298044|NCT03318861|454378669|FG004|Overall Study|Informed Consent Withdraw|0|||
126298045|NCT03318861|454378665|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
126298046|NCT03318861|454378666|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
126298047|NCT03318861|454378667|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
126298048|NCT03318861|454378668|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
126298049|NCT03318861|454378669|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
126298050|NCT00917852|454378670|FG000|Overall Study|Death|6|||
126298051|NCT00471081|454378671|FG000|Active Phase|Protocol Violation|1|||
126298052|NCT00471081|454378672|FG001|Active Phase|Protocol Violation|1|||
126298053|NCT00471081|454378671|FG000|Active Phase|Withdrawal by Subject|0|||
126102604|NCT00790751|453668345|FG002|Overall Study|Requirement for restricted medication|0|||
126102605|NCT00790751|453668346|FG003|Overall Study|Requirement for restricted medication|0|||
126102606|NCT00790751|453668343|FG000|Overall Study|Death|0|||
126102607|NCT00790751|453668344|FG001|Overall Study|Death|0|||
126102608|NCT00790751|453668345|FG002|Overall Study|Death|1|||
126102609|NCT00790751|453668346|FG003|Overall Study|Death|0|||
126102610|NCT00790751|453668343|FG000|Overall Study|Physician Decision|0|||
126102611|NCT00790751|453668344|FG001|Overall Study|Physician Decision|0|||
126102612|NCT00790751|453668345|FG002|Overall Study|Physician Decision|0|||
126102613|NCT00790751|453668346|FG003|Overall Study|Physician Decision|1|||
126102614|NCT05330312|453668347|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
126102615|NCT05330312|453668348|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
126102616|NCT05330312|453668349|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
126102617|NCT05330312|453668347|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
126102618|NCT05330312|453668348|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
126102619|NCT05330312|453668349|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
126102620|NCT05330312|453668347|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
126102621|NCT05330312|453668348|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
126102622|NCT05330312|453668349|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
126102623|NCT05330312|453668347|FG000|Pivotal Investigation - Part 2|Death|1|||
126102624|NCT05330312|453668348|FG001|Pivotal Investigation - Part 2|Death|4|||
126102625|NCT05330312|453668349|FG002|Pivotal Investigation - Part 2|Death|0|||
126102626|NCT01078454|453668352|FG000|Overall Study|Adverse Event|1|||
126102627|NCT01078454|453668353|FG001|Overall Study|Adverse Event|1|||
126102628|NCT01078454|453668352|FG000|Overall Study|Death|0|||
126102629|NCT01078454|453668353|FG001|Overall Study|Death|1|||
126102630|NCT00346268|453670155|FG000|Overall Study|Adverse Event|1|||
126102631|NCT00346268|453670156|FG001|Overall Study|Adverse Event|0|||
126102632|NCT00346268|453670155|FG000|Overall Study|Protocol Violation|1|||
126102633|NCT00346268|453670156|FG001|Overall Study|Protocol Violation|0|||
126102634|NCT00346268|453670155|FG000|Overall Study|Participant refused|0|||
126102635|NCT00346268|453670156|FG001|Overall Study|Participant refused|3|||
126102636|NCT02186223|453670160|FG000|Overall Study|Not eligible for device placement|6|||
126102637|NCT02186223|453670160|FG000|Overall Study|Unable to obtain femoral access|3|||
126102638|NCT02186223|453670160|FG000|Overall Study|Death|3|||
126102639|NCT02186223|453670160|FG000|Overall Study|Device in place less than 48 hours|9|||
126102640|NCT00252733|453670161|FG000|Overall Study|Withdrawal by Subject|73|||
126102641|NCT00252733|453670162|FG001|Overall Study|Withdrawal by Subject|67|||
126102642|NCT00252733|453670161|FG000|Overall Study|Death|7|||
126102643|NCT00252733|453670162|FG001|Overall Study|Death|5|||
126102644|NCT00252733|453670161|FG000|Overall Study|Lost to Follow-up|12|||
126102645|NCT00252733|453670162|FG001|Overall Study|Lost to Follow-up|6|||
126102646|NCT00252733|453670161|FG000|Overall Study|Multiple Reasons|14|||
126102647|NCT00252733|453670162|FG001|Overall Study|Multiple Reasons|14|||
126102648|NCT01350336|453670163|FG000|Overall Study|Lost to Follow-up|31|||
126298054|NCT00471081|454378672|FG001|Active Phase|Withdrawal by Subject|3|||
126298055|NCT00471081|454378671|FG000|Active Phase|Lost to Follow-up|0|||
126298056|NCT00471081|454378672|FG001|Active Phase|Lost to Follow-up|1|||
126298057|NCT00471081|454378671|FG000|Active Phase|Lost health plan/insurance|1|||
126298058|NCT00471081|454378672|FG001|Active Phase|Lost health plan/insurance|8|||
126298059|NCT00471081|454378671|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
126298060|NCT00471081|454378672|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
126298061|NCT00471081|454378671|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
126298062|NCT00471081|454378672|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
126298063|NCT00471081|454378671|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
126298064|NCT00471081|454378672|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
126298065|NCT02844933|454378673|FG000|Overall Study|Discontinued due to premature termination of study|3|||
126298066|NCT02844933|454378674|FG001|Overall Study|Discontinued due to premature termination of study|2|||
126298067|NCT02393950|454378675|FG000|Overall Study|Adverse Event|1|||
125883572|NCT01746901|452871514|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126043328|NCT05513937|453456081|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
126043329|NCT05513937|453456082|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
126043330|NCT05513937|453456079|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
126043331|NCT05513937|453456080|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
126043332|NCT05513937|453456081|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
126043333|NCT05513937|453456082|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
126043334|NCT05513937|453456079|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
126043335|NCT05513937|453456080|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
126043336|NCT05513937|453456081|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
126043337|NCT05513937|453456082|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
126043338|NCT05513937|453456079|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
126043339|NCT05513937|453456080|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
126043340|NCT05513937|453456081|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
126043341|NCT05513937|453456082|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
126043342|NCT05513937|453456079|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
126043343|NCT05513937|453456080|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
126043344|NCT05513937|453456081|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
126043345|NCT05513937|453456082|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
126043346|NCT05513937|453456079|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
126043347|NCT05513937|453456080|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
125883573|NCT01746901|452871515|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125883574|NCT01746901|452871516|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126366962|NCT01051661|454639366|FG005|Overall Study|Subject lost legal representation|0|||
126366963|NCT01051661|454639361|FG000|Overall Study|Protocol Violation|0|||
126366964|NCT01051661|454639362|FG001|Overall Study|Protocol Violation|0|||
126366965|NCT01051661|454639363|FG002|Overall Study|Protocol Violation|0|||
126366966|NCT01051661|454639364|FG003|Overall Study|Protocol Violation|1|||
126366967|NCT01051661|454639365|FG004|Overall Study|Protocol Violation|2|||
126366968|NCT01051661|454639366|FG005|Overall Study|Protocol Violation|1|||
126366969|NCT01051661|454639361|FG000|Overall Study|Withdrawal by Subject|16|||
126366970|NCT01051661|454639362|FG001|Overall Study|Withdrawal by Subject|30|||
126366971|NCT01051661|454639363|FG002|Overall Study|Withdrawal by Subject|13|||
126366972|NCT01051661|454639364|FG003|Overall Study|Withdrawal by Subject|28|||
126366973|NCT01051661|454639365|FG004|Overall Study|Withdrawal by Subject|12|||
126366974|NCT01051661|454639366|FG005|Overall Study|Withdrawal by Subject|34|||
126366975|NCT04642079|454639367|FG000|Overall Study|Lost to Follow-up|2|||
126366976|NCT04642079|454639368|FG001|Overall Study|Lost to Follow-up|5|||
126043348|NCT05513937|453456081|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
126043349|NCT05513937|453456082|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
126043350|NCT03245840|453456085|FG000|Overall Study|Adverse Event|6|||
126043351|NCT03245840|453456086|FG001|Overall Study|Adverse Event|0|||
126043352|NCT03245840|453456085|FG000|Overall Study|Death|2|||
126043353|NCT03245840|453456086|FG001|Overall Study|Death|0|||
126043354|NCT03245840|453456085|FG000|Overall Study|Withdrawal by Subject|31|||
126043355|NCT03245840|453456086|FG001|Overall Study|Withdrawal by Subject|1|||
126043356|NCT03245840|453456085|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126043357|NCT03245840|453456086|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126043358|NCT03245840|453456085|FG000|Overall Study|Physician Decision|4|||
126043359|NCT03245840|453456086|FG001|Overall Study|Physician Decision|1|||
126043360|NCT03245840|453456085|FG000|Overall Study|Study Terminated by Sponsor|56|||
126043361|NCT03245840|453456086|FG001|Overall Study|Study Terminated by Sponsor|6|||
126043362|NCT03245840|453456085|FG000|Overall Study|Site Terminated by Sponsor|4|||
126043363|NCT03245840|453456086|FG001|Overall Study|Site Terminated by Sponsor|0|||
126043364|NCT03245840|453456085|FG000|Overall Study|Lost to Follow-up|12|||
126043365|NCT03245840|453456086|FG001|Overall Study|Lost to Follow-up|2|||
126043366|NCT03245840|453456085|FG000|Overall Study|Pregnancy|2|||
126043367|NCT03245840|453456086|FG001|Overall Study|Pregnancy|0|||
126043368|NCT03245840|453456085|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126043369|NCT03245840|453456086|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126043370|NCT03245840|453456085|FG000|Overall Study|Not treated|1|||
126043371|NCT03245840|453456086|FG001|Overall Study|Not treated|1|||
126043372|NCT04707768|453456091|FG000|Overall Study|Adverse Event|9|||
126043373|NCT04707768|453456092|FG001|Overall Study|Adverse Event|18|||
126043374|NCT04707768|453456093|FG002|Overall Study|Adverse Event|3|||
126043375|NCT04707768|453456091|FG000|Overall Study|Investigator's Discretion|8|||
126043376|NCT04707768|453456092|FG001|Overall Study|Investigator's Discretion|4|||
126043377|NCT04707768|453456093|FG002|Overall Study|Investigator's Discretion|3|||
126043378|NCT04707768|453456091|FG000|Overall Study|Withdrawal by Subject|6|||
126043379|NCT04707768|453456092|FG001|Overall Study|Withdrawal by Subject|8|||
126043380|NCT04707768|453456093|FG002|Overall Study|Withdrawal by Subject|2|||
126043381|NCT04707768|453456091|FG000|Overall Study|Lack of Efficacy|1|||
126043382|NCT04707768|453456092|FG001|Overall Study|Lack of Efficacy|3|||
126043383|NCT04707768|453456093|FG002|Overall Study|Lack of Efficacy|0|||
126043384|NCT04707768|453456091|FG000|Overall Study|Lost to Follow-up|0|||
126043385|NCT04707768|453456092|FG001|Overall Study|Lost to Follow-up|0|||
126043386|NCT04707768|453456093|FG002|Overall Study|Lost to Follow-up|3|||
126043387|NCT04707768|453456091|FG000|Overall Study|Death|13|||
126102649|NCT01350336|453670163|FG000|Overall Study|Withdrawal by Subject|14|||
126102650|NCT01350336|453670163|FG000|Overall Study|Physician Decision|8|||
126366977|NCT04642079|454639369|FG002|Overall Study|Lost to Follow-up|2|||
126366978|NCT04642079|454639370|FG003|Overall Study|Lost to Follow-up|0|||
126043388|NCT04707768|453456092|FG001|Overall Study|Death|11|||
126043389|NCT04707768|453456093|FG002|Overall Study|Death|13|||
126043390|NCT04707768|453456091|FG000|Overall Study|Protocol Violation|2|||
126043391|NCT04707768|453456092|FG001|Overall Study|Protocol Violation|1|||
126043392|NCT04707768|453456093|FG002|Overall Study|Protocol Violation|0|||
126102651|NCT01350336|453670163|FG000|Overall Study|Death|4|||
126366979|NCT04642079|454639367|FG000|Overall Study|Withdrawal by Subject|0|||
126366980|NCT04642079|454639368|FG001|Overall Study|Withdrawal by Subject|4|||
126043393|NCT04707768|453456091|FG000|Overall Study|Non Compliance with Study Drug|1|||
126102652|NCT02079610|453670167|FG000|Overall Study|Withdrawal by Subject|1|||
126366981|NCT04642079|454639369|FG002|Overall Study|Withdrawal by Subject|1|||
126043394|NCT04707768|453456092|FG001|Overall Study|Non Compliance with Study Drug|0|||
126043395|NCT04707768|453456093|FG002|Overall Study|Non Compliance with Study Drug|0|||
126043396|NCT04707768|453456091|FG000|Overall Study|Transplant|4|||
126043397|NCT04707768|453456092|FG001|Overall Study|Transplant|4|||
126043398|NCT04707768|453456093|FG002|Overall Study|Transplant|8|||
126043399|NCT04707768|453456091|FG000|Overall Study|Other|9|||
126366982|NCT04642079|454639370|FG003|Overall Study|Withdrawal by Subject|2|||
126043400|NCT04707768|453456092|FG001|Overall Study|Other|5|||
126043401|NCT04707768|453456093|FG002|Overall Study|Other|2|||
126043402|NCT02518048|453456094|FG000|Overall Study|Withdrawal by Subject|1|||
126043403|NCT04282980|453457285|FG000|Overall Study|Remained on treatment|6|||
126043404|NCT04282980|453457285|FG000|Overall Study|Survival follow-up|11|||
126043405|NCT04282980|453457285|FG000|Overall Study|Withdrawal of informed consent|1|||
126043406|NCT04282980|453457285|FG000|Overall Study|Lost to Follow-up|1|||
126043407|NCT03571386|453457287|FG000|Overall Study|scheduling conflict|4|||
126043408|NCT03571386|453457288|FG001|Overall Study|scheduling conflict|0|||
126043409|NCT03571386|453457287|FG000|Overall Study|Withdrawal by Subject|15|||
126043410|NCT03571386|453457288|FG001|Overall Study|Withdrawal by Subject|5|||
126043411|NCT02278211|453457289|FG000|Overall Study|Unable to analyse PET scan|2|||
126043412|NCT05224544|453457290|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
126043413|NCT05224544|453457291|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
126043414|NCT04881461|453457292|FG000|Overall Study|Adverse Event|2|||
126043415|NCT04881461|453457293|FG001|Overall Study|Adverse Event|4|||
126043416|NCT04881461|453457292|FG000|Overall Study|Withdrawal by Subject|19|||
126043417|NCT04881461|453457293|FG001|Overall Study|Withdrawal by Subject|19|||
126043418|NCT04881461|453457292|FG000|Overall Study|Lost to Follow-up|4|||
126043419|NCT04881461|453457293|FG001|Overall Study|Lost to Follow-up|4|||
126366983|NCT04642079|454639367|FG000|Overall Study|Other|0|||
126366984|NCT04642079|454639368|FG001|Overall Study|Other|0|||
126366985|NCT04642079|454639369|FG002|Overall Study|Other|0|||
126366986|NCT04642079|454639370|FG003|Overall Study|Other|1|||
126366987|NCT04642079|454639367|FG000|Overall Study|No longer met eligibility criteria|1|||
126366988|NCT04642079|454639368|FG001|Overall Study|No longer met eligibility criteria|0|||
126366989|NCT04642079|454639369|FG002|Overall Study|No longer met eligibility criteria|1|||
126366990|NCT04642079|454639370|FG003|Overall Study|No longer met eligibility criteria|1|||
126366991|NCT03038620|454639373|FG000|Overall Study|Lost to Follow-up|18|||
126366992|NCT03038620|454639374|FG001|Overall Study|Lost to Follow-up|23|||
126366993|NCT03038620|454639373|FG000|Overall Study|Withdrawal by Subject|0|||
126366994|NCT03038620|454639374|FG001|Overall Study|Withdrawal by Subject|15|||
126366995|NCT03038620|454639373|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
126366996|NCT03038620|454639374|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
126366997|NCT04875533|454639380|FG000|Overall Study|Adverse Event|6|||
126366998|NCT04875533|454639381|FG001|Overall Study|Adverse Event|4|||
126366999|NCT04875533|454639380|FG000|Overall Study|Protocol Violation|4|||
126367000|NCT04875533|454639381|FG001|Overall Study|Protocol Violation|0|||
126367001|NCT04875533|454639380|FG000|Overall Study|Withdrawal by Subject|8|||
126367002|NCT04875533|454639381|FG001|Overall Study|Withdrawal by Subject|5|||
126367003|NCT04875533|454639380|FG000|Overall Study|No longer meets eligibility criteria|1|||
126367004|NCT04875533|454639381|FG001|Overall Study|No longer meets eligibility criteria|0|||
126367005|NCT04875533|454639380|FG000|Overall Study|Other|0|||
126367006|NCT04875533|454639381|FG001|Overall Study|Other|2|||
126367007|NCT02657343|454639385|FG000|Overall Study|Death|0|||
126367008|NCT02657343|454639386|FG001|Overall Study|Death|2|||
126367009|NCT02657343|454639387|FG002|Overall Study|Death|0|||
126367010|NCT02657343|454639388|FG003|Overall Study|Death|0|||
126367011|NCT02657343|454639389|FG004|Overall Study|Death|0|||
126367012|NCT02657343|454639390|FG005|Overall Study|Death|0|||
126367013|NCT02657343|454639385|FG000|Overall Study|Patient went to hospice|1|||
126367014|NCT02657343|454639386|FG001|Overall Study|Patient went to hospice|0|||
126367015|NCT02657343|454639387|FG002|Overall Study|Patient went to hospice|0|||
126367016|NCT02657343|454639388|FG003|Overall Study|Patient went to hospice|0|||
126367017|NCT02657343|454639389|FG004|Overall Study|Patient went to hospice|0|||
126367018|NCT02657343|454639390|FG005|Overall Study|Patient went to hospice|0|||
126367019|NCT02657343|454639385|FG000|Overall Study|Withdrawal by Subject|0|||
126367020|NCT02657343|454639386|FG001|Overall Study|Withdrawal by Subject|0|||
126367021|NCT02657343|454639387|FG002|Overall Study|Withdrawal by Subject|0|||
126043420|NCT04881461|453457292|FG000|Overall Study|Lack of Efficacy|1|||
126043421|NCT04881461|453457293|FG001|Overall Study|Lack of Efficacy|0|||
126367022|NCT02657343|454639388|FG003|Overall Study|Withdrawal by Subject|0|||
126367023|NCT02657343|454639389|FG004|Overall Study|Withdrawal by Subject|1|||
126367024|NCT02657343|454639390|FG005|Overall Study|Withdrawal by Subject|0|||
126367025|NCT02011542|454639392|FG000|Overall Study|Physician Decision|1|||
126367026|NCT00982280|454639396|FG000|Observation Period|Not eligible to be dosed|19|||
126367027|NCT00982280|454639396|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
126043422|NCT04881461|453457292|FG000|Overall Study|"Reason stated as other in CRF"|1|||
126043423|NCT04881461|453457293|FG001|Overall Study|"Reason stated as other in CRF"|2|||
126043424|NCT04158739|453457294|FG000|Overall Study|Adverse Event|1|||
126102653|NCT02079610|453670168|FG001|Overall Study|Withdrawal by Subject|1|||
126102654|NCT01111474|453670169|FG000|Overall Study|Lost to Follow-up|12|||
126102655|NCT01016977|453670170|FG000|Overall Study|Lost to Follow-up|1|||
126102656|NCT01016977|453670171|FG001|Overall Study|Lost to Follow-up|0|||
126102657|NCT01016977|453670170|FG000|Overall Study|Withdrawal by Subject|2|||
126102658|NCT01016977|453670171|FG001|Overall Study|Withdrawal by Subject|2|||
126102659|NCT00824161|453670172|FG000|Overall Study|Withdrawal by Subject|1|||
126102660|NCT00824161|453670172|FG000|Overall Study|Screen Failure|1|||
126102661|NCT04882995|453670173|FG000|Overall Study|Withdrawal by Subject|1|||
126102662|NCT04882995|453670174|FG001|Overall Study|Withdrawal by Subject|2|||
126102663|NCT04882995|453670173|FG000|Overall Study|Protocol Violation|4|||
126102664|NCT04882995|453670174|FG001|Overall Study|Protocol Violation|4|||
126102665|NCT04882995|453670173|FG000|Overall Study|Surgery postponed due to COVID|1|||
126102666|NCT04882995|453670174|FG001|Overall Study|Surgery postponed due to COVID|1|||
126102667|NCT00477334|453670175|FG000|Overall Study|Discontinued prior to taking study drug|106|||
126102668|NCT00477334|453670176|FG001|Overall Study|Discontinued prior to taking study drug|53|||
126102669|NCT00477334|453670175|FG000|Overall Study|Adverse Event|1|||
126102670|NCT00477334|453670176|FG001|Overall Study|Adverse Event|2|||
126102671|NCT00477334|453670175|FG000|Overall Study|Withdrawal by Subject|2|||
126102672|NCT00477334|453670176|FG001|Overall Study|Withdrawal by Subject|1|||
126102673|NCT00477334|453670175|FG000|Overall Study|Lost to Follow-up|15|||
126102674|NCT00477334|453670176|FG001|Overall Study|Lost to Follow-up|4|||
126102675|NCT00477334|453670175|FG000|Overall Study|Administrative Problems|39|||
126102676|NCT00477334|453670176|FG001|Overall Study|Administrative Problems|15|||
126102677|NCT00477334|453670175|FG000|Overall Study|Protocol Violation|7|||
126102678|NCT00477334|453670176|FG001|Overall Study|Protocol Violation|1|||
126102679|NCT03587974|453670180|FG000|Overall Study|caregiver demented, care recipient died|3|||
126102680|NCT03587974|453670181|FG001|Overall Study|caregiver demented, care recipient died|3|||
126102681|NCT03587974|453670180|FG000|Overall Study|Withdrawal by Subject|2|||
126102682|NCT03587974|453670181|FG001|Overall Study|Withdrawal by Subject|1|||
126102683|NCT02354508|453670182|FG000|Period 1: Core Phase|Adverse Event|1|||
126102684|NCT02354508|453670183|FG001|Period 1: Core Phase|Adverse Event|1|||
126102685|NCT02354508|453670184|FG002|Period 1: Core Phase|Adverse Event|2|||
126102686|NCT02354508|453670182|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
126102687|NCT02354508|453670183|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
126102688|NCT02354508|453670184|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
126102689|NCT02354508|453670182|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
126102690|NCT02354508|453670183|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
126102691|NCT02354508|453670184|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
126102692|NCT02354508|453670182|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
126102693|NCT02354508|453670183|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
126102694|NCT02354508|453670184|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
126102695|NCT02354508|453670182|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
126102696|NCT02354508|453670183|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
126102697|NCT02354508|453670184|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
126102698|NCT02354508|453670182|FG000|Period 2: Extension Phase|Physician Decision|5|||
126102699|NCT02354508|453670183|FG001|Period 2: Extension Phase|Physician Decision|0|||
126102700|NCT02354508|453670184|FG002|Period 2: Extension Phase|Physician Decision|1|||
126102701|NCT02354508|453670182|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
126102702|NCT02354508|453670183|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
126102703|NCT02354508|453670184|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
126102704|NCT02354508|453670182|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
126102705|NCT02354508|453670183|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
126367028|NCT00982280|454639396|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
126367029|NCT00982280|454639396|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
126367030|NCT00982280|454639396|FG000|Maintenance Period|Adverse Event|1|||
126102706|NCT02354508|453670184|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
126102707|NCT02354508|453670182|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
126102708|NCT02354508|453670183|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
126102709|NCT02354508|453670184|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
126102710|NCT04371198|453670185|FG000|Overall Study|inadequate sample|4|||
126102711|NCT00372229|453670186|FG000|Study Phase|Graft loss|0|||
126102712|NCT00372229|453670187|FG001|Study Phase|Graft loss|3|||
126102713|NCT00372229|453670186|FG000|Study Phase|Protocol Violation|3|||
126102714|NCT00372229|453670187|FG001|Study Phase|Protocol Violation|4|||
126102715|NCT00372229|453670186|FG000|Study Phase|Consent withdrawn|16|||
126102716|NCT00372229|453670187|FG001|Study Phase|Consent withdrawn|14|||
126102717|NCT00372229|453670186|FG000|Study Phase|Refused treatment/did not cooperate|3|||
126102718|NCT00372229|453670187|FG001|Study Phase|Refused treatment/did not cooperate|1|||
126102719|NCT00372229|453670186|FG000|Study Phase|Death|3|||
126102720|NCT00372229|453670187|FG001|Study Phase|Death|2|||
126102721|NCT00372229|453670186|FG000|Study Phase|Reason not specified|3|||
126102722|NCT00372229|453670187|FG001|Study Phase|Reason not specified|2|||
126102723|NCT00372229|453670186|FG000|Study Phase|Lost to Follow-up|3|||
126102724|NCT00372229|453670187|FG001|Study Phase|Lost to Follow-up|3|||
126102725|NCT00372229|453670186|FG000|Follow-Up Phase|Graft loss|8|||
126102726|NCT00372229|453670187|FG001|Follow-Up Phase|Graft loss|7|||
126102727|NCT00372229|453670186|FG000|Follow-Up Phase|Consent withdrawn|13|||
126102728|NCT00372229|453670187|FG001|Follow-Up Phase|Consent withdrawn|19|||
126298068|NCT02393950|454378676|FG001|Overall Study|Adverse Event|0|||
126102729|NCT00372229|453670186|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
126298069|NCT02393950|454378675|FG000|Overall Study|Withdrawal by Subject|0|||
126298070|NCT02393950|454378676|FG001|Overall Study|Withdrawal by Subject|1|||
126298071|NCT04537078|454378677|FG000|Overall Study|Protocol Violation|3|||
126298072|NCT04537078|454378678|FG001|Overall Study|Protocol Violation|2|||
126298073|NCT04537078|454378677|FG000|Overall Study|Lost to Follow-up|1|||
126298074|NCT04537078|454378678|FG001|Overall Study|Lost to Follow-up|0|||
126298075|NCT04537078|454378677|FG000|Overall Study|Withdrawal by Subject|0|||
126298076|NCT04537078|454378678|FG001|Overall Study|Withdrawal by Subject|1|||
126298077|NCT01568892|454378679|FG000|Open-label Phase|Adverse Event|2|||
126298078|NCT01568892|454378680|FG001|Open-label Phase|Adverse Event|0|||
126298079|NCT01568892|454378679|FG000|Open-label Phase|Lack of Efficacy|4|||
126298080|NCT01568892|454378680|FG001|Open-label Phase|Lack of Efficacy|2|||
126298081|NCT01568892|454378679|FG000|Open-label Phase|Lost to Follow-up|0|||
126298082|NCT01568892|454378680|FG001|Open-label Phase|Lost to Follow-up|1|||
126298083|NCT03922308|454378687|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
126298084|NCT03922308|454378688|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
126298085|NCT03922308|454378689|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
126298086|NCT03922308|454378687|FG000|Overall Study|Lost to Follow-up|1|||
126298087|NCT03922308|454378688|FG001|Overall Study|Lost to Follow-up|0|||
126298088|NCT03922308|454378689|FG002|Overall Study|Lost to Follow-up|0|||
126298089|NCT03922308|454378687|FG000|Overall Study|Reason not Specified|0|||
126298090|NCT03922308|454378688|FG001|Overall Study|Reason not Specified|2|||
125883575|NCT01746901|452871517|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126102730|NCT00372229|453670187|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
126298091|NCT03922308|454378689|FG002|Overall Study|Reason not Specified|1|||
126043425|NCT04158739|453457295|FG001|Overall Study|Adverse Event|0|||
126043426|NCT04158739|453457294|FG000|Overall Study|Death|0|||
126043427|NCT04158739|453457295|FG001|Overall Study|Death|1|||
126043428|NCT04158739|453457294|FG000|Overall Study|Lack of Efficacy|3|||
126043429|NCT04158739|453457295|FG001|Overall Study|Lack of Efficacy|7|||
126043430|NCT04158739|453457294|FG000|Overall Study|Physician Decision|0|||
126043431|NCT04158739|453457295|FG001|Overall Study|Physician Decision|1|||
126043432|NCT04158739|453457294|FG000|Overall Study|Withdrawal by Subject|3|||
126043433|NCT04158739|453457295|FG001|Overall Study|Withdrawal by Subject|0|||
126043434|NCT04778410|453457296|FG000|Safety Run-in Period|Death|5|||
126043435|NCT04778410|453457297|FG001|Safety Run-in Period|Death|6|||
126043436|NCT04778410|453457298|FG002|Safety Run-in Period|Death|0|||
126043437|NCT04778410|453457299|FG003|Safety Run-in Period|Death|0|||
126298092|NCT01697748|454378690|FG000|Overall Study|ineligible skin incision|1|||
126298093|NCT01697748|454378691|FG001|Overall Study|ineligible skin incision|2|||
126298094|NCT01697748|454378690|FG000|Overall Study|ineligible uterine incision|4|||
126298095|NCT01697748|454378691|FG001|Overall Study|ineligible uterine incision|1|||
126298096|NCT01697748|454378690|FG000|Overall Study|Lost to Follow-up|53|||
126298097|NCT01697748|454378691|FG001|Overall Study|Lost to Follow-up|65|||
126298098|NCT01704495|454378695|FG000|Subjects Randomized|Other Reason|3|||
126298099|NCT01704495|454378696|FG001|Subjects Randomized|Other Reason|2|||
126298100|NCT01704495|454378697|FG002|Subjects Randomized|Other Reason|3|||
126298101|NCT01704495|454378698|FG003|Subjects Randomized|Other Reason|2|||
126298102|NCT01704495|454378695|FG000|Subjects Randomized|Discontinuation criteria met|4|||
126298103|NCT01704495|454378696|FG001|Subjects Randomized|Discontinuation criteria met|2|||
126298104|NCT01704495|454378697|FG002|Subjects Randomized|Discontinuation criteria met|2|||
126298105|NCT01704495|454378698|FG003|Subjects Randomized|Discontinuation criteria met|0|||
126298106|NCT01704495|454378695|FG000|Subjects Randomized|Adverse Event|8|||
126298107|NCT01704495|454378696|FG001|Subjects Randomized|Adverse Event|2|||
126298108|NCT01704495|454378697|FG002|Subjects Randomized|Adverse Event|0|||
126298109|NCT01704495|454378698|FG003|Subjects Randomized|Adverse Event|7|||
126298110|NCT01704495|454378695|FG000|Subjects Randomized|Withdrawal by Subject|5|||
126298111|NCT01704495|454378696|FG001|Subjects Randomized|Withdrawal by Subject|5|||
126298112|NCT01704495|454378697|FG002|Subjects Randomized|Withdrawal by Subject|5|||
126298113|NCT01704495|454378698|FG003|Subjects Randomized|Withdrawal by Subject|5|||
126298114|NCT01704495|454378695|FG000|Subjects Randomized|Protocol Violation|1|||
126298115|NCT01704495|454378696|FG001|Subjects Randomized|Protocol Violation|1|||
126298116|NCT01704495|454378697|FG002|Subjects Randomized|Protocol Violation|2|||
126043438|NCT04778410|453457300|FG004|Safety Run-in Period|Death|0|||
126043439|NCT04778410|453457301|FG005|Safety Run-in Period|Death|0|||
126043440|NCT04778410|453457296|FG000|Phase 2 Period|Death|0|||
126298117|NCT01704495|454378698|FG003|Subjects Randomized|Protocol Violation|0|||
126298118|NCT01704495|454378695|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
126298119|NCT01704495|454378696|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
126298120|NCT01704495|454378697|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
126298121|NCT01704495|454378698|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
126298122|NCT01704495|454378695|FG000|Optional Safety Extension|Adverse Event|0|||
126298123|NCT01704495|454378696|FG001|Optional Safety Extension|Adverse Event|4|||
126298124|NCT01704495|454378697|FG002|Optional Safety Extension|Adverse Event|0|||
126298125|NCT01704495|454378698|FG003|Optional Safety Extension|Adverse Event|1|||
126298126|NCT01704495|454378695|FG000|Optional Safety Extension|Other reason|27|||
126043441|NCT04778410|453457297|FG001|Phase 2 Period|Death|0|||
126043442|NCT04778410|453457298|FG002|Phase 2 Period|Death|0|||
126043443|NCT04778410|453457299|FG003|Phase 2 Period|Death|5|||
126043444|NCT04778410|453457300|FG004|Phase 2 Period|Death|18|||
126298127|NCT01704495|454378696|FG001|Optional Safety Extension|Other reason|29|||
126298128|NCT01704495|454378697|FG002|Optional Safety Extension|Other reason|30|||
126298129|NCT01704495|454378698|FG003|Optional Safety Extension|Other reason|28|||
126298130|NCT01704495|454378695|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
126298131|NCT01704495|454378696|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
126298132|NCT01704495|454378697|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
126298133|NCT01704495|454378698|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
126298134|NCT03866512|454378699|FG000|Overall Study|Lost to Follow-up|1|||
126298135|NCT03866512|454378700|FG001|Overall Study|Lost to Follow-up|2|||
126298136|NCT03866512|454378701|FG002|Overall Study|Lost to Follow-up|1|||
126298137|NCT03866512|454378699|FG000|Overall Study|Cannulation issues|0|||
126298138|NCT03866512|454378700|FG001|Overall Study|Cannulation issues|1|||
126298139|NCT03866512|454378701|FG002|Overall Study|Cannulation issues|2|||
126298140|NCT00997373|454378706|FG000|Overall Study|Withdrawal by Subject|5|||
126298141|NCT00997373|454378707|FG001|Overall Study|Withdrawal by Subject|0|||
126298142|NCT00997373|454378706|FG000|Overall Study|wrong tumor type|4|||
126298143|NCT00997373|454378707|FG001|Overall Study|wrong tumor type|0|||
126298144|NCT00997373|454378706|FG000|Overall Study|could not have hysterectomy|6|||
126298145|NCT00997373|454378707|FG001|Overall Study|could not have hysterectomy|0|||
126298146|NCT04177095|454378711|FG000|Overall Study|Withdrawal by Subject|3|||
126298147|NCT04177095|454378711|FG000|Overall Study|Screen Failure|3|||
126298148|NCT04177095|454378711|FG000|Overall Study|Problems with the Trugraf assay|1|||
126298149|NCT00777296|454378712|FG000|Overall Study|Adverse Event|0|||
126298150|NCT00777296|454378713|FG001|Overall Study|Adverse Event|1|||
126298151|NCT00777296|454378714|FG002|Overall Study|Adverse Event|0|||
126298152|NCT00777296|454378715|FG003|Overall Study|Adverse Event|1|||
126298153|NCT00777296|454378712|FG000|Overall Study|Withdrawal by Subject|1|||
126298154|NCT00777296|454378713|FG001|Overall Study|Withdrawal by Subject|0|||
126298155|NCT00777296|454378714|FG002|Overall Study|Withdrawal by Subject|0|||
126298156|NCT00777296|454378715|FG003|Overall Study|Withdrawal by Subject|0|||
126298157|NCT00777296|454378712|FG000|Overall Study|CRF form not completed|0|||
126298158|NCT00777296|454378713|FG001|Overall Study|CRF form not completed|0|||
126298159|NCT00777296|454378714|FG002|Overall Study|CRF form not completed|2|||
126298160|NCT00777296|454378715|FG003|Overall Study|CRF form not completed|0|||
126298161|NCT01592786|454378718|FG000|Overall Study|Adverse Event|60|||
126298162|NCT01592786|454378718|FG000|Overall Study|Lack of Efficacy|19|||
126298163|NCT01592786|454378718|FG000|Overall Study|Protocol Violation|14|||
126298164|NCT01592786|454378718|FG000|Overall Study|Withdrawal by Subject|23|||
126298165|NCT01592786|454378718|FG000|Overall Study|Lost to Follow-up|19|||
126298166|NCT01592786|454378718|FG000|Overall Study|Other|3|||
126298167|NCT02172664|454378721|FG000|Overall Study|Lost to Follow-up|4|||
126298168|NCT02172664|454378722|FG001|Overall Study|Lost to Follow-up|4|||
126298169|NCT02172664|454378721|FG000|Overall Study|Death|1|||
126298170|NCT02172664|454378722|FG001|Overall Study|Death|1|||
126298171|NCT02172664|454378721|FG000|Overall Study|Moved out of area|1|||
126298172|NCT02172664|454378722|FG001|Overall Study|Moved out of area|1|||
126298173|NCT01753310|454378724|FG000|Overall Study|Entered into open label extension study|25|||
126298174|NCT01753310|454378725|FG001|Overall Study|Entered into open label extension study|22|||
126298175|NCT01753310|454378724|FG000|Overall Study|Adverse Event|1|||
126298176|NCT01753310|454378725|FG001|Overall Study|Adverse Event|0|||
126298177|NCT01753310|454378724|FG000|Overall Study|Lost to Follow-up|2|||
126298178|NCT01753310|454378725|FG001|Overall Study|Lost to Follow-up|0|||
126298179|NCT01753310|454378724|FG000|Overall Study|Subject decision|2|||
126298180|NCT01753310|454378725|FG001|Overall Study|Subject decision|2|||
126298181|NCT01753310|454378724|FG000|Overall Study|Sponsor decision|1|||
126298182|NCT01753310|454378725|FG001|Overall Study|Sponsor decision|0|||
126298183|NCT01753310|454378724|FG000|Overall Study|Withdrawal by Subject|1|||
126298184|NCT01753310|454378725|FG001|Overall Study|Withdrawal by Subject|0|||
126298185|NCT02022202|454378726|FG000|Overall Study|Withdrawal by Subject|2|||
126298186|NCT02022202|454378726|FG000|Overall Study|Disease Progression|3|||
126298187|NCT02022202|454378726|FG000|Overall Study|Desire go to immediately to surgery|3|||
126298188|NCT05581641|454378727|FG000|Overall Study|Withdrawal by Subject|0|||
126298189|NCT05581641|454378728|FG001|Overall Study|Withdrawal by Subject|1|||
126298190|NCT05581641|454378729|FG002|Overall Study|Withdrawal by Subject|3|||
126298191|NCT05581641|454378730|FG003|Overall Study|Withdrawal by Subject|1|||
126298192|NCT05581641|454378727|FG000|Overall Study|Lost to Follow-up|0|||
126298193|NCT05581641|454378728|FG001|Overall Study|Lost to Follow-up|1|||
126298194|NCT05581641|454378729|FG002|Overall Study|Lost to Follow-up|0|||
126298195|NCT05581641|454378730|FG003|Overall Study|Lost to Follow-up|1|||
126298196|NCT05581641|454378727|FG000|Overall Study|Protocol Violation|1|||
126298197|NCT05581641|454378728|FG001|Overall Study|Protocol Violation|0|||
126298198|NCT05581641|454378729|FG002|Overall Study|Protocol Violation|0|||
126298199|NCT05581641|454378730|FG003|Overall Study|Protocol Violation|0|||
126298200|NCT05581641|454378727|FG000|Overall Study|Other|1|||
126043445|NCT04778410|453457301|FG005|Phase 2 Period|Death|0|||
126043446|NCT04778410|453457296|FG000|Phase 2 Period|Lost to Follow-up|0|||
126043447|NCT04778410|453457297|FG001|Phase 2 Period|Lost to Follow-up|0|||
126043448|NCT04778410|453457298|FG002|Phase 2 Period|Lost to Follow-up|0|||
126298201|NCT05581641|454378728|FG001|Overall Study|Other|0|||
126298202|NCT05581641|454378729|FG002|Overall Study|Other|2|||
126298203|NCT05581641|454378730|FG003|Overall Study|Other|1|||
126298204|NCT02166333|454378731|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
126298205|NCT02166333|454378732|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
126298206|NCT02166333|454378733|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
126298207|NCT02166333|454378734|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
126298208|NCT02166333|454378735|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
126298209|NCT02166333|454378736|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
126298210|NCT02166333|454378731|FG000|Stage 1|Death|4|||
126298211|NCT02166333|454378732|FG001|Stage 1|Death|0|||
126298212|NCT02166333|454378733|FG002|Stage 1|Death|2|||
126298213|NCT02166333|454378734|FG003|Stage 1|Death|0|||
126298214|NCT02166333|454378735|FG004|Stage 1|Death|3|||
126298215|NCT02166333|454378736|FG005|Stage 1|Death|2|||
126298216|NCT02166333|454378731|FG000|Stage 1|Lost to Follow-up|12|||
126298217|NCT02166333|454378732|FG001|Stage 1|Lost to Follow-up|0|||
126298218|NCT02166333|454378733|FG002|Stage 1|Lost to Follow-up|6|||
126298219|NCT02166333|454378734|FG003|Stage 1|Lost to Follow-up|0|||
126298220|NCT02166333|454378735|FG004|Stage 1|Lost to Follow-up|3|||
126298221|NCT02166333|454378736|FG005|Stage 1|Lost to Follow-up|3|||
126298222|NCT02166333|454378731|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
126298223|NCT02166333|454378732|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
126298224|NCT02166333|454378733|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
126298225|NCT02166333|454378734|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
126298226|NCT02166333|454378735|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
126298227|NCT02166333|454378736|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
126298228|NCT02166333|454378731|FG000|Stage 2|Death|4|||
126298229|NCT02166333|454378732|FG001|Stage 2|Death|2|||
126298230|NCT02166333|454378733|FG002|Stage 2|Death|1|||
126298231|NCT02166333|454378734|FG003|Stage 2|Death|0|||
126298232|NCT02166333|454378735|FG004|Stage 2|Death|0|||
126298233|NCT02166333|454378736|FG005|Stage 2|Death|1|||
126298234|NCT02166333|454378731|FG000|Stage 2|Lost to Follow-up|23|||
126298235|NCT02166333|454378732|FG001|Stage 2|Lost to Follow-up|4|||
126298236|NCT02166333|454378733|FG002|Stage 2|Lost to Follow-up|11|||
126367031|NCT01979185|454639397|FG000|Period 2|Other|0|||
126367032|NCT01979185|454639398|FG001|Period 2|Other|1|||
126367033|NCT00980798|454639399|FG000|Overall Study|Adverse Event|7|||
126367034|NCT00980798|454639400|FG001|Overall Study|Adverse Event|36|||
126367035|NCT00980798|454639399|FG000|Overall Study|Lack of Efficacy|16|||
126367036|NCT00980798|454639400|FG001|Overall Study|Lack of Efficacy|5|||
126367037|NCT00980798|454639399|FG000|Overall Study|Lost to Follow-up|0|||
126367038|NCT00980798|454639400|FG001|Overall Study|Lost to Follow-up|1|||
126367039|NCT00980798|454639399|FG000|Overall Study|Physician Decision|2|||
126367040|NCT00980798|454639400|FG001|Overall Study|Physician Decision|1|||
126367041|NCT00980798|454639399|FG000|Overall Study|Withdrawal by Subject|8|||
126367042|NCT00980798|454639400|FG001|Overall Study|Withdrawal by Subject|11|||
126367043|NCT00980798|454639399|FG000|Overall Study|Other|0|||
126367044|NCT00980798|454639400|FG001|Overall Study|Other|1|||
126367045|NCT04724837|454639401|FG000|Overall Study|Other|4|||
126367046|NCT04724837|454639402|FG001|Overall Study|Other|16|||
126367047|NCT04724837|454639403|FG002|Overall Study|Other|0|||
126367048|NCT04724837|454639401|FG000|Overall Study|Withdrawal by Subject|2|||
126367049|NCT04724837|454639402|FG001|Overall Study|Withdrawal by Subject|9|||
126367050|NCT04724837|454639403|FG002|Overall Study|Withdrawal by Subject|9|||
126367051|NCT04724837|454639401|FG000|Overall Study|Adverse Event|2|||
126367052|NCT04724837|454639402|FG001|Overall Study|Adverse Event|7|||
126367053|NCT04724837|454639403|FG002|Overall Study|Adverse Event|4|||
126367054|NCT04724837|454639401|FG000|Overall Study|Lost to Follow-up|0|||
126367055|NCT04724837|454639402|FG001|Overall Study|Lost to Follow-up|1|||
126367056|NCT04724837|454639403|FG002|Overall Study|Lost to Follow-up|3|||
126367057|NCT04724837|454639401|FG000|Overall Study|Physician Decision|1|||
126367058|NCT04724837|454639402|FG001|Overall Study|Physician Decision|2|||
126367059|NCT04724837|454639403|FG002|Overall Study|Physician Decision|0|||
126367060|NCT04724837|454639401|FG000|Overall Study|Death|0|||
126367061|NCT04724837|454639402|FG001|Overall Study|Death|0|||
126367062|NCT04724837|454639403|FG002|Overall Study|Death|1|||
126367063|NCT04724837|454639401|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
126367064|NCT04724837|454639402|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
126367065|NCT04724837|454639403|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
126367066|NCT04724837|454639401|FG000|Overall Study|Study Terminated by Sponsor|0|||
126367067|NCT04724837|454639402|FG001|Overall Study|Study Terminated by Sponsor|1|||
126043449|NCT04778410|453457299|FG003|Phase 2 Period|Lost to Follow-up|1|||
126043450|NCT04778410|453457300|FG004|Phase 2 Period|Lost to Follow-up|1|||
126298237|NCT02166333|454378734|FG003|Stage 2|Lost to Follow-up|9|||
126298238|NCT02166333|454378735|FG004|Stage 2|Lost to Follow-up|3|||
126298239|NCT02166333|454378736|FG005|Stage 2|Lost to Follow-up|6|||
126298240|NCT00682786|454378741|FG000|Overall Study|Withdrawal by Subject|2|||
126298241|NCT00682786|454378742|FG001|Overall Study|Withdrawal by Subject|2|||
126298242|NCT00682786|454378741|FG000|Overall Study|Did not receive irinotecan|0|||
126298243|NCT00682786|454378742|FG001|Overall Study|Did not receive irinotecan|1|||
126298244|NCT00359424|454378743|FG000|Overall Study|Death|99|||
126298245|NCT00359424|454378744|FG001|Overall Study|Death|58|||
126298246|NCT00359424|454378743|FG000|Overall Study|Lost to Follow-up|19|||
126298247|NCT00359424|454378744|FG001|Overall Study|Lost to Follow-up|7|||
126298248|NCT00359424|454378743|FG000|Overall Study|Withdrawal by Subject|10|||
126298249|NCT00359424|454378744|FG001|Overall Study|Withdrawal by Subject|2|||
126298250|NCT00359424|454378743|FG000|Overall Study|follow up not conducted|2|||
126298251|NCT00359424|454378744|FG001|Overall Study|follow up not conducted|0|||
126298252|NCT02462603|454378747|FG000|Overall Study|Investigator Decision|1|||
126298253|NCT02462603|454378747|FG000|Overall Study|Non-Compliance|1|||
126298254|NCT02462603|454378747|FG000|Overall Study|Withdrawal by Subject|2|||
126298255|NCT01591096|454378749|FG000|Overall Study|Adverse Event|1|||
126298256|NCT01831635|454378750|FG000|Overall Study|Withdrawal by Subject|0|||
126298257|NCT01831635|454378751|FG001|Overall Study|Withdrawal by Subject|2|||
126298258|NCT01831635|454378752|FG002|Overall Study|Withdrawal by Subject|0|||
126298259|NCT03805412|454378755|FG000|Overall Study|Lost to Follow-up|0|||
126298260|NCT03805412|454378756|FG001|Overall Study|Lost to Follow-up|1|||
126298261|NCT05514873|454378762|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
126298262|NCT05514873|454378762|FG000|Main Treatment Period|Adverse Event|2|||
126298263|NCT05514873|454378762|FG000|Extension Treatment Period|Lost to Follow-up|3|||
126298264|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
126298265|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
126298266|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
126298267|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
126298268|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
126298269|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
126298270|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
126298271|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
126298272|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
126298273|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
126298274|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
126298275|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
126298276|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
126298277|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
126298278|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
126298279|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
126298280|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
126298281|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
126298282|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
126298283|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
126298284|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
126298285|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
126298286|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
126298287|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
126298288|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
126298289|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
126298290|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
126298291|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
126298292|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
126298293|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
126298294|NCT02747108|454378770|FG000|Overall Study|Death|2|||
126298295|NCT02747108|454378771|FG001|Overall Study|Death|2|||
126298296|NCT02747108|454378770|FG000|Overall Study|Withdrawal by Subject|1|||
126298297|NCT02747108|454378771|FG001|Overall Study|Withdrawal by Subject|0|||
126298298|NCT02747108|454378770|FG000|Overall Study|Protocol Violation|2|||
126298299|NCT02747108|454378771|FG001|Overall Study|Protocol Violation|0|||
126298300|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
126298301|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298302|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
126298303|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298304|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
126298305|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298306|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298307|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298308|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298309|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298310|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
126298311|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298312|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298313|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
126298314|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298315|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298316|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298317|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298318|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
126298319|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298320|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298321|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
126298322|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298323|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
126298324|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
126298325|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
126298326|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
126298327|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
126298328|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
126298329|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
126298330|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
126298331|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
126298332|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298333|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298334|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
126298335|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298336|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298337|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298338|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
126298339|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298340|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298341|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298342|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
126298343|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298344|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298345|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
126298346|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298347|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
126298348|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
126298349|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
126298350|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298351|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298352|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125883576|NCT01746901|452871518|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126298353|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298354|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298355|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298356|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298357|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
126298358|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298359|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298360|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298361|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298362|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298363|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298364|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298365|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298366|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298367|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298368|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
126298369|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298370|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298371|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298372|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298373|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298374|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298375|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298376|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298377|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
126298378|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298379|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298380|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298381|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298382|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298383|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298384|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298385|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
126298386|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
126298387|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298388|NCT00210210|454380161|FG000|Overall Study|Withdrawal by Subject|3|||
126298389|NCT00210210|454380162|FG001|Overall Study|Withdrawal by Subject|2|||
126298390|NCT00210210|454380161|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
126298391|NCT00210210|454380162|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
126298392|NCT02275546|454380171|FG000|Treatment Period 2|Withdrawal by Subject|2|||
126298393|NCT02275546|454380172|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126298394|NCT02275546|454380171|FG000|Treatment Period 2|Protocol Violation|0|||
126298395|NCT02275546|454380172|FG001|Treatment Period 2|Protocol Violation|1|||
126298396|NCT02955355|454380176|FG000|Overall Study|Adverse Event|4|||
126298397|NCT02955355|454380176|FG000|Overall Study|Death|1|||
126298398|NCT02955355|454380176|FG000|Overall Study|Physician Decision|21|||
126298399|NCT02955355|454380176|FG000|Overall Study|Site Terminated by Sponsor|35|||
126298400|NCT02955355|454380176|FG000|Overall Study|Withdrawal by Subject|19|||
126298401|NCT02955355|454380176|FG000|Overall Study|Reason Not Specified|5|||
126298402|NCT02612623|454380177|FG000|Overall Study|Withdrawal by Subject|0|||
126043451|NCT04778410|453457301|FG005|Phase 2 Period|Lost to Follow-up|0|||
126043452|NCT04778410|453457296|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
126298403|NCT02612623|454380178|FG001|Overall Study|Withdrawal by Subject|1|||
126298404|NCT02612623|454380179|FG002|Overall Study|Withdrawal by Subject|0|||
126298405|NCT02612623|454380180|FG003|Overall Study|Withdrawal by Subject|0|||
126298406|NCT02612623|454380177|FG000|Overall Study|Adverse Event|1|||
126298407|NCT02612623|454380178|FG001|Overall Study|Adverse Event|0|||
126298408|NCT02612623|454380179|FG002|Overall Study|Adverse Event|1|||
126298409|NCT02612623|454380180|FG003|Overall Study|Adverse Event|0|||
126298410|NCT05177484|454380181|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
126298411|NCT05177484|454380182|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
126298412|NCT05177484|454380181|FG000|Overall Study|Inadvertently withdrawn|3|||
126298413|NCT05177484|454380182|FG001|Overall Study|Inadvertently withdrawn|1|||
126298414|NCT05177484|454380181|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
126298415|NCT05177484|454380182|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
126298416|NCT05486091|454380187|FG000|Overall Study|Withdrawal by Subject|1|||
126298417|NCT05486091|454380187|FG000|Overall Study|Lost to Follow-up|2|||
126298418|NCT03971071|454380188|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
126298419|NCT03971071|454380189|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
126298420|NCT03971071|454380190|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
126298421|NCT03971071|454380191|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
126298422|NCT03971071|454380192|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
126298423|NCT03971071|454380188|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
126298424|NCT03971071|454380189|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
126298425|NCT03971071|454380190|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
126298426|NCT03971071|454380191|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126298427|NCT03971071|454380192|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126298428|NCT03971071|454380188|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
126298429|NCT03971071|454380189|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
126298430|NCT03971071|454380190|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
126298431|NCT03971071|454380191|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
126298432|NCT03971071|454380192|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
126298433|NCT03971071|454380188|FG000|Open-label Treatment Period|Sponsor decision|0|||
126298434|NCT03971071|454380189|FG001|Open-label Treatment Period|Sponsor decision|0|||
126298435|NCT03971071|454380190|FG002|Open-label Treatment Period|Sponsor decision|0|||
126298436|NCT03971071|454380191|FG003|Open-label Treatment Period|Sponsor decision|0|||
126298437|NCT03971071|454380192|FG004|Open-label Treatment Period|Sponsor decision|1|||
126298438|NCT03971071|454380188|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
126298439|NCT03971071|454380189|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126298440|NCT03971071|454380190|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
126298441|NCT03971071|454380191|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
126298442|NCT03971071|454380192|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
126298443|NCT03971071|454380188|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126298444|NCT03971071|454380189|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
126298445|NCT03971071|454380190|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
126298446|NCT03971071|454380191|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
126298447|NCT03971071|454380192|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
126298448|NCT03210714|454380195|FG000|Overall Study|Adverse Event|6|||
126298449|NCT03210714|454380195|FG000|Overall Study|Physician Decision|1|||
126367068|NCT04724837|454639403|FG002|Overall Study|Study Terminated by Sponsor|0|||
126367069|NCT00522379|454639404|FG000|Overall Study|Adverse Event|12|||
126367070|NCT00522379|454639405|FG001|Overall Study|Adverse Event|15|||
126367071|NCT00522379|454639406|FG002|Overall Study|Adverse Event|12|||
126367072|NCT00522379|454639407|FG003|Overall Study|Adverse Event|5|||
126367073|NCT00522379|454639408|FG004|Overall Study|Adverse Event|17|||
126367074|NCT00522379|454639404|FG000|Overall Study|Lack of Efficacy|3|||
126367075|NCT00522379|454639405|FG001|Overall Study|Lack of Efficacy|0|||
126367076|NCT00522379|454639406|FG002|Overall Study|Lack of Efficacy|2|||
126367077|NCT00522379|454639407|FG003|Overall Study|Lack of Efficacy|2|||
126367078|NCT00522379|454639408|FG004|Overall Study|Lack of Efficacy|7|||
126367079|NCT00522379|454639404|FG000|Overall Study|Withdrawal by Subject|2|||
126367080|NCT00522379|454639405|FG001|Overall Study|Withdrawal by Subject|3|||
126367081|NCT00522379|454639406|FG002|Overall Study|Withdrawal by Subject|1|||
126367082|NCT00522379|454639407|FG003|Overall Study|Withdrawal by Subject|2|||
126367083|NCT00522379|454639408|FG004|Overall Study|Withdrawal by Subject|0|||
126043453|NCT04778410|453457297|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
126298450|NCT03210714|454380195|FG000|Overall Study|Progressive disease|11|||
126367084|NCT00522379|454639404|FG000|Overall Study|Protocol Violation|1|||
126367085|NCT00522379|454639405|FG001|Overall Study|Protocol Violation|1|||
126367086|NCT00522379|454639406|FG002|Overall Study|Protocol Violation|2|||
126367087|NCT00522379|454639407|FG003|Overall Study|Protocol Violation|0|||
126367088|NCT00522379|454639408|FG004|Overall Study|Protocol Violation|0|||
126298451|NCT03210714|454380195|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
126298452|NCT01909934|454380196|FG000|Overall Study|Withdrawal by Subject|3|||
126298453|NCT01909934|454380196|FG000|Overall Study|Lost to Follow-up|1|||
126298454|NCT01909934|454380196|FG000|Overall Study|Death|25|||
126298455|NCT01909934|454380196|FG000|Overall Study|Withdrawal of Informed Consent|1|||
126298456|NCT01909934|454380196|FG000|Overall Study|Reason Not Specified|1|||
126298457|NCT03810092|454380197|FG000|Overall Study|no ground support|17|||
126298458|NCT03810092|454380197|FG000|Overall Study|ADL not done at J0|16|||
126298459|NCT03810092|454380197|FG000|Overall Study|No hemoglobin measure at J5|27|||
126298460|NCT01139775|454380200|FG000|Overall Study|Adverse Event|0|||
126298461|NCT01139775|454380201|FG001|Overall Study|Adverse Event|6|||
126298462|NCT01139775|454380202|FG002|Overall Study|Adverse Event|2|||
126298463|NCT01139775|454380200|FG000|Overall Study|Protocol Violation|0|||
126298464|NCT01139775|454380201|FG001|Overall Study|Protocol Violation|5|||
126298465|NCT01139775|454380202|FG002|Overall Study|Protocol Violation|0|||
126298466|NCT01139775|454380200|FG000|Overall Study|Withdrawal by Subject|1|||
126298467|NCT01139775|454380201|FG001|Overall Study|Withdrawal by Subject|0|||
126298468|NCT01139775|454380202|FG002|Overall Study|Withdrawal by Subject|2|||
126298469|NCT01139775|454380200|FG000|Overall Study|Physician Decision|0|||
126298470|NCT01139775|454380201|FG001|Overall Study|Physician Decision|2|||
126298471|NCT01139775|454380202|FG002|Overall Study|Physician Decision|2|||
126298472|NCT03193853|454380205|FG000|Overall Study|Death|6|||
126298473|NCT01956773|454380213|FG000|Overall Study|Lost to Follow-up|628|||
126298474|NCT01956773|454380214|FG001|Overall Study|Lost to Follow-up|1|||
126298475|NCT00450437|454380219|FG000|Overall Study|Withdrawal by Subject|10|||
126298476|NCT00450437|454380220|FG001|Overall Study|Withdrawal by Subject|2|||
126298477|NCT00450437|454380221|FG002|Overall Study|Withdrawal by Subject|0|||
126298478|NCT00450437|454380222|FG003|Overall Study|Withdrawal by Subject|1|||
126298479|NCT00450437|454380219|FG000|Overall Study|Lost to Follow-up|31|||
126298480|NCT00450437|454380220|FG001|Overall Study|Lost to Follow-up|12|||
126298481|NCT00450437|454380221|FG002|Overall Study|Lost to Follow-up|19|||
126298482|NCT00450437|454380222|FG003|Overall Study|Lost to Follow-up|9|||
126298483|NCT00450437|454380219|FG000|Overall Study|Protocol Violation|0|||
126298484|NCT00450437|454380220|FG001|Overall Study|Protocol Violation|1|||
126298485|NCT00450437|454380221|FG002|Overall Study|Protocol Violation|0|||
126298486|NCT00450437|454380222|FG003|Overall Study|Protocol Violation|1|||
126298487|NCT00450437|454380219|FG000|Overall Study|Inappropriate enrollment|4|||
126298488|NCT00450437|454380220|FG001|Overall Study|Inappropriate enrollment|1|||
126298489|NCT00450437|454380221|FG002|Overall Study|Inappropriate enrollment|3|||
126298490|NCT00450437|454380222|FG003|Overall Study|Inappropriate enrollment|0|||
126298491|NCT00450437|454380219|FG000|Overall Study|Administrative reason|0|||
126298492|NCT00450437|454380220|FG001|Overall Study|Administrative reason|0|||
126298493|NCT00450437|454380221|FG002|Overall Study|Administrative reason|1|||
126298494|NCT00450437|454380222|FG003|Overall Study|Administrative reason|0|||
126298495|NCT00450437|454380219|FG000|Overall Study|Unable to Classify|1|||
126298496|NCT00450437|454380220|FG001|Overall Study|Unable to Classify|0|||
126298497|NCT00450437|454380221|FG002|Overall Study|Unable to Classify|1|||
126298498|NCT00450437|454380222|FG003|Overall Study|Unable to Classify|0|||
126298499|NCT02492867|454380223|FG000|Overall Study|Alternate therapy|1|||
126298500|NCT02492867|454380223|FG000|Overall Study|Withdrawal by Subject|2|||
126298501|NCT02492867|454380223|FG000|Overall Study|Disease progression after treatment started|1|||
126298502|NCT02492867|454380223|FG000|Overall Study|Death|1|||
126298503|NCT03296527|454380224|FG000|Overall Study|Adverse Event|15|||
126298504|NCT03296527|454380225|FG001|Overall Study|Adverse Event|33|||
126298505|NCT03296527|454380224|FG000|Overall Study|Protocol Deviation|4|||
126298506|NCT03296527|454380225|FG001|Overall Study|Protocol Deviation|0|||
126298507|NCT03296527|454380224|FG000|Overall Study|Participant withdrew consent|3|||
126298508|NCT03296527|454380225|FG001|Overall Study|Participant withdrew consent|1|||
126298509|NCT03296527|454380224|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
126298510|NCT03296527|454380225|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
126043454|NCT04778410|453457298|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
126043455|NCT04778410|453457299|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
126043456|NCT04778410|453457300|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
126298511|NCT03296527|454380224|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
126298512|NCT03296527|454380225|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
126298513|NCT03296527|454380224|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
126298514|NCT03296527|454380225|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
126298515|NCT03296527|454380224|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
126298516|NCT03296527|454380225|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
126298517|NCT03296527|454380224|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
126298518|NCT03296527|454380225|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
126298519|NCT00122382|454380226|FG000|Double-Blind Study|Adverse Event|9|||
126298520|NCT00122382|454380227|FG001|Double-Blind Study|Adverse Event|11|||
126043457|NCT04778410|453457301|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
126298521|NCT00122382|454380228|FG002|Double-Blind Study|Adverse Event|0|||
126298522|NCT00122382|454380226|FG000|Double-Blind Study|Death|2|||
126298523|NCT00122382|454380227|FG001|Double-Blind Study|Death|2|||
126298524|NCT00122382|454380228|FG002|Double-Blind Study|Death|0|||
126298525|NCT00122382|454380226|FG000|Double-Blind Study|Lack of Efficacy|0|||
126298526|NCT00122382|454380227|FG001|Double-Blind Study|Lack of Efficacy|8|||
126298527|NCT00122382|454380228|FG002|Double-Blind Study|Lack of Efficacy|0|||
126298528|NCT00122382|454380226|FG000|Double-Blind Study|Lost to Follow-up|2|||
126298529|NCT00122382|454380227|FG001|Double-Blind Study|Lost to Follow-up|1|||
126298530|NCT00122382|454380228|FG002|Double-Blind Study|Lost to Follow-up|0|||
126298531|NCT00122382|454380226|FG000|Double-Blind Study|Pregnancy|2|||
126298532|NCT00122382|454380227|FG001|Double-Blind Study|Pregnancy|0|||
126298533|NCT00122382|454380228|FG002|Double-Blind Study|Pregnancy|0|||
126298534|NCT00122382|454380226|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
126298535|NCT00122382|454380227|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
126298536|NCT00122382|454380228|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
126298537|NCT00122382|454380226|FG000|Double-Blind Study|Withdrawal of Consent|7|||
126298538|NCT00122382|454380227|FG001|Double-Blind Study|Withdrawal of Consent|3|||
126298539|NCT00122382|454380228|FG002|Double-Blind Study|Withdrawal of Consent|0|||
126298540|NCT00122382|454380226|FG000|Double-Blind Study|Protocol Violation|1|||
126298541|NCT00122382|454380227|FG001|Double-Blind Study|Protocol Violation|0|||
126298542|NCT00122382|454380228|FG002|Double-Blind Study|Protocol Violation|0|||
126298543|NCT00122382|454380226|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
126298544|NCT00122382|454380227|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
126298545|NCT00122382|454380228|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
126298546|NCT00122382|454380226|FG000|Double-Blind Study|Randomized but not treated|0|||
126298547|NCT00122382|454380227|FG001|Double-Blind Study|Randomized but not treated|2|||
126298548|NCT00122382|454380228|FG002|Double-Blind Study|Randomized but not treated|0|||
126298549|NCT00122382|454380226|FG000|Open-Label Study|Adverse Event|0|||
126298550|NCT00122382|454380227|FG001|Open-Label Study|Adverse Event|0|||
126298551|NCT00122382|454380228|FG002|Open-Label Study|Adverse Event|11|||
126298552|NCT00122382|454380226|FG000|Open-Label Study|Death|0|||
126298553|NCT00122382|454380227|FG001|Open-Label Study|Death|0|||
126298554|NCT00122382|454380228|FG002|Open-Label Study|Death|2|||
126298555|NCT00122382|454380226|FG000|Open-Label Study|Lack of Efficacy|0|||
126298556|NCT00122382|454380227|FG001|Open-Label Study|Lack of Efficacy|0|||
126298557|NCT00122382|454380228|FG002|Open-Label Study|Lack of Efficacy|3|||
126298558|NCT00122382|454380226|FG000|Open-Label Study|Lost to Follow-up|0|||
126298559|NCT00122382|454380227|FG001|Open-Label Study|Lost to Follow-up|0|||
126298560|NCT00122382|454380228|FG002|Open-Label Study|Lost to Follow-up|3|||
126298561|NCT00122382|454380226|FG000|Open-Label Study|Pregnancy|0|||
126298562|NCT00122382|454380227|FG001|Open-Label Study|Pregnancy|0|||
126298563|NCT00122382|454380228|FG002|Open-Label Study|Pregnancy|2|||
126298564|NCT00122382|454380226|FG000|Open-Label Study|Poor/Non-Compliance|0|||
126298565|NCT00122382|454380227|FG001|Open-Label Study|Poor/Non-Compliance|0|||
126298566|NCT00122382|454380228|FG002|Open-Label Study|Poor/Non-Compliance|1|||
126298567|NCT00122382|454380226|FG000|Open-Label Study|Withdrawal of Consent|0|||
126298568|NCT00122382|454380227|FG001|Open-Label Study|Withdrawal of Consent|0|||
126298569|NCT00122382|454380228|FG002|Open-Label Study|Withdrawal of Consent|4|||
126298570|NCT02040805|454380229|FG000|Overall Study|Lost to Follow-up|14|||
126298571|NCT02040805|454380230|FG001|Overall Study|Lost to Follow-up|9|||
126298572|NCT02040805|454380229|FG000|Overall Study|Withdrawal by Subject|28|||
126298573|NCT02040805|454380230|FG001|Overall Study|Withdrawal by Subject|41|||
126298574|NCT01213966|454380232|FG000|Overall Study|Protocol Violation|1|||
126298575|NCT01213966|454380233|FG001|Overall Study|Protocol Violation|0|||
126298576|NCT01213966|454380234|FG002|Overall Study|Protocol Violation|3|||
126298577|NCT01213966|454380235|FG003|Overall Study|Protocol Violation|1|||
126298578|NCT03591874|454380236|FG000|Overall Study|Adverse Event|4|||
126298579|NCT03591874|454380237|FG001|Overall Study|Adverse Event|0|||
126298580|NCT03591874|454380236|FG000|Overall Study|Withdrawal by Subject|2|||
126298581|NCT03591874|454380237|FG001|Overall Study|Withdrawal by Subject|1|||
126298582|NCT03591874|454380236|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
126298583|NCT03591874|454380237|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
126298584|NCT03591874|454380236|FG000|Overall Study|On Study at Time of Study Termination|12|||
126298585|NCT03591874|454380237|FG001|Overall Study|On Study at Time of Study Termination|6|||
126298586|NCT03644342|454380240|FG000|Overall Study|Adverse Event|2|||
126298587|NCT03644342|454380241|FG001|Overall Study|Adverse Event|0|||
126298588|NCT03644342|454380240|FG000|Overall Study|Protocol Violation|0|||
126298589|NCT03644342|454380241|FG001|Overall Study|Protocol Violation|1|||
126298590|NCT04762160|454380244|FG000|Overall Study|Study terminated early due to business reasons|5|||
126298591|NCT03655405|454380247|FG000|Overall Study|Death after initial data collection|4|||
126298592|NCT03655405|454380248|FG001|Overall Study|Death after initial data collection|2|||
126298593|NCT03655405|454380247|FG000|Overall Study|Died before initial data collection|1|||
126298594|NCT03655405|454380248|FG001|Overall Study|Died before initial data collection|2|||
126043458|NCT04778410|453457296|FG000|Phase 2 Period|Withdrew Consent|0|||
126298595|NCT03655405|454380247|FG000|Overall Study|Protocol Violation|0|||
126298596|NCT03655405|454380248|FG001|Overall Study|Protocol Violation|1|||
126298597|NCT01991743|454380251|FG000|Overall Study|external cephalic version not performed|0|||
126298598|NCT01991743|454380252|FG001|Overall Study|external cephalic version not performed|0|||
126298599|NCT01991743|454380253|FG002|Overall Study|external cephalic version not performed|1|||
126298600|NCT01991743|454380254|FG003|Overall Study|external cephalic version not performed|0|||
126298601|NCT02859337|454380255|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
126298602|NCT02859337|454380256|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
126298603|NCT02859337|454380257|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
126298604|NCT02859337|454380255|FG000|Overall Study|Withdrawal by Subject|3|||
126298605|NCT02859337|454380256|FG001|Overall Study|Withdrawal by Subject|1|||
126298606|NCT02859337|454380257|FG002|Overall Study|Withdrawal by Subject|0|||
126298607|NCT02859337|454380255|FG000|Overall Study|Lost to Follow-up|1|||
126298608|NCT02859337|454380256|FG001|Overall Study|Lost to Follow-up|0|||
126298609|NCT02859337|454380257|FG002|Overall Study|Lost to Follow-up|0|||
126298610|NCT01445730|454380258|FG000|Overall Study|Adverse Event|1|||
126298611|NCT01445730|454380258|FG000|Overall Study|For the advice of a dentist|1|||
126298612|NCT01445730|454380258|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
126298613|NCT01167140|454380259|FG000|Overall Study|Withdrawal by Subject|1|||
126298614|NCT04390113|454380264|FG000|Overall Study|Not Treated|0|||
126298615|NCT04390113|454380265|FG001|Overall Study|Not Treated|1|||
126298616|NCT04390113|454380264|FG000|Overall Study|Adverse Event|1|||
126298617|NCT04390113|454380265|FG001|Overall Study|Adverse Event|0|||
126298618|NCT04390113|454380264|FG000|Overall Study|Death|2|||
126298619|NCT04390113|454380265|FG001|Overall Study|Death|1|||
126298620|NCT04390113|454380264|FG000|Overall Study|Physician Decision|1|||
126298621|NCT04390113|454380265|FG001|Overall Study|Physician Decision|3|||
126298622|NCT04390113|454380264|FG000|Overall Study|Study Terminated by Sponsor|5|||
126298623|NCT04390113|454380265|FG001|Overall Study|Study Terminated by Sponsor|3|||
126298624|NCT04390113|454380264|FG000|Overall Study|Withdrawal by Subject|10|||
126298625|NCT04390113|454380265|FG001|Overall Study|Withdrawal by Subject|5|||
126298626|NCT04390113|454380264|FG000|Overall Study|Other|1|||
126298627|NCT04390113|454380265|FG001|Overall Study|Other|0|||
126298628|NCT04390113|454380264|FG000|Overall Study|Missing|0|||
126298629|NCT04390113|454380265|FG001|Overall Study|Missing|1|||
126298630|NCT00030901|454380268|FG000|Initial Registration|Ineligible|167|||
126298631|NCT00030901|454380269|FG001|Initial Registration|Ineligible|0|||
126298632|NCT00030901|454380270|FG002|Initial Registration|Ineligible|0|||
126298633|NCT00030901|454380268|FG000|Randomization|Adverse Event|0|||
126298634|NCT00030901|454380269|FG001|Randomization|Adverse Event|11|||
126298635|NCT00030901|454380270|FG002|Randomization|Adverse Event|7|||
126298636|NCT00030901|454380268|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
126298637|NCT00030901|454380269|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
126298638|NCT00030901|454380270|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
126298639|NCT00030901|454380268|FG000|Randomization|Progression/Relapse|0|||
126298640|NCT00030901|454380269|FG001|Randomization|Progression/Relapse|22|||
126298641|NCT00030901|454380270|FG002|Randomization|Progression/Relapse|21|||
126298642|NCT00030901|454380268|FG000|Randomization|Death|0|||
126298643|NCT00030901|454380269|FG001|Randomization|Death|1|||
126298644|NCT00030901|454380270|FG002|Randomization|Death|3|||
126298645|NCT00030901|454380268|FG000|Randomization|Other|0|||
126298646|NCT00030901|454380269|FG001|Randomization|Other|36|||
126298647|NCT00030901|454380270|FG002|Randomization|Other|33|||
126298648|NCT00030901|454380268|FG000|Randomization|Ineligible|0|||
126298649|NCT00030901|454380269|FG001|Randomization|Ineligible|15|||
126298650|NCT00030901|454380270|FG002|Randomization|Ineligible|14|||
126298651|NCT02576847|454380271|FG000|Overall Study|Adverse Event|27|||
126298652|NCT02576847|454380271|FG000|Overall Study|Lost to Follow-up|22|||
126298653|NCT02576847|454380271|FG000|Overall Study|Physician Decision|1|||
126298654|NCT02576847|454380271|FG000|Overall Study|Pregnancy|1|||
126298655|NCT02576847|454380271|FG000|Overall Study|Protocol Violation|3|||
126298656|NCT02576847|454380271|FG000|Overall Study|Withdrawal by Subject|78|||
126298657|NCT02576847|454380271|FG000|Overall Study|Other|5|||
126298658|NCT01806051|454380272|FG000|Overall Study|Withdrawal by Subject|6|||
126298659|NCT01205776|454380273|FG000|Overall Study|Lost to Follow-up|53|||
126298660|NCT01205776|454380274|FG001|Overall Study|Lost to Follow-up|61|||
126298661|NCT01205776|454380273|FG000|Overall Study|Withdrawal by Subject|11|||
126298662|NCT01205776|454380274|FG001|Overall Study|Withdrawal by Subject|34|||
126298663|NCT00734994|454380277|FG000|Overall Study|Withdrawal by Subject|1|||
126298664|NCT03817190|454380278|FG000|Overall Study|Early Termination|13|||
126298665|NCT03817190|454380279|FG001|Overall Study|Early Termination|20|||
126298666|NCT03817190|454380278|FG000|Overall Study|Adverse Event|10|||
126298667|NCT03817190|454380279|FG001|Overall Study|Adverse Event|17|||
126298668|NCT03817190|454380278|FG000|Overall Study|Withdrawal by Subject|12|||
126298669|NCT03817190|454380279|FG001|Overall Study|Withdrawal by Subject|8|||
126298670|NCT03817190|454380278|FG000|Overall Study|Lost to Follow-up|11|||
126298671|NCT03817190|454380279|FG001|Overall Study|Lost to Follow-up|7|||
126298672|NCT03817190|454380278|FG000|Overall Study|Lack of Efficacy|7|||
126298673|NCT03817190|454380279|FG001|Overall Study|Lack of Efficacy|5|||
126298674|NCT03817190|454380278|FG000|Overall Study|Investigator Decision|5|||
126298675|NCT03817190|454380279|FG001|Overall Study|Investigator Decision|1|||
126298676|NCT03817190|454380278|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
126298677|NCT03817190|454380279|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
126298678|NCT03817190|454380278|FG000|Overall Study|Lack of Contact|1|||
126298679|NCT03817190|454380279|FG001|Overall Study|Lack of Contact|0|||
126298680|NCT03817190|454380278|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
126298681|NCT03817190|454380279|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
126298682|NCT00437021|454380872|FG000|Overall Study|Adverse Event|0|||
126298683|NCT00437021|454380873|FG001|Overall Study|Adverse Event|0|||
126298684|NCT00437021|454380874|FG002|Overall Study|Adverse Event|0|||
126298685|NCT00437021|454380875|FG003|Overall Study|Adverse Event|0|||
126298686|NCT00437021|454380876|FG004|Overall Study|Adverse Event|0|||
126298687|NCT00437021|454380877|FG005|Overall Study|Adverse Event|0|||
126298688|NCT00437021|454380878|FG006|Overall Study|Adverse Event|1|||
126298689|NCT00437021|454380879|FG007|Overall Study|Adverse Event|0|||
126298690|NCT00437021|454380880|FG008|Overall Study|Adverse Event|0|||
126298691|NCT00437021|454380881|FG009|Overall Study|Adverse Event|0|||
126298692|NCT00437021|454380882|FG010|Overall Study|Adverse Event|0|||
126298693|NCT00437021|454380883|FG011|Overall Study|Adverse Event|0|||
126298694|NCT00437021|454380872|FG000|Overall Study|Lost to Follow-up|0|||
126298695|NCT00437021|454380873|FG001|Overall Study|Lost to Follow-up|3|||
126298696|NCT00437021|454380874|FG002|Overall Study|Lost to Follow-up|0|||
126298697|NCT00437021|454380875|FG003|Overall Study|Lost to Follow-up|0|||
126298698|NCT00437021|454380876|FG004|Overall Study|Lost to Follow-up|0|||
126298699|NCT00437021|454380877|FG005|Overall Study|Lost to Follow-up|2|||
126298700|NCT00437021|454380878|FG006|Overall Study|Lost to Follow-up|0|||
126298701|NCT00437021|454380879|FG007|Overall Study|Lost to Follow-up|1|||
126298702|NCT00437021|454380880|FG008|Overall Study|Lost to Follow-up|0|||
126298703|NCT00437021|454380881|FG009|Overall Study|Lost to Follow-up|0|||
126298704|NCT00437021|454380882|FG010|Overall Study|Lost to Follow-up|0|||
126298705|NCT00437021|454380883|FG011|Overall Study|Lost to Follow-up|0|||
126298706|NCT00437021|454380872|FG000|Overall Study|Withdrawal by Subject|2|||
126298707|NCT00437021|454380873|FG001|Overall Study|Withdrawal by Subject|1|||
126298708|NCT00437021|454380874|FG002|Overall Study|Withdrawal by Subject|0|||
126298709|NCT00437021|454380875|FG003|Overall Study|Withdrawal by Subject|0|||
126298710|NCT00437021|454380876|FG004|Overall Study|Withdrawal by Subject|0|||
126298711|NCT00437021|454380877|FG005|Overall Study|Withdrawal by Subject|0|||
126298712|NCT00437021|454380878|FG006|Overall Study|Withdrawal by Subject|0|||
126298713|NCT00437021|454380879|FG007|Overall Study|Withdrawal by Subject|0|||
126298714|NCT00437021|454380880|FG008|Overall Study|Withdrawal by Subject|0|||
126298715|NCT00437021|454380881|FG009|Overall Study|Withdrawal by Subject|0|||
126298716|NCT00437021|454380882|FG010|Overall Study|Withdrawal by Subject|0|||
126298717|NCT00437021|454380883|FG011|Overall Study|Withdrawal by Subject|0|||
126298718|NCT05573464|454380884|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
126298719|NCT05573464|454380885|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
126043459|NCT04778410|453457297|FG001|Phase 2 Period|Withdrew Consent|0|||
126298720|NCT05573464|454380884|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
126298721|NCT05573464|454380885|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
126298722|NCT05573464|454380884|FG000|12-week Treatment Period|Protocol Violation|3|||
126298723|NCT05573464|454380885|FG001|12-week Treatment Period|Protocol Violation|1|||
126298724|NCT05573464|454380884|FG000|12-week Treatment Period|Physician Decision|1|||
126043460|NCT04778410|453457298|FG002|Phase 2 Period|Withdrew Consent|0|||
126298725|NCT05573464|454380885|FG001|12-week Treatment Period|Physician Decision|2|||
126298726|NCT05573464|454380884|FG000|12-week Treatment Period|Lost to Follow-up|2|||
126298727|NCT05573464|454380885|FG001|12-week Treatment Period|Lost to Follow-up|0|||
126298728|NCT05573464|454380884|FG000|12-week Treatment Period|Adverse Event|20|||
126298729|NCT05573464|454380885|FG001|12-week Treatment Period|Adverse Event|9|||
126298730|NCT05573464|454380884|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
126298731|NCT05573464|454380885|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
126298732|NCT05573464|454380884|FG000|12-week Treatment Period|Randomised, not treated|0|||
126043461|NCT04778410|453457299|FG003|Phase 2 Period|Withdrew Consent|0|||
126367089|NCT00522379|454639404|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
126367090|NCT00522379|454639405|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
126367091|NCT00522379|454639406|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
126367092|NCT00522379|454639407|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
126367093|NCT00522379|454639408|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
126367094|NCT00522379|454639404|FG000|Overall Study|Lost to Follow-up|1|||
126367095|NCT00522379|454639405|FG001|Overall Study|Lost to Follow-up|0|||
126367096|NCT00522379|454639406|FG002|Overall Study|Lost to Follow-up|4|||
126367097|NCT00522379|454639407|FG003|Overall Study|Lost to Follow-up|2|||
126367098|NCT00522379|454639408|FG004|Overall Study|Lost to Follow-up|2|||
126367099|NCT00522379|454639404|FG000|Overall Study|Randomization error|0|||
126367100|NCT00522379|454639405|FG001|Overall Study|Randomization error|0|||
126367101|NCT00522379|454639406|FG002|Overall Study|Randomization error|0|||
126367102|NCT00522379|454639407|FG003|Overall Study|Randomization error|0|||
126367103|NCT00522379|454639408|FG004|Overall Study|Randomization error|1|||
126367104|NCT00522379|454639404|FG000|Overall Study|Dispensing error|1|||
126367105|NCT00522379|454639405|FG001|Overall Study|Dispensing error|0|||
126367106|NCT00522379|454639406|FG002|Overall Study|Dispensing error|0|||
126367107|NCT00522379|454639407|FG003|Overall Study|Dispensing error|1|||
126367108|NCT00522379|454639408|FG004|Overall Study|Dispensing error|0|||
126367109|NCT00522379|454639404|FG000|Overall Study|Subject Moved|1|||
126367110|NCT00522379|454639405|FG001|Overall Study|Subject Moved|1|||
126367111|NCT00522379|454639406|FG002|Overall Study|Subject Moved|0|||
126367112|NCT00522379|454639407|FG003|Overall Study|Subject Moved|0|||
126367113|NCT00522379|454639408|FG004|Overall Study|Subject Moved|0|||
126367114|NCT00522379|454639404|FG000|Overall Study|Sponsor Request|0|||
126367115|NCT00522379|454639405|FG001|Overall Study|Sponsor Request|1|||
126367116|NCT00522379|454639406|FG002|Overall Study|Sponsor Request|0|||
126367117|NCT00522379|454639407|FG003|Overall Study|Sponsor Request|0|||
126367118|NCT00522379|454639408|FG004|Overall Study|Sponsor Request|0|||
126367119|NCT00522379|454639404|FG000|Overall Study|Family Problem|0|||
126367120|NCT00522379|454639405|FG001|Overall Study|Family Problem|0|||
126367121|NCT00522379|454639406|FG002|Overall Study|Family Problem|1|||
126367122|NCT00522379|454639407|FG003|Overall Study|Family Problem|0|||
126367123|NCT00522379|454639408|FG004|Overall Study|Family Problem|0|||
126367124|NCT00522379|454639404|FG000|Overall Study|Site Closed|0|||
126367125|NCT00522379|454639405|FG001|Overall Study|Site Closed|0|||
126367126|NCT00522379|454639406|FG002|Overall Study|Site Closed|0|||
126367127|NCT00522379|454639407|FG003|Overall Study|Site Closed|1|||
126367128|NCT00522379|454639408|FG004|Overall Study|Site Closed|0|||
126367129|NCT00522379|454639404|FG000|Overall Study|Subject Withdrawal|0|||
126367130|NCT00522379|454639405|FG001|Overall Study|Subject Withdrawal|0|||
126367131|NCT00522379|454639406|FG002|Overall Study|Subject Withdrawal|0|||
126367132|NCT00522379|454639407|FG003|Overall Study|Subject Withdrawal|1|||
126367133|NCT00522379|454639408|FG004|Overall Study|Subject Withdrawal|0|||
126367134|NCT00967499|454639413|FG000|Overall Study|Adverse Event|0|||
126367135|NCT00967499|454639414|FG001|Overall Study|Adverse Event|1|||
126367136|NCT00967499|454639413|FG000|Overall Study|Protocol Violation|1|||
126367137|NCT00967499|454639414|FG001|Overall Study|Protocol Violation|0|||
126367138|NCT00967499|454639413|FG000|Overall Study|Sponsor Decision|1|||
126367139|NCT00967499|454639414|FG001|Overall Study|Sponsor Decision|0|||
126367140|NCT00967499|454639413|FG000|Overall Study|Randomized but not treated|63|||
126367141|NCT00967499|454639414|FG001|Overall Study|Randomized but not treated|59|||
126367142|NCT02607722|454639416|FG000|Overall Study|No data reliability|1|||
126367143|NCT02607722|454639416|FG000|Overall Study|no patient visit|18|||
126367144|NCT02607722|454639416|FG000|Overall Study|missing info in CRF|13|||
126367145|NCT02607722|454639416|FG000|Overall Study|Withdrawal by Subject|616|||
126367146|NCT02607722|454639416|FG000|Overall Study|Lost to Follow-up|312|||
126367147|NCT02607722|454639416|FG000|Overall Study|Improved|22|||
126367148|NCT02607722|454639416|FG000|Overall Study|Lack of Efficacy|316|||
126367149|NCT02607722|454639416|FG000|Overall Study|Adverse Event|2553|||
126367150|NCT02607722|454639416|FG000|Overall Study|Not treated|1|||
126367151|NCT02607722|454639416|FG000|Overall Study|No CRF collected|138|||
126367152|NCT02607722|454639416|FG000|Overall Study|without CRF|4225|||
126367153|NCT02607722|454639416|FG000|Overall Study|Physician Decision|367|||
126367154|NCT04562090|454639417|FG000|Overall Study|Withdrawal by Subject|3|||
126367155|NCT04562090|454639418|FG001|Overall Study|Withdrawal by Subject|4|||
126367156|NCT04562090|454639417|FG000|Overall Study|Protocol Violation|2|||
126367157|NCT04562090|454639418|FG001|Overall Study|Protocol Violation|0|||
126367158|NCT04562090|454639417|FG000|Overall Study|Lack of Efficacy|0|||
126367159|NCT04562090|454639418|FG001|Overall Study|Lack of Efficacy|1|||
126367160|NCT04562090|454639417|FG000|Overall Study|Adverse Event|1|||
126367161|NCT04562090|454639418|FG001|Overall Study|Adverse Event|4|||
126367162|NCT04562090|454639417|FG000|Overall Study|Miscellaneous|0|||
126367163|NCT04562090|454639418|FG001|Overall Study|Miscellaneous|3|||
126367164|NCT03633058|454639419|FG000|Overall Study|Adverse Event|0|||
126367165|NCT03633058|454639420|FG001|Overall Study|Adverse Event|0|||
126367166|NCT03633058|454639421|FG002|Overall Study|Adverse Event|1|||
126367167|NCT03633058|454639422|FG003|Overall Study|Adverse Event|0|||
126367168|NCT03034044|454639423|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
126298733|NCT05573464|454380885|FG001|12-week Treatment Period|Randomised, not treated|1|||
126298734|NCT05573464|454380884|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
126298735|NCT05573464|454380885|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
126298736|NCT05573464|454380884|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
126298737|NCT05573464|454380885|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
126298738|NCT05573464|454380884|FG000|52-week Treatment Period|Protocol Violation|1|||
126298739|NCT05573464|454380885|FG001|52-week Treatment Period|Protocol Violation|1|||
126298740|NCT05573464|454380884|FG000|52-week Treatment Period|Physician Decision|2|||
126298741|NCT05573464|454380885|FG001|52-week Treatment Period|Physician Decision|2|||
126298742|NCT05573464|454380884|FG000|52-week Treatment Period|Lost to Follow-up|1|||
126298743|NCT05573464|454380885|FG001|52-week Treatment Period|Lost to Follow-up|1|||
126298744|NCT05573464|454380884|FG000|52-week Treatment Period|Adverse Event|11|||
126298745|NCT05573464|454380885|FG001|52-week Treatment Period|Adverse Event|8|||
126298746|NCT05573464|454380884|FG000|52-week Treatment Period|Death|1|||
126298747|NCT05573464|454380885|FG001|52-week Treatment Period|Death|1|||
126298748|NCT05734157|454380886|FG000|Overall Study|Death|3|||
126298749|NCT05734157|454380886|FG000|Overall Study|Withdrawal by Subject|2|||
126298750|NCT05734157|454380886|FG000|Overall Study|Lost to Follow-up|1|||
126298751|NCT05734157|454380886|FG000|Overall Study|Telephone call|3|||
126298752|NCT01611935|454380887|FG000|Overall Study|Family Declined Participation|1|||
126298753|NCT01611935|454380888|FG001|Overall Study|Family Declined Participation|0|||
126298754|NCT03817853|454380892|FG000|Induction Phase|Adverse Event|5|||
126298755|NCT03817853|454380893|FG001|Induction Phase|Adverse Event|0|||
126298756|NCT03817853|454380894|FG002|Induction Phase|Adverse Event|0|||
126298757|NCT03817853|454380892|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
126298758|NCT03817853|454380893|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
126298759|NCT03817853|454380894|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
126298760|NCT03817853|454380892|FG000|Induction Phase|Physician Decision|2|||
126298761|NCT03817853|454380893|FG001|Induction Phase|Physician Decision|0|||
126298762|NCT03817853|454380894|FG002|Induction Phase|Physician Decision|0|||
126298763|NCT03817853|454380892|FG000|Induction Phase|Progressive Disease|6|||
126298764|NCT03817853|454380893|FG001|Induction Phase|Progressive Disease|0|||
126298765|NCT03817853|454380894|FG002|Induction Phase|Progressive Disease|0|||
126298766|NCT03817853|454380892|FG000|Induction Phase|Withdrawal by Subject|4|||
126298767|NCT03817853|454380893|FG001|Induction Phase|Withdrawal by Subject|0|||
126298768|NCT03817853|454380894|FG002|Induction Phase|Withdrawal by Subject|0|||
126298769|NCT03817853|454380892|FG000|Maintenance Phase|Adverse Event|0|||
126298770|NCT03817853|454380893|FG001|Maintenance Phase|Adverse Event|8|||
126298771|NCT03817853|454380894|FG002|Maintenance Phase|Adverse Event|0|||
126298772|NCT03817853|454380892|FG000|Maintenance Phase|Death|0|||
126298773|NCT03817853|454380893|FG001|Maintenance Phase|Death|5|||
126298774|NCT03817853|454380894|FG002|Maintenance Phase|Death|0|||
126298775|NCT03817853|454380892|FG000|Maintenance Phase|Progressive Disease|0|||
126298776|NCT03817853|454380893|FG001|Maintenance Phase|Progressive Disease|7|||
126298777|NCT03817853|454380894|FG002|Maintenance Phase|Progressive Disease|0|||
126298778|NCT03817853|454380892|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126298779|NCT03817853|454380893|FG001|Maintenance Phase|Withdrawal by Subject|2|||
126298780|NCT03817853|454380894|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126298781|NCT03817853|454380892|FG000|Maintenance Phase|Physician Decision|0|||
126298782|NCT03817853|454380893|FG001|Maintenance Phase|Physician Decision|1|||
126298783|NCT03817853|454380894|FG002|Maintenance Phase|Physician Decision|0|||
126298784|NCT03817853|454380892|FG000|Maintenance Phase|Various reasons|0|||
126298785|NCT03817853|454380893|FG001|Maintenance Phase|Various reasons|4|||
126298786|NCT03817853|454380894|FG002|Maintenance Phase|Various reasons|0|||
126298787|NCT03817853|454380892|FG000|Maintenance Phase|Protocol Deviation|0|||
126298788|NCT03817853|454380893|FG001|Maintenance Phase|Protocol Deviation|1|||
126298789|NCT03817853|454380894|FG002|Maintenance Phase|Protocol Deviation|0|||
126298790|NCT03817853|454380892|FG000|Follow-up Phase|Adverse Event|0|||
126298791|NCT03817853|454380893|FG001|Follow-up Phase|Adverse Event|0|||
126298792|NCT03817853|454380894|FG002|Follow-up Phase|Adverse Event|2|||
126298793|NCT03817853|454380892|FG000|Follow-up Phase|Death|0|||
126298794|NCT03817853|454380893|FG001|Follow-up Phase|Death|0|||
126298795|NCT03817853|454380894|FG002|Follow-up Phase|Death|1|||
126298796|NCT03817853|454380892|FG000|Follow-up Phase|Progressive Disease|0|||
126298797|NCT03817853|454380893|FG001|Follow-up Phase|Progressive Disease|0|||
126298798|NCT03817853|454380894|FG002|Follow-up Phase|Progressive Disease|3|||
126298799|NCT03817853|454380892|FG000|Follow-up Phase|Withdrawal by Subject|0|||
126298800|NCT03817853|454380893|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126298801|NCT03817853|454380894|FG002|Follow-up Phase|Withdrawal by Subject|1|||
126298802|NCT00314340|454380895|FG000|Overall Study|lost interest|1|||
125883577|NCT01746901|452871519|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126298803|NCT01620138|454380898|FG000|Overall Study|Withdrawal by Subject|3|||
126298804|NCT01620138|454380899|FG001|Overall Study|Withdrawal by Subject|0|||
126298805|NCT01620138|454380898|FG000|Overall Study|Lack of Efficacy|1|||
126298806|NCT01620138|454380899|FG001|Overall Study|Lack of Efficacy|0|||
126298807|NCT01620138|454380898|FG000|Overall Study|Adverse Event|2|||
126298808|NCT01620138|454380899|FG001|Overall Study|Adverse Event|0|||
126298809|NCT03252535|454380900|FG000|Overall Study|Withdrawal by Subject|1|||
126298810|NCT03252535|454380901|FG001|Overall Study|Withdrawal by Subject|0|||
126298811|NCT03252535|454380902|FG002|Overall Study|Withdrawal by Subject|0|||
126298812|NCT03252535|454380900|FG000|Overall Study|Physician Decision|0|||
126298813|NCT03252535|454380901|FG001|Overall Study|Physician Decision|1|||
126298814|NCT03252535|454380902|FG002|Overall Study|Physician Decision|0|||
126298815|NCT03252535|454380900|FG000|Overall Study|Met discontinuation criteria|0|||
126298816|NCT03252535|454380901|FG001|Overall Study|Met discontinuation criteria|1|||
126298817|NCT03252535|454380902|FG002|Overall Study|Met discontinuation criteria|0|||
126298818|NCT05600283|454380903|FG000|Overall Study|Withdrawal by Subject|3|||
126298819|NCT05600283|454380904|FG001|Overall Study|Withdrawal by Subject|8|||
126298820|NCT05600283|454380903|FG000|Overall Study|invalid individual swab|1|||
126298821|NCT05600283|454380904|FG001|Overall Study|invalid individual swab|0|||
126298822|NCT05600283|454380903|FG000|Overall Study|missing clinician collection|3|||
126298823|NCT05600283|454380904|FG001|Overall Study|missing clinician collection|0|||
126298824|NCT05600283|454380903|FG000|Overall Study|screening failure|0|||
126298825|NCT05600283|454380904|FG001|Overall Study|screening failure|2|||
126298826|NCT03907488|454380905|FG000|Overall Study|Adverse Event|20|||
126298827|NCT03907488|454380906|FG001|Overall Study|Adverse Event|20|||
126298828|NCT03907488|454380905|FG000|Overall Study|Withdrawal by Subject|9|||
126298829|NCT03907488|454380906|FG001|Overall Study|Withdrawal by Subject|13|||
126298830|NCT03907488|454380905|FG000|Overall Study|Lack of Efficacy|0|||
126298831|NCT03907488|454380906|FG001|Overall Study|Lack of Efficacy|9|||
126298832|NCT03907488|454380905|FG000|Overall Study|Death|3|||
126298833|NCT03907488|454380906|FG001|Overall Study|Death|8|||
126298834|NCT03907488|454380905|FG000|Overall Study|not protocol specified|5|||
126298835|NCT03907488|454380906|FG001|Overall Study|not protocol specified|8|||
126298836|NCT03907488|454380905|FG000|Overall Study|Ineligible|9|||
126298837|NCT03907488|454380906|FG001|Overall Study|Ineligible|15|||
126298838|NCT02269098|454380907|FG000|Overall Study|Lost to Follow-up|14|||
126298839|NCT02269098|454380908|FG001|Overall Study|Lost to Follow-up|9|||
126298840|NCT03194542|454380911|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
126298841|NCT03194542|454380912|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
126298842|NCT03194542|454380913|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
126298843|NCT03194542|454380914|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
126298844|NCT03194542|454380911|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
126298845|NCT03194542|454380912|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
126298846|NCT03194542|454380913|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
126298847|NCT03194542|454380914|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
126298848|NCT03194542|454380911|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
126298849|NCT03194542|454380912|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
126298850|NCT03194542|454380913|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
126043462|NCT04778410|453457300|FG004|Phase 2 Period|Withdrew Consent|2|||
126043463|NCT04778410|453457301|FG005|Phase 2 Period|Withdrew Consent|0|||
126298851|NCT03194542|454380914|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
126298852|NCT03194542|454380911|FG000|Overall Study|Loss of Response|4|||
126298853|NCT03194542|454380912|FG001|Overall Study|Loss of Response|2|||
126298854|NCT03194542|454380913|FG002|Overall Study|Loss of Response|3|||
126298855|NCT03194542|454380914|FG003|Overall Study|Loss of Response|4|||
126298856|NCT03194542|454380911|FG000|Overall Study|Physician Decision|0|||
126298857|NCT03194542|454380912|FG001|Overall Study|Physician Decision|1|||
126298858|NCT03194542|454380913|FG002|Overall Study|Physician Decision|0|||
126367169|NCT03312543|454639424|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
126367170|NCT03312543|454639425|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
126367171|NCT03312543|454639424|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
126367172|NCT03312543|454639425|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
126367173|NCT03312543|454639424|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
126367174|NCT03312543|454639425|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
126367175|NCT03312543|454639424|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
126367176|NCT03312543|454639425|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
126367177|NCT03312543|454639424|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
126367178|NCT03312543|454639425|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
126367179|NCT03312543|454639424|FG000|Regression (Week 12 to Week 24)|Death|0|||
126367180|NCT03312543|454639425|FG001|Regression (Week 12 to Week 24)|Death|1|||
126367181|NCT05535972|454639426|FG000|Overall Study|Withdrawal by Subject|31|||
126367182|NCT05535972|454639426|FG000|Overall Study|Lost to Follow-up|5|||
126367183|NCT05535972|454639426|FG000|Overall Study|Adverse Event|6|||
126367184|NCT05535972|454639426|FG000|Overall Study|Protocol Deviation|2|||
126367185|NCT02402647|454639429|FG000|Overall Study|Lost to Follow-up|13|||
126367186|NCT02402647|454639430|FG001|Overall Study|Lost to Follow-up|7|||
126102731|NCT00372229|453670186|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
126102732|NCT00372229|453670187|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
126102733|NCT00372229|453670186|FG000|Follow-Up Phase|Death|9|||
126102734|NCT00372229|453670187|FG001|Follow-Up Phase|Death|12|||
126102735|NCT00372229|453670186|FG000|Follow-Up Phase|Administrative|1|||
126102736|NCT00372229|453670187|FG001|Follow-Up Phase|Administrative|0|||
126102737|NCT00372229|453670186|FG000|Follow-Up Phase|Reason not specified|2|||
126102738|NCT00372229|453670187|FG001|Follow-Up Phase|Reason not specified|3|||
126102739|NCT00372229|453670186|FG000|Follow-Up Phase|Lost to Follow-up|12|||
126102740|NCT00372229|453670187|FG001|Follow-Up Phase|Lost to Follow-up|10|||
126102741|NCT03536143|453670188|FG000|Overall Study|Early termination, Sponsor decision|1|||
126102742|NCT04754477|453670189|FG000|Overall Study|Withdrawal by Subject|1|||
126102743|NCT01347762|453670190|FG000|Overall Study|Lost to Follow-up|0|||
126102744|NCT01347762|453670191|FG001|Overall Study|Lost to Follow-up|1|||
126102745|NCT01347762|453670192|FG002|Overall Study|Lost to Follow-up|6|||
126102746|NCT01347762|453670193|FG003|Overall Study|Lost to Follow-up|5|||
126102747|NCT01347762|453670190|FG000|Overall Study|Withdrawal by Subject|4|||
126102748|NCT01347762|453670191|FG001|Overall Study|Withdrawal by Subject|1|||
126102749|NCT01347762|453670192|FG002|Overall Study|Withdrawal by Subject|3|||
126102750|NCT01347762|453670193|FG003|Overall Study|Withdrawal by Subject|3|||
126102751|NCT00871780|453670194|FG000|Overall Study|Enrolled But Not Treated|6|||
126102752|NCT00871780|453670194|FG000|Overall Study|Withdrawal by Subject|9|||
126102753|NCT00871780|453670194|FG000|Overall Study|Adverse Event|6|||
126367187|NCT02402647|454639429|FG000|Overall Study|Protocol Violation|1|||
126367188|NCT02402647|454639430|FG001|Overall Study|Protocol Violation|1|||
126367189|NCT02402647|454639429|FG000|Overall Study|scheduled and timed out|2|||
126367190|NCT02402647|454639430|FG001|Overall Study|scheduled and timed out|1|||
126367191|NCT02402647|454639429|FG000|Overall Study|medical illness|2|||
126367192|NCT02402647|454639430|FG001|Overall Study|medical illness|4|||
126367193|NCT02402647|454639429|FG000|Overall Study|Moved|2|||
126367194|NCT02402647|454639430|FG001|Overall Study|Moved|0|||
126367195|NCT02402647|454639429|FG000|Overall Study|loved one illness|1|||
126367196|NCT02402647|454639430|FG001|Overall Study|loved one illness|0|||
126367197|NCT02402647|454639429|FG000|Overall Study|deceased preexisting condition|2|||
126367198|NCT02402647|454639430|FG001|Overall Study|deceased preexisting condition|0|||
126367199|NCT02402647|454639429|FG000|Overall Study|Other|2|||
126367200|NCT02402647|454639430|FG001|Overall Study|Other|1|||
126367201|NCT04197583|454639431|FG000|Overall Study|Study Stent Replacement|34|||
126102754|NCT00871780|453670194|FG000|Overall Study|Voluntary Discontinuation|4|||
126102755|NCT00871780|453670194|FG000|Overall Study|Death|1|||
126102756|NCT00871780|453670194|FG000|Overall Study|Physician Decision|1|||
126102757|NCT03406260|453670195|FG000|Period 1|Adverse Event|0|||
126102758|NCT03406260|453670196|FG001|Period 1|Adverse Event|0|||
126102759|NCT03406260|453670197|FG002|Period 1|Adverse Event|0|||
126102760|NCT03406260|453670198|FG003|Period 1|Adverse Event|0|||
126102761|NCT03406260|453670199|FG004|Period 1|Adverse Event|1|||
126102762|NCT03406260|453670200|FG005|Period 1|Adverse Event|0|||
126102763|NCT02527343|453670201|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
126102764|NCT02527343|453670202|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126102765|NCT02527343|453670203|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126102766|NCT02527343|453670204|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126102767|NCT02527343|453670205|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126102768|NCT02527343|453670206|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126102769|NCT02527343|453670201|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
126367202|NCT04197583|454639432|FG001|Overall Study|Study Stent Replacement|8|||
126367203|NCT04197583|454639431|FG000|Overall Study|Lost to Follow-up|14|||
126367204|NCT04197583|454639432|FG001|Overall Study|Lost to Follow-up|3|||
126367205|NCT04197583|454639431|FG000|Overall Study|Death|3|||
126298859|NCT03194542|454380914|FG003|Overall Study|Physician Decision|0|||
126298860|NCT03194542|454380911|FG000|Overall Study|Lack of Efficacy|2|||
126298861|NCT03194542|454380912|FG001|Overall Study|Lack of Efficacy|2|||
126298862|NCT03194542|454380913|FG002|Overall Study|Lack of Efficacy|2|||
126298863|NCT03194542|454380914|FG003|Overall Study|Lack of Efficacy|6|||
126298864|NCT03194542|454380911|FG000|Overall Study|Withdrawal by Subject|2|||
126298865|NCT03194542|454380912|FG001|Overall Study|Withdrawal by Subject|1|||
126298866|NCT03194542|454380913|FG002|Overall Study|Withdrawal by Subject|5|||
126298867|NCT03194542|454380914|FG003|Overall Study|Withdrawal by Subject|4|||
126298868|NCT03194542|454380911|FG000|Overall Study|Progressive Disease|1|||
126298869|NCT03194542|454380912|FG001|Overall Study|Progressive Disease|0|||
126298870|NCT03194542|454380913|FG002|Overall Study|Progressive Disease|1|||
126298871|NCT03194542|454380914|FG003|Overall Study|Progressive Disease|1|||
126298872|NCT03194542|454380911|FG000|Overall Study|Adverse Event|1|||
126298873|NCT03194542|454380912|FG001|Overall Study|Adverse Event|2|||
126298874|NCT03194542|454380913|FG002|Overall Study|Adverse Event|0|||
126298875|NCT03194542|454380914|FG003|Overall Study|Adverse Event|5|||
126298876|NCT03194542|454380911|FG000|Overall Study|Death|1|||
126298877|NCT03194542|454380912|FG001|Overall Study|Death|2|||
125883578|NCT01746901|452871511|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125883579|NCT01746901|452871512|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
125883580|NCT01746901|452871513|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
125883581|NCT01746901|452871514|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125883582|NCT01746901|452871515|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125883583|NCT01746901|452871516|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126043464|NCT00677365|453457306|FG000|Overall Study|Adverse Event|2|||
126043465|NCT00677365|453457307|FG001|Overall Study|Adverse Event|1|||
126043466|NCT00677365|453457308|FG002|Overall Study|Adverse Event|1|||
126043467|NCT00677365|453457309|FG003|Overall Study|Adverse Event|2|||
126043468|NCT00677365|453457306|FG000|Overall Study|Withdrawal by Subject|0|||
126043469|NCT00677365|453457307|FG001|Overall Study|Withdrawal by Subject|0|||
126043470|NCT00677365|453457308|FG002|Overall Study|Withdrawal by Subject|1|||
126043471|NCT00677365|453457309|FG003|Overall Study|Withdrawal by Subject|0|||
126043472|NCT00677365|453457306|FG000|Overall Study|Other reason|0|||
126043473|NCT00677365|453457307|FG001|Overall Study|Other reason|0|||
126043474|NCT00677365|453457308|FG002|Overall Study|Other reason|0|||
126043475|NCT00677365|453457309|FG003|Overall Study|Other reason|1|||
126043476|NCT05422885|453457310|FG000|Overall Study|Lost to Follow-up|1|||
126043477|NCT05422885|453457310|FG000|Overall Study|Withdrawal by Subject|2|||
126043478|NCT02944968|453457311|FG000|Overall Study|Subject excluded before study procedure|1|||
126043479|NCT02944968|453457311|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
126043480|NCT02905331|453457312|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
126043481|NCT02905331|453457313|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
126043482|NCT02905331|453457314|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
126043483|NCT02905331|453457312|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
126043484|NCT02905331|453457313|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
126043485|NCT02905331|453457314|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
126043486|NCT02905331|453457312|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
126043487|NCT02905331|453457313|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
126043488|NCT02905331|453457314|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
126043489|NCT02905331|453457312|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
126043490|NCT02905331|453457313|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
126298878|NCT03194542|454380913|FG002|Overall Study|Death|0|||
126298879|NCT03194542|454380914|FG003|Overall Study|Death|5|||
126298880|NCT03194542|454380911|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
126298881|NCT03194542|454380912|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
126367206|NCT04197583|454639432|FG001|Overall Study|Death|0|||
126367207|NCT04197583|454639431|FG000|Overall Study|Physician Decision|1|||
126367208|NCT04197583|454639432|FG001|Overall Study|Physician Decision|0|||
126367209|NCT04197583|454639431|FG000|Overall Study|Withdrawal by Subject|1|||
126367210|NCT04197583|454639432|FG001|Overall Study|Withdrawal by Subject|1|||
126367211|NCT04197583|454639431|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
126367212|NCT04197583|454639432|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
126367213|NCT04197583|454639431|FG000|Overall Study|Screen Failure|0|||
126367214|NCT04197583|454639432|FG001|Overall Study|Screen Failure|20|||
126367215|NCT04134936|454639434|FG000|Overall Study|Adverse Event|3|||
126367216|NCT04134936|454639435|FG001|Overall Study|Adverse Event|2|||
126367217|NCT04134936|454639434|FG000|Overall Study|Withdrawal by Subject|2|||
126367218|NCT04134936|454639435|FG001|Overall Study|Withdrawal by Subject|3|||
126367219|NCT04134936|454639434|FG000|Overall Study|Physician Decision|0|||
126367220|NCT04134936|454639435|FG001|Overall Study|Physician Decision|1|||
126367221|NCT04134936|454639434|FG000|Overall Study|Progressive disease, joined another trial|1|||
126102770|NCT02527343|453670202|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126102771|NCT02527343|453670203|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126102772|NCT02527343|453670204|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126102773|NCT02527343|453670205|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126102774|NCT02527343|453670206|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126102775|NCT02527343|453670201|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126102776|NCT02527343|453670202|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
126102777|NCT02527343|453670203|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126102778|NCT02527343|453670204|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126102779|NCT02527343|453670205|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126102780|NCT02527343|453670206|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126102781|NCT02527343|453670201|FG000|RT Period: Weeks 1 to 52|Other|4|||
126102782|NCT02527343|453670202|FG001|RT Period: Weeks 1 to 52|Other|3|||
126102783|NCT02527343|453670203|FG002|RT Period: Weeks 1 to 52|Other|0|||
126102784|NCT02527343|453670204|FG003|RT Period: Weeks 1 to 52|Other|0|||
126102785|NCT02527343|453670205|FG004|RT Period: Weeks 1 to 52|Other|0|||
126102786|NCT02527343|453670206|FG005|RT Period: Weeks 1 to 52|Other|0|||
126102787|NCT02527343|453670201|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126102788|NCT02527343|453670202|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126102789|NCT02527343|453670203|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
126102790|NCT02527343|453670204|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126102791|NCT02527343|453670205|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126102792|NCT02527343|453670206|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126102793|NCT02527343|453670201|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126102794|NCT02527343|453670202|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126102795|NCT02527343|453670203|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126102796|NCT02527343|453670204|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
126102797|NCT02527343|453670205|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126102798|NCT02527343|453670206|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126367222|NCT04134936|454639435|FG001|Overall Study|Progressive disease, joined another trial|0|||
126367223|NCT04134936|454639434|FG000|Overall Study|Progressive disease|1|||
126367224|NCT04134936|454639435|FG001|Overall Study|Progressive disease|0|||
126367225|NCT00323622|454639438|FG000|Overall Study|Other|30|||
126367226|NCT00323622|454639439|FG001|Overall Study|Other|91|||
126367227|NCT00323622|454639440|FG002|Overall Study|Other|4|||
126367228|NCT00323622|454639441|FG003|Overall Study|Other|12|||
126367229|NCT00323622|454639442|FG004|Overall Study|Other|32|||
126367230|NCT00323622|454639443|FG005|Overall Study|Other|74|||
126367231|NCT00323622|454639444|FG006|Overall Study|Other|5|||
126367232|NCT00323622|454639445|FG007|Overall Study|Other|13|||
126367233|NCT00323622|454639438|FG000|Overall Study|Death|1|||
126367234|NCT00323622|454639439|FG001|Overall Study|Death|1|||
126367235|NCT00323622|454639440|FG002|Overall Study|Death|0|||
126367236|NCT00323622|454639441|FG003|Overall Study|Death|0|||
126367237|NCT00323622|454639442|FG004|Overall Study|Death|7|||
126367238|NCT00323622|454639443|FG005|Overall Study|Death|0|||
126367239|NCT00323622|454639444|FG006|Overall Study|Death|0|||
126367240|NCT00323622|454639445|FG007|Overall Study|Death|2|||
126367241|NCT02420717|454639446|FG000|Overall Study|Did not receive all study medication|2|||
126367242|NCT02420717|454639447|FG001|Overall Study|Did not receive all study medication|0|||
126367243|NCT02420717|454639448|FG002|Overall Study|Did not receive all study medication|0|||
126367244|NCT04191135|454639465|FG000|Induction Treatment|Not Treated|2|||
126367245|NCT04191135|454639466|FG001|Induction Treatment|Not Treated|0|||
126367246|NCT04191135|454639467|FG002|Induction Treatment|Not Treated|0|||
126367247|NCT04191135|454639465|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
126367248|NCT04191135|454639466|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
126367249|NCT04191135|454639467|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
126367250|NCT04191135|454639465|FG000|Induction Treatment|Adverse Event|25|||
126367251|NCT04191135|454639466|FG001|Induction Treatment|Adverse Event|0|||
126367252|NCT04191135|454639467|FG002|Induction Treatment|Adverse Event|0|||
126367253|NCT04191135|454639465|FG000|Induction Treatment|Clinical Progression|8|||
126367254|NCT04191135|454639466|FG001|Induction Treatment|Clinical Progression|0|||
126367255|NCT04191135|454639467|FG002|Induction Treatment|Clinical Progression|0|||
126367256|NCT04191135|454639465|FG000|Induction Treatment|Excluded Medication|1|||
126367257|NCT04191135|454639466|FG001|Induction Treatment|Excluded Medication|0|||
126367258|NCT04191135|454639467|FG002|Induction Treatment|Excluded Medication|0|||
126367259|NCT04191135|454639465|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
126043491|NCT02905331|453457314|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
126043492|NCT02905331|453457312|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
126043493|NCT02905331|453457313|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
126043494|NCT02905331|453457314|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
126043495|NCT04102111|453457316|FG000|Overall Study|Withdrawal by Subject|2|||
126298882|NCT03194542|454380913|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
126298883|NCT03194542|454380914|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
126298884|NCT01611883|454380917|FG000|Overall Study|Adverse Event|1|||
126298885|NCT01611883|454380918|FG001|Overall Study|Adverse Event|1|||
126298886|NCT01622673|454380919|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126298887|NCT01622673|454380920|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126298888|NCT01622673|454380921|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126298889|NCT01622673|454380922|FG003|Treatment Period 1|Withdrawal by Subject|1|||
126298890|NCT01622673|454380923|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126298891|NCT01622673|454380924|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126298892|NCT01622673|454380919|FG000|Treatment Period 1|Protocol Violation|0|||
126298893|NCT01622673|454380920|FG001|Treatment Period 1|Protocol Violation|1|||
126298894|NCT01622673|454380921|FG002|Treatment Period 1|Protocol Violation|0|||
126298895|NCT01622673|454380922|FG003|Treatment Period 1|Protocol Violation|0|||
126298896|NCT01622673|454380923|FG004|Treatment Period 1|Protocol Violation|0|||
126298897|NCT01622673|454380924|FG005|Treatment Period 1|Protocol Violation|0|||
126298898|NCT01622673|454380919|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126298899|NCT01622673|454380920|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126298900|NCT01622673|454380921|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126298901|NCT01622673|454380922|FG003|Treatment Period 2|Withdrawal by Subject|1|||
126102799|NCT02527343|453670201|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126298902|NCT01622673|454380923|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126298903|NCT01622673|454380924|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126298904|NCT01622673|454380919|FG000|Treatment Period 3|Protocol Violation|0|||
126298905|NCT01622673|454380920|FG001|Treatment Period 3|Protocol Violation|1|||
126298906|NCT01622673|454380921|FG002|Treatment Period 3|Protocol Violation|0|||
126298907|NCT01622673|454380922|FG003|Treatment Period 3|Protocol Violation|0|||
126298908|NCT01622673|454380923|FG004|Treatment Period 3|Protocol Violation|0|||
126298909|NCT01622673|454380924|FG005|Treatment Period 3|Protocol Violation|0|||
126298910|NCT04146012|454380927|FG000|Overall Study|Study Terminated|30|||
126298911|NCT04146012|454380928|FG001|Overall Study|Study Terminated|15|||
126298912|NCT05142722|454381640|FG000|Overall Study|Lost to Follow-up|16|||
126298913|NCT05142722|454381641|FG001|Overall Study|Lost to Follow-up|38|||
126298914|NCT05142722|454381640|FG000|Overall Study|Withdrawal by Subject|20|||
126298915|NCT05142722|454381641|FG001|Overall Study|Withdrawal by Subject|27|||
126298916|NCT05142722|454381640|FG000|Overall Study|Death|11|||
126298917|NCT05142722|454381641|FG001|Overall Study|Death|17|||
126298918|NCT05142722|454381640|FG000|Overall Study|Physician Decision|0|||
126298919|NCT05142722|454381641|FG001|Overall Study|Physician Decision|1|||
126298920|NCT05142722|454381640|FG000|Overall Study|Participant Moved Away|0|||
126298921|NCT05142722|454381641|FG001|Overall Study|Participant Moved Away|2|||
126298922|NCT05142722|454381640|FG000|Overall Study|Adverse Event|2|||
126298923|NCT05142722|454381641|FG001|Overall Study|Adverse Event|1|||
126298924|NCT05731700|454381642|FG000|Overall Study|Death|1|||
126298925|NCT05468164|454381659|FG000|Treatment Period 4|Adverse Event|0|||
126298926|NCT05468164|454381660|FG001|Treatment Period 4|Adverse Event|0|||
126298927|NCT05468164|454381661|FG002|Treatment Period 4|Adverse Event|0|||
126298928|NCT05468164|454381662|FG003|Treatment Period 4|Adverse Event|1|||
126298929|NCT01467713|454381663|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
126298930|NCT01467713|454381664|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
126298931|NCT01467713|454381665|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
126298932|NCT01467713|454381666|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
126298933|NCT01467713|454381663|FG000|Overall Study|Major Protocol Deviation|2|||
126298934|NCT01467713|454381664|FG001|Overall Study|Major Protocol Deviation|4|||
126298935|NCT01467713|454381665|FG002|Overall Study|Major Protocol Deviation|4|||
126298936|NCT01467713|454381666|FG003|Overall Study|Major Protocol Deviation|1|||
126298937|NCT01467713|454381663|FG000|Overall Study|Lost to Follow-up|9|||
126298938|NCT01467713|454381664|FG001|Overall Study|Lost to Follow-up|12|||
126298939|NCT01467713|454381665|FG002|Overall Study|Lost to Follow-up|6|||
126298940|NCT01467713|454381666|FG003|Overall Study|Lost to Follow-up|9|||
126298941|NCT01467713|454381663|FG000|Overall Study|Voluntary Withdrawal|18|||
126298942|NCT01467713|454381664|FG001|Overall Study|Voluntary Withdrawal|14|||
126298943|NCT01467713|454381665|FG002|Overall Study|Voluntary Withdrawal|21|||
126298944|NCT01467713|454381666|FG003|Overall Study|Voluntary Withdrawal|20|||
126298945|NCT01467713|454381663|FG000|Overall Study|Study Termination|23|||
126298946|NCT01467713|454381664|FG001|Overall Study|Study Termination|33|||
126298947|NCT01467713|454381665|FG002|Overall Study|Study Termination|28|||
126298948|NCT01467713|454381666|FG003|Overall Study|Study Termination|29|||
126298949|NCT01467713|454381663|FG000|Overall Study|Pregnancy|0|||
126298950|NCT01467713|454381664|FG001|Overall Study|Pregnancy|1|||
126298951|NCT01467713|454381665|FG002|Overall Study|Pregnancy|1|||
126298952|NCT01467713|454381666|FG003|Overall Study|Pregnancy|3|||
126298953|NCT01467713|454381663|FG000|Overall Study|Relapse|35|||
126367260|NCT04191135|454639466|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
126298954|NCT01467713|454381664|FG001|Overall Study|Relapse|25|||
126298955|NCT01467713|454381665|FG002|Overall Study|Relapse|28|||
126298956|NCT01467713|454381666|FG003|Overall Study|Relapse|35|||
126367261|NCT04191135|454639467|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
126367262|NCT04191135|454639465|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
126367263|NCT04191135|454639466|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
126367264|NCT04191135|454639467|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
126367265|NCT04191135|454639465|FG000|Induction Treatment|Physician Decision|2|||
126367266|NCT04191135|454639466|FG001|Induction Treatment|Physician Decision|0|||
126367267|NCT04191135|454639467|FG002|Induction Treatment|Physician Decision|0|||
126367268|NCT04191135|454639465|FG000|Induction Treatment|Progressive Disease|135|||
126367269|NCT04191135|454639466|FG001|Induction Treatment|Progressive Disease|0|||
126367270|NCT04191135|454639467|FG002|Induction Treatment|Progressive Disease|0|||
126367271|NCT04191135|454639465|FG000|Induction Treatment|Protocol Violation|10|||
126367272|NCT04191135|454639466|FG001|Induction Treatment|Protocol Violation|0|||
126298957|NCT01467713|454381663|FG000|Overall Study|Reason not Specified|6|||
126367273|NCT04191135|454639467|FG002|Induction Treatment|Protocol Violation|0|||
126298958|NCT01467713|454381664|FG001|Overall Study|Reason not Specified|11|||
126298959|NCT01467713|454381665|FG002|Overall Study|Reason not Specified|8|||
126367274|NCT04191135|454639465|FG000|Induction Treatment|Withdrawal by Subject|4|||
126298960|NCT01467713|454381666|FG003|Overall Study|Reason not Specified|7|||
126298961|NCT04846569|454381667|FG000|Overall Study|Withdrawal by Subject|3|||
126298962|NCT04846569|454381668|FG001|Overall Study|Withdrawal by Subject|1|||
126043496|NCT04102111|453457317|FG001|Overall Study|Withdrawal by Subject|3|||
126298963|NCT00536939|454381669|FG000|Overall Study|Withdrawal by Subject|1|||
126298964|NCT00536939|454381670|FG001|Overall Study|Withdrawal by Subject|0|||
126298965|NCT00536939|454381669|FG000|Overall Study|Other Complicating Disease|1|||
126298966|NCT00536939|454381670|FG001|Overall Study|Other Complicating Disease|0|||
126298967|NCT01100086|454381673|FG000|Period 1|Withdrawal by Subject|1|||
126298968|NCT01100086|454381674|FG001|Period 1|Withdrawal by Subject|0|||
126298969|NCT02954601|454381675|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
126298970|NCT02954601|454381676|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
126298971|NCT02954601|454381677|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
126298972|NCT02954601|454381678|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
126298973|NCT02075203|454381679|FG000|Overall Study|Withdrawal by Subject|1|||
126298974|NCT02075203|454381680|FG001|Overall Study|Withdrawal by Subject|0|||
126298975|NCT02075203|454381681|FG002|Overall Study|Withdrawal by Subject|1|||
126298976|NCT02075203|454381679|FG000|Overall Study|Adverse Event|1|||
126298977|NCT02075203|454381680|FG001|Overall Study|Adverse Event|0|||
126298978|NCT02075203|454381681|FG002|Overall Study|Adverse Event|0|||
126298979|NCT02075203|454381679|FG000|Overall Study|participant refused to use contraception|1|||
126298980|NCT02075203|454381680|FG001|Overall Study|participant refused to use contraception|0|||
126298981|NCT02075203|454381681|FG002|Overall Study|participant refused to use contraception|0|||
126298982|NCT05344560|454381682|FG000|Period 1|Subject out of visit window|1|||
126298983|NCT05344560|454381683|FG001|Period 1|Subject out of visit window|1|||
126298984|NCT05344560|454381682|FG000|Period 2|Covid-19 Related|1|||
126298985|NCT05344560|454381683|FG001|Period 2|Covid-19 Related|0|||
126298986|NCT05344560|454381682|FG000|Period 2|Adverse Event|1|||
126298987|NCT05344560|454381683|FG001|Period 2|Adverse Event|0|||
126298988|NCT05344560|454381682|FG000|Period 2|Subject out of visit window|1|||
126298989|NCT05344560|454381683|FG001|Period 2|Subject out of visit window|1|||
126298990|NCT05344560|454381682|FG000|Period 3|Subject out of visit window|1|||
126298991|NCT05344560|454381683|FG001|Period 3|Subject out of visit window|0|||
126298992|NCT00360282|454381684|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
126298993|NCT00360282|454381685|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
126298994|NCT00360282|454381686|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
126298995|NCT00360282|454381687|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
126298996|NCT00360282|454381684|FG000|Second Intervention|Adverse Event|0|||
126298997|NCT00360282|454381685|FG001|Second Intervention|Adverse Event|1|||
126298998|NCT00360282|454381686|FG002|Second Intervention|Adverse Event|0|||
126298999|NCT00360282|454381687|FG003|Second Intervention|Adverse Event|0|||
126299000|NCT00558467|454381693|FG000|Overall Study|Adverse Event|1|||
126299001|NCT00558467|454381694|FG001|Overall Study|Adverse Event|2|||
126299002|NCT00558467|454381693|FG000|Overall Study|Lack of Efficacy|0|||
126299003|NCT00558467|454381694|FG001|Overall Study|Lack of Efficacy|1|||
126299004|NCT00558467|454381693|FG000|Overall Study|Patient moving out of state|0|||
126299005|NCT00558467|454381694|FG001|Overall Study|Patient moving out of state|1|||
126299006|NCT02025725|454381697|FG000|Overall Study|Adverse Event|5|||
126299007|NCT02025725|454381698|FG001|Overall Study|Adverse Event|0|||
126299008|NCT02025725|454381697|FG000|Overall Study|Lost to Follow-up|2|||
126299009|NCT02025725|454381698|FG001|Overall Study|Lost to Follow-up|0|||
126299010|NCT02025725|454381697|FG000|Overall Study|Protocol Violation|1|||
126299011|NCT02025725|454381698|FG001|Overall Study|Protocol Violation|1|||
126299012|NCT02025725|454381697|FG000|Overall Study|Withdrawal by Subject|3|||
126299013|NCT02025725|454381698|FG001|Overall Study|Withdrawal by Subject|2|||
126299014|NCT02025725|454381697|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
126299015|NCT02025725|454381698|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
126299016|NCT02867592|454381699|FG000|Overall Study|Adverse Event|3|||
126299017|NCT02867592|454381700|FG001|Overall Study|Adverse Event|0|||
126043497|NCT04102111|453457316|FG000|Overall Study|Adverse Event|1|||
126043498|NCT04102111|453457317|FG001|Overall Study|Adverse Event|1|||
126299018|NCT02867592|454381701|FG002|Overall Study|Adverse Event|2|||
126299019|NCT02867592|454381702|FG003|Overall Study|Adverse Event|1|||
126299020|NCT02867592|454381703|FG004|Overall Study|Adverse Event|1|||
126299021|NCT02867592|454381704|FG005|Overall Study|Adverse Event|5|||
126043499|NCT04102111|453457316|FG000|Overall Study|Study terminated by sponsor|1|||
126299022|NCT02867592|454381699|FG000|Overall Study|Death|0|||
126299023|NCT02867592|454381700|FG001|Overall Study|Death|0|||
126299024|NCT02867592|454381701|FG002|Overall Study|Death|0|||
126299025|NCT02867592|454381702|FG003|Overall Study|Death|1|||
126299026|NCT02867592|454381703|FG004|Overall Study|Death|0|||
126299027|NCT02867592|454381704|FG005|Overall Study|Death|1|||
126299028|NCT02867592|454381699|FG000|Overall Study|Lack of Efficacy|8|||
126299029|NCT02867592|454381700|FG001|Overall Study|Lack of Efficacy|10|||
126299030|NCT02867592|454381701|FG002|Overall Study|Lack of Efficacy|8|||
126299031|NCT02867592|454381702|FG003|Overall Study|Lack of Efficacy|8|||
126299032|NCT02867592|454381703|FG004|Overall Study|Lack of Efficacy|12|||
126299033|NCT02867592|454381704|FG005|Overall Study|Lack of Efficacy|17|||
126299034|NCT02867592|454381699|FG000|Overall Study|Physician Decision|1|||
126299035|NCT02867592|454381700|FG001|Overall Study|Physician Decision|2|||
126299036|NCT02867592|454381701|FG002|Overall Study|Physician Decision|2|||
126102800|NCT02527343|453670202|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126102801|NCT02527343|453670203|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126102802|NCT02527343|453670204|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126102803|NCT02527343|453670205|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
126102804|NCT02527343|453670206|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126102805|NCT02527343|453670201|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
126102806|NCT02527343|453670202|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
126102807|NCT02527343|453670203|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
126102808|NCT02527343|453670204|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
126102809|NCT02527343|453670205|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
126102810|NCT02527343|453670206|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
126102811|NCT02527343|453670201|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
126102812|NCT02527343|453670202|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
126102813|NCT02527343|453670203|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
126102814|NCT02527343|453670204|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
126102815|NCT02527343|453670205|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
126102816|NCT02527343|453670206|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
126102817|NCT02527343|453670201|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
126102818|NCT02527343|453670202|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
126102819|NCT02527343|453670203|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
126102820|NCT02527343|453670204|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
126102821|NCT02527343|453670205|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
126102822|NCT02527343|453670206|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
126102823|NCT02527343|453670201|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
126102824|NCT02527343|453670202|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
126102825|NCT02527343|453670203|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
126102826|NCT02527343|453670204|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
126102827|NCT02527343|453670205|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
126102828|NCT02527343|453670206|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
126102829|NCT02527343|453670201|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126102830|NCT02527343|453670202|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126102831|NCT02527343|453670203|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126102832|NCT02527343|453670204|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126102833|NCT02527343|453670205|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
126102834|NCT02527343|453670206|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126102835|NCT02527343|453670201|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
126102836|NCT02527343|453670202|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
126102837|NCT02527343|453670203|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
126102838|NCT02527343|453670204|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
126102839|NCT02527343|453670205|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
126102840|NCT02527343|453670206|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
126102841|NCT00701220|453670207|FG000|Overall Study|Withdrawal by Subject|0|||
126102842|NCT00701220|453670208|FG001|Overall Study|Withdrawal by Subject|2|||
126299037|NCT02867592|454381702|FG003|Overall Study|Physician Decision|0|||
126299038|NCT02867592|454381703|FG004|Overall Study|Physician Decision|5|||
126299039|NCT02867592|454381704|FG005|Overall Study|Physician Decision|1|||
126299040|NCT02867592|454381699|FG000|Overall Study|Protocol Violation|0|||
126299041|NCT02867592|454381700|FG001|Overall Study|Protocol Violation|0|||
126299042|NCT02867592|454381701|FG002|Overall Study|Protocol Violation|0|||
126299043|NCT02867592|454381702|FG003|Overall Study|Protocol Violation|0|||
126299044|NCT02867592|454381703|FG004|Overall Study|Protocol Violation|1|||
126299045|NCT02867592|454381704|FG005|Overall Study|Protocol Violation|1|||
126299046|NCT02867592|454381699|FG000|Overall Study|Withdrawal by Subject|0|||
126299047|NCT02867592|454381700|FG001|Overall Study|Withdrawal by Subject|1|||
126299048|NCT02867592|454381701|FG002|Overall Study|Withdrawal by Subject|0|||
126299049|NCT02867592|454381702|FG003|Overall Study|Withdrawal by Subject|1|||
125883584|NCT01746901|452871517|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126102843|NCT00701220|453670207|FG000|Overall Study|Protocol Violation|2|||
126102844|NCT00701220|453670208|FG001|Overall Study|Protocol Violation|0|||
126102845|NCT00440999|453670211|FG000|Overall Study|Adverse Event|0|||
126299050|NCT02867592|454381703|FG004|Overall Study|Withdrawal by Subject|3|||
126299051|NCT02867592|454381704|FG005|Overall Study|Withdrawal by Subject|3|||
126299052|NCT02867592|454381699|FG000|Overall Study|Ineligible|1|||
126299053|NCT02867592|454381700|FG001|Overall Study|Ineligible|1|||
126299054|NCT02867592|454381701|FG002|Overall Study|Ineligible|0|||
126299055|NCT02867592|454381702|FG003|Overall Study|Ineligible|0|||
126299056|NCT02867592|454381703|FG004|Overall Study|Ineligible|2|||
126299057|NCT02867592|454381704|FG005|Overall Study|Ineligible|0|||
126299058|NCT02867592|454381699|FG000|Overall Study|No Treatment|1|||
126299059|NCT02867592|454381700|FG001|Overall Study|No Treatment|0|||
126299060|NCT02867592|454381701|FG002|Overall Study|No Treatment|0|||
126043500|NCT04102111|453457317|FG001|Overall Study|Study terminated by sponsor|3|||
126043501|NCT02641730|453457318|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
126043502|NCT02641730|453457319|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126043503|NCT02641730|453457320|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126043504|NCT02641730|453457321|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
126043505|NCT02641730|453457322|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
126043506|NCT02641730|453457318|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126043507|NCT02641730|453457319|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
126043508|NCT02641730|453457320|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
126043509|NCT02641730|453457321|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
126043510|NCT02641730|453457322|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
126043511|NCT02641730|453457318|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
126043512|NCT02641730|453457319|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
126043513|NCT02641730|453457320|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
126043514|NCT02641730|453457321|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
126043515|NCT02641730|453457322|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
126043516|NCT02641730|453457318|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126043517|NCT02641730|453457319|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126043518|NCT02641730|453457320|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126043519|NCT02641730|453457321|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
126043520|NCT02641730|453457322|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
126043521|NCT02641730|453457318|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
126043522|NCT02641730|453457319|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
126043523|NCT02641730|453457320|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
126043524|NCT02641730|453457321|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
126043525|NCT02641730|453457322|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
126043526|NCT02641730|453457318|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
126043527|NCT02641730|453457319|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
126043528|NCT02641730|453457320|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
126043529|NCT02641730|453457321|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
126043530|NCT02641730|453457322|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
126043531|NCT00319046|453457323|FG000|Overall Study|withdrawal of subject's consent|7|||
126043532|NCT00319046|453457323|FG000|Overall Study|administrative reason|1|||
126043533|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
126043534|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
126043535|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
126043536|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
126043537|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
126043538|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
126043539|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
126043540|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
126043541|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
126043542|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
126102846|NCT00440999|453670212|FG001|Overall Study|Adverse Event|2|||
126299061|NCT02867592|454381702|FG003|Overall Study|No Treatment|0|||
126299062|NCT02867592|454381703|FG004|Overall Study|No Treatment|0|||
126299063|NCT02867592|454381704|FG005|Overall Study|No Treatment|0|||
126299064|NCT02867592|454381699|FG000|Overall Study|Still on Therapy|0|||
126043543|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
126043544|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
126299065|NCT02867592|454381700|FG001|Overall Study|Still on Therapy|0|||
126299066|NCT02867592|454381701|FG002|Overall Study|Still on Therapy|0|||
126299067|NCT02867592|454381702|FG003|Overall Study|Still on Therapy|0|||
126299068|NCT02867592|454381703|FG004|Overall Study|Still on Therapy|1|||
126299069|NCT02867592|454381704|FG005|Overall Study|Still on Therapy|0|||
126299070|NCT02867592|454381699|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299071|NCT02867592|454381700|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299072|NCT02867592|454381701|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299073|NCT02867592|454381702|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299074|NCT02867592|454381703|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299075|NCT02867592|454381704|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
126299076|NCT02867592|454381699|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
126299077|NCT02867592|454381700|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
126299078|NCT02867592|454381701|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
126299079|NCT02867592|454381702|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
126299080|NCT02867592|454381703|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
126299081|NCT02867592|454381704|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
126299082|NCT00571727|454381714|FG000|Overall Study|Did not enter in this study|1|||
126299083|NCT00571727|454381714|FG000|Overall Study|Non-compliance|4|||
126299084|NCT00571727|454381714|FG000|Overall Study|Lost to Follow-up|30|||
126299085|NCT00571727|454381714|FG000|Overall Study|Poor growth|1|||
126299086|NCT00571727|454381714|FG000|Overall Study|Parent/patient decision|2|||
126299087|NCT00571727|454381714|FG000|Overall Study|Participant transferred to commercial drug|14|||
126299088|NCT00571727|454381714|FG000|Overall Study|Unable to provide study drug|6|||
126299089|NCT00571727|454381714|FG000|Overall Study|On-treatment at end of study|8|||
126299090|NCT03581292|454381715|FG000|Overall Study|Physician Decision|9|||
126299091|NCT03581292|454381716|FG001|Overall Study|Physician Decision|5|||
126299092|NCT03581292|454381715|FG000|Overall Study|Withdrawal by Subject|3|||
126299093|NCT03581292|454381716|FG001|Overall Study|Withdrawal by Subject|0|||
126299094|NCT03581292|454381715|FG000|Overall Study|Withdrawal before Therapy Start|1|||
126299095|NCT03581292|454381716|FG001|Overall Study|Withdrawal before Therapy Start|0|||
126299096|NCT01735916|454383365|FG000|Overall Study|Subject not eligible to be randomized|11|||
126299097|NCT01735916|454383366|FG001|Overall Study|Subject not eligible to be randomized|0|||
126299098|NCT01735916|454383367|FG002|Overall Study|Subject not eligible to be randomized|0|||
126299099|NCT01735916|454383365|FG000|Overall Study|Early termination of study by sponsor|4|||
126299100|NCT01735916|454383366|FG001|Overall Study|Early termination of study by sponsor|19|||
126299101|NCT01735916|454383367|FG002|Overall Study|Early termination of study by sponsor|7|||
126299102|NCT01735916|454383365|FG000|Overall Study|Withdrawal by Subject|3|||
126299103|NCT01735916|454383366|FG001|Overall Study|Withdrawal by Subject|0|||
126299104|NCT01735916|454383367|FG002|Overall Study|Withdrawal by Subject|0|||
126299105|NCT04227197|454383371|FG000|Randomization|Protocol Violation|1|||
126299106|NCT04227197|454383372|FG001|Randomization|Protocol Violation|0|||
126299107|NCT04227197|454383371|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
126299108|NCT04227197|454383372|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
126299109|NCT04227197|454383371|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
126299110|NCT04227197|454383372|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
126299111|NCT04227197|454383371|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
126299112|NCT04227197|454383372|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
126299113|NCT04227197|454383371|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
126299114|NCT04227197|454383372|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
126299115|NCT04227197|454383371|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
126299116|NCT04227197|454383372|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
126299117|NCT04227197|454383371|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
126299118|NCT04227197|454383372|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
126299119|NCT00333983|454383373|FG000|Overall Study|Lost to Follow-up|2|||
126299120|NCT00333983|454383374|FG001|Overall Study|Lost to Follow-up|1|||
126299121|NCT00333983|454383375|FG002|Overall Study|Lost to Follow-up|0|||
126299122|NCT00333983|454383373|FG000|Overall Study|Adverse Event|1|||
126299123|NCT00333983|454383374|FG001|Overall Study|Adverse Event|1|||
126299124|NCT00333983|454383375|FG002|Overall Study|Adverse Event|1|||
126299125|NCT00333983|454383373|FG000|Overall Study|Withdrawal by Subject|0|||
126299126|NCT00333983|454383374|FG001|Overall Study|Withdrawal by Subject|3|||
126299127|NCT00333983|454383375|FG002|Overall Study|Withdrawal by Subject|1|||
126299128|NCT00833105|454383376|FG000|Overall Study|Withdrawal by Subject|1|||
126299129|NCT00833105|454383376|FG000|Overall Study|Adverse Event|2|||
126299130|NCT00570141|454383381|FG000|Overall Study|Adverse Event|1|||
126299131|NCT00570141|454383381|FG000|Overall Study|Missed visits|1|||
126299132|NCT00570141|454383381|FG000|Overall Study|Lost to Follow-up|1|||
126299133|NCT01209949|454383393|FG000|Overall Study|Lost to Follow-up|3|||
126299134|NCT00729612|454383398|FG000|Overall Study|Non evaluable for response|10|||
126299135|NCT03214224|454383407|FG000|Overall Study|Protocol Violation|1|||
126299136|NCT03214224|454383407|FG000|Overall Study|Withdrawal by Subject|2|||
126299137|NCT03214224|454383407|FG000|Overall Study|Practice controls or therapists|6|||
126299138|NCT02712320|454383408|FG000|Overall Study|Lost to Follow-up|1|||
126299139|NCT02712320|454383408|FG000|Overall Study|Withdrawal by Subject|1|||
126299140|NCT02712320|454383408|FG000|Overall Study|Transferred to another facility|1|||
126299141|NCT02712320|454383408|FG000|Overall Study|Treating with the prohibited medications|2|||
126299142|NCT00568451|454383409|FG000|Overall Study|Disease Progression|0|||
126299143|NCT00568451|454383410|FG001|Overall Study|Disease Progression|0|||
126299144|NCT00568451|454383411|FG002|Overall Study|Disease Progression|2|||
126299145|NCT00568451|454383412|FG003|Overall Study|Disease Progression|7|||
126299146|NCT05266053|454383415|FG000|Overall Study|Withdrawal by Subject|8|||
126299147|NCT05266053|454383416|FG001|Overall Study|Withdrawal by Subject|4|||
126299148|NCT01343043|454383419|FG000|Overall Study|Disease progression before treatment|1|||
126299149|NCT01343043|454383420|FG001|Overall Study|Disease progression before treatment|0|||
126299150|NCT01343043|454383421|FG002|Overall Study|Disease progression before treatment|0|||
126299151|NCT01343043|454383422|FG003|Overall Study|Disease progression before treatment|0|||
126299152|NCT01343043|454383419|FG000|Overall Study|Withdrawal by Subject|1|||
126299153|NCT01343043|454383420|FG001|Overall Study|Withdrawal by Subject|0|||
126299154|NCT01343043|454383421|FG002|Overall Study|Withdrawal by Subject|0|||
126299155|NCT01343043|454383422|FG003|Overall Study|Withdrawal by Subject|0|||
126299156|NCT01343043|454383419|FG000|Overall Study|Death|1|||
126299157|NCT01343043|454383420|FG001|Overall Study|Death|1|||
126299158|NCT01343043|454383421|FG002|Overall Study|Death|0|||
126299159|NCT01343043|454383422|FG003|Overall Study|Death|1|||
126299160|NCT00925704|454383423|FG000|First Intervention|Withdrew consent|0|||
126299161|NCT00925704|454383424|FG001|First Intervention|Withdrew consent|0|||
126299162|NCT00925704|454383425|FG002|First Intervention|Withdrew consent|0|||
126299163|NCT00925704|454383426|FG003|First Intervention|Withdrew consent|1|||
126299164|NCT00925704|454383427|FG004|First Intervention|Withdrew consent|1|||
126299165|NCT00925704|454383428|FG005|First Intervention|Withdrew consent|0|||
126299166|NCT00925704|454383423|FG000|Second Intervention|Withdrawal by Subject|1|||
126299167|NCT00925704|454383424|FG001|Second Intervention|Withdrawal by Subject|0|||
126299168|NCT00925704|454383425|FG002|Second Intervention|Withdrawal by Subject|0|||
126299169|NCT00925704|454383426|FG003|Second Intervention|Withdrawal by Subject|0|||
126299170|NCT00925704|454383427|FG004|Second Intervention|Withdrawal by Subject|1|||
126299171|NCT00925704|454383428|FG005|Second Intervention|Withdrawal by Subject|0|||
126299172|NCT00925704|454383423|FG000|Third Intervention|Withdrew consent|0|||
126299173|NCT00925704|454383424|FG001|Third Intervention|Withdrew consent|0|||
126299174|NCT00925704|454383425|FG002|Third Intervention|Withdrew consent|0|||
126299175|NCT00925704|454383426|FG003|Third Intervention|Withdrew consent|0|||
126299176|NCT00925704|454383427|FG004|Third Intervention|Withdrew consent|0|||
126299177|NCT00925704|454383428|FG005|Third Intervention|Withdrew consent|1|||
126299178|NCT02996968|454383429|FG000|Overall Study|Withdrawal by Subject|1|||
126299179|NCT02996968|454383430|FG001|Overall Study|Withdrawal by Subject|0|||
126299180|NCT02044302|454383434|FG000|Overall Study|study terminated|2|||
126299181|NCT02044302|454383435|FG001|Overall Study|study terminated|0|||
126299182|NCT03207815|454383438|FG000|Overall Study|Protocol Violation|3|||
126299183|NCT03207815|454383439|FG001|Overall Study|Protocol Violation|1|||
126299184|NCT03207815|454383438|FG000|Overall Study|Adverse Event|1|||
126299185|NCT03207815|454383439|FG001|Overall Study|Adverse Event|2|||
126299186|NCT03207815|454383438|FG000|Overall Study|Lost to Follow-up|1|||
126299187|NCT03207815|454383439|FG001|Overall Study|Lost to Follow-up|2|||
126299188|NCT03207815|454383438|FG000|Overall Study|Investigator's Discretion|1|||
126299189|NCT03207815|454383439|FG001|Overall Study|Investigator's Discretion|1|||
126299190|NCT03207815|454383438|FG000|Overall Study|Lack of Efficacy|0|||
126299191|NCT03207815|454383439|FG001|Overall Study|Lack of Efficacy|1|||
126102847|NCT00440999|453670211|FG000|Overall Study|Lack of Efficacy|6|||
126299192|NCT03207815|454383438|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
126299193|NCT03207815|454383439|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
126299194|NCT03207815|454383438|FG000|Overall Study|Withdrew Consent|1|||
126299195|NCT03207815|454383439|FG001|Overall Study|Withdrew Consent|0|||
126299196|NCT01671007|454383440|FG000|Overall Study|Other reasons than listed|166|||
126102848|NCT00440999|453670212|FG001|Overall Study|Lack of Efficacy|7|||
126299197|NCT01671007|454383441|FG001|Overall Study|Other reasons than listed|373|||
126299198|NCT01671007|454383442|FG002|Overall Study|Other reasons than listed|197|||
126299199|NCT01671007|454383443|FG003|Overall Study|Other reasons than listed|228|||
126299200|NCT01671007|454383444|FG004|Overall Study|Other reasons than listed|14|||
126299201|NCT01671007|454383445|FG005|Overall Study|Other reasons than listed|71|||
126299202|NCT01671007|454383446|FG006|Overall Study|Other reasons than listed|17|||
126299203|NCT01671007|454383447|FG007|Overall Study|Other reasons than listed|66|||
126299204|NCT01671007|454383448|FG008|Overall Study|Other reasons than listed|0|||
126102849|NCT00440999|453670211|FG000|Overall Study|Lost to Follow-up|19|||
126102850|NCT00440999|453670212|FG001|Overall Study|Lost to Follow-up|12|||
126102851|NCT00440999|453670211|FG000|Overall Study|Protocol Violation|1|||
126102852|NCT00440999|453670212|FG001|Overall Study|Protocol Violation|0|||
126102853|NCT00440999|453670211|FG000|Overall Study|Withdrawal by Subject|2|||
126102854|NCT00440999|453670212|FG001|Overall Study|Withdrawal by Subject|5|||
126299205|NCT01671007|454383440|FG000|Overall Study|Withdrawal by Subject|36|||
126299206|NCT01671007|454383441|FG001|Overall Study|Withdrawal by Subject|59|||
126299207|NCT01671007|454383442|FG002|Overall Study|Withdrawal by Subject|53|||
126299208|NCT01671007|454383443|FG003|Overall Study|Withdrawal by Subject|58|||
126299209|NCT01671007|454383444|FG004|Overall Study|Withdrawal by Subject|4|||
126299210|NCT01671007|454383445|FG005|Overall Study|Withdrawal by Subject|15|||
126299211|NCT01671007|454383446|FG006|Overall Study|Withdrawal by Subject|1|||
126299212|NCT01671007|454383447|FG007|Overall Study|Withdrawal by Subject|19|||
126299213|NCT01671007|454383448|FG008|Overall Study|Withdrawal by Subject|0|||
126299214|NCT01671007|454383440|FG000|Overall Study|Lost to Follow-up|93|||
126299215|NCT01671007|454383441|FG001|Overall Study|Lost to Follow-up|142|||
126299216|NCT01671007|454383442|FG002|Overall Study|Lost to Follow-up|91|||
126299217|NCT01671007|454383443|FG003|Overall Study|Lost to Follow-up|63|||
126299218|NCT01671007|454383444|FG004|Overall Study|Lost to Follow-up|7|||
126299219|NCT01671007|454383445|FG005|Overall Study|Lost to Follow-up|20|||
126299220|NCT01671007|454383446|FG006|Overall Study|Lost to Follow-up|2|||
126299221|NCT01671007|454383447|FG007|Overall Study|Lost to Follow-up|28|||
126299222|NCT01671007|454383448|FG008|Overall Study|Lost to Follow-up|0|||
126299223|NCT01671007|454383440|FG000|Overall Study|No end of study case report form|3|||
126299224|NCT01671007|454383441|FG001|Overall Study|No end of study case report form|1|||
126299225|NCT01671007|454383442|FG002|Overall Study|No end of study case report form|0|||
126299226|NCT01671007|454383443|FG003|Overall Study|No end of study case report form|2|||
126299227|NCT01671007|454383444|FG004|Overall Study|No end of study case report form|0|||
126299228|NCT01671007|454383445|FG005|Overall Study|No end of study case report form|0|||
126299229|NCT01671007|454383446|FG006|Overall Study|No end of study case report form|0|||
126299230|NCT01671007|454383447|FG007|Overall Study|No end of study case report form|0|||
126299231|NCT01671007|454383448|FG008|Overall Study|No end of study case report form|0|||
126299232|NCT01671007|454383440|FG000|Overall Study|Not eligible|23|||
126299233|NCT01671007|454383441|FG001|Overall Study|Not eligible|76|||
126299234|NCT01671007|454383442|FG002|Overall Study|Not eligible|25|||
126299235|NCT01671007|454383443|FG003|Overall Study|Not eligible|17|||
126299236|NCT01671007|454383444|FG004|Overall Study|Not eligible|0|||
126299237|NCT01671007|454383445|FG005|Overall Study|Not eligible|6|||
126299238|NCT01671007|454383446|FG006|Overall Study|Not eligible|1|||
126367275|NCT04191135|454639466|FG001|Induction Treatment|Withdrawal by Subject|0|||
126367276|NCT04191135|454639467|FG002|Induction Treatment|Withdrawal by Subject|0|||
126367277|NCT04191135|454639465|FG000|Randomized Treatment|Death|0|||
126367278|NCT04191135|454639466|FG001|Randomized Treatment|Death|50|||
126367279|NCT04191135|454639467|FG002|Randomized Treatment|Death|54|||
126367280|NCT04191135|454639465|FG000|Randomized Treatment|Lost to Follow-up|0|||
126367281|NCT04191135|454639466|FG001|Randomized Treatment|Lost to Follow-up|0|||
126367282|NCT04191135|454639467|FG002|Randomized Treatment|Lost to Follow-up|1|||
126367283|NCT04191135|454639465|FG000|Randomized Treatment|Withdrawal by Subject|0|||
126367284|NCT04191135|454639466|FG001|Randomized Treatment|Withdrawal by Subject|2|||
126367285|NCT04191135|454639467|FG002|Randomized Treatment|Withdrawal by Subject|0|||
126367286|NCT04191135|454639465|FG000|Randomized Treatment|Ongoing in Trial|0|||
126367287|NCT04191135|454639466|FG001|Randomized Treatment|Ongoing in Trial|83|||
126367288|NCT04191135|454639467|FG002|Randomized Treatment|Ongoing in Trial|81|||
126369557|NCT01497197|454650597|FG001|Overall Study|Excessive/lack of response to treatment|0|||
126369558|NCT01497197|454650596|FG000|Overall Study|Risk of OHSS|1|||
126369559|NCT01497197|454650597|FG001|Overall Study|Risk of OHSS|0|||
126369560|NCT01497197|454650596|FG000|Overall Study|No oocytes retrieved|3|||
126369561|NCT01497197|454650597|FG001|Overall Study|No oocytes retrieved|2|||
126369562|NCT01497197|454650596|FG000|Overall Study|No fertilisation|6|||
126369563|NCT01497197|454650597|FG001|Overall Study|No fertilisation|5|||
126369564|NCT01497197|454650596|FG000|Overall Study|Intention to freeze all embryos|0|||
126369565|NCT01497197|454650597|FG001|Overall Study|Intention to freeze all embryos|1|||
126369566|NCT01497197|454650596|FG000|Overall Study|All embryos discarded|0|||
126369567|NCT01497197|454650597|FG001|Overall Study|All embryos discarded|3|||
126369568|NCT01497197|454650596|FG000|Overall Study|Other|3|||
126369569|NCT01497197|454650597|FG001|Overall Study|Other|1|||
126369570|NCT00565747|454650603|FG000|Overall Study|No embryo transfer|67|||
126369571|NCT00565747|454650604|FG001|Overall Study|No embryo transfer|73|||
126299239|NCT01671007|454383447|FG007|Overall Study|Not eligible|19|||
126299240|NCT01671007|454383448|FG008|Overall Study|Not eligible|0|||
126299241|NCT00391768|454383449|FG000|Overall Study|Withdrawal by Subject|0|||
126299242|NCT00391768|454383450|FG001|Overall Study|Withdrawal by Subject|0|||
126299243|NCT00391768|454383451|FG002|Overall Study|Withdrawal by Subject|1|||
126299244|NCT00391768|454383452|FG003|Overall Study|Withdrawal by Subject|0|||
126299245|NCT00391768|454383453|FG004|Overall Study|Withdrawal by Subject|0|||
126299246|NCT00391768|454383454|FG005|Overall Study|Withdrawal by Subject|1|||
126299247|NCT00391768|454383455|FG006|Overall Study|Withdrawal by Subject|1|||
126299248|NCT00391768|454383449|FG000|Overall Study|Lost to Follow-up|0|||
126299249|NCT00391768|454383450|FG001|Overall Study|Lost to Follow-up|0|||
126299250|NCT00391768|454383451|FG002|Overall Study|Lost to Follow-up|0|||
126299251|NCT00391768|454383452|FG003|Overall Study|Lost to Follow-up|1|||
126299252|NCT00391768|454383453|FG004|Overall Study|Lost to Follow-up|2|||
126299253|NCT00391768|454383454|FG005|Overall Study|Lost to Follow-up|2|||
126299254|NCT00391768|454383455|FG006|Overall Study|Lost to Follow-up|3|||
126299255|NCT00449865|454383456|FG000|Overall Study|Withdrawal by Subject|110|||
126299256|NCT00449865|454383457|FG001|Overall Study|Withdrawal by Subject|110|||
126299257|NCT00449865|454383456|FG000|Overall Study|Lost to Follow-up|36|||
126299258|NCT00449865|454383457|FG001|Overall Study|Lost to Follow-up|37|||
126299259|NCT00449865|454383456|FG000|Overall Study|Physician Decision|13|||
126299260|NCT00449865|454383457|FG001|Overall Study|Physician Decision|12|||
126299261|NCT00449865|454383456|FG000|Overall Study|Death|31|||
126299262|NCT00449865|454383457|FG001|Overall Study|Death|40|||
126299263|NCT00449865|454383456|FG000|Overall Study|Protocol Violation|8|||
126299264|NCT00449865|454383457|FG001|Overall Study|Protocol Violation|7|||
126299265|NCT00449865|454383456|FG000|Overall Study|Study was stopped|324|||
126299266|NCT00449865|454383457|FG001|Overall Study|Study was stopped|328|||
126299267|NCT00444535|454383458|FG000|Overall Study|Withdrawal by Subject|5|||
126299268|NCT00444535|454383458|FG000|Overall Study|Physician Decision|5|||
126299269|NCT00444535|454383458|FG000|Overall Study|progressive disease|1|||
126299270|NCT00444535|454383458|FG000|Overall Study|Adverse Event|2|||
126299271|NCT00406367|454383459|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
126299272|NCT00406367|454383460|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
126299273|NCT00406367|454383459|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
126299274|NCT00406367|454383460|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
126299275|NCT00406367|454383459|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
126299276|NCT00406367|454383460|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
126299277|NCT00406367|454383459|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
126299278|NCT00406367|454383460|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
126299279|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
126299280|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
126299281|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
126299282|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
126299283|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
126299284|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
126299285|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
126299286|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
126299287|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
126299288|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
126299289|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
126299290|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
126299291|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
126299292|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
126043545|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
126043546|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
126043547|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
126043548|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
126043549|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
126043550|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
126299293|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
126299294|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
126299295|NCT00171210|454383461|FG000|Overall Study|Adverse Event|16|||
126367289|NCT03514134|454640892|FG000|Overall Study|Lost to Follow-up|0|||
126367290|NCT03514134|454640893|FG001|Overall Study|Lost to Follow-up|1|||
126367291|NCT02471144|454640894|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
126367292|NCT02471144|454640895|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
126367293|NCT02471144|454640896|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
126367294|NCT02471144|454640897|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
126367295|NCT02471144|454640898|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
126367296|NCT02471144|454640899|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
126367297|NCT02471144|454640900|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
126367298|NCT02471144|454640901|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
126367299|NCT02471144|454640902|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
126367300|NCT02471144|454640903|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
126367301|NCT02471144|454640904|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
126367302|NCT02471144|454640894|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367303|NCT02471144|454640895|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367304|NCT02471144|454640896|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367305|NCT02471144|454640897|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
126367306|NCT02471144|454640898|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367307|NCT02471144|454640899|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367308|NCT02471144|454640900|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367309|NCT02471144|454640901|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367310|NCT02471144|454640902|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367311|NCT02471144|454640903|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367312|NCT02471144|454640904|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367313|NCT02471144|454640894|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367314|NCT02471144|454640895|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367315|NCT02471144|454640896|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
126367316|NCT02471144|454640897|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367317|NCT02471144|454640898|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367318|NCT02471144|454640899|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367319|NCT02471144|454640900|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367320|NCT02471144|454640901|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367321|NCT02471144|454640902|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367322|NCT02471144|454640903|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367323|NCT02471144|454640904|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367324|NCT02471144|454640894|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
126367325|NCT02471144|454640895|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
126367326|NCT02471144|454640896|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367327|NCT02471144|454640897|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367328|NCT02471144|454640898|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367329|NCT02471144|454640899|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367330|NCT02471144|454640900|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367331|NCT02471144|454640901|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367332|NCT02471144|454640902|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367333|NCT02471144|454640903|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367334|NCT02471144|454640904|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367335|NCT02471144|454640894|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367336|NCT02471144|454640895|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367337|NCT02471144|454640896|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367338|NCT02471144|454640897|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367339|NCT02471144|454640898|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
126367340|NCT02471144|454640899|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367341|NCT02471144|454640900|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
126367342|NCT02471144|454640901|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367343|NCT02471144|454640902|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
126367344|NCT02471144|454640903|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367345|NCT02471144|454640904|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367346|NCT02471144|454640894|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367347|NCT02471144|454640895|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367348|NCT02471144|454640896|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367349|NCT02471144|454640897|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367350|NCT02471144|454640898|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367351|NCT02471144|454640899|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
126367352|NCT02471144|454640900|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367353|NCT02471144|454640901|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367354|NCT02471144|454640902|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
126369572|NCT00183248|454650605|FG000|Overall Study|Lost to Follow-up|0|||
126367355|NCT02471144|454640903|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367356|NCT02471144|454640904|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367357|NCT02471144|454640894|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367358|NCT02471144|454640895|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126043551|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
126043552|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
126043553|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
126043554|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
126043555|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
126043556|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
126043557|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
126043558|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
126043559|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
126043560|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
126043561|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
126043562|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
126043563|NCT04614948|453457324|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
126043564|NCT04614948|453457325|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
126043565|NCT04614948|453457326|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
126043566|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
126043567|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
126043568|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
126043569|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
126043570|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
126043571|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
126043572|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
126043573|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
126043574|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
126043575|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
126043576|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
126043577|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
126043578|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
126043579|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
126043580|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
126043581|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
126043582|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
126043583|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
126043584|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
126043585|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
126043586|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
126043587|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
126043588|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
126043589|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
126043590|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
126043591|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
126043592|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
126043593|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
126043594|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
126043595|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
126299296|NCT00171210|454383462|FG001|Overall Study|Adverse Event|27|||
126299297|NCT00171210|454383461|FG000|Overall Study|Abnormal laboratory value(s)|6|||
126299298|NCT00171210|454383462|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126299299|NCT00171210|454383461|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126299300|NCT00171210|454383462|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126299301|NCT00171210|454383461|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
126299302|NCT00171210|454383462|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
126299303|NCT00171210|454383461|FG000|Overall Study|Protocol Violation|0|||
126299304|NCT00171210|454383462|FG001|Overall Study|Protocol Violation|2|||
126299305|NCT00171210|454383461|FG000|Overall Study|Withdrawal by Subject|32|||
126299306|NCT00171210|454383462|FG001|Overall Study|Withdrawal by Subject|30|||
126299307|NCT00171210|454383461|FG000|Overall Study|Lost to Follow-up|1|||
126299308|NCT00171210|454383462|FG001|Overall Study|Lost to Follow-up|0|||
126299309|NCT00171210|454383461|FG000|Overall Study|Administrative problems|1|||
126299310|NCT00171210|454383462|FG001|Overall Study|Administrative problems|1|||
126299311|NCT00171210|454383461|FG000|Overall Study|Death|2|||
126102855|NCT00440999|453670211|FG000|Overall Study|Subjets missed the visit|1|||
126102856|NCT00440999|453670212|FG001|Overall Study|Subjets missed the visit|0|||
126102857|NCT00440999|453670211|FG000|Overall Study|Mixed infection at entry|1|||
126102858|NCT00440999|453670212|FG001|Overall Study|Mixed infection at entry|0|||
126102859|NCT00440999|453670211|FG000|Overall Study|P. falciparum malaria|5|||
126102860|NCT00440999|453670212|FG001|Overall Study|P. falciparum malaria|14|||
126102861|NCT00440999|453670211|FG000|Overall Study|Subj left hosp without inform staff|0|||
126102862|NCT00440999|453670212|FG001|Overall Study|Subj left hosp without inform staff|1|||
126102863|NCT04745026|453670215|FG000|Overall Study|Physician Decision|1|||
126102864|NCT04745026|453670216|FG001|Overall Study|Physician Decision|0|||
126102865|NCT04745026|453670215|FG000|Overall Study|Adverse Event|2|||
126102866|NCT04745026|453670216|FG001|Overall Study|Adverse Event|2|||
126102867|NCT04745026|453670215|FG000|Overall Study|Protocol Violation|1|||
126102868|NCT04745026|453670216|FG001|Overall Study|Protocol Violation|3|||
126102869|NCT04745026|453670215|FG000|Overall Study|Lost to Follow-up|4|||
126102870|NCT04745026|453670216|FG001|Overall Study|Lost to Follow-up|3|||
126102871|NCT04745026|453670215|FG000|Overall Study|Withdrawal by Subject|5|||
126102872|NCT04745026|453670216|FG001|Overall Study|Withdrawal by Subject|5|||
126102873|NCT01205152|453670217|FG000|Overall Study|Death|1|||
126102874|NCT03256851|453670218|FG000|Overall Study|Withdrawal by Subject|1|||
126102875|NCT03256851|453670219|FG001|Overall Study|Withdrawal by Subject|0|||
126102876|NCT00249002|453670220|FG000|Overall Study|Adverse Event|2|||
126102877|NCT00249002|453670220|FG000|Overall Study|Study cancellation|3|||
126102878|NCT00249002|453670220|FG000|Overall Study|Other|2|||
126102879|NCT02208999|453670222|FG000|Overall Study|Lost to Follow-up|1|||
126102880|NCT00319839|453670223|FG000|Overall Study|Adverse Event|5|||
126102881|NCT00319839|453670223|FG000|Overall Study|Withdrawal by Subject|1|||
126102882|NCT01577745|453670224|FG000|Overall Study|Withdrawal by Subject|0|||
126102883|NCT01577745|453670225|FG001|Overall Study|Withdrawal by Subject|1|||
126102884|NCT01577745|453670226|FG002|Overall Study|Withdrawal by Subject|0|||
126102885|NCT01577745|453670227|FG003|Overall Study|Withdrawal by Subject|3|||
126102886|NCT01577745|453670228|FG004|Overall Study|Withdrawal by Subject|2|||
126102887|NCT01577745|453670229|FG005|Overall Study|Withdrawal by Subject|0|||
126102888|NCT01577745|453670224|FG000|Overall Study|Death|3|||
126102889|NCT01577745|453670225|FG001|Overall Study|Death|2|||
126102890|NCT01577745|453670226|FG002|Overall Study|Death|2|||
126102891|NCT01577745|453670227|FG003|Overall Study|Death|1|||
126102892|NCT01577745|453670228|FG004|Overall Study|Death|1|||
126102893|NCT01577745|453670229|FG005|Overall Study|Death|3|||
126102894|NCT01577745|453670224|FG000|Overall Study|Physician Decision|0|||
126102895|NCT01577745|453670225|FG001|Overall Study|Physician Decision|0|||
126102896|NCT01577745|453670226|FG002|Overall Study|Physician Decision|0|||
126102897|NCT01577745|453670227|FG003|Overall Study|Physician Decision|1|||
126102898|NCT01577745|453670228|FG004|Overall Study|Physician Decision|1|||
126102899|NCT01577745|453670229|FG005|Overall Study|Physician Decision|0|||
126102900|NCT01577745|453670224|FG000|Overall Study|Lost to Follow-up|0|||
126102901|NCT01577745|453670225|FG001|Overall Study|Lost to Follow-up|0|||
126102902|NCT01577745|453670226|FG002|Overall Study|Lost to Follow-up|0|||
126102903|NCT01577745|453670227|FG003|Overall Study|Lost to Follow-up|0|||
126102904|NCT01577745|453670228|FG004|Overall Study|Lost to Follow-up|0|||
126102905|NCT01577745|453670229|FG005|Overall Study|Lost to Follow-up|1|||
126102906|NCT01577745|453670224|FG000|Overall Study|Alternative Therapy|0|||
126102907|NCT01577745|453670225|FG001|Overall Study|Alternative Therapy|0|||
126102908|NCT01577745|453670226|FG002|Overall Study|Alternative Therapy|0|||
126102909|NCT01577745|453670227|FG003|Overall Study|Alternative Therapy|1|||
126299312|NCT00171210|454383462|FG001|Overall Study|Death|3|||
126299313|NCT00171210|454383461|FG000|Overall Study|Stopped at end of core|0|||
126299314|NCT00171210|454383462|FG001|Overall Study|Stopped at end of core|32|||
126299315|NCT00171210|454383461|FG000|Overall Study|Stopped at end of extension 1|0|||
126299316|NCT00171210|454383462|FG001|Overall Study|Stopped at end of extension 1|1|||
126299317|NCT03187301|454383465|FG000|Titration Period|Adverse Event|0|||
126299318|NCT03187301|454383466|FG001|Titration Period|Adverse Event|0|||
126102910|NCT01577745|453670228|FG004|Overall Study|Alternative Therapy|1|||
126102911|NCT01577745|453670229|FG005|Overall Study|Alternative Therapy|0|||
126102912|NCT02483585|453670230|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
126102913|NCT02483585|453670231|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
126102914|NCT02483585|453670230|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
126102915|NCT02483585|453670231|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
126102916|NCT02483585|453670230|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
126102917|NCT02483585|453670231|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
126102918|NCT02483585|453670230|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
126102919|NCT02483585|453670231|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
126102920|NCT02483585|453670230|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
126299319|NCT03187301|454383467|FG002|Titration Period|Adverse Event|0|||
126299320|NCT03187301|454383468|FG003|Titration Period|Adverse Event|0|||
126299321|NCT03187301|454383469|FG004|Titration Period|Adverse Event|0|||
126299322|NCT03187301|454383470|FG005|Titration Period|Adverse Event|0|||
126299323|NCT03187301|454383471|FG006|Titration Period|Adverse Event|5|||
126299324|NCT03187301|454383465|FG000|Titration Period|Withdrawal by Subject|0|||
126299325|NCT03187301|454383466|FG001|Titration Period|Withdrawal by Subject|0|||
126299326|NCT03187301|454383467|FG002|Titration Period|Withdrawal by Subject|0|||
126299327|NCT03187301|454383468|FG003|Titration Period|Withdrawal by Subject|0|||
126299328|NCT03187301|454383469|FG004|Titration Period|Withdrawal by Subject|0|||
126299329|NCT03187301|454383470|FG005|Titration Period|Withdrawal by Subject|0|||
126299330|NCT03187301|454383471|FG006|Titration Period|Withdrawal by Subject|1|||
126299331|NCT03187301|454383465|FG000|Titration Period|Exclusion Criteria Met|0|||
126299332|NCT03187301|454383466|FG001|Titration Period|Exclusion Criteria Met|0|||
126299333|NCT03187301|454383467|FG002|Titration Period|Exclusion Criteria Met|0|||
126299334|NCT03187301|454383468|FG003|Titration Period|Exclusion Criteria Met|0|||
126299335|NCT03187301|454383469|FG004|Titration Period|Exclusion Criteria Met|0|||
126299336|NCT03187301|454383470|FG005|Titration Period|Exclusion Criteria Met|0|||
126299337|NCT03187301|454383471|FG006|Titration Period|Exclusion Criteria Met|1|||
126299338|NCT03187301|454383465|FG000|Pre-Intervention|Withdrawal by Subject|1|||
126299339|NCT03187301|454383466|FG001|Pre-Intervention|Withdrawal by Subject|0|||
126299340|NCT03187301|454383467|FG002|Pre-Intervention|Withdrawal by Subject|0|||
126299341|NCT03187301|454383468|FG003|Pre-Intervention|Withdrawal by Subject|0|||
126299342|NCT03187301|454383469|FG004|Pre-Intervention|Withdrawal by Subject|0|||
126299343|NCT03187301|454383470|FG005|Pre-Intervention|Withdrawal by Subject|0|||
126299344|NCT03187301|454383471|FG006|Pre-Intervention|Withdrawal by Subject|0|||
126299345|NCT05005507|454383477|FG000|Overall Study|Premature termination of study|1|||
126299346|NCT04630002|454383482|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
126299347|NCT04630002|454383483|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
126299348|NCT04630002|454383484|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
126299349|NCT04630002|454383482|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
126299350|NCT04630002|454383483|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
126299351|NCT04630002|454383484|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
126299352|NCT04630002|454383482|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
126299353|NCT04630002|454383483|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
126299354|NCT04630002|454383484|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
126299355|NCT04630002|454383482|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
126299356|NCT04630002|454383483|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
126299357|NCT04630002|454383484|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
126299358|NCT04630002|454383482|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
126299359|NCT04630002|454383483|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
126299360|NCT04630002|454383484|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
126102921|NCT02483585|453670231|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
126102922|NCT02483585|453670230|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
126102923|NCT02483585|453670231|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
126102924|NCT02483585|453670230|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
126102925|NCT02483585|453670231|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
126102926|NCT01324440|453670236|FG000|Overall Study|Subject moved|0|||
126102927|NCT01324440|453670237|FG001|Overall Study|Subject moved|1|||
126102928|NCT00903630|453670238|FG000|Phase 2|Adverse Event|0|||
126102929|NCT00903630|453670239|FG001|Phase 2|Adverse Event|0|||
126102930|NCT00903630|453670240|FG002|Phase 2|Adverse Event|1|||
126102931|NCT04025580|453670241|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
126102932|NCT04025580|453670242|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
126102933|NCT04025580|453670243|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
126102934|NCT00138671|453670244|FG000|Overall Study|Death|0|||
126102935|NCT00138671|453670245|FG001|Overall Study|Death|3|||
126102936|NCT00138671|453670244|FG000|Overall Study|Adverse Event|6|||
126102937|NCT00138671|453670245|FG001|Overall Study|Adverse Event|3|||
126102938|NCT00138671|453670244|FG000|Overall Study|Lost to Follow-up|1|||
126102939|NCT00138671|453670245|FG001|Overall Study|Lost to Follow-up|2|||
126102940|NCT00138671|453670244|FG000|Overall Study|Withdrawal by Subject|3|||
126102941|NCT00138671|453670245|FG001|Overall Study|Withdrawal by Subject|5|||
126102942|NCT00138671|453670244|FG000|Overall Study|Other|3|||
126102943|NCT00138671|453670245|FG001|Overall Study|Other|3|||
126299361|NCT04630002|454383482|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
126367359|NCT02471144|454640896|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126299362|NCT04630002|454383483|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
126299363|NCT04630002|454383484|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
126299364|NCT04630002|454383482|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
126367360|NCT02471144|454640897|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126102944|NCT01488487|453670246|FG000|Overall Study|Adverse Event|6|||
126102945|NCT01488487|453670246|FG000|Overall Study|Death|1|||
126102946|NCT01488487|453670246|FG000|Overall Study|Withdrawal by Subject|2|||
125883585|NCT01746901|452871518|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125883586|NCT01746901|452871519|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126043596|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
126043597|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
126043598|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
126043599|NCT04614948|453457324|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
126043600|NCT04614948|453457325|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
126043601|NCT04614948|453457326|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
126043602|NCT04055012|453457327|FG000|Overall Study|Withdrawal by Subject|1|||
126043603|NCT04055012|453457328|FG001|Overall Study|Withdrawal by Subject|3|||
126043604|NCT04055012|453457329|FG002|Overall Study|Withdrawal by Subject|1|||
126043605|NCT04055012|453457330|FG003|Overall Study|Withdrawal by Subject|0|||
126043606|NCT04055012|453457327|FG000|Overall Study|Metformin Recall|1|||
126043607|NCT04055012|453457328|FG001|Overall Study|Metformin Recall|1|||
126043608|NCT04055012|453457329|FG002|Overall Study|Metformin Recall|1|||
126043609|NCT04055012|453457330|FG003|Overall Study|Metformin Recall|0|||
126043610|NCT03663205|453457333|FG000|Overall Study|Death|144|||
126043611|NCT03663205|453457334|FG001|Overall Study|Death|69|||
126043612|NCT03663205|453457333|FG000|Overall Study|Sponsor decision|53|||
126043613|NCT03663205|453457334|FG001|Overall Study|Sponsor decision|19|||
126043614|NCT03663205|453457333|FG000|Overall Study|Withdrawal by Subject|8|||
126043615|NCT03663205|453457334|FG001|Overall Study|Withdrawal by Subject|11|||
126043616|NCT03663205|453457333|FG000|Overall Study|Lost to Follow-up|7|||
126043617|NCT03663205|453457334|FG001|Overall Study|Lost to Follow-up|9|||
126043618|NCT03663205|453457333|FG000|Overall Study|Transferred to long term extension study|11|||
126043619|NCT03663205|453457334|FG001|Overall Study|Transferred to long term extension study|3|||
126043620|NCT02577354|453457335|FG000|Overall Study|Lack of Efficacy|4|||
126043621|NCT02577354|453457336|FG001|Overall Study|Lack of Efficacy|4|||
126043622|NCT02577354|453457335|FG000|Overall Study|Lost to Follow-up|3|||
126043623|NCT02577354|453457336|FG001|Overall Study|Lost to Follow-up|1|||
126043624|NCT02577354|453457335|FG000|Overall Study|Missed Visit|4|||
126043625|NCT02577354|453457336|FG001|Overall Study|Missed Visit|3|||
126043626|NCT02577354|453457335|FG000|Overall Study|Adverse Event|4|||
126043627|NCT02577354|453457336|FG001|Overall Study|Adverse Event|5|||
126043628|NCT04924400|453457337|FG000|Overall Study|Lost to Follow-up|3|||
126043629|NCT04924400|453457338|FG001|Overall Study|Lost to Follow-up|0|||
126043630|NCT04424316|453457339|FG000|Overall Study|Adverse Event|0|||
126043631|NCT04424316|453457340|FG001|Overall Study|Adverse Event|1|||
126043632|NCT04424316|453457341|FG002|Overall Study|Adverse Event|0|||
126043633|NCT04424316|453457342|FG003|Overall Study|Adverse Event|0|||
126043634|NCT04424316|453457339|FG000|Overall Study|Death|1|||
126043635|NCT04424316|453457340|FG001|Overall Study|Death|0|||
126043636|NCT04424316|453457341|FG002|Overall Study|Death|8|||
126043637|NCT04424316|453457342|FG003|Overall Study|Death|14|||
126043638|NCT04424316|453457339|FG000|Overall Study|Lost to Follow-up|93|||
126043639|NCT04424316|453457340|FG001|Overall Study|Lost to Follow-up|88|||
126043640|NCT04424316|453457341|FG002|Overall Study|Lost to Follow-up|224|||
126043641|NCT04424316|453457342|FG003|Overall Study|Lost to Follow-up|211|||
126043642|NCT04424316|453457339|FG000|Overall Study|No longer met eligibility criteria|1|||
126043643|NCT04424316|453457340|FG001|Overall Study|No longer met eligibility criteria|0|||
126043644|NCT04424316|453457341|FG002|Overall Study|No longer met eligibility criteria|0|||
126043645|NCT04424316|453457342|FG003|Overall Study|No longer met eligibility criteria|0|||
126043646|NCT04424316|453457339|FG000|Overall Study|Other|15|||
126043647|NCT04424316|453457340|FG001|Overall Study|Other|11|||
126043648|NCT04424316|453457341|FG002|Overall Study|Other|34|||
126043649|NCT04424316|453457342|FG003|Overall Study|Other|45|||
126043650|NCT04424316|453457339|FG000|Overall Study|Physician Decision|1|||
126043651|NCT04424316|453457340|FG001|Overall Study|Physician Decision|0|||
126043652|NCT04424316|453457341|FG002|Overall Study|Physician Decision|1|||
126043653|NCT04424316|453457342|FG003|Overall Study|Physician Decision|1|||
126043654|NCT04424316|453457339|FG000|Overall Study|Protocol Violation|0|||
126043655|NCT04424316|453457340|FG001|Overall Study|Protocol Violation|1|||
126043656|NCT04424316|453457341|FG002|Overall Study|Protocol Violation|0|||
126043657|NCT04424316|453457342|FG003|Overall Study|Protocol Violation|0|||
126043658|NCT04424316|453457339|FG000|Overall Study|Withdrawal by Subject|71|||
126043659|NCT04424316|453457340|FG001|Overall Study|Withdrawal by Subject|77|||
126043660|NCT04424316|453457341|FG002|Overall Study|Withdrawal by Subject|0|||
126043661|NCT04424316|453457342|FG003|Overall Study|Withdrawal by Subject|0|||
126043662|NCT04424316|453457339|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126043663|NCT04424316|453457340|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126043664|NCT04424316|453457341|FG002|Overall Study|Withdrawal by parent/guardian|74|||
126043665|NCT04424316|453457342|FG003|Overall Study|Withdrawal by parent/guardian|81|||
126043666|NCT04424316|453457339|FG000|Overall Study|Randomized but not vaccinated|13|||
126043667|NCT04424316|453457340|FG001|Overall Study|Randomized but not vaccinated|21|||
126043668|NCT04424316|453457341|FG002|Overall Study|Randomized but not vaccinated|0|||
126043669|NCT04424316|453457342|FG003|Overall Study|Randomized but not vaccinated|0|||
126043670|NCT04424316|453457339|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
126102947|NCT01136772|453670249|FG000|Overall Study|Adverse Event|15|||
126102948|NCT01136772|453670250|FG001|Overall Study|Adverse Event|14|||
126102949|NCT01136772|453670249|FG000|Overall Study|Lack of Efficacy|42|||
126102950|NCT01136772|453670250|FG001|Overall Study|Lack of Efficacy|39|||
126102951|NCT01136772|453670249|FG000|Overall Study|Administrative|14|||
126102952|NCT01136772|453670250|FG001|Overall Study|Administrative|12|||
126102953|NCT01136772|453670249|FG000|Overall Study|Withdrawal by Subject|33|||
126102954|NCT01136772|453670250|FG001|Overall Study|Withdrawal by Subject|36|||
126102955|NCT01136772|453670249|FG000|Overall Study|Did not receive injection|10|||
126102956|NCT01136772|453670250|FG001|Overall Study|Did not receive injection|7|||
126102957|NCT01136772|453670249|FG000|Overall Study|Did not follow up after first injection|2|||
126102958|NCT01136772|453670250|FG001|Overall Study|Did not follow up after first injection|2|||
126102959|NCT00928746|453670254|FG000|Overall Study|Adverse Event|2|||
126102960|NCT00928746|453670254|FG000|Overall Study|Protocol Violation|1|||
126102961|NCT00928746|453670254|FG000|Overall Study|Withdrawal by Subject|1|||
126102962|NCT00928746|453670254|FG000|Overall Study|Other|2|||
126102963|NCT02004353|453670260|FG000|Overall Study|Voluntary participation|1334|||
126102964|NCT02581631|453670261|FG000|Overall Study|Disease progression|29|||
126102965|NCT02581631|453670262|FG001|Overall Study|Disease progression|19|||
126102966|NCT02581631|453670263|FG002|Overall Study|Disease progression|13|||
126102967|NCT02581631|453670264|FG003|Overall Study|Disease progression|5|||
126102968|NCT02581631|453670265|FG004|Overall Study|Disease progression|8|||
126102969|NCT02581631|453670261|FG000|Overall Study|Study drug toxicity|4|||
126102970|NCT02581631|453670262|FG001|Overall Study|Study drug toxicity|6|||
126102971|NCT02581631|453670263|FG002|Overall Study|Study drug toxicity|7|||
126102972|NCT02581631|453670264|FG003|Overall Study|Study drug toxicity|0|||
126102973|NCT02581631|453670265|FG004|Overall Study|Study drug toxicity|3|||
126102974|NCT02581631|453670261|FG000|Overall Study|AE unrelated to study drug|3|||
126102975|NCT02581631|453670262|FG001|Overall Study|AE unrelated to study drug|1|||
126102976|NCT02581631|453670263|FG002|Overall Study|AE unrelated to study drug|1|||
126102977|NCT02581631|453670264|FG003|Overall Study|AE unrelated to study drug|0|||
126102978|NCT02581631|453670265|FG004|Overall Study|AE unrelated to study drug|2|||
126102979|NCT02581631|453670261|FG000|Overall Study|Request to discontinue|1|||
126102980|NCT02581631|453670262|FG001|Overall Study|Request to discontinue|0|||
126102981|NCT02581631|453670263|FG002|Overall Study|Request to discontinue|3|||
126102982|NCT02581631|453670264|FG003|Overall Study|Request to discontinue|0|||
126102983|NCT02581631|453670265|FG004|Overall Study|Request to discontinue|1|||
126102984|NCT02581631|453670261|FG000|Overall Study|participant withdrew consent|3|||
126102985|NCT02581631|453670262|FG001|Overall Study|participant withdrew consent|0|||
126102986|NCT02581631|453670263|FG002|Overall Study|participant withdrew consent|1|||
126102987|NCT02581631|453670264|FG003|Overall Study|participant withdrew consent|0|||
126102988|NCT02581631|453670265|FG004|Overall Study|participant withdrew consent|0|||
126102989|NCT02581631|453670261|FG000|Overall Study|Maximum clinical benefit|1|||
126102990|NCT02581631|453670262|FG001|Overall Study|Maximum clinical benefit|7|||
126102991|NCT02581631|453670263|FG002|Overall Study|Maximum clinical benefit|1|||
126102992|NCT02581631|453670264|FG003|Overall Study|Maximum clinical benefit|3|||
126102993|NCT02581631|453670265|FG004|Overall Study|Maximum clinical benefit|13|||
126102994|NCT02581631|453670261|FG000|Overall Study|Other Reasons|1|||
126102995|NCT02581631|453670262|FG001|Overall Study|Other Reasons|0|||
126102996|NCT02581631|453670263|FG002|Overall Study|Other Reasons|2|||
126102997|NCT02581631|453670264|FG003|Overall Study|Other Reasons|2|||
126102998|NCT02581631|453670265|FG004|Overall Study|Other Reasons|3|||
126102999|NCT02581631|453670261|FG000|Overall Study|Poor/Non-Compliance|0|||
126103000|NCT02581631|453670262|FG001|Overall Study|Poor/Non-Compliance|0|||
126103001|NCT02581631|453670263|FG002|Overall Study|Poor/Non-Compliance|1|||
126103002|NCT02581631|453670264|FG003|Overall Study|Poor/Non-Compliance|0|||
126103003|NCT02581631|453670265|FG004|Overall Study|Poor/Non-Compliance|0|||
126103004|NCT00819390|453670266|FG000|Overall Study|Lost to Follow-up|1|||
126103005|NCT00819390|453670267|FG001|Overall Study|Lost to Follow-up|1|||
126103006|NCT00819390|453670268|FG002|Overall Study|Lost to Follow-up|0|||
126103007|NCT00819390|453670269|FG003|Overall Study|Lost to Follow-up|0|||
126103008|NCT00819390|453670266|FG000|Overall Study|Withdrawal by Subject|2|||
126103009|NCT00819390|453670267|FG001|Overall Study|Withdrawal by Subject|0|||
126103010|NCT00819390|453670268|FG002|Overall Study|Withdrawal by Subject|0|||
126103011|NCT00819390|453670269|FG003|Overall Study|Withdrawal by Subject|0|||
126103012|NCT00819390|453670266|FG000|Overall Study|Adverse Event|0|||
126103013|NCT00819390|453670267|FG001|Overall Study|Adverse Event|0|||
126103014|NCT00819390|453670268|FG002|Overall Study|Adverse Event|1|||
126103015|NCT00819390|453670269|FG003|Overall Study|Adverse Event|0|||
126103016|NCT01270971|453670276|FG000|Overall Study|Withdrawal by Subject|24|||
126103017|NCT01270971|453670277|FG001|Overall Study|Withdrawal by Subject|11|||
126103018|NCT01270971|453670276|FG000|Overall Study|Lost to Follow-up|18|||
126103019|NCT01270971|453670277|FG001|Overall Study|Lost to Follow-up|5|||
126103020|NCT01270971|453670276|FG000|Overall Study|Adverse Event|1|||
126103021|NCT01270971|453670277|FG001|Overall Study|Adverse Event|2|||
126103022|NCT01270971|453670276|FG000|Overall Study|Non compliance|2|||
126103023|NCT01270971|453670277|FG001|Overall Study|Non compliance|2|||
126103024|NCT01270971|453670276|FG000|Overall Study|Non-specific|7|||
126103025|NCT01270971|453670277|FG001|Overall Study|Non-specific|3|||
126103026|NCT01588496|453670278|FG000|Overall Study|Withdrawal by Subject|0|||
126103027|NCT01588496|453670279|FG001|Overall Study|Withdrawal by Subject|1|||
126103028|NCT01588496|453670280|FG002|Overall Study|Withdrawal by Subject|0|||
126299365|NCT04630002|454383483|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
126299366|NCT04630002|454383484|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
126299367|NCT04630002|454383482|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
126299368|NCT04630002|454383483|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
126299369|NCT04630002|454383484|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
126299370|NCT02375971|454383486|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
126299371|NCT02375971|454383487|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
126299372|NCT02375971|454383488|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
126299373|NCT02375971|454383486|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
126299374|NCT02375971|454383487|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
126299375|NCT02375971|454383488|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
126299376|NCT02375971|454383486|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
126103029|NCT01013285|453670281|FG000|Overall Study|Death|48|||
126103030|NCT01013285|453670282|FG001|Overall Study|Death|89|||
126103031|NCT00953745|453670285|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
126103032|NCT00953745|453670286|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
126103033|NCT00953745|453670285|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
126103034|NCT00953745|453670286|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
126299377|NCT02375971|454383487|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
126103035|NCT00953745|453670285|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
126299378|NCT02375971|454383488|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
126299379|NCT02375971|454383486|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
126299380|NCT02375971|454383487|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
126299381|NCT02375971|454383488|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
126299382|NCT02375971|454383486|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
126299383|NCT02375971|454383487|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
126299384|NCT02375971|454383488|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
126299385|NCT02375971|454383486|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
126299386|NCT02375971|454383487|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
126299387|NCT02375971|454383488|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
126299388|NCT02375971|454383486|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
126299389|NCT02375971|454383487|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
126299390|NCT02375971|454383488|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
126299391|NCT02375971|454383486|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
126299392|NCT02375971|454383487|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
126299393|NCT02375971|454383488|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
126299394|NCT02556775|454383489|FG000|Overall Study|Withdrawal by Subject|1|||
126299395|NCT02556775|454383490|FG001|Overall Study|Withdrawal by Subject|0|||
126299396|NCT02556775|454383491|FG002|Overall Study|Withdrawal by Subject|1|||
126299397|NCT02556775|454383492|FG003|Overall Study|Withdrawal by Subject|0|||
126299398|NCT02556775|454383489|FG000|Overall Study|Lost to Follow-up|1|||
126299399|NCT02556775|454383490|FG001|Overall Study|Lost to Follow-up|0|||
126299400|NCT02556775|454383491|FG002|Overall Study|Lost to Follow-up|0|||
126299401|NCT02556775|454383492|FG003|Overall Study|Lost to Follow-up|0|||
126299402|NCT01346059|454383493|FG000|Overall Study|Withdrawal by Subject|1|||
126299403|NCT01346059|454383494|FG001|Overall Study|Withdrawal by Subject|0|||
126299404|NCT05047211|454383504|FG000|Overall Study|Lost to Follow-up|8|||
126299405|NCT05047211|454383505|FG001|Overall Study|Lost to Follow-up|5|||
126299406|NCT00561392|454383506|FG000|Overall Study|Adverse Event|38|||
126299407|NCT00561392|454383506|FG000|Overall Study|Lack of Efficacy|2|||
126299408|NCT00561392|454383506|FG000|Overall Study|Protocol Violation|1|||
126299409|NCT00561392|454383506|FG000|Overall Study|Withdrawal by Subject|8|||
126299410|NCT00561392|454383506|FG000|Overall Study|Administrative problems|4|||
126299411|NCT00594165|454383507|FG000|Overall Study|Major protocol violation|1|||
126299412|NCT00594165|454383507|FG000|Overall Study|Lack of Efficacy|12|||
126299413|NCT00594165|454383507|FG000|Overall Study|Adverse Event|52|||
126299414|NCT00594165|454383507|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
126299415|NCT00594165|454383507|FG000|Overall Study|Subject withdrew consent|27|||
126299416|NCT00594165|454383507|FG000|Overall Study|Study ended per sponsor|102|||
126299417|NCT00594165|454383507|FG000|Overall Study|Lost to Follow-up|4|||
126299418|NCT00594165|454383507|FG000|Overall Study|Other: PI discretion|5|||
126299419|NCT00594165|454383507|FG000|Overall Study|Other: Subject moving|3|||
126299420|NCT00594165|454383507|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
126299421|NCT00594165|454383507|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
126299422|NCT00594165|454383507|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
126299423|NCT00594165|454383507|FG000|Overall Study|Other: Site terminated participation|2|||
126299424|NCT01662492|454383508|FG000|Overall Study|Other miscellaneous reasons.|1|||
126299425|NCT01662492|454383509|FG001|Overall Study|Other miscellaneous reasons.|0|||
126299426|NCT01662492|454383510|FG002|Overall Study|Other miscellaneous reasons.|1|||
126299427|NCT01662492|454383508|FG000|Overall Study|Withdrawal by Subject|0|||
126299428|NCT01662492|454383509|FG001|Overall Study|Withdrawal by Subject|0|||
126299429|NCT01662492|454383510|FG002|Overall Study|Withdrawal by Subject|1|||
126299430|NCT01662492|454383508|FG000|Overall Study|Protocol Violation|1|||
126299431|NCT01662492|454383509|FG001|Overall Study|Protocol Violation|0|||
126299432|NCT01662492|454383510|FG002|Overall Study|Protocol Violation|0|||
126299433|NCT01662492|454383508|FG000|Overall Study|Lost to Follow-up|0|||
126299434|NCT01662492|454383509|FG001|Overall Study|Lost to Follow-up|0|||
126299435|NCT01662492|454383510|FG002|Overall Study|Lost to Follow-up|2|||
126299436|NCT01662492|454383508|FG000|Overall Study|Lack of Efficacy|1|||
126299437|NCT01662492|454383509|FG001|Overall Study|Lack of Efficacy|1|||
126299438|NCT01662492|454383510|FG002|Overall Study|Lack of Efficacy|2|||
126299439|NCT04509076|454385072|FG000|Overall Study|Withdrawal by Subject|1|||
126299440|NCT04509076|454385073|FG001|Overall Study|Withdrawal by Subject|2|||
126299441|NCT04509076|454385072|FG000|Overall Study|Lost to Follow-up|1|||
126299442|NCT04509076|454385073|FG001|Overall Study|Lost to Follow-up|2|||
126299443|NCT01812109|454385074|FG000|Overall Study|research personnel delay|16|||
126299444|NCT01812109|454385074|FG000|Overall Study|NIRS Unattainable|17|||
126299445|NCT00442897|454385075|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
126299446|NCT00442897|454385076|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
126299447|NCT00442897|454385075|FG000|Base Study (12 Week Follow-up)|Death|0|||
126103036|NCT00953745|453670286|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
126103037|NCT00953745|453670285|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
126299448|NCT00442897|454385076|FG001|Base Study (12 Week Follow-up)|Death|1|||
126299449|NCT00442897|454385075|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
126299450|NCT00442897|454385076|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
126299451|NCT00442897|454385075|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
126299452|NCT00442897|454385076|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
126299453|NCT00442897|454385075|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
126299454|NCT00442897|454385076|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
126299455|NCT00442897|454385075|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
126299456|NCT00442897|454385076|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
126299457|NCT00442897|454385075|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
126299458|NCT00442897|454385076|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
126299459|NCT00442897|454385075|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
126299460|NCT00442897|454385076|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
126299461|NCT04498182|454385077|FG000|Overall Study|Adverse Event|2|||
126299462|NCT04498182|454385078|FG001|Overall Study|Adverse Event|3|||
126299463|NCT04498182|454385079|FG002|Overall Study|Adverse Event|2|||
126299464|NCT04498182|454385077|FG000|Overall Study|Withdrawal of Consent|3|||
126299465|NCT04498182|454385078|FG001|Overall Study|Withdrawal of Consent|4|||
126299466|NCT04498182|454385079|FG002|Overall Study|Withdrawal of Consent|3|||
126299467|NCT04498182|454385077|FG000|Overall Study|Non-Compliant|1|||
126299468|NCT04498182|454385078|FG001|Overall Study|Non-Compliant|0|||
126299469|NCT04498182|454385079|FG002|Overall Study|Non-Compliant|1|||
126299470|NCT04498182|454385077|FG000|Overall Study|Lost to Follow-up|0|||
126299471|NCT04498182|454385078|FG001|Overall Study|Lost to Follow-up|0|||
126299472|NCT04498182|454385079|FG002|Overall Study|Lost to Follow-up|1|||
126299473|NCT04498182|454385077|FG000|Overall Study|Investigator Decision|0|||
126299474|NCT04498182|454385078|FG001|Overall Study|Investigator Decision|0|||
126299475|NCT04498182|454385079|FG002|Overall Study|Investigator Decision|1|||
126299476|NCT04498182|454385077|FG000|Overall Study|Protocol Violation|1|||
126299477|NCT04498182|454385078|FG001|Overall Study|Protocol Violation|0|||
126299478|NCT04498182|454385079|FG002|Overall Study|Protocol Violation|2|||
126299479|NCT02182843|454385080|FG000|Overall Study|Withdrawal by Subject|7|||
126299480|NCT02182843|454385080|FG000|Overall Study|Lost to Follow-up|2|||
126299481|NCT02182843|454385080|FG000|Overall Study|Adverse Event|1|||
126299482|NCT00832455|454385083|FG000|Overall Study|Adverse Event|13|||
126299483|NCT00832455|454385083|FG000|Overall Study|Lost to Follow-up|26|||
126299484|NCT00832455|454385083|FG000|Overall Study|Protocol Violation|4|||
126299485|NCT00832455|454385083|FG000|Overall Study|Withdrawal by Subject|17|||
126299486|NCT00832455|454385083|FG000|Overall Study|Screening Failure|2|||
126299487|NCT00832455|454385083|FG000|Overall Study|Stopped Medication|4|||
126299488|NCT00832455|454385083|FG000|Overall Study|Parent misunderstood study|1|||
126299489|NCT00832455|454385083|FG000|Overall Study|Parent dissatisfied|1|||
126299490|NCT00832455|454385083|FG000|Overall Study|No improvement|3|||
126299491|NCT00832455|454385083|FG000|Overall Study|Patient moved|1|||
126299492|NCT04548193|454385085|FG000|Overall Study|Lost to Follow-up|0|||
126299493|NCT04548193|454385086|FG001|Overall Study|Lost to Follow-up|1|||
126299494|NCT04548193|454385085|FG000|Overall Study|Death|0|||
126299495|NCT04548193|454385086|FG001|Overall Study|Death|1|||
126299496|NCT04548193|454385085|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
126299497|NCT04548193|454385086|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
126299498|NCT04548193|454385085|FG000|Overall Study|Withdrawal by Subject|2|||
126299499|NCT04548193|454385086|FG001|Overall Study|Withdrawal by Subject|2|||
126299500|NCT02275819|454385088|FG000|Overall Study|Adverse Event|0|||
126299501|NCT02275819|454385089|FG001|Overall Study|Adverse Event|1|||
126299502|NCT02211209|454385090|FG000|Overall Study|Investigator judgment|0|||
126299503|NCT02211209|454385091|FG001|Overall Study|Investigator judgment|1|||
126299504|NCT02211209|454385090|FG000|Overall Study|Voluntary withdrawal|1|||
126299505|NCT02211209|454385091|FG001|Overall Study|Voluntary withdrawal|4|||
126299506|NCT02211209|454385090|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
126299507|NCT02211209|454385091|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
126299508|NCT02211209|454385090|FG000|Overall Study|Reason Not Specified|1|||
126299509|NCT02211209|454385091|FG001|Overall Study|Reason Not Specified|0|||
126299510|NCT00931255|454385092|FG000|Overall Study|Follow up biopsy not done|2|||
126299511|NCT00931255|454385093|FG001|Overall Study|Follow up biopsy not done|3|||
126299512|NCT01372995|454385094|FG000|Overall Study|Spouse withdrew participant from study|0|||
126299513|NCT01372995|454385095|FG001|Overall Study|Spouse withdrew participant from study|1|||
126299514|NCT01372995|454385096|FG002|Overall Study|Spouse withdrew participant from study|0|||
126299515|NCT01372995|454385094|FG000|Overall Study|Physician Decision|0|||
126299516|NCT01372995|454385095|FG001|Overall Study|Physician Decision|0|||
126299517|NCT01372995|454385096|FG002|Overall Study|Physician Decision|1|||
126299518|NCT01575834|454385097|FG000|Overall Study|Withdrawal by Subject|352|||
126299519|NCT01575834|454385098|FG001|Overall Study|Withdrawal by Subject|390|||
126299520|NCT01575834|454385097|FG000|Overall Study|Death|81|||
126299521|NCT01575834|454385098|FG001|Overall Study|Death|74|||
126299522|NCT01575834|454385097|FG000|Overall Study|Other|70|||
126299523|NCT01575834|454385098|FG001|Overall Study|Other|70|||
126299524|NCT01575834|454385097|FG000|Overall Study|Adverse Event|63|||
126299525|NCT01575834|454385098|FG001|Overall Study|Adverse Event|61|||
126299526|NCT01575834|454385097|FG000|Overall Study|Lost to Follow-up|55|||
126299527|NCT01575834|454385098|FG001|Overall Study|Lost to Follow-up|68|||
126299528|NCT01575834|454385097|FG000|Overall Study|Noncompliance|52|||
126299529|NCT01575834|454385098|FG001|Overall Study|Noncompliance|27|||
126299530|NCT01575834|454385097|FG000|Overall Study|Administrative decision|15|||
126299531|NCT01575834|454385098|FG001|Overall Study|Administrative decision|33|||
126299532|NCT01575834|454385097|FG000|Overall Study|Ineligibility Determined|5|||
126299533|NCT01575834|454385098|FG001|Overall Study|Ineligibility Determined|8|||
126299534|NCT01575834|454385097|FG000|Overall Study|Protocol Deviation|4|||
126043671|NCT04424316|453457340|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
126043672|NCT04424316|453457341|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
126043673|NCT04424316|453457342|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
126043674|NCT00412607|453457345|FG000|Overall Study|Withdrawal by Subject|9|||
126043675|NCT00412607|453457345|FG000|Overall Study|Lost to Follow-up|19|||
126043676|NCT00412607|453457345|FG000|Overall Study|Death|61|||
126043677|NCT00412607|453457345|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
126043678|NCT04109066|453457347|FG000|Pre-treatment|Participant withdrew consent|2|||
126043679|NCT04109066|453457348|FG001|Pre-treatment|Participant withdrew consent|0|||
126043680|NCT04109066|453457347|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
126043681|NCT04109066|453457348|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
126043682|NCT04109066|453457347|FG000|Treatment|Lack of Efficacy|2|||
126043683|NCT04109066|453457348|FG001|Treatment|Lack of Efficacy|4|||
126043684|NCT04109066|453457347|FG000|Treatment|Adverse Event|23|||
126043685|NCT04109066|453457348|FG001|Treatment|Adverse Event|7|||
126043686|NCT04109066|453457347|FG000|Treatment|Participant request to discontinue Study treatment|15|||
126043687|NCT04109066|453457348|FG001|Treatment|Participant request to discontinue Study treatment|14|||
126043688|NCT04109066|453457347|FG000|Treatment|Withdrawal by Subject|8|||
126043689|NCT04109066|453457348|FG001|Treatment|Withdrawal by Subject|8|||
126043690|NCT04109066|453457347|FG000|Treatment|Death|3|||
126043691|NCT04109066|453457348|FG001|Treatment|Death|0|||
126043692|NCT04109066|453457347|FG000|Treatment|Participant no longer meets study criteria|2|||
126043693|NCT04109066|453457348|FG001|Treatment|Participant no longer meets study criteria|2|||
126043694|NCT04109066|453457347|FG000|Treatment|Administrative reasons by sponsor|2|||
126043695|NCT04109066|453457348|FG001|Treatment|Administrative reasons by sponsor|3|||
126043696|NCT04109066|453457347|FG000|Treatment|Other reasons|17|||
126043697|NCT04109066|453457348|FG001|Treatment|Other reasons|23|||
126043698|NCT04109066|453457347|FG000|Treatment|Disease Progression|4|||
126043699|NCT04109066|453457348|FG001|Treatment|Disease Progression|7|||
126043700|NCT04109066|453457347|FG000|Treatment|Study drug toxicity|12|||
126299535|NCT01575834|454385098|FG001|Overall Study|Protocol Deviation|3|||
126299536|NCT01575834|454385097|FG000|Overall Study|Requirement for Alternative Therapy|2|||
126299537|NCT01575834|454385098|FG001|Overall Study|Requirement for Alternative Therapy|4|||
126299538|NCT01741688|454385100|FG000|Overall Study|Lack of insurance coverage|2|||
126299539|NCT01741688|454385100|FG000|Overall Study|Withdrawal by Subject|1|||
126299540|NCT02220764|454385106|FG000|Overall Study|Lost to Follow-up|3|||
126299541|NCT02220764|454385107|FG001|Overall Study|Lost to Follow-up|1|||
126299542|NCT02220764|454385106|FG000|Overall Study|Death|1|||
125883587|NCT01746901|452871511|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125883588|NCT01746901|452871512|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
126043701|NCT04109066|453457348|FG001|Treatment|Study drug toxicity|5|||
126299543|NCT02220764|454385107|FG001|Overall Study|Death|0|||
126299544|NCT05000164|454385108|FG000|Overall Study|Adverse Event|1|||
126299545|NCT05000164|454385108|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
126299546|NCT05000164|454385108|FG000|Overall Study|Lens Discomfort|3|||
126299547|NCT05000164|454385108|FG000|Overall Study|Withdrew Consent during Study|2|||
126299548|NCT05000164|454385108|FG000|Overall Study|Subject Withdrawn by PI|2|||
126299549|NCT05000164|454385108|FG000|Overall Study|Other Fractured Test Article|1|||
126299550|NCT02198664|454385111|FG000|Overall Study|Adverse Event|2|||
126299551|NCT02198664|454385112|FG001|Overall Study|Adverse Event|0|||
126299552|NCT02198664|454385111|FG000|Overall Study|Withdrawal by Subject|11|||
126299553|NCT02198664|454385112|FG001|Overall Study|Withdrawal by Subject|8|||
126299554|NCT02198664|454385111|FG000|Overall Study|Failure to tolerate|2|||
126299555|NCT02198664|454385112|FG001|Overall Study|Failure to tolerate|0|||
126299556|NCT02198664|454385111|FG000|Overall Study|Not stated|1|||
126299557|NCT02198664|454385112|FG001|Overall Study|Not stated|0|||
126299558|NCT06509438|454385115|FG000|Overall Study|Adverse Event|1|||
126299559|NCT06509438|454385115|FG000|Overall Study|Lost to Follow-up|3|||
126299560|NCT03331796|454385116|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
126299561|NCT03331796|454385117|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
126299562|NCT03331796|454385118|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
126299563|NCT03331796|454385116|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
126299564|NCT03331796|454385117|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
126299565|NCT03331796|454385118|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
126299566|NCT03331796|454385116|FG000|Extended Follow-up|Adverse Event|1|||
126299567|NCT03331796|454385117|FG001|Extended Follow-up|Adverse Event|0|||
126299568|NCT03331796|454385118|FG002|Extended Follow-up|Adverse Event|1|||
126299569|NCT03331796|454385116|FG000|Extended Follow-up|Lost to Follow-up|0|||
126299570|NCT03331796|454385117|FG001|Extended Follow-up|Lost to Follow-up|0|||
126299571|NCT03331796|454385118|FG002|Extended Follow-up|Lost to Follow-up|1|||
126299572|NCT03331796|454385116|FG000|Extended Follow-up|Withdrawal by Subject|1|||
126299573|NCT03331796|454385117|FG001|Extended Follow-up|Withdrawal by Subject|0|||
126299574|NCT03331796|454385118|FG002|Extended Follow-up|Withdrawal by Subject|0|||
126299575|NCT03331796|454385116|FG000|Extended Follow-up|Termination of Funding|0|||
126299576|NCT03331796|454385117|FG001|Extended Follow-up|Termination of Funding|1|||
126299577|NCT03331796|454385118|FG002|Extended Follow-up|Termination of Funding|0|||
126299578|NCT01262872|454385120|FG000|Step 2|Death|0|||
126299579|NCT01262872|454385121|FG001|Step 2|Death|0|||
126103038|NCT00953745|453670286|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
126103039|NCT00953745|453670285|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
126103040|NCT00953745|453670286|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
126103041|NCT00953745|453670285|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
126103042|NCT00953745|453670286|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
126103043|NCT02640157|453670289|FG000|Overall Study|Adverse Event|2|||
126103044|NCT02640157|453670290|FG001|Overall Study|Adverse Event|2|||
126103045|NCT02640157|453670291|FG002|Overall Study|Adverse Event|1|||
126103046|NCT02640157|453670289|FG000|Overall Study|Withdrew consent|2|||
126103047|NCT02640157|453670290|FG001|Overall Study|Withdrew consent|0|||
126103048|NCT02640157|453670291|FG002|Overall Study|Withdrew consent|2|||
126103049|NCT02640157|453670289|FG000|Overall Study|Lost to Follow-up|9|||
126103050|NCT02640157|453670290|FG001|Overall Study|Lost to Follow-up|2|||
126103051|NCT02640157|453670291|FG002|Overall Study|Lost to Follow-up|7|||
126103052|NCT02640157|453670289|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
126103053|NCT02640157|453670290|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
126103054|NCT02640157|453670291|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
126103055|NCT01679405|453670292|FG000|Overall Study|Death|2|||
126103056|NCT01679405|453670293|FG001|Overall Study|Death|5|||
126103057|NCT02374671|453670294|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
126103058|NCT02374671|453670295|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
126103059|NCT02374671|453670296|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
126103060|NCT02374671|453670294|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
126103061|NCT02374671|453670295|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
126103062|NCT02374671|453670296|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
126103063|NCT02374671|453670294|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
126103064|NCT02374671|453670295|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
126103065|NCT02374671|453670296|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
126103066|NCT02374671|453670294|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
126103067|NCT02374671|453670295|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
126103068|NCT02374671|453670296|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
126103069|NCT02374671|453670294|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
126103070|NCT02374671|453670295|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
126103071|NCT02374671|453670296|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
126103072|NCT03866473|453670299|FG000|Phase 1|Death|1|||
126103073|NCT03866473|453670300|FG001|Phase 1|Death|0|||
126103074|NCT03866473|453670299|FG000|Phase 2|Death|0|||
126103075|NCT03866473|453670300|FG001|Phase 2|Death|2|||
126103076|NCT03866473|453670299|FG000|Phase 2|Dropped|1|||
126103077|NCT03866473|453670300|FG001|Phase 2|Dropped|1|||
126103078|NCT03866473|453670299|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
126103079|NCT03866473|453670300|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
126103080|NCT00600886|453670301|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
126103081|NCT00600886|453670302|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
126103082|NCT00600886|453670301|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
126103083|NCT00600886|453670302|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
126103084|NCT00600886|453670301|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
126103085|NCT00600886|453670302|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
126103086|NCT00600886|453670301|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
126103087|NCT00600886|453670302|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
126103088|NCT00600886|453670301|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
126103089|NCT00600886|453670302|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
126103090|NCT00600886|453670301|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
126043702|NCT04109066|453457347|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
126043703|NCT04109066|453457348|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
126043704|NCT04109066|453457347|FG000|Treatment|Disease Recurrence|0|||
126043705|NCT04109066|453457348|FG001|Treatment|Disease Recurrence|2|||
126043706|NCT04109066|453457347|FG000|Treatment|Not reported|4|||
126043707|NCT04109066|453457348|FG001|Treatment|Not reported|8|||
126043708|NCT05652010|453457349|FG000|First Intervention|Withdrawal by Subject|0|||
126043709|NCT05652010|453457350|FG001|First Intervention|Withdrawal by Subject|1|||
126043710|NCT05652010|453457349|FG000|Second Intervention|Withdrawal by Subject|1|||
126043711|NCT05652010|453457350|FG001|Second Intervention|Withdrawal by Subject|0|||
126043712|NCT05741294|453457352|FG000|Overall Study|Lost to Follow-up|3|||
126043713|NCT05741294|453457352|FG000|Overall Study|Protocol deviation|3|||
126043714|NCT05741294|453457352|FG000|Overall Study|Withdrawal by Subject|1|||
126103091|NCT00600886|453670302|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
126103092|NCT00600886|453670301|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
126103093|NCT00600886|453670302|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
126103094|NCT00600886|453670301|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
126103095|NCT00600886|453670302|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
126043715|NCT04078152|453457353|FG000|Overall Study|Other|83|||
126043716|NCT04078152|453457354|FG001|Overall Study|Other|22|||
126043717|NCT04078152|453457355|FG002|Overall Study|Other|25|||
126043718|NCT04078152|453457353|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
126043719|NCT04078152|453457354|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
126043720|NCT04078152|453457355|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
126043721|NCT04078152|453457353|FG000|Overall Study|Withdrawal by Subject|5|||
126043722|NCT04078152|453457354|FG001|Overall Study|Withdrawal by Subject|0|||
126043723|NCT04078152|453457355|FG002|Overall Study|Withdrawal by Subject|1|||
126043724|NCT04078152|453457353|FG000|Overall Study|Death|10|||
126043725|NCT04078152|453457354|FG001|Overall Study|Death|2|||
126043726|NCT04078152|453457355|FG002|Overall Study|Death|12|||
126043727|NCT04078152|453457353|FG000|Overall Study|Adverse Event|1|||
126043728|NCT04078152|453457354|FG001|Overall Study|Adverse Event|0|||
126043729|NCT04078152|453457355|FG002|Overall Study|Adverse Event|0|||
126043730|NCT02510235|453457356|FG000|Overall Study|Withdrawal by Subject|1|||
126043731|NCT02510235|453457357|FG001|Overall Study|Withdrawal by Subject|0|||
126043732|NCT05890105|453457358|FG000|Overall Study|Adverse Event|1|||
126043733|NCT05890105|453457359|FG001|Overall Study|Adverse Event|0|||
126043734|NCT05890105|453457360|FG002|Overall Study|Adverse Event|0|||
126043735|NCT05890105|453457358|FG000|Overall Study|Other|1|||
126043736|NCT05890105|453457359|FG001|Overall Study|Other|2|||
126043737|NCT05890105|453457360|FG002|Overall Study|Other|0|||
126043738|NCT04678856|453457361|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
126043739|NCT04678856|453457362|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
126043740|NCT04678856|453457361|FG000|Overall Study|Withdrawal by Subject|5|||
126043741|NCT04678856|453457362|FG001|Overall Study|Withdrawal by Subject|1|||
126043742|NCT03367156|453458608|FG000|Overall Study|Lack of interest|3|||
126043743|NCT03367156|453458609|FG001|Overall Study|Lack of interest|1|||
126043744|NCT03367156|453458608|FG000|Overall Study|Death|2|||
126043745|NCT03367156|453458609|FG001|Overall Study|Death|0|||
126043746|NCT03367156|453458608|FG000|Overall Study|Lost to Follow-up|2|||
126043747|NCT03367156|453458609|FG001|Overall Study|Lost to Follow-up|1|||
126043748|NCT03367156|453458608|FG000|Overall Study|Became ineligible|1|||
126043749|NCT03367156|453458609|FG001|Overall Study|Became ineligible|2|||
126043750|NCT03367156|453458608|FG000|Overall Study|Hospitalization|1|||
126043751|NCT03367156|453458609|FG001|Overall Study|Hospitalization|0|||
126043752|NCT03367156|453458608|FG000|Overall Study|Concerned about Treatment|11|||
126043753|NCT03367156|453458609|FG001|Overall Study|Concerned about Treatment|3|||
126043754|NCT03367156|453458608|FG000|Overall Study|Started new treatment|4|||
126043755|NCT03367156|453458609|FG001|Overall Study|Started new treatment|1|||
126043756|NCT05507437|453458610|FG000|Overall Study|Withdrawal by Subject|1|||
126043757|NCT05507437|453458611|FG001|Overall Study|Withdrawal by Subject|1|||
126043758|NCT05507437|453458610|FG000|Overall Study|Death|3|||
126043759|NCT05507437|453458611|FG001|Overall Study|Death|0|||
126043760|NCT04311632|453458613|FG000|Overall Study|Withdrawal by Subject|0|||
126043761|NCT04311632|453458614|FG001|Overall Study|Withdrawal by Subject|0|||
126043762|NCT04311632|453458615|FG002|Overall Study|Withdrawal by Subject|1|||
126043763|NCT04605159|453458616|FG000|Overall Study|Adverse Event|6|||
126043764|NCT04605159|453458617|FG001|Overall Study|Adverse Event|3|||
126043765|NCT04605159|453458618|FG002|Overall Study|Adverse Event|21|||
126043766|NCT04605159|453458619|FG003|Overall Study|Adverse Event|4|||
126043767|NCT04605159|453458616|FG000|Overall Study|Lost to Follow-up|74|||
126043768|NCT04605159|453458617|FG001|Overall Study|Lost to Follow-up|45|||
126043769|NCT04605159|453458618|FG002|Overall Study|Lost to Follow-up|119|||
126043770|NCT04605159|453458619|FG003|Overall Study|Lost to Follow-up|80|||
126043771|NCT04605159|453458616|FG000|Overall Study|Protocol Violation|4|||
126043772|NCT04605159|453458617|FG001|Overall Study|Protocol Violation|5|||
126043773|NCT04605159|453458618|FG002|Overall Study|Protocol Violation|2|||
126043774|NCT04605159|453458619|FG003|Overall Study|Protocol Violation|0|||
126043775|NCT04605159|453458616|FG000|Overall Study|Withdrawal by Subject|66|||
126043776|NCT04605159|453458617|FG001|Overall Study|Withdrawal by Subject|37|||
126043777|NCT04605159|453458618|FG002|Overall Study|Withdrawal by Subject|68|||
126043778|NCT04605159|453458619|FG003|Overall Study|Withdrawal by Subject|50|||
126043779|NCT04605159|453458616|FG000|Overall Study|Migrated / moved from the study area|32|||
126043780|NCT04605159|453458617|FG001|Overall Study|Migrated / moved from the study area|22|||
126043781|NCT04605159|453458618|FG002|Overall Study|Migrated / moved from the study area|41|||
126043782|NCT04605159|453458619|FG003|Overall Study|Migrated / moved from the study area|21|||
126043783|NCT04605159|453458616|FG000|Overall Study|Other|1|||
126043784|NCT04605159|453458617|FG001|Overall Study|Other|2|||
126043785|NCT04605159|453458618|FG002|Overall Study|Other|7|||
126299580|NCT01262872|454385122|FG002|Step 2|Death|0|||
126299581|NCT01262872|454385123|FG003|Step 2|Death|1|||
126299582|NCT01262872|454385124|FG004|Step 2|Death|0|||
126299583|NCT01262872|454385125|FG005|Step 2|Death|2|||
126299584|NCT01262872|454385126|FG006|Step 2|Death|2|||
126299585|NCT01262872|454385127|FG007|Step 2|Death|1|||
126299586|NCT01262872|454385120|FG000|Step 2|Protocol Violation|0|||
126299587|NCT01262872|454385121|FG001|Step 2|Protocol Violation|0|||
126299588|NCT01262872|454385122|FG002|Step 2|Protocol Violation|1|||
126299589|NCT01262872|454385123|FG003|Step 2|Protocol Violation|0|||
126299590|NCT01262872|454385124|FG004|Step 2|Protocol Violation|0|||
126299591|NCT01262872|454385125|FG005|Step 2|Protocol Violation|0|||
126299592|NCT01262872|454385126|FG006|Step 2|Protocol Violation|3|||
126299593|NCT01262872|454385127|FG007|Step 2|Protocol Violation|1|||
126299594|NCT01262872|454385120|FG000|Step 2|Withdrawal by Subject|0|||
126299595|NCT01262872|454385121|FG001|Step 2|Withdrawal by Subject|0|||
126299596|NCT01262872|454385122|FG002|Step 2|Withdrawal by Subject|4|||
126299597|NCT01262872|454385123|FG003|Step 2|Withdrawal by Subject|6|||
126299598|NCT01262872|454385124|FG004|Step 2|Withdrawal by Subject|3|||
126299599|NCT01262872|454385125|FG005|Step 2|Withdrawal by Subject|1|||
126299600|NCT01262872|454385126|FG006|Step 2|Withdrawal by Subject|2|||
126299601|NCT01262872|454385127|FG007|Step 2|Withdrawal by Subject|1|||
126299602|NCT01262872|454385120|FG000|Step 2|Migrated/moved from study area|0|||
126299603|NCT01262872|454385121|FG001|Step 2|Migrated/moved from study area|0|||
126299604|NCT01262872|454385122|FG002|Step 2|Migrated/moved from study area|4|||
126299605|NCT01262872|454385123|FG003|Step 2|Migrated/moved from study area|3|||
126299606|NCT01262872|454385124|FG004|Step 2|Migrated/moved from study area|2|||
126299607|NCT01262872|454385125|FG005|Step 2|Migrated/moved from study area|6|||
126299608|NCT01262872|454385126|FG006|Step 2|Migrated/moved from study area|2|||
126299609|NCT01262872|454385127|FG007|Step 2|Migrated/moved from study area|3|||
126299610|NCT01753570|454385128|FG000|Overall Study|Adverse Event|1|||
126299611|NCT01753570|454385129|FG001|Overall Study|Adverse Event|0|||
126299612|NCT01753570|454385130|FG002|Overall Study|Adverse Event|1|||
126299613|NCT01753570|454385128|FG000|Overall Study|Physician Decision|0|||
126299614|NCT01753570|454385129|FG001|Overall Study|Physician Decision|1|||
126299615|NCT01753570|454385130|FG002|Overall Study|Physician Decision|0|||
125883589|NCT01746901|452871513|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
126299616|NCT01753570|454385128|FG000|Overall Study|Withdrawal by Subject|1|||
126299617|NCT01753570|454385129|FG001|Overall Study|Withdrawal by Subject|4|||
126299618|NCT01753570|454385130|FG002|Overall Study|Withdrawal by Subject|0|||
126299619|NCT01000155|454385133|FG000|Overall Study|Withdrawal by Subject|1|||
126299620|NCT01000155|454385133|FG000|Overall Study|Adverse Event|1|||
126299621|NCT00720213|454385136|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
126299622|NCT00720213|454385137|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
125883590|NCT01746901|452871514|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126299623|NCT00720213|454385138|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
126299624|NCT01808066|454385143|FG000|Overall Study|Withdrawal by Subject|15|||
126299625|NCT00365794|454385144|FG000|Overall Study|Withdrawal by Subject|2|||
126299626|NCT00745901|454385145|FG000|Overall Study|Adverse Event|3|||
126299627|NCT00745901|454385146|FG001|Overall Study|Adverse Event|4|||
126299628|NCT00745901|454385145|FG000|Overall Study|Protocol Violation|0|||
126299629|NCT00745901|454385146|FG001|Overall Study|Protocol Violation|1|||
126299630|NCT00745901|454385145|FG000|Overall Study|Withdrawal by Subject|1|||
126299631|NCT00745901|454385146|FG001|Overall Study|Withdrawal by Subject|0|||
126299632|NCT00745901|454385145|FG000|Overall Study|Lost to Follow-up|7|||
126299633|NCT00745901|454385146|FG001|Overall Study|Lost to Follow-up|4|||
126299634|NCT00745901|454385145|FG000|Overall Study|Pregnancy|2|||
126299635|NCT00745901|454385146|FG001|Overall Study|Pregnancy|4|||
126299636|NCT00745901|454385145|FG000|Overall Study|Lack of compliance|2|||
126299637|NCT00745901|454385146|FG001|Overall Study|Lack of compliance|2|||
126299638|NCT00745901|454385145|FG000|Overall Study|Patient's next menses did not start with|1|||
126299639|NCT00745901|454385146|FG001|Overall Study|Patient's next menses did not start with|0|||
126299640|NCT00745901|454385145|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
126299641|NCT00745901|454385146|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
126299642|NCT00745901|454385145|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
126299643|NCT00745901|454385146|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
126299644|NCT00745901|454385145|FG000|Overall Study|Patient didn't take any study medication|7|||
126299645|NCT00745901|454385146|FG001|Overall Study|Patient didn't take any study medication|3|||
126299646|NCT00884117|454385149|FG000|Overall Study|Adverse Event|2|||
126299647|NCT00884117|454385149|FG000|Overall Study|Withdrawal by Subject|89|||
126299648|NCT00884117|454385149|FG000|Overall Study|Death|3|||
126299649|NCT00884117|454385149|FG000|Overall Study|Lost to Follow-up|143|||
126299650|NCT00884117|454385149|FG000|Overall Study|Other|12|||
126299651|NCT03859427|454385151|FG000|Overall Study|Withdrawal by Subject|4|||
126299652|NCT03859427|454385152|FG001|Overall Study|Withdrawal by Subject|7|||
126299653|NCT03859427|454385151|FG000|Overall Study|Decision by sponsor|0|||
126299654|NCT03859427|454385152|FG001|Overall Study|Decision by sponsor|3|||
126299655|NCT03859427|454385151|FG000|Overall Study|Lost to Follow-up|3|||
126299656|NCT03859427|454385152|FG001|Overall Study|Lost to Follow-up|2|||
126299657|NCT03859427|454385151|FG000|Overall Study|Death|22|||
126299658|NCT03859427|454385152|FG001|Overall Study|Death|25|||
126299659|NCT02503540|454385153|FG000|Overall Study|Death|2|||
126299660|NCT02503540|454385153|FG000|Overall Study|Withdrawal by Subject|1|||
126299661|NCT01804946|454385154|FG000|Overall Study|Protocol Violation|1|||
126299662|NCT01804946|454385155|FG001|Overall Study|Protocol Violation|0|||
126299663|NCT01804946|454385154|FG000|Overall Study|Adverse Event|0|||
126299664|NCT01804946|454385155|FG001|Overall Study|Adverse Event|1|||
126299665|NCT01804946|454385154|FG000|Overall Study|Insufficient data available|0|||
126299666|NCT01804946|454385155|FG001|Overall Study|Insufficient data available|1|||
126299667|NCT01804946|454385154|FG000|Overall Study|Do not meet inclusion criteria|1|||
126299668|NCT01804946|454385155|FG001|Overall Study|Do not meet inclusion criteria|2|||
126299669|NCT00722137|454385156|FG000|Overall Study|Overt Disease Progression|5|||
126299670|NCT00722137|454385157|FG001|Overall Study|Overt Disease Progression|4|||
126299671|NCT00722137|454385156|FG000|Overall Study|Adverse Event|17|||
126299672|NCT00722137|454385157|FG001|Overall Study|Adverse Event|21|||
126299673|NCT00722137|454385156|FG000|Overall Study|Death|12|||
126299674|NCT00722137|454385157|FG001|Overall Study|Death|7|||
126299675|NCT00722137|454385156|FG000|Overall Study|Withdrawal by Subject|6|||
126299676|NCT00722137|454385157|FG001|Overall Study|Withdrawal by Subject|9|||
126299677|NCT00722137|454385156|FG000|Overall Study|Other Reason Unknown|3|||
126299678|NCT00722137|454385157|FG001|Overall Study|Other Reason Unknown|4|||
126299679|NCT00722137|454385156|FG000|Overall Study|Randomized But Not Treated|2|||
126299680|NCT00722137|454385157|FG001|Overall Study|Randomized But Not Treated|3|||
126299681|NCT01129557|454385158|FG000|Overall Study|Adverse Event|1|||
126299682|NCT01129557|454385159|FG001|Overall Study|Adverse Event|2|||
126043786|NCT04605159|453458619|FG003|Overall Study|Other|3|||
126043787|NCT04084574|453458620|FG000|Overall Study|Lost to Follow-up|1|||
126043788|NCT04084574|453458621|FG001|Overall Study|Lost to Follow-up|0|||
126043789|NCT04084574|453458620|FG000|Overall Study|Physician Decision|1|||
126043790|NCT04084574|453458621|FG001|Overall Study|Physician Decision|0|||
126043791|NCT04084574|453458620|FG000|Overall Study|Relocated out of state|1|||
126043792|NCT04084574|453458621|FG001|Overall Study|Relocated out of state|0|||
126043793|NCT00942877|453458622|FG000|Overall Study|Refused further treatment|1|||
126043794|NCT00942877|453458623|FG001|Overall Study|Refused further treatment|1|||
126043795|NCT00942877|453458622|FG000|Overall Study|Patient was not treated|1|||
126043796|NCT00942877|453458623|FG001|Overall Study|Patient was not treated|0|||
126043797|NCT00942877|453458622|FG000|Overall Study|Adverse Event|1|||
126043798|NCT00942877|453458623|FG001|Overall Study|Adverse Event|0|||
126043799|NCT00942877|453458622|FG000|Overall Study|Progressive disease|42|||
126043800|NCT00942877|453458623|FG001|Overall Study|Progressive disease|3|||
126043801|NCT01385202|453458626|FG000|Overall Study|Lost to Follow-up|6|||
126043802|NCT01385202|453458626|FG000|Overall Study|Not Eligible|11|||
126043803|NCT01385202|453458626|FG000|Overall Study|Withdrawn|1|||
126043804|NCT03681262|453458627|FG000|Overall Study|Continuing on study|3|||
126043805|NCT03681262|453458628|FG001|Overall Study|Continuing on study|3|||
126043806|NCT03681262|453458627|FG000|Overall Study|Lost to Follow-up|1|||
126043807|NCT03681262|453458628|FG001|Overall Study|Lost to Follow-up|0|||
126043808|NCT00887198|453458629|FG000|Randomized Period|Ongoing|42|||
126043809|NCT00887198|453458630|FG001|Randomized Period|Ongoing|0|||
126043810|NCT00887198|453458631|FG002|Randomized Period|Ongoing|0|||
126043811|NCT00887198|453458629|FG000|Randomized Period|Adverse Event|50|||
126043812|NCT00887198|453458630|FG001|Randomized Period|Adverse Event|33|||
126043813|NCT00887198|453458631|FG002|Randomized Period|Adverse Event|0|||
126043814|NCT00887198|453458629|FG000|Randomized Period|Lost to Follow-up|1|||
126043815|NCT00887198|453458630|FG001|Randomized Period|Lost to Follow-up|0|||
126043816|NCT00887198|453458631|FG002|Randomized Period|Lost to Follow-up|0|||
126043817|NCT00887198|453458629|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
126043818|NCT00887198|453458630|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
126043819|NCT00887198|453458631|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
126043820|NCT00887198|453458629|FG000|Randomized Period|Withdrawal by Subject|41|||
126043821|NCT00887198|453458630|FG001|Randomized Period|Withdrawal by Subject|56|||
126043822|NCT00887198|453458631|FG002|Randomized Period|Withdrawal by Subject|0|||
126043823|NCT00887198|453458629|FG000|Randomized Period|Progressive disease|366|||
126043824|NCT00887198|453458630|FG001|Randomized Period|Progressive disease|370|||
126043825|NCT00887198|453458631|FG002|Randomized Period|Progressive disease|0|||
126043826|NCT00887198|453458629|FG000|Randomized Period|Other|42|||
126043827|NCT00887198|453458630|FG001|Randomized Period|Other|30|||
126043828|NCT00887198|453458631|FG002|Randomized Period|Other|0|||
126043829|NCT00887198|453458629|FG000|Randomized Period|Randomized, Not treated|4|||
126043830|NCT00887198|453458630|FG001|Randomized Period|Randomized, Not treated|2|||
126043831|NCT00887198|453458631|FG002|Randomized Period|Randomized, Not treated|0|||
126043832|NCT00887198|453458629|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
126043833|NCT00887198|453458630|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
126043834|NCT00887198|453458631|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
126043835|NCT00887198|453458629|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
126043836|NCT00887198|453458630|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
126043837|NCT00887198|453458631|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
126043838|NCT00887198|453458629|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
126043839|NCT00887198|453458630|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
126043840|NCT00887198|453458631|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
126043841|NCT00887198|453458629|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
126043842|NCT00887198|453458630|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
126043843|NCT00887198|453458631|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
126043844|NCT00887198|453458629|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
126043845|NCT00887198|453458630|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
126043846|NCT00887198|453458631|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
126043847|NCT00887198|453458629|FG000|Cross Over (Placebo to AA)|Other|0|||
126043848|NCT00887198|453458630|FG001|Cross Over (Placebo to AA)|Other|0|||
126043849|NCT00887198|453458631|FG002|Cross Over (Placebo to AA)|Other|19|||
126043850|NCT02782676|453458632|FG000|Overall Study|Lost to Follow-up|0|||
126043851|NCT02782676|453458633|FG001|Overall Study|Lost to Follow-up|1|||
126043852|NCT03334695|453458634|FG000|Overall Study|Lost to Follow-up|3|||
126043853|NCT03334695|453458635|FG001|Overall Study|Lost to Follow-up|3|||
126043854|NCT03334695|453458634|FG000|Overall Study|Physician Decision|1|||
126043855|NCT03334695|453458635|FG001|Overall Study|Physician Decision|2|||
126043856|NCT03334695|453458634|FG000|Overall Study|Protocol Violation|0|||
126043857|NCT03334695|453458635|FG001|Overall Study|Protocol Violation|1|||
126043858|NCT05007080|453458636|FG000|Overall Study|Lost to Follow-up|0|||
126043859|NCT05007080|453458637|FG001|Overall Study|Lost to Follow-up|1|||
126103096|NCT00600886|453670301|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
126103097|NCT00600886|453670302|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
126103098|NCT00600886|453670301|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
126103099|NCT00600886|453670302|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
126103100|NCT00600886|453670301|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
126103101|NCT00600886|453670302|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
126103102|NCT00600886|453670301|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
126103103|NCT00600886|453670302|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
126103104|NCT00600886|453670301|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
126103105|NCT00600886|453670302|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
126103106|NCT00600886|453670301|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
126103107|NCT00600886|453670302|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
126103108|NCT00600886|453670301|FG000|Extension - Same Treatment (FAS)|Death|1|||
126103109|NCT00600886|453670302|FG001|Extension - Same Treatment (FAS)|Death|1|||
126103110|NCT00600886|453670301|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
126103111|NCT00600886|453670302|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
126103112|NCT00600886|453670301|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
126103113|NCT00600886|453670302|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
126103114|NCT00600886|453670301|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
126103115|NCT00600886|453670302|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
126103116|NCT00600886|453670301|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
126103117|NCT00600886|453670302|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
126367361|NCT02471144|454640898|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367362|NCT02471144|454640899|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125883591|NCT01746901|452871515|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126103118|NCT00600886|453670301|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
126103119|NCT00600886|453670302|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
126103120|NCT00600886|453670301|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
126103121|NCT00600886|453670302|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
126103122|NCT00600886|453670301|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
126103123|NCT00600886|453670302|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
126103124|NCT00600886|453670301|FG000|Extension - After Crossover (CAS)|Death|1|||
126103125|NCT00600886|453670302|FG001|Extension - After Crossover (CAS)|Death|0|||
126103126|NCT03075410|453670303|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
126103127|NCT03075410|453670304|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
126103128|NCT03075410|453670305|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
126103129|NCT03075410|453670306|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
126103130|NCT03075410|453670307|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
126103131|NCT03075410|453670308|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
126103132|NCT03075410|453670309|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
126103133|NCT03075410|453670310|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
126103134|NCT03075410|453670311|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
126103135|NCT03075410|453670303|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
126103136|NCT03075410|453670304|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126103137|NCT03075410|453670305|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126103138|NCT03075410|453670306|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126103139|NCT03075410|453670307|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126103140|NCT03075410|453670308|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126103141|NCT03075410|453670309|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126103142|NCT03075410|453670310|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126103143|NCT03075410|453670311|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126103144|NCT02523599|453670312|FG000|Overall Study|Adverse Event|1|||
126103145|NCT02523599|453670313|FG001|Overall Study|Adverse Event|0|||
126103146|NCT02523599|453670312|FG000|Overall Study|Physician Decision|1|||
126103147|NCT02523599|453670313|FG001|Overall Study|Physician Decision|0|||
126367363|NCT02471144|454640900|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367364|NCT02471144|454640901|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367365|NCT02471144|454640902|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
126367366|NCT02471144|454640903|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367367|NCT02471144|454640904|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367368|NCT02471144|454640894|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367369|NCT02471144|454640895|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367370|NCT02471144|454640896|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367371|NCT02471144|454640897|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367372|NCT02471144|454640898|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126369573|NCT00183248|454650606|FG001|Overall Study|Lost to Follow-up|1|||
125883592|NCT01746901|452871516|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126299683|NCT01129557|454385160|FG002|Overall Study|Adverse Event|2|||
126299684|NCT01129557|454385158|FG000|Overall Study|Novartis terminated study early|3|||
126299685|NCT01129557|454385159|FG001|Overall Study|Novartis terminated study early|3|||
126299686|NCT01129557|454385160|FG002|Overall Study|Novartis terminated study early|2|||
126299687|NCT00669669|454385161|FG000|Overall Study|To late to start treatment|1|||
126299688|NCT00848718|454385162|FG000|Overall Study|Adverse Event|2|||
126299689|NCT00848718|454385163|FG001|Overall Study|Adverse Event|2|||
126043860|NCT05007080|453458638|FG002|Overall Study|Lost to Follow-up|0|||
126043861|NCT05007080|453458639|FG003|Overall Study|Lost to Follow-up|1|||
126043862|NCT05007080|453458640|FG004|Overall Study|Lost to Follow-up|1|||
126043863|NCT05007080|453458641|FG005|Overall Study|Lost to Follow-up|1|||
126043864|NCT05007080|453458636|FG000|Overall Study|Death|0|||
126043865|NCT05007080|453458637|FG001|Overall Study|Death|1|||
126043866|NCT05007080|453458638|FG002|Overall Study|Death|0|||
126043867|NCT05007080|453458639|FG003|Overall Study|Death|0|||
126043868|NCT05007080|453458640|FG004|Overall Study|Death|0|||
126043869|NCT05007080|453458641|FG005|Overall Study|Death|0|||
126043870|NCT05007080|453458636|FG000|Overall Study|Withdrawal by Subject|1|||
126043871|NCT05007080|453458637|FG001|Overall Study|Withdrawal by Subject|2|||
126043872|NCT05007080|453458638|FG002|Overall Study|Withdrawal by Subject|0|||
126043873|NCT05007080|453458639|FG003|Overall Study|Withdrawal by Subject|2|||
126043874|NCT05007080|453458640|FG004|Overall Study|Withdrawal by Subject|1|||
126043875|NCT05007080|453458641|FG005|Overall Study|Withdrawal by Subject|1|||
126043876|NCT05007080|453458636|FG000|Overall Study|Other|1|||
126043877|NCT05007080|453458637|FG001|Overall Study|Other|0|||
126043878|NCT05007080|453458638|FG002|Overall Study|Other|1|||
126043879|NCT05007080|453458639|FG003|Overall Study|Other|1|||
126043880|NCT05007080|453458640|FG004|Overall Study|Other|0|||
126043881|NCT05007080|453458641|FG005|Overall Study|Other|2|||
126043882|NCT05007080|453458636|FG000|Overall Study|Randomized not vaccinated|0|||
126043883|NCT05007080|453458637|FG001|Overall Study|Randomized not vaccinated|0|||
126043884|NCT05007080|453458638|FG002|Overall Study|Randomized not vaccinated|0|||
126043885|NCT05007080|453458639|FG003|Overall Study|Randomized not vaccinated|0|||
126043886|NCT05007080|453458640|FG004|Overall Study|Randomized not vaccinated|0|||
126043887|NCT05007080|453458641|FG005|Overall Study|Randomized not vaccinated|1|||
126043888|NCT02874742|453458642|FG000|Overall Study|Death|0|||
126043889|NCT02874742|453458643|FG001|Overall Study|Death|1|||
126043890|NCT02874742|453458644|FG002|Overall Study|Death|0|||
126043891|NCT02874742|453458642|FG000|Overall Study|Lost to Follow-up|5|||
126043892|NCT02874742|453458643|FG001|Overall Study|Lost to Follow-up|4|||
126043893|NCT02874742|453458644|FG002|Overall Study|Lost to Follow-up|1|||
126043894|NCT02874742|453458642|FG000|Overall Study|Withdrawal by Subject|17|||
126043895|NCT02874742|453458643|FG001|Overall Study|Withdrawal by Subject|8|||
126043896|NCT02874742|453458644|FG002|Overall Study|Withdrawal by Subject|0|||
126043897|NCT02874742|453458642|FG000|Overall Study|Other|4|||
126043898|NCT02874742|453458643|FG001|Overall Study|Other|1|||
126043899|NCT02874742|453458644|FG002|Overall Study|Other|0|||
126043900|NCT02874742|453458642|FG000|Overall Study|Progressive Disease|1|||
126043901|NCT02874742|453458643|FG001|Overall Study|Progressive Disease|0|||
126043902|NCT02874742|453458644|FG002|Overall Study|Progressive Disease|0|||
126043903|NCT02874742|453458642|FG000|Overall Study|Screen Failure|0|||
126043904|NCT02874742|453458643|FG001|Overall Study|Screen Failure|2|||
126043905|NCT02874742|453458644|FG002|Overall Study|Screen Failure|0|||
126043906|NCT02326974|453458648|FG000|Overall Study|Withdrawal by Subject|2|||
126043907|NCT02326974|453458648|FG000|Overall Study|failed heterogenity evaluation|5|||
126043908|NCT05070741|453458658|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
126043909|NCT03812614|453458659|FG000|Intervention|Withdrawal by Subject|7|||
126043910|NCT03812614|453458660|FG001|Intervention|Withdrawal by Subject|2|||
126043911|NCT03812614|453458661|FG002|Intervention|Withdrawal by Subject|7|||
126043912|NCT03812614|453458662|FG003|Intervention|Withdrawal by Subject|2|||
126043913|NCT03812614|453458659|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
126043914|NCT03812614|453458660|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
126043915|NCT03812614|453458661|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
126299690|NCT00848718|454385164|FG002|Overall Study|Adverse Event|1|||
126299691|NCT00848718|454385165|FG003|Overall Study|Adverse Event|1|||
126299692|NCT00848718|454385166|FG004|Overall Study|Adverse Event|1|||
126299693|NCT00848718|454385167|FG005|Overall Study|Adverse Event|0|||
126043916|NCT03812614|453458662|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
126043917|NCT03812614|453458659|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
126043918|NCT03812614|453458660|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
126043919|NCT03812614|453458661|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
126043920|NCT03812614|453458662|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
126043921|NCT03812614|453458659|FG000|6-month Follow-up|Lost to Follow-up|0|||
126299694|NCT00848718|454385168|FG006|Overall Study|Adverse Event|0|||
126299695|NCT00848718|454385169|FG007|Overall Study|Adverse Event|1|||
126299696|NCT00848718|454385170|FG008|Overall Study|Adverse Event|1|||
126299697|NCT00848718|454385171|FG009|Overall Study|Adverse Event|0|||
126299698|NCT00848718|454385172|FG010|Overall Study|Adverse Event|0|||
126299699|NCT00848718|454385173|FG011|Overall Study|Adverse Event|0|||
126299700|NCT00848718|454385174|FG012|Overall Study|Adverse Event|2|||
126299701|NCT00848718|454385162|FG000|Overall Study|Lack of Efficacy|0|||
126299702|NCT00848718|454385163|FG001|Overall Study|Lack of Efficacy|0|||
126299703|NCT00848718|454385164|FG002|Overall Study|Lack of Efficacy|1|||
126299704|NCT00848718|454385165|FG003|Overall Study|Lack of Efficacy|0|||
126299705|NCT00848718|454385166|FG004|Overall Study|Lack of Efficacy|0|||
126299706|NCT00848718|454385167|FG005|Overall Study|Lack of Efficacy|0|||
126299707|NCT00848718|454385168|FG006|Overall Study|Lack of Efficacy|1|||
126299708|NCT00848718|454385169|FG007|Overall Study|Lack of Efficacy|0|||
125883593|NCT01746901|452871517|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125883594|NCT01746901|452871518|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125883595|NCT01746901|452871519|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125883596|NCT01746901|452871511|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
126299709|NCT00848718|454385170|FG008|Overall Study|Lack of Efficacy|0|||
126299710|NCT00848718|454385171|FG009|Overall Study|Lack of Efficacy|0|||
126299711|NCT00848718|454385172|FG010|Overall Study|Lack of Efficacy|0|||
126299712|NCT00848718|454385173|FG011|Overall Study|Lack of Efficacy|0|||
126299713|NCT00848718|454385174|FG012|Overall Study|Lack of Efficacy|0|||
126299714|NCT00848718|454385162|FG000|Overall Study|Physician Decision|0|||
126299715|NCT00848718|454385163|FG001|Overall Study|Physician Decision|1|||
126299716|NCT00848718|454385164|FG002|Overall Study|Physician Decision|0|||
126299717|NCT00848718|454385165|FG003|Overall Study|Physician Decision|0|||
126299718|NCT00848718|454385166|FG004|Overall Study|Physician Decision|1|||
126299719|NCT00848718|454385167|FG005|Overall Study|Physician Decision|1|||
126299720|NCT00848718|454385168|FG006|Overall Study|Physician Decision|0|||
126299721|NCT00848718|454385169|FG007|Overall Study|Physician Decision|0|||
125883597|NCT01746901|452871512|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
126103148|NCT02523599|453670312|FG000|Overall Study|Lost to Follow-up|4|||
126103149|NCT02523599|453670313|FG001|Overall Study|Lost to Follow-up|1|||
126103150|NCT02523599|453670312|FG000|Overall Study|Did not return for Day 30 visit|2|||
126103151|NCT02523599|453670313|FG001|Overall Study|Did not return for Day 30 visit|0|||
126103152|NCT01427751|453670314|FG000|Overall Study|Adverse Event|18|||
126103153|NCT01427751|453670315|FG001|Overall Study|Adverse Event|2|||
126103154|NCT01427751|453670314|FG000|Overall Study|No further treatment benefit expected|5|||
126103155|NCT01427751|453670315|FG001|Overall Study|No further treatment benefit expected|1|||
126103156|NCT01427751|453670314|FG000|Overall Study|Lost to Follow-up|3|||
126103157|NCT01427751|453670315|FG001|Overall Study|Lost to Follow-up|1|||
126103158|NCT01427751|453670314|FG000|Overall Study|Withdrawal of consent|2|||
126103159|NCT01427751|453670315|FG001|Overall Study|Withdrawal of consent|2|||
126103160|NCT01427751|453670314|FG000|Overall Study|Protocol Violation|6|||
126299722|NCT00848718|454385170|FG008|Overall Study|Physician Decision|1|||
126299723|NCT00848718|454385171|FG009|Overall Study|Physician Decision|2|||
126103161|NCT01427751|453670315|FG001|Overall Study|Protocol Violation|4|||
126299724|NCT00848718|454385172|FG010|Overall Study|Physician Decision|0|||
126299725|NCT00848718|454385173|FG011|Overall Study|Physician Decision|0|||
126299726|NCT00848718|454385174|FG012|Overall Study|Physician Decision|1|||
125883598|NCT01746901|452871513|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
125883599|NCT01746901|452871514|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
125883600|NCT01746901|452871515|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
125883601|NCT01746901|452871516|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
125883602|NCT01746901|452871517|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
125883603|NCT01746901|452871518|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
126103162|NCT01427751|453670314|FG000|Overall Study|Death|2|||
126103163|NCT01427751|453670315|FG001|Overall Study|Death|0|||
126103164|NCT01427751|453670314|FG000|Overall Study|Other miscellaneous reasons|6|||
126103165|NCT01427751|453670315|FG001|Overall Study|Other miscellaneous reasons|4|||
126103166|NCT03319849|453670316|FG000|Overall Study|Adverse Event|1|||
126103167|NCT03319849|453670317|FG001|Overall Study|Adverse Event|0|||
126103168|NCT03319849|453670316|FG000|Overall Study|Physician Decision|0|||
126299727|NCT00848718|454385162|FG000|Overall Study|Progressive disease before treatment|1|||
126299728|NCT00848718|454385163|FG001|Overall Study|Progressive disease before treatment|5|||
126299729|NCT00848718|454385164|FG002|Overall Study|Progressive disease before treatment|1|||
126299730|NCT00848718|454385165|FG003|Overall Study|Progressive disease before treatment|3|||
126299731|NCT00848718|454385166|FG004|Overall Study|Progressive disease before treatment|4|||
126299732|NCT00848718|454385167|FG005|Overall Study|Progressive disease before treatment|4|||
126299733|NCT00848718|454385168|FG006|Overall Study|Progressive disease before treatment|2|||
126299734|NCT00848718|454385169|FG007|Overall Study|Progressive disease before treatment|1|||
126299735|NCT00848718|454385170|FG008|Overall Study|Progressive disease before treatment|2|||
126299736|NCT00848718|454385171|FG009|Overall Study|Progressive disease before treatment|7|||
126299737|NCT00848718|454385172|FG010|Overall Study|Progressive disease before treatment|3|||
126299738|NCT00848718|454385173|FG011|Overall Study|Progressive disease before treatment|6|||
126299739|NCT00848718|454385174|FG012|Overall Study|Progressive disease before treatment|2|||
126299740|NCT00848718|454385162|FG000|Overall Study|Protocol Violation|0|||
126299741|NCT00848718|454385163|FG001|Overall Study|Protocol Violation|1|||
126299742|NCT00848718|454385164|FG002|Overall Study|Protocol Violation|0|||
126299743|NCT00848718|454385165|FG003|Overall Study|Protocol Violation|0|||
126299744|NCT00848718|454385166|FG004|Overall Study|Protocol Violation|0|||
126299745|NCT00848718|454385167|FG005|Overall Study|Protocol Violation|0|||
126299746|NCT00848718|454385168|FG006|Overall Study|Protocol Violation|0|||
126299747|NCT00848718|454385169|FG007|Overall Study|Protocol Violation|1|||
126299748|NCT00848718|454385170|FG008|Overall Study|Protocol Violation|0|||
126299749|NCT00848718|454385171|FG009|Overall Study|Protocol Violation|0|||
126299750|NCT00848718|454385172|FG010|Overall Study|Protocol Violation|0|||
126299751|NCT00848718|454385173|FG011|Overall Study|Protocol Violation|0|||
126299752|NCT00848718|454385174|FG012|Overall Study|Protocol Violation|1|||
126299753|NCT00848718|454385162|FG000|Overall Study|Withdrawal by Subject|1|||
126299754|NCT00848718|454385163|FG001|Overall Study|Withdrawal by Subject|0|||
126299755|NCT00848718|454385164|FG002|Overall Study|Withdrawal by Subject|0|||
126299756|NCT00848718|454385165|FG003|Overall Study|Withdrawal by Subject|1|||
126299757|NCT00848718|454385166|FG004|Overall Study|Withdrawal by Subject|0|||
126299758|NCT00848718|454385167|FG005|Overall Study|Withdrawal by Subject|0|||
126299759|NCT00848718|454385168|FG006|Overall Study|Withdrawal by Subject|0|||
126299760|NCT00848718|454385169|FG007|Overall Study|Withdrawal by Subject|0|||
126299761|NCT00848718|454385170|FG008|Overall Study|Withdrawal by Subject|0|||
126299762|NCT00848718|454385171|FG009|Overall Study|Withdrawal by Subject|0|||
126299763|NCT00848718|454385172|FG010|Overall Study|Withdrawal by Subject|1|||
126299764|NCT00848718|454385173|FG011|Overall Study|Withdrawal by Subject|0|||
126299765|NCT00848718|454385174|FG012|Overall Study|Withdrawal by Subject|0|||
126299766|NCT00848718|454385162|FG000|Overall Study|Progressive disease during treatment|3|||
126299767|NCT00848718|454385163|FG001|Overall Study|Progressive disease during treatment|0|||
126299768|NCT00848718|454385164|FG002|Overall Study|Progressive disease during treatment|3|||
126299769|NCT00848718|454385165|FG003|Overall Study|Progressive disease during treatment|0|||
126299770|NCT00848718|454385166|FG004|Overall Study|Progressive disease during treatment|0|||
126299771|NCT00848718|454385167|FG005|Overall Study|Progressive disease during treatment|0|||
126299772|NCT00848718|454385168|FG006|Overall Study|Progressive disease during treatment|0|||
126299773|NCT00848718|454385169|FG007|Overall Study|Progressive disease during treatment|2|||
126299774|NCT00848718|454385170|FG008|Overall Study|Progressive disease during treatment|0|||
126299775|NCT00848718|454385171|FG009|Overall Study|Progressive disease during treatment|0|||
126299776|NCT00848718|454385172|FG010|Overall Study|Progressive disease during treatment|0|||
126299777|NCT00848718|454385173|FG011|Overall Study|Progressive disease during treatment|0|||
126299778|NCT00848718|454385174|FG012|Overall Study|Progressive disease during treatment|2|||
126299779|NCT02418182|454385176|FG000|Overall Study|Unable to re-consent|18|||
126103169|NCT03319849|453670317|FG001|Overall Study|Physician Decision|1|||
126103170|NCT03319849|453670316|FG000|Overall Study|Withdrawal by Subject|0|||
126103171|NCT03319849|453670317|FG001|Overall Study|Withdrawal by Subject|1|||
126299780|NCT02418182|454385177|FG001|Overall Study|Unable to re-consent|15|||
126299781|NCT02418182|454385176|FG000|Overall Study|Lost to Follow-up|0|||
126299782|NCT02418182|454385177|FG001|Overall Study|Lost to Follow-up|2|||
126299783|NCT02431676|454385180|FG000|Overall Study|no lab obtained|0|||
126299784|NCT02431676|454385181|FG001|Overall Study|no lab obtained|1|||
126299785|NCT02431676|454385182|FG002|Overall Study|no lab obtained|2|||
126299786|NCT00570687|454387006|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299787|NCT00570687|454387007|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299788|NCT00570687|454387008|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299789|NCT00570687|454387009|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299790|NCT00570687|454387010|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
126299791|NCT00570687|454387011|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
126299792|NCT00570687|454387012|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
126299793|NCT00570687|454387013|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
126299794|NCT00570687|454387014|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
126299795|NCT00570687|454387015|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
126299796|NCT00570687|454387006|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299797|NCT00570687|454387007|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299798|NCT00570687|454387008|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299799|NCT00570687|454387009|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299800|NCT00570687|454387010|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299801|NCT00570687|454387011|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299802|NCT00570687|454387012|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299803|NCT00570687|454387013|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299804|NCT00570687|454387014|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
126299805|NCT00570687|454387015|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299806|NCT00570687|454387006|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299807|NCT00570687|454387007|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299808|NCT00570687|454387008|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299809|NCT00570687|454387009|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299810|NCT00570687|454387010|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299811|NCT00570687|454387011|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299812|NCT00570687|454387012|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
126299813|NCT00570687|454387013|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299814|NCT00570687|454387014|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299815|NCT00570687|454387015|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299816|NCT01120184|454387016|FG000|Overall Study|Adverse Event|0|||
126299817|NCT01120184|454387017|FG001|Overall Study|Adverse Event|1|||
126299818|NCT01120184|454387018|FG002|Overall Study|Adverse Event|0|||
126299819|NCT01120184|454387016|FG000|Overall Study|Lost to Follow-up|13|||
126299820|NCT01120184|454387017|FG001|Overall Study|Lost to Follow-up|13|||
126299821|NCT01120184|454387018|FG002|Overall Study|Lost to Follow-up|11|||
126299822|NCT01120184|454387016|FG000|Overall Study|Physician Decision|9|||
126299823|NCT01120184|454387017|FG001|Overall Study|Physician Decision|1|||
126367373|NCT02471144|454640899|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367374|NCT02471144|454640900|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367375|NCT02471144|454640901|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
126367376|NCT02471144|454640902|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
126367377|NCT02471144|454640903|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367378|NCT02471144|454640904|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367379|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367380|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367381|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367382|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367383|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367384|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367385|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367386|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126103172|NCT03319849|453670316|FG000|Overall Study|COVID-19|0|||
126299824|NCT01120184|454387018|FG002|Overall Study|Physician Decision|3|||
126299825|NCT01120184|454387016|FG000|Overall Study|Reason not Specified|8|||
126299826|NCT01120184|454387017|FG001|Overall Study|Reason not Specified|3|||
126299827|NCT01120184|454387018|FG002|Overall Study|Reason not Specified|12|||
126299828|NCT01120184|454387016|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
126299829|NCT01120184|454387017|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
126299830|NCT01120184|454387018|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
126299831|NCT01120184|454387016|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
126299832|NCT01120184|454387017|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
126299833|NCT01120184|454387018|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
126299834|NCT01120184|454387016|FG000|Overall Study|Death|170|||
126299835|NCT01120184|454387017|FG001|Overall Study|Death|176|||
126299836|NCT01120184|454387018|FG002|Overall Study|Death|169|||
126299837|NCT04003636|454387019|FG000|Overall Study|Death|409|||
126299838|NCT04003636|454387020|FG001|Overall Study|Death|443|||
126299839|NCT04003636|454387019|FG000|Overall Study|Lost to Follow-up|0|||
126299840|NCT04003636|454387020|FG001|Overall Study|Lost to Follow-up|1|||
126299841|NCT04003636|454387019|FG000|Overall Study|Withdrawal by Subject|5|||
126299842|NCT04003636|454387020|FG001|Overall Study|Withdrawal by Subject|2|||
126299843|NCT04003636|454387019|FG000|Overall Study|Participant On-going|119|||
126299844|NCT04003636|454387020|FG001|Overall Study|Participant On-going|90|||
126299845|NCT00824772|454387021|FG000|Overall Study|Withdrawal by Subject|8|||
126299846|NCT03656068|454387022|FG000|Overall Study|Withdrawal by Subject|4|||
126299847|NCT03656068|454387022|FG000|Overall Study|Adverse Event|1|||
126299848|NCT03270657|454387023|FG000|Overall Study|Withdrawal by Subject|1|||
126299849|NCT00162981|454387024|FG000|Overall Study|Adverse Event|2|||
126299850|NCT00162981|454387025|FG001|Overall Study|Adverse Event|5|||
126299851|NCT00162981|454387024|FG000|Overall Study|Withdrawal by Subject|1|||
126299852|NCT00162981|454387025|FG001|Overall Study|Withdrawal by Subject|1|||
126299853|NCT00162981|454387024|FG000|Overall Study|Physician Decision|1|||
126299854|NCT00162981|454387025|FG001|Overall Study|Physician Decision|0|||
126299855|NCT00455403|454387032|FG000|Overall Study|Lost to Follow-up|2|||
126299856|NCT00455403|454387033|FG001|Overall Study|Lost to Follow-up|1|||
126299857|NCT00455403|454387032|FG000|Overall Study|Withdrawal by Subject|1|||
126299858|NCT00455403|454387033|FG001|Overall Study|Withdrawal by Subject|3|||
126299859|NCT00455403|454387032|FG000|Overall Study|Protocol Violation|0|||
126299860|NCT00455403|454387033|FG001|Overall Study|Protocol Violation|2|||
126299861|NCT00350207|454387034|FG000|Overall Study|Adverse Event|5|||
126299862|NCT00350207|454387035|FG001|Overall Study|Adverse Event|2|||
126299863|NCT00350207|454387036|FG002|Overall Study|Adverse Event|2|||
126299864|NCT00350207|454387034|FG000|Overall Study|Lack of Efficacy|1|||
126299865|NCT00350207|454387035|FG001|Overall Study|Lack of Efficacy|0|||
126299866|NCT00350207|454387036|FG002|Overall Study|Lack of Efficacy|2|||
126299867|NCT00350207|454387034|FG000|Overall Study|Lost to Follow-up|1|||
126299868|NCT00350207|454387035|FG001|Overall Study|Lost to Follow-up|0|||
126299869|NCT00350207|454387036|FG002|Overall Study|Lost to Follow-up|1|||
126299870|NCT00350207|454387034|FG000|Overall Study|Withdrawal by Subject|0|||
126299871|NCT00350207|454387035|FG001|Overall Study|Withdrawal by Subject|1|||
126103173|NCT03319849|453670317|FG001|Overall Study|COVID-19|1|||
126103174|NCT03319849|453670316|FG000|Overall Study|Other|1|||
126103175|NCT03319849|453670317|FG001|Overall Study|Other|2|||
126103176|NCT03319849|453670316|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
126103177|NCT03319849|453670317|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
126103178|NCT03319849|453670316|FG000|Overall Study|Lost to Follow-up|0|||
126103179|NCT03319849|453670317|FG001|Overall Study|Lost to Follow-up|2|||
126103180|NCT01036763|453672078|FG000|Overall Study|Adverse Event|25|||
126103181|NCT01036763|453672078|FG000|Overall Study|Lost to Follow-up|28|||
126103182|NCT01036763|453672078|FG000|Overall Study|Other reason (not specified)|40|||
126103183|NCT01672723|453672079|FG000|First Intervention|Adverse Event|3|||
126103184|NCT01672723|453672080|FG001|First Intervention|Adverse Event|0|||
126103185|NCT00743275|453672081|FG000|Overall Study|Protocol Violation|0|||
126299872|NCT00350207|454387036|FG002|Overall Study|Withdrawal by Subject|1|||
126299873|NCT00350207|454387034|FG000|Overall Study|Other|1|||
126299874|NCT00350207|454387035|FG001|Overall Study|Other|3|||
126299875|NCT00350207|454387036|FG002|Overall Study|Other|1|||
126299876|NCT00495391|454387037|FG000|Overall Study|Lack of Efficacy|34|||
126299877|NCT00495391|454387038|FG001|Overall Study|Lack of Efficacy|18|||
126367387|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367388|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
126103186|NCT00743275|453672082|FG001|Overall Study|Protocol Violation|1|||
126299878|NCT00495391|454387037|FG000|Overall Study|Withdrawal by Subject|2|||
126299879|NCT00495391|454387038|FG001|Overall Study|Withdrawal by Subject|3|||
126299880|NCT00502242|454387051|FG000|Overall Study|Lack of Efficacy|1|||
126367389|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
126103187|NCT03938545|453672086|FG000|Overall Study|Lost to Follow-up|0|||
126299881|NCT00502242|454387052|FG001|Overall Study|Lack of Efficacy|11|||
126299882|NCT00502242|454387051|FG000|Overall Study|Adverse Event|31|||
126103188|NCT03938545|453672087|FG001|Overall Study|Lost to Follow-up|0|||
126103189|NCT03938545|453672088|FG002|Overall Study|Lost to Follow-up|0|||
126299883|NCT00502242|454387052|FG001|Overall Study|Adverse Event|20|||
126299884|NCT00502242|454387051|FG000|Overall Study|Physician Decision|2|||
126299885|NCT00502242|454387052|FG001|Overall Study|Physician Decision|3|||
126299886|NCT00502242|454387051|FG000|Overall Study|Other - Unspecified|8|||
126043922|NCT03812614|453458660|FG001|6-month Follow-up|Lost to Follow-up|0|||
126043923|NCT03812614|453458661|FG002|6-month Follow-up|Lost to Follow-up|12|||
126299887|NCT00502242|454387052|FG001|Overall Study|Other - Unspecified|14|||
126299888|NCT00502242|454387051|FG000|Overall Study|Protocol Violation|3|||
126299889|NCT00502242|454387052|FG001|Overall Study|Protocol Violation|1|||
126299890|NCT00502242|454387051|FG000|Overall Study|Withdrawal by Subject|6|||
126299891|NCT00502242|454387052|FG001|Overall Study|Withdrawal by Subject|7|||
126299892|NCT03313180|454387053|FG000|Overall Study|Adverse Event|120|||
126299893|NCT03313180|454387053|FG000|Overall Study|Lost to Follow-up|3|||
126299894|NCT03313180|454387053|FG000|Overall Study|Withdrawal by Subject|39|||
126299895|NCT03313180|454387053|FG000|Overall Study|Other than listed above|15|||
126299896|NCT03313180|454387053|FG000|Overall Study|Covid-19 related|2|||
126299897|NCT01966120|454387054|FG000|Overall Study|Withdrawal by Subject|0|||
126299898|NCT01966120|454387055|FG001|Overall Study|Withdrawal by Subject|5|||
126299899|NCT01966120|454387054|FG000|Overall Study|Lost to Follow-up|1|||
126299900|NCT01966120|454387055|FG001|Overall Study|Lost to Follow-up|1|||
126299901|NCT00461630|454387056|FG000|Overall Study|Death|798|||
126299902|NCT00461630|454387057|FG001|Overall Study|Death|732|||
126043924|NCT03812614|453458662|FG003|6-month Follow-up|Lost to Follow-up|8|||
126043925|NCT03812614|453458659|FG000|12-month Follow-up|Lost to Follow-up|18|||
126043926|NCT03812614|453458660|FG001|12-month Follow-up|Lost to Follow-up|17|||
126043927|NCT03812614|453458661|FG002|12-month Follow-up|Lost to Follow-up|5|||
126043928|NCT03812614|453458662|FG003|12-month Follow-up|Lost to Follow-up|2|||
126043929|NCT05205161|453458663|FG000|Overall Study|Study terminated by sponsor|3|||
126043930|NCT05205161|453458664|FG001|Overall Study|Study terminated by sponsor|3|||
126043931|NCT05205161|453458665|FG002|Overall Study|Study terminated by sponsor|1|||
126043932|NCT04675034|453458668|FG000|Overall Study|Lost to Follow-up|1|||
126043933|NCT04675034|453458669|FG001|Overall Study|Lost to Follow-up|1|||
126043934|NCT04675034|453458670|FG002|Overall Study|Lost to Follow-up|0|||
126043935|NCT04675034|453458671|FG003|Overall Study|Lost to Follow-up|2|||
126043936|NCT04675034|453458672|FG004|Overall Study|Lost to Follow-up|0|||
126043937|NCT04675034|453458668|FG000|Overall Study|Protocol Violation|1|||
126043938|NCT04675034|453458669|FG001|Overall Study|Protocol Violation|0|||
126043939|NCT04675034|453458670|FG002|Overall Study|Protocol Violation|0|||
126043940|NCT04675034|453458671|FG003|Overall Study|Protocol Violation|1|||
126043941|NCT04675034|453458672|FG004|Overall Study|Protocol Violation|3|||
126043942|NCT04675034|453458668|FG000|Overall Study|Withdrawal by Subject|9|||
126043943|NCT04675034|453458669|FG001|Overall Study|Withdrawal by Subject|3|||
126043944|NCT04675034|453458670|FG002|Overall Study|Withdrawal by Subject|4|||
126043945|NCT04675034|453458671|FG003|Overall Study|Withdrawal by Subject|8|||
126043946|NCT04675034|453458672|FG004|Overall Study|Withdrawal by Subject|6|||
126043947|NCT04163991|453458673|FG000|Overall Study|Adverse Event|0|||
126043948|NCT04163991|453458674|FG001|Overall Study|Adverse Event|0|||
126043949|NCT04163991|453458675|FG002|Overall Study|Adverse Event|0|||
126043950|NCT04163991|453458676|FG003|Overall Study|Adverse Event|1|||
126043951|NCT04163991|453458677|FG004|Overall Study|Adverse Event|0|||
126043952|NCT04163991|453458673|FG000|Overall Study|Death|0|||
126043953|NCT04163991|453458674|FG001|Overall Study|Death|0|||
126043954|NCT04163991|453458675|FG002|Overall Study|Death|1|||
126043955|NCT04163991|453458676|FG003|Overall Study|Death|0|||
126043956|NCT04163991|453458677|FG004|Overall Study|Death|0|||
126043957|NCT04163991|453458673|FG000|Overall Study|Lost to Follow-up|0|||
126043958|NCT04163991|453458674|FG001|Overall Study|Lost to Follow-up|1|||
126043959|NCT04163991|453458675|FG002|Overall Study|Lost to Follow-up|0|||
126043960|NCT04163991|453458676|FG003|Overall Study|Lost to Follow-up|0|||
126043961|NCT04163991|453458677|FG004|Overall Study|Lost to Follow-up|0|||
126299903|NCT00461630|454387056|FG000|Overall Study|Lost to Follow-up|108|||
126299904|NCT00461630|454387057|FG001|Overall Study|Lost to Follow-up|95|||
126299905|NCT00891020|454387062|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
126299906|NCT00891020|454387063|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
126043962|NCT04163991|453458673|FG000|Overall Study|Withdrawal by Subject|1|||
126043963|NCT04163991|453458674|FG001|Overall Study|Withdrawal by Subject|1|||
126103190|NCT03938545|453672089|FG003|Overall Study|Lost to Follow-up|1|||
126043964|NCT04163991|453458675|FG002|Overall Study|Withdrawal by Subject|3|||
126043965|NCT04163991|453458676|FG003|Overall Study|Withdrawal by Subject|1|||
126043966|NCT04163991|453458677|FG004|Overall Study|Withdrawal by Subject|1|||
126043967|NCT04163991|453458673|FG000|Overall Study|Other, Not Specified|0|||
126043968|NCT04163991|453458674|FG001|Overall Study|Other, Not Specified|1|||
126043969|NCT04163991|453458675|FG002|Overall Study|Other, Not Specified|1|||
126043970|NCT04163991|453458676|FG003|Overall Study|Other, Not Specified|1|||
126043971|NCT04163991|453458677|FG004|Overall Study|Other, Not Specified|0|||
126299907|NCT00891020|454387064|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
126103191|NCT03938545|453672086|FG000|Overall Study|Non-compliance with study drug|0|||
126103192|NCT03938545|453672087|FG001|Overall Study|Non-compliance with study drug|0|||
126103193|NCT03938545|453672088|FG002|Overall Study|Non-compliance with study drug|1|||
126103194|NCT03938545|453672089|FG003|Overall Study|Non-compliance with study drug|0|||
126103195|NCT03938545|453672086|FG000|Overall Study|Pregnancy|1|||
126103196|NCT03938545|453672087|FG001|Overall Study|Pregnancy|0|||
126103197|NCT03938545|453672088|FG002|Overall Study|Pregnancy|0|||
126103198|NCT03938545|453672089|FG003|Overall Study|Pregnancy|0|||
126103199|NCT03938545|453672086|FG000|Overall Study|Study terminated by sponsor|6|||
126103200|NCT03938545|453672087|FG001|Overall Study|Study terminated by sponsor|4|||
126103201|NCT03938545|453672088|FG002|Overall Study|Study terminated by sponsor|2|||
126103202|NCT03938545|453672089|FG003|Overall Study|Study terminated by sponsor|4|||
126103203|NCT03938545|453672086|FG000|Overall Study|Withdrawal by Subject|0|||
126103204|NCT03938545|453672087|FG001|Overall Study|Withdrawal by Subject|1|||
126103205|NCT03938545|453672088|FG002|Overall Study|Withdrawal by Subject|0|||
126103206|NCT03938545|453672089|FG003|Overall Study|Withdrawal by Subject|0|||
126103207|NCT03938545|453672086|FG000|Overall Study|Adverse Event|1|||
126103208|NCT03938545|453672087|FG001|Overall Study|Adverse Event|0|||
126103209|NCT03938545|453672088|FG002|Overall Study|Adverse Event|0|||
126103210|NCT03938545|453672089|FG003|Overall Study|Adverse Event|0|||
126103211|NCT01060540|453672090|FG000|Overall Study|Withdrawal by Subject|10|||
126103212|NCT01060540|453672091|FG001|Overall Study|Withdrawal by Subject|20|||
126103213|NCT01060540|453672090|FG000|Overall Study|Lost to Follow-up|52|||
126103214|NCT01060540|453672091|FG001|Overall Study|Lost to Follow-up|43|||
126103215|NCT01060540|453672090|FG000|Overall Study|Death|2|||
126103216|NCT01060540|453672091|FG001|Overall Study|Death|1|||
126103217|NCT01060540|453672090|FG000|Overall Study|Physician Decision|0|||
126103218|NCT01060540|453672091|FG001|Overall Study|Physician Decision|1|||
126103219|NCT02502097|453672096|FG000|Period 1|Adverse Event|0|||
126103220|NCT02502097|453672097|FG001|Period 1|Adverse Event|0|||
126103221|NCT02502097|453672098|FG002|Period 1|Adverse Event|1|||
126103222|NCT02502097|453672099|FG003|Period 1|Adverse Event|0|||
126103223|NCT02502097|453672096|FG000|Wash Out Period|Adverse Event|0|||
126103224|NCT02502097|453672097|FG001|Wash Out Period|Adverse Event|1|||
126103225|NCT02502097|453672098|FG002|Wash Out Period|Adverse Event|1|||
126103226|NCT02502097|453672099|FG003|Wash Out Period|Adverse Event|1|||
126103227|NCT02502097|453672096|FG000|Period 2|Adverse Event|0|||
126103228|NCT02502097|453672097|FG001|Period 2|Adverse Event|0|||
126103229|NCT02502097|453672098|FG002|Period 2|Adverse Event|1|||
126103230|NCT02502097|453672099|FG003|Period 2|Adverse Event|0|||
126103231|NCT01201317|453672100|FG000|Overall Study|Withdrawal by Subject|5|||
126103232|NCT01201317|453672101|FG001|Overall Study|Withdrawal by Subject|0|||
126103233|NCT01201317|453672102|FG002|Overall Study|Withdrawal by Subject|3|||
126103234|NCT01201317|453672100|FG000|Overall Study|Adverse Event|2|||
126103235|NCT01201317|453672101|FG001|Overall Study|Adverse Event|2|||
126103236|NCT01201317|453672102|FG002|Overall Study|Adverse Event|2|||
126103237|NCT01201317|453672100|FG000|Overall Study|Screen failure|1|||
126103238|NCT01201317|453672101|FG001|Overall Study|Screen failure|1|||
126103239|NCT01201317|453672102|FG002|Overall Study|Screen failure|0|||
126103240|NCT01201317|453672100|FG000|Overall Study|Protocol Violation|0|||
126103241|NCT01201317|453672101|FG001|Overall Study|Protocol Violation|1|||
126103242|NCT01201317|453672102|FG002|Overall Study|Protocol Violation|1|||
126103243|NCT01201317|453672100|FG000|Overall Study|Death|0|||
126103244|NCT01201317|453672101|FG001|Overall Study|Death|1|||
126103245|NCT01201317|453672102|FG002|Overall Study|Death|0|||
126103246|NCT01201317|453672100|FG000|Overall Study|Study-specific withdrawal criteria|0|||
126103247|NCT01201317|453672101|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126103248|NCT01201317|453672102|FG002|Overall Study|Study-specific withdrawal criteria|1|||
126103249|NCT01201317|453672100|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
126103250|NCT01201317|453672101|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
126103251|NCT01201317|453672102|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
126103252|NCT01201317|453672100|FG000|Overall Study|Decrease in renal function|0|||
126103253|NCT01201317|453672101|FG001|Overall Study|Decrease in renal function|1|||
126103254|NCT01201317|453672102|FG002|Overall Study|Decrease in renal function|0|||
126103255|NCT01201317|453672100|FG000|Overall Study|Lack of Efficacy|1|||
126103256|NCT01201317|453672101|FG001|Overall Study|Lack of Efficacy|0|||
126103257|NCT01201317|453672102|FG002|Overall Study|Lack of Efficacy|0|||
126103258|NCT01201317|453672100|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
126103259|NCT01201317|453672101|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
126103260|NCT01201317|453672102|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
126103261|NCT01491672|453672103|FG000|Overall Study|Lost to Follow-up|0|||
126103262|NCT01491672|453672104|FG001|Overall Study|Lost to Follow-up|4|||
126103263|NCT01491672|453672105|FG002|Overall Study|Lost to Follow-up|1|||
126103264|NCT01491672|453672103|FG000|Overall Study|Withdrawal by Subject|6|||
126103265|NCT01491672|453672104|FG001|Overall Study|Withdrawal by Subject|7|||
126103266|NCT01491672|453672105|FG002|Overall Study|Withdrawal by Subject|0|||
126103267|NCT01491672|453672103|FG000|Overall Study|Adverse Event|8|||
126103268|NCT01491672|453672104|FG001|Overall Study|Adverse Event|10|||
126103269|NCT01491672|453672105|FG002|Overall Study|Adverse Event|4|||
126103270|NCT01491672|453672103|FG000|Overall Study|Disease progression|42|||
126103271|NCT01491672|453672104|FG001|Overall Study|Disease progression|34|||
126103272|NCT01491672|453672105|FG002|Overall Study|Disease progression|6|||
126103273|NCT01491672|453672103|FG000|Overall Study|Protocol deviation|0|||
126103274|NCT01491672|453672104|FG001|Overall Study|Protocol deviation|1|||
126103275|NCT01491672|453672105|FG002|Overall Study|Protocol deviation|0|||
126103276|NCT01491672|453672103|FG000|Overall Study|Death|0|||
126103277|NCT01491672|453672104|FG001|Overall Study|Death|4|||
126103278|NCT01491672|453672105|FG002|Overall Study|Death|0|||
126103279|NCT03310268|453672106|FG000|Overall Study|(Not specified)|1|||
126103280|NCT03310268|453672107|FG001|Overall Study|(Not specified)|5|||
126103281|NCT03310268|453672108|FG002|Overall Study|(Not specified)|0|||
126103282|NCT00706433|453672111|FG000|Overall Study|Lost to Follow-up|3|||
126103283|NCT00706433|453672112|FG001|Overall Study|Lost to Follow-up|1|||
126103284|NCT00706433|453672113|FG002|Overall Study|Lost to Follow-up|6|||
126103285|NCT00706433|453672114|FG003|Overall Study|Lost to Follow-up|0|||
126103286|NCT00706433|453672111|FG000|Overall Study|Withdrawal by Subject|1|||
126103287|NCT00706433|453672112|FG001|Overall Study|Withdrawal by Subject|2|||
126103288|NCT00706433|453672113|FG002|Overall Study|Withdrawal by Subject|3|||
126103289|NCT00706433|453672114|FG003|Overall Study|Withdrawal by Subject|1|||
126367390|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367391|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125883604|NCT01746901|452871519|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
125883605|NCT01746901|452871511|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125883606|NCT01746901|452871512|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125883607|NCT01746901|452871513|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125883608|NCT01746901|452871514|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125883609|NCT01746901|452871515|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125883610|NCT01746901|452871516|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125883611|NCT01746901|452871517|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125883612|NCT01746901|452871518|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
125883613|NCT01746901|452871519|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125883614|NCT01746901|452871511|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
125883615|NCT01746901|452871512|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
125883616|NCT01746901|452871513|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
125883617|NCT01746901|452871514|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
125883618|NCT01746901|452871515|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
125883619|NCT01746901|452871516|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
125883620|NCT01746901|452871517|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
125883621|NCT01746901|452871518|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
125883622|NCT01746901|452871519|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
125883623|NCT01746901|452871511|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125883624|NCT01746901|452871512|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125883625|NCT01746901|452871513|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125883626|NCT01746901|452871514|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
125883627|NCT01746901|452871515|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125883628|NCT01746901|452871516|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126043972|NCT04214418|453458678|FG000|Overall Study|Withdrawal by Subject|1|||
126043973|NCT04214418|453458679|FG001|Overall Study|Withdrawal by Subject|0|||
126043974|NCT04214418|453458680|FG002|Overall Study|Withdrawal by Subject|0|||
126043975|NCT04214418|453458681|FG003|Overall Study|Withdrawal by Subject|0|||
126043976|NCT04214418|453458682|FG004|Overall Study|Withdrawal by Subject|0|||
126043977|NCT04214418|453458683|FG005|Overall Study|Withdrawal by Subject|0|||
126043978|NCT04214418|453458678|FG000|Overall Study|Adverse Event|0|||
126043979|NCT04214418|453458679|FG001|Overall Study|Adverse Event|2|||
126043980|NCT04214418|453458680|FG002|Overall Study|Adverse Event|0|||
126043981|NCT04214418|453458681|FG003|Overall Study|Adverse Event|0|||
126043982|NCT04214418|453458682|FG004|Overall Study|Adverse Event|0|||
126043983|NCT04214418|453458683|FG005|Overall Study|Adverse Event|0|||
126103290|NCT00706433|453672111|FG000|Overall Study|Adverse Event|0|||
126103291|NCT00706433|453672112|FG001|Overall Study|Adverse Event|0|||
126103292|NCT00706433|453672113|FG002|Overall Study|Adverse Event|1|||
126103293|NCT00706433|453672114|FG003|Overall Study|Adverse Event|0|||
126103294|NCT00706433|453672111|FG000|Overall Study|Protocol Violation|1|||
126103295|NCT00706433|453672112|FG001|Overall Study|Protocol Violation|0|||
126103296|NCT00706433|453672113|FG002|Overall Study|Protocol Violation|0|||
126043984|NCT04214418|453458678|FG000|Overall Study|Death|1|||
126103297|NCT00706433|453672114|FG003|Overall Study|Protocol Violation|0|||
126043985|NCT04214418|453458679|FG001|Overall Study|Death|0|||
126299908|NCT00891020|454387062|FG000|24 Week Treatment Period|Death|0|||
126299909|NCT00891020|454387063|FG001|24 Week Treatment Period|Death|2|||
126299910|NCT00891020|454387064|FG002|24 Week Treatment Period|Death|0|||
126299911|NCT00891020|454387062|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
126299912|NCT00891020|454387063|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
126299913|NCT00891020|454387064|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
126299914|NCT00891020|454387062|FG000|24 Week Treatment Period|Failure to return|4|||
126299915|NCT00891020|454387063|FG001|24 Week Treatment Period|Failure to return|5|||
126299916|NCT00891020|454387064|FG002|24 Week Treatment Period|Failure to return|5|||
126299917|NCT00891020|454387062|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
126299918|NCT00891020|454387063|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
126299919|NCT00891020|454387064|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
126299920|NCT00891020|454387062|FG000|24 Week Treatment Period|Other protocol violation|1|||
126299921|NCT00891020|454387063|FG001|24 Week Treatment Period|Other protocol violation|1|||
126299922|NCT00891020|454387064|FG002|24 Week Treatment Period|Other protocol violation|2|||
126299923|NCT00891020|454387062|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
126299924|NCT00891020|454387063|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
126299925|NCT00891020|454387064|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
126299926|NCT00891020|454387062|FG000|24 Week Treatment Period|Withdrew consent|6|||
126299927|NCT00891020|454387063|FG001|24 Week Treatment Period|Withdrew consent|3|||
126299928|NCT00891020|454387064|FG002|24 Week Treatment Period|Withdrew consent|15|||
126299929|NCT00891020|454387062|FG000|24 Week Treatment Period|Administrative/Other|5|||
126299930|NCT00891020|454387063|FG001|24 Week Treatment Period|Administrative/Other|6|||
126299931|NCT00891020|454387064|FG002|24 Week Treatment Period|Administrative/Other|1|||
126299932|NCT00891020|454387062|FG000|Long-term Extension Period|Adverse Event|1|||
126043986|NCT04214418|453458680|FG002|Overall Study|Death|0|||
126043987|NCT04214418|453458681|FG003|Overall Study|Death|0|||
126043988|NCT04214418|453458682|FG004|Overall Study|Death|0|||
126043989|NCT04214418|453458683|FG005|Overall Study|Death|0|||
126043990|NCT00450216|453458687|FG000|Overall Study|Adverse Event|38|||
126043991|NCT00450216|453458688|FG001|Overall Study|Adverse Event|23|||
126043992|NCT00450216|453458687|FG000|Overall Study|Withdrawal by Subject|48|||
126043993|NCT00450216|453458688|FG001|Overall Study|Withdrawal by Subject|26|||
126043994|NCT00450216|453458687|FG000|Overall Study|Lost to Follow-up|16|||
126043995|NCT00450216|453458688|FG001|Overall Study|Lost to Follow-up|9|||
126043996|NCT00450216|453458687|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
126043997|NCT00450216|453458688|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
126043998|NCT00450216|453458687|FG000|Overall Study|misc|21|||
126043999|NCT00450216|453458688|FG001|Overall Study|misc|20|||
126044000|NCT04206787|453458689|FG000|Overall Study|Other than listed|2|||
126044001|NCT04206787|453458689|FG000|Overall Study|Investigator decision|1|||
126044002|NCT04206787|453458689|FG000|Overall Study|Death|25|||
126044003|NCT04206787|453458689|FG000|Overall Study|Lost to Follow-up|9|||
126044004|NCT04206787|453458689|FG000|Overall Study|Withdrawal of consent|9|||
126044005|NCT03011034|453458691|FG000|Overall Study|Adverse Event|1|||
126044006|NCT03011034|453458692|FG001|Overall Study|Adverse Event|0|||
126044007|NCT03735979|453458697|FG000|Overall Study|Lost to Follow-up|1|||
126044008|NCT03735979|453458698|FG001|Overall Study|Lost to Follow-up|12|||
126044009|NCT03735979|453458699|FG002|Overall Study|Lost to Follow-up|14|||
126044010|NCT03735979|453458697|FG000|Overall Study|Withdrawal by Subject|1|||
126044011|NCT03735979|453458698|FG001|Overall Study|Withdrawal by Subject|5|||
126044012|NCT03735979|453458699|FG002|Overall Study|Withdrawal by Subject|2|||
126044013|NCT03735979|453458697|FG000|Overall Study|Not due to the above reasons|1|||
126044014|NCT03735979|453458698|FG001|Overall Study|Not due to the above reasons|0|||
126044015|NCT03735979|453458699|FG002|Overall Study|Not due to the above reasons|0|||
126044016|NCT00319111|453458702|FG000|Overall Study|Adverse Event|20|||
126044017|NCT00319111|453458702|FG000|Overall Study|Withdrawal of consent|11|||
126044018|NCT00319111|453458702|FG000|Overall Study|Death|9|||
126044019|NCT00319111|453458702|FG000|Overall Study|Lack of clinical improvement|4|||
126044020|NCT00319111|453458702|FG000|Overall Study|Administrative|2|||
126044021|NCT00319111|453458702|FG000|Overall Study|Treatment failure|1|||
126044022|NCT04743973|453458704|FG000|Overall Study|Withdrawal by Subject|5|||
126044023|NCT05654662|453458705|FG000|Overall Study|Withdrawal by Subject|1|||
126044024|NCT05654662|453458706|FG001|Overall Study|Withdrawal by Subject|0|||
126044025|NCT05654662|453458705|FG000|Overall Study|A death in the family|1|||
126044026|NCT05654662|453458706|FG001|Overall Study|A death in the family|0|||
126367392|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367393|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126044027|NCT03165955|453458707|FG000|Treatment|Withdrawal by Subject|3|||
126044028|NCT03165955|453458707|FG000|Treatment|Death|1|||
126044029|NCT03165955|453458707|FG000|Treatment|Adverse Event|1|||
126044030|NCT03165955|453458707|FG000|Treatment|Progressive disease|3|||
126044031|NCT04499521|453458710|FG000|Overall Study|Disease Progression|1|||
126044032|NCT04499521|453458711|FG001|Overall Study|Disease Progression|0|||
126103298|NCT00706433|453672111|FG000|Overall Study|new job|0|||
126103299|NCT00706433|453672112|FG001|Overall Study|new job|0|||
126103300|NCT00706433|453672113|FG002|Overall Study|new job|0|||
126299933|NCT00891020|454387063|FG001|Long-term Extension Period|Adverse Event|11|||
126299934|NCT00891020|454387064|FG002|Long-term Extension Period|Adverse Event|10|||
126299935|NCT00891020|454387062|FG000|Long-term Extension Period|Death|0|||
126299936|NCT00891020|454387063|FG001|Long-term Extension Period|Death|0|||
126299937|NCT00891020|454387064|FG002|Long-term Extension Period|Death|1|||
126299938|NCT00891020|454387062|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
126299939|NCT00891020|454387063|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
126299940|NCT00891020|454387064|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
126299941|NCT00891020|454387062|FG000|Long-term Extension Period|Protocol Violation|0|||
126299942|NCT00891020|454387063|FG001|Long-term Extension Period|Protocol Violation|1|||
126299943|NCT00891020|454387064|FG002|Long-term Extension Period|Protocol Violation|1|||
126299944|NCT00891020|454387062|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
126299945|NCT00891020|454387063|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
126299946|NCT00891020|454387064|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
126299947|NCT00891020|454387062|FG000|Long-term Extension Period|Failure to return|0|||
126299948|NCT00891020|454387063|FG001|Long-term Extension Period|Failure to return|2|||
126299949|NCT00891020|454387064|FG002|Long-term Extension Period|Failure to return|3|||
126299950|NCT00891020|454387062|FG000|Long-term Extension Period|Administrative|1|||
126299951|NCT00891020|454387063|FG001|Long-term Extension Period|Administrative|2|||
126299952|NCT00891020|454387064|FG002|Long-term Extension Period|Administrative|2|||
126299953|NCT00320710|454387072|FG000|Overall Study|Disease progression|24|||
126299954|NCT00320710|454387073|FG001|Overall Study|Disease progression|19|||
126299955|NCT00320710|454387074|FG002|Overall Study|Disease progression|2|||
126299956|NCT00320710|454387072|FG000|Overall Study|Death|10|||
126299957|NCT00320710|454387073|FG001|Overall Study|Death|7|||
126299958|NCT00320710|454387074|FG002|Overall Study|Death|1|||
126299959|NCT00320710|454387072|FG000|Overall Study|Administrative problems|1|||
126299960|NCT00320710|454387073|FG001|Overall Study|Administrative problems|2|||
126299961|NCT00320710|454387074|FG002|Overall Study|Administrative problems|0|||
126299962|NCT00320710|454387072|FG000|Overall Study|Withdrawal by Subject|20|||
126299963|NCT00320710|454387073|FG001|Overall Study|Withdrawal by Subject|26|||
126299964|NCT00320710|454387074|FG002|Overall Study|Withdrawal by Subject|1|||
126299965|NCT00320710|454387072|FG000|Overall Study|Protocol Violation|6|||
126299966|NCT00320710|454387073|FG001|Overall Study|Protocol Violation|5|||
126299967|NCT00320710|454387074|FG002|Overall Study|Protocol Violation|0|||
126299968|NCT00320710|454387072|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126299969|NCT00320710|454387073|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126299970|NCT00320710|454387074|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126299971|NCT00320710|454387072|FG000|Overall Study|Abnormal laboratory value(s)|12|||
126299972|NCT00320710|454387073|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126299973|NCT00320710|454387074|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126299974|NCT00320710|454387072|FG000|Overall Study|Adverse Event|18|||
126299975|NCT00320710|454387073|FG001|Overall Study|Adverse Event|14|||
126299976|NCT00320710|454387074|FG002|Overall Study|Adverse Event|1|||
126299977|NCT00320710|454387072|FG000|Overall Study|Lost to Follow-up|1|||
126299978|NCT00320710|454387073|FG001|Overall Study|Lost to Follow-up|0|||
126299979|NCT00320710|454387074|FG002|Overall Study|Lost to Follow-up|0|||
126299980|NCT03448419|454387075|FG000|Overall Study|Adverse Event|10|||
126299981|NCT03448419|454387076|FG001|Overall Study|Adverse Event|9|||
126299982|NCT03448419|454387075|FG000|Overall Study|Lost to Follow-up|0|||
126299983|NCT03448419|454387076|FG001|Overall Study|Lost to Follow-up|2|||
126299984|NCT03448419|454387075|FG000|Overall Study|Withdrawal by Subject|3|||
126299985|NCT03448419|454387076|FG001|Overall Study|Withdrawal by Subject|1|||
126299986|NCT03448419|454387075|FG000|Overall Study|Not treated|0|||
126103301|NCT00706433|453672114|FG003|Overall Study|new job|1|||
126103302|NCT01236365|453672115|FG000|Overall Study|Lost to Follow-up|0|||
126103303|NCT01236365|453672116|FG001|Overall Study|Lost to Follow-up|2|||
126103304|NCT01236365|453672115|FG000|Overall Study|Moved Out of State|1|||
126103305|NCT01236365|453672116|FG001|Overall Study|Moved Out of State|0|||
126103306|NCT01236365|453672115|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
126299987|NCT03448419|454387076|FG001|Overall Study|Not treated|1|||
126299988|NCT03448419|454387075|FG000|Overall Study|Patient did not attend all visits|0|||
126299989|NCT03448419|454387076|FG001|Overall Study|Patient did not attend all visits|2|||
126299990|NCT03448419|454387075|FG000|Overall Study|Withdrawn by Sponsor|0|||
126299991|NCT03448419|454387076|FG001|Overall Study|Withdrawn by Sponsor|1|||
126103307|NCT01236365|453672116|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
126103308|NCT00717067|453672117|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
126299992|NCT02841995|454387077|FG000|Overall Study|Disease progression|5|||
126299993|NCT02841995|454387078|FG001|Overall Study|Disease progression|11|||
126299994|NCT02841995|454387079|FG002|Overall Study|Disease progression|8|||
126299995|NCT02841995|454387077|FG000|Overall Study|Withdrawal by Subject|2|||
126299996|NCT02841995|454387078|FG001|Overall Study|Withdrawal by Subject|4|||
126299997|NCT02841995|454387079|FG002|Overall Study|Withdrawal by Subject|4|||
126103309|NCT00717067|453672118|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
126103310|NCT00717067|453672119|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
126103311|NCT00717067|453672120|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
126103312|NCT00717067|453672121|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
126103313|NCT01689337|453672122|FG000|Overall Study|Study Discontinuation|1|||
126103314|NCT02572882|453672123|FG000|Overall Study|Withdrawal by Subject|1|||
126103315|NCT02572882|453672123|FG000|Overall Study|Participant received kidney transplant|1|||
126103316|NCT01590017|453672124|FG000|Overall Study|Adverse Event|1|||
126103317|NCT01590017|453672124|FG000|Overall Study|Withdrawal by Subject|1|||
126103318|NCT01590017|453672124|FG000|Overall Study|Lack of Efficacy|1|||
126367394|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126103319|NCT01590017|453672124|FG000|Overall Study|Physician Decision|1|||
126103320|NCT05041101|453672125|FG000|Overall Study|Adverse Event|1|||
126103321|NCT05041101|453672126|FG001|Overall Study|Adverse Event|0|||
126103322|NCT05041101|453672127|FG002|Overall Study|Adverse Event|0|||
126103323|NCT05041101|453672125|FG000|Overall Study|Diease Progression|5|||
126103324|NCT05041101|453672126|FG001|Overall Study|Diease Progression|0|||
126103325|NCT05041101|453672127|FG002|Overall Study|Diease Progression|0|||
126103326|NCT04426851|453672128|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
126367395|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367396|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367397|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367398|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367399|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
126044033|NCT03990883|453458712|FG000|Blinded Treatment Phase|Adverse Event|1|||
126044034|NCT03990883|453458713|FG001|Blinded Treatment Phase|Adverse Event|1|||
126044035|NCT03990883|453458714|FG002|Blinded Treatment Phase|Adverse Event|0|||
126044036|NCT03990883|453458712|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
126044037|NCT03990883|453458713|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
126044038|NCT03990883|453458714|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
126044039|NCT03990883|453458712|FG000|Blinded Treatment Phase|Physician Decision|1|||
126044040|NCT03990883|453458713|FG001|Blinded Treatment Phase|Physician Decision|0|||
126044041|NCT03990883|453458714|FG002|Blinded Treatment Phase|Physician Decision|0|||
126044042|NCT03990883|453458712|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
126044043|NCT03990883|453458713|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
126044044|NCT03990883|453458714|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
126044045|NCT03990883|453458712|FG000|Blinded Treatment Phase|COVID-19|3|||
126044046|NCT03990883|453458713|FG001|Blinded Treatment Phase|COVID-19|2|||
126044047|NCT03990883|453458714|FG002|Blinded Treatment Phase|COVID-19|0|||
126044048|NCT03990883|453458712|FG000|Blinded Treatment Phase|Personal Reasons|6|||
126044049|NCT03990883|453458713|FG001|Blinded Treatment Phase|Personal Reasons|3|||
126044050|NCT03990883|453458714|FG002|Blinded Treatment Phase|Personal Reasons|0|||
126044051|NCT03990883|453458712|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
126044052|NCT03990883|453458713|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
126044053|NCT03990883|453458714|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
126044054|NCT03990883|453458712|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
126044055|NCT03990883|453458713|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
126044056|NCT03990883|453458714|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
126044057|NCT03990883|453458712|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
126044058|NCT03990883|453458713|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
126044059|NCT03990883|453458714|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
126044060|NCT04427007|453459509|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
126044061|NCT04427007|453459510|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
126044062|NCT04633278|453459511|FG000|Overall Study|Adverse Event|1|||
126044063|NCT04633278|453459512|FG001|Overall Study|Adverse Event|0|||
126044064|NCT04633278|453459511|FG000|Overall Study|Withdrawal by Subject|1|||
126044065|NCT04633278|453459512|FG001|Overall Study|Withdrawal by Subject|0|||
126044066|NCT04633278|453459511|FG000|Overall Study|Death|11|||
126044067|NCT04633278|453459512|FG001|Overall Study|Death|7|||
126044068|NCT04633278|453459511|FG000|Overall Study|Sponsor Decision|3|||
126044069|NCT04633278|453459512|FG001|Overall Study|Sponsor Decision|0|||
126103327|NCT04426851|453672129|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
126103328|NCT04426851|453672128|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
126103329|NCT04426851|453672129|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
126103330|NCT00986674|453672130|FG000|Overall Study|Lack of Efficacy|28|||
126103331|NCT00986674|453672131|FG001|Overall Study|Lack of Efficacy|25|||
126103332|NCT00986674|453672132|FG002|Overall Study|Lack of Efficacy|23|||
126367400|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126044070|NCT04633278|453459511|FG000|Overall Study|Not Listed|1|||
126044071|NCT04633278|453459512|FG001|Overall Study|Not Listed|0|||
126044072|NCT03505710|453459513|FG000|Overall Study|Progressive Disease|24|||
126044073|NCT03505710|453459514|FG001|Overall Study|Progressive Disease|17|||
126103333|NCT00986674|453672130|FG000|Overall Study|Adverse Event|4|||
126103334|NCT00986674|453672131|FG001|Overall Study|Adverse Event|8|||
126103335|NCT00986674|453672132|FG002|Overall Study|Adverse Event|9|||
126103336|NCT00986674|453672130|FG000|Overall Study|Death|5|||
126103337|NCT00986674|453672131|FG001|Overall Study|Death|0|||
126103338|NCT00986674|453672132|FG002|Overall Study|Death|4|||
126103339|NCT00986674|453672130|FG000|Overall Study|Withdrawal by Subject|6|||
126103340|NCT00986674|453672131|FG001|Overall Study|Withdrawal by Subject|2|||
126103341|NCT00986674|453672132|FG002|Overall Study|Withdrawal by Subject|1|||
126103342|NCT00986674|453672130|FG000|Overall Study|alternative therapy|0|||
126103343|NCT00986674|453672131|FG001|Overall Study|alternative therapy|0|||
126103344|NCT00986674|453672132|FG002|Overall Study|alternative therapy|1|||
126103345|NCT00986674|453672130|FG000|Overall Study|not start protocol therapy|4|||
126103346|NCT00986674|453672131|FG001|Overall Study|not start protocol therapy|3|||
126103347|NCT00986674|453672132|FG002|Overall Study|not start protocol therapy|1|||
126103348|NCT00986674|453672130|FG000|Overall Study|unknown/not specify|0|||
126103349|NCT00986674|453672131|FG001|Overall Study|unknown/not specify|7|||
126103350|NCT00986674|453672132|FG002|Overall Study|unknown/not specify|9|||
126103351|NCT02128542|453672133|FG000|Overall Study|Lost to Follow-up|3|||
126103352|NCT02128542|453672134|FG001|Overall Study|Lost to Follow-up|0|||
126103353|NCT02128542|453672133|FG000|Overall Study|Withdrew Consent|1|||
126103354|NCT02128542|453672134|FG001|Overall Study|Withdrew Consent|0|||
126103355|NCT01853137|453672135|FG000|Overall Study|Lost to Follow-up|4|||
126103356|NCT01853137|453672136|FG001|Overall Study|Lost to Follow-up|1|||
126103357|NCT00825916|453672137|FG000|Overall Study|Lost to Follow-up|4|||
126103358|NCT00825916|453672138|FG001|Overall Study|Lost to Follow-up|2|||
126103359|NCT00825916|453672139|FG002|Overall Study|Lost to Follow-up|1|||
126103360|NCT01990560|453672140|FG000|Overall Study|Withdrawal by Subject|1|||
126103361|NCT01778023|453672141|FG000|Overall Study|Withdrawal by Subject|0|||
126103362|NCT01778023|453672142|FG001|Overall Study|Withdrawal by Subject|3|||
126103363|NCT01098097|453672143|FG000|Overall Study|Adverse Event|17|||
126103364|NCT01098097|453672143|FG000|Overall Study|Lost to Follow-up|18|||
126103365|NCT01098097|453672143|FG000|Overall Study|Status unknown|16|||
126103366|NCT01098097|453672143|FG000|Overall Study|No reason reported|31|||
126044074|NCT03505710|453459515|FG002|Overall Study|Progressive Disease|43|||
126044075|NCT03505710|453459513|FG000|Overall Study|Clinical Progression|6|||
126044076|NCT03505710|453459514|FG001|Overall Study|Clinical Progression|8|||
126044077|NCT03505710|453459515|FG002|Overall Study|Clinical Progression|3|||
126044078|NCT03505710|453459513|FG000|Overall Study|Adverse Event|12|||
126044079|NCT03505710|453459514|FG001|Overall Study|Adverse Event|6|||
126044080|NCT03505710|453459515|FG002|Overall Study|Adverse Event|28|||
126044081|NCT03505710|453459513|FG000|Overall Study|Withdrawal by Subject|1|||
126044082|NCT03505710|453459514|FG001|Overall Study|Withdrawal by Subject|3|||
126044083|NCT03505710|453459515|FG002|Overall Study|Withdrawal by Subject|7|||
126044084|NCT03505710|453459513|FG000|Overall Study|Physician Decision|1|||
126044085|NCT03505710|453459514|FG001|Overall Study|Physician Decision|1|||
126044086|NCT03505710|453459515|FG002|Overall Study|Physician Decision|2|||
126044087|NCT03505710|453459513|FG000|Overall Study|Death|4|||
126044088|NCT03505710|453459514|FG001|Overall Study|Death|5|||
126044089|NCT03505710|453459515|FG002|Overall Study|Death|6|||
126044090|NCT03505710|453459513|FG000|Overall Study|Other Reasons|1|||
126044091|NCT03505710|453459514|FG001|Overall Study|Other Reasons|1|||
126044092|NCT03505710|453459515|FG002|Overall Study|Other Reasons|1|||
126044093|NCT03505710|453459513|FG000|Overall Study|Study Terminated by Sponsor|0|||
126044094|NCT03505710|453459514|FG001|Overall Study|Study Terminated by Sponsor|0|||
126044095|NCT03505710|453459515|FG002|Overall Study|Study Terminated by Sponsor|1|||
126044096|NCT04623775|453459519|FG000|Randomization|No Longer Meets Study Criteria|2|||
126044097|NCT04623775|453459520|FG001|Randomization|No Longer Meets Study Criteria|1|||
126044098|NCT04623775|453459521|FG002|Randomization|No Longer Meets Study Criteria|0|||
126044099|NCT04623775|453459522|FG003|Randomization|No Longer Meets Study Criteria|0|||
126044100|NCT04623775|453459519|FG000|Randomization|Withdrew Consent|0|||
126044101|NCT04623775|453459520|FG001|Randomization|Withdrew Consent|0|||
126044102|NCT04623775|453459521|FG002|Randomization|Withdrew Consent|0|||
126044103|NCT04623775|453459522|FG003|Randomization|Withdrew Consent|1|||
126103367|NCT01411215|453672144|FG000|Overall Study|Adverse Event|1|||
126103368|NCT01411215|453672145|FG001|Overall Study|Adverse Event|2|||
126103369|NCT01411215|453672144|FG000|Overall Study|Lack of Efficacy|2|||
126103370|NCT01411215|453672145|FG001|Overall Study|Lack of Efficacy|4|||
126103371|NCT01411215|453672144|FG000|Overall Study|Lost to Follow-up|12|||
126103372|NCT01411215|453672145|FG001|Overall Study|Lost to Follow-up|18|||
126044104|NCT04623775|453459519|FG000|Randomization|Other Reasons|0|||
126103373|NCT01411215|453672144|FG000|Overall Study|Did not meet entrance criteria|0|||
126044105|NCT04623775|453459520|FG001|Randomization|Other Reasons|0|||
126044106|NCT04623775|453459521|FG002|Randomization|Other Reasons|0|||
126044107|NCT04623775|453459522|FG003|Randomization|Other Reasons|1|||
126044108|NCT04623775|453459519|FG000|Treatment Period|participant withdrew consent|4|||
126044109|NCT04623775|453459520|FG001|Treatment Period|participant withdrew consent|0|||
126044110|NCT04623775|453459521|FG002|Treatment Period|participant withdrew consent|1|||
126044111|NCT04623775|453459522|FG003|Treatment Period|participant withdrew consent|2|||
126103374|NCT01411215|453672145|FG001|Overall Study|Did not meet entrance criteria|1|||
126103375|NCT01411215|453672144|FG000|Overall Study|Study terminated by sponsor|2|||
126103376|NCT01411215|453672145|FG001|Overall Study|Study terminated by sponsor|15|||
126103377|NCT01411215|453672144|FG000|Overall Study|Protocol Violation|3|||
126103378|NCT01411215|453672145|FG001|Overall Study|Protocol Violation|5|||
126103379|NCT01411215|453672144|FG000|Overall Study|Withdrawal by Subject|34|||
126103380|NCT01411215|453672145|FG001|Overall Study|Withdrawal by Subject|21|||
126103381|NCT01411215|453672144|FG000|Overall Study|Other|12|||
126103382|NCT01411215|453672145|FG001|Overall Study|Other|17|||
126103383|NCT01411215|453672144|FG000|Overall Study|Screen failure|0|||
126103384|NCT01411215|453672145|FG001|Overall Study|Screen failure|1|||
126103385|NCT00848926|453672146|FG000|Treatment Period|Progressive disease|45|||
126103386|NCT00848926|453672146|FG000|Treatment Period|Adverse Event|20|||
126103387|NCT00848926|453672146|FG000|Treatment Period|Physician Decision|12|||
126103388|NCT00848926|453672146|FG000|Treatment Period|Withdrawal by Subject|7|||
126103389|NCT00848926|453672146|FG000|Follow-up Period|Lost to Follow-up|7|||
125883629|NCT01746901|452871517|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125883630|NCT01746901|452871518|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125883631|NCT01746901|452871519|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125883632|NCT01746901|452871511|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125883633|NCT01746901|452871512|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125883634|NCT01746901|452871513|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126044112|NCT04623775|453459519|FG000|Treatment Period|Death|3|||
126044113|NCT04623775|453459520|FG001|Treatment Period|Death|1|||
126044114|NCT04623775|453459521|FG002|Treatment Period|Death|4|||
126044115|NCT04623775|453459522|FG003|Treatment Period|Death|2|||
126044116|NCT04623775|453459519|FG000|Treatment Period|Lost to Follow-up|0|||
126044117|NCT04623775|453459520|FG001|Treatment Period|Lost to Follow-up|2|||
126044118|NCT04623775|453459521|FG002|Treatment Period|Lost to Follow-up|0|||
126044119|NCT04623775|453459522|FG003|Treatment Period|Lost to Follow-up|0|||
126044120|NCT04623775|453459519|FG000|Treatment Period|poor/non compliance|0|||
126044121|NCT04623775|453459520|FG001|Treatment Period|poor/non compliance|0|||
126044122|NCT04623775|453459521|FG002|Treatment Period|poor/non compliance|1|||
126044123|NCT04623775|453459522|FG003|Treatment Period|poor/non compliance|0|||
126044124|NCT04623775|453459519|FG000|Treatment Period|participant no longer meets study criteria|0|||
126044125|NCT04623775|453459520|FG001|Treatment Period|participant no longer meets study criteria|1|||
126044126|NCT04623775|453459521|FG002|Treatment Period|participant no longer meets study criteria|0|||
126044127|NCT04623775|453459522|FG003|Treatment Period|participant no longer meets study criteria|0|||
126044128|NCT04623775|453459519|FG000|Treatment Period|administrative reasons by sponsor|3|||
126044129|NCT04623775|453459520|FG001|Treatment Period|administrative reasons by sponsor|2|||
126044130|NCT04623775|453459521|FG002|Treatment Period|administrative reasons by sponsor|0|||
126044131|NCT04623775|453459522|FG003|Treatment Period|administrative reasons by sponsor|0|||
126044132|NCT04623775|453459519|FG000|Treatment Period|other reasons|2|||
126044133|NCT04623775|453459520|FG001|Treatment Period|other reasons|0|||
126044134|NCT04623775|453459521|FG002|Treatment Period|other reasons|1|||
126044135|NCT04623775|453459522|FG003|Treatment Period|other reasons|1|||
126044136|NCT04623775|453459519|FG000|Treatment Period|disease progression|40|||
126044137|NCT04623775|453459520|FG001|Treatment Period|disease progression|35|||
126044138|NCT04623775|453459521|FG002|Treatment Period|disease progression|63|||
126044139|NCT04623775|453459522|FG003|Treatment Period|disease progression|63|||
126044140|NCT04623775|453459519|FG000|Treatment Period|study drug toxicity|12|||
126044141|NCT04623775|453459520|FG001|Treatment Period|study drug toxicity|15|||
126044142|NCT04623775|453459521|FG002|Treatment Period|study drug toxicity|13|||
126044143|NCT04623775|453459522|FG003|Treatment Period|study drug toxicity|12|||
126044144|NCT04623775|453459519|FG000|Treatment Period|AE unrelated to study drug|4|||
126044145|NCT04623775|453459520|FG001|Treatment Period|AE unrelated to study drug|9|||
126044146|NCT04623775|453459521|FG002|Treatment Period|AE unrelated to study drug|12|||
126044147|NCT04623775|453459522|FG003|Treatment Period|AE unrelated to study drug|9|||
126044148|NCT04623775|453459519|FG000|Treatment Period|participant request to discontinue treatment|0|||
126044149|NCT04623775|453459520|FG001|Treatment Period|participant request to discontinue treatment|2|||
126044150|NCT04623775|453459521|FG002|Treatment Period|participant request to discontinue treatment|2|||
126044151|NCT04623775|453459522|FG003|Treatment Period|participant request to discontinue treatment|0|||
126044152|NCT00964392|453459523|FG000|Overall Study|Withdrawal by Subject|4|||
126044153|NCT00964392|453459524|FG001|Overall Study|Withdrawal by Subject|6|||
126044154|NCT00964392|453459523|FG000|Overall Study|Lost to Follow-up|4|||
126044155|NCT00964392|453459524|FG001|Overall Study|Lost to Follow-up|10|||
126044156|NCT00964392|453459523|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
126044157|NCT00964392|453459524|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
125883635|NCT01746901|452871514|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125883636|NCT01746901|452871515|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126044158|NCT00964392|453459523|FG000|Overall Study|Not completed|44|||
126044159|NCT00964392|453459524|FG001|Overall Study|Not completed|168|||
126103390|NCT00848926|453672146|FG000|Follow-up Period|Withdrawal by Subject|3|||
126103391|NCT00848926|453672146|FG000|Follow-up Period|Other|2|||
126299998|NCT02841995|454387077|FG000|Overall Study|Adverse Event|2|||
126299999|NCT02841995|454387078|FG001|Overall Study|Adverse Event|0|||
126300000|NCT02841995|454387079|FG002|Overall Study|Adverse Event|1|||
126300001|NCT02841995|454387077|FG000|Overall Study|Investigator decision|2|||
126300002|NCT02841995|454387078|FG001|Overall Study|Investigator decision|0|||
126300003|NCT02841995|454387079|FG002|Overall Study|Investigator decision|1|||
126300004|NCT02841995|454387077|FG000|Overall Study|Death|0|||
126300005|NCT02841995|454387078|FG001|Overall Study|Death|0|||
126300006|NCT02841995|454387079|FG002|Overall Study|Death|2|||
126300007|NCT02841995|454387077|FG000|Overall Study|Noncompliance to protocol|1|||
126300008|NCT02841995|454387078|FG001|Overall Study|Noncompliance to protocol|0|||
126300009|NCT02841995|454387079|FG002|Overall Study|Noncompliance to protocol|0|||
126300010|NCT02841995|454387077|FG000|Overall Study|Sponsor decision|1|||
126300011|NCT02841995|454387078|FG001|Overall Study|Sponsor decision|0|||
126300012|NCT02841995|454387079|FG002|Overall Study|Sponsor decision|0|||
126300013|NCT02841995|454387077|FG000|Overall Study|Other|4|||
126300014|NCT02841995|454387078|FG001|Overall Study|Other|1|||
126300015|NCT02841995|454387079|FG002|Overall Study|Other|5|||
126300016|NCT01703260|454387080|FG000|Overall Study|Adverse Event|1|||
126300017|NCT01703260|454387081|FG001|Overall Study|Adverse Event|2|||
126300018|NCT01703260|454387082|FG002|Overall Study|Adverse Event|2|||
126300019|NCT01703260|454387080|FG000|Overall Study|Lost to Follow-up|1|||
126300020|NCT01703260|454387081|FG001|Overall Study|Lost to Follow-up|0|||
126300021|NCT01703260|454387082|FG002|Overall Study|Lost to Follow-up|0|||
126300022|NCT01703260|454387080|FG000|Overall Study|Withdrawal by Subject|0|||
126300023|NCT01703260|454387081|FG001|Overall Study|Withdrawal by Subject|0|||
126300024|NCT01703260|454387082|FG002|Overall Study|Withdrawal by Subject|1|||
126300025|NCT01703260|454387080|FG000|Overall Study|Study Termination|1|||
126300026|NCT01703260|454387081|FG001|Overall Study|Study Termination|2|||
126300027|NCT01703260|454387082|FG002|Overall Study|Study Termination|0|||
126300028|NCT00630825|454387084|FG000|Overall Study|Adverse Event|4|||
126300029|NCT00630825|454387085|FG001|Overall Study|Adverse Event|4|||
126300030|NCT00630825|454387086|FG002|Overall Study|Adverse Event|3|||
126300031|NCT00630825|454387087|FG003|Overall Study|Adverse Event|1|||
126300032|NCT00630825|454387084|FG000|Overall Study|Entry Criteria Not Met|1|||
126300033|NCT00630825|454387085|FG001|Overall Study|Entry Criteria Not Met|0|||
126300034|NCT00630825|454387086|FG002|Overall Study|Entry Criteria Not Met|2|||
126300035|NCT00630825|454387087|FG003|Overall Study|Entry Criteria Not Met|1|||
126300036|NCT00630825|454387084|FG000|Overall Study|Lost to Follow-up|1|||
126300037|NCT00630825|454387085|FG001|Overall Study|Lost to Follow-up|1|||
126300038|NCT00630825|454387086|FG002|Overall Study|Lost to Follow-up|1|||
126300039|NCT00630825|454387087|FG003|Overall Study|Lost to Follow-up|1|||
126300040|NCT00630825|454387084|FG000|Overall Study|Physician Decision|1|||
126300041|NCT00630825|454387085|FG001|Overall Study|Physician Decision|0|||
126300042|NCT00630825|454387086|FG002|Overall Study|Physician Decision|0|||
126300043|NCT00630825|454387087|FG003|Overall Study|Physician Decision|0|||
126300044|NCT00630825|454387084|FG000|Overall Study|Withdrawal by Subject|2|||
126300045|NCT00630825|454387085|FG001|Overall Study|Withdrawal by Subject|2|||
126300046|NCT00630825|454387086|FG002|Overall Study|Withdrawal by Subject|2|||
126300047|NCT00630825|454387087|FG003|Overall Study|Withdrawal by Subject|3|||
126300048|NCT02792062|454387091|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
126300049|NCT02792062|454387092|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300050|NCT02792062|454387093|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300051|NCT02792062|454387094|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300052|NCT02792062|454387095|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300053|NCT02792062|454387096|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300054|NCT03309943|454387099|FG000|Overall Study|Withdrawal by Subject|0|||
126300055|NCT03309943|454387100|FG001|Overall Study|Withdrawal by Subject|1|||
126300056|NCT03309943|454387099|FG000|Overall Study|Inappropriate behavior towards staff|0|||
126300057|NCT03309943|454387100|FG001|Overall Study|Inappropriate behavior towards staff|1|||
126300058|NCT03123393|454387106|FG000|Overall Study|Study Terminated by Sponsor|6|||
126300059|NCT03123393|454387107|FG001|Overall Study|Study Terminated by Sponsor|9|||
126300060|NCT03123393|454387106|FG000|Overall Study|Withdrawal by Subject|2|||
126300061|NCT03123393|454387107|FG001|Overall Study|Withdrawal by Subject|1|||
126300062|NCT03123393|454387106|FG000|Overall Study|Reason not Specified|13|||
126300063|NCT03123393|454387107|FG001|Overall Study|Reason not Specified|13|||
126300064|NCT00427648|454387108|FG000|Overall Study|Protocol Violation|1|||
126300065|NCT00427648|454387109|FG001|Overall Study|Protocol Violation|2|||
126300066|NCT00427648|454387108|FG000|Overall Study|Adverse Event|0|||
126300067|NCT00427648|454387109|FG001|Overall Study|Adverse Event|1|||
126300068|NCT01297517|454387110|FG000|Overall Study|Adverse Event|21|||
126300069|NCT01297517|454387111|FG001|Overall Study|Adverse Event|7|||
126300070|NCT01297517|454387112|FG002|Overall Study|Adverse Event|16|||
126300071|NCT01297517|454387110|FG000|Overall Study|Lost to Follow-up|1|||
126300072|NCT01297517|454387111|FG001|Overall Study|Lost to Follow-up|0|||
126300073|NCT01297517|454387112|FG002|Overall Study|Lost to Follow-up|1|||
126300074|NCT01297517|454387110|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
126300075|NCT01297517|454387111|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
126300076|NCT01297517|454387112|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
126300077|NCT01297517|454387110|FG000|Overall Study|Noncompliance|1|||
126300078|NCT01297517|454387111|FG001|Overall Study|Noncompliance|0|||
126300079|NCT01297517|454387112|FG002|Overall Study|Noncompliance|0|||
126300080|NCT01297517|454387110|FG000|Overall Study|Protocol Violation|1|||
126300081|NCT01297517|454387111|FG001|Overall Study|Protocol Violation|1|||
126300082|NCT01297517|454387112|FG002|Overall Study|Protocol Violation|1|||
126300083|NCT01297517|454387110|FG000|Overall Study|Inadequate Control of IOP|1|||
126300084|NCT01297517|454387111|FG001|Overall Study|Inadequate Control of IOP|1|||
126300085|NCT01297517|454387112|FG002|Overall Study|Inadequate Control of IOP|2|||
126300086|NCT01681212|454387115|FG000|Overall Study|No longer met study criteria|5|||
126300087|NCT01681212|454387115|FG000|Overall Study|Administrative reason by sponsor|1|||
126300088|NCT01464424|454387116|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
126300089|NCT01464424|454387117|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
126300090|NCT01464333|454387118|FG000|Overall Study|Adverse Event|34|||
126300091|NCT01464333|454387118|FG000|Overall Study|Lack of Efficacy|72|||
126300092|NCT01464333|454387118|FG000|Overall Study|Withdrawal by Subject|11|||
126300093|NCT01464333|454387118|FG000|Overall Study|Other|4|||
126300094|NCT01464333|454387118|FG000|Overall Study|No Hospital Visit|42|||
126300095|NCT02282813|454387119|FG000|Overall Study|Withdrawal by Subject|4|||
126300096|NCT02282813|454387120|FG001|Overall Study|Withdrawal by Subject|5|||
126300097|NCT02282813|454387121|FG002|Overall Study|Withdrawal by Subject|0|||
126300098|NCT02282813|454387119|FG000|Overall Study|Adverse Event|3|||
126300099|NCT02282813|454387120|FG001|Overall Study|Adverse Event|10|||
126300100|NCT02282813|454387121|FG002|Overall Study|Adverse Event|1|||
126300101|NCT02282813|454387119|FG000|Overall Study|Subject non-compliance|1|||
126300102|NCT02282813|454387120|FG001|Overall Study|Subject non-compliance|4|||
126300103|NCT02282813|454387121|FG002|Overall Study|Subject non-compliance|0|||
126300104|NCT02282813|454387119|FG000|Overall Study|Physician Decision|0|||
126300105|NCT02282813|454387120|FG001|Overall Study|Physician Decision|3|||
126300106|NCT02282813|454387121|FG002|Overall Study|Physician Decision|1|||
126300107|NCT02282813|454387119|FG000|Overall Study|Lost to Follow-up|2|||
126300108|NCT02282813|454387120|FG001|Overall Study|Lost to Follow-up|0|||
126300109|NCT02282813|454387121|FG002|Overall Study|Lost to Follow-up|1|||
126300110|NCT02282813|454387119|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
126300111|NCT02282813|454387120|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
126300112|NCT02282813|454387121|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
126300113|NCT02282813|454387119|FG000|Overall Study|Lack of Efficacy|1|||
126300114|NCT02282813|454387120|FG001|Overall Study|Lack of Efficacy|0|||
126300115|NCT02282813|454387121|FG002|Overall Study|Lack of Efficacy|0|||
126300116|NCT02282813|454387119|FG000|Overall Study|Administrative reasons|0|||
126300117|NCT02282813|454387120|FG001|Overall Study|Administrative reasons|1|||
126300118|NCT02282813|454387121|FG002|Overall Study|Administrative reasons|0|||
126300119|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
126300120|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
126300121|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
126300122|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
126300123|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
126300124|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
126300125|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
126300126|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
126300127|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
126300128|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
126300129|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
126300130|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
126300131|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
126300132|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
126300133|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
126300134|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
126300135|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
126300136|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
126300137|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
126300138|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
126300139|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
126300140|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
126300141|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
126300142|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
126300143|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
126300144|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
126300145|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
126300146|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
126300147|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
126300148|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
126300149|NCT03493854|454387124|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
126300150|NCT03493854|454387125|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
126300151|NCT03493854|454387124|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
126300152|NCT03493854|454387125|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
126300153|NCT03493854|454387124|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
126300154|NCT03493854|454387125|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
126300155|NCT00739661|454387126|FG000|Overall Study|Adverse Event|2|||
126300156|NCT00739661|454387127|FG001|Overall Study|Adverse Event|0|||
126300157|NCT00739661|454387126|FG000|Overall Study|Physician decision to withdraw patient|1|||
126300158|NCT00739661|454387127|FG001|Overall Study|Physician decision to withdraw patient|0|||
126300159|NCT00739661|454387126|FG000|Overall Study|Patient decision to withdraw|9|||
126300160|NCT00739661|454387127|FG001|Overall Study|Patient decision to withdraw|4|||
126300161|NCT00739661|454387126|FG000|Overall Study|Disease progression, radiographic|33|||
126300162|NCT00739661|454387127|FG001|Overall Study|Disease progression, radiographic|37|||
126300163|NCT00739661|454387126|FG000|Overall Study|Reason for discontinuation not available|1|||
126300164|NCT00739661|454387127|FG001|Overall Study|Reason for discontinuation not available|1|||
126300165|NCT05343364|454387129|FG000|Overall Study|Miscellaneous|0|||
126300166|NCT05343364|454387130|FG001|Overall Study|Miscellaneous|1|||
126300167|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
126300168|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300169|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300170|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300171|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300172|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300173|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
126300174|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
126300175|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
126300176|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
126300177|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
126300178|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
126300179|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
126300180|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
126300181|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300182|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300183|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300184|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300185|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
126300186|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
126300187|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125883637|NCT01746901|452871516|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
125883638|NCT01746901|452871517|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125883639|NCT01746901|452871518|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125883640|NCT01746901|452871519|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
125883641|NCT01746901|452871511|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125883642|NCT01746901|452871512|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125883643|NCT01746901|452871513|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125883644|NCT01746901|452871514|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125883645|NCT01746901|452871515|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125883646|NCT01746901|452871516|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125883647|NCT01746901|452871517|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
125883648|NCT01746901|452871518|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125883649|NCT01746901|452871519|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
125883650|NCT02968004|452871523|FG000|Main Study Phase|Adverse Event|1|||
125883651|NCT02968004|452871524|FG001|Main Study Phase|Adverse Event|0|||
125883652|NCT02968004|452871523|FG000|Main Study Phase|Withdrawal by Subject|0|||
125883653|NCT02968004|452871524|FG001|Main Study Phase|Withdrawal by Subject|1|||
125883654|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
125883655|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
125883656|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
125883657|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
125883658|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
125883659|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
125883660|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
125883661|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
125883662|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
125883663|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
125883664|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
125883665|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
125883666|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
125883667|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
125883668|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
125883669|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
125883670|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
125883671|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
125883672|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
125883673|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
125883674|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
125883675|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
125883676|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
125883677|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
125883678|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
125883679|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
125883680|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
125883681|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
125883682|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
125883683|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
126044160|NCT03652272|453459531|FG000|3 Month|Withdrawal by Subject|1|||
125883684|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
125883685|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
125883686|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
125883687|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
125883688|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
125883689|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
125883690|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
125883691|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
125883692|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
126044161|NCT03652272|453459532|FG001|3 Month|Withdrawal by Subject|1|||
126044162|NCT03652272|453459531|FG000|3 Month|Lost to Follow-up|16|||
126044163|NCT03652272|453459532|FG001|3 Month|Lost to Follow-up|14|||
126044164|NCT04173247|453459533|FG000|Overall Study|Withdrawal by Subject|0|||
126044165|NCT04173247|453459534|FG001|Overall Study|Withdrawal by Subject|2|||
126044166|NCT04173247|453459533|FG000|Overall Study|Death|1|||
126044167|NCT04173247|453459534|FG001|Overall Study|Death|0|||
126044168|NCT04173247|453459533|FG000|Overall Study|Physician Decision|1|||
126044169|NCT04173247|453459534|FG001|Overall Study|Physician Decision|0|||
126044170|NCT03884101|453459543|FG000|Overall Study|Participant Ongoing in Study|202|||
126044171|NCT03884101|453459544|FG001|Overall Study|Participant Ongoing in Study|186|||
126044172|NCT03884101|453459543|FG000|Overall Study|Death|212|||
125883693|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
125883694|NCT02968004|452871523|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
125883695|NCT02968004|452871524|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
125883696|NCT05029362|452871525|FG000|Overall Study|Lost to Follow-up|9|||
126044173|NCT03884101|453459544|FG001|Overall Study|Death|224|||
125883697|NCT00419952|452871528|FG000|Overall Study|Adverse Event|8|||
125883698|NCT00419952|452871529|FG001|Overall Study|Adverse Event|10|||
125883699|NCT00419952|452871528|FG000|Overall Study|Withdrawal by Subject|44|||
125883700|NCT00419952|452871529|FG001|Overall Study|Withdrawal by Subject|43|||
125883701|NCT00419952|452871528|FG000|Overall Study|Lost to Follow-up|43|||
125883702|NCT00419952|452871529|FG001|Overall Study|Lost to Follow-up|34|||
125883703|NCT00419952|452871528|FG000|Overall Study|Protocol Violation|32|||
125883704|NCT00419952|452871529|FG001|Overall Study|Protocol Violation|24|||
125883705|NCT00419952|452871528|FG000|Overall Study|Pregnancy|4|||
125883706|NCT00419952|452871529|FG001|Overall Study|Pregnancy|2|||
125883707|NCT00419952|452871528|FG000|Overall Study|Physician Decision|1|||
125883708|NCT00419952|452871529|FG001|Overall Study|Physician Decision|3|||
125883709|NCT00419952|452871528|FG000|Overall Study|Incorrectly enrolled|10|||
125883710|NCT00419952|452871529|FG001|Overall Study|Incorrectly enrolled|3|||
125883711|NCT00419952|452871528|FG000|Overall Study|Intake of prohibited medication|2|||
125883712|NCT00419952|452871529|FG001|Overall Study|Intake of prohibited medication|2|||
126044174|NCT03884101|453459543|FG000|Overall Study|Lost to Follow-up|0|||
126044175|NCT03884101|453459544|FG001|Overall Study|Lost to Follow-up|1|||
126044176|NCT03884101|453459543|FG000|Overall Study|Withdrawal by Subject|6|||
126044177|NCT03884101|453459544|FG001|Overall Study|Withdrawal by Subject|11|||
126044178|NCT03582033|453459549|FG000|Part A|Other|0|||
126044179|NCT03582033|453459550|FG001|Part A|Other|0|||
126044180|NCT03582033|453459551|FG002|Part A|Other|0|||
126044181|NCT03582033|453459552|FG003|Part A|Other|0|||
126044182|NCT03582033|453459553|FG004|Part A|Other|2|||
126044183|NCT03582033|453459554|FG005|Part A|Other|0|||
126044184|NCT03582033|453459555|FG006|Part A|Other|0|||
126044185|NCT03582033|453459556|FG007|Part A|Other|0|||
126044186|NCT03582033|453459557|FG008|Part A|Other|0|||
126044187|NCT03582033|453459558|FG009|Part A|Other|0|||
126044188|NCT03582033|453459549|FG000|Part A|Death|1|||
126044189|NCT03582033|453459550|FG001|Part A|Death|1|||
126044190|NCT03582033|453459551|FG002|Part A|Death|2|||
126044191|NCT03582033|453459552|FG003|Part A|Death|4|||
126044192|NCT03582033|453459553|FG004|Part A|Death|11|||
126044193|NCT03582033|453459554|FG005|Part A|Death|0|||
126044194|NCT03582033|453459555|FG006|Part A|Death|0|||
126044195|NCT03582033|453459556|FG007|Part A|Death|0|||
126044196|NCT03582033|453459557|FG008|Part A|Death|0|||
126044197|NCT03582033|453459558|FG009|Part A|Death|0|||
126044198|NCT03582033|453459549|FG000|Part A|Lost to Follow-up|0|||
126044199|NCT03582033|453459550|FG001|Part A|Lost to Follow-up|0|||
126044200|NCT03582033|453459551|FG002|Part A|Lost to Follow-up|0|||
126044201|NCT03582033|453459552|FG003|Part A|Lost to Follow-up|0|||
126044202|NCT03582033|453459553|FG004|Part A|Lost to Follow-up|1|||
126044203|NCT03582033|453459554|FG005|Part A|Lost to Follow-up|0|||
126044204|NCT03582033|453459555|FG006|Part A|Lost to Follow-up|0|||
126044205|NCT03582033|453459556|FG007|Part A|Lost to Follow-up|0|||
126044206|NCT03582033|453459557|FG008|Part A|Lost to Follow-up|0|||
126044207|NCT03582033|453459558|FG009|Part A|Lost to Follow-up|0|||
126044208|NCT03582033|453459549|FG000|Part A|Study terminated by sponsor|0|||
126044209|NCT03582033|453459550|FG001|Part A|Study terminated by sponsor|0|||
126044210|NCT03582033|453459551|FG002|Part A|Study terminated by sponsor|0|||
125883713|NCT00419952|452871528|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
125883714|NCT00419952|452871529|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
126044211|NCT03582033|453459552|FG003|Part A|Study terminated by sponsor|2|||
126044212|NCT03582033|453459553|FG004|Part A|Study terminated by sponsor|1|||
126044213|NCT03582033|453459554|FG005|Part A|Study terminated by sponsor|0|||
126044214|NCT03582033|453459555|FG006|Part A|Study terminated by sponsor|0|||
126044215|NCT03582033|453459556|FG007|Part A|Study terminated by sponsor|0|||
126367401|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367402|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367403|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367404|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367405|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367406|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367407|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367408|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367409|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367410|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367411|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
126367412|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367413|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126300188|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300189|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300190|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300191|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
126300192|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
126300193|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
126300194|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
126300195|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
126300196|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
126300197|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300198|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
126300199|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300200|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300201|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300202|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300203|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
126300204|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
126300205|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
126300206|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
126300207|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
126300208|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
126300209|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
126300210|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
126300211|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
126300212|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
126300213|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
126300214|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
126300215|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300216|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300217|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
126300218|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
126300219|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300220|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300221|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300222|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300223|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
126300224|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
126300225|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300226|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300227|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300228|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300229|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
126300230|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300231|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300232|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300233|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300234|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300235|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300236|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
126300237|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300238|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300239|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126300240|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126300241|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
126300242|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126300243|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126367414|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367415|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367416|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367417|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367418|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126300244|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126300245|NCT02105987|454387131|FG000|Continuation Phase|Protocol Violation|0|||
126300246|NCT02105987|454387132|FG001|Continuation Phase|Protocol Violation|0|||
126367419|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126300247|NCT02105987|454387133|FG002|Continuation Phase|Protocol Violation|0|||
126300248|NCT02105987|454387134|FG003|Continuation Phase|Protocol Violation|0|||
126300249|NCT02105987|454387135|FG004|Continuation Phase|Protocol Violation|1|||
126044216|NCT03582033|453459557|FG008|Part A|Study terminated by sponsor|0|||
126044217|NCT03582033|453459558|FG009|Part A|Study terminated by sponsor|0|||
126044218|NCT03582033|453459549|FG000|Part A|Withdrawal by Subject|1|||
126044219|NCT03582033|453459550|FG001|Part A|Withdrawal by Subject|1|||
126044220|NCT03582033|453459551|FG002|Part A|Withdrawal by Subject|0|||
126044221|NCT03582033|453459552|FG003|Part A|Withdrawal by Subject|1|||
126044222|NCT03582033|453459553|FG004|Part A|Withdrawal by Subject|7|||
126044223|NCT03582033|453459554|FG005|Part A|Withdrawal by Subject|0|||
126044224|NCT03582033|453459555|FG006|Part A|Withdrawal by Subject|0|||
126044225|NCT03582033|453459556|FG007|Part A|Withdrawal by Subject|0|||
126044226|NCT03582033|453459557|FG008|Part A|Withdrawal by Subject|0|||
126044227|NCT03582033|453459558|FG009|Part A|Withdrawal by Subject|0|||
126044228|NCT03582033|453459549|FG000|Part B|Death|0|||
126044229|NCT03582033|453459550|FG001|Part B|Death|0|||
126044230|NCT03582033|453459551|FG002|Part B|Death|0|||
126044231|NCT03582033|453459552|FG003|Part B|Death|0|||
126044232|NCT03582033|453459553|FG004|Part B|Death|0|||
126044233|NCT03582033|453459554|FG005|Part B|Death|2|||
126044234|NCT03582033|453459555|FG006|Part B|Death|0|||
126044235|NCT03582033|453459556|FG007|Part B|Death|0|||
126044236|NCT03582033|453459557|FG008|Part B|Death|0|||
126044237|NCT03582033|453459558|FG009|Part B|Death|0|||
126044238|NCT03582033|453459549|FG000|Part B|Study terminated by sponsor|0|||
126044239|NCT03582033|453459550|FG001|Part B|Study terminated by sponsor|0|||
126044240|NCT03582033|453459551|FG002|Part B|Study terminated by sponsor|0|||
126044241|NCT03582033|453459552|FG003|Part B|Study terminated by sponsor|0|||
126044242|NCT03582033|453459553|FG004|Part B|Study terminated by sponsor|0|||
126044243|NCT03582033|453459554|FG005|Part B|Study terminated by sponsor|12|||
126044244|NCT03582033|453459555|FG006|Part B|Study terminated by sponsor|0|||
126300250|NCT02105987|454387136|FG005|Continuation Phase|Protocol Violation|0|||
126300251|NCT01420068|454387138|FG000|Overall Study|Administrative problems|1|||
126300252|NCT01420068|454387139|FG001|Overall Study|Administrative problems|3|||
126300253|NCT01420068|454387138|FG000|Overall Study|Withdrawal by Subject|1|||
126300254|NCT01420068|454387139|FG001|Overall Study|Withdrawal by Subject|2|||
126300255|NCT01252095|454387140|FG000|Overall Study|Disease progression|1|||
126300256|NCT01252095|454387141|FG001|Overall Study|Disease progression|0|||
126300257|NCT04830969|454387144|FG000|Overall Study|Withdrawal by Subject|6|||
126300258|NCT04830969|454387145|FG001|Overall Study|Withdrawal by Subject|2|||
126300259|NCT04830969|454387144|FG000|Overall Study|Protocol Violation|3|||
126300260|NCT04830969|454387145|FG001|Overall Study|Protocol Violation|9|||
126300261|NCT04830969|454387144|FG000|Overall Study|Lost to Follow-up|4|||
126300262|NCT04830969|454387145|FG001|Overall Study|Lost to Follow-up|4|||
126300263|NCT01153815|454387149|FG000|Overall Study|Adverse Event|3|||
126300264|NCT01153815|454387150|FG001|Overall Study|Adverse Event|1|||
126300265|NCT01153815|454387149|FG000|Overall Study|Withdrawal by Subject|6|||
126300266|NCT01153815|454387150|FG001|Overall Study|Withdrawal by Subject|4|||
126300267|NCT01786993|454387151|FG000|Overall Study|Death|6|||
126300268|NCT01786993|454387152|FG001|Overall Study|Death|7|||
126300269|NCT01786993|454387151|FG000|Overall Study|Withdrawal by Subject|3|||
126300270|NCT01786993|454387152|FG001|Overall Study|Withdrawal by Subject|2|||
126300271|NCT01786993|454387151|FG000|Overall Study|Lost to Follow-up|0|||
126300272|NCT01786993|454387152|FG001|Overall Study|Lost to Follow-up|1|||
126300273|NCT01786993|454387151|FG000|Overall Study|Subject Non-Compliance|1|||
126300274|NCT01786993|454387152|FG001|Overall Study|Subject Non-Compliance|0|||
126300275|NCT01786993|454387151|FG000|Overall Study|System Explant|1|||
126300276|NCT01786993|454387152|FG001|Overall Study|System Explant|0|||
126300277|NCT01786993|454387151|FG000|Overall Study|Hospice Admission|1|||
126300278|NCT01786993|454387152|FG001|Overall Study|Hospice Admission|0|||
126300279|NCT01890122|454387153|FG000|Overall Study|Adverse Event|1|||
126300280|NCT01890122|454387154|FG001|Overall Study|Adverse Event|1|||
126300281|NCT01890122|454387155|FG002|Overall Study|Adverse Event|1|||
126300282|NCT01890122|454387156|FG003|Overall Study|Adverse Event|2|||
126300283|NCT01890122|454387153|FG000|Overall Study|Major Protocol Deviation|3|||
126300284|NCT01890122|454387154|FG001|Overall Study|Major Protocol Deviation|1|||
126044245|NCT03582033|453459556|FG007|Part B|Study terminated by sponsor|0|||
126044246|NCT03582033|453459557|FG008|Part B|Study terminated by sponsor|0|||
126044247|NCT03582033|453459558|FG009|Part B|Study terminated by sponsor|0|||
126044248|NCT03582033|453459549|FG000|Part B|Withdrawal by Subject|0|||
126044249|NCT03582033|453459550|FG001|Part B|Withdrawal by Subject|0|||
126044250|NCT03582033|453459551|FG002|Part B|Withdrawal by Subject|0|||
126044251|NCT03582033|453459552|FG003|Part B|Withdrawal by Subject|0|||
126044252|NCT03582033|453459553|FG004|Part B|Withdrawal by Subject|0|||
126300285|NCT01890122|454387155|FG002|Overall Study|Major Protocol Deviation|0|||
126300286|NCT01890122|454387156|FG003|Overall Study|Major Protocol Deviation|1|||
126300287|NCT01890122|454387153|FG000|Overall Study|Lost to Follow-up|0|||
126300288|NCT01890122|454387154|FG001|Overall Study|Lost to Follow-up|1|||
126300289|NCT01890122|454387155|FG002|Overall Study|Lost to Follow-up|2|||
126300290|NCT01890122|454387156|FG003|Overall Study|Lost to Follow-up|2|||
126044253|NCT03582033|453459554|FG005|Part B|Withdrawal by Subject|6|||
126044254|NCT03582033|453459555|FG006|Part B|Withdrawal by Subject|0|||
126300291|NCT01890122|454387153|FG000|Overall Study|Voluntary Withdrawal|8|||
125883715|NCT00419952|452871528|FG000|Overall Study|Diary or medication non-compliance|2|||
125883716|NCT00419952|452871529|FG001|Overall Study|Diary or medication non-compliance|4|||
125883717|NCT00419952|452871528|FG000|Overall Study|Abnormal ECG|1|||
125883718|NCT00419952|452871529|FG001|Overall Study|Abnormal ECG|0|||
125883719|NCT03126591|452871530|FG000|Overall Study|Death|6|||
125883720|NCT03126591|452871531|FG001|Overall Study|Death|3|||
125883721|NCT03126591|452871532|FG002|Overall Study|Death|17|||
125883722|NCT03126591|452871530|FG000|Overall Study|Progressive Disease|0|||
125883723|NCT03126591|452871531|FG001|Overall Study|Progressive Disease|1|||
125883724|NCT03126591|452871532|FG002|Overall Study|Progressive Disease|2|||
125883725|NCT03126591|452871530|FG000|Overall Study|Terminated by Sponsor|0|||
125883726|NCT03126591|452871531|FG001|Overall Study|Terminated by Sponsor|1|||
125883727|NCT03126591|452871532|FG002|Overall Study|Terminated by Sponsor|4|||
126300292|NCT01890122|454387154|FG001|Overall Study|Voluntary Withdrawal|8|||
126300293|NCT01890122|454387155|FG002|Overall Study|Voluntary Withdrawal|2|||
126300294|NCT01890122|454387156|FG003|Overall Study|Voluntary Withdrawal|11|||
126300295|NCT01890122|454387153|FG000|Overall Study|Lack of Efficacy|14|||
126300296|NCT01890122|454387154|FG001|Overall Study|Lack of Efficacy|24|||
126300297|NCT01890122|454387155|FG002|Overall Study|Lack of Efficacy|7|||
126300298|NCT01890122|454387156|FG003|Overall Study|Lack of Efficacy|41|||
126300299|NCT01890122|454387153|FG000|Overall Study|Reason not Specified|0|||
126300300|NCT01890122|454387154|FG001|Overall Study|Reason not Specified|1|||
126300301|NCT01890122|454387155|FG002|Overall Study|Reason not Specified|1|||
126300302|NCT01890122|454387156|FG003|Overall Study|Reason not Specified|2|||
126300303|NCT01890122|454387153|FG000|Overall Study|Randomized but not Treated|1|||
126300304|NCT01890122|454387154|FG001|Overall Study|Randomized but not Treated|1|||
126300305|NCT01890122|454387155|FG002|Overall Study|Randomized but not Treated|0|||
126300306|NCT01890122|454387156|FG003|Overall Study|Randomized but not Treated|0|||
126300307|NCT02062450|454387157|FG000|Overall Study|No follow-up visit|124|||
126300308|NCT02907177|454387161|FG000|Overall Study|Death|0|||
126300309|NCT02907177|454387162|FG001|Overall Study|Death|1|||
126300310|NCT02907177|454387161|FG000|Overall Study|Physician Decision|3|||
126300311|NCT02907177|454387162|FG001|Overall Study|Physician Decision|3|||
126300312|NCT02907177|454387161|FG000|Overall Study|Withdrawal by Subject|15|||
126300313|NCT02907177|454387162|FG001|Overall Study|Withdrawal by Subject|7|||
126300314|NCT02907177|454387161|FG000|Overall Study|Sponsor's Decision|50|||
126300315|NCT02907177|454387162|FG001|Overall Study|Sponsor's Decision|57|||
126300316|NCT02505217|454387163|FG000|Overall Study|Withdrawal by Subject|1|||
126300317|NCT02505217|454387164|FG001|Overall Study|Withdrawal by Subject|2|||
126300318|NCT00153179|454387165|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
126300319|NCT00153179|454387166|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
126300320|NCT00153179|454387167|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
126300321|NCT00153179|454387168|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
126300322|NCT04495829|454387169|FG000|Overall Study|Lost to Follow-up|2|||
126300323|NCT04495829|454387169|FG000|Overall Study|Inclusion criterion not met|3|||
126300324|NCT02712554|454387171|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
126300325|NCT02712554|454387172|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
126300326|NCT02712554|454387171|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
126300327|NCT02712554|454387172|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
126300328|NCT02712554|454387171|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
126300329|NCT02712554|454387172|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
126300330|NCT02712554|454387171|FG000|Part B: Qualification Phase|Adverse Event|0|||
126300331|NCT02712554|454387172|FG001|Part B: Qualification Phase|Adverse Event|1|||
126300332|NCT02712554|454387171|FG000|Part B: Treatment Phase|Adverse Event|0|||
126300333|NCT02712554|454387172|FG001|Part B: Treatment Phase|Adverse Event|1|||
126300334|NCT02712554|454387171|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
126300335|NCT02712554|454387172|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
126300336|NCT02712554|454387171|FG000|Part B: Treatment Phase|Other|0|||
126300337|NCT02712554|454387172|FG001|Part B: Treatment Phase|Other|1|||
126300338|NCT01102257|454388986|FG000|Overall Study|Adverse Event|1|||
126300339|NCT01102257|454388987|FG001|Overall Study|Adverse Event|0|||
125883728|NCT03126591|452871530|FG000|Overall Study|Withdrawal by Subject|1|||
125883729|NCT03126591|452871531|FG001|Overall Study|Withdrawal by Subject|1|||
125883730|NCT03126591|452871532|FG002|Overall Study|Withdrawal by Subject|4|||
126300340|NCT01102257|454388986|FG000|Overall Study|Adverse Event|1|||
126300341|NCT01102257|454388987|FG001|Overall Study|Adverse Event|0|||
126300342|NCT02525783|454388988|FG000|Overall Study|Lost to Follow-up|10|||
126300343|NCT03048747|454388989|FG000|Overall Study|Adverse Event|2|||
126300344|NCT03048747|454388989|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
126300345|NCT03048747|454388989|FG000|Overall Study|Physician Decision|1|||
125883731|NCT02158546|452871533|FG000|Overall Study|Physician Decision|0|||
125883732|NCT02158546|452871534|FG001|Overall Study|Physician Decision|1|||
125883733|NCT02158546|452871535|FG002|Overall Study|Physician Decision|0|||
125883734|NCT02158546|452871536|FG003|Overall Study|Physician Decision|0|||
125883735|NCT02158546|452871533|FG000|Overall Study|Non-compliance|0|||
126300346|NCT00866281|454388990|FG000|Overall Study|Adverse Event|1|||
126300347|NCT00866281|454388991|FG001|Overall Study|Adverse Event|0|||
126300348|NCT00866281|454388990|FG000|Overall Study|Withdrawal by participants|3|||
126300349|NCT00866281|454388991|FG001|Overall Study|Withdrawal by participants|0|||
126300350|NCT00866281|454388990|FG000|Overall Study|Disease progression|3|||
126300351|NCT00866281|454388991|FG001|Overall Study|Disease progression|11|||
126300352|NCT00866281|454388990|FG000|Overall Study|New cancer therapy|0|||
126300353|NCT00866281|454388991|FG001|Overall Study|New cancer therapy|4|||
126300354|NCT01894841|454388992|FG000|Overall Study|Withdrawal by Subject|9|||
126300355|NCT01894841|454388993|FG001|Overall Study|Withdrawal by Subject|4|||
126300356|NCT01894841|454388992|FG000|Overall Study|Withdrawn by investigator|2|||
126300357|NCT01894841|454388993|FG001|Overall Study|Withdrawn by investigator|2|||
126300358|NCT01894841|454388992|FG000|Overall Study|Lost to Follow-up|7|||
126300359|NCT01894841|454388993|FG001|Overall Study|Lost to Follow-up|3|||
126300360|NCT00529087|454388997|FG000|Overall Study|Adverse Event|10|||
126300361|NCT00529087|454388998|FG001|Overall Study|Adverse Event|13|||
126300362|NCT00529087|454388999|FG002|Overall Study|Adverse Event|4|||
126300363|NCT00529087|454388997|FG000|Overall Study|Lost to Follow-up|6|||
126300364|NCT00529087|454388998|FG001|Overall Study|Lost to Follow-up|4|||
126300365|NCT00529087|454388999|FG002|Overall Study|Lost to Follow-up|1|||
126300366|NCT00529087|454388997|FG000|Overall Study|Protocol Violation|8|||
126300367|NCT00529087|454388998|FG001|Overall Study|Protocol Violation|7|||
126300368|NCT00529087|454388999|FG002|Overall Study|Protocol Violation|6|||
126300369|NCT00529087|454388997|FG000|Overall Study|Withdrawal by Subject|3|||
126300370|NCT00529087|454388998|FG001|Overall Study|Withdrawal by Subject|3|||
126300371|NCT00529087|454388999|FG002|Overall Study|Withdrawal by Subject|3|||
126300372|NCT00529087|454388997|FG000|Overall Study|Protocol deviation|1|||
126300373|NCT00529087|454388998|FG001|Overall Study|Protocol deviation|1|||
126300374|NCT00529087|454388999|FG002|Overall Study|Protocol deviation|2|||
126300375|NCT00318474|454389000|FG000|Overall Study|Adverse Event|1|||
126300376|NCT00318474|454389001|FG001|Overall Study|Adverse Event|1|||
126300377|NCT00318474|454389000|FG000|Overall Study|Lost to Follow-up|0|||
126300378|NCT00318474|454389001|FG001|Overall Study|Lost to Follow-up|1|||
126300379|NCT00318474|454389000|FG000|Overall Study|Pregnancy|0|||
126300380|NCT00318474|454389001|FG001|Overall Study|Pregnancy|2|||
126300381|NCT00318474|454389000|FG000|Overall Study|Protocol Violation|1|||
126300382|NCT00318474|454389001|FG001|Overall Study|Protocol Violation|0|||
126300383|NCT00318474|454389000|FG000|Overall Study|Withdrawal by Subject|3|||
126300384|NCT00318474|454389001|FG001|Overall Study|Withdrawal by Subject|2|||
126300385|NCT00318474|454389000|FG000|Overall Study|Fall in GFR|3|||
126300386|NCT00318474|454389001|FG001|Overall Study|Fall in GFR|3|||
126300387|NCT00318474|454389000|FG000|Overall Study|Post-therapy hyperflycemia|0|||
126300388|NCT00318474|454389001|FG001|Overall Study|Post-therapy hyperflycemia|1|||
126300389|NCT00318474|454389000|FG000|Overall Study|Trial terminated|10|||
126300390|NCT00318474|454389001|FG001|Overall Study|Trial terminated|7|||
126300391|NCT00457002|454389006|FG000|Overall Study|Death|40|||
126300392|NCT00457002|454389007|FG001|Overall Study|Death|47|||
126300393|NCT00457002|454389006|FG000|Overall Study|Adverse Event|284|||
126300394|NCT00457002|454389007|FG001|Overall Study|Adverse Event|260|||
126300395|NCT00457002|454389006|FG000|Overall Study|Withdrawal by Subject|299|||
126300396|NCT00457002|454389007|FG001|Overall Study|Withdrawal by Subject|271|||
126300397|NCT00457002|454389006|FG000|Overall Study|Lost to Follow-up|72|||
126300398|NCT00457002|454389007|FG001|Overall Study|Lost to Follow-up|71|||
126300399|NCT00457002|454389006|FG000|Overall Study|Poor/Non-compliance|46|||
126300400|NCT00457002|454389007|FG001|Overall Study|Poor/Non-compliance|33|||
126300401|NCT00457002|454389006|FG000|Overall Study|No longer met criteria|41|||
126300402|NCT00457002|454389007|FG001|Overall Study|No longer met criteria|37|||
126300403|NCT00457002|454389006|FG000|Overall Study|Administrative reason by Sponsor|1|||
126300404|NCT00457002|454389007|FG001|Overall Study|Administrative reason by Sponsor|0|||
126300405|NCT00457002|454389006|FG000|Overall Study|non-specified|29|||
126300406|NCT00457002|454389007|FG001|Overall Study|non-specified|38|||
126300407|NCT00457002|454389006|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
126300408|NCT00457002|454389007|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
126300409|NCT00454246|454389013|FG000|Overall Study|Adverse Event|2|||
126300410|NCT00454246|454389014|FG001|Overall Study|Adverse Event|2|||
126300411|NCT00454246|454389015|FG002|Overall Study|Adverse Event|0|||
126300412|NCT00454246|454389013|FG000|Overall Study|Violation of selection criteria at entry|6|||
126300413|NCT00454246|454389014|FG001|Overall Study|Violation of selection criteria at entry|0|||
126300414|NCT00454246|454389015|FG002|Overall Study|Violation of selection criteria at entry|0|||
126300415|NCT00454246|454389013|FG000|Overall Study|Protocol Violation|1|||
126300416|NCT00454246|454389014|FG001|Overall Study|Protocol Violation|0|||
126300417|NCT00454246|454389015|FG002|Overall Study|Protocol Violation|0|||
126300418|NCT00454246|454389013|FG000|Overall Study|Refused Treatment|1|||
126300419|NCT00454246|454389014|FG001|Overall Study|Refused Treatment|1|||
126300420|NCT00454246|454389015|FG002|Overall Study|Refused Treatment|0|||
126300421|NCT00454246|454389013|FG000|Overall Study|Failure to return|1|||
125883736|NCT02158546|452871534|FG001|Overall Study|Non-compliance|1|||
126300422|NCT00454246|454389014|FG001|Overall Study|Failure to return|0|||
126300423|NCT00454246|454389015|FG002|Overall Study|Failure to return|0|||
126300424|NCT00454246|454389013|FG000|Overall Study|Early termination of study|62|||
126300425|NCT00454246|454389014|FG001|Overall Study|Early termination of study|26|||
126300426|NCT00454246|454389015|FG002|Overall Study|Early termination of study|9|||
126300427|NCT02283268|454389016|FG000|Overall Study|Withdrawal by Subject|1|||
126300428|NCT05326529|454389017|FG000|Overall Study|Lack of Efficacy|0|||
126300429|NCT05326529|454389018|FG001|Overall Study|Lack of Efficacy|1|||
126300430|NCT05326529|454389019|FG002|Overall Study|Lack of Efficacy|0|||
126300431|NCT05326529|454389017|FG000|Overall Study|Physician Decision|0|||
126300432|NCT05326529|454389018|FG001|Overall Study|Physician Decision|0|||
126300433|NCT05326529|454389019|FG002|Overall Study|Physician Decision|2|||
126300434|NCT01379768|454389020|FG000|Overall Study|Adverse Event|1|||
126300435|NCT01379768|454389021|FG001|Overall Study|Adverse Event|1|||
126300436|NCT01379768|454389022|FG002|Overall Study|Adverse Event|0|||
126300437|NCT01379768|454389020|FG000|Overall Study|Lost to Follow-up|2|||
126300438|NCT01379768|454389021|FG001|Overall Study|Lost to Follow-up|0|||
126300439|NCT01379768|454389022|FG002|Overall Study|Lost to Follow-up|0|||
126300440|NCT00708552|454389028|FG000|Overall Study|Adverse Event|10|||
126300441|NCT00708552|454389029|FG001|Overall Study|Adverse Event|3|||
126300442|NCT00708552|454389030|FG002|Overall Study|Adverse Event|4|||
126300443|NCT00708552|454389031|FG003|Overall Study|Adverse Event|6|||
126300444|NCT00708552|454389028|FG000|Overall Study|Lack of Efficacy|0|||
126300445|NCT00708552|454389029|FG001|Overall Study|Lack of Efficacy|4|||
126300446|NCT00708552|454389030|FG002|Overall Study|Lack of Efficacy|1|||
126300447|NCT00708552|454389031|FG003|Overall Study|Lack of Efficacy|0|||
126300448|NCT00708552|454389028|FG000|Overall Study|Protocol Violation|0|||
126300449|NCT00708552|454389029|FG001|Overall Study|Protocol Violation|0|||
126300450|NCT00708552|454389030|FG002|Overall Study|Protocol Violation|2|||
126300451|NCT00708552|454389031|FG003|Overall Study|Protocol Violation|4|||
126300452|NCT00708552|454389028|FG000|Overall Study|Lost to Follow-up|4|||
126300453|NCT00708552|454389029|FG001|Overall Study|Lost to Follow-up|2|||
126300454|NCT00708552|454389030|FG002|Overall Study|Lost to Follow-up|0|||
126300455|NCT00708552|454389031|FG003|Overall Study|Lost to Follow-up|1|||
126300456|NCT00708552|454389028|FG000|Overall Study|Physician Decision|1|||
126300457|NCT00708552|454389029|FG001|Overall Study|Physician Decision|2|||
126300458|NCT00708552|454389030|FG002|Overall Study|Physician Decision|0|||
126300459|NCT00708552|454389031|FG003|Overall Study|Physician Decision|0|||
126300460|NCT00708552|454389028|FG000|Overall Study|Withdrawal by Subject|12|||
126300461|NCT00708552|454389029|FG001|Overall Study|Withdrawal by Subject|7|||
126300462|NCT00708552|454389030|FG002|Overall Study|Withdrawal by Subject|8|||
126300463|NCT00708552|454389031|FG003|Overall Study|Withdrawal by Subject|10|||
126300464|NCT01017874|454389032|FG000|Overall Study|Withdrawal by Subject|23|||
126300465|NCT01017874|454389033|FG001|Overall Study|Withdrawal by Subject|20|||
126300466|NCT01017874|454389032|FG000|Overall Study|Sponsor decision|3|||
126300467|NCT01017874|454389033|FG001|Overall Study|Sponsor decision|1|||
126300468|NCT01017874|454389032|FG000|Overall Study|Lost to Follow-up|3|||
126300469|NCT01017874|454389033|FG001|Overall Study|Lost to Follow-up|2|||
126300470|NCT01017874|454389032|FG000|Overall Study|Physician Decision|1|||
126300471|NCT01017874|454389033|FG001|Overall Study|Physician Decision|3|||
126300472|NCT02588612|454389034|FG000|Overall Study|Physician Decision|1|||
126300473|NCT02588612|454389034|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
126300474|NCT02588612|454389034|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
126300475|NCT02588612|454389034|FG000|Overall Study|Death prior to T-cell infusion|1|||
126300476|NCT03809663|454389042|FG000|Overall Study|Decision by sponsor|24|||
126300477|NCT03809663|454389043|FG001|Overall Study|Decision by sponsor|18|||
126300478|NCT03809663|454389044|FG002|Overall Study|Decision by sponsor|20|||
126300479|NCT03809663|454389045|FG003|Overall Study|Decision by sponsor|20|||
126300480|NCT03809663|454389046|FG004|Overall Study|Decision by sponsor|0|||
126300481|NCT03809663|454389047|FG005|Overall Study|Decision by sponsor|0|||
126300482|NCT03809663|454389042|FG000|Overall Study|Withdrawal by Subject|26|||
126300483|NCT03809663|454389043|FG001|Overall Study|Withdrawal by Subject|22|||
126300484|NCT03809663|454389044|FG002|Overall Study|Withdrawal by Subject|27|||
126300485|NCT03809663|454389045|FG003|Overall Study|Withdrawal by Subject|26|||
126300486|NCT03809663|454389046|FG004|Overall Study|Withdrawal by Subject|0|||
126300487|NCT03809663|454389047|FG005|Overall Study|Withdrawal by Subject|0|||
126300488|NCT03809663|454389042|FG000|Overall Study|Lost to Follow-up|1|||
125883737|NCT02158546|452871535|FG002|Overall Study|Non-compliance|0|||
125883738|NCT02158546|452871536|FG003|Overall Study|Non-compliance|1|||
125883739|NCT02158546|452871533|FG000|Overall Study|Failure to meet eligibility criteria|0|||
126300489|NCT03809663|454389043|FG001|Overall Study|Lost to Follow-up|4|||
125883740|NCT02158546|452871534|FG001|Overall Study|Failure to meet eligibility criteria|1|||
126300490|NCT03809663|454389044|FG002|Overall Study|Lost to Follow-up|1|||
126300491|NCT03809663|454389045|FG003|Overall Study|Lost to Follow-up|1|||
126300492|NCT03809663|454389046|FG004|Overall Study|Lost to Follow-up|0|||
126300493|NCT03809663|454389047|FG005|Overall Study|Lost to Follow-up|0|||
125883741|NCT02158546|452871535|FG002|Overall Study|Failure to meet eligibility criteria|0|||
125883742|NCT02158546|452871536|FG003|Overall Study|Failure to meet eligibility criteria|0|||
125883743|NCT02158546|452871533|FG000|Overall Study|Lack of Efficacy|1|||
126300494|NCT02042014|454389049|FG000|Overall Study|Adverse Event|1|||
126300495|NCT02042014|454389049|FG000|Overall Study|Physician Decision|7|||
126300496|NCT00558701|454389054|FG000|Overall Study|Protocol Deviations|1|||
126300497|NCT00558701|454389055|FG001|Overall Study|Protocol Deviations|4|||
126300498|NCT00105079|454389056|FG000|Overall Study|Adverse Event|5|||
126300499|NCT00105079|454389057|FG001|Overall Study|Adverse Event|12|||
126300500|NCT00105079|454389056|FG000|Overall Study|Death|3|||
126300501|NCT00105079|454389057|FG001|Overall Study|Death|1|||
126300502|NCT00105079|454389056|FG000|Overall Study|Lost to Follow-up|12|||
126300503|NCT00105079|454389057|FG001|Overall Study|Lost to Follow-up|12|||
126300504|NCT00105079|454389056|FG000|Overall Study|Lack of Efficacy|9|||
126300505|NCT00105079|454389057|FG001|Overall Study|Lack of Efficacy|3|||
126300506|NCT00105079|454389056|FG000|Overall Study|Refused treatment|6|||
126300507|NCT00105079|454389057|FG001|Overall Study|Refused treatment|4|||
126300508|NCT00105079|454389056|FG000|Overall Study|Violation of selection criteria at entry|0|||
126300509|NCT00105079|454389057|FG001|Overall Study|Violation of selection criteria at entry|2|||
126300510|NCT00105079|454389056|FG000|Overall Study|Protocol Violation|1|||
126300511|NCT00105079|454389057|FG001|Overall Study|Protocol Violation|0|||
126300512|NCT00105079|454389056|FG000|Overall Study|Other|3|||
126300513|NCT00105079|454389057|FG001|Overall Study|Other|1|||
126300514|NCT00386360|454389058|FG000|Overall Study|Adverse Event|4|||
126300515|NCT00386360|454389059|FG001|Overall Study|Adverse Event|2|||
126300516|NCT00386360|454389058|FG000|Overall Study|Physician Decision|2|||
126300517|NCT00386360|454389059|FG001|Overall Study|Physician Decision|2|||
126300518|NCT00386360|454389058|FG000|Overall Study|Lost to Follow-up|0|||
126300519|NCT00386360|454389059|FG001|Overall Study|Lost to Follow-up|2|||
126300520|NCT00386360|454389058|FG000|Overall Study|Protocol Violation|0|||
126300521|NCT00386360|454389059|FG001|Overall Study|Protocol Violation|3|||
126300522|NCT00386360|454389058|FG000|Overall Study|Withdrawal by Subject|3|||
126300523|NCT00386360|454389059|FG001|Overall Study|Withdrawal by Subject|6|||
126300524|NCT00386360|454389058|FG000|Overall Study|Did not take any study medication|0|||
126300525|NCT00386360|454389059|FG001|Overall Study|Did not take any study medication|2|||
126300526|NCT02230904|454389062|FG000|Overall Study|Safety follow up could not take place|0|||
126300527|NCT02230904|454389063|FG001|Overall Study|Safety follow up could not take place|1|||
126300528|NCT00789373|454389067|FG000|Induction|Adverse Event|64|||
126300529|NCT00789373|454389068|FG001|Induction|Adverse Event|0|||
126300530|NCT00789373|454389069|FG002|Induction|Adverse Event|0|||
126300531|NCT00789373|454389067|FG000|Induction|Death Due to study disease|24|||
126300532|NCT00789373|454389068|FG001|Induction|Death Due to study disease|0|||
126300533|NCT00789373|454389069|FG002|Induction|Death Due to study disease|0|||
126300534|NCT00789373|454389067|FG000|Induction|Death due to adverse event|19|||
126300535|NCT00789373|454389068|FG001|Induction|Death due to adverse event|0|||
126300536|NCT00789373|454389069|FG002|Induction|Death due to adverse event|0|||
126300537|NCT00789373|454389067|FG000|Induction|Death due to toxicity|11|||
126300538|NCT00789373|454389068|FG001|Induction|Death due to toxicity|0|||
126300539|NCT00789373|454389069|FG002|Induction|Death due to toxicity|0|||
126300540|NCT00789373|454389067|FG000|Induction|Death due to procedure|1|||
126300541|NCT00789373|454389068|FG001|Induction|Death due to procedure|0|||
126300542|NCT00789373|454389069|FG002|Induction|Death due to procedure|0|||
126300543|NCT00789373|454389067|FG000|Induction|Investigator decision|7|||
126300544|NCT00789373|454389068|FG001|Induction|Investigator decision|0|||
126300545|NCT00789373|454389069|FG002|Induction|Investigator decision|0|||
126300546|NCT00789373|454389067|FG000|Induction|Protocol entry criteria not met|9|||
126300547|NCT00789373|454389068|FG001|Induction|Protocol entry criteria not met|0|||
126300548|NCT00789373|454389069|FG002|Induction|Protocol entry criteria not met|0|||
126300549|NCT00789373|454389067|FG000|Induction|Lost to Follow-up|6|||
126300550|NCT00789373|454389068|FG001|Induction|Lost to Follow-up|0|||
126300551|NCT00789373|454389069|FG002|Induction|Lost to Follow-up|0|||
126044255|NCT03582033|453459556|FG007|Part B|Withdrawal by Subject|0|||
126300552|NCT00789373|454389067|FG000|Induction|Protocol Violation|1|||
126300553|NCT00789373|454389068|FG001|Induction|Protocol Violation|0|||
126300554|NCT00789373|454389069|FG002|Induction|Protocol Violation|0|||
126300555|NCT00789373|454389067|FG000|Induction|Progressive Disease|220|||
126300556|NCT00789373|454389068|FG001|Induction|Progressive Disease|0|||
126300557|NCT00789373|454389069|FG002|Induction|Progressive Disease|0|||
126300558|NCT00789373|454389067|FG000|Induction|Withdrawal by Subject|37|||
126044256|NCT03582033|453459557|FG008|Part B|Withdrawal by Subject|0|||
126044257|NCT03582033|453459558|FG009|Part B|Withdrawal by Subject|0|||
126044258|NCT03582033|453459549|FG000|Part C|Other|0|||
126044259|NCT03582033|453459550|FG001|Part C|Other|0|||
126044260|NCT03582033|453459551|FG002|Part C|Other|0|||
126044261|NCT03582033|453459552|FG003|Part C|Other|0|||
126044262|NCT03582033|453459553|FG004|Part C|Other|0|||
126300559|NCT00789373|454389068|FG001|Induction|Withdrawal by Subject|0|||
126300560|NCT00789373|454389069|FG002|Induction|Withdrawal by Subject|0|||
126300561|NCT00789373|454389067|FG000|Maintenance|Adverse Event|0|||
126300562|NCT00789373|454389068|FG001|Maintenance|Adverse Event|65|||
126300563|NCT00789373|454389069|FG002|Maintenance|Adverse Event|12|||
126044263|NCT03582033|453459554|FG005|Part C|Other|0|||
126300564|NCT00789373|454389067|FG000|Maintenance|Death due to study disease|0|||
126300565|NCT00789373|454389068|FG001|Maintenance|Death due to study disease|3|||
126044264|NCT03582033|453459555|FG006|Part C|Other|2|||
126044265|NCT03582033|453459556|FG007|Part C|Other|0|||
126044266|NCT03582033|453459557|FG008|Part C|Other|0|||
126044267|NCT03582033|453459558|FG009|Part C|Other|0|||
126044268|NCT03582033|453459549|FG000|Part C|Death|0|||
126044269|NCT03582033|453459550|FG001|Part C|Death|0|||
126044270|NCT03582033|453459551|FG002|Part C|Death|0|||
126044271|NCT03582033|453459552|FG003|Part C|Death|0|||
126300566|NCT00789373|454389069|FG002|Maintenance|Death due to study disease|1|||
126300567|NCT00789373|454389067|FG000|Maintenance|Death due to adverse event|0|||
126300568|NCT00789373|454389068|FG001|Maintenance|Death due to adverse event|4|||
126300569|NCT00789373|454389069|FG002|Maintenance|Death due to adverse event|1|||
126300570|NCT00789373|454389067|FG000|Maintenance|Death due to toxicity|0|||
126300571|NCT00789373|454389068|FG001|Maintenance|Death due to toxicity|1|||
126300572|NCT00789373|454389069|FG002|Maintenance|Death due to toxicity|2|||
126300573|NCT00789373|454389067|FG000|Maintenance|Investigator Decision|0|||
126300574|NCT00789373|454389068|FG001|Maintenance|Investigator Decision|4|||
126300575|NCT00789373|454389069|FG002|Maintenance|Investigator Decision|2|||
126300576|NCT00789373|454389067|FG000|Maintenance|Protocol entry criteria not met|0|||
126300577|NCT00789373|454389068|FG001|Maintenance|Protocol entry criteria not met|2|||
126300578|NCT00789373|454389069|FG002|Maintenance|Protocol entry criteria not met|0|||
126300579|NCT00789373|454389067|FG000|Maintenance|Lost to Follow-up|0|||
126300580|NCT00789373|454389068|FG001|Maintenance|Lost to Follow-up|2|||
126300581|NCT00789373|454389069|FG002|Maintenance|Lost to Follow-up|0|||
126300582|NCT00789373|454389067|FG000|Maintenance|Progressive Disease|0|||
126300583|NCT00789373|454389068|FG001|Maintenance|Progressive Disease|253|||
126300584|NCT00789373|454389069|FG002|Maintenance|Progressive Disease|152|||
126300585|NCT00789373|454389067|FG000|Maintenance|Withdrawal by Subject|0|||
126300586|NCT00789373|454389068|FG001|Maintenance|Withdrawal by Subject|21|||
126300587|NCT00789373|454389069|FG002|Maintenance|Withdrawal by Subject|8|||
126300588|NCT00789373|454389067|FG000|Maintenance|Sponsor Decision|0|||
126300589|NCT00789373|454389068|FG001|Maintenance|Sponsor Decision|0|||
126300590|NCT00789373|454389069|FG002|Maintenance|Sponsor Decision|2|||
126300591|NCT00789373|454389067|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
126300592|NCT00789373|454389068|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
126300593|NCT00789373|454389069|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
126300594|NCT03321968|454389070|FG000|Overall Study|Withdrawal by Subject|1|||
126300595|NCT03321968|454389071|FG001|Overall Study|Withdrawal by Subject|2|||
126300596|NCT03321968|454389072|FG002|Overall Study|Withdrawal by Subject|1|||
126300597|NCT03321968|454389070|FG000|Overall Study|Lost to Follow-up|2|||
126300598|NCT03321968|454389071|FG001|Overall Study|Lost to Follow-up|0|||
126300599|NCT03321968|454389072|FG002|Overall Study|Lost to Follow-up|1|||
126300600|NCT03321968|454389070|FG000|Overall Study|Other than specified|0|||
126300601|NCT03321968|454389071|FG001|Overall Study|Other than specified|0|||
126300602|NCT03321968|454389072|FG002|Overall Study|Other than specified|1|||
126300603|NCT01532518|454389073|FG000|Overall Study|Withdrawal by Subject|0|||
126300604|NCT01532518|454389074|FG001|Overall Study|Withdrawal by Subject|0|||
126300605|NCT01532518|454389075|FG002|Overall Study|Withdrawal by Subject|1|||
126044272|NCT03582033|453459553|FG004|Part C|Death|0|||
126044273|NCT03582033|453459554|FG005|Part C|Death|0|||
126044274|NCT03582033|453459555|FG006|Part C|Death|6|||
126044275|NCT03582033|453459556|FG007|Part C|Death|1|||
126044276|NCT03582033|453459557|FG008|Part C|Death|2|||
126103392|NCT04507126|453672149|FG000|Overall Study|Withdrawal by Subject|1|||
125883744|NCT02158546|452871534|FG001|Overall Study|Lack of Efficacy|1|||
126300606|NCT02155283|454389078|FG000|Overall Study|Lost to Follow-up|3|||
126300607|NCT02155283|454389078|FG000|Overall Study|Withdrawal by Subject|1|||
126044277|NCT03582033|453459558|FG009|Part C|Death|0|||
126300608|NCT02155283|454389078|FG000|Overall Study|Protocol Violation|3|||
126300609|NCT00463047|454389083|FG000|Titration Period 1|Adverse Event|10|||
126044278|NCT03582033|453459549|FG000|Part C|Study terminated by sponsor|0|||
126044279|NCT03582033|453459550|FG001|Part C|Study terminated by sponsor|0|||
126300610|NCT00463047|454389084|FG001|Titration Period 1|Adverse Event|8|||
126300611|NCT00463047|454389083|FG000|Titration Period 1|Lack of Efficacy|10|||
126300612|NCT00463047|454389084|FG001|Titration Period 1|Lack of Efficacy|4|||
126300613|NCT00463047|454389083|FG000|Titration Period 1|Lost to Follow-up|2|||
126300614|NCT00463047|454389084|FG001|Titration Period 1|Lost to Follow-up|0|||
126300615|NCT00463047|454389083|FG000|Titration Period 1|Non-compliance with study medication|3|||
126300616|NCT00463047|454389084|FG001|Titration Period 1|Non-compliance with study medication|5|||
126300617|NCT00463047|454389083|FG000|Titration Period 1|Protocol Violation|5|||
126300618|NCT00463047|454389084|FG001|Titration Period 1|Protocol Violation|5|||
126300619|NCT00463047|454389083|FG000|Titration Period 1|Withdrawal by Subject|3|||
126300620|NCT00463047|454389084|FG001|Titration Period 1|Withdrawal by Subject|5|||
126300621|NCT00463047|454389083|FG000|Titration Period 1|Non-compliance procedures|4|||
126300622|NCT00463047|454389084|FG001|Titration Period 1|Non-compliance procedures|10|||
126300623|NCT00463047|454389083|FG000|Titration Period 1|Other|0|||
126300624|NCT00463047|454389084|FG001|Titration Period 1|Other|2|||
126300625|NCT00463047|454389083|FG000|Titration Period 2|Adverse Event|9|||
126300626|NCT00463047|454389084|FG001|Titration Period 2|Adverse Event|9|||
126300627|NCT00463047|454389083|FG000|Titration Period 2|Lack of Efficacy|6|||
126300628|NCT00463047|454389084|FG001|Titration Period 2|Lack of Efficacy|4|||
126300629|NCT00463047|454389083|FG000|Titration Period 2|Withdrawal by Subject|1|||
126300630|NCT00463047|454389084|FG001|Titration Period 2|Withdrawal by Subject|0|||
126300631|NCT00463047|454389083|FG000|Titration Period 2|Protocol Violation|2|||
126300632|NCT00463047|454389084|FG001|Titration Period 2|Protocol Violation|3|||
126300633|NCT00463047|454389083|FG000|Titration Period 2|Lost to Follow-up|1|||
126300634|NCT00463047|454389084|FG001|Titration Period 2|Lost to Follow-up|2|||
126300635|NCT00463047|454389083|FG000|Titration Period 2|Non-compliance study medication|4|||
126300636|NCT00463047|454389084|FG001|Titration Period 2|Non-compliance study medication|2|||
126300637|NCT00463047|454389083|FG000|Titration Period 2|Non-compliance procedures|4|||
126300638|NCT00463047|454389084|FG001|Titration Period 2|Non-compliance procedures|1|||
126300639|NCT00463047|454389083|FG000|Titration Period 2|Other|3|||
126300640|NCT00463047|454389084|FG001|Titration Period 2|Other|2|||
126300641|NCT00463047|454389083|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
126300642|NCT00463047|454389084|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
126300643|NCT00463047|454389083|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
126300644|NCT00463047|454389084|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
126300645|NCT00463047|454389083|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
126300646|NCT00463047|454389084|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
126300647|NCT00463047|454389083|FG000|Double-Blind Treatment Period 1|Other|1|||
126300648|NCT00463047|454389084|FG001|Double-Blind Treatment Period 1|Other|0|||
126300649|NCT00463047|454389083|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
126300650|NCT00463047|454389084|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
126300651|NCT00463047|454389083|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
126300652|NCT00463047|454389084|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
126300653|NCT00463047|454389083|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
126300654|NCT00463047|454389084|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
126300655|NCT02554682|454389090|FG000|Overall Study|Lost to Follow-up|11|||
126300656|NCT02554682|454389091|FG001|Overall Study|Lost to Follow-up|9|||
126300657|NCT02554682|454389092|FG002|Overall Study|Lost to Follow-up|4|||
126300658|NCT02554682|454389093|FG003|Overall Study|Lost to Follow-up|3|||
126300659|NCT02554682|454389094|FG004|Overall Study|Lost to Follow-up|2|||
126300660|NCT02554682|454389095|FG005|Overall Study|Lost to Follow-up|1|||
126300661|NCT02554682|454389096|FG006|Overall Study|Lost to Follow-up|6|||
126300662|NCT02554682|454389097|FG007|Overall Study|Lost to Follow-up|6|||
126300663|NCT02554682|454389098|FG008|Overall Study|Lost to Follow-up|2|||
126300664|NCT02554682|454389099|FG009|Overall Study|Lost to Follow-up|2|||
126300665|NCT02554682|454389090|FG000|Overall Study|Withdrawal by Subject|2|||
126300666|NCT02554682|454389091|FG001|Overall Study|Withdrawal by Subject|1|||
126300667|NCT02554682|454389092|FG002|Overall Study|Withdrawal by Subject|0|||
126300668|NCT02554682|454389093|FG003|Overall Study|Withdrawal by Subject|0|||
126300669|NCT02554682|454389094|FG004|Overall Study|Withdrawal by Subject|0|||
126300670|NCT02554682|454389095|FG005|Overall Study|Withdrawal by Subject|0|||
126300671|NCT02554682|454389096|FG006|Overall Study|Withdrawal by Subject|0|||
126300672|NCT02554682|454389097|FG007|Overall Study|Withdrawal by Subject|0|||
126300673|NCT02554682|454389098|FG008|Overall Study|Withdrawal by Subject|0|||
126300674|NCT02554682|454389099|FG009|Overall Study|Withdrawal by Subject|0|||
126300675|NCT02554682|454389090|FG000|Overall Study|Physician Decision|2|||
126300676|NCT02554682|454389091|FG001|Overall Study|Physician Decision|2|||
126300677|NCT02554682|454389092|FG002|Overall Study|Physician Decision|0|||
126300678|NCT02554682|454389093|FG003|Overall Study|Physician Decision|0|||
126300679|NCT02554682|454389094|FG004|Overall Study|Physician Decision|0|||
126300680|NCT02554682|454389095|FG005|Overall Study|Physician Decision|0|||
126300681|NCT02554682|454389096|FG006|Overall Study|Physician Decision|0|||
126300682|NCT02554682|454389097|FG007|Overall Study|Physician Decision|0|||
126300683|NCT02554682|454389098|FG008|Overall Study|Physician Decision|0|||
126300684|NCT02554682|454389099|FG009|Overall Study|Physician Decision|0|||
126300685|NCT01537042|454389117|FG000|Overall Study|Adverse Event|0|||
126300686|NCT01537042|454389118|FG001|Overall Study|Adverse Event|2|||
126300687|NCT01537042|454389117|FG000|Overall Study|Lack of Efficacy|0|||
126300688|NCT01537042|454389118|FG001|Overall Study|Lack of Efficacy|1|||
126300689|NCT01537042|454389117|FG000|Overall Study|Protocol Violation|0|||
126300690|NCT01537042|454389118|FG001|Overall Study|Protocol Violation|1|||
126300691|NCT01537042|454389117|FG000|Overall Study|Other|0|||
126300692|NCT01537042|454389118|FG001|Overall Study|Other|1|||
126300693|NCT00979654|454389119|FG000|Overall Study|Lost to Follow-up|1|||
126300694|NCT00979654|454389119|FG000|Overall Study|Withdrawal by Subject|22|||
126300695|NCT00979654|454389119|FG000|Overall Study|Death|1|||
126300696|NCT00979654|454389119|FG000|Overall Study|Lack of Efficacy|6|||
126300697|NCT00979654|454389119|FG000|Overall Study|Adverse Event|1|||
126300698|NCT00979654|454389119|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
126300699|NCT00979654|454389119|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
126300700|NCT00979654|454389119|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
126300701|NCT00979654|454389119|FG000|Overall Study|Serious Adverse Event|1|||
126300702|NCT00979654|454389119|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
126300703|NCT01779440|454389120|FG000|Overall Study|Withdrawal by Subject|3|||
126300704|NCT01779440|454389121|FG001|Overall Study|Withdrawal by Subject|5|||
126300705|NCT01205269|454389122|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300706|NCT01205269|454389123|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300707|NCT01205269|454389124|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300708|NCT01205269|454389125|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
126300709|NCT01205269|454389126|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300710|NCT01205269|454389127|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300711|NCT01408303|454389128|FG000|Overall Study|Adverse Event|3|||
126300712|NCT01408303|454389129|FG001|Overall Study|Adverse Event|7|||
126300713|NCT01408303|454389130|FG002|Overall Study|Adverse Event|2|||
126300714|NCT01408303|454389128|FG000|Overall Study|Lost to Follow-up|0|||
126300715|NCT01408303|454389129|FG001|Overall Study|Lost to Follow-up|1|||
126300716|NCT01408303|454389130|FG002|Overall Study|Lost to Follow-up|2|||
126300717|NCT01408303|454389128|FG000|Overall Study|Withdrawal by Subject|2|||
126300718|NCT01408303|454389129|FG001|Overall Study|Withdrawal by Subject|3|||
126300719|NCT01408303|454389130|FG002|Overall Study|Withdrawal by Subject|1|||
126300720|NCT01408303|454389128|FG000|Overall Study|Protocol Violation|0|||
126300721|NCT01408303|454389129|FG001|Overall Study|Protocol Violation|1|||
126300722|NCT01408303|454389130|FG002|Overall Study|Protocol Violation|0|||
126300723|NCT01408303|454389128|FG000|Overall Study|Noncompliance|1|||
126300724|NCT01408303|454389129|FG001|Overall Study|Noncompliance|0|||
126300725|NCT01408303|454389130|FG002|Overall Study|Noncompliance|1|||
126300726|NCT01207687|454389131|FG000|Overall Study|Adverse Event|1|||
126300727|NCT01207687|454389131|FG000|Overall Study|Withdrawal by Subject|1|||
126300728|NCT01486446|454389132|FG000|Overall Study|Adverse Event|1|||
126300729|NCT01486446|454389133|FG001|Overall Study|Adverse Event|0|||
126300730|NCT01801865|454389134|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
126300731|NCT01801865|454389134|FG000|Overall Study|Physician Decision|7|||
126300732|NCT01367886|454389137|FG000|Overall Study|Lost to Follow-up|4|||
126300733|NCT01367886|454389137|FG000|Overall Study|Lack of Efficacy|2|||
126300734|NCT01367886|454389137|FG000|Overall Study|Death|1|||
126300735|NCT00985504|454389142|FG000|Acute Treatment Period|Adverse Event|3|||
126300736|NCT00985504|454389143|FG001|Acute Treatment Period|Adverse Event|4|||
126300737|NCT00985504|454389142|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
126300738|NCT00985504|454389143|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
126300739|NCT00985504|454389142|FG000|Acute Treatment Period|Protocol Violation|2|||
126300740|NCT00985504|454389143|FG001|Acute Treatment Period|Protocol Violation|0|||
126300741|NCT00985504|454389142|FG000|Acute Treatment Period|Sponsor Decision|0|||
126300742|NCT00985504|454389143|FG001|Acute Treatment Period|Sponsor Decision|1|||
126300743|NCT00985504|454389142|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
126300744|NCT00985504|454389143|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
126300745|NCT00985504|454389142|FG000|Optimization Period|Adverse Event|7|||
126300746|NCT00985504|454389143|FG001|Optimization Period|Adverse Event|9|||
126300747|NCT00985504|454389142|FG000|Optimization Period|Death|0|||
126300748|NCT00985504|454389143|FG001|Optimization Period|Death|1|||
126300749|NCT00985504|454389142|FG000|Optimization Period|Lack of Efficacy|5|||
126300750|NCT00985504|454389143|FG001|Optimization Period|Lack of Efficacy|3|||
126300751|NCT00985504|454389142|FG000|Optimization Period|Lost to Follow-up|0|||
126300752|NCT00985504|454389143|FG001|Optimization Period|Lost to Follow-up|1|||
126300753|NCT00985504|454389142|FG000|Optimization Period|Physician Decision|1|||
126300754|NCT00985504|454389143|FG001|Optimization Period|Physician Decision|0|||
126300755|NCT00985504|454389142|FG000|Optimization Period|Protocol Violation|3|||
126300756|NCT00985504|454389143|FG001|Optimization Period|Protocol Violation|1|||
126300757|NCT00985504|454389142|FG000|Optimization Period|Withdrawal by Subject|10|||
126300758|NCT00985504|454389143|FG001|Optimization Period|Withdrawal by Subject|8|||
126300759|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
126300760|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
126300761|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
126300762|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
126300763|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
126300764|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
126300765|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
126300766|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
126300767|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
126300768|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
126300769|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
126300770|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
126300771|NCT03379727|454389146|FG000|Overall Study|Lack of Efficacy|73|||
126300772|NCT03379727|454389146|FG000|Overall Study|Adverse Event|32|||
126300773|NCT03379727|454389146|FG000|Overall Study|Death|18|||
125883745|NCT02158546|452871535|FG002|Overall Study|Lack of Efficacy|0|||
125883746|NCT02158546|452871536|FG003|Overall Study|Lack of Efficacy|0|||
125883747|NCT02158546|452871533|FG000|Overall Study|Adverse Event|2|||
125883748|NCT02158546|452871534|FG001|Overall Study|Adverse Event|2|||
125883749|NCT02158546|452871535|FG002|Overall Study|Adverse Event|0|||
125883750|NCT02158546|452871536|FG003|Overall Study|Adverse Event|0|||
125883751|NCT02158546|452871533|FG000|Overall Study|Withdrawal by Subject|6|||
125883752|NCT02158546|452871534|FG001|Overall Study|Withdrawal by Subject|2|||
125883753|NCT02158546|452871535|FG002|Overall Study|Withdrawal by Subject|1|||
125883754|NCT02158546|452871536|FG003|Overall Study|Withdrawal by Subject|0|||
125883755|NCT02158546|452871533|FG000|Overall Study|Lost to Follow-up|5|||
125883756|NCT02158546|452871534|FG001|Overall Study|Lost to Follow-up|4|||
125883757|NCT02158546|452871535|FG002|Overall Study|Lost to Follow-up|0|||
125883758|NCT02158546|452871536|FG003|Overall Study|Lost to Follow-up|1|||
125883759|NCT02158546|452871533|FG000|Overall Study|Site Excluded|5|||
125883760|NCT02158546|452871534|FG001|Overall Study|Site Excluded|5|||
125883761|NCT02158546|452871535|FG002|Overall Study|Site Excluded|3|||
125883762|NCT02158546|452871536|FG003|Overall Study|Site Excluded|4|||
125883763|NCT02900378|452871537|FG000|Randomization (Visit 2)|Adverse Event|14|||
125883764|NCT02900378|452871538|FG001|Randomization (Visit 2)|Adverse Event|11|||
125883765|NCT02900378|452871537|FG000|Randomization (Visit 2)|Death|1|||
125883766|NCT02900378|452871538|FG001|Randomization (Visit 2)|Death|4|||
125883767|NCT02900378|452871537|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
125883768|NCT02900378|452871538|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
125883769|NCT02900378|452871537|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
125883770|NCT02900378|452871538|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
125883771|NCT02900378|452871537|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
125883772|NCT02900378|452871538|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
125883773|NCT02900378|452871537|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
125883774|NCT02900378|452871538|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
125883775|NCT02900378|452871537|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
125883776|NCT02900378|452871538|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
125883777|NCT02531802|452871540|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
125883778|NCT02531802|452871541|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
125883779|NCT02531802|452871542|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
125883780|NCT02531802|452871543|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
125883781|NCT02531802|452871544|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
125883782|NCT02531802|452871545|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
125883783|NCT02531802|452871546|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
125883784|NCT02531802|452871547|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
125883785|NCT02531802|452871548|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
125883786|NCT02531802|452871549|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
125883787|NCT02531802|452871550|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
125883788|NCT02531802|452871551|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
125883789|NCT02531802|452871552|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
126300774|NCT03379727|454389146|FG000|Overall Study|Patient/guardian decision|17|||
126300775|NCT03379727|454389146|FG000|Overall Study|Physician Decision|104|||
126300776|NCT03379727|454389146|FG000|Overall Study|Protocol Violation|4|||
126300777|NCT03379727|454389146|FG000|Overall Study|Lost to Follow-up|1|||
125883790|NCT02531802|452871553|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
125883791|NCT02531802|452871554|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
125883792|NCT02531802|452871555|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
126103393|NCT04507126|453672149|FG000|Overall Study|Protocol Violation|2|||
126103394|NCT04507126|453672149|FG000|Overall Study|Physician Decision|1|||
126300778|NCT04031846|454389150|FG000|Overall Study|Lost to Follow-up|4|||
126300779|NCT04031846|454389151|FG001|Overall Study|Lost to Follow-up|4|||
126300780|NCT04031846|454389150|FG000|Overall Study|Physician Decision|0|||
126300781|NCT04031846|454389151|FG001|Overall Study|Physician Decision|1|||
126300782|NCT04031846|454389150|FG000|Overall Study|Protocol Violation|1|||
126300783|NCT04031846|454389151|FG001|Overall Study|Protocol Violation|1|||
126300784|NCT04031846|454389150|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
126300785|NCT04031846|454389151|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
126300786|NCT06868654|454389152|FG000|Overall Study|Death|4|||
126300787|NCT06868654|454389153|FG001|Overall Study|Death|14|||
126300788|NCT06868654|454389152|FG000|Overall Study|Lost to Follow-up|0|||
126300789|NCT06868654|454389153|FG001|Overall Study|Lost to Follow-up|1|||
126300790|NCT06868654|454389152|FG000|Overall Study|Withdrawal by Subject|5|||
126300791|NCT06868654|454389153|FG001|Overall Study|Withdrawal by Subject|3|||
126300792|NCT06868654|454389152|FG000|Overall Study|Physician Decision|0|||
126300793|NCT06868654|454389153|FG001|Overall Study|Physician Decision|1|||
126300794|NCT06868654|454389152|FG000|Overall Study|Ongoing|23|||
126300795|NCT06868654|454389153|FG001|Overall Study|Ongoing|21|||
126300796|NCT00764660|454389158|FG000|Overall Study|Adverse Event|6|||
126300797|NCT00764660|454389159|FG001|Overall Study|Adverse Event|3|||
126300798|NCT00764660|454389158|FG000|Overall Study|Lost to Follow-up|3|||
126300799|NCT00764660|454389159|FG001|Overall Study|Lost to Follow-up|4|||
126300800|NCT00764660|454389158|FG000|Overall Study|Withdrawal by Subject|7|||
126300801|NCT00764660|454389159|FG001|Overall Study|Withdrawal by Subject|3|||
126300802|NCT00764660|454389158|FG000|Overall Study|Noncompliance With Protocol|5|||
126300803|NCT00764660|454389159|FG001|Overall Study|Noncompliance With Protocol|1|||
126300804|NCT00764660|454389158|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
126300805|NCT00764660|454389159|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
126300806|NCT01131455|454389160|FG000|Overall Study|Death of PI|6|||
126300807|NCT01131455|454389161|FG001|Overall Study|Death of PI|4|||
126300808|NCT01131455|454389162|FG002|Overall Study|Death of PI|0|||
126300809|NCT03103152|454389163|FG000|Overall Study|Physician Decision|5|||
126300810|NCT03103152|454389164|FG001|Overall Study|Physician Decision|2|||
126300811|NCT03103152|454389165|FG002|Overall Study|Physician Decision|6|||
126300812|NCT03103152|454389166|FG003|Overall Study|Physician Decision|3|||
126300813|NCT03103152|454389167|FG004|Overall Study|Physician Decision|3|||
126300814|NCT03103152|454389168|FG005|Overall Study|Physician Decision|1|||
126300815|NCT03103152|454389163|FG000|Overall Study|Protocol Violation|2|||
126300816|NCT03103152|454389164|FG001|Overall Study|Protocol Violation|2|||
126300817|NCT03103152|454389165|FG002|Overall Study|Protocol Violation|1|||
126300818|NCT03103152|454389166|FG003|Overall Study|Protocol Violation|2|||
126300819|NCT03103152|454389167|FG004|Overall Study|Protocol Violation|1|||
126300820|NCT03103152|454389168|FG005|Overall Study|Protocol Violation|1|||
126300821|NCT03103152|454389163|FG000|Overall Study|Inter-current illness|0|||
126300822|NCT03103152|454389164|FG001|Overall Study|Inter-current illness|0|||
126300823|NCT03103152|454389165|FG002|Overall Study|Inter-current illness|1|||
126300824|NCT03103152|454389166|FG003|Overall Study|Inter-current illness|0|||
126300825|NCT03103152|454389167|FG004|Overall Study|Inter-current illness|0|||
126300826|NCT03103152|454389168|FG005|Overall Study|Inter-current illness|0|||
126300827|NCT03103152|454389163|FG000|Overall Study|Death|0|||
126300828|NCT03103152|454389164|FG001|Overall Study|Death|1|||
126300829|NCT03103152|454389165|FG002|Overall Study|Death|0|||
126300830|NCT03103152|454389166|FG003|Overall Study|Death|0|||
126300831|NCT03103152|454389167|FG004|Overall Study|Death|0|||
126300832|NCT03103152|454389168|FG005|Overall Study|Death|0|||
126300833|NCT03103152|454389163|FG000|Overall Study|Adverse Event|0|||
126300834|NCT03103152|454389164|FG001|Overall Study|Adverse Event|0|||
126300835|NCT03103152|454389165|FG002|Overall Study|Adverse Event|1|||
126300836|NCT03103152|454389166|FG003|Overall Study|Adverse Event|0|||
126300837|NCT03103152|454389167|FG004|Overall Study|Adverse Event|0|||
126300838|NCT03103152|454389168|FG005|Overall Study|Adverse Event|1|||
126300839|NCT03103152|454389163|FG000|Overall Study|Withdrawal by Subject|1|||
126300840|NCT03103152|454389164|FG001|Overall Study|Withdrawal by Subject|0|||
126300841|NCT03103152|454389165|FG002|Overall Study|Withdrawal by Subject|1|||
126300842|NCT03103152|454389166|FG003|Overall Study|Withdrawal by Subject|1|||
126300843|NCT03103152|454389167|FG004|Overall Study|Withdrawal by Subject|1|||
126300844|NCT03103152|454389168|FG005|Overall Study|Withdrawal by Subject|1|||
126300845|NCT03103152|454389163|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
126300846|NCT03103152|454389164|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
126300847|NCT03103152|454389165|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
126300848|NCT03103152|454389166|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
126300849|NCT03103152|454389167|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
126300850|NCT03103152|454389168|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
126300851|NCT03103152|454389163|FG000|Overall Study|Unacceptable side effects|0|||
126300852|NCT03103152|454389164|FG001|Overall Study|Unacceptable side effects|0|||
126300853|NCT03103152|454389165|FG002|Overall Study|Unacceptable side effects|0|||
126300854|NCT03103152|454389166|FG003|Overall Study|Unacceptable side effects|0|||
126300855|NCT03103152|454389167|FG004|Overall Study|Unacceptable side effects|0|||
126300856|NCT03103152|454389168|FG005|Overall Study|Unacceptable side effects|1|||
126300857|NCT03103152|454389163|FG000|Overall Study|Lost to Follow-up|0|||
126300858|NCT03103152|454389164|FG001|Overall Study|Lost to Follow-up|1|||
126300859|NCT03103152|454389165|FG002|Overall Study|Lost to Follow-up|0|||
126300860|NCT03103152|454389166|FG003|Overall Study|Lost to Follow-up|1|||
126300861|NCT03103152|454389167|FG004|Overall Study|Lost to Follow-up|0|||
126044280|NCT03582033|453459551|FG002|Part C|Study terminated by sponsor|0|||
126300862|NCT03103152|454389168|FG005|Overall Study|Lost to Follow-up|1|||
126300863|NCT03103152|454389163|FG000|Overall Study|Testicular pain|0|||
126300864|NCT03103152|454389164|FG001|Overall Study|Testicular pain|0|||
126300865|NCT03103152|454389165|FG002|Overall Study|Testicular pain|0|||
126300866|NCT03103152|454389166|FG003|Overall Study|Testicular pain|1|||
126300867|NCT03103152|454389167|FG004|Overall Study|Testicular pain|0|||
126300868|NCT03103152|454389168|FG005|Overall Study|Testicular pain|0|||
126300869|NCT01540487|454390816|FG000|Overall Study|Protocol Violation|1|||
126300870|NCT01540487|454390817|FG001|Overall Study|Protocol Violation|0|||
126300871|NCT03503370|454390818|FG000|Overall Study|Death|3|||
126300872|NCT03503370|454390819|FG001|Overall Study|Death|1|||
126300873|NCT00298272|454390824|FG000|Double-blind Phase|Adverse Event|2|||
126300874|NCT00298272|454390825|FG001|Double-blind Phase|Adverse Event|0|||
126300875|NCT00298272|454390824|FG000|Double-blind Phase|Failure to Return|2|||
126300876|NCT00298272|454390825|FG001|Double-blind Phase|Failure to Return|0|||
126300877|NCT00298272|454390824|FG000|Double-blind Phase|Protocol Violation|2|||
126300878|NCT00298272|454390825|FG001|Double-blind Phase|Protocol Violation|0|||
126300879|NCT00298272|454390824|FG000|Double-blind Phase|Withdrawal by Subject|2|||
126300880|NCT00298272|454390825|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126300881|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Adverse Event|1|||
126300882|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Adverse Event|2|||
126300883|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
126300884|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
126300885|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Failure to Return|1|||
126300886|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Failure to Return|0|||
126300887|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
126300888|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
126300889|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
126300890|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
126300891|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
126300892|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
126300893|NCT00298272|454390824|FG000|Safety Follow-up Phase|Failure to Return|1|||
126300894|NCT00298272|454390825|FG001|Safety Follow-up Phase|Failure to Return|1|||
126300895|NCT00298272|454390824|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
126300896|NCT00298272|454390825|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
126300897|NCT00298272|454390824|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
126300898|NCT00298272|454390825|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
126300899|NCT04168112|454390826|FG000|Overall Study|Lost to Follow-up|1|||
126300900|NCT04168112|454390827|FG001|Overall Study|Lost to Follow-up|0|||
126300901|NCT04168112|454390826|FG000|Overall Study|Withdrawal by Subject|1|||
126300902|NCT04168112|454390827|FG001|Overall Study|Withdrawal by Subject|0|||
126300903|NCT01344824|454390830|FG000|Overall Study|Adverse Event|15|||
126300904|NCT01344824|454390830|FG000|Overall Study|Withdrawal by Subject|6|||
126300905|NCT01344824|454390830|FG000|Overall Study|Other complicating disease|1|||
126300906|NCT01344824|454390830|FG000|Overall Study|Progression|15|||
126300907|NCT01295671|454390838|FG000|Overall Study|Lost to Follow-up|4|||
126300908|NCT01295671|454390839|FG001|Overall Study|Lost to Follow-up|6|||
126044281|NCT03582033|453459552|FG003|Part C|Study terminated by sponsor|0|||
126300909|NCT01295671|454390840|FG002|Overall Study|Lost to Follow-up|3|||
126300910|NCT01295671|454390838|FG000|Overall Study|Withdrawal by Subject|3|||
125883793|NCT02531802|452871556|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
125883794|NCT02531802|452871557|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
125883795|NCT02531802|452871558|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
125883796|NCT02531802|452871559|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
125883797|NCT02531802|452871560|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
125883798|NCT02531802|452871540|FG000|Received Vaccination 2|Physician Decision|0|||
125883799|NCT02531802|452871541|FG001|Received Vaccination 2|Physician Decision|0|||
125883800|NCT02531802|452871542|FG002|Received Vaccination 2|Physician Decision|0|||
125883801|NCT02531802|452871543|FG003|Received Vaccination 2|Physician Decision|0|||
125883802|NCT02531802|452871544|FG004|Received Vaccination 2|Physician Decision|0|||
125883803|NCT02531802|452871545|FG005|Received Vaccination 2|Physician Decision|1|||
125883804|NCT02531802|452871546|FG006|Received Vaccination 2|Physician Decision|0|||
125883805|NCT02531802|452871547|FG007|Received Vaccination 2|Physician Decision|0|||
125883806|NCT02531802|452871548|FG008|Received Vaccination 2|Physician Decision|0|||
125883807|NCT02531802|452871549|FG009|Received Vaccination 2|Physician Decision|2|||
125883808|NCT02531802|452871550|FG010|Received Vaccination 2|Physician Decision|0|||
125883809|NCT02531802|452871551|FG011|Received Vaccination 2|Physician Decision|0|||
125883810|NCT02531802|452871552|FG012|Received Vaccination 2|Physician Decision|0|||
125883811|NCT02531802|452871553|FG013|Received Vaccination 2|Physician Decision|1|||
125883812|NCT02531802|452871554|FG014|Received Vaccination 2|Physician Decision|0|||
125883813|NCT02531802|452871555|FG015|Received Vaccination 2|Physician Decision|0|||
125883814|NCT02531802|452871556|FG016|Received Vaccination 2|Physician Decision|0|||
125883815|NCT02531802|452871557|FG017|Received Vaccination 2|Physician Decision|1|||
125883816|NCT02531802|452871558|FG018|Received Vaccination 2|Physician Decision|0|||
125883817|NCT02531802|452871559|FG019|Received Vaccination 2|Physician Decision|0|||
125883818|NCT02531802|452871560|FG020|Received Vaccination 2|Physician Decision|0|||
125883819|NCT02531802|452871540|FG000|Received Vaccination 2|Adverse Event|0|||
125883820|NCT02531802|452871541|FG001|Received Vaccination 2|Adverse Event|0|||
125883821|NCT02531802|452871542|FG002|Received Vaccination 2|Adverse Event|0|||
125883822|NCT02531802|452871543|FG003|Received Vaccination 2|Adverse Event|0|||
125883823|NCT02531802|452871544|FG004|Received Vaccination 2|Adverse Event|0|||
125883824|NCT02531802|452871545|FG005|Received Vaccination 2|Adverse Event|2|||
125883825|NCT02531802|452871546|FG006|Received Vaccination 2|Adverse Event|0|||
125883826|NCT02531802|452871547|FG007|Received Vaccination 2|Adverse Event|0|||
125883827|NCT02531802|452871548|FG008|Received Vaccination 2|Adverse Event|0|||
125883828|NCT02531802|452871549|FG009|Received Vaccination 2|Adverse Event|0|||
125883829|NCT02531802|452871550|FG010|Received Vaccination 2|Adverse Event|0|||
125883830|NCT02531802|452871551|FG011|Received Vaccination 2|Adverse Event|0|||
125883831|NCT02531802|452871552|FG012|Received Vaccination 2|Adverse Event|0|||
125883832|NCT02531802|452871553|FG013|Received Vaccination 2|Adverse Event|0|||
125883833|NCT02531802|452871554|FG014|Received Vaccination 2|Adverse Event|0|||
125883834|NCT02531802|452871555|FG015|Received Vaccination 2|Adverse Event|0|||
125883835|NCT02531802|452871556|FG016|Received Vaccination 2|Adverse Event|0|||
125883836|NCT02531802|452871557|FG017|Received Vaccination 2|Adverse Event|2|||
125883837|NCT02531802|452871558|FG018|Received Vaccination 2|Adverse Event|1|||
125883838|NCT02531802|452871559|FG019|Received Vaccination 2|Adverse Event|0|||
125883839|NCT02531802|452871560|FG020|Received Vaccination 2|Adverse Event|1|||
125883840|NCT02531802|452871540|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
125883841|NCT02531802|452871541|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
125883842|NCT02531802|452871542|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
125883843|NCT02531802|452871543|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
125883844|NCT02531802|452871544|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
125883845|NCT02531802|452871545|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
125883846|NCT02531802|452871546|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
125883847|NCT02531802|452871547|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
125883848|NCT02531802|452871548|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
125883849|NCT02531802|452871549|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
125883850|NCT02531802|452871550|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
125883851|NCT02531802|452871551|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
125883852|NCT02531802|452871552|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
125883853|NCT02531802|452871553|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
125883854|NCT02531802|452871554|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
125883855|NCT02531802|452871555|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
125883856|NCT02531802|452871556|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
125883857|NCT02531802|452871557|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
125883858|NCT02531802|452871558|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
125883859|NCT02531802|452871559|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
125883860|NCT02531802|452871560|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
125883861|NCT01249261|452871565|FG000|Overall Study|Withdrawal by Subject|1|||
125883862|NCT01249261|452871566|FG001|Overall Study|Withdrawal by Subject|0|||
125883863|NCT02819804|452871567|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
125883864|NCT00482053|452871571|FG000|Inter-treatment Period|Disease progression|1|||
125883865|NCT00346697|452871573|FG000|Overall Study|Lost to Follow-up|0|||
125883866|NCT00346697|452871574|FG001|Overall Study|Lost to Follow-up|1|||
125883867|NCT03815929|452871575|FG000|Overall Study|Lost to Follow-up|2|||
125883868|NCT03815929|452871576|FG001|Overall Study|Lost to Follow-up|1|||
125883869|NCT03815929|452871577|FG002|Overall Study|Lost to Follow-up|0|||
125883870|NCT03815929|452871575|FG000|Overall Study|Physician Decision|2|||
125883871|NCT03815929|452871576|FG001|Overall Study|Physician Decision|2|||
125883872|NCT03815929|452871577|FG002|Overall Study|Physician Decision|0|||
125883873|NCT03815929|452871575|FG000|Overall Study|Withdrawal by Subject|0|||
125883874|NCT03815929|452871576|FG001|Overall Study|Withdrawal by Subject|0|||
125883875|NCT03815929|452871577|FG002|Overall Study|Withdrawal by Subject|1|||
125883876|NCT02864394|452871583|FG000|Overall Study|Death|184|||
125883877|NCT02864394|452871584|FG001|Overall Study|Death|189|||
125883878|NCT02864394|452871583|FG000|Overall Study|Lost to Follow-up|0|||
125883879|NCT02864394|452871584|FG001|Overall Study|Lost to Follow-up|2|||
125883880|NCT02864394|452871583|FG000|Overall Study|Sponsor Decision|26|||
125883881|NCT02864394|452871584|FG001|Overall Study|Sponsor Decision|11|||
125883882|NCT02864394|452871583|FG000|Overall Study|Withdrawal by Subject|3|||
125883883|NCT02864394|452871584|FG001|Overall Study|Withdrawal by Subject|10|||
125883884|NCT00777153|452873089|FG000|Overall Study|Lost to Follow-up|1|||
125883885|NCT00777153|452873090|FG001|Overall Study|Lost to Follow-up|1|||
125883886|NCT00777153|452873091|FG002|Overall Study|Lost to Follow-up|0|||
125883887|NCT00777153|452873089|FG000|Overall Study|Death|85|||
125883888|NCT00777153|452873090|FG001|Overall Study|Death|73|||
125883889|NCT00777153|452873091|FG002|Overall Study|Death|33|||
125883890|NCT00777153|452873089|FG000|Overall Study|Withdrawal by Subject|3|||
125883891|NCT00777153|452873090|FG001|Overall Study|Withdrawal by Subject|4|||
125883892|NCT00777153|452873091|FG002|Overall Study|Withdrawal by Subject|3|||
125883893|NCT00777153|452873089|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
125883894|NCT00777153|452873090|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
125883895|NCT00777153|452873091|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
125883896|NCT00554216|452873093|FG000|Overall Study|Lost to Follow-up|92|||
125883897|NCT00554216|452873094|FG001|Overall Study|Lost to Follow-up|31|||
125883898|NCT00554216|452873095|FG002|Overall Study|Lost to Follow-up|63|||
125883899|NCT00554216|452873093|FG000|Overall Study|Adverse Event|16|||
125883900|NCT00554216|452873094|FG001|Overall Study|Adverse Event|16|||
125883901|NCT00554216|452873095|FG002|Overall Study|Adverse Event|36|||
125883902|NCT00554216|452873093|FG000|Overall Study|Withdrawal by Subject|92|||
125883903|NCT00554216|452873094|FG001|Overall Study|Withdrawal by Subject|31|||
125883904|NCT00554216|452873095|FG002|Overall Study|Withdrawal by Subject|43|||
125883905|NCT00554216|452873093|FG000|Overall Study|Non compliance|10|||
125883906|NCT00554216|452873094|FG001|Overall Study|Non compliance|4|||
125883907|NCT00554216|452873095|FG002|Overall Study|Non compliance|5|||
126300911|NCT01295671|454390839|FG001|Overall Study|Withdrawal by Subject|1|||
126300912|NCT01295671|454390840|FG002|Overall Study|Withdrawal by Subject|0|||
126300913|NCT01754129|454390841|FG000|Overall Study|Death|13|||
126300914|NCT01754129|454390841|FG000|Overall Study|Duodopa discontinuation|9|||
126300915|NCT01754129|454390841|FG000|Overall Study|Lost to Follow-up|7|||
126300916|NCT01754129|454390841|FG000|Overall Study|Withdrew consent|1|||
126300917|NCT01754129|454390841|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
126300918|NCT01609010|454390843|FG000|Overall Study|Stable disease (SD)|22|||
126300919|NCT01609010|454390844|FG001|Overall Study|Stable disease (SD)|16|||
126300920|NCT01609010|454390843|FG000|Overall Study|Progressive disease (PD)|8|||
126300921|NCT01609010|454390844|FG001|Overall Study|Progressive disease (PD)|10|||
126300922|NCT01609010|454390843|FG000|Overall Study|Adverse Event|3|||
126300923|NCT01609010|454390844|FG001|Overall Study|Adverse Event|6|||
126300924|NCT01609010|454390843|FG000|Overall Study|Withdrawal by Subject|2|||
126300925|NCT01609010|454390844|FG001|Overall Study|Withdrawal by Subject|2|||
126300926|NCT01609010|454390843|FG000|Overall Study|Other|2|||
126300927|NCT01609010|454390844|FG001|Overall Study|Other|0|||
126300928|NCT01609010|454390843|FG000|Overall Study|Other malignancy|1|||
126300929|NCT01609010|454390844|FG001|Overall Study|Other malignancy|0|||
126300930|NCT01609010|454390843|FG000|Overall Study|Pathology review|2|||
126300931|NCT01609010|454390844|FG001|Overall Study|Pathology review|1|||
126300932|NCT01609010|454390843|FG000|Overall Study|Protocol Violation|1|||
126300933|NCT01609010|454390844|FG001|Overall Study|Protocol Violation|1|||
126300934|NCT01609010|454390843|FG000|Overall Study|New cancer|1|||
126300935|NCT01609010|454390844|FG001|Overall Study|New cancer|0|||
126300936|NCT01609010|454390843|FG000|Overall Study|Lost to Follow-up|1|||
126300937|NCT01609010|454390844|FG001|Overall Study|Lost to Follow-up|1|||
126300938|NCT00808210|454390846|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
126300939|NCT00808210|454390847|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
126300940|NCT00808210|454390846|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
126300941|NCT00808210|454390847|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
126300942|NCT00808210|454390846|FG000|Double-Blind TX Period|Adverse Event|0|||
126300943|NCT00808210|454390847|FG001|Double-Blind TX Period|Adverse Event|1|||
126300944|NCT00808210|454390846|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
126300945|NCT00808210|454390847|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
126300946|NCT00808210|454390846|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
126300947|NCT00808210|454390847|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
126300948|NCT00808210|454390846|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
126300949|NCT00808210|454390847|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
126300950|NCT03150719|454390850|FG000|Overall Study|Adverse Event|0|||
126300951|NCT03150719|454390851|FG001|Overall Study|Adverse Event|1|||
126300952|NCT03150719|454390850|FG000|Overall Study|Death|0|||
126300953|NCT03150719|454390851|FG001|Overall Study|Death|1|||
126300954|NCT03150719|454390850|FG000|Overall Study|Other|1|||
126300955|NCT03150719|454390851|FG001|Overall Study|Other|0|||
126300956|NCT01790984|454390852|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
126300957|NCT01790984|454390853|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
126300958|NCT01790984|454390854|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
126300959|NCT01790984|454390855|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
126300960|NCT01346696|454390857|FG000|Overall Study|Death|1|||
126300961|NCT01051791|454390867|FG000|Overall Study|Failed screening|3|||
126300962|NCT01051791|454390867|FG000|Overall Study|Withdrawal by Subject|1|||
126300963|NCT00288626|454390868|FG000|Overall Study|Death|3|||
126300964|NCT00288626|454390868|FG000|Overall Study|Withdrawal by Subject|4|||
126300965|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
126300966|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126300967|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126300968|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126300969|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
126300970|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
126300971|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
126300972|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
126300973|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
126300974|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
126300975|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
126300976|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
126300977|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
126300978|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126300979|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126300980|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126300981|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
126300982|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126300983|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126300984|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126300985|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
126300986|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126300987|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126300988|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126300989|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
126300990|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
126300991|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
126300992|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
126300993|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
126300994|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
126300995|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
126300996|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
126300997|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
126300998|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126300999|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301000|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301001|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
126301002|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
126301003|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
126301004|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
126301005|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
126301006|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
126301007|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
126301008|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
126301009|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
126301010|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
126301011|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
126301012|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
126301013|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
126301014|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
126301015|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
126301016|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
126301017|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
126301018|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
126301019|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
126301020|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
126301021|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
126301022|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
126301023|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
126301024|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
126301025|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
126301026|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
126301027|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
126301028|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
126301029|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
126301030|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
126301031|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
126301032|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
126301033|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
126301034|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
126301035|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
126301036|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
126301037|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126301038|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126301039|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126367420|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367421|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
126367422|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
126367423|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125883908|NCT00554216|452873093|FG000|Overall Study|Pregnancy|2|||
125883909|NCT00554216|452873094|FG001|Overall Study|Pregnancy|1|||
125883910|NCT00554216|452873095|FG002|Overall Study|Pregnancy|14|||
125883911|NCT00554216|452873093|FG000|Overall Study|Restricted med|3|||
125883912|NCT00554216|452873094|FG001|Overall Study|Restricted med|1|||
125883913|NCT00554216|452873095|FG002|Overall Study|Restricted med|1|||
125883914|NCT00554216|452873093|FG000|Overall Study|Other|12|||
125883915|NCT00554216|452873094|FG001|Overall Study|Other|7|||
125883916|NCT00554216|452873095|FG002|Overall Study|Other|10|||
125883917|NCT00554216|452873093|FG000|Overall Study|Lack of Efficacy|15|||
125883918|NCT00554216|452873094|FG001|Overall Study|Lack of Efficacy|3|||
125883919|NCT00554216|452873095|FG002|Overall Study|Lack of Efficacy|0|||
125883920|NCT02079246|452873096|FG000|OLEX|Withdrawal before treatment|1|||
126301040|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
126301041|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126301042|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126301043|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126301044|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
126301045|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126301046|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126301047|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126301048|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
126301049|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301050|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301051|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301052|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
126301053|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126301054|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126301055|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126301056|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
126301057|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
126301058|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
126301059|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
126301060|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
126301061|NCT04578457|454390883|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
126301062|NCT04578457|454390883|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
126301063|NCT04578457|454390883|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
126301064|NCT04578457|454390883|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
126301065|NCT01609296|454390890|FG000|Overall Study|Death|253|||
126301066|NCT01609296|454390890|FG000|Overall Study|Withdrawal by Subject|151|||
126301067|NCT01609296|454390890|FG000|Overall Study|Lost to Follow-up|21|||
126301068|NCT01609296|454390890|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
126301069|NCT01609296|454390890|FG000|Overall Study|missed visit but known to be alive|28|||
126301070|NCT00628212|454390891|FG000|Overall Study|Adverse Event|2|||
126301071|NCT00628212|454390892|FG001|Overall Study|Adverse Event|0|||
126301072|NCT00628212|454390893|FG002|Overall Study|Adverse Event|1|||
126301073|NCT00628212|454390894|FG003|Overall Study|Adverse Event|2|||
126301074|NCT00628212|454390891|FG000|Overall Study|Physician Decision|1|||
126301075|NCT00628212|454390892|FG001|Overall Study|Physician Decision|1|||
126301076|NCT00628212|454390893|FG002|Overall Study|Physician Decision|2|||
126301077|NCT00628212|454390894|FG003|Overall Study|Physician Decision|3|||
126301078|NCT02187198|454390897|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
126301079|NCT02187198|454390898|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
126301080|NCT02187198|454390897|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
126301081|NCT02187198|454390898|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
126301082|NCT00546377|454390899|FG000|Overall Study|Deemed ineligible|1|||
126301083|NCT00546377|454390899|FG000|Overall Study|Adverse Event|6|||
126301084|NCT03020992|454390902|FG000|Overall Study|Adverse Event|5|||
126301085|NCT03020992|454390902|FG000|Overall Study|Withdrawal by Subject|1|||
126301086|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
126301087|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
125883921|NCT02079246|452873097|FG001|OLEX|Withdrawal before treatment|0|||
125883922|NCT02079246|452873096|FG000|OLEX|Death|11|||
125883923|NCT02079246|452873097|FG001|OLEX|Death|0|||
126301088|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
126301089|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
125883924|NCT02079246|452873096|FG000|OLEX|Adverse Event|66|||
125883925|NCT02079246|452873097|FG001|OLEX|Adverse Event|0|||
125883926|NCT02079246|452873096|FG000|OLEX|Withdrawal by Subject|60|||
125883927|NCT02079246|452873097|FG001|OLEX|Withdrawal by Subject|0|||
125883928|NCT02079246|452873096|FG000|OLEX|Lost to Follow-up|6|||
126301090|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Pregnancy|0|||
126301091|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Pregnancy|1|||
126301092|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
126301093|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
126301094|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
126301095|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
126301096|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
126301097|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
126301098|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Other|3|||
126301099|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Other|0|||
126301100|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Adverse Event|0|||
126301101|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Adverse Event|4|||
126301102|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
126301103|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
126301104|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
126301105|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
126301106|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
126301107|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
126301108|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
126301109|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
126301110|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Death|0|||
126301111|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Death|1|||
126301112|NCT00529308|454390907|FG000|Overall Study|Withdrawal by Subject|1|||
126301113|NCT00529308|454390908|FG001|Overall Study|Withdrawal by Subject|1|||
126301114|NCT01791894|454390919|FG000|Overall Study|Adverse Event|1|||
126301115|NCT02268916|454390920|FG000|Overall Study|Lost to Follow-up|1|||
126301116|NCT02268916|454390921|FG001|Overall Study|Lost to Follow-up|1|||
126301117|NCT02268916|454390920|FG000|Overall Study|Withdrawal by Subject|6|||
126301118|NCT02268916|454390921|FG001|Overall Study|Withdrawal by Subject|5|||
126301119|NCT02268916|454390920|FG000|Overall Study|Participant did not have diabetes|1|||
126301120|NCT02268916|454390921|FG001|Overall Study|Participant did not have diabetes|0|||
126301121|NCT02268916|454390920|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
126301122|NCT02268916|454390921|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
126301123|NCT02418949|454390922|FG000|Overall Study|Withdrawal by Subject|1|||
126301124|NCT02418949|454390923|FG001|Overall Study|Withdrawal by Subject|0|||
126301125|NCT02418949|454390924|FG002|Overall Study|Withdrawal by Subject|1|||
126301126|NCT02418949|454390925|FG003|Overall Study|Withdrawal by Subject|1|||
126301127|NCT02418949|454390922|FG000|Overall Study|Lost to Follow-up|1|||
126301128|NCT02418949|454390923|FG001|Overall Study|Lost to Follow-up|0|||
126301129|NCT02418949|454390924|FG002|Overall Study|Lost to Follow-up|1|||
126301130|NCT02418949|454390925|FG003|Overall Study|Lost to Follow-up|0|||
126301131|NCT02418949|454390922|FG000|Overall Study|Physician Decision|1|||
126301132|NCT02418949|454390923|FG001|Overall Study|Physician Decision|1|||
126301133|NCT02418949|454390924|FG002|Overall Study|Physician Decision|1|||
126301134|NCT02418949|454390925|FG003|Overall Study|Physician Decision|0|||
126301135|NCT03926117|454390926|FG000|Overall Study|Unclassified|1|||
126301136|NCT03926117|454390927|FG001|Overall Study|Unclassified|4|||
126301137|NCT03926117|454390928|FG002|Overall Study|Unclassified|1|||
126301138|NCT03926117|454390929|FG003|Overall Study|Unclassified|4|||
126301139|NCT03926117|454390926|FG000|Overall Study|Withdrawal by Subject|3|||
126301140|NCT03926117|454390927|FG001|Overall Study|Withdrawal by Subject|0|||
126301141|NCT03926117|454390928|FG002|Overall Study|Withdrawal by Subject|1|||
126301142|NCT03926117|454390929|FG003|Overall Study|Withdrawal by Subject|1|||
126301143|NCT03926117|454390926|FG000|Overall Study|Lost to Follow-up|0|||
126301144|NCT03926117|454390927|FG001|Overall Study|Lost to Follow-up|2|||
126301145|NCT03926117|454390928|FG002|Overall Study|Lost to Follow-up|1|||
126301146|NCT03926117|454390929|FG003|Overall Study|Lost to Follow-up|0|||
126301147|NCT03926117|454390926|FG000|Overall Study|Adverse Event|1|||
126301148|NCT03926117|454390927|FG001|Overall Study|Adverse Event|2|||
126301149|NCT03926117|454390928|FG002|Overall Study|Adverse Event|3|||
126301150|NCT03926117|454390929|FG003|Overall Study|Adverse Event|1|||
126301151|NCT03926117|454390926|FG000|Overall Study|Randomized but not treated|1|||
126301152|NCT03926117|454390927|FG001|Overall Study|Randomized but not treated|1|||
126301153|NCT03926117|454390928|FG002|Overall Study|Randomized but not treated|0|||
126301154|NCT03926117|454390929|FG003|Overall Study|Randomized but not treated|1|||
126301155|NCT04526288|454390933|FG000|Overall Study|Disease Progression|1|||
126301156|NCT04526288|454390934|FG001|Overall Study|Disease Progression|0|||
126301157|NCT02684097|454390937|FG000|Overall Study|Lack of Efficacy|13|||
126301158|NCT02684097|454390938|FG001|Overall Study|Lack of Efficacy|6|||
126301159|NCT00460811|454390939|FG000|Overall Study|Adverse Event|4|||
126367424|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367425|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126301160|NCT00460811|454390940|FG001|Overall Study|Adverse Event|6|||
126301161|NCT00460811|454390941|FG002|Overall Study|Adverse Event|3|||
126301162|NCT00460811|454390942|FG003|Overall Study|Adverse Event|10|||
126301163|NCT00460811|454390943|FG004|Overall Study|Adverse Event|2|||
126301164|NCT00460811|454390939|FG000|Overall Study|Noncompliance|1|||
126301165|NCT00460811|454390940|FG001|Overall Study|Noncompliance|0|||
126301166|NCT00460811|454390941|FG002|Overall Study|Noncompliance|0|||
126301167|NCT00460811|454390942|FG003|Overall Study|Noncompliance|2|||
126301168|NCT00460811|454390943|FG004|Overall Study|Noncompliance|1|||
126301169|NCT00460811|454390939|FG000|Overall Study|Withdrawal by Subject|7|||
126301170|NCT00460811|454390940|FG001|Overall Study|Withdrawal by Subject|7|||
126301171|NCT00460811|454390941|FG002|Overall Study|Withdrawal by Subject|6|||
126044282|NCT03582033|453459553|FG004|Part C|Study terminated by sponsor|0|||
126044283|NCT03582033|453459554|FG005|Part C|Study terminated by sponsor|0|||
126044284|NCT03582033|453459555|FG006|Part C|Study terminated by sponsor|3|||
126044285|NCT03582033|453459556|FG007|Part C|Study terminated by sponsor|3|||
126044286|NCT03582033|453459557|FG008|Part C|Study terminated by sponsor|2|||
126044287|NCT03582033|453459558|FG009|Part C|Study terminated by sponsor|0|||
126044288|NCT03582033|453459549|FG000|Part C|Withdrawal by Subject|0|||
126044289|NCT03582033|453459550|FG001|Part C|Withdrawal by Subject|0|||
126301172|NCT00460811|454390942|FG003|Overall Study|Withdrawal by Subject|3|||
126301173|NCT00460811|454390943|FG004|Overall Study|Withdrawal by Subject|11|||
126301174|NCT00460811|454390939|FG000|Overall Study|Physician Decision|1|||
126367426|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367427|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367428|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367429|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367430|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367431|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367432|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
126367433|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367434|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126044290|NCT03582033|453459551|FG002|Part C|Withdrawal by Subject|0|||
126044291|NCT03582033|453459552|FG003|Part C|Withdrawal by Subject|0|||
126044292|NCT03582033|453459553|FG004|Part C|Withdrawal by Subject|0|||
126044293|NCT03582033|453459554|FG005|Part C|Withdrawal by Subject|0|||
126044294|NCT03582033|453459555|FG006|Part C|Withdrawal by Subject|1|||
126044295|NCT03582033|453459556|FG007|Part C|Withdrawal by Subject|2|||
126044296|NCT03582033|453459557|FG008|Part C|Withdrawal by Subject|1|||
126044297|NCT03582033|453459558|FG009|Part C|Withdrawal by Subject|0|||
126044298|NCT03582033|453459549|FG000|Part D|Death|0|||
126044299|NCT03582033|453459550|FG001|Part D|Death|0|||
126044300|NCT03582033|453459551|FG002|Part D|Death|0|||
126044301|NCT03582033|453459552|FG003|Part D|Death|0|||
126301175|NCT00460811|454390940|FG001|Overall Study|Physician Decision|0|||
126044302|NCT03582033|453459553|FG004|Part D|Death|0|||
126044303|NCT03582033|453459554|FG005|Part D|Death|0|||
126301176|NCT00460811|454390941|FG002|Overall Study|Physician Decision|0|||
126301177|NCT00460811|454390942|FG003|Overall Study|Physician Decision|0|||
126301178|NCT00460811|454390943|FG004|Overall Study|Physician Decision|0|||
126301179|NCT00460811|454390939|FG000|Overall Study|Lost to Follow-up|3|||
126301180|NCT00460811|454390940|FG001|Overall Study|Lost to Follow-up|2|||
126301181|NCT00460811|454390941|FG002|Overall Study|Lost to Follow-up|5|||
126301182|NCT00460811|454390942|FG003|Overall Study|Lost to Follow-up|3|||
126301183|NCT00460811|454390943|FG004|Overall Study|Lost to Follow-up|6|||
126301184|NCT02748356|454390944|FG000|Overall Study|Withdrawal by Subject|1|||
126301185|NCT00996125|454390945|FG000|Overall Study|Adverse Event|0|||
126301186|NCT00996125|454390946|FG001|Overall Study|Adverse Event|2|||
126301187|NCT00996125|454390945|FG000|Overall Study|Lost to Follow-up|1|||
126301188|NCT00996125|454390946|FG001|Overall Study|Lost to Follow-up|6|||
126301189|NCT00996125|454390945|FG000|Overall Study|Withdrawal by Subject|4|||
126301190|NCT00996125|454390946|FG001|Overall Study|Withdrawal by Subject|3|||
126301191|NCT03515811|454390948|FG000|Overall Study|Lost to Follow-up|2|||
126301192|NCT03515811|454390949|FG001|Overall Study|Lost to Follow-up|1|||
126301193|NCT03515811|454390948|FG000|Overall Study|Protocol Violation|1|||
126301194|NCT03515811|454390949|FG001|Overall Study|Protocol Violation|1|||
126301195|NCT03515811|454390948|FG000|Overall Study|Death|1|||
126301196|NCT03515811|454390949|FG001|Overall Study|Death|1|||
126301197|NCT03515811|454390948|FG000|Overall Study|Withdrawal by Subject|0|||
126301198|NCT03515811|454390949|FG001|Overall Study|Withdrawal by Subject|2|||
126301199|NCT03515811|454390948|FG000|Overall Study|Technical Problems|1|||
126301200|NCT03515811|454390949|FG001|Overall Study|Technical Problems|0|||
126301201|NCT03515811|454390948|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
126301202|NCT03515811|454390949|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
126301203|NCT03515811|454390948|FG000|Overall Study|COVID-19|0|||
126301204|NCT03515811|454390949|FG001|Overall Study|COVID-19|1|||
126301205|NCT00237458|454390950|FG000|Overall Study|Lack of Efficacy|1|||
126301206|NCT00237458|454390950|FG000|Overall Study|Adverse Event|1|||
126301207|NCT00237458|454390950|FG000|Overall Study|Withdrawal by Subject|1|||
126301208|NCT00952068|454390951|FG000|Overall Study|Adverse Event|3|||
126301209|NCT00952068|454390951|FG000|Overall Study|Withdrawal by Subject|4|||
126301210|NCT04331067|454390952|FG000|Overall Study|Adverse Event|1|||
126301211|NCT04331067|454390953|FG001|Overall Study|Adverse Event|3|||
126301212|NCT04331067|454390954|FG002|Overall Study|Adverse Event|1|||
126301213|NCT04331067|454390952|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
126301214|NCT04331067|454390953|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
126301215|NCT04331067|454390954|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
126301216|NCT04339062|454390955|FG000|Overall Study|Death|0|||
126301217|NCT04339062|454390956|FG001|Overall Study|Death|1|||
126301218|NCT05870371|454390957|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
126301219|NCT05870371|454390958|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
126301220|NCT00708461|454390962|FG000|Overall Study|Lost to Follow-up|18|||
126301221|NCT00708461|454390963|FG001|Overall Study|Lost to Follow-up|11|||
126301222|NCT00708461|454390962|FG000|Overall Study|Withdrawal by Subject|8|||
126301223|NCT00708461|454390963|FG001|Overall Study|Withdrawal by Subject|9|||
126301224|NCT00708461|454390962|FG000|Overall Study|left workforce|115|||
126301225|NCT00708461|454390963|FG001|Overall Study|left workforce|180|||
126301226|NCT01796392|454390968|FG000|Overall Study|Withdrawal by Subject|2|||
126301227|NCT01796392|454390969|FG001|Overall Study|Withdrawal by Subject|0|||
126301228|NCT01796392|454390968|FG000|Overall Study|Death|5|||
126301229|NCT01796392|454390969|FG001|Overall Study|Death|1|||
126301230|NCT01796392|454390968|FG000|Overall Study|Excluded for medical reasons|1|||
126301231|NCT01796392|454390969|FG001|Overall Study|Excluded for medical reasons|2|||
125883929|NCT02079246|452873097|FG001|OLEX|Lost to Follow-up|0|||
125883930|NCT02079246|452873096|FG000|OLEX|Protocol Violation|6|||
125883931|NCT02079246|452873097|FG001|OLEX|Protocol Violation|0|||
126301232|NCT01796392|454390968|FG000|Overall Study|Lost to Follow-up|1|||
126301233|NCT01796392|454390969|FG001|Overall Study|Lost to Follow-up|0|||
126301234|NCT03517540|454390972|FG000|Overall Study|Protocol Violation|2|||
126301235|NCT03517540|454390973|FG001|Overall Study|Protocol Violation|0|||
126301236|NCT03517540|454390974|FG002|Overall Study|Protocol Violation|0|||
126301237|NCT03517540|454390975|FG003|Overall Study|Protocol Violation|1|||
126301238|NCT03517540|454390972|FG000|Overall Study|Adverse Event|9|||
126301239|NCT03517540|454390973|FG001|Overall Study|Adverse Event|3|||
126301240|NCT03517540|454390974|FG002|Overall Study|Adverse Event|8|||
126367435|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126301241|NCT03517540|454390975|FG003|Overall Study|Adverse Event|1|||
126301242|NCT03517540|454390972|FG000|Overall Study|Withdrawal by Subject|3|||
126301243|NCT03517540|454390973|FG001|Overall Study|Withdrawal by Subject|4|||
126301244|NCT03517540|454390974|FG002|Overall Study|Withdrawal by Subject|1|||
126301245|NCT03517540|454390975|FG003|Overall Study|Withdrawal by Subject|3|||
126301246|NCT00523848|454390976|FG000|Overall Study|Adverse Event|11|||
125883932|NCT02079246|452873096|FG000|OLEX|Lack of Efficacy|3|||
126301247|NCT00523848|454390976|FG000|Overall Study|Withdrawal by Subject|2|||
126301248|NCT00523848|454390976|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
126301249|NCT00523848|454390976|FG000|Overall Study|Disease Progression|5|||
126301250|NCT00523848|454390976|FG000|Overall Study|Other, unspecified|4|||
126301251|NCT01777282|454390977|FG000|Overall Study|Persistent Hyperglycemia|0|||
126301252|NCT01777282|454390978|FG001|Overall Study|Persistent Hyperglycemia|0|||
126301253|NCT01777282|454390979|FG002|Overall Study|Persistent Hyperglycemia|1|||
126301254|NCT01777282|454390980|FG003|Overall Study|Persistent Hyperglycemia|0|||
126301255|NCT01777282|454390981|FG004|Overall Study|Persistent Hyperglycemia|0|||
126301256|NCT01777282|454390977|FG000|Overall Study|New Antidiabetic Medication|0|||
126301257|NCT01777282|454390978|FG001|Overall Study|New Antidiabetic Medication|0|||
126301258|NCT01777282|454390979|FG002|Overall Study|New Antidiabetic Medication|1|||
126301259|NCT01777282|454390980|FG003|Overall Study|New Antidiabetic Medication|0|||
126301260|NCT01777282|454390981|FG004|Overall Study|New Antidiabetic Medication|0|||
126301261|NCT01777282|454390977|FG000|Overall Study|Adverse Event|4|||
126301262|NCT01777282|454390978|FG001|Overall Study|Adverse Event|4|||
126301263|NCT01777282|454390979|FG002|Overall Study|Adverse Event|2|||
126103395|NCT02924064|453672150|FG000|Overall Study|Adverse Event|2|||
126301264|NCT01777282|454390980|FG003|Overall Study|Adverse Event|1|||
126301265|NCT01777282|454390981|FG004|Overall Study|Adverse Event|3|||
126301266|NCT01777282|454390977|FG000|Overall Study|Withdrawal by Subject|4|||
126367436|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367437|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367438|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367439|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367440|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367441|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367442|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367443|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
126367444|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
126367445|NCT00003645|454640905|FG000|Overall Study|Death|4|||
126367446|NCT00003645|454640906|FG001|Overall Study|Death|1|||
126367447|NCT00003645|454640905|FG000|Overall Study|Lost to Follow-up|7|||
126367448|NCT00003645|454640906|FG001|Overall Study|Lost to Follow-up|8|||
126367449|NCT00003645|454640905|FG000|Overall Study|Withdrawal by Subject|1|||
126367450|NCT00003645|454640906|FG001|Overall Study|Withdrawal by Subject|3|||
126367451|NCT03768336|454640909|FG000|Overall Study|Lost to Follow-up|3|||
126367452|NCT03768336|454640910|FG001|Overall Study|Lost to Follow-up|2|||
126367453|NCT03768336|454640909|FG000|Overall Study|Became Ineligible|2|||
126367454|NCT03768336|454640910|FG001|Overall Study|Became Ineligible|0|||
126044304|NCT03582033|453459555|FG006|Part D|Death|0|||
126044305|NCT03582033|453459556|FG007|Part D|Death|0|||
126044306|NCT03582033|453459557|FG008|Part D|Death|0|||
126044307|NCT03582033|453459558|FG009|Part D|Death|1|||
126044308|NCT03582033|453459549|FG000|Part D|Study terminated by sponsor|0|||
126044309|NCT03582033|453459550|FG001|Part D|Study terminated by sponsor|0|||
126044310|NCT03582033|453459551|FG002|Part D|Study terminated by sponsor|0|||
126044311|NCT03582033|453459552|FG003|Part D|Study terminated by sponsor|0|||
126044312|NCT03582033|453459553|FG004|Part D|Study terminated by sponsor|0|||
126044313|NCT03582033|453459554|FG005|Part D|Study terminated by sponsor|0|||
126044314|NCT03582033|453459555|FG006|Part D|Study terminated by sponsor|0|||
126044315|NCT03582033|453459556|FG007|Part D|Study terminated by sponsor|0|||
126044316|NCT03582033|453459557|FG008|Part D|Study terminated by sponsor|0|||
126044317|NCT03582033|453459558|FG009|Part D|Study terminated by sponsor|4|||
126044318|NCT05008055|453459565|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
126044319|NCT05008055|453459566|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
126044320|NCT05008055|453459567|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
126044321|NCT04635059|453459568|FG000|Overall Study|Study terminated early.|4|||
126044322|NCT03248479|453459572|FG000|Overall Study|Death|12|||
126044323|NCT03248479|453459573|FG001|Overall Study|Death|44|||
126044324|NCT03248479|453459574|FG002|Overall Study|Death|1|||
126044325|NCT03248479|453459575|FG003|Overall Study|Death|72|||
126044326|NCT03248479|453459576|FG004|Overall Study|Death|17|||
126044327|NCT03248479|453459577|FG005|Overall Study|Death|6|||
126044328|NCT03248479|453459578|FG006|Overall Study|Death|1|||
126044329|NCT03248479|453459579|FG007|Overall Study|Death|14|||
126044330|NCT03248479|453459580|FG008|Overall Study|Death|3|||
126044331|NCT03248479|453459581|FG009|Overall Study|Death|7|||
126044332|NCT03248479|453459582|FG010|Overall Study|Death|3|||
126044333|NCT03248479|453459583|FG011|Overall Study|Death|1|||
126044334|NCT03248479|453459584|FG012|Overall Study|Death|1|||
126044335|NCT03248479|453459572|FG000|Overall Study|Study terminated by sponsor|12|||
126044336|NCT03248479|453459573|FG001|Overall Study|Study terminated by sponsor|15|||
126044337|NCT03248479|453459574|FG002|Overall Study|Study terminated by sponsor|0|||
126044338|NCT03248479|453459575|FG003|Overall Study|Study terminated by sponsor|5|||
126044339|NCT03248479|453459576|FG004|Overall Study|Study terminated by sponsor|0|||
126044340|NCT03248479|453459577|FG005|Overall Study|Study terminated by sponsor|0|||
126044341|NCT03248479|453459578|FG006|Overall Study|Study terminated by sponsor|0|||
126044342|NCT03248479|453459579|FG007|Overall Study|Study terminated by sponsor|1|||
126044343|NCT03248479|453459580|FG008|Overall Study|Study terminated by sponsor|1|||
126044344|NCT03248479|453459581|FG009|Overall Study|Study terminated by sponsor|0|||
126044345|NCT03248479|453459582|FG010|Overall Study|Study terminated by sponsor|5|||
126044346|NCT03248479|453459583|FG011|Overall Study|Study terminated by sponsor|4|||
126044347|NCT03248479|453459584|FG012|Overall Study|Study terminated by sponsor|0|||
126044348|NCT03248479|453459572|FG000|Overall Study|Consent withdrawn|6|||
126044349|NCT03248479|453459573|FG001|Overall Study|Consent withdrawn|3|||
126044350|NCT03248479|453459574|FG002|Overall Study|Consent withdrawn|0|||
126044351|NCT03248479|453459575|FG003|Overall Study|Consent withdrawn|9|||
126044352|NCT03248479|453459576|FG004|Overall Study|Consent withdrawn|1|||
126044353|NCT03248479|453459577|FG005|Overall Study|Consent withdrawn|0|||
126044354|NCT03248479|453459578|FG006|Overall Study|Consent withdrawn|0|||
126044355|NCT03248479|453459579|FG007|Overall Study|Consent withdrawn|1|||
126044356|NCT03248479|453459580|FG008|Overall Study|Consent withdrawn|0|||
126044357|NCT03248479|453459581|FG009|Overall Study|Consent withdrawn|3|||
126044358|NCT03248479|453459582|FG010|Overall Study|Consent withdrawn|1|||
126044359|NCT03248479|453459583|FG011|Overall Study|Consent withdrawn|0|||
126044360|NCT03248479|453459584|FG012|Overall Study|Consent withdrawn|1|||
126044361|NCT03248479|453459572|FG000|Overall Study|Lost to Follow-up|2|||
126367455|NCT03768336|454640909|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
126367456|NCT03768336|454640910|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
126367457|NCT03768336|454640909|FG000|Overall Study|Missed final survey (post-treatment|0|||
126367458|NCT03768336|454640910|FG001|Overall Study|Missed final survey (post-treatment|1|||
126367459|NCT03977155|454640911|FG000|Overall Study|Adverse Event|3|||
126367460|NCT03977155|454640912|FG001|Overall Study|Adverse Event|0|||
126367461|NCT03977155|454640913|FG002|Overall Study|Adverse Event|0|||
126367462|NCT03977155|454640911|FG000|Overall Study|Lost to Follow-up|0|||
126367463|NCT03977155|454640912|FG001|Overall Study|Lost to Follow-up|1|||
126367464|NCT03977155|454640913|FG002|Overall Study|Lost to Follow-up|0|||
126367465|NCT03977155|454640911|FG000|Overall Study|Withdrawal by Subject|1|||
126367466|NCT03977155|454640912|FG001|Overall Study|Withdrawal by Subject|1|||
126367467|NCT03977155|454640913|FG002|Overall Study|Withdrawal by Subject|2|||
126367468|NCT03977155|454640911|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
126367469|NCT03977155|454640912|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
126367470|NCT03977155|454640913|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
126367471|NCT03502681|454640916|FG000|Overall Study|Adverse Event|1|||
126367472|NCT03502681|454640917|FG001|Overall Study|Adverse Event|1|||
126044362|NCT03248479|453459573|FG001|Overall Study|Lost to Follow-up|1|||
126044363|NCT03248479|453459574|FG002|Overall Study|Lost to Follow-up|0|||
126044364|NCT03248479|453459575|FG003|Overall Study|Lost to Follow-up|0|||
126044365|NCT03248479|453459576|FG004|Overall Study|Lost to Follow-up|0|||
126044366|NCT03248479|453459577|FG005|Overall Study|Lost to Follow-up|0|||
126044367|NCT03248479|453459578|FG006|Overall Study|Lost to Follow-up|0|||
126044368|NCT03248479|453459579|FG007|Overall Study|Lost to Follow-up|0|||
126044369|NCT03248479|453459580|FG008|Overall Study|Lost to Follow-up|0|||
126044370|NCT03248479|453459581|FG009|Overall Study|Lost to Follow-up|0|||
126044371|NCT03248479|453459582|FG010|Overall Study|Lost to Follow-up|0|||
126044372|NCT03248479|453459583|FG011|Overall Study|Lost to Follow-up|0|||
126044373|NCT03248479|453459584|FG012|Overall Study|Lost to Follow-up|1|||
126044374|NCT03248479|453459572|FG000|Overall Study|Not reported|0|||
126044375|NCT03248479|453459573|FG001|Overall Study|Not reported|0|||
126044376|NCT03248479|453459574|FG002|Overall Study|Not reported|0|||
126044377|NCT03248479|453459575|FG003|Overall Study|Not reported|1|||
126044378|NCT03248479|453459576|FG004|Overall Study|Not reported|1|||
126044379|NCT03248479|453459577|FG005|Overall Study|Not reported|0|||
126044380|NCT03248479|453459578|FG006|Overall Study|Not reported|0|||
126044381|NCT03248479|453459579|FG007|Overall Study|Not reported|1|||
126044382|NCT03248479|453459580|FG008|Overall Study|Not reported|1|||
126044383|NCT03248479|453459581|FG009|Overall Study|Not reported|0|||
126044384|NCT03248479|453459582|FG010|Overall Study|Not reported|0|||
126044385|NCT03248479|453459583|FG011|Overall Study|Not reported|0|||
126044386|NCT03248479|453459584|FG012|Overall Study|Not reported|0|||
126044387|NCT04679389|453459585|FG000|Overall Study|Adverse Event|1|||
126044388|NCT04679389|453459586|FG001|Overall Study|Adverse Event|0|||
126044389|NCT04679389|453459585|FG000|Overall Study|Protocol Violation|2|||
126044390|NCT04679389|453459586|FG001|Overall Study|Protocol Violation|0|||
126044391|NCT04679389|453459585|FG000|Overall Study|Physician Decision|3|||
126044392|NCT04679389|453459586|FG001|Overall Study|Physician Decision|5|||
126044393|NCT04679389|453459585|FG000|Overall Study|Withdrawal by Subject|5|||
126044394|NCT04679389|453459586|FG001|Overall Study|Withdrawal by Subject|7|||
126044395|NCT05123027|453459589|FG000|Overall Study|Lost to Follow-up|17|||
126044396|NCT05123027|453459590|FG001|Overall Study|Lost to Follow-up|22|||
126044397|NCT05123027|453459589|FG000|Overall Study|Incarceration|3|||
126044398|NCT05123027|453459590|FG001|Overall Study|Incarceration|4|||
126044399|NCT05123027|453459589|FG000|Overall Study|Death|2|||
126044400|NCT05123027|453459590|FG001|Overall Study|Death|2|||
126044401|NCT05123027|453459589|FG000|Overall Study|Other|2|||
126044402|NCT05123027|453459590|FG001|Overall Study|Other|0|||
126044403|NCT05112900|453459591|FG000|Overall Study|Withdrawal by Subject|960|||
126044404|NCT05112900|453459592|FG001|Overall Study|Withdrawal by Subject|921|||
126044405|NCT05112900|453459593|FG002|Overall Study|Withdrawal by Subject|968|||
126044406|NCT05525104|453459594|FG000|Overall Study|Failed caudal analgesia|1|||
126044407|NCT05525104|453459595|FG001|Overall Study|Failed caudal analgesia|3|||
126044408|NCT05525104|453459594|FG000|Overall Study|Premedication needed|0|||
126044409|NCT05525104|453459595|FG001|Overall Study|Premedication needed|1|||
126044410|NCT05525104|453459594|FG000|Overall Study|Protocol Violation|10|||
126044411|NCT05525104|453459595|FG001|Overall Study|Protocol Violation|0|||
126044412|NCT05525104|453459594|FG000|Overall Study|Cancelled operation|1|||
126044413|NCT05525104|453459595|FG001|Overall Study|Cancelled operation|0|||
126044414|NCT03636490|453461024|FG000|Overall Study|Dropped out or incomplete data|141|||
126044415|NCT05247034|453461025|FG000|Overall Study|Lost to Follow-up|3|||
126301267|NCT01777282|454390978|FG001|Overall Study|Withdrawal by Subject|0|||
126301268|NCT01777282|454390979|FG002|Overall Study|Withdrawal by Subject|0|||
126301269|NCT01777282|454390980|FG003|Overall Study|Withdrawal by Subject|1|||
126301270|NCT01777282|454390981|FG004|Overall Study|Withdrawal by Subject|2|||
126301271|NCT01777282|454390977|FG000|Overall Study|Protocol Violation|2|||
126301272|NCT01777282|454390978|FG001|Overall Study|Protocol Violation|0|||
126301273|NCT01777282|454390979|FG002|Overall Study|Protocol Violation|1|||
126301274|NCT01777282|454390980|FG003|Overall Study|Protocol Violation|0|||
126301275|NCT01777282|454390981|FG004|Overall Study|Protocol Violation|2|||
126301276|NCT01777282|454390977|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
126301277|NCT01777282|454390978|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
126301278|NCT01777282|454390979|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
126301279|NCT01777282|454390980|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
126301280|NCT01777282|454390981|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
126301281|NCT01068678|454392566|FG000|Overall Study|Lack of Efficacy|3|||
126301282|NCT01068678|454392567|FG001|Overall Study|Lack of Efficacy|2|||
126301283|NCT01068678|454392566|FG000|Overall Study|Protocol Violation|5|||
126301284|NCT01068678|454392567|FG001|Overall Study|Protocol Violation|1|||
126301285|NCT01068678|454392566|FG000|Overall Study|Withdrawal criteria|12|||
126301286|NCT01068678|454392567|FG001|Overall Study|Withdrawal criteria|6|||
126301287|NCT01068678|454392566|FG000|Overall Study|Unclassified|18|||
126301288|NCT01068678|454392567|FG001|Overall Study|Unclassified|15|||
126301289|NCT03055338|454392568|FG000|Overall Study|Lost to Follow-up|9|||
126301290|NCT03055338|454392569|FG001|Overall Study|Lost to Follow-up|2|||
126301291|NCT03055338|454392570|FG002|Overall Study|Lost to Follow-up|3|||
126301292|NCT03055338|454392568|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
126301293|NCT03055338|454392569|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
126301294|NCT03055338|454392570|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
126301295|NCT03055338|454392568|FG000|Overall Study|Physician Decision|0|||
126301296|NCT03055338|454392569|FG001|Overall Study|Physician Decision|0|||
126301297|NCT03055338|454392570|FG002|Overall Study|Physician Decision|2|||
126301298|NCT03055338|454392568|FG000|Overall Study|Withdrawal by Subject|9|||
126301299|NCT03055338|454392569|FG001|Overall Study|Withdrawal by Subject|8|||
126301300|NCT03055338|454392570|FG002|Overall Study|Withdrawal by Subject|7|||
126301301|NCT00975611|454392571|FG000|Overall Study|Screen Fail|16|||
126301302|NCT00975611|454392571|FG000|Overall Study|Physician Decision|1|||
126301303|NCT03058705|454392572|FG000|Overall Study|Withdrawal by Subject|2|||
126301304|NCT03058705|454392572|FG000|Overall Study|Physician Decision|2|||
126301305|NCT01682226|454392573|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
126301306|NCT01682226|454392573|FG000|Overall Study|Participants did not receive treatment|2|||
126301307|NCT01682226|454392573|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
126301308|NCT02151851|454392574|FG000|Overall Study|Lack of Efficacy|67|||
126301309|NCT02151851|454392575|FG001|Overall Study|Lack of Efficacy|94|||
126301310|NCT02151851|454392574|FG000|Overall Study|Protocol Violation|0|||
126301311|NCT02151851|454392575|FG001|Overall Study|Protocol Violation|1|||
126301312|NCT02151851|454392574|FG000|Overall Study|Withdrawal by Subject|2|||
126301313|NCT02151851|454392575|FG001|Overall Study|Withdrawal by Subject|5|||
126301314|NCT02151851|454392574|FG000|Overall Study|Medical impairment|1|||
126301315|NCT02151851|454392575|FG001|Overall Study|Medical impairment|0|||
126301316|NCT02151851|454392574|FG000|Overall Study|Low compliance to study visits|0|||
126301317|NCT02151851|454392575|FG001|Overall Study|Low compliance to study visits|1|||
126301318|NCT02151851|454392574|FG000|Overall Study|Subject entered into study in error|0|||
126301319|NCT02151851|454392575|FG001|Overall Study|Subject entered into study in error|1|||
126301320|NCT02151851|454392574|FG000|Overall Study|Adverse Event|6|||
126301321|NCT02151851|454392575|FG001|Overall Study|Adverse Event|28|||
126301322|NCT02159053|454392576|FG000|Overall Study|Death|2|||
126301323|NCT02159053|454392577|FG001|Overall Study|Death|0|||
126301324|NCT02159053|454392578|FG002|Overall Study|Death|1|||
126301325|NCT02159053|454392576|FG000|Overall Study|Physician Decision|0|||
126301326|NCT02159053|454392577|FG001|Overall Study|Physician Decision|1|||
126301327|NCT02159053|454392578|FG002|Overall Study|Physician Decision|1|||
126301328|NCT02159053|454392576|FG000|Overall Study|Lack of Efficacy|3|||
126301329|NCT02159053|454392577|FG001|Overall Study|Lack of Efficacy|4|||
126301330|NCT02159053|454392578|FG002|Overall Study|Lack of Efficacy|7|||
126301331|NCT02159053|454392576|FG000|Overall Study|Adverse Event|7|||
126301332|NCT02159053|454392577|FG001|Overall Study|Adverse Event|6|||
126301333|NCT02159053|454392578|FG002|Overall Study|Adverse Event|5|||
126301334|NCT02159053|454392576|FG000|Overall Study|Participants/guardian decision|8|||
126301335|NCT02159053|454392577|FG001|Overall Study|Participants/guardian decision|10|||
126301336|NCT02159053|454392578|FG002|Overall Study|Participants/guardian decision|6|||
126301337|NCT01436370|454392586|FG000|Overall Study|Lost to Follow-up|0|||
126301338|NCT01436370|454392587|FG001|Overall Study|Lost to Follow-up|0|||
126301339|NCT01436370|454392588|FG002|Overall Study|Lost to Follow-up|0|||
126301340|NCT01436370|454392589|FG003|Overall Study|Lost to Follow-up|0|||
126301341|NCT01436370|454392590|FG004|Overall Study|Lost to Follow-up|1|||
126301342|NCT01436370|454392591|FG005|Overall Study|Lost to Follow-up|0|||
126301343|NCT01436370|454392592|FG006|Overall Study|Lost to Follow-up|0|||
125883933|NCT02079246|452873097|FG001|OLEX|Lack of Efficacy|0|||
125883934|NCT02079246|452873096|FG000|OLEX|Results of the lead-in studies|58|||
125883935|NCT02079246|452873097|FG001|OLEX|Results of the lead-in studies|0|||
125883936|NCT02079246|452873096|FG000|OLEX|Other: Disallowed medication|8|||
125883937|NCT02079246|452873097|FG001|OLEX|Other: Disallowed medication|0|||
125883938|NCT02079246|452873096|FG000|OLEX|Other: Insufficient compliance|2|||
125883939|NCT02079246|452873097|FG001|OLEX|Other: Insufficient compliance|0|||
125883940|NCT02079246|452873096|FG000|OLEX|Other: Caregiver unavailable|3|||
125883941|NCT02079246|452873097|FG001|OLEX|Other: Caregiver unavailable|0|||
125883942|NCT02079246|452873096|FG000|OLEX|Other: Coordinator decision|1|||
125883943|NCT02079246|452873097|FG001|OLEX|Other: Coordinator decision|0|||
125883944|NCT02079246|452873096|FG000|OLEX|Other: Worsening of condition|1|||
125883945|NCT02079246|452873097|FG001|OLEX|Other: Worsening of condition|0|||
125883946|NCT02079246|452873096|FG000|OLEX|Other: Moved to nursing home|1|||
125883947|NCT02079246|452873097|FG001|OLEX|Other: Moved to nursing home|0|||
125883948|NCT02079246|452873096|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
125883949|NCT02079246|452873097|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
125883950|NCT02079246|452873096|FG000|OLEX-MEM|Adverse Event|0|||
125883951|NCT02079246|452873097|FG001|OLEX-MEM|Adverse Event|6|||
125883952|NCT02079246|452873096|FG000|OLEX-MEM|Withdrawal by Subject|0|||
125883953|NCT02079246|452873097|FG001|OLEX-MEM|Withdrawal by Subject|7|||
125883954|NCT02079246|452873096|FG000|OLEX-MEM|Protocol Violation|0|||
125883955|NCT02079246|452873097|FG001|OLEX-MEM|Protocol Violation|2|||
125883956|NCT02079246|452873096|FG000|OLEX-MEM|Lost to Follow-up|0|||
125883957|NCT02079246|452873097|FG001|OLEX-MEM|Lost to Follow-up|1|||
126301344|NCT01436370|454392593|FG007|Overall Study|Lost to Follow-up|0|||
126301345|NCT02395848|454392594|FG000|Overall Study|Lost to Follow-up|2|||
126301346|NCT02058537|454392595|FG000|Overall Study|Withdrawal by Subject|1|||
126301347|NCT02126579|454392596|FG000|Overall Study|disease progression|0|||
126301348|NCT02126579|454392597|FG001|Overall Study|disease progression|0|||
126301349|NCT02126579|454392598|FG002|Overall Study|disease progression|0|||
126301350|NCT02126579|454392599|FG003|Overall Study|disease progression|1|||
126301351|NCT02126579|454392600|FG004|Overall Study|disease progression|0|||
126301352|NCT02126579|454392601|FG005|Overall Study|disease progression|0|||
126301353|NCT02126579|454392602|FG006|Overall Study|disease progression|1|||
126301354|NCT01780038|454392606|FG000|Overall Study|Lost to Follow-up|4|||
126301355|NCT01780038|454392607|FG001|Overall Study|Lost to Follow-up|1|||
126301356|NCT01085630|454392608|FG000|Overall Study|Insufficient data|1|||
126301357|NCT01085630|454392609|FG001|Overall Study|Insufficient data|0|||
126301358|NCT01085630|454392608|FG000|Overall Study|Ineligible|3|||
126301359|NCT01085630|454392609|FG001|Overall Study|Ineligible|0|||
126301360|NCT02609607|454392615|FG000|Overall Study|Lost to Follow-up|0|||
126301361|NCT02609607|454392616|FG001|Overall Study|Lost to Follow-up|1|||
126301362|NCT03168711|454392619|FG000|Overall Study|Adverse Event|2|||
126301363|NCT03168711|454392620|FG001|Overall Study|Adverse Event|0|||
126301364|NCT03168711|454392619|FG000|Overall Study|Withdrawal by Subject|0|||
126301365|NCT03168711|454392620|FG001|Overall Study|Withdrawal by Subject|1|||
126301366|NCT03168711|454392619|FG000|Overall Study|Death|0|||
126301367|NCT03168711|454392620|FG001|Overall Study|Death|1|||
126301368|NCT00651261|454392621|FG000|Overall Study|Adverse Event|32|||
126301369|NCT00651261|454392622|FG001|Overall Study|Adverse Event|22|||
126301370|NCT00651261|454392621|FG000|Overall Study|Death|18|||
126301371|NCT00651261|454392622|FG001|Overall Study|Death|18|||
126301372|NCT00651261|454392621|FG000|Overall Study|Withdrawal by Subject|22|||
126301373|NCT00651261|454392622|FG001|Overall Study|Withdrawal by Subject|40|||
126301374|NCT00651261|454392621|FG000|Overall Study|Induction failure|24|||
126301375|NCT00651261|454392622|FG001|Overall Study|Induction failure|35|||
126301376|NCT00651261|454392621|FG000|Overall Study|Disease progression|58|||
126301377|NCT00651261|454392622|FG001|Overall Study|Disease progression|58|||
126301378|NCT00651261|454392621|FG000|Overall Study|Alternative therapy|109|||
126301379|NCT00651261|454392622|FG001|Overall Study|Alternative therapy|107|||
126301380|NCT00651261|454392621|FG000|Overall Study|Other disease or participant decisions|23|||
126367473|NCT03502681|454640916|FG000|Overall Study|Disease Progression|2|||
125883958|NCT02079246|452873096|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
125883959|NCT02079246|452873097|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
125883960|NCT00956007|452873098|FG000|Overall Study|Protocol Violation|27|||
126044416|NCT05247034|453461026|FG001|Overall Study|Lost to Follow-up|2|||
125883961|NCT00956007|452873099|FG001|Overall Study|Protocol Violation|23|||
125883962|NCT00724698|452873100|FG000|Overall Study|Adverse Event|9|||
125883963|NCT00724698|452873100|FG000|Overall Study|Failure of Therapy|4|||
125883964|NCT00724698|452873100|FG000|Overall Study|Poor Compliance|16|||
126301381|NCT00651261|454392622|FG001|Overall Study|Other disease or participant decisions|23|||
126301382|NCT00651261|454392621|FG000|Overall Study|Never treated|5|||
126301383|NCT00651261|454392622|FG001|Overall Study|Never treated|3|||
126301384|NCT05483686|454392623|FG000|Overall Study|Lost to Follow-up|5|||
126301385|NCT05483686|454392624|FG001|Overall Study|Lost to Follow-up|7|||
126301386|NCT03351608|454392633|FG000|Overall Study|Lost to Follow-up|0|||
126301387|NCT03351608|454392634|FG001|Overall Study|Lost to Follow-up|1|||
126301388|NCT03351608|454392635|FG002|Overall Study|Lost to Follow-up|1|||
126301389|NCT03351608|454392636|FG003|Overall Study|Lost to Follow-up|1|||
126044417|NCT05247034|453461025|FG000|Overall Study|Organizational problems when attending appointments|1|||
126301390|NCT03351608|454392637|FG004|Overall Study|Lost to Follow-up|1|||
126301391|NCT03351608|454392633|FG000|Overall Study|Physician Decision|1|||
126301392|NCT03351608|454392634|FG001|Overall Study|Physician Decision|0|||
126301393|NCT03351608|454392635|FG002|Overall Study|Physician Decision|0|||
126301394|NCT03351608|454392636|FG003|Overall Study|Physician Decision|2|||
126301395|NCT03351608|454392637|FG004|Overall Study|Physician Decision|1|||
126301396|NCT03351608|454392633|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
126301397|NCT03351608|454392634|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
126301398|NCT03351608|454392635|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
126301399|NCT03351608|454392636|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
126301400|NCT03351608|454392637|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
126301401|NCT03351608|454392633|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126301402|NCT03351608|454392634|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126301403|NCT03351608|454392635|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126301404|NCT03351608|454392636|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126301405|NCT03351608|454392637|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126301406|NCT03351608|454392633|FG000|Overall Study|Other|0|||
126301407|NCT03351608|454392634|FG001|Overall Study|Other|1|||
126301408|NCT03351608|454392635|FG002|Overall Study|Other|1|||
126301409|NCT03351608|454392636|FG003|Overall Study|Other|3|||
126301410|NCT03351608|454392637|FG004|Overall Study|Other|0|||
126301411|NCT02877004|454392638|FG000|Overall Study|Pregnancy|0|||
126301412|NCT02877004|454392639|FG001|Overall Study|Pregnancy|0|||
126301413|NCT02877004|454392640|FG002|Overall Study|Pregnancy|1|||
126301414|NCT02727478|454392641|FG000|Overall Study|Withdrawal by Subject|8|||
126301415|NCT02727478|454392642|FG001|Overall Study|Withdrawal by Subject|10|||
126301416|NCT02633293|454392643|FG000|Overall Study|Death|56|||
126301417|NCT02633293|454392643|FG000|Overall Study|Progressive Disease|12|||
126301418|NCT02633293|454392643|FG000|Overall Study|Adverse Event|29|||
126301419|NCT02633293|454392643|FG000|Overall Study|Withdrawal by Subject|41|||
126301420|NCT02633293|454392643|FG000|Overall Study|Protocol Violation|1|||
126301421|NCT02633293|454392643|FG000|Overall Study|Lost to Follow-up|1|||
126301422|NCT02633293|454392643|FG000|Overall Study|Study Terminated by Sponsor|24|||
126301423|NCT02633293|454392643|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
126301424|NCT02633293|454392643|FG000|Overall Study|Lung Transplant|5|||
126301425|NCT02633293|454392643|FG000|Overall Study|Lack of Efficacy|2|||
126301426|NCT02633293|454392643|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
126301427|NCT03877068|454392647|FG000|Overall Study|Physician Decision|9|||
126301428|NCT03877068|454392648|FG001|Overall Study|Physician Decision|3|||
126301429|NCT00778817|454392649|FG000|Overall Study|Adverse Event|2|||
126301430|NCT00778817|454392649|FG000|Overall Study|Withdrawal by Subject|2|||
126301431|NCT02356588|454392650|FG000|Overall Study|Lack of Efficacy|4|||
126301432|NCT02356588|454392651|FG001|Overall Study|Lack of Efficacy|10|||
126301433|NCT02356588|454392650|FG000|Overall Study|Adverse Event|0|||
126301434|NCT02356588|454392651|FG001|Overall Study|Adverse Event|2|||
126301435|NCT02356588|454392650|FG000|Overall Study|Withdrawal by Subject|1|||
126301436|NCT02356588|454392651|FG001|Overall Study|Withdrawal by Subject|0|||
126301437|NCT02356588|454392650|FG000|Overall Study|Protocol Violation|0|||
126301438|NCT02356588|454392651|FG001|Overall Study|Protocol Violation|1|||
126301439|NCT01418378|454392652|FG000|Overall Study|Death|1|||
126301440|NCT01418378|454392653|FG001|Overall Study|Death|2|||
126301441|NCT01418378|454392652|FG000|Overall Study|Physician Decision|0|||
126301442|NCT01418378|454392653|FG001|Overall Study|Physician Decision|1|||
126301443|NCT01418378|454392652|FG000|Overall Study|ligament imbalance|0|||
126301444|NCT01418378|454392653|FG001|Overall Study|ligament imbalance|1|||
126301445|NCT01418378|454392652|FG000|Overall Study|developed chronic myopathy|0|||
126301446|NCT01418378|454392653|FG001|Overall Study|developed chronic myopathy|1|||
126301447|NCT01081769|454392655|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
126301448|NCT01081769|454392656|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
126301449|NCT01081769|454392655|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
126301450|NCT01081769|454392656|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
126301451|NCT01081769|454392655|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
126301452|NCT01081769|454392656|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
126301453|NCT01081769|454392655|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
126301454|NCT01081769|454392656|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
126301455|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Adverse Event|14|||
126301456|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Adverse Event|11|||
126301457|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Death|1|||
126301458|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Death|1|||
126301459|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
126301460|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
126301461|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
126301462|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
126301463|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Pregnancy|1|||
126301464|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Pregnancy|0|||
126301465|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
126301466|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
126301467|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
126301468|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
126301469|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Other|0|||
126301470|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Other|1|||
126301471|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Ineligibility|3|||
126301472|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Ineligibility|4|||
126301473|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
126301474|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
126301475|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Patient Moved|2|||
126301476|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Patient Moved|2|||
126301477|NCT00507455|454392657|FG000|Overall Study|Adverse Event|3|||
126301478|NCT00507455|454392658|FG001|Overall Study|Adverse Event|3|||
126301479|NCT00507455|454392659|FG002|Overall Study|Adverse Event|6|||
126301480|NCT00507455|454392657|FG000|Overall Study|Withdrawal by Subject|2|||
126301481|NCT00507455|454392658|FG001|Overall Study|Withdrawal by Subject|1|||
126301482|NCT00507455|454392659|FG002|Overall Study|Withdrawal by Subject|2|||
126301483|NCT00507455|454392657|FG000|Overall Study|Protocol Violation|4|||
126301484|NCT00507455|454392658|FG001|Overall Study|Protocol Violation|1|||
126301485|NCT00507455|454392659|FG002|Overall Study|Protocol Violation|1|||
126301486|NCT00507455|454392657|FG000|Overall Study|Lost to Follow-up|2|||
126301487|NCT00507455|454392658|FG001|Overall Study|Lost to Follow-up|0|||
126301488|NCT00507455|454392659|FG002|Overall Study|Lost to Follow-up|2|||
126301489|NCT00507455|454392657|FG000|Overall Study|Lack of Efficacy|0|||
126301490|NCT00507455|454392658|FG001|Overall Study|Lack of Efficacy|1|||
126301491|NCT00507455|454392659|FG002|Overall Study|Lack of Efficacy|0|||
126301492|NCT00507455|454392657|FG000|Overall Study|Other - miscellaneous reason|1|||
126301493|NCT00507455|454392658|FG001|Overall Study|Other - miscellaneous reason|0|||
126301494|NCT00507455|454392659|FG002|Overall Study|Other - miscellaneous reason|1|||
126301495|NCT02019264|454392660|FG000|Overall Study|Not treated|6|||
126301496|NCT02019264|454392661|FG001|Overall Study|Not treated|4|||
126367474|NCT03502681|454640917|FG001|Overall Study|Disease Progression|1|||
126367475|NCT06790303|454640918|FG000|Overall Study|Study Terminated by sponsor|4|||
126367476|NCT06790303|454640918|FG000|Overall Study|Death|4|||
126367477|NCT02374255|454640927|FG000|Overall Study|Withdrawal by Subject|2|||
126367478|NCT02374255|454640928|FG001|Overall Study|Withdrawal by Subject|0|||
126367479|NCT02374255|454640929|FG002|Overall Study|Withdrawal by Subject|0|||
126367480|NCT02374255|454640930|FG003|Overall Study|Withdrawal by Subject|0|||
126367481|NCT02093520|454640931|FG000|Overall Study|Not treated|6|||
126367482|NCT02093520|454640932|FG001|Overall Study|Not treated|22|||
126367483|NCT03014089|454640933|FG000|Overall Study|Withdrawal by Subject|0|||
126367484|NCT03014089|454640934|FG001|Overall Study|Withdrawal by Subject|1|||
126367485|NCT03014089|454640935|FG002|Overall Study|Withdrawal by Subject|1|||
126367486|NCT03014089|454640936|FG003|Overall Study|Withdrawal by Subject|1|||
126367487|NCT03014089|454640933|FG000|Overall Study|Lost to Follow-up|1|||
126367488|NCT03014089|454640934|FG001|Overall Study|Lost to Follow-up|0|||
126367489|NCT03014089|454640935|FG002|Overall Study|Lost to Follow-up|0|||
126367490|NCT03014089|454640936|FG003|Overall Study|Lost to Follow-up|0|||
126367491|NCT03014089|454640933|FG000|Overall Study|Adverse Event|1|||
126367492|NCT03014089|454640934|FG001|Overall Study|Adverse Event|0|||
126367493|NCT03014089|454640935|FG002|Overall Study|Adverse Event|1|||
126367494|NCT03014089|454640936|FG003|Overall Study|Adverse Event|0|||
126367495|NCT00321932|454640937|FG000|Overall Study|Death|3|||
126367496|NCT00321932|454640938|FG001|Overall Study|Death|6|||
126367497|NCT00321932|454640937|FG000|Overall Study|Withdrawal by Subject|3|||
126301497|NCT02019264|454392660|FG000|Overall Study|Lost to Follow-up|50|||
126301498|NCT02019264|454392661|FG001|Overall Study|Lost to Follow-up|47|||
126367498|NCT00321932|454640938|FG001|Overall Study|Withdrawal by Subject|6|||
126367499|NCT00321932|454640937|FG000|Overall Study|Early relapse|2|||
126367500|NCT00321932|454640938|FG001|Overall Study|Early relapse|8|||
126367501|NCT00321932|454640937|FG000|Overall Study|Missing data|2|||
126367502|NCT00321932|454640938|FG001|Overall Study|Missing data|1|||
126367503|NCT03257657|454640940|FG000|Overall Study|Lost to Follow-up|0|||
126367504|NCT03257657|454640941|FG001|Overall Study|Lost to Follow-up|3|||
126367505|NCT03257657|454640940|FG000|Overall Study|Withdrawn|0|||
126367506|NCT03257657|454640941|FG001|Overall Study|Withdrawn|1|||
126367507|NCT03257657|454640940|FG000|Overall Study|Noted not eligible right after enrolled|0|||
126367508|NCT03257657|454640941|FG001|Overall Study|Noted not eligible right after enrolled|1|||
126367509|NCT01992757|454640956|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
126367510|NCT04992273|454640957|FG000|Overall Study|Lost to Follow-up|0|||
126367511|NCT04992273|454640958|FG001|Overall Study|Lost to Follow-up|1|||
126367512|NCT00688740|454640959|FG000|Overall Study|Adverse Event|45|||
126367513|NCT00688740|454640960|FG001|Overall Study|Adverse Event|8|||
126367514|NCT00688740|454640959|FG000|Overall Study|Death|2|||
126367515|NCT00688740|454640960|FG001|Overall Study|Death|2|||
126367516|NCT00688740|454640959|FG000|Overall Study|Lost to Follow-up|0|||
126367517|NCT00688740|454640960|FG001|Overall Study|Lost to Follow-up|1|||
125883965|NCT00724698|452873100|FG000|Overall Study|Lost to Follow-up|36|||
125883966|NCT00724698|452873100|FG000|Overall Study|No Info|25|||
125883967|NCT05021978|452873101|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
125883968|NCT05021978|452873102|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125883969|NCT05021978|452873103|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125883970|NCT05021978|452873104|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125883971|NCT05021978|452873101|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125883972|NCT05021978|452873102|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
125883973|NCT05021978|452873103|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125883974|NCT05021978|452873104|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125883975|NCT02177032|452873107|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
125883976|NCT02177032|452873108|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
125883977|NCT02177032|452873109|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
125883978|NCT02177032|452873110|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
125883979|NCT02177032|452873107|FG000|Overall Study|Lost to Follow-up|0|||
125883980|NCT02177032|452873108|FG001|Overall Study|Lost to Follow-up|2|||
125883981|NCT02177032|452873109|FG002|Overall Study|Lost to Follow-up|0|||
125883982|NCT02177032|452873110|FG003|Overall Study|Lost to Follow-up|0|||
125883983|NCT02177032|452873107|FG000|Overall Study|OTHER|2|||
125883984|NCT02177032|452873108|FG001|Overall Study|OTHER|0|||
126367518|NCT00688740|454640959|FG000|Overall Study|Consent Withdrawn|17|||
126367519|NCT00688740|454640960|FG001|Overall Study|Consent Withdrawn|17|||
126367520|NCT00688740|454640959|FG000|Overall Study|Breast Cancer Relapse|1|||
126367521|NCT00688740|454640960|FG001|Overall Study|Breast Cancer Relapse|4|||
126367522|NCT00688740|454640959|FG000|Overall Study|Violation of Inclusion Criteria|1|||
126367523|NCT00688740|454640960|FG001|Overall Study|Violation of Inclusion Criteria|3|||
125883985|NCT02177032|452873109|FG002|Overall Study|OTHER|1|||
125883986|NCT02177032|452873110|FG003|Overall Study|OTHER|0|||
125883987|NCT02177032|452873107|FG000|Overall Study|Withdrawal by Subject|1|||
125883988|NCT02177032|452873108|FG001|Overall Study|Withdrawal by Subject|0|||
125883989|NCT02177032|452873109|FG002|Overall Study|Withdrawal by Subject|1|||
125883990|NCT02177032|452873110|FG003|Overall Study|Withdrawal by Subject|0|||
125883991|NCT00665652|452873111|FG000|Overall Study|Adverse Event|4|||
126367524|NCT00856557|454640963|FG000|Overall Study|No patients with contextual flags|12|||
126367525|NCT00856557|454640964|FG001|Overall Study|No patients with contextual flags|16|||
126367526|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
126367527|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
126367528|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
126367529|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
126367530|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
126367531|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
126367532|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
126367533|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
126367534|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
126367535|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
126367536|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
126367537|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
126367538|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
126367539|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
126367540|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
126367541|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
126367542|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
126367543|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
126367544|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
126367545|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
125883992|NCT00665652|452873111|FG000|Overall Study|Death|1|||
125883993|NCT00665652|452873111|FG000|Overall Study|No longer met inclusion criteria.|1|||
125883994|NCT02556177|452873114|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
126301499|NCT02019264|454392660|FG000|Overall Study|Withdrawal by Subject|142|||
126301500|NCT02019264|454392661|FG001|Overall Study|Withdrawal by Subject|117|||
126301501|NCT02019264|454392660|FG000|Overall Study|Administrative reason|36|||
126301502|NCT02019264|454392661|FG001|Overall Study|Administrative reason|28|||
126301503|NCT02019264|454392660|FG000|Overall Study|Missing|14|||
126301504|NCT02019264|454392661|FG001|Overall Study|Missing|11|||
126301505|NCT01964222|454392662|FG000|Overall Study|Lost to Follow-up|7|||
126301506|NCT01964222|454392663|FG001|Overall Study|Lost to Follow-up|5|||
126301507|NCT01964222|454392662|FG000|Overall Study|Withdrawal by Subject|6|||
126301508|NCT01964222|454392663|FG001|Overall Study|Withdrawal by Subject|6|||
126301509|NCT01964222|454392662|FG000|Overall Study|Screening Failure|2|||
126301510|NCT01964222|454392663|FG001|Overall Study|Screening Failure|0|||
126301511|NCT01737710|454392671|FG000|Overall Study|Lost to Follow-up|0|||
126301512|NCT01737710|454392672|FG001|Overall Study|Lost to Follow-up|2|||
126301513|NCT01737710|454392673|FG002|Overall Study|Lost to Follow-up|2|||
126301514|NCT01737710|454392674|FG003|Overall Study|Lost to Follow-up|0|||
126301515|NCT01737710|454392675|FG004|Overall Study|Lost to Follow-up|0|||
126301516|NCT01737710|454392671|FG000|Overall Study|Withdrawal by Subject|1|||
126301517|NCT01737710|454392672|FG001|Overall Study|Withdrawal by Subject|1|||
126301518|NCT01737710|454392673|FG002|Overall Study|Withdrawal by Subject|1|||
126301519|NCT01737710|454392674|FG003|Overall Study|Withdrawal by Subject|0|||
126301520|NCT01737710|454392675|FG004|Overall Study|Withdrawal by Subject|0|||
126301521|NCT01737710|454392671|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
126301522|NCT01737710|454392672|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
126301523|NCT01737710|454392673|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
126301524|NCT01737710|454392674|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
126301525|NCT01737710|454392675|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
126301526|NCT03363776|454392676|FG000|Overall Study|Progressive disease|2|||
126301527|NCT03363776|454392677|FG001|Overall Study|Progressive disease|3|||
126301528|NCT03363776|454392678|FG002|Overall Study|Progressive disease|1|||
126301529|NCT03363776|454392676|FG000|Overall Study|Study drug toxicity|0|||
126301530|NCT03363776|454392677|FG001|Overall Study|Study drug toxicity|0|||
126301531|NCT03363776|454392678|FG002|Overall Study|Study drug toxicity|1|||
126301532|NCT03363776|454392676|FG000|Overall Study|Death|1|||
126301533|NCT03363776|454392677|FG001|Overall Study|Death|0|||
126301534|NCT03363776|454392678|FG002|Overall Study|Death|0|||
126301535|NCT02097238|454392685|FG000|Overall Study|Death|1|||
126301536|NCT02097238|454392685|FG000|Overall Study|Physician Decision|1|||
126301537|NCT02097238|454392685|FG000|Overall Study|Progressive Disease|17|||
126301538|NCT01106911|454392686|FG000|Overall Study|Physician Decision|2|||
126301539|NCT01106911|454392686|FG000|Overall Study|deemed ineligible after screening|3|||
126301540|NCT01814696|454392688|FG000|Overall Study|Withdrawal by Subject|1|||
126301541|NCT01814696|454392689|FG001|Overall Study|Withdrawal by Subject|0|||
126301542|NCT01814696|454392688|FG000|Overall Study|Randomized to wrong group|1|||
126301543|NCT01814696|454392689|FG001|Overall Study|Randomized to wrong group|0|||
126301544|NCT02861807|454392690|FG000|Overall Study|Lost to Follow-up|7|||
126301545|NCT02861807|454392691|FG001|Overall Study|Lost to Follow-up|6|||
126301546|NCT02861807|454392690|FG000|Overall Study|Withdrawal by Subject|5|||
126301547|NCT02861807|454392691|FG001|Overall Study|Withdrawal by Subject|8|||
126301548|NCT00410813|454392692|FG000|Overall Study|Adverse Event|6|||
126301549|NCT00410813|454392693|FG001|Overall Study|Adverse Event|11|||
126301550|NCT00410813|454392692|FG000|Overall Study|Progression|32|||
126301551|NCT00410813|454392693|FG001|Overall Study|Progression|21|||
126301552|NCT00410813|454392692|FG000|Overall Study|Not protocol specified|3|||
126301553|NCT00410813|454392693|FG001|Overall Study|Not protocol specified|4|||
126301554|NCT00410813|454392692|FG000|Overall Study|Ineligible|2|||
126301555|NCT00410813|454392693|FG001|Overall Study|Ineligible|4|||
126301556|NCT00410813|454392692|FG000|Overall Study|Death|0|||
126301557|NCT00410813|454392693|FG001|Overall Study|Death|2|||
126301558|NCT00812981|454392694|FG000|Overall Study|Other|0|||
126301559|NCT00812981|454392695|FG001|Overall Study|Other|1|||
126301560|NCT02199795|454392696|FG000|Overall Study|no longer met inclusion criteria|1|||
126301561|NCT02199795|454392697|FG001|Overall Study|no longer met inclusion criteria|0|||
126301562|NCT02199795|454392696|FG000|Overall Study|withdrew due to shoulder pain|1|||
126301563|NCT02199795|454392697|FG001|Overall Study|withdrew due to shoulder pain|0|||
126301564|NCT02677922|454392702|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
126301565|NCT02677922|454392703|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
126301566|NCT02677922|454392704|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
126301567|NCT02677922|454392705|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
126301568|NCT02677922|454392706|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
126301569|NCT02677922|454392707|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
126301570|NCT02677922|454392702|FG000|Treatment Period|Adverse Event|0|||
126301571|NCT02677922|454392703|FG001|Treatment Period|Adverse Event|0|||
126301572|NCT02677922|454392704|FG002|Treatment Period|Adverse Event|1|||
126301573|NCT02677922|454392705|FG003|Treatment Period|Adverse Event|3|||
126301574|NCT02677922|454392706|FG004|Treatment Period|Adverse Event|5|||
126367546|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
126103396|NCT02924064|453672151|FG001|Overall Study|Adverse Event|2|||
126044418|NCT05247034|453461026|FG001|Overall Study|Organizational problems when attending appointments|0|||
126044419|NCT04464564|453461029|FG000|Period A (Placebo lead-in)|Other|5|||
126367547|NCT01432444|454640965|FG000|Treatment Phase|Lost to Follow-up|0|||
126367548|NCT01432444|454640966|FG001|Treatment Phase|Lost to Follow-up|33|||
126367549|NCT01432444|454640967|FG002|Treatment Phase|Lost to Follow-up|0|||
126367550|NCT01432444|454640965|FG000|Treatment Phase|Adverse Event|0|||
126367551|NCT01432444|454640966|FG001|Treatment Phase|Adverse Event|37|||
126367552|NCT01432444|454640967|FG002|Treatment Phase|Adverse Event|0|||
126044420|NCT04464564|453461030|FG001|Period A (Placebo lead-in)|Other|0|||
126367553|NCT01432444|454640965|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
126367554|NCT01432444|454640966|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
126367555|NCT01432444|454640967|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
126367556|NCT01432444|454640965|FG000|Treatment Phase|Physician Decision|0|||
126367557|NCT01432444|454640966|FG001|Treatment Phase|Physician Decision|5|||
126367558|NCT01432444|454640967|FG002|Treatment Phase|Physician Decision|0|||
126367559|NCT01432444|454640965|FG000|Treatment Phase|Withdrawal by Subject|0|||
126367560|NCT01432444|454640966|FG001|Treatment Phase|Withdrawal by Subject|41|||
126367561|NCT01432444|454640967|FG002|Treatment Phase|Withdrawal by Subject|0|||
126367562|NCT01432444|454640965|FG000|Treatment Phase|Protocol Deviation|0|||
126367563|NCT01432444|454640966|FG001|Treatment Phase|Protocol Deviation|3|||
126367564|NCT01432444|454640967|FG002|Treatment Phase|Protocol Deviation|0|||
126044421|NCT04464564|453461031|FG002|Period A (Placebo lead-in)|Other|0|||
126044422|NCT04464564|453461032|FG003|Period A (Placebo lead-in)|Other|0|||
126044423|NCT04464564|453461029|FG000|Period B (Randomization Period)|Adverse Event|0|||
126044424|NCT04464564|453461030|FG001|Period B (Randomization Period)|Adverse Event|1|||
126044425|NCT04464564|453461031|FG002|Period B (Randomization Period)|Adverse Event|2|||
126044426|NCT04464564|453461032|FG003|Period B (Randomization Period)|Adverse Event|8|||
126044427|NCT04464564|453461029|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
126044428|NCT04464564|453461030|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
126044429|NCT04464564|453461031|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
126044430|NCT04464564|453461032|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
126044431|NCT04464564|453461029|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
126044432|NCT04464564|453461030|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
126044433|NCT04464564|453461031|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
126044434|NCT04464564|453461032|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
126044435|NCT04464564|453461029|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
126044436|NCT04464564|453461030|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
126044437|NCT04464564|453461031|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
126044438|NCT04464564|453461032|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
126044439|NCT04464564|453461029|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
126044440|NCT04464564|453461030|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
126044441|NCT04464564|453461031|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
126044442|NCT04464564|453461032|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
126044443|NCT04464564|453461029|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
126044444|NCT04464564|453461030|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
126044445|NCT04464564|453461031|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
126044446|NCT04464564|453461032|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
126044447|NCT04464564|453461029|FG000|Period B (Randomization Period)|Reason not Specified|0|||
126044448|NCT04464564|453461030|FG001|Period B (Randomization Period)|Reason not Specified|3|||
126044449|NCT04464564|453461031|FG002|Period B (Randomization Period)|Reason not Specified|3|||
126044450|NCT04464564|453461032|FG003|Period B (Randomization Period)|Reason not Specified|3|||
126044451|NCT04389957|453461033|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
126044452|NCT04389957|453461034|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
126044453|NCT04389957|453461035|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
126044454|NCT04389957|453461036|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
126044455|NCT04389957|453461037|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
126044456|NCT06655818|453461051|FG000|Overall Study|Withdrawal by Subject|1|||
126044457|NCT02095691|453461052|FG000|Overall Study|Physician Decision|1|||
126044458|NCT05147584|453461053|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
126044459|NCT05460871|453461054|FG000|Overall Study|Withdrawal by Subject|1|||
126044460|NCT05460871|453461055|FG001|Overall Study|Withdrawal by Subject|2|||
126044461|NCT03498521|453461066|FG000|Overall Study|Death|191|||
126044462|NCT03498521|453461067|FG001|Overall Study|Death|64|||
126044463|NCT03498521|453461068|FG002|Overall Study|Death|72|||
126044464|NCT03498521|453461066|FG000|Overall Study|Exclusion criteria|1|||
126044465|NCT03498521|453461067|FG001|Overall Study|Exclusion criteria|0|||
126044466|NCT03498521|453461068|FG002|Overall Study|Exclusion criteria|0|||
126367565|NCT01432444|454640965|FG000|Treatment Phase|Lack of Efficacy|0|||
126367566|NCT01432444|454640966|FG001|Treatment Phase|Lack of Efficacy|10|||
125883995|NCT02556177|452873115|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
125883996|NCT01055197|452873128|FG000|Overall Study|Protocol Violation|7|||
125883997|NCT01055197|452873129|FG001|Overall Study|Protocol Violation|2|||
125883998|NCT01055197|452873128|FG000|Overall Study|Withdrawal by Subject|2|||
125883999|NCT01055197|452873129|FG001|Overall Study|Withdrawal by Subject|0|||
125884000|NCT00389610|452873130|FG000|Overall Study|Disease Progression|0|||
125884001|NCT00389610|452873131|FG001|Overall Study|Disease Progression|19|||
125884002|NCT00389610|452873130|FG000|Overall Study|Death|0|||
125884003|NCT00389610|452873131|FG001|Overall Study|Death|1|||
125884004|NCT00389610|452873130|FG000|Overall Study|Physician Decision|0|||
125884005|NCT00389610|452873131|FG001|Overall Study|Physician Decision|1|||
125884006|NCT00389610|452873130|FG000|Overall Study|Withdrawal by Subject|0|||
125884007|NCT00389610|452873131|FG001|Overall Study|Withdrawal by Subject|1|||
125884008|NCT00538902|452873132|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
125884009|NCT00538902|452873133|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
125884010|NCT00538902|452873134|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
125884011|NCT00538902|452873132|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
125884012|NCT00538902|452873133|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
125884013|NCT00538902|452873134|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
125884014|NCT00538902|452873132|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
125884015|NCT00538902|452873133|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
125884016|NCT00538902|452873134|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
125884017|NCT00538902|452873132|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125884018|NCT00538902|452873133|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125884019|NCT00538902|452873134|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125884020|NCT00538902|452873132|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
125884021|NCT00538902|452873133|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
125884022|NCT00538902|452873134|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
125884023|NCT00538902|452873132|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
125884024|NCT00538902|452873133|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
125884025|NCT00538902|452873134|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
125884026|NCT00538902|452873132|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
125884027|NCT00538902|452873133|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
125884028|NCT00538902|452873134|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
125884029|NCT00538902|452873132|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
125884030|NCT00538902|452873133|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
125884031|NCT00538902|452873134|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
126044467|NCT03498521|453461066|FG000|Overall Study|Lost to Follow-up|3|||
126044468|NCT03498521|453461067|FG001|Overall Study|Lost to Follow-up|3|||
126044469|NCT03498521|453461068|FG002|Overall Study|Lost to Follow-up|3|||
126044470|NCT03498521|453461066|FG000|Overall Study|No profile due to technical failure|1|||
126044471|NCT03498521|453461067|FG001|Overall Study|No profile due to technical failure|0|||
126044472|NCT03498521|453461068|FG002|Overall Study|No profile due to technical failure|0|||
126044473|NCT03498521|453461066|FG000|Overall Study|Physician Decision|0|||
126044474|NCT03498521|453461067|FG001|Overall Study|Physician Decision|1|||
126044475|NCT03498521|453461068|FG002|Overall Study|Physician Decision|0|||
126044476|NCT03498521|453461066|FG000|Overall Study|Withdrawal by Subject|9|||
126044477|NCT03498521|453461067|FG001|Overall Study|Withdrawal by Subject|6|||
126044478|NCT03498521|453461068|FG002|Overall Study|Withdrawal by Subject|2|||
125884032|NCT03739203|452873135|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
125884033|NCT03739203|452873136|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
125884034|NCT03739203|452873137|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
125884035|NCT03739203|452873135|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125884036|NCT03739203|452873136|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126301575|NCT02677922|454392707|FG005|Treatment Period|Adverse Event|2|||
126301576|NCT02677922|454392702|FG000|Treatment Period|Progressive Disease|1|||
126301577|NCT02677922|454392703|FG001|Treatment Period|Progressive Disease|1|||
126301578|NCT02677922|454392704|FG002|Treatment Period|Progressive Disease|0|||
126301579|NCT02677922|454392705|FG003|Treatment Period|Progressive Disease|0|||
126301580|NCT02677922|454392706|FG004|Treatment Period|Progressive Disease|8|||
126301581|NCT02677922|454392707|FG005|Treatment Period|Progressive Disease|7|||
126301582|NCT02677922|454392702|FG000|Treatment Period|Lack of Efficacy|0|||
126301583|NCT02677922|454392703|FG001|Treatment Period|Lack of Efficacy|0|||
126301584|NCT02677922|454392704|FG002|Treatment Period|Lack of Efficacy|0|||
126301585|NCT02677922|454392705|FG003|Treatment Period|Lack of Efficacy|1|||
126301586|NCT02677922|454392706|FG004|Treatment Period|Lack of Efficacy|1|||
126301587|NCT02677922|454392707|FG005|Treatment Period|Lack of Efficacy|6|||
126301588|NCT02677922|454392702|FG000|Treatment Period|Withdrawal by Subject|0|||
126301589|NCT02677922|454392703|FG001|Treatment Period|Withdrawal by Subject|0|||
126301590|NCT02677922|454392704|FG002|Treatment Period|Withdrawal by Subject|1|||
126301591|NCT02677922|454392705|FG003|Treatment Period|Withdrawal by Subject|3|||
126301592|NCT02677922|454392706|FG004|Treatment Period|Withdrawal by Subject|5|||
126301593|NCT02677922|454392707|FG005|Treatment Period|Withdrawal by Subject|5|||
126301594|NCT02677922|454392702|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
126301595|NCT02677922|454392703|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
126301596|NCT02677922|454392704|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
126301597|NCT02677922|454392705|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
126301598|NCT02677922|454392706|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
126301599|NCT02677922|454392707|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
126301600|NCT02677922|454392702|FG000|Treatment Period|Disease Relapse|0|||
126301601|NCT02677922|454392703|FG001|Treatment Period|Disease Relapse|0|||
126301602|NCT02677922|454392704|FG002|Treatment Period|Disease Relapse|0|||
126301603|NCT02677922|454392705|FG003|Treatment Period|Disease Relapse|3|||
126301604|NCT02677922|454392706|FG004|Treatment Period|Disease Relapse|6|||
126301605|NCT02677922|454392707|FG005|Treatment Period|Disease Relapse|1|||
126301606|NCT02677922|454392702|FG000|Treatment Period|Allogeneic HSCT|1|||
126301607|NCT02677922|454392703|FG001|Treatment Period|Allogeneic HSCT|0|||
126301608|NCT02677922|454392704|FG002|Treatment Period|Allogeneic HSCT|0|||
126301609|NCT02677922|454392705|FG003|Treatment Period|Allogeneic HSCT|1|||
126301610|NCT02677922|454392706|FG004|Treatment Period|Allogeneic HSCT|4|||
126301611|NCT02677922|454392707|FG005|Treatment Period|Allogeneic HSCT|1|||
126301612|NCT02677922|454392702|FG000|Treatment Period|Other Reasons|0|||
126301613|NCT02677922|454392703|FG001|Treatment Period|Other Reasons|0|||
126301614|NCT02677922|454392704|FG002|Treatment Period|Other Reasons|0|||
126301615|NCT02677922|454392705|FG003|Treatment Period|Other Reasons|1|||
126301616|NCT02677922|454392706|FG004|Treatment Period|Other Reasons|3|||
126301617|NCT02677922|454392707|FG005|Treatment Period|Other Reasons|5|||
126301618|NCT02677922|454392702|FG000|Treatment Period|Death|0|||
126301619|NCT02677922|454392703|FG001|Treatment Period|Death|0|||
126301620|NCT02677922|454392704|FG002|Treatment Period|Death|0|||
126301621|NCT02677922|454392705|FG003|Treatment Period|Death|0|||
126301622|NCT02677922|454392706|FG004|Treatment Period|Death|12|||
126301623|NCT02677922|454392707|FG005|Treatment Period|Death|1|||
126301624|NCT02677922|454392702|FG000|Treatment Period|Non-compliance with Study Drug|0|||
126301625|NCT02677922|454392703|FG001|Treatment Period|Non-compliance with Study Drug|0|||
126301626|NCT02677922|454392704|FG002|Treatment Period|Non-compliance with Study Drug|0|||
126301627|NCT02677922|454392705|FG003|Treatment Period|Non-compliance with Study Drug|0|||
126301628|NCT02677922|454392706|FG004|Treatment Period|Non-compliance with Study Drug|1|||
126301629|NCT02677922|454392707|FG005|Treatment Period|Non-compliance with Study Drug|0|||
126301630|NCT02677922|454392702|FG000|Treatment Period|Physician Decision|0|||
126301631|NCT02677922|454392703|FG001|Treatment Period|Physician Decision|0|||
126301632|NCT02677922|454392704|FG002|Treatment Period|Physician Decision|0|||
126301633|NCT02677922|454392705|FG003|Treatment Period|Physician Decision|0|||
126301634|NCT02677922|454392706|FG004|Treatment Period|Physician Decision|0|||
126301635|NCT02677922|454392707|FG005|Treatment Period|Physician Decision|1|||
126301636|NCT02677922|454392702|FG000|Treatment Period|Symptomatic Deterioration|0|||
126301637|NCT02677922|454392703|FG001|Treatment Period|Symptomatic Deterioration|0|||
126301638|NCT02677922|454392704|FG002|Treatment Period|Symptomatic Deterioration|0|||
126301639|NCT02677922|454392705|FG003|Treatment Period|Symptomatic Deterioration|0|||
126301640|NCT02677922|454392706|FG004|Treatment Period|Symptomatic Deterioration|1|||
126301641|NCT02677922|454392707|FG005|Treatment Period|Symptomatic Deterioration|0|||
126301642|NCT05310071|454392708|FG000|Overall Study|Death|0|||
126301643|NCT05310071|454392709|FG001|Overall Study|Death|3|||
126301644|NCT05310071|454392708|FG000|Overall Study|Adverse Event|4|||
126301645|NCT05310071|454392709|FG001|Overall Study|Adverse Event|31|||
126301646|NCT05310071|454392708|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
126301647|NCT05310071|454392709|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
126301648|NCT05310071|454392708|FG000|Overall Study|Protocol Deviation|2|||
126301649|NCT05310071|454392709|FG001|Overall Study|Protocol Deviation|0|||
126301650|NCT05310071|454392708|FG000|Overall Study|Randomized by Mistake|0|||
126301651|NCT05310071|454392709|FG001|Overall Study|Randomized by Mistake|1|||
126301652|NCT05310071|454392708|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
126301653|NCT05310071|454392709|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
126301654|NCT05310071|454392708|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
126301655|NCT05310071|454392709|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
126301656|NCT05310071|454392708|FG000|Overall Study|Site Terminated by Sponsor|0|||
126301657|NCT05310071|454392709|FG001|Overall Study|Site Terminated by Sponsor|2|||
126301658|NCT05310071|454392708|FG000|Overall Study|Study Terminated by Sponsor|282|||
126301659|NCT05310071|454392709|FG001|Overall Study|Study Terminated by Sponsor|559|||
126301660|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
126301661|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
126301662|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
126301663|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
126301664|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
126301665|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
126301666|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
126301667|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
126301668|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant - Other|25|||
126301669|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant - Other|30|||
126301670|NCT05310071|454392708|FG000|Overall Study|Lost to Follow-up|2|||
126301671|NCT05310071|454392709|FG001|Overall Study|Lost to Follow-up|4|||
126301672|NCT05310071|454392708|FG000|Overall Study|Reason Not Specified|1|||
126301673|NCT05310071|454392709|FG001|Overall Study|Reason Not Specified|3|||
126301674|NCT02203721|454392715|FG000|Overall Study|Lost to Follow-up|1|||
126301675|NCT02203721|454392716|FG001|Overall Study|Lost to Follow-up|0|||
126301676|NCT02203721|454392715|FG000|Overall Study|Death|0|||
126301677|NCT02203721|454392716|FG001|Overall Study|Death|2|||
126301678|NCT02203721|454392715|FG000|Overall Study|Illness|0|||
126301679|NCT02203721|454392716|FG001|Overall Study|Illness|1|||
126301680|NCT02630251|454392717|FG000|Overall Study|Physician Decision|0|||
126301681|NCT02630251|454392718|FG001|Overall Study|Physician Decision|0|||
126301682|NCT02630251|454392719|FG002|Overall Study|Physician Decision|1|||
126301683|NCT02630251|454392720|FG003|Overall Study|Physician Decision|0|||
126301684|NCT00961350|454392721|FG000|Overall Study|Adverse Event|18|||
126301685|NCT00961350|454392722|FG001|Overall Study|Adverse Event|33|||
126301686|NCT00961350|454392721|FG000|Overall Study|Withdrawal by Subject|10|||
126301687|NCT00961350|454392722|FG001|Overall Study|Withdrawal by Subject|10|||
126301688|NCT00961350|454392721|FG000|Overall Study|Lost to Follow-up|3|||
126301689|NCT00961350|454392722|FG001|Overall Study|Lost to Follow-up|3|||
126301690|NCT00961350|454392721|FG000|Overall Study|Misc|16|||
126301691|NCT00961350|454392722|FG001|Overall Study|Misc|21|||
126301692|NCT02134015|454392723|FG000|Overall Study|Protocol Violation|0|||
126301693|NCT02134015|454392724|FG001|Overall Study|Protocol Violation|1|||
126301694|NCT02134015|454392723|FG000|Overall Study|Death|2|||
126301695|NCT02134015|454392724|FG001|Overall Study|Death|1|||
126301696|NCT02134015|454392723|FG000|Overall Study|Reason not provided|1|||
126301697|NCT02134015|454392724|FG001|Overall Study|Reason not provided|2|||
126301698|NCT02134015|454392723|FG000|Overall Study|Clinical progression|14|||
126301699|NCT02134015|454392724|FG001|Overall Study|Clinical progression|7|||
126301700|NCT02134015|454392723|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
126301701|NCT02134015|454392724|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
126301702|NCT02134015|454392723|FG000|Overall Study|Study terminated by sponsor|2|||
126301703|NCT02134015|454392724|FG001|Overall Study|Study terminated by sponsor|3|||
126301704|NCT02134015|454392723|FG000|Overall Study|Adverse Event|9|||
126301705|NCT02134015|454392724|FG001|Overall Study|Adverse Event|10|||
126301706|NCT02134015|454392723|FG000|Overall Study|Withdrawal by Subject|3|||
126301707|NCT02134015|454392724|FG001|Overall Study|Withdrawal by Subject|7|||
126301708|NCT03668119|454394757|FG000|Pre-treatment|Disease Progression|1|||
126301709|NCT03668119|454394758|FG001|Pre-treatment|Disease Progression|0|||
126301710|NCT03668119|454394757|FG000|Treatment|Disease Progression|76|||
126367567|NCT01432444|454640967|FG002|Treatment Phase|Lack of Efficacy|0|||
126367568|NCT01432444|454640965|FG000|Extension Phase|Lost to Follow-up|0|||
126367569|NCT01432444|454640966|FG001|Extension Phase|Lost to Follow-up|0|||
126367570|NCT01432444|454640967|FG002|Extension Phase|Lost to Follow-up|17|||
126367571|NCT01432444|454640965|FG000|Extension Phase|Adverse Event|0|||
126367572|NCT01432444|454640966|FG001|Extension Phase|Adverse Event|0|||
126367573|NCT01432444|454640967|FG002|Extension Phase|Adverse Event|10|||
126367574|NCT01432444|454640965|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
126301711|NCT03668119|454394758|FG001|Treatment|Disease Progression|57|||
126301712|NCT03668119|454394757|FG000|Treatment|Study drug toxicity|19|||
126301713|NCT03668119|454394758|FG001|Treatment|Study drug toxicity|1|||
126301714|NCT03668119|454394757|FG000|Treatment|Death|3|||
126301715|NCT03668119|454394758|FG001|Treatment|Death|0|||
126301716|NCT03668119|454394757|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
126301717|NCT03668119|454394758|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
126301718|NCT03668119|454394757|FG000|Treatment|Withdrawal by Subject|1|||
126301719|NCT03668119|454394758|FG001|Treatment|Withdrawal by Subject|1|||
126301720|NCT03668119|454394757|FG000|Treatment|Participant request to discontinue study treatment|3|||
126301721|NCT03668119|454394758|FG001|Treatment|Participant request to discontinue study treatment|1|||
126301722|NCT03668119|454394757|FG000|Treatment|Maximum Clinical Benefit|0|||
126301723|NCT03668119|454394758|FG001|Treatment|Maximum Clinical Benefit|1|||
126301724|NCT03668119|454394757|FG000|Treatment|Participants completed treatment|27|||
126301725|NCT03668119|454394758|FG001|Treatment|Participants completed treatment|11|||
126301726|NCT03668119|454394757|FG000|Treatment|Other reasons|2|||
126301727|NCT03668119|454394758|FG001|Treatment|Other reasons|1|||
126301728|NCT05336227|454394759|FG000|Overall Study|Adverse Event|1|||
126301729|NCT05336227|454394760|FG001|Overall Study|Adverse Event|0|||
126301730|NCT05336227|454394759|FG000|Overall Study|Lost to Follow-up|2|||
126301731|NCT05336227|454394760|FG001|Overall Study|Lost to Follow-up|0|||
126301732|NCT05336227|454394759|FG000|Overall Study|Withdrawal by Subject|1|||
126301733|NCT05336227|454394760|FG001|Overall Study|Withdrawal by Subject|0|||
126301734|NCT00347958|454394763|FG000|Overall Study|Adverse Event|1|||
126301735|NCT00347958|454394763|FG000|Overall Study|Protocol Violation|2|||
126301736|NCT00347958|454394763|FG000|Overall Study|Withdrawal by Subject|1|||
126301737|NCT00754234|454394764|FG000|Overall Study|Withdrawal by Subject|3|||
126301738|NCT00326716|454394765|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
126301739|NCT00326716|454394766|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
126301740|NCT00326716|454394767|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
126301741|NCT00326716|454394768|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
126301742|NCT00684411|454394769|FG000|Overall Study|New Primary Cancer|1|||
126301743|NCT00684411|454394769|FG000|Overall Study|Disease Progression|10|||
126301744|NCT00684411|454394769|FG000|Overall Study|Adverse Event|1|||
126301745|NCT05253573|454394770|FG000|Overall Study|Death|1|||
126301746|NCT05253573|454394771|FG001|Overall Study|Death|0|||
126301747|NCT02276560|454394772|FG000|Overall Study|Adverse Event|1|||
126301748|NCT02276560|454394773|FG001|Overall Study|Adverse Event|0|||
126301749|NCT02276560|454394774|FG002|Overall Study|Adverse Event|0|||
126301750|NCT00687271|454394775|FG000|Overall Study|Adverse Event|1|||
126301751|NCT00687271|454394776|FG001|Overall Study|Adverse Event|3|||
126301752|NCT00687271|454394777|FG002|Overall Study|Adverse Event|1|||
126301753|NCT00687271|454394778|FG003|Overall Study|Adverse Event|0|||
126301754|NCT00687271|454394775|FG000|Overall Study|Lost to Follow-up|0|||
126301755|NCT00687271|454394776|FG001|Overall Study|Lost to Follow-up|1|||
126301756|NCT00687271|454394777|FG002|Overall Study|Lost to Follow-up|0|||
126301757|NCT00687271|454394778|FG003|Overall Study|Lost to Follow-up|0|||
126301758|NCT00687271|454394775|FG000|Overall Study|Protocol Violation|2|||
126301759|NCT00687271|454394776|FG001|Overall Study|Protocol Violation|1|||
126301760|NCT00687271|454394777|FG002|Overall Study|Protocol Violation|1|||
126301761|NCT00687271|454394778|FG003|Overall Study|Protocol Violation|0|||
126301762|NCT00687271|454394775|FG000|Overall Study|Withdrawal by Subject|0|||
126301763|NCT00687271|454394776|FG001|Overall Study|Withdrawal by Subject|1|||
126301764|NCT00687271|454394777|FG002|Overall Study|Withdrawal by Subject|3|||
126301765|NCT00687271|454394778|FG003|Overall Study|Withdrawal by Subject|0|||
126301766|NCT03850496|454394785|FG000|Overall Study|Withdrawal by Subject|1|||
126301767|NCT03850496|454394786|FG001|Overall Study|Withdrawal by Subject|0|||
126301768|NCT03850496|454394787|FG002|Overall Study|Withdrawal by Subject|0|||
126301769|NCT03850496|454394785|FG000|Overall Study|Lost to Follow-up|0|||
126301770|NCT03850496|454394786|FG001|Overall Study|Lost to Follow-up|1|||
126301771|NCT03850496|454394787|FG002|Overall Study|Lost to Follow-up|4|||
126301772|NCT03777436|454394788|FG000|Placebo-controlled Phase|Adverse Event|8|||
126301773|NCT03777436|454394789|FG001|Placebo-controlled Phase|Adverse Event|10|||
126301774|NCT03777436|454394790|FG002|Placebo-controlled Phase|Adverse Event|0|||
126301775|NCT03777436|454394788|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
126301776|NCT03777436|454394789|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
126301777|NCT03777436|454394790|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
126301778|NCT03777436|454394788|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
126301779|NCT03777436|454394789|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
126301780|NCT03777436|454394790|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
126301781|NCT03777436|454394788|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
126301782|NCT03777436|454394789|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
126301783|NCT03777436|454394790|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
126044479|NCT03498521|453461066|FG000|Overall Study|Study ongoing|121|||
126301784|NCT03777436|454394788|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
126301785|NCT03777436|454394789|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
126301786|NCT03777436|454394790|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
126301787|NCT03777436|454394788|FG000|Placebo-controlled Phase|Physician Decision|0|||
126301788|NCT03777436|454394789|FG001|Placebo-controlled Phase|Physician Decision|1|||
126301789|NCT03777436|454394790|FG002|Placebo-controlled Phase|Physician Decision|0|||
126301790|NCT03777436|454394788|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
126301791|NCT03777436|454394789|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
126301792|NCT03777436|454394790|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
126301793|NCT03777436|454394788|FG000|Apremilast Extension Phase|Adverse Event|0|||
126301794|NCT03777436|454394789|FG001|Apremilast Extension Phase|Adverse Event|0|||
126301795|NCT03777436|454394790|FG002|Apremilast Extension Phase|Adverse Event|6|||
126301796|NCT03777436|454394788|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
126301797|NCT03777436|454394789|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
126301798|NCT03777436|454394790|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
126301799|NCT03777436|454394788|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
126301800|NCT03777436|454394789|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
126301801|NCT03777436|454394790|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
126301802|NCT03777436|454394788|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
126301803|NCT03777436|454394789|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
126301804|NCT03777436|454394790|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
126301805|NCT03777436|454394788|FG000|Apremilast Extension Phase|Miscellaneous|0|||
126301806|NCT03777436|454394789|FG001|Apremilast Extension Phase|Miscellaneous|0|||
126301807|NCT03777436|454394790|FG002|Apremilast Extension Phase|Miscellaneous|1|||
126301808|NCT00869999|454394793|FG000|Overall Study|Withdrawal by Subject|1|||
126301809|NCT00869999|454394793|FG000|Overall Study|removed prior to starting therapy|1|||
126301810|NCT04478695|454394794|FG000|Overall Study|Death|1|||
126301811|NCT04478695|454394795|FG001|Overall Study|Death|0|||
126301812|NCT00644917|454394796|FG000|Overall Study|Withdrawal by Subject|2|||
126301813|NCT00758485|454394797|FG000|Overall Study|Lost to Follow-up|0|||
126301814|NCT00758485|454394798|FG001|Overall Study|Lost to Follow-up|1|||
126301815|NCT00758485|454394797|FG000|Overall Study|Not Treated|1|||
126301816|NCT00758485|454394798|FG001|Overall Study|Not Treated|2|||
126301817|NCT02347774|454394799|FG000|Study Participation|Lost to Follow-up|3|||
126301818|NCT02347774|454394800|FG001|Study Participation|Lost to Follow-up|6|||
126301819|NCT02347774|454394801|FG002|Study Participation|Lost to Follow-up|2|||
126301820|NCT02347774|454394799|FG000|Study Participation|Withdrawal by Subject|8|||
126301821|NCT02347774|454394800|FG001|Study Participation|Withdrawal by Subject|9|||
126301822|NCT02347774|454394801|FG002|Study Participation|Withdrawal by Subject|15|||
126301823|NCT02347774|454394799|FG000|Study Participation|Adverse Event|1|||
126301824|NCT02347774|454394800|FG001|Study Participation|Adverse Event|4|||
126301825|NCT02347774|454394801|FG002|Study Participation|Adverse Event|6|||
126301826|NCT02347774|454394799|FG000|Study Participation|withdrew consent|1|||
126301827|NCT02347774|454394800|FG001|Study Participation|withdrew consent|1|||
126301828|NCT02347774|454394801|FG002|Study Participation|withdrew consent|1|||
126301829|NCT02347774|454394799|FG000|Study Participation|Met Prolonged QT criteria|1|||
126301830|NCT02347774|454394800|FG001|Study Participation|Met Prolonged QT criteria|0|||
126301831|NCT02347774|454394801|FG002|Study Participation|Met Prolonged QT criteria|0|||
126301832|NCT02347774|454394799|FG000|Study Participation|non-compliance with study drug|0|||
126301833|NCT02347774|454394800|FG001|Study Participation|non-compliance with study drug|1|||
126301834|NCT02347774|454394801|FG002|Study Participation|non-compliance with study drug|0|||
126301835|NCT02347774|454394799|FG000|Study Participation|incarceration|1|||
126301836|NCT02347774|454394800|FG001|Study Participation|incarceration|0|||
126301837|NCT02347774|454394801|FG002|Study Participation|incarceration|0|||
126301838|NCT02347774|454394799|FG000|Study Participation|randomized in error|0|||
126301839|NCT02347774|454394800|FG001|Study Participation|randomized in error|0|||
126301840|NCT02347774|454394801|FG002|Study Participation|randomized in error|1|||
126301841|NCT02347774|454394799|FG000|On Study Treatment|Adverse Event|9|||
126301842|NCT02347774|454394800|FG001|On Study Treatment|Adverse Event|15|||
126301843|NCT02347774|454394801|FG002|On Study Treatment|Adverse Event|19|||
126301844|NCT02347774|454394799|FG000|On Study Treatment|Lack of Efficacy|3|||
126301845|NCT02347774|454394800|FG001|On Study Treatment|Lack of Efficacy|0|||
126301846|NCT02347774|454394801|FG002|On Study Treatment|Lack of Efficacy|2|||
126301847|NCT02347774|454394799|FG000|On Study Treatment|non-complicance with study medication|0|||
126301848|NCT02347774|454394800|FG001|On Study Treatment|non-complicance with study medication|2|||
126301849|NCT02347774|454394801|FG002|On Study Treatment|non-complicance with study medication|0|||
126301850|NCT02347774|454394799|FG000|On Study Treatment|Protocol Violation|0|||
126301851|NCT02347774|454394800|FG001|On Study Treatment|Protocol Violation|0|||
126301852|NCT02347774|454394801|FG002|On Study Treatment|Protocol Violation|1|||
126301853|NCT02347774|454394799|FG000|On Study Treatment|withdrew consent|9|||
126301854|NCT02347774|454394800|FG001|On Study Treatment|withdrew consent|8|||
126301855|NCT02347774|454394801|FG002|On Study Treatment|withdrew consent|12|||
126301856|NCT02347774|454394799|FG000|On Study Treatment|Lost to Follow-up|2|||
126301857|NCT02347774|454394800|FG001|On Study Treatment|Lost to Follow-up|6|||
126301858|NCT02347774|454394801|FG002|On Study Treatment|Lost to Follow-up|1|||
126301859|NCT02347774|454394799|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
126301860|NCT02347774|454394800|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
126301861|NCT02347774|454394801|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
126301862|NCT02347774|454394799|FG000|On Study Treatment|ranomized in error|0|||
126301863|NCT02347774|454394800|FG001|On Study Treatment|ranomized in error|0|||
126301864|NCT02347774|454394801|FG002|On Study Treatment|ranomized in error|1|||
125884037|NCT03739203|452873137|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125884038|NCT03739203|452873135|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
125884039|NCT03739203|452873136|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
125884040|NCT03739203|452873137|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
125884041|NCT03739203|452873135|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125884042|NCT03739203|452873136|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125884043|NCT03739203|452873137|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
125884044|NCT03739203|452873135|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
125884045|NCT03739203|452873136|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
125884046|NCT03739203|452873137|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
125884047|NCT03739203|452873135|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
126044480|NCT03498521|453461067|FG001|Overall Study|Study ongoing|36|||
126367575|NCT01432444|454640966|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
126367576|NCT01432444|454640967|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
126367577|NCT01432444|454640965|FG000|Extension Phase|Met Withdrawal Criteria|0|||
126367578|NCT01432444|454640966|FG001|Extension Phase|Met Withdrawal Criteria|0|||
126367579|NCT01432444|454640967|FG002|Extension Phase|Met Withdrawal Criteria|144|||
126367580|NCT01432444|454640965|FG000|Extension Phase|Physician Decision|0|||
126367581|NCT01432444|454640966|FG001|Extension Phase|Physician Decision|0|||
126044481|NCT03498521|453461068|FG002|Overall Study|Study ongoing|15|||
126044482|NCT04214834|453461070|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
126301865|NCT00921557|454394802|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
126301866|NCT00921557|454394803|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
126301867|NCT00921557|454394804|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
126301868|NCT00921557|454394802|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
126301869|NCT00921557|454394803|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
126301870|NCT00921557|454394804|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
126301871|NCT00921557|454394802|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
126301872|NCT00921557|454394803|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
126301873|NCT00921557|454394804|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
126301874|NCT00921557|454394802|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
126301875|NCT00921557|454394803|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
126301876|NCT00921557|454394804|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
126301877|NCT00921557|454394802|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
126301878|NCT00921557|454394803|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
126301879|NCT00921557|454394804|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
126301880|NCT00656292|454394805|FG000|Overall Study|Withdrawal by Subject|2|||
126301881|NCT00656292|454394806|FG001|Overall Study|Withdrawal by Subject|3|||
126301882|NCT00656292|454394805|FG000|Overall Study|Screen failure|1|||
126301883|NCT00656292|454394806|FG001|Overall Study|Screen failure|2|||
126301884|NCT01431716|454394814|FG000|Overall Study|Withdrawal of consent|1|||
126301885|NCT00954941|454394815|FG000|Overall Study|Received treatment at home|1|||
126301886|NCT00954941|454394816|FG001|Overall Study|Received treatment at home|0|||
126367582|NCT01432444|454640967|FG002|Extension Phase|Physician Decision|1|||
126367583|NCT01432444|454640965|FG000|Extension Phase|Withdrawal by Subject|0|||
126367584|NCT01432444|454640966|FG001|Extension Phase|Withdrawal by Subject|0|||
126367585|NCT01432444|454640967|FG002|Extension Phase|Withdrawal by Subject|13|||
126044483|NCT04214834|453461071|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
126044484|NCT03370913|453461072|FG000|Overall Study|Death|1|||
126044485|NCT03370913|453461072|FG000|Overall Study|Lost to Follow-up|1|||
126044486|NCT04633538|453461073|FG000|Overall Study|Death|1|||
126044487|NCT04633538|453461073|FG000|Overall Study|Lost to Follow-up|3|||
126044488|NCT04633538|453461073|FG000|Overall Study|Withdrawal by Subject|1|||
126044489|NCT02938520|453461076|FG000|Overall Study|On-going at the time of analysis|258|||
126044490|NCT02938520|453461077|FG001|Overall Study|On-going at the time of analysis|261|||
126044491|NCT02938520|453461076|FG000|Overall Study|Physician Decision|2|||
126044492|NCT02938520|453461077|FG001|Overall Study|Physician Decision|5|||
126044493|NCT02938520|453461076|FG000|Overall Study|Lost to Follow-up|2|||
126044494|NCT02938520|453461077|FG001|Overall Study|Lost to Follow-up|2|||
126044495|NCT02938520|453461076|FG000|Overall Study|Withdrawal by Subject|7|||
126044496|NCT02938520|453461077|FG001|Overall Study|Withdrawal by Subject|7|||
126044497|NCT02938520|453461076|FG000|Overall Study|Protocol Violation|0|||
126044498|NCT02938520|453461077|FG001|Overall Study|Protocol Violation|1|||
126301887|NCT00954941|454394815|FG000|Overall Study|Withdrawal by Subject|1|||
126301888|NCT00954941|454394816|FG001|Overall Study|Withdrawal by Subject|0|||
126367586|NCT02301897|454640968|FG000|Treatment Course 1|Non-Compliance|0|||
126044499|NCT02938520|453461076|FG000|Overall Study|Lack of Efficacy|5|||
126044500|NCT02938520|453461077|FG001|Overall Study|Lack of Efficacy|3|||
126044501|NCT02938520|453461076|FG000|Overall Study|Adverse Event|9|||
126044502|NCT02938520|453461077|FG001|Overall Study|Adverse Event|4|||
126301889|NCT00954941|454394815|FG000|Overall Study|Insurance Denial|2|||
126367587|NCT02301897|454640969|FG001|Treatment Course 1|Non-Compliance|0|||
126044503|NCT03372057|453461080|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
126044504|NCT03372057|453461081|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
126044505|NCT03372057|453461082|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
126301890|NCT00954941|454394816|FG001|Overall Study|Insurance Denial|2|||
126301891|NCT00954941|454394815|FG000|Overall Study|Physician Decision|2|||
126301892|NCT00954941|454394816|FG001|Overall Study|Physician Decision|2|||
126301893|NCT00954941|454394815|FG000|Overall Study|Ineligible|2|||
126301894|NCT00954941|454394816|FG001|Overall Study|Ineligible|2|||
126301895|NCT00954941|454394815|FG000|Overall Study|Adverse Event|0|||
126301896|NCT00954941|454394816|FG001|Overall Study|Adverse Event|1|||
126301897|NCT05027451|454394817|FG000|Overall Study|Lost to Follow-up|1|||
126301898|NCT05027451|454394818|FG001|Overall Study|Lost to Follow-up|1|||
126301899|NCT02097745|454394835|FG000|Overall Study|Adverse Event|25|||
126301900|NCT02097745|454394835|FG000|Overall Study|Death|16|||
126301901|NCT02097745|454394835|FG000|Overall Study|Failure to Return|14|||
126301902|NCT02097745|454394835|FG000|Overall Study|Administrative/Other|27|||
126301903|NCT02097745|454394835|FG000|Overall Study|Reason Not Specified|96|||
126301904|NCT00425750|454394836|FG000|Overall Study|Death|1|||
126301905|NCT00425750|454394836|FG000|Overall Study|Withdrawal by Subject|3|||
126301906|NCT00425750|454394836|FG000|Overall Study|Adverse Event|3|||
126301907|NCT00425750|454394836|FG000|Overall Study|Progression of disease|18|||
126301908|NCT01757184|454394841|FG000|Double-blind Period|Adverse Event|1|||
126301909|NCT01757184|454394842|FG001|Double-blind Period|Adverse Event|0|||
126301910|NCT01757184|454394843|FG002|Double-blind Period|Adverse Event|0|||
126301911|NCT01757184|454394844|FG003|Double-blind Period|Adverse Event|0|||
126301912|NCT01757184|454394841|FG000|Open-label Period|Lost to Follow-up|0|||
126301913|NCT01757184|454394842|FG001|Open-label Period|Lost to Follow-up|0|||
126301914|NCT01757184|454394843|FG002|Open-label Period|Lost to Follow-up|2|||
126301915|NCT01757184|454394844|FG003|Open-label Period|Lost to Follow-up|0|||
126301916|NCT01757184|454394841|FG000|Open-label Period|Withdrawal by Subject|0|||
126301917|NCT01757184|454394842|FG001|Open-label Period|Withdrawal by Subject|0|||
126301918|NCT01757184|454394843|FG002|Open-label Period|Withdrawal by Subject|1|||
126301919|NCT01757184|454394844|FG003|Open-label Period|Withdrawal by Subject|1|||
126301920|NCT01757184|454394841|FG000|Open-label Period|Discontinued by Sponsor|0|||
126301921|NCT01757184|454394842|FG001|Open-label Period|Discontinued by Sponsor|0|||
126301922|NCT01757184|454394843|FG002|Open-label Period|Discontinued by Sponsor|1|||
126301923|NCT01757184|454394844|FG003|Open-label Period|Discontinued by Sponsor|2|||
126301924|NCT00488644|454394845|FG000|Overall Study|Not Eligible|1|||
126301925|NCT00488644|454394845|FG000|Overall Study|Not Evaluable|1|||
126301926|NCT02977572|454394846|FG000|Overall Study|Exclusion criterion|2|||
126301927|NCT02977572|454394847|FG001|Overall Study|Exclusion criterion|2|||
126301928|NCT05107492|454394848|FG000|Overall Study|Lost to Follow-up|1|||
126301929|NCT05107492|454394849|FG001|Overall Study|Lost to Follow-up|0|||
126301930|NCT01197534|454394851|FG000|Overall Study|Not reported|16|||
126301931|NCT01197534|454394852|FG001|Overall Study|Not reported|10|||
126301932|NCT01197534|454394853|FG002|Overall Study|Not reported|16|||
126301933|NCT01197534|454394851|FG000|Overall Study|Enrolment in long term extension|57|||
126103397|NCT02924064|453672150|FG000|Overall Study|Lost to Follow-up|0|||
126301934|NCT01197534|454394852|FG001|Overall Study|Enrolment in long term extension|66|||
126301935|NCT01197534|454394853|FG002|Overall Study|Enrolment in long term extension|119|||
126301936|NCT01197534|454394851|FG000|Overall Study|Severe non-compliance to protocol|3|||
126301937|NCT01197534|454394852|FG001|Overall Study|Severe non-compliance to protocol|4|||
126301938|NCT01197534|454394853|FG002|Overall Study|Severe non-compliance to protocol|1|||
126301939|NCT01197534|454394851|FG000|Overall Study|Lack of therapeutic response|9|||
126301940|NCT01197534|454394852|FG001|Overall Study|Lack of therapeutic response|4|||
126301941|NCT01197534|454394853|FG002|Overall Study|Lack of therapeutic response|9|||
126301942|NCT01197534|454394851|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
126301943|NCT01197534|454394852|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
126301944|NCT01197534|454394853|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
126301945|NCT01197534|454394851|FG000|Overall Study|Lost to Follow-up|1|||
126301946|NCT01197534|454394852|FG001|Overall Study|Lost to Follow-up|4|||
126301947|NCT01197534|454394853|FG002|Overall Study|Lost to Follow-up|2|||
126301948|NCT01197534|454394851|FG000|Overall Study|Adverse Event|35|||
126301949|NCT01197534|454394852|FG001|Overall Study|Adverse Event|36|||
126301950|NCT01197534|454394853|FG002|Overall Study|Adverse Event|24|||
126301951|NCT02589639|454394864|FG000|Overall Study|Lost to Follow-up|1|||
126301952|NCT02589639|454394865|FG001|Overall Study|Lost to Follow-up|0|||
126301953|NCT02589639|454394866|FG002|Overall Study|Lost to Follow-up|0|||
126301954|NCT02589639|454394864|FG000|Overall Study|Protocol Violation|1|||
126301955|NCT02589639|454394865|FG001|Overall Study|Protocol Violation|0|||
126301956|NCT02589639|454394866|FG002|Overall Study|Protocol Violation|0|||
126301957|NCT02589639|454394864|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
126301958|NCT02589639|454394865|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
126301959|NCT02589639|454394866|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
126301960|NCT02589639|454394864|FG000|Overall Study|Adverse Event|4|||
126301961|NCT02589639|454394865|FG001|Overall Study|Adverse Event|5|||
126301962|NCT02589639|454394866|FG002|Overall Study|Adverse Event|3|||
126301963|NCT02589639|454394864|FG000|Overall Study|Other reason than specified above|1|||
126301964|NCT02589639|454394865|FG001|Overall Study|Other reason than specified above|2|||
126301965|NCT02589639|454394866|FG002|Overall Study|Other reason than specified above|1|||
126301966|NCT02589639|454394864|FG000|Overall Study|Not Treated|0|||
126301967|NCT02589639|454394865|FG001|Overall Study|Not Treated|3|||
126301968|NCT02589639|454394866|FG002|Overall Study|Not Treated|0|||
126301969|NCT01276756|454394867|FG000|Overall Study|Lost to Follow-up|2|||
126301970|NCT01276756|454394868|FG001|Overall Study|Lost to Follow-up|0|||
126301971|NCT01276756|454394867|FG000|Overall Study|Adverse Event|3|||
126301972|NCT01276756|454394868|FG001|Overall Study|Adverse Event|2|||
126301973|NCT02593097|454394878|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
126301974|NCT02593097|454394879|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
126301975|NCT02593097|454394878|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126301976|NCT02593097|454394879|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
126301977|NCT02593097|454394878|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
126301978|NCT02593097|454394879|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
126301979|NCT02593097|454394878|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
126301980|NCT02593097|454394879|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
126301981|NCT02593097|454394878|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
126301982|NCT02593097|454394879|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
126301983|NCT00703157|454394880|FG000|Overall Study|Lost to Follow-up|0|||
126301984|NCT00703157|454394881|FG001|Overall Study|Lost to Follow-up|1|||
126301985|NCT00703157|454394880|FG000|Overall Study|source data permanently lost/ other|4|||
126301986|NCT00703157|454394881|FG001|Overall Study|source data permanently lost/ other|1|||
126301987|NCT02522884|454394882|FG000|Overall Study|Withdrawal by Subject|6|||
126301988|NCT02522884|454394882|FG000|Overall Study|Death|3|||
126301989|NCT02522884|454394882|FG000|Overall Study|Missed 12-month Follow-up|9|||
126301990|NCT02968173|454394883|FG000|Overall Study|Withdrawal by Subject|1|||
126301991|NCT02670525|454394884|FG000|Overall Study|Death|94|||
126301992|NCT02670525|454394885|FG001|Overall Study|Death|14|||
126301993|NCT02670525|454394884|FG000|Overall Study|Lost to Follow-up|4|||
126301994|NCT02670525|454394885|FG001|Overall Study|Lost to Follow-up|1|||
126301995|NCT02670525|454394884|FG000|Overall Study|Subject withdrew consent|1|||
126301996|NCT02670525|454394885|FG001|Overall Study|Subject withdrew consent|0|||
126301997|NCT02670525|454394884|FG000|Overall Study|Unknown, data entry delayed|123|||
126301998|NCT02670525|454394885|FG001|Overall Study|Unknown, data entry delayed|78|||
126301999|NCT00591565|454394886|FG000|Overall Study|lost follow up, withdrawn|5|||
126302000|NCT03564119|454394890|FG000|Overall Study|Adverse Event|4|||
126302001|NCT03564119|454394891|FG001|Overall Study|Adverse Event|0|||
126302002|NCT03564119|454394890|FG000|Overall Study|Lost to Follow-up|1|||
126302003|NCT03564119|454394891|FG001|Overall Study|Lost to Follow-up|4|||
126302004|NCT03564119|454394890|FG000|Overall Study|Protocol Violation|1|||
126302005|NCT03564119|454394891|FG001|Overall Study|Protocol Violation|0|||
126302006|NCT03564119|454394890|FG000|Overall Study|Withdrawal by Subject|9|||
126302007|NCT03564119|454394891|FG001|Overall Study|Withdrawal by Subject|4|||
126302008|NCT03564119|454394890|FG000|Overall Study|Other Than Specified|0|||
126302009|NCT03564119|454394891|FG001|Overall Study|Other Than Specified|1|||
126302010|NCT00634036|454394892|FG000|Overall Study|Lost to Follow-up|1|||
126302011|NCT00634036|454394893|FG001|Overall Study|Lost to Follow-up|1|||
126302012|NCT00634036|454394892|FG000|Overall Study|Withdrawal by Subject|1|||
126302013|NCT00634036|454394893|FG001|Overall Study|Withdrawal by Subject|1|||
126302014|NCT03896022|454394894|FG000|Overall Study|Withdrawal by Subject|1|||
126302015|NCT03896022|454394895|FG001|Overall Study|Withdrawal by Subject|0|||
126302016|NCT03896022|454394896|FG002|Overall Study|Withdrawal by Subject|0|||
126302017|NCT03896022|454394894|FG000|Overall Study|Did not have procedure|3|||
126302018|NCT03896022|454394895|FG001|Overall Study|Did not have procedure|0|||
126302019|NCT03896022|454394896|FG002|Overall Study|Did not have procedure|0|||
126302020|NCT01554527|454394906|FG000|Overall Study|Withdrawal by Subject|1|||
126302021|NCT01554527|454394907|FG001|Overall Study|Withdrawal by Subject|0|||
126302022|NCT01554527|454394908|FG002|Overall Study|Withdrawal by Subject|3|||
126302023|NCT01554527|454394906|FG000|Overall Study|Lost to Follow-up|0|||
126302024|NCT01554527|454394907|FG001|Overall Study|Lost to Follow-up|0|||
126103398|NCT02924064|453672151|FG001|Overall Study|Lost to Follow-up|2|||
126302025|NCT01554527|454394908|FG002|Overall Study|Lost to Follow-up|4|||
126302026|NCT01554527|454394906|FG000|Overall Study|Physician Decision|0|||
126302027|NCT01554527|454394907|FG001|Overall Study|Physician Decision|0|||
126302028|NCT01554527|454394908|FG002|Overall Study|Physician Decision|1|||
126302029|NCT01052480|454394909|FG000|Overall Study|Lost to Follow-up|3|||
126302030|NCT01052480|454394910|FG001|Overall Study|Lost to Follow-up|3|||
126302031|NCT01052480|454394909|FG000|Overall Study|Protocol Violation|1|||
126302032|NCT01052480|454394910|FG001|Overall Study|Protocol Violation|0|||
126302033|NCT01052480|454394909|FG000|Overall Study|Withdrawal by Subject|3|||
126302034|NCT01052480|454394910|FG001|Overall Study|Withdrawal by Subject|7|||
126302035|NCT01052480|454394909|FG000|Overall Study|Physician Decision|0|||
126302036|NCT01052480|454394910|FG001|Overall Study|Physician Decision|2|||
126302037|NCT01052480|454394909|FG000|Overall Study|Death|1|||
126302038|NCT01052480|454394910|FG001|Overall Study|Death|5|||
126302039|NCT00529373|454394911|FG000|Base Study|Adverse Event|525|||
126302040|NCT00529373|454394912|FG001|Base Study|Adverse Event|470|||
126302041|NCT00529373|454394911|FG000|Base Study|Lack of Efficacy|16|||
126302042|NCT00529373|454394912|FG001|Base Study|Lack of Efficacy|75|||
126302043|NCT00529373|454394911|FG000|Base Study|Lost to Follow-up|221|||
126302044|NCT00529373|454394912|FG001|Base Study|Lost to Follow-up|208|||
126302045|NCT00529373|454394911|FG000|Base Study|Other Protocol Specified Criteria|19|||
126302046|NCT00529373|454394912|FG001|Base Study|Other Protocol Specified Criteria|20|||
126302047|NCT00529373|454394911|FG000|Base Study|Physician Decision|60|||
126302048|NCT00529373|454394912|FG001|Base Study|Physician Decision|52|||
126302049|NCT00529373|454394911|FG000|Base Study|Protocol Violation|48|||
126302050|NCT00529373|454394912|FG001|Base Study|Protocol Violation|38|||
126302051|NCT00529373|454394911|FG000|Base Study|Withdrawal by Subject|1062|||
126302052|NCT00529373|454394912|FG001|Base Study|Withdrawal by Subject|967|||
126302053|NCT00529373|454394911|FG000|Base Study|Did not continue into Extension|1795|||
126302054|NCT00529373|454394912|FG001|Base Study|Did not continue into Extension|2238|||
126302055|NCT00529373|454394911|FG000|First Extension Study|Adverse Event|162|||
126302056|NCT00529373|454394912|FG001|First Extension Study|Adverse Event|142|||
126302057|NCT00529373|454394911|FG000|First Extension Study|Lack of Efficacy|65|||
126302058|NCT00529373|454394912|FG001|First Extension Study|Lack of Efficacy|427|||
126302059|NCT00529373|454394911|FG000|First Extension Study|Lost to Follow-up|41|||
126302060|NCT00529373|454394912|FG001|First Extension Study|Lost to Follow-up|37|||
126302061|NCT00529373|454394911|FG000|First Extension Study|Other|27|||
126302062|NCT00529373|454394912|FG001|First Extension Study|Other|47|||
126302063|NCT00529373|454394911|FG000|First Extension Study|Physician Decision|50|||
126302064|NCT00529373|454394912|FG001|First Extension Study|Physician Decision|45|||
126302065|NCT00529373|454394911|FG000|First Extension Study|Protocol Violation|16|||
126302066|NCT00529373|454394912|FG001|First Extension Study|Protocol Violation|13|||
126302067|NCT00529373|454394911|FG000|First Extension Study|Withdrawal by Subject|296|||
126302068|NCT00529373|454394912|FG001|First Extension Study|Withdrawal by Subject|287|||
126302069|NCT00529373|454394911|FG000|First Extension Study|Disposition record non-existing|0|||
126302070|NCT00529373|454394912|FG001|First Extension Study|Disposition record non-existing|1|||
126302071|NCT00529373|454394911|FG000|First Extension Study|Discontinued after 5 years completion|208|||
126302072|NCT00529373|454394912|FG001|First Extension Study|Discontinued after 5 years completion|346|||
126302073|NCT00529373|454394911|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
126302074|NCT00529373|454394912|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
126302075|NCT00529373|454394911|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
126302076|NCT00529373|454394912|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
126302077|NCT00529373|454394911|FG000|Second Extension Study|Adverse Event|101|||
126302078|NCT00529373|454394912|FG001|Second Extension Study|Adverse Event|51|||
126302079|NCT00529373|454394911|FG000|Second Extension Study|Lack of Efficacy|7|||
126367588|NCT02301897|454640970|FG002|Treatment Course 1|Non-Compliance|1|||
126367589|NCT02301897|454640968|FG000|Treatment Course 1|Adverse Event|1|||
126367590|NCT02301897|454640969|FG001|Treatment Course 1|Adverse Event|1|||
126367591|NCT02301897|454640970|FG002|Treatment Course 1|Adverse Event|0|||
126367592|NCT02301897|454640968|FG000|Treatment Course 1|Lost to Follow-up|1|||
126367593|NCT02301897|454640969|FG001|Treatment Course 1|Lost to Follow-up|2|||
126367594|NCT02301897|454640970|FG002|Treatment Course 1|Lost to Follow-up|1|||
126367595|NCT02301897|454640968|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
126367596|NCT02301897|454640969|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
126302080|NCT00529373|454394912|FG001|Second Extension Study|Lack of Efficacy|15|||
126302081|NCT00529373|454394911|FG000|Second Extension Study|Lost to Follow-up|18|||
126302082|NCT00529373|454394912|FG001|Second Extension Study|Lost to Follow-up|12|||
126302083|NCT00529373|454394911|FG000|Second Extension Study|Other|7|||
126302084|NCT00529373|454394912|FG001|Second Extension Study|Other|12|||
126302085|NCT00529373|454394911|FG000|Second Extension Study|Physician Decision|63|||
126302086|NCT00529373|454394912|FG001|Second Extension Study|Physician Decision|26|||
126302087|NCT00529373|454394911|FG000|Second Extension Study|Protocol Violation|2|||
126302088|NCT00529373|454394912|FG001|Second Extension Study|Protocol Violation|1|||
126367597|NCT02301897|454640970|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
126044506|NCT03372057|453461080|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
126302089|NCT00529373|454394911|FG000|Second Extension Study|Withdrawal by Subject|97|||
126302090|NCT00529373|454394912|FG001|Second Extension Study|Withdrawal by Subject|75|||
126302091|NCT00529373|454394911|FG000|Second Extension Study|Status Missing|5|||
126302092|NCT00529373|454394912|FG001|Second Extension Study|Status Missing|5|||
126302093|NCT01863667|454394919|FG000|Overall Study|Adverse Event|1|||
126302094|NCT01863667|454394920|FG001|Overall Study|Adverse Event|0|||
126302095|NCT01863667|454394919|FG000|Overall Study|Study terminated by Sponsor|30|||
126302096|NCT01863667|454394920|FG001|Overall Study|Study terminated by Sponsor|30|||
126302097|NCT01863667|454394919|FG000|Overall Study|Withdrawal by Subject|2|||
126302098|NCT01863667|454394920|FG001|Overall Study|Withdrawal by Subject|2|||
126302099|NCT03627546|454394921|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
126302100|NCT03627546|454394922|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
126302101|NCT03627546|454394923|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
126302102|NCT03627546|454394921|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
126302103|NCT03627546|454394922|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
126302104|NCT03627546|454394923|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
126302105|NCT00615550|454394924|FG000|Overall Study|Lost to Follow-up|6|||
126302106|NCT00615550|454394925|FG001|Overall Study|Lost to Follow-up|1|||
126302107|NCT00564850|454394926|FG000|Overall Study|Protocol Violation|2|||
126302108|NCT02640664|454394927|FG000|Epoch 1|Withdrawal of informed consent|1|||
126302109|NCT02640664|454394928|FG001|Epoch 1|Withdrawal of informed consent|0|||
126302110|NCT02640664|454394929|FG002|Epoch 1|Withdrawal of informed consent|0|||
126302111|NCT02640664|454394927|FG000|Epoch 1|Death|0|||
126302112|NCT02640664|454394928|FG001|Epoch 1|Death|0|||
126302113|NCT02640664|454394929|FG002|Epoch 1|Death|1|||
126302114|NCT02640664|454394927|FG000|Epoch 2|Withdrawal of informed consent|3|||
126302115|NCT02640664|454394928|FG001|Epoch 2|Withdrawal of informed consent|4|||
126302116|NCT02640664|454394929|FG002|Epoch 2|Withdrawal of informed consent|2|||
126302117|NCT02640664|454394927|FG000|Epoch 2|Subject/guardian decision|0|||
126302118|NCT02640664|454394928|FG001|Epoch 2|Subject/guardian decision|2|||
126302119|NCT02640664|454394929|FG002|Epoch 2|Subject/guardian decision|2|||
126302120|NCT02640664|454394927|FG000|Epoch 2|Lost to Follow-up|3|||
126302121|NCT02640664|454394928|FG001|Epoch 2|Lost to Follow-up|4|||
126302122|NCT02640664|454394929|FG002|Epoch 2|Lost to Follow-up|1|||
126302123|NCT02640664|454394927|FG000|Epoch 2|Death|0|||
126302124|NCT02640664|454394928|FG001|Epoch 2|Death|0|||
126302125|NCT02640664|454394929|FG002|Epoch 2|Death|1|||
126302126|NCT00314327|454394930|FG000|Overall Study|Withdrawal by Subject|1|||
126302127|NCT02741076|454394933|FG000|Overall Study|Adverse Event|0|||
126302128|NCT02741076|454394934|FG001|Overall Study|Adverse Event|1|||
126302129|NCT02741076|454394935|FG002|Overall Study|Adverse Event|1|||
126302130|NCT02741076|454394936|FG003|Overall Study|Adverse Event|0|||
126302131|NCT02741076|454394933|FG000|Overall Study|Lack of Efficacy|1|||
126302132|NCT02741076|454394934|FG001|Overall Study|Lack of Efficacy|0|||
126302133|NCT02741076|454394935|FG002|Overall Study|Lack of Efficacy|0|||
126302134|NCT02741076|454394936|FG003|Overall Study|Lack of Efficacy|0|||
126302135|NCT02741076|454394933|FG000|Overall Study|Withdrawal by Subject|0|||
126302136|NCT02741076|454394934|FG001|Overall Study|Withdrawal by Subject|1|||
126302137|NCT02741076|454394935|FG002|Overall Study|Withdrawal by Subject|0|||
126302138|NCT02741076|454394936|FG003|Overall Study|Withdrawal by Subject|0|||
126302139|NCT02741076|454394933|FG000|Overall Study|Sponsor Request|2|||
126302140|NCT02741076|454394934|FG001|Overall Study|Sponsor Request|3|||
126302141|NCT02741076|454394935|FG002|Overall Study|Sponsor Request|0|||
126302142|NCT02741076|454394936|FG003|Overall Study|Sponsor Request|1|||
126302143|NCT02741076|454394933|FG000|Overall Study|No additional information available|0|||
126302144|NCT02741076|454394934|FG001|Overall Study|No additional information available|0|||
126302145|NCT02741076|454394935|FG002|Overall Study|No additional information available|1|||
126302146|NCT02741076|454394936|FG003|Overall Study|No additional information available|1|||
126302147|NCT02965573|454394939|FG000|Overall Study|Lack of Efficacy|1|||
126302148|NCT02965573|454394940|FG001|Overall Study|Lack of Efficacy|0|||
126302149|NCT00086619|454394941|FG000|Overall Study|Withdrawal by Subject|6|||
126302150|NCT00086619|454394942|FG001|Overall Study|Withdrawal by Subject|6|||
126302151|NCT00086619|454394941|FG000|Overall Study|Adverse Event|8|||
126302152|NCT00086619|454394942|FG001|Overall Study|Adverse Event|10|||
126302153|NCT00086619|454394941|FG000|Overall Study|Protocol Violation|1|||
126302154|NCT00086619|454394942|FG001|Overall Study|Protocol Violation|1|||
126302155|NCT01209520|454394943|FG000|Overall Study|Withdrawal by Subject|3|||
126302156|NCT00617890|454396198|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
126302157|NCT00617890|454396199|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
126302158|NCT00617890|454396200|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
126302159|NCT00617890|454396201|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
126302160|NCT00617890|454396198|FG000|Overall Study|Lack of Efficacy|23|||
126302161|NCT00617890|454396199|FG001|Overall Study|Lack of Efficacy|26|||
126302162|NCT00617890|454396200|FG002|Overall Study|Lack of Efficacy|30|||
126302163|NCT00617890|454396201|FG003|Overall Study|Lack of Efficacy|97|||
126302164|NCT00617890|454396198|FG000|Overall Study|Lost to Follow-up|0|||
126302165|NCT00617890|454396199|FG001|Overall Study|Lost to Follow-up|0|||
126302166|NCT00617890|454396200|FG002|Overall Study|Lost to Follow-up|1|||
126302167|NCT00617890|454396201|FG003|Overall Study|Lost to Follow-up|2|||
126302168|NCT00617890|454396198|FG000|Overall Study|Withdrawal by Subject|4|||
126302169|NCT00617890|454396199|FG001|Overall Study|Withdrawal by Subject|1|||
126302170|NCT00617890|454396200|FG002|Overall Study|Withdrawal by Subject|0|||
126302171|NCT00617890|454396201|FG003|Overall Study|Withdrawal by Subject|2|||
126302172|NCT00617890|454396198|FG000|Overall Study|Protocol Violation|2|||
126302173|NCT00617890|454396199|FG001|Overall Study|Protocol Violation|1|||
126302174|NCT00617890|454396200|FG002|Overall Study|Protocol Violation|0|||
126302175|NCT00617890|454396201|FG003|Overall Study|Protocol Violation|0|||
126302176|NCT00617890|454396198|FG000|Overall Study|Adverse Event|1|||
126302177|NCT00617890|454396199|FG001|Overall Study|Adverse Event|0|||
126302178|NCT00617890|454396200|FG002|Overall Study|Adverse Event|3|||
126302179|NCT00617890|454396201|FG003|Overall Study|Adverse Event|8|||
126302180|NCT00617890|454396198|FG000|Overall Study|Not treated|1|||
126302181|NCT00617890|454396199|FG001|Overall Study|Not treated|0|||
126302182|NCT00617890|454396200|FG002|Overall Study|Not treated|1|||
126302183|NCT00617890|454396201|FG003|Overall Study|Not treated|1|||
126302184|NCT02640950|454396203|FG000|Overall Study|Adverse Event|1|||
126302185|NCT02640950|454396203|FG000|Overall Study|Withdrawal by Subject|1|||
126302186|NCT00915018|454396204|FG000|Overall Study|Death|75|||
126302187|NCT00915018|454396205|FG001|Overall Study|Death|70|||
126302188|NCT00915018|454396204|FG000|Overall Study|Lost to Follow-up|10|||
126302189|NCT00915018|454396205|FG001|Overall Study|Lost to Follow-up|5|||
126302190|NCT00915018|454396204|FG000|Overall Study|Withdrawal by Subject|38|||
126302191|NCT00915018|454396205|FG001|Overall Study|Withdrawal by Subject|27|||
126302192|NCT00915018|454396204|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
126302193|NCT00915018|454396205|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
126302194|NCT00154284|454396206|FG000|Overall Study|Adverse Event|6|||
126302195|NCT00154284|454396207|FG001|Overall Study|Adverse Event|9|||
126302196|NCT00154284|454396206|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126302197|NCT00154284|454396207|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126302198|NCT00154284|454396206|FG000|Overall Study|Lack of Efficacy|1|||
126302199|NCT00154284|454396207|FG001|Overall Study|Lack of Efficacy|2|||
126302200|NCT00154284|454396206|FG000|Overall Study|Protocol Violation|0|||
126302201|NCT00154284|454396207|FG001|Overall Study|Protocol Violation|1|||
126302202|NCT00566020|454396208|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
126302203|NCT00566020|454396209|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
126302204|NCT00566020|454396208|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
126302205|NCT00566020|454396209|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
126302206|NCT00566020|454396208|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
126302207|NCT00566020|454396209|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
126302208|NCT00566020|454396208|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
126302209|NCT00566020|454396209|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
126302210|NCT00566020|454396208|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
126302211|NCT00566020|454396209|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
126302212|NCT00566020|454396208|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
126302213|NCT00566020|454396209|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
126302214|NCT06098339|454396210|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
126302215|NCT06098339|454396211|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
126302216|NCT06098339|454396210|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
126302217|NCT06098339|454396211|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
126302218|NCT04134767|454396212|FG000|Overall Study|Death|0|||
126302219|NCT04134767|454396213|FG001|Overall Study|Death|1|||
126044507|NCT03372057|453461081|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
126302220|NCT04134767|454396212|FG000|Overall Study|Removed for harassing staff|0|||
126302221|NCT04134767|454396213|FG001|Overall Study|Removed for harassing staff|1|||
126302222|NCT04134767|454396212|FG000|Overall Study|Lost to Follow-up|44|||
126302223|NCT04134767|454396213|FG001|Overall Study|Lost to Follow-up|40|||
126302224|NCT00300885|454396214|FG000|Treatment|Adverse Event|134|||
126302225|NCT00300885|454396215|FG001|Treatment|Adverse Event|82|||
126302226|NCT00300885|454396214|FG000|Treatment|Death|20|||
126302227|NCT00300885|454396215|FG001|Treatment|Death|7|||
126302228|NCT00300885|454396214|FG000|Treatment|Lack of Efficacy|1|||
126302229|NCT00300885|454396215|FG001|Treatment|Lack of Efficacy|1|||
126044508|NCT03372057|453461082|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
126302230|NCT00300885|454396214|FG000|Treatment|Lost to Follow-up|3|||
126302231|NCT00300885|454396215|FG001|Treatment|Lost to Follow-up|2|||
126302232|NCT00300885|454396214|FG000|Treatment|Physician Decision|4|||
126302233|NCT00300885|454396215|FG001|Treatment|Physician Decision|5|||
126302234|NCT00300885|454396214|FG000|Treatment|Protocol Violation|11|||
126302235|NCT00300885|454396215|FG001|Treatment|Protocol Violation|11|||
126302236|NCT00300885|454396214|FG000|Treatment|Withdrawal by Subject|26|||
126302237|NCT00300885|454396215|FG001|Treatment|Withdrawal by Subject|23|||
126302238|NCT00300885|454396214|FG000|Treatment|Disease progression|171|||
126302239|NCT00300885|454396215|FG001|Treatment|Disease progression|238|||
126302240|NCT00300885|454396214|FG000|Treatment|Random code broken (subject died)|0|||
126302241|NCT00300885|454396215|FG001|Treatment|Random code broken (subject died)|1|||
126302242|NCT00300885|454396214|FG000|Treatment|Non-compliant with study medication|3|||
126302243|NCT00300885|454396215|FG001|Treatment|Non-compliant with study medication|4|||
126302244|NCT00300885|454396214|FG000|Follow-up|Death|141|||
126302245|NCT00300885|454396215|FG001|Follow-up|Death|163|||
126302246|NCT00300885|454396214|FG000|Follow-up|Lost to Follow-up|11|||
126302247|NCT00300885|454396215|FG001|Follow-up|Lost to Follow-up|7|||
126302248|NCT00300885|454396214|FG000|Follow-up|Withdrawal by Subject|26|||
126302249|NCT00300885|454396215|FG001|Follow-up|Withdrawal by Subject|25|||
126302250|NCT02582242|454396216|FG000|Overall Study|Adverse Event|4|||
126302251|NCT02582242|454396217|FG001|Overall Study|Adverse Event|3|||
126302252|NCT02582242|454396216|FG000|Overall Study|Protocol Violation|3|||
126302253|NCT02582242|454396217|FG001|Overall Study|Protocol Violation|1|||
126302254|NCT02582242|454396216|FG000|Overall Study|Lost to Follow-up|0|||
126302255|NCT02582242|454396217|FG001|Overall Study|Lost to Follow-up|1|||
126302256|NCT02582242|454396216|FG000|Overall Study|Withdrawal by Subject|11|||
126302257|NCT02582242|454396217|FG001|Overall Study|Withdrawal by Subject|11|||
126302258|NCT02582242|454396216|FG000|Overall Study|Unclassified|2|||
126302259|NCT02582242|454396217|FG001|Overall Study|Unclassified|1|||
126302260|NCT02101736|454396221|FG000|Overall Study|Protocol Violation|3|||
126302261|NCT02101736|454396222|FG001|Overall Study|Protocol Violation|0|||
126302262|NCT02101736|454396221|FG000|Overall Study|Withdrawal by Subject|1|||
126302263|NCT02101736|454396222|FG001|Overall Study|Withdrawal by Subject|1|||
126302264|NCT00459290|454396223|FG000|Overall Study|Adverse Event|3|||
126302265|NCT00459290|454396223|FG000|Overall Study|Ineligible|2|||
126302266|NCT02366637|454396224|FG000|First Intervention Period|Adverse Event|0|||
126302267|NCT02366637|454396225|FG001|First Intervention Period|Adverse Event|1|||
126302268|NCT02366637|454396224|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
126302269|NCT02366637|454396225|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
126302270|NCT02366637|454396224|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
126302271|NCT02366637|454396225|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
126302272|NCT02309411|454396231|FG000|Overall Study|Physician Decision|1|||
126302273|NCT02309411|454396232|FG001|Overall Study|Physician Decision|0|||
126302274|NCT02309411|454396233|FG002|Overall Study|Physician Decision|0|||
126302275|NCT02309411|454396231|FG000|Overall Study|Withdrawal by Subject|1|||
126302276|NCT02309411|454396232|FG001|Overall Study|Withdrawal by Subject|1|||
126302277|NCT02309411|454396233|FG002|Overall Study|Withdrawal by Subject|0|||
126302278|NCT01134107|454396234|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
126302279|NCT01134107|454396235|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
126302280|NCT01134107|454396234|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
126302281|NCT01134107|454396235|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
126302282|NCT01134107|454396234|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
126302283|NCT01134107|454396235|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
126302284|NCT01134107|454396234|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
126302285|NCT01134107|454396235|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
126302286|NCT01134107|454396234|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
126302287|NCT01134107|454396235|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
126302288|NCT01134107|454396234|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
126302289|NCT01134107|454396235|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
126367598|NCT02301897|454640968|FG000|Treatment Course 1|Withdrawal by Subject|0|||
126367599|NCT02301897|454640969|FG001|Treatment Course 1|Withdrawal by Subject|0|||
126367600|NCT02301897|454640970|FG002|Treatment Course 1|Withdrawal by Subject|2|||
126367601|NCT02301897|454640968|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
126367602|NCT02301897|454640969|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
126367603|NCT02301897|454640970|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
126367604|NCT02301897|454640968|FG000|Treatment Course 2|Lost to Follow-up|0|||
126367605|NCT02301897|454640969|FG001|Treatment Course 2|Lost to Follow-up|2|||
126367606|NCT02301897|454640970|FG002|Treatment Course 2|Lost to Follow-up|0|||
126367607|NCT02301897|454640968|FG000|Treatment Course 2|Pregnancy|0|||
126367608|NCT02301897|454640969|FG001|Treatment Course 2|Pregnancy|1|||
126302290|NCT01134107|454396234|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
126302291|NCT01134107|454396235|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
126044509|NCT03372057|453461080|FG000|Dose Optimization Phase|Death|16|||
126302292|NCT03656692|454396236|FG000|Overall Study|Worsening of disease activity|2|||
126302293|NCT03656692|454396236|FG000|Overall Study|Physician Decision|1|||
126302294|NCT02801617|454396247|FG000|Overall Study|Protocol Violation|2|||
126302295|NCT02801617|454396248|FG001|Overall Study|Protocol Violation|6|||
126302296|NCT01372618|454396249|FG000|Overall Study|PI Died. Study Terminated|9|||
126302297|NCT01954056|454396250|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
126302298|NCT01954056|454396251|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
126302299|NCT06110494|454396252|FG000|Overall Study|Protocol Violation|2|||
126302300|NCT06110494|454396253|FG001|Overall Study|Protocol Violation|0|||
126302301|NCT06110494|454396254|FG002|Overall Study|Protocol Violation|1|||
126302302|NCT06110494|454396252|FG000|Overall Study|Dixon's test for outlier analysis|1|||
126302303|NCT06110494|454396253|FG001|Overall Study|Dixon's test for outlier analysis|1|||
126302304|NCT06110494|454396254|FG002|Overall Study|Dixon's test for outlier analysis|0|||
126302305|NCT02914613|454396255|FG000|Overall Study|Withdrawal by Subject|1|||
126302306|NCT02914613|454396256|FG001|Overall Study|Withdrawal by Subject|2|||
126302307|NCT02914613|454396255|FG000|Overall Study|Adverse Event|1|||
126302308|NCT02914613|454396256|FG001|Overall Study|Adverse Event|0|||
126302309|NCT00984542|454396265|FG000|Overall Study|disease progression|19|||
126302310|NCT00984542|454396265|FG000|Overall Study|toxicity|7|||
126302311|NCT00984542|454396265|FG000|Overall Study|Death|7|||
126302312|NCT00984542|454396265|FG000|Overall Study|complicating disease|3|||
126302313|NCT00984542|454396265|FG000|Overall Study|Withdrawal by Subject|3|||
126302314|NCT00984542|454396265|FG000|Overall Study|clinical deterioration|2|||
126302315|NCT01422889|454396268|FG000|Overall Study|No Data Entered for Study Stent|9|||
126302316|NCT02929589|454396269|FG000|Overall Study|Withdrawal by Subject|1|||
126302317|NCT02929589|454396270|FG001|Overall Study|Withdrawal by Subject|0|||
126302318|NCT02929589|454396271|FG002|Overall Study|Withdrawal by Subject|0|||
126302319|NCT02929589|454396272|FG003|Overall Study|Withdrawal by Subject|0|||
126302320|NCT02929589|454396269|FG000|Overall Study|Physician Decision|2|||
126302321|NCT02929589|454396270|FG001|Overall Study|Physician Decision|0|||
126302322|NCT02929589|454396271|FG002|Overall Study|Physician Decision|0|||
126302323|NCT02929589|454396272|FG003|Overall Study|Physician Decision|0|||
126302324|NCT02091089|454396273|FG000|Overall Study|Lost to Follow-up|2|||
126302325|NCT02343939|454396274|FG000|Overall Study|Death|0|||
126302326|NCT02343939|454396275|FG001|Overall Study|Death|15|||
126302327|NCT02343939|454396276|FG002|Overall Study|Death|4|||
126302328|NCT02343939|454396277|FG003|Overall Study|Death|2|||
126302329|NCT02343939|454396278|FG004|Overall Study|Death|5|||
126302330|NCT02343939|454396279|FG005|Overall Study|Death|11|||
126302331|NCT02343939|454396280|FG006|Overall Study|Death|8|||
126302332|NCT02343939|454396281|FG007|Overall Study|Death|22|||
126302333|NCT02343939|454396282|FG008|Overall Study|Death|1|||
126302334|NCT02343939|454396274|FG000|Overall Study|Study terminated by sponsor|0|||
126302335|NCT02343939|454396275|FG001|Overall Study|Study terminated by sponsor|27|||
126302336|NCT02343939|454396276|FG002|Overall Study|Study terminated by sponsor|0|||
126302337|NCT02343939|454396277|FG003|Overall Study|Study terminated by sponsor|1|||
126302338|NCT02343939|454396278|FG004|Overall Study|Study terminated by sponsor|1|||
126302339|NCT02343939|454396279|FG005|Overall Study|Study terminated by sponsor|5|||
126302340|NCT02343939|454396280|FG006|Overall Study|Study terminated by sponsor|3|||
126302341|NCT02343939|454396281|FG007|Overall Study|Study terminated by sponsor|4|||
126302342|NCT02343939|454396282|FG008|Overall Study|Study terminated by sponsor|0|||
126302343|NCT02343939|454396274|FG000|Overall Study|Withdrew consent|3|||
126302344|NCT02343939|454396275|FG001|Overall Study|Withdrew consent|6|||
126302345|NCT02343939|454396276|FG002|Overall Study|Withdrew consent|1|||
126302346|NCT02343939|454396277|FG003|Overall Study|Withdrew consent|2|||
126302347|NCT02343939|454396278|FG004|Overall Study|Withdrew consent|2|||
126302348|NCT02343939|454396279|FG005|Overall Study|Withdrew consent|0|||
126302349|NCT02343939|454396280|FG006|Overall Study|Withdrew consent|0|||
126302350|NCT02343939|454396281|FG007|Overall Study|Withdrew consent|8|||
126302351|NCT02343939|454396282|FG008|Overall Study|Withdrew consent|6|||
126302352|NCT02343939|454396274|FG000|Overall Study|Treatment failure|0|||
126302353|NCT02343939|454396275|FG001|Overall Study|Treatment failure|0|||
126302354|NCT02343939|454396276|FG002|Overall Study|Treatment failure|0|||
126302355|NCT02343939|454396277|FG003|Overall Study|Treatment failure|0|||
126302356|NCT02343939|454396278|FG004|Overall Study|Treatment failure|0|||
126044510|NCT03372057|453461081|FG001|Dose Optimization Phase|Death|11|||
126302357|NCT02343939|454396279|FG005|Overall Study|Treatment failure|0|||
126302358|NCT02343939|454396280|FG006|Overall Study|Treatment failure|2|||
126302359|NCT02343939|454396281|FG007|Overall Study|Treatment failure|1|||
126302360|NCT02343939|454396282|FG008|Overall Study|Treatment failure|0|||
126302361|NCT02343939|454396274|FG000|Overall Study|Investigator's discretion|0|||
126302362|NCT02343939|454396275|FG001|Overall Study|Investigator's discretion|0|||
126302363|NCT02343939|454396276|FG002|Overall Study|Investigator's discretion|0|||
126302364|NCT02343939|454396277|FG003|Overall Study|Investigator's discretion|1|||
126302365|NCT02343939|454396278|FG004|Overall Study|Investigator's discretion|0|||
126302366|NCT02343939|454396279|FG005|Overall Study|Investigator's discretion|0|||
126302367|NCT02343939|454396280|FG006|Overall Study|Investigator's discretion|1|||
126302368|NCT02343939|454396281|FG007|Overall Study|Investigator's discretion|0|||
126302369|NCT02343939|454396282|FG008|Overall Study|Investigator's discretion|0|||
126302370|NCT02343939|454396274|FG000|Overall Study|Adverse Event|0|||
126302371|NCT02343939|454396275|FG001|Overall Study|Adverse Event|0|||
126302372|NCT02343939|454396276|FG002|Overall Study|Adverse Event|0|||
126302373|NCT02343939|454396277|FG003|Overall Study|Adverse Event|0|||
126302374|NCT02343939|454396278|FG004|Overall Study|Adverse Event|0|||
126302375|NCT02343939|454396279|FG005|Overall Study|Adverse Event|1|||
126302376|NCT02343939|454396280|FG006|Overall Study|Adverse Event|0|||
126302377|NCT02343939|454396281|FG007|Overall Study|Adverse Event|0|||
126302378|NCT02343939|454396282|FG008|Overall Study|Adverse Event|0|||
126302379|NCT02343939|454396274|FG000|Overall Study|Never Treated With ENTO|0|||
126302380|NCT02343939|454396275|FG001|Overall Study|Never Treated With ENTO|0|||
126302381|NCT02343939|454396276|FG002|Overall Study|Never Treated With ENTO|0|||
126302382|NCT02343939|454396277|FG003|Overall Study|Never Treated With ENTO|0|||
126302383|NCT02343939|454396278|FG004|Overall Study|Never Treated With ENTO|0|||
126302384|NCT02343939|454396279|FG005|Overall Study|Never Treated With ENTO|0|||
126302385|NCT02343939|454396280|FG006|Overall Study|Never Treated With ENTO|1|||
126302386|NCT02343939|454396281|FG007|Overall Study|Never Treated With ENTO|2|||
126302387|NCT02343939|454396282|FG008|Overall Study|Never Treated With ENTO|0|||
126302388|NCT01303172|454396289|FG000|Overall Study|Physician Decision|9|||
126302389|NCT01303172|454396290|FG001|Overall Study|Physician Decision|6|||
126302390|NCT01303172|454396289|FG000|Overall Study|Adverse Event|5|||
126302391|NCT01303172|454396290|FG001|Overall Study|Adverse Event|2|||
126302392|NCT01303172|454396289|FG000|Overall Study|Withdrawal by Subject|4|||
126302393|NCT01303172|454396290|FG001|Overall Study|Withdrawal by Subject|2|||
126302394|NCT01303172|454396289|FG000|Overall Study|Death|20|||
126302395|NCT01303172|454396290|FG001|Overall Study|Death|7|||
126302396|NCT01303172|454396289|FG000|Overall Study|Lack of Efficacy|25|||
126302397|NCT01303172|454396290|FG001|Overall Study|Lack of Efficacy|17|||
126302398|NCT01580670|454396293|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
126302399|NCT01580670|454396293|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
126302400|NCT00462709|454396294|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
126302401|NCT00462709|454396294|FG000|Overall Study|Lost to Follow-up|10|||
126302402|NCT00462709|454396294|FG000|Overall Study|Withdrawal by Subject|8|||
126302403|NCT00462709|454396294|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
126302404|NCT00462709|454396294|FG000|Overall Study|Death|2|||
126302405|NCT00462709|454396294|FG000|Overall Study|Logistical reasons|2|||
126302406|NCT00462709|454396294|FG000|Overall Study|Physician Decision|1|||
126302407|NCT00462709|454396294|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
126302408|NCT04468347|454396295|FG000|Overall Study|Withdrawal by Subject|0|||
126302409|NCT04468347|454396296|FG001|Overall Study|Withdrawal by Subject|1|||
126302410|NCT04468347|454396297|FG002|Overall Study|Withdrawal by Subject|3|||
126302411|NCT04468347|454396298|FG003|Overall Study|Withdrawal by Subject|3|||
126302412|NCT04468347|454396295|FG000|Overall Study|Lost to Follow-up|0|||
126302413|NCT04468347|454396296|FG001|Overall Study|Lost to Follow-up|0|||
126302414|NCT04468347|454396297|FG002|Overall Study|Lost to Follow-up|1|||
126302415|NCT04468347|454396298|FG003|Overall Study|Lost to Follow-up|1|||
126302416|NCT04468347|454396295|FG000|Overall Study|Physician Decision|1|||
126302417|NCT04468347|454396296|FG001|Overall Study|Physician Decision|0|||
126302418|NCT04468347|454396297|FG002|Overall Study|Physician Decision|2|||
126302419|NCT04468347|454396298|FG003|Overall Study|Physician Decision|0|||
126302420|NCT04468347|454396295|FG000|Overall Study|Protocol Violation|1|||
126302421|NCT04468347|454396296|FG001|Overall Study|Protocol Violation|0|||
126302422|NCT04468347|454396297|FG002|Overall Study|Protocol Violation|0|||
126302423|NCT04468347|454396298|FG003|Overall Study|Protocol Violation|0|||
126302424|NCT00554515|454396299|FG000|Overall Study|Withdrawal by Subject|3|||
126302425|NCT00554515|454396299|FG000|Overall Study|Disease progression|52|||
126302426|NCT00554515|454396299|FG000|Overall Study|Physician Decision|18|||
126302427|NCT00554515|454396299|FG000|Overall Study|Withdrawal by Subject|11|||
126302428|NCT00554515|454396299|FG000|Overall Study|Adverse Event|9|||
126302429|NCT00554515|454396299|FG000|Overall Study|Death|2|||
126302430|NCT00554515|454396299|FG000|Overall Study|Achieved Stable Disease|7|||
126302431|NCT00554515|454396299|FG000|Overall Study|Other|1|||
126302432|NCT00554515|454396299|FG000|Overall Study|Misc|15|||
126302433|NCT00665431|454396302|FG000|Overall Study|Adverse Event|16|||
126302434|NCT00665431|454396303|FG001|Overall Study|Adverse Event|22|||
126302435|NCT00665431|454396304|FG002|Overall Study|Adverse Event|6|||
126302436|NCT00665431|454396302|FG000|Overall Study|Withdrawal by Subject|17|||
126367609|NCT02301897|454640970|FG002|Treatment Course 2|Pregnancy|1|||
126367610|NCT02301897|454640968|FG000|Treatment Course 2|Withdrawal by Subject|0|||
126367611|NCT02301897|454640969|FG001|Treatment Course 2|Withdrawal by Subject|2|||
126367612|NCT02301897|454640970|FG002|Treatment Course 2|Withdrawal by Subject|0|||
126367613|NCT02301897|454640968|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
126367614|NCT02301897|454640969|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
126367615|NCT02301897|454640970|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
126367616|NCT02439957|454640971|FG000|Overall Study|Study Terminated|3|||
126367617|NCT02439957|454640972|FG001|Overall Study|Study Terminated|3|||
126367618|NCT00478257|454640973|FG000|Overall Study|Withdrawal by Subject|8|||
126302437|NCT00665431|454396303|FG001|Overall Study|Withdrawal by Subject|25|||
126302438|NCT00665431|454396304|FG002|Overall Study|Withdrawal by Subject|15|||
126302439|NCT00665431|454396302|FG000|Overall Study|Lost to Follow-up|3|||
126302440|NCT00665431|454396303|FG001|Overall Study|Lost to Follow-up|3|||
126302441|NCT00665431|454396304|FG002|Overall Study|Lost to Follow-up|1|||
126302442|NCT00665431|454396302|FG000|Overall Study|Other|4|||
126302443|NCT00665431|454396303|FG001|Overall Study|Other|7|||
126302444|NCT00665431|454396304|FG002|Overall Study|Other|2|||
126302445|NCT00315458|454396310|FG000|Overall Study|Administrative|0|||
126302446|NCT00315458|454396311|FG001|Overall Study|Administrative|3|||
126302447|NCT00315458|454396312|FG002|Overall Study|Administrative|8|||
126302448|NCT00315458|454396313|FG003|Overall Study|Administrative|21|||
126302449|NCT00315458|454396310|FG000|Overall Study|Adverse Event|2|||
126302450|NCT00315458|454396311|FG001|Overall Study|Adverse Event|4|||
126302451|NCT00315458|454396312|FG002|Overall Study|Adverse Event|23|||
126302452|NCT00315458|454396313|FG003|Overall Study|Adverse Event|3|||
126302453|NCT00315458|454396310|FG000|Overall Study|Lost to Follow-up|1|||
126302454|NCT00315458|454396311|FG001|Overall Study|Lost to Follow-up|2|||
126302455|NCT00315458|454396312|FG002|Overall Study|Lost to Follow-up|0|||
126302456|NCT00315458|454396313|FG003|Overall Study|Lost to Follow-up|2|||
126302457|NCT00315458|454396310|FG000|Overall Study|Withdrawal by Subject|0|||
126302458|NCT00315458|454396311|FG001|Overall Study|Withdrawal by Subject|3|||
126302459|NCT00315458|454396312|FG002|Overall Study|Withdrawal by Subject|0|||
126302460|NCT00315458|454396313|FG003|Overall Study|Withdrawal by Subject|2|||
126302461|NCT00315458|454396310|FG000|Overall Study|Lack of Efficacy|0|||
126302462|NCT00315458|454396311|FG001|Overall Study|Lack of Efficacy|0|||
126302463|NCT00315458|454396312|FG002|Overall Study|Lack of Efficacy|20|||
126302464|NCT00315458|454396313|FG003|Overall Study|Lack of Efficacy|1|||
126302465|NCT00315458|454396310|FG000|Overall Study|Did not qualify|0|||
126302466|NCT00315458|454396311|FG001|Overall Study|Did not qualify|0|||
126302467|NCT00315458|454396312|FG002|Overall Study|Did not qualify|1|||
126302468|NCT00315458|454396313|FG003|Overall Study|Did not qualify|0|||
126302469|NCT00987337|454396314|FG000|Overall Study|Adverse Event|10|||
126302470|NCT00987337|454396315|FG001|Overall Study|Adverse Event|9|||
126302471|NCT00987337|454396316|FG002|Overall Study|Adverse Event|8|||
126302472|NCT00987337|454396314|FG000|Overall Study|Insufficient Virologic Response|10|||
126302473|NCT00987337|454396315|FG001|Overall Study|Insufficient Virologic Response|7|||
126302474|NCT00987337|454396316|FG002|Overall Study|Insufficient Virologic Response|12|||
126302475|NCT00987337|454396314|FG000|Overall Study|Virologic Breakthrough|2|||
126302476|NCT00987337|454396315|FG001|Overall Study|Virologic Breakthrough|2|||
126302477|NCT00987337|454396316|FG002|Overall Study|Virologic Breakthrough|8|||
126302478|NCT00987337|454396314|FG000|Overall Study|Lost to Follow-up|10|||
126302479|NCT00987337|454396315|FG001|Overall Study|Lost to Follow-up|6|||
126302480|NCT00987337|454396316|FG002|Overall Study|Lost to Follow-up|2|||
126302481|NCT00987337|454396314|FG000|Overall Study|Withdrawal by Subject|6|||
126302482|NCT00987337|454396315|FG001|Overall Study|Withdrawal by Subject|9|||
126302483|NCT00987337|454396316|FG002|Overall Study|Withdrawal by Subject|9|||
126302484|NCT00987337|454396314|FG000|Overall Study|Other|0|||
126302485|NCT00987337|454396315|FG001|Overall Study|Other|2|||
126302486|NCT00987337|454396316|FG002|Overall Study|Other|5|||
126302487|NCT00987337|454396314|FG000|Overall Study|Protocol Violation|1|||
126302488|NCT00987337|454396315|FG001|Overall Study|Protocol Violation|0|||
126302489|NCT00987337|454396316|FG002|Overall Study|Protocol Violation|2|||
126302490|NCT00987337|454396314|FG000|Overall Study|Participant Relapsed|18|||
126302491|NCT00987337|454396315|FG001|Overall Study|Participant Relapsed|20|||
126302492|NCT00987337|454396316|FG002|Overall Study|Participant Relapsed|5|||
126302493|NCT00489918|454396320|FG000|Overall Study|Withdrawal by Subject|2|||
126302494|NCT00489918|454396321|FG001|Overall Study|Withdrawal by Subject|1|||
126302495|NCT00489918|454396322|FG002|Overall Study|Withdrawal by Subject|1|||
126302496|NCT00489918|454396323|FG003|Overall Study|Withdrawal by Subject|0|||
126302497|NCT00489918|454396324|FG004|Overall Study|Withdrawal by Subject|1|||
126302498|NCT00489918|454396320|FG000|Overall Study|Adverse Event|0|||
126302499|NCT00489918|454396321|FG001|Overall Study|Adverse Event|1|||
126302500|NCT00489918|454396322|FG002|Overall Study|Adverse Event|1|||
126302501|NCT00489918|454396323|FG003|Overall Study|Adverse Event|0|||
126302502|NCT00489918|454396324|FG004|Overall Study|Adverse Event|0|||
126302503|NCT00489918|454396320|FG000|Overall Study|Lost to Follow-up|0|||
126302504|NCT00489918|454396321|FG001|Overall Study|Lost to Follow-up|0|||
126302505|NCT00489918|454396322|FG002|Overall Study|Lost to Follow-up|1|||
126302506|NCT00489918|454396323|FG003|Overall Study|Lost to Follow-up|1|||
126302507|NCT00489918|454396324|FG004|Overall Study|Lost to Follow-up|0|||
126302508|NCT00489918|454396320|FG000|Overall Study|Physician Decision|0|||
126302509|NCT00489918|454396321|FG001|Overall Study|Physician Decision|0|||
126302510|NCT00489918|454396322|FG002|Overall Study|Physician Decision|1|||
126302511|NCT00489918|454396323|FG003|Overall Study|Physician Decision|0|||
126302512|NCT00489918|454396324|FG004|Overall Study|Physician Decision|0|||
126302513|NCT02748213|454396325|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
126302514|NCT02748213|454396326|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
126302515|NCT02748213|454396325|FG000|Overall Study|Abnormal Laboratory Test|1|||
126367619|NCT00478257|454640974|FG001|Overall Study|Withdrawal by Subject|3|||
126367620|NCT03931330|454640975|FG000|Overall Study|Physician Decision|1|||
126367621|NCT03412929|454640976|FG000|Overall Study|Protocol Violation|3|||
126367622|NCT00023595|454640981|FG000|5 Year Follow up|Lost to Follow-up|2|||
126367623|NCT00023595|454640982|FG001|5 Year Follow up|Lost to Follow-up|2|||
126367624|NCT00023595|454640983|FG002|5 Year Follow up|Lost to Follow-up|1|||
126367625|NCT00023595|454640984|FG003|5 Year Follow up|Lost to Follow-up|7|||
126367626|NCT00023595|454640985|FG004|5 Year Follow up|Lost to Follow-up|3|||
126367627|NCT00023595|454640981|FG000|10 Year Follow up|Lost to Follow-up|12|||
126367628|NCT00023595|454640982|FG001|10 Year Follow up|Lost to Follow-up|10|||
126367629|NCT00023595|454640983|FG002|10 Year Follow up|Lost to Follow-up|3|||
126367630|NCT00023595|454640984|FG003|10 Year Follow up|Lost to Follow-up|0|||
126367631|NCT00023595|454640985|FG004|10 Year Follow up|Lost to Follow-up|0|||
126367632|NCT01472185|454640986|FG000|Overall Study|Randomized but Not Treated|0|||
126367633|NCT01472185|454640987|FG001|Overall Study|Randomized but Not Treated|1|||
126367634|NCT01472185|454640986|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
126367635|NCT01472185|454640987|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
126367636|NCT01472185|454640986|FG000|Overall Study|Hyperglycemia|5|||
126367637|NCT01472185|454640987|FG001|Overall Study|Hyperglycemia|2|||
126367638|NCT01472185|454640986|FG000|Overall Study|Investigator's Discretion|3|||
126367639|NCT01472185|454640987|FG001|Overall Study|Investigator's Discretion|1|||
126367640|NCT01472185|454640986|FG000|Overall Study|Lost to Follow-up|4|||
126367641|NCT01472185|454640987|FG001|Overall Study|Lost to Follow-up|1|||
126367642|NCT01472185|454640986|FG000|Overall Study|Protocol Violation|5|||
126367643|NCT01472185|454640987|FG001|Overall Study|Protocol Violation|1|||
126367644|NCT01472185|454640986|FG000|Overall Study|Subject Noncompliance|8|||
126367645|NCT01472185|454640987|FG001|Overall Study|Subject Noncompliance|15|||
126367646|NCT01472185|454640986|FG000|Overall Study|Subject Withdrew Consent|6|||
126367647|NCT01472185|454640987|FG001|Overall Study|Subject Withdrew Consent|3|||
126367648|NCT00635050|454640992|FG000|Overall Study|Withdrawal by Subject|1|||
126367649|NCT00759395|454640993|FG000|Overall Study|Adverse Event|1|||
126367650|NCT00759395|454640994|FG001|Overall Study|Adverse Event|0|||
126367651|NCT00759395|454640993|FG000|Overall Study|Withdrawal by Subject|1|||
126367652|NCT00759395|454640994|FG001|Overall Study|Withdrawal by Subject|0|||
126367653|NCT00759395|454640993|FG000|Overall Study|Lack of Efficacy|0|||
126367654|NCT00759395|454640994|FG001|Overall Study|Lack of Efficacy|2|||
126302516|NCT02748213|454396326|FG001|Overall Study|Abnormal Laboratory Test|0|||
126302517|NCT02748213|454396325|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
126302518|NCT02748213|454396326|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
126302519|NCT02748213|454396325|FG000|Overall Study|Death|5|||
126302520|NCT02748213|454396326|FG001|Overall Study|Death|3|||
126302521|NCT02748213|454396325|FG000|Overall Study|Insufficient Therapeutic Response|56|||
126302522|NCT02748213|454396326|FG001|Overall Study|Insufficient Therapeutic Response|57|||
126302523|NCT02748213|454396325|FG000|Overall Study|Violation of Selection Criteria|2|||
126302524|NCT02748213|454396326|FG001|Overall Study|Violation of Selection Criteria|0|||
126302525|NCT02748213|454396325|FG000|Overall Study|Protocol Violation|6|||
126302526|NCT02748213|454396326|FG001|Overall Study|Protocol Violation|4|||
126367655|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
126302527|NCT02748213|454396325|FG000|Overall Study|Refused Treatment*|6|||
126302528|NCT02748213|454396326|FG001|Overall Study|Refused Treatment*|6|||
126302529|NCT02748213|454396325|FG000|Overall Study|Failure to Return|1|||
126302530|NCT02748213|454396326|FG001|Overall Study|Failure to Return|0|||
126302531|NCT02748213|454396325|FG000|Overall Study|Other|30|||
126302532|NCT02748213|454396326|FG001|Overall Study|Other|29|||
126367656|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
126367657|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
126367658|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
126367659|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
126302533|NCT04200651|454396327|FG000|Overall Study|Moved to another country during follow-up|2|||
126302534|NCT04200651|454396328|FG001|Overall Study|Moved to another country during follow-up|2|||
126302535|NCT04200651|454396327|FG000|Overall Study|Lost to Follow-up|1|||
126302536|NCT04200651|454396328|FG001|Overall Study|Lost to Follow-up|3|||
126302537|NCT01500382|454396333|FG000|Washout Period|Study site went out of business|0|||
126302538|NCT01500382|454396334|FG001|Washout Period|Study site went out of business|0|||
126302539|NCT01500382|454396335|FG002|Washout Period|Study site went out of business|1|||
126302540|NCT01500382|454396336|FG003|Washout Period|Study site went out of business|0|||
126302541|NCT01870973|454396337|FG000|Overall Study|Lost to Follow-up|10|||
126302542|NCT01870973|454396338|FG001|Overall Study|Lost to Follow-up|3|||
126302543|NCT01266291|454396339|FG000|Overall Study|Adverse Event|1|||
126302544|NCT03291431|454396340|FG000|Overall Study|Protocol Violation|2|||
126302545|NCT03291431|454396341|FG001|Overall Study|Protocol Violation|1|||
126302546|NCT03291431|454396340|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
126302547|NCT03291431|454396341|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
126302548|NCT03291431|454396340|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
126302549|NCT03291431|454396341|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
126302550|NCT00550745|454396344|FG000|Overall Study|Death|20|||
126302551|NCT00550745|454396345|FG001|Overall Study|Death|16|||
126302552|NCT00550745|454396344|FG000|Overall Study|Lost to Follow-up|45|||
126302553|NCT00550745|454396345|FG001|Overall Study|Lost to Follow-up|30|||
126302554|NCT00550745|454396344|FG000|Overall Study|Physician Decision|0|||
126302555|NCT00550745|454396345|FG001|Overall Study|Physician Decision|2|||
126302556|NCT00550745|454396344|FG000|Overall Study|Protocol Violation|4|||
126302557|NCT00550745|454396345|FG001|Overall Study|Protocol Violation|2|||
126302558|NCT00550745|454396344|FG000|Overall Study|Withdrawal by Subject|17|||
126302559|NCT00550745|454396345|FG001|Overall Study|Withdrawal by Subject|10|||
126302560|NCT00550745|454396344|FG000|Overall Study|Screen failure|1|||
126302561|NCT00550745|454396345|FG001|Overall Study|Screen failure|0|||
126302562|NCT02498444|454398379|FG000|Overall Study|Withdrawal by Subject|3|||
126302563|NCT02498444|454398380|FG001|Overall Study|Withdrawal by Subject|0|||
126302564|NCT02498444|454398379|FG000|Overall Study|Physician Decision|1|||
126302565|NCT02498444|454398380|FG001|Overall Study|Physician Decision|0|||
126302566|NCT02027545|454398381|FG000|Overall Study|Failed to sign HIPAA|0|||
126302567|NCT02027545|454398382|FG001|Overall Study|Failed to sign HIPAA|2|||
126302568|NCT02027545|454398381|FG000|Overall Study|Failed to attend study visit|2|||
126302569|NCT02027545|454398382|FG001|Overall Study|Failed to attend study visit|0|||
126302570|NCT02027545|454398381|FG000|Overall Study|Protocol Violation|1|||
126302571|NCT02027545|454398382|FG001|Overall Study|Protocol Violation|0|||
126302572|NCT02453334|454398383|FG000|Overall Study|Death|15|||
126302573|NCT02453334|454398384|FG001|Overall Study|Death|13|||
126302574|NCT02453334|454398383|FG000|Overall Study|Adverse Event|2|||
126302575|NCT02453334|454398384|FG001|Overall Study|Adverse Event|1|||
126302576|NCT02453334|454398383|FG000|Overall Study|Lost to Follow-up|5|||
126302577|NCT02453334|454398384|FG001|Overall Study|Lost to Follow-up|9|||
126302578|NCT02453334|454398383|FG000|Overall Study|Physician Decision|1|||
126302579|NCT02453334|454398384|FG001|Overall Study|Physician Decision|0|||
126302580|NCT02453334|454398383|FG000|Overall Study|Withdrawal by Subject|17|||
126302581|NCT02453334|454398384|FG001|Overall Study|Withdrawal by Subject|13|||
126302582|NCT02453334|454398383|FG000|Overall Study|Other reason|1|||
126302583|NCT02453334|454398384|FG001|Overall Study|Other reason|4|||
126302584|NCT02693106|454398387|FG000|Overall Study|No time|3|||
126302585|NCT02509507|454398388|FG000|Overall Study|Death|21|||
126302586|NCT02509507|454398389|FG001|Overall Study|Death|3|||
126302587|NCT02509507|454398390|FG002|Overall Study|Death|22|||
126302588|NCT02509507|454398391|FG003|Overall Study|Death|14|||
126302589|NCT02509507|454398392|FG004|Overall Study|Death|8|||
126302590|NCT02509507|454398393|FG005|Overall Study|Death|12|||
126302591|NCT02509507|454398394|FG006|Overall Study|Death|5|||
126302592|NCT02509507|454398395|FG007|Overall Study|Death|4|||
126302593|NCT02509507|454398396|FG008|Overall Study|Death|8|||
126302594|NCT02509507|454398388|FG000|Overall Study|Lost to Follow-up|0|||
126302595|NCT02509507|454398389|FG001|Overall Study|Lost to Follow-up|1|||
126302596|NCT02509507|454398390|FG002|Overall Study|Lost to Follow-up|0|||
126302597|NCT02509507|454398391|FG003|Overall Study|Lost to Follow-up|0|||
126302598|NCT02509507|454398392|FG004|Overall Study|Lost to Follow-up|0|||
126302599|NCT02509507|454398393|FG005|Overall Study|Lost to Follow-up|2|||
126302600|NCT02509507|454398394|FG006|Overall Study|Lost to Follow-up|0|||
126302601|NCT02509507|454398395|FG007|Overall Study|Lost to Follow-up|0|||
126302602|NCT02509507|454398396|FG008|Overall Study|Lost to Follow-up|0|||
126302603|NCT02509507|454398388|FG000|Overall Study|Withdrawal by Subject|2|||
126302604|NCT02509507|454398389|FG001|Overall Study|Withdrawal by Subject|0|||
126302605|NCT02509507|454398390|FG002|Overall Study|Withdrawal by Subject|1|||
126302606|NCT02509507|454398391|FG003|Overall Study|Withdrawal by Subject|4|||
126302607|NCT02509507|454398392|FG004|Overall Study|Withdrawal by Subject|1|||
126302608|NCT02509507|454398393|FG005|Overall Study|Withdrawal by Subject|3|||
126302609|NCT02509507|454398394|FG006|Overall Study|Withdrawal by Subject|4|||
126302610|NCT02509507|454398395|FG007|Overall Study|Withdrawal by Subject|0|||
126302611|NCT02509507|454398396|FG008|Overall Study|Withdrawal by Subject|1|||
126302612|NCT00839800|454398400|FG000|Overall Study|Adverse Event|8|||
126302613|NCT00839800|454398401|FG001|Overall Study|Adverse Event|12|||
126302614|NCT00839800|454398400|FG000|Overall Study|Lost to Follow-up|31|||
126302615|NCT00839800|454398401|FG001|Overall Study|Lost to Follow-up|26|||
126302616|NCT00839800|454398400|FG000|Overall Study|Withdrawal by Subject|28|||
126302617|NCT00839800|454398401|FG001|Overall Study|Withdrawal by Subject|34|||
126302618|NCT00839800|454398400|FG000|Overall Study|Incorrect Enrolment|3|||
126302619|NCT00839800|454398401|FG001|Overall Study|Incorrect Enrolment|3|||
126302620|NCT00839800|454398400|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
126302621|NCT00839800|454398401|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
126302622|NCT00839800|454398400|FG000|Overall Study|Safety Reasons|2|||
126302623|NCT00839800|454398401|FG001|Overall Study|Safety Reasons|1|||
126302624|NCT00839800|454398400|FG000|Overall Study|Other|8|||
126302625|NCT00839800|454398401|FG001|Overall Study|Other|14|||
126302626|NCT00839800|454398400|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
126302627|NCT00839800|454398401|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
126302628|NCT02510664|454398402|FG000|Overall Study|Transferred Care|9|||
126302629|NCT02510664|454398403|FG001|Overall Study|Transferred Care|9|||
126302630|NCT02510664|454398404|FG002|Overall Study|Transferred Care|0|||
126302631|NCT02510664|454398402|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
126302632|NCT02510664|454398403|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
126302633|NCT02510664|454398404|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
126302634|NCT02510664|454398402|FG000|Overall Study|Time Constraints|1|||
126302635|NCT02510664|454398403|FG001|Overall Study|Time Constraints|1|||
126302636|NCT02510664|454398404|FG002|Overall Study|Time Constraints|0|||
126302637|NCT03337113|454398407|FG000|Overall Study|Adverse Event|1|||
126302638|NCT03337113|454398408|FG001|Overall Study|Adverse Event|1|||
126302639|NCT03337113|454398409|FG002|Overall Study|Adverse Event|0|||
126302640|NCT03337113|454398410|FG003|Overall Study|Adverse Event|1|||
126302641|NCT03337113|454398407|FG000|Overall Study|Physician Decision|0|||
126302642|NCT03337113|454398408|FG001|Overall Study|Physician Decision|2|||
126302643|NCT03337113|454398409|FG002|Overall Study|Physician Decision|0|||
126302644|NCT03337113|454398410|FG003|Overall Study|Physician Decision|1|||
126302645|NCT03337113|454398407|FG000|Overall Study|Withdrawal by Subject|0|||
126302646|NCT03337113|454398408|FG001|Overall Study|Withdrawal by Subject|0|||
126302647|NCT03337113|454398409|FG002|Overall Study|Withdrawal by Subject|1|||
126302648|NCT03337113|454398410|FG003|Overall Study|Withdrawal by Subject|0|||
126302649|NCT02176655|454398415|FG000|Overall Study|Subjects did not treat|6|||
126302650|NCT01464593|454398420|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
126302651|NCT01019694|454398431|FG000|Overall Study|Adverse Event|12|||
126302652|NCT01019694|454398432|FG001|Overall Study|Adverse Event|16|||
126302653|NCT01019694|454398433|FG002|Overall Study|Adverse Event|19|||
126302654|NCT01019694|454398431|FG000|Overall Study|Protocol Violation|2|||
126302655|NCT01019694|454398432|FG001|Overall Study|Protocol Violation|6|||
126302656|NCT01019694|454398433|FG002|Overall Study|Protocol Violation|4|||
126302657|NCT01019694|454398431|FG000|Overall Study|Lost to Follow-up|5|||
126302658|NCT01019694|454398432|FG001|Overall Study|Lost to Follow-up|3|||
126302659|NCT01019694|454398433|FG002|Overall Study|Lost to Follow-up|3|||
126302660|NCT01019694|454398431|FG000|Overall Study|Withdrawal by Subject|4|||
126302661|NCT01019694|454398432|FG001|Overall Study|Withdrawal by Subject|6|||
126302662|NCT01019694|454398433|FG002|Overall Study|Withdrawal by Subject|12|||
126302663|NCT01019694|454398431|FG000|Overall Study|Not treated|0|||
126302664|NCT01019694|454398432|FG001|Overall Study|Not treated|2|||
126302665|NCT01019694|454398433|FG002|Overall Study|Not treated|3|||
126302666|NCT01019694|454398431|FG000|Overall Study|Other reason (not specified)|1|||
126302667|NCT01019694|454398432|FG001|Overall Study|Other reason (not specified)|5|||
126302668|NCT01019694|454398433|FG002|Overall Study|Other reason (not specified)|6|||
126302669|NCT00026494|454398436|FG000|Overall Study|Withdrawal by Subject|1|||
126302670|NCT00026494|454398437|FG001|Overall Study|Withdrawal by Subject|0|||
126302671|NCT00026494|454398438|FG002|Overall Study|Withdrawal by Subject|1|||
126302672|NCT00026494|454398439|FG003|Overall Study|Withdrawal by Subject|0|||
126302673|NCT00026494|454398436|FG000|Overall Study|Patient non-compliance|1|||
126302674|NCT00026494|454398437|FG001|Overall Study|Patient non-compliance|0|||
126302675|NCT00026494|454398438|FG002|Overall Study|Patient non-compliance|0|||
126302676|NCT00026494|454398439|FG003|Overall Study|Patient non-compliance|0|||
125884048|NCT03739203|452873136|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
125884049|NCT03739203|452873137|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
126044511|NCT03372057|453461082|FG002|Dose Optimization Phase|Death|0|||
126302677|NCT00026494|454398436|FG000|Overall Study|Patient not treated|0|||
126044512|NCT03372057|453461080|FG000|Expansion Phase|Withdrawal by Subject|0|||
126302678|NCT00026494|454398437|FG001|Overall Study|Patient not treated|0|||
126302679|NCT00026494|454398438|FG002|Overall Study|Patient not treated|2|||
126302680|NCT00026494|454398439|FG003|Overall Study|Patient not treated|0|||
125884050|NCT03739203|452873135|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
125884051|NCT03739203|452873136|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
125884052|NCT03739203|452873137|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
125884053|NCT03739203|452873135|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
125884054|NCT03739203|452873136|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
125884055|NCT03739203|452873137|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
125884056|NCT03739203|452873135|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
125884057|NCT03739203|452873136|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
125884058|NCT03739203|452873137|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
125884059|NCT03739203|452873135|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
125884060|NCT03739203|452873136|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
125884061|NCT03739203|452873137|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
125884062|NCT03739203|452873135|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
125884063|NCT03739203|452873136|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
125884064|NCT03739203|452873137|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
125884065|NCT03131570|452873138|FG000|Overall Study|Adverse Event|1|||
125884066|NCT03131570|452873139|FG001|Overall Study|Adverse Event|0|||
125884067|NCT01782378|452873140|FG000|First Series|Lost to Follow-up|7|||
125884068|NCT01782378|452873141|FG001|First Series|Lost to Follow-up|8|||
125884069|NCT01782378|452873140|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
125884070|NCT01782378|452873141|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
125884071|NCT01782378|452873140|FG000|Second Series|Lost to Follow-up|8|||
125884072|NCT01782378|452873141|FG001|Second Series|Lost to Follow-up|7|||
125884073|NCT01782378|452873140|FG000|Second Series|Did not choose to complete S2 Optional|18|||
125884074|NCT01782378|452873141|FG001|Second Series|Did not choose to complete S2 Optional|0|||
125884075|NCT00830440|452873142|FG000|Overall Study|Protocol Violation|1|||
125884076|NCT00830440|452873143|FG001|Overall Study|Protocol Violation|0|||
125884077|NCT00830440|452873142|FG000|Overall Study|Withdrawal by Subject|1|||
125884078|NCT00830440|452873143|FG001|Overall Study|Withdrawal by Subject|0|||
125884079|NCT00830440|452873142|FG000|Overall Study|unsuccessful procedure|4|||
125884080|NCT00830440|452873143|FG001|Overall Study|unsuccessful procedure|0|||
125884081|NCT00830440|452873142|FG000|Overall Study|Adverse Event|2|||
125884082|NCT00830440|452873143|FG001|Overall Study|Adverse Event|0|||
125884083|NCT01967940|452873148|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
125884084|NCT01967940|452873149|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
125884085|NCT01967940|452873150|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
125884086|NCT01967940|452873151|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
125884087|NCT01967940|452873148|FG000|Part 2|Adverse Event|0|||
125884088|NCT01967940|452873149|FG001|Part 2|Adverse Event|0|||
125884089|NCT01967940|452873150|FG002|Part 2|Adverse Event|0|||
125884090|NCT01967940|452873151|FG003|Part 2|Adverse Event|1|||
125884091|NCT01967940|452873148|FG000|Part 2|Unknown Reason|0|||
125884092|NCT01967940|452873149|FG001|Part 2|Unknown Reason|0|||
125884093|NCT01967940|452873150|FG002|Part 2|Unknown Reason|0|||
125884094|NCT01967940|452873151|FG003|Part 2|Unknown Reason|1|||
125884095|NCT01663103|452873152|FG000|Overall Study|Withdrawal by Subject|1|||
125884096|NCT01663103|452873153|FG001|Overall Study|Withdrawal by Subject|2|||
125884097|NCT01663103|452873152|FG000|Overall Study|Adverse Event|1|||
125884098|NCT01663103|452873153|FG001|Overall Study|Adverse Event|0|||
125884099|NCT01663103|452873152|FG000|Overall Study|dog bite|1|||
125884100|NCT01663103|452873153|FG001|Overall Study|dog bite|0|||
125884101|NCT03113487|452873158|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
126044513|NCT03372057|453461081|FG001|Expansion Phase|Withdrawal by Subject|0|||
126367660|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
126367661|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
126367662|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
126367663|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
126367664|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
126367665|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
126367666|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
126367667|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
126367668|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
125884102|NCT00391586|452873162|FG000|Overall Study|Progressive disease|13|||
125884103|NCT00391586|452873162|FG000|Overall Study|Adverse Event|5|||
125884104|NCT00391586|452873162|FG000|Overall Study|Physician Decision|2|||
125884105|NCT00391586|452873162|FG000|Overall Study|Death|4|||
125884106|NCT00904982|452873164|FG000|Overall Study|Withdrawal by Subject|2|||
125884107|NCT00904982|452873165|FG001|Overall Study|Withdrawal by Subject|0|||
125884108|NCT00904982|452873166|FG002|Overall Study|Withdrawal by Subject|0|||
125884109|NCT00904982|452873167|FG003|Overall Study|Withdrawal by Subject|0|||
125884110|NCT02420821|452873175|FG000|Overall Study|Lost to Follow-up|6|||
125884111|NCT02420821|452873176|FG001|Overall Study|Lost to Follow-up|6|||
125884112|NCT02420821|452873175|FG000|Overall Study|Non-compliance|0|||
125884113|NCT02420821|452873176|FG001|Overall Study|Non-compliance|2|||
126367669|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
126367670|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
126367671|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
125884114|NCT02420821|452873175|FG000|Overall Study|Physician Decision|6|||
125884115|NCT02420821|452873176|FG001|Overall Study|Physician Decision|2|||
125884116|NCT02420821|452873175|FG000|Overall Study|Withdrawal by Subject|32|||
125884117|NCT02420821|452873176|FG001|Overall Study|Withdrawal by Subject|25|||
125884118|NCT02420821|452873175|FG000|Overall Study|Death|270|||
126367672|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
126367673|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
126367674|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
126367675|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
126367676|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
126367677|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
126367678|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
126367679|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
126367680|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
126367681|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
126367682|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
125884119|NCT02420821|452873176|FG001|Overall Study|Death|263|||
125884120|NCT02420821|452873175|FG000|Overall Study|Study Terminated By Sponsor|145|||
126367683|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
126367684|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
125884121|NCT02420821|452873176|FG001|Overall Study|Study Terminated By Sponsor|149|||
125884122|NCT02420821|452873175|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
125884123|NCT02420821|452873176|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
125884124|NCT02420821|452873175|FG000|Overall Study|Adverse Event|0|||
125884125|NCT02420821|452873176|FG001|Overall Study|Adverse Event|1|||
125884126|NCT02420821|452873175|FG000|Overall Study|Protinuria|0|||
125884127|NCT02420821|452873176|FG001|Overall Study|Protinuria|1|||
125884128|NCT02420821|452873175|FG000|Overall Study|Progressive Disease|1|||
125884129|NCT02420821|452873176|FG001|Overall Study|Progressive Disease|1|||
125884130|NCT02420821|452873175|FG000|Overall Study|Disease Progression|0|||
125884131|NCT02420821|452873176|FG001|Overall Study|Disease Progression|1|||
125884132|NCT02420821|452873175|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
125884133|NCT02420821|452873176|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
125884134|NCT00686712|452873177|FG000|Overall Study|Protocol Violation|8|||
125884135|NCT00686712|452873178|FG001|Overall Study|Protocol Violation|8|||
125884136|NCT00686712|452873179|FG002|Overall Study|Protocol Violation|10|||
125884137|NCT00686712|452873177|FG000|Overall Study|Lost to Follow-up|1|||
125884138|NCT00686712|452873178|FG001|Overall Study|Lost to Follow-up|2|||
125884139|NCT00686712|452873179|FG002|Overall Study|Lost to Follow-up|3|||
125884140|NCT00686712|452873177|FG000|Overall Study|Adverse Event|1|||
125884141|NCT00686712|452873178|FG001|Overall Study|Adverse Event|1|||
125884142|NCT00686712|452873179|FG002|Overall Study|Adverse Event|0|||
125884143|NCT04119414|452873180|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
125884144|NCT03058146|452873181|FG000|Overall Study|Withdrawal by Subject|4|||
125884145|NCT03058146|452873182|FG001|Overall Study|Withdrawal by Subject|1|||
125884146|NCT03058146|452873181|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
125884147|NCT03058146|452873182|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
125884148|NCT01352793|452873185|FG000|Overall Study|Lost to Follow-up|289|||
125884149|NCT01352793|452873186|FG001|Overall Study|Lost to Follow-up|125|||
125884150|NCT01352793|452873185|FG000|Overall Study|Withdrawal by Subject|120|||
125884151|NCT01352793|452873186|FG001|Overall Study|Withdrawal by Subject|55|||
125884152|NCT01352793|452873185|FG000|Overall Study|Protocol Violation|44|||
125884153|NCT01352793|452873186|FG001|Overall Study|Protocol Violation|23|||
125884154|NCT01352793|452873185|FG000|Overall Study|Adverse Event|44|||
125884155|NCT01352793|452873186|FG001|Overall Study|Adverse Event|10|||
125884156|NCT01352793|452873185|FG000|Overall Study|Physician Decision|1|||
125884157|NCT01352793|452873186|FG001|Overall Study|Physician Decision|0|||
125884158|NCT01352793|452873185|FG000|Overall Study|Pregnancy|26|||
125884159|NCT01352793|452873186|FG001|Overall Study|Pregnancy|8|||
125884160|NCT01352793|452873185|FG000|Overall Study|Other|25|||
125884161|NCT01352793|452873186|FG001|Overall Study|Other|7|||
125884162|NCT01352793|452873185|FG000|Overall Study|Medication error|2|||
125884163|NCT01352793|452873186|FG001|Overall Study|Medication error|2|||
125884164|NCT01352793|452873185|FG000|Overall Study|Death|1|||
125884165|NCT01352793|452873186|FG001|Overall Study|Death|0|||
125884166|NCT01352793|452873185|FG000|Overall Study|Randomized but not vaccinated|8|||
125884167|NCT01352793|452873186|FG001|Overall Study|Randomized but not vaccinated|0|||
125884168|NCT01352793|452873185|FG000|Overall Study|No longer meets eligibility criteria|25|||
125884169|NCT01352793|452873186|FG001|Overall Study|No longer meets eligibility criteria|15|||
125884170|NCT02839200|452873189|FG000|Overall Study|Withdrawal by Subject|2|||
125884171|NCT02839200|452873190|FG001|Overall Study|Withdrawal by Subject|0|||
125884172|NCT02839200|452873191|FG002|Overall Study|Withdrawal by Subject|1|||
125884173|NCT02839200|452873192|FG003|Overall Study|Withdrawal by Subject|0|||
125884174|NCT02839200|452873193|FG004|Overall Study|Withdrawal by Subject|0|||
125884175|NCT02839200|452873194|FG005|Overall Study|Withdrawal by Subject|1|||
125884176|NCT02839200|452873189|FG000|Overall Study|Lost to Follow-up|2|||
125884177|NCT02839200|452873190|FG001|Overall Study|Lost to Follow-up|0|||
125884178|NCT02839200|452873191|FG002|Overall Study|Lost to Follow-up|0|||
126367685|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
126367686|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
126367687|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
126367688|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
126367689|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
126369574|NCT00183248|454650605|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
125884179|NCT02839200|452873192|FG003|Overall Study|Lost to Follow-up|0|||
125884180|NCT02839200|452873193|FG004|Overall Study|Lost to Follow-up|1|||
125884181|NCT02839200|452873194|FG005|Overall Study|Lost to Follow-up|0|||
125884182|NCT02839200|452873189|FG000|Overall Study|Adverse Event|0|||
125884183|NCT02839200|452873190|FG001|Overall Study|Adverse Event|0|||
125884184|NCT02839200|452873191|FG002|Overall Study|Adverse Event|0|||
125884185|NCT02839200|452873192|FG003|Overall Study|Adverse Event|0|||
125884186|NCT02839200|452873193|FG004|Overall Study|Adverse Event|1|||
125884187|NCT02839200|452873194|FG005|Overall Study|Adverse Event|0|||
126302681|NCT00026494|454398436|FG000|Overall Study|Clinical progression|0|||
126302682|NCT00026494|454398437|FG001|Overall Study|Clinical progression|0|||
126302683|NCT00026494|454398438|FG002|Overall Study|Clinical progression|3|||
126302684|NCT00026494|454398439|FG003|Overall Study|Clinical progression|0|||
126302685|NCT01684423|454398440|FG000|Overall Study|Withdrawal by Subject|0|||
126302686|NCT01684423|454398441|FG001|Overall Study|Withdrawal by Subject|0|||
126302687|NCT01684423|454398442|FG002|Overall Study|Withdrawal by Subject|1|||
126302688|NCT01684423|454398443|FG003|Overall Study|Withdrawal by Subject|0|||
126302689|NCT01684423|454398444|FG004|Overall Study|Withdrawal by Subject|0|||
126302690|NCT01455597|454398445|FG000|Overall Study|Adverse Event|7|||
126302691|NCT01455597|454398446|FG001|Overall Study|Adverse Event|0|||
126302692|NCT01455597|454398447|FG002|Overall Study|Adverse Event|5|||
126302693|NCT01455597|454398448|FG003|Overall Study|Adverse Event|1|||
126302694|NCT01455597|454398445|FG000|Overall Study|Lack of Efficacy|0|||
126302695|NCT01455597|454398446|FG001|Overall Study|Lack of Efficacy|1|||
126302696|NCT01455597|454398447|FG002|Overall Study|Lack of Efficacy|2|||
126302697|NCT01455597|454398448|FG003|Overall Study|Lack of Efficacy|0|||
126302698|NCT01455597|454398445|FG000|Overall Study|Lost to Follow-up|3|||
126302699|NCT01455597|454398446|FG001|Overall Study|Lost to Follow-up|0|||
126302700|NCT01455597|454398447|FG002|Overall Study|Lost to Follow-up|2|||
126302701|NCT01455597|454398448|FG003|Overall Study|Lost to Follow-up|1|||
126302702|NCT01455597|454398445|FG000|Overall Study|Withdrew Consent|6|||
126302703|NCT01455597|454398446|FG001|Overall Study|Withdrew Consent|5|||
126302704|NCT01455597|454398447|FG002|Overall Study|Withdrew Consent|8|||
126302705|NCT01455597|454398448|FG003|Overall Study|Withdrew Consent|5|||
126302706|NCT01455597|454398445|FG000|Overall Study|Reason not Specified|1|||
126302707|NCT01455597|454398446|FG001|Overall Study|Reason not Specified|2|||
126302708|NCT01455597|454398447|FG002|Overall Study|Reason not Specified|3|||
126302709|NCT01455597|454398448|FG003|Overall Study|Reason not Specified|3|||
126302710|NCT03412734|454398451|FG000|Overall Study|Incorrect labeling of samples|2|||
126302711|NCT03412734|454398452|FG001|Overall Study|Incorrect labeling of samples|0|||
126302712|NCT03412734|454398451|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
126302713|NCT03412734|454398452|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
126302714|NCT00423332|454398453|FG000|Overall Study|Adverse Event|6|||
126302715|NCT00423332|454398454|FG001|Overall Study|Adverse Event|2|||
126302716|NCT00423332|454398453|FG000|Overall Study|Withdrawal by Subject|1|||
126302717|NCT00423332|454398454|FG001|Overall Study|Withdrawal by Subject|0|||
126302718|NCT00423332|454398453|FG000|Overall Study|Condition under investigation worsened|1|||
126302719|NCT00423332|454398454|FG001|Overall Study|Condition under investigation worsened|1|||
126302720|NCT00423332|454398453|FG000|Overall Study|Progressive at Week 6|0|||
126302721|NCT00423332|454398454|FG001|Overall Study|Progressive at Week 6|1|||
126302722|NCT00423332|454398453|FG000|Overall Study|Unblinded before 12 weeks|1|||
126302723|NCT00423332|454398454|FG001|Overall Study|Unblinded before 12 weeks|3|||
126302724|NCT04747886|454398455|FG000|Overall Study|Withdrawal by Subject|1|||
126302725|NCT04747886|454398456|FG001|Overall Study|Withdrawal by Subject|4|||
126302726|NCT01136356|454398459|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
126302727|NCT01136356|454398460|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
126302728|NCT01136356|454398459|FG000|First 18-day Withdrawal|Physician Decision|1|||
126302729|NCT01136356|454398460|FG001|First 18-day Withdrawal|Physician Decision|0|||
126302730|NCT01136356|454398459|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
126302731|NCT01136356|454398460|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
126302732|NCT00402688|454398461|FG000|Overall Study|Adverse Event|12|||
126302733|NCT00402688|454398462|FG001|Overall Study|Adverse Event|9|||
126302734|NCT00402688|454398463|FG002|Overall Study|Adverse Event|3|||
126302735|NCT00402688|454398461|FG000|Overall Study|Withdrawal by Subject|3|||
126302736|NCT00402688|454398462|FG001|Overall Study|Withdrawal by Subject|1|||
126302737|NCT00402688|454398463|FG002|Overall Study|Withdrawal by Subject|1|||
126302738|NCT00402688|454398461|FG000|Overall Study|Physician Decision|0|||
126302739|NCT00402688|454398462|FG001|Overall Study|Physician Decision|0|||
126302740|NCT00402688|454398463|FG002|Overall Study|Physician Decision|1|||
126302741|NCT00402688|454398461|FG000|Overall Study|Lack of Efficacy|4|||
126302742|NCT00402688|454398462|FG001|Overall Study|Lack of Efficacy|4|||
126302743|NCT00402688|454398463|FG002|Overall Study|Lack of Efficacy|5|||
126302744|NCT00402688|454398461|FG000|Overall Study|Protocol Violation|1|||
126302745|NCT00402688|454398462|FG001|Overall Study|Protocol Violation|1|||
126302746|NCT00402688|454398463|FG002|Overall Study|Protocol Violation|1|||
126302747|NCT00402688|454398461|FG000|Overall Study|Lost to Follow-up|1|||
126302748|NCT00402688|454398462|FG001|Overall Study|Lost to Follow-up|0|||
126302749|NCT00402688|454398463|FG002|Overall Study|Lost to Follow-up|2|||
126302750|NCT00402688|454398461|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
126302751|NCT00402688|454398462|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
126367690|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
126302752|NCT00402688|454398463|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
126302753|NCT00402688|454398461|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
126302754|NCT00402688|454398462|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
126302755|NCT00402688|454398463|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
126302756|NCT00402688|454398461|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
126302757|NCT00402688|454398462|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
126302758|NCT00402688|454398463|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
126302759|NCT00927862|454398464|FG000|Overall Study|Missing data needed for endpt analyses|27|||
126302760|NCT00927862|454398465|FG001|Overall Study|Missing data needed for endpt analyses|45|||
126302761|NCT00820248|454398467|FG000|Overall Study|No treated|4|||
126302762|NCT00820248|454398468|FG001|Overall Study|No treated|1|||
126302763|NCT03259425|454398469|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
126302764|NCT04112043|454398470|FG000|Overall Study|Withdrawal by Subject|1|||
126302765|NCT04112043|454398471|FG001|Overall Study|Withdrawal by Subject|1|||
126302766|NCT04112043|454398472|FG002|Overall Study|Withdrawal by Subject|1|||
126302767|NCT04112043|454398470|FG000|Overall Study|Taking NR supplement|1|||
126302768|NCT04112043|454398471|FG001|Overall Study|Taking NR supplement|0|||
126302769|NCT04112043|454398472|FG002|Overall Study|Taking NR supplement|0|||
126302770|NCT04112043|454398470|FG000|Overall Study|Adverse Event|0|||
126302771|NCT04112043|454398471|FG001|Overall Study|Adverse Event|1|||
126302772|NCT04112043|454398472|FG002|Overall Study|Adverse Event|0|||
126044514|NCT03372057|453461082|FG002|Expansion Phase|Withdrawal by Subject|4|||
126044515|NCT03372057|453461080|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
126044516|NCT03372057|453461081|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
126044517|NCT03372057|453461082|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
126302773|NCT04157296|454398473|FG000|Overall Study|Withdrawal by Subject|0|||
126302774|NCT04157296|454398474|FG001|Overall Study|Withdrawal by Subject|1|||
126302775|NCT04157296|454398473|FG000|Overall Study|Did not obtain second fMRI.|0|||
126302776|NCT04157296|454398474|FG001|Overall Study|Did not obtain second fMRI.|1|||
126302777|NCT04157296|454398473|FG000|Overall Study|MRI failed/no second fMRI|0|||
126302778|NCT04157296|454398474|FG001|Overall Study|MRI failed/no second fMRI|1|||
126302779|NCT02237196|454398475|FG000|Overall Study|Adverse Event|0|||
126302780|NCT02237196|454398476|FG001|Overall Study|Adverse Event|1|||
126302781|NCT02237196|454398477|FG002|Overall Study|Adverse Event|1|||
126302782|NCT02237196|454398478|FG003|Overall Study|Adverse Event|0|||
126302783|NCT02237196|454398475|FG000|Overall Study|Lost to Follow-up|4|||
126302784|NCT02237196|454398476|FG001|Overall Study|Lost to Follow-up|2|||
126302785|NCT02237196|454398477|FG002|Overall Study|Lost to Follow-up|4|||
126302786|NCT02237196|454398478|FG003|Overall Study|Lost to Follow-up|6|||
126302787|NCT02237196|454398475|FG000|Overall Study|Physician Decision|2|||
126302788|NCT02237196|454398476|FG001|Overall Study|Physician Decision|0|||
126302789|NCT02237196|454398477|FG002|Overall Study|Physician Decision|0|||
126302790|NCT02237196|454398478|FG003|Overall Study|Physician Decision|1|||
126302791|NCT02237196|454398475|FG000|Overall Study|Pregnancy|0|||
126302792|NCT02237196|454398476|FG001|Overall Study|Pregnancy|0|||
126044518|NCT03372057|453461080|FG000|Expansion Phase|Death|0|||
126044519|NCT03372057|453461081|FG001|Expansion Phase|Death|0|||
126044520|NCT03372057|453461082|FG002|Expansion Phase|Death|78|||
126044521|NCT03372057|453461080|FG000|Expansion Phase|Progressive Disease|0|||
126044522|NCT03372057|453461081|FG001|Expansion Phase|Progressive Disease|0|||
126044523|NCT03372057|453461082|FG002|Expansion Phase|Progressive Disease|1|||
126044524|NCT03372057|453461080|FG000|Expansion Phase|Adverse Event|0|||
126044525|NCT03372057|453461081|FG001|Expansion Phase|Adverse Event|0|||
126044526|NCT03372057|453461082|FG002|Expansion Phase|Adverse Event|1|||
126044527|NCT05953740|453461083|FG000|Period 1|Physician Decision|0|||
126044528|NCT05953740|453461084|FG001|Period 1|Physician Decision|1|||
126044529|NCT05953740|453461085|FG002|Period 1|Physician Decision|0|||
126044530|NCT05953740|453461086|FG003|Period 1|Physician Decision|0|||
126044531|NCT05953740|453461087|FG004|Period 1|Physician Decision|0|||
126044532|NCT05953740|453461088|FG005|Period 1|Physician Decision|0|||
126044533|NCT05953740|453461089|FG006|Period 1|Physician Decision|0|||
126044534|NCT05953740|453461090|FG007|Period 1|Physician Decision|0|||
126044535|NCT05953740|453461083|FG000|Period 2|Withdrawal by Subject|0|||
126044536|NCT05953740|453461084|FG001|Period 2|Withdrawal by Subject|1|||
126044537|NCT05953740|453461085|FG002|Period 2|Withdrawal by Subject|1|||
126044538|NCT05953740|453461086|FG003|Period 2|Withdrawal by Subject|0|||
126044539|NCT05953740|453461087|FG004|Period 2|Withdrawal by Subject|0|||
126044540|NCT05953740|453461088|FG005|Period 2|Withdrawal by Subject|0|||
126044541|NCT05953740|453461089|FG006|Period 2|Withdrawal by Subject|0|||
126044542|NCT05953740|453461090|FG007|Period 2|Withdrawal by Subject|0|||
126044543|NCT03880955|453461091|FG000|Overall Study|Adverse Event|1|||
126044544|NCT03880955|453461091|FG000|Overall Study|Death|1|||
126044545|NCT03880955|453461091|FG000|Overall Study|Lost to Follow-up|12|||
126044546|NCT03880955|453461091|FG000|Overall Study|Withdrawal by Subject|4|||
126044547|NCT03880955|453461091|FG000|Overall Study|Missing- Study Site Closed|27|||
126044548|NCT05541484|453461112|FG000|Overall Study|Withdrawal by Subject|1|||
126044549|NCT05541484|453461113|FG001|Overall Study|Withdrawal by Subject|0|||
126302793|NCT02237196|454398477|FG002|Overall Study|Pregnancy|1|||
126302794|NCT02237196|454398478|FG003|Overall Study|Pregnancy|1|||
126302795|NCT02237196|454398475|FG000|Overall Study|Withdrawal by Subject|1|||
126302796|NCT02237196|454398476|FG001|Overall Study|Withdrawal by Subject|1|||
126302797|NCT02237196|454398477|FG002|Overall Study|Withdrawal by Subject|4|||
126302798|NCT02237196|454398478|FG003|Overall Study|Withdrawal by Subject|1|||
126302799|NCT02237196|454398475|FG000|Overall Study|Site Error|1|||
126302800|NCT02237196|454398476|FG001|Overall Study|Site Error|2|||
126302801|NCT02237196|454398477|FG002|Overall Study|Site Error|0|||
126302802|NCT02237196|454398478|FG003|Overall Study|Site Error|2|||
126302803|NCT01750697|454398481|FG000|Overall Study|Transferred Back to Local Hospital|1|||
126302804|NCT01750697|454398481|FG000|Overall Study|Physician and Family Decision|1|||
126302805|NCT01750697|454398481|FG000|Overall Study|Transferred to Adult Services|5|||
126302806|NCT01750697|454398481|FG000|Overall Study|Physician Decision|1|||
126302807|NCT01750697|454398481|FG000|Overall Study|Withdrawal by Subject|1|||
126302808|NCT00862823|454398491|FG000|First Intervention|Withdrawal by Subject|1|||
126302809|NCT00862823|454398492|FG001|First Intervention|Withdrawal by Subject|1|||
126302810|NCT03674112|454398493|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
126302811|NCT03674112|454398494|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
126302812|NCT03674112|454398493|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
126302813|NCT03674112|454398494|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
126302814|NCT03674112|454398493|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
126302815|NCT03674112|454398494|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
126302816|NCT03674112|454398493|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
126302817|NCT03674112|454398494|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
126302818|NCT03674112|454398493|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
126302819|NCT03674112|454398494|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
126302820|NCT03674112|454398493|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
126302821|NCT03674112|454398494|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
126302822|NCT03674112|454398493|FG000|Follow-Up Period (≥3 Years)|Death|2|||
126302823|NCT03674112|454398494|FG001|Follow-Up Period (≥3 Years)|Death|0|||
126302824|NCT03674112|454398493|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
126302825|NCT03674112|454398494|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
126302826|NCT01421225|454398499|FG000|Overall Study|Withdrawal by Subject|0|||
126302827|NCT01421225|454398500|FG001|Overall Study|Withdrawal by Subject|1|||
126302828|NCT02049814|454398502|FG000|Overall Study|Reason not Specified|4|||
126302829|NCT02049814|454398503|FG001|Overall Study|Reason not Specified|3|||
126302830|NCT02049814|454398502|FG000|Overall Study|Pregnancy|1|||
126302831|NCT02049814|454398503|FG001|Overall Study|Pregnancy|0|||
126302832|NCT02049814|454398502|FG000|Overall Study|Lost to Follow-up|2|||
126302833|NCT02049814|454398503|FG001|Overall Study|Lost to Follow-up|3|||
126302834|NCT02049814|454398502|FG000|Overall Study|Serious Protocol Violation|5|||
126302835|NCT02049814|454398503|FG001|Overall Study|Serious Protocol Violation|7|||
126302836|NCT02049814|454398502|FG000|Overall Study|Study Termination|0|||
126302837|NCT02049814|454398503|FG001|Overall Study|Study Termination|1|||
126302838|NCT02049814|454398502|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
126302839|NCT02049814|454398503|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
126302840|NCT02049814|454398502|FG000|Overall Study|Voluntary withdrawal|9|||
126302841|NCT02049814|454398503|FG001|Overall Study|Voluntary withdrawal|8|||
126302842|NCT01282372|454398504|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
126302843|NCT01282372|454398504|FG000|Overall Study|Lost to Follow-up|23|||
126302844|NCT01282372|454398504|FG000|Overall Study|Withdrawal by Subject|11|||
126302845|NCT01282372|454398504|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
126302846|NCT01282372|454398504|FG000|Overall Study|Death|1|||
126302847|NCT01282372|454398504|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
126302848|NCT01282372|454398504|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
126302849|NCT01282372|454398504|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
126302850|NCT01282372|454398504|FG000|Overall Study|Adverse Event|12|||
126302851|NCT01322490|454398506|FG000|Treatment Period|Adverse Event|12|||
126302852|NCT01322490|454398507|FG001|Treatment Period|Adverse Event|18|||
126302853|NCT01322490|454398508|FG002|Treatment Period|Adverse Event|15|||
126302854|NCT01322490|454398506|FG000|Treatment Period|Death|5|||
126302855|NCT01322490|454398507|FG001|Treatment Period|Death|7|||
126302856|NCT01322490|454398508|FG002|Treatment Period|Death|3|||
126302857|NCT01322490|454398506|FG000|Treatment Period|Lack of Efficacy|89|||
126302858|NCT01322490|454398507|FG001|Treatment Period|Lack of Efficacy|100|||
126302859|NCT01322490|454398508|FG002|Treatment Period|Lack of Efficacy|112|||
126302860|NCT01322490|454398506|FG000|Treatment Period|Physician Decision|0|||
126302861|NCT01322490|454398507|FG001|Treatment Period|Physician Decision|2|||
126302862|NCT01322490|454398508|FG002|Treatment Period|Physician Decision|1|||
126302863|NCT01322490|454398506|FG000|Treatment Period|Protocol Violation|7|||
126302864|NCT01322490|454398507|FG001|Treatment Period|Protocol Violation|5|||
126302865|NCT01322490|454398508|FG002|Treatment Period|Protocol Violation|4|||
126302866|NCT01322490|454398506|FG000|Treatment Period|Withdrawal by Subject|14|||
126302867|NCT01322490|454398507|FG001|Treatment Period|Withdrawal by Subject|16|||
126302868|NCT01322490|454398508|FG002|Treatment Period|Withdrawal by Subject|11|||
126302869|NCT01322490|454398506|FG000|Treatment Period|Non-compliance with study drug|0|||
126302870|NCT01322490|454398507|FG001|Treatment Period|Non-compliance with study drug|0|||
125884188|NCT02839200|452873189|FG000|Overall Study|Randomized in error|0|||
125884189|NCT02839200|452873190|FG001|Overall Study|Randomized in error|1|||
125884190|NCT02839200|452873191|FG002|Overall Study|Randomized in error|0|||
125884191|NCT02839200|452873192|FG003|Overall Study|Randomized in error|0|||
125884192|NCT02839200|452873193|FG004|Overall Study|Randomized in error|0|||
125884193|NCT02839200|452873194|FG005|Overall Study|Randomized in error|0|||
125884194|NCT01094119|452873197|FG000|Overall Study|Lack of Efficacy|2|||
125884195|NCT01094119|452873198|FG001|Overall Study|Lack of Efficacy|4|||
125884196|NCT02205736|452873201|FG000|Overall Study|Lost to Follow-up|106|||
125884197|NCT03326713|452873202|FG000|Overall Study|Death|2|||
125884198|NCT03326713|452873203|FG001|Overall Study|Death|1|||
125884199|NCT03326713|452873204|FG002|Overall Study|Death|0|||
126367691|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
126367692|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
126367693|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
126367694|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
126367695|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
126367696|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
126367697|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
126367698|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
126367699|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
126367700|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
126367701|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
126367702|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
126367703|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
126367704|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
126367705|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
126367706|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
125884200|NCT03326713|452873202|FG000|Overall Study|Lost to Follow-up|20|||
125884201|NCT03326713|452873203|FG001|Overall Study|Lost to Follow-up|21|||
125884202|NCT03326713|452873204|FG002|Overall Study|Lost to Follow-up|33|||
125884203|NCT03326713|452873202|FG000|Overall Study|Withdrawal by Subject|1|||
125884204|NCT03326713|452873203|FG001|Overall Study|Withdrawal by Subject|2|||
126367707|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
126367708|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
125884205|NCT03326713|452873204|FG002|Overall Study|Withdrawal by Subject|11|||
125884206|NCT03326713|452873202|FG000|Overall Study|Found Ineligible|11|||
125884207|NCT03326713|452873203|FG001|Overall Study|Found Ineligible|11|||
125884208|NCT03326713|452873204|FG002|Overall Study|Found Ineligible|8|||
126367709|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
126367710|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
126367711|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
126367712|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
125884209|NCT06078124|452873210|FG000|Overall Study|Lost to Follow-up|14|||
125884210|NCT06078124|452873211|FG001|Overall Study|Lost to Follow-up|14|||
125884211|NCT01198977|452873212|FG000|Overall Study|Lost to Follow-up|1|||
125884212|NCT01198977|452873213|FG001|Overall Study|Lost to Follow-up|0|||
125884213|NCT01285557|452873214|FG000|Overall Study|Death|173|||
125884214|NCT01285557|452873215|FG001|Overall Study|Death|90|||
125884215|NCT01285557|452873214|FG000|Overall Study|Lost to Follow-up|6|||
125884216|NCT01285557|452873215|FG001|Overall Study|Lost to Follow-up|2|||
125884217|NCT01285557|452873214|FG000|Overall Study|Withdrew Consent|6|||
125884218|NCT01285557|452873215|FG001|Overall Study|Withdrew Consent|1|||
125884219|NCT01285557|452873214|FG000|Overall Study|Sponsor Study Termination|23|||
125884220|NCT01285557|452873215|FG001|Overall Study|Sponsor Study Termination|13|||
125884221|NCT01285557|452873214|FG000|Overall Study|Randomized but not treated|1|||
125884222|NCT01285557|452873215|FG001|Overall Study|Randomized but not treated|1|||
125884223|NCT01285557|452873214|FG000|Overall Study|Study follow-up ongoing|28|||
125884224|NCT01285557|452873215|FG001|Overall Study|Study follow-up ongoing|14|||
125884225|NCT01285557|452873214|FG000|Overall Study|Sponsor Decision|2|||
125884226|NCT01285557|452873215|FG001|Overall Study|Sponsor Decision|1|||
125884227|NCT05615922|452873217|FG000|Overall Study|Lost to Follow-up|1|||
125884228|NCT03173248|452873221|FG000|Overall Study|Death|28|||
126367713|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
126367714|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
125884229|NCT03173248|452873222|FG001|Overall Study|Death|46|||
125884230|NCT03173248|452873221|FG000|Overall Study|Lost to Follow-up|0|||
125884231|NCT03173248|452873222|FG001|Overall Study|Lost to Follow-up|1|||
125884232|NCT03173248|452873221|FG000|Overall Study|Withdrawal by Subject|6|||
125884233|NCT03173248|452873222|FG001|Overall Study|Withdrawal by Subject|4|||
125884234|NCT03173248|452873221|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
125884235|NCT03173248|452873222|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
125884236|NCT01648751|452873225|FG000|Overall Study|Withdrawal by Subject|2|||
125884237|NCT01648751|452873226|FG001|Overall Study|Withdrawal by Subject|3|||
125884238|NCT02991768|452873230|FG000|Overall Study|Physician Decision|4|||
125884239|NCT03467750|452873231|FG000|Overall Study|Surgery canceled|1|||
125884240|NCT03467750|452873232|FG001|Overall Study|Surgery canceled|0|||
125884241|NCT03467750|452873231|FG000|Overall Study|Protocol Violation|1|||
125884242|NCT03467750|452873232|FG001|Overall Study|Protocol Violation|1|||
125884243|NCT03467750|452873231|FG000|Overall Study|Withdrawal by Subject|0|||
125884244|NCT03467750|452873232|FG001|Overall Study|Withdrawal by Subject|1|||
125884245|NCT05673876|452873233|FG000|Overall Study|Death|3|||
125884246|NCT05673876|452873234|FG001|Overall Study|Death|1|||
125884247|NCT05673876|452873233|FG000|Overall Study|Study Terminated by Sponsor|0|||
125884248|NCT05673876|452873234|FG001|Overall Study|Study Terminated by Sponsor|1|||
125884249|NCT05673876|452873233|FG000|Overall Study|Physician Decision|0|||
125884250|NCT05673876|452873234|FG001|Overall Study|Physician Decision|1|||
125884251|NCT04500158|452873237|FG000|Overall Study|Physician Decision|17|||
125884252|NCT04500158|452873238|FG001|Overall Study|Physician Decision|11|||
125884253|NCT02749422|452873241|FG000|Overall Study|Lost to Follow-up|0|||
125884254|NCT02749422|452873242|FG001|Overall Study|Lost to Follow-up|2|||
125884255|NCT02749422|452873241|FG000|Overall Study|Ineligible|0|||
125884256|NCT02749422|452873242|FG001|Overall Study|Ineligible|1|||
125884257|NCT02807402|452873247|FG000|Overall Study|Failure to Return|1|||
125884258|NCT02807402|452873247|FG000|Overall Study|Death|3|||
125884259|NCT02807402|452873247|FG000|Overall Study|Other|2|||
125884260|NCT04922216|452873248|FG000|Overall Study|Withdrawal by Subject|0|||
125884261|NCT04922216|452873249|FG001|Overall Study|Withdrawal by Subject|1|||
125884262|NCT04922216|452873250|FG002|Overall Study|Withdrawal by Subject|0|||
125884263|NCT04922216|452873251|FG003|Overall Study|Withdrawal by Subject|0|||
125884264|NCT04922216|452873252|FG004|Overall Study|Withdrawal by Subject|0|||
125884265|NCT04922216|452873253|FG005|Overall Study|Withdrawal by Subject|0|||
125884266|NCT04922216|452873254|FG006|Overall Study|Withdrawal by Subject|0|||
126302871|NCT01322490|454398508|FG002|Treatment Period|Non-compliance with study drug|1|||
126302872|NCT01322490|454398506|FG000|Treatment Period|Other per report|2|||
126302873|NCT01322490|454398507|FG001|Treatment Period|Other per report|2|||
126302874|NCT01322490|454398508|FG002|Treatment Period|Other per report|1|||
126302875|NCT01322490|454398506|FG000|Treatment Period|Randomized but Not Treated|3|||
126302876|NCT01322490|454398507|FG001|Treatment Period|Randomized but Not Treated|3|||
125884267|NCT04922216|452873255|FG007|Overall Study|Withdrawal by Subject|2|||
125884268|NCT04922216|452873256|FG008|Overall Study|Withdrawal by Subject|0|||
125884269|NCT04922216|452873257|FG009|Overall Study|Withdrawal by Subject|0|||
125884270|NCT04922216|452873258|FG010|Overall Study|Withdrawal by Subject|0|||
125884271|NCT04922216|452873259|FG011|Overall Study|Withdrawal by Subject|0|||
125884272|NCT04922216|452873260|FG012|Overall Study|Withdrawal by Subject|1|||
126302877|NCT01322490|454398508|FG002|Treatment Period|Randomized but Not Treated|5|||
125884273|NCT04922216|452873261|FG013|Overall Study|Withdrawal by Subject|1|||
125884274|NCT04922216|452873262|FG014|Overall Study|Withdrawal by Subject|1|||
125884275|NCT04922216|452873263|FG015|Overall Study|Withdrawal by Subject|0|||
125884276|NCT04922216|452873264|FG016|Overall Study|Withdrawal by Subject|0|||
125884277|NCT04922216|452873265|FG017|Overall Study|Withdrawal by Subject|1|||
125884278|NCT04922216|452873266|FG018|Overall Study|Withdrawal by Subject|1|||
125884279|NCT04922216|452873267|FG019|Overall Study|Withdrawal by Subject|1|||
125884280|NCT04922216|452873268|FG020|Overall Study|Withdrawal by Subject|1|||
125884281|NCT04922216|452873269|FG021|Overall Study|Withdrawal by Subject|0|||
125884282|NCT04922216|452873270|FG022|Overall Study|Withdrawal by Subject|0|||
125884283|NCT04922216|452873271|FG023|Overall Study|Withdrawal by Subject|2|||
125884284|NCT04922216|452873272|FG024|Overall Study|Withdrawal by Subject|0|||
125884285|NCT04922216|452873273|FG025|Overall Study|Withdrawal by Subject|0|||
125884286|NCT04922216|452873274|FG026|Overall Study|Withdrawal by Subject|1|||
125884287|NCT04922216|452873275|FG027|Overall Study|Withdrawal by Subject|0|||
125884288|NCT04922216|452873276|FG028|Overall Study|Withdrawal by Subject|0|||
125884289|NCT04922216|452873277|FG029|Overall Study|Withdrawal by Subject|0|||
125884290|NCT04922216|452873278|FG030|Overall Study|Withdrawal by Subject|1|||
125884291|NCT04922216|452873279|FG031|Overall Study|Withdrawal by Subject|0|||
125884292|NCT04922216|452873248|FG000|Overall Study|Lost to Follow-up|1|||
125884293|NCT04922216|452873249|FG001|Overall Study|Lost to Follow-up|0|||
125884294|NCT04922216|452873250|FG002|Overall Study|Lost to Follow-up|2|||
125884295|NCT04922216|452873251|FG003|Overall Study|Lost to Follow-up|0|||
125884296|NCT04922216|452873252|FG004|Overall Study|Lost to Follow-up|0|||
125884297|NCT04922216|452873253|FG005|Overall Study|Lost to Follow-up|2|||
125884298|NCT04922216|452873254|FG006|Overall Study|Lost to Follow-up|0|||
125884299|NCT04922216|452873255|FG007|Overall Study|Lost to Follow-up|1|||
125884300|NCT04922216|452873256|FG008|Overall Study|Lost to Follow-up|1|||
125884301|NCT04922216|452873257|FG009|Overall Study|Lost to Follow-up|2|||
125884302|NCT04922216|452873258|FG010|Overall Study|Lost to Follow-up|2|||
125884303|NCT04922216|452873259|FG011|Overall Study|Lost to Follow-up|1|||
125884304|NCT04922216|452873260|FG012|Overall Study|Lost to Follow-up|1|||
125884305|NCT04922216|452873261|FG013|Overall Study|Lost to Follow-up|0|||
125884306|NCT04922216|452873262|FG014|Overall Study|Lost to Follow-up|1|||
125884307|NCT04922216|452873263|FG015|Overall Study|Lost to Follow-up|0|||
125884308|NCT04922216|452873264|FG016|Overall Study|Lost to Follow-up|0|||
125884309|NCT04922216|452873265|FG017|Overall Study|Lost to Follow-up|2|||
125884310|NCT04922216|452873266|FG018|Overall Study|Lost to Follow-up|1|||
125884311|NCT04922216|452873267|FG019|Overall Study|Lost to Follow-up|0|||
125884312|NCT04922216|452873268|FG020|Overall Study|Lost to Follow-up|1|||
125884313|NCT04922216|452873269|FG021|Overall Study|Lost to Follow-up|0|||
126367715|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
126367716|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
126367717|NCT00049543|454640997|FG000|Overall Study|still on treatment|2|||
126367718|NCT00049543|454640998|FG001|Overall Study|still on treatment|9|||
126367719|NCT02106832|454640999|FG000|Overall Study|Adverse Event|1|||
126367720|NCT02106832|454641000|FG001|Overall Study|Adverse Event|2|||
126367721|NCT02106832|454641001|FG002|Overall Study|Adverse Event|3|||
126367722|NCT02106832|454641002|FG003|Overall Study|Adverse Event|0|||
126367723|NCT02106832|454640999|FG000|Overall Study|Death|4|||
126367724|NCT02106832|454641000|FG001|Overall Study|Death|4|||
126367725|NCT02106832|454641001|FG002|Overall Study|Death|1|||
126367726|NCT02106832|454641002|FG003|Overall Study|Death|4|||
126367727|NCT02106832|454640999|FG000|Overall Study|Deterioration of general conditions|0|||
125884314|NCT04922216|452873270|FG022|Overall Study|Lost to Follow-up|2|||
125884315|NCT04922216|452873271|FG023|Overall Study|Lost to Follow-up|1|||
125884316|NCT04922216|452873272|FG024|Overall Study|Lost to Follow-up|0|||
125884317|NCT04922216|452873273|FG025|Overall Study|Lost to Follow-up|2|||
125884318|NCT04922216|452873274|FG026|Overall Study|Lost to Follow-up|0|||
126367728|NCT02106832|454641000|FG001|Overall Study|Deterioration of general conditions|0|||
126367729|NCT02106832|454641001|FG002|Overall Study|Deterioration of general conditions|1|||
125884319|NCT04922216|452873275|FG027|Overall Study|Lost to Follow-up|0|||
126044550|NCT01438853|453461118|FG000|Overall Study|Death|0|||
126044551|NCT01438853|453461119|FG001|Overall Study|Death|0|||
126044552|NCT01438853|453461120|FG002|Overall Study|Death|0|||
126302878|NCT01322490|454398506|FG000|Long Term Follow-up Period|Death|235|||
126302879|NCT01322490|454398507|FG001|Long Term Follow-up Period|Death|239|||
126302880|NCT01322490|454398508|FG002|Long Term Follow-up Period|Death|236|||
126302881|NCT01322490|454398506|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
126302882|NCT01322490|454398507|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
126302883|NCT01322490|454398508|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
126302884|NCT01322490|454398506|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
126302885|NCT01322490|454398507|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
126302886|NCT01322490|454398508|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
126302887|NCT01322490|454398506|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
126302888|NCT01322490|454398507|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
126302889|NCT01322490|454398508|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
126302890|NCT01322490|454398506|FG000|Long Term Follow-up Period|Other per report|3|||
126302891|NCT01322490|454398507|FG001|Long Term Follow-up Period|Other per report|2|||
126302892|NCT01322490|454398508|FG002|Long Term Follow-up Period|Other per report|2|||
126302893|NCT01322490|454398506|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
126302894|NCT01322490|454398507|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
126302895|NCT01322490|454398508|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
126302896|NCT00356148|454398509|FG000|Overall Study|Reoperation within 30 days|2|||
126302897|NCT00356148|454398510|FG001|Overall Study|Reoperation within 30 days|1|||
126302898|NCT02693002|454398511|FG000|Overall Study|Withdrawal by Subject|1|||
126302899|NCT02693002|454398512|FG001|Overall Study|Withdrawal by Subject|0|||
126302900|NCT00014495|454398513|FG000|Overall Study|Death|0|||
126302901|NCT00014495|454398514|FG001|Overall Study|Death|0|||
126302902|NCT00014495|454398515|FG002|Overall Study|Death|1|||
126302903|NCT00014495|454398516|FG003|Overall Study|Death|0|||
126302904|NCT00014495|454398513|FG000|Overall Study|Clinical deterioration|0|||
126302905|NCT00014495|454398514|FG001|Overall Study|Clinical deterioration|0|||
126302906|NCT00014495|454398515|FG002|Overall Study|Clinical deterioration|0|||
126302907|NCT00014495|454398516|FG003|Overall Study|Clinical deterioration|1|||
126302908|NCT03225105|454398550|FG000|Overall Study|Withdrawal by Subject|1|||
126302909|NCT03225105|454398551|FG001|Overall Study|Withdrawal by Subject|0|||
126302910|NCT03225105|454398552|FG002|Overall Study|Withdrawal by Subject|0|||
126302911|NCT03225105|454398553|FG003|Overall Study|Withdrawal by Subject|0|||
126302912|NCT03225105|454398550|FG000|Overall Study|Death|0|||
126302913|NCT03225105|454398551|FG001|Overall Study|Death|4|||
126367730|NCT02106832|454641002|FG003|Overall Study|Deterioration of general conditions|0|||
126367731|NCT02106832|454640999|FG000|Overall Study|Lost to Follow-up|0|||
126367732|NCT02106832|454641000|FG001|Overall Study|Lost to Follow-up|1|||
126367733|NCT02106832|454641001|FG002|Overall Study|Lost to Follow-up|1|||
126367734|NCT02106832|454641002|FG003|Overall Study|Lost to Follow-up|3|||
126367735|NCT02106832|454640999|FG000|Overall Study|Physician Decision|1|||
126367736|NCT02106832|454641000|FG001|Overall Study|Physician Decision|0|||
126367737|NCT02106832|454641001|FG002|Overall Study|Physician Decision|0|||
126367738|NCT02106832|454641002|FG003|Overall Study|Physician Decision|0|||
126367739|NCT02106832|454640999|FG000|Overall Study|Protocol Violation|0|||
126367740|NCT02106832|454641000|FG001|Overall Study|Protocol Violation|0|||
126367741|NCT02106832|454641001|FG002|Overall Study|Protocol Violation|0|||
126367742|NCT02106832|454641002|FG003|Overall Study|Protocol Violation|1|||
126367743|NCT02106832|454640999|FG000|Overall Study|Withdrawal by Subject|17|||
126367744|NCT02106832|454641000|FG001|Overall Study|Withdrawal by Subject|17|||
126367745|NCT02106832|454641001|FG002|Overall Study|Withdrawal by Subject|10|||
126367746|NCT02106832|454641002|FG003|Overall Study|Withdrawal by Subject|7|||
126367747|NCT02106832|454640999|FG000|Overall Study|Technical problems|0|||
126044553|NCT01438853|453461121|FG003|Overall Study|Death|1|||
126367748|NCT02106832|454641000|FG001|Overall Study|Technical problems|1|||
126367749|NCT02106832|454641001|FG002|Overall Study|Technical problems|0|||
126367750|NCT02106832|454641002|FG003|Overall Study|Technical problems|0|||
126367751|NCT03485157|454641003|FG000|Double Blind Phase|Lost to Follow-up|4|||
126367752|NCT03485157|454641004|FG001|Double Blind Phase|Lost to Follow-up|4|||
126367753|NCT03485157|454641003|FG000|Double Blind Phase|Adverse Event|2|||
126367754|NCT03485157|454641004|FG001|Double Blind Phase|Adverse Event|1|||
126367755|NCT03485157|454641003|FG000|Double Blind Phase|Withdrawal by Subject|6|||
126367756|NCT03485157|454641004|FG001|Double Blind Phase|Withdrawal by Subject|9|||
126367757|NCT03485157|454641003|FG000|Double Blind Phase|Removal by PI|3|||
126367758|NCT03485157|454641004|FG001|Double Blind Phase|Removal by PI|7|||
126367759|NCT03485157|454641003|FG000|Open Label Phase|Lost to Follow-up|1|||
126367760|NCT03485157|454641004|FG001|Open Label Phase|Lost to Follow-up|2|||
126367761|NCT03485157|454641003|FG000|Open Label Phase|Adverse Event|0|||
126367762|NCT03485157|454641004|FG001|Open Label Phase|Adverse Event|1|||
126367763|NCT03485157|454641003|FG000|Open Label Phase|Withdrawal by Subject|1|||
126367764|NCT03485157|454641004|FG001|Open Label Phase|Withdrawal by Subject|2|||
126367765|NCT03485157|454641003|FG000|Open Label Phase|Removal by PI|2|||
126367766|NCT03485157|454641004|FG001|Open Label Phase|Removal by PI|0|||
126367767|NCT00265122|454641005|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
126367768|NCT00265122|454641006|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
126367769|NCT00265122|454641007|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
126367770|NCT00265122|454641008|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
126367771|NCT00265122|454641009|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
126367772|NCT00265122|454641010|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
126367773|NCT00265122|454641005|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
126367774|NCT00265122|454641006|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
126367775|NCT00265122|454641007|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
126367776|NCT00265122|454641008|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
126367777|NCT00265122|454641009|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
126367778|NCT00265122|454641010|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125884320|NCT04922216|452873276|FG028|Overall Study|Lost to Follow-up|1|||
125884321|NCT04922216|452873277|FG029|Overall Study|Lost to Follow-up|0|||
125884322|NCT04922216|452873278|FG030|Overall Study|Lost to Follow-up|2|||
125884323|NCT04922216|452873279|FG031|Overall Study|Lost to Follow-up|1|||
126367779|NCT00265122|454641005|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
126367780|NCT00265122|454641006|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
126367781|NCT00265122|454641007|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
126367782|NCT00265122|454641008|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
126367783|NCT00265122|454641009|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
126367784|NCT00265122|454641010|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
126367785|NCT00265122|454641005|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
126367786|NCT00265122|454641006|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
126367787|NCT00265122|454641007|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
126367788|NCT00265122|454641008|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
126367789|NCT00265122|454641009|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
126367790|NCT00265122|454641010|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
126367791|NCT00265122|454641005|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
126367792|NCT00265122|454641006|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
126367793|NCT00265122|454641007|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
126367794|NCT00265122|454641008|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
126367795|NCT00265122|454641009|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
126367796|NCT00265122|454641010|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
126367797|NCT00265122|454641005|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
126367798|NCT00265122|454641006|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
126367799|NCT00265122|454641007|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
126367800|NCT00265122|454641008|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
126367801|NCT00265122|454641009|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
126367802|NCT00265122|454641010|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
126367803|NCT05205616|454641017|FG000|Overall Study|Lost to Follow-up|4|||
126367804|NCT05205616|454641018|FG001|Overall Study|Lost to Follow-up|4|||
126367805|NCT00663260|454641024|FG000|Overall Study|Lack of Efficacy|2|||
126367806|NCT00663260|454641025|FG001|Overall Study|Lack of Efficacy|0|||
126367807|NCT00663260|454641026|FG002|Overall Study|Lack of Efficacy|0|||
126367808|NCT00663260|454641024|FG000|Overall Study|Adverse Event|12|||
126367809|NCT00663260|454641025|FG001|Overall Study|Adverse Event|7|||
126367810|NCT00663260|454641026|FG002|Overall Study|Adverse Event|6|||
126367811|NCT00663260|454641024|FG000|Overall Study|Withdrawal by Subject|3|||
126367812|NCT00663260|454641025|FG001|Overall Study|Withdrawal by Subject|1|||
126367813|NCT00663260|454641026|FG002|Overall Study|Withdrawal by Subject|6|||
126367814|NCT00663260|454641024|FG000|Overall Study|Death|1|||
126367815|NCT00663260|454641025|FG001|Overall Study|Death|0|||
126302914|NCT03225105|454398552|FG002|Overall Study|Death|2|||
126302915|NCT03225105|454398553|FG003|Overall Study|Death|0|||
126302916|NCT03225105|454398550|FG000|Overall Study|Study termination per Sponsor Decision|2|||
126302917|NCT03225105|454398551|FG001|Overall Study|Study termination per Sponsor Decision|0|||
126302918|NCT03225105|454398552|FG002|Overall Study|Study termination per Sponsor Decision|3|||
126302919|NCT03225105|454398553|FG003|Overall Study|Study termination per Sponsor Decision|3|||
126302920|NCT00757042|454398554|FG000|Overall Study|Lost to Follow-up|0|||
126302921|NCT00757042|454398555|FG001|Overall Study|Lost to Follow-up|0|||
126302922|NCT00757042|454398556|FG002|Overall Study|Lost to Follow-up|0|||
126302923|NCT00757042|454398557|FG003|Overall Study|Lost to Follow-up|0|||
126302924|NCT00757042|454398558|FG004|Overall Study|Lost to Follow-up|0|||
126302925|NCT00757042|454398559|FG005|Overall Study|Lost to Follow-up|0|||
126302926|NCT00757042|454398560|FG006|Overall Study|Lost to Follow-up|0|||
126302927|NCT00757042|454398561|FG007|Overall Study|Lost to Follow-up|0|||
126302928|NCT00757042|454398562|FG008|Overall Study|Lost to Follow-up|1|||
126302929|NCT00757042|454398563|FG009|Overall Study|Lost to Follow-up|0|||
126302930|NCT00757042|454398564|FG010|Overall Study|Lost to Follow-up|0|||
126302931|NCT00757042|454398554|FG000|Overall Study|Ineligibility Determined|0|||
126302932|NCT00757042|454398555|FG001|Overall Study|Ineligibility Determined|0|||
126302933|NCT00757042|454398556|FG002|Overall Study|Ineligibility Determined|0|||
126302934|NCT00757042|454398557|FG003|Overall Study|Ineligibility Determined|0|||
126302935|NCT00757042|454398558|FG004|Overall Study|Ineligibility Determined|0|||
126302936|NCT00757042|454398559|FG005|Overall Study|Ineligibility Determined|0|||
126302937|NCT00757042|454398560|FG006|Overall Study|Ineligibility Determined|0|||
126302938|NCT00757042|454398561|FG007|Overall Study|Ineligibility Determined|0|||
126302939|NCT00757042|454398562|FG008|Overall Study|Ineligibility Determined|0|||
126302940|NCT00757042|454398563|FG009|Overall Study|Ineligibility Determined|0|||
126302941|NCT00757042|454398564|FG010|Overall Study|Ineligibility Determined|1|||
126302942|NCT00757042|454398554|FG000|Overall Study|Withdrawal by Subject|0|||
126302943|NCT00757042|454398555|FG001|Overall Study|Withdrawal by Subject|0|||
126302944|NCT00757042|454398556|FG002|Overall Study|Withdrawal by Subject|0|||
126302945|NCT00757042|454398557|FG003|Overall Study|Withdrawal by Subject|0|||
126302946|NCT00757042|454398558|FG004|Overall Study|Withdrawal by Subject|0|||
126302947|NCT00757042|454398559|FG005|Overall Study|Withdrawal by Subject|0|||
126302948|NCT00757042|454398560|FG006|Overall Study|Withdrawal by Subject|0|||
125884324|NCT04721977|452873280|FG000|Overall Study|Death|15|||
126302949|NCT00757042|454398561|FG007|Overall Study|Withdrawal by Subject|0|||
126302950|NCT00757042|454398562|FG008|Overall Study|Withdrawal by Subject|0|||
126302951|NCT00757042|454398563|FG009|Overall Study|Withdrawal by Subject|1|||
126044554|NCT01438853|453461118|FG000|Overall Study|Withdrawal by Subject|0|||
126044555|NCT01438853|453461119|FG001|Overall Study|Withdrawal by Subject|0|||
126044556|NCT01438853|453461120|FG002|Overall Study|Withdrawal by Subject|1|||
126044557|NCT01438853|453461121|FG003|Overall Study|Withdrawal by Subject|0|||
126044558|NCT02624050|453461122|FG000|Overall Study|Physician Decision|4|||
126044559|NCT02624050|453461123|FG001|Overall Study|Physician Decision|0|||
126044560|NCT02624050|453461122|FG000|Overall Study|Protocol Violation|2|||
126044561|NCT02624050|453461123|FG001|Overall Study|Protocol Violation|0|||
126044562|NCT05215054|453461124|FG000|Overall Study|Lost to Follow-up|1|||
126044563|NCT05215054|453461125|FG001|Overall Study|Lost to Follow-up|1|||
126044564|NCT05215054|453461124|FG000|Overall Study|Protocol Violation|1|||
126044565|NCT05215054|453461125|FG001|Overall Study|Protocol Violation|1|||
126044566|NCT05215054|453461124|FG000|Overall Study|Withdrawal by Subject|4|||
126044567|NCT05215054|453461125|FG001|Overall Study|Withdrawal by Subject|4|||
126044568|NCT03279978|453461126|FG000|Overall Study|Withdrawal by Subject|0|||
126044569|NCT03279978|453461127|FG001|Overall Study|Withdrawal by Subject|1|||
126044570|NCT03279978|453461128|FG002|Overall Study|Withdrawal by Subject|0|||
126044571|NCT03279978|453461129|FG003|Overall Study|Withdrawal by Subject|0|||
126044572|NCT03279978|453461130|FG004|Overall Study|Withdrawal by Subject|0|||
126044573|NCT03279978|453461131|FG005|Overall Study|Withdrawal by Subject|0|||
126044574|NCT03279978|453461132|FG006|Overall Study|Withdrawal by Subject|0|||
126044575|NCT03279978|453461133|FG007|Overall Study|Withdrawal by Subject|0|||
126044576|NCT03279978|453461134|FG008|Overall Study|Withdrawal by Subject|0|||
126044577|NCT03279978|453461135|FG009|Overall Study|Withdrawal by Subject|1|||
126044578|NCT03279978|453461126|FG000|Overall Study|Lost to Follow-up|1|||
126044579|NCT03279978|453461127|FG001|Overall Study|Lost to Follow-up|0|||
126044580|NCT03279978|453461128|FG002|Overall Study|Lost to Follow-up|1|||
126302952|NCT00757042|454398564|FG010|Overall Study|Withdrawal by Subject|0|||
126302953|NCT03850483|454398568|FG000|Treatment for Stage 1|Adverse Event|1|||
126302954|NCT03850483|454398569|FG001|Treatment for Stage 1|Adverse Event|1|||
126302955|NCT03850483|454398570|FG002|Treatment for Stage 1|Adverse Event|3|||
126302956|NCT03850483|454398571|FG003|Treatment for Stage 1|Adverse Event|0|||
126302957|NCT03850483|454398572|FG004|Treatment for Stage 1|Adverse Event|2|||
126302958|NCT03850483|454398573|FG005|Treatment for Stage 1|Adverse Event|0|||
126302959|NCT03850483|454398574|FG006|Treatment for Stage 1|Adverse Event|2|||
126302960|NCT03850483|454398575|FG007|Treatment for Stage 1|Adverse Event|2|||
126302961|NCT03850483|454398576|FG008|Treatment for Stage 1|Adverse Event|0|||
126302962|NCT03850483|454398577|FG009|Treatment for Stage 1|Adverse Event|0|||
126302963|NCT03850483|454398568|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
126302964|NCT03850483|454398569|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
126302965|NCT03850483|454398570|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
126302966|NCT03850483|454398571|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
126302967|NCT03850483|454398572|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
126302968|NCT03850483|454398573|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
126302969|NCT03850483|454398574|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
126302970|NCT03850483|454398575|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
126302971|NCT03850483|454398576|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
126302972|NCT03850483|454398577|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
126302973|NCT03850483|454398568|FG000|Treatment for Stage 1|Protocol Violation|1|||
126302974|NCT03850483|454398569|FG001|Treatment for Stage 1|Protocol Violation|0|||
126302975|NCT03850483|454398570|FG002|Treatment for Stage 1|Protocol Violation|0|||
126302976|NCT03850483|454398571|FG003|Treatment for Stage 1|Protocol Violation|0|||
126302977|NCT03850483|454398572|FG004|Treatment for Stage 1|Protocol Violation|0|||
126302978|NCT03850483|454398573|FG005|Treatment for Stage 1|Protocol Violation|0|||
126302979|NCT03850483|454398574|FG006|Treatment for Stage 1|Protocol Violation|1|||
126302980|NCT03850483|454398575|FG007|Treatment for Stage 1|Protocol Violation|0|||
126302981|NCT03850483|454398576|FG008|Treatment for Stage 1|Protocol Violation|0|||
126302982|NCT03850483|454398577|FG009|Treatment for Stage 1|Protocol Violation|0|||
126302983|NCT03850483|454398568|FG000|Treatment for Stage 1|Physician Decision|0|||
126302984|NCT03850483|454398569|FG001|Treatment for Stage 1|Physician Decision|0|||
126302985|NCT03850483|454398570|FG002|Treatment for Stage 1|Physician Decision|0|||
126302986|NCT03850483|454398571|FG003|Treatment for Stage 1|Physician Decision|0|||
126302987|NCT03850483|454398572|FG004|Treatment for Stage 1|Physician Decision|0|||
126044581|NCT03279978|453461129|FG003|Overall Study|Lost to Follow-up|0|||
126044582|NCT03279978|453461130|FG004|Overall Study|Lost to Follow-up|0|||
126044583|NCT03279978|453461131|FG005|Overall Study|Lost to Follow-up|0|||
126302988|NCT03850483|454398573|FG005|Treatment for Stage 1|Physician Decision|1|||
126302989|NCT03850483|454398574|FG006|Treatment for Stage 1|Physician Decision|0|||
126302990|NCT03850483|454398575|FG007|Treatment for Stage 1|Physician Decision|0|||
126302991|NCT03850483|454398576|FG008|Treatment for Stage 1|Physician Decision|0|||
126302992|NCT03850483|454398577|FG009|Treatment for Stage 1|Physician Decision|0|||
126302993|NCT03850483|454398568|FG000|Treatment for Stage 1|Other|0|||
126302994|NCT03850483|454398569|FG001|Treatment for Stage 1|Other|0|||
126302995|NCT03850483|454398570|FG002|Treatment for Stage 1|Other|0|||
126302996|NCT03850483|454398571|FG003|Treatment for Stage 1|Other|0|||
126302997|NCT03850483|454398572|FG004|Treatment for Stage 1|Other|2|||
126302998|NCT03850483|454398573|FG005|Treatment for Stage 1|Other|1|||
126302999|NCT03850483|454398574|FG006|Treatment for Stage 1|Other|0|||
126303000|NCT03850483|454398575|FG007|Treatment for Stage 1|Other|0|||
126303001|NCT03850483|454398576|FG008|Treatment for Stage 1|Other|0|||
126303002|NCT03850483|454398577|FG009|Treatment for Stage 1|Other|0|||
126303003|NCT03850483|454398568|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303004|NCT03850483|454398569|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303005|NCT03850483|454398570|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
126303006|NCT03850483|454398571|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303007|NCT03850483|454398572|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303008|NCT03850483|454398573|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303009|NCT03850483|454398574|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303010|NCT03850483|454398575|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303011|NCT03850483|454398576|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303012|NCT03850483|454398577|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303013|NCT03850483|454398568|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303014|NCT03850483|454398569|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303015|NCT03850483|454398570|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303016|NCT03850483|454398571|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303017|NCT03850483|454398572|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303018|NCT03850483|454398573|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
126303019|NCT03850483|454398574|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303020|NCT03850483|454398575|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303021|NCT03850483|454398576|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303022|NCT03850483|454398577|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303023|NCT03850483|454398568|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
126303024|NCT03850483|454398569|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
126303025|NCT03850483|454398570|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
126303026|NCT03850483|454398571|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
126303027|NCT03850483|454398572|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
126303028|NCT03850483|454398573|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
126303029|NCT03850483|454398574|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
126303030|NCT03850483|454398575|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
126303031|NCT03850483|454398576|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
126303032|NCT03850483|454398577|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
126303033|NCT03850483|454398568|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
126303034|NCT03850483|454398569|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
126303035|NCT03850483|454398570|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
126303036|NCT03850483|454398571|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
126303037|NCT03850483|454398572|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
126303038|NCT03850483|454398573|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
126303039|NCT03850483|454398574|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
126303040|NCT03850483|454398575|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
126303041|NCT03850483|454398576|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
126303042|NCT03850483|454398577|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
126303043|NCT03850483|454398568|FG000|Treatment for Stage 1|Death|0|||
126303044|NCT03850483|454398569|FG001|Treatment for Stage 1|Death|0|||
126303045|NCT03850483|454398570|FG002|Treatment for Stage 1|Death|0|||
126303046|NCT03850483|454398571|FG003|Treatment for Stage 1|Death|0|||
126303047|NCT03850483|454398572|FG004|Treatment for Stage 1|Death|0|||
126303048|NCT03850483|454398573|FG005|Treatment for Stage 1|Death|1|||
126303049|NCT03850483|454398574|FG006|Treatment for Stage 1|Death|0|||
126367816|NCT00663260|454641026|FG002|Overall Study|Death|1|||
126367817|NCT00663260|454641024|FG000|Overall Study|Lost to Follow-up|0|||
126367818|NCT00663260|454641025|FG001|Overall Study|Lost to Follow-up|1|||
126367819|NCT00663260|454641026|FG002|Overall Study|Lost to Follow-up|0|||
126367820|NCT00663260|454641024|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
126367821|NCT00663260|454641025|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
126367822|NCT00663260|454641026|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
126367823|NCT02231580|454641033|FG000|Overall Study|Adverse Event|5|||
126367824|NCT02231580|454641034|FG001|Overall Study|Adverse Event|0|||
126367825|NCT03620981|454641035|FG000|Overall Study|Adverse Event|14|||
126367826|NCT03620981|454641036|FG001|Overall Study|Adverse Event|38|||
126367827|NCT03620981|454641037|FG002|Overall Study|Adverse Event|25|||
126367828|NCT03620981|454641035|FG000|Overall Study|Lack of Efficacy|2|||
126367829|NCT03620981|454641036|FG001|Overall Study|Lack of Efficacy|1|||
126367830|NCT03620981|454641037|FG002|Overall Study|Lack of Efficacy|1|||
126367831|NCT03620981|454641035|FG000|Overall Study|Physician Decision|7|||
126367832|NCT03620981|454641036|FG001|Overall Study|Physician Decision|4|||
126367833|NCT03620981|454641037|FG002|Overall Study|Physician Decision|4|||
126367834|NCT03620981|454641035|FG000|Overall Study|Protocol Violation|1|||
126367835|NCT03620981|454641036|FG001|Overall Study|Protocol Violation|2|||
126367836|NCT03620981|454641037|FG002|Overall Study|Protocol Violation|1|||
126367837|NCT03620981|454641035|FG000|Overall Study|Withdrawal by Legal Representative|2|||
126367838|NCT03620981|454641036|FG001|Overall Study|Withdrawal by Legal Representative|1|||
126367839|NCT03620981|454641037|FG002|Overall Study|Withdrawal by Legal Representative|1|||
126367840|NCT03620981|454641035|FG000|Overall Study|Withdrawal by Care Giver|2|||
126044584|NCT03279978|453461132|FG006|Overall Study|Lost to Follow-up|0|||
126044585|NCT03279978|453461133|FG007|Overall Study|Lost to Follow-up|0|||
126044586|NCT03279978|453461134|FG008|Overall Study|Lost to Follow-up|0|||
126303050|NCT03850483|454398575|FG007|Treatment for Stage 1|Death|0|||
126303051|NCT03850483|454398576|FG008|Treatment for Stage 1|Death|0|||
126303052|NCT03850483|454398577|FG009|Treatment for Stage 1|Death|0|||
126303053|NCT03850483|454398568|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
126303054|NCT03850483|454398569|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
126303055|NCT03850483|454398570|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
126303056|NCT03850483|454398571|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
126303057|NCT03850483|454398572|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
126303058|NCT03850483|454398573|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
126303059|NCT03850483|454398574|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
126303060|NCT03850483|454398575|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
126303061|NCT03850483|454398576|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
126303062|NCT03850483|454398577|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
126303063|NCT03850483|454398568|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
126303064|NCT03850483|454398569|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
126303065|NCT03850483|454398570|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
126303066|NCT03850483|454398571|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
126303067|NCT03850483|454398572|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
126303068|NCT03850483|454398573|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
126303069|NCT03850483|454398574|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
126303070|NCT03850483|454398575|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
126303071|NCT03850483|454398576|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
126303072|NCT03850483|454398577|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
126303073|NCT03850483|454398568|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303074|NCT03850483|454398569|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303075|NCT03850483|454398570|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303076|NCT03850483|454398571|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303077|NCT03850483|454398572|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303078|NCT03850483|454398573|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303079|NCT03850483|454398574|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
126303080|NCT03850483|454398575|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
126367841|NCT03620981|454641036|FG001|Overall Study|Withdrawal by Care Giver|0|||
126367842|NCT03620981|454641037|FG002|Overall Study|Withdrawal by Care Giver|1|||
126367843|NCT03620981|454641035|FG000|Overall Study|Non-compliance with Study Drug|1|||
126367844|NCT03620981|454641036|FG001|Overall Study|Non-compliance with Study Drug|1|||
126367845|NCT03620981|454641037|FG002|Overall Study|Non-compliance with Study Drug|0|||
126044587|NCT03279978|453461135|FG009|Overall Study|Lost to Follow-up|0|||
126044588|NCT03279978|453461126|FG000|Overall Study|Other than stated above|0|||
126303081|NCT03850483|454398576|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303082|NCT03850483|454398577|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
126367846|NCT03238196|454641040|FG000|Overall Study|Adverse Event|3|||
126367847|NCT03238196|454641041|FG001|Overall Study|Adverse Event|0|||
126367848|NCT03238196|454641042|FG002|Overall Study|Adverse Event|2|||
126367849|NCT03238196|454641043|FG003|Overall Study|Adverse Event|2|||
126367850|NCT03238196|454641040|FG000|Overall Study|Withdrawal by Subject|4|||
126044589|NCT03279978|453461127|FG001|Overall Study|Other than stated above|0|||
126303083|NCT03850483|454398568|FG000|Follow-up for Stage 1|Physician Decision|0|||
126303084|NCT03850483|454398569|FG001|Follow-up for Stage 1|Physician Decision|0|||
126303085|NCT03850483|454398570|FG002|Follow-up for Stage 1|Physician Decision|0|||
126303086|NCT03850483|454398571|FG003|Follow-up for Stage 1|Physician Decision|0|||
126303087|NCT03850483|454398572|FG004|Follow-up for Stage 1|Physician Decision|1|||
126303088|NCT03850483|454398573|FG005|Follow-up for Stage 1|Physician Decision|0|||
126303089|NCT03850483|454398574|FG006|Follow-up for Stage 1|Physician Decision|1|||
126303090|NCT03850483|454398575|FG007|Follow-up for Stage 1|Physician Decision|0|||
126303091|NCT03850483|454398576|FG008|Follow-up for Stage 1|Physician Decision|0|||
126303092|NCT03850483|454398577|FG009|Follow-up for Stage 1|Physician Decision|0|||
126303093|NCT03850483|454398568|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
126303094|NCT03850483|454398569|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
126303095|NCT03850483|454398570|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
126303096|NCT03850483|454398571|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
126303097|NCT03850483|454398572|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
126303098|NCT03850483|454398573|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
126303099|NCT03850483|454398574|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
126303100|NCT03850483|454398575|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
126303101|NCT03850483|454398576|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
126303102|NCT03850483|454398577|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
126303103|NCT03850483|454398568|FG000|Follow-up for Stage 1|Adverse Event|0|||
126303104|NCT03850483|454398569|FG001|Follow-up for Stage 1|Adverse Event|0|||
126303105|NCT03850483|454398570|FG002|Follow-up for Stage 1|Adverse Event|1|||
126303106|NCT03850483|454398571|FG003|Follow-up for Stage 1|Adverse Event|0|||
126303107|NCT03850483|454398572|FG004|Follow-up for Stage 1|Adverse Event|0|||
126303108|NCT03850483|454398573|FG005|Follow-up for Stage 1|Adverse Event|1|||
126303109|NCT03850483|454398574|FG006|Follow-up for Stage 1|Adverse Event|0|||
126303110|NCT03850483|454398575|FG007|Follow-up for Stage 1|Adverse Event|0|||
126303111|NCT03850483|454398576|FG008|Follow-up for Stage 1|Adverse Event|0|||
126303112|NCT03850483|454398577|FG009|Follow-up for Stage 1|Adverse Event|0|||
126303113|NCT03850483|454398568|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303114|NCT03850483|454398569|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
126303115|NCT03850483|454398570|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303116|NCT03850483|454398571|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303117|NCT03850483|454398572|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
126303118|NCT03850483|454398573|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
126303119|NCT03850483|454398574|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303120|NCT03850483|454398575|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303121|NCT03850483|454398576|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303122|NCT03850483|454398577|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303123|NCT03850483|454398568|FG000|Follow-up for Stage 1|Other|0|||
126303124|NCT03850483|454398569|FG001|Follow-up for Stage 1|Other|2|||
126303125|NCT03850483|454398570|FG002|Follow-up for Stage 1|Other|0|||
126303126|NCT03850483|454398571|FG003|Follow-up for Stage 1|Other|2|||
126303127|NCT03850483|454398572|FG004|Follow-up for Stage 1|Other|0|||
126303128|NCT03850483|454398573|FG005|Follow-up for Stage 1|Other|1|||
126303129|NCT03850483|454398574|FG006|Follow-up for Stage 1|Other|0|||
126303130|NCT03850483|454398575|FG007|Follow-up for Stage 1|Other|0|||
126303131|NCT03850483|454398576|FG008|Follow-up for Stage 1|Other|0|||
126303132|NCT03850483|454398577|FG009|Follow-up for Stage 1|Other|0|||
126303133|NCT03850483|454398568|FG000|Treatment for Stage 2|Adverse Event|0|||
126303134|NCT03850483|454398569|FG001|Treatment for Stage 2|Adverse Event|0|||
126303135|NCT03850483|454398570|FG002|Treatment for Stage 2|Adverse Event|0|||
126303136|NCT03850483|454398571|FG003|Treatment for Stage 2|Adverse Event|0|||
126303137|NCT03850483|454398572|FG004|Treatment for Stage 2|Adverse Event|0|||
126303138|NCT03850483|454398573|FG005|Treatment for Stage 2|Adverse Event|0|||
126303139|NCT03850483|454398574|FG006|Treatment for Stage 2|Adverse Event|0|||
126303140|NCT03850483|454398575|FG007|Treatment for Stage 2|Adverse Event|0|||
126303141|NCT03850483|454398576|FG008|Treatment for Stage 2|Adverse Event|0|||
126303142|NCT03850483|454398577|FG009|Treatment for Stage 2|Adverse Event|1|||
126303143|NCT03850483|454398568|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
126103399|NCT02924064|453672150|FG000|Overall Study|Physician Decision|0|||
126303144|NCT03850483|454398569|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
126303145|NCT03850483|454398570|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
126303146|NCT03850483|454398571|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
126303147|NCT03850483|454398572|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
126303148|NCT03850483|454398573|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
126303149|NCT03850483|454398574|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
126303150|NCT03850483|454398575|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
126303151|NCT03850483|454398576|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
126367851|NCT03238196|454641041|FG001|Overall Study|Withdrawal by Subject|1|||
126367852|NCT03238196|454641042|FG002|Overall Study|Withdrawal by Subject|1|||
126367853|NCT03238196|454641043|FG003|Overall Study|Withdrawal by Subject|0|||
126367854|NCT03238196|454641040|FG000|Overall Study|Disease progression|14|||
126367855|NCT03238196|454641041|FG001|Overall Study|Disease progression|2|||
126303152|NCT03850483|454398577|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
126303153|NCT03850483|454398568|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
126303154|NCT03850483|454398569|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
126303155|NCT03850483|454398570|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
126303156|NCT03850483|454398571|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
126303157|NCT03850483|454398572|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
126303158|NCT03850483|454398573|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
126303159|NCT03850483|454398574|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
126303160|NCT03850483|454398575|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
126303161|NCT03850483|454398576|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
126303162|NCT03850483|454398577|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
126303163|NCT03850483|454398568|FG000|Treatment for Stage 2|Physician Decision|0|||
126303164|NCT03850483|454398569|FG001|Treatment for Stage 2|Physician Decision|0|||
126303165|NCT03850483|454398570|FG002|Treatment for Stage 2|Physician Decision|0|||
126303166|NCT03850483|454398571|FG003|Treatment for Stage 2|Physician Decision|0|||
126303167|NCT03850483|454398572|FG004|Treatment for Stage 2|Physician Decision|0|||
126303168|NCT03850483|454398573|FG005|Treatment for Stage 2|Physician Decision|0|||
126303169|NCT03850483|454398574|FG006|Treatment for Stage 2|Physician Decision|0|||
126303170|NCT03850483|454398575|FG007|Treatment for Stage 2|Physician Decision|0|||
126303171|NCT03850483|454398576|FG008|Treatment for Stage 2|Physician Decision|0|||
126303172|NCT03850483|454398577|FG009|Treatment for Stage 2|Physician Decision|1|||
126303173|NCT03850483|454398568|FG000|Treatment for Stage 2|Protocol Violation|0|||
126303174|NCT03850483|454398569|FG001|Treatment for Stage 2|Protocol Violation|0|||
126303175|NCT03850483|454398570|FG002|Treatment for Stage 2|Protocol Violation|0|||
126303176|NCT03850483|454398571|FG003|Treatment for Stage 2|Protocol Violation|0|||
126303177|NCT03850483|454398572|FG004|Treatment for Stage 2|Protocol Violation|0|||
126303178|NCT03850483|454398573|FG005|Treatment for Stage 2|Protocol Violation|0|||
126303179|NCT03850483|454398574|FG006|Treatment for Stage 2|Protocol Violation|0|||
126303180|NCT03850483|454398575|FG007|Treatment for Stage 2|Protocol Violation|0|||
126303181|NCT03850483|454398576|FG008|Treatment for Stage 2|Protocol Violation|1|||
126303182|NCT03850483|454398577|FG009|Treatment for Stage 2|Protocol Violation|0|||
126303183|NCT03850483|454398568|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
126303184|NCT03850483|454398569|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
126303185|NCT03850483|454398570|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
126303186|NCT03850483|454398571|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
126303187|NCT03850483|454398572|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
126303188|NCT03850483|454398573|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
126303189|NCT03850483|454398574|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
126303190|NCT03850483|454398575|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
126303191|NCT03850483|454398576|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
126303192|NCT03850483|454398577|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
126303193|NCT03850483|454398568|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303194|NCT03850483|454398569|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303195|NCT03850483|454398570|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303196|NCT03850483|454398571|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303197|NCT03850483|454398572|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303198|NCT03850483|454398573|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303199|NCT03850483|454398574|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303200|NCT03850483|454398575|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303201|NCT03850483|454398576|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303202|NCT03850483|454398577|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
126303203|NCT03850483|454398568|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
126303204|NCT03850483|454398569|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
126303205|NCT03850483|454398570|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
126303206|NCT03850483|454398571|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
126303207|NCT03850483|454398572|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
126367856|NCT03238196|454641042|FG002|Overall Study|Disease progression|3|||
126367857|NCT03238196|454641043|FG003|Overall Study|Disease progression|2|||
126367858|NCT03238196|454641040|FG000|Overall Study|Still on treatment|1|||
126367859|NCT03238196|454641041|FG001|Overall Study|Still on treatment|0|||
126303208|NCT03850483|454398573|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
126303209|NCT03850483|454398574|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
126303210|NCT03850483|454398575|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
126303211|NCT03850483|454398576|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
126303212|NCT03850483|454398577|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
126303213|NCT03850483|454398568|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
126303214|NCT03850483|454398569|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
126303215|NCT03850483|454398570|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
126303216|NCT03850483|454398571|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
126367860|NCT03238196|454641042|FG002|Overall Study|Still on treatment|0|||
126367861|NCT03238196|454641043|FG003|Overall Study|Still on treatment|0|||
126303217|NCT03850483|454398572|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
126367862|NCT04938427|454641044|FG000|Overall Study|Adverse Event|5|||
126367863|NCT04938427|454641045|FG001|Overall Study|Adverse Event|19|||
126367864|NCT04938427|454641044|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126367865|NCT04938427|454641045|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126367866|NCT04938427|454641044|FG000|Overall Study|Withdrawal by Subject|1|||
126367867|NCT04938427|454641045|FG001|Overall Study|Withdrawal by Subject|0|||
126367868|NCT04938427|454641044|FG000|Overall Study|Reason Not Specified|2|||
126367869|NCT04938427|454641045|FG001|Overall Study|Reason Not Specified|1|||
126367870|NCT05852470|454641046|FG000|Overall Study|Withdrawal by Subject|0|||
126367871|NCT05852470|454641047|FG001|Overall Study|Withdrawal by Subject|1|||
126367872|NCT01373281|454642828|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
126367873|NCT01373281|454642829|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
126367874|NCT01373281|454642828|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
126367875|NCT01373281|454642829|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
126367876|NCT01373281|454642828|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
126367877|NCT01373281|454642829|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
126367878|NCT01373281|454642828|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
126367879|NCT01373281|454642829|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
126367880|NCT01373281|454642828|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
126367881|NCT01373281|454642829|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
126367882|NCT01373281|454642828|FG000|Surveillance Expansion Period|Protocol Violation|9|||
126367883|NCT01373281|454642829|FG001|Surveillance Expansion Period|Protocol Violation|1|||
126367884|NCT01373281|454642828|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
126367885|NCT01373281|454642829|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
126367886|NCT01373281|454642828|FG000|Surveillance Expansion Period|Serious adverse event|3|||
126367887|NCT01373281|454642829|FG001|Surveillance Expansion Period|Serious adverse event|4|||
126367888|NCT01444781|454642830|FG000|Overall Study|Lost to Follow-up|0|||
126367889|NCT01444781|454642831|FG001|Overall Study|Lost to Follow-up|3|||
126367890|NCT01444781|454642832|FG002|Overall Study|Lost to Follow-up|1|||
126367891|NCT01444781|454642830|FG000|Overall Study|Withdrawal by Subject|3|||
126367892|NCT01444781|454642831|FG001|Overall Study|Withdrawal by Subject|1|||
126367893|NCT01444781|454642832|FG002|Overall Study|Withdrawal by Subject|2|||
126367894|NCT03033784|454642833|FG000|Overall Study|Anxiety related to MRI scanner|0|||
126367895|NCT03033784|454642834|FG001|Overall Study|Anxiety related to MRI scanner|1|||
126367896|NCT03033784|454642835|FG002|Overall Study|Anxiety related to MRI scanner|0|||
126367897|NCT03033784|454642836|FG003|Overall Study|Anxiety related to MRI scanner|0|||
126367898|NCT03033784|454642837|FG004|Overall Study|Anxiety related to MRI scanner|0|||
126367899|NCT03033784|454642838|FG005|Overall Study|Anxiety related to MRI scanner|0|||
126367900|NCT03033784|454642839|FG006|Overall Study|Anxiety related to MRI scanner|0|||
126367901|NCT03033784|454642840|FG007|Overall Study|Anxiety related to MRI scanner|0|||
126367902|NCT03033784|454642841|FG008|Overall Study|Anxiety related to MRI scanner|0|||
126367903|NCT03033784|454642842|FG009|Overall Study|Anxiety related to MRI scanner|0|||
126367904|NCT03033784|454642843|FG010|Overall Study|Anxiety related to MRI scanner|0|||
126367905|NCT03033784|454642844|FG011|Overall Study|Anxiety related to MRI scanner|0|||
126367906|NCT03033784|454642845|FG012|Overall Study|Anxiety related to MRI scanner|0|||
126367907|NCT03033784|454642833|FG000|Overall Study|Withdrawal by Subject|0|||
126367908|NCT03033784|454642834|FG001|Overall Study|Withdrawal by Subject|0|||
126367909|NCT03033784|454642835|FG002|Overall Study|Withdrawal by Subject|0|||
126367910|NCT03033784|454642836|FG003|Overall Study|Withdrawal by Subject|0|||
126367911|NCT03033784|454642837|FG004|Overall Study|Withdrawal by Subject|0|||
126367912|NCT03033784|454642838|FG005|Overall Study|Withdrawal by Subject|0|||
126367913|NCT03033784|454642839|FG006|Overall Study|Withdrawal by Subject|0|||
126367914|NCT03033784|454642840|FG007|Overall Study|Withdrawal by Subject|0|||
126367915|NCT03033784|454642841|FG008|Overall Study|Withdrawal by Subject|0|||
126367916|NCT03033784|454642842|FG009|Overall Study|Withdrawal by Subject|0|||
126367917|NCT03033784|454642843|FG010|Overall Study|Withdrawal by Subject|0|||
126367918|NCT03033784|454642844|FG011|Overall Study|Withdrawal by Subject|0|||
126367919|NCT03033784|454642845|FG012|Overall Study|Withdrawal by Subject|2|||
126367920|NCT03332056|454642846|FG000|Overall Study|Incomplete questionnaires|8|||
126367921|NCT03332056|454642847|FG001|Overall Study|Incomplete questionnaires|9|||
126367922|NCT03332056|454642846|FG000|Overall Study|Passed stone prior to surgery date|1|||
126367923|NCT03332056|454642847|FG001|Overall Study|Passed stone prior to surgery date|0|||
126367924|NCT03332056|454642846|FG000|Overall Study|Did not require a ureteral stent|0|||
126367925|NCT03332056|454642847|FG001|Overall Study|Did not require a ureteral stent|1|||
126367926|NCT00851084|454642848|FG000|Overall Study|Randomized but not treated|1|||
126367927|NCT00851084|454642849|FG001|Overall Study|Randomized but not treated|0|||
126367928|NCT00851084|454642848|FG000|Overall Study|Adverse Event|26|||
126367929|NCT00851084|454642849|FG001|Overall Study|Adverse Event|36|||
126367930|NCT00851084|454642848|FG000|Overall Study|Disease progression|52|||
126367931|NCT00851084|454642849|FG001|Overall Study|Disease progression|47|||
126367932|NCT00851084|454642848|FG000|Overall Study|Poor compliance to protocol|1|||
126367933|NCT00851084|454642849|FG001|Overall Study|Poor compliance to protocol|1|||
126303218|NCT03850483|454398573|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
126303219|NCT03850483|454398574|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
126303220|NCT03850483|454398575|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
126303221|NCT03850483|454398576|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
126303222|NCT03850483|454398577|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
126303223|NCT03850483|454398568|FG000|Follow-up For Stage 2|Other|0|||
126303224|NCT03850483|454398569|FG001|Follow-up For Stage 2|Other|0|||
126303225|NCT03850483|454398570|FG002|Follow-up For Stage 2|Other|0|||
126303226|NCT03850483|454398571|FG003|Follow-up For Stage 2|Other|0|||
126303227|NCT03850483|454398572|FG004|Follow-up For Stage 2|Other|0|||
126303228|NCT03850483|454398573|FG005|Follow-up For Stage 2|Other|0|||
126303229|NCT03850483|454398574|FG006|Follow-up For Stage 2|Other|0|||
126303230|NCT03850483|454398575|FG007|Follow-up For Stage 2|Other|0|||
126303231|NCT03850483|454398576|FG008|Follow-up For Stage 2|Other|0|||
126303232|NCT03850483|454398577|FG009|Follow-up For Stage 2|Other|1|||
126303233|NCT04432831|454400273|FG000|Overall Study|Withdrawal by Subject|24|||
126303234|NCT04432831|454400274|FG001|Overall Study|Withdrawal by Subject|28|||
126303235|NCT04432831|454400275|FG002|Overall Study|Withdrawal by Subject|21|||
126303236|NCT04432831|454400273|FG000|Overall Study|Death|23|||
126303237|NCT04432831|454400274|FG001|Overall Study|Death|23|||
126303238|NCT04432831|454400275|FG002|Overall Study|Death|17|||
126303239|NCT04432831|454400273|FG000|Overall Study|Lost to Follow-up|15|||
126303240|NCT04432831|454400274|FG001|Overall Study|Lost to Follow-up|15|||
126303241|NCT04432831|454400275|FG002|Overall Study|Lost to Follow-up|12|||
126303242|NCT04432831|454400273|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
126303243|NCT04432831|454400274|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
126303244|NCT04432831|454400275|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
126303245|NCT04432831|454400273|FG000|Overall Study|Reason Not Specified|7|||
126303246|NCT04432831|454400274|FG001|Overall Study|Reason Not Specified|11|||
126303247|NCT04432831|454400275|FG002|Overall Study|Reason Not Specified|9|||
126303248|NCT04432831|454400273|FG000|Overall Study|Adverse Event|7|||
126303249|NCT04432831|454400274|FG001|Overall Study|Adverse Event|7|||
126303250|NCT04432831|454400275|FG002|Overall Study|Adverse Event|7|||
126303251|NCT04432831|454400273|FG000|Overall Study|Physician Decision|1|||
126303252|NCT04432831|454400274|FG001|Overall Study|Physician Decision|3|||
126303253|NCT04432831|454400275|FG002|Overall Study|Physician Decision|6|||
126303254|NCT04432831|454400273|FG000|Overall Study|Protocol Violation|1|||
126303255|NCT04432831|454400274|FG001|Overall Study|Protocol Violation|0|||
126303256|NCT04432831|454400275|FG002|Overall Study|Protocol Violation|2|||
126303257|NCT04432831|454400273|FG000|Overall Study|Pregnancy|0|||
126303258|NCT04432831|454400274|FG001|Overall Study|Pregnancy|1|||
126303259|NCT04432831|454400275|FG002|Overall Study|Pregnancy|0|||
126303260|NCT04432831|454400273|FG000|Overall Study|Lack of Efficacy|0|||
126303261|NCT04432831|454400274|FG001|Overall Study|Lack of Efficacy|0|||
126303262|NCT04432831|454400275|FG002|Overall Study|Lack of Efficacy|2|||
126303263|NCT00652626|454400278|FG000|Initial Treatment Phase|Adverse Event|0|||
126303264|NCT00652626|454400279|FG001|Initial Treatment Phase|Adverse Event|0|||
126303265|NCT00652626|454400280|FG002|Initial Treatment Phase|Adverse Event|0|||
126303266|NCT00652626|454400281|FG003|Initial Treatment Phase|Adverse Event|0|||
126303267|NCT00652626|454400282|FG004|Initial Treatment Phase|Adverse Event|1|||
126303268|NCT00652626|454400283|FG005|Initial Treatment Phase|Adverse Event|0|||
126303269|NCT00652626|454400284|FG006|Initial Treatment Phase|Adverse Event|0|||
126303270|NCT00652626|454400278|FG000|Initial Treatment Phase|Protocol Violation|0|||
126303271|NCT00652626|454400279|FG001|Initial Treatment Phase|Protocol Violation|0|||
126303272|NCT00652626|454400280|FG002|Initial Treatment Phase|Protocol Violation|0|||
126303273|NCT00652626|454400281|FG003|Initial Treatment Phase|Protocol Violation|1|||
126303274|NCT00652626|454400282|FG004|Initial Treatment Phase|Protocol Violation|0|||
126303275|NCT00652626|454400283|FG005|Initial Treatment Phase|Protocol Violation|0|||
126303276|NCT00652626|454400284|FG006|Initial Treatment Phase|Protocol Violation|0|||
126303277|NCT00652626|454400278|FG000|Initial Treatment Phase|Physician Decision|0|||
126303278|NCT00652626|454400279|FG001|Initial Treatment Phase|Physician Decision|0|||
126303279|NCT00652626|454400280|FG002|Initial Treatment Phase|Physician Decision|0|||
126303280|NCT00652626|454400281|FG003|Initial Treatment Phase|Physician Decision|0|||
126303281|NCT00652626|454400282|FG004|Initial Treatment Phase|Physician Decision|1|||
126303282|NCT00652626|454400283|FG005|Initial Treatment Phase|Physician Decision|0|||
126303283|NCT00652626|454400284|FG006|Initial Treatment Phase|Physician Decision|0|||
126303284|NCT00652626|454400278|FG000|Initial Treatment Phase|Sponsor Request|0|||
126303285|NCT00652626|454400279|FG001|Initial Treatment Phase|Sponsor Request|0|||
126303286|NCT00652626|454400280|FG002|Initial Treatment Phase|Sponsor Request|1|||
126303287|NCT00652626|454400281|FG003|Initial Treatment Phase|Sponsor Request|0|||
126303288|NCT00652626|454400282|FG004|Initial Treatment Phase|Sponsor Request|0|||
126303289|NCT00652626|454400283|FG005|Initial Treatment Phase|Sponsor Request|0|||
126303290|NCT00652626|454400284|FG006|Initial Treatment Phase|Sponsor Request|0|||
126303291|NCT00652626|454400278|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
126303292|NCT00652626|454400279|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
126303293|NCT00652626|454400280|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
126303294|NCT00652626|454400281|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
126303295|NCT00652626|454400282|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
126303296|NCT00652626|454400283|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
126303297|NCT00652626|454400284|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
126303298|NCT00652626|454400278|FG000|Extension Phase|Withdrawal by Subject|0|||
126303299|NCT00652626|454400279|FG001|Extension Phase|Withdrawal by Subject|0|||
126303300|NCT00652626|454400280|FG002|Extension Phase|Withdrawal by Subject|0|||
126303301|NCT00652626|454400281|FG003|Extension Phase|Withdrawal by Subject|0|||
126303302|NCT00652626|454400282|FG004|Extension Phase|Withdrawal by Subject|0|||
126303303|NCT00652626|454400283|FG005|Extension Phase|Withdrawal by Subject|2|||
126303304|NCT00652626|454400284|FG006|Extension Phase|Withdrawal by Subject|0|||
126303305|NCT00652626|454400278|FG000|Extension Phase|Adverse Event|0|||
126303306|NCT00652626|454400279|FG001|Extension Phase|Adverse Event|0|||
126303307|NCT00652626|454400280|FG002|Extension Phase|Adverse Event|0|||
126303308|NCT00652626|454400281|FG003|Extension Phase|Adverse Event|0|||
126303309|NCT00652626|454400282|FG004|Extension Phase|Adverse Event|0|||
126303310|NCT00652626|454400283|FG005|Extension Phase|Adverse Event|2|||
126303311|NCT00652626|454400284|FG006|Extension Phase|Adverse Event|1|||
126303312|NCT00652626|454400278|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303313|NCT00652626|454400279|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303314|NCT00652626|454400280|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303315|NCT00652626|454400281|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303316|NCT00652626|454400282|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303317|NCT00652626|454400283|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
126303318|NCT00652626|454400284|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303319|NCT00652626|454400278|FG000|Extension Phase|Physician Decision|0|||
126303320|NCT00652626|454400279|FG001|Extension Phase|Physician Decision|0|||
126303321|NCT00652626|454400280|FG002|Extension Phase|Physician Decision|0|||
126303322|NCT00652626|454400281|FG003|Extension Phase|Physician Decision|0|||
126303323|NCT00652626|454400282|FG004|Extension Phase|Physician Decision|0|||
126303324|NCT00652626|454400283|FG005|Extension Phase|Physician Decision|1|||
126303325|NCT00652626|454400284|FG006|Extension Phase|Physician Decision|1|||
126303326|NCT00652626|454400278|FG000|Extension Phase|Death|0|||
126303327|NCT00652626|454400279|FG001|Extension Phase|Death|0|||
126303328|NCT00652626|454400280|FG002|Extension Phase|Death|0|||
126303329|NCT00652626|454400281|FG003|Extension Phase|Death|0|||
126303330|NCT00652626|454400282|FG004|Extension Phase|Death|0|||
126303331|NCT00652626|454400283|FG005|Extension Phase|Death|1|||
126303332|NCT00652626|454400284|FG006|Extension Phase|Death|1|||
126303333|NCT01623310|454400285|FG000|Overall Study|Adverse Event|21|||
126303334|NCT01623310|454400285|FG000|Overall Study|Lost to Follow-up|18|||
126303335|NCT01623310|454400285|FG000|Overall Study|Lack of Efficacy|6|||
126303336|NCT01623310|454400285|FG000|Overall Study|Protocol Violation|6|||
126303337|NCT01623310|454400285|FG000|Overall Study|Withdrawal by Subject|25|||
126303338|NCT01623310|454400285|FG000|Overall Study|Became potentially child-bearing|1|||
126303339|NCT01623310|454400285|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
126303340|NCT01623310|454400285|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
126303341|NCT02898597|454400286|FG000|Overall Study|Protocol Violation|4|||
126303342|NCT02898597|454400287|FG001|Overall Study|Protocol Violation|2|||
126303343|NCT02898597|454400286|FG000|Overall Study|Lost to Follow-up|0|||
126303344|NCT02898597|454400287|FG001|Overall Study|Lost to Follow-up|9|||
126303345|NCT02898597|454400286|FG000|Overall Study|Death|0|||
126303346|NCT02898597|454400287|FG001|Overall Study|Death|1|||
126303347|NCT02530125|454400288|FG000|Completed Treatment|Early termination of study|1|||
126303348|NCT02530125|454400288|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
126303349|NCT00356603|454400289|FG000|Overall Study|Other|6|||
126303350|NCT00356603|454400290|FG001|Overall Study|Other|3|||
126303351|NCT01568034|454400292|FG000|Overall Study|Withdrawal by Subject|1|||
126303352|NCT01568034|454400293|FG001|Overall Study|Withdrawal by Subject|0|||
126303353|NCT01568034|454400294|FG002|Overall Study|Withdrawal by Subject|0|||
126303354|NCT01568034|454400295|FG003|Overall Study|Withdrawal by Subject|0|||
126303355|NCT00728468|454400296|FG000|Overall Study|Enrolled but not treated|1|||
126303356|NCT00728468|454400296|FG000|Overall Study|Death|1|||
126367934|NCT00851084|454642848|FG000|Overall Study|Physician Decision|13|||
126367935|NCT00851084|454642849|FG001|Overall Study|Physician Decision|14|||
126367936|NCT00851084|454642848|FG000|Overall Study|Consent withdrawn|0|||
126367937|NCT00851084|454642849|FG001|Overall Study|Consent withdrawn|2|||
126367938|NCT00851084|454642848|FG000|Overall Study|Withdrawal by Subject|11|||
126367939|NCT00851084|454642849|FG001|Overall Study|Withdrawal by Subject|12|||
126367940|NCT00851084|454642848|FG000|Overall Study|Metastatic surgery|6|||
126367941|NCT00851084|454642849|FG001|Overall Study|Metastatic surgery|6|||
126367942|NCT00851084|454642848|FG000|Overall Study|Other|7|||
126303357|NCT00728468|454400296|FG000|Overall Study|Protocol Violation|4|||
126367943|NCT00851084|454642849|FG001|Overall Study|Other|1|||
126367944|NCT00734032|454642850|FG000|Overall Study|Adverse Event|0|||
126367945|NCT00734032|454642851|FG001|Overall Study|Adverse Event|1|||
126303358|NCT00728468|454400296|FG000|Overall Study|Objective progression or relapse|9|||
126303359|NCT00728468|454400296|FG000|Overall Study|Study terminated by sponsor|1|||
126303360|NCT01262287|454400297|FG000|Overall Study|Lost to Follow-up|2|||
126303361|NCT01262287|454400298|FG001|Overall Study|Lost to Follow-up|1|||
126303362|NCT00932373|454400299|FG000|Overall Study|Progressive disease|3|||
126303363|NCT00932373|454400300|FG001|Overall Study|Progressive disease|1|||
126303364|NCT00932373|454400301|FG002|Overall Study|Progressive disease|0|||
126303365|NCT00932373|454400302|FG003|Overall Study|Progressive disease|0|||
126303366|NCT00932373|454400303|FG004|Overall Study|Progressive disease|10|||
126303367|NCT00932373|454400304|FG005|Overall Study|Progressive disease|1|||
126303368|NCT00932373|454400305|FG006|Overall Study|Progressive disease|0|||
126303369|NCT00932373|454400306|FG007|Overall Study|Progressive disease|2|||
126303370|NCT00932373|454400307|FG008|Overall Study|Progressive disease|1|||
126303371|NCT00932373|454400308|FG009|Overall Study|Progressive disease|9|||
126303372|NCT00932373|454400309|FG010|Overall Study|Progressive disease|2|||
126303373|NCT00932373|454400299|FG000|Overall Study|Adverse Event|0|||
126303374|NCT00932373|454400300|FG001|Overall Study|Adverse Event|0|||
126303375|NCT00932373|454400301|FG002|Overall Study|Adverse Event|0|||
126303376|NCT00932373|454400302|FG003|Overall Study|Adverse Event|0|||
126303377|NCT00932373|454400303|FG004|Overall Study|Adverse Event|2|||
126303378|NCT00932373|454400304|FG005|Overall Study|Adverse Event|1|||
126303379|NCT00932373|454400305|FG006|Overall Study|Adverse Event|0|||
126303380|NCT00932373|454400306|FG007|Overall Study|Adverse Event|1|||
126303381|NCT00932373|454400307|FG008|Overall Study|Adverse Event|0|||
126303382|NCT00932373|454400308|FG009|Overall Study|Adverse Event|2|||
126303383|NCT00932373|454400309|FG010|Overall Study|Adverse Event|1|||
126303384|NCT00932373|454400299|FG000|Overall Study|Physician Decision|0|||
126303385|NCT00932373|454400300|FG001|Overall Study|Physician Decision|0|||
126303386|NCT00932373|454400301|FG002|Overall Study|Physician Decision|1|||
126303387|NCT00932373|454400302|FG003|Overall Study|Physician Decision|0|||
126303388|NCT00932373|454400303|FG004|Overall Study|Physician Decision|2|||
126303389|NCT00932373|454400304|FG005|Overall Study|Physician Decision|0|||
126303390|NCT00932373|454400305|FG006|Overall Study|Physician Decision|0|||
126303391|NCT00932373|454400306|FG007|Overall Study|Physician Decision|0|||
126303392|NCT00932373|454400307|FG008|Overall Study|Physician Decision|0|||
126303393|NCT00932373|454400308|FG009|Overall Study|Physician Decision|1|||
126303394|NCT00932373|454400309|FG010|Overall Study|Physician Decision|0|||
126303395|NCT00932373|454400299|FG000|Overall Study|Dose limiting toxicity|0|||
126303396|NCT00932373|454400300|FG001|Overall Study|Dose limiting toxicity|0|||
126303397|NCT00932373|454400301|FG002|Overall Study|Dose limiting toxicity|0|||
126303398|NCT00932373|454400302|FG003|Overall Study|Dose limiting toxicity|0|||
126303399|NCT00932373|454400303|FG004|Overall Study|Dose limiting toxicity|0|||
126303400|NCT00932373|454400304|FG005|Overall Study|Dose limiting toxicity|1|||
126303401|NCT00932373|454400305|FG006|Overall Study|Dose limiting toxicity|0|||
126303402|NCT00932373|454400306|FG007|Overall Study|Dose limiting toxicity|0|||
126303403|NCT00932373|454400307|FG008|Overall Study|Dose limiting toxicity|0|||
126303404|NCT00932373|454400308|FG009|Overall Study|Dose limiting toxicity|0|||
126303405|NCT00932373|454400309|FG010|Overall Study|Dose limiting toxicity|0|||
126303406|NCT00932373|454400299|FG000|Overall Study|Withdrawal by Subject|0|||
126303407|NCT00932373|454400300|FG001|Overall Study|Withdrawal by Subject|0|||
126303408|NCT00932373|454400301|FG002|Overall Study|Withdrawal by Subject|0|||
126303409|NCT00932373|454400302|FG003|Overall Study|Withdrawal by Subject|0|||
126303410|NCT00932373|454400303|FG004|Overall Study|Withdrawal by Subject|0|||
126303411|NCT00932373|454400304|FG005|Overall Study|Withdrawal by Subject|0|||
126303412|NCT00932373|454400305|FG006|Overall Study|Withdrawal by Subject|0|||
126367946|NCT00734032|454642852|FG002|Overall Study|Adverse Event|0|||
126367947|NCT00734032|454642853|FG003|Overall Study|Adverse Event|0|||
126367948|NCT03360344|454642858|FG000|Overall Study|Withdrawal by Subject|0|||
126367949|NCT03360344|454642859|FG001|Overall Study|Withdrawal by Subject|1|||
126367950|NCT03360344|454642860|FG002|Overall Study|Withdrawal by Subject|1|||
126367951|NCT00133705|454642865|FG000|Overall Study|Withdrawal by Subject|2|||
126367952|NCT00133705|454642866|FG001|Overall Study|Withdrawal by Subject|3|||
126367953|NCT03847519|454642876|FG000|Overall Study|Death|5|||
126367954|NCT03847519|454642877|FG001|Overall Study|Death|8|||
126367955|NCT03847519|454642878|FG002|Overall Study|Death|1|||
126367956|NCT03847519|454642876|FG000|Overall Study|Lost to Follow-up|1|||
126303413|NCT00932373|454400306|FG007|Overall Study|Withdrawal by Subject|0|||
126303414|NCT00932373|454400307|FG008|Overall Study|Withdrawal by Subject|1|||
126367957|NCT03847519|454642877|FG001|Overall Study|Lost to Follow-up|2|||
126367958|NCT03847519|454642878|FG002|Overall Study|Lost to Follow-up|0|||
126303415|NCT00932373|454400308|FG009|Overall Study|Withdrawal by Subject|0|||
126303416|NCT00932373|454400309|FG010|Overall Study|Withdrawal by Subject|0|||
126303417|NCT00932373|454400299|FG000|Overall Study|Clinical progression|0|||
126303418|NCT00932373|454400300|FG001|Overall Study|Clinical progression|0|||
126303419|NCT00932373|454400301|FG002|Overall Study|Clinical progression|0|||
126367959|NCT03847519|454642876|FG000|Overall Study|Study Terminated by Sponsor|0|||
126367960|NCT03847519|454642877|FG001|Overall Study|Study Terminated by Sponsor|3|||
126367961|NCT03847519|454642878|FG002|Overall Study|Study Terminated by Sponsor|2|||
126303420|NCT00932373|454400302|FG003|Overall Study|Clinical progression|0|||
126303421|NCT00932373|454400303|FG004|Overall Study|Clinical progression|0|||
126303422|NCT00932373|454400304|FG005|Overall Study|Clinical progression|0|||
126303423|NCT00932373|454400305|FG006|Overall Study|Clinical progression|1|||
126303424|NCT00932373|454400306|FG007|Overall Study|Clinical progression|0|||
126303425|NCT00932373|454400307|FG008|Overall Study|Clinical progression|0|||
126303426|NCT00932373|454400308|FG009|Overall Study|Clinical progression|0|||
126303427|NCT00932373|454400309|FG010|Overall Study|Clinical progression|0|||
126303428|NCT00932373|454400299|FG000|Overall Study|Lack of Efficacy|0|||
126303429|NCT00932373|454400300|FG001|Overall Study|Lack of Efficacy|0|||
126303430|NCT00932373|454400301|FG002|Overall Study|Lack of Efficacy|0|||
126303431|NCT00932373|454400302|FG003|Overall Study|Lack of Efficacy|0|||
126303432|NCT00932373|454400303|FG004|Overall Study|Lack of Efficacy|0|||
126303433|NCT00932373|454400304|FG005|Overall Study|Lack of Efficacy|0|||
126303434|NCT00932373|454400305|FG006|Overall Study|Lack of Efficacy|0|||
126303435|NCT00932373|454400306|FG007|Overall Study|Lack of Efficacy|0|||
126303436|NCT00932373|454400307|FG008|Overall Study|Lack of Efficacy|0|||
126303437|NCT00932373|454400308|FG009|Overall Study|Lack of Efficacy|1|||
126303438|NCT00932373|454400309|FG010|Overall Study|Lack of Efficacy|0|||
126303439|NCT01637922|454400310|FG000|Overall Study|Adverse Event|0|||
126303440|NCT01637922|454400311|FG001|Overall Study|Adverse Event|1|||
126303441|NCT01637922|454400310|FG000|Overall Study|Protocol Violation|0|||
126303442|NCT01637922|454400311|FG001|Overall Study|Protocol Violation|1|||
126303443|NCT01637922|454400310|FG000|Overall Study|Withdrawal by Subject|0|||
126303444|NCT01637922|454400311|FG001|Overall Study|Withdrawal by Subject|3|||
126303445|NCT01637922|454400310|FG000|Overall Study|Lost to Follow-up|2|||
126303446|NCT01637922|454400311|FG001|Overall Study|Lost to Follow-up|0|||
126303447|NCT00638404|454400312|FG000|Overall Study|Physician Decision|8|||
126303448|NCT00638404|454400313|FG001|Overall Study|Physician Decision|0|||
126303449|NCT02492984|454400314|FG000|Overall Study|Adverse Event|1|||
126303450|NCT02492984|454400315|FG001|Overall Study|Adverse Event|0|||
126303451|NCT02492984|454400314|FG000|Overall Study|Protocol Violation|1|||
126303452|NCT02492984|454400315|FG001|Overall Study|Protocol Violation|0|||
126303453|NCT02492984|454400314|FG000|Overall Study|Withdrawal by Subject|1|||
126303454|NCT02492984|454400315|FG001|Overall Study|Withdrawal by Subject|0|||
126303455|NCT04090060|454400321|FG000|Overall Study|Lost to Follow-up|76|||
126303456|NCT04090060|454400322|FG001|Overall Study|Lost to Follow-up|77|||
126303457|NCT01164579|454400329|FG000|Overall Study|Lack of Efficacy|0|||
126303458|NCT01164579|454400330|FG001|Overall Study|Lack of Efficacy|0|||
126303459|NCT01164579|454400331|FG002|Overall Study|Lack of Efficacy|6|||
126303460|NCT01164579|454400329|FG000|Overall Study|Lost to Follow-up|1|||
126303461|NCT01164579|454400330|FG001|Overall Study|Lost to Follow-up|1|||
126303462|NCT01164579|454400331|FG002|Overall Study|Lost to Follow-up|0|||
126303463|NCT01164579|454400329|FG000|Overall Study|Withdrawal by Subject|2|||
126303464|NCT01164579|454400330|FG001|Overall Study|Withdrawal by Subject|5|||
126303465|NCT01164579|454400331|FG002|Overall Study|Withdrawal by Subject|3|||
126303466|NCT01164579|454400329|FG000|Overall Study|Protocol Violation|0|||
126303467|NCT01164579|454400330|FG001|Overall Study|Protocol Violation|1|||
126303468|NCT01164579|454400331|FG002|Overall Study|Protocol Violation|2|||
126303469|NCT01164579|454400329|FG000|Overall Study|Adverse Event|4|||
126303470|NCT01164579|454400330|FG001|Overall Study|Adverse Event|2|||
126303471|NCT01164579|454400331|FG002|Overall Study|Adverse Event|5|||
126303472|NCT01164579|454400329|FG000|Overall Study|Reason not specified|1|||
126303473|NCT01164579|454400330|FG001|Overall Study|Reason not specified|0|||
126303474|NCT01164579|454400331|FG002|Overall Study|Reason not specified|0|||
126303475|NCT00302328|454400338|FG000|Overall Study|Physician Decision|0|||
126303476|NCT00302328|454400339|FG001|Overall Study|Physician Decision|1|||
126303477|NCT00302328|454400340|FG002|Overall Study|Physician Decision|0|||
126303478|NCT01288937|454400347|FG000|Overall Study|Adverse Event|1|||
126303479|NCT01288937|454400348|FG001|Overall Study|Adverse Event|0|||
126303480|NCT02490371|454400349|FG000|Overall Study|Lost to Follow-up|1|||
125884325|NCT04721977|452873280|FG000|Overall Study|Ongoing|51|||
125884326|NCT04988477|452873282|FG000|Overall Study|Death|1|||
125884327|NCT04988477|452873283|FG001|Overall Study|Death|0|||
125884328|NCT04988477|452873284|FG002|Overall Study|Death|0|||
125884329|NCT04988477|452873282|FG000|Overall Study|Lost to Follow-up|5|||
125884330|NCT04988477|452873283|FG001|Overall Study|Lost to Follow-up|2|||
125884331|NCT04988477|452873284|FG002|Overall Study|Lost to Follow-up|0|||
126303481|NCT02490371|454400350|FG001|Overall Study|Lost to Follow-up|1|||
126303482|NCT02476578|454400353|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
126303483|NCT02476578|454400354|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
126303484|NCT02476578|454400353|FG000|Overall Study|Lost to Follow-up|6|||
126303485|NCT02476578|454400354|FG001|Overall Study|Lost to Follow-up|13|||
126303486|NCT03491462|454400355|FG000|Overall Study|Lost to Follow-up|2|||
126303487|NCT03491462|454400356|FG001|Overall Study|Lost to Follow-up|0|||
126303488|NCT03491462|454400355|FG000|Overall Study|Adverse Event|11|||
126303489|NCT03491462|454400356|FG001|Overall Study|Adverse Event|1|||
126303490|NCT03491462|454400355|FG000|Overall Study|Physician Decision|3|||
125884332|NCT04988477|452873282|FG000|Overall Study|Withdrawal by Subject|2|||
125884333|NCT04988477|452873283|FG001|Overall Study|Withdrawal by Subject|0|||
126303491|NCT03491462|454400356|FG001|Overall Study|Physician Decision|0|||
126303492|NCT03491462|454400355|FG000|Overall Study|Withdrawal by Subject|22|||
126303493|NCT03491462|454400356|FG001|Overall Study|Withdrawal by Subject|15|||
126303494|NCT04938180|454400357|FG000|Overall Study|Adverse Event|1|||
126303495|NCT03018080|454400358|FG000|Overall Study|Death|12|||
126303496|NCT03018080|454400359|FG001|Overall Study|Death|19|||
126303497|NCT00740792|454400360|FG000|Overall Study|Adverse Event|3|||
126303498|NCT00740792|454400361|FG001|Overall Study|Adverse Event|1|||
126303499|NCT00740792|454400362|FG002|Overall Study|Adverse Event|1|||
126303500|NCT00740792|454400363|FG003|Overall Study|Adverse Event|3|||
126303501|NCT00740792|454400360|FG000|Overall Study|Lack of Efficacy|1|||
126303502|NCT00740792|454400361|FG001|Overall Study|Lack of Efficacy|1|||
126303503|NCT00740792|454400362|FG002|Overall Study|Lack of Efficacy|0|||
126303504|NCT00740792|454400363|FG003|Overall Study|Lack of Efficacy|3|||
126303505|NCT00740792|454400360|FG000|Overall Study|Lost to Follow-up|2|||
126303506|NCT00740792|454400361|FG001|Overall Study|Lost to Follow-up|1|||
126303507|NCT00740792|454400362|FG002|Overall Study|Lost to Follow-up|0|||
126303508|NCT00740792|454400363|FG003|Overall Study|Lost to Follow-up|0|||
126303509|NCT00740792|454400360|FG000|Overall Study|Protocol Violation|0|||
126303510|NCT00740792|454400361|FG001|Overall Study|Protocol Violation|1|||
126303511|NCT00740792|454400362|FG002|Overall Study|Protocol Violation|0|||
126303512|NCT00740792|454400363|FG003|Overall Study|Protocol Violation|2|||
126303513|NCT00740792|454400360|FG000|Overall Study|Withdrawal by Subject|1|||
126303514|NCT00740792|454400361|FG001|Overall Study|Withdrawal by Subject|1|||
126303515|NCT00740792|454400362|FG002|Overall Study|Withdrawal by Subject|0|||
126303516|NCT00740792|454400363|FG003|Overall Study|Withdrawal by Subject|0|||
126303517|NCT00740792|454400360|FG000|Overall Study|administrative|3|||
126303518|NCT00740792|454400361|FG001|Overall Study|administrative|3|||
126303519|NCT00740792|454400362|FG002|Overall Study|administrative|8|||
126303520|NCT00740792|454400363|FG003|Overall Study|administrative|2|||
126303521|NCT00441129|454400368|FG000|Overall Study|Withdrawal by Subject|6|||
126303522|NCT00441129|454400369|FG001|Overall Study|Withdrawal by Subject|14|||
126303523|NCT00912743|454400370|FG000|Overall Study|Adverse Event|3|||
126303524|NCT00912743|454400371|FG001|Overall Study|Adverse Event|1|||
126303525|NCT00912743|454400370|FG000|Overall Study|Lack of Efficacy|9|||
126303526|NCT00912743|454400371|FG001|Overall Study|Lack of Efficacy|18|||
126303527|NCT00912743|454400370|FG000|Overall Study|Toxicity|0|||
126044590|NCT03279978|453461128|FG002|Overall Study|Other than stated above|0|||
126044591|NCT03279978|453461129|FG003|Overall Study|Other than stated above|0|||
126044592|NCT03279978|453461130|FG004|Overall Study|Other than stated above|0|||
126044593|NCT03279978|453461131|FG005|Overall Study|Other than stated above|0|||
126044594|NCT03279978|453461132|FG006|Overall Study|Other than stated above|1|||
126044595|NCT03279978|453461133|FG007|Overall Study|Other than stated above|0|||
126044596|NCT03279978|453461134|FG008|Overall Study|Other than stated above|0|||
126044597|NCT03279978|453461135|FG009|Overall Study|Other than stated above|0|||
126044598|NCT04330040|453461136|FG000|Overall Study|Other: Adverse event|5|||
126044599|NCT04330040|453461137|FG001|Overall Study|Other: Adverse event|0|||
126044600|NCT04330040|453461138|FG002|Overall Study|Other: Adverse event|0|||
126044601|NCT04330040|453461136|FG000|Overall Study|Disease progression|38|||
126044602|NCT04330040|453461137|FG001|Overall Study|Disease progression|10|||
126044603|NCT04330040|453461138|FG002|Overall Study|Disease progression|0|||
126044604|NCT04330040|453461136|FG000|Overall Study|Physician Decision|5|||
126044605|NCT04330040|453461137|FG001|Overall Study|Physician Decision|3|||
126044606|NCT04330040|453461138|FG002|Overall Study|Physician Decision|0|||
126044607|NCT04330040|453461136|FG000|Overall Study|Lost to Follow-up|1|||
126044608|NCT04330040|453461137|FG001|Overall Study|Lost to Follow-up|1|||
126044609|NCT04330040|453461138|FG002|Overall Study|Lost to Follow-up|0|||
126044610|NCT04330040|453461136|FG000|Overall Study|Death|2|||
126044611|NCT04330040|453461137|FG001|Overall Study|Death|1|||
126044612|NCT04330040|453461138|FG002|Overall Study|Death|0|||
126044613|NCT04330040|453461136|FG000|Overall Study|Withdrawal by Subject|3|||
126044614|NCT04330040|453461137|FG001|Overall Study|Withdrawal by Subject|3|||
126044615|NCT04330040|453461138|FG002|Overall Study|Withdrawal by Subject|0|||
126044616|NCT04330040|453461136|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
126044617|NCT04330040|453461137|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
126044618|NCT04330040|453461138|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
126044619|NCT04330040|453461136|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
126044620|NCT04330040|453461137|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
126044621|NCT04330040|453461138|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
126303528|NCT00912743|454400371|FG001|Overall Study|Toxicity|1|||
126303529|NCT00912743|454400370|FG000|Overall Study|End of treatment form was not collected|1|||
126303530|NCT00912743|454400371|FG001|Overall Study|End of treatment form was not collected|0|||
126303531|NCT00179660|454400381|FG000|Overall Study|Adverse Event|7|||
126303532|NCT00179660|454400381|FG000|Overall Study|Lack of therapeutic effect|28|||
126303533|NCT00179660|454400381|FG000|Overall Study|Withdrawal by Subject|2|||
126044622|NCT04330040|453461136|FG000|Overall Study|Other: Disease progression|1|||
126044623|NCT04330040|453461137|FG001|Overall Study|Other: Disease progression|0|||
126367962|NCT02314923|454642879|FG000|Overall Study|Death|0|||
126367963|NCT02314923|454642880|FG001|Overall Study|Death|0|||
126367964|NCT02314923|454642881|FG002|Overall Study|Death|0|||
126367965|NCT02314923|454642882|FG003|Overall Study|Death|1|||
126367966|NCT02314923|454642883|FG004|Overall Study|Death|0|||
126367967|NCT02314923|454642884|FG005|Overall Study|Death|0|||
126367968|NCT02314923|454642885|FG006|Overall Study|Death|0|||
126367969|NCT02314923|454642886|FG007|Overall Study|Death|0|||
126303534|NCT00179660|454400381|FG000|Overall Study|Lost to Follow-up|1|||
126303535|NCT00179660|454400381|FG000|Overall Study|Death|3|||
126303536|NCT00179660|454400381|FG000|Overall Study|Other - Unspecified|9|||
126303537|NCT00685399|454400387|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126303538|NCT00685399|454400388|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126303539|NCT00685399|454400389|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126303540|NCT00685399|454400390|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126303541|NCT00685399|454400391|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126303542|NCT00685399|454400392|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126303543|NCT00685399|454400393|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126303544|NCT00685399|454400394|FG007|Treatment Period 1|Withdrawal by Subject|0|||
126303545|NCT00685399|454400387|FG000|Treatment Period 1|Protocol Violation|1|||
126303546|NCT00685399|454400388|FG001|Treatment Period 1|Protocol Violation|0|||
126303547|NCT00685399|454400389|FG002|Treatment Period 1|Protocol Violation|0|||
126303548|NCT00685399|454400390|FG003|Treatment Period 1|Protocol Violation|0|||
126303549|NCT00685399|454400391|FG004|Treatment Period 1|Protocol Violation|0|||
126303550|NCT00685399|454400392|FG005|Treatment Period 1|Protocol Violation|0|||
126303551|NCT00685399|454400393|FG006|Treatment Period 1|Protocol Violation|0|||
126303552|NCT00685399|454400394|FG007|Treatment Period 1|Protocol Violation|0|||
126303553|NCT00685399|454400387|FG000|Treatment Period 1|Administrative|2|||
126303554|NCT00685399|454400388|FG001|Treatment Period 1|Administrative|0|||
126303555|NCT00685399|454400389|FG002|Treatment Period 1|Administrative|0|||
126303556|NCT00685399|454400390|FG003|Treatment Period 1|Administrative|0|||
126303557|NCT00685399|454400391|FG004|Treatment Period 1|Administrative|0|||
126303558|NCT00685399|454400392|FG005|Treatment Period 1|Administrative|0|||
126303559|NCT00685399|454400393|FG006|Treatment Period 1|Administrative|0|||
126303560|NCT00685399|454400394|FG007|Treatment Period 1|Administrative|0|||
126303561|NCT00685399|454400387|FG000|Treatment Period 1|Lack of Efficacy|1|||
126303562|NCT00685399|454400388|FG001|Treatment Period 1|Lack of Efficacy|0|||
126303563|NCT00685399|454400389|FG002|Treatment Period 1|Lack of Efficacy|0|||
126303564|NCT00685399|454400390|FG003|Treatment Period 1|Lack of Efficacy|0|||
126303565|NCT00685399|454400391|FG004|Treatment Period 1|Lack of Efficacy|0|||
126303566|NCT00685399|454400392|FG005|Treatment Period 1|Lack of Efficacy|0|||
126303567|NCT00685399|454400393|FG006|Treatment Period 1|Lack of Efficacy|0|||
126303568|NCT00685399|454400394|FG007|Treatment Period 1|Lack of Efficacy|0|||
126303569|NCT00685399|454400387|FG000|Treatment Period 2|Administrative Problems|0|||
126303570|NCT00685399|454400388|FG001|Treatment Period 2|Administrative Problems|2|||
126367970|NCT02314923|454642887|FG008|Overall Study|Death|0|||
126367971|NCT02314923|454642888|FG009|Overall Study|Death|0|||
126367972|NCT02314923|454642879|FG000|Overall Study|Lost to Follow-up|2|||
126303571|NCT00685399|454400389|FG002|Treatment Period 2|Administrative Problems|1|||
126303572|NCT00685399|454400390|FG003|Treatment Period 2|Administrative Problems|0|||
126303573|NCT00685399|454400391|FG004|Treatment Period 2|Administrative Problems|0|||
126303574|NCT00685399|454400392|FG005|Treatment Period 2|Administrative Problems|0|||
126303575|NCT00685399|454400393|FG006|Treatment Period 2|Administrative Problems|0|||
126303576|NCT00685399|454400394|FG007|Treatment Period 2|Administrative Problems|0|||
126303577|NCT00685399|454400387|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126303578|NCT00685399|454400388|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126303579|NCT00685399|454400389|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126303580|NCT00685399|454400390|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126367973|NCT02314923|454642880|FG001|Overall Study|Lost to Follow-up|3|||
126367974|NCT02314923|454642881|FG002|Overall Study|Lost to Follow-up|1|||
126367975|NCT02314923|454642882|FG003|Overall Study|Lost to Follow-up|0|||
126367976|NCT02314923|454642883|FG004|Overall Study|Lost to Follow-up|0|||
126303581|NCT00685399|454400391|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126303582|NCT00685399|454400392|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126303583|NCT00685399|454400393|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126303584|NCT00685399|454400394|FG007|Treatment Period 2|Withdrawal by Subject|2|||
126303585|NCT00685399|454400387|FG000|Treatment Period 2|Adverse Event|0|||
126303586|NCT00685399|454400388|FG001|Treatment Period 2|Adverse Event|0|||
126303587|NCT00685399|454400389|FG002|Treatment Period 2|Adverse Event|0|||
126303588|NCT00685399|454400390|FG003|Treatment Period 2|Adverse Event|0|||
126303589|NCT00685399|454400391|FG004|Treatment Period 2|Adverse Event|0|||
126303590|NCT00685399|454400392|FG005|Treatment Period 2|Adverse Event|1|||
126303591|NCT00685399|454400393|FG006|Treatment Period 2|Adverse Event|0|||
126303592|NCT00685399|454400394|FG007|Treatment Period 2|Adverse Event|0|||
126303593|NCT00685399|454400387|FG000|Treatment Period 2|Lack of Efficacy|0|||
126303594|NCT00685399|454400388|FG001|Treatment Period 2|Lack of Efficacy|10|||
126303595|NCT00685399|454400389|FG002|Treatment Period 2|Lack of Efficacy|2|||
126303596|NCT00685399|454400390|FG003|Treatment Period 2|Lack of Efficacy|0|||
126303597|NCT00685399|454400391|FG004|Treatment Period 2|Lack of Efficacy|0|||
126303598|NCT00685399|454400392|FG005|Treatment Period 2|Lack of Efficacy|1|||
126303599|NCT00685399|454400393|FG006|Treatment Period 2|Lack of Efficacy|0|||
126303600|NCT00685399|454400394|FG007|Treatment Period 2|Lack of Efficacy|0|||
126303601|NCT00685399|454400387|FG000|Extension|Administrative Issues|0|||
126303602|NCT00685399|454400388|FG001|Extension|Administrative Issues|0|||
126303603|NCT00685399|454400389|FG002|Extension|Administrative Issues|0|||
126303604|NCT00685399|454400390|FG003|Extension|Administrative Issues|1|||
126303605|NCT00685399|454400391|FG004|Extension|Administrative Issues|0|||
126303606|NCT00685399|454400392|FG005|Extension|Administrative Issues|0|||
126303607|NCT00685399|454400393|FG006|Extension|Administrative Issues|0|||
126303608|NCT00685399|454400394|FG007|Extension|Administrative Issues|0|||
126303609|NCT00685399|454400387|FG000|Extension|Withdrawal by Subject|0|||
126303610|NCT00685399|454400388|FG001|Extension|Withdrawal by Subject|0|||
126303611|NCT00685399|454400389|FG002|Extension|Withdrawal by Subject|0|||
126303612|NCT00685399|454400390|FG003|Extension|Withdrawal by Subject|1|||
126303613|NCT00685399|454400391|FG004|Extension|Withdrawal by Subject|0|||
126303614|NCT00685399|454400392|FG005|Extension|Withdrawal by Subject|0|||
126303615|NCT00685399|454400393|FG006|Extension|Withdrawal by Subject|0|||
126303616|NCT00685399|454400394|FG007|Extension|Withdrawal by Subject|0|||
126303617|NCT00685399|454400387|FG000|Extension|Protocol Violation|0|||
126303618|NCT00685399|454400388|FG001|Extension|Protocol Violation|0|||
126303619|NCT00685399|454400389|FG002|Extension|Protocol Violation|0|||
126303620|NCT00685399|454400390|FG003|Extension|Protocol Violation|1|||
126303621|NCT00685399|454400391|FG004|Extension|Protocol Violation|0|||
126303622|NCT00685399|454400392|FG005|Extension|Protocol Violation|0|||
126303623|NCT00685399|454400393|FG006|Extension|Protocol Violation|0|||
126303624|NCT00685399|454400394|FG007|Extension|Protocol Violation|0|||
126303625|NCT00685399|454400387|FG000|Extension|Lack of Efficacy|0|||
126303626|NCT00685399|454400388|FG001|Extension|Lack of Efficacy|0|||
126303627|NCT00685399|454400389|FG002|Extension|Lack of Efficacy|0|||
126303628|NCT00685399|454400390|FG003|Extension|Lack of Efficacy|2|||
126303629|NCT00685399|454400391|FG004|Extension|Lack of Efficacy|0|||
126303630|NCT00685399|454400392|FG005|Extension|Lack of Efficacy|0|||
126303631|NCT00685399|454400393|FG006|Extension|Lack of Efficacy|0|||
126303632|NCT00685399|454400394|FG007|Extension|Lack of Efficacy|0|||
126303633|NCT00685399|454400387|FG000|Extension|Adverse Event|0|||
126303634|NCT00685399|454400388|FG001|Extension|Adverse Event|0|||
126303635|NCT00685399|454400389|FG002|Extension|Adverse Event|0|||
126303636|NCT00685399|454400390|FG003|Extension|Adverse Event|2|||
126303637|NCT00685399|454400391|FG004|Extension|Adverse Event|0|||
126303638|NCT00685399|454400392|FG005|Extension|Adverse Event|0|||
126303639|NCT00685399|454400393|FG006|Extension|Adverse Event|0|||
126303640|NCT00685399|454400394|FG007|Extension|Adverse Event|0|||
126303641|NCT00178685|454400395|FG000|Overall Study|Death|3|||
126303642|NCT00178685|454400396|FG001|Overall Study|Death|3|||
126303643|NCT00178685|454400397|FG002|Overall Study|Death|6|||
126303644|NCT00178685|454400395|FG000|Overall Study|Lost to Follow-up|100|||
126303645|NCT00178685|454400396|FG001|Overall Study|Lost to Follow-up|187|||
126303646|NCT00178685|454400397|FG002|Overall Study|Lost to Follow-up|183|||
126303647|NCT00178685|454400395|FG000|Overall Study|Withdrawal by Subject|8|||
126303648|NCT00178685|454400396|FG001|Overall Study|Withdrawal by Subject|14|||
126303649|NCT00178685|454400397|FG002|Overall Study|Withdrawal by Subject|7|||
126367977|NCT02314923|454642884|FG005|Overall Study|Lost to Follow-up|0|||
126367978|NCT02314923|454642885|FG006|Overall Study|Lost to Follow-up|3|||
126303650|NCT01562782|454400400|FG000|Overall Study|Withdrawal by Subject|3|||
126303651|NCT01562782|454400401|FG001|Overall Study|Withdrawal by Subject|3|||
126303652|NCT01562782|454400400|FG000|Overall Study|screen failure|1|||
126303653|NCT01562782|454400401|FG001|Overall Study|screen failure|2|||
126303654|NCT02993250|454400406|FG000|Overall Study|Lost to Follow-up|0|||
126303655|NCT02993250|454400407|FG001|Overall Study|Lost to Follow-up|1|||
126303656|NCT02527434|454400408|FG000|Overall Study|Lost to Follow-up|2|||
126303657|NCT02527434|454400409|FG001|Overall Study|Lost to Follow-up|2|||
126303658|NCT02527434|454400410|FG002|Overall Study|Lost to Follow-up|0|||
126303659|NCT02527434|454400408|FG000|Overall Study|Death|19|||
126367979|NCT02314923|454642886|FG007|Overall Study|Lost to Follow-up|4|||
126367980|NCT02314923|454642887|FG008|Overall Study|Lost to Follow-up|2|||
126367981|NCT02314923|454642888|FG009|Overall Study|Lost to Follow-up|0|||
126367982|NCT02314923|454642879|FG000|Overall Study|Withdrawal by Subject|0|||
126367983|NCT02314923|454642880|FG001|Overall Study|Withdrawal by Subject|0|||
126367984|NCT02314923|454642881|FG002|Overall Study|Withdrawal by Subject|1|||
126367985|NCT02314923|454642882|FG003|Overall Study|Withdrawal by Subject|0|||
126367986|NCT02314923|454642883|FG004|Overall Study|Withdrawal by Subject|1|||
126367987|NCT02314923|454642884|FG005|Overall Study|Withdrawal by Subject|0|||
126367988|NCT02314923|454642885|FG006|Overall Study|Withdrawal by Subject|1|||
126367989|NCT02314923|454642886|FG007|Overall Study|Withdrawal by Subject|0|||
126367990|NCT02314923|454642887|FG008|Overall Study|Withdrawal by Subject|0|||
126367991|NCT02314923|454642888|FG009|Overall Study|Withdrawal by Subject|0|||
126367992|NCT02314923|454642879|FG000|Overall Study|Physician Decision|0|||
126367993|NCT02314923|454642880|FG001|Overall Study|Physician Decision|1|||
126367994|NCT02314923|454642881|FG002|Overall Study|Physician Decision|0|||
126367995|NCT02314923|454642882|FG003|Overall Study|Physician Decision|0|||
126367996|NCT02314923|454642883|FG004|Overall Study|Physician Decision|0|||
126367997|NCT02314923|454642884|FG005|Overall Study|Physician Decision|0|||
126367998|NCT02314923|454642885|FG006|Overall Study|Physician Decision|0|||
126367999|NCT02314923|454642886|FG007|Overall Study|Physician Decision|0|||
126368000|NCT02314923|454642887|FG008|Overall Study|Physician Decision|0|||
126368001|NCT02314923|454642888|FG009|Overall Study|Physician Decision|0|||
126368002|NCT02314923|454642879|FG000|Overall Study|Participant unavailable|0|||
126368003|NCT02314923|454642880|FG001|Overall Study|Participant unavailable|0|||
126368004|NCT02314923|454642881|FG002|Overall Study|Participant unavailable|0|||
126368005|NCT02314923|454642882|FG003|Overall Study|Participant unavailable|0|||
126368006|NCT02314923|454642883|FG004|Overall Study|Participant unavailable|0|||
126368007|NCT02314923|454642884|FG005|Overall Study|Participant unavailable|1|||
126368008|NCT02314923|454642885|FG006|Overall Study|Participant unavailable|0|||
126368009|NCT02314923|454642886|FG007|Overall Study|Participant unavailable|0|||
126368010|NCT02314923|454642887|FG008|Overall Study|Participant unavailable|0|||
126368011|NCT02314923|454642888|FG009|Overall Study|Participant unavailable|0|||
126368012|NCT02314923|454642879|FG000|Overall Study|Screen failure|0|||
126368013|NCT02314923|454642880|FG001|Overall Study|Screen failure|0|||
126368014|NCT02314923|454642881|FG002|Overall Study|Screen failure|0|||
126368015|NCT02314923|454642882|FG003|Overall Study|Screen failure|0|||
126368016|NCT02314923|454642883|FG004|Overall Study|Screen failure|0|||
126368017|NCT02314923|454642884|FG005|Overall Study|Screen failure|0|||
126368018|NCT02314923|454642885|FG006|Overall Study|Screen failure|1|||
126368019|NCT02314923|454642886|FG007|Overall Study|Screen failure|0|||
126368020|NCT02314923|454642887|FG008|Overall Study|Screen failure|0|||
126368021|NCT02314923|454642888|FG009|Overall Study|Screen failure|0|||
126368022|NCT02314923|454642879|FG000|Overall Study|Participant relocation|1|||
126368023|NCT02314923|454642880|FG001|Overall Study|Participant relocation|0|||
126368024|NCT02314923|454642881|FG002|Overall Study|Participant relocation|0|||
126368025|NCT02314923|454642882|FG003|Overall Study|Participant relocation|0|||
126368026|NCT02314923|454642883|FG004|Overall Study|Participant relocation|0|||
126368027|NCT02314923|454642884|FG005|Overall Study|Participant relocation|0|||
126368028|NCT02314923|454642885|FG006|Overall Study|Participant relocation|0|||
125884334|NCT04988477|452873284|FG002|Overall Study|Withdrawal by Subject|0|||
126368029|NCT02314923|454642886|FG007|Overall Study|Participant relocation|1|||
126368030|NCT02314923|454642887|FG008|Overall Study|Participant relocation|0|||
126368031|NCT02314923|454642888|FG009|Overall Study|Participant relocation|0|||
126368032|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Adverse Event|20|||
126368033|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Adverse Event|10|||
126368034|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Adverse Event|5|||
126368035|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Adverse Event|0|||
126368036|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Adverse Event|0|||
126368037|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Adverse Event|0|||
126368038|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Adverse Event|0|||
126368039|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Adverse Event|0|||
126368040|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Adverse Event|0|||
126368041|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Adverse Event|0|||
126368042|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Adverse Event|0|||
126368043|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Adverse Event|0|||
126368044|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368045|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368046|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
126368047|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368048|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368049|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368050|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368051|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368052|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368053|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
126303660|NCT02527434|454400409|FG001|Overall Study|Death|6|||
126303661|NCT02527434|454400410|FG002|Overall Study|Death|17|||
126303662|NCT02527434|454400408|FG000|Overall Study|Withdrawal by Subject|5|||
126303663|NCT02527434|454400409|FG001|Overall Study|Withdrawal by Subject|3|||
126303664|NCT02527434|454400410|FG002|Overall Study|Withdrawal by Subject|3|||
126303665|NCT02527434|454400408|FG000|Overall Study|Reason Not Specified|1|||
126303666|NCT02527434|454400409|FG001|Overall Study|Reason Not Specified|0|||
126303667|NCT02527434|454400410|FG002|Overall Study|Reason Not Specified|0|||
126303668|NCT02527434|454400408|FG000|Overall Study|Site closure|1|||
126303669|NCT02527434|454400409|FG001|Overall Study|Site closure|0|||
126303670|NCT02527434|454400410|FG002|Overall Study|Site closure|0|||
126303671|NCT00568061|454400411|FG000|Overall Study|Inclusion / exclusion criteria|5|||
126303672|NCT00568061|454400412|FG001|Overall Study|Inclusion / exclusion criteria|1|||
126303673|NCT00568061|454400411|FG000|Overall Study|Adverse Event|0|||
126303674|NCT00568061|454400412|FG001|Overall Study|Adverse Event|1|||
126303675|NCT01896128|454400413|FG000|Overall Study|Withdrawal by Subject|3|||
126303676|NCT01896128|454400414|FG001|Overall Study|Withdrawal by Subject|3|||
126303677|NCT02484456|454400417|FG000|Washout Period|Withdrawal by Subject|0|||
126303678|NCT02484456|454400418|FG001|Washout Period|Withdrawal by Subject|1|||
126303679|NCT02484456|454400417|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
126303680|NCT02484456|454400418|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
126303681|NCT02484456|454400417|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
126303682|NCT02484456|454400418|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
126303683|NCT02484456|454400417|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
126303684|NCT02484456|454400418|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
126303685|NCT01996254|454400419|FG000|Overall Study|Change in Eligibility|0|||
126303686|NCT01996254|454400420|FG001|Overall Study|Change in Eligibility|2|||
126303687|NCT01996254|454400421|FG002|Overall Study|Change in Eligibility|0|||
126303688|NCT01996254|454400419|FG000|Overall Study|Withdrawal by Subject|0|||
126303689|NCT01996254|454400420|FG001|Overall Study|Withdrawal by Subject|3|||
126303690|NCT01996254|454400421|FG002|Overall Study|Withdrawal by Subject|4|||
126303691|NCT01996254|454400419|FG000|Overall Study|Lost to Follow-up|1|||
126303692|NCT01996254|454400420|FG001|Overall Study|Lost to Follow-up|0|||
126303693|NCT01996254|454400421|FG002|Overall Study|Lost to Follow-up|4|||
126303694|NCT03348930|454400424|FG000|Washout (1 Week)|Lost to Follow-up|1|||
126303695|NCT03348930|454400425|FG001|Washout (1 Week)|Lost to Follow-up|1|||
126303696|NCT00708214|454400428|FG000|Overall Study|Other Adverse Event|3|||
126303697|NCT00708214|454400429|FG001|Overall Study|Other Adverse Event|6|||
126303698|NCT00708214|454400430|FG002|Overall Study|Other Adverse Event|2|||
126303699|NCT00708214|454400428|FG000|Overall Study|Other|0|||
126303700|NCT00708214|454400429|FG001|Overall Study|Other|1|||
126303701|NCT00708214|454400430|FG002|Overall Study|Other|1|||
126303702|NCT00708214|454400428|FG000|Overall Study|Progressive Disease|4|||
126303703|NCT00708214|454400429|FG001|Overall Study|Progressive Disease|6|||
126303704|NCT00708214|454400430|FG002|Overall Study|Progressive Disease|5|||
126303705|NCT02411396|454400431|FG000|Overall Study|Lost to Follow-up|31|||
126303706|NCT02411396|454400431|FG000|Overall Study|Death|10|||
126303707|NCT02865499|454400432|FG000|Baseline|Adverse Event|1|||
126303708|NCT02865499|454400432|FG000|Baseline|Withdrawal by Subject|1|||
126303709|NCT01931995|454400433|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
126303710|NCT01931995|454400434|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
126103400|NCT02924064|453672151|FG001|Overall Study|Physician Decision|2|||
126303711|NCT01931995|454400433|FG000|First Intervention (1 Day)|Physician Decision|1|||
126303712|NCT01931995|454400434|FG001|First Intervention (1 Day)|Physician Decision|1|||
126303713|NCT01931995|454400433|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
126303714|NCT01931995|454400434|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
126303715|NCT02064816|454400438|FG000|Overall Study|Adverse Event|3|||
126303716|NCT02064816|454400439|FG001|Overall Study|Adverse Event|2|||
126303717|NCT02064816|454400438|FG000|Overall Study|Withdrawal by Subject|2|||
126303718|NCT02064816|454400439|FG001|Overall Study|Withdrawal by Subject|1|||
126303719|NCT02064816|454400438|FG000|Overall Study|Lost to Follow-up|2|||
126303720|NCT02064816|454400439|FG001|Overall Study|Lost to Follow-up|1|||
126303721|NCT02064816|454400438|FG000|Overall Study|Therapeutic failure|0|||
126303722|NCT02064816|454400439|FG001|Overall Study|Therapeutic failure|1|||
126303723|NCT02064816|454400438|FG000|Overall Study|Other|1|||
126303724|NCT02064816|454400439|FG001|Overall Study|Other|3|||
126303725|NCT01732458|454400440|FG000|Overall Study|Lost to Follow-up|0|||
126303726|NCT01732458|454400441|FG001|Overall Study|Lost to Follow-up|2|||
126303727|NCT01732458|454400442|FG002|Overall Study|Lost to Follow-up|0|||
126303728|NCT01732458|454400443|FG003|Overall Study|Lost to Follow-up|0|||
126303729|NCT01732458|454400440|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126303730|NCT01732458|454400441|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126303731|NCT01732458|454400442|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126303732|NCT01732458|454400443|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126303733|NCT01732458|454400440|FG000|Overall Study|Physician Decision|1|||
126303734|NCT01732458|454400441|FG001|Overall Study|Physician Decision|2|||
126303735|NCT01732458|454400442|FG002|Overall Study|Physician Decision|2|||
126303736|NCT01732458|454400443|FG003|Overall Study|Physician Decision|0|||
126303737|NCT01732458|454400440|FG000|Overall Study|Protocol Violation|2|||
126303738|NCT01732458|454400441|FG001|Overall Study|Protocol Violation|0|||
126303739|NCT01732458|454400442|FG002|Overall Study|Protocol Violation|0|||
126303740|NCT01732458|454400443|FG003|Overall Study|Protocol Violation|2|||
126303741|NCT01732458|454400440|FG000|Overall Study|Screen Failure|0|||
126303742|NCT01732458|454400441|FG001|Overall Study|Screen Failure|1|||
126303743|NCT01732458|454400442|FG002|Overall Study|Screen Failure|0|||
126303744|NCT01732458|454400443|FG003|Overall Study|Screen Failure|0|||
126303745|NCT03759587|454400444|FG000|Overall Study|Adverse Event|5|||
126303746|NCT03759587|454400444|FG000|Overall Study|Progressive Disease|10|||
126303747|NCT03759587|454400444|FG000|Overall Study|Site Terminated by Sponsor|3|||
126303748|NCT03759587|454400444|FG000|Overall Study|Withdrawal by Subject|1|||
126303749|NCT04615403|454400445|FG000|Overall Study|Death|1|||
126303750|NCT05119595|454402444|FG000|Overall Study|Death|1|||
126303751|NCT05119595|454402444|FG000|Overall Study|Lost to Follow-up|7|||
126303752|NCT03483961|454402445|FG000|Overall Study|Lost to Follow-up|7|||
126303753|NCT03483961|454402446|FG001|Overall Study|Lost to Follow-up|6|||
126303754|NCT03483961|454402447|FG002|Overall Study|Lost to Follow-up|6|||
126303755|NCT03483961|454402448|FG003|Overall Study|Lost to Follow-up|6|||
126303756|NCT03483961|454402449|FG004|Overall Study|Lost to Follow-up|6|||
126303757|NCT03483961|454402450|FG005|Overall Study|Lost to Follow-up|4|||
126303758|NCT03483961|454402451|FG006|Overall Study|Lost to Follow-up|4|||
126303759|NCT03483961|454402452|FG007|Overall Study|Lost to Follow-up|11|||
126303760|NCT03483961|454402453|FG008|Overall Study|Lost to Follow-up|1|||
126303761|NCT03483961|454402454|FG009|Overall Study|Lost to Follow-up|0|||
126303762|NCT03483961|454402445|FG000|Overall Study|Withdrawal by Subject|3|||
126303763|NCT03483961|454402446|FG001|Overall Study|Withdrawal by Subject|4|||
126303764|NCT03483961|454402447|FG002|Overall Study|Withdrawal by Subject|5|||
126303765|NCT03483961|454402448|FG003|Overall Study|Withdrawal by Subject|3|||
126303766|NCT03483961|454402449|FG004|Overall Study|Withdrawal by Subject|4|||
126303767|NCT03483961|454402450|FG005|Overall Study|Withdrawal by Subject|2|||
126303768|NCT03483961|454402451|FG006|Overall Study|Withdrawal by Subject|1|||
126303769|NCT03483961|454402452|FG007|Overall Study|Withdrawal by Subject|2|||
126303770|NCT03483961|454402453|FG008|Overall Study|Withdrawal by Subject|1|||
126044624|NCT04330040|453461138|FG002|Overall Study|Other: Disease progression|0|||
126044625|NCT04330040|453461136|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
126044626|NCT04330040|453461137|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
126044627|NCT04330040|453461138|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
126044628|NCT04330040|453461136|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
126044629|NCT04330040|453461137|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
126044630|NCT04330040|453461138|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
126044631|NCT04330040|453461136|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
126044632|NCT04330040|453461137|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
126044633|NCT04330040|453461138|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
126044634|NCT00626795|453461141|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
126044635|NCT00626795|453461142|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
126044636|NCT00626795|453461143|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
126044637|NCT00626795|453461141|FG000|Blinded Treatment|Lack of Efficacy|2|||
126044638|NCT00626795|453461142|FG001|Blinded Treatment|Lack of Efficacy|0|||
126044639|NCT00626795|453461143|FG002|Blinded Treatment|Lack of Efficacy|0|||
126044640|NCT00626795|453461141|FG000|Blinded Treatment|Unacceptable adverse event|0|||
126044641|NCT00626795|453461142|FG001|Blinded Treatment|Unacceptable adverse event|0|||
126044642|NCT00626795|453461143|FG002|Blinded Treatment|Unacceptable adverse event|1|||
126044643|NCT00626795|453461141|FG000|Blinded Treatment|Protocol Violation|0|||
126044644|NCT00626795|453461142|FG001|Blinded Treatment|Protocol Violation|1|||
126044645|NCT00626795|453461143|FG002|Blinded Treatment|Protocol Violation|1|||
126044646|NCT00626795|453461141|FG000|Blinded Treatment|Withdrawal by Subject|1|||
126044647|NCT00626795|453461142|FG001|Blinded Treatment|Withdrawal by Subject|1|||
126303771|NCT03483961|454402454|FG009|Overall Study|Withdrawal by Subject|0|||
126303772|NCT03483961|454402445|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
126303773|NCT03483961|454402446|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303774|NCT03483961|454402447|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125884335|NCT04610281|452874962|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
126044648|NCT00626795|453461143|FG002|Blinded Treatment|Withdrawal by Subject|0|||
126044649|NCT00626795|453461141|FG000|Blinded Treatment|Other reasons|2|||
126044650|NCT00626795|453461142|FG001|Blinded Treatment|Other reasons|0|||
126044651|NCT00626795|453461143|FG002|Blinded Treatment|Other reasons|2|||
126044652|NCT00626795|453461141|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
126044653|NCT00626795|453461142|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
126303775|NCT03483961|454402448|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303776|NCT03483961|454402449|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303777|NCT03483961|454402450|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303778|NCT03483961|454402451|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303779|NCT03483961|454402452|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303780|NCT03483961|454402453|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303781|NCT03483961|454402454|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303782|NCT03483961|454402445|FG000|Overall Study|Adverse Event|0|||
126303783|NCT03483961|454402446|FG001|Overall Study|Adverse Event|0|||
126303784|NCT03483961|454402447|FG002|Overall Study|Adverse Event|1|||
126303785|NCT03483961|454402448|FG003|Overall Study|Adverse Event|0|||
126303786|NCT03483961|454402449|FG004|Overall Study|Adverse Event|0|||
126303787|NCT03483961|454402450|FG005|Overall Study|Adverse Event|0|||
126303788|NCT03483961|454402451|FG006|Overall Study|Adverse Event|0|||
126303789|NCT03483961|454402452|FG007|Overall Study|Adverse Event|0|||
126303790|NCT03483961|454402453|FG008|Overall Study|Adverse Event|0|||
126303791|NCT03483961|454402454|FG009|Overall Study|Adverse Event|0|||
126303792|NCT00443079|454402455|FG000|Overall Study|Lost to Follow-up|0|||
126303793|NCT00443079|454402456|FG001|Overall Study|Lost to Follow-up|1|||
126044654|NCT00626795|453461143|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
126044655|NCT04159519|453461144|FG000|Overall Study|Adverse Event|1|||
126044656|NCT04159519|453461145|FG001|Overall Study|Adverse Event|1|||
126044657|NCT04159519|453461144|FG000|Overall Study|Lack of Efficacy|1|||
126044658|NCT04159519|453461145|FG001|Overall Study|Lack of Efficacy|0|||
126044659|NCT04159519|453461144|FG000|Overall Study|Discontinued from study|1|||
126044660|NCT04159519|453461145|FG001|Overall Study|Discontinued from study|0|||
126044661|NCT04159519|453461144|FG000|Overall Study|Protocol Violation|1|||
126044662|NCT04159519|453461145|FG001|Overall Study|Protocol Violation|1|||
126044663|NCT04159519|453461144|FG000|Overall Study|Withdrawal by Subject|4|||
126044664|NCT04159519|453461145|FG001|Overall Study|Withdrawal by Subject|4|||
126044665|NCT02246127|453461885|FG000|First Course Treatment|Adverse Event|9|||
126044666|NCT02246127|453461886|FG001|First Course Treatment|Adverse Event|7|||
126044667|NCT02246127|453461885|FG000|First Course Treatment|Withdrawal by Subject|6|||
126044668|NCT02246127|453461886|FG001|First Course Treatment|Withdrawal by Subject|7|||
126044669|NCT02246127|453461885|FG000|First Course Treatment|Physician Decision|9|||
126044670|NCT02246127|453461886|FG001|First Course Treatment|Physician Decision|9|||
126044671|NCT02246127|453461885|FG000|First Course Treatment|Death|3|||
126044672|NCT02246127|453461886|FG001|First Course Treatment|Death|3|||
126044673|NCT02246127|453461885|FG000|First Course Treatment|Not reported reasons|6|||
126044674|NCT02246127|453461886|FG001|First Course Treatment|Not reported reasons|7|||
126044675|NCT02246127|453461885|FG000|First Course Treatment|Not treated|3|||
126044676|NCT02246127|453461886|FG001|First Course Treatment|Not treated|3|||
126044677|NCT06262347|453461889|FG000|Overall Study|Lost to Follow-up|4|||
126044678|NCT06262347|453461890|FG001|Overall Study|Lost to Follow-up|3|||
126044679|NCT06262347|453461889|FG000|Overall Study|Withdrawal by Subject|0|||
126044680|NCT06262347|453461890|FG001|Overall Study|Withdrawal by Subject|1|||
126044681|NCT05830799|453461893|FG000|Overall Study|Withdrawal by Subject|1|||
126044682|NCT02163694|453461894|FG000|Overall Study|Adverse event- related to progression|4|||
126044683|NCT02163694|453461895|FG001|Overall Study|Adverse event- related to progression|10|||
126044684|NCT02163694|453461894|FG000|Overall Study|Adverse event- not related to progression|7|||
126044685|NCT02163694|453461895|FG001|Overall Study|Adverse event- not related to progression|22|||
126044686|NCT02163694|453461894|FG000|Overall Study|Withdrew consent|13|||
126044687|NCT02163694|453461895|FG001|Overall Study|Withdrew consent|28|||
126044688|NCT02163694|453461894|FG000|Overall Study|Lost to Follow-up|2|||
126044689|NCT02163694|453461895|FG001|Overall Study|Lost to Follow-up|2|||
126044690|NCT02163694|453461894|FG000|Overall Study|Sponsor discontinued study|3|||
126044691|NCT02163694|453461895|FG001|Overall Study|Sponsor discontinued study|29|||
126044692|NCT02163694|453461894|FG000|Overall Study|Progressive disease per protocol|125|||
126044693|NCT02163694|453461895|FG001|Overall Study|Progressive disease per protocol|224|||
126044694|NCT02163694|453461894|FG000|Overall Study|Other, not specified|17|||
126044695|NCT02163694|453461895|FG001|Overall Study|Other, not specified|22|||
126044696|NCT02163694|453461894|FG000|Overall Study|Randomized but Not Treated|1|||
126044697|NCT02163694|453461895|FG001|Overall Study|Randomized but Not Treated|0|||
126044698|NCT02163694|453461894|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
126044699|NCT02163694|453461895|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
126044700|NCT04631016|453461898|FG000|Overall Study|Adverse Event|3|||
126044701|NCT04631016|453461899|FG001|Overall Study|Adverse Event|0|||
126044702|NCT04631016|453461898|FG000|Overall Study|Withdrawal by Subject|5|||
126044703|NCT04631016|453461899|FG001|Overall Study|Withdrawal by Subject|4|||
126044704|NCT04631016|453461898|FG000|Overall Study|Reason unspecified|1|||
126303794|NCT02649439|454402457|FG000|Overall Study|Switched to alternative treatment|6|||
126303795|NCT02649439|454402458|FG001|Overall Study|Switched to alternative treatment|4|||
126303796|NCT02649439|454402457|FG000|Overall Study|Patient decision|1|||
126303797|NCT02649439|454402458|FG001|Overall Study|Patient decision|0|||
126303798|NCT02649439|454402457|FG000|Overall Study|Patient going out of country|1|||
126303799|NCT02649439|454402458|FG001|Overall Study|Patient going out of country|0|||
126303800|NCT02649439|454402457|FG000|Overall Study|To start finasteride|1|||
126303801|NCT02649439|454402458|FG001|Overall Study|To start finasteride|0|||
126303802|NCT02649439|454402457|FG000|Overall Study|Physician Decision|1|||
126303803|NCT02649439|454402458|FG001|Overall Study|Physician Decision|0|||
126303804|NCT02649439|454402457|FG000|Overall Study|Disease progression on study|12|||
126303805|NCT02649439|454402458|FG001|Overall Study|Disease progression on study|13|||
126303806|NCT02649439|454402457|FG000|Overall Study|Refused further treatment|1|||
126303807|NCT02649439|454402458|FG001|Overall Study|Refused further treatment|0|||
126303808|NCT02649439|454402457|FG000|Overall Study|Refused further follow up|2|||
126303809|NCT02649439|454402458|FG001|Overall Study|Refused further follow up|7|||
126303810|NCT02649439|454402457|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
125884336|NCT04610281|452874963|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
125884337|NCT01458392|452874965|FG000|Overall Study|Death|2|||
125884338|NCT01458392|452874966|FG001|Overall Study|Death|11|||
125884339|NCT01458392|452874967|FG002|Overall Study|Death|22|||
125884340|NCT01458392|452874965|FG000|Overall Study|At the discretion of the sponsor|0|||
125884341|NCT01458392|452874966|FG001|Overall Study|At the discretion of the sponsor|2|||
125884342|NCT01458392|452874967|FG002|Overall Study|At the discretion of the sponsor|7|||
125884343|NCT01458392|452874965|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
126303811|NCT02649439|454402458|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
126303812|NCT02649439|454402457|FG000|Overall Study|No treatment, per protocol|1|||
126303813|NCT02649439|454402458|FG001|Overall Study|No treatment, per protocol|0|||
126303814|NCT02649439|454402457|FG000|Overall Study|PSA DT makes ineligible|0|||
126303815|NCT02649439|454402458|FG001|Overall Study|PSA DT makes ineligible|1|||
126303816|NCT02649439|454402457|FG000|Overall Study|Rising PSA No Mets|0|||
126303817|NCT02649439|454402458|FG001|Overall Study|Rising PSA No Mets|1|||
126303818|NCT02649439|454402457|FG000|Overall Study|Rising PSA|0|||
126303819|NCT02649439|454402458|FG001|Overall Study|Rising PSA|1|||
126303820|NCT02649439|454402457|FG000|Overall Study|Signed follow up protocol|0|||
126303821|NCT02649439|454402458|FG001|Overall Study|Signed follow up protocol|1|||
126303822|NCT02714595|454402462|FG000|Overall Study|Lost to Follow-up|1|||
126303823|NCT02714595|454402463|FG001|Overall Study|Lost to Follow-up|0|||
126303824|NCT02714595|454402462|FG000|Overall Study|Withdrawal by Subject|1|||
126303825|NCT02714595|454402463|FG001|Overall Study|Withdrawal by Subject|2|||
126303826|NCT02714595|454402462|FG000|Overall Study|Lack of Efficacy|0|||
126303827|NCT02714595|454402463|FG001|Overall Study|Lack of Efficacy|1|||
126303828|NCT02714595|454402462|FG000|Overall Study|Death|30|||
126303829|NCT02714595|454402463|FG001|Overall Study|Death|9|||
126303830|NCT02714595|454402462|FG000|Overall Study|Other-Miscellaneous|0|||
126303831|NCT02714595|454402463|FG001|Overall Study|Other-Miscellaneous|1|||
126303832|NCT00713258|454402464|FG000|Overall Study|Adverse Event|2|||
126303833|NCT00713258|454402465|FG001|Overall Study|Adverse Event|4|||
126303834|NCT00713258|454402464|FG000|Overall Study|Non-Compliance|2|||
126303835|NCT00713258|454402465|FG001|Overall Study|Non-Compliance|1|||
126303836|NCT00713258|454402464|FG000|Overall Study|Other|1|||
126303837|NCT00713258|454402465|FG001|Overall Study|Other|1|||
126303838|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
126303839|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
126303840|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
126303841|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
126303842|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
126303843|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
126303844|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
126303845|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
126303846|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
126303847|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
126303848|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
126303849|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
126303850|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
126303851|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
126303852|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
126303853|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
126303854|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
126303855|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
126303856|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
126303857|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
126303858|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
126303859|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
126303860|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
126303861|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
126303862|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
126303863|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
126303864|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
126303865|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
126303866|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
126303867|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
126303868|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
126303869|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
126303870|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
126303871|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
126303872|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
126303873|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
126303874|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
126303875|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
126303876|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
126303877|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
126303878|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
126303879|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
126303880|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303881|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303882|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303883|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303884|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303885|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
126303886|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
126303887|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
126303888|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
126303889|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
126303890|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
126303891|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
126303892|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
126303893|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
126303894|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
126303895|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
126303896|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
126303897|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
126303898|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Death|0|||
126303899|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Death|0|||
126303900|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Death|0|||
126303901|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Death|0|||
126303902|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Death|0|||
126303903|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Death|1|||
126303904|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
126303905|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
126303906|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
126303907|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
126303908|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
126303909|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
126303910|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
126303911|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
126303912|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
126303913|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
126303914|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
126303915|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
126303916|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
126303917|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
126303918|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
126303919|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
126303920|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
126303921|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
126303922|NCT02016105|454402466|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
126303923|NCT02016105|454402467|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
126303924|NCT02016105|454402468|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
126303925|NCT02016105|454402469|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
126303926|NCT02016105|454402470|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
126303927|NCT02016105|454402471|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
126303928|NCT02016105|454402466|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
126303929|NCT02016105|454402467|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
126303930|NCT02016105|454402468|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
126303931|NCT02016105|454402469|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
126303932|NCT02016105|454402470|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
126303933|NCT02016105|454402471|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
126303934|NCT02016105|454402466|FG000|EXTENSION PERIOD|Adverse Event|0|||
126303935|NCT02016105|454402467|FG001|EXTENSION PERIOD|Adverse Event|0|||
126303936|NCT02016105|454402468|FG002|EXTENSION PERIOD|Adverse Event|2|||
126303937|NCT02016105|454402469|FG003|EXTENSION PERIOD|Adverse Event|0|||
126303938|NCT02016105|454402470|FG004|EXTENSION PERIOD|Adverse Event|1|||
126303939|NCT02016105|454402471|FG005|EXTENSION PERIOD|Adverse Event|0|||
126303940|NCT02016105|454402466|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
126303941|NCT02016105|454402467|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
126303942|NCT02016105|454402468|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
126303943|NCT02016105|454402469|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
126303944|NCT02016105|454402470|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
126303945|NCT02016105|454402471|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
126303946|NCT02016105|454402466|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303947|NCT02016105|454402467|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303948|NCT02016105|454402468|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303949|NCT02016105|454402469|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303950|NCT02016105|454402470|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
126303951|NCT02016105|454402471|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303952|NCT02016105|454402466|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
126303953|NCT02016105|454402467|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
126303954|NCT02016105|454402468|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
126303955|NCT02016105|454402469|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
126303956|NCT02016105|454402470|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
126303957|NCT02016105|454402471|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
126303958|NCT01908829|454402475|FG000|Overall Study|Adverse Event|13|||
126303959|NCT01908829|454402476|FG001|Overall Study|Adverse Event|11|||
126303960|NCT01908829|454402477|FG002|Overall Study|Adverse Event|13|||
126303961|NCT01908829|454402475|FG000|Overall Study|Lost to Follow-up|4|||
126303962|NCT01908829|454402476|FG001|Overall Study|Lost to Follow-up|2|||
126303963|NCT01908829|454402477|FG002|Overall Study|Lost to Follow-up|1|||
126303964|NCT01908829|454402475|FG000|Overall Study|Randomized no double-blind drug received|1|||
126303965|NCT01908829|454402476|FG001|Overall Study|Randomized no double-blind drug received|0|||
126303966|NCT01908829|454402477|FG002|Overall Study|Randomized no double-blind drug received|1|||
126303967|NCT01908829|454402475|FG000|Overall Study|Discontinued (no EoT page)|2|||
126303968|NCT01908829|454402476|FG001|Overall Study|Discontinued (no EoT page)|0|||
126303969|NCT01908829|454402477|FG002|Overall Study|Discontinued (no EoT page)|0|||
126303970|NCT01908829|454402475|FG000|Overall Study|Miscellaneous|0|||
126303971|NCT01908829|454402476|FG001|Overall Study|Miscellaneous|2|||
126303972|NCT01908829|454402477|FG002|Overall Study|Miscellaneous|0|||
126303973|NCT01908829|454402475|FG000|Overall Study|Protocol Violation|2|||
126303974|NCT01908829|454402476|FG001|Overall Study|Protocol Violation|2|||
126303975|NCT01908829|454402477|FG002|Overall Study|Protocol Violation|0|||
126303976|NCT01908829|454402475|FG000|Overall Study|Lack of Efficacy|1|||
126368054|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
126303977|NCT01908829|454402476|FG001|Overall Study|Lack of Efficacy|3|||
126303978|NCT01908829|454402477|FG002|Overall Study|Lack of Efficacy|2|||
126303979|NCT01908829|454402475|FG000|Overall Study|Withdrawal by Subject|26|||
126303980|NCT01908829|454402476|FG001|Overall Study|Withdrawal by Subject|29|||
126368055|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368056|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
126368057|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
126368058|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
126368059|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
126368060|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
126368061|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
126368062|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
126368063|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
126368064|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
126368065|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
126368066|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
126368067|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
126368068|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
126368069|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
126368070|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
126368071|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
126368072|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
126368073|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
126368074|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
126368075|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
126368076|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
126368077|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
126368078|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
126368079|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
126368080|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Other|50|||
126303981|NCT01908829|454402477|FG002|Overall Study|Withdrawal by Subject|22|||
126303982|NCT02247440|454402478|FG000|Overall Study|Withdrawal by Subject|1|||
126303983|NCT02247440|454402478|FG000|Overall Study|Lack of Efficacy|3|||
126303984|NCT02320058|454402479|FG000|Overall Study|Death|25|||
126303985|NCT02320058|454402480|FG001|Overall Study|Death|10|||
126303986|NCT02320058|454402479|FG000|Overall Study|Lost to Follow-up|4|||
126303987|NCT02320058|454402480|FG001|Overall Study|Lost to Follow-up|0|||
126303988|NCT02320058|454402479|FG000|Overall Study|Other reasons|4|||
126303989|NCT02320058|454402480|FG001|Overall Study|Other reasons|1|||
126303990|NCT02320058|454402479|FG000|Overall Study|Withdrawal by Subject|8|||
126303991|NCT02320058|454402480|FG001|Overall Study|Withdrawal by Subject|2|||
126303992|NCT02320058|454402479|FG000|Overall Study|Not reported|1|||
126303993|NCT02320058|454402480|FG001|Overall Study|Not reported|0|||
126303994|NCT01339923|454402481|FG000|Overall Study|Adverse Event|1|||
126303995|NCT01339923|454402482|FG001|Overall Study|Adverse Event|1|||
126303996|NCT01339923|454402483|FG002|Overall Study|Adverse Event|1|||
126303997|NCT01339923|454402484|FG003|Overall Study|Adverse Event|0|||
126303998|NCT01339923|454402485|FG004|Overall Study|Adverse Event|0|||
126303999|NCT01339923|454402486|FG005|Overall Study|Adverse Event|0|||
126304000|NCT01339923|454402487|FG006|Overall Study|Adverse Event|1|||
126304001|NCT01339923|454402481|FG000|Overall Study|Inappropriate Enrollment|1|||
126304002|NCT01339923|454402482|FG001|Overall Study|Inappropriate Enrollment|0|||
126304003|NCT01339923|454402483|FG002|Overall Study|Inappropriate Enrollment|0|||
126304004|NCT01339923|454402484|FG003|Overall Study|Inappropriate Enrollment|0|||
126304005|NCT01339923|454402485|FG004|Overall Study|Inappropriate Enrollment|0|||
126304006|NCT01339923|454402486|FG005|Overall Study|Inappropriate Enrollment|1|||
126304007|NCT01339923|454402487|FG006|Overall Study|Inappropriate Enrollment|0|||
126304008|NCT01339923|454402481|FG000|Overall Study|Lost to Follow-up|4|||
126304009|NCT01339923|454402482|FG001|Overall Study|Lost to Follow-up|4|||
126304010|NCT01339923|454402483|FG002|Overall Study|Lost to Follow-up|0|||
126304011|NCT01339923|454402484|FG003|Overall Study|Lost to Follow-up|3|||
126304012|NCT01339923|454402485|FG004|Overall Study|Lost to Follow-up|1|||
126304013|NCT01339923|454402486|FG005|Overall Study|Lost to Follow-up|1|||
125884344|NCT01458392|452874966|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
125884345|NCT01458392|452874967|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
125884346|NCT00753506|452874970|FG000|Overall Study|Withdrawal by Subject|4|||
125884347|NCT00753506|452874971|FG001|Overall Study|Withdrawal by Subject|1|||
125884348|NCT00753506|452874970|FG000|Overall Study|Lost to Follow-up|2|||
125884349|NCT00753506|452874971|FG001|Overall Study|Lost to Follow-up|0|||
125884350|NCT00753506|452874970|FG000|Overall Study|Other reason|1|||
125884351|NCT00753506|452874971|FG001|Overall Study|Other reason|1|||
125884352|NCT03557034|452874980|FG000|Overall Study|Withdrawal by Subject|1|||
125884353|NCT03557034|452874981|FG001|Overall Study|Withdrawal by Subject|0|||
125884354|NCT00719472|452874985|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
125884355|NCT00719472|452874985|FG000|Enrolled in Study|Subject decision to withdraw|8|||
125884356|NCT00719472|452874985|FG000|Enrolled in Study|Various Reasons|17|||
126304014|NCT01339923|454402487|FG006|Overall Study|Lost to Follow-up|5|||
126304015|NCT01339923|454402481|FG000|Overall Study|Protocol Violation|0|||
125884357|NCT00719472|452874985|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
125884358|NCT00719472|452874985|FG000|Received Cycle 1 Treatment|Death|5|||
126304016|NCT01339923|454402482|FG001|Overall Study|Protocol Violation|0|||
126304017|NCT01339923|454402483|FG002|Overall Study|Protocol Violation|0|||
126304018|NCT01339923|454402484|FG003|Overall Study|Protocol Violation|0|||
126304019|NCT01339923|454402485|FG004|Overall Study|Protocol Violation|0|||
126304020|NCT01339923|454402486|FG005|Overall Study|Protocol Violation|3|||
126304021|NCT01339923|454402487|FG006|Overall Study|Protocol Violation|1|||
126304022|NCT01339923|454402481|FG000|Overall Study|Unable to Classify|1|||
126304023|NCT01339923|454402482|FG001|Overall Study|Unable to Classify|0|||
126304024|NCT01339923|454402483|FG002|Overall Study|Unable to Classify|1|||
126304025|NCT01339923|454402484|FG003|Overall Study|Unable to Classify|0|||
126304026|NCT01339923|454402485|FG004|Overall Study|Unable to Classify|0|||
126304027|NCT01339923|454402486|FG005|Overall Study|Unable to Classify|1|||
126304028|NCT01339923|454402487|FG006|Overall Study|Unable to Classify|5|||
126304029|NCT01339923|454402481|FG000|Overall Study|Withdrawal by Subject|7|||
126304030|NCT01339923|454402482|FG001|Overall Study|Withdrawal by Subject|11|||
126304031|NCT01339923|454402483|FG002|Overall Study|Withdrawal by Subject|6|||
126304032|NCT01339923|454402484|FG003|Overall Study|Withdrawal by Subject|1|||
126304033|NCT01339923|454402485|FG004|Overall Study|Withdrawal by Subject|4|||
126304034|NCT01339923|454402486|FG005|Overall Study|Withdrawal by Subject|3|||
126304035|NCT01339923|454402487|FG006|Overall Study|Withdrawal by Subject|2|||
126304036|NCT01430403|454402491|FG000|Overall Study|Lost to Follow-up|5|||
126304037|NCT01430403|454402492|FG001|Overall Study|Lost to Follow-up|5|||
125884359|NCT00719472|452874985|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
125884360|NCT00719472|452874985|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
125884361|NCT00719472|452874985|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
125884362|NCT00719472|452874985|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
125884363|NCT00719472|452874985|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
125884364|NCT00719472|452874985|FG000|Received Cycle 2 Treatment|Death|6|||
125884365|NCT00719472|452874985|FG000|Received Cycle 2 Treatment|Disease progression|3|||
125884366|NCT00719472|452874985|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
125884367|NCT00719472|452874985|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
125884368|NCT00719472|452874985|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
126304038|NCT01430403|454402493|FG002|Overall Study|Lost to Follow-up|3|||
126304039|NCT01430403|454402491|FG000|Overall Study|Physician Decision|1|||
126304040|NCT01430403|454402492|FG001|Overall Study|Physician Decision|0|||
126304041|NCT01430403|454402493|FG002|Overall Study|Physician Decision|0|||
126304042|NCT01430403|454402491|FG000|Overall Study|Protocol Violation|2|||
126304043|NCT01430403|454402492|FG001|Overall Study|Protocol Violation|3|||
126304044|NCT01430403|454402493|FG002|Overall Study|Protocol Violation|2|||
126304045|NCT01430403|454402491|FG000|Overall Study|Withdrawal by Subject|9|||
126304046|NCT01430403|454402492|FG001|Overall Study|Withdrawal by Subject|1|||
126304047|NCT01430403|454402493|FG002|Overall Study|Withdrawal by Subject|3|||
126304048|NCT02099110|454402498|FG000|Overall Study|Protocol Violation|2|||
126304049|NCT02099110|454402499|FG001|Overall Study|Protocol Violation|1|||
126304050|NCT02099110|454402500|FG002|Overall Study|Protocol Violation|0|||
126304051|NCT02099110|454402501|FG003|Overall Study|Protocol Violation|3|||
126304052|NCT02099110|454402502|FG004|Overall Study|Protocol Violation|1|||
126304053|NCT02099110|454402498|FG000|Overall Study|Participant moved|1|||
126304054|NCT02099110|454402499|FG001|Overall Study|Participant moved|1|||
126304055|NCT02099110|454402500|FG002|Overall Study|Participant moved|1|||
126304056|NCT02099110|454402501|FG003|Overall Study|Participant moved|0|||
126304057|NCT02099110|454402502|FG004|Overall Study|Participant moved|2|||
126304058|NCT02099110|454402498|FG000|Overall Study|Withdrawal by Subject|7|||
126304059|NCT02099110|454402499|FG001|Overall Study|Withdrawal by Subject|11|||
125884369|NCT00719472|452874985|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
125884370|NCT01244893|452874986|FG000|Baseline|Protocol Violation|0|||
125884371|NCT01244893|452874987|FG001|Baseline|Protocol Violation|1|||
125884372|NCT01244893|452874986|FG000|1-Week Follow Up|Lost to Follow-up|1|||
126044705|NCT04631016|453461899|FG001|Overall Study|Reason unspecified|0|||
126304060|NCT02099110|454402500|FG002|Overall Study|Withdrawal by Subject|13|||
126304061|NCT02099110|454402501|FG003|Overall Study|Withdrawal by Subject|9|||
126304062|NCT02099110|454402502|FG004|Overall Study|Withdrawal by Subject|13|||
126304063|NCT02099110|454402498|FG000|Overall Study|Adverse Event|3|||
126368081|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Other|38|||
126368082|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Other|24|||
126368083|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Other|0|||
126368084|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Other|0|||
126368085|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Other|0|||
126368086|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Other|0|||
126368087|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Other|0|||
126368088|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Other|0|||
126368089|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Other|0|||
126368090|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Other|0|||
126368091|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Other|0|||
126368092|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368093|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368094|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368095|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
126368096|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
126368097|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
126368098|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368099|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126304064|NCT02099110|454402499|FG001|Overall Study|Adverse Event|5|||
126304065|NCT02099110|454402500|FG002|Overall Study|Adverse Event|2|||
126304066|NCT02099110|454402501|FG003|Overall Study|Adverse Event|3|||
126368100|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126304067|NCT02099110|454402502|FG004|Overall Study|Adverse Event|2|||
126304068|NCT02099110|454402498|FG000|Overall Study|Lost to Follow-up|6|||
126304069|NCT02099110|454402499|FG001|Overall Study|Lost to Follow-up|12|||
126304070|NCT02099110|454402500|FG002|Overall Study|Lost to Follow-up|11|||
126304071|NCT02099110|454402501|FG003|Overall Study|Lost to Follow-up|5|||
126304072|NCT02099110|454402502|FG004|Overall Study|Lost to Follow-up|6|||
126304073|NCT02099110|454402498|FG000|Overall Study|Death|0|||
126304074|NCT02099110|454402499|FG001|Overall Study|Death|1|||
126304075|NCT02099110|454402500|FG002|Overall Study|Death|0|||
126304076|NCT02099110|454402501|FG003|Overall Study|Death|0|||
126304077|NCT02099110|454402502|FG004|Overall Study|Death|0|||
126304078|NCT02099110|454402498|FG000|Overall Study|Screen failure|0|||
126304079|NCT02099110|454402499|FG001|Overall Study|Screen failure|0|||
126304080|NCT02099110|454402500|FG002|Overall Study|Screen failure|0|||
126304081|NCT02099110|454402501|FG003|Overall Study|Screen failure|0|||
126304082|NCT02099110|454402502|FG004|Overall Study|Screen failure|1|||
126304083|NCT02099110|454402498|FG000|Overall Study|Non-compliance with study drug|2|||
126304084|NCT02099110|454402499|FG001|Overall Study|Non-compliance with study drug|0|||
126304085|NCT02099110|454402500|FG002|Overall Study|Non-compliance with study drug|0|||
126304086|NCT02099110|454402501|FG003|Overall Study|Non-compliance with study drug|0|||
126304087|NCT02099110|454402502|FG004|Overall Study|Non-compliance with study drug|1|||
126304088|NCT02099110|454402498|FG000|Overall Study|Physician Decision|3|||
126304089|NCT02099110|454402499|FG001|Overall Study|Physician Decision|0|||
126304090|NCT02099110|454402500|FG002|Overall Study|Physician Decision|1|||
126304091|NCT02099110|454402501|FG003|Overall Study|Physician Decision|2|||
126304092|NCT02099110|454402502|FG004|Overall Study|Physician Decision|1|||
126304093|NCT00994461|454402506|FG000|Overall Study|Adverse Event|2|||
126304094|NCT00994461|454402507|FG001|Overall Study|Adverse Event|1|||
126304095|NCT00994461|454402508|FG002|Overall Study|Adverse Event|0|||
126304096|NCT02887248|454402509|FG000|Overall Study|Withdrawal by Subject|1|||
126304097|NCT02887248|454402509|FG000|Overall Study|Adverse Event|1|||
126304098|NCT02887248|454402509|FG000|Overall Study|Progressive Disease|1|||
126304099|NCT01166438|454402510|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
126304100|NCT01166438|454402511|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
126304101|NCT01166438|454402510|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
126304102|NCT01166438|454402511|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
126304103|NCT01166438|454402510|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
126304104|NCT01166438|454402511|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
126304105|NCT01166438|454402510|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
126304106|NCT01166438|454402511|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
126304107|NCT01166438|454402510|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
126304108|NCT01166438|454402511|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
126304109|NCT01166438|454402510|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
126304110|NCT01166438|454402511|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
126304111|NCT01377922|454402516|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
126304112|NCT01377922|454402517|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
126304113|NCT03170362|454402518|FG000|Overall Study|Death|2|||
126304114|NCT03170362|454402519|FG001|Overall Study|Death|2|||
126304115|NCT03170362|454402518|FG000|Overall Study|Withdrawal by Subject|23|||
126304116|NCT03170362|454402519|FG001|Overall Study|Withdrawal by Subject|22|||
126304117|NCT03170362|454402518|FG000|Overall Study|Lost to Follow-up|187|||
126304118|NCT03170362|454402519|FG001|Overall Study|Lost to Follow-up|167|||
126304119|NCT03340454|454402522|FG000|Overall Study|Lost to Follow-up|0|||
126304120|NCT03340454|454402523|FG001|Overall Study|Lost to Follow-up|4|||
126304121|NCT01464164|454402524|FG000|Overall Study|Screen failure|0|||
126304122|NCT01464164|454402525|FG001|Overall Study|Screen failure|1|||
126304123|NCT01464164|454402526|FG002|Overall Study|Screen failure|2|||
126304124|NCT01464164|454402527|FG003|Overall Study|Screen failure|0|||
126304125|NCT01464164|454402528|FG004|Overall Study|Screen failure|0|||
126304126|NCT01464164|454402529|FG005|Overall Study|Screen failure|0|||
126304127|NCT01464164|454402530|FG006|Overall Study|Screen failure|0|||
126304128|NCT01464164|454402524|FG000|Overall Study|Physician Decision|0|||
126368101|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368102|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368103|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368104|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Death|0|||
126368105|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Death|0|||
126368106|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Death|0|||
126368107|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Death|0|||
126368108|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Death|1|||
126368109|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Death|0|||
126368110|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Death|0|||
126304129|NCT01464164|454402525|FG001|Overall Study|Physician Decision|1|||
126304130|NCT01464164|454402526|FG002|Overall Study|Physician Decision|0|||
126304131|NCT01464164|454402527|FG003|Overall Study|Physician Decision|0|||
126304132|NCT01464164|454402528|FG004|Overall Study|Physician Decision|0|||
126304133|NCT01464164|454402529|FG005|Overall Study|Physician Decision|0|||
126304134|NCT01464164|454402530|FG006|Overall Study|Physician Decision|2|||
126304135|NCT03682848|454402531|FG000|Overall Study|Withdrawal by Subject|2|||
126304136|NCT03682848|454402531|FG000|Overall Study|Site closed|5|||
126304137|NCT03682848|454402531|FG000|Overall Study|Protocol Deviation|1|||
126304138|NCT03682848|454402531|FG000|Overall Study|Adverse Event|1|||
126304139|NCT00454363|454402532|FG000|Overall Study|Adverse Event|1|||
126304140|NCT00454363|454402533|FG001|Overall Study|Adverse Event|2|||
126304141|NCT00454363|454402532|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
126304142|NCT00454363|454402533|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
126304143|NCT00570063|454402534|FG000|Overall Study|Adverse Event|4|||
126304144|NCT00570063|454402535|FG001|Overall Study|Adverse Event|1|||
126304145|NCT00570063|454402534|FG000|Overall Study|Lack of Efficacy|0|||
126304146|NCT00570063|454402535|FG001|Overall Study|Lack of Efficacy|1|||
126304147|NCT00570063|454402534|FG000|Overall Study|Withdrawal by Subject|4|||
126304148|NCT00570063|454402535|FG001|Overall Study|Withdrawal by Subject|3|||
126304149|NCT00570063|454402534|FG000|Overall Study|Sponsor's Decision|7|||
126304150|NCT00570063|454402535|FG001|Overall Study|Sponsor's Decision|3|||
126304151|NCT00697463|454402536|FG000|Overall Study|Withdrawal by Subject|1|||
126304152|NCT03307252|454402537|FG000|Part 2, Period 1|Treatment not received|0|||
126304153|NCT03307252|454402538|FG001|Part 2, Period 1|Treatment not received|0|||
126304154|NCT03307252|454402539|FG002|Part 2, Period 1|Treatment not received|0|||
126304155|NCT03307252|454402540|FG003|Part 2, Period 1|Treatment not received|0|||
126304156|NCT03307252|454402541|FG004|Part 2, Period 1|Treatment not received|0|||
126304157|NCT03307252|454402542|FG005|Part 2, Period 1|Treatment not received|1|||
126304158|NCT03307252|454402543|FG006|Part 2, Period 1|Treatment not received|0|||
126304159|NCT03307252|454402544|FG007|Part 2, Period 1|Treatment not received|0|||
126304160|NCT03307252|454402545|FG008|Part 2, Period 1|Treatment not received|0|||
126304161|NCT03307252|454402546|FG009|Part 2, Period 1|Treatment not received|0|||
126304162|NCT03307252|454402547|FG010|Part 2, Period 1|Treatment not received|0|||
126304163|NCT03307252|454402537|FG000|Part 2, Period 3|Other than listed|0|||
126304164|NCT03307252|454402538|FG001|Part 2, Period 3|Other than listed|0|||
126304165|NCT03307252|454402539|FG002|Part 2, Period 3|Other than listed|0|||
126304166|NCT03307252|454402540|FG003|Part 2, Period 3|Other than listed|0|||
126304167|NCT03307252|454402541|FG004|Part 2, Period 3|Other than listed|1|||
126304168|NCT03307252|454402542|FG005|Part 2, Period 3|Other than listed|0|||
126304169|NCT03307252|454402543|FG006|Part 2, Period 3|Other than listed|0|||
126304170|NCT03307252|454402544|FG007|Part 2, Period 3|Other than listed|0|||
126304171|NCT03307252|454402545|FG008|Part 2, Period 3|Other than listed|0|||
126304172|NCT03307252|454402546|FG009|Part 2, Period 3|Other than listed|0|||
126304173|NCT03307252|454402547|FG010|Part 2, Period 3|Other than listed|0|||
126304174|NCT03307252|454402537|FG000|Part 2, Period 4|Other than listed|0|||
126304175|NCT03307252|454402538|FG001|Part 2, Period 4|Other than listed|0|||
126304176|NCT03307252|454402539|FG002|Part 2, Period 4|Other than listed|0|||
126304177|NCT03307252|454402540|FG003|Part 2, Period 4|Other than listed|0|||
126304178|NCT03307252|454402541|FG004|Part 2, Period 4|Other than listed|0|||
126304179|NCT03307252|454402542|FG005|Part 2, Period 4|Other than listed|0|||
126304180|NCT03307252|454402543|FG006|Part 2, Period 4|Other than listed|1|||
126304181|NCT03307252|454402544|FG007|Part 2, Period 4|Other than listed|0|||
126304182|NCT03307252|454402545|FG008|Part 2, Period 4|Other than listed|0|||
126304183|NCT03307252|454402546|FG009|Part 2, Period 4|Other than listed|0|||
126304184|NCT03307252|454402547|FG010|Part 2, Period 4|Other than listed|0|||
126304185|NCT03307252|454402537|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126044706|NCT04631016|453461898|FG000|Overall Study|Failure to meet randomization criteria|2|||
126044707|NCT04631016|453461899|FG001|Overall Study|Failure to meet randomization criteria|1|||
126044708|NCT06010836|453461900|FG000|Overall Study|Lost to Follow-up|2|||
126044709|NCT06010836|453461901|FG001|Overall Study|Lost to Follow-up|2|||
126304186|NCT03307252|454402538|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304187|NCT03307252|454402539|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304188|NCT03307252|454402540|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304189|NCT03307252|454402541|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304190|NCT03307252|454402542|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304191|NCT03307252|454402543|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304192|NCT03307252|454402544|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304193|NCT03307252|454402545|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304194|NCT03307252|454402546|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304195|NCT03307252|454402547|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
126304196|NCT03482453|454402548|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304197|NCT03482453|454402549|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304198|NCT03482453|454402550|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304199|NCT03482453|454402551|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304200|NCT03482453|454402552|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304201|NCT03482453|454402553|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304202|NCT03482453|454402554|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304203|NCT03482453|454402555|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304204|NCT03482453|454402556|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304205|NCT03482453|454402557|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304206|NCT03482453|454402558|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
126304207|NCT03482453|454402559|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304208|NCT02568189|454402560|FG000|Overall Study|Protocol Violation|0|||
126304209|NCT02568189|454402561|FG001|Overall Study|Protocol Violation|0|||
126304210|NCT02568189|454402562|FG002|Overall Study|Protocol Violation|19|||
126304211|NCT02568189|454402563|FG003|Overall Study|Protocol Violation|18|||
126304212|NCT02157376|454402564|FG000|Overall Study|Death|10|||
126304213|NCT02157376|454402565|FG001|Overall Study|Death|4|||
126304214|NCT02157376|454402564|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126304215|NCT02157376|454402565|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126304216|NCT02157376|454402564|FG000|Overall Study|Withdrawal by Subject|3|||
126304217|NCT02157376|454402565|FG001|Overall Study|Withdrawal by Subject|8|||
126304218|NCT02157376|454402564|FG000|Overall Study|Not treated|8|||
126304219|NCT02157376|454402565|FG001|Overall Study|Not treated|3|||
126304220|NCT02157376|454402564|FG000|Overall Study|Investigator's misjudgement|1|||
126304221|NCT02157376|454402565|FG001|Overall Study|Investigator's misjudgement|2|||
126304222|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
126304223|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
126304224|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
126304225|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
126304226|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
126304227|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
126304228|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
126304229|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
126304230|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
126304231|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
126304232|NCT01074268|454402566|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
126304233|NCT01074268|454402567|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
126304234|NCT01074268|454402566|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
126304235|NCT01074268|454402567|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
126304236|NCT01074268|454402566|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
126304237|NCT01074268|454402567|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
126304238|NCT01074268|454402566|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
126304239|NCT01074268|454402567|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
126304240|NCT01578239|454402570|FG000|Treatment Period|Progressive Disease|19|||
126304241|NCT01578239|454402571|FG001|Treatment Period|Progressive Disease|64|||
126304242|NCT01578239|454402570|FG000|Treatment Period|Physician Decision|17|||
126304243|NCT01578239|454402571|FG001|Treatment Period|Physician Decision|17|||
126304244|NCT01578239|454402570|FG000|Treatment Period|Adverse Event|13|||
126304245|NCT01578239|454402571|FG001|Treatment Period|Adverse Event|10|||
126304246|NCT01578239|454402570|FG000|Treatment Period|Non-compliance|2|||
126304247|NCT01578239|454402571|FG001|Treatment Period|Non-compliance|0|||
126304248|NCT01578239|454402570|FG000|Treatment Period|Withdrawal by Subject|10|||
126304249|NCT01578239|454402571|FG001|Treatment Period|Withdrawal by Subject|9|||
126304250|NCT01578239|454402570|FG000|Treatment Period|Other|6|||
126304251|NCT01578239|454402571|FG001|Treatment Period|Other|1|||
126304252|NCT01578239|454402570|FG000|Long-term Follow-Up Period|Death|69|||
126304253|NCT01578239|454402571|FG001|Long-term Follow-Up Period|Death|64|||
126304254|NCT01578239|454402570|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
126304255|NCT01578239|454402571|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
126304256|NCT01578239|454402570|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
126304257|NCT01578239|454402571|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
126304258|NCT01578239|454402570|FG000|Long-term Follow-Up Period|Other|2|||
126304259|NCT01578239|454402571|FG001|Long-term Follow-Up Period|Other|2|||
126304260|NCT02347813|454402575|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
126304261|NCT02347813|454402576|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
126304262|NCT02347813|454402575|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
126304263|NCT02347813|454402576|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
125884373|NCT01244893|452874987|FG001|1-Week Follow Up|Lost to Follow-up|0|||
125884374|NCT03584789|452874988|FG000|Overall Study|refused EHR permission|19|||
125884375|NCT03584789|452874989|FG001|Overall Study|refused EHR permission|28|||
125884376|NCT03584789|452874990|FG002|Overall Study|refused EHR permission|23|||
125884377|NCT03584789|452874988|FG000|Overall Study|patients tied to a provider who retired|0|||
125884378|NCT03584789|452874989|FG001|Overall Study|patients tied to a provider who retired|0|||
125884379|NCT03584789|452874990|FG002|Overall Study|patients tied to a provider who retired|3|||
125884380|NCT00711191|452874991|FG000|Overall Study|Adverse Event|1|||
125884381|NCT00711191|452874992|FG001|Overall Study|Adverse Event|1|||
125884382|NCT00711191|452874993|FG002|Overall Study|Adverse Event|2|||
125884383|NCT00711191|452874991|FG000|Overall Study|Objective progression or relapse|2|||
125884384|NCT00711191|452874992|FG001|Overall Study|Objective progression or relapse|3|||
125884385|NCT00711191|452874993|FG002|Overall Study|Objective progression or relapse|7|||
125884386|NCT00711191|452874991|FG000|Overall Study|Withdrawal by Subject|0|||
125884387|NCT00711191|452874992|FG001|Overall Study|Withdrawal by Subject|1|||
125884388|NCT00711191|452874993|FG002|Overall Study|Withdrawal by Subject|3|||
125884389|NCT02803580|452874995|FG000|Overall Study|Death|13|||
125884390|NCT02803580|452874995|FG000|Overall Study|Lost to Follow-up|19|||
125884391|NCT02803580|452874995|FG000|Overall Study|Withdrawal by Subject|3|||
125884392|NCT02803580|452874995|FG000|Overall Study|Inclusion in clinical trial|1|||
125884393|NCT00836693|452874996|FG000|Overall Study|Adverse Event|4|||
125884394|NCT00836693|452874997|FG001|Overall Study|Adverse Event|1|||
125884395|NCT00836693|452874996|FG000|Overall Study|Sponsor Decision|0|||
125884396|NCT00836693|452874997|FG001|Overall Study|Sponsor Decision|1|||
125884397|NCT00836693|452874996|FG000|Overall Study|Physician Decision|2|||
125884398|NCT00836693|452874997|FG001|Overall Study|Physician Decision|0|||
125884399|NCT00836693|452874996|FG000|Overall Study|Withdrawal by Subject|9|||
125884400|NCT00836693|452874997|FG001|Overall Study|Withdrawal by Subject|4|||
125884401|NCT00836693|452874996|FG000|Overall Study|Protocol Violation|1|||
125884402|NCT00836693|452874997|FG001|Overall Study|Protocol Violation|0|||
125884403|NCT00836693|452874996|FG000|Overall Study|Lost to Follow-up|1|||
125884404|NCT00836693|452874997|FG001|Overall Study|Lost to Follow-up|0|||
125884405|NCT02612779|452874998|FG000|Overall Study|Administrative reason by sponsor|4|||
125884406|NCT02612779|452874999|FG001|Overall Study|Administrative reason by sponsor|1|||
125884407|NCT02612779|452874998|FG000|Overall Study|No longer meet study criteria|0|||
125884408|NCT02612779|452874999|FG001|Overall Study|No longer meet study criteria|1|||
125884409|NCT02612779|452874998|FG000|Overall Study|Disease progression|29|||
125884410|NCT02612779|452874999|FG001|Overall Study|Disease progression|2|||
125884411|NCT02612779|452874998|FG000|Overall Study|Study drug toxicity|10|||
125884412|NCT02612779|452874999|FG001|Overall Study|Study drug toxicity|1|||
125884413|NCT02612779|452874998|FG000|Overall Study|Death|1|||
125884414|NCT02612779|452874999|FG001|Overall Study|Death|0|||
126304264|NCT02837731|454402581|FG000|Allocation|Admitted to General Floor|3|||
126304265|NCT02837731|454402582|FG001|Allocation|Admitted to General Floor|4|||
126304266|NCT02837731|454402581|FG000|Allocation|Immediate surgery/withdrew|2|||
126304267|NCT02837731|454402582|FG001|Allocation|Immediate surgery/withdrew|0|||
126304268|NCT02837731|454402581|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
126304269|NCT02837731|454402582|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
126304270|NCT02837731|454402581|FG000|Allocation|Withdrawal by Subject|2|||
126304271|NCT02837731|454402582|FG001|Allocation|Withdrawal by Subject|0|||
126304272|NCT02837731|454402581|FG000|Allocation|Device not available|1|||
126304273|NCT02837731|454402582|FG001|Allocation|Device not available|0|||
126304274|NCT02837731|454402581|FG000|Allocation|Protocol not implemented|7|||
126304275|NCT02837731|454402582|FG001|Allocation|Protocol not implemented|0|||
125884415|NCT02612779|452874998|FG000|Overall Study|Adverse event unrelated to study drug|5|||
126304276|NCT02837731|454402581|FG000|Allocation|Moribund/Do not resuscitate|2|||
125884416|NCT02612779|452874999|FG001|Overall Study|Adverse event unrelated to study drug|0|||
125884417|NCT02612779|452874998|FG000|Overall Study|Participant withdrew consent|4|||
125884418|NCT02612779|452874999|FG001|Overall Study|Participant withdrew consent|0|||
125884419|NCT02612779|452874998|FG000|Overall Study|Lost to Follow-up|1|||
125884420|NCT02612779|452874999|FG001|Overall Study|Lost to Follow-up|0|||
125884421|NCT02612779|452874998|FG000|Overall Study|Maximum clinical benefit|10|||
125884422|NCT02612779|452874999|FG001|Overall Study|Maximum clinical benefit|1|||
125884423|NCT02612779|452874998|FG000|Overall Study|Other reasons|4|||
126304277|NCT02837731|454402582|FG001|Allocation|Moribund/Do not resuscitate|0|||
126304278|NCT02837731|454402581|FG000|Allocation|Did not meet sepsis criteria|1|||
126304279|NCT02837731|454402582|FG001|Allocation|Did not meet sepsis criteria|2|||
125884424|NCT02612779|452874999|FG001|Overall Study|Other reasons|0|||
125884425|NCT02118961|452875000|FG000|Overall Study|Withdrawal by Subject|1|||
125884426|NCT02118961|452875001|FG001|Overall Study|Withdrawal by Subject|0|||
125884427|NCT01750229|452875002|FG000|Randomized Crossover Phase|Adverse Event|1|||
125884428|NCT01750229|452875002|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
125884429|NCT01750229|452875002|FG000|Long-term Follow-up Phase|Adverse Event|2|||
125884430|NCT01750229|452875002|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
126304280|NCT02837731|454402581|FG000|Allocation|Known aortic abnormalities|0|||
126304281|NCT02837731|454402582|FG001|Allocation|Known aortic abnormalities|1|||
126304282|NCT01119859|454402583|FG000|Overall Study|Adverse Event|9|||
126304283|NCT01119859|454402584|FG001|Overall Study|Adverse Event|10|||
126304284|NCT01119859|454402583|FG000|Overall Study|Death|2|||
126304285|NCT01119859|454402584|FG001|Overall Study|Death|0|||
126304286|NCT01119859|454402583|FG000|Overall Study|Insufficient therapeutic response|7|||
126304287|NCT01119859|454402584|FG001|Overall Study|Insufficient therapeutic response|14|||
126304288|NCT01119859|454402583|FG000|Overall Study|Refused treatment|3|||
126304289|NCT01119859|454402584|FG001|Overall Study|Refused treatment|6|||
126304290|NCT01119859|454402583|FG000|Overall Study|Failure to return|3|||
126304291|NCT01119859|454402584|FG001|Overall Study|Failure to return|0|||
126304292|NCT00603473|454402585|FG000|Overall Study|Adverse Event|4|||
126304293|NCT00603473|454402585|FG000|Overall Study|Lack of Efficacy|4|||
126304294|NCT00603473|454402585|FG000|Overall Study|Protocol Violation|1|||
126304295|NCT02644668|454402589|FG000|Overall Study|Adverse Event|2|||
126304296|NCT02644668|454402590|FG001|Overall Study|Adverse Event|0|||
126304297|NCT02644668|454402591|FG002|Overall Study|Adverse Event|1|||
126304298|NCT02644668|454402589|FG000|Overall Study|Protocol Violation|0|||
126368111|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Death|0|||
126368112|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Death|0|||
126368113|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Death|0|||
126368114|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Death|0|||
126368115|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Death|0|||
126044710|NCT06010836|453461900|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
126044711|NCT06010836|453461901|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
126044712|NCT06010836|453461900|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
126044713|NCT06010836|453461901|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
126044714|NCT06010836|453461900|FG000|Overall Study|Did not receive intervention discussion|0|||
126044715|NCT06010836|453461901|FG001|Overall Study|Did not receive intervention discussion|4|||
126044716|NCT04496752|453461902|FG000|Second Assessment|Lost to Follow-up|3|||
126044717|NCT04496752|453461903|FG001|Second Assessment|Lost to Follow-up|3|||
126044718|NCT04496752|453461902|FG000|Second Assessment|Adverse Event|2|||
126044719|NCT04496752|453461903|FG001|Second Assessment|Adverse Event|0|||
126044720|NCT04524689|453461906|FG000|Overall Study|Withdrawal by Subject|1|||
126044721|NCT04524689|453461907|FG001|Overall Study|Withdrawal by Subject|1|||
126044722|NCT04524689|453461908|FG002|Overall Study|Withdrawal by Subject|0|||
126044723|NCT04524689|453461909|FG003|Overall Study|Withdrawal by Subject|0|||
126044724|NCT04524689|453461910|FG004|Overall Study|Withdrawal by Subject|1|||
126044725|NCT04524689|453461911|FG005|Overall Study|Withdrawal by Subject|0|||
126044726|NCT04524689|453461906|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
126044727|NCT04524689|453461907|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
126044728|NCT04524689|453461908|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
126044729|NCT04524689|453461909|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
126304299|NCT02644668|454402590|FG001|Overall Study|Protocol Violation|0|||
126304300|NCT02644668|454402591|FG002|Overall Study|Protocol Violation|1|||
126304301|NCT02644668|454402589|FG000|Overall Study|Withdrawal by Subject|0|||
126304302|NCT02644668|454402590|FG001|Overall Study|Withdrawal by Subject|0|||
126304303|NCT02644668|454402591|FG002|Overall Study|Withdrawal by Subject|1|||
126304304|NCT01134939|454402592|FG000|Overall Study|Adverse Event|9|||
126368116|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368117|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368118|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368119|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
126368120|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368121|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368122|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368123|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368124|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368125|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368126|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368127|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368128|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368129|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368130|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368131|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368132|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368133|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
126368134|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368135|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368136|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368137|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368138|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368139|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368140|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Other|0|||
126368141|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Other|0|||
126368142|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Other|0|||
126304305|NCT01134939|454402593|FG001|Overall Study|Adverse Event|3|||
126304306|NCT01134939|454402594|FG002|Overall Study|Adverse Event|4|||
126304307|NCT01134939|454402595|FG003|Overall Study|Adverse Event|5|||
126304308|NCT01134939|454402596|FG004|Overall Study|Adverse Event|5|||
126304309|NCT01134939|454402597|FG005|Overall Study|Adverse Event|5|||
126304310|NCT01134939|454402598|FG006|Overall Study|Adverse Event|1|||
126304311|NCT01134939|454402599|FG007|Overall Study|Adverse Event|0|||
126304312|NCT01134939|454402592|FG000|Overall Study|Lack of Efficacy|2|||
126304313|NCT01134939|454402593|FG001|Overall Study|Lack of Efficacy|5|||
126304314|NCT01134939|454402594|FG002|Overall Study|Lack of Efficacy|1|||
126304315|NCT01134939|454402595|FG003|Overall Study|Lack of Efficacy|0|||
126304316|NCT01134939|454402596|FG004|Overall Study|Lack of Efficacy|3|||
126304317|NCT01134939|454402597|FG005|Overall Study|Lack of Efficacy|0|||
126304318|NCT01134939|454402598|FG006|Overall Study|Lack of Efficacy|1|||
126304319|NCT01134939|454402599|FG007|Overall Study|Lack of Efficacy|0|||
126304320|NCT01134939|454402592|FG000|Overall Study|Lost to Follow-up|2|||
126304321|NCT01134939|454402593|FG001|Overall Study|Lost to Follow-up|3|||
126304322|NCT01134939|454402594|FG002|Overall Study|Lost to Follow-up|0|||
126304323|NCT01134939|454402595|FG003|Overall Study|Lost to Follow-up|1|||
126304324|NCT01134939|454402596|FG004|Overall Study|Lost to Follow-up|2|||
126304325|NCT01134939|454402597|FG005|Overall Study|Lost to Follow-up|1|||
126304326|NCT01134939|454402598|FG006|Overall Study|Lost to Follow-up|0|||
126044730|NCT04524689|453461910|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
126044731|NCT04524689|453461911|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
126044732|NCT04524689|453461906|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
126304327|NCT01134939|454402599|FG007|Overall Study|Lost to Follow-up|0|||
126304328|NCT01134939|454402592|FG000|Overall Study|Death|0|||
126304329|NCT01134939|454402593|FG001|Overall Study|Death|1|||
126304330|NCT01134939|454402594|FG002|Overall Study|Death|0|||
126304331|NCT01134939|454402595|FG003|Overall Study|Death|0|||
126304332|NCT01134939|454402596|FG004|Overall Study|Death|0|||
126304333|NCT01134939|454402597|FG005|Overall Study|Death|0|||
126304334|NCT01134939|454402598|FG006|Overall Study|Death|0|||
126304335|NCT01134939|454402599|FG007|Overall Study|Death|0|||
126044733|NCT04524689|453461907|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
126044734|NCT04524689|453461908|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
126044735|NCT04524689|453461909|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
126044736|NCT04524689|453461910|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
126044737|NCT04524689|453461911|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
126044738|NCT04967599|453461912|FG000|Overall Study|Lost to Follow-up|35|||
126044739|NCT04967599|453461913|FG001|Overall Study|Lost to Follow-up|19|||
126044740|NCT04967599|453461914|FG002|Overall Study|Lost to Follow-up|23|||
126044741|NCT04369911|453461915|FG000|Overall Study|Lost to Follow-up|3|||
126044742|NCT04369911|453461916|FG001|Overall Study|Lost to Follow-up|3|||
126044743|NCT04369911|453461915|FG000|Overall Study|Withdrawal by Subject|1|||
126044744|NCT04369911|453461916|FG001|Overall Study|Withdrawal by Subject|2|||
126044745|NCT05451693|453461917|FG000|Overall Study|Withdrawal by Subject|1|||
126044746|NCT05451693|453461918|FG001|Overall Study|Withdrawal by Subject|1|||
126044747|NCT03662022|453461919|FG000|Year 1 2019|prevalent case|83|||
126044748|NCT03662022|453461920|FG001|Year 1 2019|prevalent case|116|||
126044749|NCT03662022|453461921|FG002|Year 1 2019|prevalent case|158|||
126044750|NCT03662022|453461922|FG003|Year 1 2019|prevalent case|99|||
126304336|NCT01134939|454402592|FG000|Overall Study|Termination page not available|4|||
126304337|NCT01134939|454402593|FG001|Overall Study|Termination page not available|6|||
126304338|NCT01134939|454402594|FG002|Overall Study|Termination page not available|5|||
126304339|NCT01134939|454402595|FG003|Overall Study|Termination page not available|8|||
126304340|NCT01134939|454402596|FG004|Overall Study|Termination page not available|0|||
126304341|NCT01134939|454402597|FG005|Overall Study|Termination page not available|3|||
126304342|NCT01134939|454402598|FG006|Overall Study|Termination page not available|7|||
126304343|NCT01134939|454402599|FG007|Overall Study|Termination page not available|0|||
125884431|NCT03809104|452875003|FG000|Overall Study|Withdrawal by Subject|3|||
125884432|NCT00790842|452875004|FG000|Dose Level 1|Adverse Event|1|||
125884433|NCT00790842|452875005|FG001|Dose Level 1|Adverse Event|0|||
125884434|NCT00790842|452875006|FG002|Dose Level 1|Adverse Event|0|||
125884435|NCT00790842|452875007|FG003|Dose Level 1|Adverse Event|2|||
126304344|NCT00733421|454402600|FG000|Overall Study|Withdrawal by Subject|1|||
126304345|NCT00733421|454402601|FG001|Overall Study|Withdrawal by Subject|1|||
126304346|NCT02547220|454402607|FG000|Overall Study|Withdrawal by Subject|1|||
126304347|NCT02547220|454402608|FG001|Overall Study|Withdrawal by Subject|0|||
126304348|NCT02547220|454402607|FG000|Overall Study|Study terminated by sponsor|18|||
126304349|NCT02547220|454402608|FG001|Overall Study|Study terminated by sponsor|20|||
126304350|NCT00550043|454402609|FG000|Overall Study|Adverse Event|0|||
126304351|NCT00550043|454402610|FG001|Overall Study|Adverse Event|0|||
125884436|NCT00790842|452875008|FG004|Dose Level 1|Adverse Event|0|||
125884437|NCT00790842|452875009|FG005|Dose Level 1|Adverse Event|0|||
125884438|NCT00790842|452875010|FG006|Dose Level 1|Adverse Event|0|||
125884439|NCT00790842|452875011|FG007|Dose Level 1|Adverse Event|1|||
125884440|NCT00790842|452875012|FG008|Dose Level 1|Adverse Event|0|||
125884441|NCT00790842|452875013|FG009|Dose Level 1|Adverse Event|0|||
125884442|NCT00790842|452875014|FG010|Dose Level 1|Adverse Event|0|||
125884443|NCT00790842|452875004|FG000|Dose Level 1|Physician Decision|1|||
125884444|NCT00790842|452875005|FG001|Dose Level 1|Physician Decision|0|||
125884445|NCT00790842|452875006|FG002|Dose Level 1|Physician Decision|0|||
125884446|NCT00790842|452875007|FG003|Dose Level 1|Physician Decision|0|||
125884447|NCT00790842|452875008|FG004|Dose Level 1|Physician Decision|0|||
125884448|NCT00790842|452875009|FG005|Dose Level 1|Physician Decision|0|||
125884449|NCT00790842|452875010|FG006|Dose Level 1|Physician Decision|0|||
125884450|NCT00790842|452875011|FG007|Dose Level 1|Physician Decision|1|||
125884451|NCT00790842|452875012|FG008|Dose Level 1|Physician Decision|0|||
125884452|NCT00790842|452875013|FG009|Dose Level 1|Physician Decision|0|||
125884453|NCT00790842|452875014|FG010|Dose Level 1|Physician Decision|0|||
125884454|NCT00790842|452875004|FG000|Dose Level 1|Withdrawal by Subject|1|||
125884455|NCT00790842|452875005|FG001|Dose Level 1|Withdrawal by Subject|0|||
126304352|NCT00550043|454402611|FG002|Overall Study|Adverse Event|0|||
126304353|NCT00550043|454402612|FG003|Overall Study|Adverse Event|1|||
125884456|NCT00790842|452875006|FG002|Dose Level 1|Withdrawal by Subject|0|||
125884457|NCT00790842|452875007|FG003|Dose Level 1|Withdrawal by Subject|0|||
125884458|NCT00790842|452875008|FG004|Dose Level 1|Withdrawal by Subject|0|||
125884459|NCT00790842|452875009|FG005|Dose Level 1|Withdrawal by Subject|0|||
125884460|NCT00790842|452875010|FG006|Dose Level 1|Withdrawal by Subject|0|||
125884461|NCT00790842|452875011|FG007|Dose Level 1|Withdrawal by Subject|0|||
125884462|NCT00790842|452875012|FG008|Dose Level 1|Withdrawal by Subject|0|||
125884463|NCT00790842|452875013|FG009|Dose Level 1|Withdrawal by Subject|0|||
125884464|NCT00790842|452875014|FG010|Dose Level 1|Withdrawal by Subject|0|||
125884465|NCT00790842|452875004|FG000|Dose Level 2|Death|0|||
125884466|NCT00790842|452875005|FG001|Dose Level 2|Death|1|||
125884467|NCT00790842|452875006|FG002|Dose Level 2|Death|0|||
125884468|NCT00790842|452875007|FG003|Dose Level 2|Death|0|||
125884469|NCT00790842|452875008|FG004|Dose Level 2|Death|1|||
125884470|NCT00790842|452875009|FG005|Dose Level 2|Death|0|||
125884471|NCT00790842|452875010|FG006|Dose Level 2|Death|0|||
125884472|NCT00790842|452875011|FG007|Dose Level 2|Death|0|||
125884473|NCT00790842|452875012|FG008|Dose Level 2|Death|0|||
125884474|NCT00790842|452875013|FG009|Dose Level 2|Death|0|||
125884475|NCT00790842|452875014|FG010|Dose Level 2|Death|0|||
125884476|NCT00790842|452875004|FG000|Dose Level 2|Physician Decision|0|||
125884477|NCT00790842|452875005|FG001|Dose Level 2|Physician Decision|1|||
125884478|NCT00790842|452875006|FG002|Dose Level 2|Physician Decision|0|||
125884479|NCT00790842|452875007|FG003|Dose Level 2|Physician Decision|0|||
126304354|NCT00550043|454402613|FG004|Overall Study|Adverse Event|1|||
126304355|NCT00550043|454402609|FG000|Overall Study|Subject Withdrew Consent|0|||
126304356|NCT00550043|454402610|FG001|Overall Study|Subject Withdrew Consent|2|||
125884480|NCT00790842|452875008|FG004|Dose Level 2|Physician Decision|0|||
126304357|NCT00550043|454402611|FG002|Overall Study|Subject Withdrew Consent|1|||
126304358|NCT00550043|454402612|FG003|Overall Study|Subject Withdrew Consent|0|||
126304359|NCT00550043|454402613|FG004|Overall Study|Subject Withdrew Consent|0|||
126304360|NCT00550043|454402609|FG000|Overall Study|Other Reasons- Unspecified|0|||
126304361|NCT00550043|454402610|FG001|Overall Study|Other Reasons- Unspecified|1|||
126304362|NCT00550043|454402611|FG002|Overall Study|Other Reasons- Unspecified|0|||
126304363|NCT00550043|454402612|FG003|Overall Study|Other Reasons- Unspecified|1|||
125884481|NCT00790842|452875009|FG005|Dose Level 2|Physician Decision|0|||
125884482|NCT00790842|452875010|FG006|Dose Level 2|Physician Decision|0|||
125884483|NCT00790842|452875011|FG007|Dose Level 2|Physician Decision|0|||
125884484|NCT00790842|452875012|FG008|Dose Level 2|Physician Decision|0|||
125884485|NCT00790842|452875013|FG009|Dose Level 2|Physician Decision|0|||
125884486|NCT00790842|452875014|FG010|Dose Level 2|Physician Decision|0|||
125884487|NCT00790842|452875004|FG000|Dose Level 2|Withdrawal by Subject|0|||
125884488|NCT00790842|452875005|FG001|Dose Level 2|Withdrawal by Subject|1|||
126304364|NCT00550043|454402613|FG004|Overall Study|Other Reasons- Unspecified|0|||
126304365|NCT02887183|454402615|FG000|Overall Study|Adverse Event|44|||
125884489|NCT00790842|452875006|FG002|Dose Level 2|Withdrawal by Subject|0|||
125884490|NCT00790842|452875007|FG003|Dose Level 2|Withdrawal by Subject|0|||
125884491|NCT00790842|452875008|FG004|Dose Level 2|Withdrawal by Subject|0|||
125884492|NCT00790842|452875009|FG005|Dose Level 2|Withdrawal by Subject|0|||
125884493|NCT00790842|452875010|FG006|Dose Level 2|Withdrawal by Subject|0|||
125884494|NCT00790842|452875011|FG007|Dose Level 2|Withdrawal by Subject|0|||
125884495|NCT00790842|452875012|FG008|Dose Level 2|Withdrawal by Subject|0|||
125884496|NCT00790842|452875013|FG009|Dose Level 2|Withdrawal by Subject|0|||
125884497|NCT00790842|452875014|FG010|Dose Level 2|Withdrawal by Subject|0|||
125884498|NCT00790842|452875004|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125884499|NCT00790842|452875005|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125884500|NCT00790842|452875006|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125884501|NCT00790842|452875007|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125884502|NCT00790842|452875008|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126044751|NCT03662022|453461919|FG000|Year 2 2020|incident case|18|||
126044752|NCT03662022|453461920|FG001|Year 2 2020|incident case|18|||
126044753|NCT03662022|453461921|FG002|Year 2 2020|incident case|16|||
126044754|NCT03662022|453461922|FG003|Year 2 2020|incident case|26|||
126044755|NCT03662022|453461919|FG000|Year 2 2020|other case|18|||
126044756|NCT03662022|453461920|FG001|Year 2 2020|other case|16|||
126044757|NCT03662022|453461921|FG002|Year 2 2020|other case|16|||
126044758|NCT03662022|453461922|FG003|Year 2 2020|other case|24|||
126044759|NCT03662022|453461919|FG000|Year 2 2020|Lost to Follow-up|1633|||
126044760|NCT03662022|453461920|FG001|Year 2 2020|Lost to Follow-up|1183|||
126044761|NCT03662022|453461921|FG002|Year 2 2020|Lost to Follow-up|1381|||
126044762|NCT03662022|453461922|FG003|Year 2 2020|Lost to Follow-up|2858|||
126044763|NCT03662022|453461919|FG000|Year 3 2021|incident case|24|||
126044764|NCT03662022|453461920|FG001|Year 3 2021|incident case|27|||
126044765|NCT03662022|453461921|FG002|Year 3 2021|incident case|24|||
126044766|NCT03662022|453461922|FG003|Year 3 2021|incident case|11|||
126044767|NCT03662022|453461919|FG000|Year 3 2021|other case|4|||
126044768|NCT03662022|453461920|FG001|Year 3 2021|other case|15|||
126044769|NCT03662022|453461921|FG002|Year 3 2021|other case|10|||
126044770|NCT03662022|453461922|FG003|Year 3 2021|other case|14|||
126044771|NCT03662022|453461919|FG000|Year 3 2021|Lost to Follow-up|179|||
126044772|NCT03662022|453461920|FG001|Year 3 2021|Lost to Follow-up|244|||
126044773|NCT03662022|453461921|FG002|Year 3 2021|Lost to Follow-up|480|||
126044774|NCT03662022|453461922|FG003|Year 3 2021|Lost to Follow-up|477|||
126044775|NCT03662022|453461919|FG000|Year 4 2022|incident case|25|||
126044776|NCT03662022|453461920|FG001|Year 4 2022|incident case|41|||
126044777|NCT03662022|453461921|FG002|Year 4 2022|incident case|28|||
126044778|NCT03662022|453461922|FG003|Year 4 2022|incident case|7|||
126044779|NCT03662022|453461919|FG000|Year 4 2022|other case|8|||
126044780|NCT03662022|453461920|FG001|Year 4 2022|other case|19|||
126044781|NCT03662022|453461921|FG002|Year 4 2022|other case|13|||
126044782|NCT03662022|453461922|FG003|Year 4 2022|other case|7|||
126044783|NCT03662022|453461919|FG000|Year 4 2022|Lost to Follow-up|986|||
126044784|NCT03662022|453461920|FG001|Year 4 2022|Lost to Follow-up|1079|||
126044785|NCT03662022|453461921|FG002|Year 4 2022|Lost to Follow-up|1236|||
126044786|NCT03662022|453461922|FG003|Year 4 2022|Lost to Follow-up|1826|||
126044787|NCT04490109|453461933|FG000|Overall Study|Lost to Follow-up|3|||
126044788|NCT04490109|453461934|FG001|Overall Study|Lost to Follow-up|10|||
126044789|NCT04490109|453461935|FG002|Overall Study|Lost to Follow-up|4|||
126044790|NCT04490109|453461933|FG000|Overall Study|Withdrawal by Subject|8|||
126044791|NCT04490109|453461934|FG001|Overall Study|Withdrawal by Subject|6|||
126044792|NCT04490109|453461935|FG002|Overall Study|Withdrawal by Subject|9|||
126044793|NCT04490109|453461933|FG000|Overall Study|Physician Decision|0|||
126044794|NCT04490109|453461934|FG001|Overall Study|Physician Decision|2|||
126044795|NCT04490109|453461935|FG002|Overall Study|Physician Decision|3|||
126044796|NCT04490109|453461933|FG000|Overall Study|Adverse Event|2|||
126044797|NCT04490109|453461934|FG001|Overall Study|Adverse Event|1|||
125884503|NCT00790842|452875009|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125884504|NCT00790842|452875010|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125884505|NCT00790842|452875011|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126044798|NCT04490109|453461935|FG002|Overall Study|Adverse Event|0|||
126044799|NCT04490109|453461933|FG000|Overall Study|Significant Non-Compliance|2|||
126044800|NCT04490109|453461934|FG001|Overall Study|Significant Non-Compliance|4|||
126044801|NCT04490109|453461935|FG002|Overall Study|Significant Non-Compliance|4|||
126044802|NCT04490109|453461933|FG000|Overall Study|Significant Clinical Event|0|||
126044803|NCT04490109|453461934|FG001|Overall Study|Significant Clinical Event|1|||
126044804|NCT04490109|453461935|FG002|Overall Study|Significant Clinical Event|0|||
126044805|NCT04490109|453461933|FG000|Overall Study|Other Reason|4|||
126044806|NCT04490109|453461934|FG001|Overall Study|Other Reason|1|||
125884506|NCT00790842|452875012|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
125884507|NCT00790842|452875013|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126044807|NCT04490109|453461935|FG002|Overall Study|Other Reason|1|||
126044808|NCT03884439|453461943|FG000|Overall Study|No informed consent for publication of study results|38|||
126044809|NCT03884439|453461943|FG000|Overall Study|Contract violation/deficiency|7|||
126044810|NCT03904576|453461944|FG000|Washout Period|Protocol Violation|1|||
126044811|NCT03904576|453461945|FG001|Washout Period|Protocol Violation|1|||
126304366|NCT02887183|454402615|FG000|Overall Study|Death|30|||
126304367|NCT02887183|454402615|FG000|Overall Study|Pregnancy|1|||
126304368|NCT02887183|454402615|FG000|Overall Study|Protocol Violation|6|||
126304369|NCT02887183|454402615|FG000|Overall Study|Technical Problems|2|||
126304370|NCT02887183|454402615|FG000|Overall Study|Lost to Follow-up|13|||
126304371|NCT02887183|454402615|FG000|Overall Study|Physician Decision|10|||
126304372|NCT02887183|454402615|FG000|Overall Study|Withdrawal by Subject|35|||
126304373|NCT01031680|454402616|FG000|Overall Study|Adverse Event|8|||
126044812|NCT04780581|453461949|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
126044813|NCT04780581|453461950|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
126044814|NCT04780581|453461949|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
126044815|NCT04780581|453461950|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
126044816|NCT01756300|453461951|FG000|Overall Study|Death|1|||
126044817|NCT01756300|453461951|FG000|Overall Study|Withdrawal by Subject|1|||
126044818|NCT05311176|453462623|FG000|Overall Study|Death|6|||
126044819|NCT05311176|453462623|FG000|Overall Study|Sponsor discontinued the study|1|||
126044820|NCT01880515|453462624|FG000|Overall Study|Lost to Follow-up|3|||
126044821|NCT01880515|453462625|FG001|Overall Study|Lost to Follow-up|2|||
126044822|NCT01880515|453462624|FG000|Overall Study|Disease Progression|5|||
126044823|NCT01880515|453462625|FG001|Overall Study|Disease Progression|7|||
126044824|NCT04560179|453462644|FG000|Overall Study|Physician Decision|1|||
126044825|NCT04560179|453462645|FG001|Overall Study|Physician Decision|0|||
126044826|NCT04560179|453462646|FG002|Overall Study|Physician Decision|0|||
126044827|NCT04560179|453462647|FG003|Overall Study|Physician Decision|0|||
126044828|NCT04560179|453462648|FG004|Overall Study|Physician Decision|0|||
126044829|NCT04560179|453462644|FG000|Overall Study|Adverse Event|0|||
126044830|NCT04560179|453462645|FG001|Overall Study|Adverse Event|0|||
126044831|NCT04560179|453462646|FG002|Overall Study|Adverse Event|0|||
126044832|NCT04560179|453462647|FG003|Overall Study|Adverse Event|1|||
126044833|NCT04560179|453462648|FG004|Overall Study|Adverse Event|0|||
126044834|NCT05836012|453462659|FG000|Overall Study|Lost to Follow-up|1|||
126044835|NCT05836012|453462660|FG001|Overall Study|Lost to Follow-up|0|||
126044836|NCT05836012|453462659|FG000|Overall Study|Withdrawal by Subject|1|||
126044837|NCT05836012|453462660|FG001|Overall Study|Withdrawal by Subject|3|||
126044838|NCT05836012|453462659|FG000|Overall Study|Reason not included in pre-specified categories|2|||
126044839|NCT05836012|453462660|FG001|Overall Study|Reason not included in pre-specified categories|1|||
126044840|NCT03817983|453462661|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
126044841|NCT03817983|453462662|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
126044842|NCT03817983|453462663|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
126044843|NCT03744676|453462664|FG000|Pre-Treatment Phase|Disease related complications|2|||
126044844|NCT03744676|453462664|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
126044845|NCT03744676|453462664|FG000|Pre-Treatment Phase|Death|7|||
126044846|NCT03744676|453462664|FG000|Pre-Treatment Phase|Other Reasons|7|||
126044847|NCT03744676|453462664|FG000|Treatment Phase|Participant withdrew consent|8|||
126044848|NCT03744676|453462664|FG000|Treatment Phase|Death|33|||
126044849|NCT03744676|453462664|FG000|Treatment Phase|other reasons|6|||
126044850|NCT05454514|453462665|FG000|Overall Study|Withdrawal by Subject|4|||
126044851|NCT03533257|453462667|FG000|Overall Study|Adverse Event|4|||
126044852|NCT03533257|453462668|FG001|Overall Study|Adverse Event|2|||
126044853|NCT03533257|453462667|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
126044854|NCT03533257|453462668|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
126044855|NCT03587805|453462669|FG000|Overall Study|Adverse Event|72|||
126044856|NCT03587805|453462669|FG000|Overall Study|Death|1|||
126044857|NCT03587805|453462669|FG000|Overall Study|Lost to Follow-up|78|||
126044858|NCT03587805|453462669|FG000|Overall Study|Withdrawal by Subject|105|||
126044859|NCT03587805|453462669|FG000|Overall Study|Lack of Efficacy|119|||
126044860|NCT03587805|453462669|FG000|Overall Study|Reason unknown|26|||
126044861|NCT03587805|453462669|FG000|Overall Study|COVID_19 pandemic|4|||
126044862|NCT03587805|453462669|FG000|Overall Study|Various reasons|121|||
126044863|NCT03587805|453462669|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126044864|NCT04626427|453462670|FG000|Overall Study|Death|1|||
126044865|NCT04626427|453462670|FG000|Overall Study|Withdrawal by Subject|1|||
126044866|NCT04626427|453462670|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
126044867|NCT04626427|453462670|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
126044868|NCT01651000|453462671|FG000|Overall Study|Adverse Event|2|||
126044869|NCT01651000|453462672|FG001|Overall Study|Adverse Event|8|||
126044870|NCT01651000|453462671|FG000|Overall Study|Lost to Follow-up|3|||
126044871|NCT01651000|453462672|FG001|Overall Study|Lost to Follow-up|2|||
126044872|NCT01651000|453462671|FG000|Overall Study|Protocol Violation|0|||
126044873|NCT01651000|453462672|FG001|Overall Study|Protocol Violation|3|||
126044874|NCT01651000|453462671|FG000|Overall Study|Withdrawal by Subject|2|||
126044875|NCT01651000|453462672|FG001|Overall Study|Withdrawal by Subject|10|||
126304374|NCT01031680|454402617|FG001|Overall Study|Adverse Event|3|||
126044876|NCT01651000|453462671|FG000|Overall Study|Subject noncompliance|0|||
126044877|NCT01651000|453462672|FG001|Overall Study|Subject noncompliance|3|||
126044878|NCT01651000|453462671|FG000|Overall Study|Lack of Efficacy|1|||
126044879|NCT01651000|453462672|FG001|Overall Study|Lack of Efficacy|1|||
125884508|NCT00790842|452875014|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125884509|NCT00790842|452875004|FG000|Dose Level 3|Adverse Event|0|||
125884510|NCT00790842|452875005|FG001|Dose Level 3|Adverse Event|0|||
125884511|NCT00790842|452875006|FG002|Dose Level 3|Adverse Event|1|||
125884512|NCT00790842|452875007|FG003|Dose Level 3|Adverse Event|0|||
125884513|NCT00790842|452875008|FG004|Dose Level 3|Adverse Event|0|||
125884514|NCT00790842|452875009|FG005|Dose Level 3|Adverse Event|0|||
125884515|NCT00790842|452875010|FG006|Dose Level 3|Adverse Event|0|||
125884516|NCT00790842|452875011|FG007|Dose Level 3|Adverse Event|0|||
125884517|NCT00790842|452875012|FG008|Dose Level 3|Adverse Event|0|||
125884518|NCT00790842|452875013|FG009|Dose Level 3|Adverse Event|0|||
125884519|NCT00790842|452875014|FG010|Dose Level 3|Adverse Event|0|||
125884520|NCT00790842|452875004|FG000|Dose Level 3|Withdrawal by Subject|0|||
125884521|NCT00790842|452875005|FG001|Dose Level 3|Withdrawal by Subject|0|||
126304375|NCT01031680|454402616|FG000|Overall Study|Lost to Follow-up|2|||
126304376|NCT01031680|454402617|FG001|Overall Study|Lost to Follow-up|10|||
126304377|NCT01031680|454402616|FG000|Overall Study|Withdrawal by Subject|12|||
126304378|NCT01031680|454402617|FG001|Overall Study|Withdrawal by Subject|16|||
125884522|NCT00790842|452875006|FG002|Dose Level 3|Withdrawal by Subject|3|||
125884523|NCT00790842|452875007|FG003|Dose Level 3|Withdrawal by Subject|0|||
125884524|NCT00790842|452875008|FG004|Dose Level 3|Withdrawal by Subject|0|||
125884525|NCT00790842|452875009|FG005|Dose Level 3|Withdrawal by Subject|0|||
125884526|NCT00790842|452875010|FG006|Dose Level 3|Withdrawal by Subject|0|||
125884527|NCT00790842|452875011|FG007|Dose Level 3|Withdrawal by Subject|0|||
125884528|NCT00790842|452875012|FG008|Dose Level 3|Withdrawal by Subject|0|||
125884529|NCT00790842|452875013|FG009|Dose Level 3|Withdrawal by Subject|2|||
125884530|NCT00790842|452875014|FG010|Dose Level 3|Withdrawal by Subject|0|||
126044880|NCT01651000|453462671|FG000|Overall Study|Physician Decision|1|||
126304379|NCT01031680|454402616|FG000|Overall Study|Death|2|||
126304380|NCT01031680|454402617|FG001|Overall Study|Death|1|||
126304381|NCT01031680|454402616|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
126304382|NCT01031680|454402617|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
126304383|NCT01031680|454402616|FG000|Overall Study|Poor/Non-compliance|5|||
126304384|NCT01031680|454402617|FG001|Overall Study|Poor/Non-compliance|6|||
126304385|NCT01031680|454402616|FG000|Overall Study|Safety|1|||
125884531|NCT00790842|452875004|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884532|NCT00790842|452875005|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126304386|NCT01031680|454402617|FG001|Overall Study|Safety|0|||
126368143|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Other|15|||
126368144|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Other|20|||
126368145|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Other|44|||
126368146|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Other|0|||
126368147|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Other|0|||
126368148|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Other|0|||
126368149|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Other|0|||
126368150|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Other|0|||
126368151|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Other|0|||
126368152|NCT00725985|454642889|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368153|NCT00725985|454642890|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368154|NCT00725985|454642891|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368155|NCT00725985|454642892|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368156|NCT00725985|454642893|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368157|NCT00725985|454642894|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368158|NCT00725985|454642895|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368159|NCT00725985|454642896|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
126368160|NCT00725985|454642897|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368161|NCT00725985|454642898|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368162|NCT00725985|454642899|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368163|NCT00725985|454642900|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368164|NCT00725985|454642889|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368165|NCT00725985|454642890|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368166|NCT00725985|454642891|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368167|NCT00725985|454642892|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368168|NCT00725985|454642893|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368169|NCT00725985|454642894|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368170|NCT00725985|454642895|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368171|NCT00725985|454642896|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368172|NCT00725985|454642897|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
126368173|NCT00725985|454642898|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368174|NCT00725985|454642899|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368175|NCT00725985|454642900|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368176|NCT00725985|454642889|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368177|NCT00725985|454642890|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368178|NCT00725985|454642891|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368179|NCT00725985|454642892|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368180|NCT00725985|454642893|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368181|NCT00725985|454642894|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368182|NCT00725985|454642895|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
126368183|NCT00725985|454642896|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
126368184|NCT00725985|454642897|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
126368185|NCT00725985|454642898|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368186|NCT00725985|454642899|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125884533|NCT00790842|452875006|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884534|NCT00790842|452875007|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884535|NCT00790842|452875008|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884536|NCT00790842|452875009|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
125884537|NCT00790842|452875010|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884538|NCT00790842|452875011|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884539|NCT00790842|452875012|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884540|NCT00790842|452875013|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884541|NCT00790842|452875014|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125884542|NCT00790842|452875004|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884543|NCT00790842|452875005|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884544|NCT00790842|452875006|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
125884545|NCT00790842|452875007|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884546|NCT00790842|452875008|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884547|NCT00790842|452875009|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884548|NCT00790842|452875010|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884549|NCT00790842|452875011|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884550|NCT00790842|452875012|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884551|NCT00790842|452875013|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884552|NCT00790842|452875014|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125884553|NCT00790842|452875004|FG000|Dose Level 4|Adverse Event|0|||
125884554|NCT00790842|452875005|FG001|Dose Level 4|Adverse Event|0|||
125884555|NCT00790842|452875006|FG002|Dose Level 4|Adverse Event|0|||
126304387|NCT01031680|454402616|FG000|Overall Study|Incorrect Enrolment|1|||
126304388|NCT01031680|454402617|FG001|Overall Study|Incorrect Enrolment|2|||
126304389|NCT01031680|454402616|FG000|Overall Study|Administrative Reason by Sponsor|0|||
125884556|NCT00790842|452875007|FG003|Dose Level 4|Adverse Event|0|||
125884557|NCT00790842|452875008|FG004|Dose Level 4|Adverse Event|0|||
125884558|NCT00790842|452875009|FG005|Dose Level 4|Adverse Event|0|||
126304390|NCT01031680|454402617|FG001|Overall Study|Administrative Reason by Sponsor|1|||
126304391|NCT01031680|454402616|FG000|Overall Study|Various|0|||
126304392|NCT01031680|454402617|FG001|Overall Study|Various|2|||
125884559|NCT00790842|452875010|FG006|Dose Level 4|Adverse Event|1|||
125884560|NCT00790842|452875011|FG007|Dose Level 4|Adverse Event|0|||
125884561|NCT00790842|452875012|FG008|Dose Level 4|Adverse Event|0|||
125884562|NCT00790842|452875013|FG009|Dose Level 4|Adverse Event|0|||
125884563|NCT00790842|452875014|FG010|Dose Level 4|Adverse Event|0|||
126304393|NCT02654977|454402622|FG000|Overall Study|Death|1|||
125884564|NCT00790842|452875004|FG000|Dose Level 4|Physician Decision|0|||
126044881|NCT01651000|453462672|FG001|Overall Study|Physician Decision|0|||
126304394|NCT02654977|454402622|FG000|Overall Study|Lost to Follow-up|1|||
126304395|NCT02654977|454402622|FG000|Overall Study|Adverse Event|1|||
126304396|NCT02654977|454402622|FG000|Overall Study|Withdrawal by Subject|1|||
126304397|NCT02654977|454402622|FG000|Overall Study|Lack of Efficacy|3|||
126304398|NCT01921101|454402623|FG000|Overall Study|Death|16|||
126304399|NCT01921101|454402624|FG001|Overall Study|Death|6|||
126304400|NCT01483027|454402625|FG000|Overall Study|Administrative Reasons|2|||
126304401|NCT01483027|454402626|FG001|Overall Study|Administrative Reasons|1|||
126304402|NCT01483027|454402625|FG000|Overall Study|Withdrawal by Subject|21|||
126304403|NCT01483027|454402626|FG001|Overall Study|Withdrawal by Subject|32|||
126304404|NCT01483027|454402625|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
126304405|NCT01483027|454402626|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
126304406|NCT01483027|454402625|FG000|Overall Study|Lost to Follow-up|1|||
126304407|NCT01483027|454402626|FG001|Overall Study|Lost to Follow-up|1|||
126304408|NCT01483027|454402625|FG000|Overall Study|Adverse Event|0|||
126304409|NCT01483027|454402626|FG001|Overall Study|Adverse Event|1|||
126304410|NCT01483027|454402625|FG000|Overall Study|Withdrawal by Subject|0|||
126304411|NCT01483027|454402626|FG001|Overall Study|Withdrawal by Subject|1|||
126304412|NCT03300505|454404208|FG000|Overall Study|Death|0|||
126304413|NCT03300505|454404209|FG001|Overall Study|Death|1|||
126304414|NCT03300505|454404210|FG002|Overall Study|Death|0|||
126304415|NCT03300505|454404208|FG000|Overall Study|Withdrawal by Subject|0|||
126304416|NCT03300505|454404209|FG001|Overall Study|Withdrawal by Subject|1|||
126304417|NCT03300505|454404210|FG002|Overall Study|Withdrawal by Subject|1|||
126304418|NCT03300505|454404208|FG000|Overall Study|Sponsor Termination|0|||
126304419|NCT03300505|454404209|FG001|Overall Study|Sponsor Termination|1|||
126304420|NCT03300505|454404210|FG002|Overall Study|Sponsor Termination|0|||
126304421|NCT03300505|454404208|FG000|Overall Study|Adverse Event|0|||
126304422|NCT03300505|454404209|FG001|Overall Study|Adverse Event|0|||
126304423|NCT03300505|454404210|FG002|Overall Study|Adverse Event|2|||
126304424|NCT00679029|454404211|FG000|Overall Study|Adverse Event|3|||
126304425|NCT00679029|454404211|FG000|Overall Study|Withdrawal by Subject|1|||
126304426|NCT00679029|454404211|FG000|Overall Study|Lost to Follow-up|1|||
126304427|NCT01108341|454404212|FG000|Overall Study|Death|2|||
126304428|NCT01108341|454404212|FG000|Overall Study|Withdrawal by Subject|1|||
126304429|NCT01108341|454404212|FG000|Overall Study|Lost to Follow-up|1|||
126304430|NCT01108341|454404212|FG000|Overall Study|Other|1|||
126304431|NCT01718535|454404215|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
126304432|NCT01718535|454404216|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
126304433|NCT01718535|454404217|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
126304434|NCT01718535|454404218|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
126304435|NCT01718535|454404219|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
126304436|NCT01718535|454404220|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
126044882|NCT01651000|453462671|FG000|Overall Study|Administrative reason|1|||
126103401|NCT02924064|453672150|FG000|Overall Study|Protocol Violation|1|||
126304437|NCT01718535|454404221|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
126304438|NCT01718535|454404222|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
126304439|NCT01718535|454404223|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
126304440|NCT01718535|454404224|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
125884565|NCT00790842|452875005|FG001|Dose Level 4|Physician Decision|0|||
125884566|NCT00790842|452875006|FG002|Dose Level 4|Physician Decision|0|||
125884567|NCT00790842|452875007|FG003|Dose Level 4|Physician Decision|0|||
125884568|NCT00790842|452875008|FG004|Dose Level 4|Physician Decision|0|||
125884569|NCT00790842|452875009|FG005|Dose Level 4|Physician Decision|0|||
125884570|NCT00790842|452875010|FG006|Dose Level 4|Physician Decision|1|||
125884571|NCT00790842|452875011|FG007|Dose Level 4|Physician Decision|0|||
125884572|NCT00790842|452875012|FG008|Dose Level 4|Physician Decision|0|||
125884573|NCT00790842|452875013|FG009|Dose Level 4|Physician Decision|0|||
125884574|NCT00790842|452875014|FG010|Dose Level 4|Physician Decision|1|||
125884575|NCT00790842|452875004|FG000|Dose Level 4|Withdrawal by Subject|0|||
125884576|NCT00790842|452875005|FG001|Dose Level 4|Withdrawal by Subject|0|||
125884577|NCT00790842|452875006|FG002|Dose Level 4|Withdrawal by Subject|0|||
125884578|NCT00790842|452875007|FG003|Dose Level 4|Withdrawal by Subject|0|||
125884579|NCT00790842|452875008|FG004|Dose Level 4|Withdrawal by Subject|0|||
125884580|NCT00790842|452875009|FG005|Dose Level 4|Withdrawal by Subject|0|||
125884581|NCT00790842|452875010|FG006|Dose Level 4|Withdrawal by Subject|0|||
125884582|NCT00790842|452875011|FG007|Dose Level 4|Withdrawal by Subject|0|||
125884583|NCT00790842|452875012|FG008|Dose Level 4|Withdrawal by Subject|0|||
125884584|NCT00790842|452875013|FG009|Dose Level 4|Withdrawal by Subject|0|||
125884585|NCT00790842|452875014|FG010|Dose Level 4|Withdrawal by Subject|1|||
125884586|NCT00790842|452875004|FG000|Expansion Cohort|Adverse Event|0|||
125884587|NCT00790842|452875005|FG001|Expansion Cohort|Adverse Event|0|||
125884588|NCT00790842|452875006|FG002|Expansion Cohort|Adverse Event|0|||
125884589|NCT00790842|452875007|FG003|Expansion Cohort|Adverse Event|0|||
125884590|NCT00790842|452875008|FG004|Expansion Cohort|Adverse Event|0|||
125884591|NCT00790842|452875009|FG005|Expansion Cohort|Adverse Event|0|||
125884592|NCT00790842|452875010|FG006|Expansion Cohort|Adverse Event|1|||
125884593|NCT00790842|452875011|FG007|Expansion Cohort|Adverse Event|0|||
125884594|NCT00790842|452875012|FG008|Expansion Cohort|Adverse Event|0|||
125884595|NCT00790842|452875013|FG009|Expansion Cohort|Adverse Event|0|||
125884596|NCT00790842|452875014|FG010|Expansion Cohort|Adverse Event|0|||
125884597|NCT00790842|452875004|FG000|Expansion Cohort|Death|0|||
125884598|NCT00790842|452875005|FG001|Expansion Cohort|Death|0|||
125884599|NCT00790842|452875006|FG002|Expansion Cohort|Death|2|||
125884600|NCT00790842|452875007|FG003|Expansion Cohort|Death|0|||
125884601|NCT00790842|452875008|FG004|Expansion Cohort|Death|0|||
125884602|NCT00790842|452875009|FG005|Expansion Cohort|Death|0|||
125884603|NCT00790842|452875010|FG006|Expansion Cohort|Death|0|||
125884604|NCT00790842|452875011|FG007|Expansion Cohort|Death|0|||
125884605|NCT00790842|452875012|FG008|Expansion Cohort|Death|0|||
125884606|NCT00790842|452875013|FG009|Expansion Cohort|Death|0|||
125884607|NCT00790842|452875014|FG010|Expansion Cohort|Death|0|||
125884608|NCT00790842|452875004|FG000|Expansion Cohort|Physician Decision|0|||
126304441|NCT01073605|454404228|FG000|Overall Study|Ongoing at Cutoff Date|1|||
126304442|NCT01073605|454404229|FG001|Overall Study|Ongoing at Cutoff Date|1|||
126304443|NCT01073605|454404230|FG002|Overall Study|Ongoing at Cutoff Date|0|||
126304444|NCT01073605|454404228|FG000|Overall Study|Adverse Event|2|||
125884609|NCT00790842|452875005|FG001|Expansion Cohort|Physician Decision|0|||
125884610|NCT00790842|452875006|FG002|Expansion Cohort|Physician Decision|1|||
125884611|NCT00790842|452875007|FG003|Expansion Cohort|Physician Decision|0|||
125884612|NCT00790842|452875008|FG004|Expansion Cohort|Physician Decision|0|||
125884613|NCT00790842|452875009|FG005|Expansion Cohort|Physician Decision|0|||
125884614|NCT00790842|452875010|FG006|Expansion Cohort|Physician Decision|0|||
125884615|NCT00790842|452875011|FG007|Expansion Cohort|Physician Decision|0|||
125884616|NCT00790842|452875012|FG008|Expansion Cohort|Physician Decision|0|||
125884617|NCT00790842|452875013|FG009|Expansion Cohort|Physician Decision|0|||
125884618|NCT00790842|452875014|FG010|Expansion Cohort|Physician Decision|0|||
125884619|NCT00790842|452875004|FG000|Expansion Cohort|Withdrawal by Subject|0|||
125884620|NCT00790842|452875005|FG001|Expansion Cohort|Withdrawal by Subject|0|||
125884621|NCT00790842|452875006|FG002|Expansion Cohort|Withdrawal by Subject|3|||
125884622|NCT00790842|452875007|FG003|Expansion Cohort|Withdrawal by Subject|0|||
125884623|NCT00790842|452875008|FG004|Expansion Cohort|Withdrawal by Subject|0|||
125884624|NCT00790842|452875009|FG005|Expansion Cohort|Withdrawal by Subject|0|||
125884625|NCT00790842|452875010|FG006|Expansion Cohort|Withdrawal by Subject|0|||
125884626|NCT00790842|452875011|FG007|Expansion Cohort|Withdrawal by Subject|0|||
125884627|NCT00790842|452875012|FG008|Expansion Cohort|Withdrawal by Subject|0|||
125884628|NCT00790842|452875013|FG009|Expansion Cohort|Withdrawal by Subject|0|||
125884629|NCT00790842|452875014|FG010|Expansion Cohort|Withdrawal by Subject|0|||
125884630|NCT00790842|452875004|FG000|Expansion Cohort|Study Closure|0|||
125884631|NCT00790842|452875005|FG001|Expansion Cohort|Study Closure|0|||
125884632|NCT00790842|452875006|FG002|Expansion Cohort|Study Closure|1|||
125884633|NCT00790842|452875007|FG003|Expansion Cohort|Study Closure|0|||
125884634|NCT00790842|452875008|FG004|Expansion Cohort|Study Closure|0|||
125884635|NCT00790842|452875009|FG005|Expansion Cohort|Study Closure|0|||
125884636|NCT00790842|452875010|FG006|Expansion Cohort|Study Closure|0|||
125884637|NCT00790842|452875011|FG007|Expansion Cohort|Study Closure|0|||
125884638|NCT00790842|452875012|FG008|Expansion Cohort|Study Closure|0|||
125884639|NCT00790842|452875013|FG009|Expansion Cohort|Study Closure|0|||
125884640|NCT00790842|452875014|FG010|Expansion Cohort|Study Closure|0|||
125884641|NCT03722238|452875017|FG000|Overall Study|Protocol Violation|1|||
125884642|NCT03722238|452875018|FG001|Overall Study|Protocol Violation|0|||
125884643|NCT03722238|452875017|FG000|Overall Study|Physician Decision|1|||
125884644|NCT03722238|452875018|FG001|Overall Study|Physician Decision|0|||
125884645|NCT03722238|452875017|FG000|Overall Study|Death|1|||
125884646|NCT03722238|452875018|FG001|Overall Study|Death|0|||
125884647|NCT03722238|452875017|FG000|Overall Study|Lost to Follow-up|6|||
125884648|NCT03722238|452875018|FG001|Overall Study|Lost to Follow-up|0|||
125884649|NCT03722238|452875017|FG000|Overall Study|Partial missing data|44|||
125884650|NCT03722238|452875018|FG001|Overall Study|Partial missing data|1|||
125884651|NCT03722238|452875017|FG000|Overall Study|Withdrawal by Subject|2|||
125884652|NCT03722238|452875018|FG001|Overall Study|Withdrawal by Subject|0|||
125884653|NCT03722238|452875017|FG000|Overall Study|Other|4|||
125884654|NCT03722238|452875018|FG001|Overall Study|Other|0|||
125884655|NCT03722238|452875017|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
125884656|NCT03722238|452875018|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
125884657|NCT03722238|452875017|FG000|Overall Study|Did not meet risk classification group criteria|90|||
125884658|NCT03722238|452875018|FG001|Overall Study|Did not meet risk classification group criteria|0|||
125884659|NCT03722238|452875017|FG000|Overall Study|Did not sign consent|17|||
125884660|NCT03722238|452875018|FG001|Overall Study|Did not sign consent|0|||
125884661|NCT03722238|452875017|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
125884662|NCT03722238|452875018|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
125884663|NCT03722238|452875017|FG000|Overall Study|Not willing to purchase study medication|142|||
125884664|NCT03722238|452875018|FG001|Overall Study|Not willing to purchase study medication|0|||
125884665|NCT03722238|452875017|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
125884666|NCT03722238|452875018|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
125884667|NCT00885170|452875027|FG000|Overall Study|Adverse Event|12|||
125884668|NCT00885170|452875028|FG001|Overall Study|Adverse Event|4|||
125884669|NCT00885170|452875027|FG000|Overall Study|Excessive bone loss|6|||
125884670|NCT00885170|452875028|FG001|Overall Study|Excessive bone loss|3|||
125884671|NCT00885170|452875027|FG000|Overall Study|Lost to Follow-up|2|||
125884672|NCT00885170|452875028|FG001|Overall Study|Lost to Follow-up|1|||
125884673|NCT00885170|452875027|FG000|Overall Study|Physician Decision|2|||
125884674|NCT00885170|452875028|FG001|Overall Study|Physician Decision|1|||
125884675|NCT00885170|452875027|FG000|Overall Study|Protocol Violation|3|||
125884676|NCT00885170|452875028|FG001|Overall Study|Protocol Violation|1|||
125884677|NCT00885170|452875027|FG000|Overall Study|Withdrawal by Subject|13|||
125884678|NCT00885170|452875028|FG001|Overall Study|Withdrawal by Subject|13|||
125884679|NCT03771664|452875029|FG000|Overall Study|Adverse Event|1|||
125884680|NCT03771664|452875030|FG001|Overall Study|Adverse Event|0|||
125884681|NCT03771664|452875029|FG000|Overall Study|Lost to Follow-up|1|||
125884682|NCT03771664|452875030|FG001|Overall Study|Lost to Follow-up|0|||
125884683|NCT03771664|452875029|FG000|Overall Study|Withdrawal by Participant|1|||
125884684|NCT03771664|452875030|FG001|Overall Study|Withdrawal by Participant|4|||
125884685|NCT03771664|452875029|FG000|Overall Study|Randomized but not Treated|0|||
125884686|NCT03771664|452875030|FG001|Overall Study|Randomized but not Treated|1|||
125884687|NCT00561925|452875031|FG000|14 Day Lead-In Period|Adverse Event|38|||
125884688|NCT00561925|452875032|FG001|14 Day Lead-In Period|Adverse Event|0|||
125884689|NCT00561925|452875033|FG002|14 Day Lead-In Period|Adverse Event|0|||
125884690|NCT00561925|452875034|FG003|14 Day Lead-In Period|Adverse Event|0|||
125884691|NCT00561925|452875035|FG004|14 Day Lead-In Period|Adverse Event|0|||
125884692|NCT00561925|452875031|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
126044883|NCT01651000|453462672|FG001|Overall Study|Administrative reason|0|||
126304445|NCT01073605|454404229|FG001|Overall Study|Adverse Event|1|||
126304446|NCT01073605|454404230|FG002|Overall Study|Adverse Event|0|||
126304447|NCT01073605|454404228|FG000|Overall Study|Lost to Follow-up|3|||
126304448|NCT01073605|454404229|FG001|Overall Study|Lost to Follow-up|4|||
126304449|NCT01073605|454404230|FG002|Overall Study|Lost to Follow-up|9|||
126304450|NCT01073605|454404228|FG000|Overall Study|Other|25|||
126304451|NCT01073605|454404229|FG001|Overall Study|Other|21|||
126304452|NCT01073605|454404230|FG002|Overall Study|Other|29|||
126304453|NCT01073605|454404228|FG000|Overall Study|Withdrawal by Subject|31|||
126304454|NCT01073605|454404229|FG001|Overall Study|Withdrawal by Subject|39|||
126304455|NCT01073605|454404230|FG002|Overall Study|Withdrawal by Subject|22|||
126304456|NCT01073605|454404228|FG000|Overall Study|Randomized But Not Treated|0|||
126304457|NCT01073605|454404229|FG001|Overall Study|Randomized But Not Treated|1|||
126304458|NCT01073605|454404230|FG002|Overall Study|Randomized But Not Treated|1|||
126304459|NCT02035202|454404231|FG000|Overall Study|Lost to Follow-up|8|||
126304460|NCT02035202|454404232|FG001|Overall Study|Lost to Follow-up|16|||
126304461|NCT02035202|454404233|FG002|Overall Study|Lost to Follow-up|2|||
126304462|NCT00083759|454404234|FG000|Overall Study|Adverse Event|5|||
126304463|NCT00083759|454404235|FG001|Overall Study|Adverse Event|3|||
126304464|NCT00083759|454404234|FG000|Overall Study|Lost to Follow-up|1|||
126304465|NCT00083759|454404235|FG001|Overall Study|Lost to Follow-up|0|||
126304466|NCT00083759|454404234|FG000|Overall Study|Death|1|||
126304467|NCT00083759|454404235|FG001|Overall Study|Death|1|||
126304468|NCT00083759|454404234|FG000|Overall Study|Inadequate Therapeutic Response|32|||
126304469|NCT00083759|454404235|FG001|Overall Study|Inadequate Therapeutic Response|35|||
126304470|NCT00083759|454404234|FG000|Overall Study|Subject Withdrew Consent|2|||
126304471|NCT00083759|454404235|FG001|Overall Study|Subject Withdrew Consent|2|||
126304472|NCT00083759|454404234|FG000|Overall Study|Non-Compliance|1|||
126304473|NCT00083759|454404235|FG001|Overall Study|Non-Compliance|0|||
126304474|NCT00083759|454404234|FG000|Overall Study|Sponsor's Discretion|28|||
126304475|NCT00083759|454404235|FG001|Overall Study|Sponsor's Discretion|29|||
126304476|NCT00083759|454404234|FG000|Overall Study|Other|14|||
126304477|NCT00083759|454404235|FG001|Overall Study|Other|13|||
126304478|NCT02875613|454404236|FG000|Overall Study|Withdrawal by Subject|1|||
126304479|NCT02875613|454404236|FG000|Overall Study|Screen Failure|1|||
126304480|NCT00267969|454404246|FG000|Controlled Period|Adverse Event|6|||
126304481|NCT00267969|454404247|FG001|Controlled Period|Adverse Event|0|||
126304482|NCT00267969|454404248|FG002|Controlled Period|Adverse Event|2|||
126304483|NCT00267969|454404249|FG003|Controlled Period|Adverse Event|0|||
126304484|NCT00267969|454404250|FG004|Controlled Period|Adverse Event|0|||
126304485|NCT00267969|454404251|FG005|Controlled Period|Adverse Event|0|||
126304486|NCT00267969|454404252|FG006|Controlled Period|Adverse Event|0|||
126304487|NCT00267969|454404246|FG000|Controlled Period|Lack of Efficacy|3|||
126304488|NCT00267969|454404247|FG001|Controlled Period|Lack of Efficacy|0|||
126304489|NCT00267969|454404248|FG002|Controlled Period|Lack of Efficacy|1|||
126304490|NCT00267969|454404249|FG003|Controlled Period|Lack of Efficacy|0|||
126304491|NCT00267969|454404250|FG004|Controlled Period|Lack of Efficacy|0|||
126304492|NCT00267969|454404251|FG005|Controlled Period|Lack of Efficacy|0|||
126304493|NCT00267969|454404252|FG006|Controlled Period|Lack of Efficacy|0|||
126304494|NCT00267969|454404246|FG000|Controlled Period|Lost to Follow-up|1|||
126304495|NCT00267969|454404247|FG001|Controlled Period|Lost to Follow-up|0|||
126304496|NCT00267969|454404248|FG002|Controlled Period|Lost to Follow-up|1|||
126304497|NCT00267969|454404249|FG003|Controlled Period|Lost to Follow-up|0|||
126304498|NCT00267969|454404250|FG004|Controlled Period|Lost to Follow-up|0|||
126304499|NCT00267969|454404251|FG005|Controlled Period|Lost to Follow-up|0|||
126304500|NCT00267969|454404252|FG006|Controlled Period|Lost to Follow-up|0|||
126304501|NCT00267969|454404246|FG000|Controlled Period|Randomized but not treated|0|||
126044884|NCT01651000|453462671|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
126304502|NCT00267969|454404247|FG001|Controlled Period|Randomized but not treated|0|||
126304503|NCT00267969|454404248|FG002|Controlled Period|Randomized but not treated|1|||
126304504|NCT00267969|454404249|FG003|Controlled Period|Randomized but not treated|0|||
126304505|NCT00267969|454404250|FG004|Controlled Period|Randomized but not treated|0|||
126304506|NCT00267969|454404251|FG005|Controlled Period|Randomized but not treated|0|||
126304507|NCT00267969|454404252|FG006|Controlled Period|Randomized but not treated|0|||
126304508|NCT00267969|454404246|FG000|Controlled Period|Other|2|||
126304509|NCT00267969|454404247|FG001|Controlled Period|Other|1|||
126304510|NCT00267969|454404248|FG002|Controlled Period|Other|6|||
126304511|NCT00267969|454404249|FG003|Controlled Period|Other|0|||
126304512|NCT00267969|454404250|FG004|Controlled Period|Other|0|||
126304513|NCT00267969|454404251|FG005|Controlled Period|Other|0|||
126304514|NCT00267969|454404252|FG006|Controlled Period|Other|0|||
126304515|NCT00267969|454404246|FG000|After Controlled Period|Adverse Event|0|||
126304516|NCT00267969|454404247|FG001|After Controlled Period|Adverse Event|0|||
126304517|NCT00267969|454404248|FG002|After Controlled Period|Adverse Event|0|||
126304518|NCT00267969|454404249|FG003|After Controlled Period|Adverse Event|7|||
126304519|NCT00267969|454404250|FG004|After Controlled Period|Adverse Event|8|||
126304520|NCT00267969|454404251|FG005|After Controlled Period|Adverse Event|23|||
126304521|NCT00267969|454404252|FG006|After Controlled Period|Adverse Event|21|||
126044885|NCT01651000|453462672|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
126044886|NCT03982186|453462673|FG000|Overall Study|Lost to Follow-up|0|||
126044887|NCT03982186|453462674|FG001|Overall Study|Lost to Follow-up|1|||
126044888|NCT03982186|453462675|FG002|Overall Study|Lost to Follow-up|2|||
126044889|NCT03982186|453462676|FG003|Overall Study|Lost to Follow-up|1|||
126044890|NCT03982186|453462677|FG004|Overall Study|Lost to Follow-up|1|||
126044891|NCT03982186|453462678|FG005|Overall Study|Lost to Follow-up|0|||
126044892|NCT03982186|453462673|FG000|Overall Study|Physician Decision|0|||
126044893|NCT03982186|453462674|FG001|Overall Study|Physician Decision|1|||
126044894|NCT03982186|453462675|FG002|Overall Study|Physician Decision|0|||
126044895|NCT03982186|453462676|FG003|Overall Study|Physician Decision|0|||
126044896|NCT03982186|453462677|FG004|Overall Study|Physician Decision|0|||
126044897|NCT03982186|453462678|FG005|Overall Study|Physician Decision|0|||
126304522|NCT00267969|454404246|FG000|After Controlled Period|Death|0|||
126304523|NCT00267969|454404247|FG001|After Controlled Period|Death|0|||
126304524|NCT00267969|454404248|FG002|After Controlled Period|Death|0|||
126304525|NCT00267969|454404249|FG003|After Controlled Period|Death|1|||
126044898|NCT03982186|453462673|FG000|Overall Study|Withdrawal by Subject|3|||
126044899|NCT03982186|453462674|FG001|Overall Study|Withdrawal by Subject|4|||
126044900|NCT03982186|453462675|FG002|Overall Study|Withdrawal by Subject|1|||
126044901|NCT03982186|453462676|FG003|Overall Study|Withdrawal by Subject|7|||
126304526|NCT00267969|454404250|FG004|After Controlled Period|Death|2|||
126304527|NCT00267969|454404251|FG005|After Controlled Period|Death|0|||
126304528|NCT00267969|454404252|FG006|After Controlled Period|Death|1|||
126304529|NCT00267969|454404246|FG000|After Controlled Period|Lack of Efficacy|0|||
126304530|NCT00267969|454404247|FG001|After Controlled Period|Lack of Efficacy|0|||
126304531|NCT00267969|454404248|FG002|After Controlled Period|Lack of Efficacy|0|||
126304532|NCT00267969|454404249|FG003|After Controlled Period|Lack of Efficacy|10|||
126304533|NCT00267969|454404250|FG004|After Controlled Period|Lack of Efficacy|6|||
126304534|NCT00267969|454404251|FG005|After Controlled Period|Lack of Efficacy|28|||
126304535|NCT00267969|454404252|FG006|After Controlled Period|Lack of Efficacy|15|||
126304536|NCT00267969|454404246|FG000|After Controlled Period|Lost to Follow-up|0|||
126304537|NCT00267969|454404247|FG001|After Controlled Period|Lost to Follow-up|0|||
126304538|NCT00267969|454404248|FG002|After Controlled Period|Lost to Follow-up|0|||
126304539|NCT00267969|454404249|FG003|After Controlled Period|Lost to Follow-up|5|||
126304540|NCT00267969|454404250|FG004|After Controlled Period|Lost to Follow-up|8|||
126044902|NCT03982186|453462677|FG004|Overall Study|Withdrawal by Subject|2|||
126304541|NCT00267969|454404251|FG005|After Controlled Period|Lost to Follow-up|9|||
126044903|NCT03982186|453462678|FG005|Overall Study|Withdrawal by Subject|0|||
126044904|NCT03982186|453462673|FG000|Overall Study|Randomized and not treated|0|||
126304542|NCT00267969|454404252|FG006|After Controlled Period|Lost to Follow-up|10|||
126304543|NCT00267969|454404246|FG000|After Controlled Period|Other|0|||
126304544|NCT00267969|454404247|FG001|After Controlled Period|Other|0|||
126304545|NCT00267969|454404248|FG002|After Controlled Period|Other|0|||
126304546|NCT00267969|454404249|FG003|After Controlled Period|Other|13|||
126304547|NCT00267969|454404250|FG004|After Controlled Period|Other|11|||
126304548|NCT00267969|454404251|FG005|After Controlled Period|Other|22|||
126044905|NCT03982186|453462674|FG001|Overall Study|Randomized and not treated|0|||
126044906|NCT03982186|453462675|FG002|Overall Study|Randomized and not treated|0|||
126044907|NCT03982186|453462676|FG003|Overall Study|Randomized and not treated|1|||
126044908|NCT03982186|453462677|FG004|Overall Study|Randomized and not treated|0|||
126044909|NCT03982186|453462678|FG005|Overall Study|Randomized and not treated|0|||
126044910|NCT02765412|453462679|FG000|Overall Study|Death|482|||
126044911|NCT02765412|453462680|FG001|Overall Study|Death|855|||
126044912|NCT04244175|453463833|FG000|Overall Study|Adverse Event|3|||
126044913|NCT04244175|453463834|FG001|Overall Study|Adverse Event|2|||
126044914|NCT04244175|453463835|FG002|Overall Study|Adverse Event|5|||
126044915|NCT04244175|453463833|FG000|Overall Study|Lack of Efficacy|1|||
126044916|NCT04244175|453463834|FG001|Overall Study|Lack of Efficacy|0|||
126044917|NCT04244175|453463835|FG002|Overall Study|Lack of Efficacy|1|||
126044918|NCT04244175|453463833|FG000|Overall Study|Lost to Follow-up|1|||
126044919|NCT04244175|453463834|FG001|Overall Study|Lost to Follow-up|0|||
126044920|NCT04244175|453463835|FG002|Overall Study|Lost to Follow-up|0|||
126044921|NCT04244175|453463833|FG000|Overall Study|Non-compliance with study drug|1|||
126044922|NCT04244175|453463834|FG001|Overall Study|Non-compliance with study drug|0|||
126044923|NCT04244175|453463835|FG002|Overall Study|Non-compliance with study drug|1|||
126044924|NCT04244175|453463833|FG000|Overall Study|Protocol deviation|0|||
126044925|NCT04244175|453463834|FG001|Overall Study|Protocol deviation|1|||
126044926|NCT04244175|453463835|FG002|Overall Study|Protocol deviation|0|||
126044927|NCT04244175|453463833|FG000|Overall Study|Withdrawal by Subject|1|||
126044928|NCT04244175|453463834|FG001|Overall Study|Withdrawal by Subject|3|||
126044929|NCT04244175|453463835|FG002|Overall Study|Withdrawal by Subject|1|||
126044930|NCT04244175|453463833|FG000|Overall Study|Other, not specified|0|||
126044931|NCT04244175|453463834|FG001|Overall Study|Other, not specified|1|||
126044932|NCT04244175|453463835|FG002|Overall Study|Other, not specified|2|||
126044933|NCT04595331|453463836|FG000|Overall Study|Withdrawal by Subject|0|||
126044934|NCT04595331|453463837|FG001|Overall Study|Withdrawal by Subject|1|||
126044935|NCT04595331|453463836|FG000|Overall Study|Lost to Follow-up|0|||
126044936|NCT04595331|453463837|FG001|Overall Study|Lost to Follow-up|5|||
126044937|NCT04595331|453463836|FG000|Overall Study|Medical reason|0|||
126044938|NCT04595331|453463837|FG001|Overall Study|Medical reason|1|||
126044939|NCT03781089|453463838|FG000|Overall Study|Constipation|1|||
126044940|NCT03781089|453463839|FG001|Overall Study|Constipation|0|||
126044941|NCT03781089|453463838|FG000|Overall Study|Positive pregnancy test|0|||
126044942|NCT03781089|453463839|FG001|Overall Study|Positive pregnancy test|1|||
126044943|NCT05020353|453463840|FG000|Overall Study|Protocol Violation|7|||
126044944|NCT05020353|453463840|FG000|Overall Study|Withdrawal by Subject|33|||
126044945|NCT03333915|453463849|FG000|Overall Study|Lost to Follow-up|0|||
126044946|NCT03333915|453463850|FG001|Overall Study|Lost to Follow-up|0|||
126044947|NCT03333915|453463851|FG002|Overall Study|Lost to Follow-up|1|||
126044948|NCT03333915|453463852|FG003|Overall Study|Lost to Follow-up|0|||
126044949|NCT03333915|453463853|FG004|Overall Study|Lost to Follow-up|0|||
126044950|NCT03333915|453463849|FG000|Overall Study|Disease Progression|0|||
126044951|NCT03333915|453463850|FG001|Overall Study|Disease Progression|1|||
126044952|NCT03333915|453463851|FG002|Overall Study|Disease Progression|0|||
126044953|NCT03333915|453463852|FG003|Overall Study|Disease Progression|0|||
126044954|NCT03333915|453463853|FG004|Overall Study|Disease Progression|0|||
126044955|NCT03333915|453463849|FG000|Overall Study|Death|0|||
126304549|NCT00267969|454404252|FG006|After Controlled Period|Other|25|||
126304550|NCT02308540|454404257|FG000|Overall Study|Lost to Follow-up|0|||
126044956|NCT03333915|453463850|FG001|Overall Study|Death|0|||
126044957|NCT03333915|453463851|FG002|Overall Study|Death|0|||
126044958|NCT03333915|453463852|FG003|Overall Study|Death|37|||
126044959|NCT03333915|453463853|FG004|Overall Study|Death|18|||
126304551|NCT02308540|454404258|FG001|Overall Study|Lost to Follow-up|0|||
126304552|NCT02308540|454404259|FG002|Overall Study|Lost to Follow-up|0|||
126044960|NCT03333915|453463849|FG000|Overall Study|Sponsor's Decision|0|||
126044961|NCT03333915|453463850|FG001|Overall Study|Sponsor's Decision|0|||
126044962|NCT03333915|453463851|FG002|Overall Study|Sponsor's Decision|0|||
126044963|NCT03333915|453463852|FG003|Overall Study|Sponsor's Decision|48|||
126044964|NCT03333915|453463853|FG004|Overall Study|Sponsor's Decision|4|||
126044965|NCT03333915|453463849|FG000|Overall Study|Withdrawal by Subject|0|||
126304553|NCT02308540|454404260|FG003|Overall Study|Lost to Follow-up|0|||
126044966|NCT03333915|453463850|FG001|Overall Study|Withdrawal by Subject|0|||
126044967|NCT03333915|453463851|FG002|Overall Study|Withdrawal by Subject|0|||
126044968|NCT03333915|453463852|FG003|Overall Study|Withdrawal by Subject|5|||
126044969|NCT03333915|453463853|FG004|Overall Study|Withdrawal by Subject|1|||
126044970|NCT05785130|453463868|FG000|Overall Study|Withdrawal by Subject|1|||
126044971|NCT05785130|453463869|FG001|Overall Study|Withdrawal by Subject|0|||
126044972|NCT05785130|453463868|FG000|Overall Study|Lack of Efficacy|0|||
126044973|NCT05785130|453463869|FG001|Overall Study|Lack of Efficacy|1|||
126044974|NCT03547271|453463875|FG000|Overall Study|Adverse Event|1|||
126044975|NCT03547271|453463876|FG001|Overall Study|Adverse Event|1|||
126044976|NCT03547271|453463877|FG002|Overall Study|Adverse Event|0|||
126044977|NCT03547271|453463878|FG003|Overall Study|Adverse Event|0|||
126044978|NCT03547271|453463875|FG000|Overall Study|Protocol deviation|5|||
126044979|NCT03547271|453463876|FG001|Overall Study|Protocol deviation|7|||
126044980|NCT03547271|453463877|FG002|Overall Study|Protocol deviation|3|||
126044981|NCT03547271|453463878|FG003|Overall Study|Protocol deviation|0|||
126044982|NCT03547271|453463875|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
126044983|NCT03547271|453463876|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
126044984|NCT03547271|453463877|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
126044985|NCT03547271|453463878|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
126044986|NCT03547271|453463875|FG000|Overall Study|Lost to Follow-up|3|||
126044987|NCT03547271|453463876|FG001|Overall Study|Lost to Follow-up|3|||
126044988|NCT03547271|453463877|FG002|Overall Study|Lost to Follow-up|1|||
126044989|NCT03547271|453463878|FG003|Overall Study|Lost to Follow-up|0|||
126044990|NCT06065735|453463883|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
126044991|NCT06065735|453463884|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
126044992|NCT06065735|453463885|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
126044993|NCT06065735|453463883|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
126044994|NCT06065735|453463884|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
126044995|NCT06065735|453463885|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
125884693|NCT00561925|452875032|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
125884694|NCT00561925|452875033|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
126044996|NCT06065735|453463883|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
126044997|NCT06065735|453463884|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
126044998|NCT06065735|453463885|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
126044999|NCT06065735|453463883|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
126045000|NCT06065735|453463884|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
126045001|NCT06065735|453463885|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
126045002|NCT06065735|453463883|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
126045003|NCT06065735|453463884|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
126045004|NCT06065735|453463885|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
126045005|NCT02532621|453463886|FG000|Overall Study|Death|3|||
126045006|NCT02532621|453463886|FG000|Overall Study|Lost to Follow-up|3|||
126045007|NCT02532621|453463886|FG000|Overall Study|Withdrawal by Subject|6|||
126045008|NCT02532621|453463886|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
126045009|NCT02532621|453463886|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
126045010|NCT03522298|453463887|FG000|Overall Study|Adverse Event|1|||
126045011|NCT03522298|453463888|FG001|Overall Study|Adverse Event|0|||
126045012|NCT03522298|453463889|FG002|Overall Study|Adverse Event|0|||
126045013|NCT03522298|453463890|FG003|Overall Study|Adverse Event|1|||
126045014|NCT03522298|453463887|FG000|Overall Study|Death|2|||
125884695|NCT00561925|452875034|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
125884696|NCT00561925|452875035|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
126045015|NCT03522298|453463888|FG001|Overall Study|Death|4|||
126045016|NCT03522298|453463889|FG002|Overall Study|Death|8|||
126045017|NCT03522298|453463890|FG003|Overall Study|Death|8|||
126045018|NCT03522298|453463887|FG000|Overall Study|Patient decision|0|||
126045019|NCT03522298|453463888|FG001|Overall Study|Patient decision|2|||
126045020|NCT03522298|453463889|FG002|Overall Study|Patient decision|2|||
126045021|NCT03522298|453463890|FG003|Overall Study|Patient decision|2|||
126045022|NCT04795245|453463893|FG000|Overall Study|Unkown reason|7|||
126045023|NCT04795245|453463893|FG000|Overall Study|Death|17|||
126045024|NCT04795245|453463893|FG000|Overall Study|Other than listed|19|||
126045025|NCT04795245|453463893|FG000|Overall Study|Adverse Event|143|||
126045026|NCT04795245|453463893|FG000|Overall Study|Progressive disease|512|||
126045027|NCT04795245|453463893|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
126045028|NCT02919917|453463894|FG000|Overall Study|Withdrawal by Subject|4|||
126045029|NCT02919917|453463895|FG001|Overall Study|Withdrawal by Subject|8|||
126045030|NCT03418740|453463896|FG000|Overall Study|Lost to Follow-up|13|||
126045031|NCT03418740|453463896|FG000|Overall Study|Scheduling Issues|7|||
126045032|NCT03418740|453463896|FG000|Overall Study|Withdrawal by Subject|2|||
126045033|NCT03418740|453463896|FG000|Overall Study|Unable to Continue Consent|1|||
126045034|NCT04157517|453463901|FG000|Overall Study|Death|1|||
126045035|NCT04157517|453463902|FG001|Overall Study|Death|2|||
126045036|NCT04157517|453463903|FG002|Overall Study|Death|2|||
126045037|NCT04157517|453463904|FG003|Overall Study|Death|3|||
126045038|NCT04157517|453463905|FG004|Overall Study|Death|3|||
126045039|NCT04157517|453463906|FG005|Overall Study|Death|4|||
126045040|NCT04157517|453463907|FG006|Overall Study|Death|1|||
126045041|NCT04157517|453463908|FG007|Overall Study|Death|2|||
126045042|NCT04157517|453463909|FG008|Overall Study|Death|4|||
126045043|NCT04157517|453463910|FG009|Overall Study|Death|0|||
126045044|NCT04157517|453463901|FG000|Overall Study|Withdrawal by Subject|1|||
126045045|NCT04157517|453463902|FG001|Overall Study|Withdrawal by Subject|1|||
126045046|NCT04157517|453463903|FG002|Overall Study|Withdrawal by Subject|1|||
126045047|NCT04157517|453463904|FG003|Overall Study|Withdrawal by Subject|0|||
126045048|NCT04157517|453463905|FG004|Overall Study|Withdrawal by Subject|0|||
126045049|NCT04157517|453463906|FG005|Overall Study|Withdrawal by Subject|1|||
126045050|NCT04157517|453463907|FG006|Overall Study|Withdrawal by Subject|0|||
126045051|NCT04157517|453463908|FG007|Overall Study|Withdrawal by Subject|0|||
126045052|NCT04157517|453463909|FG008|Overall Study|Withdrawal by Subject|1|||
126045053|NCT04157517|453463910|FG009|Overall Study|Withdrawal by Subject|0|||
126045054|NCT04157517|453463901|FG000|Overall Study|Other|1|||
126304554|NCT02308540|454404261|FG004|Overall Study|Lost to Follow-up|0|||
126304555|NCT02308540|454404262|FG005|Overall Study|Lost to Follow-up|1|||
126304556|NCT01053663|454404263|FG000|Overall Study|Death|2|||
126304557|NCT01053663|454404263|FG000|Overall Study|Lost to Follow-up|1|||
126304558|NCT01053663|454404263|FG000|Overall Study|Poor IV Access|1|||
126304559|NCT01053663|454404263|FG000|Overall Study|Transferred to Another Hospital|1|||
126304560|NCT01053663|454404263|FG000|Overall Study|Negative Influenza Diagnosis|1|||
126045055|NCT04157517|453463902|FG001|Overall Study|Other|0|||
126045056|NCT04157517|453463903|FG002|Overall Study|Other|0|||
126045057|NCT04157517|453463904|FG003|Overall Study|Other|0|||
126045058|NCT04157517|453463905|FG004|Overall Study|Other|0|||
126045059|NCT04157517|453463906|FG005|Overall Study|Other|1|||
126045060|NCT04157517|453463907|FG006|Overall Study|Other|2|||
126045061|NCT04157517|453463908|FG007|Overall Study|Other|7|||
126304561|NCT03533114|454404264|FG000|Overall|Adverse Event|16|||
126304562|NCT03533114|454404265|FG001|Overall|Adverse Event|11|||
126304563|NCT03533114|454404264|FG000|Overall|Consent Withdrawal by Participant|7|||
126045062|NCT04157517|453463909|FG008|Overall Study|Other|7|||
126045063|NCT04157517|453463910|FG009|Overall Study|Other|0|||
126045064|NCT02933489|453463911|FG000|Overall Study|Ineligible|3|||
126045065|NCT02933489|453463912|FG001|Overall Study|Ineligible|3|||
126045066|NCT02933489|453463911|FG000|Overall Study|Withdrawal by Subject|27|||
126045067|NCT02933489|453463912|FG001|Overall Study|Withdrawal by Subject|18|||
126045068|NCT02933489|453463911|FG000|Overall Study|Unable to complete exams (other)|14|||
126045069|NCT02933489|453463912|FG001|Overall Study|Unable to complete exams (other)|7|||
126045070|NCT02461134|453463913|FG000|Overall Study|Adverse Event|1|||
126045071|NCT04761198|453463914|FG000|Overall Study|Progressive Disease|1|||
126045072|NCT04761198|453463915|FG001|Overall Study|Progressive Disease|0|||
126045073|NCT04761198|453463916|FG002|Overall Study|Progressive Disease|0|||
126045074|NCT04761198|453463917|FG003|Overall Study|Progressive Disease|1|||
126045075|NCT04761198|453463918|FG004|Overall Study|Progressive Disease|4|||
126045076|NCT04761198|453463919|FG005|Overall Study|Progressive Disease|1|||
126045077|NCT04761198|453463920|FG006|Overall Study|Progressive Disease|2|||
126045078|NCT04761198|453463914|FG000|Overall Study|Protocol Violation|0|||
126045079|NCT04761198|453463915|FG001|Overall Study|Protocol Violation|0|||
126045080|NCT04761198|453463916|FG002|Overall Study|Protocol Violation|0|||
126045081|NCT04761198|453463917|FG003|Overall Study|Protocol Violation|0|||
126045082|NCT04761198|453463918|FG004|Overall Study|Protocol Violation|1|||
126304564|NCT03533114|454404265|FG001|Overall|Consent Withdrawal by Participant|6|||
126304565|NCT03533114|454404264|FG000|Overall|Lack of Efficacy|5|||
126304566|NCT03533114|454404265|FG001|Overall|Lack of Efficacy|3|||
126304567|NCT03533114|454404264|FG000|Overall|Lost to Follow-up|1|||
126304568|NCT03533114|454404265|FG001|Overall|Lost to Follow-up|1|||
126304569|NCT03533114|454404264|FG000|Overall|Physician Decision|0|||
126304570|NCT03533114|454404265|FG001|Overall|Physician Decision|2|||
126304571|NCT03533114|454404264|FG000|Overall|Protocol deviation|1|||
126304572|NCT03533114|454404265|FG001|Overall|Protocol deviation|1|||
126304573|NCT03533114|454404264|FG000|Overall|Failure to meet randomization criteria|1|||
126304574|NCT03533114|454404265|FG001|Overall|Failure to meet randomization criteria|2|||
126304575|NCT03533114|454404264|FG000|Overall|Non-Compliance with study drug|0|||
126304576|NCT03533114|454404265|FG001|Overall|Non-Compliance with study drug|1|||
126304577|NCT03533114|454404264|FG000|Overall|Other|0|||
126304578|NCT03533114|454404265|FG001|Overall|Other|1|||
126304579|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Adverse Event|11|||
126304580|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Adverse Event|8|||
126304581|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
126304582|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
126304583|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
126304584|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
126304585|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
126304586|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
126304587|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
126304588|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
126304589|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
126304590|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
126304591|NCT03533114|454404264|FG000|Stable Dose|Adverse Event|0|||
126304592|NCT03533114|454404265|FG001|Stable Dose|Adverse Event|2|||
126304593|NCT03533114|454404264|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
126304594|NCT03533114|454404265|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
126304595|NCT03533114|454404264|FG000|Stable Dose|Lack of Efficacy|1|||
126304596|NCT03533114|454404265|FG001|Stable Dose|Lack of Efficacy|0|||
126304597|NCT03533114|454404264|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
126304598|NCT03533114|454404265|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
126304599|NCT03533114|454404264|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
126304600|NCT03533114|454404265|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
126304601|NCT03533114|454404264|FG000|Open-Label Safety Extension|Adverse Event|3|||
126304602|NCT03533114|454404265|FG001|Open-Label Safety Extension|Adverse Event|0|||
126304603|NCT03533114|454404264|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
126304604|NCT03533114|454404265|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
126304605|NCT03533114|454404264|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
126368187|NCT00725985|454642900|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368188|NCT00725985|454642889|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126045083|NCT04761198|453463919|FG005|Overall Study|Protocol Violation|0|||
126045084|NCT04761198|453463920|FG006|Overall Study|Protocol Violation|0|||
126045085|NCT04761198|453463914|FG000|Overall Study|Death|2|||
126045086|NCT04761198|453463915|FG001|Overall Study|Death|1|||
126045087|NCT04761198|453463916|FG002|Overall Study|Death|2|||
126045088|NCT04761198|453463917|FG003|Overall Study|Death|5|||
126304606|NCT03533114|454404265|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
126304607|NCT03533114|454404264|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
126304608|NCT03533114|454404265|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
126304609|NCT03533114|454404264|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
126304610|NCT03533114|454404265|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
126304611|NCT01862250|454404266|FG000|Overall Study|Adverse Event|4|||
126304612|NCT02423343|454404267|FG000|Overall Study|Withdrawal by Subject|0|||
126304613|NCT02423343|454404268|FG001|Overall Study|Withdrawal by Subject|1|||
126304614|NCT02423343|454404269|FG002|Overall Study|Withdrawal by Subject|0|||
126304615|NCT02423343|454404270|FG003|Overall Study|Withdrawal by Subject|0|||
126045089|NCT04761198|453463918|FG004|Overall Study|Death|14|||
126045090|NCT04761198|453463919|FG005|Overall Study|Death|2|||
126045091|NCT04761198|453463920|FG006|Overall Study|Death|5|||
126045092|NCT04761198|453463914|FG000|Overall Study|Lost to Follow-up|0|||
126045093|NCT04761198|453463915|FG001|Overall Study|Lost to Follow-up|0|||
126045094|NCT04761198|453463916|FG002|Overall Study|Lost to Follow-up|0|||
126045095|NCT04761198|453463917|FG003|Overall Study|Lost to Follow-up|0|||
126045096|NCT04761198|453463918|FG004|Overall Study|Lost to Follow-up|1|||
126045097|NCT04761198|453463919|FG005|Overall Study|Lost to Follow-up|0|||
126045098|NCT04761198|453463920|FG006|Overall Study|Lost to Follow-up|0|||
126045099|NCT04761198|453463914|FG000|Overall Study|Withdrawal by Subject|2|||
126045100|NCT04761198|453463915|FG001|Overall Study|Withdrawal by Subject|0|||
126045101|NCT04761198|453463916|FG002|Overall Study|Withdrawal by Subject|1|||
126045102|NCT04761198|453463917|FG003|Overall Study|Withdrawal by Subject|0|||
126045103|NCT04761198|453463918|FG004|Overall Study|Withdrawal by Subject|2|||
126045104|NCT04761198|453463919|FG005|Overall Study|Withdrawal by Subject|0|||
126045105|NCT04761198|453463920|FG006|Overall Study|Withdrawal by Subject|1|||
126045106|NCT04761198|453463914|FG000|Overall Study|Study Terminated by Sponsor|6|||
126045107|NCT04761198|453463915|FG001|Overall Study|Study Terminated by Sponsor|0|||
126045108|NCT04761198|453463916|FG002|Overall Study|Study Terminated by Sponsor|5|||
126045109|NCT04761198|453463917|FG003|Overall Study|Study Terminated by Sponsor|3|||
126045110|NCT04761198|453463918|FG004|Overall Study|Study Terminated by Sponsor|10|||
126045111|NCT04761198|453463919|FG005|Overall Study|Study Terminated by Sponsor|1|||
126045112|NCT04761198|453463920|FG006|Overall Study|Study Terminated by Sponsor|2|||
126045113|NCT02994927|453463921|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126045114|NCT02994927|453463922|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126045115|NCT02994927|453463921|FG000|Overall Study|Did not meet eligibility criteria|0|||
126045116|NCT02994927|453463922|FG001|Overall Study|Did not meet eligibility criteria|1|||
126045117|NCT02994927|453463921|FG000|Overall Study|Physician Decision|4|||
126045118|NCT02994927|453463922|FG001|Overall Study|Physician Decision|3|||
126045119|NCT02994927|453463921|FG000|Overall Study|Death|4|||
126045120|NCT02994927|453463922|FG001|Overall Study|Death|2|||
126045121|NCT02994927|453463921|FG000|Overall Study|Adverse Event|2|||
126045122|NCT02994927|453463922|FG001|Overall Study|Adverse Event|1|||
126045123|NCT02994927|453463921|FG000|Overall Study|Withdrawal by Subject|3|||
126045124|NCT02994927|453463922|FG001|Overall Study|Withdrawal by Subject|6|||
126045125|NCT02994927|453463921|FG000|Overall Study|Lost to Follow-up|2|||
126045126|NCT02994927|453463922|FG001|Overall Study|Lost to Follow-up|1|||
126045127|NCT03250676|453463924|FG000|Overall Study|Adverse Event|0|||
126045128|NCT03250676|453463925|FG001|Overall Study|Adverse Event|0|||
126045129|NCT03250676|453463926|FG002|Overall Study|Adverse Event|0|||
126045130|NCT03250676|453463927|FG003|Overall Study|Adverse Event|1|||
126045131|NCT03250676|453463928|FG004|Overall Study|Adverse Event|2|||
126045132|NCT03250676|453463929|FG005|Overall Study|Adverse Event|9|||
126045133|NCT03250676|453463924|FG000|Overall Study|Withdrawal by Subject|1|||
126045134|NCT03250676|453463925|FG001|Overall Study|Withdrawal by Subject|0|||
126045135|NCT03250676|453463926|FG002|Overall Study|Withdrawal by Subject|0|||
126045136|NCT03250676|453463927|FG003|Overall Study|Withdrawal by Subject|1|||
126045137|NCT03250676|453463928|FG004|Overall Study|Withdrawal by Subject|1|||
126045138|NCT03250676|453463929|FG005|Overall Study|Withdrawal by Subject|2|||
126045139|NCT03250676|453463924|FG000|Overall Study|Physician Decision|0|||
126045140|NCT03250676|453463925|FG001|Overall Study|Physician Decision|0|||
126045141|NCT03250676|453463926|FG002|Overall Study|Physician Decision|0|||
126045142|NCT03250676|453463927|FG003|Overall Study|Physician Decision|2|||
126045143|NCT03250676|453463928|FG004|Overall Study|Physician Decision|0|||
126304616|NCT02423343|454404271|FG004|Overall Study|Withdrawal by Subject|0|||
126045144|NCT03250676|453463929|FG005|Overall Study|Physician Decision|3|||
126045145|NCT03250676|453463924|FG000|Overall Study|Withdrawal of consent|0|||
126045146|NCT03250676|453463925|FG001|Overall Study|Withdrawal of consent|0|||
126045147|NCT03250676|453463926|FG002|Overall Study|Withdrawal of consent|2|||
126045148|NCT03250676|453463927|FG003|Overall Study|Withdrawal of consent|0|||
126045149|NCT03250676|453463928|FG004|Overall Study|Withdrawal of consent|0|||
126045150|NCT03250676|453463929|FG005|Overall Study|Withdrawal of consent|2|||
126045151|NCT03250676|453463924|FG000|Overall Study|Other|1|||
126045152|NCT03250676|453463925|FG001|Overall Study|Other|0|||
126045153|NCT03250676|453463926|FG002|Overall Study|Other|0|||
126045154|NCT03250676|453463927|FG003|Overall Study|Other|0|||
126045155|NCT03250676|453463928|FG004|Overall Study|Other|0|||
126304617|NCT02423343|454404272|FG005|Overall Study|Withdrawal by Subject|0|||
126304618|NCT02423343|454404267|FG000|Overall Study|Progressive Disease|0|||
126304619|NCT02423343|454404268|FG001|Overall Study|Progressive Disease|0|||
126304620|NCT02423343|454404269|FG002|Overall Study|Progressive Disease|0|||
126304621|NCT02423343|454404270|FG003|Overall Study|Progressive Disease|0|||
126304622|NCT02423343|454404271|FG004|Overall Study|Progressive Disease|2|||
126304623|NCT02423343|454404272|FG005|Overall Study|Progressive Disease|0|||
126304624|NCT02423343|454404267|FG000|Overall Study|Adverse Event|0|||
126304625|NCT02423343|454404268|FG001|Overall Study|Adverse Event|0|||
126304626|NCT02423343|454404269|FG002|Overall Study|Adverse Event|0|||
126304627|NCT02423343|454404270|FG003|Overall Study|Adverse Event|0|||
126304628|NCT02423343|454404271|FG004|Overall Study|Adverse Event|2|||
126304629|NCT02423343|454404272|FG005|Overall Study|Adverse Event|0|||
126304630|NCT02423343|454404267|FG000|Overall Study|Death|0|||
126304631|NCT02423343|454404268|FG001|Overall Study|Death|0|||
126304632|NCT02423343|454404269|FG002|Overall Study|Death|0|||
126304633|NCT02423343|454404270|FG003|Overall Study|Death|0|||
126304634|NCT02423343|454404271|FG004|Overall Study|Death|1|||
126304635|NCT02423343|454404272|FG005|Overall Study|Death|0|||
126304636|NCT00090493|454404273|FG000|Overall Study|Physician Decision|2|||
126304637|NCT02071706|454404274|FG000|Overall Study|Adverse Event|1|||
126304638|NCT02071706|454404274|FG000|Overall Study|Withdrawal by Subject|2|||
126304639|NCT02792192|454404277|FG000|Overall Study|Death|1|||
126045156|NCT03250676|453463929|FG005|Overall Study|Other|0|||
126045157|NCT03250676|453463924|FG000|Overall Study|Disease progression|4|||
126045158|NCT03250676|453463925|FG001|Overall Study|Disease progression|12|||
126045159|NCT03250676|453463926|FG002|Overall Study|Disease progression|9|||
126045160|NCT03250676|453463927|FG003|Overall Study|Disease progression|7|||
126045161|NCT03250676|453463928|FG004|Overall Study|Disease progression|4|||
126045162|NCT03250676|453463929|FG005|Overall Study|Disease progression|88|||
126304640|NCT02792192|454404278|FG001|Overall Study|Death|0|||
126304641|NCT02792192|454404279|FG002|Overall Study|Death|0|||
126304642|NCT02792192|454404280|FG003|Overall Study|Death|0|||
126304643|NCT02792192|454404277|FG000|Overall Study|Informed Consent Withdrawn|4|||
126304644|NCT02792192|454404278|FG001|Overall Study|Informed Consent Withdrawn|0|||
126304645|NCT02792192|454404279|FG002|Overall Study|Informed Consent Withdrawn|0|||
126304646|NCT02792192|454404280|FG003|Overall Study|Informed Consent Withdrawn|0|||
126304647|NCT02792192|454404277|FG000|Overall Study|Physician Decision|1|||
126304648|NCT02792192|454404278|FG001|Overall Study|Physician Decision|0|||
126304649|NCT02792192|454404279|FG002|Overall Study|Physician Decision|0|||
126304650|NCT02792192|454404280|FG003|Overall Study|Physician Decision|0|||
126304651|NCT02792192|454404277|FG000|Overall Study|Progressive Disease|0|||
126304652|NCT02792192|454404278|FG001|Overall Study|Progressive Disease|1|||
126304653|NCT02792192|454404279|FG002|Overall Study|Progressive Disease|0|||
126304654|NCT02792192|454404280|FG003|Overall Study|Progressive Disease|0|||
126304655|NCT02792192|454404277|FG000|Overall Study|Study Terminated By Sponsor|6|||
126304656|NCT02792192|454404278|FG001|Overall Study|Study Terminated By Sponsor|10|||
126304657|NCT02792192|454404279|FG002|Overall Study|Study Terminated By Sponsor|0|||
126304658|NCT02792192|454404280|FG003|Overall Study|Study Terminated By Sponsor|0|||
126304659|NCT04481789|454404283|FG000|Period 1|Withdrawal by Subject|1|||
126304660|NCT04481789|454404284|FG001|Period 1|Withdrawal by Subject|0|||
126304661|NCT04481789|454404285|FG002|Period 1|Withdrawal by Subject|0|||
126304662|NCT04481789|454404286|FG003|Period 1|Withdrawal by Subject|0|||
126045163|NCT04281498|453463930|FG000|Overall Study|Progression of disease|1|||
126304663|NCT04481789|454404287|FG004|Period 1|Withdrawal by Subject|0|||
126304664|NCT04481789|454404288|FG005|Period 1|Withdrawal by Subject|0|||
126304665|NCT02751450|454404289|FG000|Overall Study|Adverse Event|1|||
126304666|NCT02751450|454404290|FG001|Overall Study|Adverse Event|0|||
126304667|NCT00562302|454404291|FG000|Overall Study|Lost to Follow-up|3|||
126304668|NCT00562302|454404292|FG001|Overall Study|Lost to Follow-up|3|||
126304669|NCT00562302|454404291|FG000|Overall Study|Adverse Event|0|||
126304670|NCT00562302|454404292|FG001|Overall Study|Adverse Event|6|||
126304671|NCT00562302|454404291|FG000|Overall Study|Non-compliance|1|||
126304672|NCT00562302|454404292|FG001|Overall Study|Non-compliance|2|||
126045164|NCT04281498|453463930|FG000|Overall Study|Planned SCT|1|||
126304673|NCT00562302|454404291|FG000|Overall Study|Withdrawal by Subject|7|||
126304674|NCT00562302|454404292|FG001|Overall Study|Withdrawal by Subject|8|||
126304675|NCT00562302|454404291|FG000|Overall Study|Death|1|||
126304676|NCT00562302|454404292|FG001|Overall Study|Death|2|||
126304677|NCT00562302|454404291|FG000|Overall Study|Lung resection prior to study completion|7|||
126045165|NCT04281498|453463930|FG000|Overall Study|Alternative Treatment|1|||
126045166|NCT03417284|453464230|FG000|Overall Study|Inadequate supply on study drug|1|||
126045167|NCT03417284|453464231|FG001|Overall Study|Inadequate supply on study drug|0|||
126045168|NCT03417284|453464232|FG002|Overall Study|Inadequate supply on study drug|0|||
126045169|NCT03417284|453464233|FG003|Overall Study|Inadequate supply on study drug|0|||
126045170|NCT03417284|453464230|FG000|Overall Study|Disease Progression|0|||
126045171|NCT03417284|453464231|FG001|Overall Study|Disease Progression|0|||
126045172|NCT03417284|453464232|FG002|Overall Study|Disease Progression|1|||
126045173|NCT03417284|453464233|FG003|Overall Study|Disease Progression|0|||
126045174|NCT05132400|453464234|FG000|Overall Study|Withdrawal by Subject|14|||
126045175|NCT05132400|453464235|FG001|Overall Study|Withdrawal by Subject|8|||
126045176|NCT05132400|453464234|FG000|Overall Study|Lost to Follow-up|132|||
126045177|NCT05132400|453464235|FG001|Overall Study|Lost to Follow-up|121|||
126045178|NCT02076009|453464237|FG000|Overall Study|Death|172|||
126045179|NCT02076009|453464238|FG001|Overall Study|Death|153|||
126045180|NCT02076009|453464237|FG000|Overall Study|Withdrawal by Subject|16|||
126045181|NCT02076009|453464238|FG001|Overall Study|Withdrawal by Subject|12|||
126045182|NCT02076009|453464237|FG000|Overall Study|Lost to Follow-up|4|||
126045183|NCT02076009|453464238|FG001|Overall Study|Lost to Follow-up|2|||
126045184|NCT02076009|453464237|FG000|Overall Study|Progressive Disease|1|||
126045185|NCT02076009|453464238|FG001|Overall Study|Progressive Disease|0|||
126045186|NCT02076009|453464237|FG000|Overall Study|Physician Decision|0|||
125884697|NCT00561925|452875031|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
125884698|NCT00561925|452875032|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
126304678|NCT00562302|454404292|FG001|Overall Study|Lung resection prior to study completion|7|||
126304679|NCT00562302|454404291|FG000|Overall Study|Not stated|1|||
126304680|NCT00562302|454404292|FG001|Overall Study|Not stated|4|||
126304681|NCT01290679|454404293|FG000|Overall Study|Adverse Event|2|||
126304682|NCT01290679|454404294|FG001|Overall Study|Adverse Event|0|||
126304683|NCT01290679|454404293|FG000|Overall Study|Lost to Follow-up|8|||
125884699|NCT00561925|452875033|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
125884700|NCT00561925|452875034|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
125884701|NCT00561925|452875035|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
125884702|NCT00561925|452875031|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
125884703|NCT00561925|452875032|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
125884704|NCT00561925|452875033|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
125884705|NCT00561925|452875034|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
125884706|NCT00561925|452875035|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
126304684|NCT01290679|454404294|FG001|Overall Study|Lost to Follow-up|10|||
126304685|NCT01290679|454404293|FG000|Overall Study|Protocol Violation|0|||
126304686|NCT01290679|454404294|FG001|Overall Study|Protocol Violation|1|||
126304687|NCT01290679|454404293|FG000|Overall Study|Withdrawal by Subject|6|||
126304688|NCT01290679|454404294|FG001|Overall Study|Withdrawal by Subject|5|||
126304689|NCT01290679|454404293|FG000|Overall Study|Subject Entered Another Trial|0|||
126304690|NCT01290679|454404294|FG001|Overall Study|Subject Entered Another Trial|5|||
126304691|NCT03124407|454404300|FG000|Overall Study|Lost to Follow-up|1|||
126304692|NCT03124407|454404301|FG001|Overall Study|Lost to Follow-up|0|||
126304693|NCT03124407|454404302|FG002|Overall Study|Lost to Follow-up|0|||
126304694|NCT03124407|454404303|FG003|Overall Study|Lost to Follow-up|0|||
126304695|NCT03124407|454404300|FG000|Overall Study|Adverse Event|0|||
126304696|NCT03124407|454404301|FG001|Overall Study|Adverse Event|0|||
126304697|NCT03124407|454404302|FG002|Overall Study|Adverse Event|1|||
126304698|NCT03124407|454404303|FG003|Overall Study|Adverse Event|0|||
126304699|NCT01860040|454404306|FG000|Overall Study|Withdrawal by Subject|1|||
126304700|NCT01860040|454404307|FG001|Overall Study|Withdrawal by Subject|0|||
126304701|NCT00403481|454404308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
126304702|NCT00403481|454404308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
126368189|NCT00725985|454642890|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126045187|NCT02076009|453464238|FG001|Overall Study|Physician Decision|1|||
126045188|NCT02076009|453464237|FG000|Overall Study|End of data collection|90|||
125884707|NCT00561925|452875031|FG000|14 Day Lead-In Period|Other|5|||
126045189|NCT02076009|453464238|FG001|Overall Study|End of data collection|118|||
126045190|NCT05985395|453464244|FG000|Overall Study|Physician Decision|2|||
126045191|NCT05985395|453464245|FG001|Overall Study|Physician Decision|1|||
126304703|NCT00403481|454404308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
126304704|NCT00403481|454404308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
126304705|NCT00403481|454404308|FG000|Olm 40 mg|Adverse Event|2|||
126304706|NCT00403481|454404308|FG000|Olm 40 mg|Protocol Violation|1|||
126304707|NCT00403481|454404308|FG000|Olm 40 mg|Withdrawal by Subject|1|||
126304708|NCT00403481|454404308|FG000|Olm 40 mg|Other|1|||
126304709|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
126304710|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
126368190|NCT00725985|454642891|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125884708|NCT00561925|452875032|FG001|14 Day Lead-In Period|Other|0|||
125884709|NCT00561925|452875033|FG002|14 Day Lead-In Period|Other|0|||
126045192|NCT05985395|453464244|FG000|Overall Study|Withdrawal by Subject|1|||
126045193|NCT05985395|453464245|FG001|Overall Study|Withdrawal by Subject|0|||
126304711|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
126304712|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
126304713|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
126304714|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
126304715|NCT02821754|454404309|FG000|Overall Study|Procedure not required prior to amendment change|13|||
126304716|NCT02821754|454404310|FG001|Overall Study|Procedure not required prior to amendment change|11|||
126304717|NCT02821754|454404311|FG002|Overall Study|Procedure not required prior to amendment change|0|||
126304718|NCT02821754|454404309|FG000|Overall Study|Participant's Clinical status|2|||
126304719|NCT02821754|454404310|FG001|Overall Study|Participant's Clinical status|0|||
126304720|NCT02821754|454404311|FG002|Overall Study|Participant's Clinical status|0|||
126304721|NCT02821754|454404309|FG000|Overall Study|Participant removed for noncompliance|1|||
126304722|NCT02821754|454404310|FG001|Overall Study|Participant removed for noncompliance|0|||
126304723|NCT02821754|454404311|FG002|Overall Study|Participant removed for noncompliance|0|||
126304724|NCT02821754|454404309|FG000|Overall Study|Drug not available.|0|||
126304725|NCT02821754|454404310|FG001|Overall Study|Drug not available.|0|||
126304726|NCT02821754|454404311|FG002|Overall Study|Drug not available.|1|||
126304727|NCT02821754|454404309|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
126304728|NCT02821754|454404310|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
126304729|NCT02821754|454404311|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
126304730|NCT03793842|454404327|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
126304731|NCT03793842|454404328|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
126304732|NCT03793842|454404327|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
126304733|NCT03793842|454404328|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
126304734|NCT04657198|454404329|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
126304735|NCT04657198|454404330|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
126304736|NCT04657198|454404331|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
126304737|NCT00427921|454404337|FG000|Overall Study|Adverse Event|26|||
126304738|NCT00427921|454404337|FG000|Overall Study|Withdrawal by Subject|4|||
126304739|NCT00427921|454404337|FG000|Overall Study|Lost to Follow-up|2|||
126304740|NCT00427921|454404337|FG000|Overall Study|Other reason not specified|10|||
126304741|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Hospitalization|1|||
126045194|NCT02777593|453464246|FG000|Overall Study|Still in study|1|||
126045195|NCT02777593|453464247|FG001|Overall Study|Still in study|32|||
126045196|NCT02777593|453464248|FG002|Overall Study|Still in study|3|||
126045197|NCT02777593|453464249|FG003|Overall Study|Still in study|6|||
126045198|NCT02777593|453464250|FG004|Overall Study|Still in study|5|||
126045199|NCT02777593|453464246|FG000|Overall Study|Death|21|||
126045200|NCT02777593|453464247|FG001|Overall Study|Death|28|||
126045201|NCT02777593|453464248|FG002|Overall Study|Death|0|||
126045202|NCT02777593|453464249|FG003|Overall Study|Death|5|||
126045203|NCT02777593|453464250|FG004|Overall Study|Death|0|||
126045204|NCT02777593|453464246|FG000|Overall Study|Withdrawal by Subject|8|||
126045205|NCT02777593|453464247|FG001|Overall Study|Withdrawal by Subject|4|||
126045206|NCT02777593|453464248|FG002|Overall Study|Withdrawal by Subject|1|||
126045207|NCT02777593|453464249|FG003|Overall Study|Withdrawal by Subject|1|||
126045208|NCT02777593|453464250|FG004|Overall Study|Withdrawal by Subject|0|||
126045209|NCT02777593|453464246|FG000|Overall Study|Lost to Follow-up|8|||
126045210|NCT02777593|453464247|FG001|Overall Study|Lost to Follow-up|16|||
126045211|NCT02777593|453464248|FG002|Overall Study|Lost to Follow-up|5|||
126045212|NCT02777593|453464249|FG003|Overall Study|Lost to Follow-up|0|||
126045213|NCT02777593|453464250|FG004|Overall Study|Lost to Follow-up|1|||
126045214|NCT02777593|453464246|FG000|Overall Study|Physician Decision|2|||
126045215|NCT02777593|453464247|FG001|Overall Study|Physician Decision|2|||
126045216|NCT02777593|453464248|FG002|Overall Study|Physician Decision|0|||
126304742|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
126304743|NCT00427921|454404337|FG000|Overall Study|Adverse Event + No Response|1|||
126304744|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
126304745|NCT00427921|454404337|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
126304746|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Lost Response|1|||
126304747|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
126304748|NCT00427921|454404337|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
126304749|NCT00900159|454404338|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
126304750|NCT00900159|454404339|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
126304751|NCT01075256|454404340|FG000|Overall Study|Withdrawal by Subject|1|||
126304752|NCT01075256|454404341|FG001|Overall Study|Withdrawal by Subject|0|||
126304753|NCT01075256|454404342|FG002|Overall Study|Withdrawal by Subject|0|||
126304754|NCT02858583|454404345|FG000|Overall Study|Declined consent|1|||
126304755|NCT02858583|454404346|FG001|Overall Study|Declined consent|1|||
126304756|NCT00347009|454404347|FG000|Overall Study|Death|1|||
126304757|NCT00347009|454404347|FG000|Overall Study|Adverse Event|6|||
126368191|NCT00725985|454642892|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368192|NCT00725985|454642893|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368193|NCT00725985|454642894|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368194|NCT00725985|454642895|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368195|NCT00725985|454642896|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368196|NCT00725985|454642897|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368197|NCT00725985|454642898|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
126368198|NCT00725985|454642899|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
126368199|NCT00725985|454642900|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
126368200|NCT04476784|454642901|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
126368201|NCT04476784|454642902|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
126368202|NCT00863304|454642903|FG000|Overall Study|Adverse Event|10|||
126368203|NCT00863304|454642904|FG001|Overall Study|Adverse Event|4|||
126368204|NCT00863304|454642905|FG002|Overall Study|Adverse Event|14|||
126368205|NCT00863304|454642906|FG003|Overall Study|Adverse Event|16|||
126368206|NCT00863304|454642903|FG000|Overall Study|Lost to Follow-up|1|||
126368207|NCT00863304|454642904|FG001|Overall Study|Lost to Follow-up|5|||
126368208|NCT00863304|454642905|FG002|Overall Study|Lost to Follow-up|4|||
126368209|NCT00863304|454642906|FG003|Overall Study|Lost to Follow-up|2|||
126368210|NCT00863304|454642903|FG000|Overall Study|Lack of Efficacy|57|||
126368211|NCT00863304|454642904|FG001|Overall Study|Lack of Efficacy|26|||
126368212|NCT00863304|454642905|FG002|Overall Study|Lack of Efficacy|30|||
126368213|NCT00863304|454642906|FG003|Overall Study|Lack of Efficacy|28|||
126368214|NCT00863304|454642903|FG000|Overall Study|Withdrawal by Subject|19|||
126368215|NCT00863304|454642904|FG001|Overall Study|Withdrawal by Subject|14|||
126368216|NCT00863304|454642905|FG002|Overall Study|Withdrawal by Subject|20|||
126368217|NCT00863304|454642906|FG003|Overall Study|Withdrawal by Subject|18|||
126368218|NCT00863304|454642903|FG000|Overall Study|Other|1|||
126368219|NCT00863304|454642904|FG001|Overall Study|Other|0|||
126045217|NCT02777593|453464249|FG003|Overall Study|Physician Decision|0|||
126045218|NCT02777593|453464250|FG004|Overall Study|Physician Decision|0|||
126368220|NCT00863304|454642905|FG002|Overall Study|Other|0|||
126368221|NCT00863304|454642906|FG003|Overall Study|Other|1|||
126045219|NCT02777593|453464246|FG000|Overall Study|Discontinued due to Other|1|||
126045220|NCT02777593|453464247|FG001|Overall Study|Discontinued due to Other|0|||
126304758|NCT00347009|454404347|FG000|Overall Study|Withdrawal by Subject|3|||
126304759|NCT00347009|454404347|FG000|Overall Study|Physician Decision|5|||
126368222|NCT00863304|454642903|FG000|Overall Study|Protocol Violation|2|||
126368223|NCT00863304|454642904|FG001|Overall Study|Protocol Violation|6|||
126304760|NCT00347009|454404347|FG000|Overall Study|Lost to Follow-up|4|||
126304761|NCT00347009|454404347|FG000|Overall Study|Protocol Violation|2|||
126304762|NCT00347009|454404347|FG000|Overall Study|Adverse Laboratory Experience|1|||
126045221|NCT02777593|453464248|FG002|Overall Study|Discontinued due to Other|0|||
126045222|NCT02777593|453464249|FG003|Overall Study|Discontinued due to Other|0|||
126045223|NCT02777593|453464250|FG004|Overall Study|Discontinued due to Other|0|||
126045224|NCT01897441|453464252|FG000|Overall Study|Lost to Follow-up|0|||
126045225|NCT01897441|453464253|FG001|Overall Study|Lost to Follow-up|0|||
126045226|NCT01897441|453464254|FG002|Overall Study|Lost to Follow-up|1|||
126045227|NCT01897441|453464255|FG003|Overall Study|Lost to Follow-up|0|||
126045228|NCT01897441|453464256|FG004|Overall Study|Lost to Follow-up|0|||
126045229|NCT01897441|453464257|FG005|Overall Study|Lost to Follow-up|0|||
126045230|NCT01897441|453464252|FG000|Overall Study|Withdrawal by Subject|0|||
126045231|NCT01897441|453464253|FG001|Overall Study|Withdrawal by Subject|0|||
126045232|NCT01897441|453464254|FG002|Overall Study|Withdrawal by Subject|0|||
126045233|NCT01897441|453464255|FG003|Overall Study|Withdrawal by Subject|0|||
126045234|NCT01897441|453464256|FG004|Overall Study|Withdrawal by Subject|1|||
126045235|NCT01897441|453464257|FG005|Overall Study|Withdrawal by Subject|0|||
126045236|NCT01897441|453464252|FG000|Overall Study|Withdrawn by Provider|0|||
126045237|NCT01897441|453464253|FG001|Overall Study|Withdrawn by Provider|2|||
126045238|NCT01897441|453464254|FG002|Overall Study|Withdrawn by Provider|0|||
126045239|NCT01897441|453464255|FG003|Overall Study|Withdrawn by Provider|0|||
126045240|NCT01897441|453464256|FG004|Overall Study|Withdrawn by Provider|0|||
126045241|NCT01897441|453464257|FG005|Overall Study|Withdrawn by Provider|0|||
126045242|NCT04093869|453464267|FG000|Overall Study|Death|0|||
126045243|NCT04093869|453464268|FG001|Overall Study|Death|1|||
126045244|NCT04093869|453464267|FG000|Overall Study|Withdrawal by Subject|1|||
126045245|NCT04093869|453464268|FG001|Overall Study|Withdrawal by Subject|0|||
126045246|NCT02806726|453464273|FG000|Overall Study|Lost to Follow-up|1|||
126045247|NCT05129501|453464274|FG000|Overall Study|Lost to Follow-up|54|||
126045248|NCT05129501|453464275|FG001|Overall Study|Lost to Follow-up|41|||
126045249|NCT05866926|453464276|FG000|Overall Study|Death|16|||
126045250|NCT05866926|453464277|FG001|Overall Study|Death|9|||
126045251|NCT05866926|453464276|FG000|Overall Study|Lost to Follow-up|0|||
126045252|NCT05866926|453464277|FG001|Overall Study|Lost to Follow-up|1|||
126045253|NCT05866926|453464276|FG000|Overall Study|Adverse Event|1|||
126045254|NCT05866926|453464277|FG001|Overall Study|Adverse Event|0|||
126045255|NCT05866926|453464276|FG000|Overall Study|Withdrawal by Subject|5|||
126045256|NCT05866926|453464277|FG001|Overall Study|Withdrawal by Subject|1|||
126045257|NCT05866926|453464276|FG000|Overall Study|Disease progression|1|||
126045258|NCT05866926|453464277|FG001|Overall Study|Disease progression|0|||
126045259|NCT05866926|453464276|FG000|Overall Study|other causes|2|||
126045260|NCT05866926|453464277|FG001|Overall Study|other causes|1|||
126045261|NCT05267639|453464655|FG000|Overall Study|Withdrawal by Subject|1|||
126045262|NCT05267639|453464656|FG001|Overall Study|Withdrawal by Subject|0|||
126045263|NCT03816397|453464658|FG000|Overall Study|Censored at interim analysis date.|13|||
126045264|NCT03816397|453464659|FG001|Overall Study|Censored at interim analysis date.|6|||
126045265|NCT03816397|453464658|FG000|Overall Study|Withdrawal by Subject|1|||
126045266|NCT03816397|453464659|FG001|Overall Study|Withdrawal by Subject|1|||
126045267|NCT05718687|453464664|FG000|Overall Study|Withdrawal by Subject|3|||
126045268|NCT03493542|453464665|FG000|Base Study|Withdrawal by Subject|0|||
126045269|NCT03493542|453464666|FG001|Base Study|Withdrawal by Subject|4|||
126045270|NCT03493542|453464667|FG002|Base Study|Withdrawal by Subject|0|||
126045271|NCT03493542|453464665|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
126045272|NCT03493542|453464666|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
126045273|NCT03493542|453464667|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
126045274|NCT03493542|453464665|FG000|Extension Study|Withdrawal by Subject|0|||
126045275|NCT03493542|453464666|FG001|Extension Study|Withdrawal by Subject|0|||
126045276|NCT03493542|453464667|FG002|Extension Study|Withdrawal by Subject|25|||
126045277|NCT05485935|453464668|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
126045278|NCT05485935|453464669|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
126045279|NCT05485935|453464668|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
126304763|NCT00347009|454404347|FG000|Overall Study|Insufficient Viral Suppression|3|||
126304764|NCT00347009|454404347|FG000|Overall Study|Increased ALT/HBV DNA|1|||
126304765|NCT00347009|454404347|FG000|Overall Study|Serious Adverse Event|1|||
126045280|NCT05485935|453464669|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
126045281|NCT05485935|453464668|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
126045282|NCT05485935|453464669|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
126045283|NCT05485935|453464668|FG000|Period 2 (T2 and V3)|loss of contact|0|||
126045284|NCT05485935|453464669|FG001|Period 2 (T2 and V3)|loss of contact|1|||
126103402|NCT02924064|453672151|FG001|Overall Study|Protocol Violation|3|||
126103403|NCT02924064|453672150|FG000|Overall Study|Withdrawal by Subject|4|||
126103404|NCT02924064|453672151|FG001|Overall Study|Withdrawal by Subject|5|||
126103405|NCT02924064|453672150|FG000|Overall Study|Other|17|||
126103406|NCT02924064|453672151|FG001|Overall Study|Other|29|||
126304766|NCT03478644|454404353|FG000|Phase 2|Withdrawal by Subject|2|||
126304767|NCT03478644|454404354|FG001|Phase 2|Withdrawal by Subject|1|||
125884710|NCT00561925|452875034|FG003|14 Day Lead-In Period|Other|0|||
125884711|NCT00561925|452875035|FG004|14 Day Lead-In Period|Other|0|||
125884712|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
125884713|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
125884714|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
125884715|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
125884716|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
125884717|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
125884718|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
125884719|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
125884720|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
125884721|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
125884722|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125884723|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
125884724|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
125884725|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125884726|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125884727|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125884728|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
125884729|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
125884730|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125884731|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125884732|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125884733|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
125884734|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
125884735|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125884736|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125884737|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
125884738|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
125884739|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
126304768|NCT03478644|454404353|FG000|Phase 2|Lost to Follow-up|1|||
126304769|NCT03478644|454404354|FG001|Phase 2|Lost to Follow-up|0|||
126304770|NCT01029782|454404355|FG000|Overall Study|Lost to Follow-up|2|||
126103407|NCT00966277|453672154|FG000|Overall Study|Withdrawal by Subject|3|||
126103408|NCT00966277|453672155|FG001|Overall Study|Withdrawal by Subject|0|||
126103409|NCT00966277|453672154|FG000|Overall Study|Ineligible|1|||
126103410|NCT00966277|453672155|FG001|Overall Study|Ineligible|3|||
126103411|NCT00966277|453672154|FG000|Overall Study|Treatment Plan Changed|0|||
126103412|NCT00966277|453672155|FG001|Overall Study|Treatment Plan Changed|1|||
126103413|NCT01100034|453672156|FG000|Overall Study|Lost to Follow-up|11|||
126103414|NCT01100034|453672156|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
126103415|NCT01100034|453672156|FG000|Overall Study|Withdrawal by Subject|4|||
126103416|NCT01100034|453672156|FG000|Overall Study|Sponsor decision|21|||
126103417|NCT01100034|453672156|FG000|Overall Study|Participated in another clinical trial|1|||
126103418|NCT01100034|453672156|FG000|Overall Study|Participants moved to another hospital|4|||
126103419|NCT01100034|453672156|FG000|Overall Study|Site closed due to non-responsiveness|1|||
126103420|NCT01831856|453672157|FG000|Overall Study|Adverse Event|5|||
126103421|NCT01831856|453672158|FG001|Overall Study|Adverse Event|8|||
126045305|NCT01527188|453464679|FG000|Overall Study|Adverse Event|5|||
126045306|NCT01527188|453464680|FG001|Overall Study|Adverse Event|5|||
126045307|NCT01527188|453464681|FG002|Overall Study|Adverse Event|11|||
126045308|NCT01527188|453464682|FG003|Overall Study|Adverse Event|0|||
126045309|NCT01527188|453464679|FG000|Overall Study|Withdrawal by Subject|3|||
126045310|NCT01527188|453464680|FG001|Overall Study|Withdrawal by Subject|6|||
126045311|NCT01527188|453464681|FG002|Overall Study|Withdrawal by Subject|4|||
126045312|NCT01527188|453464682|FG003|Overall Study|Withdrawal by Subject|4|||
126045313|NCT01527188|453464679|FG000|Overall Study|Any other reason not above-mentioned|6|||
126045314|NCT01527188|453464680|FG001|Overall Study|Any other reason not above-mentioned|7|||
126045315|NCT01527188|453464681|FG002|Overall Study|Any other reason not above-mentioned|8|||
126045316|NCT01527188|453464682|FG003|Overall Study|Any other reason not above-mentioned|8|||
126045317|NCT01265537|453464684|FG000|Overall Study|Adverse Event|2|||
126304771|NCT01029782|454404356|FG001|Overall Study|Lost to Follow-up|2|||
126304772|NCT01029782|454404355|FG000|Overall Study|Diagnosis changed|1|||
126045318|NCT01265537|453464685|FG001|Overall Study|Adverse Event|1|||
126045319|NCT01265537|453464684|FG000|Overall Study|Physician Decision|0|||
126045320|NCT01265537|453464685|FG001|Overall Study|Physician Decision|1|||
125884740|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
125884741|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
125884742|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Death|0|||
126045321|NCT03782116|453464686|FG000|Completed Intervetion|Lost to Follow-up|11|||
126103422|NCT01831856|453672157|FG000|Overall Study|Lack of Efficacy|13|||
126304773|NCT01029782|454404356|FG001|Overall Study|Diagnosis changed|1|||
125884743|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Death|6|||
125884744|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Death|3|||
125884745|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Death|0|||
125884746|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Death|0|||
125884747|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125884748|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
125884749|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125884750|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125884751|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125884752|NCT00561925|452875031|FG000|144-week Double-blind, Double-dummy|Other|0|||
125884753|NCT00561925|452875032|FG001|144-week Double-blind, Double-dummy|Other|8|||
125884754|NCT00561925|452875033|FG002|144-week Double-blind, Double-dummy|Other|11|||
125884755|NCT00561925|452875034|FG003|144-week Double-blind, Double-dummy|Other|0|||
125884756|NCT00561925|452875035|FG004|144-week Double-blind, Double-dummy|Other|0|||
125884757|NCT00561925|452875031|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
125884758|NCT00561925|452875032|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
125884759|NCT00561925|452875033|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
125884760|NCT00561925|452875034|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
125884761|NCT00561925|452875035|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
125884762|NCT00891904|452875036|FG000|Overall Study|Death|1|||
125884763|NCT00891904|452875036|FG000|Overall Study|Adverse Event|1|||
125884764|NCT03096288|452875038|FG000|Overall Study|Withdrawal by Subject|0|||
125884765|NCT03096288|452875039|FG001|Overall Study|Withdrawal by Subject|1|||
125884766|NCT03096288|452875040|FG002|Overall Study|Withdrawal by Subject|0|||
125884767|NCT03096288|452875041|FG003|Overall Study|Withdrawal by Subject|1|||
125884768|NCT01411891|452875045|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
125884769|NCT01411891|452875046|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
125884770|NCT02004093|452875047|FG000|Overall Study|Death|2|||
125884771|NCT02004093|452875048|FG001|Overall Study|Death|1|||
125884772|NCT02004093|452875047|FG000|Overall Study|Lack of Efficacy|66|||
125884773|NCT02004093|452875048|FG001|Overall Study|Lack of Efficacy|62|||
125884774|NCT02004093|452875047|FG000|Overall Study|Protocol Violation|0|||
125884775|NCT02004093|452875048|FG001|Overall Study|Protocol Violation|1|||
125884776|NCT02004093|452875047|FG000|Overall Study|Lost to Follow-up|0|||
125884777|NCT02004093|452875048|FG001|Overall Study|Lost to Follow-up|1|||
125884778|NCT02004093|452875047|FG000|Overall Study|Withdrawal by Subject|3|||
125884779|NCT02004093|452875048|FG001|Overall Study|Withdrawal by Subject|7|||
125884780|NCT02004093|452875047|FG000|Overall Study|Other|3|||
125884781|NCT02004093|452875048|FG001|Overall Study|Other|1|||
125884782|NCT04639258|452875050|FG000|Overall Study|Screen failure|5|||
125884783|NCT04639258|452875050|FG000|Overall Study|Physician Decision|2|||
125884784|NCT04639258|452875050|FG000|Overall Study|Early study termination|3|||
125884785|NCT04639258|452875050|FG000|Overall Study|Withdrawal by Subject|1|||
126304774|NCT01029782|454404355|FG000|Overall Study|Adverse Event|0|||
126304775|NCT01029782|454404356|FG001|Overall Study|Adverse Event|1|||
126304776|NCT01029782|454404355|FG000|Overall Study|Physician Decision|0|||
125884786|NCT02558296|452875051|FG000|Completed the Study Through Week 24|Adverse Event|9|||
125884787|NCT02558296|452875052|FG001|Completed the Study Through Week 24|Adverse Event|3|||
125884788|NCT02558296|452875051|FG000|Completed the Study Through Week 24|Death|7|||
125884789|NCT02558296|452875052|FG001|Completed the Study Through Week 24|Death|7|||
125884790|NCT02558296|452875051|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
126045322|NCT03782116|453464687|FG001|Completed Intervetion|Lost to Follow-up|7|||
126045323|NCT03782116|453464686|FG000|Completed Intervetion|Withdrawal by Subject|6|||
126045324|NCT03782116|453464687|FG001|Completed Intervetion|Withdrawal by Subject|5|||
126045325|NCT03782116|453464686|FG000|Included in Analysis|Protocol Violation|5|||
126045326|NCT03782116|453464687|FG001|Included in Analysis|Protocol Violation|5|||
126045327|NCT03512301|453465154|FG000|Overall Study|Protocol Violation|2|||
126045328|NCT03512301|453465154|FG000|Overall Study|Did Not Qualify|3|||
126045329|NCT03512301|453465154|FG000|Overall Study|Age-ineligible|1|||
126045330|NCT03512301|453465154|FG000|Overall Study|Inadequate fluency with the English language|3|||
126045331|NCT00447980|453465155|FG000|Overall Study|Withdrawal by Subject|1|||
126045332|NCT00447980|453465156|FG001|Overall Study|Withdrawal by Subject|1|||
126045333|NCT00447980|453465157|FG002|Overall Study|Withdrawal by Subject|4|||
126045334|NCT00447980|453465158|FG003|Overall Study|Withdrawal by Subject|4|||
126045335|NCT00447980|453465155|FG000|Overall Study|Lost to Follow-up|1|||
126045336|NCT00447980|453465156|FG001|Overall Study|Lost to Follow-up|1|||
126045337|NCT00447980|453465157|FG002|Overall Study|Lost to Follow-up|0|||
126045338|NCT00447980|453465158|FG003|Overall Study|Lost to Follow-up|0|||
126045339|NCT00447980|453465155|FG000|Overall Study|Did not proceed with surgery|3|||
126304777|NCT01029782|454404356|FG001|Overall Study|Physician Decision|1|||
125884791|NCT02558296|452875052|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
125884792|NCT02558296|452875051|FG000|Completed the Study Through Week 24|Physician Decision|1|||
126045340|NCT00447980|453465156|FG001|Overall Study|Did not proceed with surgery|3|||
126304778|NCT01029782|454404355|FG000|Overall Study|Protocol Violation|0|||
126045341|NCT00447980|453465157|FG002|Overall Study|Did not proceed with surgery|2|||
126045342|NCT00447980|453465158|FG003|Overall Study|Did not proceed with surgery|2|||
126045343|NCT03635567|453465161|FG000|Overall Study|Lost to Follow-up|4|||
126045344|NCT03635567|453465162|FG001|Overall Study|Lost to Follow-up|1|||
126045345|NCT03635567|453465161|FG000|Overall Study|Withdrawal by Subject|11|||
126045346|NCT03635567|453465162|FG001|Overall Study|Withdrawal by Subject|16|||
126045347|NCT03635567|453465161|FG000|Overall Study|Sponsor Decision|99|||
126045348|NCT03635567|453465162|FG001|Overall Study|Sponsor Decision|57|||
126045349|NCT03635567|453465161|FG000|Overall Study|Death|194|||
126045350|NCT03635567|453465162|FG001|Overall Study|Death|235|||
126045351|NCT05157841|453465163|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
126368224|NCT00863304|454642905|FG002|Overall Study|Protocol Violation|2|||
126368225|NCT00863304|454642906|FG003|Overall Study|Protocol Violation|0|||
126368226|NCT00863304|454642903|FG000|Overall Study|Randomized, but not Treated|3|||
126368227|NCT00863304|454642904|FG001|Overall Study|Randomized, but not Treated|1|||
126368228|NCT00863304|454642905|FG002|Overall Study|Randomized, but not Treated|4|||
126368229|NCT00863304|454642906|FG003|Overall Study|Randomized, but not Treated|1|||
126368230|NCT00863304|454642903|FG000|Overall Study|Entered extension study|101|||
126368231|NCT00863304|454642904|FG001|Overall Study|Entered extension study|129|||
126368232|NCT00863304|454642905|FG002|Overall Study|Entered extension study|113|||
126368233|NCT00863304|454642906|FG003|Overall Study|Entered extension study|125|||
126368234|NCT06582732|454642907|FG000|Initial Study Period|Adverse Event|0|||
126368235|NCT06582732|454642908|FG001|Initial Study Period|Adverse Event|0|||
126368236|NCT06582732|454642909|FG002|Initial Study Period|Adverse Event|0|||
126368237|NCT06582732|454642910|FG003|Initial Study Period|Adverse Event|2|||
126368238|NCT06582732|454642911|FG004|Initial Study Period|Adverse Event|0|||
126368239|NCT06582732|454642912|FG005|Initial Study Period|Adverse Event|0|||
126368240|NCT06582732|454642913|FG006|Initial Study Period|Adverse Event|0|||
126368241|NCT06582732|454642907|FG000|Initial Study Period|Death|1|||
126368242|NCT06582732|454642908|FG001|Initial Study Period|Death|0|||
126368243|NCT06582732|454642909|FG002|Initial Study Period|Death|0|||
126368244|NCT06582732|454642910|FG003|Initial Study Period|Death|0|||
126368245|NCT06582732|454642911|FG004|Initial Study Period|Death|1|||
126368246|NCT06582732|454642912|FG005|Initial Study Period|Death|0|||
126368247|NCT06582732|454642913|FG006|Initial Study Period|Death|0|||
126368248|NCT06582732|454642907|FG000|Initial Study Period|Lost to Follow-up|0|||
126368249|NCT06582732|454642908|FG001|Initial Study Period|Lost to Follow-up|0|||
126368250|NCT06582732|454642909|FG002|Initial Study Period|Lost to Follow-up|2|||
126368251|NCT06582732|454642910|FG003|Initial Study Period|Lost to Follow-up|0|||
126368252|NCT06582732|454642911|FG004|Initial Study Period|Lost to Follow-up|0|||
126368253|NCT06582732|454642912|FG005|Initial Study Period|Lost to Follow-up|0|||
126368254|NCT06582732|454642913|FG006|Initial Study Period|Lost to Follow-up|0|||
126368255|NCT06582732|454642907|FG000|Initial Study Period|Withdrawal by Subject|0|||
126368256|NCT06582732|454642908|FG001|Initial Study Period|Withdrawal by Subject|1|||
126368257|NCT06582732|454642909|FG002|Initial Study Period|Withdrawal by Subject|0|||
126368258|NCT06582732|454642910|FG003|Initial Study Period|Withdrawal by Subject|1|||
126368259|NCT06582732|454642911|FG004|Initial Study Period|Withdrawal by Subject|3|||
126368260|NCT06582732|454642912|FG005|Initial Study Period|Withdrawal by Subject|1|||
126368261|NCT06582732|454642913|FG006|Initial Study Period|Withdrawal by Subject|2|||
126368262|NCT06582732|454642907|FG000|Initial Study Period|Moved Away|0|||
126368263|NCT06582732|454642908|FG001|Initial Study Period|Moved Away|0|||
126368264|NCT06582732|454642909|FG002|Initial Study Period|Moved Away|0|||
126368265|NCT06582732|454642910|FG003|Initial Study Period|Moved Away|0|||
126368266|NCT06582732|454642911|FG004|Initial Study Period|Moved Away|1|||
126368267|NCT06582732|454642912|FG005|Initial Study Period|Moved Away|0|||
126368268|NCT06582732|454642913|FG006|Initial Study Period|Moved Away|0|||
126368269|NCT03528902|454642916|FG000|Overall Study|Adverse Event|1|||
126368270|NCT03528902|454642917|FG001|Overall Study|Adverse Event|0|||
126368271|NCT05030766|454642918|FG000|Phase 1 Participants|Lost to Follow-up|12|||
126368272|NCT05030766|454642919|FG001|Phase 1 Participants|Lost to Follow-up|22|||
126368273|NCT05030766|454642920|FG002|Phase 1 Participants|Lost to Follow-up|0|||
126368274|NCT05030766|454642921|FG003|Phase 1 Participants|Lost to Follow-up|0|||
126368275|NCT05030766|454642918|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
126368276|NCT05030766|454642919|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
126368277|NCT05030766|454642920|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
126368278|NCT05030766|454642921|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
126368279|NCT05030766|454642918|FG000|Phase 2 Participants|Lost to Follow-up|0|||
126368280|NCT05030766|454642919|FG001|Phase 2 Participants|Lost to Follow-up|0|||
126368281|NCT05030766|454642920|FG002|Phase 2 Participants|Lost to Follow-up|6|||
126368282|NCT05030766|454642921|FG003|Phase 2 Participants|Lost to Follow-up|2|||
126368283|NCT00645658|454642922|FG000|Overall Study|Withdrawal by Subject|1|||
126368284|NCT00645658|454642923|FG001|Overall Study|Withdrawal by Subject|0|||
126368285|NCT00645658|454642922|FG000|Overall Study|Did not complete all assesments|0|||
126045352|NCT05157841|453465164|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
125884793|NCT02558296|452875052|FG001|Completed the Study Through Week 24|Physician Decision|0|||
125884794|NCT02558296|452875051|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
125884795|NCT02558296|452875052|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
125884796|NCT02558296|452875051|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
125884797|NCT02558296|452875052|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
125884798|NCT02558296|452875051|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
125884799|NCT02558296|452875052|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
125884800|NCT02558296|452875051|FG000|Completed the Study|Adverse Event|14|||
125884801|NCT02558296|452875052|FG001|Completed the Study|Adverse Event|5|||
125884802|NCT02558296|452875051|FG000|Completed the Study|Death|39|||
125884803|NCT02558296|452875052|FG001|Completed the Study|Death|25|||
125884804|NCT02558296|452875051|FG000|Completed the Study|Lost to Follow-up|31|||
125884805|NCT02558296|452875052|FG001|Completed the Study|Lost to Follow-up|23|||
125884806|NCT02558296|452875051|FG000|Completed the Study|Physician Decision|6|||
125884807|NCT02558296|452875052|FG001|Completed the Study|Physician Decision|0|||
125884808|NCT02558296|452875051|FG000|Completed the Study|Protocol Violation|2|||
125884809|NCT02558296|452875052|FG001|Completed the Study|Protocol Violation|1|||
125884810|NCT02558296|452875051|FG000|Completed the Study|Withdrawal by Subject|53|||
125884811|NCT02558296|452875052|FG001|Completed the Study|Withdrawal by Subject|31|||
125884812|NCT02558296|452875051|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
125884813|NCT02558296|452875052|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
125884814|NCT00734539|452875061|FG000|Main Study|Death|33|||
125884815|NCT00734539|452875062|FG001|Main Study|Death|32|||
125884816|NCT00734539|452875061|FG000|Main Study|Physician Decision|2|||
125884817|NCT00734539|452875062|FG001|Main Study|Physician Decision|0|||
125884818|NCT00734539|452875061|FG000|Main Study|Withdrawal by Subject|1|||
125884819|NCT00734539|452875062|FG001|Main Study|Withdrawal by Subject|3|||
125884820|NCT00734539|452875061|FG000|Main Study|Enrolled in error; ineligible|1|||
125884821|NCT00734539|452875062|FG001|Main Study|Enrolled in error; ineligible|0|||
125884822|NCT02504151|452875065|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
125884823|NCT02504151|452875066|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
125884824|NCT02504151|452875065|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
125884825|NCT02504151|452875066|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
125884826|NCT02504151|452875065|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125884827|NCT02504151|452875066|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125884828|NCT02504151|452875065|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
125884829|NCT02504151|452875066|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
125884830|NCT02557139|452875072|FG000|Overall Study|Significant liver elevation|1|||
125884831|NCT02557139|452875073|FG001|Overall Study|Significant liver elevation|0|||
125884832|NCT02557139|452875074|FG002|Overall Study|Significant liver elevation|1|||
125884833|NCT02557139|452875072|FG000|Overall Study|Withdrawal by Subject|1|||
125884834|NCT02557139|452875073|FG001|Overall Study|Withdrawal by Subject|0|||
125884835|NCT02557139|452875074|FG002|Overall Study|Withdrawal by Subject|0|||
125884836|NCT02557139|452875072|FG000|Overall Study|Illness of prohibited medication|0|||
125884837|NCT02557139|452875073|FG001|Overall Study|Illness of prohibited medication|0|||
125884838|NCT02557139|452875074|FG002|Overall Study|Illness of prohibited medication|1|||
125884839|NCT01454102|452875076|FG000|Overall Study|Continuing in the treatment period|0|||
125884840|NCT01454102|452875077|FG001|Overall Study|Continuing in the treatment period|0|||
125884841|NCT01454102|452875078|FG002|Overall Study|Continuing in the treatment period|0|||
125884842|NCT01454102|452875079|FG003|Overall Study|Continuing in the treatment period|0|||
125884843|NCT01454102|452875080|FG004|Overall Study|Continuing in the treatment period|3|||
126045353|NCT05157841|453465165|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
126045354|NCT05157841|453465163|FG000|Part A (14 Days)|Adverse Event|1|||
126045355|NCT05157841|453465164|FG001|Part A (14 Days)|Adverse Event|0|||
126045356|NCT05157841|453465165|FG002|Part A (14 Days)|Adverse Event|0|||
126045357|NCT05157841|453465163|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
126045358|NCT05157841|453465164|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
126045359|NCT05157841|453465165|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
126045360|NCT04933474|453465168|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
126045361|NCT04933474|453465169|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
126045362|NCT04933474|453465168|FG000|Overall Study|Lost to Follow-up|19|||
126045363|NCT04933474|453465169|FG001|Overall Study|Lost to Follow-up|9|||
126045364|NCT04933474|453465168|FG000|Overall Study|Life Burden - unable to participate|6|||
126045365|NCT04933474|453465169|FG001|Overall Study|Life Burden - unable to participate|2|||
126045366|NCT04933474|453465168|FG000|Overall Study|Disease Burden - unable to participate|4|||
126045367|NCT04933474|453465169|FG001|Overall Study|Disease Burden - unable to participate|1|||
126045368|NCT04933474|453465168|FG000|Overall Study|Surgery/Hospitalization|1|||
126045369|NCT04933474|453465169|FG001|Overall Study|Surgery/Hospitalization|2|||
126045370|NCT04933474|453465168|FG000|Overall Study|Dissatisfied with Intervention|1|||
126045371|NCT04933474|453465169|FG001|Overall Study|Dissatisfied with Intervention|1|||
126045372|NCT04933474|453465168|FG000|Overall Study|Withdrew interest in participation|1|||
126045373|NCT04933474|453465169|FG001|Overall Study|Withdrew interest in participation|0|||
126045374|NCT04933474|453465168|FG000|Overall Study|Had previously enrolled in the study|0|||
126045375|NCT04933474|453465169|FG001|Overall Study|Had previously enrolled in the study|1|||
126045376|NCT00942734|453465179|FG000|Overall Study|Adverse Event|2|||
126045377|NCT00942734|453465179|FG000|Overall Study|Protocol Violation|3|||
126045378|NCT00942734|453465179|FG000|Overall Study|Disease Progression|2|||
126045379|NCT00942734|453465179|FG000|Overall Study|Physician Decision|1|||
126045380|NCT04586244|453465187|FG000|Overall Study|Lost to Follow-up|1|||
126045381|NCT04586244|453465188|FG001|Overall Study|Lost to Follow-up|0|||
126045382|NCT04586244|453465189|FG002|Overall Study|Lost to Follow-up|0|||
126045383|NCT04586244|453465190|FG003|Overall Study|Lost to Follow-up|1|||
126045384|NCT04586244|453465191|FG004|Overall Study|Lost to Follow-up|0|||
126045385|NCT04586244|453465187|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
126045386|NCT04586244|453465188|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
126045387|NCT04586244|453465189|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
126045388|NCT04586244|453465190|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
126045389|NCT04586244|453465191|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
126045390|NCT05771467|453465193|FG000|Overall Study|Lost to Follow-up|6|||
126045391|NCT05771467|453465194|FG001|Overall Study|Lost to Follow-up|3|||
126045392|NCT01220531|453465197|FG000|Overall Study|Death|7|||
126045393|NCT01220531|453465197|FG000|Overall Study|Lost to Follow-up|1|||
126045394|NCT04873232|453465198|FG000|Overall Study|Lost to Follow-up|1|||
126045395|NCT04873232|453465199|FG001|Overall Study|Lost to Follow-up|4|||
126045396|NCT04873232|453465198|FG000|Overall Study|Withdrawal by Subject|1|||
126045397|NCT04873232|453465199|FG001|Overall Study|Withdrawal by Subject|0|||
126045398|NCT02325154|453465202|FG000|Overall Study|Physician Decision|1|||
126045399|NCT00709956|453465203|FG000|Overall Study|Withdrawal by Subject|1|||
126045400|NCT00709956|453465204|FG001|Overall Study|Withdrawal by Subject|1|||
126045401|NCT00709956|453465203|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
126045402|NCT00709956|453465204|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
126045403|NCT02611687|453465894|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
126045404|NCT02611687|453465895|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
126045405|NCT03983382|453465896|FG000|Overall Study|Death|1|||
126045406|NCT03983382|453465896|FG000|Overall Study|Lost to Follow-up|3|||
126045407|NCT03983382|453465896|FG000|Overall Study|Physician Decision|2|||
126045408|NCT03983382|453465896|FG000|Overall Study|Withdrawal by Subject|10|||
126045409|NCT03983382|453465896|FG000|Overall Study|Change in cancer treatment|2|||
126045410|NCT04165213|453465897|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
126045411|NCT04165213|453465898|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
126045412|NCT04165213|453465897|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
126045413|NCT04165213|453465898|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
126045414|NCT04165213|453465897|FG000|Clinician Enrollment|Termination from site|0|||
126045415|NCT04165213|453465898|FG001|Clinician Enrollment|Termination from site|1|||
126045416|NCT04165213|453465897|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
126045417|NCT04165213|453465898|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
126045418|NCT04165213|453465897|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
126045419|NCT04165213|453465898|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
126045420|NCT04165213|453465897|FG000|Caregiver Enrollment|Physician Decision|1|||
126045421|NCT04165213|453465898|FG001|Caregiver Enrollment|Physician Decision|0|||
126045422|NCT04165213|453465897|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
126045423|NCT04165213|453465898|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
126045424|NCT04165213|453465897|FG000|Caregiver Enrollment|PLWD death|2|||
126045425|NCT04165213|453465898|FG001|Caregiver Enrollment|PLWD death|0|||
126045426|NCT04165213|453465897|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
126045427|NCT04165213|453465898|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
126045428|NCT04165213|453465897|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
126045429|NCT04165213|453465898|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
126045430|NCT04165213|453465897|FG000|PLWD Enrollment|Lost to Follow-up|1|||
126045431|NCT04165213|453465898|FG001|PLWD Enrollment|Lost to Follow-up|1|||
126045432|NCT04165213|453465897|FG000|PLWD Enrollment|Physician Decision|1|||
126045433|NCT04165213|453465898|FG001|PLWD Enrollment|Physician Decision|0|||
126045434|NCT04165213|453465897|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
125884844|NCT01454102|452875081|FG005|Overall Study|Continuing in the treatment period|3|||
125884845|NCT01454102|452875082|FG006|Overall Study|Continuing in the treatment period|2|||
125884846|NCT01454102|452875083|FG007|Overall Study|Continuing in the treatment period|0|||
125884847|NCT01454102|452875084|FG008|Overall Study|Continuing in the treatment period|1|||
125884848|NCT01454102|452875085|FG009|Overall Study|Continuing in the treatment period|0|||
125884849|NCT01454102|452875086|FG010|Overall Study|Continuing in the treatment period|0|||
125884850|NCT01454102|452875087|FG011|Overall Study|Continuing in the treatment period|4|||
125884851|NCT01454102|452875088|FG012|Overall Study|Continuing in the treatment period|7|||
125884852|NCT01454102|452875089|FG013|Overall Study|Continuing in the treatment period|4|||
126304779|NCT01029782|454404356|FG001|Overall Study|Protocol Violation|2|||
126304780|NCT01029782|454404355|FG000|Overall Study|Withdrawal by Subject|0|||
126304781|NCT01029782|454404356|FG001|Overall Study|Withdrawal by Subject|1|||
126304782|NCT00596817|454404358|FG000|Open-label Period|Adverse Event|0|||
126304783|NCT00596817|454404359|FG001|Open-label Period|Adverse Event|49|||
126304784|NCT00596817|454404358|FG000|Open-label Period|Lack of Efficacy|0|||
126304785|NCT00596817|454404359|FG001|Open-label Period|Lack of Efficacy|33|||
126045435|NCT04165213|453465898|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
126045436|NCT04165213|453465897|FG000|PLWD Enrollment|Death|2|||
126045437|NCT04165213|453465898|FG001|PLWD Enrollment|Death|0|||
126045438|NCT04165213|453465897|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
126045439|NCT04165213|453465898|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
126045440|NCT04174170|453465899|FG000|Placebo Run-in Period|Not Randomized|38|||
126045441|NCT04174170|453465900|FG001|Placebo Run-in Period|Not Randomized|0|||
126045442|NCT04174170|453465901|FG002|Placebo Run-in Period|Not Randomized|0|||
126045443|NCT04174170|453465902|FG003|Placebo Run-in Period|Not Randomized|0|||
126045444|NCT04174170|453465899|FG000|Double Blind Treatment Period|Adverse Event|0|||
126045445|NCT04174170|453465900|FG001|Double Blind Treatment Period|Adverse Event|9|||
126045446|NCT04174170|453465901|FG002|Double Blind Treatment Period|Adverse Event|9|||
126045447|NCT04174170|453465902|FG003|Double Blind Treatment Period|Adverse Event|8|||
126045448|NCT04174170|453465899|FG000|Double Blind Treatment Period|Death|0|||
126045449|NCT04174170|453465900|FG001|Double Blind Treatment Period|Death|1|||
126045450|NCT04174170|453465901|FG002|Double Blind Treatment Period|Death|0|||
126045451|NCT04174170|453465902|FG003|Double Blind Treatment Period|Death|0|||
126045452|NCT04174170|453465899|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
126045453|NCT04174170|453465900|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
126045454|NCT04174170|453465901|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
126045455|NCT04174170|453465902|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
126045456|NCT04174170|453465899|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
126045457|NCT04174170|453465900|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
126045458|NCT04174170|453465901|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
126045459|NCT04174170|453465902|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
126045460|NCT04174170|453465899|FG000|Double Blind Treatment Period|Physician Decision|0|||
126045461|NCT04174170|453465900|FG001|Double Blind Treatment Period|Physician Decision|1|||
126045462|NCT04174170|453465901|FG002|Double Blind Treatment Period|Physician Decision|0|||
126045463|NCT04174170|453465902|FG003|Double Blind Treatment Period|Physician Decision|1|||
126045464|NCT04174170|453465899|FG000|Double Blind Treatment Period|Pregnancy|0|||
126045465|NCT04174170|453465900|FG001|Double Blind Treatment Period|Pregnancy|1|||
126045466|NCT04174170|453465901|FG002|Double Blind Treatment Period|Pregnancy|0|||
126045467|NCT04174170|453465902|FG003|Double Blind Treatment Period|Pregnancy|1|||
126045468|NCT04174170|453465899|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
126045469|NCT04174170|453465900|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
126045470|NCT04174170|453465901|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
125884853|NCT01454102|452875090|FG014|Overall Study|Continuing in the treatment period|3|||
126045471|NCT04174170|453465902|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
126045472|NCT04174170|453465899|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
126304786|NCT00596817|454404358|FG000|Open-label Period|Other Reasons|0|||
125884854|NCT01454102|452875091|FG015|Overall Study|Continuing in the treatment period|1|||
125884855|NCT02592798|452875096|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
125884856|NCT02592798|452875097|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
125884857|NCT02592798|452875096|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
125884858|NCT02592798|452875097|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
125884859|NCT02592798|452875096|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
125884860|NCT02592798|452875097|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
125884861|NCT02592798|452875096|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
125884862|NCT02592798|452875097|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
125884863|NCT02592798|452875096|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
125884864|NCT02592798|452875097|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
125884865|NCT02592798|452875096|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
125884866|NCT02592798|452875097|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
125884867|NCT02592798|452875096|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
125884868|NCT02592798|452875097|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
125884869|NCT02592798|452875096|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
125884870|NCT02592798|452875097|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
125884871|NCT02592798|452875096|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
125884872|NCT02592798|452875097|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
125884873|NCT02592798|452875096|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
125884874|NCT02592798|452875097|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
125884875|NCT02592798|452875096|FG000|Transition From DB2 to OLE|Other reasons|1|||
125884876|NCT02592798|452875097|FG001|Transition From DB2 to OLE|Other reasons|0|||
125884877|NCT02592798|452875096|FG000|Open Label Period (OLE)|Other reasons|0|||
125884878|NCT02592798|452875097|FG001|Open Label Period (OLE)|Other reasons|2|||
125884879|NCT02592798|452875096|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
125884880|NCT02592798|452875097|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
125884881|NCT02592798|452875096|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
125884882|NCT02592798|452875097|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
126045473|NCT04174170|453465900|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
126045474|NCT04174170|453465901|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
126045475|NCT04174170|453465902|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
126045476|NCT04174170|453465899|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
126045477|NCT04174170|453465900|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
126045478|NCT04174170|453465901|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
126045479|NCT04174170|453465902|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
126045480|NCT04772534|453465910|FG000|Overall Study|Physician Decision|1|||
126045481|NCT04772534|453465911|FG001|Overall Study|Physician Decision|0|||
126045482|NCT04772534|453465912|FG002|Overall Study|Physician Decision|0|||
126045483|NCT04772534|453465910|FG000|Overall Study|Withdrawal by Subject|3|||
126045484|NCT04772534|453465911|FG001|Overall Study|Withdrawal by Subject|0|||
126045485|NCT04772534|453465912|FG002|Overall Study|Withdrawal by Subject|1|||
126045486|NCT04194450|453465913|FG000|Overall Study|not eligible|1|||
126045487|NCT04194450|453465914|FG001|Overall Study|not eligible|0|||
126045488|NCT03242915|453465933|FG000|Overall Study|Adverse Event|5|||
126045489|NCT03242915|453465934|FG001|Overall Study|Adverse Event|1|||
126045490|NCT03242915|453465933|FG000|Overall Study|Withdrawal by Subject|0|||
126045491|NCT03242915|453465934|FG001|Overall Study|Withdrawal by Subject|2|||
126045492|NCT03242915|453465933|FG000|Overall Study|Physician Decision|4|||
126045493|NCT03242915|453465934|FG001|Overall Study|Physician Decision|1|||
126045494|NCT05988398|453465935|FG000|Overall Study|Lack of time|21|||
126045495|NCT05988398|453465936|FG001|Overall Study|Lack of time|0|||
126045496|NCT05988398|453465935|FG000|Overall Study|Absent from school|0|||
126045497|NCT05988398|453465936|FG001|Overall Study|Absent from school|38|||
126045498|NCT05988398|453465935|FG000|Overall Study|Chose not to participate|0|||
126045499|NCT05988398|453465936|FG001|Overall Study|Chose not to participate|42|||
126045500|NCT05988398|453465935|FG000|Overall Study|Other commitments (e.g., sports)|0|||
126045501|NCT05988398|453465936|FG001|Overall Study|Other commitments (e.g., sports)|25|||
126045502|NCT04908930|453465940|FG000|Overall Study|Lost to Follow-up|1|||
126045503|NCT04908930|453465941|FG001|Overall Study|Lost to Follow-up|1|||
126045504|NCT04908930|453465942|FG002|Overall Study|Lost to Follow-up|0|||
126045505|NCT04908930|453465943|FG003|Overall Study|Lost to Follow-up|0|||
126045506|NCT04908930|453465944|FG004|Overall Study|Lost to Follow-up|0|||
126045507|NCT04908930|453465940|FG000|Overall Study|hardware in mouth|1|||
126045508|NCT04908930|453465941|FG001|Overall Study|hardware in mouth|1|||
125884883|NCT02592798|452875096|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
126045509|NCT04908930|453465942|FG002|Overall Study|hardware in mouth|0|||
126045510|NCT04908930|453465943|FG003|Overall Study|hardware in mouth|0|||
126045511|NCT04908930|453465944|FG004|Overall Study|hardware in mouth|0|||
126045512|NCT04908930|453465940|FG000|Overall Study|wrong team|1|||
125884884|NCT02592798|452875097|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
125884885|NCT02592798|452875096|FG000|Open Label Period (OLE)|Adverse Event|0|||
125884886|NCT02592798|452875097|FG001|Open Label Period (OLE)|Adverse Event|1|||
125884887|NCT00705016|452875098|FG000|Overall Study|Adverse Event|6|||
125884888|NCT00705016|452875099|FG001|Overall Study|Adverse Event|11|||
125884889|NCT00705016|452875100|FG002|Overall Study|Adverse Event|10|||
125884890|NCT00705016|452875098|FG000|Overall Study|Death|5|||
125884891|NCT00705016|452875099|FG001|Overall Study|Death|7|||
125884892|NCT00705016|452875100|FG002|Overall Study|Death|5|||
125884893|NCT00705016|452875098|FG000|Overall Study|Protocol Violation|0|||
125884894|NCT00705016|452875099|FG001|Overall Study|Protocol Violation|1|||
125884895|NCT00705016|452875100|FG002|Overall Study|Protocol Violation|1|||
125884896|NCT00705016|452875098|FG000|Overall Study|Withdrawal by Subject|4|||
125884897|NCT00705016|452875099|FG001|Overall Study|Withdrawal by Subject|3|||
125884898|NCT00705016|452875100|FG002|Overall Study|Withdrawal by Subject|2|||
125884899|NCT00705016|452875098|FG000|Overall Study|Progressive Disease|33|||
125884900|NCT00705016|452875099|FG001|Overall Study|Progressive Disease|29|||
125884901|NCT00705016|452875100|FG002|Overall Study|Progressive Disease|33|||
125884902|NCT00705016|452875098|FG000|Overall Study|Symptomatic Deterioration|3|||
125884903|NCT00705016|452875099|FG001|Overall Study|Symptomatic Deterioration|1|||
125884904|NCT00705016|452875100|FG002|Overall Study|Symptomatic Deterioration|1|||
125884905|NCT00705016|452875098|FG000|Overall Study|Other|9|||
125884906|NCT00705016|452875099|FG001|Overall Study|Other|6|||
125884907|NCT00705016|452875100|FG002|Overall Study|Other|6|||
125884908|NCT00942604|452875104|FG000|Overall Study|Protocol Violation|1|||
125884909|NCT00942604|452875105|FG001|Overall Study|Protocol Violation|1|||
125884910|NCT00942604|452875104|FG000|Overall Study|Adverse Event|0|||
125884911|NCT00942604|452875105|FG001|Overall Study|Adverse Event|1|||
125884912|NCT00942604|452875104|FG000|Overall Study|Withdrawal by Subject|0|||
125884913|NCT00942604|452875105|FG001|Overall Study|Withdrawal by Subject|1|||
125884914|NCT00942604|452875104|FG000|Overall Study|Patient relocation|1|||
125884915|NCT00942604|452875105|FG001|Overall Study|Patient relocation|1|||
125884916|NCT01188343|452875106|FG000|Overall Study|Not vaccinated|0|||
125884917|NCT01188343|452875107|FG001|Overall Study|Not vaccinated|2|||
125884918|NCT01188343|452875108|FG002|Overall Study|Not vaccinated|1|||
125884919|NCT01188343|452875106|FG000|Overall Study|Withdrawal by Subject|1|||
125884920|NCT01188343|452875107|FG001|Overall Study|Withdrawal by Subject|24|||
125884921|NCT01188343|452875108|FG002|Overall Study|Withdrawal by Subject|0|||
125884922|NCT01143246|452875109|FG000|Overall Study|Adverse Event|24|||
125884923|NCT01143246|452875110|FG001|Overall Study|Adverse Event|28|||
125884924|NCT01143246|452875109|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
125884925|NCT01143246|452875110|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
125884926|NCT01143246|452875109|FG000|Overall Study|Lost to Follow-up|0|||
125884927|NCT01143246|452875110|FG001|Overall Study|Lost to Follow-up|1|||
125884928|NCT01143246|452875109|FG000|Overall Study|Death|16|||
125884929|NCT01143246|452875110|FG001|Overall Study|Death|15|||
125884930|NCT01143246|452875109|FG000|Overall Study|Reason not Specified|3|||
125884931|NCT01143246|452875110|FG001|Overall Study|Reason not Specified|5|||
125884932|NCT05375760|452875111|FG000|Overall Study|Adverse Event|1|||
125884933|NCT05375760|452875112|FG001|Overall Study|Adverse Event|0|||
125884934|NCT05375760|452875111|FG000|Overall Study|Death|0|||
125884935|NCT05375760|452875112|FG001|Overall Study|Death|1|||
125884936|NCT05375760|452875111|FG000|Overall Study|Lost to Follow-up|6|||
125884937|NCT05375760|452875112|FG001|Overall Study|Lost to Follow-up|6|||
125884938|NCT05375760|452875111|FG000|Overall Study|Withdrawal by Subject|17|||
125884939|NCT05375760|452875112|FG001|Overall Study|Withdrawal by Subject|19|||
125884940|NCT05375760|452875111|FG000|Overall Study|Dosing halted by FDA|96|||
125884941|NCT05375760|452875112|FG001|Overall Study|Dosing halted by FDA|100|||
125884942|NCT05375760|452875111|FG000|Overall Study|Not compliant with study visit|2|||
125884943|NCT05375760|452875112|FG001|Overall Study|Not compliant with study visit|0|||
125884944|NCT05375760|452875111|FG000|Overall Study|Physician Decision|1|||
125884945|NCT05375760|452875112|FG001|Overall Study|Physician Decision|0|||
125884946|NCT05375760|452875111|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
125884947|NCT05375760|452875112|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
125884948|NCT05375760|452875111|FG000|Overall Study|Participant moved|1|||
126304787|NCT00596817|454404359|FG001|Open-label Period|Other Reasons|65|||
126304788|NCT00596817|454404358|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
125884949|NCT05375760|452875112|FG001|Overall Study|Participant moved|0|||
125884950|NCT00363480|452875113|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
125884951|NCT00363480|452875113|FG000|Overall Study|Adverse Event|4|||
125884952|NCT00363480|452875113|FG000|Overall Study|Lost to Follow-up|5|||
125884953|NCT00363480|452875113|FG000|Overall Study|Withdrawal by Subject|5|||
125884954|NCT00363480|452875113|FG000|Overall Study|Non-compliance of subject|1|||
125884955|NCT00363480|452875113|FG000|Overall Study|Participant discontinued on its own|1|||
125884956|NCT05567783|452875114|FG000|Overall Study|Death|2|||
125884957|NCT05567783|452875115|FG001|Overall Study|Death|3|||
125884958|NCT05567783|452875116|FG002|Overall Study|Death|0|||
125884959|NCT05567783|452875114|FG000|Overall Study|Lost to Follow-up|25|||
125884960|NCT05567783|452875115|FG001|Overall Study|Lost to Follow-up|19|||
125884961|NCT05567783|452875116|FG002|Overall Study|Lost to Follow-up|17|||
125884962|NCT05567783|452875114|FG000|Overall Study|Physician Decision|10|||
125884963|NCT05567783|452875115|FG001|Overall Study|Physician Decision|7|||
126045513|NCT04908930|453465941|FG001|Overall Study|wrong team|0|||
126045514|NCT04908930|453465942|FG002|Overall Study|wrong team|0|||
126045515|NCT04908930|453465943|FG003|Overall Study|wrong team|0|||
126045516|NCT04908930|453465944|FG004|Overall Study|wrong team|0|||
126045517|NCT04908930|453465940|FG000|Overall Study|quit team|2|||
126045518|NCT04908930|453465941|FG001|Overall Study|quit team|4|||
126045519|NCT04908930|453465942|FG002|Overall Study|quit team|0|||
126045520|NCT04908930|453465943|FG003|Overall Study|quit team|0|||
126045521|NCT04908930|453465944|FG004|Overall Study|quit team|0|||
126045522|NCT04908930|453465940|FG000|Overall Study|Withdrawal by Subject|1|||
126045523|NCT04908930|453465941|FG001|Overall Study|Withdrawal by Subject|2|||
126045524|NCT04908930|453465942|FG002|Overall Study|Withdrawal by Subject|0|||
126045525|NCT04908930|453465943|FG003|Overall Study|Withdrawal by Subject|0|||
126045526|NCT04908930|453465944|FG004|Overall Study|Withdrawal by Subject|0|||
126045527|NCT04908930|453465940|FG000|Overall Study|parent not liking program|0|||
126045528|NCT04908930|453465941|FG001|Overall Study|parent not liking program|1|||
126045529|NCT04908930|453465942|FG002|Overall Study|parent not liking program|0|||
126045530|NCT04908930|453465943|FG003|Overall Study|parent not liking program|0|||
126045531|NCT04908930|453465944|FG004|Overall Study|parent not liking program|0|||
126045532|NCT03872466|453465947|FG000|Overall Study|Withdrawal by Subject|1|||
126045533|NCT03872466|453465948|FG001|Overall Study|Withdrawal by Subject|0|||
126045534|NCT03872466|453465947|FG000|Overall Study|Physician Decision|2|||
126045535|NCT03872466|453465948|FG001|Overall Study|Physician Decision|0|||
126045536|NCT01499368|453465949|FG000|Overall Study|Did not meet I/E criteria|8|||
126045537|NCT01499368|453465950|FG001|Overall Study|Did not meet I/E criteria|4|||
126045538|NCT01499368|453465951|FG002|Overall Study|Did not meet I/E criteria|4|||
126045539|NCT01499368|453465949|FG000|Overall Study|Prohibited Concomitant medication|1|||
126045540|NCT01499368|453465950|FG001|Overall Study|Prohibited Concomitant medication|1|||
126045541|NCT01499368|453465951|FG002|Overall Study|Prohibited Concomitant medication|0|||
126045542|NCT01499368|453465949|FG000|Overall Study|Withdrawal by Subject|11|||
126045543|NCT01499368|453465950|FG001|Overall Study|Withdrawal by Subject|10|||
126045544|NCT01499368|453465951|FG002|Overall Study|Withdrawal by Subject|8|||
126045545|NCT01499368|453465949|FG000|Overall Study|Lost to Follow-up|3|||
126045546|NCT01499368|453465950|FG001|Overall Study|Lost to Follow-up|2|||
126045547|NCT01499368|453465951|FG002|Overall Study|Lost to Follow-up|5|||
126045548|NCT01499368|453465949|FG000|Overall Study|Adverse Event|4|||
126045549|NCT01499368|453465950|FG001|Overall Study|Adverse Event|0|||
126045550|NCT01499368|453465951|FG002|Overall Study|Adverse Event|2|||
126045551|NCT01499368|453465949|FG000|Overall Study|Physician Decision|0|||
126045552|NCT01499368|453465950|FG001|Overall Study|Physician Decision|1|||
126045553|NCT01499368|453465951|FG002|Overall Study|Physician Decision|0|||
126045554|NCT01499368|453465949|FG000|Overall Study|Deviation from visit window|0|||
126045555|NCT01499368|453465950|FG001|Overall Study|Deviation from visit window|0|||
126045556|NCT01499368|453465951|FG002|Overall Study|Deviation from visit window|1|||
126045557|NCT01499368|453465949|FG000|Overall Study|Error of Prescriptions|0|||
126045558|NCT01499368|453465950|FG001|Overall Study|Error of Prescriptions|0|||
126045559|NCT01499368|453465951|FG002|Overall Study|Error of Prescriptions|1|||
126045560|NCT06059443|453465952|FG000|Overall Study|Withdrawal by Subject|2|||
126045561|NCT06059443|453465953|FG001|Overall Study|Withdrawal by Subject|0|||
126045562|NCT06059443|453465952|FG000|Overall Study|Lost to Follow-up|2|||
126045563|NCT06059443|453465953|FG001|Overall Study|Lost to Follow-up|2|||
126045564|NCT03092674|453465954|FG000|Overall Study|Adverse Event or Side Effects|1|||
126045565|NCT03092674|453465955|FG001|Overall Study|Adverse Event or Side Effects|4|||
126045566|NCT03092674|453465956|FG002|Overall Study|Adverse Event or Side Effects|4|||
126045567|NCT03092674|453465954|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
126045568|NCT03092674|453465955|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
126045569|NCT03092674|453465956|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
126045570|NCT03092674|453465954|FG000|Overall Study|Progression/Relapse|5|||
126045571|NCT03092674|453465955|FG001|Overall Study|Progression/Relapse|4|||
126045572|NCT03092674|453465956|FG002|Overall Study|Progression/Relapse|8|||
126045573|NCT03092674|453465954|FG000|Overall Study|Death|4|||
126045574|NCT03092674|453465955|FG001|Overall Study|Death|8|||
126045575|NCT03092674|453465956|FG002|Overall Study|Death|2|||
126045576|NCT03092674|453465954|FG000|Overall Study|Other - Not Protocol Specified|11|||
126045577|NCT03092674|453465955|FG001|Overall Study|Other - Not Protocol Specified|8|||
126045578|NCT03092674|453465956|FG002|Overall Study|Other - Not Protocol Specified|8|||
126045579|NCT01105091|453465957|FG000|Overall Study|Death|2|||
126045580|NCT01105091|453465958|FG001|Overall Study|Death|0|||
126045581|NCT03008382|453465959|FG000|Overall Study|Withdrawal by Subject|2|||
126045582|NCT03008382|453465960|FG001|Overall Study|Withdrawal by Subject|5|||
126045583|NCT03008382|453465961|FG002|Overall Study|Withdrawal by Subject|2|||
126045584|NCT03008382|453465962|FG003|Overall Study|Withdrawal by Subject|0|||
126045585|NCT03008382|453465959|FG000|Overall Study|Protocol Violation|1|||
126045586|NCT03008382|453465960|FG001|Overall Study|Protocol Violation|0|||
126045587|NCT03008382|453465961|FG002|Overall Study|Protocol Violation|0|||
126045588|NCT03008382|453465962|FG003|Overall Study|Protocol Violation|0|||
126045589|NCT03008382|453465959|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
126103423|NCT01831856|453672158|FG001|Overall Study|Lack of Efficacy|11|||
126045590|NCT03008382|453465960|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
126045591|NCT03008382|453465961|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
126045592|NCT03008382|453465962|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
126045593|NCT03008382|453465959|FG000|Overall Study|Lost to Follow-up|0|||
126045594|NCT03008382|453465960|FG001|Overall Study|Lost to Follow-up|0|||
126045595|NCT03008382|453465961|FG002|Overall Study|Lost to Follow-up|1|||
126045596|NCT03008382|453465962|FG003|Overall Study|Lost to Follow-up|0|||
126045597|NCT03008382|453465959|FG000|Overall Study|Screenfail|0|||
126045598|NCT03008382|453465960|FG001|Overall Study|Screenfail|0|||
126045599|NCT03008382|453465961|FG002|Overall Study|Screenfail|2|||
126045600|NCT03008382|453465962|FG003|Overall Study|Screenfail|0|||
126045601|NCT00328783|453466398|FG000|Overall Study|Could not tolerate ABC|21|||
126045602|NCT00328783|453466398|FG000|Overall Study|No heart in RT field|4|||
126045603|NCT00328783|453466398|FG000|Overall Study|Withdrawal by Subject|1|||
126045604|NCT00357682|453466399|FG000|Overall Study|Did not receive allocated Treatment|10|||
126045605|NCT00357682|453466400|FG001|Overall Study|Did not receive allocated Treatment|9|||
126045606|NCT00357682|453466401|FG002|Overall Study|Did not receive allocated Treatment|9|||
126045607|NCT00357682|453466402|FG003|Overall Study|Did not receive allocated Treatment|10|||
126045608|NCT00357682|453466399|FG000|Overall Study|Withdrew consent|6|||
126045609|NCT00357682|453466400|FG001|Overall Study|Withdrew consent|6|||
126045610|NCT00357682|453466401|FG002|Overall Study|Withdrew consent|5|||
126045611|NCT00357682|453466402|FG003|Overall Study|Withdrew consent|5|||
126045612|NCT00357682|453466399|FG000|Overall Study|Lost to Follow-up|39|||
126045613|NCT00357682|453466400|FG001|Overall Study|Lost to Follow-up|33|||
126045614|NCT00357682|453466401|FG002|Overall Study|Lost to Follow-up|26|||
126045615|NCT00357682|453466402|FG003|Overall Study|Lost to Follow-up|35|||
126045616|NCT00357682|453466399|FG000|Overall Study|Adverse Event|24|||
126045617|NCT00357682|453466400|FG001|Overall Study|Adverse Event|32|||
126045618|NCT00357682|453466401|FG002|Overall Study|Adverse Event|22|||
126045619|NCT00357682|453466402|FG003|Overall Study|Adverse Event|27|||
126045620|NCT00357682|453466399|FG000|Overall Study|Physician Decision|32|||
126045621|NCT00357682|453466400|FG001|Overall Study|Physician Decision|20|||
126045622|NCT00357682|453466401|FG002|Overall Study|Physician Decision|24|||
126045623|NCT00357682|453466402|FG003|Overall Study|Physician Decision|30|||
126045624|NCT00357682|453466399|FG000|Overall Study|Patient decision|73|||
126045625|NCT00357682|453466400|FG001|Overall Study|Patient decision|80|||
126045626|NCT00357682|453466401|FG002|Overall Study|Patient decision|51|||
126045627|NCT00357682|453466402|FG003|Overall Study|Patient decision|59|||
126045628|NCT00357682|453466399|FG000|Overall Study|Other reason|157|||
126045629|NCT00357682|453466400|FG001|Overall Study|Other reason|130|||
126045630|NCT00357682|453466401|FG002|Overall Study|Other reason|114|||
126045631|NCT00357682|453466402|FG003|Overall Study|Other reason|99|||
126045632|NCT04408755|453466404|FG000|Period A (Placebo lead-in)|Other|11|||
126045633|NCT04408755|453466405|FG001|Period A (Placebo lead-in)|Other|0|||
126045634|NCT04408755|453466406|FG002|Period A (Placebo lead-in)|Other|0|||
126045635|NCT04408755|453466407|FG003|Period A (Placebo lead-in)|Other|0|||
126045636|NCT04408755|453466404|FG000|Period B (Randomization Period)|Adverse Event|0|||
126045637|NCT04408755|453466405|FG001|Period B (Randomization Period)|Adverse Event|3|||
126045638|NCT04408755|453466406|FG002|Period B (Randomization Period)|Adverse Event|0|||
126045639|NCT04408755|453466407|FG003|Period B (Randomization Period)|Adverse Event|1|||
126045640|NCT04408755|453466404|FG000|Period B (Randomization Period)|Death|0|||
126045641|NCT04408755|453466405|FG001|Period B (Randomization Period)|Death|0|||
126045642|NCT04408755|453466406|FG002|Period B (Randomization Period)|Death|1|||
126045643|NCT04408755|453466407|FG003|Period B (Randomization Period)|Death|0|||
126045644|NCT04408755|453466404|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
126045645|NCT04408755|453466405|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
126045646|NCT04408755|453466406|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
126045647|NCT04408755|453466407|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
126045648|NCT04408755|453466404|FG000|Period B (Randomization Period)|Physician Decision|0|||
126045649|NCT04408755|453466405|FG001|Period B (Randomization Period)|Physician Decision|0|||
126045650|NCT04408755|453466406|FG002|Period B (Randomization Period)|Physician Decision|1|||
126045651|NCT04408755|453466407|FG003|Period B (Randomization Period)|Physician Decision|0|||
126045652|NCT04408755|453466404|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
126045653|NCT04408755|453466405|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
126045654|NCT04408755|453466406|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
126045655|NCT04408755|453466407|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
126045656|NCT04408755|453466404|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
126045657|NCT04408755|453466405|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
126045658|NCT04408755|453466406|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
126045659|NCT04408755|453466407|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
126045660|NCT04408755|453466404|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
126045661|NCT04408755|453466405|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
126045662|NCT04408755|453466406|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
126045663|NCT04408755|453466407|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
126304789|NCT00596817|454404359|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
126304790|NCT00596817|454404358|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
126304791|NCT00596817|454404359|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
126304792|NCT00596817|454404358|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
126304793|NCT00596817|454404359|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
126045664|NCT04408755|453466404|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
126045665|NCT04408755|453466405|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
126045666|NCT04408755|453466406|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
126045667|NCT04408755|453466407|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
126045668|NCT04408755|453466404|FG000|Period B (Randomization Period)|Reason not Specified|0|||
126045669|NCT04408755|453466405|FG001|Period B (Randomization Period)|Reason not Specified|1|||
126045670|NCT04408755|453466406|FG002|Period B (Randomization Period)|Reason not Specified|0|||
126045671|NCT04408755|453466407|FG003|Period B (Randomization Period)|Reason not Specified|2|||
126045672|NCT00308997|453466408|FG000|Overall Study|Subject feigned clinical data|0|||
126045673|NCT00308997|453466409|FG001|Overall Study|Subject feigned clinical data|1|||
126045674|NCT00308997|453466408|FG000|Overall Study|Unable to tolerate intervention|1|||
126045675|NCT00308997|453466409|FG001|Overall Study|Unable to tolerate intervention|0|||
126045676|NCT04490356|453466410|FG000|Overall Study|Lost to Follow-up|1|||
126045677|NCT03733626|453466411|FG000|Overall Study|Physician Decision|4|||
126045678|NCT03733626|453466412|FG001|Overall Study|Physician Decision|4|||
126045679|NCT03142009|453466423|FG000|Overall Study|Lost to Follow-up|45|||
126045680|NCT03142009|453466424|FG001|Overall Study|Lost to Follow-up|30|||
126045681|NCT01778686|453466425|FG000|Overall Study|Adverse Event|0|||
126045682|NCT01778686|453466426|FG001|Overall Study|Adverse Event|0|||
126045683|NCT01778686|453466427|FG002|Overall Study|Adverse Event|1|||
126045684|NCT01553149|453466430|FG000|Overall Study|Adverse Event|0|||
126045685|NCT01553149|453466431|FG001|Overall Study|Adverse Event|9|||
126045686|NCT01553149|453466430|FG000|Overall Study|Physician Decision|5|||
126045687|NCT01553149|453466431|FG001|Overall Study|Physician Decision|10|||
126045688|NCT01553149|453466430|FG000|Overall Study|Ineligible|0|||
126045689|NCT01553149|453466431|FG001|Overall Study|Ineligible|1|||
126045690|NCT03215706|453466441|FG000|Randomization|Adverse Event unrelated to study drug|1|||
126045691|NCT03215706|453466442|FG001|Randomization|Adverse Event unrelated to study drug|0|||
126045692|NCT03215706|453466441|FG000|Randomization|participant withdrew consent|1|||
126045693|NCT03215706|453466442|FG001|Randomization|participant withdrew consent|3|||
126045694|NCT03215706|453466441|FG000|Randomization|no longer meets study criteria|1|||
126045695|NCT03215706|453466442|FG001|Randomization|no longer meets study criteria|4|||
126045696|NCT03215706|453466441|FG000|Randomization|other reasons|0|||
126045697|NCT03215706|453466442|FG001|Randomization|other reasons|2|||
126045698|NCT03215706|453466441|FG000|Treatment Period|Disease Progression|150|||
126045699|NCT03215706|453466442|FG001|Treatment Period|Disease Progression|142|||
126045700|NCT03215706|453466441|FG000|Treatment Period|Study Drug Toxicity|53|||
126045701|NCT03215706|453466442|FG001|Treatment Period|Study Drug Toxicity|21|||
126045702|NCT03215706|453466441|FG000|Treatment Period|Death|2|||
126045703|NCT03215706|453466442|FG001|Treatment Period|Death|1|||
126045704|NCT03215706|453466441|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
126045705|NCT03215706|453466442|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
126045706|NCT03215706|453466441|FG000|Treatment Period|Request to D/C treatment|1|||
126045707|NCT03215706|453466442|FG001|Treatment Period|Request to D/C treatment|6|||
126045708|NCT03215706|453466441|FG000|Treatment Period|Participant withdrew consent|3|||
126045709|NCT03215706|453466442|FG001|Treatment Period|Participant withdrew consent|4|||
126045710|NCT03215706|453466441|FG000|Treatment Period|Lost to Follow-up|0|||
126045711|NCT03215706|453466442|FG001|Treatment Period|Lost to Follow-up|1|||
126045712|NCT03215706|453466441|FG000|Treatment Period|Other Reasons|4|||
126045713|NCT03215706|453466442|FG001|Treatment Period|Other Reasons|5|||
126045714|NCT03215706|453466441|FG000|Treatment Period|Ongoing in the treatment period|105|||
126045715|NCT03215706|453466442|FG001|Treatment Period|Ongoing in the treatment period|43|||
126045716|NCT00945724|453466443|FG000|Overall Study|Withdrawal by Subject|2|||
126045717|NCT00945724|453466443|FG000|Overall Study|Physician Decision|1|||
126045718|NCT00945724|453466443|FG000|Overall Study|Adverse Event|5|||
126045719|NCT00945724|453466443|FG000|Overall Study|Second malignancy|1|||
126045720|NCT00994643|453467131|FG000|Overall Study|Withdrawal by Subject|1|||
126045721|NCT00968149|453467132|FG000|Overall Study|Adverse Event|5|||
126045722|NCT00968149|453467133|FG001|Overall Study|Adverse Event|1|||
126045723|NCT00968149|453467132|FG000|Overall Study|Lack of Efficacy|0|||
126045724|NCT00968149|453467133|FG001|Overall Study|Lack of Efficacy|4|||
126304794|NCT00596817|454404358|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
126304795|NCT00596817|454404359|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
126045725|NCT00968149|453467132|FG000|Overall Study|Lost to Follow-up|0|||
126045726|NCT00968149|453467133|FG001|Overall Study|Lost to Follow-up|1|||
126045727|NCT00968149|453467132|FG000|Overall Study|Protocol Violation|4|||
126045728|NCT00968149|453467133|FG001|Overall Study|Protocol Violation|0|||
126304796|NCT00596817|454404358|FG000|Double-blind Period|Adverse Event|5|||
126304797|NCT00596817|454404359|FG001|Double-blind Period|Adverse Event|16|||
126304798|NCT00596817|454404358|FG000|Double-blind Period|Lack of Efficacy|52|||
126304799|NCT00596817|454404359|FG001|Double-blind Period|Lack of Efficacy|28|||
126304800|NCT00596817|454404358|FG000|Double-blind Period|Non-compliance With Study Product|3|||
126304801|NCT00596817|454404359|FG001|Double-blind Period|Non-compliance With Study Product|4|||
126304802|NCT00596817|454404358|FG000|Double-blind Period|Protocol Violation|11|||
126304803|NCT00596817|454404359|FG001|Double-blind Period|Protocol Violation|8|||
126304804|NCT00596817|454404358|FG000|Double-blind Period|Withdrawal of Consent|7|||
126304805|NCT00596817|454404359|FG001|Double-blind Period|Withdrawal of Consent|3|||
126304806|NCT00596817|454404358|FG000|Double-blind Period|Lost to Follow-up|0|||
126304807|NCT00596817|454404359|FG001|Double-blind Period|Lost to Follow-up|2|||
126304808|NCT00596817|454404358|FG000|Double-blind Period|Other Reasons|10|||
126304809|NCT00596817|454404359|FG001|Double-blind Period|Other Reasons|18|||
126304810|NCT04402138|454405508|FG000|Overall Study|Progressive Disease|2|||
126304811|NCT04402138|454405508|FG000|Overall Study|Adverse Event|1|||
126304812|NCT03056638|454405511|FG000|Overall Study|Death|1|||
126304813|NCT03056638|454405512|FG001|Overall Study|Death|0|||
126304814|NCT03508726|454405513|FG000|Overall Study|Withdrawal by Subject|0|||
126304815|NCT03508726|454405514|FG001|Overall Study|Withdrawal by Subject|1|||
126304816|NCT01515865|454405516|FG000|Part A (Open-label)|Other|3|||
126304817|NCT01515865|454405517|FG001|Part A (Open-label)|Other|0|||
126304818|NCT01515865|454405518|FG002|Part A (Open-label)|Other|0|||
126304819|NCT01515865|454405516|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
126304820|NCT01515865|454405517|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
126304821|NCT01515865|454405518|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
126368286|NCT00645658|454642923|FG001|Overall Study|Did not complete all assesments|2|||
126368287|NCT03605693|454642930|FG000|Overall Study|Lost to Follow-up|4|||
126045729|NCT00968149|453467132|FG000|Overall Study|Withdrawal by Subject|2|||
126045730|NCT00968149|453467133|FG001|Overall Study|Withdrawal by Subject|0|||
126045731|NCT03934931|453467134|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
126045732|NCT03934931|453467135|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
126045733|NCT03934931|453467136|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
126045734|NCT02720068|453467137|FG000|Overall Study|Adverse Event|0|||
126045735|NCT02720068|453467138|FG001|Overall Study|Adverse Event|0|||
126045736|NCT02720068|453467139|FG002|Overall Study|Adverse Event|0|||
126045737|NCT02720068|453467140|FG003|Overall Study|Adverse Event|0|||
126045738|NCT02720068|453467141|FG004|Overall Study|Adverse Event|0|||
126045739|NCT02720068|453467142|FG005|Overall Study|Adverse Event|0|||
126045740|NCT02720068|453467143|FG006|Overall Study|Adverse Event|0|||
126045741|NCT02720068|453467144|FG007|Overall Study|Adverse Event|0|||
126045742|NCT02720068|453467145|FG008|Overall Study|Adverse Event|0|||
126045743|NCT02720068|453467146|FG009|Overall Study|Adverse Event|0|||
126045744|NCT02720068|453467147|FG010|Overall Study|Adverse Event|0|||
126045745|NCT02720068|453467148|FG011|Overall Study|Adverse Event|1|||
126045746|NCT02720068|453467149|FG012|Overall Study|Adverse Event|0|||
126045747|NCT02720068|453467150|FG013|Overall Study|Adverse Event|0|||
126045748|NCT02720068|453467151|FG014|Overall Study|Adverse Event|0|||
126045749|NCT02720068|453467152|FG015|Overall Study|Adverse Event|0|||
126045750|NCT02720068|453467153|FG016|Overall Study|Adverse Event|0|||
126045751|NCT02720068|453467154|FG017|Overall Study|Adverse Event|0|||
126045752|NCT02720068|453467137|FG000|Overall Study|Death|1|||
126045753|NCT02720068|453467138|FG001|Overall Study|Death|3|||
126045754|NCT02720068|453467139|FG002|Overall Study|Death|2|||
126045755|NCT02720068|453467140|FG003|Overall Study|Death|1|||
126045756|NCT02720068|453467141|FG004|Overall Study|Death|2|||
126045757|NCT02720068|453467142|FG005|Overall Study|Death|1|||
126045758|NCT02720068|453467143|FG006|Overall Study|Death|2|||
126045759|NCT02720068|453467144|FG007|Overall Study|Death|2|||
126304822|NCT01515865|454405516|FG000|Part B (Open-label)|Other|1|||
126304823|NCT01515865|454405517|FG001|Part B (Open-label)|Other|0|||
126304824|NCT01515865|454405518|FG002|Part B (Open-label)|Other|0|||
126304825|NCT03691207|454405520|FG000|Overall Study|Death|41|||
126304826|NCT03691207|454405521|FG001|Overall Study|Death|26|||
126368288|NCT03605693|454642931|FG001|Overall Study|Lost to Follow-up|0|||
126368289|NCT03605693|454642930|FG000|Overall Study|Physician Decision|1|||
126368290|NCT03605693|454642931|FG001|Overall Study|Physician Decision|0|||
126368291|NCT03895372|454642934|FG000|Investigational Treatment Period|Adverse Event|1|||
126368292|NCT03895372|454642935|FG001|Investigational Treatment Period|Adverse Event|0|||
126368293|NCT03895372|454642936|FG002|Investigational Treatment Period|Adverse Event|0|||
126368294|NCT03895372|454642937|FG003|Investigational Treatment Period|Adverse Event|0|||
126368295|NCT03895372|454642938|FG004|Investigational Treatment Period|Adverse Event|0|||
126368296|NCT03895372|454642939|FG005|Investigational Treatment Period|Adverse Event|0|||
126368297|NCT03895372|454642940|FG006|Investigational Treatment Period|Adverse Event|4|||
126045760|NCT02720068|453467145|FG008|Overall Study|Death|3|||
126045761|NCT02720068|453467146|FG009|Overall Study|Death|1|||
126045762|NCT02720068|453467147|FG010|Overall Study|Death|20|||
126045763|NCT02720068|453467148|FG011|Overall Study|Death|166|||
126304827|NCT03691207|454405520|FG000|Overall Study|Lost to Follow-up|1|||
126368298|NCT03895372|454642941|FG007|Investigational Treatment Period|Adverse Event|3|||
126045764|NCT02720068|453467149|FG012|Overall Study|Death|34|||
126045765|NCT02720068|453467150|FG013|Overall Study|Death|30|||
126045766|NCT02720068|453467151|FG014|Overall Study|Death|45|||
126045767|NCT02720068|453467152|FG015|Overall Study|Death|16|||
126045768|NCT02720068|453467153|FG016|Overall Study|Death|20|||
126045769|NCT02720068|453467154|FG017|Overall Study|Death|28|||
126045770|NCT02720068|453467137|FG000|Overall Study|Lost to Follow-up|0|||
126045771|NCT02720068|453467138|FG001|Overall Study|Lost to Follow-up|0|||
126045772|NCT02720068|453467139|FG002|Overall Study|Lost to Follow-up|0|||
126045773|NCT02720068|453467140|FG003|Overall Study|Lost to Follow-up|0|||
126045774|NCT02720068|453467141|FG004|Overall Study|Lost to Follow-up|0|||
126045775|NCT02720068|453467142|FG005|Overall Study|Lost to Follow-up|0|||
126045776|NCT02720068|453467143|FG006|Overall Study|Lost to Follow-up|0|||
126045777|NCT02720068|453467144|FG007|Overall Study|Lost to Follow-up|0|||
126045778|NCT02720068|453467145|FG008|Overall Study|Lost to Follow-up|0|||
126045779|NCT02720068|453467146|FG009|Overall Study|Lost to Follow-up|0|||
126045780|NCT02720068|453467147|FG010|Overall Study|Lost to Follow-up|0|||
126045781|NCT02720068|453467148|FG011|Overall Study|Lost to Follow-up|1|||
126045782|NCT02720068|453467149|FG012|Overall Study|Lost to Follow-up|0|||
126045783|NCT02720068|453467150|FG013|Overall Study|Lost to Follow-up|1|||
126045784|NCT02720068|453467151|FG014|Overall Study|Lost to Follow-up|2|||
126045785|NCT02720068|453467152|FG015|Overall Study|Lost to Follow-up|0|||
126045786|NCT02720068|453467153|FG016|Overall Study|Lost to Follow-up|0|||
126045787|NCT02720068|453467154|FG017|Overall Study|Lost to Follow-up|1|||
126045788|NCT02720068|453467137|FG000|Overall Study|Physician Decision|0|||
126045789|NCT02720068|453467138|FG001|Overall Study|Physician Decision|0|||
126368299|NCT03895372|454642934|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
126045790|NCT02720068|453467139|FG002|Overall Study|Physician Decision|0|||
126045791|NCT02720068|453467140|FG003|Overall Study|Physician Decision|1|||
126045792|NCT02720068|453467141|FG004|Overall Study|Physician Decision|0|||
126045793|NCT02720068|453467142|FG005|Overall Study|Physician Decision|0|||
126368300|NCT03895372|454642935|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
126368301|NCT03895372|454642936|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
126368302|NCT03895372|454642937|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
126368303|NCT03895372|454642938|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
126368304|NCT03895372|454642939|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
126368305|NCT03895372|454642940|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
126368306|NCT03895372|454642941|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
126368307|NCT03895372|454642934|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
126368308|NCT03895372|454642935|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
126368309|NCT03895372|454642936|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
126368310|NCT03895372|454642937|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
126368311|NCT03895372|454642938|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
126368312|NCT03895372|454642939|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
126368313|NCT03895372|454642940|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
126368314|NCT03895372|454642941|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
126368315|NCT03895372|454642934|FG000|Investigational Treatment Period|Other|0|||
126368316|NCT03895372|454642935|FG001|Investigational Treatment Period|Other|0|||
126368317|NCT03895372|454642936|FG002|Investigational Treatment Period|Other|0|||
126368318|NCT03895372|454642937|FG003|Investigational Treatment Period|Other|0|||
126368319|NCT03895372|454642938|FG004|Investigational Treatment Period|Other|0|||
126368320|NCT03895372|454642939|FG005|Investigational Treatment Period|Other|1|||
126368321|NCT03895372|454642940|FG006|Investigational Treatment Period|Other|0|||
126368322|NCT03895372|454642941|FG007|Investigational Treatment Period|Other|2|||
126368323|NCT03895372|454642934|FG000|Investigational Treatment Period|Protocol Violation|0|||
126368324|NCT03895372|454642935|FG001|Investigational Treatment Period|Protocol Violation|0|||
126368325|NCT03895372|454642936|FG002|Investigational Treatment Period|Protocol Violation|0|||
126368326|NCT03895372|454642937|FG003|Investigational Treatment Period|Protocol Violation|1|||
126368327|NCT03895372|454642938|FG004|Investigational Treatment Period|Protocol Violation|0|||
126368328|NCT03895372|454642939|FG005|Investigational Treatment Period|Protocol Violation|0|||
126368329|NCT03895372|454642940|FG006|Investigational Treatment Period|Protocol Violation|0|||
126368330|NCT03895372|454642941|FG007|Investigational Treatment Period|Protocol Violation|0|||
126368331|NCT03895372|454642934|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
126368332|NCT03895372|454642935|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
126368333|NCT03895372|454642936|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
126368334|NCT03895372|454642937|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
126368335|NCT03895372|454642938|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
126368336|NCT03895372|454642939|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
126045794|NCT02720068|453467143|FG006|Overall Study|Physician Decision|0|||
126045795|NCT02720068|453467144|FG007|Overall Study|Physician Decision|0|||
126045796|NCT02720068|453467145|FG008|Overall Study|Physician Decision|0|||
126045797|NCT02720068|453467146|FG009|Overall Study|Physician Decision|0|||
126045798|NCT02720068|453467147|FG010|Overall Study|Physician Decision|0|||
126045799|NCT02720068|453467148|FG011|Overall Study|Physician Decision|1|||
126045800|NCT02720068|453467149|FG012|Overall Study|Physician Decision|0|||
126045801|NCT02720068|453467150|FG013|Overall Study|Physician Decision|0|||
126045802|NCT02720068|453467151|FG014|Overall Study|Physician Decision|0|||
126045803|NCT02720068|453467152|FG015|Overall Study|Physician Decision|0|||
126045804|NCT02720068|453467153|FG016|Overall Study|Physician Decision|0|||
126045805|NCT02720068|453467154|FG017|Overall Study|Physician Decision|1|||
126045806|NCT02720068|453467137|FG000|Overall Study|Progressive Disease|2|||
126045807|NCT02720068|453467138|FG001|Overall Study|Progressive Disease|3|||
126045808|NCT02720068|453467139|FG002|Overall Study|Progressive Disease|1|||
126045809|NCT02720068|453467140|FG003|Overall Study|Progressive Disease|1|||
126045810|NCT02720068|453467141|FG004|Overall Study|Progressive Disease|1|||
126045811|NCT02720068|453467142|FG005|Overall Study|Progressive Disease|2|||
126045812|NCT02720068|453467143|FG006|Overall Study|Progressive Disease|1|||
126045813|NCT02720068|453467144|FG007|Overall Study|Progressive Disease|1|||
126045814|NCT02720068|453467145|FG008|Overall Study|Progressive Disease|0|||
126045815|NCT02720068|453467146|FG009|Overall Study|Progressive Disease|1|||
126045816|NCT02720068|453467147|FG010|Overall Study|Progressive Disease|0|||
126045817|NCT02720068|453467148|FG011|Overall Study|Progressive Disease|4|||
126045818|NCT02720068|453467149|FG012|Overall Study|Progressive Disease|1|||
126045819|NCT02720068|453467150|FG013|Overall Study|Progressive Disease|0|||
126045820|NCT02720068|453467151|FG014|Overall Study|Progressive Disease|0|||
126045821|NCT02720068|453467152|FG015|Overall Study|Progressive Disease|0|||
126045822|NCT02720068|453467153|FG016|Overall Study|Progressive Disease|0|||
126045823|NCT02720068|453467154|FG017|Overall Study|Progressive Disease|0|||
126045824|NCT02720068|453467137|FG000|Overall Study|Sponsor Decision|0|||
126045825|NCT02720068|453467138|FG001|Overall Study|Sponsor Decision|0|||
126045826|NCT02720068|453467139|FG002|Overall Study|Sponsor Decision|0|||
126045827|NCT02720068|453467140|FG003|Overall Study|Sponsor Decision|0|||
126045828|NCT02720068|453467141|FG004|Overall Study|Sponsor Decision|0|||
126045829|NCT02720068|453467142|FG005|Overall Study|Sponsor Decision|0|||
126045830|NCT02720068|453467143|FG006|Overall Study|Sponsor Decision|0|||
126045831|NCT02720068|453467144|FG007|Overall Study|Sponsor Decision|0|||
126045832|NCT02720068|453467145|FG008|Overall Study|Sponsor Decision|0|||
126045833|NCT02720068|453467146|FG009|Overall Study|Sponsor Decision|0|||
126045834|NCT02720068|453467147|FG010|Overall Study|Sponsor Decision|0|||
126045835|NCT02720068|453467148|FG011|Overall Study|Sponsor Decision|6|||
126045836|NCT02720068|453467149|FG012|Overall Study|Sponsor Decision|3|||
126045837|NCT02720068|453467150|FG013|Overall Study|Sponsor Decision|2|||
126045838|NCT02720068|453467151|FG014|Overall Study|Sponsor Decision|4|||
126045839|NCT02720068|453467152|FG015|Overall Study|Sponsor Decision|4|||
126045840|NCT02720068|453467153|FG016|Overall Study|Sponsor Decision|0|||
126045841|NCT02720068|453467154|FG017|Overall Study|Sponsor Decision|8|||
126045842|NCT02720068|453467137|FG000|Overall Study|Withdrawal by Subject|0|||
126045843|NCT02720068|453467138|FG001|Overall Study|Withdrawal by Subject|0|||
126045844|NCT02720068|453467139|FG002|Overall Study|Withdrawal by Subject|0|||
126045845|NCT02720068|453467140|FG003|Overall Study|Withdrawal by Subject|0|||
126045846|NCT02720068|453467141|FG004|Overall Study|Withdrawal by Subject|0|||
126045847|NCT02720068|453467142|FG005|Overall Study|Withdrawal by Subject|0|||
126045848|NCT02720068|453467143|FG006|Overall Study|Withdrawal by Subject|0|||
126045849|NCT02720068|453467144|FG007|Overall Study|Withdrawal by Subject|0|||
126045850|NCT02720068|453467145|FG008|Overall Study|Withdrawal by Subject|0|||
126045851|NCT02720068|453467146|FG009|Overall Study|Withdrawal by Subject|1|||
126045852|NCT02720068|453467147|FG010|Overall Study|Withdrawal by Subject|0|||
126368337|NCT03895372|454642940|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
126368338|NCT03895372|454642941|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
126368339|NCT03895372|454642934|FG000|Extension Treatment Period|Adverse Event|0|||
126368340|NCT03895372|454642935|FG001|Extension Treatment Period|Adverse Event|1|||
126368341|NCT03895372|454642936|FG002|Extension Treatment Period|Adverse Event|0|||
126368342|NCT03895372|454642937|FG003|Extension Treatment Period|Adverse Event|1|||
126368343|NCT03895372|454642938|FG004|Extension Treatment Period|Adverse Event|0|||
126368344|NCT03895372|454642939|FG005|Extension Treatment Period|Adverse Event|0|||
126368345|NCT03895372|454642940|FG006|Extension Treatment Period|Adverse Event|3|||
126368346|NCT03895372|454642941|FG007|Extension Treatment Period|Adverse Event|3|||
126368347|NCT03895372|454642934|FG000|Extension Treatment Period|Other|1|||
126368348|NCT03895372|454642935|FG001|Extension Treatment Period|Other|3|||
126368349|NCT03895372|454642936|FG002|Extension Treatment Period|Other|0|||
126368350|NCT03895372|454642937|FG003|Extension Treatment Period|Other|0|||
126368351|NCT03895372|454642938|FG004|Extension Treatment Period|Other|1|||
126368352|NCT03895372|454642939|FG005|Extension Treatment Period|Other|0|||
126368353|NCT03895372|454642940|FG006|Extension Treatment Period|Other|0|||
126368354|NCT03895372|454642941|FG007|Extension Treatment Period|Other|2|||
126368355|NCT03895372|454642934|FG000|Extension Treatment Period|Pregnancy|0|||
126368356|NCT03895372|454642935|FG001|Extension Treatment Period|Pregnancy|0|||
126368357|NCT03895372|454642936|FG002|Extension Treatment Period|Pregnancy|0|||
126368358|NCT03895372|454642937|FG003|Extension Treatment Period|Pregnancy|0|||
126368359|NCT03895372|454642938|FG004|Extension Treatment Period|Pregnancy|1|||
126368360|NCT03895372|454642939|FG005|Extension Treatment Period|Pregnancy|0|||
126368361|NCT03895372|454642940|FG006|Extension Treatment Period|Pregnancy|0|||
126368362|NCT03895372|454642941|FG007|Extension Treatment Period|Pregnancy|0|||
125884964|NCT05567783|452875116|FG002|Overall Study|Physician Decision|9|||
125884965|NCT05567783|452875114|FG000|Overall Study|Study Terminated by Sponsor|924|||
125884966|NCT05567783|452875115|FG001|Overall Study|Study Terminated by Sponsor|937|||
125884967|NCT05567783|452875116|FG002|Overall Study|Study Terminated by Sponsor|941|||
125884968|NCT05567783|452875114|FG000|Overall Study|Withdrawal by Subject|23|||
125884969|NCT05567783|452875115|FG001|Overall Study|Withdrawal by Subject|27|||
125884970|NCT05567783|452875116|FG002|Overall Study|Withdrawal by Subject|24|||
125884971|NCT05567783|452875114|FG000|Overall Study|Incarcerated|1|||
125884972|NCT05567783|452875115|FG001|Overall Study|Incarcerated|0|||
125884973|NCT05567783|452875116|FG002|Overall Study|Incarcerated|0|||
125884974|NCT05567783|452875114|FG000|Overall Study|Participant randomized in error|4|||
125884975|NCT05567783|452875115|FG001|Overall Study|Participant randomized in error|2|||
125884976|NCT05567783|452875116|FG002|Overall Study|Participant randomized in error|2|||
125884977|NCT03944577|452875124|FG000|Overall Study|Adverse Event|3|||
125884978|NCT00949702|452875129|FG000|Overall Study|Death|40|||
125884979|NCT00949702|452875129|FG000|Overall Study|Disease progression|7|||
125884980|NCT00949702|452875129|FG000|Overall Study|Withdrawal of consent|1|||
125884981|NCT01654302|452875130|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
125884982|NCT01654302|452875131|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
125884983|NCT00630838|452875136|FG000|Overall Study|Death|0|||
126368363|NCT03895372|454642934|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
126368364|NCT03895372|454642935|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
126368365|NCT03895372|454642936|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
126368366|NCT03895372|454642937|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
126368367|NCT03895372|454642938|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
126368368|NCT03895372|454642939|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
126368369|NCT03895372|454642940|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
126368370|NCT03895372|454642941|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
126368371|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
126368372|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
126368373|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
126368374|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
126368375|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
125884984|NCT00630838|452875137|FG001|Overall Study|Death|1|||
125884985|NCT00630838|452875136|FG000|Overall Study|Lost to Follow-up|0|||
126368376|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
126368377|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
125884986|NCT00630838|452875137|FG001|Overall Study|Lost to Follow-up|1|||
125884987|NCT00670748|452875138|FG000|Overall Study|Death during treatment|1|||
126304828|NCT03691207|454405521|FG001|Overall Study|Lost to Follow-up|1|||
126304829|NCT03691207|454405520|FG000|Overall Study|Withdrawal by Subject|2|||
126304830|NCT03691207|454405521|FG001|Overall Study|Withdrawal by Subject|8|||
126045853|NCT02720068|453467148|FG011|Overall Study|Withdrawal by Subject|27|||
126045854|NCT02720068|453467149|FG012|Overall Study|Withdrawal by Subject|2|||
126304831|NCT03691207|454405520|FG000|Overall Study|Sponsor decision|1|||
126304832|NCT03691207|454405521|FG001|Overall Study|Sponsor decision|7|||
126304833|NCT01736397|454405522|FG000|Overall Study|Lack of Efficacy|1|||
126304834|NCT01736397|454405523|FG001|Overall Study|Lack of Efficacy|11|||
126304835|NCT01736397|454405522|FG000|Overall Study|Withdrawal by Subject|6|||
126045855|NCT02720068|453467150|FG013|Overall Study|Withdrawal by Subject|8|||
126045856|NCT02720068|453467151|FG014|Overall Study|Withdrawal by Subject|7|||
126045857|NCT02720068|453467152|FG015|Overall Study|Withdrawal by Subject|0|||
126045858|NCT02720068|453467153|FG016|Overall Study|Withdrawal by Subject|0|||
126045859|NCT02720068|453467154|FG017|Overall Study|Withdrawal by Subject|2|||
126045860|NCT02720068|453467137|FG000|Overall Study|Protocol Violation|0|||
126045861|NCT02720068|453467138|FG001|Overall Study|Protocol Violation|0|||
126045862|NCT02720068|453467139|FG002|Overall Study|Protocol Violation|0|||
126045863|NCT02720068|453467140|FG003|Overall Study|Protocol Violation|0|||
126045864|NCT02720068|453467141|FG004|Overall Study|Protocol Violation|0|||
126045865|NCT02720068|453467142|FG005|Overall Study|Protocol Violation|0|||
126045866|NCT02720068|453467143|FG006|Overall Study|Protocol Violation|0|||
126045867|NCT02720068|453467144|FG007|Overall Study|Protocol Violation|0|||
126304836|NCT01736397|454405523|FG001|Overall Study|Withdrawal by Subject|5|||
126304837|NCT01736397|454405522|FG000|Overall Study|Lost to Follow-up|0|||
126045868|NCT02720068|453467145|FG008|Overall Study|Protocol Violation|0|||
126045869|NCT02720068|453467146|FG009|Overall Study|Protocol Violation|0|||
126045870|NCT02720068|453467147|FG010|Overall Study|Protocol Violation|1|||
126045871|NCT02720068|453467148|FG011|Overall Study|Protocol Violation|0|||
126045872|NCT02720068|453467149|FG012|Overall Study|Protocol Violation|0|||
126045873|NCT02720068|453467150|FG013|Overall Study|Protocol Violation|0|||
126045874|NCT02720068|453467151|FG014|Overall Study|Protocol Violation|1|||
126045875|NCT02720068|453467152|FG015|Overall Study|Protocol Violation|0|||
126045876|NCT02720068|453467153|FG016|Overall Study|Protocol Violation|1|||
126045877|NCT02720068|453467154|FG017|Overall Study|Protocol Violation|0|||
126045878|NCT04227899|453467156|FG000|Overall Study|Withdrawal by Subject|6|||
126045879|NCT04227899|453467157|FG001|Overall Study|Withdrawal by Subject|3|||
126045880|NCT04227899|453467156|FG000|Overall Study|Death|12|||
126045881|NCT04227899|453467157|FG001|Overall Study|Death|6|||
126045882|NCT04227899|453467156|FG000|Overall Study|Lost to Follow-up|2|||
126045883|NCT04227899|453467157|FG001|Overall Study|Lost to Follow-up|1|||
126045884|NCT04664881|453467159|FG000|Overall Study|Withdrawal by Subject|1|||
126045885|NCT04664881|453467160|FG001|Overall Study|Withdrawal by Subject|8|||
126045886|NCT04664881|453467159|FG000|Overall Study|Physician Decision|0|||
126045887|NCT04664881|453467160|FG001|Overall Study|Physician Decision|5|||
126045888|NCT04664881|453467159|FG000|Overall Study|Lost to Follow-up|1|||
126045889|NCT04664881|453467160|FG001|Overall Study|Lost to Follow-up|0|||
126045890|NCT02231749|453467163|FG000|Overall Study|Disease progression|229|||
126045891|NCT02231749|453467164|FG001|Overall Study|Disease progression|297|||
126045892|NCT02231749|453467163|FG000|Overall Study|Study Drug Toxicity|134|||
126045893|NCT02231749|453467164|FG001|Overall Study|Study Drug Toxicity|63|||
126045894|NCT02231749|453467163|FG000|Overall Study|Death|1|||
126045895|NCT02231749|453467164|FG001|Overall Study|Death|1|||
126045896|NCT02231749|453467163|FG000|Overall Study|AE unrelated to Study drug|32|||
126045897|NCT02231749|453467164|FG001|Overall Study|AE unrelated to Study drug|31|||
126045898|NCT02231749|453467163|FG000|Overall Study|Participant's request to discontinue|10|||
126045899|NCT02231749|453467164|FG001|Overall Study|Participant's request to discontinue|21|||
126045900|NCT02231749|453467163|FG000|Overall Study|Participant withdrew Consent|8|||
126045901|NCT02231749|453467164|FG001|Overall Study|Participant withdrew Consent|15|||
126045902|NCT02231749|453467163|FG000|Overall Study|Lost to Follow-up|1|||
126045903|NCT02231749|453467164|FG001|Overall Study|Lost to Follow-up|2|||
126045904|NCT02231749|453467163|FG000|Overall Study|Maximum Clinical Benefit|5|||
126045905|NCT02231749|453467164|FG001|Overall Study|Maximum Clinical Benefit|8|||
126045906|NCT02231749|453467163|FG000|Overall Study|Poor/Non-Compliance|0|||
126045907|NCT02231749|453467164|FG001|Overall Study|Poor/Non-Compliance|3|||
126045908|NCT02231749|453467163|FG000|Overall Study|Pregnancy|1|||
126045909|NCT02231749|453467164|FG001|Overall Study|Pregnancy|0|||
126045910|NCT02231749|453467163|FG000|Overall Study|other|0|||
126045911|NCT02231749|453467164|FG001|Overall Study|other|8|||
126045912|NCT02231749|453467163|FG000|Overall Study|No longer meets Study Criteria|1|||
126045913|NCT02231749|453467164|FG001|Overall Study|No longer meets Study Criteria|0|||
126045914|NCT03786926|453467169|FG000|Overall Study|Adverse Event|0|||
126045915|NCT03786926|453467170|FG001|Overall Study|Adverse Event|0|||
126045916|NCT03786926|453467171|FG002|Overall Study|Adverse Event|0|||
126045917|NCT03786926|453467172|FG003|Overall Study|Adverse Event|0|||
126045918|NCT03786926|453467173|FG004|Overall Study|Adverse Event|0|||
126045919|NCT03786926|453467174|FG005|Overall Study|Adverse Event|0|||
126045920|NCT03786926|453467175|FG006|Overall Study|Adverse Event|0|||
126045921|NCT03786926|453467176|FG007|Overall Study|Adverse Event|1|||
126045922|NCT03786926|453467177|FG008|Overall Study|Adverse Event|1|||
126045923|NCT03786926|453467178|FG009|Overall Study|Adverse Event|0|||
126045924|NCT03786926|453467179|FG010|Overall Study|Adverse Event|1|||
126045925|NCT03786926|453467169|FG000|Overall Study|Progressive disease|3|||
126045926|NCT03786926|453467170|FG001|Overall Study|Progressive disease|0|||
126045927|NCT03786926|453467171|FG002|Overall Study|Progressive disease|3|||
126045928|NCT03786926|453467172|FG003|Overall Study|Progressive disease|1|||
126045929|NCT03786926|453467173|FG004|Overall Study|Progressive disease|2|||
126045930|NCT03786926|453467174|FG005|Overall Study|Progressive disease|2|||
126045931|NCT03786926|453467175|FG006|Overall Study|Progressive disease|1|||
126045932|NCT03786926|453467176|FG007|Overall Study|Progressive disease|6|||
126045933|NCT03786926|453467177|FG008|Overall Study|Progressive disease|1|||
126045934|NCT03786926|453467178|FG009|Overall Study|Progressive disease|1|||
126045935|NCT03786926|453467179|FG010|Overall Study|Progressive disease|1|||
126045936|NCT03786926|453467169|FG000|Overall Study|Death|0|||
126045937|NCT03786926|453467170|FG001|Overall Study|Death|1|||
126045938|NCT03786926|453467171|FG002|Overall Study|Death|1|||
126045939|NCT03786926|453467172|FG003|Overall Study|Death|0|||
126045940|NCT03786926|453467173|FG004|Overall Study|Death|0|||
126045941|NCT03786926|453467174|FG005|Overall Study|Death|0|||
126045942|NCT03786926|453467175|FG006|Overall Study|Death|0|||
126045943|NCT03786926|453467176|FG007|Overall Study|Death|0|||
126045944|NCT03786926|453467177|FG008|Overall Study|Death|0|||
126045945|NCT03786926|453467178|FG009|Overall Study|Death|1|||
126045946|NCT03786926|453467179|FG010|Overall Study|Death|2|||
126045947|NCT03786926|453467169|FG000|Overall Study|Physician Decision|0|||
126045948|NCT03786926|453467170|FG001|Overall Study|Physician Decision|1|||
126045949|NCT03786926|453467171|FG002|Overall Study|Physician Decision|0|||
126045950|NCT03786926|453467172|FG003|Overall Study|Physician Decision|1|||
126045951|NCT03786926|453467173|FG004|Overall Study|Physician Decision|2|||
126045952|NCT03786926|453467174|FG005|Overall Study|Physician Decision|0|||
126045953|NCT03786926|453467175|FG006|Overall Study|Physician Decision|0|||
126045954|NCT03786926|453467176|FG007|Overall Study|Physician Decision|2|||
126045955|NCT03786926|453467177|FG008|Overall Study|Physician Decision|1|||
126045956|NCT03786926|453467178|FG009|Overall Study|Physician Decision|1|||
126045957|NCT03786926|453467179|FG010|Overall Study|Physician Decision|0|||
126045958|NCT03786926|453467169|FG000|Overall Study|Withdrawal by Subject|0|||
126045959|NCT03786926|453467170|FG001|Overall Study|Withdrawal by Subject|1|||
126045960|NCT03786926|453467171|FG002|Overall Study|Withdrawal by Subject|1|||
126045961|NCT03786926|453467172|FG003|Overall Study|Withdrawal by Subject|0|||
126045962|NCT03786926|453467173|FG004|Overall Study|Withdrawal by Subject|0|||
126045963|NCT03786926|453467174|FG005|Overall Study|Withdrawal by Subject|0|||
126045964|NCT03786926|453467175|FG006|Overall Study|Withdrawal by Subject|1|||
126045965|NCT03786926|453467176|FG007|Overall Study|Withdrawal by Subject|0|||
126045966|NCT03786926|453467177|FG008|Overall Study|Withdrawal by Subject|1|||
126045967|NCT03786926|453467178|FG009|Overall Study|Withdrawal by Subject|0|||
126045968|NCT03786926|453467179|FG010|Overall Study|Withdrawal by Subject|1|||
126045969|NCT03786926|453467169|FG000|Overall Study|Study terminated by Sponsor|0|||
126045970|NCT03786926|453467170|FG001|Overall Study|Study terminated by Sponsor|0|||
126045971|NCT03786926|453467171|FG002|Overall Study|Study terminated by Sponsor|0|||
126045972|NCT03786926|453467172|FG003|Overall Study|Study terminated by Sponsor|0|||
126045973|NCT03786926|453467173|FG004|Overall Study|Study terminated by Sponsor|1|||
126304838|NCT01736397|454405523|FG001|Overall Study|Lost to Follow-up|1|||
126304839|NCT01736397|454405522|FG000|Overall Study|Adverse Event|6|||
126304840|NCT01736397|454405523|FG001|Overall Study|Adverse Event|3|||
126045974|NCT03786926|453467174|FG005|Overall Study|Study terminated by Sponsor|0|||
126304841|NCT01736397|454405522|FG000|Overall Study|Not stated|1|||
126304842|NCT01736397|454405523|FG001|Overall Study|Not stated|4|||
126304843|NCT02448537|454405528|FG000|Overall Study|Withdrawal by Subject|1|||
126304844|NCT02448537|454405529|FG001|Overall Study|Withdrawal by Subject|1|||
126304845|NCT02448537|454405530|FG002|Overall Study|Withdrawal by Subject|1|||
126304846|NCT04696055|454405534|FG000|Overall Study|Adverse Event|10|||
126304847|NCT04696055|454405535|FG001|Overall Study|Adverse Event|2|||
126304848|NCT04696055|454405534|FG000|Overall Study|Death|4|||
126304849|NCT04696055|454405535|FG001|Overall Study|Death|0|||
126304850|NCT04696055|454405534|FG000|Overall Study|Other|7|||
126304851|NCT04696055|454405535|FG001|Overall Study|Other|2|||
126304852|NCT04696055|454405534|FG000|Overall Study|Physician Decision|3|||
126304853|NCT04696055|454405535|FG001|Overall Study|Physician Decision|0|||
126304854|NCT04696055|454405534|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
126304855|NCT04696055|454405535|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
126304856|NCT04696055|454405534|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
126304857|NCT04696055|454405535|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
126045975|NCT03786926|453467175|FG006|Overall Study|Study terminated by Sponsor|0|||
126045976|NCT03786926|453467176|FG007|Overall Study|Study terminated by Sponsor|4|||
126045977|NCT03786926|453467177|FG008|Overall Study|Study terminated by Sponsor|0|||
126045978|NCT03786926|453467178|FG009|Overall Study|Study terminated by Sponsor|0|||
126045979|NCT03786926|453467179|FG010|Overall Study|Study terminated by Sponsor|0|||
126045980|NCT03786926|453467169|FG000|Overall Study|Anti-neoplasm treatment|0|||
126304858|NCT04696055|454405534|FG000|Overall Study|Subject Decision|1|||
126304859|NCT04696055|454405535|FG001|Overall Study|Subject Decision|2|||
126304860|NCT04411810|454405536|FG000|Overall Study|Screen failure|1|||
126304861|NCT04411810|454405536|FG000|Overall Study|Withdrawal by Subject|1|||
126045981|NCT03786926|453467170|FG001|Overall Study|Anti-neoplasm treatment|0|||
126045982|NCT03786926|453467171|FG002|Overall Study|Anti-neoplasm treatment|0|||
126304862|NCT01920958|454405537|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
126368378|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
126368379|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
126368380|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
126368381|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
126368382|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
126368383|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
126368384|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
126368385|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
126368386|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
126368387|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
126368388|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
126368389|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
126368390|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
126368391|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
126368392|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
126368393|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
126368394|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
126368395|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
126368396|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
126368397|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
126368398|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
126368399|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
126368400|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
126368401|NCT03093415|454642942|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
126368402|NCT03093415|454642943|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
126368403|NCT03093415|454642944|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
126368404|NCT03331354|454642945|FG000|Overall Study|Withdrawal by Subject|1|||
126368405|NCT03331354|454642946|FG001|Overall Study|Withdrawal by Subject|3|||
126368406|NCT03331354|454642945|FG000|Overall Study|Lost to Follow-up|3|||
126368407|NCT03331354|454642946|FG001|Overall Study|Lost to Follow-up|3|||
126368408|NCT03331354|454642945|FG000|Overall Study|Found employment before initiated active intervention|0|||
126368409|NCT03331354|454642946|FG001|Overall Study|Found employment before initiated active intervention|4|||
126368410|NCT05889468|454642953|FG000|Overall Study|Lost to Follow-up|9|||
126368411|NCT05889468|454642954|FG001|Overall Study|Lost to Follow-up|2|||
126368412|NCT05889468|454642953|FG000|Overall Study|Withdrawal by Subject|2|||
126368413|NCT05889468|454642954|FG001|Overall Study|Withdrawal by Subject|2|||
126368414|NCT01309230|454642955|FG000|Overall Study|Withdrawal by Subject|0|||
126368415|NCT01309230|454642956|FG001|Overall Study|Withdrawal by Subject|2|||
126368416|NCT01309230|454642955|FG000|Overall Study|Observation arm closed|0|||
126368417|NCT01309230|454642956|FG001|Overall Study|Observation arm closed|2|||
126368418|NCT03900650|454642961|FG000|Overall Study|Withdrawal by Subject|1|||
126368419|NCT03900650|454642962|FG001|Overall Study|Withdrawal by Subject|1|||
126368420|NCT03900650|454642963|FG002|Overall Study|Withdrawal by Subject|0|||
126368421|NCT03900650|454642964|FG003|Overall Study|Withdrawal by Subject|0|||
126368422|NCT03900650|454642961|FG000|Overall Study|Withdrawn by staff|1|||
126368423|NCT03900650|454642962|FG001|Overall Study|Withdrawn by staff|0|||
126368424|NCT03900650|454642963|FG002|Overall Study|Withdrawn by staff|0|||
126368425|NCT03900650|454642964|FG003|Overall Study|Withdrawn by staff|0|||
126368426|NCT00427700|454642965|FG000|Overall Study|Lost to Follow-up|2|||
126368427|NCT00427700|454642966|FG001|Overall Study|Lost to Follow-up|5|||
126368428|NCT00427700|454642965|FG000|Overall Study|no induction of menses|1|||
126368429|NCT00427700|454642966|FG001|Overall Study|no induction of menses|4|||
126045983|NCT03786926|453467172|FG003|Overall Study|Anti-neoplasm treatment|0|||
126045984|NCT03786926|453467173|FG004|Overall Study|Anti-neoplasm treatment|1|||
126045985|NCT03786926|453467174|FG005|Overall Study|Anti-neoplasm treatment|0|||
126045986|NCT03786926|453467175|FG006|Overall Study|Anti-neoplasm treatment|1|||
126045987|NCT03786926|453467176|FG007|Overall Study|Anti-neoplasm treatment|0|||
126045988|NCT03786926|453467177|FG008|Overall Study|Anti-neoplasm treatment|0|||
126045989|NCT03786926|453467178|FG009|Overall Study|Anti-neoplasm treatment|0|||
126045990|NCT03786926|453467179|FG010|Overall Study|Anti-neoplasm treatment|0|||
126368430|NCT00427700|454642965|FG000|Overall Study|Pregnancy|0|||
126045991|NCT03786926|453467169|FG000|Overall Study|Other|0|||
126368431|NCT00427700|454642966|FG001|Overall Study|Pregnancy|2|||
126045992|NCT03786926|453467170|FG001|Overall Study|Other|0|||
126045993|NCT03786926|453467171|FG002|Overall Study|Other|0|||
126045994|NCT03786926|453467172|FG003|Overall Study|Other|1|||
126368432|NCT04581395|454642967|FG000|Overall Study|Protocol Violation|4|||
126368433|NCT04581395|454642968|FG001|Overall Study|Protocol Violation|3|||
126368434|NCT04581395|454642969|FG002|Overall Study|Protocol Violation|2|||
126368435|NCT04581395|454642967|FG000|Overall Study|Physician Decision|0|||
126368436|NCT04581395|454642968|FG001|Overall Study|Physician Decision|1|||
126368437|NCT04581395|454642969|FG002|Overall Study|Physician Decision|0|||
126368438|NCT00815633|454642972|FG000|Overall Study|study terminated|1|||
126368439|NCT00721110|454642973|FG000|Overall Study|Ultram use|1|||
126368440|NCT00721110|454642974|FG001|Overall Study|Ultram use|0|||
126368441|NCT00721110|454642975|FG002|Overall Study|Ultram use|0|||
126368442|NCT00721110|454642976|FG003|Overall Study|Ultram use|0|||
126368443|NCT00721110|454642973|FG000|Overall Study|vertical incision|0|||
126368444|NCT00721110|454642974|FG001|Overall Study|vertical incision|0|||
126368445|NCT00721110|454642975|FG002|Overall Study|vertical incision|1|||
126368446|NCT00721110|454642976|FG003|Overall Study|vertical incision|0|||
126368447|NCT01554904|454642977|FG000|Overall Study|Withdrawal by Subject|3|||
126368448|NCT01554904|454642977|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
126368449|NCT01605097|454642978|FG000|Overall Study|Protocol Violation|1|||
126368450|NCT02038647|454642979|FG000|Overall Study|Progressive Disease|50|||
126368451|NCT02038647|454642980|FG001|Overall Study|Progressive Disease|59|||
126368452|NCT02038647|454642979|FG000|Overall Study|Adverse Event|18|||
126368453|NCT02038647|454642980|FG001|Overall Study|Adverse Event|10|||
126368454|NCT02038647|454642979|FG000|Overall Study|Symptomatic Deterioration|7|||
126368455|NCT02038647|454642980|FG001|Overall Study|Symptomatic Deterioration|7|||
126368456|NCT02038647|454642979|FG000|Overall Study|Withdrawal by Subject|5|||
126368457|NCT02038647|454642980|FG001|Overall Study|Withdrawal by Subject|2|||
126368458|NCT02038647|454642979|FG000|Overall Study|Not Reported|0|||
126368459|NCT02038647|454642980|FG001|Overall Study|Not Reported|1|||
126368460|NCT02038647|454642979|FG000|Overall Study|Ongoing at Datacut|9|||
126368461|NCT02038647|454642980|FG001|Overall Study|Ongoing at Datacut|10|||
126368462|NCT02757430|454642981|FG000|Overall Study|Physician Decision|6|||
126368463|NCT02757430|454642981|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
126368464|NCT02757430|454642981|FG000|Overall Study|No informed consent|1|||
126368465|NCT02757430|454642981|FG000|Overall Study|No procedure performed|2|||
126368466|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
126368467|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
126368468|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
126368469|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
126368470|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
126368471|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
126368472|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
126368473|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
126368474|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
126368475|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
126368476|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368477|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368478|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368479|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368480|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368481|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368482|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368483|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
126368484|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368485|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368486|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368487|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368488|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368489|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368490|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368491|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
126368492|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368493|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368494|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368495|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368496|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368497|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368498|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368499|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368500|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
126368501|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
126368502|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
126368503|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
126368504|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
126368505|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368506|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368507|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368508|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368509|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368510|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368511|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368512|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368513|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
126368514|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368515|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368516|NCT05852340|454642994|FG000|Period 5|Not completing the meal|0|||
126368517|NCT05852340|454642995|FG001|Period 5|Not completing the meal|1|||
126368518|NCT05852340|454642996|FG002|Period 5|Not completing the meal|0|||
126368519|NCT05852340|454642997|FG003|Period 5|Not completing the meal|0|||
126368520|NCT05852340|454642994|FG000|Period 5|Adverse Event|0|||
126368521|NCT05852340|454642995|FG001|Period 5|Adverse Event|0|||
126368522|NCT05852340|454642996|FG002|Period 5|Adverse Event|0|||
126368523|NCT05852340|454642997|FG003|Period 5|Adverse Event|1|||
126368524|NCT01903863|454642998|FG000|Overall Study|Physician Decision|2|||
126368525|NCT01903863|454642999|FG001|Overall Study|Physician Decision|0|||
125884988|NCT00670748|452875139|FG001|Overall Study|Death during treatment|1|||
125884989|NCT00670748|452875140|FG002|Overall Study|Death during treatment|1|||
125884990|NCT00670748|452875141|FG003|Overall Study|Death during treatment|0|||
125884991|NCT00670748|452875138|FG000|Overall Study|Not off study|2|||
125884992|NCT00670748|452875139|FG001|Overall Study|Not off study|1|||
125884993|NCT00670748|452875140|FG002|Overall Study|Not off study|1|||
125884994|NCT00670748|452875141|FG003|Overall Study|Not off study|1|||
125884995|NCT03278249|452875148|FG000|Overall Study|Withdrawal by Subject|2|||
126368526|NCT04144517|454643002|FG000|Overall Study|Physician Decision|0|||
126368527|NCT04144517|454643003|FG001|Overall Study|Physician Decision|1|||
126368528|NCT04144517|454643002|FG000|Overall Study|Other|2|||
126368529|NCT04144517|454643003|FG001|Overall Study|Other|2|||
126368530|NCT04144517|454643002|FG000|Overall Study|Death|6|||
126368531|NCT04144517|454643003|FG001|Overall Study|Death|3|||
126368532|NCT00835367|454643006|FG000|Washout|Adverse Event|2|||
126368533|NCT00835367|454643007|FG001|Washout|Adverse Event|0|||
126368534|NCT00835367|454643006|FG000|Washout|Withdrawal by Subject|1|||
126368535|NCT00835367|454643007|FG001|Washout|Withdrawal by Subject|0|||
126368536|NCT00835367|454643006|FG000|Second Intervention|Adverse Event|1|||
126368537|NCT00835367|454643007|FG001|Second Intervention|Adverse Event|1|||
126368538|NCT00936936|454644352|FG000|Overall Study|Adverse Event|7|||
126368539|NCT00936936|454644353|FG001|Overall Study|Adverse Event|1|||
126368540|NCT00936936|454644352|FG000|Overall Study|Disease Progression|2|||
126368541|NCT00936936|454644353|FG001|Overall Study|Disease Progression|2|||
126368542|NCT00936936|454644352|FG000|Overall Study|Unrelated|3|||
126368543|NCT00936936|454644353|FG001|Overall Study|Unrelated|1|||
126368544|NCT01397253|454644354|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
126368545|NCT01397253|454644355|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
126368546|NCT01892189|454644356|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
126368547|NCT01892189|454644357|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
126368548|NCT01892189|454644358|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
126368549|NCT01892189|454644359|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
126368550|NCT01892189|454644360|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
125884996|NCT03278249|452875148|FG000|Overall Study|Lost to Follow-up|1|||
125884997|NCT00775190|452876750|FG000|Overall Study|Lost to Follow-up|2|||
125884998|NCT00775190|452876751|FG001|Overall Study|Lost to Follow-up|3|||
125884999|NCT00775190|452876750|FG000|Overall Study|Withdrawal by Subject|1|||
125885000|NCT00775190|452876751|FG001|Overall Study|Withdrawal by Subject|2|||
126045995|NCT03786926|453467173|FG004|Overall Study|Other|0|||
126045996|NCT03786926|453467174|FG005|Overall Study|Other|1|||
126045997|NCT03786926|453467175|FG006|Overall Study|Other|0|||
126045998|NCT03786926|453467176|FG007|Overall Study|Other|0|||
126045999|NCT03786926|453467177|FG008|Overall Study|Other|2|||
126368551|NCT01892189|454644361|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
126368552|NCT01892189|454644362|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
126368553|NCT01892189|454644363|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
126368554|NCT01892189|454644364|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
126368555|NCT01892189|454644356|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126368556|NCT01892189|454644357|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126368557|NCT01892189|454644358|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
125885001|NCT00775190|452876750|FG000|Overall Study|Protocol Violation|1|||
125885002|NCT00775190|452876751|FG001|Overall Study|Protocol Violation|0|||
125885003|NCT00904033|452876756|FG000|Overall Study|Withdrawal by Subject|1|||
125885004|NCT00904033|452876757|FG001|Overall Study|Withdrawal by Subject|1|||
126368558|NCT01892189|454644359|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126368559|NCT01892189|454644360|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126046000|NCT03786926|453467178|FG009|Overall Study|Other|0|||
126046001|NCT03786926|453467179|FG010|Overall Study|Other|0|||
126046002|NCT05875701|453467183|FG000|Overall Study|Lost to Follow-up|2|||
125885005|NCT00904033|452876758|FG002|Overall Study|Withdrawal by Subject|0|||
126368560|NCT01892189|454644361|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126368561|NCT01892189|454644362|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126368562|NCT01892189|454644363|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126368563|NCT01892189|454644364|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126368564|NCT01892189|454644356|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368565|NCT01892189|454644357|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368566|NCT01892189|454644358|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368567|NCT01892189|454644359|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368568|NCT01892189|454644360|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368569|NCT01892189|454644361|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
126368570|NCT01892189|454644362|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368571|NCT01892189|454644363|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368572|NCT01892189|454644364|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368573|NCT03440411|454644365|FG000|Overall Study|Adverse Event|0|||
126368574|NCT03440411|454644366|FG001|Overall Study|Adverse Event|0|||
126368575|NCT03440411|454644367|FG002|Overall Study|Adverse Event|1|||
126368576|NCT03440411|454644368|FG003|Overall Study|Adverse Event|0|||
126368577|NCT03440411|454644365|FG000|Overall Study|PD|2|||
126368578|NCT03440411|454644366|FG001|Overall Study|PD|1|||
126368579|NCT03440411|454644367|FG002|Overall Study|PD|1|||
126368580|NCT03440411|454644368|FG003|Overall Study|PD|1|||
126368581|NCT03440411|454644365|FG000|Overall Study|Withdrawal by Subject|1|||
126368582|NCT03440411|454644366|FG001|Overall Study|Withdrawal by Subject|0|||
126368583|NCT03440411|454644367|FG002|Overall Study|Withdrawal by Subject|0|||
126368584|NCT03440411|454644368|FG003|Overall Study|Withdrawal by Subject|0|||
126368585|NCT03440411|454644365|FG000|Overall Study|Closed study by sponsor|0|||
126368586|NCT03440411|454644366|FG001|Overall Study|Closed study by sponsor|0|||
126368587|NCT03440411|454644367|FG002|Overall Study|Closed study by sponsor|0|||
126368588|NCT03440411|454644368|FG003|Overall Study|Closed study by sponsor|1|||
126368589|NCT03322566|454644378|FG000|Overall Study|Death|34|||
126368590|NCT03322566|454644379|FG001|Overall Study|Death|35|||
126368591|NCT03322566|454644380|FG002|Overall Study|Death|23|||
126368592|NCT03322566|454644378|FG000|Overall Study|Physician Decision|6|||
126368593|NCT03322566|454644379|FG001|Overall Study|Physician Decision|7|||
126368594|NCT03322566|454644380|FG002|Overall Study|Physician Decision|2|||
126368595|NCT03322566|454644378|FG000|Overall Study|Withdrawal by Subject|4|||
126368596|NCT03322566|454644379|FG001|Overall Study|Withdrawal by Subject|3|||
126368597|NCT03322566|454644380|FG002|Overall Study|Withdrawal by Subject|6|||
126368598|NCT03322566|454644378|FG000|Overall Study|Lost to Follow-up|0|||
126368599|NCT03322566|454644379|FG001|Overall Study|Lost to Follow-up|0|||
126368600|NCT03322566|454644380|FG002|Overall Study|Lost to Follow-up|1|||
126368601|NCT03322566|454644378|FG000|Overall Study|Study terminated by sponsor|1|||
126368602|NCT03322566|454644379|FG001|Overall Study|Study terminated by sponsor|0|||
126368603|NCT03322566|454644380|FG002|Overall Study|Study terminated by sponsor|1|||
126368604|NCT02546323|454644386|FG000|Overall Study|Withdrawal by Subject|36|||
126368605|NCT02546323|454644387|FG001|Overall Study|Withdrawal by Subject|33|||
126368606|NCT02546323|454644386|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
126368607|NCT02546323|454644387|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
126368608|NCT02546323|454644386|FG000|Overall Study|Adverse Event|17|||
126368609|NCT02546323|454644387|FG001|Overall Study|Adverse Event|11|||
126368610|NCT02546323|454644386|FG000|Overall Study|Patient Specific Reasons|1|||
126368611|NCT02546323|454644387|FG001|Overall Study|Patient Specific Reasons|2|||
126368612|NCT02546323|454644386|FG000|Overall Study|Lost to Follow-up|2|||
126368613|NCT02546323|454644387|FG001|Overall Study|Lost to Follow-up|3|||
126368614|NCT02546323|454644386|FG000|Overall Study|Non-compliance with Study Drug|2|||
126368615|NCT02546323|454644387|FG001|Overall Study|Non-compliance with Study Drug|2|||
126368616|NCT02546323|454644386|FG000|Overall Study|Met Withdrawal Criteria|2|||
126368617|NCT02546323|454644387|FG001|Overall Study|Met Withdrawal Criteria|14|||
126368618|NCT01055028|454644388|FG000|Screening|Screen Failure|1|||
126368619|NCT01055028|454644389|FG001|Screening|Screen Failure|1|||
126368620|NCT01055028|454644388|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
125885006|NCT00904033|452876759|FG003|Overall Study|Withdrawal by Subject|0|||
126368621|NCT01055028|454644389|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
126368622|NCT01055028|454644388|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
126368623|NCT01055028|454644389|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
126368624|NCT01055028|454644388|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
126368625|NCT01055028|454644389|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
126368626|NCT02507934|454644390|FG000|Overall Study|Lost to Follow-up|2|||
126368627|NCT02507934|454644391|FG001|Overall Study|Lost to Follow-up|0|||
126368628|NCT02507934|454644390|FG000|Overall Study|Withdrawal by Subject|2|||
126368629|NCT02507934|454644391|FG001|Overall Study|Withdrawal by Subject|0|||
126368630|NCT03559530|454644392|FG000|Overall Study|non-location of medical records|44|||
126368631|NCT03559530|454644393|FG001|Overall Study|non-location of medical records|0|||
126368632|NCT03559530|454644392|FG000|Overall Study|culture results not considered for treat|29|||
126368633|NCT03559530|454644393|FG001|Overall Study|culture results not considered for treat|0|||
126368634|NCT03559530|454644392|FG000|Overall Study|duplicate cases|8|||
126368635|NCT03559530|454644393|FG001|Overall Study|duplicate cases|0|||
126368636|NCT03559530|454644392|FG000|Overall Study|other species of Acinetobacte|7|||
126046003|NCT05875701|453467184|FG001|Overall Study|Lost to Follow-up|0|||
126046004|NCT05875701|453467183|FG000|Overall Study|Withdrawal by Subject|1|||
126046005|NCT05875701|453467184|FG001|Overall Study|Withdrawal by Subject|1|||
126046006|NCT02989662|453467185|FG000|Overall Study|Lost to Follow-up|0|||
126046007|NCT02989662|453467186|FG001|Overall Study|Lost to Follow-up|0|||
126046008|NCT02989662|453467187|FG002|Overall Study|Lost to Follow-up|0|||
126368637|NCT03559530|454644393|FG001|Overall Study|other species of Acinetobacte|0|||
126368638|NCT03559530|454644392|FG000|Overall Study|contamination / colonization|3|||
126368639|NCT03559530|454644393|FG001|Overall Study|contamination / colonization|0|||
126368640|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
126368641|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368642|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368643|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368644|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368645|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368646|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368647|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
126368648|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
126368649|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
126368650|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
126368651|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
126368652|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
126368653|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
126368654|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
126368655|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
126368656|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
126368657|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
126368658|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
126368659|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
126368660|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
126368661|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
126368662|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
126368663|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
126368664|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
126368665|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
126368666|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
126368667|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
126046009|NCT02989662|453467188|FG003|Overall Study|Lost to Follow-up|2|||
126046010|NCT02989662|453467185|FG000|Overall Study|Physician Decision|3|||
126046011|NCT02989662|453467186|FG001|Overall Study|Physician Decision|0|||
126046012|NCT02989662|453467187|FG002|Overall Study|Physician Decision|0|||
126368668|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
126368669|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
126368670|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
126368671|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
126368672|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
126368673|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
126368674|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
126368675|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
126368676|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
126046013|NCT02989662|453467188|FG003|Overall Study|Physician Decision|0|||
126368677|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
126368678|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
126368679|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
126368680|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
126368681|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
125885007|NCT00904033|452876756|FG000|Overall Study|Physician Decision|0|||
126046014|NCT02989662|453467185|FG000|Overall Study|Withdrawal by Subject|1|||
125885008|NCT00904033|452876757|FG001|Overall Study|Physician Decision|0|||
125885009|NCT00904033|452876758|FG002|Overall Study|Physician Decision|1|||
125885010|NCT00904033|452876759|FG003|Overall Study|Physician Decision|0|||
125885011|NCT00904033|452876756|FG000|Overall Study|Unable to obtain final blood draw|0|||
125885012|NCT00904033|452876757|FG001|Overall Study|Unable to obtain final blood draw|0|||
125885013|NCT00904033|452876758|FG002|Overall Study|Unable to obtain final blood draw|0|||
125885014|NCT00904033|452876759|FG003|Overall Study|Unable to obtain final blood draw|2|||
125885015|NCT01357850|452876760|FG000|Overall Study|Lost to Follow-up|1|||
125885016|NCT01357850|452876761|FG001|Overall Study|Lost to Follow-up|0|||
125885017|NCT01357850|452876762|FG002|Overall Study|Lost to Follow-up|0|||
125885018|NCT01357850|452876763|FG003|Overall Study|Lost to Follow-up|0|||
125885019|NCT01600716|452876766|FG000|Overall Study|Other Reasons|3|||
125885020|NCT01600716|452876767|FG001|Overall Study|Other Reasons|1|||
125885021|NCT01600716|452876766|FG000|Overall Study|Personal Reasons|0|||
125885022|NCT01600716|452876767|FG001|Overall Study|Personal Reasons|2|||
125885023|NCT01600716|452876766|FG000|Overall Study|Lost to Follow-up|0|||
125885024|NCT01600716|452876767|FG001|Overall Study|Lost to Follow-up|2|||
125885025|NCT01600716|452876766|FG000|Overall Study|Pregnancy|1|||
125885026|NCT01600716|452876767|FG001|Overall Study|Pregnancy|0|||
125885027|NCT01600716|452876766|FG000|Overall Study|Lack of Efficacy|2|||
125885028|NCT01600716|452876767|FG001|Overall Study|Lack of Efficacy|1|||
125885029|NCT01600716|452876766|FG000|Overall Study|Adverse Event|1|||
125885030|NCT01600716|452876767|FG001|Overall Study|Adverse Event|1|||
125885031|NCT03349034|452876770|FG000|Overall Study|catheters dislodged during transport|2|||
125885032|NCT03349034|452876771|FG001|Overall Study|catheters dislodged during transport|0|||
125885033|NCT03349034|452876770|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
125885034|NCT03349034|452876771|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
125885035|NCT03349034|452876770|FG000|Overall Study|soft tissue flap used|1|||
125885036|NCT03349034|452876771|FG001|Overall Study|soft tissue flap used|0|||
125885037|NCT03349034|452876770|FG000|Overall Study|Other|0|||
125885038|NCT03349034|452876771|FG001|Overall Study|Other|1|||
125885039|NCT01177397|452876772|FG000|Overall Study|Protocol Violation|0|||
125885040|NCT01177397|452876773|FG001|Overall Study|Protocol Violation|0|||
125885041|NCT01177397|452876774|FG002|Overall Study|Protocol Violation|0|||
125885042|NCT01177397|452876775|FG003|Overall Study|Protocol Violation|0|||
125885043|NCT01177397|452876776|FG004|Overall Study|Protocol Violation|0|||
125885044|NCT01177397|452876777|FG005|Overall Study|Protocol Violation|1|||
125885045|NCT01177397|452876778|FG006|Overall Study|Protocol Violation|0|||
125885046|NCT01177397|452876779|FG007|Overall Study|Protocol Violation|0|||
125885047|NCT01177397|452876780|FG008|Overall Study|Protocol Violation|0|||
125885048|NCT01177397|452876781|FG009|Overall Study|Protocol Violation|0|||
125885049|NCT01177397|452876782|FG010|Overall Study|Protocol Violation|0|||
125885050|NCT01177397|452876783|FG011|Overall Study|Protocol Violation|0|||
125885051|NCT01177397|452876772|FG000|Overall Study|Lost to Follow-up|0|||
125885052|NCT01177397|452876773|FG001|Overall Study|Lost to Follow-up|0|||
125885053|NCT01177397|452876774|FG002|Overall Study|Lost to Follow-up|0|||
125885054|NCT01177397|452876775|FG003|Overall Study|Lost to Follow-up|0|||
125885055|NCT01177397|452876776|FG004|Overall Study|Lost to Follow-up|1|||
125885056|NCT01177397|452876777|FG005|Overall Study|Lost to Follow-up|0|||
125885057|NCT01177397|452876778|FG006|Overall Study|Lost to Follow-up|0|||
125885058|NCT01177397|452876779|FG007|Overall Study|Lost to Follow-up|2|||
125885059|NCT01177397|452876780|FG008|Overall Study|Lost to Follow-up|0|||
125885060|NCT01177397|452876781|FG009|Overall Study|Lost to Follow-up|0|||
125885061|NCT01177397|452876782|FG010|Overall Study|Lost to Follow-up|0|||
125885062|NCT01177397|452876783|FG011|Overall Study|Lost to Follow-up|0|||
125885063|NCT01177397|452876772|FG000|Overall Study|Death|0|||
125885064|NCT01177397|452876773|FG001|Overall Study|Death|0|||
125885065|NCT01177397|452876774|FG002|Overall Study|Death|1|||
125885066|NCT01177397|452876775|FG003|Overall Study|Death|1|||
125885067|NCT01177397|452876776|FG004|Overall Study|Death|0|||
125885068|NCT01177397|452876777|FG005|Overall Study|Death|0|||
125885069|NCT01177397|452876778|FG006|Overall Study|Death|0|||
125885070|NCT01177397|452876779|FG007|Overall Study|Death|5|||
125885071|NCT01177397|452876780|FG008|Overall Study|Death|2|||
125885072|NCT01177397|452876781|FG009|Overall Study|Death|1|||
125885073|NCT01177397|452876782|FG010|Overall Study|Death|0|||
125885074|NCT01177397|452876783|FG011|Overall Study|Death|0|||
125885075|NCT01177397|452876772|FG000|Overall Study|Withdrawal by Subject|0|||
125885076|NCT01177397|452876773|FG001|Overall Study|Withdrawal by Subject|0|||
125885077|NCT01177397|452876774|FG002|Overall Study|Withdrawal by Subject|1|||
125885078|NCT01177397|452876775|FG003|Overall Study|Withdrawal by Subject|1|||
125885079|NCT01177397|452876776|FG004|Overall Study|Withdrawal by Subject|1|||
125885080|NCT01177397|452876777|FG005|Overall Study|Withdrawal by Subject|2|||
125885081|NCT01177397|452876778|FG006|Overall Study|Withdrawal by Subject|0|||
125885082|NCT01177397|452876779|FG007|Overall Study|Withdrawal by Subject|5|||
125885083|NCT01177397|452876780|FG008|Overall Study|Withdrawal by Subject|9|||
125885084|NCT01177397|452876781|FG009|Overall Study|Withdrawal by Subject|1|||
125885085|NCT01177397|452876782|FG010|Overall Study|Withdrawal by Subject|1|||
125885086|NCT01177397|452876783|FG011|Overall Study|Withdrawal by Subject|0|||
125885087|NCT01177397|452876772|FG000|Overall Study|Adverse Event|0|||
126368682|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
126368683|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368684|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368685|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368686|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368687|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368688|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368689|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368690|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
126368691|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368692|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368693|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368694|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368695|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368696|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Death on study|0|||
126368697|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Death on study|0|||
126368698|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Death on study|0|||
126368699|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Death on study|1|||
126368700|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Death on study|0|||
126368701|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Death on study|0|||
126368702|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Death on study|0|||
126368703|NCT01362790|454644396|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
126368704|NCT01362790|454644397|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
126368705|NCT01362790|454644398|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
126368706|NCT01362790|454644399|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
126368707|NCT01362790|454644400|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
126368708|NCT01362790|454644401|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
126368709|NCT01362790|454644402|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
126368710|NCT01362790|454644396|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368711|NCT01362790|454644397|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368712|NCT01362790|454644398|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368713|NCT01362790|454644399|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368714|NCT01362790|454644400|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
126368715|NCT01362790|454644401|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368716|NCT01362790|454644402|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368717|NCT01362790|454644396|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
126368718|NCT01362790|454644397|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
126368719|NCT01362790|454644398|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
126368720|NCT01362790|454644399|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
126368721|NCT01362790|454644400|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
126368722|NCT01362790|454644401|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
126368723|NCT01362790|454644402|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
126368724|NCT02457065|454644403|FG000|Overall Study|Lost to Follow-up|9|||
126368725|NCT02457065|454644404|FG001|Overall Study|Lost to Follow-up|11|||
126368726|NCT05805150|454644406|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
126368727|NCT05805150|454644407|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
126368728|NCT01506726|454644413|FG000|Overall Study|Adverse Event|1|||
126368729|NCT01506726|454644414|FG001|Overall Study|Adverse Event|2|||
126368730|NCT04347538|454644418|FG000|Overall Study|Lost to Follow-up|4|||
126368731|NCT04347538|454644419|FG001|Overall Study|Lost to Follow-up|5|||
126368732|NCT04347538|454644420|FG002|Overall Study|Lost to Follow-up|7|||
126368733|NCT02135133|454644421|FG000|Overall Study|Adverse Event|10|||
126368734|NCT02135133|454644421|FG000|Overall Study|regulatory mandate|5|||
126368735|NCT05081843|454644422|FG000|Overall Study|Lost to Follow-up|135|||
126368736|NCT05081843|454644423|FG001|Overall Study|Lost to Follow-up|145|||
126368737|NCT02303821|454644424|FG000|Overall Study|Withdrawal by Subject|0|||
126368738|NCT02303821|454644425|FG001|Overall Study|Withdrawal by Subject|0|||
126368739|NCT02303821|454644426|FG002|Overall Study|Withdrawal by Subject|0|||
126368740|NCT02303821|454644427|FG003|Overall Study|Withdrawal by Subject|0|||
126368741|NCT02303821|454644428|FG004|Overall Study|Withdrawal by Subject|0|||
126368742|NCT02303821|454644429|FG005|Overall Study|Withdrawal by Subject|0|||
126368743|NCT02303821|454644430|FG006|Overall Study|Withdrawal by Subject|0|||
126368744|NCT02303821|454644431|FG007|Overall Study|Withdrawal by Subject|2|||
126368745|NCT02303821|454644424|FG000|Overall Study|Death|0|||
126368746|NCT02303821|454644425|FG001|Overall Study|Death|2|||
126368747|NCT02303821|454644426|FG002|Overall Study|Death|0|||
126368748|NCT02303821|454644427|FG003|Overall Study|Death|0|||
126368749|NCT02303821|454644428|FG004|Overall Study|Death|0|||
126368750|NCT02303821|454644429|FG005|Overall Study|Death|3|||
126046015|NCT02989662|453467186|FG001|Overall Study|Withdrawal by Subject|0|||
126046016|NCT02989662|453467187|FG002|Overall Study|Withdrawal by Subject|0|||
126046017|NCT02989662|453467188|FG003|Overall Study|Withdrawal by Subject|0|||
126046018|NCT02726386|453467191|FG000|Overall Study|Adverse Event|17|||
126046019|NCT02726386|453467192|FG001|Overall Study|Adverse Event|20|||
126046020|NCT02726386|453467191|FG000|Overall Study|Withdrawal by Subject|14|||
126046021|NCT02726386|453467192|FG001|Overall Study|Withdrawal by Subject|28|||
126046022|NCT02726386|453467191|FG000|Overall Study|Other reasons|7|||
126046023|NCT02726386|453467192|FG001|Overall Study|Other reasons|8|||
126046024|NCT04174560|453467195|FG000|Overall Study|Lost to Follow-up|1|||
126046025|NCT04174560|453467196|FG001|Overall Study|Lost to Follow-up|0|||
126046026|NCT04174560|453467197|FG002|Overall Study|Lost to Follow-up|0|||
126046027|NCT04174560|453467198|FG003|Overall Study|Lost to Follow-up|0|||
126046028|NCT04174560|453467195|FG000|Overall Study|Withdrawal by Subject|0|||
126046029|NCT04174560|453467196|FG001|Overall Study|Withdrawal by Subject|0|||
126046030|NCT04174560|453467197|FG002|Overall Study|Withdrawal by Subject|2|||
126046031|NCT04174560|453467198|FG003|Overall Study|Withdrawal by Subject|0|||
126046032|NCT05424718|453467200|FG000|Overall Study|Lost to Follow-up|5|||
126046033|NCT05424718|453467201|FG001|Overall Study|Lost to Follow-up|4|||
126046034|NCT04046549|453467203|FG000|Overall Study|Adverse Event|1|||
126046035|NCT04046549|453467203|FG000|Overall Study|Physician Decision|1|||
126046036|NCT04046549|453467203|FG000|Overall Study|Withdrawal by Subject|3|||
126046037|NCT04046549|453467203|FG000|Overall Study|Other, Not Specified|5|||
126046038|NCT04012567|453467204|FG000|Overall Study|Lost to Follow-up|0|||
126046039|NCT04012567|453467205|FG001|Overall Study|Lost to Follow-up|1|||
126046040|NCT04012567|453467204|FG000|Overall Study|Withdrawal by Subject|1|||
126046041|NCT04012567|453467205|FG001|Overall Study|Withdrawal by Subject|0|||
126046042|NCT05412004|453468195|FG000|Overall Study|Adverse Event|0|||
126046043|NCT05412004|453468196|FG001|Overall Study|Adverse Event|2|||
126046044|NCT05412004|453468197|FG002|Overall Study|Adverse Event|1|||
126046045|NCT05412004|453468198|FG003|Overall Study|Adverse Event|5|||
126046046|NCT05412004|453468195|FG000|Overall Study|Assigned Treatment by Mistake|5|||
126046047|NCT05412004|453468196|FG001|Overall Study|Assigned Treatment by Mistake|10|||
126046048|NCT05412004|453468197|FG002|Overall Study|Assigned Treatment by Mistake|2|||
126046049|NCT05412004|453468198|FG003|Overall Study|Assigned Treatment by Mistake|5|||
126046050|NCT05412004|453468195|FG000|Overall Study|Lost to Follow-up|3|||
126046051|NCT05412004|453468196|FG001|Overall Study|Lost to Follow-up|0|||
126046052|NCT05412004|453468197|FG002|Overall Study|Lost to Follow-up|0|||
126046053|NCT05412004|453468198|FG003|Overall Study|Lost to Follow-up|0|||
126046054|NCT05412004|453468195|FG000|Overall Study|Patient could not travel to site|0|||
126046055|NCT05412004|453468196|FG001|Overall Study|Patient could not travel to site|1|||
126046056|NCT05412004|453468197|FG002|Overall Study|Patient could not travel to site|0|||
126046057|NCT05412004|453468198|FG003|Overall Study|Patient could not travel to site|0|||
126046058|NCT05412004|453468195|FG000|Overall Study|Physician Decision|0|||
126046059|NCT05412004|453468196|FG001|Overall Study|Physician Decision|1|||
126046060|NCT05412004|453468197|FG002|Overall Study|Physician Decision|0|||
126046061|NCT05412004|453468198|FG003|Overall Study|Physician Decision|0|||
126046062|NCT05412004|453468195|FG000|Overall Study|Pregnancy|0|||
126046063|NCT05412004|453468196|FG001|Overall Study|Pregnancy|1|||
126304863|NCT00610155|454405538|FG000|Period 1|Withdrawal by Subject|0|||
126304864|NCT00610155|454405539|FG001|Period 1|Withdrawal by Subject|0|||
126304865|NCT00610155|454405540|FG002|Period 1|Withdrawal by Subject|1|||
126304866|NCT00610155|454405541|FG003|Period 1|Withdrawal by Subject|0|||
126304867|NCT00610155|454405542|FG004|Period 1|Withdrawal by Subject|0|||
126304868|NCT00610155|454405543|FG005|Period 1|Withdrawal by Subject|0|||
126304869|NCT00610155|454405538|FG000|Period 3|Adverse Event|1|||
126304870|NCT00610155|454405539|FG001|Period 3|Adverse Event|0|||
126304871|NCT00610155|454405540|FG002|Period 3|Adverse Event|0|||
126046064|NCT05412004|453468197|FG002|Overall Study|Pregnancy|0|||
126046065|NCT05412004|453468198|FG003|Overall Study|Pregnancy|0|||
126046066|NCT05412004|453468195|FG000|Overall Study|Protocol Violation|1|||
126046067|NCT05412004|453468196|FG001|Overall Study|Protocol Violation|0|||
126046068|NCT05412004|453468197|FG002|Overall Study|Protocol Violation|0|||
126046069|NCT05412004|453468198|FG003|Overall Study|Protocol Violation|0|||
126046070|NCT05412004|453468195|FG000|Overall Study|Withdrawal by Subject|4|||
126046071|NCT05412004|453468196|FG001|Overall Study|Withdrawal by Subject|19|||
126046072|NCT05412004|453468197|FG002|Overall Study|Withdrawal by Subject|4|||
126304872|NCT00610155|454405541|FG003|Period 3|Adverse Event|0|||
126304873|NCT00610155|454405542|FG004|Period 3|Adverse Event|0|||
126046073|NCT05412004|453468198|FG003|Overall Study|Withdrawal by Subject|14|||
126046074|NCT05412004|453468195|FG000|Overall Study|Screen Failure|0|||
125885088|NCT01177397|452876773|FG001|Overall Study|Adverse Event|0|||
125885089|NCT01177397|452876774|FG002|Overall Study|Adverse Event|1|||
126046075|NCT05412004|453468196|FG001|Overall Study|Screen Failure|0|||
126046076|NCT05412004|453468197|FG002|Overall Study|Screen Failure|0|||
126304874|NCT00610155|454405543|FG005|Period 3|Adverse Event|0|||
126304875|NCT01560234|454405544|FG000|Overall Study|Lost to Follow-up|3|||
126304876|NCT01560234|454405545|FG001|Overall Study|Lost to Follow-up|0|||
126304877|NCT01560234|454405546|FG002|Overall Study|Lost to Follow-up|1|||
126304878|NCT01560234|454405547|FG003|Overall Study|Lost to Follow-up|0|||
126304879|NCT01560234|454405548|FG004|Overall Study|Lost to Follow-up|0|||
126304880|NCT01560234|454405549|FG005|Overall Study|Lost to Follow-up|2|||
126304881|NCT01560234|454405550|FG006|Overall Study|Lost to Follow-up|0|||
126304882|NCT01560234|454405551|FG007|Overall Study|Lost to Follow-up|2|||
126304883|NCT01284348|454405552|FG000|Overall Study|Death|1|||
126304884|NCT01284348|454405553|FG001|Overall Study|Death|1|||
126304885|NCT01284348|454405552|FG000|Overall Study|Withdrew consent|0|||
126304886|NCT01284348|454405553|FG001|Overall Study|Withdrew consent|1|||
126304887|NCT01284348|454405552|FG000|Overall Study|Status not recorded|9|||
126304888|NCT01284348|454405553|FG001|Overall Study|Status not recorded|10|||
126304889|NCT03645395|454405560|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
126304890|NCT03645395|454405561|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
126304891|NCT03645395|454405562|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
126304892|NCT03645395|454405563|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
126304893|NCT03645395|454405560|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
126304894|NCT03645395|454405561|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
126304895|NCT03645395|454405562|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
126304896|NCT03645395|454405563|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
126304897|NCT03645395|454405560|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
126304898|NCT03645395|454405561|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
126304899|NCT03645395|454405562|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
126304900|NCT03645395|454405563|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
126304901|NCT03645395|454405560|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
126304902|NCT03645395|454405561|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
126304903|NCT03645395|454405562|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
126304904|NCT03645395|454405563|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
126304905|NCT02088905|454405564|FG000|Overall Study|Withdrawal by Subject|5|||
126304906|NCT02088905|454405565|FG001|Overall Study|Withdrawal by Subject|1|||
126304907|NCT02285166|454405567|FG000|Overall Study|Case Report Forms Uncollected|564|||
126304908|NCT02285166|454405567|FG000|Overall Study|Protocol Deviation|402|||
126304909|NCT00384839|454405570|FG000|Overall Study|Adverse Event|4|||
126304910|NCT00384839|454405570|FG000|Overall Study|Investigator Request|1|||
126304911|NCT00384839|454405570|FG000|Overall Study|Patient Request|1|||
126304912|NCT00384839|454405570|FG000|Overall Study|Ineligible|2|||
126304913|NCT04606394|454405571|FG000|Overall Study|Withdrawal by Subject|3|||
126304914|NCT04606394|454405571|FG000|Overall Study|Exclusion criteria screen failure|12|||
126304915|NCT03423173|454405572|FG000|Overall Study|Randomized but not vaccinated|1|||
126304916|NCT03423173|454405573|FG001|Overall Study|Randomized but not vaccinated|0|||
126304917|NCT03423173|454405574|FG002|Overall Study|Randomized but not vaccinated|2|||
126304918|NCT03423173|454405575|FG003|Overall Study|Randomized but not vaccinated|1|||
126304919|NCT03423173|454405572|FG000|Overall Study|Adverse Event|1|||
126304920|NCT03423173|454405573|FG001|Overall Study|Adverse Event|1|||
126304921|NCT03423173|454405574|FG002|Overall Study|Adverse Event|1|||
126304922|NCT03423173|454405575|FG003|Overall Study|Adverse Event|1|||
126304923|NCT03423173|454405572|FG000|Overall Study|Lost to Follow-up|10|||
126304924|NCT03423173|454405573|FG001|Overall Study|Lost to Follow-up|19|||
126304925|NCT03423173|454405574|FG002|Overall Study|Lost to Follow-up|17|||
125885090|NCT01177397|452876775|FG003|Overall Study|Adverse Event|2|||
125885091|NCT01177397|452876776|FG004|Overall Study|Adverse Event|0|||
126304926|NCT03423173|454405575|FG003|Overall Study|Lost to Follow-up|22|||
126304927|NCT03423173|454405572|FG000|Overall Study|Withdrawal of consent|4|||
126304928|NCT03423173|454405573|FG001|Overall Study|Withdrawal of consent|10|||
126304929|NCT03423173|454405574|FG002|Overall Study|Withdrawal of consent|4|||
126304930|NCT03423173|454405575|FG003|Overall Study|Withdrawal of consent|5|||
126368751|NCT02303821|454644430|FG006|Overall Study|Death|41|||
126368752|NCT02303821|454644431|FG007|Overall Study|Death|29|||
126368753|NCT02303821|454644424|FG000|Overall Study|Lost to Follow-up|0|||
126368754|NCT02303821|454644425|FG001|Overall Study|Lost to Follow-up|0|||
126368755|NCT02303821|454644426|FG002|Overall Study|Lost to Follow-up|0|||
126368756|NCT02303821|454644427|FG003|Overall Study|Lost to Follow-up|0|||
126368757|NCT02303821|454644428|FG004|Overall Study|Lost to Follow-up|0|||
126368758|NCT02303821|454644429|FG005|Overall Study|Lost to Follow-up|0|||
126368759|NCT02303821|454644430|FG006|Overall Study|Lost to Follow-up|1|||
126368760|NCT02303821|454644431|FG007|Overall Study|Lost to Follow-up|0|||
126368761|NCT02303821|454644424|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368762|NCT02303821|454644425|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368763|NCT02303821|454644426|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368764|NCT02303821|454644427|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368765|NCT02303821|454644428|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368766|NCT02303821|454644429|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368767|NCT02303821|454644430|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
126368768|NCT02303821|454644431|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368769|NCT02303821|454644424|FG000|Overall Study|Decision by sponsor|0|||
126368770|NCT02303821|454644425|FG001|Overall Study|Decision by sponsor|0|||
126368771|NCT02303821|454644426|FG002|Overall Study|Decision by sponsor|0|||
126368772|NCT02303821|454644427|FG003|Overall Study|Decision by sponsor|0|||
126368773|NCT02303821|454644428|FG004|Overall Study|Decision by sponsor|0|||
126368774|NCT02303821|454644429|FG005|Overall Study|Decision by sponsor|1|||
126368775|NCT02303821|454644430|FG006|Overall Study|Decision by sponsor|0|||
126368776|NCT02303821|454644431|FG007|Overall Study|Decision by sponsor|0|||
126368777|NCT02303821|454644424|FG000|Overall Study|Protocol-specified criteria|0|||
126368778|NCT02303821|454644425|FG001|Overall Study|Protocol-specified criteria|1|||
126368779|NCT02303821|454644426|FG002|Overall Study|Protocol-specified criteria|0|||
126368780|NCT02303821|454644427|FG003|Overall Study|Protocol-specified criteria|0|||
126368781|NCT02303821|454644428|FG004|Overall Study|Protocol-specified criteria|0|||
126368782|NCT02303821|454644429|FG005|Overall Study|Protocol-specified criteria|1|||
126368783|NCT02303821|454644430|FG006|Overall Study|Protocol-specified criteria|0|||
126368784|NCT02303821|454644431|FG007|Overall Study|Protocol-specified criteria|0|||
126368785|NCT04116489|454644444|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
126368786|NCT04116489|454644444|FG000|Overall Study|Withdrawal by Subject|1|||
126368787|NCT03734536|454644445|FG000|Overall Study|Withdrew Consent|1|||
126368788|NCT03734536|454644446|FG001|Overall Study|Withdrew Consent|5|||
126368789|NCT03734536|454644445|FG000|Overall Study|Lost to Follow-up|10|||
126368790|NCT03734536|454644446|FG001|Overall Study|Lost to Follow-up|7|||
126368791|NCT04727151|454644447|FG000|Overall Study|Death|0|||
126368792|NCT04727151|454644448|FG001|Overall Study|Death|0|||
126368793|NCT04727151|454644449|FG002|Overall Study|Death|0|||
126368794|NCT04727151|454644450|FG003|Overall Study|Death|0|||
126368795|NCT04727151|454644451|FG004|Overall Study|Death|3|||
126368796|NCT04727151|454644447|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
126368797|NCT04727151|454644448|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
126368798|NCT04727151|454644449|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
126368799|NCT04727151|454644450|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
126368800|NCT04727151|454644451|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
126368801|NCT01346592|454644453|FG000|Overall Study|Lost to Follow-up|62|||
126368802|NCT01346592|454644454|FG001|Overall Study|Lost to Follow-up|29|||
126368803|NCT01346592|454644455|FG002|Overall Study|Lost to Follow-up|29|||
126368804|NCT01346592|454644453|FG000|Overall Study|Protocol Violation|2|||
126368805|NCT01346592|454644454|FG001|Overall Study|Protocol Violation|1|||
126368806|NCT01346592|454644455|FG002|Overall Study|Protocol Violation|0|||
126368807|NCT01346592|454644453|FG000|Overall Study|Death|1|||
126368808|NCT01346592|454644454|FG001|Overall Study|Death|3|||
126368809|NCT01346592|454644455|FG002|Overall Study|Death|4|||
126368810|NCT01346592|454644453|FG000|Overall Study|Adverse Event|0|||
126368811|NCT01346592|454644454|FG001|Overall Study|Adverse Event|1|||
126368812|NCT01346592|454644455|FG002|Overall Study|Adverse Event|0|||
126368813|NCT01346592|454644453|FG000|Overall Study|Withdrawal by Subject|77|||
126368814|NCT01346592|454644454|FG001|Overall Study|Withdrawal by Subject|51|||
126368815|NCT01346592|454644455|FG002|Overall Study|Withdrawal by Subject|38|||
126368816|NCT01346592|454644453|FG000|Overall Study|Inappropriate enrollment|3|||
126368817|NCT01346592|454644454|FG001|Overall Study|Inappropriate enrollment|1|||
126368818|NCT01346592|454644455|FG002|Overall Study|Inappropriate enrollment|1|||
126368819|NCT01346592|454644453|FG000|Overall Study|Administrative reason|1|||
126368820|NCT01346592|454644454|FG001|Overall Study|Administrative reason|0|||
126368821|NCT01346592|454644455|FG002|Overall Study|Administrative reason|0|||
126368822|NCT01346592|454644453|FG000|Overall Study|Unable to Classify|7|||
126368823|NCT01346592|454644454|FG001|Overall Study|Unable to Classify|3|||
126368824|NCT01346592|454644455|FG002|Overall Study|Unable to Classify|6|||
126368825|NCT02679274|454644456|FG000|Overall Study|Withdrawal by Subject|1|||
126368826|NCT02679274|454644457|FG001|Overall Study|Withdrawal by Subject|0|||
126368827|NCT02038036|454644462|FG000|Core Study|Adverse Event|7|||
126046077|NCT05412004|453468198|FG003|Overall Study|Screen Failure|1|||
126046078|NCT05412004|453468195|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
126046079|NCT05412004|453468196|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
126046080|NCT05412004|453468197|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
126046081|NCT05412004|453468198|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
126046082|NCT03705793|453468199|FG000|Overall Study|Lost to Follow-up|3|||
126046083|NCT03705793|453468200|FG001|Overall Study|Lost to Follow-up|4|||
126046084|NCT03705793|453468199|FG000|Overall Study|Withdrawal by Subject|2|||
126046085|NCT03705793|453468200|FG001|Overall Study|Withdrawal by Subject|1|||
126046086|NCT02719574|453468201|FG000|Phase 1 (Dose Escalation)|Other|0|||
126046087|NCT02719574|453468202|FG001|Phase 1 (Dose Escalation)|Other|2|||
126046088|NCT02719574|453468203|FG002|Phase 1 (Dose Escalation)|Other|1|||
126046089|NCT02719574|453468204|FG003|Phase 1 (Dose Escalation)|Other|2|||
126046090|NCT02719574|453468205|FG004|Phase 1 (Dose Escalation)|Other|2|||
126046091|NCT02719574|453468206|FG005|Phase 1 (Dose Escalation)|Other|0|||
126046092|NCT02719574|453468207|FG006|Phase 1 (Dose Escalation)|Other|0|||
126046093|NCT02719574|453468208|FG007|Phase 1 (Dose Escalation)|Other|0|||
126046094|NCT02719574|453468209|FG008|Phase 1 (Dose Escalation)|Other|0|||
126046095|NCT02719574|453468210|FG009|Phase 1 (Dose Escalation)|Other|0|||
126046096|NCT02719574|453468211|FG010|Phase 1 (Dose Escalation)|Other|0|||
126046097|NCT02719574|453468212|FG011|Phase 1 (Dose Escalation)|Other|0|||
126046098|NCT02719574|453468213|FG012|Phase 1 (Dose Escalation)|Other|0|||
126046099|NCT02719574|453468214|FG013|Phase 1 (Dose Escalation)|Other|0|||
126046100|NCT02719574|453468215|FG014|Phase 1 (Dose Escalation)|Other|0|||
126046101|NCT02719574|453468216|FG015|Phase 1 (Dose Escalation)|Other|0|||
126046102|NCT02719574|453468217|FG016|Phase 1 (Dose Escalation)|Other|0|||
126046103|NCT02719574|453468201|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
126046104|NCT02719574|453468202|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
126046105|NCT02719574|453468203|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
126046106|NCT02719574|453468204|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
126046107|NCT02719574|453468205|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
126304931|NCT03423173|454405572|FG000|Overall Study|Death|1|||
126304932|NCT03423173|454405573|FG001|Overall Study|Death|0|||
126304933|NCT03423173|454405574|FG002|Overall Study|Death|0|||
126304934|NCT03423173|454405575|FG003|Overall Study|Death|0|||
126304935|NCT03423173|454405572|FG000|Overall Study|Reason not Specified|2|||
126304936|NCT03423173|454405573|FG001|Overall Study|Reason not Specified|5|||
126304937|NCT03423173|454405574|FG002|Overall Study|Reason not Specified|3|||
126304938|NCT03423173|454405575|FG003|Overall Study|Reason not Specified|1|||
126304939|NCT01028014|454405577|FG000|Overall Study|Lost to Follow-up|1|||
126304940|NCT01028014|454405578|FG001|Overall Study|Lost to Follow-up|2|||
126304941|NCT01028014|454405579|FG002|Overall Study|Lost to Follow-up|0|||
126304942|NCT01028014|454405580|FG003|Overall Study|Lost to Follow-up|1|||
126304943|NCT01028014|454405581|FG004|Overall Study|Lost to Follow-up|1|||
126304944|NCT01028014|454405582|FG005|Overall Study|Lost to Follow-up|2|||
126304945|NCT00729157|454405587|FG000|Overall Study|Withdrawal by Subject|1|||
126304946|NCT00661609|454405588|FG000|Overall Study|Adverse Event|4|||
126304947|NCT00661609|454405588|FG000|Overall Study|Death|20|||
126304948|NCT00661609|454405588|FG000|Overall Study|Withdrawal by Subject|2|||
126304949|NCT00661609|454405588|FG000|Overall Study|PI Decision|1|||
126304950|NCT00661609|454405588|FG000|Overall Study|Survival follow up stage discontinued|11|||
126304951|NCT00661609|454405588|FG000|Overall Study|Disease progression|3|||
126304952|NCT01855243|454405589|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
126304953|NCT01855243|454405590|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
126368828|NCT02038036|454644463|FG001|Core Study|Adverse Event|7|||
126368829|NCT02038036|454644462|FG000|Core Study|Death|1|||
126368830|NCT02038036|454644463|FG001|Core Study|Death|1|||
126368831|NCT02038036|454644462|FG000|Core Study|Disease progression|2|||
126368832|NCT02038036|454644463|FG001|Core Study|Disease progression|2|||
126368833|NCT02038036|454644462|FG000|Core Study|Lost to Follow-up|0|||
126368834|NCT02038036|454644463|FG001|Core Study|Lost to Follow-up|1|||
126368835|NCT02038036|454644462|FG000|Core Study|Physician Decision|2|||
126368836|NCT02038036|454644463|FG001|Core Study|Physician Decision|1|||
126368837|NCT02038036|454644462|FG000|Core Study|Subject/guardian decision|0|||
126368838|NCT02038036|454644463|FG001|Core Study|Subject/guardian decision|1|||
126368839|NCT02038036|454644462|FG000|Core Study|Withdrawal by Subject|3|||
126368840|NCT02038036|454644463|FG001|Core Study|Withdrawal by Subject|1|||
126368841|NCT02038036|454644462|FG000|Crossover Period|Withdrawal by Subject|0|||
126368842|NCT02038036|454644463|FG001|Crossover Period|Withdrawal by Subject|3|||
126368843|NCT02038036|454644462|FG000|Crossover Period|Adverse Event|0|||
126368844|NCT02038036|454644463|FG001|Crossover Period|Adverse Event|9|||
126368845|NCT02038036|454644462|FG000|Crossover Period|Death|0|||
126368846|NCT02038036|454644463|FG001|Crossover Period|Death|2|||
126368847|NCT02038036|454644462|FG000|Crossover Period|Disease progression|0|||
126368848|NCT02038036|454644463|FG001|Crossover Period|Disease progression|3|||
126368849|NCT02038036|454644462|FG000|Crossover Period|Lost to Follow-up|0|||
125885092|NCT01177397|452876777|FG005|Overall Study|Adverse Event|12|||
125885093|NCT01177397|452876778|FG006|Overall Study|Adverse Event|1|||
125885094|NCT01177397|452876779|FG007|Overall Study|Adverse Event|14|||
125885095|NCT01177397|452876780|FG008|Overall Study|Adverse Event|8|||
125885096|NCT01177397|452876781|FG009|Overall Study|Adverse Event|6|||
125885097|NCT01177397|452876782|FG010|Overall Study|Adverse Event|3|||
125885098|NCT01177397|452876783|FG011|Overall Study|Adverse Event|7|||
125885099|NCT01177397|452876772|FG000|Overall Study|Disease progression|1|||
125885100|NCT01177397|452876773|FG001|Overall Study|Disease progression|2|||
125885101|NCT01177397|452876774|FG002|Overall Study|Disease progression|5|||
125885102|NCT01177397|452876775|FG003|Overall Study|Disease progression|5|||
125885103|NCT01177397|452876776|FG004|Overall Study|Disease progression|4|||
125885104|NCT01177397|452876777|FG005|Overall Study|Disease progression|10|||
125885105|NCT01177397|452876778|FG006|Overall Study|Disease progression|10|||
125885106|NCT01177397|452876779|FG007|Overall Study|Disease progression|21|||
125885107|NCT01177397|452876780|FG008|Overall Study|Disease progression|18|||
125885108|NCT01177397|452876781|FG009|Overall Study|Disease progression|12|||
125885109|NCT01177397|452876782|FG010|Overall Study|Disease progression|10|||
125885110|NCT01177397|452876783|FG011|Overall Study|Disease progression|8|||
125885111|NCT01177397|452876772|FG000|Overall Study|Other reasons|0|||
125885112|NCT01177397|452876773|FG001|Overall Study|Other reasons|0|||
126046108|NCT02719574|453468206|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
126046109|NCT02719574|453468207|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046110|NCT02719574|453468208|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046111|NCT02719574|453468209|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046112|NCT02719574|453468210|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126304954|NCT01855243|454405591|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
126304955|NCT03315286|454405594|FG000|Overall Study|Lost to Follow-up|0|||
126304956|NCT03315286|454405595|FG001|Overall Study|Lost to Follow-up|3|||
126304957|NCT03315286|454405594|FG000|Overall Study|Withdrawal by Subject|1|||
126304958|NCT03315286|454405595|FG001|Overall Study|Withdrawal by Subject|0|||
126304959|NCT03315286|454405594|FG000|Overall Study|Protocol Violation|0|||
126304960|NCT03315286|454405595|FG001|Overall Study|Protocol Violation|1|||
126304961|NCT03075891|454405596|FG000|Overall Study|Withdrawal by Subject|3|||
126304962|NCT03075891|454405597|FG001|Overall Study|Withdrawal by Subject|6|||
126304963|NCT03075891|454405596|FG000|Overall Study|Lost to Follow-up|1|||
126304964|NCT03075891|454405597|FG001|Overall Study|Lost to Follow-up|0|||
126304965|NCT03075891|454405596|FG000|Overall Study|Pregnancy|3|||
126304966|NCT03075891|454405597|FG001|Overall Study|Pregnancy|1|||
126304967|NCT03075891|454405596|FG000|Overall Study|visits not performed (no time)|1|||
126304968|NCT03075891|454405597|FG001|Overall Study|visits not performed (no time)|0|||
126304969|NCT03075891|454405596|FG000|Overall Study|Drug abuse relapse issue|0|||
126304970|NCT03075891|454405597|FG001|Overall Study|Drug abuse relapse issue|1|||
126304971|NCT03075891|454405596|FG000|Overall Study|Participant requiring study withdrawal|0|||
126304972|NCT03075891|454405597|FG001|Overall Study|Participant requiring study withdrawal|1|||
126304973|NCT03075891|454405596|FG000|Overall Study|Adverse event, non-fatal|1|||
126304974|NCT03075891|454405597|FG001|Overall Study|Adverse event, non-fatal|4|||
126304975|NCT00828568|454405600|FG000|Randomized|Withdrawal by Subject|1|||
126304976|NCT00828568|454405601|FG001|Randomized|Withdrawal by Subject|0|||
126304977|NCT00828568|454405602|FG002|Randomized|Withdrawal by Subject|2|||
126304978|NCT00828568|454405600|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
126304979|NCT00828568|454405601|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
126304980|NCT00828568|454405602|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
126304981|NCT00828568|454405600|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
126304982|NCT00828568|454405601|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
126304983|NCT00828568|454405602|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
126304984|NCT00828568|454405600|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
126304985|NCT00828568|454405601|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
126304986|NCT00828568|454405602|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
126304987|NCT00828568|454405600|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
126304988|NCT00828568|454405601|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
126304989|NCT00828568|454405602|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
126304990|NCT00766636|454405603|FG000|Overall Study|Withdrawal by Subject|1|||
126304991|NCT00766636|454405604|FG001|Overall Study|Withdrawal by Subject|1|||
126304992|NCT00766636|454405603|FG000|Overall Study|Incomplete Treatment|0|||
126304993|NCT00766636|454405604|FG001|Overall Study|Incomplete Treatment|1|||
126368850|NCT02038036|454644463|FG001|Crossover Period|Lost to Follow-up|1|||
125885113|NCT01177397|452876774|FG002|Overall Study|Other reasons|1|||
125885114|NCT01177397|452876775|FG003|Overall Study|Other reasons|0|||
126304994|NCT00766636|454405603|FG000|Overall Study|Adverse Event|1|||
126304995|NCT00766636|454405604|FG001|Overall Study|Adverse Event|0|||
126304996|NCT00766636|454405603|FG000|Overall Study|Disease Progression|1|||
126304997|NCT00766636|454405604|FG001|Overall Study|Disease Progression|0|||
126304998|NCT02477332|454405605|FG000|Overall Study|Adverse Event|0|||
125885115|NCT01177397|452876776|FG004|Overall Study|Other reasons|1|||
126046113|NCT02719574|453468211|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046114|NCT02719574|453468212|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046115|NCT02719574|453468213|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126304999|NCT02477332|454405606|FG001|Overall Study|Adverse Event|1|||
126305000|NCT02477332|454405607|FG002|Overall Study|Adverse Event|1|||
126305001|NCT02477332|454405608|FG003|Overall Study|Adverse Event|2|||
126305002|NCT02477332|454405609|FG004|Overall Study|Adverse Event|1|||
126305003|NCT02477332|454405610|FG005|Overall Study|Adverse Event|2|||
126305004|NCT02477332|454405605|FG000|Overall Study|Lack of Efficacy|1|||
126305005|NCT02477332|454405606|FG001|Overall Study|Lack of Efficacy|2|||
126305006|NCT02477332|454405607|FG002|Overall Study|Lack of Efficacy|1|||
126305007|NCT02477332|454405608|FG003|Overall Study|Lack of Efficacy|2|||
126305008|NCT02477332|454405609|FG004|Overall Study|Lack of Efficacy|1|||
126305009|NCT02477332|454405610|FG005|Overall Study|Lack of Efficacy|1|||
126305010|NCT02477332|454405605|FG000|Overall Study|Non-compliance with study treatment|0|||
126305011|NCT02477332|454405606|FG001|Overall Study|Non-compliance with study treatment|1|||
126305012|NCT02477332|454405607|FG002|Overall Study|Non-compliance with study treatment|2|||
126305013|NCT02477332|454405608|FG003|Overall Study|Non-compliance with study treatment|0|||
126305014|NCT02477332|454405609|FG004|Overall Study|Non-compliance with study treatment|0|||
126305015|NCT02477332|454405610|FG005|Overall Study|Non-compliance with study treatment|0|||
126305016|NCT02477332|454405605|FG000|Overall Study|Pregnancy|0|||
126305017|NCT02477332|454405606|FG001|Overall Study|Pregnancy|0|||
126305018|NCT02477332|454405607|FG002|Overall Study|Pregnancy|0|||
126305019|NCT02477332|454405608|FG003|Overall Study|Pregnancy|1|||
126305020|NCT02477332|454405609|FG004|Overall Study|Pregnancy|0|||
126305021|NCT02477332|454405610|FG005|Overall Study|Pregnancy|0|||
126305022|NCT02477332|454405605|FG000|Overall Study|Protocol Violation|2|||
126305023|NCT02477332|454405606|FG001|Overall Study|Protocol Violation|0|||
126305024|NCT02477332|454405607|FG002|Overall Study|Protocol Violation|3|||
126305025|NCT02477332|454405608|FG003|Overall Study|Protocol Violation|3|||
126305026|NCT02477332|454405609|FG004|Overall Study|Protocol Violation|1|||
126305027|NCT02477332|454405610|FG005|Overall Study|Protocol Violation|1|||
126305028|NCT02477332|454405605|FG000|Overall Study|Technical problems|0|||
126305029|NCT02477332|454405606|FG001|Overall Study|Technical problems|0|||
126305030|NCT02477332|454405607|FG002|Overall Study|Technical problems|1|||
126305031|NCT02477332|454405608|FG003|Overall Study|Technical problems|0|||
126305032|NCT02477332|454405609|FG004|Overall Study|Technical problems|0|||
126305033|NCT02477332|454405610|FG005|Overall Study|Technical problems|0|||
126305034|NCT02477332|454405605|FG000|Overall Study|Lost to Follow-up|0|||
126368851|NCT02038036|454644462|FG000|Crossover Period|Physician Decision|0|||
126368852|NCT02038036|454644463|FG001|Crossover Period|Physician Decision|2|||
126368853|NCT03537508|454644471|FG000|Overall Study|Adverse Event|2|||
126368854|NCT03537508|454644472|FG001|Overall Study|Adverse Event|1|||
126368855|NCT03537508|454644471|FG000|Overall Study|Protocol Violation|65|||
126368856|NCT03537508|454644472|FG001|Overall Study|Protocol Violation|48|||
126368857|NCT03537508|454644471|FG000|Overall Study|Lost to Follow-up|86|||
126368858|NCT03537508|454644472|FG001|Overall Study|Lost to Follow-up|60|||
126305035|NCT02477332|454405606|FG001|Overall Study|Lost to Follow-up|0|||
126305036|NCT02477332|454405607|FG002|Overall Study|Lost to Follow-up|2|||
126305037|NCT02477332|454405608|FG003|Overall Study|Lost to Follow-up|0|||
126305038|NCT02477332|454405609|FG004|Overall Study|Lost to Follow-up|0|||
126305039|NCT02477332|454405610|FG005|Overall Study|Lost to Follow-up|0|||
126305040|NCT02477332|454405605|FG000|Overall Study|Physician Decision|0|||
126305041|NCT02477332|454405606|FG001|Overall Study|Physician Decision|0|||
126305042|NCT02477332|454405607|FG002|Overall Study|Physician Decision|1|||
126368859|NCT03537508|454644471|FG000|Overall Study|Withdrawal by parent/guardian|263|||
126368860|NCT03537508|454644472|FG001|Overall Study|Withdrawal by parent/guardian|149|||
126368861|NCT01972659|454644473|FG000|Overall Study|Protocol Violation|2|||
126368862|NCT01972659|454644474|FG001|Overall Study|Protocol Violation|2|||
126368863|NCT01972659|454644473|FG000|Overall Study|problems realted to acceleromyograph|2|||
126368864|NCT01972659|454644474|FG001|Overall Study|problems realted to acceleromyograph|1|||
126368865|NCT02495883|454644481|FG000|Overall Study|Excessive head motion|1|||
126368866|NCT02495883|454644482|FG001|Overall Study|Excessive head motion|0|||
126368867|NCT02776735|454644483|FG000|Overall Study|Adverse Event|0|||
126368868|NCT02776735|454644484|FG001|Overall Study|Adverse Event|0|||
126368869|NCT02776735|454644485|FG002|Overall Study|Adverse Event|0|||
126368870|NCT02776735|454644486|FG003|Overall Study|Adverse Event|1|||
126368871|NCT02776735|454644487|FG004|Overall Study|Adverse Event|0|||
126368872|NCT02776735|454644488|FG005|Overall Study|Adverse Event|1|||
126368873|NCT02776735|454644483|FG000|Overall Study|Lost to Follow-up|0|||
126368874|NCT02776735|454644484|FG001|Overall Study|Lost to Follow-up|0|||
126368875|NCT02776735|454644485|FG002|Overall Study|Lost to Follow-up|0|||
126368876|NCT02776735|454644486|FG003|Overall Study|Lost to Follow-up|1|||
126368877|NCT02776735|454644487|FG004|Overall Study|Lost to Follow-up|0|||
125885116|NCT01177397|452876777|FG005|Overall Study|Other reasons|1|||
126305043|NCT02477332|454405608|FG003|Overall Study|Physician Decision|3|||
126305044|NCT02477332|454405609|FG004|Overall Study|Physician Decision|0|||
126305045|NCT02477332|454405610|FG005|Overall Study|Physician Decision|1|||
126305046|NCT02477332|454405605|FG000|Overall Study|Withdrawal by Subject|0|||
126305047|NCT02477332|454405606|FG001|Overall Study|Withdrawal by Subject|3|||
126305048|NCT02477332|454405607|FG002|Overall Study|Withdrawal by Subject|1|||
126305049|NCT02477332|454405608|FG003|Overall Study|Withdrawal by Subject|2|||
126305050|NCT02477332|454405609|FG004|Overall Study|Withdrawal by Subject|1|||
126305051|NCT02477332|454405610|FG005|Overall Study|Withdrawal by Subject|0|||
126305052|NCT02549287|454405611|FG000|Overall Study|Lost to Follow-up|65|||
126305053|NCT02549287|454405612|FG001|Overall Study|Lost to Follow-up|26|||
126305054|NCT02549287|454405611|FG000|Overall Study|Withdrawal by Subject|15|||
126305055|NCT02549287|454405612|FG001|Overall Study|Withdrawal by Subject|6|||
126305056|NCT00765336|454405613|FG000|Overall Study|Protocol Violation|4|||
126305057|NCT00765336|454405614|FG001|Overall Study|Protocol Violation|2|||
126305058|NCT00765336|454405613|FG000|Overall Study|Withdrawal by Subject|6|||
126305059|NCT00765336|454405614|FG001|Overall Study|Withdrawal by Subject|4|||
126305060|NCT00765336|454405613|FG000|Overall Study|Lost to Follow-up|7|||
126305061|NCT00765336|454405614|FG001|Overall Study|Lost to Follow-up|9|||
126305062|NCT00765336|454405613|FG000|Overall Study|Adverse Event|2|||
126305063|NCT00765336|454405614|FG001|Overall Study|Adverse Event|1|||
126305064|NCT01972438|454405615|FG000|Baseline-Month 3 Crossover Period|Death|1|||
126305065|NCT01972438|454405616|FG001|Baseline-Month 3 Crossover Period|Death|0|||
126305066|NCT01972438|454405615|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
126305067|NCT01972438|454405616|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
126305068|NCT01972438|454405615|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
126305069|NCT01972438|454405616|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
126305070|NCT01972438|454405615|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
126305071|NCT01972438|454405616|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
126305072|NCT01972438|454405615|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
126305073|NCT01972438|454405616|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
126305074|NCT01972438|454405615|FG000|Months 6-12 Study Period|Death|1|||
126305075|NCT01972438|454405616|FG001|Months 6-12 Study Period|Death|0|||
126305076|NCT01972438|454405615|FG000|Months 6-12 Study Period|Early Study Closure|2|||
126305077|NCT01972438|454405616|FG001|Months 6-12 Study Period|Early Study Closure|2|||
126305078|NCT01972438|454405615|FG000|Post Month 12 Study Period|Early Study Closure|3|||
126368878|NCT02776735|454644488|FG005|Overall Study|Lost to Follow-up|0|||
126368879|NCT02776735|454644483|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126368880|NCT02776735|454644484|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126368881|NCT02776735|454644485|FG002|Overall Study|Withdrawal by parent/guardian|2|||
126368882|NCT02776735|454644486|FG003|Overall Study|Withdrawal by parent/guardian|2|||
126368883|NCT02776735|454644487|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126368884|NCT02776735|454644488|FG005|Overall Study|Withdrawal by parent/guardian|0|||
126368885|NCT02776735|454644483|FG000|Overall Study|Withdrawal by Subject|1|||
126368886|NCT02776735|454644484|FG001|Overall Study|Withdrawal by Subject|0|||
126368887|NCT02776735|454644485|FG002|Overall Study|Withdrawal by Subject|0|||
126368888|NCT02776735|454644486|FG003|Overall Study|Withdrawal by Subject|0|||
126368889|NCT02776735|454644487|FG004|Overall Study|Withdrawal by Subject|0|||
126368890|NCT02776735|454644488|FG005|Overall Study|Withdrawal by Subject|1|||
126368891|NCT02776735|454644483|FG000|Overall Study|Other|0|||
125885117|NCT01177397|452876778|FG006|Overall Study|Other reasons|2|||
126305079|NCT01972438|454405616|FG001|Post Month 12 Study Period|Early Study Closure|4|||
126305080|NCT02195869|454405621|FG000|Overall Study|cGVHD Progression|5|||
126305081|NCT02195869|454405621|FG000|Overall Study|Malignancy Progression/relapse|2|||
126305082|NCT02195869|454405621|FG000|Overall Study|Adverse Event|15|||
126368892|NCT02776735|454644484|FG001|Overall Study|Other|0|||
125885118|NCT01177397|452876779|FG007|Overall Study|Other reasons|6|||
126305083|NCT02195869|454405621|FG000|Overall Study|Withdrawal by Subject|7|||
126305084|NCT02195869|454405621|FG000|Overall Study|Physician Decision|4|||
126305085|NCT02195869|454405621|FG000|Overall Study|Study Terminated by Sponsor|7|||
126305086|NCT02195869|454405621|FG000|Overall Study|Noncompliance with study drug|2|||
126305087|NCT00789698|454405622|FG000|Overall Study|Lack of Efficacy|10|||
126305088|NCT00789698|454405623|FG001|Overall Study|Lack of Efficacy|4|||
126305089|NCT00789698|454405624|FG002|Overall Study|Lack of Efficacy|5|||
126305090|NCT00789698|454405625|FG003|Overall Study|Lack of Efficacy|18|||
126305091|NCT00789698|454405622|FG000|Overall Study|Adverse Event|5|||
126305092|NCT00789698|454405623|FG001|Overall Study|Adverse Event|5|||
126305093|NCT00789698|454405624|FG002|Overall Study|Adverse Event|3|||
126305094|NCT00789698|454405625|FG003|Overall Study|Adverse Event|4|||
126305095|NCT00789698|454405622|FG000|Overall Study|Lost to Follow-up|5|||
126305096|NCT00789698|454405623|FG001|Overall Study|Lost to Follow-up|5|||
126305097|NCT00789698|454405624|FG002|Overall Study|Lost to Follow-up|2|||
126305098|NCT00789698|454405625|FG003|Overall Study|Lost to Follow-up|9|||
126305099|NCT00789698|454405622|FG000|Overall Study|Protocol Violation|6|||
126305100|NCT00789698|454405623|FG001|Overall Study|Protocol Violation|1|||
126305101|NCT00789698|454405624|FG002|Overall Study|Protocol Violation|2|||
126305102|NCT00789698|454405625|FG003|Overall Study|Protocol Violation|1|||
126305103|NCT00789698|454405622|FG000|Overall Study|Withdrawal by Subject|14|||
126305104|NCT00789698|454405623|FG001|Overall Study|Withdrawal by Subject|15|||
126305105|NCT00789698|454405624|FG002|Overall Study|Withdrawal by Subject|12|||
126305106|NCT00789698|454405625|FG003|Overall Study|Withdrawal by Subject|19|||
126305107|NCT00789698|454405622|FG000|Overall Study|Administrative|0|||
126305108|NCT00789698|454405623|FG001|Overall Study|Administrative|3|||
126305109|NCT00789698|454405624|FG002|Overall Study|Administrative|3|||
126305110|NCT00789698|454405625|FG003|Overall Study|Administrative|1|||
126305111|NCT04981470|454407184|FG000|Overall Study|Device failure in all 4 patients|4|||
126305112|NCT04390503|454407186|FG000|Overall Study|Physician Decision|2|||
126305113|NCT04390503|454407187|FG001|Overall Study|Physician Decision|1|||
126305114|NCT04390503|454407186|FG000|Overall Study|Adverse Event|1|||
126305115|NCT04390503|454407187|FG001|Overall Study|Adverse Event|0|||
126305116|NCT00468481|454407188|FG000|Overall Study|Adverse Event|13|||
126305117|NCT00468481|454407189|FG001|Overall Study|Adverse Event|3|||
126305118|NCT00468481|454407188|FG000|Overall Study|Lost to Follow-up|25|||
126305119|NCT00468481|454407189|FG001|Overall Study|Lost to Follow-up|8|||
126305120|NCT00468481|454407188|FG000|Overall Study|Pregnancy|2|||
126305121|NCT00468481|454407189|FG001|Overall Study|Pregnancy|0|||
126305122|NCT00468481|454407188|FG000|Overall Study|Protocol Violation|18|||
126305123|NCT00468481|454407189|FG001|Overall Study|Protocol Violation|8|||
126305124|NCT00468481|454407188|FG000|Overall Study|Withdrawal by Subject|12|||
126305125|NCT00468481|454407189|FG001|Overall Study|Withdrawal by Subject|3|||
126305126|NCT00468481|454407188|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
126305127|NCT00468481|454407189|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
126305128|NCT00468481|454407188|FG000|Overall Study|Prohibited Medication|1|||
126305129|NCT00468481|454407189|FG001|Overall Study|Prohibited Medication|1|||
126305130|NCT00468481|454407188|FG000|Overall Study|Egg Donor|1|||
126305131|NCT00468481|454407189|FG001|Overall Study|Egg Donor|0|||
126305132|NCT00468481|454407188|FG000|Overall Study|Moved out of area|4|||
126305133|NCT00468481|454407189|FG001|Overall Study|Moved out of area|1|||
126305134|NCT00468481|454407188|FG000|Overall Study|Non-Compliance|5|||
126305135|NCT00468481|454407189|FG001|Overall Study|Non-Compliance|0|||
126305136|NCT00468481|454407188|FG000|Overall Study|Other|6|||
126305137|NCT00468481|454407189|FG001|Overall Study|Other|0|||
126305138|NCT00593684|454407191|FG000|Overall Study|Death|2|||
125885119|NCT01177397|452876780|FG008|Overall Study|Other reasons|10|||
126305139|NCT00593684|454407192|FG001|Overall Study|Death|1|||
126305140|NCT00734162|454407193|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
126305141|NCT00734162|454407194|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
126305142|NCT00734162|454407195|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
126305143|NCT00734162|454407196|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
126305144|NCT00734162|454407193|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
126305145|NCT00734162|454407194|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
126305146|NCT00734162|454407195|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
126305147|NCT00734162|454407196|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
126305148|NCT00734162|454407193|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
126305149|NCT00734162|454407194|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
126305150|NCT00734162|454407195|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
126305151|NCT00734162|454407196|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
126305152|NCT00734162|454407193|FG000|Open-Label Phase|Withdrew Consent|1|||
126305153|NCT00734162|454407194|FG001|Open-Label Phase|Withdrew Consent|0|||
126305154|NCT00734162|454407195|FG002|Open-Label Phase|Withdrew Consent|1|||
126305155|NCT00734162|454407196|FG003|Open-Label Phase|Withdrew Consent|1|||
126305156|NCT00734162|454407193|FG000|Open-Label Phase|Lost to Follow-up|1|||
126305157|NCT00734162|454407194|FG001|Open-Label Phase|Lost to Follow-up|2|||
126368893|NCT02776735|454644485|FG002|Overall Study|Other|3|||
126368894|NCT02776735|454644486|FG003|Overall Study|Other|0|||
126368895|NCT02776735|454644487|FG004|Overall Study|Other|0|||
126368896|NCT02776735|454644488|FG005|Overall Study|Other|0|||
126368897|NCT00791648|454646490|FG000|Overall Study|Physician Decision|0|||
126368898|NCT00791648|454646491|FG001|Overall Study|Physician Decision|1|||
126368899|NCT00791648|454646490|FG000|Overall Study|Withdrawal by Subject|0|||
126368900|NCT00791648|454646491|FG001|Overall Study|Withdrawal by Subject|1|||
126368901|NCT00462826|454646492|FG000|Overall Study|Ineligible - second primary|1|||
126368902|NCT00462826|454646492|FG000|Overall Study|Ineligible - wrong cell type|1|||
126368903|NCT00462826|454646492|FG000|Overall Study|Ineligible - wrong primary|2|||
126368904|NCT00462826|454646492|FG000|Overall Study|Never treated|1|||
126368905|NCT04976777|454646493|FG000|Overall Study|COVID-19 Infection|1|||
126368906|NCT04976777|454646494|FG001|Overall Study|COVID-19 Infection|0|||
126368907|NCT02278003|454646495|FG000|Overall Study|Withdrawal by Subject|11|||
126368908|NCT02278003|454646496|FG001|Overall Study|Withdrawal by Subject|0|||
126368909|NCT02278003|454646495|FG000|Overall Study|Not Treated|1|||
126368910|NCT02278003|454646496|FG001|Overall Study|Not Treated|0|||
126368911|NCT02278003|454646495|FG000|Overall Study|Recognition task improperly completed|7|||
126368912|NCT02278003|454646496|FG001|Overall Study|Recognition task improperly completed|0|||
126368913|NCT04123704|454646511|FG000|Overall Study|Disease progression|2|||
126368914|NCT00939185|454646512|FG000|Overall Study|Adverse Event|3|||
126368915|NCT00939185|454646512|FG000|Overall Study|Lack of Efficacy|1|||
126368916|NCT00939185|454646512|FG000|Overall Study|Lost to Follow-up|6|||
126368917|NCT00939185|454646512|FG000|Overall Study|Other|3|||
126368918|NCT00939185|454646512|FG000|Overall Study|Withdrawal by Subject|2|||
126368919|NCT00939185|454646512|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
126368920|NCT00363298|454646513|FG000|First Study Week|Lack of Efficacy|6|||
126368921|NCT00363298|454646514|FG001|First Study Week|Lack of Efficacy|5|||
126368922|NCT00363298|454646513|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
126368923|NCT00363298|454646514|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
126368924|NCT00836706|454646515|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
126368925|NCT00836706|454646516|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
126368926|NCT04484857|454646525|FG000|Overall Study|Adverse Event|2|||
126368927|NCT04484857|454646525|FG000|Overall Study|Death|10|||
126368928|NCT04484857|454646525|FG000|Overall Study|Withdrawal by Subject|3|||
126368929|NCT04484857|454646525|FG000|Overall Study|Transferred/Relocation|5|||
126368930|NCT04484857|454646525|FG000|Overall Study|Kidney Transplant|7|||
126368931|NCT04484857|454646525|FG000|Overall Study|Other than specified|4|||
126368932|NCT04484857|454646525|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
126368933|NCT02390076|454646526|FG000|Overall Study|Lost to Follow-up|2|||
126368934|NCT02390076|454646527|FG001|Overall Study|Lost to Follow-up|1|||
126368935|NCT02390076|454646528|FG002|Overall Study|Lost to Follow-up|4|||
126046116|NCT02719574|453468214|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046117|NCT02719574|453468215|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046118|NCT02719574|453468216|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046119|NCT02719574|453468217|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126046120|NCT02719574|453468201|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046121|NCT02719574|453468202|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
126046122|NCT02719574|453468203|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
126305158|NCT00734162|454407195|FG002|Open-Label Phase|Lost to Follow-up|0|||
126305159|NCT00734162|454407196|FG003|Open-Label Phase|Lost to Follow-up|1|||
126305160|NCT00734162|454407193|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126305161|NCT00734162|454407194|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126305162|NCT00734162|454407195|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126305163|NCT00734162|454407196|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
126305164|NCT00596687|454407199|FG000|Overall Study|< 24 hours of insulin treatment|8|||
126305165|NCT00596687|454407200|FG001|Overall Study|< 24 hours of insulin treatment|6|||
126305166|NCT00596687|454407199|FG000|Overall Study|continuous insulin infusion during TPN|2|||
126305167|NCT00596687|454407200|FG001|Overall Study|continuous insulin infusion during TPN|1|||
126305168|NCT00596687|454407199|FG000|Overall Study|Withdrawal by Subject|3|||
126305169|NCT00596687|454407200|FG001|Overall Study|Withdrawal by Subject|1|||
126305170|NCT00596687|454407199|FG000|Overall Study|cancelled surgery|1|||
126305171|NCT00596687|454407200|FG001|Overall Study|cancelled surgery|1|||
126305172|NCT03831113|454407201|FG000|Overall Study|Withdrawal by Subject|0|||
126305173|NCT03831113|454407202|FG001|Overall Study|Withdrawal by Subject|2|||
126305174|NCT03831113|454407201|FG000|Overall Study|Protocol Violation|0|||
126305175|NCT03831113|454407202|FG001|Overall Study|Protocol Violation|9|||
126305176|NCT01068730|454407203|FG000|Period 3|Personal reason|1|||
126305177|NCT01068730|454407204|FG001|Period 3|Personal reason|0|||
126305178|NCT01068730|454407205|FG002|Period 3|Personal reason|0|||
126305179|NCT01068730|454407206|FG003|Period 3|Personal reason|0|||
126305180|NCT01068730|454407203|FG000|Period 4|Family emergency|0|||
126305181|NCT01068730|454407204|FG001|Period 4|Family emergency|1|||
126368936|NCT01358734|454646530|FG000|Overall Study|Adverse Event|4|||
126368937|NCT01358734|454646531|FG001|Overall Study|Adverse Event|7|||
126368938|NCT01358734|454646532|FG002|Overall Study|Adverse Event|3|||
126305182|NCT01068730|454407205|FG002|Period 4|Family emergency|0|||
126305183|NCT01068730|454407206|FG003|Period 4|Family emergency|0|||
126305184|NCT03981926|454407207|FG000|Overall Study|Lost to Follow-up|5|||
126305185|NCT03981926|454407208|FG001|Overall Study|Lost to Follow-up|9|||
126305186|NCT01057810|454407216|FG000|Overall Study|Disease progression|156|||
126305187|NCT01057810|454407217|FG001|Overall Study|Disease progression|197|||
126305188|NCT01057810|454407216|FG000|Overall Study|Study drug toxicity|5|||
126305189|NCT01057810|454407217|FG001|Overall Study|Study drug toxicity|114|||
126305190|NCT01057810|454407216|FG000|Overall Study|Adverse event unrelated to study drug|13|||
126305191|NCT01057810|454407217|FG001|Overall Study|Adverse event unrelated to study drug|29|||
126305192|NCT01057810|454407216|FG000|Overall Study|Withdrawal by Subject|10|||
126305193|NCT01057810|454407217|FG001|Overall Study|Withdrawal by Subject|25|||
126305194|NCT01057810|454407216|FG000|Overall Study|Death|2|||
126305195|NCT01057810|454407217|FG001|Overall Study|Death|12|||
126305196|NCT01057810|454407216|FG000|Overall Study|Maximum clinical benefit|5|||
126305197|NCT01057810|454407217|FG001|Overall Study|Maximum clinical benefit|5|||
126305198|NCT01057810|454407216|FG000|Overall Study|Poor/non-compliance|0|||
126305199|NCT01057810|454407217|FG001|Overall Study|Poor/non-compliance|1|||
126305200|NCT01057810|454407216|FG000|Overall Study|No longer met study criteria|0|||
126305201|NCT01057810|454407217|FG001|Overall Study|No longer met study criteria|1|||
126305202|NCT01057810|454407216|FG000|Overall Study|Other|7|||
126305203|NCT01057810|454407217|FG001|Overall Study|Other|14|||
126305204|NCT02564900|454407218|FG000|Dose Escalation|Progressive disease per RECIST|2|||
126305205|NCT02564900|454407219|FG001|Dose Escalation|Progressive disease per RECIST|3|||
126305206|NCT02564900|454407220|FG002|Dose Escalation|Progressive disease per RECIST|3|||
126305207|NCT02564900|454407221|FG003|Dose Escalation|Progressive disease per RECIST|3|||
126305208|NCT02564900|454407222|FG004|Dose Escalation|Progressive disease per RECIST|3|||
126305209|NCT02564900|454407223|FG005|Dose Escalation|Progressive disease per RECIST|1|||
126305210|NCT02564900|454407224|FG006|Dose Escalation|Progressive disease per RECIST|0|||
126305211|NCT02564900|454407225|FG007|Dose Escalation|Progressive disease per RECIST|0|||
126305212|NCT02564900|454407226|FG008|Dose Escalation|Progressive disease per RECIST|0|||
126305213|NCT02564900|454407227|FG009|Dose Escalation|Progressive disease per RECIST|0|||
126305214|NCT02564900|454407228|FG010|Dose Escalation|Progressive disease per RECIST|0|||
126305215|NCT02564900|454407229|FG011|Dose Escalation|Progressive disease per RECIST|0|||
126305216|NCT02564900|454407230|FG012|Dose Escalation|Progressive disease per RECIST|0|||
126305217|NCT02564900|454407231|FG013|Dose Escalation|Progressive disease per RECIST|0|||
126305218|NCT02564900|454407232|FG014|Dose Escalation|Progressive disease per RECIST|0|||
126305219|NCT02564900|454407218|FG000|Dose Escalation|Ongoing|1|||
126305220|NCT02564900|454407219|FG001|Dose Escalation|Ongoing|0|||
126305221|NCT02564900|454407220|FG002|Dose Escalation|Ongoing|0|||
126305222|NCT02564900|454407221|FG003|Dose Escalation|Ongoing|2|||
126305223|NCT02564900|454407222|FG004|Dose Escalation|Ongoing|2|||
126305224|NCT02564900|454407223|FG005|Dose Escalation|Ongoing|2|||
126305225|NCT02564900|454407224|FG006|Dose Escalation|Ongoing|0|||
126305226|NCT02564900|454407225|FG007|Dose Escalation|Ongoing|0|||
126305227|NCT02564900|454407226|FG008|Dose Escalation|Ongoing|0|||
126305228|NCT02564900|454407227|FG009|Dose Escalation|Ongoing|0|||
126305229|NCT02564900|454407228|FG010|Dose Escalation|Ongoing|0|||
126305230|NCT02564900|454407229|FG011|Dose Escalation|Ongoing|0|||
126305231|NCT02564900|454407230|FG012|Dose Escalation|Ongoing|0|||
126305232|NCT02564900|454407231|FG013|Dose Escalation|Ongoing|0|||
126305233|NCT02564900|454407232|FG014|Dose Escalation|Ongoing|0|||
126305234|NCT02564900|454407218|FG000|Dose Escalation|Adverse Event|0|||
126305235|NCT02564900|454407219|FG001|Dose Escalation|Adverse Event|0|||
126305236|NCT02564900|454407220|FG002|Dose Escalation|Adverse Event|0|||
126305237|NCT02564900|454407221|FG003|Dose Escalation|Adverse Event|1|||
126305238|NCT02564900|454407222|FG004|Dose Escalation|Adverse Event|1|||
126305239|NCT02564900|454407223|FG005|Dose Escalation|Adverse Event|3|||
126305240|NCT02564900|454407224|FG006|Dose Escalation|Adverse Event|0|||
126305241|NCT02564900|454407225|FG007|Dose Escalation|Adverse Event|0|||
126305242|NCT02564900|454407226|FG008|Dose Escalation|Adverse Event|0|||
126305243|NCT02564900|454407227|FG009|Dose Escalation|Adverse Event|0|||
126305244|NCT02564900|454407228|FG010|Dose Escalation|Adverse Event|0|||
126305245|NCT02564900|454407229|FG011|Dose Escalation|Adverse Event|0|||
126305246|NCT02564900|454407230|FG012|Dose Escalation|Adverse Event|0|||
126305247|NCT02564900|454407231|FG013|Dose Escalation|Adverse Event|0|||
126305248|NCT02564900|454407232|FG014|Dose Escalation|Adverse Event|0|||
126305249|NCT02564900|454407218|FG000|Dose Expansion|Progressive disease per RECIST|0|||
126305250|NCT02564900|454407219|FG001|Dose Expansion|Progressive disease per RECIST|0|||
126305251|NCT02564900|454407220|FG002|Dose Expansion|Progressive disease per RECIST|0|||
126305252|NCT02564900|454407221|FG003|Dose Expansion|Progressive disease per RECIST|0|||
126305253|NCT02564900|454407222|FG004|Dose Expansion|Progressive disease per RECIST|0|||
126305254|NCT02564900|454407223|FG005|Dose Expansion|Progressive disease per RECIST|0|||
126305255|NCT02564900|454407224|FG006|Dose Expansion|Progressive disease per RECIST|19|||
126305256|NCT02564900|454407225|FG007|Dose Expansion|Progressive disease per RECIST|17|||
126305257|NCT02564900|454407226|FG008|Dose Expansion|Progressive disease per RECIST|8|||
126305258|NCT02564900|454407227|FG009|Dose Expansion|Progressive disease per RECIST|16|||
126305259|NCT02564900|454407228|FG010|Dose Expansion|Progressive disease per RECIST|13|||
126305260|NCT02564900|454407229|FG011|Dose Expansion|Progressive disease per RECIST|19|||
126305261|NCT02564900|454407230|FG012|Dose Expansion|Progressive disease per RECIST|10|||
126305262|NCT02564900|454407231|FG013|Dose Expansion|Progressive disease per RECIST|13|||
126305263|NCT02564900|454407232|FG014|Dose Expansion|Progressive disease per RECIST|11|||
126305264|NCT02564900|454407218|FG000|Dose Expansion|Clinical progression|0|||
126305265|NCT02564900|454407219|FG001|Dose Expansion|Clinical progression|0|||
126305266|NCT02564900|454407220|FG002|Dose Expansion|Clinical progression|0|||
126305267|NCT02564900|454407221|FG003|Dose Expansion|Clinical progression|0|||
126305268|NCT02564900|454407222|FG004|Dose Expansion|Clinical progression|0|||
126305269|NCT02564900|454407223|FG005|Dose Expansion|Clinical progression|0|||
126305270|NCT02564900|454407224|FG006|Dose Expansion|Clinical progression|5|||
126305271|NCT02564900|454407225|FG007|Dose Expansion|Clinical progression|12|||
126305272|NCT02564900|454407226|FG008|Dose Expansion|Clinical progression|0|||
126305273|NCT02564900|454407227|FG009|Dose Expansion|Clinical progression|3|||
126305274|NCT02564900|454407228|FG010|Dose Expansion|Clinical progression|2|||
126305275|NCT02564900|454407229|FG011|Dose Expansion|Clinical progression|0|||
126305276|NCT02564900|454407230|FG012|Dose Expansion|Clinical progression|1|||
126305277|NCT02564900|454407231|FG013|Dose Expansion|Clinical progression|3|||
126305278|NCT02564900|454407232|FG014|Dose Expansion|Clinical progression|1|||
126305279|NCT02564900|454407218|FG000|Dose Expansion|Adverse Event|0|||
126305280|NCT02564900|454407219|FG001|Dose Expansion|Adverse Event|0|||
126305281|NCT02564900|454407220|FG002|Dose Expansion|Adverse Event|0|||
126305282|NCT02564900|454407221|FG003|Dose Expansion|Adverse Event|0|||
126305283|NCT02564900|454407222|FG004|Dose Expansion|Adverse Event|0|||
126305284|NCT02564900|454407223|FG005|Dose Expansion|Adverse Event|0|||
126305285|NCT02564900|454407224|FG006|Dose Expansion|Adverse Event|9|||
126305286|NCT02564900|454407225|FG007|Dose Expansion|Adverse Event|22|||
126305287|NCT02564900|454407226|FG008|Dose Expansion|Adverse Event|0|||
126305288|NCT02564900|454407227|FG009|Dose Expansion|Adverse Event|11|||
126305289|NCT02564900|454407228|FG010|Dose Expansion|Adverse Event|0|||
126305290|NCT02564900|454407229|FG011|Dose Expansion|Adverse Event|5|||
126305291|NCT02564900|454407230|FG012|Dose Expansion|Adverse Event|2|||
126305292|NCT02564900|454407231|FG013|Dose Expansion|Adverse Event|2|||
126305293|NCT02564900|454407232|FG014|Dose Expansion|Adverse Event|1|||
126305294|NCT02564900|454407218|FG000|Dose Expansion|Ongoing|0|||
126305295|NCT02564900|454407219|FG001|Dose Expansion|Ongoing|0|||
126305296|NCT02564900|454407220|FG002|Dose Expansion|Ongoing|0|||
126305297|NCT02564900|454407221|FG003|Dose Expansion|Ongoing|0|||
126305298|NCT02564900|454407222|FG004|Dose Expansion|Ongoing|0|||
126305299|NCT02564900|454407223|FG005|Dose Expansion|Ongoing|0|||
126305300|NCT02564900|454407224|FG006|Dose Expansion|Ongoing|9|||
126305301|NCT02564900|454407225|FG007|Dose Expansion|Ongoing|10|||
126305302|NCT02564900|454407226|FG008|Dose Expansion|Ongoing|11|||
126305303|NCT02564900|454407227|FG009|Dose Expansion|Ongoing|3|||
126305304|NCT02564900|454407228|FG010|Dose Expansion|Ongoing|0|||
126305305|NCT02564900|454407229|FG011|Dose Expansion|Ongoing|0|||
126305306|NCT02564900|454407230|FG012|Dose Expansion|Ongoing|4|||
126305307|NCT02564900|454407231|FG013|Dose Expansion|Ongoing|0|||
126305308|NCT02564900|454407232|FG014|Dose Expansion|Ongoing|6|||
126305309|NCT02564900|454407218|FG000|Dose Expansion|Death|0|||
126305310|NCT02564900|454407219|FG001|Dose Expansion|Death|0|||
126305311|NCT02564900|454407220|FG002|Dose Expansion|Death|0|||
126305312|NCT02564900|454407221|FG003|Dose Expansion|Death|0|||
126305313|NCT02564900|454407222|FG004|Dose Expansion|Death|0|||
126305314|NCT02564900|454407223|FG005|Dose Expansion|Death|0|||
126305315|NCT02564900|454407224|FG006|Dose Expansion|Death|1|||
126305316|NCT02564900|454407225|FG007|Dose Expansion|Death|0|||
126368939|NCT01358734|454646530|FG000|Overall Study|Lack of Efficacy|0|||
126368940|NCT01358734|454646531|FG001|Overall Study|Lack of Efficacy|1|||
126368941|NCT01358734|454646532|FG002|Overall Study|Lack of Efficacy|3|||
126368942|NCT01358734|454646530|FG000|Overall Study|Withdrawal by Subject|1|||
126305317|NCT02564900|454407226|FG008|Dose Expansion|Death|0|||
126368943|NCT01358734|454646531|FG001|Overall Study|Withdrawal by Subject|6|||
126368944|NCT01358734|454646532|FG002|Overall Study|Withdrawal by Subject|3|||
126368945|NCT01358734|454646530|FG000|Overall Study|Death|3|||
126305318|NCT02564900|454407227|FG009|Dose Expansion|Death|0|||
126305319|NCT02564900|454407228|FG010|Dose Expansion|Death|1|||
126305320|NCT02564900|454407229|FG011|Dose Expansion|Death|0|||
126305321|NCT02564900|454407230|FG012|Dose Expansion|Death|1|||
126305322|NCT02564900|454407231|FG013|Dose Expansion|Death|1|||
126305323|NCT02564900|454407232|FG014|Dose Expansion|Death|0|||
126305324|NCT02564900|454407218|FG000|Dose Expansion|Withdrawal by Subject|0|||
126305325|NCT02564900|454407219|FG001|Dose Expansion|Withdrawal by Subject|0|||
126368946|NCT01358734|454646531|FG001|Overall Study|Death|7|||
126305326|NCT02564900|454407220|FG002|Dose Expansion|Withdrawal by Subject|0|||
126305327|NCT02564900|454407221|FG003|Dose Expansion|Withdrawal by Subject|0|||
126305328|NCT02564900|454407222|FG004|Dose Expansion|Withdrawal by Subject|0|||
126305329|NCT02564900|454407223|FG005|Dose Expansion|Withdrawal by Subject|0|||
126305330|NCT02564900|454407224|FG006|Dose Expansion|Withdrawal by Subject|4|||
126305331|NCT02564900|454407225|FG007|Dose Expansion|Withdrawal by Subject|0|||
126305332|NCT02564900|454407226|FG008|Dose Expansion|Withdrawal by Subject|0|||
126305333|NCT02564900|454407227|FG009|Dose Expansion|Withdrawal by Subject|0|||
126305334|NCT02564900|454407228|FG010|Dose Expansion|Withdrawal by Subject|1|||
126305335|NCT02564900|454407229|FG011|Dose Expansion|Withdrawal by Subject|0|||
126305336|NCT02564900|454407230|FG012|Dose Expansion|Withdrawal by Subject|0|||
126305337|NCT02564900|454407231|FG013|Dose Expansion|Withdrawal by Subject|1|||
126305338|NCT02564900|454407232|FG014|Dose Expansion|Withdrawal by Subject|1|||
126305339|NCT02564900|454407218|FG000|Dose Expansion|Other|0|||
126305340|NCT02564900|454407219|FG001|Dose Expansion|Other|0|||
126305341|NCT02564900|454407220|FG002|Dose Expansion|Other|0|||
126305342|NCT02564900|454407221|FG003|Dose Expansion|Other|0|||
126305343|NCT02564900|454407222|FG004|Dose Expansion|Other|0|||
126305344|NCT02564900|454407223|FG005|Dose Expansion|Other|0|||
126305345|NCT02564900|454407224|FG006|Dose Expansion|Other|1|||
126305346|NCT02564900|454407225|FG007|Dose Expansion|Other|0|||
126305347|NCT02564900|454407226|FG008|Dose Expansion|Other|1|||
126305348|NCT02564900|454407227|FG009|Dose Expansion|Other|0|||
126305349|NCT02564900|454407228|FG010|Dose Expansion|Other|0|||
126305350|NCT02564900|454407229|FG011|Dose Expansion|Other|0|||
126305351|NCT02564900|454407230|FG012|Dose Expansion|Other|0|||
126305352|NCT02564900|454407231|FG013|Dose Expansion|Other|0|||
126305353|NCT02564900|454407232|FG014|Dose Expansion|Other|1|||
126305354|NCT02564900|454407218|FG000|Dose Expansion|Did not receive treatment|0|||
126305355|NCT02564900|454407219|FG001|Dose Expansion|Did not receive treatment|0|||
126305356|NCT02564900|454407220|FG002|Dose Expansion|Did not receive treatment|0|||
126305357|NCT02564900|454407221|FG003|Dose Expansion|Did not receive treatment|0|||
126305358|NCT02564900|454407222|FG004|Dose Expansion|Did not receive treatment|0|||
126305359|NCT02564900|454407223|FG005|Dose Expansion|Did not receive treatment|0|||
126305360|NCT02564900|454407224|FG006|Dose Expansion|Did not receive treatment|1|||
126305361|NCT02564900|454407225|FG007|Dose Expansion|Did not receive treatment|1|||
126305362|NCT02564900|454407226|FG008|Dose Expansion|Did not receive treatment|0|||
126305363|NCT02564900|454407227|FG009|Dose Expansion|Did not receive treatment|0|||
126305364|NCT02564900|454407228|FG010|Dose Expansion|Did not receive treatment|0|||
126305365|NCT02564900|454407229|FG011|Dose Expansion|Did not receive treatment|0|||
126305366|NCT02564900|454407230|FG012|Dose Expansion|Did not receive treatment|0|||
126305367|NCT02564900|454407231|FG013|Dose Expansion|Did not receive treatment|0|||
126305368|NCT02564900|454407232|FG014|Dose Expansion|Did not receive treatment|1|||
126305369|NCT00887315|454407234|FG000|Overall Study|Study termination|7|||
126305370|NCT00887315|454407235|FG001|Overall Study|Study termination|4|||
126305371|NCT00619892|454407236|FG000|Overall Study|Adverse Event|3|||
126305372|NCT00619892|454407237|FG001|Overall Study|Adverse Event|0|||
126305373|NCT00619892|454407236|FG000|Overall Study|Lost to Follow-up|0|||
126305374|NCT00619892|454407237|FG001|Overall Study|Lost to Follow-up|1|||
126305375|NCT00619892|454407236|FG000|Overall Study|Intercurrent illness|0|||
126305376|NCT00619892|454407237|FG001|Overall Study|Intercurrent illness|1|||
126305377|NCT00379080|454407238|FG000|Overall Study|Withdrawal by Subject|0|||
126305378|NCT00379080|454407239|FG001|Overall Study|Withdrawal by Subject|4|||
126305379|NCT00379080|454407240|FG002|Overall Study|Withdrawal by Subject|0|||
126305380|NCT00857896|454407246|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
126305381|NCT01091662|454407247|FG000|Overall Study|Adverse Event|1|||
126305382|NCT01091662|454407248|FG001|Overall Study|Adverse Event|9|||
126305383|NCT01091662|454407247|FG000|Overall Study|Physician Decision|1|||
126305384|NCT01091662|454407248|FG001|Overall Study|Physician Decision|1|||
126305385|NCT01091662|454407247|FG000|Overall Study|Withdrawal by Subject|7|||
126305386|NCT01091662|454407248|FG001|Overall Study|Withdrawal by Subject|6|||
126305387|NCT01091662|454407247|FG000|Overall Study|met exit criteria|7|||
126305388|NCT01091662|454407248|FG001|Overall Study|met exit criteria|13|||
126305389|NCT01091662|454407247|FG000|Overall Study|met exclusion criteria|1|||
126305390|NCT01091662|454407248|FG001|Overall Study|met exclusion criteria|0|||
126305391|NCT01091662|454407247|FG000|Overall Study|Lost to Follow-up|0|||
126305392|NCT01091662|454407248|FG001|Overall Study|Lost to Follow-up|1|||
126305393|NCT01091662|454407247|FG000|Overall Study|Pregnancy|0|||
126305394|NCT01091662|454407248|FG001|Overall Study|Pregnancy|1|||
126305395|NCT01091662|454407247|FG000|Overall Study|Protocol Violation|0|||
126305396|NCT01091662|454407248|FG001|Overall Study|Protocol Violation|2|||
126305397|NCT01091662|454407247|FG000|Overall Study|unable to swallow capsule|0|||
126305398|NCT01091662|454407248|FG001|Overall Study|unable to swallow capsule|1|||
126305399|NCT01222520|454407249|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
126305400|NCT01222520|454407250|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
126305401|NCT01222520|454407249|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
126305402|NCT01222520|454407250|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
126305403|NCT01222520|454407249|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
126305404|NCT01222520|454407250|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
126305405|NCT01222520|454407249|FG000|Double-blind Period|Adverse Event|0|||
126305406|NCT01222520|454407250|FG001|Double-blind Period|Adverse Event|1|||
126305407|NCT01222520|454407249|FG000|Double-blind Period|Lack of Efficacy|0|||
126305408|NCT01222520|454407250|FG001|Double-blind Period|Lack of Efficacy|1|||
126305409|NCT01222520|454407249|FG000|Double-blind Period|Study medication stolen|1|||
126305410|NCT01222520|454407250|FG001|Double-blind Period|Study medication stolen|0|||
126305411|NCT04109391|454407251|FG000|Overall Study|Adverse Event|2|||
126305412|NCT04109391|454407252|FG001|Overall Study|Adverse Event|2|||
126305413|NCT04109391|454407253|FG002|Overall Study|Adverse Event|0|||
126305414|NCT04109391|454407251|FG000|Overall Study|Withdrawal by Subject|2|||
126305415|NCT04109391|454407252|FG001|Overall Study|Withdrawal by Subject|0|||
126305416|NCT04109391|454407253|FG002|Overall Study|Withdrawal by Subject|0|||
126305417|NCT04109391|454407251|FG000|Overall Study|Pregnancy|1|||
126305418|NCT04109391|454407252|FG001|Overall Study|Pregnancy|0|||
126305419|NCT04109391|454407253|FG002|Overall Study|Pregnancy|0|||
126305420|NCT04109391|454407251|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
126305421|NCT04109391|454407252|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
126305422|NCT04109391|454407253|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
126305423|NCT04109391|454407251|FG000|Overall Study|Lost to Follow-up|0|||
126305424|NCT04109391|454407252|FG001|Overall Study|Lost to Follow-up|0|||
126305425|NCT04109391|454407253|FG002|Overall Study|Lost to Follow-up|1|||
126305426|NCT04109391|454407251|FG000|Overall Study|Lack of Efficacy|2|||
126305427|NCT04109391|454407252|FG001|Overall Study|Lack of Efficacy|2|||
126305428|NCT04109391|454407253|FG002|Overall Study|Lack of Efficacy|3|||
126305429|NCT01089608|454407256|FG000|Overall Study|Adverse Event|0|||
126305430|NCT01089608|454407257|FG001|Overall Study|Adverse Event|4|||
126305431|NCT01089608|454407256|FG000|Overall Study|Lost to Follow-up|0|||
126305432|NCT01089608|454407257|FG001|Overall Study|Lost to Follow-up|2|||
126305433|NCT00280397|454407258|FG000|Overall Study|Adverse Event|1|||
126305434|NCT02257489|454407259|FG000|Overall Study|Withdrawal by Subject|0|||
126305435|NCT02257489|454407260|FG001|Overall Study|Withdrawal by Subject|0|||
126305436|NCT02257489|454407261|FG002|Overall Study|Withdrawal by Subject|0|||
126305437|NCT02257489|454407262|FG003|Overall Study|Withdrawal by Subject|1|||
126305438|NCT02257489|454407263|FG004|Overall Study|Withdrawal by Subject|0|||
126305439|NCT02257489|454407264|FG005|Overall Study|Withdrawal by Subject|0|||
126305440|NCT02257489|454407265|FG006|Overall Study|Withdrawal by Subject|0|||
126305441|NCT02257489|454407266|FG007|Overall Study|Withdrawal by Subject|0|||
126305442|NCT02257489|454407267|FG008|Overall Study|Withdrawal by Subject|0|||
126305443|NCT00955955|454407270|FG000|Overall Study|Lost to Follow-up|2|||
126305444|NCT00955955|454407271|FG001|Overall Study|Lost to Follow-up|0|||
126305445|NCT00955955|454407272|FG002|Overall Study|Lost to Follow-up|0|||
126305446|NCT03169881|454407273|FG000|Overall Study|Incomplete Follow-up|10|||
126305447|NCT03169881|454407274|FG001|Overall Study|Incomplete Follow-up|15|||
126305448|NCT03169881|454407273|FG000|Overall Study|Lost to Follow-up|18|||
126305449|NCT03169881|454407274|FG001|Overall Study|Lost to Follow-up|20|||
126305450|NCT03169881|454407273|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
126305451|NCT03169881|454407274|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
126305452|NCT03852264|454407275|FG000|Third Research Visit|Lost to Follow-up|1|||
126305453|NCT03852264|454407276|FG001|Third Research Visit|Lost to Follow-up|0|||
126305454|NCT00637000|454407278|FG000|Overall Study|Withdrawal by Subject|4|||
126305455|NCT00637000|454407279|FG001|Overall Study|Withdrawal by Subject|3|||
126305456|NCT00396656|454407284|FG000|First Treatment Period|Withdrawal by Subject|0|||
126305457|NCT00396656|454407285|FG001|First Treatment Period|Withdrawal by Subject|2|||
126305458|NCT00396656|454407284|FG000|Second Treatment Period|Adverse Event|0|||
126305459|NCT00396656|454407285|FG001|Second Treatment Period|Adverse Event|1|||
126368947|NCT01358734|454646532|FG002|Overall Study|Death|2|||
126368948|NCT01358734|454646530|FG000|Overall Study|Progressive Disease|5|||
126368949|NCT01358734|454646531|FG001|Overall Study|Progressive Disease|13|||
126368950|NCT01358734|454646532|FG002|Overall Study|Progressive Disease|16|||
126368951|NCT01358734|454646530|FG000|Overall Study|Non-compliance with study drug|0|||
126305460|NCT00552396|454407286|FG000|Overall Study|protocol withdrawal criteria|3|||
126305461|NCT00552396|454407287|FG001|Overall Study|protocol withdrawal criteria|3|||
126305462|NCT00552396|454407288|FG002|Overall Study|protocol withdrawal criteria|3|||
126305463|NCT00552396|454407289|FG003|Overall Study|protocol withdrawal criteria|6|||
126305464|NCT00552396|454407290|FG004|Overall Study|protocol withdrawal criteria|3|||
126305465|NCT00552396|454407291|FG005|Overall Study|protocol withdrawal criteria|3|||
126305466|NCT00552396|454407292|FG006|Overall Study|protocol withdrawal criteria|9|||
126305467|NCT04185220|454407293|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
126305468|NCT04185220|454407294|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
126368952|NCT01358734|454646531|FG001|Overall Study|Non-compliance with study drug|0|||
126046123|NCT02719574|453468204|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046124|NCT02719574|453468205|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
126046125|NCT02719574|453468206|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
126046126|NCT02719574|453468207|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126305469|NCT04185220|454407293|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
126305470|NCT04185220|454407294|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
126305471|NCT01186692|454407297|FG000|Overall Study|Not Catheterized|11|||
126305472|NCT01186692|454407297|FG000|Overall Study|Futher testing contraindicated implant|19|||
126305473|NCT01186692|454407297|FG000|Overall Study|Adverse Event|2|||
126305474|NCT00767455|454407298|FG000|Overall Study|Investigator error|19|||
126305475|NCT00022698|454407299|FG000|Overall Study|Adverse Event|5|||
126305476|NCT00022698|454407300|FG001|Overall Study|Adverse Event|9|||
126305477|NCT00022698|454407299|FG000|Overall Study|Death|0|||
126305478|NCT00022698|454407300|FG001|Overall Study|Death|2|||
126046127|NCT02719574|453468208|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046128|NCT02719574|453468209|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046129|NCT02719574|453468210|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046130|NCT02719574|453468211|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046131|NCT02719574|453468212|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046132|NCT02719574|453468213|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046133|NCT02719574|453468214|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046134|NCT02719574|453468215|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125885120|NCT01177397|452876781|FG009|Overall Study|Other reasons|8|||
125885121|NCT01177397|452876782|FG010|Overall Study|Other reasons|0|||
126305479|NCT00022698|454407299|FG000|Overall Study|Failure to return|0|||
126305480|NCT00022698|454407300|FG001|Overall Study|Failure to return|1|||
126305481|NCT00022698|454407299|FG000|Overall Study|Refused treatment|0|||
126305482|NCT00022698|454407300|FG001|Overall Study|Refused treatment|2|||
126305483|NCT00022698|454407299|FG000|Overall Study|Insufficient therapeutic response|2|||
126305484|NCT00022698|454407300|FG001|Overall Study|Insufficient therapeutic response|14|||
126305485|NCT00022698|454407299|FG000|Overall Study|Administrative /other|1|||
126305486|NCT00022698|454407300|FG001|Overall Study|Administrative /other|7|||
126305487|NCT03425396|454407307|FG000|Overall Study|Lost to Follow-up|2|||
126305488|NCT03425396|454407308|FG001|Overall Study|Lost to Follow-up|5|||
126305489|NCT03425396|454407309|FG002|Overall Study|Lost to Follow-up|2|||
126305490|NCT03425396|454407310|FG003|Overall Study|Lost to Follow-up|0|||
126305491|NCT03425396|454407311|FG004|Overall Study|Lost to Follow-up|0|||
126305492|NCT03425396|454407307|FG000|Overall Study|Withdrawal by Subject|0|||
126305493|NCT03425396|454407308|FG001|Overall Study|Withdrawal by Subject|1|||
126305494|NCT03425396|454407309|FG002|Overall Study|Withdrawal by Subject|0|||
126305495|NCT03425396|454407310|FG003|Overall Study|Withdrawal by Subject|1|||
126305496|NCT03425396|454407311|FG004|Overall Study|Withdrawal by Subject|0|||
126305497|NCT03425396|454407307|FG000|Overall Study|Other|0|||
126305498|NCT03425396|454407308|FG001|Overall Study|Other|1|||
126305499|NCT03425396|454407309|FG002|Overall Study|Other|1|||
126305500|NCT03425396|454407310|FG003|Overall Study|Other|0|||
126305501|NCT03425396|454407311|FG004|Overall Study|Other|1|||
126305502|NCT04520997|454407315|FG000|Overall Study|Lost to Follow-up|1|||
126305503|NCT04520997|454407316|FG001|Overall Study|Lost to Follow-up|1|||
126305504|NCT04520997|454407315|FG000|Overall Study|Withdrawal by Subject|1|||
126305505|NCT04520997|454407316|FG001|Overall Study|Withdrawal by Subject|0|||
126305506|NCT04520997|454407315|FG000|Overall Study|Not Treated|0|||
126305507|NCT04520997|454407316|FG001|Overall Study|Not Treated|1|||
126305508|NCT02981082|454407317|FG000|Overall Study|Withdrawal by Subject|2|||
126305509|NCT02981082|454407318|FG001|Overall Study|Withdrawal by Subject|0|||
126305510|NCT02981082|454407317|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
126305511|NCT02981082|454407318|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
126305512|NCT02981082|454407317|FG000|Overall Study|Adverse Event|0|||
126305513|NCT02981082|454407318|FG001|Overall Study|Adverse Event|1|||
126305514|NCT05367973|454407319|FG000|Overall Study|Adverse Event|0|||
126046135|NCT02719574|453468216|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046136|NCT02719574|453468217|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126046137|NCT02719574|453468201|FG000|Phase 1 (Dose Escalation)|Death|2|||
126046138|NCT02719574|453468202|FG001|Phase 1 (Dose Escalation)|Death|1|||
126046139|NCT02719574|453468203|FG002|Phase 1 (Dose Escalation)|Death|1|||
126046140|NCT02719574|453468204|FG003|Phase 1 (Dose Escalation)|Death|0|||
126046141|NCT02719574|453468205|FG004|Phase 1 (Dose Escalation)|Death|0|||
126305515|NCT05367973|454407320|FG001|Overall Study|Adverse Event|2|||
126305516|NCT01314872|454407324|FG000|Treatment Period 1|Protocol Violation|2|||
126305517|NCT01314872|454407325|FG001|Treatment Period 1|Protocol Violation|1|||
126305518|NCT01314872|454407326|FG002|Treatment Period 1|Protocol Violation|1|||
126305519|NCT01314872|454407327|FG003|Treatment Period 1|Protocol Violation|0|||
126046142|NCT02719574|453468206|FG005|Phase 1 (Dose Escalation)|Death|0|||
126305520|NCT01314872|454407328|FG004|Treatment Period 1|Protocol Violation|1|||
126305521|NCT01314872|454407329|FG005|Treatment Period 1|Protocol Violation|0|||
125885122|NCT01177397|452876783|FG011|Overall Study|Other reasons|2|||
126368953|NCT01358734|454646532|FG002|Overall Study|Non-compliance with study drug|1|||
126368954|NCT01358734|454646530|FG000|Overall Study|Other|2|||
126368955|NCT01358734|454646531|FG001|Overall Study|Other|5|||
126368956|NCT01358734|454646532|FG002|Overall Study|Other|4|||
126368957|NCT01358734|454646530|FG000|Overall Study|Protocol Violation|0|||
126368958|NCT01358734|454646531|FG001|Overall Study|Protocol Violation|0|||
126368959|NCT01358734|454646532|FG002|Overall Study|Protocol Violation|2|||
126368960|NCT01822925|454646533|FG000|Overall Study|Adverse Event|1|||
126368961|NCT01822925|454646534|FG001|Overall Study|Adverse Event|1|||
126368962|NCT01822925|454646535|FG002|Overall Study|Adverse Event|1|||
126368963|NCT01822925|454646536|FG003|Overall Study|Adverse Event|1|||
126368964|NCT01822925|454646533|FG000|Overall Study|Lost to Follow-up|0|||
126368965|NCT01822925|454646534|FG001|Overall Study|Lost to Follow-up|1|||
126368966|NCT01822925|454646535|FG002|Overall Study|Lost to Follow-up|0|||
126368967|NCT01822925|454646536|FG003|Overall Study|Lost to Follow-up|0|||
126368968|NCT01822925|454646533|FG000|Overall Study|Protocol Violation|1|||
126368969|NCT01822925|454646534|FG001|Overall Study|Protocol Violation|0|||
126368970|NCT01822925|454646535|FG002|Overall Study|Protocol Violation|0|||
126368971|NCT01822925|454646536|FG003|Overall Study|Protocol Violation|1|||
126368972|NCT01822925|454646533|FG000|Overall Study|Withdrawal by Subject|2|||
126368973|NCT01822925|454646534|FG001|Overall Study|Withdrawal by Subject|0|||
126368974|NCT01822925|454646535|FG002|Overall Study|Withdrawal by Subject|2|||
126368975|NCT01822925|454646536|FG003|Overall Study|Withdrawal by Subject|2|||
126368976|NCT01822925|454646533|FG000|Overall Study|Taking prohibited medication|2|||
126368977|NCT01822925|454646534|FG001|Overall Study|Taking prohibited medication|0|||
126368978|NCT01822925|454646535|FG002|Overall Study|Taking prohibited medication|0|||
126368979|NCT01822925|454646536|FG003|Overall Study|Taking prohibited medication|1|||
126368980|NCT04617860|454646538|FG000|Overall Study|Adverse Event|0|||
126368981|NCT04617860|454646539|FG001|Overall Study|Adverse Event|2|||
126368982|NCT04617860|454646540|FG002|Overall Study|Adverse Event|2|||
126368983|NCT04617860|454646538|FG000|Overall Study|Withdrawal by Subject|0|||
126368984|NCT04617860|454646539|FG001|Overall Study|Withdrawal by Subject|0|||
126368985|NCT04617860|454646540|FG002|Overall Study|Withdrawal by Subject|2|||
126368986|NCT04617860|454646538|FG000|Overall Study|Physician Decision|0|||
126368987|NCT04617860|454646539|FG001|Overall Study|Physician Decision|1|||
126368988|NCT04617860|454646540|FG002|Overall Study|Physician Decision|0|||
126368989|NCT04617860|454646538|FG000|Overall Study|Sponsor Decision|0|||
126368990|NCT04617860|454646539|FG001|Overall Study|Sponsor Decision|3|||
126368991|NCT04617860|454646540|FG002|Overall Study|Sponsor Decision|1|||
126368992|NCT04617860|454646538|FG000|Overall Study|Termination of Study by Sponsor|8|||
126368993|NCT04617860|454646539|FG001|Overall Study|Termination of Study by Sponsor|4|||
126368994|NCT04617860|454646540|FG002|Overall Study|Termination of Study by Sponsor|13|||
126368995|NCT01182350|454646541|FG000|Overall Study|Adverse Event|5|||
126368996|NCT01182350|454646542|FG001|Overall Study|Adverse Event|0|||
126368997|NCT01182350|454646543|FG002|Overall Study|Adverse Event|0|||
126368998|NCT01182350|454646544|FG003|Overall Study|Adverse Event|0|||
126368999|NCT01182350|454646545|FG004|Overall Study|Adverse Event|0|||
126369000|NCT01182350|454646541|FG000|Overall Study|Disease Progression|15|||
126369001|NCT01182350|454646542|FG001|Overall Study|Disease Progression|12|||
126369002|NCT01182350|454646543|FG002|Overall Study|Disease Progression|0|||
126369003|NCT01182350|454646544|FG003|Overall Study|Disease Progression|1|||
126369004|NCT01182350|454646545|FG004|Overall Study|Disease Progression|0|||
126369005|NCT01182350|454646541|FG000|Overall Study|Death|0|||
126369006|NCT01182350|454646542|FG001|Overall Study|Death|1|||
126369007|NCT01182350|454646543|FG002|Overall Study|Death|1|||
126369008|NCT01182350|454646544|FG003|Overall Study|Death|0|||
126369009|NCT01182350|454646545|FG004|Overall Study|Death|0|||
126369010|NCT01182350|454646541|FG000|Overall Study|Withdrawal by Subject|3|||
126369011|NCT01182350|454646542|FG001|Overall Study|Withdrawal by Subject|1|||
126369012|NCT01182350|454646543|FG002|Overall Study|Withdrawal by Subject|0|||
126369013|NCT01182350|454646544|FG003|Overall Study|Withdrawal by Subject|1|||
126369014|NCT01182350|454646545|FG004|Overall Study|Withdrawal by Subject|0|||
126369015|NCT01182350|454646541|FG000|Overall Study|Alternative Therapy|2|||
126369016|NCT01182350|454646542|FG001|Overall Study|Alternative Therapy|0|||
126369017|NCT01182350|454646543|FG002|Overall Study|Alternative Therapy|1|||
126369018|NCT01182350|454646544|FG003|Overall Study|Alternative Therapy|0|||
126369019|NCT01182350|454646545|FG004|Overall Study|Alternative Therapy|0|||
126369020|NCT01182350|454646541|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
126369021|NCT01182350|454646542|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
126369022|NCT01182350|454646543|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
126369023|NCT01182350|454646544|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
126369024|NCT01182350|454646545|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
126369025|NCT01182350|454646541|FG000|Overall Study|Unevaluable for Biopsy|0|||
126369026|NCT01182350|454646542|FG001|Overall Study|Unevaluable for Biopsy|0|||
126369027|NCT01182350|454646543|FG002|Overall Study|Unevaluable for Biopsy|0|||
126369028|NCT01182350|454646544|FG003|Overall Study|Unevaluable for Biopsy|0|||
126369029|NCT01182350|454646545|FG004|Overall Study|Unevaluable for Biopsy|3|||
126369030|NCT03898180|454646546|FG000|Overall Study|Death|178|||
126046143|NCT02719574|453468207|FG006|Phase 1 (Dose Escalation)|Death|0|||
126046144|NCT02719574|453468208|FG007|Phase 1 (Dose Escalation)|Death|0|||
126046145|NCT02719574|453468209|FG008|Phase 1 (Dose Escalation)|Death|0|||
126046146|NCT02719574|453468210|FG009|Phase 1 (Dose Escalation)|Death|0|||
126046147|NCT02719574|453468211|FG010|Phase 1 (Dose Escalation)|Death|0|||
126046148|NCT02719574|453468212|FG011|Phase 1 (Dose Escalation)|Death|0|||
126046149|NCT02719574|453468213|FG012|Phase 1 (Dose Escalation)|Death|0|||
126046150|NCT02719574|453468214|FG013|Phase 1 (Dose Escalation)|Death|0|||
126046151|NCT02719574|453468215|FG014|Phase 1 (Dose Escalation)|Death|0|||
126046152|NCT02719574|453468216|FG015|Phase 1 (Dose Escalation)|Death|0|||
126046153|NCT02719574|453468217|FG016|Phase 1 (Dose Escalation)|Death|0|||
126046154|NCT02719574|453468201|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046155|NCT02719574|453468202|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
126046156|NCT02719574|453468203|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046157|NCT02719574|453468204|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046158|NCT02719574|453468205|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
126046159|NCT02719574|453468206|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
126046160|NCT02719574|453468207|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046161|NCT02719574|453468208|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046162|NCT02719574|453468209|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046163|NCT02719574|453468210|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046164|NCT02719574|453468211|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046165|NCT02719574|453468212|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046166|NCT02719574|453468213|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046167|NCT02719574|453468214|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046168|NCT02719574|453468215|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046169|NCT02719574|453468216|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046170|NCT02719574|453468217|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
126046171|NCT02719574|453468201|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046172|NCT02719574|453468202|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046173|NCT02719574|453468203|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046174|NCT02719574|453468204|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046175|NCT02719574|453468205|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
126305522|NCT01314872|454407330|FG006|Treatment Period 1|Protocol Violation|0|||
126305523|NCT01314872|454407331|FG007|Treatment Period 1|Protocol Violation|0|||
126305524|NCT01314872|454407332|FG008|Treatment Period 1|Protocol Violation|0|||
126305525|NCT01314872|454407333|FG009|Treatment Period 1|Protocol Violation|1|||
126305526|NCT01314872|454407334|FG010|Treatment Period 1|Protocol Violation|1|||
126305527|NCT01314872|454407335|FG011|Treatment Period 1|Protocol Violation|0|||
126305528|NCT01314872|454407336|FG012|Treatment Period 1|Protocol Violation|0|||
126305529|NCT01314872|454407337|FG013|Treatment Period 1|Protocol Violation|0|||
126305530|NCT01314872|454407338|FG014|Treatment Period 1|Protocol Violation|0|||
126305531|NCT01314872|454407324|FG000|Treatment Period 1|Physician Decision|0|||
126305532|NCT01314872|454407325|FG001|Treatment Period 1|Physician Decision|1|||
126305533|NCT01314872|454407326|FG002|Treatment Period 1|Physician Decision|0|||
126305534|NCT01314872|454407327|FG003|Treatment Period 1|Physician Decision|1|||
126305535|NCT01314872|454407328|FG004|Treatment Period 1|Physician Decision|0|||
126305536|NCT01314872|454407329|FG005|Treatment Period 1|Physician Decision|0|||
126305537|NCT01314872|454407330|FG006|Treatment Period 1|Physician Decision|0|||
126305538|NCT01314872|454407331|FG007|Treatment Period 1|Physician Decision|0|||
126305539|NCT01314872|454407332|FG008|Treatment Period 1|Physician Decision|0|||
126305540|NCT01314872|454407333|FG009|Treatment Period 1|Physician Decision|1|||
126305541|NCT01314872|454407334|FG010|Treatment Period 1|Physician Decision|0|||
126305542|NCT01314872|454407335|FG011|Treatment Period 1|Physician Decision|0|||
126305543|NCT01314872|454407336|FG012|Treatment Period 1|Physician Decision|0|||
126305544|NCT01314872|454407337|FG013|Treatment Period 1|Physician Decision|0|||
126305545|NCT01314872|454407338|FG014|Treatment Period 1|Physician Decision|0|||
126046176|NCT02719574|453468206|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
126046177|NCT02719574|453468207|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046178|NCT02719574|453468208|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
126305546|NCT01314872|454407324|FG000|Treatment Period 1|Lack of Efficacy|1|||
126305547|NCT01314872|454407325|FG001|Treatment Period 1|Lack of Efficacy|0|||
126046179|NCT02719574|453468209|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046180|NCT02719574|453468210|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046181|NCT02719574|453468211|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046182|NCT02719574|453468212|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046183|NCT02719574|453468213|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046184|NCT02719574|453468214|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
126305548|NCT01314872|454407326|FG002|Treatment Period 1|Lack of Efficacy|0|||
126305549|NCT01314872|454407327|FG003|Treatment Period 1|Lack of Efficacy|0|||
126305550|NCT01314872|454407328|FG004|Treatment Period 1|Lack of Efficacy|0|||
126305551|NCT01314872|454407329|FG005|Treatment Period 1|Lack of Efficacy|1|||
126305552|NCT01314872|454407330|FG006|Treatment Period 1|Lack of Efficacy|0|||
125885123|NCT00865566|452876784|FG000|Overall Study|Death|1|||
126369031|NCT03898180|454646547|FG001|Overall Study|Death|173|||
126369032|NCT03898180|454646546|FG000|Overall Study|Physician Decision|1|||
126369033|NCT03898180|454646547|FG001|Overall Study|Physician Decision|0|||
126369034|NCT03898180|454646546|FG000|Overall Study|Sponsor Decision|3|||
126369035|NCT03898180|454646547|FG001|Overall Study|Sponsor Decision|0|||
126369036|NCT03898180|454646546|FG000|Overall Study|Lost to Follow-up|1|||
126369037|NCT03898180|454646547|FG001|Overall Study|Lost to Follow-up|0|||
126369038|NCT03898180|454646546|FG000|Overall Study|Withdrawal by Subject|5|||
126369039|NCT03898180|454646547|FG001|Overall Study|Withdrawal by Subject|4|||
126369040|NCT01646827|454646548|FG000|Overall Study|Lost to Follow-up|0|||
126369041|NCT01646827|454646549|FG001|Overall Study|Lost to Follow-up|3|||
126369042|NCT01646827|454646548|FG000|Overall Study|Physician Decision|1|||
126369043|NCT01646827|454646549|FG001|Overall Study|Physician Decision|2|||
126369044|NCT01646827|454646548|FG000|Overall Study|Withdrawal by Subject|1|||
126369045|NCT01646827|454646549|FG001|Overall Study|Withdrawal by Subject|0|||
126369046|NCT00928668|454646550|FG000|Overall Study|Adverse Event|1|||
126369047|NCT00928668|454646551|FG001|Overall Study|Adverse Event|0|||
126369048|NCT00928668|454646552|FG002|Overall Study|Adverse Event|0|||
126369049|NCT00928668|454646553|FG003|Overall Study|Adverse Event|0|||
126369050|NCT00928668|454646554|FG004|Overall Study|Adverse Event|0|||
126369051|NCT00928668|454646550|FG000|Overall Study|Protocol Violation|0|||
126369052|NCT00928668|454646551|FG001|Overall Study|Protocol Violation|0|||
126369053|NCT00928668|454646552|FG002|Overall Study|Protocol Violation|0|||
126369054|NCT00928668|454646553|FG003|Overall Study|Protocol Violation|0|||
126369055|NCT00928668|454646554|FG004|Overall Study|Protocol Violation|1|||
126369056|NCT00928668|454646550|FG000|Overall Study|Withdrawal by Subject|0|||
126369057|NCT00928668|454646551|FG001|Overall Study|Withdrawal by Subject|1|||
126369058|NCT00928668|454646552|FG002|Overall Study|Withdrawal by Subject|1|||
126369059|NCT00928668|454646553|FG003|Overall Study|Withdrawal by Subject|0|||
126369060|NCT00928668|454646554|FG004|Overall Study|Withdrawal by Subject|0|||
126369061|NCT00928668|454646550|FG000|Overall Study|Other reasons not listed above|0|||
126369062|NCT00928668|454646551|FG001|Overall Study|Other reasons not listed above|0|||
126369063|NCT00928668|454646552|FG002|Overall Study|Other reasons not listed above|0|||
126369064|NCT00928668|454646553|FG003|Overall Study|Other reasons not listed above|1|||
126369065|NCT00928668|454646554|FG004|Overall Study|Other reasons not listed above|0|||
126369066|NCT01767987|454646558|FG000|Overall Study|Physician Decision|4|||
126369067|NCT01767987|454646559|FG001|Overall Study|Physician Decision|1|||
126369068|NCT03232567|454646560|FG000|Overall Study|Withdrawal by Subject|0|||
126369069|NCT03232567|454646561|FG001|Overall Study|Withdrawal by Subject|1|||
126369070|NCT03232567|454646562|FG002|Overall Study|Withdrawal by Subject|0|||
126369071|NCT03232567|454646563|FG003|Overall Study|Withdrawal by Subject|0|||
126369072|NCT05837481|454646564|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
125885124|NCT00865566|452876785|FG001|Overall Study|Death|11|||
125885125|NCT00865566|452876784|FG000|Overall Study|Lost to Follow-up|314|||
125885126|NCT00865566|452876785|FG001|Overall Study|Lost to Follow-up|315|||
125885127|NCT00865566|452876784|FG000|Overall Study|Withdrawal by Subject|45|||
125885128|NCT00865566|452876785|FG001|Overall Study|Withdrawal by Subject|65|||
125885129|NCT00865566|452876784|FG000|Overall Study|Physician Decision|0|||
125885130|NCT00865566|452876785|FG001|Overall Study|Physician Decision|1|||
126305553|NCT01314872|454407331|FG007|Treatment Period 1|Lack of Efficacy|2|||
126305554|NCT01314872|454407332|FG008|Treatment Period 1|Lack of Efficacy|0|||
126305555|NCT01314872|454407333|FG009|Treatment Period 1|Lack of Efficacy|0|||
126305556|NCT01314872|454407334|FG010|Treatment Period 1|Lack of Efficacy|0|||
126305557|NCT01314872|454407335|FG011|Treatment Period 1|Lack of Efficacy|0|||
126305558|NCT01314872|454407336|FG012|Treatment Period 1|Lack of Efficacy|0|||
126305559|NCT01314872|454407337|FG013|Treatment Period 1|Lack of Efficacy|0|||
126305560|NCT01314872|454407338|FG014|Treatment Period 1|Lack of Efficacy|0|||
126305561|NCT01314872|454407324|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
126305562|NCT01314872|454407325|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
126305563|NCT01314872|454407326|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
126305564|NCT01314872|454407327|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
126305565|NCT01314872|454407328|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
126305566|NCT01314872|454407329|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
126305567|NCT01314872|454407330|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
126305568|NCT01314872|454407331|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
126305569|NCT01314872|454407332|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
126305570|NCT01314872|454407333|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
126305571|NCT01314872|454407334|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
126305572|NCT01314872|454407335|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
126305573|NCT01314872|454407336|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
126305574|NCT01314872|454407337|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
126305575|NCT01314872|454407338|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
126305576|NCT01314872|454407324|FG000|Treatment Period 1|Withdrawal by Subject|3|||
126305577|NCT01314872|454407325|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126046185|NCT02719574|453468215|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046186|NCT02719574|453468216|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046187|NCT02719574|453468217|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
126046188|NCT02719574|453468201|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046189|NCT02719574|453468202|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046190|NCT02719574|453468203|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
126046191|NCT02719574|453468204|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046192|NCT02719574|453468205|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046193|NCT02719574|453468206|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046194|NCT02719574|453468207|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046195|NCT02719574|453468208|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046196|NCT02719574|453468209|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046197|NCT02719574|453468210|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046198|NCT02719574|453468211|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046199|NCT02719574|453468212|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046200|NCT02719574|453468213|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046201|NCT02719574|453468214|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046202|NCT02719574|453468215|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126369073|NCT05837481|454646565|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
126369074|NCT03038087|454646571|FG000|Overall Study|lost data|1|||
126369075|NCT00654355|454646572|FG000|Overall Study|Lost to Follow-up|2|||
126369076|NCT00654355|454646573|FG001|Overall Study|Lost to Follow-up|2|||
126369077|NCT02284893|454646582|FG000|26 Week (Short Term)|Adverse Event|1|||
126369078|NCT02284893|454646583|FG001|26 Week (Short Term)|Adverse Event|9|||
126369079|NCT02284893|454646582|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
126369080|NCT02284893|454646583|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
126369081|NCT02284893|454646582|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
126369082|NCT02284893|454646583|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
126369083|NCT02284893|454646582|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
126369084|NCT02284893|454646583|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
126369085|NCT02284893|454646582|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
126369086|NCT02284893|454646583|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
126369087|NCT02284893|454646582|FG000|26 Week (Short Term)|Other|1|||
126369088|NCT02284893|454646583|FG001|26 Week (Short Term)|Other|1|||
126369089|NCT02284893|454646582|FG000|52 Week (Long Term)|Adverse Event|3|||
126369090|NCT02284893|454646583|FG001|52 Week (Long Term)|Adverse Event|1|||
126369091|NCT02284893|454646582|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
126369092|NCT02284893|454646583|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
126369093|NCT02284893|454646582|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
126369094|NCT02284893|454646583|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
126369095|NCT02284893|454646582|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
126369096|NCT02284893|454646583|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
126369097|NCT02284893|454646582|FG000|52 Week (Long Term)|Non-Compliance|2|||
126369098|NCT02284893|454646583|FG001|52 Week (Long Term)|Non-Compliance|3|||
126369099|NCT00105066|454646586|FG000|Overall Study|Adverse Event|2|||
126369100|NCT00105066|454646587|FG001|Overall Study|Adverse Event|5|||
126369101|NCT02259231|454646620|FG000|Overall Study|Adverse Event|1|||
126369102|NCT02259231|454646621|FG001|Overall Study|Adverse Event|1|||
126369103|NCT02259231|454646622|FG002|Overall Study|Adverse Event|2|||
126369104|NCT02259231|454646623|FG003|Overall Study|Adverse Event|0|||
126369105|NCT02259231|454646624|FG004|Overall Study|Adverse Event|0|||
126046203|NCT02719574|453468216|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126046204|NCT02719574|453468217|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126369106|NCT02259231|454646625|FG005|Overall Study|Adverse Event|0|||
126369107|NCT02259231|454646626|FG006|Overall Study|Adverse Event|0|||
126369108|NCT02259231|454646620|FG000|Overall Study|Progressive Disease|4|||
126369109|NCT02259231|454646621|FG001|Overall Study|Progressive Disease|5|||
126369110|NCT02259231|454646622|FG002|Overall Study|Progressive Disease|4|||
126369111|NCT02259231|454646623|FG003|Overall Study|Progressive Disease|5|||
126369112|NCT02259231|454646624|FG004|Overall Study|Progressive Disease|4|||
126046205|NCT02719574|453468201|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046206|NCT02719574|453468202|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126369113|NCT02259231|454646625|FG005|Overall Study|Progressive Disease|5|||
126369114|NCT02259231|454646626|FG006|Overall Study|Progressive Disease|4|||
126369115|NCT02259231|454646620|FG000|Overall Study|Sponsor termination of study|1|||
126046207|NCT02719574|453468203|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046208|NCT02719574|453468204|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046209|NCT02719574|453468205|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126369116|NCT02259231|454646621|FG001|Overall Study|Sponsor termination of study|0|||
126369117|NCT02259231|454646622|FG002|Overall Study|Sponsor termination of study|0|||
126369118|NCT02259231|454646623|FG003|Overall Study|Sponsor termination of study|1|||
126369119|NCT02259231|454646624|FG004|Overall Study|Sponsor termination of study|2|||
126046210|NCT02719574|453468206|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126305578|NCT01314872|454407326|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126305579|NCT01314872|454407327|FG003|Treatment Period 1|Withdrawal by Subject|2|||
126305580|NCT01314872|454407328|FG004|Treatment Period 1|Withdrawal by Subject|3|||
126305581|NCT01314872|454407329|FG005|Treatment Period 1|Withdrawal by Subject|1|||
126305582|NCT01314872|454407330|FG006|Treatment Period 1|Withdrawal by Subject|3|||
126305583|NCT01314872|454407331|FG007|Treatment Period 1|Withdrawal by Subject|2|||
126305584|NCT01314872|454407332|FG008|Treatment Period 1|Withdrawal by Subject|2|||
126305585|NCT01314872|454407333|FG009|Treatment Period 1|Withdrawal by Subject|2|||
126305586|NCT01314872|454407334|FG010|Treatment Period 1|Withdrawal by Subject|1|||
126305587|NCT01314872|454407335|FG011|Treatment Period 1|Withdrawal by Subject|0|||
126305588|NCT01314872|454407336|FG012|Treatment Period 1|Withdrawal by Subject|0|||
126305589|NCT01314872|454407337|FG013|Treatment Period 1|Withdrawal by Subject|0|||
126305590|NCT01314872|454407338|FG014|Treatment Period 1|Withdrawal by Subject|0|||
126305591|NCT01314872|454407324|FG000|Treatment Period 1|Lost to Follow-up|0|||
126305592|NCT01314872|454407325|FG001|Treatment Period 1|Lost to Follow-up|1|||
126305593|NCT01314872|454407326|FG002|Treatment Period 1|Lost to Follow-up|2|||
126305594|NCT01314872|454407327|FG003|Treatment Period 1|Lost to Follow-up|2|||
126305595|NCT01314872|454407328|FG004|Treatment Period 1|Lost to Follow-up|1|||
126305596|NCT01314872|454407329|FG005|Treatment Period 1|Lost to Follow-up|1|||
126305597|NCT01314872|454407330|FG006|Treatment Period 1|Lost to Follow-up|1|||
126305598|NCT01314872|454407331|FG007|Treatment Period 1|Lost to Follow-up|1|||
126305599|NCT01314872|454407332|FG008|Treatment Period 1|Lost to Follow-up|1|||
126305600|NCT01314872|454407333|FG009|Treatment Period 1|Lost to Follow-up|0|||
126305601|NCT01314872|454407334|FG010|Treatment Period 1|Lost to Follow-up|0|||
126305602|NCT01314872|454407335|FG011|Treatment Period 1|Lost to Follow-up|0|||
126305603|NCT01314872|454407336|FG012|Treatment Period 1|Lost to Follow-up|0|||
126305604|NCT01314872|454407337|FG013|Treatment Period 1|Lost to Follow-up|0|||
126305605|NCT01314872|454407338|FG014|Treatment Period 1|Lost to Follow-up|0|||
126305606|NCT01314872|454407324|FG000|Period 2|Protocol Violation|0|||
126305607|NCT01314872|454407325|FG001|Period 2|Protocol Violation|0|||
126305608|NCT01314872|454407326|FG002|Period 2|Protocol Violation|0|||
126305609|NCT01314872|454407327|FG003|Period 2|Protocol Violation|0|||
126305610|NCT01314872|454407328|FG004|Period 2|Protocol Violation|0|||
126305611|NCT01314872|454407329|FG005|Period 2|Protocol Violation|0|||
126305612|NCT01314872|454407330|FG006|Period 2|Protocol Violation|0|||
126305613|NCT01314872|454407331|FG007|Period 2|Protocol Violation|0|||
126305614|NCT01314872|454407332|FG008|Period 2|Protocol Violation|0|||
126305615|NCT01314872|454407333|FG009|Period 2|Protocol Violation|0|||
126305616|NCT01314872|454407334|FG010|Period 2|Protocol Violation|0|||
126305617|NCT01314872|454407335|FG011|Period 2|Protocol Violation|3|||
126305618|NCT01314872|454407336|FG012|Period 2|Protocol Violation|3|||
126305619|NCT01314872|454407337|FG013|Period 2|Protocol Violation|2|||
126305620|NCT01314872|454407338|FG014|Period 2|Protocol Violation|0|||
126305621|NCT01314872|454407324|FG000|Period 2|Non-compliance with study drug|0|||
126305622|NCT01314872|454407325|FG001|Period 2|Non-compliance with study drug|0|||
126305623|NCT01314872|454407326|FG002|Period 2|Non-compliance with study drug|0|||
126305624|NCT01314872|454407327|FG003|Period 2|Non-compliance with study drug|0|||
126305625|NCT01314872|454407328|FG004|Period 2|Non-compliance with study drug|0|||
126305626|NCT01314872|454407329|FG005|Period 2|Non-compliance with study drug|0|||
126305627|NCT01314872|454407330|FG006|Period 2|Non-compliance with study drug|0|||
126305628|NCT01314872|454407331|FG007|Period 2|Non-compliance with study drug|0|||
126305629|NCT01314872|454407332|FG008|Period 2|Non-compliance with study drug|0|||
126305630|NCT01314872|454407333|FG009|Period 2|Non-compliance with study drug|0|||
126305631|NCT01314872|454407334|FG010|Period 2|Non-compliance with study drug|0|||
126305632|NCT01314872|454407335|FG011|Period 2|Non-compliance with study drug|3|||
126305633|NCT01314872|454407336|FG012|Period 2|Non-compliance with study drug|3|||
126305634|NCT01314872|454407337|FG013|Period 2|Non-compliance with study drug|1|||
126305635|NCT01314872|454407338|FG014|Period 2|Non-compliance with study drug|2|||
126305636|NCT01314872|454407324|FG000|Period 2|Lack of Efficacy|0|||
126305637|NCT01314872|454407325|FG001|Period 2|Lack of Efficacy|0|||
126305638|NCT01314872|454407326|FG002|Period 2|Lack of Efficacy|0|||
126305639|NCT01314872|454407327|FG003|Period 2|Lack of Efficacy|0|||
126305640|NCT01314872|454407328|FG004|Period 2|Lack of Efficacy|0|||
126305641|NCT01314872|454407329|FG005|Period 2|Lack of Efficacy|0|||
126305642|NCT01314872|454407330|FG006|Period 2|Lack of Efficacy|0|||
126305643|NCT01314872|454407331|FG007|Period 2|Lack of Efficacy|0|||
126305644|NCT01314872|454407332|FG008|Period 2|Lack of Efficacy|0|||
126305645|NCT01314872|454407333|FG009|Period 2|Lack of Efficacy|0|||
126305646|NCT01314872|454407334|FG010|Period 2|Lack of Efficacy|0|||
126305647|NCT01314872|454407335|FG011|Period 2|Lack of Efficacy|7|||
126305648|NCT01314872|454407336|FG012|Period 2|Lack of Efficacy|12|||
126305649|NCT01314872|454407337|FG013|Period 2|Lack of Efficacy|9|||
126305650|NCT01314872|454407338|FG014|Period 2|Lack of Efficacy|2|||
126305651|NCT01314872|454407324|FG000|Period 2|Pregnancy|0|||
126305652|NCT01314872|454407325|FG001|Period 2|Pregnancy|0|||
126305653|NCT01314872|454407326|FG002|Period 2|Pregnancy|0|||
126305654|NCT01314872|454407327|FG003|Period 2|Pregnancy|0|||
126305655|NCT01314872|454407328|FG004|Period 2|Pregnancy|0|||
126305656|NCT01314872|454407329|FG005|Period 2|Pregnancy|0|||
126305657|NCT01314872|454407330|FG006|Period 2|Pregnancy|0|||
126305658|NCT01314872|454407331|FG007|Period 2|Pregnancy|0|||
126305659|NCT01314872|454407332|FG008|Period 2|Pregnancy|0|||
126305660|NCT01314872|454407333|FG009|Period 2|Pregnancy|0|||
126305661|NCT01314872|454407334|FG010|Period 2|Pregnancy|0|||
126305662|NCT01314872|454407335|FG011|Period 2|Pregnancy|0|||
126305663|NCT01314872|454407336|FG012|Period 2|Pregnancy|0|||
126305664|NCT01314872|454407337|FG013|Period 2|Pregnancy|0|||
126305665|NCT01314872|454407338|FG014|Period 2|Pregnancy|1|||
126305666|NCT01314872|454407324|FG000|Period 2|Study terminated by Sponsor|0|||
126305667|NCT01314872|454407325|FG001|Period 2|Study terminated by Sponsor|0|||
126305668|NCT01314872|454407326|FG002|Period 2|Study terminated by Sponsor|0|||
126305669|NCT01314872|454407327|FG003|Period 2|Study terminated by Sponsor|0|||
126305670|NCT01314872|454407328|FG004|Period 2|Study terminated by Sponsor|0|||
126305671|NCT01314872|454407329|FG005|Period 2|Study terminated by Sponsor|0|||
126305672|NCT01314872|454407330|FG006|Period 2|Study terminated by Sponsor|0|||
126305673|NCT01314872|454407331|FG007|Period 2|Study terminated by Sponsor|0|||
126305674|NCT01314872|454407332|FG008|Period 2|Study terminated by Sponsor|0|||
126305675|NCT01314872|454407333|FG009|Period 2|Study terminated by Sponsor|0|||
126305676|NCT01314872|454407334|FG010|Period 2|Study terminated by Sponsor|0|||
126305677|NCT01314872|454407335|FG011|Period 2|Study terminated by Sponsor|2|||
126305678|NCT01314872|454407336|FG012|Period 2|Study terminated by Sponsor|2|||
126305679|NCT01314872|454407337|FG013|Period 2|Study terminated by Sponsor|3|||
126305680|NCT01314872|454407338|FG014|Period 2|Study terminated by Sponsor|0|||
126305681|NCT01314872|454407324|FG000|Period 2|Adverse event, non-fatal|0|||
126305682|NCT01314872|454407325|FG001|Period 2|Adverse event, non-fatal|0|||
126305683|NCT01314872|454407326|FG002|Period 2|Adverse event, non-fatal|0|||
126305684|NCT01314872|454407327|FG003|Period 2|Adverse event, non-fatal|0|||
126305685|NCT01314872|454407328|FG004|Period 2|Adverse event, non-fatal|0|||
126305686|NCT01314872|454407329|FG005|Period 2|Adverse event, non-fatal|0|||
126305687|NCT01314872|454407330|FG006|Period 2|Adverse event, non-fatal|0|||
126305688|NCT01314872|454407331|FG007|Period 2|Adverse event, non-fatal|0|||
126305689|NCT01314872|454407332|FG008|Period 2|Adverse event, non-fatal|0|||
126305690|NCT01314872|454407333|FG009|Period 2|Adverse event, non-fatal|0|||
126305691|NCT01314872|454407334|FG010|Period 2|Adverse event, non-fatal|0|||
126305692|NCT01314872|454407335|FG011|Period 2|Adverse event, non-fatal|13|||
126305693|NCT01314872|454407336|FG012|Period 2|Adverse event, non-fatal|16|||
126305694|NCT01314872|454407337|FG013|Period 2|Adverse event, non-fatal|24|||
126305695|NCT01314872|454407338|FG014|Period 2|Adverse event, non-fatal|9|||
126305696|NCT01314872|454407324|FG000|Period 2|Withdrawal by Subject|0|||
126305697|NCT01314872|454407325|FG001|Period 2|Withdrawal by Subject|0|||
126305698|NCT01314872|454407326|FG002|Period 2|Withdrawal by Subject|0|||
126305699|NCT01314872|454407327|FG003|Period 2|Withdrawal by Subject|0|||
126305700|NCT01314872|454407328|FG004|Period 2|Withdrawal by Subject|0|||
126305701|NCT01314872|454407329|FG005|Period 2|Withdrawal by Subject|0|||
126305702|NCT01314872|454407330|FG006|Period 2|Withdrawal by Subject|0|||
126305703|NCT01314872|454407331|FG007|Period 2|Withdrawal by Subject|0|||
126305704|NCT01314872|454407332|FG008|Period 2|Withdrawal by Subject|0|||
126305705|NCT01314872|454407333|FG009|Period 2|Withdrawal by Subject|0|||
126305706|NCT01314872|454407334|FG010|Period 2|Withdrawal by Subject|0|||
126305707|NCT01314872|454407335|FG011|Period 2|Withdrawal by Subject|14|||
126305708|NCT01314872|454407336|FG012|Period 2|Withdrawal by Subject|17|||
126305709|NCT01314872|454407337|FG013|Period 2|Withdrawal by Subject|12|||
126369120|NCT02259231|454646625|FG005|Overall Study|Sponsor termination of study|1|||
126369121|NCT02259231|454646626|FG006|Overall Study|Sponsor termination of study|1|||
126369122|NCT00847730|454646630|FG000|Overall Study|Multiple interruptions in therapy|8|||
126369123|NCT04507269|454646635|FG000|Overall Study|Withdrawal by Subject|1|||
126369124|NCT04507269|454646636|FG001|Overall Study|Withdrawal by Subject|1|||
126369125|NCT04507269|454646637|FG002|Overall Study|Withdrawal by Subject|0|||
126369126|NCT04507269|454646638|FG003|Overall Study|Withdrawal by Subject|0|||
126369127|NCT04507269|454646639|FG004|Overall Study|Withdrawal by Subject|0|||
126305710|NCT01314872|454407338|FG014|Period 2|Withdrawal by Subject|4|||
126305711|NCT01314872|454407324|FG000|Period 2|Lost to Follow-up|0|||
126305712|NCT01314872|454407325|FG001|Period 2|Lost to Follow-up|0|||
126305713|NCT01314872|454407326|FG002|Period 2|Lost to Follow-up|0|||
126305714|NCT01314872|454407327|FG003|Period 2|Lost to Follow-up|0|||
126305715|NCT01314872|454407328|FG004|Period 2|Lost to Follow-up|0|||
126305716|NCT01314872|454407329|FG005|Period 2|Lost to Follow-up|0|||
126305717|NCT01314872|454407330|FG006|Period 2|Lost to Follow-up|0|||
126305718|NCT01314872|454407331|FG007|Period 2|Lost to Follow-up|0|||
126305719|NCT01314872|454407332|FG008|Period 2|Lost to Follow-up|0|||
126305720|NCT01314872|454407333|FG009|Period 2|Lost to Follow-up|0|||
126305721|NCT01314872|454407334|FG010|Period 2|Lost to Follow-up|0|||
126305722|NCT01314872|454407335|FG011|Period 2|Lost to Follow-up|6|||
126369128|NCT04507269|454646640|FG005|Overall Study|Withdrawal by Subject|0|||
126305723|NCT01314872|454407336|FG012|Period 2|Lost to Follow-up|7|||
126305724|NCT01314872|454407337|FG013|Period 2|Lost to Follow-up|2|||
126305725|NCT01314872|454407338|FG014|Period 2|Lost to Follow-up|6|||
126305726|NCT03232931|454408764|FG000|Overall Study|Physician Decision|1|||
126305727|NCT03232931|454408765|FG001|Overall Study|Physician Decision|1|||
126305728|NCT03232931|454408764|FG000|Overall Study|Withdrawal by Subject|6|||
126305729|NCT03232931|454408765|FG001|Overall Study|Withdrawal by Subject|0|||
126305730|NCT03232931|454408764|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
126305731|NCT03232931|454408765|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
126305732|NCT03232931|454408764|FG000|Overall Study|Parent did not record voice|1|||
126305733|NCT03232931|454408765|FG001|Overall Study|Parent did not record voice|2|||
126305734|NCT03232931|454408764|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
126305735|NCT03232931|454408765|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
126305736|NCT04925557|454408766|FG000|Overall Study|Study closed|5|||
126305737|NCT04925557|454408767|FG001|Overall Study|Study closed|3|||
126305738|NCT05488470|454408768|FG000|Overall Study|Physician Decision|2|||
126305739|NCT05488470|454408768|FG000|Overall Study|Withdrawal by Subject|1|||
126305740|NCT05488470|454408768|FG000|Overall Study|Death|1|||
126305741|NCT00068393|454408773|FG000|Overall Study|Adverse Event|2|||
126305742|NCT00068393|454408773|FG000|Overall Study|Death|3|||
126305743|NCT00068393|454408773|FG000|Overall Study|Withdrawal by Subject|3|||
126305744|NCT00068393|454408773|FG000|Overall Study|Alternative treatment|1|||
126305745|NCT00068393|454408773|FG000|Overall Study|Quality of life worsening|1|||
126305746|NCT05088603|454408777|FG000|Overall Study|Protocol Violation|6|||
126305747|NCT05088603|454408778|FG001|Overall Study|Protocol Violation|1|||
126305748|NCT00594100|454408783|FG000|Procedure|Technical Failure|9|||
126305749|NCT00594100|454408783|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
126305750|NCT00594100|454408783|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
126305751|NCT00594100|454408783|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
126305752|NCT01270464|454408784|FG000|Overall Study|Protocol Violation|4|||
126305753|NCT01270464|454408785|FG001|Overall Study|Protocol Violation|3|||
126305754|NCT01270464|454408786|FG002|Overall Study|Protocol Violation|2|||
126305755|NCT01270464|454408784|FG000|Overall Study|Lack of Efficacy|2|||
126305756|NCT01270464|454408785|FG001|Overall Study|Lack of Efficacy|3|||
126305757|NCT01270464|454408786|FG002|Overall Study|Lack of Efficacy|1|||
126305758|NCT01270464|454408784|FG000|Overall Study|Adverse Event|9|||
126305759|NCT01270464|454408785|FG001|Overall Study|Adverse Event|1|||
126305760|NCT01270464|454408786|FG002|Overall Study|Adverse Event|7|||
126305761|NCT01270464|454408784|FG000|Overall Study|Withdrawal by Subject|2|||
126305762|NCT01270464|454408785|FG001|Overall Study|Withdrawal by Subject|1|||
126305763|NCT01270464|454408786|FG002|Overall Study|Withdrawal by Subject|4|||
126305764|NCT01270464|454408784|FG000|Overall Study|Lost to Follow-up|2|||
126305765|NCT01270464|454408785|FG001|Overall Study|Lost to Follow-up|3|||
126305766|NCT01270464|454408786|FG002|Overall Study|Lost to Follow-up|1|||
126305767|NCT01270464|454408784|FG000|Overall Study|Other|1|||
126305768|NCT01270464|454408785|FG001|Overall Study|Other|1|||
126305769|NCT01270464|454408786|FG002|Overall Study|Other|3|||
126305770|NCT03981900|454408787|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
126305771|NCT03981900|454408787|FG000|Overall Study|Adverse Event|5|||
126305772|NCT03981900|454408787|FG000|Overall Study|Protocol Violation|1|||
126305773|NCT03981900|454408787|FG000|Overall Study|Withdrawal by Subject|7|||
126305774|NCT03981900|454408787|FG000|Overall Study|Lost to Follow-up|46|||
126305775|NCT03981900|454408787|FG000|Overall Study|Decision of the researcher|3|||
126305776|NCT03981900|454408787|FG000|Overall Study|Death|3|||
126305777|NCT03981900|454408787|FG000|Overall Study|Other|5|||
126305778|NCT02162719|454408788|FG000|Overall Study|Death|41|||
126305779|NCT02162719|454408789|FG001|Overall Study|Death|46|||
126305780|NCT02162719|454408788|FG000|Overall Study|Lost to Follow-up|1|||
126305781|NCT02162719|454408789|FG001|Overall Study|Lost to Follow-up|3|||
126305782|NCT02162719|454408788|FG000|Overall Study|Disease Progression|2|||
126305783|NCT02162719|454408789|FG001|Overall Study|Disease Progression|1|||
126305784|NCT02162719|454408788|FG000|Overall Study|Withdrawal by Subject|8|||
126305785|NCT02162719|454408789|FG001|Overall Study|Withdrawal by Subject|2|||
126305786|NCT02162719|454408788|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
126305787|NCT02162719|454408789|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
126305788|NCT04725812|454408791|FG000|Overall Study|Withdrawal by Subject|1|||
126305789|NCT03969901|454408796|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126305790|NCT03969901|454408797|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126305791|NCT03969901|454408798|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126305792|NCT03969901|454408799|FG003|Overall Study|Withdrawal by parent/guardian|0|||
126305793|NCT03969901|454408800|FG004|Overall Study|Withdrawal by parent/guardian|1|||
126305794|NCT03969901|454408801|FG005|Overall Study|Withdrawal by parent/guardian|0|||
126305795|NCT03969901|454408802|FG006|Overall Study|Withdrawal by parent/guardian|0|||
126305796|NCT03969901|454408803|FG007|Overall Study|Withdrawal by parent/guardian|1|||
126305797|NCT03969901|454408804|FG008|Overall Study|Withdrawal by parent/guardian|1|||
126305798|NCT03969901|454408805|FG009|Overall Study|Withdrawal by parent/guardian|0|||
126305799|NCT02589626|454408809|FG000|Overall Study|Other than the reason specified|1|||
126305800|NCT02589626|454408810|FG001|Overall Study|Other than the reason specified|0|||
126305801|NCT02589626|454408809|FG000|Overall Study|Withdrawal by Subject|1|||
126305802|NCT02589626|454408810|FG001|Overall Study|Withdrawal by Subject|1|||
126305803|NCT02589626|454408809|FG000|Overall Study|Adverse Event|1|||
126305804|NCT02589626|454408810|FG001|Overall Study|Adverse Event|1|||
126305805|NCT00892151|454408811|FG000|Overall Study|Protocol Violation|1|||
126305806|NCT04075682|454408814|FG000|Overall Study|Lost to Follow-up|5|||
126305807|NCT04075682|454408815|FG001|Overall Study|Lost to Follow-up|5|||
126305808|NCT04075682|454408816|FG002|Overall Study|Lost to Follow-up|2|||
126305809|NCT04075682|454408817|FG003|Overall Study|Lost to Follow-up|2|||
126305810|NCT04075682|454408814|FG000|Overall Study|Withdrawal by Subject|1|||
126305811|NCT04075682|454408815|FG001|Overall Study|Withdrawal by Subject|0|||
126305812|NCT04075682|454408816|FG002|Overall Study|Withdrawal by Subject|1|||
126305813|NCT04075682|454408817|FG003|Overall Study|Withdrawal by Subject|0|||
126305814|NCT04075682|454408814|FG000|Overall Study|Protocol Violation|0|||
126305815|NCT04075682|454408815|FG001|Overall Study|Protocol Violation|1|||
126305816|NCT04075682|454408816|FG002|Overall Study|Protocol Violation|1|||
126305817|NCT04075682|454408817|FG003|Overall Study|Protocol Violation|0|||
126305818|NCT04075682|454408814|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
126305819|NCT04075682|454408815|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
126305820|NCT04075682|454408816|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
126305821|NCT04075682|454408817|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
126305822|NCT04075682|454408814|FG000|Overall Study|Lost study phone the first day of study participation|0|||
126305823|NCT04075682|454408815|FG001|Overall Study|Lost study phone the first day of study participation|1|||
126305824|NCT04075682|454408816|FG002|Overall Study|Lost study phone the first day of study participation|0|||
126305825|NCT04075682|454408817|FG003|Overall Study|Lost study phone the first day of study participation|0|||
126305826|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
126305827|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
126305828|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
126305829|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
126305830|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
126305831|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
126305832|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
126305833|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
126305834|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
126305835|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
126305836|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
126305837|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
126305838|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
126305839|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
126305840|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
126305841|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
126305842|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
126305843|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
126305844|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
126305845|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
126305846|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
125885131|NCT00865566|452876784|FG000|Overall Study|Participant relocated|78|||
126305847|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
126305848|NCT02920008|454408823|FG000|Overall Study|Death|117|||
126305849|NCT02920008|454408824|FG001|Overall Study|Death|127|||
126305850|NCT02920008|454408823|FG000|Overall Study|Withdrawal by Subject|3|||
126305851|NCT02920008|454408824|FG001|Overall Study|Withdrawal by Subject|6|||
126305852|NCT02920008|454408823|FG000|Overall Study|Lost to Follow-up|0|||
126305853|NCT02920008|454408824|FG001|Overall Study|Lost to Follow-up|1|||
126305854|NCT02737930|454408825|FG000|Overall Study|Withdrawal by Subject|0|||
126305855|NCT02737930|454408826|FG001|Overall Study|Withdrawal by Subject|1|||
126305856|NCT01127451|454408834|FG000|Overall Study|Other|2|||
126305857|NCT01127451|454408835|FG001|Overall Study|Other|1|||
125885132|NCT00865566|452876785|FG001|Overall Study|Participant relocated|107|||
126305858|NCT01127451|454408834|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
126305859|NCT01127451|454408835|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
126305860|NCT01127451|454408834|FG000|Overall Study|Death|22|||
126305861|NCT01127451|454408835|FG001|Overall Study|Death|17|||
126305862|NCT01127451|454408834|FG000|Overall Study|Lost to Follow-up|3|||
126305863|NCT01127451|454408835|FG001|Overall Study|Lost to Follow-up|0|||
126305864|NCT01127451|454408834|FG000|Overall Study|Administrative Reason by Sponsor|2|||
126046211|NCT02719574|453468207|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
126046212|NCT02719574|453468208|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
126046213|NCT02719574|453468209|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
126046214|NCT02719574|453468210|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046215|NCT02719574|453468211|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046216|NCT02719574|453468212|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046217|NCT02719574|453468213|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046218|NCT02719574|453468214|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046219|NCT02719574|453468215|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046220|NCT02719574|453468216|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046221|NCT02719574|453468217|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126046222|NCT02719574|453468201|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046223|NCT02719574|453468202|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046224|NCT02719574|453468203|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046225|NCT02719574|453468204|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046226|NCT02719574|453468205|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046227|NCT02719574|453468206|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046228|NCT02719574|453468207|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
126046229|NCT02719574|453468208|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
126305865|NCT01127451|454408835|FG001|Overall Study|Administrative Reason by Sponsor|2|||
126305866|NCT00930774|454408836|FG000|Overall Study|Withdrawal by Subject|1|||
126305867|NCT00930774|454408837|FG001|Overall Study|Withdrawal by Subject|9|||
126305868|NCT00930774|454408838|FG002|Overall Study|Withdrawal by Subject|2|||
126305869|NCT00930774|454408839|FG003|Overall Study|Withdrawal by Subject|0|||
126305870|NCT03200704|454408840|FG000|Overall Study|Withdrawal by Subject|1|||
126305871|NCT02217410|454408841|FG000|Overall Study|Graft Loss|0|||
126305872|NCT02217410|454408842|FG001|Overall Study|Graft Loss|0|||
126305873|NCT02217410|454408843|FG002|Overall Study|Graft Loss|2|||
126046230|NCT02719574|453468209|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046231|NCT02719574|453468210|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046232|NCT02719574|453468211|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046233|NCT02719574|453468212|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046234|NCT02719574|453468213|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046235|NCT02719574|453468214|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046236|NCT02719574|453468215|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046237|NCT02719574|453468216|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046238|NCT02719574|453468217|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126046239|NCT02719574|453468201|FG000|Phase 1 (Dose Expansion)|Death|0|||
126046240|NCT02719574|453468202|FG001|Phase 1 (Dose Expansion)|Death|0|||
126046241|NCT02719574|453468203|FG002|Phase 1 (Dose Expansion)|Death|0|||
126046242|NCT02719574|453468204|FG003|Phase 1 (Dose Expansion)|Death|0|||
126046243|NCT02719574|453468205|FG004|Phase 1 (Dose Expansion)|Death|0|||
126046244|NCT02719574|453468206|FG005|Phase 1 (Dose Expansion)|Death|0|||
126046245|NCT02719574|453468207|FG006|Phase 1 (Dose Expansion)|Death|1|||
126046246|NCT02719574|453468208|FG007|Phase 1 (Dose Expansion)|Death|6|||
126046247|NCT02719574|453468209|FG008|Phase 1 (Dose Expansion)|Death|0|||
126046248|NCT02719574|453468210|FG009|Phase 1 (Dose Expansion)|Death|0|||
126046249|NCT02719574|453468211|FG010|Phase 1 (Dose Expansion)|Death|0|||
126046250|NCT02719574|453468212|FG011|Phase 1 (Dose Expansion)|Death|0|||
126046251|NCT02719574|453468213|FG012|Phase 1 (Dose Expansion)|Death|0|||
126046252|NCT02719574|453468214|FG013|Phase 1 (Dose Expansion)|Death|0|||
126046253|NCT02719574|453468215|FG014|Phase 1 (Dose Expansion)|Death|0|||
126046254|NCT02719574|453468216|FG015|Phase 1 (Dose Expansion)|Death|0|||
126046255|NCT02719574|453468217|FG016|Phase 1 (Dose Expansion)|Death|0|||
126046256|NCT02719574|453468201|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046257|NCT02719574|453468202|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046258|NCT02719574|453468203|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
126305874|NCT02217410|454408841|FG000|Overall Study|Withdrawal by Subject|0|||
126305875|NCT02217410|454408842|FG001|Overall Study|Withdrawal by Subject|0|||
126305876|NCT02217410|454408843|FG002|Overall Study|Withdrawal by Subject|2|||
126046259|NCT02719574|453468204|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
126305877|NCT02217410|454408841|FG000|Overall Study|Lost to Follow-up|0|||
126046260|NCT02719574|453468205|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
125885133|NCT00865566|452876784|FG000|Overall Study|Participant unable to adhere|27|||
125885134|NCT00865566|452876785|FG001|Overall Study|Participant unable to adhere|42|||
125885135|NCT00865566|452876784|FG000|Overall Study|Other; N=245 due to early study closure|154|||
126046261|NCT02719574|453468206|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046262|NCT02719574|453468207|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
126046263|NCT02719574|453468208|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
126305878|NCT02217410|454408842|FG001|Overall Study|Lost to Follow-up|0|||
125885136|NCT00865566|452876785|FG001|Overall Study|Other; N=245 due to early study closure|139|||
126046264|NCT02719574|453468209|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046265|NCT02719574|453468210|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046266|NCT02719574|453468211|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046267|NCT02719574|453468212|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046268|NCT02719574|453468213|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
126305879|NCT02217410|454408843|FG002|Overall Study|Lost to Follow-up|1|||
126305880|NCT02217410|454408841|FG000|Overall Study|Lack of Efficacy|0|||
126305881|NCT02217410|454408842|FG001|Overall Study|Lack of Efficacy|1|||
126305882|NCT02217410|454408843|FG002|Overall Study|Lack of Efficacy|0|||
126305883|NCT02217410|454408841|FG000|Overall Study|Physician Decision|1|||
126305884|NCT02217410|454408842|FG001|Overall Study|Physician Decision|3|||
126305885|NCT02217410|454408843|FG002|Overall Study|Physician Decision|0|||
126305886|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
126305887|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
126305888|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
126305889|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
126305890|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
126305891|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
126305892|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
126305893|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
126305894|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
126305895|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
126305896|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
126305897|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
126305898|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
126305899|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
126305900|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
126305901|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
126305902|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
126305903|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
126305904|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
126305905|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
126305906|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
126305907|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
126305908|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
126305909|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
126305910|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
126305911|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
126305912|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
126305913|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
126305914|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
126305915|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
126305916|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
126305917|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
126305918|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
126305919|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
126305920|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
126305921|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
126305922|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
126305923|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
126305924|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
126305925|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
126305926|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
126305927|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
126305928|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
126305929|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
126369129|NCT04507269|454646635|FG000|Overall Study|Lost to Follow-up|0|||
126369130|NCT04507269|454646636|FG001|Overall Study|Lost to Follow-up|0|||
126369131|NCT04507269|454646637|FG002|Overall Study|Lost to Follow-up|0|||
126369132|NCT04507269|454646638|FG003|Overall Study|Lost to Follow-up|0|||
126369133|NCT04507269|454646639|FG004|Overall Study|Lost to Follow-up|1|||
126369134|NCT04507269|454646640|FG005|Overall Study|Lost to Follow-up|0|||
125885137|NCT00865566|452876784|FG000|Overall Study|HIV infection|5|||
126369135|NCT00071032|454646644|FG000|Overall Study|Lost to Follow-up|1|||
126369136|NCT00071032|454646645|FG001|Overall Study|Lost to Follow-up|1|||
125885138|NCT00865566|452876785|FG001|Overall Study|HIV infection|7|||
126369137|NCT00071032|454646644|FG000|Overall Study|Withdrawal by Subject|8|||
126369138|NCT00071032|454646645|FG001|Overall Study|Withdrawal by Subject|6|||
126369139|NCT00071032|454646644|FG000|Overall Study|Missing Primary Outcome|0|||
126369140|NCT00071032|454646645|FG001|Overall Study|Missing Primary Outcome|1|||
126369141|NCT06071104|454646646|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
126369142|NCT03518060|454646647|FG000|Overall Study|Death|1|||
126369143|NCT03518060|454646647|FG000|Overall Study|Poor adherence|1|||
126369144|NCT03518060|454646647|FG000|Overall Study|Withdrawal of informed consent|2|||
126369145|NCT03518060|454646647|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
126305930|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
126305931|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
126305932|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
126305933|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
126305934|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
126305935|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
126305936|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
126305937|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
126305938|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
126305939|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
126305940|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
126305941|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
126305942|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
126305943|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
126305944|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
126305945|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
126305946|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
126305947|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
126305948|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
126305949|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
126305950|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
126305951|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
126305952|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
126305953|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
126305954|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
126305955|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
126305956|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
126305957|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
126305958|NCT01704651|454408848|FG000|Overall Study|Pre-op withdrawal by subject|1|||
126305959|NCT01704651|454408849|FG001|Overall Study|Pre-op withdrawal by subject|1|||
126305960|NCT01704651|454408848|FG000|Overall Study|Pre-op change in treatment plan|1|||
126305961|NCT01704651|454408849|FG001|Overall Study|Pre-op change in treatment plan|4|||
126305962|NCT01704651|454408848|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
126305963|NCT01704651|454408849|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
126305964|NCT01704651|454408848|FG000|Overall Study|Post-op did not have laparotomy|2|||
126305965|NCT01704651|454408849|FG001|Overall Study|Post-op did not have laparotomy|1|||
126305966|NCT00634803|454408851|FG000|Overall Study|Lost to Follow-up|6|||
126305967|NCT00634803|454408852|FG001|Overall Study|Lost to Follow-up|7|||
126305968|NCT00634803|454408853|FG002|Overall Study|Lost to Follow-up|7|||
126305969|NCT00364923|454408855|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
126305970|NCT00364923|454408855|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
126305971|NCT03474731|454408857|FG000|Overall Study|Withdrawal by Subject|36|||
126305972|NCT03474731|454408858|FG001|Overall Study|Withdrawal by Subject|29|||
126305973|NCT03474731|454408859|FG002|Overall Study|Withdrawal by Subject|11|||
126305974|NCT03474731|454408860|FG003|Overall Study|Withdrawal by Subject|27|||
126305975|NCT03474731|454408857|FG000|Overall Study|COVID|0|||
126305976|NCT03474731|454408858|FG001|Overall Study|COVID|23|||
126305977|NCT03474731|454408859|FG002|Overall Study|COVID|0|||
126305978|NCT03474731|454408860|FG003|Overall Study|COVID|0|||
126305979|NCT03474731|454408857|FG000|Overall Study|Participant moved from area|1|||
126305980|NCT03474731|454408858|FG001|Overall Study|Participant moved from area|0|||
126305981|NCT03474731|454408859|FG002|Overall Study|Participant moved from area|0|||
126305982|NCT03474731|454408860|FG003|Overall Study|Participant moved from area|0|||
126305983|NCT03474731|454408857|FG000|Overall Study|Lost to Follow-up|11|||
126305984|NCT03474731|454408858|FG001|Overall Study|Lost to Follow-up|3|||
126305985|NCT03474731|454408859|FG002|Overall Study|Lost to Follow-up|18|||
126305986|NCT03474731|454408860|FG003|Overall Study|Lost to Follow-up|17|||
126305987|NCT03474731|454408857|FG000|Overall Study|Death|0|||
126305988|NCT03474731|454408858|FG001|Overall Study|Death|1|||
126369146|NCT03518060|454646647|FG000|Overall Study|Physician Decision|7|||
126369147|NCT03518060|454646647|FG000|Overall Study|Adverse drug reactions|23|||
126369148|NCT03518060|454646647|FG000|Overall Study|Withdrawal by Subject|25|||
126369149|NCT03518060|454646647|FG000|Overall Study|Lost to Follow-up|13|||
126369150|NCT01969058|454646649|FG000|Overall Study|Withdrawal by Subject|2|||
126369151|NCT01969058|454646650|FG001|Overall Study|Withdrawal by Subject|0|||
126369152|NCT01969058|454646649|FG000|Overall Study|Adverse Event|1|||
126369153|NCT01969058|454646650|FG001|Overall Study|Adverse Event|0|||
126369154|NCT04976855|454646651|FG000|Part I|Withdrawal by Subject|0|||
126369155|NCT04976855|454646652|FG001|Part I|Withdrawal by Subject|1|||
126369156|NCT04976855|454646653|FG002|Part I|Withdrawal by Subject|0|||
126369157|NCT04976855|454646654|FG003|Part I|Withdrawal by Subject|0|||
126369158|NCT04976855|454646655|FG004|Part I|Withdrawal by Subject|0|||
126369159|NCT04976855|454646656|FG005|Part I|Withdrawal by Subject|0|||
126369160|NCT04976855|454646657|FG006|Part I|Withdrawal by Subject|0|||
126369161|NCT04976855|454646651|FG000|Part II|Adverse Event|0|||
126369162|NCT04976855|454646652|FG001|Part II|Adverse Event|0|||
126369163|NCT04976855|454646653|FG002|Part II|Adverse Event|0|||
126369164|NCT04976855|454646654|FG003|Part II|Adverse Event|1|||
126369165|NCT04976855|454646655|FG004|Part II|Adverse Event|0|||
126369166|NCT04976855|454646656|FG005|Part II|Adverse Event|0|||
126369167|NCT04976855|454646657|FG006|Part II|Adverse Event|0|||
126369168|NCT04976855|454646651|FG000|Part II|Withdrawal by Subject|0|||
126369169|NCT04976855|454646652|FG001|Part II|Withdrawal by Subject|0|||
126369170|NCT04976855|454646653|FG002|Part II|Withdrawal by Subject|0|||
126369171|NCT04976855|454646654|FG003|Part II|Withdrawal by Subject|0|||
126369172|NCT04976855|454646655|FG004|Part II|Withdrawal by Subject|1|||
126369173|NCT04976855|454646656|FG005|Part II|Withdrawal by Subject|0|||
126369174|NCT04976855|454646657|FG006|Part II|Withdrawal by Subject|0|||
126369175|NCT04976855|454646651|FG000|Part II|Lost to Follow-up|0|||
126369176|NCT04976855|454646652|FG001|Part II|Lost to Follow-up|0|||
126369177|NCT04976855|454646653|FG002|Part II|Lost to Follow-up|0|||
126369178|NCT04976855|454646654|FG003|Part II|Lost to Follow-up|0|||
126369179|NCT04976855|454646655|FG004|Part II|Lost to Follow-up|0|||
126369180|NCT04976855|454646656|FG005|Part II|Lost to Follow-up|1|||
126369181|NCT04976855|454646657|FG006|Part II|Lost to Follow-up|0|||
126369182|NCT02757768|454646672|FG000|Overall Study|Randomized Never Received Study Drug|3|||
126369183|NCT02757768|454646673|FG001|Overall Study|Randomized Never Received Study Drug|4|||
126369184|NCT02757768|454646672|FG000|Overall Study|Adverse Event|5|||
126369185|NCT02757768|454646673|FG001|Overall Study|Adverse Event|3|||
126369186|NCT02757768|454646672|FG000|Overall Study|Lack of Efficacy|2|||
126369187|NCT02757768|454646673|FG001|Overall Study|Lack of Efficacy|1|||
126369188|NCT02757768|454646672|FG000|Overall Study|Lost to Follow-up|1|||
126369189|NCT02757768|454646673|FG001|Overall Study|Lost to Follow-up|0|||
126369190|NCT02757768|454646672|FG000|Overall Study|Protocol Deviation|2|||
126369191|NCT02757768|454646673|FG001|Overall Study|Protocol Deviation|9|||
126369192|NCT02757768|454646672|FG000|Overall Study|Withdrawal by Subject|16|||
126369193|NCT02757768|454646673|FG001|Overall Study|Withdrawal by Subject|9|||
126369194|NCT02757768|454646672|FG000|Overall Study|Miscellaneous|4|||
126369195|NCT02757768|454646673|FG001|Overall Study|Miscellaneous|2|||
126369196|NCT00618787|454646687|FG000|Overall Study|Adverse Event|0|||
126369197|NCT00618787|454646688|FG001|Overall Study|Adverse Event|1|||
126369198|NCT00618787|454646687|FG000|Overall Study|Withdrawal by Subject|2|||
126369199|NCT00618787|454646688|FG001|Overall Study|Withdrawal by Subject|1|||
126369200|NCT00618787|454646687|FG000|Overall Study|Lost to Follow-up|1|||
126369201|NCT00618787|454646688|FG001|Overall Study|Lost to Follow-up|0|||
126369202|NCT01107886|454646689|FG000|Overall Study|Lost to Follow-up|15|||
126369203|NCT01107886|454646690|FG001|Overall Study|Lost to Follow-up|13|||
126369204|NCT01107886|454646689|FG000|Overall Study|Withdrawal by Subject|180|||
126369205|NCT01107886|454646690|FG001|Overall Study|Withdrawal by Subject|196|||
126369206|NCT01107886|454646689|FG000|Overall Study|Administrative withdrawal of consent|7|||
126369207|NCT01107886|454646690|FG001|Overall Study|Administrative withdrawal of consent|5|||
126369208|NCT01649869|454646695|FG000|Overall Study|Family member illness|1|||
126369209|NCT01649869|454646696|FG001|Overall Study|Family member illness|0|||
126369210|NCT01649869|454646695|FG000|Overall Study|Required treatment outside protocol|1|||
126369211|NCT01649869|454646696|FG001|Overall Study|Required treatment outside protocol|0|||
126369212|NCT01649869|454646695|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
126369213|NCT01649869|454646696|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
126369214|NCT03440385|454648144|FG000|Overall Study|Other Reason|4|||
126369215|NCT03440385|454648145|FG001|Overall Study|Other Reason|1|||
126369216|NCT03440385|454648144|FG000|Overall Study|Site Closed|1|||
126369217|NCT03440385|454648145|FG001|Overall Study|Site Closed|0|||
126369218|NCT03440385|454648144|FG000|Overall Study|Lost to Follow-up|2|||
126369219|NCT03440385|454648145|FG001|Overall Study|Lost to Follow-up|0|||
126369220|NCT03440385|454648144|FG000|Overall Study|Withdrawal by Subject|12|||
126369221|NCT03440385|454648145|FG001|Overall Study|Withdrawal by Subject|6|||
126369222|NCT03440385|454648144|FG000|Overall Study|Lack of Efficacy|9|||
126369223|NCT03440385|454648145|FG001|Overall Study|Lack of Efficacy|2|||
126369224|NCT03440385|454648144|FG000|Overall Study|Adverse Event|15|||
126046269|NCT02719574|453468214|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046270|NCT02719574|453468215|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046271|NCT02719574|453468216|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046272|NCT02719574|453468217|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
126046273|NCT02719574|453468201|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046274|NCT02719574|453468202|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
126305989|NCT03474731|454408859|FG002|Overall Study|Death|0|||
126305990|NCT03474731|454408860|FG003|Overall Study|Death|0|||
126305991|NCT03474731|454408857|FG000|Overall Study|Participant Removed|0|||
126305992|NCT03474731|454408858|FG001|Overall Study|Participant Removed|0|||
126305993|NCT03474731|454408859|FG002|Overall Study|Participant Removed|0|||
126305994|NCT03474731|454408860|FG003|Overall Study|Participant Removed|1|||
126305995|NCT00478777|454408866|FG000|Overall Study|Adverse Event|29|||
126305996|NCT00478777|454408866|FG000|Overall Study|Lack of Efficacy|23|||
126305997|NCT00478777|454408866|FG000|Overall Study|Withdrawal by Subject|4|||
126305998|NCT00478777|454408866|FG000|Overall Study|Death|3|||
126305999|NCT00478777|454408866|FG000|Overall Study|Protocol Violation|3|||
126306000|NCT00478777|454408866|FG000|Overall Study|Lost to Follow-up|3|||
126306001|NCT00478777|454408866|FG000|Overall Study|Physician Decision|1|||
126306002|NCT00478777|454408866|FG000|Overall Study|Intolerance of therapy|1|||
126306003|NCT00478777|454408866|FG000|Overall Study|Lack of compliance|1|||
126306004|NCT00478777|454408866|FG000|Overall Study|Lymphocytes infusion|1|||
126306005|NCT00478777|454408866|FG000|Overall Study|End of therapy|2|||
126306006|NCT00478777|454408866|FG000|Overall Study|Not treated with lenalidomide|6|||
126306007|NCT01218087|454408867|FG000|Overall Study|Death|2|||
126306008|NCT01218087|454408868|FG001|Overall Study|Death|1|||
126306009|NCT01218087|454408867|FG000|Overall Study|Withdrawal by Subject|5|||
126306010|NCT01218087|454408868|FG001|Overall Study|Withdrawal by Subject|0|||
126306011|NCT01218087|454408867|FG000|Overall Study|Transferred|8|||
126306012|NCT01218087|454408868|FG001|Overall Study|Transferred|5|||
126306013|NCT02553499|454408869|FG000|Overall Study|Adverse Event|0|||
126306014|NCT02553499|454408870|FG001|Overall Study|Adverse Event|0|||
126306015|NCT02553499|454408871|FG002|Overall Study|Adverse Event|0|||
126306016|NCT02553499|454408872|FG003|Overall Study|Adverse Event|0|||
126306017|NCT02553499|454408873|FG004|Overall Study|Adverse Event|0|||
126306018|NCT02553499|454408874|FG005|Overall Study|Adverse Event|0|||
126306019|NCT02553499|454408875|FG006|Overall Study|Adverse Event|1|||
126306020|NCT02553499|454408876|FG007|Overall Study|Adverse Event|1|||
126369225|NCT03440385|454648145|FG001|Overall Study|Adverse Event|11|||
126369226|NCT03552029|454648146|FG000|Overall Study|Death|3|||
126369227|NCT03552029|454648147|FG001|Overall Study|Death|0|||
126046275|NCT02719574|453468203|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046276|NCT02719574|453468204|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046277|NCT02719574|453468205|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046278|NCT02719574|453468206|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046279|NCT02719574|453468207|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
126046280|NCT02719574|453468208|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
126046281|NCT02719574|453468209|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046282|NCT02719574|453468210|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046283|NCT02719574|453468211|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046284|NCT02719574|453468212|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046285|NCT02719574|453468213|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046286|NCT02719574|453468214|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046287|NCT02719574|453468215|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046288|NCT02719574|453468216|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046289|NCT02719574|453468217|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
126046290|NCT02719574|453468201|FG000|Phase 1 (Dose Expansion)|Other|0|||
126046291|NCT02719574|453468202|FG001|Phase 1 (Dose Expansion)|Other|0|||
126369228|NCT03552029|454648146|FG000|Overall Study|Adverse Event|1|||
126369229|NCT03552029|454648147|FG001|Overall Study|Adverse Event|0|||
126369230|NCT03552029|454648146|FG000|Overall Study|Lack of Efficacy|0|||
125885139|NCT00815659|452876786|FG000|Overall Study|Adverse Event|9|||
126046292|NCT02719574|453468203|FG002|Phase 1 (Dose Expansion)|Other|0|||
126046293|NCT02719574|453468204|FG003|Phase 1 (Dose Expansion)|Other|0|||
126046294|NCT02719574|453468205|FG004|Phase 1 (Dose Expansion)|Other|0|||
126046295|NCT02719574|453468206|FG005|Phase 1 (Dose Expansion)|Other|0|||
126046296|NCT02719574|453468207|FG006|Phase 1 (Dose Expansion)|Other|1|||
126306021|NCT02553499|454408877|FG008|Overall Study|Adverse Event|0|||
126306022|NCT02553499|454408878|FG009|Overall Study|Adverse Event|0|||
126306023|NCT02553499|454408879|FG010|Overall Study|Adverse Event|0|||
126306024|NCT02553499|454408880|FG011|Overall Study|Adverse Event|0|||
126306025|NCT02553499|454408881|FG012|Overall Study|Adverse Event|0|||
126306026|NCT02553499|454408882|FG013|Overall Study|Adverse Event|1|||
126306027|NCT02553499|454408869|FG000|Overall Study|Death|0|||
126306028|NCT02553499|454408870|FG001|Overall Study|Death|1|||
126369231|NCT03552029|454648147|FG001|Overall Study|Lack of Efficacy|2|||
126369232|NCT03552029|454648146|FG000|Overall Study|Physician Decision|0|||
126369233|NCT03552029|454648147|FG001|Overall Study|Physician Decision|1|||
126046297|NCT02719574|453468208|FG007|Phase 1 (Dose Expansion)|Other|7|||
126046298|NCT02719574|453468209|FG008|Phase 1 (Dose Expansion)|Other|0|||
126046299|NCT02719574|453468210|FG009|Phase 1 (Dose Expansion)|Other|0|||
126046300|NCT02719574|453468211|FG010|Phase 1 (Dose Expansion)|Other|0|||
126046301|NCT02719574|453468212|FG011|Phase 1 (Dose Expansion)|Other|0|||
126046302|NCT02719574|453468213|FG012|Phase 1 (Dose Expansion)|Other|0|||
126046303|NCT02719574|453468214|FG013|Phase 1 (Dose Expansion)|Other|0|||
126046304|NCT02719574|453468215|FG014|Phase 1 (Dose Expansion)|Other|0|||
126046305|NCT02719574|453468216|FG015|Phase 1 (Dose Expansion)|Other|0|||
126046306|NCT02719574|453468217|FG016|Phase 1 (Dose Expansion)|Other|0|||
126306029|NCT02553499|454408871|FG002|Overall Study|Death|1|||
126306030|NCT02553499|454408872|FG003|Overall Study|Death|0|||
126306031|NCT02553499|454408873|FG004|Overall Study|Death|1|||
126306032|NCT02553499|454408874|FG005|Overall Study|Death|2|||
126306033|NCT02553499|454408875|FG006|Overall Study|Death|0|||
126306034|NCT02553499|454408876|FG007|Overall Study|Death|0|||
126306035|NCT02553499|454408877|FG008|Overall Study|Death|0|||
126306036|NCT02553499|454408878|FG009|Overall Study|Death|0|||
126306037|NCT02553499|454408879|FG010|Overall Study|Death|1|||
126306038|NCT02553499|454408880|FG011|Overall Study|Death|0|||
126306039|NCT02553499|454408881|FG012|Overall Study|Death|0|||
126306040|NCT02553499|454408882|FG013|Overall Study|Death|0|||
126306041|NCT02553499|454408869|FG000|Overall Study|Lost to Follow-up|0|||
126046307|NCT02719574|453468201|FG000|Phase 2|Protocol Defined Disease Progression|0|||
126046308|NCT02719574|453468202|FG001|Phase 2|Protocol Defined Disease Progression|0|||
126306042|NCT02553499|454408870|FG001|Overall Study|Lost to Follow-up|0|||
126306043|NCT02553499|454408871|FG002|Overall Study|Lost to Follow-up|0|||
126306044|NCT02553499|454408872|FG003|Overall Study|Lost to Follow-up|0|||
126369234|NCT03552029|454648146|FG000|Overall Study|Study terminated by Sponsor|0|||
126369235|NCT03552029|454648147|FG001|Overall Study|Study terminated by Sponsor|1|||
126369236|NCT03552029|454648146|FG000|Overall Study|Other|0|||
126369237|NCT03552029|454648147|FG001|Overall Study|Other|2|||
126369238|NCT03468998|454648153|FG000|Overall Study|Withdrawal by Subject|1|||
126369239|NCT03468998|454648154|FG001|Overall Study|Withdrawal by Subject|1|||
126369240|NCT03468998|454648155|FG002|Overall Study|Withdrawal by Subject|0|||
126369241|NCT03468998|454648156|FG003|Overall Study|Withdrawal by Subject|4|||
126369242|NCT03468998|454648157|FG004|Overall Study|Withdrawal by Subject|1|||
126369243|NCT03468998|454648158|FG005|Overall Study|Withdrawal by Subject|0|||
126369244|NCT00633126|454648163|FG000|Overall Study|Did not receive full dose|1|||
126369245|NCT02297516|454648168|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
126369246|NCT02297516|454648169|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
126369247|NCT02297516|454648168|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
126369248|NCT02297516|454648169|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
126369249|NCT02297516|454648168|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
126369250|NCT02297516|454648169|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
126369251|NCT02332928|454648171|FG000|Overall Study|Withdrawal by Subject|0|||
126369252|NCT02332928|454648172|FG001|Overall Study|Withdrawal by Subject|2|||
126369253|NCT02332928|454648171|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
126369254|NCT02332928|454648172|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
126369255|NCT01425814|454648173|FG000|Period 1|Stability criteria not fulfilled|0|||
126369256|NCT01425814|454648174|FG001|Period 1|Stability criteria not fulfilled|1|||
126369257|NCT01425814|454648175|FG002|Period 1|Stability criteria not fulfilled|0|||
126369258|NCT01425814|454648176|FG003|Period 1|Stability criteria not fulfilled|0|||
126369259|NCT01425814|454648177|FG004|Period 1|Stability criteria not fulfilled|0|||
126369260|NCT01425814|454648178|FG005|Period 1|Stability criteria not fulfilled|0|||
126369261|NCT01425814|454648173|FG000|Period 2|Stability criteria not fulfilled|0|||
126369262|NCT01425814|454648174|FG001|Period 2|Stability criteria not fulfilled|1|||
126369263|NCT01425814|454648175|FG002|Period 2|Stability criteria not fulfilled|0|||
126369264|NCT01425814|454648176|FG003|Period 2|Stability criteria not fulfilled|0|||
126369265|NCT01425814|454648177|FG004|Period 2|Stability criteria not fulfilled|0|||
126369266|NCT01425814|454648178|FG005|Period 2|Stability criteria not fulfilled|0|||
126369267|NCT01425814|454648173|FG000|Period 3|Adverse Event|0|||
126369268|NCT01425814|454648174|FG001|Period 3|Adverse Event|0|||
126369269|NCT01425814|454648175|FG002|Period 3|Adverse Event|0|||
126369270|NCT01425814|454648176|FG003|Period 3|Adverse Event|0|||
126369271|NCT01425814|454648177|FG004|Period 3|Adverse Event|0|||
126369272|NCT01425814|454648178|FG005|Period 3|Adverse Event|1|||
126369273|NCT01425814|454648173|FG000|Period 4|Adverse Event|1|||
126369274|NCT01425814|454648174|FG001|Period 4|Adverse Event|0|||
126369275|NCT01425814|454648175|FG002|Period 4|Adverse Event|1|||
126369276|NCT01425814|454648176|FG003|Period 4|Adverse Event|0|||
126369277|NCT01425814|454648177|FG004|Period 4|Adverse Event|0|||
126369278|NCT01425814|454648178|FG005|Period 4|Adverse Event|0|||
126369279|NCT01425814|454648173|FG000|Period 5|Stability criteria not fulfilled|0|||
126369280|NCT01425814|454648174|FG001|Period 5|Stability criteria not fulfilled|0|||
126369281|NCT01425814|454648175|FG002|Period 5|Stability criteria not fulfilled|1|||
126369282|NCT01425814|454648176|FG003|Period 5|Stability criteria not fulfilled|0|||
126369283|NCT01425814|454648177|FG004|Period 5|Stability criteria not fulfilled|0|||
126369284|NCT01425814|454648178|FG005|Period 5|Stability criteria not fulfilled|1|||
126369285|NCT00573768|454648183|FG000|Overall Study|Adverse Event|1|||
126369286|NCT00573768|454648184|FG001|Overall Study|Adverse Event|1|||
126369287|NCT00573768|454648185|FG002|Overall Study|Adverse Event|2|||
126369288|NCT00573768|454648183|FG000|Overall Study|Protocol Violation|1|||
126369289|NCT00573768|454648184|FG001|Overall Study|Protocol Violation|0|||
126369290|NCT00573768|454648185|FG002|Overall Study|Protocol Violation|1|||
126369291|NCT00573768|454648183|FG000|Overall Study|Withdrawal by Subject|0|||
126369292|NCT00573768|454648184|FG001|Overall Study|Withdrawal by Subject|1|||
126369293|NCT00573768|454648185|FG002|Overall Study|Withdrawal by Subject|0|||
126369294|NCT00573768|454648183|FG000|Overall Study|Lost to Follow-up|0|||
126369295|NCT00573768|454648184|FG001|Overall Study|Lost to Follow-up|0|||
126369296|NCT00573768|454648185|FG002|Overall Study|Lost to Follow-up|1|||
126369297|NCT03243084|454648186|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
126369298|NCT03243084|454648187|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
126369299|NCT02090764|454648190|FG000|Overall Study|Adverse Event|1|||
126369300|NCT02090764|454648191|FG001|Overall Study|Adverse Event|3|||
126369301|NCT02090764|454648190|FG000|Overall Study|Lack of Efficacy|0|||
126369302|NCT02090764|454648191|FG001|Overall Study|Lack of Efficacy|13|||
126369303|NCT02090764|454648190|FG000|Overall Study|Withdrawal by Subject|2|||
126369304|NCT02090764|454648191|FG001|Overall Study|Withdrawal by Subject|1|||
126369305|NCT02090764|454648190|FG000|Overall Study|Intercurrent illness and other|1|||
126046309|NCT02719574|453468203|FG002|Phase 2|Protocol Defined Disease Progression|0|||
126046310|NCT02719574|453468204|FG003|Phase 2|Protocol Defined Disease Progression|0|||
126046311|NCT02719574|453468205|FG004|Phase 2|Protocol Defined Disease Progression|0|||
126046312|NCT02719574|453468206|FG005|Phase 2|Protocol Defined Disease Progression|0|||
126046313|NCT02719574|453468207|FG006|Phase 2|Protocol Defined Disease Progression|0|||
126046314|NCT02719574|453468208|FG007|Phase 2|Protocol Defined Disease Progression|0|||
126046315|NCT02719574|453468209|FG008|Phase 2|Protocol Defined Disease Progression|0|||
126046316|NCT02719574|453468210|FG009|Phase 2|Protocol Defined Disease Progression|65|||
126046317|NCT02719574|453468211|FG010|Phase 2|Protocol Defined Disease Progression|8|||
126046318|NCT02719574|453468212|FG011|Phase 2|Protocol Defined Disease Progression|2|||
126046319|NCT02719574|453468213|FG012|Phase 2|Protocol Defined Disease Progression|4|||
126046320|NCT02719574|453468214|FG013|Phase 2|Protocol Defined Disease Progression|9|||
126046321|NCT02719574|453468215|FG014|Phase 2|Protocol Defined Disease Progression|11|||
126046322|NCT02719574|453468216|FG015|Phase 2|Protocol Defined Disease Progression|3|||
126046323|NCT02719574|453468217|FG016|Phase 2|Protocol Defined Disease Progression|4|||
126046324|NCT02719574|453468201|FG000|Phase 2|Adverse Event|0|||
126046325|NCT02719574|453468202|FG001|Phase 2|Adverse Event|0|||
126046326|NCT02719574|453468203|FG002|Phase 2|Adverse Event|0|||
126046327|NCT02719574|453468204|FG003|Phase 2|Adverse Event|0|||
126046328|NCT02719574|453468205|FG004|Phase 2|Adverse Event|0|||
126046329|NCT02719574|453468206|FG005|Phase 2|Adverse Event|0|||
126046330|NCT02719574|453468207|FG006|Phase 2|Adverse Event|0|||
126046331|NCT02719574|453468208|FG007|Phase 2|Adverse Event|0|||
126046332|NCT02719574|453468209|FG008|Phase 2|Adverse Event|0|||
126046333|NCT02719574|453468210|FG009|Phase 2|Adverse Event|27|||
126046334|NCT02719574|453468211|FG010|Phase 2|Adverse Event|0|||
126046335|NCT02719574|453468212|FG011|Phase 2|Adverse Event|1|||
126046336|NCT02719574|453468213|FG012|Phase 2|Adverse Event|1|||
126046337|NCT02719574|453468214|FG013|Phase 2|Adverse Event|1|||
126046338|NCT02719574|453468215|FG014|Phase 2|Adverse Event|2|||
126046339|NCT02719574|453468216|FG015|Phase 2|Adverse Event|2|||
126046340|NCT02719574|453468217|FG016|Phase 2|Adverse Event|3|||
126046341|NCT02719574|453468201|FG000|Phase 2|Other|0|||
126046342|NCT02719574|453468202|FG001|Phase 2|Other|0|||
126046343|NCT02719574|453468203|FG002|Phase 2|Other|0|||
126046344|NCT02719574|453468204|FG003|Phase 2|Other|0|||
126046345|NCT02719574|453468205|FG004|Phase 2|Other|0|||
126046346|NCT02719574|453468206|FG005|Phase 2|Other|0|||
126046347|NCT02719574|453468207|FG006|Phase 2|Other|0|||
126046348|NCT02719574|453468208|FG007|Phase 2|Other|0|||
126046349|NCT02719574|453468209|FG008|Phase 2|Other|0|||
126046350|NCT02719574|453468210|FG009|Phase 2|Other|20|||
126046351|NCT02719574|453468211|FG010|Phase 2|Other|7|||
126046352|NCT02719574|453468212|FG011|Phase 2|Other|0|||
126046353|NCT02719574|453468213|FG012|Phase 2|Other|5|||
126046354|NCT02719574|453468214|FG013|Phase 2|Other|7|||
126046355|NCT02719574|453468215|FG014|Phase 2|Other|0|||
126046356|NCT02719574|453468216|FG015|Phase 2|Other|1|||
126046357|NCT02719574|453468217|FG016|Phase 2|Other|4|||
126046358|NCT02719574|453468201|FG000|Phase 2|Transplant|0|||
126046359|NCT02719574|453468202|FG001|Phase 2|Transplant|0|||
126046360|NCT02719574|453468203|FG002|Phase 2|Transplant|0|||
126046361|NCT02719574|453468204|FG003|Phase 2|Transplant|0|||
126046362|NCT02719574|453468205|FG004|Phase 2|Transplant|0|||
126046363|NCT02719574|453468206|FG005|Phase 2|Transplant|0|||
126046364|NCT02719574|453468207|FG006|Phase 2|Transplant|0|||
126046365|NCT02719574|453468208|FG007|Phase 2|Transplant|0|||
126046366|NCT02719574|453468209|FG008|Phase 2|Transplant|0|||
126046367|NCT02719574|453468210|FG009|Phase 2|Transplant|15|||
126046368|NCT02719574|453468211|FG010|Phase 2|Transplant|2|||
126046369|NCT02719574|453468212|FG011|Phase 2|Transplant|0|||
126046370|NCT02719574|453468213|FG012|Phase 2|Transplant|6|||
126046371|NCT02719574|453468214|FG013|Phase 2|Transplant|1|||
126046372|NCT02719574|453468215|FG014|Phase 2|Transplant|1|||
126046373|NCT02719574|453468216|FG015|Phase 2|Transplant|0|||
126046374|NCT02719574|453468217|FG016|Phase 2|Transplant|0|||
126046375|NCT02719574|453468201|FG000|Phase 2|Death|0|||
126046376|NCT02719574|453468202|FG001|Phase 2|Death|0|||
126046377|NCT02719574|453468203|FG002|Phase 2|Death|0|||
126046378|NCT02719574|453468204|FG003|Phase 2|Death|0|||
126046379|NCT02719574|453468205|FG004|Phase 2|Death|0|||
126046380|NCT02719574|453468206|FG005|Phase 2|Death|0|||
126046381|NCT02719574|453468207|FG006|Phase 2|Death|0|||
126046382|NCT02719574|453468208|FG007|Phase 2|Death|0|||
126046383|NCT02719574|453468209|FG008|Phase 2|Death|0|||
126046384|NCT02719574|453468210|FG009|Phase 2|Death|14|||
126046385|NCT02719574|453468211|FG010|Phase 2|Death|0|||
126046386|NCT02719574|453468212|FG011|Phase 2|Death|0|||
126046387|NCT02719574|453468213|FG012|Phase 2|Death|1|||
126046388|NCT02719574|453468214|FG013|Phase 2|Death|1|||
126046389|NCT02719574|453468215|FG014|Phase 2|Death|2|||
126046390|NCT02719574|453468216|FG015|Phase 2|Death|0|||
126046391|NCT02719574|453468217|FG016|Phase 2|Death|0|||
126046392|NCT02719574|453468201|FG000|Phase 2|Investigator Decision|0|||
125885165|NCT03847896|452876792|FG003|Overall Study|Withdrawal by Subject|9|||
125885166|NCT03847896|452876793|FG004|Overall Study|Withdrawal by Subject|8|||
125885167|NCT03847896|452876789|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125885168|NCT03847896|452876790|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125885169|NCT03847896|452876791|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125885170|NCT03847896|452876792|FG003|Overall Study|Withdrawal by parent/guardian|0|||
125885171|NCT03847896|452876793|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125885172|NCT03847896|452876789|FG000|Overall Study|Adverse Event|2|||
125885173|NCT03847896|452876790|FG001|Overall Study|Adverse Event|1|||
125885174|NCT03847896|452876791|FG002|Overall Study|Adverse Event|3|||
125885175|NCT03847896|452876792|FG003|Overall Study|Adverse Event|2|||
125885176|NCT03847896|452876793|FG004|Overall Study|Adverse Event|4|||
125885177|NCT03847896|452876789|FG000|Overall Study|A severe exacerbation event|0|||
125885178|NCT03847896|452876790|FG001|Overall Study|A severe exacerbation event|0|||
125885179|NCT03847896|452876791|FG002|Overall Study|A severe exacerbation event|0|||
125885180|NCT03847896|452876792|FG003|Overall Study|A severe exacerbation event|0|||
125885181|NCT03847896|452876793|FG004|Overall Study|A severe exacerbation event|3|||
125885182|NCT03847896|452876789|FG000|Overall Study|Protocol Violation|0|||
125885183|NCT03847896|452876790|FG001|Overall Study|Protocol Violation|2|||
125885184|NCT03847896|452876791|FG002|Overall Study|Protocol Violation|1|||
125885185|NCT03847896|452876792|FG003|Overall Study|Protocol Violation|0|||
125885186|NCT03847896|452876793|FG004|Overall Study|Protocol Violation|2|||
125885187|NCT03847896|452876789|FG000|Overall Study|Lost to Follow-up|0|||
125885188|NCT03847896|452876790|FG001|Overall Study|Lost to Follow-up|0|||
125885189|NCT03847896|452876791|FG002|Overall Study|Lost to Follow-up|0|||
125885190|NCT03847896|452876792|FG003|Overall Study|Lost to Follow-up|1|||
125885191|NCT03847896|452876793|FG004|Overall Study|Lost to Follow-up|0|||
125885192|NCT03847896|452876789|FG000|Overall Study|Condition under investigation worsened|0|||
125885193|NCT03847896|452876790|FG001|Overall Study|Condition under investigation worsened|0|||
126306335|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
126306336|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126306337|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126306338|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306339|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306340|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306341|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
126306342|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306343|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306344|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306345|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306346|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306347|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
126306348|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306349|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306350|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306351|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306352|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306353|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
126306354|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306355|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306356|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306357|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306358|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306359|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
126306360|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306361|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306362|NCT02244463|454410274|FG000|Period 5: Phase II|Disease Progression|0|||
126306363|NCT02244463|454410275|FG001|Period 5: Phase II|Disease Progression|0|||
126306364|NCT02244463|454410276|FG002|Period 5: Phase II|Disease Progression|0|||
126306365|NCT02244463|454410277|FG003|Period 5: Phase II|Disease Progression|0|||
126306366|NCT02244463|454410278|FG004|Period 5: Phase II|Disease Progression|10|||
126306367|NCT02244463|454410279|FG005|Period 5: Phase II|Disease Progression|11|||
126306368|NCT02244463|454410274|FG000|Period 5: Phase II|Physician Decision|0|||
126306369|NCT02244463|454410275|FG001|Period 5: Phase II|Physician Decision|0|||
126306370|NCT02244463|454410276|FG002|Period 5: Phase II|Physician Decision|0|||
125885194|NCT03847896|452876791|FG002|Overall Study|Condition under investigation worsened|0|||
126306371|NCT02244463|454410277|FG003|Period 5: Phase II|Physician Decision|0|||
126306372|NCT02244463|454410278|FG004|Period 5: Phase II|Physician Decision|3|||
126306373|NCT02244463|454410279|FG005|Period 5: Phase II|Physician Decision|2|||
126306374|NCT02244463|454410274|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
125885195|NCT03847896|452876792|FG003|Overall Study|Condition under investigation worsened|1|||
126369575|NCT00183248|454650606|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
126369576|NCT03309202|454650607|FG000|Overall Study|Lost to Follow-up|1|||
126369577|NCT03309202|454650608|FG001|Overall Study|Lost to Follow-up|0|||
126369578|NCT03309202|454650609|FG002|Overall Study|Lost to Follow-up|0|||
126369579|NCT03309202|454650610|FG003|Overall Study|Lost to Follow-up|0|||
126369580|NCT00415636|454650613|FG000|Overall Study|Symptomatic deterioration|1|||
126369581|NCT00415636|454650614|FG001|Overall Study|Symptomatic deterioration|0|||
126369582|NCT00415636|454650615|FG002|Overall Study|Symptomatic deterioration|1|||
126369583|NCT00415636|454650616|FG003|Overall Study|Symptomatic deterioration|2|||
126369584|NCT00415636|454650617|FG004|Overall Study|Symptomatic deterioration|0|||
126369585|NCT00415636|454650618|FG005|Overall Study|Symptomatic deterioration|1|||
126369586|NCT00415636|454650613|FG000|Overall Study|Adverse Event|0|||
126369587|NCT00415636|454650614|FG001|Overall Study|Adverse Event|0|||
126369588|NCT00415636|454650615|FG002|Overall Study|Adverse Event|0|||
126369589|NCT00415636|454650616|FG003|Overall Study|Adverse Event|1|||
126369590|NCT00415636|454650617|FG004|Overall Study|Adverse Event|1|||
126369591|NCT00415636|454650618|FG005|Overall Study|Adverse Event|0|||
126369592|NCT00415636|454650613|FG000|Overall Study|Withdrawal by Subject|0|||
126369593|NCT00415636|454650614|FG001|Overall Study|Withdrawal by Subject|0|||
126369594|NCT00415636|454650615|FG002|Overall Study|Withdrawal by Subject|0|||
126369595|NCT00415636|454650616|FG003|Overall Study|Withdrawal by Subject|0|||
126369596|NCT00415636|454650617|FG004|Overall Study|Withdrawal by Subject|1|||
126369597|NCT00415636|454650618|FG005|Overall Study|Withdrawal by Subject|0|||
126369598|NCT00415636|454650613|FG000|Overall Study|Disease progression|0|||
126369599|NCT00415636|454650614|FG001|Overall Study|Disease progression|0|||
126369600|NCT00415636|454650615|FG002|Overall Study|Disease progression|0|||
126369601|NCT00415636|454650616|FG003|Overall Study|Disease progression|3|||
126369602|NCT00415636|454650617|FG004|Overall Study|Disease progression|0|||
126369603|NCT00415636|454650618|FG005|Overall Study|Disease progression|1|||
126369604|NCT04734210|454650619|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
126369605|NCT04734210|454650620|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
126369606|NCT04734210|454650621|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
126369607|NCT04734210|454650619|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
126369608|NCT04734210|454650620|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
126369609|NCT04734210|454650621|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
126369610|NCT04734210|454650619|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
126369611|NCT04734210|454650620|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
126369612|NCT04734210|454650621|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
126369613|NCT04734210|454650619|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
126369614|NCT04734210|454650620|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
126046521|NCT03868930|453468246|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
126046522|NCT03868930|453468247|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
126046523|NCT03286114|453468252|FG000|Overall Study|Adverse Event|6|||
126046524|NCT03286114|453468252|FG000|Overall Study|Death|3|||
126046525|NCT01773993|453468253|FG000|Overall Study|No Visit After Treatment|35|||
126046526|NCT02656706|453468257|FG000|Overall Study|Insurance Denial|1|||
126369615|NCT04734210|454650621|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
126369616|NCT02684461|454650622|FG000|Overall Study|Adverse Event|1|||
126369617|NCT02684461|454650623|FG001|Overall Study|Adverse Event|0|||
126369618|NCT02684461|454650624|FG002|Overall Study|Adverse Event|0|||
126369619|NCT02684461|454650622|FG000|Overall Study|Lack of Efficacy|1|||
126369620|NCT02684461|454650623|FG001|Overall Study|Lack of Efficacy|2|||
126046527|NCT03725332|453468258|FG000|Overall Study|Adverse Event|5|||
126046528|NCT03725332|453468259|FG001|Overall Study|Adverse Event|10|||
126046529|NCT03725332|453468258|FG000|Overall Study|Death|1|||
126369621|NCT02684461|454650624|FG002|Overall Study|Lack of Efficacy|0|||
126369622|NCT02138825|454650625|FG000|Main Study Treatment|Adverse Event|11|||
126369623|NCT02138825|454650626|FG001|Main Study Treatment|Adverse Event|3|||
126369624|NCT02138825|454650625|FG000|Main Study Treatment|Death|1|||
126369625|NCT02138825|454650626|FG001|Main Study Treatment|Death|2|||
126046530|NCT03725332|453468259|FG001|Overall Study|Death|3|||
126046531|NCT03725332|453468258|FG000|Overall Study|Lost to Follow-up|43|||
126046532|NCT03725332|453468259|FG001|Overall Study|Lost to Follow-up|122|||
126046533|NCT03725332|453468258|FG000|Overall Study|Withdrawal by Subject|0|||
126046534|NCT03725332|453468259|FG001|Overall Study|Withdrawal by Subject|1|||
125885196|NCT03847896|452876793|FG004|Overall Study|Condition under investigation worsened|1|||
126369626|NCT02138825|454650625|FG000|Main Study Treatment|Protocol Violation|2|||
126046535|NCT03725332|453468258|FG000|Overall Study|Duplicate enrollment|0|||
126046536|NCT03725332|453468259|FG001|Overall Study|Duplicate enrollment|1|||
126046537|NCT03725332|453468258|FG000|Overall Study|Did not consent|0|||
126369627|NCT02138825|454650626|FG001|Main Study Treatment|Protocol Violation|2|||
126369628|NCT02138825|454650625|FG000|Main Study Treatment|Sponsor decision|12|||
126369629|NCT02138825|454650626|FG001|Main Study Treatment|Sponsor decision|18|||
126369630|NCT02138825|454650625|FG000|Main Study Treatment|Study terminated by sponsor|10|||
126369631|NCT02138825|454650626|FG001|Main Study Treatment|Study terminated by sponsor|9|||
126369632|NCT02138825|454650625|FG000|Main Study Treatment|Withdrawal by Subject|3|||
126369633|NCT02138825|454650626|FG001|Main Study Treatment|Withdrawal by Subject|1|||
126369634|NCT02138825|454650625|FG000|Main Study Treatment|Medical decision|1|||
126369635|NCT02138825|454650626|FG001|Main Study Treatment|Medical decision|0|||
126369636|NCT02138825|454650625|FG000|Long-term Extension|Study termination by sponsor|32|||
126369637|NCT02138825|454650626|FG001|Long-term Extension|Study termination by sponsor|38|||
126369638|NCT02138825|454650625|FG000|Safety Follow-up|Adverse Event|4|||
126369639|NCT02138825|454650626|FG001|Safety Follow-up|Adverse Event|3|||
126369640|NCT02138825|454650625|FG000|Safety Follow-up|Death|11|||
126369641|NCT02138825|454650626|FG001|Safety Follow-up|Death|5|||
126369642|NCT02138825|454650625|FG000|Safety Follow-up|Withdrawal by Subject|5|||
125885197|NCT03847896|452876789|FG000|Overall Study|Lack of Efficacy|0|||
125885198|NCT03847896|452876790|FG001|Overall Study|Lack of Efficacy|0|||
125885199|NCT03847896|452876791|FG002|Overall Study|Lack of Efficacy|0|||
125885200|NCT03847896|452876792|FG003|Overall Study|Lack of Efficacy|2|||
125885201|NCT03847896|452876793|FG004|Overall Study|Lack of Efficacy|2|||
125885202|NCT03847896|452876789|FG000|Overall Study|Other reasons|3|||
125885203|NCT03847896|452876790|FG001|Overall Study|Other reasons|3|||
125885204|NCT03847896|452876791|FG002|Overall Study|Other reasons|1|||
125885205|NCT03847896|452876792|FG003|Overall Study|Other reasons|2|||
125885206|NCT03847896|452876793|FG004|Overall Study|Other reasons|1|||
125885207|NCT00118417|452876794|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
125885208|NCT00118417|452876795|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
125885209|NCT00118417|452876794|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
125885210|NCT00118417|452876795|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
125885211|NCT00118417|452876794|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
125885212|NCT00118417|452876795|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
126369643|NCT02138825|454650626|FG001|Safety Follow-up|Withdrawal by Subject|3|||
126369644|NCT02138825|454650625|FG000|Safety Follow-up|clinic worsening|1|||
126369645|NCT02138825|454650626|FG001|Safety Follow-up|clinic worsening|0|||
126369646|NCT02138825|454650625|FG000|Safety Follow-up|withdrawal by PI|1|||
126369647|NCT02138825|454650626|FG001|Safety Follow-up|withdrawal by PI|0|||
126369648|NCT02138825|454650625|FG000|Safety Follow-up|logistical difficulties|0|||
126369649|NCT02138825|454650626|FG001|Safety Follow-up|logistical difficulties|1|||
126369650|NCT02138825|454650625|FG000|Safety Follow-up|progressive disease|0|||
126369651|NCT02138825|454650626|FG001|Safety Follow-up|progressive disease|2|||
126369652|NCT02138825|454650625|FG000|Safety Follow-up|too unwell to attend the visit|0|||
126369653|NCT02138825|454650626|FG001|Safety Follow-up|too unwell to attend the visit|1|||
126369654|NCT02138825|454650625|FG000|Safety Follow-up|treatment unblinded|0|||
126369655|NCT02138825|454650626|FG001|Safety Follow-up|treatment unblinded|1|||
126369656|NCT02138825|454650625|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
126369657|NCT02138825|454650626|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
126369658|NCT05201807|454650630|FG000|Overall Study|Adverse Event|1|||
126369659|NCT05201807|454650630|FG000|Overall Study|COVID-19 Related|1|||
125885213|NCT00118417|452876794|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
125885214|NCT00118417|452876795|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
125885215|NCT00118417|452876794|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
125885216|NCT00118417|452876795|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
126369660|NCT01209767|454650631|FG000|Overall Study|Withdrawal by Subject|1|||
126369661|NCT01209767|454650631|FG000|Overall Study|Lost to Follow-up|3|||
126369662|NCT01702298|454650632|FG000|Overall Study|Withdrawal by Subject|1|||
126369663|NCT01029535|454650634|FG000|Overall Study|Lost to Follow-up|24|||
126369664|NCT01029535|454650634|FG000|Overall Study|Protocol Violation|2|||
126369665|NCT01029535|454650634|FG000|Overall Study|Participant Withdrew Consent|2|||
125885217|NCT02978781|452876796|FG000|Part A|Adverse Event|1|||
126369666|NCT01029535|454650634|FG000|Overall Study|Adverse Event|1|||
126369667|NCT01029535|454650634|FG000|Overall Study|Use of Another Treatment|1|||
126369668|NCT01029535|454650634|FG000|Overall Study|Death|1|||
126369669|NCT00904371|454650639|FG000|Overall Study|Adverse Event|2|||
126369670|NCT00904371|454650639|FG000|Overall Study|Lost to Follow-up|4|||
126369671|NCT00904371|454650639|FG000|Overall Study|Discontinued at target blood pressure|2|||
126369672|NCT00904371|454650639|FG000|Overall Study|Continued with Tritace|1|||
126369673|NCT00583219|454650640|FG000|Phase 2|Withdrawal by Subject|1|||
126369674|NCT05448950|454650641|FG000|Overall Study|Death|2|||
126369675|NCT05448950|454650641|FG000|Overall Study|Withdrawal by Subject|1|||
126369676|NCT05448950|454650641|FG000|Overall Study|AVG abandoned|4|||
126369677|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126369678|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
126369679|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126369680|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126369681|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
126369682|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
126369683|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
126369684|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
126369685|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
126369686|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
126369687|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
126369688|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
126369689|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126369690|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126369691|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126369692|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126369693|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
126369694|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
126369695|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
126369696|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
126369697|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
126369698|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
126369699|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
126369700|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
126369701|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
126369702|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
126369703|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
126369704|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
126369705|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
126369706|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
126369707|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
126369708|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
126369709|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Death|0|||
126369710|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Death|0|||
126369711|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Death|1|||
126369712|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Death|0|||
126369713|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
126369714|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
126369715|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
126369716|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
126369717|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
126369718|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
126369719|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
126369720|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
126369721|NCT04752566|454650646|FG000|Overall Study|Protocol Violation|0|||
126369722|NCT04752566|454650647|FG001|Overall Study|Protocol Violation|1|||
126369723|NCT04752566|454650646|FG000|Overall Study|Death|1|||
126369724|NCT04752566|454650647|FG001|Overall Study|Death|0|||
126369725|NCT04752566|454650646|FG000|Overall Study|Adverse Event|1|||
126369726|NCT04752566|454650647|FG001|Overall Study|Adverse Event|0|||
126046538|NCT03725332|453468259|FG001|Overall Study|Did not consent|1|||
126369727|NCT04752566|454650646|FG000|Overall Study|Withdrawal by Subject|2|||
126369728|NCT04752566|454650647|FG001|Overall Study|Withdrawal by Subject|0|||
126369729|NCT04752566|454650646|FG000|Overall Study|Physician Decision|1|||
126369730|NCT04752566|454650647|FG001|Overall Study|Physician Decision|1|||
126369731|NCT01728246|454650648|FG000|Overall Study|Participant needed rescue medication|1|||
126369732|NCT01728246|454650649|FG001|Overall Study|Participant needed rescue medication|5|||
126369733|NCT01728246|454650648|FG000|Overall Study|Protocol Violation|1|||
126369734|NCT01728246|454650649|FG001|Overall Study|Protocol Violation|0|||
126369735|NCT01728246|454650648|FG000|Overall Study|Withdrawal by Subject|2|||
126369736|NCT01728246|454650649|FG001|Overall Study|Withdrawal by Subject|3|||
126369737|NCT01728246|454650648|FG000|Overall Study|Lost to Follow-up|23|||
126369738|NCT01728246|454650649|FG001|Overall Study|Lost to Follow-up|22|||
126369739|NCT01728246|454650648|FG000|Overall Study|Lack of Efficacy|1|||
126369740|NCT01728246|454650649|FG001|Overall Study|Lack of Efficacy|1|||
126369741|NCT01728246|454650648|FG000|Overall Study|Adverse Event|8|||
126369742|NCT01728246|454650649|FG001|Overall Study|Adverse Event|5|||
126369743|NCT01983111|454650650|FG000|Overall Study|Withdrawal by Subject|8|||
126369744|NCT01983111|454650651|FG001|Overall Study|Withdrawal by Subject|6|||
126369745|NCT01983111|454650650|FG000|Overall Study|Adverse Event|4|||
126369746|NCT01983111|454650651|FG001|Overall Study|Adverse Event|0|||
126369747|NCT01983111|454650650|FG000|Overall Study|Protocol Violation|0|||
126369748|NCT01983111|454650651|FG001|Overall Study|Protocol Violation|1|||
126369749|NCT00855335|454650652|FG000|Overall Study|Lost to Follow-up|0|||
126369750|NCT00855335|454650653|FG001|Overall Study|Lost to Follow-up|0|||
126369751|NCT00855335|454650654|FG002|Overall Study|Lost to Follow-up|3|||
126369752|NCT00855335|454650655|FG003|Overall Study|Lost to Follow-up|1|||
126369753|NCT00855335|454650656|FG004|Overall Study|Lost to Follow-up|0|||
126369754|NCT00855335|454650652|FG000|Overall Study|Withdrawal by Subject|0|||
126369755|NCT00855335|454650653|FG001|Overall Study|Withdrawal by Subject|0|||
126369756|NCT00855335|454650654|FG002|Overall Study|Withdrawal by Subject|0|||
126369757|NCT00855335|454650655|FG003|Overall Study|Withdrawal by Subject|1|||
126369758|NCT00855335|454650656|FG004|Overall Study|Withdrawal by Subject|0|||
126369759|NCT00855335|454650652|FG000|Overall Study|Adverse Event|2|||
126369760|NCT00855335|454650653|FG001|Overall Study|Adverse Event|0|||
126369761|NCT00855335|454650654|FG002|Overall Study|Adverse Event|0|||
126369762|NCT00855335|454650655|FG003|Overall Study|Adverse Event|0|||
126369763|NCT00855335|454650656|FG004|Overall Study|Adverse Event|0|||
126369764|NCT00855335|454650652|FG000|Overall Study|Physician Decision|1|||
126369765|NCT00855335|454650653|FG001|Overall Study|Physician Decision|1|||
126369766|NCT00855335|454650654|FG002|Overall Study|Physician Decision|0|||
126369767|NCT00855335|454650655|FG003|Overall Study|Physician Decision|0|||
126369768|NCT00855335|454650656|FG004|Overall Study|Physician Decision|0|||
126369769|NCT00855335|454650652|FG000|Overall Study|Other|2|||
126369770|NCT00855335|454650653|FG001|Overall Study|Other|1|||
126369771|NCT00855335|454650654|FG002|Overall Study|Other|2|||
126369772|NCT00855335|454650655|FG003|Overall Study|Other|5|||
126369773|NCT00855335|454650656|FG004|Overall Study|Other|1|||
126369774|NCT02706392|454650658|FG000|Overall Study|Death|1|||
126369775|NCT02706392|454650659|FG001|Overall Study|Death|0|||
126369776|NCT02706392|454650660|FG002|Overall Study|Death|2|||
125885218|NCT02978781|452876797|FG001|Part A|Adverse Event|1|||
125885219|NCT02978781|452876798|FG002|Part A|Adverse Event|0|||
126369777|NCT02706392|454650661|FG003|Overall Study|Death|2|||
126369778|NCT02706392|454650662|FG004|Overall Study|Death|5|||
125885220|NCT02978781|452876799|FG003|Part A|Adverse Event|0|||
126369779|NCT02706392|454650663|FG005|Overall Study|Death|2|||
126369780|NCT00619866|454650666|FG000|Weeks 1 - 12|Adverse Event|0|||
126369781|NCT00619866|454650667|FG001|Weeks 1 - 12|Adverse Event|1|||
125885221|NCT02978781|452876800|FG004|Part A|Adverse Event|0|||
125885222|NCT02978781|452876796|FG000|Part A|Withdrawal by Subject|0|||
126369782|NCT00619866|454650668|FG002|Weeks 1 - 12|Adverse Event|2|||
126369783|NCT00619866|454650669|FG003|Weeks 1 - 12|Adverse Event|0|||
126369784|NCT00619866|454650670|FG004|Weeks 1 - 12|Adverse Event|0|||
126369785|NCT00619866|454650666|FG000|Weeks 1 - 12|Non-compliance|0|||
126369786|NCT00619866|454650667|FG001|Weeks 1 - 12|Non-compliance|0|||
126369787|NCT00619866|454650668|FG002|Weeks 1 - 12|Non-compliance|1|||
126369788|NCT00619866|454650669|FG003|Weeks 1 - 12|Non-compliance|0|||
126369789|NCT00619866|454650670|FG004|Weeks 1 - 12|Non-compliance|0|||
126369790|NCT00619866|454650666|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
126369791|NCT00619866|454650667|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
126369792|NCT00619866|454650668|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
126369793|NCT00619866|454650669|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
126369794|NCT00619866|454650670|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
126369795|NCT00619866|454650666|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
126369796|NCT00619866|454650667|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
126369797|NCT00619866|454650668|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
126369798|NCT00619866|454650669|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
126369799|NCT00619866|454650670|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
126369800|NCT00619866|454650666|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
126369801|NCT00619866|454650667|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
126369802|NCT00619866|454650668|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
126369803|NCT00619866|454650669|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
126369804|NCT00619866|454650670|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
126369805|NCT00619866|454650666|FG000|Weeks 1 - 12|Sponsor Decision|0|||
126369806|NCT00619866|454650667|FG001|Weeks 1 - 12|Sponsor Decision|1|||
126369807|NCT00619866|454650668|FG002|Weeks 1 - 12|Sponsor Decision|0|||
126369808|NCT00619866|454650669|FG003|Weeks 1 - 12|Sponsor Decision|0|||
126369809|NCT00619866|454650670|FG004|Weeks 1 - 12|Sponsor Decision|0|||
126369810|NCT00619866|454650666|FG000|Weeks 13 - 24|Adverse Event|0|||
126369811|NCT00619866|454650667|FG001|Weeks 13 - 24|Adverse Event|0|||
126369812|NCT00619866|454650668|FG002|Weeks 13 - 24|Adverse Event|2|||
126369813|NCT00619866|454650669|FG003|Weeks 13 - 24|Adverse Event|1|||
126369814|NCT00619866|454650670|FG004|Weeks 13 - 24|Adverse Event|0|||
126369815|NCT00619866|454650666|FG000|Weeks 13 - 24|Protocol Deviation|0|||
126369816|NCT00619866|454650667|FG001|Weeks 13 - 24|Protocol Deviation|0|||
126369817|NCT00619866|454650668|FG002|Weeks 13 - 24|Protocol Deviation|0|||
125885223|NCT02978781|452876797|FG001|Part A|Withdrawal by Subject|1|||
125885224|NCT02978781|452876798|FG002|Part A|Withdrawal by Subject|0|||
126369818|NCT00619866|454650669|FG003|Weeks 13 - 24|Protocol Deviation|1|||
126369819|NCT00619866|454650670|FG004|Weeks 13 - 24|Protocol Deviation|0|||
126369820|NCT00619866|454650666|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
126369821|NCT00619866|454650667|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
125885225|NCT02978781|452876799|FG003|Part A|Withdrawal by Subject|0|||
125885226|NCT02978781|452876800|FG004|Part A|Withdrawal by Subject|0|||
125885227|NCT02978781|452876796|FG000|Part B|Withdrawal by Subject|0|||
126369822|NCT00619866|454650668|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
126369823|NCT00619866|454650669|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
126369824|NCT00619866|454650670|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
126369825|NCT00619866|454650666|FG000|Weeks 13 - 24|Non-compliance|0|||
126369826|NCT00619866|454650667|FG001|Weeks 13 - 24|Non-compliance|1|||
126369827|NCT00619866|454650668|FG002|Weeks 13 - 24|Non-compliance|1|||
126369828|NCT00619866|454650669|FG003|Weeks 13 - 24|Non-compliance|0|||
126369829|NCT00619866|454650670|FG004|Weeks 13 - 24|Non-compliance|0|||
126369830|NCT00619866|454650666|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
126369831|NCT00619866|454650667|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
126369832|NCT00619866|454650668|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
126369833|NCT00619866|454650669|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
126369834|NCT00619866|454650670|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
126369835|NCT01968980|454650674|FG000|Overall Study|Death|0|||
126369836|NCT01968980|454650675|FG001|Overall Study|Death|1|||
126369837|NCT01968980|454650674|FG000|Overall Study|Adverse Event|1|||
126369838|NCT01968980|454650675|FG001|Overall Study|Adverse Event|3|||
126369839|NCT01968980|454650674|FG000|Overall Study|Does not meet entry criteria|1|||
126369840|NCT01968980|454650675|FG001|Overall Study|Does not meet entry criteria|3|||
126369841|NCT01968980|454650674|FG000|Overall Study|Withdrawal by Subject|13|||
126369842|NCT01968980|454650675|FG001|Overall Study|Withdrawal by Subject|5|||
126369843|NCT01968980|454650674|FG000|Overall Study|Other unspecified|1|||
126369844|NCT01968980|454650675|FG001|Overall Study|Other unspecified|2|||
126369845|NCT02589938|454650679|FG000|Overall Study|Withdrawal by Subject|11|||
126369846|NCT02589938|454650680|FG001|Overall Study|Withdrawal by Subject|5|||
126369847|NCT02589938|454650681|FG002|Overall Study|Withdrawal by Subject|6|||
126369848|NCT02589938|454650679|FG000|Overall Study|Lost to Follow-up|3|||
126369849|NCT02589938|454650680|FG001|Overall Study|Lost to Follow-up|3|||
126369850|NCT02589938|454650681|FG002|Overall Study|Lost to Follow-up|3|||
126369851|NCT02589938|454650679|FG000|Overall Study|Death|1|||
126369852|NCT02589938|454650680|FG001|Overall Study|Death|0|||
126369853|NCT02589938|454650681|FG002|Overall Study|Death|1|||
126369854|NCT02589938|454650679|FG000|Overall Study|Protocol Violation|6|||
126369855|NCT02589938|454650680|FG001|Overall Study|Protocol Violation|2|||
126369856|NCT02589938|454650681|FG002|Overall Study|Protocol Violation|3|||
126369857|NCT02589938|454650679|FG000|Overall Study|Physician Decision|1|||
126369858|NCT02589938|454650680|FG001|Overall Study|Physician Decision|0|||
126369859|NCT02589938|454650681|FG002|Overall Study|Physician Decision|0|||
126369860|NCT02589938|454650679|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
126369861|NCT02589938|454650680|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
126369862|NCT02589938|454650681|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
126369863|NCT02521285|454650682|FG000|Overall Study|Lost to Follow-up|1|||
126369864|NCT02521285|454650683|FG001|Overall Study|Lost to Follow-up|1|||
126369865|NCT02521285|454650682|FG000|Overall Study|Withdrawal by Subject|1|||
126369866|NCT02521285|454650683|FG001|Overall Study|Withdrawal by Subject|1|||
126369867|NCT02521285|454650682|FG000|Overall Study|Adverse Event|0|||
126369868|NCT02521285|454650683|FG001|Overall Study|Adverse Event|1|||
126369869|NCT00787150|454650690|FG000|Overall Study|Adverse Event|4|||
126369870|NCT00787150|454650691|FG001|Overall Study|Adverse Event|4|||
126369871|NCT00787150|454650692|FG002|Overall Study|Adverse Event|4|||
126369872|NCT00787150|454650690|FG000|Overall Study|Physician Decision|1|||
126369873|NCT00787150|454650691|FG001|Overall Study|Physician Decision|2|||
126369874|NCT00787150|454650692|FG002|Overall Study|Physician Decision|1|||
126369875|NCT00787150|454650690|FG000|Overall Study|Withdrawal by Subject|2|||
126369876|NCT00787150|454650691|FG001|Overall Study|Withdrawal by Subject|1|||
126369877|NCT00787150|454650692|FG002|Overall Study|Withdrawal by Subject|0|||
126369878|NCT00787150|454650690|FG000|Overall Study|Dosing incorrect study durg|2|||
126369879|NCT00787150|454650691|FG001|Overall Study|Dosing incorrect study durg|0|||
126369880|NCT00787150|454650692|FG002|Overall Study|Dosing incorrect study durg|0|||
126369881|NCT01849276|454650693|FG000|Followed for Survival for 5 Years|Death|1|||
126369882|NCT01849276|454650693|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
126369883|NCT00879398|454650696|FG000|Overall Study|Visit Stop|399|||
126369884|NCT00879398|454650696|FG000|Overall Study|Lack of Efficacy|64|||
126369885|NCT00879398|454650696|FG000|Overall Study|Adverse Event|41|||
126369886|NCT00879398|454650696|FG000|Overall Study|Other Reasons|171|||
126046539|NCT02951052|453468267|FG000|Overall Study|Adverse Event|13|||
126046540|NCT02951052|453468268|FG001|Overall Study|Adverse Event|5|||
126046541|NCT02951052|453468267|FG000|Overall Study|Withdrawal by Subject|1|||
126046542|NCT02951052|453468268|FG001|Overall Study|Withdrawal by Subject|5|||
126369887|NCT01722669|454650699|FG000|Overall Study|Withdrawal by Subject|0|||
126369888|NCT01722669|454650700|FG001|Overall Study|Withdrawal by Subject|0|||
126046543|NCT02951052|453468267|FG000|Overall Study|Physician Decision|2|||
126046544|NCT02951052|453468268|FG001|Overall Study|Physician Decision|0|||
126046545|NCT02951052|453468267|FG000|Overall Study|Lost to Follow-up|1|||
126046546|NCT02951052|453468268|FG001|Overall Study|Lost to Follow-up|1|||
126046547|NCT02951052|453468267|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
126369889|NCT01722669|454650701|FG002|Overall Study|Withdrawal by Subject|0|||
126369890|NCT01722669|454650702|FG003|Overall Study|Withdrawal by Subject|0|||
126369891|NCT01722669|454650703|FG004|Overall Study|Withdrawal by Subject|0|||
126369892|NCT01722669|454650704|FG005|Overall Study|Withdrawal by Subject|2|||
126369893|NCT03012880|454650708|FG000|Overall Study|Withdrawal by Subject|1|||
126369894|NCT03012880|454650709|FG001|Overall Study|Withdrawal by Subject|0|||
126369895|NCT03012880|454650708|FG000|Overall Study|Ineligible|1|||
126369896|NCT03012880|454650709|FG001|Overall Study|Ineligible|0|||
126046548|NCT02951052|453468268|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
126046549|NCT02951052|453468267|FG000|Overall Study|Protocol Violation|5|||
126369897|NCT01587196|454650710|FG000|Overall Study|Lost to Follow-up|50|||
126306375|NCT02244463|454410275|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
126306376|NCT02244463|454410276|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
126306377|NCT02244463|454410277|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
126306378|NCT02244463|454410278|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
126306379|NCT02244463|454410279|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
126306380|NCT02244463|454410274|FG000|Period 5: Phase II|Intercurrent Illness|0|||
126306381|NCT02244463|454410275|FG001|Period 5: Phase II|Intercurrent Illness|0|||
126306382|NCT02244463|454410276|FG002|Period 5: Phase II|Intercurrent Illness|0|||
126306383|NCT02244463|454410277|FG003|Period 5: Phase II|Intercurrent Illness|0|||
126306384|NCT02244463|454410278|FG004|Period 5: Phase II|Intercurrent Illness|2|||
126306385|NCT02244463|454410279|FG005|Period 5: Phase II|Intercurrent Illness|0|||
126306386|NCT02244463|454410274|FG000|Period 5: Phase II|Adverse Event|0|||
126306387|NCT02244463|454410275|FG001|Period 5: Phase II|Adverse Event|0|||
126306388|NCT02244463|454410276|FG002|Period 5: Phase II|Adverse Event|0|||
126306389|NCT02244463|454410277|FG003|Period 5: Phase II|Adverse Event|0|||
126306390|NCT02244463|454410278|FG004|Period 5: Phase II|Adverse Event|0|||
126306391|NCT02244463|454410279|FG005|Period 5: Phase II|Adverse Event|2|||
126306392|NCT02244463|454410274|FG000|Period 5: Phase II|Still On treatment|0|||
126306393|NCT02244463|454410275|FG001|Period 5: Phase II|Still On treatment|0|||
126306394|NCT02244463|454410276|FG002|Period 5: Phase II|Still On treatment|0|||
126306395|NCT02244463|454410277|FG003|Period 5: Phase II|Still On treatment|0|||
126306396|NCT02244463|454410278|FG004|Period 5: Phase II|Still On treatment|0|||
126306397|NCT02244463|454410279|FG005|Period 5: Phase II|Still On treatment|3|||
126306398|NCT01769508|454410280|FG000|Overall Study|Death|3|||
126306399|NCT01769508|454410280|FG000|Overall Study|Withdrawal by Subject|1|||
126306400|NCT01769508|454410280|FG000|Overall Study|Adverse Event|1|||
126306401|NCT01769508|454410280|FG000|Overall Study|Lost to Follow-up|1|||
126306402|NCT01598090|454410281|FG000|Treatment Period|Poor/non-compliance|0|||
126306403|NCT01598090|454410282|FG001|Treatment Period|Poor/non-compliance|2|||
126306404|NCT01598090|454410283|FG002|Treatment Period|Poor/non-compliance|0|||
126306405|NCT01598090|454410281|FG000|Treatment Period|No longer meet study criteria|0|||
126306406|NCT01598090|454410282|FG001|Treatment Period|No longer meet study criteria|1|||
126306407|NCT01598090|454410283|FG002|Treatment Period|No longer meet study criteria|0|||
126306408|NCT01598090|454410281|FG000|Treatment Period|Lack of Efficacy|5|||
126306409|NCT01598090|454410282|FG001|Treatment Period|Lack of Efficacy|14|||
126306410|NCT01598090|454410283|FG002|Treatment Period|Lack of Efficacy|6|||
126306411|NCT01598090|454410281|FG000|Treatment Period|Adverse Event|2|||
126306412|NCT01598090|454410282|FG001|Treatment Period|Adverse Event|33|||
126306413|NCT01598090|454410283|FG002|Treatment Period|Adverse Event|17|||
126306414|NCT01598090|454410281|FG000|Treatment Period|Other reasons|0|||
126306415|NCT01598090|454410282|FG001|Treatment Period|Other reasons|4|||
126306416|NCT01598090|454410283|FG002|Treatment Period|Other reasons|1|||
126306417|NCT01598090|454410281|FG000|Treatment Period|Withdrawal by Subject|3|||
126306418|NCT01598090|454410282|FG001|Treatment Period|Withdrawal by Subject|13|||
126306419|NCT01598090|454410283|FG002|Treatment Period|Withdrawal by Subject|10|||
126306420|NCT01598090|454410281|FG000|Treatment Period|Lost to Follow-up|1|||
126306421|NCT01598090|454410282|FG001|Treatment Period|Lost to Follow-up|5|||
126306422|NCT01598090|454410283|FG002|Treatment Period|Lost to Follow-up|1|||
126306423|NCT01598090|454410281|FG000|Follow-up Period|Death|0|||
126306424|NCT01598090|454410282|FG001|Follow-up Period|Death|1|||
126306425|NCT01598090|454410283|FG002|Follow-up Period|Death|0|||
126369898|NCT01587196|454650710|FG000|Overall Study|Withdrawal by Subject|4|||
125885228|NCT02978781|452876797|FG001|Part B|Withdrawal by Subject|0|||
125885229|NCT02978781|452876798|FG002|Part B|Withdrawal by Subject|0|||
125885230|NCT02978781|452876799|FG003|Part B|Withdrawal by Subject|1|||
125885231|NCT02978781|452876800|FG004|Part B|Withdrawal by Subject|0|||
125885232|NCT02978781|452876796|FG000|Part C|Adverse Event|0|||
125885233|NCT02978781|452876797|FG001|Part C|Adverse Event|0|||
125885234|NCT02978781|452876798|FG002|Part C|Adverse Event|0|||
125885235|NCT02978781|452876799|FG003|Part C|Adverse Event|0|||
125885236|NCT02978781|452876800|FG004|Part C|Adverse Event|2|||
125885237|NCT02978781|452876796|FG000|Part C|Withdrawal by Subject|0|||
125885238|NCT02978781|452876797|FG001|Part C|Withdrawal by Subject|0|||
125885239|NCT02978781|452876798|FG002|Part C|Withdrawal by Subject|0|||
125885240|NCT02978781|452876799|FG003|Part C|Withdrawal by Subject|0|||
125885241|NCT02978781|452876800|FG004|Part C|Withdrawal by Subject|1|||
126306426|NCT01598090|454410281|FG000|Follow-up Period|No longer required per protocol|1|||
126306427|NCT01598090|454410282|FG001|Follow-up Period|No longer required per protocol|3|||
126306428|NCT01598090|454410283|FG002|Follow-up Period|No longer required per protocol|2|||
126306429|NCT01598090|454410281|FG000|Follow-up Period|Not reported|0|||
126306430|NCT01598090|454410282|FG001|Follow-up Period|Not reported|10|||
126306431|NCT01598090|454410283|FG002|Follow-up Period|Not reported|4|||
126306432|NCT01598090|454410281|FG000|Follow-up Period|Withdrawal by Subject|0|||
126306433|NCT01598090|454410282|FG001|Follow-up Period|Withdrawal by Subject|3|||
126306434|NCT01598090|454410283|FG002|Follow-up Period|Withdrawal by Subject|2|||
126306435|NCT01598090|454410281|FG000|Follow-up Period|Other reasons|2|||
126306436|NCT01598090|454410282|FG001|Follow-up Period|Other reasons|8|||
126306437|NCT01598090|454410283|FG002|Follow-up Period|Other reasons|8|||
126369899|NCT02769481|454650711|FG000|Overall Study|Protocol Violation|1|||
126369900|NCT02769481|454650712|FG001|Overall Study|Protocol Violation|0|||
126369901|NCT02769481|454650711|FG000|Overall Study|Adverse Event|3|||
126369902|NCT02769481|454650712|FG001|Overall Study|Adverse Event|6|||
126369903|NCT02769481|454650711|FG000|Overall Study|Entry Criteria Not Met|1|||
126369904|NCT02769481|454650712|FG001|Overall Study|Entry Criteria Not Met|2|||
126369905|NCT02769481|454650711|FG000|Overall Study|Withdrawal by Subject|14|||
126369906|NCT02769481|454650712|FG001|Overall Study|Withdrawal by Subject|16|||
126369907|NCT02769481|454650711|FG000|Overall Study|Lost to Follow-up|9|||
126369908|NCT02769481|454650712|FG001|Overall Study|Lost to Follow-up|9|||
126369909|NCT02769481|454650711|FG000|Overall Study|Physician Decision|0|||
125885242|NCT02978781|452876796|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
125885243|NCT02978781|452876797|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
125885244|NCT02978781|452876798|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
126369910|NCT02769481|454650712|FG001|Overall Study|Physician Decision|1|||
126369911|NCT02769481|454650711|FG000|Overall Study|Terminated by Sponsor|1|||
126369912|NCT02769481|454650712|FG001|Overall Study|Terminated by Sponsor|0|||
126306438|NCT01598090|454410281|FG000|Follow-up Period|Lost to Follow-up|2|||
126306439|NCT01598090|454410282|FG001|Follow-up Period|Lost to Follow-up|10|||
126306440|NCT01598090|454410283|FG002|Follow-up Period|Lost to Follow-up|12|||
126306441|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
126306442|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
126306443|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
126306444|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
126306445|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306446|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306447|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306448|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306449|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306450|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306451|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306452|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
126306453|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306454|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
126306455|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
126306456|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306457|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306458|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306459|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306460|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306461|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306462|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306463|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
126306464|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
126306465|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
126306466|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
126306467|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306468|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306469|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126369913|NCT02769481|454650711|FG000|Overall Study|Death|0|||
126369914|NCT02769481|454650712|FG001|Overall Study|Death|1|||
126369915|NCT02769481|454650711|FG000|Overall Study|Undefined|4|||
126369916|NCT02769481|454650712|FG001|Overall Study|Undefined|1|||
126369917|NCT03510715|454650713|FG000|Overall Study|Adverse Event|1|||
126369918|NCT03510715|454650714|FG001|Overall Study|Adverse Event|0|||
126369919|NCT00643279|454650719|FG000|Overall Study|Death|13|||
126369920|NCT00643279|454650720|FG001|Overall Study|Death|11|||
126369921|NCT00643279|454650719|FG000|Overall Study|Withdrawal by Subject|3|||
126369922|NCT00643279|454650720|FG001|Overall Study|Withdrawal by Subject|0|||
126369923|NCT00643279|454650719|FG000|Overall Study|Lost to Follow-up|0|||
126369924|NCT00643279|454650720|FG001|Overall Study|Lost to Follow-up|1|||
126369925|NCT00643279|454650719|FG000|Overall Study|Physician Decision|0|||
126369926|NCT00643279|454650720|FG001|Overall Study|Physician Decision|1|||
126369927|NCT05715827|454650727|FG000|Overall Study|Physician Decision|0|||
126369928|NCT05715827|454650728|FG001|Overall Study|Physician Decision|1|||
126369929|NCT05715827|454650727|FG000|Overall Study|console communication error|0|||
126369930|NCT05715827|454650728|FG001|Overall Study|console communication error|1|||
125885245|NCT02978781|452876799|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
125885246|NCT02978781|452876800|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
125885247|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
125885248|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
125885249|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Adverse Event|31|||
125885250|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Adverse Event|21|||
125885251|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
125885252|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
125885253|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
125885254|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
126046550|NCT02951052|453468268|FG001|Overall Study|Protocol Violation|3|||
126046551|NCT02951052|453468267|FG000|Overall Study|Lack of Efficacy|3|||
126306470|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126369931|NCT03814044|454650729|FG000|Overall Study|Protocol deviation|1|||
126369932|NCT05929326|454650730|FG000|Overall Study|unqualified sample|2|||
126369933|NCT05929326|454650731|FG001|Overall Study|unqualified sample|3|||
126369934|NCT05929326|454650732|FG002|Overall Study|unqualified sample|7|||
126369935|NCT03557502|454650741|FG000|Protocol 2|Withdrawal by Subject|1|||
126369936|NCT03557502|454650742|FG001|Protocol 2|Withdrawal by Subject|1|||
126369937|NCT03557502|454650741|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
126369938|NCT03557502|454650742|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
126369939|NCT02333799|454652218|FG000|Treatment Period|Withdrawal by Subject|1|||
126369940|NCT02333799|454652218|FG000|Treatment Period|Death|6|||
126046552|NCT02951052|453468268|FG001|Overall Study|Lack of Efficacy|4|||
126046553|NCT02951052|453468267|FG000|Overall Study|Ongoing|1|||
126046554|NCT02951052|453468268|FG001|Overall Study|Ongoing|0|||
126046555|NCT05795153|453469049|FG000|Overall Study|Adverse Event|2|||
126046556|NCT05795153|453469049|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126046557|NCT05795153|453469049|FG000|Overall Study|Lost to Follow-up|1|||
126046558|NCT05795153|453469049|FG000|Overall Study|Subject decision|2|||
126046559|NCT04644029|453469053|FG000|Overall Study|Death|1|||
126046560|NCT04644029|453469054|FG001|Overall Study|Death|0|||
126046561|NCT04644029|453469053|FG000|Overall Study|Physician Decision|1|||
126046562|NCT04644029|453469054|FG001|Overall Study|Physician Decision|2|||
126046563|NCT04644029|453469053|FG000|Overall Study|Withdrawal by Subject|21|||
126046564|NCT04644029|453469054|FG001|Overall Study|Withdrawal by Subject|19|||
126046565|NCT04644029|453469053|FG000|Overall Study|Lost to Follow-up|31|||
126046566|NCT04644029|453469054|FG001|Overall Study|Lost to Follow-up|34|||
126046567|NCT04644029|453469053|FG000|Overall Study|Study Terminated by Sponsor|308|||
126046568|NCT04644029|453469054|FG001|Overall Study|Study Terminated by Sponsor|309|||
126046569|NCT04644029|453469053|FG000|Overall Study|Randomized in Error|2|||
126046570|NCT04644029|453469054|FG001|Overall Study|Randomized in Error|1|||
126046571|NCT04644029|453469053|FG000|Overall Study|Other|0|||
125885255|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
125885256|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
125885257|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
126369941|NCT02333799|454652218|FG000|6 Month Follow Up Period|Physician Decision|1|||
126369942|NCT02333799|454652218|FG000|6 Month Follow Up Period|Death|1|||
126369943|NCT02333799|454652218|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
126369944|NCT02333799|454652218|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
126369945|NCT01657370|454652222|FG000|Overall Study|Withdrawal by Subject|0|||
126369946|NCT01657370|454652223|FG001|Overall Study|Withdrawal by Subject|0|||
126369947|NCT01657370|454652224|FG002|Overall Study|Withdrawal by Subject|1|||
126369948|NCT01657370|454652225|FG003|Overall Study|Withdrawal by Subject|0|||
126369949|NCT01657370|454652226|FG004|Overall Study|Withdrawal by Subject|0|||
126369950|NCT01657370|454652227|FG005|Overall Study|Withdrawal by Subject|1|||
126369951|NCT01657370|454652222|FG000|Overall Study|Physician Decision|2|||
126369952|NCT01657370|454652223|FG001|Overall Study|Physician Decision|3|||
126369953|NCT01657370|454652224|FG002|Overall Study|Physician Decision|1|||
126369954|NCT01657370|454652225|FG003|Overall Study|Physician Decision|2|||
126369955|NCT01657370|454652226|FG004|Overall Study|Physician Decision|5|||
126369956|NCT01657370|454652227|FG005|Overall Study|Physician Decision|0|||
126369957|NCT01657370|454652222|FG000|Overall Study|Lack of Qualifying Event|1|||
126369958|NCT01657370|454652223|FG001|Overall Study|Lack of Qualifying Event|0|||
126369959|NCT01657370|454652224|FG002|Overall Study|Lack of Qualifying Event|3|||
126369960|NCT01657370|454652225|FG003|Overall Study|Lack of Qualifying Event|2|||
126369961|NCT01657370|454652226|FG004|Overall Study|Lack of Qualifying Event|1|||
126369962|NCT01657370|454652227|FG005|Overall Study|Lack of Qualifying Event|2|||
126369963|NCT01657370|454652222|FG000|Overall Study|Adverse Event|0|||
126369964|NCT01657370|454652223|FG001|Overall Study|Adverse Event|0|||
126369965|NCT01657370|454652224|FG002|Overall Study|Adverse Event|0|||
126369966|NCT01657370|454652225|FG003|Overall Study|Adverse Event|0|||
126369967|NCT01657370|454652226|FG004|Overall Study|Adverse Event|1|||
126369968|NCT01657370|454652227|FG005|Overall Study|Adverse Event|0|||
126369969|NCT01657370|454652222|FG000|Overall Study|Protocol Violation|1|||
126369970|NCT01657370|454652223|FG001|Overall Study|Protocol Violation|1|||
126369971|NCT01657370|454652224|FG002|Overall Study|Protocol Violation|1|||
126369972|NCT01657370|454652225|FG003|Overall Study|Protocol Violation|1|||
126369973|NCT01657370|454652226|FG004|Overall Study|Protocol Violation|0|||
126046572|NCT04644029|453469054|FG001|Overall Study|Other|1|||
126046573|NCT00739908|453469056|FG000|Overall Study|Adverse Event|5|||
126046574|NCT00739908|453469057|FG001|Overall Study|Adverse Event|6|||
126369974|NCT01657370|454652227|FG005|Overall Study|Protocol Violation|0|||
126046575|NCT00739908|453469056|FG000|Overall Study|Withdrawal by Subject|4|||
126046576|NCT00739908|453469057|FG001|Overall Study|Withdrawal by Subject|2|||
126046577|NCT00739908|453469056|FG000|Overall Study|Lost to Follow-up|14|||
126046578|NCT00739908|453469057|FG001|Overall Study|Lost to Follow-up|9|||
126046579|NCT00739908|453469056|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
126369975|NCT01657370|454652222|FG000|Overall Study|Lost to Follow-up|2|||
126369976|NCT01657370|454652223|FG001|Overall Study|Lost to Follow-up|0|||
126369977|NCT01657370|454652224|FG002|Overall Study|Lost to Follow-up|1|||
126369978|NCT01657370|454652225|FG003|Overall Study|Lost to Follow-up|0|||
126369979|NCT01657370|454652226|FG004|Overall Study|Lost to Follow-up|0|||
126369980|NCT01657370|454652227|FG005|Overall Study|Lost to Follow-up|1|||
126369981|NCT03021486|454652228|FG000|Overall Study|Withdrawal by Subject|1|||
126369982|NCT03021486|454652229|FG001|Overall Study|Withdrawal by Subject|1|||
126369983|NCT03021486|454652230|FG002|Overall Study|Withdrawal by Subject|3|||
126369984|NCT03021486|454652228|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
126369985|NCT03021486|454652229|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
126369986|NCT03021486|454652230|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
126369987|NCT04795531|454652231|FG000|Overall Study|Withdrawal by Subject|4|||
126369988|NCT04795531|454652232|FG001|Overall Study|Withdrawal by Subject|4|||
126369989|NCT04795531|454652231|FG000|Overall Study|Lost to Follow-up|0|||
126369990|NCT04795531|454652232|FG001|Overall Study|Lost to Follow-up|1|||
126369991|NCT04795531|454652231|FG000|Overall Study|Physician Decision|0|||
126369992|NCT04795531|454652232|FG001|Overall Study|Physician Decision|2|||
126369993|NCT04795531|454652231|FG000|Overall Study|Death|2|||
126369994|NCT04795531|454652232|FG001|Overall Study|Death|1|||
126369995|NCT04887831|454652233|FG000|Overall Study|Death|26|||
126369996|NCT04887831|454652234|FG001|Overall Study|Death|26|||
126369997|NCT04887831|454652233|FG000|Overall Study|Lost to Follow-up|0|||
126369998|NCT04887831|454652234|FG001|Overall Study|Lost to Follow-up|1|||
126369999|NCT04887831|454652233|FG000|Overall Study|Withdrawal by Subject|2|||
126370000|NCT04887831|454652234|FG001|Overall Study|Withdrawal by Subject|1|||
126370001|NCT04887831|454652233|FG000|Overall Study|Study Terminated by Sponsor|18|||
126370002|NCT04887831|454652234|FG001|Overall Study|Study Terminated by Sponsor|17|||
126370003|NCT04887831|454652233|FG000|Overall Study|Other|1|||
126370004|NCT04887831|454652234|FG001|Overall Study|Other|0|||
126370005|NCT00730327|454652235|FG000|Overall Study|Lost to Follow-up|14|||
126370006|NCT00730327|454652236|FG001|Overall Study|Lost to Follow-up|16|||
126370007|NCT00730327|454652235|FG000|Overall Study|Adverse Event|8|||
126370008|NCT00730327|454652236|FG001|Overall Study|Adverse Event|1|||
126370009|NCT00730327|454652235|FG000|Overall Study|Withdrawal by Subject|3|||
126370010|NCT00730327|454652236|FG001|Overall Study|Withdrawal by Subject|13|||
126370011|NCT00730327|454652235|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
126370012|NCT00730327|454652236|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
126370013|NCT02552225|454652237|FG000|Overall Study|Withdrawal by Subject|1|||
126370014|NCT02552225|454652238|FG001|Overall Study|Withdrawal by Subject|0|||
126370015|NCT04507204|454652241|FG000|Overall Study|Adverse Event|8|||
126370016|NCT04507204|454652242|FG001|Overall Study|Adverse Event|13|||
126370017|NCT04507204|454652241|FG000|Overall Study|Death|0|||
126370018|NCT04507204|454652242|FG001|Overall Study|Death|1|||
126370019|NCT04507204|454652241|FG000|Overall Study|Lost to Follow-up|15|||
126370020|NCT04507204|454652242|FG001|Overall Study|Lost to Follow-up|14|||
126370021|NCT04507204|454652241|FG000|Overall Study|Poor Compliance with Protocol|2|||
126370022|NCT04507204|454652242|FG001|Overall Study|Poor Compliance with Protocol|4|||
126370023|NCT04507204|454652241|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
126370024|NCT04507204|454652242|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
126370025|NCT04507204|454652241|FG000|Overall Study|Withdrawal of Patient Consent|21|||
126370026|NCT04507204|454652242|FG001|Overall Study|Withdrawal of Patient Consent|13|||
126370027|NCT01206517|454652247|FG000|Overall Study|Withdrawal by Subject|0|||
126370028|NCT01206517|454652248|FG001|Overall Study|Withdrawal by Subject|0|||
126370029|NCT01206517|454652249|FG002|Overall Study|Withdrawal by Subject|2|||
126370030|NCT01206517|454652250|FG003|Overall Study|Withdrawal by Subject|0|||
126370031|NCT01206517|454652251|FG004|Overall Study|Withdrawal by Subject|1|||
126370032|NCT01206517|454652252|FG005|Overall Study|Withdrawal by Subject|0|||
126370033|NCT03493958|454652253|FG000|Overall Study|Withdrawal by Subject|6|||
126370034|NCT03493958|454652253|FG000|Overall Study|Lost to Follow-up|7|||
126370035|NCT03493958|454652253|FG000|Overall Study|Did not complete all required study procedures|2|||
126370036|NCT04047446|454652254|FG000|Overall Study|Physician Decision|1|||
126046580|NCT00739908|453469057|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
126370037|NCT04047446|454652255|FG001|Overall Study|Physician Decision|0|||
126370038|NCT02367456|454652256|FG000|Overall Study|Death|8|||
126370039|NCT02367456|454652257|FG001|Overall Study|Death|24|||
126370040|NCT02367456|454652258|FG002|Overall Study|Death|17|||
126370041|NCT02367456|454652256|FG000|Overall Study|Lost to Follow-up|1|||
126370042|NCT02367456|454652257|FG001|Overall Study|Lost to Follow-up|3|||
126370043|NCT02367456|454652258|FG002|Overall Study|Lost to Follow-up|1|||
126370044|NCT02367456|454652256|FG000|Overall Study|Other reason|3|||
126370045|NCT02367456|454652257|FG001|Overall Study|Other reason|3|||
126370046|NCT02367456|454652258|FG002|Overall Study|Other reason|9|||
126370047|NCT02367456|454652256|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
126370048|NCT02367456|454652257|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
125885258|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
125885259|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Administrative problems|3|||
125885260|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Administrative problems|3|||
125885261|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Death|5|||
125885262|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Death|8|||
125885263|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Disease progression|139|||
125885264|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Disease progression|119|||
125885265|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
125885266|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
125885267|NCT00785785|452876801|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
125885268|NCT00785785|452876802|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
125885269|NCT00785785|452876801|FG000|Optional Extension Phase|Adverse Event|4|||
125885270|NCT00785785|452876802|FG001|Optional Extension Phase|Adverse Event|5|||
125885271|NCT00785785|452876801|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
125885272|NCT00785785|452876802|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
125885273|NCT00785785|452876801|FG000|Optional Extension Phase|Lost to Follow-up|1|||
125885274|NCT00785785|452876802|FG001|Optional Extension Phase|Lost to Follow-up|0|||
125885275|NCT00785785|452876801|FG000|Optional Extension Phase|Administrative problems|2|||
125885276|NCT00785785|452876802|FG001|Optional Extension Phase|Administrative problems|0|||
125885277|NCT00785785|452876801|FG000|Optional Extension Phase|Death|1|||
125885278|NCT00785785|452876802|FG001|Optional Extension Phase|Death|5|||
125885279|NCT00785785|452876801|FG000|Optional Extension Phase|Disease progression|22|||
125885280|NCT00785785|452876802|FG001|Optional Extension Phase|Disease progression|70|||
125885281|NCT00785785|452876801|FG000|Optional Extension Phase|Protocol deviation|0|||
125885282|NCT00785785|452876802|FG001|Optional Extension Phase|Protocol deviation|2|||
125885283|NCT00785785|452876801|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
125885284|NCT00785785|452876802|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
125885285|NCT02453321|452876803|FG000|Overall Study|Weakness|1|||
126306471|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306472|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306473|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306474|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
126306475|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
126306476|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
126306477|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
126306478|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306479|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306480|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306481|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306482|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306483|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306484|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306485|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306486|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306487|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306488|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
126306489|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306490|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306491|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306492|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306493|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306494|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306495|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306496|NCT04791319|454410284|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306497|NCT04791319|454410285|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306498|NCT04791319|454410286|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306499|NCT04791319|454410287|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306500|NCT04791319|454410288|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
126306501|NCT04791319|454410289|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
126306502|NCT04791319|454410290|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
125885286|NCT02453321|452876804|FG001|Overall Study|Weakness|1|||
125885287|NCT02453321|452876805|FG002|Overall Study|Weakness|2|||
125885288|NCT02453321|452876803|FG000|Overall Study|Deep Venous Thrombosis|0|||
125885289|NCT02453321|452876804|FG001|Overall Study|Deep Venous Thrombosis|1|||
125885290|NCT02453321|452876805|FG002|Overall Study|Deep Venous Thrombosis|0|||
125885291|NCT00357552|452876806|FG000|Screening|Did not meet eligibility criteria|84|||
126370049|NCT02367456|454652258|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
126370050|NCT01198587|454652264|FG000|Overall Study|Lost to Follow-up|8|||
126370051|NCT01198587|454652265|FG001|Overall Study|Lost to Follow-up|0|||
126370052|NCT01198587|454652266|FG002|Overall Study|Lost to Follow-up|9|||
126370053|NCT01198587|454652267|FG003|Overall Study|Lost to Follow-up|0|||
126370054|NCT02095106|454652270|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
126370055|NCT02095106|454652271|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
126370056|NCT00553254|454652274|FG000|Overall Study|Death|3|||
126370057|NCT00553254|454652275|FG001|Overall Study|Death|6|||
126370058|NCT00553254|454652276|FG002|Overall Study|Death|25|||
126370059|NCT00553254|454652274|FG000|Overall Study|Lost to Follow-up|0|||
126370060|NCT00553254|454652275|FG001|Overall Study|Lost to Follow-up|0|||
126370061|NCT00553254|454652276|FG002|Overall Study|Lost to Follow-up|2|||
126370062|NCT00553254|454652274|FG000|Overall Study|Withdrawal by Subject|2|||
126370063|NCT00553254|454652275|FG001|Overall Study|Withdrawal by Subject|0|||
126370064|NCT00553254|454652276|FG002|Overall Study|Withdrawal by Subject|2|||
126370065|NCT00553254|454652274|FG000|Overall Study|Study terminated by Sponsor|0|||
126370066|NCT00553254|454652275|FG001|Overall Study|Study terminated by Sponsor|0|||
126370067|NCT00553254|454652276|FG002|Overall Study|Study terminated by Sponsor|1|||
126370068|NCT00553254|454652274|FG000|Overall Study|Other|1|||
126370069|NCT00553254|454652275|FG001|Overall Study|Other|0|||
126370070|NCT00553254|454652276|FG002|Overall Study|Other|13|||
126370071|NCT01500317|454652284|FG000|Overall Study|Withdrawal by Subject|3|||
126370072|NCT01500317|454652285|FG001|Overall Study|Withdrawal by Subject|2|||
126370073|NCT01500317|454652286|FG002|Overall Study|Withdrawal by Subject|0|||
126370074|NCT00754572|454652287|FG000|Overall Study|Adverse Event|19|||
126370075|NCT00754572|454652287|FG000|Overall Study|Other|39|||
126370076|NCT00754572|454652287|FG000|Overall Study|Protocol Violation|3|||
126370077|NCT00754572|454652287|FG000|Overall Study|Withdrawal by Subject|3|||
126370078|NCT00754572|454652287|FG000|Overall Study|Lack of Efficacy|2|||
126370079|NCT00754572|454652287|FG000|Overall Study|Death|1|||
126370080|NCT00754572|454652287|FG000|Overall Study|Administrative Reason|3|||
126370081|NCT00754572|454652287|FG000|Overall Study|Lost to Follow-up|1|||
126370082|NCT03746015|454652291|FG000|Overall Study|Withdrawal of Consent|1|||
126370083|NCT03746015|454652292|FG001|Overall Study|Withdrawal of Consent|0|||
126370084|NCT03746015|454652293|FG002|Overall Study|Withdrawal of Consent|0|||
126370085|NCT05134649|454652294|FG000|Overall Study|Lost to Follow-up|12|||
126370086|NCT05134649|454652294|FG000|Overall Study|Withdrawal by Subject|14|||
126370087|NCT05134649|454652294|FG000|Overall Study|Pregnancy|1|||
126370088|NCT05134649|454652294|FG000|Overall Study|Other, not specified|3|||
126370089|NCT01559935|454652295|FG000|Car Phase|Toxicity|4|||
126370090|NCT01559935|454652295|FG000|Car Phase|Death|1|||
126370091|NCT01559935|454652295|FG000|Car Phase|Lack of Efficacy|2|||
126370092|NCT01559935|454652295|FG000|Car Phase|Lost to Follow-up|1|||
126370093|NCT01559935|454652295|FG000|Car Phase|Physician Decision|1|||
126370094|NCT01559935|454652295|FG000|Car Phase|Withdrawal by Subject|2|||
126370095|NCT01559935|454652295|FG000|Car Phase|Per protocol|1|||
126370096|NCT01559935|454652295|FG000|Car Phase|Insurance|1|||
126370097|NCT01559935|454652295|FG000|Car Phase|non-compliance|1|||
126370098|NCT01559935|454652295|FG000|BiRD Phase|Toxicity|1|||
126370099|NCT01559935|454652295|FG000|BiRD Phase|Lack of Efficacy|1|||
126370100|NCT01559935|454652295|FG000|BiRD Phase|Withdrawal by Subject|2|||
126370101|NCT01559935|454652295|FG000|Maintenance Phase|Remains on study|28|||
126370102|NCT01559935|454652295|FG000|Maintenance Phase|Toxicity|1|||
126370103|NCT01559935|454652295|FG000|Maintenance Phase|Lack of Efficacy|18|||
126370104|NCT01559935|454652295|FG000|Maintenance Phase|Withdrawal by Subject|5|||
126370105|NCT01559935|454652295|FG000|Maintenance Phase|Non-compliance|2|||
126370106|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370107|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
126370108|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370109|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
126370110|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
126370111|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
126370112|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
126370113|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370114|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370115|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370116|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370117|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370118|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370119|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126046581|NCT00739908|453469056|FG000|Overall Study|Non-Compliance With Study Medication|0|||
126046582|NCT00739908|453469057|FG001|Overall Study|Non-Compliance With Study Medication|3|||
126046583|NCT00739908|453469056|FG000|Overall Study|Lack of Efficacy|0|||
126370120|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370121|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370122|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
126370123|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
126370124|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
126370125|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
126370126|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
126370127|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
126370128|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
126370129|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
126370130|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
126046584|NCT00739908|453469057|FG001|Overall Study|Lack of Efficacy|1|||
126370131|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
126370132|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
126370133|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
126370134|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
126370135|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
126370136|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
126370137|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
126370138|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
126370139|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
126370140|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370141|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370142|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370143|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370144|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370145|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370146|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370147|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370148|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370149|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370150|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370151|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370152|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370153|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370154|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
126370155|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370156|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
126370157|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
126370158|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
126370159|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
126370160|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
126370161|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370162|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370163|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370164|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370165|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370166|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370167|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370168|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370169|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370170|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370171|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370172|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370173|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
126370174|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370175|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370176|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
126370177|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126046585|NCT00739908|453469056|FG000|Overall Study|Relocation|0|||
126046586|NCT00739908|453469057|FG001|Overall Study|Relocation|1|||
126046587|NCT03875313|453469058|FG000|Overall Study|Withdrawal by Subject|1|||
126370178|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370179|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370180|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370181|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125885292|NCT00357552|452876806|FG000|Weeks 0 to 24|Death|1|||
125885293|NCT00357552|452876806|FG000|Weeks 24 to 104|Death|3|||
125885294|NCT00357552|452876806|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
125885295|NCT00521404|452876809|FG000|Overall Study|Adverse Event|13|||
125885296|NCT00521404|452876809|FG000|Overall Study|Disease Progression|33|||
125885297|NCT00521404|452876809|FG000|Overall Study|Investigator decision|5|||
125885298|NCT00521404|452876809|FG000|Overall Study|Withdrawal of consent|3|||
125885299|NCT00521404|452876809|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
125885300|NCT00521404|452876809|FG000|Overall Study|Other|7|||
125885301|NCT02282605|452876811|FG000|Overall Study|negative SA result on Day -1|3|||
125885302|NCT02282605|452876812|FG001|Overall Study|negative SA result on Day -1|0|||
125885303|NCT02282605|452876813|FG002|Overall Study|negative SA result on Day -1|0|||
125885304|NCT02035267|452876816|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
125885305|NCT02035267|452876817|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
125885306|NCT02035267|452876818|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
125885307|NCT02035267|452876819|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
125885308|NCT02035267|452876816|FG000|Overall Study|Adverse Event|0|||
125885309|NCT02035267|452876817|FG001|Overall Study|Adverse Event|0|||
125885310|NCT02035267|452876818|FG002|Overall Study|Adverse Event|1|||
125885311|NCT02035267|452876819|FG003|Overall Study|Adverse Event|0|||
125885312|NCT02035267|452876816|FG000|Overall Study|Lost to Follow-up|0|||
125885313|NCT02035267|452876817|FG001|Overall Study|Lost to Follow-up|0|||
125885314|NCT02035267|452876818|FG002|Overall Study|Lost to Follow-up|0|||
125885315|NCT02035267|452876819|FG003|Overall Study|Lost to Follow-up|1|||
125885316|NCT02035267|452876816|FG000|Overall Study|Other unspecified|0|||
125885317|NCT02035267|452876817|FG001|Overall Study|Other unspecified|1|||
125885318|NCT02035267|452876818|FG002|Overall Study|Other unspecified|0|||
125885319|NCT02035267|452876819|FG003|Overall Study|Other unspecified|0|||
125885320|NCT00414596|452876827|FG000|Overall Study|Protocol Violation|2|||
125885321|NCT00297258|452876829|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
125885322|NCT00297258|452876829|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
125885323|NCT00297258|452876829|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
125885324|NCT00297258|452876829|FG000|Overall Study|Intercurrent Illness|3|||
125885325|NCT00297258|452876829|FG000|Overall Study|Intercurrent Death|2|||
125885326|NCT00297258|452876829|FG000|Overall Study|Deteriorization of General Condition|1|||
125885327|NCT00297258|452876829|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
126046588|NCT03875313|453469059|FG001|Overall Study|Withdrawal by Subject|3|||
126046589|NCT03875313|453469060|FG002|Overall Study|Withdrawal by Subject|0|||
126046590|NCT03875313|453469061|FG003|Overall Study|Withdrawal by Subject|0|||
126046591|NCT03875313|453469062|FG004|Overall Study|Withdrawal by Subject|0|||
126046592|NCT03875313|453469058|FG000|Overall Study|Death|0|||
126046593|NCT03875313|453469059|FG001|Overall Study|Death|0|||
126046594|NCT03875313|453469060|FG002|Overall Study|Death|0|||
126046595|NCT03875313|453469061|FG003|Overall Study|Death|0|||
126306503|NCT04791319|454410291|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306504|NCT04791319|454410292|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306505|NCT04791319|454410293|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306506|NCT04791319|454410294|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
126306507|NCT04791319|454410284|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306508|NCT04791319|454410285|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306509|NCT04791319|454410286|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306510|NCT04791319|454410287|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306511|NCT04791319|454410288|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306512|NCT04791319|454410289|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306513|NCT04791319|454410290|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306514|NCT04791319|454410291|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306515|NCT04791319|454410292|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306516|NCT04791319|454410293|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
126306517|NCT04791319|454410294|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306518|NCT04791319|454410284|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306519|NCT04791319|454410285|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126046596|NCT03875313|453469062|FG004|Overall Study|Death|1|||
126046597|NCT03875313|453469058|FG000|Overall Study|Lost to Follow-up|0|||
126046598|NCT03875313|453469059|FG001|Overall Study|Lost to Follow-up|0|||
126306520|NCT04791319|454410286|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306521|NCT04791319|454410287|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306522|NCT04791319|454410288|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
126046599|NCT03875313|453469060|FG002|Overall Study|Lost to Follow-up|0|||
126046600|NCT03875313|453469061|FG003|Overall Study|Lost to Follow-up|0|||
126306523|NCT04791319|454410289|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
126306524|NCT04791319|454410290|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
126306525|NCT04791319|454410291|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306526|NCT04791319|454410292|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
126306527|NCT04791319|454410293|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
126306528|NCT04791319|454410294|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
126306529|NCT04791319|454410284|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
126306530|NCT04791319|454410285|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
126306531|NCT04791319|454410286|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
126306532|NCT04791319|454410287|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
126306533|NCT04791319|454410288|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
126306534|NCT04791319|454410289|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
126306535|NCT04791319|454410290|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
126306536|NCT04791319|454410291|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
126306537|NCT04791319|454410292|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
126306538|NCT04791319|454410293|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
126306539|NCT04791319|454410294|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
126306540|NCT04087720|454410301|FG000|Overall Study|Withdrawal by Subject|2|||
126306541|NCT04087720|454410301|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
126306542|NCT03706430|454410302|FG000|Overall Study|No A-Line placed|5|||
126306543|NCT03706430|454410302|FG000|Overall Study|Subject had gel nail polish|1|||
126306544|NCT03706430|454410302|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
126306545|NCT03706430|454410302|FG000|Overall Study|Cancelled Case|6|||
126306546|NCT03706430|454410302|FG000|Overall Study|Physician Decision|2|||
126306547|NCT00520533|454410303|FG000|Overall Study|Death|1|||
126306548|NCT00520533|454410303|FG000|Overall Study|Suspension of the study for safety reasons|1|||
126306549|NCT00520533|454410303|FG000|Overall Study|Withdrawal by Subject|1|||
126306550|NCT00520533|454410303|FG000|Overall Study|Physician Decision|1|||
126306551|NCT01726270|454410310|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
126306552|NCT01726270|454410310|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
126306553|NCT01726270|454410310|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
126306554|NCT01726270|454410310|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
126306555|NCT01726270|454410310|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
126306556|NCT01726270|454410310|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
126306557|NCT00582608|454410311|FG000|Overall Study|Not Treated|7|||
126306558|NCT00582608|454410311|FG000|Overall Study|Patient Ineligible|1|||
126306559|NCT00582608|454410311|FG000|Overall Study|Lack of accrual|4|||
126306560|NCT02504827|454410323|FG000|Overall Study|Could not produce sputum|1|||
126306561|NCT03386994|454410324|FG000|Overall Study|Lung transplant|1|||
126306562|NCT03386994|454410324|FG000|Overall Study|Adverse Event|14|||
126306563|NCT03386994|454410324|FG000|Overall Study|Lost to Follow-up|4|||
126306564|NCT03386994|454410324|FG000|Overall Study|Withdrawal by Subject|3|||
126306565|NCT03386994|454410324|FG000|Overall Study|Death|16|||
126306566|NCT01732640|454410330|FG000|Overall Study|Adverse Event|0|||
126306567|NCT01732640|454410331|FG001|Overall Study|Adverse Event|1|||
126306568|NCT01732640|454410330|FG000|Overall Study|Death|0|||
126306569|NCT01732640|454410331|FG001|Overall Study|Death|1|||
126306570|NCT00877487|454410332|FG000|Open-label Treatment Phase|Adverse Event|1|||
126306571|NCT00877487|454410333|FG001|Open-label Treatment Phase|Adverse Event|0|||
126306572|NCT00877487|454410332|FG000|Open-label Treatment Phase|Protocol Violation|3|||
126306573|NCT00877487|454410333|FG001|Open-label Treatment Phase|Protocol Violation|0|||
126306574|NCT00877487|454410332|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
126306575|NCT00877487|454410333|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
126306576|NCT00877487|454410332|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
126046601|NCT03875313|453469062|FG004|Overall Study|Lost to Follow-up|1|||
126046602|NCT03875313|453469058|FG000|Overall Study|Study Termination by Sponsor|0|||
126306577|NCT00877487|454410333|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
126306578|NCT00877487|454410332|FG000|Open-label Treatment Phase|Out of country for business|1|||
126306579|NCT00877487|454410333|FG001|Open-label Treatment Phase|Out of country for business|0|||
126306580|NCT00877487|454410332|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
126306581|NCT00877487|454410333|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
126306582|NCT00877487|454410332|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
126306583|NCT00877487|454410333|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
126306584|NCT00877487|454410332|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
126306585|NCT00877487|454410333|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
125885328|NCT00297258|452876829|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
125885329|NCT00297258|452876829|FG000|Overall Study|Switch to Commercial Treatment|1|||
125885330|NCT00297258|452876829|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
125885331|NCT05038982|452876830|FG000|Overall Study|Withdrawal by Subject|0|||
125885332|NCT05038982|452876831|FG001|Overall Study|Withdrawal by Subject|2|||
125885333|NCT03133793|452876832|FG000|Overall Study|Withdrawal by Subject|0|||
125885334|NCT03133793|452876833|FG001|Overall Study|Withdrawal by Subject|4|||
125885335|NCT03133793|452876834|FG002|Overall Study|Withdrawal by Subject|2|||
125885336|NCT03133793|452876835|FG003|Overall Study|Withdrawal by Subject|4|||
125885337|NCT03133793|452876832|FG000|Overall Study|Lost to Follow-up|1|||
126306586|NCT00877487|454410332|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
126306587|NCT00877487|454410333|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
126306588|NCT03070002|454410334|FG000|Follow up for 2 Years|Death|1|||
126306589|NCT00712543|454410335|FG000|Day 8-14|Lost to Follow-up|0|||
126306590|NCT00712543|454410336|FG001|Day 8-14|Lost to Follow-up|2|||
126306591|NCT02729051|454410339|FG000|Overall Study|Adverse Event|21|||
125885338|NCT03133793|452876833|FG001|Overall Study|Lost to Follow-up|0|||
125885339|NCT03133793|452876834|FG002|Overall Study|Lost to Follow-up|2|||
125885340|NCT03133793|452876835|FG003|Overall Study|Lost to Follow-up|0|||
125885341|NCT03133793|452876832|FG000|Overall Study|Death|0|||
125885342|NCT03133793|452876833|FG001|Overall Study|Death|0|||
125885343|NCT03133793|452876834|FG002|Overall Study|Death|0|||
125885344|NCT03133793|452876835|FG003|Overall Study|Death|1|||
125885345|NCT04476797|452876836|FG000|Overall Study|Withdrawal by Subject|1|||
126103486|NCT01691768|453672171|FG000|Overall Study|Withdrawal by Subject|10|||
126103487|NCT01691768|453672172|FG001|Overall Study|Withdrawal by Subject|9|||
126103488|NCT01691768|453672171|FG000|Overall Study|Relocated|0|||
126306592|NCT02729051|454410340|FG001|Overall Study|Adverse Event|11|||
126306593|NCT02729051|454410339|FG000|Overall Study|Lack of Efficacy|1|||
126306594|NCT02729051|454410340|FG001|Overall Study|Lack of Efficacy|1|||
126306595|NCT02729051|454410339|FG000|Overall Study|Lost to Follow-up|1|||
126306596|NCT02729051|454410340|FG001|Overall Study|Lost to Follow-up|2|||
126306597|NCT02729051|454410339|FG000|Overall Study|Physician Decision|1|||
126306598|NCT02729051|454410340|FG001|Overall Study|Physician Decision|1|||
126306599|NCT02729051|454410339|FG000|Overall Study|Withdrawal by Subject|6|||
126306600|NCT02729051|454410340|FG001|Overall Study|Withdrawal by Subject|17|||
126306601|NCT02702388|454410341|FG000|Overall Study|Disease Progression|18|||
126306602|NCT02702388|454410342|FG001|Overall Study|Disease Progression|25|||
126306603|NCT02702388|454410341|FG000|Overall Study|Withdrawal by Subject|9|||
126306604|NCT02702388|454410342|FG001|Overall Study|Withdrawal by Subject|7|||
126306605|NCT02702388|454410341|FG000|Overall Study|Adverse Event|11|||
126306606|NCT02702388|454410342|FG001|Overall Study|Adverse Event|15|||
126306607|NCT02702388|454410341|FG000|Overall Study|Other|2|||
126306608|NCT02702388|454410342|FG001|Overall Study|Other|4|||
126306609|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
126306610|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
126306611|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
126306612|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
126306613|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
126306614|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
126306615|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
126370182|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370183|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370184|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370185|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370186|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370187|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370188|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
126370189|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370190|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370191|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370192|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125885346|NCT04476797|452876837|FG001|Overall Study|Withdrawal by Subject|0|||
126370193|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370194|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370195|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370196|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370197|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370198|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370199|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125885347|NCT04476797|452876838|FG002|Overall Study|Withdrawal by Subject|0|||
125885348|NCT04476797|452876836|FG000|Overall Study|Death|0|||
126103489|NCT01691768|453672172|FG001|Overall Study|Relocated|1|||
126103490|NCT01691768|453672171|FG000|Overall Study|Investigator decision|1|||
126103491|NCT01691768|453672172|FG001|Overall Study|Investigator decision|1|||
126103492|NCT01759368|453672173|FG000|Overall Study|Lost to Follow-up|1|||
126103493|NCT01759368|453672174|FG001|Overall Study|Lost to Follow-up|0|||
126103494|NCT01191268|453672175|FG000|Overall Study|Withdrawal by Subject|19|||
126306616|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
126306617|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
126306618|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
126306619|NCT04740827|454410352|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
126306620|NCT04740827|454410353|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
126306621|NCT02147158|454410354|FG000|Treatment Course 1|Adverse Event|1|||
126306622|NCT02147158|454410355|FG001|Treatment Course 1|Adverse Event|4|||
126306623|NCT02147158|454410356|FG002|Treatment Course 1|Adverse Event|3|||
126306624|NCT02147158|454410357|FG003|Treatment Course 1|Adverse Event|4|||
126306625|NCT02147158|454410358|FG004|Treatment Course 1|Adverse Event|1|||
126306626|NCT02147158|454410359|FG005|Treatment Course 1|Adverse Event|2|||
126306627|NCT02147158|454410354|FG000|Treatment Course 1|Lost to Follow-up|2|||
126306628|NCT02147158|454410355|FG001|Treatment Course 1|Lost to Follow-up|4|||
126306629|NCT02147158|454410356|FG002|Treatment Course 1|Lost to Follow-up|3|||
126306630|NCT02147158|454410357|FG003|Treatment Course 1|Lost to Follow-up|3|||
126306631|NCT02147158|454410358|FG004|Treatment Course 1|Lost to Follow-up|2|||
126306632|NCT02147158|454410359|FG005|Treatment Course 1|Lost to Follow-up|4|||
126306633|NCT02147158|454410354|FG000|Treatment Course 1|Protocol Violation|0|||
126306634|NCT02147158|454410355|FG001|Treatment Course 1|Protocol Violation|0|||
126306635|NCT02147158|454410356|FG002|Treatment Course 1|Protocol Violation|1|||
126306636|NCT02147158|454410357|FG003|Treatment Course 1|Protocol Violation|1|||
126306637|NCT02147158|454410358|FG004|Treatment Course 1|Protocol Violation|0|||
126306638|NCT02147158|454410359|FG005|Treatment Course 1|Protocol Violation|0|||
126306639|NCT02147158|454410354|FG000|Treatment Course 1|Withdrawal of Consent|1|||
126306640|NCT02147158|454410355|FG001|Treatment Course 1|Withdrawal of Consent|1|||
126306641|NCT02147158|454410356|FG002|Treatment Course 1|Withdrawal of Consent|1|||
126306642|NCT02147158|454410357|FG003|Treatment Course 1|Withdrawal of Consent|5|||
126306643|NCT02147158|454410358|FG004|Treatment Course 1|Withdrawal of Consent|3|||
126306644|NCT02147158|454410359|FG005|Treatment Course 1|Withdrawal of Consent|2|||
126306645|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Adverse Event|1|||
126306646|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Adverse Event|0|||
126306647|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Adverse Event|0|||
126306648|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Adverse Event|1|||
126306649|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Adverse Event|0|||
126306650|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Adverse Event|0|||
126306651|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
126306652|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
126306653|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
126306654|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
126306655|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
126306656|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
126306657|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
126306658|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
126306659|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
126306660|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
126306661|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
126306662|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
126306663|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
126306664|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
126306665|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
126306666|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
126306667|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
126306668|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
126306669|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
126370200|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126306670|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
126306671|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
126306672|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
126306673|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
126306674|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
126306675|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
126306676|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
126306677|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
126306678|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
126306679|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
126370201|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125885349|NCT04476797|452876837|FG001|Overall Study|Death|1|||
126370202|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
126370203|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
126370204|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
126370205|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370206|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370207|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370208|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370209|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370210|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370211|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370212|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370213|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370214|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370215|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370216|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370217|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370218|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
126370219|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
126370220|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
126370221|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
126370222|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
126370223|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
126370224|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
126370225|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
126370226|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
126046603|NCT03875313|453469059|FG001|Overall Study|Study Termination by Sponsor|1|||
126046604|NCT03875313|453469060|FG002|Overall Study|Study Termination by Sponsor|1|||
126370227|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
126370228|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
126046605|NCT03875313|453469061|FG003|Overall Study|Study Termination by Sponsor|0|||
126046606|NCT03875313|453469062|FG004|Overall Study|Study Termination by Sponsor|1|||
126046607|NCT03875313|453469058|FG000|Overall Study|New Anticancer Treatment|0|||
126046608|NCT03875313|453469059|FG001|Overall Study|New Anticancer Treatment|1|||
126046609|NCT03875313|453469060|FG002|Overall Study|New Anticancer Treatment|2|||
126046610|NCT03875313|453469061|FG003|Overall Study|New Anticancer Treatment|1|||
126370229|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
126370230|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
126370231|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
126370232|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
126370233|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
126370234|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370235|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370236|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370237|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370238|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
126370239|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370240|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370241|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370242|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370243|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370244|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370245|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370246|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370247|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370248|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370249|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370250|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370251|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370252|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370253|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370254|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370255|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370256|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370257|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126370258|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126370259|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
126370260|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126046611|NCT03875313|453469062|FG004|Overall Study|New Anticancer Treatment|0|||
126046612|NCT03875313|453469058|FG000|Overall Study|Other, Not Specified|2|||
126046613|NCT03875313|453469059|FG001|Overall Study|Other, Not Specified|11|||
126370261|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126046614|NCT03875313|453469060|FG002|Overall Study|Other, Not Specified|3|||
126306680|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
126306681|NCT02147158|454410354|FG000|Treatment Course 2|Adverse Event|0|||
126306682|NCT02147158|454410355|FG001|Treatment Course 2|Adverse Event|4|||
126306683|NCT02147158|454410356|FG002|Treatment Course 2|Adverse Event|2|||
126306684|NCT02147158|454410357|FG003|Treatment Course 2|Adverse Event|1|||
126306685|NCT02147158|454410358|FG004|Treatment Course 2|Adverse Event|0|||
126306686|NCT02147158|454410359|FG005|Treatment Course 2|Adverse Event|1|||
126306687|NCT02147158|454410354|FG000|Treatment Course 2|Withdrawal of Consent|0|||
126306688|NCT02147158|454410355|FG001|Treatment Course 2|Withdrawal of Consent|1|||
126306689|NCT02147158|454410356|FG002|Treatment Course 2|Withdrawal of Consent|2|||
126306690|NCT02147158|454410357|FG003|Treatment Course 2|Withdrawal of Consent|3|||
126306691|NCT02147158|454410358|FG004|Treatment Course 2|Withdrawal of Consent|0|||
126306692|NCT02147158|454410359|FG005|Treatment Course 2|Withdrawal of Consent|0|||
126306693|NCT02147158|454410354|FG000|Treatment Course 2|Lost to Follow-up|1|||
126306694|NCT02147158|454410355|FG001|Treatment Course 2|Lost to Follow-up|0|||
126306695|NCT02147158|454410356|FG002|Treatment Course 2|Lost to Follow-up|1|||
126306696|NCT02147158|454410357|FG003|Treatment Course 2|Lost to Follow-up|1|||
126306697|NCT02147158|454410358|FG004|Treatment Course 2|Lost to Follow-up|0|||
126306698|NCT02147158|454410359|FG005|Treatment Course 2|Lost to Follow-up|1|||
126306699|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
126306700|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
126306701|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
126306702|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
126306703|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
126306704|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
126306705|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
126306706|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
126306707|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
126306708|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
126306709|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
126306710|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
126306711|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
126306712|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
126306713|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
126306714|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
126306715|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
126306716|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
126306717|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
126306718|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
126306719|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
126306720|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
126306721|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
126306722|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
126306723|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
126306724|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
126306725|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
126306726|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
126306727|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
126306728|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
126306729|NCT01441765|454410360|FG000|Overall Study|Death|1|||
126306730|NCT01441765|454410361|FG001|Overall Study|Death|0|||
126306731|NCT04445714|454410362|FG000|Overall Study|Discontinuation of the study|14|||
126306732|NCT04445714|454410362|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
126306733|NCT04445714|454410362|FG000|Overall Study|Withdrawal of Informed Consent|8|||
126306734|NCT02805660|454410363|FG000|Overall Study|Death|5|||
126306735|NCT02805660|454410364|FG001|Overall Study|Death|2|||
126306736|NCT02805660|454410365|FG002|Overall Study|Death|9|||
126306737|NCT02805660|454410366|FG003|Overall Study|Death|5|||
126306738|NCT02805660|454410367|FG004|Overall Study|Death|0|||
126306739|NCT02805660|454410368|FG005|Overall Study|Death|14|||
126306740|NCT02805660|454410369|FG006|Overall Study|Death|12|||
126306741|NCT02805660|454410363|FG000|Overall Study|Lost to Follow-up|0|||
126306742|NCT02805660|454410364|FG001|Overall Study|Lost to Follow-up|1|||
126306743|NCT02805660|454410365|FG002|Overall Study|Lost to Follow-up|1|||
126370262|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
126370263|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126370264|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126370265|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
126370266|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370267|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370268|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370269|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126306744|NCT02805660|454410366|FG003|Overall Study|Lost to Follow-up|2|||
126306745|NCT02805660|454410367|FG004|Overall Study|Lost to Follow-up|0|||
126306746|NCT02805660|454410368|FG005|Overall Study|Lost to Follow-up|0|||
126306747|NCT02805660|454410369|FG006|Overall Study|Lost to Follow-up|0|||
126306748|NCT02805660|454410363|FG000|Overall Study|Withdrawal by Subject|0|||
126306749|NCT02805660|454410364|FG001|Overall Study|Withdrawal by Subject|0|||
126306750|NCT02805660|454410365|FG002|Overall Study|Withdrawal by Subject|0|||
126306751|NCT02805660|454410366|FG003|Overall Study|Withdrawal by Subject|3|||
126306752|NCT02805660|454410367|FG004|Overall Study|Withdrawal by Subject|1|||
126306753|NCT02805660|454410368|FG005|Overall Study|Withdrawal by Subject|0|||
126306754|NCT02805660|454410369|FG006|Overall Study|Withdrawal by Subject|2|||
126306755|NCT02805660|454410363|FG000|Overall Study|Study terminated by Sponsor|0|||
126306756|NCT02805660|454410364|FG001|Overall Study|Study terminated by Sponsor|0|||
126306757|NCT02805660|454410365|FG002|Overall Study|Study terminated by Sponsor|1|||
126306758|NCT02805660|454410366|FG003|Overall Study|Study terminated by Sponsor|4|||
126306759|NCT02805660|454410367|FG004|Overall Study|Study terminated by Sponsor|2|||
126306760|NCT02805660|454410368|FG005|Overall Study|Study terminated by Sponsor|3|||
126306761|NCT02805660|454410369|FG006|Overall Study|Study terminated by Sponsor|1|||
126306762|NCT02805660|454410363|FG000|Overall Study|Miscellaneous|0|||
126306763|NCT02805660|454410364|FG001|Overall Study|Miscellaneous|1|||
126306764|NCT02805660|454410365|FG002|Overall Study|Miscellaneous|0|||
126306765|NCT02805660|454410366|FG003|Overall Study|Miscellaneous|4|||
126306766|NCT02805660|454410367|FG004|Overall Study|Miscellaneous|0|||
126306767|NCT02805660|454410368|FG005|Overall Study|Miscellaneous|6|||
126306768|NCT02805660|454410369|FG006|Overall Study|Miscellaneous|4|||
126306769|NCT01435018|454411886|FG000|Overall Study|Death|37|||
126306770|NCT01435018|454411887|FG001|Overall Study|Death|18|||
126306771|NCT01435018|454411888|FG002|Overall Study|Death|25|||
126306772|NCT01435018|454411886|FG000|Overall Study|Site is closing|4|||
126306773|NCT01435018|454411887|FG001|Overall Study|Site is closing|9|||
126306774|NCT01435018|454411888|FG002|Overall Study|Site is closing|7|||
126306775|NCT01435018|454411886|FG000|Overall Study|Withdrew consent|0|||
126306776|NCT01435018|454411887|FG001|Overall Study|Withdrew consent|3|||
126306777|NCT01435018|454411888|FG002|Overall Study|Withdrew consent|1|||
126306778|NCT01435018|454411886|FG000|Overall Study|Not willing to adhere to requirements|0|||
126306779|NCT01435018|454411887|FG001|Overall Study|Not willing to adhere to requirements|2|||
126306780|NCT01435018|454411888|FG002|Overall Study|Not willing to adhere to requirements|3|||
126306781|NCT01435018|454411886|FG000|Overall Study|Not able to get to clinic|2|||
126306782|NCT01435018|454411887|FG001|Overall Study|Not able to get to clinic|0|||
126306783|NCT01435018|454411888|FG002|Overall Study|Not able to get to clinic|2|||
126306784|NCT01435018|454411886|FG000|Overall Study|Severe debilitation, unable to continue|0|||
126306785|NCT01435018|454411887|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126306786|NCT01435018|454411888|FG002|Overall Study|Severe debilitation, unable to continue|1|||
126306787|NCT01435018|454411886|FG000|Overall Study|Unable to contact participant/parent|1|||
126306788|NCT01435018|454411887|FG001|Overall Study|Unable to contact participant/parent|1|||
126306789|NCT01435018|454411888|FG002|Overall Study|Unable to contact participant/parent|1|||
126306790|NCT01435018|454411886|FG000|Overall Study|Enrollment Violation|0|||
126306791|NCT01435018|454411887|FG001|Overall Study|Enrollment Violation|1|||
126306792|NCT01435018|454411888|FG002|Overall Study|Enrollment Violation|0|||
126306793|NCT01435018|454411886|FG000|Overall Study|Never started chemotherapy|3|||
126306794|NCT01435018|454411887|FG001|Overall Study|Never started chemotherapy|0|||
126306795|NCT01435018|454411888|FG002|Overall Study|Never started chemotherapy|1|||
126306796|NCT00769067|454411889|FG000|Overall Study|Death|89|||
126306797|NCT00769067|454411890|FG001|Overall Study|Death|86|||
126306798|NCT00769067|454411889|FG000|Overall Study|Lost to Follow-up|3|||
126306799|NCT00769067|454411890|FG001|Overall Study|Lost to Follow-up|1|||
126306800|NCT00769067|454411889|FG000|Overall Study|Study terminated by sponsor|1|||
126306801|NCT00769067|454411890|FG001|Overall Study|Study terminated by sponsor|3|||
126306802|NCT00769067|454411889|FG000|Overall Study|Other|1|||
126306803|NCT00769067|454411890|FG001|Overall Study|Other|3|||
126306804|NCT00769067|454411889|FG000|Overall Study|Withdrawal by Subject|0|||
126306805|NCT00769067|454411890|FG001|Overall Study|Withdrawal by Subject|1|||
126306806|NCT03806933|454411891|FG000|Main Period|Physician Decision|0|||
126306807|NCT03806933|454411892|FG001|Main Period|Physician Decision|0|||
126306808|NCT03806933|454411893|FG002|Main Period|Physician Decision|0|||
126306809|NCT03806933|454411894|FG003|Main Period|Physician Decision|1|||
126306810|NCT03806933|454411891|FG000|Main Period|Pregnancy|0|||
126306811|NCT03806933|454411892|FG001|Main Period|Pregnancy|0|||
126306812|NCT03806933|454411893|FG002|Main Period|Pregnancy|1|||
126306813|NCT03806933|454411894|FG003|Main Period|Pregnancy|0|||
126306814|NCT03806933|454411891|FG000|Main Period|Withdrawal by Subject|2|||
126306815|NCT03806933|454411892|FG001|Main Period|Withdrawal by Subject|1|||
126306816|NCT03806933|454411893|FG002|Main Period|Withdrawal by Subject|1|||
126306817|NCT03806933|454411894|FG003|Main Period|Withdrawal by Subject|2|||
126306818|NCT03806933|454411891|FG000|Main Period|Lost to Follow-up|2|||
126306819|NCT03806933|454411892|FG001|Main Period|Lost to Follow-up|2|||
126306820|NCT03806933|454411893|FG002|Main Period|Lost to Follow-up|0|||
126306821|NCT03806933|454411894|FG003|Main Period|Lost to Follow-up|0|||
126370270|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370271|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370272|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370273|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370274|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
126370275|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
126370276|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370277|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
126370278|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370279|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
126370280|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370281|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
126370282|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370283|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370284|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370285|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370286|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370287|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370288|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370289|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370290|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370291|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
126370292|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370293|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370294|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370295|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370296|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370297|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
126370298|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370299|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370300|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370301|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370302|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370303|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370304|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370305|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370306|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370307|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370308|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370309|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
126370310|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
126370311|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
126370312|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
126370313|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
126370314|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
126370315|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
126370316|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
126370317|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
126370318|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
126370319|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
126370320|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
126370321|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
126370322|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
126370323|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
126370324|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
126370325|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
126046615|NCT03875313|453469061|FG003|Overall Study|Other, Not Specified|3|||
126046616|NCT03875313|453469062|FG004|Overall Study|Other, Not Specified|1|||
126046617|NCT04121546|453469063|FG000|Overall Study|Lost to Follow-up|1|||
126046618|NCT04121546|453469064|FG001|Overall Study|Lost to Follow-up|3|||
126046619|NCT01046825|453469067|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
126046620|NCT01046825|453469068|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
126046621|NCT01046825|453469069|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
126046622|NCT01046825|453469070|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
126046623|NCT01046825|453469071|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
126046624|NCT01046825|453469067|FG000|Overall Study|Physician Decision|0|||
126046625|NCT01046825|453469068|FG001|Overall Study|Physician Decision|1|||
126046626|NCT01046825|453469069|FG002|Overall Study|Physician Decision|2|||
126046627|NCT01046825|453469070|FG003|Overall Study|Physician Decision|0|||
125885350|NCT04476797|452876838|FG002|Overall Study|Death|2|||
125885351|NCT04476797|452876836|FG000|Overall Study|Sponsor Terminated Study|0|||
125885352|NCT04476797|452876837|FG001|Overall Study|Sponsor Terminated Study|18|||
125885353|NCT04476797|452876838|FG002|Overall Study|Sponsor Terminated Study|17|||
125885354|NCT03614156|452876839|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
125885355|NCT03614156|452876840|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125885356|NCT03614156|452876841|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125885357|NCT03614156|452876842|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125885358|NCT03614156|452876839|FG000|Open-Label Treatment Period|Adverse Event|7|||
125885359|NCT03614156|452876840|FG001|Open-Label Treatment Period|Adverse Event|0|||
125885360|NCT03614156|452876841|FG002|Open-Label Treatment Period|Adverse Event|0|||
125885361|NCT03614156|452876842|FG003|Open-Label Treatment Period|Adverse Event|0|||
125885362|NCT03614156|452876839|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
125885363|NCT03614156|452876840|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125885364|NCT03614156|452876841|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125885365|NCT03614156|452876842|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
126046628|NCT01046825|453469071|FG004|Overall Study|Physician Decision|0|||
126046629|NCT01046825|453469067|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
126046630|NCT01046825|453469068|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
126046631|NCT01046825|453469069|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
126046632|NCT01046825|453469070|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
126046633|NCT01046825|453469071|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
126046634|NCT01046825|453469067|FG000|Overall Study|Found to be ineligible|0|||
126046635|NCT01046825|453469068|FG001|Overall Study|Found to be ineligible|1|||
126046636|NCT01046825|453469069|FG002|Overall Study|Found to be ineligible|0|||
126046637|NCT01046825|453469070|FG003|Overall Study|Found to be ineligible|0|||
126046638|NCT01046825|453469071|FG004|Overall Study|Found to be ineligible|0|||
126046639|NCT01046825|453469067|FG000|Overall Study|Death|0|||
126046640|NCT01046825|453469068|FG001|Overall Study|Death|0|||
126370326|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
126370327|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
126370328|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
126370329|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
126370330|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370331|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370332|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370333|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370334|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370335|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370336|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370337|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370338|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370339|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370340|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370341|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370342|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370343|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
126370344|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370345|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370346|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370347|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370348|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370349|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370350|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370351|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370352|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370353|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370354|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370355|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370356|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370357|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370358|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370359|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
126370360|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370361|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370362|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370363|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370364|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370365|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370366|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370367|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370368|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370369|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370370|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370371|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
126370372|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370373|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370374|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370375|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370376|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126046641|NCT01046825|453469069|FG002|Overall Study|Death|0|||
126046642|NCT01046825|453469070|FG003|Overall Study|Death|1|||
126046643|NCT01046825|453469071|FG004|Overall Study|Death|0|||
126046644|NCT01046825|453469067|FG000|Overall Study|Did not submit biology samples|0|||
126370377|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370378|NCT01038323|454652325|FG000|Overall Study|Withdrawal by Subject|3|||
126370379|NCT01038323|454652326|FG001|Overall Study|Withdrawal by Subject|2|||
126370380|NCT01038323|454652327|FG002|Overall Study|Withdrawal by Subject|4|||
126370381|NCT01143402|454652328|FG000|Overall Study|Rapid clinical decline|1|||
126370382|NCT01143402|454652329|FG001|Overall Study|Rapid clinical decline|1|||
126370383|NCT01143402|454652330|FG002|Overall Study|Rapid clinical decline|0|||
126046645|NCT01046825|453469068|FG001|Overall Study|Did not submit biology samples|0|||
126370384|NCT01143402|454652328|FG000|Overall Study|Not Treated|0|||
126370385|NCT01143402|454652329|FG001|Overall Study|Not Treated|0|||
126306822|NCT03806933|454411891|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
126306823|NCT03806933|454411892|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
126306824|NCT03806933|454411893|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
126306825|NCT03806933|454411894|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
126306826|NCT03625466|454411895|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
126306827|NCT03625466|454411896|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
126306828|NCT03625466|454411897|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
126306829|NCT03625466|454411895|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
126306830|NCT03625466|454411896|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
126306831|NCT03625466|454411897|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
126306832|NCT03625466|454411895|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
126306833|NCT03625466|454411896|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
126306834|NCT03625466|454411897|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
126306835|NCT00809471|454411900|FG000|Overall Study|Protocol non-compliance|15|||
126306836|NCT00809471|454411901|FG001|Overall Study|Protocol non-compliance|15|||
126306837|NCT00809471|454411902|FG002|Overall Study|Protocol non-compliance|6|||
126306838|NCT00809471|454411900|FG000|Overall Study|Lost to Follow-up|4|||
126306839|NCT00809471|454411901|FG001|Overall Study|Lost to Follow-up|2|||
126306840|NCT00809471|454411902|FG002|Overall Study|Lost to Follow-up|9|||
126306841|NCT00809471|454411900|FG000|Overall Study|Adverse Event|0|||
126306842|NCT00809471|454411901|FG001|Overall Study|Adverse Event|2|||
126306843|NCT00809471|454411902|FG002|Overall Study|Adverse Event|2|||
126306844|NCT00809471|454411900|FG000|Overall Study|Requirement for restricted medication|1|||
126306845|NCT00809471|454411901|FG001|Overall Study|Requirement for restricted medication|1|||
126306846|NCT00809471|454411902|FG002|Overall Study|Requirement for restricted medication|0|||
126306847|NCT01868438|454411903|FG000|First Intervention|Withdrawal by Subject|5|||
126306848|NCT01868438|454411904|FG001|First Intervention|Withdrawal by Subject|1|||
126306849|NCT01868438|454411903|FG000|First Intervention|Lost to Follow-up|2|||
126306850|NCT01868438|454411904|FG001|First Intervention|Lost to Follow-up|3|||
126306851|NCT01868438|454411903|FG000|First Intervention|Meeting the non-redosing criteria|0|||
126306852|NCT01868438|454411904|FG001|First Intervention|Meeting the non-redosing criteria|1|||
126306853|NCT01868438|454411903|FG000|Second Intervention|Adverse Event|3|||
126306854|NCT01868438|454411904|FG001|Second Intervention|Adverse Event|3|||
126306855|NCT03528369|454411907|FG000|Overall Study|Withdrawal by Subject|2|||
126306856|NCT03528369|454411908|FG001|Overall Study|Withdrawal by Subject|0|||
126306857|NCT03528369|454411909|FG002|Overall Study|Withdrawal by Subject|0|||
126306858|NCT03528369|454411907|FG000|Overall Study|Lost to Follow-up|1|||
126306859|NCT03528369|454411908|FG001|Overall Study|Lost to Follow-up|0|||
126306860|NCT03528369|454411909|FG002|Overall Study|Lost to Follow-up|0|||
126306861|NCT03528369|454411907|FG000|Overall Study|Adverse Event|0|||
126306862|NCT03528369|454411908|FG001|Overall Study|Adverse Event|1|||
126306863|NCT03528369|454411909|FG002|Overall Study|Adverse Event|0|||
126306864|NCT03555565|454411910|FG000|Overall Study|Case Report Forms Uncollected|2|||
126306865|NCT03555565|454411910|FG000|Overall Study|Protocol Deviation|13|||
126306866|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
126306867|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
126306868|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
126306869|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
126306870|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
126306871|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
126306872|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
126306873|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
126306874|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Death|0|||
126306875|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Death|1|||
126306876|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
126306877|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
126306878|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
126306879|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
126306880|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
126306881|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
126306882|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
126306883|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
126306884|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
126306885|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
126306886|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Non compliance|0|||
126306887|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Non compliance|1|||
126370386|NCT01143402|454652330|FG002|Overall Study|Not Treated|1|||
126370387|NCT02526290|454652331|FG000|Overall Study|Adverse Event|3|||
126370388|NCT02526290|454652331|FG000|Overall Study|Withdrawal by Subject|4|||
126370389|NCT02526290|454652331|FG000|Overall Study|Physician Decision|1|||
126370390|NCT01380080|454652333|FG000|Overall Study|Death|36|||
126370391|NCT01380080|454652334|FG001|Overall Study|Death|44|||
126370392|NCT01380080|454652333|FG000|Overall Study|Site is closing|28|||
126370393|NCT01380080|454652334|FG001|Overall Study|Site is closing|31|||
126370394|NCT01380080|454652333|FG000|Overall Study|Not able to get to clinic|7|||
126370395|NCT01380080|454652334|FG001|Overall Study|Not able to get to clinic|1|||
126370396|NCT01380080|454652333|FG000|Overall Study|Not willing to adhere to requirements|6|||
126370397|NCT01380080|454652334|FG001|Overall Study|Not willing to adhere to requirements|2|||
126370398|NCT01380080|454652333|FG000|Overall Study|Withdrawal by Subject|5|||
126370399|NCT01380080|454652334|FG001|Overall Study|Withdrawal by Subject|2|||
126370400|NCT01380080|454652333|FG000|Overall Study|Lost to Follow-up|3|||
126370401|NCT01380080|454652334|FG001|Overall Study|Lost to Follow-up|3|||
126370402|NCT00210132|454652339|FG000|Overall Study|Protocol Violation|1|||
126370403|NCT00210132|454652340|FG001|Overall Study|Protocol Violation|4|||
126370404|NCT00432965|454652341|FG000|Overall Study|Lost to Follow-up|22|||
126370405|NCT00432965|454652342|FG001|Overall Study|Lost to Follow-up|19|||
126370406|NCT00432965|454652341|FG000|Overall Study|Withdrawal by Subject|13|||
126370407|NCT00432965|454652342|FG001|Overall Study|Withdrawal by Subject|13|||
126370408|NCT00432965|454652341|FG000|Overall Study|Physician Decision|14|||
126370409|NCT00432965|454652342|FG001|Overall Study|Physician Decision|13|||
126370410|NCT00432965|454652341|FG000|Overall Study|Lack of Efficacy|8|||
126370411|NCT00432965|454652342|FG001|Overall Study|Lack of Efficacy|13|||
126370412|NCT00432965|454652341|FG000|Overall Study|Non-compliance|7|||
126370413|NCT00432965|454652342|FG001|Overall Study|Non-compliance|0|||
126370414|NCT00432965|454652341|FG000|Overall Study|Adverse Event|22|||
126370415|NCT00432965|454652342|FG001|Overall Study|Adverse Event|19|||
126370416|NCT00432965|454652341|FG000|Overall Study|Death|3|||
126370417|NCT00432965|454652342|FG001|Overall Study|Death|4|||
126370418|NCT00432965|454652341|FG000|Overall Study|Exclusionary Methods|1|||
126370419|NCT00432965|454652342|FG001|Overall Study|Exclusionary Methods|2|||
126370420|NCT00432965|454652341|FG000|Overall Study|Incomplete Data|4|||
126370421|NCT00432965|454652342|FG001|Overall Study|Incomplete Data|3|||
126370422|NCT03636022|454652343|FG000|Overall Study|Withdrawal by Subject|1|||
126370423|NCT03636022|454652344|FG001|Overall Study|Withdrawal by Subject|3|||
126370424|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
126370425|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
126370426|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
126370427|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
126370428|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
126370429|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
126370430|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
126370431|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
126370432|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
126370433|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
126370434|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
126370435|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
126370436|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
126370437|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
126370438|NCT04532749|454652345|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
126370439|NCT04532749|454652346|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
126370440|NCT04532749|454652345|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
126370441|NCT04532749|454652346|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
126370442|NCT04532749|454652345|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
126370443|NCT04532749|454652346|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
126370444|NCT00642759|454652347|FG000|Overall Study|Protocol Violation|1|||
126370445|NCT03612570|454652352|FG000|Overall Study|Lost to Follow-up|1|||
126370446|NCT02255435|454653631|FG000|Overall Study|Patient's Limited Time Availability|0|||
126370447|NCT02255435|454653632|FG001|Overall Study|Patient's Limited Time Availability|0|||
126370448|NCT02255435|454653633|FG002|Overall Study|Patient's Limited Time Availability|0|||
126370449|NCT02255435|454653634|FG003|Overall Study|Patient's Limited Time Availability|0|||
126370450|NCT02255435|454653635|FG004|Overall Study|Patient's Limited Time Availability|0|||
126370451|NCT02255435|454653636|FG005|Overall Study|Patient's Limited Time Availability|0|||
126046646|NCT01046825|453469069|FG002|Overall Study|Did not submit biology samples|0|||
126046647|NCT01046825|453469070|FG003|Overall Study|Did not submit biology samples|0|||
126046648|NCT01046825|453469071|FG004|Overall Study|Did not submit biology samples|13|||
126370452|NCT02255435|454653637|FG006|Overall Study|Patient's Limited Time Availability|0|||
126370453|NCT02255435|454653638|FG007|Overall Study|Patient's Limited Time Availability|1|||
126370454|NCT02255435|454653639|FG008|Overall Study|Patient's Limited Time Availability|0|||
126046649|NCT02075554|453469073|FG000|Overall Study|Lost to Follow-up|7|||
126370455|NCT02255435|454653640|FG009|Overall Study|Patient's Limited Time Availability|0|||
126370456|NCT02255435|454653631|FG000|Overall Study|Withdrawal by Subject|0|||
126088913|NCT00335140|453620013|FG000|Overall Study|Ineligible|1|||
126306888|NCT00394836|454411911|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
126306889|NCT00394836|454411912|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
126306890|NCT00394836|454411911|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
126306891|NCT00394836|454411912|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
126306892|NCT00394836|454411911|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
126306893|NCT00394836|454411912|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
126306894|NCT00394836|454411911|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
126306895|NCT00394836|454411912|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
126306896|NCT01289639|454411927|FG000|Overall Study|Lost to Follow-up|1|||
126306897|NCT01289639|454411928|FG001|Overall Study|Lost to Follow-up|0|||
126306898|NCT01289639|454411929|FG002|Overall Study|Lost to Follow-up|0|||
126306899|NCT02780713|454411930|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
126306900|NCT02780713|454411931|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
126306901|NCT02780713|454411932|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
126306902|NCT02780713|454411933|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
126306903|NCT02780713|454411934|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
126306904|NCT02111577|454411935|FG000|Overall Study|Protocol Violation|2|||
126306905|NCT02111577|454411936|FG001|Overall Study|Protocol Violation|0|||
126306906|NCT02111577|454411935|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
126306907|NCT02111577|454411936|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
126306908|NCT02111577|454411935|FG000|Overall Study|Failure to produce study treatment|6|||
126306909|NCT02111577|454411936|FG001|Overall Study|Failure to produce study treatment|0|||
126306910|NCT02111577|454411935|FG000|Overall Study|Death|518|||
126306911|NCT02111577|454411936|FG001|Overall Study|Death|254|||
126306912|NCT02111577|454411935|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
126306913|NCT02111577|454411936|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
126306914|NCT02111577|454411935|FG000|Overall Study|Adverse Event|1|||
126306915|NCT02111577|454411936|FG001|Overall Study|Adverse Event|1|||
126306916|NCT02111577|454411935|FG000|Overall Study|Withdrawal by Subject|51|||
126306917|NCT02111577|454411936|FG001|Overall Study|Withdrawal by Subject|23|||
126306918|NCT02111577|454411935|FG000|Overall Study|Disease progression|0|||
126306919|NCT02111577|454411936|FG001|Overall Study|Disease progression|1|||
126306920|NCT02111577|454411935|FG000|Overall Study|Lost to Follow-up|19|||
126306921|NCT02111577|454411936|FG001|Overall Study|Lost to Follow-up|10|||
126306922|NCT02042950|454411937|FG000|Overall Study|Progressive Disease|4|||
126306923|NCT02429778|454411940|FG000|Overall Study|Lost to Follow-up|2|||
126306924|NCT02429778|454411941|FG001|Overall Study|Lost to Follow-up|0|||
126306925|NCT02429778|454411940|FG000|Overall Study|Withdrawal by Subject|5|||
126306926|NCT02429778|454411941|FG001|Overall Study|Withdrawal by Subject|0|||
126306927|NCT03521115|454411942|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
126306928|NCT03521115|454411943|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
126306929|NCT03521115|454411942|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
126306930|NCT03521115|454411943|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
126306931|NCT01981954|454411950|FG000|Titration Period|Protocol Deviation|1|||
126306932|NCT01981954|454411950|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
126306933|NCT03655470|454411951|FG000|Overall Study|Lost to Follow-up|6|||
126306934|NCT03655470|454411952|FG001|Overall Study|Lost to Follow-up|7|||
126306935|NCT01893281|454411953|FG000|Overall Study|Adverse Event|1|||
126306936|NCT01893281|454411953|FG000|Overall Study|Protocol Violation|1|||
126306937|NCT01893281|454411953|FG000|Overall Study|Withdrawal by Subject|1|||
126306938|NCT05481125|454411954|FG000|Overall Study|Adverse Event|1|||
126306939|NCT05481125|454411955|FG001|Overall Study|Adverse Event|0|||
126306940|NCT05481125|454411954|FG000|Overall Study|Lost to Follow-up|0|||
126306941|NCT05481125|454411955|FG001|Overall Study|Lost to Follow-up|1|||
126306942|NCT05481125|454411954|FG000|Overall Study|Withdrawal by Subject|0|||
126306943|NCT05481125|454411955|FG001|Overall Study|Withdrawal by Subject|1|||
126306944|NCT03615144|454411956|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
126306945|NCT03615144|454411957|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
126306946|NCT02587598|454411960|FG000|Overall Study|Death|4|||
126306947|NCT02587598|454411961|FG001|Overall Study|Death|8|||
126306948|NCT02587598|454411962|FG002|Overall Study|Death|4|||
126306949|NCT02587598|454411963|FG003|Overall Study|Death|16|||
126306950|NCT02587598|454411964|FG004|Overall Study|Death|9|||
126306951|NCT02587598|454411965|FG005|Overall Study|Death|4|||
126306952|NCT02587598|454411966|FG006|Overall Study|Death|6|||
126306953|NCT02587598|454411967|FG007|Overall Study|Death|7|||
126306954|NCT02587598|454411968|FG008|Overall Study|Death|9|||
126088914|NCT04546425|453620014|FG000|Overall Study|Protocol Violation|1|||
126088915|NCT04546425|453620015|FG001|Overall Study|Protocol Violation|1|||
126088916|NCT04546425|453620016|FG002|Overall Study|Protocol Violation|0|||
126088917|NCT04546425|453620017|FG003|Overall Study|Protocol Violation|0|||
126088918|NCT04546425|453620014|FG000|Overall Study|Adverse Event|3|||
126088919|NCT04546425|453620015|FG001|Overall Study|Adverse Event|0|||
126088920|NCT04546425|453620016|FG002|Overall Study|Adverse Event|0|||
126306955|NCT02587598|454411969|FG009|Overall Study|Death|1|||
126306956|NCT02587598|454411970|FG010|Overall Study|Death|3|||
126306957|NCT02587598|454411960|FG000|Overall Study|Study Terminated by the Sponsor|0|||
126306958|NCT02587598|454411961|FG001|Overall Study|Study Terminated by the Sponsor|1|||
126306959|NCT02587598|454411962|FG002|Overall Study|Study Terminated by the Sponsor|0|||
126306960|NCT02587598|454411963|FG003|Overall Study|Study Terminated by the Sponsor|3|||
126306961|NCT02587598|454411964|FG004|Overall Study|Study Terminated by the Sponsor|0|||
126306962|NCT02587598|454411965|FG005|Overall Study|Study Terminated by the Sponsor|1|||
126306963|NCT02587598|454411966|FG006|Overall Study|Study Terminated by the Sponsor|0|||
126306964|NCT02587598|454411967|FG007|Overall Study|Study Terminated by the Sponsor|0|||
126306965|NCT02587598|454411968|FG008|Overall Study|Study Terminated by the Sponsor|0|||
126103495|NCT01191268|453672176|FG001|Overall Study|Withdrawal by Subject|25|||
126103496|NCT01191268|453672177|FG002|Overall Study|Withdrawal by Subject|21|||
126103497|NCT01191268|453672175|FG000|Overall Study|Adverse Event|21|||
126306966|NCT02587598|454411969|FG009|Overall Study|Study Terminated by the Sponsor|1|||
126370457|NCT02255435|454653632|FG001|Overall Study|Withdrawal by Subject|0|||
126046650|NCT02075554|453469073|FG000|Overall Study|Withdrawal by Subject|5|||
126046651|NCT02075554|453469073|FG000|Overall Study|Physician Decision|3|||
126046652|NCT04993677|453469080|FG000|Overall Study|Lost to Follow-up|1|||
126046653|NCT04993677|453469081|FG001|Overall Study|Lost to Follow-up|0|||
126046654|NCT04993677|453469082|FG002|Overall Study|Lost to Follow-up|0|||
126046655|NCT04993677|453469083|FG003|Overall Study|Lost to Follow-up|0|||
126046656|NCT04993677|453469080|FG000|Overall Study|Death|11|||
126046657|NCT04993677|453469081|FG001|Overall Study|Death|8|||
126046658|NCT04993677|453469082|FG002|Overall Study|Death|3|||
126046659|NCT04993677|453469083|FG003|Overall Study|Death|1|||
126046660|NCT04993677|453469080|FG000|Overall Study|Subject withdrawal of consent|4|||
126046661|NCT04993677|453469081|FG001|Overall Study|Subject withdrawal of consent|3|||
126046662|NCT04993677|453469082|FG002|Overall Study|Subject withdrawal of consent|0|||
126046663|NCT04993677|453469083|FG003|Overall Study|Subject withdrawal of consent|2|||
126046664|NCT04993677|453469080|FG000|Overall Study|Study termination by sponsor|3|||
126046665|NCT04993677|453469081|FG001|Overall Study|Study termination by sponsor|25|||
126046666|NCT04993677|453469082|FG002|Overall Study|Study termination by sponsor|3|||
126046667|NCT04993677|453469083|FG003|Overall Study|Study termination by sponsor|3|||
126046668|NCT04993677|453469080|FG000|Overall Study|Other|2|||
126046669|NCT04993677|453469081|FG001|Overall Study|Other|3|||
126046670|NCT04993677|453469082|FG002|Overall Study|Other|3|||
126046671|NCT04993677|453469083|FG003|Overall Study|Other|2|||
126046672|NCT00003222|453469092|FG000|Overall Study|Physician Decision|0|||
126046673|NCT00003222|453469093|FG001|Overall Study|Physician Decision|1|||
126046674|NCT03248492|453469094|FG000|Overall Study|Progressive Disease|24|||
126046675|NCT03248492|453469095|FG001|Overall Study|Progressive Disease|23|||
126103498|NCT01191268|453672176|FG001|Overall Study|Adverse Event|13|||
126103499|NCT01191268|453672177|FG002|Overall Study|Adverse Event|8|||
126306967|NCT02587598|454411970|FG010|Overall Study|Study Terminated by the Sponsor|6|||
126306968|NCT02587598|454411960|FG000|Overall Study|Reason for study withdrawal not specified|0|||
126306969|NCT02587598|454411961|FG001|Overall Study|Reason for study withdrawal not specified|1|||
126370458|NCT02255435|454653633|FG002|Overall Study|Withdrawal by Subject|0|||
126370459|NCT02255435|454653634|FG003|Overall Study|Withdrawal by Subject|0|||
126370460|NCT02255435|454653635|FG004|Overall Study|Withdrawal by Subject|0|||
126370461|NCT02255435|454653636|FG005|Overall Study|Withdrawal by Subject|0|||
126370462|NCT02255435|454653637|FG006|Overall Study|Withdrawal by Subject|0|||
126370463|NCT02255435|454653638|FG007|Overall Study|Withdrawal by Subject|0|||
126370464|NCT02255435|454653639|FG008|Overall Study|Withdrawal by Subject|1|||
126370465|NCT02255435|454653640|FG009|Overall Study|Withdrawal by Subject|4|||
126370466|NCT02255435|454653631|FG000|Overall Study|Administrative reasons|0|||
126370467|NCT02255435|454653632|FG001|Overall Study|Administrative reasons|0|||
126370468|NCT02255435|454653633|FG002|Overall Study|Administrative reasons|0|||
126370469|NCT02255435|454653634|FG003|Overall Study|Administrative reasons|0|||
126370470|NCT02255435|454653635|FG004|Overall Study|Administrative reasons|0|||
126370471|NCT02255435|454653636|FG005|Overall Study|Administrative reasons|0|||
126370472|NCT02255435|454653637|FG006|Overall Study|Administrative reasons|0|||
126370473|NCT02255435|454653638|FG007|Overall Study|Administrative reasons|0|||
126370474|NCT02255435|454653639|FG008|Overall Study|Administrative reasons|0|||
126370475|NCT02255435|454653640|FG009|Overall Study|Administrative reasons|2|||
126370476|NCT00442702|454653641|FG000|Titration Period|Adverse Event|2|||
126370477|NCT00442702|454653642|FG001|Titration Period|Adverse Event|0|||
126370478|NCT00442702|454653641|FG000|Titration Period|Death|3|||
126046676|NCT03248492|453469096|FG002|Overall Study|Progressive Disease|11|||
126046677|NCT03248492|453469097|FG003|Overall Study|Progressive Disease|66|||
126046678|NCT03248492|453469098|FG004|Overall Study|Progressive Disease|1|||
126046679|NCT03248492|453469094|FG000|Overall Study|Adverse Event|14|||
126046680|NCT03248492|453469095|FG001|Overall Study|Adverse Event|13|||
126046681|NCT03248492|453469096|FG002|Overall Study|Adverse Event|9|||
126046682|NCT03248492|453469097|FG003|Overall Study|Adverse Event|22|||
126103500|NCT01191268|453672175|FG000|Overall Study|Physician Decision|6|||
126370479|NCT00442702|454653642|FG001|Titration Period|Death|2|||
126306970|NCT02587598|454411962|FG002|Overall Study|Reason for study withdrawal not specified|0|||
126306971|NCT02587598|454411963|FG003|Overall Study|Reason for study withdrawal not specified|0|||
126306972|NCT02587598|454411964|FG004|Overall Study|Reason for study withdrawal not specified|0|||
126306973|NCT02587598|454411965|FG005|Overall Study|Reason for study withdrawal not specified|0|||
126306974|NCT02587598|454411966|FG006|Overall Study|Reason for study withdrawal not specified|0|||
126306975|NCT02587598|454411967|FG007|Overall Study|Reason for study withdrawal not specified|0|||
126306976|NCT02587598|454411968|FG008|Overall Study|Reason for study withdrawal not specified|0|||
125885366|NCT03614156|452876839|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
125885367|NCT03614156|452876840|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
125885368|NCT03614156|452876841|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
125885369|NCT03614156|452876842|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
125885370|NCT03614156|452876839|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
125885371|NCT03614156|452876840|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
125885372|NCT03614156|452876841|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
125885373|NCT03614156|452876842|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
125885374|NCT03614156|452876839|FG000|Open-Label Treatment Period|Protocol Violation|2|||
125885375|NCT03614156|452876840|FG001|Open-Label Treatment Period|Protocol Violation|0|||
125885376|NCT03614156|452876841|FG002|Open-Label Treatment Period|Protocol Violation|0|||
125885377|NCT03614156|452876842|FG003|Open-Label Treatment Period|Protocol Violation|0|||
125885378|NCT03614156|452876839|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
125885379|NCT03614156|452876840|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
125885380|NCT03614156|452876841|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
125885381|NCT03614156|452876842|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
125885382|NCT03614156|452876839|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
125885383|NCT03614156|452876840|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
125885384|NCT03614156|452876841|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
125885385|NCT03614156|452876842|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
125885386|NCT03614156|452876839|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
125885387|NCT03614156|452876840|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
125885388|NCT03614156|452876841|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
125885389|NCT03614156|452876842|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
125885390|NCT03614156|452876839|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125885391|NCT03614156|452876840|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
125885392|NCT03614156|452876841|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125885393|NCT03614156|452876842|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125885394|NCT03614156|452876839|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125885395|NCT03614156|452876840|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125885396|NCT03614156|452876841|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
126046683|NCT03248492|453469098|FG004|Overall Study|Adverse Event|2|||
126370480|NCT00442702|454653641|FG000|Titration Period|Insufficient Therapeutic Response|1|||
126370481|NCT00442702|454653642|FG001|Titration Period|Insufficient Therapeutic Response|0|||
126370482|NCT00442702|454653641|FG000|Titration Period|Refused Treatment|4|||
126370483|NCT00442702|454653642|FG001|Titration Period|Refused Treatment|1|||
126370484|NCT00442702|454653641|FG000|Titration Period|Failure to return|1|||
126370485|NCT00442702|454653642|FG001|Titration Period|Failure to return|0|||
126370486|NCT00442702|454653641|FG000|Titration Period|Hospitalized in another hospital|1|||
126370487|NCT00442702|454653642|FG001|Titration Period|Hospitalized in another hospital|0|||
126370488|NCT00442702|454653641|FG000|Evaluation Period|Adverse Event|1|||
126370489|NCT00442702|454653642|FG001|Evaluation Period|Adverse Event|0|||
126370490|NCT00442702|454653641|FG000|Evaluation Period|Death|1|||
126370491|NCT00442702|454653642|FG001|Evaluation Period|Death|1|||
126370492|NCT00442702|454653641|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
126370493|NCT00442702|454653642|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
125885397|NCT03614156|452876842|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
125885398|NCT03614156|452876839|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
125885399|NCT03614156|452876840|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125885400|NCT03614156|452876841|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125885401|NCT03614156|452876842|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125885402|NCT03614156|452876839|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
125885403|NCT03614156|452876840|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
125885404|NCT03614156|452876841|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
125885405|NCT03614156|452876842|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
125885406|NCT03614156|452876839|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125885407|NCT03614156|452876840|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
125885408|NCT03614156|452876841|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125885409|NCT03614156|452876842|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125885410|NCT03614156|452876839|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
125885411|NCT03614156|452876840|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125885412|NCT03614156|452876841|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125885413|NCT03614156|452876842|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125885414|NCT03614156|452876839|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
125885415|NCT03614156|452876840|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
125885416|NCT03614156|452876841|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
125885417|NCT03614156|452876842|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
125885418|NCT03614156|452876839|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
125885419|NCT03614156|452876840|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
125885420|NCT03614156|452876841|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
125885421|NCT03614156|452876842|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
125885422|NCT04287517|452876844|FG000|Overall Study|Withdrawal by Subject|1|||
125885423|NCT04287517|452876845|FG001|Overall Study|Withdrawal by Subject|1|||
125885424|NCT03070964|452876846|FG000|Overall Study|Progressive disease|8|||
125885425|NCT03070964|452876846|FG000|Overall Study|Treatment-unrelated adverse event|2|||
125885426|NCT03070964|452876846|FG000|Overall Study|Never treated|1|||
125885427|NCT03070964|452876846|FG000|Overall Study|Physician Decision|1|||
125885428|NCT03070964|452876846|FG000|Overall Study|Withdrawal by Subject|1|||
125885429|NCT03070964|452876846|FG000|Overall Study|Adverse Event|1|||
125885430|NCT00834093|452876849|FG000|Overall Study|Progressive Disease|3|||
125885431|NCT00834093|452876849|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
125885432|NCT02745119|452876850|FG000|Overall Study|Adverse Event|1|||
125885433|NCT02745119|452876851|FG001|Overall Study|Adverse Event|0|||
125885434|NCT02745119|452876852|FG002|Overall Study|Adverse Event|1|||
125885435|NCT02745119|452876853|FG003|Overall Study|Adverse Event|3|||
125885436|NCT02745119|452876850|FG000|Overall Study|Death|3|||
125885437|NCT02745119|452876851|FG001|Overall Study|Death|3|||
125885438|NCT02745119|452876852|FG002|Overall Study|Death|0|||
125885439|NCT02745119|452876853|FG003|Overall Study|Death|4|||
125885440|NCT02745119|452876850|FG000|Overall Study|Lost to Follow-up|0|||
125885441|NCT02745119|452876851|FG001|Overall Study|Lost to Follow-up|0|||
125885442|NCT02745119|452876852|FG002|Overall Study|Lost to Follow-up|0|||
125885443|NCT02745119|452876853|FG003|Overall Study|Lost to Follow-up|1|||
125885444|NCT02745119|452876850|FG000|Overall Study|Protocol Deviation|0|||
125885445|NCT02745119|452876851|FG001|Overall Study|Protocol Deviation|0|||
125885446|NCT02745119|452876852|FG002|Overall Study|Protocol Deviation|0|||
125885447|NCT02745119|452876853|FG003|Overall Study|Protocol Deviation|1|||
125885448|NCT02745119|452876850|FG000|Overall Study|Withdrawal by Subject|7|||
125885449|NCT02745119|452876851|FG001|Overall Study|Withdrawal by Subject|15|||
125885450|NCT02745119|452876852|FG002|Overall Study|Withdrawal by Subject|8|||
125885451|NCT02745119|452876853|FG003|Overall Study|Withdrawal by Subject|14|||
125885452|NCT02745119|452876850|FG000|Overall Study|Study Terminated by Sponsor|134|||
125885453|NCT02745119|452876851|FG001|Overall Study|Study Terminated by Sponsor|252|||
125885454|NCT02745119|452876852|FG002|Overall Study|Study Terminated by Sponsor|135|||
125885455|NCT02745119|452876853|FG003|Overall Study|Study Terminated by Sponsor|251|||
126103501|NCT01191268|453672176|FG001|Overall Study|Physician Decision|8|||
126103502|NCT01191268|453672177|FG002|Overall Study|Physician Decision|9|||
126103503|NCT01191268|453672175|FG000|Overall Study|Lost to Follow-up|8|||
126103504|NCT01191268|453672176|FG001|Overall Study|Lost to Follow-up|5|||
126103505|NCT01191268|453672177|FG002|Overall Study|Lost to Follow-up|9|||
126370494|NCT00442702|454653641|FG000|Evaluation Period|Refused treatment|1|||
126370495|NCT00442702|454653642|FG001|Evaluation Period|Refused treatment|1|||
126370496|NCT00442702|454653641|FG000|Evaluation Period|Renal transplant|0|||
126370497|NCT00442702|454653642|FG001|Evaluation Period|Renal transplant|1|||
126370498|NCT00442702|454653641|FG000|Evaluation Period|Failure to return|1|||
126103506|NCT01191268|453672175|FG000|Overall Study|Entry Criteria Not Met|3|||
126103507|NCT01191268|453672176|FG001|Overall Study|Entry Criteria Not Met|1|||
126103508|NCT01191268|453672177|FG002|Overall Study|Entry Criteria Not Met|1|||
126103509|NCT01191268|453672175|FG000|Overall Study|Death|0|||
126103510|NCT01191268|453672176|FG001|Overall Study|Death|1|||
126103511|NCT01191268|453672177|FG002|Overall Study|Death|3|||
126370499|NCT00442702|454653642|FG001|Evaluation Period|Failure to return|0|||
126370500|NCT00442702|454653641|FG000|Evaluation Period|Site closure|0|||
126046684|NCT03248492|453469094|FG000|Overall Study|Withdrawal by Subject|5|||
126046685|NCT03248492|453469095|FG001|Overall Study|Withdrawal by Subject|4|||
126046686|NCT03248492|453469096|FG002|Overall Study|Withdrawal by Subject|0|||
126046687|NCT03248492|453469097|FG003|Overall Study|Withdrawal by Subject|8|||
126046688|NCT03248492|453469098|FG004|Overall Study|Withdrawal by Subject|1|||
126046689|NCT03248492|453469094|FG000|Overall Study|Physician Decision|1|||
126046690|NCT03248492|453469095|FG001|Overall Study|Physician Decision|1|||
126046691|NCT03248492|453469096|FG002|Overall Study|Physician Decision|1|||
126046692|NCT03248492|453469097|FG003|Overall Study|Physician Decision|7|||
126046693|NCT03248492|453469098|FG004|Overall Study|Physician Decision|0|||
126046694|NCT03248492|453469094|FG000|Overall Study|Death|1|||
126046695|NCT03248492|453469095|FG001|Overall Study|Death|1|||
126046696|NCT03248492|453469096|FG002|Overall Study|Death|0|||
126046697|NCT03248492|453469097|FG003|Overall Study|Death|6|||
126046698|NCT03248492|453469098|FG004|Overall Study|Death|0|||
126046699|NCT03248492|453469094|FG000|Overall Study|Study Terminated by Sponsor|3|||
126046700|NCT03248492|453469095|FG001|Overall Study|Study Terminated by Sponsor|1|||
126046701|NCT03248492|453469096|FG002|Overall Study|Study Terminated by Sponsor|0|||
126046702|NCT03248492|453469097|FG003|Overall Study|Study Terminated by Sponsor|7|||
126046703|NCT03248492|453469098|FG004|Overall Study|Study Terminated by Sponsor|0|||
126046704|NCT03248492|453469094|FG000|Overall Study|Other|2|||
126046705|NCT03248492|453469095|FG001|Overall Study|Other|5|||
126046706|NCT03248492|453469096|FG002|Overall Study|Other|0|||
126046707|NCT03248492|453469097|FG003|Overall Study|Other|14|||
126046708|NCT03248492|453469098|FG004|Overall Study|Other|0|||
126046709|NCT03767335|453469099|FG000|Overall Study|Physician Decision|1|||
126046710|NCT03767335|453469100|FG001|Overall Study|Physician Decision|1|||
126046711|NCT03767335|453469101|FG002|Overall Study|Physician Decision|0|||
126046712|NCT03767335|453469099|FG000|Overall Study|Withdrawal by Subject|0|||
126046713|NCT03767335|453469100|FG001|Overall Study|Withdrawal by Subject|0|||
126046714|NCT03767335|453469101|FG002|Overall Study|Withdrawal by Subject|6|||
126046715|NCT03767335|453469099|FG000|Overall Study|Participant excluded from efficacy population|0|||
126046716|NCT03767335|453469100|FG001|Overall Study|Participant excluded from efficacy population|0|||
126046717|NCT03767335|453469101|FG002|Overall Study|Participant excluded from efficacy population|1|||
126046718|NCT03767335|453469099|FG000|Overall Study|Death|0|||
126046719|NCT03767335|453469100|FG001|Overall Study|Death|0|||
126046720|NCT03767335|453469101|FG002|Overall Study|Death|2|||
126046721|NCT03767335|453469099|FG000|Overall Study|Progressive Disease|2|||
126046722|NCT03767335|453469100|FG001|Overall Study|Progressive Disease|2|||
126103512|NCT01191268|453672175|FG000|Overall Study|Protocol Violation|1|||
126103513|NCT01191268|453672176|FG001|Overall Study|Protocol Violation|0|||
126370501|NCT00442702|454653642|FG001|Evaluation Period|Site closure|1|||
126046723|NCT03767335|453469101|FG002|Overall Study|Progressive Disease|2|||
126046724|NCT03767335|453469099|FG000|Overall Study|Disease progression needing additional medication|0|||
126046725|NCT03767335|453469100|FG001|Overall Study|Disease progression needing additional medication|0|||
126046726|NCT03767335|453469101|FG002|Overall Study|Disease progression needing additional medication|17|||
126046727|NCT03767335|453469099|FG000|Overall Study|Sponsor decision|0|||
126046728|NCT03767335|453469100|FG001|Overall Study|Sponsor decision|0|||
126046729|NCT03767335|453469101|FG002|Overall Study|Sponsor decision|2|||
126103514|NCT01191268|453672177|FG002|Overall Study|Protocol Violation|1|||
126046730|NCT03767335|453469099|FG000|Overall Study|Other Medical Reasons|0|||
126370502|NCT03580044|454653643|FG000|Overall Study|Death|2|||
126370503|NCT03580044|454653644|FG001|Overall Study|Death|1|||
126370504|NCT03580044|454653643|FG000|Overall Study|Withdrawal by Subject|1|||
126370505|NCT03580044|454653644|FG001|Overall Study|Withdrawal by Subject|1|||
126370506|NCT01664624|454653645|FG000|Overall Study|Adverse Event|0|||
126370507|NCT01664624|454653646|FG001|Overall Study|Adverse Event|1|||
126046731|NCT03767335|453469100|FG001|Overall Study|Other Medical Reasons|0|||
126046732|NCT03767335|453469101|FG002|Overall Study|Other Medical Reasons|3|||
126046733|NCT04757753|453469108|FG000|Overall Study|Lost to Follow-up|7|||
126046734|NCT04757753|453469109|FG001|Overall Study|Lost to Follow-up|7|||
126046735|NCT04757753|453469108|FG000|Overall Study|Withdrawal by Subject|0|||
126046736|NCT04757753|453469109|FG001|Overall Study|Withdrawal by Subject|3|||
126046737|NCT04757753|453469108|FG000|Overall Study|Endodontic treatment failure|1|||
126046738|NCT04757753|453469109|FG001|Overall Study|Endodontic treatment failure|2|||
126046739|NCT04757753|453469108|FG000|Overall Study|Tooth fracture/extraction|3|||
126046740|NCT04757753|453469109|FG001|Overall Study|Tooth fracture/extraction|0|||
126046741|NCT01313559|453469110|FG000|Overall Study|Withdrawal by Subject|1|||
126046742|NCT01313559|453469111|FG001|Overall Study|Withdrawal by Subject|2|||
126046743|NCT01313559|453469110|FG000|Overall Study|Disease progression|1|||
126046744|NCT01313559|453469111|FG001|Overall Study|Disease progression|0|||
126046745|NCT01313559|453469110|FG000|Overall Study|Rising PSA|2|||
126046746|NCT01313559|453469111|FG001|Overall Study|Rising PSA|0|||
126046747|NCT03201939|453469118|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
126046748|NCT03201939|453469119|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
126046749|NCT05707351|453469120|FG000|Overall Study|Withdrawal by Subject|2|||
126046750|NCT05707351|453469120|FG000|Overall Study|Reason Not Specified|1|||
126046751|NCT04908514|453469125|FG000|Overall Study|Lost to Follow-up|2|||
126046752|NCT04908514|453469125|FG000|Overall Study|Withdrawal by Subject|1|||
126046753|NCT03891758|453469126|FG000|Overall Study|Adverse Event|2|||
126046754|NCT03891758|453469127|FG001|Overall Study|Adverse Event|0|||
126046755|NCT03891758|453469126|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126046756|NCT03891758|453469127|FG001|Overall Study|Withdrawal by parent/guardian|2|||
126046757|NCT05180539|453469651|FG000|Overall Study|Lost to Follow-up|27|||
126046758|NCT05180539|453469652|FG001|Overall Study|Lost to Follow-up|30|||
126046759|NCT02566889|453469655|FG000|Overall Study|Withdrawal by Subject|3|||
126046760|NCT02566889|453469656|FG001|Overall Study|Withdrawal by Subject|1|||
126046761|NCT02566889|453469655|FG000|Overall Study|Adverse Event|4|||
126046762|NCT02566889|453469656|FG001|Overall Study|Adverse Event|2|||
126046763|NCT02566889|453469655|FG000|Overall Study|Other|6|||
126046764|NCT02566889|453469656|FG001|Overall Study|Other|2|||
126046765|NCT04518943|453469657|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
126046766|NCT04518943|453469658|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
126046767|NCT04518943|453469659|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
126046768|NCT04518943|453469660|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
126046769|NCT04518943|453469661|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
126046770|NCT04518943|453469662|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
126046771|NCT04518943|453469663|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
126046772|NCT04518943|453469664|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
126046773|NCT04518943|453469665|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
126046774|NCT04518943|453469666|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
126103515|NCT01191268|453672175|FG000|Overall Study|Sponsor Decision|0|||
126046775|NCT04518943|453469667|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
126046776|NCT04518943|453469668|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
126046777|NCT04518943|453469669|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
126046778|NCT04518943|453469670|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
126046779|NCT04518943|453469671|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
126370508|NCT01664624|454653647|FG002|Overall Study|Adverse Event|0|||
126370509|NCT01664624|454653648|FG003|Overall Study|Adverse Event|0|||
126103516|NCT01191268|453672176|FG001|Overall Study|Sponsor Decision|2|||
126103517|NCT01191268|453672177|FG002|Overall Study|Sponsor Decision|0|||
126103518|NCT01959334|453672180|FG000|Second Dose|Adverse Event|1|||
126103519|NCT01959334|453672181|FG001|Second Dose|Adverse Event|0|||
126103520|NCT01959334|453672180|FG000|Third Dose|Adverse Event|0|||
126103521|NCT01959334|453672181|FG001|Third Dose|Adverse Event|1|||
126103522|NCT02294227|453672182|FG000|Overall Study|Death|0|||
126103523|NCT02294227|453672183|FG001|Overall Study|Death|0|||
126103524|NCT02294227|453672184|FG002|Overall Study|Death|1|||
126103525|NCT02294227|453672182|FG000|Overall Study|Subject/Guardian Decision|6|||
126103526|NCT02294227|453672183|FG001|Overall Study|Subject/Guardian Decision|3|||
126103527|NCT02294227|453672184|FG002|Overall Study|Subject/Guardian Decision|7|||
126103528|NCT02294227|453672182|FG000|Overall Study|Physician Decision|1|||
126103529|NCT02294227|453672183|FG001|Overall Study|Physician Decision|2|||
126103530|NCT02294227|453672184|FG002|Overall Study|Physician Decision|1|||
126103531|NCT02294227|453672182|FG000|Overall Study|Lost to Follow-up|1|||
126103532|NCT02294227|453672183|FG001|Overall Study|Lost to Follow-up|0|||
126103533|NCT02294227|453672184|FG002|Overall Study|Lost to Follow-up|0|||
126370510|NCT00335829|454653651|FG000|Overall Study|Withdrawal by Subject|1|||
126103534|NCT02294227|453672182|FG000|Overall Study|Lack of Efficacy|11|||
126103535|NCT02294227|453672183|FG001|Overall Study|Lack of Efficacy|12|||
126103536|NCT02294227|453672184|FG002|Overall Study|Lack of Efficacy|8|||
126103537|NCT02294227|453672182|FG000|Overall Study|Adverse Event|6|||
126103538|NCT02294227|453672183|FG001|Overall Study|Adverse Event|8|||
126103539|NCT02294227|453672184|FG002|Overall Study|Adverse Event|2|||
126370511|NCT00335829|454653651|FG000|Overall Study|Lost to Follow-up|1|||
126370512|NCT00335829|454653651|FG000|Overall Study|Adverse Event|1|||
126370513|NCT04067011|454653653|FG000|Overall Study|Not Treated|8|||
126370514|NCT04067011|454653654|FG001|Overall Study|Not Treated|7|||
126370515|NCT04067011|454653655|FG002|Overall Study|Not Treated|5|||
126370516|NCT04067011|454653653|FG000|Overall Study|Adverse Event|2|||
126103540|NCT01768637|453672185|FG000|Overall Study|Lost to Follow-up|2|||
126103541|NCT01768637|453672186|FG001|Overall Study|Lost to Follow-up|7|||
126103542|NCT01768637|453672185|FG000|Overall Study|Difficult blood draw|1|||
126103543|NCT01768637|453672186|FG001|Overall Study|Difficult blood draw|0|||
126200133|NCT02394028|454017877|FG000|Induction Phase|Non-compliance|0|||
126200134|NCT02394028|454017878|FG001|Induction Phase|Non-compliance|1|||
126200135|NCT02394028|454017879|FG002|Induction Phase|Non-compliance|3|||
126200136|NCT02394028|454017880|FG003|Induction Phase|Non-compliance|1|||
126200137|NCT02394028|454017881|FG004|Induction Phase|Non-compliance|3|||
126200138|NCT02394028|454017882|FG005|Induction Phase|Non-compliance|0|||
126200139|NCT02394028|454017883|FG006|Induction Phase|Non-compliance|1|||
126200140|NCT02394028|454017884|FG007|Induction Phase|Non-compliance|1|||
126200141|NCT02394028|454017885|FG008|Induction Phase|Non-compliance|0|||
126200142|NCT02394028|454017886|FG009|Induction Phase|Non-compliance|0|||
126200143|NCT02394028|454017887|FG010|Induction Phase|Non-compliance|0|||
126200144|NCT02394028|454017877|FG000|Induction Phase|Physician Decision|0|||
126200145|NCT02394028|454017878|FG001|Induction Phase|Physician Decision|0|||
126200146|NCT02394028|454017879|FG002|Induction Phase|Physician Decision|1|||
126200147|NCT02394028|454017880|FG003|Induction Phase|Physician Decision|4|||
126200148|NCT02394028|454017881|FG004|Induction Phase|Physician Decision|0|||
126200149|NCT02394028|454017882|FG005|Induction Phase|Physician Decision|2|||
126200150|NCT02394028|454017883|FG006|Induction Phase|Physician Decision|1|||
126200151|NCT02394028|454017884|FG007|Induction Phase|Physician Decision|0|||
126200152|NCT02394028|454017885|FG008|Induction Phase|Physician Decision|0|||
126200153|NCT02394028|454017886|FG009|Induction Phase|Physician Decision|0|||
126200154|NCT02394028|454017887|FG010|Induction Phase|Physician Decision|0|||
126200155|NCT02394028|454017877|FG000|Induction Phase|Protocol Violation|0|||
126200156|NCT02394028|454017878|FG001|Induction Phase|Protocol Violation|2|||
126200157|NCT02394028|454017879|FG002|Induction Phase|Protocol Violation|0|||
126200158|NCT02394028|454017880|FG003|Induction Phase|Protocol Violation|3|||
126200159|NCT02394028|454017881|FG004|Induction Phase|Protocol Violation|0|||
126200160|NCT02394028|454017882|FG005|Induction Phase|Protocol Violation|1|||
126200161|NCT02394028|454017883|FG006|Induction Phase|Protocol Violation|1|||
126200162|NCT02394028|454017884|FG007|Induction Phase|Protocol Violation|0|||
126200163|NCT02394028|454017885|FG008|Induction Phase|Protocol Violation|0|||
126200164|NCT02394028|454017886|FG009|Induction Phase|Protocol Violation|0|||
126200165|NCT02394028|454017887|FG010|Induction Phase|Protocol Violation|0|||
126200166|NCT02394028|454017877|FG000|Induction Phase|Withdrawal by Subject|1|||
126200167|NCT02394028|454017878|FG001|Induction Phase|Withdrawal by Subject|2|||
126200168|NCT02394028|454017879|FG002|Induction Phase|Withdrawal by Subject|4|||
126200169|NCT02394028|454017880|FG003|Induction Phase|Withdrawal by Subject|6|||
126200170|NCT02394028|454017881|FG004|Induction Phase|Withdrawal by Subject|7|||
126200171|NCT02394028|454017882|FG005|Induction Phase|Withdrawal by Subject|4|||
126200172|NCT02394028|454017883|FG006|Induction Phase|Withdrawal by Subject|3|||
126200173|NCT02394028|454017884|FG007|Induction Phase|Withdrawal by Subject|6|||
126200174|NCT02394028|454017885|FG008|Induction Phase|Withdrawal by Subject|0|||
126103544|NCT00887432|453672187|FG000|Overall Study|Start Excluded Therapy|3|||
126103545|NCT00887432|453672188|FG001|Overall Study|Start Excluded Therapy|0|||
126103546|NCT00887432|453672187|FG000|Overall Study|Did not complete treatment|6|||
126103547|NCT00887432|453672188|FG001|Overall Study|Did not complete treatment|8|||
126306977|NCT02587598|454411969|FG009|Overall Study|Reason for study withdrawal not specified|0|||
126306978|NCT02587598|454411970|FG010|Overall Study|Reason for study withdrawal not specified|0|||
126306979|NCT02587598|454411960|FG000|Overall Study|Withdrawal by Subject|0|||
126103548|NCT00887432|453672187|FG000|Overall Study|Protocol Violation|2|||
126103549|NCT00887432|453672188|FG001|Overall Study|Protocol Violation|3|||
126306980|NCT02587598|454411961|FG001|Overall Study|Withdrawal by Subject|1|||
126306981|NCT02587598|454411962|FG002|Overall Study|Withdrawal by Subject|0|||
126306982|NCT02587598|454411963|FG003|Overall Study|Withdrawal by Subject|2|||
126306983|NCT02587598|454411964|FG004|Overall Study|Withdrawal by Subject|3|||
126306984|NCT02587598|454411965|FG005|Overall Study|Withdrawal by Subject|1|||
126306985|NCT02587598|454411966|FG006|Overall Study|Withdrawal by Subject|0|||
126306986|NCT02587598|454411967|FG007|Overall Study|Withdrawal by Subject|0|||
126306987|NCT02587598|454411968|FG008|Overall Study|Withdrawal by Subject|0|||
126306988|NCT02587598|454411969|FG009|Overall Study|Withdrawal by Subject|1|||
126306989|NCT02587598|454411970|FG010|Overall Study|Withdrawal by Subject|2|||
126306990|NCT02587598|454411960|FG000|Overall Study|Physician Decision|0|||
126306991|NCT02587598|454411961|FG001|Overall Study|Physician Decision|0|||
126306992|NCT02587598|454411962|FG002|Overall Study|Physician Decision|0|||
126306993|NCT02587598|454411963|FG003|Overall Study|Physician Decision|0|||
126306994|NCT02587598|454411964|FG004|Overall Study|Physician Decision|0|||
126306995|NCT02587598|454411965|FG005|Overall Study|Physician Decision|0|||
126306996|NCT02587598|454411966|FG006|Overall Study|Physician Decision|0|||
126306997|NCT02587598|454411967|FG007|Overall Study|Physician Decision|0|||
126306998|NCT02587598|454411968|FG008|Overall Study|Physician Decision|0|||
126306999|NCT02587598|454411969|FG009|Overall Study|Physician Decision|0|||
126307000|NCT02587598|454411970|FG010|Overall Study|Physician Decision|3|||
126307001|NCT00355147|454411975|FG000|Overall Study|Lost to Follow-up|10|||
126307002|NCT00355147|454411976|FG001|Overall Study|Lost to Follow-up|8|||
126307003|NCT00355147|454411975|FG000|Overall Study|Withdrawal by Subject|8|||
126307004|NCT00355147|454411976|FG001|Overall Study|Withdrawal by Subject|12|||
126307005|NCT02353442|454411977|FG000|Overall Study|Withdrawal by Subject|3|||
126307006|NCT02353442|454411978|FG001|Overall Study|Withdrawal by Subject|4|||
126307007|NCT06586788|454411980|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
126307008|NCT03514485|454411981|FG000|Overall Study|Lost to Follow-up|5|||
126307009|NCT03514485|454411982|FG001|Overall Study|Lost to Follow-up|3|||
126307010|NCT03514485|454411983|FG002|Overall Study|Lost to Follow-up|2|||
126307011|NCT03514485|454411984|FG003|Overall Study|Lost to Follow-up|0|||
126307012|NCT03514485|454411985|FG004|Overall Study|Lost to Follow-up|1|||
126307013|NCT03514485|454411986|FG005|Overall Study|Lost to Follow-up|4|||
126307014|NCT03514485|454411981|FG000|Overall Study|Withdrawal by Subject|0|||
126307015|NCT03514485|454411982|FG001|Overall Study|Withdrawal by Subject|1|||
126307016|NCT03514485|454411983|FG002|Overall Study|Withdrawal by Subject|3|||
126307017|NCT03514485|454411984|FG003|Overall Study|Withdrawal by Subject|1|||
126307018|NCT03514485|454411985|FG004|Overall Study|Withdrawal by Subject|2|||
126307019|NCT03514485|454411986|FG005|Overall Study|Withdrawal by Subject|1|||
126307020|NCT00791661|454411987|FG000|7 Day Wash-out|Adverse Event|0|||
126307021|NCT00791661|454411988|FG001|7 Day Wash-out|Adverse Event|0|||
126307022|NCT00791661|454411989|FG002|7 Day Wash-out|Adverse Event|1|||
126307023|NCT00791661|454411987|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
126307024|NCT00791661|454411988|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
126307025|NCT00791661|454411989|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
126307026|NCT00679289|454411990|FG000|Overall Study|Progressive disease|4|||
126307027|NCT00679289|454411991|FG001|Overall Study|Progressive disease|5|||
126307028|NCT00679289|454411992|FG002|Overall Study|Progressive disease|18|||
126307029|NCT00679289|454411990|FG000|Overall Study|Withdrawal by Subject|0|||
126307030|NCT00679289|454411991|FG001|Overall Study|Withdrawal by Subject|1|||
126307031|NCT00679289|454411992|FG002|Overall Study|Withdrawal by Subject|1|||
126307032|NCT00679289|454411990|FG000|Overall Study|Adverse Event|0|||
126307033|NCT00679289|454411991|FG001|Overall Study|Adverse Event|0|||
126307034|NCT00679289|454411992|FG002|Overall Study|Adverse Event|3|||
126307035|NCT00679289|454411990|FG000|Overall Study|Physician Decision|1|||
126307036|NCT00679289|454411991|FG001|Overall Study|Physician Decision|0|||
126307037|NCT00679289|454411992|FG002|Overall Study|Physician Decision|1|||
126307038|NCT01355575|454411994|FG000|Overall Study|Withdrawal by Subject|2|||
126307039|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
126307040|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
126307041|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
126307042|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126370517|NCT04067011|454653654|FG001|Overall Study|Adverse Event|1|||
126370518|NCT04067011|454653655|FG002|Overall Study|Adverse Event|0|||
126103550|NCT00887432|453672187|FG000|Overall Study|Withdrawal by Subject|3|||
126103551|NCT00887432|453672188|FG001|Overall Study|Withdrawal by Subject|2|||
126370519|NCT04067011|454653653|FG000|Overall Study|Withdrawal by Subject|6|||
126370520|NCT04067011|454653654|FG001|Overall Study|Withdrawal by Subject|2|||
126370521|NCT04067011|454653655|FG002|Overall Study|Withdrawal by Subject|1|||
126370522|NCT04067011|454653653|FG000|Overall Study|Lost to Follow-up|0|||
126370523|NCT04067011|454653654|FG001|Overall Study|Lost to Follow-up|0|||
126370524|NCT04067011|454653655|FG002|Overall Study|Lost to Follow-up|1|||
126370525|NCT04067011|454653653|FG000|Overall Study|Physician Decision|1|||
126370526|NCT04067011|454653654|FG001|Overall Study|Physician Decision|1|||
126103552|NCT00887432|453672187|FG000|Overall Study|Lost to Follow-up|1|||
126103553|NCT00887432|453672188|FG001|Overall Study|Lost to Follow-up|0|||
126103554|NCT00887432|453672187|FG000|Overall Study|No reason provided|0|||
126103555|NCT00887432|453672188|FG001|Overall Study|No reason provided|1|||
126103556|NCT00899548|453672189|FG000|Overall Study|Physician Decision|3|||
126103557|NCT01636960|453672190|FG000|Induction Phase|Adverse Event|2|||
126103558|NCT01636960|453672190|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
126103559|NCT01636960|453672190|FG000|Maintenance Phase|Adverse Event|3|||
126103560|NCT01636960|453672190|FG000|Maintenance Phase|Progressive disease|1|||
126103561|NCT01580969|453672193|FG000|Overall Study|Physician Decision|3|||
126103562|NCT01580969|453672194|FG001|Overall Study|Physician Decision|0|||
126103563|NCT01580969|453672195|FG002|Overall Study|Physician Decision|0|||
126103564|NCT01209780|453672196|FG000|Overall Study|Adverse Event|0|||
126370527|NCT04067011|454653655|FG002|Overall Study|Physician Decision|0|||
126370528|NCT04067011|454653653|FG000|Overall Study|Other Reasons|2|||
126370529|NCT04067011|454653654|FG001|Overall Study|Other Reasons|0|||
126370530|NCT04067011|454653655|FG002|Overall Study|Other Reasons|1|||
126103565|NCT01209780|453672197|FG001|Overall Study|Adverse Event|1|||
125885456|NCT02745119|452876850|FG000|Overall Study|Physician Decision|0|||
126103566|NCT01209780|453672198|FG002|Overall Study|Adverse Event|0|||
126103567|NCT01209780|453672199|FG003|Overall Study|Adverse Event|0|||
126103568|NCT01209780|453672200|FG004|Overall Study|Adverse Event|0|||
126200328|NCT03758612|454019414|FG006|Period 2|Protocol Violation|0|||
126200329|NCT03758612|454019415|FG007|Period 2|Protocol Violation|0|||
126200330|NCT03758612|454019416|FG008|Period 2|Protocol Violation|0|||
126200331|NCT03758612|454019417|FG009|Period 2|Protocol Violation|0|||
126200332|NCT03758612|454019418|FG010|Period 2|Protocol Violation|0|||
126200333|NCT03758612|454019419|FG011|Period 2|Protocol Violation|0|||
126200334|NCT01603615|454019421|FG000|Overall Study|Did not Receive Treatment|7|||
126200335|NCT01603615|454019421|FG000|Overall Study|Lost to Follow-up|9|||
126200336|NCT01603615|454019421|FG000|Overall Study|Personal Reasons|17|||
126200337|NCT01603615|454019421|FG000|Overall Study|Other Miscellaneous|1|||
126200338|NCT03419741|454019422|FG000|Overall Study|Adverse Event|1|||
126200339|NCT03419741|454019423|FG001|Overall Study|Adverse Event|0|||
126200340|NCT03419741|454019422|FG000|Overall Study|Withdrawal by Subject|1|||
126200341|NCT03419741|454019423|FG001|Overall Study|Withdrawal by Subject|2|||
126200342|NCT04354870|454019424|FG000|Overall Study|Lost to Follow-up|32|||
126200343|NCT04354870|454019425|FG001|Overall Study|Lost to Follow-up|12|||
126200344|NCT04354870|454019424|FG000|Overall Study|Withdrawal by Subject|10|||
126200345|NCT04354870|454019425|FG001|Overall Study|Withdrawal by Subject|16|||
126200346|NCT04354870|454019424|FG000|Overall Study|Did not complete all study visits|6|||
126200347|NCT04354870|454019425|FG001|Overall Study|Did not complete all study visits|5|||
126200348|NCT03384316|454019426|FG000|Overall Study|Screen failure|0|||
126200349|NCT03384316|454019427|FG001|Overall Study|Screen failure|1|||
126200350|NCT02194699|454019437|FG000|Randomised|Did not receive treatment|1|||
126370531|NCT04067011|454653653|FG000|Overall Study|Missing|0|||
126370532|NCT04067011|454653654|FG001|Overall Study|Missing|2|||
126370533|NCT04067011|454653655|FG002|Overall Study|Missing|0|||
126370534|NCT05209386|454653656|FG000|Overall Study|Withdrawal by Subject|8|||
126370535|NCT05209386|454653656|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
126370536|NCT04462471|454653657|FG000|Overall Study|Adverse Event|0|||
126370537|NCT04462471|454653658|FG001|Overall Study|Adverse Event|1|||
126370538|NCT04462471|454653659|FG002|Overall Study|Adverse Event|0|||
126370539|NCT04462471|454653660|FG003|Overall Study|Adverse Event|0|||
126370540|NCT04462471|454653657|FG000|Overall Study|Disease progression|1|||
126370541|NCT04462471|454653658|FG001|Overall Study|Disease progression|0|||
126046780|NCT04518943|453469672|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
126046781|NCT03699163|453469673|FG000|Overall Study|Physician Decision|12|||
126046782|NCT03699163|453469674|FG001|Overall Study|Physician Decision|0|||
126046783|NCT03699163|453469673|FG000|Overall Study|failed QC measures|205|||
126046784|NCT03699163|453469674|FG001|Overall Study|failed QC measures|206|||
126046785|NCT03705390|453469687|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
126046786|NCT03705390|453469687|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
126046787|NCT04495621|453469688|FG000|Overall Study|Withdrawal by Subject|0|||
126046788|NCT04495621|453469689|FG001|Overall Study|Withdrawal by Subject|3|||
126046789|NCT04495621|453469688|FG000|Overall Study|Death|7|||
126046790|NCT04495621|453469689|FG001|Overall Study|Death|11|||
126046791|NCT04495621|453469688|FG000|Overall Study|Investigator Decision|0|||
126046792|NCT04495621|453469689|FG001|Overall Study|Investigator Decision|7|||
126046793|NCT04495621|453469688|FG000|Overall Study|Lost to Follow-up|0|||
126046794|NCT04495621|453469689|FG001|Overall Study|Lost to Follow-up|1|||
126046795|NCT02701283|453469695|FG000|Overall Study|Death|25|||
126046796|NCT02701283|453469696|FG001|Overall Study|Death|29|||
126046797|NCT02701283|453469697|FG002|Overall Study|Death|19|||
126046798|NCT02701283|453469695|FG000|Overall Study|Lost to Follow-up|3|||
126046799|NCT02701283|453469696|FG001|Overall Study|Lost to Follow-up|8|||
126046800|NCT02701283|453469697|FG002|Overall Study|Lost to Follow-up|1|||
126046801|NCT02701283|453469695|FG000|Overall Study|Withdrawal by Subject|12|||
126046802|NCT02701283|453469696|FG001|Overall Study|Withdrawal by Subject|41|||
126046803|NCT02701283|453469697|FG002|Overall Study|Withdrawal by Subject|1|||
126046804|NCT02701283|453469695|FG000|Overall Study|Missed 2-year visit|22|||
126046805|NCT02701283|453469696|FG001|Overall Study|Missed 2-year visit|27|||
126046806|NCT02701283|453469697|FG002|Overall Study|Missed 2-year visit|0|||
126046807|NCT02701283|453469695|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
126046808|NCT02701283|453469696|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
126046809|NCT02701283|453469697|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
126046810|NCT01830595|453469701|FG000|First Period|Withdrawal by Subject|1|||
126046811|NCT01830595|453469702|FG001|First Period|Withdrawal by Subject|3|||
126046812|NCT01830595|453469701|FG000|Washout|Withdrawal by Subject|2|||
126046813|NCT01830595|453469702|FG001|Washout|Withdrawal by Subject|2|||
126046814|NCT04940624|453469703|FG000|Overall Study|Adverse Event|4|||
126046815|NCT04940624|453469704|FG001|Overall Study|Adverse Event|11|||
126046816|NCT04940624|453469703|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126046817|NCT04940624|453469704|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126046818|NCT04940624|453469703|FG000|Overall Study|Physician Decision|1|||
126046819|NCT04940624|453469704|FG001|Overall Study|Physician Decision|0|||
126046820|NCT04940624|453469703|FG000|Overall Study|Lost to Follow-up|1|||
126046821|NCT04940624|453469704|FG001|Overall Study|Lost to Follow-up|0|||
126046822|NCT04940624|453469703|FG000|Overall Study|Reason Not Specified|1|||
126046823|NCT04940624|453469704|FG001|Overall Study|Reason Not Specified|0|||
126046824|NCT04479787|453469705|FG000|Through 6 Months|Withdrawal by Subject|16|||
126046825|NCT04479787|453469706|FG001|Through 6 Months|Withdrawal by Subject|14|||
126046826|NCT04479787|453469705|FG000|Through 6 Months|Unsuccessful Trial|17|||
126046827|NCT04479787|453469706|FG001|Through 6 Months|Unsuccessful Trial|0|||
126046828|NCT04479787|453469705|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
126370542|NCT04462471|454653659|FG002|Overall Study|Disease progression|0|||
126370543|NCT04462471|454653660|FG003|Overall Study|Disease progression|0|||
126370544|NCT01121757|454653666|FG000|First Drug|Death|1|||
126370545|NCT01121757|454653667|FG001|First Drug|Death|0|||
126370546|NCT01121757|454653666|FG000|First Drug|Disease Progression|0|||
126370547|NCT01121757|454653667|FG001|First Drug|Disease Progression|2|||
126370548|NCT01121757|454653666|FG000|Combination|Physician Decision|0|||
126046829|NCT04479787|453469706|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
126046830|NCT04479787|453469705|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
126046831|NCT04479787|453469706|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
126046832|NCT04479787|453469705|FG000|Through 6 Months|Lost to Follow-up|3|||
126046833|NCT04479787|453469706|FG001|Through 6 Months|Lost to Follow-up|2|||
126046834|NCT04479787|453469705|FG000|Through 6 Months|Death|3|||
126370549|NCT01121757|454653667|FG001|Combination|Physician Decision|1|||
126307043|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
126307044|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126307045|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126307046|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126307047|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
126046835|NCT04479787|453469706|FG001|Through 6 Months|Death|0|||
126046836|NCT04479787|453469705|FG000|Through 6 Months|Inclusion/Exclusion|2|||
126046837|NCT04479787|453469706|FG001|Through 6 Months|Inclusion/Exclusion|1|||
126046838|NCT04479787|453469705|FG000|Through 6 Months|Subject Became Pregnant|1|||
126046839|NCT04479787|453469706|FG001|Through 6 Months|Subject Became Pregnant|1|||
126046840|NCT04479787|453469705|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
126046841|NCT04479787|453469706|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
126046842|NCT04479787|453469705|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
126046843|NCT04479787|453469706|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
126046844|NCT04479787|453469705|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
126046845|NCT04479787|453469706|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
126046846|NCT04479787|453469705|FG000|After 6 Months|Withdrawal by Subject|3|||
126046847|NCT04479787|453469706|FG001|After 6 Months|Withdrawal by Subject|13|||
126046848|NCT04479787|453469705|FG000|After 6 Months|Unsuccessful Trial|0|||
126046849|NCT04479787|453469706|FG001|After 6 Months|Unsuccessful Trial|7|||
126046850|NCT04479787|453469705|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
126046851|NCT04479787|453469706|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
126046852|NCT04479787|453469705|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
126046853|NCT04479787|453469706|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
126307048|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
126307049|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126307050|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126307051|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
126307052|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
126307053|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
126307054|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
126307055|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
126307056|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
126307057|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
126307058|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
126307059|NCT02438826|454411996|FG000|Open-Label Treatment Phase|Adverse Event|11|||
126307060|NCT02438826|454411997|FG001|Open-Label Treatment Phase|Adverse Event|6|||
126307061|NCT02438826|454411998|FG002|Open-Label Treatment Phase|Adverse Event|0|||
126307062|NCT02438826|454411999|FG003|Open-Label Treatment Phase|Adverse Event|0|||
126307063|NCT02438826|454411996|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
126307064|NCT02438826|454411997|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
126307065|NCT02438826|454411998|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
126307066|NCT02438826|454411999|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
126307067|NCT02438826|454411996|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
126307068|NCT02438826|454411997|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
126307069|NCT02438826|454411998|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
126307070|NCT02438826|454411999|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
126307071|NCT02438826|454411996|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
126307072|NCT02438826|454411997|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
126307073|NCT02438826|454411998|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
126307074|NCT02438826|454411999|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
126307075|NCT02438826|454411996|FG000|Post-Treatment Phase|Adverse Event|3|||
126307076|NCT02438826|454411997|FG001|Post-Treatment Phase|Adverse Event|0|||
126307077|NCT02438826|454411998|FG002|Post-Treatment Phase|Adverse Event|0|||
126307078|NCT02438826|454411999|FG003|Post-Treatment Phase|Adverse Event|0|||
126307079|NCT02438826|454411996|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
126307080|NCT02438826|454411997|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
126370550|NCT01121757|454653666|FG000|Combination|Disease Progression|2|||
126046854|NCT04479787|453469705|FG000|After 6 Months|Death|2|||
126046855|NCT04479787|453469706|FG001|After 6 Months|Death|0|||
126046856|NCT04479787|453469705|FG000|After 6 Months|Lost to Follow-up|1|||
126046857|NCT04479787|453469706|FG001|After 6 Months|Lost to Follow-up|1|||
126046858|NCT04479787|453469705|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
126307081|NCT02438826|454411998|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
126307082|NCT02438826|454411999|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
126370551|NCT01121757|454653667|FG001|Combination|Disease Progression|0|||
126307083|NCT02438826|454411996|FG000|Post-Treatment Phase|Physician Decision|1|||
126307084|NCT02438826|454411997|FG001|Post-Treatment Phase|Physician Decision|0|||
126307085|NCT02438826|454411998|FG002|Post-Treatment Phase|Physician Decision|0|||
126307086|NCT02438826|454411999|FG003|Post-Treatment Phase|Physician Decision|0|||
126307087|NCT02438826|454411996|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
126103569|NCT01209780|453672196|FG000|Overall Study|Withdrawal by Subject|9|||
126103570|NCT01209780|453672197|FG001|Overall Study|Withdrawal by Subject|2|||
126103571|NCT01209780|453672198|FG002|Overall Study|Withdrawal by Subject|1|||
126103572|NCT01209780|453672199|FG003|Overall Study|Withdrawal by Subject|1|||
126103573|NCT01209780|453672200|FG004|Overall Study|Withdrawal by Subject|0|||
126103574|NCT01209780|453672196|FG000|Overall Study|Lost to Follow-up|17|||
126103575|NCT01209780|453672197|FG001|Overall Study|Lost to Follow-up|12|||
126046859|NCT04479787|453469706|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
126046860|NCT04479787|453469705|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
126046861|NCT04479787|453469706|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
126046862|NCT04479787|453469705|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
126046863|NCT04479787|453469706|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
126046864|NCT04479787|453469705|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
126046865|NCT04479787|453469706|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
126046866|NCT05039021|453470345|FG000|Overall Study|Death|1|||
126046867|NCT05039021|453470345|FG000|Overall Study|Lost to Follow-up|3|||
126046868|NCT03653364|453470346|FG000|Overall Study|Withdrawal by Subject|1|||
126046869|NCT03653364|453470346|FG000|Overall Study|Enrolled in Error|1|||
126046870|NCT03653364|453470346|FG000|Overall Study|Death|1|||
126046871|NCT03213457|453470347|FG000|Screening Period|Withdrawal by Subject|0|||
126046872|NCT03213457|453470348|FG001|Screening Period|Withdrawal by Subject|1|||
126046873|NCT03213457|453470349|FG002|Screening Period|Withdrawal by Subject|0|||
126046874|NCT03213457|453470347|FG000|Screening Period|Other|1|||
126046875|NCT03213457|453470348|FG001|Screening Period|Other|0|||
126046876|NCT03213457|453470349|FG002|Screening Period|Other|0|||
126046877|NCT03213457|453470347|FG000|Double-Blind Period|Adverse Event|3|||
126046878|NCT03213457|453470348|FG001|Double-Blind Period|Adverse Event|2|||
126046879|NCT03213457|453470349|FG002|Double-Blind Period|Adverse Event|7|||
126046880|NCT03213457|453470347|FG000|Double-Blind Period|Withdrawal by Subject|14|||
126046881|NCT03213457|453470348|FG001|Double-Blind Period|Withdrawal by Subject|2|||
126046882|NCT03213457|453470349|FG002|Double-Blind Period|Withdrawal by Subject|14|||
126046883|NCT03213457|453470347|FG000|Double-Blind Period|Lost to Follow-up|2|||
126046884|NCT03213457|453470348|FG001|Double-Blind Period|Lost to Follow-up|3|||
126046885|NCT03213457|453470349|FG002|Double-Blind Period|Lost to Follow-up|9|||
126046886|NCT03213457|453470347|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
126046887|NCT03213457|453470348|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
126046888|NCT03213457|453470349|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
126046889|NCT03213457|453470347|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
126046890|NCT03213457|453470348|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
126046891|NCT03213457|453470349|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
126046892|NCT03213457|453470347|FG000|Double-Blind Period|Pregnancy|5|||
126046893|NCT03213457|453470348|FG001|Double-Blind Period|Pregnancy|0|||
126046894|NCT03213457|453470349|FG002|Double-Blind Period|Pregnancy|0|||
126046895|NCT03213457|453470347|FG000|Double-Blind Period|Other|10|||
126046896|NCT03213457|453470348|FG001|Double-Blind Period|Other|3|||
126046897|NCT03213457|453470349|FG002|Double-Blind Period|Other|17|||
126046898|NCT03213457|453470347|FG000|Open-Label Period|Adverse Event|1|||
126046899|NCT03213457|453470348|FG001|Open-Label Period|Adverse Event|2|||
126046900|NCT03213457|453470349|FG002|Open-Label Period|Adverse Event|2|||
126046901|NCT03213457|453470347|FG000|Open-Label Period|Withdrawal by Subject|12|||
126046902|NCT03213457|453470348|FG001|Open-Label Period|Withdrawal by Subject|5|||
126046903|NCT03213457|453470349|FG002|Open-Label Period|Withdrawal by Subject|24|||
126046904|NCT03213457|453470347|FG000|Open-Label Period|Lost to Follow-up|1|||
126046905|NCT03213457|453470348|FG001|Open-Label Period|Lost to Follow-up|2|||
126046906|NCT03213457|453470349|FG002|Open-Label Period|Lost to Follow-up|8|||
126046907|NCT03213457|453470347|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
126046908|NCT03213457|453470348|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
126046909|NCT03213457|453470349|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
126046910|NCT03213457|453470347|FG000|Open-Label Period|Non-compliance with study procedures|1|||
126046911|NCT03213457|453470348|FG001|Open-Label Period|Non-compliance with study procedures|1|||
126046912|NCT03213457|453470349|FG002|Open-Label Period|Non-compliance with study procedures|2|||
126046913|NCT03213457|453470347|FG000|Open-Label Period|Exclusionary medications|0|||
126046914|NCT03213457|453470348|FG001|Open-Label Period|Exclusionary medications|0|||
126046915|NCT03213457|453470349|FG002|Open-Label Period|Exclusionary medications|1|||
126046916|NCT03213457|453470347|FG000|Open-Label Period|Other|1|||
126046917|NCT03213457|453470348|FG001|Open-Label Period|Other|1|||
126046918|NCT03213457|453470349|FG002|Open-Label Period|Other|6|||
126046919|NCT03213457|453470347|FG000|Follow-Up Period|Adverse Event|16|||
126046920|NCT03213457|453470348|FG001|Follow-Up Period|Adverse Event|8|||
126103576|NCT01209780|453672198|FG002|Overall Study|Lost to Follow-up|3|||
126103577|NCT01209780|453672199|FG003|Overall Study|Lost to Follow-up|9|||
126103578|NCT01209780|453672200|FG004|Overall Study|Lost to Follow-up|4|||
126103579|NCT01209780|453672196|FG000|Overall Study|Protocol Violation|0|||
126103580|NCT01209780|453672197|FG001|Overall Study|Protocol Violation|1|||
126103581|NCT01209780|453672198|FG002|Overall Study|Protocol Violation|0|||
126103582|NCT01209780|453672199|FG003|Overall Study|Protocol Violation|0|||
126103583|NCT01209780|453672200|FG004|Overall Study|Protocol Violation|0|||
126103584|NCT01209780|453672196|FG000|Overall Study|Inappropriate enrollment|0|||
126103585|NCT01209780|453672197|FG001|Overall Study|Inappropriate enrollment|2|||
126103586|NCT01209780|453672198|FG002|Overall Study|Inappropriate enrollment|0|||
126103587|NCT01209780|453672199|FG003|Overall Study|Inappropriate enrollment|0|||
126103588|NCT01209780|453672200|FG004|Overall Study|Inappropriate enrollment|1|||
126103589|NCT02709096|453672206|FG000|Overall Study|non-compliance|1|||
126103590|NCT02709096|453672207|FG001|Overall Study|non-compliance|1|||
126103591|NCT00511472|453672208|FG000|Overall Study|Clinical Adverse Event|1|||
126103592|NCT00511472|453672209|FG001|Overall Study|Clinical Adverse Event|2|||
126103593|NCT00511472|453672208|FG000|Overall Study|Laboratory Adverse Event|0|||
126103594|NCT00511472|453672209|FG001|Overall Study|Laboratory Adverse Event|2|||
126103595|NCT00511472|453672208|FG000|Overall Study|Not reported|2|||
126103596|NCT00511472|453672209|FG001|Overall Study|Not reported|2|||
126103597|NCT00505284|453672210|FG000|Overall Study|Adverse Event|3|||
126103598|NCT00505284|453672211|FG001|Overall Study|Adverse Event|7|||
126103599|NCT00505284|453672212|FG002|Overall Study|Adverse Event|9|||
126103600|NCT00505284|453672213|FG003|Overall Study|Adverse Event|14|||
126103601|NCT00505284|453672214|FG004|Overall Study|Adverse Event|22|||
126103602|NCT00505284|453672210|FG000|Overall Study|Protocol Violation|0|||
126103603|NCT00505284|453672211|FG001|Overall Study|Protocol Violation|1|||
126103604|NCT00505284|453672212|FG002|Overall Study|Protocol Violation|1|||
126103605|NCT00505284|453672213|FG003|Overall Study|Protocol Violation|0|||
126103606|NCT00505284|453672214|FG004|Overall Study|Protocol Violation|0|||
126103607|NCT00505284|453672210|FG000|Overall Study|Withdrawal by Subject|2|||
126103608|NCT00505284|453672211|FG001|Overall Study|Withdrawal by Subject|6|||
126103609|NCT00505284|453672212|FG002|Overall Study|Withdrawal by Subject|1|||
126103610|NCT00505284|453672213|FG003|Overall Study|Withdrawal by Subject|0|||
126103611|NCT00505284|453672214|FG004|Overall Study|Withdrawal by Subject|6|||
126103612|NCT00505284|453672210|FG000|Overall Study|Lack of Efficacy|0|||
126103613|NCT00505284|453672211|FG001|Overall Study|Lack of Efficacy|1|||
126103614|NCT00505284|453672212|FG002|Overall Study|Lack of Efficacy|1|||
126103615|NCT00505284|453672213|FG003|Overall Study|Lack of Efficacy|1|||
126103616|NCT00505284|453672214|FG004|Overall Study|Lack of Efficacy|1|||
126103617|NCT00505284|453672210|FG000|Overall Study|Physician Decision|0|||
126103618|NCT00505284|453672211|FG001|Overall Study|Physician Decision|1|||
126103619|NCT00505284|453672212|FG002|Overall Study|Physician Decision|0|||
126103620|NCT00505284|453672213|FG003|Overall Study|Physician Decision|0|||
126103621|NCT00505284|453672214|FG004|Overall Study|Physician Decision|0|||
126103622|NCT00505284|453672210|FG000|Overall Study|Other|5|||
126046921|NCT03213457|453470349|FG002|Follow-Up Period|Adverse Event|37|||
126046922|NCT03213457|453470347|FG000|Follow-Up Period|Withdrawal by Subject|18|||
126046923|NCT03213457|453470348|FG001|Follow-Up Period|Withdrawal by Subject|11|||
126046924|NCT03213457|453470349|FG002|Follow-Up Period|Withdrawal by Subject|55|||
126046925|NCT03213457|453470347|FG000|Follow-Up Period|Lost to Follow-up|28|||
126046926|NCT03213457|453470348|FG001|Follow-Up Period|Lost to Follow-up|15|||
126046927|NCT03213457|453470349|FG002|Follow-Up Period|Lost to Follow-up|50|||
126046928|NCT03213457|453470347|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
126046929|NCT03213457|453470348|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
126046930|NCT03213457|453470349|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
126046931|NCT03213457|453470347|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
126046932|NCT03213457|453470348|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
126046933|NCT03213457|453470349|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
126046934|NCT03213457|453470347|FG000|Follow-Up Period|Pregnancy|7|||
126046935|NCT03213457|453470348|FG001|Follow-Up Period|Pregnancy|0|||
126046936|NCT03213457|453470349|FG002|Follow-Up Period|Pregnancy|18|||
126103623|NCT00505284|453672211|FG001|Overall Study|Other|0|||
126103624|NCT00505284|453672212|FG002|Overall Study|Other|0|||
126103625|NCT00505284|453672213|FG003|Overall Study|Other|4|||
126103626|NCT00505284|453672214|FG004|Overall Study|Other|4|||
126103627|NCT00731120|453672215|FG000|Overall Study|Adverse Event|7|||
126370552|NCT04251533|454653668|FG000|Overall Study|Progressive disease|33|||
126370553|NCT04251533|454653669|FG001|Overall Study|Progressive disease|29|||
126103628|NCT00731120|453672216|FG001|Overall Study|Adverse Event|6|||
126103629|NCT00731120|453672217|FG002|Overall Study|Adverse Event|8|||
126103630|NCT00731120|453672215|FG000|Overall Study|Lack of Efficacy|4|||
126103631|NCT00731120|453672216|FG001|Overall Study|Lack of Efficacy|5|||
126103632|NCT00731120|453672217|FG002|Overall Study|Lack of Efficacy|4|||
126103633|NCT00731120|453672215|FG000|Overall Study|Noncompliance with Study Drug|3|||
126103634|NCT00731120|453672216|FG001|Overall Study|Noncompliance with Study Drug|3|||
126103635|NCT00731120|453672217|FG002|Overall Study|Noncompliance with Study Drug|1|||
126103636|NCT00731120|453672215|FG000|Overall Study|Protocol Deviations|1|||
126103637|NCT00731120|453672216|FG001|Overall Study|Protocol Deviations|6|||
126103638|NCT00731120|453672217|FG002|Overall Study|Protocol Deviations|1|||
126103639|NCT00731120|453672215|FG000|Overall Study|Withdrawal of Consent|13|||
126103640|NCT00731120|453672216|FG001|Overall Study|Withdrawal of Consent|8|||
126103641|NCT00731120|453672217|FG002|Overall Study|Withdrawal of Consent|4|||
126103642|NCT00731120|453672215|FG000|Overall Study|Lost to Follow-up|10|||
126103643|NCT00731120|453672216|FG001|Overall Study|Lost to Follow-up|15|||
126103644|NCT00731120|453672217|FG002|Overall Study|Lost to Follow-up|17|||
126103645|NCT00731120|453672215|FG000|Overall Study|Other|4|||
126103646|NCT00731120|453672216|FG001|Overall Study|Other|0|||
126103647|NCT00731120|453672217|FG002|Overall Study|Other|1|||
126103648|NCT01551212|453672223|FG000|Overall Study|Graft loss/Retransplantation|0|||
126103649|NCT01551212|453672224|FG001|Overall Study|Graft loss/Retransplantation|1|||
126103650|NCT01551212|453672223|FG000|Overall Study|Administrative problems|1|||
126103651|NCT01551212|453672224|FG001|Overall Study|Administrative problems|2|||
126103652|NCT01551212|453672223|FG000|Overall Study|Lost to Follow-up|0|||
126103653|NCT01551212|453672224|FG001|Overall Study|Lost to Follow-up|1|||
126103654|NCT01551212|453672223|FG000|Overall Study|Protocol Violation|0|||
126103655|NCT01551212|453672224|FG001|Overall Study|Protocol Violation|1|||
126103656|NCT01551212|453672223|FG000|Overall Study|Withdrawal by Subject|0|||
126103657|NCT01551212|453672224|FG001|Overall Study|Withdrawal by Subject|7|||
126103658|NCT01551212|453672223|FG000|Overall Study|Death|2|||
126103659|NCT01551212|453672224|FG001|Overall Study|Death|4|||
126103660|NCT01551212|453672223|FG000|Overall Study|Never Received Study Treatment|2|||
126103661|NCT01551212|453672224|FG001|Overall Study|Never Received Study Treatment|4|||
126103662|NCT00705523|453672225|FG000|Overall Study|Lost to Follow-up|2|||
126103663|NCT00705523|453672226|FG001|Overall Study|Lost to Follow-up|3|||
126103664|NCT03110185|453672229|FG000|Overall Study|Death|0|||
126103665|NCT03110185|453672230|FG001|Overall Study|Death|1|||
126103666|NCT03110185|453672229|FG000|Overall Study|Withdrawal by Subject|2|||
126103667|NCT03110185|453672230|FG001|Overall Study|Withdrawal by Subject|7|||
126103668|NCT03110185|453672229|FG000|Overall Study|Time Constraints|0|||
126103669|NCT03110185|453672230|FG001|Overall Study|Time Constraints|6|||
126103670|NCT03110185|453672229|FG000|Overall Study|Conflict with care|5|||
126103671|NCT03110185|453672230|FG001|Overall Study|Conflict with care|12|||
126103672|NCT03110185|453672229|FG000|Overall Study|Protocol Violation|1|||
126103673|NCT03110185|453672230|FG001|Overall Study|Protocol Violation|4|||
126103674|NCT03110185|453672229|FG000|Overall Study|MRI Incompatible|2|||
126103675|NCT03110185|453672230|FG001|Overall Study|MRI Incompatible|0|||
126103676|NCT03110185|453672229|FG000|Overall Study|Patient Refusal|0|||
126103677|NCT03110185|453672230|FG001|Overall Study|Patient Refusal|1|||
126103678|NCT01050790|453672231|FG000|Overall Study|Adverse Event|1|||
126103679|NCT03705832|453672232|FG000|Overall Study|Physician Decision|0|||
126103680|NCT03705832|453672233|FG001|Overall Study|Physician Decision|1|||
126103681|NCT03705832|453672232|FG000|Overall Study|Withdrawal by Subject|1|||
126103682|NCT03705832|453672233|FG001|Overall Study|Withdrawal by Subject|0|||
126103683|NCT01912456|453673769|FG000|Period 1|Physician Decision|0|||
126103684|NCT01912456|453673770|FG001|Period 1|Physician Decision|0|||
126103685|NCT01912456|453673771|FG002|Period 1|Physician Decision|1|||
126103686|NCT01912456|453673772|FG003|Period 1|Physician Decision|0|||
126103687|NCT01912456|453673769|FG000|Period 1|non-compliance|1|||
126103688|NCT01912456|453673770|FG001|Period 1|non-compliance|0|||
126103689|NCT01912456|453673771|FG002|Period 1|non-compliance|0|||
126103690|NCT01912456|453673772|FG003|Period 1|non-compliance|1|||
126103691|NCT01912456|453673769|FG000|Period 1|Adverse Event|1|||
126103692|NCT01912456|453673770|FG001|Period 1|Adverse Event|0|||
126103693|NCT01912456|453673771|FG002|Period 1|Adverse Event|0|||
126103694|NCT01912456|453673772|FG003|Period 1|Adverse Event|1|||
126103695|NCT01912456|453673769|FG000|Period 1|Withdrawal by Subject|0|||
126103696|NCT01912456|453673770|FG001|Period 1|Withdrawal by Subject|1|||
126103697|NCT01912456|453673771|FG002|Period 1|Withdrawal by Subject|1|||
126103698|NCT01912456|453673772|FG003|Period 1|Withdrawal by Subject|1|||
126103699|NCT01912456|453673769|FG000|Period 2|Lack of Efficacy|0|||
126103700|NCT01912456|453673770|FG001|Period 2|Lack of Efficacy|2|||
126103701|NCT01912456|453673771|FG002|Period 2|Lack of Efficacy|0|||
126103702|NCT01912456|453673772|FG003|Period 2|Lack of Efficacy|0|||
126103703|NCT01912456|453673769|FG000|Period 2|Adverse Event|0|||
126103704|NCT01912456|453673770|FG001|Period 2|Adverse Event|0|||
126103705|NCT01912456|453673771|FG002|Period 2|Adverse Event|0|||
126103706|NCT01912456|453673772|FG003|Period 2|Adverse Event|1|||
126103707|NCT01201343|453673773|FG000|Overall Study|Adverse Event|6|||
126103708|NCT01201343|453673773|FG000|Overall Study|Withdrawal by Subject|5|||
126103709|NCT01201343|453673773|FG000|Overall Study|Lost to Follow-up|2|||
126103710|NCT01201343|453673773|FG000|Overall Study|Lack of Efficacy|2|||
126103711|NCT01201343|453673773|FG000|Overall Study|Participant wrongly included in trial|1|||
126103712|NCT01201343|453673773|FG000|Overall Study|Randomized, not treated|3|||
126103713|NCT02401867|453673782|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
126103714|NCT02401867|453673782|FG000|Analysis|Cervical assay could not be conducted|9|||
125885457|NCT02745119|452876851|FG001|Overall Study|Physician Decision|2|||
126046937|NCT03213457|453470347|FG000|Follow-Up Period|Exclusionary medications|1|||
126046938|NCT03213457|453470348|FG001|Follow-Up Period|Exclusionary medications|1|||
126046939|NCT03213457|453470349|FG002|Follow-Up Period|Exclusionary medications|5|||
126046940|NCT03213457|453470347|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
126046941|NCT03213457|453470348|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
126046942|NCT03213457|453470349|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
126046943|NCT03213457|453470347|FG000|Follow-Up Period|Other|14|||
126046944|NCT03213457|453470348|FG001|Follow-Up Period|Other|10|||
126046945|NCT03213457|453470349|FG002|Follow-Up Period|Other|31|||
126046946|NCT05934292|453470357|FG000|Overall Study|Lost to Follow-up|0|||
126046947|NCT05934292|453470358|FG001|Overall Study|Lost to Follow-up|0|||
126046948|NCT05934292|453470359|FG002|Overall Study|Lost to Follow-up|1|||
126046949|NCT05934292|453470360|FG003|Overall Study|Lost to Follow-up|0|||
126046950|NCT05714059|453470363|FG000|Overall Study|Withdrawal by Subject|2|||
126046951|NCT05714059|453470364|FG001|Overall Study|Withdrawal by Subject|2|||
126046952|NCT05714059|453470363|FG000|Overall Study|Adverse Event|0|||
126046953|NCT05714059|453470364|FG001|Overall Study|Adverse Event|1|||
126046954|NCT05714059|453470363|FG000|Overall Study|Lost to Follow-up|0|||
126046955|NCT05714059|453470364|FG001|Overall Study|Lost to Follow-up|1|||
126046956|NCT05714059|453470363|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
126046957|NCT05714059|453470364|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
126046958|NCT05714059|453470363|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
126046959|NCT05714059|453470364|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
126046960|NCT04899674|453470365|FG000|Test|Adverse Event|1|||
126046961|NCT05116774|453470366|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
126046962|NCT05116774|453470367|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
126046963|NCT05116774|453470366|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
126046964|NCT05116774|453470367|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
126046965|NCT05116774|453470366|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
126046966|NCT05116774|453470367|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
126046967|NCT05116774|453470366|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
126046968|NCT05116774|453470367|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
126046969|NCT03150862|453470369|FG000|Overall Study|Death|2|||
126046970|NCT03150862|453470370|FG001|Overall Study|Death|7|||
126046971|NCT03150862|453470371|FG002|Overall Study|Death|8|||
126046972|NCT03150862|453470372|FG003|Overall Study|Death|27|||
126046973|NCT03150862|453470373|FG004|Overall Study|Death|4|||
126046974|NCT03150862|453470374|FG005|Overall Study|Death|8|||
126046975|NCT03150862|453470375|FG006|Overall Study|Death|6|||
126046976|NCT03150862|453470376|FG007|Overall Study|Death|21|||
126046977|NCT03150862|453470369|FG000|Overall Study|Withdrawal by Subject|1|||
126046978|NCT03150862|453470370|FG001|Overall Study|Withdrawal by Subject|1|||
126046979|NCT03150862|453470371|FG002|Overall Study|Withdrawal by Subject|0|||
126046980|NCT03150862|453470372|FG003|Overall Study|Withdrawal by Subject|3|||
126046981|NCT03150862|453470373|FG004|Overall Study|Withdrawal by Subject|1|||
126046982|NCT03150862|453470374|FG005|Overall Study|Withdrawal by Subject|1|||
126046983|NCT03150862|453470375|FG006|Overall Study|Withdrawal by Subject|1|||
126046984|NCT03150862|453470376|FG007|Overall Study|Withdrawal by Subject|3|||
126046985|NCT03150862|453470369|FG000|Overall Study|Lost to Follow-up|0|||
126046986|NCT03150862|453470370|FG001|Overall Study|Lost to Follow-up|0|||
126046987|NCT03150862|453470371|FG002|Overall Study|Lost to Follow-up|1|||
126046988|NCT03150862|453470372|FG003|Overall Study|Lost to Follow-up|0|||
126046989|NCT03150862|453470373|FG004|Overall Study|Lost to Follow-up|0|||
126046990|NCT03150862|453470374|FG005|Overall Study|Lost to Follow-up|0|||
126046991|NCT03150862|453470375|FG006|Overall Study|Lost to Follow-up|0|||
126046992|NCT03150862|453470376|FG007|Overall Study|Lost to Follow-up|2|||
126046993|NCT03150862|453470369|FG000|Overall Study|Sponsor's decision|0|||
126046994|NCT03150862|453470370|FG001|Overall Study|Sponsor's decision|0|||
126046995|NCT03150862|453470371|FG002|Overall Study|Sponsor's decision|0|||
126046996|NCT03150862|453470372|FG003|Overall Study|Sponsor's decision|10|||
126046997|NCT03150862|453470373|FG004|Overall Study|Sponsor's decision|3|||
126046998|NCT03150862|453470374|FG005|Overall Study|Sponsor's decision|0|||
126046999|NCT03150862|453470375|FG006|Overall Study|Sponsor's decision|1|||
126047000|NCT03150862|453470376|FG007|Overall Study|Sponsor's decision|1|||
126047001|NCT03150862|453470369|FG000|Overall Study|Change in Methylation status|0|||
126047002|NCT03150862|453470370|FG001|Overall Study|Change in Methylation status|0|||
126047003|NCT03150862|453470371|FG002|Overall Study|Change in Methylation status|0|||
126047004|NCT03150862|453470372|FG003|Overall Study|Change in Methylation status|0|||
126047005|NCT03150862|453470373|FG004|Overall Study|Change in Methylation status|1|||
126047006|NCT03150862|453470374|FG005|Overall Study|Change in Methylation status|0|||
126103715|NCT02795429|453673783|FG000|Overall Study|Adverse Event|1|||
125885458|NCT02745119|452876852|FG002|Overall Study|Physician Decision|2|||
126047007|NCT03150862|453470375|FG006|Overall Study|Change in Methylation status|0|||
126103716|NCT02795429|453673784|FG001|Overall Study|Adverse Event|2|||
126103717|NCT02795429|453673785|FG002|Overall Study|Adverse Event|1|||
126047008|NCT03150862|453470376|FG007|Overall Study|Change in Methylation status|0|||
126047009|NCT03150862|453470369|FG000|Overall Study|Roll over in to Long Term Extension|0|||
126047010|NCT03150862|453470370|FG001|Overall Study|Roll over in to Long Term Extension|0|||
126047011|NCT03150862|453470371|FG002|Overall Study|Roll over in to Long Term Extension|0|||
126047012|NCT03150862|453470372|FG003|Overall Study|Roll over in to Long Term Extension|0|||
126103718|NCT02795429|453673786|FG003|Overall Study|Adverse Event|2|||
126047013|NCT03150862|453470373|FG004|Overall Study|Roll over in to Long Term Extension|0|||
126047014|NCT03150862|453470374|FG005|Overall Study|Roll over in to Long Term Extension|0|||
126047015|NCT03150862|453470375|FG006|Overall Study|Roll over in to Long Term Extension|0|||
126047016|NCT03150862|453470376|FG007|Overall Study|Roll over in to Long Term Extension|1|||
126103719|NCT02795429|453673787|FG004|Overall Study|Adverse Event|1|||
126307088|NCT02438826|454411997|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
126307089|NCT02438826|454411998|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
126307090|NCT02438826|454411999|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
126307091|NCT00595517|454412001|FG000|Overall Study|Adverse Event|6|||
126307092|NCT00595517|454412001|FG000|Overall Study|Withdrawal by Subject|4|||
126307093|NCT00595517|454412001|FG000|Overall Study|Protocol Violation|2|||
126307094|NCT00595517|454412001|FG000|Overall Study|Recurrence of ulcer|5|||
126307095|NCT00595517|454412001|FG000|Overall Study|usage of prohibited treatment|1|||
126307096|NCT00595517|454412001|FG000|Overall Study|No intention to attend regularly|1|||
126307097|NCT04105218|454412002|FG000|Overall Study|Withdrawal by Subject|3|||
126307098|NCT04105218|454412003|FG001|Overall Study|Withdrawal by Subject|2|||
126307099|NCT04105218|454412002|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
126307100|NCT04105218|454412003|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
126307101|NCT04105218|454412002|FG000|Overall Study|Failed screening tests|2|||
126307102|NCT04105218|454412003|FG001|Overall Study|Failed screening tests|1|||
126307103|NCT01167881|454412006|FG000|Overall Study|Adverse Event|47|||
126307104|NCT01167881|454412007|FG001|Overall Study|Adverse Event|51|||
126307105|NCT01167881|454412006|FG000|Overall Study|Lack of Efficacy|4|||
126307106|NCT01167881|454412007|FG001|Overall Study|Lack of Efficacy|7|||
126307107|NCT01167881|454412006|FG000|Overall Study|Non compliant with protocol|9|||
126307108|NCT01167881|454412007|FG001|Overall Study|Non compliant with protocol|18|||
126307109|NCT01167881|454412006|FG000|Overall Study|Lost to Follow-up|19|||
126307110|NCT01167881|454412007|FG001|Overall Study|Lost to Follow-up|20|||
126307111|NCT01167881|454412006|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
126307112|NCT01167881|454412007|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
126307113|NCT01167881|454412006|FG000|Overall Study|Not treated|4|||
126307114|NCT01167881|454412007|FG001|Overall Study|Not treated|0|||
126307115|NCT01167881|454412006|FG000|Overall Study|Other not defined above|31|||
126307116|NCT01167881|454412007|FG001|Overall Study|Other not defined above|55|||
126307117|NCT01706939|454412008|FG000|Pre Randomization|Screen Failure|1|||
126307118|NCT01706939|454412009|FG001|Pre Randomization|Screen Failure|0|||
126307119|NCT01706939|454412010|FG002|Pre Randomization|Screen Failure|0|||
126307120|NCT01706939|454412008|FG000|Pre Randomization|Ineligible for Randomization|1|||
126307121|NCT01706939|454412009|FG001|Pre Randomization|Ineligible for Randomization|0|||
126307122|NCT01706939|454412010|FG002|Pre Randomization|Ineligible for Randomization|0|||
126307123|NCT01706939|454412008|FG000|Pre Randomization|Withdrawal by Subject|1|||
126307124|NCT01706939|454412009|FG001|Pre Randomization|Withdrawal by Subject|0|||
126307125|NCT01706939|454412010|FG002|Pre Randomization|Withdrawal by Subject|0|||
126307126|NCT01706939|454412008|FG000|Randomization|Insufficient QoL survey compliance|0|||
126307127|NCT01706939|454412009|FG001|Randomization|Insufficient QoL survey compliance|1|||
126307128|NCT01706939|454412010|FG002|Randomization|Insufficient QoL survey compliance|1|||
126307129|NCT01706939|454412008|FG000|Randomization|Progression of disease|0|||
126307130|NCT01706939|454412009|FG001|Randomization|Progression of disease|2|||
126307131|NCT01706939|454412010|FG002|Randomization|Progression of disease|1|||
126307132|NCT01094301|454412021|FG000|Trial Stage|Withdrawal by Subject|1|||
126047017|NCT03150862|453470369|FG000|Overall Study|Progressive Disease|0|||
126047018|NCT03150862|453470370|FG001|Overall Study|Progressive Disease|0|||
126047019|NCT03150862|453470371|FG002|Overall Study|Progressive Disease|0|||
126047020|NCT03150862|453470372|FG003|Overall Study|Progressive Disease|0|||
126047021|NCT03150862|453470373|FG004|Overall Study|Progressive Disease|0|||
126047022|NCT03150862|453470374|FG005|Overall Study|Progressive Disease|0|||
126047023|NCT03150862|453470375|FG006|Overall Study|Progressive Disease|0|||
126047024|NCT03150862|453470376|FG007|Overall Study|Progressive Disease|2|||
126047025|NCT04158141|453470379|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
126047026|NCT04158141|453470380|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
126047027|NCT04158141|453470381|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
126047028|NCT04158141|453470379|FG000|Step 1: Registration|Adverse Event|1|||
126047029|NCT04158141|453470380|FG001|Step 1: Registration|Adverse Event|0|||
126047030|NCT04158141|453470381|FG002|Step 1: Registration|Adverse Event|0|||
126047031|NCT04158141|453470379|FG000|Step 1: Registration|Withdrawal by Subject|1|||
126047032|NCT04158141|453470380|FG001|Step 1: Registration|Withdrawal by Subject|0|||
126047033|NCT04158141|453470381|FG002|Step 1: Registration|Withdrawal by Subject|0|||
126047034|NCT04158141|453470379|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
126047035|NCT04158141|453470380|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
126047036|NCT04158141|453470381|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
126047037|NCT04505722|453470386|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
126047038|NCT04505722|453470387|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
126307133|NCT01094301|454412021|FG000|Implant Stage|Adverse Event|1|||
126307134|NCT01094301|454412021|FG000|Implant Stage|Protocol Violation|1|||
126307135|NCT01094301|454412021|FG000|Implant Stage|Withdrawal by Subject|2|||
126307136|NCT01094301|454412021|FG000|Implant Stage|No return of pain|4|||
126047039|NCT04505722|453470388|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
126307137|NCT00586820|454412022|FG000|Overall Study|Unsuccessful PCI|1|||
126307138|NCT00586820|454412023|FG001|Overall Study|Unsuccessful PCI|0|||
126047040|NCT04505722|453470386|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
126047041|NCT04505722|453470387|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
126047042|NCT04505722|453470388|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
126047043|NCT04505722|453470386|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
126047044|NCT04505722|453470387|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
126047045|NCT04505722|453470388|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
126047046|NCT04505722|453470386|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
126047047|NCT04505722|453470387|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
126047048|NCT04505722|453470388|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
126047049|NCT04505722|453470386|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
126047050|NCT04505722|453470387|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
126047051|NCT04505722|453470388|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
126047052|NCT04505722|453470386|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
126047053|NCT04505722|453470387|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
126047054|NCT04505722|453470388|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
126047055|NCT04505722|453470386|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
126047056|NCT04505722|453470387|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
126047057|NCT04505722|453470388|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
126047058|NCT04505722|453470386|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
126047059|NCT04505722|453470387|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
126047060|NCT04505722|453470388|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
126047061|NCT04505722|453470386|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
126047062|NCT04505722|453470387|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
126047063|NCT04505722|453470388|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
126047064|NCT04505722|453470386|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
126047065|NCT04505722|453470387|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
126047066|NCT04505722|453470388|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
126047067|NCT04505722|453470386|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
126047068|NCT04505722|453470387|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
126047069|NCT04505722|453470388|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
126047070|NCT04505722|453470386|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
126047071|NCT04505722|453470387|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
126047072|NCT04505722|453470388|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
126307139|NCT03887442|454412024|FG000|Overall Study|Adverse Event|1|||
126307140|NCT03887442|454412025|FG001|Overall Study|Adverse Event|0|||
126103720|NCT02795429|453673783|FG000|Overall Study|Death|1|||
126103721|NCT02795429|453673784|FG001|Overall Study|Death|0|||
126103722|NCT02795429|453673785|FG002|Overall Study|Death|1|||
126103723|NCT02795429|453673786|FG003|Overall Study|Death|2|||
126103724|NCT02795429|453673787|FG004|Overall Study|Death|1|||
126103725|NCT02795429|453673783|FG000|Overall Study|Physician Decision|0|||
126103726|NCT02795429|453673784|FG001|Overall Study|Physician Decision|0|||
126103727|NCT02795429|453673785|FG002|Overall Study|Physician Decision|2|||
126103728|NCT02795429|453673786|FG003|Overall Study|Physician Decision|1|||
126103729|NCT02795429|453673787|FG004|Overall Study|Physician Decision|5|||
126103730|NCT02795429|453673783|FG000|Overall Study|Progressive disease|3|||
126103731|NCT02795429|453673784|FG001|Overall Study|Progressive disease|7|||
126103732|NCT02795429|453673785|FG002|Overall Study|Progressive disease|6|||
126103733|NCT02795429|453673786|FG003|Overall Study|Progressive disease|26|||
126103734|NCT02795429|453673787|FG004|Overall Study|Progressive disease|20|||
126103735|NCT02795429|453673783|FG000|Overall Study|Subject/guardian decision|1|||
126103736|NCT02795429|453673784|FG001|Overall Study|Subject/guardian decision|1|||
126103737|NCT02795429|453673785|FG002|Overall Study|Subject/guardian decision|1|||
126103738|NCT02795429|453673786|FG003|Overall Study|Subject/guardian decision|1|||
126103739|NCT02795429|453673787|FG004|Overall Study|Subject/guardian decision|3|||
126103740|NCT01640054|453673790|FG000|Overall Study|Study-specific disc criteria|1|||
126103741|NCT01640054|453673790|FG000|Overall Study|Lack of Efficacy|3|||
126103742|NCT01640054|453673790|FG000|Overall Study|Adverse Event|2|||
126103743|NCT02080221|453673791|FG000|Overall Study|Withdrawal by Subject|1|||
126103744|NCT02080221|453673791|FG000|Overall Study|Clinical Progression of Disease|1|||
126103745|NCT01386788|453673794|FG000|Overall Study|Lost to Follow-up|2|||
126103746|NCT02808143|453673797|FG000|Maintenance Phase|Disease recurrence|1|||
126103747|NCT02808143|453673798|FG001|Maintenance Phase|Disease recurrence|3|||
126103748|NCT02808143|453673797|FG000|Maintenance Phase|Disease progression|1|||
126103749|NCT02808143|453673798|FG001|Maintenance Phase|Disease progression|2|||
126103750|NCT02808143|453673797|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
126103751|NCT02808143|453673798|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
126103752|NCT02808143|453673797|FG000|Survival Follow-Up|Disease recurrence|0|||
126307141|NCT00686829|454412026|FG000|Overall Study|Adverse Event|5|||
126307142|NCT00686829|454412026|FG000|Overall Study|Lack of Efficacy|6|||
126307143|NCT00686829|454412026|FG000|Overall Study|Lost to Follow-up|4|||
126307144|NCT00686829|454412026|FG000|Overall Study|Withdrawal by Subject|14|||
126307145|NCT00686829|454412026|FG000|Overall Study|Protocol Violation|3|||
126307146|NCT00686829|454412026|FG000|Overall Study|Sponsor discontinued VCV|47|||
126307147|NCT01217476|454412029|FG000|Overall Study|Adverse Event|6|||
126370554|NCT04251533|454653670|FG002|Overall Study|Progressive disease|22|||
126370555|NCT04251533|454653668|FG000|Overall Study|Death|5|||
126370556|NCT04251533|454653669|FG001|Overall Study|Death|1|||
126370557|NCT04251533|454653670|FG002|Overall Study|Death|3|||
126370558|NCT04251533|454653668|FG000|Overall Study|Physician Decision|3|||
126370559|NCT04251533|454653669|FG001|Overall Study|Physician Decision|2|||
126370560|NCT04251533|454653670|FG002|Overall Study|Physician Decision|4|||
126370561|NCT04251533|454653668|FG000|Overall Study|Participant decision|1|||
126370562|NCT04251533|454653669|FG001|Overall Study|Participant decision|3|||
126370563|NCT04251533|454653670|FG002|Overall Study|Participant decision|1|||
126370564|NCT04251533|454653668|FG000|Overall Study|Adverse Event|2|||
126370565|NCT04251533|454653669|FG001|Overall Study|Adverse Event|1|||
126370566|NCT04251533|454653670|FG002|Overall Study|Adverse Event|1|||
126370567|NCT05901636|454653671|FG000|Overall Study|Lost to Follow-up|0|||
126370568|NCT05901636|454653672|FG001|Overall Study|Lost to Follow-up|1|||
126370569|NCT05901636|454653673|FG002|Overall Study|Lost to Follow-up|0|||
126370570|NCT05901636|454653674|FG003|Overall Study|Lost to Follow-up|1|||
126103753|NCT02808143|453673798|FG001|Survival Follow-Up|Disease recurrence|2|||
126103754|NCT02808143|453673797|FG000|Survival Follow-Up|Adverse Event|0|||
126103755|NCT02808143|453673798|FG001|Survival Follow-Up|Adverse Event|1|||
126307148|NCT01217476|454412030|FG001|Overall Study|Adverse Event|1|||
126307149|NCT01217476|454412029|FG000|Overall Study|Physician Decision|0|||
126103756|NCT02808143|453673797|FG000|Survival Follow-Up|Death|1|||
126370571|NCT05901636|454653675|FG004|Overall Study|Lost to Follow-up|1|||
126370572|NCT05901636|454653676|FG005|Overall Study|Lost to Follow-up|3|||
126370573|NCT05901636|454653677|FG006|Overall Study|Lost to Follow-up|1|||
126047073|NCT04505722|453470386|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
126047074|NCT04505722|453470387|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
126047075|NCT04505722|453470388|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
126047076|NCT04505722|453470386|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
126047077|NCT04505722|453470387|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
126047078|NCT04505722|453470388|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
126047079|NCT04505722|453470386|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
126047080|NCT04505722|453470387|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
126047081|NCT04505722|453470388|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
126047082|NCT04755595|453470389|FG000|Overall Study|Lost to Follow-up|1|||
126047083|NCT00319696|453470390|FG000|Overall Study|Adverse Event|36|||
126047084|NCT00319696|453470390|FG000|Overall Study|withdrawal of consent|14|||
126047085|NCT00319696|453470390|FG000|Overall Study|administrative|7|||
126047086|NCT00319696|453470390|FG000|Overall Study|Lost to Follow-up|3|||
126047087|NCT02206828|453470391|FG000|Overall Study|Lost to Follow-up|7|||
126047088|NCT04977583|453471118|FG000|Overall Study|Lost to Follow-up|8|||
126047089|NCT04977583|453471119|FG001|Overall Study|Lost to Follow-up|4|||
126047090|NCT04977583|453471120|FG002|Overall Study|Lost to Follow-up|13|||
126047091|NCT04977583|453471118|FG000|Overall Study|Withdrawal by Subject|3|||
126047092|NCT04977583|453471119|FG001|Overall Study|Withdrawal by Subject|2|||
126047093|NCT04977583|453471120|FG002|Overall Study|Withdrawal by Subject|1|||
126047094|NCT02422615|453471123|FG000|Treatment Period|Progressive disease|314|||
126047095|NCT02422615|453471124|FG001|Treatment Period|Progressive disease|200|||
126047096|NCT02422615|453471123|FG000|Treatment Period|Adverse Event|51|||
126047097|NCT02422615|453471124|FG001|Treatment Period|Adverse Event|9|||
126047098|NCT02422615|453471123|FG000|Treatment Period|Physician Decision|32|||
126047099|NCT02422615|453471124|FG001|Treatment Period|Physician Decision|8|||
126047100|NCT02422615|453471123|FG000|Treatment Period|Subject/guardian decision|38|||
126047101|NCT02422615|453471124|FG001|Treatment Period|Subject/guardian decision|8|||
126047102|NCT02422615|453471123|FG000|Treatment Period|Death|2|||
126047103|NCT02422615|453471124|FG001|Treatment Period|Death|1|||
126047104|NCT02422615|453471123|FG000|Treatment Period|Technical problems|0|||
126047105|NCT02422615|453471124|FG001|Treatment Period|Technical problems|1|||
126047106|NCT02422615|453471123|FG000|Treatment Period|Protocol deviation|1|||
126047107|NCT02422615|453471124|FG001|Treatment Period|Protocol deviation|1|||
126047108|NCT02422615|453471123|FG000|Treatment Period|Study terminated as per protocol|46|||
126047109|NCT02422615|453471124|FG001|Treatment Period|Study terminated as per protocol|14|||
126047110|NCT02422615|453471123|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
126370574|NCT05901636|454653671|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
126370575|NCT05901636|454653672|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
126370576|NCT05901636|454653673|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
126370577|NCT05901636|454653674|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
126370578|NCT05901636|454653675|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
126370579|NCT05901636|454653676|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
126370580|NCT05901636|454653677|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
126370581|NCT05901636|454653671|FG000|Overall Study|Withdrawal by Subject|1|||
126370582|NCT05901636|454653672|FG001|Overall Study|Withdrawal by Subject|1|||
126370583|NCT05901636|454653673|FG002|Overall Study|Withdrawal by Subject|0|||
126370584|NCT05901636|454653674|FG003|Overall Study|Withdrawal by Subject|0|||
126370585|NCT05901636|454653675|FG004|Overall Study|Withdrawal by Subject|1|||
126370586|NCT05901636|454653676|FG005|Overall Study|Withdrawal by Subject|1|||
126370587|NCT05901636|454653677|FG006|Overall Study|Withdrawal by Subject|0|||
126370588|NCT05901636|454653671|FG000|Overall Study|Other|0|||
126370589|NCT05901636|454653672|FG001|Overall Study|Other|0|||
126370590|NCT05901636|454653673|FG002|Overall Study|Other|1|||
126370591|NCT05901636|454653674|FG003|Overall Study|Other|1|||
126370592|NCT05901636|454653675|FG004|Overall Study|Other|0|||
126370593|NCT05901636|454653676|FG005|Overall Study|Other|0|||
126370594|NCT05901636|454653677|FG006|Overall Study|Other|0|||
126370595|NCT04583618|454653678|FG000|Overall Study|Adverse Event|0|||
126370596|NCT04583618|454653679|FG001|Overall Study|Adverse Event|0|||
126370597|NCT04583618|454653680|FG002|Overall Study|Adverse Event|1|||
126370598|NCT04583618|454653681|FG003|Overall Study|Adverse Event|0|||
126370599|NCT04583618|454653682|FG004|Overall Study|Adverse Event|0|||
126370600|NCT04583618|454653678|FG000|Overall Study|Protocol deviation|1|||
126370601|NCT04583618|454653679|FG001|Overall Study|Protocol deviation|1|||
126370602|NCT04583618|454653680|FG002|Overall Study|Protocol deviation|1|||
126370603|NCT04583618|454653681|FG003|Overall Study|Protocol deviation|0|||
126370604|NCT04583618|454653682|FG004|Overall Study|Protocol deviation|0|||
126370605|NCT04583618|454653678|FG000|Overall Study|Withdrawal by Subject|2|||
126370606|NCT04583618|454653679|FG001|Overall Study|Withdrawal by Subject|1|||
126370607|NCT04583618|454653680|FG002|Overall Study|Withdrawal by Subject|3|||
126047111|NCT02422615|453471124|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126370608|NCT04583618|454653681|FG003|Overall Study|Withdrawal by Subject|1|||
126370609|NCT04583618|454653682|FG004|Overall Study|Withdrawal by Subject|1|||
126047112|NCT02422615|453471123|FG000|Post-treatment Efficacy Follow-up|Death|2|||
126047113|NCT02422615|453471124|FG001|Post-treatment Efficacy Follow-up|Death|1|||
126047114|NCT02422615|453471123|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
126047115|NCT02422615|453471124|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126047116|NCT02422615|453471123|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
126047117|NCT02422615|453471124|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
126047118|NCT02422615|453471123|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
126047119|NCT02422615|453471124|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
126047120|NCT02422615|453471123|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
126047121|NCT02422615|453471124|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
126047122|NCT01639131|453471125|FG000|Overall Study|Disease Progression|6|||
126047123|NCT01105975|453471132|FG000|Overall Study|Adverse Event|2|||
126047124|NCT01105975|453471133|FG001|Overall Study|Adverse Event|1|||
126047125|NCT01105975|453471134|FG002|Overall Study|Adverse Event|5|||
126047126|NCT01105975|453471135|FG003|Overall Study|Adverse Event|1|||
126047127|NCT01105975|453471136|FG004|Overall Study|Adverse Event|0|||
126047128|NCT01105975|453471137|FG005|Overall Study|Adverse Event|1|||
126047129|NCT01105975|453471138|FG006|Overall Study|Adverse Event|2|||
126047130|NCT01105975|453471139|FG007|Overall Study|Adverse Event|4|||
126047131|NCT01105975|453471140|FG008|Overall Study|Adverse Event|1|||
126047132|NCT01105975|453471141|FG009|Overall Study|Adverse Event|4|||
126047133|NCT01105975|453471132|FG000|Overall Study|Withdrawal by Subject|2|||
126047134|NCT01105975|453471133|FG001|Overall Study|Withdrawal by Subject|2|||
126047135|NCT01105975|453471134|FG002|Overall Study|Withdrawal by Subject|2|||
126047136|NCT01105975|453471135|FG003|Overall Study|Withdrawal by Subject|0|||
126047137|NCT01105975|453471136|FG004|Overall Study|Withdrawal by Subject|4|||
126047138|NCT01105975|453471137|FG005|Overall Study|Withdrawal by Subject|1|||
126047139|NCT01105975|453471138|FG006|Overall Study|Withdrawal by Subject|2|||
126047140|NCT01105975|453471139|FG007|Overall Study|Withdrawal by Subject|1|||
126047141|NCT01105975|453471140|FG008|Overall Study|Withdrawal by Subject|0|||
126047142|NCT01105975|453471141|FG009|Overall Study|Withdrawal by Subject|3|||
126047143|NCT01105975|453471132|FG000|Overall Study|Lost to Follow-up|1|||
126047144|NCT01105975|453471133|FG001|Overall Study|Lost to Follow-up|0|||
126047145|NCT01105975|453471134|FG002|Overall Study|Lost to Follow-up|0|||
126047146|NCT01105975|453471135|FG003|Overall Study|Lost to Follow-up|1|||
126047147|NCT01105975|453471136|FG004|Overall Study|Lost to Follow-up|1|||
126047148|NCT01105975|453471137|FG005|Overall Study|Lost to Follow-up|0|||
126047149|NCT01105975|453471138|FG006|Overall Study|Lost to Follow-up|0|||
126307150|NCT01217476|454412030|FG001|Overall Study|Physician Decision|1|||
126307151|NCT01217476|454412029|FG000|Overall Study|Withdrawal by Subject|3|||
126307152|NCT01217476|454412030|FG001|Overall Study|Withdrawal by Subject|3|||
126307153|NCT01217476|454412029|FG000|Overall Study|Surgery on the Target Limb|0|||
126307154|NCT01217476|454412030|FG001|Overall Study|Surgery on the Target Limb|2|||
126307155|NCT01217476|454412029|FG000|Overall Study|Protocol Deviation|1|||
126307156|NCT01217476|454412030|FG001|Overall Study|Protocol Deviation|0|||
126307157|NCT01217476|454412029|FG000|Overall Study|Other|2|||
126307158|NCT01217476|454412030|FG001|Overall Study|Other|0|||
126307159|NCT03033602|454412031|FG000|Overall Study|Withdrawal by Subject|11|||
126307160|NCT03033602|454412032|FG001|Overall Study|Withdrawal by Subject|21|||
126307161|NCT03033602|454412031|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
126307162|NCT03033602|454412032|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
126307163|NCT01684943|454412033|FG000|Overall Study|Inadequate Venous Access|3|||
126307164|NCT01684943|454412034|FG001|Overall Study|Inadequate Venous Access|0|||
126307165|NCT01684943|454412035|FG002|Overall Study|Inadequate Venous Access|0|||
126307166|NCT01684943|454412033|FG000|Overall Study|Principal Investigator Determination|1|||
126307167|NCT01684943|454412034|FG001|Overall Study|Principal Investigator Determination|0|||
126307168|NCT01684943|454412035|FG002|Overall Study|Principal Investigator Determination|0|||
126307169|NCT01684943|454412033|FG000|Overall Study|Excluded from Analysis|1|||
126307170|NCT01684943|454412034|FG001|Overall Study|Excluded from Analysis|1|||
126307171|NCT01684943|454412035|FG002|Overall Study|Excluded from Analysis|1|||
126307172|NCT01684943|454412033|FG000|Overall Study|Lost to Follow-up|3|||
126307173|NCT01684943|454412034|FG001|Overall Study|Lost to Follow-up|0|||
126370610|NCT04583618|454653678|FG000|Overall Study|Lost to Follow-up|0|||
125885459|NCT02745119|452876853|FG003|Overall Study|Physician Decision|2|||
126047150|NCT01105975|453471139|FG007|Overall Study|Lost to Follow-up|0|||
126047151|NCT01105975|453471140|FG008|Overall Study|Lost to Follow-up|1|||
126307174|NCT01684943|454412035|FG002|Overall Study|Lost to Follow-up|0|||
126047152|NCT01105975|453471141|FG009|Overall Study|Lost to Follow-up|0|||
126047153|NCT01105975|453471132|FG000|Overall Study|Physician Decision|0|||
126047154|NCT01105975|453471133|FG001|Overall Study|Physician Decision|0|||
126047155|NCT01105975|453471134|FG002|Overall Study|Physician Decision|0|||
126307175|NCT01684943|454412033|FG000|Overall Study|Planning Pregnancy|1|||
126307176|NCT01684943|454412034|FG001|Overall Study|Planning Pregnancy|0|||
126047156|NCT01105975|453471135|FG003|Overall Study|Physician Decision|0|||
126047157|NCT01105975|453471136|FG004|Overall Study|Physician Decision|0|||
126047158|NCT01105975|453471137|FG005|Overall Study|Physician Decision|0|||
126047159|NCT01105975|453471138|FG006|Overall Study|Physician Decision|2|||
126047160|NCT01105975|453471139|FG007|Overall Study|Physician Decision|0|||
126047161|NCT01105975|453471140|FG008|Overall Study|Physician Decision|0|||
126047162|NCT01105975|453471141|FG009|Overall Study|Physician Decision|0|||
126047163|NCT01105975|453471132|FG000|Overall Study|Protocol Violation|0|||
126047164|NCT01105975|453471133|FG001|Overall Study|Protocol Violation|2|||
126047165|NCT01105975|453471134|FG002|Overall Study|Protocol Violation|2|||
126047166|NCT01105975|453471135|FG003|Overall Study|Protocol Violation|0|||
126047167|NCT01105975|453471136|FG004|Overall Study|Protocol Violation|1|||
126047168|NCT01105975|453471137|FG005|Overall Study|Protocol Violation|1|||
126047169|NCT01105975|453471138|FG006|Overall Study|Protocol Violation|1|||
126047170|NCT01105975|453471139|FG007|Overall Study|Protocol Violation|1|||
126047171|NCT01105975|453471140|FG008|Overall Study|Protocol Violation|2|||
126047172|NCT01105975|453471141|FG009|Overall Study|Protocol Violation|2|||
126047173|NCT01105975|453471132|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126047174|NCT01105975|453471133|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126047175|NCT01105975|453471134|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126047176|NCT01105975|453471135|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126047177|NCT01105975|453471136|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126047178|NCT01105975|453471137|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
126047179|NCT01105975|453471138|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126047180|NCT01105975|453471139|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126047181|NCT01105975|453471140|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
126047182|NCT01105975|453471141|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126047183|NCT00686595|453471142|FG000|Overall Study|Adverse Event|3|||
126047184|NCT00686595|453471142|FG000|Overall Study|Protocol Violation|1|||
126047185|NCT00686595|453471142|FG000|Overall Study|Lost to Follow-up|1|||
126047186|NCT00686595|453471142|FG000|Overall Study|Lack of Efficacy|1|||
126047187|NCT00686595|453471142|FG000|Overall Study|Poor Compliance|1|||
126047188|NCT03776812|453471150|FG000|Overall Study|Death|27|||
126047189|NCT03776812|453471151|FG001|Overall Study|Death|19|||
126047190|NCT03776812|453471152|FG002|Overall Study|Death|29|||
126047191|NCT03776812|453471150|FG000|Overall Study|Withdrawal by Subject|1|||
126047192|NCT03776812|453471151|FG001|Overall Study|Withdrawal by Subject|7|||
126047193|NCT03776812|453471152|FG002|Overall Study|Withdrawal by Subject|1|||
126047194|NCT03776812|453471150|FG000|Overall Study|Lost to Follow-up|0|||
126047195|NCT03776812|453471151|FG001|Overall Study|Lost to Follow-up|1|||
126047196|NCT03776812|453471152|FG002|Overall Study|Lost to Follow-up|0|||
126047197|NCT03776812|453471150|FG000|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
126047198|NCT03776812|453471151|FG001|Overall Study|Still on study as of March 22, 2021 data cutoff date|33|||
126047199|NCT03776812|453471152|FG002|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
126047200|NCT00087685|453471158|FG000|Overall Study|Adverse Event|5|||
126047201|NCT00087685|453471158|FG000|Overall Study|Non-Compliance|1|||
126047202|NCT00087685|453471158|FG000|Overall Study|Progressive Disease|5|||
126047203|NCT00087685|453471158|FG000|Overall Study|Withdrawal by Subject|3|||
126047204|NCT05018143|453471159|FG000|Overall Study|Lost to Follow-up|5|||
126103757|NCT02808143|453673798|FG001|Survival Follow-Up|Death|0|||
126307177|NCT01684943|454412035|FG002|Overall Study|Planning Pregnancy|0|||
126307178|NCT01190410|454414377|FG000|Overall Study|Adverse Event|0|||
126307179|NCT01190410|454414378|FG001|Overall Study|Adverse Event|3|||
126307180|NCT01190410|454414377|FG000|Overall Study|Lack of Efficacy|0|||
126307181|NCT01190410|454414378|FG001|Overall Study|Lack of Efficacy|2|||
126307182|NCT01190410|454414377|FG000|Overall Study|Withdrawal by Subject|0|||
126307183|NCT01190410|454414378|FG001|Overall Study|Withdrawal by Subject|2|||
126307184|NCT01190410|454414377|FG000|Overall Study|Administrative decision|1|||
126307185|NCT01190410|454414378|FG001|Overall Study|Administrative decision|0|||
126307186|NCT01190410|454414377|FG000|Overall Study|PI discretion|0|||
126307187|NCT01190410|454414378|FG001|Overall Study|PI discretion|2|||
126307188|NCT01399047|454414379|FG000|Overall Study|Withdrawal by Subject|0|||
126307189|NCT01399047|454414380|FG001|Overall Study|Withdrawal by Subject|1|||
126307190|NCT00504725|454414386|FG000|Overall Study|Protocol Violation|1|||
126307191|NCT00504725|454414387|FG001|Overall Study|Protocol Violation|0|||
126307192|NCT00956592|454414392|FG000|Overall Study|Protocol Violation|1|||
126307193|NCT00956592|454414393|FG001|Overall Study|Protocol Violation|3|||
126307194|NCT00160706|454414395|FG000|Overall Study|Adverse Event|53|||
126307195|NCT00160706|454414395|FG000|Overall Study|Adverse Event and Other Reason|105|||
126307196|NCT00160706|454414395|FG000|Overall Study|Protocol Violation|3|||
126047205|NCT05018143|453471160|FG001|Overall Study|Lost to Follow-up|4|||
126047206|NCT05018143|453471159|FG000|Overall Study|Withdrawal by Subject|0|||
126307197|NCT00160706|454414395|FG000|Overall Study|Withdrawal by Subject|41|||
126047207|NCT05018143|453471160|FG001|Overall Study|Withdrawal by Subject|1|||
126047208|NCT06688357|453471161|FG000|Overall Study|Adverse Event|0|||
126047209|NCT06688357|453471162|FG001|Overall Study|Adverse Event|1|||
126307198|NCT00160706|454414395|FG000|Overall Study|Withdrawal by Subject and Other|12|||
126047210|NCT03774472|453471163|FG000|Overall Study|Physician Decision|1|||
126047211|NCT03774472|453471164|FG001|Overall Study|Physician Decision|0|||
126047212|NCT03774472|453471165|FG002|Overall Study|Physician Decision|0|||
126047213|NCT03774472|453471163|FG000|Overall Study|Progression prior to 4 weeks|0|||
126047214|NCT03774472|453471164|FG001|Overall Study|Progression prior to 4 weeks|1|||
126047215|NCT03774472|453471165|FG002|Overall Study|Progression prior to 4 weeks|0|||
126047216|NCT03774472|453471163|FG000|Overall Study|Withdrawal by Subject|0|||
126047217|NCT03774472|453471164|FG001|Overall Study|Withdrawal by Subject|1|||
126047218|NCT03774472|453471165|FG002|Overall Study|Withdrawal by Subject|0|||
126047219|NCT04059406|453471166|FG000|Overall Study|Early Treatment Termination|5|||
126047220|NCT04059406|453471167|FG001|Overall Study|Early Treatment Termination|5|||
126047221|NCT04059406|453471168|FG002|Overall Study|Early Treatment Termination|15|||
126047222|NCT05155306|453471169|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
126047223|NCT05155306|453471170|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
126047224|NCT05155306|453471171|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
126047225|NCT05155306|453471172|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
126047226|NCT05155306|453471169|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
126047227|NCT05155306|453471170|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
126047228|NCT05155306|453471171|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
126047229|NCT05155306|453471172|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
126047230|NCT05601882|453471173|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
126047231|NCT05601882|453471174|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
126047232|NCT05601882|453471175|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
126047233|NCT05601882|453471176|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
126047234|NCT05601882|453471173|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
126047235|NCT05601882|453471174|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
126047236|NCT05601882|453471175|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
126047237|NCT05601882|453471176|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
126047238|NCT05601882|453471173|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
126047239|NCT05601882|453471174|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
126047240|NCT05601882|453471175|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
126047241|NCT05601882|453471176|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
126047242|NCT05601882|453471173|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
126047243|NCT05601882|453471174|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
126047244|NCT05601882|453471175|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
126047245|NCT05601882|453471176|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
126047246|NCT05601882|453471173|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
126047247|NCT05601882|453471174|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
126047248|NCT05601882|453471175|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
126047249|NCT05601882|453471176|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
126047250|NCT05601882|453471173|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
126047251|NCT05601882|453471174|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
126047252|NCT05601882|453471175|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
126047253|NCT05601882|453471176|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
126047254|NCT03524092|453471177|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
126047255|NCT03524092|453471178|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
126047256|NCT03524092|453471179|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
126047257|NCT03524092|453471180|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
126047258|NCT03524092|453471181|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
126047259|NCT03524092|453471182|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
126047260|NCT03524092|453471177|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
126047261|NCT03524092|453471178|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
126047262|NCT03524092|453471179|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
126047263|NCT03524092|453471180|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
126047264|NCT03524092|453471181|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
126103758|NCT04964388|453673799|FG000|Overall Study|Lost to Follow-up|3|||
126103759|NCT04964388|453673800|FG001|Overall Study|Lost to Follow-up|2|||
126307199|NCT00160706|454414395|FG000|Overall Study|Physician Decision|10|||
126307200|NCT00160706|454414395|FG000|Overall Study|Physician Decision and Other|3|||
126307201|NCT00160706|454414395|FG000|Overall Study|Lost to Follow-up|4|||
126307202|NCT00160706|454414395|FG000|Overall Study|Lost to Follow-up and Other|1|||
126307203|NCT00160706|454414395|FG000|Overall Study|Lack of Efficacy|42|||
126307204|NCT00160706|454414395|FG000|Overall Study|Lack of Efficacy and Other|1|||
126307205|NCT00160706|454414395|FG000|Overall Study|Other Reason|11|||
126307206|NCT03214380|454414396|FG000|Lead-in|Adverse Event|3|||
126307207|NCT03214380|454414397|FG001|Lead-in|Adverse Event|0|||
126307208|NCT03214380|454414398|FG002|Lead-in|Adverse Event|0|||
126307209|NCT03214380|454414399|FG003|Lead-in|Adverse Event|1|||
126307210|NCT03214380|454414400|FG004|Lead-in|Adverse Event|0|||
126370611|NCT04583618|454653679|FG001|Overall Study|Lost to Follow-up|1|||
126307211|NCT03214380|454414401|FG005|Lead-in|Adverse Event|0|||
126307212|NCT03214380|454414396|FG000|Lead-in|Lost to Follow-up|4|||
126307213|NCT03214380|454414397|FG001|Lead-in|Lost to Follow-up|0|||
126307214|NCT03214380|454414398|FG002|Lead-in|Lost to Follow-up|0|||
126307215|NCT03214380|454414399|FG003|Lead-in|Lost to Follow-up|1|||
126307216|NCT03214380|454414400|FG004|Lead-in|Lost to Follow-up|0|||
126307217|NCT03214380|454414401|FG005|Lead-in|Lost to Follow-up|0|||
126307218|NCT03214380|454414396|FG000|Lead-in|Eligibility Criteria|3|||
126307219|NCT03214380|454414397|FG001|Lead-in|Eligibility Criteria|0|||
126307220|NCT03214380|454414398|FG002|Lead-in|Eligibility Criteria|0|||
126307221|NCT03214380|454414399|FG003|Lead-in|Eligibility Criteria|0|||
126307222|NCT03214380|454414400|FG004|Lead-in|Eligibility Criteria|0|||
126307223|NCT03214380|454414401|FG005|Lead-in|Eligibility Criteria|0|||
126307224|NCT03214380|454414396|FG000|Lead-in|Physician Decision|6|||
126307225|NCT03214380|454414397|FG001|Lead-in|Physician Decision|0|||
126047265|NCT03524092|453471182|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
126047266|NCT03524092|453471177|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126047267|NCT03524092|453471178|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
126047268|NCT03524092|453471179|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126047269|NCT03524092|453471180|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126047270|NCT03524092|453471181|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126047271|NCT03524092|453471182|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126047272|NCT03524092|453471177|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126047273|NCT03524092|453471178|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
126047274|NCT03524092|453471179|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126047275|NCT03524092|453471180|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
125885460|NCT02745119|452876850|FG000|Overall Study|Reason Not Specified|0|||
125885461|NCT02745119|452876851|FG001|Overall Study|Reason Not Specified|2|||
125885462|NCT02745119|452876852|FG002|Overall Study|Reason Not Specified|0|||
125885463|NCT02745119|452876853|FG003|Overall Study|Reason Not Specified|1|||
125885464|NCT01587924|452876854|FG000|Overall Study|Adverse Event|0|||
125885465|NCT01587924|452876855|FG001|Overall Study|Adverse Event|2|||
125885466|NCT01587924|452876856|FG002|Overall Study|Adverse Event|0|||
125885467|NCT01587924|452876857|FG003|Overall Study|Adverse Event|0|||
125885468|NCT01587924|452876854|FG000|Overall Study|Protocol Violation|2|||
125885469|NCT01587924|452876855|FG001|Overall Study|Protocol Violation|1|||
125885470|NCT01587924|452876856|FG002|Overall Study|Protocol Violation|2|||
125885471|NCT01587924|452876857|FG003|Overall Study|Protocol Violation|1|||
125885472|NCT01587924|452876854|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
125885473|NCT01587924|452876855|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
125885474|NCT01587924|452876856|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
126088921|NCT04546425|453620017|FG003|Overall Study|Adverse Event|0|||
126088922|NCT04546425|453620014|FG000|Overall Study|Lost to Follow-up|5|||
126088923|NCT04546425|453620015|FG001|Overall Study|Lost to Follow-up|4|||
125885475|NCT01587924|452876857|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
126088924|NCT04546425|453620016|FG002|Overall Study|Lost to Follow-up|0|||
126088925|NCT04546425|453620017|FG003|Overall Study|Lost to Follow-up|0|||
126088926|NCT04546425|453620014|FG000|Overall Study|No Longer met eligibility criteria|3|||
126088927|NCT04546425|453620015|FG001|Overall Study|No Longer met eligibility criteria|3|||
126088928|NCT04546425|453620016|FG002|Overall Study|No Longer met eligibility criteria|1|||
126088929|NCT04546425|453620017|FG003|Overall Study|No Longer met eligibility criteria|1|||
126088930|NCT04546425|453620014|FG000|Overall Study|Withdrawal by parent/guardian|6|||
126088931|NCT04546425|453620015|FG001|Overall Study|Withdrawal by parent/guardian|5|||
126088932|NCT04546425|453620016|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126088933|NCT04546425|453620017|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126088934|NCT02979249|453620020|FG000|Overall Study|Lost to Follow-up|2|||
126088935|NCT02979249|453620020|FG000|Overall Study|Withdrawal by Subject|4|||
126088936|NCT01125046|453620021|FG000|First 6 Months of Treatment|Death|1|||
126088937|NCT01125046|453620021|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
126088938|NCT01125046|453620021|FG000|First 6 Months of Treatment|Non-compliance|1|||
126088939|NCT01125046|453620021|FG000|First 6 Months of Treatment|Surgery|1|||
126088940|NCT01125046|453620021|FG000|First 6 Months of Treatment|Progressive Disease|7|||
126088941|NCT01125046|453620021|FG000|First 6 Months of Treatment|Adverse Event|2|||
126088942|NCT01125046|453620021|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
126088943|NCT01125046|453620021|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
126088944|NCT01125046|453620021|FG000|Follow-up/Data Cut Off Point|Death|29|||
126088945|NCT01125046|453620021|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
126088946|NCT01685229|453620023|FG000|Overall Study|Subjects missing Study Exit form|3|||
126088947|NCT01685229|453620024|FG001|Overall Study|Subjects missing Study Exit form|1|||
126088948|NCT01685229|453620023|FG000|Overall Study|Lost to Follow-up|16|||
126088949|NCT01685229|453620024|FG001|Overall Study|Lost to Follow-up|10|||
126088950|NCT01685229|453620023|FG000|Overall Study|Withdrawal by Subject|6|||
126088951|NCT01685229|453620024|FG001|Overall Study|Withdrawal by Subject|5|||
126088952|NCT01685229|453620023|FG000|Overall Study|Death|1|||
126088953|NCT01685229|453620024|FG001|Overall Study|Death|0|||
126088954|NCT03868787|453620025|FG000|Overall Study|Withdrawal by Subject|2|||
126307226|NCT03214380|454414398|FG002|Lead-in|Physician Decision|0|||
126307227|NCT03214380|454414399|FG003|Lead-in|Physician Decision|0|||
126307228|NCT03214380|454414400|FG004|Lead-in|Physician Decision|0|||
126307229|NCT03214380|454414401|FG005|Lead-in|Physician Decision|0|||
126307230|NCT03214380|454414396|FG000|Lead-in|Protocol Deviation|7|||
126307231|NCT03214380|454414397|FG001|Lead-in|Protocol Deviation|0|||
126307232|NCT03214380|454414398|FG002|Lead-in|Protocol Deviation|0|||
126307233|NCT03214380|454414399|FG003|Lead-in|Protocol Deviation|3|||
126307234|NCT03214380|454414400|FG004|Lead-in|Protocol Deviation|0|||
126307235|NCT03214380|454414401|FG005|Lead-in|Protocol Deviation|0|||
126307236|NCT03214380|454414396|FG000|Lead-in|Withdrawal by Subject|41|||
126307237|NCT03214380|454414397|FG001|Lead-in|Withdrawal by Subject|0|||
126307238|NCT03214380|454414398|FG002|Lead-in|Withdrawal by Subject|0|||
126307239|NCT03214380|454414399|FG003|Lead-in|Withdrawal by Subject|14|||
126307240|NCT03214380|454414400|FG004|Lead-in|Withdrawal by Subject|0|||
126307241|NCT03214380|454414401|FG005|Lead-in|Withdrawal by Subject|0|||
126307242|NCT03214380|454414396|FG000|Lead-in|Family Emergency|1|||
126307243|NCT03214380|454414397|FG001|Lead-in|Family Emergency|0|||
126307244|NCT03214380|454414398|FG002|Lead-in|Family Emergency|0|||
126307245|NCT03214380|454414399|FG003|Lead-in|Family Emergency|0|||
126307246|NCT03214380|454414400|FG004|Lead-in|Family Emergency|0|||
126307247|NCT03214380|454414401|FG005|Lead-in|Family Emergency|0|||
126307248|NCT03214380|454414396|FG000|Lead-in|Natural Disaster|9|||
126307249|NCT03214380|454414397|FG001|Lead-in|Natural Disaster|0|||
126307250|NCT03214380|454414398|FG002|Lead-in|Natural Disaster|0|||
126307251|NCT03214380|454414399|FG003|Lead-in|Natural Disaster|0|||
126307252|NCT03214380|454414400|FG004|Lead-in|Natural Disaster|0|||
126307253|NCT03214380|454414401|FG005|Lead-in|Natural Disaster|0|||
126307254|NCT03214380|454414396|FG000|Lead-in|Non Compliance|1|||
126307255|NCT03214380|454414397|FG001|Lead-in|Non Compliance|0|||
126047276|NCT03524092|453471181|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126047277|NCT03524092|453471182|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126307256|NCT03214380|454414398|FG002|Lead-in|Non Compliance|0|||
126307257|NCT03214380|454414399|FG003|Lead-in|Non Compliance|0|||
126370612|NCT04583618|454653680|FG002|Overall Study|Lost to Follow-up|3|||
126370613|NCT04583618|454653681|FG003|Overall Study|Lost to Follow-up|1|||
126047278|NCT03524092|453471177|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126047279|NCT03524092|453471178|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126047280|NCT03524092|453471179|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
126047281|NCT03524092|453471180|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126047282|NCT03524092|453471181|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126047283|NCT03524092|453471182|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126047284|NCT03524092|453471177|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
126047285|NCT03524092|453471178|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
126047286|NCT03524092|453471179|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
126047287|NCT03524092|453471180|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
126047288|NCT03524092|453471181|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
126047289|NCT03524092|453471182|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
126047290|NCT03524092|453471177|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
126047291|NCT03524092|453471178|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
126047292|NCT03524092|453471179|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
126047293|NCT03524092|453471180|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
126047294|NCT03524092|453471181|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
126047295|NCT03524092|453471182|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
126047296|NCT03524092|453471177|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
126047297|NCT03524092|453471178|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
126047298|NCT03524092|453471179|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
126047299|NCT03524092|453471180|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
126047300|NCT03524092|453471181|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
126047301|NCT03524092|453471182|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
126047302|NCT03524092|453471177|FG000|Loss of Response Rescue Period|Adverse Event|0|||
126307258|NCT03214380|454414400|FG004|Lead-in|Non Compliance|0|||
126307259|NCT03214380|454414401|FG005|Lead-in|Non Compliance|0|||
126307260|NCT03214380|454414396|FG000|Lead-in|Participant Schedule|2|||
126307261|NCT03214380|454414397|FG001|Lead-in|Participant Schedule|0|||
126307262|NCT03214380|454414398|FG002|Lead-in|Participant Schedule|0|||
126307263|NCT03214380|454414399|FG003|Lead-in|Participant Schedule|0|||
126370614|NCT04583618|454653682|FG004|Overall Study|Lost to Follow-up|1|||
126370615|NCT02711202|454653683|FG000|Overall Study|Adverse Event|3|||
126370616|NCT02711202|454653684|FG001|Overall Study|Adverse Event|0|||
126370617|NCT02711202|454653683|FG000|Overall Study|graft loss|1|||
126307264|NCT03214380|454414400|FG004|Lead-in|Participant Schedule|0|||
126307265|NCT03214380|454414401|FG005|Lead-in|Participant Schedule|0|||
126307266|NCT03214380|454414396|FG000|Treatment Period|Adverse Event|0|||
126370618|NCT02711202|454653684|FG001|Overall Study|graft loss|0|||
126370619|NCT03189719|454653692|FG000|Overall Study|Death|325|||
126370620|NCT03189719|454653693|FG001|Overall Study|Death|361|||
126370621|NCT03189719|454653692|FG000|Overall Study|Physician Decision|1|||
126370622|NCT03189719|454653693|FG001|Overall Study|Physician Decision|0|||
126370623|NCT03189719|454653692|FG000|Overall Study|Sponsor Decision|40|||
126370624|NCT03189719|454653693|FG001|Overall Study|Sponsor Decision|12|||
126370625|NCT03189719|454653692|FG000|Overall Study|Withdrawal by Subject|7|||
126370626|NCT03189719|454653693|FG001|Overall Study|Withdrawal by Subject|3|||
126370627|NCT03448393|454653694|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370628|NCT03448393|454653695|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370629|NCT03448393|454653696|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
126370630|NCT03448393|454653697|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370631|NCT03448393|454653698|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370632|NCT03448393|454653699|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370633|NCT03448393|454653700|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370634|NCT03448393|454653701|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370635|NCT03448393|454653702|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
126370636|NCT03448393|454653694|FG000|Dose Expansion|Not treated - screen failure|0|||
126370637|NCT03448393|454653695|FG001|Dose Expansion|Not treated - screen failure|0|||
126370638|NCT03448393|454653696|FG002|Dose Expansion|Not treated - screen failure|0|||
126370639|NCT03448393|454653697|FG003|Dose Expansion|Not treated - screen failure|0|||
126370640|NCT03448393|454653698|FG004|Dose Expansion|Not treated - screen failure|0|||
126370641|NCT03448393|454653699|FG005|Dose Expansion|Not treated - screen failure|0|||
126370642|NCT03448393|454653700|FG006|Dose Expansion|Not treated - screen failure|0|||
126307267|NCT03214380|454414397|FG001|Treatment Period|Adverse Event|1|||
126307268|NCT03214380|454414398|FG002|Treatment Period|Adverse Event|1|||
126307269|NCT03214380|454414399|FG003|Treatment Period|Adverse Event|0|||
126307270|NCT03214380|454414400|FG004|Treatment Period|Adverse Event|1|||
126307271|NCT03214380|454414401|FG005|Treatment Period|Adverse Event|0|||
126307272|NCT03214380|454414396|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
126307273|NCT03214380|454414397|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
126307274|NCT03214380|454414398|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
126307275|NCT03214380|454414399|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
126307276|NCT03214380|454414400|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
126307277|NCT03214380|454414401|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
126307278|NCT03214380|454414396|FG000|Treatment Period|Withdrawal by Subject|0|||
126307279|NCT03214380|454414397|FG001|Treatment Period|Withdrawal by Subject|10|||
126307280|NCT03214380|454414398|FG002|Treatment Period|Withdrawal by Subject|8|||
126307281|NCT03214380|454414399|FG003|Treatment Period|Withdrawal by Subject|0|||
126307282|NCT03214380|454414400|FG004|Treatment Period|Withdrawal by Subject|7|||
126307283|NCT03214380|454414401|FG005|Treatment Period|Withdrawal by Subject|11|||
126307284|NCT03214380|454414396|FG000|Treatment Period|Death|0|||
126307285|NCT03214380|454414397|FG001|Treatment Period|Death|1|||
126307286|NCT03214380|454414398|FG002|Treatment Period|Death|2|||
126307287|NCT03214380|454414399|FG003|Treatment Period|Death|0|||
126307288|NCT03214380|454414400|FG004|Treatment Period|Death|0|||
126307289|NCT03214380|454414401|FG005|Treatment Period|Death|0|||
126307290|NCT03214380|454414396|FG000|Treatment Period|Lost to Follow-up|0|||
126307291|NCT03214380|454414397|FG001|Treatment Period|Lost to Follow-up|6|||
126307292|NCT03214380|454414398|FG002|Treatment Period|Lost to Follow-up|3|||
126307293|NCT03214380|454414399|FG003|Treatment Period|Lost to Follow-up|0|||
126307294|NCT03214380|454414400|FG004|Treatment Period|Lost to Follow-up|0|||
126307295|NCT03214380|454414401|FG005|Treatment Period|Lost to Follow-up|0|||
126307296|NCT03214380|454414396|FG000|Treatment Period|Participant schedule|0|||
126307297|NCT03214380|454414397|FG001|Treatment Period|Participant schedule|0|||
126307298|NCT03214380|454414398|FG002|Treatment Period|Participant schedule|1|||
126307299|NCT03214380|454414399|FG003|Treatment Period|Participant schedule|0|||
126307300|NCT03214380|454414400|FG004|Treatment Period|Participant schedule|0|||
126307301|NCT03214380|454414401|FG005|Treatment Period|Participant schedule|0|||
126307302|NCT03214380|454414396|FG000|Treatment Period|Treatment Interruption|0|||
126370643|NCT03448393|454653701|FG007|Dose Expansion|Not treated - screen failure|0|||
126370644|NCT03448393|454653702|FG008|Dose Expansion|Not treated - screen failure|7|||
126370645|NCT03330847|454653703|FG000|Overall Study|Patients ongoing study|62|||
126370646|NCT03330847|454653704|FG001|Overall Study|Patients ongoing study|65|||
126370647|NCT03330847|454653705|FG002|Overall Study|Patients ongoing study|15|||
125885476|NCT01587924|452876854|FG000|Overall Study|Withdrawal by Subject|0|||
126307303|NCT03214380|454414397|FG001|Treatment Period|Treatment Interruption|0|||
126307304|NCT03214380|454414398|FG002|Treatment Period|Treatment Interruption|1|||
126307305|NCT03214380|454414399|FG003|Treatment Period|Treatment Interruption|0|||
126307306|NCT03214380|454414400|FG004|Treatment Period|Treatment Interruption|0|||
126307307|NCT03214380|454414401|FG005|Treatment Period|Treatment Interruption|0|||
126307308|NCT01163851|454414402|FG000|Overall Study|Site Closure|0|||
126307309|NCT01163851|454414403|FG001|Overall Study|Site Closure|1|||
126103760|NCT00448279|453673802|FG000|Overall Study|Lost to Follow-up|2|||
126370648|NCT01355627|454653706|FG000|Overall Study|Request By the Patient to Discontinue|5|||
126370649|NCT01355627|454653707|FG001|Overall Study|Request By the Patient to Discontinue|7|||
126370650|NCT01355627|454653706|FG000|Overall Study|Lost to Follow-up|8|||
126370651|NCT01355627|454653707|FG001|Overall Study|Lost to Follow-up|7|||
126370652|NCT01355627|454653706|FG000|Overall Study|Fatal Adverse Event|19|||
126370653|NCT01355627|454653707|FG001|Overall Study|Fatal Adverse Event|23|||
126370654|NCT01355627|454653706|FG000|Overall Study|Other|1|||
126370655|NCT01355627|454653707|FG001|Overall Study|Other|1|||
126370656|NCT02293551|454653710|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
126370657|NCT02293551|454653711|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
126370658|NCT02293551|454653712|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
126370659|NCT02293551|454653713|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
125885477|NCT01587924|452876855|FG001|Overall Study|Withdrawal by Subject|1|||
125885478|NCT01587924|452876856|FG002|Overall Study|Withdrawal by Subject|1|||
126370660|NCT02293551|454653714|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
126370661|NCT02293551|454653715|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
126370662|NCT02293551|454653710|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
126370663|NCT02293551|454653711|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
126370664|NCT02293551|454653712|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
126370665|NCT02293551|454653713|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
126370666|NCT02293551|454653714|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
126370667|NCT02293551|454653715|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
126370668|NCT02293551|454653710|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
126370669|NCT02293551|454653711|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
126370670|NCT02293551|454653712|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
126370671|NCT02293551|454653713|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
126370672|NCT02293551|454653714|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
126370673|NCT02293551|454653715|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
126370674|NCT04756531|454653721|FG000|Overall Study|Adverse Event|0|||
126370675|NCT04756531|454653722|FG001|Overall Study|Adverse Event|0|||
126370676|NCT04756531|454653723|FG002|Overall Study|Adverse Event|0|||
126370677|NCT04756531|454653724|FG003|Overall Study|Adverse Event|0|||
126370678|NCT04756531|454653725|FG004|Overall Study|Adverse Event|1|||
126370679|NCT04756531|454653726|FG005|Overall Study|Adverse Event|0|||
126370680|NCT04756531|454653727|FG006|Overall Study|Adverse Event|0|||
126370681|NCT04756531|454653728|FG007|Overall Study|Adverse Event|0|||
125885479|NCT01587924|452876857|FG003|Overall Study|Withdrawal by Subject|0|||
126370682|NCT04756531|454653729|FG008|Overall Study|Adverse Event|0|||
126370683|NCT04756531|454653730|FG009|Overall Study|Adverse Event|0|||
126370684|NCT04756531|454653731|FG010|Overall Study|Adverse Event|0|||
126370685|NCT04756531|454653732|FG011|Overall Study|Adverse Event|0|||
126370686|NCT04756531|454653733|FG012|Overall Study|Adverse Event|0|||
126370687|NCT04756531|454653734|FG013|Overall Study|Adverse Event|0|||
125885480|NCT00432172|452876858|FG000|Overall Study|Physician Decision|0|||
126370688|NCT04756531|454653735|FG014|Overall Study|Adverse Event|0|||
126370689|NCT04756531|454653736|FG015|Overall Study|Adverse Event|0|||
126370690|NCT04756531|454653737|FG016|Overall Study|Adverse Event|0|||
126370691|NCT04756531|454653738|FG017|Overall Study|Adverse Event|0|||
126370692|NCT04756531|454653721|FG000|Overall Study|Withdrawal by Subject|0|||
126370693|NCT04756531|454653722|FG001|Overall Study|Withdrawal by Subject|0|||
126047303|NCT03524092|453471178|FG001|Loss of Response Rescue Period|Adverse Event|0|||
126047304|NCT03524092|453471179|FG002|Loss of Response Rescue Period|Adverse Event|0|||
126047305|NCT03524092|453471180|FG003|Loss of Response Rescue Period|Adverse Event|2|||
126047306|NCT03524092|453471181|FG004|Loss of Response Rescue Period|Adverse Event|0|||
126047307|NCT03524092|453471182|FG005|Loss of Response Rescue Period|Adverse Event|0|||
126047308|NCT03524092|453471177|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
126047309|NCT03524092|453471178|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
126307310|NCT01163851|454414402|FG000|Overall Study|Enrolled but not treated|1|||
126307311|NCT01163851|454414403|FG001|Overall Study|Enrolled but not treated|0|||
126307312|NCT02028767|454414404|FG000|Treatment Period 2|Non compliant with protocol|1|||
126307313|NCT02028767|454414405|FG001|Treatment Period 2|Non compliant with protocol|0|||
126307314|NCT02028767|454414404|FG000|Treatment Period 2|Reason other than those specified above|1|||
126307315|NCT02028767|454414405|FG001|Treatment Period 2|Reason other than those specified above|0|||
126307316|NCT03192306|454414406|FG000|Overall Study|Did not treat cold sore during study|149|||
126307317|NCT03192306|454414407|FG001|Overall Study|Did not treat cold sore during study|143|||
126307318|NCT03192306|454414406|FG000|Overall Study|Withdrawal by Subject|1|||
126307319|NCT03192306|454414407|FG001|Overall Study|Withdrawal by Subject|1|||
126307320|NCT03192306|454414406|FG000|Overall Study|Lost to Follow-up|1|||
126307321|NCT03192306|454414407|FG001|Overall Study|Lost to Follow-up|0|||
126307322|NCT03192306|454414406|FG000|Overall Study|Protocol Violation|1|||
126307323|NCT03192306|454414407|FG001|Overall Study|Protocol Violation|1|||
126307324|NCT03436693|454414408|FG000|Overall Study|Adverse Event|22|||
126307325|NCT03436693|454414409|FG001|Overall Study|Adverse Event|10|||
126307326|NCT03436693|454414408|FG000|Overall Study|Physician Decision|3|||
126307327|NCT03436693|454414409|FG001|Overall Study|Physician Decision|3|||
126307328|NCT03436693|454414408|FG000|Overall Study|Withdrawal by Subject|4|||
126307329|NCT03436693|454414409|FG001|Overall Study|Withdrawal by Subject|13|||
126307330|NCT03436693|454414408|FG000|Overall Study|Progressive Disease|1|||
126307331|NCT03436693|454414409|FG001|Overall Study|Progressive Disease|1|||
126307332|NCT00654875|454414412|FG000|Overall Study|Adverse Event|5|||
126307333|NCT00654875|454414413|FG001|Overall Study|Adverse Event|5|||
126307334|NCT00654875|454414412|FG000|Overall Study|Withdrawal by Subject|4|||
126307335|NCT00654875|454414413|FG001|Overall Study|Withdrawal by Subject|4|||
126307336|NCT00654875|454414412|FG000|Overall Study|Protocol Violation|3|||
126307337|NCT00654875|454414413|FG001|Overall Study|Protocol Violation|3|||
126307338|NCT00654875|454414412|FG000|Overall Study|Lack of Efficacy|2|||
126307339|NCT00654875|454414413|FG001|Overall Study|Lack of Efficacy|2|||
126307340|NCT00654875|454414412|FG000|Overall Study|Lost to Follow-up|1|||
126307341|NCT00654875|454414413|FG001|Overall Study|Lost to Follow-up|3|||
126307342|NCT00654875|454414412|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
126307343|NCT00654875|454414413|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126307344|NCT00654875|454414412|FG000|Overall Study|Administrative Problems|1|||
126307345|NCT00654875|454414413|FG001|Overall Study|Administrative Problems|0|||
126307346|NCT04967885|454414414|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
126307347|NCT04967885|454414415|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
126307348|NCT04967885|454414414|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
126307349|NCT04967885|454414415|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
126307350|NCT04967885|454414414|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
126307351|NCT04967885|454414415|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
126307352|NCT04967885|454414414|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
126307353|NCT04967885|454414415|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
126307354|NCT04967885|454414414|FG000|EMI-II Intervention|Lost to Follow-up|14|||
126307355|NCT04967885|454414415|FG001|EMI-II Intervention|Lost to Follow-up|10|||
126307356|NCT00886743|454414416|FG000|Overall Study|Adverse Event|3|||
126307357|NCT00886743|454414416|FG000|Overall Study|Other|1|||
126307358|NCT05217641|454414417|FG000|Overall Study|Lost to Follow-up|1|||
126307359|NCT05217641|454414418|FG001|Overall Study|Lost to Follow-up|1|||
126307360|NCT05217641|454414419|FG002|Overall Study|Lost to Follow-up|0|||
126307361|NCT05217641|454414420|FG003|Overall Study|Lost to Follow-up|1|||
126307362|NCT05217641|454414421|FG004|Overall Study|Lost to Follow-up|1|||
126307363|NCT05217641|454414422|FG005|Overall Study|Lost to Follow-up|0|||
126307364|NCT05217641|454414417|FG000|Overall Study|Withdrawal by Subject|0|||
126370694|NCT04756531|454653723|FG002|Overall Study|Withdrawal by Subject|0|||
126047310|NCT03524092|453471179|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
126370695|NCT04756531|454653724|FG003|Overall Study|Withdrawal by Subject|0|||
126370696|NCT04756531|454653725|FG004|Overall Study|Withdrawal by Subject|0|||
126047311|NCT03524092|453471180|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
126307365|NCT05217641|454414418|FG001|Overall Study|Withdrawal by Subject|0|||
126307366|NCT05217641|454414419|FG002|Overall Study|Withdrawal by Subject|0|||
126307367|NCT05217641|454414420|FG003|Overall Study|Withdrawal by Subject|3|||
126307368|NCT05217641|454414421|FG004|Overall Study|Withdrawal by Subject|1|||
126307369|NCT05217641|454414422|FG005|Overall Study|Withdrawal by Subject|0|||
126307370|NCT05217641|454414417|FG000|Overall Study|Other: participant did not specify reason|0|||
126307371|NCT05217641|454414418|FG001|Overall Study|Other: participant did not specify reason|0|||
126103761|NCT00448279|453673803|FG001|Overall Study|Lost to Follow-up|2|||
126047312|NCT03524092|453471181|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
126047313|NCT03524092|453471182|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
126047314|NCT03524092|453471177|FG000|Loss of Response Rescue Period|Pregnancy|0|||
126047315|NCT03524092|453471178|FG001|Loss of Response Rescue Period|Pregnancy|0|||
126047316|NCT03524092|453471179|FG002|Loss of Response Rescue Period|Pregnancy|0|||
126047317|NCT03524092|453471180|FG003|Loss of Response Rescue Period|Pregnancy|1|||
126047318|NCT03524092|453471181|FG004|Loss of Response Rescue Period|Pregnancy|0|||
126047319|NCT03524092|453471182|FG005|Loss of Response Rescue Period|Pregnancy|0|||
126047320|NCT03524092|453471177|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126103762|NCT00448279|453673802|FG000|Overall Study|Adverse Event|1|||
126103763|NCT00448279|453673803|FG001|Overall Study|Adverse Event|1|||
126103764|NCT00448279|453673802|FG000|Overall Study|Disease progression|16|||
126103765|NCT00448279|453673803|FG001|Overall Study|Disease progression|18|||
126103766|NCT00448279|453673802|FG000|Overall Study|Withdrawal by Subject|4|||
126103767|NCT00448279|453673803|FG001|Overall Study|Withdrawal by Subject|3|||
126103768|NCT00448279|453673802|FG000|Overall Study|Other|6|||
126103769|NCT00448279|453673803|FG001|Overall Study|Other|4|||
126103770|NCT00448279|453673802|FG000|Overall Study|Protocol Violation|0|||
126103771|NCT00448279|453673803|FG001|Overall Study|Protocol Violation|1|||
126103772|NCT03907410|453673804|FG000|Overall Study|Lost to Follow-up|4|||
126103773|NCT03907410|453673805|FG001|Overall Study|Lost to Follow-up|1|||
126103774|NCT03907410|453673806|FG002|Overall Study|Lost to Follow-up|1|||
126103775|NCT03907410|453673804|FG000|Overall Study|Lost to follow-up and research burden|0|||
126103776|NCT03907410|453673805|FG001|Overall Study|Lost to follow-up and research burden|0|||
126103777|NCT03907410|453673806|FG002|Overall Study|Lost to follow-up and research burden|1|||
126103778|NCT03718533|453673807|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
126103779|NCT03718533|453673807|FG000|Overall Study|Protocol deviation|1|||
126103780|NCT03718533|453673807|FG000|Overall Study|Disease progression|1|||
126103781|NCT03718533|453673807|FG000|Overall Study|Relapse|1|||
126103782|NCT03718533|453673807|FG000|Overall Study|Physician Decision|2|||
126103783|NCT03718533|453673807|FG000|Overall Study|Physician Decision and Adverse Event|1|||
126103784|NCT01295034|453673808|FG000|Overall Study|Lost to Follow-up|5|||
126103785|NCT01295034|453673809|FG001|Overall Study|Lost to Follow-up|5|||
126103786|NCT01174160|453673812|FG000|Overall Study|Adverse Event|1|||
126103787|NCT01174160|453673813|FG001|Overall Study|Adverse Event|0|||
126103788|NCT01174160|453673812|FG000|Overall Study|Lost to Follow-up|1|||
126103789|NCT01174160|453673813|FG001|Overall Study|Lost to Follow-up|0|||
126103790|NCT01174160|453673812|FG000|Overall Study|Physician Decision|1|||
126103791|NCT01174160|453673813|FG001|Overall Study|Physician Decision|0|||
126103792|NCT01174160|453673812|FG000|Overall Study|Protocol Violation|4|||
126103793|NCT01174160|453673813|FG001|Overall Study|Protocol Violation|6|||
126103794|NCT01174160|453673812|FG000|Overall Study|Withdrawal by Subject|1|||
126103795|NCT01174160|453673813|FG001|Overall Study|Withdrawal by Subject|0|||
126307372|NCT05217641|454414419|FG002|Overall Study|Other: participant did not specify reason|0|||
126307373|NCT05217641|454414420|FG003|Overall Study|Other: participant did not specify reason|0|||
126307374|NCT05217641|454414421|FG004|Overall Study|Other: participant did not specify reason|1|||
126307375|NCT05217641|454414422|FG005|Overall Study|Other: participant did not specify reason|0|||
126307376|NCT05217641|454414417|FG000|Overall Study|Extended Follow up|1|||
126307377|NCT05217641|454414418|FG001|Overall Study|Extended Follow up|1|||
126307378|NCT05217641|454414419|FG002|Overall Study|Extended Follow up|0|||
126307379|NCT05217641|454414420|FG003|Overall Study|Extended Follow up|0|||
126307380|NCT05217641|454414421|FG004|Overall Study|Extended Follow up|1|||
126307381|NCT05217641|454414422|FG005|Overall Study|Extended Follow up|0|||
126047321|NCT03524092|453471178|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126047322|NCT03524092|453471179|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126047323|NCT03524092|453471180|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
126047324|NCT03524092|453471181|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126047325|NCT03524092|453471182|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126047326|NCT03524092|453471177|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126047327|NCT03524092|453471178|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126047328|NCT03524092|453471179|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126047329|NCT03524092|453471180|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126103796|NCT04218084|453673814|FG000|Overall Study|Adverse Event|7|||
126103797|NCT04218084|453673815|FG001|Overall Study|Adverse Event|2|||
126103798|NCT04218084|453673814|FG000|Overall Study|Withdrawal of Consent|4|||
126103799|NCT04218084|453673815|FG001|Overall Study|Withdrawal of Consent|5|||
126103800|NCT04218084|453673814|FG000|Overall Study|Physician Decision|1|||
126103801|NCT04218084|453673815|FG001|Overall Study|Physician Decision|1|||
126103802|NCT04218084|453673814|FG000|Overall Study|Lost to Follow-up|1|||
126103803|NCT04218084|453673815|FG001|Overall Study|Lost to Follow-up|1|||
126103804|NCT04218084|453673814|FG000|Overall Study|Non-compliance with study drug|1|||
126103805|NCT04218084|453673815|FG001|Overall Study|Non-compliance with study drug|1|||
126103806|NCT04218084|453673814|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
126307382|NCT00626821|454414430|FG000|Overall Study|Adverse Event|44|||
125885481|NCT00432172|452876859|FG001|Overall Study|Physician Decision|0|||
126370697|NCT04756531|454653726|FG005|Overall Study|Withdrawal by Subject|0|||
126370698|NCT04756531|454653727|FG006|Overall Study|Withdrawal by Subject|1|||
126370699|NCT04756531|454653728|FG007|Overall Study|Withdrawal by Subject|0|||
126370700|NCT04756531|454653729|FG008|Overall Study|Withdrawal by Subject|0|||
126370701|NCT04756531|454653730|FG009|Overall Study|Withdrawal by Subject|0|||
126370702|NCT04756531|454653731|FG010|Overall Study|Withdrawal by Subject|0|||
126370703|NCT04756531|454653732|FG011|Overall Study|Withdrawal by Subject|0|||
126370704|NCT04756531|454653733|FG012|Overall Study|Withdrawal by Subject|0|||
126370705|NCT04756531|454653734|FG013|Overall Study|Withdrawal by Subject|0|||
126370706|NCT04756531|454653735|FG014|Overall Study|Withdrawal by Subject|0|||
126370707|NCT04756531|454653736|FG015|Overall Study|Withdrawal by Subject|0|||
126370708|NCT04756531|454653737|FG016|Overall Study|Withdrawal by Subject|0|||
126370709|NCT04756531|454653738|FG017|Overall Study|Withdrawal by Subject|0|||
126370710|NCT05643495|454653739|FG000|Overall Study|Adverse Event|0|||
126370711|NCT05643495|454653740|FG001|Overall Study|Adverse Event|1|||
126370712|NCT05643495|454653739|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
126370713|NCT05643495|454653740|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
126370714|NCT02257528|454653741|FG000|Overall Study|Never received study treatment|1|||
126370715|NCT06272383|454653742|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
126370716|NCT06272383|454653743|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
126370717|NCT04569084|454653748|FG000|Overall Study|Adverse Event|10|||
126370718|NCT04569084|454653749|FG001|Overall Study|Adverse Event|14|||
126370719|NCT04569084|454653748|FG000|Overall Study|Death|2|||
126370720|NCT04569084|454653749|FG001|Overall Study|Death|3|||
125885482|NCT00432172|452876860|FG002|Overall Study|Physician Decision|2|||
126047330|NCT03524092|453471181|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
126047331|NCT03524092|453471182|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126047332|NCT03524092|453471177|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126047333|NCT03524092|453471178|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126047334|NCT03524092|453471179|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126047335|NCT03524092|453471180|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126047336|NCT03524092|453471181|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
126047337|NCT03524092|453471182|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126047338|NCT03524092|453471177|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126047339|NCT03524092|453471178|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126047340|NCT03524092|453471179|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126047341|NCT03524092|453471180|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126047342|NCT03524092|453471181|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
126047343|NCT03524092|453471182|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126047344|NCT03524092|453471177|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126047345|NCT03524092|453471178|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126047346|NCT03524092|453471179|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126047347|NCT03524092|453471180|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126047348|NCT03524092|453471181|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
126047349|NCT03524092|453471182|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126047350|NCT03524092|453471177|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126047351|NCT03524092|453471178|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126047352|NCT03524092|453471179|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126047353|NCT03524092|453471180|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126047354|NCT03524092|453471181|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
126047355|NCT03524092|453471182|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126047356|NCT03524092|453471177|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126047357|NCT03524092|453471178|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126047358|NCT03524092|453471179|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126047359|NCT03524092|453471180|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126047360|NCT03524092|453471181|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
126047361|NCT03524092|453471182|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126047362|NCT03524092|453471177|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126047363|NCT03524092|453471178|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126088955|NCT03868787|453620026|FG001|Overall Study|Withdrawal by Subject|1|||
126088956|NCT01399697|453620039|FG000|Overall Study|Adverse Event|13|||
126088957|NCT01399697|453620040|FG001|Overall Study|Adverse Event|3|||
126370721|NCT04569084|454653748|FG000|Overall Study|Lost to Follow-up|1|||
126370722|NCT04569084|454653749|FG001|Overall Study|Lost to Follow-up|1|||
125885483|NCT00432172|452876861|FG003|Overall Study|Physician Decision|0|||
125885484|NCT00432172|452876858|FG000|Overall Study|Adverse Event|4|||
126103807|NCT04218084|453673815|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
126103808|NCT04218084|453673814|FG000|Overall Study|Other|0|||
126103809|NCT04218084|453673815|FG001|Overall Study|Other|1|||
126103810|NCT04218084|453673814|FG000|Overall Study|Ongoing at data cut-off date|62|||
126103811|NCT04218084|453673815|FG001|Overall Study|Ongoing at data cut-off date|58|||
126103812|NCT05580588|453673816|FG000|Overall Study|Lack of Efficacy|12|||
126103813|NCT00211185|453673819|FG000|Overall Study|Death|2|||
126103814|NCT00211185|453673819|FG000|Overall Study|Disease progression|7|||
126103815|NCT00211185|453673819|FG000|Overall Study|Withdrawal by Subject|6|||
126103816|NCT00211185|453673819|FG000|Overall Study|Physician Decision|5|||
126103817|NCT00712673|453673820|FG000|Overall Study|Adverse Event|3|||
126103818|NCT00712673|453673821|FG001|Overall Study|Adverse Event|3|||
126103819|NCT00712673|453673822|FG002|Overall Study|Adverse Event|21|||
126103820|NCT00712673|453673823|FG003|Overall Study|Adverse Event|26|||
126103821|NCT00712673|453673820|FG000|Overall Study|Lack of Efficacy|2|||
126103822|NCT00712673|453673821|FG001|Overall Study|Lack of Efficacy|8|||
126103823|NCT00712673|453673822|FG002|Overall Study|Lack of Efficacy|8|||
126103824|NCT00712673|453673823|FG003|Overall Study|Lack of Efficacy|6|||
126103825|NCT00712673|453673820|FG000|Overall Study|Poor Compliance to Protocol|3|||
126103826|NCT00712673|453673821|FG001|Overall Study|Poor Compliance to Protocol|3|||
126103827|NCT00712673|453673822|FG002|Overall Study|Poor Compliance to Protocol|4|||
126103828|NCT00712673|453673823|FG003|Overall Study|Poor Compliance to Protocol|16|||
126103829|NCT00712673|453673820|FG000|Overall Study|Lost to Follow-up|1|||
126103830|NCT00712673|453673821|FG001|Overall Study|Lost to Follow-up|0|||
126103831|NCT00712673|453673822|FG002|Overall Study|Lost to Follow-up|2|||
126103832|NCT00712673|453673823|FG003|Overall Study|Lost to Follow-up|0|||
126103833|NCT00712673|453673820|FG000|Overall Study|Withdrawal by Subject|6|||
126103834|NCT00712673|453673821|FG001|Overall Study|Withdrawal by Subject|7|||
126103835|NCT00712673|453673822|FG002|Overall Study|Withdrawal by Subject|15|||
126103836|NCT00712673|453673823|FG003|Overall Study|Withdrawal by Subject|20|||
126103837|NCT00712673|453673820|FG000|Overall Study|Familial and Personal Reasons|5|||
126103838|NCT00712673|453673821|FG001|Overall Study|Familial and Personal Reasons|0|||
126103839|NCT00712673|453673822|FG002|Overall Study|Familial and Personal Reasons|5|||
126103840|NCT00712673|453673823|FG003|Overall Study|Familial and Personal Reasons|2|||
126103841|NCT00712673|453673820|FG000|Overall Study|Investigator's Decision|1|||
126103842|NCT00712673|453673821|FG001|Overall Study|Investigator's Decision|0|||
126103843|NCT00712673|453673822|FG002|Overall Study|Investigator's Decision|0|||
126103844|NCT00712673|453673823|FG003|Overall Study|Investigator's Decision|0|||
126103845|NCT00712673|453673820|FG000|Overall Study|Protocol Violation|0|||
126103846|NCT00712673|453673821|FG001|Overall Study|Protocol Violation|0|||
126103847|NCT00712673|453673822|FG002|Overall Study|Protocol Violation|2|||
126103848|NCT00712673|453673823|FG003|Overall Study|Protocol Violation|0|||
126103849|NCT03658668|453673824|FG000|Overall Study|Time Commitment|1|||
126103850|NCT03658668|453673825|FG001|Overall Study|Time Commitment|1|||
126103851|NCT03305731|453673826|FG000|Overall Study|Protocol Violation|1|||
126103852|NCT01952054|453673827|FG000|Overall Study|Physician Decision|1|||
126103853|NCT05208866|453673828|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
126103854|NCT02070588|453673829|FG000|Overall Study|Withdrawal by Subject|29|||
126103855|NCT02070588|453673830|FG001|Overall Study|Withdrawal by Subject|1|||
126103856|NCT02070588|453673831|FG002|Overall Study|Withdrawal by Subject|0|||
126103857|NCT02070588|453673829|FG000|Overall Study|Writhdrawal due to early termination|9|||
126103858|NCT02070588|453673830|FG001|Overall Study|Writhdrawal due to early termination|0|||
126103859|NCT02070588|453673831|FG002|Overall Study|Writhdrawal due to early termination|0|||
126103860|NCT02070588|453673829|FG000|Overall Study|Adverse Event|1|||
126103861|NCT02070588|453673830|FG001|Overall Study|Adverse Event|0|||
126103862|NCT02070588|453673831|FG002|Overall Study|Adverse Event|0|||
126103863|NCT00836095|453673833|FG000|Overall Study|Physician Decision|0|||
126103864|NCT00836095|453673834|FG001|Overall Study|Physician Decision|3|||
126103865|NCT02745392|453673840|FG000|Overall Study|Lost to Follow-up|0|||
126103866|NCT02745392|453673841|FG001|Overall Study|Lost to Follow-up|1|||
126307383|NCT00626821|454414430|FG000|Overall Study|Protocol Violation|33|||
126307384|NCT00626821|454414430|FG000|Overall Study|Withdrawal by Subject|10|||
126103867|NCT02745392|453673842|FG002|Overall Study|Lost to Follow-up|0|||
126103868|NCT02745392|453673843|FG003|Overall Study|Lost to Follow-up|0|||
126103869|NCT04781387|453673846|FG000|Overall Study|Withdrawal by Subject|1|||
126103870|NCT04781387|453673847|FG001|Overall Study|Withdrawal by Subject|0|||
126103871|NCT04781387|453673848|FG002|Overall Study|Withdrawal by Subject|1|||
126103872|NCT04781387|453673846|FG000|Overall Study|Lost to Follow-up|1|||
126103873|NCT04781387|453673847|FG001|Overall Study|Lost to Follow-up|0|||
126103874|NCT04781387|453673848|FG002|Overall Study|Lost to Follow-up|0|||
126103875|NCT01079741|453673849|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
126103876|NCT01079741|453673850|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
126103877|NCT01079741|453673851|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
126103878|NCT01079741|453673852|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
126103879|NCT01079741|453673853|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
126103880|NCT01079741|453673849|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
126047364|NCT03524092|453471179|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126047365|NCT03524092|453471180|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126047366|NCT03524092|453471181|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
126047367|NCT03524092|453471182|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126307385|NCT00626821|454414430|FG000|Overall Study|Physician Decision|9|||
126307386|NCT00626821|454414430|FG000|Overall Study|Product dysfunction|21|||
126307387|NCT00626821|454414430|FG000|Overall Study|other/unknown reason|104|||
126307388|NCT02632409|454414431|FG000|Randomized|AE unrelated to study Drug|0|||
126307389|NCT02632409|454414432|FG001|Randomized|AE unrelated to study Drug|1|||
126307390|NCT02632409|454414431|FG000|Randomized|Participant withdrew consent|2|||
126307391|NCT02632409|454414432|FG001|Randomized|Participant withdrew consent|1|||
126307392|NCT02632409|454414431|FG000|Randomized|No Longer meets study criteria|5|||
126307393|NCT02632409|454414432|FG001|Randomized|No Longer meets study criteria|0|||
126307394|NCT02632409|454414431|FG000|Randomized|other reasons|1|||
126307395|NCT02632409|454414432|FG001|Randomized|other reasons|0|||
126307396|NCT02632409|454414431|FG000|Treatment Period|Ongoing Treatment|20|||
126307397|NCT02632409|454414432|FG001|Treatment Period|Ongoing Treatment|21|||
126307398|NCT02632409|454414431|FG000|Treatment Period|Disease Recurrence|147|||
126307399|NCT02632409|454414432|FG001|Treatment Period|Disease Recurrence|90|||
126307400|NCT02632409|454414431|FG000|Treatment Period|Study Drug Toxicity|8|||
126307401|NCT02632409|454414432|FG001|Treatment Period|Study Drug Toxicity|49|||
126307402|NCT02632409|454414431|FG000|Treatment Period|Death|1|||
126307403|NCT02632409|454414432|FG001|Treatment Period|Death|0|||
126307404|NCT02632409|454414431|FG000|Treatment Period|AE unrelated to study drug|15|||
126307405|NCT02632409|454414432|FG001|Treatment Period|AE unrelated to study drug|16|||
126307406|NCT02632409|454414431|FG000|Treatment Period|Request to discontinue treatment|4|||
126307407|NCT02632409|454414432|FG001|Treatment Period|Request to discontinue treatment|19|||
126307408|NCT02632409|454414431|FG000|Treatment Period|Participant withdrew consent|7|||
126307409|NCT02632409|454414432|FG001|Treatment Period|Participant withdrew consent|5|||
126307410|NCT02632409|454414431|FG000|Treatment Period|Lost to Follow-up|0|||
126307411|NCT02632409|454414432|FG001|Treatment Period|Lost to Follow-up|1|||
126307412|NCT02632409|454414431|FG000|Treatment Period|Maximum clinical benefit|1|||
126307413|NCT02632409|454414432|FG001|Treatment Period|Maximum clinical benefit|0|||
126307414|NCT02632409|454414431|FG000|Treatment Period|No longer meets study criteria|3|||
126307415|NCT02632409|454414432|FG001|Treatment Period|No longer meets study criteria|0|||
126307416|NCT02632409|454414431|FG000|Treatment Period|Administrative Reason by sponsor|0|||
126307417|NCT02632409|454414432|FG001|Treatment Period|Administrative Reason by sponsor|1|||
126307418|NCT02632409|454414431|FG000|Treatment Period|Other Reasons|10|||
126307419|NCT02632409|454414432|FG001|Treatment Period|Other Reasons|6|||
126307420|NCT01471340|454414433|FG000|Overall Study|Death|5|||
126307421|NCT01471340|454414434|FG001|Overall Study|Death|4|||
126307422|NCT01471340|454414433|FG000|Overall Study|Lost to Follow-up|0|||
126307423|NCT01471340|454414434|FG001|Overall Study|Lost to Follow-up|1|||
126307424|NCT01471340|454414433|FG000|Overall Study|Investigational site closure|0|||
126307425|NCT01471340|454414434|FG001|Overall Study|Investigational site closure|1|||
126307426|NCT01471340|454414433|FG000|Overall Study|Invalid informed consent|1|||
126307427|NCT01471340|454414434|FG001|Overall Study|Invalid informed consent|0|||
126307428|NCT00526669|454414437|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
126307429|NCT00526669|454414438|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
126307430|NCT00526669|454414437|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
126307431|NCT00526669|454414438|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
126307432|NCT00526669|454414437|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
126307433|NCT00526669|454414438|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
126307434|NCT00526669|454414437|FG000|Combined Treatment Phase|Death|0|||
126307435|NCT00526669|454414438|FG001|Combined Treatment Phase|Death|2|||
126307436|NCT03499899|454414440|FG000|Overall Study|Adverse Event|2|||
126307437|NCT03499899|454414441|FG001|Overall Study|Adverse Event|3|||
126307438|NCT03499899|454414442|FG002|Overall Study|Adverse Event|3|||
126307439|NCT03499899|454414440|FG000|Overall Study|Death|0|||
126370723|NCT04569084|454653748|FG000|Overall Study|Physician Decision|3|||
126047368|NCT03524092|453471177|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126047369|NCT03524092|453471178|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126047370|NCT03524092|453471179|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126307440|NCT03499899|454414441|FG001|Overall Study|Death|0|||
126307441|NCT03499899|454414442|FG002|Overall Study|Death|1|||
126307442|NCT03499899|454414440|FG000|Overall Study|Physician Decision|3|||
126307443|NCT03499899|454414441|FG001|Overall Study|Physician Decision|6|||
126307444|NCT03499899|454414442|FG002|Overall Study|Physician Decision|6|||
126307445|NCT03499899|454414440|FG000|Overall Study|Progressive disease|15|||
126307446|NCT03499899|454414441|FG001|Overall Study|Progressive disease|23|||
126307447|NCT03499899|454414442|FG002|Overall Study|Progressive disease|23|||
126307448|NCT03499899|454414440|FG000|Overall Study|Patient decision|0|||
126307449|NCT03499899|454414441|FG001|Overall Study|Patient decision|1|||
126307450|NCT03499899|454414442|FG002|Overall Study|Patient decision|1|||
126370724|NCT04569084|454653749|FG001|Overall Study|Physician Decision|3|||
126047371|NCT03524092|453471180|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126047372|NCT03524092|453471181|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126307451|NCT03499899|454414440|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
126307452|NCT03499899|454414441|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
126307453|NCT03499899|454414442|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
126307454|NCT01082211|454414444|FG000|Overall Study|Protocol Violation|4|||
126307455|NCT01082211|454414444|FG000|Overall Study|No protocol treatment received|3|||
126307456|NCT04016779|454414454|FG000|Overall Study|Adverse Event|9|||
126307457|NCT04016779|454414455|FG001|Overall Study|Adverse Event|17|||
126307458|NCT04016779|454414454|FG000|Overall Study|Lack of Efficacy|4|||
126307459|NCT04016779|454414455|FG001|Overall Study|Lack of Efficacy|1|||
126307460|NCT04016779|454414454|FG000|Overall Study|Lost to Follow-up|5|||
126307461|NCT04016779|454414455|FG001|Overall Study|Lost to Follow-up|14|||
126307462|NCT04016779|454414454|FG000|Overall Study|Physician Decision|1|||
126307463|NCT04016779|454414455|FG001|Overall Study|Physician Decision|3|||
126307464|NCT04016779|454414454|FG000|Overall Study|Withdrawal by Subject|6|||
126307465|NCT04016779|454414455|FG001|Overall Study|Withdrawal by Subject|8|||
126307466|NCT04016779|454414454|FG000|Overall Study|Non-compliance with Study Drug|2|||
126307467|NCT04016779|454414455|FG001|Overall Study|Non-compliance with Study Drug|3|||
126307468|NCT04016779|454414454|FG000|Overall Study|Other, Multiple categories|17|||
126307469|NCT04016779|454414455|FG001|Overall Study|Other, Multiple categories|17|||
126307470|NCT02295020|454414456|FG000|Overall Study|Adverse Event|0|||
126307471|NCT02295020|454414457|FG001|Overall Study|Adverse Event|1|||
126307472|NCT02295020|454414456|FG000|Overall Study|Withdrawal by Subject|3|||
126307473|NCT02295020|454414457|FG001|Overall Study|Withdrawal by Subject|2|||
126307474|NCT02394340|454414462|FG000|Overall Study|Failed drug screen test|1|||
126307475|NCT02394340|454414462|FG000|Overall Study|Adverse Event|1|||
126307476|NCT02828124|454414463|FG000|Overall Study|Disease Progression|1|||
126307477|NCT02828124|454414464|FG001|Overall Study|Disease Progression|2|||
126307478|NCT02828124|454414465|FG002|Overall Study|Disease Progression|1|||
126307479|NCT02828124|454414466|FG003|Overall Study|Disease Progression|4|||
126307480|NCT02828124|454414463|FG000|Overall Study|AE Unrelated to Study Drug|0|||
126307481|NCT02828124|454414464|FG001|Overall Study|AE Unrelated to Study Drug|0|||
126307482|NCT02828124|454414465|FG002|Overall Study|AE Unrelated to Study Drug|0|||
126307483|NCT02828124|454414466|FG003|Overall Study|AE Unrelated to Study Drug|1|||
126307484|NCT02828124|454414463|FG000|Overall Study|Subject Withdrew Consent|0|||
126307485|NCT02828124|454414464|FG001|Overall Study|Subject Withdrew Consent|0|||
126307486|NCT02828124|454414465|FG002|Overall Study|Subject Withdrew Consent|0|||
126307487|NCT02828124|454414466|FG003|Overall Study|Subject Withdrew Consent|1|||
126307488|NCT00256854|454414468|FG000|Overall Study|Withdrawal by Subject|2|||
126307489|NCT00256854|454414469|FG001|Overall Study|Withdrawal by Subject|3|||
126307490|NCT00256854|454414470|FG002|Overall Study|Withdrawal by Subject|0|||
126307491|NCT00256854|454414471|FG003|Overall Study|Withdrawal by Subject|0|||
126307492|NCT00256854|454414472|FG004|Overall Study|Withdrawal by Subject|0|||
126307493|NCT00256854|454414473|FG005|Overall Study|Withdrawal by Subject|0|||
126307494|NCT00256854|454414468|FG000|Overall Study|Lack of Efficacy|1|||
126307495|NCT00256854|454414469|FG001|Overall Study|Lack of Efficacy|0|||
126307496|NCT00256854|454414470|FG002|Overall Study|Lack of Efficacy|0|||
126307497|NCT00256854|454414471|FG003|Overall Study|Lack of Efficacy|0|||
126307498|NCT00256854|454414472|FG004|Overall Study|Lack of Efficacy|0|||
126307499|NCT00256854|454414473|FG005|Overall Study|Lack of Efficacy|0|||
126307500|NCT00256854|454414468|FG000|Overall Study|Protocol Violation|0|||
126307501|NCT00256854|454414469|FG001|Overall Study|Protocol Violation|1|||
126307502|NCT00256854|454414470|FG002|Overall Study|Protocol Violation|1|||
126307503|NCT00256854|454414471|FG003|Overall Study|Protocol Violation|1|||
126307504|NCT00256854|454414472|FG004|Overall Study|Protocol Violation|0|||
126307505|NCT00256854|454414473|FG005|Overall Study|Protocol Violation|0|||
126307506|NCT00256854|454414468|FG000|Overall Study|Adverse Event|0|||
126307507|NCT00256854|454414469|FG001|Overall Study|Adverse Event|0|||
126307508|NCT00256854|454414470|FG002|Overall Study|Adverse Event|2|||
126307509|NCT00256854|454414471|FG003|Overall Study|Adverse Event|2|||
126307510|NCT00256854|454414472|FG004|Overall Study|Adverse Event|0|||
126307511|NCT00256854|454414473|FG005|Overall Study|Adverse Event|1|||
126307512|NCT00256854|454414468|FG000|Overall Study|Not compliant with the study drug|0|||
126307513|NCT00256854|454414469|FG001|Overall Study|Not compliant with the study drug|0|||
126307514|NCT00256854|454414470|FG002|Overall Study|Not compliant with the study drug|0|||
126307515|NCT00256854|454414471|FG003|Overall Study|Not compliant with the study drug|0|||
126307516|NCT00256854|454414472|FG004|Overall Study|Not compliant with the study drug|1|||
126307517|NCT00256854|454414473|FG005|Overall Study|Not compliant with the study drug|0|||
126307518|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
126307519|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
126307520|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
126047373|NCT03524092|453471182|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
126307521|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
126307522|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
126370725|NCT04569084|454653748|FG000|Overall Study|Protocol Violation|2|||
126370726|NCT04569084|454653749|FG001|Overall Study|Protocol Violation|1|||
126047374|NCT03524092|453471177|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126047375|NCT03524092|453471178|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126047376|NCT03524092|453471179|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126047377|NCT03524092|453471180|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126047378|NCT03524092|453471181|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126307523|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
126307524|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
126307525|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
126307526|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
126307527|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
126307528|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Death|1|||
126307529|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Death|0|||
126307530|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
126307531|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
126307532|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
126307533|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
126307534|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
126307535|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
126307536|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
126307537|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
126307538|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Adverse Event|2|||
126307539|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Adverse Event|6|||
126307540|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
126307541|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
126307542|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Progressive disease|4|||
126307543|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Progressive disease|35|||
126307544|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
126307545|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
126307546|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
126307547|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
126307548|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Death|0|||
126307549|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Death|1|||
126307550|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Other than specified above|9|||
126307551|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Other than specified above|18|||
126307552|NCT03605862|454414476|FG000|Overall Study|Withdrawal by Subject|12|||
126307553|NCT03605862|454414477|FG001|Overall Study|Withdrawal by Subject|9|||
126307554|NCT03605862|454414476|FG000|Overall Study|Adverse Event|2|||
126307555|NCT03605862|454414477|FG001|Overall Study|Adverse Event|1|||
126307556|NCT03605862|454414476|FG000|Overall Study|Physician Decision|3|||
126307557|NCT03605862|454414477|FG001|Overall Study|Physician Decision|1|||
126307558|NCT03605862|454414476|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
126307559|NCT03605862|454414477|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
126307560|NCT00937040|454414478|FG000|Overall Study|Adverse Event|5|||
126307561|NCT00937040|454414479|FG001|Overall Study|Adverse Event|8|||
126307562|NCT00937040|454414478|FG000|Overall Study|Lost to Follow-up|12|||
126047379|NCT03524092|453471182|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
126047380|NCT03524092|453471177|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126047381|NCT03524092|453471178|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126047382|NCT03524092|453471179|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126047383|NCT03524092|453471180|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126047384|NCT03524092|453471181|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126047385|NCT03524092|453471182|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
126307563|NCT00937040|454414479|FG001|Overall Study|Lost to Follow-up|12|||
126370727|NCT04569084|454653748|FG000|Overall Study|Withdrawal by Subject|20|||
126370728|NCT04569084|454653749|FG001|Overall Study|Withdrawal by Subject|21|||
126370729|NCT04569084|454653748|FG000|Overall Study|Study terminated by sponsor|26|||
126370730|NCT04569084|454653749|FG001|Overall Study|Study terminated by sponsor|23|||
126370731|NCT04569084|454653748|FG000|Overall Study|Other|3|||
126370732|NCT04569084|454653749|FG001|Overall Study|Other|5|||
126370733|NCT01994876|454653750|FG000|Test Period 1|Withdrawal by Subject|0|||
126370734|NCT01994876|454653751|FG001|Test Period 1|Withdrawal by Subject|1|||
126307564|NCT00937040|454414478|FG000|Overall Study|Protocol Violation|3|||
126307565|NCT00937040|454414479|FG001|Overall Study|Protocol Violation|0|||
126370735|NCT01994876|454653750|FG000|Test Period 1|Adverse Event|0|||
126370736|NCT01994876|454653751|FG001|Test Period 1|Adverse Event|1|||
126370737|NCT01994876|454653750|FG000|Test Period 2|Adverse Event|1|||
126370738|NCT01994876|454653751|FG001|Test Period 2|Adverse Event|0|||
126370739|NCT01994876|454653750|FG000|Test Period 2|Protocol Violation|0|||
126370740|NCT01994876|454653751|FG001|Test Period 2|Protocol Violation|1|||
126370741|NCT01346176|454653752|FG000|Recruited|Protocol Violation|1|||
126370742|NCT01346176|454653753|FG001|Recruited|Protocol Violation|0|||
126370743|NCT01346176|454653754|FG002|Recruited|Protocol Violation|0|||
126370744|NCT01346176|454653752|FG000|Completed Advance Directive|Death|3|||
126370745|NCT01346176|454653753|FG001|Completed Advance Directive|Death|2|||
126370746|NCT01346176|454653754|FG002|Completed Advance Directive|Death|2|||
126370747|NCT01346176|454653752|FG000|Completed Advance Directive|Became Ineligible|3|||
126370748|NCT01346176|454653753|FG001|Completed Advance Directive|Became Ineligible|0|||
126370749|NCT01346176|454653754|FG002|Completed Advance Directive|Became Ineligible|1|||
126370750|NCT01346176|454653752|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
126370751|NCT01346176|454653753|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
126370752|NCT01346176|454653754|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
126370753|NCT01346176|454653752|FG000|Completed Satisfaction Survey|Death|3|||
126370754|NCT01346176|454653753|FG001|Completed Satisfaction Survey|Death|0|||
126370755|NCT01346176|454653754|FG002|Completed Satisfaction Survey|Death|2|||
126370756|NCT01346176|454653752|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
126370757|NCT01346176|454653753|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
126103881|NCT01079741|453673850|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
126103882|NCT01079741|453673851|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
126103883|NCT01079741|453673852|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
126103884|NCT01079741|453673853|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
126103885|NCT00446992|453673854|FG000|Overall Study|Adverse Event|11|||
126103886|NCT00446992|453673854|FG000|Overall Study|Lost to Follow-up|5|||
126103887|NCT01275131|453673855|FG000|Period 1|Withdrawal by Subject|1|||
126103888|NCT01275131|453673856|FG001|Period 1|Withdrawal by Subject|0|||
126103889|NCT01275131|453673857|FG002|Period 1|Withdrawal by Subject|3|||
126103890|NCT01275131|453673858|FG003|Period 1|Withdrawal by Subject|2|||
126103891|NCT01275131|453673855|FG000|Period 1|Physician Decision|1|||
126103892|NCT01275131|453673856|FG001|Period 1|Physician Decision|0|||
126370758|NCT01346176|454653754|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
126370759|NCT01400412|454653755|FG000|Overall Study|Lost to Follow-up|4|||
126370760|NCT01400412|454653756|FG001|Overall Study|Lost to Follow-up|7|||
126370761|NCT01400412|454653755|FG000|Overall Study|Withdrawal by Subject|3|||
126370762|NCT01400412|454653756|FG001|Overall Study|Withdrawal by Subject|4|||
126370763|NCT01400412|454653755|FG000|Overall Study|Unable to complete|3|||
126370764|NCT01400412|454653756|FG001|Overall Study|Unable to complete|3|||
126370765|NCT01400412|454653755|FG000|Overall Study|Never started study treatment|0|||
126370766|NCT01400412|454653756|FG001|Overall Study|Never started study treatment|3|||
126370767|NCT04043286|454655211|FG000|Overall Study|Withdrawal by Subject|2|||
126370768|NCT04043286|454655212|FG001|Overall Study|Withdrawal by Subject|2|||
126370769|NCT01323192|454655213|FG000|Overall Study|Adverse Event|6|||
126370770|NCT01323192|454655214|FG001|Overall Study|Adverse Event|1|||
126370771|NCT01323192|454655213|FG000|Overall Study|Withdrawal by Subject|3|||
126370772|NCT01323192|454655214|FG001|Overall Study|Withdrawal by Subject|1|||
126370773|NCT01323192|454655213|FG000|Overall Study|Noncompliance with study medication|0|||
126103893|NCT01275131|453673857|FG002|Period 1|Physician Decision|0|||
126103894|NCT01275131|453673858|FG003|Period 1|Physician Decision|0|||
126103895|NCT01275131|453673855|FG000|Period 2 (Crossover)|Adverse Event|0|||
126103896|NCT01275131|453673856|FG001|Period 2 (Crossover)|Adverse Event|1|||
126103897|NCT01275131|453673857|FG002|Period 2 (Crossover)|Adverse Event|0|||
126370774|NCT01323192|454655214|FG001|Overall Study|Noncompliance with study medication|3|||
126370775|NCT01323192|454655213|FG000|Overall Study|Nonmedical reasons|0|||
126370776|NCT01323192|454655214|FG001|Overall Study|Nonmedical reasons|1|||
126370777|NCT02296476|454655215|FG000|Overall Study|Disease Progression|6|||
126370778|NCT02296476|454655216|FG001|Overall Study|Disease Progression|4|||
126103898|NCT01275131|453673858|FG003|Period 2 (Crossover)|Adverse Event|0|||
126370779|NCT02296476|454655217|FG002|Overall Study|Disease Progression|2|||
125885485|NCT00432172|452876859|FG001|Overall Study|Adverse Event|2|||
126103899|NCT01275131|453673855|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
126103900|NCT01275131|453673856|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
126103901|NCT01275131|453673857|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
126103902|NCT01275131|453673858|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
126370780|NCT03122184|454655224|FG000|Overall Study|Lost to Follow-up|4|||
126370781|NCT03122184|454655225|FG001|Overall Study|Lost to Follow-up|6|||
126370782|NCT03122184|454655224|FG000|Overall Study|Withdrawal by Subject|3|||
126370783|NCT03122184|454655225|FG001|Overall Study|Withdrawal by Subject|0|||
126370784|NCT03122184|454655224|FG000|Overall Study|Terminated due to cognitive problem|1|||
125885486|NCT00432172|452876860|FG002|Overall Study|Adverse Event|4|||
126103903|NCT00710021|453673859|FG000|Overall Study|Lost to Follow-up|1|||
126103904|NCT00710021|453673860|FG001|Overall Study|Lost to Follow-up|0|||
126370785|NCT03122184|454655225|FG001|Overall Study|Terminated due to cognitive problem|0|||
126047386|NCT03524092|453471177|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126047387|NCT03524092|453471178|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126047388|NCT03524092|453471179|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126047389|NCT03524092|453471180|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126047390|NCT03524092|453471181|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126047391|NCT03524092|453471182|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
126047392|NCT03834740|453471183|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
126047393|NCT03834740|453471184|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
126047394|NCT03834740|453471185|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
126047395|NCT00115934|453471186|FG000|Overall Study|Lost to Follow-up|1|||
126047396|NCT00115934|453471187|FG001|Overall Study|Lost to Follow-up|0|||
126047397|NCT00115934|453471186|FG000|Overall Study|Did not receive intervention|3|||
126307566|NCT00937040|454414478|FG000|Overall Study|Withdrawal by Subject|13|||
126307567|NCT00937040|454414479|FG001|Overall Study|Withdrawal by Subject|7|||
126307568|NCT00937040|454414478|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
126307569|NCT00937040|454414479|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
126307570|NCT00937040|454414478|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
126307571|NCT00937040|454414479|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
126307572|NCT00492648|454414480|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
126307573|NCT00492648|454414481|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
126307574|NCT02294396|454414484|FG000|Overall Study|Adverse Event|26|||
126307575|NCT02294396|454414485|FG001|Overall Study|Adverse Event|25|||
126307576|NCT02294396|454414486|FG002|Overall Study|Adverse Event|21|||
126307577|NCT02294396|454414487|FG003|Overall Study|Adverse Event|24|||
126307578|NCT02294396|454414484|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
126307579|NCT02294396|454414485|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
126307580|NCT02294396|454414486|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
126307581|NCT02294396|454414487|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
126307582|NCT02294396|454414484|FG000|Overall Study|Withdrawal by Subject|8|||
126307583|NCT02294396|454414485|FG001|Overall Study|Withdrawal by Subject|6|||
126307584|NCT02294396|454414486|FG002|Overall Study|Withdrawal by Subject|6|||
126307585|NCT02294396|454414487|FG003|Overall Study|Withdrawal by Subject|8|||
126307586|NCT02294396|454414484|FG000|Overall Study|Lost to Follow-up|0|||
126307587|NCT02294396|454414485|FG001|Overall Study|Lost to Follow-up|0|||
126307588|NCT02294396|454414486|FG002|Overall Study|Lost to Follow-up|1|||
126307589|NCT02294396|454414487|FG003|Overall Study|Lost to Follow-up|1|||
126307590|NCT02294396|454414484|FG000|Overall Study|Protocol Deviation|3|||
126307591|NCT02294396|454414485|FG001|Overall Study|Protocol Deviation|2|||
126307592|NCT02294396|454414486|FG002|Overall Study|Protocol Deviation|2|||
126088958|NCT01399697|453620041|FG002|Overall Study|Adverse Event|1|||
126307593|NCT02294396|454414487|FG003|Overall Study|Protocol Deviation|1|||
126307594|NCT02294396|454414484|FG000|Overall Study|Miscellaneous|2|||
126307595|NCT02294396|454414485|FG001|Overall Study|Miscellaneous|0|||
126307596|NCT02294396|454414486|FG002|Overall Study|Miscellaneous|5|||
126307597|NCT02294396|454414487|FG003|Overall Study|Miscellaneous|2|||
126370786|NCT02835690|454655226|FG000|Overall Study|Death|12|||
126370787|NCT02835690|454655227|FG001|Overall Study|Death|11|||
126370788|NCT02835690|454655228|FG002|Overall Study|Death|13|||
126370789|NCT02835690|454655226|FG000|Overall Study|Transferred to Extension Study|2|||
126370790|NCT02835690|454655227|FG001|Overall Study|Transferred to Extension Study|2|||
126370791|NCT02835690|454655228|FG002|Overall Study|Transferred to Extension Study|1|||
126370792|NCT02835690|454655226|FG000|Overall Study|Did Not Continue on Extension Study|0|||
126370793|NCT02835690|454655227|FG001|Overall Study|Did Not Continue on Extension Study|0|||
126370794|NCT02835690|454655228|FG002|Overall Study|Did Not Continue on Extension Study|1|||
126370795|NCT02835690|454655226|FG000|Overall Study|Not Treated|0|||
126370796|NCT02835690|454655227|FG001|Overall Study|Not Treated|2|||
126047398|NCT00115934|453471187|FG001|Overall Study|Did not receive intervention|2|||
126307598|NCT02120833|454414488|FG000|Overall Study|Adverse Event|1|||
126307599|NCT02120833|454414489|FG001|Overall Study|Adverse Event|0|||
126307600|NCT02120833|454414488|FG000|Overall Study|Withdrawal by Subject|2|||
126307601|NCT02120833|454414489|FG001|Overall Study|Withdrawal by Subject|0|||
126307602|NCT02120833|454414488|FG000|Overall Study|Lost to Follow-up|1|||
126307603|NCT02120833|454414489|FG001|Overall Study|Lost to Follow-up|1|||
126307604|NCT03502070|454414490|FG000|Overall Study|Withdrawal by Subject|1|||
126307605|NCT03502070|454414490|FG000|Overall Study|Screen Failure|1|||
126307606|NCT01435460|454414500|FG000|Overall Study|Adverse Event|2|||
126307607|NCT01435460|454414501|FG001|Overall Study|Adverse Event|1|||
126307608|NCT01435460|454414500|FG000|Overall Study|Lost to Follow-up|6|||
126307609|NCT01435460|454414501|FG001|Overall Study|Lost to Follow-up|1|||
126307610|NCT01435460|454414500|FG000|Overall Study|Withdrawal by Subject|1|||
126307611|NCT01435460|454414501|FG001|Overall Study|Withdrawal by Subject|3|||
126307612|NCT01435460|454414500|FG000|Overall Study|Protocol Violation|0|||
126307613|NCT01435460|454414501|FG001|Overall Study|Protocol Violation|1|||
126307614|NCT01435460|454414500|FG000|Overall Study|Did not meet eligibility criteria|2|||
126307615|NCT01435460|454414501|FG001|Overall Study|Did not meet eligibility criteria|0|||
126307616|NCT01046903|454414502|FG000|Overall Study|Lost to Follow-up|16|||
126307617|NCT01046903|454414502|FG000|Overall Study|Adverse Event|4|||
126307618|NCT01046903|454414502|FG000|Overall Study|Withdrawal by Subject|3|||
126307619|NCT01046903|454414502|FG000|Overall Study|Other|5|||
126307620|NCT01894100|454414505|FG000|Overall Study|Lost to Follow-up|0|||
126307621|NCT01894100|454414506|FG001|Overall Study|Lost to Follow-up|1|||
126307622|NCT01894100|454414505|FG000|Overall Study|Withdrawal by Subject|3|||
126307623|NCT01894100|454414506|FG001|Overall Study|Withdrawal by Subject|0|||
126307624|NCT02235077|454414507|FG000|Overall Study|Death|5|||
126307625|NCT02235077|454414508|FG001|Overall Study|Death|7|||
126307626|NCT02235077|454414507|FG000|Overall Study|Lost to Follow-up|5|||
126307627|NCT02235077|454414508|FG001|Overall Study|Lost to Follow-up|6|||
126307628|NCT02235077|454414507|FG000|Overall Study|Withdrawal by Subject|8|||
126307629|NCT02235077|454414508|FG001|Overall Study|Withdrawal by Subject|5|||
126307630|NCT02235077|454414507|FG000|Overall Study|Physician Decision|0|||
126370797|NCT02835690|454655228|FG002|Overall Study|Not Treated|0|||
126370798|NCT03674281|454655229|FG000|Overall Study|screen failure|2|||
126370799|NCT03674281|454655230|FG001|Overall Study|screen failure|0|||
126370800|NCT03674281|454655231|FG002|Overall Study|screen failure|0|||
126370801|NCT03674281|454655229|FG000|Overall Study|Withdrawal by Subject|1|||
126370802|NCT03674281|454655230|FG001|Overall Study|Withdrawal by Subject|3|||
126370803|NCT03674281|454655231|FG002|Overall Study|Withdrawal by Subject|3|||
126370804|NCT00710593|454655232|FG000|Overall Study|Incarceration|1|||
126370805|NCT00710593|454655233|FG001|Overall Study|Incarceration|0|||
126370806|NCT00710593|454655232|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
126370807|NCT00710593|454655233|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
126370808|NCT00710593|454655232|FG000|Overall Study|Lost to Follow-up|3|||
126370809|NCT00710593|454655233|FG001|Overall Study|Lost to Follow-up|1|||
126370810|NCT00710593|454655232|FG000|Overall Study|Moved out of area|1|||
126370811|NCT00710593|454655233|FG001|Overall Study|Moved out of area|0|||
126370812|NCT00710593|454655232|FG000|Overall Study|Failure to adhere or complete study eval|1|||
126370813|NCT00710593|454655233|FG001|Overall Study|Failure to adhere or complete study eval|1|||
126370814|NCT00710593|454655232|FG000|Overall Study|Protocol Violation|1|||
126370815|NCT00710593|454655233|FG001|Overall Study|Protocol Violation|1|||
126370816|NCT00710593|454655232|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
126370817|NCT00710593|454655233|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
126370818|NCT04490278|454655234|FG000|Overall Study|Lost to Follow-up|6|||
126370819|NCT02829996|454655237|FG000|Overall Study|Withdrawal by Subject|1|||
126370820|NCT02829996|454655238|FG001|Overall Study|Withdrawal by Subject|0|||
126370821|NCT02829996|454655239|FG002|Overall Study|Withdrawal by Subject|0|||
126370822|NCT02829996|454655240|FG003|Overall Study|Withdrawal by Subject|0|||
126370823|NCT02829996|454655241|FG004|Overall Study|Withdrawal by Subject|0|||
126307631|NCT02235077|454414508|FG001|Overall Study|Physician Decision|1|||
126307632|NCT04013672|454414510|FG000|Overall Study|Withdrawal by Subject|3|||
126307633|NCT04013672|454414511|FG001|Overall Study|Withdrawal by Subject|0|||
126307634|NCT04013672|454414510|FG000|Overall Study|Death|1|||
126307635|NCT04013672|454414511|FG001|Overall Study|Death|0|||
125885487|NCT00432172|452876861|FG003|Overall Study|Adverse Event|3|||
125885488|NCT00432172|452876858|FG000|Overall Study|Disease progression|0|||
125885489|NCT00432172|452876859|FG001|Overall Study|Disease progression|2|||
125885490|NCT00432172|452876860|FG002|Overall Study|Disease progression|5|||
125885491|NCT00432172|452876861|FG003|Overall Study|Disease progression|1|||
125885492|NCT00432172|452876858|FG000|Overall Study|Withdrawal by Subject|0|||
125885493|NCT00432172|452876859|FG001|Overall Study|Withdrawal by Subject|1|||
125885494|NCT00432172|452876860|FG002|Overall Study|Withdrawal by Subject|0|||
125885495|NCT00432172|452876861|FG003|Overall Study|Withdrawal by Subject|2|||
125885496|NCT00432172|452876858|FG000|Overall Study|No treatment received|2|||
125885497|NCT00432172|452876859|FG001|Overall Study|No treatment received|2|||
125885498|NCT00432172|452876860|FG002|Overall Study|No treatment received|0|||
125885499|NCT00432172|452876861|FG003|Overall Study|No treatment received|1|||
125885500|NCT02425943|452876862|FG000|Overall Study|Adverse Event|3|||
125885501|NCT02425943|452876863|FG001|Overall Study|Adverse Event|1|||
125885502|NCT02425943|452876862|FG000|Overall Study|Lost to Follow-up|59|||
125885503|NCT02425943|452876863|FG001|Overall Study|Lost to Follow-up|37|||
125885504|NCT02425943|452876862|FG000|Overall Study|Protocol Violation|4|||
126307636|NCT04013672|454414510|FG000|Overall Study|Physician Decision|5|||
126370824|NCT01441960|454655242|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
126370825|NCT01441960|454655243|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
126370826|NCT01441960|454655242|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
126370827|NCT01441960|454655243|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
126370828|NCT01441960|454655242|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
126370829|NCT01441960|454655243|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
126370830|NCT02986074|454655245|FG000|First Trial Period|Adverse Event|1|||
126370831|NCT02986074|454655246|FG001|First Trial Period|Adverse Event|0|||
126370832|NCT02986074|454655247|FG002|First Trial Period|Adverse Event|0|||
126370833|NCT02986074|454655248|FG003|First Trial Period|Adverse Event|0|||
126370834|NCT02986074|454655245|FG000|Follow up Period|system explant|0|||
126370835|NCT02986074|454655246|FG001|Follow up Period|system explant|0|||
126370836|NCT02986074|454655247|FG002|Follow up Period|system explant|1|||
126370837|NCT02986074|454655248|FG003|Follow up Period|system explant|2|||
126370838|NCT02986074|454655245|FG000|Follow up Period|Physician Decision|0|||
126370839|NCT02986074|454655246|FG001|Follow up Period|Physician Decision|0|||
126370840|NCT02986074|454655247|FG002|Follow up Period|Physician Decision|0|||
126370841|NCT02986074|454655248|FG003|Follow up Period|Physician Decision|1|||
126370842|NCT00069641|454655253|FG000|Overall Study|Death|1|||
126370843|NCT00069641|454655254|FG001|Overall Study|Death|0|||
126370844|NCT00069641|454655255|FG002|Overall Study|Death|1|||
126370845|NCT03186638|454655256|FG000|Overall Study|Withdrawal by Subject|4|||
126370846|NCT03186638|454655257|FG001|Overall Study|Withdrawal by Subject|4|||
126370847|NCT03186638|454655256|FG000|Overall Study|Withdrawn due to medical problem|3|||
126370848|NCT03186638|454655257|FG001|Overall Study|Withdrawn due to medical problem|2|||
126370849|NCT03186638|454655256|FG000|Overall Study|Lost to Follow-up|1|||
126370850|NCT03186638|454655257|FG001|Overall Study|Lost to Follow-up|0|||
126370851|NCT01263119|454655258|FG000|Period 1|Protocol Violation|2|||
125885505|NCT02425943|452876863|FG001|Overall Study|Protocol Violation|1|||
125885506|NCT02425943|452876862|FG000|Overall Study|Withdrawal by Subject|64|||
126307637|NCT04013672|454414511|FG001|Overall Study|Physician Decision|0|||
126307638|NCT00101166|454414514|FG000|Overall Study|progressive disease|10|||
126307639|NCT01868022|454414515|FG000|Overall Study|Withdrawal by Subject|0|||
126307640|NCT01868022|454414516|FG001|Overall Study|Withdrawal by Subject|0|||
126307641|NCT01868022|454414517|FG002|Overall Study|Withdrawal by Subject|1|||
126307642|NCT01868022|454414518|FG003|Overall Study|Withdrawal by Subject|1|||
126307643|NCT01868022|454414519|FG004|Overall Study|Withdrawal by Subject|0|||
126307644|NCT01868022|454414520|FG005|Overall Study|Withdrawal by Subject|0|||
126307645|NCT01868022|454414521|FG006|Overall Study|Withdrawal by Subject|0|||
126307646|NCT01868022|454414522|FG007|Overall Study|Withdrawal by Subject|1|||
126307647|NCT01868022|454414523|FG008|Overall Study|Withdrawal by Subject|0|||
126307648|NCT01868022|454414515|FG000|Overall Study|Adverse Event|0|||
126307649|NCT01868022|454414516|FG001|Overall Study|Adverse Event|0|||
126307650|NCT01868022|454414517|FG002|Overall Study|Adverse Event|0|||
126307651|NCT01868022|454414518|FG003|Overall Study|Adverse Event|0|||
126307652|NCT01868022|454414519|FG004|Overall Study|Adverse Event|2|||
126370852|NCT01263119|454655258|FG000|Period 2|Adverse Event|2|||
126370853|NCT03983421|454655259|FG000|Overall Study|Lost to Follow-up|1|||
126370854|NCT04573972|454655260|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
125885507|NCT02425943|452876863|FG001|Overall Study|Withdrawal by Subject|31|||
125885508|NCT02425943|452876862|FG000|Overall Study|Other|6|||
125885509|NCT02425943|452876863|FG001|Overall Study|Other|0|||
125885510|NCT01106248|452876865|FG000|Overall Study|Adverse Event|1|||
125885511|NCT01106248|452876865|FG000|Overall Study|Administrative|2|||
126307653|NCT01868022|454414520|FG005|Overall Study|Adverse Event|0|||
126370855|NCT04573972|454655261|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
126370856|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
126103905|NCT00710021|453673861|FG002|Overall Study|Lost to Follow-up|0|||
126103906|NCT00710021|453673859|FG000|Overall Study|Subject's Decision|0|||
126103907|NCT00710021|453673860|FG001|Overall Study|Subject's Decision|1|||
126103908|NCT00710021|453673861|FG002|Overall Study|Subject's Decision|0|||
126103909|NCT00710021|453673859|FG000|Overall Study|Subject misrandomized|0|||
126103910|NCT00710021|453673860|FG001|Overall Study|Subject misrandomized|1|||
126103911|NCT00710021|453673861|FG002|Overall Study|Subject misrandomized|1|||
126103912|NCT00710021|453673859|FG000|Overall Study|Physician Decision|0|||
126103913|NCT00710021|453673860|FG001|Overall Study|Physician Decision|1|||
126103914|NCT00710021|453673861|FG002|Overall Study|Physician Decision|0|||
126103915|NCT01575028|453673865|FG000|Overall Study|Physician Decision|0|||
126103916|NCT01575028|453673866|FG001|Overall Study|Physician Decision|1|||
126103917|NCT00529958|453673870|FG000|2-Year Follow-up|Lost to Follow-up|1|||
126103918|NCT00529958|453673871|FG001|2-Year Follow-up|Lost to Follow-up|2|||
126103919|NCT00529958|453673872|FG002|2-Year Follow-up|Lost to Follow-up|2|||
126103920|NCT00529958|453673870|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
126103921|NCT00529958|453673871|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
126103922|NCT00529958|453673872|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
126103923|NCT00529958|453673870|FG000|5-Year Follow-up|Lost to Follow-up|2|||
126103924|NCT00529958|453673871|FG001|5-Year Follow-up|Lost to Follow-up|3|||
126103925|NCT00529958|453673872|FG002|5-Year Follow-up|Lost to Follow-up|1|||
126103926|NCT00529958|453673870|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
126103927|NCT00529958|453673871|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
126103928|NCT00529958|453673872|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
126103929|NCT03534284|453673874|FG000|Overall Study|Death|2|||
126103930|NCT03534284|453673875|FG001|Overall Study|Death|3|||
126103931|NCT03534284|453673876|FG002|Overall Study|Death|3|||
126103932|NCT03534284|453673874|FG000|Overall Study|Withdrawal by Subject|5|||
126103933|NCT03534284|453673875|FG001|Overall Study|Withdrawal by Subject|0|||
126103934|NCT03534284|453673876|FG002|Overall Study|Withdrawal by Subject|0|||
126103935|NCT03316300|453673877|FG000|Overall Study|Withdrawal by Subject|3|||
126103936|NCT03316300|453673878|FG001|Overall Study|Withdrawal by Subject|2|||
126103937|NCT03316300|453673877|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
126103938|NCT03316300|453673878|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
126103939|NCT03316300|453673877|FG000|Overall Study|Adverse Event|1|||
126103940|NCT03316300|453673878|FG001|Overall Study|Adverse Event|0|||
126103941|NCT03316300|453673877|FG000|Overall Study|COVID-19|0|||
126103942|NCT03316300|453673878|FG001|Overall Study|COVID-19|1|||
126103943|NCT04737187|453673880|FG000|Overall Study|Switched to marketed drug|32|||
126103944|NCT04737187|453673881|FG001|Overall Study|Switched to marketed drug|4|||
126103945|NCT04737187|453673880|FG000|Overall Study|Radiological Progressive Disease|145|||
126103946|NCT04737187|453673881|FG001|Overall Study|Radiological Progressive Disease|146|||
126103947|NCT04737187|453673880|FG000|Overall Study|Clinical Progressive Disease|20|||
126103948|NCT04737187|453673881|FG001|Overall Study|Clinical Progressive Disease|20|||
126103949|NCT04737187|453673880|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
126103950|NCT04737187|453673881|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
126103951|NCT04737187|453673880|FG000|Overall Study|Adverse Event|16|||
126103952|NCT04737187|453673881|FG001|Overall Study|Adverse Event|16|||
125885512|NCT00357903|452876866|FG000|Overall Study|Adverse Event|87|||
125885513|NCT00357903|452876867|FG001|Overall Study|Adverse Event|4|||
125885514|NCT00357903|452876866|FG000|Overall Study|Death|33|||
125885515|NCT00357903|452876867|FG001|Overall Study|Death|0|||
125885516|NCT00357903|452876866|FG000|Overall Study|Lost to Follow-up|23|||
125885517|NCT00357903|452876867|FG001|Overall Study|Lost to Follow-up|4|||
125885518|NCT00357903|452876866|FG000|Overall Study|Physician Decision|39|||
125885519|NCT00357903|452876867|FG001|Overall Study|Physician Decision|5|||
125885520|NCT00357903|452876866|FG000|Overall Study|Withdrawal by Subject|57|||
125885521|NCT00357903|452876867|FG001|Overall Study|Withdrawal by Subject|7|||
125885522|NCT00357903|452876866|FG000|Overall Study|Completed month 12 only|0|||
125885523|NCT00357903|452876867|FG001|Overall Study|Completed month 12 only|1|||
125885524|NCT00357903|452876866|FG000|Overall Study|Protocol issues|14|||
125885525|NCT00357903|452876867|FG001|Overall Study|Protocol issues|3|||
125885526|NCT00357903|452876866|FG000|Overall Study|Response status|61|||
125885527|NCT00357903|452876867|FG001|Overall Study|Response status|9|||
125885528|NCT00357903|452876866|FG000|Overall Study|Other|49|||
125885529|NCT00357903|452876867|FG001|Overall Study|Other|10|||
125885530|NCT00606593|452876868|FG000|Overall Study|Adverse Event|0|||
126103953|NCT04737187|453673880|FG000|Overall Study|Physician Decision|2|||
126103954|NCT04737187|453673881|FG001|Overall Study|Physician Decision|0|||
126103955|NCT04737187|453673880|FG000|Overall Study|Withdrawal by Subject|5|||
126103956|NCT04737187|453673881|FG001|Overall Study|Withdrawal by Subject|8|||
126103957|NCT03756129|453673882|FG000|Overall Study|Adverse Event|1|||
126103958|NCT03756129|453673883|FG001|Overall Study|Adverse Event|1|||
125885531|NCT00606593|452876869|FG001|Overall Study|Adverse Event|0|||
126103959|NCT03756129|453673884|FG002|Overall Study|Adverse Event|0|||
126103960|NCT03756129|453673885|FG003|Overall Study|Adverse Event|2|||
126103961|NCT03756129|453673886|FG004|Overall Study|Adverse Event|0|||
125885532|NCT00606593|452876870|FG002|Overall Study|Adverse Event|0|||
126307654|NCT01868022|454414521|FG006|Overall Study|Adverse Event|0|||
126307655|NCT01868022|454414522|FG007|Overall Study|Adverse Event|2|||
126307656|NCT01868022|454414523|FG008|Overall Study|Adverse Event|2|||
126307657|NCT01868022|454414515|FG000|Overall Study|Physician Decision|0|||
126307658|NCT01868022|454414516|FG001|Overall Study|Physician Decision|0|||
126307659|NCT01868022|454414517|FG002|Overall Study|Physician Decision|0|||
126307660|NCT01868022|454414518|FG003|Overall Study|Physician Decision|0|||
126307661|NCT01868022|454414519|FG004|Overall Study|Physician Decision|0|||
126307662|NCT01868022|454414520|FG005|Overall Study|Physician Decision|1|||
126307663|NCT01868022|454414521|FG006|Overall Study|Physician Decision|0|||
126307664|NCT01868022|454414522|FG007|Overall Study|Physician Decision|2|||
126307665|NCT01868022|454414523|FG008|Overall Study|Physician Decision|0|||
126307666|NCT01868022|454414515|FG000|Overall Study|Study closed/terminated|0|||
126307667|NCT01868022|454414516|FG001|Overall Study|Study closed/terminated|0|||
126307668|NCT01868022|454414517|FG002|Overall Study|Study closed/terminated|0|||
126307669|NCT01868022|454414518|FG003|Overall Study|Study closed/terminated|0|||
126307670|NCT01868022|454414519|FG004|Overall Study|Study closed/terminated|0|||
126307671|NCT01868022|454414520|FG005|Overall Study|Study closed/terminated|0|||
126307672|NCT01868022|454414521|FG006|Overall Study|Study closed/terminated|0|||
126307673|NCT01868022|454414522|FG007|Overall Study|Study closed/terminated|1|||
126307674|NCT01868022|454414523|FG008|Overall Study|Study closed/terminated|0|||
126307675|NCT01868022|454414515|FG000|Overall Study|Ongoing|0|||
126307676|NCT01868022|454414516|FG001|Overall Study|Ongoing|0|||
126307677|NCT01868022|454414517|FG002|Overall Study|Ongoing|0|||
126307678|NCT01868022|454414518|FG003|Overall Study|Ongoing|0|||
126307679|NCT01868022|454414519|FG004|Overall Study|Ongoing|0|||
126307680|NCT01868022|454414520|FG005|Overall Study|Ongoing|0|||
126307681|NCT01868022|454414521|FG006|Overall Study|Ongoing|0|||
126307682|NCT01868022|454414522|FG007|Overall Study|Ongoing|3|||
126307683|NCT01868022|454414523|FG008|Overall Study|Ongoing|0|||
126307684|NCT01672710|454414524|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
126307685|NCT01672710|454414525|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
126307686|NCT01672710|454414524|FG000|3 Month Follow up|Lost to Follow-up|2|||
126307687|NCT01672710|454414525|FG001|3 Month Follow up|Lost to Follow-up|3|||
126307688|NCT01672710|454414524|FG000|3 Month Follow up|follow up due after termination date|4|||
126307689|NCT01672710|454414525|FG001|3 Month Follow up|follow up due after termination date|1|||
126307690|NCT02122887|454414526|FG000|Overall Study|Withdrawal by Subject|20|||
125885533|NCT00606593|452876871|FG003|Overall Study|Adverse Event|1|||
125885534|NCT00606593|452876872|FG004|Overall Study|Adverse Event|1|||
125885535|NCT00606593|452876873|FG005|Overall Study|Adverse Event|0|||
125885536|NCT00606593|452876874|FG006|Overall Study|Adverse Event|1|||
125885537|NCT00606593|452876875|FG007|Overall Study|Adverse Event|2|||
125885538|NCT00606593|452876876|FG008|Overall Study|Adverse Event|1|||
125885539|NCT00606593|452876877|FG009|Overall Study|Adverse Event|0|||
125885540|NCT00606593|452876868|FG000|Overall Study|Withdrawal of consent|1|||
125885541|NCT00606593|452876869|FG001|Overall Study|Withdrawal of consent|0|||
125885542|NCT00606593|452876870|FG002|Overall Study|Withdrawal of consent|1|||
125885543|NCT00606593|452876871|FG003|Overall Study|Withdrawal of consent|0|||
125885544|NCT00606593|452876872|FG004|Overall Study|Withdrawal of consent|0|||
125885545|NCT00606593|452876873|FG005|Overall Study|Withdrawal of consent|0|||
125885546|NCT00606593|452876874|FG006|Overall Study|Withdrawal of consent|0|||
126047399|NCT03997474|453471188|FG000|Overall Study|Death|6|||
126047400|NCT03997474|453471189|FG001|Overall Study|Death|2|||
126047401|NCT03997474|453471190|FG002|Overall Study|Death|1|||
126047402|NCT03997474|453471188|FG000|Overall Study|Physician Decision|2|||
126047403|NCT03997474|453471189|FG001|Overall Study|Physician Decision|0|||
126047404|NCT03997474|453471190|FG002|Overall Study|Physician Decision|0|||
126047405|NCT03997474|453471188|FG000|Overall Study|study terminated by sponsor|1|||
126047406|NCT03997474|453471189|FG001|Overall Study|study terminated by sponsor|0|||
126047407|NCT03997474|453471190|FG002|Overall Study|study terminated by sponsor|1|||
126047408|NCT02325466|453471784|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
126047409|NCT02325466|453471785|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
126047410|NCT02325466|453471786|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
126047411|NCT02325466|453471784|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
126047412|NCT02325466|453471785|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
126047413|NCT02325466|453471786|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
126047414|NCT02325466|453471784|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
126307691|NCT02122887|454414527|FG001|Overall Study|Withdrawal by Subject|2|||
126307692|NCT04999163|454414532|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
126307693|NCT04999163|454414533|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
126307694|NCT04999163|454414532|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
126307695|NCT04999163|454414533|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
125885547|NCT00606593|452876875|FG007|Overall Study|Withdrawal of consent|0|||
126307696|NCT04999163|454414532|FG000|Overall Study|Withdrawal by Subject|1|||
126307697|NCT04999163|454414533|FG001|Overall Study|Withdrawal by Subject|0|||
126047415|NCT02325466|453471785|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
126047416|NCT02325466|453471786|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
126047417|NCT02325466|453471784|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
126047418|NCT02325466|453471785|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
126047419|NCT02325466|453471786|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
126047420|NCT02325466|453471784|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
126047421|NCT02325466|453471785|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
126047422|NCT02325466|453471786|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
126047423|NCT02325466|453471784|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
126047424|NCT02325466|453471785|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
126047425|NCT02325466|453471786|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
126047426|NCT02325466|453471784|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
126047427|NCT02325466|453471785|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
126047428|NCT02325466|453471786|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
126047429|NCT02325466|453471784|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
126047430|NCT02325466|453471785|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
126047431|NCT02325466|453471786|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
126047432|NCT02325466|453471784|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
126047433|NCT02325466|453471785|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
126047434|NCT02325466|453471786|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
126047435|NCT04018495|453471787|FG000|Overall Study|Physician Decision|1|||
126047436|NCT04121741|453471790|FG000|Overall Study|Protocol Violation|1|||
126047437|NCT04121741|453471791|FG001|Overall Study|Protocol Violation|0|||
126047438|NCT04121741|453471792|FG002|Overall Study|Protocol Violation|0|||
126047439|NCT04121741|453471793|FG003|Overall Study|Protocol Violation|0|||
126047440|NCT04121741|453471794|FG004|Overall Study|Protocol Violation|0|||
126047441|NCT04121741|453471795|FG005|Overall Study|Protocol Violation|0|||
126047442|NCT01084863|453471796|FG000|Main Study Treatment Period|Disease progression|11|||
126047443|NCT01084863|453471797|FG001|Main Study Treatment Period|Disease progression|7|||
126047444|NCT01084863|453471796|FG000|Main Study Treatment Period|Adverse Event|5|||
126047445|NCT01084863|453471797|FG001|Main Study Treatment Period|Adverse Event|3|||
126047446|NCT01084863|453471796|FG000|Main Study Treatment Period|Other Reason|0|||
126047447|NCT01084863|453471797|FG001|Main Study Treatment Period|Other Reason|1|||
126047448|NCT01084863|453471796|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
126047449|NCT01084863|453471797|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
126047450|NCT01084863|453471796|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
126047451|NCT01084863|453471797|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
126047452|NCT01084863|453471796|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
126047453|NCT01084863|453471797|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
126047454|NCT01084863|453471796|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
126047455|NCT01084863|453471797|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
126047456|NCT01084863|453471796|FG000|Treatment Period Beyond Cycle 8|Other|0|||
126047457|NCT01084863|453471797|FG001|Treatment Period Beyond Cycle 8|Other|1|||
126047458|NCT01084863|453471796|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
126047459|NCT01084863|453471797|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
126047460|NCT03473223|453471798|FG000|Overall Study|Lost to Follow-up|1|||
126047461|NCT03473223|453471799|FG001|Overall Study|Lost to Follow-up|1|||
126047462|NCT03473223|453471798|FG000|Overall Study|Withdrawal by Subject|47|||
126047463|NCT03473223|453471799|FG001|Overall Study|Withdrawal by Subject|42|||
126047464|NCT03473223|453471798|FG000|Overall Study|Indirect contact|32|||
126047465|NCT03473223|453471799|FG001|Overall Study|Indirect contact|29|||
126047466|NCT03473223|453471798|FG000|Overall Study|Other (Not specified)|32|||
126047467|NCT03473223|453471799|FG001|Overall Study|Other (Not specified)|20|||
126047468|NCT03275285|453471802|FG000|Overall Study|Ongoing|45|||
126047469|NCT03275285|453471803|FG001|Overall Study|Ongoing|69|||
126047470|NCT06191679|453471804|FG000|Baseline|Lost to Follow-up|1|||
126103962|NCT03756129|453673887|FG005|Overall Study|Adverse Event|0|||
126103963|NCT03756129|453673882|FG000|Overall Study|Withdrawal by Subject|2|||
126047471|NCT06191679|453471805|FG001|Baseline|Lost to Follow-up|0|||
126047472|NCT06191679|453471806|FG002|Baseline|Lost to Follow-up|1|||
126047473|NCT06191679|453471807|FG003|Baseline|Lost to Follow-up|0|||
126047474|NCT06191679|453471804|FG000|Allocation to Group|Withdrawal by Subject|0|||
126047475|NCT06191679|453471805|FG001|Allocation to Group|Withdrawal by Subject|1|||
126103964|NCT03756129|453673883|FG001|Overall Study|Withdrawal by Subject|1|||
126047476|NCT06191679|453471806|FG002|Allocation to Group|Withdrawal by Subject|2|||
126307698|NCT03652636|454416021|FG000|Overall Study|Withdrawal by Subject|7|||
126047477|NCT06191679|453471807|FG003|Allocation to Group|Withdrawal by Subject|0|||
126047478|NCT06191679|453471804|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
126047479|NCT06191679|453471805|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
126047480|NCT06191679|453471806|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
126047481|NCT06191679|453471807|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
126047482|NCT06191679|453471804|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
126047483|NCT06191679|453471805|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
126047484|NCT06191679|453471806|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
126047485|NCT06191679|453471807|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
126047486|NCT06191679|453471804|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
126047487|NCT06191679|453471805|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
126047488|NCT06191679|453471806|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
126047489|NCT06191679|453471807|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
126047490|NCT03211247|453471808|FG000|Overall Study|Adverse Event|8|||
126047491|NCT03211247|453471809|FG001|Overall Study|Adverse Event|0|||
126047492|NCT03211247|453471810|FG002|Overall Study|Adverse Event|1|||
126047493|NCT03211247|453471811|FG003|Overall Study|Adverse Event|0|||
126047494|NCT03211247|453471812|FG004|Overall Study|Adverse Event|0|||
126047495|NCT03211247|453471808|FG000|Overall Study|Lost to Follow-up|2|||
126307699|NCT01283334|454416023|FG000|Overall Study|Withdrawal by Subject|1|||
126307700|NCT01283334|454416023|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
126307701|NCT01283334|454416023|FG000|Overall Study|Adverse Event|4|||
126307702|NCT01283334|454416023|FG000|Overall Study|Physician Decision|1|||
126047496|NCT03211247|453471809|FG001|Overall Study|Lost to Follow-up|1|||
126307703|NCT03233529|454416025|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
126307704|NCT03233529|454416025|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
126307705|NCT01177293|454416026|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
126307706|NCT01177293|454416027|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
126307707|NCT01905553|454416031|FG000|Period 2|Adverse Event|1|||
126307708|NCT01905553|454416032|FG001|Period 2|Adverse Event|0|||
126307709|NCT00076752|454416038|FG000|Overall Study|Death|2|||
126307710|NCT00076752|454416038|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
126307711|NCT03854370|454416039|FG000|Overall Study|samples not collected|1|||
126307712|NCT03854370|454416040|FG001|Overall Study|samples not collected|1|||
126307713|NCT03854370|454416041|FG002|Overall Study|samples not collected|1|||
126307714|NCT03854370|454416042|FG003|Overall Study|samples not collected|1|||
126307715|NCT00452673|454416043|FG000|Dose Escalation Period|Disease Progression|6|||
126307716|NCT00452673|454416044|FG001|Dose Escalation Period|Disease Progression|6|||
126307717|NCT00452673|454416045|FG002|Dose Escalation Period|Disease Progression|2|||
126307718|NCT00452673|454416046|FG003|Dose Escalation Period|Disease Progression|6|||
126307719|NCT00452673|454416047|FG004|Dose Escalation Period|Disease Progression|0|||
126307720|NCT00452673|454416043|FG000|Dose Escalation Period|study drug toxicity|1|||
126307721|NCT00452673|454416044|FG001|Dose Escalation Period|study drug toxicity|3|||
126307722|NCT00452673|454416045|FG002|Dose Escalation Period|study drug toxicity|3|||
126307723|NCT00452673|454416046|FG003|Dose Escalation Period|study drug toxicity|1|||
126307724|NCT00452673|454416047|FG004|Dose Escalation Period|study drug toxicity|0|||
126307725|NCT00452673|454416043|FG000|Dose Escalation Period|Other|0|||
126307726|NCT00452673|454416044|FG001|Dose Escalation Period|Other|0|||
126307727|NCT00452673|454416045|FG002|Dose Escalation Period|Other|1|||
126307728|NCT00452673|454416046|FG003|Dose Escalation Period|Other|0|||
126307729|NCT00452673|454416047|FG004|Dose Escalation Period|Other|0|||
126307730|NCT00452673|454416043|FG000|Dose Escalation Period|Adverse Event|0|||
126307731|NCT00452673|454416044|FG001|Dose Escalation Period|Adverse Event|0|||
126307732|NCT00452673|454416045|FG002|Dose Escalation Period|Adverse Event|0|||
126307733|NCT00452673|454416046|FG003|Dose Escalation Period|Adverse Event|1|||
126307734|NCT00452673|454416047|FG004|Dose Escalation Period|Adverse Event|0|||
126307735|NCT00452673|454416043|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
126047497|NCT03211247|453471810|FG002|Overall Study|Lost to Follow-up|0|||
126047498|NCT03211247|453471811|FG003|Overall Study|Lost to Follow-up|0|||
126307736|NCT00452673|454416044|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
126307737|NCT00452673|454416045|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
126307738|NCT00452673|454416046|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
126307739|NCT00452673|454416047|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
126307740|NCT00452673|454416043|FG000|Dose Expansion Period|Disease Progression|0|||
126307741|NCT00452673|454416044|FG001|Dose Expansion Period|Disease Progression|0|||
126370857|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
126370858|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
126370859|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
126370860|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
126370861|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
126370862|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
126370863|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
126370864|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
126370865|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
126370866|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
126370867|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
126370868|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
126370869|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
126370870|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
126370871|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
126370872|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
126370873|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
126370874|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
126370875|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
126370876|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
126370877|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
126370878|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
126370879|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
126370880|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
126370881|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
126370882|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
126370883|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
126370884|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
126370885|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
126370886|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
126370887|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
126370888|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
126370889|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
126370890|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
126370891|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
126370892|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
126370893|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
126370894|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
126370895|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
126370896|NCT00261833|454655266|FG000|Overall Study|Death|1|||
126370897|NCT00261833|454655267|FG001|Overall Study|Death|3|||
126370898|NCT00261833|454655266|FG000|Overall Study|Adverse Event|1|||
126370899|NCT00261833|454655267|FG001|Overall Study|Adverse Event|4|||
126370900|NCT00261833|454655266|FG000|Overall Study|Withdrawal by Subject|5|||
126370901|NCT00261833|454655267|FG001|Overall Study|Withdrawal by Subject|7|||
126370902|NCT00261833|454655266|FG000|Overall Study|Protocol Violation|0|||
126370903|NCT00261833|454655267|FG001|Overall Study|Protocol Violation|1|||
126370904|NCT00261833|454655266|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
126370905|NCT00261833|454655267|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
126370906|NCT00261833|454655266|FG000|Overall Study|Lung transplantation|1|||
126370907|NCT00261833|454655267|FG001|Overall Study|Lung transplantation|1|||
126370908|NCT00261833|454655266|FG000|Overall Study|Missing reason|1|||
126370909|NCT00261833|454655267|FG001|Overall Study|Missing reason|0|||
126370910|NCT00261833|454655266|FG000|Overall Study|Not interested in being participant|0|||
126370911|NCT00261833|454655267|FG001|Overall Study|Not interested in being participant|1|||
126370912|NCT00622726|454655268|FG000|March, 2008 to August, 2010|Death|5|||
126370913|NCT00622726|454655269|FG001|March, 2008 to August, 2010|Death|2|||
126370914|NCT00622726|454655268|FG000|August, 2010 to April, 2013|Death|1|||
126370915|NCT00622726|454655269|FG001|August, 2010 to April, 2013|Death|5|||
126370916|NCT01948427|454655270|FG000|Overall Study|Serious Adverse Event|3|||
126370917|NCT01948427|454655271|FG001|Overall Study|Serious Adverse Event|0|||
126370918|NCT01948427|454655272|FG002|Overall Study|Serious Adverse Event|0|||
126370919|NCT01948427|454655273|FG003|Overall Study|Serious Adverse Event|0|||
126370920|NCT01948427|454655274|FG004|Overall Study|Serious Adverse Event|1|||
126370921|NCT01948427|454655270|FG000|Overall Study|Investigator Request|0|||
126370922|NCT01948427|454655271|FG001|Overall Study|Investigator Request|8|||
126370923|NCT01948427|454655272|FG002|Overall Study|Investigator Request|0|||
126370924|NCT01948427|454655273|FG003|Overall Study|Investigator Request|0|||
126370925|NCT01948427|454655274|FG004|Overall Study|Investigator Request|6|||
126370926|NCT01948427|454655270|FG000|Overall Study|Lost to Follow-up|1|||
126370927|NCT01948427|454655271|FG001|Overall Study|Lost to Follow-up|0|||
126370928|NCT01948427|454655272|FG002|Overall Study|Lost to Follow-up|0|||
126370929|NCT01948427|454655273|FG003|Overall Study|Lost to Follow-up|0|||
126370930|NCT01948427|454655274|FG004|Overall Study|Lost to Follow-up|4|||
126370931|NCT01948427|454655270|FG000|Overall Study|Withdrawal by Subject|2|||
126370932|NCT01948427|454655271|FG001|Overall Study|Withdrawal by Subject|0|||
126370933|NCT01948427|454655272|FG002|Overall Study|Withdrawal by Subject|0|||
126370934|NCT01948427|454655273|FG003|Overall Study|Withdrawal by Subject|0|||
126370935|NCT01948427|454655274|FG004|Overall Study|Withdrawal by Subject|1|||
126370936|NCT01948427|454655270|FG000|Overall Study|Other, Not Specified|1|||
126370937|NCT01948427|454655271|FG001|Overall Study|Other, Not Specified|9|||
126370938|NCT01948427|454655272|FG002|Overall Study|Other, Not Specified|0|||
126370939|NCT01948427|454655273|FG003|Overall Study|Other, Not Specified|0|||
126370940|NCT01948427|454655274|FG004|Overall Study|Other, Not Specified|2|||
126370941|NCT00402987|454655275|FG000|Overall Study|Lack of Efficacy|0|||
126370942|NCT00402987|454655276|FG001|Overall Study|Lack of Efficacy|0|||
126370943|NCT00402987|454655277|FG002|Overall Study|Lack of Efficacy|1|||
126370944|NCT00402987|454655278|FG003|Overall Study|Lack of Efficacy|0|||
126370945|NCT05200845|454655290|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
126370946|NCT05200845|454655291|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
126370947|NCT05200845|454655292|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
126370948|NCT05200845|454655293|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
126370949|NCT05200845|454655290|FG000|Overall Study|Withdrawal by Subject|0|||
126370950|NCT05200845|454655291|FG001|Overall Study|Withdrawal by Subject|1|||
126370951|NCT05200845|454655292|FG002|Overall Study|Withdrawal by Subject|1|||
126370952|NCT05200845|454655293|FG003|Overall Study|Withdrawal by Subject|0|||
126370953|NCT02303262|454655294|FG000|Overall Study|Withdrawal by Subject|2|||
126370954|NCT04138056|454655298|FG000|Primary Study|Lost to Follow-up|3|||
126370955|NCT04138056|454655299|FG001|Primary Study|Lost to Follow-up|4|||
126370956|NCT04138056|454655300|FG002|Primary Study|Lost to Follow-up|1|||
126370957|NCT04138056|454655301|FG003|Primary Study|Lost to Follow-up|1|||
126370958|NCT04138056|454655302|FG004|Primary Study|Lost to Follow-up|4|||
126370959|NCT04138056|454655298|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
126370960|NCT04138056|454655299|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
126370961|NCT04138056|454655300|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
126370962|NCT04138056|454655301|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
126370963|NCT04138056|454655302|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
126370964|NCT04138056|454655298|FG000|Extension Study|Lost to Follow-up|1|||
126370965|NCT04138056|454655299|FG001|Extension Study|Lost to Follow-up|2|||
126370966|NCT04138056|454655300|FG002|Extension Study|Lost to Follow-up|1|||
126370967|NCT04138056|454655301|FG003|Extension Study|Lost to Follow-up|0|||
126370968|NCT04138056|454655302|FG004|Extension Study|Lost to Follow-up|1|||
126370969|NCT01215851|454655303|FG000|Treatment Period|Adverse Event|1|||
126370970|NCT01215851|454655304|FG001|Treatment Period|Adverse Event|1|||
126370971|NCT01215851|454655305|FG002|Treatment Period|Adverse Event|1|||
126370972|NCT01215851|454655306|FG003|Treatment Period|Adverse Event|3|||
126370973|NCT01215851|454655307|FG004|Treatment Period|Adverse Event|0|||
126370974|NCT01215851|454655308|FG005|Treatment Period|Adverse Event|1|||
126370975|NCT01215851|454655303|FG000|Follow up Period|Lost to Follow-up|0|||
126370976|NCT01215851|454655304|FG001|Follow up Period|Lost to Follow-up|0|||
126370977|NCT01215851|454655305|FG002|Follow up Period|Lost to Follow-up|0|||
126370978|NCT01215851|454655306|FG003|Follow up Period|Lost to Follow-up|0|||
126370979|NCT01215851|454655307|FG004|Follow up Period|Lost to Follow-up|0|||
126370980|NCT01215851|454655308|FG005|Follow up Period|Lost to Follow-up|1|||
126370981|NCT00862940|454655312|FG000|Overall Study|Adverse Event|15|||
126370982|NCT00862940|454655313|FG001|Overall Study|Adverse Event|12|||
126370983|NCT00862940|454655312|FG000|Overall Study|Lack of Efficacy|1|||
126370984|NCT00862940|454655313|FG001|Overall Study|Lack of Efficacy|3|||
126370985|NCT00862940|454655312|FG000|Overall Study|Protocol Violation|2|||
126370986|NCT00862940|454655313|FG001|Overall Study|Protocol Violation|5|||
126370987|NCT00862940|454655312|FG000|Overall Study|Withdrawal by Subject|4|||
126370988|NCT00862940|454655313|FG001|Overall Study|Withdrawal by Subject|6|||
126370989|NCT00862940|454655312|FG000|Overall Study|Non-compliance|4|||
126370990|NCT00862940|454655313|FG001|Overall Study|Non-compliance|0|||
126370991|NCT00862940|454655312|FG000|Overall Study|Lost to Follow-up|0|||
126370992|NCT00862940|454655313|FG001|Overall Study|Lost to Follow-up|1|||
126370993|NCT00862940|454655312|FG000|Overall Study|Administrative or other reason(s)|4|||
126047499|NCT03211247|453471812|FG004|Overall Study|Lost to Follow-up|0|||
126047500|NCT03211247|453471808|FG000|Overall Study|Physician Decision|1|||
126370994|NCT00862940|454655313|FG001|Overall Study|Administrative or other reason(s)|3|||
126047501|NCT03211247|453471809|FG001|Overall Study|Physician Decision|2|||
126047502|NCT03211247|453471810|FG002|Overall Study|Physician Decision|0|||
126370995|NCT05552859|454655314|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
126370996|NCT05552859|454655315|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
126370997|NCT02581930|454655324|FG000|Overall Study|Withdrawal by Subject|1|||
126370998|NCT02581930|454655324|FG000|Overall Study|patient declined further treatment|1|||
126370999|NCT03386773|454656646|FG000|Overall Study|Lost to Follow-up|24|||
126371000|NCT03386773|454656647|FG001|Overall Study|Lost to Follow-up|33|||
126371001|NCT03386773|454656646|FG000|Overall Study|Withdrawal by Subject|3|||
126371002|NCT03386773|454656647|FG001|Overall Study|Withdrawal by Subject|2|||
126307742|NCT00452673|454416045|FG002|Dose Expansion Period|Disease Progression|0|||
126307743|NCT00452673|454416046|FG003|Dose Expansion Period|Disease Progression|0|||
126307744|NCT00452673|454416047|FG004|Dose Expansion Period|Disease Progression|19|||
126307745|NCT00452673|454416043|FG000|Dose Expansion Period|Other|0|||
126307746|NCT00452673|454416044|FG001|Dose Expansion Period|Other|0|||
126307747|NCT00452673|454416045|FG002|Dose Expansion Period|Other|0|||
126307748|NCT00452673|454416046|FG003|Dose Expansion Period|Other|0|||
126307749|NCT00452673|454416047|FG004|Dose Expansion Period|Other|2|||
126307750|NCT02656290|454416048|FG000|Overall Study|Lost to Follow-up|1|||
126307751|NCT02656290|454416048|FG000|Overall Study|Reintervention|3|||
126307752|NCT01608087|454416051|FG000|Overall Study|Lost to Follow-up|0|||
126307753|NCT01608087|454416052|FG001|Overall Study|Lost to Follow-up|1|||
126307754|NCT01608087|454416053|FG002|Overall Study|Lost to Follow-up|0|||
126307755|NCT01608087|454416051|FG000|Overall Study|Other Reason|0|||
126307756|NCT01608087|454416052|FG001|Overall Study|Other Reason|1|||
126307757|NCT01608087|454416053|FG002|Overall Study|Other Reason|0|||
126307758|NCT00348595|454416054|FG000|Overall Study|Adverse Event|5|||
126307759|NCT00348595|454416055|FG001|Overall Study|Adverse Event|8|||
126307760|NCT01942486|454416058|FG000|Overall Study|Lost to Follow-up|27|||
126307761|NCT02048826|454416059|FG000|Overall Study|Withdrawal by Subject|1|||
126307762|NCT02048826|454416060|FG001|Overall Study|Withdrawal by Subject|0|||
126307763|NCT01011465|454416061|FG000|Overall Study|Withdrawal by Subject|2|||
126307764|NCT01011465|454416062|FG001|Overall Study|Withdrawal by Subject|1|||
126307765|NCT01011465|454416063|FG002|Overall Study|Withdrawal by Subject|0|||
126307766|NCT01011465|454416064|FG003|Overall Study|Withdrawal by Subject|0|||
126307767|NCT01011465|454416065|FG004|Overall Study|Withdrawal by Subject|1|||
126307768|NCT01011465|454416066|FG005|Overall Study|Withdrawal by Subject|0|||
126307769|NCT01011465|454416067|FG006|Overall Study|Withdrawal by Subject|1|||
126307770|NCT01011465|454416068|FG007|Overall Study|Withdrawal by Subject|0|||
126307771|NCT00723008|454416070|FG000|Enrollment|Lost to Follow-up|1|||
126307772|NCT00723008|454416071|FG001|Enrollment|Lost to Follow-up|0|||
126307773|NCT00723008|454416070|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
126307774|NCT00723008|454416071|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
126307775|NCT00723008|454416070|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
126307776|NCT00723008|454416071|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
126307777|NCT00723008|454416070|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
126307778|NCT00723008|454416071|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
126307779|NCT00723008|454416070|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
126307780|NCT00723008|454416071|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
126307781|NCT00723008|454416070|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
126307782|NCT00723008|454416071|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
126307783|NCT01014988|454416074|FG000|Overall Study|Adverse Event|20|||
126307784|NCT01014988|454416075|FG001|Overall Study|Adverse Event|0|||
126307785|NCT01014988|454416076|FG002|Overall Study|Adverse Event|1|||
126307786|NCT01014988|454416077|FG003|Overall Study|Adverse Event|0|||
126307787|NCT01014988|454416078|FG004|Overall Study|Adverse Event|1|||
126307788|NCT01014988|454416079|FG005|Overall Study|Adverse Event|3|||
126307789|NCT01014988|454416074|FG000|Overall Study|Lost to Follow-up|1|||
126307790|NCT01014988|454416075|FG001|Overall Study|Lost to Follow-up|0|||
126307791|NCT01014988|454416076|FG002|Overall Study|Lost to Follow-up|1|||
126307792|NCT01014988|454416077|FG003|Overall Study|Lost to Follow-up|0|||
126307793|NCT01014988|454416078|FG004|Overall Study|Lost to Follow-up|0|||
126307794|NCT01014988|454416079|FG005|Overall Study|Lost to Follow-up|0|||
126307795|NCT01014988|454416074|FG000|Overall Study|Physician Decision|1|||
126307796|NCT01014988|454416075|FG001|Overall Study|Physician Decision|0|||
126307797|NCT01014988|454416076|FG002|Overall Study|Physician Decision|0|||
126307798|NCT01014988|454416077|FG003|Overall Study|Physician Decision|0|||
126307799|NCT01014988|454416078|FG004|Overall Study|Physician Decision|0|||
126307800|NCT01014988|454416079|FG005|Overall Study|Physician Decision|0|||
126307801|NCT01014988|454416074|FG000|Overall Study|Withdrawal by Subject|1|||
126307802|NCT01014988|454416075|FG001|Overall Study|Withdrawal by Subject|0|||
126307803|NCT01014988|454416076|FG002|Overall Study|Withdrawal by Subject|0|||
126307804|NCT01014988|454416077|FG003|Overall Study|Withdrawal by Subject|0|||
125885548|NCT00606593|452876876|FG008|Overall Study|Withdrawal of consent|0|||
125885549|NCT00606593|452876877|FG009|Overall Study|Withdrawal of consent|0|||
126307805|NCT01014988|454416078|FG004|Overall Study|Withdrawal by Subject|0|||
126307806|NCT01014988|454416079|FG005|Overall Study|Withdrawal by Subject|0|||
126307807|NCT01683266|454416080|FG000|Overall Study|Adverse Event|5|||
126307808|NCT01683266|454416081|FG001|Overall Study|Adverse Event|4|||
126307809|NCT01683266|454416080|FG000|Overall Study|Lack of Efficacy|5|||
126307810|NCT01683266|454416081|FG001|Overall Study|Lack of Efficacy|2|||
126307811|NCT01683266|454416080|FG000|Overall Study|Protocol Violation|13|||
126307812|NCT01683266|454416081|FG001|Overall Study|Protocol Violation|6|||
126307813|NCT01683266|454416080|FG000|Overall Study|Personal Reason|17|||
126307814|NCT01683266|454416081|FG001|Overall Study|Personal Reason|25|||
126307815|NCT01683266|454416080|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
126307816|NCT01683266|454416081|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
126307817|NCT01683266|454416080|FG000|Overall Study|Lost to Follow-up|5|||
125885550|NCT00606593|452876868|FG000|Overall Study|Administrative/Other|0|||
125885551|NCT00606593|452876869|FG001|Overall Study|Administrative/Other|0|||
125885552|NCT00606593|452876870|FG002|Overall Study|Administrative/Other|1|||
125885553|NCT00606593|452876871|FG003|Overall Study|Administrative/Other|0|||
125885554|NCT00606593|452876872|FG004|Overall Study|Administrative/Other|0|||
125885555|NCT00606593|452876873|FG005|Overall Study|Administrative/Other|0|||
125885556|NCT00606593|452876874|FG006|Overall Study|Administrative/Other|0|||
125885557|NCT00606593|452876875|FG007|Overall Study|Administrative/Other|0|||
126047503|NCT03211247|453471811|FG003|Overall Study|Physician Decision|0|||
126047504|NCT03211247|453471812|FG004|Overall Study|Physician Decision|0|||
126047505|NCT03211247|453471808|FG000|Overall Study|Non-compliance with study drug|2|||
126047506|NCT03211247|453471809|FG001|Overall Study|Non-compliance with study drug|0|||
126047507|NCT03211247|453471810|FG002|Overall Study|Non-compliance with study drug|0|||
126047508|NCT03211247|453471811|FG003|Overall Study|Non-compliance with study drug|0|||
126307818|NCT01683266|454416081|FG001|Overall Study|Lost to Follow-up|0|||
126307819|NCT01683266|454416080|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
126307820|NCT01683266|454416081|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
126307821|NCT01683266|454416080|FG000|Overall Study|Nonserious Hypoglycemia|0|||
126307822|NCT01683266|454416081|FG001|Overall Study|Nonserious Hypoglycemia|3|||
126307823|NCT01683266|454416080|FG000|Overall Study|Perceived Lack of Efficacy|1|||
126307824|NCT01683266|454416081|FG001|Overall Study|Perceived Lack of Efficacy|1|||
126307825|NCT01683266|454416080|FG000|Overall Study|Possibly Hypoglycemia|1|||
126307826|NCT01683266|454416081|FG001|Overall Study|Possibly Hypoglycemia|0|||
126307827|NCT01683266|454416080|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
126307828|NCT01683266|454416081|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
126307829|NCT01867710|454416084|FG000|Overall Study|Death|25|||
126307830|NCT01867710|454416085|FG001|Overall Study|Death|15|||
126307831|NCT01867710|454416086|FG002|Overall Study|Death|27|||
126307832|NCT01867710|454416087|FG003|Overall Study|Death|20|||
126307833|NCT01867710|454416084|FG000|Overall Study|Lost to Follow-up|3|||
126307834|NCT01867710|454416085|FG001|Overall Study|Lost to Follow-up|4|||
126307835|NCT01867710|454416086|FG002|Overall Study|Lost to Follow-up|3|||
126307836|NCT01867710|454416087|FG003|Overall Study|Lost to Follow-up|2|||
126307837|NCT01867710|454416084|FG000|Overall Study|Withdrawal of consent|2|||
126307838|NCT01867710|454416085|FG001|Overall Study|Withdrawal of consent|5|||
126307839|NCT01867710|454416086|FG002|Overall Study|Withdrawal of consent|1|||
126371003|NCT03639610|454656648|FG000|Overall Study|Adverse Event|7|||
126371004|NCT03639610|454656649|FG001|Overall Study|Adverse Event|1|||
126371005|NCT03639610|454656650|FG002|Overall Study|Adverse Event|0|||
126371006|NCT03639610|454656648|FG000|Overall Study|Physician Decision|3|||
126371007|NCT03639610|454656649|FG001|Overall Study|Physician Decision|1|||
126371008|NCT03639610|454656650|FG002|Overall Study|Physician Decision|0|||
126371009|NCT03639610|454656648|FG000|Overall Study|Disease progression|8|||
126371010|NCT03639610|454656649|FG001|Overall Study|Disease progression|5|||
126371011|NCT03639610|454656650|FG002|Overall Study|Disease progression|3|||
126371012|NCT03639610|454656648|FG000|Overall Study|Study terminated by sponsor|2|||
126371013|NCT03639610|454656649|FG001|Overall Study|Study terminated by sponsor|1|||
126371014|NCT03639610|454656650|FG002|Overall Study|Study terminated by sponsor|1|||
126371015|NCT03639610|454656648|FG000|Overall Study|Patient request to stop treatment|1|||
126371016|NCT03639610|454656649|FG001|Overall Study|Patient request to stop treatment|2|||
126371017|NCT03639610|454656650|FG002|Overall Study|Patient request to stop treatment|0|||
126371018|NCT02410772|454656655|FG000|Overall Study|Death|3|||
126371019|NCT02410772|454656656|FG001|Overall Study|Death|4|||
126371020|NCT02410772|454656657|FG002|Overall Study|Death|8|||
126371021|NCT02410772|454656655|FG000|Overall Study|Lost to Follow-up|31|||
126371022|NCT02410772|454656656|FG001|Overall Study|Lost to Follow-up|23|||
126371023|NCT02410772|454656657|FG002|Overall Study|Lost to Follow-up|22|||
126371024|NCT02410772|454656655|FG000|Overall Study|Pregnancy|8|||
126371025|NCT02410772|454656656|FG001|Overall Study|Pregnancy|4|||
126371026|NCT02410772|454656657|FG002|Overall Study|Pregnancy|5|||
126371027|NCT02410772|454656655|FG000|Overall Study|Protocol Violation|8|||
126371028|NCT02410772|454656656|FG001|Overall Study|Protocol Violation|8|||
126371029|NCT02410772|454656657|FG002|Overall Study|Protocol Violation|4|||
126371030|NCT02410772|454656655|FG000|Overall Study|Baseline Drug Resistance|49|||
126371031|NCT02410772|454656656|FG001|Overall Study|Baseline Drug Resistance|40|||
126371032|NCT02410772|454656657|FG002|Overall Study|Baseline Drug Resistance|51|||
126371033|NCT02410772|454656655|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
126371034|NCT02410772|454656656|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
126371035|NCT02410772|454656657|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
126371036|NCT02410772|454656655|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
126371037|NCT02410772|454656656|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
126371038|NCT02410772|454656657|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
126371039|NCT01517984|454656658|FG000|Overall Study|Lost to Follow-up|0|||
126371040|NCT01517984|454656659|FG001|Overall Study|Lost to Follow-up|1|||
126371041|NCT01517984|454656660|FG002|Overall Study|Lost to Follow-up|0|||
126371042|NCT01517984|454656661|FG003|Overall Study|Lost to Follow-up|0|||
126307840|NCT01867710|454416087|FG003|Overall Study|Withdrawal of consent|2|||
126307841|NCT01867710|454416084|FG000|Overall Study|Study Terminated by Sponsor|9|||
126307842|NCT01867710|454416085|FG001|Overall Study|Study Terminated by Sponsor|13|||
126307843|NCT01867710|454416086|FG002|Overall Study|Study Terminated by Sponsor|8|||
126307844|NCT01867710|454416087|FG003|Overall Study|Study Terminated by Sponsor|16|||
126307845|NCT01867710|454416084|FG000|Overall Study|Biochemical progression|0|||
126307846|NCT01867710|454416085|FG001|Overall Study|Biochemical progression|1|||
126307847|NCT01867710|454416086|FG002|Overall Study|Biochemical progression|0|||
126307848|NCT01867710|454416087|FG003|Overall Study|Biochemical progression|0|||
126307849|NCT01867710|454416084|FG000|Overall Study|Clinical progression|0|||
126307850|NCT01867710|454416085|FG001|Overall Study|Clinical progression|0|||
126307851|NCT01867710|454416086|FG002|Overall Study|Clinical progression|1|||
126307852|NCT01867710|454416087|FG003|Overall Study|Clinical progression|0|||
126307853|NCT01867710|454416084|FG000|Overall Study|Disease progression|1|||
126307854|NCT01867710|454416085|FG001|Overall Study|Disease progression|0|||
126307855|NCT01867710|454416086|FG002|Overall Study|Disease progression|0|||
126307856|NCT01867710|454416087|FG003|Overall Study|Disease progression|0|||
126307857|NCT01867710|454416084|FG000|Overall Study|Patient decision|0|||
126307858|NCT01867710|454416085|FG001|Overall Study|Patient decision|0|||
126307859|NCT01867710|454416086|FG002|Overall Study|Patient decision|0|||
126307860|NCT01867710|454416087|FG003|Overall Study|Patient decision|1|||
126307861|NCT01867710|454416084|FG000|Overall Study|Patient to follow subsequent treatment|0|||
126307862|NCT01867710|454416085|FG001|Overall Study|Patient to follow subsequent treatment|1|||
126307863|NCT01867710|454416086|FG002|Overall Study|Patient to follow subsequent treatment|0|||
126307864|NCT01867710|454416087|FG003|Overall Study|Patient to follow subsequent treatment|0|||
126307865|NCT01867710|454416084|FG000|Overall Study|Progressive disease|1|||
126307866|NCT01867710|454416085|FG001|Overall Study|Progressive disease|0|||
126307867|NCT01867710|454416086|FG002|Overall Study|Progressive disease|0|||
126307868|NCT01867710|454416087|FG003|Overall Study|Progressive disease|0|||
126307869|NCT01867710|454416084|FG000|Overall Study|Protocol Violation|0|||
126307870|NCT01867710|454416085|FG001|Overall Study|Protocol Violation|0|||
126307871|NCT01867710|454416086|FG002|Overall Study|Protocol Violation|0|||
126307872|NCT01867710|454416087|FG003|Overall Study|Protocol Violation|1|||
126307873|NCT01867710|454416084|FG000|Overall Study|PSA-progression|0|||
126307874|NCT01867710|454416085|FG001|Overall Study|PSA-progression|1|||
126307875|NCT01867710|454416086|FG002|Overall Study|PSA-progression|0|||
126307876|NCT01867710|454416087|FG003|Overall Study|PSA-progression|0|||
126307877|NCT01867710|454416084|FG000|Overall Study|Study medication no longer effective|0|||
126307878|NCT01867710|454416085|FG001|Overall Study|Study medication no longer effective|1|||
126307879|NCT01867710|454416086|FG002|Overall Study|Study medication no longer effective|0|||
126307880|NCT01867710|454416087|FG003|Overall Study|Study medication no longer effective|0|||
126307881|NCT01062113|454416088|FG000|Overall Study|Adverse Event|1|||
126307882|NCT01062113|454416089|FG001|Overall Study|Adverse Event|0|||
126307883|NCT01062113|454416090|FG002|Overall Study|Adverse Event|0|||
126307884|NCT01062113|454416088|FG000|Overall Study|Lack of Efficacy|38|||
126307885|NCT01062113|454416089|FG001|Overall Study|Lack of Efficacy|22|||
126307886|NCT01062113|454416090|FG002|Overall Study|Lack of Efficacy|31|||
126307887|NCT01062113|454416088|FG000|Overall Study|Withdrawal by Subject|1|||
126307888|NCT01062113|454416089|FG001|Overall Study|Withdrawal by Subject|0|||
126307889|NCT01062113|454416090|FG002|Overall Study|Withdrawal by Subject|0|||
126307890|NCT03702010|454416093|FG000|Follow-up (30days)|Lack of Efficacy|2|||
126307891|NCT03702010|454416094|FG001|Follow-up (30days)|Lack of Efficacy|2|||
126307892|NCT02004886|454416099|FG000|Overall Study|Adverse Event|0|||
126307893|NCT02004886|454416100|FG001|Overall Study|Adverse Event|1|||
126307894|NCT02004886|454416101|FG002|Overall Study|Adverse Event|0|||
126307895|NCT02004886|454416102|FG003|Overall Study|Adverse Event|0|||
126307896|NCT02004886|454416099|FG000|Overall Study|Unable to attend future visits|1|||
126307897|NCT02004886|454416100|FG001|Overall Study|Unable to attend future visits|0|||
126307898|NCT02004886|454416101|FG002|Overall Study|Unable to attend future visits|0|||
126307899|NCT02004886|454416102|FG003|Overall Study|Unable to attend future visits|0|||
126307900|NCT05239494|454416103|FG000|Overall Study|Lost to Follow-up|1|||
126307901|NCT01194531|454416104|FG000|Overall Study|Withdrawal by Subject|1|||
126307902|NCT01194531|454416105|FG001|Overall Study|Withdrawal by Subject|0|||
126307903|NCT01194531|454416104|FG000|Overall Study|Protocol Violation|4|||
126307904|NCT01194531|454416105|FG001|Overall Study|Protocol Violation|1|||
126307905|NCT01194531|454416104|FG000|Overall Study|Physician Decision|0|||
126307906|NCT01194531|454416105|FG001|Overall Study|Physician Decision|2|||
126307907|NCT03891862|454416106|FG000|Open-label Period|Adverse Event|2|||
126371043|NCT01517984|454656658|FG000|Overall Study|Withdrawal by Subject|1|||
126307908|NCT03891862|454416107|FG001|Open-label Period|Adverse Event|0|||
126307909|NCT03891862|454416108|FG002|Open-label Period|Adverse Event|0|||
126307910|NCT03891862|454416106|FG000|Open-label Period|Protocol Violation|5|||
126307911|NCT03891862|454416107|FG001|Open-label Period|Protocol Violation|0|||
126307912|NCT03891862|454416108|FG002|Open-label Period|Protocol Violation|0|||
126307913|NCT03891862|454416106|FG000|Open-label Period|Withdrawal by Subject|6|||
126307914|NCT03891862|454416107|FG001|Open-label Period|Withdrawal by Subject|0|||
126307915|NCT03891862|454416108|FG002|Open-label Period|Withdrawal by Subject|0|||
126307916|NCT03891862|454416106|FG000|Open-label Period|Death|1|||
126307917|NCT03891862|454416107|FG001|Open-label Period|Death|0|||
126307918|NCT03891862|454416108|FG002|Open-label Period|Death|0|||
126307919|NCT03891862|454416106|FG000|Open-label Period|Lost to Follow-up|2|||
126307920|NCT03891862|454416107|FG001|Open-label Period|Lost to Follow-up|0|||
126307921|NCT03891862|454416108|FG002|Open-label Period|Lost to Follow-up|0|||
126307922|NCT03891862|454416106|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
126307923|NCT03891862|454416107|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
126307924|NCT03891862|454416108|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
126307925|NCT03891862|454416106|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
126307926|NCT03891862|454416107|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
126307927|NCT03891862|454416108|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
126307928|NCT03891862|454416106|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
126307929|NCT03891862|454416107|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
126307930|NCT03891862|454416108|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
126307931|NCT03891862|454416106|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
126307932|NCT03891862|454416107|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
126307933|NCT03891862|454416108|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
126307934|NCT01053962|454416109|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
126307935|NCT01053962|454416110|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
126307936|NCT01053962|454416111|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
126307937|NCT01053962|454416112|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
126307938|NCT01053962|454416113|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
126307939|NCT01053962|454416109|FG000|Pretreatment Period|Venipuncture Failure|0|||
126307940|NCT01053962|454416110|FG001|Pretreatment Period|Venipuncture Failure|0|||
126307941|NCT01053962|454416111|FG002|Pretreatment Period|Venipuncture Failure|1|||
126307942|NCT01053962|454416112|FG003|Pretreatment Period|Venipuncture Failure|0|||
126307943|NCT01053962|454416113|FG004|Pretreatment Period|Venipuncture Failure|0|||
126307944|NCT01053962|454416109|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
126307945|NCT01053962|454416110|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
126307946|NCT01053962|454416111|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
126307947|NCT01053962|454416112|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
126307948|NCT01053962|454416113|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
126307949|NCT01053962|454416109|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
126307950|NCT01053962|454416110|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
126307951|NCT01053962|454416111|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
126307952|NCT01053962|454416112|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
126103965|NCT03756129|453673884|FG002|Overall Study|Withdrawal by Subject|3|||
126307953|NCT01053962|454416113|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
126307954|NCT01053962|454416109|FG000|Treatment Period|Lack of Efficacy|0|||
125885558|NCT00606593|452876876|FG008|Overall Study|Administrative/Other|0|||
126103966|NCT03756129|453673885|FG003|Overall Study|Withdrawal by Subject|1|||
126371044|NCT01517984|454656659|FG001|Overall Study|Withdrawal by Subject|8|||
126371045|NCT01517984|454656660|FG002|Overall Study|Withdrawal by Subject|4|||
126371046|NCT01517984|454656661|FG003|Overall Study|Withdrawal by Subject|1|||
126371047|NCT01517984|454656658|FG000|Overall Study|Screen Failure|4|||
126371048|NCT01517984|454656659|FG001|Overall Study|Screen Failure|0|||
126371049|NCT01517984|454656660|FG002|Overall Study|Screen Failure|0|||
126371050|NCT01517984|454656661|FG003|Overall Study|Screen Failure|0|||
126371051|NCT01517984|454656658|FG000|Overall Study|Ineligible for randomization|0|||
126371052|NCT01517984|454656659|FG001|Overall Study|Ineligible for randomization|14|||
126371053|NCT01517984|454656660|FG002|Overall Study|Ineligible for randomization|0|||
126371054|NCT01517984|454656661|FG003|Overall Study|Ineligible for randomization|0|||
126371055|NCT01645176|454656662|FG000|Overall Study|Lack of Efficacy|4|||
126371056|NCT01645176|454656662|FG000|Overall Study|did not complete final MRI|1|||
126047509|NCT03211247|453471812|FG004|Overall Study|Non-compliance with study drug|0|||
126047510|NCT03211247|453471808|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
126047511|NCT03211247|453471809|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
126371057|NCT02234362|454656663|FG000|Overall Study|Not eligible after first screening visit|17|||
126371058|NCT02234362|454656663|FG000|Overall Study|Lost to Follow-up|6|||
126371059|NCT02234362|454656663|FG000|Overall Study|Withdrawal by Subject|3|||
125885559|NCT00606593|452876877|FG009|Overall Study|Administrative/Other|0|||
125885560|NCT03181529|452876880|FG000|Overall Study|Withdrawal by Subject|1|||
125885561|NCT03181529|452876881|FG001|Overall Study|Withdrawal by Subject|1|||
126047512|NCT03211247|453471810|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
126371060|NCT00560417|454656664|FG000|Overall Study|Adverse Event|3|||
126371061|NCT00560417|454656665|FG001|Overall Study|Adverse Event|2|||
126371062|NCT00560417|454656664|FG000|Overall Study|Entry Criteria Not Met|1|||
126371063|NCT00560417|454656665|FG001|Overall Study|Entry Criteria Not Met|0|||
126371064|NCT00560417|454656664|FG000|Overall Study|Lost to Follow-up|0|||
126371065|NCT00560417|454656665|FG001|Overall Study|Lost to Follow-up|1|||
126371066|NCT00560417|454656664|FG000|Overall Study|Physician Decision|2|||
126371067|NCT00560417|454656665|FG001|Overall Study|Physician Decision|6|||
126371068|NCT00560417|454656664|FG000|Overall Study|Protocol Violation|6|||
126371069|NCT00560417|454656665|FG001|Overall Study|Protocol Violation|5|||
126371070|NCT00560417|454656664|FG000|Overall Study|Sponsor Decision|2|||
126371071|NCT00560417|454656665|FG001|Overall Study|Sponsor Decision|0|||
126371072|NCT00560417|454656664|FG000|Overall Study|Withdrawal by Subject|3|||
126371073|NCT00560417|454656665|FG001|Overall Study|Withdrawal by Subject|3|||
126371074|NCT02164864|454656668|FG000|Overall Study|Trial disease worsening|7|||
126371075|NCT02164864|454656669|FG001|Overall Study|Trial disease worsening|5|||
126371076|NCT02164864|454656670|FG002|Overall Study|Trial disease worsening|1|||
126371077|NCT02164864|454656668|FG000|Overall Study|Other pre-existing disease worsening|6|||
126371078|NCT02164864|454656669|FG001|Overall Study|Other pre-existing disease worsening|4|||
126371079|NCT02164864|454656670|FG002|Overall Study|Other pre-existing disease worsening|9|||
126371080|NCT02164864|454656668|FG000|Overall Study|Other Adverse Event (AE)|52|||
126371081|NCT02164864|454656669|FG001|Overall Study|Other Adverse Event (AE)|32|||
126371082|NCT02164864|454656670|FG002|Overall Study|Other Adverse Event (AE)|49|||
126371083|NCT02164864|454656668|FG000|Overall Study|Protocol Violation|2|||
126371084|NCT02164864|454656669|FG001|Overall Study|Protocol Violation|4|||
126371085|NCT02164864|454656670|FG002|Overall Study|Protocol Violation|1|||
126371086|NCT02164864|454656668|FG000|Overall Study|Lost to Follow-up|4|||
126371087|NCT02164864|454656669|FG001|Overall Study|Lost to Follow-up|3|||
126371088|NCT02164864|454656670|FG002|Overall Study|Lost to Follow-up|2|||
126371089|NCT02164864|454656668|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
126371090|NCT02164864|454656669|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
126371091|NCT02164864|454656670|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
126371092|NCT02164864|454656668|FG000|Overall Study|Other than stated|3|||
126371093|NCT02164864|454656669|FG001|Overall Study|Other than stated|4|||
126371094|NCT02164864|454656670|FG002|Overall Study|Other than stated|14|||
126371095|NCT02569853|454656671|FG000|Overall Study|Adverse Event|2|||
126371096|NCT02569853|454656672|FG001|Overall Study|Adverse Event|0|||
126371097|NCT02569853|454656671|FG000|Overall Study|Withdrawal by Subject|3|||
126371098|NCT02569853|454656672|FG001|Overall Study|Withdrawal by Subject|2|||
126371099|NCT02569853|454656671|FG000|Overall Study|Lost to Follow-up|3|||
126371100|NCT02569853|454656672|FG001|Overall Study|Lost to Follow-up|3|||
126371101|NCT02569853|454656671|FG000|Overall Study|Protocol Violation|1|||
126371102|NCT02569853|454656672|FG001|Overall Study|Protocol Violation|1|||
126371103|NCT02569853|454656671|FG000|Overall Study|Did not experience migraine attack|10|||
126371104|NCT02569853|454656672|FG001|Overall Study|Did not experience migraine attack|7|||
126371105|NCT02569853|454656671|FG000|Overall Study|Physician Decision|1|||
126371106|NCT02569853|454656672|FG001|Overall Study|Physician Decision|1|||
126371107|NCT02434081|454656675|FG000|Overall Study|Death (never started treatment)|2|||
126047513|NCT03211247|453471811|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
126047514|NCT03211247|453471812|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
126047515|NCT03211247|453471808|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
126047516|NCT03211247|453471809|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
126047517|NCT03211247|453471810|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
126047518|NCT03211247|453471811|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
126371108|NCT02434081|454656675|FG000|Overall Study|Death|2|||
126371109|NCT02434081|454656675|FG000|Overall Study|Progression|20|||
126371110|NCT02434081|454656675|FG000|Overall Study|Adverse Event|20|||
125885562|NCT03181529|452876880|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
126047519|NCT03211247|453471812|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
126047520|NCT03211247|453471808|FG000|Overall Study|Protocol Violation|0|||
126047521|NCT03211247|453471809|FG001|Overall Study|Protocol Violation|1|||
126047522|NCT03211247|453471810|FG002|Overall Study|Protocol Violation|0|||
126371111|NCT02434081|454656675|FG000|Overall Study|Physician Decision|2|||
126371112|NCT02434081|454656675|FG000|Overall Study|Withdrawal by Subject|1|||
126371113|NCT02434081|454656675|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
126371114|NCT00419744|454656676|FG000|Overall Study|Adverse Event|39|||
126371115|NCT00419744|454656677|FG001|Overall Study|Adverse Event|40|||
126371116|NCT00419744|454656678|FG002|Overall Study|Adverse Event|50|||
126371117|NCT00419744|454656676|FG000|Overall Study|Withdrawal by Subject|45|||
126371118|NCT00419744|454656677|FG001|Overall Study|Withdrawal by Subject|49|||
126047523|NCT03211247|453471811|FG003|Overall Study|Protocol Violation|0|||
126307955|NCT01053962|454416110|FG001|Treatment Period|Lack of Efficacy|0|||
126307956|NCT01053962|454416111|FG002|Treatment Period|Lack of Efficacy|0|||
126307957|NCT01053962|454416112|FG003|Treatment Period|Lack of Efficacy|0|||
126307958|NCT01053962|454416113|FG004|Treatment Period|Lack of Efficacy|1|||
126307959|NCT01053962|454416109|FG000|Treatment Period|Adverse Event|0|||
126307960|NCT01053962|454416110|FG001|Treatment Period|Adverse Event|0|||
126307961|NCT01053962|454416111|FG002|Treatment Period|Adverse Event|0|||
126307962|NCT01053962|454416112|FG003|Treatment Period|Adverse Event|0|||
126307963|NCT01053962|454416113|FG004|Treatment Period|Adverse Event|1|||
126307964|NCT01053962|454416109|FG000|Treatment Period|Withdrawal by Subject|0|||
126307965|NCT01053962|454416110|FG001|Treatment Period|Withdrawal by Subject|0|||
126307966|NCT01053962|454416111|FG002|Treatment Period|Withdrawal by Subject|0|||
126307967|NCT01053962|454416112|FG003|Treatment Period|Withdrawal by Subject|0|||
126307968|NCT01053962|454416113|FG004|Treatment Period|Withdrawal by Subject|1|||
126307969|NCT01053962|454416109|FG000|Treatment Period|Noncompliance with protocol|1|||
126307970|NCT01053962|454416110|FG001|Treatment Period|Noncompliance with protocol|0|||
126307971|NCT01053962|454416111|FG002|Treatment Period|Noncompliance with protocol|0|||
126307972|NCT01053962|454416112|FG003|Treatment Period|Noncompliance with protocol|0|||
126307973|NCT01053962|454416113|FG004|Treatment Period|Noncompliance with protocol|0|||
126307974|NCT00638443|454416114|FG000|First Intervention|Adverse Event|2|||
126307975|NCT00638443|454416115|FG001|First Intervention|Adverse Event|1|||
126307976|NCT04603482|454416117|FG000|Overall Study|Lost to Follow-up|15|||
126307977|NCT04603482|454416118|FG001|Overall Study|Lost to Follow-up|15|||
126307978|NCT04603482|454416119|FG002|Overall Study|Lost to Follow-up|15|||
126307979|NCT01054196|454416120|FG000|Overall Study|Physician Decision|0|||
126307980|NCT01054196|454416121|FG001|Overall Study|Physician Decision|0|||
126307981|NCT01054196|454416122|FG002|Overall Study|Physician Decision|0|||
126307982|NCT01054196|454416123|FG003|Overall Study|Physician Decision|1|||
126307983|NCT01054196|454416124|FG004|Overall Study|Physician Decision|0|||
126307984|NCT01054196|454416125|FG005|Overall Study|Physician Decision|0|||
126307985|NCT01054196|454416126|FG006|Overall Study|Physician Decision|1|||
126307986|NCT02949843|454416127|FG000|Overall Study|Withdrawal by Subject|0|||
126307987|NCT02949843|454416128|FG001|Overall Study|Withdrawal by Subject|1|||
126307988|NCT02949843|454416129|FG002|Overall Study|Withdrawal by Subject|1|||
126307989|NCT02253316|454416130|FG000|Consolidation|Progression|4|||
126307990|NCT02253316|454416131|FG001|Consolidation|Progression|0|||
126307991|NCT02253316|454416132|FG002|Consolidation|Progression|0|||
126307992|NCT02253316|454416130|FG000|Consolidation|Non-Compliance|1|||
126307993|NCT02253316|454416131|FG001|Consolidation|Non-Compliance|0|||
126307994|NCT02253316|454416132|FG002|Consolidation|Non-Compliance|0|||
126307995|NCT02253316|454416130|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
126307996|NCT02253316|454416131|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
126307997|NCT02253316|454416132|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
126307998|NCT02253316|454416130|FG000|Consolidation|Secondary Malignancy|2|||
126307999|NCT02253316|454416131|FG001|Consolidation|Secondary Malignancy|0|||
126308000|NCT02253316|454416132|FG002|Consolidation|Secondary Malignancy|0|||
126308001|NCT02253316|454416130|FG000|Consolidation|Adverse Event|7|||
126308002|NCT02253316|454416131|FG001|Consolidation|Adverse Event|0|||
126308003|NCT02253316|454416132|FG002|Consolidation|Adverse Event|0|||
126308004|NCT02253316|454416130|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
126308005|NCT02253316|454416131|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
126308006|NCT02253316|454416132|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
126308007|NCT02253316|454416130|FG000|Maintenance|Physician Decision|0|||
126308008|NCT02253316|454416131|FG001|Maintenance|Physician Decision|7|||
126308009|NCT02253316|454416132|FG002|Maintenance|Physician Decision|16|||
126308010|NCT02253316|454416130|FG000|Maintenance|Non-Compliance|0|||
126308011|NCT02253316|454416131|FG001|Maintenance|Non-Compliance|1|||
126308012|NCT02253316|454416132|FG002|Maintenance|Non-Compliance|1|||
126308013|NCT02253316|454416130|FG000|Maintenance|Secondary Malignancy|0|||
126308014|NCT02253316|454416131|FG001|Maintenance|Secondary Malignancy|2|||
126308015|NCT02253316|454416132|FG002|Maintenance|Secondary Malignancy|6|||
126308016|NCT02253316|454416130|FG000|Maintenance|Adverse Event|0|||
126308017|NCT02253316|454416131|FG001|Maintenance|Adverse Event|8|||
126308018|NCT02253316|454416132|FG002|Maintenance|Adverse Event|12|||
126308019|NCT02253316|454416130|FG000|Maintenance|Still receiving active treatment|0|||
126308020|NCT02253316|454416131|FG001|Maintenance|Still receiving active treatment|5|||
126308021|NCT02253316|454416132|FG002|Maintenance|Still receiving active treatment|0|||
126047524|NCT03211247|453471812|FG004|Overall Study|Protocol Violation|0|||
126308022|NCT00135512|454416137|FG000|Overall Study|Adverse Event|56|||
126308023|NCT00135512|454416137|FG000|Overall Study|Lack of Efficacy|25|||
126308024|NCT00135512|454416137|FG000|Overall Study|Other|42|||
126308025|NCT04152837|454416138|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
126308026|NCT04152837|454416138|FG000|Maintenance Period|Adverse Event|1|||
126308027|NCT04152837|454416138|FG000|Maintenance Period|Withdrawal by Subject|1|||
126308028|NCT04152837|454416138|FG000|Maintenance Period|Sponsor Termination of Study|2|||
126308029|NCT01668173|454416143|FG000|Overall Study|Adverse Event|3|||
126371119|NCT00419744|454656678|FG002|Overall Study|Withdrawal by Subject|52|||
126371120|NCT00419744|454656676|FG000|Overall Study|Lost to Follow-up|8|||
126371121|NCT00419744|454656677|FG001|Overall Study|Lost to Follow-up|10|||
126371122|NCT00419744|454656678|FG002|Overall Study|Lost to Follow-up|6|||
126371123|NCT00419744|454656676|FG000|Overall Study|Protocol Violation|4|||
126371124|NCT00419744|454656677|FG001|Overall Study|Protocol Violation|7|||
126371125|NCT00419744|454656678|FG002|Overall Study|Protocol Violation|8|||
126371126|NCT00419744|454656676|FG000|Overall Study|Randomized in error|9|||
126371127|NCT00419744|454656677|FG001|Overall Study|Randomized in error|6|||
126371128|NCT00419744|454656678|FG002|Overall Study|Randomized in error|7|||
126371129|NCT00419744|454656676|FG000|Overall Study|Moving out of state|2|||
126371130|NCT00419744|454656677|FG001|Overall Study|Moving out of state|0|||
126371131|NCT00419744|454656678|FG002|Overall Study|Moving out of state|1|||
126371132|NCT00419744|454656676|FG000|Overall Study|Physician Decision|10|||
126371133|NCT00419744|454656677|FG001|Overall Study|Physician Decision|5|||
126371134|NCT00419744|454656678|FG002|Overall Study|Physician Decision|6|||
126371135|NCT00419744|454656676|FG000|Overall Study|Spirometry mouthpiece issues|0|||
126371136|NCT00419744|454656677|FG001|Overall Study|Spirometry mouthpiece issues|1|||
126371137|NCT00419744|454656678|FG002|Overall Study|Spirometry mouthpiece issues|2|||
126371138|NCT00419744|454656676|FG000|Overall Study|Incorrect medication kit dispensed|0|||
126371139|NCT00419744|454656677|FG001|Overall Study|Incorrect medication kit dispensed|0|||
126371140|NCT00419744|454656678|FG002|Overall Study|Incorrect medication kit dispensed|1|||
126371141|NCT01668004|454656679|FG000|Overall Study|Adverse Event|7|||
126371142|NCT01668004|454656679|FG000|Overall Study|Withdrawal by Subject|2|||
126371143|NCT01668004|454656679|FG000|Overall Study|Lost to Follow-up|5|||
126371144|NCT01668004|454656679|FG000|Overall Study|Lack of Efficacy|9|||
126371145|NCT01668004|454656679|FG000|Overall Study|Non-compliance with treatment|2|||
126371146|NCT02448381|454656684|FG000|Overall Study|Adverse Event|2|||
126371147|NCT02448381|454656685|FG001|Overall Study|Adverse Event|0|||
126371148|NCT02448381|454656684|FG000|Overall Study|Lost to Follow-up|16|||
126371149|NCT02448381|454656685|FG001|Overall Study|Lost to Follow-up|9|||
126371150|NCT02448381|454656684|FG000|Overall Study|Physician Decision|1|||
126371151|NCT02448381|454656685|FG001|Overall Study|Physician Decision|1|||
126371152|NCT02448381|454656684|FG000|Overall Study|Pregnancy|1|||
126371153|NCT02448381|454656685|FG001|Overall Study|Pregnancy|0|||
126371154|NCT02448381|454656684|FG000|Overall Study|Withdrawal by Subject|13|||
126371155|NCT02448381|454656685|FG001|Overall Study|Withdrawal by Subject|9|||
126371156|NCT02448381|454656684|FG000|Overall Study|Noncompliance with Study Procedures|2|||
126371157|NCT02448381|454656685|FG001|Overall Study|Noncompliance with Study Procedures|0|||
126371158|NCT02006927|454656686|FG000|Overall Study|Adverse Event|2|||
126371159|NCT02006927|454656686|FG000|Overall Study|Withdrawal by Subject|1|||
126371160|NCT02735200|454656687|FG000|Overall Study|Lost to Follow-up|0|||
126371161|NCT02735200|454656688|FG001|Overall Study|Lost to Follow-up|5|||
126371162|NCT02735200|454656687|FG000|Overall Study|Withdrawal by Subject|8|||
126371163|NCT02735200|454656688|FG001|Overall Study|Withdrawal by Subject|0|||
126371164|NCT00673920|454656689|FG000|Baseline up to Week 48|Withdrew consent|1|||
126371165|NCT00673920|454656690|FG001|Baseline up to Week 48|Withdrew consent|0|||
126371166|NCT00673920|454656691|FG002|Baseline up to Week 48|Withdrew consent|2|||
126371167|NCT00673920|454656692|FG003|Baseline up to Week 48|Withdrew consent|0|||
126371168|NCT00673920|454656693|FG004|Baseline up to Week 48|Withdrew consent|0|||
126371169|NCT00673920|454656694|FG005|Baseline up to Week 48|Withdrew consent|0|||
126103967|NCT03756129|453673886|FG004|Overall Study|Withdrawal by Subject|1|||
126371170|NCT00673920|454656695|FG006|Baseline up to Week 48|Withdrew consent|0|||
126371171|NCT00673920|454656696|FG007|Baseline up to Week 48|Withdrew consent|0|||
126371172|NCT00673920|454656689|FG000|Baseline up to Week 48|Refused treatment|1|||
126371173|NCT00673920|454656690|FG001|Baseline up to Week 48|Refused treatment|0|||
126371174|NCT00673920|454656691|FG002|Baseline up to Week 48|Refused treatment|0|||
126371175|NCT00673920|454656692|FG003|Baseline up to Week 48|Refused treatment|0|||
126371176|NCT00673920|454656693|FG004|Baseline up to Week 48|Refused treatment|0|||
126371177|NCT00673920|454656694|FG005|Baseline up to Week 48|Refused treatment|0|||
126371178|NCT00673920|454656695|FG006|Baseline up to Week 48|Refused treatment|0|||
126371179|NCT00673920|454656696|FG007|Baseline up to Week 48|Refused treatment|0|||
126371180|NCT00673920|454656689|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
126371181|NCT00673920|454656690|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
126371182|NCT00673920|454656691|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371183|NCT00673920|454656692|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371184|NCT00673920|454656693|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371185|NCT00673920|454656694|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371186|NCT00673920|454656695|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
126103968|NCT03756129|453673887|FG005|Overall Study|Withdrawal by Subject|3|||
125885563|NCT03181529|452876881|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
125885564|NCT06042855|452876888|FG000|Overall Study|No Receipt of Study Drug|48|||
125885565|NCT06042855|452876889|FG001|Overall Study|No Receipt of Study Drug|57|||
125885566|NCT06042855|452876888|FG000|Overall Study|Administratively Withdrawn|59|||
125885567|NCT06042855|452876889|FG001|Overall Study|Administratively Withdrawn|59|||
125885568|NCT03313037|452876890|FG000|Overall Study|Protocol Violation|4|||
125885569|NCT03313037|452876891|FG001|Overall Study|Protocol Violation|1|||
125885570|NCT03313037|452876890|FG000|Overall Study|Other|1|||
125885571|NCT03313037|452876891|FG001|Overall Study|Other|1|||
125885572|NCT03313037|452876890|FG000|Overall Study|Withdrawal by Subject|4|||
125885573|NCT03313037|452876891|FG001|Overall Study|Withdrawal by Subject|3|||
125885574|NCT03313037|452876890|FG000|Overall Study|No longer meets eligibility criteria|1|||
125885575|NCT03313037|452876891|FG001|Overall Study|No longer meets eligibility criteria|7|||
125885576|NCT03313037|452876890|FG000|Overall Study|Lost to Follow-up|9|||
125885577|NCT03313037|452876891|FG001|Overall Study|Lost to Follow-up|8|||
125885578|NCT03313037|452876890|FG000|Overall Study|Randomized but not treated|1|||
125885579|NCT03313037|452876891|FG001|Overall Study|Randomized but not treated|0|||
125885580|NCT02379091|452876892|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125885581|NCT02379091|452876893|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125885582|NCT02379091|452876894|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125885583|NCT02379091|452876895|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
125885584|NCT02379091|452876892|FG000|Overall Study|Principal Investigator Discretion|0|||
125885585|NCT02379091|452876893|FG001|Overall Study|Principal Investigator Discretion|1|||
125885586|NCT02379091|452876894|FG002|Overall Study|Principal Investigator Discretion|0|||
125885587|NCT02379091|452876895|FG003|Overall Study|Principal Investigator Discretion|0|||
125885588|NCT02379091|452876892|FG000|Overall Study|Lost to Follow-up|0|||
125885589|NCT02379091|452876893|FG001|Overall Study|Lost to Follow-up|0|||
125885590|NCT02379091|452876894|FG002|Overall Study|Lost to Follow-up|0|||
125885591|NCT02379091|452876895|FG003|Overall Study|Lost to Follow-up|1|||
125885592|NCT02379091|452876892|FG000|Overall Study|Voluntary Withdrawal|2|||
125885593|NCT02379091|452876893|FG001|Overall Study|Voluntary Withdrawal|5|||
125885594|NCT02379091|452876894|FG002|Overall Study|Voluntary Withdrawal|2|||
125885595|NCT02379091|452876895|FG003|Overall Study|Voluntary Withdrawal|4|||
125885596|NCT02379091|452876892|FG000|Overall Study|Study Termination|7|||
125885597|NCT02379091|452876893|FG001|Overall Study|Study Termination|2|||
125885598|NCT02379091|452876894|FG002|Overall Study|Study Termination|5|||
125885599|NCT02379091|452876895|FG003|Overall Study|Study Termination|8|||
125885600|NCT02379091|452876892|FG000|Overall Study|Lack of Efficacy|3|||
125885601|NCT02379091|452876893|FG001|Overall Study|Lack of Efficacy|0|||
125885602|NCT02379091|452876894|FG002|Overall Study|Lack of Efficacy|0|||
125885603|NCT02379091|452876895|FG003|Overall Study|Lack of Efficacy|0|||
125885604|NCT02129699|452876898|FG000|Overall Study|Did not start treatment|3|||
125885605|NCT02129699|452876899|FG001|Overall Study|Did not start treatment|2|||
125885606|NCT01076361|452876903|FG000|Overall Study|22 leads were excluded from analysis|21|||
125885607|NCT04801420|452876909|FG000|Overall Study|Other|1|||
125885608|NCT04801420|452876910|FG001|Overall Study|Other|2|||
125885609|NCT04801420|452876911|FG002|Overall Study|Other|1|||
125885610|NCT04801420|452876909|FG000|Overall Study|Lost to Follow-up|7|||
125885611|NCT04801420|452876910|FG001|Overall Study|Lost to Follow-up|9|||
125885612|NCT04801420|452876911|FG002|Overall Study|Lost to Follow-up|10|||
126047525|NCT02039401|453471813|FG000|Overall Study|Adverse Event|0|||
126047526|NCT02039401|453471814|FG001|Overall Study|Adverse Event|1|||
126047527|NCT05827068|453471818|FG000|Overall Study|Lost to Follow-up|1|||
126308030|NCT01668173|454416143|FG000|Overall Study|Trial suspension|4|||
126308031|NCT00746564|454416144|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
126308032|NCT01628198|454416146|FG000|Overall Study|Lost to Follow-up|7|||
126308033|NCT01628198|454416146|FG000|Overall Study|Withdrawal by Subject|10|||
126308034|NCT01628198|454416146|FG000|Overall Study|Screen failure|1|||
126308035|NCT00986921|454416155|FG000|Overall Study|Physician Decision|1|||
126308036|NCT00986921|454416156|FG001|Overall Study|Physician Decision|0|||
126308037|NCT00833482|454416157|FG000|Days 11-20|Adverse Event|0|||
126308038|NCT00833482|454416158|FG001|Days 11-20|Adverse Event|2|||
126308039|NCT00833482|454416159|FG002|Days 11-20|Adverse Event|0|||
126308040|NCT00833482|454416160|FG003|Days 11-20|Adverse Event|0|||
126308041|NCT00833482|454416161|FG004|Days 11-20|Adverse Event|0|||
126308042|NCT00833482|454416162|FG005|Days 11-20|Adverse Event|0|||
126308043|NCT00833482|454416157|FG000|Days 11-20|Withdrawal by Subject|0|||
126308044|NCT00833482|454416158|FG001|Days 11-20|Withdrawal by Subject|1|||
126308045|NCT00833482|454416159|FG002|Days 11-20|Withdrawal by Subject|0|||
126308046|NCT00833482|454416160|FG003|Days 11-20|Withdrawal by Subject|0|||
126308047|NCT00833482|454416161|FG004|Days 11-20|Withdrawal by Subject|0|||
126308048|NCT00833482|454416162|FG005|Days 11-20|Withdrawal by Subject|0|||
126308049|NCT00833482|454416157|FG000|Days 21-30|Adverse Event|0|||
126308050|NCT00833482|454416158|FG001|Days 21-30|Adverse Event|0|||
126308051|NCT00833482|454416159|FG002|Days 21-30|Adverse Event|1|||
126308052|NCT00833482|454416160|FG003|Days 21-30|Adverse Event|0|||
126308053|NCT00833482|454416161|FG004|Days 21-30|Adverse Event|0|||
126308054|NCT00833482|454416162|FG005|Days 21-30|Adverse Event|0|||
126047528|NCT05827068|453471819|FG001|Overall Study|Lost to Follow-up|4|||
126047529|NCT05827068|453471820|FG002|Overall Study|Lost to Follow-up|1|||
126047530|NCT05827068|453471821|FG003|Overall Study|Lost to Follow-up|1|||
126047531|NCT05827068|453471822|FG004|Overall Study|Lost to Follow-up|2|||
126047532|NCT05827068|453471823|FG005|Overall Study|Lost to Follow-up|4|||
126047533|NCT05827068|453471824|FG006|Overall Study|Lost to Follow-up|1|||
126047534|NCT05827068|453471818|FG000|Overall Study|Withdrawal by Subject|4|||
126047535|NCT05827068|453471819|FG001|Overall Study|Withdrawal by Subject|0|||
126047536|NCT05827068|453471820|FG002|Overall Study|Withdrawal by Subject|1|||
126047537|NCT05827068|453471821|FG003|Overall Study|Withdrawal by Subject|2|||
126047538|NCT05827068|453471822|FG004|Overall Study|Withdrawal by Subject|3|||
126047539|NCT05827068|453471823|FG005|Overall Study|Withdrawal by Subject|0|||
126047540|NCT05827068|453471824|FG006|Overall Study|Withdrawal by Subject|1|||
126047541|NCT05827068|453471818|FG000|Overall Study|Physician Decision|0|||
126047542|NCT05827068|453471819|FG001|Overall Study|Physician Decision|0|||
126371187|NCT00673920|454656696|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371188|NCT00673920|454656689|FG000|Baseline up to Week 48|Protocol Violation|0|||
126371189|NCT00673920|454656690|FG001|Baseline up to Week 48|Protocol Violation|0|||
126371190|NCT00673920|454656691|FG002|Baseline up to Week 48|Protocol Violation|1|||
126371191|NCT00673920|454656692|FG003|Baseline up to Week 48|Protocol Violation|0|||
126371192|NCT00673920|454656693|FG004|Baseline up to Week 48|Protocol Violation|0|||
126371193|NCT00673920|454656694|FG005|Baseline up to Week 48|Protocol Violation|0|||
126371194|NCT00673920|454656695|FG006|Baseline up to Week 48|Protocol Violation|0|||
126371195|NCT00673920|454656696|FG007|Baseline up to Week 48|Protocol Violation|0|||
126371196|NCT00673920|454656689|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371197|NCT00673920|454656690|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371198|NCT00673920|454656691|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
126371199|NCT00673920|454656692|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371200|NCT00673920|454656693|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371201|NCT00673920|454656694|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371202|NCT00673920|454656695|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371203|NCT00673920|454656696|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371204|NCT00673920|454656689|FG000|Baseline up to Week 48|Administrative/Other|0|||
126371205|NCT00673920|454656690|FG001|Baseline up to Week 48|Administrative/Other|1|||
126047543|NCT05827068|453471820|FG002|Overall Study|Physician Decision|0|||
126047544|NCT05827068|453471821|FG003|Overall Study|Physician Decision|0|||
126047545|NCT05827068|453471822|FG004|Overall Study|Physician Decision|1|||
126047546|NCT05827068|453471823|FG005|Overall Study|Physician Decision|0|||
126047547|NCT05827068|453471824|FG006|Overall Study|Physician Decision|1|||
126047548|NCT05827068|453471818|FG000|Overall Study|Other Than Specified|0|||
126047549|NCT05827068|453471819|FG001|Overall Study|Other Than Specified|1|||
126047550|NCT05827068|453471820|FG002|Overall Study|Other Than Specified|0|||
126047551|NCT05827068|453471821|FG003|Overall Study|Other Than Specified|0|||
126047552|NCT05827068|453471822|FG004|Overall Study|Other Than Specified|0|||
126371206|NCT00673920|454656691|FG002|Baseline up to Week 48|Administrative/Other|2|||
126371207|NCT00673920|454656692|FG003|Baseline up to Week 48|Administrative/Other|0|||
126371208|NCT00673920|454656693|FG004|Baseline up to Week 48|Administrative/Other|0|||
126047553|NCT05827068|453471823|FG005|Overall Study|Other Than Specified|0|||
126047554|NCT05827068|453471824|FG006|Overall Study|Other Than Specified|0|||
126047555|NCT04039113|453471825|FG000|Overall Study|Withdrawal by Subject|8|||
126047556|NCT04039113|453471826|FG001|Overall Study|Withdrawal by Subject|11|||
126308055|NCT00833482|454416157|FG000|Days 21-30|Withdrawal by Subject|0|||
126308056|NCT00833482|454416158|FG001|Days 21-30|Withdrawal by Subject|0|||
126308057|NCT00833482|454416159|FG002|Days 21-30|Withdrawal by Subject|0|||
126308058|NCT00833482|454416160|FG003|Days 21-30|Withdrawal by Subject|0|||
126308059|NCT00833482|454416161|FG004|Days 21-30|Withdrawal by Subject|1|||
126308060|NCT00833482|454416162|FG005|Days 21-30|Withdrawal by Subject|0|||
126308061|NCT02778074|454416163|FG000|Overall Study|Lost to Follow-up|7|||
126308062|NCT02778074|454416164|FG001|Overall Study|Lost to Follow-up|10|||
126308063|NCT01817582|454416165|FG000|Overall Study|Withdrawal by Subject|0|||
126308064|NCT01817582|454416166|FG001|Overall Study|Withdrawal by Subject|1|||
126308065|NCT01817582|454416167|FG002|Overall Study|Withdrawal by Subject|0|||
126308066|NCT01817582|454416165|FG000|Overall Study|Participant revealed masked treatment|1|||
126308067|NCT01817582|454416166|FG001|Overall Study|Participant revealed masked treatment|0|||
126308068|NCT01817582|454416167|FG002|Overall Study|Participant revealed masked treatment|0|||
126308069|NCT01817582|454416165|FG000|Overall Study|Randomized but exclusion criteria met|1|||
126308070|NCT01817582|454416166|FG001|Overall Study|Randomized but exclusion criteria met|0|||
126308071|NCT01817582|454416167|FG002|Overall Study|Randomized but exclusion criteria met|0|||
126308072|NCT03617770|454416170|FG000|Overall Study|Lost to Follow-up|1|||
126308073|NCT03617770|454416171|FG001|Overall Study|Lost to Follow-up|0|||
126308074|NCT00356135|454416172|FG000|Overall Study|Protocol Violation|1|||
126308075|NCT00356135|454416173|FG001|Overall Study|Protocol Violation|0|||
126308076|NCT00356135|454416174|FG002|Overall Study|Protocol Violation|0|||
126308077|NCT00356135|454416172|FG000|Overall Study|Adverse Event|1|||
126308078|NCT00356135|454416173|FG001|Overall Study|Adverse Event|0|||
126308079|NCT00356135|454416174|FG002|Overall Study|Adverse Event|0|||
126308080|NCT00356135|454416172|FG000|Overall Study|Lost to Follow-up|0|||
126308081|NCT00356135|454416173|FG001|Overall Study|Lost to Follow-up|0|||
126308082|NCT00356135|454416174|FG002|Overall Study|Lost to Follow-up|1|||
126308083|NCT00356135|454416172|FG000|Overall Study|Physician Decision|1|||
126308084|NCT00356135|454416173|FG001|Overall Study|Physician Decision|1|||
126308085|NCT00356135|454416174|FG002|Overall Study|Physician Decision|1|||
126308086|NCT00356135|454416172|FG000|Overall Study|Subject non-compliance|1|||
126308087|NCT00356135|454416173|FG001|Overall Study|Subject non-compliance|1|||
126308088|NCT00356135|454416174|FG002|Overall Study|Subject non-compliance|3|||
126308089|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126308090|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
126308091|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
126308092|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
126308093|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
126308094|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
126308095|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
126308096|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
126308097|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
126308098|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
126308099|NCT03963232|454416175|FG000|Open-Label Treatment Phase|Adverse Event|1|||
126308100|NCT03963232|454416176|FG001|Open-Label Treatment Phase|Adverse Event|2|||
126308101|NCT03963232|454416175|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
126308102|NCT03963232|454416176|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
126308103|NCT03963232|454416175|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
126308104|NCT03963232|454416176|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
126308105|NCT03963232|454416175|FG000|Open-Label Treatment Phase|Pregnancy|1|||
126308106|NCT03963232|454416176|FG001|Open-Label Treatment Phase|Pregnancy|0|||
126308107|NCT03963232|454416175|FG000|Follow-up Phase|Withdrawal by Subject|7|||
126308108|NCT03963232|454416176|FG001|Follow-up Phase|Withdrawal by Subject|5|||
126308109|NCT03963232|454416175|FG000|Follow-up Phase|Protocol Violation|0|||
126308110|NCT03963232|454416176|FG001|Follow-up Phase|Protocol Violation|2|||
126308111|NCT03963232|454416175|FG000|Follow-up Phase|Adverse Event|0|||
126308112|NCT03963232|454416176|FG001|Follow-up Phase|Adverse Event|1|||
126308113|NCT03963232|454416175|FG000|Follow-up Phase|Lost to Follow-up|0|||
126308114|NCT03963232|454416176|FG001|Follow-up Phase|Lost to Follow-up|1|||
126308115|NCT03512210|454416178|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
126308116|NCT03512210|454416178|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
126308117|NCT03512210|454416178|FG000|Step 2:Post-MINMON|Death|2|||
126308118|NCT03512210|454416178|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
126047557|NCT04039113|453471825|FG000|Overall Study|Lost to Follow-up|1|||
126308119|NCT03512210|454416178|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
126308120|NCT00378508|454418629|FG000|Overall Study|Withdrawal by Subject|1|||
126308121|NCT00378508|454418630|FG001|Overall Study|Withdrawal by Subject|3|||
126308122|NCT00378508|454418629|FG000|Overall Study|Lost to Follow-up|1|||
126308123|NCT00378508|454418630|FG001|Overall Study|Lost to Follow-up|0|||
126308124|NCT03467217|454418631|FG000|Overall Study|Trial stopped early|5|||
126308125|NCT03467217|454418632|FG001|Overall Study|Trial stopped early|2|||
126308126|NCT03467217|454418631|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
126308127|NCT03467217|454418632|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
126308128|NCT03467217|454418631|FG000|Overall Study|Lost to Follow-up|0|||
126308129|NCT03467217|454418632|FG001|Overall Study|Lost to Follow-up|2|||
126308130|NCT03991299|454418635|FG000|Overall Study|Study closed, sponsor decision|3|||
126308131|NCT03991299|454418635|FG000|Overall Study|Withdrawal by Subject|1|||
126308132|NCT04304235|454418636|FG000|Overall Study|incomplete triage data|0|||
126308133|NCT04304235|454418637|FG001|Overall Study|incomplete triage data|69|||
126308134|NCT04304235|454418638|FG002|Overall Study|incomplete triage data|0|||
126308135|NCT04304235|454418639|FG003|Overall Study|incomplete triage data|0|||
126308136|NCT04304235|454418640|FG004|Overall Study|incomplete triage data|289|||
126308137|NCT04304235|454418641|FG005|Overall Study|incomplete triage data|123|||
126308138|NCT04304235|454418642|FG006|Overall Study|incomplete triage data|65|||
126308139|NCT03728426|454418649|FG000|Overall Study|Death|3|||
126308140|NCT04429555|454418653|FG000|Overall Study|Death|0|||
126308141|NCT04429555|454418654|FG001|Overall Study|Death|2|||
126308142|NCT04429555|454418653|FG000|Overall Study|Other|2|||
126308143|NCT04429555|454418654|FG001|Overall Study|Other|0|||
126308144|NCT00231114|454418656|FG000|Randomized|Withdrawal by Subject|6|||
126308145|NCT00231114|454418657|FG001|Randomized|Withdrawal by Subject|3|||
126308146|NCT00231114|454418656|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
126308147|NCT00231114|454418657|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
126308148|NCT00231114|454418656|FG000|Post-Treatment Period|Lost to Follow-up|6|||
126308149|NCT00231114|454418657|FG001|Post-Treatment Period|Lost to Follow-up|1|||
126308150|NCT00231114|454418656|FG000|Post-Treatment Period|Physician Decision|1|||
126308151|NCT00231114|454418657|FG001|Post-Treatment Period|Physician Decision|0|||
126308152|NCT00231114|454418656|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
126308153|NCT00231114|454418657|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
126308154|NCT04470544|454418658|FG000|Overall Study|Withdrawal by Subject|4|||
126308155|NCT04470544|454418659|FG001|Overall Study|Withdrawal by Subject|6|||
126308156|NCT00712881|454418661|FG000|Overall Study|Adverse Event|3|||
126308157|NCT00712881|454418662|FG001|Overall Study|Adverse Event|3|||
126308158|NCT00712881|454418661|FG000|Overall Study|Withdrawal by Subject|1|||
126308159|NCT00712881|454418662|FG001|Overall Study|Withdrawal by Subject|1|||
126308160|NCT00712881|454418661|FG000|Overall Study|Disease Progression|2|||
126308161|NCT00712881|454418662|FG001|Overall Study|Disease Progression|1|||
126308162|NCT00712881|454418661|FG000|Overall Study|Lost to Follow-up|1|||
126308163|NCT00712881|454418662|FG001|Overall Study|Lost to Follow-up|1|||
126308164|NCT00712881|454418661|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
126308165|NCT00712881|454418662|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
126308166|NCT00712881|454418661|FG000|Overall Study|Protocol Violation|1|||
126308167|NCT00712881|454418662|FG001|Overall Study|Protocol Violation|1|||
126308168|NCT00712881|454418661|FG000|Overall Study|Randomized but not treated|1|||
126308169|NCT00712881|454418662|FG001|Overall Study|Randomized but not treated|0|||
126308170|NCT01194999|454418663|FG000|Overall Study|Lost to Follow-up|17|||
126308171|NCT05835011|454418664|FG000|Overall Study|Study Terminated by the Sponsor|1|||
126308172|NCT05835011|454418664|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
126308173|NCT04720911|454418669|FG000|Overall Study|Withdrawal by Subject|0|||
126308174|NCT04720911|454418670|FG001|Overall Study|Withdrawal by Subject|1|||
126308175|NCT04720911|454418671|FG002|Overall Study|Withdrawal by Subject|0|||
126308176|NCT00090220|454418672|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
126308177|NCT00090220|454418673|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
126308178|NCT00090220|454418674|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126308179|NCT00090220|454418675|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126308180|NCT00090220|454418676|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126308181|NCT00090220|454418677|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126308182|NCT00090220|454418672|FG000|Base Study Vaccination Period|Adverse Event|6|||
126308183|NCT00090220|454418673|FG001|Base Study Vaccination Period|Adverse Event|1|||
126308184|NCT00090220|454418674|FG002|Base Study Vaccination Period|Adverse Event|0|||
126308185|NCT00090220|454418675|FG003|Base Study Vaccination Period|Adverse Event|0|||
126308186|NCT00090220|454418676|FG004|Base Study Vaccination Period|Adverse Event|0|||
126308187|NCT00090220|454418677|FG005|Base Study Vaccination Period|Adverse Event|0|||
126308188|NCT00090220|454418672|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
126308189|NCT00090220|454418673|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
126308190|NCT00090220|454418674|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
126308191|NCT00090220|454418675|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
126308192|NCT00090220|454418676|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
126308193|NCT00090220|454418677|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
126308194|NCT00090220|454418672|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
126308195|NCT00090220|454418673|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
126308196|NCT00090220|454418674|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
126308197|NCT00090220|454418675|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
126308198|NCT00090220|454418676|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
126308199|NCT00090220|454418677|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
126308200|NCT00090220|454418672|FG000|Base Study Vaccination Period|Patient Moved|6|||
126308201|NCT00090220|454418673|FG001|Base Study Vaccination Period|Patient Moved|2|||
126308202|NCT00090220|454418674|FG002|Base Study Vaccination Period|Patient Moved|0|||
126308203|NCT00090220|454418675|FG003|Base Study Vaccination Period|Patient Moved|0|||
126308204|NCT00090220|454418676|FG004|Base Study Vaccination Period|Patient Moved|0|||
126308205|NCT00090220|454418677|FG005|Base Study Vaccination Period|Patient Moved|0|||
126308206|NCT00090220|454418672|FG000|Base Study Vaccination Period|Other|4|||
126308207|NCT00090220|454418673|FG001|Base Study Vaccination Period|Other|4|||
126308208|NCT00090220|454418674|FG002|Base Study Vaccination Period|Other|0|||
126308209|NCT00090220|454418675|FG003|Base Study Vaccination Period|Other|0|||
126308210|NCT00090220|454418676|FG004|Base Study Vaccination Period|Other|0|||
126308211|NCT00090220|454418677|FG005|Base Study Vaccination Period|Other|0|||
126308212|NCT00090220|454418672|FG000|Base Study Follow-up Period|Adverse Event|6|||
126308213|NCT00090220|454418673|FG001|Base Study Follow-up Period|Adverse Event|1|||
126308214|NCT00090220|454418674|FG002|Base Study Follow-up Period|Adverse Event|0|||
126308215|NCT00090220|454418675|FG003|Base Study Follow-up Period|Adverse Event|0|||
126308216|NCT00090220|454418676|FG004|Base Study Follow-up Period|Adverse Event|0|||
126308217|NCT00090220|454418677|FG005|Base Study Follow-up Period|Adverse Event|0|||
126308218|NCT00090220|454418672|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
126308219|NCT00090220|454418673|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
126308220|NCT00090220|454418674|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
126308221|NCT00090220|454418675|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
126308222|NCT00090220|454418676|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
126308223|NCT00090220|454418677|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
126308224|NCT00090220|454418672|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
126308225|NCT00090220|454418673|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
126308226|NCT00090220|454418674|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
126308227|NCT00090220|454418675|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
126308228|NCT00090220|454418676|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
126308229|NCT00090220|454418677|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
126308230|NCT00090220|454418672|FG000|Base Study Follow-up Period|Patient Moved|20|||
126308231|NCT00090220|454418673|FG001|Base Study Follow-up Period|Patient Moved|28|||
126308232|NCT00090220|454418674|FG002|Base Study Follow-up Period|Patient Moved|0|||
126308233|NCT00090220|454418675|FG003|Base Study Follow-up Period|Patient Moved|0|||
126308234|NCT00090220|454418676|FG004|Base Study Follow-up Period|Patient Moved|0|||
126308235|NCT00090220|454418677|FG005|Base Study Follow-up Period|Patient Moved|0|||
126308236|NCT00090220|454418672|FG000|Base Study Follow-up Period|Other|19|||
126308237|NCT00090220|454418673|FG001|Base Study Follow-up Period|Other|21|||
126308238|NCT00090220|454418674|FG002|Base Study Follow-up Period|Other|0|||
126308239|NCT00090220|454418675|FG003|Base Study Follow-up Period|Other|0|||
126308240|NCT00090220|454418676|FG004|Base Study Follow-up Period|Other|0|||
126308241|NCT00090220|454418677|FG005|Base Study Follow-up Period|Other|0|||
126308242|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Adverse Event|0|||
126308243|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Adverse Event|0|||
126308244|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Adverse Event|4|||
126308245|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Adverse Event|0|||
126308246|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Adverse Event|0|||
126308247|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Adverse Event|0|||
126047558|NCT04039113|453471826|FG001|Overall Study|Lost to Follow-up|1|||
126047559|NCT04039113|453471825|FG000|Overall Study|Adverse Event|2|||
126308248|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
126047560|NCT04039113|453471826|FG001|Overall Study|Adverse Event|2|||
126308249|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
126308250|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
126308251|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
126308252|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
125885613|NCT04801420|452876909|FG000|Overall Study|Moved from study area|0|||
125885614|NCT04801420|452876910|FG001|Overall Study|Moved from study area|1|||
125885615|NCT04801420|452876911|FG002|Overall Study|Moved from study area|1|||
125885616|NCT04801420|452876909|FG000|Overall Study|Withdrawal by Subject|5|||
125885617|NCT04801420|452876910|FG001|Overall Study|Withdrawal by Subject|1|||
125885618|NCT04801420|452876911|FG002|Overall Study|Withdrawal by Subject|4|||
125885619|NCT04801420|452876909|FG000|Overall Study|Individual stopping criteria reached|0|||
125885620|NCT04801420|452876910|FG001|Overall Study|Individual stopping criteria reached|1|||
125885621|NCT04801420|452876911|FG002|Overall Study|Individual stopping criteria reached|0|||
125885622|NCT04801420|452876909|FG000|Overall Study|Ongoing in the study|195|||
125885623|NCT04801420|452876910|FG001|Overall Study|Ongoing in the study|195|||
125885624|NCT04801420|452876911|FG002|Overall Study|Ongoing in the study|192|||
125885625|NCT04774094|452876912|FG000|Overall Study|Other|2|||
125885626|NCT04774094|452876912|FG000|Overall Study|Withdrawal by Subject|9|||
125885627|NCT04774094|452876912|FG000|Overall Study|Lost to Follow-up|7|||
125885628|NCT04774094|452876912|FG000|Overall Study|Lack of Efficacy|5|||
125885629|NCT04774094|452876912|FG000|Overall Study|Death|17|||
125885630|NCT04774094|452876912|FG000|Overall Study|Adverse Event|4|||
125885631|NCT04145349|452878781|FG000|Overall Study|Withdrawal by Subject|3|||
125885632|NCT04145349|452878782|FG001|Overall Study|Withdrawal by Subject|0|||
125885633|NCT04145349|452878781|FG000|Overall Study|Lost to Follow-up|0|||
125885634|NCT04145349|452878782|FG001|Overall Study|Lost to Follow-up|1|||
125885635|NCT04145349|452878781|FG000|Overall Study|On study treatment (Ongoing)|0|||
125885636|NCT04145349|452878782|FG001|Overall Study|On study treatment (Ongoing)|1|||
125885637|NCT01148979|452878783|FG000|Overall Study|Lost to Follow-up|0|||
125885638|NCT01148979|452878784|FG001|Overall Study|Lost to Follow-up|1|||
125885639|NCT01376804|452878785|FG000|Treatment Period|Withdrawal by Subject|1|||
125885640|NCT01376804|452878785|FG000|Treatment Period|Adverse Event|6|||
125885641|NCT01376804|452878785|FG000|Treatment Period|Patient did not receive study drug|1|||
125885642|NCT00882557|452878786|FG000|Overall Study|Withdrawal by Subject|1|||
125885643|NCT00882557|452878787|FG001|Overall Study|Withdrawal by Subject|0|||
125885644|NCT00882557|452878786|FG000|Overall Study|Trouble with Vein Access|1|||
125885645|NCT00882557|452878787|FG001|Overall Study|Trouble with Vein Access|0|||
125885646|NCT00882557|452878786|FG000|Overall Study|Randomized Not Treated|0|||
125885647|NCT00882557|452878787|FG001|Overall Study|Randomized Not Treated|1|||
125885648|NCT01383356|452878792|FG000|Period 1|Adverse Event|5|||
125885649|NCT01383356|452878793|FG001|Period 1|Adverse Event|3|||
125885650|NCT01383356|452878792|FG000|Period 1|Non-compliance|3|||
125885651|NCT01383356|452878793|FG001|Period 1|Non-compliance|0|||
125885652|NCT01383356|452878792|FG000|Period 1|Out of Range Mid-study-Test|0|||
125885653|NCT01383356|452878793|FG001|Period 1|Out of Range Mid-study-Test|1|||
125885654|NCT01383356|452878792|FG000|Period 1|Personal|0|||
125885655|NCT01383356|452878793|FG001|Period 1|Personal|2|||
125885656|NCT00602472|452878799|FG000|Overall Study|Adverse Event|5|||
125885657|NCT00602472|452878800|FG001|Overall Study|Adverse Event|23|||
125885658|NCT00602472|452878799|FG000|Overall Study|Protocol Violation|4|||
125885659|NCT00602472|452878800|FG001|Overall Study|Protocol Violation|19|||
125885660|NCT00602472|452878799|FG000|Overall Study|Withdrawal by Subject|8|||
125885661|NCT00602472|452878800|FG001|Overall Study|Withdrawal by Subject|14|||
125885662|NCT00602472|452878799|FG000|Overall Study|Other incl. lack of efficacy|4|||
125885663|NCT00602472|452878800|FG001|Overall Study|Other incl. lack of efficacy|2|||
125885664|NCT03038880|452878801|FG000|Overall Study|Death|1|||
125885665|NCT03038880|452878802|FG001|Overall Study|Death|2|||
125885666|NCT03038880|452878803|FG002|Overall Study|Death|0|||
125885667|NCT03038880|452878801|FG000|Overall Study|Physician Decision|2|||
125885668|NCT03038880|452878802|FG001|Overall Study|Physician Decision|1|||
125885669|NCT03038880|452878803|FG002|Overall Study|Physician Decision|0|||
125885670|NCT02054104|452878810|FG000|Overall Study|Did not want to continue due to college classes|1|||
125885671|NCT02054104|452878811|FG001|Overall Study|Did not want to continue due to college classes|0|||
125885672|NCT02054104|452878810|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
126047561|NCT04039113|453471825|FG000|Overall Study|Death|2|||
126047562|NCT04039113|453471826|FG001|Overall Study|Death|4|||
126047563|NCT04039113|453471825|FG000|Overall Study|Site Closure|6|||
126308253|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
126308254|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Moved|0|||
125885673|NCT02054104|452878811|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
125885674|NCT02054104|452878810|FG000|Overall Study|No evidence of immunologic response|2|||
125885675|NCT02054104|452878811|FG001|Overall Study|No evidence of immunologic response|2|||
125885676|NCT02054104|452878810|FG000|Overall Study|Disease Progression On Study|4|||
125885677|NCT02054104|452878811|FG001|Overall Study|Disease Progression On Study|5|||
125885678|NCT02054104|452878810|FG000|Overall Study|Diagnosis of lymphoma|0|||
125885679|NCT02054104|452878811|FG001|Overall Study|Diagnosis of lymphoma|1|||
125885680|NCT02054104|452878810|FG000|Overall Study|Inconclusive response|0|||
125885681|NCT02054104|452878811|FG001|Overall Study|Inconclusive response|1|||
125885682|NCT00823615|452878812|FG000|Period 2|Lost to Follow-up|2|||
125885683|NCT00823615|452878813|FG001|Period 2|Lost to Follow-up|0|||
126047564|NCT04039113|453471826|FG001|Overall Study|Site Closure|0|||
126308255|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Moved|0|||
126308256|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Moved|2|||
126308257|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Moved|1|||
126308258|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Moved|0|||
126308259|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Moved|0|||
126308260|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308261|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308262|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
126308263|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308264|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308265|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308266|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
126371209|NCT00673920|454656694|FG005|Baseline up to Week 48|Administrative/Other|0|||
126371210|NCT00673920|454656695|FG006|Baseline up to Week 48|Administrative/Other|0|||
126371211|NCT00673920|454656696|FG007|Baseline up to Week 48|Administrative/Other|0|||
126371212|NCT00673920|454656689|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371213|NCT00673920|454656690|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
126371214|NCT00673920|454656691|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
126371215|NCT00673920|454656692|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371216|NCT00673920|454656693|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371217|NCT00673920|454656694|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371218|NCT00673920|454656695|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371219|NCT00673920|454656696|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371220|NCT00673920|454656689|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371221|NCT00673920|454656690|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371222|NCT00673920|454656691|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371223|NCT00673920|454656692|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371224|NCT00673920|454656693|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371225|NCT00673920|454656694|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371226|NCT00673920|454656695|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
126371227|NCT00673920|454656696|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371228|NCT00673920|454656689|FG000|Week 24 to Week 48|Failure to return|0|||
126371229|NCT00673920|454656690|FG001|Week 24 to Week 48|Failure to return|0|||
126371230|NCT00673920|454656691|FG002|Week 24 to Week 48|Failure to return|0|||
126371231|NCT00673920|454656692|FG003|Week 24 to Week 48|Failure to return|0|||
126371232|NCT00673920|454656693|FG004|Week 24 to Week 48|Failure to return|0|||
126371233|NCT00673920|454656694|FG005|Week 24 to Week 48|Failure to return|1|||
126371234|NCT00673920|454656695|FG006|Week 24 to Week 48|Failure to return|0|||
126371235|NCT00673920|454656696|FG007|Week 24 to Week 48|Failure to return|0|||
126371236|NCT00673920|454656689|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371237|NCT00673920|454656690|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371238|NCT00673920|454656691|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371239|NCT00673920|454656692|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371240|NCT00673920|454656693|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371241|NCT00673920|454656694|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
126371242|NCT00673920|454656695|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371243|NCT00673920|454656696|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
126308267|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
126308268|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
126308269|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
126371244|NCT00673920|454656689|FG000|Week 24 to Week 48|Death|0|||
126371245|NCT00673920|454656690|FG001|Week 24 to Week 48|Death|0|||
126371246|NCT00673920|454656691|FG002|Week 24 to Week 48|Death|0|||
126371247|NCT00673920|454656692|FG003|Week 24 to Week 48|Death|0|||
126371248|NCT00673920|454656693|FG004|Week 24 to Week 48|Death|0|||
126371249|NCT00673920|454656694|FG005|Week 24 to Week 48|Death|1|||
126371250|NCT00673920|454656695|FG006|Week 24 to Week 48|Death|0|||
126308270|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
126308271|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
126308272|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Other reason|0|||
126308273|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Other reason|0|||
126103969|NCT03756129|453673882|FG000|Overall Study|Lost to Follow-up|0|||
126103970|NCT03756129|453673883|FG001|Overall Study|Lost to Follow-up|0|||
126103971|NCT03756129|453673884|FG002|Overall Study|Lost to Follow-up|0|||
126308274|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Other reason|2|||
126308275|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Other reason|0|||
126308276|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Other reason|0|||
126308277|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Other reason|0|||
126308278|NCT00090220|454418672|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126308279|NCT00090220|454418673|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126308280|NCT00090220|454418674|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126308281|NCT00090220|454418675|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126308282|NCT00090220|454418676|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
126308283|NCT00090220|454418677|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
126308284|NCT00090220|454418672|FG000|Long-term Follow-up (EXT2)|Death|0|||
126308285|NCT00090220|454418673|FG001|Long-term Follow-up (EXT2)|Death|0|||
126308286|NCT00090220|454418674|FG002|Long-term Follow-up (EXT2)|Death|0|||
126308287|NCT00090220|454418675|FG003|Long-term Follow-up (EXT2)|Death|0|||
126308288|NCT00090220|454418676|FG004|Long-term Follow-up (EXT2)|Death|1|||
126308289|NCT00090220|454418677|FG005|Long-term Follow-up (EXT2)|Death|1|||
126308290|NCT00090220|454418672|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126308291|NCT00090220|454418673|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126308292|NCT00090220|454418674|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126308293|NCT00090220|454418675|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126308294|NCT00090220|454418676|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
126308295|NCT00090220|454418677|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
126308296|NCT00090220|454418672|FG000|Long-term Follow-up (EXT2)|Other|0|||
126308297|NCT00090220|454418673|FG001|Long-term Follow-up (EXT2)|Other|0|||
126308298|NCT00090220|454418674|FG002|Long-term Follow-up (EXT2)|Other|0|||
126308299|NCT00090220|454418675|FG003|Long-term Follow-up (EXT2)|Other|0|||
126308300|NCT00090220|454418676|FG004|Long-term Follow-up (EXT2)|Other|1|||
126308301|NCT00090220|454418677|FG005|Long-term Follow-up (EXT2)|Other|0|||
126308302|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
126308303|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
126308304|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
126308305|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
126308306|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
126308307|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
126308308|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
126308309|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
126308310|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
126308311|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
126308312|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
126308313|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
126308314|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
126308315|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
126308316|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
126308317|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Death|0|||
126308318|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Death|0|||
126308319|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Death|1|||
126308320|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Death|2|||
126308321|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Death|7|||
126308322|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
126308323|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
126308324|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
126308325|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
126308326|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
126371251|NCT00673920|454656696|FG007|Week 24 to Week 48|Death|0|||
126371252|NCT00673920|454656689|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
126371253|NCT00673920|454656690|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
126371254|NCT00673920|454656691|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
126371255|NCT00673920|454656692|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
126371256|NCT00673920|454656693|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
126371257|NCT00673920|454656694|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
126371258|NCT00673920|454656695|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
126371259|NCT00673920|454656696|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
126371260|NCT01164007|454656697|FG000|Overall Study|Adverse Event|5|||
126371261|NCT01164007|454656697|FG000|Overall Study|Progression of Disease|30|||
126371262|NCT01164007|454656697|FG000|Overall Study|Protocol Violation|1|||
126371263|NCT01164007|454656697|FG000|Overall Study|Withdrawal by Subject|1|||
126308327|NCT00941863|454418678|FG000|Continued After PCD|Withdrawal by Subject|0|||
126308328|NCT00941863|454418679|FG001|Continued After PCD|Withdrawal by Subject|0|||
126371264|NCT01164007|454656697|FG000|Overall Study|Medical Decision|3|||
126371265|NCT04856527|454656698|FG000|Overall Study|Unable to complete experimental task|2|||
126371266|NCT04856527|454656699|FG001|Overall Study|Unable to complete experimental task|0|||
126371267|NCT01816295|454656700|FG000|Double Blind Phase|Adverse Event|11|||
126371268|NCT01816295|454656701|FG001|Double Blind Phase|Adverse Event|8|||
126371269|NCT01816295|454656700|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
126371270|NCT01816295|454656701|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
126371271|NCT01816295|454656700|FG000|Double Blind Phase|Lost to Follow-up|3|||
126371272|NCT01816295|454656701|FG001|Double Blind Phase|Lost to Follow-up|5|||
126371273|NCT01816295|454656700|FG000|Double Blind Phase|Physician Decision|2|||
126371274|NCT01816295|454656701|FG001|Double Blind Phase|Physician Decision|2|||
126371275|NCT01816295|454656700|FG000|Double Blind Phase|Protocol Violation|17|||
126371276|NCT01816295|454656701|FG001|Double Blind Phase|Protocol Violation|11|||
126371277|NCT01816295|454656700|FG000|Double Blind Phase|Sponsor Decision|8|||
126371278|NCT01816295|454656701|FG001|Double Blind Phase|Sponsor Decision|8|||
126371279|NCT01816295|454656700|FG000|Double Blind Phase|Withdrawal by Subject|22|||
126371280|NCT01816295|454656701|FG001|Double Blind Phase|Withdrawal by Subject|20|||
126371281|NCT01816295|454656700|FG000|OLE Phase|Adverse Event|17|||
126371282|NCT01816295|454656701|FG001|OLE Phase|Adverse Event|15|||
126371283|NCT01816295|454656700|FG000|OLE Phase|Death|1|||
126371284|NCT01816295|454656701|FG001|OLE Phase|Death|0|||
126371285|NCT01816295|454656700|FG000|OLE Phase|Entry Criteria Not Met|3|||
126371286|NCT01816295|454656701|FG001|OLE Phase|Entry Criteria Not Met|5|||
126371287|NCT01816295|454656700|FG000|OLE Phase|Lost to Follow-up|5|||
126371288|NCT01816295|454656701|FG001|OLE Phase|Lost to Follow-up|5|||
126371289|NCT01816295|454656700|FG000|OLE Phase|Physician Decision|3|||
126371290|NCT01816295|454656701|FG001|OLE Phase|Physician Decision|1|||
126371291|NCT01816295|454656700|FG000|OLE Phase|Protocol Violation|4|||
126371292|NCT01816295|454656701|FG001|OLE Phase|Protocol Violation|4|||
126371293|NCT01816295|454656700|FG000|OLE Phase|Sponsor Decision|7|||
126371294|NCT01816295|454656701|FG001|OLE Phase|Sponsor Decision|9|||
126371295|NCT01816295|454656700|FG000|OLE Phase|Withdrawal by Subject|10|||
126371296|NCT01816295|454656701|FG001|OLE Phase|Withdrawal by Subject|10|||
126371297|NCT01816295|454656700|FG000|OLE Phase|Lack of Efficacy|3|||
126371298|NCT01816295|454656701|FG001|OLE Phase|Lack of Efficacy|7|||
126371299|NCT04165824|454656702|FG000|Overall Study|Adverse Event|23|||
126371300|NCT04165824|454656702|FG000|Overall Study|Physician Decision|1|||
126371301|NCT04165824|454656702|FG000|Overall Study|Withdrawal by Subject|17|||
126371302|NCT04165824|454656702|FG000|Overall Study|Other|5|||
126371303|NCT01823289|454656703|FG000|Overall Study|Lost to Follow-up|5|||
126371304|NCT01823289|454656703|FG000|Overall Study|Adverse Event|5|||
126371305|NCT01823289|454656703|FG000|Overall Study|Lack of Efficacy|1|||
126371306|NCT01823289|454656703|FG000|Overall Study|Physician Decision|9|||
126371307|NCT01823289|454656703|FG000|Overall Study|Administered contraindicated medicine|1|||
126371308|NCT01823289|454656703|FG000|Overall Study|Transaminase increased more than 3 times|1|||
126371309|NCT01823289|454656703|FG000|Overall Study|Drug affected efficacy and safety|1|||
126371310|NCT01823289|454656703|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
126371311|NCT01656161|454656713|FG000|Overall Study|Death|3|||
126371312|NCT01656161|454656713|FG000|Overall Study|Adverse Event|2|||
126371313|NCT01656161|454656713|FG000|Overall Study|Protocol Violation|1|||
126371314|NCT01656161|454656713|FG000|Overall Study|Withdrawal by Subject|1|||
126371315|NCT03510273|454656714|FG000|Overall Study|Withdrawal by Subject|2|||
126371316|NCT03510273|454656714|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
126371317|NCT03510273|454656714|FG000|Overall Study|Moved away from study area|4|||
126371318|NCT01276106|454656715|FG000|Overall Study|Adverse Event|3|||
126371319|NCT01276106|454656716|FG001|Overall Study|Adverse Event|3|||
126371320|NCT01276106|454656717|FG002|Overall Study|Adverse Event|11|||
126371321|NCT01276106|454656718|FG003|Overall Study|Adverse Event|3|||
126371322|NCT01276106|454656715|FG000|Overall Study|Withdrawal by Subject|6|||
126371323|NCT01276106|454656716|FG001|Overall Study|Withdrawal by Subject|3|||
126371324|NCT01276106|454656717|FG002|Overall Study|Withdrawal by Subject|1|||
126047565|NCT04039113|453471825|FG000|Overall Study|Failure to meet randomisation criteria|4|||
126371325|NCT01276106|454656718|FG003|Overall Study|Withdrawal by Subject|6|||
126047566|NCT04039113|453471826|FG001|Overall Study|Failure to meet randomisation criteria|0|||
126047567|NCT00353496|453471827|FG000|Overall Study|Adverse Event|1|||
126047568|NCT00353496|453471828|FG001|Overall Study|Adverse Event|0|||
126047569|NCT00353496|453471827|FG000|Overall Study|Protocol Violation|2|||
126371326|NCT01276106|454656715|FG000|Overall Study|Lack of Efficacy|0|||
126047570|NCT00353496|453471828|FG001|Overall Study|Protocol Violation|2|||
126371327|NCT01276106|454656716|FG001|Overall Study|Lack of Efficacy|1|||
126371328|NCT01276106|454656717|FG002|Overall Study|Lack of Efficacy|0|||
126371329|NCT01276106|454656718|FG003|Overall Study|Lack of Efficacy|1|||
126371330|NCT01276106|454656715|FG000|Overall Study|Lost to Follow-up|2|||
126371331|NCT01276106|454656716|FG001|Overall Study|Lost to Follow-up|1|||
126371332|NCT01276106|454656717|FG002|Overall Study|Lost to Follow-up|1|||
126371333|NCT01276106|454656718|FG003|Overall Study|Lost to Follow-up|0|||
126371334|NCT01276106|454656715|FG000|Overall Study|Physician Decision|0|||
126371335|NCT01276106|454656716|FG001|Overall Study|Physician Decision|0|||
126371336|NCT01276106|454656717|FG002|Overall Study|Physician Decision|1|||
126088959|NCT01399697|453620039|FG000|Overall Study|Lost to Follow-up|2|||
126308329|NCT00941863|454418680|FG002|Continued After PCD|Withdrawal by Subject|0|||
126308330|NCT00941863|454418681|FG003|Continued After PCD|Withdrawal by Subject|0|||
126308331|NCT00941863|454418682|FG004|Continued After PCD|Withdrawal by Subject|1|||
126308332|NCT00941863|454418678|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
126308333|NCT00941863|454418679|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
126308334|NCT00941863|454418680|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
126308335|NCT00941863|454418681|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
126308336|NCT00941863|454418682|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
126308337|NCT00537316|454418683|FG000|Part 1|Adverse Event|7|||
126308338|NCT00537316|454418684|FG001|Part 1|Adverse Event|11|||
126308339|NCT00537316|454418685|FG002|Part 1|Adverse Event|8|||
126308340|NCT00537316|454418686|FG003|Part 1|Adverse Event|0|||
126308341|NCT00537316|454418687|FG004|Part 1|Adverse Event|0|||
126308342|NCT00537316|454418688|FG005|Part 1|Adverse Event|0|||
126308343|NCT00537316|454418689|FG006|Part 1|Adverse Event|0|||
126308344|NCT00537316|454418683|FG000|Part 1|Protocol defined clinical event|1|||
126308345|NCT00537316|454418684|FG001|Part 1|Protocol defined clinical event|0|||
126308346|NCT00537316|454418685|FG002|Part 1|Protocol defined clinical event|0|||
126308347|NCT00537316|454418686|FG003|Part 1|Protocol defined clinical event|0|||
126308348|NCT00537316|454418687|FG004|Part 1|Protocol defined clinical event|0|||
126308349|NCT00537316|454418688|FG005|Part 1|Protocol defined clinical event|0|||
126308350|NCT00537316|454418689|FG006|Part 1|Protocol defined clinical event|0|||
126308351|NCT00537316|454418683|FG000|Part 1|Lost to Follow-up|1|||
126308352|NCT00537316|454418684|FG001|Part 1|Lost to Follow-up|0|||
126308353|NCT00537316|454418685|FG002|Part 1|Lost to Follow-up|0|||
126308354|NCT00537316|454418686|FG003|Part 1|Lost to Follow-up|0|||
126308355|NCT00537316|454418687|FG004|Part 1|Lost to Follow-up|0|||
126308356|NCT00537316|454418688|FG005|Part 1|Lost to Follow-up|0|||
126308357|NCT00537316|454418689|FG006|Part 1|Lost to Follow-up|0|||
126308358|NCT00537316|454418683|FG000|Part 1|Withdrawal by Subject|3|||
126308359|NCT00537316|454418684|FG001|Part 1|Withdrawal by Subject|8|||
126308360|NCT00537316|454418685|FG002|Part 1|Withdrawal by Subject|4|||
126308361|NCT00537316|454418686|FG003|Part 1|Withdrawal by Subject|0|||
126308362|NCT00537316|454418687|FG004|Part 1|Withdrawal by Subject|0|||
126308363|NCT00537316|454418688|FG005|Part 1|Withdrawal by Subject|0|||
126308364|NCT00537316|454418689|FG006|Part 1|Withdrawal by Subject|0|||
126308365|NCT00537316|454418683|FG000|Part 1|Protocol Violation|1|||
126308366|NCT00537316|454418684|FG001|Part 1|Protocol Violation|5|||
125885684|NCT00823615|452878812|FG000|Period 2|Time/Job Conflict|1|||
125885685|NCT00823615|452878813|FG001|Period 2|Time/Job Conflict|2|||
125885686|NCT03926611|452878814|FG000|Overall Study|Adverse Event|0|||
125885687|NCT03926611|452878815|FG001|Overall Study|Adverse Event|0|||
125885688|NCT03926611|452878816|FG002|Overall Study|Adverse Event|0|||
125885689|NCT03926611|452878817|FG003|Overall Study|Adverse Event|3|||
125885690|NCT03926611|452878818|FG004|Overall Study|Adverse Event|1|||
125885691|NCT03926611|452878819|FG005|Overall Study|Adverse Event|3|||
125885692|NCT03926611|452878820|FG006|Overall Study|Adverse Event|0|||
125885693|NCT03926611|452878814|FG000|Overall Study|Lack of Efficacy|1|||
125885694|NCT03926611|452878815|FG001|Overall Study|Lack of Efficacy|2|||
125885695|NCT03926611|452878816|FG002|Overall Study|Lack of Efficacy|0|||
125885696|NCT03926611|452878817|FG003|Overall Study|Lack of Efficacy|0|||
126308367|NCT00537316|454418685|FG002|Part 1|Protocol Violation|1|||
126308368|NCT00537316|454418686|FG003|Part 1|Protocol Violation|0|||
126308369|NCT00537316|454418687|FG004|Part 1|Protocol Violation|0|||
126308370|NCT00537316|454418688|FG005|Part 1|Protocol Violation|0|||
126308371|NCT00537316|454418689|FG006|Part 1|Protocol Violation|0|||
125885697|NCT03926611|452878818|FG004|Overall Study|Lack of Efficacy|1|||
126308372|NCT00537316|454418683|FG000|Part 1|Did not meet protocol eligibility|1|||
126308373|NCT00537316|454418684|FG001|Part 1|Did not meet protocol eligibility|3|||
125885698|NCT03926611|452878819|FG005|Overall Study|Lack of Efficacy|0|||
126308374|NCT00537316|454418685|FG002|Part 1|Did not meet protocol eligibility|2|||
126308375|NCT00537316|454418686|FG003|Part 1|Did not meet protocol eligibility|0|||
125885699|NCT03926611|452878820|FG006|Overall Study|Lack of Efficacy|1|||
125885700|NCT03926611|452878814|FG000|Overall Study|Physician Decision|0|||
125885701|NCT03926611|452878815|FG001|Overall Study|Physician Decision|0|||
126308376|NCT00537316|454418687|FG004|Part 1|Did not meet protocol eligibility|0|||
126308377|NCT00537316|454418688|FG005|Part 1|Did not meet protocol eligibility|0|||
126308378|NCT00537316|454418689|FG006|Part 1|Did not meet protocol eligibility|0|||
126308379|NCT00537316|454418683|FG000|Part 1|Administrative|0|||
126308380|NCT00537316|454418684|FG001|Part 1|Administrative|0|||
126308381|NCT00537316|454418685|FG002|Part 1|Administrative|2|||
126308382|NCT00537316|454418686|FG003|Part 1|Administrative|0|||
126308383|NCT00537316|454418687|FG004|Part 1|Administrative|0|||
126308384|NCT00537316|454418688|FG005|Part 1|Administrative|0|||
126308385|NCT00537316|454418689|FG006|Part 1|Administrative|0|||
126308386|NCT00537316|454418683|FG000|Part 2|Never entered follow-up|0|||
126308387|NCT00537316|454418684|FG001|Part 2|Never entered follow-up|0|||
126308388|NCT00537316|454418685|FG002|Part 2|Never entered follow-up|0|||
126308389|NCT00537316|454418686|FG003|Part 2|Never entered follow-up|0|||
126308390|NCT00537316|454418687|FG004|Part 2|Never entered follow-up|0|||
126308391|NCT00537316|454418688|FG005|Part 2|Never entered follow-up|0|||
126308392|NCT00537316|454418689|FG006|Part 2|Never entered follow-up|1|||
126308393|NCT00537316|454418683|FG000|Part 2|Adverse Event|4|||
126308394|NCT00537316|454418684|FG001|Part 2|Adverse Event|0|||
126308395|NCT00537316|454418685|FG002|Part 2|Adverse Event|2|||
126308396|NCT00537316|454418686|FG003|Part 2|Adverse Event|0|||
126308397|NCT00537316|454418687|FG004|Part 2|Adverse Event|0|||
126308398|NCT00537316|454418688|FG005|Part 2|Adverse Event|0|||
126308399|NCT00537316|454418689|FG006|Part 2|Adverse Event|0|||
126308400|NCT00537316|454418683|FG000|Part 2|Lost to Follow-up|1|||
126308401|NCT00537316|454418684|FG001|Part 2|Lost to Follow-up|0|||
126308402|NCT00537316|454418685|FG002|Part 2|Lost to Follow-up|2|||
126308403|NCT00537316|454418686|FG003|Part 2|Lost to Follow-up|0|||
126308404|NCT00537316|454418687|FG004|Part 2|Lost to Follow-up|0|||
126308405|NCT00537316|454418688|FG005|Part 2|Lost to Follow-up|0|||
126308406|NCT00537316|454418689|FG006|Part 2|Lost to Follow-up|0|||
126308407|NCT00537316|454418683|FG000|Part 2|Withdrawal by Subject|5|||
126308408|NCT00537316|454418684|FG001|Part 2|Withdrawal by Subject|1|||
126308409|NCT00537316|454418685|FG002|Part 2|Withdrawal by Subject|4|||
126308410|NCT00537316|454418686|FG003|Part 2|Withdrawal by Subject|0|||
126308411|NCT00537316|454418687|FG004|Part 2|Withdrawal by Subject|0|||
126308412|NCT00537316|454418688|FG005|Part 2|Withdrawal by Subject|0|||
126308413|NCT00537316|454418689|FG006|Part 2|Withdrawal by Subject|0|||
126308414|NCT00537316|454418683|FG000|Part 2|Administrative|16|||
126308415|NCT00537316|454418684|FG001|Part 2|Administrative|8|||
126308416|NCT00537316|454418685|FG002|Part 2|Administrative|24|||
126308417|NCT00537316|454418686|FG003|Part 2|Administrative|3|||
126308418|NCT00537316|454418687|FG004|Part 2|Administrative|1|||
126308419|NCT00537316|454418688|FG005|Part 2|Administrative|4|||
126308420|NCT00537316|454418689|FG006|Part 2|Administrative|1|||
126308421|NCT05113979|454418692|FG000|Overall Study|Death|2|||
126308422|NCT05113979|454418692|FG000|Overall Study|Lost to Follow-up|1|||
126308423|NCT01137110|454418702|FG000|Overall Study|Protocol Violation|1|||
126308424|NCT01137110|454418703|FG001|Overall Study|Protocol Violation|0|||
126308425|NCT03557931|454418706|FG000|Overall Study|Adverse Event|4|||
126308426|NCT03557931|454418707|FG001|Overall Study|Adverse Event|6|||
126308427|NCT03557931|454418708|FG002|Overall Study|Adverse Event|1|||
126308428|NCT03557931|454418706|FG000|Overall Study|Lost to Follow-up|4|||
126308429|NCT03557931|454418707|FG001|Overall Study|Lost to Follow-up|4|||
126308430|NCT03557931|454418708|FG002|Overall Study|Lost to Follow-up|1|||
126308431|NCT03557931|454418706|FG000|Overall Study|Protocol Violation|1|||
126308432|NCT03557931|454418707|FG001|Overall Study|Protocol Violation|4|||
126047571|NCT00353496|453471827|FG000|Overall Study|Withdrawal by Subject|3|||
126047572|NCT00353496|453471828|FG001|Overall Study|Withdrawal by Subject|4|||
126047573|NCT00353496|453471827|FG000|Overall Study|Physician Decision|6|||
126047574|NCT00353496|453471828|FG001|Overall Study|Physician Decision|9|||
126308433|NCT03557931|454418708|FG002|Overall Study|Protocol Violation|1|||
126308434|NCT03557931|454418706|FG000|Overall Study|Withdrawal by Subject|14|||
126308435|NCT03557931|454418707|FG001|Overall Study|Withdrawal by Subject|0|||
126308436|NCT03557931|454418708|FG002|Overall Study|Withdrawal by Subject|7|||
126308437|NCT03557931|454418706|FG000|Overall Study|Miscellaneous|8|||
126308438|NCT03557931|454418707|FG001|Overall Study|Miscellaneous|5|||
126308439|NCT03557931|454418708|FG002|Overall Study|Miscellaneous|3|||
126308440|NCT02829723|454418711|FG000|Overall Study|Adverse Event|0|||
126308441|NCT02829723|454418712|FG001|Overall Study|Adverse Event|0|||
126308442|NCT02829723|454418713|FG002|Overall Study|Adverse Event|1|||
126308443|NCT02829723|454418714|FG003|Overall Study|Adverse Event|1|||
126308444|NCT02829723|454418715|FG004|Overall Study|Adverse Event|0|||
126308445|NCT02829723|454418716|FG005|Overall Study|Adverse Event|0|||
126308446|NCT02829723|454418717|FG006|Overall Study|Adverse Event|0|||
126047575|NCT00353496|453471827|FG000|Overall Study|Not otherwise specified|4|||
126308447|NCT02829723|454418718|FG007|Overall Study|Adverse Event|1|||
126308448|NCT02829723|454418719|FG008|Overall Study|Adverse Event|0|||
126308449|NCT02829723|454418720|FG009|Overall Study|Adverse Event|0|||
126308450|NCT02829723|454418721|FG010|Overall Study|Adverse Event|0|||
126308451|NCT02829723|454418722|FG011|Overall Study|Adverse Event|0|||
126308452|NCT02829723|454418723|FG012|Overall Study|Adverse Event|0|||
126308453|NCT02829723|454418724|FG013|Overall Study|Adverse Event|0|||
126308454|NCT02829723|454418725|FG014|Overall Study|Adverse Event|1|||
126308455|NCT02829723|454418726|FG015|Overall Study|Adverse Event|1|||
126047576|NCT00353496|453471828|FG001|Overall Study|Not otherwise specified|2|||
126047577|NCT04980300|453471830|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
126047578|NCT04980300|453471831|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
126047579|NCT04980300|453471830|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
126047580|NCT04980300|453471831|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
126047581|NCT04980300|453471830|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
126047582|NCT04980300|453471831|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
126047583|NCT04980300|453471830|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
126308456|NCT02829723|454418727|FG016|Overall Study|Adverse Event|1|||
125885702|NCT03926611|452878816|FG002|Overall Study|Physician Decision|0|||
125885703|NCT03926611|452878817|FG003|Overall Study|Physician Decision|0|||
125885704|NCT03926611|452878818|FG004|Overall Study|Physician Decision|0|||
125885705|NCT03926611|452878819|FG005|Overall Study|Physician Decision|1|||
125885706|NCT03926611|452878820|FG006|Overall Study|Physician Decision|0|||
125885707|NCT03926611|452878814|FG000|Overall Study|Protocol Violation|1|||
125885708|NCT03926611|452878815|FG001|Overall Study|Protocol Violation|0|||
125885709|NCT03926611|452878816|FG002|Overall Study|Protocol Violation|0|||
125885710|NCT03926611|452878817|FG003|Overall Study|Protocol Violation|1|||
125885711|NCT03926611|452878818|FG004|Overall Study|Protocol Violation|1|||
125885712|NCT03926611|452878819|FG005|Overall Study|Protocol Violation|1|||
125885713|NCT03926611|452878820|FG006|Overall Study|Protocol Violation|1|||
125885714|NCT03926611|452878814|FG000|Overall Study|Technical problems|0|||
125885715|NCT03926611|452878815|FG001|Overall Study|Technical problems|0|||
125885716|NCT03926611|452878816|FG002|Overall Study|Technical problems|0|||
125885717|NCT03926611|452878817|FG003|Overall Study|Technical problems|0|||
125885718|NCT03926611|452878818|FG004|Overall Study|Technical problems|0|||
125885719|NCT03926611|452878819|FG005|Overall Study|Technical problems|1|||
125885720|NCT03926611|452878820|FG006|Overall Study|Technical problems|0|||
125885721|NCT03926611|452878814|FG000|Overall Study|Withdrawal by Subject|1|||
125885722|NCT03926611|452878815|FG001|Overall Study|Withdrawal by Subject|1|||
125885723|NCT03926611|452878816|FG002|Overall Study|Withdrawal by Subject|1|||
125885724|NCT03926611|452878817|FG003|Overall Study|Withdrawal by Subject|0|||
125885725|NCT03926611|452878818|FG004|Overall Study|Withdrawal by Subject|0|||
125885726|NCT03926611|452878819|FG005|Overall Study|Withdrawal by Subject|1|||
125885727|NCT03926611|452878820|FG006|Overall Study|Withdrawal by Subject|3|||
125885728|NCT03926611|452878814|FG000|Overall Study|Covid-19 pandemic|0|||
125885729|NCT03926611|452878815|FG001|Overall Study|Covid-19 pandemic|0|||
125885730|NCT03926611|452878816|FG002|Overall Study|Covid-19 pandemic|1|||
125885731|NCT03926611|452878817|FG003|Overall Study|Covid-19 pandemic|0|||
125885732|NCT03926611|452878818|FG004|Overall Study|Covid-19 pandemic|1|||
125885733|NCT03926611|452878819|FG005|Overall Study|Covid-19 pandemic|2|||
125885734|NCT03926611|452878820|FG006|Overall Study|Covid-19 pandemic|0|||
125885735|NCT00084136|452878821|FG000|PI Comparison|Death|10|||
125885736|NCT00084136|452878822|FG001|PI Comparison|Death|9|||
125885737|NCT00084136|452878823|FG002|PI Comparison|Death|0|||
125885738|NCT00084136|452878821|FG000|PI Comparison|Lost to Follow-up|11|||
125885739|NCT00084136|452878822|FG001|PI Comparison|Lost to Follow-up|8|||
125885740|NCT00084136|452878823|FG002|PI Comparison|Lost to Follow-up|0|||
125885741|NCT00084136|452878821|FG000|PI Comparison|Withdrawal by Subject|33|||
125885742|NCT00084136|452878822|FG001|PI Comparison|Withdrawal by Subject|30|||
125885743|NCT00084136|452878823|FG002|PI Comparison|Withdrawal by Subject|0|||
125885744|NCT00084136|452878821|FG000|PI Comparison|Clinic site closed|1|||
125885745|NCT00084136|452878822|FG001|PI Comparison|Clinic site closed|0|||
125885746|NCT00084136|452878823|FG002|PI Comparison|Clinic site closed|0|||
125885747|NCT00084136|452878821|FG000|NRTI Comparison|Death|20|||
125885748|NCT00084136|452878822|FG001|NRTI Comparison|Death|0|||
125885749|NCT00084136|452878823|FG002|NRTI Comparison|Death|18|||
126308457|NCT02829723|454418728|FG017|Overall Study|Adverse Event|2|||
126308458|NCT02829723|454418729|FG018|Overall Study|Adverse Event|1|||
126308459|NCT02829723|454418730|FG019|Overall Study|Adverse Event|1|||
126308460|NCT02829723|454418731|FG020|Overall Study|Adverse Event|3|||
126308461|NCT02829723|454418732|FG021|Overall Study|Adverse Event|0|||
126308462|NCT02829723|454418733|FG022|Overall Study|Adverse Event|0|||
125885750|NCT00084136|452878821|FG000|NRTI Comparison|Lost to Follow-up|14|||
125885751|NCT00084136|452878822|FG001|NRTI Comparison|Lost to Follow-up|0|||
126308463|NCT02829723|454418734|FG023|Overall Study|Adverse Event|1|||
125885752|NCT00084136|452878823|FG002|NRTI Comparison|Lost to Follow-up|12|||
125885753|NCT00084136|452878821|FG000|NRTI Comparison|Withdrawal by Subject|54|||
125885754|NCT00084136|452878822|FG001|NRTI Comparison|Withdrawal by Subject|0|||
125885755|NCT00084136|452878823|FG002|NRTI Comparison|Withdrawal by Subject|38|||
125885756|NCT00084136|452878821|FG000|NRTI Comparison|Clinic site closed|12|||
125885757|NCT00084136|452878822|FG001|NRTI Comparison|Clinic site closed|0|||
125885758|NCT00084136|452878823|FG002|NRTI Comparison|Clinic site closed|14|||
125885759|NCT00084136|452878821|FG000|NRTI Comparison|Not reason above|1|||
125885760|NCT00084136|452878822|FG001|NRTI Comparison|Not reason above|0|||
125885761|NCT00084136|452878823|FG002|NRTI Comparison|Not reason above|0|||
125885762|NCT02230670|452878824|FG000|Overall Study|Adverse Event|1|||
125885763|NCT02230670|452878825|FG001|Overall Study|Adverse Event|2|||
125885764|NCT02230670|452878824|FG000|Overall Study|Withdrawal by Subject|2|||
126308464|NCT02829723|454418735|FG024|Overall Study|Adverse Event|1|||
126308465|NCT02829723|454418736|FG025|Overall Study|Adverse Event|3|||
126308466|NCT02829723|454418737|FG026|Overall Study|Adverse Event|5|||
126308467|NCT02829723|454418711|FG000|Overall Study|Death|1|||
126308468|NCT02829723|454418712|FG001|Overall Study|Death|0|||
126308469|NCT02829723|454418713|FG002|Overall Study|Death|1|||
126308470|NCT02829723|454418714|FG003|Overall Study|Death|1|||
126308471|NCT02829723|454418715|FG004|Overall Study|Death|0|||
126308472|NCT02829723|454418716|FG005|Overall Study|Death|0|||
126308473|NCT02829723|454418717|FG006|Overall Study|Death|2|||
126308474|NCT02829723|454418718|FG007|Overall Study|Death|0|||
126308475|NCT02829723|454418719|FG008|Overall Study|Death|1|||
126308476|NCT02829723|454418720|FG009|Overall Study|Death|0|||
126308477|NCT02829723|454418721|FG010|Overall Study|Death|0|||
126308478|NCT02829723|454418722|FG011|Overall Study|Death|0|||
126308479|NCT02829723|454418723|FG012|Overall Study|Death|2|||
126308480|NCT02829723|454418724|FG013|Overall Study|Death|1|||
126308481|NCT02829723|454418725|FG014|Overall Study|Death|0|||
126308482|NCT02829723|454418726|FG015|Overall Study|Death|0|||
126308483|NCT02829723|454418727|FG016|Overall Study|Death|0|||
126308484|NCT02829723|454418728|FG017|Overall Study|Death|0|||
126308485|NCT02829723|454418729|FG018|Overall Study|Death|0|||
126308486|NCT02829723|454418730|FG019|Overall Study|Death|0|||
126308487|NCT02829723|454418731|FG020|Overall Study|Death|0|||
126308488|NCT02829723|454418732|FG021|Overall Study|Death|2|||
126308489|NCT02829723|454418733|FG022|Overall Study|Death|0|||
126308490|NCT02829723|454418734|FG023|Overall Study|Death|0|||
126308491|NCT02829723|454418735|FG024|Overall Study|Death|0|||
126308492|NCT02829723|454418736|FG025|Overall Study|Death|1|||
126308493|NCT02829723|454418737|FG026|Overall Study|Death|2|||
126308494|NCT02829723|454418711|FG000|Overall Study|Physician Decision|0|||
126308495|NCT02829723|454418712|FG001|Overall Study|Physician Decision|0|||
126308496|NCT02829723|454418713|FG002|Overall Study|Physician Decision|0|||
126308497|NCT02829723|454418714|FG003|Overall Study|Physician Decision|0|||
126308498|NCT02829723|454418715|FG004|Overall Study|Physician Decision|0|||
126308499|NCT02829723|454418716|FG005|Overall Study|Physician Decision|0|||
126308500|NCT02829723|454418717|FG006|Overall Study|Physician Decision|0|||
126308501|NCT02829723|454418718|FG007|Overall Study|Physician Decision|0|||
126308502|NCT02829723|454418719|FG008|Overall Study|Physician Decision|0|||
126308503|NCT02829723|454418720|FG009|Overall Study|Physician Decision|1|||
126308504|NCT02829723|454418721|FG010|Overall Study|Physician Decision|1|||
126308505|NCT02829723|454418722|FG011|Overall Study|Physician Decision|0|||
126308506|NCT02829723|454418723|FG012|Overall Study|Physician Decision|0|||
126308507|NCT02829723|454418724|FG013|Overall Study|Physician Decision|1|||
126308508|NCT02829723|454418725|FG014|Overall Study|Physician Decision|0|||
126308509|NCT02829723|454418726|FG015|Overall Study|Physician Decision|0|||
126308510|NCT02829723|454418727|FG016|Overall Study|Physician Decision|2|||
126308511|NCT02829723|454418728|FG017|Overall Study|Physician Decision|0|||
126308512|NCT02829723|454418729|FG018|Overall Study|Physician Decision|0|||
126308513|NCT02829723|454418730|FG019|Overall Study|Physician Decision|0|||
126308514|NCT02829723|454418731|FG020|Overall Study|Physician Decision|0|||
126308515|NCT02829723|454418732|FG021|Overall Study|Physician Decision|0|||
126308516|NCT02829723|454418733|FG022|Overall Study|Physician Decision|1|||
126308517|NCT02829723|454418734|FG023|Overall Study|Physician Decision|1|||
126308518|NCT02829723|454418735|FG024|Overall Study|Physician Decision|1|||
126308519|NCT02829723|454418736|FG025|Overall Study|Physician Decision|1|||
126308520|NCT02829723|454418737|FG026|Overall Study|Physician Decision|3|||
126308521|NCT02829723|454418711|FG000|Overall Study|Progressive disease|4|||
126308522|NCT02829723|454418712|FG001|Overall Study|Progressive disease|6|||
126308523|NCT02829723|454418713|FG002|Overall Study|Progressive disease|3|||
126308524|NCT02829723|454418714|FG003|Overall Study|Progressive disease|3|||
126308525|NCT02829723|454418715|FG004|Overall Study|Progressive disease|3|||
126308526|NCT02829723|454418716|FG005|Overall Study|Progressive disease|5|||
126308527|NCT02829723|454418717|FG006|Overall Study|Progressive disease|4|||
126308528|NCT02829723|454418718|FG007|Overall Study|Progressive disease|6|||
126308529|NCT02829723|454418719|FG008|Overall Study|Progressive disease|8|||
126308530|NCT02829723|454418720|FG009|Overall Study|Progressive disease|4|||
126308531|NCT02829723|454418721|FG010|Overall Study|Progressive disease|9|||
126308532|NCT02829723|454418722|FG011|Overall Study|Progressive disease|0|||
126308533|NCT02829723|454418723|FG012|Overall Study|Progressive disease|3|||
126308534|NCT02829723|454418724|FG013|Overall Study|Progressive disease|4|||
126308535|NCT02829723|454418725|FG014|Overall Study|Progressive disease|2|||
126308536|NCT02829723|454418726|FG015|Overall Study|Progressive disease|4|||
126308537|NCT02829723|454418727|FG016|Overall Study|Progressive disease|5|||
126308538|NCT02829723|454418728|FG017|Overall Study|Progressive disease|3|||
126308539|NCT02829723|454418729|FG018|Overall Study|Progressive disease|4|||
126308540|NCT02829723|454418730|FG019|Overall Study|Progressive disease|4|||
126308541|NCT02829723|454418731|FG020|Overall Study|Progressive disease|7|||
126308542|NCT02829723|454418732|FG021|Overall Study|Progressive disease|6|||
126308543|NCT02829723|454418733|FG022|Overall Study|Progressive disease|3|||
126308544|NCT02829723|454418734|FG023|Overall Study|Progressive disease|3|||
126308545|NCT02829723|454418735|FG024|Overall Study|Progressive disease|3|||
126308546|NCT02829723|454418736|FG025|Overall Study|Progressive disease|16|||
126371337|NCT01276106|454656718|FG003|Overall Study|Physician Decision|1|||
126371338|NCT01276106|454656715|FG000|Overall Study|Protocol Violation|1|||
126371339|NCT01276106|454656716|FG001|Overall Study|Protocol Violation|1|||
126371340|NCT01276106|454656717|FG002|Overall Study|Protocol Violation|0|||
126371341|NCT01276106|454656718|FG003|Overall Study|Protocol Violation|2|||
126371342|NCT01276106|454656715|FG000|Overall Study|Insufficient therapeutic effects|0|||
126371343|NCT01276106|454656716|FG001|Overall Study|Insufficient therapeutic effects|0|||
126371344|NCT01276106|454656717|FG002|Overall Study|Insufficient therapeutic effects|2|||
126371345|NCT01276106|454656718|FG003|Overall Study|Insufficient therapeutic effects|0|||
126371346|NCT04079738|454656721|FG000|Study Treatment|Death|1|||
125885765|NCT02230670|452878825|FG001|Overall Study|Withdrawal by Subject|2|||
125885766|NCT02230670|452878824|FG000|Overall Study|Physician Decision|0|||
126308547|NCT02829723|454418737|FG026|Overall Study|Progressive disease|10|||
126308548|NCT02829723|454418711|FG000|Overall Study|Subject/guardian decision|0|||
126308549|NCT02829723|454418712|FG001|Overall Study|Subject/guardian decision|1|||
126308550|NCT02829723|454418713|FG002|Overall Study|Subject/guardian decision|0|||
126308551|NCT02829723|454418714|FG003|Overall Study|Subject/guardian decision|1|||
126308552|NCT02829723|454418715|FG004|Overall Study|Subject/guardian decision|0|||
126308553|NCT02829723|454418716|FG005|Overall Study|Subject/guardian decision|0|||
126308554|NCT02829723|454418717|FG006|Overall Study|Subject/guardian decision|0|||
126308555|NCT02829723|454418718|FG007|Overall Study|Subject/guardian decision|1|||
126308556|NCT02829723|454418719|FG008|Overall Study|Subject/guardian decision|0|||
126308557|NCT02829723|454418720|FG009|Overall Study|Subject/guardian decision|0|||
126308558|NCT02829723|454418721|FG010|Overall Study|Subject/guardian decision|0|||
126308559|NCT02829723|454418722|FG011|Overall Study|Subject/guardian decision|0|||
126308560|NCT02829723|454418723|FG012|Overall Study|Subject/guardian decision|0|||
126308561|NCT02829723|454418724|FG013|Overall Study|Subject/guardian decision|0|||
126308562|NCT02829723|454418725|FG014|Overall Study|Subject/guardian decision|1|||
126308563|NCT02829723|454418726|FG015|Overall Study|Subject/guardian decision|0|||
126308564|NCT02829723|454418727|FG016|Overall Study|Subject/guardian decision|1|||
126308565|NCT02829723|454418728|FG017|Overall Study|Subject/guardian decision|0|||
126308566|NCT02829723|454418729|FG018|Overall Study|Subject/guardian decision|1|||
126308567|NCT02829723|454418730|FG019|Overall Study|Subject/guardian decision|0|||
126308568|NCT02829723|454418731|FG020|Overall Study|Subject/guardian decision|1|||
126308569|NCT02829723|454418732|FG021|Overall Study|Subject/guardian decision|0|||
126308570|NCT02829723|454418733|FG022|Overall Study|Subject/guardian decision|0|||
126308571|NCT02829723|454418734|FG023|Overall Study|Subject/guardian decision|1|||
126308572|NCT02829723|454418735|FG024|Overall Study|Subject/guardian decision|0|||
126308573|NCT02829723|454418736|FG025|Overall Study|Subject/guardian decision|1|||
126308574|NCT02829723|454418737|FG026|Overall Study|Subject/guardian decision|1|||
126308575|NCT02829723|454418711|FG000|Overall Study|Study terminated by sponsor|0|||
126308576|NCT02829723|454418712|FG001|Overall Study|Study terminated by sponsor|0|||
126308577|NCT02829723|454418713|FG002|Overall Study|Study terminated by sponsor|0|||
126308578|NCT02829723|454418714|FG003|Overall Study|Study terminated by sponsor|0|||
126308579|NCT02829723|454418715|FG004|Overall Study|Study terminated by sponsor|0|||
126308580|NCT02829723|454418716|FG005|Overall Study|Study terminated by sponsor|0|||
126308581|NCT02829723|454418717|FG006|Overall Study|Study terminated by sponsor|0|||
126308582|NCT02829723|454418718|FG007|Overall Study|Study terminated by sponsor|0|||
126308583|NCT02829723|454418719|FG008|Overall Study|Study terminated by sponsor|0|||
126308584|NCT02829723|454418720|FG009|Overall Study|Study terminated by sponsor|0|||
126308585|NCT02829723|454418721|FG010|Overall Study|Study terminated by sponsor|0|||
126308586|NCT02829723|454418722|FG011|Overall Study|Study terminated by sponsor|0|||
126308587|NCT02829723|454418723|FG012|Overall Study|Study terminated by sponsor|0|||
126308588|NCT02829723|454418724|FG013|Overall Study|Study terminated by sponsor|0|||
126308589|NCT02829723|454418725|FG014|Overall Study|Study terminated by sponsor|0|||
126308590|NCT02829723|454418726|FG015|Overall Study|Study terminated by sponsor|0|||
126308591|NCT02829723|454418727|FG016|Overall Study|Study terminated by sponsor|0|||
126308592|NCT02829723|454418728|FG017|Overall Study|Study terminated by sponsor|0|||
126308593|NCT02829723|454418729|FG018|Overall Study|Study terminated by sponsor|0|||
126308594|NCT02829723|454418730|FG019|Overall Study|Study terminated by sponsor|0|||
126308595|NCT02829723|454418731|FG020|Overall Study|Study terminated by sponsor|0|||
126308596|NCT02829723|454418732|FG021|Overall Study|Study terminated by sponsor|1|||
126308597|NCT02829723|454418733|FG022|Overall Study|Study terminated by sponsor|0|||
126308598|NCT02829723|454418734|FG023|Overall Study|Study terminated by sponsor|0|||
126308599|NCT02829723|454418735|FG024|Overall Study|Study terminated by sponsor|0|||
126308600|NCT02829723|454418736|FG025|Overall Study|Study terminated by sponsor|0|||
126308601|NCT02829723|454418737|FG026|Overall Study|Study terminated by sponsor|0|||
126308602|NCT02989649|454418738|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
126308603|NCT02989649|454418738|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
126308604|NCT02989649|454418738|FG000|Overall Study|Lost For Observation During Study|3|||
126308605|NCT02989649|454418738|FG000|Overall Study|Reason Not Specified|13|||
126308606|NCT00330343|454418739|FG000|Overall Study|Lost to Follow-up|5|||
126308607|NCT00281632|454418740|FG000|Overall Study|Adverse Event|7|||
126308608|NCT00281632|454418740|FG000|Overall Study|Withdrawal by Subject|2|||
126308609|NCT00281632|454418740|FG000|Overall Study|Disease Progression|22|||
126308610|NCT00281632|454418740|FG000|Overall Study|Death|1|||
126308611|NCT00281632|454418740|FG000|Overall Study|Physician Decision|1|||
126308612|NCT00281632|454418740|FG000|Overall Study|Ongoing|3|||
126308613|NCT03990571|454418741|FG000|Overall Study|Withdrawal by Subject|1|||
126308614|NCT03990571|454418741|FG000|Overall Study|Insurance Issues|3|||
126308615|NCT03990571|454418741|FG000|Overall Study|Covid Restrictions|2|||
126308616|NCT04143594|454418746|FG000|Overall Study|Withdrew consent|3|||
125885767|NCT02230670|452878825|FG001|Overall Study|Physician Decision|1|||
126308617|NCT04143594|454418747|FG001|Overall Study|Withdrew consent|10|||
126308618|NCT04143594|454418748|FG002|Overall Study|Withdrew consent|3|||
125885768|NCT02230670|452878824|FG000|Overall Study|Protocol Violation|0|||
126371347|NCT04079738|454656722|FG001|Study Treatment|Death|0|||
126371348|NCT04079738|454656723|FG002|Study Treatment|Death|0|||
126371349|NCT04079738|454656724|FG003|Study Treatment|Death|0|||
126371350|NCT04079738|454656721|FG000|Study Treatment|Adverse Event|2|||
126371351|NCT04079738|454656722|FG001|Study Treatment|Adverse Event|0|||
126371352|NCT04079738|454656723|FG002|Study Treatment|Adverse Event|0|||
126371353|NCT04079738|454656724|FG003|Study Treatment|Adverse Event|0|||
126371354|NCT04079738|454656721|FG000|Study Treatment|withdrawal before treatment|1|||
126371355|NCT04079738|454656722|FG001|Study Treatment|withdrawal before treatment|0|||
126371356|NCT04079738|454656723|FG002|Study Treatment|withdrawal before treatment|0|||
126371357|NCT04079738|454656724|FG003|Study Treatment|withdrawal before treatment|0|||
126371358|NCT04079738|454656721|FG000|Study Treatment|symptomatic deterioration|2|||
126371359|NCT04079738|454656722|FG001|Study Treatment|symptomatic deterioration|0|||
126371360|NCT04079738|454656723|FG002|Study Treatment|symptomatic deterioration|0|||
126371361|NCT04079738|454656724|FG003|Study Treatment|symptomatic deterioration|0|||
126371362|NCT04079738|454656721|FG000|Study Treatment|Disease Progression|1|||
126371363|NCT04079738|454656722|FG001|Study Treatment|Disease Progression|0|||
126371364|NCT04079738|454656723|FG002|Study Treatment|Disease Progression|0|||
126371365|NCT04079738|454656724|FG003|Study Treatment|Disease Progression|0|||
126371366|NCT04079738|454656721|FG000|Study Treatment|withdrawal after treatment|1|||
126371367|NCT04079738|454656722|FG001|Study Treatment|withdrawal after treatment|0|||
126371368|NCT04079738|454656723|FG002|Study Treatment|withdrawal after treatment|0|||
126371369|NCT04079738|454656724|FG003|Study Treatment|withdrawal after treatment|0|||
126371370|NCT04079738|454656721|FG000|Follow up|Withdrawal by Subject|3|||
125885769|NCT02230670|452878825|FG001|Overall Study|Protocol Violation|1|||
125885770|NCT02230670|452878824|FG000|Overall Study|Progression to Child-Pugh C|1|||
125885771|NCT02230670|452878825|FG001|Overall Study|Progression to Child-Pugh C|2|||
126371371|NCT04079738|454656722|FG001|Follow up|Withdrawal by Subject|0|||
126371372|NCT04079738|454656723|FG002|Follow up|Withdrawal by Subject|0|||
126371373|NCT04079738|454656724|FG003|Follow up|Withdrawal by Subject|0|||
126371374|NCT04079738|454656721|FG000|Follow up|Death|5|||
126371375|NCT04079738|454656722|FG001|Follow up|Death|0|||
126371376|NCT04079738|454656723|FG002|Follow up|Death|0|||
125885772|NCT00892099|452878827|FG000|Overall Study|Death|1|||
125885773|NCT00892099|452878828|FG001|Overall Study|Death|0|||
126047584|NCT04980300|453471831|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
126047585|NCT01470144|453471837|FG000|Overall Study|Adverse Event|2|||
126047586|NCT01470144|453471837|FG000|Overall Study|Death|1|||
126047587|NCT01470144|453471837|FG000|Overall Study|Lung transplant|6|||
126047588|NCT01470144|453471837|FG000|Overall Study|Patient's and investigator's decision|1|||
126047589|NCT03459196|453472872|FG000|Overall Study|Subject didn't receive study catheter|2|||
126371377|NCT04079738|454656724|FG003|Follow up|Death|0|||
126371378|NCT00867035|454656727|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
126371379|NCT00867035|454656728|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
126371380|NCT00867035|454656727|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
126371381|NCT00867035|454656728|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
126371382|NCT00404248|454656729|FG000|Overall Study|pts declining status|0|||
126371383|NCT00404248|454656730|FG001|Overall Study|pts declining status|1|||
126371384|NCT00404248|454656731|FG002|Overall Study|pts declining status|0|||
126371385|NCT00404248|454656732|FG003|Overall Study|pts declining status|0|||
126371386|NCT00404248|454656733|FG004|Overall Study|pts declining status|0|||
126371387|NCT00404248|454656734|FG005|Overall Study|pts declining status|0|||
126371388|NCT00404248|454656735|FG006|Overall Study|pts declining status|0|||
125885774|NCT00892099|452878829|FG002|Overall Study|Death|1|||
125885775|NCT00892099|452878827|FG000|Overall Study|Adverse Event|1|||
126371389|NCT00404248|454656736|FG007|Overall Study|pts declining status|0|||
126371390|NCT00404248|454656737|FG008|Overall Study|pts declining status|0|||
126371391|NCT00789555|454656738|FG000|Overall Study|Protocol Amendment|78|||
126371392|NCT00789555|454656739|FG001|Overall Study|Protocol Amendment|76|||
126371393|NCT00789555|454656740|FG002|Overall Study|Protocol Amendment|80|||
126371394|NCT00789555|454656738|FG000|Overall Study|Adverse Event|17|||
126371395|NCT00789555|454656739|FG001|Overall Study|Adverse Event|7|||
126371396|NCT00789555|454656740|FG002|Overall Study|Adverse Event|10|||
126371397|NCT00789555|454656738|FG000|Overall Study|Lost to Follow-up|9|||
126371398|NCT00789555|454656739|FG001|Overall Study|Lost to Follow-up|10|||
126371399|NCT00789555|454656740|FG002|Overall Study|Lost to Follow-up|18|||
126371400|NCT00789555|454656738|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
126371401|NCT00789555|454656739|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
126371402|NCT00789555|454656740|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
126371403|NCT00789555|454656738|FG000|Overall Study|Treatment failure|11|||
126371404|NCT00789555|454656739|FG001|Overall Study|Treatment failure|8|||
126371405|NCT00789555|454656740|FG002|Overall Study|Treatment failure|12|||
126371406|NCT00789555|454656738|FG000|Overall Study|Protocol Violation|6|||
126371407|NCT00789555|454656739|FG001|Overall Study|Protocol Violation|9|||
126371408|NCT00789555|454656740|FG002|Overall Study|Protocol Violation|13|||
126371409|NCT04646005|454656741|FG000|Overall Study|Adverse Event|1|||
126371410|NCT04646005|454656741|FG000|Overall Study|Progressive Disease|71|||
126371411|NCT04646005|454656741|FG000|Overall Study|Death|20|||
126371412|NCT04646005|454656741|FG000|Overall Study|Withdrawal by Subject|12|||
126371413|NCT04646005|454656741|FG000|Overall Study|Sponsor Request|9|||
126371414|NCT04398706|454656742|FG000|Overall Study|Adverse Event|0|||
126371415|NCT04398706|454656743|FG001|Overall Study|Adverse Event|0|||
126371416|NCT04398706|454656744|FG002|Overall Study|Adverse Event|0|||
126371417|NCT04398706|454656745|FG003|Overall Study|Adverse Event|0|||
126371418|NCT04398706|454656746|FG004|Overall Study|Adverse Event|0|||
126371419|NCT04398706|454656747|FG005|Overall Study|Adverse Event|1|||
126371420|NCT04398706|454656748|FG006|Overall Study|Adverse Event|1|||
126371421|NCT04398706|454656749|FG007|Overall Study|Adverse Event|0|||
126371422|NCT04398706|454656742|FG000|Overall Study|Lost to Follow-up|0|||
126371423|NCT04398706|454656743|FG001|Overall Study|Lost to Follow-up|1|||
126371424|NCT04398706|454656744|FG002|Overall Study|Lost to Follow-up|2|||
126371425|NCT04398706|454656745|FG003|Overall Study|Lost to Follow-up|1|||
126371426|NCT04398706|454656746|FG004|Overall Study|Lost to Follow-up|6|||
126371427|NCT04398706|454656747|FG005|Overall Study|Lost to Follow-up|3|||
126371428|NCT04398706|454656748|FG006|Overall Study|Lost to Follow-up|8|||
126371429|NCT04398706|454656749|FG007|Overall Study|Lost to Follow-up|2|||
126371430|NCT04398706|454656742|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126371431|NCT04398706|454656743|FG001|Overall Study|Withdrawal by parent/guardian|2|||
126371432|NCT04398706|454656744|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126371433|NCT04398706|454656745|FG003|Overall Study|Withdrawal by parent/guardian|2|||
126371434|NCT04398706|454656746|FG004|Overall Study|Withdrawal by parent/guardian|19|||
126371435|NCT04398706|454656747|FG005|Overall Study|Withdrawal by parent/guardian|23|||
126371436|NCT04398706|454656748|FG006|Overall Study|Withdrawal by parent/guardian|13|||
126371437|NCT04398706|454656749|FG007|Overall Study|Withdrawal by parent/guardian|11|||
126371438|NCT04398706|454656742|FG000|Overall Study|Protocol deviation|0|||
126371439|NCT04398706|454656743|FG001|Overall Study|Protocol deviation|1|||
126371440|NCT04398706|454656744|FG002|Overall Study|Protocol deviation|0|||
126371441|NCT04398706|454656745|FG003|Overall Study|Protocol deviation|0|||
126371442|NCT04398706|454656746|FG004|Overall Study|Protocol deviation|6|||
126103972|NCT03756129|453673885|FG003|Overall Study|Lost to Follow-up|0|||
126103973|NCT03756129|453673886|FG004|Overall Study|Lost to Follow-up|0|||
126371443|NCT04398706|454656747|FG005|Overall Study|Protocol deviation|4|||
126371444|NCT04398706|454656748|FG006|Overall Study|Protocol deviation|6|||
126371445|NCT04398706|454656749|FG007|Overall Study|Protocol deviation|3|||
126371446|NCT02611037|454656750|FG000|Overall Study|Withdrawal prior to treatment|2|||
126371447|NCT02611037|454656751|FG001|Overall Study|Withdrawal prior to treatment|0|||
126371448|NCT04577404|454656752|FG000|Overall Study|Adverse Event|31|||
126371449|NCT04577404|454656752|FG000|Overall Study|Death|1|||
126371450|NCT04577404|454656752|FG000|Overall Study|Lack of Efficacy|3|||
126371451|NCT04577404|454656752|FG000|Overall Study|Physician Decision|7|||
126371452|NCT04577404|454656752|FG000|Overall Study|Withdrawal by Subject|21|||
126371453|NCT04577404|454656752|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
126371454|NCT04237584|454656759|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
125885776|NCT00892099|452878828|FG001|Overall Study|Adverse Event|0|||
125885777|NCT00892099|452878829|FG002|Overall Study|Adverse Event|0|||
126103974|NCT03756129|453673887|FG005|Overall Study|Lost to Follow-up|1|||
126308619|NCT04143594|454418749|FG003|Overall Study|Withdrew consent|1|||
126308620|NCT04143594|454418746|FG000|Overall Study|Lost to Follow-up|3|||
126308621|NCT04143594|454418747|FG001|Overall Study|Lost to Follow-up|5|||
126308622|NCT04143594|454418748|FG002|Overall Study|Lost to Follow-up|11|||
126308623|NCT04143594|454418749|FG003|Overall Study|Lost to Follow-up|0|||
126308624|NCT04143594|454418746|FG000|Overall Study|Investigator's discretion|2|||
126308625|NCT04143594|454418747|FG001|Overall Study|Investigator's discretion|2|||
126308626|NCT04143594|454418748|FG002|Overall Study|Investigator's discretion|0|||
126308627|NCT04143594|454418749|FG003|Overall Study|Investigator's discretion|0|||
126308628|NCT04143594|454418746|FG000|Overall Study|Randomized but never treated|0|||
126308629|NCT04143594|454418747|FG001|Overall Study|Randomized but never treated|0|||
126308630|NCT04143594|454418748|FG002|Overall Study|Randomized but never treated|0|||
126308631|NCT04143594|454418749|FG003|Overall Study|Randomized but never treated|1|||
126308632|NCT04143594|454418746|FG000|Overall Study|Death|1|||
126308633|NCT04143594|454418747|FG001|Overall Study|Death|0|||
126308634|NCT04143594|454418748|FG002|Overall Study|Death|1|||
126308635|NCT04143594|454418749|FG003|Overall Study|Death|0|||
126308636|NCT04143594|454418746|FG000|Overall Study|Adverse Event|1|||
126308637|NCT04143594|454418747|FG001|Overall Study|Adverse Event|0|||
126308638|NCT04143594|454418748|FG002|Overall Study|Adverse Event|0|||
126308639|NCT04143594|454418749|FG003|Overall Study|Adverse Event|0|||
126308640|NCT04143594|454418746|FG000|Overall Study|Pregnancy|0|||
126308641|NCT04143594|454418747|FG001|Overall Study|Pregnancy|0|||
126308642|NCT04143594|454418748|FG002|Overall Study|Pregnancy|1|||
126308643|NCT04143594|454418749|FG003|Overall Study|Pregnancy|0|||
126308644|NCT04143594|454418746|FG000|Overall Study|Lack of Efficacy|1|||
126308645|NCT04143594|454418747|FG001|Overall Study|Lack of Efficacy|1|||
126308646|NCT04143594|454418748|FG002|Overall Study|Lack of Efficacy|0|||
126308647|NCT04143594|454418749|FG003|Overall Study|Lack of Efficacy|0|||
126308648|NCT00179673|454418750|FG000|Overall Study|Adverse Event|7|||
126308649|NCT00179673|454418750|FG000|Overall Study|Lack of Efficacy|15|||
126308650|NCT00179673|454418750|FG000|Overall Study|Withdrawal by Subject|3|||
126308651|NCT00179673|454418750|FG000|Overall Study|Death|4|||
126308652|NCT00179673|454418750|FG000|Overall Study|Other Observations and options|14|||
126308653|NCT00282113|454418751|FG000|Overall Study|Removed at parents request|1|||
126308654|NCT00282113|454418752|FG001|Overall Study|Removed at parents request|0|||
126308655|NCT00282113|454418753|FG002|Overall Study|Removed at parents request|0|||
126308656|NCT02107859|454418760|FG000|Overall Study|Withdrawal by Subject|14|||
126308657|NCT02107859|454418760|FG000|Overall Study|Adverse Event|3|||
126308658|NCT02107859|454418760|FG000|Overall Study|Study closure|41|||
126308659|NCT02107859|454418760|FG000|Overall Study|Other than specified|3|||
126308660|NCT01582178|454418761|FG000|Overall Study|Physician Decision|6|||
126308661|NCT01582178|454418762|FG001|Overall Study|Physician Decision|5|||
126308662|NCT04439214|454418763|FG000|Overall Study|Adverse Event|13|||
126308663|NCT04439214|454418763|FG000|Overall Study|Disease progression|16|||
126308664|NCT04439214|454418763|FG000|Overall Study|Death|1|||
126308665|NCT04439214|454418763|FG000|Overall Study|Withdrawal by Subject|2|||
126308666|NCT04439214|454418763|FG000|Overall Study|Declining health|1|||
126308667|NCT04439214|454418763|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
126308668|NCT04439214|454418763|FG000|Overall Study|Ineligible|5|||
126308669|NCT03852628|454418764|FG000|Overall Study|Lost to Follow-up|7|||
126308670|NCT03852628|454418765|FG001|Overall Study|Lost to Follow-up|6|||
126308671|NCT03852628|454418764|FG000|Overall Study|Lack of Efficacy|6|||
126308672|NCT03852628|454418765|FG001|Overall Study|Lack of Efficacy|6|||
126308673|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
126308674|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
126308675|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
126308676|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
126308677|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
126308678|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
126308679|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
126308680|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
125885778|NCT00892099|452878827|FG000|Overall Study|replocated|1|||
126308681|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
126308682|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
126308683|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
126308684|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
126308685|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
126308686|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
126308687|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
126308688|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
125885779|NCT00892099|452878828|FG001|Overall Study|replocated|0|||
126308689|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
126371455|NCT04237584|454656760|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
126371456|NCT04237584|454656761|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
126371457|NCT04237584|454656762|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
126371458|NCT04237584|454656759|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
126371459|NCT04237584|454656760|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
126371460|NCT04237584|454656761|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
126371461|NCT04237584|454656762|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
126371462|NCT04237584|454656759|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
126371463|NCT04237584|454656760|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
126371464|NCT04237584|454656761|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
126371465|NCT04237584|454656762|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
126371466|NCT04237584|454656759|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
126371467|NCT04237584|454656760|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
126371468|NCT04237584|454656761|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
126371469|NCT04237584|454656762|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
126371470|NCT04237584|454656759|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
126371471|NCT04237584|454656760|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
126371472|NCT04237584|454656761|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
126371473|NCT04237584|454656762|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
126371474|NCT03586973|454656763|FG000|Overall Study|Death|15|||
126371475|NCT03586973|454656764|FG001|Overall Study|Death|8|||
126371476|NCT03586973|454656763|FG000|Overall Study|Site Terminated by Sponsor|3|||
126371477|NCT03586973|454656764|FG001|Overall Study|Site Terminated by Sponsor|6|||
126371478|NCT03586973|454656763|FG000|Overall Study|Withdrawal by Subject|1|||
126371479|NCT03586973|454656764|FG001|Overall Study|Withdrawal by Subject|0|||
126371480|NCT03586973|454656763|FG000|Overall Study|Lost to Follow-up|1|||
126371481|NCT03586973|454656764|FG001|Overall Study|Lost to Follow-up|0|||
126371482|NCT03423979|454656765|FG000|Overall Study|Death|1|||
126371483|NCT05239221|454656766|FG000|Overall Study|Adverse Event|0|||
126371484|NCT05239221|454656767|FG001|Overall Study|Adverse Event|0|||
126371485|NCT05239221|454656768|FG002|Overall Study|Adverse Event|0|||
126371486|NCT05239221|454656769|FG003|Overall Study|Adverse Event|0|||
126371487|NCT05239221|454656770|FG004|Overall Study|Adverse Event|0|||
126371488|NCT05239221|454656771|FG005|Overall Study|Adverse Event|0|||
126371489|NCT05239221|454656772|FG006|Overall Study|Adverse Event|1|||
126371490|NCT05239221|454656773|FG007|Overall Study|Adverse Event|0|||
126371491|NCT05239221|454656774|FG008|Overall Study|Adverse Event|0|||
126371492|NCT05239221|454656775|FG009|Overall Study|Adverse Event|0|||
126371493|NCT05239221|454656776|FG010|Overall Study|Adverse Event|1|||
126371494|NCT05239221|454656777|FG011|Overall Study|Adverse Event|1|||
126371495|NCT05239221|454656778|FG012|Overall Study|Adverse Event|0|||
126371496|NCT05239221|454656779|FG013|Overall Study|Adverse Event|0|||
126371497|NCT05239221|454656780|FG014|Overall Study|Adverse Event|0|||
126371498|NCT05239221|454656781|FG015|Overall Study|Adverse Event|0|||
126371499|NCT05239221|454656766|FG000|Overall Study|Withdrawal by Subject|0|||
126371500|NCT05239221|454656767|FG001|Overall Study|Withdrawal by Subject|0|||
126371501|NCT05239221|454656768|FG002|Overall Study|Withdrawal by Subject|0|||
126371502|NCT05239221|454656769|FG003|Overall Study|Withdrawal by Subject|0|||
126371503|NCT05239221|454656770|FG004|Overall Study|Withdrawal by Subject|0|||
126371504|NCT05239221|454656771|FG005|Overall Study|Withdrawal by Subject|0|||
126103975|NCT03756129|453673882|FG000|Overall Study|Physician Decision|0|||
126103976|NCT03756129|453673883|FG001|Overall Study|Physician Decision|0|||
126103977|NCT03756129|453673884|FG002|Overall Study|Physician Decision|0|||
126103978|NCT03756129|453673885|FG003|Overall Study|Physician Decision|0|||
126371505|NCT05239221|454656772|FG006|Overall Study|Withdrawal by Subject|0|||
126371506|NCT05239221|454656773|FG007|Overall Study|Withdrawal by Subject|0|||
126371507|NCT05239221|454656774|FG008|Overall Study|Withdrawal by Subject|0|||
126371508|NCT05239221|454656775|FG009|Overall Study|Withdrawal by Subject|0|||
126371509|NCT05239221|454656776|FG010|Overall Study|Withdrawal by Subject|1|||
126371510|NCT05239221|454656777|FG011|Overall Study|Withdrawal by Subject|0|||
126047590|NCT03183050|453472873|FG000|Overall Study|Lost to Follow-up|23|||
126047591|NCT00754065|453472874|FG000|Overall Study|Never received treatment|12|||
126047592|NCT00754065|453472875|FG001|Overall Study|Never received treatment|2|||
126047593|NCT00754065|453472874|FG000|Overall Study|Adverse Event|19|||
126047594|NCT00754065|453472875|FG001|Overall Study|Adverse Event|25|||
126308690|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
126308691|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
126308692|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
126308693|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
126308694|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
126308695|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
126308696|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
126308697|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
126308698|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
126308699|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
126308700|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
126308701|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
126308702|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
126308703|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
126308704|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
126308705|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
126308706|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
126308707|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
126308708|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
126308709|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
126308710|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
126308711|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
126308712|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
126308713|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Death|0|||
126308714|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Death|0|||
126308715|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Death|0|||
126308716|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Death|1|||
126308717|NCT01295827|454418777|FG000|Overall Study|Adverse Event|1|||
126308718|NCT01295827|454418778|FG001|Overall Study|Adverse Event|2|||
126308719|NCT01295827|454418779|FG002|Overall Study|Adverse Event|2|||
126308720|NCT01295827|454418780|FG003|Overall Study|Adverse Event|1|||
126308721|NCT01295827|454418781|FG004|Overall Study|Adverse Event|1|||
126308722|NCT01295827|454418782|FG005|Overall Study|Adverse Event|4|||
126308723|NCT01295827|454418783|FG006|Overall Study|Adverse Event|15|||
126308724|NCT01295827|454418784|FG007|Overall Study|Adverse Event|49|||
126308725|NCT01295827|454418785|FG008|Overall Study|Adverse Event|22|||
126308726|NCT01295827|454418786|FG009|Overall Study|Adverse Event|7|||
126308727|NCT01295827|454418787|FG010|Overall Study|Adverse Event|50|||
126308728|NCT01295827|454418788|FG011|Overall Study|Adverse Event|21|||
126308729|NCT01295827|454418789|FG012|Overall Study|Adverse Event|0|||
126308730|NCT01295827|454418790|FG013|Overall Study|Adverse Event|0|||
126308731|NCT01295827|454418791|FG014|Overall Study|Adverse Event|0|||
126308732|NCT01295827|454418777|FG000|Overall Study|Lost to Follow-up|0|||
126308733|NCT01295827|454418778|FG001|Overall Study|Lost to Follow-up|0|||
126308734|NCT01295827|454418779|FG002|Overall Study|Lost to Follow-up|3|||
126308735|NCT01295827|454418780|FG003|Overall Study|Lost to Follow-up|0|||
126308736|NCT01295827|454418781|FG004|Overall Study|Lost to Follow-up|1|||
126308737|NCT01295827|454418782|FG005|Overall Study|Lost to Follow-up|0|||
126308738|NCT01295827|454418783|FG006|Overall Study|Lost to Follow-up|4|||
126308739|NCT01295827|454418784|FG007|Overall Study|Lost to Follow-up|8|||
126308740|NCT01295827|454418785|FG008|Overall Study|Lost to Follow-up|7|||
126308741|NCT01295827|454418786|FG009|Overall Study|Lost to Follow-up|4|||
126308742|NCT01295827|454418787|FG010|Overall Study|Lost to Follow-up|7|||
126308743|NCT01295827|454418788|FG011|Overall Study|Lost to Follow-up|3|||
126308744|NCT01295827|454418789|FG012|Overall Study|Lost to Follow-up|0|||
126308745|NCT01295827|454418790|FG013|Overall Study|Lost to Follow-up|0|||
126371511|NCT05239221|454656778|FG012|Overall Study|Withdrawal by Subject|0|||
126371512|NCT05239221|454656779|FG013|Overall Study|Withdrawal by Subject|0|||
126308746|NCT01295827|454418791|FG014|Overall Study|Lost to Follow-up|0|||
126308747|NCT01295827|454418777|FG000|Overall Study|Not Reported|0|||
126371513|NCT05239221|454656780|FG014|Overall Study|Withdrawal by Subject|0|||
126371514|NCT05239221|454656781|FG015|Overall Study|Withdrawal by Subject|1|||
126047595|NCT00754065|453472874|FG000|Overall Study|Lost to Follow-up|7|||
126308748|NCT01295827|454418778|FG001|Overall Study|Not Reported|0|||
126308749|NCT01295827|454418779|FG002|Overall Study|Not Reported|0|||
126308750|NCT01295827|454418780|FG003|Overall Study|Not Reported|1|||
126308751|NCT01295827|454418781|FG004|Overall Study|Not Reported|0|||
126371515|NCT02661672|454656782|FG000|Overall Study|Lost to Follow-up|1|||
126371516|NCT02661672|454656782|FG000|Overall Study|Death|4|||
126371517|NCT04696146|454658392|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
126371518|NCT04696146|454658393|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
126371519|NCT04696146|454658392|FG000|Overall Study|Off hours issue with product|1|||
126371520|NCT04696146|454658393|FG001|Overall Study|Off hours issue with product|0|||
126371521|NCT00529633|454658398|FG000|Overall Study|Withdrawal by Subject|1|||
126371522|NCT00529633|454658399|FG001|Overall Study|Withdrawal by Subject|1|||
126371523|NCT01576783|454658400|FG000|Overall Study|Change in Medical Care|1|||
126371524|NCT01576783|454658401|FG001|Overall Study|Change in Medical Care|0|||
126371525|NCT01576783|454658400|FG000|Overall Study|Lost to Follow-up|14|||
126371526|NCT01576783|454658401|FG001|Overall Study|Lost to Follow-up|16|||
126371527|NCT01576783|454658400|FG000|Overall Study|Withdrawal by Subject|5|||
126371528|NCT01576783|454658401|FG001|Overall Study|Withdrawal by Subject|1|||
126371529|NCT01897493|454658403|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
126371530|NCT05489328|454658404|FG000|Overall Study|Lost to Follow-up|0|||
126371531|NCT05489328|454658405|FG001|Overall Study|Lost to Follow-up|0|||
126371532|NCT05489328|454658406|FG002|Overall Study|Lost to Follow-up|1|||
126371533|NCT05489328|454658407|FG003|Overall Study|Lost to Follow-up|0|||
126371534|NCT05489328|454658408|FG004|Overall Study|Lost to Follow-up|2|||
126371535|NCT05489328|454658409|FG005|Overall Study|Lost to Follow-up|0|||
126371536|NCT05489328|454658410|FG006|Overall Study|Lost to Follow-up|0|||
126371537|NCT05489328|454658411|FG007|Overall Study|Lost to Follow-up|1|||
126371538|NCT05489328|454658412|FG008|Overall Study|Lost to Follow-up|0|||
126371539|NCT05489328|454658404|FG000|Overall Study|Withdrawal by Subject|0|||
126371540|NCT05489328|454658405|FG001|Overall Study|Withdrawal by Subject|0|||
126371541|NCT05489328|454658406|FG002|Overall Study|Withdrawal by Subject|0|||
126371542|NCT05489328|454658407|FG003|Overall Study|Withdrawal by Subject|0|||
126371543|NCT05489328|454658408|FG004|Overall Study|Withdrawal by Subject|0|||
126371544|NCT05489328|454658409|FG005|Overall Study|Withdrawal by Subject|0|||
126371545|NCT05489328|454658410|FG006|Overall Study|Withdrawal by Subject|1|||
126371546|NCT05489328|454658411|FG007|Overall Study|Withdrawal by Subject|1|||
126371547|NCT05489328|454658412|FG008|Overall Study|Withdrawal by Subject|0|||
126371548|NCT05489328|454658404|FG000|Overall Study|Other|0|||
126371549|NCT05489328|454658405|FG001|Overall Study|Other|0|||
126371550|NCT05489328|454658406|FG002|Overall Study|Other|0|||
126371551|NCT05489328|454658407|FG003|Overall Study|Other|0|||
126371552|NCT05489328|454658408|FG004|Overall Study|Other|0|||
126371553|NCT05489328|454658409|FG005|Overall Study|Other|0|||
126371554|NCT05489328|454658410|FG006|Overall Study|Other|0|||
126371555|NCT05489328|454658411|FG007|Overall Study|Other|1|||
126371556|NCT05489328|454658412|FG008|Overall Study|Other|1|||
126371557|NCT01083602|454658413|FG000|Overall Study|Adverse Event|11|||
126371558|NCT01083602|454658413|FG000|Overall Study|New Cancer Therapy|2|||
126371559|NCT01083602|454658413|FG000|Overall Study|Death|1|||
126371560|NCT01083602|454658413|FG000|Overall Study|Withdrawal by Subject|5|||
126371561|NCT01083602|454658413|FG000|Overall Study|Lack of Efficacy|36|||
126371562|NCT03698279|454658414|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126371563|NCT03698279|454658415|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126371564|NCT03698279|454658416|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126371565|NCT03698279|454658417|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126371566|NCT03698279|454658418|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126371567|NCT03698279|454658419|FG005|Overall Study|Withdrawal by parent/guardian|0|||
126371568|NCT03698279|454658414|FG000|Overall Study|Protocol deviation|1|||
126371569|NCT03698279|454658415|FG001|Overall Study|Protocol deviation|0|||
126371570|NCT03698279|454658416|FG002|Overall Study|Protocol deviation|1|||
126371571|NCT03698279|454658417|FG003|Overall Study|Protocol deviation|0|||
126371572|NCT03698279|454658418|FG004|Overall Study|Protocol deviation|0|||
126371573|NCT03698279|454658419|FG005|Overall Study|Protocol deviation|0|||
126371574|NCT03698279|454658414|FG000|Overall Study|Withdrawal by Subject|0|||
126371575|NCT03698279|454658415|FG001|Overall Study|Withdrawal by Subject|0|||
126371576|NCT03698279|454658416|FG002|Overall Study|Withdrawal by Subject|1|||
126371577|NCT03698279|454658417|FG003|Overall Study|Withdrawal by Subject|0|||
126371578|NCT03698279|454658418|FG004|Overall Study|Withdrawal by Subject|0|||
125885780|NCT00892099|452878829|FG002|Overall Study|replocated|2|||
126047596|NCT00754065|453472875|FG001|Overall Study|Lost to Follow-up|11|||
126371579|NCT03698279|454658419|FG005|Overall Study|Withdrawal by Subject|0|||
126371580|NCT03698279|454658414|FG000|Overall Study|Lost to Follow-up|3|||
126047597|NCT00754065|453472874|FG000|Overall Study|Protocol Violation|12|||
126047598|NCT00754065|453472875|FG001|Overall Study|Protocol Violation|10|||
126371581|NCT03698279|454658415|FG001|Overall Study|Lost to Follow-up|1|||
126371582|NCT03698279|454658416|FG002|Overall Study|Lost to Follow-up|4|||
126371583|NCT03698279|454658417|FG003|Overall Study|Lost to Follow-up|5|||
126371584|NCT03698279|454658418|FG004|Overall Study|Lost to Follow-up|0|||
126371585|NCT03698279|454658419|FG005|Overall Study|Lost to Follow-up|0|||
126371586|NCT01276704|454658422|FG000|Overall Study|Lost to Follow-up|2|||
126371587|NCT01276704|454658423|FG001|Overall Study|Lost to Follow-up|3|||
126371588|NCT01276704|454658422|FG000|Overall Study|Non-compliant|2|||
126371589|NCT01276704|454658423|FG001|Overall Study|Non-compliant|2|||
125885781|NCT00892099|452878827|FG000|Overall Study|Prolonged hospitalization|1|||
126371590|NCT01276704|454658422|FG000|Overall Study|Withdrawal by Subject|7|||
126308752|NCT01295827|454418782|FG005|Overall Study|Not Reported|0|||
126308753|NCT01295827|454418783|FG006|Overall Study|Not Reported|24|||
126308754|NCT01295827|454418784|FG007|Overall Study|Not Reported|58|||
126308755|NCT01295827|454418785|FG008|Overall Study|Not Reported|41|||
126308756|NCT01295827|454418786|FG009|Overall Study|Not Reported|2|||
126308757|NCT01295827|454418787|FG010|Overall Study|Not Reported|23|||
126308758|NCT01295827|454418788|FG011|Overall Study|Not Reported|13|||
126308759|NCT01295827|454418789|FG012|Overall Study|Not Reported|0|||
126308760|NCT01295827|454418790|FG013|Overall Study|Not Reported|0|||
126308761|NCT01295827|454418791|FG014|Overall Study|Not Reported|0|||
126308762|NCT01295827|454418777|FG000|Overall Study|Progressive Disease|2|||
126308763|NCT01295827|454418778|FG001|Overall Study|Progressive Disease|1|||
126308764|NCT01295827|454418779|FG002|Overall Study|Progressive Disease|5|||
126308765|NCT01295827|454418780|FG003|Overall Study|Progressive Disease|2|||
126308766|NCT01295827|454418781|FG004|Overall Study|Progressive Disease|0|||
126308767|NCT01295827|454418782|FG005|Overall Study|Progressive Disease|1|||
126308768|NCT01295827|454418783|FG006|Overall Study|Progressive Disease|87|||
126308769|NCT01295827|454418784|FG007|Overall Study|Progressive Disease|144|||
126308770|NCT01295827|454418785|FG008|Overall Study|Progressive Disease|85|||
126308771|NCT01295827|454418786|FG009|Overall Study|Progressive Disease|40|||
126308772|NCT01295827|454418787|FG010|Overall Study|Progressive Disease|175|||
126308773|NCT01295827|454418788|FG011|Overall Study|Progressive Disease|136|||
126308774|NCT01295827|454418789|FG012|Overall Study|Progressive Disease|0|||
126308775|NCT01295827|454418790|FG013|Overall Study|Progressive Disease|0|||
126308776|NCT01295827|454418791|FG014|Overall Study|Progressive Disease|0|||
126308777|NCT01295827|454418777|FG000|Overall Study|Screen Failure|0|||
126308778|NCT01295827|454418778|FG001|Overall Study|Screen Failure|0|||
126308779|NCT01295827|454418779|FG002|Overall Study|Screen Failure|0|||
126308780|NCT01295827|454418780|FG003|Overall Study|Screen Failure|0|||
126308781|NCT01295827|454418781|FG004|Overall Study|Screen Failure|0|||
126308782|NCT01295827|454418782|FG005|Overall Study|Screen Failure|0|||
126308783|NCT01295827|454418783|FG006|Overall Study|Screen Failure|2|||
126308784|NCT01295827|454418784|FG007|Overall Study|Screen Failure|2|||
126308785|NCT01295827|454418785|FG008|Overall Study|Screen Failure|2|||
126308786|NCT01295827|454418786|FG009|Overall Study|Screen Failure|0|||
126308787|NCT01295827|454418787|FG010|Overall Study|Screen Failure|1|||
126308788|NCT01295827|454418788|FG011|Overall Study|Screen Failure|0|||
126308789|NCT01295827|454418789|FG012|Overall Study|Screen Failure|0|||
126308790|NCT01295827|454418790|FG013|Overall Study|Screen Failure|0|||
126308791|NCT01295827|454418791|FG014|Overall Study|Screen Failure|0|||
126308792|NCT01295827|454418777|FG000|Overall Study|Withdrawal by Subject|1|||
126308793|NCT01295827|454418778|FG001|Overall Study|Withdrawal by Subject|0|||
126308794|NCT01295827|454418779|FG002|Overall Study|Withdrawal by Subject|2|||
126308795|NCT01295827|454418780|FG003|Overall Study|Withdrawal by Subject|0|||
126308796|NCT01295827|454418781|FG004|Overall Study|Withdrawal by Subject|0|||
126308797|NCT01295827|454418782|FG005|Overall Study|Withdrawal by Subject|1|||
126308798|NCT01295827|454418783|FG006|Overall Study|Withdrawal by Subject|13|||
126308799|NCT01295827|454418784|FG007|Overall Study|Withdrawal by Subject|35|||
126308800|NCT01295827|454418785|FG008|Overall Study|Withdrawal by Subject|11|||
126308801|NCT01295827|454418786|FG009|Overall Study|Withdrawal by Subject|2|||
126308802|NCT01295827|454418787|FG010|Overall Study|Withdrawal by Subject|18|||
126308803|NCT01295827|454418788|FG011|Overall Study|Withdrawal by Subject|13|||
126308804|NCT01295827|454418789|FG012|Overall Study|Withdrawal by Subject|0|||
126308805|NCT01295827|454418790|FG013|Overall Study|Withdrawal by Subject|0|||
126308806|NCT01295827|454418791|FG014|Overall Study|Withdrawal by Subject|0|||
126308807|NCT01295827|454418777|FG000|Overall Study|Other|0|||
126308808|NCT01295827|454418778|FG001|Overall Study|Other|0|||
126308809|NCT01295827|454418779|FG002|Overall Study|Other|0|||
126308810|NCT01295827|454418780|FG003|Overall Study|Other|0|||
126308811|NCT01295827|454418781|FG004|Overall Study|Other|0|||
126308812|NCT01295827|454418782|FG005|Overall Study|Other|0|||
126308813|NCT01295827|454418783|FG006|Overall Study|Other|1|||
126308814|NCT01295827|454418784|FG007|Overall Study|Other|1|||
126308815|NCT01295827|454418785|FG008|Overall Study|Other|1|||
126308816|NCT01295827|454418786|FG009|Overall Study|Other|0|||
126308817|NCT01295827|454418787|FG010|Overall Study|Other|2|||
126308818|NCT01295827|454418788|FG011|Overall Study|Other|0|||
126308819|NCT01295827|454418789|FG012|Overall Study|Other|0|||
126308820|NCT01295827|454418790|FG013|Overall Study|Other|0|||
126308821|NCT01295827|454418791|FG014|Overall Study|Other|0|||
126308822|NCT01743560|454418792|FG000|Overall Study|Disease progression|26|||
126308823|NCT01743560|454418792|FG000|Overall Study|Adverse Event|8|||
126308824|NCT01743560|454418792|FG000|Overall Study|Death|3|||
126308825|NCT01743560|454418792|FG000|Overall Study|Withdrawal by Subject|2|||
126308826|NCT01743560|454418792|FG000|Overall Study|Protocol Violation|1|||
126308827|NCT01743560|454418792|FG000|Overall Study|>1 dose of study drug|3|||
126371591|NCT01276704|454658423|FG001|Overall Study|Withdrawal by Subject|1|||
126308828|NCT03226769|454418793|FG000|Overall Study|Withdrawal by Subject|0|||
126308829|NCT03226769|454418794|FG001|Overall Study|Withdrawal by Subject|1|||
126308830|NCT01827267|454418795|FG000|Overall Study|Did not receive study drug|1|||
126047599|NCT00754065|453472874|FG000|Overall Study|Withdrawal by Subject|4|||
126047600|NCT00754065|453472875|FG001|Overall Study|Withdrawal by Subject|5|||
126047601|NCT00754065|453472874|FG000|Overall Study|Pregnancy|6|||
126047602|NCT00754065|453472875|FG001|Overall Study|Pregnancy|0|||
126047603|NCT00754065|453472874|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
126308831|NCT01827267|454418796|FG001|Overall Study|Did not receive study drug|1|||
126308832|NCT01827267|454418795|FG000|Overall Study|Physician Decision|1|||
126308833|NCT01827267|454418796|FG001|Overall Study|Physician Decision|0|||
126308834|NCT01827267|454418795|FG000|Overall Study|Disease Progression|1|||
126308835|NCT01827267|454418796|FG001|Overall Study|Disease Progression|1|||
126308836|NCT01827267|454418795|FG000|Overall Study|Sponsor Discontinued Study|2|||
126308837|NCT01827267|454418796|FG001|Overall Study|Sponsor Discontinued Study|8|||
126308838|NCT01827267|454418795|FG000|Overall Study|Still on study|0|||
126308839|NCT01827267|454418796|FG001|Overall Study|Still on study|2|||
126308840|NCT02640677|454418801|FG000|Overall Study|Lost to Follow-up|1|||
126308841|NCT02640677|454418801|FG000|Overall Study|Withdrawal by Subject|1|||
126308842|NCT01516008|454418802|FG000|Overall Study|Adverse Event|0|||
126308843|NCT01516008|454418803|FG001|Overall Study|Adverse Event|2|||
126308844|NCT01516008|454418804|FG002|Overall Study|Adverse Event|7|||
126308845|NCT01516008|454418802|FG000|Overall Study|Lack of Efficacy|44|||
126308846|NCT01516008|454418803|FG001|Overall Study|Lack of Efficacy|14|||
126308847|NCT01516008|454418804|FG002|Overall Study|Lack of Efficacy|10|||
126308848|NCT01516008|454418802|FG000|Overall Study|Protocol Violation|1|||
126308849|NCT01516008|454418803|FG001|Overall Study|Protocol Violation|0|||
126308850|NCT01516008|454418804|FG002|Overall Study|Protocol Violation|0|||
126308851|NCT01516008|454418802|FG000|Overall Study|Reason not specified|0|||
126308852|NCT01516008|454418803|FG001|Overall Study|Reason not specified|0|||
126308853|NCT01516008|454418804|FG002|Overall Study|Reason not specified|1|||
126308854|NCT00813813|454418807|FG000|Overall Study|Withdrawal by Subject|1|||
126308855|NCT00813813|454418808|FG001|Overall Study|Withdrawal by Subject|1|||
126308856|NCT00813813|454418807|FG000|Overall Study|Lost to Follow-up|2|||
126308857|NCT00813813|454418808|FG001|Overall Study|Lost to Follow-up|7|||
126308858|NCT00813813|454418807|FG000|Overall Study|Other|0|||
126308859|NCT00813813|454418808|FG001|Overall Study|Other|1|||
126308860|NCT03489707|454418809|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
126308861|NCT03489707|454418810|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
126308862|NCT03489707|454418809|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
126308863|NCT03489707|454418810|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
126308864|NCT00199797|454420892|FG000|Overall Study|Progressive Disease|1|||
126308865|NCT00199797|454420892|FG000|Overall Study|Adverse Event|1|||
126308866|NCT00199797|454420892|FG000|Overall Study|Physician Decision|1|||
126308867|NCT04250350|454420897|FG000|Overall Study|Withdrawal by Subject|13|||
126308868|NCT04250350|454420897|FG000|Overall Study|Lost to Follow-up|8|||
126308869|NCT04250350|454420897|FG000|Overall Study|Adverse Event|5|||
126308870|NCT04250350|454420897|FG000|Overall Study|Lack of Efficacy|4|||
126308871|NCT04250350|454420897|FG000|Overall Study|Physician Decision|1|||
126308872|NCT04250350|454420897|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
126308873|NCT02836236|454420900|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
126308874|NCT02836236|454420901|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
126308875|NCT02836236|454420902|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
126308876|NCT02836236|454420903|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
126308877|NCT02836236|454420900|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
126047604|NCT00754065|453472875|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
126103979|NCT03756129|453673886|FG004|Overall Study|Physician Decision|0|||
126103980|NCT03756129|453673887|FG005|Overall Study|Physician Decision|1|||
126103981|NCT01315353|453673888|FG000|Overall Study|Death|2|||
126103982|NCT01315353|453673889|FG001|Overall Study|Death|1|||
126103983|NCT01315353|453673890|FG002|Overall Study|Death|0|||
126103984|NCT01315353|453673888|FG000|Overall Study|Withdrawal by Subject|2|||
126371592|NCT01276704|454658422|FG000|Overall Study|Physician Decision|3|||
126371593|NCT01276704|454658423|FG001|Overall Study|Physician Decision|5|||
126371594|NCT02276040|454658424|FG000|Overall Study|Physician Decision|15|||
126371595|NCT02239926|454658425|FG000|Overall Study|Withdrawal by Subject|0|||
126371596|NCT02239926|454658426|FG001|Overall Study|Withdrawal by Subject|1|||
126371597|NCT03801525|454658427|FG000|Overall Study|Adverse Event|17|||
126371598|NCT03801525|454658428|FG001|Overall Study|Adverse Event|1|||
126371599|NCT03801525|454658429|FG002|Overall Study|Adverse Event|0|||
126371600|NCT03801525|454658427|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
126371601|NCT03801525|454658428|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
126371602|NCT03801525|454658429|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
126371603|NCT03801525|454658427|FG000|Overall Study|Death|29|||
126371604|NCT03801525|454658428|FG001|Overall Study|Death|1|||
126371605|NCT03801525|454658429|FG002|Overall Study|Death|4|||
126371606|NCT03801525|454658427|FG000|Overall Study|Disease Progression|6|||
126371607|NCT03801525|454658428|FG001|Overall Study|Disease Progression|0|||
126371608|NCT03801525|454658429|FG002|Overall Study|Disease Progression|1|||
126371609|NCT03801525|454658427|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
126371610|NCT03801525|454658428|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
126371611|NCT03801525|454658429|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
126371612|NCT03801525|454658427|FG000|Overall Study|Investigator Decision|18|||
126371613|NCT03801525|454658428|FG001|Overall Study|Investigator Decision|1|||
126371614|NCT03801525|454658429|FG002|Overall Study|Investigator Decision|0|||
126371615|NCT03801525|454658427|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
126371616|NCT03801525|454658428|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
126371617|NCT03801525|454658429|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
126371618|NCT03801525|454658427|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
126371619|NCT03801525|454658428|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
126371620|NCT03801525|454658429|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
126371621|NCT03801525|454658427|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
126371622|NCT03801525|454658428|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
126371623|NCT03801525|454658429|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
126371624|NCT03801525|454658427|FG000|Overall Study|Withdrawal of Subject Consent|38|||
126371625|NCT03801525|454658428|FG001|Overall Study|Withdrawal of Subject Consent|2|||
126371626|NCT03801525|454658429|FG002|Overall Study|Withdrawal of Subject Consent|1|||
126371627|NCT03801525|454658427|FG000|Overall Study|Reason not Specified|4|||
126371628|NCT03801525|454658428|FG001|Overall Study|Reason not Specified|0|||
126371629|NCT03801525|454658429|FG002|Overall Study|Reason not Specified|4|||
126371630|NCT04388826|454658433|FG000|Overall Study|Lost to Follow-up|3|||
126371631|NCT04388826|454658434|FG001|Overall Study|Lost to Follow-up|2|||
126371632|NCT04388826|454658433|FG000|Overall Study|Adverse Event|1|||
126371633|NCT04388826|454658434|FG001|Overall Study|Adverse Event|0|||
126371634|NCT00329420|454658435|FG000|Re-induction Phase|Lack of Efficacy|0|||
126371635|NCT00329420|454658436|FG001|Re-induction Phase|Lack of Efficacy|1|||
126371636|NCT00329420|454658437|FG002|Re-induction Phase|Lack of Efficacy|0|||
126371637|NCT00329420|454658435|FG000|Re-induction Phase|Withdrawal of Consent|0|||
126371638|NCT00329420|454658436|FG001|Re-induction Phase|Withdrawal of Consent|0|||
126371639|NCT00329420|454658437|FG002|Re-induction Phase|Withdrawal of Consent|1|||
126371640|NCT00329420|454658435|FG000|Re-induction Phase|Did not respond to re-induction|6|||
126371641|NCT00329420|454658436|FG001|Re-induction Phase|Did not respond to re-induction|5|||
126371642|NCT00329420|454658437|FG002|Re-induction Phase|Did not respond to re-induction|7|||
126371643|NCT00329420|454658435|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
126371644|NCT00329420|454658436|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
126371645|NCT00329420|454658437|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
126371646|NCT00329420|454658435|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
126371647|NCT00329420|454658436|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
126371648|NCT00329420|454658437|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
126371649|NCT00329420|454658435|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
126371650|NCT00329420|454658436|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
126371651|NCT00329420|454658437|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
126371652|NCT02862574|454658438|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126371653|NCT02862574|454658439|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126371654|NCT02862574|454658440|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126371655|NCT02862574|454658438|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
126371656|NCT02862574|454658439|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
126371657|NCT02862574|454658440|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
126371658|NCT02862574|454658438|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
125885782|NCT00892099|452878828|FG001|Overall Study|Prolonged hospitalization|0|||
126371659|NCT02862574|454658439|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
126371660|NCT02862574|454658440|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
126371661|NCT00320606|454658450|FG000|Overall Study|Adverse Event|1|||
126371662|NCT00320606|454658450|FG000|Overall Study|Protocol Violation|1|||
126371663|NCT00320606|454658450|FG000|Overall Study|Withdrawal by Subject|1|||
126371664|NCT03984825|454658451|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
126371665|NCT03984825|454658451|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
126371666|NCT03984825|454658451|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
126371667|NCT00399035|454658454|FG000|Overall Study|Death|289|||
126371668|NCT00399035|454658455|FG001|Overall Study|Death|141|||
126371669|NCT00399035|454658456|FG002|Overall Study|Death|234|||
126371670|NCT00399035|454658454|FG000|Overall Study|Lost to Follow-up|2|||
126371671|NCT00399035|454658455|FG001|Overall Study|Lost to Follow-up|1|||
126371672|NCT00399035|454658456|FG002|Overall Study|Lost to Follow-up|5|||
126371673|NCT00399035|454658454|FG000|Overall Study|Withdrawal by Subject|19|||
126371674|NCT00399035|454658455|FG001|Overall Study|Withdrawal by Subject|15|||
126371675|NCT00399035|454658456|FG002|Overall Study|Withdrawal by Subject|12|||
126371676|NCT00399035|454658454|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
126371677|NCT00399035|454658455|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
126371678|NCT00399035|454658456|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
126371679|NCT00399035|454658454|FG000|Overall Study|Severe non-compliance with protocol|2|||
126371680|NCT00399035|454658455|FG001|Overall Study|Severe non-compliance with protocol|1|||
126371681|NCT00399035|454658456|FG002|Overall Study|Severe non-compliance with protocol|0|||
126371682|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Adverse Event|6|||
126371683|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Adverse Event|15|||
126371684|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Adverse Event|0|||
126371685|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Death|0|||
126371686|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Death|2|||
126371687|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Death|0|||
126371688|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
126371689|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
126371690|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
126371691|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
126371692|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
126371693|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
126371694|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Physician Decision|1|||
126371695|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Physician Decision|1|||
126371696|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Physician Decision|0|||
126371697|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
126371698|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
126371699|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
126371700|NCT02921256|454658465|FG000|Arm Ib v Arm III|Adverse Event|9|||
126371701|NCT02921256|454658466|FG001|Arm Ib v Arm III|Adverse Event|0|||
126371702|NCT02921256|454658467|FG002|Arm Ib v Arm III|Adverse Event|4|||
126371703|NCT02921256|454658465|FG000|Arm Ib v Arm III|Death|1|||
126371704|NCT02921256|454658466|FG001|Arm Ib v Arm III|Death|0|||
126371705|NCT02921256|454658467|FG002|Arm Ib v Arm III|Death|1|||
126371706|NCT02921256|454658465|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
126371707|NCT02921256|454658466|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
126371708|NCT02921256|454658467|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
126371709|NCT02921256|454658465|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
126371710|NCT02921256|454658466|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
126371711|NCT02921256|454658467|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
126371712|NCT02921256|454658465|FG000|Arm Ib v Arm III|Physician Decision|4|||
126371713|NCT02921256|454658466|FG001|Arm Ib v Arm III|Physician Decision|0|||
126371714|NCT02921256|454658467|FG002|Arm Ib v Arm III|Physician Decision|1|||
126371715|NCT02921256|454658465|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
126371716|NCT02921256|454658466|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
126371717|NCT02921256|454658467|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
126371718|NCT02943473|454658468|FG000|Overall Study|enrolled but not dosed|1|||
126371719|NCT02943473|454658468|FG000|Overall Study|screen failure|1|||
126200427|NCT00545740|454019444|FG002|Overall Study|Lack of time|0|||
126371720|NCT02943473|454658468|FG000|Overall Study|Physician Decision|4|||
126371721|NCT04211363|454658469|FG000|Overall Study|Adverse Event|5|||
126371722|NCT04211363|454658470|FG001|Overall Study|Adverse Event|2|||
126371723|NCT04211363|454658469|FG000|Overall Study|Physician Decision|0|||
126371724|NCT04211363|454658470|FG001|Overall Study|Physician Decision|1|||
126371725|NCT04211363|454658469|FG000|Overall Study|Protocol Violation|1|||
126371726|NCT04211363|454658470|FG001|Overall Study|Protocol Violation|0|||
126371727|NCT04211363|454658469|FG000|Overall Study|Pregnancy|1|||
126371728|NCT04211363|454658470|FG001|Overall Study|Pregnancy|0|||
126371729|NCT04211363|454658469|FG000|Overall Study|Lost to Follow-up|12|||
126371730|NCT04211363|454658470|FG001|Overall Study|Lost to Follow-up|4|||
126371731|NCT04211363|454658469|FG000|Overall Study|Withdrawal by Subject|11|||
126371732|NCT04211363|454658470|FG001|Overall Study|Withdrawal by Subject|11|||
126371733|NCT04211363|454658469|FG000|Overall Study|Other|1|||
126371734|NCT04211363|454658470|FG001|Overall Study|Other|2|||
126371735|NCT03097289|454658471|FG000|Overall Study|Adverse Event|1|||
126371736|NCT03097289|454658471|FG000|Overall Study|Equipment failure|2|||
125885783|NCT00892099|452878829|FG002|Overall Study|Prolonged hospitalization|1|||
125885784|NCT00892099|452878827|FG000|Overall Study|no further details|1|||
125885785|NCT00892099|452878828|FG001|Overall Study|no further details|0|||
126371737|NCT03097289|454658471|FG000|Overall Study|Collected platelet product unusable|3|||
126371738|NCT01736917|454658472|FG000|Overall Study|Adverse Event|1|||
126371739|NCT01736917|454658472|FG000|Overall Study|Protocol Violation|10|||
126371740|NCT01911260|454658473|FG000|Supplementation Period|transference or evasion of school|7|||
126371741|NCT01911260|454658474|FG001|Supplementation Period|transference or evasion of school|9|||
126371742|NCT01911260|454658475|FG002|Supplementation Period|transference or evasion of school|7|||
125885786|NCT00892099|452878829|FG002|Overall Study|no further details|1|||
125885787|NCT00892099|452878827|FG000|Overall Study|kidney function recovered|0|||
125885788|NCT00892099|452878828|FG001|Overall Study|kidney function recovered|1|||
125885789|NCT00892099|452878829|FG002|Overall Study|kidney function recovered|0|||
125885790|NCT00892099|452878827|FG000|Overall Study|investigator decision|0|||
125885791|NCT00892099|452878828|FG001|Overall Study|investigator decision|0|||
125885792|NCT00892099|452878829|FG002|Overall Study|investigator decision|1|||
125885793|NCT00892099|452878827|FG000|Overall Study|Lost to Follow-up|0|||
125885794|NCT00892099|452878828|FG001|Overall Study|Lost to Follow-up|0|||
126308878|NCT02836236|454420901|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
126371743|NCT01911260|454658476|FG003|Supplementation Period|transference or evasion of school|6|||
126371744|NCT01911260|454658473|FG000|Supplementation Period|Adverse Event|2|||
126371745|NCT01911260|454658474|FG001|Supplementation Period|Adverse Event|0|||
126371746|NCT01911260|454658475|FG002|Supplementation Period|Adverse Event|1|||
126371747|NCT01911260|454658476|FG003|Supplementation Period|Adverse Event|0|||
126308879|NCT02836236|454420902|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
126308880|NCT02836236|454420903|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
126308881|NCT02836236|454420900|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126308882|NCT02836236|454420901|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
126308883|NCT02836236|454420902|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
126308884|NCT02836236|454420903|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126308885|NCT02836236|454420900|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
126308886|NCT02836236|454420901|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126308887|NCT02836236|454420902|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126308888|NCT02836236|454420903|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126308889|NCT02836236|454420900|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
126308890|NCT02836236|454420901|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
126308891|NCT02836236|454420902|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
126308892|NCT02836236|454420903|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
126308893|NCT02836236|454420900|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
126308894|NCT02836236|454420901|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
126308895|NCT02836236|454420902|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
126308896|NCT02836236|454420903|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
126308897|NCT02836236|454420900|FG000|Open-Label TAF Treatment Phase|Death|0|||
126308898|NCT02836236|454420901|FG001|Open-Label TAF Treatment Phase|Death|0|||
126308899|NCT02836236|454420902|FG002|Open-Label TAF Treatment Phase|Death|1|||
126308900|NCT02836236|454420903|FG003|Open-Label TAF Treatment Phase|Death|1|||
126308901|NCT02836236|454420900|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
126308902|NCT02836236|454420901|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
126308903|NCT02836236|454420902|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
126308904|NCT02836236|454420903|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
126371748|NCT01911260|454658473|FG000|Supplementation Period|refused to receive supplement|1|||
126371749|NCT01911260|454658474|FG001|Supplementation Period|refused to receive supplement|0|||
126371750|NCT01911260|454658475|FG002|Supplementation Period|refused to receive supplement|1|||
126371751|NCT01911260|454658476|FG003|Supplementation Period|refused to receive supplement|0|||
126371752|NCT01911260|454658473|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
126371753|NCT01911260|454658474|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
126371754|NCT01911260|454658475|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
126371755|NCT01911260|454658476|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
126371756|NCT01911260|454658473|FG000|Follow-up Period|transference or evasion of school|13|||
126371757|NCT01911260|454658474|FG001|Follow-up Period|transference or evasion of school|20|||
126371758|NCT01911260|454658475|FG002|Follow-up Period|transference or evasion of school|15|||
126371759|NCT01911260|454658476|FG003|Follow-up Period|transference or evasion of school|12|||
126371760|NCT01734902|454658479|FG000|Overall Study|Other than listed|0|||
126371761|NCT01734902|454658480|FG001|Overall Study|Other than listed|2|||
126371762|NCT01959932|454658481|FG000|Overall Study|Withdrawal by Subject|1|||
125885795|NCT00892099|452878829|FG002|Overall Study|Lost to Follow-up|1|||
126047605|NCT01074294|453472878|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
126047606|NCT01074294|453472879|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
125885796|NCT01657019|452878830|FG000|Overall Study|Withdrawal by Subject|65|||
125885797|NCT01657019|452878830|FG000|Overall Study|Adverse Event|55|||
125885798|NCT01657019|452878830|FG000|Overall Study|Lost to Follow-up|48|||
126308905|NCT01806961|454420904|FG000|Overall Study|sponsor decision|16|||
126308906|NCT00972816|454420906|FG000|Overall Study|Adverse Event|0|||
126308907|NCT00972816|454420907|FG001|Overall Study|Adverse Event|0|||
126308908|NCT00972816|454420908|FG002|Overall Study|Adverse Event|1|||
126308909|NCT00972816|454420909|FG003|Overall Study|Adverse Event|0|||
126308910|NCT00972816|454420910|FG004|Overall Study|Adverse Event|0|||
125885799|NCT01657019|452878830|FG000|Overall Study|Protocol Violation|6|||
126047607|NCT01074294|453472880|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
126047608|NCT01074294|453472881|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
126308911|NCT00972816|454420911|FG005|Overall Study|Adverse Event|0|||
126308912|NCT00972816|454420912|FG006|Overall Study|Adverse Event|0|||
126308913|NCT00972816|454420913|FG007|Overall Study|Adverse Event|0|||
126308914|NCT00972816|454420906|FG000|Overall Study|Withdrawal by Subject|4|||
126308915|NCT00972816|454420907|FG001|Overall Study|Withdrawal by Subject|2|||
126308916|NCT00972816|454420908|FG002|Overall Study|Withdrawal by Subject|1|||
126308917|NCT00972816|454420909|FG003|Overall Study|Withdrawal by Subject|3|||
126308918|NCT00972816|454420910|FG004|Overall Study|Withdrawal by Subject|0|||
126308919|NCT00972816|454420911|FG005|Overall Study|Withdrawal by Subject|1|||
126308920|NCT00972816|454420912|FG006|Overall Study|Withdrawal by Subject|1|||
126308921|NCT00972816|454420913|FG007|Overall Study|Withdrawal by Subject|2|||
126308922|NCT00972816|454420906|FG000|Overall Study|Lost to Follow-up|11|||
126308923|NCT00972816|454420907|FG001|Overall Study|Lost to Follow-up|9|||
126308924|NCT00972816|454420908|FG002|Overall Study|Lost to Follow-up|7|||
126308925|NCT00972816|454420909|FG003|Overall Study|Lost to Follow-up|5|||
126308926|NCT00972816|454420910|FG004|Overall Study|Lost to Follow-up|11|||
126308927|NCT00972816|454420911|FG005|Overall Study|Lost to Follow-up|10|||
126308928|NCT00972816|454420912|FG006|Overall Study|Lost to Follow-up|7|||
126308929|NCT00972816|454420913|FG007|Overall Study|Lost to Follow-up|7|||
126308930|NCT00972816|454420906|FG000|Overall Study|Inappropriate enrolment|0|||
126308931|NCT00972816|454420907|FG001|Overall Study|Inappropriate enrolment|0|||
126308932|NCT00972816|454420908|FG002|Overall Study|Inappropriate enrolment|0|||
126308933|NCT00972816|454420909|FG003|Overall Study|Inappropriate enrolment|0|||
126308934|NCT00972816|454420910|FG004|Overall Study|Inappropriate enrolment|0|||
126308935|NCT00972816|454420911|FG005|Overall Study|Inappropriate enrolment|0|||
126308936|NCT00972816|454420912|FG006|Overall Study|Inappropriate enrolment|2|||
126308937|NCT00972816|454420913|FG007|Overall Study|Inappropriate enrolment|0|||
126308938|NCT00972816|454420906|FG000|Overall Study|Unable to classify|2|||
126308939|NCT00972816|454420907|FG001|Overall Study|Unable to classify|0|||
126308940|NCT00972816|454420908|FG002|Overall Study|Unable to classify|0|||
126308941|NCT00972816|454420909|FG003|Overall Study|Unable to classify|0|||
126308942|NCT00972816|454420910|FG004|Overall Study|Unable to classify|1|||
126308943|NCT00972816|454420911|FG005|Overall Study|Unable to classify|0|||
126308944|NCT00972816|454420912|FG006|Overall Study|Unable to classify|0|||
126308945|NCT00972816|454420913|FG007|Overall Study|Unable to classify|0|||
126308946|NCT05318092|454420917|FG000|Overall Study|Lost to Follow-up|3|||
126308947|NCT05318092|454420917|FG000|Overall Study|Withdrawal by Subject|1|||
126308948|NCT03917472|454420918|FG000|Overall Study|Physician Decision|4|||
126371763|NCT01959932|454658482|FG001|Overall Study|Withdrawal by Subject|0|||
126371764|NCT01959932|454658483|FG002|Overall Study|Withdrawal by Subject|0|||
126371765|NCT00060944|454658486|FG000|Overall Study|Adverse Event|12|||
126371766|NCT00060944|454658487|FG001|Overall Study|Adverse Event|10|||
126371767|NCT00060944|454658486|FG000|Overall Study|Death|2|||
126371768|NCT00060944|454658487|FG001|Overall Study|Death|3|||
126371769|NCT00060944|454658486|FG000|Overall Study|Withdrawal by Subject|18|||
126371770|NCT00060944|454658487|FG001|Overall Study|Withdrawal by Subject|5|||
126371771|NCT00060944|454658486|FG000|Overall Study|Disease Progression|93|||
126371772|NCT00060944|454658487|FG001|Overall Study|Disease Progression|94|||
126371773|NCT00060944|454658486|FG000|Overall Study|Lost to Follow-up|1|||
126371774|NCT00060944|454658487|FG001|Overall Study|Lost to Follow-up|0|||
126371775|NCT00060944|454658486|FG000|Overall Study|Subject Ineligible To Continue|2|||
126371776|NCT00060944|454658487|FG001|Overall Study|Subject Ineligible To Continue|1|||
126371777|NCT00060944|454658486|FG000|Overall Study|Treatment Switch|0|||
126371778|NCT00060944|454658487|FG001|Overall Study|Treatment Switch|13|||
126371779|NCT00060944|454658486|FG000|Overall Study|Other|2|||
126371780|NCT00060944|454658487|FG001|Overall Study|Other|4|||
126371781|NCT00060944|454658486|FG000|Overall Study|randomized but not treated|6|||
126371782|NCT00060944|454658487|FG001|Overall Study|randomized but not treated|4|||
126371783|NCT00776230|454658491|FG000|Overall Study|Lost to Follow-up|2|||
126371784|NCT00776230|454658492|FG001|Overall Study|Lost to Follow-up|1|||
126371785|NCT00776230|454658493|FG002|Overall Study|Lost to Follow-up|5|||
126371786|NCT00776230|454658491|FG000|Overall Study|Not vaccinated at Day 0|1|||
126371787|NCT00776230|454658492|FG001|Overall Study|Not vaccinated at Day 0|0|||
126371788|NCT00776230|454658493|FG002|Overall Study|Not vaccinated at Day 0|0|||
126371789|NCT00776230|454658491|FG000|Overall Study|Withdrawal by Subject|0|||
125885800|NCT01657019|452878830|FG000|Overall Study|Lack of Efficacy|3|||
125885801|NCT01657019|452878830|FG000|Overall Study|Other|58|||
126103985|NCT01315353|453673889|FG001|Overall Study|Withdrawal by Subject|6|||
126103986|NCT01315353|453673890|FG002|Overall Study|Withdrawal by Subject|1|||
126103987|NCT01315353|453673888|FG000|Overall Study|Lost to Follow-up|13|||
126103988|NCT01315353|453673889|FG001|Overall Study|Lost to Follow-up|6|||
126371790|NCT00776230|454658492|FG001|Overall Study|Withdrawal by Subject|1|||
126371791|NCT00776230|454658493|FG002|Overall Study|Withdrawal by Subject|0|||
126371792|NCT00776230|454658491|FG000|Overall Study|Subject missed Visit 4|0|||
126371793|NCT00776230|454658492|FG001|Overall Study|Subject missed Visit 4|1|||
125885802|NCT00998296|452878833|FG000|Overall Study|Progressive disease|0|||
126371794|NCT00776230|454658493|FG002|Overall Study|Subject missed Visit 4|0|||
126371795|NCT01242514|454658495|FG000|Overall Study|e.g., project closure|1042|||
126371796|NCT01242514|454658496|FG001|Overall Study|e.g., project closure|305|||
126371797|NCT01242514|454658497|FG002|Overall Study|e.g., project closure|171|||
126371798|NCT01242514|454658495|FG000|Overall Study|Subject decision|33|||
126371799|NCT01242514|454658496|FG001|Overall Study|Subject decision|8|||
126371800|NCT01242514|454658497|FG002|Overall Study|Subject decision|2|||
126371801|NCT01242514|454658495|FG000|Overall Study|Severe non-compliance to protocol|5|||
126371802|NCT01242514|454658496|FG001|Overall Study|Severe non-compliance to protocol|2|||
126371803|NCT01242514|454658497|FG002|Overall Study|Severe non-compliance to protocol|1|||
126371804|NCT01242514|454658495|FG000|Overall Study|Lack of therapeutic response|99|||
126371805|NCT01242514|454658496|FG001|Overall Study|Lack of therapeutic response|16|||
126371806|NCT01242514|454658497|FG002|Overall Study|Lack of therapeutic response|10|||
126371807|NCT01242514|454658495|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
126371808|NCT01242514|454658496|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
126371809|NCT01242514|454658497|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
126371810|NCT01242514|454658495|FG000|Overall Study|Lost to Follow-up|14|||
126371811|NCT01242514|454658496|FG001|Overall Study|Lost to Follow-up|5|||
126371812|NCT01242514|454658497|FG002|Overall Study|Lost to Follow-up|4|||
126371813|NCT01242514|454658495|FG000|Overall Study|Adverse Event|129|||
126371814|NCT01242514|454658496|FG001|Overall Study|Adverse Event|18|||
126371815|NCT01242514|454658497|FG002|Overall Study|Adverse Event|19|||
126371816|NCT03213509|454658511|FG000|Overall Study|Did not consent for verbal autopsy|4|||
126371817|NCT03213509|454658512|FG001|Overall Study|Did not consent for verbal autopsy|5|||
126371818|NCT04549454|454658515|FG000|T1 to T2|Lost to Follow-up|22|||
126371819|NCT04549454|454658516|FG001|T1 to T2|Lost to Follow-up|26|||
126371820|NCT04549454|454658515|FG000|T1 to T3|Lost to Follow-up|31|||
126371821|NCT04549454|454658516|FG001|T1 to T3|Lost to Follow-up|36|||
126371822|NCT00016354|454658517|FG000|Overall Study|Lack of Efficacy|0|||
126371823|NCT00016354|454658518|FG001|Overall Study|Lack of Efficacy|0|||
126371824|NCT00016354|454658519|FG002|Overall Study|Lack of Efficacy|0|||
126371825|NCT00016354|454658520|FG003|Overall Study|Lack of Efficacy|0|||
126371826|NCT00016354|454658521|FG004|Overall Study|Lack of Efficacy|0|||
126371827|NCT00016354|454658522|FG005|Overall Study|Lack of Efficacy|0|||
126371828|NCT00016354|454658523|FG006|Overall Study|Lack of Efficacy|0|||
126371829|NCT00016354|454658524|FG007|Overall Study|Lack of Efficacy|1|||
126371830|NCT03110562|454658525|FG000|Initial Treatment Period|Disease Progression|1|||
126371831|NCT03110562|454658526|FG001|Initial Treatment Period|Disease Progression|1|||
126371832|NCT03110562|454658527|FG002|Initial Treatment Period|Disease Progression|0|||
126371833|NCT03110562|454658528|FG003|Initial Treatment Period|Disease Progression|0|||
126371834|NCT03110562|454658525|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
126371835|NCT03110562|454658526|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
126371836|NCT03110562|454658527|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
126371837|NCT03110562|454658528|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
126371838|NCT03110562|454658525|FG000|Initial Treatment Period|Adverse Event|1|||
126371839|NCT03110562|454658526|FG001|Initial Treatment Period|Adverse Event|0|||
126371840|NCT03110562|454658527|FG002|Initial Treatment Period|Adverse Event|0|||
126371841|NCT03110562|454658528|FG003|Initial Treatment Period|Adverse Event|0|||
126371842|NCT03110562|454658525|FG000|Initial Treatment Period|Death|74|||
126371843|NCT03110562|454658526|FG001|Initial Treatment Period|Death|82|||
126371844|NCT03110562|454658527|FG002|Initial Treatment Period|Death|0|||
126371845|NCT03110562|454658528|FG003|Initial Treatment Period|Death|0|||
126371846|NCT03110562|454658525|FG000|Initial Treatment Period|Lost to Follow-up|13|||
126371847|NCT03110562|454658526|FG001|Initial Treatment Period|Lost to Follow-up|8|||
126371848|NCT03110562|454658527|FG002|Initial Treatment Period|Lost to Follow-up|0|||
126371849|NCT03110562|454658528|FG003|Initial Treatment Period|Lost to Follow-up|0|||
126371850|NCT03110562|454658525|FG000|Initial Treatment Period|Protocol Deviation|1|||
126088960|NCT01399697|453620040|FG001|Overall Study|Lost to Follow-up|0|||
126371851|NCT03110562|454658526|FG001|Initial Treatment Period|Protocol Deviation|0|||
126371852|NCT03110562|454658527|FG002|Initial Treatment Period|Protocol Deviation|0|||
126371853|NCT03110562|454658528|FG003|Initial Treatment Period|Protocol Deviation|0|||
126371854|NCT03110562|454658525|FG000|Initial Treatment Period|Physician Decision|2|||
126371855|NCT03110562|454658526|FG001|Initial Treatment Period|Physician Decision|1|||
126371856|NCT03110562|454658527|FG002|Initial Treatment Period|Physician Decision|0|||
126371857|NCT03110562|454658528|FG003|Initial Treatment Period|Physician Decision|0|||
126371858|NCT03110562|454658525|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
126371859|NCT03110562|454658526|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
126371860|NCT03110562|454658527|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
126371861|NCT03110562|454658528|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
126371862|NCT03110562|454658525|FG000|Initial Treatment Period|Other|5|||
126371863|NCT03110562|454658526|FG001|Initial Treatment Period|Other|4|||
126371864|NCT03110562|454658527|FG002|Initial Treatment Period|Other|0|||
126371865|NCT03110562|454658528|FG003|Initial Treatment Period|Other|0|||
126371866|NCT03110562|454658525|FG000|Initial Treatment Period|Randomized but never treated|0|||
126371867|NCT03110562|454658526|FG001|Initial Treatment Period|Randomized but never treated|3|||
126371868|NCT03110562|454658527|FG002|Initial Treatment Period|Randomized but never treated|0|||
126371869|NCT03110562|454658528|FG003|Initial Treatment Period|Randomized but never treated|0|||
126371870|NCT03110562|454658525|FG000|Crossover Period|Disease Progression|0|||
126371871|NCT03110562|454658526|FG001|Crossover Period|Disease Progression|0|||
126371872|NCT03110562|454658527|FG002|Crossover Period|Disease Progression|1|||
126371873|NCT03110562|454658528|FG003|Crossover Period|Disease Progression|0|||
126371874|NCT03110562|454658525|FG000|Crossover Period|Withdrawal by Subject|0|||
126371875|NCT03110562|454658526|FG001|Crossover Period|Withdrawal by Subject|0|||
126371876|NCT03110562|454658527|FG002|Crossover Period|Withdrawal by Subject|8|||
126371877|NCT03110562|454658528|FG003|Crossover Period|Withdrawal by Subject|6|||
126371878|NCT03110562|454658525|FG000|Crossover Period|Death|0|||
126371879|NCT03110562|454658526|FG001|Crossover Period|Death|0|||
126371880|NCT03110562|454658527|FG002|Crossover Period|Death|37|||
126371881|NCT03110562|454658528|FG003|Crossover Period|Death|3|||
126371882|NCT03110562|454658525|FG000|Crossover Period|Lost to Follow-up|0|||
126371883|NCT03110562|454658526|FG001|Crossover Period|Lost to Follow-up|0|||
126371884|NCT03110562|454658527|FG002|Crossover Period|Lost to Follow-up|0|||
126371885|NCT03110562|454658528|FG003|Crossover Period|Lost to Follow-up|1|||
126371886|NCT03110562|454658525|FG000|Crossover Period|Other|0|||
126371887|NCT03110562|454658526|FG001|Crossover Period|Other|0|||
126371888|NCT03110562|454658527|FG002|Crossover Period|Other|1|||
126371889|NCT03110562|454658528|FG003|Crossover Period|Other|1|||
126371890|NCT03110562|454658525|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
126371891|NCT03110562|454658526|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
126371892|NCT03110562|454658527|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
126371893|NCT03110562|454658528|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
126371894|NCT02936323|454658531|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371895|NCT02936323|454658532|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
126371896|NCT02936323|454658533|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371897|NCT02936323|454658534|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
126371898|NCT02936323|454658535|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
126371899|NCT02936323|454658536|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
126371900|NCT02936323|454658537|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371901|NCT02936323|454658538|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371902|NCT02936323|454658539|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371903|NCT02936323|454658540|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371904|NCT02936323|454658531|FG000|Phase 1 Dose Escalation|Death|2|||
126371905|NCT02936323|454658532|FG001|Phase 1 Dose Escalation|Death|1|||
126047609|NCT01074294|453472878|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
126047610|NCT01074294|453472879|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
126047611|NCT01074294|453472880|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
126371906|NCT02936323|454658533|FG002|Phase 1 Dose Escalation|Death|3|||
126371907|NCT02936323|454658534|FG003|Phase 1 Dose Escalation|Death|1|||
126371908|NCT02936323|454658535|FG004|Phase 1 Dose Escalation|Death|2|||
126371909|NCT02936323|454658536|FG005|Phase 1 Dose Escalation|Death|3|||
126371910|NCT02936323|454658537|FG006|Phase 1 Dose Escalation|Death|3|||
126371911|NCT02936323|454658538|FG007|Phase 1 Dose Escalation|Death|0|||
126371912|NCT02936323|454658539|FG008|Phase 1 Dose Escalation|Death|0|||
126371913|NCT02936323|454658540|FG009|Phase 1 Dose Escalation|Death|0|||
126371914|NCT02936323|454658531|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371915|NCT02936323|454658532|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371916|NCT02936323|454658533|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371917|NCT02936323|454658534|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371918|NCT02936323|454658535|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126088961|NCT01399697|453620041|FG002|Overall Study|Lost to Follow-up|0|||
126103989|NCT01315353|453673890|FG002|Overall Study|Lost to Follow-up|6|||
126308949|NCT03917472|454420919|FG001|Overall Study|Physician Decision|0|||
126308950|NCT03917472|454420918|FG000|Overall Study|Adverse Event|3|||
126308951|NCT03917472|454420919|FG001|Overall Study|Adverse Event|1|||
126308952|NCT03917472|454420918|FG000|Overall Study|Death|7|||
126308953|NCT03917472|454420919|FG001|Overall Study|Death|5|||
126308954|NCT03917472|454420918|FG000|Overall Study|Withdrawal by Subject|11|||
126308955|NCT03917472|454420919|FG001|Overall Study|Withdrawal by Subject|4|||
126308956|NCT03917472|454420918|FG000|Overall Study|Lost to Follow-up|10|||
126308957|NCT03917472|454420919|FG001|Overall Study|Lost to Follow-up|5|||
126308958|NCT04434469|454420920|FG000|Overall Study|Death|2|||
126308959|NCT04434469|454420921|FG001|Overall Study|Death|3|||
126308960|NCT04434469|454420922|FG002|Overall Study|Death|2|||
126308961|NCT04434469|454420923|FG003|Overall Study|Death|2|||
126308962|NCT04434469|454420924|FG004|Overall Study|Death|2|||
126308963|NCT04434469|454420925|FG005|Overall Study|Death|0|||
126308964|NCT04434469|454420920|FG000|Overall Study|Lost to Follow-up|0|||
126308965|NCT04434469|454420921|FG001|Overall Study|Lost to Follow-up|0|||
126308966|NCT04434469|454420922|FG002|Overall Study|Lost to Follow-up|0|||
126308967|NCT04434469|454420923|FG003|Overall Study|Lost to Follow-up|1|||
126308968|NCT04434469|454420924|FG004|Overall Study|Lost to Follow-up|1|||
126308969|NCT04434469|454420925|FG005|Overall Study|Lost to Follow-up|0|||
126308970|NCT04434469|454420920|FG000|Overall Study|Study terminated by sponsor|1|||
126308971|NCT04434469|454420921|FG001|Overall Study|Study terminated by sponsor|1|||
126308972|NCT04434469|454420922|FG002|Overall Study|Study terminated by sponsor|1|||
126308973|NCT04434469|454420923|FG003|Overall Study|Study terminated by sponsor|2|||
126308974|NCT04434469|454420924|FG004|Overall Study|Study terminated by sponsor|3|||
126308975|NCT04434469|454420925|FG005|Overall Study|Study terminated by sponsor|3|||
126308976|NCT04434469|454420920|FG000|Overall Study|Withdrawal by Subject|0|||
126308977|NCT04434469|454420921|FG001|Overall Study|Withdrawal by Subject|0|||
126308978|NCT04434469|454420922|FG002|Overall Study|Withdrawal by Subject|1|||
126308979|NCT04434469|454420923|FG003|Overall Study|Withdrawal by Subject|0|||
126308980|NCT04434469|454420924|FG004|Overall Study|Withdrawal by Subject|0|||
126308981|NCT04434469|454420925|FG005|Overall Study|Withdrawal by Subject|0|||
126308982|NCT01953601|454420929|FG000|Part 1 (Base Study)|Adverse Event|24|||
126308983|NCT01953601|454420930|FG001|Part 1 (Base Study)|Adverse Event|37|||
126308984|NCT01953601|454420931|FG002|Part 1 (Base Study)|Adverse Event|15|||
126308985|NCT01953601|454420929|FG000|Part 1 (Base Study)|Death|2|||
126308986|NCT01953601|454420930|FG001|Part 1 (Base Study)|Death|0|||
126308987|NCT01953601|454420931|FG002|Part 1 (Base Study)|Death|3|||
126308988|NCT01953601|454420929|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
126308989|NCT01953601|454420930|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
126308990|NCT01953601|454420931|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
126308991|NCT01953601|454420929|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
126103990|NCT01315353|453673888|FG000|Overall Study|Unwilling to adhere to requirements|5|||
126371919|NCT02936323|454658536|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
126371920|NCT02936323|454658537|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371921|NCT02936323|454658538|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371922|NCT02936323|454658539|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371923|NCT02936323|454658540|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371924|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371925|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371926|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371927|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371928|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371929|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371930|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371931|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
126371932|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
126371933|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
126371934|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
126371935|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
126371936|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
126371937|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
126371938|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
126371939|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
126371940|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
126371941|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
126371942|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
126103991|NCT01315353|453673889|FG001|Overall Study|Unwilling to adhere to requirements|5|||
126103992|NCT01315353|453673890|FG002|Overall Study|Unwilling to adhere to requirements|4|||
126103993|NCT01315353|453673888|FG000|Overall Study|Site closing|7|||
126103994|NCT01315353|453673889|FG001|Overall Study|Site closing|4|||
126371943|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
126371944|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371945|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126308992|NCT01953601|454420930|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
126308993|NCT01953601|454420931|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
126308994|NCT01953601|454420929|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
126308995|NCT01953601|454420930|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
126308996|NCT01953601|454420931|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
126308997|NCT01953601|454420929|FG000|Part 1 (Base Study)|Physician Decision|3|||
126308998|NCT01953601|454420930|FG001|Part 1 (Base Study)|Physician Decision|7|||
126308999|NCT01953601|454420931|FG002|Part 1 (Base Study)|Physician Decision|4|||
126309000|NCT01953601|454420929|FG000|Part 1 (Base Study)|Screen failure|1|||
126309001|NCT01953601|454420930|FG001|Part 1 (Base Study)|Screen failure|0|||
126309002|NCT01953601|454420931|FG002|Part 1 (Base Study)|Screen failure|1|||
126309003|NCT01953601|454420929|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
126309004|NCT01953601|454420930|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
126309005|NCT01953601|454420931|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
126309006|NCT01953601|454420929|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
126309007|NCT01953601|454420930|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
126309008|NCT01953601|454420931|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
126309009|NCT01953601|454420929|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
126309010|NCT01953601|454420930|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
126371946|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371947|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371948|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371949|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371950|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371951|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
126371952|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
126371953|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371954|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371955|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371956|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371957|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371958|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371959|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371960|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371961|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371962|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371963|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
126371964|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Death|0|||
126371965|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Death|0|||
126371966|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Death|0|||
126371967|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Death|0|||
126371968|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Death|0|||
126371969|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Death|0|||
126371970|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Death|0|||
126371971|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Death|4|||
126371972|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Death|8|||
126371973|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Death|10|||
126371974|NCT05788991|454658541|FG000|Overall Study|Not treated with study medication|1|||
126371975|NCT05788991|454658542|FG001|Overall Study|Not treated with study medication|3|||
126371976|NCT05788991|454658541|FG000|Overall Study|Withdrawal by Subject|1|||
126371977|NCT05788991|454658542|FG001|Overall Study|Withdrawal by Subject|0|||
126371978|NCT05788991|454658541|FG000|Overall Study|Lack of Efficacy|0|||
126371979|NCT05788991|454658542|FG001|Overall Study|Lack of Efficacy|1|||
126371980|NCT05788991|454658541|FG000|Overall Study|Protocol Violation|1|||
126371981|NCT05788991|454658542|FG001|Overall Study|Protocol Violation|2|||
126371982|NCT05270863|454658543|FG000|Visit 2 First Intervention|Randomization error|0|||
126371983|NCT05270863|454658544|FG001|Visit 2 First Intervention|Randomization error|0|||
125885803|NCT00998296|452878834|FG001|Overall Study|Progressive disease|1|||
125885804|NCT00998296|452878835|FG002|Overall Study|Progressive disease|0|||
125885805|NCT00998296|452878836|FG003|Overall Study|Progressive disease|0|||
125885806|NCT00998296|452878837|FG004|Overall Study|Progressive disease|0|||
125885807|NCT00998296|452878838|FG005|Overall Study|Progressive disease|0|||
125885808|NCT00998296|452878839|FG006|Overall Study|Progressive disease|1|||
125885809|NCT00998296|452878840|FG007|Overall Study|Progressive disease|0|||
125885810|NCT00998296|452878841|FG008|Overall Study|Progressive disease|0|||
125885811|NCT00998296|452878842|FG009|Overall Study|Progressive disease|14|||
125885812|NCT00998296|452878843|FG010|Overall Study|Progressive disease|5|||
125885813|NCT00998296|452878833|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
125885814|NCT00998296|452878834|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
125885815|NCT00998296|452878835|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
125885816|NCT00998296|452878836|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
126103995|NCT01315353|453673890|FG002|Overall Study|Site closing|0|||
126371984|NCT05270863|454658545|FG002|Visit 2 First Intervention|Randomization error|0|||
126371985|NCT05270863|454658546|FG003|Visit 2 First Intervention|Randomization error|1|||
126371986|NCT05270863|454658547|FG004|Visit 2 First Intervention|Randomization error|0|||
126371987|NCT05270863|454658548|FG005|Visit 2 First Intervention|Randomization error|0|||
126371988|NCT05270863|454658543|FG000|First Washout|Withdrawal by Subject|0|||
126371989|NCT05270863|454658544|FG001|First Washout|Withdrawal by Subject|0|||
126371990|NCT05270863|454658545|FG002|First Washout|Withdrawal by Subject|0|||
126371991|NCT05270863|454658546|FG003|First Washout|Withdrawal by Subject|0|||
126371992|NCT05270863|454658547|FG004|First Washout|Withdrawal by Subject|1|||
126371993|NCT05270863|454658548|FG005|First Washout|Withdrawal by Subject|1|||
126371994|NCT05270863|454658543|FG000|First Washout|Lost to Follow-up|0|||
126371995|NCT05270863|454658544|FG001|First Washout|Lost to Follow-up|0|||
126371996|NCT05270863|454658545|FG002|First Washout|Lost to Follow-up|0|||
126371997|NCT05270863|454658546|FG003|First Washout|Lost to Follow-up|0|||
126371998|NCT05270863|454658547|FG004|First Washout|Lost to Follow-up|0|||
126371999|NCT05270863|454658548|FG005|First Washout|Lost to Follow-up|1|||
126372000|NCT05270863|454658543|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
126372001|NCT05270863|454658544|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
126372002|NCT05270863|454658545|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
126372003|NCT05270863|454658546|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
126372004|NCT05270863|454658547|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
126372005|NCT05270863|454658548|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
126372006|NCT05270863|454658543|FG000|Second Washout|Withdrawal by Subject|1|||
126372007|NCT05270863|454658544|FG001|Second Washout|Withdrawal by Subject|1|||
126372008|NCT05270863|454658545|FG002|Second Washout|Withdrawal by Subject|0|||
126372009|NCT05270863|454658546|FG003|Second Washout|Withdrawal by Subject|0|||
126372010|NCT05270863|454658547|FG004|Second Washout|Withdrawal by Subject|0|||
126372011|NCT05270863|454658548|FG005|Second Washout|Withdrawal by Subject|0|||
126372012|NCT05270863|454658543|FG000|Second Washout|Lost to Follow-up|0|||
126372013|NCT05270863|454658544|FG001|Second Washout|Lost to Follow-up|0|||
126372014|NCT05270863|454658545|FG002|Second Washout|Lost to Follow-up|0|||
126372015|NCT05270863|454658546|FG003|Second Washout|Lost to Follow-up|1|||
126372016|NCT05270863|454658547|FG004|Second Washout|Lost to Follow-up|0|||
126372017|NCT05270863|454658548|FG005|Second Washout|Lost to Follow-up|0|||
126372018|NCT04464473|454658549|FG000|Overall Study|New piercing could not be removed for scanning|0|||
126372019|NCT04464473|454658550|FG001|Overall Study|New piercing could not be removed for scanning|0|||
126372020|NCT04464473|454658551|FG002|Overall Study|New piercing could not be removed for scanning|0|||
126372021|NCT04464473|454658552|FG003|Overall Study|New piercing could not be removed for scanning|1|||
126372022|NCT04464473|454658553|FG004|Overall Study|New piercing could not be removed for scanning|0|||
126372023|NCT04464473|454658554|FG005|Overall Study|New piercing could not be removed for scanning|0|||
126372024|NCT04464473|454658549|FG000|Overall Study|Adverse Event|0|||
126372025|NCT04464473|454658550|FG001|Overall Study|Adverse Event|0|||
126372026|NCT04464473|454658551|FG002|Overall Study|Adverse Event|0|||
126372027|NCT04464473|454658552|FG003|Overall Study|Adverse Event|1|||
126372028|NCT04464473|454658553|FG004|Overall Study|Adverse Event|0|||
126372029|NCT04464473|454658554|FG005|Overall Study|Adverse Event|0|||
126372030|NCT04464473|454658549|FG000|Overall Study|Lost to Follow-up|0|||
126372031|NCT04464473|454658550|FG001|Overall Study|Lost to Follow-up|0|||
126372032|NCT04464473|454658551|FG002|Overall Study|Lost to Follow-up|0|||
126372033|NCT04464473|454658552|FG003|Overall Study|Lost to Follow-up|1|||
126372034|NCT04464473|454658553|FG004|Overall Study|Lost to Follow-up|0|||
126372035|NCT04464473|454658554|FG005|Overall Study|Lost to Follow-up|0|||
126372036|NCT01334918|454659747|FG000|Overall Study|Did not receive study drug|6|||
126372037|NCT01334918|454659748|FG001|Overall Study|Did not receive study drug|0|||
126372038|NCT01334918|454659747|FG000|Overall Study|Adverse Event|2|||
126372039|NCT01334918|454659748|FG001|Overall Study|Adverse Event|0|||
126372040|NCT01334918|454659747|FG000|Overall Study|Withdrawal by Subject|0|||
126372041|NCT01334918|454659748|FG001|Overall Study|Withdrawal by Subject|1|||
126372042|NCT00805389|454659749|FG000|Overall Study|Adverse Event|0|||
126372043|NCT00805389|454659750|FG001|Overall Study|Adverse Event|0|||
126372044|NCT00805389|454659751|FG002|Overall Study|Adverse Event|1|||
126200428|NCT00545740|454019445|FG003|Overall Study|Lack of time|0|||
126200429|NCT00545740|454019442|FG000|Overall Study|Non-adherence to visits|0|||
126200430|NCT00545740|454019443|FG001|Overall Study|Non-adherence to visits|1|||
126200431|NCT00545740|454019444|FG002|Overall Study|Non-adherence to visits|0|||
126200432|NCT00545740|454019445|FG003|Overall Study|Non-adherence to visits|0|||
126200433|NCT00545740|454019442|FG000|Overall Study|Patient difficulties|0|||
126200434|NCT00545740|454019443|FG001|Overall Study|Patient difficulties|1|||
126200435|NCT00545740|454019444|FG002|Overall Study|Patient difficulties|0|||
126200436|NCT00545740|454019445|FG003|Overall Study|Patient difficulties|0|||
126200437|NCT00545740|454019442|FG000|Overall Study|Husband against study|0|||
126200438|NCT00545740|454019443|FG001|Overall Study|Husband against study|0|||
126200439|NCT00545740|454019444|FG002|Overall Study|Husband against study|1|||
126200440|NCT00545740|454019445|FG003|Overall Study|Husband against study|0|||
126200441|NCT02177942|454019450|FG000|Overall Study|Adverse Event|1|||
126200442|NCT02177942|454019451|FG001|Overall Study|Adverse Event|0|||
126372045|NCT00805389|454659752|FG003|Overall Study|Adverse Event|2|||
126372046|NCT00805389|454659753|FG004|Overall Study|Adverse Event|0|||
126372047|NCT00805389|454659749|FG000|Overall Study|Lost to Follow-up|4|||
126372048|NCT00805389|454659750|FG001|Overall Study|Lost to Follow-up|3|||
126372049|NCT00805389|454659751|FG002|Overall Study|Lost to Follow-up|6|||
126372050|NCT00805389|454659752|FG003|Overall Study|Lost to Follow-up|10|||
126372051|NCT00805389|454659753|FG004|Overall Study|Lost to Follow-up|9|||
126372052|NCT00805389|454659749|FG000|Overall Study|Protocol Violation|0|||
126372053|NCT00805389|454659750|FG001|Overall Study|Protocol Violation|0|||
126372054|NCT00805389|454659751|FG002|Overall Study|Protocol Violation|1|||
126103996|NCT01315353|453673888|FG000|Overall Study|Taken off study by site in error|0|||
126103997|NCT01315353|453673889|FG001|Overall Study|Taken off study by site in error|1|||
126103998|NCT01315353|453673890|FG002|Overall Study|Taken off study by site in error|0|||
126103999|NCT01315353|453673888|FG000|Overall Study|Inadvertent randomization/assignment|0|||
126104000|NCT01315353|453673889|FG001|Overall Study|Inadvertent randomization/assignment|0|||
126104001|NCT01315353|453673890|FG002|Overall Study|Inadvertent randomization/assignment|2|||
126104002|NCT03567434|453673891|FG000|Overall Study|Lost to Follow-up|1|||
126104003|NCT03567434|453673892|FG001|Overall Study|Lost to Follow-up|3|||
126372055|NCT00805389|454659752|FG003|Overall Study|Protocol Violation|0|||
126372056|NCT00805389|454659753|FG004|Overall Study|Protocol Violation|0|||
126372057|NCT00805389|454659749|FG000|Overall Study|Withdrawal by Subject|3|||
126372058|NCT00805389|454659750|FG001|Overall Study|Withdrawal by Subject|2|||
126372059|NCT00805389|454659751|FG002|Overall Study|Withdrawal by Subject|4|||
126372060|NCT00805389|454659752|FG003|Overall Study|Withdrawal by Subject|5|||
126372061|NCT00805389|454659753|FG004|Overall Study|Withdrawal by Subject|4|||
126372062|NCT02704208|454659756|FG000|Overall Study|Lost to Follow-up|42|||
126372063|NCT02704208|454659757|FG001|Overall Study|Lost to Follow-up|37|||
126372064|NCT02724839|454659762|FG000|Overall Study|Withdrawal by Subject|1|||
126372065|NCT02724839|454659763|FG001|Overall Study|Withdrawal by Subject|1|||
126372066|NCT02724839|454659764|FG002|Overall Study|Withdrawal by Subject|0|||
126372067|NCT02724839|454659762|FG000|Overall Study|Lost to Follow-up|0|||
126372068|NCT02724839|454659763|FG001|Overall Study|Lost to Follow-up|3|||
126372069|NCT02724839|454659764|FG002|Overall Study|Lost to Follow-up|2|||
126372070|NCT02724839|454659762|FG000|Overall Study|Physician Decision|0|||
126372071|NCT02724839|454659763|FG001|Overall Study|Physician Decision|0|||
126372072|NCT02724839|454659764|FG002|Overall Study|Physician Decision|3|||
126372073|NCT01155050|454659765|FG000|Overall Study|Lost to Follow-up|15|||
126372074|NCT01155050|454659766|FG001|Overall Study|Lost to Follow-up|20|||
126372075|NCT01155050|454659767|FG002|Overall Study|Lost to Follow-up|19|||
126372076|NCT01155050|454659768|FG003|Overall Study|Lost to Follow-up|22|||
126372077|NCT05878067|454659770|FG000|Overall Study|Lost to Follow-up|2|||
126372078|NCT00949533|454659771|FG000|Overall Study|Lost to Follow-up|0|||
126104004|NCT03035201|453673893|FG000|Overall Study|Death|9|||
126104005|NCT03035201|453673894|FG001|Overall Study|Death|12|||
126372079|NCT00949533|454659772|FG001|Overall Study|Lost to Follow-up|1|||
126372080|NCT01959529|454659773|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
126372081|NCT01959529|454659774|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
126372082|NCT01959529|454659773|FG000|Overall Study|Lost to Follow-up|4|||
126372083|NCT01959529|454659774|FG001|Overall Study|Lost to Follow-up|1|||
126372084|NCT01959529|454659773|FG000|Overall Study|Other|70|||
126372085|NCT01959529|454659774|FG001|Overall Study|Other|68|||
126372086|NCT01959529|454659773|FG000|Overall Study|Hypoglycaemia|1|||
126104006|NCT03035201|453673895|FG002|Overall Study|Death|9|||
126104007|NCT03035201|453673896|FG003|Overall Study|Death|10|||
126372087|NCT01959529|454659774|FG001|Overall Study|Hypoglycaemia|1|||
126372088|NCT01959529|454659773|FG000|Overall Study|Lack of glycaemic control|1|||
126372089|NCT01959529|454659774|FG001|Overall Study|Lack of glycaemic control|1|||
126372090|NCT00557193|454659775|FG000|Induction|Adverse Event|2|||
126372091|NCT00557193|454659776|FG001|Induction|Adverse Event|0|||
126372092|NCT00557193|454659777|FG002|Induction|Adverse Event|0|||
126372093|NCT00557193|454659778|FG003|Induction|Adverse Event|0|||
126372094|NCT00557193|454659779|FG004|Induction|Adverse Event|0|||
126372095|NCT00557193|454659780|FG005|Induction|Adverse Event|0|||
126372096|NCT00557193|454659775|FG000|Induction|Death|6|||
126372097|NCT00557193|454659776|FG001|Induction|Death|0|||
126372098|NCT00557193|454659777|FG002|Induction|Death|0|||
126372099|NCT00557193|454659778|FG003|Induction|Death|0|||
126372100|NCT00557193|454659779|FG004|Induction|Death|0|||
126309011|NCT01953601|454420931|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
126309012|NCT01953601|454420929|FG000|Part 1 (Base Study)|Subject moved|2|||
126309013|NCT01953601|454420930|FG001|Part 1 (Base Study)|Subject moved|2|||
126309014|NCT01953601|454420931|FG002|Part 1 (Base Study)|Subject moved|1|||
126309015|NCT01953601|454420929|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
126309016|NCT01953601|454420930|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
126309017|NCT01953601|454420931|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
126309018|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Adverse Event|1|||
126309019|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Adverse Event|1|||
126309020|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Adverse Event|10|||
126309021|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Death|0|||
126309022|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Death|3|||
126309023|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Death|0|||
126309024|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
126309025|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
126309026|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
126309027|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
126309028|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
126309029|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
126309030|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Physician Decision|2|||
126309031|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Physician Decision|0|||
126309032|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Physician Decision|2|||
126309033|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
126309034|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
126309035|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
126309036|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
126309037|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
126309038|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
126309039|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
126309040|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
126309041|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
126309042|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Subject moved|0|||
126309043|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Subject moved|0|||
126309044|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Subject moved|1|||
126309045|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
126309046|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
126309047|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
126309048|NCT01936181|454420950|FG000|Randomised, Double-blind|Adverse Event|27|||
126309049|NCT01936181|454420951|FG001|Randomised, Double-blind|Adverse Event|21|||
126309050|NCT01936181|454420952|FG002|Randomised, Double-blind|Adverse Event|0|||
126309051|NCT01936181|454420953|FG003|Randomised, Double-blind|Adverse Event|0|||
126309052|NCT01936181|454420950|FG000|Randomised, Double-blind|Protocol Violation|1|||
126309053|NCT01936181|454420951|FG001|Randomised, Double-blind|Protocol Violation|5|||
126309054|NCT01936181|454420952|FG002|Randomised, Double-blind|Protocol Violation|0|||
126309055|NCT01936181|454420953|FG003|Randomised, Double-blind|Protocol Violation|0|||
126309056|NCT01936181|454420950|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
126309057|NCT01936181|454420951|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
126309058|NCT01936181|454420952|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
126309059|NCT01936181|454420953|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
126309060|NCT01936181|454420950|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
126309061|NCT01936181|454420951|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
126309062|NCT01936181|454420952|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
126309063|NCT01936181|454420953|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
126309064|NCT01936181|454420950|FG000|Randomised, Double-blind|Pregnancy|0|||
126309065|NCT01936181|454420951|FG001|Randomised, Double-blind|Pregnancy|1|||
126372101|NCT00557193|454659780|FG005|Induction|Death|0|||
126309066|NCT01936181|454420952|FG002|Randomised, Double-blind|Pregnancy|0|||
126309067|NCT01936181|454420953|FG003|Randomised, Double-blind|Pregnancy|0|||
126309068|NCT01936181|454420950|FG000|Randomised, Double-blind|Physician Decision|4|||
126372102|NCT00557193|454659775|FG000|Induction|Physician Decision|3|||
126372103|NCT00557193|454659776|FG001|Induction|Physician Decision|0|||
126372104|NCT00557193|454659777|FG002|Induction|Physician Decision|0|||
126372105|NCT00557193|454659778|FG003|Induction|Physician Decision|0|||
126372106|NCT00557193|454659779|FG004|Induction|Physician Decision|0|||
126372107|NCT00557193|454659780|FG005|Induction|Physician Decision|0|||
126372108|NCT00557193|454659775|FG000|Induction|Withdrawal by Subject|1|||
126309069|NCT01936181|454420951|FG001|Randomised, Double-blind|Physician Decision|4|||
126372109|NCT00557193|454659776|FG001|Induction|Withdrawal by Subject|0|||
126372110|NCT00557193|454659777|FG002|Induction|Withdrawal by Subject|0|||
126372111|NCT00557193|454659778|FG003|Induction|Withdrawal by Subject|0|||
126309070|NCT01936181|454420952|FG002|Randomised, Double-blind|Physician Decision|0|||
126372112|NCT00557193|454659779|FG004|Induction|Withdrawal by Subject|0|||
126372113|NCT00557193|454659780|FG005|Induction|Withdrawal by Subject|0|||
126372114|NCT00557193|454659775|FG000|Induction|Refusal of Further Protocol Therapy|2|||
126372115|NCT00557193|454659776|FG001|Induction|Refusal of Further Protocol Therapy|0|||
126372116|NCT00557193|454659777|FG002|Induction|Refusal of Further Protocol Therapy|0|||
126372117|NCT00557193|454659778|FG003|Induction|Refusal of Further Protocol Therapy|0|||
126372118|NCT00557193|454659779|FG004|Induction|Refusal of Further Protocol Therapy|0|||
126372119|NCT00557193|454659780|FG005|Induction|Refusal of Further Protocol Therapy|0|||
126372120|NCT00557193|454659775|FG000|Induction|Ineligible|8|||
126372121|NCT00557193|454659776|FG001|Induction|Ineligible|0|||
126372122|NCT00557193|454659777|FG002|Induction|Ineligible|0|||
126372123|NCT00557193|454659778|FG003|Induction|Ineligible|0|||
125885817|NCT00998296|452878837|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
125885818|NCT00998296|452878838|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
125885819|NCT00998296|452878839|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
126372124|NCT00557193|454659779|FG004|Induction|Ineligible|0|||
125885820|NCT00998296|452878840|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
126372125|NCT00557193|454659780|FG005|Induction|Ineligible|0|||
126372126|NCT00557193|454659775|FG000|Induction|Inevaluable for post Induction|2|||
126372127|NCT00557193|454659776|FG001|Induction|Inevaluable for post Induction|0|||
126372128|NCT00557193|454659777|FG002|Induction|Inevaluable for post Induction|0|||
126372129|NCT00557193|454659778|FG003|Induction|Inevaluable for post Induction|0|||
125885821|NCT00998296|452878841|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
125885822|NCT00998296|452878842|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
125885823|NCT00998296|452878843|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
126372130|NCT00557193|454659779|FG004|Induction|Inevaluable for post Induction|0|||
126372131|NCT00557193|454659780|FG005|Induction|Inevaluable for post Induction|0|||
126372132|NCT00557193|454659775|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
126372133|NCT00557193|454659776|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372134|NCT00557193|454659777|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372135|NCT00557193|454659778|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372136|NCT00557193|454659779|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372137|NCT00557193|454659780|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372138|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126372139|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
126372140|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
126372141|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
126372142|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126372143|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
126372144|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
126372145|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
126372146|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
126372147|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
126372148|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
126372149|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
126372150|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
126372151|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
126372152|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
126372153|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
126372154|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
126372155|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
126372156|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
126372157|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
126372158|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
126372159|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
126372160|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
126372161|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
126372162|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
126372163|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
126372164|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
126372165|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
125885824|NCT00998296|452878833|FG000|Overall Study|Other adverse event|0|||
125885825|NCT00998296|452878834|FG001|Overall Study|Other adverse event|0|||
126372166|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
126372167|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
126372168|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372169|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372170|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
126372171|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372172|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372173|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372174|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372175|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372176|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
126372177|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372178|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372179|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372180|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
126372181|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
126372182|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
126372183|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
126372184|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
126372185|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
126372186|NCT00652834|454659781|FG000|Overall Study|Withdrawal by Subject|3|||
126372187|NCT00652834|454659781|FG000|Overall Study|Lost to Follow-up|2|||
126372188|NCT00976456|454659783|FG000|Overall Study|Adverse Event|17|||
126372189|NCT00976456|454659784|FG001|Overall Study|Adverse Event|22|||
126372190|NCT00976456|454659783|FG000|Overall Study|Death|7|||
126372191|NCT00976456|454659784|FG001|Overall Study|Death|9|||
126372192|NCT00976456|454659783|FG000|Overall Study|Lack of Efficacy|5|||
126372193|NCT00976456|454659784|FG001|Overall Study|Lack of Efficacy|2|||
126372194|NCT00976456|454659783|FG000|Overall Study|Withdrawal by Subject|3|||
126372195|NCT00976456|454659784|FG001|Overall Study|Withdrawal by Subject|1|||
126372196|NCT00976456|454659783|FG000|Overall Study|screening failure, unknown|11|||
126372197|NCT00976456|454659784|FG001|Overall Study|screening failure, unknown|4|||
126372198|NCT02037529|454659785|FG000|Overall Study|Withdrawal by Subject|1|||
126372199|NCT02037529|454659786|FG001|Overall Study|Withdrawal by Subject|3|||
125885826|NCT00998296|452878835|FG002|Overall Study|Other adverse event|0|||
126372200|NCT02037529|454659785|FG000|Overall Study|Adverse Event|0|||
126372201|NCT02037529|454659786|FG001|Overall Study|Adverse Event|1|||
126372202|NCT02131766|454659787|FG000|Overall Study|Withdrawal by Subject|4|||
126372203|NCT00718315|454659788|FG000|Overall Study|Adverse Event|1|||
126372204|NCT00718315|454659789|FG001|Overall Study|Adverse Event|2|||
126372205|NCT00718315|454659790|FG002|Overall Study|Adverse Event|3|||
126372206|NCT00718315|454659788|FG000|Overall Study|Death|6|||
126372207|NCT00718315|454659789|FG001|Overall Study|Death|6|||
126372208|NCT00718315|454659790|FG002|Overall Study|Death|5|||
126372209|NCT00718315|454659788|FG000|Overall Study|Lost to Follow-up|2|||
126372210|NCT00718315|454659789|FG001|Overall Study|Lost to Follow-up|3|||
126372211|NCT00718315|454659790|FG002|Overall Study|Lost to Follow-up|4|||
126372212|NCT00718315|454659788|FG000|Overall Study|Protocol Violation|5|||
126372213|NCT00718315|454659789|FG001|Overall Study|Protocol Violation|5|||
126372214|NCT00718315|454659790|FG002|Overall Study|Protocol Violation|3|||
126372215|NCT00718315|454659788|FG000|Overall Study|Erlotinib dose decreased|4|||
126372216|NCT00718315|454659789|FG001|Overall Study|Erlotinib dose decreased|3|||
126372217|NCT00718315|454659790|FG002|Overall Study|Erlotinib dose decreased|1|||
126372218|NCT00718315|454659788|FG000|Overall Study|Use of Minocyclin|1|||
126372219|NCT00718315|454659789|FG001|Overall Study|Use of Minocyclin|1|||
126372220|NCT00718315|454659790|FG002|Overall Study|Use of Minocyclin|1|||
126372221|NCT00718315|454659788|FG000|Overall Study|Disease progression|0|||
126372222|NCT00718315|454659789|FG001|Overall Study|Disease progression|1|||
126372223|NCT00718315|454659790|FG002|Overall Study|Disease progression|1|||
126372224|NCT00718315|454659788|FG000|Overall Study|Other|0|||
126372225|NCT00718315|454659789|FG001|Overall Study|Other|0|||
126372226|NCT00718315|454659790|FG002|Overall Study|Other|1|||
126372227|NCT00718315|454659788|FG000|Overall Study|Use of ATB and Corticoids|0|||
126372228|NCT00718315|454659789|FG001|Overall Study|Use of ATB and Corticoids|1|||
126372229|NCT00718315|454659790|FG002|Overall Study|Use of ATB and Corticoids|2|||
126372230|NCT01170663|454659791|FG000|Overall Study|Lost to Follow-up|3|||
126372231|NCT01170663|454659792|FG001|Overall Study|Lost to Follow-up|9|||
126372232|NCT01170663|454659791|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
126372233|NCT01170663|454659792|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
126372234|NCT02746809|454659795|FG000|Enrollment|Inclusion Exclusion not met|9|||
126372235|NCT02746809|454659795|FG000|Enrollment|Withdrawal by Subject|1|||
126372236|NCT02746809|454659795|FG000|Enrollment|Expected Enrollment Met|2|||
126372237|NCT02746809|454659795|FG000|Procedure|Death|1|||
126372238|NCT02746809|454659795|FG000|1-Month|Death|5|||
126372239|NCT02746809|454659795|FG000|6-Month|Death|2|||
126372240|NCT02746809|454659795|FG000|6-Month|Withdrawal by Subject|1|||
126372241|NCT02746809|454659795|FG000|12-Month|Death|3|||
126372242|NCT02746809|454659795|FG000|12-Month|Withdrawal by Subject|2|||
126372243|NCT02746809|454659795|FG000|24-Month|Death|1|||
126372244|NCT02746809|454659795|FG000|24-Month|Withdrawal by Subject|1|||
126372245|NCT02746809|454659795|FG000|36-Month|Death|8|||
126372246|NCT02746809|454659795|FG000|36-Month|Withdrawal by Subject|1|||
126372247|NCT02746809|454659795|FG000|48-Month|Death|7|||
126372248|NCT02746809|454659795|FG000|48-Month|Withdrawal by Subject|1|||
126372249|NCT02746809|454659795|FG000|60-Month|Death|1|||
126372250|NCT02746809|454659795|FG000|60-Month|Lost to Follow-up|2|||
126372251|NCT00894387|454659798|FG000|Overall Study|Adverse Event|44|||
126372252|NCT00894387|454659799|FG001|Overall Study|Adverse Event|45|||
126372253|NCT00894387|454659798|FG000|Overall Study|Abnormal Laboratory values|2|||
125885827|NCT00998296|452878836|FG003|Overall Study|Other adverse event|0|||
126372254|NCT00894387|454659799|FG001|Overall Study|Abnormal Laboratory values|2|||
126372255|NCT00894387|454659798|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126372256|NCT00894387|454659799|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126372257|NCT00894387|454659798|FG000|Overall Study|Lost to Follow-up|3|||
126372258|NCT00894387|454659799|FG001|Overall Study|Lost to Follow-up|5|||
126372259|NCT00894387|454659798|FG000|Overall Study|Administrative problems|2|||
126372260|NCT00894387|454659799|FG001|Overall Study|Administrative problems|2|||
126372261|NCT00894387|454659798|FG000|Overall Study|Death|77|||
126372262|NCT00894387|454659799|FG001|Overall Study|Death|76|||
125885828|NCT00998296|452878837|FG004|Overall Study|Other adverse event|1|||
126372263|NCT00894387|454659798|FG000|Overall Study|Protocol Deviation|4|||
126372264|NCT00894387|454659799|FG001|Overall Study|Protocol Deviation|0|||
126372265|NCT00894387|454659798|FG000|Overall Study|Patient's request|25|||
126372266|NCT00894387|454659799|FG001|Overall Study|Patient's request|30|||
126372267|NCT00894387|454659798|FG000|Overall Study|Other (Missing)|5|||
126372268|NCT00894387|454659799|FG001|Overall Study|Other (Missing)|3|||
126372269|NCT00894387|454659798|FG000|Overall Study|Mis-randomized|13|||
125885829|NCT00998296|452878838|FG005|Overall Study|Other adverse event|0|||
125885830|NCT00998296|452878839|FG006|Overall Study|Other adverse event|0|||
125885831|NCT00998296|452878840|FG007|Overall Study|Other adverse event|0|||
126047612|NCT01074294|453472881|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
126309071|NCT01936181|454420953|FG003|Randomised, Double-blind|Physician Decision|0|||
126309072|NCT01936181|454420950|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
126309073|NCT01936181|454420951|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
126309074|NCT01936181|454420952|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
126309075|NCT01936181|454420953|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
126309076|NCT01936181|454420950|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
126309077|NCT01936181|454420951|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
126309078|NCT01936181|454420952|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
126309079|NCT01936181|454420953|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
126309080|NCT01936181|454420950|FG000|Transition-extension|Adverse Event|3|||
126309081|NCT01936181|454420951|FG001|Transition-extension|Adverse Event|0|||
126309082|NCT01936181|454420952|FG002|Transition-extension|Adverse Event|3|||
126309083|NCT01936181|454420953|FG003|Transition-extension|Adverse Event|1|||
126309084|NCT01936181|454420950|FG000|Transition-extension|Lost to Follow-up|3|||
126309085|NCT01936181|454420951|FG001|Transition-extension|Lost to Follow-up|0|||
126309086|NCT01936181|454420952|FG002|Transition-extension|Lost to Follow-up|1|||
126309087|NCT01936181|454420953|FG003|Transition-extension|Lost to Follow-up|2|||
126309088|NCT01936181|454420950|FG000|Transition-extension|Physician Decision|2|||
126309089|NCT01936181|454420951|FG001|Transition-extension|Physician Decision|0|||
126309090|NCT01936181|454420952|FG002|Transition-extension|Physician Decision|0|||
126309091|NCT01936181|454420953|FG003|Transition-extension|Physician Decision|1|||
126309092|NCT01936181|454420950|FG000|Transition-extension|Withdrawal by Subject|7|||
126309093|NCT01936181|454420951|FG001|Transition-extension|Withdrawal by Subject|0|||
126309094|NCT01936181|454420952|FG002|Transition-extension|Withdrawal by Subject|2|||
126309095|NCT01936181|454420953|FG003|Transition-extension|Withdrawal by Subject|1|||
126309096|NCT00970632|454420954|FG000|Overall Study|Adverse Event|2|||
126309097|NCT00970632|454420955|FG001|Overall Study|Adverse Event|2|||
126309098|NCT00970632|454420956|FG002|Overall Study|Adverse Event|1|||
126309099|NCT00970632|454420954|FG000|Overall Study|Lack of Efficacy|3|||
126309100|NCT00970632|454420955|FG001|Overall Study|Lack of Efficacy|0|||
126309101|NCT00970632|454420956|FG002|Overall Study|Lack of Efficacy|0|||
126309102|NCT00970632|454420954|FG000|Overall Study|Lost to Follow-up|3|||
126309103|NCT00970632|454420955|FG001|Overall Study|Lost to Follow-up|0|||
126309104|NCT00970632|454420956|FG002|Overall Study|Lost to Follow-up|2|||
126309105|NCT00970632|454420954|FG000|Overall Study|Protocol Violation|8|||
126309106|NCT00970632|454420955|FG001|Overall Study|Protocol Violation|5|||
126309107|NCT00970632|454420956|FG002|Overall Study|Protocol Violation|8|||
126309108|NCT00970632|454420954|FG000|Overall Study|Withdrawal by Subject|7|||
126309109|NCT00970632|454420955|FG001|Overall Study|Withdrawal by Subject|6|||
126309110|NCT00970632|454420956|FG002|Overall Study|Withdrawal by Subject|4|||
126309111|NCT00970632|454420954|FG000|Overall Study|Entry criteria not met|0|||
126309112|NCT00970632|454420955|FG001|Overall Study|Entry criteria not met|2|||
126047613|NCT01074294|453472878|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
126047614|NCT01074294|453472879|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
126047615|NCT01074294|453472880|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
126047616|NCT01074294|453472881|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
126372270|NCT00894387|454659799|FG001|Overall Study|Mis-randomized|9|||
126372271|NCT00894387|454659798|FG000|Overall Study|GCP non-compliance|0|||
126372272|NCT00894387|454659799|FG001|Overall Study|GCP non-compliance|2|||
126372273|NCT01128569|454659800|FG000|Washout Period 1|Adverse Event|0|||
126372274|NCT01128569|454659801|FG001|Washout Period 1|Adverse Event|0|||
126372275|NCT01128569|454659802|FG002|Washout Period 1|Adverse Event|1|||
126372276|NCT01128569|454659803|FG003|Washout Period 1|Adverse Event|0|||
126372277|NCT01128569|454659804|FG004|Washout Period 1|Adverse Event|0|||
126372278|NCT01128569|454659805|FG005|Washout Period 1|Adverse Event|0|||
126372279|NCT01128569|454659800|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126372280|NCT01128569|454659801|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126372281|NCT01128569|454659802|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126372282|NCT01128569|454659803|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126372283|NCT01128569|454659804|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126372284|NCT01128569|454659805|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126372285|NCT02519842|454659806|FG000|Base Study: Cycle 1|Screening Failure|1|||
126372286|NCT02519842|454659807|FG001|Base Study: Cycle 1|Screening Failure|1|||
126372287|NCT02519842|454659808|FG002|Base Study: Cycle 1|Screening Failure|0|||
126372288|NCT02519842|454659806|FG000|Base Study: Cycle 1|Adverse Event|1|||
126372289|NCT02519842|454659807|FG001|Base Study: Cycle 1|Adverse Event|0|||
126372290|NCT02519842|454659808|FG002|Base Study: Cycle 1|Adverse Event|0|||
126372291|NCT02519842|454659806|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
126372292|NCT02519842|454659807|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
126372293|NCT02519842|454659808|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
126372294|NCT02519842|454659806|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
126372295|NCT02519842|454659807|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
126372296|NCT02519842|454659808|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
126372297|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
126372298|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
126372299|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
126372300|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
126372301|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
126372302|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
126372303|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126372304|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126372305|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
126372306|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
126372307|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
126372308|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
126372309|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Death|0|||
126372310|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Death|0|||
126372311|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Death|1|||
126372312|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
126372313|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
126372314|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
126372315|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
126372316|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
126372317|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
126372318|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
126372319|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
126372320|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
126372321|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
126372322|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
126372323|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
126372324|NCT01493414|454659814|FG000|Overall Study|Adverse Event|405|||
126372325|NCT01493414|454659814|FG000|Overall Study|Disease progression|204|||
126372326|NCT01493414|454659814|FG000|Overall Study|Death|101|||
126372327|NCT01493414|454659814|FG000|Overall Study|Physician Decision|93|||
126372328|NCT01493414|454659814|FG000|Overall Study|Withdrawal by Subject|79|||
126372329|NCT01493414|454659814|FG000|Overall Study|Protocol deviation|27|||
126372330|NCT01493414|454659814|FG000|Overall Study|Administrative problems|25|||
126372331|NCT01493414|454659814|FG000|Overall Study|Lost to Follow-up|16|||
126372332|NCT01977222|454659819|FG000|Overall Study|Withdrawal by Subject|1|||
126372333|NCT00945659|454659829|FG000|Overall Study|Lost to Follow-up|7|||
126372334|NCT00945659|454659830|FG001|Overall Study|Lost to Follow-up|20|||
126372335|NCT00945659|454659831|FG002|Overall Study|Lost to Follow-up|17|||
126372336|NCT04562116|454659832|FG000|Overall Study|Lost to Follow-up|1|||
126372337|NCT04562116|454659832|FG000|Overall Study|Withdrawal by Subject|3|||
126372338|NCT02412670|454659835|FG000|Overall Study|Adverse Event|4|||
126372339|NCT02412670|454659836|FG001|Overall Study|Adverse Event|1|||
126372340|NCT02412670|454659835|FG000|Overall Study|Physician Decision|1|||
126372341|NCT02412670|454659836|FG001|Overall Study|Physician Decision|0|||
126372342|NCT02412670|454659835|FG000|Overall Study|Withdrawal by Subject|1|||
126372343|NCT02412670|454659836|FG001|Overall Study|Withdrawal by Subject|0|||
126372344|NCT02412670|454659835|FG000|Overall Study|Ineligible|1|||
126372345|NCT02412670|454659836|FG001|Overall Study|Ineligible|0|||
126372346|NCT00654732|454659839|FG000|Overall Study|Adverse Event|4|||
126372347|NCT00654732|454659840|FG001|Overall Study|Adverse Event|6|||
126372348|NCT03342560|454659841|FG000|Overall Study|Lost to Follow-up|2|||
126372349|NCT02993263|454659854|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
126372350|NCT01405196|454659855|FG000|Overall Study|Study Terminated by Sponsor|0|||
126372351|NCT01405196|454659856|FG001|Overall Study|Study Terminated by Sponsor|0|||
126372352|NCT01405196|454659857|FG002|Overall Study|Study Terminated by Sponsor|9|||
126372353|NCT01405196|454659858|FG003|Overall Study|Study Terminated by Sponsor|0|||
126372354|NCT01405196|454659855|FG000|Overall Study|Other|2|||
126372355|NCT01405196|454659856|FG001|Overall Study|Other|2|||
126372356|NCT01405196|454659857|FG002|Overall Study|Other|5|||
126372357|NCT01405196|454659858|FG003|Overall Study|Other|0|||
126372358|NCT01405196|454659855|FG000|Overall Study|Withdrawal by Subject|4|||
125885832|NCT00998296|452878841|FG008|Overall Study|Other adverse event|0|||
126372359|NCT01405196|454659856|FG001|Overall Study|Withdrawal by Subject|6|||
126372360|NCT01405196|454659857|FG002|Overall Study|Withdrawal by Subject|3|||
126372361|NCT01405196|454659858|FG003|Overall Study|Withdrawal by Subject|6|||
126372362|NCT01405196|454659855|FG000|Overall Study|Adverse Event|2|||
126372363|NCT01405196|454659856|FG001|Overall Study|Adverse Event|2|||
126372364|NCT01405196|454659857|FG002|Overall Study|Adverse Event|0|||
126372365|NCT01405196|454659858|FG003|Overall Study|Adverse Event|2|||
126372366|NCT01405196|454659855|FG000|Overall Study|Death|1|||
126047617|NCT01074294|453472878|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
126372367|NCT01405196|454659856|FG001|Overall Study|Death|0|||
126372368|NCT01405196|454659857|FG002|Overall Study|Death|3|||
125885833|NCT00998296|452878842|FG009|Overall Study|Other adverse event|1|||
125885834|NCT00998296|452878843|FG010|Overall Study|Other adverse event|2|||
125885835|NCT00998296|452878833|FG000|Overall Study|Refused to continue taking trial med.|0|||
125885836|NCT00998296|452878834|FG001|Overall Study|Refused to continue taking trial med.|0|||
125885837|NCT00998296|452878835|FG002|Overall Study|Refused to continue taking trial med.|0|||
125885838|NCT00998296|452878836|FG003|Overall Study|Refused to continue taking trial med.|0|||
125885839|NCT00998296|452878837|FG004|Overall Study|Refused to continue taking trial med.|0|||
125885840|NCT00998296|452878838|FG005|Overall Study|Refused to continue taking trial med.|0|||
125885841|NCT00998296|452878839|FG006|Overall Study|Refused to continue taking trial med.|0|||
125885842|NCT00998296|452878840|FG007|Overall Study|Refused to continue taking trial med.|0|||
125885843|NCT00998296|452878841|FG008|Overall Study|Refused to continue taking trial med.|0|||
125885844|NCT00998296|452878842|FG009|Overall Study|Refused to continue taking trial med.|2|||
125885845|NCT00998296|452878843|FG010|Overall Study|Refused to continue taking trial med.|0|||
125885846|NCT00998296|452878833|FG000|Overall Study|Reason other than those specified above|0|||
125885847|NCT00998296|452878834|FG001|Overall Study|Reason other than those specified above|0|||
125885848|NCT00998296|452878835|FG002|Overall Study|Reason other than those specified above|0|||
125885849|NCT00998296|452878836|FG003|Overall Study|Reason other than those specified above|0|||
125885850|NCT00998296|452878837|FG004|Overall Study|Reason other than those specified above|0|||
125885851|NCT00998296|452878838|FG005|Overall Study|Reason other than those specified above|0|||
125885852|NCT00998296|452878839|FG006|Overall Study|Reason other than those specified above|0|||
125885853|NCT00998296|452878840|FG007|Overall Study|Reason other than those specified above|0|||
125885854|NCT00998296|452878841|FG008|Overall Study|Reason other than those specified above|0|||
125885855|NCT00998296|452878842|FG009|Overall Study|Reason other than those specified above|1|||
125885856|NCT00998296|452878843|FG010|Overall Study|Reason other than those specified above|0|||
126372369|NCT01405196|454659858|FG003|Overall Study|Death|0|||
126372370|NCT01405196|454659855|FG000|Overall Study|Lost to Follow-up|2|||
126372371|NCT01405196|454659856|FG001|Overall Study|Lost to Follow-up|2|||
126372372|NCT01405196|454659857|FG002|Overall Study|Lost to Follow-up|3|||
126372373|NCT01405196|454659858|FG003|Overall Study|Lost to Follow-up|1|||
126372374|NCT01729039|454659859|FG000|Overall Study|disqualified|2|||
126372375|NCT01729039|454659860|FG001|Overall Study|disqualified|5|||
126372376|NCT01729039|454659859|FG000|Overall Study|Withdrawal by Subject|8|||
126372377|NCT01729039|454659860|FG001|Overall Study|Withdrawal by Subject|7|||
126372378|NCT00698841|454659861|FG000|Overall Study|Withdrawal by Subject|2|||
126372379|NCT00698841|454659861|FG000|Overall Study|Adverse Event|3|||
126200443|NCT02177942|454019450|FG000|Overall Study|Lost to Follow-up|1|||
126200444|NCT02177942|454019451|FG001|Overall Study|Lost to Follow-up|1|||
126200445|NCT02177942|454019450|FG000|Overall Study|Protocol Violation|4|||
126200446|NCT02177942|454019451|FG001|Overall Study|Protocol Violation|6|||
126200447|NCT02177942|454019450|FG000|Overall Study|Withdrawal by Subject|71|||
126200448|NCT02177942|454019451|FG001|Overall Study|Withdrawal by Subject|81|||
126200449|NCT01351415|454019452|FG000|Overall Study|Withdrawal by Subject|15|||
126200450|NCT01351415|454019453|FG001|Overall Study|Withdrawal by Subject|17|||
126372380|NCT00698841|454659861|FG000|Overall Study|Disease progression|7|||
126372381|NCT00698841|454659861|FG000|Overall Study|Failure to meet eligibility criteria|2|||
126372382|NCT00698841|454659861|FG000|Overall Study|Study drug toxicity|2|||
126372383|NCT00698841|454659861|FG000|Overall Study|Other|2|||
126372384|NCT02114177|454661351|FG000|Overall Study|Lost to Follow-up|1|||
126047618|NCT01074294|453472879|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
126047619|NCT01074294|453472880|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
126047620|NCT01074294|453472881|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
126047621|NCT01074294|453472878|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
126047622|NCT01074294|453472879|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
126047623|NCT01074294|453472880|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
126309113|NCT00970632|454420956|FG002|Overall Study|Entry criteria not met|2|||
126309114|NCT00970632|454420954|FG000|Overall Study|Sponsor decision|1|||
126309115|NCT00970632|454420955|FG001|Overall Study|Sponsor decision|0|||
126309116|NCT00970632|454420956|FG002|Overall Study|Sponsor decision|1|||
126309117|NCT02817516|454420957|FG000|Overall Study|Other|0|||
126309118|NCT02817516|454420958|FG001|Overall Study|Other|0|||
126309119|NCT02817516|454420959|FG002|Overall Study|Other|1|||
126309120|NCT02817516|454420960|FG003|Overall Study|Other|0|||
126309121|NCT00664859|454420961|FG000|Overall Study|Adverse Event|2|||
126309122|NCT00664859|454420962|FG001|Overall Study|Adverse Event|1|||
126309123|NCT00664859|454420963|FG002|Overall Study|Adverse Event|3|||
126309124|NCT00664859|454420961|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
126309125|NCT00664859|454420962|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
126309126|NCT00664859|454420963|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
126309127|NCT00664859|454420961|FG000|Overall Study|Noncompliance with protocol|1|||
126309128|NCT00664859|454420962|FG001|Overall Study|Noncompliance with protocol|0|||
126309129|NCT00664859|454420963|FG002|Overall Study|Noncompliance with protocol|4|||
126309130|NCT00664859|454420961|FG000|Overall Study|Laboratory abnormality|2|||
126309131|NCT00664859|454420962|FG001|Overall Study|Laboratory abnormality|1|||
126309132|NCT00664859|454420963|FG002|Overall Study|Laboratory abnormality|4|||
126309133|NCT00664859|454420961|FG000|Overall Study|Withdrawal by Subject|4|||
126309134|NCT00664859|454420962|FG001|Overall Study|Withdrawal by Subject|1|||
126309135|NCT00664859|454420963|FG002|Overall Study|Withdrawal by Subject|3|||
126309136|NCT00664859|454420961|FG000|Overall Study|Lost to Follow-up|2|||
126309137|NCT00664859|454420962|FG001|Overall Study|Lost to Follow-up|2|||
126309138|NCT00664859|454420963|FG002|Overall Study|Lost to Follow-up|1|||
126309139|NCT00664859|454420961|FG000|Overall Study|Other|0|||
126309140|NCT00664859|454420962|FG001|Overall Study|Other|1|||
126309141|NCT00664859|454420963|FG002|Overall Study|Other|2|||
126309142|NCT01943851|454420964|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309143|NCT01943851|454420965|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309144|NCT01943851|454420966|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309145|NCT01943851|454420967|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
126309146|NCT01943851|454420968|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309147|NCT01943851|454420969|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309148|NCT01943851|454420970|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
126309149|NCT01943851|454420971|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
126309150|NCT01943851|454420972|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
126309151|NCT01943851|454420973|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309152|NCT01943851|454420974|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309153|NCT01943851|454420975|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309154|NCT01943851|454420976|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309155|NCT01943851|454420977|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309156|NCT01943851|454420978|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309157|NCT01943851|454420979|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126372385|NCT02114177|454661352|FG001|Overall Study|Lost to Follow-up|2|||
126372386|NCT02114177|454661351|FG000|Overall Study|Withdrawal by Subject|6|||
126372387|NCT02114177|454661352|FG001|Overall Study|Withdrawal by Subject|1|||
126372388|NCT02114177|454661351|FG000|Overall Study|Other|2|||
126309158|NCT01943851|454420980|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309159|NCT01943851|454420981|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309160|NCT01943851|454420964|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126372389|NCT02114177|454661352|FG001|Overall Study|Other|1|||
126372390|NCT01585025|454661353|FG000|Overall Study|Withdrawal by Subject|0|||
126372391|NCT01585025|454661354|FG001|Overall Study|Withdrawal by Subject|3|||
126372392|NCT01585025|454661355|FG002|Overall Study|Withdrawal by Subject|4|||
126372393|NCT00582907|454661356|FG000|1st Course|Withdrawal by Subject|1|||
126372394|NCT00582907|454661357|FG001|1st Course|Withdrawal by Subject|0|||
126372395|NCT00582907|454661358|FG002|1st Course|Withdrawal by Subject|0|||
126372396|NCT00582907|454661359|FG003|1st Course|Withdrawal by Subject|0|||
126372397|NCT00582907|454661356|FG000|1st Course|Lost to Follow-up|0|||
126372398|NCT00582907|454661357|FG001|1st Course|Lost to Follow-up|0|||
126372399|NCT00582907|454661358|FG002|1st Course|Lost to Follow-up|0|||
126372400|NCT00582907|454661359|FG003|1st Course|Lost to Follow-up|1|||
125885857|NCT02346721|452878844|FG000|Overall Study|Withdrew Consent|3|||
125885858|NCT02346721|452878844|FG000|Overall Study|Lack of Efficacy|1|||
125885859|NCT04396639|452878847|FG000|Overall Study|Withdrawal by Subject|1|||
125885860|NCT04396639|452878847|FG000|Overall Study|Other|1|||
125885861|NCT01544335|452878848|FG000|Overall Study|Lost to Follow-up|27|||
125885862|NCT01544335|452878848|FG000|Overall Study|Death|4|||
125885863|NCT01544335|452878848|FG000|Overall Study|Disease progression|3|||
125885864|NCT01544335|452878848|FG000|Overall Study|Baseline Measurements not Available|19|||
125885865|NCT01532986|452878851|FG000|Overall Study|Death|9|||
125885866|NCT01532986|452878852|FG001|Overall Study|Death|9|||
125885867|NCT01532986|452878851|FG000|Overall Study|Withdrawal by Subject|7|||
125885868|NCT01532986|452878852|FG001|Overall Study|Withdrawal by Subject|10|||
125885869|NCT01532986|452878851|FG000|Overall Study|Physician Decision|7|||
125885870|NCT01532986|452878852|FG001|Overall Study|Physician Decision|5|||
125885871|NCT04614974|452878853|FG000|Overall Study|Lost to Follow-up|14|||
125885872|NCT04614974|452878854|FG001|Overall Study|Lost to Follow-up|11|||
125885873|NCT01635153|452878855|FG000|Overall Study|Lost to Follow-up|40|||
125885874|NCT01635153|452878856|FG001|Overall Study|Lost to Follow-up|43|||
126047624|NCT01074294|453472881|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
126047625|NCT01074294|453472878|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
126047626|NCT01074294|453472879|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
126372401|NCT00582907|454661356|FG000|2nd Course|Lack of Efficacy|1|||
126372402|NCT00582907|454661357|FG001|2nd Course|Lack of Efficacy|0|||
126372403|NCT00582907|454661358|FG002|2nd Course|Lack of Efficacy|0|||
126372404|NCT00582907|454661359|FG003|2nd Course|Lack of Efficacy|0|||
126372405|NCT03610048|454661364|FG000|Overall Study|Study terminated by sponsor|84|||
126372406|NCT03610048|454661364|FG000|Overall Study|Adverse Event|32|||
126372407|NCT03610048|454661364|FG000|Overall Study|Withdrawal by Subject|31|||
126372408|NCT03610048|454661364|FG000|Overall Study|Lost to Follow-up|8|||
126372409|NCT03610048|454661364|FG000|Overall Study|Other|4|||
126372410|NCT03610048|454661364|FG000|Overall Study|Physician Decision|1|||
126372411|NCT03610048|454661364|FG000|Overall Study|Pregnancy|1|||
126372412|NCT01146613|454661365|FG000|Overall Study|Lost to Follow-up|3|||
126372413|NCT01146613|454661366|FG001|Overall Study|Lost to Follow-up|8|||
126372414|NCT01146613|454661365|FG000|Overall Study|Lack of Efficacy|0|||
126372415|NCT01146613|454661366|FG001|Overall Study|Lack of Efficacy|1|||
126372416|NCT01146613|454661365|FG000|Overall Study|Death|1|||
126372417|NCT01146613|454661366|FG001|Overall Study|Death|0|||
126372418|NCT01146613|454661365|FG000|Overall Study|Physician Decision|1|||
126372419|NCT01146613|454661366|FG001|Overall Study|Physician Decision|0|||
126372420|NCT01146613|454661365|FG000|Overall Study|Withdrawal by Subject|0|||
126372421|NCT01146613|454661366|FG001|Overall Study|Withdrawal by Subject|3|||
126372422|NCT01146613|454661365|FG000|Overall Study|schedule conflict|1|||
126372423|NCT01146613|454661366|FG001|Overall Study|schedule conflict|0|||
126372424|NCT01146613|454661365|FG000|Overall Study|Outpatient detox|1|||
126372425|NCT01146613|454661366|FG001|Overall Study|Outpatient detox|0|||
126372426|NCT00854360|454661373|FG000|Overall Study|Adverse Event|0|||
126372427|NCT00854360|454661374|FG001|Overall Study|Adverse Event|1|||
126372428|NCT00854360|454661375|FG002|Overall Study|Adverse Event|2|||
126372429|NCT00854360|454661376|FG003|Overall Study|Adverse Event|6|||
126372430|NCT00854360|454661373|FG000|Overall Study|Withdrawal by Subject|0|||
126372431|NCT00854360|454661374|FG001|Overall Study|Withdrawal by Subject|0|||
126372432|NCT00854360|454661375|FG002|Overall Study|Withdrawal by Subject|0|||
126372433|NCT00854360|454661376|FG003|Overall Study|Withdrawal by Subject|1|||
126372434|NCT00854360|454661373|FG000|Overall Study|Pregnancy|0|||
126372435|NCT00854360|454661374|FG001|Overall Study|Pregnancy|1|||
126372436|NCT00854360|454661375|FG002|Overall Study|Pregnancy|0|||
126372437|NCT00854360|454661376|FG003|Overall Study|Pregnancy|0|||
126372438|NCT00854360|454661373|FG000|Overall Study|Lack of Efficacy|2|||
126372439|NCT00854360|454661374|FG001|Overall Study|Lack of Efficacy|1|||
126372440|NCT00854360|454661375|FG002|Overall Study|Lack of Efficacy|0|||
126372441|NCT00854360|454661376|FG003|Overall Study|Lack of Efficacy|0|||
126372442|NCT00854360|454661373|FG000|Overall Study|Other|0|||
126372443|NCT00854360|454661374|FG001|Overall Study|Other|0|||
126372444|NCT00854360|454661375|FG002|Overall Study|Other|0|||
126372445|NCT00854360|454661376|FG003|Overall Study|Other|3|||
126372446|NCT01541371|454661377|FG000|Overall Study|Withdrawal by Subject|14|||
126372447|NCT01541371|454661377|FG000|Overall Study|Lost to Follow-up|21|||
126372448|NCT01541371|454661377|FG000|Overall Study|Adverse Event|15|||
126372449|NCT01541371|454661377|FG000|Overall Study|Lack of Efficacy|12|||
126372450|NCT01541371|454661377|FG000|Overall Study|Protocol Violation|6|||
126372451|NCT01541371|454661377|FG000|Overall Study|Study medication non-compliance|3|||
126372452|NCT01541371|454661377|FG000|Overall Study|Other|6|||
125885875|NCT00658359|452878857|FG000|Overall Study|Death|3|||
125885876|NCT00658359|452878858|FG001|Overall Study|Death|1|||
125885877|NCT00658359|452878859|FG002|Overall Study|Death|2|||
125885878|NCT00658359|452878857|FG000|Overall Study|Adverse Event|13|||
126047627|NCT01074294|453472880|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
126372453|NCT02441218|454661378|FG000|Overall Study|Death|503|||
126372454|NCT02441218|454661379|FG001|Overall Study|Death|553|||
126372455|NCT02441218|454661378|FG000|Overall Study|Withdrawal by Subject|73|||
126372456|NCT02441218|454661379|FG001|Overall Study|Withdrawal by Subject|58|||
126372457|NCT02441218|454661378|FG000|Overall Study|Lost to Follow-up|2|||
126372458|NCT02441218|454661379|FG001|Overall Study|Lost to Follow-up|1|||
126372459|NCT02271880|454661383|FG000|Overall Study|Premature discontinuation of study|3|||
126372460|NCT02271880|454661384|FG001|Overall Study|Premature discontinuation of study|4|||
126372461|NCT00806585|454661385|FG000|Overall Study|Study terminated by Sponsor|0|||
126372462|NCT00806585|454661386|FG001|Overall Study|Study terminated by Sponsor|0|||
126372463|NCT00806585|454661387|FG002|Overall Study|Study terminated by Sponsor|1|||
126372464|NCT00806585|454661388|FG003|Overall Study|Study terminated by Sponsor|2|||
126372465|NCT00806585|454661389|FG004|Overall Study|Study terminated by Sponsor|0|||
126372466|NCT00806585|454661385|FG000|Overall Study|Protocol Violation|3|||
126372467|NCT00806585|454661386|FG001|Overall Study|Protocol Violation|1|||
126372468|NCT00806585|454661387|FG002|Overall Study|Protocol Violation|2|||
126372469|NCT00806585|454661388|FG003|Overall Study|Protocol Violation|0|||
126372470|NCT00806585|454661389|FG004|Overall Study|Protocol Violation|0|||
126372471|NCT00806585|454661385|FG000|Overall Study|Physician Decision|0|||
126372472|NCT00806585|454661386|FG001|Overall Study|Physician Decision|2|||
126372473|NCT00806585|454661387|FG002|Overall Study|Physician Decision|3|||
126372474|NCT00806585|454661388|FG003|Overall Study|Physician Decision|0|||
126372475|NCT00806585|454661389|FG004|Overall Study|Physician Decision|1|||
126372476|NCT00806585|454661385|FG000|Overall Study|Lost to Follow-up|2|||
126372477|NCT00806585|454661386|FG001|Overall Study|Lost to Follow-up|1|||
126372478|NCT00806585|454661387|FG002|Overall Study|Lost to Follow-up|2|||
126372479|NCT00806585|454661388|FG003|Overall Study|Lost to Follow-up|2|||
126372480|NCT00806585|454661389|FG004|Overall Study|Lost to Follow-up|5|||
126372481|NCT00806585|454661385|FG000|Overall Study|Lack of Efficacy|1|||
126372482|NCT00806585|454661386|FG001|Overall Study|Lack of Efficacy|0|||
126372483|NCT00806585|454661387|FG002|Overall Study|Lack of Efficacy|0|||
126372484|NCT00806585|454661388|FG003|Overall Study|Lack of Efficacy|0|||
126372485|NCT00806585|454661389|FG004|Overall Study|Lack of Efficacy|0|||
126372486|NCT00806585|454661385|FG000|Overall Study|Adverse Event|1|||
126372487|NCT00806585|454661386|FG001|Overall Study|Adverse Event|5|||
126372488|NCT00806585|454661387|FG002|Overall Study|Adverse Event|3|||
126372489|NCT00806585|454661388|FG003|Overall Study|Adverse Event|4|||
126372490|NCT00806585|454661389|FG004|Overall Study|Adverse Event|2|||
126372491|NCT00806585|454661385|FG000|Overall Study|Withdrawal by Subject|10|||
126372492|NCT00806585|454661386|FG001|Overall Study|Withdrawal by Subject|8|||
126372493|NCT00806585|454661387|FG002|Overall Study|Withdrawal by Subject|9|||
126372494|NCT00806585|454661388|FG003|Overall Study|Withdrawal by Subject|3|||
126372495|NCT00806585|454661389|FG004|Overall Study|Withdrawal by Subject|11|||
126372496|NCT00806585|454661385|FG000|Overall Study|Completion status unknown|15|||
126372497|NCT00806585|454661386|FG001|Overall Study|Completion status unknown|14|||
126372498|NCT00806585|454661387|FG002|Overall Study|Completion status unknown|12|||
126372499|NCT00806585|454661388|FG003|Overall Study|Completion status unknown|4|||
126372500|NCT00806585|454661389|FG004|Overall Study|Completion status unknown|12|||
126372501|NCT00474903|454661390|FG000|Overall Study|Protocol Violation|1|||
125885879|NCT00658359|452878858|FG001|Overall Study|Adverse Event|6|||
125885880|NCT00658359|452878859|FG002|Overall Study|Adverse Event|9|||
125885881|NCT00658359|452878857|FG000|Overall Study|Protocol Violation|1|||
125885882|NCT00658359|452878858|FG001|Overall Study|Protocol Violation|0|||
125885883|NCT00658359|452878859|FG002|Overall Study|Protocol Violation|0|||
126372502|NCT00474903|454661391|FG001|Overall Study|Protocol Violation|5|||
126372503|NCT00474903|454661392|FG002|Overall Study|Protocol Violation|2|||
126372504|NCT01936831|454661393|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372505|NCT01936831|454661394|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372506|NCT01936831|454661395|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372507|NCT01936831|454661396|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372508|NCT01936831|454661397|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372509|NCT01936831|454661398|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
126372510|NCT01936831|454661399|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372511|NCT01936831|454661400|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372512|NCT01936831|454661401|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372513|NCT03435380|454661407|FG000|Overall Study|Death|1|||
126372514|NCT03435380|454661408|FG001|Overall Study|Death|2|||
126372515|NCT03435380|454661409|FG002|Overall Study|Death|1|||
126372516|NCT03435380|454661407|FG000|Overall Study|Lost to Follow-up|12|||
126372517|NCT03435380|454661408|FG001|Overall Study|Lost to Follow-up|8|||
126372518|NCT03435380|454661409|FG002|Overall Study|Lost to Follow-up|6|||
126372519|NCT03435380|454661407|FG000|Overall Study|Physician Decision|1|||
126372520|NCT03435380|454661408|FG001|Overall Study|Physician Decision|0|||
125885884|NCT00658359|452878857|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
125885885|NCT00658359|452878858|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
126047628|NCT01074294|453472881|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
126372521|NCT03435380|454661409|FG002|Overall Study|Physician Decision|0|||
126372522|NCT03435380|454661407|FG000|Overall Study|Withdrawal by Subject|0|||
126372523|NCT03435380|454661408|FG001|Overall Study|Withdrawal by Subject|1|||
126372524|NCT03435380|454661409|FG002|Overall Study|Withdrawal by Subject|1|||
126372525|NCT03435380|454661407|FG000|Overall Study|Ineligible|0|||
125885886|NCT00658359|452878859|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
125885887|NCT00658359|452878857|FG000|Overall Study|Withdrawal by Subject|7|||
125885888|NCT00658359|452878858|FG001|Overall Study|Withdrawal by Subject|4|||
125885889|NCT00658359|452878859|FG002|Overall Study|Withdrawal by Subject|2|||
125885890|NCT00658359|452878857|FG000|Overall Study|Lost to Follow-up|2|||
125885891|NCT00658359|452878858|FG001|Overall Study|Lost to Follow-up|2|||
125885892|NCT00658359|452878859|FG002|Overall Study|Lost to Follow-up|4|||
125885893|NCT00658359|452878857|FG000|Overall Study|Lack of Efficacy|0|||
125885894|NCT00658359|452878858|FG001|Overall Study|Lack of Efficacy|1|||
125885895|NCT00658359|452878859|FG002|Overall Study|Lack of Efficacy|0|||
125885896|NCT02754440|452878860|FG000|Overall Study|Protocol Violation|3|||
125885897|NCT02754440|452878861|FG001|Overall Study|Protocol Violation|2|||
125885898|NCT02754440|452878862|FG002|Overall Study|Protocol Violation|2|||
125885899|NCT02754440|452878863|FG003|Overall Study|Protocol Violation|6|||
125885900|NCT02754440|452878860|FG000|Overall Study|Adverse Event|3|||
125885901|NCT02754440|452878861|FG001|Overall Study|Adverse Event|1|||
125885902|NCT02754440|452878862|FG002|Overall Study|Adverse Event|0|||
125885903|NCT02754440|452878863|FG003|Overall Study|Adverse Event|9|||
125885904|NCT02754440|452878860|FG000|Overall Study|Withdrawal by Subject|0|||
125885905|NCT02754440|452878861|FG001|Overall Study|Withdrawal by Subject|0|||
125885906|NCT02754440|452878862|FG002|Overall Study|Withdrawal by Subject|0|||
125885907|NCT02754440|452878863|FG003|Overall Study|Withdrawal by Subject|1|||
125885908|NCT02754440|452878860|FG000|Overall Study|Equipment failure|0|||
125885909|NCT02754440|452878861|FG001|Overall Study|Equipment failure|5|||
125885910|NCT02754440|452878862|FG002|Overall Study|Equipment failure|5|||
125885911|NCT02754440|452878863|FG003|Overall Study|Equipment failure|7|||
125885912|NCT02754440|452878860|FG000|Overall Study|Subject issues not resulting in AE|0|||
125885913|NCT02754440|452878861|FG001|Overall Study|Subject issues not resulting in AE|0|||
125885914|NCT02754440|452878862|FG002|Overall Study|Subject issues not resulting in AE|0|||
125885915|NCT02754440|452878863|FG003|Overall Study|Subject issues not resulting in AE|12|||
125885916|NCT02560558|452878864|FG000|Overall Study|Adverse Event|1|||
125885917|NCT02560558|452878865|FG001|Overall Study|Adverse Event|0|||
126047629|NCT01074294|453472878|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
126047630|NCT01074294|453472879|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
126047631|NCT01074294|453472880|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
125885918|NCT02560558|452878864|FG000|Overall Study|Death|0|||
125885919|NCT02560558|452878865|FG001|Overall Study|Death|2|||
125885920|NCT02560558|452878864|FG000|Overall Study|Lost to Follow-up|0|||
125885921|NCT02560558|452878865|FG001|Overall Study|Lost to Follow-up|4|||
125885922|NCT02560558|452878864|FG000|Overall Study|Protocol Violation|3|||
125885923|NCT02560558|452878865|FG001|Overall Study|Protocol Violation|0|||
125885924|NCT02560558|452878864|FG000|Overall Study|Withdrawal by Subject|3|||
125885925|NCT02560558|452878865|FG001|Overall Study|Withdrawal by Subject|0|||
125885926|NCT01263197|452878872|FG000|First Intervention (Period 1)|Adverse Event|0|||
126047632|NCT01074294|453472881|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
125885927|NCT01263197|452878873|FG001|First Intervention (Period 1)|Adverse Event|0|||
126372526|NCT03435380|454661408|FG001|Overall Study|Ineligible|1|||
126372527|NCT03435380|454661409|FG002|Overall Study|Ineligible|1|||
126372528|NCT02115321|454661414|FG000|Overall Study|Death|1|||
126372529|NCT02115321|454661415|FG001|Overall Study|Death|0|||
126372530|NCT02493764|454661416|FG000|Overall Study|Adverse Event|2|||
126372531|NCT02493764|454661417|FG001|Overall Study|Adverse Event|2|||
126372532|NCT02493764|454661416|FG000|Overall Study|Death|44|||
126372533|NCT02493764|454661417|FG001|Overall Study|Death|58|||
126372534|NCT02493764|454661416|FG000|Overall Study|Lost to Follow-up|2|||
126372535|NCT02493764|454661417|FG001|Overall Study|Lost to Follow-up|1|||
126372536|NCT02493764|454661416|FG000|Overall Study|Protocol Violation|6|||
126372537|NCT02493764|454661417|FG001|Overall Study|Protocol Violation|7|||
126372538|NCT02493764|454661416|FG000|Overall Study|Physician Decision|1|||
126372539|NCT02493764|454661417|FG001|Overall Study|Physician Decision|1|||
126372540|NCT02493764|454661416|FG000|Overall Study|Participant moved|17|||
126372541|NCT02493764|454661417|FG001|Overall Study|Participant moved|5|||
126372542|NCT02493764|454661416|FG000|Overall Study|Withdrawal parent/guardian|0|||
126372543|NCT02493764|454661417|FG001|Overall Study|Withdrawal parent/guardian|1|||
126372544|NCT02493764|454661416|FG000|Overall Study|Withdrawal by Subject|11|||
126372545|NCT02493764|454661417|FG001|Overall Study|Withdrawal by Subject|7|||
126372546|NCT01561976|454661421|FG000|Period 1|Adverse Event|0|||
126372547|NCT01561976|454661422|FG001|Period 1|Adverse Event|0|||
126372548|NCT01561976|454661423|FG002|Period 1|Adverse Event|1|||
126372549|NCT01561976|454661424|FG003|Period 1|Adverse Event|0|||
126372550|NCT01561976|454661425|FG004|Period 1|Adverse Event|0|||
126372551|NCT01561976|454661426|FG005|Period 1|Adverse Event|0|||
126372552|NCT01561976|454661421|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
126372553|NCT01561976|454661422|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
126372554|NCT01561976|454661423|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
126372555|NCT01561976|454661424|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
126372556|NCT01561976|454661425|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
126372557|NCT01561976|454661426|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
126047633|NCT01074294|453472878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
126047634|NCT01074294|453472879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
126047635|NCT01074294|453472880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
126047636|NCT01074294|453472881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
126047637|NCT01074294|453472878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
126047638|NCT01074294|453472879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
126047639|NCT01074294|453472880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
126047640|NCT01074294|453472881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
126047641|NCT01074294|453472878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
126047642|NCT01074294|453472879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
126047643|NCT01074294|453472880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
126047644|NCT01074294|453472881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
126372558|NCT01561976|454661421|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372559|NCT01561976|454661422|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372560|NCT01561976|454661423|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372561|NCT01561976|454661424|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372562|NCT01561976|454661425|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372563|NCT01561976|454661426|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126372564|NCT01561976|454661421|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
126372565|NCT01561976|454661422|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
126372566|NCT01561976|454661423|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
126372567|NCT01561976|454661424|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
126372568|NCT01561976|454661425|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
126372569|NCT01561976|454661426|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
126372570|NCT03218917|454661427|FG000|Overall Study|Adverse Event|3|||
126372571|NCT03218917|454661428|FG001|Overall Study|Adverse Event|3|||
126372572|NCT03218917|454661429|FG002|Overall Study|Adverse Event|2|||
126372573|NCT03218917|454661427|FG000|Overall Study|Subject withdrew consent|2|||
126372574|NCT03218917|454661428|FG001|Overall Study|Subject withdrew consent|4|||
126372575|NCT03218917|454661429|FG002|Overall Study|Subject withdrew consent|10|||
126372576|NCT03218917|454661427|FG000|Overall Study|Physician Decision|0|||
126372577|NCT03218917|454661428|FG001|Overall Study|Physician Decision|1|||
126372578|NCT03218917|454661429|FG002|Overall Study|Physician Decision|1|||
126372579|NCT03218917|454661427|FG000|Overall Study|Lost to Follow-up|1|||
126372580|NCT03218917|454661428|FG001|Overall Study|Lost to Follow-up|0|||
126372581|NCT03218917|454661429|FG002|Overall Study|Lost to Follow-up|0|||
126372582|NCT03218917|454661427|FG000|Overall Study|Reason Missing|0|||
126372583|NCT03218917|454661428|FG001|Overall Study|Reason Missing|2|||
126372584|NCT03218917|454661429|FG002|Overall Study|Reason Missing|0|||
126372585|NCT03218917|454661427|FG000|Overall Study|Death|0|||
126372586|NCT03218917|454661428|FG001|Overall Study|Death|1|||
126372587|NCT03218917|454661429|FG002|Overall Study|Death|0|||
126372588|NCT03218917|454661427|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126047645|NCT01074294|453472878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
126047646|NCT01074294|453472879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
126047647|NCT01074294|453472880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
126372589|NCT03218917|454661428|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126372590|NCT03218917|454661429|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125885928|NCT01263197|452878874|FG002|First Intervention (Period 1)|Adverse Event|0|||
125885929|NCT01263197|452878875|FG003|First Intervention (Period 1)|Adverse Event|0|||
125885930|NCT01263197|452878876|FG004|First Intervention (Period 1)|Adverse Event|0|||
125885931|NCT01263197|452878877|FG005|First Intervention (Period 1)|Adverse Event|1|||
126309161|NCT01943851|454420965|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309162|NCT01943851|454420966|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309163|NCT01943851|454420967|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309164|NCT01943851|454420968|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
126309165|NCT01943851|454420969|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309166|NCT01943851|454420970|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309167|NCT01943851|454420971|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
126309168|NCT01943851|454420972|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309169|NCT01943851|454420973|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309170|NCT01943851|454420974|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309171|NCT01943851|454420975|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309172|NCT01943851|454420976|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309173|NCT01943851|454420977|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309174|NCT01943851|454420978|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309175|NCT01943851|454420979|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309176|NCT01943851|454420980|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309177|NCT01943851|454420981|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309178|NCT01943851|454420964|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309179|NCT01943851|454420965|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309180|NCT01943851|454420966|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309181|NCT01943851|454420967|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309182|NCT01943851|454420968|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309183|NCT01943851|454420969|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309184|NCT01943851|454420970|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309185|NCT01943851|454420971|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309186|NCT01943851|454420972|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309187|NCT01943851|454420973|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126047648|NCT01074294|453472881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
126047649|NCT01074294|453472878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
126047650|NCT01074294|453472879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
126047651|NCT01074294|453472880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
126047652|NCT01074294|453472881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
126309188|NCT01943851|454420974|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309189|NCT01943851|454420975|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309190|NCT01943851|454420976|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309191|NCT01943851|454420977|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
126309192|NCT01943851|454420978|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309193|NCT01943851|454420979|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309194|NCT01943851|454420980|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309195|NCT01943851|454420981|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126047653|NCT01074294|453472878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
126309196|NCT01943851|454420964|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125885932|NCT01263197|452878872|FG000|Washout Period 1|Protocol Violation|0|||
126309197|NCT01943851|454420965|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309198|NCT01943851|454420966|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125885933|NCT01263197|452878873|FG001|Washout Period 1|Protocol Violation|0|||
126047654|NCT01074294|453472879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
126047655|NCT01074294|453472880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
126047656|NCT01074294|453472881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
126309199|NCT01943851|454420967|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309200|NCT01943851|454420968|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309201|NCT01943851|454420969|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309202|NCT01943851|454420970|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309203|NCT01943851|454420971|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309204|NCT01943851|454420972|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309205|NCT01943851|454420973|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309206|NCT01943851|454420974|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309207|NCT01943851|454420975|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309208|NCT01943851|454420976|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309209|NCT01943851|454420977|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309210|NCT01943851|454420978|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309211|NCT01943851|454420979|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
126309212|NCT01943851|454420980|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309213|NCT01943851|454420981|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309214|NCT01943851|454420964|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309215|NCT01943851|454420965|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309216|NCT01943851|454420966|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309217|NCT01943851|454420967|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309218|NCT01943851|454420968|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309219|NCT01943851|454420969|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309220|NCT01943851|454420970|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309221|NCT01943851|454420971|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309222|NCT01943851|454420972|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309223|NCT01943851|454420973|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309224|NCT01943851|454420974|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126372591|NCT01307449|454661430|FG000|Overall Study|Adverse Event|1|||
126372592|NCT01307449|454661431|FG001|Overall Study|Adverse Event|0|||
126372593|NCT01307449|454661432|FG002|Overall Study|Adverse Event|0|||
126372594|NCT01307449|454661433|FG003|Overall Study|Adverse Event|0|||
126372595|NCT01463527|454661436|FG000|Overall Study|Protocol Violation|1|||
126372596|NCT01463527|454661437|FG001|Overall Study|Protocol Violation|1|||
126372597|NCT01463527|454661436|FG000|Overall Study|Crying >20% of sedation|5|||
126372598|NCT01463527|454661437|FG001|Overall Study|Crying >20% of sedation|6|||
126372599|NCT05136170|454661438|FG000|Overall Study|Withdrawal by Subject|2|||
126372600|NCT05136170|454661439|FG001|Overall Study|Withdrawal by Subject|2|||
126372601|NCT05136170|454661438|FG000|Overall Study|Can no longer make office visits|1|||
126372602|NCT05136170|454661439|FG001|Overall Study|Can no longer make office visits|0|||
126372603|NCT01788943|454661440|FG000|Overall Study|Withdrawal by Subject|1|||
126372604|NCT01788943|454661441|FG001|Overall Study|Withdrawal by Subject|0|||
126372605|NCT01119287|454661442|FG000|Overall Study|Patient Decision, not related to AE|0|||
126372606|NCT01119287|454661443|FG001|Overall Study|Patient Decision, not related to AE|0|||
126372607|NCT01119287|454661444|FG002|Overall Study|Patient Decision, not related to AE|2|||
126372608|NCT01119287|454661445|FG003|Overall Study|Patient Decision, not related to AE|2|||
126372609|NCT01119287|454661446|FG004|Overall Study|Patient Decision, not related to AE|1|||
126372610|NCT01119287|454661447|FG005|Overall Study|Patient Decision, not related to AE|0|||
126372611|NCT04403919|454661452|FG000|Overall Study|Lost to Follow-up|0|||
126047657|NCT02284113|453472883|FG000|Overall Study|Adverse Event|1|||
126047658|NCT02284113|453472884|FG001|Overall Study|Adverse Event|0|||
126047659|NCT02284113|453472883|FG000|Overall Study|non-compliance|0|||
126047660|NCT02284113|453472884|FG001|Overall Study|non-compliance|1|||
126047661|NCT02284113|453472883|FG000|Overall Study|Withdrawal by Subject|0|||
126047662|NCT02284113|453472884|FG001|Overall Study|Withdrawal by Subject|1|||
126372612|NCT04403919|454661453|FG001|Overall Study|Lost to Follow-up|0|||
126372613|NCT04403919|454661454|FG002|Overall Study|Lost to Follow-up|0|||
126372614|NCT04403919|454661455|FG003|Overall Study|Lost to Follow-up|1|||
126372615|NCT01612676|454661456|FG000|Overall Study|Adverse Event|2|||
126372616|NCT01612676|454661457|FG001|Overall Study|Adverse Event|3|||
126372617|NCT01612676|454661458|FG002|Overall Study|Adverse Event|1|||
126372618|NCT01612676|454661459|FG003|Overall Study|Adverse Event|3|||
126372619|NCT01612676|454661456|FG000|Overall Study|Protocol Violation|0|||
126372620|NCT01612676|454661457|FG001|Overall Study|Protocol Violation|1|||
126372621|NCT01612676|454661458|FG002|Overall Study|Protocol Violation|0|||
126372622|NCT01612676|454661459|FG003|Overall Study|Protocol Violation|0|||
126372623|NCT01156844|454661462|FG000|Overall Study|Adverse Event|0|||
126372624|NCT01156844|454661463|FG001|Overall Study|Adverse Event|0|||
126372625|NCT01156844|454661464|FG002|Overall Study|Adverse Event|1|||
126372626|NCT01156844|454661465|FG003|Overall Study|Adverse Event|1|||
126372627|NCT01156844|454661462|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126372628|NCT01156844|454661463|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126372629|NCT01156844|454661464|FG002|Overall Study|Abnormal test procedure result(s)|2|||
126372630|NCT01156844|454661465|FG003|Overall Study|Abnormal test procedure result(s)|2|||
126372631|NCT01156844|454661462|FG000|Overall Study|Withdrawal by Subject|0|||
126372632|NCT01156844|454661463|FG001|Overall Study|Withdrawal by Subject|0|||
126372633|NCT01156844|454661464|FG002|Overall Study|Withdrawal by Subject|2|||
126372634|NCT01156844|454661465|FG003|Overall Study|Withdrawal by Subject|2|||
126372635|NCT01156844|454661462|FG000|Overall Study|Lost to Follow-up|0|||
126372636|NCT01156844|454661463|FG001|Overall Study|Lost to Follow-up|0|||
126372637|NCT01156844|454661464|FG002|Overall Study|Lost to Follow-up|1|||
126372638|NCT01156844|454661465|FG003|Overall Study|Lost to Follow-up|0|||
126372639|NCT01156844|454661462|FG000|Overall Study|Administrative problems|0|||
126372640|NCT01156844|454661463|FG001|Overall Study|Administrative problems|1|||
126372641|NCT01156844|454661464|FG002|Overall Study|Administrative problems|0|||
126372642|NCT01156844|454661465|FG003|Overall Study|Administrative problems|1|||
126372643|NCT01156844|454661462|FG000|Overall Study|Protocol deviation|2|||
126372644|NCT01156844|454661463|FG001|Overall Study|Protocol deviation|0|||
126372645|NCT01156844|454661464|FG002|Overall Study|Protocol deviation|0|||
126372646|NCT01156844|454661465|FG003|Overall Study|Protocol deviation|0|||
126372647|NCT00107276|454661469|FG000|Overall Study|Progression|46|||
126372648|NCT00107276|454661469|FG000|Overall Study|Adverse Event|6|||
126372649|NCT00107276|454661469|FG000|Overall Study|M.D. decision|2|||
126372650|NCT00107276|454661469|FG000|Overall Study|Patient refusal|1|||
126372651|NCT00107276|454661469|FG000|Overall Study|Death|1|||
126372652|NCT00107276|454661469|FG000|Overall Study|Ineligible|16|||
126372653|NCT04846231|454661470|FG000|Overall Study|Lost to Follow-up|1|||
126372654|NCT04846231|454661471|FG001|Overall Study|Lost to Follow-up|0|||
126372655|NCT04846231|454661472|FG002|Overall Study|Lost to Follow-up|0|||
126372656|NCT04846231|454661473|FG003|Overall Study|Lost to Follow-up|0|||
126047663|NCT02284113|453472883|FG000|Overall Study|not provided|0|||
126047664|NCT02284113|453472884|FG001|Overall Study|not provided|1|||
126372657|NCT04846231|454661474|FG004|Overall Study|Lost to Follow-up|0|||
126372658|NCT04846231|454661475|FG005|Overall Study|Lost to Follow-up|0|||
126372659|NCT04846231|454661476|FG006|Overall Study|Lost to Follow-up|0|||
126372660|NCT04846231|454661477|FG007|Overall Study|Lost to Follow-up|1|||
126047665|NCT02284113|453472883|FG000|Overall Study|surgery cancelled|2|||
126047666|NCT02284113|453472884|FG001|Overall Study|surgery cancelled|0|||
126047667|NCT01171976|453472885|FG000|Overall Study|Protocol Violation|0|||
126047668|NCT01171976|453472886|FG001|Overall Study|Protocol Violation|0|||
126309225|NCT01943851|454420975|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309226|NCT01943851|454420976|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309227|NCT01943851|454420977|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309228|NCT01943851|454420978|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309229|NCT01943851|454420979|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
126309230|NCT01943851|454420980|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
126309231|NCT01943851|454420981|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
126309232|NCT00900757|454420982|FG000|Overall Study|screen failure|19|||
126309233|NCT00748189|454420983|FG000|Overall Study|Death|99|||
126309234|NCT00748189|454420984|FG001|Overall Study|Death|84|||
126309235|NCT00748189|454420983|FG000|Overall Study|Withdrawal by Subject|23|||
126309236|NCT00748189|454420984|FG001|Overall Study|Withdrawal by Subject|29|||
126309237|NCT00748189|454420983|FG000|Overall Study|Physician Decision|16|||
126309238|NCT00748189|454420984|FG001|Overall Study|Physician Decision|5|||
126309239|NCT00748189|454420983|FG000|Overall Study|Lost to Follow-up|8|||
126309240|NCT00748189|454420984|FG001|Overall Study|Lost to Follow-up|15|||
126309241|NCT00748189|454420983|FG000|Overall Study|Study terminated by Sponsor|70|||
126309242|NCT00748189|454420984|FG001|Overall Study|Study terminated by Sponsor|79|||
126309243|NCT03320850|454420985|FG000|Overall Study|Lost to Follow-up|0|||
126309244|NCT03320850|454420986|FG001|Overall Study|Lost to Follow-up|0|||
126309245|NCT03320850|454420987|FG002|Overall Study|Lost to Follow-up|0|||
126309246|NCT03320850|454420988|FG003|Overall Study|Lost to Follow-up|0|||
126309247|NCT03320850|454420989|FG004|Overall Study|Lost to Follow-up|1|||
126309248|NCT03320850|454420990|FG005|Overall Study|Lost to Follow-up|2|||
126309249|NCT03320850|454420991|FG006|Overall Study|Lost to Follow-up|2|||
126309250|NCT03320850|454420992|FG007|Overall Study|Lost to Follow-up|0|||
126309251|NCT03320850|454420993|FG008|Overall Study|Lost to Follow-up|6|||
126309252|NCT03320850|454420994|FG009|Overall Study|Lost to Follow-up|4|||
126309253|NCT03320850|454420985|FG000|Overall Study|Withdrawal by Subject|0|||
126309254|NCT03320850|454420986|FG001|Overall Study|Withdrawal by Subject|0|||
126309255|NCT03320850|454420987|FG002|Overall Study|Withdrawal by Subject|0|||
126309256|NCT03320850|454420988|FG003|Overall Study|Withdrawal by Subject|0|||
126309257|NCT03320850|454420989|FG004|Overall Study|Withdrawal by Subject|1|||
126309258|NCT03320850|454420990|FG005|Overall Study|Withdrawal by Subject|2|||
126309259|NCT03320850|454420991|FG006|Overall Study|Withdrawal by Subject|4|||
126309260|NCT03320850|454420992|FG007|Overall Study|Withdrawal by Subject|5|||
126309261|NCT03320850|454420993|FG008|Overall Study|Withdrawal by Subject|2|||
126372661|NCT04846231|454661470|FG000|Overall Study|Withdrawal by Subject|0|||
126372662|NCT04846231|454661471|FG001|Overall Study|Withdrawal by Subject|1|||
126372663|NCT04846231|454661472|FG002|Overall Study|Withdrawal by Subject|2|||
126372664|NCT04846231|454661473|FG003|Overall Study|Withdrawal by Subject|1|||
126372665|NCT04846231|454661474|FG004|Overall Study|Withdrawal by Subject|0|||
126372666|NCT04846231|454661475|FG005|Overall Study|Withdrawal by Subject|0|||
126372667|NCT04846231|454661476|FG006|Overall Study|Withdrawal by Subject|0|||
126372668|NCT04846231|454661477|FG007|Overall Study|Withdrawal by Subject|0|||
126372669|NCT04846231|454661470|FG000|Overall Study|Protocol Violation|0|||
126047669|NCT01171976|453472887|FG002|Overall Study|Protocol Violation|1|||
126372670|NCT04846231|454661471|FG001|Overall Study|Protocol Violation|1|||
126372671|NCT04846231|454661472|FG002|Overall Study|Protocol Violation|0|||
126372672|NCT04846231|454661473|FG003|Overall Study|Protocol Violation|0|||
126372673|NCT04846231|454661474|FG004|Overall Study|Protocol Violation|0|||
126372674|NCT04846231|454661475|FG005|Overall Study|Protocol Violation|0|||
126372675|NCT04846231|454661476|FG006|Overall Study|Protocol Violation|0|||
126372676|NCT04846231|454661477|FG007|Overall Study|Protocol Violation|0|||
126372677|NCT04846231|454661470|FG000|Overall Study|Adverse Event|0|||
126372678|NCT04846231|454661471|FG001|Overall Study|Adverse Event|0|||
126372679|NCT04846231|454661472|FG002|Overall Study|Adverse Event|0|||
126372680|NCT04846231|454661473|FG003|Overall Study|Adverse Event|0|||
126372681|NCT04846231|454661474|FG004|Overall Study|Adverse Event|0|||
126372682|NCT04846231|454661475|FG005|Overall Study|Adverse Event|0|||
126372683|NCT04846231|454661476|FG006|Overall Study|Adverse Event|1|||
126372684|NCT04846231|454661477|FG007|Overall Study|Adverse Event|1|||
126372685|NCT02980107|454661478|FG000|Overall Study|Withdrawal by Subject|51|||
126309262|NCT03320850|454420994|FG009|Overall Study|Withdrawal by Subject|1|||
126309263|NCT03320850|454420985|FG000|Overall Study|Lack of Efficacy|0|||
126309264|NCT03320850|454420986|FG001|Overall Study|Lack of Efficacy|0|||
126309265|NCT03320850|454420987|FG002|Overall Study|Lack of Efficacy|0|||
126309266|NCT03320850|454420988|FG003|Overall Study|Lack of Efficacy|1|||
126309267|NCT03320850|454420989|FG004|Overall Study|Lack of Efficacy|0|||
126104008|NCT03035201|453673893|FG000|Overall Study|Withdrawal by Subject|51|||
126104009|NCT03035201|453673894|FG001|Overall Study|Withdrawal by Subject|49|||
126104010|NCT03035201|453673895|FG002|Overall Study|Withdrawal by Subject|37|||
126104011|NCT03035201|453673896|FG003|Overall Study|Withdrawal by Subject|46|||
126309268|NCT03320850|454420990|FG005|Overall Study|Lack of Efficacy|1|||
126309269|NCT03320850|454420991|FG006|Overall Study|Lack of Efficacy|0|||
126309270|NCT03320850|454420992|FG007|Overall Study|Lack of Efficacy|2|||
126309271|NCT03320850|454420993|FG008|Overall Study|Lack of Efficacy|0|||
126309272|NCT03320850|454420994|FG009|Overall Study|Lack of Efficacy|3|||
126309273|NCT03320850|454420985|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
126309274|NCT03320850|454420986|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126309275|NCT03320850|454420987|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
126309276|NCT03320850|454420988|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
126309277|NCT03320850|454420989|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
126309278|NCT03320850|454420990|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
126309279|NCT03320850|454420991|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
126309280|NCT03320850|454420992|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
126309281|NCT03320850|454420993|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
126309282|NCT03320850|454420994|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
126309283|NCT03320850|454420985|FG000|Overall Study|Adverse Event|0|||
126309284|NCT03320850|454420986|FG001|Overall Study|Adverse Event|0|||
126309285|NCT03320850|454420987|FG002|Overall Study|Adverse Event|0|||
126309286|NCT03320850|454420988|FG003|Overall Study|Adverse Event|0|||
126309287|NCT03320850|454420989|FG004|Overall Study|Adverse Event|0|||
126309288|NCT03320850|454420990|FG005|Overall Study|Adverse Event|2|||
126309289|NCT03320850|454420991|FG006|Overall Study|Adverse Event|1|||
126309290|NCT03320850|454420992|FG007|Overall Study|Adverse Event|0|||
126309291|NCT03320850|454420993|FG008|Overall Study|Adverse Event|2|||
126309292|NCT03320850|454420994|FG009|Overall Study|Adverse Event|0|||
126309293|NCT03320850|454420985|FG000|Overall Study|Reason Not Specified|0|||
126309294|NCT03320850|454420986|FG001|Overall Study|Reason Not Specified|0|||
126309295|NCT03320850|454420987|FG002|Overall Study|Reason Not Specified|0|||
126309296|NCT03320850|454420988|FG003|Overall Study|Reason Not Specified|0|||
126309297|NCT03320850|454420989|FG004|Overall Study|Reason Not Specified|0|||
126309298|NCT03320850|454420990|FG005|Overall Study|Reason Not Specified|1|||
126309299|NCT03320850|454420991|FG006|Overall Study|Reason Not Specified|0|||
126309300|NCT03320850|454420992|FG007|Overall Study|Reason Not Specified|0|||
126309301|NCT03320850|454420993|FG008|Overall Study|Reason Not Specified|0|||
126309302|NCT03320850|454420994|FG009|Overall Study|Reason Not Specified|1|||
126309303|NCT00546117|454420995|FG000|Overall Study|Withdrawal by Subject|3|||
126309304|NCT00546117|454420996|FG001|Overall Study|Withdrawal by Subject|0|||
126372686|NCT02980107|454661479|FG001|Overall Study|Withdrawal by Subject|62|||
126372687|NCT01448616|454661481|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
126372688|NCT01448616|454661482|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
126372689|NCT01448616|454661483|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
126372690|NCT01448616|454661484|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
126372691|NCT01448616|454661481|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
126372692|NCT01448616|454661482|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
126372693|NCT01448616|454661483|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
126372694|NCT01448616|454661484|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
126372695|NCT01448616|454661481|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
126372696|NCT01448616|454661482|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
126372697|NCT01448616|454661483|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
126372698|NCT01448616|454661484|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
126372699|NCT01448616|454661481|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
126372700|NCT01448616|454661482|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
126372701|NCT01448616|454661483|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
126372702|NCT01448616|454661484|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
126372703|NCT01448616|454661481|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
126372704|NCT01448616|454661482|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
126372705|NCT01448616|454661483|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
126372706|NCT01448616|454661484|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
126372707|NCT00397540|454661487|FG000|Overall Study|short follow-up duration < 12 months|1|||
126104012|NCT03035201|453673893|FG000|Overall Study|Lost to Follow-up|67|||
126309305|NCT00546117|454420995|FG000|Overall Study|Inability to schedule follow-up visit|1|||
126309306|NCT00546117|454420996|FG001|Overall Study|Inability to schedule follow-up visit|0|||
126309307|NCT01424514|454420997|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
126309308|NCT01424514|454420998|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
126309309|NCT01424514|454420997|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
126309310|NCT01424514|454420998|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
125885934|NCT01263197|452878874|FG002|Washout Period 1|Protocol Violation|0|||
125885935|NCT01263197|452878875|FG003|Washout Period 1|Protocol Violation|0|||
125885936|NCT01263197|452878876|FG004|Washout Period 1|Protocol Violation|1|||
125885937|NCT01263197|452878877|FG005|Washout Period 1|Protocol Violation|0|||
125885938|NCT01263197|452878872|FG000|Washout Period 2|Physician Decision|0|||
125885939|NCT01263197|452878873|FG001|Washout Period 2|Physician Decision|0|||
125885940|NCT01263197|452878874|FG002|Washout Period 2|Physician Decision|0|||
125885941|NCT01263197|452878875|FG003|Washout Period 2|Physician Decision|0|||
125885942|NCT01263197|452878876|FG004|Washout Period 2|Physician Decision|0|||
125885943|NCT01263197|452878877|FG005|Washout Period 2|Physician Decision|1|||
125885944|NCT01263197|452878872|FG000|Washout Period 2|Protocol Violation|0|||
125885945|NCT01263197|452878873|FG001|Washout Period 2|Protocol Violation|0|||
125885946|NCT01263197|452878874|FG002|Washout Period 2|Protocol Violation|0|||
125885947|NCT01263197|452878875|FG003|Washout Period 2|Protocol Violation|1|||
125885948|NCT01263197|452878876|FG004|Washout Period 2|Protocol Violation|0|||
125885949|NCT01263197|452878877|FG005|Washout Period 2|Protocol Violation|0|||
125885950|NCT01263197|452878872|FG000|Third Intervention (Period 3)|Adverse Event|0|||
125885951|NCT01263197|452878873|FG001|Third Intervention (Period 3)|Adverse Event|1|||
125885952|NCT01263197|452878874|FG002|Third Intervention (Period 3)|Adverse Event|0|||
125885953|NCT01263197|452878875|FG003|Third Intervention (Period 3)|Adverse Event|0|||
125885954|NCT01263197|452878876|FG004|Third Intervention (Period 3)|Adverse Event|0|||
125885955|NCT01263197|452878877|FG005|Third Intervention (Period 3)|Adverse Event|0|||
125885956|NCT01134055|452878878|FG000|Overall Study|Adverse Event|5|||
125885957|NCT01134055|452878879|FG001|Overall Study|Adverse Event|2|||
125885958|NCT01134055|452878880|FG002|Overall Study|Adverse Event|2|||
125885959|NCT01134055|452878881|FG003|Overall Study|Adverse Event|2|||
125885960|NCT01134055|452878882|FG004|Overall Study|Adverse Event|5|||
125885961|NCT01134055|452878883|FG005|Overall Study|Adverse Event|7|||
125885962|NCT01134055|452878884|FG006|Overall Study|Adverse Event|2|||
125885963|NCT01134055|452878878|FG000|Overall Study|Lost to Follow-up|0|||
125885964|NCT01134055|452878879|FG001|Overall Study|Lost to Follow-up|1|||
126372708|NCT00397540|454661488|FG001|Overall Study|short follow-up duration < 12 months|0|||
126372709|NCT00485173|454661492|FG000|Overall Study|Death|4|||
126372710|NCT00485173|454661493|FG001|Overall Study|Death|3|||
126372711|NCT00485173|454661492|FG000|Overall Study|Lost to Follow-up|32|||
126372712|NCT00485173|454661493|FG001|Overall Study|Lost to Follow-up|61|||
126372713|NCT00746811|454661494|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
126372714|NCT00746811|454661495|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
126372715|NCT00545779|454661499|FG000|Overall Study|Violation of selection criteria at entry|8|||
126372716|NCT00545779|454661499|FG000|Overall Study|Other protocol violation|1|||
126372717|NCT00545779|454661499|FG000|Overall Study|Did not cooperate|7|||
126372718|NCT00545779|454661499|FG000|Overall Study|Withdrawal by Subject|20|||
126372719|NCT00545779|454661499|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
126372720|NCT00545779|454661499|FG000|Overall Study|Failure to return|3|||
126372721|NCT00829998|454661502|FG000|Washout|Adverse Event|0|||
126372722|NCT00829998|454661503|FG001|Washout|Adverse Event|1|||
125885965|NCT01134055|452878880|FG002|Overall Study|Lost to Follow-up|0|||
125885966|NCT01134055|452878881|FG003|Overall Study|Lost to Follow-up|1|||
125885967|NCT01134055|452878882|FG004|Overall Study|Lost to Follow-up|0|||
125885968|NCT01134055|452878883|FG005|Overall Study|Lost to Follow-up|0|||
125885969|NCT01134055|452878884|FG006|Overall Study|Lost to Follow-up|0|||
125885970|NCT01134055|452878878|FG000|Overall Study|Withdrawal by Subject|3|||
126372723|NCT04712669|454661506|FG000|Double Blind Phase|Adverse Event|4|||
125885971|NCT01134055|452878879|FG001|Overall Study|Withdrawal by Subject|3|||
125885972|NCT01134055|452878880|FG002|Overall Study|Withdrawal by Subject|1|||
125885973|NCT01134055|452878881|FG003|Overall Study|Withdrawal by Subject|2|||
126047670|NCT01171976|453472885|FG000|Overall Study|Death|2|||
126047671|NCT01171976|453472886|FG001|Overall Study|Death|4|||
126047672|NCT01171976|453472887|FG002|Overall Study|Death|1|||
126047673|NCT01171976|453472885|FG000|Overall Study|Lost to Follow-up|4|||
126047674|NCT01171976|453472886|FG001|Overall Study|Lost to Follow-up|0|||
126047675|NCT01171976|453472887|FG002|Overall Study|Lost to Follow-up|2|||
126047676|NCT01171976|453472885|FG000|Overall Study|Withdrawal by Subject|1|||
126047677|NCT01171976|453472886|FG001|Overall Study|Withdrawal by Subject|5|||
126047678|NCT01171976|453472887|FG002|Overall Study|Withdrawal by Subject|6|||
126047679|NCT01171976|453472885|FG000|Overall Study|Abnormal test result|1|||
126047680|NCT01171976|453472886|FG001|Overall Study|Abnormal test result|0|||
126309311|NCT02653170|454421001|FG000|Overall Study|Withdrawal by Subject|3|||
126309312|NCT02653170|454421002|FG001|Overall Study|Withdrawal by Subject|8|||
126309313|NCT02653170|454421003|FG002|Overall Study|Withdrawal by Subject|3|||
126309314|NCT02653170|454421001|FG000|Overall Study|withdrawn by study team|2|||
126309315|NCT02653170|454421002|FG001|Overall Study|withdrawn by study team|4|||
126309316|NCT02653170|454421003|FG002|Overall Study|withdrawn by study team|5|||
126309317|NCT02653170|454421001|FG000|Overall Study|Lost to Follow-up|12|||
126309318|NCT02653170|454421002|FG001|Overall Study|Lost to Follow-up|4|||
126309319|NCT02653170|454421003|FG002|Overall Study|Lost to Follow-up|10|||
126309320|NCT01609543|454421019|FG000|Overall Study|Disease Progression|28|||
126309321|NCT01609543|454421019|FG000|Overall Study|Adverse Event|5|||
126309322|NCT01609543|454421019|FG000|Overall Study|Withdrawal by Subject|1|||
126309323|NCT01609543|454421019|FG000|Overall Study|Protocol Violation|1|||
126309324|NCT01609543|454421019|FG000|Overall Study|Death|7|||
126309325|NCT00507819|454421020|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
126309326|NCT00507819|454421021|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
126309327|NCT03452488|454421022|FG000|Overall Study|Adverse Event|4|||
126309328|NCT03452488|454421023|FG001|Overall Study|Adverse Event|6|||
126309329|NCT03452488|454421024|FG002|Overall Study|Adverse Event|1|||
126309330|NCT03452488|454421022|FG000|Overall Study|Death|0|||
126309331|NCT03452488|454421023|FG001|Overall Study|Death|0|||
126309332|NCT03452488|454421024|FG002|Overall Study|Death|1|||
126309333|NCT03452488|454421022|FG000|Overall Study|Lost to Follow-up|1|||
126309334|NCT03452488|454421023|FG001|Overall Study|Lost to Follow-up|2|||
126309335|NCT03452488|454421024|FG002|Overall Study|Lost to Follow-up|0|||
126309336|NCT03452488|454421022|FG000|Overall Study|PI Decision|1|||
126309337|NCT03452488|454421023|FG001|Overall Study|PI Decision|0|||
126309338|NCT03452488|454421024|FG002|Overall Study|PI Decision|0|||
126309339|NCT03452488|454421022|FG000|Overall Study|Withdrew consent|4|||
126309340|NCT03452488|454421023|FG001|Overall Study|Withdrew consent|2|||
126309341|NCT03452488|454421024|FG002|Overall Study|Withdrew consent|2|||
126309342|NCT03452488|454421022|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
126309343|NCT03452488|454421023|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
126309344|NCT03452488|454421024|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
126309345|NCT03452488|454421022|FG000|Overall Study|Other|0|||
126309346|NCT03452488|454421023|FG001|Overall Study|Other|2|||
126309347|NCT03452488|454421024|FG002|Overall Study|Other|2|||
126309348|NCT03614078|454421027|FG000|Overall Study|Withdrawal by Subject|2|||
126309349|NCT03614078|454421028|FG001|Overall Study|Withdrawal by Subject|2|||
126309350|NCT03614078|454421029|FG002|Overall Study|Withdrawal by Subject|3|||
126309351|NCT03614078|454421027|FG000|Overall Study|Participant Did Not Return for Visit|0|||
126309352|NCT03614078|454421028|FG001|Overall Study|Participant Did Not Return for Visit|1|||
126309353|NCT03614078|454421029|FG002|Overall Study|Participant Did Not Return for Visit|0|||
126309354|NCT03614078|454421027|FG000|Overall Study|High Neutrophils|0|||
126309355|NCT03614078|454421028|FG001|Overall Study|High Neutrophils|0|||
126309356|NCT03614078|454421029|FG002|Overall Study|High Neutrophils|2|||
126309357|NCT03614078|454421027|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
126309358|NCT03614078|454421028|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
126309359|NCT03614078|454421029|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
126309360|NCT03614078|454421027|FG000|Overall Study|Exacerbation of Psoriasis|0|||
126309361|NCT03614078|454421028|FG001|Overall Study|Exacerbation of Psoriasis|1|||
126047681|NCT01171976|453472887|FG002|Overall Study|Abnormal test result|0|||
126047682|NCT01171976|453472885|FG000|Overall Study|Adverse Event|6|||
126047683|NCT01171976|453472886|FG001|Overall Study|Adverse Event|2|||
126309362|NCT03614078|454421029|FG002|Overall Study|Exacerbation of Psoriasis|0|||
126309363|NCT03614078|454421027|FG000|Overall Study|Adverse Event|0|||
126309364|NCT03614078|454421028|FG001|Overall Study|Adverse Event|2|||
126309365|NCT03614078|454421029|FG002|Overall Study|Adverse Event|0|||
126309366|NCT03614078|454421027|FG000|Overall Study|Dizziness and Rash|0|||
126309367|NCT03614078|454421028|FG001|Overall Study|Dizziness and Rash|1|||
126309368|NCT03614078|454421029|FG002|Overall Study|Dizziness and Rash|0|||
126309369|NCT02691936|454421030|FG000|Overall Study|Withdrawal by Subject|2|||
125885974|NCT01134055|452878882|FG004|Overall Study|Withdrawal by Subject|0|||
126372724|NCT04712669|454661507|FG001|Double Blind Phase|Adverse Event|4|||
126372725|NCT04712669|454661508|FG002|Double Blind Phase|Adverse Event|3|||
126372726|NCT04712669|454661509|FG003|Double Blind Phase|Adverse Event|0|||
126372727|NCT04712669|454661510|FG004|Double Blind Phase|Adverse Event|0|||
126372728|NCT04712669|454661511|FG005|Double Blind Phase|Adverse Event|0|||
126372729|NCT04712669|454661512|FG006|Double Blind Phase|Adverse Event|0|||
126372730|NCT04712669|454661513|FG007|Double Blind Phase|Adverse Event|0|||
126372731|NCT04712669|454661506|FG000|Double Blind Phase|Physician Decision|1|||
126372732|NCT04712669|454661507|FG001|Double Blind Phase|Physician Decision|0|||
126372733|NCT04712669|454661508|FG002|Double Blind Phase|Physician Decision|0|||
126372734|NCT04712669|454661509|FG003|Double Blind Phase|Physician Decision|0|||
126372735|NCT04712669|454661510|FG004|Double Blind Phase|Physician Decision|0|||
126372736|NCT04712669|454661511|FG005|Double Blind Phase|Physician Decision|0|||
126372737|NCT04712669|454661512|FG006|Double Blind Phase|Physician Decision|0|||
126372738|NCT04712669|454661513|FG007|Double Blind Phase|Physician Decision|0|||
126372739|NCT04712669|454661506|FG000|Double Blind Phase|Withdrawal by Subject|3|||
126372740|NCT04712669|454661507|FG001|Double Blind Phase|Withdrawal by Subject|6|||
126372741|NCT04712669|454661508|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126372742|NCT04712669|454661509|FG003|Double Blind Phase|Withdrawal by Subject|0|||
126372743|NCT04712669|454661510|FG004|Double Blind Phase|Withdrawal by Subject|0|||
126372744|NCT04712669|454661511|FG005|Double Blind Phase|Withdrawal by Subject|0|||
126372745|NCT04712669|454661512|FG006|Double Blind Phase|Withdrawal by Subject|0|||
126372746|NCT04712669|454661513|FG007|Double Blind Phase|Withdrawal by Subject|0|||
126372747|NCT04712669|454661506|FG000|Double Blind Phase|Termination by Sponsor|0|||
126372748|NCT04712669|454661507|FG001|Double Blind Phase|Termination by Sponsor|0|||
126372749|NCT04712669|454661508|FG002|Double Blind Phase|Termination by Sponsor|1|||
126372750|NCT04712669|454661509|FG003|Double Blind Phase|Termination by Sponsor|0|||
126372751|NCT04712669|454661510|FG004|Double Blind Phase|Termination by Sponsor|0|||
126372752|NCT04712669|454661511|FG005|Double Blind Phase|Termination by Sponsor|0|||
126372753|NCT04712669|454661512|FG006|Double Blind Phase|Termination by Sponsor|0|||
126372754|NCT04712669|454661513|FG007|Double Blind Phase|Termination by Sponsor|0|||
126372755|NCT04712669|454661506|FG000|Open Label Phase|Adverse Event|0|||
126372756|NCT04712669|454661507|FG001|Open Label Phase|Adverse Event|0|||
126372757|NCT04712669|454661508|FG002|Open Label Phase|Adverse Event|0|||
126372758|NCT04712669|454661509|FG003|Open Label Phase|Adverse Event|1|||
126372759|NCT04712669|454661510|FG004|Open Label Phase|Adverse Event|1|||
126372760|NCT04712669|454661511|FG005|Open Label Phase|Adverse Event|3|||
126372761|NCT04712669|454661512|FG006|Open Label Phase|Adverse Event|1|||
126372762|NCT04712669|454661513|FG007|Open Label Phase|Adverse Event|2|||
126372763|NCT04712669|454661506|FG000|Open Label Phase|Death|0|||
126372764|NCT04712669|454661507|FG001|Open Label Phase|Death|0|||
126372765|NCT04712669|454661508|FG002|Open Label Phase|Death|0|||
125885975|NCT01134055|452878883|FG005|Overall Study|Withdrawal by Subject|0|||
126047684|NCT01171976|453472887|FG002|Overall Study|Adverse Event|5|||
126047685|NCT03885232|453472888|FG000|Overall Study|Lost to Follow-up|74|||
126047686|NCT03885232|453472889|FG001|Overall Study|Lost to Follow-up|32|||
126372766|NCT04712669|454661509|FG003|Open Label Phase|Death|1|||
126372767|NCT04712669|454661510|FG004|Open Label Phase|Death|0|||
126372768|NCT04712669|454661511|FG005|Open Label Phase|Death|0|||
126372769|NCT04712669|454661512|FG006|Open Label Phase|Death|0|||
126372770|NCT04712669|454661513|FG007|Open Label Phase|Death|0|||
126372771|NCT04712669|454661506|FG000|Open Label Phase|Lack of Efficacy|0|||
126372772|NCT04712669|454661507|FG001|Open Label Phase|Lack of Efficacy|0|||
126372773|NCT04712669|454661508|FG002|Open Label Phase|Lack of Efficacy|0|||
126372774|NCT04712669|454661509|FG003|Open Label Phase|Lack of Efficacy|0|||
126372775|NCT04712669|454661510|FG004|Open Label Phase|Lack of Efficacy|1|||
126372776|NCT04712669|454661511|FG005|Open Label Phase|Lack of Efficacy|0|||
126372777|NCT04712669|454661512|FG006|Open Label Phase|Lack of Efficacy|0|||
126372778|NCT04712669|454661513|FG007|Open Label Phase|Lack of Efficacy|0|||
126372779|NCT04712669|454661506|FG000|Open Label Phase|Lost to Follow-up|0|||
126372780|NCT04712669|454661507|FG001|Open Label Phase|Lost to Follow-up|0|||
126372781|NCT04712669|454661508|FG002|Open Label Phase|Lost to Follow-up|0|||
126372782|NCT04712669|454661509|FG003|Open Label Phase|Lost to Follow-up|0|||
126372783|NCT04712669|454661510|FG004|Open Label Phase|Lost to Follow-up|0|||
126372784|NCT04712669|454661511|FG005|Open Label Phase|Lost to Follow-up|0|||
126372785|NCT04712669|454661512|FG006|Open Label Phase|Lost to Follow-up|1|||
125885976|NCT01134055|452878884|FG006|Overall Study|Withdrawal by Subject|8|||
126047687|NCT03885232|453472888|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
126372786|NCT04712669|454661513|FG007|Open Label Phase|Lost to Follow-up|1|||
126372787|NCT04712669|454661506|FG000|Open Label Phase|Physician Decision|0|||
126372788|NCT04712669|454661507|FG001|Open Label Phase|Physician Decision|0|||
126372789|NCT04712669|454661508|FG002|Open Label Phase|Physician Decision|0|||
126372790|NCT04712669|454661509|FG003|Open Label Phase|Physician Decision|1|||
126372791|NCT04712669|454661510|FG004|Open Label Phase|Physician Decision|0|||
126372792|NCT04712669|454661511|FG005|Open Label Phase|Physician Decision|0|||
126372793|NCT04712669|454661512|FG006|Open Label Phase|Physician Decision|0|||
126372794|NCT04712669|454661513|FG007|Open Label Phase|Physician Decision|0|||
126372795|NCT04712669|454661506|FG000|Open Label Phase|Withdrawal by Subject|0|||
126372796|NCT04712669|454661507|FG001|Open Label Phase|Withdrawal by Subject|0|||
126372797|NCT04712669|454661508|FG002|Open Label Phase|Withdrawal by Subject|0|||
126372798|NCT04712669|454661509|FG003|Open Label Phase|Withdrawal by Subject|1|||
126372799|NCT04712669|454661510|FG004|Open Label Phase|Withdrawal by Subject|5|||
126372800|NCT04712669|454661511|FG005|Open Label Phase|Withdrawal by Subject|5|||
126372801|NCT04712669|454661512|FG006|Open Label Phase|Withdrawal by Subject|0|||
126372802|NCT04712669|454661513|FG007|Open Label Phase|Withdrawal by Subject|4|||
126372803|NCT04712669|454661506|FG000|Open Label Phase|Termination by Sponsor|0|||
126372804|NCT04712669|454661507|FG001|Open Label Phase|Termination by Sponsor|0|||
126372805|NCT04712669|454661508|FG002|Open Label Phase|Termination by Sponsor|0|||
126372806|NCT04712669|454661509|FG003|Open Label Phase|Termination by Sponsor|11|||
126372807|NCT04712669|454661510|FG004|Open Label Phase|Termination by Sponsor|9|||
126372808|NCT04712669|454661511|FG005|Open Label Phase|Termination by Sponsor|14|||
126372809|NCT04712669|454661512|FG006|Open Label Phase|Termination by Sponsor|0|||
126372810|NCT04712669|454661513|FG007|Open Label Phase|Termination by Sponsor|14|||
126372811|NCT03802396|454661514|FG000|Overall Study|Withdrawal by Subject|2|||
126372812|NCT03802396|454661515|FG001|Overall Study|Withdrawal by Subject|0|||
126372813|NCT03802396|454661514|FG000|Overall Study|Surgery Cancelled|1|||
126372814|NCT03802396|454661515|FG001|Overall Study|Surgery Cancelled|0|||
126372815|NCT02561962|454661519|FG000|Overall Study|Withdrawal by Subject|1|||
126372816|NCT02561962|454661520|FG001|Overall Study|Withdrawal by Subject|0|||
126372817|NCT02561962|454661521|FG002|Overall Study|Withdrawal by Subject|0|||
126372818|NCT02561962|454661522|FG003|Overall Study|Withdrawal by Subject|0|||
126372819|NCT02561962|454661523|FG004|Overall Study|Withdrawal by Subject|1|||
126372820|NCT02561962|454661524|FG005|Overall Study|Withdrawal by Subject|1|||
126372821|NCT02561962|454661525|FG006|Overall Study|Withdrawal by Subject|2|||
126372822|NCT02561962|454661526|FG007|Overall Study|Withdrawal by Subject|1|||
126372823|NCT02561962|454661527|FG008|Overall Study|Withdrawal by Subject|0|||
126372824|NCT02561962|454661519|FG000|Overall Study|Decision by sponsor|0|||
126372825|NCT02561962|454661520|FG001|Overall Study|Decision by sponsor|0|||
126372826|NCT02561962|454661521|FG002|Overall Study|Decision by sponsor|0|||
126372827|NCT02561962|454661522|FG003|Overall Study|Decision by sponsor|0|||
126372828|NCT02561962|454661523|FG004|Overall Study|Decision by sponsor|1|||
126372829|NCT02561962|454661524|FG005|Overall Study|Decision by sponsor|1|||
126372830|NCT02561962|454661525|FG006|Overall Study|Decision by sponsor|0|||
126372831|NCT02561962|454661526|FG007|Overall Study|Decision by sponsor|3|||
126372832|NCT02561962|454661527|FG008|Overall Study|Decision by sponsor|0|||
126372833|NCT02561962|454661519|FG000|Overall Study|Lost to Follow-up|0|||
126372834|NCT02561962|454661520|FG001|Overall Study|Lost to Follow-up|0|||
126372835|NCT02561962|454661521|FG002|Overall Study|Lost to Follow-up|0|||
126372836|NCT02561962|454661522|FG003|Overall Study|Lost to Follow-up|0|||
126372837|NCT02561962|454661523|FG004|Overall Study|Lost to Follow-up|0|||
126372838|NCT02561962|454661524|FG005|Overall Study|Lost to Follow-up|1|||
126372839|NCT02561962|454661525|FG006|Overall Study|Lost to Follow-up|0|||
126372840|NCT02561962|454661526|FG007|Overall Study|Lost to Follow-up|0|||
126372841|NCT02561962|454661527|FG008|Overall Study|Lost to Follow-up|0|||
126372842|NCT01150357|454661528|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
126372843|NCT01150357|454661529|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
126372844|NCT01150357|454661530|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
126372845|NCT01150357|454661528|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
126372846|NCT01150357|454661529|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
126104013|NCT03035201|453673894|FG001|Overall Study|Lost to Follow-up|51|||
126372847|NCT01150357|454661530|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
126372848|NCT01150357|454661528|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
126372849|NCT01150357|454661529|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
126372850|NCT01150357|454661530|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
126372851|NCT01150357|454661528|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
126372852|NCT01150357|454661529|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
126372853|NCT01150357|454661530|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
126372854|NCT01150357|454661528|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
126372855|NCT01150357|454661529|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
125885977|NCT01134055|452878878|FG000|Overall Study|Protocol Violation|0|||
126047688|NCT03885232|453472889|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
126047689|NCT01315132|453472890|FG000|Overall Study|not treated due to disease progression|1|||
126047690|NCT03840902|453472893|FG000|Overall Study|Randomized but not treated|1|||
126372856|NCT01150357|454661530|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
126372857|NCT01150357|454661528|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
126372858|NCT01150357|454661529|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
126372859|NCT01150357|454661530|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
126372860|NCT01150357|454661528|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
126372861|NCT01150357|454661529|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
126372862|NCT01150357|454661530|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
126372863|NCT01819272|454663278|FG000|Overall Study|Adverse Event|1|||
126372864|NCT01819272|454663279|FG001|Overall Study|Adverse Event|0|||
126372865|NCT01819272|454663280|FG002|Overall Study|Adverse Event|0|||
126372866|NCT01819272|454663281|FG003|Overall Study|Adverse Event|2|||
126372867|NCT01819272|454663282|FG004|Overall Study|Adverse Event|0|||
126372868|NCT01819272|454663283|FG005|Overall Study|Adverse Event|0|||
126372869|NCT01819272|454663278|FG000|Overall Study|Lost to Follow-up|3|||
126372870|NCT01819272|454663279|FG001|Overall Study|Lost to Follow-up|0|||
126372871|NCT01819272|454663280|FG002|Overall Study|Lost to Follow-up|1|||
126372872|NCT01819272|454663281|FG003|Overall Study|Lost to Follow-up|0|||
126372873|NCT01819272|454663282|FG004|Overall Study|Lost to Follow-up|0|||
126372874|NCT01819272|454663283|FG005|Overall Study|Lost to Follow-up|3|||
126372875|NCT01819272|454663278|FG000|Overall Study|Protocol Violation|0|||
126372876|NCT01819272|454663279|FG001|Overall Study|Protocol Violation|0|||
126372877|NCT01819272|454663280|FG002|Overall Study|Protocol Violation|0|||
126372878|NCT01819272|454663281|FG003|Overall Study|Protocol Violation|1|||
126372879|NCT01819272|454663282|FG004|Overall Study|Protocol Violation|2|||
126372880|NCT01819272|454663283|FG005|Overall Study|Protocol Violation|3|||
126372881|NCT01819272|454663278|FG000|Overall Study|Physician Decision|0|||
126372882|NCT01819272|454663279|FG001|Overall Study|Physician Decision|1|||
126372883|NCT01819272|454663280|FG002|Overall Study|Physician Decision|0|||
126372884|NCT01819272|454663281|FG003|Overall Study|Physician Decision|0|||
126372885|NCT01819272|454663282|FG004|Overall Study|Physician Decision|0|||
126372886|NCT01819272|454663283|FG005|Overall Study|Physician Decision|0|||
126047691|NCT03840902|453472894|FG001|Overall Study|Randomized but not treated|1|||
126047692|NCT03660930|453472895|FG000|Overall Study|Adverse Event|0|||
126047693|NCT03660930|453472896|FG001|Overall Study|Adverse Event|0|||
126047694|NCT03660930|453472897|FG002|Overall Study|Adverse Event|0|||
126104014|NCT03035201|453673895|FG002|Overall Study|Lost to Follow-up|64|||
126104015|NCT03035201|453673896|FG003|Overall Study|Lost to Follow-up|69|||
126104016|NCT01880528|453673898|FG000|Overall Study|Other|1|||
126104017|NCT01880528|453673899|FG001|Overall Study|Other|1|||
126104018|NCT01439360|453673900|FG000|Overall Study|Adverse Event|4|||
126104019|NCT01439360|453673901|FG001|Overall Study|Adverse Event|16|||
126104020|NCT01439360|453673900|FG000|Overall Study|Lost to Follow-up|43|||
126104021|NCT01439360|453673901|FG001|Overall Study|Lost to Follow-up|58|||
126104022|NCT01439360|453673900|FG000|Overall Study|Others|10|||
126104023|NCT01439360|453673901|FG001|Overall Study|Others|5|||
126104024|NCT01439360|453673900|FG000|Overall Study|Protocol Violation|1|||
126372887|NCT01819272|454663278|FG000|Overall Study|Withdrawal of Consent|0|||
126372888|NCT01819272|454663279|FG001|Overall Study|Withdrawal of Consent|1|||
126372889|NCT01819272|454663280|FG002|Overall Study|Withdrawal of Consent|2|||
126372890|NCT01819272|454663281|FG003|Overall Study|Withdrawal of Consent|1|||
126372891|NCT01819272|454663282|FG004|Overall Study|Withdrawal of Consent|0|||
126372892|NCT01819272|454663283|FG005|Overall Study|Withdrawal of Consent|1|||
126047695|NCT03660930|453472898|FG003|Overall Study|Adverse Event|2|||
126047696|NCT03660930|453472899|FG004|Overall Study|Adverse Event|0|||
126047697|NCT03660930|453472900|FG005|Overall Study|Adverse Event|1|||
126047698|NCT03660930|453472901|FG006|Overall Study|Adverse Event|0|||
126047699|NCT03660930|453472902|FG007|Overall Study|Adverse Event|0|||
126047700|NCT03660930|453472895|FG000|Overall Study|Withdrawal by Subject|0|||
126047701|NCT03660930|453472896|FG001|Overall Study|Withdrawal by Subject|0|||
126047702|NCT03660930|453472897|FG002|Overall Study|Withdrawal by Subject|0|||
126047703|NCT03660930|453472898|FG003|Overall Study|Withdrawal by Subject|0|||
126047704|NCT03660930|453472899|FG004|Overall Study|Withdrawal by Subject|0|||
126047705|NCT03660930|453472900|FG005|Overall Study|Withdrawal by Subject|1|||
126047706|NCT03660930|453472901|FG006|Overall Study|Withdrawal by Subject|0|||
126047707|NCT03660930|453472902|FG007|Overall Study|Withdrawal by Subject|0|||
126047708|NCT03280030|453472906|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
126104025|NCT01439360|453673901|FG001|Overall Study|Protocol Violation|0|||
126372893|NCT01819272|454663278|FG000|Overall Study|Loss of Glucose Control|2|||
126372894|NCT01819272|454663279|FG001|Overall Study|Loss of Glucose Control|1|||
126047709|NCT03280030|453472907|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
126047710|NCT03280030|453472908|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
126047711|NCT03280030|453472906|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
126047712|NCT03280030|453472907|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
126104026|NCT01439360|453673900|FG000|Overall Study|Withdrawal by Subject|140|||
126372895|NCT01819272|454663280|FG002|Overall Study|Loss of Glucose Control|0|||
126372896|NCT01819272|454663281|FG003|Overall Study|Loss of Glucose Control|1|||
126372897|NCT01819272|454663282|FG004|Overall Study|Loss of Glucose Control|2|||
126372898|NCT01819272|454663283|FG005|Overall Study|Loss of Glucose Control|0|||
126372899|NCT00503984|454663284|FG000|Overall Study|Protocol Violation|0|||
126372900|NCT00503984|454663285|FG001|Overall Study|Protocol Violation|1|||
126372901|NCT00503984|454663286|FG002|Overall Study|Protocol Violation|0|||
126372902|NCT00503984|454663287|FG003|Overall Study|Protocol Violation|0|||
126372903|NCT00503984|454663288|FG004|Overall Study|Protocol Violation|0|||
126372904|NCT00503984|454663289|FG005|Overall Study|Protocol Violation|0|||
126372905|NCT00503984|454663284|FG000|Overall Study|Adverse Event|0|||
126372906|NCT00503984|454663285|FG001|Overall Study|Adverse Event|1|||
126372907|NCT00503984|454663286|FG002|Overall Study|Adverse Event|0|||
126372908|NCT00503984|454663287|FG003|Overall Study|Adverse Event|0|||
126372909|NCT00503984|454663288|FG004|Overall Study|Adverse Event|0|||
126372910|NCT00503984|454663289|FG005|Overall Study|Adverse Event|0|||
126372911|NCT00503984|454663284|FG000|Overall Study|Death|0|||
126372912|NCT00503984|454663285|FG001|Overall Study|Death|0|||
126372913|NCT00503984|454663286|FG002|Overall Study|Death|0|||
126372914|NCT00503984|454663287|FG003|Overall Study|Death|0|||
126372915|NCT00503984|454663288|FG004|Overall Study|Death|1|||
126372916|NCT00503984|454663289|FG005|Overall Study|Death|0|||
126372917|NCT01246960|454663292|FG000|Overall Study|Lost to Follow-up|3|||
126372918|NCT01246960|454663293|FG001|Overall Study|Lost to Follow-up|1|||
126372919|NCT01246960|454663292|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
126372920|NCT01246960|454663293|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
126372921|NCT00140140|454663298|FG000|Overall Study|Unacceptable toxicity|1|||
126372922|NCT00140140|454663299|FG001|Overall Study|Unacceptable toxicity|1|||
126372923|NCT00140140|454663300|FG002|Overall Study|Unacceptable toxicity|2|||
126372924|NCT00140140|454663298|FG000|Overall Study|Physician Decision|1|||
126372925|NCT00140140|454663299|FG001|Overall Study|Physician Decision|1|||
126372926|NCT00140140|454663300|FG002|Overall Study|Physician Decision|0|||
126372927|NCT03376516|454663301|FG000|Overall Study|Not treated|1|||
126372928|NCT03376516|454663301|FG000|Overall Study|Consent withdrawn|1|||
126372929|NCT01359956|454663302|FG000|Overall Study|Death|58|||
126372930|NCT01359956|454663303|FG001|Overall Study|Death|60|||
126372931|NCT01359956|454663304|FG002|Overall Study|Death|66|||
126372932|NCT01359956|454663305|FG003|Overall Study|Death|57|||
126372933|NCT01359956|454663302|FG000|Overall Study|Lost to Follow-up|3|||
126372934|NCT01359956|454663303|FG001|Overall Study|Lost to Follow-up|4|||
126372935|NCT01359956|454663304|FG002|Overall Study|Lost to Follow-up|1|||
126372936|NCT01359956|454663305|FG003|Overall Study|Lost to Follow-up|1|||
126372937|NCT01784029|454663306|FG000|Overall Study|Lost to Follow-up|19|||
126372938|NCT01784029|454663307|FG001|Overall Study|Lost to Follow-up|20|||
126104027|NCT01439360|453673901|FG001|Overall Study|Withdrawal by Subject|129|||
126104028|NCT03727438|453673907|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
126104029|NCT03727438|453673908|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
126372939|NCT01784029|454663308|FG002|Overall Study|Lost to Follow-up|22|||
126372940|NCT00639457|454663309|FG000|Overall Study|Withdrawal by Subject|2|||
126372941|NCT00639457|454663310|FG001|Overall Study|Withdrawal by Subject|3|||
125885978|NCT01134055|452878879|FG001|Overall Study|Protocol Violation|0|||
125885979|NCT01134055|452878880|FG002|Overall Study|Protocol Violation|0|||
125885980|NCT01134055|452878881|FG003|Overall Study|Protocol Violation|1|||
126372942|NCT00370292|454663311|FG000|Overall Study|Disease Progression|4|||
126372943|NCT00370292|454663311|FG000|Overall Study|Adverse Event|7|||
126372944|NCT00370292|454663311|FG000|Overall Study|Physician Decision|2|||
125885981|NCT01134055|452878882|FG004|Overall Study|Protocol Violation|1|||
126372945|NCT00276419|454663312|FG000|First Intervention|Adverse Event|1|||
126372946|NCT00276419|454663313|FG001|First Intervention|Adverse Event|0|||
126372947|NCT00276419|454663312|FG000|First Intervention|Withdrawal by Subject|0|||
126372948|NCT00276419|454663313|FG001|First Intervention|Withdrawal by Subject|2|||
125885982|NCT01134055|452878883|FG005|Overall Study|Protocol Violation|0|||
125885983|NCT01134055|452878884|FG006|Overall Study|Protocol Violation|0|||
125885984|NCT01134055|452878878|FG000|Overall Study|Physician Decision|0|||
125885985|NCT01134055|452878879|FG001|Overall Study|Physician Decision|0|||
125885986|NCT01134055|452878880|FG002|Overall Study|Physician Decision|0|||
125885987|NCT01134055|452878881|FG003|Overall Study|Physician Decision|0|||
125885988|NCT01134055|452878882|FG004|Overall Study|Physician Decision|0|||
125885989|NCT01134055|452878883|FG005|Overall Study|Physician Decision|0|||
125885990|NCT01134055|452878884|FG006|Overall Study|Physician Decision|1|||
125885991|NCT03023397|452878889|FG000|Run-In|Failed screening allergen challenge|1|||
125885992|NCT03023397|452878890|FG001|Run-In|Failed screening allergen challenge|0|||
125885993|NCT03023397|452878891|FG002|Run-In|Failed screening allergen challenge|0|||
125885994|NCT03023397|452878889|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
125885995|NCT03023397|452878890|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
125885996|NCT03023397|452878891|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
125885997|NCT01146795|452878895|FG000|Overall Study|Withdrawal by Subject|4|||
125885998|NCT01146795|452878895|FG000|Overall Study|Adverse Event|6|||
125885999|NCT01146795|452878895|FG000|Overall Study|Still in treatment at study closure|10|||
125886000|NCT03853109|452878896|FG000|Overall Study|Withdrawal by Subject|0|||
125886001|NCT03853109|452878897|FG001|Overall Study|Withdrawal by Subject|0|||
125886002|NCT03853109|452878898|FG002|Overall Study|Withdrawal by Subject|1|||
125886003|NCT03853109|452878899|FG003|Overall Study|Withdrawal by Subject|2|||
125886004|NCT03853109|452878900|FG004|Overall Study|Withdrawal by Subject|1|||
125886005|NCT03853109|452878901|FG005|Overall Study|Withdrawal by Subject|4|||
125886006|NCT03853109|452878902|FG006|Overall Study|Withdrawal by Subject|5|||
125886007|NCT03853109|452878903|FG007|Overall Study|Withdrawal by Subject|3|||
125886008|NCT03853109|452878896|FG000|Overall Study|Decision by Sponsor|0|||
125886009|NCT03853109|452878897|FG001|Overall Study|Decision by Sponsor|0|||
125886010|NCT03853109|452878898|FG002|Overall Study|Decision by Sponsor|1|||
126047713|NCT03280030|453472908|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
126047714|NCT03280030|453472906|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
126047715|NCT03280030|453472907|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
126372949|NCT03545672|454663314|FG000|Overall Study|Uncertain diagnosis|2|||
126372950|NCT03545672|454663315|FG001|Overall Study|Uncertain diagnosis|1|||
126372951|NCT03545672|454663314|FG000|Overall Study|Protocol Violation|2|||
126372952|NCT03545672|454663315|FG001|Overall Study|Protocol Violation|2|||
126372953|NCT01628913|454663316|FG000|Overall Study|Adverse Event|12|||
126372954|NCT01628913|454663317|FG001|Overall Study|Adverse Event|5|||
126372955|NCT01628913|454663316|FG000|Overall Study|Disease Progression|11|||
125886011|NCT03853109|452878899|FG003|Overall Study|Decision by Sponsor|0|||
125886012|NCT03853109|452878900|FG004|Overall Study|Decision by Sponsor|1|||
125886013|NCT03853109|452878901|FG005|Overall Study|Decision by Sponsor|1|||
125886014|NCT03853109|452878902|FG006|Overall Study|Decision by Sponsor|10|||
125886015|NCT03853109|452878903|FG007|Overall Study|Decision by Sponsor|2|||
125886016|NCT03853109|452878896|FG000|Overall Study|Lost to Follow-up|0|||
125886017|NCT03853109|452878897|FG001|Overall Study|Lost to Follow-up|0|||
126372956|NCT01628913|454663317|FG001|Overall Study|Disease Progression|14|||
125886018|NCT03853109|452878898|FG002|Overall Study|Lost to Follow-up|0|||
125886019|NCT03853109|452878899|FG003|Overall Study|Lost to Follow-up|0|||
126372957|NCT01628913|454663316|FG000|Overall Study|Protocol Violation|1|||
126047716|NCT03280030|453472908|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
126047717|NCT03280030|453472906|FG000|Part 2 - Efficacy|Adverse Event|0|||
126047718|NCT03280030|453472907|FG001|Part 2 - Efficacy|Adverse Event|4|||
126047719|NCT03280030|453472908|FG002|Part 2 - Efficacy|Adverse Event|6|||
126047720|NCT03280030|453472906|FG000|Part 2 - Efficacy|Death|0|||
126047721|NCT03280030|453472907|FG001|Part 2 - Efficacy|Death|3|||
126047722|NCT03280030|453472908|FG002|Part 2 - Efficacy|Death|0|||
126047723|NCT03280030|453472906|FG000|Part 2 - Efficacy|Physician Decision|0|||
126047724|NCT03280030|453472907|FG001|Part 2 - Efficacy|Physician Decision|10|||
126047725|NCT03280030|453472908|FG002|Part 2 - Efficacy|Physician Decision|16|||
126047726|NCT03280030|453472906|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
126047727|NCT03280030|453472907|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
126047728|NCT03280030|453472908|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
126047729|NCT03280030|453472906|FG000|Part 2 - Efficacy|Progressive disease|0|||
126047730|NCT03280030|453472907|FG001|Part 2 - Efficacy|Progressive disease|7|||
126047731|NCT03280030|453472908|FG002|Part 2 - Efficacy|Progressive disease|5|||
126047732|NCT03222609|453472909|FG000|Overall Study|Withdrew consent|2|||
126047733|NCT03222609|453472910|FG001|Overall Study|Withdrew consent|3|||
126047734|NCT03222609|453472911|FG002|Overall Study|Withdrew consent|4|||
126047735|NCT03222609|453472912|FG003|Overall Study|Withdrew consent|2|||
126047736|NCT03222609|453472909|FG000|Overall Study|Lost to Follow-up|1|||
126047737|NCT03222609|453472910|FG001|Overall Study|Lost to Follow-up|0|||
126047738|NCT03222609|453472911|FG002|Overall Study|Lost to Follow-up|0|||
126047739|NCT03222609|453472912|FG003|Overall Study|Lost to Follow-up|0|||
126047740|NCT03222609|453472909|FG000|Overall Study|Death|16|||
126047741|NCT03222609|453472910|FG001|Overall Study|Death|13|||
126047742|NCT03222609|453472911|FG002|Overall Study|Death|9|||
126047743|NCT03222609|453472912|FG003|Overall Study|Death|6|||
126047744|NCT03222609|453472909|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
126047745|NCT03222609|453472910|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
126047746|NCT03222609|453472911|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
126047747|NCT03222609|453472912|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
126047748|NCT05139992|453472915|FG000|Overall Study|Withdrawal by Subject|12|||
126047749|NCT05139992|453472915|FG000|Overall Study|Lost to Follow-up|6|||
126047750|NCT01208974|453472916|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
126047751|NCT01208974|453472917|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
126047752|NCT01208974|453472918|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
126047753|NCT01208974|453472919|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
126047754|NCT01208974|453472916|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
126047755|NCT01208974|453472917|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
126047756|NCT01208974|453472918|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
126047757|NCT01208974|453472919|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
126047758|NCT01208974|453472916|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
126047759|NCT01208974|453472917|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
126047760|NCT01208974|453472918|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
126047761|NCT01208974|453472919|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
126047762|NCT05521516|453472920|FG000|Overall Study|Withdrawal by Subject|1|||
126047763|NCT05521516|453472921|FG001|Overall Study|Withdrawal by Subject|1|||
126047764|NCT04305327|453472922|FG000|Overall Study|Study early termination|2|||
126047765|NCT04305327|453472923|FG001|Overall Study|Study early termination|5|||
126047766|NCT04305327|453472924|FG002|Overall Study|Study early termination|2|||
126047767|NCT04305327|453472925|FG003|Overall Study|Study early termination|2|||
126047768|NCT04305327|453472922|FG000|Overall Study|Withdrawal by Subject|0|||
126047769|NCT04305327|453472923|FG001|Overall Study|Withdrawal by Subject|1|||
125886020|NCT03853109|452878900|FG004|Overall Study|Lost to Follow-up|1|||
125886021|NCT03853109|452878901|FG005|Overall Study|Lost to Follow-up|3|||
125886022|NCT03853109|452878902|FG006|Overall Study|Lost to Follow-up|0|||
126104030|NCT03727438|453673907|FG000|Intervention Period|Excluded (health)|1|||
126309370|NCT02691936|454421031|FG001|Overall Study|Withdrawal by Subject|5|||
126309371|NCT00834639|454421032|FG000|Second Intervention|Physician Decision|0|||
126309372|NCT00834639|454421033|FG001|Second Intervention|Physician Decision|2|||
126309373|NCT03382834|454421036|FG000|Step 1|Lost to Follow-up|0|||
126309374|NCT03382834|454421037|FG001|Step 1|Lost to Follow-up|1|||
126309375|NCT03382834|454421036|FG000|Step 2|Death|1|||
126309376|NCT03382834|454421037|FG001|Step 2|Death|0|||
126309377|NCT03382834|454421036|FG000|Step 2|Lost to Follow-up|2|||
126309378|NCT03382834|454421037|FG001|Step 2|Lost to Follow-up|2|||
126309379|NCT03382834|454421036|FG000|Step 2|Site Terminated by Sponsor|1|||
126309380|NCT03382834|454421037|FG001|Step 2|Site Terminated by Sponsor|0|||
126309381|NCT02387957|454421038|FG000|Overall Study|The study was discontinued|21|||
126309382|NCT02387957|454421039|FG001|Overall Study|The study was discontinued|21|||
126309383|NCT02387957|454421040|FG002|Overall Study|The study was discontinued|20|||
126309384|NCT00977314|454421045|FG000|Overall Study|Withdrawal by Subject|1|||
126309385|NCT00977314|454421046|FG001|Overall Study|Withdrawal by Subject|0|||
126309386|NCT00977314|454421045|FG000|Overall Study|Physician Decision|1|||
126309387|NCT00977314|454421046|FG001|Overall Study|Physician Decision|0|||
126309388|NCT01343277|454421050|FG000|Overall Study|Other|3|||
126309389|NCT01343277|454421051|FG001|Overall Study|Other|3|||
126309390|NCT01343277|454421050|FG000|Overall Study|Withdrawal by Subject|18|||
126309391|NCT01343277|454421051|FG001|Overall Study|Withdrawal by Subject|13|||
126309392|NCT01343277|454421050|FG000|Overall Study|Physician Decision|1|||
126309393|NCT01343277|454421051|FG001|Overall Study|Physician Decision|2|||
126309394|NCT01343277|454421050|FG000|Overall Study|Death|10|||
126309395|NCT01343277|454421051|FG001|Overall Study|Death|1|||
125886023|NCT03853109|452878903|FG007|Overall Study|Lost to Follow-up|0|||
125886024|NCT03853109|452878896|FG000|Overall Study|Death|2|||
126309396|NCT01343277|454421050|FG000|Overall Study|Adverse Event|67|||
126309397|NCT01343277|454421051|FG001|Overall Study|Adverse Event|13|||
126309398|NCT01343277|454421050|FG000|Overall Study|Disease progression|270|||
126309399|NCT01343277|454421051|FG001|Overall Study|Disease progression|138|||
126309400|NCT01343277|454421050|FG000|Overall Study|Randomized not treated|6|||
126309401|NCT01343277|454421051|FG001|Overall Study|Randomized not treated|21|||
126309402|NCT01343277|454421050|FG000|Overall Study|Treatment ongoing|8|||
125886025|NCT03853109|452878897|FG001|Overall Study|Death|5|||
125886026|NCT03853109|452878898|FG002|Overall Study|Death|8|||
125886027|NCT03853109|452878899|FG003|Overall Study|Death|10|||
125886028|NCT03853109|452878900|FG004|Overall Study|Death|3|||
125886029|NCT03853109|452878901|FG005|Overall Study|Death|20|||
125886030|NCT03853109|452878902|FG006|Overall Study|Death|10|||
125886031|NCT03853109|452878903|FG007|Overall Study|Death|5|||
125886032|NCT01721044|452878906|FG000|Treatment Period|Adverse Event|7|||
125886033|NCT01721044|452878907|FG001|Treatment Period|Adverse Event|7|||
125886034|NCT01721044|452878908|FG002|Treatment Period|Adverse Event|10|||
125886035|NCT01721044|452878906|FG000|Treatment Period|Death|0|||
125886036|NCT01721044|452878907|FG001|Treatment Period|Death|0|||
125886037|NCT01721044|452878908|FG002|Treatment Period|Death|1|||
125886038|NCT01721044|452878906|FG000|Treatment Period|Lack of Efficacy|16|||
125886039|NCT01721044|452878907|FG001|Treatment Period|Lack of Efficacy|4|||
125886040|NCT01721044|452878908|FG002|Treatment Period|Lack of Efficacy|4|||
125886041|NCT01721044|452878906|FG000|Treatment Period|Lost to Follow-up|0|||
125886042|NCT01721044|452878907|FG001|Treatment Period|Lost to Follow-up|0|||
125886043|NCT01721044|452878908|FG002|Treatment Period|Lost to Follow-up|1|||
125886044|NCT01721044|452878906|FG000|Treatment Period|Physician Decision|1|||
125886045|NCT01721044|452878907|FG001|Treatment Period|Physician Decision|0|||
125886046|NCT01721044|452878908|FG002|Treatment Period|Physician Decision|2|||
125886047|NCT01721044|452878906|FG000|Treatment Period|Protocol Violation|1|||
125886048|NCT01721044|452878907|FG001|Treatment Period|Protocol Violation|0|||
125886049|NCT01721044|452878908|FG002|Treatment Period|Protocol Violation|0|||
125886050|NCT01721044|452878906|FG000|Treatment Period|Withdrawal by Subject|7|||
125886051|NCT01721044|452878907|FG001|Treatment Period|Withdrawal by Subject|6|||
125886052|NCT01721044|452878908|FG002|Treatment Period|Withdrawal by Subject|1|||
125886053|NCT04032093|452878909|FG000|Overall Study|Lost to Follow-up|7|||
125886054|NCT04032093|452878910|FG001|Overall Study|Lost to Follow-up|7|||
125886055|NCT04032093|452878911|FG002|Overall Study|Lost to Follow-up|6|||
126047770|NCT04305327|453472924|FG002|Overall Study|Withdrawal by Subject|0|||
126047771|NCT04305327|453472925|FG003|Overall Study|Withdrawal by Subject|0|||
126047772|NCT03656718|453472926|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
126309403|NCT01343277|454421051|FG001|Overall Study|Treatment ongoing|2|||
126309404|NCT01343277|454421050|FG000|Overall Study|Subsequent anticancer therapy|1|||
126309405|NCT01343277|454421051|FG001|Overall Study|Subsequent anticancer therapy|0|||
125886056|NCT04032093|452878912|FG003|Overall Study|Lost to Follow-up|10|||
125886057|NCT04032093|452878913|FG004|Overall Study|Lost to Follow-up|13|||
126047773|NCT03656718|453472927|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
125886058|NCT04032093|452878914|FG005|Overall Study|Lost to Follow-up|7|||
125886059|NCT04032093|452878915|FG006|Overall Study|Lost to Follow-up|7|||
125886060|NCT04032093|452878916|FG007|Overall Study|Lost to Follow-up|5|||
125886061|NCT04032093|452878917|FG008|Overall Study|Lost to Follow-up|9|||
125886062|NCT04032093|452878918|FG009|Overall Study|Lost to Follow-up|12|||
125886063|NCT04032093|452878909|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125886064|NCT04032093|452878910|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126309406|NCT02964208|454421059|FG000|Overall Study|Death|103|||
126047774|NCT03656718|453472928|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
126309407|NCT02964208|454421059|FG000|Overall Study|Withdrawal by Subject|6|||
126309408|NCT02964208|454421059|FG000|Overall Study|Lost to Follow-up|6|||
126309409|NCT02964208|454421059|FG000|Overall Study|Unsuccessful Procedure|5|||
126309410|NCT02964208|454421059|FG000|Overall Study|Device Explant|1|||
126309411|NCT02964208|454421059|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
126309412|NCT05270395|454421075|FG000|Overall Study|Lost to Follow-up|2|||
126309413|NCT05270395|454421076|FG001|Overall Study|Lost to Follow-up|2|||
126309414|NCT05270395|454421075|FG000|Overall Study|Death|1|||
126309415|NCT05270395|454421076|FG001|Overall Study|Death|2|||
126309416|NCT05270395|454421075|FG000|Overall Study|Study Team Withdrew|1|||
126309417|NCT05270395|454421076|FG001|Overall Study|Study Team Withdrew|0|||
126309418|NCT03725761|454421077|FG000|Overall Study|still on study|1|||
126309419|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
126309420|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
126309421|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
126309422|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
126309423|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Death|0|||
126309424|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Death|0|||
126372958|NCT01628913|454663317|FG001|Overall Study|Protocol Violation|0|||
126372959|NCT01628913|454663316|FG000|Overall Study|Death|1|||
126372960|NCT01628913|454663317|FG001|Overall Study|Death|0|||
126372961|NCT01628913|454663316|FG000|Overall Study|study terminated by Sponsor|4|||
126372962|NCT01628913|454663317|FG001|Overall Study|study terminated by Sponsor|9|||
126372963|NCT01628913|454663316|FG000|Overall Study|Withdrawal by Subject|1|||
126372964|NCT01628913|454663317|FG001|Overall Study|Withdrawal by Subject|0|||
126372965|NCT01628913|454663316|FG000|Overall Study|Physician Decision|1|||
126372966|NCT01628913|454663317|FG001|Overall Study|Physician Decision|3|||
126372967|NCT04778592|454663325|FG000|Overall Study|Adverse Event|1|||
126372968|NCT04778592|454663326|FG001|Overall Study|Adverse Event|2|||
126372969|NCT04778592|454663325|FG000|Overall Study|Withdrawal by Subject|1|||
126372970|NCT04778592|454663326|FG001|Overall Study|Withdrawal by Subject|2|||
126372971|NCT01192126|454663327|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
126372972|NCT01192126|454663328|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
126372973|NCT01192126|454663327|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
126372974|NCT01192126|454663328|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
126372975|NCT04102007|454663329|FG000|Overall Study|Adverse Event|4|||
126372976|NCT04102007|454663329|FG000|Overall Study|Lost to Follow-up|3|||
126372977|NCT04102007|454663329|FG000|Overall Study|Withdrawal by Subject|12|||
126372978|NCT04102007|454663329|FG000|Overall Study|Eligibility Violation|5|||
126372979|NCT04102007|454663329|FG000|Overall Study|Lack of Efficacy|6|||
126372980|NCT04102007|454663329|FG000|Overall Study|Protocol Deviation|5|||
126372981|NCT04102007|454663329|FG000|Overall Study|Protocol Compliance|1|||
126372982|NCT04102007|454663329|FG000|Overall Study|Withdrew Treatment|2|||
126372983|NCT04102007|454663329|FG000|Overall Study|Pregnancy|1|||
126372984|NCT02660229|454663330|FG000|Overall Study|Adverse Event|2|||
126372985|NCT02660229|454663331|FG001|Overall Study|Adverse Event|0|||
126372986|NCT02660229|454663330|FG000|Overall Study|Withdrawal by Subject|0|||
126372987|NCT02660229|454663331|FG001|Overall Study|Withdrawal by Subject|1|||
126372988|NCT00892008|454663332|FG000|Overall Study|Death|5|||
126372989|NCT00892008|454663332|FG000|Overall Study|Lack of Efficacy|3|||
126372990|NCT00892008|454663332|FG000|Overall Study|Lost to Follow-up|142|||
126372991|NCT00892008|454663332|FG000|Overall Study|Other|378|||
126372992|NCT00892008|454663332|FG000|Overall Study|Adverse Event|37|||
126372993|NCT00399529|454663333|FG000|Overall Study|Off Study Prior to Treatment|2|||
126372994|NCT02133573|454663334|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
126372995|NCT02133573|454663335|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
126372996|NCT02133573|454663334|FG000|Overall Study|Child Deaths|3|||
126372997|NCT02133573|454663335|FG001|Overall Study|Child Deaths|5|||
126372998|NCT02133573|454663334|FG000|Overall Study|Child Declined Follow Ups|2|||
126372999|NCT02133573|454663335|FG001|Overall Study|Child Declined Follow Ups|1|||
126373000|NCT02133573|454663334|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
126373001|NCT02133573|454663335|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
126373002|NCT02431325|454663338|FG000|Overall Study|Adverse Event|3|||
126373003|NCT02431325|454663339|FG001|Overall Study|Adverse Event|0|||
126373004|NCT02431325|454663338|FG000|Overall Study|Lost to Follow-up|0|||
126373005|NCT02431325|454663339|FG001|Overall Study|Lost to Follow-up|1|||
126373006|NCT02431325|454663338|FG000|Overall Study|Withdrawal by Subject|1|||
126373007|NCT02431325|454663339|FG001|Overall Study|Withdrawal by Subject|2|||
126373008|NCT02431325|454663338|FG000|Overall Study|Declined to take study medication|1|||
126373009|NCT02431325|454663339|FG001|Overall Study|Declined to take study medication|0|||
126373010|NCT02431325|454663338|FG000|Overall Study|Withdrew before starting study medication|1|||
126373011|NCT02431325|454663339|FG001|Overall Study|Withdrew before starting study medication|0|||
125886065|NCT04032093|452878911|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125886066|NCT04032093|452878912|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
125886067|NCT04032093|452878913|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
125886068|NCT04032093|452878914|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125886069|NCT04032093|452878915|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
125886070|NCT04032093|452878916|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125886071|NCT04032093|452878917|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
125886072|NCT04032093|452878918|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
125886073|NCT04032093|452878909|FG000|Overall Study|Other|1|||
125886074|NCT04032093|452878910|FG001|Overall Study|Other|0|||
125886075|NCT04032093|452878911|FG002|Overall Study|Other|0|||
125886076|NCT04032093|452878912|FG003|Overall Study|Other|1|||
125886077|NCT04032093|452878913|FG004|Overall Study|Other|1|||
125886078|NCT04032093|452878914|FG005|Overall Study|Other|0|||
125886079|NCT04032093|452878915|FG006|Overall Study|Other|0|||
125886080|NCT04032093|452878916|FG007|Overall Study|Other|0|||
126309425|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Death|1|||
126309426|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Death|0|||
126309427|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
126309428|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
126309429|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
126309430|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
126309431|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
126309432|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
126309433|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
126309434|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
126309435|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
126309436|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
126309437|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
126309438|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
126309439|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
126309440|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
126309441|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
126309442|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
126309443|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
126309444|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
126309445|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
126309446|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
126309447|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
126309448|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
126309449|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
126309450|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
126309451|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126309452|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
126309453|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126309454|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126309455|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
126309456|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
126309457|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
126309458|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
126309459|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
126309460|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
126309461|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
126309462|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
126309463|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Other|8|||
126309464|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Other|14|||
126309465|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Other|8|||
126309466|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Other|23|||
126309467|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
126309468|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
126309469|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
125886081|NCT04032093|452878917|FG008|Overall Study|Other|0|||
125886082|NCT04032093|452878918|FG009|Overall Study|Other|1|||
125886083|NCT04032093|452878909|FG000|Overall Study|Withdrawal by Subject|1|||
126309470|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
125886084|NCT04032093|452878910|FG001|Overall Study|Withdrawal by Subject|3|||
126104031|NCT03727438|453673908|FG001|Intervention Period|Excluded (health)|0|||
125886085|NCT04032093|452878911|FG002|Overall Study|Withdrawal by Subject|2|||
125886086|NCT04032093|452878912|FG003|Overall Study|Withdrawal by Subject|2|||
125886087|NCT04032093|452878913|FG004|Overall Study|Withdrawal by Subject|3|||
125886088|NCT04032093|452878914|FG005|Overall Study|Withdrawal by Subject|0|||
125886089|NCT04032093|452878915|FG006|Overall Study|Withdrawal by Subject|0|||
125886090|NCT04032093|452878916|FG007|Overall Study|Withdrawal by Subject|0|||
125886091|NCT04032093|452878917|FG008|Overall Study|Withdrawal by Subject|0|||
125886092|NCT04032093|452878918|FG009|Overall Study|Withdrawal by Subject|0|||
125886093|NCT04032093|452878909|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125886094|NCT04032093|452878910|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125886095|NCT04032093|452878911|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125886096|NCT04032093|452878912|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125886097|NCT04032093|452878913|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125886098|NCT04032093|452878914|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125886099|NCT04032093|452878915|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
125886100|NCT04032093|452878916|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
125886101|NCT04032093|452878917|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
125886102|NCT04032093|452878918|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
125886103|NCT04032093|452878909|FG000|Overall Study|Adverse Event|0|||
125886104|NCT04032093|452878910|FG001|Overall Study|Adverse Event|0|||
125886105|NCT04032093|452878911|FG002|Overall Study|Adverse Event|0|||
125886106|NCT04032093|452878912|FG003|Overall Study|Adverse Event|0|||
125886107|NCT04032093|452878913|FG004|Overall Study|Adverse Event|0|||
125886108|NCT04032093|452878914|FG005|Overall Study|Adverse Event|0|||
125886109|NCT04032093|452878915|FG006|Overall Study|Adverse Event|0|||
125886110|NCT04032093|452878916|FG007|Overall Study|Adverse Event|0|||
125886111|NCT04032093|452878917|FG008|Overall Study|Adverse Event|0|||
125886112|NCT04032093|452878918|FG009|Overall Study|Adverse Event|1|||
125886113|NCT04032093|452878909|FG000|Overall Study|Physician Decision|0|||
125886114|NCT04032093|452878910|FG001|Overall Study|Physician Decision|0|||
125886115|NCT04032093|452878911|FG002|Overall Study|Physician Decision|0|||
125886116|NCT04032093|452878912|FG003|Overall Study|Physician Decision|0|||
125886117|NCT04032093|452878913|FG004|Overall Study|Physician Decision|0|||
125886118|NCT04032093|452878914|FG005|Overall Study|Physician Decision|1|||
125886119|NCT04032093|452878915|FG006|Overall Study|Physician Decision|0|||
125886120|NCT04032093|452878916|FG007|Overall Study|Physician Decision|0|||
125886121|NCT04032093|452878917|FG008|Overall Study|Physician Decision|0|||
125886122|NCT04032093|452878918|FG009|Overall Study|Physician Decision|0|||
125886123|NCT01457703|452878923|FG000|Overall Study|Screen Failure|5|||
125886124|NCT01457703|452878924|FG001|Overall Study|Screen Failure|7|||
125886125|NCT01457703|452878923|FG000|Overall Study|Withdrawal by Subject|1|||
125886126|NCT01457703|452878924|FG001|Overall Study|Withdrawal by Subject|4|||
125886127|NCT02952820|452878925|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
125886128|NCT02952820|452878926|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
125886129|NCT02952820|452878927|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
125886130|NCT02952820|452878925|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
125886131|NCT02952820|452878926|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
125886132|NCT02952820|452878927|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
125886133|NCT02952820|452878925|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
125886134|NCT02952820|452878926|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
125886135|NCT02952820|452878927|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
125886136|NCT02952820|452878925|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
125886137|NCT02952820|452878926|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
125886138|NCT02952820|452878927|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
125886139|NCT02952820|452878925|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
125886140|NCT02952820|452878926|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
126104032|NCT03727438|453673907|FG000|Intervention Period|Withdrawal by Subject|3|||
126309471|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126309472|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126309473|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
126309474|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
126309475|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Death|0|||
126309476|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Death|0|||
126309477|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Death|0|||
126309478|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Death|1|||
126309479|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
125886141|NCT02952820|452878927|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
125886142|NCT02952820|452878925|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
125886143|NCT02952820|452878926|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
125886144|NCT02952820|452878927|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
125886145|NCT02952820|452878925|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
125886146|NCT02952820|452878926|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
126047775|NCT03656718|453472929|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
126047776|NCT03656718|453472930|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
126047777|NCT03656718|453472931|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
126309480|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
126309481|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
126309482|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
126309483|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126309484|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
126309485|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
126309486|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
126309487|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
126309488|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
125886147|NCT02952820|452878927|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
125886148|NCT02952820|452878925|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
125886149|NCT02952820|452878926|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
126047778|NCT03656718|453472932|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
126047779|NCT03656718|453472926|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
126047780|NCT03656718|453472927|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
126047781|NCT03656718|453472928|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
126309489|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
126309490|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
126309491|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126309492|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126309493|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126309494|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126309495|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126309496|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
126309497|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
126309498|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126309499|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
126309500|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
126309501|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
126309502|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
126309503|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126309504|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126309505|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126309506|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
126309507|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Other|6|||
126309508|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Other|5|||
126309509|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Other|8|||
126309510|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Other|5|||
126309511|NCT03937908|454423103|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
126309512|NCT03937908|454423104|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
126309513|NCT03875092|454423105|FG000|Overall Study|Adverse Event|2|||
126309514|NCT03875092|454423106|FG001|Overall Study|Adverse Event|5|||
126309515|NCT03875092|454423105|FG000|Overall Study|Death|44|||
126309516|NCT03875092|454423106|FG001|Overall Study|Death|51|||
126309517|NCT03875092|454423105|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
126309518|NCT03875092|454423106|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
126309519|NCT03205761|454423107|FG000|Overall Study|Withdrawal by Subject|1|||
126309520|NCT03205761|454423107|FG000|Overall Study|Progressive Disease|10|||
126309521|NCT04420585|454423108|FG000|Overall Study|Adverse Event|1|||
126309522|NCT04420585|454423108|FG000|Overall Study|Never initiated medication|2|||
126309523|NCT02163226|454423109|FG000|Overall Study|Death|2|||
126309524|NCT02163226|454423110|FG001|Overall Study|Death|1|||
126309525|NCT02163226|454423109|FG000|Overall Study|Withdrawal by Subject|5|||
126309526|NCT02163226|454423110|FG001|Overall Study|Withdrawal by Subject|2|||
126309527|NCT02163226|454423109|FG000|Overall Study|Returned home, local radiotherapy|3|||
126309528|NCT02163226|454423110|FG001|Overall Study|Returned home, local radiotherapy|0|||
126373012|NCT02431325|454663338|FG000|Overall Study|Placebo shortage|2|||
126373013|NCT02431325|454663339|FG001|Overall Study|Placebo shortage|0|||
126373014|NCT00744861|454663340|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
126373015|NCT00744861|454663341|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
126373016|NCT00744861|454663342|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
126373017|NCT00744861|454663343|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
126373018|NCT00744861|454663340|FG000|Feasibility Stage 1|Pregnancy|0|||
126373019|NCT00744861|454663341|FG001|Feasibility Stage 1|Pregnancy|1|||
126373020|NCT00744861|454663342|FG002|Feasibility Stage 1|Pregnancy|0|||
126373021|NCT00744861|454663343|FG003|Feasibility Stage 1|Pregnancy|0|||
126373022|NCT00744861|454663340|FG000|Pivotal Stage 2|Adverse Event|0|||
126373023|NCT00744861|454663341|FG001|Pivotal Stage 2|Adverse Event|0|||
126373024|NCT00744861|454663342|FG002|Pivotal Stage 2|Adverse Event|6|||
126373025|NCT00744861|454663343|FG003|Pivotal Stage 2|Adverse Event|11|||
126373026|NCT00744861|454663340|FG000|Pivotal Stage 2|Death|0|||
126373027|NCT00744861|454663341|FG001|Pivotal Stage 2|Death|0|||
126373028|NCT00744861|454663342|FG002|Pivotal Stage 2|Death|0|||
126373029|NCT00744861|454663343|FG003|Pivotal Stage 2|Death|1|||
126373030|NCT00744861|454663340|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
126373031|NCT00744861|454663341|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
126373032|NCT00744861|454663342|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
126373033|NCT00744861|454663343|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
126373034|NCT00744861|454663340|FG000|Pivotal Stage 2|Physician Decision|0|||
126373035|NCT00744861|454663341|FG001|Pivotal Stage 2|Physician Decision|0|||
125886150|NCT02952820|452878927|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
125886151|NCT02952820|452878925|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
125886152|NCT02952820|452878926|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
125886153|NCT02952820|452878927|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
125886154|NCT02952820|452878925|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
125886155|NCT02952820|452878926|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
125886156|NCT02952820|452878927|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
125886157|NCT02952820|452878925|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
125886158|NCT02952820|452878926|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
125886159|NCT02952820|452878927|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
125886160|NCT02952820|452878925|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
125886161|NCT02952820|452878926|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
126309529|NCT02163226|454423109|FG000|Overall Study|Repeat imaging showed no disease|2|||
126309530|NCT02163226|454423110|FG001|Overall Study|Repeat imaging showed no disease|0|||
126309531|NCT02163226|454423109|FG000|Overall Study|Incomplete radiotherapy|3|||
126309532|NCT02163226|454423110|FG001|Overall Study|Incomplete radiotherapy|0|||
126309533|NCT02163226|454423109|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
126309534|NCT02163226|454423110|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
126309535|NCT02163226|454423109|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
126309536|NCT02163226|454423110|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
126309537|NCT02163226|454423109|FG000|Overall Study|ineligible|0|||
126309538|NCT02163226|454423110|FG001|Overall Study|ineligible|3|||
126309539|NCT04114357|454423111|FG000|Baseline-Randomization|Adverse Event|2|||
126309540|NCT04114357|454423112|FG001|Baseline-Randomization|Adverse Event|1|||
126309541|NCT04114357|454423111|FG000|Baseline-Randomization|Lost to Follow-up|1|||
126309542|NCT04114357|454423112|FG001|Baseline-Randomization|Lost to Follow-up|1|||
126309543|NCT04114357|454423111|FG000|Cross-over|Adverse Event|0|||
126309544|NCT04114357|454423112|FG001|Cross-over|Adverse Event|1|||
126309545|NCT00477750|454423113|FG000|Overall Study|Currently Receiving Treatment|11|||
126309546|NCT00784238|454423114|FG000|Overall Study|Adverse Event|14|||
126309547|NCT00784238|454423114|FG000|Overall Study|Death|2|||
126309548|NCT00784238|454423114|FG000|Overall Study|Lack of Efficacy|33|||
126309549|NCT00784238|454423114|FG000|Overall Study|Lost to Follow-up|29|||
126373036|NCT00744861|454663342|FG002|Pivotal Stage 2|Physician Decision|3|||
126373037|NCT00744861|454663343|FG003|Pivotal Stage 2|Physician Decision|1|||
126373038|NCT00744861|454663340|FG000|Pivotal Stage 2|Protocol Violation|0|||
126373039|NCT00744861|454663341|FG001|Pivotal Stage 2|Protocol Violation|0|||
126373040|NCT00744861|454663342|FG002|Pivotal Stage 2|Protocol Violation|0|||
126373041|NCT00744861|454663343|FG003|Pivotal Stage 2|Protocol Violation|1|||
126373042|NCT00744861|454663340|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
126373043|NCT00744861|454663341|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
126373044|NCT00744861|454663342|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
126373045|NCT00744861|454663343|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
126373046|NCT00744861|454663340|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
126373047|NCT00744861|454663341|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
126373048|NCT00744861|454663342|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
126373049|NCT00744861|454663343|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
126373050|NCT01567722|454663354|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
126373051|NCT01567722|454663355|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
126373052|NCT01567722|454663356|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
126373053|NCT01567722|454663354|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
126373054|NCT01567722|454663355|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
126373055|NCT01567722|454663356|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
126373056|NCT01567722|454663354|FG000|Overall Study|Protocol closure by the OCG|2|||
126373057|NCT01567722|454663355|FG001|Overall Study|Protocol closure by the OCG|0|||
126373058|NCT01567722|454663356|FG002|Overall Study|Protocol closure by the OCG|0|||
126373059|NCT01567722|454663354|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
126373060|NCT01567722|454663355|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
126373061|NCT01567722|454663356|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
126373062|NCT00382174|454663357|FG000|Overall Study|Lost to Follow-up|1|||
126373063|NCT00382174|454663358|FG001|Overall Study|Lost to Follow-up|4|||
126373064|NCT00382174|454663359|FG002|Overall Study|Lost to Follow-up|5|||
126373065|NCT00382174|454663357|FG000|Overall Study|Adverse Event|1|||
126373066|NCT00382174|454663358|FG001|Overall Study|Adverse Event|4|||
126373067|NCT00382174|454663359|FG002|Overall Study|Adverse Event|5|||
126373068|NCT00382174|454663357|FG000|Overall Study|Withdrawal by Subject|1|||
126309550|NCT00784238|454423114|FG000|Overall Study|Pregnancy|1|||
126309551|NCT00784238|454423114|FG000|Overall Study|Withdrawal by Subject|26|||
126309552|NCT00784238|454423114|FG000|Overall Study|Other|14|||
126309553|NCT03693612|454423115|FG000|Overall Study|Lost to Follow-up|0|||
126104033|NCT03727438|453673908|FG001|Intervention Period|Withdrawal by Subject|1|||
126309554|NCT03693612|454423116|FG001|Overall Study|Lost to Follow-up|0|||
126309555|NCT03693612|454423117|FG002|Overall Study|Lost to Follow-up|0|||
126309556|NCT03693612|454423118|FG003|Overall Study|Lost to Follow-up|0|||
126309557|NCT03693612|454423119|FG004|Overall Study|Lost to Follow-up|1|||
126309558|NCT03693612|454423120|FG005|Overall Study|Lost to Follow-up|0|||
126309559|NCT03693612|454423121|FG006|Overall Study|Lost to Follow-up|0|||
126309560|NCT03693612|454423115|FG000|Overall Study|Withdrawal by Subject|0|||
126309561|NCT03693612|454423116|FG001|Overall Study|Withdrawal by Subject|0|||
126309562|NCT03693612|454423117|FG002|Overall Study|Withdrawal by Subject|1|||
126309563|NCT03693612|454423118|FG003|Overall Study|Withdrawal by Subject|0|||
126309564|NCT03693612|454423119|FG004|Overall Study|Withdrawal by Subject|2|||
126309565|NCT03693612|454423120|FG005|Overall Study|Withdrawal by Subject|0|||
126309566|NCT03693612|454423121|FG006|Overall Study|Withdrawal by Subject|0|||
126309567|NCT03693612|454423115|FG000|Overall Study|Study Terminated by Sponsor|0|||
126309568|NCT03693612|454423116|FG001|Overall Study|Study Terminated by Sponsor|1|||
126309569|NCT03693612|454423117|FG002|Overall Study|Study Terminated by Sponsor|0|||
126309570|NCT03693612|454423118|FG003|Overall Study|Study Terminated by Sponsor|0|||
126309571|NCT03693612|454423119|FG004|Overall Study|Study Terminated by Sponsor|3|||
126309572|NCT03693612|454423120|FG005|Overall Study|Study Terminated by Sponsor|0|||
126309573|NCT03693612|454423121|FG006|Overall Study|Study Terminated by Sponsor|0|||
126309574|NCT03030989|454423125|FG000|Overall Study|Fever|2|||
126309575|NCT03030989|454423126|FG001|Overall Study|Fever|2|||
126309576|NCT03030989|454423125|FG000|Overall Study|Rash|2|||
126309577|NCT03030989|454423126|FG001|Overall Study|Rash|1|||
126373069|NCT00382174|454663358|FG001|Overall Study|Withdrawal by Subject|4|||
126373070|NCT00382174|454663359|FG002|Overall Study|Withdrawal by Subject|5|||
126373071|NCT00382174|454663357|FG000|Overall Study|Non compliance|1|||
126373072|NCT00382174|454663358|FG001|Overall Study|Non compliance|0|||
126373073|NCT00382174|454663359|FG002|Overall Study|Non compliance|1|||
126373074|NCT00382174|454663357|FG000|Overall Study|Physician Decision|0|||
126373075|NCT00382174|454663358|FG001|Overall Study|Physician Decision|2|||
126373076|NCT00382174|454663359|FG002|Overall Study|Physician Decision|2|||
126373077|NCT00382174|454663357|FG000|Overall Study|Failed to meet criteria|0|||
126373078|NCT00382174|454663358|FG001|Overall Study|Failed to meet criteria|1|||
126373079|NCT00382174|454663359|FG002|Overall Study|Failed to meet criteria|1|||
126373080|NCT00382174|454663357|FG000|Overall Study|Wounds merged|0|||
126373081|NCT00382174|454663358|FG001|Overall Study|Wounds merged|2|||
126373082|NCT00382174|454663359|FG002|Overall Study|Wounds merged|2|||
126373083|NCT02170064|454663365|FG000|Overall Study|Withdrawal by Subject|5|||
126373084|NCT02170064|454663366|FG001|Overall Study|Withdrawal by Subject|1|||
126373085|NCT02170064|454663367|FG002|Overall Study|Withdrawal by Subject|1|||
126373086|NCT02170064|454663365|FG000|Overall Study|Physician Decision|1|||
126373087|NCT02170064|454663366|FG001|Overall Study|Physician Decision|1|||
126373088|NCT02170064|454663367|FG002|Overall Study|Physician Decision|0|||
126373089|NCT03323164|454663368|FG000|Overall Study|Poor quality imaging/scans|2|||
126373090|NCT03323164|454663369|FG001|Overall Study|Poor quality imaging/scans|2|||
126373091|NCT03434834|454663370|FG000|Overall Study|unable to swallow OCT probe|16|||
126373092|NCT03508050|454663378|FG000|Overall Study|Pleural adhesions|1|||
126373093|NCT03508050|454663379|FG001|Overall Study|Pleural adhesions|0|||
126373094|NCT03508050|454663378|FG000|Overall Study|Mucus plug|1|||
126373095|NCT03508050|454663379|FG001|Overall Study|Mucus plug|0|||
126373096|NCT03508050|454663378|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
126373097|NCT03508050|454663379|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
126373098|NCT03508050|454663378|FG000|Overall Study|Sustained desaturation|0|||
126373099|NCT03508050|454663379|FG001|Overall Study|Sustained desaturation|1|||
126373100|NCT03710889|454663383|FG000|Overall Study|Adverse Event|2|||
126309578|NCT03030989|454423125|FG000|Overall Study|Fatigue/Overwhelmed|1|||
125886162|NCT02952820|452878927|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
125886163|NCT02952820|452878925|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
126047782|NCT03656718|453472929|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
126047783|NCT03656718|453472930|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
126047784|NCT03656718|453472931|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
126047785|NCT03656718|453472932|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
126047786|NCT03656718|453472926|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
126047787|NCT03656718|453472927|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
126047788|NCT03656718|453472928|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
126309579|NCT03030989|454423126|FG001|Overall Study|Fatigue/Overwhelmed|5|||
126309580|NCT03030989|454423125|FG000|Overall Study|Positive Blood Cultures|2|||
126309581|NCT03030989|454423126|FG001|Overall Study|Positive Blood Cultures|1|||
126309582|NCT03030989|454423125|FG000|Overall Study|Line Removed|0|||
126309583|NCT03030989|454423126|FG001|Overall Study|Line Removed|2|||
126309584|NCT03030989|454423125|FG000|Overall Study|No longer interested|5|||
126309585|NCT03030989|454423126|FG001|Overall Study|No longer interested|3|||
126309586|NCT02706886|454423127|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
126309587|NCT02706886|454423128|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
126309588|NCT02706886|454423129|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
126309589|NCT02706886|454423130|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
126309590|NCT02706886|454423131|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
126309591|NCT02706886|454423132|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
126309592|NCT02706886|454423133|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
126309593|NCT02706886|454423134|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
126309594|NCT02706886|454423135|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
126309595|NCT01669174|454423142|FG000|Overall Study|Subject withdrew consent|2|||
126309596|NCT01669174|454423143|FG001|Overall Study|Subject withdrew consent|2|||
126309597|NCT01669174|454423142|FG000|Overall Study|Lost to Follow-up|1|||
126309598|NCT01669174|454423143|FG001|Overall Study|Lost to Follow-up|0|||
126309599|NCT01669174|454423142|FG000|Overall Study|Adverse Event|2|||
126309600|NCT01669174|454423143|FG001|Overall Study|Adverse Event|2|||
126309601|NCT01669174|454423142|FG000|Overall Study|Administrative problems|1|||
126309602|NCT01669174|454423143|FG001|Overall Study|Administrative problems|2|||
126309603|NCT01154296|454423146|FG000|Randomization and Intervention|Decided to decline|1|||
126309604|NCT01154296|454423147|FG001|Randomization and Intervention|Decided to decline|1|||
126309605|NCT01154296|454423146|FG000|Randomization and Intervention|Declined by staff|1|||
126309606|NCT01154296|454423147|FG001|Randomization and Intervention|Declined by staff|0|||
126309607|NCT01154296|454423146|FG000|Randomization and Intervention|Did not return|1|||
126309608|NCT01154296|454423147|FG001|Randomization and Intervention|Did not return|0|||
126309609|NCT01154296|454423146|FG000|Randomization and Intervention|Left before test|0|||
126309610|NCT01154296|454423147|FG001|Randomization and Intervention|Left before test|1|||
126309611|NCT01154296|454423146|FG000|Randomization and Intervention|Left clinic early|2|||
126309612|NCT01154296|454423147|FG001|Randomization and Intervention|Left clinic early|0|||
126309613|NCT01154296|454423146|FG000|6-month Follow-up|Lost contact|269|||
126309614|NCT01154296|454423147|FG001|6-month Follow-up|Lost contact|275|||
126309615|NCT01154296|454423146|FG000|6-month Follow-up|Incarcerated|37|||
126309616|NCT01154296|454423147|FG001|6-month Follow-up|Incarcerated|32|||
126309617|NCT01154296|454423146|FG000|6-month Follow-up|Withdrew consent|14|||
126309618|NCT01154296|454423147|FG001|6-month Follow-up|Withdrew consent|15|||
126309619|NCT01154296|454423146|FG000|6-month Follow-up|Death|3|||
126309620|NCT01154296|454423147|FG001|6-month Follow-up|Death|2|||
126309621|NCT01154296|454423146|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
126309622|NCT01154296|454423147|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
126373101|NCT03710889|454663383|FG000|Overall Study|Protocol Deviation|1|||
126373102|NCT00570713|454663384|FG000|Overall Study|Adverse Event|16|||
126373103|NCT00570713|454663385|FG001|Overall Study|Adverse Event|9|||
126373104|NCT00570713|454663384|FG000|Overall Study|Death|7|||
126373105|NCT00570713|454663385|FG001|Overall Study|Death|7|||
126373106|NCT00570713|454663384|FG000|Overall Study|Lack of Efficacy|40|||
126373107|NCT00570713|454663385|FG001|Overall Study|Lack of Efficacy|49|||
126373108|NCT00570713|454663384|FG000|Overall Study|Physician Decision|2|||
126373109|NCT00570713|454663385|FG001|Overall Study|Physician Decision|2|||
126373110|NCT00570713|454663384|FG000|Overall Study|Withdrawal by Subject|3|||
126047789|NCT03656718|453472929|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
126309623|NCT04310397|454423148|FG000|Overall Study|Lack of Efficacy|3|||
126309624|NCT04310397|454423148|FG000|Overall Study|Withdrawal by Subject|1|||
126309625|NCT00723255|454423149|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
126309626|NCT00723255|454423149|FG000|Overall Study|Ineligible: Second primary|1|||
126309627|NCT00723255|454423149|FG000|Overall Study|Ineligible: Wrong Primary|2|||
126309628|NCT02759055|454423150|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
126309629|NCT02759055|454423151|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
126309630|NCT00614523|454423152|FG000|Overall Study|Adverse Event|4|||
126309631|NCT00614523|454423153|FG001|Overall Study|Adverse Event|20|||
126373111|NCT00570713|454663385|FG001|Overall Study|Withdrawal by Subject|3|||
126309632|NCT00614523|454423152|FG000|Overall Study|Death|5|||
126309633|NCT00614523|454423153|FG001|Overall Study|Death|8|||
126309634|NCT00614523|454423152|FG000|Overall Study|Lack of Efficacy|9|||
126309635|NCT00614523|454423153|FG001|Overall Study|Lack of Efficacy|11|||
126309636|NCT00614523|454423152|FG000|Overall Study|Lost to Follow-up|0|||
126309637|NCT00614523|454423153|FG001|Overall Study|Lost to Follow-up|1|||
126309638|NCT00614523|454423152|FG000|Overall Study|Protocol Violation|3|||
126309639|NCT00614523|454423153|FG001|Overall Study|Protocol Violation|2|||
126309640|NCT00614523|454423152|FG000|Overall Study|Withdrawal by Subject|12|||
126309641|NCT00614523|454423153|FG001|Overall Study|Withdrawal by Subject|22|||
126309642|NCT00614523|454423152|FG000|Overall Study|Other|6|||
126309643|NCT00614523|454423153|FG001|Overall Study|Other|11|||
126309644|NCT00614523|454423152|FG000|Overall Study|Ineligibility Determined|1|||
126309645|NCT00614523|454423153|FG001|Overall Study|Ineligibility Determined|2|||
126309646|NCT00614523|454423152|FG000|Overall Study|Disease Progression|0|||
126309647|NCT00614523|454423153|FG001|Overall Study|Disease Progression|8|||
126309648|NCT00614523|454423152|FG000|Overall Study|Administrative Decision|23|||
126309649|NCT00614523|454423153|FG001|Overall Study|Administrative Decision|46|||
126309650|NCT03692325|454423167|FG000|Overall Study|Adverse Event|2|||
126309651|NCT03692325|454423167|FG000|Overall Study|Progression/Recurrence|2|||
126309652|NCT00425061|454423168|FG000|Overall Study|Adverse Event|1|||
126309653|NCT00425061|454423169|FG001|Overall Study|Adverse Event|0|||
126309654|NCT00425061|454423170|FG002|Overall Study|Adverse Event|0|||
126309655|NCT00425061|454423171|FG003|Overall Study|Adverse Event|2|||
126309656|NCT00425061|454423172|FG004|Overall Study|Adverse Event|2|||
126309657|NCT00425061|454423173|FG005|Overall Study|Adverse Event|0|||
126309658|NCT00425061|454423174|FG006|Overall Study|Adverse Event|0|||
126309659|NCT00425061|454423168|FG000|Overall Study|Lost to Follow-up|0|||
126309660|NCT00425061|454423169|FG001|Overall Study|Lost to Follow-up|1|||
126309661|NCT00425061|454423170|FG002|Overall Study|Lost to Follow-up|0|||
126309662|NCT00425061|454423171|FG003|Overall Study|Lost to Follow-up|0|||
126373112|NCT00570713|454663384|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
126373113|NCT00570713|454663385|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
126373114|NCT04881760|454663386|FG000|Overall Study|Adverse Event|0|||
126373115|NCT04881760|454663387|FG001|Overall Study|Adverse Event|1|||
126373116|NCT04881760|454663388|FG002|Overall Study|Adverse Event|1|||
126373117|NCT04881760|454663389|FG003|Overall Study|Adverse Event|0|||
126373118|NCT04881760|454663390|FG004|Overall Study|Adverse Event|1|||
126373119|NCT04881760|454663391|FG005|Overall Study|Adverse Event|1|||
126373120|NCT04881760|454663392|FG006|Overall Study|Adverse Event|2|||
126373121|NCT04881760|454663386|FG000|Overall Study|Death|0|||
126373122|NCT04881760|454663387|FG001|Overall Study|Death|0|||
126373123|NCT04881760|454663388|FG002|Overall Study|Death|0|||
126373124|NCT04881760|454663389|FG003|Overall Study|Death|1|||
126373125|NCT04881760|454663390|FG004|Overall Study|Death|0|||
126373126|NCT04881760|454663391|FG005|Overall Study|Death|0|||
126373127|NCT04881760|454663392|FG006|Overall Study|Death|0|||
126373128|NCT04881760|454663386|FG000|Overall Study|Lost to Follow-up|5|||
126373129|NCT04881760|454663387|FG001|Overall Study|Lost to Follow-up|7|||
126373130|NCT04881760|454663388|FG002|Overall Study|Lost to Follow-up|5|||
126373131|NCT04881760|454663389|FG003|Overall Study|Lost to Follow-up|1|||
126373132|NCT04881760|454663390|FG004|Overall Study|Lost to Follow-up|2|||
126373133|NCT04881760|454663391|FG005|Overall Study|Lost to Follow-up|4|||
126373134|NCT04881760|454663392|FG006|Overall Study|Lost to Follow-up|4|||
126373135|NCT04881760|454663386|FG000|Overall Study|Withdrawal by Subject|13|||
126373136|NCT04881760|454663387|FG001|Overall Study|Withdrawal by Subject|1|||
126373137|NCT04881760|454663388|FG002|Overall Study|Withdrawal by Subject|1|||
126373138|NCT04881760|454663389|FG003|Overall Study|Withdrawal by Subject|4|||
126373139|NCT04881760|454663390|FG004|Overall Study|Withdrawal by Subject|2|||
126373140|NCT04881760|454663391|FG005|Overall Study|Withdrawal by Subject|1|||
126373141|NCT04881760|454663392|FG006|Overall Study|Withdrawal by Subject|2|||
126373142|NCT04881760|454663386|FG000|Overall Study|Randomized but Never Treated|0|||
126373143|NCT04881760|454663387|FG001|Overall Study|Randomized but Never Treated|0|||
126373144|NCT04881760|454663388|FG002|Overall Study|Randomized but Never Treated|0|||
126373145|NCT04881760|454663389|FG003|Overall Study|Randomized but Never Treated|1|||
126373146|NCT04881760|454663390|FG004|Overall Study|Randomized but Never Treated|0|||
126309663|NCT00425061|454423172|FG004|Overall Study|Lost to Follow-up|0|||
126309664|NCT00425061|454423173|FG005|Overall Study|Lost to Follow-up|0|||
126309665|NCT00425061|454423174|FG006|Overall Study|Lost to Follow-up|0|||
126309666|NCT00425061|454423168|FG000|Overall Study|Protocol Violation|1|||
126309667|NCT00425061|454423169|FG001|Overall Study|Protocol Violation|0|||
126309668|NCT00425061|454423170|FG002|Overall Study|Protocol Violation|0|||
126309669|NCT00425061|454423171|FG003|Overall Study|Protocol Violation|0|||
126373147|NCT04881760|454663391|FG005|Overall Study|Randomized but Never Treated|0|||
126373148|NCT04881760|454663392|FG006|Overall Study|Randomized but Never Treated|0|||
126373149|NCT04881760|454663386|FG000|Overall Study|Inadvertent Enrollment|2|||
126373150|NCT04881760|454663387|FG001|Overall Study|Inadvertent Enrollment|0|||
126373151|NCT04881760|454663388|FG002|Overall Study|Inadvertent Enrollment|0|||
126373152|NCT04881760|454663389|FG003|Overall Study|Inadvertent Enrollment|0|||
126373153|NCT04881760|454663390|FG004|Overall Study|Inadvertent Enrollment|0|||
126373154|NCT04881760|454663391|FG005|Overall Study|Inadvertent Enrollment|0|||
126373155|NCT04881760|454663392|FG006|Overall Study|Inadvertent Enrollment|0|||
126373156|NCT04881760|454663386|FG000|Overall Study|Site Closure|0|||
126373157|NCT04881760|454663387|FG001|Overall Study|Site Closure|0|||
126373158|NCT04881760|454663388|FG002|Overall Study|Site Closure|0|||
126373159|NCT04881760|454663389|FG003|Overall Study|Site Closure|1|||
126373160|NCT04881760|454663390|FG004|Overall Study|Site Closure|0|||
126373161|NCT04881760|454663391|FG005|Overall Study|Site Closure|0|||
126373162|NCT04881760|454663392|FG006|Overall Study|Site Closure|0|||
126373163|NCT01538199|454663396|FG000|Overall Study|Lost to Follow-up|1|||
126373164|NCT01538199|454663397|FG001|Overall Study|Lost to Follow-up|2|||
126373165|NCT01538199|454663398|FG002|Overall Study|Lost to Follow-up|1|||
126373166|NCT01538199|454663399|FG003|Overall Study|Lost to Follow-up|0|||
126373167|NCT01538199|454663396|FG000|Overall Study|participant did not have time|1|||
126309670|NCT00425061|454423172|FG004|Overall Study|Protocol Violation|0|||
126309671|NCT00425061|454423173|FG005|Overall Study|Protocol Violation|0|||
126309672|NCT00425061|454423174|FG006|Overall Study|Protocol Violation|0|||
126309673|NCT00425061|454423168|FG000|Overall Study|Withdrawal by Subject|0|||
126309674|NCT00425061|454423169|FG001|Overall Study|Withdrawal by Subject|1|||
126309675|NCT00425061|454423170|FG002|Overall Study|Withdrawal by Subject|0|||
126309676|NCT00425061|454423171|FG003|Overall Study|Withdrawal by Subject|0|||
126309677|NCT00425061|454423172|FG004|Overall Study|Withdrawal by Subject|1|||
126309678|NCT00425061|454423173|FG005|Overall Study|Withdrawal by Subject|0|||
126309679|NCT00425061|454423174|FG006|Overall Study|Withdrawal by Subject|3|||
126309680|NCT00425061|454423168|FG000|Overall Study|Sponsor's request|0|||
126309681|NCT00425061|454423169|FG001|Overall Study|Sponsor's request|0|||
126309682|NCT00425061|454423170|FG002|Overall Study|Sponsor's request|0|||
126309683|NCT00425061|454423171|FG003|Overall Study|Sponsor's request|0|||
126309684|NCT00425061|454423172|FG004|Overall Study|Sponsor's request|19|||
126309685|NCT00425061|454423173|FG005|Overall Study|Sponsor's request|4|||
126309686|NCT00425061|454423174|FG006|Overall Study|Sponsor's request|15|||
126309687|NCT00425061|454423168|FG000|Overall Study|Physician Decision|0|||
126309688|NCT00425061|454423169|FG001|Overall Study|Physician Decision|0|||
126309689|NCT00425061|454423170|FG002|Overall Study|Physician Decision|0|||
126309690|NCT00425061|454423171|FG003|Overall Study|Physician Decision|0|||
126309691|NCT00425061|454423172|FG004|Overall Study|Physician Decision|1|||
126309692|NCT00425061|454423173|FG005|Overall Study|Physician Decision|0|||
126309693|NCT00425061|454423174|FG006|Overall Study|Physician Decision|0|||
126309694|NCT00425061|454423168|FG000|Overall Study|Other|0|||
126309695|NCT00425061|454423169|FG001|Overall Study|Other|0|||
126309696|NCT00425061|454423170|FG002|Overall Study|Other|0|||
126309697|NCT00425061|454423171|FG003|Overall Study|Other|0|||
126309698|NCT00425061|454423172|FG004|Overall Study|Other|3|||
126309699|NCT00425061|454423173|FG005|Overall Study|Other|0|||
126373168|NCT01538199|454663397|FG001|Overall Study|participant did not have time|0|||
126373169|NCT01538199|454663398|FG002|Overall Study|participant did not have time|0|||
126373170|NCT01538199|454663399|FG003|Overall Study|participant did not have time|2|||
126373171|NCT01538199|454663396|FG000|Overall Study|Lack of Efficacy|0|||
126373172|NCT01538199|454663397|FG001|Overall Study|Lack of Efficacy|1|||
126373173|NCT01538199|454663398|FG002|Overall Study|Lack of Efficacy|0|||
126373174|NCT01538199|454663399|FG003|Overall Study|Lack of Efficacy|0|||
126309700|NCT00425061|454423174|FG006|Overall Study|Other|1|||
126309701|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
126373175|NCT02081586|454663400|FG000|Overall Study|Lost to Follow-up|0|||
126047790|NCT03656718|453472930|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
126047791|NCT03656718|453472931|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
126047792|NCT03656718|453472932|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
126047793|NCT03656718|453472926|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126047794|NCT03656718|453472927|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126047795|NCT03656718|453472928|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126047796|NCT03656718|453472929|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126047797|NCT03656718|453472930|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126047798|NCT03656718|453472931|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
126047799|NCT03656718|453472932|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126047800|NCT03656718|453472926|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
126047801|NCT03656718|453472927|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126047802|NCT03656718|453472928|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126047803|NCT03656718|453472929|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126047804|NCT03656718|453472930|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126047805|NCT03656718|453472931|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126047806|NCT03656718|453472932|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
126047807|NCT03656718|453472926|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126047808|NCT03656718|453472927|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126047809|NCT03656718|453472928|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126047810|NCT03656718|453472929|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126047811|NCT03656718|453472930|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126104034|NCT03727438|453673907|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
126309702|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
126309703|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
126309704|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
126309705|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
126309706|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
126309707|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
126309708|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
126309709|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
126309710|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
126309711|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
126309712|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
126309713|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
126309714|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
126309715|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
126309716|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
126309717|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
126309718|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
126309719|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
126309720|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
126309721|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
126309722|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
126309723|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
126309724|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
126309725|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
126309726|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
126309727|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
126309728|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
126309729|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
126309730|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
126309731|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Other|0|||
126309732|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Other|1|||
126309733|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Other|0|||
126309734|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
126309735|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
126309736|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
126309737|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Early site closure|0|||
126309738|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Early site closure|2|||
126309739|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Early site closure|0|||
126309740|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
126309741|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
126309742|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
126373176|NCT02081586|454663401|FG001|Overall Study|Lost to Follow-up|1|||
126373177|NCT02081586|454663402|FG002|Overall Study|Lost to Follow-up|0|||
126373178|NCT02081586|454663403|FG003|Overall Study|Lost to Follow-up|1|||
126373179|NCT02081586|454663400|FG000|Overall Study|Head injury not related to study|0|||
126373180|NCT02081586|454663401|FG001|Overall Study|Head injury not related to study|0|||
126373181|NCT02081586|454663402|FG002|Overall Study|Head injury not related to study|1|||
126373182|NCT02081586|454663403|FG003|Overall Study|Head injury not related to study|0|||
126373183|NCT01677988|454663406|FG000|Overall Study|Lack of Efficacy|2|||
126373184|NCT00659425|454663410|FG000|Overall Study|Disease progression|1|||
126373185|NCT00659425|454663411|FG001|Overall Study|Disease progression|0|||
126373186|NCT00659425|454663412|FG002|Overall Study|Disease progression|0|||
126373187|NCT00659425|454663413|FG003|Overall Study|Disease progression|1|||
126373188|NCT00659425|454663414|FG004|Overall Study|Disease progression|0|||
126373189|NCT00659425|454663415|FG005|Overall Study|Disease progression|2|||
126373190|NCT00659425|454663416|FG006|Overall Study|Disease progression|4|||
126373191|NCT00659425|454663417|FG007|Overall Study|Disease progression|3|||
126373192|NCT00659425|454663418|FG008|Overall Study|Disease progression|5|||
126373193|NCT00659425|454663419|FG009|Overall Study|Disease progression|3|||
126373194|NCT00659425|454663410|FG000|Overall Study|Death|0|||
126373195|NCT00659425|454663411|FG001|Overall Study|Death|0|||
126373196|NCT00659425|454663412|FG002|Overall Study|Death|0|||
126373197|NCT00659425|454663413|FG003|Overall Study|Death|1|||
126373198|NCT00659425|454663414|FG004|Overall Study|Death|0|||
126373199|NCT00659425|454663415|FG005|Overall Study|Death|0|||
126373200|NCT00659425|454663416|FG006|Overall Study|Death|1|||
126373201|NCT00659425|454663417|FG007|Overall Study|Death|0|||
126373202|NCT00659425|454663418|FG008|Overall Study|Death|0|||
126373203|NCT00659425|454663419|FG009|Overall Study|Death|0|||
126047812|NCT03656718|453472931|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
126047813|NCT03656718|453472932|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
126047814|NCT03656718|453472926|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126373204|NCT00659425|454663410|FG000|Overall Study|Adverse Event|0|||
126373205|NCT00659425|454663411|FG001|Overall Study|Adverse Event|0|||
126373206|NCT00659425|454663412|FG002|Overall Study|Adverse Event|0|||
126373207|NCT00659425|454663413|FG003|Overall Study|Adverse Event|0|||
126373208|NCT00659425|454663414|FG004|Overall Study|Adverse Event|0|||
126373209|NCT00659425|454663415|FG005|Overall Study|Adverse Event|1|||
126373210|NCT00659425|454663416|FG006|Overall Study|Adverse Event|0|||
126373211|NCT00659425|454663417|FG007|Overall Study|Adverse Event|3|||
126373212|NCT00659425|454663418|FG008|Overall Study|Adverse Event|1|||
126373213|NCT00659425|454663419|FG009|Overall Study|Adverse Event|4|||
126373214|NCT00659425|454663410|FG000|Overall Study|Investigator Discretion|0|||
126373215|NCT00659425|454663411|FG001|Overall Study|Investigator Discretion|0|||
126373216|NCT00659425|454663412|FG002|Overall Study|Investigator Discretion|0|||
126373217|NCT00659425|454663413|FG003|Overall Study|Investigator Discretion|0|||
126373218|NCT00659425|454663414|FG004|Overall Study|Investigator Discretion|0|||
126373219|NCT00659425|454663415|FG005|Overall Study|Investigator Discretion|1|||
126373220|NCT00659425|454663416|FG006|Overall Study|Investigator Discretion|0|||
126373221|NCT00659425|454663417|FG007|Overall Study|Investigator Discretion|3|||
126373222|NCT00659425|454663418|FG008|Overall Study|Investigator Discretion|0|||
126373223|NCT00659425|454663419|FG009|Overall Study|Investigator Discretion|0|||
126373224|NCT00659425|454663410|FG000|Overall Study|Other|0|||
126373225|NCT00659425|454663411|FG001|Overall Study|Other|1|||
126373226|NCT00659425|454663412|FG002|Overall Study|Other|1|||
126373227|NCT00659425|454663413|FG003|Overall Study|Other|2|||
126373228|NCT00659425|454663414|FG004|Overall Study|Other|4|||
126373229|NCT00659425|454663415|FG005|Overall Study|Other|0|||
126373230|NCT00659425|454663416|FG006|Overall Study|Other|3|||
126373231|NCT00659425|454663417|FG007|Overall Study|Other|2|||
126373232|NCT00659425|454663418|FG008|Overall Study|Other|0|||
126373233|NCT00659425|454663419|FG009|Overall Study|Other|6|||
126373234|NCT00271544|454663420|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
126373235|NCT00271544|454663420|FG000|Overall Study|Model 4196 lead not attempted|9|||
126373236|NCT00271544|454663420|FG000|Overall Study|Implant not attempted|4|||
126373237|NCT03358030|454663421|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
126373238|NCT03358030|454663422|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
126373239|NCT03358030|454663423|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
126373240|NCT03358030|454663424|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
126373241|NCT03358030|454663421|FG000|Overall Study|Ineligibility|0|||
126373242|NCT03358030|454663422|FG001|Overall Study|Ineligibility|0|||
126373243|NCT03358030|454663423|FG002|Overall Study|Ineligibility|0|||
126373244|NCT03358030|454663424|FG003|Overall Study|Ineligibility|2|||
126373245|NCT03358030|454663421|FG000|Overall Study|Voluntary Withdrawal|1|||
126373246|NCT03358030|454663422|FG001|Overall Study|Voluntary Withdrawal|1|||
126373247|NCT03358030|454663423|FG002|Overall Study|Voluntary Withdrawal|3|||
126373248|NCT03358030|454663424|FG003|Overall Study|Voluntary Withdrawal|1|||
126373249|NCT03358030|454663421|FG000|Overall Study|Other|0|||
126373250|NCT03358030|454663422|FG001|Overall Study|Other|0|||
126373251|NCT03358030|454663423|FG002|Overall Study|Other|1|||
126373252|NCT03358030|454663424|FG003|Overall Study|Other|0|||
126373253|NCT00829244|454663425|FG000|Overall Study|Adverse Event|1|||
126373254|NCT00829244|454663426|FG001|Overall Study|Adverse Event|3|||
126373255|NCT00829244|454663425|FG000|Overall Study|Protocol Violation|1|||
126373256|NCT00829244|454663426|FG001|Overall Study|Protocol Violation|0|||
126373257|NCT00829244|454663425|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
126373258|NCT00829244|454663426|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
126373259|NCT00829244|454663425|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
126373260|NCT00829244|454663426|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
126373261|NCT00829244|454663425|FG000|Overall Study|No fertilization|2|||
126373262|NCT00829244|454663426|FG001|Overall Study|No fertilization|2|||
126373263|NCT00829244|454663425|FG000|Overall Study|All embryos discarded|0|||
126373264|NCT00829244|454663426|FG001|Overall Study|All embryos discarded|3|||
126373265|NCT00829244|454663425|FG000|Overall Study|No embryo cleavage|0|||
126373266|NCT00829244|454663426|FG001|Overall Study|No embryo cleavage|2|||
126373267|NCT02604511|454663427|FG000|Overall Study|Adverse Event|3|||
126373268|NCT02604511|454663427|FG000|Overall Study|Disease Progression|4|||
126373269|NCT02604511|454663427|FG000|Overall Study|Withdrawal by Subject|3|||
126373270|NCT02604511|454663427|FG000|Overall Study|Participant ineligible|1|||
126373271|NCT02604511|454663427|FG000|Overall Study|Intercurrent illness|1|||
126373272|NCT03770286|454663428|FG000|Overall Study|Lost to Follow-up|6|||
126373273|NCT03770286|454663429|FG001|Overall Study|Lost to Follow-up|4|||
126373274|NCT03770286|454663430|FG002|Overall Study|Lost to Follow-up|3|||
126373275|NCT03770286|454663428|FG000|Overall Study|Protocol Violation|1|||
126373276|NCT03770286|454663429|FG001|Overall Study|Protocol Violation|0|||
126373277|NCT03770286|454663430|FG002|Overall Study|Protocol Violation|2|||
126373278|NCT02505425|454663431|FG000|Overall Study|Lost to Follow-up|41|||
126373279|NCT02505425|454663432|FG001|Overall Study|Lost to Follow-up|61|||
126373280|NCT02505425|454663433|FG002|Overall Study|Lost to Follow-up|31|||
126373281|NCT02505425|454663434|FG003|Overall Study|Lost to Follow-up|19|||
126373282|NCT02505425|454663431|FG000|Overall Study|Withdrawal by Subject|39|||
126373283|NCT02505425|454663432|FG001|Overall Study|Withdrawal by Subject|9|||
126373284|NCT02505425|454663433|FG002|Overall Study|Withdrawal by Subject|19|||
126373285|NCT02505425|454663434|FG003|Overall Study|Withdrawal by Subject|7|||
126373286|NCT02505425|454663431|FG000|Overall Study|Death|8|||
126373287|NCT02505425|454663432|FG001|Overall Study|Death|12|||
126373288|NCT02505425|454663433|FG002|Overall Study|Death|0|||
126373289|NCT02505425|454663434|FG003|Overall Study|Death|0|||
126373290|NCT02297412|454663435|FG000|Overall Study|Canceled|1|||
126373291|NCT02297412|454663436|FG001|Overall Study|Canceled|1|||
126373292|NCT02031302|454663437|FG000|Overall Study|Death|115|||
126373293|NCT02031302|454663438|FG001|Overall Study|Death|0|||
126373294|NCT02031302|454663437|FG000|Overall Study|Not treated with study valve system|18|||
126373295|NCT02031302|454663438|FG001|Overall Study|Not treated with study valve system|0|||
126373296|NCT02031302|454663437|FG000|Overall Study|Missed Follow Up|27|||
126373297|NCT02031302|454663438|FG001|Overall Study|Missed Follow Up|0|||
126373298|NCT02031302|454663437|FG000|Overall Study|Lost to Follow-up|4|||
126373299|NCT02031302|454663438|FG001|Overall Study|Lost to Follow-up|0|||
126373300|NCT03950856|454663439|FG000|Overall Study|Death|1|||
126373301|NCT03950856|454663440|FG001|Overall Study|Death|2|||
126373302|NCT03950856|454663441|FG002|Overall Study|Death|0|||
126373303|NCT03950856|454663442|FG003|Overall Study|Death|0|||
126373304|NCT03950856|454663439|FG000|Overall Study|Lost to Follow-up|5|||
126373305|NCT03950856|454663440|FG001|Overall Study|Lost to Follow-up|6|||
126373306|NCT03950856|454663441|FG002|Overall Study|Lost to Follow-up|8|||
126373307|NCT03950856|454663442|FG003|Overall Study|Lost to Follow-up|2|||
126373308|NCT03950856|454663439|FG000|Overall Study|Protocol Violation|2|||
126373309|NCT03950856|454663440|FG001|Overall Study|Protocol Violation|0|||
126373310|NCT03950856|454663441|FG002|Overall Study|Protocol Violation|0|||
126373311|NCT03950856|454663442|FG003|Overall Study|Protocol Violation|1|||
126373312|NCT03950856|454663439|FG000|Overall Study|Withdrawal by Subject|4|||
126373313|NCT03950856|454663440|FG001|Overall Study|Withdrawal by Subject|1|||
126373314|NCT03950856|454663441|FG002|Overall Study|Withdrawal by Subject|3|||
126373315|NCT03950856|454663442|FG003|Overall Study|Withdrawal by Subject|1|||
126373316|NCT03950856|454663439|FG000|Overall Study|Unable to phone|7|||
126373317|NCT03950856|454663440|FG001|Overall Study|Unable to phone|6|||
126373318|NCT03950856|454663441|FG002|Overall Study|Unable to phone|7|||
126373319|NCT03950856|454663442|FG003|Overall Study|Unable to phone|2|||
126373320|NCT05899829|454663443|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
126373321|NCT05899829|454663444|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
126373322|NCT05899829|454663443|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
126373323|NCT05899829|454663444|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
126373324|NCT02781558|454663448|FG000|Overall Study|Lost to Follow-up|2|||
126373325|NCT02781558|454663449|FG001|Overall Study|Lost to Follow-up|2|||
126373326|NCT02781558|454663448|FG000|Overall Study|Adverse Event|1|||
126373327|NCT02781558|454663449|FG001|Overall Study|Adverse Event|0|||
126373328|NCT01732536|454665062|FG000|Overall Study|Withdrawal by Subject|1|||
126373329|NCT01732536|454665063|FG001|Overall Study|Withdrawal by Subject|1|||
126373330|NCT01581684|454665066|FG000|Overall Study|Other reason not defined|0|||
126373331|NCT01581684|454665067|FG001|Overall Study|Other reason not defined|0|||
126047815|NCT03656718|453472927|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126047816|NCT03656718|453472928|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126047817|NCT03656718|453472929|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126047818|NCT03656718|453472930|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126047819|NCT03656718|453472931|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126047820|NCT03656718|453472932|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
126309743|NCT02137850|454423177|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
126309744|NCT02137850|454423178|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
126309745|NCT02137850|454423179|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
126309746|NCT02137850|454423177|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
126309747|NCT02137850|454423178|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
126309748|NCT02137850|454423179|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
126309749|NCT02137850|454423177|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
126309750|NCT02137850|454423178|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
126309751|NCT02137850|454423179|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
126309752|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
126309753|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
126309754|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
126309755|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
126309756|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
126309757|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
126309758|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
126309759|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
126309760|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
126309761|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Other|0|||
126309762|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Other|1|||
126309763|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Other|0|||
126309764|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
126309765|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
126309766|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
126309767|NCT02651155|454423180|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126309768|NCT02651155|454423181|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
126309769|NCT02651155|454423180|FG000|Overall Study|Voluntary Withdrawal|5|||
126309770|NCT02651155|454423181|FG001|Overall Study|Voluntary Withdrawal|0|||
126309771|NCT04533412|454423182|FG000|Overall Study|Withdrawal by Subject|1|||
126309772|NCT04533412|454423183|FG001|Overall Study|Withdrawal by Subject|1|||
126309773|NCT04533412|454423182|FG000|Overall Study|Lost to Follow-up|1|||
126309774|NCT04533412|454423183|FG001|Overall Study|Lost to Follow-up|4|||
126309775|NCT00968981|454423191|FG000|Overall Study|Adverse Event|2|||
126309776|NCT00968981|454423192|FG001|Overall Study|Adverse Event|0|||
126309777|NCT00968981|454423193|FG002|Overall Study|Adverse Event|0|||
126309778|NCT00968981|454423191|FG000|Overall Study|Disease Progression|14|||
126309779|NCT00968981|454423192|FG001|Overall Study|Disease Progression|16|||
126309780|NCT00968981|454423193|FG002|Overall Study|Disease Progression|13|||
126309781|NCT00968981|454423191|FG000|Overall Study|Lost to Follow-up|0|||
126309782|NCT00968981|454423192|FG001|Overall Study|Lost to Follow-up|0|||
126309783|NCT00968981|454423193|FG002|Overall Study|Lost to Follow-up|1|||
126309784|NCT00968981|454423191|FG000|Overall Study|Physician Decision|5|||
126309785|NCT00968981|454423192|FG001|Overall Study|Physician Decision|3|||
126309786|NCT00968981|454423193|FG002|Overall Study|Physician Decision|5|||
126309787|NCT00968981|454423191|FG000|Overall Study|Withdrawal by Subject|1|||
126309788|NCT00968981|454423192|FG001|Overall Study|Withdrawal by Subject|3|||
126309789|NCT00968981|454423193|FG002|Overall Study|Withdrawal by Subject|3|||
126309790|NCT01489254|454423194|FG000|Double-blind Part|Adverse Event|7|||
126309791|NCT01489254|454423195|FG001|Double-blind Part|Adverse Event|2|||
126309792|NCT01489254|454423196|FG002|Double-blind Part|Adverse Event|2|||
126309793|NCT01489254|454423197|FG003|Double-blind Part|Adverse Event|0|||
126309794|NCT01489254|454423194|FG000|Double-blind Part|Pregnancy|1|||
126309795|NCT01489254|454423195|FG001|Double-blind Part|Pregnancy|3|||
126309796|NCT01489254|454423196|FG002|Double-blind Part|Pregnancy|0|||
126309797|NCT01489254|454423197|FG003|Double-blind Part|Pregnancy|0|||
126047821|NCT03656718|453472926|FG000|Treatment Period Part C|Disease progression|0|||
126309798|NCT01489254|454423194|FG000|Double-blind Part|Withdrawal by Subject|12|||
126309799|NCT01489254|454423195|FG001|Double-blind Part|Withdrawal by Subject|20|||
126309800|NCT01489254|454423196|FG002|Double-blind Part|Withdrawal by Subject|1|||
126309801|NCT01489254|454423197|FG003|Double-blind Part|Withdrawal by Subject|0|||
126309802|NCT01489254|454423194|FG000|Double-blind Part|Lost to Follow-up|1|||
126309803|NCT01489254|454423195|FG001|Double-blind Part|Lost to Follow-up|2|||
126309804|NCT01489254|454423196|FG002|Double-blind Part|Lost to Follow-up|0|||
126309805|NCT01489254|454423197|FG003|Double-blind Part|Lost to Follow-up|0|||
126309806|NCT01489254|454423194|FG000|Double-blind Part|Other reasons for not completing study|4|||
126309807|NCT01489254|454423195|FG001|Double-blind Part|Other reasons for not completing study|6|||
126373332|NCT01581684|454665068|FG002|Overall Study|Other reason not defined|0|||
126373333|NCT01581684|454665069|FG003|Overall Study|Other reason not defined|0|||
126373334|NCT01581684|454665070|FG004|Overall Study|Other reason not defined|0|||
126373335|NCT01581684|454665071|FG005|Overall Study|Other reason not defined|0|||
126373336|NCT01581684|454665072|FG006|Overall Study|Other reason not defined|0|||
126373337|NCT01581684|454665073|FG007|Overall Study|Other reason not defined|0|||
126373338|NCT01581684|454665074|FG008|Overall Study|Other reason not defined|1|||
126373339|NCT01581684|454665075|FG009|Overall Study|Other reason not defined|0|||
126373340|NCT03728933|454665076|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126373341|NCT03728933|454665077|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126373342|NCT03728933|454665078|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126373343|NCT03728933|454665076|FG000|Overall Study|Withdrawal by Subject|0|||
126373344|NCT03728933|454665077|FG001|Overall Study|Withdrawal by Subject|0|||
126373345|NCT03728933|454665078|FG002|Overall Study|Withdrawal by Subject|1|||
126373346|NCT03728933|454665076|FG000|Overall Study|Lost to Follow-up|0|||
126373347|NCT03728933|454665077|FG001|Overall Study|Lost to Follow-up|1|||
126373348|NCT03728933|454665078|FG002|Overall Study|Lost to Follow-up|0|||
126373349|NCT03728933|454665076|FG000|Overall Study|Adverse Event|1|||
126373350|NCT03728933|454665077|FG001|Overall Study|Adverse Event|0|||
126373351|NCT03728933|454665078|FG002|Overall Study|Adverse Event|0|||
126373352|NCT03235050|454665079|FG000|Overall Study|Adverse Event|0|||
126373353|NCT03235050|454665080|FG001|Overall Study|Adverse Event|0|||
126373354|NCT03235050|454665081|FG002|Overall Study|Adverse Event|1|||
126373355|NCT03235050|454665082|FG003|Overall Study|Adverse Event|4|||
126373356|NCT03235050|454665083|FG004|Overall Study|Adverse Event|1|||
126373357|NCT03235050|454665079|FG000|Overall Study|Death|0|||
126373358|NCT03235050|454665080|FG001|Overall Study|Death|0|||
126373359|NCT03235050|454665081|FG002|Overall Study|Death|0|||
126373360|NCT03235050|454665082|FG003|Overall Study|Death|2|||
126373361|NCT03235050|454665083|FG004|Overall Study|Death|1|||
126373362|NCT03235050|454665079|FG000|Overall Study|Lost to Follow-up|1|||
126373363|NCT03235050|454665080|FG001|Overall Study|Lost to Follow-up|2|||
126373364|NCT03235050|454665081|FG002|Overall Study|Lost to Follow-up|1|||
126373365|NCT03235050|454665082|FG003|Overall Study|Lost to Follow-up|2|||
126373366|NCT03235050|454665083|FG004|Overall Study|Lost to Follow-up|0|||
126373367|NCT03235050|454665079|FG000|Overall Study|Withdrawal by Subject|3|||
126373368|NCT03235050|454665080|FG001|Overall Study|Withdrawal by Subject|2|||
126373369|NCT03235050|454665081|FG002|Overall Study|Withdrawal by Subject|2|||
126373370|NCT03235050|454665082|FG003|Overall Study|Withdrawal by Subject|5|||
126373371|NCT03235050|454665083|FG004|Overall Study|Withdrawal by Subject|7|||
126047822|NCT03656718|453472927|FG001|Treatment Period Part C|Disease progression|0|||
126047823|NCT03656718|453472928|FG002|Treatment Period Part C|Disease progression|0|||
126047824|NCT03656718|453472929|FG003|Treatment Period Part C|Disease progression|0|||
126047825|NCT03656718|453472930|FG004|Treatment Period Part C|Disease progression|12|||
126047826|NCT03656718|453472931|FG005|Treatment Period Part C|Disease progression|0|||
126373372|NCT03235050|454665079|FG000|Overall Study|Other reasons|0|||
126373373|NCT03235050|454665080|FG001|Overall Study|Other reasons|1|||
126373374|NCT03235050|454665081|FG002|Overall Study|Other reasons|0|||
126373375|NCT03235050|454665082|FG003|Overall Study|Other reasons|1|||
126373376|NCT03235050|454665083|FG004|Overall Study|Other reasons|2|||
126373377|NCT02415556|454665084|FG000|Overall Study|Adverse Event|3|||
126373378|NCT02415556|454665085|FG001|Overall Study|Adverse Event|4|||
126373379|NCT02415556|454665086|FG002|Overall Study|Adverse Event|2|||
126373380|NCT02415556|454665087|FG003|Overall Study|Adverse Event|4|||
126373381|NCT02415556|454665084|FG000|Overall Study|Lost to Follow-up|4|||
126309808|NCT01489254|454423196|FG002|Double-blind Part|Other reasons for not completing study|0|||
126309809|NCT01489254|454423197|FG003|Double-blind Part|Other reasons for not completing study|0|||
126309810|NCT01489254|454423194|FG000|Open-label Extension Part|Adverse Event|0|||
126309811|NCT01489254|454423195|FG001|Open-label Extension Part|Adverse Event|0|||
126309812|NCT01489254|454423196|FG002|Open-label Extension Part|Adverse Event|0|||
126309813|NCT01489254|454423197|FG003|Open-label Extension Part|Adverse Event|10|||
126309814|NCT01489254|454423194|FG000|Open-label Extension Part|Pregnancy|0|||
126309815|NCT01489254|454423195|FG001|Open-label Extension Part|Pregnancy|0|||
126309816|NCT01489254|454423196|FG002|Open-label Extension Part|Pregnancy|0|||
126309817|NCT01489254|454423197|FG003|Open-label Extension Part|Pregnancy|3|||
126309818|NCT01489254|454423194|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
126309819|NCT01489254|454423195|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
126309820|NCT01489254|454423196|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
126309821|NCT01489254|454423197|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
126309822|NCT01489254|454423194|FG000|Open-label Extension Part|Protocol Violation|0|||
126309823|NCT01489254|454423195|FG001|Open-label Extension Part|Protocol Violation|0|||
126309824|NCT01489254|454423196|FG002|Open-label Extension Part|Protocol Violation|0|||
126309825|NCT01489254|454423197|FG003|Open-label Extension Part|Protocol Violation|1|||
126309826|NCT01489254|454423194|FG000|Open-label Extension Part|Lost to Follow-up|0|||
126309827|NCT01489254|454423195|FG001|Open-label Extension Part|Lost to Follow-up|0|||
126309828|NCT01489254|454423196|FG002|Open-label Extension Part|Lost to Follow-up|0|||
126309829|NCT01489254|454423197|FG003|Open-label Extension Part|Lost to Follow-up|9|||
125886164|NCT02952820|452878926|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
126309830|NCT01489254|454423194|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
126309831|NCT01489254|454423195|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
126373382|NCT02415556|454665085|FG001|Overall Study|Lost to Follow-up|5|||
126373383|NCT02415556|454665086|FG002|Overall Study|Lost to Follow-up|4|||
126373384|NCT02415556|454665087|FG003|Overall Study|Lost to Follow-up|1|||
126373385|NCT02415556|454665084|FG000|Overall Study|Withdrawal by Subject|13|||
126373386|NCT02415556|454665085|FG001|Overall Study|Withdrawal by Subject|4|||
126373387|NCT02415556|454665086|FG002|Overall Study|Withdrawal by Subject|14|||
126373388|NCT02415556|454665087|FG003|Overall Study|Withdrawal by Subject|12|||
126373389|NCT02415556|454665084|FG000|Overall Study|Physician Decision|1|||
126373390|NCT02415556|454665085|FG001|Overall Study|Physician Decision|3|||
126373391|NCT02415556|454665086|FG002|Overall Study|Physician Decision|1|||
126373392|NCT02415556|454665087|FG003|Overall Study|Physician Decision|2|||
126373393|NCT02415556|454665084|FG000|Overall Study|Censored - study completion|4|||
126373394|NCT02415556|454665085|FG001|Overall Study|Censored - study completion|5|||
126373395|NCT02415556|454665086|FG002|Overall Study|Censored - study completion|1|||
126373396|NCT02415556|454665087|FG003|Overall Study|Censored - study completion|0|||
126373397|NCT02415556|454665084|FG000|Overall Study|Family-related issues|0|||
126373398|NCT02415556|454665085|FG001|Overall Study|Family-related issues|0|||
126373399|NCT02415556|454665086|FG002|Overall Study|Family-related issues|0|||
126373400|NCT02415556|454665087|FG003|Overall Study|Family-related issues|1|||
126373401|NCT00105534|454665088|FG000|Overall Study|Adverse Event|2|||
126373402|NCT00105534|454665089|FG001|Overall Study|Adverse Event|5|||
126373403|NCT00105534|454665088|FG000|Overall Study|Protocol Violation|1|||
126373404|NCT00105534|454665089|FG001|Overall Study|Protocol Violation|4|||
126373405|NCT00105534|454665088|FG000|Overall Study|Withdrawal by Subject|6|||
126373406|NCT00105534|454665089|FG001|Overall Study|Withdrawal by Subject|6|||
126373407|NCT00105534|454665088|FG000|Overall Study|Lost to Follow-up|5|||
126373408|NCT00105534|454665089|FG001|Overall Study|Lost to Follow-up|1|||
126373409|NCT00105534|454665088|FG000|Overall Study|Lack of Efficacy|7|||
126373410|NCT00105534|454665089|FG001|Overall Study|Lack of Efficacy|15|||
126373411|NCT00105534|454665088|FG000|Overall Study|Treatment unmasked|1|||
126373412|NCT00105534|454665089|FG001|Overall Study|Treatment unmasked|0|||
126373413|NCT00105534|454665088|FG000|Overall Study|Other Reason|0|||
126373414|NCT00105534|454665089|FG001|Overall Study|Other Reason|2|||
126373415|NCT01621178|454665090|FG000|Overall Study|Adverse Event|5|||
126373416|NCT01621178|454665091|FG001|Overall Study|Adverse Event|2|||
126373417|NCT01621178|454665092|FG002|Overall Study|Adverse Event|8|||
126373418|NCT01621178|454665090|FG000|Overall Study|Death|6|||
126373419|NCT01621178|454665091|FG001|Overall Study|Death|7|||
126373420|NCT01621178|454665092|FG002|Overall Study|Death|2|||
126373421|NCT01621178|454665090|FG000|Overall Study|Lost to Follow-up|1|||
126373422|NCT01621178|454665091|FG001|Overall Study|Lost to Follow-up|2|||
126373423|NCT01621178|454665092|FG002|Overall Study|Lost to Follow-up|1|||
126373424|NCT01621178|454665090|FG000|Overall Study|Withdrawal by Subject|14|||
126373425|NCT01621178|454665091|FG001|Overall Study|Withdrawal by Subject|17|||
126373426|NCT01621178|454665092|FG002|Overall Study|Withdrawal by Subject|18|||
126373427|NCT01621178|454665090|FG000|Overall Study|Physician Decision|5|||
126373428|NCT01621178|454665091|FG001|Overall Study|Physician Decision|2|||
126373429|NCT01621178|454665092|FG002|Overall Study|Physician Decision|7|||
126373430|NCT02935192|454665093|FG000|Overall Study|Withdrawal by Subject|8|||
126373431|NCT02935192|454665094|FG001|Overall Study|Withdrawal by Subject|4|||
126373432|NCT02896257|454665095|FG000|Providers|Without eligible patients|21|||
126373433|NCT02896257|454665096|FG001|Providers|Without eligible patients|28|||
126373434|NCT02896257|454665095|FG000|Patients|PFT entry criteria not met|43|||
126373435|NCT02896257|454665096|FG001|Patients|PFT entry criteria not met|50|||
126373436|NCT02896257|454665095|FG000|Patients|No capacity to review|8|||
126373437|NCT02896257|454665096|FG001|Patients|No capacity to review|11|||
126373438|NCT02896257|454665095|FG000|Patients|Appointment rescheduled/cancelled|5|||
126373439|NCT02896257|454665096|FG001|Patients|Appointment rescheduled/cancelled|7|||
126373440|NCT02896257|454665095|FG000|Patients|PCP not assigned a clinic|4|||
126373441|NCT02896257|454665096|FG001|Patients|PCP not assigned a clinic|0|||
126373442|NCT02896257|454665095|FG000|Patients|No history of COPD|0|||
126047827|NCT03656718|453472932|FG006|Treatment Period Part C|Disease progression|0|||
126047828|NCT03656718|453472926|FG000|Treatment Period Part C|Death|0|||
126373443|NCT02896257|454665096|FG001|Patients|No history of COPD|1|||
126373444|NCT02896257|454665095|FG000|Patients|Deceased between review and index date|0|||
126373445|NCT02896257|454665096|FG001|Patients|Deceased between review and index date|1|||
126373446|NCT02896257|454665095|FG000|Patients|No ICS Rx upon review|1|||
126373447|NCT02896257|454665096|FG001|Patients|No ICS Rx upon review|1|||
126373448|NCT02896257|454665095|FG000|Patients|Protocol Violation|2|||
126373449|NCT02896257|454665096|FG001|Patients|Protocol Violation|1|||
126373450|NCT02896257|454665095|FG000|Patients|Hospice care|0|||
126373451|NCT02896257|454665096|FG001|Patients|Hospice care|1|||
126373452|NCT02465931|454665097|FG000|Overall Study|Lost to Follow-up|9|||
126373453|NCT02465931|454665098|FG001|Overall Study|Lost to Follow-up|11|||
126373454|NCT02465931|454665097|FG000|Overall Study|Protocol Violation|1|||
126373455|NCT02465931|454665098|FG001|Overall Study|Protocol Violation|0|||
126047829|NCT03656718|453472927|FG001|Treatment Period Part C|Death|0|||
126373456|NCT02465931|454665097|FG000|Overall Study|Withdrawal by Subject|1|||
126373457|NCT02465931|454665098|FG001|Overall Study|Withdrawal by Subject|0|||
126309832|NCT01489254|454423196|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
126309833|NCT01489254|454423197|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
126309834|NCT01254318|454423198|FG000|Overall Study|Lost to Follow-up|5|||
126309835|NCT01254318|454423198|FG000|Overall Study|Death|47|||
126309836|NCT00782184|454423205|FG000|Overall Study|Adverse Event|1|||
126309837|NCT00782184|454423206|FG001|Overall Study|Adverse Event|2|||
126309838|NCT00782184|454423205|FG000|Overall Study|Protocol Violation|0|||
126309839|NCT00782184|454423206|FG001|Overall Study|Protocol Violation|1|||
126309840|NCT00782184|454423205|FG000|Overall Study|Withdrawal by Subject|3|||
126309841|NCT00782184|454423206|FG001|Overall Study|Withdrawal by Subject|2|||
126309842|NCT01878084|454423208|FG000|Overall Study|Physician Decision|2|||
126309843|NCT00749684|454423209|FG000|Overall Study|Death|1|||
126309844|NCT00749684|454423209|FG000|Overall Study|Adverse Event|27|||
126309845|NCT00749684|454423209|FG000|Overall Study|Participant's Wish|10|||
126309846|NCT00749684|454423209|FG000|Overall Study|Not Documented|1|||
126309847|NCT00749684|454423209|FG000|Overall Study|Progressive Desease|31|||
126309848|NCT00749684|454423209|FG000|Overall Study|Therapy according to protocol + AE|2|||
126309849|NCT00749684|454423209|FG000|Overall Study|AE+discontinuation on participants wish|1|||
126309850|NCT00749684|454423209|FG000|Overall Study|Missing|9|||
126309851|NCT02892422|454423211|FG000|Overall Study|Enrolled not treated|4|||
126309852|NCT02892422|454423211|FG000|Overall Study|Adverse Event|38|||
126309853|NCT02892422|454423211|FG000|Overall Study|Lack of Efficacy|32|||
126309854|NCT02892422|454423211|FG000|Overall Study|Non-compliance with study drug|11|||
126309855|NCT02892422|454423211|FG000|Overall Study|Protocol Violation|4|||
126309856|NCT02892422|454423211|FG000|Overall Study|Withdrawal by Subject|56|||
126309857|NCT02892422|454423211|FG000|Overall Study|Lost to Follow-up|5|||
126309858|NCT02892422|454423211|FG000|Overall Study|sponsor information 16159A results|21|||
126309859|NCT02892422|454423211|FG000|Overall Study|withdrawal of consent|13|||
126309860|NCT02892422|454423211|FG000|Overall Study|exclusion criteria met|3|||
126309861|NCT02892422|454423211|FG000|Overall Study|moving elsewhere|4|||
126309862|NCT02892422|454423211|FG000|Overall Study|non-compliance|10|||
126309863|NCT02892422|454423211|FG000|Overall Study|patient legally incapable|1|||
126309864|NCT02892422|454423211|FG000|Overall Study|patient decision|7|||
126309865|NCT02892422|454423211|FG000|Overall Study|Investigator decision|1|||
126309866|NCT01023256|454423212|FG000|Overall Study|Protocol Violation|2|||
126309867|NCT01023256|454423213|FG001|Overall Study|Protocol Violation|3|||
126309868|NCT01023256|454423214|FG002|Overall Study|Protocol Violation|0|||
126309869|NCT01023256|454423215|FG003|Overall Study|Protocol Violation|0|||
126309870|NCT01023256|454423212|FG000|Overall Study|Randomized but not treated|1|||
126309871|NCT01023256|454423213|FG001|Overall Study|Randomized but not treated|0|||
126309872|NCT01023256|454423214|FG002|Overall Study|Randomized but not treated|1|||
126309873|NCT01023256|454423215|FG003|Overall Study|Randomized but not treated|0|||
126309874|NCT01023256|454423212|FG000|Overall Study|Other|1|||
126309875|NCT01023256|454423213|FG001|Overall Study|Other|0|||
126309876|NCT01023256|454423214|FG002|Overall Study|Other|0|||
126309877|NCT01023256|454423215|FG003|Overall Study|Other|2|||
126309878|NCT01023256|454423212|FG000|Overall Study|Adverse Event|0|||
126309879|NCT01023256|454423213|FG001|Overall Study|Adverse Event|0|||
126309880|NCT01023256|454423214|FG002|Overall Study|Adverse Event|0|||
126309881|NCT01023256|454423215|FG003|Overall Study|Adverse Event|1|||
126309882|NCT01023256|454423212|FG000|Overall Study|Withdrawal by Subject|0|||
126309883|NCT01023256|454423213|FG001|Overall Study|Withdrawal by Subject|0|||
126309884|NCT01023256|454423214|FG002|Overall Study|Withdrawal by Subject|0|||
126309885|NCT01023256|454423215|FG003|Overall Study|Withdrawal by Subject|2|||
126309886|NCT03155178|454423216|FG000|Overall Study|Did not meet treatment day baseline|7|||
126309887|NCT03155178|454423217|FG001|Overall Study|Did not meet treatment day baseline|7|||
126309888|NCT03155178|454423218|FG002|Overall Study|Did not meet treatment day baseline|7|||
126309889|NCT03155178|454423219|FG003|Overall Study|Did not meet treatment day baseline|7|||
126309890|NCT03089697|454423220|FG000|Overall Study|Adverse Event|1|||
126309891|NCT03089697|454423221|FG001|Overall Study|Adverse Event|2|||
126309892|NCT03089697|454423220|FG000|Overall Study|Withdrawal by Subject|1|||
126309893|NCT03089697|454423221|FG001|Overall Study|Withdrawal by Subject|0|||
126047830|NCT03656718|453472928|FG002|Treatment Period Part C|Death|0|||
126309894|NCT03613649|454423222|FG000|Second Treatment|Lost to Follow-up|0|||
126309895|NCT03613649|454423223|FG001|Second Treatment|Lost to Follow-up|0|||
126309896|NCT03613649|454423224|FG002|Second Treatment|Lost to Follow-up|1|||
126309897|NCT03613649|454423225|FG003|Second Treatment|Lost to Follow-up|0|||
126309898|NCT03613649|454423226|FG004|Second Treatment|Lost to Follow-up|0|||
126309899|NCT03613649|454423227|FG005|Second Treatment|Lost to Follow-up|0|||
126309900|NCT03613649|454423228|FG006|Second Treatment|Lost to Follow-up|0|||
126309901|NCT03613649|454423229|FG007|Second Treatment|Lost to Follow-up|0|||
126047831|NCT03656718|453472929|FG003|Treatment Period Part C|Death|0|||
126047832|NCT03656718|453472930|FG004|Treatment Period Part C|Death|1|||
126047833|NCT03656718|453472931|FG005|Treatment Period Part C|Death|0|||
126047834|NCT03656718|453472932|FG006|Treatment Period Part C|Death|0|||
126047835|NCT03656718|453472926|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126088962|NCT01399697|453620039|FG000|Overall Study|Withdrawal by Subject|8|||
125886165|NCT02952820|452878927|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
125886166|NCT02952820|452878925|FG000|Active Treatment Period (6 Months)|Not treated|0|||
125886167|NCT02952820|452878926|FG001|Active Treatment Period (6 Months)|Not treated|0|||
125886168|NCT02952820|452878927|FG002|Active Treatment Period (6 Months)|Not treated|1|||
125886169|NCT04139018|452878928|FG000|Overall Study|Screen fail|1|||
125886170|NCT04139018|452878929|FG001|Overall Study|Screen fail|0|||
125886171|NCT04139018|452878928|FG000|Overall Study|Withdrawal by Subject|2|||
125886172|NCT04139018|452878929|FG001|Overall Study|Withdrawal by Subject|0|||
125886173|NCT04139018|452878928|FG000|Overall Study|Lost to Follow-up|0|||
125886174|NCT04139018|452878929|FG001|Overall Study|Lost to Follow-up|1|||
125886175|NCT03486834|452878930|FG000|Overall Study|Withdrawal by Subject|46|||
125886176|NCT03486834|452878931|FG001|Overall Study|Withdrawal by Subject|46|||
125886177|NCT03486834|452878932|FG002|Overall Study|Withdrawal by Subject|52|||
126047836|NCT03656718|453472927|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126309902|NCT03613649|454423230|FG008|Second Treatment|Lost to Follow-up|0|||
126309903|NCT03613649|454423231|FG009|Second Treatment|Lost to Follow-up|0|||
126309904|NCT03613649|454423232|FG010|Second Treatment|Lost to Follow-up|0|||
126309905|NCT03613649|454423233|FG011|Second Treatment|Lost to Follow-up|0|||
126309906|NCT03613649|454423222|FG000|Second Treatment|Withdrawal by Subject|0|||
126309907|NCT03613649|454423223|FG001|Second Treatment|Withdrawal by Subject|0|||
126309908|NCT03613649|454423224|FG002|Second Treatment|Withdrawal by Subject|0|||
126309909|NCT03613649|454423225|FG003|Second Treatment|Withdrawal by Subject|0|||
126309910|NCT03613649|454423226|FG004|Second Treatment|Withdrawal by Subject|1|||
126309911|NCT03613649|454423227|FG005|Second Treatment|Withdrawal by Subject|0|||
126309912|NCT03613649|454423228|FG006|Second Treatment|Withdrawal by Subject|0|||
126309913|NCT03613649|454423229|FG007|Second Treatment|Withdrawal by Subject|0|||
126309914|NCT03613649|454423230|FG008|Second Treatment|Withdrawal by Subject|0|||
126309915|NCT03613649|454423231|FG009|Second Treatment|Withdrawal by Subject|0|||
126309916|NCT03613649|454423232|FG010|Second Treatment|Withdrawal by Subject|0|||
126309917|NCT03613649|454423233|FG011|Second Treatment|Withdrawal by Subject|0|||
126309918|NCT03613649|454423222|FG000|Third Treatment|Lost to Follow-up|0|||
126309919|NCT03613649|454423223|FG001|Third Treatment|Lost to Follow-up|0|||
126309920|NCT03613649|454423224|FG002|Third Treatment|Lost to Follow-up|0|||
126309921|NCT03613649|454423225|FG003|Third Treatment|Lost to Follow-up|0|||
126309922|NCT03613649|454423226|FG004|Third Treatment|Lost to Follow-up|1|||
126309923|NCT03613649|454423227|FG005|Third Treatment|Lost to Follow-up|0|||
126309924|NCT03613649|454423228|FG006|Third Treatment|Lost to Follow-up|0|||
126309925|NCT03613649|454423229|FG007|Third Treatment|Lost to Follow-up|0|||
126309926|NCT03613649|454423230|FG008|Third Treatment|Lost to Follow-up|0|||
126309927|NCT03613649|454423231|FG009|Third Treatment|Lost to Follow-up|0|||
126309928|NCT03613649|454423232|FG010|Third Treatment|Lost to Follow-up|0|||
126309929|NCT03613649|454423233|FG011|Third Treatment|Lost to Follow-up|1|||
126309930|NCT03613649|454423222|FG000|Third Treatment|Protocol Violation|0|||
126309931|NCT03613649|454423223|FG001|Third Treatment|Protocol Violation|0|||
126309932|NCT03613649|454423224|FG002|Third Treatment|Protocol Violation|0|||
126309933|NCT03613649|454423225|FG003|Third Treatment|Protocol Violation|0|||
126309934|NCT03613649|454423226|FG004|Third Treatment|Protocol Violation|0|||
126309935|NCT03613649|454423227|FG005|Third Treatment|Protocol Violation|0|||
126309936|NCT03613649|454423228|FG006|Third Treatment|Protocol Violation|1|||
126309937|NCT03613649|454423229|FG007|Third Treatment|Protocol Violation|0|||
126309938|NCT03613649|454423230|FG008|Third Treatment|Protocol Violation|0|||
126309939|NCT03613649|454423231|FG009|Third Treatment|Protocol Violation|0|||
126309940|NCT03613649|454423232|FG010|Third Treatment|Protocol Violation|0|||
126309941|NCT03613649|454423233|FG011|Third Treatment|Protocol Violation|1|||
126309942|NCT03613649|454423222|FG000|Fourth Treatment|Protocol Violation|1|||
126309943|NCT03613649|454423223|FG001|Fourth Treatment|Protocol Violation|0|||
126309944|NCT03613649|454423224|FG002|Fourth Treatment|Protocol Violation|0|||
126309945|NCT03613649|454423225|FG003|Fourth Treatment|Protocol Violation|0|||
126309946|NCT03613649|454423226|FG004|Fourth Treatment|Protocol Violation|1|||
126309947|NCT03613649|454423227|FG005|Fourth Treatment|Protocol Violation|0|||
126309948|NCT03613649|454423228|FG006|Fourth Treatment|Protocol Violation|0|||
126088963|NCT01399697|453620040|FG001|Overall Study|Withdrawal by Subject|0|||
126309949|NCT03613649|454423229|FG007|Fourth Treatment|Protocol Violation|0|||
125886178|NCT03486834|452878930|FG000|Overall Study|Adverse Event|8|||
126309950|NCT03613649|454423230|FG008|Fourth Treatment|Protocol Violation|0|||
126309951|NCT03613649|454423231|FG009|Fourth Treatment|Protocol Violation|0|||
126309952|NCT03613649|454423232|FG010|Fourth Treatment|Protocol Violation|0|||
126309953|NCT03613649|454423233|FG011|Fourth Treatment|Protocol Violation|0|||
126309954|NCT03613649|454423222|FG000|Fourth Treatment|Physician Decision|0|||
125886179|NCT03486834|452878931|FG001|Overall Study|Adverse Event|7|||
125886180|NCT03486834|452878932|FG002|Overall Study|Adverse Event|0|||
126309955|NCT03613649|454423223|FG001|Fourth Treatment|Physician Decision|0|||
126309956|NCT03613649|454423224|FG002|Fourth Treatment|Physician Decision|0|||
126309957|NCT03613649|454423225|FG003|Fourth Treatment|Physician Decision|0|||
126309958|NCT03613649|454423226|FG004|Fourth Treatment|Physician Decision|0|||
126309959|NCT03613649|454423227|FG005|Fourth Treatment|Physician Decision|0|||
125886181|NCT03486834|452878930|FG000|Overall Study|Lost to Follow-up|41|||
125886182|NCT03486834|452878931|FG001|Overall Study|Lost to Follow-up|24|||
125886183|NCT03486834|452878932|FG002|Overall Study|Lost to Follow-up|39|||
125886184|NCT03486834|452878930|FG000|Overall Study|Non-compliance with Study Drug|2|||
125886185|NCT03486834|452878931|FG001|Overall Study|Non-compliance with Study Drug|2|||
125886186|NCT03486834|452878932|FG002|Overall Study|Non-compliance with Study Drug|0|||
125886187|NCT03486834|452878930|FG000|Overall Study|Physician Decision|5|||
125886188|NCT03486834|452878931|FG001|Overall Study|Physician Decision|2|||
125886189|NCT03486834|452878932|FG002|Overall Study|Physician Decision|3|||
125886190|NCT03486834|452878930|FG000|Overall Study|Pregnancy|10|||
125886191|NCT03486834|452878931|FG001|Overall Study|Pregnancy|12|||
125886192|NCT03486834|452878932|FG002|Overall Study|Pregnancy|12|||
125886193|NCT03486834|452878930|FG000|Overall Study|Protocol Deviation|2|||
125886194|NCT03486834|452878931|FG001|Overall Study|Protocol Deviation|3|||
126047837|NCT03656718|453472928|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126047838|NCT03656718|453472929|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126047839|NCT03656718|453472930|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
126309960|NCT03613649|454423228|FG006|Fourth Treatment|Physician Decision|1|||
126309961|NCT03613649|454423229|FG007|Fourth Treatment|Physician Decision|0|||
126309962|NCT03613649|454423230|FG008|Fourth Treatment|Physician Decision|0|||
126309963|NCT03613649|454423231|FG009|Fourth Treatment|Physician Decision|0|||
126309964|NCT03613649|454423232|FG010|Fourth Treatment|Physician Decision|0|||
126309965|NCT03613649|454423233|FG011|Fourth Treatment|Physician Decision|0|||
126309966|NCT00675428|454423234|FG000|Overall Study|Disease Progression|2|||
126309967|NCT00675428|454423235|FG001|Overall Study|Disease Progression|2|||
126309968|NCT00675428|454423234|FG000|Overall Study|No Disease Response After Cycle 6|0|||
126309969|NCT00675428|454423235|FG001|Overall Study|No Disease Response After Cycle 6|1|||
126309970|NCT00675428|454423234|FG000|Overall Study|Physician Decision|1|||
126309971|NCT00675428|454423235|FG001|Overall Study|Physician Decision|0|||
126309972|NCT00319592|454423236|FG000|Overall Study|Protocol Violation|1|||
126309973|NCT00319592|454423237|FG001|Overall Study|Protocol Violation|0|||
126309974|NCT00319592|454423236|FG000|Overall Study|Physician Decision|0|||
126309975|NCT00319592|454423237|FG001|Overall Study|Physician Decision|1|||
126309976|NCT01500187|454423240|FG000|Overall Study|Lost to Follow-up|6|||
126309977|NCT01500187|454423241|FG001|Overall Study|Lost to Follow-up|0|||
126309978|NCT01992653|454423244|FG000|Overall Study|Death|0|||
126309979|NCT01992653|454423245|FG001|Overall Study|Death|0|||
126309980|NCT01992653|454423246|FG002|Overall Study|Death|1|||
126309981|NCT01992653|454423247|FG003|Overall Study|Death|0|||
126309982|NCT01992653|454423248|FG004|Overall Study|Death|1|||
126309983|NCT01992653|454423249|FG005|Overall Study|Death|0|||
126309984|NCT01992653|454423250|FG006|Overall Study|Death|4|||
126309985|NCT01992653|454423251|FG007|Overall Study|Death|2|||
126309986|NCT01992653|454423244|FG000|Overall Study|Lost to Follow-up|0|||
126309987|NCT01992653|454423245|FG001|Overall Study|Lost to Follow-up|0|||
126309988|NCT01992653|454423246|FG002|Overall Study|Lost to Follow-up|0|||
126309989|NCT01992653|454423247|FG003|Overall Study|Lost to Follow-up|0|||
126309990|NCT01992653|454423248|FG004|Overall Study|Lost to Follow-up|0|||
126309991|NCT01992653|454423249|FG005|Overall Study|Lost to Follow-up|0|||
126309992|NCT01992653|454423250|FG006|Overall Study|Lost to Follow-up|0|||
126309993|NCT01992653|454423251|FG007|Overall Study|Lost to Follow-up|1|||
126309994|NCT01992653|454423244|FG000|Overall Study|Study Completed|0|||
126309995|NCT01992653|454423245|FG001|Overall Study|Study Completed|0|||
126309996|NCT01992653|454423246|FG002|Overall Study|Study Completed|0|||
126309997|NCT01992653|454423247|FG003|Overall Study|Study Completed|0|||
126309998|NCT01992653|454423248|FG004|Overall Study|Study Completed|0|||
126309999|NCT01992653|454423249|FG005|Overall Study|Study Completed|0|||
126310000|NCT01992653|454423250|FG006|Overall Study|Study Completed|0|||
126310001|NCT01992653|454423251|FG007|Overall Study|Study Completed|1|||
126310002|NCT01992653|454423244|FG000|Overall Study|Disease Progression|0|||
126310003|NCT01992653|454423245|FG001|Overall Study|Disease Progression|0|||
126310004|NCT01992653|454423246|FG002|Overall Study|Disease Progression|0|||
126310005|NCT01992653|454423247|FG003|Overall Study|Disease Progression|0|||
126310006|NCT01992653|454423248|FG004|Overall Study|Disease Progression|0|||
125886195|NCT03486834|452878932|FG002|Overall Study|Protocol Deviation|3|||
126310007|NCT01992653|454423249|FG005|Overall Study|Disease Progression|0|||
126310008|NCT01992653|454423250|FG006|Overall Study|Disease Progression|4|||
126310009|NCT01992653|454423251|FG007|Overall Study|Disease Progression|0|||
126310010|NCT04553471|454423252|FG000|Overall Study|Did not start treatment on protocol|3|||
126310011|NCT04553471|454423252|FG000|Overall Study|Death|1|||
126310012|NCT00940823|454423253|FG000|Overall Study|Death|8|||
126310013|NCT00940823|454423254|FG001|Overall Study|Death|12|||
125886196|NCT03486834|452878930|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126310014|NCT00940823|454423253|FG000|Overall Study|Lost to Follow-up|27|||
126310015|NCT00940823|454423254|FG001|Overall Study|Lost to Follow-up|20|||
126310016|NCT02572076|454423257|FG000|Overall Study|Protocol Violation|1|||
126310017|NCT01397786|454425185|FG000|Phase A|Lost to Follow-up|0|||
126310018|NCT01397786|454425186|FG001|Phase A|Lost to Follow-up|0|||
126310019|NCT01397786|454425187|FG002|Phase A|Lost to Follow-up|6|||
126310020|NCT01397786|454425185|FG000|Phase A|Adverse Event|0|||
126373458|NCT00492557|454665099|FG000|Overall Study|Subject request|12|||
126373459|NCT00492557|454665100|FG001|Overall Study|Subject request|11|||
126373460|NCT00492557|454665099|FG000|Overall Study|Protocol Violation|7|||
126373461|NCT00492557|454665100|FG001|Overall Study|Protocol Violation|8|||
126373462|NCT00492557|454665099|FG000|Overall Study|Other|2|||
126373463|NCT00492557|454665100|FG001|Overall Study|Other|2|||
126373464|NCT00492557|454665099|FG000|Overall Study|Death|1|||
126373465|NCT00492557|454665100|FG001|Overall Study|Death|1|||
126373466|NCT00492557|454665099|FG000|Overall Study|Adverse Event|1|||
126373467|NCT00492557|454665100|FG001|Overall Study|Adverse Event|0|||
126104035|NCT03727438|453673908|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
126104036|NCT03727438|453673907|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
126373468|NCT00492557|454665099|FG000|Overall Study|Failed to return|1|||
126373469|NCT00492557|454665100|FG001|Overall Study|Failed to return|0|||
126373470|NCT00492557|454665099|FG000|Overall Study|Lost to Follow-up|0|||
126373471|NCT00492557|454665100|FG001|Overall Study|Lost to Follow-up|1|||
126373472|NCT01493089|454665104|FG000|Overall Study|Protocol Violation|2|||
126373473|NCT01493089|454665105|FG001|Overall Study|Protocol Violation|2|||
126373474|NCT01493089|454665104|FG000|Overall Study|Withdrawal by Subject|1|||
126373475|NCT01493089|454665105|FG001|Overall Study|Withdrawal by Subject|0|||
126373476|NCT01493089|454665104|FG000|Overall Study|Physician Decision|0|||
126373477|NCT01493089|454665105|FG001|Overall Study|Physician Decision|1|||
126373478|NCT00329030|454665106|FG000|Overall Study|Withdrawal by Subject|1|||
126373479|NCT00329030|454665107|FG001|Overall Study|Withdrawal by Subject|3|||
126373480|NCT00329030|454665106|FG000|Overall Study|Progressive Disease|6|||
126373481|NCT00329030|454665107|FG001|Overall Study|Progressive Disease|2|||
126373482|NCT00329030|454665106|FG000|Overall Study|Ineligible Pathology|1|||
126373483|NCT00329030|454665107|FG001|Overall Study|Ineligible Pathology|1|||
126373484|NCT00325143|454665108|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
126373485|NCT00325143|454665108|FG000|Overall Study|Migrated/moved from study area|1|||
126373486|NCT00325143|454665108|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
126373487|NCT00325143|454665108|FG000|Overall Study|Withdrawal by Subject|8|||
126373488|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Physician Decision|2|||
126373489|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Physician Decision|0|||
126373490|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Physician Decision|0|||
126373491|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Adverse Event|33|||
126373492|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Adverse Event|0|||
126373493|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Adverse Event|0|||
126310021|NCT01397786|454425186|FG001|Phase A|Adverse Event|0|||
126310022|NCT01397786|454425187|FG002|Phase A|Adverse Event|8|||
126310023|NCT01397786|454425185|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
126310024|NCT01397786|454425186|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
126310025|NCT01397786|454425187|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
126310026|NCT01397786|454425185|FG000|Phase A|Physician Decision|0|||
126310027|NCT01397786|454425186|FG001|Phase A|Physician Decision|0|||
126310028|NCT01397786|454425187|FG002|Phase A|Physician Decision|1|||
126310029|NCT01397786|454425185|FG000|Phase A|Withdrawal by Subject|0|||
126310030|NCT01397786|454425186|FG001|Phase A|Withdrawal by Subject|0|||
126310031|NCT01397786|454425187|FG002|Phase A|Withdrawal by Subject|5|||
126310032|NCT01397786|454425185|FG000|Phase A|Lack of Efficacy|0|||
126310033|NCT01397786|454425186|FG001|Phase A|Lack of Efficacy|0|||
126310034|NCT01397786|454425187|FG002|Phase A|Lack of Efficacy|1|||
126310035|NCT01397786|454425185|FG000|Phase B|Lost to Follow-up|22|||
126310036|NCT01397786|454425186|FG001|Phase B|Lost to Follow-up|12|||
126310037|NCT01397786|454425187|FG002|Phase B|Lost to Follow-up|22|||
126310038|NCT01397786|454425185|FG000|Phase B|Adverse Event|109|||
126310039|NCT01397786|454425186|FG001|Phase B|Adverse Event|23|||
126310040|NCT01397786|454425187|FG002|Phase B|Adverse Event|27|||
126310041|NCT01397786|454425185|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
126310042|NCT01397786|454425186|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
126310043|NCT01397786|454425187|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
126310044|NCT01397786|454425185|FG000|Phase B|Physician Decision|9|||
126310045|NCT01397786|454425186|FG001|Phase B|Physician Decision|1|||
126310046|NCT01397786|454425187|FG002|Phase B|Physician Decision|3|||
126310047|NCT01397786|454425185|FG000|Phase B|Withdrawal by Subject|102|||
126310048|NCT01397786|454425186|FG001|Phase B|Withdrawal by Subject|45|||
126310049|NCT01397786|454425187|FG002|Phase B|Withdrawal by Subject|30|||
126310050|NCT01397786|454425185|FG000|Phase B|Protocol Deviation|1|||
126373494|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
126373495|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
126373496|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
126047840|NCT03656718|453472931|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126047841|NCT03656718|453472932|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126047842|NCT03656718|453472926|FG000|Treatment Period Part C|Other reasons|0|||
126047843|NCT03656718|453472927|FG001|Treatment Period Part C|Other reasons|0|||
126310051|NCT01397786|454425186|FG001|Phase B|Protocol Deviation|2|||
126310052|NCT01397786|454425187|FG002|Phase B|Protocol Deviation|4|||
126373497|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
126310053|NCT01397786|454425185|FG000|Phase B|Lack of Efficacy|22|||
126310054|NCT01397786|454425186|FG001|Phase B|Lack of Efficacy|7|||
126310055|NCT01397786|454425187|FG002|Phase B|Lack of Efficacy|14|||
126310056|NCT00784550|454425188|FG000|Overall Study|Adverse Event|12|||
126310057|NCT00784550|454425189|FG001|Overall Study|Adverse Event|10|||
126310058|NCT00784550|454425188|FG000|Overall Study|Lack of Efficacy|0|||
126310059|NCT00784550|454425189|FG001|Overall Study|Lack of Efficacy|1|||
126373498|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
126373499|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
126373500|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
126373501|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
126373502|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
126373503|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
126373504|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
126373505|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
126373506|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
126373507|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
126373508|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
126373509|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
126373510|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
126373511|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
126373512|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
126373513|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
126373514|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
126373515|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
126373516|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
126373517|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
126373518|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
126373519|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
126373520|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
126373521|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
126373522|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
126373523|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
126373524|NCT01627691|454665112|FG000|Overall Study|Death|11|||
126373525|NCT01627691|454665112|FG000|Overall Study|Lost to Follow-up|3|||
126373526|NCT01627691|454665112|FG000|Overall Study|Withdrawal by Subject|1|||
126373527|NCT01627691|454665112|FG000|Overall Study|Missed the visit|3|||
126373528|NCT00181844|454665113|FG000|Signed Consent|Withdrawal by Subject|5|||
126373529|NCT00181844|454665113|FG000|Signed Consent|Did not meet entrance criteria|7|||
126373530|NCT00181844|454665113|FG000|Exposed to Study Medication|Adverse Event|10|||
126373531|NCT00181844|454665113|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
126373532|NCT00181844|454665113|FG000|Exposed to Study Medication|Non-compliance|2|||
126373533|NCT00181844|454665113|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
126373534|NCT00181844|454665113|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
126373535|NCT04661033|454665114|FG000|Overall Study|Adverse Event|0|||
126373536|NCT04661033|454665115|FG001|Overall Study|Adverse Event|0|||
126373537|NCT04661033|454665116|FG002|Overall Study|Adverse Event|1|||
126373538|NCT04661033|454665117|FG003|Overall Study|Adverse Event|0|||
126373539|NCT04661033|454665114|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
126373540|NCT04661033|454665115|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
126373541|NCT04661033|454665116|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
126373542|NCT04661033|454665117|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
126373543|NCT04661033|454665114|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
126373544|NCT04661033|454665115|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
126373545|NCT04661033|454665116|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
126373546|NCT04661033|454665117|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
126373547|NCT04661033|454665114|FG000|Overall Study|Early discontinuation as per PI|1|||
126373548|NCT04661033|454665115|FG001|Overall Study|Early discontinuation as per PI|0|||
126373549|NCT04661033|454665116|FG002|Overall Study|Early discontinuation as per PI|0|||
126373550|NCT04661033|454665117|FG003|Overall Study|Early discontinuation as per PI|0|||
126373551|NCT00565409|454665120|FG000|Period 1 Open Label|Adverse Event|17|||
126373552|NCT00565409|454665121|FG001|Period 1 Open Label|Adverse Event|0|||
126373553|NCT00565409|454665122|FG002|Period 1 Open Label|Adverse Event|0|||
126373554|NCT00565409|454665123|FG003|Period 1 Open Label|Adverse Event|0|||
126373555|NCT00565409|454665120|FG000|Period 1 Open Label|Death|2|||
126373556|NCT00565409|454665121|FG001|Period 1 Open Label|Death|0|||
126373557|NCT00565409|454665122|FG002|Period 1 Open Label|Death|0|||
126373558|NCT00565409|454665123|FG003|Period 1 Open Label|Death|0|||
126373559|NCT00565409|454665120|FG000|Period 1 Open Label|Lost to Follow-up|1|||
126373560|NCT00565409|454665121|FG001|Period 1 Open Label|Lost to Follow-up|0|||
126373561|NCT00565409|454665122|FG002|Period 1 Open Label|Lost to Follow-up|0|||
126373562|NCT00565409|454665123|FG003|Period 1 Open Label|Lost to Follow-up|0|||
126310060|NCT00784550|454425188|FG000|Overall Study|Protocol Violation|10|||
126310061|NCT00784550|454425189|FG001|Overall Study|Protocol Violation|10|||
126310062|NCT00784550|454425188|FG000|Overall Study|Lost to Follow-up|8|||
126310063|NCT00784550|454425189|FG001|Overall Study|Lost to Follow-up|5|||
126310064|NCT00784550|454425188|FG000|Overall Study|Physician Decision|2|||
126310065|NCT00784550|454425189|FG001|Overall Study|Physician Decision|3|||
126310066|NCT00784550|454425188|FG000|Overall Study|Withdrawal by Subject|4|||
126310067|NCT00784550|454425189|FG001|Overall Study|Withdrawal by Subject|13|||
126310068|NCT00688701|454425190|FG000|Overall Study|Adverse Event|1|||
126310069|NCT00688701|454425191|FG001|Overall Study|Adverse Event|0|||
126310070|NCT00688701|454425192|FG002|Overall Study|Adverse Event|5|||
126310071|NCT00688701|454425193|FG003|Overall Study|Adverse Event|3|||
126310072|NCT00688701|454425190|FG000|Overall Study|Lack of Efficacy|0|||
126310073|NCT00688701|454425191|FG001|Overall Study|Lack of Efficacy|1|||
126310074|NCT00688701|454425192|FG002|Overall Study|Lack of Efficacy|0|||
126310075|NCT00688701|454425193|FG003|Overall Study|Lack of Efficacy|0|||
126310076|NCT00688701|454425190|FG000|Overall Study|Withdrawal by Subject|3|||
126310077|NCT00688701|454425191|FG001|Overall Study|Withdrawal by Subject|3|||
126310078|NCT00688701|454425192|FG002|Overall Study|Withdrawal by Subject|4|||
126310079|NCT00688701|454425193|FG003|Overall Study|Withdrawal by Subject|8|||
126310080|NCT00688701|454425190|FG000|Overall Study|Poor compliance to protocol|0|||
126310081|NCT00688701|454425191|FG001|Overall Study|Poor compliance to protocol|1|||
126310082|NCT00688701|454425192|FG002|Overall Study|Poor compliance to protocol|1|||
126310083|NCT00688701|454425193|FG003|Overall Study|Poor compliance to protocol|0|||
126310084|NCT03558152|454425201|FG000|Overall Study|Adverse Event|0|||
126310085|NCT03558152|454425202|FG001|Overall Study|Adverse Event|0|||
126310086|NCT03558152|454425203|FG002|Overall Study|Adverse Event|1|||
126310087|NCT03558152|454425204|FG003|Overall Study|Adverse Event|1|||
126310088|NCT03558152|454425205|FG004|Overall Study|Adverse Event|2|||
126310089|NCT03558152|454425206|FG005|Overall Study|Adverse Event|1|||
126047844|NCT03656718|453472928|FG002|Treatment Period Part C|Other reasons|0|||
126047845|NCT03656718|453472929|FG003|Treatment Period Part C|Other reasons|0|||
126047846|NCT03656718|453472930|FG004|Treatment Period Part C|Other reasons|1|||
126310090|NCT03558152|454425207|FG006|Overall Study|Adverse Event|1|||
126047847|NCT03656718|453472931|FG005|Treatment Period Part C|Other reasons|0|||
126047848|NCT03656718|453472932|FG006|Treatment Period Part C|Other reasons|0|||
126310091|NCT03558152|454425208|FG007|Overall Study|Adverse Event|0|||
126310092|NCT03558152|454425201|FG000|Overall Study|Death|0|||
126310093|NCT03558152|454425202|FG001|Overall Study|Death|0|||
126310094|NCT03558152|454425203|FG002|Overall Study|Death|0|||
126310095|NCT03558152|454425204|FG003|Overall Study|Death|0|||
126310096|NCT03558152|454425205|FG004|Overall Study|Death|1|||
126310097|NCT03558152|454425206|FG005|Overall Study|Death|0|||
126310098|NCT03558152|454425207|FG006|Overall Study|Death|0|||
126373563|NCT00565409|454665120|FG000|Period 1 Open Label|Other|21|||
126373564|NCT00565409|454665121|FG001|Period 1 Open Label|Other|0|||
126373565|NCT00565409|454665122|FG002|Period 1 Open Label|Other|0|||
126373566|NCT00565409|454665123|FG003|Period 1 Open Label|Other|0|||
126373567|NCT00565409|454665120|FG000|Period 1 Open Label|Protocol Violation|14|||
126373568|NCT00565409|454665121|FG001|Period 1 Open Label|Protocol Violation|0|||
126373569|NCT00565409|454665122|FG002|Period 1 Open Label|Protocol Violation|0|||
126373570|NCT00565409|454665123|FG003|Period 1 Open Label|Protocol Violation|0|||
126373571|NCT00565409|454665120|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
126373572|NCT00565409|454665121|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
126373573|NCT00565409|454665122|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
126373574|NCT00565409|454665123|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
126373575|NCT00565409|454665120|FG000|Period 1 Open Label|no conclusion of participation record|1|||
126373576|NCT00565409|454665121|FG001|Period 1 Open Label|no conclusion of participation record|0|||
126373577|NCT00565409|454665122|FG002|Period 1 Open Label|no conclusion of participation record|0|||
126373578|NCT00565409|454665123|FG003|Period 1 Open Label|no conclusion of participation record|0|||
126373579|NCT00565409|454665120|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
126373580|NCT00565409|454665121|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
126373581|NCT00565409|454665122|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
126373582|NCT00565409|454665123|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
126373583|NCT00565409|454665120|FG000|Period 2 Double-Blind|Adverse Event|0|||
126373584|NCT00565409|454665121|FG001|Period 2 Double-Blind|Adverse Event|7|||
126373585|NCT00565409|454665122|FG002|Period 2 Double-Blind|Adverse Event|4|||
126373586|NCT00565409|454665123|FG003|Period 2 Double-Blind|Adverse Event|5|||
126373587|NCT00565409|454665120|FG000|Period 2 Double-Blind|Death|0|||
126373588|NCT00565409|454665121|FG001|Period 2 Double-Blind|Death|2|||
126373589|NCT00565409|454665122|FG002|Period 2 Double-Blind|Death|0|||
126373590|NCT00565409|454665123|FG003|Period 2 Double-Blind|Death|0|||
125886197|NCT03486834|452878931|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125886198|NCT03486834|452878932|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125886199|NCT03486834|452878930|FG000|Overall Study|Randomized but not treated|4|||
125886200|NCT03486834|452878931|FG001|Overall Study|Randomized but not treated|4|||
125886201|NCT03486834|452878932|FG002|Overall Study|Randomized but not treated|1|||
125886202|NCT00525161|452878957|FG000|Overall Study|Adverse Event|1|||
125886203|NCT02447003|452878958|FG000|Overall Study|Other|0|||
125886204|NCT02447003|452878959|FG001|Overall Study|Other|4|||
125886205|NCT02447003|452878958|FG000|Overall Study|Site discontinued|0|||
125886206|NCT02447003|452878959|FG001|Overall Study|Site discontinued|2|||
125886207|NCT02447003|452878958|FG000|Overall Study|Physician Decision|0|||
125886208|NCT02447003|452878959|FG001|Overall Study|Physician Decision|1|||
125886209|NCT02447003|452878958|FG000|Overall Study|Withdrawal by Subject|4|||
125886210|NCT02447003|452878959|FG001|Overall Study|Withdrawal by Subject|3|||
125886211|NCT02447003|452878958|FG000|Overall Study|Sponsor Decision|6|||
125886212|NCT02447003|452878959|FG001|Overall Study|Sponsor Decision|11|||
125886213|NCT02447003|452878958|FG000|Overall Study|Progressive Disease|1|||
125886214|NCT02447003|452878959|FG001|Overall Study|Progressive Disease|0|||
125886215|NCT02447003|452878958|FG000|Overall Study|Lost to Follow-up|5|||
125886216|NCT02447003|452878959|FG001|Overall Study|Lost to Follow-up|0|||
125886217|NCT02447003|452878958|FG000|Overall Study|Death|154|||
126310099|NCT03558152|454425208|FG007|Overall Study|Death|0|||
126310100|NCT03558152|454425201|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
126310101|NCT03558152|454425202|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310102|NCT03558152|454425203|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310103|NCT03558152|454425204|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310104|NCT03558152|454425205|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310105|NCT03558152|454425206|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310106|NCT03558152|454425207|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310107|NCT03558152|454425208|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310108|NCT03558152|454425201|FG000|Overall Study|Miscalculation in mmcs|0|||
126310109|NCT03558152|454425202|FG001|Overall Study|Miscalculation in mmcs|0|||
126310110|NCT03558152|454425203|FG002|Overall Study|Miscalculation in mmcs|0|||
126373591|NCT00565409|454665120|FG000|Period 2 Double-Blind|Protocol Violation|0|||
125886218|NCT02447003|452878959|FG001|Overall Study|Death|63|||
125886219|NCT03848728|452878960|FG000|Overall Study|Death|16|||
126373592|NCT00565409|454665121|FG001|Period 2 Double-Blind|Protocol Violation|4|||
125886220|NCT03848728|452878961|FG001|Overall Study|Death|13|||
125886221|NCT03848728|452878960|FG000|Overall Study|Outmigrated to non-study community|98|||
126373593|NCT00565409|454665122|FG002|Period 2 Double-Blind|Protocol Violation|6|||
126373594|NCT00565409|454665123|FG003|Period 2 Double-Blind|Protocol Violation|2|||
126373595|NCT00565409|454665120|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
126373596|NCT00565409|454665121|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
125886222|NCT03848728|452878961|FG001|Overall Study|Outmigrated to non-study community|106|||
125886223|NCT03848728|452878960|FG000|Overall Study|Transfered to non-study clinic|32|||
125886224|NCT03848728|452878961|FG001|Overall Study|Transfered to non-study clinic|48|||
126310111|NCT03558152|454425204|FG003|Overall Study|Miscalculation in mmcs|0|||
126310112|NCT03558152|454425205|FG004|Overall Study|Miscalculation in mmcs|0|||
126310113|NCT03558152|454425206|FG005|Overall Study|Miscalculation in mmcs|0|||
126310114|NCT03558152|454425207|FG006|Overall Study|Miscalculation in mmcs|1|||
126310115|NCT03558152|454425208|FG007|Overall Study|Miscalculation in mmcs|0|||
126310116|NCT03558152|454425201|FG000|Overall Study|Mistake in calculation|0|||
126310117|NCT03558152|454425202|FG001|Overall Study|Mistake in calculation|0|||
126310118|NCT03558152|454425203|FG002|Overall Study|Mistake in calculation|0|||
126310119|NCT03558152|454425204|FG003|Overall Study|Mistake in calculation|1|||
126310120|NCT03558152|454425205|FG004|Overall Study|Mistake in calculation|0|||
126310121|NCT03558152|454425206|FG005|Overall Study|Mistake in calculation|0|||
126310122|NCT03558152|454425207|FG006|Overall Study|Mistake in calculation|0|||
126310123|NCT03558152|454425208|FG007|Overall Study|Mistake in calculation|0|||
126310124|NCT03558152|454425201|FG000|Overall Study|Mistake in evaluation of disease status|0|||
126310125|NCT03558152|454425202|FG001|Overall Study|Mistake in evaluation of disease status|0|||
126310126|NCT03558152|454425203|FG002|Overall Study|Mistake in evaluation of disease status|0|||
126310127|NCT03558152|454425204|FG003|Overall Study|Mistake in evaluation of disease status|0|||
126310128|NCT03558152|454425205|FG004|Overall Study|Mistake in evaluation of disease status|0|||
126310129|NCT03558152|454425206|FG005|Overall Study|Mistake in evaluation of disease status|0|||
126310130|NCT03558152|454425207|FG006|Overall Study|Mistake in evaluation of disease status|0|||
126310131|NCT03558152|454425208|FG007|Overall Study|Mistake in evaluation of disease status|1|||
126310132|NCT03558152|454425201|FG000|Overall Study|Physician Decision|0|||
126310133|NCT03558152|454425202|FG001|Overall Study|Physician Decision|0|||
126310134|NCT03558152|454425203|FG002|Overall Study|Physician Decision|0|||
126310135|NCT03558152|454425204|FG003|Overall Study|Physician Decision|0|||
126310136|NCT03558152|454425205|FG004|Overall Study|Physician Decision|0|||
126310137|NCT03558152|454425206|FG005|Overall Study|Physician Decision|0|||
126310138|NCT03558152|454425207|FG006|Overall Study|Physician Decision|1|||
126310139|NCT03558152|454425208|FG007|Overall Study|Physician Decision|0|||
126310140|NCT03558152|454425201|FG000|Overall Study|Withdrawal by Subject|2|||
126310141|NCT03558152|454425202|FG001|Overall Study|Withdrawal by Subject|3|||
126310142|NCT03558152|454425203|FG002|Overall Study|Withdrawal by Subject|2|||
126310143|NCT03558152|454425204|FG003|Overall Study|Withdrawal by Subject|1|||
126310144|NCT03558152|454425205|FG004|Overall Study|Withdrawal by Subject|1|||
126310145|NCT03558152|454425206|FG005|Overall Study|Withdrawal by Subject|1|||
126310146|NCT03558152|454425207|FG006|Overall Study|Withdrawal by Subject|3|||
126310147|NCT03558152|454425208|FG007|Overall Study|Withdrawal by Subject|2|||
126310148|NCT03558152|454425201|FG000|Overall Study|Lack of Efficacy|11|||
126310149|NCT03558152|454425202|FG001|Overall Study|Lack of Efficacy|11|||
126310150|NCT03558152|454425203|FG002|Overall Study|Lack of Efficacy|10|||
126310151|NCT03558152|454425204|FG003|Overall Study|Lack of Efficacy|11|||
126310152|NCT03558152|454425205|FG004|Overall Study|Lack of Efficacy|14|||
126310153|NCT03558152|454425206|FG005|Overall Study|Lack of Efficacy|12|||
126310154|NCT03558152|454425207|FG006|Overall Study|Lack of Efficacy|14|||
126310155|NCT03558152|454425208|FG007|Overall Study|Lack of Efficacy|13|||
126310156|NCT03558152|454425201|FG000|Overall Study|Protocol Violation|1|||
126310157|NCT03558152|454425202|FG001|Overall Study|Protocol Violation|1|||
126310158|NCT03558152|454425203|FG002|Overall Study|Protocol Violation|0|||
126310159|NCT03558152|454425204|FG003|Overall Study|Protocol Violation|1|||
126310160|NCT03558152|454425205|FG004|Overall Study|Protocol Violation|1|||
126310161|NCT03558152|454425206|FG005|Overall Study|Protocol Violation|0|||
126310162|NCT03558152|454425207|FG006|Overall Study|Protocol Violation|2|||
126310163|NCT03558152|454425208|FG007|Overall Study|Protocol Violation|0|||
126310164|NCT00601172|454425209|FG000|Overall Study|Adverse Event|43|||
126310165|NCT00601172|454425210|FG001|Overall Study|Adverse Event|32|||
126310166|NCT00601172|454425209|FG000|Overall Study|Lack of Efficacy|11|||
126310167|NCT00601172|454425210|FG001|Overall Study|Lack of Efficacy|12|||
126310168|NCT00601172|454425209|FG000|Overall Study|Protocol Violation|2|||
126310169|NCT00601172|454425210|FG001|Overall Study|Protocol Violation|5|||
126310170|NCT00601172|454425209|FG000|Overall Study|Lost to Follow-up|4|||
126310171|NCT00601172|454425210|FG001|Overall Study|Lost to Follow-up|3|||
126310172|NCT00601172|454425209|FG000|Overall Study|Physician Decision|27|||
126310173|NCT00601172|454425210|FG001|Overall Study|Physician Decision|28|||
126310174|NCT00601172|454425209|FG000|Overall Study|Withdrawal by Subject|35|||
126310175|NCT00601172|454425210|FG001|Overall Study|Withdrawal by Subject|27|||
126310176|NCT00601172|454425209|FG000|Overall Study|Did not meet continuation criteria|19|||
126310177|NCT00601172|454425210|FG001|Overall Study|Did not meet continuation criteria|20|||
126310178|NCT01300338|454425213|FG000|Overall Study|Lost to Follow-up|5|||
126310179|NCT01300338|454425214|FG001|Overall Study|Lost to Follow-up|0|||
126310180|NCT02461524|454425215|FG000|Overall Study|Death|16|||
126310181|NCT02461524|454425215|FG000|Overall Study|Withdrawal by Subject|4|||
126310182|NCT02461524|454425215|FG000|Overall Study|Device Explanted|5|||
126310183|NCT02461524|454425215|FG000|Overall Study|Missed Visit|6|||
126310184|NCT04481191|454425226|FG000|Overall Study|Withdrawn by parent/guardian|15|||
126310185|NCT04481191|454425227|FG001|Overall Study|Withdrawn by parent/guardian|10|||
126373597|NCT00565409|454665122|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
126373598|NCT00565409|454665123|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
126373599|NCT00565409|454665120|FG000|Period 2 Double-Blind|Other|0|||
126373600|NCT00565409|454665121|FG001|Period 2 Double-Blind|Other|4|||
126373601|NCT00565409|454665122|FG002|Period 2 Double-Blind|Other|5|||
126373602|NCT00565409|454665123|FG003|Period 2 Double-Blind|Other|9|||
126373603|NCT00565409|454665120|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
126373604|NCT00565409|454665121|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
126373605|NCT00565409|454665122|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
126373606|NCT00565409|454665123|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
126373607|NCT04064905|454665141|FG000|Overall Study|Lost to Follow-up|0|||
126373608|NCT04064905|454665142|FG001|Overall Study|Lost to Follow-up|3|||
126373609|NCT04064905|454665143|FG002|Overall Study|Lost to Follow-up|1|||
126373610|NCT04064905|454665144|FG003|Overall Study|Lost to Follow-up|4|||
126373611|NCT04064905|454665145|FG004|Overall Study|Lost to Follow-up|2|||
126373612|NCT02257684|454665146|FG000|Overall Study|Adverse Event|2|||
126373613|NCT02257684|454665146|FG000|Overall Study|Lack of Efficacy|1|||
126373614|NCT02257684|454665146|FG000|Overall Study|Sponsor's Decision|1|||
126373615|NCT01570387|454665147|FG000|Overall Study|Adverse Event|1|||
126047849|NCT03656718|453472926|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
126047850|NCT03656718|453472927|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
126047851|NCT03656718|453472928|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
126047852|NCT03656718|453472929|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
126047853|NCT03656718|453472930|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
126373616|NCT01570387|454665148|FG001|Overall Study|Adverse Event|0|||
126373617|NCT01570387|454665149|FG002|Overall Study|Adverse Event|0|||
126373618|NCT01570387|454665150|FG003|Overall Study|Adverse Event|0|||
126373619|NCT01570387|454665147|FG000|Overall Study|Death|0|||
126373620|NCT01570387|454665148|FG001|Overall Study|Death|0|||
126373621|NCT01570387|454665149|FG002|Overall Study|Death|0|||
126373622|NCT01570387|454665150|FG003|Overall Study|Death|1|||
126373623|NCT01570387|454665147|FG000|Overall Study|Withdrawal by Subject|0|||
126373624|NCT01570387|454665148|FG001|Overall Study|Withdrawal by Subject|0|||
126373625|NCT01570387|454665149|FG002|Overall Study|Withdrawal by Subject|0|||
126373626|NCT01570387|454665150|FG003|Overall Study|Withdrawal by Subject|1|||
126373627|NCT01987557|454665151|FG000|Overall Study|Protocol Violation|1|||
126373628|NCT01987557|454665152|FG001|Overall Study|Protocol Violation|0|||
126047854|NCT03656718|453472931|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
126373629|NCT01987557|454665153|FG002|Overall Study|Protocol Violation|1|||
126373630|NCT01987557|454665151|FG000|Overall Study|Withdrawal by Subject|2|||
126373631|NCT01987557|454665152|FG001|Overall Study|Withdrawal by Subject|1|||
126373632|NCT01987557|454665153|FG002|Overall Study|Withdrawal by Subject|2|||
126373633|NCT01987557|454665151|FG000|Overall Study|Adverse Event|0|||
126373634|NCT01987557|454665152|FG001|Overall Study|Adverse Event|2|||
126373635|NCT01987557|454665153|FG002|Overall Study|Adverse Event|0|||
126373636|NCT00431964|454665154|FG000|Overall Study|Adverse Event|1|||
126373637|NCT00431964|454665155|FG001|Overall Study|Adverse Event|0|||
126373638|NCT00431964|454665154|FG000|Overall Study|Lost to Follow-up|1|||
126373639|NCT00431964|454665155|FG001|Overall Study|Lost to Follow-up|2|||
126373640|NCT00431964|454665154|FG000|Overall Study|Physician Decision|2|||
126373641|NCT00431964|454665155|FG001|Overall Study|Physician Decision|2|||
126373642|NCT00431964|454665154|FG000|Overall Study|Withdrawal by Subject|2|||
126373643|NCT00431964|454665155|FG001|Overall Study|Withdrawal by Subject|1|||
126047855|NCT03656718|453472932|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
126373644|NCT00431964|454665154|FG000|Overall Study|Parental Consent Withdrawn|0|||
126373645|NCT00431964|454665155|FG001|Overall Study|Parental Consent Withdrawn|2|||
126047856|NCT03777657|453472933|FG000|Overall Study|Death|397|||
126047857|NCT03777657|453472934|FG001|Overall Study|Death|431|||
126047858|NCT03777657|453472933|FG000|Overall Study|Study Closed by Sponsor|77|||
126047859|NCT03777657|453472934|FG001|Overall Study|Study Closed by Sponsor|38|||
126047860|NCT03777657|453472933|FG000|Overall Study|Withdrawal by Subject|20|||
126047861|NCT03777657|453472934|FG001|Overall Study|Withdrawal by Subject|17|||
126104037|NCT03727438|453673908|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
126104038|NCT03727438|453673907|FG000|8 Week Assessment|Withdrawal by Subject|6|||
126373646|NCT00431964|454665154|FG000|Overall Study|Due to Unstable Health|0|||
126373647|NCT00431964|454665155|FG001|Overall Study|Due to Unstable Health|1|||
126373648|NCT01657305|454665157|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
126373649|NCT01657305|454665157|FG000|Overall Study|Withdrawal by Subject|4|||
126373650|NCT01657305|454665157|FG000|Overall Study|Adverse Event|1|||
126373651|NCT01657305|454665157|FG000|Overall Study|Lost to Follow-up|1|||
126373652|NCT01657305|454665157|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
126373653|NCT04103450|454665158|FG000|Overall Study|Adverse Event|4|||
126373654|NCT04103450|454665159|FG001|Overall Study|Adverse Event|2|||
126373655|NCT04103450|454665158|FG000|Overall Study|Lack of Efficacy|3|||
126373656|NCT04103450|454665159|FG001|Overall Study|Lack of Efficacy|0|||
126373657|NCT04103450|454665158|FG000|Overall Study|Withdrawal by Subject|5|||
126310186|NCT02487771|454425228|FG000|Overall Study|Lost to Follow-up|2|||
126310187|NCT02487771|454425229|FG001|Overall Study|Lost to Follow-up|3|||
126310188|NCT02487771|454425228|FG000|Overall Study|Moved out of area|5|||
126310189|NCT02487771|454425229|FG001|Overall Study|Moved out of area|6|||
126310190|NCT02487771|454425228|FG000|Overall Study|Withdrawal by Subject|3|||
126310191|NCT02487771|454425229|FG001|Overall Study|Withdrawal by Subject|5|||
126310192|NCT02002533|454425230|FG000|Overall Study|Withdrawal by Subject|6|||
126310193|NCT02002533|454425231|FG001|Overall Study|Withdrawal by Subject|13|||
126310194|NCT02002533|454425230|FG000|Overall Study|Protocol Violation|0|||
126310195|NCT02002533|454425231|FG001|Overall Study|Protocol Violation|1|||
126310196|NCT02002533|454425230|FG000|Overall Study|Adverse Event|0|||
126310197|NCT02002533|454425231|FG001|Overall Study|Adverse Event|3|||
126310198|NCT02002533|454425230|FG000|Overall Study|Lost to Follow-up|0|||
126310199|NCT02002533|454425231|FG001|Overall Study|Lost to Follow-up|1|||
126310200|NCT04984278|454425236|FG000|Period 1|Withdrawal by Subject|1|||
126310201|NCT04984278|454425237|FG001|Period 1|Withdrawal by Subject|0|||
126310202|NCT04984278|454425236|FG000|Period 1|Other|0|||
126310203|NCT04984278|454425237|FG001|Period 1|Other|1|||
126310204|NCT04984278|454425236|FG000|Period 2|Adverse Event|1|||
126310205|NCT04984278|454425237|FG001|Period 2|Adverse Event|0|||
126310206|NCT04984278|454425236|FG000|Period 2|Other|0|||
126310207|NCT04984278|454425237|FG001|Period 2|Other|1|||
126310208|NCT01482065|454425238|FG000|Overall Study|Withdrawal by Subject|0|||
126310209|NCT01482065|454425239|FG001|Overall Study|Withdrawal by Subject|1|||
126310210|NCT01895270|454425240|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
126310211|NCT01895270|454425241|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
126310212|NCT01895270|454425240|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
126310213|NCT01895270|454425241|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
126310214|NCT01895270|454425240|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
126310215|NCT01895270|454425241|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
126310216|NCT01895270|454425240|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
126310217|NCT01895270|454425241|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
126310218|NCT01895270|454425240|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
126310219|NCT01895270|454425241|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
126310220|NCT01895270|454425240|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
126310221|NCT01895270|454425241|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
126310222|NCT01895270|454425240|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
126310223|NCT01895270|454425241|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
126310224|NCT00976820|454425242|FG000|Overall Study|Lost to Follow-up|5|||
126310225|NCT00976820|454425243|FG001|Overall Study|Lost to Follow-up|16|||
126310226|NCT00976820|454425244|FG002|Overall Study|Lost to Follow-up|2|||
126310227|NCT00976820|454425245|FG003|Overall Study|Lost to Follow-up|3|||
126310228|NCT00976820|454425242|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
126310229|NCT00976820|454425243|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
126310230|NCT00976820|454425244|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
126310231|NCT00976820|454425245|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
126310232|NCT00976820|454425242|FG000|Overall Study|Withdrawal by Subject|2|||
126310233|NCT00976820|454425243|FG001|Overall Study|Withdrawal by Subject|4|||
126310234|NCT00976820|454425244|FG002|Overall Study|Withdrawal by Subject|1|||
126310235|NCT00976820|454425245|FG003|Overall Study|Withdrawal by Subject|4|||
126310236|NCT03261674|454425251|FG000|Overall Study|Lost to Follow-up|6|||
126310237|NCT03261674|454425252|FG001|Overall Study|Lost to Follow-up|7|||
126310238|NCT03261674|454425251|FG000|Overall Study|Protocol Violation|1|||
126310239|NCT03261674|454425252|FG001|Overall Study|Protocol Violation|4|||
126310240|NCT03261674|454425251|FG000|Overall Study|Withdrawal by Subject|1|||
126310241|NCT03261674|454425252|FG001|Overall Study|Withdrawal by Subject|4|||
126310242|NCT03261674|454425251|FG000|Overall Study|Physician Decision|1|||
126310243|NCT03261674|454425252|FG001|Overall Study|Physician Decision|0|||
126310244|NCT00623935|454425257|FG000|Overall Study|Death|1|||
126310245|NCT00623935|454425257|FG000|Overall Study|Patient Declined Transplant|1|||
126310246|NCT00747474|454425260|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310247|NCT00747474|454425261|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310248|NCT00747474|454425262|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310249|NCT00747474|454425263|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126373658|NCT04103450|454665159|FG001|Overall Study|Withdrawal by Subject|3|||
126373659|NCT04103450|454665158|FG000|Overall Study|Lost to Follow-up|1|||
126373660|NCT04103450|454665159|FG001|Overall Study|Lost to Follow-up|2|||
126373661|NCT04103450|454665158|FG000|Overall Study|Physician Decision|1|||
126373662|NCT04103450|454665159|FG001|Overall Study|Physician Decision|2|||
126373663|NCT04103450|454665158|FG000|Overall Study|Protocol Violation|1|||
126373664|NCT04103450|454665159|FG001|Overall Study|Protocol Violation|0|||
126373665|NCT04103450|454665158|FG000|Overall Study|Other|1|||
126310250|NCT00747474|454425264|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126373666|NCT04103450|454665159|FG001|Overall Study|Other|1|||
126373667|NCT01696643|454665169|FG000|Overall Study|Adverse Event|15|||
126373668|NCT01696643|454665170|FG001|Overall Study|Adverse Event|7|||
126373669|NCT01696643|454665169|FG000|Overall Study|Death|1|||
126373670|NCT01696643|454665170|FG001|Overall Study|Death|2|||
126373671|NCT01696643|454665169|FG000|Overall Study|Lack of Efficacy|3|||
126373672|NCT01696643|454665170|FG001|Overall Study|Lack of Efficacy|0|||
126373673|NCT01696643|454665169|FG000|Overall Study|Lost to Follow-up|67|||
126373674|NCT01696643|454665170|FG001|Overall Study|Lost to Follow-up|67|||
126373675|NCT01696643|454665169|FG000|Overall Study|Physician Decision|3|||
126373676|NCT01696643|454665170|FG001|Overall Study|Physician Decision|2|||
126373677|NCT01696643|454665169|FG000|Overall Study|Pregnancy|0|||
126373678|NCT01696643|454665170|FG001|Overall Study|Pregnancy|1|||
126373679|NCT01696643|454665169|FG000|Overall Study|Protocol Violation|7|||
126373680|NCT01696643|454665170|FG001|Overall Study|Protocol Violation|7|||
126373681|NCT01696643|454665169|FG000|Overall Study|Study Terminated by Sponsor|286|||
126373682|NCT01696643|454665170|FG001|Overall Study|Study Terminated by Sponsor|294|||
126373683|NCT01696643|454665169|FG000|Overall Study|Withdrawal by Subject|142|||
126373684|NCT01696643|454665170|FG001|Overall Study|Withdrawal by Subject|149|||
126373685|NCT01696643|454665169|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
126373686|NCT01696643|454665170|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
126373687|NCT01696643|454665169|FG000|Overall Study|Site Error|2|||
126373688|NCT01696643|454665170|FG001|Overall Study|Site Error|1|||
126373689|NCT01696643|454665169|FG000|Overall Study|Participant Incarcerated|0|||
126373690|NCT01696643|454665170|FG001|Overall Study|Participant Incarcerated|1|||
126373691|NCT01696643|454665169|FG000|Overall Study|Medical Monitor Decision|0|||
126373692|NCT01696643|454665170|FG001|Overall Study|Medical Monitor Decision|2|||
126373693|NCT01696643|454665169|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
126373694|NCT01696643|454665170|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
126373695|NCT00518180|454665171|FG000|Overall Study|Withdrawal by Subject|29|||
126373696|NCT00518180|454665172|FG001|Overall Study|Withdrawal by Subject|30|||
126373697|NCT00518180|454665173|FG002|Overall Study|Withdrawal by Subject|42|||
126373698|NCT00518180|454665171|FG000|Overall Study|Lost to Follow-up|30|||
126373699|NCT00518180|454665172|FG001|Overall Study|Lost to Follow-up|28|||
126373700|NCT00518180|454665173|FG002|Overall Study|Lost to Follow-up|34|||
126373701|NCT00518180|454665171|FG000|Overall Study|Administrative reason|0|||
126373702|NCT00518180|454665172|FG001|Overall Study|Administrative reason|2|||
126373703|NCT00518180|454665173|FG002|Overall Study|Administrative reason|2|||
126373704|NCT00518180|454665171|FG000|Overall Study|Protocol Violation|5|||
126373705|NCT00518180|454665172|FG001|Overall Study|Protocol Violation|7|||
126373706|NCT00518180|454665173|FG002|Overall Study|Protocol Violation|4|||
126373707|NCT00518180|454665171|FG000|Overall Study|Unable to classify|0|||
126373708|NCT00518180|454665172|FG001|Overall Study|Unable to classify|2|||
126373709|NCT00518180|454665173|FG002|Overall Study|Unable to classify|0|||
126373710|NCT00518180|454665171|FG000|Overall Study|Adverse Event|1|||
126373711|NCT00518180|454665172|FG001|Overall Study|Adverse Event|0|||
126373712|NCT00518180|454665173|FG002|Overall Study|Adverse Event|0|||
126373713|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
126373714|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
126373715|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
126373716|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Death|0|||
126373717|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Death|0|||
126373718|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Death|1|||
126047862|NCT03777657|453472933|FG000|Overall Study|Lost to Follow-up|6|||
126373719|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
126373720|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
126373721|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
126373722|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
126373723|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
126373724|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
126373725|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
126373726|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
126373727|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
126373728|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Graft loss|0|||
126373729|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Graft loss|0|||
126373730|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Graft loss|7|||
126373731|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
126373732|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
126373733|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
126373734|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
126373735|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
126373736|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
126373737|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
126373738|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
126373739|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
126373740|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
126373741|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
126373742|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
126373743|NCT00956293|454665177|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
126373744|NCT00956293|454665178|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
126373745|NCT00956293|454665179|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
126373746|NCT00956293|454665177|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
126373747|NCT00956293|454665178|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
126373748|NCT00956293|454665179|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
126373749|NCT00956293|454665177|FG000|Main Period (Randomization)|Adverse Event|0|||
126373750|NCT00956293|454665178|FG001|Main Period (Randomization)|Adverse Event|15|||
126373751|NCT00956293|454665179|FG002|Main Period (Randomization)|Adverse Event|0|||
126373752|NCT00956293|454665177|FG000|Follow-up Period|Follow-up period was terminated.|20|||
126373753|NCT00956293|454665178|FG001|Follow-up Period|Follow-up period was terminated.|32|||
126373754|NCT00956293|454665179|FG002|Follow-up Period|Follow-up period was terminated.|0|||
126373755|NCT02536664|454665180|FG000|Overall Study|Inadequate completion of documentation|2|||
126373756|NCT02536664|454665181|FG001|Overall Study|Inadequate completion of documentation|4|||
126373757|NCT02536664|454665180|FG000|Overall Study|Progression|13|||
126373758|NCT02536664|454665181|FG001|Overall Study|Progression|18|||
126373759|NCT02536664|454665180|FG000|Overall Study|Death due to lymphoma|2|||
126373760|NCT02536664|454665181|FG001|Overall Study|Death due to lymphoma|1|||
126373761|NCT02536664|454665180|FG000|Overall Study|Death due to other reason|3|||
126373762|NCT02536664|454665181|FG001|Overall Study|Death due to other reason|2|||
126373763|NCT02536664|454665180|FG000|Overall Study|Intolerability|8|||
126373764|NCT02536664|454665181|FG001|Overall Study|Intolerability|6|||
126373765|NCT02536664|454665180|FG000|Overall Study|Withdrawal by Subject|8|||
126373766|NCT02536664|454665181|FG001|Overall Study|Withdrawal by Subject|5|||
126373767|NCT02536664|454665180|FG000|Overall Study|Other|18|||
126373768|NCT02536664|454665181|FG001|Overall Study|Other|24|||
126373769|NCT02536664|454665180|FG000|Overall Study|Missing|53|||
126373770|NCT02536664|454665181|FG001|Overall Study|Missing|20|||
126373771|NCT03383666|454665182|FG000|Overall Study|Withdrawal by Subject|2|||
126373772|NCT03383666|454665182|FG000|Overall Study|Lost to Follow-up|2|||
126373773|NCT03961308|454665189|FG000|Overall Study|Withdrawal by Subject|1|||
126373774|NCT03961308|454665190|FG001|Overall Study|Withdrawal by Subject|0|||
126373775|NCT03961308|454665189|FG000|Overall Study|Other|1|||
126373776|NCT03961308|454665190|FG001|Overall Study|Other|0|||
126373777|NCT03961308|454665189|FG000|Overall Study|Lost to Follow-up|0|||
126373778|NCT03961308|454665190|FG001|Overall Study|Lost to Follow-up|1|||
126373779|NCT03961308|454665189|FG000|Overall Study|Adverse Event|0|||
126373780|NCT03961308|454665190|FG001|Overall Study|Adverse Event|1|||
126373781|NCT01174563|454665197|FG000|Overall Study|Progressive Disease|45|||
126373782|NCT01174563|454665197|FG000|Overall Study|Death|5|||
126373783|NCT01174563|454665197|FG000|Overall Study|Investigator's Discretion|5|||
126373784|NCT01174563|454665197|FG000|Overall Study|Participant Withdrew Consent|3|||
126373785|NCT01174563|454665197|FG000|Overall Study|Rash Adverse Event|1|||
126373786|NCT01174563|454665197|FG000|Overall Study|Sponsor's decision|1|||
126373787|NCT03402841|454665198|FG000|Overall Study|Withdrawal by Subject|3|||
126373788|NCT03402841|454665198|FG000|Overall Study|Lost to Follow-up|2|||
126373789|NCT03402841|454665198|FG000|Overall Study|Death|146|||
126373790|NCT01542788|454665203|FG000|Overall Study|Randomized but Not Treated|2|||
126373791|NCT01542788|454665204|FG001|Overall Study|Randomized but Not Treated|0|||
126373792|NCT01542788|454665203|FG000|Overall Study|Lack of Efficacy|41|||
126310251|NCT00747474|454425265|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310252|NCT00747474|454425266|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310253|NCT00747474|454425267|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
126310254|NCT00747474|454425268|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310255|NCT00747474|454425269|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310256|NCT00747474|454425270|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310257|NCT00747474|454425271|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310258|NCT04507256|454425272|FG000|Overall Study|Withdrawal by Subject|1|||
126310259|NCT04507256|454425273|FG001|Overall Study|Withdrawal by Subject|0|||
126310260|NCT04507256|454425274|FG002|Overall Study|Withdrawal by Subject|0|||
126310261|NCT04507256|454425275|FG003|Overall Study|Withdrawal by Subject|1|||
126310262|NCT04507256|454425276|FG004|Overall Study|Withdrawal by Subject|0|||
126310263|NCT04507256|454425277|FG005|Overall Study|Withdrawal by Subject|0|||
126310264|NCT00631410|454425278|FG000|Overall Study|Adverse Event|1|||
126310265|NCT00631410|454425279|FG001|Overall Study|Adverse Event|3|||
126310266|NCT00631410|454425278|FG000|Overall Study|Objective Progression or Relapse|4|||
126310267|NCT00631410|454425279|FG001|Overall Study|Objective Progression or Relapse|3|||
126310268|NCT00631410|454425278|FG000|Overall Study|Surgery|1|||
126310269|NCT00631410|454425279|FG001|Overall Study|Surgery|0|||
126310270|NCT00890084|454425280|FG000|Overall Study|Adverse Event|16|||
126310271|NCT00890084|454425280|FG000|Overall Study|Lost to Follow-up|126|||
126310272|NCT01647516|454425285|FG000|Induction Period (IP)|Physician Decision|2|||
126310273|NCT01647516|454425286|FG001|Induction Period (IP)|Physician Decision|0|||
126310274|NCT01647516|454425287|FG002|Induction Period (IP)|Physician Decision|0|||
126310275|NCT01647516|454425288|FG003|Induction Period (IP)|Physician Decision|0|||
126310276|NCT01647516|454425289|FG004|Induction Period (IP)|Physician Decision|0|||
126310277|NCT01647516|454425290|FG005|Induction Period (IP)|Physician Decision|0|||
126310278|NCT01647516|454425285|FG000|Induction Period (IP)|Adverse Event|1|||
126310279|NCT01647516|454425286|FG001|Induction Period (IP)|Adverse Event|2|||
126310280|NCT01647516|454425287|FG002|Induction Period (IP)|Adverse Event|0|||
126310281|NCT01647516|454425288|FG003|Induction Period (IP)|Adverse Event|0|||
126310282|NCT01647516|454425289|FG004|Induction Period (IP)|Adverse Event|0|||
126310283|NCT01647516|454425290|FG005|Induction Period (IP)|Adverse Event|0|||
126310284|NCT01647516|454425285|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
126310285|NCT01647516|454425286|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
126310286|NCT01647516|454425287|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
126310287|NCT01647516|454425288|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
126310288|NCT01647516|454425289|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
126310289|NCT01647516|454425290|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
126310290|NCT01647516|454425285|FG000|Induction Period (IP)|Participant Choice|0|||
126310291|NCT01647516|454425286|FG001|Induction Period (IP)|Participant Choice|0|||
126310292|NCT01647516|454425287|FG002|Induction Period (IP)|Participant Choice|1|||
126310293|NCT01647516|454425288|FG003|Induction Period (IP)|Participant Choice|0|||
126310294|NCT01647516|454425289|FG004|Induction Period (IP)|Participant Choice|0|||
126310295|NCT01647516|454425290|FG005|Induction Period (IP)|Participant Choice|0|||
126310296|NCT01647516|454425285|FG000|Induction Period (IP)|Lack of Efficacy|1|||
126310297|NCT01647516|454425286|FG001|Induction Period (IP)|Lack of Efficacy|0|||
126310298|NCT01647516|454425287|FG002|Induction Period (IP)|Lack of Efficacy|0|||
126310299|NCT01647516|454425288|FG003|Induction Period (IP)|Lack of Efficacy|0|||
126310300|NCT01647516|454425289|FG004|Induction Period (IP)|Lack of Efficacy|0|||
126310301|NCT01647516|454425290|FG005|Induction Period (IP)|Lack of Efficacy|0|||
126310302|NCT01647516|454425285|FG000|Induction Period (IP)|No study drug received|1|||
126310303|NCT01647516|454425286|FG001|Induction Period (IP)|No study drug received|1|||
126310304|NCT01647516|454425287|FG002|Induction Period (IP)|No study drug received|0|||
126310305|NCT01647516|454425288|FG003|Induction Period (IP)|No study drug received|0|||
126310306|NCT01647516|454425289|FG004|Induction Period (IP)|No study drug received|0|||
126310307|NCT01647516|454425290|FG005|Induction Period (IP)|No study drug received|0|||
126310308|NCT01647516|454425285|FG000|Maintenance Period (MP)|Adverse Event|2|||
126310309|NCT01647516|454425286|FG001|Maintenance Period (MP)|Adverse Event|1|||
126310310|NCT01647516|454425287|FG002|Maintenance Period (MP)|Adverse Event|0|||
126310311|NCT01647516|454425288|FG003|Maintenance Period (MP)|Adverse Event|0|||
126310312|NCT01647516|454425289|FG004|Maintenance Period (MP)|Adverse Event|0|||
126310313|NCT01647516|454425290|FG005|Maintenance Period (MP)|Adverse Event|0|||
126310314|NCT01647516|454425285|FG000|Maintenance Period (MP)|Non-compliance|1|||
126373793|NCT01542788|454665204|FG001|Overall Study|Lack of Efficacy|71|||
126373794|NCT01542788|454665203|FG000|Overall Study|Lost to Follow-up|5|||
126373795|NCT01542788|454665204|FG001|Overall Study|Lost to Follow-up|0|||
126373796|NCT01542788|454665203|FG000|Overall Study|Death|3|||
126373797|NCT01542788|454665204|FG001|Overall Study|Death|0|||
126373798|NCT01542788|454665203|FG000|Overall Study|Protocol Violation|2|||
126373799|NCT01542788|454665204|FG001|Overall Study|Protocol Violation|0|||
126373800|NCT01542788|454665203|FG000|Overall Study|Physician Decision|1|||
126373801|NCT01542788|454665204|FG001|Overall Study|Physician Decision|0|||
126373802|NCT01542788|454665203|FG000|Overall Study|Withdrawal by Subject|1|||
126373803|NCT01542788|454665204|FG001|Overall Study|Withdrawal by Subject|0|||
126373804|NCT01280968|454665205|FG000|Overall Study|Lost to Follow-up|8|||
126373805|NCT01280968|454665206|FG001|Overall Study|Lost to Follow-up|2|||
126373806|NCT01280968|454665205|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
126373807|NCT01280968|454665206|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
126373808|NCT01280968|454665205|FG000|Overall Study|Commuting Problems|2|||
126373809|NCT01280968|454665206|FG001|Overall Study|Commuting Problems|0|||
126373810|NCT01280968|454665205|FG000|Overall Study|Anxiety|2|||
126373811|NCT01280968|454665206|FG001|Overall Study|Anxiety|0|||
126373812|NCT01280968|454665205|FG000|Overall Study|Adverse Event|1|||
126373813|NCT01280968|454665206|FG001|Overall Study|Adverse Event|0|||
126373814|NCT01280968|454665205|FG000|Overall Study|Scheduling Conflicts|1|||
126373815|NCT01280968|454665206|FG001|Overall Study|Scheduling Conflicts|1|||
126373816|NCT01280968|454665205|FG000|Overall Study|Pre-existing Neurological Condition|1|||
126373817|NCT01280968|454665206|FG001|Overall Study|Pre-existing Neurological Condition|0|||
126373818|NCT01280968|454665205|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
126373819|NCT01280968|454665206|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
126373820|NCT04704193|454665207|FG000|Overall Study|Withdrawal by Subject|1|||
126373821|NCT00542178|454665208|FG000|Overall Study|did not complete year 4 follow-up|75|||
126373822|NCT00542178|454665209|FG001|Overall Study|did not complete year 4 follow-up|80|||
126373823|NCT00542178|454665210|FG002|Overall Study|did not complete year 4 follow-up|74|||
126373824|NCT00542178|454665211|FG003|Overall Study|did not complete year 4 follow-up|62|||
126373825|NCT00542178|454665212|FG004|Overall Study|did not complete year 4 follow-up|64|||
126373826|NCT00542178|454665213|FG005|Overall Study|did not complete year 4 follow-up|89|||
126373827|NCT00542178|454665214|FG006|Overall Study|did not complete year 4 follow-up|87|||
126373828|NCT00542178|454665215|FG007|Overall Study|did not complete year 4 follow-up|85|||
126373829|NCT03984188|454665221|FG000|Overall Study|Death|2|||
126373830|NCT03984188|454665222|FG001|Overall Study|Death|4|||
126373831|NCT03984188|454665221|FG000|Overall Study|Physician Decision|0|||
126373832|NCT03984188|454665222|FG001|Overall Study|Physician Decision|2|||
126373833|NCT03984188|454665221|FG000|Overall Study|Lost to Follow-up|3|||
126373834|NCT03984188|454665222|FG001|Overall Study|Lost to Follow-up|2|||
126373835|NCT03984188|454665221|FG000|Overall Study|Withdrawal by Subject|6|||
126373836|NCT03984188|454665222|FG001|Overall Study|Withdrawal by Subject|0|||
126373837|NCT01978145|454666823|FG000|Treatment Period 1|Adverse Event|1|||
126373838|NCT01978145|454666824|FG001|Treatment Period 1|Adverse Event|9|||
126373839|NCT01978145|454666823|FG000|Treatment Period 1|Physician Decision|1|||
126373840|NCT01978145|454666824|FG001|Treatment Period 1|Physician Decision|0|||
126373841|NCT01978145|454666823|FG000|Treatment Period 1|Withdrawal by Subject|5|||
126373842|NCT01978145|454666824|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126373843|NCT01978145|454666823|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
126373844|NCT01978145|454666824|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
126373845|NCT01978145|454666823|FG000|Washout Period 1|Adverse Event|0|||
126373846|NCT01978145|454666824|FG001|Washout Period 1|Adverse Event|1|||
126373847|NCT01978145|454666823|FG000|Washout Period 1|Withdrawal by Subject|1|||
126373848|NCT01978145|454666824|FG001|Washout Period 1|Withdrawal by Subject|1|||
126373849|NCT01978145|454666823|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
126373850|NCT01978145|454666824|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
126373851|NCT01978145|454666823|FG000|Treatment Period 2|Adverse Event|3|||
126373852|NCT01978145|454666824|FG001|Treatment Period 2|Adverse Event|3|||
126373853|NCT01978145|454666823|FG000|Treatment Period 2|Protocol Violation|0|||
126373854|NCT01978145|454666824|FG001|Treatment Period 2|Protocol Violation|1|||
126373855|NCT01978145|454666823|FG000|Treatment Period 2|Lost to Follow-up|1|||
126373856|NCT01978145|454666824|FG001|Treatment Period 2|Lost to Follow-up|1|||
126373857|NCT01978145|454666823|FG000|Treatment Period 2|Withdrawal by Subject|7|||
126373858|NCT01978145|454666824|FG001|Treatment Period 2|Withdrawal by Subject|4|||
126373859|NCT01978145|454666823|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
126373860|NCT01978145|454666824|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
126373861|NCT01173679|454666825|FG000|Overall Study|Death|1|||
126373862|NCT01250054|454666826|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
126373863|NCT01250054|454666827|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
126373864|NCT02777086|454666828|FG000|Overall Study|Lost to Follow-up|96|||
126373865|NCT02777086|454666829|FG001|Overall Study|Lost to Follow-up|99|||
126373866|NCT01133665|454666834|FG000|Overall Study|Physician Decision|2|||
126373867|NCT02122380|454666835|FG000|First Intervention (30 Days)|Adverse Event|1|||
126104039|NCT03727438|453673908|FG001|8 Week Assessment|Withdrawal by Subject|1|||
126104040|NCT03727438|453673907|FG000|6 mo Assessment|did not complete assessment|10|||
126104041|NCT03727438|453673908|FG001|6 mo Assessment|did not complete assessment|11|||
126310315|NCT01647516|454425286|FG001|Maintenance Period (MP)|Non-compliance|0|||
126310316|NCT01647516|454425287|FG002|Maintenance Period (MP)|Non-compliance|0|||
126310317|NCT01647516|454425288|FG003|Maintenance Period (MP)|Non-compliance|0|||
126310318|NCT01647516|454425289|FG004|Maintenance Period (MP)|Non-compliance|0|||
126310319|NCT01647516|454425290|FG005|Maintenance Period (MP)|Non-compliance|0|||
126310320|NCT01647516|454425285|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
126310321|NCT01647516|454425286|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
126310322|NCT01647516|454425287|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
126310323|NCT01647516|454425288|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
126310324|NCT01647516|454425289|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
126310325|NCT01647516|454425290|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
126310326|NCT01647516|454425285|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
126310327|NCT01647516|454425286|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
126310328|NCT01647516|454425287|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
126310329|NCT01647516|454425288|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
126310330|NCT01647516|454425289|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
126310331|NCT01647516|454425290|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
126310332|NCT01647516|454425285|FG000|Open-Label Period|Adverse Event|0|||
126310333|NCT01647516|454425286|FG001|Open-Label Period|Adverse Event|0|||
126310334|NCT01647516|454425287|FG002|Open-Label Period|Adverse Event|0|||
126310335|NCT01647516|454425288|FG003|Open-Label Period|Adverse Event|5|||
126310336|NCT01647516|454425289|FG004|Open-Label Period|Adverse Event|6|||
126310337|NCT01647516|454425290|FG005|Open-Label Period|Adverse Event|3|||
126310338|NCT01647516|454425285|FG000|Open-Label Period|Pregnancy|0|||
126310339|NCT01647516|454425286|FG001|Open-Label Period|Pregnancy|0|||
126310340|NCT01647516|454425287|FG002|Open-Label Period|Pregnancy|0|||
126310341|NCT01647516|454425288|FG003|Open-Label Period|Pregnancy|0|||
126310342|NCT01647516|454425289|FG004|Open-Label Period|Pregnancy|0|||
126310343|NCT01647516|454425290|FG005|Open-Label Period|Pregnancy|1|||
126310344|NCT01647516|454425285|FG000|Open-Label Period|Non-compliance|0|||
126310345|NCT01647516|454425286|FG001|Open-Label Period|Non-compliance|0|||
126310346|NCT01647516|454425287|FG002|Open-Label Period|Non-compliance|0|||
126310347|NCT01647516|454425288|FG003|Open-Label Period|Non-compliance|1|||
126104042|NCT00001962|453675797|FG000|Overall Study|Lack of Efficacy|18|||
126104043|NCT00001962|453675797|FG000|Overall Study|Lack of Accrual|6|||
126104044|NCT00001962|453675797|FG000|Overall Study|Death|1|||
126104045|NCT00001962|453675797|FG000|Overall Study|Lost to Follow-up|2|||
126104046|NCT00001962|453675797|FG000|Overall Study|Adverse Event|1|||
126310348|NCT01647516|454425289|FG004|Open-Label Period|Non-compliance|0|||
126310349|NCT01647516|454425290|FG005|Open-Label Period|Non-compliance|1|||
126310350|NCT01647516|454425285|FG000|Open-Label Period|Physician Decision|0|||
126310351|NCT01647516|454425286|FG001|Open-Label Period|Physician Decision|0|||
126310352|NCT01647516|454425287|FG002|Open-Label Period|Physician Decision|0|||
126310353|NCT01647516|454425288|FG003|Open-Label Period|Physician Decision|1|||
126310354|NCT01647516|454425289|FG004|Open-Label Period|Physician Decision|1|||
126310355|NCT01647516|454425290|FG005|Open-Label Period|Physician Decision|0|||
126310356|NCT01647516|454425285|FG000|Open-Label Period|Withdrawal by Subject|0|||
126310357|NCT01647516|454425286|FG001|Open-Label Period|Withdrawal by Subject|0|||
126310358|NCT01647516|454425287|FG002|Open-Label Period|Withdrawal by Subject|0|||
126310359|NCT01647516|454425288|FG003|Open-Label Period|Withdrawal by Subject|9|||
126310360|NCT01647516|454425289|FG004|Open-Label Period|Withdrawal by Subject|11|||
126310361|NCT01647516|454425290|FG005|Open-Label Period|Withdrawal by Subject|6|||
126310362|NCT01647516|454425285|FG000|Open-Label Period|Lost to Follow-up|0|||
126310363|NCT01647516|454425286|FG001|Open-Label Period|Lost to Follow-up|0|||
126310364|NCT01647516|454425287|FG002|Open-Label Period|Lost to Follow-up|0|||
126310365|NCT01647516|454425288|FG003|Open-Label Period|Lost to Follow-up|1|||
126310366|NCT01647516|454425289|FG004|Open-Label Period|Lost to Follow-up|0|||
126310367|NCT01647516|454425290|FG005|Open-Label Period|Lost to Follow-up|1|||
126310368|NCT01647516|454425285|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
126310369|NCT01647516|454425286|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
126310370|NCT01647516|454425287|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
126310371|NCT01647516|454425288|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
126310372|NCT01647516|454425289|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
126310373|NCT01647516|454425290|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
126373868|NCT02122380|454666836|FG001|First Intervention (30 Days)|Adverse Event|0|||
126373869|NCT02122380|454666835|FG000|First Intervention (30 Days)|Physician Decision|0|||
126373870|NCT02122380|454666836|FG001|First Intervention (30 Days)|Physician Decision|1|||
126373871|NCT02122380|454666835|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
126373872|NCT02122380|454666836|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
126373873|NCT02122380|454666835|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
126373874|NCT02122380|454666836|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
126104047|NCT01440374|453675798|FG000|Part 1: Open-label Phase|Adverse Event|5|||
126104048|NCT01440374|453675799|FG001|Part 1: Open-label Phase|Adverse Event|0|||
126104049|NCT01440374|453675800|FG002|Part 1: Open-label Phase|Adverse Event|0|||
126104050|NCT01440374|453675801|FG003|Part 1: Open-label Phase|Adverse Event|0|||
126104051|NCT01440374|453675798|FG000|Part 1: Open-label Phase|Physician Decision|1|||
126104052|NCT01440374|453675799|FG001|Part 1: Open-label Phase|Physician Decision|0|||
126104053|NCT01440374|453675800|FG002|Part 1: Open-label Phase|Physician Decision|0|||
126104054|NCT01440374|453675801|FG003|Part 1: Open-label Phase|Physician Decision|0|||
126104055|NCT01440374|453675798|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
126104056|NCT01440374|453675799|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
126104057|NCT01440374|453675800|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
126104058|NCT01440374|453675801|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
126104059|NCT01440374|453675798|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
126104060|NCT01440374|453675799|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
126310374|NCT01647516|454425285|FG000|Open-Label Period|Lack of Efficacy|0|||
126310375|NCT01647516|454425286|FG001|Open-Label Period|Lack of Efficacy|0|||
126310376|NCT01647516|454425287|FG002|Open-Label Period|Lack of Efficacy|0|||
126310377|NCT01647516|454425288|FG003|Open-Label Period|Lack of Efficacy|7|||
126310378|NCT01647516|454425289|FG004|Open-Label Period|Lack of Efficacy|9|||
126310379|NCT01647516|454425290|FG005|Open-Label Period|Lack of Efficacy|10|||
126310380|NCT01647516|454425285|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
126310381|NCT01647516|454425286|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
126373875|NCT02122380|454666835|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
126373876|NCT02122380|454666836|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
126310382|NCT01647516|454425287|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
126310383|NCT01647516|454425288|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
126310384|NCT01647516|454425289|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
126310385|NCT01647516|454425290|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
126310386|NCT01647516|454425285|FG000|Open-Label Period|No completion / discontinuation visit|0|||
126310387|NCT01647516|454425286|FG001|Open-Label Period|No completion / discontinuation visit|0|||
126310388|NCT01647516|454425287|FG002|Open-Label Period|No completion / discontinuation visit|0|||
126310389|NCT01647516|454425288|FG003|Open-Label Period|No completion / discontinuation visit|0|||
126310390|NCT01647516|454425289|FG004|Open-Label Period|No completion / discontinuation visit|2|||
126310391|NCT01647516|454425290|FG005|Open-Label Period|No completion / discontinuation visit|1|||
126047863|NCT03777657|453472934|FG001|Overall Study|Lost to Follow-up|10|||
126047864|NCT02500576|453472935|FG000|Overall Study|Adverse Event|0|||
126047865|NCT02500576|453472936|FG001|Overall Study|Adverse Event|1|||
126047866|NCT02500576|453472935|FG000|Overall Study|Death|2|||
126047867|NCT02500576|453472936|FG001|Overall Study|Death|1|||
126047868|NCT02500576|453472935|FG000|Overall Study|Lack of Efficacy|5|||
126047869|NCT02500576|453472936|FG001|Overall Study|Lack of Efficacy|5|||
126310392|NCT02980341|454425291|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
126310393|NCT02980341|454425292|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
126310394|NCT02980341|454425293|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
126310395|NCT02980341|454425294|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
126310396|NCT02980341|454425295|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
126310397|NCT02980341|454425296|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310398|NCT02980341|454425297|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310399|NCT02980341|454425298|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310400|NCT02980341|454425299|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310401|NCT02980341|454425300|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310402|NCT02980341|454425301|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310403|NCT02980341|454425291|FG000|Dose Escalation|Clinical progression|0|||
126310404|NCT02980341|454425292|FG001|Dose Escalation|Clinical progression|0|||
126310405|NCT02980341|454425293|FG002|Dose Escalation|Clinical progression|2|||
126310406|NCT02980341|454425294|FG003|Dose Escalation|Clinical progression|1|||
126310407|NCT02980341|454425295|FG004|Dose Escalation|Clinical progression|0|||
126310408|NCT02980341|454425296|FG005|Dose Escalation|Clinical progression|0|||
126310409|NCT02980341|454425297|FG006|Dose Escalation|Clinical progression|0|||
126310410|NCT02980341|454425298|FG007|Dose Escalation|Clinical progression|0|||
126310411|NCT02980341|454425299|FG008|Dose Escalation|Clinical progression|0|||
126310412|NCT02980341|454425300|FG009|Dose Escalation|Clinical progression|0|||
126310413|NCT02980341|454425301|FG010|Dose Escalation|Clinical progression|0|||
126047870|NCT02500576|453472935|FG000|Overall Study|Withdrawal by Subject|1|||
126310414|NCT02980341|454425291|FG000|Dose Escalation|Adverse Event|0|||
126373877|NCT00272792|454666837|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
126373878|NCT00272792|454666838|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
126373879|NCT00272792|454666837|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
126373880|NCT00272792|454666838|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
126373881|NCT00272792|454666837|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
126373882|NCT00272792|454666838|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
126373883|NCT00272792|454666837|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
126373884|NCT00272792|454666838|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
126373885|NCT02921789|454666839|FG000|Overall Study|Adverse Event|0|||
126373886|NCT02921789|454666840|FG001|Overall Study|Adverse Event|1|||
126373887|NCT02921789|454666839|FG000|Overall Study|Lost to Follow-up|1|||
126373888|NCT02921789|454666840|FG001|Overall Study|Lost to Follow-up|0|||
126373889|NCT02921789|454666839|FG000|Overall Study|Protocol Deviation|2|||
126373890|NCT02921789|454666840|FG001|Overall Study|Protocol Deviation|0|||
126373891|NCT02921789|454666839|FG000|Overall Study|Withdrawal by Subject|2|||
126373892|NCT02921789|454666840|FG001|Overall Study|Withdrawal by Subject|1|||
126373893|NCT02921789|454666839|FG000|Overall Study|Miscellaneous|3|||
126373894|NCT02921789|454666840|FG001|Overall Study|Miscellaneous|2|||
126373895|NCT04099277|454666841|FG000|Overall Study|Physician Decision|1|||
126373896|NCT04099277|454666841|FG000|Overall Study|Withdrawal by Subject|1|||
126373897|NCT00598650|454666844|FG000|Overall Study|Withdrawal by Subject|3|||
126373898|NCT00598650|454666844|FG000|Overall Study|Adverse Event|18|||
126373899|NCT00598650|454666844|FG000|Overall Study|No treatment for 3 weeks|1|||
126373900|NCT00598650|454666844|FG000|Overall Study|Not eligible|1|||
126373901|NCT00598650|454666844|FG000|Overall Study|Prohibited Concomitant Medication|2|||
126373902|NCT00598650|454666844|FG000|Overall Study|Physician Decision|2|||
126373903|NCT03423602|454666845|FG000|Overall Study|Death|1|||
126373904|NCT03423602|454666845|FG000|Overall Study|Lost to Follow-up|6|||
126373905|NCT03423602|454666845|FG000|Overall Study|Protocol Violation|1|||
126373906|NCT03423602|454666845|FG000|Overall Study|Withdrawal by Subject|4|||
126373907|NCT03423121|454666846|FG000|Overall Study|Lost to Follow-up|2|||
126373908|NCT03423121|454666847|FG001|Overall Study|Lost to Follow-up|6|||
126373909|NCT03423121|454666846|FG000|Overall Study|Adverse Event|1|||
126373910|NCT03423121|454666847|FG001|Overall Study|Adverse Event|0|||
126373911|NCT00560508|454666848|FG000|12 Week Double-blind Period|Adverse Event|3|||
126373912|NCT00560508|454666849|FG001|12 Week Double-blind Period|Adverse Event|2|||
126373913|NCT00560508|454666848|FG000|12 Week Double-blind Period|Protocol Violation|1|||
126373914|NCT00560508|454666849|FG001|12 Week Double-blind Period|Protocol Violation|0|||
126373915|NCT00560508|454666848|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
126373916|NCT00560508|454666849|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
126373917|NCT00560508|454666848|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
126373918|NCT00560508|454666849|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
126373919|NCT00560508|454666848|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
126373920|NCT00560508|454666849|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
126373921|NCT00560508|454666848|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
126373922|NCT00560508|454666849|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
126373923|NCT00560508|454666848|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
126373924|NCT00560508|454666849|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
126373925|NCT01354223|454666850|FG000|Overall Study|Withdrawal by Subject|3|||
126373926|NCT01354223|454666851|FG001|Overall Study|Withdrawal by Subject|1|||
126373927|NCT00948688|454666859|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
126373928|NCT00948688|454666860|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
126047871|NCT02500576|453472936|FG001|Overall Study|Withdrawal by Subject|1|||
126373929|NCT00948688|454666859|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
126373930|NCT00948688|454666860|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
126373931|NCT00948688|454666859|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
126373932|NCT00948688|454666860|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
126373933|NCT02852967|454666861|FG000|Overall Study|Adverse Event|3|||
126373934|NCT02852967|454666862|FG001|Overall Study|Adverse Event|1|||
126373935|NCT02852967|454666863|FG002|Overall Study|Adverse Event|0|||
126373936|NCT02852967|454666864|FG003|Overall Study|Adverse Event|1|||
126373937|NCT02852967|454666865|FG004|Overall Study|Adverse Event|0|||
126373938|NCT02852967|454666861|FG000|Overall Study|Death|1|||
126373939|NCT02852967|454666862|FG001|Overall Study|Death|0|||
126373940|NCT02852967|454666863|FG002|Overall Study|Death|0|||
126373941|NCT02852967|454666864|FG003|Overall Study|Death|0|||
126373942|NCT02852967|454666865|FG004|Overall Study|Death|0|||
126373943|NCT02852967|454666861|FG000|Overall Study|Lost to Follow-up|1|||
126373944|NCT02852967|454666862|FG001|Overall Study|Lost to Follow-up|2|||
126373945|NCT02852967|454666863|FG002|Overall Study|Lost to Follow-up|3|||
126373946|NCT02852967|454666864|FG003|Overall Study|Lost to Follow-up|4|||
126373947|NCT02852967|454666865|FG004|Overall Study|Lost to Follow-up|4|||
126373948|NCT02852967|454666861|FG000|Overall Study|Withdrawal by Subject|6|||
126373949|NCT02852967|454666862|FG001|Overall Study|Withdrawal by Subject|12|||
126373950|NCT02852967|454666863|FG002|Overall Study|Withdrawal by Subject|7|||
126047872|NCT03691493|453472942|FG000|Overall Study|Withdrawal by Subject|1|||
126047873|NCT03867201|453472943|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
126310415|NCT02980341|454425292|FG001|Dose Escalation|Adverse Event|0|||
126310416|NCT02980341|454425293|FG002|Dose Escalation|Adverse Event|1|||
126310417|NCT02980341|454425294|FG003|Dose Escalation|Adverse Event|2|||
126310418|NCT02980341|454425295|FG004|Dose Escalation|Adverse Event|2|||
126310419|NCT02980341|454425296|FG005|Dose Escalation|Adverse Event|0|||
126310420|NCT02980341|454425297|FG006|Dose Escalation|Adverse Event|0|||
126310421|NCT02980341|454425298|FG007|Dose Escalation|Adverse Event|0|||
126310422|NCT02980341|454425299|FG008|Dose Escalation|Adverse Event|0|||
126373951|NCT02852967|454666864|FG003|Overall Study|Withdrawal by Subject|10|||
126373952|NCT02852967|454666865|FG004|Overall Study|Withdrawal by Subject|10|||
126373953|NCT02852967|454666861|FG000|Overall Study|SAE|0|||
126373954|NCT02852967|454666862|FG001|Overall Study|SAE|0|||
126373955|NCT02852967|454666863|FG002|Overall Study|SAE|0|||
126373956|NCT02852967|454666864|FG003|Overall Study|SAE|3|||
126373957|NCT02852967|454666865|FG004|Overall Study|SAE|0|||
126373958|NCT02852967|454666861|FG000|Overall Study|Elevated Liver Enzymes|2|||
126373959|NCT02852967|454666862|FG001|Overall Study|Elevated Liver Enzymes|0|||
126373960|NCT02852967|454666863|FG002|Overall Study|Elevated Liver Enzymes|0|||
126373961|NCT02852967|454666864|FG003|Overall Study|Elevated Liver Enzymes|2|||
126373962|NCT02852967|454666865|FG004|Overall Study|Elevated Liver Enzymes|2|||
126373963|NCT02852967|454666861|FG000|Overall Study|Physician Decision|0|||
126373964|NCT02852967|454666862|FG001|Overall Study|Physician Decision|0|||
126373965|NCT02852967|454666863|FG002|Overall Study|Physician Decision|0|||
126373966|NCT02852967|454666864|FG003|Overall Study|Physician Decision|1|||
126373967|NCT02852967|454666865|FG004|Overall Study|Physician Decision|0|||
126373968|NCT02852967|454666861|FG000|Overall Study|Lack of Efficacy|0|||
126373969|NCT02852967|454666862|FG001|Overall Study|Lack of Efficacy|1|||
126373970|NCT02852967|454666863|FG002|Overall Study|Lack of Efficacy|0|||
126373971|NCT02852967|454666864|FG003|Overall Study|Lack of Efficacy|0|||
126373972|NCT02852967|454666865|FG004|Overall Study|Lack of Efficacy|0|||
126373973|NCT02852967|454666861|FG000|Overall Study|Non-compliance|0|||
126373974|NCT02852967|454666862|FG001|Overall Study|Non-compliance|0|||
126373975|NCT02852967|454666863|FG002|Overall Study|Non-compliance|1|||
126373976|NCT02852967|454666864|FG003|Overall Study|Non-compliance|1|||
126373977|NCT02852967|454666865|FG004|Overall Study|Non-compliance|0|||
126373978|NCT02852967|454666861|FG000|Overall Study|Dispensing Drug Violation|0|||
126373979|NCT02852967|454666862|FG001|Overall Study|Dispensing Drug Violation|0|||
126373980|NCT02852967|454666863|FG002|Overall Study|Dispensing Drug Violation|1|||
126373981|NCT02852967|454666864|FG003|Overall Study|Dispensing Drug Violation|0|||
126373982|NCT02852967|454666865|FG004|Overall Study|Dispensing Drug Violation|0|||
126373983|NCT02852967|454666861|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
126373984|NCT02852967|454666862|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
126373985|NCT02852967|454666863|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
126373986|NCT02852967|454666864|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
126373987|NCT02852967|454666865|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
126373988|NCT01693367|454666866|FG000|Overall Study|Withdrawal by Subject|1|||
125886225|NCT03848728|452878960|FG000|Overall Study|Withdrawal by Subject|1|||
126373989|NCT01693367|454666867|FG001|Overall Study|Withdrawal by Subject|1|||
126373990|NCT01693367|454666866|FG000|Overall Study|Physician Decision|0|||
126373991|NCT01693367|454666867|FG001|Overall Study|Physician Decision|1|||
126373992|NCT02136914|454666868|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
126373993|NCT02136914|454666869|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
126373994|NCT02136914|454666868|FG000|Overall Study|Withdrawal by Subject|3|||
126310423|NCT02980341|454425300|FG009|Dose Escalation|Adverse Event|0|||
126310424|NCT02980341|454425301|FG010|Dose Escalation|Adverse Event|0|||
126310425|NCT02980341|454425291|FG000|Dose Escalation|Withdrawal by Subject|0|||
126310426|NCT02980341|454425292|FG001|Dose Escalation|Withdrawal by Subject|0|||
126104061|NCT01440374|453675800|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
126310427|NCT02980341|454425293|FG002|Dose Escalation|Withdrawal by Subject|1|||
126310428|NCT02980341|454425294|FG003|Dose Escalation|Withdrawal by Subject|0|||
126310429|NCT02980341|454425295|FG004|Dose Escalation|Withdrawal by Subject|0|||
126310430|NCT02980341|454425296|FG005|Dose Escalation|Withdrawal by Subject|0|||
126310431|NCT02980341|454425297|FG006|Dose Escalation|Withdrawal by Subject|0|||
126310432|NCT02980341|454425298|FG007|Dose Escalation|Withdrawal by Subject|0|||
126310433|NCT02980341|454425299|FG008|Dose Escalation|Withdrawal by Subject|0|||
126310434|NCT02980341|454425300|FG009|Dose Escalation|Withdrawal by Subject|0|||
126310435|NCT02980341|454425301|FG010|Dose Escalation|Withdrawal by Subject|0|||
126310436|NCT02980341|454425291|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310437|NCT02980341|454425292|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310438|NCT02980341|454425293|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310439|NCT02980341|454425294|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
126310440|NCT02980341|454425295|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310441|NCT02980341|454425296|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310442|NCT02980341|454425297|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310443|NCT02980341|454425298|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310444|NCT02980341|454425299|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310445|NCT02980341|454425300|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310446|NCT02980341|454425301|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310447|NCT02980341|454425291|FG000|Dose Escalation|Due to investigator's decision|0|||
126310448|NCT02980341|454425292|FG001|Dose Escalation|Due to investigator's decision|0|||
126310449|NCT02980341|454425293|FG002|Dose Escalation|Due to investigator's decision|0|||
126310450|NCT02980341|454425294|FG003|Dose Escalation|Due to investigator's decision|0|||
126310451|NCT02980341|454425295|FG004|Dose Escalation|Due to investigator's decision|1|||
126310452|NCT02980341|454425296|FG005|Dose Escalation|Due to investigator's decision|0|||
126310453|NCT02980341|454425297|FG006|Dose Escalation|Due to investigator's decision|0|||
126310454|NCT02980341|454425298|FG007|Dose Escalation|Due to investigator's decision|0|||
126310455|NCT02980341|454425299|FG008|Dose Escalation|Due to investigator's decision|0|||
126310456|NCT02980341|454425300|FG009|Dose Escalation|Due to investigator's decision|0|||
126310457|NCT02980341|454425301|FG010|Dose Escalation|Due to investigator's decision|0|||
126310458|NCT02980341|454425291|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310459|NCT02980341|454425292|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310460|NCT02980341|454425293|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310461|NCT02980341|454425294|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310462|NCT02980341|454425295|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310463|NCT02980341|454425296|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
126310464|NCT02980341|454425297|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
126310465|NCT02980341|454425298|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310466|NCT02980341|454425299|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310467|NCT02980341|454425300|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310468|NCT02980341|454425301|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310469|NCT02980341|454425291|FG000|Dose Finding|Adverse Event|0|||
126310470|NCT02980341|454425292|FG001|Dose Finding|Adverse Event|0|||
126310471|NCT02980341|454425293|FG002|Dose Finding|Adverse Event|0|||
126310472|NCT02980341|454425294|FG003|Dose Finding|Adverse Event|0|||
126310473|NCT02980341|454425295|FG004|Dose Finding|Adverse Event|0|||
126310474|NCT02980341|454425296|FG005|Dose Finding|Adverse Event|3|||
126310475|NCT02980341|454425297|FG006|Dose Finding|Adverse Event|0|||
126310476|NCT02980341|454425298|FG007|Dose Finding|Adverse Event|0|||
126310477|NCT02980341|454425299|FG008|Dose Finding|Adverse Event|0|||
126310478|NCT02980341|454425300|FG009|Dose Finding|Adverse Event|0|||
126310479|NCT02980341|454425301|FG010|Dose Finding|Adverse Event|0|||
126310480|NCT02980341|454425291|FG000|Dose Finding|Withdrawal by Subject|0|||
126310481|NCT02980341|454425292|FG001|Dose Finding|Withdrawal by Subject|0|||
126310482|NCT02980341|454425293|FG002|Dose Finding|Withdrawal by Subject|0|||
126310483|NCT02980341|454425294|FG003|Dose Finding|Withdrawal by Subject|0|||
126310484|NCT02980341|454425295|FG004|Dose Finding|Withdrawal by Subject|0|||
126310485|NCT02980341|454425296|FG005|Dose Finding|Withdrawal by Subject|1|||
126310486|NCT02980341|454425297|FG006|Dose Finding|Withdrawal by Subject|1|||
126310487|NCT02980341|454425298|FG007|Dose Finding|Withdrawal by Subject|0|||
126310488|NCT02980341|454425299|FG008|Dose Finding|Withdrawal by Subject|0|||
126310489|NCT02980341|454425300|FG009|Dose Finding|Withdrawal by Subject|0|||
126310490|NCT02980341|454425301|FG010|Dose Finding|Withdrawal by Subject|0|||
126310491|NCT02980341|454425291|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126104062|NCT01440374|453675801|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
126104063|NCT01440374|453675798|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
126310492|NCT02980341|454425292|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310493|NCT02980341|454425293|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310494|NCT02980341|454425294|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310495|NCT02980341|454425295|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310496|NCT02980341|454425296|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310497|NCT02980341|454425297|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310498|NCT02980341|454425298|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
126310499|NCT02980341|454425299|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
126310500|NCT02980341|454425300|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
126310501|NCT02980341|454425301|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
126310502|NCT02980341|454425291|FG000|Dose Expansion|Clinical progression|0|||
126310503|NCT02980341|454425292|FG001|Dose Expansion|Clinical progression|0|||
126310504|NCT02980341|454425293|FG002|Dose Expansion|Clinical progression|0|||
126310505|NCT02980341|454425294|FG003|Dose Expansion|Clinical progression|0|||
126310506|NCT02980341|454425295|FG004|Dose Expansion|Clinical progression|0|||
126310507|NCT02980341|454425296|FG005|Dose Expansion|Clinical progression|0|||
126310508|NCT02980341|454425297|FG006|Dose Expansion|Clinical progression|0|||
126310509|NCT02980341|454425298|FG007|Dose Expansion|Clinical progression|4|||
126310510|NCT02980341|454425299|FG008|Dose Expansion|Clinical progression|3|||
126310511|NCT02980341|454425300|FG009|Dose Expansion|Clinical progression|1|||
126310512|NCT02980341|454425301|FG010|Dose Expansion|Clinical progression|4|||
126310513|NCT02980341|454425291|FG000|Dose Expansion|Adverse Event|0|||
126310514|NCT02980341|454425292|FG001|Dose Expansion|Adverse Event|0|||
126310515|NCT02980341|454425293|FG002|Dose Expansion|Adverse Event|0|||
126310516|NCT02980341|454425294|FG003|Dose Expansion|Adverse Event|0|||
126310517|NCT02980341|454425295|FG004|Dose Expansion|Adverse Event|0|||
126310518|NCT02980341|454425296|FG005|Dose Expansion|Adverse Event|0|||
126310519|NCT02980341|454425297|FG006|Dose Expansion|Adverse Event|0|||
126310520|NCT02980341|454425298|FG007|Dose Expansion|Adverse Event|3|||
126310521|NCT02980341|454425299|FG008|Dose Expansion|Adverse Event|0|||
126310522|NCT02980341|454425300|FG009|Dose Expansion|Adverse Event|1|||
126310523|NCT02980341|454425301|FG010|Dose Expansion|Adverse Event|3|||
126310524|NCT02980341|454425291|FG000|Dose Expansion|Death|0|||
126310525|NCT02980341|454425292|FG001|Dose Expansion|Death|0|||
126310526|NCT02980341|454425293|FG002|Dose Expansion|Death|0|||
126310527|NCT02980341|454425294|FG003|Dose Expansion|Death|0|||
126310528|NCT02980341|454425295|FG004|Dose Expansion|Death|0|||
126310529|NCT02980341|454425296|FG005|Dose Expansion|Death|0|||
126310530|NCT02980341|454425297|FG006|Dose Expansion|Death|0|||
126310531|NCT02980341|454425298|FG007|Dose Expansion|Death|0|||
126310532|NCT02980341|454425299|FG008|Dose Expansion|Death|2|||
126310533|NCT02980341|454425300|FG009|Dose Expansion|Death|1|||
126310534|NCT02980341|454425301|FG010|Dose Expansion|Death|0|||
126310535|NCT02980341|454425291|FG000|Dose Expansion|Withdrawal by Subject|0|||
126310536|NCT02980341|454425292|FG001|Dose Expansion|Withdrawal by Subject|0|||
126373995|NCT02136914|454666869|FG001|Overall Study|Withdrawal by Subject|10|||
126373996|NCT02136914|454666868|FG000|Overall Study|Subject Unwilling to Proceed|7|||
126373997|NCT02136914|454666869|FG001|Overall Study|Subject Unwilling to Proceed|2|||
126373998|NCT02136914|454666868|FG000|Overall Study|Lost to Follow-up|1|||
126373999|NCT02136914|454666869|FG001|Overall Study|Lost to Follow-up|1|||
126374000|NCT02136914|454666868|FG000|Overall Study|Did Not Receive Study Drug|2|||
126374001|NCT02136914|454666869|FG001|Overall Study|Did Not Receive Study Drug|0|||
126374002|NCT02136914|454666868|FG000|Overall Study|Lack of Efficacy|1|||
126374003|NCT02136914|454666869|FG001|Overall Study|Lack of Efficacy|0|||
126374004|NCT02136914|454666868|FG000|Overall Study|Death|0|||
126374005|NCT02136914|454666869|FG001|Overall Study|Death|1|||
126374006|NCT03012334|454666872|FG000|Period 1|Withdrawal by Subject|0|||
126374007|NCT03012334|454666873|FG001|Period 1|Withdrawal by Subject|0|||
126374008|NCT03012334|454666874|FG002|Period 1|Withdrawal by Subject|0|||
126374009|NCT03012334|454666875|FG003|Period 1|Withdrawal by Subject|0|||
126374010|NCT03012334|454666876|FG004|Period 1|Withdrawal by Subject|0|||
126374011|NCT03012334|454666877|FG005|Period 1|Withdrawal by Subject|0|||
126374012|NCT03012334|454666878|FG006|Period 1|Withdrawal by Subject|0|||
126374013|NCT03012334|454666879|FG007|Period 1|Withdrawal by Subject|0|||
126374014|NCT03012334|454666880|FG008|Period 1|Withdrawal by Subject|0|||
126374015|NCT03012334|454666881|FG009|Period 1|Withdrawal by Subject|1|||
126374016|NCT03012334|454666872|FG000|Period 2|Withdrawal by Subject|0|||
126374017|NCT03012334|454666873|FG001|Period 2|Withdrawal by Subject|1|||
126374018|NCT03012334|454666874|FG002|Period 2|Withdrawal by Subject|0|||
126374019|NCT03012334|454666875|FG003|Period 2|Withdrawal by Subject|0|||
126374020|NCT03012334|454666876|FG004|Period 2|Withdrawal by Subject|0|||
126374021|NCT03012334|454666877|FG005|Period 2|Withdrawal by Subject|0|||
126374022|NCT03012334|454666878|FG006|Period 2|Withdrawal by Subject|0|||
126374023|NCT03012334|454666879|FG007|Period 2|Withdrawal by Subject|0|||
126374024|NCT03012334|454666880|FG008|Period 2|Withdrawal by Subject|0|||
126374025|NCT03012334|454666881|FG009|Period 2|Withdrawal by Subject|0|||
126374026|NCT03012334|454666872|FG000|Period 2|Protocol Violation|0|||
126374027|NCT03012334|454666873|FG001|Period 2|Protocol Violation|0|||
126374028|NCT03012334|454666874|FG002|Period 2|Protocol Violation|1|||
126310537|NCT02980341|454425293|FG002|Dose Expansion|Withdrawal by Subject|0|||
126374029|NCT03012334|454666875|FG003|Period 2|Protocol Violation|0|||
126374030|NCT03012334|454666876|FG004|Period 2|Protocol Violation|0|||
126047874|NCT03867201|453472944|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
126310538|NCT02980341|454425294|FG003|Dose Expansion|Withdrawal by Subject|0|||
126310539|NCT02980341|454425295|FG004|Dose Expansion|Withdrawal by Subject|0|||
126310540|NCT02980341|454425296|FG005|Dose Expansion|Withdrawal by Subject|0|||
126310541|NCT02980341|454425297|FG006|Dose Expansion|Withdrawal by Subject|0|||
126310542|NCT02980341|454425298|FG007|Dose Expansion|Withdrawal by Subject|2|||
126310543|NCT02980341|454425299|FG008|Dose Expansion|Withdrawal by Subject|0|||
126310544|NCT02980341|454425300|FG009|Dose Expansion|Withdrawal by Subject|1|||
126310545|NCT02980341|454425301|FG010|Dose Expansion|Withdrawal by Subject|0|||
126310546|NCT02980341|454425291|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310547|NCT02980341|454425292|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310548|NCT02980341|454425293|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310549|NCT02980341|454425294|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310550|NCT02980341|454425295|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310551|NCT02980341|454425296|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310552|NCT02980341|454425297|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310553|NCT02980341|454425298|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
126310554|NCT02980341|454425299|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310555|NCT02980341|454425300|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310556|NCT02980341|454425301|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310557|NCT02980341|454425291|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310558|NCT02980341|454425292|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310559|NCT02980341|454425293|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310560|NCT02980341|454425294|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310561|NCT02980341|454425295|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310562|NCT02980341|454425296|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310563|NCT02980341|454425297|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310564|NCT02980341|454425298|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310565|NCT02980341|454425299|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
126310566|NCT02980341|454425300|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310567|NCT02980341|454425301|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310568|NCT02980341|454425291|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310569|NCT02980341|454425292|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310570|NCT02980341|454425293|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310571|NCT02980341|454425294|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310572|NCT02980341|454425295|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310573|NCT02980341|454425296|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310574|NCT02980341|454425297|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310575|NCT02980341|454425298|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310576|NCT02980341|454425299|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
126310577|NCT02980341|454425300|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310578|NCT02980341|454425301|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310579|NCT02980341|454425291|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310580|NCT02980341|454425292|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310581|NCT02980341|454425293|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310582|NCT02980341|454425294|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126374031|NCT03012334|454666877|FG005|Period 2|Protocol Violation|0|||
126374032|NCT03012334|454666878|FG006|Period 2|Protocol Violation|0|||
126374033|NCT03012334|454666879|FG007|Period 2|Protocol Violation|1|||
126374034|NCT03012334|454666880|FG008|Period 2|Protocol Violation|0|||
126374035|NCT03012334|454666881|FG009|Period 2|Protocol Violation|0|||
126374036|NCT03012334|454666872|FG000|Period 4|Non-Compliance|0|||
126374037|NCT03012334|454666873|FG001|Period 4|Non-Compliance|0|||
126374038|NCT03012334|454666874|FG002|Period 4|Non-Compliance|0|||
126374039|NCT03012334|454666875|FG003|Period 4|Non-Compliance|0|||
126374040|NCT03012334|454666876|FG004|Period 4|Non-Compliance|0|||
126374041|NCT03012334|454666877|FG005|Period 4|Non-Compliance|0|||
126374042|NCT03012334|454666878|FG006|Period 4|Non-Compliance|1|||
126374043|NCT03012334|454666879|FG007|Period 4|Non-Compliance|0|||
126374044|NCT03012334|454666880|FG008|Period 4|Non-Compliance|0|||
126374045|NCT03012334|454666881|FG009|Period 4|Non-Compliance|0|||
126374046|NCT03012334|454666872|FG000|Period 4|Adverse Event|0|||
126310583|NCT02980341|454425295|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310584|NCT02980341|454425296|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310585|NCT02980341|454425297|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310586|NCT02980341|454425298|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310587|NCT02980341|454425299|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310588|NCT02980341|454425300|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310589|NCT02980341|454425301|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
126310590|NCT03193801|454425306|FG000|Overall Study|Physician Decision|2|||
126310591|NCT03193801|454425306|FG000|Overall Study|Withdrawal by Subject|1|||
126310592|NCT04964544|454425309|FG000|Overall Study|Screen failure or other uncategorised|10|||
126310593|NCT04964544|454425309|FG000|Overall Study|Physician Decision|4|||
126310594|NCT04964544|454425309|FG000|Overall Study|Lost to Follow-up|9|||
126310595|NCT04964544|454425309|FG000|Overall Study|Withdrawal by Subject|18|||
126310596|NCT04964544|454425309|FG000|Overall Study|Death|1|||
126310597|NCT01613222|454425310|FG000|Overall Study|Physician Decision|1|||
126310598|NCT01613222|454425310|FG000|Overall Study|Unable to place arterial line|1|||
126310599|NCT01613222|454425310|FG000|Overall Study|Reused disposable sensors|10|||
126310600|NCT04323306|454425311|FG000|Overall Study|Physician Decision|1|||
126310601|NCT04323306|454425312|FG001|Overall Study|Physician Decision|0|||
126310602|NCT04323306|454425313|FG002|Overall Study|Physician Decision|0|||
126310603|NCT04323306|454425314|FG003|Overall Study|Physician Decision|0|||
126310604|NCT04323306|454425315|FG004|Overall Study|Physician Decision|0|||
126310605|NCT04323306|454425316|FG005|Overall Study|Physician Decision|0|||
126310606|NCT04323306|454425317|FG006|Overall Study|Physician Decision|0|||
126310607|NCT04323306|454425318|FG007|Overall Study|Physician Decision|0|||
126310608|NCT04323306|454425319|FG008|Overall Study|Physician Decision|0|||
126310609|NCT04323306|454425311|FG000|Overall Study|Withdrawal by Subject|0|||
126310610|NCT04323306|454425312|FG001|Overall Study|Withdrawal by Subject|0|||
126310611|NCT04323306|454425313|FG002|Overall Study|Withdrawal by Subject|0|||
126310612|NCT04323306|454425314|FG003|Overall Study|Withdrawal by Subject|0|||
126310613|NCT04323306|454425315|FG004|Overall Study|Withdrawal by Subject|0|||
126310614|NCT04323306|454425316|FG005|Overall Study|Withdrawal by Subject|1|||
126310615|NCT04323306|454425317|FG006|Overall Study|Withdrawal by Subject|3|||
126310616|NCT04323306|454425318|FG007|Overall Study|Withdrawal by Subject|0|||
126310617|NCT04323306|454425319|FG008|Overall Study|Withdrawal by Subject|1|||
126310618|NCT00089778|454425320|FG000|Overall Study|Protocol Violation|0|||
126310619|NCT00089778|454425321|FG001|Overall Study|Protocol Violation|0|||
126310620|NCT00089778|454425322|FG002|Overall Study|Protocol Violation|1|||
126310621|NCT01154088|454425323|FG000|Overall Study|Lost to Follow-up|4|||
126310622|NCT01154088|454425324|FG001|Overall Study|Lost to Follow-up|6|||
126310623|NCT01154088|454425325|FG002|Overall Study|Lost to Follow-up|7|||
126310624|NCT00750139|454425329|FG000|Overall Study|Adverse Event|1|||
126310625|NCT00750139|454425330|FG001|Overall Study|Adverse Event|2|||
126310626|NCT00750139|454425331|FG002|Overall Study|Adverse Event|0|||
126310627|NCT00750139|454425332|FG003|Overall Study|Adverse Event|1|||
126310628|NCT00750139|454425329|FG000|Overall Study|Lost to Follow-up|17|||
126310629|NCT00750139|454425330|FG001|Overall Study|Lost to Follow-up|12|||
126310630|NCT00750139|454425331|FG002|Overall Study|Lost to Follow-up|15|||
126310631|NCT00750139|454425332|FG003|Overall Study|Lost to Follow-up|6|||
126310632|NCT00750139|454425329|FG000|Overall Study|Withdrawal by Subject|3|||
126310633|NCT00750139|454425330|FG001|Overall Study|Withdrawal by Subject|2|||
126374047|NCT03012334|454666873|FG001|Period 4|Adverse Event|0|||
126374048|NCT03012334|454666874|FG002|Period 4|Adverse Event|0|||
126374049|NCT03012334|454666875|FG003|Period 4|Adverse Event|0|||
126374050|NCT03012334|454666876|FG004|Period 4|Adverse Event|0|||
126374051|NCT03012334|454666877|FG005|Period 4|Adverse Event|0|||
126374052|NCT03012334|454666878|FG006|Period 4|Adverse Event|0|||
126374053|NCT03012334|454666879|FG007|Period 4|Adverse Event|0|||
126374054|NCT03012334|454666880|FG008|Period 4|Adverse Event|1|||
126374055|NCT03012334|454666881|FG009|Period 4|Adverse Event|0|||
126374056|NCT01870869|454666882|FG000|Overall Study|Implanted with nonstudy device|1|||
126374057|NCT01870869|454666883|FG001|Overall Study|Implanted with nonstudy device|3|||
126374058|NCT01870869|454666884|FG002|Overall Study|Implanted with nonstudy device|14|||
126374059|NCT01870869|454666885|FG003|Overall Study|Implanted with nonstudy device|4|||
126374060|NCT01870869|454666882|FG000|Overall Study|Death|0|||
126374061|NCT01870869|454666883|FG001|Overall Study|Death|0|||
126374062|NCT01870869|454666884|FG002|Overall Study|Death|7|||
126374063|NCT01870869|454666885|FG003|Overall Study|Death|1|||
126374064|NCT01870869|454666882|FG000|Overall Study|Subject choice|6|||
126374065|NCT01870869|454666883|FG001|Overall Study|Subject choice|2|||
126374066|NCT01870869|454666884|FG002|Overall Study|Subject choice|22|||
126374067|NCT01870869|454666885|FG003|Overall Study|Subject choice|8|||
126374068|NCT01870869|454666882|FG000|Overall Study|Lost to Follow-up|10|||
126374069|NCT01870869|454666883|FG001|Overall Study|Lost to Follow-up|2|||
126374070|NCT01870869|454666884|FG002|Overall Study|Lost to Follow-up|25|||
126374071|NCT01870869|454666885|FG003|Overall Study|Lost to Follow-up|3|||
126374072|NCT01870869|454666882|FG000|Overall Study|Reason not Specified|1|||
126374073|NCT01870869|454666883|FG001|Overall Study|Reason not Specified|2|||
126374074|NCT01870869|454666884|FG002|Overall Study|Reason not Specified|20|||
126374075|NCT01870869|454666885|FG003|Overall Study|Reason not Specified|4|||
126374076|NCT01870869|454666882|FG000|Overall Study|Not evaluable|10|||
126374077|NCT01870869|454666883|FG001|Overall Study|Not evaluable|5|||
126374078|NCT01870869|454666884|FG002|Overall Study|Not evaluable|42|||
126374079|NCT01870869|454666885|FG003|Overall Study|Not evaluable|10|||
126374080|NCT02286895|454666886|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
126374081|NCT02286895|454666887|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
126374082|NCT02286895|454666886|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
126374083|NCT02286895|454666887|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
126374084|NCT02286895|454666886|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
126374085|NCT02286895|454666887|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
126374086|NCT01073293|454666888|FG000|Overall Study|Lost to Follow-up|0|||
126374087|NCT01073293|454666889|FG001|Overall Study|Lost to Follow-up|1|||
126374088|NCT01073293|454666888|FG000|Overall Study|Withdrawal by Subject|5|||
126374089|NCT01073293|454666889|FG001|Overall Study|Withdrawal by Subject|10|||
126374090|NCT03036852|454666890|FG000|Overall Study|Death|2|||
126374091|NCT03036852|454666890|FG000|Overall Study|Lack of Efficacy|2|||
126374092|NCT03036852|454666890|FG000|Overall Study|Adverse Event|1|||
126374093|NCT03036852|454666890|FG000|Overall Study|Lost to Follow-up|1|||
126374094|NCT00002766|454666893|FG000|Overall Study|Withdrawal by Subject|0|||
126374095|NCT00002766|454666894|FG001|Overall Study|Withdrawal by Subject|1|||
126374096|NCT00002766|454666893|FG000|Overall Study|Patient Not Treated|1|||
126374097|NCT00002766|454666894|FG001|Overall Study|Patient Not Treated|2|||
126374098|NCT00002766|454666893|FG000|Overall Study|Adverse Event|1|||
126374099|NCT00002766|454666894|FG001|Overall Study|Adverse Event|1|||
126374100|NCT00002766|454666893|FG000|Overall Study|Protocol Violation|1|||
126374101|NCT00002766|454666894|FG001|Overall Study|Protocol Violation|0|||
126374102|NCT00077974|454666897|FG000|Overall Study|Adverse Event|22|||
126374103|NCT00077974|454666897|FG000|Overall Study|Protocol Violation|1|||
126374104|NCT00077974|454666897|FG000|Overall Study|Withdrawal by Subject|3|||
126374105|NCT00077974|454666897|FG000|Overall Study|Lack of Efficacy|76|||
126374106|NCT00077974|454666897|FG000|Overall Study|Decision of Sponsor|2|||
126374107|NCT00256126|454666898|FG000|Overall Study|Adverse Event|1|||
126374108|NCT00256126|454666899|FG001|Overall Study|Adverse Event|0|||
126374109|NCT00256126|454666898|FG000|Overall Study|Other|1|||
126374110|NCT00256126|454666899|FG001|Overall Study|Other|2|||
126374111|NCT02949011|454666908|FG000|Overall Study|Adverse Event|6|||
126374112|NCT02949011|454666909|FG001|Overall Study|Adverse Event|7|||
126374113|NCT02949011|454666910|FG002|Overall Study|Adverse Event|3|||
126374114|NCT02949011|454666908|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
126374115|NCT02949011|454666909|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
126374116|NCT02949011|454666910|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
126374117|NCT02949011|454666908|FG000|Overall Study|Protocol Deviation|5|||
126374118|NCT02949011|454666909|FG001|Overall Study|Protocol Deviation|3|||
126374119|NCT02949011|454666910|FG002|Overall Study|Protocol Deviation|3|||
126374120|NCT02949011|454666908|FG000|Overall Study|Lack of Efficacy|0|||
126374121|NCT02949011|454666909|FG001|Overall Study|Lack of Efficacy|2|||
126374122|NCT02949011|454666910|FG002|Overall Study|Lack of Efficacy|0|||
126374123|NCT02949011|454666908|FG000|Overall Study|Withdrawal by Subject|13|||
126374124|NCT02949011|454666909|FG001|Overall Study|Withdrawal by Subject|13|||
126374125|NCT02949011|454666910|FG002|Overall Study|Withdrawal by Subject|21|||
126374126|NCT02949011|454666908|FG000|Overall Study|Lost to Follow-up|7|||
126374127|NCT02949011|454666909|FG001|Overall Study|Lost to Follow-up|5|||
126374128|NCT02949011|454666910|FG002|Overall Study|Lost to Follow-up|5|||
126374129|NCT02949011|454666908|FG000|Overall Study|Death|0|||
126374130|NCT02949011|454666909|FG001|Overall Study|Death|0|||
126374131|NCT02949011|454666910|FG002|Overall Study|Death|1|||
126374132|NCT02949011|454666908|FG000|Overall Study|Miscellaneous|2|||
126374133|NCT02949011|454666909|FG001|Overall Study|Miscellaneous|4|||
126374134|NCT02949011|454666910|FG002|Overall Study|Miscellaneous|6|||
126374135|NCT00163189|454666911|FG000|Overall Study|Other|6|||
126374136|NCT00163189|454666911|FG000|Overall Study|Lost to Follow-up|1|||
126374137|NCT00163189|454666911|FG000|Overall Study|Protocol Violation|2|||
126374138|NCT00163189|454666911|FG000|Overall Study|Death|3|||
125886226|NCT03848728|452878961|FG001|Overall Study|Withdrawal by Subject|0|||
125886227|NCT04161157|452878962|FG000|Overall Study|Lost to Follow-up|4|||
126310634|NCT00750139|454425331|FG002|Overall Study|Withdrawal by Subject|6|||
126310635|NCT00750139|454425332|FG003|Overall Study|Withdrawal by Subject|2|||
126310636|NCT00750139|454425329|FG000|Overall Study|Physician Decision|1|||
126310637|NCT00750139|454425330|FG001|Overall Study|Physician Decision|1|||
126310638|NCT00750139|454425331|FG002|Overall Study|Physician Decision|0|||
126310639|NCT00750139|454425332|FG003|Overall Study|Physician Decision|0|||
126310640|NCT00750139|454425329|FG000|Overall Study|Non-compliance|1|||
126310641|NCT00750139|454425330|FG001|Overall Study|Non-compliance|0|||
126310642|NCT00750139|454425331|FG002|Overall Study|Non-compliance|1|||
126310643|NCT00750139|454425332|FG003|Overall Study|Non-compliance|3|||
126310644|NCT00750139|454425329|FG000|Overall Study|Termination by sponsor|4|||
126310645|NCT00750139|454425330|FG001|Overall Study|Termination by sponsor|0|||
126310646|NCT00750139|454425331|FG002|Overall Study|Termination by sponsor|0|||
126310647|NCT00750139|454425332|FG003|Overall Study|Termination by sponsor|1|||
126310648|NCT00750139|454425329|FG000|Overall Study|Non-specific|62|||
126310649|NCT00750139|454425330|FG001|Overall Study|Non-specific|42|||
126310650|NCT00750139|454425331|FG002|Overall Study|Non-specific|79|||
126310651|NCT00750139|454425332|FG003|Overall Study|Non-specific|33|||
126310652|NCT02537431|454425333|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
126310653|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
126310654|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
126310655|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
125886228|NCT04161157|452878962|FG000|Overall Study|Death|3|||
125886229|NCT04161157|452878962|FG000|Overall Study|Ineligible|2|||
126310656|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
126310657|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
126310658|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
126310659|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
126374139|NCT00163189|454666911|FG000|Overall Study|Adverse Event|6|||
126374140|NCT00163189|454666911|FG000|Overall Study|Lack of Efficacy|7|||
126374141|NCT00163189|454666911|FG000|Overall Study|Study terminated by sponsor|11|||
126374142|NCT00163189|454666911|FG000|Overall Study|Withdrawal by Subject|11|||
126047875|NCT03867201|453472943|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
126047876|NCT03867201|453472944|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
126047877|NCT03867201|453472943|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
126310660|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310661|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
126310662|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
126310663|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310664|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310665|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310666|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310667|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
126310668|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
126310669|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310670|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310671|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310672|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310673|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310674|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310675|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
126310676|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310677|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310678|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310679|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310680|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310681|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
126310682|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310683|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
126310684|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310685|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310686|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310687|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310688|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
126310689|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
126310690|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
126310691|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
126310692|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
126310693|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
126310694|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
126310695|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
126310696|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
126310697|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
126310698|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
126310699|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
126310700|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
126310701|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
126310702|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
126310703|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
126047878|NCT03867201|453472944|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
126047879|NCT03867201|453472943|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
126047880|NCT03867201|453472944|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
126047881|NCT03867201|453472943|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
126310704|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
126310705|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
126310706|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
126310707|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
126310708|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
126310709|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310710|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125886230|NCT04161157|452878962|FG000|Overall Study|Withdrawal by Subject|4|||
125886231|NCT01108185|452878963|FG000|Overall Study|Non-compliance|15|||
125886232|NCT01108185|452878963|FG000|Overall Study|Lost to Follow-up|12|||
125886233|NCT02581410|452878964|FG000|Vaccination Phase|Adverse Event|2|||
126310711|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310712|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310713|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
126310714|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310715|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310716|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
126310717|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
126310718|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
126310719|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
126310720|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
126310721|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
126310722|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
126310723|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126310724|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126310725|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126310726|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
125886234|NCT02581410|452878965|FG001|Vaccination Phase|Adverse Event|1|||
126310727|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125886235|NCT02581410|452878964|FG000|Vaccination Phase|Withdrawal by Subject|0|||
125886236|NCT02581410|452878965|FG001|Vaccination Phase|Withdrawal by Subject|1|||
126104064|NCT01440374|453675799|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
126310728|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
126310729|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126310730|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
126310731|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
126310732|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
126310733|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
126310734|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
126310735|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
126310736|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
126310737|NCT01741792|454427443|FG000|Overall Study|Death|6|||
126310738|NCT01741792|454427444|FG001|Overall Study|Death|1|||
126310739|NCT01741792|454427445|FG002|Overall Study|Death|12|||
126310740|NCT03696108|454427446|FG000|Overall Study|Physician Decision|1|||
126310741|NCT03696108|454427447|FG001|Overall Study|Physician Decision|0|||
126310742|NCT03696108|454427446|FG000|Overall Study|Withdrawal by Subject|3|||
126310743|NCT03696108|454427447|FG001|Overall Study|Withdrawal by Subject|6|||
126310744|NCT02833844|454427451|FG000|Double-Blind Period|Withdrawal by Subject|2|||
126310745|NCT02833844|454427452|FG001|Double-Blind Period|Withdrawal by Subject|3|||
126310746|NCT02833844|454427451|FG000|Double-Blind Period|Protocol Violation|0|||
126310747|NCT02833844|454427452|FG001|Double-Blind Period|Protocol Violation|4|||
126310748|NCT02833844|454427451|FG000|Open-Label Period|Death|0|||
126310749|NCT02833844|454427452|FG001|Open-Label Period|Death|2|||
126310750|NCT02833844|454427451|FG000|Open-Label Period|Lost to Follow-up|1|||
126310751|NCT02833844|454427452|FG001|Open-Label Period|Lost to Follow-up|0|||
126310752|NCT02833844|454427451|FG000|Open-Label Period|Withdrawal by Subject|1|||
126310753|NCT02833844|454427452|FG001|Open-Label Period|Withdrawal by Subject|0|||
126310754|NCT01899742|454427453|FG000|Overall Study|Adverse Event|5|||
126310755|NCT01899742|454427454|FG001|Overall Study|Adverse Event|4|||
126310756|NCT01899742|454427453|FG000|Overall Study|Lack of Efficacy|1|||
126310757|NCT01899742|454427454|FG001|Overall Study|Lack of Efficacy|5|||
126310758|NCT01899742|454427453|FG000|Overall Study|Protocol Violation|2|||
126310759|NCT01899742|454427454|FG001|Overall Study|Protocol Violation|2|||
126310760|NCT01899742|454427453|FG000|Overall Study|Withdrawal by Subject|9|||
126310761|NCT01899742|454427454|FG001|Overall Study|Withdrawal by Subject|5|||
126310762|NCT02662764|454427455|FG000|Overall Study|Adverse Event|6|||
126310763|NCT02662764|454427455|FG000|Overall Study|Lack of Efficacy|8|||
126310764|NCT02662764|454427455|FG000|Overall Study|Protocol Violation|1|||
126310765|NCT02662764|454427455|FG000|Overall Study|Withdrawal by Subject|5|||
126310766|NCT02662764|454427455|FG000|Overall Study|Device failure|4|||
126310767|NCT02662764|454427455|FG000|Overall Study|Patient changed treatment|1|||
126310768|NCT02662764|454427455|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
126310769|NCT05129137|454427458|FG000|Second Period|Adverse Event|1|||
126310770|NCT05129137|454427459|FG001|Second Period|Adverse Event|0|||
126310771|NCT05129137|454427460|FG002|Second Period|Adverse Event|0|||
126310772|NCT05129137|454427461|FG003|Second Period|Adverse Event|0|||
126310773|NCT05129137|454427458|FG000|Second Period|Protocol Violation|0|||
126310774|NCT05129137|454427459|FG001|Second Period|Protocol Violation|0|||
126310775|NCT05129137|454427460|FG002|Second Period|Protocol Violation|0|||
126310776|NCT05129137|454427461|FG003|Second Period|Protocol Violation|1|||
126310777|NCT05129137|454427458|FG000|Third Period|Protocol Violation|0|||
126310778|NCT05129137|454427459|FG001|Third Period|Protocol Violation|0|||
126310779|NCT05129137|454427460|FG002|Third Period|Protocol Violation|0|||
126310780|NCT05129137|454427461|FG003|Third Period|Protocol Violation|1|||
126310781|NCT05129137|454427458|FG000|Forth Period|Protocol Violation|0|||
126310782|NCT05129137|454427459|FG001|Forth Period|Protocol Violation|1|||
126310783|NCT05129137|454427460|FG002|Forth Period|Protocol Violation|0|||
126310784|NCT05129137|454427461|FG003|Forth Period|Protocol Violation|0|||
126310785|NCT05129137|454427458|FG000|Forth Period|Withdrawal by Subject|0|||
126310786|NCT05129137|454427459|FG001|Forth Period|Withdrawal by Subject|0|||
126310787|NCT05129137|454427460|FG002|Forth Period|Withdrawal by Subject|1|||
126310788|NCT05129137|454427461|FG003|Forth Period|Withdrawal by Subject|0|||
126310789|NCT01104246|454427462|FG000|Overall Study|Withdrawal by Subject|1|||
126310790|NCT01104246|454427462|FG000|Overall Study|did not meet inclusion criteria|4|||
126310791|NCT05178641|454427473|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
126310792|NCT05178641|454427474|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
126310793|NCT05178641|454427473|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
126310794|NCT05178641|454427474|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
126310795|NCT01869699|454427475|FG000|Overall Study|Withdrawal by Subject|1|||
126310796|NCT01869699|454427476|FG001|Overall Study|Withdrawal by Subject|0|||
126310797|NCT01475851|454427477|FG000|Overall Study|Protocol defined stopping criteria|1|||
126310798|NCT01475851|454427478|FG001|Overall Study|Protocol defined stopping criteria|0|||
126310799|NCT01867294|454427481|FG000|Overall Study|Withdrawal by Subject|1|||
126310800|NCT01867294|454427482|FG001|Overall Study|Withdrawal by Subject|1|||
126310801|NCT01867294|454427483|FG002|Overall Study|Withdrawal by Subject|0|||
126310802|NCT01867294|454427484|FG003|Overall Study|Withdrawal by Subject|0|||
126310803|NCT02447497|454427485|FG000|Overall Study|Did not meet treatment day baseline.|6|||
126310804|NCT02447497|454427486|FG001|Overall Study|Did not meet treatment day baseline.|5|||
126310805|NCT02447497|454427487|FG002|Overall Study|Did not meet treatment day baseline.|2|||
126310806|NCT02447497|454427488|FG003|Overall Study|Did not meet treatment day baseline.|2|||
126310807|NCT02447497|454427485|FG000|Overall Study|Dressing was compromised|0|||
126310808|NCT02447497|454427486|FG001|Overall Study|Dressing was compromised|1|||
126310809|NCT02447497|454427487|FG002|Overall Study|Dressing was compromised|0|||
126310810|NCT02447497|454427488|FG003|Overall Study|Dressing was compromised|0|||
126310811|NCT02017912|454427489|FG000|Overall Study|Withdrawal by Subject|2|||
126310812|NCT02017912|454427490|FG001|Overall Study|Withdrawal by Subject|1|||
126310813|NCT02017912|454427489|FG000|Overall Study|miscellaneous|1|||
126310814|NCT02017912|454427490|FG001|Overall Study|miscellaneous|1|||
126310815|NCT01322035|454427491|FG000|Overall Study|Lost to Follow-up|8|||
126310816|NCT01322035|454427492|FG001|Overall Study|Lost to Follow-up|3|||
126310817|NCT00732758|454427493|FG000|Overall Study|Lost to Follow-up|8|||
126310818|NCT00732758|454427494|FG001|Overall Study|Lost to Follow-up|16|||
126310819|NCT04240457|454427497|FG000|Overall Study|Lost to Follow-up|5|||
126310820|NCT04240457|454427498|FG001|Overall Study|Lost to Follow-up|1|||
126310821|NCT01508130|454427502|FG000|Overall Study|Adverse Event|81|||
125886237|NCT02581410|452878964|FG000|Vaccination Phase|Migrated/moved from study area|0|||
125886238|NCT02581410|452878965|FG001|Vaccination Phase|Migrated/moved from study area|1|||
125886239|NCT02581410|452878964|FG000|End of Study Phase|Adverse Event|4|||
125886240|NCT02581410|452878965|FG001|End of Study Phase|Adverse Event|3|||
125886241|NCT02581410|452878964|FG000|End of Study Phase|Withdrawal by Subject|1|||
125886242|NCT02581410|452878965|FG001|End of Study Phase|Withdrawal by Subject|2|||
125886243|NCT02581410|452878964|FG000|End of Study Phase|Migrated/moved from study area|0|||
126047882|NCT03867201|453472944|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
126310822|NCT01508130|454427503|FG001|Overall Study|Adverse Event|28|||
126310823|NCT01508130|454427502|FG000|Overall Study|Death|3|||
126310824|NCT01508130|454427503|FG001|Overall Study|Death|1|||
126310825|NCT01508130|454427502|FG000|Overall Study|Protocol Violation|2|||
126310826|NCT01508130|454427503|FG001|Overall Study|Protocol Violation|0|||
126310827|NCT01508130|454427502|FG000|Overall Study|Lost to Follow-up|25|||
126310828|NCT01508130|454427503|FG001|Overall Study|Lost to Follow-up|2|||
126310829|NCT01508130|454427502|FG000|Overall Study|Withdrawal by Subject|3|||
126310830|NCT01508130|454427503|FG001|Overall Study|Withdrawal by Subject|3|||
126310831|NCT01508130|454427502|FG000|Overall Study|Subject's substantial non-compliance|25|||
126374143|NCT00163189|454666911|FG000|Overall Study|Did not meet continuation criterion|16|||
126374144|NCT00506142|454666912|FG000|Overall Study|Adverse Event|8|||
126374145|NCT00506142|454666913|FG001|Overall Study|Adverse Event|7|||
126374146|NCT00506142|454666912|FG000|Overall Study|Lack of Efficacy|21|||
126374147|NCT00506142|454666913|FG001|Overall Study|Lack of Efficacy|7|||
126374148|NCT00506142|454666912|FG000|Overall Study|Withdrawal by Subject|4|||
126374149|NCT00506142|454666913|FG001|Overall Study|Withdrawal by Subject|5|||
126374150|NCT00506142|454666912|FG000|Overall Study|Physician Decision|1|||
126374151|NCT00506142|454666913|FG001|Overall Study|Physician Decision|0|||
126374152|NCT00506142|454666912|FG000|Overall Study|New health condition|1|||
126374153|NCT00506142|454666913|FG001|Overall Study|New health condition|0|||
126374154|NCT02154061|454666914|FG000|Overall Study|Pregnancy|1|||
126374155|NCT02154061|454666915|FG001|Overall Study|Pregnancy|0|||
126374156|NCT02154061|454666914|FG000|Overall Study|enrolled but not vaccinated|1|||
126374157|NCT02154061|454666915|FG001|Overall Study|enrolled but not vaccinated|0|||
126374158|NCT00454116|454666916|FG000|Overall Study|Adverse Event|5|||
126374159|NCT00454116|454666917|FG001|Overall Study|Adverse Event|11|||
126374160|NCT00454116|454666918|FG002|Overall Study|Adverse Event|9|||
126374161|NCT00454116|454666916|FG000|Overall Study|Condition under investigation worsened|17|||
126374162|NCT00454116|454666917|FG001|Overall Study|Condition under investigation worsened|13|||
126374163|NCT00454116|454666918|FG002|Overall Study|Condition under investigation worsened|18|||
126374164|NCT00454116|454666916|FG000|Overall Study|Withdrawal by Subject|3|||
126374165|NCT00454116|454666917|FG001|Overall Study|Withdrawal by Subject|3|||
126374166|NCT00454116|454666918|FG002|Overall Study|Withdrawal by Subject|1|||
126374167|NCT00454116|454666916|FG000|Overall Study|Other|2|||
126374168|NCT00454116|454666917|FG001|Overall Study|Other|2|||
126374169|NCT00454116|454666918|FG002|Overall Study|Other|0|||
126374170|NCT01917318|454666921|FG000|First Treatment|Withdrawal by Subject|0|||
126374171|NCT01917318|454666922|FG001|First Treatment|Withdrawal by Subject|1|||
126374172|NCT00742625|454666923|FG000|Remission Induction|Progression|6|||
126374173|NCT00742625|454666923|FG000|Remission Induction|Failed induction|8|||
126374174|NCT00742625|454666923|FG000|Remission Induction|Adverse Event|3|||
126374175|NCT00742625|454666923|FG000|Remission Induction|Death|10|||
126374176|NCT00742625|454666923|FG000|Remission Induction|Refusal|5|||
126374177|NCT00742625|454666923|FG000|Remission Induction|Non protocol treatment|17|||
126374178|NCT00742625|454666923|FG000|Remission Induction|Other, not specified|5|||
126374179|NCT00742625|454666923|FG000|Consolidation|Progression|5|||
126374180|NCT00742625|454666923|FG000|Consolidation|Adverse Event|1|||
126374181|NCT00742625|454666923|FG000|Consolidation|Death|1|||
126374182|NCT00742625|454666923|FG000|Consolidation|Refused|1|||
126374183|NCT00742625|454666923|FG000|Consolidation|Non protocol therapy|13|||
126374184|NCT03338400|454666924|FG000|Overall Study|Lost to Follow-up|1|||
126374185|NCT03338400|454666925|FG001|Overall Study|Lost to Follow-up|2|||
126374186|NCT01865487|454666928|FG000|Overall Study|Lost to Follow-up|0|||
126374187|NCT01865487|454666929|FG001|Overall Study|Lost to Follow-up|0|||
126047883|NCT03867201|453472943|FG000|Open-Label Period From Week 12|Adverse Event|5|||
126047884|NCT03867201|453472944|FG001|Open-Label Period From Week 12|Adverse Event|11|||
126047885|NCT03867201|453472943|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
126374188|NCT01865487|454666930|FG002|Overall Study|Lost to Follow-up|0|||
126374189|NCT01865487|454666931|FG003|Overall Study|Lost to Follow-up|1|||
126374190|NCT01865487|454666932|FG004|Overall Study|Lost to Follow-up|0|||
126374191|NCT01865487|454666933|FG005|Overall Study|Lost to Follow-up|0|||
126374192|NCT01865487|454666934|FG006|Overall Study|Lost to Follow-up|1|||
126374193|NCT01865487|454666935|FG007|Overall Study|Lost to Follow-up|0|||
126374194|NCT01865487|454666936|FG008|Overall Study|Lost to Follow-up|0|||
126374195|NCT01865487|454666937|FG009|Overall Study|Lost to Follow-up|0|||
126374196|NCT01865487|454666928|FG000|Overall Study|Withdrawal by Subject|0|||
126374197|NCT01865487|454666929|FG001|Overall Study|Withdrawal by Subject|0|||
126374198|NCT01865487|454666930|FG002|Overall Study|Withdrawal by Subject|0|||
126374199|NCT01865487|454666931|FG003|Overall Study|Withdrawal by Subject|0|||
126374200|NCT01865487|454666932|FG004|Overall Study|Withdrawal by Subject|1|||
126374201|NCT01865487|454666933|FG005|Overall Study|Withdrawal by Subject|0|||
126374202|NCT01865487|454666934|FG006|Overall Study|Withdrawal by Subject|0|||
126374203|NCT01865487|454666935|FG007|Overall Study|Withdrawal by Subject|0|||
126374204|NCT01865487|454666936|FG008|Overall Study|Withdrawal by Subject|0|||
126374205|NCT01865487|454666937|FG009|Overall Study|Withdrawal by Subject|0|||
126374206|NCT01213082|454666941|FG000|Overall Study|Lost to Follow-up|6|||
126374207|NCT01213082|454666942|FG001|Overall Study|Lost to Follow-up|7|||
126374208|NCT01213082|454666943|FG002|Overall Study|Lost to Follow-up|4|||
126374209|NCT01213082|454666941|FG000|Overall Study|Physician Decision|0|||
126374210|NCT01213082|454666942|FG001|Overall Study|Physician Decision|0|||
126374211|NCT01213082|454666943|FG002|Overall Study|Physician Decision|1|||
126374212|NCT03848416|454666946|FG000|Overall Study|Withdrawal by Subject|1|||
126374213|NCT03848416|454666947|FG001|Overall Study|Withdrawal by Subject|0|||
126374214|NCT03848416|454666948|FG002|Overall Study|Withdrawal by Subject|0|||
126374215|NCT03848416|454666946|FG000|Overall Study|Death|0|||
126374216|NCT03848416|454666947|FG001|Overall Study|Death|0|||
126374217|NCT03848416|454666948|FG002|Overall Study|Death|1|||
126374218|NCT01908140|454666949|FG000|Overall Study|Other or Progressive Disease|5|||
126374219|NCT01908140|454666950|FG001|Overall Study|Other or Progressive Disease|12|||
126374220|NCT01908140|454666949|FG000|Overall Study|Lack of Efficacy|7|||
126374221|NCT01908140|454666950|FG001|Overall Study|Lack of Efficacy|5|||
126374222|NCT01908140|454666949|FG000|Overall Study|Withdrawal by Subject|23|||
126374223|NCT01908140|454666950|FG001|Overall Study|Withdrawal by Subject|24|||
126374224|NCT01908140|454666949|FG000|Overall Study|Lost to Follow-up|1|||
126374225|NCT01908140|454666950|FG001|Overall Study|Lost to Follow-up|6|||
126374226|NCT01908140|454666949|FG000|Overall Study|Protocol Violation|8|||
126374227|NCT01908140|454666950|FG001|Overall Study|Protocol Violation|9|||
126374228|NCT01908140|454666949|FG000|Overall Study|Adverse Event|22|||
126374229|NCT01908140|454666950|FG001|Overall Study|Adverse Event|23|||
126374230|NCT02639390|454666951|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
126374231|NCT02639390|454666952|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
126374232|NCT01436110|454666953|FG000|Overall Study|Lack of Efficacy|23|||
126374233|NCT01436110|454666954|FG001|Overall Study|Lack of Efficacy|14|||
126374234|NCT01436110|454666955|FG002|Overall Study|Lack of Efficacy|9|||
126374235|NCT01436110|454666953|FG000|Overall Study|Withdrawal by Subject|6|||
126374236|NCT01436110|454666954|FG001|Overall Study|Withdrawal by Subject|8|||
126374237|NCT01436110|454666955|FG002|Overall Study|Withdrawal by Subject|4|||
126374238|NCT01436110|454666953|FG000|Overall Study|Adverse Event|2|||
126374239|NCT01436110|454666954|FG001|Overall Study|Adverse Event|1|||
126374240|NCT01436110|454666955|FG002|Overall Study|Adverse Event|2|||
126374241|NCT01436110|454666953|FG000|Overall Study|Physician Decision|3|||
126374242|NCT01436110|454666954|FG001|Overall Study|Physician Decision|1|||
126374243|NCT01436110|454666955|FG002|Overall Study|Physician Decision|1|||
126374244|NCT01436110|454666953|FG000|Overall Study|Lost to Follow-up|1|||
126374245|NCT01436110|454666954|FG001|Overall Study|Lost to Follow-up|1|||
126374246|NCT01436110|454666955|FG002|Overall Study|Lost to Follow-up|3|||
126374247|NCT01436110|454666953|FG000|Overall Study|Protocol Violation|3|||
126374248|NCT01436110|454666954|FG001|Overall Study|Protocol Violation|1|||
126374249|NCT01436110|454666955|FG002|Overall Study|Protocol Violation|1|||
126374250|NCT01436110|454666953|FG000|Overall Study|Did Not Receive Trial Medication|1|||
126374251|NCT01436110|454666954|FG001|Overall Study|Did Not Receive Trial Medication|0|||
126374252|NCT01436110|454666955|FG002|Overall Study|Did Not Receive Trial Medication|3|||
126374253|NCT01088503|454666957|FG000|Overall Study|Withdrawal by Subject|118|||
126374254|NCT01088503|454666958|FG001|Overall Study|Withdrawal by Subject|327|||
126374255|NCT01088503|454666959|FG002|Overall Study|Withdrawal by Subject|10|||
126374256|NCT01088503|454666957|FG000|Overall Study|Death|64|||
126374257|NCT01088503|454666958|FG001|Overall Study|Death|358|||
126374258|NCT01088503|454666959|FG002|Overall Study|Death|7|||
126374259|NCT01531998|454666960|FG000|Overall Study|Withdrawal by Subject|3|||
126374260|NCT00186628|454666965|FG000|Overall Study|Death|2|||
126374261|NCT00186628|454666965|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
126374262|NCT02927795|454666966|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
126374263|NCT02927795|454666966|FG000|Overall Study|Not Treated|4|||
126374264|NCT01076010|454666967|FG000|Overall Study|Death|15|||
126374265|NCT01076010|454666968|FG001|Overall Study|Death|1|||
126374266|NCT01076010|454666969|FG002|Overall Study|Death|0|||
126374267|NCT01076010|454666967|FG000|Overall Study|Adverse Event|7|||
126374268|NCT01076010|454666968|FG001|Overall Study|Adverse Event|2|||
126374269|NCT01076010|454666969|FG002|Overall Study|Adverse Event|0|||
126374270|NCT01076010|454666967|FG000|Overall Study|Progressive disease|90|||
126374271|NCT01076010|454666968|FG001|Overall Study|Progressive disease|30|||
126374272|NCT01076010|454666969|FG002|Overall Study|Progressive disease|1|||
126047886|NCT03867201|453472944|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
126047887|NCT03867201|453472943|FG000|Open-Label Period From Week 12|Physician Decision|6|||
126047888|NCT03867201|453472944|FG001|Open-Label Period From Week 12|Physician Decision|3|||
126047889|NCT03867201|453472943|FG000|Open-Label Period From Week 12|Pregnancy|2|||
126047890|NCT03867201|453472944|FG001|Open-Label Period From Week 12|Pregnancy|2|||
126310832|NCT01508130|454427503|FG001|Overall Study|Subject's substantial non-compliance|9|||
126310833|NCT01508130|454427502|FG000|Overall Study|Insufficient therapeutic response|74|||
126047891|NCT03867201|453472943|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
126047892|NCT03867201|453472944|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
126104065|NCT01440374|453675800|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
126104066|NCT01440374|453675801|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
126310834|NCT01508130|454427503|FG001|Overall Study|Insufficient therapeutic response|23|||
126310835|NCT01508130|454427502|FG000|Overall Study|Administrative|14|||
126310836|NCT01508130|454427503|FG001|Overall Study|Administrative|3|||
126310837|NCT01680159|454427504|FG000|Screening Period|Not meet criteria for dose-up period|7|||
126310838|NCT01680159|454427504|FG000|Increased Dose Period|Adverse Event|6|||
126310839|NCT01680159|454427504|FG000|Increased Dose Period|Withdrawal by Subject|2|||
126310840|NCT01252563|454427507|FG000|Overall Study|Contract Deviation|41|||
126310841|NCT01252563|454427507|FG000|Overall Study|Centralized Registration Deviation|30|||
126310842|NCT01252563|454427507|FG000|Overall Study|Lost to Follow-up|161|||
126310843|NCT01252563|454427507|FG000|Overall Study|No visit after first day of treatment|194|||
126310844|NCT01252563|454427507|FG000|Overall Study|No drug administration|6|||
126310845|NCT01880086|454427508|FG000|Overall Study|Lost to Follow-up|1|||
126310846|NCT01880086|454427509|FG001|Overall Study|Lost to Follow-up|1|||
126310847|NCT03429244|454427510|FG000|Overall Study|Withdrawal by Subject|2|||
126310848|NCT03429244|454427511|FG001|Overall Study|Withdrawal by Subject|1|||
126310849|NCT03429244|454427512|FG002|Overall Study|Withdrawal by Subject|1|||
126310850|NCT03403751|454427515|FG000|Overall Study|Death|5|||
126310851|NCT03403751|454427516|FG001|Overall Study|Death|6|||
126310852|NCT03403751|454427515|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
126310853|NCT03403751|454427516|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
126310854|NCT01820572|454427517|FG000|Randomization|Not Treated|2|||
126310855|NCT01820572|454427518|FG001|Randomization|Not Treated|1|||
126310856|NCT01820572|454427517|FG000|Treatment Period|Adverse Event|12|||
126310857|NCT01820572|454427518|FG001|Treatment Period|Adverse Event|7|||
126310858|NCT01820572|454427517|FG000|Treatment Period|Death|3|||
126047893|NCT03867201|453472943|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
126310859|NCT01820572|454427518|FG001|Treatment Period|Death|3|||
126310860|NCT01820572|454427517|FG000|Treatment Period|Lack of Efficacy|1|||
126310861|NCT01820572|454427518|FG001|Treatment Period|Lack of Efficacy|0|||
126310862|NCT01820572|454427517|FG000|Treatment Period|poor/non compliance|0|||
126310863|NCT01820572|454427518|FG001|Treatment Period|poor/non compliance|3|||
125886244|NCT02581410|452878965|FG001|End of Study Phase|Migrated/moved from study area|3|||
126310864|NCT01820572|454427517|FG000|Treatment Period|request to discontinue|6|||
126310865|NCT01820572|454427518|FG001|Treatment Period|request to discontinue|11|||
126310866|NCT01820572|454427517|FG000|Treatment Period|No longer meets study criteria|3|||
126310867|NCT01820572|454427518|FG001|Treatment Period|No longer meets study criteria|10|||
126310868|NCT01820572|454427517|FG000|Treatment Period|withdrew consent|1|||
126310869|NCT01820572|454427518|FG001|Treatment Period|withdrew consent|2|||
126310870|NCT00658775|454427522|FG000|Overall Study|Adverse Event|4|||
126047894|NCT03867201|453472944|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
126047895|NCT03867201|453472943|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
126047896|NCT03867201|453472944|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
126310871|NCT00658775|454427523|FG001|Overall Study|Adverse Event|6|||
126310872|NCT00658775|454427522|FG000|Overall Study|Lost to Follow-up|17|||
126310873|NCT00658775|454427523|FG001|Overall Study|Lost to Follow-up|18|||
126310874|NCT00658775|454427522|FG000|Overall Study|Withdrawal by Subject|6|||
126310875|NCT00658775|454427523|FG001|Overall Study|Withdrawal by Subject|4|||
126310876|NCT00658775|454427522|FG000|Overall Study|Withdrawal of consent|8|||
126310877|NCT00658775|454427523|FG001|Overall Study|Withdrawal of consent|7|||
126310878|NCT00658775|454427522|FG000|Overall Study|Other|7|||
126310879|NCT00658775|454427523|FG001|Overall Study|Other|8|||
126310880|NCT00387010|454427524|FG000|Dose Titration Period|Adverse Event|12|||
126310881|NCT00387010|454427524|FG000|Dose Titration Period|Lack of Efficacy|5|||
126310882|NCT00387010|454427524|FG000|Dose Titration Period|Withdrawal by Subject|3|||
126310883|NCT00387010|454427524|FG000|Dose Titration Period|Protocol Violation|1|||
126310884|NCT00387010|454427524|FG000|Dose Titration Period|Lost to Follow-up|2|||
126310885|NCT00387010|454427524|FG000|Dose Titration Period|Noncompliance with study medication|8|||
126310886|NCT00387010|454427524|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
126310887|NCT00387010|454427524|FG000|Treatment Period|Adverse Event|4|||
126310888|NCT00387010|454427524|FG000|Treatment Period|Withdrawal by Subject|1|||
126310889|NCT00387010|454427524|FG000|Treatment Period|Noncompliance with study medication|2|||
126310890|NCT00387010|454427524|FG000|Treatment Period|Noncompliance with study procedures|3|||
126310891|NCT00387010|454427524|FG000|Treatment Period|Participant reported study drug stolen|1|||
126310892|NCT01931956|454427527|FG000|Overall Study|Death|42|||
126374273|NCT01076010|454666967|FG000|Overall Study|Lack of Efficacy|4|||
126374274|NCT01076010|454666968|FG001|Overall Study|Lack of Efficacy|0|||
126374275|NCT01076010|454666969|FG002|Overall Study|Lack of Efficacy|0|||
126374276|NCT01076010|454666967|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
126374277|NCT01076010|454666968|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
126374278|NCT01076010|454666969|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
126374279|NCT01076010|454666967|FG000|Overall Study|Significant Surgical Procedure|0|||
126374280|NCT01076010|454666968|FG001|Overall Study|Significant Surgical Procedure|1|||
126374281|NCT01076010|454666969|FG002|Overall Study|Significant Surgical Procedure|0|||
126374282|NCT01076010|454666967|FG000|Overall Study|Protocol Violation|0|||
126374283|NCT01076010|454666968|FG001|Overall Study|Protocol Violation|1|||
126374284|NCT01076010|454666969|FG002|Overall Study|Protocol Violation|0|||
126374285|NCT01076010|454666967|FG000|Overall Study|Noncompliance|1|||
126374286|NCT01076010|454666968|FG001|Overall Study|Noncompliance|1|||
126374287|NCT01076010|454666969|FG002|Overall Study|Noncompliance|0|||
126374288|NCT01076010|454666967|FG000|Overall Study|Withdrawal by Subject|3|||
126374289|NCT01076010|454666968|FG001|Overall Study|Withdrawal by Subject|0|||
126374290|NCT01076010|454666969|FG002|Overall Study|Withdrawal by Subject|1|||
126374291|NCT01076010|454666967|FG000|Overall Study|Other|5|||
126374292|NCT01076010|454666968|FG001|Overall Study|Other|2|||
126374293|NCT01076010|454666969|FG002|Overall Study|Other|0|||
126374294|NCT03440008|454666972|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
126374295|NCT03440008|454666973|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
126374296|NCT03440008|454666972|FG000|Overall Study|Withdrawal by Subject|1|||
126374297|NCT03440008|454666973|FG001|Overall Study|Withdrawal by Subject|0|||
126374298|NCT03498716|454666979|FG000|Overall Study|Withdrawal by Subject|88|||
126374299|NCT03498716|454666980|FG001|Overall Study|Withdrawal by Subject|73|||
126374300|NCT03498716|454666979|FG000|Overall Study|Study Terminated By Sponsor|933|||
126374301|NCT03498716|454666980|FG001|Overall Study|Study Terminated By Sponsor|927|||
126374302|NCT03498716|454666979|FG000|Overall Study|Lost to Follow-up|15|||
126374303|NCT03498716|454666980|FG001|Overall Study|Lost to Follow-up|26|||
126374304|NCT03498716|454666979|FG000|Overall Study|Disease Relapse|0|||
126374305|NCT03498716|454666980|FG001|Overall Study|Disease Relapse|1|||
126374306|NCT03498716|454666979|FG000|Overall Study|Death|58|||
126374307|NCT03498716|454666980|FG001|Overall Study|Death|72|||
126374308|NCT03498716|454666979|FG000|Overall Study|Physician Decision|4|||
126047897|NCT03867201|453472943|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
126047898|NCT03867201|453472944|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
126047899|NCT01983683|453472945|FG000|Overall Study|Withdrawal by Subject|14|||
126374309|NCT03498716|454666980|FG001|Overall Study|Physician Decision|2|||
126374310|NCT00760552|454666984|FG000|Overall Study|Death|2|||
126374311|NCT00760552|454666985|FG001|Overall Study|Death|0|||
126374312|NCT00760552|454666984|FG000|Overall Study|Lost to Follow-up|11|||
126374313|NCT00760552|454666985|FG001|Overall Study|Lost to Follow-up|10|||
126374314|NCT02216526|454666986|FG000|Overall Study|Adverse Event|1|||
126374315|NCT02216526|454666987|FG001|Overall Study|Adverse Event|1|||
126374316|NCT02216526|454666988|FG002|Overall Study|Adverse Event|0|||
126374317|NCT02216526|454666986|FG000|Overall Study|Death|0|||
126374318|NCT02216526|454666987|FG001|Overall Study|Death|1|||
126047900|NCT01983683|453472946|FG001|Overall Study|Withdrawal by Subject|18|||
126047901|NCT01983683|453472945|FG000|Overall Study|Death|11|||
126047902|NCT01983683|453472946|FG001|Overall Study|Death|15|||
126047903|NCT01983683|453472945|FG000|Overall Study|Physician Decision|8|||
126310893|NCT01931956|454427528|FG001|Overall Study|Death|7|||
126310894|NCT01931956|454427529|FG002|Overall Study|Death|379|||
126310895|NCT01931956|454427530|FG003|Overall Study|Death|96|||
126310896|NCT01931956|454427527|FG000|Overall Study|Withdrawal by Subject|5|||
126310897|NCT01931956|454427528|FG001|Overall Study|Withdrawal by Subject|0|||
126310898|NCT01931956|454427529|FG002|Overall Study|Withdrawal by Subject|70|||
126310899|NCT01931956|454427530|FG003|Overall Study|Withdrawal by Subject|30|||
126310900|NCT01931956|454427527|FG000|Overall Study|Lost to Follow-up|2|||
126310901|NCT01931956|454427528|FG001|Overall Study|Lost to Follow-up|0|||
126310902|NCT01931956|454427529|FG002|Overall Study|Lost to Follow-up|11|||
126310903|NCT01931956|454427530|FG003|Overall Study|Lost to Follow-up|7|||
126310904|NCT01931956|454427527|FG000|Overall Study|Expected|2|||
126310905|NCT01931956|454427528|FG001|Overall Study|Expected|0|||
126310906|NCT01931956|454427529|FG002|Overall Study|Expected|6|||
126310907|NCT01931956|454427530|FG003|Overall Study|Expected|0|||
126310908|NCT01931956|454427527|FG000|Overall Study|Not due|0|||
126310909|NCT01931956|454427528|FG001|Overall Study|Not due|0|||
126310910|NCT01931956|454427529|FG002|Overall Study|Not due|21|||
126310911|NCT01931956|454427530|FG003|Overall Study|Not due|0|||
126310912|NCT02847494|454427531|FG000|Overall Study|Lost to Follow-up|8|||
126310913|NCT02847494|454427532|FG001|Overall Study|Lost to Follow-up|5|||
126310914|NCT02841280|454427535|FG000|Overall Study|Adverse Event|2|||
126310915|NCT02841280|454427536|FG001|Overall Study|Adverse Event|1|||
126310916|NCT02841280|454427535|FG000|Overall Study|Death|1|||
126310917|NCT02841280|454427536|FG001|Overall Study|Death|0|||
126310918|NCT02841280|454427535|FG000|Overall Study|Lost to Follow-up|2|||
126310919|NCT02841280|454427536|FG001|Overall Study|Lost to Follow-up|2|||
126310920|NCT02841280|454427535|FG000|Overall Study|Withdrawal by Subject|7|||
126310921|NCT02841280|454427536|FG001|Overall Study|Withdrawal by Subject|3|||
126310922|NCT02841280|454427535|FG000|Overall Study|Stop Point: BP above threshold|2|||
126310923|NCT02841280|454427536|FG001|Overall Study|Stop Point: BP above threshold|0|||
126310924|NCT02727777|454427537|FG000|Overall Study|Screen Failure|2|||
126310925|NCT02727777|454427538|FG001|Overall Study|Screen Failure|0|||
126310926|NCT02727777|454427539|FG002|Overall Study|Screen Failure|0|||
126310927|NCT02727777|454427537|FG000|Overall Study|Progressive disease|2|||
126310928|NCT02727777|454427538|FG001|Overall Study|Progressive disease|0|||
126310929|NCT02727777|454427539|FG002|Overall Study|Progressive disease|0|||
126310930|NCT01738503|454427540|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
126310931|NCT01738503|454427541|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310932|NCT01738503|454427542|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310933|NCT01738503|454427543|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310934|NCT01738503|454427544|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310935|NCT01738503|454427545|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310936|NCT01738503|454427546|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310937|NCT01738503|454427540|FG000|Treatment Period|Adverse Event|0|||
126310938|NCT01738503|454427541|FG001|Treatment Period|Adverse Event|1|||
126310939|NCT01738503|454427542|FG002|Treatment Period|Adverse Event|0|||
126310940|NCT01738503|454427543|FG003|Treatment Period|Adverse Event|1|||
126310941|NCT01738503|454427544|FG004|Treatment Period|Adverse Event|2|||
126310942|NCT01738503|454427545|FG005|Treatment Period|Adverse Event|2|||
126310943|NCT01738503|454427546|FG006|Treatment Period|Adverse Event|2|||
126310944|NCT01738503|454427540|FG000|Treatment Period|Lost to Follow-up|0|||
126310945|NCT01738503|454427541|FG001|Treatment Period|Lost to Follow-up|0|||
126310946|NCT01738503|454427542|FG002|Treatment Period|Lost to Follow-up|3|||
126310947|NCT01738503|454427543|FG003|Treatment Period|Lost to Follow-up|4|||
126310948|NCT01738503|454427544|FG004|Treatment Period|Lost to Follow-up|1|||
126310949|NCT01738503|454427545|FG005|Treatment Period|Lost to Follow-up|1|||
125886245|NCT02581410|452878964|FG000|End of Study Phase|Lost to Follow-up|0|||
126310950|NCT01738503|454427546|FG006|Treatment Period|Lost to Follow-up|5|||
126310951|NCT01738503|454427540|FG000|Treatment Period|Withdrawal by Subject|0|||
126310952|NCT01738503|454427541|FG001|Treatment Period|Withdrawal by Subject|1|||
126310953|NCT01738503|454427542|FG002|Treatment Period|Withdrawal by Subject|0|||
126310954|NCT01738503|454427543|FG003|Treatment Period|Withdrawal by Subject|1|||
126310955|NCT01738503|454427544|FG004|Treatment Period|Withdrawal by Subject|1|||
126047904|NCT01983683|453472946|FG001|Overall Study|Physician Decision|9|||
126310956|NCT01738503|454427545|FG005|Treatment Period|Withdrawal by Subject|1|||
126310957|NCT01738503|454427546|FG006|Treatment Period|Withdrawal by Subject|1|||
126310958|NCT01738503|454427540|FG000|Treatment Period|Protocol Violation|0|||
126310959|NCT01738503|454427541|FG001|Treatment Period|Protocol Violation|3|||
126310960|NCT01738503|454427542|FG002|Treatment Period|Protocol Violation|1|||
126310961|NCT01738503|454427543|FG003|Treatment Period|Protocol Violation|0|||
126310962|NCT01738503|454427544|FG004|Treatment Period|Protocol Violation|4|||
126310963|NCT01738503|454427545|FG005|Treatment Period|Protocol Violation|2|||
126310964|NCT01738503|454427546|FG006|Treatment Period|Protocol Violation|0|||
126310965|NCT01738503|454427540|FG000|Treatment Period|Other|0|||
126104067|NCT01440374|453675798|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
126310966|NCT01738503|454427541|FG001|Treatment Period|Other|0|||
126310967|NCT01738503|454427542|FG002|Treatment Period|Other|1|||
126310968|NCT01738503|454427543|FG003|Treatment Period|Other|0|||
126310969|NCT01738503|454427544|FG004|Treatment Period|Other|0|||
126310970|NCT01738503|454427545|FG005|Treatment Period|Other|0|||
126310971|NCT01738503|454427546|FG006|Treatment Period|Other|0|||
126310972|NCT01738503|454427540|FG000|PET Imaging Sub-study|Adverse Event|0|||
126310973|NCT01738503|454427541|FG001|PET Imaging Sub-study|Adverse Event|0|||
126310974|NCT01738503|454427542|FG002|PET Imaging Sub-study|Adverse Event|0|||
126310975|NCT01738503|454427543|FG003|PET Imaging Sub-study|Adverse Event|0|||
126310976|NCT01738503|454427544|FG004|PET Imaging Sub-study|Adverse Event|0|||
126310977|NCT01738503|454427545|FG005|PET Imaging Sub-study|Adverse Event|1|||
126310978|NCT01738503|454427546|FG006|PET Imaging Sub-study|Adverse Event|0|||
126310979|NCT01738503|454427540|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310980|NCT01738503|454427541|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310981|NCT01738503|454427542|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310982|NCT01738503|454427543|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310983|NCT01738503|454427544|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310984|NCT01738503|454427545|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
126310985|NCT01738503|454427546|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
126310986|NCT01758731|454427547|FG000|Overall Study|Physician Decision|1|||
126310987|NCT01340027|454427548|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
126310988|NCT01340027|454427549|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
126310989|NCT01340027|454427550|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
126310990|NCT01340027|454427551|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
126310991|NCT01340027|454427552|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
126310992|NCT01340027|454427553|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
126310993|NCT01340027|454427554|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
126310994|NCT01340027|454427555|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
126310995|NCT01340027|454427556|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
126310996|NCT01340027|454427557|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
126310997|NCT01340027|454427558|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
126310998|NCT01340027|454427559|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
126310999|NCT01340027|454427548|FG000|Overall Study|Adverse Event|0|||
126311000|NCT01340027|454427549|FG001|Overall Study|Adverse Event|1|||
126311001|NCT01340027|454427550|FG002|Overall Study|Adverse Event|2|||
126311002|NCT01340027|454427551|FG003|Overall Study|Adverse Event|0|||
126311003|NCT01340027|454427552|FG004|Overall Study|Adverse Event|1|||
126311004|NCT01340027|454427553|FG005|Overall Study|Adverse Event|2|||
126311005|NCT01340027|454427554|FG006|Overall Study|Adverse Event|2|||
126311006|NCT01340027|454427555|FG007|Overall Study|Adverse Event|1|||
126311007|NCT01340027|454427556|FG008|Overall Study|Adverse Event|4|||
126311008|NCT01340027|454427557|FG009|Overall Study|Adverse Event|1|||
126311009|NCT01340027|454427558|FG010|Overall Study|Adverse Event|1|||
126311010|NCT01340027|454427559|FG011|Overall Study|Adverse Event|3|||
126311011|NCT01340027|454427548|FG000|Overall Study|Lack of Efficacy|0|||
126311012|NCT01340027|454427549|FG001|Overall Study|Lack of Efficacy|0|||
126311013|NCT01340027|454427550|FG002|Overall Study|Lack of Efficacy|0|||
126311014|NCT01340027|454427551|FG003|Overall Study|Lack of Efficacy|0|||
126311015|NCT01340027|454427552|FG004|Overall Study|Lack of Efficacy|0|||
126311016|NCT01340027|454427553|FG005|Overall Study|Lack of Efficacy|0|||
126311017|NCT01340027|454427554|FG006|Overall Study|Lack of Efficacy|1|||
126311018|NCT01340027|454427555|FG007|Overall Study|Lack of Efficacy|1|||
126311019|NCT01340027|454427556|FG008|Overall Study|Lack of Efficacy|1|||
126311020|NCT01340027|454427557|FG009|Overall Study|Lack of Efficacy|0|||
126311021|NCT01340027|454427558|FG010|Overall Study|Lack of Efficacy|0|||
126311022|NCT01340027|454427559|FG011|Overall Study|Lack of Efficacy|0|||
126311023|NCT01340027|454427548|FG000|Overall Study|Lost to Follow-up|0|||
126311024|NCT01340027|454427549|FG001|Overall Study|Lost to Follow-up|1|||
126311025|NCT01340027|454427550|FG002|Overall Study|Lost to Follow-up|0|||
126311026|NCT01340027|454427551|FG003|Overall Study|Lost to Follow-up|0|||
126311027|NCT01340027|454427552|FG004|Overall Study|Lost to Follow-up|0|||
126311028|NCT01340027|454427553|FG005|Overall Study|Lost to Follow-up|0|||
126311029|NCT01340027|454427554|FG006|Overall Study|Lost to Follow-up|1|||
126311030|NCT01340027|454427555|FG007|Overall Study|Lost to Follow-up|0|||
126311031|NCT01340027|454427556|FG008|Overall Study|Lost to Follow-up|0|||
126311032|NCT01340027|454427557|FG009|Overall Study|Lost to Follow-up|1|||
126311033|NCT01340027|454427558|FG010|Overall Study|Lost to Follow-up|0|||
126311034|NCT01340027|454427559|FG011|Overall Study|Lost to Follow-up|0|||
126311035|NCT01340027|454427548|FG000|Overall Study|Protocol Violation|1|||
126311036|NCT01340027|454427549|FG001|Overall Study|Protocol Violation|2|||
126311037|NCT01340027|454427550|FG002|Overall Study|Protocol Violation|0|||
126311038|NCT01340027|454427551|FG003|Overall Study|Protocol Violation|0|||
126311039|NCT01340027|454427552|FG004|Overall Study|Protocol Violation|6|||
126311040|NCT01340027|454427553|FG005|Overall Study|Protocol Violation|0|||
126311041|NCT01340027|454427554|FG006|Overall Study|Protocol Violation|0|||
126311042|NCT01340027|454427555|FG007|Overall Study|Protocol Violation|1|||
126311043|NCT01340027|454427556|FG008|Overall Study|Protocol Violation|2|||
126311044|NCT01340027|454427557|FG009|Overall Study|Protocol Violation|2|||
126311045|NCT01340027|454427558|FG010|Overall Study|Protocol Violation|0|||
126311046|NCT01340027|454427559|FG011|Overall Study|Protocol Violation|0|||
126311047|NCT01340027|454427548|FG000|Overall Study|Withdrawal by Subject|4|||
126311048|NCT01340027|454427549|FG001|Overall Study|Withdrawal by Subject|3|||
126311049|NCT01340027|454427550|FG002|Overall Study|Withdrawal by Subject|1|||
126311050|NCT01340027|454427551|FG003|Overall Study|Withdrawal by Subject|3|||
126311051|NCT01340027|454427552|FG004|Overall Study|Withdrawal by Subject|3|||
126311052|NCT01340027|454427553|FG005|Overall Study|Withdrawal by Subject|2|||
126311053|NCT01340027|454427554|FG006|Overall Study|Withdrawal by Subject|3|||
126311054|NCT01340027|454427555|FG007|Overall Study|Withdrawal by Subject|4|||
126311055|NCT01340027|454427556|FG008|Overall Study|Withdrawal by Subject|1|||
126374319|NCT02216526|454666988|FG002|Overall Study|Death|3|||
126374320|NCT02216526|454666986|FG000|Overall Study|Protocol Violation|2|||
126374321|NCT02216526|454666987|FG001|Overall Study|Protocol Violation|0|||
126374322|NCT02216526|454666988|FG002|Overall Study|Protocol Violation|2|||
126374323|NCT02216526|454666986|FG000|Overall Study|Hospitalization|2|||
126374324|NCT02216526|454666987|FG001|Overall Study|Hospitalization|1|||
126374325|NCT02216526|454666988|FG002|Overall Study|Hospitalization|3|||
126374326|NCT02271529|454666996|FG000|Overall Study|Withdrawal by Subject|1|||
126374327|NCT03507127|454666997|FG000|Overall Study|Withdrawal by Subject|1|||
126374328|NCT03507127|454666998|FG001|Overall Study|Withdrawal by Subject|0|||
126374329|NCT03507127|454666997|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
126374330|NCT03507127|454666998|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
126374331|NCT01492426|454669010|FG000|Treatment|Death|0|||
126374332|NCT01492426|454669011|FG001|Treatment|Death|1|||
126374333|NCT01492426|454669010|FG000|Treatment|Other|1|||
126311056|NCT01340027|454427557|FG009|Overall Study|Withdrawal by Subject|2|||
126311057|NCT01340027|454427558|FG010|Overall Study|Withdrawal by Subject|0|||
126311058|NCT01340027|454427559|FG011|Overall Study|Withdrawal by Subject|1|||
126374334|NCT01492426|454669011|FG001|Treatment|Other|0|||
126374335|NCT01492426|454669010|FG000|Treatment|Adverse Event|25|||
126374336|NCT01492426|454669011|FG001|Treatment|Adverse Event|25|||
126374337|NCT01492426|454669010|FG000|Treatment|Lack of Efficacy|38|||
126374338|NCT01492426|454669011|FG001|Treatment|Lack of Efficacy|5|||
126374339|NCT01492426|454669010|FG000|Treatment|Participant withdrew consent|1|||
126374340|NCT01492426|454669011|FG001|Treatment|Participant withdrew consent|2|||
126374341|NCT01492426|454669010|FG000|Treatment|Poor compliance/noncompliance|1|||
126374342|NCT01492426|454669011|FG001|Treatment|Poor compliance/noncompliance|0|||
126374343|NCT01492426|454669010|FG000|Treatment|Subject requested discontinue study drug|7|||
126374344|NCT01492426|454669011|FG001|Treatment|Subject requested discontinue study drug|3|||
126374345|NCT01492426|454669010|FG000|Treatment|Lost to Follow-up|9|||
126374346|NCT01492426|454669011|FG001|Treatment|Lost to Follow-up|4|||
126374347|NCT01492426|454669010|FG000|Treatment|Participant does not meet study criteria|1|||
126374348|NCT01492426|454669011|FG001|Treatment|Participant does not meet study criteria|0|||
126374349|NCT01492426|454669010|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
126374350|NCT01492426|454669011|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
126374351|NCT01492426|454669010|FG000|Follow-Up|Death|1|||
126374352|NCT01492426|454669011|FG001|Follow-Up|Death|0|||
126374353|NCT01492426|454669010|FG000|Follow-Up|Other|4|||
126374354|NCT01492426|454669011|FG001|Follow-Up|Other|2|||
126374355|NCT01492426|454669010|FG000|Follow-Up|Participant Withdrew Consent|6|||
126374356|NCT01492426|454669011|FG001|Follow-Up|Participant Withdrew Consent|1|||
126374357|NCT01492426|454669010|FG000|Follow-Up|Lost to Follow-up|12|||
126374358|NCT01492426|454669011|FG001|Follow-Up|Lost to Follow-up|6|||
126374359|NCT00322049|454669012|FG000|Overall Study|Moved out of area|0|||
126374360|NCT00322049|454669013|FG001|Overall Study|Moved out of area|0|||
126374361|NCT00322049|454669014|FG002|Overall Study|Moved out of area|0|||
126374362|NCT00322049|454669015|FG003|Overall Study|Moved out of area|1|||
126374363|NCT00322049|454669012|FG000|Overall Study|Infected with Dengue during study|0|||
126374364|NCT00322049|454669013|FG001|Overall Study|Infected with Dengue during study|1|||
126374365|NCT00322049|454669014|FG002|Overall Study|Infected with Dengue during study|0|||
126374366|NCT00322049|454669015|FG003|Overall Study|Infected with Dengue during study|0|||
126374367|NCT02026011|454669016|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
126374368|NCT02026011|454669017|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
126374369|NCT02026011|454669016|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
126374370|NCT02026011|454669017|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
126374371|NCT02026011|454669016|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
126374372|NCT02026011|454669017|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
126374373|NCT02026011|454669016|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
126374374|NCT02026011|454669017|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
126374375|NCT01770743|454669018|FG000|Overall Study|Adverse Event|1|||
126311059|NCT01340027|454427548|FG000|Overall Study|Miscellaneous|0|||
126311060|NCT01340027|454427549|FG001|Overall Study|Miscellaneous|0|||
126311061|NCT01340027|454427550|FG002|Overall Study|Miscellaneous|0|||
126311062|NCT01340027|454427551|FG003|Overall Study|Miscellaneous|1|||
126311063|NCT01340027|454427552|FG004|Overall Study|Miscellaneous|0|||
126311064|NCT01340027|454427553|FG005|Overall Study|Miscellaneous|0|||
126311065|NCT01340027|454427554|FG006|Overall Study|Miscellaneous|0|||
126311066|NCT01340027|454427555|FG007|Overall Study|Miscellaneous|0|||
126311067|NCT01340027|454427556|FG008|Overall Study|Miscellaneous|0|||
126311068|NCT01340027|454427557|FG009|Overall Study|Miscellaneous|0|||
126311069|NCT01340027|454427558|FG010|Overall Study|Miscellaneous|1|||
126311070|NCT01340027|454427559|FG011|Overall Study|Miscellaneous|0|||
126311071|NCT03005327|454427560|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
126311072|NCT03005327|454427561|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
126311073|NCT03005327|454427562|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
126311074|NCT03005327|454427563|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
126311075|NCT03005327|454427560|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126311076|NCT03005327|454427561|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126311077|NCT03005327|454427562|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126311078|NCT03005327|454427563|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126311079|NCT04687072|454427564|FG000|Overall Study|Adverse Event|2|||
126311080|NCT04687072|454427565|FG001|Overall Study|Adverse Event|0|||
126311081|NCT04687072|454427564|FG000|Overall Study|Death|1|||
126311082|NCT04687072|454427565|FG001|Overall Study|Death|0|||
126311083|NCT04687072|454427564|FG000|Overall Study|Lack of Efficacy|2|||
126311084|NCT04687072|454427565|FG001|Overall Study|Lack of Efficacy|1|||
126311085|NCT04687072|454427564|FG000|Overall Study|Physician Decision|1|||
126311086|NCT04687072|454427565|FG001|Overall Study|Physician Decision|0|||
126311087|NCT04687072|454427564|FG000|Overall Study|Pregnancy|1|||
126311088|NCT04687072|454427565|FG001|Overall Study|Pregnancy|0|||
126311089|NCT04687072|454427564|FG000|Overall Study|Requires Prohibited Medication|2|||
126311090|NCT04687072|454427565|FG001|Overall Study|Requires Prohibited Medication|0|||
126311091|NCT04687072|454427564|FG000|Overall Study|Withdrawal of Consent|11|||
126311092|NCT04687072|454427565|FG001|Overall Study|Withdrawal of Consent|6|||
126311093|NCT04687072|454427564|FG000|Overall Study|Miscellaneous|4|||
126311094|NCT04687072|454427565|FG001|Overall Study|Miscellaneous|1|||
126311095|NCT00915876|454427566|FG000|Overall Study|Adverse Event|0|||
126311096|NCT00915876|454427567|FG001|Overall Study|Adverse Event|1|||
126311097|NCT02496091|454427572|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126311098|NCT02272842|454427573|FG000|Overall Study|Lost to Follow-up|8|||
126311099|NCT02272842|454427574|FG001|Overall Study|Lost to Follow-up|8|||
126311100|NCT02272842|454427573|FG000|Overall Study|Withdrawal by Subject|8|||
126311101|NCT02272842|454427574|FG001|Overall Study|Withdrawal by Subject|2|||
126311102|NCT05033262|454427575|FG000|Overall Study|Lost to Follow-up|1|||
126311103|NCT05033262|454427576|FG001|Overall Study|Lost to Follow-up|0|||
126311104|NCT05033262|454427577|FG002|Overall Study|Lost to Follow-up|0|||
126311105|NCT05033262|454427578|FG003|Overall Study|Lost to Follow-up|1|||
126311106|NCT01493284|454427581|FG000|Overall Study|Death|29|||
126311107|NCT01493284|454427581|FG000|Overall Study|Withdrawal by Subject|32|||
126311108|NCT00519428|454427582|FG000|Overall Study|Adverse Event|5|||
126311109|NCT00519428|454427583|FG001|Overall Study|Adverse Event|2|||
126311110|NCT00519428|454427584|FG002|Overall Study|Adverse Event|10|||
126311111|NCT00519428|454427582|FG000|Overall Study|Lost to Follow-up|7|||
126311112|NCT00519428|454427583|FG001|Overall Study|Lost to Follow-up|7|||
125886246|NCT02581410|452878965|FG001|End of Study Phase|Lost to Follow-up|2|||
126311113|NCT00519428|454427584|FG002|Overall Study|Lost to Follow-up|6|||
126311114|NCT00519428|454427582|FG000|Overall Study|Withdrawal by Subject|8|||
126311115|NCT00519428|454427583|FG001|Overall Study|Withdrawal by Subject|3|||
126311116|NCT00519428|454427584|FG002|Overall Study|Withdrawal by Subject|7|||
126311117|NCT00519428|454427582|FG000|Overall Study|unstated|1|||
126311118|NCT00519428|454427583|FG001|Overall Study|unstated|3|||
126311119|NCT00519428|454427584|FG002|Overall Study|unstated|2|||
126311120|NCT00325156|454427585|FG000|Overall Study|Protocol Violation|8|||
126311121|NCT00325156|454427585|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
126374376|NCT01770743|454669019|FG001|Overall Study|Adverse Event|0|||
126374377|NCT01770743|454669020|FG002|Overall Study|Adverse Event|0|||
126374378|NCT01770743|454669021|FG003|Overall Study|Adverse Event|0|||
126374379|NCT01770743|454669022|FG004|Overall Study|Adverse Event|0|||
126374380|NCT01770743|454669018|FG000|Overall Study|Withdrawal by Subject|0|||
126374381|NCT01770743|454669019|FG001|Overall Study|Withdrawal by Subject|0|||
126374382|NCT01770743|454669020|FG002|Overall Study|Withdrawal by Subject|1|||
126374383|NCT01770743|454669021|FG003|Overall Study|Withdrawal by Subject|1|||
126374384|NCT01770743|454669022|FG004|Overall Study|Withdrawal by Subject|1|||
126374385|NCT01770743|454669018|FG000|Overall Study|Lost to Follow-up|0|||
126374386|NCT01770743|454669019|FG001|Overall Study|Lost to Follow-up|2|||
126374387|NCT01770743|454669020|FG002|Overall Study|Lost to Follow-up|0|||
126374388|NCT01770743|454669021|FG003|Overall Study|Lost to Follow-up|0|||
126374389|NCT01770743|454669022|FG004|Overall Study|Lost to Follow-up|1|||
126047905|NCT01983683|453472945|FG000|Overall Study|Lost to Follow-up|4|||
126047906|NCT01983683|453472946|FG001|Overall Study|Lost to Follow-up|8|||
126047907|NCT01983683|453472945|FG000|Overall Study|Sponsor Decision|1|||
126047908|NCT01983683|453472946|FG001|Overall Study|Sponsor Decision|1|||
126047909|NCT05464732|453472949|FG000|Overall Study|Lost to Follow-up|0|||
126047910|NCT05464732|453472950|FG001|Overall Study|Lost to Follow-up|1|||
126047911|NCT05464732|453472949|FG000|Overall Study|Adverse Event|1|||
126047912|NCT05464732|453472950|FG001|Overall Study|Adverse Event|0|||
126047913|NCT05786612|453472959|FG000|Overall Study|Adverse Event|1|||
126311122|NCT00325156|454427585|FG000|Overall Study|Migrated/moved from study area|12|||
126311123|NCT00325156|454427585|FG000|Overall Study|Adverse event, non-fatal|3|||
126311124|NCT00325156|454427585|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
126311125|NCT00325156|454427585|FG000|Overall Study|Other|1|||
126311126|NCT00325156|454427585|FG000|Overall Study|Withdrawal by Subject|31|||
126311127|NCT03626363|454427588|FG000|Overall Study|Protocol Violation|4|||
126311128|NCT03626363|454427589|FG001|Overall Study|Protocol Violation|0|||
126311129|NCT03626363|454427588|FG000|Overall Study|Lost to Follow-up|5|||
126311130|NCT03626363|454427589|FG001|Overall Study|Lost to Follow-up|7|||
126311131|NCT00533702|454427590|FG000|Overall Study|Withdrawal by Subject|3|||
126311132|NCT00533702|454427591|FG001|Overall Study|Withdrawal by Subject|1|||
126311133|NCT00533702|454427590|FG000|Overall Study|Found ineligible after randomization|2|||
126311134|NCT00533702|454427591|FG001|Overall Study|Found ineligible after randomization|1|||
126311135|NCT03053063|454427594|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
126311136|NCT03053063|454427595|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
126311137|NCT03053063|454427596|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
126311138|NCT03053063|454427597|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
126311139|NCT03053063|454427594|FG000|Randomized Phase|Withdrew consent|8|||
126311140|NCT03053063|454427595|FG001|Randomized Phase|Withdrew consent|11|||
126311141|NCT03053063|454427596|FG002|Randomized Phase|Withdrew consent|5|||
126311142|NCT03053063|454427597|FG003|Randomized Phase|Withdrew consent|0|||
126311143|NCT03053063|454427594|FG000|Randomized Phase|Investigator's Discretion|8|||
126311144|NCT03053063|454427595|FG001|Randomized Phase|Investigator's Discretion|6|||
126311145|NCT03053063|454427596|FG002|Randomized Phase|Investigator's Discretion|2|||
126311146|NCT03053063|454427597|FG003|Randomized Phase|Investigator's Discretion|0|||
126311147|NCT03053063|454427594|FG000|Randomized Phase|Lost to Follow-up|3|||
126311148|NCT03053063|454427595|FG001|Randomized Phase|Lost to Follow-up|5|||
126311149|NCT03053063|454427596|FG002|Randomized Phase|Lost to Follow-up|1|||
126311150|NCT03053063|454427597|FG003|Randomized Phase|Lost to Follow-up|0|||
126311151|NCT03053063|454427594|FG000|Randomized Phase|Adverse Event|0|||
126311152|NCT03053063|454427595|FG001|Randomized Phase|Adverse Event|1|||
126311153|NCT03053063|454427596|FG002|Randomized Phase|Adverse Event|0|||
126311154|NCT03053063|454427597|FG003|Randomized Phase|Adverse Event|0|||
126311155|NCT03053063|454427594|FG000|Randomized Phase|Randomized but Never Treated|1|||
126311156|NCT03053063|454427595|FG001|Randomized Phase|Randomized but Never Treated|3|||
126311157|NCT03053063|454427596|FG002|Randomized Phase|Randomized but Never Treated|2|||
126311158|NCT03053063|454427597|FG003|Randomized Phase|Randomized but Never Treated|0|||
126311159|NCT03053063|454427594|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
126311160|NCT03053063|454427595|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
126311161|NCT03053063|454427596|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
126311162|NCT03053063|454427597|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
126311163|NCT03053063|454427594|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
126311164|NCT03053063|454427595|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
126311165|NCT03053063|454427596|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
126311166|NCT03053063|454427597|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
126311167|NCT03053063|454427594|FG000|Open-Label Phase|Death|0|||
126311168|NCT03053063|454427595|FG001|Open-Label Phase|Death|0|||
126311169|NCT03053063|454427596|FG002|Open-Label Phase|Death|0|||
126311170|NCT03053063|454427597|FG003|Open-Label Phase|Death|2|||
126311171|NCT03053063|454427594|FG000|Open-Label Phase|Investigator's discretion|0|||
126311172|NCT03053063|454427595|FG001|Open-Label Phase|Investigator's discretion|0|||
126311173|NCT03053063|454427596|FG002|Open-Label Phase|Investigator's discretion|0|||
126311174|NCT03053063|454427597|FG003|Open-Label Phase|Investigator's discretion|2|||
126311175|NCT02600845|454427598|FG000|Overall Study|Reason Not Specified|3|||
126311176|NCT02600845|454427598|FG000|Overall Study|Non-compliance with Study Procedures|10|||
126311177|NCT02600845|454427598|FG000|Overall Study|Consent Withdrawal|5|||
126374390|NCT01770743|454669018|FG000|Overall Study|Sponsor Terminated Subject|1|||
126374391|NCT01770743|454669019|FG001|Overall Study|Sponsor Terminated Subject|0|||
126374392|NCT01770743|454669020|FG002|Overall Study|Sponsor Terminated Subject|0|||
126374393|NCT01770743|454669021|FG003|Overall Study|Sponsor Terminated Subject|1|||
126374394|NCT01770743|454669022|FG004|Overall Study|Sponsor Terminated Subject|0|||
126374395|NCT01770743|454669018|FG000|Overall Study|Moving Out of State|0|||
126374396|NCT01770743|454669019|FG001|Overall Study|Moving Out of State|1|||
126374397|NCT01770743|454669020|FG002|Overall Study|Moving Out of State|0|||
126374398|NCT01770743|454669021|FG003|Overall Study|Moving Out of State|0|||
126374399|NCT01770743|454669022|FG004|Overall Study|Moving Out of State|0|||
126374400|NCT00529243|454669023|FG000|Overall Study|Adverse Event|1|||
126374401|NCT00529243|454669023|FG000|Overall Study|Death|1|||
126374402|NCT00529243|454669023|FG000|Overall Study|Relocated|1|||
126374403|NCT00698828|454669028|FG000|Overall Study|Adverse Event|3|||
126374404|NCT00698828|454669029|FG001|Overall Study|Adverse Event|4|||
126374405|NCT00698828|454669030|FG002|Overall Study|Adverse Event|4|||
126374406|NCT00698828|454669028|FG000|Overall Study|Death|0|||
126374407|NCT00698828|454669029|FG001|Overall Study|Death|0|||
126374408|NCT00698828|454669030|FG002|Overall Study|Death|1|||
126374409|NCT00698828|454669028|FG000|Overall Study|Exacerbation of COPD|1|||
126374410|NCT00698828|454669029|FG001|Overall Study|Exacerbation of COPD|3|||
126374411|NCT00698828|454669030|FG002|Overall Study|Exacerbation of COPD|0|||
126374412|NCT00698828|454669028|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
126374413|NCT00698828|454669029|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
126374414|NCT00698828|454669030|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
126374415|NCT00698828|454669028|FG000|Overall Study|Investigator/Sponsor decision|1|||
126374416|NCT00698828|454669029|FG001|Overall Study|Investigator/Sponsor decision|0|||
126374417|NCT00698828|454669030|FG002|Overall Study|Investigator/Sponsor decision|2|||
126374418|NCT00698828|454669028|FG000|Overall Study|Lost to Follow-up|1|||
126374419|NCT00698828|454669029|FG001|Overall Study|Lost to Follow-up|1|||
126374420|NCT00698828|454669030|FG002|Overall Study|Lost to Follow-up|0|||
126374421|NCT00698828|454669028|FG000|Overall Study|Withdrew consent|0|||
126374422|NCT00698828|454669029|FG001|Overall Study|Withdrew consent|7|||
126374423|NCT00698828|454669030|FG002|Overall Study|Withdrew consent|4|||
126374424|NCT00698828|454669028|FG000|Overall Study|Withdrew consent (not treated)|2|||
126374425|NCT00698828|454669029|FG001|Overall Study|Withdrew consent (not treated)|0|||
126374426|NCT00698828|454669030|FG002|Overall Study|Withdrew consent (not treated)|0|||
126374427|NCT02013609|454669031|FG000|Overall Study|Withdrawal by Subject|9|||
126374428|NCT02013609|454669031|FG000|Overall Study|Lost to Follow-up|3|||
126374429|NCT02013609|454669031|FG000|Overall Study|Adverse Event|3|||
126374430|NCT02013609|454669031|FG000|Overall Study|Met Withdrawal Criteria|3|||
126374431|NCT00856609|454669032|FG000|Overall Study|Adverse Event|1|||
126374432|NCT00856609|454669033|FG001|Overall Study|Adverse Event|0|||
126374433|NCT00783432|454669034|FG000|Overall Study|Adverse Event|22|||
126374434|NCT00783432|454669035|FG001|Overall Study|Adverse Event|17|||
126374435|NCT00783432|454669034|FG000|Overall Study|Lack of Efficacy|20|||
126374436|NCT00783432|454669035|FG001|Overall Study|Lack of Efficacy|21|||
126374437|NCT00783432|454669034|FG000|Overall Study|Lost to Follow-up|11|||
126374438|NCT00783432|454669035|FG001|Overall Study|Lost to Follow-up|6|||
126374439|NCT00783432|454669034|FG000|Overall Study|Withdrawal by Subject|23|||
126374440|NCT00783432|454669035|FG001|Overall Study|Withdrawal by Subject|20|||
126374441|NCT00783432|454669034|FG000|Overall Study|subject moved|3|||
126374442|NCT00783432|454669035|FG001|Overall Study|subject moved|5|||
126374443|NCT00783432|454669034|FG000|Overall Study|Protocol Violation|6|||
126374444|NCT00783432|454669035|FG001|Overall Study|Protocol Violation|9|||
126374445|NCT03273907|454669036|FG000|Overall Study|Death|1|||
126374446|NCT03273907|454669036|FG000|Overall Study|Lost to Follow-up|4|||
126374447|NCT03273907|454669036|FG000|Overall Study|Withdrawal by Subject|2|||
126374448|NCT03273907|454669036|FG000|Overall Study|COVID 19|2|||
126374449|NCT00110214|454669037|FG000|Overall Study|Never started treatment|21|||
126374450|NCT00110214|454669038|FG001|Overall Study|Never started treatment|20|||
126374451|NCT00110214|454669037|FG000|Overall Study|Disease progression or death|260|||
126374452|NCT00110214|454669038|FG001|Overall Study|Disease progression or death|151|||
126374453|NCT00110214|454669037|FG000|Overall Study|Adverse Event|115|||
126374454|NCT00110214|454669038|FG001|Overall Study|Adverse Event|192|||
126374455|NCT00110214|454669037|FG000|Overall Study|Refused further treatment|52|||
126374456|NCT00110214|454669038|FG001|Overall Study|Refused further treatment|65|||
126374457|NCT00110214|454669037|FG000|Overall Study|Other (not specified)|61|||
126374458|NCT00110214|454669038|FG001|Overall Study|Other (not specified)|75|||
126374459|NCT02581891|454669039|FG000|Overall Study|Adverse Event|4|||
126374460|NCT02581891|454669040|FG001|Overall Study|Adverse Event|6|||
126374461|NCT02581891|454669039|FG000|Overall Study|Death|3|||
126374462|NCT02581891|454669040|FG001|Overall Study|Death|4|||
126374463|NCT02581891|454669039|FG000|Overall Study|Lost to Follow-up|1|||
126374464|NCT02581891|454669040|FG001|Overall Study|Lost to Follow-up|2|||
126374465|NCT02581891|454669039|FG000|Overall Study|Physician Decision|0|||
126374466|NCT02581891|454669040|FG001|Overall Study|Physician Decision|1|||
126374467|NCT02581891|454669039|FG000|Overall Study|Withdrawal by Subject|4|||
126374468|NCT02581891|454669040|FG001|Overall Study|Withdrawal by Subject|5|||
126374469|NCT02581891|454669039|FG000|Overall Study|Other Reasons|3|||
126374470|NCT02581891|454669040|FG001|Overall Study|Other Reasons|1|||
126374471|NCT02581891|454669039|FG000|Overall Study|Discontinued during followup|1|||
126374472|NCT02581891|454669040|FG001|Overall Study|Discontinued during followup|0|||
126374473|NCT05518461|454669045|FG000|Overall Study|Lost to Follow-up|25|||
126374474|NCT03179761|454669046|FG000|Overall Study|Death|2|||
126374475|NCT03179761|454669047|FG001|Overall Study|Death|5|||
126374476|NCT03179761|454669046|FG000|Overall Study|Lost to Follow-up|2|||
126374477|NCT03179761|454669047|FG001|Overall Study|Lost to Follow-up|2|||
126374478|NCT03179761|454669046|FG000|Overall Study|Protocol Violation|1|||
126374479|NCT03179761|454669047|FG001|Overall Study|Protocol Violation|0|||
126104068|NCT01440374|453675799|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
126374480|NCT03179761|454669046|FG000|Overall Study|Withdrawal by Subject|1|||
126374481|NCT03179761|454669047|FG001|Overall Study|Withdrawal by Subject|4|||
126374482|NCT03179761|454669046|FG000|Overall Study|Investigator Request|0|||
126374483|NCT03179761|454669047|FG001|Overall Study|Investigator Request|2|||
126374484|NCT00448448|454669049|FG000|Overall Study|Withdrawal by Subject|13|||
126374485|NCT00448448|454669050|FG001|Overall Study|Withdrawal by Subject|2|||
126374486|NCT00448448|454669049|FG000|Overall Study|On protocol when study ended|83|||
126374487|NCT00448448|454669050|FG001|Overall Study|On protocol when study ended|36|||
126374488|NCT00448448|454669049|FG000|Overall Study|Lost to Follow-up|2|||
126374489|NCT00448448|454669050|FG001|Overall Study|Lost to Follow-up|1|||
126374490|NCT00448448|454669049|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
126374491|NCT00448448|454669050|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
126374492|NCT00448448|454669049|FG000|Overall Study|Signed consent lost|0|||
126374493|NCT00448448|454669050|FG001|Overall Study|Signed consent lost|1|||
126374494|NCT02284191|454669051|FG000|Overall Study|Withdrawal by Subject|1|||
126374495|NCT02284191|454669052|FG001|Overall Study|Withdrawal by Subject|3|||
126374496|NCT02284191|454669051|FG000|Overall Study|Lost to Follow-up|1|||
126374497|NCT02284191|454669052|FG001|Overall Study|Lost to Follow-up|0|||
126374498|NCT01188967|454669053|FG000|Overall Study|Withdrawal by Subject|1|||
126374499|NCT01188967|454669054|FG001|Overall Study|Withdrawal by Subject|1|||
126374500|NCT01188967|454669053|FG000|Overall Study|Physician Decision|1|||
126374501|NCT01188967|454669054|FG001|Overall Study|Physician Decision|1|||
126374502|NCT01188967|454669053|FG000|Overall Study|Lost to Follow-up|3|||
126374503|NCT01188967|454669054|FG001|Overall Study|Lost to Follow-up|2|||
126374504|NCT01832727|454669059|FG000|Overall Study|Adverse Event|4|||
126374505|NCT01832727|454669060|FG001|Overall Study|Adverse Event|6|||
126374506|NCT01832727|454669061|FG002|Overall Study|Adverse Event|1|||
126374507|NCT01832727|454669062|FG003|Overall Study|Adverse Event|0|||
126374508|NCT01832727|454669063|FG004|Overall Study|Adverse Event|1|||
126374509|NCT01832727|454669064|FG005|Overall Study|Adverse Event|1|||
126374510|NCT01832727|454669065|FG006|Overall Study|Adverse Event|2|||
126374511|NCT01832727|454669066|FG007|Overall Study|Adverse Event|1|||
126374512|NCT01832727|454669067|FG008|Overall Study|Adverse Event|9|||
126374513|NCT01832727|454669059|FG000|Overall Study|Disease progression|3|||
126374514|NCT01832727|454669060|FG001|Overall Study|Disease progression|0|||
126374515|NCT01832727|454669061|FG002|Overall Study|Disease progression|2|||
126374516|NCT01832727|454669062|FG003|Overall Study|Disease progression|1|||
126374517|NCT01832727|454669063|FG004|Overall Study|Disease progression|3|||
126374518|NCT01832727|454669064|FG005|Overall Study|Disease progression|3|||
126374519|NCT01832727|454669065|FG006|Overall Study|Disease progression|6|||
126374520|NCT01832727|454669066|FG007|Overall Study|Disease progression|2|||
126374521|NCT01832727|454669067|FG008|Overall Study|Disease progression|7|||
126374522|NCT01832727|454669059|FG000|Overall Study|Lost to Follow-up|0|||
126374523|NCT01832727|454669060|FG001|Overall Study|Lost to Follow-up|0|||
126374524|NCT01832727|454669061|FG002|Overall Study|Lost to Follow-up|0|||
126374525|NCT01832727|454669062|FG003|Overall Study|Lost to Follow-up|1|||
126374526|NCT01832727|454669063|FG004|Overall Study|Lost to Follow-up|0|||
126374527|NCT01832727|454669064|FG005|Overall Study|Lost to Follow-up|0|||
126374528|NCT01832727|454669065|FG006|Overall Study|Lost to Follow-up|0|||
126374529|NCT01832727|454669066|FG007|Overall Study|Lost to Follow-up|0|||
126374530|NCT01832727|454669067|FG008|Overall Study|Lost to Follow-up|0|||
126374531|NCT01832727|454669059|FG000|Overall Study|Physician Decision|1|||
126374532|NCT01832727|454669060|FG001|Overall Study|Physician Decision|0|||
126374533|NCT01832727|454669061|FG002|Overall Study|Physician Decision|0|||
126374534|NCT01832727|454669062|FG003|Overall Study|Physician Decision|1|||
126374535|NCT01832727|454669063|FG004|Overall Study|Physician Decision|0|||
126374536|NCT01832727|454669064|FG005|Overall Study|Physician Decision|1|||
126374537|NCT01832727|454669065|FG006|Overall Study|Physician Decision|0|||
126374538|NCT01832727|454669066|FG007|Overall Study|Physician Decision|0|||
126374539|NCT01832727|454669067|FG008|Overall Study|Physician Decision|0|||
126374540|NCT01832727|454669059|FG000|Overall Study|Withdrawal by Subject|1|||
126374541|NCT01832727|454669060|FG001|Overall Study|Withdrawal by Subject|1|||
126374542|NCT01832727|454669061|FG002|Overall Study|Withdrawal by Subject|0|||
126374543|NCT01832727|454669062|FG003|Overall Study|Withdrawal by Subject|1|||
126374544|NCT01832727|454669063|FG004|Overall Study|Withdrawal by Subject|0|||
126374545|NCT01832727|454669064|FG005|Overall Study|Withdrawal by Subject|1|||
126374546|NCT01832727|454669065|FG006|Overall Study|Withdrawal by Subject|0|||
126104069|NCT01440374|453675800|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
126374547|NCT01832727|454669066|FG007|Overall Study|Withdrawal by Subject|2|||
126374548|NCT01832727|454669067|FG008|Overall Study|Withdrawal by Subject|1|||
126374549|NCT01832727|454669059|FG000|Overall Study|Study terminated by sponsor|0|||
126374550|NCT01832727|454669060|FG001|Overall Study|Study terminated by sponsor|0|||
126374551|NCT01832727|454669061|FG002|Overall Study|Study terminated by sponsor|0|||
126374552|NCT01832727|454669062|FG003|Overall Study|Study terminated by sponsor|0|||
126374553|NCT01832727|454669063|FG004|Overall Study|Study terminated by sponsor|0|||
126374554|NCT01832727|454669064|FG005|Overall Study|Study terminated by sponsor|0|||
126374555|NCT01832727|454669065|FG006|Overall Study|Study terminated by sponsor|0|||
126374556|NCT01832727|454669066|FG007|Overall Study|Study terminated by sponsor|1|||
126374557|NCT01832727|454669067|FG008|Overall Study|Study terminated by sponsor|1|||
126374558|NCT04436744|454669074|FG000|Overall Study|Adverse Event|1|||
126374559|NCT04436744|454669075|FG001|Overall Study|Adverse Event|1|||
126374560|NCT04436744|454669074|FG000|Overall Study|Death|1|||
126374561|NCT04436744|454669075|FG001|Overall Study|Death|0|||
126374562|NCT04436744|454669074|FG000|Overall Study|Lost to Follow-up|0|||
126374563|NCT04436744|454669075|FG001|Overall Study|Lost to Follow-up|2|||
126374564|NCT04436744|454669074|FG000|Overall Study|Physician Decision|0|||
126374565|NCT04436744|454669075|FG001|Overall Study|Physician Decision|1|||
126374566|NCT04436744|454669074|FG000|Overall Study|Progressive Disease|0|||
126374567|NCT04436744|454669075|FG001|Overall Study|Progressive Disease|4|||
126374568|NCT04436744|454669074|FG000|Overall Study|Protocol Deviation|1|||
126374569|NCT04436744|454669075|FG001|Overall Study|Protocol Deviation|1|||
126374570|NCT04436744|454669074|FG000|Overall Study|Withdrawal by Subject|1|||
126374571|NCT04436744|454669075|FG001|Overall Study|Withdrawal by Subject|2|||
126374572|NCT01133847|454669076|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
126374573|NCT01133847|454669077|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
126374574|NCT01133847|454669078|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
126374575|NCT01133847|454669076|FG000|Follow-Up Phase|Lost to Follow-up|1|||
126374576|NCT01133847|454669077|FG001|Follow-Up Phase|Lost to Follow-up|3|||
126374577|NCT01133847|454669078|FG002|Follow-Up Phase|Lost to Follow-up|7|||
126374578|NCT01463033|454669079|FG000|Overall Study|Lost to Follow-up|4|||
126374579|NCT01463033|454669080|FG001|Overall Study|Lost to Follow-up|4|||
126374580|NCT01463033|454669079|FG000|Overall Study|Death|3|||
126374581|NCT01463033|454669080|FG001|Overall Study|Death|2|||
126374582|NCT00967616|454669081|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
126374583|NCT00967616|454669082|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
126374584|NCT00967616|454669081|FG000|Overall Study|Death|0|||
126374585|NCT00967616|454669082|FG001|Overall Study|Death|3|||
126374586|NCT00967616|454669081|FG000|Overall Study|Withdrawal by Subject|8|||
126374587|NCT00967616|454669082|FG001|Overall Study|Withdrawal by Subject|4|||
126374588|NCT00967616|454669081|FG000|Overall Study|Progressive Disease|31|||
126374589|NCT00967616|454669082|FG001|Overall Study|Progressive Disease|18|||
126374590|NCT00967616|454669081|FG000|Overall Study|Other|8|||
126374591|NCT00967616|454669082|FG001|Overall Study|Other|8|||
126374592|NCT00967616|454669081|FG000|Overall Study|Protocol Violation|1|||
126374593|NCT00967616|454669082|FG001|Overall Study|Protocol Violation|0|||
126374594|NCT01368614|454669083|FG000|Screening Period|Screen Failure|58|||
126374595|NCT01368614|454669084|FG001|Screening Period|Screen Failure|0|||
126374596|NCT01368614|454669085|FG002|Screening Period|Screen Failure|0|||
126374597|NCT01368614|454669086|FG003|Screening Period|Screen Failure|0|||
126374598|NCT01368614|454669083|FG000|Study Period|Withdrawal by Subject|0|||
126374599|NCT01368614|454669084|FG001|Study Period|Withdrawal by Subject|1|||
126374600|NCT01368614|454669085|FG002|Study Period|Withdrawal by Subject|1|||
126374601|NCT01368614|454669086|FG003|Study Period|Withdrawal by Subject|3|||
126374602|NCT01368614|454669083|FG000|Study Period|Lost to Follow-up|0|||
126374603|NCT01368614|454669084|FG001|Study Period|Lost to Follow-up|0|||
126374604|NCT01368614|454669085|FG002|Study Period|Lost to Follow-up|1|||
126374605|NCT01368614|454669086|FG003|Study Period|Lost to Follow-up|0|||
126374606|NCT02951780|454669087|FG000|Period 1|Adverse Event|0|||
126374607|NCT02951780|454669088|FG001|Period 1|Adverse Event|0|||
126374608|NCT02951780|454669089|FG002|Period 1|Adverse Event|0|||
126374609|NCT02951780|454669090|FG003|Period 1|Adverse Event|1|||
126374610|NCT02951780|454669091|FG004|Period 1|Adverse Event|0|||
126374611|NCT02951780|454669092|FG005|Period 1|Adverse Event|0|||
126374612|NCT02951780|454669093|FG006|Period 1|Adverse Event|0|||
126374613|NCT02951780|454669094|FG007|Period 1|Adverse Event|0|||
126374614|NCT02951780|454669095|FG008|Period 1|Adverse Event|0|||
126374615|NCT02951780|454669087|FG000|Period 1|Scheduling Conflicts|0|||
126374616|NCT02951780|454669088|FG001|Period 1|Scheduling Conflicts|0|||
126374617|NCT02951780|454669089|FG002|Period 1|Scheduling Conflicts|0|||
126374618|NCT02951780|454669090|FG003|Period 1|Scheduling Conflicts|0|||
126374619|NCT02951780|454669091|FG004|Period 1|Scheduling Conflicts|0|||
126374620|NCT02951780|454669092|FG005|Period 1|Scheduling Conflicts|0|||
126374621|NCT02951780|454669093|FG006|Period 1|Scheduling Conflicts|0|||
126374622|NCT02951780|454669094|FG007|Period 1|Scheduling Conflicts|1|||
126374623|NCT02951780|454669095|FG008|Period 1|Scheduling Conflicts|0|||
126374624|NCT02951780|454669087|FG000|Period 2|Scheduling Conflicts|0|||
126374625|NCT02951780|454669088|FG001|Period 2|Scheduling Conflicts|0|||
126374626|NCT02951780|454669089|FG002|Period 2|Scheduling Conflicts|0|||
126374627|NCT02951780|454669090|FG003|Period 2|Scheduling Conflicts|0|||
126047914|NCT05786612|453472960|FG001|Overall Study|Adverse Event|2|||
126374628|NCT02951780|454669091|FG004|Period 2|Scheduling Conflicts|0|||
126374629|NCT02951780|454669092|FG005|Period 2|Scheduling Conflicts|0|||
126374630|NCT02951780|454669093|FG006|Period 2|Scheduling Conflicts|0|||
126374631|NCT02951780|454669094|FG007|Period 2|Scheduling Conflicts|1|||
126374632|NCT02951780|454669095|FG008|Period 2|Scheduling Conflicts|0|||
126374633|NCT01374425|454669096|FG000|Overall Study|Radiographic Disease Progression|86|||
126374634|NCT01374425|454669097|FG001|Overall Study|Radiographic Disease Progression|81|||
126374635|NCT01374425|454669096|FG000|Overall Study|Clinical Disease Progression|9|||
126374636|NCT01374425|454669097|FG001|Overall Study|Clinical Disease Progression|6|||
126374637|NCT01374425|454669096|FG000|Overall Study|Adverse Event|29|||
126374638|NCT01374425|454669097|FG001|Overall Study|Adverse Event|18|||
126374639|NCT01374425|454669096|FG000|Overall Study|Death (Progression of Disease)|1|||
126374640|NCT01374425|454669097|FG001|Overall Study|Death (Progression of Disease)|0|||
126374641|NCT01374425|454669096|FG000|Overall Study|Death (Adverse Event)|2|||
126374642|NCT01374425|454669097|FG001|Overall Study|Death (Adverse Event)|4|||
126374643|NCT01374425|454669096|FG000|Overall Study|Withdrawal by Subject|6|||
126374644|NCT01374425|454669097|FG001|Overall Study|Withdrawal by Subject|7|||
126374645|NCT01374425|454669096|FG000|Overall Study|Refused Treatment|10|||
126374646|NCT01374425|454669097|FG001|Overall Study|Refused Treatment|24|||
126374647|NCT01374425|454669096|FG000|Overall Study|Protocol Violation|2|||
126374648|NCT01374425|454669097|FG001|Overall Study|Protocol Violation|3|||
126374649|NCT01374425|454669096|FG000|Overall Study|Sponsor Decision|0|||
126374650|NCT01374425|454669097|FG001|Overall Study|Sponsor Decision|1|||
126374651|NCT01374425|454669096|FG000|Overall Study|Lost to Follow-up|2|||
126374652|NCT01374425|454669097|FG001|Overall Study|Lost to Follow-up|1|||
126374653|NCT01374425|454669096|FG000|Overall Study|Other|41|||
126374654|NCT01374425|454669097|FG001|Overall Study|Other|43|||
126374655|NCT02359903|454669098|FG000|Overall Study|Adverse Event|0|||
126374656|NCT02359903|454669099|FG001|Overall Study|Adverse Event|2|||
126374657|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
126374658|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
126374659|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
126374660|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
126374661|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
126374662|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
126374663|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
126374664|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
126374665|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
126374666|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
126374667|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
126374668|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
126374669|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
126374670|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
126374671|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
126374672|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
126374673|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
126374674|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
126374675|NCT00546481|454669100|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
126374676|NCT00546481|454669101|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
126374677|NCT00546481|454669102|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
126374678|NCT00546481|454669100|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
126374679|NCT00546481|454669101|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
126374680|NCT00546481|454669102|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
126374681|NCT00546481|454669100|FG000|Maintenance Phase (CERA)|Other Reason|0|||
126047915|NCT05786612|453472959|FG000|Overall Study|one screening failure|0|||
126374682|NCT00546481|454669101|FG001|Maintenance Phase (CERA)|Other Reason|0|||
126374683|NCT00546481|454669102|FG002|Maintenance Phase (CERA)|Other Reason|1|||
126374684|NCT01240863|454669105|FG000|Open-label Titration Period|Adverse Event|47|||
126374685|NCT01240863|454669106|FG001|Open-label Titration Period|Adverse Event|0|||
126374686|NCT01240863|454669107|FG002|Open-label Titration Period|Adverse Event|0|||
126374687|NCT01240863|454669105|FG000|Open-label Titration Period|Lack of Efficacy|19|||
126374688|NCT01240863|454669106|FG001|Open-label Titration Period|Lack of Efficacy|0|||
126374689|NCT01240863|454669107|FG002|Open-label Titration Period|Lack of Efficacy|0|||
126374690|NCT01240863|454669105|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
126374691|NCT01240863|454669106|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
126374692|NCT01240863|454669107|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
126374693|NCT01240863|454669105|FG000|Open-label Titration Period|Protocol Violation|7|||
126374694|NCT01240863|454669106|FG001|Open-label Titration Period|Protocol Violation|0|||
126374695|NCT01240863|454669107|FG002|Open-label Titration Period|Protocol Violation|0|||
126374696|NCT01240863|454669105|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
126374697|NCT01240863|454669106|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
126374698|NCT01240863|454669107|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
126374699|NCT01240863|454669105|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
126374700|NCT01240863|454669106|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
126374701|NCT01240863|454669107|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
126374702|NCT01240863|454669105|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
126374703|NCT01240863|454669106|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
126374704|NCT01240863|454669107|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
126374705|NCT01240863|454669105|FG000|Open-label Titration Period|Other|7|||
126374706|NCT01240863|454669106|FG001|Open-label Titration Period|Other|0|||
126374707|NCT01240863|454669107|FG002|Open-label Titration Period|Other|0|||
126374708|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
126374709|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
126374710|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
126374711|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126374712|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
125886247|NCT02581410|452878964|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
125886248|NCT02581410|452878965|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
125886249|NCT06083506|452878971|FG000|Overall Study|Physician Decision|2|||
125886250|NCT06083506|452878971|FG000|Overall Study|Lack of Efficacy|1|||
125886251|NCT02000115|452878972|FG000|Overall Study|Death|56|||
126374713|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
126374714|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126374715|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
126374716|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
126374717|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
126374718|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
125886252|NCT02000115|452878973|FG001|Overall Study|Death|45|||
125886253|NCT02000115|452878974|FG002|Overall Study|Death|0|||
125886254|NCT02000115|452878975|FG003|Overall Study|Death|0|||
125886255|NCT02000115|452878972|FG000|Overall Study|Missed Visit|6|||
125886256|NCT02000115|452878973|FG001|Overall Study|Missed Visit|8|||
125886257|NCT02000115|452878974|FG002|Overall Study|Missed Visit|1|||
125886258|NCT02000115|452878975|FG003|Overall Study|Missed Visit|0|||
125886259|NCT02000115|452878972|FG000|Overall Study|Protocol Violation|2|||
126104070|NCT01440374|453675801|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
126104071|NCT01440374|453675798|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
126104072|NCT01440374|453675799|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
126104073|NCT01440374|453675800|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
126104074|NCT01440374|453675801|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
126104075|NCT01440374|453675798|FG000|Part 2; Double-blind Phase|Not treated|0|||
126104076|NCT01440374|453675799|FG001|Part 2; Double-blind Phase|Not treated|0|||
126104077|NCT01440374|453675800|FG002|Part 2; Double-blind Phase|Not treated|1|||
126104078|NCT01440374|453675801|FG003|Part 2; Double-blind Phase|Not treated|0|||
126104079|NCT01440374|453675798|FG000|Part 3: Extension|Withdrawal by Subject|0|||
126104080|NCT01440374|453675799|FG001|Part 3: Extension|Withdrawal by Subject|0|||
126104081|NCT01440374|453675800|FG002|Part 3: Extension|Withdrawal by Subject|0|||
126104082|NCT01440374|453675801|FG003|Part 3: Extension|Withdrawal by Subject|5|||
126104083|NCT01440374|453675798|FG000|Part 3: Extension|Adverse Event|0|||
126104084|NCT01440374|453675799|FG001|Part 3: Extension|Adverse Event|0|||
126104085|NCT01440374|453675800|FG002|Part 3: Extension|Adverse Event|0|||
126104086|NCT01440374|453675801|FG003|Part 3: Extension|Adverse Event|13|||
126104087|NCT01440374|453675798|FG000|Part 3: Extension|Physician Decision|0|||
126104088|NCT01440374|453675799|FG001|Part 3: Extension|Physician Decision|0|||
126104089|NCT01440374|453675800|FG002|Part 3: Extension|Physician Decision|0|||
126104090|NCT01440374|453675801|FG003|Part 3: Extension|Physician Decision|14|||
125886260|NCT02000115|452878973|FG001|Overall Study|Protocol Violation|1|||
125886261|NCT02000115|452878974|FG002|Overall Study|Protocol Violation|0|||
125886262|NCT02000115|452878975|FG003|Overall Study|Protocol Violation|0|||
125886263|NCT02000115|452878972|FG000|Overall Study|Physician Decision|2|||
125886264|NCT02000115|452878973|FG001|Overall Study|Physician Decision|0|||
125886265|NCT02000115|452878974|FG002|Overall Study|Physician Decision|0|||
125886266|NCT02000115|452878975|FG003|Overall Study|Physician Decision|0|||
125886267|NCT02000115|452878972|FG000|Overall Study|Withdrawal by Subject|11|||
125886268|NCT02000115|452878973|FG001|Overall Study|Withdrawal by Subject|11|||
125886269|NCT02000115|452878974|FG002|Overall Study|Withdrawal by Subject|0|||
126374719|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
126374720|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
126374721|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
126374722|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
126374723|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
126374724|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
126374725|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
126374726|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
126374727|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
126374728|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
126374729|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
126374730|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
126374731|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
126374732|NCT03783780|454669112|FG000|Overall Study|Withdrawn prior to completion|1|||
126374733|NCT03768427|454669113|FG000|Overall Study|Death|0|||
126374734|NCT03768427|454669114|FG001|Overall Study|Death|0|||
126374735|NCT03768427|454669115|FG002|Overall Study|Death|1|||
126374736|NCT03768427|454669116|FG003|Overall Study|Death|0|||
126374737|NCT03768427|454669113|FG000|Overall Study|Lost to Follow-up|2|||
126374738|NCT03768427|454669114|FG001|Overall Study|Lost to Follow-up|0|||
126374739|NCT03768427|454669115|FG002|Overall Study|Lost to Follow-up|0|||
126374740|NCT03768427|454669116|FG003|Overall Study|Lost to Follow-up|0|||
126374741|NCT03768427|454669113|FG000|Overall Study|Physician Decision|3|||
126374742|NCT03768427|454669114|FG001|Overall Study|Physician Decision|2|||
126374743|NCT03768427|454669115|FG002|Overall Study|Physician Decision|4|||
126374744|NCT03768427|454669116|FG003|Overall Study|Physician Decision|4|||
126374745|NCT03768427|454669113|FG000|Overall Study|Withdrawal by Subject|7|||
126374746|NCT03768427|454669114|FG001|Overall Study|Withdrawal by Subject|2|||
126374747|NCT03768427|454669115|FG002|Overall Study|Withdrawal by Subject|6|||
126374748|NCT03768427|454669116|FG003|Overall Study|Withdrawal by Subject|7|||
126374749|NCT00776789|454669117|FG000|Overall Study|Consent refusal|2|||
126374750|NCT00776789|454669118|FG001|Overall Study|Consent refusal|2|||
126374751|NCT00776789|454669117|FG000|Overall Study|Poor quality video|1|||
126374752|NCT00776789|454669118|FG001|Overall Study|Poor quality video|1|||
126374753|NCT02629861|454669124|FG000|Overall Study|Adverse Event|7|||
126374754|NCT02629861|454669125|FG001|Overall Study|Adverse Event|5|||
126374755|NCT02629861|454669126|FG002|Overall Study|Adverse Event|4|||
126374756|NCT02629861|454669124|FG000|Overall Study|Withdrawal by Subject|5|||
126374757|NCT02629861|454669125|FG001|Overall Study|Withdrawal by Subject|8|||
126374758|NCT02629861|454669126|FG002|Overall Study|Withdrawal by Subject|13|||
126374759|NCT02629861|454669124|FG000|Overall Study|Protocol Violation|2|||
126374760|NCT02629861|454669125|FG001|Overall Study|Protocol Violation|3|||
126374761|NCT02629861|454669126|FG002|Overall Study|Protocol Violation|7|||
126374762|NCT02629861|454669124|FG000|Overall Study|Lost to Follow-up|12|||
126374763|NCT02629861|454669125|FG001|Overall Study|Lost to Follow-up|9|||
126374764|NCT02629861|454669126|FG002|Overall Study|Lost to Follow-up|4|||
126374765|NCT02629861|454669124|FG000|Overall Study|Other|1|||
126374766|NCT02629861|454669125|FG001|Overall Study|Other|1|||
126374767|NCT02629861|454669126|FG002|Overall Study|Other|0|||
126374768|NCT02629861|454669124|FG000|Overall Study|Pregnancy|2|||
126374769|NCT02629861|454669125|FG001|Overall Study|Pregnancy|1|||
126374770|NCT02629861|454669126|FG002|Overall Study|Pregnancy|0|||
126374771|NCT00907621|454669130|FG000|Overall Study|Lost to Follow-up|6|||
126374772|NCT00907621|454669131|FG001|Overall Study|Lost to Follow-up|3|||
126374773|NCT00907621|454669130|FG000|Overall Study|intercurrent febrile illness|1|||
126374774|NCT00907621|454669131|FG001|Overall Study|intercurrent febrile illness|1|||
126374775|NCT00902330|454669134|FG000|Overall Study|Too overwhelmed by treatment|2|||
126374776|NCT00902330|454669135|FG001|Overall Study|Too overwhelmed by treatment|5|||
125886270|NCT02000115|452878975|FG003|Overall Study|Withdrawal by Subject|0|||
126374777|NCT00902330|454669134|FG000|Overall Study|Adverse Event|1|||
126374778|NCT00902330|454669135|FG001|Overall Study|Adverse Event|0|||
126374779|NCT00902330|454669134|FG000|Overall Study|No post baseline data|1|||
126374780|NCT00902330|454669135|FG001|Overall Study|No post baseline data|0|||
126374781|NCT00165789|454669136|FG000|Overall Study|Adverse Event|0|||
126374782|NCT00165789|454669137|FG001|Overall Study|Adverse Event|3|||
126374783|NCT00165789|454669138|FG002|Overall Study|Adverse Event|0|||
126374784|NCT00165789|454669139|FG003|Overall Study|Adverse Event|12|||
126374785|NCT00165789|454669136|FG000|Overall Study|Withdrawal by Subject|0|||
125886271|NCT02000115|452878972|FG000|Overall Study|Lost to Follow-up|0|||
126374786|NCT00165789|454669137|FG001|Overall Study|Withdrawal by Subject|1|||
126374787|NCT00165789|454669138|FG002|Overall Study|Withdrawal by Subject|1|||
126374788|NCT00165789|454669139|FG003|Overall Study|Withdrawal by Subject|2|||
126374789|NCT01816048|454669140|FG000|Overall Study|Adverse Event|1|||
126374790|NCT01816048|454669140|FG000|Overall Study|Death|1|||
126374791|NCT01816048|454669140|FG000|Overall Study|Withdrawal by Subject|1|||
126374792|NCT01816048|454669140|FG000|Overall Study|Disease Progression|3|||
126374793|NCT04290624|454669141|FG000|Overall Study|Adverse Event|1|||
126374794|NCT04290624|454669142|FG001|Overall Study|Adverse Event|0|||
126374795|NCT00656370|454669147|FG000|Overall Study|Screen Failures|7|||
126374796|NCT00656370|454669147|FG000|Overall Study|Alternates|3|||
126374797|NCT01816984|454669148|FG000|Overall Study|declining health status|1|||
126374798|NCT01342094|454669151|FG000|Overall Study|Adverse Event|5|||
126374799|NCT01342094|454669152|FG001|Overall Study|Adverse Event|0|||
126374800|NCT01342094|454669151|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126374801|NCT01342094|454669152|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126374802|NCT01342094|454669151|FG000|Overall Study|Withdrawal by Subject|0|||
126374803|NCT01342094|454669152|FG001|Overall Study|Withdrawal by Subject|2|||
126374804|NCT02121509|454669153|FG000|Washout Period (35 Days)|Adverse Event|1|||
126374805|NCT02121509|454669154|FG001|Washout Period (35 Days)|Adverse Event|1|||
126374806|NCT02121509|454669155|FG002|Washout Period (35 Days)|Adverse Event|0|||
126374807|NCT02121509|454669156|FG003|Washout Period (35 Days)|Adverse Event|0|||
126374808|NCT02121509|454669153|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
126374809|NCT02121509|454669154|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
126374810|NCT02121509|454669155|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
126374811|NCT02121509|454669156|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
126374812|NCT02121509|454669153|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
126374813|NCT02121509|454669154|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
126374814|NCT02121509|454669155|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
126374815|NCT02121509|454669156|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
126374816|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
126374817|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
126374818|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
126374819|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
126374820|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
126374821|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
126374822|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
126374823|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
126374824|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
126374825|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
126374826|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
126374827|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
126374828|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
126374829|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
126374830|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
126374831|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
126374832|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
126374833|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
126374834|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
126374835|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
126374836|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
126374837|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
126374838|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
126374839|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
126374840|NCT04021290|454669163|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
126374841|NCT04021290|454669164|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
126374842|NCT04021290|454669165|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
126374843|NCT04021290|454669163|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
126374844|NCT04021290|454669164|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
126374845|NCT04021290|454669165|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
126374846|NCT04021290|454669163|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
126374847|NCT04021290|454669164|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
126374848|NCT04021290|454669165|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
126374849|NCT04021290|454669163|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
126374850|NCT04021290|454669164|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
126374851|NCT04021290|454669165|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
126374852|NCT00636181|454669166|FG000|Overall Study|Withdrawal by Subject|8|||
126374853|NCT00636181|454669167|FG001|Overall Study|Withdrawal by Subject|6|||
126374854|NCT00636181|454669168|FG002|Overall Study|Withdrawal by Subject|10|||
126047916|NCT05786612|453472960|FG001|Overall Study|one screening failure|2|||
125886272|NCT02000115|452878973|FG001|Overall Study|Lost to Follow-up|1|||
125886273|NCT02000115|452878974|FG002|Overall Study|Lost to Follow-up|0|||
125886274|NCT02000115|452878975|FG003|Overall Study|Lost to Follow-up|0|||
125886275|NCT02000115|452878972|FG000|Overall Study|Non-compliance|2|||
125886276|NCT02000115|452878973|FG001|Overall Study|Non-compliance|1|||
125886277|NCT02000115|452878974|FG002|Overall Study|Non-compliance|0|||
125886278|NCT02000115|452878975|FG003|Overall Study|Non-compliance|0|||
125886279|NCT02000115|452878972|FG000|Overall Study|Withdrawn on day of randomization|0|||
125886280|NCT02000115|452878973|FG001|Overall Study|Withdrawn on day of randomization|1|||
125886281|NCT02000115|452878974|FG002|Overall Study|Withdrawn on day of randomization|0|||
126047917|NCT04926740|453472961|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
126047918|NCT04926740|453472962|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
126047919|NCT04926740|453472961|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
126047920|NCT04926740|453472962|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
126374855|NCT03069716|454669171|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
126374856|NCT03069716|454669172|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
126374857|NCT03069716|454669173|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
126374858|NCT03069716|454669171|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
126374859|NCT03069716|454669172|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
126374860|NCT03069716|454669173|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
126374861|NCT03069716|454669171|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
126374862|NCT03069716|454669172|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
126374863|NCT03069716|454669173|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
126374864|NCT03069716|454669171|FG000|Randomized Treatment|Withdrawal by Subject|0|||
126374865|NCT03069716|454669172|FG001|Randomized Treatment|Withdrawal by Subject|2|||
126374866|NCT03069716|454669173|FG002|Randomized Treatment|Withdrawal by Subject|0|||
126374867|NCT05076045|454669179|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
126374868|NCT05076045|454669180|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
126374869|NCT03391882|454669181|FG000|Study Overall|Adverse Event|3|||
126374870|NCT03391882|454669182|FG001|Study Overall|Adverse Event|6|||
126374871|NCT03391882|454669183|FG002|Study Overall|Adverse Event|1|||
126374872|NCT03391882|454669184|FG003|Study Overall|Adverse Event|1|||
125886282|NCT02000115|452878975|FG003|Overall Study|Withdrawn on day of randomization|0|||
125886283|NCT02000115|452878972|FG000|Overall Study|Still on Study|0|||
126047921|NCT00655499|453473802|FG000|Overall Study|not eligible|4|||
126047922|NCT03140670|453473808|FG000|Overall Study|Withdrawal by Subject|2|||
126047923|NCT03140670|453473808|FG000|Overall Study|Lost to Follow-up|1|||
126047924|NCT03140670|453473808|FG000|Overall Study|Physician Decision|1|||
126374873|NCT03391882|454669185|FG004|Study Overall|Adverse Event|3|||
126374874|NCT03391882|454669186|FG005|Study Overall|Adverse Event|1|||
126374875|NCT03391882|454669181|FG000|Study Overall|Lack of Efficacy|13|||
126374876|NCT03391882|454669182|FG001|Study Overall|Lack of Efficacy|9|||
126374877|NCT03391882|454669183|FG002|Study Overall|Lack of Efficacy|0|||
126374878|NCT03391882|454669184|FG003|Study Overall|Lack of Efficacy|0|||
126374879|NCT03391882|454669185|FG004|Study Overall|Lack of Efficacy|0|||
126374880|NCT03391882|454669186|FG005|Study Overall|Lack of Efficacy|0|||
126374881|NCT03391882|454669181|FG000|Study Overall|Withdrawal by Subject|3|||
126374882|NCT03391882|454669182|FG001|Study Overall|Withdrawal by Subject|3|||
126374883|NCT03391882|454669183|FG002|Study Overall|Withdrawal by Subject|2|||
126374884|NCT03391882|454669184|FG003|Study Overall|Withdrawal by Subject|2|||
126374885|NCT03391882|454669185|FG004|Study Overall|Withdrawal by Subject|1|||
126374886|NCT03391882|454669186|FG005|Study Overall|Withdrawal by Subject|3|||
126374887|NCT03391882|454669181|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374888|NCT03391882|454669182|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
126374889|NCT03391882|454669183|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374890|NCT03391882|454669184|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374891|NCT03391882|454669185|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374892|NCT03391882|454669186|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374893|NCT03391882|454669181|FG000|Study Overall|Protocol Violation|1|||
126374894|NCT03391882|454669182|FG001|Study Overall|Protocol Violation|0|||
126374895|NCT03391882|454669183|FG002|Study Overall|Protocol Violation|0|||
126374896|NCT03391882|454669184|FG003|Study Overall|Protocol Violation|0|||
126374897|NCT03391882|454669185|FG004|Study Overall|Protocol Violation|0|||
126374898|NCT03391882|454669186|FG005|Study Overall|Protocol Violation|0|||
126374899|NCT03391882|454669181|FG000|Part A - Titration Phase|Adverse Event|3|||
126374900|NCT03391882|454669182|FG001|Part A - Titration Phase|Adverse Event|6|||
126374901|NCT03391882|454669183|FG002|Part A - Titration Phase|Adverse Event|0|||
126374902|NCT03391882|454669184|FG003|Part A - Titration Phase|Adverse Event|0|||
126374903|NCT03391882|454669185|FG004|Part A - Titration Phase|Adverse Event|0|||
126374904|NCT03391882|454669186|FG005|Part A - Titration Phase|Adverse Event|0|||
126374905|NCT03391882|454669181|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
126374906|NCT03391882|454669182|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
126374907|NCT03391882|454669183|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
126374908|NCT03391882|454669184|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
126374909|NCT03391882|454669185|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
126374910|NCT03391882|454669186|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
126374911|NCT03391882|454669181|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
126374912|NCT03391882|454669182|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
126374913|NCT03391882|454669183|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
126374914|NCT03391882|454669184|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
126374915|NCT03391882|454669185|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
126374916|NCT03391882|454669186|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
126374917|NCT03391882|454669181|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374918|NCT03391882|454669182|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
126374919|NCT03391882|454669183|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374920|NCT03391882|454669184|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374921|NCT03391882|454669185|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374922|NCT03391882|454669186|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374923|NCT03391882|454669181|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
126374924|NCT03391882|454669182|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
126374925|NCT03391882|454669183|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
126374926|NCT03391882|454669184|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
126374927|NCT03391882|454669185|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
126374928|NCT03391882|454669186|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
126374929|NCT03391882|454669181|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
126374930|NCT03391882|454669182|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
126374931|NCT03391882|454669183|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
126374932|NCT03391882|454669184|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
126374933|NCT03391882|454669185|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
126374934|NCT03391882|454669186|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
126374935|NCT03391882|454669181|FG000|Part B - Treatment Phase|Adverse Event|0|||
126374936|NCT03391882|454669182|FG001|Part B - Treatment Phase|Adverse Event|0|||
126374937|NCT03391882|454669183|FG002|Part B - Treatment Phase|Adverse Event|1|||
126374938|NCT03391882|454669184|FG003|Part B - Treatment Phase|Adverse Event|1|||
126374939|NCT03391882|454669185|FG004|Part B - Treatment Phase|Adverse Event|3|||
126047925|NCT00220805|453473809|FG000|Overall Study|Adverse Event|1|||
126047926|NCT00220805|453473810|FG001|Overall Study|Adverse Event|3|||
126374940|NCT03391882|454669186|FG005|Part B - Treatment Phase|Adverse Event|1|||
126374941|NCT03391882|454669181|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
126374942|NCT03391882|454669182|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
126374943|NCT03391882|454669183|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
126374944|NCT03391882|454669184|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
126374945|NCT03391882|454669185|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
126374946|NCT03391882|454669186|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
125886284|NCT02000115|452878973|FG001|Overall Study|Still on Study|0|||
126374947|NCT03913130|454669187|FG000|Overall Study|Sponsor Decision|1|||
126374948|NCT01085214|454669190|FG000|Overall Study|Alternate treatment required|1|||
126374949|NCT01634152|454669191|FG000|Overall Study|Adverse Event|2|||
126374950|NCT01634152|454669192|FG001|Overall Study|Adverse Event|0|||
126374951|NCT01634152|454669193|FG002|Overall Study|Adverse Event|2|||
126374952|NCT01634152|454669191|FG000|Overall Study|Consent withdrawn not due to AE|1|||
126374953|NCT01634152|454669192|FG001|Overall Study|Consent withdrawn not due to AE|0|||
126374954|NCT01634152|454669193|FG002|Overall Study|Consent withdrawn not due to AE|1|||
126374955|NCT01634152|454669191|FG000|Overall Study|Not treated|0|||
126374956|NCT01634152|454669192|FG001|Overall Study|Not treated|1|||
126374957|NCT01634152|454669193|FG002|Overall Study|Not treated|0|||
126374958|NCT01634152|454669191|FG000|Overall Study|Other reason not defined above|1|||
126374959|NCT01634152|454669192|FG001|Overall Study|Other reason not defined above|0|||
126374960|NCT01634152|454669193|FG002|Overall Study|Other reason not defined above|1|||
126374961|NCT01985022|454669210|FG000|Overall Study|Lost to Follow-up|0|||
126374962|NCT01985022|454669211|FG001|Overall Study|Lost to Follow-up|1|||
126374963|NCT01985022|454669210|FG000|Overall Study|Protocol Violation|0|||
126374964|NCT01985022|454669211|FG001|Overall Study|Protocol Violation|1|||
126374965|NCT01985022|454669210|FG000|Overall Study|Withdrawal by Subject|4|||
125886285|NCT02000115|452878974|FG002|Overall Study|Still on Study|0|||
125886286|NCT02000115|452878975|FG003|Overall Study|Still on Study|53|||
125886287|NCT03493464|452878980|FG000|Overall Study|Surgery not performed|1|||
125886288|NCT02374450|452878981|FG000|Overall Study|Protocol Violation|0|||
125886289|NCT02374450|452878982|FG001|Overall Study|Protocol Violation|1|||
125886290|NCT02374450|452878983|FG002|Overall Study|Protocol Violation|0|||
126374966|NCT01985022|454669211|FG001|Overall Study|Withdrawal by Subject|1|||
126374967|NCT01152437|454669212|FG000|Overall Study|Other Adverse Event|8|||
126374968|NCT01152437|454669213|FG001|Overall Study|Other Adverse Event|1|||
126374969|NCT01152437|454669214|FG002|Overall Study|Other Adverse Event|7|||
126374970|NCT01152437|454669212|FG000|Overall Study|Not treated|0|||
126374971|NCT01152437|454669213|FG001|Overall Study|Not treated|1|||
126374972|NCT01152437|454669214|FG002|Overall Study|Not treated|2|||
126374973|NCT01152437|454669212|FG000|Overall Study|Progressive disease|27|||
126374974|NCT01152437|454669213|FG001|Overall Study|Progressive disease|13|||
126374975|NCT01152437|454669214|FG002|Overall Study|Progressive disease|32|||
126374976|NCT01152437|454669212|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
126374977|NCT01152437|454669213|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
126374978|NCT01152437|454669214|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
126374979|NCT00279214|454669215|FG000|Overall Study|Physician Decision|3|||
126374980|NCT00279214|454669216|FG001|Overall Study|Physician Decision|2|||
126374981|NCT01214837|454669217|FG000|Overall Study|Death|0|||
126374982|NCT01214837|454669218|FG001|Overall Study|Death|0|||
126374983|NCT01214837|454669219|FG002|Overall Study|Death|1|||
126374984|NCT01214837|454669217|FG000|Overall Study|Adverse Event|1|||
126374985|NCT01214837|454669218|FG001|Overall Study|Adverse Event|2|||
126374986|NCT01214837|454669219|FG002|Overall Study|Adverse Event|1|||
126374987|NCT01214837|454669217|FG000|Overall Study|Withdrawal by Subject|27|||
126374988|NCT01214837|454669218|FG001|Overall Study|Withdrawal by Subject|36|||
126374989|NCT01214837|454669219|FG002|Overall Study|Withdrawal by Subject|28|||
126374990|NCT01214837|454669217|FG000|Overall Study|Lost to Follow-up|20|||
126374991|NCT01214837|454669218|FG001|Overall Study|Lost to Follow-up|15|||
126374992|NCT01214837|454669219|FG002|Overall Study|Lost to Follow-up|21|||
126374993|NCT01214837|454669217|FG000|Overall Study|Inappropriate Enrolment|0|||
126374994|NCT01214837|454669218|FG001|Overall Study|Inappropriate Enrolment|1|||
126374995|NCT01214837|454669219|FG002|Overall Study|Inappropriate Enrolment|2|||
126374996|NCT01214837|454669217|FG000|Overall Study|Administrative Reason|2|||
126374997|NCT01214837|454669218|FG001|Overall Study|Administrative Reason|6|||
126374998|NCT01214837|454669219|FG002|Overall Study|Administrative Reason|4|||
126374999|NCT01214837|454669217|FG000|Overall Study|Protocol Violation|3|||
126375000|NCT01214837|454669218|FG001|Overall Study|Protocol Violation|1|||
126375001|NCT01214837|454669219|FG002|Overall Study|Protocol Violation|5|||
126375002|NCT01214837|454669217|FG000|Overall Study|Unable to Classify|1|||
126375003|NCT01214837|454669218|FG001|Overall Study|Unable to Classify|3|||
126375004|NCT01214837|454669219|FG002|Overall Study|Unable to Classify|0|||
126375005|NCT00457626|454669220|FG000|Overall Study|Adverse Event|3|||
126047927|NCT00220805|453473809|FG000|Overall Study|Withdrawal by Subject|3|||
126047928|NCT00220805|453473810|FG001|Overall Study|Withdrawal by Subject|0|||
126047929|NCT00220805|453473809|FG000|Overall Study|Lack of Efficacy|1|||
126047930|NCT00220805|453473810|FG001|Overall Study|Lack of Efficacy|0|||
126375006|NCT00457626|454669220|FG000|Overall Study|Administrative Problems|2|||
126375007|NCT00457626|454669220|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
126047931|NCT00220805|453473809|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
126047932|NCT00220805|453473810|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
126047933|NCT00146172|453473811|FG000|Overall Study|Adverse Event|0|||
126047934|NCT00146172|453473812|FG001|Overall Study|Adverse Event|0|||
126375008|NCT03549338|454671240|FG000|Overall Study|Progressive Disease|1|||
126375009|NCT03549338|454671241|FG001|Overall Study|Progressive Disease|0|||
126375010|NCT03549338|454671242|FG002|Overall Study|Progressive Disease|0|||
126375011|NCT03549338|454671240|FG000|Overall Study|Clinical Progression|0|||
126375012|NCT03549338|454671241|FG001|Overall Study|Clinical Progression|1|||
126375013|NCT03549338|454671242|FG002|Overall Study|Clinical Progression|0|||
126375014|NCT00652743|454671243|FG000|Months 12-18|Lost to Follow-up|1|||
126375015|NCT00652743|454671244|FG001|Months 12-18|Lost to Follow-up|2|||
126375016|NCT00652743|454671245|FG002|Months 12-18|Lost to Follow-up|7|||
126375017|NCT00652743|454671243|FG000|Months 24-30|Other|5|||
125886291|NCT02374450|452878981|FG000|Overall Study|Withdrawal by Subject|91|||
125886292|NCT02374450|452878982|FG001|Overall Study|Withdrawal by Subject|110|||
126375018|NCT00652743|454671244|FG001|Months 24-30|Other|1|||
126375019|NCT00652743|454671245|FG002|Months 24-30|Other|11|||
126375020|NCT00652743|454671243|FG000|Months 36-42|Serious Adverse Events|0|||
126375021|NCT00652743|454671244|FG001|Months 36-42|Serious Adverse Events|1|||
126375022|NCT00652743|454671245|FG002|Months 36-42|Serious Adverse Events|1|||
126375023|NCT00652743|454671243|FG000|Months 36-42|Withdrawal by Subject|1|||
126375024|NCT00652743|454671244|FG001|Months 36-42|Withdrawal by Subject|1|||
126375025|NCT00652743|454671245|FG002|Months 36-42|Withdrawal by Subject|0|||
126375026|NCT00652743|454671243|FG000|Months 36-42|Lost to Follow-up|0|||
126375027|NCT00652743|454671244|FG001|Months 36-42|Lost to Follow-up|1|||
126375028|NCT00652743|454671245|FG002|Months 36-42|Lost to Follow-up|0|||
126375029|NCT00652743|454671243|FG000|Months 36-42|Migrated/moved from study area|1|||
126375030|NCT00652743|454671244|FG001|Months 36-42|Migrated/moved from study area|0|||
126375031|NCT00652743|454671245|FG002|Months 36-42|Migrated/moved from study area|0|||
126375032|NCT00652743|454671243|FG000|Months 36-42|Other|4|||
126375033|NCT00652743|454671244|FG001|Months 36-42|Other|2|||
126375034|NCT00652743|454671245|FG002|Months 36-42|Other|8|||
126375035|NCT00269113|454671246|FG000|Overall Study|Adverse Event|14|||
126375036|NCT00269113|454671247|FG001|Overall Study|Adverse Event|7|||
126375037|NCT00269113|454671246|FG000|Overall Study|Lack of Efficacy|35|||
126375038|NCT00269113|454671247|FG001|Overall Study|Lack of Efficacy|18|||
126375039|NCT00269113|454671246|FG000|Overall Study|Early Improvement|2|||
126375040|NCT00269113|454671247|FG001|Overall Study|Early Improvement|0|||
126375041|NCT00269113|454671246|FG000|Overall Study|Withdrawal by Subject|0|||
126375042|NCT00269113|454671247|FG001|Overall Study|Withdrawal by Subject|2|||
126375043|NCT00269113|454671246|FG000|Overall Study|Death|6|||
126375044|NCT00269113|454671247|FG001|Overall Study|Death|2|||
126375045|NCT00269113|454671246|FG000|Overall Study|Lost to Follow-up|2|||
126375046|NCT00269113|454671247|FG001|Overall Study|Lost to Follow-up|1|||
126375047|NCT00269113|454671246|FG000|Overall Study|Protocol Violation|15|||
126375048|NCT00269113|454671247|FG001|Overall Study|Protocol Violation|5|||
126375049|NCT00269113|454671246|FG000|Overall Study|Other|0|||
126375050|NCT00269113|454671247|FG001|Overall Study|Other|2|||
126375051|NCT00755807|454671250|FG000|Acute Phase|Adverse Event|16|||
126375052|NCT00755807|454671251|FG001|Acute Phase|Adverse Event|5|||
126375053|NCT00755807|454671250|FG000|Acute Phase|Protocol Violation|1|||
126375054|NCT00755807|454671251|FG001|Acute Phase|Protocol Violation|3|||
126375055|NCT00755807|454671250|FG000|Acute Phase|Withdrawal by Subject|1|||
126375056|NCT00755807|454671251|FG001|Acute Phase|Withdrawal by Subject|2|||
126375057|NCT00755807|454671250|FG000|Acute Phase|Lack of Efficacy|0|||
126375058|NCT00755807|454671251|FG001|Acute Phase|Lack of Efficacy|1|||
126375059|NCT00755807|454671250|FG000|Acute Phase|Physician Decision|0|||
126375060|NCT00755807|454671251|FG001|Acute Phase|Physician Decision|1|||
126375061|NCT00755807|454671250|FG000|Open-label Extension Phase|Adverse Event|7|||
126375062|NCT00755807|454671251|FG001|Open-label Extension Phase|Adverse Event|7|||
126375063|NCT00755807|454671250|FG000|Open-label Extension Phase|Protocol Violation|5|||
126375064|NCT00755807|454671251|FG001|Open-label Extension Phase|Protocol Violation|2|||
126375065|NCT00755807|454671250|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
126375066|NCT00755807|454671251|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
125886293|NCT02374450|452878983|FG002|Overall Study|Withdrawal by Subject|4|||
125886294|NCT02374450|452878981|FG000|Overall Study|Lost to Follow-up|168|||
126375067|NCT00755807|454671250|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
126375068|NCT00755807|454671251|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
126375069|NCT00755807|454671250|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
126375070|NCT00755807|454671251|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
125886295|NCT02374450|452878982|FG001|Overall Study|Lost to Follow-up|194|||
125886296|NCT02374450|452878983|FG002|Overall Study|Lost to Follow-up|138|||
126375071|NCT00755807|454671250|FG000|Open-label Extension Phase|Sponsor Decision|0|||
126375072|NCT00755807|454671251|FG001|Open-label Extension Phase|Sponsor Decision|1|||
126375073|NCT05111145|454671256|FG000|Overall Study|Commercial drug is available for participant|76|||
126047935|NCT00146172|453473813|FG002|Overall Study|Adverse Event|1|||
126047936|NCT00146172|453473814|FG003|Overall Study|Adverse Event|1|||
126047937|NCT00146172|453473815|FG004|Overall Study|Adverse Event|0|||
126047938|NCT00146172|453473816|FG005|Overall Study|Adverse Event|2|||
126047939|NCT00146172|453473817|FG006|Overall Study|Adverse Event|3|||
126047940|NCT00146172|453473818|FG007|Overall Study|Adverse Event|10|||
126047941|NCT00146172|453473811|FG000|Overall Study|Lost to Follow-up|0|||
126047942|NCT00146172|453473812|FG001|Overall Study|Lost to Follow-up|0|||
126047943|NCT00146172|453473813|FG002|Overall Study|Lost to Follow-up|0|||
126047944|NCT00146172|453473814|FG003|Overall Study|Lost to Follow-up|0|||
126047945|NCT00146172|453473815|FG004|Overall Study|Lost to Follow-up|0|||
126047946|NCT00146172|453473816|FG005|Overall Study|Lost to Follow-up|0|||
126375074|NCT05111145|454671256|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
126375075|NCT02336815|454671257|FG000|Overall Study|Disease Progression|45|||
126375076|NCT02336815|454671258|FG001|Overall Study|Disease Progression|70|||
126375077|NCT02336815|454671257|FG000|Overall Study|Adverse Event|18|||
126375078|NCT02336815|454671258|FG001|Overall Study|Adverse Event|39|||
126375079|NCT02336815|454671257|FG000|Overall Study|Physician Decision|11|||
126375080|NCT02336815|454671258|FG001|Overall Study|Physician Decision|4|||
126375081|NCT02336815|454671257|FG000|Overall Study|Withdrawal by Subject|3|||
126375082|NCT02336815|454671258|FG001|Overall Study|Withdrawal by Subject|2|||
126375083|NCT02336815|454671257|FG000|Overall Study|Lost to Follow-up|1|||
126375084|NCT02336815|454671258|FG001|Overall Study|Lost to Follow-up|3|||
126375085|NCT02336815|454671257|FG000|Overall Study|Other|1|||
126375086|NCT02336815|454671258|FG001|Overall Study|Other|5|||
126375087|NCT00952705|454671259|FG000|Overall Study|Lost to Follow-up|24|||
126375088|NCT00952705|454671260|FG001|Overall Study|Lost to Follow-up|8|||
126375089|NCT00952705|454671261|FG002|Overall Study|Lost to Follow-up|9|||
126375090|NCT00952705|454671259|FG000|Overall Study|Withdrawal by Subject|2|||
126375091|NCT00952705|454671260|FG001|Overall Study|Withdrawal by Subject|1|||
126375092|NCT00952705|454671261|FG002|Overall Study|Withdrawal by Subject|1|||
126375093|NCT00952705|454671259|FG000|Overall Study|Death|2|||
126375094|NCT00952705|454671260|FG001|Overall Study|Death|0|||
126375095|NCT00952705|454671261|FG002|Overall Study|Death|0|||
126375096|NCT00952705|454671259|FG000|Overall Study|Incarcerated post dose|5|||
126375097|NCT00952705|454671260|FG001|Overall Study|Incarcerated post dose|0|||
126375098|NCT00952705|454671261|FG002|Overall Study|Incarcerated post dose|0|||
126375099|NCT00952705|454671259|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
126375100|NCT00952705|454671260|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
126375101|NCT00952705|454671261|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
126375102|NCT03759600|454671263|FG000|Overall Study|Adverse Event|2|||
126375103|NCT03759600|454671263|FG000|Overall Study|Progressive Disease|15|||
126375104|NCT03759600|454671263|FG000|Overall Study|Site Terminated by Sponsor|3|||
126375105|NCT05173974|454671264|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
126375106|NCT05173974|454671265|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
126375107|NCT05173974|454671266|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
126375108|NCT05173974|454671267|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
126375109|NCT05173974|454671264|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
126375110|NCT05173974|454671265|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
126375111|NCT05173974|454671266|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
126375112|NCT05173974|454671267|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
126375113|NCT03257358|454671269|FG000|Overall Study|Adverse Event|25|||
126375114|NCT03257358|454671270|FG001|Overall Study|Adverse Event|12|||
126375115|NCT03257358|454671269|FG000|Overall Study|Lack of Efficacy|1|||
126375116|NCT03257358|454671270|FG001|Overall Study|Lack of Efficacy|1|||
126375117|NCT03257358|454671269|FG000|Overall Study|Lost to Follow-up|12|||
126375118|NCT03257358|454671270|FG001|Overall Study|Lost to Follow-up|4|||
126375119|NCT03257358|454671269|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
126375120|NCT03257358|454671270|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
126375121|NCT03257358|454671269|FG000|Overall Study|Physician Decision|2|||
126375122|NCT03257358|454671270|FG001|Overall Study|Physician Decision|2|||
126375123|NCT03257358|454671269|FG000|Overall Study|Protocol Violation|5|||
126375124|NCT03257358|454671270|FG001|Overall Study|Protocol Violation|3|||
126375125|NCT03257358|454671269|FG000|Overall Study|Technical problems|4|||
126104091|NCT01177722|453675807|FG000|Overall Study|Serious Adverse Event|0|||
126375126|NCT03257358|454671270|FG001|Overall Study|Technical problems|1|||
126375127|NCT03257358|454671269|FG000|Overall Study|Withdrawal by Subject|8|||
126375128|NCT03257358|454671270|FG001|Overall Study|Withdrawal by Subject|3|||
126375129|NCT03257358|454671269|FG000|Overall Study|Withdrawal of informed consent|9|||
126375130|NCT03257358|454671270|FG001|Overall Study|Withdrawal of informed consent|5|||
126375131|NCT03257358|454671269|FG000|Overall Study|New therapy for study indication|1|||
126047947|NCT00146172|453473817|FG006|Overall Study|Lost to Follow-up|0|||
126104092|NCT01177722|453675808|FG001|Overall Study|Serious Adverse Event|0|||
126047948|NCT00146172|453473818|FG007|Overall Study|Lost to Follow-up|1|||
126104093|NCT01177722|453675809|FG002|Overall Study|Serious Adverse Event|1|||
126047949|NCT00146172|453473811|FG000|Overall Study|Disease Progression|2|||
126375132|NCT03257358|454671270|FG001|Overall Study|New therapy for study indication|0|||
126375133|NCT03257358|454671269|FG000|Overall Study|No longer requires treatment|0|||
126375134|NCT03257358|454671270|FG001|Overall Study|No longer requires treatment|1|||
126375135|NCT03289143|454671271|FG000|Overall Study|Caregiver Unavailability|1|||
126375136|NCT03289143|454671272|FG001|Overall Study|Caregiver Unavailability|1|||
126375137|NCT03289143|454671273|FG002|Overall Study|Caregiver Unavailability|0|||
126375138|NCT03289143|454671274|FG003|Overall Study|Caregiver Unavailability|0|||
126375139|NCT03289143|454671271|FG000|Overall Study|Research Department Closure|0|||
126375140|NCT03289143|454671272|FG001|Overall Study|Research Department Closure|0|||
126375141|NCT03289143|454671273|FG002|Overall Study|Research Department Closure|1|||
126375142|NCT03289143|454671274|FG003|Overall Study|Research Department Closure|0|||
126375143|NCT03289143|454671271|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
126375144|NCT03289143|454671272|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
126375145|NCT03289143|454671273|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
126375146|NCT03289143|454671274|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
126375147|NCT03289143|454671271|FG000|Overall Study|Medical Monitor Decision|1|||
126375148|NCT03289143|454671272|FG001|Overall Study|Medical Monitor Decision|0|||
126375149|NCT03289143|454671273|FG002|Overall Study|Medical Monitor Decision|0|||
126375150|NCT03289143|454671274|FG003|Overall Study|Medical Monitor Decision|0|||
126375151|NCT03289143|454671271|FG000|Overall Study|Participant Non-Compliance|0|||
126375152|NCT03289143|454671272|FG001|Overall Study|Participant Non-Compliance|0|||
126375153|NCT03289143|454671273|FG002|Overall Study|Participant Non-Compliance|1|||
126375154|NCT03289143|454671274|FG003|Overall Study|Participant Non-Compliance|0|||
126375155|NCT03289143|454671271|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
126375156|NCT03289143|454671272|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
126375157|NCT03289143|454671273|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
126375158|NCT03289143|454671274|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
126375159|NCT03289143|454671271|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
126375160|NCT03289143|454671272|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
126375161|NCT03289143|454671273|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
126375162|NCT03289143|454671274|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
126375163|NCT03289143|454671271|FG000|Overall Study|Caregiver Passed Away|1|||
126375164|NCT03289143|454671272|FG001|Overall Study|Caregiver Passed Away|0|||
126375165|NCT03289143|454671273|FG002|Overall Study|Caregiver Passed Away|0|||
126375166|NCT03289143|454671274|FG003|Overall Study|Caregiver Passed Away|0|||
126375167|NCT03289143|454671271|FG000|Overall Study|Physician Decision|0|||
126375168|NCT03289143|454671272|FG001|Overall Study|Physician Decision|2|||
126375169|NCT03289143|454671273|FG002|Overall Study|Physician Decision|2|||
126375170|NCT03289143|454671274|FG003|Overall Study|Physician Decision|2|||
126375171|NCT03289143|454671271|FG000|Overall Study|Protocol Deviation|2|||
126375172|NCT03289143|454671272|FG001|Overall Study|Protocol Deviation|1|||
126375173|NCT03289143|454671273|FG002|Overall Study|Protocol Deviation|3|||
126375174|NCT03289143|454671274|FG003|Overall Study|Protocol Deviation|1|||
126375175|NCT03289143|454671271|FG000|Overall Study|Study Terminated By Sponsor|101|||
126375176|NCT03289143|454671272|FG001|Overall Study|Study Terminated By Sponsor|75|||
126375177|NCT03289143|454671273|FG002|Overall Study|Study Terminated By Sponsor|100|||
126375178|NCT03289143|454671274|FG003|Overall Study|Study Terminated By Sponsor|69|||
126375179|NCT03289143|454671271|FG000|Overall Study|Withdrawal by Subject|14|||
126375180|NCT03289143|454671272|FG001|Overall Study|Withdrawal by Subject|6|||
126375181|NCT03289143|454671273|FG002|Overall Study|Withdrawal by Subject|14|||
126375182|NCT03289143|454671274|FG003|Overall Study|Withdrawal by Subject|12|||
126375183|NCT03289143|454671271|FG000|Overall Study|Adverse Event|10|||
126375184|NCT03289143|454671272|FG001|Overall Study|Adverse Event|7|||
126375185|NCT03289143|454671273|FG002|Overall Study|Adverse Event|6|||
126375186|NCT03289143|454671274|FG003|Overall Study|Adverse Event|5|||
126375187|NCT03289143|454671271|FG000|Overall Study|Death|2|||
126375188|NCT03289143|454671272|FG001|Overall Study|Death|0|||
126375189|NCT03289143|454671273|FG002|Overall Study|Death|2|||
126375190|NCT03289143|454671274|FG003|Overall Study|Death|1|||
126375191|NCT03289143|454671271|FG000|Overall Study|Lost to Follow-up|2|||
126375192|NCT03289143|454671272|FG001|Overall Study|Lost to Follow-up|1|||
126375193|NCT03289143|454671273|FG002|Overall Study|Lost to Follow-up|1|||
126375194|NCT03289143|454671274|FG003|Overall Study|Lost to Follow-up|0|||
126375195|NCT03289143|454671271|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
126104094|NCT01177722|453675810|FG003|Overall Study|Serious Adverse Event|0|||
126375196|NCT03289143|454671272|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
126375197|NCT03289143|454671273|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
126375198|NCT03289143|454671274|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
126375199|NCT03289143|454671271|FG000|Overall Study|Withdrawal by Caregiver|0|||
126375200|NCT03289143|454671272|FG001|Overall Study|Withdrawal by Caregiver|1|||
126375201|NCT03289143|454671273|FG002|Overall Study|Withdrawal by Caregiver|0|||
126375202|NCT03289143|454671274|FG003|Overall Study|Withdrawal by Caregiver|0|||
126375203|NCT03289143|454671271|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
126375204|NCT03289143|454671272|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
126375205|NCT03289143|454671273|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
126375206|NCT03289143|454671274|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
126375207|NCT03289143|454671271|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
126375208|NCT03289143|454671272|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
126375209|NCT03289143|454671273|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
126375210|NCT03289143|454671274|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
126375211|NCT00730756|454671275|FG000|Overall Study|Adverse Event|2|||
126375212|NCT00730756|454671276|FG001|Overall Study|Adverse Event|0|||
126375213|NCT00730756|454671275|FG000|Overall Study|Lack of Efficacy|1|||
126375214|NCT00730756|454671276|FG001|Overall Study|Lack of Efficacy|1|||
126375215|NCT00730756|454671275|FG000|Overall Study|Protocol Deviation|1|||
126375216|NCT00730756|454671276|FG001|Overall Study|Protocol Deviation|2|||
126375217|NCT00730756|454671275|FG000|Overall Study|Lost to Follow-up|0|||
126375218|NCT00730756|454671276|FG001|Overall Study|Lost to Follow-up|1|||
126375219|NCT00730756|454671275|FG000|Overall Study|Withdrew Consent|0|||
126375220|NCT00730756|454671276|FG001|Overall Study|Withdrew Consent|1|||
126375221|NCT00305877|454671277|FG000|Overall Study|Lack of Efficacy|6|||
126375222|NCT00305877|454671278|FG001|Overall Study|Lack of Efficacy|9|||
126375223|NCT00305877|454671277|FG000|Overall Study|Adverse Event|9|||
126375224|NCT00305877|454671278|FG001|Overall Study|Adverse Event|14|||
126375225|NCT00305877|454671277|FG000|Overall Study|Death|0|||
126375226|NCT00305877|454671278|FG001|Overall Study|Death|1|||
126375227|NCT00305877|454671277|FG000|Overall Study|Withdrawal by Subject|4|||
126375228|NCT00305877|454671278|FG001|Overall Study|Withdrawal by Subject|2|||
126375229|NCT00305877|454671277|FG000|Overall Study|Physician Decision|1|||
126375230|NCT00305877|454671278|FG001|Overall Study|Physician Decision|1|||
126375231|NCT00305877|454671277|FG000|Overall Study|Never start treatment|2|||
126375232|NCT00305877|454671278|FG001|Overall Study|Never start treatment|5|||
126375233|NCT00305877|454671277|FG000|Overall Study|Ineligible|2|||
126375234|NCT00305877|454671278|FG001|Overall Study|Ineligible|1|||
126375235|NCT00305877|454671277|FG000|Overall Study|Transportation issue with daily RT|0|||
126375236|NCT00305877|454671278|FG001|Overall Study|Transportation issue with daily RT|1|||
126375237|NCT01126190|454671279|FG000|Double-Blind Phase|Death|0|||
126375238|NCT01126190|454671280|FG001|Double-Blind Phase|Death|1|||
126375239|NCT01126190|454671281|FG002|Double-Blind Phase|Death|0|||
126104095|NCT01177722|453675807|FG000|Overall Study|Protocol Violation|0|||
126104096|NCT01177722|453675808|FG001|Overall Study|Protocol Violation|0|||
126375240|NCT01126190|454671279|FG000|Double-Blind Phase|Adverse Event|1|||
126375241|NCT01126190|454671280|FG001|Double-Blind Phase|Adverse Event|2|||
126375242|NCT01126190|454671281|FG002|Double-Blind Phase|Adverse Event|0|||
126375243|NCT01126190|454671279|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
126375244|NCT01126190|454671280|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
126375245|NCT01126190|454671281|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126375246|NCT01126190|454671279|FG000|Double-Blind Phase|Request of Investigator|1|||
126375247|NCT01126190|454671280|FG001|Double-Blind Phase|Request of Investigator|0|||
126375248|NCT01126190|454671281|FG002|Double-Blind Phase|Request of Investigator|0|||
126375249|NCT01126190|454671279|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
126375250|NCT01126190|454671280|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
126375251|NCT01126190|454671281|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
126375252|NCT01126190|454671279|FG000|Double-Blind Phase|Non-compliance|1|||
126375253|NCT01126190|454671280|FG001|Double-Blind Phase|Non-compliance|0|||
126375254|NCT01126190|454671281|FG002|Double-Blind Phase|Non-compliance|0|||
126375255|NCT01126190|454671279|FG000|Double-Blind Phase|Lost to Follow-up|1|||
126375256|NCT01126190|454671280|FG001|Double-Blind Phase|Lost to Follow-up|3|||
126375257|NCT01126190|454671281|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126375258|NCT01126190|454671279|FG000|Open-Label Phase|Death|0|||
126375259|NCT01126190|454671280|FG001|Open-Label Phase|Death|0|||
126375260|NCT01126190|454671281|FG002|Open-Label Phase|Death|1|||
125886297|NCT02374450|452878981|FG000|Overall Study|Death|173|||
126375261|NCT01126190|454671279|FG000|Open-Label Phase|Adverse Event|0|||
126375262|NCT01126190|454671280|FG001|Open-Label Phase|Adverse Event|0|||
126375263|NCT01126190|454671281|FG002|Open-Label Phase|Adverse Event|4|||
126375264|NCT01126190|454671279|FG000|Open-Label Phase|Withdrawal by Subject|0|||
126375265|NCT01126190|454671280|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126375266|NCT01126190|454671281|FG002|Open-Label Phase|Withdrawal by Subject|6|||
126375267|NCT00524121|454671284|FG000|Overall Study|Disease progression|6|||
126375268|NCT00524121|454671284|FG000|Overall Study|Adverse Event|4|||
126375269|NCT00524121|454671284|FG000|Overall Study|Patient refused|2|||
126375270|NCT00524121|454671284|FG000|Overall Study|Other|1|||
126375271|NCT00524121|454671284|FG000|Overall Study|Death|1|||
126375272|NCT00524121|454671284|FG000|Overall Study|Not treated (became ineligible)|4|||
126375273|NCT00524121|454671284|FG000|Overall Study|Not treated (changed mind)|1|||
126375274|NCT01114737|454671285|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
126375275|NCT01114737|454671286|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
126375276|NCT01114737|454671285|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
126375277|NCT01114737|454671286|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
126375278|NCT01114737|454671285|FG000|Randomized Treatment Period|Pregnancy|1|||
126375279|NCT01114737|454671286|FG001|Randomized Treatment Period|Pregnancy|0|||
126375280|NCT01114737|454671285|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
126375281|NCT01114737|454671286|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
126375282|NCT01114737|454671285|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
126375283|NCT01114737|454671286|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
126375284|NCT01114737|454671285|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
126375285|NCT01114737|454671286|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
126375286|NCT01446874|454671287|FG000|Overall Study|Not eligible|1|||
126375287|NCT01446874|454671288|FG001|Overall Study|Not eligible|0|||
126375288|NCT01446874|454671289|FG002|Overall Study|Not eligible|0|||
126375289|NCT01446874|454671287|FG000|Overall Study|No surgery/No qualifying surgery|1|||
126375290|NCT01446874|454671288|FG001|Overall Study|No surgery/No qualifying surgery|0|||
126375291|NCT01446874|454671289|FG002|Overall Study|No surgery/No qualifying surgery|12|||
126375292|NCT01446874|454671287|FG000|Overall Study|Non-compliance|0|||
126375293|NCT01446874|454671288|FG001|Overall Study|Non-compliance|4|||
126375294|NCT01446874|454671289|FG002|Overall Study|Non-compliance|0|||
126375295|NCT01446874|454671287|FG000|Overall Study|Antibiotics for pre-op infection|0|||
126375296|NCT01446874|454671288|FG001|Overall Study|Antibiotics for pre-op infection|0|||
126375297|NCT01446874|454671289|FG002|Overall Study|Antibiotics for pre-op infection|2|||
126375298|NCT01446874|454671287|FG000|Overall Study|Withdrawal by Subject|0|||
126375299|NCT01446874|454671288|FG001|Overall Study|Withdrawal by Subject|0|||
126375300|NCT01446874|454671289|FG002|Overall Study|Withdrawal by Subject|4|||
126375301|NCT00457392|454671290|FG000|Overall Study|Objective Progression or Relapse|229|||
126375302|NCT00457392|454671291|FG001|Overall Study|Objective Progression or Relapse|296|||
126375303|NCT00457392|454671290|FG000|Overall Study|Death|106|||
126375304|NCT00457392|454671291|FG001|Overall Study|Death|106|||
126375305|NCT00457392|454671290|FG000|Overall Study|Adverse Event|84|||
126375306|NCT00457392|454671291|FG001|Overall Study|Adverse Event|41|||
126375307|NCT00457392|454671290|FG000|Overall Study|Global Deterioration of Health Status|22|||
126375308|NCT00457392|454671291|FG001|Overall Study|Global Deterioration of Health Status|8|||
126375309|NCT00457392|454671290|FG000|Overall Study|Withdrawal by Subject|14|||
126375310|NCT00457392|454671291|FG001|Overall Study|Withdrawal by Subject|8|||
126375311|NCT00457392|454671290|FG000|Overall Study|Lost to Follow-up|6|||
126375312|NCT00457392|454671291|FG001|Overall Study|Lost to Follow-up|7|||
126375313|NCT00457392|454671290|FG000|Overall Study|Protocol Violation|4|||
126375314|NCT00457392|454671291|FG001|Overall Study|Protocol Violation|3|||
126375315|NCT00457392|454671290|FG000|Overall Study|Other|7|||
126375316|NCT00457392|454671291|FG001|Overall Study|Other|4|||
126375317|NCT00457392|454671290|FG000|Overall Study|Study Terminated by Sponsor|1|||
126375318|NCT00457392|454671291|FG001|Overall Study|Study Terminated by Sponsor|4|||
126375319|NCT00457392|454671290|FG000|Overall Study|Randomized, Not Treated|7|||
126375320|NCT00457392|454671291|FG001|Overall Study|Randomized, Not Treated|3|||
126375321|NCT01135992|454671292|FG000|Overall Study|Adverse Event|1|||
126375322|NCT01135992|454671292|FG000|Overall Study|Lack of Efficacy|1|||
126375323|NCT01135992|454671292|FG000|Overall Study|Protocol Violation|2|||
126375324|NCT01135992|454671292|FG000|Overall Study|Withdrawal criteria|10|||
126375325|NCT01135992|454671292|FG000|Overall Study|Unclassified|7|||
126104097|NCT01177722|453675809|FG002|Overall Study|Protocol Violation|1|||
126375326|NCT01977898|454671293|FG000|Overall Study|Non functioning catheter|1|||
126375327|NCT01977898|454671294|FG001|Overall Study|Non functioning catheter|1|||
126375328|NCT01466491|454671296|FG000|Overall Study|Protocol Violation|0|||
126375329|NCT01466491|454671297|FG001|Overall Study|Protocol Violation|3|||
126375330|NCT01466491|454671298|FG002|Overall Study|Protocol Violation|2|||
126375331|NCT01466491|454671299|FG003|Overall Study|Protocol Violation|0|||
126375332|NCT01466491|454671296|FG000|Overall Study|Missing Data|0|||
126375333|NCT01466491|454671297|FG001|Overall Study|Missing Data|0|||
126375334|NCT01466491|454671298|FG002|Overall Study|Missing Data|1|||
126375335|NCT01466491|454671299|FG003|Overall Study|Missing Data|0|||
126375336|NCT02727322|454671300|FG000|Overall Study|Withdrawal by Subject|1|||
126375337|NCT02727322|454671301|FG001|Overall Study|Withdrawal by Subject|1|||
126375338|NCT02727322|454671300|FG000|Overall Study|Protocol Violation|1|||
126375339|NCT02727322|454671301|FG001|Overall Study|Protocol Violation|0|||
126375340|NCT00355030|454671308|FG000|Study Period 1 Treatment|Adverse Event|1|||
126375341|NCT00355030|454671309|FG001|Study Period 1 Treatment|Adverse Event|1|||
126375342|NCT00355030|454671308|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
126375343|NCT00355030|454671309|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
126375344|NCT00355030|454671308|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
126375345|NCT00355030|454671309|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
126375346|NCT00355030|454671308|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
126375347|NCT00355030|454671309|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
126375348|NCT00355030|454671308|FG000|Study Period 1 Treatment|Physician Decision|0|||
126375349|NCT00355030|454671309|FG001|Study Period 1 Treatment|Physician Decision|1|||
126375350|NCT00355030|454671308|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
126375351|NCT00355030|454671309|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
126375352|NCT00355030|454671308|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
126375353|NCT00355030|454671309|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
126375354|NCT00355030|454671308|FG000|Study Period 1 Treatment|Other|2|||
126375355|NCT00355030|454671309|FG001|Study Period 1 Treatment|Other|6|||
126375356|NCT00355030|454671308|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
126375357|NCT00355030|454671309|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
126375358|NCT00355030|454671308|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
126375359|NCT00355030|454671309|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
126375360|NCT01123148|454671310|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
126375361|NCT01123148|454671310|FG000|Overall Study|Didn't meet milestone criteria|1|||
126375362|NCT01049373|454671311|FG000|Overall Study|Protocol Violation|9|||
126375363|NCT01049373|454671312|FG001|Overall Study|Protocol Violation|9|||
126375364|NCT01049373|454671311|FG000|Overall Study|Withdrawal by Subject|8|||
126375365|NCT01049373|454671312|FG001|Overall Study|Withdrawal by Subject|5|||
126375366|NCT01049373|454671311|FG000|Overall Study|Adverse Event|3|||
126375367|NCT01049373|454671312|FG001|Overall Study|Adverse Event|3|||
126375368|NCT01049373|454671311|FG000|Overall Study|Lost to Follow-up|9|||
126375369|NCT01049373|454671312|FG001|Overall Study|Lost to Follow-up|4|||
126375370|NCT01049373|454671311|FG000|Overall Study|no evaluable study values|9|||
126375371|NCT01049373|454671312|FG001|Overall Study|no evaluable study values|21|||
126375372|NCT01049373|454671311|FG000|Overall Study|Other|1|||
126375373|NCT01049373|454671312|FG001|Overall Study|Other|1|||
126375374|NCT01049373|454671311|FG000|Overall Study|Non-cooperation|0|||
126375375|NCT01049373|454671312|FG001|Overall Study|Non-cooperation|1|||
126375376|NCT00339040|454671313|FG000|Stage I|Not able to attend clinic|1|||
126375377|NCT00339040|454671314|FG001|Stage I|Not able to attend clinic|0|||
126375378|NCT00339040|454671313|FG000|Stage I|Protocol Violation|1|||
126375379|NCT00339040|454671314|FG001|Stage I|Protocol Violation|1|||
126375380|NCT00339040|454671313|FG000|Stage II|Lost to Follow-up|3|||
126375381|NCT00339040|454671314|FG001|Stage II|Lost to Follow-up|0|||
126375382|NCT00339040|454671313|FG000|Stage II|Withdrawal by Subject|1|||
126375383|NCT00339040|454671314|FG001|Stage II|Withdrawal by Subject|2|||
126375384|NCT00339040|454671313|FG000|Stage II|Protocol Violation|3|||
126375385|NCT00339040|454671314|FG001|Stage II|Protocol Violation|0|||
126375386|NCT00339040|454671313|FG000|Stage II|Not able to attend clinic|1|||
126375387|NCT00339040|454671314|FG001|Stage II|Not able to attend clinic|0|||
126375388|NCT00339040|454671313|FG000|Stage II|Site closing|2|||
126375389|NCT00339040|454671314|FG001|Stage II|Site closing|0|||
126375390|NCT00812955|454671319|FG000|Overall Study|Adverse Event|7|||
126375391|NCT00812955|454671320|FG001|Overall Study|Adverse Event|6|||
126375392|NCT00812955|454671321|FG002|Overall Study|Adverse Event|3|||
126375393|NCT00812955|454671322|FG003|Overall Study|Adverse Event|4|||
126375394|NCT00812955|454671319|FG000|Overall Study|Lost to Follow-up|2|||
126375395|NCT00812955|454671320|FG001|Overall Study|Lost to Follow-up|1|||
126375396|NCT00812955|454671321|FG002|Overall Study|Lost to Follow-up|1|||
126104098|NCT01177722|453675810|FG003|Overall Study|Protocol Violation|0|||
126375397|NCT00812955|454671322|FG003|Overall Study|Lost to Follow-up|2|||
126375398|NCT00812955|454671319|FG000|Overall Study|Withdrawal by Subject|1|||
126375399|NCT00812955|454671320|FG001|Overall Study|Withdrawal by Subject|0|||
126375400|NCT00812955|454671321|FG002|Overall Study|Withdrawal by Subject|1|||
125886298|NCT02374450|452878982|FG001|Overall Study|Death|185|||
125886299|NCT02374450|452878983|FG002|Overall Study|Death|81|||
125886300|NCT02374450|452878981|FG000|Overall Study|Migrated from the study area|538|||
125886301|NCT02374450|452878982|FG001|Overall Study|Migrated from the study area|648|||
126375401|NCT00812955|454671322|FG003|Overall Study|Withdrawal by Subject|2|||
126375402|NCT00812955|454671319|FG000|Overall Study|randomized in error|0|||
126375403|NCT00812955|454671320|FG001|Overall Study|randomized in error|0|||
126375404|NCT00812955|454671321|FG002|Overall Study|randomized in error|1|||
126375405|NCT00812955|454671322|FG003|Overall Study|randomized in error|0|||
126375406|NCT02391311|454671323|FG000|Overall Study|Lost to Follow-up|2|||
126375407|NCT02391311|454671324|FG001|Overall Study|Lost to Follow-up|1|||
126375408|NCT02391311|454671323|FG000|Overall Study|deemed ineligible after baseline|1|||
126375409|NCT02391311|454671324|FG001|Overall Study|deemed ineligible after baseline|1|||
126375410|NCT01815424|454671327|FG000|Week 0 to 16|Adverse Event|1|||
126375411|NCT01815424|454671328|FG001|Week 0 to 16|Adverse Event|3|||
126375412|NCT01815424|454671329|FG002|Week 0 to 16|Adverse Event|3|||
126375413|NCT01815424|454671330|FG003|Week 0 to 16|Adverse Event|0|||
126375414|NCT01815424|454671331|FG004|Week 0 to 16|Adverse Event|0|||
126375415|NCT01815424|454671327|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
126375416|NCT01815424|454671328|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
126375417|NCT01815424|454671329|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
126375418|NCT01815424|454671330|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
126375419|NCT01815424|454671331|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
126375420|NCT01815424|454671327|FG000|Week 0 to 16|Lost to Follow-up|0|||
126375421|NCT01815424|454671328|FG001|Week 0 to 16|Lost to Follow-up|1|||
126375422|NCT01815424|454671329|FG002|Week 0 to 16|Lost to Follow-up|0|||
126375423|NCT01815424|454671330|FG003|Week 0 to 16|Lost to Follow-up|0|||
126375424|NCT01815424|454671331|FG004|Week 0 to 16|Lost to Follow-up|0|||
126375425|NCT01815424|454671327|FG000|Week 0 to 16|Withdrawal by Subject|0|||
126375426|NCT01815424|454671328|FG001|Week 0 to 16|Withdrawal by Subject|0|||
126375427|NCT01815424|454671329|FG002|Week 0 to 16|Withdrawal by Subject|1|||
126375428|NCT01815424|454671330|FG003|Week 0 to 16|Withdrawal by Subject|0|||
126375429|NCT01815424|454671331|FG004|Week 0 to 16|Withdrawal by Subject|0|||
126375430|NCT01815424|454671327|FG000|Week 0 to 16|Other|1|||
126375431|NCT01815424|454671328|FG001|Week 0 to 16|Other|0|||
126375432|NCT01815424|454671329|FG002|Week 0 to 16|Other|3|||
126375433|NCT01815424|454671330|FG003|Week 0 to 16|Other|0|||
126375434|NCT01815424|454671331|FG004|Week 0 to 16|Other|0|||
126375435|NCT01815424|454671327|FG000|Week 0 to 16|Protocol Violation|1|||
126375436|NCT01815424|454671328|FG001|Week 0 to 16|Protocol Violation|0|||
126375437|NCT01815424|454671329|FG002|Week 0 to 16|Protocol Violation|0|||
126375438|NCT01815424|454671330|FG003|Week 0 to 16|Protocol Violation|0|||
126375439|NCT01815424|454671331|FG004|Week 0 to 16|Protocol Violation|0|||
126375440|NCT01815424|454671327|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
126375441|NCT01815424|454671328|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
126375442|NCT01815424|454671329|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
126375443|NCT01815424|454671330|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
126375444|NCT01815424|454671331|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
126375445|NCT01815424|454671327|FG000|Week 16 to 52|Other|0|||
126375446|NCT01815424|454671328|FG001|Week 16 to 52|Other|1|||
126375447|NCT01815424|454671329|FG002|Week 16 to 52|Other|0|||
126375448|NCT01815424|454671330|FG003|Week 16 to 52|Other|0|||
126375449|NCT01815424|454671331|FG004|Week 16 to 52|Other|0|||
126375450|NCT01815424|454671327|FG000|Week 16 to 52|Adverse Event|0|||
126375451|NCT01815424|454671328|FG001|Week 16 to 52|Adverse Event|0|||
126375452|NCT01815424|454671329|FG002|Week 16 to 52|Adverse Event|0|||
126375453|NCT01815424|454671330|FG003|Week 16 to 52|Adverse Event|0|||
126375454|NCT01815424|454671331|FG004|Week 16 to 52|Adverse Event|1|||
126375455|NCT01815424|454671327|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
126375456|NCT01815424|454671328|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
126375457|NCT01815424|454671329|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
126375458|NCT01815424|454671330|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
126375459|NCT01815424|454671331|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
126375460|NCT01815424|454671327|FG000|Week 16 to 52|Lost to Follow-up|0|||
126375461|NCT01815424|454671328|FG001|Week 16 to 52|Lost to Follow-up|2|||
126375462|NCT01815424|454671329|FG002|Week 16 to 52|Lost to Follow-up|0|||
126375463|NCT01815424|454671330|FG003|Week 16 to 52|Lost to Follow-up|2|||
126375464|NCT01815424|454671331|FG004|Week 16 to 52|Lost to Follow-up|1|||
126375465|NCT01815424|454671327|FG000|Week 16 to 52|Withdrawal by Subject|1|||
126375466|NCT01815424|454671328|FG001|Week 16 to 52|Withdrawal by Subject|2|||
126375467|NCT01815424|454671329|FG002|Week 16 to 52|Withdrawal by Subject|0|||
126375468|NCT01815424|454671330|FG003|Week 16 to 52|Withdrawal by Subject|0|||
126375469|NCT01815424|454671331|FG004|Week 16 to 52|Withdrawal by Subject|0|||
126375470|NCT01309204|454671332|FG000|Overall Study|Adverse Event|48|||
126375471|NCT01309204|454671333|FG001|Overall Study|Adverse Event|58|||
126375472|NCT01309204|454671332|FG000|Overall Study|Lost to Follow-up|2|||
126375473|NCT01309204|454671333|FG001|Overall Study|Lost to Follow-up|2|||
126375474|NCT01309204|454671332|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
126375475|NCT01309204|454671333|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
126375476|NCT01309204|454671332|FG000|Overall Study|Inadequate control of IOP|4|||
126375477|NCT01309204|454671333|FG001|Overall Study|Inadequate control of IOP|4|||
126375478|NCT01309204|454671332|FG000|Overall Study|Other|4|||
126375479|NCT01309204|454671333|FG001|Overall Study|Other|1|||
126375480|NCT03046446|454671334|FG000|Overall Study|Lack of Efficacy|7|||
126375481|NCT03046446|454671334|FG000|Overall Study|Adverse Event|6|||
126375482|NCT03046446|454671334|FG000|Overall Study|Lost to Follow-up|3|||
126375483|NCT03046446|454671334|FG000|Overall Study|Withdrawal by Subject|14|||
126375484|NCT03046446|454671334|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
126375485|NCT03046446|454671334|FG000|Overall Study|Disease Progression (see caveats)|25|||
126375486|NCT03046446|454671334|FG000|Overall Study|Non OA related knee surgery|1|||
126375487|NCT02808897|454671335|FG000|Overall Study|Lost to Follow-up|9|||
126375488|NCT02808897|454671336|FG001|Overall Study|Lost to Follow-up|11|||
126375489|NCT00925002|454671337|FG000|Overall Study|Other|1|||
126375490|NCT00925002|454671338|FG001|Overall Study|Other|4|||
126375491|NCT00925002|454671339|FG002|Overall Study|Other|0|||
126375492|NCT00925002|454671337|FG000|Overall Study|Death|1|||
126375493|NCT00925002|454671338|FG001|Overall Study|Death|1|||
126375494|NCT00925002|454671339|FG002|Overall Study|Death|5|||
126375495|NCT00925002|454671337|FG000|Overall Study|Adverse Event|3|||
126375496|NCT00925002|454671338|FG001|Overall Study|Adverse Event|1|||
126375497|NCT00925002|454671339|FG002|Overall Study|Adverse Event|2|||
126375498|NCT00925002|454671337|FG000|Overall Study|Participant withdrew consent|1|||
126375499|NCT00925002|454671338|FG001|Overall Study|Participant withdrew consent|3|||
126375500|NCT00925002|454671339|FG002|Overall Study|Participant withdrew consent|3|||
126375501|NCT01496287|454671340|FG000|Overall Study|Lost to Follow-up|1|||
126375502|NCT01496287|454671340|FG000|Overall Study|Incomplete anesthesia|5|||
126375503|NCT00305448|454671341|FG000|Overall Study|Protocol Violation|0|||
126375504|NCT00305448|454671342|FG001|Overall Study|Protocol Violation|1|||
126375505|NCT00305448|454671343|FG002|Overall Study|Protocol Violation|0|||
126375506|NCT00305448|454671341|FG000|Overall Study|Withdrawal by Subject|2|||
126104099|NCT01177722|453675807|FG000|Overall Study|Lost to Follow-up|3|||
126104100|NCT01177722|453675808|FG001|Overall Study|Lost to Follow-up|4|||
126375507|NCT00305448|454671342|FG001|Overall Study|Withdrawal by Subject|0|||
126375508|NCT00305448|454671343|FG002|Overall Study|Withdrawal by Subject|1|||
126375509|NCT00305448|454671341|FG000|Overall Study|Adverse Event|1|||
126375510|NCT00305448|454671342|FG001|Overall Study|Adverse Event|0|||
126375511|NCT00305448|454671343|FG002|Overall Study|Adverse Event|1|||
126375512|NCT00305448|454671341|FG000|Overall Study|Disease Progression|27|||
126375513|NCT00305448|454671342|FG001|Overall Study|Disease Progression|31|||
126375514|NCT00305448|454671343|FG002|Overall Study|Disease Progression|28|||
126375515|NCT00305448|454671341|FG000|Overall Study|Subjective Disease Progression|1|||
126375516|NCT00305448|454671342|FG001|Overall Study|Subjective Disease Progression|2|||
126375517|NCT00305448|454671343|FG002|Overall Study|Subjective Disease Progression|2|||
126375518|NCT00305448|454671341|FG000|Overall Study|Tumor Marker Elevation|0|||
126104101|NCT01177722|453675809|FG002|Overall Study|Lost to Follow-up|3|||
126104102|NCT01177722|453675810|FG003|Overall Study|Lost to Follow-up|1|||
126104103|NCT01177722|453675807|FG000|Overall Study|Withdrawal by Subject|10|||
126375519|NCT00305448|454671342|FG001|Overall Study|Tumor Marker Elevation|0|||
126375520|NCT00305448|454671343|FG002|Overall Study|Tumor Marker Elevation|1|||
126375521|NCT00328172|454671344|FG000|Overall Study|Adverse Event|3|||
126375522|NCT00328172|454671345|FG001|Overall Study|Adverse Event|2|||
126375523|NCT00328172|454671346|FG002|Overall Study|Adverse Event|1|||
126375524|NCT00328172|454671347|FG003|Overall Study|Adverse Event|2|||
126375525|NCT00328172|454671348|FG004|Overall Study|Adverse Event|1|||
126375526|NCT00328172|454671344|FG000|Overall Study|Protocol Violation|0|||
126375527|NCT00328172|454671345|FG001|Overall Study|Protocol Violation|1|||
126375528|NCT00328172|454671346|FG002|Overall Study|Protocol Violation|1|||
126375529|NCT00328172|454671347|FG003|Overall Study|Protocol Violation|0|||
126375530|NCT00328172|454671348|FG004|Overall Study|Protocol Violation|0|||
126375531|NCT00328172|454671344|FG000|Overall Study|Lost to Follow-up|1|||
126375532|NCT00328172|454671345|FG001|Overall Study|Lost to Follow-up|1|||
126375533|NCT00328172|454671346|FG002|Overall Study|Lost to Follow-up|2|||
126375534|NCT00328172|454671347|FG003|Overall Study|Lost to Follow-up|1|||
126375535|NCT00328172|454671348|FG004|Overall Study|Lost to Follow-up|1|||
126375536|NCT00328172|454671344|FG000|Overall Study|Withdrawal by Subject|1|||
126375537|NCT00328172|454671345|FG001|Overall Study|Withdrawal by Subject|1|||
126375538|NCT00328172|454671346|FG002|Overall Study|Withdrawal by Subject|1|||
125886302|NCT02374450|452878983|FG002|Overall Study|Migrated from the study area|181|||
126375539|NCT00328172|454671347|FG003|Overall Study|Withdrawal by Subject|6|||
126375540|NCT00328172|454671348|FG004|Overall Study|Withdrawal by Subject|0|||
126375541|NCT00328172|454671344|FG000|Overall Study|Lack of Efficacy|14|||
126375542|NCT00328172|454671345|FG001|Overall Study|Lack of Efficacy|9|||
126375543|NCT00328172|454671346|FG002|Overall Study|Lack of Efficacy|4|||
126375544|NCT00328172|454671347|FG003|Overall Study|Lack of Efficacy|4|||
126375545|NCT00328172|454671348|FG004|Overall Study|Lack of Efficacy|3|||
126375546|NCT00328172|454671344|FG000|Overall Study|Other reason (not specified)|3|||
126375547|NCT00328172|454671345|FG001|Overall Study|Other reason (not specified)|0|||
126375548|NCT00328172|454671346|FG002|Overall Study|Other reason (not specified)|1|||
126375549|NCT00328172|454671347|FG003|Overall Study|Other reason (not specified)|0|||
126375550|NCT00328172|454671348|FG004|Overall Study|Other reason (not specified)|0|||
126375551|NCT00558636|454671353|FG000|Treatment|Adverse Event|9|||
126375552|NCT00558636|454671354|FG001|Treatment|Adverse Event|2|||
126375553|NCT00558636|454671353|FG000|Treatment|Withdrawal by Subject|2|||
126375554|NCT00558636|454671354|FG001|Treatment|Withdrawal by Subject|0|||
126375555|NCT00558636|454671353|FG000|Treatment|Premature termination of the study|35|||
126375556|NCT00558636|454671354|FG001|Treatment|Premature termination of the study|37|||
126375557|NCT00558636|454671353|FG000|Treatment|Disease progression|1|||
126375558|NCT00558636|454671354|FG001|Treatment|Disease progression|5|||
126375559|NCT00558636|454671353|FG000|Follow-up|Premature termination of the study|12|||
126375560|NCT00558636|454671354|FG001|Follow-up|Premature termination of the study|7|||
126375561|NCT01990742|454671355|FG000|Overall Study|Withdrawal by facility|407|||
126375562|NCT01990742|454671356|FG001|Overall Study|Withdrawal by facility|1083|||
126375563|NCT01990742|454671355|FG000|Overall Study|Facility closed|0|||
126375564|NCT01990742|454671356|FG001|Overall Study|Facility closed|270|||
126375565|NCT03443687|454671357|FG000|Overall Study|Lost to Follow-up|3|||
126375566|NCT03443687|454671358|FG001|Overall Study|Lost to Follow-up|5|||
126375567|NCT03443687|454671357|FG000|Overall Study|Withdrawal by Subject|1|||
126375568|NCT03443687|454671358|FG001|Overall Study|Withdrawal by Subject|0|||
126375569|NCT03443687|454671357|FG000|Overall Study|Discontinued intervention|1|||
126375570|NCT03443687|454671358|FG001|Overall Study|Discontinued intervention|1|||
126375571|NCT04108273|454671359|FG000|Overall Study|COVID Pandemic|1|||
126375572|NCT04108273|454671360|FG001|Overall Study|COVID Pandemic|0|||
126375573|NCT02897115|454671364|FG000|Overall Study|Early termination of study by sponsor|11|||
126375574|NCT02897115|454671365|FG001|Overall Study|Early termination of study by sponsor|8|||
126375575|NCT00487981|454671366|FG000|Overall Study|Hypothyroidism diagnosis|1|||
126375576|NCT02808429|454671371|FG000|Overall Study|Lost to Follow-up|1|||
126375577|NCT02808429|454671372|FG001|Overall Study|Lost to Follow-up|0|||
126375578|NCT02808429|454671373|FG002|Overall Study|Lost to Follow-up|0|||
126375579|NCT02808429|454671371|FG000|Overall Study|Protocol Violation|0|||
126375580|NCT02808429|454671372|FG001|Overall Study|Protocol Violation|1|||
126375581|NCT02808429|454671373|FG002|Overall Study|Protocol Violation|0|||
126375582|NCT02808429|454671371|FG000|Overall Study|Premature study termination by sponsor|2|||
126375583|NCT02808429|454671372|FG001|Overall Study|Premature study termination by sponsor|0|||
126375584|NCT02808429|454671373|FG002|Overall Study|Premature study termination by sponsor|1|||
126375585|NCT02808429|454671371|FG000|Overall Study|Relocation|0|||
126375586|NCT02808429|454671372|FG001|Overall Study|Relocation|0|||
126375587|NCT02808429|454671373|FG002|Overall Study|Relocation|1|||
126375588|NCT03886493|454671378|FG000|Overall Study|Adverse Event|1|||
126375589|NCT04828707|454671379|FG000|Overall Study|Lost to Follow-up|3|||
126375590|NCT04828707|454671380|FG001|Overall Study|Lost to Follow-up|2|||
126375591|NCT04828707|454671379|FG000|Overall Study|Withdrawal by Subject|2|||
126375592|NCT04828707|454671380|FG001|Overall Study|Withdrawal by Subject|1|||
126375593|NCT03139448|454671381|FG000|Overall Study|Lack of Efficacy|6|||
126375594|NCT03139448|454671382|FG001|Overall Study|Lack of Efficacy|7|||
126375595|NCT03139448|454671381|FG000|Overall Study|Location of procedure changed|2|||
126375596|NCT03139448|454671382|FG001|Overall Study|Location of procedure changed|8|||
126375597|NCT03139448|454671381|FG000|Overall Study|Withdrawal by Subject|3|||
126375598|NCT03139448|454671382|FG001|Overall Study|Withdrawal by Subject|6|||
126375599|NCT03139448|454671381|FG000|Overall Study|Screen fail|1|||
126375600|NCT03139448|454671382|FG001|Overall Study|Screen fail|3|||
126375601|NCT03139448|454671381|FG000|Overall Study|Physician Decision|0|||
126375602|NCT03139448|454671382|FG001|Overall Study|Physician Decision|2|||
126375603|NCT00523978|454671383|FG000|Overall Study|Withdrawal by Subject|3|||
126375604|NCT00523978|454671384|FG001|Overall Study|Withdrawal by Subject|7|||
126375605|NCT00523978|454671383|FG000|Overall Study|Screen Failures|5|||
126375606|NCT00523978|454671384|FG001|Overall Study|Screen Failures|1|||
126375607|NCT00523978|454671383|FG000|Overall Study|Death|1|||
126375608|NCT00523978|454671384|FG001|Overall Study|Death|0|||
126375609|NCT00696878|454671385|FG000|Overall Study|Adverse Event|8|||
126375610|NCT00696878|454671385|FG000|Overall Study|Withdrawal by Subject|87|||
126375611|NCT00696878|454671385|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
126375612|NCT00696878|454671385|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
126375613|NCT00696878|454671385|FG000|Overall Study|Trial stopped|32|||
126375614|NCT00696878|454671385|FG000|Overall Study|Other reason (not specified)|55|||
126375615|NCT02712788|454671386|FG000|Overall Study|Physician Decision|1|||
126375616|NCT02712788|454671387|FG001|Overall Study|Physician Decision|0|||
126375617|NCT02712788|454671386|FG000|Overall Study|Protocol Violation|1|||
126375618|NCT02712788|454671387|FG001|Overall Study|Protocol Violation|0|||
125886303|NCT02374450|452878981|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
126375619|NCT01880957|454671388|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
126375620|NCT01880957|454671389|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
126375621|NCT01880957|454671388|FG000|Overall Study|Lost to Follow-up|11|||
126375622|NCT01880957|454671389|FG001|Overall Study|Lost to Follow-up|0|||
126375623|NCT01880957|454671388|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
126375624|NCT01880957|454671389|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
126375625|NCT00940602|454671390|FG000|Overall Study|Administrative problems|1|||
126375626|NCT00940602|454671391|FG001|Overall Study|Administrative problems|1|||
126375627|NCT00940602|454671390|FG000|Overall Study|Patient/guardian decision|13|||
126375628|NCT00940602|454671391|FG001|Overall Study|Patient/guardian decision|28|||
126375629|NCT00940602|454671390|FG000|Overall Study|Physician Decision|8|||
126375630|NCT00940602|454671391|FG001|Overall Study|Physician Decision|5|||
126375631|NCT00940602|454671390|FG000|Overall Study|Pregnancy|1|||
126375632|NCT00940602|454671391|FG001|Overall Study|Pregnancy|0|||
126375633|NCT00940602|454671390|FG000|Overall Study|Protocol Deviation (untreated)|1|||
126375634|NCT00940602|454671391|FG001|Overall Study|Protocol Deviation (untreated)|0|||
126375635|NCT00940602|454671390|FG000|Overall Study|Disease progression|8|||
126375636|NCT00940602|454671391|FG001|Overall Study|Disease progression|2|||
126375637|NCT00940602|454671390|FG000|Overall Study|Death|38|||
126375638|NCT00940602|454671391|FG001|Overall Study|Death|19|||
126375639|NCT00940602|454671390|FG000|Overall Study|Lost to Follow-up|3|||
126375640|NCT00940602|454671391|FG001|Overall Study|Lost to Follow-up|1|||
126375641|NCT00940602|454671390|FG000|Overall Study|Patient withdrew consent|26|||
126375642|NCT00940602|454671391|FG001|Overall Study|Patient withdrew consent|13|||
126375643|NCT00940602|454671390|FG000|Overall Study|Adverse Event|7|||
126375644|NCT00940602|454671391|FG001|Overall Study|Adverse Event|2|||
126375645|NCT00940602|454671390|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
126375646|NCT00940602|454671391|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
126375647|NCT00575666|454671394|FG000|Overall Study|Withdrawal by Subject|3|||
126375648|NCT00575666|454671395|FG001|Overall Study|Withdrawal by Subject|2|||
126375649|NCT00575666|454671394|FG000|Overall Study|Physician Decision|1|||
126375650|NCT00575666|454671395|FG001|Overall Study|Physician Decision|1|||
126375651|NCT00508482|454671396|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
126375652|NCT00508482|454671397|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
126375653|NCT00508482|454671398|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
126375654|NCT00508482|454671396|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
126375655|NCT00508482|454671397|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
126375656|NCT00508482|454671398|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
126375657|NCT00508482|454671396|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
126375658|NCT00508482|454671397|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
126375659|NCT00508482|454671398|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
126375660|NCT02289469|454671399|FG000|Overall Study|Unable to match a control|6|||
126375661|NCT02289469|454671400|FG001|Overall Study|Unable to match a control|0|||
126375662|NCT02750930|454671404|FG000|Overall Study|Study closed/terminated|8|||
126375663|NCT01944020|454672951|FG000|Overall Study|Withdrawal by Subject|5|||
126375664|NCT01944020|454672952|FG001|Overall Study|Withdrawal by Subject|0|||
125886304|NCT02374450|452878982|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
125886305|NCT02374450|452878983|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
126375665|NCT00811954|454672958|FG000|Overall Study|Death|10|||
126375666|NCT00811954|454672959|FG001|Overall Study|Death|6|||
126375667|NCT00811954|454672960|FG002|Overall Study|Death|13|||
126375668|NCT00811954|454672958|FG000|Overall Study|Lost to Follow-up|29|||
126375669|NCT00811954|454672959|FG001|Overall Study|Lost to Follow-up|23|||
126375670|NCT00811954|454672960|FG002|Overall Study|Lost to Follow-up|34|||
126375671|NCT00811954|454672958|FG000|Overall Study|Not able to get to clinic|28|||
126375672|NCT00811954|454672959|FG001|Overall Study|Not able to get to clinic|35|||
126375673|NCT00811954|454672960|FG002|Overall Study|Not able to get to clinic|30|||
126375674|NCT00811954|454672958|FG000|Overall Study|Not willing to adhere to requirements|12|||
126375675|NCT00811954|454672959|FG001|Overall Study|Not willing to adhere to requirements|2|||
126375676|NCT00811954|454672960|FG002|Overall Study|Not willing to adhere to requirements|16|||
126375677|NCT00811954|454672958|FG000|Overall Study|Withdraw consent prior study completion|4|||
126375678|NCT00811954|454672959|FG001|Overall Study|Withdraw consent prior study completion|6|||
126375679|NCT00811954|454672960|FG002|Overall Study|Withdraw consent prior study completion|5|||
126375680|NCT00811954|454672958|FG000|Overall Study|Site Closure|4|||
126375681|NCT00811954|454672959|FG001|Overall Study|Site Closure|0|||
126375682|NCT00811954|454672960|FG002|Overall Study|Site Closure|1|||
126375683|NCT00811954|454672958|FG000|Overall Study|Severe Debilitation|2|||
126375684|NCT00811954|454672959|FG001|Overall Study|Severe Debilitation|0|||
126375685|NCT00811954|454672960|FG002|Overall Study|Severe Debilitation|1|||
126375686|NCT00811954|454672958|FG000|Overall Study|Complete Protocol: No follow-up|0|||
126375687|NCT00811954|454672959|FG001|Overall Study|Complete Protocol: No follow-up|0|||
126047950|NCT00146172|453473812|FG001|Overall Study|Disease Progression|4|||
126047951|NCT00146172|453473813|FG002|Overall Study|Disease Progression|2|||
126047952|NCT00146172|453473814|FG003|Overall Study|Disease Progression|5|||
126047953|NCT00146172|453473815|FG004|Overall Study|Disease Progression|2|||
126375688|NCT00811954|454672960|FG002|Overall Study|Complete Protocol: No follow-up|1|||
126375689|NCT01016067|454672961|FG000|Overall Study|Lost to Follow-up|1|||
126375690|NCT01016067|454672962|FG001|Overall Study|Lost to Follow-up|2|||
126375691|NCT01016067|454672961|FG000|Overall Study|Physician Decision|1|||
126375692|NCT01016067|454672962|FG001|Overall Study|Physician Decision|1|||
126375693|NCT01016067|454672961|FG000|Overall Study|Withdrew due to Relocation|0|||
126375694|NCT01016067|454672962|FG001|Overall Study|Withdrew due to Relocation|1|||
126375695|NCT01534481|454672969|FG000|Overall Study|Lost to Follow-up|29|||
126375696|NCT01534481|454672970|FG001|Overall Study|Lost to Follow-up|24|||
126375697|NCT01534481|454672969|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
126375698|NCT01534481|454672970|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
126375699|NCT01130337|454672971|FG000|Overall Study|Withdrawal by Subject|3|||
126375700|NCT01130337|454672971|FG000|Overall Study|Principal investigator decision|1|||
126375701|NCT01130337|454672971|FG000|Overall Study|Death|1|||
126375702|NCT01130337|454672971|FG000|Overall Study|Disease progression|1|||
126375703|NCT01130337|454672971|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
126375704|NCT01130337|454672971|FG000|Overall Study|Surgical resection (R2)|1|||
126375705|NCT05525910|454672972|FG000|Period 4|Per sponsor due to study timelines|0|||
126375706|NCT05525910|454672973|FG001|Period 4|Per sponsor due to study timelines|0|||
126375707|NCT05525910|454672974|FG002|Period 4|Per sponsor due to study timelines|1|||
126375708|NCT05525910|454672975|FG003|Period 4|Per sponsor due to study timelines|1|||
126375709|NCT05525910|454672976|FG004|Period 4|Per sponsor due to study timelines|1|||
126375710|NCT00658541|454672977|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
126375711|NCT00658541|454672978|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126375712|NCT00658541|454672977|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126375713|NCT00658541|454672978|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126375714|NCT01063348|454672979|FG000|Overall Study|Lost to Follow-up|3|||
126375715|NCT01063348|454672980|FG001|Overall Study|Lost to Follow-up|10|||
126375716|NCT03326063|454672981|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
126375717|NCT03326063|454672982|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
126375718|NCT02750514|454672983|FG000|Track 1|Disease progression|20|||
126375719|NCT02750514|454672984|FG001|Track 1|Disease progression|1|||
126375720|NCT02750514|454672985|FG002|Track 1|Disease progression|0|||
126375721|NCT02750514|454672986|FG003|Track 1|Disease progression|1|||
126375722|NCT02750514|454672987|FG004|Track 1|Disease progression|0|||
126375723|NCT02750514|454672983|FG000|Track 1|Adverse event unrelated to study drug|1|||
126375724|NCT02750514|454672984|FG001|Track 1|Adverse event unrelated to study drug|0|||
126375725|NCT02750514|454672985|FG002|Track 1|Adverse event unrelated to study drug|0|||
126375726|NCT02750514|454672986|FG003|Track 1|Adverse event unrelated to study drug|0|||
126375727|NCT02750514|454672987|FG004|Track 1|Adverse event unrelated to study drug|0|||
126375728|NCT02750514|454672983|FG000|Track 1|Study drug toxicity|4|||
126375729|NCT02750514|454672984|FG001|Track 1|Study drug toxicity|1|||
126375730|NCT02750514|454672985|FG002|Track 1|Study drug toxicity|0|||
126375731|NCT02750514|454672986|FG003|Track 1|Study drug toxicity|1|||
126375732|NCT02750514|454672987|FG004|Track 1|Study drug toxicity|0|||
126375733|NCT02750514|454672983|FG000|Track 1|Participant request to discontinue|1|||
126375734|NCT02750514|454672984|FG001|Track 1|Participant request to discontinue|0|||
126375735|NCT02750514|454672985|FG002|Track 1|Participant request to discontinue|0|||
126375736|NCT02750514|454672986|FG003|Track 1|Participant request to discontinue|0|||
126375737|NCT02750514|454672987|FG004|Track 1|Participant request to discontinue|0|||
126375738|NCT02750514|454672983|FG000|Track 1|Other reasons|1|||
126047954|NCT00146172|453473816|FG005|Overall Study|Disease Progression|2|||
126375739|NCT02750514|454672984|FG001|Track 1|Other reasons|0|||
126375740|NCT02750514|454672985|FG002|Track 1|Other reasons|0|||
126375741|NCT02750514|454672986|FG003|Track 1|Other reasons|0|||
126047955|NCT00146172|453473817|FG006|Overall Study|Disease Progression|1|||
126047956|NCT00146172|453473818|FG007|Overall Study|Disease Progression|22|||
126047957|NCT00146172|453473811|FG000|Overall Study|Death|0|||
126047958|NCT00146172|453473812|FG001|Overall Study|Death|0|||
126047959|NCT00146172|453473813|FG002|Overall Study|Death|0|||
126375742|NCT02750514|454672987|FG004|Track 1|Other reasons|0|||
126375743|NCT02750514|454672983|FG000|Track 2|Disease progression|4|||
126375744|NCT02750514|454672984|FG001|Track 2|Disease progression|5|||
126375745|NCT02750514|454672985|FG002|Track 2|Disease progression|2|||
126375746|NCT02750514|454672986|FG003|Track 2|Disease progression|5|||
126375747|NCT02750514|454672987|FG004|Track 2|Disease progression|0|||
126375748|NCT02750514|454672983|FG000|Track 2|Adverse event unrelated to study drug|1|||
126375749|NCT02750514|454672984|FG001|Track 2|Adverse event unrelated to study drug|0|||
126375750|NCT02750514|454672985|FG002|Track 2|Adverse event unrelated to study drug|0|||
126375751|NCT02750514|454672986|FG003|Track 2|Adverse event unrelated to study drug|0|||
126047960|NCT00146172|453473814|FG003|Overall Study|Death|0|||
126047961|NCT00146172|453473815|FG004|Overall Study|Death|0|||
126375752|NCT02750514|454672987|FG004|Track 2|Adverse event unrelated to study drug|0|||
126375753|NCT02750514|454672983|FG000|Track 2|Study drug toxicity|1|||
126375754|NCT02750514|454672984|FG001|Track 2|Study drug toxicity|2|||
126375755|NCT02750514|454672985|FG002|Track 2|Study drug toxicity|0|||
126375756|NCT02750514|454672986|FG003|Track 2|Study drug toxicity|2|||
126375757|NCT02750514|454672987|FG004|Track 2|Study drug toxicity|0|||
126375758|NCT02750514|454672983|FG000|Track 2|Participant withdrew consent|0|||
126375759|NCT02750514|454672984|FG001|Track 2|Participant withdrew consent|1|||
126375760|NCT02750514|454672985|FG002|Track 2|Participant withdrew consent|0|||
126375761|NCT02750514|454672986|FG003|Track 2|Participant withdrew consent|0|||
126375762|NCT02750514|454672987|FG004|Track 2|Participant withdrew consent|0|||
126375763|NCT02750514|454672983|FG000|Track 3|Disease progression|0|||
126375764|NCT02750514|454672984|FG001|Track 3|Disease progression|24|||
126375765|NCT02750514|454672985|FG002|Track 3|Disease progression|13|||
126375766|NCT02750514|454672986|FG003|Track 3|Disease progression|14|||
126375767|NCT02750514|454672987|FG004|Track 3|Disease progression|0|||
126375768|NCT02750514|454672983|FG000|Track 3|Adverse event unrelated to study drug|0|||
126375769|NCT02750514|454672984|FG001|Track 3|Adverse event unrelated to study drug|1|||
126375770|NCT02750514|454672985|FG002|Track 3|Adverse event unrelated to study drug|1|||
126375771|NCT02750514|454672986|FG003|Track 3|Adverse event unrelated to study drug|1|||
126375772|NCT02750514|454672987|FG004|Track 3|Adverse event unrelated to study drug|0|||
126375773|NCT02750514|454672983|FG000|Track 3|Study drug toxicity|0|||
126375774|NCT02750514|454672984|FG001|Track 3|Study drug toxicity|3|||
126375775|NCT02750514|454672985|FG002|Track 3|Study drug toxicity|0|||
126375776|NCT02750514|454672986|FG003|Track 3|Study drug toxicity|1|||
126375777|NCT02750514|454672987|FG004|Track 3|Study drug toxicity|0|||
126375778|NCT02750514|454672983|FG000|Track 3|Participant request to discontinue|0|||
126375779|NCT02750514|454672984|FG001|Track 3|Participant request to discontinue|2|||
126375780|NCT02750514|454672985|FG002|Track 3|Participant request to discontinue|0|||
126375781|NCT02750514|454672986|FG003|Track 3|Participant request to discontinue|0|||
126375782|NCT02750514|454672987|FG004|Track 3|Participant request to discontinue|0|||
126375783|NCT02750514|454672983|FG000|Track 3|Participant withdrew consent|0|||
126375784|NCT02750514|454672984|FG001|Track 3|Participant withdrew consent|3|||
126375785|NCT02750514|454672985|FG002|Track 3|Participant withdrew consent|1|||
126375786|NCT02750514|454672986|FG003|Track 3|Participant withdrew consent|0|||
126375787|NCT02750514|454672987|FG004|Track 3|Participant withdrew consent|0|||
126375788|NCT02750514|454672983|FG000|Track 3|Other reasons|0|||
126375789|NCT02750514|454672984|FG001|Track 3|Other reasons|3|||
126375790|NCT02750514|454672985|FG002|Track 3|Other reasons|0|||
126375791|NCT02750514|454672986|FG003|Track 3|Other reasons|0|||
126375792|NCT02750514|454672987|FG004|Track 3|Other reasons|0|||
126375793|NCT02750514|454672983|FG000|Track 4|Study drug toxicity|0|||
126375794|NCT02750514|454672984|FG001|Track 4|Study drug toxicity|6|||
126375795|NCT02750514|454672985|FG002|Track 4|Study drug toxicity|0|||
126375796|NCT02750514|454672986|FG003|Track 4|Study drug toxicity|5|||
126375797|NCT02750514|454672987|FG004|Track 4|Study drug toxicity|0|||
126375798|NCT02750514|454672983|FG000|Track 4|Participant request to discontinue|0|||
126375799|NCT02750514|454672984|FG001|Track 4|Participant request to discontinue|1|||
126375800|NCT02750514|454672985|FG002|Track 4|Participant request to discontinue|0|||
126375801|NCT02750514|454672986|FG003|Track 4|Participant request to discontinue|1|||
126375802|NCT02750514|454672987|FG004|Track 4|Participant request to discontinue|0|||
126375803|NCT02750514|454672983|FG000|Track 4|Participant withdrew consent|0|||
126375804|NCT02750514|454672984|FG001|Track 4|Participant withdrew consent|1|||
126375805|NCT02750514|454672985|FG002|Track 4|Participant withdrew consent|0|||
126375806|NCT02750514|454672986|FG003|Track 4|Participant withdrew consent|0|||
126375807|NCT02750514|454672987|FG004|Track 4|Participant withdrew consent|0|||
126375808|NCT02750514|454672983|FG000|Track 4|Other reasons|0|||
126375809|NCT02750514|454672984|FG001|Track 4|Other reasons|5|||
126375810|NCT02750514|454672985|FG002|Track 4|Other reasons|0|||
126375811|NCT02750514|454672986|FG003|Track 4|Other reasons|3|||
126375812|NCT02750514|454672987|FG004|Track 4|Other reasons|0|||
126375813|NCT02750514|454672983|FG000|Track 4|Disease progression|0|||
126375814|NCT02750514|454672984|FG001|Track 4|Disease progression|33|||
126375815|NCT02750514|454672985|FG002|Track 4|Disease progression|0|||
126375816|NCT02750514|454672986|FG003|Track 4|Disease progression|32|||
126375817|NCT02750514|454672987|FG004|Track 4|Disease progression|0|||
126375818|NCT02750514|454672983|FG000|Track 4|Adverse event unrelated to study drug|0|||
126375819|NCT02750514|454672984|FG001|Track 4|Adverse event unrelated to study drug|5|||
126375820|NCT02750514|454672985|FG002|Track 4|Adverse event unrelated to study drug|0|||
126375821|NCT02750514|454672986|FG003|Track 4|Adverse event unrelated to study drug|0|||
126375822|NCT02750514|454672987|FG004|Track 4|Adverse event unrelated to study drug|0|||
126375823|NCT02750514|454672983|FG000|Track 4|Death|0|||
126375824|NCT02750514|454672984|FG001|Track 4|Death|0|||
126375825|NCT02750514|454672985|FG002|Track 4|Death|0|||
126375826|NCT02750514|454672986|FG003|Track 4|Death|1|||
126375827|NCT02750514|454672987|FG004|Track 4|Death|0|||
126375828|NCT02750514|454672983|FG000|Track 5|Disease progression|0|||
126375829|NCT02750514|454672984|FG001|Track 5|Disease progression|0|||
126375830|NCT02750514|454672985|FG002|Track 5|Disease progression|0|||
126375831|NCT02750514|454672986|FG003|Track 5|Disease progression|0|||
126375832|NCT02750514|454672987|FG004|Track 5|Disease progression|34|||
126375833|NCT02750514|454672983|FG000|Track 5|Adverse event unrelated to study drug|0|||
126375834|NCT02750514|454672984|FG001|Track 5|Adverse event unrelated to study drug|0|||
126375835|NCT02750514|454672985|FG002|Track 5|Adverse event unrelated to study drug|0|||
126375836|NCT02750514|454672986|FG003|Track 5|Adverse event unrelated to study drug|0|||
126375837|NCT02750514|454672987|FG004|Track 5|Adverse event unrelated to study drug|2|||
126375838|NCT02750514|454672983|FG000|Track 5|Study drug toxicity|0|||
126375839|NCT02750514|454672984|FG001|Track 5|Study drug toxicity|0|||
126375840|NCT02750514|454672985|FG002|Track 5|Study drug toxicity|0|||
126375841|NCT02750514|454672986|FG003|Track 5|Study drug toxicity|0|||
126375842|NCT02750514|454672987|FG004|Track 5|Study drug toxicity|2|||
126375843|NCT02750514|454672983|FG000|Track 5|Participant request to discontinue|0|||
126375844|NCT02750514|454672984|FG001|Track 5|Participant request to discontinue|0|||
126375845|NCT02750514|454672985|FG002|Track 5|Participant request to discontinue|0|||
126375846|NCT02750514|454672986|FG003|Track 5|Participant request to discontinue|0|||
126375847|NCT02750514|454672987|FG004|Track 5|Participant request to discontinue|3|||
126375848|NCT02750514|454672983|FG000|Track 5|Other reasons|0|||
126375849|NCT02750514|454672984|FG001|Track 5|Other reasons|0|||
126375850|NCT02750514|454672985|FG002|Track 5|Other reasons|0|||
126375851|NCT02750514|454672986|FG003|Track 5|Other reasons|0|||
126375852|NCT02750514|454672987|FG004|Track 5|Other reasons|2|||
126375853|NCT02553629|454672988|FG000|Overall Study|Logistic reasons|3|||
126375854|NCT02553629|454672989|FG001|Overall Study|Logistic reasons|6|||
126375855|NCT01812057|454672990|FG000|Overall Study|Protocol Violation|1|||
126375856|NCT01812057|454672991|FG001|Overall Study|Protocol Violation|0|||
126375857|NCT01812057|454672990|FG000|Overall Study|Physician Decision|1|||
126375858|NCT01812057|454672991|FG001|Overall Study|Physician Decision|0|||
126375859|NCT01882465|454672994|FG000|Period 1|Lens Discomfort|0|||
126375860|NCT01882465|454672995|FG001|Period 1|Lens Discomfort|0|||
126375861|NCT01882465|454672996|FG002|Period 1|Lens Discomfort|0|||
126375862|NCT01882465|454672997|FG003|Period 1|Lens Discomfort|1|||
126375863|NCT01882465|454672998|FG004|Period 1|Lens Discomfort|0|||
126375864|NCT01882465|454672999|FG005|Period 1|Lens Discomfort|0|||
126375865|NCT01882465|454673000|FG006|Period 1|Lens Discomfort|0|||
126375866|NCT01882465|454672994|FG000|Period 1|Withdrawal by Subject|0|||
126375867|NCT01882465|454672995|FG001|Period 1|Withdrawal by Subject|0|||
126375868|NCT01882465|454672996|FG002|Period 1|Withdrawal by Subject|0|||
126375869|NCT01882465|454672997|FG003|Period 1|Withdrawal by Subject|0|||
126375870|NCT01882465|454672998|FG004|Period 1|Withdrawal by Subject|0|||
126375871|NCT01882465|454672999|FG005|Period 1|Withdrawal by Subject|0|||
126375872|NCT01882465|454673000|FG006|Period 1|Withdrawal by Subject|1|||
126375873|NCT01882465|454672994|FG000|Period 2|Protocol Violation|0|||
126375874|NCT01882465|454672995|FG001|Period 2|Protocol Violation|0|||
126375875|NCT01882465|454672996|FG002|Period 2|Protocol Violation|0|||
126375876|NCT01882465|454672997|FG003|Period 2|Protocol Violation|0|||
126375877|NCT01882465|454672998|FG004|Period 2|Protocol Violation|1|||
126375878|NCT01882465|454672999|FG005|Period 2|Protocol Violation|0|||
126375879|NCT01882465|454673000|FG006|Period 2|Protocol Violation|0|||
126375880|NCT02259114|454673005|FG000|Overall Study|Progressive Disease|14|||
126375881|NCT02259114|454673006|FG001|Overall Study|Progressive Disease|2|||
126375882|NCT02259114|454673007|FG002|Overall Study|Progressive Disease|10|||
126375883|NCT02259114|454673008|FG003|Overall Study|Progressive Disease|2|||
126375884|NCT02259114|454673009|FG004|Overall Study|Progressive Disease|5|||
126375885|NCT02259114|454673005|FG000|Overall Study|Adverse Event|2|||
126375886|NCT02259114|454673006|FG001|Overall Study|Adverse Event|1|||
126375887|NCT02259114|454673007|FG002|Overall Study|Adverse Event|0|||
126375888|NCT02259114|454673008|FG003|Overall Study|Adverse Event|0|||
126375889|NCT02259114|454673009|FG004|Overall Study|Adverse Event|1|||
126375890|NCT02259114|454673005|FG000|Overall Study|Death|3|||
126375891|NCT02259114|454673006|FG001|Overall Study|Death|0|||
126375892|NCT02259114|454673007|FG002|Overall Study|Death|1|||
126375893|NCT02259114|454673008|FG003|Overall Study|Death|0|||
126375894|NCT02259114|454673009|FG004|Overall Study|Death|0|||
126375895|NCT02259114|454673005|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
126375896|NCT02259114|454673006|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
126375897|NCT02259114|454673007|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
126375898|NCT02259114|454673008|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
126375899|NCT02259114|454673009|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
126375900|NCT02259114|454673005|FG000|Overall Study|Withdrawal by Subject|0|||
126375901|NCT02259114|454673006|FG001|Overall Study|Withdrawal by Subject|0|||
126375902|NCT02259114|454673007|FG002|Overall Study|Withdrawal by Subject|1|||
126375903|NCT02259114|454673008|FG003|Overall Study|Withdrawal by Subject|1|||
126375904|NCT02259114|454673009|FG004|Overall Study|Withdrawal by Subject|0|||
126375905|NCT02259114|454673005|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
126375906|NCT02259114|454673006|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
126375907|NCT02259114|454673007|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
126375908|NCT02259114|454673008|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
126375909|NCT02259114|454673009|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
126375910|NCT02259114|454673005|FG000|Overall Study|Not Treated|1|||
126375911|NCT02259114|454673006|FG001|Overall Study|Not Treated|0|||
126375912|NCT02259114|454673007|FG002|Overall Study|Not Treated|0|||
126375913|NCT02259114|454673008|FG003|Overall Study|Not Treated|0|||
126375914|NCT02259114|454673009|FG004|Overall Study|Not Treated|0|||
126375915|NCT03937479|454673010|FG000|Overall Study|Adverse Event|2|||
126375916|NCT03937479|454673011|FG001|Overall Study|Adverse Event|3|||
126375917|NCT03937479|454673012|FG002|Overall Study|Adverse Event|0|||
126375918|NCT03937479|454673013|FG003|Overall Study|Adverse Event|0|||
126375919|NCT03937479|454673014|FG004|Overall Study|Adverse Event|1|||
126375920|NCT03937479|454673010|FG000|Overall Study|Withdrawal by Subject|3|||
126375921|NCT03937479|454673011|FG001|Overall Study|Withdrawal by Subject|5|||
126375922|NCT03937479|454673012|FG002|Overall Study|Withdrawal by Subject|2|||
126375923|NCT03937479|454673013|FG003|Overall Study|Withdrawal by Subject|2|||
126375924|NCT03937479|454673014|FG004|Overall Study|Withdrawal by Subject|1|||
126375925|NCT03937479|454673010|FG000|Overall Study|Protocol Violation|5|||
126375926|NCT03937479|454673011|FG001|Overall Study|Protocol Violation|6|||
126375927|NCT03937479|454673012|FG002|Overall Study|Protocol Violation|4|||
126375928|NCT03937479|454673013|FG003|Overall Study|Protocol Violation|3|||
126375929|NCT03937479|454673014|FG004|Overall Study|Protocol Violation|2|||
126375930|NCT03937479|454673010|FG000|Overall Study|Lost to Follow-up|0|||
126375931|NCT03937479|454673011|FG001|Overall Study|Lost to Follow-up|1|||
125886306|NCT02374450|452878981|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
125886307|NCT02374450|452878982|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
126375932|NCT03937479|454673012|FG002|Overall Study|Lost to Follow-up|0|||
126375933|NCT03937479|454673013|FG003|Overall Study|Lost to Follow-up|1|||
126375934|NCT03937479|454673014|FG004|Overall Study|Lost to Follow-up|0|||
126375935|NCT03937479|454673010|FG000|Overall Study|Physician Decision|0|||
126375936|NCT03937479|454673011|FG001|Overall Study|Physician Decision|0|||
126375937|NCT03937479|454673012|FG002|Overall Study|Physician Decision|1|||
126375938|NCT03937479|454673013|FG003|Overall Study|Physician Decision|0|||
126375939|NCT03937479|454673014|FG004|Overall Study|Physician Decision|1|||
126375940|NCT01378117|454673017|FG000|Overall Study|withdrawal|2|||
126375941|NCT01378117|454673018|FG001|Overall Study|withdrawal|1|||
126375942|NCT01378117|454673019|FG002|Overall Study|withdrawal|2|||
126375943|NCT01378117|454673017|FG000|Overall Study|discharged before med given|2|||
126375944|NCT01378117|454673018|FG001|Overall Study|discharged before med given|0|||
126375945|NCT01378117|454673019|FG002|Overall Study|discharged before med given|1|||
125886308|NCT02374450|452878983|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
125886309|NCT02374450|452878981|FG000|Overall Study|Other|0|||
125886310|NCT02374450|452878982|FG001|Overall Study|Other|21|||
126375946|NCT01854528|454673021|FG000|Overall Study|Adverse Event|0|||
126375947|NCT01854528|454673022|FG001|Overall Study|Adverse Event|4|||
126375948|NCT01854528|454673021|FG000|Overall Study|Withdrawal by Subject|0|||
126375949|NCT01854528|454673022|FG001|Overall Study|Withdrawal by Subject|2|||
125886311|NCT02374450|452878983|FG002|Overall Study|Other|79|||
126375950|NCT01854528|454673021|FG000|Overall Study|Virologic Failure|0|||
126375951|NCT01854528|454673022|FG001|Overall Study|Virologic Failure|9|||
126375952|NCT02961244|454673023|FG000|Overall Study|Protocol Violation|0|||
126375953|NCT02961244|454673024|FG001|Overall Study|Protocol Violation|1|||
126375954|NCT02961244|454673023|FG000|Overall Study|Withdrawal by Subject|1|||
126375955|NCT02961244|454673024|FG001|Overall Study|Withdrawal by Subject|2|||
126375956|NCT02961244|454673023|FG000|Overall Study|Surgery plan change after study approval|0|||
126375957|NCT02961244|454673024|FG001|Overall Study|Surgery plan change after study approval|2|||
126375958|NCT02961244|454673023|FG000|Overall Study|Lost to Follow-up|0|||
126375959|NCT02961244|454673024|FG001|Overall Study|Lost to Follow-up|2|||
126375960|NCT02961244|454673023|FG000|Overall Study|İnadequate data|0|||
126375961|NCT02961244|454673024|FG001|Overall Study|İnadequate data|2|||
126375962|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
126375963|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
126375964|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
126375965|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
126375966|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
126375967|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
126375968|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
126375969|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
126375970|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
126375971|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
126375972|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
126375973|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
126375974|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
126375975|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
126375976|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
126375977|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
126375978|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
126375979|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
126375980|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
126375981|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
126375982|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
126375983|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
126375984|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
126375985|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
126104104|NCT01177722|453675808|FG001|Overall Study|Withdrawal by Subject|6|||
126104105|NCT01177722|453675809|FG002|Overall Study|Withdrawal by Subject|4|||
126375986|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
126375987|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
126375988|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
126375989|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
126375990|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
126375991|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
126375992|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
126375993|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
126375994|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
126375995|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
126375996|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
126375997|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
126375998|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
126375999|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
126376000|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
126376001|NCT01904721|454673029|FG000|Overall Study|Other Reasons|0|||
126376002|NCT01904721|454673030|FG001|Overall Study|Other Reasons|0|||
126376003|NCT01904721|454673031|FG002|Overall Study|Other Reasons|1|||
126376004|NCT01904721|454673032|FG003|Overall Study|Other Reasons|1|||
126376005|NCT01904721|454673033|FG004|Overall Study|Other Reasons|2|||
126376006|NCT01904721|454673034|FG005|Overall Study|Other Reasons|2|||
126376007|NCT01904721|454673035|FG006|Overall Study|Other Reasons|2|||
126376008|NCT01904721|454673029|FG000|Overall Study|Personal Reasons|0|||
126376009|NCT01904721|454673030|FG001|Overall Study|Personal Reasons|0|||
126376010|NCT01904721|454673031|FG002|Overall Study|Personal Reasons|0|||
126376011|NCT01904721|454673032|FG003|Overall Study|Personal Reasons|0|||
126376012|NCT01904721|454673033|FG004|Overall Study|Personal Reasons|2|||
126376013|NCT01904721|454673034|FG005|Overall Study|Personal Reasons|3|||
126376014|NCT01904721|454673035|FG006|Overall Study|Personal Reasons|3|||
126376015|NCT01904721|454673029|FG000|Overall Study|Lost to Follow-up|0|||
126376016|NCT01904721|454673030|FG001|Overall Study|Lost to Follow-up|0|||
126376017|NCT01904721|454673031|FG002|Overall Study|Lost to Follow-up|0|||
126376018|NCT01904721|454673032|FG003|Overall Study|Lost to Follow-up|0|||
126376019|NCT01904721|454673033|FG004|Overall Study|Lost to Follow-up|1|||
126376020|NCT01904721|454673034|FG005|Overall Study|Lost to Follow-up|3|||
126376021|NCT01904721|454673035|FG006|Overall Study|Lost to Follow-up|1|||
126376022|NCT01904721|454673029|FG000|Overall Study|Lack of Efficacy|0|||
126376023|NCT01904721|454673030|FG001|Overall Study|Lack of Efficacy|0|||
126376024|NCT01904721|454673031|FG002|Overall Study|Lack of Efficacy|0|||
126376025|NCT01904721|454673032|FG003|Overall Study|Lack of Efficacy|0|||
126376026|NCT01904721|454673033|FG004|Overall Study|Lack of Efficacy|0|||
126376027|NCT01904721|454673034|FG005|Overall Study|Lack of Efficacy|0|||
126376028|NCT01904721|454673035|FG006|Overall Study|Lack of Efficacy|1|||
126376029|NCT01904721|454673029|FG000|Overall Study|Adverse Event|0|||
126376030|NCT01904721|454673030|FG001|Overall Study|Adverse Event|0|||
126376031|NCT01904721|454673031|FG002|Overall Study|Adverse Event|0|||
126376032|NCT01904721|454673032|FG003|Overall Study|Adverse Event|0|||
126376033|NCT01904721|454673033|FG004|Overall Study|Adverse Event|3|||
126376034|NCT01904721|454673034|FG005|Overall Study|Adverse Event|1|||
126376035|NCT01904721|454673035|FG006|Overall Study|Adverse Event|0|||
126376036|NCT01082614|454673036|FG000|Overall Study|Adverse Event|1|||
126376037|NCT01082614|454673037|FG001|Overall Study|Adverse Event|4|||
126376038|NCT01082614|454673036|FG000|Overall Study|Equipment Malfunction|0|||
126376039|NCT01082614|454673037|FG001|Overall Study|Equipment Malfunction|1|||
126376040|NCT01082614|454673036|FG000|Overall Study|Physician Decision|2|||
126376041|NCT01082614|454673037|FG001|Overall Study|Physician Decision|0|||
126376042|NCT00811720|454673041|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
126376043|NCT00811720|454673042|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
126376044|NCT00811720|454673041|FG000|All Treated Patients|Adverse Event|20|||
126376045|NCT00811720|454673042|FG001|All Treated Patients|Adverse Event|62|||
126104106|NCT01177722|453675810|FG003|Overall Study|Withdrawal by Subject|6|||
126376046|NCT00811720|454673041|FG000|All Treated Patients|Lack of Efficacy|22|||
126376047|NCT00811720|454673042|FG001|All Treated Patients|Lack of Efficacy|18|||
126376048|NCT00811720|454673041|FG000|All Treated Patients|Non-compliance|0|||
126376049|NCT00811720|454673042|FG001|All Treated Patients|Non-compliance|14|||
126376050|NCT00811720|454673041|FG000|All Treated Patients|Protocol Violation|9|||
126376051|NCT00811720|454673042|FG001|All Treated Patients|Protocol Violation|16|||
126376052|NCT00811720|454673041|FG000|All Treated Patients|Withdrawal by Subject|28|||
126376053|NCT00811720|454673042|FG001|All Treated Patients|Withdrawal by Subject|34|||
126376054|NCT00811720|454673041|FG000|All Treated Patients|Lost to Follow-up|10|||
126376055|NCT00811720|454673042|FG001|All Treated Patients|Lost to Follow-up|16|||
126376056|NCT00811720|454673041|FG000|All Treated Patients|Other Reason|7|||
126376057|NCT00811720|454673042|FG001|All Treated Patients|Other Reason|4|||
126376058|NCT01077063|454673043|FG000|Overall Study|Adverse Event|3|||
126376059|NCT01077063|454673044|FG001|Overall Study|Adverse Event|0|||
126376060|NCT01077063|454673043|FG000|Overall Study|Death|1|||
126376061|NCT01077063|454673044|FG001|Overall Study|Death|1|||
126376062|NCT01077063|454673043|FG000|Overall Study|Withdrawal by Subject|0|||
126376063|NCT01077063|454673044|FG001|Overall Study|Withdrawal by Subject|2|||
126376064|NCT03894891|454673045|FG000|Overall Study|Withdrawal by Subject|1|||
126376065|NCT03894891|454673045|FG000|Overall Study|Completed protocol treatment per protocol|5|||
126376066|NCT00553631|454673046|FG000|Overall Study|Withdrawal by Subject|0|||
126376067|NCT00553631|454673047|FG001|Overall Study|Withdrawal by Subject|1|||
126376068|NCT00553631|454673046|FG000|Overall Study|Lost to Follow-up|1|||
126376069|NCT00553631|454673047|FG001|Overall Study|Lost to Follow-up|0|||
126376070|NCT02761642|454673048|FG000|Overall Study|Did not Receive Study Treatment|3|||
126376071|NCT02761642|454673048|FG000|Overall Study|Adverse Event|13|||
126376072|NCT02761642|454673048|FG000|Overall Study|Withdrawal by Subject|2|||
126376073|NCT02761642|454673048|FG000|Overall Study|Non-compliant|7|||
126376074|NCT02761642|454673048|FG000|Overall Study|Death|3|||
126376075|NCT02761642|454673048|FG000|Overall Study|Lack of Efficacy|20|||
126376076|NCT02761642|454673048|FG000|Overall Study|Physician Decision|1|||
126376077|NCT02761642|454673048|FG000|Overall Study|Reason Unspecified|21|||
126376078|NCT00950651|454673049|FG000|Overall Study|Adverse Event|17|||
126376079|NCT00950651|454673050|FG001|Overall Study|Adverse Event|20|||
126376080|NCT00950651|454673049|FG000|Overall Study|Death|1|||
126376081|NCT00950651|454673050|FG001|Overall Study|Death|0|||
126376082|NCT00950651|454673049|FG000|Overall Study|Lack of Efficacy|2|||
126376083|NCT00950651|454673050|FG001|Overall Study|Lack of Efficacy|2|||
126376084|NCT00950651|454673049|FG000|Overall Study|Protocol Violation|3|||
126376085|NCT00950651|454673050|FG001|Overall Study|Protocol Violation|4|||
126376086|NCT00950651|454673049|FG000|Overall Study|Withdrawal by Subject|8|||
126376087|NCT00950651|454673050|FG001|Overall Study|Withdrawal by Subject|9|||
126376088|NCT02850978|454673055|FG000|Overall Study|Uncollectable CRF|27|||
126376089|NCT02850978|454673055|FG000|Overall Study|No visit since the first visit|35|||
126376090|NCT02850978|454673055|FG000|Overall Study|Adverse Event|81|||
126376091|NCT02850978|454673055|FG000|Overall Study|Lack of Efficacy|40|||
126376092|NCT02850978|454673055|FG000|Overall Study|Improvement in condition|34|||
126376093|NCT02850978|454673055|FG000|Overall Study|Lost to Follow-up|121|||
126376094|NCT02850978|454673055|FG000|Overall Study|Reason not listed|88|||
126376095|NCT03188263|454673058|FG000|Overall Study|Withdrawal by Subject|3|||
126376096|NCT03188263|454673059|FG001|Overall Study|Withdrawal by Subject|0|||
126376097|NCT03188263|454673058|FG000|Overall Study|Physician Decision|1|||
126376098|NCT03188263|454673059|FG001|Overall Study|Physician Decision|0|||
126376099|NCT01030822|454673060|FG000|Overall Study|Moved/migrated from study area|6|||
126376100|NCT01030822|454673061|FG001|Overall Study|Moved/migrated from study area|7|||
126376101|NCT01030822|454673062|FG002|Overall Study|Moved/migrated from study area|3|||
126376102|NCT01030822|454673060|FG000|Overall Study|Withdrawal by Subject|16|||
126376103|NCT01030822|454673061|FG001|Overall Study|Withdrawal by Subject|13|||
126376104|NCT01030822|454673062|FG002|Overall Study|Withdrawal by Subject|16|||
126376105|NCT01030822|454673060|FG000|Overall Study|Lost to Follow-up|9|||
126376106|NCT01030822|454673061|FG001|Overall Study|Lost to Follow-up|4|||
126376107|NCT01030822|454673062|FG002|Overall Study|Lost to Follow-up|7|||
126376108|NCT00539240|454673063|FG000|Overall Study|Withdrawal by Subject|0|||
126376109|NCT00539240|454673064|FG001|Overall Study|Withdrawal by Subject|2|||
126376110|NCT00539240|454673065|FG002|Overall Study|Withdrawal by Subject|0|||
126376111|NCT00539240|454673063|FG000|Overall Study|Protocol Violation|1|||
126376112|NCT00539240|454673064|FG001|Overall Study|Protocol Violation|1|||
126376113|NCT00539240|454673065|FG002|Overall Study|Protocol Violation|4|||
126376114|NCT00539240|454673063|FG000|Overall Study|Lost to Follow-up|2|||
126376115|NCT00539240|454673064|FG001|Overall Study|Lost to Follow-up|3|||
126376116|NCT00539240|454673065|FG002|Overall Study|Lost to Follow-up|1|||
126376117|NCT00539240|454673063|FG000|Overall Study|Adverse Event|3|||
126376118|NCT00539240|454673064|FG001|Overall Study|Adverse Event|1|||
126376119|NCT00539240|454673065|FG002|Overall Study|Adverse Event|10|||
126376120|NCT01055613|454673066|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
126376121|NCT01055613|454673067|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126376122|NCT01055613|454673066|FG000|Overall Study|Unacceptable lens fit|1|||
126376123|NCT01055613|454673067|FG001|Overall Study|Unacceptable lens fit|0|||
126376124|NCT01055613|454673066|FG000|Overall Study|Discomfort|2|||
126376125|NCT01055613|454673067|FG001|Overall Study|Discomfort|1|||
126376126|NCT01055613|454673066|FG000|Overall Study|Lost to Follow-up|1|||
126376127|NCT01055613|454673067|FG001|Overall Study|Lost to Follow-up|1|||
126376128|NCT01055613|454673066|FG000|Overall Study|Protocol Violation|1|||
126376129|NCT01055613|454673067|FG001|Overall Study|Protocol Violation|1|||
126376130|NCT01055613|454673066|FG000|Overall Study|Subject Disinterest|1|||
126376131|NCT01055613|454673067|FG001|Overall Study|Subject Disinterest|1|||
126376132|NCT02765399|454673068|FG000|Overall Study|Nausea|1|||
126376133|NCT02765399|454673069|FG001|Overall Study|Nausea|0|||
126376134|NCT01182298|454673076|FG000|Overall Study|Lack of Efficacy|4|||
126376135|NCT01182298|454673076|FG000|Overall Study|Withdrawal by Subject|2|||
126376136|NCT04540367|454673090|FG000|Overall Study|Withdrawal by Subject|0|||
126376137|NCT04540367|454673091|FG001|Overall Study|Withdrawal by Subject|0|||
126376138|NCT04540367|454673092|FG002|Overall Study|Withdrawal by Subject|0|||
126376139|NCT04540367|454673093|FG003|Overall Study|Withdrawal by Subject|2|||
126376140|NCT04540367|454673090|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
126376141|NCT04540367|454673091|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
126376142|NCT04540367|454673092|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
126376143|NCT04540367|454673093|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
126376144|NCT04540367|454673090|FG000|Overall Study|Adverse Event|0|||
126376145|NCT04540367|454673091|FG001|Overall Study|Adverse Event|0|||
126376146|NCT04540367|454673092|FG002|Overall Study|Adverse Event|1|||
126376147|NCT04540367|454673093|FG003|Overall Study|Adverse Event|1|||
126376148|NCT03958331|454673095|FG000|Overall Study|Withdrawal by Subject|3|||
126376149|NCT03958331|454673096|FG001|Overall Study|Withdrawal by Subject|1|||
126376150|NCT03958331|454673097|FG002|Overall Study|Withdrawal by Subject|5|||
126376151|NCT03958331|454673095|FG000|Overall Study|Weaned from medicine|2|||
126376152|NCT03958331|454673096|FG001|Overall Study|Weaned from medicine|0|||
126376153|NCT03958331|454673097|FG002|Overall Study|Weaned from medicine|0|||
126376154|NCT03958331|454673095|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
126376155|NCT03958331|454673096|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
126376156|NCT03958331|454673097|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
126376157|NCT04422431|454673100|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
126376158|NCT04422431|454673100|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
126376159|NCT04422431|454673100|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
126376160|NCT04422431|454673100|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
126376161|NCT04422431|454673100|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
126376162|NCT04422431|454673100|FG000|Extension Period (48 Weeks)|Other than specified|2|||
126376163|NCT02317627|454673103|FG000|Overall Study|Withdrawal by Subject|0|||
126376164|NCT02317627|454673104|FG001|Overall Study|Withdrawal by Subject|1|||
126376165|NCT02317627|454673105|FG002|Overall Study|Withdrawal by Subject|1|||
126376166|NCT02317627|454673103|FG000|Overall Study|Lost to Follow-up|2|||
126376167|NCT02317627|454673104|FG001|Overall Study|Lost to Follow-up|0|||
126376168|NCT02317627|454673105|FG002|Overall Study|Lost to Follow-up|0|||
126376169|NCT02317627|454673103|FG000|Overall Study|Stopped by Investigator|0|||
126376170|NCT02317627|454673104|FG001|Overall Study|Stopped by Investigator|1|||
126376171|NCT02317627|454673105|FG002|Overall Study|Stopped by Investigator|0|||
126376172|NCT02317627|454673103|FG000|Overall Study|Adverse Event|0|||
126376173|NCT02317627|454673104|FG001|Overall Study|Adverse Event|2|||
126376174|NCT02317627|454673105|FG002|Overall Study|Adverse Event|3|||
126376175|NCT02317627|454673103|FG000|Overall Study|Non-compliance with study drug|0|||
126376176|NCT02317627|454673104|FG001|Overall Study|Non-compliance with study drug|1|||
126376177|NCT02317627|454673105|FG002|Overall Study|Non-compliance with study drug|0|||
126376178|NCT01088906|454673107|FG000|Overall Study|Inclusion error|1|||
126376179|NCT01088906|454673107|FG000|Overall Study|Did not receive study treatment|3|||
126376180|NCT01088906|454673107|FG000|Overall Study|Missing data|1|||
126376181|NCT00027560|454673108|FG000|Overall Study|Withdrawal by Subject|1|||
126047962|NCT00146172|453473816|FG005|Overall Study|Death|0|||
126376182|NCT03384875|454673109|FG000|Overall Study|Death|1|||
126376183|NCT03384875|454673110|FG001|Overall Study|Death|1|||
126376184|NCT03384875|454673111|FG002|Overall Study|Death|0|||
126376185|NCT03384875|454673109|FG000|Overall Study|Reason not provided|1|||
126376186|NCT03384875|454673110|FG001|Overall Study|Reason not provided|0|||
126376187|NCT03384875|454673111|FG002|Overall Study|Reason not provided|0|||
126376188|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
126376189|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
126376190|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
126376191|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
126376192|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
126376193|NCT02735421|454674529|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
126376194|NCT02735421|454674529|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
126376195|NCT00939107|454674530|FG000|Overall Study|Lost to Follow-up|14|||
126376196|NCT00939107|454674531|FG001|Overall Study|Lost to Follow-up|12|||
126376197|NCT05010070|454674532|FG000|Overall Study|Lost to Follow-up|1|||
126376198|NCT05010070|454674532|FG000|Overall Study|Withdrawal by Subject|1|||
126376199|NCT01772550|454674544|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
126376200|NCT01772550|454674545|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
126376201|NCT01772550|454674546|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
126376202|NCT01772550|454674544|FG000|Overall Study|Adverse Event|0|||
126376203|NCT01772550|454674545|FG001|Overall Study|Adverse Event|0|||
126376204|NCT01772550|454674546|FG002|Overall Study|Adverse Event|1|||
126376205|NCT03374358|454674549|FG000|Overall Study|Withdrawal by Subject|0|||
126376206|NCT03374358|454674550|FG001|Overall Study|Withdrawal by Subject|2|||
126376207|NCT03183063|454674551|FG000|Overall Study|Withdrawal by Subject|2|||
126376208|NCT03183063|454674552|FG001|Overall Study|Withdrawal by Subject|0|||
126047963|NCT00146172|453473817|FG006|Overall Study|Death|1|||
126376209|NCT03183063|454674553|FG002|Overall Study|Withdrawal by Subject|0|||
126376210|NCT03183063|454674551|FG000|Overall Study|Physician Decision|3|||
126376211|NCT03183063|454674552|FG001|Overall Study|Physician Decision|4|||
125886312|NCT01646125|452879985|FG000|Overall Study|Untreated|2|||
126376212|NCT03183063|454674553|FG002|Overall Study|Physician Decision|4|||
126376213|NCT01127633|454674554|FG000|Overall Study|Adverse Event|74|||
126376214|NCT01127633|454674555|FG001|Overall Study|Adverse Event|73|||
126376215|NCT01127633|454674554|FG000|Overall Study|Death|40|||
126376216|NCT01127633|454674555|FG001|Overall Study|Death|43|||
126376217|NCT01127633|454674554|FG000|Overall Study|Lost to Follow-up|4|||
126376218|NCT01127633|454674555|FG001|Overall Study|Lost to Follow-up|0|||
126376219|NCT01127633|454674554|FG000|Overall Study|Parent/Caregiver Decision|246|||
126376220|NCT01127633|454674555|FG001|Overall Study|Parent/Caregiver Decision|228|||
126376221|NCT01127633|454674554|FG000|Overall Study|Physician Decision|60|||
126376222|NCT01127633|454674555|FG001|Overall Study|Physician Decision|45|||
126376223|NCT01127633|454674554|FG000|Overall Study|Withdrawal by Subject|57|||
126376224|NCT01127633|454674555|FG001|Overall Study|Withdrawal by Subject|72|||
126376225|NCT01127633|454674554|FG000|Overall Study|Sponsor Decision|163|||
126376226|NCT01127633|454674555|FG001|Overall Study|Sponsor Decision|195|||
126376227|NCT01127633|454674554|FG000|Overall Study|Protocol Violation|8|||
126376228|NCT01127633|454674555|FG001|Overall Study|Protocol Violation|16|||
126376229|NCT01127633|454674554|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
126376230|NCT01127633|454674555|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
126376231|NCT01127633|454674554|FG000|Overall Study|Not treated|1|||
126376232|NCT01127633|454674555|FG001|Overall Study|Not treated|0|||
126376233|NCT00688467|454674557|FG000|Treatment Period 1|Adverse Event|2|||
126376234|NCT00688467|454674558|FG001|Treatment Period 1|Adverse Event|1|||
126376235|NCT00688467|454674557|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
126376236|NCT00688467|454674558|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
126376237|NCT00688467|454674557|FG000|Treatment Period 2|Protocol Violation|0|||
126376238|NCT00688467|454674558|FG001|Treatment Period 2|Protocol Violation|1|||
126376239|NCT00688467|454674557|FG000|Treatment Period 2|Adverse Event|0|||
126376240|NCT00688467|454674558|FG001|Treatment Period 2|Adverse Event|1|||
126376241|NCT00690794|454674561|FG000|Overall Study|Adverse Event|12|||
126376242|NCT00690794|454674562|FG001|Overall Study|Adverse Event|10|||
126376243|NCT00690794|454674561|FG000|Overall Study|Lost to Follow-up|1|||
126047964|NCT00146172|453473818|FG007|Overall Study|Death|0|||
126376244|NCT00690794|454674562|FG001|Overall Study|Lost to Follow-up|4|||
126376245|NCT00690794|454674561|FG000|Overall Study|Withdrawal by Subject|0|||
126376246|NCT00690794|454674562|FG001|Overall Study|Withdrawal by Subject|9|||
125886313|NCT01646125|452879986|FG001|Overall Study|Untreated|5|||
126376247|NCT00690794|454674561|FG000|Overall Study|Protocol Violation|6|||
126376248|NCT00690794|454674562|FG001|Overall Study|Protocol Violation|7|||
126376249|NCT00690794|454674561|FG000|Overall Study|Noncompliance|1|||
126376250|NCT00690794|454674562|FG001|Overall Study|Noncompliance|2|||
126376251|NCT00690794|454674561|FG000|Overall Study|Other not specified|1|||
126376252|NCT00690794|454674562|FG001|Overall Study|Other not specified|3|||
126047965|NCT00146172|453473811|FG000|Overall Study|Physician Decision|0|||
126047966|NCT00146172|453473812|FG001|Overall Study|Physician Decision|0|||
126376253|NCT01823107|454674563|FG000|Overall Study|Withdrawal by Subject|1|||
126047967|NCT00146172|453473813|FG002|Overall Study|Physician Decision|0|||
126047968|NCT00146172|453473814|FG003|Overall Study|Physician Decision|0|||
126376254|NCT01343888|454674564|FG000|Overall Study|Adverse Event|12|||
126376255|NCT01343888|454674565|FG001|Overall Study|Adverse Event|22|||
126376256|NCT01343888|454674566|FG002|Overall Study|Adverse Event|5|||
126376257|NCT01343888|454674564|FG000|Overall Study|Lack of Efficacy|9|||
126376258|NCT01343888|454674565|FG001|Overall Study|Lack of Efficacy|9|||
126376259|NCT01343888|454674566|FG002|Overall Study|Lack of Efficacy|13|||
126376260|NCT01343888|454674564|FG000|Overall Study|Lost to Follow-up|0|||
126376261|NCT01343888|454674565|FG001|Overall Study|Lost to Follow-up|2|||
126376262|NCT01343888|454674566|FG002|Overall Study|Lost to Follow-up|1|||
126376263|NCT01343888|454674564|FG000|Overall Study|Protocol Violation|0|||
126376264|NCT01343888|454674565|FG001|Overall Study|Protocol Violation|2|||
126376265|NCT01343888|454674566|FG002|Overall Study|Protocol Violation|0|||
126376266|NCT01343888|454674564|FG000|Overall Study|Withdrawal by Subject|4|||
126376267|NCT01343888|454674565|FG001|Overall Study|Withdrawal by Subject|4|||
126376268|NCT01343888|454674566|FG002|Overall Study|Withdrawal by Subject|2|||
126376269|NCT01343888|454674564|FG000|Overall Study|other than stated above|0|||
126376270|NCT01343888|454674565|FG001|Overall Study|other than stated above|0|||
126376271|NCT01343888|454674566|FG002|Overall Study|other than stated above|1|||
126376272|NCT00800735|454674569|FG000|Overall Study|Administrative/Other|2|||
126376273|NCT00800735|454674569|FG000|Overall Study|Insufficient Therapeutic Response|2|||
126376274|NCT00800735|454674569|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
126376275|NCT00800735|454674569|FG000|Overall Study|Withdrew Consent|3|||
126376276|NCT02805790|454674570|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
126376277|NCT02805790|454674571|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
126376278|NCT04460183|454674572|FG000|Overall Study|Lost to Follow-up|3|||
126376279|NCT04460183|454674573|FG001|Overall Study|Lost to Follow-up|1|||
126376280|NCT04460183|454674572|FG000|Overall Study|Withdrawal by Subject|1|||
126376281|NCT04460183|454674573|FG001|Overall Study|Withdrawal by Subject|0|||
126376282|NCT00856323|454674574|FG000|Overall Study|Withdrawal by Subject|2|||
126376283|NCT01847092|454674575|FG000|Overall Study|Adverse Event|12|||
126376284|NCT01847092|454674576|FG001|Overall Study|Adverse Event|3|||
126376285|NCT01847092|454674575|FG000|Overall Study|Withdrawal by Subject|5|||
126376286|NCT01847092|454674576|FG001|Overall Study|Withdrawal by Subject|5|||
126376287|NCT01847092|454674575|FG000|Overall Study|Protocol Specified|8|||
126376288|NCT01847092|454674576|FG001|Overall Study|Protocol Specified|0|||
126376289|NCT01847092|454674575|FG000|Overall Study|Physician Decision|1|||
126376290|NCT01847092|454674576|FG001|Overall Study|Physician Decision|1|||
126376291|NCT01847092|454674575|FG000|Overall Study|Protocol Violation|0|||
126376292|NCT01847092|454674576|FG001|Overall Study|Protocol Violation|2|||
126376293|NCT00825994|454674577|FG000|Overall Study|Withdrawal by Subject|2|||
126376294|NCT00825994|454674577|FG000|Overall Study|Lost to Follow-up|1|||
126376295|NCT00825994|454674577|FG000|Overall Study|Protocol Violation|1|||
126376296|NCT00825994|454674577|FG000|Overall Study|Placebo Responder at V2|1|||
126376297|NCT01331681|454674578|FG000|Overall Study|Adverse Event|10|||
126376298|NCT01331681|454674579|FG001|Overall Study|Adverse Event|13|||
126376299|NCT01331681|454674580|FG002|Overall Study|Adverse Event|10|||
126376300|NCT01331681|454674578|FG000|Overall Study|Death|6|||
126376301|NCT01331681|454674579|FG001|Overall Study|Death|6|||
126376302|NCT01331681|454674580|FG002|Overall Study|Death|2|||
126376303|NCT01331681|454674578|FG000|Overall Study|Lack of Efficacy|0|||
126376304|NCT01331681|454674579|FG001|Overall Study|Lack of Efficacy|1|||
126376305|NCT01331681|454674580|FG002|Overall Study|Lack of Efficacy|0|||
126376306|NCT01331681|454674578|FG000|Overall Study|Withdrawal by Subject|12|||
126376307|NCT01331681|454674579|FG001|Overall Study|Withdrawal by Subject|8|||
126376308|NCT01331681|454674580|FG002|Overall Study|Withdrawal by Subject|15|||
126376309|NCT01331681|454674578|FG000|Overall Study|Protocol Violation|1|||
126376310|NCT01331681|454674579|FG001|Overall Study|Protocol Violation|1|||
126376311|NCT01331681|454674580|FG002|Overall Study|Protocol Violation|0|||
126376312|NCT01331681|454674578|FG000|Overall Study|Lost to Follow-up|2|||
126376313|NCT01331681|454674579|FG001|Overall Study|Lost to Follow-up|4|||
126376314|NCT01331681|454674580|FG002|Overall Study|Lost to Follow-up|1|||
126047969|NCT00146172|453473815|FG004|Overall Study|Physician Decision|0|||
126376315|NCT01331681|454674578|FG000|Overall Study|Physician Decision|2|||
126376316|NCT01331681|454674579|FG001|Overall Study|Physician Decision|0|||
126376317|NCT01331681|454674580|FG002|Overall Study|Physician Decision|4|||
126376318|NCT01331681|454674578|FG000|Overall Study|Therapeutic procedure required|1|||
126376319|NCT01331681|454674579|FG001|Overall Study|Therapeutic procedure required|0|||
126376320|NCT01331681|454674580|FG002|Overall Study|Therapeutic procedure required|0|||
125886314|NCT01646125|452879985|FG000|Overall Study|Adverse Event|2|||
125886315|NCT01646125|452879986|FG001|Overall Study|Adverse Event|1|||
126376321|NCT01331681|454674578|FG000|Overall Study|Sponsor decision|1|||
126376322|NCT01331681|454674579|FG001|Overall Study|Sponsor decision|1|||
126376323|NCT01331681|454674580|FG002|Overall Study|Sponsor decision|0|||
126376324|NCT01331681|454674578|FG000|Overall Study|Switching to other therapy|0|||
126376325|NCT01331681|454674579|FG001|Overall Study|Switching to other therapy|0|||
126376326|NCT01331681|454674580|FG002|Overall Study|Switching to other therapy|1|||
126376327|NCT01331681|454674578|FG000|Overall Study|Not Received Study Treatment|0|||
126376328|NCT01331681|454674579|FG001|Overall Study|Not Received Study Treatment|0|||
126376329|NCT01331681|454674580|FG002|Overall Study|Not Received Study Treatment|2|||
126376330|NCT01876381|454674582|FG000|Overall Study|Lack of Efficacy|5|||
126376331|NCT01876381|454674582|FG000|Overall Study|Physician Decision|1|||
126376332|NCT01876381|454674582|FG000|Overall Study|Withdrawal by Subject|1|||
126376333|NCT00461708|454674583|FG000|Overall Study|Adverse Event|17|||
126376334|NCT00461708|454674584|FG001|Overall Study|Adverse Event|7|||
126376335|NCT00461708|454674583|FG000|Overall Study|Lack of Efficacy|68|||
126376336|NCT00461708|454674584|FG001|Overall Study|Lack of Efficacy|20|||
126376337|NCT00461708|454674583|FG000|Overall Study|Physician Decision|10|||
126376338|NCT00461708|454674584|FG001|Overall Study|Physician Decision|4|||
126376339|NCT00461708|454674583|FG000|Overall Study|Withdrawal by Subject|8|||
126376340|NCT00461708|454674584|FG001|Overall Study|Withdrawal by Subject|2|||
126376341|NCT00461708|454674583|FG000|Overall Study|Other|4|||
126376342|NCT00461708|454674584|FG001|Overall Study|Other|4|||
126376343|NCT00461708|454674583|FG000|Overall Study|Death|8|||
126376344|NCT00461708|454674584|FG001|Overall Study|Death|1|||
126376345|NCT02394561|454674585|FG000|CORE Phase|Adverse Event|7|||
126376346|NCT02394561|454674586|FG001|CORE Phase|Adverse Event|9|||
126376347|NCT02394561|454674585|FG000|CORE Phase|Death|0|||
126376348|NCT02394561|454674586|FG001|CORE Phase|Death|1|||
126376349|NCT02394561|454674585|FG000|CORE Phase|Pregnancy|1|||
126047970|NCT00146172|453473816|FG005|Overall Study|Physician Decision|0|||
126376350|NCT02394561|454674586|FG001|CORE Phase|Pregnancy|0|||
126376351|NCT02394561|454674585|FG000|CORE Phase|Lost to Follow-up|1|||
126376352|NCT02394561|454674586|FG001|CORE Phase|Lost to Follow-up|0|||
126376353|NCT02394561|454674585|FG000|CORE Phase|Physician Decision|1|||
126376354|NCT02394561|454674586|FG001|CORE Phase|Physician Decision|1|||
126376355|NCT02394561|454674585|FG000|CORE Phase|Withdrawal by Subject|2|||
126376356|NCT02394561|454674586|FG001|CORE Phase|Withdrawal by Subject|2|||
126376357|NCT02394561|454674585|FG000|CORE Phase|Lack of Efficacy|1|||
126376358|NCT02394561|454674586|FG001|CORE Phase|Lack of Efficacy|6|||
126376359|NCT02394561|454674585|FG000|Extension Phase|Adverse Event|6|||
126376360|NCT02394561|454674586|FG001|Extension Phase|Adverse Event|1|||
126376361|NCT02394561|454674585|FG000|Extension Phase|Death|0|||
126376362|NCT02394561|454674586|FG001|Extension Phase|Death|1|||
126376363|NCT02394561|454674585|FG000|Extension Phase|Protocol Violation|1|||
126376364|NCT02394561|454674586|FG001|Extension Phase|Protocol Violation|0|||
126376365|NCT02394561|454674585|FG000|Extension Phase|Lost to Follow-up|1|||
126376366|NCT02394561|454674586|FG001|Extension Phase|Lost to Follow-up|0|||
126376367|NCT02394561|454674585|FG000|Extension Phase|Physician Decision|0|||
126376368|NCT02394561|454674586|FG001|Extension Phase|Physician Decision|2|||
126376369|NCT02394561|454674585|FG000|Extension Phase|Withdrawal by Subject|0|||
126376370|NCT02394561|454674586|FG001|Extension Phase|Withdrawal by Subject|5|||
126376371|NCT02394561|454674585|FG000|Extension Phase|Lack of Efficacy|3|||
126376372|NCT02394561|454674586|FG001|Extension Phase|Lack of Efficacy|3|||
126376373|NCT00501644|454674587|FG000|Overall Study|Adverse Event|4|||
126376374|NCT00501644|454674587|FG000|Overall Study|Withdrawal by Subject|1|||
126376375|NCT02803203|454674588|FG000|Overall Study|Adverse Event|4|||
126376376|NCT02803203|454674588|FG000|Overall Study|Death|4|||
126376377|NCT02803203|454674588|FG000|Overall Study|Progressive disease|29|||
126376378|NCT02803203|454674588|FG000|Overall Study|Withdrawal by Subject|8|||
126376379|NCT02803203|454674588|FG000|Overall Study|Complete resection of target disease|2|||
126376380|NCT02803203|454674588|FG000|Overall Study|Switched to commercial Osi|1|||
126376381|NCT02803203|454674588|FG000|Overall Study|Participant moved away|1|||
126376382|NCT04577781|454674589|FG000|Overall Study|Adverse Event|2|||
126376383|NCT04577781|454674590|FG001|Overall Study|Adverse Event|2|||
126376384|NCT04577781|454674589|FG000|Overall Study|Physician Decision|1|||
126376385|NCT04577781|454674590|FG001|Overall Study|Physician Decision|0|||
126376386|NCT01957865|454674591|FG000|Overall Study|Found HIV negative|0|||
126376387|NCT01957865|454674592|FG001|Overall Study|Found HIV negative|0|||
126376388|NCT01957865|454674593|FG002|Overall Study|Found HIV negative|1|||
126376389|NCT01957865|454674591|FG000|Overall Study|Lost to Follow-up|0|||
126376390|NCT01957865|454674592|FG001|Overall Study|Lost to Follow-up|2|||
126376391|NCT01957865|454674593|FG002|Overall Study|Lost to Follow-up|2|||
126376392|NCT01644643|454674601|FG000|Overall Study|Death|1|||
126376393|NCT01644643|454674602|FG001|Overall Study|Death|0|||
126047971|NCT00146172|453473817|FG006|Overall Study|Physician Decision|0|||
126047972|NCT00146172|453473818|FG007|Overall Study|Physician Decision|1|||
126376394|NCT01644643|454674603|FG002|Overall Study|Death|3|||
126376395|NCT01644643|454674604|FG003|Overall Study|Death|3|||
126376396|NCT01644643|454674601|FG000|Overall Study|Lost to Follow-up|0|||
126376397|NCT01644643|454674602|FG001|Overall Study|Lost to Follow-up|0|||
126376398|NCT01644643|454674603|FG002|Overall Study|Lost to Follow-up|0|||
126376399|NCT01644643|454674604|FG003|Overall Study|Lost to Follow-up|4|||
126376400|NCT01644643|454674601|FG000|Overall Study|Withdrawal by Subject|1|||
126376401|NCT01644643|454674602|FG001|Overall Study|Withdrawal by Subject|0|||
126376402|NCT01644643|454674603|FG002|Overall Study|Withdrawal by Subject|2|||
126376403|NCT01644643|454674604|FG003|Overall Study|Withdrawal by Subject|1|||
126376404|NCT01644643|454674601|FG000|Overall Study|Other Eligibility criteria|0|||
126376405|NCT01644643|454674602|FG001|Overall Study|Other Eligibility criteria|0|||
126376406|NCT01644643|454674603|FG002|Overall Study|Other Eligibility criteria|0|||
126376407|NCT01644643|454674604|FG003|Overall Study|Other Eligibility criteria|2|||
126376408|NCT02756403|454674605|FG000|Overall Study|Unable to swallow medication|0|||
126376409|NCT02756403|454674606|FG001|Overall Study|Unable to swallow medication|1|||
126376410|NCT02756403|454674607|FG002|Overall Study|Unable to swallow medication|1|||
126376411|NCT02756403|454674608|FG003|Overall Study|Unable to swallow medication|1|||
126376412|NCT02756403|454674605|FG000|Overall Study|Did not complete Procedure|0|||
126376413|NCT02756403|454674606|FG001|Overall Study|Did not complete Procedure|1|||
126376414|NCT02756403|454674607|FG002|Overall Study|Did not complete Procedure|0|||
126376415|NCT02756403|454674608|FG003|Overall Study|Did not complete Procedure|0|||
126376416|NCT02756403|454674605|FG000|Overall Study|Changed Mind About Procedure|0|||
126376417|NCT02756403|454674606|FG001|Overall Study|Changed Mind About Procedure|0|||
126376418|NCT02756403|454674607|FG002|Overall Study|Changed Mind About Procedure|1|||
126376419|NCT02756403|454674608|FG003|Overall Study|Changed Mind About Procedure|0|||
126376420|NCT02756403|454674605|FG000|Overall Study|Protocol Violation|0|||
126376421|NCT02756403|454674606|FG001|Overall Study|Protocol Violation|1|||
126376422|NCT02756403|454674607|FG002|Overall Study|Protocol Violation|0|||
126376423|NCT02756403|454674608|FG003|Overall Study|Protocol Violation|1|||
126104107|NCT01222507|453675811|FG000|Overall Study|Physician Decision|1|||
126376424|NCT00114127|454674610|FG000|Overall Study|Adverse Event|2|||
126376425|NCT00114127|454674611|FG001|Overall Study|Adverse Event|1|||
126376426|NCT00114127|454674610|FG000|Overall Study|Lost to Follow-up|1|||
126376427|NCT00114127|454674611|FG001|Overall Study|Lost to Follow-up|0|||
126376428|NCT00114127|454674610|FG000|Overall Study|Withdrawal by Subject|1|||
126376429|NCT00114127|454674611|FG001|Overall Study|Withdrawal by Subject|3|||
126376430|NCT00699413|454674612|FG000|Overall Study|Withdrawal by Subject|0|||
126376431|NCT00699413|454674613|FG001|Overall Study|Withdrawal by Subject|2|||
126376432|NCT00699413|454674612|FG000|Overall Study|Study terminated by sponsor|4|||
126376433|NCT00699413|454674613|FG001|Overall Study|Study terminated by sponsor|2|||
126376434|NCT00881894|454674614|FG000|Overall Study|Consent withdrawn|0|||
126376435|NCT00881894|454674615|FG001|Overall Study|Consent withdrawn|1|||
126376436|NCT00881894|454674614|FG000|Overall Study|Other reasons for premature termination|1|||
126376437|NCT00881894|454674615|FG001|Overall Study|Other reasons for premature termination|2|||
126376438|NCT00421148|454674616|FG000|Overall Study|Lost to Follow-up|0|||
126376439|NCT00421148|454674617|FG001|Overall Study|Lost to Follow-up|0|||
126376440|NCT00421148|454674618|FG002|Overall Study|Lost to Follow-up|0|||
126376441|NCT00421148|454674619|FG003|Overall Study|Lost to Follow-up|0|||
126376442|NCT00421148|454674620|FG004|Overall Study|Lost to Follow-up|0|||
126376443|NCT00421148|454674621|FG005|Overall Study|Lost to Follow-up|0|||
126376444|NCT00421148|454674622|FG006|Overall Study|Lost to Follow-up|0|||
126376445|NCT00421148|454674623|FG007|Overall Study|Lost to Follow-up|0|||
126376446|NCT00421148|454674624|FG008|Overall Study|Lost to Follow-up|0|||
126376447|NCT00421148|454674625|FG009|Overall Study|Lost to Follow-up|0|||
126376448|NCT00421148|454674626|FG010|Overall Study|Lost to Follow-up|0|||
126376449|NCT00421148|454674627|FG011|Overall Study|Lost to Follow-up|0|||
126376450|NCT00421148|454674628|FG012|Overall Study|Lost to Follow-up|0|||
126376451|NCT00421148|454674629|FG013|Overall Study|Lost to Follow-up|0|||
126376452|NCT00421148|454674630|FG014|Overall Study|Lost to Follow-up|0|||
126376453|NCT00421148|454674631|FG015|Overall Study|Lost to Follow-up|0|||
126376454|NCT00421148|454674632|FG016|Overall Study|Lost to Follow-up|0|||
126376455|NCT00421148|454674633|FG017|Overall Study|Lost to Follow-up|1|||
126376456|NCT00421148|454674634|FG018|Overall Study|Lost to Follow-up|0|||
126376457|NCT00421148|454674635|FG019|Overall Study|Lost to Follow-up|0|||
126376458|NCT00421148|454674616|FG000|Overall Study|Withdrawal by Subject|0|||
126376459|NCT00421148|454674617|FG001|Overall Study|Withdrawal by Subject|0|||
126376460|NCT00421148|454674618|FG002|Overall Study|Withdrawal by Subject|0|||
125886316|NCT01646125|452879985|FG000|Overall Study|Death|1|||
126376461|NCT00421148|454674619|FG003|Overall Study|Withdrawal by Subject|0|||
126376462|NCT00421148|454674620|FG004|Overall Study|Withdrawal by Subject|0|||
126376463|NCT00421148|454674621|FG005|Overall Study|Withdrawal by Subject|0|||
126376464|NCT00421148|454674622|FG006|Overall Study|Withdrawal by Subject|0|||
126376465|NCT00421148|454674623|FG007|Overall Study|Withdrawal by Subject|0|||
126376466|NCT00421148|454674624|FG008|Overall Study|Withdrawal by Subject|0|||
125886317|NCT01646125|452879986|FG001|Overall Study|Death|1|||
126376467|NCT00421148|454674625|FG009|Overall Study|Withdrawal by Subject|0|||
126376468|NCT00421148|454674626|FG010|Overall Study|Withdrawal by Subject|0|||
126376469|NCT00421148|454674627|FG011|Overall Study|Withdrawal by Subject|0|||
126376470|NCT00421148|454674628|FG012|Overall Study|Withdrawal by Subject|0|||
126376471|NCT00421148|454674629|FG013|Overall Study|Withdrawal by Subject|0|||
126376472|NCT00421148|454674630|FG014|Overall Study|Withdrawal by Subject|0|||
126376473|NCT00421148|454674631|FG015|Overall Study|Withdrawal by Subject|0|||
126376474|NCT00421148|454674632|FG016|Overall Study|Withdrawal by Subject|0|||
126376475|NCT00421148|454674633|FG017|Overall Study|Withdrawal by Subject|1|||
126376476|NCT00421148|454674634|FG018|Overall Study|Withdrawal by Subject|0|||
126376477|NCT00421148|454674635|FG019|Overall Study|Withdrawal by Subject|0|||
126376478|NCT00421148|454674616|FG000|Overall Study|Protocol Violation|0|||
126376479|NCT00421148|454674617|FG001|Overall Study|Protocol Violation|0|||
126376480|NCT00421148|454674618|FG002|Overall Study|Protocol Violation|0|||
126376481|NCT00421148|454674619|FG003|Overall Study|Protocol Violation|0|||
126376482|NCT00421148|454674620|FG004|Overall Study|Protocol Violation|0|||
126376483|NCT00421148|454674621|FG005|Overall Study|Protocol Violation|1|||
126376484|NCT00421148|454674622|FG006|Overall Study|Protocol Violation|0|||
126376485|NCT00421148|454674623|FG007|Overall Study|Protocol Violation|0|||
126376486|NCT00421148|454674624|FG008|Overall Study|Protocol Violation|0|||
126376487|NCT00421148|454674625|FG009|Overall Study|Protocol Violation|0|||
126376488|NCT00421148|454674626|FG010|Overall Study|Protocol Violation|0|||
126376489|NCT00421148|454674627|FG011|Overall Study|Protocol Violation|0|||
126376490|NCT00421148|454674628|FG012|Overall Study|Protocol Violation|0|||
126376491|NCT00421148|454674629|FG013|Overall Study|Protocol Violation|0|||
126376492|NCT00421148|454674630|FG014|Overall Study|Protocol Violation|0|||
126376493|NCT00421148|454674631|FG015|Overall Study|Protocol Violation|0|||
126376494|NCT00421148|454674632|FG016|Overall Study|Protocol Violation|0|||
126376495|NCT00421148|454674633|FG017|Overall Study|Protocol Violation|0|||
126376496|NCT00421148|454674634|FG018|Overall Study|Protocol Violation|1|||
126376497|NCT00421148|454674635|FG019|Overall Study|Protocol Violation|0|||
126376498|NCT00469833|454674637|FG000|Overall Study|No IV access|2|||
126376499|NCT01253369|454674638|FG000|Overall Study|Adverse Event|4|||
126376500|NCT01253369|454674638|FG000|Overall Study|Withdrawal by Subject|2|||
126376501|NCT01253369|454674638|FG000|Overall Study|Death|1|||
126376502|NCT01253369|454674638|FG000|Overall Study|Progressive disease|23|||
126376503|NCT01253369|454674638|FG000|Overall Study|Not Evaluable|3|||
126376504|NCT03289533|454674639|FG000|Overall Study|Death|12|||
126376505|NCT03289533|454674639|FG000|Overall Study|Terminated from study by sponsor|10|||
126376506|NCT04016714|454674640|FG000|Overall Study|Death|1|||
126376507|NCT04016714|454674641|FG001|Overall Study|Death|0|||
126376508|NCT04016714|454674640|FG000|Overall Study|Lost to Follow-up|3|||
126376509|NCT04016714|454674641|FG001|Overall Study|Lost to Follow-up|1|||
126376510|NCT04016714|454674640|FG000|Overall Study|Physician Decision|3|||
126376511|NCT04016714|454674641|FG001|Overall Study|Physician Decision|3|||
126047973|NCT00146172|453473811|FG000|Overall Study|Withdrawal by Subject|0|||
126047974|NCT00146172|453473812|FG001|Overall Study|Withdrawal by Subject|0|||
126047975|NCT00146172|453473813|FG002|Overall Study|Withdrawal by Subject|0|||
126047976|NCT00146172|453473814|FG003|Overall Study|Withdrawal by Subject|0|||
126047977|NCT00146172|453473815|FG004|Overall Study|Withdrawal by Subject|0|||
126376512|NCT04016714|454674640|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
126376513|NCT04016714|454674641|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
126376514|NCT01822665|454674648|FG000|Overall Study|Adverse Event|3|||
126376515|NCT01822665|454674648|FG000|Overall Study|Other Reason|5|||
126376516|NCT00959907|454674650|FG000|Overall Study|Protocol Violation|0|||
126376517|NCT00959907|454674651|FG001|Overall Study|Protocol Violation|1|||
126376518|NCT00959907|454674650|FG000|Overall Study|Adverse Event|1|||
126376519|NCT00959907|454674651|FG001|Overall Study|Adverse Event|0|||
126047978|NCT00146172|453473816|FG005|Overall Study|Withdrawal by Subject|1|||
126047979|NCT00146172|453473817|FG006|Overall Study|Withdrawal by Subject|1|||
126047980|NCT00146172|453473818|FG007|Overall Study|Withdrawal by Subject|4|||
126376520|NCT00959907|454674650|FG000|Overall Study|Withdrawal by Subject|2|||
126376521|NCT00959907|454674651|FG001|Overall Study|Withdrawal by Subject|0|||
126376522|NCT01171677|454674653|FG000|Overall Study|Withdrawal by Subject|0|||
126376523|NCT01171677|454674654|FG001|Overall Study|Withdrawal by Subject|3|||
126376524|NCT01171677|454674653|FG000|Overall Study|Adverse Event|1|||
126376525|NCT01171677|454674654|FG001|Overall Study|Adverse Event|0|||
126376526|NCT01171677|454674653|FG000|Overall Study|completed <70% IntenSati classes|5|||
126376527|NCT01171677|454674654|FG001|Overall Study|completed <70% IntenSati classes|0|||
126376528|NCT01847443|454674655|FG000|Study Period 1|Withdrawal by Subject|0|||
126376529|NCT01847443|454674656|FG001|Study Period 1|Withdrawal by Subject|1|||
126047981|NCT00146172|453473811|FG000|Overall Study|Symptomatic Deterioration|1|||
126376530|NCT01847443|454674657|FG002|Study Period 1|Withdrawal by Subject|0|||
126376531|NCT01847443|454674658|FG003|Study Period 1|Withdrawal by Subject|0|||
126376532|NCT01847443|454674655|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
126376533|NCT01847443|454674656|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
126376534|NCT01847443|454674657|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
126376535|NCT01847443|454674658|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
126376536|NCT01847443|454674655|FG000|Washout Period Before Study Period 2|Other reason|1|||
126376537|NCT01847443|454674656|FG001|Washout Period Before Study Period 2|Other reason|0|||
126376538|NCT01847443|454674657|FG002|Washout Period Before Study Period 2|Other reason|0|||
126376539|NCT01847443|454674658|FG003|Washout Period Before Study Period 2|Other reason|0|||
126376540|NCT01847443|454674655|FG000|Washout Period Before Study Period 3|Other reason|1|||
126376541|NCT01847443|454674656|FG001|Washout Period Before Study Period 3|Other reason|0|||
126376542|NCT01847443|454674657|FG002|Washout Period Before Study Period 3|Other reason|0|||
126376543|NCT01847443|454674658|FG003|Washout Period Before Study Period 3|Other reason|0|||
126376544|NCT01847443|454674655|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
126376545|NCT01847443|454674656|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
126376546|NCT01847443|454674657|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
126376547|NCT01847443|454674658|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
126376548|NCT01847443|454674655|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
126376549|NCT01847443|454674656|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
126376550|NCT01847443|454674657|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
126376551|NCT01847443|454674658|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
126376552|NCT03571971|454674659|FG000|Overall Study|Lost to Follow-up|2|||
126376553|NCT03571971|454674660|FG001|Overall Study|Lost to Follow-up|2|||
126376554|NCT03571971|454674659|FG000|Overall Study|Protocol Violation|2|||
126376555|NCT03571971|454674660|FG001|Overall Study|Protocol Violation|3|||
126376556|NCT03571971|454674659|FG000|Overall Study|Withdrawal by Subject|2|||
126376557|NCT03571971|454674660|FG001|Overall Study|Withdrawal by Subject|0|||
126376558|NCT03571971|454674659|FG000|Overall Study|Incomplete primary outcome data|2|||
126376559|NCT03571971|454674660|FG001|Overall Study|Incomplete primary outcome data|0|||
126376560|NCT04046939|454674670|FG000|Primary Assessment Period|Adverse Event|1|||
126376561|NCT04046939|454674671|FG001|Primary Assessment Period|Adverse Event|0|||
126376562|NCT04046939|454674672|FG002|Primary Assessment Period|Adverse Event|0|||
126376563|NCT04046939|454674673|FG003|Primary Assessment Period|Adverse Event|0|||
126376564|NCT04046939|454674670|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
126376565|NCT04046939|454674671|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
126376566|NCT04046939|454674672|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
126376567|NCT04046939|454674673|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
126376568|NCT04046939|454674670|FG000|Primary Assessment Period|Physician Decision|0|||
126376569|NCT04046939|454674671|FG001|Primary Assessment Period|Physician Decision|0|||
126376570|NCT04046939|454674672|FG002|Primary Assessment Period|Physician Decision|1|||
126376571|NCT04046939|454674673|FG003|Primary Assessment Period|Physician Decision|0|||
126376572|NCT04046939|454674670|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
126376573|NCT04046939|454674671|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
126376574|NCT04046939|454674672|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
126376575|NCT04046939|454674673|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
126376576|NCT00403130|454674674|FG000|2 Years From Start of Treatment|Not Eligible|3|||
126376577|NCT00403130|454674674|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
126376578|NCT00403130|454674674|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
126376579|NCT00403130|454674674|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
126376580|NCT00806260|454674675|FG000|Period 1 (1 Day)|Adverse Event|0|||
126376581|NCT00806260|454674676|FG001|Period 1 (1 Day)|Adverse Event|0|||
126376582|NCT00806260|454674677|FG002|Period 1 (1 Day)|Adverse Event|0|||
126376583|NCT00806260|454674678|FG003|Period 1 (1 Day)|Adverse Event|0|||
126376584|NCT00806260|454674679|FG004|Period 1 (1 Day)|Adverse Event|3|||
126376585|NCT00806260|454674680|FG005|Period 1 (1 Day)|Adverse Event|0|||
126376586|NCT00806260|454674675|FG000|Period 2|Adverse Event|0|||
126376587|NCT00806260|454674676|FG001|Period 2|Adverse Event|0|||
126376588|NCT00806260|454674677|FG002|Period 2|Adverse Event|0|||
126376589|NCT00806260|454674678|FG003|Period 2|Adverse Event|1|||
126376590|NCT00806260|454674679|FG004|Period 2|Adverse Event|0|||
126376591|NCT00806260|454674680|FG005|Period 2|Adverse Event|0|||
126376592|NCT00806260|454674675|FG000|Period 2|Protocol Violation|1|||
126376593|NCT00806260|454674676|FG001|Period 2|Protocol Violation|0|||
126376594|NCT00806260|454674677|FG002|Period 2|Protocol Violation|1|||
126376595|NCT00806260|454674678|FG003|Period 2|Protocol Violation|0|||
126376596|NCT00806260|454674679|FG004|Period 2|Protocol Violation|0|||
126376597|NCT00806260|454674680|FG005|Period 2|Protocol Violation|0|||
126376598|NCT00806260|454674675|FG000|Period 2|Need to take concomitant medication|1|||
126376599|NCT00806260|454674676|FG001|Period 2|Need to take concomitant medication|0|||
126376600|NCT00806260|454674677|FG002|Period 2|Need to take concomitant medication|0|||
126376601|NCT00806260|454674678|FG003|Period 2|Need to take concomitant medication|0|||
126376602|NCT00806260|454674679|FG004|Period 2|Need to take concomitant medication|0|||
126376603|NCT00806260|454674680|FG005|Period 2|Need to take concomitant medication|0|||
126376604|NCT00806260|454674675|FG000|Period 2|sponsor request|0|||
126376605|NCT00806260|454674676|FG001|Period 2|sponsor request|0|||
126376606|NCT00806260|454674677|FG002|Period 2|sponsor request|1|||
126376607|NCT00806260|454674678|FG003|Period 2|sponsor request|1|||
126047982|NCT00146172|453473812|FG001|Overall Study|Symptomatic Deterioration|0|||
126047983|NCT00146172|453473813|FG002|Overall Study|Symptomatic Deterioration|1|||
126047984|NCT00146172|453473814|FG003|Overall Study|Symptomatic Deterioration|0|||
126047985|NCT00146172|453473815|FG004|Overall Study|Symptomatic Deterioration|1|||
126376608|NCT00806260|454674679|FG004|Period 2|sponsor request|0|||
126376609|NCT00806260|454674680|FG005|Period 2|sponsor request|0|||
126376610|NCT00806260|454674675|FG000|Period 3|Protocol Violation|0|||
126376611|NCT00806260|454674676|FG001|Period 3|Protocol Violation|1|||
126376612|NCT00806260|454674677|FG002|Period 3|Protocol Violation|1|||
126376613|NCT00806260|454674678|FG003|Period 3|Protocol Violation|0|||
126376614|NCT00806260|454674679|FG004|Period 3|Protocol Violation|0|||
126376615|NCT00806260|454674680|FG005|Period 3|Protocol Violation|0|||
126376616|NCT00806260|454674675|FG000|Period 3|Pregnancy|1|||
126376617|NCT00806260|454674676|FG001|Period 3|Pregnancy|0|||
126376618|NCT00806260|454674677|FG002|Period 3|Pregnancy|0|||
126376619|NCT00806260|454674678|FG003|Period 3|Pregnancy|0|||
126376620|NCT00806260|454674679|FG004|Period 3|Pregnancy|0|||
126376621|NCT00806260|454674680|FG005|Period 3|Pregnancy|0|||
126376622|NCT03559270|454674681|FG000|Overall Study|Adverse Event|6|||
126047986|NCT00146172|453473816|FG005|Overall Study|Symptomatic Deterioration|2|||
126047987|NCT00146172|453473817|FG006|Overall Study|Symptomatic Deterioration|0|||
126376623|NCT03559270|454674682|FG001|Overall Study|Adverse Event|5|||
126047988|NCT00146172|453473818|FG007|Overall Study|Symptomatic Deterioration|2|||
126376624|NCT03559270|454674683|FG002|Overall Study|Adverse Event|3|||
126047989|NCT01288443|453473821|FG000|Overall Study|Adverse Event|0|||
126376625|NCT03559270|454674684|FG003|Overall Study|Adverse Event|0|||
126376626|NCT03559270|454674681|FG000|Overall Study|Lack of Efficacy|34|||
126376627|NCT03559270|454674682|FG001|Overall Study|Lack of Efficacy|52|||
126376628|NCT03559270|454674683|FG002|Overall Study|Lack of Efficacy|37|||
126376629|NCT03559270|454674684|FG003|Overall Study|Lack of Efficacy|2|||
126376630|NCT03559270|454674681|FG000|Overall Study|Death|0|||
126376631|NCT03559270|454674682|FG001|Overall Study|Death|2|||
126376632|NCT03559270|454674683|FG002|Overall Study|Death|0|||
126376633|NCT03559270|454674684|FG003|Overall Study|Death|0|||
126376634|NCT03559270|454674681|FG000|Overall Study|Lost to Follow-up|16|||
126376635|NCT03559270|454674682|FG001|Overall Study|Lost to Follow-up|4|||
126376636|NCT03559270|454674683|FG002|Overall Study|Lost to Follow-up|12|||
126376637|NCT03559270|454674684|FG003|Overall Study|Lost to Follow-up|3|||
126376638|NCT03559270|454674681|FG000|Overall Study|Sponsor Decision|38|||
126376639|NCT03559270|454674682|FG001|Overall Study|Sponsor Decision|31|||
126376640|NCT03559270|454674683|FG002|Overall Study|Sponsor Decision|35|||
126376641|NCT03559270|454674684|FG003|Overall Study|Sponsor Decision|18|||
126376642|NCT03559270|454674681|FG000|Overall Study|Withdrawal by Subject|19|||
126376643|NCT03559270|454674682|FG001|Overall Study|Withdrawal by Subject|21|||
126376644|NCT03559270|454674683|FG002|Overall Study|Withdrawal by Subject|18|||
126376645|NCT03559270|454674684|FG003|Overall Study|Withdrawal by Subject|7|||
126376646|NCT03559270|454674681|FG000|Overall Study|Physician Decision|3|||
126376647|NCT03559270|454674682|FG001|Overall Study|Physician Decision|2|||
126376648|NCT03559270|454674683|FG002|Overall Study|Physician Decision|1|||
126376649|NCT03559270|454674684|FG003|Overall Study|Physician Decision|0|||
126376650|NCT03559270|454674681|FG000|Overall Study|Pregnancy|0|||
126376651|NCT03559270|454674682|FG001|Overall Study|Pregnancy|1|||
126376652|NCT03559270|454674683|FG002|Overall Study|Pregnancy|0|||
126376653|NCT03559270|454674684|FG003|Overall Study|Pregnancy|0|||
126376654|NCT03559270|454674681|FG000|Overall Study|Protocol Violation|1|||
126376655|NCT03559270|454674682|FG001|Overall Study|Protocol Violation|0|||
126376656|NCT03559270|454674683|FG002|Overall Study|Protocol Violation|2|||
126376657|NCT03559270|454674684|FG003|Overall Study|Protocol Violation|0|||
126376658|NCT03247829|454676621|FG000|Overall Study|Death|3|||
126376659|NCT03247829|454676622|FG001|Overall Study|Death|4|||
126376660|NCT03247829|454676621|FG000|Overall Study|Enter Hospice Care|1|||
126376661|NCT03247829|454676622|FG001|Overall Study|Enter Hospice Care|0|||
126376662|NCT03247829|454676621|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
126376663|NCT03247829|454676622|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
126376664|NCT03247829|454676621|FG000|Overall Study|LVAD Explant|1|||
126376665|NCT03247829|454676622|FG001|Overall Study|LVAD Explant|1|||
126376666|NCT03247829|454676621|FG000|Overall Study|Transplant|1|||
126376667|NCT03247829|454676622|FG001|Overall Study|Transplant|1|||
126376668|NCT01783444|454676623|FG000|Treatment Phase|Adverse Event|9|||
126376669|NCT01783444|454676624|FG001|Treatment Phase|Adverse Event|20|||
126376670|NCT01783444|454676625|FG002|Treatment Phase|Adverse Event|19|||
126376671|NCT01783444|454676623|FG000|Treatment Phase|Disease Progression|76|||
126376672|NCT01783444|454676624|FG001|Treatment Phase|Disease Progression|66|||
126376673|NCT01783444|454676625|FG002|Treatment Phase|Disease Progression|64|||
126376674|NCT01783444|454676623|FG000|Treatment Phase|Death|2|||
126376675|NCT01783444|454676624|FG001|Treatment Phase|Death|2|||
126376676|NCT01783444|454676625|FG002|Treatment Phase|Death|2|||
126376677|NCT01783444|454676623|FG000|Treatment Phase|Protocol Violation|1|||
126376678|NCT01783444|454676624|FG001|Treatment Phase|Protocol Violation|1|||
126376679|NCT01783444|454676625|FG002|Treatment Phase|Protocol Violation|2|||
126376680|NCT01783444|454676623|FG000|Treatment Phase|Withdrawal by Subject|6|||
126376681|NCT01783444|454676624|FG001|Treatment Phase|Withdrawal by Subject|8|||
126376682|NCT01783444|454676625|FG002|Treatment Phase|Withdrawal by Subject|9|||
126376683|NCT01783444|454676623|FG000|Treatment Phase|Administrative problems|2|||
126376684|NCT01783444|454676624|FG001|Treatment Phase|Administrative problems|0|||
126376685|NCT01783444|454676625|FG002|Treatment Phase|Administrative problems|1|||
126376686|NCT01783444|454676623|FG000|Treatment Phase|Physician Decision|8|||
126376687|NCT01783444|454676624|FG001|Treatment Phase|Physician Decision|6|||
126376688|NCT01783444|454676625|FG002|Treatment Phase|Physician Decision|5|||
126376689|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
126376690|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
126376691|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
126376692|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
126376693|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
126376694|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
126376695|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
126376696|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
126376697|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
126376698|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
126376699|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
126376700|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
126376701|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
126376702|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
126376703|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
126376704|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
126376705|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
126376706|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
126376707|NCT00427011|454676634|FG000|Overall Study|Adverse Event|10|||
126376708|NCT00427011|454676634|FG000|Overall Study|Withdrawal by Subject|1|||
126376709|NCT00427011|454676634|FG000|Overall Study|Lack of Efficacy|2|||
126376710|NCT00427011|454676634|FG000|Overall Study|Other|12|||
126376711|NCT01047007|454676635|FG000|Overall Study|Adverse Event|0|||
126376712|NCT01047007|454676636|FG001|Overall Study|Adverse Event|2|||
126376713|NCT01047007|454676637|FG002|Overall Study|Adverse Event|1|||
126376714|NCT01047007|454676638|FG003|Overall Study|Adverse Event|0|||
126376715|NCT01047007|454676635|FG000|Overall Study|Progressive Disease|2|||
126376716|NCT01047007|454676636|FG001|Overall Study|Progressive Disease|4|||
126376717|NCT01047007|454676637|FG002|Overall Study|Progressive Disease|1|||
126376718|NCT01047007|454676638|FG003|Overall Study|Progressive Disease|0|||
126376719|NCT04776161|454676639|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
126376720|NCT04776161|454676640|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
126376721|NCT04776161|454676641|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
126376722|NCT04776161|454676639|FG000|Overall Study|Withdrawal by Subject|1|||
126376723|NCT04776161|454676640|FG001|Overall Study|Withdrawal by Subject|0|||
126376724|NCT04776161|454676641|FG002|Overall Study|Withdrawal by Subject|1|||
126376725|NCT04776161|454676639|FG000|Overall Study|Adverse Event|0|||
126376726|NCT04776161|454676640|FG001|Overall Study|Adverse Event|1|||
126376727|NCT04776161|454676641|FG002|Overall Study|Adverse Event|1|||
126376728|NCT01334554|454676642|FG000|Overall Study|Adverse Event|4|||
126376729|NCT01334554|454676643|FG001|Overall Study|Adverse Event|2|||
126376730|NCT02393859|454676645|FG000|Overall Study|Decision by Sponsor|2|||
126376731|NCT02393859|454676646|FG001|Overall Study|Decision by Sponsor|4|||
126376732|NCT02393859|454676645|FG000|Overall Study|Withdrawal by Subject|11|||
126376733|NCT02393859|454676646|FG001|Overall Study|Withdrawal by Subject|6|||
126376734|NCT02393859|454676645|FG000|Overall Study|Death|27|||
126376735|NCT02393859|454676646|FG001|Overall Study|Death|10|||
126376736|NCT02393859|454676645|FG000|Overall Study|Lost to Follow-up|1|||
126376737|NCT02393859|454676646|FG001|Overall Study|Lost to Follow-up|1|||
126376738|NCT00954447|454676647|FG000|Overall Study|Adverse Event|33|||
126376739|NCT00954447|454676648|FG001|Overall Study|Adverse Event|25|||
126376740|NCT00954447|454676647|FG000|Overall Study|Lack of Efficacy|17|||
126376741|NCT00954447|454676648|FG001|Overall Study|Lack of Efficacy|3|||
126376742|NCT00954447|454676647|FG000|Overall Study|Protocol Violation|5|||
126376743|NCT00954447|454676648|FG001|Overall Study|Protocol Violation|7|||
126376744|NCT00954447|454676647|FG000|Overall Study|Lost to Follow-up|8|||
126376745|NCT00954447|454676648|FG001|Overall Study|Lost to Follow-up|14|||
126376746|NCT00954447|454676647|FG000|Overall Study|Withdrawal by Subject|26|||
126376747|NCT00954447|454676648|FG001|Overall Study|Withdrawal by Subject|21|||
126376748|NCT00954447|454676647|FG000|Overall Study|Other|21|||
126376749|NCT00954447|454676648|FG001|Overall Study|Other|18|||
126376750|NCT04592341|454676649|FG000|Overall Study|Physician Decision|5|||
126376751|NCT04592341|454676649|FG000|Overall Study|Study Terminated by Sponsor|5|||
126376752|NCT04592341|454676649|FG000|Overall Study|Withdrawal by Subject|53|||
126376753|NCT04592341|454676649|FG000|Overall Study|Lost to Follow-up|3|||
126376754|NCT04592341|454676649|FG000|Overall Study|Death|1|||
126376755|NCT04592341|454676649|FG000|Overall Study|Adverse Event|5|||
126376756|NCT04592341|454676649|FG000|Overall Study|other|4|||
126376757|NCT00692003|454676650|FG000|Overall Study|Sponsor Decision|5|||
126376758|NCT00692003|454676651|FG001|Overall Study|Sponsor Decision|1|||
126376759|NCT01248793|454676652|FG000|Overall Study|Lost to Follow-up|0|||
126376760|NCT01248793|454676653|FG001|Overall Study|Lost to Follow-up|1|||
126376761|NCT01248793|454676652|FG000|Overall Study|Adverse Event|1|||
126376762|NCT01248793|454676653|FG001|Overall Study|Adverse Event|1|||
126376763|NCT01248793|454676652|FG000|Overall Study|Protocol Violation|0|||
126376764|NCT01248793|454676653|FG001|Overall Study|Protocol Violation|1|||
126376765|NCT01248793|454676652|FG000|Overall Study|Withdrawal by Subject|3|||
126376766|NCT01248793|454676653|FG001|Overall Study|Withdrawal by Subject|3|||
126376767|NCT00517699|454676654|FG000|Overall Study|Withdrawal by Subject|1|||
126376768|NCT00517699|454676654|FG000|Overall Study|Lack of Efficacy|1|||
126376769|NCT00517699|454676654|FG000|Overall Study|Administrative error|1|||
126376770|NCT00517699|454676654|FG000|Overall Study|Study terminated by Sponsor|2|||
126376771|NCT02332187|454676657|FG000|Overall Study|Withdrawal by Subject|2|||
126376772|NCT02332187|454676658|FG001|Overall Study|Withdrawal by Subject|2|||
126376773|NCT02332187|454676657|FG000|Overall Study|Adverse Event|0|||
126376774|NCT02332187|454676658|FG001|Overall Study|Adverse Event|1|||
126376775|NCT01840943|454676659|FG000|Overall Study|Withdrawal by Subject|5|||
126376776|NCT01840943|454676660|FG001|Overall Study|Withdrawal by Subject|6|||
126376777|NCT01840943|454676659|FG000|Overall Study|Physician Decision|4|||
126376778|NCT01840943|454676660|FG001|Overall Study|Physician Decision|2|||
126376779|NCT01840943|454676659|FG000|Overall Study|Lost to Follow-up|4|||
126376780|NCT01840943|454676660|FG001|Overall Study|Lost to Follow-up|4|||
126376781|NCT02580877|454676663|FG000|Overall Study|Withdrawal by Subject|1|||
126376782|NCT02580877|454676664|FG001|Overall Study|Withdrawal by Subject|3|||
126376783|NCT02580877|454676663|FG000|Overall Study|Adverse Event|0|||
126376784|NCT02580877|454676664|FG001|Overall Study|Adverse Event|1|||
126376785|NCT00980148|454676665|FG000|Overall Study|Discharged from facility|89|||
126376786|NCT00980148|454676666|FG001|Overall Study|Discharged from facility|96|||
126376787|NCT00980148|454676665|FG000|Overall Study|Received other antichlamydia treatment|20|||
126376788|NCT00980148|454676666|FG001|Overall Study|Received other antichlamydia treatment|14|||
126376789|NCT00980148|454676665|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
126376790|NCT00980148|454676666|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
126376791|NCT00980148|454676665|FG000|Overall Study|Various other reasons|8|||
126376792|NCT00980148|454676666|FG001|Overall Study|Various other reasons|9|||
126376793|NCT00551031|454676667|FG000|Overall Study|Adverse Event|0|||
126376794|NCT00551031|454676668|FG001|Overall Study|Adverse Event|1|||
126376795|NCT00551031|454676669|FG002|Overall Study|Adverse Event|0|||
126376796|NCT00551031|454676670|FG003|Overall Study|Adverse Event|0|||
126376797|NCT00551031|454676671|FG004|Overall Study|Adverse Event|0|||
126376798|NCT00551031|454676667|FG000|Overall Study|Protocol Violation|1|||
126376799|NCT00551031|454676668|FG001|Overall Study|Protocol Violation|1|||
126376800|NCT00551031|454676669|FG002|Overall Study|Protocol Violation|0|||
126376801|NCT00551031|454676670|FG003|Overall Study|Protocol Violation|0|||
126376802|NCT00551031|454676671|FG004|Overall Study|Protocol Violation|0|||
126376803|NCT00551031|454676667|FG000|Overall Study|Lost to Follow-up|0|||
126376804|NCT00551031|454676668|FG001|Overall Study|Lost to Follow-up|1|||
126376805|NCT00551031|454676669|FG002|Overall Study|Lost to Follow-up|0|||
126376806|NCT00551031|454676670|FG003|Overall Study|Lost to Follow-up|1|||
126376807|NCT00551031|454676671|FG004|Overall Study|Lost to Follow-up|1|||
126376808|NCT00551031|454676667|FG000|Overall Study|Withdrawal by Subject|0|||
126376809|NCT00551031|454676668|FG001|Overall Study|Withdrawal by Subject|4|||
126376810|NCT00551031|454676669|FG002|Overall Study|Withdrawal by Subject|1|||
126376811|NCT00551031|454676670|FG003|Overall Study|Withdrawal by Subject|2|||
126376812|NCT00551031|454676671|FG004|Overall Study|Withdrawal by Subject|0|||
126376813|NCT00551031|454676667|FG000|Overall Study|Serious Adverse Event|0|||
126376814|NCT00551031|454676668|FG001|Overall Study|Serious Adverse Event|2|||
126376815|NCT00551031|454676669|FG002|Overall Study|Serious Adverse Event|1|||
126376816|NCT00551031|454676670|FG003|Overall Study|Serious Adverse Event|0|||
126376817|NCT00551031|454676671|FG004|Overall Study|Serious Adverse Event|0|||
126376818|NCT00551031|454676667|FG000|Overall Study|Did not receive vaccine|1|||
126376819|NCT00551031|454676668|FG001|Overall Study|Did not receive vaccine|2|||
126376820|NCT00551031|454676669|FG002|Overall Study|Did not receive vaccine|0|||
126376821|NCT00551031|454676670|FG003|Overall Study|Did not receive vaccine|0|||
126376822|NCT00551031|454676671|FG004|Overall Study|Did not receive vaccine|0|||
126376823|NCT02903823|454676672|FG000|Overall Study|Physician Decision|5|||
126376824|NCT02903823|454676672|FG000|Overall Study|Could not advance catheter|1|||
126376825|NCT02903823|454676672|FG000|Overall Study|Catheter dislodgement|1|||
126376826|NCT01747915|454676673|FG000|Overall Study|Other|1|||
126376827|NCT01747915|454676674|FG001|Overall Study|Other|1|||
126376828|NCT01747915|454676675|FG002|Overall Study|Other|1|||
126376829|NCT01747915|454676673|FG000|Overall Study|Adverse Event|8|||
126376830|NCT01747915|454676674|FG001|Overall Study|Adverse Event|5|||
126376831|NCT01747915|454676675|FG002|Overall Study|Adverse Event|2|||
126376832|NCT01747915|454676673|FG000|Overall Study|Death|0|||
126376833|NCT01747915|454676674|FG001|Overall Study|Death|0|||
126376834|NCT01747915|454676675|FG002|Overall Study|Death|1|||
126376835|NCT01747915|454676673|FG000|Overall Study|Lack of Efficacy|0|||
126376836|NCT01747915|454676674|FG001|Overall Study|Lack of Efficacy|1|||
126376837|NCT01747915|454676675|FG002|Overall Study|Lack of Efficacy|0|||
126376838|NCT01747915|454676673|FG000|Overall Study|Lost to Follow-up|1|||
126376839|NCT01747915|454676674|FG001|Overall Study|Lost to Follow-up|0|||
126376840|NCT01747915|454676675|FG002|Overall Study|Lost to Follow-up|0|||
126376841|NCT01747915|454676673|FG000|Overall Study|Withdrawal by Subject|4|||
126047990|NCT01288443|453473822|FG001|Overall Study|Adverse Event|0|||
126047991|NCT01288443|453473823|FG002|Overall Study|Adverse Event|1|||
126376842|NCT01747915|454676674|FG001|Overall Study|Withdrawal by Subject|4|||
126376843|NCT01747915|454676675|FG002|Overall Study|Withdrawal by Subject|1|||
126376844|NCT01747915|454676673|FG000|Overall Study|Protocol Violation|1|||
126376845|NCT01747915|454676674|FG001|Overall Study|Protocol Violation|0|||
126376846|NCT01747915|454676675|FG002|Overall Study|Protocol Violation|0|||
126376847|NCT01747915|454676673|FG000|Overall Study|Pregnancy|0|||
126376848|NCT01747915|454676674|FG001|Overall Study|Pregnancy|0|||
126376849|NCT01747915|454676675|FG002|Overall Study|Pregnancy|1|||
126376850|NCT03341637|454676676|FG000|Overall Study|Lost to Follow-up|1|||
126376851|NCT03341637|454676677|FG001|Overall Study|Lost to Follow-up|0|||
126376852|NCT03341637|454676676|FG000|Overall Study|Withdrawal by Subject|3|||
126376853|NCT03341637|454676677|FG001|Overall Study|Withdrawal by Subject|3|||
126376854|NCT03341637|454676676|FG000|Overall Study|Reason not Specified|1|||
126376855|NCT03341637|454676677|FG001|Overall Study|Reason not Specified|1|||
126376856|NCT00887159|454676678|FG000|Overall Study|Disease progression|6|||
126376857|NCT00887159|454676679|FG001|Overall Study|Disease progression|39|||
126376858|NCT00887159|454676680|FG002|Overall Study|Disease progression|33|||
126376859|NCT00887159|454676678|FG000|Overall Study|Adverse Event|3|||
126376860|NCT00887159|454676679|FG001|Overall Study|Adverse Event|4|||
126376861|NCT00887159|454676680|FG002|Overall Study|Adverse Event|17|||
126376862|NCT00887159|454676678|FG000|Overall Study|Death|2|||
126376863|NCT00887159|454676679|FG001|Overall Study|Death|2|||
126376864|NCT00887159|454676680|FG002|Overall Study|Death|0|||
126376865|NCT00887159|454676678|FG000|Overall Study|Withdrawal by Subject|4|||
126376866|NCT00887159|454676679|FG001|Overall Study|Withdrawal by Subject|4|||
126376867|NCT00887159|454676680|FG002|Overall Study|Withdrawal by Subject|2|||
126376868|NCT00887159|454676678|FG000|Overall Study|Alternative therapy|2|||
126376869|NCT00887159|454676679|FG001|Overall Study|Alternative therapy|0|||
126376870|NCT00887159|454676680|FG002|Overall Study|Alternative therapy|0|||
126376871|NCT00887159|454676678|FG000|Overall Study|Physician Decision|1|||
126376872|NCT00887159|454676679|FG001|Overall Study|Physician Decision|1|||
126376873|NCT00887159|454676680|FG002|Overall Study|Physician Decision|0|||
126376874|NCT00887159|454676678|FG000|Overall Study|Sympomatic deterioration|1|||
126376875|NCT00887159|454676679|FG001|Overall Study|Sympomatic deterioration|0|||
126376876|NCT00887159|454676680|FG002|Overall Study|Sympomatic deterioration|0|||
126376877|NCT00887159|454676678|FG000|Overall Study|Treatment delayed|1|||
125886318|NCT01646125|452879985|FG000|Overall Study|Physician Decision|1|||
125886319|NCT01646125|452879986|FG001|Overall Study|Physician Decision|3|||
125886320|NCT01646125|452879985|FG000|Overall Study|Progressive disease|22|||
125886321|NCT01646125|452879986|FG001|Overall Study|Progressive disease|16|||
125886322|NCT01646125|452879985|FG000|Overall Study|Study terminated by sponsor|2|||
125886323|NCT01646125|452879986|FG001|Overall Study|Study terminated by sponsor|1|||
125886324|NCT01646125|452879985|FG000|Overall Study|Subject/Guardian decision|1|||
125886325|NCT01646125|452879986|FG001|Overall Study|Subject/Guardian decision|1|||
125886326|NCT01528969|452879993|FG000|Overall Study|absent from the school at baseline|2|||
125886327|NCT01528969|452879994|FG001|Overall Study|absent from the school at baseline|0|||
125886328|NCT03219528|452880000|FG000|Overall Study|Lost to Follow-up|5|||
125886329|NCT03219528|452880001|FG001|Overall Study|Lost to Follow-up|4|||
125886330|NCT03219528|452880000|FG000|Overall Study|Withdrawal by Subject|4|||
125886331|NCT03219528|452880001|FG001|Overall Study|Withdrawal by Subject|4|||
125886332|NCT02120898|452880002|FG000|Overall Study|Withdrawal by Subject|4|||
125886333|NCT02120898|452880003|FG001|Overall Study|Withdrawal by Subject|2|||
125886334|NCT02120898|452880004|FG002|Overall Study|Withdrawal by Subject|2|||
125886335|NCT02120898|452880002|FG000|Overall Study|Non-compliance with study drug|3|||
125886336|NCT02120898|452880003|FG001|Overall Study|Non-compliance with study drug|0|||
125886337|NCT02120898|452880004|FG002|Overall Study|Non-compliance with study drug|0|||
125886338|NCT02120898|452880002|FG000|Overall Study|Adverse Event|1|||
125886339|NCT02120898|452880003|FG001|Overall Study|Adverse Event|2|||
125886340|NCT02120898|452880004|FG002|Overall Study|Adverse Event|1|||
125886341|NCT02120898|452880002|FG000|Overall Study|Protocol Violation|1|||
125886342|NCT02120898|452880003|FG001|Overall Study|Protocol Violation|2|||
125886343|NCT02120898|452880004|FG002|Overall Study|Protocol Violation|0|||
125886344|NCT02120898|452880002|FG000|Overall Study|Lost to Follow-up|0|||
126376878|NCT00887159|454676679|FG001|Overall Study|Treatment delayed|1|||
126376879|NCT00887159|454676680|FG002|Overall Study|Treatment delayed|0|||
126376880|NCT00887159|454676678|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
126376881|NCT00887159|454676679|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
126376882|NCT00887159|454676680|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
125886345|NCT02120898|452880003|FG001|Overall Study|Lost to Follow-up|0|||
125886346|NCT02120898|452880004|FG002|Overall Study|Lost to Follow-up|1|||
125886347|NCT00831181|452880005|FG000|Overall Study|Adverse Event|12|||
126104108|NCT01222507|453675811|FG000|Overall Study|Withdrawal by Subject|1|||
126104109|NCT02647320|453675812|FG000|Overall Study|Adverse Event|0|||
126376883|NCT00887159|454676678|FG000|Overall Study|Received more tx instead of observation|1|||
126376884|NCT00887159|454676679|FG001|Overall Study|Received more tx instead of observation|0|||
126376885|NCT00887159|454676680|FG002|Overall Study|Received more tx instead of observation|0|||
126376886|NCT00887159|454676678|FG000|Overall Study|Ineligible|5|||
125886348|NCT00196313|452880008|FG000|Overall Study|Protocol Violation|2|||
125886349|NCT00196313|452880009|FG001|Overall Study|Protocol Violation|3|||
125886350|NCT00196313|452880008|FG000|Overall Study|Withdrawal by Subject|3|||
126376887|NCT00887159|454676679|FG001|Overall Study|Ineligible|1|||
126376888|NCT00887159|454676680|FG002|Overall Study|Ineligible|0|||
126376889|NCT00887159|454676678|FG000|Overall Study|Never started assigned therapy|3|||
126376890|NCT00887159|454676679|FG001|Overall Study|Never started assigned therapy|3|||
126376891|NCT00887159|454676680|FG002|Overall Study|Never started assigned therapy|4|||
126376892|NCT03500211|454676685|FG000|Overall Study|Withdrawal by Subject|1|||
126376893|NCT03500211|454676686|FG001|Overall Study|Withdrawal by Subject|1|||
126376894|NCT01119443|454676692|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
126376895|NCT01119443|454676693|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
126376896|NCT02078752|454676696|FG000|Overall Study|Death|0|||
126376897|NCT02078752|454676697|FG001|Overall Study|Death|3|||
126376898|NCT02078752|454676698|FG002|Overall Study|Death|0|||
126376899|NCT02078752|454676699|FG003|Overall Study|Death|0|||
126376900|NCT02078752|454676700|FG004|Overall Study|Death|0|||
126376901|NCT02078752|454676701|FG005|Overall Study|Death|1|||
126376902|NCT02078752|454676702|FG006|Overall Study|Death|0|||
126376903|NCT02078752|454676703|FG007|Overall Study|Death|1|||
126376904|NCT02078752|454676704|FG008|Overall Study|Death|0|||
126376905|NCT02078752|454676705|FG009|Overall Study|Death|4|||
126376906|NCT02078752|454676696|FG000|Overall Study|Lost to Follow-up|1|||
126376907|NCT02078752|454676697|FG001|Overall Study|Lost to Follow-up|0|||
126047992|NCT01288443|453473824|FG003|Overall Study|Adverse Event|1|||
126047993|NCT01288443|453473825|FG004|Overall Study|Adverse Event|3|||
126376908|NCT02078752|454676698|FG002|Overall Study|Lost to Follow-up|0|||
126376909|NCT02078752|454676699|FG003|Overall Study|Lost to Follow-up|1|||
126376910|NCT02078752|454676700|FG004|Overall Study|Lost to Follow-up|0|||
126376911|NCT02078752|454676701|FG005|Overall Study|Lost to Follow-up|0|||
126376912|NCT02078752|454676702|FG006|Overall Study|Lost to Follow-up|0|||
126376913|NCT02078752|454676703|FG007|Overall Study|Lost to Follow-up|0|||
126376914|NCT02078752|454676704|FG008|Overall Study|Lost to Follow-up|0|||
126376915|NCT02078752|454676705|FG009|Overall Study|Lost to Follow-up|0|||
126376916|NCT02078752|454676696|FG000|Overall Study|Withdrawal by Subject|1|||
126376917|NCT02078752|454676697|FG001|Overall Study|Withdrawal by Subject|1|||
126376918|NCT02078752|454676698|FG002|Overall Study|Withdrawal by Subject|1|||
126376919|NCT02078752|454676699|FG003|Overall Study|Withdrawal by Subject|1|||
126376920|NCT02078752|454676700|FG004|Overall Study|Withdrawal by Subject|0|||
126376921|NCT02078752|454676701|FG005|Overall Study|Withdrawal by Subject|3|||
126376922|NCT02078752|454676702|FG006|Overall Study|Withdrawal by Subject|2|||
126376923|NCT02078752|454676703|FG007|Overall Study|Withdrawal by Subject|1|||
126376924|NCT02078752|454676704|FG008|Overall Study|Withdrawal by Subject|0|||
126376925|NCT02078752|454676705|FG009|Overall Study|Withdrawal by Subject|1|||
126376926|NCT02078752|454676696|FG000|Overall Study|Other|0|||
126376927|NCT02078752|454676697|FG001|Overall Study|Other|3|||
126376928|NCT02078752|454676698|FG002|Overall Study|Other|0|||
126376929|NCT02078752|454676699|FG003|Overall Study|Other|0|||
126376930|NCT02078752|454676700|FG004|Overall Study|Other|1|||
126376931|NCT02078752|454676701|FG005|Overall Study|Other|0|||
126376932|NCT02078752|454676702|FG006|Overall Study|Other|0|||
126376933|NCT02078752|454676703|FG007|Overall Study|Other|1|||
126376934|NCT02078752|454676704|FG008|Overall Study|Other|0|||
126047994|NCT01288443|453473826|FG005|Overall Study|Adverse Event|1|||
126376935|NCT02078752|454676705|FG009|Overall Study|Other|0|||
126047995|NCT01288443|453473821|FG000|Overall Study|Poor compliance to protocol|0|||
126047996|NCT01288443|453473822|FG001|Overall Study|Poor compliance to protocol|0|||
126376936|NCT02078752|454676696|FG000|Overall Study|Study terminated by sponsor|0|||
126376937|NCT02078752|454676697|FG001|Overall Study|Study terminated by sponsor|0|||
126376938|NCT02078752|454676698|FG002|Overall Study|Study terminated by sponsor|0|||
126376939|NCT02078752|454676699|FG003|Overall Study|Study terminated by sponsor|0|||
126376940|NCT02078752|454676700|FG004|Overall Study|Study terminated by sponsor|0|||
126376941|NCT02078752|454676701|FG005|Overall Study|Study terminated by sponsor|0|||
126376942|NCT02078752|454676702|FG006|Overall Study|Study terminated by sponsor|0|||
125886351|NCT00196313|452880009|FG001|Overall Study|Withdrawal by Subject|1|||
125886352|NCT00196313|452880008|FG000|Overall Study|Adverse Event|3|||
126047997|NCT01288443|453473823|FG002|Overall Study|Poor compliance to protocol|0|||
126376943|NCT02078752|454676703|FG007|Overall Study|Study terminated by sponsor|0|||
126376944|NCT02078752|454676704|FG008|Overall Study|Study terminated by sponsor|0|||
125886353|NCT00196313|452880009|FG001|Overall Study|Adverse Event|1|||
126104110|NCT02647320|453675813|FG001|Overall Study|Adverse Event|1|||
125886354|NCT00196313|452880008|FG000|Overall Study|Subject Pregnant|1|||
126376945|NCT02078752|454676705|FG009|Overall Study|Study terminated by sponsor|5|||
126376946|NCT00775268|454676706|FG000|Baseline|Drug not synthesize dose|1|||
126376947|NCT00775268|454676707|FG001|Baseline|Drug not synthesize dose|0|||
126376948|NCT00775268|454676706|FG000|Baseline|Not treated-ineligible per CT|0|||
126376949|NCT00775268|454676707|FG001|Baseline|Not treated-ineligible per CT|1|||
126376950|NCT00775268|454676706|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
126376951|NCT00775268|454676707|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
126376952|NCT00775268|454676706|FG000|After Completion|Participant missed scan appointment|1|||
126376953|NCT00775268|454676707|FG001|After Completion|Participant missed scan appointment|0|||
126376954|NCT03604497|454676708|FG000|Overall Study|Protocol Violation|52|||
126376955|NCT01194245|454676710|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
126376956|NCT01194245|454676711|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
126376957|NCT01194245|454676712|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
126376958|NCT01194245|454676713|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
126376959|NCT01194245|454676714|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
126376960|NCT01194245|454676710|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
126376961|NCT01194245|454676711|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
126376962|NCT01194245|454676712|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
126376963|NCT01194245|454676713|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
126376964|NCT01194245|454676714|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
126376965|NCT01194245|454676710|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
126376966|NCT01194245|454676711|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
126376967|NCT01194245|454676712|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
126376968|NCT01194245|454676713|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
126376969|NCT01194245|454676714|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
126376970|NCT01194245|454676710|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
126376971|NCT01194245|454676711|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
126376972|NCT01194245|454676712|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
126376973|NCT01194245|454676713|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
126376974|NCT01194245|454676714|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
126376975|NCT01194245|454676710|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126376976|NCT01194245|454676711|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126376977|NCT01194245|454676712|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126376978|NCT01194245|454676713|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126376979|NCT01194245|454676714|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
126376980|NCT01194245|454676710|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126376981|NCT01194245|454676711|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126376982|NCT01194245|454676712|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
126376983|NCT01194245|454676713|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
126376984|NCT01194245|454676714|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
126376985|NCT00269087|454676715|FG000|Overall Study|Adverse Event|20|||
126376986|NCT00269087|454676715|FG000|Overall Study|Withdrawal by Subject|1|||
126376987|NCT00269087|454676715|FG000|Overall Study|Exacerbation of COPD|13|||
126376988|NCT00041470|454676719|FG000|Overall Study|Loss of Funding|38|||
126376989|NCT02230189|454676726|FG000|Overall Study|Withdrawal by Subject|3|||
126376990|NCT02230189|454676727|FG001|Overall Study|Withdrawal by Subject|0|||
126376991|NCT02230189|454676728|FG002|Overall Study|Withdrawal by Subject|1|||
126376992|NCT02230189|454676726|FG000|Overall Study|Lost to Follow-up|1|||
126376993|NCT02230189|454676727|FG001|Overall Study|Lost to Follow-up|0|||
126376994|NCT02230189|454676728|FG002|Overall Study|Lost to Follow-up|0|||
126376995|NCT02230189|454676726|FG000|Overall Study|Physician Decision|1|||
126376996|NCT02230189|454676727|FG001|Overall Study|Physician Decision|0|||
126376997|NCT02230189|454676728|FG002|Overall Study|Physician Decision|0|||
126376998|NCT01193101|454676732|FG000|Overall Study|Adverse Event|0|||
126376999|NCT01193101|454676733|FG001|Overall Study|Adverse Event|1|||
126377000|NCT01193101|454676734|FG002|Overall Study|Adverse Event|1|||
126377001|NCT01193101|454676735|FG003|Overall Study|Adverse Event|3|||
126377002|NCT01193101|454676732|FG000|Overall Study|Lack of Efficacy|3|||
126377003|NCT01193101|454676733|FG001|Overall Study|Lack of Efficacy|1|||
126377004|NCT01193101|454676734|FG002|Overall Study|Lack of Efficacy|0|||
126377005|NCT01193101|454676735|FG003|Overall Study|Lack of Efficacy|8|||
126377006|NCT01193101|454676732|FG000|Overall Study|Withdrawal by Subject|2|||
126377007|NCT01193101|454676733|FG001|Overall Study|Withdrawal by Subject|4|||
126377008|NCT01193101|454676734|FG002|Overall Study|Withdrawal by Subject|1|||
126377009|NCT01193101|454676735|FG003|Overall Study|Withdrawal by Subject|1|||
126377010|NCT01193101|454676732|FG000|Overall Study|Administrative problems|0|||
126377011|NCT01193101|454676733|FG001|Overall Study|Administrative problems|0|||
126377012|NCT01193101|454676734|FG002|Overall Study|Administrative problems|1|||
126377013|NCT01193101|454676735|FG003|Overall Study|Administrative problems|0|||
126377014|NCT01193101|454676732|FG000|Overall Study|Abnormal test procedure results|0|||
126377015|NCT01193101|454676733|FG001|Overall Study|Abnormal test procedure results|1|||
126377016|NCT01193101|454676734|FG002|Overall Study|Abnormal test procedure results|0|||
126377017|NCT01193101|454676735|FG003|Overall Study|Abnormal test procedure results|0|||
126377018|NCT02347085|454676738|FG000|Overall Study|Adverse Event|2|||
126377019|NCT02347085|454676738|FG000|Overall Study|Lack of Efficacy|1|||
126377020|NCT02347085|454676738|FG000|Overall Study|Withdrawal by Subject|4|||
126377021|NCT02347085|454676738|FG000|Overall Study|Lost to Follow-up|1|||
126377022|NCT02347085|454676738|FG000|Overall Study|Protocol Criteria|2|||
126377023|NCT02834819|454676739|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
126377024|NCT02834819|454676740|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
126377025|NCT00800982|454676743|FG000|Overall Study|Lost to Follow-up|1|||
126377026|NCT00800982|454676744|FG001|Overall Study|Lost to Follow-up|2|||
126377027|NCT00800982|454676743|FG000|Overall Study|Withdrawal by Subject|0|||
126377028|NCT00800982|454676744|FG001|Overall Study|Withdrawal by Subject|1|||
126377029|NCT00800982|454676743|FG000|Overall Study|Patient moved out of state|1|||
126377030|NCT00800982|454676744|FG001|Overall Study|Patient moved out of state|0|||
126377031|NCT01824290|454676745|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
126377032|NCT01824290|454676746|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
126377033|NCT01824290|454676747|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
126377034|NCT01824290|454676748|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
126377035|NCT01824290|454676745|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
126377036|NCT01824290|454676746|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
126377037|NCT01824290|454676747|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
126377038|NCT01824290|454676748|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
126377039|NCT01824290|454676745|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
126377040|NCT01824290|454676746|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
126377041|NCT01824290|454676747|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
126377042|NCT01824290|454676748|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
126377043|NCT01824290|454676745|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
126377044|NCT01824290|454676746|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
126377045|NCT01824290|454676747|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
126377046|NCT01824290|454676748|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
126377047|NCT01824290|454676745|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
126377048|NCT01824290|454676746|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
126377049|NCT01824290|454676747|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
126377050|NCT01824290|454676748|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
126377051|NCT01824290|454676745|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
126377052|NCT01824290|454676746|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
126377053|NCT01824290|454676747|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
126377054|NCT01824290|454676748|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
126377055|NCT00527618|454676749|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
126377056|NCT00527618|454676750|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
126377057|NCT00527618|454676749|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
126377058|NCT00527618|454676750|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
126377059|NCT00527618|454676749|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
126377060|NCT00527618|454676750|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
126377061|NCT00527618|454676749|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
126377062|NCT00527618|454676750|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
126377063|NCT00527618|454676749|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
126377064|NCT00527618|454676750|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
126377065|NCT00527618|454676749|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
126377066|NCT00527618|454676750|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
126377067|NCT00363311|454676761|FG000|Overall Study|Adverse Event|6|||
126377068|NCT00363311|454676762|FG001|Overall Study|Adverse Event|4|||
126377069|NCT00363311|454676761|FG000|Overall Study|Lost to Follow-up|3|||
126377070|NCT00363311|454676762|FG001|Overall Study|Lost to Follow-up|0|||
126377071|NCT00363311|454676761|FG000|Overall Study|Protocol Violation|1|||
126377072|NCT00363311|454676762|FG001|Overall Study|Protocol Violation|2|||
126377073|NCT00363311|454676761|FG000|Overall Study|Withdrawal by Subject|12|||
126377074|NCT00363311|454676762|FG001|Overall Study|Withdrawal by Subject|6|||
126377075|NCT00363311|454676761|FG000|Overall Study|Physician Decision|1|||
126377076|NCT00363311|454676762|FG001|Overall Study|Physician Decision|1|||
126377077|NCT00363311|454676761|FG000|Overall Study|Sponsor Terminated Study|2|||
126377078|NCT00363311|454676762|FG001|Overall Study|Sponsor Terminated Study|2|||
126377079|NCT00363311|454676761|FG000|Overall Study|Disease Progression|46|||
126377080|NCT00363311|454676762|FG001|Overall Study|Disease Progression|26|||
126377081|NCT00363311|454676761|FG000|Overall Study|Non-Compliance|1|||
126377082|NCT00363311|454676762|FG001|Overall Study|Non-Compliance|1|||
126377083|NCT00363311|454676761|FG000|Overall Study|Participant Refused Biopsy|1|||
126377084|NCT00363311|454676762|FG001|Overall Study|Participant Refused Biopsy|0|||
126377085|NCT00363311|454676761|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
126104111|NCT02647320|453675814|FG002|Overall Study|Adverse Event|3|||
126377086|NCT00363311|454676762|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
126377087|NCT00363311|454676761|FG000|Overall Study|Participant Opted for Treatment|1|||
126377088|NCT00363311|454676762|FG001|Overall Study|Participant Opted for Treatment|0|||
126377089|NCT00363311|454676761|FG000|Overall Study|Participant Moved to Another Country|1|||
126377090|NCT00363311|454676762|FG001|Overall Study|Participant Moved to Another Country|0|||
126377091|NCT00363311|454676761|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
126377092|NCT00363311|454676762|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
126377093|NCT00363311|454676761|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
126377094|NCT00363311|454676762|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
126377095|NCT00363311|454676761|FG000|Overall Study|Participant Moved to Louisiana|0|||
126377096|NCT00363311|454676762|FG001|Overall Study|Participant Moved to Louisiana|1|||
126377097|NCT00120627|454676765|FG000|Overall Study|Withdrawal by Subject|5|||
126377098|NCT00120627|454676766|FG001|Overall Study|Withdrawal by Subject|5|||
126377099|NCT01508910|454676767|FG000|Treatment|Death|2|||
126377100|NCT01508910|454676768|FG001|Treatment|Death|3|||
126377101|NCT01508910|454676769|FG002|Treatment|Death|2|||
126377102|NCT01508910|454676770|FG003|Treatment|Death|0|||
126377103|NCT01508910|454676767|FG000|Treatment|Lost to Follow-up|0|||
126377104|NCT01508910|454676768|FG001|Treatment|Lost to Follow-up|0|||
126377105|NCT01508910|454676769|FG002|Treatment|Lost to Follow-up|2|||
126377106|NCT01508910|454676770|FG003|Treatment|Lost to Follow-up|1|||
126377107|NCT01508910|454676767|FG000|Treatment|Withdrawal by Subject|0|||
126377108|NCT01508910|454676768|FG001|Treatment|Withdrawal by Subject|1|||
126377109|NCT01508910|454676769|FG002|Treatment|Withdrawal by Subject|6|||
126377110|NCT01508910|454676770|FG003|Treatment|Withdrawal by Subject|1|||
126377111|NCT01508910|454676767|FG000|Treatment|Sponsor Decision|0|||
126377112|NCT01508910|454676768|FG001|Treatment|Sponsor Decision|0|||
126377113|NCT01508910|454676769|FG002|Treatment|Sponsor Decision|0|||
126377114|NCT01508910|454676770|FG003|Treatment|Sponsor Decision|1|||
126377115|NCT01595529|454676771|FG000|Overall Study|Adverse Event|2|||
126377116|NCT01595529|454676772|FG001|Overall Study|Adverse Event|0|||
126377117|NCT01595529|454676771|FG000|Overall Study|Subject Non-Compliant|2|||
126377118|NCT01595529|454676772|FG001|Overall Study|Subject Non-Compliant|0|||
126377119|NCT01595529|454676771|FG000|Overall Study|Lost to Follow-up|8|||
126377120|NCT01595529|454676772|FG001|Overall Study|Lost to Follow-up|14|||
126377121|NCT01595529|454676771|FG000|Overall Study|Protocol Violation|1|||
126377122|NCT01595529|454676772|FG001|Overall Study|Protocol Violation|2|||
126377123|NCT01595529|454676771|FG000|Overall Study|Physician Decision|1|||
126377124|NCT01595529|454676772|FG001|Overall Study|Physician Decision|0|||
126377125|NCT01595529|454676771|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
126377126|NCT01595529|454676772|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
126377127|NCT01595529|454676771|FG000|Overall Study|Administrative Decision|1|||
126377128|NCT01595529|454676772|FG001|Overall Study|Administrative Decision|0|||
126377129|NCT01595529|454676771|FG000|Overall Study|Entry Failure/Screening Failure|6|||
126377130|NCT01595529|454676772|FG001|Overall Study|Entry Failure/Screening Failure|1|||
126377131|NCT00730886|454676773|FG000|Overall Study|Lost to Follow-up|1|||
126377132|NCT00730886|454676774|FG001|Overall Study|Lost to Follow-up|0|||
126377133|NCT00730886|454676773|FG000|Overall Study|Physician Decision|1|||
126377134|NCT00730886|454676774|FG001|Overall Study|Physician Decision|0|||
126377135|NCT01991483|454676775|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
126377136|NCT01991483|454676776|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
126377137|NCT01991483|454676777|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
126377138|NCT01991483|454676778|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
126377139|NCT01991483|454676775|FG000|Dose Level 600 mg|Physician Decision|0|||
126377140|NCT01991483|454676776|FG001|Dose Level 600 mg|Physician Decision|0|||
126377141|NCT01991483|454676777|FG002|Dose Level 600 mg|Physician Decision|1|||
126377142|NCT01991483|454676778|FG003|Dose Level 600 mg|Physician Decision|0|||
126377143|NCT01991483|454676775|FG000|Dose Level 1000 mg|Protocol Violation|0|||
126377144|NCT01991483|454676776|FG001|Dose Level 1000 mg|Protocol Violation|0|||
126377145|NCT01991483|454676777|FG002|Dose Level 1000 mg|Protocol Violation|0|||
126377146|NCT01991483|454676778|FG003|Dose Level 1000 mg|Protocol Violation|1|||
126377147|NCT01932788|454676785|FG000|Overall Study|Protocol Violation|18|||
126377148|NCT01932788|454676786|FG001|Overall Study|Protocol Violation|0|||
126377149|NCT01932788|454676785|FG000|Overall Study|Lost to Follow-up|18|||
126377150|NCT01932788|454676786|FG001|Overall Study|Lost to Follow-up|46|||
126377151|NCT01932788|454676785|FG000|Overall Study|Lack of Efficacy|2|||
126377152|NCT01932788|454676786|FG001|Overall Study|Lack of Efficacy|0|||
126377153|NCT01932788|454676785|FG000|Overall Study|Withdrawal by Subject|0|||
126377154|NCT01932788|454676786|FG001|Overall Study|Withdrawal by Subject|5|||
126377155|NCT04819113|454676787|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126377156|NCT04819113|454676787|FG000|Overall Study|Lost to Follow-up|1|||
126377157|NCT04819113|454676787|FG000|Overall Study|Withdrawn before vaccination|2|||
126377158|NCT04067492|454676788|FG000|Overall Study|Lost to Follow-up|0|||
126377159|NCT04067492|454676789|FG001|Overall Study|Lost to Follow-up|0|||
126377160|NCT04067492|454676790|FG002|Overall Study|Lost to Follow-up|0|||
126377161|NCT04067492|454676791|FG003|Overall Study|Lost to Follow-up|0|||
126047998|NCT01288443|453473824|FG003|Overall Study|Poor compliance to protocol|0|||
126047999|NCT01288443|453473825|FG004|Overall Study|Poor compliance to protocol|0|||
126048000|NCT01288443|453473826|FG005|Overall Study|Poor compliance to protocol|1|||
126048001|NCT01288443|453473821|FG000|Overall Study|Participant Moved|0|||
126377162|NCT04067492|454676792|FG004|Overall Study|Lost to Follow-up|0|||
126377163|NCT04067492|454676793|FG005|Overall Study|Lost to Follow-up|1|||
126377164|NCT04067492|454676788|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377165|NCT04067492|454676789|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
126377166|NCT04067492|454676790|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377167|NCT04067492|454676791|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377168|NCT04067492|454676792|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377169|NCT04067492|454676793|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377170|NCT04067492|454676788|FG000|Overall Study|COVID-19 epidemiological situation|0|||
126377171|NCT04067492|454676789|FG001|Overall Study|COVID-19 epidemiological situation|0|||
126377172|NCT04067492|454676790|FG002|Overall Study|COVID-19 epidemiological situation|0|||
126377173|NCT04067492|454676791|FG003|Overall Study|COVID-19 epidemiological situation|1|||
126377174|NCT04067492|454676792|FG004|Overall Study|COVID-19 epidemiological situation|0|||
126377175|NCT04067492|454676793|FG005|Overall Study|COVID-19 epidemiological situation|0|||
126377176|NCT00833027|454676794|FG000|Overall Study|Adverse Event|33|||
126377177|NCT00833027|454676794|FG000|Overall Study|Death|1|||
126377178|NCT00833027|454676794|FG000|Overall Study|Lack of Efficacy|12|||
126377179|NCT00833027|454676794|FG000|Overall Study|Lost to Follow-up|24|||
126377180|NCT00833027|454676794|FG000|Overall Study|Protocol Violation|115|||
126377181|NCT00833027|454676794|FG000|Overall Study|Withdrawal by Subject|16|||
126377182|NCT00833027|454676794|FG000|Overall Study|Missing|10|||
126377183|NCT02806414|454676801|FG000|Overall Study|Lost to Follow-up|2|||
126377184|NCT03092479|454676804|FG000|Overall Study|Lost to Follow-up|3|||
126377185|NCT03092479|454676805|FG001|Overall Study|Lost to Follow-up|2|||
126377186|NCT03092479|454676804|FG000|Overall Study|Withdrawal by Subject|4|||
126377187|NCT03092479|454676805|FG001|Overall Study|Withdrawal by Subject|0|||
126377188|NCT00937495|454678389|FG000|Overall Study|Protocol Violation|2|||
126377189|NCT00441272|454678390|FG000|Overall Study|Study terminated prior to enrollment|25|||
126377190|NCT00441272|454678391|FG001|Overall Study|Study terminated prior to enrollment|25|||
126377191|NCT01856322|454678392|FG000|Overall Study|off study due to lack of accrual|0|||
126377192|NCT01856322|454678393|FG001|Overall Study|off study due to lack of accrual|0|||
126377193|NCT01856322|454678394|FG002|Overall Study|off study due to lack of accrual|3|||
126377194|NCT00443703|454678395|FG000|Overall Study|Never Treated|3|||
126377195|NCT00443703|454678396|FG001|Overall Study|Never Treated|1|||
126377196|NCT00443703|454678395|FG000|Overall Study|Adverse Event|7|||
126377197|NCT00443703|454678396|FG001|Overall Study|Adverse Event|3|||
126377198|NCT00443703|454678395|FG000|Overall Study|Lack of Efficacy|3|||
126377199|NCT00443703|454678396|FG001|Overall Study|Lack of Efficacy|1|||
126377200|NCT00443703|454678395|FG000|Overall Study|Lost to Follow-up|0|||
126377201|NCT00443703|454678396|FG001|Overall Study|Lost to Follow-up|4|||
126377202|NCT00443703|454678395|FG000|Overall Study|Physician Decision|4|||
126377203|NCT00443703|454678396|FG001|Overall Study|Physician Decision|2|||
126377204|NCT00443703|454678395|FG000|Overall Study|Protocol Violation|1|||
126377205|NCT00443703|454678396|FG001|Overall Study|Protocol Violation|1|||
126377206|NCT00443703|454678395|FG000|Overall Study|Withdrawal by Subject|9|||
126377207|NCT00443703|454678396|FG001|Overall Study|Withdrawal by Subject|6|||
126377208|NCT00443703|454678395|FG000|Overall Study|Progressive Disease|1|||
126377209|NCT00443703|454678396|FG001|Overall Study|Progressive Disease|0|||
126377210|NCT00661830|454678400|FG000|Overall Study|Death|37|||
126377211|NCT00661830|454678401|FG001|Overall Study|Death|33|||
126377212|NCT00661830|454678400|FG000|Overall Study|Lost to Follow-up|1|||
126377213|NCT00661830|454678401|FG001|Overall Study|Lost to Follow-up|3|||
126377214|NCT00661830|454678400|FG000|Overall Study|Withdrawal by Subject|1|||
126377215|NCT00661830|454678401|FG001|Overall Study|Withdrawal by Subject|1|||
126377216|NCT00661830|454678400|FG000|Overall Study|Other reason|1|||
126048002|NCT01288443|453473822|FG001|Overall Study|Participant Moved|0|||
126048003|NCT01288443|453473823|FG002|Overall Study|Participant Moved|0|||
126377217|NCT00661830|454678401|FG001|Overall Study|Other reason|5|||
126377218|NCT01669902|454678402|FG000|Overall Study|Adverse Event|11|||
126048004|NCT01288443|453473824|FG003|Overall Study|Participant Moved|1|||
126377219|NCT01669902|454678402|FG000|Overall Study|Lack of Efficacy|10|||
126377220|NCT01669902|454678402|FG000|Overall Study|Other|8|||
126377221|NCT01535287|454678403|FG000|Overall Study|drug not prepared in time|5|||
126377222|NCT01535287|454678404|FG001|Overall Study|drug not prepared in time|6|||
126377223|NCT02364037|454678413|FG000|Overall Study|Withdrawal by Subject|7|||
126377224|NCT02364037|454678414|FG001|Overall Study|Withdrawal by Subject|4|||
126377225|NCT02364037|454678413|FG000|Overall Study|Lost to Follow-up|37|||
126048005|NCT01288443|453473825|FG004|Overall Study|Participant Moved|2|||
126048006|NCT01288443|453473826|FG005|Overall Study|Participant Moved|1|||
126048007|NCT01288443|453473821|FG000|Overall Study|Consent withdrawn by Participant|0|||
126377226|NCT02364037|454678414|FG001|Overall Study|Lost to Follow-up|49|||
126377227|NCT04567524|454678415|FG000|Overall Study|Adverse Event|1|||
126377228|NCT04567524|454678416|FG001|Overall Study|Adverse Event|1|||
126377229|NCT04567524|454678417|FG002|Overall Study|Adverse Event|0|||
126377230|NCT04567524|454678418|FG003|Overall Study|Adverse Event|0|||
126377231|NCT04567524|454678415|FG000|Overall Study|Withdrawal by Subject|2|||
126377232|NCT04567524|454678416|FG001|Overall Study|Withdrawal by Subject|0|||
126377233|NCT04567524|454678417|FG002|Overall Study|Withdrawal by Subject|0|||
126377234|NCT04567524|454678418|FG003|Overall Study|Withdrawal by Subject|1|||
126377235|NCT01639469|454678421|FG000|Overall Study|Death|4|||
126377236|NCT01639469|454678422|FG001|Overall Study|Death|2|||
126377237|NCT01639469|454678421|FG000|Overall Study|Lost to Follow-up|1|||
126377238|NCT01639469|454678422|FG001|Overall Study|Lost to Follow-up|1|||
126377239|NCT00420381|454678423|FG000|Overall Study|Protocol Violation|1|||
126377240|NCT00616642|454678433|FG000|Overall Study|Withdrawal by Subject|0|||
126377241|NCT00616642|454678434|FG001|Overall Study|Withdrawal by Subject|1|||
126377242|NCT00589797|454678441|FG000|Overall Study|Death|1|||
126377243|NCT00589797|454678442|FG001|Overall Study|Death|0|||
126377244|NCT00589797|454678441|FG000|Overall Study|Lost to Follow-up|12|||
126377245|NCT00589797|454678442|FG001|Overall Study|Lost to Follow-up|9|||
126377246|NCT00589797|454678441|FG000|Overall Study|Physician Decision|8|||
126377247|NCT00589797|454678442|FG001|Overall Study|Physician Decision|3|||
126377248|NCT00589797|454678441|FG000|Overall Study|Withdrawal by Subject|6|||
126377249|NCT00589797|454678442|FG001|Overall Study|Withdrawal by Subject|5|||
126377250|NCT00589797|454678441|FG000|Overall Study|Non-Randomized Training Subjects|46|||
126377251|NCT00589797|454678442|FG001|Overall Study|Non-Randomized Training Subjects|6|||
126377252|NCT01881009|454678443|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
126377253|NCT01881009|454678444|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
126377254|NCT02141672|454678445|FG000|Overall Study|Adverse Event|0|||
126377255|NCT02141672|454678446|FG001|Overall Study|Adverse Event|1|||
126377256|NCT02141672|454678447|FG002|Overall Study|Adverse Event|0|||
126377257|NCT02141672|454678445|FG000|Overall Study|Death|10|||
126377258|NCT02141672|454678446|FG001|Overall Study|Death|2|||
126377259|NCT02141672|454678447|FG002|Overall Study|Death|1|||
126377260|NCT02141672|454678445|FG000|Overall Study|Lack of Efficacy|0|||
126377261|NCT02141672|454678446|FG001|Overall Study|Lack of Efficacy|0|||
126377262|NCT02141672|454678447|FG002|Overall Study|Lack of Efficacy|2|||
126377263|NCT02141672|454678445|FG000|Overall Study|Lost to Follow-up|1|||
126377264|NCT02141672|454678446|FG001|Overall Study|Lost to Follow-up|1|||
126377265|NCT02141672|454678447|FG002|Overall Study|Lost to Follow-up|3|||
126377266|NCT02141672|454678445|FG000|Overall Study|Physician Decision|1|||
126377267|NCT02141672|454678446|FG001|Overall Study|Physician Decision|2|||
126377268|NCT02141672|454678447|FG002|Overall Study|Physician Decision|5|||
126377269|NCT02141672|454678445|FG000|Overall Study|Protocol Violation|0|||
126377270|NCT02141672|454678446|FG001|Overall Study|Protocol Violation|0|||
125886355|NCT00196313|452880009|FG001|Overall Study|Subject Pregnant|1|||
126377271|NCT02141672|454678447|FG002|Overall Study|Protocol Violation|1|||
126377272|NCT02141672|454678445|FG000|Overall Study|Withdrawal by Subject|3|||
126377273|NCT02141672|454678446|FG001|Overall Study|Withdrawal by Subject|2|||
126377274|NCT02141672|454678447|FG002|Overall Study|Withdrawal by Subject|5|||
126377275|NCT02141672|454678445|FG000|Overall Study|refused to follow-up|1|||
126377276|NCT02141672|454678446|FG001|Overall Study|refused to follow-up|0|||
126377277|NCT02141672|454678447|FG002|Overall Study|refused to follow-up|1|||
126377278|NCT00332696|454678455|FG000|Overall Study|Death|24|||
126377279|NCT00332696|454678456|FG001|Overall Study|Death|14|||
126377280|NCT00332696|454678455|FG000|Overall Study|Insufficient therapeutic effect|4|||
126377281|NCT00332696|454678456|FG001|Overall Study|Insufficient therapeutic effect|11|||
126377282|NCT00332696|454678455|FG000|Overall Study|Adverse Event|1|||
126377283|NCT00332696|454678456|FG001|Overall Study|Adverse Event|2|||
126048008|NCT01288443|453473822|FG001|Overall Study|Consent withdrawn by Participant|0|||
126048009|NCT01288443|453473823|FG002|Overall Study|Consent withdrawn by Participant|0|||
126048010|NCT01288443|453473824|FG003|Overall Study|Consent withdrawn by Participant|0|||
126048011|NCT01288443|453473825|FG004|Overall Study|Consent withdrawn by Participant|0|||
126048012|NCT01288443|453473826|FG005|Overall Study|Consent withdrawn by Participant|1|||
126048013|NCT01288443|453473821|FG000|Overall Study|Lost to Follow-up|0|||
126048014|NCT01288443|453473822|FG001|Overall Study|Lost to Follow-up|1|||
126048015|NCT01288443|453473823|FG002|Overall Study|Lost to Follow-up|0|||
126048016|NCT01288443|453473824|FG003|Overall Study|Lost to Follow-up|0|||
126048017|NCT01288443|453473825|FG004|Overall Study|Lost to Follow-up|0|||
126048018|NCT01288443|453473826|FG005|Overall Study|Lost to Follow-up|0|||
126048019|NCT01288443|453473821|FG000|Overall Study|Study drug auto-injector administration|0|||
126048020|NCT01288443|453473822|FG001|Overall Study|Study drug auto-injector administration|0|||
126048021|NCT01288443|453473823|FG002|Overall Study|Study drug auto-injector administration|0|||
126048022|NCT01288443|453473824|FG003|Overall Study|Study drug auto-injector administration|0|||
126048023|NCT01288443|453473825|FG004|Overall Study|Study drug auto-injector administration|1|||
126048024|NCT01288443|453473826|FG005|Overall Study|Study drug auto-injector administration|1|||
126048025|NCT01288443|453473821|FG000|Overall Study|Other than above|0|||
126048026|NCT01288443|453473822|FG001|Overall Study|Other than above|0|||
126048027|NCT01288443|453473823|FG002|Overall Study|Other than above|0|||
126048028|NCT01288443|453473824|FG003|Overall Study|Other than above|2|||
126048029|NCT01288443|453473825|FG004|Overall Study|Other than above|1|||
126048030|NCT01288443|453473826|FG005|Overall Study|Other than above|0|||
126048031|NCT01596972|453473827|FG000|Overall Study|Physician Decision|1|||
126377284|NCT00332696|454678455|FG000|Overall Study|Condition does not justify treatment|0|||
126377285|NCT00332696|454678456|FG001|Overall Study|Condition does not justify treatment|2|||
126377286|NCT00332696|454678455|FG000|Overall Study|Lost to Follow-up|0|||
126377287|NCT00332696|454678456|FG001|Overall Study|Lost to Follow-up|1|||
126377288|NCT00332696|454678455|FG000|Overall Study|Withdrawal by Subject|1|||
126377289|NCT00332696|454678456|FG001|Overall Study|Withdrawal by Subject|0|||
126377290|NCT01061385|454678458|FG000|Overall Study|Lost to Follow-up|1|||
126377291|NCT01061385|454678459|FG001|Overall Study|Lost to Follow-up|0|||
126377292|NCT01061385|454678458|FG000|Overall Study|subject decision not related to AE|0|||
126377293|NCT01061385|454678459|FG001|Overall Study|subject decision not related to AE|1|||
126377294|NCT00533429|454678460|FG000|Overall Study|Adverse Event|3|||
126377295|NCT00533429|454678461|FG001|Overall Study|Adverse Event|1|||
126377296|NCT00533429|454678460|FG000|Overall Study|Death|1|||
126377297|NCT00533429|454678461|FG001|Overall Study|Death|0|||
126377298|NCT00533429|454678460|FG000|Overall Study|Withdrawal by Subject|2|||
126377299|NCT00533429|454678461|FG001|Overall Study|Withdrawal by Subject|0|||
126377300|NCT00533429|454678460|FG000|Overall Study|Progressive Disease|12|||
126377301|NCT00533429|454678461|FG001|Overall Study|Progressive Disease|13|||
126377302|NCT00533429|454678460|FG000|Overall Study|Symptomatic deterioration|1|||
126377303|NCT00533429|454678461|FG001|Overall Study|Symptomatic deterioration|2|||
126377304|NCT01464879|454678462|FG000|Overall Study|Physician Decision|1|||
126377305|NCT01464879|454678462|FG000|Overall Study|Non-compliance|1|||
126377306|NCT00244621|454678463|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126377307|NCT00244621|454678464|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126377308|NCT00244621|454678465|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
126377309|NCT00244621|454678463|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126377310|NCT00244621|454678464|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126377311|NCT00244621|454678465|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126377312|NCT00244621|454678463|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126377313|NCT00244621|454678464|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
126377314|NCT00244621|454678465|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
126377315|NCT00244621|454678463|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
126377316|NCT00244621|454678464|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
126377317|NCT00244621|454678465|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
126377318|NCT00244621|454678463|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126377319|NCT00244621|454678464|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
126377320|NCT00244621|454678465|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
126377321|NCT00244621|454678463|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
126377322|NCT00244621|454678464|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126377323|NCT00244621|454678465|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
126377324|NCT00244621|454678463|FG000|Open-label Treatment Period|Adverse Event|0|||
126377325|NCT00244621|454678464|FG001|Open-label Treatment Period|Adverse Event|0|||
126377326|NCT00244621|454678465|FG002|Open-label Treatment Period|Adverse Event|1|||
126048032|NCT01596972|453473828|FG001|Overall Study|Physician Decision|9|||
126048033|NCT01596972|453473827|FG000|Overall Study|Lost to Follow-up|0|||
126104112|NCT02647320|453675815|FG003|Overall Study|Adverse Event|2|||
126377327|NCT00244621|454678463|FG000|Open-label Treatment Period|Moved abroad|0|||
126377328|NCT00244621|454678464|FG001|Open-label Treatment Period|Moved abroad|0|||
126048034|NCT01596972|453473828|FG001|Overall Study|Lost to Follow-up|4|||
126048035|NCT01596972|453473827|FG000|Overall Study|Withdrawal by Subject|0|||
126377329|NCT00244621|454678465|FG002|Open-label Treatment Period|Moved abroad|1|||
126377330|NCT00648037|454678469|FG000|Overall Study|Not Treated|1|||
126377331|NCT00648037|454678469|FG000|Overall Study|Withdrawal by Subject|1|||
126377332|NCT00648037|454678469|FG000|Overall Study|Adverse Event|11|||
126377333|NCT00648037|454678469|FG000|Overall Study|Relapse|2|||
126377334|NCT00648037|454678469|FG000|Overall Study|Other|1|||
126377335|NCT02967679|454678470|FG000|Overall Study|Adverse Event|1|||
126377336|NCT00003631|454678473|FG000|Overall Study|Patient not treated|1|||
126377337|NCT00003631|454678474|FG001|Overall Study|Patient not treated|0|||
126377338|NCT00003631|454678475|FG002|Overall Study|Patient not treated|1|||
126377339|NCT00003631|454678473|FG000|Overall Study|Protocol Violation|1|||
126377340|NCT00003631|454678474|FG001|Overall Study|Protocol Violation|0|||
126377341|NCT00003631|454678475|FG002|Overall Study|Protocol Violation|0|||
126377342|NCT00003631|454678473|FG000|Overall Study|Adverse Event|1|||
126377343|NCT00003631|454678474|FG001|Overall Study|Adverse Event|1|||
126377344|NCT00003631|454678475|FG002|Overall Study|Adverse Event|5|||
126377345|NCT00003631|454678473|FG000|Overall Study|Death|0|||
126377346|NCT00003631|454678474|FG001|Overall Study|Death|0|||
126377347|NCT00003631|454678475|FG002|Overall Study|Death|1|||
126377348|NCT00003631|454678473|FG000|Overall Study|Evaluable for toxicity only|0|||
126377349|NCT00003631|454678474|FG001|Overall Study|Evaluable for toxicity only|0|||
126377350|NCT00003631|454678475|FG002|Overall Study|Evaluable for toxicity only|2|||
126377351|NCT00600067|454678476|FG000|Overall Study|Adverse Event|0|||
126377352|NCT00600067|454678477|FG001|Overall Study|Adverse Event|1|||
126377353|NCT00600067|454678476|FG000|Overall Study|Lost to Follow-up|2|||
126377354|NCT00600067|454678477|FG001|Overall Study|Lost to Follow-up|3|||
126377355|NCT00600067|454678476|FG000|Overall Study|protocol non-compliance|0|||
126377356|NCT00600067|454678477|FG001|Overall Study|protocol non-compliance|3|||
126377357|NCT00600067|454678476|FG000|Overall Study|Lack of Efficacy|1|||
126377358|NCT00600067|454678477|FG001|Overall Study|Lack of Efficacy|0|||
126377359|NCT04339413|454678478|FG000|Overall Study|Reason Not Specified|2|||
126377360|NCT04339413|454678479|FG001|Overall Study|Reason Not Specified|7|||
126377361|NCT04339413|454678478|FG000|Overall Study|Study Terminated by Sponsor|30|||
126377362|NCT04339413|454678479|FG001|Overall Study|Study Terminated by Sponsor|33|||
126377363|NCT04339413|454678478|FG000|Overall Study|Progressive Disease|9|||
126377364|NCT04339413|454678479|FG001|Overall Study|Progressive Disease|6|||
126377365|NCT04339413|454678478|FG000|Overall Study|Withdrawal by Subject|9|||
126377366|NCT04339413|454678479|FG001|Overall Study|Withdrawal by Subject|10|||
126377367|NCT04339413|454678478|FG000|Overall Study|Physician Decision|3|||
126377368|NCT04339413|454678479|FG001|Overall Study|Physician Decision|1|||
126377369|NCT04339413|454678478|FG000|Overall Study|Death|2|||
126377370|NCT04339413|454678479|FG001|Overall Study|Death|0|||
126377371|NCT04339413|454678478|FG000|Overall Study|Adverse Event|3|||
126377372|NCT04339413|454678479|FG001|Overall Study|Adverse Event|0|||
126377373|NCT00251693|454678485|FG000|Overall Study|Adverse Event|17|||
126377374|NCT00251693|454678486|FG001|Overall Study|Adverse Event|9|||
126377375|NCT00251693|454678487|FG002|Overall Study|Adverse Event|9|||
126377376|NCT00251693|454678485|FG000|Overall Study|Protocol Violation|2|||
126377377|NCT00251693|454678486|FG001|Overall Study|Protocol Violation|0|||
126377378|NCT00251693|454678487|FG002|Overall Study|Protocol Violation|2|||
126377379|NCT00251693|454678485|FG000|Overall Study|Lost to Follow-up|12|||
126377380|NCT00251693|454678486|FG001|Overall Study|Lost to Follow-up|7|||
126377381|NCT00251693|454678487|FG002|Overall Study|Lost to Follow-up|8|||
126377382|NCT00251693|454678485|FG000|Overall Study|Withdrawal by Subject|11|||
126377383|NCT00251693|454678486|FG001|Overall Study|Withdrawal by Subject|17|||
126377384|NCT00251693|454678487|FG002|Overall Study|Withdrawal by Subject|14|||
126377385|NCT00251693|454678485|FG000|Overall Study|Lack of Efficacy|0|||
126377386|NCT00251693|454678486|FG001|Overall Study|Lack of Efficacy|1|||
126377387|NCT00251693|454678487|FG002|Overall Study|Lack of Efficacy|0|||
126104113|NCT02647320|453675816|FG004|Overall Study|Adverse Event|1|||
126377388|NCT00251693|454678485|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
126377389|NCT00251693|454678486|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
126377390|NCT00251693|454678487|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
126377391|NCT00251693|454678485|FG000|Overall Study|Noncompliant|0|||
126377392|NCT00251693|454678486|FG001|Overall Study|Noncompliant|0|||
126377393|NCT00251693|454678487|FG002|Overall Study|Noncompliant|2|||
126377394|NCT00251693|454678485|FG000|Overall Study|Possible Barrett's esophagus|3|||
126377395|NCT00251693|454678486|FG001|Overall Study|Possible Barrett's esophagus|5|||
126377396|NCT00251693|454678487|FG002|Overall Study|Possible Barrett's esophagus|2|||
126377397|NCT00251693|454678485|FG000|Overall Study|Subject request/subject unavailable|1|||
126377398|NCT00251693|454678486|FG001|Overall Study|Subject request/subject unavailable|2|||
126377399|NCT00251693|454678487|FG002|Overall Study|Subject request/subject unavailable|0|||
126377400|NCT00251693|454678485|FG000|Overall Study|Abnormal laboratory findings|0|||
126104114|NCT02647320|453675812|FG000|Overall Study|Protocol Violation|0|||
126377401|NCT00251693|454678486|FG001|Overall Study|Abnormal laboratory findings|0|||
126104115|NCT02647320|453675813|FG001|Overall Study|Protocol Violation|0|||
126104116|NCT02647320|453675814|FG002|Overall Study|Protocol Violation|3|||
126104117|NCT02647320|453675815|FG003|Overall Study|Protocol Violation|0|||
126104118|NCT02647320|453675816|FG004|Overall Study|Protocol Violation|0|||
126104119|NCT02647320|453675812|FG000|Overall Study|Withdrawal by Subject|7|||
126104120|NCT02647320|453675813|FG001|Overall Study|Withdrawal by Subject|4|||
126104121|NCT02647320|453675814|FG002|Overall Study|Withdrawal by Subject|2|||
126104122|NCT02647320|453675815|FG003|Overall Study|Withdrawal by Subject|2|||
126104123|NCT02647320|453675816|FG004|Overall Study|Withdrawal by Subject|7|||
126104124|NCT02647320|453675812|FG000|Overall Study|Persistent hyperglycemia|0|||
126104125|NCT02647320|453675813|FG001|Overall Study|Persistent hyperglycemia|1|||
126104126|NCT02647320|453675814|FG002|Overall Study|Persistent hyperglycemia|1|||
126104127|NCT02647320|453675815|FG003|Overall Study|Persistent hyperglycemia|1|||
126104128|NCT02647320|453675816|FG004|Overall Study|Persistent hyperglycemia|1|||
126104129|NCT02647320|453675812|FG000|Overall Study|Study terminated by sponsor|1|||
126104130|NCT02647320|453675813|FG001|Overall Study|Study terminated by sponsor|1|||
126104131|NCT02647320|453675814|FG002|Overall Study|Study terminated by sponsor|1|||
126104132|NCT02647320|453675815|FG003|Overall Study|Study terminated by sponsor|1|||
126104133|NCT02647320|453675816|FG004|Overall Study|Study terminated by sponsor|2|||
126377402|NCT00251693|454678487|FG002|Overall Study|Abnormal laboratory findings|1|||
126377403|NCT00401843|454678488|FG000|Overall Study|Achieved Complete Response|1|||
126377404|NCT00401843|454678489|FG001|Overall Study|Achieved Complete Response|5|||
126377405|NCT00401843|454678490|FG002|Overall Study|Achieved Complete Response|11|||
126377406|NCT00401843|454678488|FG000|Overall Study|Adverse Event|7|||
126377407|NCT00401843|454678489|FG001|Overall Study|Adverse Event|26|||
126377408|NCT00401843|454678490|FG002|Overall Study|Adverse Event|27|||
126377409|NCT00401843|454678488|FG000|Overall Study|Death|0|||
126377410|NCT00401843|454678489|FG001|Overall Study|Death|8|||
126377411|NCT00401843|454678490|FG002|Overall Study|Death|10|||
126377412|NCT00401843|454678488|FG000|Overall Study|Disease progression|10|||
126377413|NCT00401843|454678489|FG001|Overall Study|Disease progression|60|||
126377414|NCT00401843|454678490|FG002|Overall Study|Disease progression|49|||
126377415|NCT00401843|454678488|FG000|Overall Study|End of Study|1|||
126377416|NCT00401843|454678489|FG001|Overall Study|End of Study|1|||
126377417|NCT00401843|454678490|FG002|Overall Study|End of Study|2|||
126377418|NCT00401843|454678488|FG000|Overall Study|Lost to Follow-up|0|||
126377419|NCT00401843|454678489|FG001|Overall Study|Lost to Follow-up|0|||
126377420|NCT00401843|454678490|FG002|Overall Study|Lost to Follow-up|2|||
126377421|NCT00401843|454678488|FG000|Overall Study|Other Unspecified|0|||
126377422|NCT00401843|454678489|FG001|Overall Study|Other Unspecified|3|||
126377423|NCT00401843|454678490|FG002|Overall Study|Other Unspecified|5|||
126377424|NCT00401843|454678488|FG000|Overall Study|Physician Decision|0|||
126377425|NCT00401843|454678489|FG001|Overall Study|Physician Decision|16|||
126377426|NCT00401843|454678490|FG002|Overall Study|Physician Decision|10|||
126377427|NCT00401843|454678488|FG000|Overall Study|Protocol Violation|0|||
126377428|NCT00401843|454678489|FG001|Overall Study|Protocol Violation|0|||
126377429|NCT00401843|454678490|FG002|Overall Study|Protocol Violation|1|||
126377430|NCT00401843|454678488|FG000|Overall Study|Withdrawal by Subject|1|||
126377431|NCT00401843|454678489|FG001|Overall Study|Withdrawal by Subject|5|||
126377432|NCT00401843|454678490|FG002|Overall Study|Withdrawal by Subject|5|||
126377433|NCT00401843|454678488|FG000|Overall Study|Withdrawal of consent to study agent|1|||
126377434|NCT00401843|454678489|FG001|Overall Study|Withdrawal of consent to study agent|15|||
126377435|NCT00401843|454678490|FG002|Overall Study|Withdrawal of consent to study agent|17|||
126377436|NCT00401843|454678488|FG000|Overall Study|Randomized but not Treated|0|||
126377437|NCT00401843|454678489|FG001|Overall Study|Randomized but not Treated|2|||
126377438|NCT00401843|454678490|FG002|Overall Study|Randomized but not Treated|3|||
126377439|NCT00401843|454678488|FG000|Overall Study|Received incorrect treatment|0|||
126377440|NCT00401843|454678489|FG001|Overall Study|Received incorrect treatment|3|||
126377441|NCT00401843|454678490|FG002|Overall Study|Received incorrect treatment|0|||
126377442|NCT02103062|454678491|FG000|Overall Study|Adverse Event|1|||
126377443|NCT02103062|454678492|FG001|Overall Study|Adverse Event|2|||
126104134|NCT02647320|453675812|FG000|Overall Study|Reason not provided|0|||
126104135|NCT02647320|453675813|FG001|Overall Study|Reason not provided|0|||
126104136|NCT02647320|453675814|FG002|Overall Study|Reason not provided|1|||
126377444|NCT02103062|454678491|FG000|Overall Study|Progressive Disease|17|||
126377445|NCT02103062|454678492|FG001|Overall Study|Progressive Disease|20|||
125886356|NCT00196313|452880008|FG000|Overall Study|Lost to Follow-up|2|||
126377446|NCT02103062|454678491|FG000|Overall Study|Death|0|||
126377447|NCT02103062|454678492|FG001|Overall Study|Death|1|||
126377448|NCT02030821|454678494|FG000|Overall Study|Physician Decision|2|||
126377449|NCT02030821|454678495|FG001|Overall Study|Physician Decision|2|||
126377450|NCT02030821|454678496|FG002|Overall Study|Physician Decision|5|||
126377451|NCT02030821|454678497|FG003|Overall Study|Physician Decision|2|||
126377452|NCT03192137|454678498|FG000|Overall Study|Adverse Event|10|||
126377453|NCT03192137|454678499|FG001|Overall Study|Adverse Event|11|||
126377454|NCT03192137|454678498|FG000|Overall Study|Physician Decision|1|||
126377455|NCT03192137|454678499|FG001|Overall Study|Physician Decision|0|||
126377456|NCT03192137|454678498|FG000|Overall Study|Lack of Efficacy|20|||
126377457|NCT03192137|454678499|FG001|Overall Study|Lack of Efficacy|37|||
126377458|NCT03192137|454678498|FG000|Overall Study|Withdrawal by Subject|3|||
126377459|NCT03192137|454678499|FG001|Overall Study|Withdrawal by Subject|3|||
126377460|NCT03192137|454678498|FG000|Overall Study|Protocol Violation|4|||
126377461|NCT03192137|454678499|FG001|Overall Study|Protocol Violation|3|||
126377462|NCT03192137|454678498|FG000|Overall Study|Surgery Cancelled|4|||
126377463|NCT03192137|454678499|FG001|Overall Study|Surgery Cancelled|1|||
126377464|NCT03192137|454678498|FG000|Overall Study|Other - Various Administrative Reasons|8|||
126377465|NCT03192137|454678499|FG001|Overall Study|Other - Various Administrative Reasons|3|||
126377466|NCT00657267|454678502|FG000|Overall Study|Progressive disease|45|||
126377467|NCT00657267|454678502|FG000|Overall Study|Adverse Event|9|||
126377468|NCT02737501|454678506|FG000|Randomized Phase|Died|41|||
126377469|NCT02737501|454678507|FG001|Randomized Phase|Died|29|||
126377470|NCT02737501|454678508|FG002|Randomized Phase|Died|0|||
126377471|NCT02737501|454678506|FG000|Randomized Phase|Withdrawal by Subject|16|||
126377472|NCT02737501|454678507|FG001|Randomized Phase|Withdrawal by Subject|6|||
126377473|NCT02737501|454678508|FG002|Randomized Phase|Withdrawal by Subject|0|||
126377474|NCT02737501|454678506|FG000|Randomized Phase|Lost to Follow-up|0|||
126377475|NCT02737501|454678507|FG001|Randomized Phase|Lost to Follow-up|1|||
126377476|NCT02737501|454678508|FG002|Randomized Phase|Lost to Follow-up|0|||
126377477|NCT02737501|454678506|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
126377478|NCT02737501|454678507|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
126377479|NCT02737501|454678508|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
126377480|NCT02737501|454678506|FG000|Randomized Phase|Reason not Specified|1|||
126377481|NCT02737501|454678507|FG001|Randomized Phase|Reason not Specified|1|||
126377482|NCT02737501|454678508|FG002|Randomized Phase|Reason not Specified|0|||
126377483|NCT02737501|454678506|FG000|Randomized Phase|Never Treated|1|||
126377484|NCT02737501|454678507|FG001|Randomized Phase|Never Treated|1|||
126377485|NCT02737501|454678508|FG002|Randomized Phase|Never Treated|0|||
126377486|NCT02737501|454678506|FG000|Crossover Phase|Died|0|||
126377487|NCT02737501|454678507|FG001|Crossover Phase|Died|0|||
126377488|NCT02737501|454678508|FG002|Crossover Phase|Died|22|||
126377489|NCT02737501|454678506|FG000|Crossover Phase|Withdrew Consent|0|||
126377490|NCT02737501|454678507|FG001|Crossover Phase|Withdrew Consent|0|||
126377491|NCT02737501|454678508|FG002|Crossover Phase|Withdrew Consent|9|||
126048036|NCT01596972|453473828|FG001|Overall Study|Withdrawal by Subject|1|||
126048037|NCT01964300|453473831|FG000|Overall Study|Ineligible after enrollment|0|||
126048038|NCT01964300|453473832|FG001|Overall Study|Ineligible after enrollment|1|||
126048039|NCT01964300|453473831|FG000|Overall Study|Adverse Event|1|||
126048040|NCT01964300|453473832|FG001|Overall Study|Adverse Event|1|||
126048041|NCT01964300|453473831|FG000|Overall Study|Lack of Efficacy|3|||
126048042|NCT01964300|453473832|FG001|Overall Study|Lack of Efficacy|5|||
126048043|NCT01964300|453473831|FG000|Overall Study|Withdrawal by Subject|0|||
126048044|NCT01964300|453473832|FG001|Overall Study|Withdrawal by Subject|1|||
126048045|NCT01964300|453473831|FG000|Overall Study|To receive alternative therapy|1|||
126048046|NCT01964300|453473832|FG001|Overall Study|To receive alternative therapy|2|||
126048047|NCT01964300|453473831|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
126048048|NCT01964300|453473832|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
126048049|NCT01964300|453473831|FG000|Overall Study|Weight criteria not met|0|||
126048050|NCT01964300|453473832|FG001|Overall Study|Weight criteria not met|1|||
126377492|NCT02737501|454678506|FG000|Crossover Phase|Physician Decision|0|||
126377493|NCT02737501|454678507|FG001|Crossover Phase|Physician Decision|0|||
126377494|NCT02737501|454678508|FG002|Crossover Phase|Physician Decision|1|||
126377495|NCT02737501|454678506|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
126377496|NCT02737501|454678507|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
126377497|NCT02737501|454678508|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
126377498|NCT01261975|454678509|FG000|Overall Study|Surgical complication|1|||
126377499|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
126377500|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377501|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377502|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377503|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377504|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377505|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
126377506|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
126377507|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
126377508|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
126377509|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
126377510|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
126377511|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
126377512|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377513|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377514|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377515|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377516|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377517|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
126377518|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
126377519|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
126377520|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
126377521|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
126377522|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
126377523|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
126377524|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
126377525|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
126377526|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
126377527|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
126377528|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
126377529|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377530|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
126377531|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377532|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377533|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377534|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377535|NCT00716274|454678510|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377536|NCT00716274|454678511|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377537|NCT00716274|454678512|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
126377538|NCT00716274|454678513|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377539|NCT00716274|454678514|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377540|NCT00716274|454678515|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377541|NCT00716274|454678510|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
126377542|NCT00716274|454678511|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
126377543|NCT00716274|454678512|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
126377544|NCT00716274|454678513|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
126377545|NCT00716274|454678514|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
126377546|NCT00716274|454678515|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
126377547|NCT00716274|454678510|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
126377548|NCT00716274|454678511|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
126377549|NCT00716274|454678512|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
126377550|NCT00716274|454678513|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
126377551|NCT00716274|454678514|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
126377552|NCT00716274|454678515|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
126377553|NCT00716274|454678510|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
126377554|NCT00716274|454678511|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
126377555|NCT00716274|454678512|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
126104137|NCT02647320|453675815|FG003|Overall Study|Reason not provided|0|||
126377556|NCT00716274|454678513|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
126377557|NCT00716274|454678514|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
126377558|NCT00716274|454678515|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
126377559|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Death|2|||
126377560|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
126377561|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
126377562|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Physician Decision|1|||
126104138|NCT02647320|453675816|FG004|Overall Study|Reason not provided|2|||
126104139|NCT02647320|453675812|FG000|Overall Study|Lost to Follow-up|1|||
126104140|NCT02647320|453675813|FG001|Overall Study|Lost to Follow-up|1|||
126104141|NCT02647320|453675814|FG002|Overall Study|Lost to Follow-up|0|||
126104142|NCT02647320|453675815|FG003|Overall Study|Lost to Follow-up|0|||
126104143|NCT02647320|453675816|FG004|Overall Study|Lost to Follow-up|0|||
126104144|NCT02647320|453675812|FG000|Overall Study|Develop anemia|1|||
126104145|NCT02647320|453675813|FG001|Overall Study|Develop anemia|0|||
126104146|NCT02647320|453675814|FG002|Overall Study|Develop anemia|0|||
126104147|NCT02647320|453675815|FG003|Overall Study|Develop anemia|0|||
126104148|NCT02647320|453675816|FG004|Overall Study|Develop anemia|0|||
126104149|NCT02647320|453675812|FG000|Overall Study|Lack of Efficacy|0|||
126377563|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
126377564|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
126377565|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Adverse Event|2|||
126377566|NCT00786422|454678518|FG000|Follow-up Period|Death|1|||
126377567|NCT00786422|454678518|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
126377568|NCT00543985|454678521|FG000|Overall Study|Withdrawal by Subject|4|||
126377569|NCT02015039|454678522|FG000|Overall Study|Not eligible|0|||
126377570|NCT02015039|454678523|FG001|Overall Study|Not eligible|1|||
126377571|NCT04570384|454678524|FG000|Overall Study|Adverse Event|2|||
126377572|NCT04570384|454678525|FG001|Overall Study|Adverse Event|1|||
126377573|NCT04570384|454678524|FG000|Overall Study|Death|2|||
126377574|NCT04570384|454678525|FG001|Overall Study|Death|5|||
126377575|NCT04570384|454678524|FG000|Overall Study|Lost to Follow-up|1|||
126377576|NCT04570384|454678525|FG001|Overall Study|Lost to Follow-up|0|||
126377577|NCT04570384|454678524|FG000|Overall Study|Other|1|||
126377578|NCT04570384|454678525|FG001|Overall Study|Other|0|||
126377579|NCT04570384|454678524|FG000|Overall Study|Protocol Violation|0|||
126377580|NCT04570384|454678525|FG001|Overall Study|Protocol Violation|1|||
126377581|NCT04570384|454678524|FG000|Overall Study|Sponsor Decision|1|||
126377582|NCT04570384|454678525|FG001|Overall Study|Sponsor Decision|0|||
126377583|NCT04570384|454678524|FG000|Overall Study|Withdrawal by Subject|4|||
126377584|NCT04570384|454678525|FG001|Overall Study|Withdrawal by Subject|2|||
126377585|NCT01673126|454678526|FG000|Overall Study|change of diagnosis|4|||
126377586|NCT01673126|454678527|FG001|Overall Study|change of diagnosis|3|||
126377587|NCT00237042|454678528|FG000|Treatment|Became ineligible post-randomization|0|||
126377588|NCT00237042|454678529|FG001|Treatment|Became ineligible post-randomization|1|||
126377589|NCT00237042|454678530|FG002|Treatment|Became ineligible post-randomization|16|||
126377590|NCT00237042|454678528|FG000|Treatment|Moved out of state|1|||
126377591|NCT00237042|454678529|FG001|Treatment|Moved out of state|1|||
126377592|NCT00237042|454678530|FG002|Treatment|Moved out of state|1|||
126048051|NCT00557492|453473833|FG000|Overall Study|Change in health insurance|1|||
126048052|NCT02438137|453473834|FG000|Overall Study|Lost to Follow-up|3|||
126048053|NCT02438137|453473835|FG001|Overall Study|Lost to Follow-up|2|||
126048054|NCT02438137|453473834|FG000|Overall Study|Adverse Event|1|||
126048055|NCT02438137|453473835|FG001|Overall Study|Adverse Event|0|||
126048056|NCT02438137|453473834|FG000|Overall Study|Withdrawal by Subject|4|||
126048057|NCT02438137|453473835|FG001|Overall Study|Withdrawal by Subject|3|||
126048058|NCT02438137|453473834|FG000|Overall Study|Physician Decision|0|||
126048059|NCT02438137|453473835|FG001|Overall Study|Physician Decision|1|||
126048060|NCT02285270|453473836|FG000|Overall Study|Lost to Follow-up|1|||
126377593|NCT00237042|454678528|FG000|Treatment|Completed no treatment|5|||
126377594|NCT00237042|454678529|FG001|Treatment|Completed no treatment|5|||
126048061|NCT02285270|453473836|FG000|Overall Study|Physician Decision|3|||
126048062|NCT02285270|453473836|FG000|Overall Study|Determined to be ineligible|1|||
126104150|NCT02647320|453675813|FG001|Overall Study|Lack of Efficacy|0|||
126377595|NCT00237042|454678530|FG002|Treatment|Completed no treatment|21|||
126377596|NCT00237042|454678528|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
126048063|NCT04868617|453473837|FG000|Overall Study|Death|1|||
126048064|NCT04868617|453473838|FG001|Overall Study|Death|0|||
126048065|NCT04868617|453473837|FG000|Overall Study|Adverse Event|1|||
126377597|NCT00237042|454678529|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
126104151|NCT02647320|453675814|FG002|Overall Study|Lack of Efficacy|0|||
126104152|NCT02647320|453675815|FG003|Overall Study|Lack of Efficacy|1|||
126104153|NCT02647320|453675816|FG004|Overall Study|Lack of Efficacy|0|||
126377598|NCT00237042|454678530|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
126377599|NCT00237042|454678528|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
126377600|NCT00237042|454678529|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
126377601|NCT00237042|454678530|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
126377602|NCT01897532|454678537|FG000|Discontinuation From Treatment|Not Treated|7|||
126377603|NCT01897532|454678538|FG001|Discontinuation From Treatment|Not Treated|5|||
126377604|NCT01897532|454678537|FG000|Discontinuation From Treatment|Other reason than specified|196|||
126377605|NCT01897532|454678538|FG001|Discontinuation From Treatment|Other reason than specified|176|||
126377606|NCT01897532|454678537|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
126377607|NCT01897532|454678538|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
126377608|NCT01897532|454678537|FG000|Discontinuation From Treatment|Non compliance|24|||
126377609|NCT01897532|454678538|FG001|Discontinuation From Treatment|Non compliance|15|||
126377610|NCT01897532|454678537|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
126377611|NCT01897532|454678538|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
126377612|NCT01897532|454678537|FG000|Discontinuation From Trial|Not Treated|7|||
126377613|NCT01897532|454678538|FG001|Discontinuation From Trial|Not Treated|5|||
126377614|NCT01897532|454678537|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
126377615|NCT01897532|454678538|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
126377616|NCT03132467|454678539|FG000|Overall Study|Adverse Event|2|||
126377617|NCT03132467|454678539|FG000|Overall Study|Withdrawal by Subject|2|||
126377618|NCT00038948|454678540|FG000|Overall Study|Adverse Event|131|||
126377619|NCT00038948|454678541|FG001|Overall Study|Adverse Event|43|||
126377620|NCT00038948|454678540|FG000|Overall Study|Lost to Follow-up|4|||
126377621|NCT00038948|454678541|FG001|Overall Study|Lost to Follow-up|4|||
126377622|NCT00038948|454678540|FG000|Overall Study|Nonmedical event|5|||
126377623|NCT00038948|454678541|FG001|Overall Study|Nonmedical event|7|||
126377624|NCT00038948|454678540|FG000|Overall Study|Withdrawal by Subject|23|||
126377625|NCT00038948|454678541|FG001|Overall Study|Withdrawal by Subject|10|||
126377626|NCT00038948|454678540|FG000|Overall Study|Protocol Violation|3|||
126377627|NCT00038948|454678541|FG001|Overall Study|Protocol Violation|7|||
126377628|NCT00038948|454678540|FG000|Overall Study|Lack of Efficacy|3|||
126377629|NCT00038948|454678541|FG001|Overall Study|Lack of Efficacy|6|||
126377630|NCT01404234|454678544|FG000|Overall Study|Withdrawal by Subject|2|||
126377631|NCT02670473|454678545|FG000|Overall Study|Withdrawal by Subject|1|||
126377632|NCT05223673|454678546|FG000|Overall Study|Protocol Violation|1|||
126377633|NCT05223673|454678546|FG000|Overall Study|Study termination|6|||
126377634|NCT04472650|454680258|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
126377635|NCT04472650|454680259|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
126377636|NCT00288015|454680264|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
126377637|NCT00288015|454680264|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
126377638|NCT00288015|454680264|FG000|First Response Assessment|Withdrawal by Subject|1|||
126377639|NCT00288015|454680264|FG000|First Response Assessment|Death|1|||
126377640|NCT00288015|454680264|FG000|First Response Assessment|Physician Decision|2|||
126377641|NCT00288015|454680264|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
126377642|NCT00288015|454680264|FG000|Follow up for Survival x 2 Years|Death|13|||
126377643|NCT00288015|454680264|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
126377644|NCT00288015|454680264|FG000|Follow up for Survival x 2 Years|Other|9|||
126377645|NCT01333722|454680265|FG000|Overall Study|Lack of Efficacy|0|||
126377646|NCT01333722|454680266|FG001|Overall Study|Lack of Efficacy|2|||
126048066|NCT04868617|453473838|FG001|Overall Study|Adverse Event|0|||
126048067|NCT04868617|453473837|FG000|Overall Study|Withdrawal by Subject|1|||
126048068|NCT04868617|453473838|FG001|Overall Study|Withdrawal by Subject|0|||
126048069|NCT04868617|453473837|FG000|Overall Study|Device deficiency|1|||
126048070|NCT04868617|453473838|FG001|Overall Study|Device deficiency|0|||
126048071|NCT01579318|453473841|FG000|Overall Study|Disease Progression|1|||
126377647|NCT01333722|454680265|FG000|Overall Study|Withdrawal by Subject|0|||
126377648|NCT01333722|454680266|FG001|Overall Study|Withdrawal by Subject|1|||
126377649|NCT00488514|454680267|FG000|Overall Study|Adverse Event|41|||
126377650|NCT00488514|454680267|FG000|Overall Study|Lost to Follow-up|44|||
126377651|NCT00488514|454680267|FG000|Overall Study|Protocol Violation|32|||
126377652|NCT00488514|454680267|FG000|Overall Study|Withdrawal by Subject|106|||
125886357|NCT00196313|452880009|FG001|Overall Study|Lost to Follow-up|2|||
125886358|NCT00043979|452880010|FG000|Period 1|recipient with progressive disease|7|||
125886359|NCT00043979|452880011|FG001|Period 1|recipient with progressive disease|4|||
125886360|NCT00043979|452880012|FG002|Period 1|recipient with progressive disease|3|||
126048072|NCT02347332|453473842|FG000|Overall Study|Not treated|5|||
126048073|NCT02347332|453473843|FG001|Overall Study|Not treated|2|||
126048074|NCT02347332|453473842|FG000|Overall Study|Progressive disease|141|||
126048075|NCT02347332|453473843|FG001|Overall Study|Progressive disease|159|||
126048076|NCT02347332|453473842|FG000|Overall Study|Adverse Event|50|||
125886361|NCT04085289|452880013|FG000|Overall Study|Withdrawal by Subject|0|||
126048077|NCT02347332|453473843|FG001|Overall Study|Adverse Event|41|||
126048078|NCT02347332|453473842|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
126048079|NCT02347332|453473843|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
126377653|NCT00488514|454680267|FG000|Overall Study|Lack of Efficacy|28|||
126377654|NCT00488514|454680267|FG000|Overall Study|Did not meet criteria for treatment|30|||
126377655|NCT00488514|454680267|FG000|Overall Study|Postive drug screen|1|||
126377656|NCT00488514|454680267|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
126377657|NCT00488514|454680267|FG000|Overall Study|Investigator decision|1|||
126377658|NCT00488514|454680267|FG000|Overall Study|Participant had too few migraines|5|||
126377659|NCT00488514|454680267|FG000|Overall Study|Increase in number of migraines|2|||
126377660|NCT00488514|454680267|FG000|Overall Study|Increased use of concomitant medication|1|||
126377661|NCT01475721|454680270|FG000|Overall Study|Death|3|||
126377662|NCT01475721|454680271|FG001|Overall Study|Death|6|||
126377663|NCT01475721|454680270|FG000|Overall Study|Withdrawal by Subject|8|||
126377664|NCT01475721|454680271|FG001|Overall Study|Withdrawal by Subject|8|||
126377665|NCT00803738|454680272|FG000|Overall Study|Adverse Event|3|||
126377666|NCT00803738|454680273|FG001|Overall Study|Adverse Event|5|||
126377667|NCT00803738|454680272|FG000|Overall Study|Lost to Follow-up|4|||
126377668|NCT00803738|454680273|FG001|Overall Study|Lost to Follow-up|4|||
126377669|NCT00803738|454680272|FG000|Overall Study|Protocol Violation|18|||
126377670|NCT00803738|454680273|FG001|Overall Study|Protocol Violation|10|||
126377671|NCT00803738|454680272|FG000|Overall Study|Withdrawal by Subject|1|||
125886362|NCT04085289|452880014|FG001|Overall Study|Withdrawal by Subject|0|||
126377672|NCT00803738|454680273|FG001|Overall Study|Withdrawal by Subject|4|||
126377673|NCT00803738|454680272|FG000|Overall Study|Lack of Efficacy|10|||
126377674|NCT00803738|454680273|FG001|Overall Study|Lack of Efficacy|16|||
126377675|NCT00803738|454680272|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
126377676|NCT00803738|454680273|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
126377677|NCT00803738|454680272|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
126377678|NCT00803738|454680273|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
126377679|NCT00387088|454680276|FG000|Overall Study|Adverse Event|143|||
126377680|NCT00387088|454680277|FG001|Overall Study|Adverse Event|156|||
126377681|NCT00387088|454680276|FG000|Overall Study|Protocol Violation|47|||
126377682|NCT00387088|454680277|FG001|Overall Study|Protocol Violation|35|||
126377683|NCT00387088|454680276|FG000|Overall Study|Withdrawal by Subject|20|||
126377684|NCT00387088|454680277|FG001|Overall Study|Withdrawal by Subject|35|||
126377685|NCT00387088|454680276|FG000|Overall Study|Lack of Efficacy|28|||
126377686|NCT00387088|454680277|FG001|Overall Study|Lack of Efficacy|67|||
126377687|NCT00387088|454680276|FG000|Overall Study|Lost to Follow-up|22|||
126377688|NCT00387088|454680277|FG001|Overall Study|Lost to Follow-up|28|||
126377689|NCT00387088|454680276|FG000|Overall Study|Other|58|||
126377690|NCT00387088|454680277|FG001|Overall Study|Other|52|||
126377691|NCT02848092|454680280|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
126377692|NCT02848092|454680281|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
126377693|NCT02848092|454680280|FG000|1-month Post-training Follow-up|Adverse Event|2|||
126377694|NCT02848092|454680281|FG001|1-month Post-training Follow-up|Adverse Event|1|||
126377695|NCT02848092|454680280|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
126377696|NCT02848092|454680281|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
126377697|NCT02848092|454680280|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
126377698|NCT02848092|454680281|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
126377699|NCT02848092|454680280|FG000|1-month Post-training Follow-up|fatigue|0|||
126377700|NCT02848092|454680281|FG001|1-month Post-training Follow-up|fatigue|1|||
126377701|NCT02848092|454680280|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
126377702|NCT02848092|454680281|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
126377703|NCT02848092|454680280|FG000|6-month Post-training Follow-up|Adverse Event|1|||
126377704|NCT02848092|454680281|FG001|6-month Post-training Follow-up|Adverse Event|1|||
126377705|NCT02848092|454680280|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
126377706|NCT02848092|454680281|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
126377707|NCT02848092|454680280|FG000|6-month Post-training Follow-up|frustrated with task|1|||
126377708|NCT02848092|454680281|FG001|6-month Post-training Follow-up|frustrated with task|0|||
126377709|NCT02848092|454680280|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
126377710|NCT02848092|454680281|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
126377711|NCT02848092|454680280|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
126377712|NCT02848092|454680281|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
126377713|NCT02329743|454680285|FG000|Overall Study|Adverse Event|1|||
126377714|NCT02329743|454680286|FG001|Overall Study|Adverse Event|1|||
126377715|NCT02329743|454680287|FG002|Overall Study|Adverse Event|3|||
126377716|NCT02329743|454680285|FG000|Overall Study|Lost to Follow-up|1|||
126377717|NCT02329743|454680286|FG001|Overall Study|Lost to Follow-up|0|||
126377718|NCT02329743|454680287|FG002|Overall Study|Lost to Follow-up|1|||
126377719|NCT02329743|454680285|FG000|Overall Study|Withdrawal by Subject|4|||
126377720|NCT02329743|454680286|FG001|Overall Study|Withdrawal by Subject|4|||
126377721|NCT02329743|454680287|FG002|Overall Study|Withdrawal by Subject|1|||
126377722|NCT02329743|454680285|FG000|Overall Study|Other|0|||
126377723|NCT02329743|454680286|FG001|Overall Study|Other|2|||
126377724|NCT02329743|454680287|FG002|Overall Study|Other|3|||
126377725|NCT01428219|454680299|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
126377726|NCT00592631|454680302|FG000|Overall Study|Lost to Follow-up|0|||
126377727|NCT00592631|454680303|FG001|Overall Study|Lost to Follow-up|2|||
126377728|NCT03745768|454680305|FG000|Overall Study|discontinued study|2|||
126377729|NCT03745768|454680306|FG001|Overall Study|discontinued study|0|||
126377730|NCT00443118|454680307|FG000|Overall Study|unknown primary outcome|3|||
126377731|NCT00443118|454680308|FG001|Overall Study|unknown primary outcome|1|||
126377732|NCT00443118|454680309|FG002|Overall Study|unknown primary outcome|0|||
126377733|NCT00443118|454680307|FG000|Overall Study|Withdrawal by Subject|1|||
126377734|NCT00443118|454680308|FG001|Overall Study|Withdrawal by Subject|0|||
126377735|NCT00443118|454680309|FG002|Overall Study|Withdrawal by Subject|0|||
126377736|NCT01023217|454680313|FG000|Overall Study|Withdrawal by Subject|1|||
126377737|NCT01023217|454680314|FG001|Overall Study|Withdrawal by Subject|0|||
126377738|NCT01106157|454680315|FG000|Overall Study|Withdrawal by Subject|1|||
126377739|NCT01106157|454680316|FG001|Overall Study|Withdrawal by Subject|0|||
126377740|NCT01673646|454680320|FG000|Overall Study|Adverse Event|2|||
126377741|NCT01673646|454680321|FG001|Overall Study|Adverse Event|1|||
126377742|NCT01673646|454680322|FG002|Overall Study|Adverse Event|1|||
126377743|NCT01673646|454680320|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126377744|NCT01673646|454680321|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126377745|NCT01673646|454680322|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126377746|NCT01673646|454680320|FG000|Overall Study|Condition no longer requires study drug|0|||
126377747|NCT01673646|454680321|FG001|Overall Study|Condition no longer requires study drug|1|||
126377748|NCT01673646|454680322|FG002|Overall Study|Condition no longer requires study drug|0|||
126377749|NCT01673646|454680320|FG000|Overall Study|Withdrawal by Subject|0|||
126377750|NCT01673646|454680321|FG001|Overall Study|Withdrawal by Subject|2|||
126377751|NCT01673646|454680322|FG002|Overall Study|Withdrawal by Subject|2|||
126377752|NCT01673646|454680320|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
126377753|NCT01673646|454680321|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
126377754|NCT01673646|454680322|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
126377755|NCT02651116|454680323|FG000|Overall Study|Adverse Event|0|||
126377756|NCT02651116|454680324|FG001|Overall Study|Adverse Event|1|||
126377757|NCT02651116|454680323|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
126377758|NCT02651116|454680324|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
126377759|NCT02457247|454680325|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
126377760|NCT02457247|454680326|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
126377761|NCT02457247|454680327|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
126377762|NCT02457247|454680328|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
126377763|NCT02457247|454680325|FG000|Period 1|Significant Protocol Deviation|1|||
126377764|NCT02457247|454680326|FG001|Period 1|Significant Protocol Deviation|1|||
126377765|NCT02457247|454680327|FG002|Period 1|Significant Protocol Deviation|0|||
126377766|NCT02457247|454680328|FG003|Period 1|Significant Protocol Deviation|0|||
126377767|NCT02457247|454680325|FG000|Period 1|Voluntary Withdrawal|1|||
126377768|NCT02457247|454680326|FG001|Period 1|Voluntary Withdrawal|0|||
126377769|NCT02457247|454680327|FG002|Period 1|Voluntary Withdrawal|0|||
126377770|NCT02457247|454680328|FG003|Period 1|Voluntary Withdrawal|0|||
126377771|NCT02457247|454680325|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
126377772|NCT02457247|454680326|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
126377773|NCT02457247|454680327|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
126377774|NCT02457247|454680328|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
126377775|NCT02457247|454680325|FG000|Period 2|Significant Protocol Deviation|1|||
126377776|NCT02457247|454680326|FG001|Period 2|Significant Protocol Deviation|0|||
126377777|NCT02457247|454680327|FG002|Period 2|Significant Protocol Deviation|0|||
126377778|NCT02457247|454680328|FG003|Period 2|Significant Protocol Deviation|0|||
126377779|NCT02457247|454680325|FG000|Period 2|Lost to Follow-up|0|||
126377780|NCT02457247|454680326|FG001|Period 2|Lost to Follow-up|1|||
126377781|NCT02457247|454680327|FG002|Period 2|Lost to Follow-up|0|||
126377782|NCT02457247|454680328|FG003|Period 2|Lost to Follow-up|0|||
126377783|NCT02457247|454680325|FG000|Period 2|Voluntary Withdrawal|1|||
126377784|NCT02457247|454680326|FG001|Period 2|Voluntary Withdrawal|1|||
126377785|NCT02457247|454680327|FG002|Period 2|Voluntary Withdrawal|0|||
126377786|NCT02457247|454680328|FG003|Period 2|Voluntary Withdrawal|0|||
126377787|NCT01492088|454680329|FG000|Overall Study|Withdrawal by Patient|0|||
126377788|NCT01492088|454680330|FG001|Overall Study|Withdrawal by Patient|2|||
126377789|NCT01492088|454680331|FG002|Overall Study|Withdrawal by Patient|0|||
126377790|NCT01492088|454680329|FG000|Overall Study|Death|1|||
126377791|NCT01492088|454680330|FG001|Overall Study|Death|6|||
126377792|NCT01492088|454680331|FG002|Overall Study|Death|2|||
126377793|NCT01492088|454680329|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
126377794|NCT01492088|454680330|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
126377795|NCT01492088|454680331|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
126377796|NCT01492088|454680329|FG000|Overall Study|Alive at Last Follow-up|0|||
126377797|NCT01492088|454680330|FG001|Overall Study|Alive at Last Follow-up|6|||
126377798|NCT01492088|454680331|FG002|Overall Study|Alive at Last Follow-up|11|||
126377799|NCT03824392|454680332|FG000|Overall Study|Adverse Event|1|||
126377800|NCT03824392|454680333|FG001|Overall Study|Adverse Event|0|||
126377801|NCT03824392|454680334|FG002|Overall Study|Adverse Event|0|||
126104154|NCT02647320|453675812|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
126377802|NCT03824392|454680335|FG003|Overall Study|Adverse Event|0|||
126377803|NCT03824392|454680332|FG000|Overall Study|Investigator Decision|0|||
126377804|NCT03824392|454680333|FG001|Overall Study|Investigator Decision|1|||
126377805|NCT03824392|454680334|FG002|Overall Study|Investigator Decision|0|||
126377806|NCT03824392|454680335|FG003|Overall Study|Investigator Decision|0|||
126377807|NCT03824392|454680332|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
126377808|NCT03824392|454680333|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
126377809|NCT03824392|454680334|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
126377810|NCT03824392|454680335|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
126377811|NCT00127855|454680336|FG000|Primary Vaccination Course|Adverse Event|0|||
126377812|NCT00127855|454680337|FG001|Primary Vaccination Course|Adverse Event|0|||
126377813|NCT00127855|454680338|FG002|Primary Vaccination Course|Adverse Event|1|||
126377814|NCT00127855|454680339|FG003|Primary Vaccination Course|Adverse Event|0|||
126377815|NCT00127855|454680340|FG004|Primary Vaccination Course|Adverse Event|0|||
126377816|NCT00127855|454680336|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
126377817|NCT00127855|454680337|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
126377818|NCT00127855|454680338|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
126377819|NCT00127855|454680339|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
126377820|NCT00127855|454680340|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
126377821|NCT00127855|454680336|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
126377822|NCT00127855|454680337|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
126377823|NCT00127855|454680338|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
126377824|NCT00127855|454680339|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
126377825|NCT00127855|454680340|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
126377826|NCT00127855|454680336|FG000|Primary Vaccination Course|Other|0|||
126377827|NCT00127855|454680337|FG001|Primary Vaccination Course|Other|0|||
126377828|NCT00127855|454680338|FG002|Primary Vaccination Course|Other|0|||
126377829|NCT00127855|454680339|FG003|Primary Vaccination Course|Other|0|||
126377830|NCT00127855|454680340|FG004|Primary Vaccination Course|Other|1|||
126377831|NCT02343302|454680341|FG000|Overall Study|Physician Decision|1|||
126377832|NCT02343302|454680342|FG001|Overall Study|Physician Decision|1|||
126377833|NCT01887717|454680343|FG000|Overall Study|Withdrawal by Subject|1|||
126377834|NCT01887717|454680344|FG001|Overall Study|Withdrawal by Subject|7|||
126377835|NCT01887717|454680343|FG000|Overall Study|Physician Decision|0|||
126377836|NCT01887717|454680344|FG001|Overall Study|Physician Decision|2|||
126377837|NCT01887717|454680343|FG000|Overall Study|Administrative reasons|5|||
126377838|NCT01887717|454680344|FG001|Overall Study|Administrative reasons|2|||
126377839|NCT02655887|454680345|FG000|Overall Study|Lost to Follow-up|3|||
126377840|NCT02655887|454680345|FG000|Overall Study|Death|4|||
126377841|NCT02655887|454680345|FG000|Overall Study|Withdrawal by Subject|3|||
126377842|NCT02655887|454680345|FG000|Overall Study|Missed 12-month follow-up visit|4|||
126377843|NCT03637491|454680346|FG000|Overall Study|Death|9|||
126377844|NCT03637491|454680347|FG001|Overall Study|Death|9|||
126377845|NCT03637491|454680348|FG002|Overall Study|Death|5|||
126377846|NCT03637491|454680349|FG003|Overall Study|Death|3|||
126377847|NCT03637491|454680346|FG000|Overall Study|Lost to Follow-up|0|||
126377848|NCT03637491|454680347|FG001|Overall Study|Lost to Follow-up|1|||
126377849|NCT03637491|454680348|FG002|Overall Study|Lost to Follow-up|0|||
126377850|NCT03637491|454680349|FG003|Overall Study|Lost to Follow-up|1|||
126377851|NCT03637491|454680346|FG000|Overall Study|Study Terminated By Sponsor|0|||
126377852|NCT03637491|454680347|FG001|Overall Study|Study Terminated By Sponsor|2|||
126377853|NCT03637491|454680348|FG002|Overall Study|Study Terminated By Sponsor|1|||
126377854|NCT03637491|454680349|FG003|Overall Study|Study Terminated By Sponsor|0|||
126377855|NCT03637491|454680346|FG000|Overall Study|Withdrawal by Subject|1|||
126377856|NCT03637491|454680347|FG001|Overall Study|Withdrawal by Subject|0|||
126377857|NCT03637491|454680348|FG002|Overall Study|Withdrawal by Subject|1|||
126377858|NCT03637491|454680349|FG003|Overall Study|Withdrawal by Subject|2|||
126377859|NCT00532844|454680351|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
126377860|NCT00532844|454680352|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
126377861|NCT00532844|454680351|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
126377862|NCT00532844|454680352|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
126377863|NCT00532844|454680351|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
126377864|NCT00532844|454680352|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
126377865|NCT00532844|454680351|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
126377866|NCT00532844|454680352|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
126377867|NCT00532844|454680351|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
126377868|NCT00532844|454680352|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
126377869|NCT04389866|454680354|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
126377870|NCT04389866|454680355|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
126377871|NCT03465722|454680359|FG000|Overall Study|Withdrawal by Subject|21|||
126377872|NCT03465722|454680360|FG001|Overall Study|Withdrawal by Subject|14|||
126377873|NCT03465722|454680359|FG000|Overall Study|Death|89|||
126377874|NCT03465722|454680360|FG001|Overall Study|Death|87|||
126377875|NCT03465722|454680359|FG000|Overall Study|Lost to Follow-up|5|||
126377876|NCT03465722|454680360|FG001|Overall Study|Lost to Follow-up|3|||
125886363|NCT04085289|452880015|FG002|Overall Study|Withdrawal by Subject|1|||
125886364|NCT02919995|452880019|FG000|Overall Study|Adverse Event|0|||
125886365|NCT02919995|452880020|FG001|Overall Study|Adverse Event|0|||
125886366|NCT02919995|452880021|FG002|Overall Study|Adverse Event|0|||
125886367|NCT02919995|452880022|FG003|Overall Study|Adverse Event|0|||
125886368|NCT02919995|452880023|FG004|Overall Study|Adverse Event|0|||
125886369|NCT02919995|452880024|FG005|Overall Study|Adverse Event|1|||
125886370|NCT03196349|452880025|FG000|Overall Study|Did not receive study drug|0|||
125886371|NCT03196349|452880026|FG001|Overall Study|Did not receive study drug|1|||
125886372|NCT03196349|452880027|FG002|Overall Study|Did not receive study drug|2|||
125886373|NCT03196349|452880025|FG000|Overall Study|No data entered|2|||
125886374|NCT03196349|452880026|FG001|Overall Study|No data entered|4|||
125886375|NCT03196349|452880027|FG002|Overall Study|No data entered|0|||
125886376|NCT03196349|452880025|FG000|Overall Study|Study Terminated early|15|||
125886377|NCT03196349|452880026|FG001|Overall Study|Study Terminated early|9|||
125886378|NCT03196349|452880027|FG002|Overall Study|Study Terminated early|11|||
125886379|NCT02892448|452880037|FG000|Overall Study|Screening failure|2|||
125886380|NCT02892448|452880038|FG001|Overall Study|Screening failure|2|||
125886381|NCT02892448|452880039|FG002|Overall Study|Screening failure|1|||
125886382|NCT01012440|452880040|FG000|Overall Study|Withdrawal by Subject|2|||
125886383|NCT00594815|452880041|FG000|Overall Study|Never Treated|3|||
125886384|NCT00594815|452880041|FG000|Overall Study|Withdrawal by Subject|2|||
125886385|NCT00594815|452880041|FG000|Overall Study|Toxicity|4|||
125886386|NCT02691507|452880042|FG000|Overall Study|Missed Visit 3|0|||
125886387|NCT02691507|452880043|FG001|Overall Study|Missed Visit 3|1|||
125886388|NCT01812252|452880044|FG000|Overall Study|Persistent Disease|1|||
125886389|NCT01812252|452880045|FG001|Overall Study|Persistent Disease|0|||
125886390|NCT01812252|452880044|FG000|Overall Study|Not transplanted|11|||
125886391|NCT01812252|452880045|FG001|Overall Study|Not transplanted|11|||
125886392|NCT01812252|452880044|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
125886393|NCT01812252|452880045|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
125886394|NCT01812252|452880044|FG000|Overall Study|Withdrawal by Subject|1|||
125886395|NCT01812252|452880045|FG001|Overall Study|Withdrawal by Subject|1|||
125886396|NCT01812252|452880044|FG000|Overall Study|Screen Failure|1|||
125886397|NCT01812252|452880045|FG001|Overall Study|Screen Failure|0|||
125886398|NCT04634253|452880047|FG000|Overall Study|Adverse Event|1|||
125886399|NCT04634253|452880048|FG001|Overall Study|Adverse Event|1|||
125886400|NCT04634253|452880049|FG002|Overall Study|Adverse Event|0|||
125886401|NCT04634253|452880047|FG000|Overall Study|Physician Decision|0|||
125886402|NCT04634253|452880048|FG001|Overall Study|Physician Decision|1|||
125886403|NCT04634253|452880049|FG002|Overall Study|Physician Decision|0|||
125886404|NCT04634253|452880047|FG000|Overall Study|Withdrawal by Subject|1|||
125886405|NCT04634253|452880048|FG001|Overall Study|Withdrawal by Subject|0|||
125886406|NCT04634253|452880049|FG002|Overall Study|Withdrawal by Subject|3|||
125886407|NCT03155841|452880050|FG000|Overall Study|Protocol Violation|3|||
125886408|NCT03155841|452880051|FG001|Overall Study|Protocol Violation|4|||
125886409|NCT00607373|452880056|FG000|Treatment Period|Adverse Event|0|||
125886410|NCT00607373|452880057|FG001|Treatment Period|Adverse Event|4|||
125886411|NCT00607373|452880056|FG000|Treatment Period|Physician Decision|0|||
125886412|NCT00607373|452880057|FG001|Treatment Period|Physician Decision|1|||
125886413|NCT00607373|452880056|FG000|Treatment Period|Withdrawal by Subject|0|||
125886414|NCT00607373|452880057|FG001|Treatment Period|Withdrawal by Subject|1|||
125886415|NCT00607373|452880056|FG000|Follow-up Period|Other|0|||
125886416|NCT00607373|452880057|FG001|Follow-up Period|Other|1|||
125886417|NCT00607373|452880056|FG000|Follow-up Period|Protocol Violation|0|||
125886418|NCT00607373|452880057|FG001|Follow-up Period|Protocol Violation|1|||
125886419|NCT00607373|452880056|FG000|Follow-up Period|Withdrawal by Subject|1|||
125886420|NCT00607373|452880057|FG001|Follow-up Period|Withdrawal by Subject|3|||
125886421|NCT01918306|452880058|FG000|Overall Study|progresive disease|4|||
125886422|NCT01918306|452880059|FG001|Overall Study|progresive disease|0|||
125886423|NCT01918306|452880060|FG002|Overall Study|progresive disease|1|||
125886424|NCT01918306|452880061|FG003|Overall Study|progresive disease|1|||
125886425|NCT01918306|452880058|FG000|Overall Study|Withdrawal by Subject|0|||
125886426|NCT01918306|452880059|FG001|Overall Study|Withdrawal by Subject|0|||
125886427|NCT01918306|452880060|FG002|Overall Study|Withdrawal by Subject|0|||
125886428|NCT01918306|452880061|FG003|Overall Study|Withdrawal by Subject|2|||
125886429|NCT01918306|452880058|FG000|Overall Study|neutropenia|1|||
125886430|NCT01918306|452880059|FG001|Overall Study|neutropenia|0|||
125886431|NCT01918306|452880060|FG002|Overall Study|neutropenia|0|||
125886432|NCT01918306|452880061|FG003|Overall Study|neutropenia|0|||
125886433|NCT01918306|452880058|FG000|Overall Study|Lack of Efficacy|1|||
125886434|NCT01918306|452880059|FG001|Overall Study|Lack of Efficacy|0|||
125886435|NCT01918306|452880060|FG002|Overall Study|Lack of Efficacy|0|||
125886436|NCT01918306|452880061|FG003|Overall Study|Lack of Efficacy|0|||
125886437|NCT01918306|452880058|FG000|Overall Study|progress disease, crossover|0|||
125886438|NCT01918306|452880059|FG001|Overall Study|progress disease, crossover|0|||
125886439|NCT01918306|452880060|FG002|Overall Study|progress disease, crossover|1|||
125886440|NCT01918306|452880061|FG003|Overall Study|progress disease, crossover|0|||
126048080|NCT02347332|453473842|FG000|Overall Study|Protocol Violation|1|||
126048081|NCT02347332|453473843|FG001|Overall Study|Protocol Violation|1|||
126048082|NCT02347332|453473842|FG000|Overall Study|Lost to Follow-up|2|||
126048083|NCT02347332|453473843|FG001|Overall Study|Lost to Follow-up|1|||
126048084|NCT02347332|453473842|FG000|Overall Study|Physician Decision|4|||
126048085|NCT02347332|453473843|FG001|Overall Study|Physician Decision|3|||
126048086|NCT02347332|453473842|FG000|Overall Study|Withdrawal by Subject|20|||
126377877|NCT03465722|454680359|FG000|Overall Study|Administrative/Other|33|||
126377878|NCT03465722|454680360|FG001|Overall Study|Administrative/Other|32|||
126377879|NCT03465722|454680359|FG000|Overall Study|Not treated|1|||
126377880|NCT03465722|454680360|FG001|Overall Study|Not treated|2|||
126377881|NCT03465722|454680359|FG000|Overall Study|Sponsor decision|91|||
126377882|NCT03465722|454680360|FG001|Overall Study|Sponsor decision|98|||
126377883|NCT01490918|454680361|FG000|Overall Study|Lost to Follow-up|2|||
126377884|NCT01490918|454680362|FG001|Overall Study|Lost to Follow-up|1|||
126377885|NCT01490918|454680363|FG002|Overall Study|Lost to Follow-up|0|||
126377886|NCT01490918|454680361|FG000|Overall Study|Withdrawal by Subject|7|||
126377887|NCT01490918|454680362|FG001|Overall Study|Withdrawal by Subject|8|||
126377888|NCT01490918|454680363|FG002|Overall Study|Withdrawal by Subject|3|||
126377889|NCT01490918|454680361|FG000|Overall Study|Adverse Event|0|||
126377890|NCT01490918|454680362|FG001|Overall Study|Adverse Event|0|||
126377891|NCT01490918|454680363|FG002|Overall Study|Adverse Event|1|||
126377892|NCT01490918|454680361|FG000|Overall Study|other cause|4|||
126377893|NCT01490918|454680362|FG001|Overall Study|other cause|5|||
126377894|NCT01490918|454680363|FG002|Overall Study|other cause|8|||
126377895|NCT04940130|454680369|FG000|Overall Study|Travel|1|||
126377896|NCT04940130|454680370|FG001|Overall Study|Travel|0|||
126377897|NCT04940130|454680371|FG002|Overall Study|Travel|2|||
126377898|NCT04940130|454680369|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
126377899|NCT04940130|454680370|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
126377900|NCT04940130|454680371|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
126377901|NCT04940130|454680369|FG000|Overall Study|Adverse Event|0|||
126377902|NCT04940130|454680370|FG001|Overall Study|Adverse Event|0|||
126377903|NCT04940130|454680371|FG002|Overall Study|Adverse Event|2|||
126377904|NCT04940130|454680369|FG000|Overall Study|Disease progression/treatment failure|0|||
126377905|NCT04940130|454680370|FG001|Overall Study|Disease progression/treatment failure|0|||
126377906|NCT04940130|454680371|FG002|Overall Study|Disease progression/treatment failure|1|||
126377907|NCT04940130|454680369|FG000|Overall Study|Participant refusal|0|||
126377908|NCT04940130|454680370|FG001|Overall Study|Participant refusal|0|||
126377909|NCT04940130|454680371|FG002|Overall Study|Participant refusal|1|||
126377910|NCT02240121|454680374|FG000|Overall Study|Protocol Violation|1|||
126377911|NCT02240121|454680375|FG001|Overall Study|Protocol Violation|2|||
126377912|NCT02240121|454680374|FG000|Overall Study|Physician Decision|0|||
126377913|NCT02240121|454680375|FG001|Overall Study|Physician Decision|1|||
126377914|NCT02240121|454680374|FG000|Overall Study|Change in protocol interpretation|1|||
126377915|NCT02240121|454680375|FG001|Overall Study|Change in protocol interpretation|0|||
126377916|NCT02240121|454680374|FG000|Overall Study|Lack of Efficacy|2|||
126377917|NCT02240121|454680375|FG001|Overall Study|Lack of Efficacy|3|||
126377918|NCT02240121|454680374|FG000|Overall Study|Site closed|1|||
126377919|NCT02240121|454680375|FG001|Overall Study|Site closed|1|||
126377920|NCT02240121|454680374|FG000|Overall Study|Pregnancy|1|||
126377921|NCT02240121|454680375|FG001|Overall Study|Pregnancy|0|||
126377922|NCT02240121|454680374|FG000|Overall Study|Adverse Event|2|||
126377923|NCT02240121|454680375|FG001|Overall Study|Adverse Event|4|||
126377924|NCT02240121|454680374|FG000|Overall Study|Withdrawal by Subject|6|||
126377925|NCT02240121|454680375|FG001|Overall Study|Withdrawal by Subject|2|||
126377926|NCT02240121|454680374|FG000|Overall Study|Lost to Follow-up|3|||
126377927|NCT02240121|454680375|FG001|Overall Study|Lost to Follow-up|4|||
126377928|NCT02240121|454680374|FG000|Overall Study|Other than specified|1|||
126377929|NCT02240121|454680375|FG001|Overall Study|Other than specified|3|||
126377930|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126377931|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126377932|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126377933|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
126377934|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
126048087|NCT02347332|453473843|FG001|Overall Study|Withdrawal by Subject|14|||
126048088|NCT02347332|453473842|FG000|Overall Study|Protocol requirement|1|||
126377935|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
126377936|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
126377937|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
126377938|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
126377939|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
126377940|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
126377941|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
126377942|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
126377943|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
126048089|NCT02347332|453473843|FG001|Overall Study|Protocol requirement|1|||
126048090|NCT02347332|453473842|FG000|Overall Study|Switch Post-Trial program|0|||
126048091|NCT02347332|453473843|FG001|Overall Study|Switch Post-Trial program|1|||
126048092|NCT00623194|453473844|FG000|Overall Study|Lack of Efficacy|1|||
126048093|NCT00623194|453473844|FG000|Overall Study|Protocol Violation|3|||
126048094|NCT00623194|453473844|FG000|Overall Study|Unclassified|1|||
126377944|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
126377945|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
126377946|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
126377947|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
126377948|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
126377949|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
126377950|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
126377951|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
126377952|NCT02779777|454680382|FG000|Overall Study|Disease Progression|1|||
126377953|NCT02779777|454680383|FG001|Overall Study|Disease Progression|0|||
126377954|NCT02779777|454680384|FG002|Overall Study|Disease Progression|0|||
126377955|NCT02779777|454680382|FG000|Overall Study|Adverse Event|3|||
126377956|NCT02779777|454680383|FG001|Overall Study|Adverse Event|1|||
126377957|NCT02779777|454680384|FG002|Overall Study|Adverse Event|0|||
126377958|NCT02779777|454680382|FG000|Overall Study|Physician Decision|9|||
126377959|NCT02779777|454680383|FG001|Overall Study|Physician Decision|0|||
126377960|NCT02779777|454680384|FG002|Overall Study|Physician Decision|1|||
126377961|NCT02779777|454680382|FG000|Overall Study|Withdrawal by Subject|1|||
126377962|NCT02779777|454680383|FG001|Overall Study|Withdrawal by Subject|0|||
126377963|NCT02779777|454680384|FG002|Overall Study|Withdrawal by Subject|0|||
126377964|NCT04571060|454680385|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
126377965|NCT04571060|454680386|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
126377966|NCT04571060|454680385|FG000|Overall Study|Never treated migraine|47|||
126377967|NCT04571060|454680386|FG001|Overall Study|Never treated migraine|36|||
126377968|NCT04571060|454680385|FG000|Overall Study|Protocol Violation|4|||
126377969|NCT04571060|454680386|FG001|Overall Study|Protocol Violation|2|||
125886441|NCT02170077|452880062|FG000|Overall Study|Withdrawal by Subject|3|||
126048095|NCT01260896|453473845|FG000|First Intervention|Withdrawn Due to Emesis|2|||
126048096|NCT01260896|453473846|FG001|First Intervention|Withdrawn Due to Emesis|0|||
126048097|NCT00312208|453473847|FG000|Overall Study|Adverse Event|97|||
126048098|NCT00312208|453473848|FG001|Overall Study|Adverse Event|61|||
126048099|NCT00312208|453473847|FG000|Overall Study|Protocol Violation|5|||
126377970|NCT04571060|454680385|FG000|Overall Study|Withdrawal by Subject|6|||
126377971|NCT04571060|454680386|FG001|Overall Study|Withdrawal by Subject|2|||
126377972|NCT04571060|454680385|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
126377973|NCT04571060|454680386|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
126377974|NCT00087698|454680392|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
126377975|NCT00087698|454680392|FG000|Overall Study|Death from Other Causes|3|||
126377976|NCT00087698|454680392|FG000|Overall Study|Adverse Event|4|||
126377977|NCT00087698|454680392|FG000|Overall Study|Withdrawal by Subject|4|||
126377978|NCT00087698|454680392|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
126377979|NCT00087698|454680392|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
126377980|NCT00087698|454680392|FG000|Overall Study|Clinical Relapse|1|||
126377981|NCT00087698|454680392|FG000|Overall Study|Death from Study Disease|2|||
126377982|NCT00087698|454680392|FG000|Overall Study|Death from Study Drug Toxicity|2|||
126377983|NCT00087698|454680392|FG000|Overall Study|Protocol Violation|1|||
126377984|NCT01900665|454680409|FG000|Placebo Controlled Period|Death|9|||
126377985|NCT01900665|454680410|FG001|Placebo Controlled Period|Death|16|||
126377986|NCT01900665|454680409|FG000|Placebo Controlled Period|Adverse Event|48|||
126377987|NCT01900665|454680410|FG001|Placebo Controlled Period|Adverse Event|39|||
126377988|NCT01900665|454680409|FG000|Placebo Controlled Period|Protocol Violation|1|||
126377989|NCT01900665|454680410|FG001|Placebo Controlled Period|Protocol Violation|7|||
126377990|NCT01900665|454680409|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
126377991|NCT01900665|454680410|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
126377992|NCT01900665|454680409|FG000|Placebo Controlled Period|Physician Decision|11|||
126377993|NCT01900665|454680410|FG001|Placebo Controlled Period|Physician Decision|7|||
126377994|NCT01900665|454680409|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
126377995|NCT01900665|454680410|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
126377996|NCT01900665|454680409|FG000|Placebo Controlled Period|Caregiver Decision|33|||
126377997|NCT01900665|454680410|FG001|Placebo Controlled Period|Caregiver Decision|41|||
126377998|NCT01900665|454680409|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
126377999|NCT01900665|454680410|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
126378000|NCT01900665|454680409|FG000|Open Label Period|Adverse Event|16|||
126378001|NCT01900665|454680410|FG001|Open Label Period|Adverse Event|20|||
126378002|NCT01900665|454680409|FG000|Open Label Period|Death|5|||
126378003|NCT01900665|454680410|FG001|Open Label Period|Death|6|||
126378004|NCT01900665|454680409|FG000|Open Label Period|Lost to Follow-up|1|||
126378005|NCT01900665|454680410|FG001|Open Label Period|Lost to Follow-up|1|||
126378006|NCT01900665|454680409|FG000|Open Label Period|Parent/Caregiver Decision|33|||
126378007|NCT01900665|454680410|FG001|Open Label Period|Parent/Caregiver Decision|34|||
126378008|NCT01900665|454680409|FG000|Open Label Period|Physician Decision|4|||
126104155|NCT02647320|453675813|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
126378009|NCT01900665|454680410|FG001|Open Label Period|Physician Decision|4|||
126378010|NCT01900665|454680409|FG000|Open Label Period|Protocol Violation|0|||
126378011|NCT01900665|454680410|FG001|Open Label Period|Protocol Violation|1|||
126378012|NCT01900665|454680409|FG000|Open Label Period|Sponsor Decision|802|||
126378013|NCT01900665|454680410|FG001|Open Label Period|Sponsor Decision|765|||
126378014|NCT01900665|454680409|FG000|Open Label Period|Withdrawal by Subject|20|||
126378015|NCT01900665|454680410|FG001|Open Label Period|Withdrawal by Subject|28|||
126378016|NCT04749745|454680412|FG000|Overall Study|Withdrawal by Subject|1|||
126378017|NCT04749745|454680413|FG001|Overall Study|Withdrawal by Subject|0|||
126378018|NCT03816176|454680418|FG000|Overall Study|Miscellaneous|5|||
126378019|NCT03816176|454680418|FG000|Overall Study|Lack of Efficacy|4|||
126378020|NCT03816176|454680418|FG000|Overall Study|Adverse Event|3|||
126378021|NCT02477527|454681476|FG000|Overall Study|Lost to Follow-up|2|||
126378022|NCT02477527|454681476|FG000|Overall Study|Withdrawal by Subject|1|||
126378023|NCT02477527|454681476|FG000|Overall Study|Screen Failure|3|||
126378024|NCT02383862|454681479|FG000|3 Month Follow up|Lost to Follow-up|23|||
126378025|NCT02383862|454681480|FG001|3 Month Follow up|Lost to Follow-up|21|||
126378026|NCT01833494|454681481|FG000|Overall Study|Adverse Event|24|||
126378027|NCT01833494|454681481|FG000|Overall Study|Physician Decision|6|||
126378028|NCT01833494|454681481|FG000|Overall Study|Withdrawal by Subject|6|||
126378029|NCT01833494|454681481|FG000|Overall Study|Decrease in serum phosphorus|4|||
126378030|NCT01833494|454681481|FG000|Overall Study|Decrease in serum calcium|4|||
126378031|NCT01833494|454681481|FG000|Overall Study|Increase in serum ferritin|1|||
126378032|NCT01694433|454681482|FG000|Overall Study|Adverse Event|7|||
126378033|NCT01694433|454681483|FG001|Overall Study|Adverse Event|0|||
126378034|NCT01694433|454681482|FG000|Overall Study|Physician Decision|1|||
126378035|NCT01694433|454681483|FG001|Overall Study|Physician Decision|0|||
126378036|NCT01694433|454681482|FG000|Overall Study|Withdrawal by Subject|3|||
126378037|NCT01694433|454681483|FG001|Overall Study|Withdrawal by Subject|4|||
126378038|NCT00374595|454681486|FG000|Overall Study|Death|23|||
126378039|NCT00374595|454681486|FG000|Overall Study|Withdrawal by Subject|39|||
126378040|NCT00374595|454681486|FG000|Overall Study|Lost to Follow-up|3|||
126378041|NCT00374595|454681486|FG000|Overall Study|too much time commitment|1|||
126378042|NCT00374595|454681486|FG000|Overall Study|transfer care to other clinical site|1|||
126378043|NCT00374595|454681486|FG000|Overall Study|relocation|3|||
126378044|NCT01664247|454681487|FG000|Overall Study|Adverse Event|5|||
126378045|NCT01664247|454681488|FG001|Overall Study|Adverse Event|3|||
126378046|NCT01664247|454681487|FG000|Overall Study|Protocol Violation|3|||
126378047|NCT01664247|454681488|FG001|Overall Study|Protocol Violation|5|||
126378048|NCT01664247|454681487|FG000|Overall Study|Withdrawal Criteria|1|||
126378049|NCT01664247|454681488|FG001|Overall Study|Withdrawal Criteria|4|||
126378050|NCT01664247|454681487|FG000|Overall Study|Unclassified|5|||
126378051|NCT01664247|454681488|FG001|Overall Study|Unclassified|29|||
126378052|NCT03064074|454681493|FG000|Overall Study|Physician Decision|0|||
126378053|NCT03064074|454681494|FG001|Overall Study|Physician Decision|0|||
126378054|NCT03064074|454681495|FG002|Overall Study|Physician Decision|0|||
126378055|NCT03064074|454681496|FG003|Overall Study|Physician Decision|1|||
126378056|NCT01118780|454681501|FG000|Overall Study|Adverse Event|15|||
126378057|NCT01118780|454681502|FG001|Overall Study|Adverse Event|15|||
126378058|NCT01118780|454681501|FG000|Overall Study|Death|1|||
126378059|NCT01118780|454681502|FG001|Overall Study|Death|0|||
126378060|NCT01118780|454681501|FG000|Overall Study|Lack of Efficacy|2|||
126378061|NCT01118780|454681502|FG001|Overall Study|Lack of Efficacy|6|||
126378062|NCT01118780|454681501|FG000|Overall Study|Physician Decision|2|||
126378063|NCT01118780|454681502|FG001|Overall Study|Physician Decision|0|||
126378064|NCT01118780|454681501|FG000|Overall Study|Protocol Violation|3|||
126378065|NCT01118780|454681502|FG001|Overall Study|Protocol Violation|6|||
126378066|NCT01118780|454681501|FG000|Overall Study|Withdrawal by Subject|13|||
126378067|NCT01118780|454681502|FG001|Overall Study|Withdrawal by Subject|8|||
126378068|NCT03962855|454681513|FG000|Overall Study|Death|0|||
126378069|NCT03962855|454681514|FG001|Overall Study|Death|1|||
126378070|NCT03962855|454681513|FG000|Overall Study|Lost to Follow-up|0|||
126378071|NCT03962855|454681514|FG001|Overall Study|Lost to Follow-up|1|||
126378072|NCT03962855|454681513|FG000|Overall Study|Adverse Event|0|||
126378073|NCT03962855|454681514|FG001|Overall Study|Adverse Event|1|||
126378074|NCT03962855|454681513|FG000|Overall Study|Physician Decision|0|||
126378075|NCT03962855|454681514|FG001|Overall Study|Physician Decision|2|||
126378076|NCT02379052|454681515|FG000|Overall Study|Protocol Violation|0|||
126378077|NCT02379052|454681516|FG001|Overall Study|Protocol Violation|1|||
126378078|NCT02379052|454681515|FG000|Overall Study|Adverse Event|0|||
126378079|NCT02379052|454681516|FG001|Overall Study|Adverse Event|1|||
126378080|NCT02379052|454681515|FG000|Overall Study|Physician Decision|1|||
126378081|NCT02379052|454681516|FG001|Overall Study|Physician Decision|1|||
126378082|NCT02379052|454681515|FG000|Overall Study|Withdrawal by Subject|2|||
126378083|NCT02379052|454681516|FG001|Overall Study|Withdrawal by Subject|0|||
126378084|NCT02379052|454681515|FG000|Overall Study|Lost to Follow-up|2|||
126378085|NCT02379052|454681516|FG001|Overall Study|Lost to Follow-up|1|||
126378086|NCT02379052|454681515|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
126378087|NCT02379052|454681516|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
126378088|NCT02379052|454681515|FG000|Overall Study|Subject was Incarcerated|0|||
126378089|NCT02379052|454681516|FG001|Overall Study|Subject was Incarcerated|1|||
126378090|NCT00846846|454681519|FG000|Overall Study|Death|56|||
126378091|NCT00846846|454681519|FG000|Overall Study|Withdrawal by Subject|19|||
126378092|NCT04419467|454681520|FG000|Overall Study|Not treated with IP|0|||
126378093|NCT04419467|454681521|FG001|Overall Study|Not treated with IP|0|||
126378094|NCT04419467|454681522|FG002|Overall Study|Not treated with IP|2|||
126378095|NCT04419467|454681520|FG000|Overall Study|Adverse Event|0|||
126378096|NCT04419467|454681521|FG001|Overall Study|Adverse Event|2|||
126378097|NCT04419467|454681522|FG002|Overall Study|Adverse Event|0|||
126378098|NCT04419467|454681520|FG000|Overall Study|Death|1|||
126378099|NCT04419467|454681521|FG001|Overall Study|Death|0|||
126378100|NCT04419467|454681522|FG002|Overall Study|Death|0|||
126378101|NCT04419467|454681520|FG000|Overall Study|Lost to Follow-up|0|||
126378102|NCT04419467|454681521|FG001|Overall Study|Lost to Follow-up|1|||
126378103|NCT04419467|454681522|FG002|Overall Study|Lost to Follow-up|2|||
126378104|NCT04419467|454681520|FG000|Overall Study|Withdrawal by Subject|0|||
126378105|NCT04419467|454681521|FG001|Overall Study|Withdrawal by Subject|0|||
126378106|NCT04419467|454681522|FG002|Overall Study|Withdrawal by Subject|4|||
126378107|NCT04419467|454681520|FG000|Overall Study|Pandemic related|0|||
126378108|NCT04419467|454681521|FG001|Overall Study|Pandemic related|0|||
126378109|NCT04419467|454681522|FG002|Overall Study|Pandemic related|1|||
126378110|NCT04419467|454681520|FG000|Overall Study|Reason not known|1|||
126378111|NCT04419467|454681521|FG001|Overall Study|Reason not known|0|||
126378112|NCT04419467|454681522|FG002|Overall Study|Reason not known|0|||
126378113|NCT00442416|454681527|FG000|Overall Study|Adverse Event|4|||
126378114|NCT00442416|454681528|FG001|Overall Study|Adverse Event|1|||
125886442|NCT02170077|452880063|FG001|Overall Study|Withdrawal by Subject|4|||
125886443|NCT02170077|452880064|FG002|Overall Study|Withdrawal by Subject|2|||
125886444|NCT02170077|452880062|FG000|Overall Study|Adverse Event|4|||
125886445|NCT02170077|452880063|FG001|Overall Study|Adverse Event|4|||
125886446|NCT02170077|452880064|FG002|Overall Study|Adverse Event|4|||
125886447|NCT02170077|452880062|FG000|Overall Study|Lost to Follow-up|0|||
125886448|NCT02170077|452880063|FG001|Overall Study|Lost to Follow-up|1|||
125886449|NCT02170077|452880064|FG002|Overall Study|Lost to Follow-up|0|||
125886450|NCT02170077|452880062|FG000|Overall Study|Exclusion criteria|2|||
125886451|NCT02170077|452880063|FG001|Overall Study|Exclusion criteria|2|||
125886452|NCT02170077|452880064|FG002|Overall Study|Exclusion criteria|5|||
125886453|NCT02170077|452880062|FG000|Overall Study|Exacerbation of seizures|0|||
125886454|NCT02170077|452880063|FG001|Overall Study|Exacerbation of seizures|2|||
125886455|NCT02170077|452880064|FG002|Overall Study|Exacerbation of seizures|1|||
125886456|NCT01780974|452880065|FG000|Overall Study|Death|1|||
125886457|NCT01780974|452880066|FG001|Overall Study|Death|0|||
125886458|NCT01780974|452880065|FG000|Overall Study|Adverse Event|1|||
125886459|NCT01780974|452880066|FG001|Overall Study|Adverse Event|3|||
125886460|NCT01724346|452880067|FG000|Overall Study|Death|42|||
125886461|NCT01724346|452880068|FG001|Overall Study|Death|42|||
125886462|NCT01724346|452880067|FG000|Overall Study|Lost to Follow-up|5|||
125886463|NCT01724346|452880068|FG001|Overall Study|Lost to Follow-up|1|||
126378115|NCT00442416|454681527|FG000|Overall Study|Death|1|||
126378116|NCT00442416|454681528|FG001|Overall Study|Death|0|||
125886464|NCT01724346|452880067|FG000|Overall Study|Withdrawal by Subject|27|||
125886465|NCT01724346|452880068|FG001|Overall Study|Withdrawal by Subject|19|||
126378117|NCT00442416|454681527|FG000|Overall Study|Lack of Efficacy|2|||
126378118|NCT00442416|454681528|FG001|Overall Study|Lack of Efficacy|0|||
125886466|NCT01724346|452880067|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
126378119|NCT00442416|454681527|FG000|Overall Study|Protocol Violation|2|||
126378120|NCT00442416|454681528|FG001|Overall Study|Protocol Violation|3|||
126378121|NCT00442416|454681527|FG000|Overall Study|Withdrew consent|1|||
126378122|NCT00442416|454681528|FG001|Overall Study|Withdrew consent|2|||
126378123|NCT00442416|454681527|FG000|Overall Study|Administrative/Other|27|||
126378124|NCT00442416|454681528|FG001|Overall Study|Administrative/Other|33|||
126378125|NCT01284959|454681531|FG000|Overall Study|Withdrawal by Subject|1|||
125886467|NCT01724346|452880068|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
125886468|NCT02876601|452880069|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
125886469|NCT02876601|452880070|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
126378126|NCT01284959|454681532|FG001|Overall Study|Withdrawal by Subject|0|||
126378127|NCT01284959|454681533|FG002|Overall Study|Withdrawal by Subject|0|||
126378128|NCT01284959|454681531|FG000|Overall Study|Adverse Event|0|||
126048100|NCT00312208|453473848|FG001|Overall Study|Protocol Violation|3|||
126048101|NCT00312208|453473847|FG000|Overall Study|Death|2|||
126048102|NCT00312208|453473848|FG001|Overall Study|Death|1|||
126048103|NCT00312208|453473847|FG000|Overall Study|Lack of Efficacy|7|||
126048104|NCT00312208|453473848|FG001|Overall Study|Lack of Efficacy|4|||
126048105|NCT00312208|453473847|FG000|Overall Study|Lost to Follow-up|3|||
126048106|NCT00312208|453473848|FG001|Overall Study|Lost to Follow-up|5|||
126048107|NCT00312208|453473847|FG000|Overall Study|Withdrawal by Subject|53|||
126378129|NCT01284959|454681532|FG001|Overall Study|Adverse Event|0|||
126378130|NCT01284959|454681533|FG002|Overall Study|Adverse Event|1|||
126378131|NCT00003869|454681535|FG000|Overall Study|Adverse Event|14|||
126378132|NCT00003869|454681536|FG001|Overall Study|Adverse Event|3|||
126378133|NCT00003869|454681535|FG000|Overall Study|Withdrawal by Subject|21|||
126378134|NCT00003869|454681536|FG001|Overall Study|Withdrawal by Subject|3|||
126378135|NCT00003869|454681535|FG000|Overall Study|Death|1|||
126378136|NCT00003869|454681536|FG001|Overall Study|Death|2|||
126378137|NCT00003869|454681535|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
126378138|NCT00003869|454681536|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
126378139|NCT03364231|454681537|FG000|Overall Study|Adverse Event|1|||
126378140|NCT03364231|454681538|FG001|Overall Study|Adverse Event|4|||
126378141|NCT03364231|454681537|FG000|Overall Study|Death|1|||
126378142|NCT03364231|454681538|FG001|Overall Study|Death|0|||
126378143|NCT03364231|454681537|FG000|Overall Study|Investigator Decision|2|||
126378144|NCT03364231|454681538|FG001|Overall Study|Investigator Decision|2|||
126378145|NCT03364231|454681537|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
126378146|NCT03364231|454681538|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
126378147|NCT03364231|454681537|FG000|Overall Study|Withdrawal of Subject Consent|1|||
126378148|NCT03364231|454681538|FG001|Overall Study|Withdrawal of Subject Consent|0|||
126378149|NCT03364231|454681537|FG000|Overall Study|Reason Not Specified|1|||
126378150|NCT03364231|454681538|FG001|Overall Study|Reason Not Specified|0|||
126378151|NCT03364231|454681537|FG000|Overall Study|Disease Progression|0|||
126378152|NCT03364231|454681538|FG001|Overall Study|Disease Progression|6|||
126378153|NCT04068922|454681539|FG000|Overall Study|Lost to Follow-up|5|||
126378154|NCT04068922|454681539|FG000|Overall Study|Withdrawal by Subject|7|||
126378155|NCT04068922|454681539|FG000|Overall Study|Adverse Event|1|||
126378156|NCT01070979|454681547|FG000|Overall Study|Adverse Event|2|||
126378157|NCT01070979|454681548|FG001|Overall Study|Adverse Event|3|||
126378158|NCT01070979|454681549|FG002|Overall Study|Adverse Event|3|||
126378159|NCT01070979|454681547|FG000|Overall Study|Lost to Follow-up|2|||
126378160|NCT01070979|454681548|FG001|Overall Study|Lost to Follow-up|1|||
126378161|NCT01070979|454681549|FG002|Overall Study|Lost to Follow-up|1|||
126378162|NCT01070979|454681547|FG000|Overall Study|Protocol Violation|0|||
126378163|NCT01070979|454681548|FG001|Overall Study|Protocol Violation|2|||
126378164|NCT01070979|454681549|FG002|Overall Study|Protocol Violation|6|||
126378165|NCT01070979|454681547|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
126378166|NCT01070979|454681548|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
126378167|NCT01070979|454681549|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
126378168|NCT01070979|454681547|FG000|Overall Study|Withdrawal by Subject|3|||
126378169|NCT01070979|454681548|FG001|Overall Study|Withdrawal by Subject|1|||
126378170|NCT01070979|454681549|FG002|Overall Study|Withdrawal by Subject|1|||
126378171|NCT01070979|454681547|FG000|Overall Study|No study drug taken|0|||
126048108|NCT00312208|453473848|FG001|Overall Study|Withdrawal by Subject|42|||
126378172|NCT01070979|454681548|FG001|Overall Study|No study drug taken|1|||
126378173|NCT01070979|454681549|FG002|Overall Study|No study drug taken|0|||
126378174|NCT00142792|454681550|FG000|Overall Study|Death|0|||
126048109|NCT00312208|453473847|FG000|Overall Study|Other|5|||
126378175|NCT00142792|454681551|FG001|Overall Study|Death|0|||
126048110|NCT00312208|453473848|FG001|Overall Study|Other|7|||
126048111|NCT00982644|453473851|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
126048112|NCT00982644|453473852|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
126048113|NCT00982644|453473851|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
126048114|NCT00982644|453473852|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
126048115|NCT00982644|453473851|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
126048116|NCT00982644|453473852|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
126048117|NCT00982644|453473851|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
126048118|NCT00982644|453473852|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
126048119|NCT00982644|453473851|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
126048120|NCT00982644|453473852|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
126048121|NCT00982644|453473851|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
126048122|NCT00982644|453473852|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
126048123|NCT00982644|453473851|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
126048124|NCT00982644|453473852|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
126048125|NCT00982644|453473851|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
126048126|NCT00982644|453473852|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
126048127|NCT00982644|453473851|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
126048128|NCT00982644|453473852|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
126378176|NCT00142792|454681552|FG002|Overall Study|Death|1|||
126378177|NCT00142792|454681550|FG000|Overall Study|Withdrawal by Subject|3|||
126378178|NCT00142792|454681551|FG001|Overall Study|Withdrawal by Subject|2|||
126378179|NCT00142792|454681552|FG002|Overall Study|Withdrawal by Subject|3|||
126378180|NCT00142792|454681550|FG000|Overall Study|Lost to Follow-up|8|||
126378181|NCT00142792|454681551|FG001|Overall Study|Lost to Follow-up|11|||
126378182|NCT00142792|454681552|FG002|Overall Study|Lost to Follow-up|7|||
126378183|NCT00142792|454681550|FG000|Overall Study|No category|1|||
126378184|NCT00142792|454681551|FG001|Overall Study|No category|2|||
126378185|NCT00142792|454681552|FG002|Overall Study|No category|1|||
126378186|NCT00444106|454681555|FG000|Overall Study|Lost to Follow-up|2|||
126378187|NCT00444106|454681556|FG001|Overall Study|Lost to Follow-up|1|||
126378188|NCT00444106|454681557|FG002|Overall Study|Lost to Follow-up|0|||
126378189|NCT00444106|454681555|FG000|Overall Study|Abnormal Test Procedure Results|0|||
126378190|NCT00444106|454681556|FG001|Overall Study|Abnormal Test Procedure Results|0|||
126378191|NCT00444106|454681557|FG002|Overall Study|Abnormal Test Procedure Results|1|||
126378192|NCT04749914|454681558|FG000|Period 1|Adverse Event|1|||
126378193|NCT04749914|454681559|FG001|Period 1|Adverse Event|0|||
126378194|NCT04749914|454681560|FG002|Period 1|Adverse Event|0|||
126378195|NCT04749914|454681561|FG003|Period 1|Adverse Event|0|||
126378196|NCT04749914|454681558|FG000|Period 1|Withdrawal by Subject|1|||
126378197|NCT04749914|454681559|FG001|Period 1|Withdrawal by Subject|0|||
126378198|NCT04749914|454681560|FG002|Period 1|Withdrawal by Subject|1|||
126378199|NCT04749914|454681561|FG003|Period 1|Withdrawal by Subject|0|||
126378200|NCT01913327|454681564|FG000|Overall Study|Withdrawal by Subject|0|||
126378201|NCT01913327|454681565|FG001|Overall Study|Withdrawal by Subject|1|||
126378202|NCT01074931|454681570|FG000|Overall Study|Economic reasons|1|||
126378203|NCT01074931|454681570|FG000|Overall Study|Death|5|||
126378204|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
126378205|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
126378206|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
126378207|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
126378208|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
126378209|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
126378210|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
126378211|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
126378212|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
126378213|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
126378214|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
126378215|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
126378216|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
126378217|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
126378218|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
126378219|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
126378220|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
126378221|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
126378222|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
126378223|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
126378224|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
126378225|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
126378226|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
126378227|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
126378228|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
126378229|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
126378230|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
126378231|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
126378232|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
126378233|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
126378234|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
126378235|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
126378236|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
126378237|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
126378238|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
126378239|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
126378240|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
126378241|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
126378242|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
126378243|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
126378244|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
126378245|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
126378246|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
126378247|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
126378248|NCT02137070|454681576|FG000|Overall Study|Adverse Event|12|||
126378249|NCT02137070|454681577|FG001|Overall Study|Adverse Event|3|||
126378250|NCT02137070|454681576|FG000|Overall Study|Death|2|||
126378251|NCT02137070|454681577|FG001|Overall Study|Death|0|||
126378252|NCT02137070|454681576|FG000|Overall Study|Lost to Follow-up|24|||
126378253|NCT02137070|454681577|FG001|Overall Study|Lost to Follow-up|9|||
126378254|NCT02137070|454681576|FG000|Overall Study|Physician Decision|0|||
126378255|NCT02137070|454681577|FG001|Overall Study|Physician Decision|1|||
126378256|NCT02137070|454681576|FG000|Overall Study|Protocol Violation|18|||
126378257|NCT02137070|454681577|FG001|Overall Study|Protocol Violation|4|||
126378258|NCT02137070|454681576|FG000|Overall Study|Withdrawal by Subject|18|||
126378259|NCT02137070|454681577|FG001|Overall Study|Withdrawal by Subject|1|||
126378260|NCT02112656|454681578|FG000|Overall Study|Death|78|||
126378261|NCT02112656|454681579|FG001|Overall Study|Death|82|||
126378262|NCT02112656|454681578|FG000|Overall Study|Withdrawal by Subject|9|||
126378263|NCT02112656|454681579|FG001|Overall Study|Withdrawal by Subject|11|||
126378264|NCT02112656|454681578|FG000|Overall Study|Lost to Follow-up|2|||
126378265|NCT02112656|454681579|FG001|Overall Study|Lost to Follow-up|4|||
126378266|NCT02112656|454681578|FG000|Overall Study|Noncompliance|1|||
126378267|NCT02112656|454681579|FG001|Overall Study|Noncompliance|2|||
126378268|NCT03761056|454681580|FG000|Overall Study|Death|8|||
126048129|NCT00982644|453473851|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
126048130|NCT00982644|453473852|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
126048131|NCT00943917|453473855|FG000|Stage I|Adverse Event|1|||
126048132|NCT00943917|453473856|FG001|Stage I|Adverse Event|2|||
126048133|NCT00943917|453473857|FG002|Stage I|Adverse Event|2|||
126048134|NCT00943917|453473858|FG003|Stage I|Adverse Event|0|||
126048135|NCT00943917|453473859|FG004|Stage I|Adverse Event|0|||
126048136|NCT00943917|453473860|FG005|Stage I|Adverse Event|0|||
126048137|NCT00943917|453473861|FG006|Stage I|Adverse Event|0|||
126048138|NCT00943917|453473862|FG007|Stage I|Adverse Event|0|||
126048139|NCT00943917|453473863|FG008|Stage I|Adverse Event|0|||
126378269|NCT03761056|454681580|FG000|Overall Study|Enrolled but never treated|2|||
126048140|NCT00943917|453473864|FG009|Stage I|Adverse Event|0|||
126378270|NCT03761056|454681580|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
126048141|NCT00943917|453473865|FG010|Stage I|Adverse Event|0|||
126378271|NCT03761056|454681580|FG000|Overall Study|Investigator decision|1|||
126378272|NCT03965403|454681585|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
126378273|NCT00552071|454682945|FG000|Overall Study|Adverse Event|1|||
126378274|NCT00552071|454682946|FG001|Overall Study|Adverse Event|0|||
126378275|NCT00552071|454682945|FG000|Overall Study|Lack of Efficacy|1|||
126378276|NCT00552071|454682946|FG001|Overall Study|Lack of Efficacy|0|||
126378277|NCT00552071|454682945|FG000|Overall Study|Physician Decision|1|||
126378278|NCT00552071|454682946|FG001|Overall Study|Physician Decision|0|||
126378279|NCT00552071|454682945|FG000|Overall Study|Pregnancy|1|||
126378280|NCT00552071|454682946|FG001|Overall Study|Pregnancy|0|||
126378281|NCT00552071|454682945|FG000|Overall Study|Death|0|||
126378282|NCT00552071|454682946|FG001|Overall Study|Death|1|||
126378283|NCT00552071|454682945|FG000|Overall Study|Withdrawal by Subject|0|||
126378284|NCT00552071|454682946|FG001|Overall Study|Withdrawal by Subject|1|||
126378285|NCT01979614|454682947|FG000|Overall Study|Adverse Event|1|||
126378286|NCT01979614|454682948|FG001|Overall Study|Adverse Event|1|||
126378287|NCT00756275|454682949|FG000|Overall Study|Lost to Follow-up|25|||
126378288|NCT00756275|454682950|FG001|Overall Study|Lost to Follow-up|21|||
126378289|NCT00756275|454682949|FG000|Overall Study|Withdrawal by Subject|4|||
126378290|NCT00756275|454682950|FG001|Overall Study|Withdrawal by Subject|7|||
126378291|NCT00938912|454682951|FG000|Overall Study|Withdrawal by Subject|28|||
126378292|NCT00938912|454682951|FG000|Overall Study|Lost to Follow-up|4|||
126378293|NCT00938912|454682951|FG000|Overall Study|Lack of Efficacy|43|||
126378294|NCT00938912|454682951|FG000|Overall Study|Adverse event, non-fatal|24|||
126378295|NCT00938912|454682951|FG000|Overall Study|Adverse event, fatal|1|||
126378296|NCT00938912|454682951|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
126378297|NCT00938912|454682951|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
126378298|NCT00938912|454682951|FG000|Overall Study|Participant needed prohibit medication|1|||
126378299|NCT00938912|454682951|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
126378300|NCT00938912|454682951|FG000|Overall Study|Did not meet Eligibility criteria|1|||
126378301|NCT00938912|454682951|FG000|Overall Study|Participant relocated not related to AE|1|||
126378302|NCT00938912|454682951|FG000|Overall Study|Participant moved to another city|1|||
126378303|NCT00938912|454682951|FG000|Overall Study|Participant experienced break through seizures|1|||
126378304|NCT00938912|454682951|FG000|Overall Study|No longer wished to participate in the study|1|||
126378305|NCT00938912|454682951|FG000|Overall Study|Protocol Deviation|2|||
126378306|NCT00456755|454682954|FG000|Overall Study|Lost to Follow-up|2|||
126378307|NCT00456755|454682955|FG001|Overall Study|Lost to Follow-up|1|||
126378308|NCT06164691|454682956|FG000|Overall Study|Withdrawal by Subject|2|||
126378309|NCT06164691|454682957|FG001|Overall Study|Withdrawal by Subject|0|||
126378310|NCT06164691|454682958|FG002|Overall Study|Withdrawal by Subject|0|||
126378311|NCT03432494|454682977|FG000|Overall Study|Death|1|||
126378312|NCT03432494|454682977|FG000|Overall Study|Noncompliance|1|||
126378313|NCT00856635|454682978|FG000|Overall Study|Lost to Follow-up|2|||
126378314|NCT00856635|454682979|FG001|Overall Study|Lost to Follow-up|5|||
126378315|NCT00856635|454682978|FG000|Overall Study|Pregnancy|1|||
126378316|NCT00856635|454682979|FG001|Overall Study|Pregnancy|0|||
126378317|NCT00856635|454682978|FG000|Overall Study|Withdrawal by Subject|3|||
126378318|NCT00856635|454682979|FG001|Overall Study|Withdrawal by Subject|1|||
126378319|NCT00856635|454682978|FG000|Overall Study|Serious Adverse Event|1|||
126378320|NCT00856635|454682979|FG001|Overall Study|Serious Adverse Event|0|||
126378321|NCT00856635|454682978|FG000|Overall Study|Other|1|||
126378322|NCT00856635|454682979|FG001|Overall Study|Other|0|||
126378323|NCT00856635|454682978|FG000|Overall Study|Discontinued at Randomization|2|||
126378324|NCT00856635|454682979|FG001|Overall Study|Discontinued at Randomization|2|||
126378325|NCT01244035|454682980|FG000|Part 1: Period 1|Adverse Event|0|||
126378326|NCT01244035|454682981|FG001|Part 1: Period 1|Adverse Event|0|||
126048142|NCT00943917|453473866|FG011|Stage I|Adverse Event|0|||
126048143|NCT00943917|453473867|FG012|Stage I|Adverse Event|0|||
126048144|NCT00943917|453473868|FG013|Stage I|Adverse Event|0|||
126048145|NCT00943917|453473869|FG014|Stage I|Adverse Event|0|||
126048146|NCT00943917|453473855|FG000|Stage I|Lost to Follow-up|0|||
126378327|NCT01244035|454682982|FG002|Part 1: Period 1|Adverse Event|0|||
126378328|NCT01244035|454682983|FG003|Part 1: Period 1|Adverse Event|0|||
126378329|NCT01244035|454682984|FG004|Part 1: Period 1|Adverse Event|0|||
126378330|NCT01244035|454682985|FG005|Part 1: Period 1|Adverse Event|1|||
126048147|NCT00943917|453473856|FG001|Stage I|Lost to Follow-up|0|||
126378331|NCT01244035|454682980|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
126378332|NCT01244035|454682981|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
126378333|NCT01244035|454682982|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
126378334|NCT01244035|454682983|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
126378335|NCT01244035|454682984|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
126378336|NCT01244035|454682985|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
126378337|NCT01244035|454682980|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
126378338|NCT01244035|454682981|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
126378339|NCT01244035|454682982|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
126378340|NCT01244035|454682983|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
126378341|NCT01244035|454682984|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
126048148|NCT00943917|453473857|FG002|Stage I|Lost to Follow-up|1|||
126048149|NCT00943917|453473858|FG003|Stage I|Lost to Follow-up|0|||
126048150|NCT00943917|453473859|FG004|Stage I|Lost to Follow-up|0|||
126048151|NCT00943917|453473860|FG005|Stage I|Lost to Follow-up|0|||
126048152|NCT00943917|453473861|FG006|Stage I|Lost to Follow-up|0|||
126048153|NCT00943917|453473862|FG007|Stage I|Lost to Follow-up|0|||
126048154|NCT00943917|453473863|FG008|Stage I|Lost to Follow-up|0|||
126048155|NCT00943917|453473864|FG009|Stage I|Lost to Follow-up|0|||
126048156|NCT00943917|453473865|FG010|Stage I|Lost to Follow-up|0|||
126048157|NCT00943917|453473866|FG011|Stage I|Lost to Follow-up|0|||
126048158|NCT00943917|453473867|FG012|Stage I|Lost to Follow-up|0|||
126048159|NCT00943917|453473868|FG013|Stage I|Lost to Follow-up|0|||
126048160|NCT00943917|453473869|FG014|Stage I|Lost to Follow-up|0|||
126048161|NCT00943917|453473855|FG000|Stage I|hyperglycemia|0|||
126048162|NCT00943917|453473856|FG001|Stage I|hyperglycemia|0|||
126048163|NCT00943917|453473857|FG002|Stage I|hyperglycemia|1|||
126048164|NCT00943917|453473858|FG003|Stage I|hyperglycemia|0|||
126048165|NCT00943917|453473859|FG004|Stage I|hyperglycemia|0|||
126048166|NCT00943917|453473860|FG005|Stage I|hyperglycemia|0|||
126048167|NCT00943917|453473861|FG006|Stage I|hyperglycemia|0|||
126048168|NCT00943917|453473862|FG007|Stage I|hyperglycemia|0|||
126048169|NCT00943917|453473863|FG008|Stage I|hyperglycemia|0|||
126048170|NCT00943917|453473864|FG009|Stage I|hyperglycemia|0|||
126048171|NCT00943917|453473865|FG010|Stage I|hyperglycemia|0|||
126048172|NCT00943917|453473866|FG011|Stage I|hyperglycemia|0|||
126048173|NCT00943917|453473867|FG012|Stage I|hyperglycemia|0|||
126048174|NCT00943917|453473868|FG013|Stage I|hyperglycemia|0|||
126048175|NCT00943917|453473869|FG014|Stage I|hyperglycemia|0|||
126048176|NCT00943917|453473855|FG000|Stage I|A1C elevation|1|||
126048177|NCT00943917|453473856|FG001|Stage I|A1C elevation|0|||
126378342|NCT01244035|454682985|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
126378343|NCT01244035|454682980|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378344|NCT01244035|454682981|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378345|NCT01244035|454682982|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
126378346|NCT01244035|454682983|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378347|NCT01244035|454682984|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378348|NCT01244035|454682985|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378349|NCT01244035|454682980|FG000|Part 1: Period 3|Adverse Event|0|||
126378350|NCT01244035|454682981|FG001|Part 1: Period 3|Adverse Event|0|||
126378351|NCT01244035|454682982|FG002|Part 1: Period 3|Adverse Event|0|||
126378352|NCT01244035|454682983|FG003|Part 1: Period 3|Adverse Event|0|||
126378353|NCT01244035|454682984|FG004|Part 1: Period 3|Adverse Event|0|||
126378354|NCT01244035|454682985|FG005|Part 1: Period 3|Adverse Event|1|||
126378355|NCT01244035|454682980|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
126378356|NCT01244035|454682981|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
126378357|NCT01244035|454682982|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
126378358|NCT01244035|454682983|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
126378359|NCT01244035|454682984|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
126378360|NCT01244035|454682985|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
126378361|NCT01244035|454682980|FG000|Part 1: Period 3|Protocol Deviation|0|||
126378362|NCT01244035|454682981|FG001|Part 1: Period 3|Protocol Deviation|1|||
126378363|NCT01244035|454682982|FG002|Part 1: Period 3|Protocol Deviation|0|||
126378364|NCT01244035|454682983|FG003|Part 1: Period 3|Protocol Deviation|0|||
126378365|NCT01244035|454682984|FG004|Part 1: Period 3|Protocol Deviation|0|||
126378366|NCT01244035|454682985|FG005|Part 1: Period 3|Protocol Deviation|0|||
126378367|NCT01696773|454682986|FG000|Days 15-27, Washout|Adverse Event|1|||
126378368|NCT01696773|454682987|FG001|Days 15-27, Washout|Adverse Event|0|||
126378369|NCT02370368|454682990|FG000|Overall Study|Adverse Event|1|||
126378370|NCT02370368|454682991|FG001|Overall Study|Adverse Event|2|||
126378371|NCT02370368|454682990|FG000|Overall Study|Withdrawal by Subject|5|||
126378372|NCT02370368|454682991|FG001|Overall Study|Withdrawal by Subject|4|||
126378373|NCT00347932|454682994|FG000|Overall Study|Adverse Event|4|||
126378374|NCT00347932|454682995|FG001|Overall Study|Adverse Event|5|||
126378375|NCT00347932|454682994|FG000|Overall Study|Lack of Efficacy|3|||
126378376|NCT00347932|454682995|FG001|Overall Study|Lack of Efficacy|14|||
126378377|NCT00347932|454682994|FG000|Overall Study|Lost to Follow-up|10|||
126378378|NCT00347932|454682995|FG001|Overall Study|Lost to Follow-up|9|||
126378379|NCT00347932|454682994|FG000|Overall Study|Withdrawal by Subject|10|||
126378380|NCT00347932|454682995|FG001|Overall Study|Withdrawal by Subject|16|||
126048178|NCT00943917|453473857|FG002|Stage I|A1C elevation|0|||
126048179|NCT00943917|453473858|FG003|Stage I|A1C elevation|0|||
126048180|NCT00943917|453473859|FG004|Stage I|A1C elevation|0|||
126048181|NCT00943917|453473860|FG005|Stage I|A1C elevation|0|||
126048182|NCT00943917|453473861|FG006|Stage I|A1C elevation|0|||
126048183|NCT00943917|453473862|FG007|Stage I|A1C elevation|0|||
126048184|NCT00943917|453473863|FG008|Stage I|A1C elevation|0|||
126048185|NCT00943917|453473864|FG009|Stage I|A1C elevation|0|||
126378381|NCT00347932|454682994|FG000|Overall Study|Did not meet inclusion criteria|4|||
126378382|NCT00347932|454682995|FG001|Overall Study|Did not meet inclusion criteria|8|||
126378383|NCT04512001|454682996|FG000|Week 0 to Week 24|Adverse Event|14|||
126378384|NCT04512001|454682997|FG001|Week 0 to Week 24|Adverse Event|10|||
126378385|NCT04512001|454682998|FG002|Week 0 to Week 24|Adverse Event|0|||
126378386|NCT04512001|454682999|FG003|Week 0 to Week 24|Adverse Event|0|||
126378387|NCT04512001|454683000|FG004|Week 0 to Week 24|Adverse Event|0|||
126378388|NCT04512001|454682996|FG000|Week 0 to Week 24|Death|0|||
126378389|NCT04512001|454682997|FG001|Week 0 to Week 24|Death|2|||
126378390|NCT04512001|454682998|FG002|Week 0 to Week 24|Death|0|||
126378391|NCT04512001|454682999|FG003|Week 0 to Week 24|Death|0|||
126378392|NCT04512001|454683000|FG004|Week 0 to Week 24|Death|0|||
126378393|NCT04512001|454682996|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
126378394|NCT04512001|454682997|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
126378395|NCT04512001|454682998|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
126378396|NCT04512001|454682999|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
126378397|NCT04512001|454683000|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
126378398|NCT04512001|454682996|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
126378399|NCT04512001|454682997|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
126378400|NCT04512001|454682998|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
126378401|NCT04512001|454682999|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
126378402|NCT04512001|454683000|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
126378403|NCT04512001|454682996|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
126378404|NCT04512001|454682997|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
126378405|NCT04512001|454682998|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
126378406|NCT04512001|454682999|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
126378407|NCT04512001|454683000|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
126378408|NCT04512001|454682996|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
126378409|NCT04512001|454682997|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
126378410|NCT04512001|454682998|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
126378411|NCT04512001|454682999|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
126378412|NCT04512001|454683000|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
126378413|NCT04512001|454682996|FG000|Week 24 to Week 63|Adverse Event|0|||
126378414|NCT04512001|454682997|FG001|Week 24 to Week 63|Adverse Event|0|||
126378415|NCT04512001|454682998|FG002|Week 24 to Week 63|Adverse Event|13|||
126378416|NCT04512001|454682999|FG003|Week 24 to Week 63|Adverse Event|8|||
126378417|NCT04512001|454683000|FG004|Week 24 to Week 63|Adverse Event|6|||
126378418|NCT04512001|454682996|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
126048186|NCT00943917|453473865|FG010|Stage I|A1C elevation|0|||
126048187|NCT00943917|453473866|FG011|Stage I|A1C elevation|0|||
126048188|NCT00943917|453473867|FG012|Stage I|A1C elevation|0|||
126048189|NCT00943917|453473868|FG013|Stage I|A1C elevation|0|||
126048190|NCT00943917|453473869|FG014|Stage I|A1C elevation|0|||
126048191|NCT00943917|453473855|FG000|Stage I|Withdrawal by Subject|2|||
126048192|NCT00943917|453473856|FG001|Stage I|Withdrawal by Subject|1|||
126048193|NCT00943917|453473857|FG002|Stage I|Withdrawal by Subject|2|||
126048194|NCT00943917|453473858|FG003|Stage I|Withdrawal by Subject|0|||
126048195|NCT00943917|453473859|FG004|Stage I|Withdrawal by Subject|0|||
126048196|NCT00943917|453473860|FG005|Stage I|Withdrawal by Subject|0|||
126048197|NCT00943917|453473861|FG006|Stage I|Withdrawal by Subject|0|||
126048198|NCT00943917|453473862|FG007|Stage I|Withdrawal by Subject|0|||
126048199|NCT00943917|453473863|FG008|Stage I|Withdrawal by Subject|0|||
126048200|NCT00943917|453473864|FG009|Stage I|Withdrawal by Subject|0|||
126048201|NCT00943917|453473865|FG010|Stage I|Withdrawal by Subject|0|||
126048202|NCT00943917|453473866|FG011|Stage I|Withdrawal by Subject|0|||
126048203|NCT00943917|453473867|FG012|Stage I|Withdrawal by Subject|0|||
126048204|NCT00943917|453473868|FG013|Stage I|Withdrawal by Subject|0|||
126048205|NCT00943917|453473869|FG014|Stage I|Withdrawal by Subject|0|||
126048206|NCT00943917|453473855|FG000|Stage II|Adverse Event|0|||
126048207|NCT00943917|453473856|FG001|Stage II|Adverse Event|0|||
126048208|NCT00943917|453473857|FG002|Stage II|Adverse Event|0|||
126048209|NCT00943917|453473858|FG003|Stage II|Adverse Event|0|||
126048210|NCT00943917|453473859|FG004|Stage II|Adverse Event|0|||
126048211|NCT00943917|453473860|FG005|Stage II|Adverse Event|1|||
126048212|NCT00943917|453473861|FG006|Stage II|Adverse Event|3|||
126048213|NCT00943917|453473862|FG007|Stage II|Adverse Event|0|||
126048214|NCT00943917|453473863|FG008|Stage II|Adverse Event|1|||
126104156|NCT02647320|453675814|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
126378419|NCT04512001|454682997|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
126378420|NCT04512001|454682998|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
126378421|NCT04512001|454682999|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
126378422|NCT04512001|454683000|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
126378423|NCT04512001|454682996|FG000|Week 24 to Week 63|Death|0|||
126048215|NCT00943917|453473864|FG009|Stage II|Adverse Event|0|||
126048216|NCT00943917|453473865|FG010|Stage II|Adverse Event|0|||
126048217|NCT00943917|453473866|FG011|Stage II|Adverse Event|0|||
126048218|NCT00943917|453473867|FG012|Stage II|Adverse Event|0|||
126378424|NCT04512001|454682997|FG001|Week 24 to Week 63|Death|0|||
126378425|NCT04512001|454682998|FG002|Week 24 to Week 63|Death|0|||
126378426|NCT04512001|454682999|FG003|Week 24 to Week 63|Death|1|||
126378427|NCT04512001|454683000|FG004|Week 24 to Week 63|Death|1|||
126378428|NCT04512001|454682996|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
126378429|NCT04512001|454682997|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
126378430|NCT04512001|454682998|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
126378431|NCT04512001|454682999|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
126378432|NCT04512001|454683000|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
126378433|NCT04512001|454682996|FG000|Week 24 to Week 63|Miscellaneous|0|||
126378434|NCT04512001|454682997|FG001|Week 24 to Week 63|Miscellaneous|0|||
126378435|NCT04512001|454682998|FG002|Week 24 to Week 63|Miscellaneous|3|||
126378436|NCT04512001|454682999|FG003|Week 24 to Week 63|Miscellaneous|2|||
126378437|NCT04512001|454683000|FG004|Week 24 to Week 63|Miscellaneous|1|||
126378438|NCT03389308|454683003|FG000|Overall Study|Withdrawal by Subject|5|||
126378439|NCT03389308|454683003|FG000|Overall Study|Lost to Follow-up|3|||
126378440|NCT03389308|454683003|FG000|Overall Study|Adverse Event|2|||
126378441|NCT03389308|454683003|FG000|Overall Study|Sponsor Request|2|||
126378442|NCT03198767|454683004|FG000|Overall Study|Protocol Violation|0|||
126378443|NCT03198767|454683005|FG001|Overall Study|Protocol Violation|0|||
126378444|NCT03198767|454683006|FG002|Overall Study|Protocol Violation|0|||
126378445|NCT03198767|454683007|FG003|Overall Study|Protocol Violation|6|||
126378446|NCT03198767|454683008|FG004|Overall Study|Protocol Violation|0|||
126378447|NCT03198767|454683009|FG005|Overall Study|Protocol Violation|0|||
126378448|NCT03198767|454683010|FG006|Overall Study|Protocol Violation|0|||
126378449|NCT00570323|454683011|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
126378450|NCT00570323|454683012|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
126378451|NCT00570323|454683011|FG000|Started Treatment After Randomization|Protocol Violation|1|||
126378452|NCT00570323|454683012|FG001|Started Treatment After Randomization|Protocol Violation|0|||
126378453|NCT00570323|454683011|FG000|Started Treatment After Randomization|Physician Decision|1|||
126378454|NCT00570323|454683012|FG001|Started Treatment After Randomization|Physician Decision|0|||
126378455|NCT00570323|454683011|FG000|Complete Study After Start|Lost to Follow-up|0|||
126378456|NCT00570323|454683012|FG001|Complete Study After Start|Lost to Follow-up|1|||
126378457|NCT00570323|454683011|FG000|Complete Study After Start|Withdrawal by Subject|2|||
126378458|NCT00570323|454683012|FG001|Complete Study After Start|Withdrawal by Subject|0|||
126378459|NCT00570323|454683011|FG000|Complete Study After Start|Physician Decision|1|||
126378460|NCT00570323|454683012|FG001|Complete Study After Start|Physician Decision|0|||
126378461|NCT04232943|454683013|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
126378462|NCT04232943|454683014|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
126378463|NCT04232943|454683015|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
126378464|NCT04232943|454683013|FG000|Overall Study|Withdrawal by Subject|1|||
126378465|NCT04232943|454683014|FG001|Overall Study|Withdrawal by Subject|1|||
126378466|NCT04232943|454683015|FG002|Overall Study|Withdrawal by Subject|0|||
126378467|NCT03896477|454683018|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
126378468|NCT03896477|454683019|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
126378469|NCT03896477|454683020|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
126378470|NCT03896477|454683018|FG000|Overall Study|Parent Requested Withdrawal|8|||
126378471|NCT03896477|454683019|FG001|Overall Study|Parent Requested Withdrawal|12|||
126378472|NCT03896477|454683020|FG002|Overall Study|Parent Requested Withdrawal|9|||
126378473|NCT03896477|454683018|FG000|Overall Study|Adverse Event|0|||
126378474|NCT03896477|454683019|FG001|Overall Study|Adverse Event|0|||
126378475|NCT03896477|454683020|FG002|Overall Study|Adverse Event|1|||
126378476|NCT03896477|454683018|FG000|Overall Study|Death|1|||
126378477|NCT03896477|454683019|FG001|Overall Study|Death|0|||
126378478|NCT03896477|454683020|FG002|Overall Study|Death|0|||
126378479|NCT03896477|454683018|FG000|Overall Study|Other|5|||
126378480|NCT03896477|454683019|FG001|Overall Study|Other|6|||
126378481|NCT03896477|454683020|FG002|Overall Study|Other|7|||
126378482|NCT03896477|454683018|FG000|Overall Study|Lost to Follow-up|2|||
126378483|NCT03896477|454683019|FG001|Overall Study|Lost to Follow-up|1|||
126378484|NCT03896477|454683020|FG002|Overall Study|Lost to Follow-up|1|||
126378485|NCT01791517|454683021|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
126378486|NCT01791517|454683022|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
126378487|NCT01791517|454683023|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
126378488|NCT01791517|454683024|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
126378489|NCT01791517|454683025|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
126378490|NCT01791517|454683026|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
126378491|NCT01791517|454683027|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
126378492|NCT01791517|454683028|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
126378493|NCT01791517|454683029|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
126378494|NCT01791517|454683030|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
126378495|NCT01791517|454683031|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
125886470|NCT02876601|452880071|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
125886471|NCT02876601|452880072|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
125886472|NCT00256997|452880073|FG000|Overall Study|Protocol Violation|1|||
125886473|NCT00256997|452880074|FG001|Overall Study|Protocol Violation|4|||
125886474|NCT00256997|452880073|FG000|Overall Study|Lack of Efficacy|1|||
125886475|NCT00256997|452880074|FG001|Overall Study|Lack of Efficacy|4|||
125886476|NCT00256997|452880073|FG000|Overall Study|Death|2|||
125886477|NCT00256997|452880074|FG001|Overall Study|Death|0|||
125886478|NCT00256997|452880073|FG000|Overall Study|Adverse Event|4|||
125886479|NCT00256997|452880074|FG001|Overall Study|Adverse Event|0|||
125886480|NCT00256997|452880073|FG000|Overall Study|Lost to Follow-up|3|||
125886481|NCT00256997|452880074|FG001|Overall Study|Lost to Follow-up|5|||
125886482|NCT00256997|452880073|FG000|Overall Study|Withdrawal by Subject|13|||
125886483|NCT00256997|452880074|FG001|Overall Study|Withdrawal by Subject|3|||
125886484|NCT00256997|452880073|FG000|Overall Study|Started but not treated|2|||
125886485|NCT00256997|452880074|FG001|Overall Study|Started but not treated|0|||
125886486|NCT00256997|452880073|FG000|Overall Study|Other|5|||
125886487|NCT00256997|452880074|FG001|Overall Study|Other|8|||
125886488|NCT00256997|452880073|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
125886489|NCT00256997|452880074|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
125886490|NCT00256997|452880073|FG000|Overall Study|Participant Non-compliant|3|||
125886491|NCT00256997|452880074|FG001|Overall Study|Participant Non-compliant|6|||
125886492|NCT00256997|452880073|FG000|Overall Study|Investigator Withdrew Participant|2|||
125886493|NCT00256997|452880074|FG001|Overall Study|Investigator Withdrew Participant|1|||
125886494|NCT03529422|452880075|FG000|Overall Study|Withdrawal by Subject|1|||
125886495|NCT03529422|452880075|FG000|Overall Study|Protocol Violation|1|||
125886496|NCT03529422|452880075|FG000|Overall Study|Disease progression|2|||
125886497|NCT05006573|452880076|FG000|Double-blind Treatment Period|Physician Decision|2|||
125886498|NCT05006573|452880077|FG001|Double-blind Treatment Period|Physician Decision|0|||
125886499|NCT05006573|452880076|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
125886500|NCT05006573|452880077|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
125886501|NCT05006573|452880076|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
126378496|NCT01791517|454683032|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
126378497|NCT01791517|454683021|FG000|Phase I: Period 1|Adverse Event|0|||
126378498|NCT01791517|454683022|FG001|Phase I: Period 1|Adverse Event|0|||
126378499|NCT01791517|454683023|FG002|Phase I: Period 1|Adverse Event|1|||
126378500|NCT01791517|454683024|FG003|Phase I: Period 1|Adverse Event|1|||
126378501|NCT01791517|454683025|FG004|Phase I: Period 1|Adverse Event|0|||
126378502|NCT01791517|454683026|FG005|Phase I: Period 1|Adverse Event|0|||
126378503|NCT01791517|454683027|FG006|Phase I: Period 1|Adverse Event|0|||
126378504|NCT01791517|454683028|FG007|Phase I: Period 1|Adverse Event|0|||
126378505|NCT01791517|454683029|FG008|Phase I: Period 1|Adverse Event|0|||
126378506|NCT01791517|454683030|FG009|Phase I: Period 1|Adverse Event|0|||
126378507|NCT01791517|454683031|FG010|Phase I: Period 1|Adverse Event|0|||
126378508|NCT01791517|454683032|FG011|Phase I: Period 1|Adverse Event|0|||
126378509|NCT01791517|454683021|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
126378510|NCT01791517|454683022|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378511|NCT01791517|454683023|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378512|NCT01791517|454683024|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378513|NCT01791517|454683025|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378514|NCT01791517|454683026|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378515|NCT01791517|454683027|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378516|NCT01791517|454683028|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378517|NCT01791517|454683029|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378518|NCT01791517|454683030|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378519|NCT01791517|454683031|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378520|NCT01791517|454683032|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378521|NCT01791517|454683021|FG000|Phase I: Period 1|Protocol Violation|0|||
126378522|NCT01791517|454683022|FG001|Phase I: Period 1|Protocol Violation|1|||
126378523|NCT01791517|454683023|FG002|Phase I: Period 1|Protocol Violation|0|||
126378524|NCT01791517|454683024|FG003|Phase I: Period 1|Protocol Violation|0|||
126378525|NCT01791517|454683025|FG004|Phase I: Period 1|Protocol Violation|0|||
126378526|NCT01791517|454683026|FG005|Phase I: Period 1|Protocol Violation|0|||
125886502|NCT05006573|452880077|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125886503|NCT05006573|452880076|FG000|Double-blind Treatment Period|Protocol Violation|2|||
126378527|NCT01791517|454683027|FG006|Phase I: Period 1|Protocol Violation|0|||
126378528|NCT01791517|454683028|FG007|Phase I: Period 1|Protocol Violation|0|||
126378529|NCT01791517|454683029|FG008|Phase I: Period 1|Protocol Violation|0|||
126378530|NCT01791517|454683030|FG009|Phase I: Period 1|Protocol Violation|0|||
126378531|NCT01791517|454683031|FG010|Phase I: Period 1|Protocol Violation|0|||
125886504|NCT05006573|452880077|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125886505|NCT05006573|452880076|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
125886506|NCT05006573|452880077|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
126378532|NCT01791517|454683032|FG011|Phase I: Period 1|Protocol Violation|0|||
125886507|NCT05006573|452880076|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
125886508|NCT05006573|452880077|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
125886509|NCT01967238|452880078|FG000|Overall Study|Adverse Event|1|||
125886510|NCT01967238|452880079|FG001|Overall Study|Adverse Event|1|||
125886511|NCT01967238|452880080|FG002|Overall Study|Adverse Event|0|||
125886512|NCT01967238|452880078|FG000|Overall Study|Lost to Follow-up|1|||
125886513|NCT01967238|452880079|FG001|Overall Study|Lost to Follow-up|0|||
125886514|NCT01967238|452880080|FG002|Overall Study|Lost to Follow-up|1|||
125886515|NCT01967238|452880078|FG000|Overall Study|Withdrawal by Subject|0|||
125886516|NCT01967238|452880079|FG001|Overall Study|Withdrawal by Subject|0|||
125886517|NCT01967238|452880080|FG002|Overall Study|Withdrawal by Subject|1|||
125886518|NCT05232682|452880081|FG000|Overall Study|Lost to Follow-up|2|||
125886519|NCT03387085|452880082|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
125886520|NCT01442103|452881757|FG000|Overall Study|Lost to Follow-up|2|||
125886521|NCT02202759|452881758|FG000|Overall Study|Study Terminated by Sponsor|3|||
125886522|NCT02202759|452881759|FG001|Overall Study|Study Terminated by Sponsor|3|||
126048219|NCT00943917|453473868|FG013|Stage II|Adverse Event|0|||
126048220|NCT00943917|453473869|FG014|Stage II|Adverse Event|0|||
126048221|NCT00943917|453473855|FG000|Stage II|Withdrawal by Subject|0|||
126048222|NCT00943917|453473856|FG001|Stage II|Withdrawal by Subject|0|||
126048223|NCT00943917|453473857|FG002|Stage II|Withdrawal by Subject|0|||
126048224|NCT00943917|453473858|FG003|Stage II|Withdrawal by Subject|0|||
126048225|NCT00943917|453473859|FG004|Stage II|Withdrawal by Subject|0|||
126048226|NCT00943917|453473860|FG005|Stage II|Withdrawal by Subject|1|||
126048227|NCT00943917|453473861|FG006|Stage II|Withdrawal by Subject|0|||
126048228|NCT00943917|453473862|FG007|Stage II|Withdrawal by Subject|0|||
126048229|NCT00943917|453473863|FG008|Stage II|Withdrawal by Subject|0|||
126048230|NCT00943917|453473864|FG009|Stage II|Withdrawal by Subject|0|||
126048231|NCT00943917|453473865|FG010|Stage II|Withdrawal by Subject|0|||
126048232|NCT00943917|453473866|FG011|Stage II|Withdrawal by Subject|0|||
126048233|NCT00943917|453473867|FG012|Stage II|Withdrawal by Subject|0|||
126048234|NCT00943917|453473868|FG013|Stage II|Withdrawal by Subject|0|||
126048235|NCT00943917|453473869|FG014|Stage II|Withdrawal by Subject|0|||
126048236|NCT00943917|453473855|FG000|Stage II|Pregnancy|0|||
126048237|NCT00943917|453473856|FG001|Stage II|Pregnancy|0|||
126048238|NCT00943917|453473857|FG002|Stage II|Pregnancy|0|||
125886523|NCT02202759|452881760|FG002|Overall Study|Study Terminated by Sponsor|3|||
125886524|NCT02202759|452881758|FG000|Overall Study|Withdrawal by Subject|2|||
126048239|NCT00943917|453473858|FG003|Stage II|Pregnancy|0|||
126048240|NCT00943917|453473859|FG004|Stage II|Pregnancy|0|||
126378533|NCT01791517|454683021|FG000|Phase I: Period 1|Lost to Follow-up|0|||
126378534|NCT01791517|454683022|FG001|Phase I: Period 1|Lost to Follow-up|0|||
126378535|NCT01791517|454683023|FG002|Phase I: Period 1|Lost to Follow-up|0|||
126378536|NCT01791517|454683024|FG003|Phase I: Period 1|Lost to Follow-up|1|||
126378537|NCT01791517|454683025|FG004|Phase I: Period 1|Lost to Follow-up|0|||
126378538|NCT01791517|454683026|FG005|Phase I: Period 1|Lost to Follow-up|0|||
126378539|NCT01791517|454683027|FG006|Phase I: Period 1|Lost to Follow-up|1|||
126378540|NCT01791517|454683028|FG007|Phase I: Period 1|Lost to Follow-up|0|||
126378541|NCT01791517|454683029|FG008|Phase I: Period 1|Lost to Follow-up|1|||
126378542|NCT01791517|454683030|FG009|Phase I: Period 1|Lost to Follow-up|1|||
126378543|NCT01791517|454683031|FG010|Phase I: Period 1|Lost to Follow-up|0|||
126378544|NCT01791517|454683032|FG011|Phase I: Period 1|Lost to Follow-up|0|||
126378545|NCT01791517|454683021|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378546|NCT01791517|454683022|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378547|NCT01791517|454683023|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378548|NCT01791517|454683024|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378549|NCT01791517|454683025|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378550|NCT01791517|454683026|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378551|NCT01791517|454683027|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378552|NCT01791517|454683028|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378553|NCT01791517|454683029|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378554|NCT01791517|454683030|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378555|NCT01791517|454683031|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378556|NCT01791517|454683032|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
126378557|NCT01791517|454683021|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
125886525|NCT02202759|452881759|FG001|Overall Study|Withdrawal by Subject|1|||
126048241|NCT00943917|453473860|FG005|Stage II|Pregnancy|1|||
126048242|NCT00943917|453473861|FG006|Stage II|Pregnancy|0|||
126378558|NCT01791517|454683022|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378559|NCT01791517|454683023|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378560|NCT01791517|454683024|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378561|NCT01791517|454683025|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378562|NCT01791517|454683026|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378563|NCT01791517|454683027|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378564|NCT01791517|454683028|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378565|NCT01791517|454683029|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378566|NCT01791517|454683030|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378567|NCT01791517|454683031|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378568|NCT01791517|454683032|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378569|NCT01791517|454683021|FG000|Phase I: Period 2|Protocol Violation|0|||
126378570|NCT01791517|454683022|FG001|Phase I: Period 2|Protocol Violation|0|||
126378571|NCT01791517|454683023|FG002|Phase I: Period 2|Protocol Violation|0|||
126378572|NCT01791517|454683024|FG003|Phase I: Period 2|Protocol Violation|1|||
126378573|NCT01791517|454683025|FG004|Phase I: Period 2|Protocol Violation|0|||
126378574|NCT01791517|454683026|FG005|Phase I: Period 2|Protocol Violation|0|||
126378575|NCT01791517|454683027|FG006|Phase I: Period 2|Protocol Violation|0|||
126378576|NCT01791517|454683028|FG007|Phase I: Period 2|Protocol Violation|0|||
126378577|NCT01791517|454683029|FG008|Phase I: Period 2|Protocol Violation|0|||
126378578|NCT01791517|454683030|FG009|Phase I: Period 2|Protocol Violation|0|||
126378579|NCT01791517|454683031|FG010|Phase I: Period 2|Protocol Violation|0|||
126378580|NCT01791517|454683032|FG011|Phase I: Period 2|Protocol Violation|0|||
126378581|NCT01791517|454683021|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
126378582|NCT01791517|454683022|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
126378583|NCT01791517|454683023|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
126378584|NCT01791517|454683024|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
126378585|NCT01791517|454683025|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
126378586|NCT01791517|454683026|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
126378587|NCT01791517|454683027|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
126378588|NCT01791517|454683028|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
126378589|NCT01791517|454683029|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
126378590|NCT01791517|454683030|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
126378591|NCT01791517|454683031|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
126378592|NCT01791517|454683032|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
126378593|NCT01791517|454683021|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378594|NCT01791517|454683022|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378595|NCT01791517|454683023|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378596|NCT01791517|454683024|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378597|NCT01791517|454683025|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378598|NCT01791517|454683026|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378599|NCT01791517|454683027|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378600|NCT01791517|454683028|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378601|NCT01791517|454683029|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378602|NCT01791517|454683030|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378603|NCT01791517|454683031|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
126378604|NCT01791517|454683032|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378605|NCT01791517|454683021|FG000|Phase I: Period 2|Lens Discomfort|0|||
126378606|NCT01791517|454683022|FG001|Phase I: Period 2|Lens Discomfort|0|||
126378607|NCT01791517|454683023|FG002|Phase I: Period 2|Lens Discomfort|0|||
126378608|NCT01791517|454683024|FG003|Phase I: Period 2|Lens Discomfort|0|||
126378609|NCT01791517|454683025|FG004|Phase I: Period 2|Lens Discomfort|0|||
126378610|NCT01791517|454683026|FG005|Phase I: Period 2|Lens Discomfort|1|||
126378611|NCT01791517|454683027|FG006|Phase I: Period 2|Lens Discomfort|0|||
126378612|NCT01791517|454683028|FG007|Phase I: Period 2|Lens Discomfort|0|||
126378613|NCT01791517|454683029|FG008|Phase I: Period 2|Lens Discomfort|0|||
126378614|NCT01791517|454683030|FG009|Phase I: Period 2|Lens Discomfort|0|||
126378615|NCT01791517|454683031|FG010|Phase I: Period 2|Lens Discomfort|0|||
126378616|NCT01791517|454683032|FG011|Phase I: Period 2|Lens Discomfort|0|||
126378617|NCT01791517|454683021|FG000|Phase I: Period 2|Lost to Follow-up|0|||
126378618|NCT01791517|454683022|FG001|Phase I: Period 2|Lost to Follow-up|3|||
126378619|NCT01791517|454683023|FG002|Phase I: Period 2|Lost to Follow-up|2|||
126378620|NCT01791517|454683024|FG003|Phase I: Period 2|Lost to Follow-up|0|||
126378621|NCT01791517|454683025|FG004|Phase I: Period 2|Lost to Follow-up|0|||
126378622|NCT01791517|454683026|FG005|Phase I: Period 2|Lost to Follow-up|0|||
126378623|NCT01791517|454683027|FG006|Phase I: Period 2|Lost to Follow-up|0|||
126378624|NCT01791517|454683028|FG007|Phase I: Period 2|Lost to Follow-up|0|||
126378625|NCT01791517|454683029|FG008|Phase I: Period 2|Lost to Follow-up|0|||
126378626|NCT01791517|454683030|FG009|Phase I: Period 2|Lost to Follow-up|0|||
126378627|NCT01791517|454683031|FG010|Phase I: Period 2|Lost to Follow-up|0|||
126378628|NCT01791517|454683032|FG011|Phase I: Period 2|Lost to Follow-up|0|||
126378629|NCT01791517|454683021|FG000|Phase I: Period 3|Lens Discomfort|0|||
126378630|NCT01791517|454683022|FG001|Phase I: Period 3|Lens Discomfort|0|||
126378631|NCT01791517|454683023|FG002|Phase I: Period 3|Lens Discomfort|0|||
126378632|NCT01791517|454683024|FG003|Phase I: Period 3|Lens Discomfort|0|||
126378633|NCT01791517|454683025|FG004|Phase I: Period 3|Lens Discomfort|0|||
126378634|NCT01791517|454683026|FG005|Phase I: Period 3|Lens Discomfort|0|||
126378635|NCT01791517|454683027|FG006|Phase I: Period 3|Lens Discomfort|0|||
126378636|NCT01791517|454683028|FG007|Phase I: Period 3|Lens Discomfort|0|||
126378637|NCT01791517|454683029|FG008|Phase I: Period 3|Lens Discomfort|0|||
126378638|NCT01791517|454683030|FG009|Phase I: Period 3|Lens Discomfort|0|||
126378639|NCT01791517|454683031|FG010|Phase I: Period 3|Lens Discomfort|0|||
126378640|NCT01791517|454683032|FG011|Phase I: Period 3|Lens Discomfort|1|||
126378641|NCT01791517|454683021|FG000|Phase I: Period 3|Lost to Follow-up|0|||
126378642|NCT01791517|454683022|FG001|Phase I: Period 3|Lost to Follow-up|1|||
126378643|NCT01791517|454683023|FG002|Phase I: Period 3|Lost to Follow-up|0|||
126378644|NCT01791517|454683024|FG003|Phase I: Period 3|Lost to Follow-up|0|||
126378645|NCT01791517|454683025|FG004|Phase I: Period 3|Lost to Follow-up|1|||
126378646|NCT01791517|454683026|FG005|Phase I: Period 3|Lost to Follow-up|0|||
126378647|NCT01791517|454683027|FG006|Phase I: Period 3|Lost to Follow-up|0|||
126378648|NCT01791517|454683028|FG007|Phase I: Period 3|Lost to Follow-up|0|||
126378649|NCT01791517|454683029|FG008|Phase I: Period 3|Lost to Follow-up|0|||
126378650|NCT01791517|454683030|FG009|Phase I: Period 3|Lost to Follow-up|0|||
126378651|NCT01791517|454683031|FG010|Phase I: Period 3|Lost to Follow-up|0|||
126378652|NCT01791517|454683032|FG011|Phase I: Period 3|Lost to Follow-up|0|||
126378653|NCT01791517|454683021|FG000|Phase I: Period 3|Adverse Event|0|||
126378654|NCT01791517|454683022|FG001|Phase I: Period 3|Adverse Event|0|||
126378655|NCT01791517|454683023|FG002|Phase I: Period 3|Adverse Event|0|||
126378656|NCT01791517|454683024|FG003|Phase I: Period 3|Adverse Event|1|||
126378657|NCT01791517|454683025|FG004|Phase I: Period 3|Adverse Event|0|||
126378658|NCT01791517|454683026|FG005|Phase I: Period 3|Adverse Event|0|||
126378659|NCT01791517|454683027|FG006|Phase I: Period 3|Adverse Event|0|||
126378660|NCT01791517|454683028|FG007|Phase I: Period 3|Adverse Event|0|||
126378661|NCT01791517|454683029|FG008|Phase I: Period 3|Adverse Event|0|||
126378662|NCT01791517|454683030|FG009|Phase I: Period 3|Adverse Event|0|||
126378663|NCT01791517|454683031|FG010|Phase I: Period 3|Adverse Event|0|||
126378664|NCT01791517|454683032|FG011|Phase I: Period 3|Adverse Event|0|||
126378665|NCT01791517|454683021|FG000|Phase II|Lost to Follow-up|1|||
126378666|NCT01791517|454683022|FG001|Phase II|Lost to Follow-up|0|||
126378667|NCT01791517|454683023|FG002|Phase II|Lost to Follow-up|1|||
126378668|NCT01791517|454683024|FG003|Phase II|Lost to Follow-up|0|||
126378669|NCT01791517|454683025|FG004|Phase II|Lost to Follow-up|1|||
126378670|NCT01791517|454683026|FG005|Phase II|Lost to Follow-up|2|||
126378671|NCT01791517|454683027|FG006|Phase II|Lost to Follow-up|0|||
126378672|NCT01791517|454683028|FG007|Phase II|Lost to Follow-up|1|||
126378673|NCT01791517|454683029|FG008|Phase II|Lost to Follow-up|1|||
126378674|NCT01791517|454683030|FG009|Phase II|Lost to Follow-up|1|||
126378675|NCT01791517|454683031|FG010|Phase II|Lost to Follow-up|0|||
126378676|NCT01791517|454683032|FG011|Phase II|Lost to Follow-up|0|||
126378677|NCT01791517|454683021|FG000|Phase II|Withdrawal by Subject|1|||
126378678|NCT01791517|454683022|FG001|Phase II|Withdrawal by Subject|0|||
126378679|NCT01791517|454683023|FG002|Phase II|Withdrawal by Subject|0|||
126378680|NCT01791517|454683024|FG003|Phase II|Withdrawal by Subject|0|||
126378681|NCT01791517|454683025|FG004|Phase II|Withdrawal by Subject|0|||
126378682|NCT01791517|454683026|FG005|Phase II|Withdrawal by Subject|2|||
126378683|NCT01791517|454683027|FG006|Phase II|Withdrawal by Subject|0|||
126378684|NCT01791517|454683028|FG007|Phase II|Withdrawal by Subject|1|||
126378685|NCT01791517|454683029|FG008|Phase II|Withdrawal by Subject|0|||
126378686|NCT01791517|454683030|FG009|Phase II|Withdrawal by Subject|0|||
126378687|NCT01791517|454683031|FG010|Phase II|Withdrawal by Subject|1|||
126378688|NCT01791517|454683032|FG011|Phase II|Withdrawal by Subject|0|||
126378689|NCT01791517|454683021|FG000|Phase II|Lack of Efficacy|0|||
126378690|NCT01791517|454683022|FG001|Phase II|Lack of Efficacy|0|||
126378691|NCT01791517|454683023|FG002|Phase II|Lack of Efficacy|0|||
126378692|NCT01791517|454683024|FG003|Phase II|Lack of Efficacy|0|||
126378693|NCT01791517|454683025|FG004|Phase II|Lack of Efficacy|1|||
126378694|NCT01791517|454683026|FG005|Phase II|Lack of Efficacy|0|||
126378695|NCT01791517|454683027|FG006|Phase II|Lack of Efficacy|0|||
126378696|NCT01791517|454683028|FG007|Phase II|Lack of Efficacy|0|||
126378697|NCT01791517|454683029|FG008|Phase II|Lack of Efficacy|0|||
126378698|NCT01791517|454683030|FG009|Phase II|Lack of Efficacy|0|||
126378699|NCT01791517|454683031|FG010|Phase II|Lack of Efficacy|0|||
126378700|NCT01791517|454683032|FG011|Phase II|Lack of Efficacy|0|||
126378701|NCT01791517|454683021|FG000|Phase II|Adverse Event|0|||
126378702|NCT01791517|454683022|FG001|Phase II|Adverse Event|0|||
126378703|NCT01791517|454683023|FG002|Phase II|Adverse Event|0|||
126378704|NCT01791517|454683024|FG003|Phase II|Adverse Event|0|||
126378705|NCT01791517|454683025|FG004|Phase II|Adverse Event|0|||
126378706|NCT01791517|454683026|FG005|Phase II|Adverse Event|0|||
126378707|NCT01791517|454683027|FG006|Phase II|Adverse Event|2|||
126378708|NCT01791517|454683028|FG007|Phase II|Adverse Event|1|||
126378709|NCT01791517|454683029|FG008|Phase II|Adverse Event|0|||
126378710|NCT01791517|454683030|FG009|Phase II|Adverse Event|1|||
126378711|NCT01791517|454683031|FG010|Phase II|Adverse Event|0|||
126378712|NCT01791517|454683032|FG011|Phase II|Adverse Event|0|||
126378713|NCT01791517|454683021|FG000|Phase II|Lens Handling Difficulties|0|||
126378714|NCT01791517|454683022|FG001|Phase II|Lens Handling Difficulties|0|||
126378715|NCT01791517|454683023|FG002|Phase II|Lens Handling Difficulties|0|||
126378716|NCT01791517|454683024|FG003|Phase II|Lens Handling Difficulties|0|||
126378717|NCT01791517|454683025|FG004|Phase II|Lens Handling Difficulties|0|||
126378718|NCT01791517|454683026|FG005|Phase II|Lens Handling Difficulties|0|||
126378719|NCT01791517|454683027|FG006|Phase II|Lens Handling Difficulties|0|||
126378720|NCT01791517|454683028|FG007|Phase II|Lens Handling Difficulties|0|||
126378721|NCT01791517|454683029|FG008|Phase II|Lens Handling Difficulties|1|||
126378722|NCT01791517|454683030|FG009|Phase II|Lens Handling Difficulties|0|||
126378723|NCT01791517|454683031|FG010|Phase II|Lens Handling Difficulties|0|||
126378724|NCT01791517|454683032|FG011|Phase II|Lens Handling Difficulties|0|||
126378725|NCT01791517|454683021|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
126378726|NCT01791517|454683022|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
126378727|NCT01791517|454683023|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
126378728|NCT01791517|454683024|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
126378729|NCT01791517|454683025|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
126378730|NCT01791517|454683026|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
126378731|NCT01791517|454683027|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
126378732|NCT01791517|454683028|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
126378733|NCT01791517|454683029|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
126378734|NCT01791517|454683030|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
126048243|NCT00943917|453473862|FG007|Stage II|Pregnancy|0|||
126378735|NCT01791517|454683031|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
126378736|NCT01791517|454683032|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
126378737|NCT01791517|454683021|FG000|Phase II|Pre-Existing Ocular Issue|0|||
126378738|NCT01791517|454683022|FG001|Phase II|Pre-Existing Ocular Issue|0|||
126378739|NCT01791517|454683023|FG002|Phase II|Pre-Existing Ocular Issue|0|||
126378740|NCT01791517|454683024|FG003|Phase II|Pre-Existing Ocular Issue|0|||
126378741|NCT01791517|454683025|FG004|Phase II|Pre-Existing Ocular Issue|0|||
126378742|NCT01791517|454683026|FG005|Phase II|Pre-Existing Ocular Issue|0|||
126378743|NCT01791517|454683027|FG006|Phase II|Pre-Existing Ocular Issue|0|||
126378744|NCT01791517|454683028|FG007|Phase II|Pre-Existing Ocular Issue|0|||
126378745|NCT01791517|454683029|FG008|Phase II|Pre-Existing Ocular Issue|0|||
126378746|NCT01791517|454683030|FG009|Phase II|Pre-Existing Ocular Issue|0|||
126378747|NCT01791517|454683031|FG010|Phase II|Pre-Existing Ocular Issue|0|||
126378748|NCT01791517|454683032|FG011|Phase II|Pre-Existing Ocular Issue|1|||
126378749|NCT04011735|454683033|FG000|Overall Study|Withdrawal by Subject|1|||
126378750|NCT04011735|454683034|FG001|Overall Study|Withdrawal by Subject|0|||
125886526|NCT02202759|452881760|FG002|Overall Study|Withdrawal by Subject|1|||
126378751|NCT04011735|454683035|FG002|Overall Study|Withdrawal by Subject|1|||
126378752|NCT04011735|454683033|FG000|Overall Study|Met exclusion criteria after study entry|0|||
126378753|NCT04011735|454683034|FG001|Overall Study|Met exclusion criteria after study entry|1|||
126378754|NCT04011735|454683035|FG002|Overall Study|Met exclusion criteria after study entry|0|||
126378755|NCT02298868|454683036|FG000|Overall Study|Adverse Event|1|||
126378756|NCT02298868|454683036|FG000|Overall Study|Death|1|||
126378757|NCT02298868|454683036|FG000|Overall Study|Patient underwent transplant|1|||
126378758|NCT01000506|454683037|FG000|Overall Study|Adverse Event|6|||
126378759|NCT01000506|454683038|FG001|Overall Study|Adverse Event|5|||
126378760|NCT01000506|454683039|FG002|Overall Study|Adverse Event|8|||
126378761|NCT01000506|454683040|FG003|Overall Study|Adverse Event|9|||
126378762|NCT01000506|454683037|FG000|Overall Study|Lack of Efficacy|8|||
126378763|NCT01000506|454683038|FG001|Overall Study|Lack of Efficacy|6|||
126378764|NCT01000506|454683039|FG002|Overall Study|Lack of Efficacy|4|||
126378765|NCT01000506|454683040|FG003|Overall Study|Lack of Efficacy|4|||
126378766|NCT01000506|454683037|FG000|Overall Study|Protocol Violation|1|||
126378767|NCT01000506|454683038|FG001|Overall Study|Protocol Violation|1|||
126378768|NCT01000506|454683039|FG002|Overall Study|Protocol Violation|0|||
126378769|NCT01000506|454683040|FG003|Overall Study|Protocol Violation|0|||
126378770|NCT01000506|454683037|FG000|Overall Study|Lost to Follow-up|1|||
126378771|NCT01000506|454683038|FG001|Overall Study|Lost to Follow-up|1|||
126378772|NCT01000506|454683039|FG002|Overall Study|Lost to Follow-up|4|||
126378773|NCT01000506|454683040|FG003|Overall Study|Lost to Follow-up|0|||
126378774|NCT01000506|454683037|FG000|Overall Study|Physician Decision|1|||
126378775|NCT01000506|454683038|FG001|Overall Study|Physician Decision|3|||
126378776|NCT01000506|454683039|FG002|Overall Study|Physician Decision|3|||
126378777|NCT01000506|454683040|FG003|Overall Study|Physician Decision|3|||
126378778|NCT01000506|454683037|FG000|Overall Study|Withdrawal by Subject|11|||
126378779|NCT01000506|454683038|FG001|Overall Study|Withdrawal by Subject|8|||
126378780|NCT01000506|454683039|FG002|Overall Study|Withdrawal by Subject|2|||
126378781|NCT01000506|454683040|FG003|Overall Study|Withdrawal by Subject|7|||
126378782|NCT00739310|454683041|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
126378783|NCT00739310|454683041|FG000|Overall Study|Withdrawal by Subject|1|||
126378784|NCT00739310|454683041|FG000|Overall Study|Lost to Follow-up|2|||
126378785|NCT01071954|454683042|FG000|Overall Study|Noncompliance|4|||
126378786|NCT01071954|454683042|FG000|Overall Study|Adverse Event|1|||
126378787|NCT01071954|454683042|FG000|Overall Study|Withdrawal by Subject|11|||
126378788|NCT01071954|454683042|FG000|Overall Study|Requirement for Alternative Therapy|5|||
126378789|NCT01071954|454683042|FG000|Overall Study|Administrative Decision|5|||
126378790|NCT01071954|454683042|FG000|Overall Study|Protocol Specified Criteria|1|||
126378791|NCT00590967|454683043|FG000|Overall Study|Withdrawal by Subject|1|||
126378792|NCT00590967|454683044|FG001|Overall Study|Withdrawal by Subject|1|||
126378793|NCT00590967|454683043|FG000|Overall Study|Ineligible|1|||
126378794|NCT00590967|454683044|FG001|Overall Study|Ineligible|0|||
126378795|NCT00590967|454683043|FG000|Overall Study|Poor performance status|0|||
126378796|NCT00590967|454683044|FG001|Overall Study|Poor performance status|1|||
126378797|NCT00590967|454683043|FG000|Overall Study|Non-compliant|0|||
126378798|NCT00590967|454683044|FG001|Overall Study|Non-compliant|2|||
126378799|NCT00590967|454683043|FG000|Overall Study|Did not sign consent form|0|||
126378800|NCT00590967|454683044|FG001|Overall Study|Did not sign consent form|1|||
126378801|NCT00590967|454683043|FG000|Overall Study|Did not receive chemo per protocol|1|||
126378802|NCT00590967|454683044|FG001|Overall Study|Did not receive chemo per protocol|0|||
126378803|NCT01847755|454683045|FG000|Overall Study|Adverse Event|2|||
126378804|NCT01847755|454683045|FG000|Overall Study|Withdrawal by Subject|2|||
126378805|NCT01847755|454683045|FG000|Overall Study|Physician Decision|1|||
126378806|NCT00920556|454683046|FG000|Overall Study|Adverse Event|16|||
125886527|NCT02202759|452881758|FG000|Overall Study|Reason not Specified|4|||
126378807|NCT00920556|454683046|FG000|Overall Study|Physician Decision|7|||
126378808|NCT00920556|454683046|FG000|Overall Study|Withdrawal by Subject|1|||
126378809|NCT04245709|454683047|FG000|Overall Study|Adverse Event|13|||
126378810|NCT04245709|454683047|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
126378811|NCT02185534|454683049|FG000|First Period|Withdrawal by Subject|0|||
126378812|NCT02185534|454683050|FG001|First Period|Withdrawal by Subject|0|||
126378813|NCT02185534|454683051|FG002|First Period|Withdrawal by Subject|0|||
126378814|NCT02185534|454683052|FG003|First Period|Withdrawal by Subject|1|||
126378815|NCT02185534|454683053|FG004|First Period|Withdrawal by Subject|0|||
126378816|NCT02185534|454683054|FG005|First Period|Withdrawal by Subject|0|||
126378817|NCT02185534|454683049|FG000|First Washout Period|Withdrawal by Subject|1|||
126378818|NCT02185534|454683050|FG001|First Washout Period|Withdrawal by Subject|0|||
126378819|NCT02185534|454683051|FG002|First Washout Period|Withdrawal by Subject|0|||
126378820|NCT02185534|454683052|FG003|First Washout Period|Withdrawal by Subject|0|||
126378821|NCT02185534|454683053|FG004|First Washout Period|Withdrawal by Subject|1|||
126378822|NCT02185534|454683054|FG005|First Washout Period|Withdrawal by Subject|0|||
126378823|NCT02185534|454683049|FG000|First Washout Period|Protocol Violation|0|||
126378824|NCT02185534|454683050|FG001|First Washout Period|Protocol Violation|0|||
126378825|NCT02185534|454683051|FG002|First Washout Period|Protocol Violation|0|||
126378826|NCT02185534|454683052|FG003|First Washout Period|Protocol Violation|0|||
126378827|NCT02185534|454683053|FG004|First Washout Period|Protocol Violation|0|||
126378828|NCT02185534|454683054|FG005|First Washout Period|Protocol Violation|1|||
126378829|NCT02041299|454683055|FG000|Overall Study|Adverse Event|9|||
126378830|NCT02041299|454683056|FG001|Overall Study|Adverse Event|3|||
126378831|NCT02041299|454683055|FG000|Overall Study|Lost to Follow-up|4|||
126378832|NCT02041299|454683056|FG001|Overall Study|Lost to Follow-up|1|||
126378833|NCT02041299|454683055|FG000|Overall Study|Physician Decision|1|||
126378834|NCT02041299|454683056|FG001|Overall Study|Physician Decision|1|||
126378835|NCT02041299|454683055|FG000|Overall Study|Withdrawal by Subject|13|||
126378836|NCT02041299|454683056|FG001|Overall Study|Withdrawal by Subject|7|||
126378837|NCT02041299|454683055|FG000|Overall Study|Protocol Violation|11|||
126378838|NCT02041299|454683056|FG001|Overall Study|Protocol Violation|4|||
126378839|NCT02041299|454683055|FG000|Overall Study|Termination of the study|7|||
126378840|NCT02041299|454683056|FG001|Overall Study|Termination of the study|3|||
126378841|NCT02041299|454683055|FG000|Overall Study|Required bone marrow transplant|0|||
126378842|NCT02041299|454683056|FG001|Overall Study|Required bone marrow transplant|1|||
126378843|NCT02041299|454683055|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
126378844|NCT02041299|454683056|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
126378845|NCT02389465|454683057|FG000|Overall Study|Lost to Follow-up|1|||
126378846|NCT02389465|454683058|FG001|Overall Study|Lost to Follow-up|3|||
126378847|NCT02389465|454683059|FG002|Overall Study|Lost to Follow-up|3|||
126378848|NCT02389465|454683060|FG003|Overall Study|Lost to Follow-up|0|||
126378849|NCT02389465|454683057|FG000|Overall Study|Physician Decision|0|||
126378850|NCT02389465|454683058|FG001|Overall Study|Physician Decision|0|||
126378851|NCT02389465|454683059|FG002|Overall Study|Physician Decision|0|||
126378852|NCT02389465|454683060|FG003|Overall Study|Physician Decision|1|||
126378853|NCT02389465|454683057|FG000|Overall Study|Withdrawal by Subject|0|||
126378854|NCT02389465|454683058|FG001|Overall Study|Withdrawal by Subject|1|||
126378855|NCT02389465|454683059|FG002|Overall Study|Withdrawal by Subject|2|||
126378856|NCT02389465|454683060|FG003|Overall Study|Withdrawal by Subject|2|||
126378857|NCT04179305|454683064|FG000|Overall Study|Death|1|||
126378858|NCT04179305|454683065|FG001|Overall Study|Death|1|||
126378859|NCT04179305|454683066|FG002|Overall Study|Death|0|||
126378860|NCT04179305|454683067|FG003|Overall Study|Death|0|||
126378861|NCT04179305|454683064|FG000|Overall Study|Lost to Follow-up|1|||
126378862|NCT04179305|454683065|FG001|Overall Study|Lost to Follow-up|1|||
126378863|NCT04179305|454683066|FG002|Overall Study|Lost to Follow-up|0|||
126378864|NCT04179305|454683067|FG003|Overall Study|Lost to Follow-up|0|||
126378865|NCT04179305|454683064|FG000|Overall Study|Withdrawal by Subject|0|||
126378866|NCT04179305|454683065|FG001|Overall Study|Withdrawal by Subject|1|||
126048244|NCT00943917|453473863|FG008|Stage II|Pregnancy|0|||
126378867|NCT04179305|454683066|FG002|Overall Study|Withdrawal by Subject|0|||
126048245|NCT00943917|453473864|FG009|Stage II|Pregnancy|0|||
126048246|NCT00943917|453473865|FG010|Stage II|Pregnancy|0|||
126378868|NCT04179305|454683067|FG003|Overall Study|Withdrawal by Subject|0|||
126378869|NCT04179305|454683064|FG000|Overall Study|Did not have scan|1|||
126378870|NCT04179305|454683065|FG001|Overall Study|Did not have scan|0|||
126048247|NCT00943917|453473866|FG011|Stage II|Pregnancy|0|||
126048248|NCT00943917|453473867|FG012|Stage II|Pregnancy|0|||
126378871|NCT04179305|454683066|FG002|Overall Study|Did not have scan|0|||
126378872|NCT04179305|454683067|FG003|Overall Study|Did not have scan|0|||
126378873|NCT04179305|454683064|FG000|Overall Study|In hospice care|3|||
126378874|NCT04179305|454683065|FG001|Overall Study|In hospice care|0|||
126378875|NCT04179305|454683066|FG002|Overall Study|In hospice care|0|||
126378876|NCT04179305|454683067|FG003|Overall Study|In hospice care|0|||
126378877|NCT00503425|454683070|FG000|Overall Study|Participant files lost|6|||
126378878|NCT00503425|454683070|FG000|Overall Study|Adverse Event|5|||
126378879|NCT00503425|454683070|FG000|Overall Study|Lack of Efficacy|25|||
126378880|NCT00503425|454683070|FG000|Overall Study|Withdrawal by Subject|8|||
126378881|NCT00503425|454683070|FG000|Overall Study|Lost to Follow-up|3|||
126378882|NCT00503425|454683070|FG000|Overall Study|Death|3|||
126378883|NCT00503425|454683070|FG000|Overall Study|Missing Data/Unknown|4|||
126048249|NCT00943917|453473868|FG013|Stage II|Pregnancy|0|||
126378884|NCT00326599|454683071|FG000|Overall Study|Withdrawal by Subject|1|||
126378885|NCT00326599|454683072|FG001|Overall Study|Withdrawal by Subject|0|||
126378886|NCT00326599|454683073|FG002|Overall Study|Withdrawal by Subject|5|||
126378887|NCT00326599|454683074|FG003|Overall Study|Withdrawal by Subject|2|||
126378888|NCT00326599|454683071|FG000|Overall Study|Adverse Event|1|||
126378889|NCT00326599|454683072|FG001|Overall Study|Adverse Event|0|||
126378890|NCT00326599|454683073|FG002|Overall Study|Adverse Event|32|||
126378891|NCT00326599|454683074|FG003|Overall Study|Adverse Event|3|||
126378892|NCT00326599|454683071|FG000|Overall Study|Disease Progression|3|||
126378893|NCT00326599|454683072|FG001|Overall Study|Disease Progression|1|||
126378894|NCT00326599|454683073|FG002|Overall Study|Disease Progression|13|||
126378895|NCT00326599|454683074|FG003|Overall Study|Disease Progression|11|||
126378896|NCT00326599|454683071|FG000|Overall Study|Alternate Treatment|1|||
126378897|NCT00326599|454683072|FG001|Overall Study|Alternate Treatment|0|||
126378898|NCT00326599|454683073|FG002|Overall Study|Alternate Treatment|0|||
126378899|NCT00326599|454683074|FG003|Overall Study|Alternate Treatment|0|||
126378900|NCT00326599|454683071|FG000|Overall Study|Death|0|||
126378901|NCT00326599|454683072|FG001|Overall Study|Death|0|||
126378902|NCT00326599|454683073|FG002|Overall Study|Death|1|||
126378903|NCT00326599|454683074|FG003|Overall Study|Death|2|||
126378904|NCT00326599|454683071|FG000|Overall Study|Other Unspecified Reason|0|||
126378905|NCT00326599|454683072|FG001|Overall Study|Other Unspecified Reason|0|||
126378906|NCT00326599|454683073|FG002|Overall Study|Other Unspecified Reason|2|||
126378907|NCT00326599|454683074|FG003|Overall Study|Other Unspecified Reason|1|||
126378908|NCT00437268|454683075|FG000|Overall Study|Adverse Event|1|||
126378909|NCT00437268|454683076|FG001|Overall Study|Adverse Event|1|||
126378910|NCT00437268|454683075|FG000|Overall Study|Withdrawal by Subject|2|||
126378911|NCT00437268|454683076|FG001|Overall Study|Withdrawal by Subject|2|||
126378912|NCT00437268|454683075|FG000|Overall Study|Progressive disease|9|||
126378913|NCT00437268|454683076|FG001|Overall Study|Progressive disease|9|||
126378914|NCT00437268|454683075|FG000|Overall Study|Physician Decision|1|||
126378915|NCT00437268|454683076|FG001|Overall Study|Physician Decision|0|||
126378916|NCT00437268|454683075|FG000|Overall Study|Death|0|||
126378917|NCT00437268|454683076|FG001|Overall Study|Death|1|||
126378918|NCT00444925|454683077|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
126378919|NCT00444925|454683078|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
126378920|NCT00444925|454683079|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
126378921|NCT00444925|454683077|FG000|Double-blind Treatment Period|Death|2|||
126378922|NCT00444925|454683078|FG001|Double-blind Treatment Period|Death|0|||
126378923|NCT00444925|454683079|FG002|Double-blind Treatment Period|Death|0|||
126378924|NCT00444925|454683077|FG000|Double-blind Treatment Period|Adverse Event|6|||
126378925|NCT00444925|454683078|FG001|Double-blind Treatment Period|Adverse Event|28|||
126378926|NCT00444925|454683079|FG002|Double-blind Treatment Period|Adverse Event|44|||
126378927|NCT00444925|454683077|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
126378928|NCT00444925|454683078|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
126378929|NCT00444925|454683079|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
126378930|NCT00444925|454683077|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
126378931|NCT00444925|454683078|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
126378932|NCT00444925|454683079|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
126378933|NCT00444925|454683077|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
126378934|NCT00444925|454683078|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
126378935|NCT00444925|454683079|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
126378936|NCT00444925|454683077|FG000|Double-blind Treatment Period|Other|7|||
126378937|NCT00444925|454683078|FG001|Double-blind Treatment Period|Other|7|||
126378938|NCT00444925|454683079|FG002|Double-blind Treatment Period|Other|12|||
126378939|NCT03484429|454683083|FG000|Overall Study|Withdrawal by Subject|1|||
126378940|NCT03484429|454683084|FG001|Overall Study|Withdrawal by Subject|0|||
126378941|NCT03484429|454683083|FG000|Overall Study|Adverse Event|2|||
126378942|NCT03484429|454683084|FG001|Overall Study|Adverse Event|0|||
126378943|NCT00943761|454683085|FG000|Overall Study|Lost to Follow-up|2|||
126378944|NCT00943761|454683086|FG001|Overall Study|Lost to Follow-up|0|||
126378945|NCT00943761|454683085|FG000|Overall Study|Withdrawal by Subject|2|||
126378946|NCT00943761|454683086|FG001|Overall Study|Withdrawal by Subject|1|||
126378947|NCT00714948|454683087|FG000|Overall Study|Adverse Event|2|||
126378948|NCT01342926|454683090|FG000|Overall Study|Adverse Event|5|||
125886528|NCT02202759|452881759|FG001|Overall Study|Reason not Specified|11|||
126048250|NCT00943917|453473869|FG014|Stage II|Pregnancy|0|||
126378949|NCT01342926|454683091|FG001|Overall Study|Adverse Event|8|||
126378950|NCT01342926|454683092|FG002|Overall Study|Adverse Event|10|||
126378951|NCT01342926|454683093|FG003|Overall Study|Adverse Event|7|||
126378952|NCT01342926|454683090|FG000|Overall Study|Lost to Follow-up|0|||
126378953|NCT01342926|454683091|FG001|Overall Study|Lost to Follow-up|1|||
126378954|NCT01342926|454683092|FG002|Overall Study|Lost to Follow-up|1|||
126378955|NCT01342926|454683093|FG003|Overall Study|Lost to Follow-up|0|||
126378956|NCT01342926|454683090|FG000|Overall Study|Investigator Discretion|2|||
126378957|NCT01342926|454683091|FG001|Overall Study|Investigator Discretion|2|||
126378958|NCT01342926|454683092|FG002|Overall Study|Investigator Discretion|0|||
126378959|NCT01342926|454683093|FG003|Overall Study|Investigator Discretion|0|||
126378960|NCT01342926|454683090|FG000|Overall Study|Withdrawal by Subject|2|||
126378961|NCT01342926|454683091|FG001|Overall Study|Withdrawal by Subject|4|||
126378962|NCT01342926|454683092|FG002|Overall Study|Withdrawal by Subject|3|||
126378963|NCT01342926|454683093|FG003|Overall Study|Withdrawal by Subject|5|||
126378964|NCT03382912|454683094|FG000|Overall Study|Physician Decision|0|||
126378965|NCT03382912|454683095|FG001|Overall Study|Physician Decision|1|||
126378966|NCT03382912|454683094|FG000|Overall Study|Sponsor Decision|6|||
126378967|NCT03382912|454683095|FG001|Overall Study|Sponsor Decision|6|||
126378968|NCT03382912|454683094|FG000|Overall Study|Withdrawal by Subject|0|||
126378969|NCT03382912|454683095|FG001|Overall Study|Withdrawal by Subject|5|||
126378970|NCT05588440|454683096|FG000|Overall Study|Sponsor Decision|2|||
126378971|NCT05588440|454683097|FG001|Overall Study|Sponsor Decision|0|||
126378972|NCT05588440|454683098|FG002|Overall Study|Sponsor Decision|1|||
126378973|NCT05588440|454683096|FG000|Overall Study|Death|1|||
126378974|NCT05588440|454683097|FG001|Overall Study|Death|1|||
126378975|NCT05588440|454683098|FG002|Overall Study|Death|1|||
126378976|NCT05588440|454683096|FG000|Overall Study|Screen Fail|0|||
126378977|NCT05588440|454683097|FG001|Overall Study|Screen Fail|1|||
126378978|NCT05588440|454683098|FG002|Overall Study|Screen Fail|1|||
126378979|NCT05588440|454683096|FG000|Overall Study|Withdrawal by Subject|0|||
126378980|NCT05588440|454683097|FG001|Overall Study|Withdrawal by Subject|0|||
126378981|NCT05588440|454683098|FG002|Overall Study|Withdrawal by Subject|1|||
126378982|NCT05653700|454683099|FG000|Overall Study|Non Responders|9|||
126378983|NCT05653700|454683100|FG001|Overall Study|Non Responders|0|||
126378984|NCT02573948|454683103|FG000|Longitudinal Cohort|Death|9|||
126378985|NCT02573948|454683103|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
126378986|NCT02573948|454683103|FG000|Longitudinal Cohort|Incarcerated|25|||
126378987|NCT00707993|454683104|FG000|Overall Study|Adverse Event|16|||
126378988|NCT00707993|454683105|FG001|Overall Study|Adverse Event|20|||
126378989|NCT00707993|454683104|FG000|Overall Study|Protocol Violation|4|||
126378990|NCT00707993|454683105|FG001|Overall Study|Protocol Violation|7|||
126378991|NCT00707993|454683104|FG000|Overall Study|Lost to Follow-up|0|||
126378992|NCT00707993|454683105|FG001|Overall Study|Lost to Follow-up|4|||
126378993|NCT00707993|454683104|FG000|Overall Study|Withdrawal by Subject|12|||
126378994|NCT00707993|454683105|FG001|Overall Study|Withdrawal by Subject|16|||
126378995|NCT00707993|454683104|FG000|Overall Study|Hyperglycemic Rescue|55|||
126378996|NCT00707993|454683105|FG001|Overall Study|Hyperglycemic Rescue|47|||
126378997|NCT00707993|454683104|FG000|Overall Study|Other|2|||
126378998|NCT00707993|454683105|FG001|Overall Study|Other|0|||
126378999|NCT05414175|454683110|FG000|Overall Study|Withdrawal by Subject|1|||
126379000|NCT05414175|454683110|FG000|Overall Study|Other Reasons|1|||
126379001|NCT00532129|454684949|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
126379002|NCT00532129|454684949|FG000|Treatment Period|Physician Decision|15|||
126379003|NCT00532129|454684949|FG000|Treatment Period|Disease progression|3|||
126379004|NCT00532129|454684949|FG000|Treatment Period|Protocol Violation|1|||
126379005|NCT00532129|454684949|FG000|Treatment Period|Other|5|||
126379006|NCT00532129|454684949|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
126379007|NCT00532129|454684949|FG000|Follow-up Period|Disease progression|57|||
126379008|NCT00532129|454684949|FG000|Follow-up Period|Lost to Follow-up|1|||
126379009|NCT00532129|454684949|FG000|Follow-up Period|Other|6|||
126379010|NCT02237001|454684950|FG000|Overall Study|Lost to Follow-up|2|||
126379011|NCT02237001|454684950|FG000|Overall Study|Withdrawal by Subject|1|||
126379012|NCT02237001|454684950|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
126379013|NCT02237001|454684950|FG000|Overall Study|Re-operation|4|||
126379014|NCT02237001|454684950|FG000|Overall Study|Incarceration|1|||
126379015|NCT00342628|454684951|FG000|Overall Study|Withdrawal by Subject|19|||
126379016|NCT00342628|454684952|FG001|Overall Study|Withdrawal by Subject|19|||
126379017|NCT00342628|454684953|FG002|Overall Study|Withdrawal by Subject|18|||
126379018|NCT00342628|454684951|FG000|Overall Study|Death|1|||
126379019|NCT00342628|454684952|FG001|Overall Study|Death|1|||
126379020|NCT00342628|454684953|FG002|Overall Study|Death|0|||
126379021|NCT00342628|454684951|FG000|Overall Study|moved residence|0|||
126379022|NCT00342628|454684952|FG001|Overall Study|moved residence|1|||
126379023|NCT00342628|454684953|FG002|Overall Study|moved residence|1|||
126379024|NCT03427814|454684954|FG000|Overall Study|Withdrawal by Subject|4|||
126379025|NCT03427814|454684955|FG001|Overall Study|Withdrawal by Subject|4|||
126379026|NCT03427814|454684954|FG000|Overall Study|Lost to Follow-up|0|||
126379027|NCT03427814|454684955|FG001|Overall Study|Lost to Follow-up|2|||
126379028|NCT03427814|454684954|FG000|Overall Study|Death|42|||
126379029|NCT03427814|454684955|FG001|Overall Study|Death|31|||
126379030|NCT03427814|454684954|FG000|Overall Study|Sponsor's Decision|1|||
126379031|NCT03427814|454684955|FG001|Overall Study|Sponsor's Decision|0|||
126379032|NCT03427814|454684954|FG000|Overall Study|Investigator's Decision|1|||
126379033|NCT03427814|454684955|FG001|Overall Study|Investigator's Decision|2|||
126379034|NCT03427814|454684954|FG000|Overall Study|Disease progression|1|||
126379035|NCT03427814|454684955|FG001|Overall Study|Disease progression|0|||
126379036|NCT03427814|454684954|FG000|Overall Study|Treatment Completed|0|||
126379037|NCT03427814|454684955|FG001|Overall Study|Treatment Completed|1|||
126379038|NCT03427814|454684954|FG000|Overall Study|Sponsor's Decision to End study|21|||
126379039|NCT03427814|454684955|FG001|Overall Study|Sponsor's Decision to End study|25|||
126379040|NCT03427814|454684954|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
126379041|NCT03427814|454684955|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
126379042|NCT03145064|454684956|FG000|Overall Study|Death|24|||
126379043|NCT03145064|454684956|FG000|Overall Study|Lost to Follow-up|3|||
126379044|NCT03145064|454684956|FG000|Overall Study|Withdrawal by Subject|6|||
126379045|NCT03145064|454684956|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
126379046|NCT03145064|454684956|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
126379047|NCT03846427|454684957|FG000|Overall Study|Death|13|||
126379048|NCT03846427|454684957|FG000|Overall Study|Withdrawal by Subject|3|||
126379049|NCT03846427|454684957|FG000|Overall Study|Physician Decision|1|||
126379050|NCT01693250|454684958|FG000|Overall Study|Lost to Follow-up|2|||
126379051|NCT01693250|454684959|FG001|Overall Study|Lost to Follow-up|2|||
126379052|NCT00628446|454684960|FG000|Overall Study|Lost to Follow-up|3|||
126379053|NCT00628446|454684960|FG000|Overall Study|Withdrawal by Subject|1|||
126379054|NCT00628446|454684960|FG000|Overall Study|Protocol Violation|3|||
126379055|NCT01396187|454684961|FG000|Overall Study|Adverse Event|0|||
126379056|NCT01396187|454684962|FG001|Overall Study|Adverse Event|1|||
126379057|NCT01396187|454684963|FG002|Overall Study|Adverse Event|0|||
126379058|NCT01396187|454684964|FG003|Overall Study|Adverse Event|0|||
126379059|NCT01396187|454684965|FG004|Overall Study|Adverse Event|0|||
126379060|NCT01396187|454684961|FG000|Overall Study|Withdrawal by Subject|0|||
126379061|NCT01396187|454684962|FG001|Overall Study|Withdrawal by Subject|1|||
126379062|NCT01396187|454684963|FG002|Overall Study|Withdrawal by Subject|1|||
126379063|NCT01396187|454684964|FG003|Overall Study|Withdrawal by Subject|0|||
126379064|NCT01396187|454684965|FG004|Overall Study|Withdrawal by Subject|0|||
126379065|NCT01396187|454684961|FG000|Overall Study|Other|1|||
126379066|NCT01396187|454684962|FG001|Overall Study|Other|1|||
126379067|NCT01396187|454684963|FG002|Overall Study|Other|0|||
126379068|NCT01396187|454684964|FG003|Overall Study|Other|0|||
126379069|NCT01396187|454684965|FG004|Overall Study|Other|1|||
126379070|NCT04971967|454684969|FG000|Overall Study|Lost to Follow-up|6|||
126379071|NCT04971967|454684970|FG001|Overall Study|Lost to Follow-up|7|||
126379072|NCT00682929|454684973|FG000|Overall Study|Adverse Event|4|||
126379073|NCT00682929|454684974|FG001|Overall Study|Adverse Event|1|||
126379074|NCT00682929|454684975|FG002|Overall Study|Adverse Event|1|||
126379075|NCT00682929|454684973|FG000|Overall Study|Withdrawal by Subject|1|||
126379076|NCT00682929|454684974|FG001|Overall Study|Withdrawal by Subject|2|||
126379077|NCT00682929|454684975|FG002|Overall Study|Withdrawal by Subject|1|||
126379078|NCT00682929|454684973|FG000|Overall Study|dosing compliance < 80%|0|||
126379079|NCT00682929|454684974|FG001|Overall Study|dosing compliance < 80%|2|||
126379080|NCT00682929|454684975|FG002|Overall Study|dosing compliance < 80%|0|||
126379081|NCT00682929|454684973|FG000|Overall Study|lag in DEA renewal|1|||
126379082|NCT00682929|454684974|FG001|Overall Study|lag in DEA renewal|0|||
126379083|NCT00682929|454684975|FG002|Overall Study|lag in DEA renewal|0|||
126104157|NCT02647320|453675815|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
126379084|NCT01462929|454684976|FG000|Overall Study|Adverse Event|3|||
126379085|NCT01462929|454684977|FG001|Overall Study|Adverse Event|3|||
126379086|NCT01462929|454684978|FG002|Overall Study|Adverse Event|4|||
126379087|NCT01462929|454684976|FG000|Overall Study|Withdrawal by Subject|2|||
126379088|NCT01462929|454684977|FG001|Overall Study|Withdrawal by Subject|1|||
126379089|NCT01462929|454684978|FG002|Overall Study|Withdrawal by Subject|0|||
126379090|NCT01462929|454684976|FG000|Overall Study|Lack of Efficacy|0|||
126379091|NCT01462929|454684977|FG001|Overall Study|Lack of Efficacy|0|||
126379092|NCT01462929|454684978|FG002|Overall Study|Lack of Efficacy|1|||
126379093|NCT03333928|454684980|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
126379094|NCT03333928|454684981|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
126379095|NCT03333928|454684982|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
126379096|NCT03333928|454684980|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
126379097|NCT03333928|454684981|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
126379098|NCT03333928|454684982|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
126379099|NCT03333928|454684980|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
126379100|NCT03333928|454684981|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
126379101|NCT03333928|454684982|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
126379102|NCT03333928|454684980|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
126379103|NCT03333928|454684981|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
126379104|NCT03333928|454684982|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
126379105|NCT03333928|454684980|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
126379106|NCT03333928|454684981|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
126379107|NCT03333928|454684982|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
126379108|NCT03333928|454684980|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
126379109|NCT03333928|454684981|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
126379110|NCT03333928|454684982|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
126379111|NCT03333928|454684980|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
126379112|NCT03333928|454684981|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
126379113|NCT03333928|454684982|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
126379114|NCT03333928|454684980|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
126379115|NCT03333928|454684981|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
126379116|NCT03333928|454684982|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
126379117|NCT04072835|454684983|FG000|Overall Study|Overall trial ended|603|||
126379118|NCT04072835|454684983|FG000|Overall Study|Ablation|97|||
126379119|NCT04072835|454684983|FG000|Overall Study|Withdrawal of consent|66|||
126379120|NCT04072835|454684983|FG000|Overall Study|Physician Decision|50|||
126379121|NCT04072835|454684983|FG000|Overall Study|Lost to Follow-up|39|||
126379122|NCT04072835|454684983|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
126379123|NCT04072835|454684983|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
126379124|NCT04072835|454684983|FG000|Overall Study|Adverse Event|25|||
126379125|NCT04072835|454684983|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
126379126|NCT04072835|454684983|FG000|Overall Study|Death|11|||
126379127|NCT04072835|454684983|FG000|Overall Study|Participant felt the drug did not work|8|||
126379128|NCT04072835|454684983|FG000|Overall Study|Participant tolerability|5|||
126379129|NCT04072835|454684983|FG000|Overall Study|Missing|5|||
126379130|NCT04072835|454684983|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
126379131|NCT04072835|454684983|FG000|Overall Study|Pregnancy|3|||
126379132|NCT04723355|454684984|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
126379133|NCT04723355|454684984|FG000|Overall Study|Errors in the informed consent form|2|||
126379134|NCT00841776|454684987|FG000|Overall Study|Lack of Efficacy|0|||
126379135|NCT00841776|454684988|FG001|Overall Study|Lack of Efficacy|1|||
126379136|NCT00841776|454684987|FG000|Overall Study|Lost to Follow-up|2|||
126379137|NCT00841776|454684988|FG001|Overall Study|Lost to Follow-up|1|||
126379138|NCT00841776|454684987|FG000|Overall Study|Withdrawal by Subject|0|||
126379139|NCT00841776|454684988|FG001|Overall Study|Withdrawal by Subject|1|||
126379140|NCT01306643|454684990|FG000|Overall Study|Adverse Event|5|||
126379141|NCT01306643|454684990|FG000|Overall Study|Disease Progression|7|||
126379142|NCT01306643|454684990|FG000|Overall Study|Other: Change in Eligibility Status|1|||
126379143|NCT02071771|454684991|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
126379144|NCT02071771|454684992|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
126379145|NCT02071771|454684991|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
126379146|NCT02071771|454684992|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
126379147|NCT02479880|454684996|FG000|Overall Study|Study Terminated by Sponsor|13|||
126379148|NCT02479880|454684997|FG001|Overall Study|Study Terminated by Sponsor|12|||
126379149|NCT02479880|454684996|FG000|Overall Study|Pregnancy|0|||
126379150|NCT02479880|454684997|FG001|Overall Study|Pregnancy|1|||
126379151|NCT00355368|454684998|FG000|Overall Study|Protocol Violation|8|||
126379152|NCT00355368|454684999|FG001|Overall Study|Protocol Violation|7|||
126379153|NCT00355368|454684998|FG000|Overall Study|cardiac arrest prior to intubation|2|||
126379154|NCT00355368|454684999|FG001|Overall Study|cardiac arrest prior to intubation|2|||
126379155|NCT01349673|454685000|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
126379156|NCT01349673|454685000|FG000|Overall Study|No Longer Qualified For Study|1|||
126379157|NCT01349673|454685000|FG000|Overall Study|Site Closure|10|||
126379158|NCT01349673|454685000|FG000|Overall Study|Withdrawal by Subject|21|||
126379159|NCT01349673|454685000|FG000|Overall Study|Lost to Follow-up|6|||
126379160|NCT01349673|454685000|FG000|Overall Study|Adverse Event|17|||
126379161|NCT01349673|454685000|FG000|Overall Study|Study Terminated By Sponsor|50|||
126379162|NCT01349673|454685000|FG000|Overall Study|Lack of Efficacy|8|||
126379163|NCT03688919|454685003|FG000|Overall Study|Lost to Follow-up|2|||
126379164|NCT03688919|454685004|FG001|Overall Study|Lost to Follow-up|1|||
126379165|NCT03688919|454685003|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
126379166|NCT03688919|454685004|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
126379167|NCT00506779|454685008|FG000|Overall Study|Withdrawal by Subject|1|||
126379168|NCT00506779|454685009|FG001|Overall Study|Withdrawal by Subject|0|||
126379169|NCT00506779|454685010|FG002|Overall Study|Withdrawal by Subject|1|||
126379170|NCT00506779|454685011|FG003|Overall Study|Withdrawal by Subject|0|||
126379171|NCT00506779|454685008|FG000|Overall Study|Adverse Event|0|||
126379172|NCT00506779|454685009|FG001|Overall Study|Adverse Event|1|||
126379173|NCT00506779|454685010|FG002|Overall Study|Adverse Event|1|||
126379174|NCT00506779|454685011|FG003|Overall Study|Adverse Event|1|||
126379175|NCT02639247|454685012|FG000|Overall Study|Lost to Follow-up|2|||
126379176|NCT02639247|454685013|FG001|Overall Study|Lost to Follow-up|1|||
126379177|NCT02639247|454685012|FG000|Overall Study|Death|2|||
126379178|NCT02639247|454685013|FG001|Overall Study|Death|0|||
126379179|NCT02639247|454685012|FG000|Overall Study|Withdrew Consent|0|||
126379180|NCT02639247|454685013|FG001|Overall Study|Withdrew Consent|1|||
126379181|NCT02639247|454685012|FG000|Overall Study|Protocol Violation|1|||
126379182|NCT02639247|454685013|FG001|Overall Study|Protocol Violation|0|||
126379183|NCT03462758|454685014|FG000|Overall Study|Chose no or other method of contraception|20|||
126379184|NCT03462758|454685015|FG001|Overall Study|Chose no or other method of contraception|23|||
126379185|NCT03462758|454685014|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
126379186|NCT03462758|454685015|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
126379187|NCT03462758|454685014|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
126379188|NCT03462758|454685015|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
126379189|NCT03462758|454685014|FG000|Overall Study|Medical contraindication|2|||
126379190|NCT03462758|454685015|FG001|Overall Study|Medical contraindication|2|||
126379191|NCT03462758|454685014|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
126379192|NCT03462758|454685015|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
126379193|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
126379194|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
126379195|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
126379196|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
126379197|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
126379198|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
126379199|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
126379200|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
126379201|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
126379202|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
126379203|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
126379204|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
126379205|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379206|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
126379207|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379208|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379209|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379210|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379211|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
126379212|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
126379213|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
126379214|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
126379215|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
126379216|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
126379217|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
126379218|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379219|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379220|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379221|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379222|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379223|NCT02820844|454685016|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
126379224|NCT02820844|454685017|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
126379225|NCT02820844|454685018|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
126379226|NCT02820844|454685019|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
126379227|NCT02820844|454685020|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
126379228|NCT02820844|454685021|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
126379229|NCT02820844|454685016|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379230|NCT02820844|454685017|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379231|NCT02820844|454685018|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
126379232|NCT02820844|454685019|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379233|NCT02820844|454685020|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379234|NCT02820844|454685021|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379235|NCT02820844|454685016|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379236|NCT02820844|454685017|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379237|NCT02820844|454685018|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
126379238|NCT02820844|454685019|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
126379239|NCT02820844|454685020|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379240|NCT02820844|454685021|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379241|NCT02820844|454685016|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379242|NCT02820844|454685017|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379243|NCT02820844|454685018|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379244|NCT02820844|454685019|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379245|NCT02820844|454685020|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
126379246|NCT02820844|454685021|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379247|NCT02820844|454685016|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379248|NCT02820844|454685017|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379249|NCT02820844|454685018|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379250|NCT02820844|454685019|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379251|NCT02820844|454685020|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379252|NCT02820844|454685021|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
126379253|NCT02266147|454685022|FG000|PART 1: Dose Escalation|Physician Decision|0|||
126379254|NCT02266147|454685023|FG001|PART 1: Dose Escalation|Physician Decision|0|||
126379255|NCT02266147|454685024|FG002|PART 1: Dose Escalation|Physician Decision|1|||
126379256|NCT02266147|454685025|FG003|PART 1: Dose Escalation|Physician Decision|0|||
126379257|NCT02266147|454685022|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
126379258|NCT02266147|454685023|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
126379259|NCT02266147|454685024|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
126379260|NCT02266147|454685025|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
126379261|NCT02266147|454685022|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
126379262|NCT02266147|454685023|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
126379263|NCT02266147|454685024|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
126379264|NCT02266147|454685025|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
126379265|NCT02266147|454685022|FG000|PART 1: Dose Escalation|Other|1|||
126379266|NCT02266147|454685023|FG001|PART 1: Dose Escalation|Other|1|||
126379267|NCT02266147|454685024|FG002|PART 1: Dose Escalation|Other|0|||
126379268|NCT02266147|454685025|FG003|PART 1: Dose Escalation|Other|0|||
126379269|NCT02266147|454685022|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
126379270|NCT02266147|454685023|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
126379271|NCT02266147|454685024|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
126379272|NCT02266147|454685025|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
126379273|NCT02266147|454685022|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
126379274|NCT02266147|454685023|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
126379275|NCT02266147|454685024|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
126379276|NCT02266147|454685025|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
126379277|NCT00413660|454685028|FG000|Up To Week 12|Adverse Event|1|||
126379278|NCT00413660|454685029|FG001|Up To Week 12|Adverse Event|3|||
126379279|NCT00413660|454685030|FG002|Up To Week 12|Adverse Event|1|||
126379280|NCT00413660|454685031|FG003|Up To Week 12|Adverse Event|4|||
126379281|NCT00413660|454685032|FG004|Up To Week 12|Adverse Event|6|||
126379282|NCT00413660|454685033|FG005|Up To Week 12|Adverse Event|4|||
126379283|NCT00413660|454685034|FG006|Up To Week 12|Adverse Event|1|||
126379284|NCT00413660|454685035|FG007|Up To Week 12|Adverse Event|0|||
126379285|NCT00413660|454685036|FG008|Up To Week 12|Adverse Event|0|||
126379286|NCT00413660|454685037|FG009|Up To Week 12|Adverse Event|0|||
126379287|NCT00413660|454685038|FG010|Up To Week 12|Adverse Event|0|||
126379288|NCT00413660|454685028|FG000|Up To Week 12|Lack of Efficacy|2|||
126379289|NCT00413660|454685029|FG001|Up To Week 12|Lack of Efficacy|0|||
126379290|NCT00413660|454685030|FG002|Up To Week 12|Lack of Efficacy|0|||
126379291|NCT00413660|454685031|FG003|Up To Week 12|Lack of Efficacy|0|||
126379292|NCT00413660|454685032|FG004|Up To Week 12|Lack of Efficacy|0|||
126379293|NCT00413660|454685033|FG005|Up To Week 12|Lack of Efficacy|0|||
126379294|NCT00413660|454685034|FG006|Up To Week 12|Lack of Efficacy|5|||
126379295|NCT00413660|454685035|FG007|Up To Week 12|Lack of Efficacy|0|||
126379296|NCT00413660|454685036|FG008|Up To Week 12|Lack of Efficacy|0|||
126379297|NCT00413660|454685037|FG009|Up To Week 12|Lack of Efficacy|0|||
126379298|NCT00413660|454685038|FG010|Up To Week 12|Lack of Efficacy|0|||
126379299|NCT00413660|454685028|FG000|Up To Week 12|Lost to Follow-up|0|||
126379300|NCT00413660|454685029|FG001|Up To Week 12|Lost to Follow-up|1|||
126379301|NCT00413660|454685030|FG002|Up To Week 12|Lost to Follow-up|0|||
126379302|NCT00413660|454685031|FG003|Up To Week 12|Lost to Follow-up|0|||
126379303|NCT00413660|454685032|FG004|Up To Week 12|Lost to Follow-up|1|||
126379304|NCT00413660|454685033|FG005|Up To Week 12|Lost to Follow-up|0|||
126379305|NCT00413660|454685034|FG006|Up To Week 12|Lost to Follow-up|0|||
126379306|NCT00413660|454685035|FG007|Up To Week 12|Lost to Follow-up|0|||
126379307|NCT00413660|454685036|FG008|Up To Week 12|Lost to Follow-up|0|||
126379308|NCT00413660|454685037|FG009|Up To Week 12|Lost to Follow-up|0|||
126379309|NCT00413660|454685038|FG010|Up To Week 12|Lost to Follow-up|0|||
126379310|NCT00413660|454685028|FG000|Up To Week 12|Withdrawal by Subject|0|||
126379311|NCT00413660|454685029|FG001|Up To Week 12|Withdrawal by Subject|2|||
126379312|NCT00413660|454685030|FG002|Up To Week 12|Withdrawal by Subject|0|||
126379313|NCT00413660|454685031|FG003|Up To Week 12|Withdrawal by Subject|2|||
126379314|NCT00413660|454685032|FG004|Up To Week 12|Withdrawal by Subject|0|||
126379315|NCT00413660|454685033|FG005|Up To Week 12|Withdrawal by Subject|2|||
126379316|NCT00413660|454685034|FG006|Up To Week 12|Withdrawal by Subject|2|||
126379317|NCT00413660|454685035|FG007|Up To Week 12|Withdrawal by Subject|0|||
126379318|NCT00413660|454685036|FG008|Up To Week 12|Withdrawal by Subject|0|||
126379319|NCT00413660|454685037|FG009|Up To Week 12|Withdrawal by Subject|0|||
126379320|NCT00413660|454685038|FG010|Up To Week 12|Withdrawal by Subject|0|||
126379321|NCT00413660|454685028|FG000|Up To Week 12|Randomized, Not Treated|1|||
126379322|NCT00413660|454685029|FG001|Up To Week 12|Randomized, Not Treated|0|||
126379323|NCT00413660|454685030|FG002|Up To Week 12|Randomized, Not Treated|0|||
126379324|NCT00413660|454685031|FG003|Up To Week 12|Randomized, Not Treated|1|||
126379325|NCT00413660|454685032|FG004|Up To Week 12|Randomized, Not Treated|0|||
126379326|NCT00413660|454685033|FG005|Up To Week 12|Randomized, Not Treated|0|||
126379327|NCT00413660|454685034|FG006|Up To Week 12|Randomized, Not Treated|0|||
126379328|NCT00413660|454685035|FG007|Up To Week 12|Randomized, Not Treated|0|||
126379329|NCT00413660|454685036|FG008|Up To Week 12|Randomized, Not Treated|0|||
126379330|NCT00413660|454685037|FG009|Up To Week 12|Randomized, Not Treated|0|||
126379331|NCT00413660|454685038|FG010|Up To Week 12|Randomized, Not Treated|0|||
126379332|NCT00413660|454685028|FG000|Up To Week 12|Other|3|||
126379333|NCT00413660|454685029|FG001|Up To Week 12|Other|1|||
126379334|NCT00413660|454685030|FG002|Up To Week 12|Other|6|||
126379335|NCT00413660|454685031|FG003|Up To Week 12|Other|1|||
126379336|NCT00413660|454685032|FG004|Up To Week 12|Other|2|||
126379337|NCT00413660|454685033|FG005|Up To Week 12|Other|4|||
126379338|NCT00413660|454685034|FG006|Up To Week 12|Other|3|||
126379339|NCT00413660|454685035|FG007|Up To Week 12|Other|0|||
126379340|NCT00413660|454685036|FG008|Up To Week 12|Other|0|||
126379341|NCT00413660|454685037|FG009|Up To Week 12|Other|0|||
126379342|NCT00413660|454685038|FG010|Up To Week 12|Other|0|||
126379343|NCT00413660|454685028|FG000|Post Week 12|Adverse Event|2|||
126379344|NCT00413660|454685029|FG001|Post Week 12|Adverse Event|0|||
126379345|NCT00413660|454685030|FG002|Post Week 12|Adverse Event|2|||
126379346|NCT00413660|454685031|FG003|Post Week 12|Adverse Event|1|||
126379347|NCT00413660|454685032|FG004|Post Week 12|Adverse Event|4|||
126379348|NCT00413660|454685033|FG005|Post Week 12|Adverse Event|2|||
126379349|NCT00413660|454685034|FG006|Post Week 12|Adverse Event|2|||
126379350|NCT00413660|454685035|FG007|Post Week 12|Adverse Event|0|||
126379351|NCT00413660|454685036|FG008|Post Week 12|Adverse Event|0|||
126379352|NCT00413660|454685037|FG009|Post Week 12|Adverse Event|0|||
126379353|NCT00413660|454685038|FG010|Post Week 12|Adverse Event|0|||
126379354|NCT00413660|454685028|FG000|Post Week 12|Lack of Efficacy|0|||
126379355|NCT00413660|454685029|FG001|Post Week 12|Lack of Efficacy|0|||
126379356|NCT00413660|454685030|FG002|Post Week 12|Lack of Efficacy|1|||
126379357|NCT00413660|454685031|FG003|Post Week 12|Lack of Efficacy|0|||
126379358|NCT00413660|454685032|FG004|Post Week 12|Lack of Efficacy|0|||
126379359|NCT00413660|454685033|FG005|Post Week 12|Lack of Efficacy|0|||
126379360|NCT00413660|454685034|FG006|Post Week 12|Lack of Efficacy|0|||
126379361|NCT00413660|454685035|FG007|Post Week 12|Lack of Efficacy|0|||
126379362|NCT00413660|454685036|FG008|Post Week 12|Lack of Efficacy|0|||
126379363|NCT00413660|454685037|FG009|Post Week 12|Lack of Efficacy|1|||
126379364|NCT00413660|454685038|FG010|Post Week 12|Lack of Efficacy|0|||
126379365|NCT00413660|454685028|FG000|Post Week 12|Lost to Follow-up|0|||
126379366|NCT00413660|454685029|FG001|Post Week 12|Lost to Follow-up|1|||
126379367|NCT00413660|454685030|FG002|Post Week 12|Lost to Follow-up|1|||
126379368|NCT00413660|454685031|FG003|Post Week 12|Lost to Follow-up|0|||
126379369|NCT00413660|454685032|FG004|Post Week 12|Lost to Follow-up|0|||
126379370|NCT00413660|454685033|FG005|Post Week 12|Lost to Follow-up|0|||
126379371|NCT00413660|454685034|FG006|Post Week 12|Lost to Follow-up|0|||
126379372|NCT00413660|454685035|FG007|Post Week 12|Lost to Follow-up|0|||
126379373|NCT00413660|454685036|FG008|Post Week 12|Lost to Follow-up|0|||
126379374|NCT00413660|454685037|FG009|Post Week 12|Lost to Follow-up|0|||
126379375|NCT00413660|454685038|FG010|Post Week 12|Lost to Follow-up|0|||
126379376|NCT00413660|454685028|FG000|Post Week 12|Withdrawal by Subject|0|||
126379377|NCT00413660|454685029|FG001|Post Week 12|Withdrawal by Subject|1|||
126379378|NCT00413660|454685030|FG002|Post Week 12|Withdrawal by Subject|1|||
126379379|NCT00413660|454685031|FG003|Post Week 12|Withdrawal by Subject|0|||
126379380|NCT00413660|454685032|FG004|Post Week 12|Withdrawal by Subject|1|||
126379381|NCT00413660|454685033|FG005|Post Week 12|Withdrawal by Subject|0|||
126379382|NCT00413660|454685034|FG006|Post Week 12|Withdrawal by Subject|0|||
126379383|NCT00413660|454685035|FG007|Post Week 12|Withdrawal by Subject|0|||
126379384|NCT00413660|454685036|FG008|Post Week 12|Withdrawal by Subject|0|||
126379385|NCT00413660|454685037|FG009|Post Week 12|Withdrawal by Subject|0|||
126379386|NCT00413660|454685038|FG010|Post Week 12|Withdrawal by Subject|1|||
126379387|NCT00413660|454685028|FG000|Post Week 12|Other|1|||
126379388|NCT00413660|454685029|FG001|Post Week 12|Other|2|||
126379389|NCT00413660|454685030|FG002|Post Week 12|Other|3|||
126379390|NCT00413660|454685031|FG003|Post Week 12|Other|0|||
126379391|NCT00413660|454685032|FG004|Post Week 12|Other|1|||
126379392|NCT00413660|454685033|FG005|Post Week 12|Other|1|||
126379393|NCT00413660|454685034|FG006|Post Week 12|Other|1|||
126379394|NCT00413660|454685035|FG007|Post Week 12|Other|0|||
126379395|NCT00413660|454685036|FG008|Post Week 12|Other|0|||
126379396|NCT00413660|454685037|FG009|Post Week 12|Other|0|||
126379397|NCT00413660|454685038|FG010|Post Week 12|Other|0|||
126379398|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
126379399|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
126379400|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
126379401|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
126379402|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
126379403|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
126379404|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
126379405|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
126379406|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
126379407|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
126379408|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
126379409|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
126379410|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
126379411|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
126379412|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
126379413|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
126379414|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
126379415|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
126379416|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Other|4|||
126379417|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Other|0|||
126379418|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Other|0|||
126379419|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
126379420|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
126379421|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
126379422|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Death|0|||
126379423|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Death|0|||
126379424|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Death|2|||
126379425|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
126379426|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
126379427|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
126379428|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
126379429|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
126379430|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
126379431|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
126379432|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
126379433|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
126379434|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Other|0|||
126379435|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Other|2|||
126379436|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Other|5|||
126379437|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
126379438|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
126379439|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
126379440|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
126379441|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
126379442|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
126379443|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
126379444|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
126379445|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
126379446|NCT01722994|454685042|FG000|Overall Study|Missing data|25|||
126379447|NCT01722994|454685043|FG001|Overall Study|Missing data|17|||
126379448|NCT01803880|454685047|FG000|Overall Study|Adverse Event|1|||
126379449|NCT01803880|454685048|FG001|Overall Study|Adverse Event|0|||
126379450|NCT01803880|454685049|FG002|Overall Study|Adverse Event|0|||
126379451|NCT01803880|454685047|FG000|Overall Study|Withdrawal by Subject|1|||
126379452|NCT01803880|454685048|FG001|Overall Study|Withdrawal by Subject|1|||
126379453|NCT01803880|454685049|FG002|Overall Study|Withdrawal by Subject|4|||
126379454|NCT01803880|454685047|FG000|Overall Study|Physician Decision|0|||
126379455|NCT01803880|454685048|FG001|Overall Study|Physician Decision|0|||
126379456|NCT01803880|454685049|FG002|Overall Study|Physician Decision|1|||
126379457|NCT01803880|454685047|FG000|Overall Study|Unable to return for follow-up visits|0|||
126379458|NCT01803880|454685048|FG001|Overall Study|Unable to return for follow-up visits|1|||
126379459|NCT01803880|454685049|FG002|Overall Study|Unable to return for follow-up visits|2|||
126379460|NCT01803880|454685047|FG000|Overall Study|Lost to Follow-up|1|||
126379461|NCT01803880|454685048|FG001|Overall Study|Lost to Follow-up|2|||
126379462|NCT01803880|454685049|FG002|Overall Study|Lost to Follow-up|3|||
126379463|NCT01803880|454685047|FG000|Overall Study|Protocol Violation|1|||
126379464|NCT01803880|454685048|FG001|Overall Study|Protocol Violation|0|||
126379465|NCT01803880|454685049|FG002|Overall Study|Protocol Violation|0|||
126379466|NCT01803880|454685047|FG000|Overall Study|Early study termination|0|||
126379467|NCT01803880|454685048|FG001|Overall Study|Early study termination|6|||
126379468|NCT01803880|454685049|FG002|Overall Study|Early study termination|5|||
126379469|NCT01803880|454685047|FG000|Overall Study|Incomplete data entry by sites|2|||
126379470|NCT01803880|454685048|FG001|Overall Study|Incomplete data entry by sites|0|||
126379471|NCT01803880|454685049|FG002|Overall Study|Incomplete data entry by sites|0|||
126379472|NCT02954887|454685050|FG000|Overall Study|Withdrawal by Subject|3|||
126379473|NCT02954887|454685050|FG000|Overall Study|Lack of Efficacy|3|||
126379474|NCT02954887|454685050|FG000|Overall Study|Other|1|||
126379475|NCT01459666|454685052|FG000|Overall Study|PI left institution|5|||
126379476|NCT01459666|454685053|FG001|Overall Study|PI left institution|4|||
126379477|NCT01152788|454685055|FG000|Overall Study|Withdrawal by Subject|0|||
126379478|NCT01152788|454685056|FG001|Overall Study|Withdrawal by Subject|3|||
126379479|NCT01152788|454685055|FG000|Overall Study|No treatment|0|||
126379480|NCT01152788|454685056|FG001|Overall Study|No treatment|1|||
126379481|NCT00889707|454685061|FG000|Overall Study|Adverse Event|1|||
126379482|NCT00889707|454685062|FG001|Overall Study|Adverse Event|0|||
126379483|NCT00889707|454685061|FG000|Overall Study|Withdrawal by Subject|4|||
126379484|NCT00889707|454685062|FG001|Overall Study|Withdrawal by Subject|3|||
126379485|NCT00889707|454685061|FG000|Overall Study|Lost to Follow-up|0|||
126379486|NCT00889707|454685062|FG001|Overall Study|Lost to Follow-up|2|||
126379487|NCT00889707|454685061|FG000|Overall Study|Lack of Efficacy|2|||
126379488|NCT00889707|454685062|FG001|Overall Study|Lack of Efficacy|5|||
126379489|NCT03542266|454685066|FG000|Treatment Phase|Withdrawal by Subject|1|||
126379490|NCT03542266|454685066|FG000|Treatment Phase|Adverse Event|1|||
126379491|NCT03542266|454685066|FG000|Treatment Phase|PD|1|||
126379492|NCT02268383|454685071|FG000|Overall Study|Death|12|||
126379493|NCT02268383|454685071|FG000|Overall Study|Lost to Follow-up|2|||
126379494|NCT02268383|454685071|FG000|Overall Study|Withdrawal by Subject|9|||
126379495|NCT02268383|454685071|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
126379496|NCT02268383|454685071|FG000|Overall Study|Protocol deviation|3|||
126379497|NCT02268383|454685071|FG000|Overall Study|Sponsor decision|22|||
126379498|NCT02268383|454685071|FG000|Overall Study|Not reported|12|||
126379499|NCT02708680|454685072|FG000|Overall Study|Withdrawal by Subject|4|||
126379500|NCT02708680|454685073|FG001|Overall Study|Withdrawal by Subject|12|||
126379501|NCT02708680|454685074|FG002|Overall Study|Withdrawal by Subject|12|||
126379502|NCT02708680|454685072|FG000|Overall Study|Death|4|||
126379503|NCT02708680|454685073|FG001|Overall Study|Death|19|||
126379504|NCT02708680|454685074|FG002|Overall Study|Death|21|||
126379505|NCT02708680|454685072|FG000|Overall Study|Lost to Follow-up|0|||
126379506|NCT02708680|454685073|FG001|Overall Study|Lost to Follow-up|3|||
126379507|NCT02708680|454685074|FG002|Overall Study|Lost to Follow-up|3|||
126379508|NCT02708680|454685072|FG000|Overall Study|Study Terminated By Sponsor|0|||
126379509|NCT02708680|454685073|FG001|Overall Study|Study Terminated By Sponsor|5|||
126379510|NCT02708680|454685074|FG002|Overall Study|Study Terminated By Sponsor|4|||
126379511|NCT02708680|454685072|FG000|Overall Study|Other than Specified|0|||
126379512|NCT02708680|454685073|FG001|Overall Study|Other than Specified|0|||
126379513|NCT02708680|454685074|FG002|Overall Study|Other than Specified|1|||
126379514|NCT02708680|454685072|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
126379515|NCT02708680|454685073|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
126379516|NCT02708680|454685074|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
126379517|NCT04162470|454685075|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
126379518|NCT01544348|454685082|FG000|Overall Study|Lost to Follow-up|1|||
126379519|NCT01544348|454685083|FG001|Overall Study|Lost to Follow-up|0|||
126379520|NCT01544348|454685084|FG002|Overall Study|Lost to Follow-up|0|||
126379521|NCT01544348|454685085|FG003|Overall Study|Lost to Follow-up|0|||
126379522|NCT01544348|454685086|FG004|Overall Study|Lost to Follow-up|0|||
126379523|NCT01544348|454685087|FG005|Overall Study|Lost to Follow-up|0|||
126379524|NCT01544348|454685088|FG006|Overall Study|Lost to Follow-up|1|||
126379525|NCT01544348|454685089|FG007|Overall Study|Lost to Follow-up|0|||
126379526|NCT01544348|454685082|FG000|Overall Study|Withdrawal by Subject|1|||
126379527|NCT01544348|454685083|FG001|Overall Study|Withdrawal by Subject|0|||
126379528|NCT01544348|454685084|FG002|Overall Study|Withdrawal by Subject|0|||
126379529|NCT01544348|454685085|FG003|Overall Study|Withdrawal by Subject|0|||
126379530|NCT01544348|454685086|FG004|Overall Study|Withdrawal by Subject|1|||
126379531|NCT01544348|454685087|FG005|Overall Study|Withdrawal by Subject|2|||
126379532|NCT01544348|454685088|FG006|Overall Study|Withdrawal by Subject|1|||
126379533|NCT01544348|454685089|FG007|Overall Study|Withdrawal by Subject|0|||
126379534|NCT01544348|454685082|FG000|Overall Study|Physician Decision|0|||
126379535|NCT01544348|454685083|FG001|Overall Study|Physician Decision|0|||
126379536|NCT01544348|454685084|FG002|Overall Study|Physician Decision|0|||
126379537|NCT01544348|454685085|FG003|Overall Study|Physician Decision|0|||
126379538|NCT01544348|454685086|FG004|Overall Study|Physician Decision|0|||
126379539|NCT01544348|454685087|FG005|Overall Study|Physician Decision|1|||
126379540|NCT01544348|454685088|FG006|Overall Study|Physician Decision|0|||
126379541|NCT01544348|454685089|FG007|Overall Study|Physician Decision|0|||
126379542|NCT01445847|454685090|FG000|Overall Study|Protocol Violation|13|||
126379543|NCT01445847|454685091|FG001|Overall Study|Protocol Violation|14|||
126379544|NCT01445847|454685090|FG000|Overall Study|Missed Data|1|||
126379545|NCT01445847|454685091|FG001|Overall Study|Missed Data|0|||
126379546|NCT04790279|454686984|FG000|Overall Study|Did not meet medication start criteria|27|||
126379547|NCT04790279|454686985|FG001|Overall Study|Did not meet medication start criteria|15|||
126379548|NCT04790279|454686984|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
126379549|NCT04790279|454686985|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
126379550|NCT04790279|454686984|FG000|Overall Study|Protocol Violation|8|||
126379551|NCT04790279|454686985|FG001|Overall Study|Protocol Violation|3|||
126379552|NCT04790279|454686984|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
126379553|NCT04790279|454686985|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
126379554|NCT00810277|454686998|FG000|Overall Study|Adverse Event|1|||
126379555|NCT00678288|454687005|FG000|Overall Study|Adverse Event|0|||
126379556|NCT00678288|454687006|FG001|Overall Study|Adverse Event|2|||
126379557|NCT00678288|454687005|FG000|Overall Study|Withdrawal by Subject|1|||
126379558|NCT00678288|454687006|FG001|Overall Study|Withdrawal by Subject|1|||
126379559|NCT00678288|454687005|FG000|Overall Study|Study terminated by the sponsor|2|||
126379560|NCT00678288|454687006|FG001|Overall Study|Study terminated by the sponsor|0|||
126379561|NCT00678288|454687005|FG000|Overall Study|Not compliant with study medication|0|||
126379562|NCT00678288|454687006|FG001|Overall Study|Not compliant with study medication|1|||
126379563|NCT00678288|454687005|FG000|Overall Study|Switch to commercial drug|0|||
126379564|NCT00678288|454687006|FG001|Overall Study|Switch to commercial drug|1|||
126379565|NCT00678288|454687005|FG000|Overall Study|Reason not reported|1|||
126379566|NCT00678288|454687006|FG001|Overall Study|Reason not reported|0|||
126379567|NCT00678288|454687005|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
126379568|NCT00678288|454687006|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
126379569|NCT02549989|454687007|FG000|Overall Study|Adverse Event|4|||
126379570|NCT02549989|454687007|FG000|Overall Study|Death|1|||
126379571|NCT02549989|454687007|FG000|Overall Study|Lack of Efficacy|19|||
126379572|NCT02549989|454687007|FG000|Overall Study|Withdrawal by Subject|3|||
126379573|NCT00972023|454687008|FG000|Overall Study|Withdrawal by Subject|1|||
126379574|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
126379575|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379576|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379577|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125886529|NCT02202759|452881760|FG002|Overall Study|Reason not Specified|10|||
125886530|NCT01987453|452881761|FG000|Overall Study|Death|0|||
125886531|NCT01987453|452881762|FG001|Overall Study|Death|0|||
126379578|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379579|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379580|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379581|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379582|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379583|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379584|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
126379585|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
126379586|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379587|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379588|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379589|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379590|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379591|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379592|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
126379593|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
126379594|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
126379595|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379596|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379597|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379598|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379599|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379600|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379601|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
126379602|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
126379603|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
126379604|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379605|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379606|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379607|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379608|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379609|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379610|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
126379611|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
126379612|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
126379613|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379614|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379615|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379616|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379617|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379618|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379619|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379620|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379621|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379622|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
126379623|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379624|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379625|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379626|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379627|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379628|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
126379629|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
126379630|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
126379631|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
126379632|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
126379633|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
125886532|NCT01987453|452881763|FG002|Overall Study|Death|1|||
125886533|NCT01987453|452881761|FG000|Overall Study|Lack of Efficacy|1|||
126379634|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
126379635|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
126379636|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
126379637|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379638|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379639|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379640|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
126379641|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
126379642|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
126379643|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
126379644|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
126379645|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
126379646|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379647|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379648|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379649|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379650|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
126379651|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379652|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379653|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
126379654|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
126379655|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
126379656|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
126379657|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
126379658|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
126379659|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
126379660|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
126379661|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
126379662|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
126379663|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
126379664|NCT00784368|454687020|FG000|Overall Study|Physician Decision|0|||
126379665|NCT00784368|454687021|FG001|Overall Study|Physician Decision|0|||
126379666|NCT00784368|454687022|FG002|Overall Study|Physician Decision|6|||
126379667|NCT00784368|454687020|FG000|Overall Study|Lack of Efficacy|2|||
126379668|NCT00784368|454687021|FG001|Overall Study|Lack of Efficacy|0|||
126379669|NCT00784368|454687022|FG002|Overall Study|Lack of Efficacy|1|||
126379670|NCT00784368|454687020|FG000|Overall Study|Adverse Event|6|||
126379671|NCT00784368|454687021|FG001|Overall Study|Adverse Event|9|||
126379672|NCT00784368|454687022|FG002|Overall Study|Adverse Event|2|||
126379673|NCT00784368|454687020|FG000|Overall Study|Diagnosis of fever|0|||
126379674|NCT00784368|454687021|FG001|Overall Study|Diagnosis of fever|0|||
126379675|NCT00784368|454687022|FG002|Overall Study|Diagnosis of fever|1|||
126379676|NCT00784368|454687020|FG000|Overall Study|Worsening of complications|0|||
126379677|NCT00784368|454687021|FG001|Overall Study|Worsening of complications|0|||
126379678|NCT00784368|454687022|FG002|Overall Study|Worsening of complications|1|||
126379679|NCT00784368|454687020|FG000|Overall Study|Worsening of symptoms|0|||
126379680|NCT00784368|454687021|FG001|Overall Study|Worsening of symptoms|1|||
126379681|NCT00784368|454687022|FG002|Overall Study|Worsening of symptoms|0|||
126379682|NCT00784368|454687020|FG000|Overall Study|Withdrawal of informed consent|0|||
126379683|NCT00784368|454687021|FG001|Overall Study|Withdrawal of informed consent|1|||
126379684|NCT00784368|454687022|FG002|Overall Study|Withdrawal of informed consent|0|||
126379685|NCT02079909|454687023|FG000|Overall Study|Adverse Event|23|||
126379686|NCT02079909|454687024|FG001|Overall Study|Adverse Event|23|||
126379687|NCT02079909|454687025|FG002|Overall Study|Adverse Event|7|||
126379688|NCT02079909|454687023|FG000|Overall Study|Withdrawal by Subject|9|||
126379689|NCT02079909|454687024|FG001|Overall Study|Withdrawal by Subject|17|||
126379690|NCT02079909|454687025|FG002|Overall Study|Withdrawal by Subject|4|||
126379691|NCT02079909|454687023|FG000|Overall Study|Lost to Follow-up|2|||
126379692|NCT02079909|454687024|FG001|Overall Study|Lost to Follow-up|3|||
126379693|NCT02079909|454687025|FG002|Overall Study|Lost to Follow-up|1|||
126379694|NCT02079909|454687023|FG000|Overall Study|Death|2|||
126379695|NCT02079909|454687024|FG001|Overall Study|Death|2|||
126379696|NCT02079909|454687025|FG002|Overall Study|Death|0|||
126379697|NCT02079909|454687023|FG000|Overall Study|Lack of Efficacy|0|||
126379698|NCT02079909|454687024|FG001|Overall Study|Lack of Efficacy|0|||
126379699|NCT02079909|454687025|FG002|Overall Study|Lack of Efficacy|1|||
126379700|NCT02079909|454687023|FG000|Overall Study|Protocol Violation|0|||
126379701|NCT02079909|454687024|FG001|Overall Study|Protocol Violation|1|||
126379702|NCT02079909|454687025|FG002|Overall Study|Protocol Violation|1|||
126379703|NCT02079909|454687023|FG000|Overall Study|Physician Decision|0|||
126379704|NCT02079909|454687024|FG001|Overall Study|Physician Decision|1|||
126379705|NCT02079909|454687025|FG002|Overall Study|Physician Decision|1|||
126379706|NCT02079909|454687023|FG000|Overall Study|Relocation etc.|2|||
126379707|NCT02079909|454687024|FG001|Overall Study|Relocation etc.|2|||
126379708|NCT02079909|454687025|FG002|Overall Study|Relocation etc.|3|||
126379709|NCT00720356|454687030|FG000|Registration to Study|Determined to have methylated MGMT|67|||
126379710|NCT00720356|454687030|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
126379711|NCT00720356|454687030|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
126379712|NCT00720356|454687030|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
126379713|NCT00720356|454687030|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
126379714|NCT00720356|454687030|FG000|Follow up Until Death|Withdrawal by Subject|1|||
126379715|NCT00720356|454687030|FG000|Follow up Until Death|Alive at last data collection|4|||
126379716|NCT01713582|454687033|FG000|Overall Study|Disease progression|3|||
126379717|NCT01713582|454687034|FG001|Overall Study|Disease progression|3|||
126379718|NCT01713582|454687035|FG002|Overall Study|Disease progression|3|||
126379719|NCT01713582|454687036|FG003|Overall Study|Disease progression|2|||
126379720|NCT01713582|454687037|FG004|Overall Study|Disease progression|3|||
126379721|NCT01713582|454687038|FG005|Overall Study|Disease progression|3|||
126379722|NCT01713582|454687039|FG006|Overall Study|Disease progression|3|||
126379723|NCT01713582|454687040|FG007|Overall Study|Disease progression|3|||
126379724|NCT01713582|454687041|FG008|Overall Study|Disease progression|3|||
126379725|NCT01713582|454687042|FG009|Overall Study|Disease progression|11|||
126379726|NCT01713582|454687043|FG010|Overall Study|Disease progression|10|||
126379727|NCT01713582|454687044|FG011|Overall Study|Disease progression|5|||
126379728|NCT01713582|454687045|FG012|Overall Study|Disease progression|3|||
126379729|NCT01713582|454687046|FG013|Overall Study|Disease progression|3|||
126379730|NCT01713582|454687047|FG014|Overall Study|Disease progression|6|||
126379731|NCT01713582|454687048|FG015|Overall Study|Disease progression|6|||
126379732|NCT01713582|454687049|FG016|Overall Study|Disease progression|5|||
126379733|NCT01713582|454687050|FG017|Overall Study|Disease progression|2|||
126379734|NCT01713582|454687051|FG018|Overall Study|Disease progression|3|||
126379735|NCT01713582|454687052|FG019|Overall Study|Disease progression|5|||
126379736|NCT01713582|454687053|FG020|Overall Study|Disease progression|15|||
126379737|NCT01713582|454687033|FG000|Overall Study|Death|0|||
126379738|NCT01713582|454687034|FG001|Overall Study|Death|0|||
126379739|NCT01713582|454687035|FG002|Overall Study|Death|0|||
126379740|NCT01713582|454687036|FG003|Overall Study|Death|1|||
126379741|NCT01713582|454687037|FG004|Overall Study|Death|1|||
126379742|NCT01713582|454687038|FG005|Overall Study|Death|3|||
126379743|NCT01713582|454687039|FG006|Overall Study|Death|3|||
126379744|NCT01713582|454687040|FG007|Overall Study|Death|2|||
126379745|NCT01713582|454687041|FG008|Overall Study|Death|3|||
126379746|NCT01713582|454687042|FG009|Overall Study|Death|4|||
126379747|NCT01713582|454687043|FG010|Overall Study|Death|3|||
126379748|NCT01713582|454687044|FG011|Overall Study|Death|0|||
126379749|NCT01713582|454687045|FG012|Overall Study|Death|0|||
126379750|NCT01713582|454687046|FG013|Overall Study|Death|0|||
126379751|NCT01713582|454687047|FG014|Overall Study|Death|0|||
126379752|NCT01713582|454687048|FG015|Overall Study|Death|0|||
126379753|NCT01713582|454687049|FG016|Overall Study|Death|0|||
126379754|NCT01713582|454687050|FG017|Overall Study|Death|0|||
126379755|NCT01713582|454687051|FG018|Overall Study|Death|0|||
126379756|NCT01713582|454687052|FG019|Overall Study|Death|0|||
126379757|NCT01713582|454687053|FG020|Overall Study|Death|0|||
126379758|NCT01713582|454687033|FG000|Overall Study|Adverse event-related|0|||
126379759|NCT01713582|454687034|FG001|Overall Study|Adverse event-related|0|||
126379760|NCT01713582|454687035|FG002|Overall Study|Adverse event-related|0|||
126379761|NCT01713582|454687036|FG003|Overall Study|Adverse event-related|0|||
126379762|NCT01713582|454687037|FG004|Overall Study|Adverse event-related|0|||
126379763|NCT01713582|454687038|FG005|Overall Study|Adverse event-related|0|||
126379764|NCT01713582|454687039|FG006|Overall Study|Adverse event-related|0|||
126104158|NCT02647320|453675816|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
126379765|NCT01713582|454687040|FG007|Overall Study|Adverse event-related|0|||
126379766|NCT01713582|454687041|FG008|Overall Study|Adverse event-related|0|||
126379767|NCT01713582|454687042|FG009|Overall Study|Adverse event-related|1|||
126379768|NCT01713582|454687043|FG010|Overall Study|Adverse event-related|1|||
126379769|NCT01713582|454687044|FG011|Overall Study|Adverse event-related|0|||
126379770|NCT01713582|454687045|FG012|Overall Study|Adverse event-related|0|||
126379771|NCT01713582|454687046|FG013|Overall Study|Adverse event-related|0|||
126379772|NCT01713582|454687047|FG014|Overall Study|Adverse event-related|0|||
126379773|NCT01713582|454687048|FG015|Overall Study|Adverse event-related|0|||
126379774|NCT01713582|454687049|FG016|Overall Study|Adverse event-related|0|||
126379775|NCT01713582|454687050|FG017|Overall Study|Adverse event-related|0|||
126379776|NCT01713582|454687051|FG018|Overall Study|Adverse event-related|1|||
126379777|NCT01713582|454687052|FG019|Overall Study|Adverse event-related|0|||
126379778|NCT01713582|454687053|FG020|Overall Study|Adverse event-related|0|||
125886534|NCT01987453|452881762|FG001|Overall Study|Lack of Efficacy|12|||
125886535|NCT01987453|452881763|FG002|Overall Study|Lack of Efficacy|0|||
126379779|NCT01713582|454687033|FG000|Overall Study|Adverse event-unrelated|0|||
126379780|NCT01713582|454687034|FG001|Overall Study|Adverse event-unrelated|0|||
126379781|NCT01713582|454687035|FG002|Overall Study|Adverse event-unrelated|0|||
126379782|NCT01713582|454687036|FG003|Overall Study|Adverse event-unrelated|0|||
126379783|NCT01713582|454687037|FG004|Overall Study|Adverse event-unrelated|0|||
126379784|NCT01713582|454687038|FG005|Overall Study|Adverse event-unrelated|1|||
126379785|NCT01713582|454687039|FG006|Overall Study|Adverse event-unrelated|1|||
126379786|NCT01713582|454687040|FG007|Overall Study|Adverse event-unrelated|1|||
126379787|NCT01713582|454687041|FG008|Overall Study|Adverse event-unrelated|0|||
126379788|NCT01713582|454687042|FG009|Overall Study|Adverse event-unrelated|0|||
126379789|NCT01713582|454687043|FG010|Overall Study|Adverse event-unrelated|0|||
126379790|NCT01713582|454687044|FG011|Overall Study|Adverse event-unrelated|0|||
126379791|NCT01713582|454687045|FG012|Overall Study|Adverse event-unrelated|0|||
126379792|NCT01713582|454687046|FG013|Overall Study|Adverse event-unrelated|1|||
126379793|NCT01713582|454687047|FG014|Overall Study|Adverse event-unrelated|1|||
126379794|NCT01713582|454687048|FG015|Overall Study|Adverse event-unrelated|0|||
126379795|NCT01713582|454687049|FG016|Overall Study|Adverse event-unrelated|0|||
126379796|NCT01713582|454687050|FG017|Overall Study|Adverse event-unrelated|0|||
126379797|NCT01713582|454687051|FG018|Overall Study|Adverse event-unrelated|0|||
126379798|NCT01713582|454687052|FG019|Overall Study|Adverse event-unrelated|0|||
126379799|NCT01713582|454687053|FG020|Overall Study|Adverse event-unrelated|0|||
126379800|NCT01713582|454687033|FG000|Overall Study|Withdrawal of consent|0|||
126379801|NCT01713582|454687034|FG001|Overall Study|Withdrawal of consent|0|||
126379802|NCT01713582|454687035|FG002|Overall Study|Withdrawal of consent|1|||
126379803|NCT01713582|454687036|FG003|Overall Study|Withdrawal of consent|0|||
126379804|NCT01713582|454687037|FG004|Overall Study|Withdrawal of consent|0|||
125886536|NCT01590888|452881765|FG000|Overall Study|Adverse Event|3|||
126379805|NCT01713582|454687038|FG005|Overall Study|Withdrawal of consent|1|||
126379806|NCT01713582|454687039|FG006|Overall Study|Withdrawal of consent|0|||
126379807|NCT01713582|454687040|FG007|Overall Study|Withdrawal of consent|0|||
125886537|NCT01590888|452881766|FG001|Overall Study|Adverse Event|0|||
125886538|NCT01590888|452881767|FG002|Overall Study|Adverse Event|1|||
125886539|NCT01590888|452881765|FG000|Overall Study|Lost to Follow-up|1|||
125886540|NCT01590888|452881766|FG001|Overall Study|Lost to Follow-up|0|||
125886541|NCT01590888|452881767|FG002|Overall Study|Lost to Follow-up|0|||
125886542|NCT04953728|452881768|FG000|Overall Study|Withdrawal by Subject|3|||
125886543|NCT04953728|452881768|FG000|Overall Study|Physician Decision|1|||
126048251|NCT00943917|453473855|FG000|Stage II Continuation|Adverse Event|0|||
126048252|NCT00943917|453473856|FG001|Stage II Continuation|Adverse Event|0|||
126048253|NCT00943917|453473857|FG002|Stage II Continuation|Adverse Event|0|||
125886544|NCT02105662|452881771|FG000|Overall Study|Lost to Follow-up|5|||
125886545|NCT02105662|452881771|FG000|Overall Study|Withdrawal by Subject|1|||
125886546|NCT02331277|452881774|FG000|Overall Study|Withdrawal by Subject|1|||
125886547|NCT02331277|452881775|FG001|Overall Study|Withdrawal by Subject|0|||
125886548|NCT03978117|452881776|FG000|Overall Study|Non-Compliance|26|||
125886549|NCT03978117|452881777|FG001|Overall Study|Non-Compliance|26|||
125886550|NCT03978117|452881776|FG000|Overall Study|Lost to Follow-up|4|||
125886551|NCT03978117|452881777|FG001|Overall Study|Lost to Follow-up|4|||
125886552|NCT05462756|452881778|FG000|Treatment Period|Adverse Event|3|||
125886553|NCT05462756|452881779|FG001|Treatment Period|Adverse Event|0|||
125886554|NCT05462756|452881778|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
125886555|NCT05462756|452881779|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
125886556|NCT05462756|452881778|FG000|Treatment Period|Death|0|||
125886557|NCT05462756|452881779|FG001|Treatment Period|Death|1|||
125886558|NCT05462756|452881778|FG000|Treatment Period|Lost to Follow-up|2|||
125886559|NCT05462756|452881779|FG001|Treatment Period|Lost to Follow-up|1|||
125886560|NCT05462756|452881778|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
125886561|NCT05462756|452881779|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
125886562|NCT05462756|452881778|FG000|Treatment Period|Physician Decision|2|||
125886563|NCT05462756|452881779|FG001|Treatment Period|Physician Decision|0|||
125886564|NCT05462756|452881778|FG000|Treatment Period|Protocol Violation|0|||
125886565|NCT05462756|452881779|FG001|Treatment Period|Protocol Violation|1|||
125886566|NCT05462756|452881778|FG000|Treatment Period|Withdrawal by Subject|5|||
125886567|NCT05462756|452881779|FG001|Treatment Period|Withdrawal by Subject|12|||
125886568|NCT05462756|452881778|FG000|Follow-Up Period|Adverse Event|1|||
125886569|NCT05462756|452881779|FG001|Follow-Up Period|Adverse Event|0|||
125886570|NCT05462756|452881778|FG000|Follow-Up Period|Death|1|||
125886571|NCT05462756|452881779|FG001|Follow-Up Period|Death|0|||
125886572|NCT05462756|452881778|FG000|Follow-Up Period|Lost to Follow-up|3|||
125886573|NCT05462756|452881779|FG001|Follow-Up Period|Lost to Follow-up|1|||
125886574|NCT05462756|452881778|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125886575|NCT05462756|452881779|FG001|Follow-Up Period|Withdrawal by Subject|4|||
125886576|NCT00990704|452881782|FG000|Overall Study|Adverse Event|1|||
125886577|NCT00990704|452881783|FG001|Overall Study|Adverse Event|1|||
125886578|NCT00990704|452881782|FG000|Overall Study|Physician Decision|0|||
125886579|NCT00990704|452881783|FG001|Overall Study|Physician Decision|1|||
125886580|NCT04040933|452881784|FG000|Overall Study|Protocol Violation|1|||
125886581|NCT04040933|452881784|FG000|Overall Study|Withdrawal by Subject|2|||
125886582|NCT01354899|452881788|FG000|Overall Study|discharge from the hospital|2|||
126048254|NCT00943917|453473858|FG003|Stage II Continuation|Adverse Event|0|||
126379808|NCT01713582|454687041|FG008|Overall Study|Withdrawal of consent|0|||
126379809|NCT01713582|454687042|FG009|Overall Study|Withdrawal of consent|1|||
126379810|NCT01713582|454687043|FG010|Overall Study|Withdrawal of consent|0|||
126379811|NCT01713582|454687044|FG011|Overall Study|Withdrawal of consent|0|||
126379812|NCT01713582|454687045|FG012|Overall Study|Withdrawal of consent|0|||
126379813|NCT01713582|454687046|FG013|Overall Study|Withdrawal of consent|0|||
126379814|NCT01713582|454687047|FG014|Overall Study|Withdrawal of consent|0|||
126379815|NCT01713582|454687048|FG015|Overall Study|Withdrawal of consent|0|||
126379816|NCT01713582|454687049|FG016|Overall Study|Withdrawal of consent|0|||
126379817|NCT01713582|454687050|FG017|Overall Study|Withdrawal of consent|0|||
126379818|NCT01713582|454687051|FG018|Overall Study|Withdrawal of consent|1|||
126379819|NCT01713582|454687052|FG019|Overall Study|Withdrawal of consent|0|||
126379820|NCT01713582|454687053|FG020|Overall Study|Withdrawal of consent|0|||
126379821|NCT01713582|454687033|FG000|Overall Study|Lack of Efficacy|0|||
126379822|NCT01713582|454687034|FG001|Overall Study|Lack of Efficacy|0|||
126379823|NCT01713582|454687035|FG002|Overall Study|Lack of Efficacy|0|||
126379824|NCT01713582|454687036|FG003|Overall Study|Lack of Efficacy|0|||
126379825|NCT01713582|454687037|FG004|Overall Study|Lack of Efficacy|0|||
125886583|NCT01354899|452881788|FG000|Overall Study|Protocol Violation|1|||
125886584|NCT00641667|452881789|FG000|Overall Study|Withdrawal by Subject|1|||
125886585|NCT00641667|452881789|FG000|Overall Study|Adverse Event|1|||
125886586|NCT00641667|452881789|FG000|Overall Study|Physician Decision|1|||
125886587|NCT00641667|452881789|FG000|Overall Study|Worsening of underlying disease|3|||
125886588|NCT01235741|452881790|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
125886589|NCT01235741|452881791|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
125886590|NCT01235741|452881792|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
126379826|NCT01713582|454687038|FG005|Overall Study|Lack of Efficacy|0|||
126379827|NCT01713582|454687039|FG006|Overall Study|Lack of Efficacy|0|||
126379828|NCT01713582|454687040|FG007|Overall Study|Lack of Efficacy|0|||
126379829|NCT01713582|454687041|FG008|Overall Study|Lack of Efficacy|0|||
126379830|NCT01713582|454687042|FG009|Overall Study|Lack of Efficacy|1|||
126379831|NCT01713582|454687043|FG010|Overall Study|Lack of Efficacy|2|||
126379832|NCT01713582|454687044|FG011|Overall Study|Lack of Efficacy|0|||
126379833|NCT01713582|454687045|FG012|Overall Study|Lack of Efficacy|0|||
126379834|NCT01713582|454687046|FG013|Overall Study|Lack of Efficacy|0|||
126379835|NCT01713582|454687047|FG014|Overall Study|Lack of Efficacy|0|||
126379836|NCT01713582|454687048|FG015|Overall Study|Lack of Efficacy|0|||
126379837|NCT01713582|454687049|FG016|Overall Study|Lack of Efficacy|0|||
126379838|NCT01713582|454687050|FG017|Overall Study|Lack of Efficacy|0|||
126379839|NCT01713582|454687051|FG018|Overall Study|Lack of Efficacy|0|||
126379840|NCT01713582|454687052|FG019|Overall Study|Lack of Efficacy|0|||
126379841|NCT01713582|454687053|FG020|Overall Study|Lack of Efficacy|0|||
126379842|NCT01713582|454687033|FG000|Overall Study|Withdrawal by Subject|0|||
126379843|NCT01713582|454687034|FG001|Overall Study|Withdrawal by Subject|0|||
126379844|NCT01713582|454687035|FG002|Overall Study|Withdrawal by Subject|0|||
126379845|NCT01713582|454687036|FG003|Overall Study|Withdrawal by Subject|0|||
126379846|NCT01713582|454687037|FG004|Overall Study|Withdrawal by Subject|0|||
126379847|NCT01713582|454687038|FG005|Overall Study|Withdrawal by Subject|0|||
126379848|NCT01713582|454687039|FG006|Overall Study|Withdrawal by Subject|0|||
126379849|NCT01713582|454687040|FG007|Overall Study|Withdrawal by Subject|0|||
126379850|NCT01713582|454687041|FG008|Overall Study|Withdrawal by Subject|0|||
126379851|NCT01713582|454687042|FG009|Overall Study|Withdrawal by Subject|0|||
126379852|NCT01713582|454687043|FG010|Overall Study|Withdrawal by Subject|0|||
126379853|NCT01713582|454687044|FG011|Overall Study|Withdrawal by Subject|0|||
126379854|NCT01713582|454687045|FG012|Overall Study|Withdrawal by Subject|0|||
126379855|NCT01713582|454687046|FG013|Overall Study|Withdrawal by Subject|0|||
126379856|NCT01713582|454687047|FG014|Overall Study|Withdrawal by Subject|0|||
126379857|NCT01713582|454687048|FG015|Overall Study|Withdrawal by Subject|0|||
126379858|NCT01713582|454687049|FG016|Overall Study|Withdrawal by Subject|0|||
126379859|NCT01713582|454687050|FG017|Overall Study|Withdrawal by Subject|1|||
126379860|NCT01713582|454687051|FG018|Overall Study|Withdrawal by Subject|0|||
126379861|NCT01713582|454687052|FG019|Overall Study|Withdrawal by Subject|0|||
126379862|NCT01713582|454687053|FG020|Overall Study|Withdrawal by Subject|0|||
126379863|NCT01713582|454687033|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
126379864|NCT01713582|454687034|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
126379865|NCT01713582|454687035|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
126379866|NCT01713582|454687036|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
126379867|NCT01713582|454687037|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
126379868|NCT01713582|454687038|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
126379869|NCT01713582|454687039|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
126379870|NCT01713582|454687040|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
126379871|NCT01713582|454687041|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
126379872|NCT01713582|454687042|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
126379873|NCT01713582|454687043|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
126379874|NCT01713582|454687044|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
126379875|NCT01713582|454687045|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
126379876|NCT01713582|454687046|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
126379877|NCT01713582|454687047|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
126379878|NCT01713582|454687048|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
126379879|NCT01713582|454687049|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
126379880|NCT01713582|454687050|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
126379881|NCT01713582|454687051|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
126379882|NCT01713582|454687052|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
126379883|NCT01713582|454687053|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
126379884|NCT01713582|454687033|FG000|Overall Study|Disease progression and adverse event|0|||
126379885|NCT01713582|454687034|FG001|Overall Study|Disease progression and adverse event|0|||
126379886|NCT01713582|454687035|FG002|Overall Study|Disease progression and adverse event|0|||
126379887|NCT01713582|454687036|FG003|Overall Study|Disease progression and adverse event|0|||
126379888|NCT01713582|454687037|FG004|Overall Study|Disease progression and adverse event|0|||
126379889|NCT01713582|454687038|FG005|Overall Study|Disease progression and adverse event|0|||
126379890|NCT01713582|454687039|FG006|Overall Study|Disease progression and adverse event|0|||
126379891|NCT01713582|454687040|FG007|Overall Study|Disease progression and adverse event|0|||
126379892|NCT01713582|454687041|FG008|Overall Study|Disease progression and adverse event|0|||
126379893|NCT01713582|454687042|FG009|Overall Study|Disease progression and adverse event|0|||
126379894|NCT01713582|454687043|FG010|Overall Study|Disease progression and adverse event|0|||
126379895|NCT01713582|454687044|FG011|Overall Study|Disease progression and adverse event|0|||
126379896|NCT01713582|454687045|FG012|Overall Study|Disease progression and adverse event|0|||
126379897|NCT01713582|454687046|FG013|Overall Study|Disease progression and adverse event|0|||
126379898|NCT01713582|454687047|FG014|Overall Study|Disease progression and adverse event|0|||
126379899|NCT01713582|454687048|FG015|Overall Study|Disease progression and adverse event|0|||
126379900|NCT01713582|454687049|FG016|Overall Study|Disease progression and adverse event|1|||
126379901|NCT01713582|454687050|FG017|Overall Study|Disease progression and adverse event|0|||
126379902|NCT01713582|454687051|FG018|Overall Study|Disease progression and adverse event|0|||
126379903|NCT01713582|454687052|FG019|Overall Study|Disease progression and adverse event|0|||
126379904|NCT01713582|454687053|FG020|Overall Study|Disease progression and adverse event|0|||
126379905|NCT04551898|454687056|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
126379906|NCT04551898|454687057|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
126379907|NCT04551898|454687058|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
126379908|NCT04551898|454687059|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
126379909|NCT04551898|454687056|FG000|Overall Study|Withdrawal by Subject|5|||
126379910|NCT04551898|454687057|FG001|Overall Study|Withdrawal by Subject|1|||
126379911|NCT04551898|454687058|FG002|Overall Study|Withdrawal by Subject|2|||
126379912|NCT04551898|454687059|FG003|Overall Study|Withdrawal by Subject|2|||
126379913|NCT04551898|454687056|FG000|Overall Study|Lost to Follow-up|2|||
126379914|NCT04551898|454687057|FG001|Overall Study|Lost to Follow-up|1|||
126379915|NCT04551898|454687058|FG002|Overall Study|Lost to Follow-up|2|||
126379916|NCT04551898|454687059|FG003|Overall Study|Lost to Follow-up|2|||
126379917|NCT04551898|454687056|FG000|Overall Study|Death|1|||
126379918|NCT04551898|454687057|FG001|Overall Study|Death|0|||
126379919|NCT04551898|454687058|FG002|Overall Study|Death|0|||
126379920|NCT04551898|454687059|FG003|Overall Study|Death|0|||
126379921|NCT04551898|454687056|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
126379922|NCT04551898|454687057|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
126379923|NCT04551898|454687058|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
126379924|NCT04551898|454687059|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
126379925|NCT01898286|454687062|FG000|Overall Study|Withdrawal by Subject|1|||
126379926|NCT01898286|454687062|FG000|Overall Study|Protocol Violation|1|||
126379927|NCT01898286|454687062|FG000|Overall Study|Lost to Follow-up|1|||
126379928|NCT02257242|454687063|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
126379929|NCT02257242|454687064|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379930|NCT02257242|454687065|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379931|NCT02257242|454687066|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379932|NCT02257242|454687067|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379933|NCT02257242|454687068|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379934|NCT02257242|454687069|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379935|NCT02257242|454687070|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379936|NCT02257242|454687071|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379937|NCT01650831|454687077|FG000|Overall Study|Screen failure|1|||
126379938|NCT01048242|454687080|FG000|Overall Study|See study flow chart|4|||
126379939|NCT01048242|454687081|FG001|Overall Study|See study flow chart|2|||
126379940|NCT02964273|454687082|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
126379941|NCT02964273|454687083|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
126379942|NCT02964273|454687084|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
126379943|NCT02964273|454687085|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
126379944|NCT02964273|454687082|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
126379945|NCT02964273|454687083|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
126379946|NCT02964273|454687084|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
126379947|NCT02964273|454687085|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
126379948|NCT02964273|454687082|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
126379949|NCT02964273|454687083|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
126379950|NCT02964273|454687084|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
126379951|NCT02964273|454687085|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
126379952|NCT02964273|454687082|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
126379953|NCT02964273|454687083|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
126379954|NCT02964273|454687084|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
126379955|NCT02964273|454687085|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
126379956|NCT02964273|454687082|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
126379957|NCT02964273|454687083|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
126379958|NCT02964273|454687084|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
126379959|NCT02964273|454687085|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
126379960|NCT02964273|454687082|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
126379961|NCT02964273|454687083|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
126379962|NCT02964273|454687084|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
126379963|NCT02964273|454687085|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
126379964|NCT01453036|454687087|FG000|Overall Study|Lost to Follow-up|26|||
126379965|NCT01453036|454687088|FG001|Overall Study|Lost to Follow-up|115|||
126379966|NCT01453036|454687089|FG002|Overall Study|Lost to Follow-up|31|||
126379967|NCT00559104|454687090|FG000|Overall Study|Lack of Efficacy|9|||
126379968|NCT00559104|454687091|FG001|Overall Study|Lack of Efficacy|0|||
126379969|NCT01336712|454687092|FG000|Overall Study|Death|2|||
126379970|NCT01336712|454687092|FG000|Overall Study|Lack of Efficacy|1|||
126379971|NCT00620373|454687094|FG000|Overall Study|Unverified cancer status|33|||
126379972|NCT00399568|454687095|FG000|Overall Study|Adverse Event|1|||
126379973|NCT00399568|454687096|FG001|Overall Study|Adverse Event|2|||
126379974|NCT00399568|454687095|FG000|Overall Study|Withdrawal by Subject|7|||
126379975|NCT00399568|454687096|FG001|Overall Study|Withdrawal by Subject|3|||
126379976|NCT00399568|454687095|FG000|Overall Study|Protocol non-compliance|2|||
126379977|NCT00399568|454687096|FG001|Overall Study|Protocol non-compliance|2|||
126379978|NCT00399568|454687095|FG000|Overall Study|Lost to Follow-up|2|||
126379979|NCT00399568|454687096|FG001|Overall Study|Lost to Follow-up|2|||
126379980|NCT03073525|454687097|FG000|Overall Study|Withdrawal by Subject|0|||
126379981|NCT03073525|454687098|FG001|Overall Study|Withdrawal by Subject|0|||
126379982|NCT03073525|454687099|FG002|Overall Study|Withdrawal by Subject|3|||
126379983|NCT01273038|454687100|FG000|Second Intervention (14 Days)|Adverse Event|0|||
126379984|NCT01273038|454687101|FG001|Second Intervention (14 Days)|Adverse Event|1|||
126379985|NCT01273038|454687100|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
126379986|NCT01273038|454687101|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
126379987|NCT03692403|454687102|FG000|Overall Study|Withdrawal by Subject|1|||
126379988|NCT03692403|454687103|FG001|Overall Study|Withdrawal by Subject|0|||
126379989|NCT03692403|454687104|FG002|Overall Study|Withdrawal by Subject|1|||
126379990|NCT03692403|454687105|FG003|Overall Study|Withdrawal by Subject|0|||
126379991|NCT03692403|454687102|FG000|Overall Study|Adverse Event|0|||
126379992|NCT03692403|454687103|FG001|Overall Study|Adverse Event|0|||
126379993|NCT03692403|454687104|FG002|Overall Study|Adverse Event|0|||
126379994|NCT03692403|454687105|FG003|Overall Study|Adverse Event|1|||
126379995|NCT03692403|454687102|FG000|Overall Study|Pregnancy|0|||
126379996|NCT03692403|454687103|FG001|Overall Study|Pregnancy|1|||
126379997|NCT03692403|454687104|FG002|Overall Study|Pregnancy|0|||
126379998|NCT03692403|454687105|FG003|Overall Study|Pregnancy|0|||
126379999|NCT03692403|454687102|FG000|Overall Study|Other|0|||
126380000|NCT03692403|454687103|FG001|Overall Study|Other|0|||
126380001|NCT03692403|454687104|FG002|Overall Study|Other|1|||
126380002|NCT03692403|454687105|FG003|Overall Study|Other|0|||
126380003|NCT02776683|454687106|FG000|Pre-switch Period|Protocol Violation|1|||
126380004|NCT02776683|454687107|FG001|Pre-switch Period|Protocol Violation|0|||
126380005|NCT02776683|454687106|FG000|Pre-switch Period|Adverse Event|21|||
126380006|NCT02776683|454687107|FG001|Pre-switch Period|Adverse Event|0|||
126380007|NCT02776683|454687106|FG000|Pre-switch Period|Withdrawal by Subject|9|||
126380008|NCT02776683|454687107|FG001|Pre-switch Period|Withdrawal by Subject|0|||
126380009|NCT02776683|454687106|FG000|Pre-switch Period|Physician Decision|7|||
126380010|NCT02776683|454687107|FG001|Pre-switch Period|Physician Decision|0|||
126380011|NCT02776683|454687106|FG000|Pre-switch Period|Progressive disease|39|||
126380012|NCT02776683|454687107|FG001|Pre-switch Period|Progressive disease|0|||
126380013|NCT02776683|454687106|FG000|Pre-switch Period|Other than listed|3|||
126380014|NCT02776683|454687107|FG001|Pre-switch Period|Other than listed|0|||
126380015|NCT02776683|454687106|FG000|Post-switch Period|Adverse Event|0|||
126380016|NCT02776683|454687107|FG001|Post-switch Period|Adverse Event|3|||
126380017|NCT02776683|454687106|FG000|Post-switch Period|Withdrawal by Subject|0|||
126380018|NCT02776683|454687107|FG001|Post-switch Period|Withdrawal by Subject|2|||
126380019|NCT02776683|454687106|FG000|Post-switch Period|Physician Decision|0|||
126380020|NCT02776683|454687107|FG001|Post-switch Period|Physician Decision|3|||
126380021|NCT02776683|454687106|FG000|Post-switch Period|Progressive disease|0|||
126380022|NCT02776683|454687107|FG001|Post-switch Period|Progressive disease|20|||
126380023|NCT02776683|454687106|FG000|Post-switch Period|Other than listed|0|||
126380024|NCT02776683|454687107|FG001|Post-switch Period|Other than listed|15|||
126380025|NCT01891396|454687110|FG000|Overall Study|Withdrawal by Subject|4|||
126380026|NCT01891396|454687111|FG001|Overall Study|Withdrawal by Subject|4|||
126380027|NCT01891396|454687112|FG002|Overall Study|Withdrawal by Subject|3|||
126380028|NCT01891396|454687110|FG000|Overall Study|Lost to Follow-up|0|||
126380029|NCT01891396|454687111|FG001|Overall Study|Lost to Follow-up|1|||
126380030|NCT01891396|454687112|FG002|Overall Study|Lost to Follow-up|0|||
126380031|NCT00400517|454687114|FG000|Overall Study|Withdrawal by Subject|1|||
126380032|NCT00400517|454687114|FG000|Overall Study|Physician Decision|1|||
126380033|NCT01881789|454687118|FG000|Overall Study|Withdrawal by Subject|0|||
126380034|NCT01881789|454687119|FG001|Overall Study|Withdrawal by Subject|2|||
126380035|NCT01881789|454687120|FG002|Overall Study|Withdrawal by Subject|1|||
126380036|NCT01881789|454687121|FG003|Overall Study|Withdrawal by Subject|0|||
126380037|NCT01881789|454687122|FG004|Overall Study|Withdrawal by Subject|1|||
126380038|NCT01881789|454687123|FG005|Overall Study|Withdrawal by Subject|1|||
126380039|NCT01881789|454687118|FG000|Overall Study|Study Terminated by Sponsor|0|||
126380040|NCT01881789|454687119|FG001|Overall Study|Study Terminated by Sponsor|0|||
126380041|NCT01881789|454687120|FG002|Overall Study|Study Terminated by Sponsor|0|||
126380042|NCT01881789|454687121|FG003|Overall Study|Study Terminated by Sponsor|0|||
126380043|NCT01881789|454687122|FG004|Overall Study|Study Terminated by Sponsor|0|||
126380044|NCT01881789|454687123|FG005|Overall Study|Study Terminated by Sponsor|1|||
126380045|NCT01881789|454687118|FG000|Overall Study|Other|3|||
126380046|NCT01881789|454687119|FG001|Overall Study|Other|5|||
126380047|NCT01881789|454687120|FG002|Overall Study|Other|2|||
126380048|NCT01881789|454687121|FG003|Overall Study|Other|3|||
126380049|NCT01881789|454687122|FG004|Overall Study|Other|1|||
126380050|NCT01881789|454687123|FG005|Overall Study|Other|1|||
126380051|NCT01282866|454687126|FG000|Overall Study|Adverse Event|1|||
126380052|NCT01299389|454687127|FG000|Double-blind|Adverse Event|45|||
126380053|NCT01299389|454687128|FG001|Double-blind|Adverse Event|27|||
126380054|NCT01299389|454687129|FG002|Double-blind|Adverse Event|0|||
126380055|NCT01299389|454687130|FG003|Double-blind|Adverse Event|0|||
126380056|NCT01299389|454687127|FG000|Double-blind|Lack of Efficacy|45|||
126380057|NCT01299389|454687128|FG001|Double-blind|Lack of Efficacy|21|||
126380058|NCT01299389|454687129|FG002|Double-blind|Lack of Efficacy|0|||
126380059|NCT01299389|454687130|FG003|Double-blind|Lack of Efficacy|0|||
126380060|NCT01299389|454687127|FG000|Double-blind|Lost to Follow-up|2|||
126380061|NCT01299389|454687128|FG001|Double-blind|Lost to Follow-up|1|||
126380062|NCT01299389|454687129|FG002|Double-blind|Lost to Follow-up|0|||
126380063|NCT01299389|454687130|FG003|Double-blind|Lost to Follow-up|0|||
126380064|NCT01299389|454687127|FG000|Double-blind|Withdrawal by Subject|16|||
126380065|NCT01299389|454687128|FG001|Double-blind|Withdrawal by Subject|13|||
126380066|NCT01299389|454687129|FG002|Double-blind|Withdrawal by Subject|0|||
126380067|NCT01299389|454687130|FG003|Double-blind|Withdrawal by Subject|0|||
126380068|NCT01299389|454687127|FG000|Double-blind|Other|1|||
126380069|NCT01299389|454687128|FG001|Double-blind|Other|1|||
126380070|NCT01299389|454687129|FG002|Double-blind|Other|0|||
126380071|NCT01299389|454687130|FG003|Double-blind|Other|0|||
126380072|NCT01299389|454687127|FG000|Double-blind|"fail to meet study population criteria"|0|||
126380073|NCT01299389|454687128|FG001|Double-blind|"fail to meet study population criteria"|1|||
126380074|NCT01299389|454687129|FG002|Double-blind|"fail to meet study population criteria"|0|||
126380075|NCT01299389|454687130|FG003|Double-blind|"fail to meet study population criteria"|0|||
126380076|NCT01299389|454687127|FG000|Post-observational|Other|0|||
126380077|NCT01299389|454687128|FG001|Post-observational|Other|0|||
126380078|NCT01299389|454687129|FG002|Post-observational|Other|12|||
126380079|NCT01299389|454687130|FG003|Post-observational|Other|6|||
126380080|NCT01151020|454687131|FG000|Overall Study|Death|25|||
126380081|NCT01151020|454687131|FG000|Overall Study|Conversion to open repair|1|||
126380082|NCT01151020|454687131|FG000|Overall Study|Lost to Follow-up|4|||
126380083|NCT01151020|454687131|FG000|Overall Study|Withdrawal by Subject|22|||
126380084|NCT01151020|454687131|FG000|Overall Study|Patients did not receive the device|2|||
126380085|NCT01635998|454687132|FG000|Overall Study|Death|1|||
126380086|NCT01635998|454687133|FG001|Overall Study|Death|1|||
126380087|NCT01635998|454687132|FG000|Overall Study|Lost to Follow-up|2|||
126380088|NCT01635998|454687133|FG001|Overall Study|Lost to Follow-up|1|||
126380089|NCT01635998|454687132|FG000|Overall Study|Withdrawal by Subject|1|||
126380090|NCT01635998|454687133|FG001|Overall Study|Withdrawal by Subject|5|||
126380091|NCT01220401|454687134|FG000|Overall Study|Withdrawal by Subject|2|||
126380092|NCT01220401|454687134|FG000|Overall Study|Protocol Violation|1|||
126380093|NCT01964378|454687135|FG000|Overall Study|Disc. due to death before first dosing|0|||
126380094|NCT01964378|454687136|FG001|Overall Study|Disc. due to death before first dosing|1|||
126380095|NCT01964378|454687135|FG000|Overall Study|Disc. due to AE before first dosing|1|||
126380096|NCT01964378|454687136|FG001|Overall Study|Disc. due to AE before first dosing|0|||
126380097|NCT01964378|454687135|FG000|Overall Study|Death|3|||
126380098|NCT01964378|454687136|FG001|Overall Study|Death|2|||
126380099|NCT01964378|454687135|FG000|Overall Study|Adverse Event|12|||
126380100|NCT01964378|454687136|FG001|Overall Study|Adverse Event|5|||
126380101|NCT01964378|454687135|FG000|Overall Study|Lack of Efficacy|0|||
126380102|NCT01964378|454687136|FG001|Overall Study|Lack of Efficacy|1|||
126380103|NCT01964378|454687135|FG000|Overall Study|Protocol Violation|0|||
126380104|NCT01964378|454687136|FG001|Overall Study|Protocol Violation|1|||
126380105|NCT01964378|454687135|FG000|Overall Study|Lost to Follow-up|0|||
126380106|NCT01964378|454687136|FG001|Overall Study|Lost to Follow-up|1|||
126380107|NCT01964378|454687135|FG000|Overall Study|Withdrawal by Subject|7|||
126380108|NCT01964378|454687136|FG001|Overall Study|Withdrawal by Subject|5|||
126380109|NCT01964378|454687135|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
126380110|NCT01964378|454687136|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
126380111|NCT01964378|454687135|FG000|Overall Study|Other|1|||
126380112|NCT01964378|454687136|FG001|Overall Study|Other|2|||
126380113|NCT01162473|454687141|FG000|Overall Study|Adverse Event|2|||
126380114|NCT01162473|454687142|FG001|Overall Study|Adverse Event|1|||
126380115|NCT01162473|454687141|FG000|Overall Study|Withdrawal by Subject|0|||
126380116|NCT01162473|454687142|FG001|Overall Study|Withdrawal by Subject|4|||
126380117|NCT01392573|454687151|FG000|Overall Study|Adverse Event|1|||
126380118|NCT01392573|454687152|FG001|Overall Study|Adverse Event|3|||
126380119|NCT01392573|454687151|FG000|Overall Study|Lack of Efficacy|1|||
126380120|NCT01392573|454687152|FG001|Overall Study|Lack of Efficacy|2|||
126380121|NCT01392573|454687151|FG000|Overall Study|Protocol Violation|0|||
126380122|NCT01392573|454687152|FG001|Overall Study|Protocol Violation|2|||
126380123|NCT01392573|454687151|FG000|Overall Study|Withdrawal Criteria|13|||
126380124|NCT01392573|454687152|FG001|Overall Study|Withdrawal Criteria|15|||
126380125|NCT01392573|454687151|FG000|Overall Study|Site closure|8|||
126380126|NCT01392573|454687152|FG001|Overall Study|Site closure|7|||
126380127|NCT01392573|454687151|FG000|Overall Study|Unclassified|9|||
126380128|NCT01392573|454687152|FG001|Overall Study|Unclassified|6|||
126380129|NCT03008070|454687153|FG000|Overall Study|Adverse Event|3|||
126380130|NCT03008070|454687154|FG001|Overall Study|Adverse Event|3|||
126380131|NCT03008070|454687155|FG002|Overall Study|Adverse Event|3|||
126380132|NCT03008070|454687153|FG000|Overall Study|Lost to Follow-up|1|||
126380133|NCT03008070|454687154|FG001|Overall Study|Lost to Follow-up|1|||
126380134|NCT03008070|454687155|FG002|Overall Study|Lost to Follow-up|0|||
126380135|NCT03008070|454687153|FG000|Overall Study|Non compliance|0|||
126380136|NCT03008070|454687154|FG001|Overall Study|Non compliance|1|||
126380137|NCT03008070|454687155|FG002|Overall Study|Non compliance|1|||
126380138|NCT03008070|454687153|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
126380139|NCT03008070|454687154|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
126380140|NCT03008070|454687155|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
126380141|NCT03008070|454687153|FG000|Overall Study|Withdrawal by Subject|2|||
126380142|NCT03008070|454687154|FG001|Overall Study|Withdrawal by Subject|0|||
126380143|NCT03008070|454687155|FG002|Overall Study|Withdrawal by Subject|1|||
126380144|NCT03008070|454687153|FG000|Overall Study|Use of prohibited drug|0|||
126380145|NCT03008070|454687154|FG001|Overall Study|Use of prohibited drug|0|||
126380146|NCT03008070|454687155|FG002|Overall Study|Use of prohibited drug|2|||
126380147|NCT04409834|454687158|FG000|Overall Study|Death|55|||
126380148|NCT04409834|454687159|FG001|Overall Study|Death|62|||
126380149|NCT01365455|454687160|FG000|Induction Period|Adverse Event|5|||
126380150|NCT01365455|454687161|FG001|Induction Period|Adverse Event|3|||
126380151|NCT01365455|454687162|FG002|Induction Period|Adverse Event|4|||
126380152|NCT01365455|454687163|FG003|Induction Period|Adverse Event|0|||
126380153|NCT01365455|454687164|FG004|Induction Period|Adverse Event|0|||
126380154|NCT01365455|454687160|FG000|Induction Period|Lack of Efficacy|1|||
126380155|NCT01365455|454687161|FG001|Induction Period|Lack of Efficacy|1|||
126380156|NCT01365455|454687162|FG002|Induction Period|Lack of Efficacy|0|||
126380157|NCT01365455|454687163|FG003|Induction Period|Lack of Efficacy|0|||
126380158|NCT01365455|454687164|FG004|Induction Period|Lack of Efficacy|0|||
126380159|NCT01365455|454687160|FG000|Induction Period|Pregnancy|0|||
126380160|NCT01365455|454687161|FG001|Induction Period|Pregnancy|1|||
126380161|NCT01365455|454687162|FG002|Induction Period|Pregnancy|0|||
126380162|NCT01365455|454687163|FG003|Induction Period|Pregnancy|0|||
126380163|NCT01365455|454687164|FG004|Induction Period|Pregnancy|0|||
126380164|NCT01365455|454687160|FG000|Induction Period|Protocol deviation|0|||
126380165|NCT01365455|454687161|FG001|Induction Period|Protocol deviation|1|||
126380166|NCT01365455|454687162|FG002|Induction Period|Protocol deviation|1|||
126380167|NCT01365455|454687163|FG003|Induction Period|Protocol deviation|0|||
126380168|NCT01365455|454687164|FG004|Induction Period|Protocol deviation|0|||
126380169|NCT01365455|454687160|FG000|Induction Period|Subject/guardian decision|9|||
126380170|NCT01365455|454687161|FG001|Induction Period|Subject/guardian decision|1|||
126380171|NCT01365455|454687162|FG002|Induction Period|Subject/guardian decision|8|||
126380172|NCT01365455|454687163|FG003|Induction Period|Subject/guardian decision|0|||
126380173|NCT01365455|454687164|FG004|Induction Period|Subject/guardian decision|0|||
126380174|NCT01365455|454687160|FG000|Induction Period|Lost to Follow-up|0|||
126380175|NCT01365455|454687161|FG001|Induction Period|Lost to Follow-up|0|||
126380176|NCT01365455|454687162|FG002|Induction Period|Lost to Follow-up|3|||
126380177|NCT01365455|454687163|FG003|Induction Period|Lost to Follow-up|0|||
126380178|NCT01365455|454687164|FG004|Induction Period|Lost to Follow-up|0|||
126380179|NCT01365455|454687160|FG000|Maintenance Period|Adverse Event|12|||
126380180|NCT01365455|454687161|FG001|Maintenance Period|Adverse Event|5|||
126380181|NCT01365455|454687162|FG002|Maintenance Period|Adverse Event|1|||
126380182|NCT01365455|454687163|FG003|Maintenance Period|Adverse Event|2|||
126380183|NCT01365455|454687164|FG004|Maintenance Period|Adverse Event|4|||
126380184|NCT01365455|454687160|FG000|Maintenance Period|Lack of Efficacy|10|||
126380185|NCT01365455|454687161|FG001|Maintenance Period|Lack of Efficacy|2|||
126380186|NCT01365455|454687162|FG002|Maintenance Period|Lack of Efficacy|0|||
126380187|NCT01365455|454687163|FG003|Maintenance Period|Lack of Efficacy|2|||
126380188|NCT01365455|454687164|FG004|Maintenance Period|Lack of Efficacy|2|||
126380189|NCT01365455|454687160|FG000|Maintenance Period|Lost to Follow-up|2|||
126380190|NCT01365455|454687161|FG001|Maintenance Period|Lost to Follow-up|4|||
126380191|NCT01365455|454687162|FG002|Maintenance Period|Lost to Follow-up|0|||
126380192|NCT01365455|454687163|FG003|Maintenance Period|Lost to Follow-up|0|||
126380193|NCT01365455|454687164|FG004|Maintenance Period|Lost to Follow-up|3|||
126380194|NCT01365455|454687160|FG000|Maintenance Period|Non-compliance with study treatment|0|||
126380195|NCT01365455|454687161|FG001|Maintenance Period|Non-compliance with study treatment|0|||
126380196|NCT01365455|454687162|FG002|Maintenance Period|Non-compliance with study treatment|0|||
126380197|NCT01365455|454687163|FG003|Maintenance Period|Non-compliance with study treatment|1|||
126380198|NCT01365455|454687164|FG004|Maintenance Period|Non-compliance with study treatment|0|||
126380199|NCT01365455|454687160|FG000|Maintenance Period|Physician Decision|0|||
126380200|NCT01365455|454687161|FG001|Maintenance Period|Physician Decision|1|||
126380201|NCT01365455|454687162|FG002|Maintenance Period|Physician Decision|0|||
126380202|NCT01365455|454687163|FG003|Maintenance Period|Physician Decision|0|||
126380203|NCT01365455|454687164|FG004|Maintenance Period|Physician Decision|1|||
126380204|NCT01365455|454687160|FG000|Maintenance Period|Pregnancy|0|||
126380205|NCT01365455|454687161|FG001|Maintenance Period|Pregnancy|4|||
126380206|NCT01365455|454687162|FG002|Maintenance Period|Pregnancy|0|||
126380207|NCT01365455|454687163|FG003|Maintenance Period|Pregnancy|0|||
126380208|NCT01365455|454687164|FG004|Maintenance Period|Pregnancy|2|||
126380209|NCT01365455|454687160|FG000|Maintenance Period|Protocol deviation|1|||
126380210|NCT01365455|454687161|FG001|Maintenance Period|Protocol deviation|1|||
126380211|NCT01365455|454687162|FG002|Maintenance Period|Protocol deviation|0|||
126380212|NCT01365455|454687163|FG003|Maintenance Period|Protocol deviation|0|||
126380213|NCT01365455|454687164|FG004|Maintenance Period|Protocol deviation|0|||
126380214|NCT01365455|454687160|FG000|Maintenance Period|Subject/guardian decision|4|||
126380215|NCT01365455|454687161|FG001|Maintenance Period|Subject/guardian decision|6|||
126380216|NCT01365455|454687162|FG002|Maintenance Period|Subject/guardian decision|2|||
126380217|NCT01365455|454687163|FG003|Maintenance Period|Subject/guardian decision|4|||
126380218|NCT01365455|454687164|FG004|Maintenance Period|Subject/guardian decision|1|||
126380219|NCT00928187|454687165|FG000|Overall Study|Death|1|||
126380220|NCT00928187|454687166|FG001|Overall Study|Death|2|||
126380221|NCT00928187|454687167|FG002|Overall Study|Death|3|||
126380222|NCT00928187|454687165|FG000|Overall Study|Lost to Follow-up|1|||
126380223|NCT00928187|454687166|FG001|Overall Study|Lost to Follow-up|2|||
126380224|NCT00928187|454687167|FG002|Overall Study|Lost to Follow-up|1|||
126380225|NCT00928187|454687165|FG000|Overall Study|Withdrawal by Subject|0|||
126380226|NCT00928187|454687166|FG001|Overall Study|Withdrawal by Subject|1|||
126380227|NCT00928187|454687167|FG002|Overall Study|Withdrawal by Subject|1|||
126380228|NCT00928187|454687165|FG000|Overall Study|Protocol Violation|0|||
126380229|NCT00928187|454687166|FG001|Overall Study|Protocol Violation|1|||
126380230|NCT00928187|454687167|FG002|Overall Study|Protocol Violation|0|||
126380231|NCT01976299|454688828|FG000|Overall Study|Withdrawal by Subject|3|||
126048255|NCT00943917|453473859|FG004|Stage II Continuation|Adverse Event|0|||
126048256|NCT00943917|453473860|FG005|Stage II Continuation|Adverse Event|0|||
126380232|NCT01976299|454688829|FG001|Overall Study|Withdrawal by Subject|1|||
126380233|NCT01976299|454688828|FG000|Overall Study|Death|4|||
126380234|NCT01976299|454688829|FG001|Overall Study|Death|2|||
126380235|NCT01976299|454688828|FG000|Overall Study|Lost to Follow-up|7|||
126380236|NCT01976299|454688829|FG001|Overall Study|Lost to Follow-up|1|||
126380237|NCT01976299|454688828|FG000|Overall Study|See clarification above in comments|9|||
126380238|NCT01976299|454688829|FG001|Overall Study|See clarification above in comments|2|||
126380239|NCT00540592|454688832|FG000|Overall Study|Adverse Event|0|||
126380240|NCT00540592|454688833|FG001|Overall Study|Adverse Event|1|||
126380241|NCT00540592|454688834|FG002|Overall Study|Adverse Event|0|||
126380242|NCT00540592|454688835|FG003|Overall Study|Adverse Event|0|||
126380243|NCT00540592|454688836|FG004|Overall Study|Adverse Event|1|||
126380244|NCT00540592|454688837|FG005|Overall Study|Adverse Event|0|||
126380245|NCT00540592|454688838|FG006|Overall Study|Adverse Event|0|||
126380246|NCT00540592|454688839|FG007|Overall Study|Adverse Event|1|||
126380247|NCT00540592|454688840|FG008|Overall Study|Adverse Event|1|||
126380248|NCT00540592|454688841|FG009|Overall Study|Adverse Event|2|||
126380249|NCT00540592|454688832|FG000|Overall Study|Lost to Follow-up|2|||
126380250|NCT00540592|454688833|FG001|Overall Study|Lost to Follow-up|0|||
126380251|NCT00540592|454688834|FG002|Overall Study|Lost to Follow-up|0|||
126380252|NCT00540592|454688835|FG003|Overall Study|Lost to Follow-up|0|||
126380253|NCT00540592|454688836|FG004|Overall Study|Lost to Follow-up|0|||
126380254|NCT00540592|454688837|FG005|Overall Study|Lost to Follow-up|0|||
126380255|NCT00540592|454688838|FG006|Overall Study|Lost to Follow-up|0|||
126380256|NCT00540592|454688839|FG007|Overall Study|Lost to Follow-up|0|||
126380257|NCT00540592|454688840|FG008|Overall Study|Lost to Follow-up|0|||
126380258|NCT00540592|454688841|FG009|Overall Study|Lost to Follow-up|0|||
126380259|NCT00540592|454688832|FG000|Overall Study|Withdrawal by Subject|0|||
126380260|NCT00540592|454688833|FG001|Overall Study|Withdrawal by Subject|0|||
126380261|NCT00540592|454688834|FG002|Overall Study|Withdrawal by Subject|1|||
126380262|NCT00540592|454688835|FG003|Overall Study|Withdrawal by Subject|1|||
126380263|NCT00540592|454688836|FG004|Overall Study|Withdrawal by Subject|0|||
126380264|NCT00540592|454688837|FG005|Overall Study|Withdrawal by Subject|0|||
126380265|NCT00540592|454688838|FG006|Overall Study|Withdrawal by Subject|0|||
126380266|NCT00540592|454688839|FG007|Overall Study|Withdrawal by Subject|0|||
126380267|NCT00540592|454688840|FG008|Overall Study|Withdrawal by Subject|0|||
126380268|NCT00540592|454688841|FG009|Overall Study|Withdrawal by Subject|0|||
126380269|NCT01456130|454688842|FG000|Overall Study|Adverse Event|4|||
126380270|NCT01456130|454688842|FG000|Overall Study|Voluntary Withdrawal|1|||
126380271|NCT01456130|454688842|FG000|Overall Study|Lack of Efficacy|4|||
126380272|NCT01456130|454688842|FG000|Overall Study|Other|1|||
126380273|NCT02688192|454688847|FG000|Overall Study|Lost to Follow-up|11|||
126380274|NCT02688192|454688848|FG001|Overall Study|Lost to Follow-up|5|||
126380275|NCT02688192|454688847|FG000|Overall Study|Physician Decision|1|||
126380276|NCT02688192|454688848|FG001|Overall Study|Physician Decision|0|||
126380277|NCT05384834|454688849|FG000|Overall Study|Lost to Follow-up|43|||
126380278|NCT05384834|454688849|FG000|Overall Study|Withdrawal by Subject|5|||
126380279|NCT02948582|454688850|FG000|Washout Period 1|Adverse Event|0|||
126380280|NCT02948582|454688851|FG001|Washout Period 1|Adverse Event|2|||
126380281|NCT02948582|454688852|FG002|Washout Period 1|Adverse Event|0|||
126380282|NCT02948582|454688853|FG003|Washout Period 1|Adverse Event|0|||
126380283|NCT02948582|454688854|FG004|Washout Period 1|Adverse Event|0|||
126380284|NCT02948582|454688855|FG005|Washout Period 1|Adverse Event|0|||
126380285|NCT02948582|454688850|FG000|Washout Period 1|Protocol Violation|0|||
126380286|NCT02948582|454688851|FG001|Washout Period 1|Protocol Violation|0|||
126380287|NCT02948582|454688852|FG002|Washout Period 1|Protocol Violation|0|||
126380288|NCT02948582|454688853|FG003|Washout Period 1|Protocol Violation|0|||
126380289|NCT02948582|454688854|FG004|Washout Period 1|Protocol Violation|0|||
126380290|NCT02948582|454688855|FG005|Washout Period 1|Protocol Violation|1|||
126380291|NCT02948582|454688850|FG000|Washout Period 2|Adverse Event|0|||
126380292|NCT02948582|454688851|FG001|Washout Period 2|Adverse Event|1|||
126380293|NCT02948582|454688852|FG002|Washout Period 2|Adverse Event|0|||
126380294|NCT02948582|454688853|FG003|Washout Period 2|Adverse Event|0|||
126380295|NCT02948582|454688854|FG004|Washout Period 2|Adverse Event|0|||
126380296|NCT02948582|454688855|FG005|Washout Period 2|Adverse Event|0|||
126380297|NCT02948582|454688850|FG000|Washout Period 2|personal reasons|0|||
126380298|NCT02948582|454688851|FG001|Washout Period 2|personal reasons|0|||
126380299|NCT02948582|454688852|FG002|Washout Period 2|personal reasons|0|||
126380300|NCT02948582|454688853|FG003|Washout Period 2|personal reasons|1|||
126380301|NCT02948582|454688854|FG004|Washout Period 2|personal reasons|0|||
126380302|NCT02948582|454688855|FG005|Washout Period 2|personal reasons|0|||
126380303|NCT02948582|454688850|FG000|Washout Period 4|Adverse Event|1|||
126380304|NCT02948582|454688851|FG001|Washout Period 4|Adverse Event|0|||
126380305|NCT02948582|454688852|FG002|Washout Period 4|Adverse Event|1|||
126380306|NCT02948582|454688853|FG003|Washout Period 4|Adverse Event|0|||
126380307|NCT02948582|454688854|FG004|Washout Period 4|Adverse Event|0|||
126380308|NCT02948582|454688855|FG005|Washout Period 4|Adverse Event|0|||
126380309|NCT03386435|454688870|FG000|Overall Study|Protocol Violation|5|||
126380310|NCT03386435|454688871|FG001|Overall Study|Protocol Violation|7|||
126380311|NCT00625586|454688872|FG000|Overall Study|Adverse Event|1|||
126380312|NCT00625586|454688872|FG000|Overall Study|Progressive disease|1|||
126380313|NCT00124072|454688875|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
126380314|NCT00124072|454688876|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
126380315|NCT00124072|454688877|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
126380316|NCT00124072|454688878|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
126380317|NCT00124072|454688875|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
126380318|NCT00124072|454688876|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
126380319|NCT00124072|454688877|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
126380320|NCT00124072|454688878|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
126380321|NCT00124072|454688875|FG000|Overall Study|Death|499|||
126380322|NCT00124072|454688876|FG001|Overall Study|Death|484|||
126380323|NCT00124072|454688877|FG002|Overall Study|Death|471|||
126380324|NCT00124072|454688878|FG003|Overall Study|Death|480|||
126380325|NCT02534883|454688879|FG000|Overall Study|Early Termination|8|||
126380326|NCT02534883|454688880|FG001|Overall Study|Early Termination|3|||
126380327|NCT03328832|454688881|FG000|Overall Study|Lost to Follow-up|0|||
126380328|NCT03328832|454688882|FG001|Overall Study|Lost to Follow-up|1|||
126380329|NCT00886769|454688883|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
126380330|NCT00886769|454688884|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
126380331|NCT00778336|454688885|FG000|Index Procedure-Discharge|Death|6|||
126380332|NCT00778336|454688886|FG001|Index Procedure-Discharge|Death|3|||
126380333|NCT00778336|454688887|FG002|Index Procedure-Discharge|Death|2|||
126380334|NCT00778336|454688888|FG003|Index Procedure-Discharge|Death|0|||
126380335|NCT00778336|454688885|FG000|3 Month Follow Up|Lost to Follow-up|15|||
126380336|NCT00778336|454688886|FG001|3 Month Follow Up|Lost to Follow-up|20|||
126380337|NCT00778336|454688887|FG002|3 Month Follow Up|Lost to Follow-up|3|||
126380338|NCT00778336|454688888|FG003|3 Month Follow Up|Lost to Follow-up|0|||
126380339|NCT00778336|454688885|FG000|3 Month Follow Up|Death|8|||
126380340|NCT00778336|454688886|FG001|3 Month Follow Up|Death|3|||
126380341|NCT00778336|454688887|FG002|3 Month Follow Up|Death|2|||
126380342|NCT00778336|454688888|FG003|3 Month Follow Up|Death|0|||
126380343|NCT00414076|454688891|FG000|Overall Study|Progression|1|||
126380344|NCT00414076|454688892|FG001|Overall Study|Progression|2|||
126380345|NCT00414076|454688891|FG000|Overall Study|Withdrawal by Subject|1|||
126380346|NCT00414076|454688892|FG001|Overall Study|Withdrawal by Subject|3|||
126380347|NCT00414076|454688891|FG000|Overall Study|Adverse Event|1|||
126380348|NCT00414076|454688892|FG001|Overall Study|Adverse Event|0|||
126380349|NCT00049257|454688893|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
126380350|NCT00049257|454688893|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
126380351|NCT00049257|454688893|FG000|Carboplatin, Paclitaxel|Death|2|||
126380352|NCT00049257|454688893|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
126380353|NCT04721158|454688894|FG000|Overall Study|Lost to Follow-up|4|||
126380354|NCT04721158|454688894|FG000|Overall Study|Device did not connect|1|||
126380355|NCT04872569|454688895|FG000|Overall Study|Withdrawal by Subject|2|||
126380356|NCT02382991|454688896|FG000|Overall Study|Adverse Event|1|||
126380357|NCT02382991|454688897|FG001|Overall Study|Adverse Event|2|||
126380358|NCT02382991|454688896|FG000|Overall Study|Lost to Follow-up|1|||
126380359|NCT02382991|454688897|FG001|Overall Study|Lost to Follow-up|0|||
126380360|NCT02382991|454688896|FG000|Overall Study|Withdrawal by Subject|0|||
126380361|NCT02382991|454688897|FG001|Overall Study|Withdrawal by Subject|1|||
126380362|NCT04466384|454688898|FG000|First Phase|Protocol Violation|1|||
126380363|NCT04466384|454688899|FG001|First Phase|Protocol Violation|0|||
126380364|NCT04466384|454688898|FG000|First Phase|Missing data|1|||
126380365|NCT04466384|454688899|FG001|First Phase|Missing data|0|||
126380366|NCT04466384|454688898|FG000|Cross Over Phase|Physician Decision|1|||
126380367|NCT04466384|454688899|FG001|Cross Over Phase|Physician Decision|0|||
126380368|NCT04466384|454688898|FG000|Cross Over Phase|Withdrawal by Subject|0|||
126380369|NCT04466384|454688899|FG001|Cross Over Phase|Withdrawal by Subject|1|||
126380370|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
126380371|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
126380372|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
126380373|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
126380374|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
126380375|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
126380376|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Other|0|||
126380377|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Other|1|||
126380378|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Other|1|||
126380379|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Other|0|||
126380380|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Other|0|||
126380381|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Other|0|||
126380382|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
126048257|NCT00943917|453473861|FG006|Stage II Continuation|Adverse Event|0|||
126380383|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
126380384|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
126380385|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
126380386|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
126380387|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
126380388|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380389|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380390|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
126380391|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380392|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380393|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380394|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
126380395|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380396|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380397|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380398|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380399|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380400|NCT03554018|454688908|FG000|Overall Study|Lost to Follow-up|3|||
126380401|NCT03554018|454688909|FG001|Overall Study|Lost to Follow-up|7|||
126380402|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
126380403|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
126380404|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
126380405|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380406|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380407|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380408|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380409|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380410|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380411|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380412|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380413|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380414|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380415|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380416|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380417|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380418|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
126380419|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
126380420|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380421|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380422|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380423|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380424|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380425|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380426|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380427|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380428|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380429|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380430|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380431|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380432|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380433|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380434|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380435|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380436|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380437|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
126380438|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380439|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380440|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380441|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380442|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380443|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380444|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380445|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380446|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380447|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380448|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380449|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380450|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380451|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380452|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
126380453|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126048258|NCT00943917|453473862|FG007|Stage II Continuation|Adverse Event|0|||
126380454|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380455|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380456|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380457|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380458|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380459|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380460|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380461|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380462|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380463|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380464|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380465|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380466|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380467|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380468|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380469|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
126380470|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380471|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380472|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380473|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380474|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380475|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380476|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380477|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380478|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380479|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380480|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380481|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380482|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380483|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380484|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380485|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
126380486|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380487|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380488|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380489|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380490|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380491|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126104159|NCT00596427|453675817|FG000|Overall Study|Withdrawal by Subject|2|||
126104160|NCT00596427|453675818|FG001|Overall Study|Withdrawal by Subject|2|||
126104161|NCT00596427|453675817|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
126104162|NCT00596427|453675818|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
126380492|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380493|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380494|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380495|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380496|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380497|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380498|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380499|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380500|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380501|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380502|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380503|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380504|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
126380505|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
126380506|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
126380507|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
126380508|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380509|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380510|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380511|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380512|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380513|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380514|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380515|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380516|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380517|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380518|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380519|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
126380520|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380521|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380522|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380523|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
126380524|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380525|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125886591|NCT01235741|452881790|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
125886592|NCT01235741|452881791|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
125886593|NCT01235741|452881792|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
125886594|NCT01235741|452881790|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
125886595|NCT01235741|452881791|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
125886596|NCT01235741|452881792|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
125886597|NCT01235741|452881790|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
125886598|NCT01235741|452881791|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
125886599|NCT01235741|452881792|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
125886600|NCT01235741|452881790|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
125886601|NCT01235741|452881791|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
125886602|NCT01235741|452881792|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
126380526|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380527|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125886603|NCT01235741|452881790|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
125886604|NCT01235741|452881791|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
125886605|NCT01235741|452881792|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
125886606|NCT01235741|452881790|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
125886607|NCT01235741|452881791|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
125886608|NCT01235741|452881792|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
125886609|NCT01235741|452881790|FG000|Randomized to Treatment|Adverse Event|0|||
125886610|NCT01235741|452881791|FG001|Randomized to Treatment|Adverse Event|1|||
125886611|NCT01235741|452881792|FG002|Randomized to Treatment|Adverse Event|1|||
125886612|NCT01235741|452881790|FG000|Randomized to Treatment|Sponsor terminated study|0|||
125886613|NCT01235741|452881791|FG001|Randomized to Treatment|Sponsor terminated study|35|||
125886614|NCT01235741|452881792|FG002|Randomized to Treatment|Sponsor terminated study|34|||
125886615|NCT01235741|452881790|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
125886616|NCT01235741|452881791|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
125886617|NCT01235741|452881792|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
125886618|NCT01235741|452881790|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
125886619|NCT01235741|452881791|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
125886620|NCT01235741|452881792|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
126380528|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380529|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380530|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380531|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380532|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380533|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380534|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380535|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125886621|NCT01235741|452881790|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
125886622|NCT01235741|452881791|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
125886623|NCT01235741|452881792|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
125886624|NCT01705509|452881793|FG000|Inclusion CPET|Screen Failure|5|||
125886625|NCT01705509|452881793|FG000|Inclusion CPET|Withdrawal by Subject|2|||
125886626|NCT01705509|452881793|FG000|CPET w/ Ranexa|Screen Failure|2|||
125886627|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
126380536|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
126380537|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
126380538|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
126380539|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
126380540|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380541|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380542|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380543|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380544|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380545|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380546|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380547|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125886628|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
125886629|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
125886630|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
126380548|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125886631|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
126380549|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380550|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
126380551|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380552|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380553|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380554|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380555|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380556|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380557|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380558|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380559|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380560|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380561|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380562|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380563|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380564|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380565|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380566|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380567|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380568|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
126380569|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380570|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380571|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380572|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380573|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380574|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380575|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380576|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380577|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380578|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380579|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380580|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380581|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380582|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380583|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380584|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380585|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
126380586|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
126380587|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
126380588|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380589|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380590|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380591|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380592|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380593|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380594|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126048259|NCT00943917|453473863|FG008|Stage II Continuation|Adverse Event|0|||
126380595|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380596|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380597|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380598|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380599|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380600|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380601|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
126380602|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380603|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380604|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380605|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380606|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380607|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380608|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380609|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380610|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380611|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380612|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380613|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380614|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380615|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380616|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380617|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380618|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
126380619|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380620|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380621|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380622|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380623|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380624|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380625|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380626|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380627|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380628|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380629|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380630|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380631|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380632|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380633|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380634|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380635|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
126380636|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380637|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380638|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380639|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380640|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380641|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380642|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380643|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380644|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380645|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380646|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380647|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380648|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380649|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380650|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380651|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
126380652|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380653|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380654|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126048260|NCT00943917|453473864|FG009|Stage II Continuation|Adverse Event|0|||
126048261|NCT00943917|453473865|FG010|Stage II Continuation|Adverse Event|0|||
126048262|NCT00943917|453473866|FG011|Stage II Continuation|Adverse Event|1|||
126048263|NCT00943917|453473867|FG012|Stage II Continuation|Adverse Event|2|||
126048264|NCT00943917|453473868|FG013|Stage II Continuation|Adverse Event|1|||
126048265|NCT00943917|453473869|FG014|Stage II Continuation|Adverse Event|1|||
126048266|NCT00943917|453473855|FG000|Stage II Continuation|Withdrawal by Subject|0|||
126048267|NCT00943917|453473856|FG001|Stage II Continuation|Withdrawal by Subject|0|||
126048268|NCT00943917|453473857|FG002|Stage II Continuation|Withdrawal by Subject|0|||
126048269|NCT00943917|453473858|FG003|Stage II Continuation|Withdrawal by Subject|0|||
126048270|NCT00943917|453473859|FG004|Stage II Continuation|Withdrawal by Subject|0|||
126104163|NCT00596427|453675817|FG000|Overall Study|Protocol Violation|1|||
126104164|NCT00596427|453675818|FG001|Overall Study|Protocol Violation|0|||
126104165|NCT00320541|453675819|FG000|Overall Study|Adverse Event|21|||
126380655|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380656|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380657|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380658|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380659|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380660|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380661|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380662|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380663|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380664|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380665|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380666|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380667|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380668|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
126104166|NCT00320541|453675820|FG001|Overall Study|Adverse Event|19|||
126380669|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380670|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380671|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380672|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380673|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380674|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380675|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380676|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380677|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380678|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380679|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380680|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380681|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380682|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380683|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380684|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
126380685|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380686|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126104167|NCT00320541|453675819|FG000|Overall Study|Protocol Violation|0|||
126104168|NCT00320541|453675820|FG001|Overall Study|Protocol Violation|1|||
126380687|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380688|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380689|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380690|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380691|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380692|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380693|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380694|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380695|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380696|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380697|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380698|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380699|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380700|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
126380701|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380702|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380703|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380704|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380705|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380706|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380707|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380708|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380709|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380710|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380711|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380712|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380713|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380714|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380715|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380716|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
126380717|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380718|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380719|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380720|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380721|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380722|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380723|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380724|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380725|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380726|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380727|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380728|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380729|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380730|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380731|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380732|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
126380733|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380734|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380735|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380736|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380737|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380738|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380739|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380740|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380741|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126048271|NCT00943917|453473860|FG005|Stage II Continuation|Withdrawal by Subject|0|||
126048272|NCT00943917|453473861|FG006|Stage II Continuation|Withdrawal by Subject|0|||
126048273|NCT00943917|453473862|FG007|Stage II Continuation|Withdrawal by Subject|0|||
126380742|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380743|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380744|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380745|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380746|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380747|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380748|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
126380749|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126048274|NCT00943917|453473863|FG008|Stage II Continuation|Withdrawal by Subject|0|||
126048275|NCT00943917|453473864|FG009|Stage II Continuation|Withdrawal by Subject|0|||
126048276|NCT00943917|453473865|FG010|Stage II Continuation|Withdrawal by Subject|0|||
126380750|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380751|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380752|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380753|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380754|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380755|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380756|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380757|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380758|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380759|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380760|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380761|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380762|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380763|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380764|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
126380765|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380766|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380767|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380768|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380769|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380770|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380771|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380772|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380773|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380774|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380775|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380776|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380777|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380778|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380779|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380780|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
126380781|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380782|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380783|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380784|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380785|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380786|NCT02891226|454688912|FG000|Follow-up Period|Withdrawal by Subject|0|||
126380787|NCT02891226|454688913|FG001|Follow-up Period|Withdrawal by Subject|0|||
126380788|NCT02891226|454688914|FG002|Follow-up Period|Withdrawal by Subject|0|||
126380789|NCT02891226|454688915|FG003|Follow-up Period|Withdrawal by Subject|0|||
126380790|NCT02891226|454688916|FG004|Follow-up Period|Withdrawal by Subject|0|||
126380791|NCT02891226|454688917|FG005|Follow-up Period|Withdrawal by Subject|0|||
126380792|NCT02891226|454688918|FG006|Follow-up Period|Withdrawal by Subject|0|||
126380793|NCT02891226|454688919|FG007|Follow-up Period|Withdrawal by Subject|0|||
126380794|NCT02891226|454688920|FG008|Follow-up Period|Withdrawal by Subject|0|||
126380795|NCT02891226|454688921|FG009|Follow-up Period|Withdrawal by Subject|0|||
126380796|NCT02891226|454688922|FG010|Follow-up Period|Withdrawal by Subject|0|||
126380797|NCT02891226|454688923|FG011|Follow-up Period|Withdrawal by Subject|1|||
125886632|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
125886633|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
125886634|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
125886635|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
126048277|NCT00943917|453473866|FG011|Stage II Continuation|Withdrawal by Subject|0|||
126380798|NCT02891226|454688924|FG012|Follow-up Period|Withdrawal by Subject|0|||
126380799|NCT02891226|454688925|FG013|Follow-up Period|Withdrawal by Subject|0|||
126380800|NCT02891226|454688926|FG014|Follow-up Period|Withdrawal by Subject|1|||
126380801|NCT02891226|454688927|FG015|Follow-up Period|Withdrawal by Subject|1|||
126380802|NCT01928433|454688928|FG000|Overall Study|Adverse Event|5|||
126380803|NCT01928433|454688929|FG001|Overall Study|Adverse Event|2|||
126380804|NCT01928433|454688930|FG002|Overall Study|Adverse Event|5|||
126380805|NCT01928433|454688928|FG000|Overall Study|Protocol Violation|0|||
126380806|NCT01928433|454688929|FG001|Overall Study|Protocol Violation|0|||
126380807|NCT01928433|454688930|FG002|Overall Study|Protocol Violation|2|||
126380808|NCT01928433|454688928|FG000|Overall Study|Lack of Efficacy|5|||
126380809|NCT01928433|454688929|FG001|Overall Study|Lack of Efficacy|4|||
126380810|NCT01928433|454688930|FG002|Overall Study|Lack of Efficacy|4|||
126380811|NCT01928433|454688928|FG000|Overall Study|Withdrawal by Subject|0|||
126380812|NCT01928433|454688929|FG001|Overall Study|Withdrawal by Subject|4|||
126380813|NCT01928433|454688930|FG002|Overall Study|Withdrawal by Subject|0|||
126380814|NCT01928433|454688928|FG000|Overall Study|Negative screening urine culture|7|||
126380815|NCT01928433|454688929|FG001|Overall Study|Negative screening urine culture|6|||
126380816|NCT01928433|454688930|FG002|Overall Study|Negative screening urine culture|10|||
126380817|NCT01928433|454688928|FG000|Overall Study|Lost to Follow-up|0|||
126380818|NCT01928433|454688929|FG001|Overall Study|Lost to Follow-up|2|||
126380819|NCT01928433|454688930|FG002|Overall Study|Lost to Follow-up|3|||
126380820|NCT01928433|454688928|FG000|Overall Study|Other reasons|3|||
126380821|NCT01928433|454688929|FG001|Overall Study|Other reasons|3|||
126380822|NCT01928433|454688930|FG002|Overall Study|Other reasons|4|||
126380823|NCT00145626|454688931|FG000|Overall Study|Did not have NK infusions|2|||
126380824|NCT00145626|454688931|FG000|Overall Study|Turned 2 years old before treatment|1|||
126380825|NCT00145626|454688931|FG000|Overall Study|Death|1|||
126380826|NCT00145626|454688931|FG000|Overall Study|Withdrawal by Subject|1|||
126380827|NCT00436436|454688932|FG000|Overall Study|Progression|4|||
126380828|NCT00436436|454688932|FG000|Overall Study|Adverse Event|2|||
126380829|NCT00436436|454688932|FG000|Overall Study|Death|6|||
126380830|NCT03654274|454688937|FG000|Overall Study|Adverse Event|19|||
126380831|NCT03654274|454688938|FG001|Overall Study|Adverse Event|23|||
126380832|NCT03654274|454688939|FG002|Overall Study|Adverse Event|24|||
126380833|NCT03654274|454688937|FG000|Overall Study|Protocol Deviation|0|||
126380834|NCT03654274|454688938|FG001|Overall Study|Protocol Deviation|2|||
126380835|NCT03654274|454688939|FG002|Overall Study|Protocol Deviation|0|||
126380836|NCT03654274|454688937|FG000|Overall Study|Lost to Follow-up|8|||
126380837|NCT03654274|454688938|FG001|Overall Study|Lost to Follow-up|6|||
126380838|NCT03654274|454688939|FG002|Overall Study|Lost to Follow-up|5|||
126380839|NCT03654274|454688937|FG000|Overall Study|Withdrawal by Subject|46|||
126380840|NCT03654274|454688938|FG001|Overall Study|Withdrawal by Subject|25|||
126380841|NCT03654274|454688939|FG002|Overall Study|Withdrawal by Subject|33|||
126380842|NCT03654274|454688937|FG000|Overall Study|Lack of Efficacy|4|||
126380843|NCT03654274|454688938|FG001|Overall Study|Lack of Efficacy|5|||
126380844|NCT03654274|454688939|FG002|Overall Study|Lack of Efficacy|7|||
126380845|NCT03654274|454688937|FG000|Overall Study|Pregnancy|2|||
126380846|NCT03654274|454688938|FG001|Overall Study|Pregnancy|2|||
126380847|NCT03654274|454688939|FG002|Overall Study|Pregnancy|1|||
126380848|NCT03654274|454688937|FG000|Overall Study|Other|27|||
126380849|NCT03654274|454688938|FG001|Overall Study|Other|29|||
126380850|NCT03654274|454688939|FG002|Overall Study|Other|32|||
126380851|NCT03654274|454688937|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
126380852|NCT03654274|454688938|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
126380853|NCT03654274|454688939|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
126380854|NCT01102491|454688942|FG000|Overall Study|Protocol Violation|11|||
126380855|NCT01102491|454688943|FG001|Overall Study|Protocol Violation|12|||
126380856|NCT05005273|454688944|FG000|Overall Study|Study Terminated|1|||
126380857|NCT05005273|454688945|FG001|Overall Study|Study Terminated|0|||
126380858|NCT02151786|454688946|FG000|Overall Study|Unavailability of Case Report Form|26|||
126380859|NCT02151786|454688946|FG000|Overall Study|Outside the Contract Period|1|||
126380860|NCT02151786|454688946|FG000|Overall Study|Randomized, not Treated|1|||
126380861|NCT02151786|454688946|FG000|Overall Study|Unavailability of Information|8|||
126380862|NCT03533660|454688947|FG000|Overall Study|Withdrawal by Subject|2|||
126380863|NCT03533660|454688948|FG001|Overall Study|Withdrawal by Subject|2|||
126380864|NCT03533660|454688947|FG000|Overall Study|Death|2|||
126380865|NCT03533660|454688948|FG001|Overall Study|Death|4|||
126380866|NCT03533660|454688947|FG000|Overall Study|Adverse Event|0|||
126380867|NCT03533660|454688948|FG001|Overall Study|Adverse Event|2|||
126380868|NCT00996658|454688949|FG000|Overall Study|Adverse Event|2|||
126380869|NCT00996658|454688950|FG001|Overall Study|Adverse Event|5|||
126380870|NCT00996658|454688949|FG000|Overall Study|Protocol Violation|0|||
126380871|NCT00996658|454688950|FG001|Overall Study|Protocol Violation|1|||
126380872|NCT00996658|454688949|FG000|Overall Study|Lost to Follow-up|2|||
126380873|NCT00996658|454688950|FG001|Overall Study|Lost to Follow-up|5|||
126380874|NCT00996658|454688949|FG000|Overall Study|Non-compliance issues|3|||
126380875|NCT00996658|454688950|FG001|Overall Study|Non-compliance issues|3|||
126380876|NCT00996658|454688949|FG000|Overall Study|Other|9|||
126380877|NCT00996658|454688950|FG001|Overall Study|Other|7|||
126380878|NCT03154476|454688959|FG000|Overall Study|Lost to Follow-up|4|||
126380879|NCT03154476|454688960|FG001|Overall Study|Lost to Follow-up|4|||
126380880|NCT02685826|454688961|FG000|Overall Study|Adverse Event|2|||
126380881|NCT02685826|454688962|FG001|Overall Study|Adverse Event|0|||
126380882|NCT02685826|454688963|FG002|Overall Study|Adverse Event|1|||
126380883|NCT02685826|454688961|FG000|Overall Study|Progressive Disease|2|||
126380884|NCT02685826|454688962|FG001|Overall Study|Progressive Disease|1|||
126380885|NCT02685826|454688963|FG002|Overall Study|Progressive Disease|0|||
126380886|NCT02685826|454688961|FG000|Overall Study|Withdrawal by Subject|2|||
126380887|NCT02685826|454688962|FG001|Overall Study|Withdrawal by Subject|0|||
126380888|NCT02685826|454688963|FG002|Overall Study|Withdrawal by Subject|0|||
126380889|NCT02685826|454688961|FG000|Overall Study|Full Clinical Hold by FDA|19|||
126380890|NCT02685826|454688962|FG001|Overall Study|Full Clinical Hold by FDA|9|||
126380891|NCT02685826|454688963|FG002|Overall Study|Full Clinical Hold by FDA|20|||
126380892|NCT00200967|454688966|FG000|First Treatment Period|Withdrawal by Subject|5|||
126380893|NCT00200967|454688967|FG001|First Treatment Period|Withdrawal by Subject|1|||
126380894|NCT00200967|454688966|FG000|First Treatment Period|Pregnancy|1|||
126380895|NCT00200967|454688967|FG001|First Treatment Period|Pregnancy|0|||
126380896|NCT00200967|454688966|FG000|Wash-out Period|Lost to Follow-up|0|||
126380897|NCT00200967|454688967|FG001|Wash-out Period|Lost to Follow-up|1|||
126380898|NCT00200967|454688966|FG000|Second Treatment Period|Withdrawal by Subject|1|||
126380899|NCT00200967|454688967|FG001|Second Treatment Period|Withdrawal by Subject|2|||
126380900|NCT00200967|454688966|FG000|Run-out Period|Lost to Follow-up|1|||
126380901|NCT00200967|454688967|FG001|Run-out Period|Lost to Follow-up|0|||
126380902|NCT01444430|454688970|FG000|Overall Study|Withdrawal by Subject|53|||
126380903|NCT01444430|454688971|FG001|Overall Study|Withdrawal by Subject|72|||
126380904|NCT01444430|454688970|FG000|Overall Study|Death|6|||
126380905|NCT01444430|454688971|FG001|Overall Study|Death|8|||
126380906|NCT01444430|454688970|FG000|Overall Study|Lost to Follow-up|2|||
126380907|NCT01444430|454688971|FG001|Overall Study|Lost to Follow-up|0|||
126380908|NCT01444430|454688970|FG000|Overall Study|CRF termination module not completed.|0|||
126380909|NCT01444430|454688971|FG001|Overall Study|CRF termination module not completed.|1|||
126380910|NCT02297815|454690351|FG000|Overall Study|Lost to Follow-up|236|||
126380911|NCT02297815|454690352|FG001|Overall Study|Lost to Follow-up|140|||
126380912|NCT00662831|454690353|FG000|Overall Study|Death|4|||
126380913|NCT00662831|454690354|FG001|Overall Study|Death|1|||
126380914|NCT00662831|454690353|FG000|Overall Study|Lack of Efficacy|6|||
126380915|NCT00662831|454690354|FG001|Overall Study|Lack of Efficacy|6|||
126380916|NCT00662831|454690353|FG000|Overall Study|Lost to Follow-up|1|||
126380917|NCT00662831|454690354|FG001|Overall Study|Lost to Follow-up|0|||
126380918|NCT00662831|454690353|FG000|Overall Study|Withdrawal by Subject|2|||
126380919|NCT00662831|454690354|FG001|Overall Study|Withdrawal by Subject|1|||
126380920|NCT00662831|454690353|FG000|Overall Study|Other|62|||
126380921|NCT00662831|454690354|FG001|Overall Study|Other|31|||
126380922|NCT00662831|454690353|FG000|Overall Study|Protocol Violation|8|||
126380923|NCT00662831|454690354|FG001|Overall Study|Protocol Violation|4|||
126380924|NCT00662831|454690353|FG000|Overall Study|Adverse Event|23|||
126380925|NCT00662831|454690354|FG001|Overall Study|Adverse Event|16|||
126380926|NCT01061723|454690356|FG000|Overall Study|Adverse Event|0|||
126380927|NCT01061723|454690357|FG001|Overall Study|Adverse Event|2|||
126380928|NCT01061723|454690358|FG002|Overall Study|Adverse Event|5|||
126380929|NCT01061723|454690359|FG003|Overall Study|Adverse Event|5|||
126380930|NCT01061723|454690360|FG004|Overall Study|Adverse Event|2|||
126380931|NCT01061723|454690361|FG005|Overall Study|Adverse Event|6|||
126380932|NCT01061723|454690356|FG000|Overall Study|Lack of Efficacy|2|||
126380933|NCT01061723|454690357|FG001|Overall Study|Lack of Efficacy|3|||
126380934|NCT01061723|454690358|FG002|Overall Study|Lack of Efficacy|4|||
126380935|NCT01061723|454690359|FG003|Overall Study|Lack of Efficacy|2|||
126380936|NCT01061723|454690360|FG004|Overall Study|Lack of Efficacy|1|||
126380937|NCT01061723|454690361|FG005|Overall Study|Lack of Efficacy|1|||
126380938|NCT01061723|454690356|FG000|Overall Study|Randomized but not treated|0|||
126380939|NCT01061723|454690357|FG001|Overall Study|Randomized but not treated|0|||
126380940|NCT01061723|454690358|FG002|Overall Study|Randomized but not treated|0|||
126380941|NCT01061723|454690359|FG003|Overall Study|Randomized but not treated|0|||
126380942|NCT01061723|454690360|FG004|Overall Study|Randomized but not treated|0|||
126380943|NCT01061723|454690361|FG005|Overall Study|Randomized but not treated|1|||
126380944|NCT01061723|454690356|FG000|Overall Study|Other than specified above|2|||
126380945|NCT01061723|454690357|FG001|Overall Study|Other than specified above|1|||
126380946|NCT01061723|454690358|FG002|Overall Study|Other than specified above|1|||
126380947|NCT01061723|454690359|FG003|Overall Study|Other than specified above|1|||
126380948|NCT01061723|454690360|FG004|Overall Study|Other than specified above|0|||
126380949|NCT01061723|454690361|FG005|Overall Study|Other than specified above|1|||
126380950|NCT00566982|454690362|FG000|Overall Study|Adverse Event|6|||
126380951|NCT00566982|454690363|FG001|Overall Study|Adverse Event|48|||
126380952|NCT00566982|454690362|FG000|Overall Study|Withdrawal by Subject|1|||
126380953|NCT00566982|454690363|FG001|Overall Study|Withdrawal by Subject|14|||
126380954|NCT00566982|454690362|FG000|Overall Study|Protocol Violation|1|||
126380955|NCT00566982|454690363|FG001|Overall Study|Protocol Violation|4|||
126380956|NCT00566982|454690362|FG000|Overall Study|Lost to Follow-up|0|||
126380957|NCT00566982|454690363|FG001|Overall Study|Lost to Follow-up|1|||
126380958|NCT00566982|454690362|FG000|Overall Study|Other-family problems & doctor's request|0|||
126380959|NCT00566982|454690363|FG001|Overall Study|Other-family problems & doctor's request|2|||
126380960|NCT04245449|454690367|FG000|Overall Study|COVID shutdown|7|||
126380961|NCT02197572|454690372|FG000|Overall Study|Progressive Disease|28|||
126380962|NCT02197572|454690372|FG000|Overall Study|Withdrawal by Subject|9|||
126380963|NCT02197572|454690372|FG000|Overall Study|Adverse Event|3|||
126380964|NCT02197572|454690372|FG000|Overall Study|Reason Not Specified|4|||
126380965|NCT01147393|454690373|FG000|Dose Level 1|Dose limiting Toxicity|2|||
126380966|NCT01147393|454690373|FG000|Dose Level -1|Dose Limited Toxicity|1|||
126380967|NCT01408277|454690377|FG000|Overall Study|Adverse Event|3|||
126380968|NCT01408277|454690378|FG001|Overall Study|Adverse Event|4|||
126380969|NCT01408277|454690377|FG000|Overall Study|Lost to Follow-up|1|||
126380970|NCT01408277|454690378|FG001|Overall Study|Lost to Follow-up|0|||
126380971|NCT01408277|454690377|FG000|Overall Study|Withdrawal by Subject|2|||
126380972|NCT01408277|454690378|FG001|Overall Study|Withdrawal by Subject|0|||
126380973|NCT01408277|454690377|FG000|Overall Study|Protocol Violation|2|||
126380974|NCT01408277|454690378|FG001|Overall Study|Protocol Violation|0|||
126380975|NCT03801928|454690381|FG000|Overall Study|Adverse Event|1|||
126380976|NCT03801928|454690382|FG001|Overall Study|Adverse Event|0|||
126380977|NCT03801928|454690383|FG002|Overall Study|Adverse Event|1|||
126380978|NCT03801928|454690384|FG003|Overall Study|Adverse Event|2|||
126380979|NCT03801928|454690385|FG004|Overall Study|Adverse Event|0|||
126380980|NCT03801928|454690386|FG005|Overall Study|Adverse Event|2|||
126380981|NCT03801928|454690381|FG000|Overall Study|Lack of Efficacy|0|||
126380982|NCT03801928|454690382|FG001|Overall Study|Lack of Efficacy|0|||
126380983|NCT03801928|454690383|FG002|Overall Study|Lack of Efficacy|1|||
126380984|NCT03801928|454690384|FG003|Overall Study|Lack of Efficacy|0|||
126380985|NCT03801928|454690385|FG004|Overall Study|Lack of Efficacy|0|||
126380986|NCT03801928|454690386|FG005|Overall Study|Lack of Efficacy|0|||
126380987|NCT03801928|454690381|FG000|Overall Study|Lost to Follow-up|5|||
126380988|NCT03801928|454690382|FG001|Overall Study|Lost to Follow-up|1|||
126380989|NCT03801928|454690383|FG002|Overall Study|Lost to Follow-up|1|||
126380990|NCT03801928|454690384|FG003|Overall Study|Lost to Follow-up|4|||
126380991|NCT03801928|454690385|FG004|Overall Study|Lost to Follow-up|4|||
126380992|NCT03801928|454690386|FG005|Overall Study|Lost to Follow-up|2|||
126380993|NCT03801928|454690381|FG000|Overall Study|Withdrawal by Subject|0|||
126380994|NCT03801928|454690382|FG001|Overall Study|Withdrawal by Subject|0|||
126380995|NCT03801928|454690383|FG002|Overall Study|Withdrawal by Subject|2|||
126380996|NCT03801928|454690384|FG003|Overall Study|Withdrawal by Subject|1|||
126380997|NCT03801928|454690385|FG004|Overall Study|Withdrawal by Subject|0|||
126380998|NCT03801928|454690386|FG005|Overall Study|Withdrawal by Subject|0|||
126380999|NCT03801928|454690381|FG000|Overall Study|Other|0|||
126381000|NCT03801928|454690382|FG001|Overall Study|Other|2|||
126381001|NCT03801928|454690383|FG002|Overall Study|Other|0|||
126381002|NCT03801928|454690384|FG003|Overall Study|Other|1|||
126381003|NCT03801928|454690385|FG004|Overall Study|Other|0|||
126381004|NCT03801928|454690386|FG005|Overall Study|Other|1|||
126381005|NCT04263766|454690387|FG000|Overall Study|Withdrawal by Subject|6|||
126381006|NCT04263766|454690388|FG001|Overall Study|Withdrawal by Subject|4|||
126381007|NCT04263766|454690387|FG000|Overall Study|Lack of Efficacy|1|||
126381008|NCT04263766|454690388|FG001|Overall Study|Lack of Efficacy|3|||
126381009|NCT00573391|454690390|FG000|Overall Study|study stopped|2|||
126381010|NCT00573391|454690391|FG001|Overall Study|study stopped|2|||
126381011|NCT00573391|454690390|FG000|Overall Study|Death|1|||
126381012|NCT00573391|454690391|FG001|Overall Study|Death|0|||
126381013|NCT03369665|454690392|FG000|Overall Study|Adverse Event|3|||
126381014|NCT03369665|454690392|FG000|Overall Study|Lost to Follow-up|7|||
126381015|NCT03369665|454690392|FG000|Overall Study|Withdrawal by Subject|15|||
126381016|NCT03369665|454690392|FG000|Overall Study|Progression Disease|2|||
126381017|NCT03369665|454690392|FG000|Overall Study|Not classified|3|||
126381018|NCT02553928|454690393|FG000|Overall Study|Adverse Event|2|||
126381019|NCT02553928|454690394|FG001|Overall Study|Adverse Event|1|||
126381020|NCT02553928|454690393|FG000|Overall Study|Lost to Follow-up|0|||
126381021|NCT02553928|454690394|FG001|Overall Study|Lost to Follow-up|1|||
126381022|NCT02553928|454690393|FG000|Overall Study|Administrative reason(s)|0|||
126381023|NCT02553928|454690394|FG001|Overall Study|Administrative reason(s)|1|||
126381024|NCT03230318|454690395|FG000|Overall Study|Radiographic disease progression|72|||
126381025|NCT03230318|454690396|FG001|Overall Study|Radiographic disease progression|19|||
126381026|NCT03230318|454690395|FG000|Overall Study|Clinical progression|17|||
126381027|NCT03230318|454690396|FG001|Overall Study|Clinical progression|7|||
126381028|NCT03230318|454690395|FG000|Overall Study|Adverse Event|5|||
126381029|NCT03230318|454690396|FG001|Overall Study|Adverse Event|3|||
126381030|NCT03230318|454690395|FG000|Overall Study|Physician Decision|2|||
126381031|NCT03230318|454690396|FG001|Overall Study|Physician Decision|3|||
126381032|NCT03230318|454690395|FG000|Overall Study|Death|3|||
126381033|NCT03230318|454690396|FG001|Overall Study|Death|2|||
126381034|NCT03230318|454690395|FG000|Overall Study|Lost to Follow-up|1|||
126381035|NCT03230318|454690396|FG001|Overall Study|Lost to Follow-up|0|||
126381036|NCT03230318|454690395|FG000|Overall Study|Withdrawal by Subject|1|||
126381037|NCT03230318|454690396|FG001|Overall Study|Withdrawal by Subject|3|||
126381038|NCT03230318|454690395|FG000|Overall Study|Other|3|||
126381039|NCT03230318|454690396|FG001|Overall Study|Other|7|||
126381040|NCT00075764|454690403|FG000|Overall Study|Adverse Event|5|||
126381041|NCT00075764|454690404|FG001|Overall Study|Adverse Event|12|||
126381042|NCT00075764|454690403|FG000|Overall Study|Death|4|||
126381043|NCT00075764|454690404|FG001|Overall Study|Death|8|||
126381044|NCT00075764|454690403|FG000|Overall Study|Withdrawal by Subject|28|||
126381045|NCT00075764|454690404|FG001|Overall Study|Withdrawal by Subject|18|||
126381046|NCT00075764|454690403|FG000|Overall Study|Progression|269|||
126381047|NCT00075764|454690404|FG001|Overall Study|Progression|274|||
126381048|NCT00075764|454690403|FG000|Overall Study|Still on treatment|8|||
126381049|NCT00075764|454690404|FG001|Overall Study|Still on treatment|15|||
126381050|NCT00075764|454690403|FG000|Overall Study|Delinquent|4|||
126381051|NCT00075764|454690404|FG001|Overall Study|Delinquent|2|||
126381052|NCT00075764|454690403|FG000|Overall Study|Not protocol specified|27|||
126381053|NCT00075764|454690404|FG001|Overall Study|Not protocol specified|19|||
126381054|NCT00075764|454690403|FG000|Overall Study|Under review|0|||
126381055|NCT00075764|454690404|FG001|Overall Study|Under review|1|||
126381056|NCT02817594|454690405|FG000|Overall Study|Withdrawal by Subject|1|||
126381057|NCT02817594|454690405|FG000|Overall Study|Other|1|||
126381058|NCT02817594|454690405|FG000|Overall Study|Did Not Receive Treatment|1|||
126381059|NCT02010593|454690406|FG000|Overall Study|Lost to Follow-up|1|||
126381060|NCT02010593|454690407|FG001|Overall Study|Lost to Follow-up|0|||
126381061|NCT02010593|454690406|FG000|Overall Study|Physician Decision|1|||
126381062|NCT02010593|454690407|FG001|Overall Study|Physician Decision|0|||
126381063|NCT02010593|454690406|FG000|Overall Study|Unable to adhere to visit schedule|0|||
126381064|NCT02010593|454690407|FG001|Overall Study|Unable to adhere to visit schedule|2|||
126381065|NCT01773967|454690408|FG000|Overall Study|Lost to Follow-up|15|||
126381066|NCT01773967|454690409|FG001|Overall Study|Lost to Follow-up|13|||
126381067|NCT01135459|454690410|FG000|Overall Study|Adverse Event|8|||
126381068|NCT01135459|454690411|FG001|Overall Study|Adverse Event|10|||
126381069|NCT01135459|454690410|FG000|Overall Study|Lack of Efficacy|3|||
126381070|NCT01135459|454690411|FG001|Overall Study|Lack of Efficacy|1|||
126381071|NCT01135459|454690410|FG000|Overall Study|Withdrawal by Subject|2|||
126381072|NCT01135459|454690411|FG001|Overall Study|Withdrawal by Subject|3|||
126381073|NCT01135459|454690410|FG000|Overall Study|Protocol Violation|5|||
126381074|NCT01135459|454690411|FG001|Overall Study|Protocol Violation|3|||
126381075|NCT01135459|454690410|FG000|Overall Study|Lost to Follow-up|2|||
126381076|NCT01135459|454690411|FG001|Overall Study|Lost to Follow-up|1|||
126381077|NCT01135459|454690410|FG000|Overall Study|Non-compliance to study procedures|0|||
126381078|NCT01135459|454690411|FG001|Overall Study|Non-compliance to study procedures|1|||
126381079|NCT01135459|454690410|FG000|Overall Study|Other than specified|1|||
126381080|NCT01135459|454690411|FG001|Overall Study|Other than specified|1|||
126381081|NCT01766037|454690412|FG000|Overall Study|Adverse Event|1|||
126381082|NCT01766037|454690413|FG001|Overall Study|Adverse Event|0|||
126381083|NCT01766037|454690412|FG000|Overall Study|Lack of Efficacy|1|||
126381084|NCT01766037|454690413|FG001|Overall Study|Lack of Efficacy|0|||
126381085|NCT01766037|454690412|FG000|Overall Study|Lost to Follow-up|0|||
126381086|NCT01766037|454690413|FG001|Overall Study|Lost to Follow-up|10|||
126381087|NCT01766037|454690412|FG000|Overall Study|Physician Decision|0|||
126381088|NCT01766037|454690413|FG001|Overall Study|Physician Decision|1|||
126381089|NCT01766037|454690412|FG000|Overall Study|Withdrawal by Subject|18|||
126381090|NCT01766037|454690413|FG001|Overall Study|Withdrawal by Subject|16|||
126381091|NCT01766037|454690412|FG000|Overall Study|Moved from area|5|||
126381092|NCT01766037|454690413|FG001|Overall Study|Moved from area|0|||
126381093|NCT01766037|454690412|FG000|Overall Study|medical - unrelated|1|||
126381094|NCT01766037|454690413|FG001|Overall Study|medical - unrelated|2|||
126381095|NCT01766037|454690412|FG000|Overall Study|nausea / discomfort|3|||
126381096|NCT01766037|454690413|FG001|Overall Study|nausea / discomfort|0|||
126381097|NCT02413996|454690414|FG000|Overall Study|not comfortable with the intervention|9|||
126381098|NCT02413996|454690415|FG001|Overall Study|not comfortable with the intervention|2|||
126381099|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
126381100|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
126381101|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
126381102|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
126381103|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
126381104|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
126381105|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
126381106|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
126381107|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
126381108|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
126381109|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
126381110|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
126381111|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
126381112|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
126381113|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
126381114|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
126381115|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
126381116|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
126381117|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
126381118|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
126381119|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
126381120|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
126381121|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
126381122|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
126381123|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
126381124|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
126381125|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
126381126|NCT01672879|454690417|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
126381127|NCT01672879|454690418|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
126048278|NCT00943917|453473867|FG012|Stage II Continuation|Withdrawal by Subject|0|||
126381128|NCT01672879|454690419|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
126381129|NCT01672879|454690417|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
126381130|NCT01672879|454690418|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
126381131|NCT01672879|454690419|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
126381132|NCT01672879|454690417|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
126381133|NCT01672879|454690418|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
126381134|NCT01672879|454690419|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
126381135|NCT01672879|454690417|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
126381136|NCT01672879|454690418|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
126381137|NCT01672879|454690419|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
126381138|NCT01871545|454690420|FG000|Overall Study|Death|2|||
126381139|NCT01871545|454690421|FG001|Overall Study|Death|0|||
126381140|NCT01871545|454690420|FG000|Overall Study|Lack of Efficacy|11|||
126381141|NCT01871545|454690421|FG001|Overall Study|Lack of Efficacy|2|||
126381142|NCT01871545|454690420|FG000|Overall Study|Physician Decision|4|||
126381143|NCT01871545|454690421|FG001|Overall Study|Physician Decision|0|||
126381144|NCT01871545|454690420|FG000|Overall Study|Withdrawal by Subject|0|||
126381145|NCT01871545|454690421|FG001|Overall Study|Withdrawal by Subject|1|||
126381146|NCT04834726|454690424|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
126381147|NCT04834726|454690425|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
126381148|NCT04834726|454690426|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
126381149|NCT04834726|454690427|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
126381150|NCT04834726|454690428|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
126381151|NCT04834726|454690429|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
126381152|NCT04834726|454690430|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
126381153|NCT04834726|454690431|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
126381154|NCT04834726|454690432|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
126381155|NCT03810014|454690436|FG000|Overall Study|Pregnancy|2|||
126381156|NCT03810014|454690437|FG001|Overall Study|Pregnancy|2|||
126381157|NCT03810014|454690438|FG002|Overall Study|Pregnancy|0|||
126381158|NCT03810014|454690439|FG003|Overall Study|Pregnancy|2|||
126381159|NCT03606486|454690440|FG000|Overall Study|Unable to collect sample|5|||
126381160|NCT01853462|454690441|FG000|Overall Study|Withdrawal by Subject|1|||
126381161|NCT01853462|454690442|FG001|Overall Study|Withdrawal by Subject|1|||
126381162|NCT02148263|454690443|FG000|Overall Study|Withdrawal by Subject|3|||
126381163|NCT02148263|454690444|FG001|Overall Study|Withdrawal by Subject|2|||
126381164|NCT00132301|454690445|FG000|Overall Study|Death|7|||
126381165|NCT00132301|454690446|FG001|Overall Study|Death|6|||
126381166|NCT00132301|454690445|FG000|Overall Study|Withdrawal by Subject|5|||
125886636|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
125886637|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
126048279|NCT00943917|453473868|FG013|Stage II Continuation|Withdrawal by Subject|1|||
126048280|NCT00943917|453473869|FG014|Stage II Continuation|Withdrawal by Subject|3|||
126048281|NCT00943917|453473855|FG000|Stage II Continuation|Protocol Violation|0|||
126048282|NCT00943917|453473856|FG001|Stage II Continuation|Protocol Violation|0|||
126048283|NCT00943917|453473857|FG002|Stage II Continuation|Protocol Violation|0|||
126381167|NCT00132301|454690446|FG001|Overall Study|Withdrawal by Subject|2|||
126381168|NCT00132301|454690445|FG000|Overall Study|Physician Decision|1|||
126381169|NCT00132301|454690446|FG001|Overall Study|Physician Decision|1|||
126381170|NCT00132301|454690445|FG000|Overall Study|Lost to Follow-up|5|||
126381171|NCT00132301|454690446|FG001|Overall Study|Lost to Follow-up|3|||
126381172|NCT00132301|454690445|FG000|Overall Study|Other|1|||
126381173|NCT00132301|454690446|FG001|Overall Study|Other|1|||
126381174|NCT00132301|454690445|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
126381175|NCT00132301|454690446|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
126381176|NCT02012218|454690447|FG000|Overall Study|Withdrawal by Subject|1|||
126381177|NCT02012218|454690448|FG001|Overall Study|Withdrawal by Subject|0|||
126381178|NCT02012218|454690449|FG002|Overall Study|Withdrawal by Subject|1|||
126381179|NCT02012218|454690450|FG003|Overall Study|Withdrawal by Subject|1|||
126381180|NCT02012218|454690451|FG004|Overall Study|Withdrawal by Subject|1|||
126381181|NCT02012218|454690447|FG000|Overall Study|Adverse Event|1|||
126381182|NCT02012218|454690448|FG001|Overall Study|Adverse Event|0|||
126381183|NCT02012218|454690449|FG002|Overall Study|Adverse Event|0|||
126381184|NCT02012218|454690450|FG003|Overall Study|Adverse Event|1|||
126381185|NCT02012218|454690451|FG004|Overall Study|Adverse Event|0|||
126381186|NCT02012218|454690447|FG000|Overall Study|Lost to Follow-up|0|||
126381187|NCT02012218|454690448|FG001|Overall Study|Lost to Follow-up|1|||
126381188|NCT02012218|454690449|FG002|Overall Study|Lost to Follow-up|1|||
126381189|NCT02012218|454690450|FG003|Overall Study|Lost to Follow-up|0|||
126381190|NCT02012218|454690451|FG004|Overall Study|Lost to Follow-up|0|||
126381191|NCT02012218|454690447|FG000|Overall Study|Protocol Specified|1|||
126381192|NCT02012218|454690448|FG001|Overall Study|Protocol Specified|0|||
126381193|NCT02012218|454690449|FG002|Overall Study|Protocol Specified|0|||
126381194|NCT02012218|454690450|FG003|Overall Study|Protocol Specified|0|||
126381195|NCT02012218|454690451|FG004|Overall Study|Protocol Specified|0|||
126381196|NCT02012218|454690447|FG000|Overall Study|Protocol Deviation|1|||
126381197|NCT02012218|454690448|FG001|Overall Study|Protocol Deviation|0|||
126381198|NCT02012218|454690449|FG002|Overall Study|Protocol Deviation|0|||
126381199|NCT02012218|454690450|FG003|Overall Study|Protocol Deviation|0|||
126381200|NCT02012218|454690451|FG004|Overall Study|Protocol Deviation|0|||
126381201|NCT02720523|454690457|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381202|NCT02720523|454690458|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381203|NCT02720523|454690459|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
126381204|NCT02720523|454690460|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
126381205|NCT02720523|454690461|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381206|NCT02720523|454690462|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381207|NCT02720523|454690463|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381208|NCT02720523|454690457|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
126381209|NCT02720523|454690458|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381210|NCT02720523|454690459|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381211|NCT02720523|454690460|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381212|NCT02720523|454690461|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381213|NCT02720523|454690462|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381214|NCT02720523|454690463|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381215|NCT02720523|454690457|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
126381216|NCT02720523|454690458|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381217|NCT02720523|454690459|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381218|NCT02720523|454690460|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381219|NCT02720523|454690461|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381220|NCT02720523|454690462|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381221|NCT02720523|454690463|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381222|NCT02720523|454690457|FG000|Period 1: Placebo-controlled Period|Other|0|||
126381223|NCT02720523|454690458|FG001|Period 1: Placebo-controlled Period|Other|0|||
126381224|NCT02720523|454690459|FG002|Period 1: Placebo-controlled Period|Other|1|||
126381225|NCT02720523|454690460|FG003|Period 1: Placebo-controlled Period|Other|1|||
126381226|NCT02720523|454690461|FG004|Period 1: Placebo-controlled Period|Other|0|||
126381227|NCT02720523|454690462|FG005|Period 1: Placebo-controlled Period|Other|0|||
126381228|NCT02720523|454690463|FG006|Period 1: Placebo-controlled Period|Other|0|||
126381229|NCT02720523|454690457|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
126381230|NCT02720523|454690458|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
126381231|NCT02720523|454690459|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
126381232|NCT02720523|454690460|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
126381233|NCT02720523|454690461|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
126381234|NCT02720523|454690462|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
126381235|NCT02720523|454690463|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
126381236|NCT02720523|454690457|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
126381237|NCT02720523|454690458|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
126381238|NCT02720523|454690459|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
126381239|NCT02720523|454690460|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
126381240|NCT02720523|454690461|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
126381241|NCT02720523|454690462|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
126381242|NCT02720523|454690463|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
126381243|NCT02720523|454690457|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
126381244|NCT02720523|454690458|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
126381245|NCT02720523|454690459|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
126381246|NCT02720523|454690460|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
126381247|NCT02720523|454690461|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
126381248|NCT02720523|454690462|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
126381249|NCT02720523|454690463|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
126381250|NCT02720523|454690457|FG000|Period 2: Long-term Extension Period|Other|0|||
126381251|NCT02720523|454690458|FG001|Period 2: Long-term Extension Period|Other|0|||
126381252|NCT02720523|454690459|FG002|Period 2: Long-term Extension Period|Other|0|||
126381253|NCT02720523|454690460|FG003|Period 2: Long-term Extension Period|Other|0|||
126381254|NCT02720523|454690461|FG004|Period 2: Long-term Extension Period|Other|2|||
126381255|NCT02720523|454690462|FG005|Period 2: Long-term Extension Period|Other|0|||
126381256|NCT02720523|454690463|FG006|Period 2: Long-term Extension Period|Other|3|||
126381257|NCT03929913|454690467|FG000|Overall Study|Death|4|||
126381258|NCT03929913|454690467|FG000|Overall Study|Lost to Follow-up|1|||
126381259|NCT03929913|454690467|FG000|Overall Study|Failed Procedure|2|||
126381260|NCT01154452|454690468|FG000|Phase Ib|Not Treated|1|||
126381261|NCT01154452|454690469|FG001|Phase Ib|Not Treated|0|||
126381262|NCT01154452|454690470|FG002|Phase Ib|Not Treated|0|||
126381263|NCT01154452|454690471|FG003|Phase Ib|Not Treated|0|||
126381264|NCT01154452|454690468|FG000|Phase Ib|Adverse Event|2|||
126381265|NCT01154452|454690469|FG001|Phase Ib|Adverse Event|1|||
126381266|NCT01154452|454690470|FG002|Phase Ib|Adverse Event|0|||
126381267|NCT01154452|454690471|FG003|Phase Ib|Adverse Event|0|||
126381268|NCT01154452|454690468|FG000|Phase II|Withdrawal by Subject|0|||
126381269|NCT01154452|454690469|FG001|Phase II|Withdrawal by Subject|0|||
126381270|NCT01154452|454690470|FG002|Phase II|Withdrawal by Subject|1|||
126381271|NCT01154452|454690471|FG003|Phase II|Withdrawal by Subject|2|||
126381272|NCT01154452|454690468|FG000|Phase II|Adverse Event|0|||
126381273|NCT01154452|454690469|FG001|Phase II|Adverse Event|0|||
126381274|NCT01154452|454690470|FG002|Phase II|Adverse Event|4|||
126381275|NCT01154452|454690471|FG003|Phase II|Adverse Event|4|||
126381276|NCT03381287|454690472|FG000|Overall Study|Withdrawal by Subject|0|||
126381277|NCT03381287|454690473|FG001|Overall Study|Withdrawal by Subject|1|||
126381278|NCT03381287|454690474|FG002|Overall Study|Withdrawal by Subject|0|||
126381279|NCT03381287|454690475|FG003|Overall Study|Withdrawal by Subject|0|||
126381280|NCT03381287|454690472|FG000|Overall Study|Adverse Event|0|||
126381281|NCT03381287|454690473|FG001|Overall Study|Adverse Event|0|||
126381282|NCT03381287|454690474|FG002|Overall Study|Adverse Event|0|||
126381283|NCT03381287|454690475|FG003|Overall Study|Adverse Event|1|||
126381284|NCT03381287|454690472|FG000|Overall Study|Physician Decision|0|||
126381285|NCT03381287|454690473|FG001|Overall Study|Physician Decision|0|||
126381286|NCT03381287|454690474|FG002|Overall Study|Physician Decision|0|||
126381287|NCT03381287|454690475|FG003|Overall Study|Physician Decision|1|||
126381288|NCT01265992|454690478|FG000|Overall Study|Lost to Follow-up|1|||
126381289|NCT01265992|454690478|FG000|Overall Study|Withdrawal by Subject|1|||
126381290|NCT01265992|454690478|FG000|Overall Study|Adverse Event|1|||
126381291|NCT01265992|454690478|FG000|Overall Study|Administrative reasons|2|||
126381292|NCT01265992|454690478|FG000|Overall Study|Stopped treatment|3|||
126381293|NCT01265992|454690478|FG000|Overall Study|Did not receive treatment|1|||
126381294|NCT01837680|454690479|FG000|Overall Study|Lost to Follow-up|2|||
126381295|NCT01837680|454690480|FG001|Overall Study|Lost to Follow-up|2|||
126381296|NCT01837680|454690479|FG000|Overall Study|lack of insurance|0|||
126381297|NCT01837680|454690480|FG001|Overall Study|lack of insurance|2|||
126381298|NCT01837680|454690479|FG000|Overall Study|allergic reaction|6|||
126381299|NCT01837680|454690480|FG001|Overall Study|allergic reaction|0|||
126381300|NCT01837680|454690479|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
126381301|NCT01837680|454690480|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
126381302|NCT00473889|454691784|FG000|Overall Study|Did not receive study medication|1|||
126381303|NCT00473889|454691785|FG001|Overall Study|Did not receive study medication|4|||
126381304|NCT00473889|454691784|FG000|Overall Study|Adverse Event|30|||
126381305|NCT00473889|454691785|FG001|Overall Study|Adverse Event|17|||
126381306|NCT00473889|454691784|FG000|Overall Study|Protocol Violation|4|||
126381307|NCT00473889|454691785|FG001|Overall Study|Protocol Violation|2|||
126381308|NCT00473889|454691784|FG000|Overall Study|Lack of Efficacy|28|||
126381309|NCT00473889|454691785|FG001|Overall Study|Lack of Efficacy|29|||
126381310|NCT00473889|454691784|FG000|Overall Study|Lost to Follow-up|2|||
126381311|NCT00473889|454691785|FG001|Overall Study|Lost to Follow-up|1|||
126381312|NCT00473889|454691784|FG000|Overall Study|Physician Decision|10|||
126381313|NCT00473889|454691785|FG001|Overall Study|Physician Decision|5|||
126381314|NCT00473889|454691784|FG000|Overall Study|Trial Terminated|3|||
126381315|NCT00473889|454691785|FG001|Overall Study|Trial Terminated|6|||
126381316|NCT00473889|454691784|FG000|Overall Study|Withdrawal by Subject|5|||
126381317|NCT00473889|454691785|FG001|Overall Study|Withdrawal by Subject|0|||
126381318|NCT02840253|454691786|FG000|Overall Study|Unsuccessful block|4|||
126381319|NCT03783962|454691787|FG000|Overall Study|Lost to Follow-up|3|||
126381320|NCT03783962|454691788|FG001|Overall Study|Lost to Follow-up|6|||
126381321|NCT03783962|454691787|FG000|Overall Study|Protocol Violation|0|||
126381322|NCT03783962|454691788|FG001|Overall Study|Protocol Violation|1|||
126381323|NCT03458325|454691789|FG000|Overall Study|Withdrawal by Subject|1|||
126381324|NCT01724216|454691798|FG000|Overall Study|Scan was not completed|1|||
126381325|NCT00175916|454691799|FG000|Overall Study|Death|19|||
126381326|NCT00175916|454691799|FG000|Overall Study|Adverse Event|81|||
126381327|NCT00175916|454691799|FG000|Overall Study|Lack of Efficacy|354|||
126381328|NCT00175916|454691799|FG000|Overall Study|Lost to Follow-up|17|||
126381329|NCT00175916|454691799|FG000|Overall Study|Subject Choice|98|||
126381330|NCT00175916|454691799|FG000|Overall Study|Lack of compliance|8|||
126381331|NCT00175916|454691799|FG000|Overall Study|Patient cannot record seizures|1|||
126381332|NCT00175916|454691799|FG000|Overall Study|Sponsor decision|17|||
126381333|NCT00175916|454691799|FG000|Overall Study|Vigabatrin intake|1|||
126381334|NCT00175916|454691799|FG000|Overall Study|Suicidal behaviour|1|||
126381335|NCT00175916|454691799|FG000|Overall Study|Withdrawal by Subject|1|||
126381336|NCT00175916|454691799|FG000|Overall Study|Seizure - free|4|||
126381337|NCT00175916|454691799|FG000|Overall Study|Administrative reason|1|||
126381338|NCT00175916|454691799|FG000|Overall Study|Pregnancy|1|||
126381339|NCT00175916|454691799|FG000|Overall Study|Patient's request|2|||
126381340|NCT00175916|454691799|FG000|Overall Study|Treating physiciant's choice|1|||
126381341|NCT00175916|454691799|FG000|Overall Study|Moved overseas|1|||
126381342|NCT00175916|454691799|FG000|Overall Study|Loss of job and economic burden|1|||
126381343|NCT00175916|454691799|FG000|Overall Study|Site was closed|9|||
126381344|NCT00175916|454691799|FG000|Overall Study|Patient went to prison|1|||
126048284|NCT00943917|453473858|FG003|Stage II Continuation|Protocol Violation|0|||
126048285|NCT00943917|453473859|FG004|Stage II Continuation|Protocol Violation|0|||
126381345|NCT00564733|454691800|FG000|Overall Study|Withdrawal by Subject|4|||
126381346|NCT00564733|454691800|FG000|Overall Study|Ineligible|5|||
126381347|NCT01014767|454691801|FG000|Overall Study|PI left institution, data unavailable|12|||
126381348|NCT01014767|454691802|FG001|Overall Study|PI left institution, data unavailable|1|||
126381349|NCT01014767|454691803|FG002|Overall Study|PI left institution, data unavailable|4|||
126381350|NCT01014767|454691804|FG003|Overall Study|PI left institution, data unavailable|1|||
126381351|NCT00310375|454691809|FG000|Primary Reporting Phase|Adverse Event|28|||
126381352|NCT00310375|454691810|FG001|Primary Reporting Phase|Adverse Event|22|||
126381353|NCT00310375|454691811|FG002|Primary Reporting Phase|Adverse Event|0|||
126381354|NCT00310375|454691809|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
126381355|NCT00310375|454691810|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
126381356|NCT00310375|454691811|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
126381357|NCT00310375|454691809|FG000|Primary Reporting Phase|Pregnancy|2|||
126381358|NCT00310375|454691810|FG001|Primary Reporting Phase|Pregnancy|2|||
126381359|NCT00310375|454691811|FG002|Primary Reporting Phase|Pregnancy|0|||
126381360|NCT00310375|454691809|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
126381361|NCT00310375|454691810|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
126381362|NCT00310375|454691811|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
126381363|NCT00310375|454691809|FG000|Primary Reporting Phase|Protocol Violation|8|||
126381364|NCT00310375|454691810|FG001|Primary Reporting Phase|Protocol Violation|5|||
126381365|NCT00310375|454691811|FG002|Primary Reporting Phase|Protocol Violation|0|||
126381366|NCT00310375|454691809|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
126381367|NCT00310375|454691810|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
126381368|NCT00310375|454691811|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
126381369|NCT00310375|454691809|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
126381370|NCT00310375|454691810|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
126381371|NCT00310375|454691811|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
126381372|NCT00310375|454691809|FG000|Primary Reporting Phase|Physician Decision|5|||
126381373|NCT00310375|454691810|FG001|Primary Reporting Phase|Physician Decision|3|||
126381374|NCT00310375|454691811|FG002|Primary Reporting Phase|Physician Decision|0|||
126381375|NCT00310375|454691809|FG000|Primary Reporting Phase|Request of the sponsor|2|||
126381376|NCT00310375|454691810|FG001|Primary Reporting Phase|Request of the sponsor|2|||
126381377|NCT00310375|454691811|FG002|Primary Reporting Phase|Request of the sponsor|0|||
126381378|NCT00310375|454691809|FG000|Primary Reporting Phase|Failed to return|1|||
126381379|NCT00310375|454691810|FG001|Primary Reporting Phase|Failed to return|3|||
126381380|NCT00310375|454691811|FG002|Primary Reporting Phase|Failed to return|0|||
126381381|NCT00310375|454691809|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
126381382|NCT00310375|454691810|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
126381383|NCT00310375|454691811|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
126381384|NCT00310375|454691809|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
126381385|NCT00310375|454691810|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
126381386|NCT00310375|454691811|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
126381387|NCT00310375|454691809|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
126381388|NCT00310375|454691810|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
126381389|NCT00310375|454691811|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
126381390|NCT00310375|454691809|FG000|Primary Reporting Phase|Site closure|3|||
126381391|NCT00310375|454691810|FG001|Primary Reporting Phase|Site closure|0|||
126381392|NCT00310375|454691811|FG002|Primary Reporting Phase|Site closure|0|||
126048286|NCT00943917|453473860|FG005|Stage II Continuation|Protocol Violation|0|||
126381393|NCT00310375|454691809|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
126381394|NCT00310375|454691810|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
126381395|NCT00310375|454691811|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
126381396|NCT00310375|454691809|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
126381397|NCT00310375|454691810|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
126381398|NCT00310375|454691811|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
126381399|NCT00310375|454691809|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
126048287|NCT00943917|453473861|FG006|Stage II Continuation|Protocol Violation|0|||
126048288|NCT00943917|453473862|FG007|Stage II Continuation|Protocol Violation|0|||
126048289|NCT00943917|453473863|FG008|Stage II Continuation|Protocol Violation|0|||
126048290|NCT00943917|453473864|FG009|Stage II Continuation|Protocol Violation|1|||
126048291|NCT00943917|453473865|FG010|Stage II Continuation|Protocol Violation|0|||
126048292|NCT00943917|453473866|FG011|Stage II Continuation|Protocol Violation|1|||
126048293|NCT00943917|453473867|FG012|Stage II Continuation|Protocol Violation|0|||
126048294|NCT00943917|453473868|FG013|Stage II Continuation|Protocol Violation|0|||
126048295|NCT00943917|453473869|FG014|Stage II Continuation|Protocol Violation|0|||
126048296|NCT00943917|453473855|FG000|Stage II Continuation|hypoglycemia|0|||
126048297|NCT00943917|453473856|FG001|Stage II Continuation|hypoglycemia|0|||
126048298|NCT00943917|453473857|FG002|Stage II Continuation|hypoglycemia|0|||
126048299|NCT00943917|453473858|FG003|Stage II Continuation|hypoglycemia|0|||
126048300|NCT00943917|453473859|FG004|Stage II Continuation|hypoglycemia|0|||
126048301|NCT00943917|453473860|FG005|Stage II Continuation|hypoglycemia|0|||
126048302|NCT00943917|453473861|FG006|Stage II Continuation|hypoglycemia|0|||
126048303|NCT00943917|453473862|FG007|Stage II Continuation|hypoglycemia|0|||
126048304|NCT00943917|453473863|FG008|Stage II Continuation|hypoglycemia|0|||
126048305|NCT00943917|453473864|FG009|Stage II Continuation|hypoglycemia|0|||
126048306|NCT00943917|453473865|FG010|Stage II Continuation|hypoglycemia|0|||
126048307|NCT00943917|453473866|FG011|Stage II Continuation|hypoglycemia|0|||
126048308|NCT00943917|453473867|FG012|Stage II Continuation|hypoglycemia|1|||
126048309|NCT00943917|453473868|FG013|Stage II Continuation|hypoglycemia|0|||
126048310|NCT00943917|453473869|FG014|Stage II Continuation|hypoglycemia|0|||
126048311|NCT00943917|453473855|FG000|Stage II Continuation|A1C elevation|0|||
126048312|NCT00943917|453473856|FG001|Stage II Continuation|A1C elevation|0|||
126048313|NCT00943917|453473857|FG002|Stage II Continuation|A1C elevation|0|||
126048314|NCT00943917|453473858|FG003|Stage II Continuation|A1C elevation|0|||
126048315|NCT00943917|453473859|FG004|Stage II Continuation|A1C elevation|0|||
126048316|NCT00943917|453473860|FG005|Stage II Continuation|A1C elevation|0|||
126048317|NCT00943917|453473861|FG006|Stage II Continuation|A1C elevation|0|||
126048318|NCT00943917|453473862|FG007|Stage II Continuation|A1C elevation|0|||
126048319|NCT00943917|453473863|FG008|Stage II Continuation|A1C elevation|0|||
126048320|NCT00943917|453473864|FG009|Stage II Continuation|A1C elevation|0|||
126048321|NCT00943917|453473865|FG010|Stage II Continuation|A1C elevation|0|||
126048322|NCT00943917|453473866|FG011|Stage II Continuation|A1C elevation|0|||
126048323|NCT00943917|453473867|FG012|Stage II Continuation|A1C elevation|0|||
126048324|NCT00943917|453473868|FG013|Stage II Continuation|A1C elevation|1|||
126048325|NCT00943917|453473869|FG014|Stage II Continuation|A1C elevation|0|||
126048326|NCT02844439|453473870|FG000|Overall Study|Withdrawal by Subject|1|||
126048327|NCT02844439|453473870|FG000|Overall Study|Lost to Follow-up|2|||
126048328|NCT02844439|453473870|FG000|Overall Study|Termination by Sponsor|4|||
126048329|NCT02844439|453473870|FG000|Overall Study|Death|28|||
126048330|NCT02844439|453473870|FG000|Overall Study|Other|5|||
126048331|NCT03170648|453473875|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
126048332|NCT03170648|453473875|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
126048333|NCT03509909|453473876|FG000|Overall Study|Withdrawal by Subject|16|||
126048334|NCT03509909|453473877|FG001|Overall Study|Withdrawal by Subject|9|||
126048335|NCT03509909|453473876|FG000|Overall Study|Lost to Follow-up|3|||
126048336|NCT03509909|453473877|FG001|Overall Study|Lost to Follow-up|4|||
126048337|NCT03509909|453473876|FG000|Overall Study|Adverse Event|2|||
126048338|NCT03509909|453473877|FG001|Overall Study|Adverse Event|0|||
126048339|NCT03500549|453473878|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
126048340|NCT03500549|453473879|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
126048341|NCT03500549|453473878|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
126048342|NCT03500549|453473879|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
126048343|NCT02754596|453473880|FG000|Overall Study|Withdrawal by Subject|3|||
126048344|NCT02754596|453473881|FG001|Overall Study|Withdrawal by Subject|4|||
126048345|NCT02754596|453473882|FG002|Overall Study|Withdrawal by Subject|0|||
126048346|NCT02754596|453473880|FG000|Overall Study|Physician Decision|1|||
126048347|NCT02754596|453473881|FG001|Overall Study|Physician Decision|1|||
126048348|NCT02754596|453473882|FG002|Overall Study|Physician Decision|1|||
126048349|NCT02754596|453473880|FG000|Overall Study|Lost to Follow-up|1|||
126048350|NCT02754596|453473881|FG001|Overall Study|Lost to Follow-up|1|||
126048351|NCT02754596|453473882|FG002|Overall Study|Lost to Follow-up|2|||
126048352|NCT02754596|453473880|FG000|Overall Study|Death|0|||
126048353|NCT02754596|453473881|FG001|Overall Study|Death|2|||
126048354|NCT02754596|453473882|FG002|Overall Study|Death|0|||
126048355|NCT02754596|453473880|FG000|Overall Study|Adverse Event|1|||
126048356|NCT02754596|453473881|FG001|Overall Study|Adverse Event|0|||
126048357|NCT02754596|453473882|FG002|Overall Study|Adverse Event|1|||
126048358|NCT02754596|453473880|FG000|Overall Study|Other|1|||
126048359|NCT02754596|453473881|FG001|Overall Study|Other|0|||
126048360|NCT02754596|453473882|FG002|Overall Study|Other|0|||
126048361|NCT02107261|453473883|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
126048362|NCT02107261|453473884|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
126048363|NCT02107261|453473883|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
126048364|NCT02107261|453473884|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
126048365|NCT04337931|453473885|FG000|Overall Study|Death|4|||
126048366|NCT04337931|453473886|FG001|Overall Study|Death|1|||
126048367|NCT04337931|453473887|FG002|Overall Study|Death|7|||
126048368|NCT04337931|453473885|FG000|Overall Study|Withdrawal by Subject|0|||
125886638|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
126048369|NCT04337931|453473886|FG001|Overall Study|Withdrawal by Subject|1|||
126048370|NCT04337931|453473887|FG002|Overall Study|Withdrawal by Subject|0|||
126048371|NCT04337931|453473885|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
126048372|NCT04337931|453473886|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
126048373|NCT04337931|453473887|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
126381400|NCT00310375|454691810|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
126381401|NCT00310375|454691811|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
126381402|NCT00310375|454691809|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
126381403|NCT00310375|454691810|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
126381404|NCT00310375|454691811|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
126381405|NCT00131352|454691812|FG000|Initial Treatment Period|Adverse Event|1|||
126381406|NCT00131352|454691813|FG001|Initial Treatment Period|Adverse Event|3|||
126381407|NCT00131352|454691812|FG000|Initial Treatment Period|Non-compliant|1|||
126381408|NCT00131352|454691813|FG001|Initial Treatment Period|Non-compliant|2|||
126381409|NCT00131352|454691812|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
126381410|NCT00131352|454691813|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
126381411|NCT00131352|454691812|FG000|Initial Treatment Period|Lack of Efficacy|6|||
126381412|NCT00131352|454691813|FG001|Initial Treatment Period|Lack of Efficacy|4|||
126381413|NCT00131352|454691812|FG000|Initial Treatment Period|Other|0|||
126381414|NCT00131352|454691813|FG001|Initial Treatment Period|Other|2|||
126381415|NCT00131352|454691812|FG000|Repeat Treatment Period|Adverse Event|1|||
126381416|NCT00131352|454691813|FG001|Repeat Treatment Period|Adverse Event|0|||
126381417|NCT00131352|454691812|FG000|Repeat Treatment Period|Other|1|||
126381418|NCT00131352|454691813|FG001|Repeat Treatment Period|Other|0|||
126381419|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
126381420|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
126381421|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381422|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381423|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381424|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381425|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381426|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381427|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381428|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381429|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
126381430|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
126381431|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381432|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381433|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381434|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381435|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381436|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381437|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381438|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381439|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
126381440|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126048374|NCT04337931|453473885|FG000|Overall Study|Study terminated by sponsor|3|||
126048375|NCT04337931|453473886|FG001|Overall Study|Study terminated by sponsor|6|||
126048376|NCT04337931|453473887|FG002|Overall Study|Study terminated by sponsor|2|||
126048377|NCT04337931|453473885|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
126048378|NCT04337931|453473886|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
126048379|NCT04337931|453473887|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
126048380|NCT04337931|453473885|FG000|Overall Study|Colorectal cancer treatment|1|||
126048381|NCT04337931|453473886|FG001|Overall Study|Colorectal cancer treatment|0|||
126381441|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381442|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381443|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381444|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381445|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381446|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381447|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381448|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381449|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
126381450|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
126381451|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381452|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381453|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381454|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381455|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381456|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381457|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381458|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381459|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381460|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
126381461|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381462|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381463|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381464|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381465|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381466|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381467|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381468|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381469|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
126381470|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
126381471|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381472|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381473|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381474|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381475|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381476|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381477|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381478|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381479|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
126381480|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
126048382|NCT04337931|453473887|FG002|Overall Study|Colorectal cancer treatment|0|||
126048383|NCT04337931|453473885|FG000|Overall Study|Participant decision|0|||
126048384|NCT04337931|453473886|FG001|Overall Study|Participant decision|1|||
126048385|NCT04337931|453473887|FG002|Overall Study|Participant decision|0|||
126048386|NCT04436289|453473889|FG000|Overall Study|Death prior to hospital discharge|8|||
126048387|NCT04436289|453473890|FG001|Overall Study|Death prior to hospital discharge|5|||
126048388|NCT04436289|453473891|FG002|Overall Study|Death prior to hospital discharge|0|||
126048389|NCT04436289|453473892|FG003|Overall Study|Death prior to hospital discharge|1|||
126048390|NCT04436289|453473889|FG000|Overall Study|Withdrawal by Subject|0|||
126048391|NCT04436289|453473890|FG001|Overall Study|Withdrawal by Subject|1|||
126048392|NCT04436289|453473891|FG002|Overall Study|Withdrawal by Subject|4|||
126048393|NCT04436289|453473892|FG003|Overall Study|Withdrawal by Subject|0|||
126048394|NCT04436289|453473889|FG000|Overall Study|Extended hospital stay|0|||
126048395|NCT04436289|453473890|FG001|Overall Study|Extended hospital stay|1|||
126048396|NCT04436289|453473891|FG002|Overall Study|Extended hospital stay|0|||
126048397|NCT04436289|453473892|FG003|Overall Study|Extended hospital stay|0|||
126048398|NCT04436289|453473889|FG000|Overall Study|Lost to Follow-up|0|||
126048399|NCT04436289|453473890|FG001|Overall Study|Lost to Follow-up|4|||
126048400|NCT04436289|453473891|FG002|Overall Study|Lost to Follow-up|1|||
126048401|NCT04436289|453473892|FG003|Overall Study|Lost to Follow-up|3|||
126048402|NCT03357952|453473895|FG000|Overall Study|Withdrawal by Subject|0|||
126048403|NCT03357952|453473896|FG001|Overall Study|Withdrawal by Subject|1|||
126048404|NCT03357952|453473895|FG000|Overall Study|Sponsor Decision|9|||
126048405|NCT03357952|453473896|FG001|Overall Study|Sponsor Decision|0|||
126048406|NCT01371994|453473897|FG000|Overall Study|Adverse Event|3|||
126381481|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126048407|NCT01371994|453473898|FG001|Overall Study|Adverse Event|6|||
126048408|NCT01371994|453473897|FG000|Overall Study|Lack of Efficacy|3|||
126048409|NCT01371994|453473898|FG001|Overall Study|Lack of Efficacy|0|||
126048410|NCT01371994|453473897|FG000|Overall Study|Withdrawal by Subject|13|||
126381482|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381483|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381484|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381485|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381486|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381487|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381488|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381489|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
126381490|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
126381491|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381492|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381493|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381494|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381495|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381496|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381497|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381498|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381499|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381500|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381501|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
126381502|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
126381503|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381504|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381505|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381506|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381507|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381508|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381509|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381510|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381511|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
126381512|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
126381513|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381514|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381515|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381516|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381517|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381518|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381519|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381520|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381521|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
126381522|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
126381523|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381524|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381525|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381526|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381527|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381528|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381529|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381530|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381531|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
126381532|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
126381533|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381534|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381535|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381536|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381537|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381538|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381539|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381540|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381541|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
126381542|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381543|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381544|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381545|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381546|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381547|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381548|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381549|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381550|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381551|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381552|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
126381553|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381554|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381555|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381556|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381557|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381558|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381559|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Other|0|||
126381560|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Other|0|||
126381561|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Other|2|||
126381562|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Other|1|||
126381563|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Other|0|||
126381564|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Other|0|||
126381565|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Other|0|||
126381566|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Other|0|||
126381567|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Other|0|||
126381568|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Other|0|||
126381569|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381570|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381571|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381572|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381573|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381574|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
126381575|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
126381576|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
126381577|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381578|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381579|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381580|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381581|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381582|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381583|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
126381584|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
126381585|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
126381586|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
126381587|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381588|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381589|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381590|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381591|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381592|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381593|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
126381594|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126048411|NCT01371994|453473898|FG001|Overall Study|Withdrawal by Subject|7|||
126048412|NCT01371994|453473897|FG000|Overall Study|Lost to Follow-up|1|||
126048413|NCT01371994|453473898|FG001|Overall Study|Lost to Follow-up|1|||
126048414|NCT01371994|453473897|FG000|Overall Study|Protocol Violation|24|||
126048415|NCT01371994|453473898|FG001|Overall Study|Protocol Violation|17|||
126048416|NCT01371994|453473897|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
126048417|NCT01371994|453473898|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
126048418|NCT01371994|453473897|FG000|Overall Study|Physician Decision|1|||
126048419|NCT01371994|453473898|FG001|Overall Study|Physician Decision|1|||
126048420|NCT01371994|453473897|FG000|Overall Study|Miscellaneous Reasons|6|||
126381595|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
126381596|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381597|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381598|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381599|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381600|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381601|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381602|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381603|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
126381604|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381605|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
126381606|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
126381607|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381608|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381609|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381610|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381611|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381612|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381613|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
126381614|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
126381615|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
126381616|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381617|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381618|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381619|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381620|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381621|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381622|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381623|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381624|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381625|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381626|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
126381627|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381628|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381629|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381630|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381631|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381632|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381633|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381634|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381635|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
126381636|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381637|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381638|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381639|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381640|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381641|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381642|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381643|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381644|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381645|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381646|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381647|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
126381648|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
126048421|NCT01371994|453473898|FG001|Overall Study|Miscellaneous Reasons|4|||
126048422|NCT04153890|453473899|FG000|Overall Study|Lost to Follow-up|9|||
126381649|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381650|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381651|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381652|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381653|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381654|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381655|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381656|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381657|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
126381658|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
126381659|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381660|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381661|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381662|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381663|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381664|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381665|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381666|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381667|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
126381668|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
126381669|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381670|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381671|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381672|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381673|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381674|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381675|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381676|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381677|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
126381678|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
126381679|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
126381680|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
126381681|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
126381682|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
126381683|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
126381684|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
126381685|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
126381686|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
126381687|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
126381688|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
126381689|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381690|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381691|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381692|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381693|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381694|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381695|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381696|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381697|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
126381698|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
126381699|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381700|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381701|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126048423|NCT04153890|453473900|FG001|Overall Study|Lost to Follow-up|0|||
126048424|NCT04153890|453473901|FG002|Overall Study|Lost to Follow-up|9|||
126048425|NCT04153890|453473902|FG003|Overall Study|Lost to Follow-up|0|||
126048426|NCT04153890|453473899|FG000|Overall Study|Death|0|||
126048427|NCT04153890|453473900|FG001|Overall Study|Death|2|||
126381702|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381703|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381704|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126048428|NCT04153890|453473901|FG002|Overall Study|Death|0|||
126048429|NCT04153890|453473902|FG003|Overall Study|Death|0|||
126048430|NCT04153890|453473899|FG000|Overall Study|Withdrawal by Subject|0|||
126048431|NCT04153890|453473900|FG001|Overall Study|Withdrawal by Subject|0|||
126048432|NCT04153890|453473901|FG002|Overall Study|Withdrawal by Subject|0|||
126048433|NCT04153890|453473902|FG003|Overall Study|Withdrawal by Subject|2|||
126048434|NCT03959423|453473903|FG000|Overall Study|Withdrawal by Subject|2|||
126048435|NCT03959423|453473904|FG001|Overall Study|Withdrawal by Subject|3|||
126381705|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381706|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381707|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
126381708|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381709|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381710|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381711|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381712|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381713|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381714|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381715|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381716|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381717|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
126381718|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
126381719|NCT00292045|454691826|FG000|Core Study (Through Week 13)|Adverse Event|1|||
126381720|NCT00292045|454691826|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
126381721|NCT04474197|454691827|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
126381722|NCT04474197|454691828|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
126381723|NCT04474197|454691829|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
126381724|NCT04474197|454691830|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
126381725|NCT02443337|454691831|FG000|Overall Study|Adverse Event|0|||
126381726|NCT02443337|454691832|FG001|Overall Study|Adverse Event|1|||
126381727|NCT02443337|454691831|FG000|Overall Study|Clinical Progressive Disease|3|||
126381728|NCT02443337|454691832|FG001|Overall Study|Clinical Progressive Disease|0|||
126381729|NCT02443337|454691831|FG000|Overall Study|Withdrawal by Subject|2|||
126381730|NCT02443337|454691832|FG001|Overall Study|Withdrawal by Subject|1|||
126381731|NCT00635349|454691834|FG000|Overall Study|Other|8|||
126381732|NCT00635349|454691835|FG001|Overall Study|Other|6|||
126381733|NCT00635349|454691834|FG000|Overall Study|Protocol Violation|18|||
126381734|NCT00635349|454691835|FG001|Overall Study|Protocol Violation|22|||
126381735|NCT00635349|454691834|FG000|Overall Study|Withdrawal by Subject|3|||
126381736|NCT00635349|454691835|FG001|Overall Study|Withdrawal by Subject|8|||
126381737|NCT00635349|454691834|FG000|Overall Study|Lost to Follow-up|4|||
126381738|NCT00635349|454691835|FG001|Overall Study|Lost to Follow-up|3|||
126381739|NCT00635349|454691834|FG000|Overall Study|Adverse Event|11|||
126381740|NCT00635349|454691835|FG001|Overall Study|Adverse Event|9|||
126381741|NCT04860869|454691840|FG000|Overall Study|Withdrawal by Subject|1|||
126381742|NCT04860869|454691841|FG001|Overall Study|Withdrawal by Subject|0|||
126381743|NCT03951766|454691842|FG000|Treatment Phase|Lost to Follow-up|1|||
126381744|NCT03951766|454691842|FG000|Follow-up Phase|Lost to Follow-up|10|||
126381745|NCT00049322|454691845|FG000|Overall Study|disease burden|0|||
126381746|NCT00049322|454691846|FG001|Overall Study|disease burden|3|||
126381747|NCT00049322|454691845|FG000|Overall Study|Adverse Event|1|||
126381748|NCT00049322|454691846|FG001|Overall Study|Adverse Event|0|||
126381749|NCT00049322|454691845|FG000|Overall Study|refused angio|0|||
126381750|NCT00049322|454691846|FG001|Overall Study|refused angio|3|||
126381751|NCT03943290|454691849|FG000|Overall Study|Sponsor Terminated Study|6|||
126381752|NCT03943290|454691850|FG001|Overall Study|Sponsor Terminated Study|1|||
126381753|NCT03943290|454691851|FG002|Overall Study|Sponsor Terminated Study|11|||
126381754|NCT03943290|454691852|FG003|Overall Study|Sponsor Terminated Study|6|||
126381755|NCT03943290|454691853|FG004|Overall Study|Sponsor Terminated Study|7|||
126381756|NCT03943290|454691854|FG005|Overall Study|Sponsor Terminated Study|6|||
126381757|NCT03943290|454691855|FG006|Overall Study|Sponsor Terminated Study|6|||
126381758|NCT03943290|454691856|FG007|Overall Study|Sponsor Terminated Study|7|||
126381759|NCT03943290|454691857|FG008|Overall Study|Sponsor Terminated Study|8|||
126381760|NCT03943290|454691849|FG000|Overall Study|Lost to Follow-up|1|||
126381761|NCT03943290|454691850|FG001|Overall Study|Lost to Follow-up|0|||
126381762|NCT03943290|454691851|FG002|Overall Study|Lost to Follow-up|1|||
126381763|NCT03943290|454691852|FG003|Overall Study|Lost to Follow-up|0|||
126381764|NCT03943290|454691853|FG004|Overall Study|Lost to Follow-up|0|||
126381765|NCT03943290|454691854|FG005|Overall Study|Lost to Follow-up|0|||
126381766|NCT03943290|454691855|FG006|Overall Study|Lost to Follow-up|0|||
126381767|NCT03943290|454691856|FG007|Overall Study|Lost to Follow-up|1|||
126381768|NCT03943290|454691857|FG008|Overall Study|Lost to Follow-up|0|||
126381769|NCT03943290|454691849|FG000|Overall Study|Withdrawal by Subject|0|||
126381770|NCT03943290|454691850|FG001|Overall Study|Withdrawal by Subject|0|||
126381771|NCT03943290|454691851|FG002|Overall Study|Withdrawal by Subject|1|||
126381772|NCT03943290|454691852|FG003|Overall Study|Withdrawal by Subject|0|||
126381773|NCT03943290|454691853|FG004|Overall Study|Withdrawal by Subject|0|||
126381774|NCT03943290|454691854|FG005|Overall Study|Withdrawal by Subject|0|||
126381775|NCT03943290|454691855|FG006|Overall Study|Withdrawal by Subject|0|||
126381776|NCT03943290|454691856|FG007|Overall Study|Withdrawal by Subject|0|||
126381777|NCT03943290|454691857|FG008|Overall Study|Withdrawal by Subject|0|||
126381778|NCT00295646|454691858|FG000|Overall Study|Protocol Violation|18|||
126381779|NCT00295646|454691859|FG001|Overall Study|Protocol Violation|20|||
126381780|NCT00295646|454691860|FG002|Overall Study|Protocol Violation|20|||
126381781|NCT00295646|454691861|FG003|Overall Study|Protocol Violation|18|||
126381782|NCT00295646|454691858|FG000|Overall Study|Withdrawal by Subject|8|||
126381783|NCT00295646|454691859|FG001|Overall Study|Withdrawal by Subject|9|||
126381784|NCT00295646|454691860|FG002|Overall Study|Withdrawal by Subject|11|||
126381785|NCT00295646|454691861|FG003|Overall Study|Withdrawal by Subject|14|||
126381786|NCT00295646|454691858|FG000|Overall Study|Lost to Follow-up|0|||
126381787|NCT00295646|454691859|FG001|Overall Study|Lost to Follow-up|5|||
126381788|NCT00295646|454691860|FG002|Overall Study|Lost to Follow-up|1|||
126381789|NCT00295646|454691861|FG003|Overall Study|Lost to Follow-up|5|||
126381790|NCT00295646|454691858|FG000|Overall Study|Death|9|||
126381791|NCT00295646|454691859|FG001|Overall Study|Death|7|||
126381792|NCT00295646|454691860|FG002|Overall Study|Death|18|||
126381793|NCT00295646|454691861|FG003|Overall Study|Death|8|||
126381794|NCT02441101|454691872|FG000|Overall Study|Withdrawal by Subject|1|||
126381795|NCT02441101|454691873|FG001|Overall Study|Withdrawal by Subject|0|||
126381796|NCT02441101|454691872|FG000|Overall Study|Lost to Follow-up|1|||
126381797|NCT02441101|454691873|FG001|Overall Study|Lost to Follow-up|0|||
126381798|NCT02441101|454691872|FG000|Overall Study|PI relocated and study terminated|1|||
126381799|NCT02441101|454691873|FG001|Overall Study|PI relocated and study terminated|0|||
126381800|NCT00955474|454691874|FG000|Overall Study|Physician Decision|7|||
126381801|NCT00955474|454691875|FG001|Overall Study|Physician Decision|5|||
126381802|NCT01737762|454691878|FG000|Overall Study|Adverse Event|2|||
126381803|NCT01737762|454691879|FG001|Overall Study|Adverse Event|2|||
126381804|NCT01737762|454691878|FG000|Overall Study|Lost to Follow-up|1|||
126381805|NCT01737762|454691879|FG001|Overall Study|Lost to Follow-up|0|||
126381806|NCT01737762|454691878|FG000|Overall Study|Withdrawal by Subject|2|||
126381807|NCT01737762|454691879|FG001|Overall Study|Withdrawal by Subject|2|||
126381808|NCT01737762|454691878|FG000|Overall Study|Progressive disease|1|||
126381809|NCT01737762|454691879|FG001|Overall Study|Progressive disease|2|||
126381810|NCT01737762|454691878|FG000|Overall Study|Physician Decision|1|||
126381811|NCT01737762|454691879|FG001|Overall Study|Physician Decision|1|||
126381812|NCT01737762|454691878|FG000|Overall Study|Moved from area|2|||
126381813|NCT01737762|454691879|FG001|Overall Study|Moved from area|1|||
126381814|NCT01737762|454691878|FG000|Overall Study|Trial termination|11|||
126381815|NCT01737762|454691879|FG001|Overall Study|Trial termination|9|||
126381816|NCT03083665|454691881|FG000|Double-Blind Period|Adverse Event|5|||
126381817|NCT03083665|454691882|FG001|Double-Blind Period|Adverse Event|4|||
126381818|NCT03083665|454691883|FG002|Double-Blind Period|Adverse Event|5|||
126381819|NCT03083665|454691884|FG003|Double-Blind Period|Adverse Event|0|||
126381820|NCT03083665|454691885|FG004|Double-Blind Period|Adverse Event|0|||
126381821|NCT03083665|454691886|FG005|Double-Blind Period|Adverse Event|0|||
126381822|NCT03083665|454691881|FG000|Double-Blind Period|Lack of Efficacy|0|||
126381823|NCT03083665|454691882|FG001|Double-Blind Period|Lack of Efficacy|0|||
126381824|NCT03083665|454691883|FG002|Double-Blind Period|Lack of Efficacy|1|||
126381825|NCT03083665|454691884|FG003|Double-Blind Period|Lack of Efficacy|0|||
126381826|NCT03083665|454691885|FG004|Double-Blind Period|Lack of Efficacy|0|||
126381827|NCT03083665|454691886|FG005|Double-Blind Period|Lack of Efficacy|0|||
126381828|NCT03083665|454691881|FG000|Double-Blind Period|Protocol Violation|1|||
126381829|NCT03083665|454691882|FG001|Double-Blind Period|Protocol Violation|0|||
126381830|NCT03083665|454691883|FG002|Double-Blind Period|Protocol Violation|1|||
126381831|NCT03083665|454691884|FG003|Double-Blind Period|Protocol Violation|0|||
126381832|NCT03083665|454691885|FG004|Double-Blind Period|Protocol Violation|0|||
126381833|NCT03083665|454691886|FG005|Double-Blind Period|Protocol Violation|0|||
126381834|NCT03083665|454691881|FG000|Double-Blind Period|Lost to Follow-up|1|||
126381835|NCT03083665|454691882|FG001|Double-Blind Period|Lost to Follow-up|0|||
126381836|NCT03083665|454691883|FG002|Double-Blind Period|Lost to Follow-up|1|||
126381837|NCT03083665|454691884|FG003|Double-Blind Period|Lost to Follow-up|0|||
126381838|NCT03083665|454691885|FG004|Double-Blind Period|Lost to Follow-up|0|||
126381839|NCT03083665|454691886|FG005|Double-Blind Period|Lost to Follow-up|0|||
126381840|NCT03083665|454691881|FG000|Double-Blind Period|Withdrawal by Subject|3|||
126381841|NCT03083665|454691882|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126381842|NCT03083665|454691883|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126381843|NCT03083665|454691884|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126381844|NCT03083665|454691885|FG004|Double-Blind Period|Withdrawal by Subject|0|||
126381845|NCT03083665|454691886|FG005|Double-Blind Period|Withdrawal by Subject|0|||
126381846|NCT03083665|454691881|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
126381847|NCT03083665|454691882|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381848|NCT03083665|454691883|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381849|NCT03083665|454691884|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381850|NCT03083665|454691885|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381851|NCT03083665|454691886|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381852|NCT03083665|454691881|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381853|NCT03083665|454691882|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
126381854|NCT03083665|454691883|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381855|NCT03083665|454691884|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381856|NCT03083665|454691885|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381857|NCT03083665|454691886|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381858|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381859|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381860|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381861|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
126381862|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381863|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381864|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381865|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381866|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381867|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381868|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381869|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
126381870|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
126381871|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
126381872|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
126381873|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
126381874|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
126381875|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
126381876|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381877|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381878|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381879|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381880|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381881|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
126381882|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381883|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381884|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381885|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
126381886|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381887|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381888|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381889|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381890|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381891|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381892|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381893|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
126381894|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381895|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381896|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381897|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381898|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381899|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
126381900|NCT01467466|454691887|FG000|Overall Study|Withdrawal by Subject|15|||
126381901|NCT01467466|454691888|FG001|Overall Study|Withdrawal by Subject|18|||
126381902|NCT01467466|454691889|FG002|Overall Study|Withdrawal by Subject|13|||
126381903|NCT01467466|454691890|FG003|Overall Study|Withdrawal by Subject|11|||
126381904|NCT01467466|454691887|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
126381905|NCT01467466|454691888|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
126381906|NCT01467466|454691889|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
126381907|NCT01467466|454691890|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
126381908|NCT01467466|454691887|FG000|Overall Study|Procedure Cancelled|46|||
126381909|NCT01467466|454691888|FG001|Overall Study|Procedure Cancelled|45|||
126381910|NCT01467466|454691889|FG002|Overall Study|Procedure Cancelled|25|||
126381911|NCT01467466|454691890|FG003|Overall Study|Procedure Cancelled|29|||
126381912|NCT01467466|454691887|FG000|Overall Study|No Endpoint Blood Draw|38|||
126381913|NCT01467466|454691888|FG001|Overall Study|No Endpoint Blood Draw|32|||
126381914|NCT01467466|454691889|FG002|Overall Study|No Endpoint Blood Draw|51|||
126381915|NCT01467466|454691890|FG003|Overall Study|No Endpoint Blood Draw|43|||
126381916|NCT01144416|454691897|FG000|Intervention Period|Adverse Event|5|||
126381917|NCT01144416|454691898|FG001|Intervention Period|Adverse Event|6|||
126381918|NCT01144416|454691897|FG000|Intervention Period|Insufficient ovarian response|11|||
126381919|NCT01144416|454691898|FG001|Intervention Period|Insufficient ovarian response|17|||
126381920|NCT01144416|454691897|FG000|Intervention Period|Risk of OHSS|0|||
126381921|NCT01144416|454691898|FG001|Intervention Period|Risk of OHSS|1|||
126381922|NCT01144416|454691897|FG000|Intervention Period|Too high ovarian response|4|||
126381923|NCT01144416|454691898|FG001|Intervention Period|Too high ovarian response|2|||
126381924|NCT01144416|454691897|FG000|Intervention Period|No/too few/bad oocytes|7|||
126381925|NCT01144416|454691898|FG001|Intervention Period|No/too few/bad oocytes|5|||
126381926|NCT01144416|454691897|FG000|Intervention Period|No or abnormal fertilization|25|||
126381927|NCT01144416|454691898|FG001|Intervention Period|No or abnormal fertilization|10|||
126381928|NCT01144416|454691897|FG000|Intervention Period|No/too few/bad quality embryos|3|||
126381929|NCT01144416|454691898|FG001|Intervention Period|No/too few/bad quality embryos|3|||
126381930|NCT01144416|454691897|FG000|Intervention Period|Other|7|||
126381931|NCT01144416|454691898|FG001|Intervention Period|Other|5|||
126381932|NCT01445613|454691903|FG000|30-day Follow-up|Withdrawal by Subject|6|||
126381933|NCT01445613|454691903|FG000|30-day Follow-up|Physician Decision|3|||
126381934|NCT01445613|454691903|FG000|30-day Follow-up|Missed visit|23|||
126381935|NCT01445613|454691903|FG000|30-day Follow-up|Death|3|||
126381936|NCT01445613|454691903|FG000|1-year Follow-up|Withdrawal by Subject|12|||
126381937|NCT01445613|454691903|FG000|1-year Follow-up|Missed visit|29|||
126381938|NCT01445613|454691903|FG000|1-year Follow-up|Lost to Follow-up|2|||
126381939|NCT01445613|454691903|FG000|1-year Follow-up|Death|30|||
126381940|NCT01445613|454691903|FG000|1-year Follow-up|Physician Decision|2|||
126381941|NCT01445613|454691903|FG000|1-year Follow-up|Received a non-study stent|2|||
126381942|NCT02131662|454691910|FG000|Overall Study|Protocol Violation|1|||
126381943|NCT02131662|454691911|FG001|Overall Study|Protocol Violation|0|||
126381944|NCT02131662|454691912|FG002|Overall Study|Protocol Violation|0|||
126381945|NCT02131662|454691913|FG003|Overall Study|Protocol Violation|0|||
126381946|NCT02131662|454691914|FG004|Overall Study|Protocol Violation|0|||
126381947|NCT02131662|454691910|FG000|Overall Study|Other|2|||
126048436|NCT03959423|453473903|FG000|Overall Study|Physician Decision|0|||
126048437|NCT03959423|453473904|FG001|Overall Study|Physician Decision|1|||
126048438|NCT03959423|453473903|FG000|Overall Study|Lost to Follow-up|1|||
126048439|NCT03959423|453473904|FG001|Overall Study|Lost to Follow-up|0|||
126048440|NCT03959423|453473903|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
126048441|NCT03959423|453473904|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126048442|NCT00593840|453473905|FG000|Overall Study|Withdrawal by Subject|1|||
126048443|NCT04530487|453475188|FG000|Overall Study|Death|1|||
126048444|NCT03876457|453475189|FG000|Overall Study|Lost to Follow-up|1|||
126048445|NCT03876457|453475190|FG001|Overall Study|Lost to Follow-up|3|||
126048446|NCT01184326|453475191|FG000|Overall Study|Adverse Event|1|||
126048447|NCT01184326|453475192|FG001|Overall Study|Adverse Event|2|||
126048448|NCT01184326|453475193|FG002|Overall Study|Adverse Event|0|||
126048449|NCT01184326|453475191|FG000|Overall Study|Death|0|||
126048450|NCT01184326|453475192|FG001|Overall Study|Death|0|||
126048451|NCT01184326|453475193|FG002|Overall Study|Death|1|||
126048452|NCT01184326|453475191|FG000|Overall Study|Withdrawal by Subject|0|||
126048453|NCT01184326|453475192|FG001|Overall Study|Withdrawal by Subject|0|||
126048454|NCT01184326|453475193|FG002|Overall Study|Withdrawal by Subject|1|||
126048455|NCT01184326|453475191|FG000|Overall Study|Physician Decision|1|||
126048456|NCT01184326|453475192|FG001|Overall Study|Physician Decision|1|||
126048457|NCT01184326|453475193|FG002|Overall Study|Physician Decision|0|||
126048458|NCT01184326|453475191|FG000|Overall Study|Disease Progression|1|||
126381948|NCT02131662|454691911|FG001|Overall Study|Other|4|||
126381949|NCT02131662|454691912|FG002|Overall Study|Other|3|||
126381950|NCT02131662|454691913|FG003|Overall Study|Other|3|||
126381951|NCT02131662|454691914|FG004|Overall Study|Other|4|||
126381952|NCT02131662|454691910|FG000|Overall Study|Adverse Event|0|||
126381953|NCT02131662|454691911|FG001|Overall Study|Adverse Event|1|||
126381954|NCT02131662|454691912|FG002|Overall Study|Adverse Event|1|||
126381955|NCT02131662|454691913|FG003|Overall Study|Adverse Event|1|||
126381956|NCT02131662|454691914|FG004|Overall Study|Adverse Event|3|||
126381957|NCT02131662|454691910|FG000|Overall Study|Pregnancy|0|||
126381958|NCT02131662|454691911|FG001|Overall Study|Pregnancy|1|||
126381959|NCT02131662|454691912|FG002|Overall Study|Pregnancy|0|||
126381960|NCT02131662|454691913|FG003|Overall Study|Pregnancy|1|||
126048459|NCT01184326|453475192|FG001|Overall Study|Disease Progression|3|||
126048460|NCT01184326|453475193|FG002|Overall Study|Disease Progression|12|||
126048461|NCT01036724|453475194|FG000|Overall Study|Adverse Event|1|||
126381961|NCT02131662|454691914|FG004|Overall Study|Pregnancy|0|||
126381962|NCT02131662|454691910|FG000|Overall Study|Wish for pregnancy|0|||
126048462|NCT01036724|453475195|FG001|Overall Study|Adverse Event|2|||
126048463|NCT01036724|453475194|FG000|Overall Study|Lack of Efficacy|1|||
126381963|NCT02131662|454691911|FG001|Overall Study|Wish for pregnancy|0|||
126381964|NCT02131662|454691912|FG002|Overall Study|Wish for pregnancy|0|||
126381965|NCT02131662|454691913|FG003|Overall Study|Wish for pregnancy|0|||
126381966|NCT02131662|454691914|FG004|Overall Study|Wish for pregnancy|1|||
126381967|NCT02131662|454691910|FG000|Overall Study|Lack of Efficacy|1|||
126381968|NCT02131662|454691911|FG001|Overall Study|Lack of Efficacy|0|||
126381969|NCT02131662|454691912|FG002|Overall Study|Lack of Efficacy|0|||
126381970|NCT02131662|454691913|FG003|Overall Study|Lack of Efficacy|0|||
126381971|NCT02131662|454691914|FG004|Overall Study|Lack of Efficacy|1|||
126381972|NCT02131662|454691910|FG000|Overall Study|Withdrawal by Subject|1|||
126381973|NCT02131662|454691911|FG001|Overall Study|Withdrawal by Subject|5|||
126381974|NCT02131662|454691912|FG002|Overall Study|Withdrawal by Subject|1|||
126381975|NCT02131662|454691913|FG003|Overall Study|Withdrawal by Subject|5|||
126381976|NCT02131662|454691914|FG004|Overall Study|Withdrawal by Subject|6|||
126381977|NCT02131662|454691910|FG000|Overall Study|Lost to Follow-up|1|||
126381978|NCT02131662|454691911|FG001|Overall Study|Lost to Follow-up|3|||
126381979|NCT02131662|454691912|FG002|Overall Study|Lost to Follow-up|0|||
126381980|NCT02131662|454691913|FG003|Overall Study|Lost to Follow-up|9|||
126381981|NCT02131662|454691914|FG004|Overall Study|Lost to Follow-up|0|||
126381982|NCT02131662|454691910|FG000|Overall Study|Not treated|2|||
126381983|NCT02131662|454691911|FG001|Overall Study|Not treated|0|||
126381984|NCT02131662|454691912|FG002|Overall Study|Not treated|2|||
126381985|NCT02131662|454691913|FG003|Overall Study|Not treated|2|||
126381986|NCT02131662|454691914|FG004|Overall Study|Not treated|3|||
126381987|NCT01402869|454691915|FG000|Overall Study|Required Tooth Extraction|0|||
126381988|NCT01402869|454691916|FG001|Overall Study|Required Tooth Extraction|0|||
126381989|NCT01402869|454691917|FG002|Overall Study|Required Tooth Extraction|1|||
126381990|NCT01740687|454691918|FG000|Overall Study|Lost to Follow-up|11|||
126381991|NCT01740687|454691918|FG000|Overall Study|Withdrawal by Subject|2|||
126381992|NCT01740687|454691918|FG000|Overall Study|other reason|22|||
126381993|NCT01740687|454691918|FG000|Overall Study|treatment not received|2|||
126381994|NCT00104728|454691920|FG000|Overall Study|screen failures|19|||
126381995|NCT01963767|454691921|FG000|Overall Study|Withdrawal by Subject|4|||
126381996|NCT01963767|454691922|FG001|Overall Study|Withdrawal by Subject|2|||
126381997|NCT01963767|454691921|FG000|Overall Study|Adverse Event|2|||
126381998|NCT01963767|454691922|FG001|Overall Study|Adverse Event|0|||
126381999|NCT03960684|454691923|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
126382000|NCT03941483|454691927|FG000|Overall Study|Miscellaneous|2|||
126382001|NCT03941483|454691928|FG001|Overall Study|Miscellaneous|3|||
126382002|NCT03941483|454691929|FG002|Overall Study|Miscellaneous|0|||
126382003|NCT03941483|454691927|FG000|Overall Study|Study Terminated by Sponsor|1|||
126382004|NCT03941483|454691928|FG001|Overall Study|Study Terminated by Sponsor|0|||
126382005|NCT03941483|454691929|FG002|Overall Study|Study Terminated by Sponsor|0|||
126382006|NCT03941483|454691927|FG000|Overall Study|Withdrawal by Subject|1|||
126382007|NCT03941483|454691928|FG001|Overall Study|Withdrawal by Subject|4|||
126382008|NCT03941483|454691929|FG002|Overall Study|Withdrawal by Subject|1|||
126382009|NCT03941483|454691927|FG000|Overall Study|Lost to Follow-up|2|||
126382010|NCT03941483|454691928|FG001|Overall Study|Lost to Follow-up|1|||
126382011|NCT03941483|454691929|FG002|Overall Study|Lost to Follow-up|8|||
126382012|NCT03941483|454691927|FG000|Overall Study|Death|3|||
126382013|NCT03941483|454691928|FG001|Overall Study|Death|2|||
126048464|NCT01036724|453475195|FG001|Overall Study|Lack of Efficacy|1|||
126048465|NCT01036724|453475194|FG000|Overall Study|Protocol Violation|4|||
126048466|NCT01036724|453475195|FG001|Overall Study|Protocol Violation|5|||
126382014|NCT03941483|454691929|FG002|Overall Study|Death|6|||
126382015|NCT01082081|454691930|FG000|Overall Study|Lost to Follow-up|0|||
126048467|NCT04213807|453475203|FG000|Overall Study|Physician Decision|0|||
126048468|NCT04213807|453475204|FG001|Overall Study|Physician Decision|0|||
126048469|NCT04213807|453475205|FG002|Overall Study|Physician Decision|1|||
126048470|NCT01574716|453475206|FG000|Part 1|Death|3|||
126048471|NCT01574716|453475207|FG001|Part 1|Death|1|||
126048472|NCT01574716|453475208|FG002|Part 1|Death|8|||
126382016|NCT01082081|454691931|FG001|Overall Study|Lost to Follow-up|0|||
126382017|NCT01082081|454691932|FG002|Overall Study|Lost to Follow-up|1|||
126382018|NCT01082081|454691930|FG000|Overall Study|Withdrawal by Subject|0|||
126382019|NCT01082081|454691931|FG001|Overall Study|Withdrawal by Subject|0|||
126382020|NCT01082081|454691932|FG002|Overall Study|Withdrawal by Subject|1|||
126382021|NCT01082081|454691930|FG000|Overall Study|Other Reason|0|||
126382022|NCT01082081|454691931|FG001|Overall Study|Other Reason|1|||
126382023|NCT01082081|454691932|FG002|Overall Study|Other Reason|0|||
126382024|NCT00670930|454691935|FG000|Overall Study|Adminstrative Problem|0|||
126048473|NCT01574716|453475209|FG003|Part 1|Death|0|||
126104169|NCT00320541|453675819|FG000|Overall Study|Withdrawal by Subject|12|||
126382025|NCT00670930|454691936|FG001|Overall Study|Adminstrative Problem|1|||
126382026|NCT00670930|454691935|FG000|Overall Study|Lost to Follow-up|1|||
126382027|NCT00670930|454691936|FG001|Overall Study|Lost to Follow-up|0|||
126382028|NCT03493451|454693476|FG000|Overall Study|Death|11|||
126048474|NCT01574716|453475210|FG004|Part 1|Death|0|||
126048475|NCT01574716|453475206|FG000|Part 1|Discontinuation of study by sponsor|0|||
126382029|NCT03493451|454693477|FG001|Overall Study|Death|26|||
126382030|NCT03493451|454693478|FG002|Overall Study|Death|3|||
126382031|NCT03493451|454693476|FG000|Overall Study|Lost to Follow-up|1|||
126382032|NCT03493451|454693477|FG001|Overall Study|Lost to Follow-up|4|||
126382033|NCT03493451|454693478|FG002|Overall Study|Lost to Follow-up|1|||
126382034|NCT03493451|454693476|FG000|Overall Study|Withdrawal by Subject|1|||
126382035|NCT03493451|454693477|FG001|Overall Study|Withdrawal by Subject|1|||
126382036|NCT03493451|454693478|FG002|Overall Study|Withdrawal by Subject|2|||
126382037|NCT03493451|454693476|FG000|Overall Study|Progressive Disease|1|||
126382038|NCT03493451|454693477|FG001|Overall Study|Progressive Disease|0|||
126382039|NCT03493451|454693478|FG002|Overall Study|Progressive Disease|0|||
126382040|NCT03493451|454693476|FG000|Overall Study|Transferred to long term extension study|8|||
126382041|NCT03493451|454693477|FG001|Overall Study|Transferred to long term extension study|13|||
126382042|NCT03493451|454693478|FG002|Overall Study|Transferred to long term extension study|5|||
126382043|NCT00600106|454693484|FG000|Overall Study|Withdrawal by Subject|1|||
126382044|NCT00600106|454693485|FG001|Overall Study|Withdrawal by Subject|1|||
126382045|NCT03015363|454693488|FG000|Overall Study|Physician Decision|14|||
126382046|NCT03015363|454693488|FG000|Overall Study|Withdrawal by Subject|3|||
126382047|NCT01947283|454693491|FG000|Overall Study|Death|1|||
126382048|NCT01947283|454693492|FG001|Overall Study|Death|1|||
126382049|NCT01947283|454693493|FG002|Overall Study|Death|1|||
126382050|NCT01947283|454693494|FG003|Overall Study|Death|0|||
126382051|NCT01947283|454693495|FG004|Overall Study|Death|0|||
126382052|NCT01947283|454693496|FG005|Overall Study|Death|0|||
126382053|NCT01947283|454693497|FG006|Overall Study|Death|0|||
126382054|NCT01947283|454693491|FG000|Overall Study|Lost to Follow-up|4|||
126382055|NCT01947283|454693492|FG001|Overall Study|Lost to Follow-up|6|||
126382056|NCT01947283|454693493|FG002|Overall Study|Lost to Follow-up|5|||
126382057|NCT01947283|454693494|FG003|Overall Study|Lost to Follow-up|5|||
126382058|NCT01947283|454693495|FG004|Overall Study|Lost to Follow-up|0|||
126382059|NCT01947283|454693496|FG005|Overall Study|Lost to Follow-up|2|||
126382060|NCT01947283|454693497|FG006|Overall Study|Lost to Follow-up|5|||
126382061|NCT01947283|454693491|FG000|Overall Study|Withdrawal by Subject|10|||
126382062|NCT01947283|454693492|FG001|Overall Study|Withdrawal by Subject|8|||
126382063|NCT01947283|454693493|FG002|Overall Study|Withdrawal by Subject|4|||
126382064|NCT01947283|454693494|FG003|Overall Study|Withdrawal by Subject|1|||
126382065|NCT01947283|454693495|FG004|Overall Study|Withdrawal by Subject|0|||
126382066|NCT01947283|454693496|FG005|Overall Study|Withdrawal by Subject|0|||
126382067|NCT01947283|454693497|FG006|Overall Study|Withdrawal by Subject|2|||
126382068|NCT01947283|454693491|FG000|Overall Study|No Clinical Recording|12|||
126048476|NCT01574716|453475207|FG001|Part 1|Discontinuation of study by sponsor|0|||
126048477|NCT01574716|453475208|FG002|Part 1|Discontinuation of study by sponsor|1|||
126048478|NCT01574716|453475209|FG003|Part 1|Discontinuation of study by sponsor|0|||
126048479|NCT01574716|453475210|FG004|Part 1|Discontinuation of study by sponsor|0|||
126048480|NCT01574716|453475206|FG000|Part 1|Withdrawal by Subject|0|||
126048481|NCT01574716|453475207|FG001|Part 1|Withdrawal by Subject|2|||
126048482|NCT01574716|453475208|FG002|Part 1|Withdrawal by Subject|0|||
126048483|NCT01574716|453475209|FG003|Part 1|Withdrawal by Subject|0|||
126048484|NCT01574716|453475210|FG004|Part 1|Withdrawal by Subject|0|||
126048485|NCT01574716|453475206|FG000|Part 1|Lost to Follow-up|0|||
126048486|NCT01574716|453475207|FG001|Part 1|Lost to Follow-up|1|||
126048487|NCT01574716|453475208|FG002|Part 1|Lost to Follow-up|0|||
126048488|NCT01574716|453475209|FG003|Part 1|Lost to Follow-up|0|||
126048489|NCT01574716|453475210|FG004|Part 1|Lost to Follow-up|0|||
126048490|NCT01574716|453475206|FG000|Part 2|Progressive disease|0|||
126048491|NCT01574716|453475207|FG001|Part 2|Progressive disease|0|||
126048492|NCT01574716|453475208|FG002|Part 2|Progressive disease|0|||
126048493|NCT01574716|453475209|FG003|Part 2|Progressive disease|1|||
126048494|NCT01574716|453475210|FG004|Part 2|Progressive disease|0|||
126048495|NCT01574716|453475206|FG000|Part 2|Death|0|||
126048496|NCT01574716|453475207|FG001|Part 2|Death|0|||
126048497|NCT01574716|453475208|FG002|Part 2|Death|0|||
126048498|NCT01574716|453475209|FG003|Part 2|Death|76|||
126048499|NCT01574716|453475210|FG004|Part 2|Death|35|||
126048500|NCT01574716|453475206|FG000|Part 2|Discontinuation of study by sponsor|0|||
126382069|NCT01947283|454693492|FG001|Overall Study|No Clinical Recording|6|||
126382070|NCT01947283|454693493|FG002|Overall Study|No Clinical Recording|8|||
126382071|NCT01947283|454693494|FG003|Overall Study|No Clinical Recording|10|||
126382072|NCT01947283|454693495|FG004|Overall Study|No Clinical Recording|0|||
126382073|NCT01947283|454693496|FG005|Overall Study|No Clinical Recording|0|||
126382074|NCT01947283|454693497|FG006|Overall Study|No Clinical Recording|0|||
126382075|NCT01947283|454693491|FG000|Overall Study|Non-coding Clinical Recording language|0|||
126382076|NCT01947283|454693492|FG001|Overall Study|Non-coding Clinical Recording language|0|||
126382077|NCT01947283|454693493|FG002|Overall Study|Non-coding Clinical Recording language|0|||
126382078|NCT01947283|454693494|FG003|Overall Study|Non-coding Clinical Recording language|1|||
126382079|NCT01947283|454693495|FG004|Overall Study|Non-coding Clinical Recording language|0|||
126048501|NCT01574716|453475207|FG001|Part 2|Discontinuation of study by sponsor|0|||
126048502|NCT01574716|453475208|FG002|Part 2|Discontinuation of study by sponsor|0|||
126048503|NCT01574716|453475209|FG003|Part 2|Discontinuation of study by sponsor|51|||
126048504|NCT01574716|453475210|FG004|Part 2|Discontinuation of study by sponsor|31|||
126382080|NCT01947283|454693496|FG005|Overall Study|Non-coding Clinical Recording language|0|||
126382081|NCT01947283|454693497|FG006|Overall Study|Non-coding Clinical Recording language|0|||
126382082|NCT01947283|454693491|FG000|Overall Study|Missing Follow-up Assessment|2|||
126382083|NCT01947283|454693492|FG001|Overall Study|Missing Follow-up Assessment|2|||
126382084|NCT01947283|454693493|FG002|Overall Study|Missing Follow-up Assessment|3|||
126382085|NCT01947283|454693494|FG003|Overall Study|Missing Follow-up Assessment|0|||
126382086|NCT01947283|454693495|FG004|Overall Study|Missing Follow-up Assessment|0|||
126382087|NCT01947283|454693496|FG005|Overall Study|Missing Follow-up Assessment|2|||
126382088|NCT01947283|454693497|FG006|Overall Study|Missing Follow-up Assessment|0|||
126382089|NCT01947283|454693491|FG000|Overall Study|No patients were enrolled in study|0|||
126382090|NCT01947283|454693492|FG001|Overall Study|No patients were enrolled in study|0|||
126382091|NCT01947283|454693493|FG002|Overall Study|No patients were enrolled in study|0|||
126382092|NCT01947283|454693494|FG003|Overall Study|No patients were enrolled in study|0|||
126382093|NCT01947283|454693495|FG004|Overall Study|No patients were enrolled in study|0|||
126382094|NCT01947283|454693496|FG005|Overall Study|No patients were enrolled in study|3|||
126382095|NCT01947283|454693497|FG006|Overall Study|No patients were enrolled in study|1|||
126382096|NCT00460655|454693498|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
126382097|NCT00460655|454693499|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126382098|NCT00460655|454693500|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126382099|NCT00460655|454693501|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126382100|NCT00460655|454693498|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
126382101|NCT00460655|454693499|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126382102|NCT00460655|454693500|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126382103|NCT00460655|454693501|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126382104|NCT00460655|454693498|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
126382105|NCT00460655|454693499|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
126382106|NCT00460655|454693500|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
126382107|NCT00460655|454693501|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
126382108|NCT00460655|454693498|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126382109|NCT00460655|454693499|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126382110|NCT00460655|454693500|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
126382111|NCT00460655|454693501|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
126382112|NCT00460655|454693498|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126382113|NCT00460655|454693499|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126382114|NCT00460655|454693500|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
126382115|NCT00460655|454693501|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
126382116|NCT00460655|454693498|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
126382117|NCT00460655|454693499|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
126382118|NCT00460655|454693500|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
126382119|NCT00460655|454693501|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
126382120|NCT00833469|454693502|FG000|Overall Study|Withdrawal by Subject|1|||
126382121|NCT00833469|454693502|FG000|Overall Study|Lost to Follow-up|1|||
126382122|NCT01665911|454693503|FG000|Overall Study|Protocol Violation|4|||
126382123|NCT01665911|454693503|FG000|Overall Study|Withdrawal by Subject|1|||
126382124|NCT01665911|454693503|FG000|Overall Study|Adverse Event|1|||
126382125|NCT00735553|454693504|FG000|Overall Study|Study prematurely terminated|77|||
126382126|NCT03650413|454693505|FG000|Overall Study|Adverse Event|1|||
126382127|NCT03650413|454693505|FG000|Overall Study|Lack of Efficacy|17|||
126382128|NCT03650413|454693505|FG000|Overall Study|Other|9|||
126382129|NCT03650413|454693505|FG000|Overall Study|Physician Decision|2|||
126382130|NCT03650413|454693505|FG000|Overall Study|Study Terminated By Sponsor|16|||
126382131|NCT03650413|454693505|FG000|Overall Study|Withdrawal by Subject|16|||
126382132|NCT03654040|454693506|FG000|Overall Study|Death|1|||
126382133|NCT03654040|454693507|FG001|Overall Study|Death|0|||
126382134|NCT03654040|454693506|FG000|Overall Study|Withdrawal by Subject|1|||
126382135|NCT03654040|454693507|FG001|Overall Study|Withdrawal by Subject|0|||
126382136|NCT03654040|454693506|FG000|Overall Study|Study terminated by sponsor|8|||
126382137|NCT03654040|454693507|FG001|Overall Study|Study terminated by sponsor|2|||
126382138|NCT03654040|454693506|FG000|Overall Study|Failure to initiate study therapy|2|||
125886639|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
125886640|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
126048505|NCT01574716|453475206|FG000|Part 2|Withdrawal by Subject|0|||
126048506|NCT01574716|453475207|FG001|Part 2|Withdrawal by Subject|0|||
126382139|NCT03654040|454693507|FG001|Overall Study|Failure to initiate study therapy|0|||
126382140|NCT03654040|454693506|FG000|Overall Study|Transplanted at another center|2|||
126382141|NCT03654040|454693507|FG001|Overall Study|Transplanted at another center|0|||
126382142|NCT03654040|454693506|FG000|Overall Study|Failure to meet eligibility criteria|14|||
126382143|NCT03654040|454693507|FG001|Overall Study|Failure to meet eligibility criteria|2|||
125886641|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
126048507|NCT01574716|453475208|FG002|Part 2|Withdrawal by Subject|0|||
126048508|NCT01574716|453475209|FG003|Part 2|Withdrawal by Subject|5|||
126382144|NCT03654040|454693506|FG000|Overall Study|No longer transplant candidate|1|||
126382145|NCT03654040|454693507|FG001|Overall Study|No longer transplant candidate|0|||
126382146|NCT03654040|454693506|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
126382147|NCT03654040|454693507|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
126382148|NCT03654040|454693506|FG000|Overall Study|Recipient ineligible|0|||
126382149|NCT03654040|454693507|FG001|Overall Study|Recipient ineligible|2|||
126382150|NCT03654040|454693506|FG000|Overall Study|Received deceased liver|0|||
126382151|NCT03654040|454693507|FG001|Overall Study|Received deceased liver|1|||
126382152|NCT01484496|454693511|FG000|Period 1|Protocol Violation|3|||
126382153|NCT01484496|454693512|FG001|Period 1|Protocol Violation|4|||
126382154|NCT01484496|454693513|FG002|Period 1|Protocol Violation|0|||
126382155|NCT01484496|454693514|FG003|Period 1|Protocol Violation|0|||
126382156|NCT01484496|454693511|FG000|Period 1|Physician Decision|5|||
126382157|NCT01484496|454693512|FG001|Period 1|Physician Decision|1|||
126382158|NCT01484496|454693513|FG002|Period 1|Physician Decision|0|||
126382159|NCT01484496|454693514|FG003|Period 1|Physician Decision|0|||
126382160|NCT01484496|454693511|FG000|Period 1|Lack of Efficacy|10|||
126382161|NCT01484496|454693512|FG001|Period 1|Lack of Efficacy|15|||
126382162|NCT01484496|454693513|FG002|Period 1|Lack of Efficacy|0|||
126382163|NCT01484496|454693514|FG003|Period 1|Lack of Efficacy|0|||
126382164|NCT01484496|454693511|FG000|Period 1|Adverse Event|25|||
126382165|NCT01484496|454693512|FG001|Period 1|Adverse Event|40|||
126382166|NCT01484496|454693513|FG002|Period 1|Adverse Event|0|||
126382167|NCT01484496|454693514|FG003|Period 1|Adverse Event|0|||
126382168|NCT01484496|454693511|FG000|Period 1|Withdrawal by Subject|15|||
126382169|NCT01484496|454693512|FG001|Period 1|Withdrawal by Subject|12|||
126382170|NCT01484496|454693513|FG002|Period 1|Withdrawal by Subject|0|||
126382171|NCT01484496|454693514|FG003|Period 1|Withdrawal by Subject|0|||
126382172|NCT01484496|454693511|FG000|Period 1|Lost to Follow-up|2|||
126382173|NCT01484496|454693512|FG001|Period 1|Lost to Follow-up|6|||
126382174|NCT01484496|454693513|FG002|Period 1|Lost to Follow-up|0|||
126382175|NCT01484496|454693514|FG003|Period 1|Lost to Follow-up|0|||
125886642|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125886643|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125886644|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125886645|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
125886646|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125886647|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126382176|NCT01484496|454693511|FG000|Period 1|Positive Pregnancy|1|||
126382177|NCT01484496|454693512|FG001|Period 1|Positive Pregnancy|6|||
126382178|NCT01484496|454693513|FG002|Period 1|Positive Pregnancy|0|||
126382179|NCT01484496|454693514|FG003|Period 1|Positive Pregnancy|0|||
126382180|NCT01484496|454693511|FG000|Period 1|Treatment Failure|3|||
126382181|NCT01484496|454693512|FG001|Period 1|Treatment Failure|6|||
126382182|NCT01484496|454693513|FG002|Period 1|Treatment Failure|0|||
126382183|NCT01484496|454693514|FG003|Period 1|Treatment Failure|0|||
126382184|NCT01484496|454693511|FG000|Period 1|Lack of Compliance|2|||
126382185|NCT01484496|454693512|FG001|Period 1|Lack of Compliance|1|||
126382186|NCT01484496|454693513|FG002|Period 1|Lack of Compliance|0|||
126382187|NCT01484496|454693514|FG003|Period 1|Lack of Compliance|0|||
126382188|NCT01484496|454693511|FG000|Period 1|Unable to Visit Site|0|||
126382189|NCT01484496|454693512|FG001|Period 1|Unable to Visit Site|2|||
126382190|NCT01484496|454693513|FG002|Period 1|Unable to Visit Site|0|||
126382191|NCT01484496|454693514|FG003|Period 1|Unable to Visit Site|0|||
126382192|NCT01484496|454693511|FG000|Period 2|Lack of Efficacy|0|||
126382193|NCT01484496|454693512|FG001|Period 2|Lack of Efficacy|0|||
126382194|NCT01484496|454693513|FG002|Period 2|Lack of Efficacy|1|||
126382195|NCT01484496|454693514|FG003|Period 2|Lack of Efficacy|3|||
126382196|NCT01484496|454693511|FG000|Period 2|Adverse Event|0|||
126382197|NCT01484496|454693512|FG001|Period 2|Adverse Event|0|||
126382198|NCT01484496|454693513|FG002|Period 2|Adverse Event|5|||
126382199|NCT01484496|454693514|FG003|Period 2|Adverse Event|13|||
126382200|NCT01484496|454693511|FG000|Period 2|Other|0|||
126382201|NCT01484496|454693512|FG001|Period 2|Other|0|||
126382202|NCT01484496|454693513|FG002|Period 2|Other|9|||
126382203|NCT01484496|454693514|FG003|Period 2|Other|6|||
126382204|NCT01645735|454693515|FG000|Overall Study|Physician Decision|2|||
126382205|NCT01645735|454693516|FG001|Overall Study|Physician Decision|0|||
126382206|NCT01645735|454693515|FG000|Overall Study|Withdrawal by Subject|1|||
125886648|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
126048509|NCT01574716|453475210|FG004|Part 2|Withdrawal by Subject|4|||
126382207|NCT01645735|454693516|FG001|Overall Study|Withdrawal by Subject|0|||
126382208|NCT01645735|454693515|FG000|Overall Study|Protocol Violation|1|||
126382209|NCT01645735|454693516|FG001|Overall Study|Protocol Violation|0|||
126382210|NCT01645735|454693515|FG000|Overall Study|Adverse Event|0|||
126382211|NCT01645735|454693516|FG001|Overall Study|Adverse Event|1|||
126382212|NCT01206140|454693517|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
126382213|NCT01206140|454693518|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
126382214|NCT00211172|454693519|FG000|Overall Study|Died or lost health plan eligibility|39|||
126382215|NCT00211172|454693520|FG001|Overall Study|Died or lost health plan eligibility|32|||
126382216|NCT00770562|454693526|FG000|Overall Study|Did not take treatment|1|||
126382217|NCT00770562|454693527|FG001|Overall Study|Did not take treatment|1|||
126382218|NCT01643408|454693528|FG000|Overall Study|Adverse Event|12|||
126382219|NCT01643408|454693528|FG000|Overall Study|Other|2|||
126382220|NCT02236572|454693529|FG000|Overall Study|Withdrawal by Subject|1|||
126382221|NCT02236572|454693529|FG000|Overall Study|Protocol Violation|1|||
126382222|NCT02236572|454693529|FG000|Overall Study|Lost to Follow-up|1|||
126382223|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
126382224|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
126382225|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
126382226|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
126382227|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
126382228|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
126382229|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
126382230|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
126382231|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
126382232|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
126382233|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
126382234|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
126382235|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
126382236|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
126382237|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
126382238|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
126382239|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
126382240|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
126382241|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
126382242|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
126382243|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
126382244|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
126382245|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
126382246|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
126382247|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
126382248|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
126382249|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
126382250|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
126382251|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
126382252|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
126382253|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
126382254|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
126382255|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
126382256|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Other|6|||
126382257|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Other|0|||
126382258|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Other|0|||
126382259|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
126382260|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
126382261|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
126382262|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
126048510|NCT01574716|453475206|FG000|Part 2|Brain metastases|0|||
126048511|NCT01574716|453475207|FG001|Part 2|Brain metastases|0|||
126048512|NCT01574716|453475208|FG002|Part 2|Brain metastases|0|||
126048513|NCT01574716|453475209|FG003|Part 2|Brain metastases|1|||
126048514|NCT01574716|453475210|FG004|Part 2|Brain metastases|0|||
126048515|NCT01574716|453475206|FG000|Part 2|Lost to Follow-up|0|||
126048516|NCT01574716|453475207|FG001|Part 2|Lost to Follow-up|0|||
126048517|NCT01574716|453475208|FG002|Part 2|Lost to Follow-up|0|||
126048518|NCT01574716|453475209|FG003|Part 2|Lost to Follow-up|3|||
126048519|NCT01574716|453475210|FG004|Part 2|Lost to Follow-up|0|||
126048520|NCT01637402|453475212|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
126048521|NCT01637402|453475213|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
126048522|NCT01637402|453475212|FG000|Standard Dose Regimen|Adverse Event|1|||
126382263|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
126382264|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
126382265|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
126382266|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
126048523|NCT01637402|453475213|FG001|Standard Dose Regimen|Adverse Event|0|||
126048524|NCT01637402|453475212|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
126048525|NCT01637402|453475213|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
126382267|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
126382268|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
126382269|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
126382270|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
126382271|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
126382272|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
126382273|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
126382274|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
126382275|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
126382276|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
126382277|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
126382278|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
126382279|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
126382280|NCT00709319|454693534|FG000|Overall Study|Death|4|||
126382281|NCT00709319|454693534|FG000|Overall Study|Withdrawal by Subject|2|||
126382282|NCT00579553|454693535|FG000|Overall Study|Lost to Follow-up|16|||
126382283|NCT00579553|454693536|FG001|Overall Study|Lost to Follow-up|13|||
126382284|NCT00363142|454693539|FG000|Overall Study|Adverse Event|2|||
126382285|NCT00363142|454693540|FG001|Overall Study|Adverse Event|0|||
126382286|NCT00363142|454693539|FG000|Overall Study|Lack of Efficacy|0|||
126382287|NCT00363142|454693540|FG001|Overall Study|Lack of Efficacy|1|||
126382288|NCT00363142|454693539|FG000|Overall Study|Lost to Follow-up|1|||
126382289|NCT00363142|454693540|FG001|Overall Study|Lost to Follow-up|0|||
126382290|NCT00363142|454693539|FG000|Overall Study|Non-compliance|1|||
126382291|NCT00363142|454693540|FG001|Overall Study|Non-compliance|1|||
126382292|NCT00363142|454693539|FG000|Overall Study|Withdrawal by Subject|3|||
126382293|NCT00363142|454693540|FG001|Overall Study|Withdrawal by Subject|1|||
126382294|NCT01541865|454693541|FG000|Overall Study|Lost to Follow-up|11|||
126382295|NCT01541865|454693541|FG000|Overall Study|Withdrawal by Subject|9|||
126382296|NCT01541865|454693541|FG000|Overall Study|Adverse Event|1|||
126382297|NCT01541865|454693541|FG000|Overall Study|Protocol Violation|1|||
126382298|NCT03072043|454693544|FG000|Overall Study|Death|0|||
126104170|NCT00320541|453675820|FG001|Overall Study|Withdrawal by Subject|16|||
126104171|NCT00320541|453675819|FG000|Overall Study|Physician Decision|9|||
126104172|NCT00320541|453675820|FG001|Overall Study|Physician Decision|13|||
126104173|NCT00320541|453675819|FG000|Overall Study|Other|3|||
126382299|NCT03072043|454693545|FG001|Overall Study|Death|0|||
126382300|NCT03072043|454693546|FG002|Overall Study|Death|3|||
126382301|NCT03072043|454693544|FG000|Overall Study|Adverse Event|0|||
126382302|NCT03072043|454693545|FG001|Overall Study|Adverse Event|0|||
126382303|NCT03072043|454693546|FG002|Overall Study|Adverse Event|2|||
126104174|NCT00320541|453675820|FG001|Overall Study|Other|4|||
125886649|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125886650|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125886651|NCT01106690|452881794|FG000|Core Period: Baseline to Week 26|Other|10|||
125886652|NCT01106690|452881795|FG001|Core Period: Baseline to Week 26|Other|2|||
125886653|NCT01106690|452881796|FG002|Core Period: Baseline to Week 26|Other|6|||
125886654|NCT01106690|452881794|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125886655|NCT01106690|452881795|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126382304|NCT03072043|454693544|FG000|Overall Study|Withdrawal by Subject|0|||
126382305|NCT03072043|454693545|FG001|Overall Study|Withdrawal by Subject|0|||
126382306|NCT03072043|454693546|FG002|Overall Study|Withdrawal by Subject|4|||
126382307|NCT01340664|454693547|FG000|Overall Study|Adverse Event|0|||
126382308|NCT01340664|454693548|FG001|Overall Study|Adverse Event|1|||
126382309|NCT01340664|454693549|FG002|Overall Study|Adverse Event|7|||
126382310|NCT01340664|454693547|FG000|Overall Study|Lost to Follow-up|2|||
126382311|NCT01340664|454693548|FG001|Overall Study|Lost to Follow-up|0|||
126382312|NCT01340664|454693549|FG002|Overall Study|Lost to Follow-up|2|||
126382313|NCT01340664|454693547|FG000|Overall Study|Withdrawal by Subject|2|||
126382314|NCT01340664|454693548|FG001|Overall Study|Withdrawal by Subject|4|||
126382315|NCT01340664|454693549|FG002|Overall Study|Withdrawal by Subject|0|||
126382316|NCT01340664|454693547|FG000|Overall Study|Glycemic withdrawal criteria|2|||
126382317|NCT01340664|454693548|FG001|Overall Study|Glycemic withdrawal criteria|0|||
126382318|NCT01340664|454693549|FG002|Overall Study|Glycemic withdrawal criteria|0|||
126382319|NCT01340664|454693547|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
126382320|NCT01340664|454693548|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
126382321|NCT01340664|454693549|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
126382322|NCT01340664|454693547|FG000|Overall Study|Other|1|||
126382323|NCT01340664|454693548|FG001|Overall Study|Other|2|||
126382324|NCT01340664|454693549|FG002|Overall Study|Other|2|||
126382325|NCT02997865|454693551|FG000|Overall Study|Death|2|||
126382326|NCT02997865|454693552|FG001|Overall Study|Death|1|||
126382327|NCT02997865|454693551|FG000|Overall Study|Lost to Follow-up|6|||
126382328|NCT02997865|454693552|FG001|Overall Study|Lost to Follow-up|3|||
126382329|NCT02997865|454693551|FG000|Overall Study|Withdrawal by Subject|5|||
126382330|NCT02997865|454693552|FG001|Overall Study|Withdrawal by Subject|0|||
126382331|NCT01926444|454693553|FG000|Overall Study|Colonoscopy not performed|0|||
126382332|NCT01926444|454693554|FG001|Overall Study|Colonoscopy not performed|0|||
126382333|NCT01926444|454693555|FG002|Overall Study|Colonoscopy not performed|4|||
126382334|NCT01926444|454693556|FG003|Overall Study|Colonoscopy not performed|2|||
126382335|NCT02528942|454693557|FG000|Overall Study|Did not meet imaging criteria|9|||
126382336|NCT02528942|454693557|FG000|Overall Study|Lost to Follow-up|25|||
126382337|NCT00881530|454693558|FG000|Overall Study|Adverse Event|5|||
126382338|NCT00881530|454693559|FG001|Overall Study|Adverse Event|1|||
126382339|NCT00881530|454693560|FG002|Overall Study|Adverse Event|1|||
126382340|NCT00881530|454693561|FG003|Overall Study|Adverse Event|4|||
126382341|NCT00881530|454693562|FG004|Overall Study|Adverse Event|10|||
126382342|NCT00881530|454693563|FG005|Overall Study|Adverse Event|2|||
126382343|NCT00881530|454693558|FG000|Overall Study|Lack of Efficacy|1|||
126382344|NCT00881530|454693559|FG001|Overall Study|Lack of Efficacy|0|||
126382345|NCT00881530|454693560|FG002|Overall Study|Lack of Efficacy|0|||
126382346|NCT00881530|454693561|FG003|Overall Study|Lack of Efficacy|0|||
126382347|NCT00881530|454693562|FG004|Overall Study|Lack of Efficacy|1|||
126382348|NCT00881530|454693563|FG005|Overall Study|Lack of Efficacy|1|||
126382349|NCT00881530|454693558|FG000|Overall Study|Not compliant with the protocol|0|||
126382350|NCT00881530|454693559|FG001|Overall Study|Not compliant with the protocol|0|||
126382351|NCT00881530|454693560|FG002|Overall Study|Not compliant with the protocol|0|||
126382352|NCT00881530|454693561|FG003|Overall Study|Not compliant with the protocol|0|||
126382353|NCT00881530|454693562|FG004|Overall Study|Not compliant with the protocol|2|||
126382354|NCT00881530|454693563|FG005|Overall Study|Not compliant with the protocol|0|||
126382355|NCT00881530|454693558|FG000|Overall Study|Lost to Follow-up|0|||
126382356|NCT00881530|454693559|FG001|Overall Study|Lost to Follow-up|1|||
126382357|NCT00881530|454693560|FG002|Overall Study|Lost to Follow-up|1|||
126382358|NCT00881530|454693561|FG003|Overall Study|Lost to Follow-up|3|||
126382359|NCT00881530|454693562|FG004|Overall Study|Lost to Follow-up|1|||
126382360|NCT00881530|454693563|FG005|Overall Study|Lost to Follow-up|0|||
126382361|NCT00881530|454693558|FG000|Overall Study|Refused to continue medication|7|||
126382362|NCT00881530|454693559|FG001|Overall Study|Refused to continue medication|2|||
126382363|NCT00881530|454693560|FG002|Overall Study|Refused to continue medication|1|||
126382364|NCT00881530|454693561|FG003|Overall Study|Refused to continue medication|2|||
126382365|NCT00881530|454693562|FG004|Overall Study|Refused to continue medication|0|||
126382366|NCT00881530|454693563|FG005|Overall Study|Refused to continue medication|0|||
126382367|NCT00881530|454693558|FG000|Overall Study|Other reason not defined above|1|||
126382368|NCT00881530|454693559|FG001|Overall Study|Other reason not defined above|1|||
126382369|NCT00881530|454693560|FG002|Overall Study|Other reason not defined above|2|||
126382370|NCT00881530|454693561|FG003|Overall Study|Other reason not defined above|0|||
126382371|NCT00881530|454693562|FG004|Overall Study|Other reason not defined above|0|||
126382372|NCT00881530|454693563|FG005|Overall Study|Other reason not defined above|2|||
126382373|NCT01509846|454693564|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
126048526|NCT01637402|453475212|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
126382374|NCT01509846|454693565|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
126382375|NCT01509846|454693566|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
126382376|NCT01509846|454693567|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
126382377|NCT01509846|454693568|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
126382378|NCT01509846|454693564|FG000|Received Vaccination 2|Illness|0|||
126382379|NCT01509846|454693565|FG001|Received Vaccination 2|Illness|0|||
126382380|NCT01509846|454693566|FG002|Received Vaccination 2|Illness|0|||
126382381|NCT01509846|454693567|FG003|Received Vaccination 2|Illness|0|||
126382382|NCT01509846|454693568|FG004|Received Vaccination 2|Illness|1|||
126382383|NCT01509846|454693564|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
126382384|NCT01509846|454693565|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
126382385|NCT01509846|454693566|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
126382386|NCT01509846|454693567|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
126382387|NCT01509846|454693568|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
126382388|NCT01509846|454693564|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
126382389|NCT01509846|454693565|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
126048527|NCT01637402|453475213|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
126104175|NCT00320541|453675819|FG000|Overall Study|Sponsor Decision|2|||
126382390|NCT01509846|454693566|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
126382391|NCT01509846|454693567|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
126382392|NCT01509846|454693568|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
126382393|NCT01509846|454693564|FG000|Received Vaccination 3|Pregnancy|0|||
126382394|NCT01509846|454693565|FG001|Received Vaccination 3|Pregnancy|0|||
126382395|NCT01509846|454693566|FG002|Received Vaccination 3|Pregnancy|0|||
126382396|NCT01509846|454693567|FG003|Received Vaccination 3|Pregnancy|1|||
126382397|NCT01509846|454693568|FG004|Received Vaccination 3|Pregnancy|0|||
126382398|NCT01509846|454693564|FG000|Received Vaccination 3|Lost to Follow-up|0|||
126382399|NCT01509846|454693565|FG001|Received Vaccination 3|Lost to Follow-up|0|||
126382400|NCT01509846|454693566|FG002|Received Vaccination 3|Lost to Follow-up|1|||
126382401|NCT01509846|454693567|FG003|Received Vaccination 3|Lost to Follow-up|0|||
126382402|NCT01509846|454693568|FG004|Received Vaccination 3|Lost to Follow-up|0|||
126382403|NCT01637584|454693569|FG000|Overall Study|Withdrawal by Subject|1|||
126382404|NCT01637584|454693570|FG001|Overall Study|Withdrawal by Subject|3|||
126382405|NCT02484443|454693571|FG000|Overall Study|Lack of Efficacy|28|||
126382406|NCT02484443|454693571|FG000|Overall Study|Physician Decision|2|||
126382407|NCT02484443|454693571|FG000|Overall Study|Ineligible|2|||
126382408|NCT02969915|454693572|FG000|Overall Study|Death|104|||
126382409|NCT02969915|454693573|FG001|Overall Study|Death|125|||
126382410|NCT02969915|454693572|FG000|Overall Study|Lost to Follow-up|108|||
126382411|NCT02969915|454693573|FG001|Overall Study|Lost to Follow-up|112|||
126382412|NCT02969915|454693572|FG000|Overall Study|Censored due to COVID-19|481|||
126382413|NCT02969915|454693573|FG001|Overall Study|Censored due to COVID-19|471|||
126382414|NCT03799952|454693574|FG000|Overall Study|Program was too easy, discontinued|1|||
126382415|NCT03799952|454693575|FG001|Overall Study|Program was too easy, discontinued|0|||
126382416|NCT03799952|454693574|FG000|Overall Study|Lost to Follow-up|0|||
126382417|NCT03799952|454693575|FG001|Overall Study|Lost to Follow-up|2|||
126382418|NCT01393899|454693576|FG000|Overall Study|Study terminated by sponsor|1|||
126382419|NCT01393899|454693577|FG001|Overall Study|Study terminated by sponsor|0|||
126382420|NCT01393899|454693578|FG002|Overall Study|Study terminated by sponsor|1|||
126382421|NCT01393899|454693576|FG000|Overall Study|Other|1|||
126382422|NCT01393899|454693577|FG001|Overall Study|Other|0|||
126382423|NCT01393899|454693578|FG002|Overall Study|Other|0|||
126382424|NCT01393899|454693576|FG000|Overall Study|Withdrawal by Subject|2|||
126382425|NCT01393899|454693577|FG001|Overall Study|Withdrawal by Subject|2|||
126382426|NCT01393899|454693578|FG002|Overall Study|Withdrawal by Subject|1|||
126382427|NCT01393899|454693576|FG000|Overall Study|Lost to Follow-up|0|||
126382428|NCT01393899|454693577|FG001|Overall Study|Lost to Follow-up|0|||
126382429|NCT01393899|454693578|FG002|Overall Study|Lost to Follow-up|1|||
126382430|NCT01393899|454693576|FG000|Overall Study|Does not meet entrance criteria|1|||
126382431|NCT01393899|454693577|FG001|Overall Study|Does not meet entrance criteria|0|||
126382432|NCT01393899|454693578|FG002|Overall Study|Does not meet entrance criteria|1|||
126382433|NCT01393899|454693576|FG000|Overall Study|Lack of Efficacy|26|||
126382434|NCT01393899|454693577|FG001|Overall Study|Lack of Efficacy|21|||
126382435|NCT01393899|454693578|FG002|Overall Study|Lack of Efficacy|16|||
126382436|NCT01393899|454693576|FG000|Overall Study|Adverse Event|1|||
126382437|NCT01393899|454693577|FG001|Overall Study|Adverse Event|5|||
126382438|NCT01393899|454693578|FG002|Overall Study|Adverse Event|3|||
126382439|NCT02503085|454693579|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
126382440|NCT02503085|454693580|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
126382441|NCT02503085|454693581|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
126382442|NCT02503085|454693582|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
126382443|NCT02595866|454693583|FG000|Overall Study|Adverse Event|2|||
126382444|NCT02595866|454693584|FG001|Overall Study|Adverse Event|5|||
126382445|NCT02595866|454693583|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
126382446|NCT02595866|454693584|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
126382447|NCT02595866|454693583|FG000|Overall Study|Death|0|||
126382448|NCT02595866|454693584|FG001|Overall Study|Death|1|||
126104176|NCT00320541|453675820|FG001|Overall Study|Sponsor Decision|1|||
126104177|NCT00320541|453675819|FG000|Overall Study|Death due to Study Disease|1|||
126382449|NCT02595866|454693583|FG000|Overall Study|Incarceration|1|||
126382450|NCT02595866|454693584|FG001|Overall Study|Incarceration|0|||
126382451|NCT02595866|454693583|FG000|Overall Study|Lack of Efficacy|17|||
126382452|NCT02595866|454693584|FG001|Overall Study|Lack of Efficacy|7|||
126382453|NCT02595866|454693583|FG000|Overall Study|Physician Decision|4|||
126382454|NCT02595866|454693584|FG001|Overall Study|Physician Decision|3|||
126382455|NCT02595866|454693583|FG000|Overall Study|Switched to Alternative Treatment|1|||
126382456|NCT02595866|454693584|FG001|Overall Study|Switched to Alternative Treatment|0|||
126382457|NCT02595866|454693583|FG000|Overall Study|Study Terminated|0|||
126382458|NCT02595866|454693584|FG001|Overall Study|Study Terminated|4|||
126382459|NCT02595866|454693583|FG000|Overall Study|Withdrawal by Subject|6|||
126382460|NCT02595866|454693584|FG001|Overall Study|Withdrawal by Subject|1|||
126382461|NCT02520388|454693585|FG000|Overall Study|Physician Decision|1|||
126382462|NCT02520388|454693586|FG001|Overall Study|Physician Decision|0|||
126382463|NCT02520388|454693585|FG000|Overall Study|Subject or parent/guardian request|0|||
126382464|NCT02520388|454693586|FG001|Overall Study|Subject or parent/guardian request|6|||
126382465|NCT02520388|454693585|FG000|Overall Study|Adverse Event|1|||
126382466|NCT02520388|454693586|FG001|Overall Study|Adverse Event|4|||
126104178|NCT00320541|453675820|FG001|Overall Study|Death due to Study Disease|3|||
126382467|NCT02520388|454693585|FG000|Overall Study|Lost to Follow-up|3|||
126104179|NCT00320541|453675819|FG000|Overall Study|Death due to Adverse Event(s)|1|||
126104180|NCT00320541|453675820|FG001|Overall Study|Death due to Adverse Event(s)|0|||
126382468|NCT02520388|454693586|FG001|Overall Study|Lost to Follow-up|2|||
126382469|NCT02520388|454693585|FG000|Overall Study|Other (reason not defined)|4|||
126382470|NCT02520388|454693586|FG001|Overall Study|Other (reason not defined)|4|||
126382471|NCT01232127|454693587|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
126382472|NCT01232127|454693588|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
126382473|NCT01232127|454693589|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
126382474|NCT03035864|454693595|FG000|Treatment Period|Adverse Event|1|||
126382475|NCT03035864|454693596|FG001|Treatment Period|Adverse Event|0|||
126382476|NCT03035864|454693595|FG000|Treatment Period|Other|3|||
126382477|NCT03035864|454693596|FG001|Treatment Period|Other|1|||
126382478|NCT03035864|454693595|FG000|Follow-up Period|Adverse Event|1|||
126382479|NCT03035864|454693596|FG001|Follow-up Period|Adverse Event|0|||
126382480|NCT03035864|454693595|FG000|Follow-up Period|Lost to Follow-up|6|||
126382481|NCT03035864|454693596|FG001|Follow-up Period|Lost to Follow-up|2|||
126382482|NCT03035864|454693595|FG000|Follow-up Period|Physician Decision|1|||
126382483|NCT03035864|454693596|FG001|Follow-up Period|Physician Decision|0|||
126382484|NCT03035864|454693595|FG000|Follow-up Period|Other|3|||
126382485|NCT03035864|454693596|FG001|Follow-up Period|Other|2|||
126382486|NCT02375373|454693597|FG000|Overall Study|Withdrawal by Subject|11|||
126382487|NCT01890265|454693598|FG000|Overall Study|Other (Unspecified reason)|0|||
126382488|NCT01890265|454693599|FG001|Overall Study|Other (Unspecified reason)|1|||
126382489|NCT01890265|454693600|FG002|Overall Study|Other (Unspecified reason)|0|||
126382490|NCT01890265|454693601|FG003|Overall Study|Other (Unspecified reason)|0|||
126382491|NCT01890265|454693602|FG004|Overall Study|Other (Unspecified reason)|0|||
126382492|NCT01890265|454693603|FG005|Overall Study|Other (Unspecified reason)|0|||
126382493|NCT01890265|454693598|FG000|Overall Study|Progressive disease|6|||
126382494|NCT01890265|454693599|FG001|Overall Study|Progressive disease|6|||
126382495|NCT01890265|454693600|FG002|Overall Study|Progressive disease|0|||
126382496|NCT01890265|454693601|FG003|Overall Study|Progressive disease|0|||
126382497|NCT01890265|454693602|FG004|Overall Study|Progressive disease|0|||
126382498|NCT01890265|454693603|FG005|Overall Study|Progressive disease|0|||
126382499|NCT01890265|454693598|FG000|Overall Study|Adverse Event|2|||
126382500|NCT01890265|454693599|FG001|Overall Study|Adverse Event|1|||
126382501|NCT01890265|454693600|FG002|Overall Study|Adverse Event|0|||
126382502|NCT01890265|454693601|FG003|Overall Study|Adverse Event|0|||
126382503|NCT01890265|454693602|FG004|Overall Study|Adverse Event|0|||
126382504|NCT01890265|454693603|FG005|Overall Study|Adverse Event|0|||
126382505|NCT01890265|454693598|FG000|Overall Study|Death|2|||
126382506|NCT01890265|454693599|FG001|Overall Study|Death|3|||
126382507|NCT01890265|454693600|FG002|Overall Study|Death|1|||
126382508|NCT01890265|454693601|FG003|Overall Study|Death|0|||
126382509|NCT01890265|454693602|FG004|Overall Study|Death|0|||
126382510|NCT01890265|454693603|FG005|Overall Study|Death|0|||
126382511|NCT01890265|454693598|FG000|Overall Study|Withdrawal by Subject|0|||
126382512|NCT01890265|454693599|FG001|Overall Study|Withdrawal by Subject|2|||
126382513|NCT01890265|454693600|FG002|Overall Study|Withdrawal by Subject|3|||
126382514|NCT01890265|454693601|FG003|Overall Study|Withdrawal by Subject|0|||
126382515|NCT01890265|454693602|FG004|Overall Study|Withdrawal by Subject|2|||
126382516|NCT01890265|454693603|FG005|Overall Study|Withdrawal by Subject|0|||
126382517|NCT00809926|454693604|FG000|Overall Study|Adverse Event|18|||
126382518|NCT00809926|454693605|FG001|Overall Study|Adverse Event|10|||
126382519|NCT00809926|454693604|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126382520|NCT00809926|454693605|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126382521|NCT00809926|454693604|FG000|Overall Study|Patient withdrew consent|8|||
126382522|NCT00809926|454693605|FG001|Overall Study|Patient withdrew consent|6|||
126382523|NCT00809926|454693604|FG000|Overall Study|Lost to Follow-up|2|||
126382524|NCT00809926|454693605|FG001|Overall Study|Lost to Follow-up|1|||
126382525|NCT00809926|454693604|FG000|Overall Study|Administrative Problems|0|||
126382526|NCT00809926|454693605|FG001|Overall Study|Administrative Problems|1|||
126382527|NCT00809926|454693604|FG000|Overall Study|Protocol deviation|0|||
126382528|NCT00809926|454693605|FG001|Overall Study|Protocol deviation|2|||
126382529|NCT00642707|454693610|FG000|Overall Study|Adverse Event|0|||
126382530|NCT00642707|454693611|FG001|Overall Study|Adverse Event|0|||
126382531|NCT00642707|454693612|FG002|Overall Study|Adverse Event|0|||
126382532|NCT00642707|454693613|FG003|Overall Study|Adverse Event|2|||
126382533|NCT00642707|454693610|FG000|Overall Study|Withdrawal by Subject|1|||
126048528|NCT01637402|453475212|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
126382534|NCT00642707|454693611|FG001|Overall Study|Withdrawal by Subject|0|||
126382535|NCT00642707|454693612|FG002|Overall Study|Withdrawal by Subject|0|||
126382536|NCT00642707|454693613|FG003|Overall Study|Withdrawal by Subject|0|||
126048529|NCT01637402|453475213|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
126048530|NCT01637402|453475212|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
126382537|NCT00130039|454693614|FG000|Overall Study|Withdrawal by Subject|15|||
126382538|NCT00130039|454693615|FG001|Overall Study|Withdrawal by Subject|11|||
126382539|NCT00130039|454693614|FG000|Overall Study|Lost to Follow-up|3|||
126382540|NCT00130039|454693615|FG001|Overall Study|Lost to Follow-up|1|||
126382541|NCT00130039|454693614|FG000|Overall Study|Adverse Event|4|||
126382542|NCT00130039|454693615|FG001|Overall Study|Adverse Event|2|||
125886656|NCT01106690|452881796|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125886657|NCT01106690|452881794|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125886658|NCT01106690|452881795|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125886659|NCT01106690|452881796|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125886660|NCT01106690|452881794|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125886661|NCT01106690|452881795|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125886662|NCT01106690|452881796|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125886663|NCT01106690|452881794|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125886664|NCT01106690|452881795|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125886665|NCT01106690|452881796|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
125886666|NCT01106690|452881794|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125886667|NCT01106690|452881795|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125886668|NCT01106690|452881796|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125886669|NCT01106690|452881794|FG000|Extension Period: Week 26 to Week 52|Other|8|||
125886670|NCT01106690|452881795|FG001|Extension Period: Week 26 to Week 52|Other|3|||
125886671|NCT01106690|452881796|FG002|Extension Period: Week 26 to Week 52|Other|4|||
125886672|NCT01106690|452881794|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
125886673|NCT01106690|452881795|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125886674|NCT01106690|452881796|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125886675|NCT01662102|452881797|FG000|Overall Study|Sponsor's decision|1|||
126048531|NCT01637402|453475213|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
126048532|NCT02111096|453475214|FG000|Overall Study|Adverse Event|4|||
126048533|NCT02111096|453475215|FG001|Overall Study|Adverse Event|1|||
125886676|NCT01662102|452881798|FG001|Overall Study|Sponsor's decision|0|||
125886677|NCT02863419|452881799|FG000|Overall Study|Lost to Follow-up|0|||
125886678|NCT02863419|452881800|FG001|Overall Study|Lost to Follow-up|1|||
125886679|NCT02863419|452881801|FG002|Overall Study|Lost to Follow-up|4|||
125886680|NCT02863419|452881799|FG000|Overall Study|Withdrawal by Subject|5|||
125886681|NCT02863419|452881800|FG001|Overall Study|Withdrawal by Subject|5|||
125886682|NCT02863419|452881801|FG002|Overall Study|Withdrawal by Subject|3|||
125886683|NCT02863419|452881799|FG000|Overall Study|Died|3|||
126048534|NCT02111096|453475216|FG002|Overall Study|Adverse Event|2|||
126382543|NCT00130039|454693614|FG000|Overall Study|Physician Decision|3|||
126382544|NCT00130039|454693615|FG001|Overall Study|Physician Decision|0|||
126382545|NCT00130039|454693614|FG000|Overall Study|clinical events without follow up MRI|5|||
126382546|NCT00130039|454693615|FG001|Overall Study|clinical events without follow up MRI|4|||
126382547|NCT00100802|454693619|FG000|Overall Study|Adverse Event|9|||
126382548|NCT00100802|454693619|FG000|Overall Study|Death|1|||
126382549|NCT00100802|454693619|FG000|Overall Study|Lack of Efficacy|47|||
126382550|NCT00100802|454693619|FG000|Overall Study|Physician Decision|5|||
126382551|NCT00100802|454693619|FG000|Overall Study|Protocol Violation|1|||
126382552|NCT00100802|454693619|FG000|Overall Study|Withdrawal by Subject|5|||
126382553|NCT00100802|454693619|FG000|Overall Study|Ineligible|12|||
126382554|NCT02709720|454693620|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
126382555|NCT02709720|454693620|FG000|Overall Study|Protocol Violation|1|||
126382556|NCT02709720|454693620|FG000|Overall Study|Not take study medication|1|||
126382557|NCT01198574|454693650|FG000|Overall Study|Resigned from schools|4|||
126382558|NCT01198574|454693651|FG001|Overall Study|Resigned from schools|1|||
126382559|NCT01198574|454693652|FG002|Overall Study|Resigned from schools|1|||
126382560|NCT01198574|454693653|FG003|Overall Study|Resigned from schools|4|||
126382561|NCT00325130|454693654|FG000|Overall Study|Lost to Follow-up|6|||
126382562|NCT00325130|454693655|FG001|Overall Study|Lost to Follow-up|14|||
126382563|NCT00325130|454693654|FG000|Overall Study|Withdrawal by Subject|12|||
126382564|NCT00325130|454693655|FG001|Overall Study|Withdrawal by Subject|14|||
126382565|NCT00325130|454693654|FG000|Overall Study|Protocol Deviation|0|||
126048535|NCT02111096|453475214|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126382566|NCT00325130|454693655|FG001|Overall Study|Protocol Deviation|1|||
126382567|NCT00325130|454693654|FG000|Overall Study|Moved|0|||
126382568|NCT00325130|454693655|FG001|Overall Study|Moved|1|||
126382569|NCT00325130|454693654|FG000|Overall Study|Patient Discontinued for Other|1|||
126382570|NCT00325130|454693655|FG001|Overall Study|Patient Discontinued for Other|0|||
125886684|NCT02863419|452881800|FG001|Overall Study|Died|4|||
126048536|NCT02111096|453475215|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126048537|NCT02111096|453475216|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126382571|NCT00326001|454693656|FG000|Overall Study|Adverse Event|4|||
125886685|NCT02863419|452881801|FG002|Overall Study|Died|1|||
126048538|NCT02111096|453475214|FG000|Overall Study|Lost to Follow Up|1|||
126382572|NCT00326001|454693657|FG001|Overall Study|Adverse Event|5|||
126382573|NCT00326001|454693656|FG000|Overall Study|Physician Decision|3|||
126382574|NCT00326001|454693657|FG001|Overall Study|Physician Decision|3|||
125886686|NCT02454517|452881817|FG000|Overall Study|Withdrawal by Subject|3|||
125886687|NCT02454517|452881818|FG001|Overall Study|Withdrawal by Subject|0|||
125886688|NCT02454517|452881817|FG000|Overall Study|Lost to Follow-up|4|||
126048539|NCT02111096|453475215|FG001|Overall Study|Lost to Follow Up|1|||
126048540|NCT02111096|453475216|FG002|Overall Study|Lost to Follow Up|1|||
126048541|NCT02111096|453475214|FG000|Overall Study|Physician Decision|0|||
126382575|NCT01042158|454693658|FG000|Overall Study|Physician Decision|1|||
126382576|NCT03640325|454694923|FG000|Overall Study|Withdrawal by Subject|4|||
126382577|NCT03640325|454694924|FG001|Overall Study|Withdrawal by Subject|1|||
126382578|NCT03640325|454694925|FG002|Overall Study|Withdrawal by Subject|0|||
126382579|NCT03640325|454694923|FG000|Overall Study|Lost to Follow-up|4|||
126382580|NCT03640325|454694924|FG001|Overall Study|Lost to Follow-up|5|||
126382581|NCT03640325|454694925|FG002|Overall Study|Lost to Follow-up|21|||
126382582|NCT03640325|454694923|FG000|Overall Study|Death|5|||
126382583|NCT03640325|454694924|FG001|Overall Study|Death|5|||
126382584|NCT03640325|454694925|FG002|Overall Study|Death|0|||
126382585|NCT01133756|454694929|FG000|Overall Study|Adverse Event|1|||
126382586|NCT01133756|454694930|FG001|Overall Study|Adverse Event|2|||
126382587|NCT01133756|454694931|FG002|Overall Study|Adverse Event|1|||
126382588|NCT01133756|454694929|FG000|Overall Study|Investigator Decision|1|||
126382589|NCT01133756|454694930|FG001|Overall Study|Investigator Decision|0|||
126382590|NCT01133756|454694931|FG002|Overall Study|Investigator Decision|0|||
126382591|NCT01133756|454694929|FG000|Overall Study|Withdrawal by Subject|0|||
126382592|NCT01133756|454694930|FG001|Overall Study|Withdrawal by Subject|1|||
126382593|NCT01133756|454694931|FG002|Overall Study|Withdrawal by Subject|0|||
126382594|NCT01133756|454694929|FG000|Overall Study|Progression of Disease|0|||
126382595|NCT01133756|454694930|FG001|Overall Study|Progression of Disease|0|||
126382596|NCT01133756|454694931|FG002|Overall Study|Progression of Disease|1|||
126382597|NCT01566149|454694932|FG000|Overall Study|Adverse Event|0|||
126382598|NCT01566149|454694933|FG001|Overall Study|Adverse Event|1|||
126382599|NCT01566149|454694932|FG000|Overall Study|Non-compliance with study medication|2|||
126382600|NCT01566149|454694933|FG001|Overall Study|Non-compliance with study medication|0|||
126382601|NCT01566149|454694932|FG000|Overall Study|Protocol Violation|0|||
126382602|NCT01566149|454694933|FG001|Overall Study|Protocol Violation|1|||
126382603|NCT01566149|454694932|FG000|Overall Study|Withdrawal by Subject|1|||
126382604|NCT01566149|454694933|FG001|Overall Study|Withdrawal by Subject|0|||
126382605|NCT03276728|454694936|FG000|Overall Study|Lost to Follow-up|0|||
126382606|NCT03276728|454694937|FG001|Overall Study|Lost to Follow-up|0|||
126382607|NCT03276728|454694938|FG002|Overall Study|Lost to Follow-up|2|||
126382608|NCT03276728|454694939|FG003|Overall Study|Lost to Follow-up|2|||
126382609|NCT03276728|454694940|FG004|Overall Study|Lost to Follow-up|0|||
126382610|NCT03276728|454694941|FG005|Overall Study|Lost to Follow-up|0|||
126382611|NCT03276728|454694942|FG006|Overall Study|Lost to Follow-up|0|||
126382612|NCT03276728|454694943|FG007|Overall Study|Lost to Follow-up|0|||
126382613|NCT03276728|454694936|FG000|Overall Study|Withdrawal by Subject|0|||
126382614|NCT03276728|454694937|FG001|Overall Study|Withdrawal by Subject|0|||
126382615|NCT03276728|454694938|FG002|Overall Study|Withdrawal by Subject|0|||
126382616|NCT03276728|454694939|FG003|Overall Study|Withdrawal by Subject|3|||
126382617|NCT03276728|454694940|FG004|Overall Study|Withdrawal by Subject|0|||
126382618|NCT03276728|454694941|FG005|Overall Study|Withdrawal by Subject|0|||
126382619|NCT03276728|454694942|FG006|Overall Study|Withdrawal by Subject|0|||
126382620|NCT03276728|454694943|FG007|Overall Study|Withdrawal by Subject|0|||
126382621|NCT03276728|454694936|FG000|Overall Study|Decision by sponsor|0|||
126382622|NCT03276728|454694937|FG001|Overall Study|Decision by sponsor|0|||
126382623|NCT03276728|454694938|FG002|Overall Study|Decision by sponsor|0|||
126382624|NCT03276728|454694939|FG003|Overall Study|Decision by sponsor|0|||
126382625|NCT03276728|454694940|FG004|Overall Study|Decision by sponsor|1|||
126382626|NCT03276728|454694941|FG005|Overall Study|Decision by sponsor|0|||
126382627|NCT03276728|454694942|FG006|Overall Study|Decision by sponsor|2|||
126382628|NCT03276728|454694943|FG007|Overall Study|Decision by sponsor|1|||
126382629|NCT03941873|454694950|FG000|Overall Study|Death|0|||
126382630|NCT03941873|454694951|FG001|Overall Study|Death|12|||
126382631|NCT03941873|454694952|FG002|Overall Study|Death|2|||
126382632|NCT03941873|454694953|FG003|Overall Study|Death|53|||
126382633|NCT03941873|454694950|FG000|Overall Study|Withdrawal by Subject|1|||
126382634|NCT03941873|454694951|FG001|Overall Study|Withdrawal by Subject|1|||
126382635|NCT03941873|454694952|FG002|Overall Study|Withdrawal by Subject|0|||
126382636|NCT03941873|454694953|FG003|Overall Study|Withdrawal by Subject|5|||
126382637|NCT03941873|454694950|FG000|Overall Study|Lost to Follow-up|1|||
126382638|NCT03941873|454694951|FG001|Overall Study|Lost to Follow-up|2|||
126382639|NCT03941873|454694952|FG002|Overall Study|Lost to Follow-up|0|||
126382640|NCT03941873|454694953|FG003|Overall Study|Lost to Follow-up|0|||
126382641|NCT03941873|454694950|FG000|Overall Study|Sponsor Decision|0|||
126382642|NCT03941873|454694951|FG001|Overall Study|Sponsor Decision|6|||
126382643|NCT03941873|454694952|FG002|Overall Study|Sponsor Decision|0|||
126382644|NCT03941873|454694953|FG003|Overall Study|Sponsor Decision|15|||
126382645|NCT02982772|454694954|FG000|Intervention|Lost to Follow-up|19|||
126382646|NCT02982772|454694955|FG001|Intervention|Lost to Follow-up|13|||
126382647|NCT02982772|454694954|FG000|1M Follow-Up|Lost to Follow-up|21|||
126382648|NCT02982772|454694955|FG001|1M Follow-Up|Lost to Follow-up|18|||
126382649|NCT02982772|454694954|FG000|3M Follow-Up|Lost to Follow-up|17|||
126382650|NCT02982772|454694955|FG001|3M Follow-Up|Lost to Follow-up|11|||
126382651|NCT02982772|454694954|FG000|6M Follow-Up|Lost to Follow-up|11|||
126382652|NCT02982772|454694955|FG001|6M Follow-Up|Lost to Follow-up|9|||
126382653|NCT02982772|454694954|FG000|12M Follow-Up|Lost to Follow-up|11|||
126382654|NCT02982772|454694955|FG001|12M Follow-Up|Lost to Follow-up|5|||
126382655|NCT01234480|454694956|FG000|Overall Study|Pregnancy|88|||
126382656|NCT01234480|454694956|FG000|Overall Study|>36/Normal History|50|||
126382657|NCT01234480|454694956|FG000|Overall Study|Age|3|||
126382658|NCT01234480|454694956|FG000|Overall Study|HPV Vaccine History|28|||
126382659|NCT01234480|454694956|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
126382660|NCT01234480|454694956|FG000|Overall Study|Hysterectomy|2|||
126382661|NCT01234480|454694956|FG000|Overall Study|Hysterectomy post enrollment|1|||
126382662|NCT01234480|454694956|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
126382663|NCT01234480|454694956|FG000|Overall Study|Informed Consent Form Violation|30|||
126382664|NCT01234480|454694956|FG000|Overall Study|Incorrect Visit|3|||
126382665|NCT01234480|454694956|FG000|Overall Study|No Florida Lab License|20|||
126382666|NCT01234480|454694956|FG000|Overall Study|Out of Window|42|||
126382667|NCT01234480|454694956|FG000|Overall Study|Sample Processing/Storage|92|||
126382668|NCT01234480|454694956|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
126382669|NCT01234480|454694956|FG000|Overall Study|Site/Subject non-compliance|44|||
126382670|NCT01234480|454694956|FG000|Overall Study|Missing Sample|9|||
126382671|NCT01238991|454694959|FG000|Overall Study|Adverse Event|1|||
126382672|NCT01238991|454694960|FG001|Overall Study|Adverse Event|0|||
126382673|NCT01238991|454694961|FG002|Overall Study|Adverse Event|3|||
126382674|NCT01238991|454694962|FG003|Overall Study|Adverse Event|1|||
126382675|NCT01238991|454694963|FG004|Overall Study|Adverse Event|1|||
126382676|NCT01238991|454694964|FG005|Overall Study|Adverse Event|0|||
126382677|NCT01238991|454694965|FG006|Overall Study|Adverse Event|1|||
126382678|NCT01238991|454694966|FG007|Overall Study|Adverse Event|1|||
126382679|NCT01238991|454694967|FG008|Overall Study|Adverse Event|0|||
126382680|NCT01238991|454694968|FG009|Overall Study|Adverse Event|0|||
126382681|NCT01238991|454694959|FG000|Overall Study|Death|0|||
126382682|NCT01238991|454694960|FG001|Overall Study|Death|0|||
126382683|NCT01238991|454694961|FG002|Overall Study|Death|0|||
126382684|NCT01238991|454694962|FG003|Overall Study|Death|1|||
126382685|NCT01238991|454694963|FG004|Overall Study|Death|0|||
126382686|NCT01238991|454694964|FG005|Overall Study|Death|0|||
126382687|NCT01238991|454694965|FG006|Overall Study|Death|0|||
126382688|NCT01238991|454694966|FG007|Overall Study|Death|0|||
126382689|NCT01238991|454694967|FG008|Overall Study|Death|0|||
126382690|NCT01238991|454694968|FG009|Overall Study|Death|0|||
126382691|NCT01238991|454694959|FG000|Overall Study|Lack of Efficacy|0|||
126382692|NCT01238991|454694960|FG001|Overall Study|Lack of Efficacy|0|||
126382693|NCT01238991|454694961|FG002|Overall Study|Lack of Efficacy|1|||
126382694|NCT01238991|454694962|FG003|Overall Study|Lack of Efficacy|0|||
126382695|NCT01238991|454694963|FG004|Overall Study|Lack of Efficacy|0|||
126382696|NCT01238991|454694964|FG005|Overall Study|Lack of Efficacy|0|||
126382697|NCT01238991|454694965|FG006|Overall Study|Lack of Efficacy|0|||
126382698|NCT01238991|454694966|FG007|Overall Study|Lack of Efficacy|0|||
126382699|NCT01238991|454694967|FG008|Overall Study|Lack of Efficacy|1|||
126382700|NCT01238991|454694968|FG009|Overall Study|Lack of Efficacy|0|||
126382701|NCT01238991|454694959|FG000|Overall Study|Withdrawal by Subject|0|||
126382702|NCT01238991|454694960|FG001|Overall Study|Withdrawal by Subject|0|||
126382703|NCT01238991|454694961|FG002|Overall Study|Withdrawal by Subject|1|||
126382704|NCT01238991|454694962|FG003|Overall Study|Withdrawal by Subject|0|||
126382705|NCT01238991|454694963|FG004|Overall Study|Withdrawal by Subject|0|||
126382706|NCT01238991|454694964|FG005|Overall Study|Withdrawal by Subject|0|||
126382707|NCT01238991|454694965|FG006|Overall Study|Withdrawal by Subject|0|||
126382708|NCT01238991|454694966|FG007|Overall Study|Withdrawal by Subject|0|||
126382709|NCT01238991|454694967|FG008|Overall Study|Withdrawal by Subject|0|||
126382710|NCT01238991|454694968|FG009|Overall Study|Withdrawal by Subject|0|||
126382711|NCT01238991|454694959|FG000|Overall Study|Study Terminated by Sponsor|0|||
126382712|NCT01238991|454694960|FG001|Overall Study|Study Terminated by Sponsor|0|||
126048542|NCT02111096|453475215|FG001|Overall Study|Physician Decision|1|||
126048543|NCT02111096|453475216|FG002|Overall Study|Physician Decision|0|||
126382713|NCT01238991|454694961|FG002|Overall Study|Study Terminated by Sponsor|0|||
126382714|NCT01238991|454694962|FG003|Overall Study|Study Terminated by Sponsor|0|||
126382715|NCT01238991|454694963|FG004|Overall Study|Study Terminated by Sponsor|1|||
126382716|NCT01238991|454694964|FG005|Overall Study|Study Terminated by Sponsor|0|||
126382717|NCT01238991|454694965|FG006|Overall Study|Study Terminated by Sponsor|7|||
126382718|NCT01238991|454694966|FG007|Overall Study|Study Terminated by Sponsor|4|||
126382719|NCT01238991|454694967|FG008|Overall Study|Study Terminated by Sponsor|2|||
126382720|NCT01238991|454694968|FG009|Overall Study|Study Terminated by Sponsor|2|||
126382721|NCT01238991|454694959|FG000|Overall Study|Caregiver's request|0|||
126382722|NCT01238991|454694960|FG001|Overall Study|Caregiver's request|0|||
126382723|NCT01238991|454694961|FG002|Overall Study|Caregiver's request|0|||
126382724|NCT01238991|454694962|FG003|Overall Study|Caregiver's request|0|||
126382725|NCT01238991|454694963|FG004|Overall Study|Caregiver's request|0|||
126382726|NCT01238991|454694964|FG005|Overall Study|Caregiver's request|0|||
126382727|NCT01238991|454694965|FG006|Overall Study|Caregiver's request|0|||
126382728|NCT01238991|454694966|FG007|Overall Study|Caregiver's request|0|||
126382729|NCT01238991|454694967|FG008|Overall Study|Caregiver's request|1|||
126382730|NCT01238991|454694968|FG009|Overall Study|Caregiver's request|0|||
126382731|NCT01238991|454694959|FG000|Overall Study|Admission to a nursing home|1|||
126382732|NCT01238991|454694960|FG001|Overall Study|Admission to a nursing home|0|||
126382733|NCT01238991|454694961|FG002|Overall Study|Admission to a nursing home|1|||
126382734|NCT01238991|454694962|FG003|Overall Study|Admission to a nursing home|0|||
126382735|NCT01238991|454694963|FG004|Overall Study|Admission to a nursing home|0|||
126382736|NCT01238991|454694964|FG005|Overall Study|Admission to a nursing home|0|||
126382737|NCT01238991|454694965|FG006|Overall Study|Admission to a nursing home|0|||
126382738|NCT01238991|454694966|FG007|Overall Study|Admission to a nursing home|0|||
126382739|NCT01238991|454694967|FG008|Overall Study|Admission to a nursing home|0|||
126382740|NCT01238991|454694968|FG009|Overall Study|Admission to a nursing home|0|||
126382741|NCT03370419|454694969|FG000|Overall Study|Lost to Follow-up|16|||
126382742|NCT01897727|454694974|FG000|Overall Study|Exclusion: central sleep apnea|0|||
126382743|NCT01897727|454694975|FG001|Overall Study|Exclusion: central sleep apnea|1|||
126382744|NCT00078806|454694976|FG000|Part 1A|Adverse Event|2|||
126382745|NCT00078806|454694977|FG001|Part 1A|Adverse Event|0|||
126382746|NCT00078806|454694978|FG002|Part 1A|Adverse Event|0|||
126382747|NCT00078806|454694979|FG003|Part 1A|Adverse Event|0|||
126382748|NCT00078806|454694976|FG000|Part 1A|Lack of Efficacy|7|||
126382749|NCT00078806|454694977|FG001|Part 1A|Lack of Efficacy|0|||
126382750|NCT00078806|454694978|FG002|Part 1A|Lack of Efficacy|0|||
126382751|NCT00078806|454694979|FG003|Part 1A|Lack of Efficacy|0|||
126382752|NCT00078806|454694976|FG000|Part 1A|Other|1|||
126382753|NCT00078806|454694977|FG001|Part 1A|Other|0|||
126382754|NCT00078806|454694978|FG002|Part 1A|Other|0|||
126382755|NCT00078806|454694979|FG003|Part 1A|Other|0|||
126382756|NCT00078806|454694976|FG000|Part 1B|Adverse Event|1|||
126382757|NCT00078806|454694977|FG001|Part 1B|Adverse Event|0|||
126382758|NCT00078806|454694978|FG002|Part 1B|Adverse Event|0|||
126382759|NCT00078806|454694979|FG003|Part 1B|Adverse Event|0|||
126382760|NCT00078806|454694976|FG000|Part 1B|Lack of Efficacy|7|||
126382761|NCT00078806|454694977|FG001|Part 1B|Lack of Efficacy|0|||
126382762|NCT00078806|454694978|FG002|Part 1B|Lack of Efficacy|0|||
126382763|NCT00078806|454694979|FG003|Part 1B|Lack of Efficacy|0|||
126382764|NCT00078806|454694976|FG000|Part 2|Adverse Event|0|||
126382765|NCT00078806|454694977|FG001|Part 2|Adverse Event|1|||
126382766|NCT00078806|454694978|FG002|Part 2|Adverse Event|0|||
126382767|NCT00078806|454694979|FG003|Part 2|Adverse Event|0|||
126382768|NCT01734785|454694980|FG000|Open-Label Period|Adverse Event|0|||
126382769|NCT01734785|454694981|FG001|Open-Label Period|Adverse Event|0|||
126382770|NCT01734785|454694982|FG002|Open-Label Period|Adverse Event|0|||
126382771|NCT01734785|454694983|FG003|Open-Label Period|Adverse Event|9|||
126382772|NCT01734785|454694980|FG000|Open-Label Period|Lack of Efficacy|0|||
126382773|NCT01734785|454694981|FG001|Open-Label Period|Lack of Efficacy|0|||
126382774|NCT01734785|454694982|FG002|Open-Label Period|Lack of Efficacy|0|||
126382775|NCT01734785|454694983|FG003|Open-Label Period|Lack of Efficacy|1|||
126382776|NCT01734785|454694980|FG000|Open-Label Period|Protocol Violation|0|||
126382777|NCT01734785|454694981|FG001|Open-Label Period|Protocol Violation|0|||
126382778|NCT01734785|454694982|FG002|Open-Label Period|Protocol Violation|0|||
126382779|NCT01734785|454694983|FG003|Open-Label Period|Protocol Violation|13|||
126382780|NCT01734785|454694980|FG000|Open-Label Period|Lost to Follow-up|0|||
126382781|NCT01734785|454694981|FG001|Open-Label Period|Lost to Follow-up|0|||
126382782|NCT01734785|454694982|FG002|Open-Label Period|Lost to Follow-up|0|||
126382783|NCT01734785|454694983|FG003|Open-Label Period|Lost to Follow-up|14|||
126382784|NCT01734785|454694980|FG000|Open-Label Period|Withdrawal by Subject|0|||
126382785|NCT01734785|454694981|FG001|Open-Label Period|Withdrawal by Subject|0|||
126382786|NCT01734785|454694982|FG002|Open-Label Period|Withdrawal by Subject|0|||
126382787|NCT01734785|454694983|FG003|Open-Label Period|Withdrawal by Subject|12|||
126382788|NCT01734785|454694980|FG000|Open-Label Period|Other Reasons|0|||
126382789|NCT01734785|454694981|FG001|Open-Label Period|Other Reasons|0|||
126382790|NCT01734785|454694982|FG002|Open-Label Period|Other Reasons|0|||
126382791|NCT01734785|454694983|FG003|Open-Label Period|Other Reasons|224|||
126382792|NCT01734785|454694980|FG000|Double-Blind Period|Adverse Event|0|||
126382793|NCT01734785|454694981|FG001|Double-Blind Period|Adverse Event|3|||
126382794|NCT01734785|454694982|FG002|Double-Blind Period|Adverse Event|2|||
126382795|NCT01734785|454694983|FG003|Double-Blind Period|Adverse Event|0|||
126382796|NCT01734785|454694980|FG000|Double-Blind Period|Lack of Efficacy|0|||
126382797|NCT01734785|454694981|FG001|Double-Blind Period|Lack of Efficacy|1|||
126382798|NCT01734785|454694982|FG002|Double-Blind Period|Lack of Efficacy|0|||
126382799|NCT01734785|454694983|FG003|Double-Blind Period|Lack of Efficacy|0|||
126382800|NCT01734785|454694980|FG000|Double-Blind Period|Protocol Violation|0|||
126382801|NCT01734785|454694981|FG001|Double-Blind Period|Protocol Violation|1|||
126382802|NCT01734785|454694982|FG002|Double-Blind Period|Protocol Violation|1|||
126382803|NCT01734785|454694983|FG003|Double-Blind Period|Protocol Violation|0|||
126382804|NCT01734785|454694980|FG000|Double-Blind Period|Lost to Follow-up|2|||
126382805|NCT01734785|454694981|FG001|Double-Blind Period|Lost to Follow-up|4|||
126382806|NCT01734785|454694982|FG002|Double-Blind Period|Lost to Follow-up|2|||
126382807|NCT01734785|454694983|FG003|Double-Blind Period|Lost to Follow-up|0|||
126382808|NCT01734785|454694980|FG000|Double-Blind Period|Withdrawal by Subject|2|||
126382809|NCT01734785|454694981|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126382810|NCT01734785|454694982|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126382811|NCT01734785|454694983|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126382812|NCT01734785|454694980|FG000|Double-Blind Period|Not treated|1|||
126382813|NCT01734785|454694981|FG001|Double-Blind Period|Not treated|0|||
126382814|NCT01734785|454694982|FG002|Double-Blind Period|Not treated|0|||
126382815|NCT01734785|454694983|FG003|Double-Blind Period|Not treated|0|||
126382816|NCT02013778|454694986|FG000|Overall Study|Death|4|||
126382817|NCT02013778|454694986|FG000|Overall Study|Withdrawal by Subject|1|||
126382818|NCT02013778|454694986|FG000|Overall Study|Physician Decision|1|||
126382819|NCT02013778|454694986|FG000|Overall Study|Adverse Event|1|||
126382820|NCT00293813|454694987|FG000|Overall Study|Physician Decision|0|||
126382821|NCT00293813|454694988|FG001|Overall Study|Physician Decision|1|||
126382822|NCT00293813|454694989|FG002|Overall Study|Physician Decision|0|||
126382823|NCT00293813|454694987|FG000|Overall Study|Adverse Event|3|||
126382824|NCT00293813|454694988|FG001|Overall Study|Adverse Event|1|||
126382825|NCT00293813|454694989|FG002|Overall Study|Adverse Event|1|||
126382826|NCT00293813|454694987|FG000|Overall Study|Withdrawal by Subject|7|||
126382827|NCT00293813|454694988|FG001|Overall Study|Withdrawal by Subject|4|||
126382828|NCT00293813|454694989|FG002|Overall Study|Withdrawal by Subject|4|||
126382829|NCT00293813|454694987|FG000|Overall Study|Lost to Follow-up|3|||
126382830|NCT00293813|454694988|FG001|Overall Study|Lost to Follow-up|2|||
126382831|NCT00293813|454694989|FG002|Overall Study|Lost to Follow-up|3|||
126382832|NCT00293813|454694987|FG000|Overall Study|Noncompliance|0|||
126382833|NCT00293813|454694988|FG001|Overall Study|Noncompliance|1|||
126382834|NCT00293813|454694989|FG002|Overall Study|Noncompliance|0|||
126382835|NCT01521923|454694992|FG000|Overall Study|AE, serious fatal|1|||
126382836|NCT01521923|454694993|FG001|Overall Study|AE, serious fatal|0|||
126382837|NCT01521923|454694994|FG002|Overall Study|AE, serious fatal|0|||
126382838|NCT01521923|454694995|FG003|Overall Study|AE, serious fatal|0|||
126382839|NCT01521923|454694992|FG000|Overall Study|SAE, non-fatal|0|||
126382840|NCT01521923|454694993|FG001|Overall Study|SAE, non-fatal|2|||
126382841|NCT01521923|454694994|FG002|Overall Study|SAE, non-fatal|2|||
126382842|NCT01521923|454694995|FG003|Overall Study|SAE, non-fatal|0|||
126382843|NCT01521923|454694992|FG000|Overall Study|AE, non-serious, non-fatal|1|||
126382844|NCT01521923|454694993|FG001|Overall Study|AE, non-serious, non-fatal|3|||
126382845|NCT01521923|454694994|FG002|Overall Study|AE, non-serious, non-fatal|6|||
126382846|NCT01521923|454694995|FG003|Overall Study|AE, non-serious, non-fatal|2|||
126382847|NCT01521923|454694992|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
126382848|NCT01521923|454694993|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
126382849|NCT01521923|454694994|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
126382850|NCT01521923|454694995|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
126382851|NCT01521923|454694992|FG000|Overall Study|Lack of Efficacy|1|||
126382852|NCT01521923|454694993|FG001|Overall Study|Lack of Efficacy|1|||
126382853|NCT01521923|454694994|FG002|Overall Study|Lack of Efficacy|0|||
126382854|NCT01521923|454694995|FG003|Overall Study|Lack of Efficacy|0|||
126382855|NCT01521923|454694992|FG000|Overall Study|Protocol Violation|0|||
126382856|NCT01521923|454694993|FG001|Overall Study|Protocol Violation|0|||
126382857|NCT01521923|454694994|FG002|Overall Study|Protocol Violation|1|||
126382858|NCT01521923|454694995|FG003|Overall Study|Protocol Violation|0|||
126382859|NCT01521923|454694992|FG000|Overall Study|Lost to Follow-up|1|||
126382860|NCT01521923|454694993|FG001|Overall Study|Lost to Follow-up|0|||
126382861|NCT01521923|454694994|FG002|Overall Study|Lost to Follow-up|2|||
126382862|NCT01521923|454694995|FG003|Overall Study|Lost to Follow-up|1|||
126382863|NCT01521923|454694992|FG000|Overall Study|Withdrawal by Subject|1|||
126382864|NCT01521923|454694993|FG001|Overall Study|Withdrawal by Subject|1|||
126382865|NCT01521923|454694994|FG002|Overall Study|Withdrawal by Subject|1|||
126382866|NCT01521923|454694995|FG003|Overall Study|Withdrawal by Subject|2|||
126382867|NCT01521923|454694992|FG000|Overall Study|Other|2|||
126382868|NCT01521923|454694993|FG001|Overall Study|Other|1|||
126382869|NCT01521923|454694994|FG002|Overall Study|Other|3|||
126382870|NCT01521923|454694995|FG003|Overall Study|Other|6|||
126382871|NCT01521923|454694992|FG000|Overall Study|AE, captured in Period 1|0|||
126382872|NCT01521923|454694993|FG001|Overall Study|AE, captured in Period 1|1|||
126382873|NCT01521923|454694994|FG002|Overall Study|AE, captured in Period 1|0|||
126382874|NCT01521923|454694995|FG003|Overall Study|AE, captured in Period 1|1|||
126382875|NCT01465386|454694999|FG000|Overall Study|Lack of Efficacy|3|||
126382876|NCT01465386|454694999|FG000|Overall Study|Adverse Event|1|||
126382877|NCT01279044|454695000|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
126382878|NCT01279044|454695001|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
126382879|NCT01279044|454695002|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
126382880|NCT01279044|454695000|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
126382881|NCT01279044|454695001|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
126382882|NCT01279044|454695002|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
126382883|NCT01279044|454695000|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
126382884|NCT01279044|454695001|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
126382885|NCT01279044|454695002|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
126382886|NCT01582009|454695003|FG000|Overall Study|Withdrawal by Subject|1|||
126382887|NCT01582009|454695003|FG000|Overall Study|Physician Decision|1|||
126382888|NCT03592771|454695008|FG000|Overall Study|Adverse Event|2|||
126382889|NCT03592771|454695009|FG001|Overall Study|Adverse Event|0|||
126382890|NCT03592771|454695010|FG002|Overall Study|Adverse Event|1|||
126382891|NCT03592771|454695008|FG000|Overall Study|Death|0|||
126382892|NCT03592771|454695009|FG001|Overall Study|Death|1|||
126382893|NCT03592771|454695010|FG002|Overall Study|Death|1|||
126382894|NCT03592771|454695008|FG000|Overall Study|Lost to Follow-up|5|||
126382895|NCT03592771|454695009|FG001|Overall Study|Lost to Follow-up|11|||
126382896|NCT03592771|454695010|FG002|Overall Study|Lost to Follow-up|15|||
126382897|NCT03592771|454695008|FG000|Overall Study|Withdrawal by Subject|0|||
126382898|NCT03592771|454695009|FG001|Overall Study|Withdrawal by Subject|2|||
126382899|NCT03592771|454695010|FG002|Overall Study|Withdrawal by Subject|0|||
126382900|NCT04830215|454695011|FG000|Overall Study|Adverse Event|6|||
126382901|NCT04830215|454695011|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
126382902|NCT04830215|454695011|FG000|Overall Study|Withdrawal by Subject|3|||
126382903|NCT04830215|454695011|FG000|Overall Study|Protocol Deviation|1|||
126382904|NCT00988052|454695015|FG000|Overall Study|Missing|1|||
126382905|NCT00988052|454695016|FG001|Overall Study|Missing|0|||
126382906|NCT00988052|454695015|FG000|Overall Study|Teva requested subject withdrawal|3|||
126382907|NCT00988052|454695016|FG001|Overall Study|Teva requested subject withdrawal|1|||
126382908|NCT00988052|454695015|FG000|Overall Study|Death|1|||
126382909|NCT00988052|454695016|FG001|Overall Study|Death|3|||
126382910|NCT00988052|454695015|FG000|Overall Study|Protocol Violation|6|||
126382911|NCT00988052|454695016|FG001|Overall Study|Protocol Violation|5|||
126382912|NCT00988052|454695015|FG000|Overall Study|Pregnancy|6|||
126382913|NCT00988052|454695016|FG001|Overall Study|Pregnancy|6|||
126382914|NCT00988052|454695015|FG000|Overall Study|Lack of Efficacy|8|||
126382915|NCT00988052|454695016|FG001|Overall Study|Lack of Efficacy|7|||
126382916|NCT00988052|454695015|FG000|Overall Study|Lost to Follow-up|6|||
126382917|NCT00988052|454695016|FG001|Overall Study|Lost to Follow-up|11|||
126382918|NCT00988052|454695015|FG000|Overall Study|Physician Decision|27|||
126382919|NCT00988052|454695016|FG001|Overall Study|Physician Decision|28|||
126382920|NCT00988052|454695015|FG000|Overall Study|Adverse Event|35|||
126382921|NCT00988052|454695016|FG001|Overall Study|Adverse Event|28|||
126382922|NCT00988052|454695015|FG000|Overall Study|Withdrawal by Subject|90|||
126382923|NCT00988052|454695016|FG001|Overall Study|Withdrawal by Subject|91|||
126382924|NCT00988052|454695015|FG000|Overall Study|Study terminated by sponsor|240|||
126382925|NCT00988052|454695016|FG001|Overall Study|Study terminated by sponsor|236|||
126382926|NCT03782064|454695017|FG000|Overall Study|Lack of Efficacy|2|||
126382927|NCT03782064|454695017|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
126382928|NCT02446769|454695018|FG000|Screening Period|Screen Failure|11|||
126382929|NCT02446769|454695019|FG001|Screening Period|Screen Failure|0|||
126382930|NCT02446769|454695020|FG002|Screening Period|Screen Failure|0|||
126382931|NCT02446769|454695018|FG000|Study Period|Randomized in Error|0|||
126382932|NCT02446769|454695019|FG001|Study Period|Randomized in Error|2|||
126382933|NCT02446769|454695020|FG002|Study Period|Randomized in Error|0|||
126382934|NCT00645840|454695021|FG000|Overall Study|Protocol Violation|3|||
126382935|NCT03994211|454695022|FG000|Core Phase|Adverse Event|0|||
126382936|NCT03994211|454695023|FG001|Core Phase|Adverse Event|1|||
126382937|NCT03994211|454695024|FG002|Core Phase|Adverse Event|0|||
126382938|NCT03994211|454695022|FG000|Extension Phase|Adverse Event|0|||
126382939|NCT03994211|454695023|FG001|Extension Phase|Adverse Event|0|||
126382940|NCT03994211|454695024|FG002|Extension Phase|Adverse Event|1|||
126382941|NCT03994211|454695022|FG000|Extension Phase|Physician Decision|0|||
126382942|NCT03994211|454695023|FG001|Extension Phase|Physician Decision|0|||
126382943|NCT03994211|454695024|FG002|Extension Phase|Physician Decision|1|||
126382944|NCT03994211|454695022|FG000|Extension Phase|Progressive Disease|0|||
126382945|NCT03994211|454695023|FG001|Extension Phase|Progressive Disease|0|||
126382946|NCT03994211|454695024|FG002|Extension Phase|Progressive Disease|20|||
126382947|NCT03994211|454695022|FG000|Extension Phase|Withdrawal by Subject|0|||
126382948|NCT03994211|454695023|FG001|Extension Phase|Withdrawal by Subject|0|||
126382949|NCT03994211|454695024|FG002|Extension Phase|Withdrawal by Subject|2|||
126382950|NCT00271856|454695030|FG000|Overall Study|Withdrawal by Subject|1|||
126382951|NCT00271856|454695031|FG001|Overall Study|Withdrawal by Subject|7|||
126048544|NCT02111096|453475214|FG000|Overall Study|Protocol Violation|1|||
126382952|NCT00271856|454695030|FG000|Overall Study|Lost to Follow-up|10|||
126382953|NCT00271856|454695031|FG001|Overall Study|Lost to Follow-up|11|||
126382954|NCT04599803|454695032|FG000|Overall Study|Withdrawal by Subject|5|||
126382955|NCT04599803|454695032|FG000|Overall Study|Lost to Follow-up|26|||
126382956|NCT04677543|454695033|FG000|Overall Study|Withdrawal by Subject|4|||
126382957|NCT04677543|454695034|FG001|Overall Study|Withdrawal by Subject|1|||
126382958|NCT04677543|454695033|FG000|Overall Study|Physician Decision|0|||
126382959|NCT04677543|454695034|FG001|Overall Study|Physician Decision|1|||
126382960|NCT04677543|454695033|FG000|Overall Study|Adverse Event|0|||
126382961|NCT04677543|454695034|FG001|Overall Study|Adverse Event|1|||
126048545|NCT02111096|453475215|FG001|Overall Study|Protocol Violation|0|||
126048546|NCT02111096|453475216|FG002|Overall Study|Protocol Violation|1|||
126382962|NCT00995436|454695039|FG000|Overall Study|Withdrawal by Subject|2|||
126382963|NCT00995436|454695040|FG001|Overall Study|Withdrawal by Subject|5|||
126382964|NCT00995436|454695041|FG002|Overall Study|Withdrawal by Subject|0|||
126382965|NCT00771927|454695043|FG000|Overall Study|Adverse Event|100|||
126382966|NCT00771927|454695044|FG001|Overall Study|Adverse Event|105|||
126382967|NCT00771927|454695043|FG000|Overall Study|Lack of Efficacy|70|||
126382968|NCT00771927|454695044|FG001|Overall Study|Lack of Efficacy|42|||
126382969|NCT00771927|454695043|FG000|Overall Study|Lost to Follow-up|46|||
126382970|NCT00771927|454695044|FG001|Overall Study|Lost to Follow-up|46|||
126382971|NCT00771927|454695043|FG000|Overall Study|Withdrawal by Subject|16|||
126382972|NCT00771927|454695044|FG001|Overall Study|Withdrawal by Subject|17|||
126382973|NCT00771927|454695043|FG000|Overall Study|Other reason|23|||
126382974|NCT00771927|454695044|FG001|Overall Study|Other reason|27|||
126382975|NCT02063984|454695045|FG000|Overall Study|Lost to Follow-up|6|||
126382976|NCT02063984|454695046|FG001|Overall Study|Lost to Follow-up|5|||
126382977|NCT00577707|454695050|FG000|Overall Study|Withdrawal by Subject|3|||
126382978|NCT03299244|454695051|FG000|Overall Study|Withdrawal by Subject|34|||
126382979|NCT03299244|454695052|FG001|Overall Study|Withdrawal by Subject|29|||
126382980|NCT03299244|454695051|FG000|Overall Study|Decision by Sponsor|4|||
126382981|NCT03299244|454695052|FG001|Overall Study|Decision by Sponsor|5|||
126382982|NCT03299244|454695051|FG000|Overall Study|Death|9|||
126382983|NCT03299244|454695052|FG001|Overall Study|Death|4|||
126382984|NCT01603043|454695053|FG000|Overall Study|Study Futility|7|||
126382985|NCT01603043|454695054|FG001|Overall Study|Study Futility|3|||
126382986|NCT02712996|454695056|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
126382987|NCT02712996|454695057|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
126382988|NCT01016132|454695058|FG000|Overall Study|Discomfort|1|||
126382989|NCT01451749|454695061|FG000|Overall Study|Protocol Violation|14|||
126382990|NCT01451749|454695062|FG001|Overall Study|Protocol Violation|7|||
126382991|NCT01451749|454695061|FG000|Overall Study|Lost to Follow-up|15|||
126382992|NCT01451749|454695062|FG001|Overall Study|Lost to Follow-up|5|||
126382993|NCT01451749|454695061|FG000|Overall Study|Meet the exclusion criteria,and|1|||
126382994|NCT01451749|454695062|FG001|Overall Study|Meet the exclusion criteria,and|1|||
126382995|NCT01451749|454695061|FG000|Overall Study|Adverse Event|2|||
126382996|NCT01451749|454695062|FG001|Overall Study|Adverse Event|0|||
126382997|NCT01451749|454695061|FG000|Overall Study|Withdrawal by Subject|0|||
126382998|NCT01451749|454695062|FG001|Overall Study|Withdrawal by Subject|1|||
126382999|NCT02454530|454695068|FG000|Overall Study|Other|8|||
126383000|NCT02454530|454695069|FG001|Overall Study|Other|13|||
126383001|NCT02454530|454695068|FG000|Overall Study|Missing information|56|||
126383002|NCT02454530|454695069|FG001|Overall Study|Missing information|69|||
126383003|NCT02454530|454695068|FG000|Overall Study|Death|2|||
126383004|NCT02454530|454695069|FG001|Overall Study|Death|41|||
126383005|NCT02454530|454695068|FG000|Overall Study|Lost to Follow-up|4|||
126383006|NCT02454530|454695069|FG001|Overall Study|Lost to Follow-up|4|||
126383007|NCT03265145|454695070|FG000|Overall Study|Protocol Violation|2|||
126383008|NCT03265145|454695071|FG001|Overall Study|Protocol Violation|0|||
126383009|NCT03265145|454695070|FG000|Overall Study|Adverse Event|1|||
126383010|NCT03265145|454695071|FG001|Overall Study|Adverse Event|0|||
126383011|NCT03265145|454695070|FG000|Overall Study|Withdrawal by Subject|23|||
126383012|NCT03265145|454695071|FG001|Overall Study|Withdrawal by Subject|19|||
126383013|NCT03265145|454695070|FG000|Overall Study|Death|12|||
126383014|NCT03265145|454695071|FG001|Overall Study|Death|12|||
126383015|NCT03265145|454695070|FG000|Overall Study|Lost to Follow-up|13|||
126383016|NCT03265145|454695071|FG001|Overall Study|Lost to Follow-up|9|||
126383017|NCT03265145|454695070|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
126383018|NCT03265145|454695071|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
126383019|NCT03265145|454695070|FG000|Overall Study|Switched back to previous medication|1|||
126383020|NCT03265145|454695071|FG001|Overall Study|Switched back to previous medication|0|||
126383021|NCT03265145|454695070|FG000|Overall Study|Did not want to take medication|1|||
126383022|NCT03265145|454695071|FG001|Overall Study|Did not want to take medication|0|||
126383023|NCT03265145|454695070|FG000|Overall Study|Subject could not afford medication|0|||
126383024|NCT03265145|454695071|FG001|Overall Study|Subject could not afford medication|1|||
126383025|NCT03265145|454695070|FG000|Overall Study|Site closed|2|||
126048547|NCT02111096|453475214|FG000|Overall Study|Terminated by Sponsor|53|||
126383026|NCT03265145|454695071|FG001|Overall Study|Site closed|3|||
126383027|NCT03265145|454695070|FG000|Overall Study|Incorrectly randomized|16|||
126383028|NCT03265145|454695071|FG001|Overall Study|Incorrectly randomized|6|||
126383029|NCT03265145|454695070|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
126383030|NCT03265145|454695071|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
126383031|NCT03265145|454695070|FG000|Overall Study|Physician Decision|0|||
126383032|NCT03265145|454695071|FG001|Overall Study|Physician Decision|3|||
126383033|NCT03265145|454695070|FG000|Overall Study|Subject transferred to another facility|0|||
126383034|NCT03265145|454695071|FG001|Overall Study|Subject transferred to another facility|1|||
126383035|NCT03159468|454695072|FG000|Overall Study|Withdrawal by Subject|0|||
126383036|NCT03159468|454695073|FG001|Overall Study|Withdrawal by Subject|0|||
126383037|NCT03159468|454695074|FG002|Overall Study|Withdrawal by Subject|3|||
126383038|NCT03159468|454695075|FG003|Overall Study|Withdrawal by Subject|0|||
126383039|NCT03159468|454695076|FG004|Overall Study|Withdrawal by Subject|0|||
126383040|NCT03159468|454695077|FG005|Overall Study|Withdrawal by Subject|0|||
126383041|NCT03280303|454696756|FG000|Overall Study|Death|505|||
126383042|NCT03280303|454696756|FG000|Overall Study|Study terminated by sponsor|383|||
126383043|NCT03280303|454696756|FG000|Overall Study|Other|148|||
126383044|NCT03280303|454696756|FG000|Overall Study|No longer willing to participate in study|101|||
126383045|NCT03280303|454696756|FG000|Overall Study|Lost to follow up|39|||
126383046|NCT03280303|454696756|FG000|Overall Study|Adverse Event|20|||
126383047|NCT02974140|454696763|FG000|Overall Study|Adverse Event|2|||
126383048|NCT02974140|454696763|FG000|Overall Study|Lost to Follow-up|1|||
126383049|NCT02974140|454696763|FG000|Overall Study|Study Terminated by Sponsor|36|||
126383050|NCT00617084|454696764|FG000|Overall Study|Withdrawal by Subject|5|||
126383051|NCT00617084|454696765|FG001|Overall Study|Withdrawal by Subject|7|||
126383052|NCT00617084|454696764|FG000|Overall Study|Missed 12 Months visit|16|||
126383053|NCT00617084|454696765|FG001|Overall Study|Missed 12 Months visit|19|||
126383054|NCT02222688|454696769|FG000|Overall Study|Withdrawal by Subject|0|||
126383055|NCT02222688|454696770|FG001|Overall Study|Withdrawal by Subject|0|||
126383056|NCT02222688|454696771|FG002|Overall Study|Withdrawal by Subject|0|||
126383057|NCT02222688|454696772|FG003|Overall Study|Withdrawal by Subject|2|||
126383058|NCT02222688|454696773|FG004|Overall Study|Withdrawal by Subject|1|||
126383059|NCT02222688|454696774|FG005|Overall Study|Withdrawal by Subject|0|||
126383060|NCT02222688|454696775|FG006|Overall Study|Withdrawal by Subject|1|||
126383061|NCT02222688|454696769|FG000|Overall Study|Disease progression|1|||
126383062|NCT02222688|454696770|FG001|Overall Study|Disease progression|0|||
126383063|NCT02222688|454696771|FG002|Overall Study|Disease progression|0|||
126383064|NCT02222688|454696772|FG003|Overall Study|Disease progression|0|||
126383065|NCT02222688|454696773|FG004|Overall Study|Disease progression|0|||
126383066|NCT02222688|454696774|FG005|Overall Study|Disease progression|0|||
126383067|NCT02222688|454696775|FG006|Overall Study|Disease progression|0|||
126383068|NCT02522429|454696784|FG000|Overall Study|Lost to Follow-up|8|||
126383069|NCT02522429|454696784|FG000|Overall Study|Adverse Event|2|||
126383070|NCT02522429|454696784|FG000|Overall Study|Death|1|||
126383071|NCT02522429|454696784|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
126383072|NCT00500357|454696788|FG000|Overall Study|Death|1|||
126383073|NCT00161616|454696789|FG000|Overall Study|Withdrawal by Subject|6|||
126383074|NCT00161616|454696790|FG001|Overall Study|Withdrawal by Subject|5|||
126383075|NCT00161616|454696789|FG000|Overall Study|Physician Decision|1|||
126383076|NCT00161616|454696790|FG001|Overall Study|Physician Decision|0|||
126383077|NCT00161616|454696789|FG000|Overall Study|Death|1|||
126383078|NCT00161616|454696790|FG001|Overall Study|Death|1|||
126383079|NCT00161616|454696789|FG000|Overall Study|Lost to Follow-up|17|||
126383080|NCT00161616|454696790|FG001|Overall Study|Lost to Follow-up|13|||
126383081|NCT00161616|454696789|FG000|Overall Study|Protocol deviation|1|||
126383082|NCT00161616|454696790|FG001|Overall Study|Protocol deviation|0|||
126383083|NCT00854724|454696791|FG000|First Intervention|Withdrawal by Subject|1|||
126383084|NCT00854724|454696792|FG001|First Intervention|Withdrawal by Subject|1|||
126383085|NCT00854724|454696791|FG000|Washout|Protocol Violation|1|||
126383086|NCT00854724|454696792|FG001|Washout|Protocol Violation|0|||
126383087|NCT00854724|454696791|FG000|Washout|Withdrawal by Subject|0|||
126383088|NCT00854724|454696792|FG001|Washout|Withdrawal by Subject|1|||
126383089|NCT00854724|454696791|FG000|Second Intervention|Protocol Violation|1|||
126383090|NCT00854724|454696792|FG001|Second Intervention|Protocol Violation|0|||
126383091|NCT00854724|454696791|FG000|Second Intervention|Physician Decision|0|||
126383092|NCT00854724|454696792|FG001|Second Intervention|Physician Decision|1|||
126383093|NCT00861757|454696794|FG000|Overall Study|Adverse Event|1|||
126383094|NCT00861757|454696795|FG001|Overall Study|Adverse Event|5|||
126383095|NCT00861757|454696796|FG002|Overall Study|Adverse Event|7|||
126383096|NCT00861757|454696797|FG003|Overall Study|Adverse Event|2|||
126383097|NCT00861757|454696794|FG000|Overall Study|Entry Criteria Not Met|1|||
126383098|NCT00861757|454696795|FG001|Overall Study|Entry Criteria Not Met|2|||
126383099|NCT00861757|454696796|FG002|Overall Study|Entry Criteria Not Met|1|||
126383100|NCT00861757|454696797|FG003|Overall Study|Entry Criteria Not Met|1|||
126383101|NCT00861757|454696794|FG000|Overall Study|Lack of Efficacy|3|||
126383102|NCT00861757|454696795|FG001|Overall Study|Lack of Efficacy|1|||
126383103|NCT00861757|454696796|FG002|Overall Study|Lack of Efficacy|0|||
126383104|NCT00861757|454696797|FG003|Overall Study|Lack of Efficacy|1|||
126383105|NCT00861757|454696794|FG000|Overall Study|Lost to Follow-up|1|||
126383106|NCT00861757|454696795|FG001|Overall Study|Lost to Follow-up|0|||
126383107|NCT00861757|454696796|FG002|Overall Study|Lost to Follow-up|1|||
126383108|NCT00861757|454696797|FG003|Overall Study|Lost to Follow-up|1|||
126383109|NCT00861757|454696794|FG000|Overall Study|Physician Decision|0|||
126383110|NCT00861757|454696795|FG001|Overall Study|Physician Decision|0|||
126383111|NCT00861757|454696796|FG002|Overall Study|Physician Decision|0|||
126383112|NCT00861757|454696797|FG003|Overall Study|Physician Decision|1|||
126383113|NCT00861757|454696794|FG000|Overall Study|Protocol Violation|2|||
126383114|NCT00861757|454696795|FG001|Overall Study|Protocol Violation|2|||
126383115|NCT00861757|454696796|FG002|Overall Study|Protocol Violation|4|||
126383116|NCT00861757|454696797|FG003|Overall Study|Protocol Violation|1|||
126383117|NCT00861757|454696794|FG000|Overall Study|Withdrawal by Subject|1|||
126383118|NCT00861757|454696795|FG001|Overall Study|Withdrawal by Subject|5|||
126383119|NCT00861757|454696796|FG002|Overall Study|Withdrawal by Subject|5|||
126383120|NCT00861757|454696797|FG003|Overall Study|Withdrawal by Subject|2|||
126383121|NCT02140970|454696800|FG000|Overall Study|Lost to Follow-up|1|||
126383122|NCT02140970|454696801|FG001|Overall Study|Lost to Follow-up|2|||
126383123|NCT02140970|454696800|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
126383124|NCT02140970|454696801|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
126383125|NCT02140970|454696800|FG000|Overall Study|Did not meet inclusion criteria|0|||
126383126|NCT02140970|454696801|FG001|Overall Study|Did not meet inclusion criteria|1|||
126383127|NCT02705105|454696802|FG000|Treatment|Objective Disease Progression|1|||
126383128|NCT02705105|454696803|FG001|Treatment|Objective Disease Progression|50|||
126383129|NCT02705105|454696802|FG000|Treatment|Withdrawal by Subject|3|||
126383130|NCT02705105|454696803|FG001|Treatment|Withdrawal by Subject|5|||
126383131|NCT02705105|454696802|FG000|Treatment|Adverse Event|0|||
126383132|NCT02705105|454696803|FG001|Treatment|Adverse Event|17|||
126383133|NCT02705105|454696802|FG000|Treatment|Clinical Disease Progression|0|||
126383134|NCT02705105|454696803|FG001|Treatment|Clinical Disease Progression|32|||
126383135|NCT02705105|454696802|FG000|Treatment|Physician Decision|0|||
126383136|NCT02705105|454696803|FG001|Treatment|Physician Decision|3|||
126383137|NCT02705105|454696802|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
126383138|NCT02705105|454696803|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
126383139|NCT02705105|454696802|FG000|Follow-Up|Death|3|||
126383140|NCT02705105|454696803|FG001|Follow-Up|Death|68|||
126383141|NCT02705105|454696802|FG000|Follow-Up|Withdrawal by Subject|1|||
126383142|NCT02705105|454696803|FG001|Follow-Up|Withdrawal by Subject|14|||
126383143|NCT02705105|454696802|FG000|Follow-Up|Study Terminated|0|||
126383144|NCT02705105|454696803|FG001|Follow-Up|Study Terminated|26|||
126383145|NCT02705105|454696802|FG000|Follow-Up|Discontinued per Amendment 3|0|||
126383146|NCT02705105|454696803|FG001|Follow-Up|Discontinued per Amendment 3|2|||
126383147|NCT01709110|454696806|FG000|Overall Study|Adverse Event|56|||
126383148|NCT01709110|454696807|FG001|Overall Study|Adverse Event|48|||
126383149|NCT01709110|454696806|FG000|Overall Study|Death|14|||
126383150|NCT01709110|454696807|FG001|Overall Study|Death|6|||
126383151|NCT01709110|454696806|FG000|Overall Study|Lost to Follow-up|7|||
126383152|NCT01709110|454696807|FG001|Overall Study|Lost to Follow-up|5|||
126383153|NCT01709110|454696806|FG000|Overall Study|Protocol Violation|4|||
126383154|NCT01709110|454696807|FG001|Overall Study|Protocol Violation|6|||
126383155|NCT01709110|454696806|FG000|Overall Study|Withdrawal by Subject|96|||
126383156|NCT01709110|454696807|FG001|Overall Study|Withdrawal by Subject|89|||
126383157|NCT01709110|454696806|FG000|Overall Study|Physician Decision|4|||
126383158|NCT01709110|454696807|FG001|Overall Study|Physician Decision|10|||
126383159|NCT01709110|454696806|FG000|Overall Study|Sponsor Decision|2|||
126383160|NCT01709110|454696807|FG001|Overall Study|Sponsor Decision|2|||
126383161|NCT01709110|454696806|FG000|Overall Study|Lack of Efficacy|1|||
126383162|NCT01709110|454696807|FG001|Overall Study|Lack of Efficacy|1|||
126383163|NCT01709110|454696806|FG000|Overall Study|Caregiver Decision|1|||
126383164|NCT01709110|454696807|FG001|Overall Study|Caregiver Decision|1|||
126048548|NCT02111096|453475215|FG001|Overall Study|Terminated by Sponsor|35|||
126048549|NCT02111096|453475216|FG002|Overall Study|Terminated by Sponsor|54|||
126383165|NCT03332173|454696808|FG000|Overall Study|Death|7|||
126383166|NCT03332173|454696808|FG000|Overall Study|Withdrawal by Subject|6|||
126383167|NCT03332173|454696808|FG000|Overall Study|Lost to Follow-up|2|||
126048550|NCT02111096|453475214|FG000|Overall Study|Withdrawal by Subject|4|||
126383168|NCT03332173|454696808|FG000|Overall Study|Transferred to long-term extension study|29|||
126383169|NCT02168101|454696809|FG000|Overall Study|Death|2|||
126383170|NCT02168101|454696810|FG001|Overall Study|Death|2|||
126383171|NCT02168101|454696811|FG002|Overall Study|Death|1|||
126383172|NCT00910910|454696812|FG000|Overall Study|Adverse Event|63|||
126383173|NCT00910910|454696813|FG001|Overall Study|Adverse Event|35|||
126383174|NCT00910910|454696812|FG000|Overall Study|PD without histologic change|27|||
126383175|NCT00910910|454696813|FG001|Overall Study|PD without histologic change|23|||
126383176|NCT00910910|454696812|FG000|Overall Study|PD with histologic change|0|||
126383177|NCT00910910|454696813|FG001|Overall Study|PD with histologic change|2|||
126048551|NCT02111096|453475215|FG001|Overall Study|Withdrawal by Subject|2|||
126383178|NCT00910910|454696812|FG000|Overall Study|Withdrawal by Subject|7|||
126383179|NCT00910910|454696813|FG001|Overall Study|Withdrawal by Subject|5|||
126383180|NCT00910910|454696812|FG000|Overall Study|Lost to Follow-up|2|||
126383181|NCT00910910|454696813|FG001|Overall Study|Lost to Follow-up|2|||
126383182|NCT00910910|454696812|FG000|Overall Study|Death|9|||
126383183|NCT00910910|454696813|FG001|Overall Study|Death|3|||
126383184|NCT00910910|454696812|FG000|Overall Study|Protocol Violation|2|||
126383185|NCT00910910|454696813|FG001|Overall Study|Protocol Violation|2|||
126383186|NCT00910910|454696812|FG000|Overall Study|Completed 13 cycles of treatment|0|||
126383187|NCT00910910|454696813|FG001|Overall Study|Completed 13 cycles of treatment|118|||
126383188|NCT00910910|454696812|FG000|Overall Study|Other|114|||
126383189|NCT00910910|454696813|FG001|Overall Study|Other|32|||
126383190|NCT00910910|454696812|FG000|Overall Study|Untreated before cycle 1|1|||
126383191|NCT00910910|454696813|FG001|Overall Study|Untreated before cycle 1|2|||
126383192|NCT01973231|454696814|FG000|Overall Study|Protocol Violation|1|||
126383193|NCT01973231|454696815|FG001|Overall Study|Protocol Violation|1|||
126383194|NCT01973231|454696814|FG000|Overall Study|Lost to Follow-up|1|||
126383195|NCT01973231|454696815|FG001|Overall Study|Lost to Follow-up|1|||
126383196|NCT01973231|454696814|FG000|Overall Study|unclassified|2|||
126383197|NCT01973231|454696815|FG001|Overall Study|unclassified|1|||
126383198|NCT01973231|454696814|FG000|Overall Study|Withdrawal by Subject|7|||
126383199|NCT01973231|454696815|FG001|Overall Study|Withdrawal by Subject|9|||
126383200|NCT01485796|454696818|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
126383201|NCT01485796|454696818|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
126383202|NCT01485796|454696818|FG000|Period 2: Epoch 2|Adverse Event|3|||
126383203|NCT01485796|454696818|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
126383204|NCT01485796|454696818|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
126383205|NCT01485796|454696818|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
126383206|NCT01485796|454696818|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
126383207|NCT01485796|454696818|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
126383208|NCT01775553|454696825|FG000|Overall Study|Adverse Event|1|||
126383209|NCT01775553|454696825|FG000|Overall Study|Disease Progression|12|||
126383210|NCT01523743|454696826|FG000|Period 1|Adverse Event|1|||
126383211|NCT01523743|454696827|FG001|Period 1|Adverse Event|0|||
126383212|NCT01523743|454696826|FG000|Period 1|Withdrawal by Subject|6|||
126383213|NCT01523743|454696827|FG001|Period 1|Withdrawal by Subject|2|||
126383214|NCT01523743|454696826|FG000|Period 1|Lost to Follow-up|1|||
126383215|NCT01523743|454696827|FG001|Period 1|Lost to Follow-up|0|||
126383216|NCT01523743|454696826|FG000|Period 1|Lack of Efficacy|1|||
126383217|NCT01523743|454696827|FG001|Period 1|Lack of Efficacy|0|||
126383218|NCT01523743|454696826|FG000|Period 1|Felt unable to empty bladder|1|||
126383219|NCT01523743|454696827|FG001|Period 1|Felt unable to empty bladder|0|||
126383220|NCT01523743|454696826|FG000|Period 2|Withdrawal by Subject|0|||
125886689|NCT02454517|452881818|FG001|Overall Study|Lost to Follow-up|7|||
126383221|NCT01523743|454696827|FG001|Period 2|Withdrawal by Subject|2|||
126383222|NCT01523743|454696826|FG000|Period 2|Adverse Event|1|||
126383223|NCT01523743|454696827|FG001|Period 2|Adverse Event|0|||
126383224|NCT02569476|454696828|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
126383225|NCT02569476|454696828|FG000|Overall Study|Death|33|||
126383226|NCT02569476|454696828|FG000|Overall Study|Withdrawal by Subject|9|||
126383227|NCT02569476|454696828|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
126383228|NCT02569476|454696828|FG000|Overall Study|Palliative care|1|||
126104181|NCT00320541|453675819|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
126104182|NCT00320541|453675820|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
126104183|NCT03057977|453675821|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
126383229|NCT02569476|454696828|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
126383230|NCT02569476|454696828|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
126383231|NCT01434654|454696829|FG000|Overall Study|Withdrawal by Subject|1|||
126383232|NCT01434654|454696830|FG001|Overall Study|Withdrawal by Subject|0|||
126383233|NCT01434654|454696829|FG000|Overall Study|Lost to Follow-up|1|||
126383234|NCT01434654|454696830|FG001|Overall Study|Lost to Follow-up|0|||
126383235|NCT00703963|454696833|FG000|Overall Study|Withdrawal by Subject|7|||
126383236|NCT00703963|454696834|FG001|Overall Study|Withdrawal by Subject|13|||
126383237|NCT00703963|454696833|FG000|Overall Study|Physician Decision|0|||
126383238|NCT00703963|454696834|FG001|Overall Study|Physician Decision|1|||
126383239|NCT00402324|454696837|FG000|Overall Study|Lost to Follow-up|11|||
126383240|NCT00402324|454696838|FG001|Overall Study|Lost to Follow-up|11|||
126383241|NCT00402324|454696837|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
126383242|NCT00402324|454696838|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
126383243|NCT00402324|454696837|FG000|Overall Study|Protocol Violation|8|||
126383244|NCT00402324|454696838|FG001|Overall Study|Protocol Violation|7|||
126383245|NCT00402324|454696837|FG000|Overall Study|Withdrawal by Subject|5|||
126383246|NCT00402324|454696838|FG001|Overall Study|Withdrawal by Subject|2|||
126383247|NCT00402324|454696837|FG000|Overall Study|Physician Decision|2|||
126383248|NCT00402324|454696838|FG001|Overall Study|Physician Decision|4|||
126383249|NCT00402324|454696837|FG000|Overall Study|Sponsor Decision|4|||
126383250|NCT00402324|454696838|FG001|Overall Study|Sponsor Decision|5|||
126383251|NCT00402324|454696837|FG000|Overall Study|Lack of Efficacy|1|||
126383252|NCT00402324|454696838|FG001|Overall Study|Lack of Efficacy|4|||
126383253|NCT00402324|454696837|FG000|Overall Study|Adverse Event|6|||
126383254|NCT00402324|454696838|FG001|Overall Study|Adverse Event|4|||
126383255|NCT00402324|454696837|FG000|Overall Study|Death|1|||
126383256|NCT00402324|454696838|FG001|Overall Study|Death|0|||
126383257|NCT01277822|454696839|FG000|Overall Study|Adverse Event|2|||
126383258|NCT01277822|454696840|FG001|Overall Study|Adverse Event|1|||
126383259|NCT01277822|454696839|FG000|Overall Study|Withdrawal by Subject|6|||
126383260|NCT01277822|454696840|FG001|Overall Study|Withdrawal by Subject|7|||
126383261|NCT01277822|454696839|FG000|Overall Study|Physician Decision|1|||
126383262|NCT01277822|454696840|FG001|Overall Study|Physician Decision|1|||
126383263|NCT01277822|454696839|FG000|Overall Study|Protocol Violation|1|||
126383264|NCT01277822|454696840|FG001|Overall Study|Protocol Violation|0|||
126383265|NCT01277822|454696839|FG000|Overall Study|Lost to Follow-up|2|||
126383266|NCT01277822|454696840|FG001|Overall Study|Lost to Follow-up|1|||
126383267|NCT01277822|454696839|FG000|Overall Study|Contraindicated medication used|2|||
126383268|NCT01277822|454696840|FG001|Overall Study|Contraindicated medication used|1|||
126383269|NCT01277822|454696839|FG000|Overall Study|Participant moved|1|||
126383270|NCT01277822|454696840|FG001|Overall Study|Participant moved|0|||
126383271|NCT02625220|454696841|FG000|Overall Study|Adverse Event|2|||
126383272|NCT02625220|454696841|FG000|Overall Study|Lost to Follow-up|2|||
126383273|NCT02625220|454696841|FG000|Overall Study|Protocol Violation|1|||
126383274|NCT02625220|454696841|FG000|Overall Study|Study discontinued at site|2|||
126383275|NCT02923531|454696842|FG000|Overall Study|Adverse Event|4|||
126383276|NCT02923531|454696842|FG000|Overall Study|Clinical Deterioration|1|||
126383277|NCT02923531|454696842|FG000|Overall Study|Disease Progression|3|||
126383278|NCT02923531|454696842|FG000|Overall Study|Study Termination|1|||
126383279|NCT00997984|454696843|FG000|Overall Study|Adverse Event|1|||
126383280|NCT00997984|454696844|FG001|Overall Study|Adverse Event|8|||
126383281|NCT00997984|454696845|FG002|Overall Study|Adverse Event|8|||
126383282|NCT00997984|454696843|FG000|Overall Study|Protocol Violation|1|||
126383283|NCT00997984|454696844|FG001|Overall Study|Protocol Violation|3|||
126383284|NCT00997984|454696845|FG002|Overall Study|Protocol Violation|0|||
126383285|NCT00997984|454696843|FG000|Overall Study|Withdrawal by Subject|6|||
126383286|NCT00997984|454696844|FG001|Overall Study|Withdrawal by Subject|9|||
126383287|NCT00997984|454696845|FG002|Overall Study|Withdrawal by Subject|5|||
126383288|NCT00997984|454696843|FG000|Overall Study|Lost to Follow-up|8|||
126383289|NCT00997984|454696844|FG001|Overall Study|Lost to Follow-up|5|||
126383290|NCT00997984|454696845|FG002|Overall Study|Lost to Follow-up|4|||
126383291|NCT00997984|454696843|FG000|Overall Study|Lack of Efficacy|20|||
126383292|NCT00997984|454696844|FG001|Overall Study|Lack of Efficacy|6|||
126383293|NCT00997984|454696845|FG002|Overall Study|Lack of Efficacy|3|||
126383294|NCT00997984|454696843|FG000|Overall Study|Met exclusion criteria|1|||
126383295|NCT00997984|454696844|FG001|Overall Study|Met exclusion criteria|0|||
126383296|NCT00997984|454696845|FG002|Overall Study|Met exclusion criteria|0|||
126383297|NCT00997984|454696843|FG000|Overall Study|non-compliance|0|||
126383298|NCT00997984|454696844|FG001|Overall Study|non-compliance|2|||
126383299|NCT00997984|454696845|FG002|Overall Study|non-compliance|3|||
126383300|NCT00997984|454696843|FG000|Overall Study|Wrong medication dispensed|0|||
126383301|NCT00997984|454696844|FG001|Overall Study|Wrong medication dispensed|1|||
126383302|NCT00997984|454696845|FG002|Overall Study|Wrong medication dispensed|0|||
126383303|NCT00997984|454696843|FG000|Overall Study|Suicidal ideation|0|||
126383304|NCT00997984|454696844|FG001|Overall Study|Suicidal ideation|0|||
126383305|NCT00997984|454696845|FG002|Overall Study|Suicidal ideation|1|||
126383306|NCT00997984|454696843|FG000|Overall Study|Work schedule|0|||
126383307|NCT00997984|454696844|FG001|Overall Study|Work schedule|0|||
126383308|NCT00997984|454696845|FG002|Overall Study|Work schedule|2|||
126383309|NCT01140867|454696846|FG000|Overall Study|Adverse Event|22|||
126383310|NCT01140867|454696846|FG000|Overall Study|Lack of Efficacy|3|||
126383311|NCT01140867|454696846|FG000|Overall Study|Lost to Follow-up|2|||
126383312|NCT01140867|454696846|FG000|Overall Study|Withdrawal by Subject|1|||
126383313|NCT01140867|454696846|FG000|Overall Study|Protocol Violation|1|||
126383314|NCT01140867|454696846|FG000|Overall Study|Uncooperative patient|2|||
126383315|NCT01140867|454696846|FG000|Overall Study|Medication Noncompliance|2|||
126383316|NCT01119066|454696848|FG000|Overall Study|Withdrawal by Subject|4|||
126383317|NCT01119066|454696849|FG001|Overall Study|Withdrawal by Subject|6|||
126383318|NCT01119066|454696850|FG002|Overall Study|Withdrawal by Subject|0|||
126383319|NCT01119066|454696851|FG003|Overall Study|Withdrawal by Subject|0|||
126383320|NCT01119066|454696848|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
126383321|NCT01119066|454696849|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
126383322|NCT01119066|454696850|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
126383323|NCT01119066|454696851|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
126383324|NCT01119066|454696848|FG000|Overall Study|Relapse identified before transplant|1|||
126383325|NCT01119066|454696849|FG001|Overall Study|Relapse identified before transplant|0|||
126383326|NCT01119066|454696850|FG002|Overall Study|Relapse identified before transplant|0|||
126383327|NCT01119066|454696851|FG003|Overall Study|Relapse identified before transplant|0|||
126383328|NCT01119066|454696848|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
126383329|NCT01119066|454696849|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
126383330|NCT01119066|454696850|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
126383331|NCT01119066|454696851|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
126383332|NCT01119066|454696848|FG000|Overall Study|Relapse identified before transplant|0|||
126383333|NCT01119066|454696849|FG001|Overall Study|Relapse identified before transplant|4|||
126383334|NCT01119066|454696850|FG002|Overall Study|Relapse identified before transplant|0|||
126383335|NCT01119066|454696851|FG003|Overall Study|Relapse identified before transplant|0|||
126383336|NCT02366923|454696852|FG000|Overall Study|Withdrawal by Subject|1|||
126383337|NCT02366923|454696852|FG000|Overall Study|Positive Slit Lamp Findings|2|||
126383338|NCT02366923|454696852|FG000|Overall Study|High Astigmatism|3|||
126383339|NCT03902392|454696853|FG000|Overall Study|Lost to Follow-up|7|||
126383340|NCT03902392|454696854|FG001|Overall Study|Lost to Follow-up|7|||
126383341|NCT01437111|454696855|FG000|Overall Study|Adverse Event|2|||
126383342|NCT01437111|454696855|FG000|Overall Study|Withdrawal by Subject|4|||
126383343|NCT01437111|454696855|FG000|Overall Study|Not reported|5|||
126383344|NCT01437111|454696855|FG000|Overall Study|Physician Decision|1|||
126383345|NCT01437111|454696855|FG000|Overall Study|Lost to Follow-up|5|||
126383346|NCT01437111|454696855|FG000|Overall Study|Protocol Violation|1|||
126383347|NCT03711370|454696856|FG000|Overall Study|Lost to Follow-up|16|||
126383348|NCT03711370|454696857|FG001|Overall Study|Lost to Follow-up|10|||
126383349|NCT03711370|454696856|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
126383350|NCT03711370|454696857|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
126383351|NCT00407602|454696858|FG000|Overall Study|Death - unrelated to device|1|||
126383352|NCT00407602|454696858|FG000|Overall Study|Device explanted|5|||
126383353|NCT00407602|454696858|FG000|Overall Study|Withdrawal by Subject|1|||
126383354|NCT00431444|454696861|FG000|Overall Study|Protocol Violation|1|||
126383355|NCT00431444|454696862|FG001|Overall Study|Protocol Violation|4|||
126383356|NCT00431444|454696861|FG000|Overall Study|Adverse Event|2|||
126383357|NCT00431444|454696862|FG001|Overall Study|Adverse Event|1|||
126383358|NCT00431444|454696861|FG000|Overall Study|Withdrawal by Subject|1|||
126383359|NCT00431444|454696862|FG001|Overall Study|Withdrawal by Subject|1|||
126383360|NCT00431444|454696861|FG000|Overall Study|Lost to Follow-up|1|||
126383361|NCT00431444|454696862|FG001|Overall Study|Lost to Follow-up|0|||
126383362|NCT00431444|454696861|FG000|Overall Study|Administrative Problems|0|||
126383363|NCT00431444|454696862|FG001|Overall Study|Administrative Problems|1|||
126383364|NCT02517398|454696877|FG000|Overall Study|Death|2|||
126383365|NCT02517398|454696878|FG001|Overall Study|Death|3|||
126383366|NCT02517398|454696879|FG002|Overall Study|Death|4|||
126383367|NCT02517398|454696880|FG003|Overall Study|Death|2|||
126383368|NCT02517398|454696881|FG004|Overall Study|Death|3|||
126383369|NCT02517398|454696882|FG005|Overall Study|Death|8|||
126383370|NCT02517398|454696883|FG006|Overall Study|Death|3|||
126383371|NCT02517398|454696884|FG007|Overall Study|Death|2|||
126383372|NCT02517398|454696885|FG008|Overall Study|Death|6|||
126383373|NCT02517398|454696886|FG009|Overall Study|Death|24|||
126383374|NCT02517398|454696887|FG010|Overall Study|Death|53|||
126383375|NCT02517398|454696888|FG011|Overall Study|Death|25|||
126383376|NCT02517398|454696889|FG012|Overall Study|Death|73|||
126383377|NCT02517398|454696890|FG013|Overall Study|Death|29|||
126383378|NCT02517398|454696891|FG014|Overall Study|Death|26|||
126383379|NCT02517398|454696892|FG015|Overall Study|Death|23|||
126383380|NCT02517398|454696893|FG016|Overall Study|Death|26|||
126383381|NCT02517398|454696894|FG017|Overall Study|Death|25|||
126383382|NCT02517398|454696895|FG018|Overall Study|Death|22|||
126383383|NCT02517398|454696896|FG019|Overall Study|Death|7|||
126383384|NCT02517398|454696897|FG020|Overall Study|Death|26|||
126383385|NCT02517398|454696898|FG021|Overall Study|Death|30|||
126383386|NCT02517398|454696899|FG022|Overall Study|Death|20|||
126383387|NCT02517398|454696877|FG000|Overall Study|Other|0|||
126383388|NCT02517398|454696878|FG001|Overall Study|Other|0|||
126383389|NCT02517398|454696879|FG002|Overall Study|Other|0|||
126383390|NCT02517398|454696880|FG003|Overall Study|Other|1|||
126383391|NCT02517398|454696881|FG004|Overall Study|Other|0|||
126383392|NCT02517398|454696882|FG005|Overall Study|Other|0|||
126383393|NCT02517398|454696883|FG006|Overall Study|Other|0|||
126383394|NCT02517398|454696884|FG007|Overall Study|Other|0|||
126383395|NCT02517398|454696885|FG008|Overall Study|Other|0|||
126383396|NCT02517398|454696886|FG009|Overall Study|Other|1|||
126383397|NCT02517398|454696887|FG010|Overall Study|Other|0|||
126383398|NCT02517398|454696888|FG011|Overall Study|Other|0|||
126383399|NCT02517398|454696889|FG012|Overall Study|Other|0|||
126383400|NCT02517398|454696890|FG013|Overall Study|Other|1|||
126383401|NCT02517398|454696891|FG014|Overall Study|Other|0|||
126383402|NCT02517398|454696892|FG015|Overall Study|Other|1|||
126383403|NCT02517398|454696893|FG016|Overall Study|Other|1|||
126383404|NCT02517398|454696894|FG017|Overall Study|Other|0|||
126383405|NCT02517398|454696895|FG018|Overall Study|Other|0|||
126383406|NCT02517398|454696896|FG019|Overall Study|Other|1|||
126383407|NCT02517398|454696897|FG020|Overall Study|Other|0|||
126383408|NCT02517398|454696898|FG021|Overall Study|Other|0|||
126383409|NCT02517398|454696899|FG022|Overall Study|Other|0|||
126383410|NCT02517398|454696877|FG000|Overall Study|Lost to Follow-up|0|||
126383411|NCT02517398|454696878|FG001|Overall Study|Lost to Follow-up|0|||
126383412|NCT02517398|454696879|FG002|Overall Study|Lost to Follow-up|0|||
126383413|NCT02517398|454696880|FG003|Overall Study|Lost to Follow-up|0|||
126383414|NCT02517398|454696881|FG004|Overall Study|Lost to Follow-up|0|||
126383415|NCT02517398|454696882|FG005|Overall Study|Lost to Follow-up|0|||
126383416|NCT02517398|454696883|FG006|Overall Study|Lost to Follow-up|0|||
126383417|NCT02517398|454696884|FG007|Overall Study|Lost to Follow-up|0|||
126383418|NCT02517398|454696885|FG008|Overall Study|Lost to Follow-up|0|||
126383419|NCT02517398|454696886|FG009|Overall Study|Lost to Follow-up|1|||
126383420|NCT02517398|454696887|FG010|Overall Study|Lost to Follow-up|0|||
126383421|NCT02517398|454696888|FG011|Overall Study|Lost to Follow-up|2|||
126383422|NCT02517398|454696889|FG012|Overall Study|Lost to Follow-up|2|||
126383423|NCT02517398|454696890|FG013|Overall Study|Lost to Follow-up|0|||
125886690|NCT02454517|452881817|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
126048552|NCT02111096|453475216|FG002|Overall Study|Withdrawal by Subject|8|||
126048553|NCT03709706|453475217|FG000|Overall Study|Adverse Event|0|||
126048554|NCT03709706|453475218|FG001|Overall Study|Adverse Event|1|||
126048555|NCT03709706|453475217|FG000|Overall Study|Physician Decision|14|||
126048556|NCT03709706|453475218|FG001|Overall Study|Physician Decision|8|||
126048557|NCT03709706|453475217|FG000|Overall Study|Withdrawal by Subject|2|||
126048558|NCT03709706|453475218|FG001|Overall Study|Withdrawal by Subject|1|||
126383424|NCT02517398|454696891|FG014|Overall Study|Lost to Follow-up|1|||
126383425|NCT02517398|454696892|FG015|Overall Study|Lost to Follow-up|1|||
126383426|NCT02517398|454696893|FG016|Overall Study|Lost to Follow-up|0|||
126383427|NCT02517398|454696894|FG017|Overall Study|Lost to Follow-up|3|||
126383428|NCT02517398|454696895|FG018|Overall Study|Lost to Follow-up|1|||
126383429|NCT02517398|454696896|FG019|Overall Study|Lost to Follow-up|0|||
126383430|NCT02517398|454696897|FG020|Overall Study|Lost to Follow-up|1|||
126383431|NCT02517398|454696898|FG021|Overall Study|Lost to Follow-up|0|||
126383432|NCT02517398|454696899|FG022|Overall Study|Lost to Follow-up|2|||
126383433|NCT02517398|454696877|FG000|Overall Study|Withdrew Consent|0|||
126383434|NCT02517398|454696878|FG001|Overall Study|Withdrew Consent|0|||
126383435|NCT02517398|454696879|FG002|Overall Study|Withdrew Consent|0|||
126383436|NCT02517398|454696880|FG003|Overall Study|Withdrew Consent|0|||
126383437|NCT02517398|454696881|FG004|Overall Study|Withdrew Consent|0|||
126383438|NCT02517398|454696882|FG005|Overall Study|Withdrew Consent|0|||
126383439|NCT02517398|454696883|FG006|Overall Study|Withdrew Consent|1|||
126383440|NCT02517398|454696884|FG007|Overall Study|Withdrew Consent|0|||
126383441|NCT02517398|454696885|FG008|Overall Study|Withdrew Consent|0|||
126383442|NCT02517398|454696886|FG009|Overall Study|Withdrew Consent|2|||
126383443|NCT02517398|454696887|FG010|Overall Study|Withdrew Consent|7|||
126383444|NCT02517398|454696888|FG011|Overall Study|Withdrew Consent|1|||
126383445|NCT02517398|454696889|FG012|Overall Study|Withdrew Consent|5|||
126383446|NCT02517398|454696890|FG013|Overall Study|Withdrew Consent|4|||
126383447|NCT02517398|454696891|FG014|Overall Study|Withdrew Consent|2|||
126383448|NCT02517398|454696892|FG015|Overall Study|Withdrew Consent|5|||
126383449|NCT02517398|454696893|FG016|Overall Study|Withdrew Consent|4|||
126383450|NCT02517398|454696894|FG017|Overall Study|Withdrew Consent|2|||
126383451|NCT02517398|454696895|FG018|Overall Study|Withdrew Consent|3|||
126383452|NCT02517398|454696896|FG019|Overall Study|Withdrew Consent|2|||
126383453|NCT02517398|454696897|FG020|Overall Study|Withdrew Consent|9|||
126383454|NCT02517398|454696898|FG021|Overall Study|Withdrew Consent|3|||
126383455|NCT02517398|454696899|FG022|Overall Study|Withdrew Consent|1|||
126383456|NCT00005947|454696900|FG000|Overall Study|Death|54|||
126383457|NCT00005947|454696901|FG001|Overall Study|Death|40|||
126383458|NCT00005947|454696900|FG000|Overall Study|Patient Refused to Continue|2|||
126383459|NCT00005947|454696901|FG001|Overall Study|Patient Refused to Continue|1|||
126383460|NCT00005947|454696900|FG000|Overall Study|Site Closure|1|||
126383461|NCT00005947|454696901|FG001|Overall Study|Site Closure|0|||
126383462|NCT00556439|454696917|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
126383463|NCT00556439|454696918|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
126383464|NCT00556439|454696919|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
126383465|NCT00556439|454696920|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
126383466|NCT00556439|454696917|FG000|Study Entry to Week 12|Physician Decision|1|||
126383467|NCT00556439|454696918|FG001|Study Entry to Week 12|Physician Decision|0|||
126383468|NCT00556439|454696919|FG002|Study Entry to Week 12|Physician Decision|0|||
126383469|NCT00556439|454696920|FG003|Study Entry to Week 12|Physician Decision|0|||
126383470|NCT00556439|454696917|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
126383471|NCT00556439|454696918|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
126383472|NCT00556439|454696919|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
126383473|NCT00556439|454696920|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
126383474|NCT00556439|454696917|FG000|Study Entry to Week 12|Recurrent infection|1|||
126383475|NCT00556439|454696918|FG001|Study Entry to Week 12|Recurrent infection|0|||
126383476|NCT00556439|454696919|FG002|Study Entry to Week 12|Recurrent infection|0|||
126383477|NCT00556439|454696920|FG003|Study Entry to Week 12|Recurrent infection|0|||
126383478|NCT00556439|454696917|FG000|Study Entry to Week 12|Malignancy|0|||
126383479|NCT00556439|454696918|FG001|Study Entry to Week 12|Malignancy|0|||
126383480|NCT00556439|454696919|FG002|Study Entry to Week 12|Malignancy|1|||
126383481|NCT00556439|454696920|FG003|Study Entry to Week 12|Malignancy|0|||
126383482|NCT00556439|454696917|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
126383483|NCT00556439|454696918|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
126383484|NCT00556439|454696919|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
126383485|NCT00556439|454696920|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
126383486|NCT00556439|454696917|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
126383487|NCT00556439|454696918|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
126383488|NCT00556439|454696919|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
126383489|NCT00556439|454696920|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
126383490|NCT00556439|454696917|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
126383491|NCT00556439|454696918|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
126383492|NCT00556439|454696919|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
126383493|NCT00556439|454696920|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
126383494|NCT00556439|454696917|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
126383495|NCT00556439|454696918|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
126383496|NCT00556439|454696919|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
126383497|NCT00556439|454696920|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
126383498|NCT02100423|454696921|FG000|Overall Study|Death|1|||
126383499|NCT02100423|454696921|FG000|Overall Study|Withdrawal by Subject|3|||
126383500|NCT02100423|454696921|FG000|Overall Study|Adverse Event|1|||
126383501|NCT02100423|454696921|FG000|Overall Study|Physician Decision|1|||
126383502|NCT02931838|454696922|FG000|Overall Study|Reason not provided by investigator|1|||
126383503|NCT02931838|454696923|FG001|Overall Study|Reason not provided by investigator|0|||
126383504|NCT02931838|454696924|FG002|Overall Study|Reason not provided by investigator|1|||
126383505|NCT02931838|454696925|FG003|Overall Study|Reason not provided by investigator|0|||
126383506|NCT02931838|454696926|FG004|Overall Study|Reason not provided by investigator|0|||
126383507|NCT02931838|454696927|FG005|Overall Study|Reason not provided by investigator|0|||
126383508|NCT02931838|454696922|FG000|Overall Study|Poor/non-compliance|0|||
126383509|NCT02931838|454696923|FG001|Overall Study|Poor/non-compliance|0|||
126383510|NCT02931838|454696924|FG002|Overall Study|Poor/non-compliance|1|||
126383511|NCT02931838|454696925|FG003|Overall Study|Poor/non-compliance|0|||
126383512|NCT02931838|454696926|FG004|Overall Study|Poor/non-compliance|0|||
126383513|NCT02931838|454696927|FG005|Overall Study|Poor/non-compliance|0|||
126383514|NCT02931838|454696922|FG000|Overall Study|Lack of Efficacy|5|||
126383515|NCT02931838|454696923|FG001|Overall Study|Lack of Efficacy|4|||
126383516|NCT02931838|454696924|FG002|Overall Study|Lack of Efficacy|0|||
126383517|NCT02931838|454696925|FG003|Overall Study|Lack of Efficacy|0|||
126383518|NCT02931838|454696926|FG004|Overall Study|Lack of Efficacy|0|||
126383519|NCT02931838|454696927|FG005|Overall Study|Lack of Efficacy|1|||
126383520|NCT02931838|454696922|FG000|Overall Study|Lost to Follow-up|1|||
126383521|NCT02931838|454696923|FG001|Overall Study|Lost to Follow-up|0|||
126383522|NCT02931838|454696924|FG002|Overall Study|Lost to Follow-up|1|||
126383523|NCT02931838|454696925|FG003|Overall Study|Lost to Follow-up|1|||
126383524|NCT02931838|454696926|FG004|Overall Study|Lost to Follow-up|2|||
126383525|NCT02931838|454696927|FG005|Overall Study|Lost to Follow-up|0|||
126383526|NCT02931838|454696922|FG000|Overall Study|Subject request to discontinue treatment|4|||
126383527|NCT02931838|454696923|FG001|Overall Study|Subject request to discontinue treatment|3|||
126383528|NCT02931838|454696924|FG002|Overall Study|Subject request to discontinue treatment|3|||
126383529|NCT02931838|454696925|FG003|Overall Study|Subject request to discontinue treatment|0|||
126383530|NCT02931838|454696926|FG004|Overall Study|Subject request to discontinue treatment|1|||
126383531|NCT02931838|454696927|FG005|Overall Study|Subject request to discontinue treatment|0|||
126383532|NCT02931838|454696922|FG000|Overall Study|Withdrawal by Subject|1|||
126383533|NCT02931838|454696923|FG001|Overall Study|Withdrawal by Subject|2|||
126383534|NCT02931838|454696924|FG002|Overall Study|Withdrawal by Subject|0|||
126383535|NCT02931838|454696925|FG003|Overall Study|Withdrawal by Subject|1|||
126383536|NCT02931838|454696926|FG004|Overall Study|Withdrawal by Subject|0|||
126383537|NCT02931838|454696927|FG005|Overall Study|Withdrawal by Subject|0|||
126383538|NCT02931838|454696922|FG000|Overall Study|Adverse Event|2|||
126383539|NCT02931838|454696923|FG001|Overall Study|Adverse Event|1|||
126383540|NCT02931838|454696924|FG002|Overall Study|Adverse Event|2|||
126383541|NCT02931838|454696925|FG003|Overall Study|Adverse Event|1|||
126383542|NCT02931838|454696926|FG004|Overall Study|Adverse Event|3|||
126383543|NCT02931838|454696927|FG005|Overall Study|Adverse Event|1|||
126383544|NCT02701764|454696928|FG000|Overall Study|Lost to Follow-up|0|||
126383545|NCT02701764|454696929|FG001|Overall Study|Lost to Follow-up|1|||
126383546|NCT02949024|454696932|FG000|Overall Study|Withdrawal by Subject|0|||
126383547|NCT02949024|454696933|FG001|Overall Study|Withdrawal by Subject|1|||
126383548|NCT01027650|454696934|FG000|Overall Study|Personal Reasons|0|||
126383549|NCT01027650|454696935|FG001|Overall Study|Personal Reasons|0|||
126383550|NCT01027650|454696936|FG002|Overall Study|Personal Reasons|0|||
126383551|NCT01027650|454696937|FG003|Overall Study|Personal Reasons|0|||
126383552|NCT01027650|454696938|FG004|Overall Study|Personal Reasons|2|||
126383553|NCT01027650|454696939|FG005|Overall Study|Personal Reasons|1|||
126383554|NCT01027650|454696940|FG006|Overall Study|Personal Reasons|0|||
126383555|NCT01027650|454696941|FG007|Overall Study|Personal Reasons|0|||
126383556|NCT01027650|454696934|FG000|Overall Study|Lost to Follow-up|0|||
126383557|NCT01027650|454696935|FG001|Overall Study|Lost to Follow-up|0|||
126383558|NCT01027650|454696936|FG002|Overall Study|Lost to Follow-up|0|||
126383559|NCT01027650|454696937|FG003|Overall Study|Lost to Follow-up|0|||
126383560|NCT01027650|454696938|FG004|Overall Study|Lost to Follow-up|0|||
126383561|NCT01027650|454696939|FG005|Overall Study|Lost to Follow-up|0|||
126383562|NCT01027650|454696940|FG006|Overall Study|Lost to Follow-up|1|||
126383563|NCT01027650|454696941|FG007|Overall Study|Lost to Follow-up|0|||
126383564|NCT01027650|454696934|FG000|Overall Study|Lack of Efficacy|0|||
126383565|NCT01027650|454696935|FG001|Overall Study|Lack of Efficacy|0|||
126383566|NCT01027650|454696936|FG002|Overall Study|Lack of Efficacy|0|||
126383567|NCT01027650|454696937|FG003|Overall Study|Lack of Efficacy|0|||
126383568|NCT01027650|454696938|FG004|Overall Study|Lack of Efficacy|0|||
126383569|NCT01027650|454696939|FG005|Overall Study|Lack of Efficacy|1|||
126383570|NCT01027650|454696940|FG006|Overall Study|Lack of Efficacy|0|||
126383571|NCT01027650|454696941|FG007|Overall Study|Lack of Efficacy|0|||
125886691|NCT02454517|452881818|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
126048559|NCT03709706|453475217|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
126383572|NCT00912782|454696942|FG000|Overall Study|Death|2|||
126383573|NCT00912782|454696943|FG001|Overall Study|Death|1|||
126383574|NCT00912782|454696942|FG000|Overall Study|Lost to Follow-up|0|||
126383575|NCT00912782|454696943|FG001|Overall Study|Lost to Follow-up|1|||
126383576|NCT00912782|454696942|FG000|Overall Study|Did not receive vascular access type|1|||
126383577|NCT00912782|454696943|FG001|Overall Study|Did not receive vascular access type|2|||
126383578|NCT00912782|454696942|FG000|Overall Study|Relocated before study completion|0|||
126383579|NCT00912782|454696943|FG001|Overall Study|Relocated before study completion|1|||
126383580|NCT00283803|454698786|FG000|Overall Study|Physician Decision|9|||
126383581|NCT00283803|454698786|FG000|Overall Study|Withdrawal by Subject|4|||
126383582|NCT01127607|454698787|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
126383583|NCT01127607|454698788|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
126383584|NCT01127607|454698787|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
126383585|NCT01127607|454698788|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
126383586|NCT02220855|454698789|FG000|Overall Study|Adverse Event|8|||
126383587|NCT02220855|454698789|FG000|Overall Study|Disease Progression|5|||
126383588|NCT02220855|454698789|FG000|Overall Study|Withdrawal by Subject|1|||
126383589|NCT03419897|454698790|FG000|Overall Study|Death|180|||
126383590|NCT03419897|454698790|FG000|Overall Study|Lost to Follow-up|1|||
126383591|NCT03419897|454698790|FG000|Overall Study|Withdrawal by Subject|6|||
126383592|NCT03419897|454698790|FG000|Overall Study|Sponsor Decision|61|||
126383593|NCT03419897|454698790|FG000|Overall Study|Physician Decision|1|||
126383594|NCT00958360|454698798|FG000|Overall Study|Withdrawal by Subject|3|||
126383595|NCT00958360|454698799|FG001|Overall Study|Withdrawal by Subject|1|||
126383596|NCT00958360|454698798|FG000|Overall Study|Death|6|||
126383597|NCT00958360|454698799|FG001|Overall Study|Death|7|||
126383598|NCT00958360|454698798|FG000|Overall Study|Physician Decision|2|||
126383599|NCT00958360|454698799|FG001|Overall Study|Physician Decision|1|||
126383600|NCT00958360|454698798|FG000|Overall Study|Lost to Follow-up|0|||
126383601|NCT00958360|454698799|FG001|Overall Study|Lost to Follow-up|1|||
126383602|NCT02719691|454698800|FG000|Overall Study|Physician Decision|0|||
126383603|NCT02719691|454698801|FG001|Overall Study|Physician Decision|0|||
126383604|NCT02719691|454698802|FG002|Overall Study|Physician Decision|1|||
126383605|NCT02719691|454698803|FG003|Overall Study|Physician Decision|0|||
126383606|NCT02719691|454698804|FG004|Overall Study|Physician Decision|0|||
126383607|NCT02719691|454698805|FG005|Overall Study|Physician Decision|0|||
126383608|NCT02719691|454698806|FG006|Overall Study|Physician Decision|0|||
126383609|NCT02719691|454698800|FG000|Overall Study|Withdrawal by Subject|0|||
126383610|NCT02719691|454698801|FG001|Overall Study|Withdrawal by Subject|0|||
126383611|NCT02719691|454698802|FG002|Overall Study|Withdrawal by Subject|0|||
126383612|NCT02719691|454698803|FG003|Overall Study|Withdrawal by Subject|0|||
126383613|NCT02719691|454698804|FG004|Overall Study|Withdrawal by Subject|0|||
126383614|NCT02719691|454698805|FG005|Overall Study|Withdrawal by Subject|1|||
126383615|NCT02719691|454698806|FG006|Overall Study|Withdrawal by Subject|0|||
126383616|NCT00336284|454698807|FG000|Overall Study|Death|52|||
126383617|NCT00336284|454698808|FG001|Overall Study|Death|26|||
126383618|NCT00336284|454698807|FG000|Overall Study|Lost to Follow-up|82|||
126383619|NCT00336284|454698808|FG001|Overall Study|Lost to Follow-up|61|||
126383620|NCT00336284|454698807|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
126383621|NCT00336284|454698808|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
126383622|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
126383623|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
126383624|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
126383625|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
126383626|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
126383627|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
126383628|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
126383629|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
126383630|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
126383631|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
126383632|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
126383633|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
126383634|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
126383635|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
126383636|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
126383637|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
126383638|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
126383639|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
126383640|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
125886692|NCT00473382|452881819|FG000|Core Study|Adverse Event|3|||
126383641|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
126383642|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
126383643|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
126383644|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
126383645|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
126383646|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
126383647|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
126383648|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
126383649|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
126383650|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
126383651|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
126383652|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
126383653|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
126383654|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
125886693|NCT00473382|452881820|FG001|Core Study|Adverse Event|1|||
126048560|NCT03709706|453475218|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
126383655|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
126383656|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
126383657|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
126383658|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
126383659|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
126383660|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
126383661|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
126383662|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
126383663|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
126383664|NCT01961297|454698821|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
126383665|NCT01961297|454698822|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
126383666|NCT02141633|454698823|FG000|Overall Study|Physician Decision|1|||
126383667|NCT02141633|454698824|FG001|Overall Study|Physician Decision|0|||
126383668|NCT02482298|454698825|FG000|Overall Study|Withdrawal by Subject|2|||
126383669|NCT02482298|454698826|FG001|Overall Study|Withdrawal by Subject|1|||
126383670|NCT02482298|454698827|FG002|Overall Study|Withdrawal by Subject|2|||
126383671|NCT02482298|454698825|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
126383672|NCT02482298|454698826|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
126383673|NCT02482298|454698827|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
126383674|NCT02482298|454698825|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
126383675|NCT02482298|454698826|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
126383676|NCT02482298|454698827|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
126383677|NCT02482298|454698825|FG000|Overall Study|Lost to Follow-up|0|||
126383678|NCT02482298|454698826|FG001|Overall Study|Lost to Follow-up|1|||
126383679|NCT02482298|454698827|FG002|Overall Study|Lost to Follow-up|0|||
126383680|NCT01188551|454698832|FG000|Overall Study|Pharmacy issues|1|||
126383681|NCT01188551|454698833|FG001|Overall Study|Pharmacy issues|0|||
126383682|NCT01188551|454698834|FG002|Overall Study|Pharmacy issues|0|||
126383683|NCT01188551|454698835|FG003|Overall Study|Pharmacy issues|0|||
126383684|NCT03782259|454698838|FG000|Overall Study|Lost to Follow-up|1|||
126383685|NCT03782259|454698839|FG001|Overall Study|Lost to Follow-up|1|||
126383686|NCT03782259|454698838|FG000|Overall Study|Moved out of state|0|||
126383687|NCT03782259|454698839|FG001|Overall Study|Moved out of state|2|||
126383688|NCT03782259|454698838|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
126383689|NCT03782259|454698839|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
126383690|NCT03782259|454698838|FG000|Overall Study|Subject discontinued intervention|1|||
126383691|NCT03782259|454698839|FG001|Overall Study|Subject discontinued intervention|0|||
126383692|NCT00603941|454698840|FG000|Overall Study|Disease progression|6|||
126383693|NCT00603941|454698841|FG001|Overall Study|Disease progression|7|||
126383694|NCT00603941|454698842|FG002|Overall Study|Disease progression|1|||
126383695|NCT00603941|454698840|FG000|Overall Study|Adverse Event|1|||
126383696|NCT00603941|454698841|FG001|Overall Study|Adverse Event|0|||
126383697|NCT00603941|454698842|FG002|Overall Study|Adverse Event|1|||
126383698|NCT00603941|454698840|FG000|Overall Study|Physician Decision|0|||
126383699|NCT00603941|454698841|FG001|Overall Study|Physician Decision|1|||
126383700|NCT00603941|454698842|FG002|Overall Study|Physician Decision|0|||
126383701|NCT00603941|454698840|FG000|Overall Study|Withdrawal by Subject|0|||
126383702|NCT00603941|454698841|FG001|Overall Study|Withdrawal by Subject|2|||
126383703|NCT00603941|454698842|FG002|Overall Study|Withdrawal by Subject|0|||
126383704|NCT05069597|454698843|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126383705|NCT05069597|454698844|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
126383706|NCT05507567|454698845|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
126383707|NCT05507567|454698846|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
126383708|NCT05507567|454698847|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
126383709|NCT05507567|454698845|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
126383710|NCT05507567|454698846|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
126383711|NCT05507567|454698847|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
126383712|NCT05507567|454698845|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
126383713|NCT05507567|454698846|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
126383714|NCT05507567|454698847|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
126383715|NCT05507567|454698845|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
126383716|NCT05507567|454698846|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
126383717|NCT05507567|454698847|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
126383718|NCT00375427|454698848|FG000|Overall Study|Adverse Event|21|||
126383719|NCT00375427|454698849|FG001|Overall Study|Adverse Event|27|||
126383720|NCT00375427|454698848|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126383721|NCT00375427|454698849|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126383722|NCT00375427|454698848|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126383723|NCT00375427|454698849|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126383724|NCT00375427|454698848|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126383725|NCT00375427|454698849|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126383726|NCT00375427|454698848|FG000|Overall Study|Patient no longer requires study drug|3|||
126383727|NCT00375427|454698849|FG001|Overall Study|Patient no longer requires study drug|7|||
126383728|NCT00375427|454698848|FG000|Overall Study|Protocol Violation|10|||
126383729|NCT00375427|454698849|FG001|Overall Study|Protocol Violation|8|||
126383730|NCT00375427|454698848|FG000|Overall Study|Withdrawal by Subject|9|||
126383731|NCT00375427|454698849|FG001|Overall Study|Withdrawal by Subject|13|||
126383732|NCT00375427|454698848|FG000|Overall Study|Lost to Follow-up|1|||
126383733|NCT00375427|454698849|FG001|Overall Study|Lost to Follow-up|1|||
126383734|NCT00375427|454698848|FG000|Overall Study|Administrative reasons|0|||
126383735|NCT00375427|454698849|FG001|Overall Study|Administrative reasons|1|||
126383736|NCT00375427|454698848|FG000|Overall Study|Death|11|||
126383737|NCT00375427|454698849|FG001|Overall Study|Death|10|||
126383738|NCT00606411|454698853|FG000|Overall Study|Adverse Event|1|||
126383739|NCT00606411|454698854|FG001|Overall Study|Adverse Event|2|||
126383740|NCT00606411|454698853|FG000|Overall Study|Lack of Adherence|1|||
126383741|NCT00606411|454698854|FG001|Overall Study|Lack of Adherence|1|||
126383742|NCT00606411|454698853|FG000|Overall Study|Lack of Efficacy|1|||
126383743|NCT00606411|454698854|FG001|Overall Study|Lack of Efficacy|1|||
126383744|NCT00606411|454698853|FG000|Overall Study|Withdrawal by Subject|2|||
126383745|NCT00606411|454698854|FG001|Overall Study|Withdrawal by Subject|0|||
126383746|NCT00606411|454698853|FG000|Overall Study|Lost to Follow-up|1|||
126383747|NCT00606411|454698854|FG001|Overall Study|Lost to Follow-up|2|||
126383748|NCT00606411|454698853|FG000|Overall Study|Move out of state|0|||
126383749|NCT00606411|454698854|FG001|Overall Study|Move out of state|1|||
126383750|NCT03726658|454698855|FG000|Overall Study|Lost to Follow-up|0|||
126383751|NCT03726658|454698856|FG001|Overall Study|Lost to Follow-up|0|||
126383752|NCT03726658|454698857|FG002|Overall Study|Lost to Follow-up|2|||
126383753|NCT03726658|454698858|FG003|Overall Study|Lost to Follow-up|0|||
126383754|NCT03726658|454698859|FG004|Overall Study|Lost to Follow-up|0|||
126383755|NCT03726658|454698860|FG005|Overall Study|Lost to Follow-up|1|||
126383756|NCT03726658|454698861|FG006|Overall Study|Lost to Follow-up|1|||
126383757|NCT03726658|454698855|FG000|Overall Study|Withdrawal by Subject|1|||
126383758|NCT03726658|454698856|FG001|Overall Study|Withdrawal by Subject|0|||
126383759|NCT03726658|454698857|FG002|Overall Study|Withdrawal by Subject|0|||
126383760|NCT03726658|454698858|FG003|Overall Study|Withdrawal by Subject|0|||
126383761|NCT03726658|454698859|FG004|Overall Study|Withdrawal by Subject|6|||
126383762|NCT03726658|454698860|FG005|Overall Study|Withdrawal by Subject|4|||
126383763|NCT03726658|454698861|FG006|Overall Study|Withdrawal by Subject|2|||
126048561|NCT01627561|453475219|FG000|Overall Study|Lost to Follow-up|1|||
126048562|NCT01627561|453475220|FG001|Overall Study|Lost to Follow-up|0|||
126048563|NCT01627561|453475219|FG000|Overall Study|Withdrawal by Subject|0|||
126048564|NCT01627561|453475220|FG001|Overall Study|Withdrawal by Subject|1|||
126048565|NCT01627561|453475219|FG000|Overall Study|Migrated/moved from study area|0|||
126048566|NCT01627561|453475220|FG001|Overall Study|Migrated/moved from study area|2|||
126048567|NCT02797132|453475221|FG000|Part A (15 Days)|Adverse Event|1|||
126048568|NCT02797132|453475221|FG000|Part B (24 Weeks)|Adverse Event|3|||
126048569|NCT01970007|453475222|FG000|Overall Study|Death|5|||
126048570|NCT01970007|453475222|FG000|Overall Study|Withdrawal by Subject|23|||
126048571|NCT01970007|453475222|FG000|Overall Study|Lost to Follow-up|24|||
126104184|NCT03057977|453675822|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
126383764|NCT03726658|454698855|FG000|Overall Study|Pregnancy|0|||
126383765|NCT03726658|454698856|FG001|Overall Study|Pregnancy|0|||
126383766|NCT03726658|454698857|FG002|Overall Study|Pregnancy|0|||
126383767|NCT03726658|454698858|FG003|Overall Study|Pregnancy|0|||
126383768|NCT03726658|454698859|FG004|Overall Study|Pregnancy|0|||
126383769|NCT03726658|454698860|FG005|Overall Study|Pregnancy|0|||
125886694|NCT00473382|452881821|FG002|Core Study|Adverse Event|1|||
126048572|NCT01970007|453475222|FG000|Overall Study|"Other endpoint"|3|||
126104185|NCT03057977|453675821|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
126383770|NCT03726658|454698861|FG006|Overall Study|Pregnancy|1|||
126383771|NCT03726658|454698855|FG000|Overall Study|Not Reported|0|||
126383772|NCT03726658|454698856|FG001|Overall Study|Not Reported|0|||
126383773|NCT03726658|454698857|FG002|Overall Study|Not Reported|0|||
126383774|NCT03726658|454698858|FG003|Overall Study|Not Reported|0|||
126104186|NCT03057977|453675822|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
126383775|NCT03726658|454698859|FG004|Overall Study|Not Reported|0|||
126383776|NCT03726658|454698860|FG005|Overall Study|Not Reported|0|||
126383777|NCT03726658|454698861|FG006|Overall Study|Not Reported|1|||
126383778|NCT00412958|454698862|FG000|Overall Study|Withdrawal by Subject|3|||
126383779|NCT00412958|454698863|FG001|Overall Study|Withdrawal by Subject|0|||
126383780|NCT00412958|454698864|FG002|Overall Study|Withdrawal by Subject|0|||
126383781|NCT00412958|454698865|FG003|Overall Study|Withdrawal by Subject|1|||
126383782|NCT00412958|454698862|FG000|Overall Study|Adverse Event|0|||
126383783|NCT00412958|454698863|FG001|Overall Study|Adverse Event|1|||
126383784|NCT00412958|454698864|FG002|Overall Study|Adverse Event|0|||
126383785|NCT00412958|454698865|FG003|Overall Study|Adverse Event|0|||
126383786|NCT00412958|454698862|FG000|Overall Study|Lost to Follow-up|0|||
126383787|NCT00412958|454698863|FG001|Overall Study|Lost to Follow-up|1|||
126383788|NCT00412958|454698864|FG002|Overall Study|Lost to Follow-up|0|||
126383789|NCT00412958|454698865|FG003|Overall Study|Lost to Follow-up|0|||
126383790|NCT00412958|454698862|FG000|Overall Study|Death|0|||
126383791|NCT00412958|454698863|FG001|Overall Study|Death|1|||
126383792|NCT00412958|454698864|FG002|Overall Study|Death|0|||
126383793|NCT00412958|454698865|FG003|Overall Study|Death|0|||
126383794|NCT00412958|454698862|FG000|Overall Study|Transport issue|0|||
126383795|NCT00412958|454698863|FG001|Overall Study|Transport issue|1|||
126383796|NCT00412958|454698864|FG002|Overall Study|Transport issue|0|||
126383797|NCT00412958|454698865|FG003|Overall Study|Transport issue|0|||
126383798|NCT01318135|454698866|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
126383799|NCT01318135|454698867|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383800|NCT01318135|454698868|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383801|NCT01318135|454698869|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383802|NCT01318135|454698870|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383803|NCT01318135|454698871|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383804|NCT01318135|454698872|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383805|NCT01318135|454698873|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383806|NCT01318135|454698866|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
126383807|NCT01318135|454698867|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383808|NCT01318135|454698868|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383809|NCT01318135|454698869|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383810|NCT01318135|454698870|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383811|NCT01318135|454698871|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383812|NCT01318135|454698872|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383813|NCT01318135|454698873|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383814|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
126383815|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
126383816|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
126383817|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
126383818|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
126383819|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
126383820|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
126383821|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
126383822|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
126383823|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
126383824|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383825|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383826|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
126383827|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383828|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383829|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383830|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126383831|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126383832|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126383833|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126383834|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126383835|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126383836|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126383837|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126383838|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
126383839|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
126383840|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
126383841|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
126383842|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
126383843|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
126383844|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126383845|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126383846|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383847|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383848|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383849|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383850|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383851|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383852|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383853|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
126383854|NCT00090779|454698874|FG000|Step 1|Withdrawal by Subject|4|||
126383855|NCT00090779|454698875|FG001|Step 1|Withdrawal by Subject|2|||
126383856|NCT00090779|454698874|FG000|Step 1|Lost to Follow-up|3|||
126383857|NCT00090779|454698875|FG001|Step 1|Lost to Follow-up|2|||
126383858|NCT00090779|454698874|FG000|Step 1|Death|0|||
126383859|NCT00090779|454698875|FG001|Step 1|Death|2|||
126383860|NCT00090779|454698874|FG000|Step 1|Physician Decision|1|||
126383861|NCT00090779|454698875|FG001|Step 1|Physician Decision|0|||
126383862|NCT00090779|454698874|FG000|Step 1|Pregnancy|1|||
126383863|NCT00090779|454698875|FG001|Step 1|Pregnancy|0|||
126383864|NCT00090779|454698874|FG000|Step 1|Non-compliance to study requirements|0|||
126383865|NCT00090779|454698875|FG001|Step 1|Non-compliance to study requirements|1|||
126383866|NCT00090779|454698874|FG000|Step 1|Subject relocated|2|||
126383867|NCT00090779|454698875|FG001|Step 1|Subject relocated|8|||
126383868|NCT00090779|454698874|FG000|Step 2|Off study per study closure|6|||
126383869|NCT00090779|454698875|FG001|Step 2|Off study per study closure|16|||
126383870|NCT00090779|454698874|FG000|Step 2|Subject relocated|0|||
126383871|NCT00090779|454698875|FG001|Step 2|Subject relocated|1|||
126383872|NCT00090779|454698874|FG000|Step 2|Non-compliance to study requirements|0|||
126383873|NCT00090779|454698875|FG001|Step 2|Non-compliance to study requirements|1|||
126383874|NCT00090779|454698874|FG000|Step 3|Initiation of ART and off extended study|3|||
126383875|NCT00090779|454698875|FG001|Step 3|Initiation of ART and off extended study|2|||
126383876|NCT00090779|454698874|FG000|Step 3|Off extended study due to study closure|4|||
126383877|NCT00090779|454698875|FG001|Step 3|Off extended study due to study closure|3|||
126383878|NCT03012828|454698884|FG000|Overall Study|Lost to Follow-up|1|||
126383879|NCT03012828|454698885|FG001|Overall Study|Lost to Follow-up|0|||
126383880|NCT03012828|454698886|FG002|Overall Study|Lost to Follow-up|1|||
126383881|NCT03012828|454698887|FG003|Overall Study|Lost to Follow-up|0|||
126383882|NCT03012828|454698888|FG004|Overall Study|Lost to Follow-up|1|||
126383883|NCT03012828|454698889|FG005|Overall Study|Lost to Follow-up|0|||
126383884|NCT03012828|454698884|FG000|Overall Study|Withdrawal by Subject|0|||
126383885|NCT03012828|454698885|FG001|Overall Study|Withdrawal by Subject|0|||
126383886|NCT03012828|454698886|FG002|Overall Study|Withdrawal by Subject|1|||
126383887|NCT03012828|454698887|FG003|Overall Study|Withdrawal by Subject|0|||
126383888|NCT03012828|454698888|FG004|Overall Study|Withdrawal by Subject|0|||
126383889|NCT03012828|454698889|FG005|Overall Study|Withdrawal by Subject|1|||
126383890|NCT03012828|454698884|FG000|Overall Study|Non-compliance with protocol|0|||
126383891|NCT03012828|454698885|FG001|Overall Study|Non-compliance with protocol|0|||
126383892|NCT03012828|454698886|FG002|Overall Study|Non-compliance with protocol|0|||
126383893|NCT03012828|454698887|FG003|Overall Study|Non-compliance with protocol|0|||
126383894|NCT03012828|454698888|FG004|Overall Study|Non-compliance with protocol|1|||
126383895|NCT03012828|454698889|FG005|Overall Study|Non-compliance with protocol|0|||
126383896|NCT03012828|454698884|FG000|Overall Study|Delay to last visit would delay DBL|0|||
126383897|NCT03012828|454698885|FG001|Overall Study|Delay to last visit would delay DBL|0|||
126383898|NCT03012828|454698886|FG002|Overall Study|Delay to last visit would delay DBL|0|||
126383899|NCT03012828|454698887|FG003|Overall Study|Delay to last visit would delay DBL|0|||
126383900|NCT03012828|454698888|FG004|Overall Study|Delay to last visit would delay DBL|0|||
126383901|NCT03012828|454698889|FG005|Overall Study|Delay to last visit would delay DBL|1|||
126383902|NCT04396795|454698894|FG000|Month 1|Lost to Follow-up|2|||
126383903|NCT04396795|454698895|FG001|Month 1|Lost to Follow-up|3|||
126383904|NCT04396795|454698894|FG000|Month 3|Lost to Follow-up|1|||
126383905|NCT04396795|454698895|FG001|Month 3|Lost to Follow-up|3|||
126383906|NCT04396795|454698894|FG000|Month 6|Lost to Follow-up|3|||
126383907|NCT04396795|454698895|FG001|Month 6|Lost to Follow-up|3|||
126383908|NCT03472495|454698899|FG000|Overall Study|Treatment no longer indicated|1|||
126383909|NCT03472495|454698900|FG001|Overall Study|Treatment no longer indicated|2|||
126383910|NCT03472495|454698899|FG000|Overall Study|Physician Decision|0|||
126383911|NCT03472495|454698900|FG001|Overall Study|Physician Decision|2|||
126383912|NCT01107392|454698901|FG000|Overall Study|Adverse Event|2|||
126383913|NCT01107392|454698902|FG001|Overall Study|Adverse Event|0|||
126383914|NCT01107392|454698901|FG000|Overall Study|Personal Reasons|2|||
126383915|NCT01107392|454698902|FG001|Overall Study|Personal Reasons|3|||
126383916|NCT01107392|454698901|FG000|Overall Study|Administrative decision|1|||
126383917|NCT01107392|454698902|FG001|Overall Study|Administrative decision|0|||
126383918|NCT02998671|454698906|FG000|Period 1|Study Terminated By Sponsor|2|||
126383919|NCT02998671|454698907|FG001|Period 1|Study Terminated By Sponsor|1|||
126383920|NCT02998671|454698908|FG002|Period 1|Study Terminated By Sponsor|0|||
126383921|NCT02998671|454698909|FG003|Period 1|Study Terminated By Sponsor|0|||
126383922|NCT02998671|454698910|FG004|Period 1|Study Terminated By Sponsor|1|||
126383923|NCT02998671|454698906|FG000|Period 1|Withdrawal by Subject|1|||
126383924|NCT02998671|454698907|FG001|Period 1|Withdrawal by Subject|2|||
126383925|NCT02998671|454698908|FG002|Period 1|Withdrawal by Subject|0|||
126383926|NCT02998671|454698909|FG003|Period 1|Withdrawal by Subject|0|||
126383927|NCT02998671|454698910|FG004|Period 1|Withdrawal by Subject|2|||
126048573|NCT00112359|453475226|FG000|Overall Study|Unrelated adverse event|16|||
126048574|NCT00112359|453475227|FG001|Overall Study|Unrelated adverse event|8|||
126048575|NCT00112359|453475226|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
126383928|NCT02998671|454698906|FG000|Period 1|Pregnancy|1|||
126383929|NCT02998671|454698907|FG001|Period 1|Pregnancy|0|||
126383930|NCT02998671|454698908|FG002|Period 1|Pregnancy|0|||
126383931|NCT02998671|454698909|FG003|Period 1|Pregnancy|0|||
126383932|NCT02998671|454698910|FG004|Period 1|Pregnancy|0|||
126383933|NCT02998671|454698906|FG000|Period 1|Adverse Event|0|||
126383934|NCT02998671|454698907|FG001|Period 1|Adverse Event|0|||
126383935|NCT02998671|454698908|FG002|Period 1|Adverse Event|0|||
126383936|NCT02998671|454698909|FG003|Period 1|Adverse Event|0|||
126383937|NCT02998671|454698910|FG004|Period 1|Adverse Event|1|||
126383938|NCT02998671|454698906|FG000|Period 2|Adverse Event|0|||
126383939|NCT02998671|454698907|FG001|Period 2|Adverse Event|1|||
126383940|NCT02998671|454698908|FG002|Period 2|Adverse Event|0|||
126383941|NCT02998671|454698909|FG003|Period 2|Adverse Event|0|||
126383942|NCT02998671|454698910|FG004|Period 2|Adverse Event|0|||
126383943|NCT02998671|454698906|FG000|Period 2|Study Terminated By Sponsor|3|||
126383944|NCT02998671|454698907|FG001|Period 2|Study Terminated By Sponsor|5|||
126383945|NCT02998671|454698908|FG002|Period 2|Study Terminated By Sponsor|1|||
126383946|NCT02998671|454698909|FG003|Period 2|Study Terminated By Sponsor|3|||
126383947|NCT02998671|454698910|FG004|Period 2|Study Terminated By Sponsor|0|||
126383948|NCT02998671|454698906|FG000|Period 2|Withdrawal by Subject|0|||
126383949|NCT02998671|454698907|FG001|Period 2|Withdrawal by Subject|1|||
126383950|NCT02998671|454698908|FG002|Period 2|Withdrawal by Subject|0|||
126383951|NCT02998671|454698909|FG003|Period 2|Withdrawal by Subject|0|||
126383952|NCT02998671|454698910|FG004|Period 2|Withdrawal by Subject|0|||
126383953|NCT02998671|454698906|FG000|Period 2|Lost to Follow-up|0|||
126383954|NCT02998671|454698907|FG001|Period 2|Lost to Follow-up|0|||
126383955|NCT02998671|454698908|FG002|Period 2|Lost to Follow-up|0|||
126383956|NCT02998671|454698909|FG003|Period 2|Lost to Follow-up|1|||
126383957|NCT02998671|454698910|FG004|Period 2|Lost to Follow-up|0|||
126383958|NCT02038946|454698912|FG000|Overall Study|Death|5|||
126383959|NCT02038946|454698912|FG000|Overall Study|Withdrawal by Subject|3|||
126383960|NCT02038946|454698912|FG000|Overall Study|Lost to Follow-up|2|||
126383961|NCT02038946|454698912|FG000|Overall Study|Other reasons|2|||
126383962|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
126383963|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
126383964|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
126383965|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
126383966|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
126383967|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
126383968|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
126383969|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
126383970|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
126383971|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
126383972|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
126383973|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
126383974|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
126383975|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
126383976|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
126383977|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
126383978|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
126383979|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
126383980|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
126383981|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
126383982|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
126383983|NCT03162796|454698914|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
126383984|NCT03162796|454698915|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
126383985|NCT03162796|454698916|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
126383986|NCT03162796|454698914|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
126383987|NCT03162796|454698915|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
126383988|NCT03162796|454698916|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
126383989|NCT03162796|454698914|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
126383990|NCT03162796|454698915|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
126383991|NCT03162796|454698916|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
126383992|NCT03162796|454698914|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
126383993|NCT03162796|454698915|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
126383994|NCT03162796|454698916|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
126383995|NCT02623205|454698917|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
126383996|NCT02623205|454698918|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
126383997|NCT02473471|454698919|FG000|Overall Study|poor oral hygiene|2|||
126383998|NCT02473471|454698919|FG000|Overall Study|Lost to Follow-up|1|||
126383999|NCT02342288|454698922|FG000|Overall Study|no protocol anesthesiologist available|3|||
126384000|NCT02342288|454698923|FG001|Overall Study|no protocol anesthesiologist available|2|||
126384001|NCT02342288|454698922|FG000|Overall Study|anesthesia leak in system|1|||
126384002|NCT02342288|454698923|FG001|Overall Study|anesthesia leak in system|0|||
126384003|NCT02342288|454698922|FG000|Overall Study|Withdrawal by Subject|1|||
126384004|NCT02342288|454698923|FG001|Overall Study|Withdrawal by Subject|0|||
126384005|NCT02342288|454698922|FG000|Overall Study|coordinator contaminated with blood|0|||
126384006|NCT02342288|454698923|FG001|Overall Study|coordinator contaminated with blood|1|||
126384007|NCT02342288|454698922|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
126384008|NCT02342288|454698923|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
126384009|NCT02342288|454698922|FG000|Overall Study|coordinator not available|0|||
126384010|NCT02342288|454698923|FG001|Overall Study|coordinator not available|2|||
126384011|NCT03082677|454698924|FG000|Overall Study|Not Treated|2|||
126384012|NCT01916824|454698929|FG000|Overall Study|Lost to Follow-up|3|||
126384013|NCT01916824|454698930|FG001|Overall Study|Lost to Follow-up|6|||
126384014|NCT01916824|454698929|FG000|Overall Study|Physician Decision|2|||
126384015|NCT01916824|454698930|FG001|Overall Study|Physician Decision|0|||
126384016|NCT01916824|454698929|FG000|Overall Study|Withdrawal by Subject|2|||
126384017|NCT01916824|454698930|FG001|Overall Study|Withdrawal by Subject|3|||
126384018|NCT02455336|454698936|FG000|Overall Study|Withdrawal by Subject|0|||
126384019|NCT02455336|454698937|FG001|Overall Study|Withdrawal by Subject|2|||
126384020|NCT02455336|454698936|FG000|Overall Study|Adverse Event|3|||
126384021|NCT02455336|454698937|FG001|Overall Study|Adverse Event|0|||
126384022|NCT02455336|454698936|FG000|Overall Study|Non-responder to treatment|2|||
126384023|NCT02455336|454698937|FG001|Overall Study|Non-responder to treatment|0|||
126384024|NCT02467192|454698938|FG000|Overall Study|Death|1|||
126384025|NCT02467192|454698938|FG000|Overall Study|revealed to have pneumonia before|2|||
126384026|NCT02195700|454698947|FG000|Overall Study|Protocol Violation|0|||
126384027|NCT02195700|454698948|FG001|Overall Study|Protocol Violation|2|||
126384028|NCT02195700|454698947|FG000|Overall Study|Noncompliance|1|||
126384029|NCT02195700|454698948|FG001|Overall Study|Noncompliance|0|||
126384030|NCT02195700|454698947|FG000|Overall Study|Adverse Event|1|||
126384031|NCT02195700|454698948|FG001|Overall Study|Adverse Event|2|||
126384032|NCT02195700|454698947|FG000|Overall Study|Withdrawal by Subject|3|||
126384033|NCT02195700|454698948|FG001|Overall Study|Withdrawal by Subject|2|||
126384034|NCT02195700|454698947|FG000|Overall Study|Lost to Follow-up|1|||
126384035|NCT02195700|454698948|FG001|Overall Study|Lost to Follow-up|1|||
126384036|NCT03110029|454698949|FG000|Overall Study|Withdrawal by Subject|1|||
126384037|NCT03110029|454698950|FG001|Overall Study|Withdrawal by Subject|1|||
126384038|NCT02524145|454698952|FG000|Overall Study|Withdrawal by Subject|2|||
126384039|NCT02524145|454698953|FG001|Overall Study|Withdrawal by Subject|2|||
126384040|NCT02524145|454698954|FG002|Overall Study|Withdrawal by Subject|3|||
126384041|NCT03107052|454700546|FG000|Overall Study|Adverse Event|6|||
126384042|NCT03107052|454700547|FG001|Overall Study|Adverse Event|1|||
126384043|NCT03107052|454700548|FG002|Overall Study|Adverse Event|2|||
126384044|NCT03107052|454700546|FG000|Overall Study|Withdrawal by Subject|9|||
126384045|NCT03107052|454700547|FG001|Overall Study|Withdrawal by Subject|5|||
126384046|NCT03107052|454700548|FG002|Overall Study|Withdrawal by Subject|8|||
126384047|NCT03107052|454700546|FG000|Overall Study|Protocol Violation|6|||
126384048|NCT03107052|454700547|FG001|Overall Study|Protocol Violation|0|||
126384049|NCT03107052|454700548|FG002|Overall Study|Protocol Violation|3|||
126384050|NCT03107052|454700546|FG000|Overall Study|Lost to Follow-up|4|||
126384051|NCT03107052|454700547|FG001|Overall Study|Lost to Follow-up|0|||
126384052|NCT03107052|454700548|FG002|Overall Study|Lost to Follow-up|1|||
126384053|NCT03107052|454700546|FG000|Overall Study|Lack of Efficacy|23|||
126384054|NCT03107052|454700547|FG001|Overall Study|Lack of Efficacy|7|||
126384055|NCT03107052|454700548|FG002|Overall Study|Lack of Efficacy|4|||
126384056|NCT03107052|454700546|FG000|Overall Study|Other than specified|4|||
126384057|NCT03107052|454700547|FG001|Overall Study|Other than specified|2|||
126384058|NCT03107052|454700548|FG002|Overall Study|Other than specified|0|||
126384059|NCT03107052|454700546|FG000|Overall Study|Study terminated due to futility|67|||
126384060|NCT03107052|454700547|FG001|Overall Study|Study terminated due to futility|31|||
126384061|NCT03107052|454700548|FG002|Overall Study|Study terminated due to futility|23|||
126384062|NCT02263326|454700549|FG000|Overall Study|Lost to Follow-up|1|||
126384063|NCT02263326|454700550|FG001|Overall Study|Lost to Follow-up|1|||
126384064|NCT02397915|454700551|FG000|Period 1|Protocol Violation|0|||
126384065|NCT02397915|454700552|FG001|Period 1|Protocol Violation|1|||
126384066|NCT02397915|454700553|FG002|Period 1|Protocol Violation|0|||
126384067|NCT02397915|454700554|FG003|Period 1|Protocol Violation|0|||
126384068|NCT02397915|454700551|FG000|Period 1|Physician Decision|1|||
126384069|NCT02397915|454700552|FG001|Period 1|Physician Decision|0|||
126384070|NCT02397915|454700553|FG002|Period 1|Physician Decision|0|||
126384071|NCT02397915|454700554|FG003|Period 1|Physician Decision|0|||
126384072|NCT00933608|454700555|FG000|Overall Study|Adverse Event|4|||
126384073|NCT00933608|454700556|FG001|Overall Study|Adverse Event|2|||
126384074|NCT00933608|454700555|FG000|Overall Study|Physician Decision|1|||
126384075|NCT00933608|454700556|FG001|Overall Study|Physician Decision|0|||
126384076|NCT00391053|454700559|FG000|Overall Study|Serious Adverse Events|1|||
126384077|NCT00391053|454700560|FG001|Overall Study|Serious Adverse Events|0|||
126384078|NCT00391053|454700561|FG002|Overall Study|Serious Adverse Events|1|||
126384079|NCT00391053|454700562|FG003|Overall Study|Serious Adverse Events|4|||
126384080|NCT00391053|454700559|FG000|Overall Study|Protocol Violation|2|||
126384081|NCT00391053|454700560|FG001|Overall Study|Protocol Violation|0|||
126384082|NCT00391053|454700561|FG002|Overall Study|Protocol Violation|0|||
126384083|NCT00391053|454700562|FG003|Overall Study|Protocol Violation|0|||
126384084|NCT00391053|454700559|FG000|Overall Study|Lost to Follow-up|1|||
126384085|NCT00391053|454700560|FG001|Overall Study|Lost to Follow-up|0|||
126384086|NCT00391053|454700561|FG002|Overall Study|Lost to Follow-up|0|||
126384087|NCT00391053|454700562|FG003|Overall Study|Lost to Follow-up|5|||
126384088|NCT00391053|454700559|FG000|Overall Study|Withdrawal by Subject|5|||
126384089|NCT00391053|454700560|FG001|Overall Study|Withdrawal by Subject|1|||
126384090|NCT00391053|454700561|FG002|Overall Study|Withdrawal by Subject|1|||
126384091|NCT00391053|454700562|FG003|Overall Study|Withdrawal by Subject|1|||
126384092|NCT04908384|454700563|FG000|Overall Study|Lost to Follow-up|4|||
126384093|NCT04908384|454700564|FG001|Overall Study|Lost to Follow-up|4|||
126384094|NCT04908384|454700565|FG002|Overall Study|Lost to Follow-up|0|||
126384095|NCT04908384|454700566|FG003|Overall Study|Lost to Follow-up|0|||
126384096|NCT05002985|454700567|FG000|Overall Study|Withdrawal by Subject|1|||
126384097|NCT01642901|454700571|FG000|12-month Follow-up|Withdrawal by Subject|1|||
126384098|NCT01642901|454700572|FG001|12-month Follow-up|Withdrawal by Subject|0|||
126384099|NCT02943070|454700574|FG000|Overall Study|Physician Decision|1|||
126384100|NCT02943070|454700574|FG000|Overall Study|Adverse Event|2|||
126384101|NCT02943070|454700574|FG000|Overall Study|Death|2|||
126384102|NCT02943070|454700574|FG000|Overall Study|Withdrawal by Subject|3|||
126384103|NCT02943070|454700574|FG000|Overall Study|Lost to Follow-up|4|||
126384104|NCT02943070|454700574|FG000|Overall Study|Retreatment or TURP|13|||
126384105|NCT02943070|454700574|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
126384106|NCT04123093|454700579|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
126384107|NCT04123093|454700580|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
126384108|NCT04123093|454700579|FG000|Phase 2|Physician Decision|0|||
126384109|NCT04123093|454700580|FG001|Phase 2|Physician Decision|1|||
126384110|NCT04123093|454700579|FG000|Phase 2|Withdrawal by Subject|0|||
126384111|NCT04123093|454700580|FG001|Phase 2|Withdrawal by Subject|1|||
126384112|NCT04556591|454700581|FG000|Overall Study|Lost to Follow-up|1|||
126384113|NCT04556591|454700582|FG001|Overall Study|Lost to Follow-up|0|||
126384114|NCT04556591|454700581|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
126384115|NCT04556591|454700582|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
126384116|NCT04551963|454700583|FG000|Overall Study|Physician Decision|1|||
126384117|NCT04551963|454700584|FG001|Overall Study|Physician Decision|1|||
126384118|NCT04551963|454700583|FG000|Overall Study|Death|1|||
126384119|NCT04551963|454700584|FG001|Overall Study|Death|0|||
126384120|NCT03379259|454700585|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
126384121|NCT03379259|454700586|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
126384122|NCT03379259|454700587|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
126384123|NCT03379259|454700588|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
126384124|NCT03379259|454700589|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
126384125|NCT03379259|454700590|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
126384126|NCT03379259|454700585|FG000|Overall Study|Death|0|||
126104187|NCT03057977|453675821|FG000|Discontinuation From Treatment|Protocol Violation|6|||
126384127|NCT03379259|454700586|FG001|Overall Study|Death|1|||
126384128|NCT03379259|454700587|FG002|Overall Study|Death|2|||
126384129|NCT03379259|454700588|FG003|Overall Study|Death|1|||
126384130|NCT03379259|454700589|FG004|Overall Study|Death|4|||
126384131|NCT03379259|454700590|FG005|Overall Study|Death|2|||
126104188|NCT03057977|453675822|FG001|Discontinuation From Treatment|Protocol Violation|5|||
126384132|NCT03379259|454700585|FG000|Overall Study|Withdrawal by Subject|0|||
126384133|NCT03379259|454700586|FG001|Overall Study|Withdrawal by Subject|0|||
126384134|NCT03379259|454700587|FG002|Overall Study|Withdrawal by Subject|1|||
126384135|NCT03379259|454700588|FG003|Overall Study|Withdrawal by Subject|0|||
126384136|NCT03379259|454700589|FG004|Overall Study|Withdrawal by Subject|2|||
126384137|NCT03379259|454700590|FG005|Overall Study|Withdrawal by Subject|0|||
126384138|NCT03379259|454700585|FG000|Overall Study|Study terminated by sponsor|0|||
126384139|NCT03379259|454700586|FG001|Overall Study|Study terminated by sponsor|0|||
126384140|NCT03379259|454700587|FG002|Overall Study|Study terminated by sponsor|0|||
126384141|NCT03379259|454700588|FG003|Overall Study|Study terminated by sponsor|1|||
126384142|NCT03379259|454700589|FG004|Overall Study|Study terminated by sponsor|1|||
126384143|NCT03379259|454700590|FG005|Overall Study|Study terminated by sponsor|4|||
126384144|NCT03379259|454700585|FG000|Overall Study|Disease progression|0|||
126384145|NCT03379259|454700586|FG001|Overall Study|Disease progression|0|||
126384146|NCT03379259|454700587|FG002|Overall Study|Disease progression|0|||
126384147|NCT03379259|454700588|FG003|Overall Study|Disease progression|1|||
126384148|NCT03379259|454700589|FG004|Overall Study|Disease progression|0|||
126384149|NCT03379259|454700590|FG005|Overall Study|Disease progression|1|||
126384150|NCT03379259|454700585|FG000|Overall Study|Lost to Follow-up|0|||
126384151|NCT03379259|454700586|FG001|Overall Study|Lost to Follow-up|0|||
126384152|NCT03379259|454700587|FG002|Overall Study|Lost to Follow-up|0|||
126384153|NCT03379259|454700588|FG003|Overall Study|Lost to Follow-up|0|||
126384154|NCT03379259|454700589|FG004|Overall Study|Lost to Follow-up|1|||
126384155|NCT03379259|454700590|FG005|Overall Study|Lost to Follow-up|0|||
126384156|NCT03379259|454700585|FG000|Overall Study|Deteriorating condition|0|||
126384157|NCT03379259|454700586|FG001|Overall Study|Deteriorating condition|0|||
126384158|NCT03379259|454700587|FG002|Overall Study|Deteriorating condition|0|||
126384159|NCT03379259|454700588|FG003|Overall Study|Deteriorating condition|0|||
126384160|NCT03379259|454700589|FG004|Overall Study|Deteriorating condition|1|||
126384161|NCT03379259|454700590|FG005|Overall Study|Deteriorating condition|0|||
126384162|NCT00700622|454700592|FG000|Overall Study|Adverse Event|4|||
126384163|NCT00700622|454700593|FG001|Overall Study|Adverse Event|0|||
126384164|NCT00700622|454700592|FG000|Overall Study|Lost to Follow-up|0|||
126384165|NCT00700622|454700593|FG001|Overall Study|Lost to Follow-up|1|||
126384166|NCT00700622|454700592|FG000|Overall Study|Physician Decision|2|||
126384167|NCT00700622|454700593|FG001|Overall Study|Physician Decision|1|||
126384168|NCT00700622|454700592|FG000|Overall Study|Protocol Violation|0|||
126384169|NCT00700622|454700593|FG001|Overall Study|Protocol Violation|1|||
126384170|NCT00700622|454700592|FG000|Overall Study|Withdrawal by Subject|4|||
126384171|NCT00700622|454700593|FG001|Overall Study|Withdrawal by Subject|1|||
126384172|NCT00700622|454700592|FG000|Overall Study|Other|3|||
126384173|NCT00700622|454700593|FG001|Overall Study|Other|1|||
126384174|NCT02526212|454700597|FG000|Overall Study|Incarceration|1|||
126384175|NCT02526212|454700598|FG001|Overall Study|Incarceration|0|||
126384176|NCT02526212|454700597|FG000|Overall Study|Lost to Follow-up|1|||
126384177|NCT02526212|454700598|FG001|Overall Study|Lost to Follow-up|0|||
126384178|NCT02526212|454700597|FG000|Overall Study|Death|0|||
126384179|NCT02526212|454700598|FG001|Overall Study|Death|1|||
126384180|NCT01390298|454700599|FG000|Overall Study|Death|1|||
126384181|NCT01390298|454700599|FG000|Overall Study|long term ICU admission|1|||
126384182|NCT01390298|454700599|FG000|Overall Study|Withdrawal by Subject|14|||
126384183|NCT01390298|454700599|FG000|Overall Study|Lost to Follow-up|7|||
126384184|NCT01390298|454700599|FG000|Overall Study|Surgery cancelled|1|||
126384185|NCT00040742|454700606|FG000|Overall Study|Death|0|||
126384186|NCT00040742|454700607|FG001|Overall Study|Death|0|||
126384187|NCT00040742|454700608|FG002|Overall Study|Death|1|||
126384188|NCT00040742|454700609|FG003|Overall Study|Death|0|||
126384189|NCT00040742|454700606|FG000|Overall Study|Adverse Event|15|||
126384190|NCT00040742|454700607|FG001|Overall Study|Adverse Event|16|||
126384191|NCT00040742|454700608|FG002|Overall Study|Adverse Event|21|||
126104189|NCT03057977|453675821|FG000|Discontinuation From Treatment|Not treated|4|||
126104190|NCT03057977|453675822|FG001|Discontinuation From Treatment|Not treated|0|||
126104191|NCT03057977|453675821|FG000|Discontinuation From Treatment|Adverse Event|343|||
126104192|NCT03057977|453675822|FG001|Discontinuation From Treatment|Adverse Event|337|||
126104193|NCT03057977|453675821|FG000|Discontinuation From Treatment|Reason Unknown|0|||
126384192|NCT00040742|454700609|FG003|Overall Study|Adverse Event|9|||
126384193|NCT00040742|454700606|FG000|Overall Study|Withdrawal by Subject|7|||
126384194|NCT00040742|454700607|FG001|Overall Study|Withdrawal by Subject|15|||
126384195|NCT00040742|454700608|FG002|Overall Study|Withdrawal by Subject|10|||
126384196|NCT00040742|454700609|FG003|Overall Study|Withdrawal by Subject|13|||
126384197|NCT00040742|454700606|FG000|Overall Study|Chemotoxicity|4|||
126384198|NCT00040742|454700607|FG001|Overall Study|Chemotoxicity|3|||
126384199|NCT00040742|454700608|FG002|Overall Study|Chemotoxicity|5|||
126384200|NCT00040742|454700609|FG003|Overall Study|Chemotoxicity|2|||
126384201|NCT00040742|454700606|FG000|Overall Study|Incomplete Forms|6|||
126384202|NCT00040742|454700607|FG001|Overall Study|Incomplete Forms|10|||
126384203|NCT00040742|454700608|FG002|Overall Study|Incomplete Forms|4|||
126384204|NCT00040742|454700609|FG003|Overall Study|Incomplete Forms|5|||
126384205|NCT00040742|454700606|FG000|Overall Study|Other medical|7|||
126384206|NCT00040742|454700607|FG001|Overall Study|Other medical|5|||
126384207|NCT00040742|454700608|FG002|Overall Study|Other medical|5|||
126384208|NCT00040742|454700609|FG003|Overall Study|Other medical|5|||
126384209|NCT03520920|454700612|FG000|Overall Study|Death|13|||
126384210|NCT03520920|454700613|FG001|Overall Study|Death|1|||
126384211|NCT03520920|454700614|FG002|Overall Study|Death|0|||
126384212|NCT03520920|454700612|FG000|Overall Study|Withdrawal by Subject|2|||
126384213|NCT03520920|454700613|FG001|Overall Study|Withdrawal by Subject|1|||
126384214|NCT03520920|454700614|FG002|Overall Study|Withdrawal by Subject|0|||
126384215|NCT03520920|454700612|FG000|Overall Study|Study Terminated by the Sponsor|5|||
126384216|NCT03520920|454700613|FG001|Overall Study|Study Terminated by the Sponsor|14|||
126384217|NCT03520920|454700614|FG002|Overall Study|Study Terminated by the Sponsor|5|||
126384218|NCT00405392|454700615|FG000|Overall Study|Adverse Event|15|||
126384219|NCT00405392|454700616|FG001|Overall Study|Adverse Event|14|||
126384220|NCT00405392|454700615|FG000|Overall Study|Did not meet Eligibility criteria|7|||
126384221|NCT00405392|454700616|FG001|Overall Study|Did not meet Eligibility criteria|2|||
126384222|NCT00405392|454700615|FG000|Overall Study|Withdrawal by Subject|4|||
126384223|NCT00405392|454700616|FG001|Overall Study|Withdrawal by Subject|3|||
126384224|NCT00405392|454700615|FG000|Overall Study|Lost to Follow-up|1|||
126384225|NCT00405392|454700616|FG001|Overall Study|Lost to Follow-up|2|||
126384226|NCT00405392|454700615|FG000|Overall Study|Data missing|2|||
126384227|NCT00405392|454700616|FG001|Overall Study|Data missing|0|||
126104194|NCT03057977|453675822|FG001|Discontinuation From Treatment|Reason Unknown|1|||
126104195|NCT03057977|453675821|FG000|Discontinuation From Treatment|Personal Reasons|1|||
126104196|NCT03057977|453675822|FG001|Discontinuation From Treatment|Personal Reasons|1|||
126104197|NCT03057977|453675821|FG000|Discontinuation From Treatment|Unblinded medication|1|||
126104198|NCT03057977|453675822|FG001|Discontinuation From Treatment|Unblinded medication|0|||
126104199|NCT03057977|453675821|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
126104200|NCT03057977|453675822|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
126384228|NCT00405392|454700615|FG000|Overall Study|Non-compliance|0|||
126384229|NCT00405392|454700616|FG001|Overall Study|Non-compliance|1|||
126384230|NCT00405392|454700615|FG000|Overall Study|Other|1|||
126384231|NCT00405392|454700616|FG001|Overall Study|Other|5|||
126384232|NCT01703091|454700627|FG000|Overall Study|Adverse Event|5|||
126384233|NCT01703091|454700628|FG001|Overall Study|Adverse Event|3|||
126384234|NCT01703091|454700627|FG000|Overall Study|Physician Decision|2|||
126384235|NCT01703091|454700628|FG001|Overall Study|Physician Decision|1|||
126384236|NCT01703091|454700627|FG000|Overall Study|Withdrawal by Subject|1|||
126384237|NCT01703091|454700628|FG001|Overall Study|Withdrawal by Subject|0|||
126384238|NCT01703091|454700627|FG000|Overall Study|Sponsor Decision|1|||
126384239|NCT01703091|454700628|FG001|Overall Study|Sponsor Decision|0|||
126384240|NCT02550288|454700632|FG000|Overall Study|Adverse Event|0|||
126384241|NCT02550288|454700633|FG001|Overall Study|Adverse Event|1|||
126384242|NCT02550288|454700634|FG002|Overall Study|Adverse Event|0|||
126384243|NCT02550288|454700635|FG003|Overall Study|Adverse Event|0|||
126384244|NCT02550288|454700636|FG004|Overall Study|Adverse Event|0|||
126384245|NCT02550288|454700632|FG000|Overall Study|Physician Decision|0|||
126384246|NCT02550288|454700633|FG001|Overall Study|Physician Decision|0|||
126384247|NCT02550288|454700634|FG002|Overall Study|Physician Decision|0|||
126384248|NCT02550288|454700635|FG003|Overall Study|Physician Decision|1|||
126384249|NCT02550288|454700636|FG004|Overall Study|Physician Decision|0|||
126384250|NCT02550288|454700632|FG000|Overall Study|Protocol Violation|2|||
126384251|NCT02550288|454700633|FG001|Overall Study|Protocol Violation|2|||
126384252|NCT02550288|454700634|FG002|Overall Study|Protocol Violation|1|||
126384253|NCT02550288|454700635|FG003|Overall Study|Protocol Violation|0|||
126384254|NCT02550288|454700636|FG004|Overall Study|Protocol Violation|3|||
126384255|NCT02550288|454700632|FG000|Overall Study|Participant moved|0|||
126384256|NCT02550288|454700633|FG001|Overall Study|Participant moved|0|||
126384257|NCT02550288|454700634|FG002|Overall Study|Participant moved|0|||
126384258|NCT02550288|454700635|FG003|Overall Study|Participant moved|1|||
126384259|NCT02550288|454700636|FG004|Overall Study|Participant moved|0|||
126384260|NCT02550288|454700632|FG000|Overall Study|Withdrawal by Subject|0|||
126384261|NCT02550288|454700633|FG001|Overall Study|Withdrawal by Subject|0|||
126384262|NCT02550288|454700634|FG002|Overall Study|Withdrawal by Subject|0|||
126384263|NCT02550288|454700635|FG003|Overall Study|Withdrawal by Subject|1|||
126384264|NCT02550288|454700636|FG004|Overall Study|Withdrawal by Subject|0|||
126384265|NCT02819297|454700637|FG000|Overall Study|Withdrawal by Subject|25|||
126384266|NCT02819297|454700638|FG001|Overall Study|Withdrawal by Subject|13|||
126384267|NCT02819297|454700637|FG000|Overall Study|Lost to Follow-up|12|||
126384268|NCT02819297|454700638|FG001|Overall Study|Lost to Follow-up|14|||
126384269|NCT02819297|454700637|FG000|Overall Study|Adverse Event|12|||
126384270|NCT02819297|454700638|FG001|Overall Study|Adverse Event|10|||
126384271|NCT02819297|454700637|FG000|Overall Study|Physician Decision|5|||
126384272|NCT02819297|454700638|FG001|Overall Study|Physician Decision|5|||
126384273|NCT02819297|454700637|FG000|Overall Study|Lack of Efficacy|5|||
126384274|NCT02819297|454700638|FG001|Overall Study|Lack of Efficacy|8|||
126384275|NCT02819297|454700637|FG000|Overall Study|Protocol Violation|1|||
126384276|NCT02819297|454700638|FG001|Overall Study|Protocol Violation|2|||
126384277|NCT01071252|454700640|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
126384278|NCT01071252|454700641|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
126384279|NCT01071252|454700642|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
126384280|NCT01071252|454700643|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
126384281|NCT01071252|454700644|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
126384282|NCT01071252|454700640|FG000|Overall Study|Withdrawal by Subject|8|||
126384283|NCT01071252|454700641|FG001|Overall Study|Withdrawal by Subject|2|||
126384284|NCT01071252|454700642|FG002|Overall Study|Withdrawal by Subject|1|||
126384285|NCT01071252|454700643|FG003|Overall Study|Withdrawal by Subject|2|||
126384286|NCT01071252|454700644|FG004|Overall Study|Withdrawal by Subject|3|||
126384287|NCT01071252|454700640|FG000|Overall Study|administrative problems|1|||
126384288|NCT01071252|454700641|FG001|Overall Study|administrative problems|1|||
126384289|NCT01071252|454700642|FG002|Overall Study|administrative problems|0|||
126384290|NCT01071252|454700643|FG003|Overall Study|administrative problems|2|||
126384291|NCT01071252|454700644|FG004|Overall Study|administrative problems|1|||
126384292|NCT01071252|454700640|FG000|Overall Study|Lost to Follow-up|1|||
126384293|NCT01071252|454700641|FG001|Overall Study|Lost to Follow-up|0|||
126384294|NCT01071252|454700642|FG002|Overall Study|Lost to Follow-up|1|||
126384295|NCT01071252|454700643|FG003|Overall Study|Lost to Follow-up|2|||
126384296|NCT01071252|454700644|FG004|Overall Study|Lost to Follow-up|0|||
126384297|NCT01071252|454700640|FG000|Overall Study|Adverse Event|1|||
126384298|NCT01071252|454700641|FG001|Overall Study|Adverse Event|1|||
126384299|NCT01071252|454700642|FG002|Overall Study|Adverse Event|0|||
126384300|NCT01071252|454700643|FG003|Overall Study|Adverse Event|1|||
126384301|NCT01071252|454700644|FG004|Overall Study|Adverse Event|0|||
126384302|NCT01071252|454700640|FG000|Overall Study|Death|0|||
126384303|NCT01071252|454700641|FG001|Overall Study|Death|0|||
126384304|NCT01071252|454700642|FG002|Overall Study|Death|0|||
126384305|NCT01071252|454700643|FG003|Overall Study|Death|0|||
126384306|NCT01071252|454700644|FG004|Overall Study|Death|1|||
126384307|NCT01945996|454700645|FG000|Overall Study|Lost to Follow-up|3|||
126384308|NCT01945996|454700646|FG001|Overall Study|Lost to Follow-up|5|||
126384309|NCT03928418|454700647|FG000|Overall Study|Lost to Follow-up|5|||
126384310|NCT03928418|454700648|FG001|Overall Study|Lost to Follow-up|3|||
126384311|NCT03928418|454700649|FG002|Overall Study|Lost to Follow-up|5|||
126384312|NCT03928418|454700647|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
126048576|NCT00112359|453475227|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
126384313|NCT03928418|454700648|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
126384314|NCT03928418|454700649|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
126384315|NCT00763256|454700650|FG000|Overall Study|Didn't return for appointments|7|||
126384316|NCT00763256|454700651|FG001|Overall Study|Didn't return for appointments|10|||
126384317|NCT02544750|454700652|FG000|Overall Study|Physician Decision|3|||
126384318|NCT02544750|454700653|FG001|Overall Study|Physician Decision|1|||
126384319|NCT02544750|454700652|FG000|Overall Study|Other reasons|69|||
125886695|NCT00473382|452881819|FG000|Core Study|Death|3|||
125886696|NCT00473382|452881820|FG001|Core Study|Death|5|||
125886697|NCT00473382|452881821|FG002|Core Study|Death|10|||
125886698|NCT00473382|452881819|FG000|Core Study|Lost to Follow-up|3|||
125886699|NCT00473382|452881820|FG001|Core Study|Lost to Follow-up|3|||
126048577|NCT00112359|453475226|FG000|Overall Study|Related adverse event|5|||
126048578|NCT00112359|453475227|FG001|Overall Study|Related adverse event|3|||
126048579|NCT00112359|453475226|FG000|Overall Study|Lost to Follow-up|0|||
126048580|NCT00112359|453475227|FG001|Overall Study|Lost to Follow-up|1|||
126048581|NCT00112359|453475226|FG000|Overall Study|Personal/administrative|1|||
126048582|NCT00112359|453475227|FG001|Overall Study|Personal/administrative|1|||
126048583|NCT00112359|453475226|FG000|Overall Study|Other|3|||
126048584|NCT00112359|453475227|FG001|Overall Study|Other|0|||
126048585|NCT01961609|453475228|FG000|Initiation|Missing|3|||
126048586|NCT01961609|453475229|FG001|Initiation|Missing|2|||
126048587|NCT01961609|453475230|FG002|Initiation|Missing|0|||
126048588|NCT01961609|453475231|FG003|Initiation|Missing|0|||
126048589|NCT01961609|453475228|FG000|Initiation|Protocol deviation|1|||
126048590|NCT01961609|453475229|FG001|Initiation|Protocol deviation|0|||
126048591|NCT01961609|453475230|FG002|Initiation|Protocol deviation|0|||
126048592|NCT01961609|453475231|FG003|Initiation|Protocol deviation|0|||
126048593|NCT01961609|453475228|FG000|Initiation|Death|0|||
126048594|NCT01961609|453475229|FG001|Initiation|Death|1|||
126048595|NCT01961609|453475230|FG002|Initiation|Death|0|||
126048596|NCT01961609|453475231|FG003|Initiation|Death|0|||
126048597|NCT01961609|453475228|FG000|Initiation|Administrative problems|1|||
126048598|NCT01961609|453475229|FG001|Initiation|Administrative problems|0|||
126048599|NCT01961609|453475230|FG002|Initiation|Administrative problems|0|||
126048600|NCT01961609|453475231|FG003|Initiation|Administrative problems|0|||
126048601|NCT01961609|453475228|FG000|Initiation|Withdrawal by Subject|1|||
126048602|NCT01961609|453475229|FG001|Initiation|Withdrawal by Subject|2|||
126048603|NCT01961609|453475230|FG002|Initiation|Withdrawal by Subject|0|||
126048604|NCT01961609|453475231|FG003|Initiation|Withdrawal by Subject|0|||
126048605|NCT01961609|453475228|FG000|Initiation|Lack of Efficacy|2|||
126048606|NCT01961609|453475229|FG001|Initiation|Lack of Efficacy|1|||
126048607|NCT01961609|453475230|FG002|Initiation|Lack of Efficacy|0|||
126048608|NCT01961609|453475231|FG003|Initiation|Lack of Efficacy|0|||
126048609|NCT01961609|453475228|FG000|Initiation|Abnormal lab values|0|||
126104201|NCT03057977|453675821|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
126384320|NCT02544750|454700653|FG001|Overall Study|Other reasons|39|||
126384321|NCT02544750|454700652|FG000|Overall Study|Met withdrawal criteria|2|||
126384322|NCT02544750|454700653|FG001|Overall Study|Met withdrawal criteria|2|||
126384323|NCT02544750|454700652|FG000|Overall Study|Transition To Commercial Product|1|||
126384324|NCT02544750|454700653|FG001|Overall Study|Transition To Commercial Product|0|||
126384325|NCT02544750|454700652|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
126384326|NCT02544750|454700653|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
126384327|NCT02544750|454700652|FG000|Overall Study|Adverse Event|8|||
126384328|NCT02544750|454700653|FG001|Overall Study|Adverse Event|10|||
126384329|NCT02544750|454700652|FG000|Overall Study|Withdrawal by Subject|10|||
126384330|NCT02544750|454700653|FG001|Overall Study|Withdrawal by Subject|4|||
126384331|NCT02544750|454700652|FG000|Overall Study|Lost to Follow-up|1|||
126384332|NCT02544750|454700653|FG001|Overall Study|Lost to Follow-up|0|||
126384333|NCT00244725|454700656|FG000|Overall Study|Lost to Follow-up|3|||
126384334|NCT00244725|454700657|FG001|Overall Study|Lost to Follow-up|4|||
126384335|NCT00244725|454700658|FG002|Overall Study|Lost to Follow-up|9|||
126384336|NCT00244725|454700659|FG003|Overall Study|Lost to Follow-up|2|||
126384337|NCT00244725|454700656|FG000|Overall Study|Withdrawal by Subject|9|||
126384338|NCT00244725|454700657|FG001|Overall Study|Withdrawal by Subject|7|||
126384339|NCT00244725|454700658|FG002|Overall Study|Withdrawal by Subject|7|||
126384340|NCT00244725|454700659|FG003|Overall Study|Withdrawal by Subject|8|||
125886700|NCT00473382|452881821|FG002|Core Study|Lost to Follow-up|3|||
125886701|NCT00473382|452881819|FG000|Core Study|Physician Decision|1|||
125886702|NCT00473382|452881820|FG001|Core Study|Physician Decision|2|||
126048610|NCT01961609|453475229|FG001|Initiation|Abnormal lab values|1|||
126048611|NCT01961609|453475230|FG002|Initiation|Abnormal lab values|0|||
126048612|NCT01961609|453475231|FG003|Initiation|Abnormal lab values|0|||
126048613|NCT01961609|453475228|FG000|Initiation|Adverse Event|3|||
126048614|NCT01961609|453475229|FG001|Initiation|Adverse Event|5|||
126048615|NCT01961609|453475230|FG002|Initiation|Adverse Event|0|||
126048616|NCT01961609|453475231|FG003|Initiation|Adverse Event|0|||
125886703|NCT00473382|452881821|FG002|Core Study|Physician Decision|2|||
126048617|NCT01961609|453475228|FG000|Initiation|Randomized but not treated|1|||
126048618|NCT01961609|453475229|FG001|Initiation|Randomized but not treated|1|||
126384341|NCT00244725|454700656|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
126048619|NCT01961609|453475230|FG002|Initiation|Randomized but not treated|0|||
126048620|NCT01961609|453475231|FG003|Initiation|Randomized but not treated|0|||
126048621|NCT01961609|453475228|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
126384342|NCT00244725|454700657|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
126384343|NCT00244725|454700658|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
126384344|NCT00244725|454700659|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
126384345|NCT00244725|454700656|FG000|Overall Study|Physician Decision|3|||
126384346|NCT00244725|454700657|FG001|Overall Study|Physician Decision|0|||
126384347|NCT00244725|454700658|FG002|Overall Study|Physician Decision|1|||
126384348|NCT00244725|454700659|FG003|Overall Study|Physician Decision|2|||
126384349|NCT00244725|454700656|FG000|Overall Study|Adverse Events|3|||
126384350|NCT00244725|454700657|FG001|Overall Study|Adverse Events|1|||
126384351|NCT00244725|454700658|FG002|Overall Study|Adverse Events|4|||
126384352|NCT00244725|454700659|FG003|Overall Study|Adverse Events|4|||
126384353|NCT00244725|454700656|FG000|Overall Study|Withdrwal by participant|1|||
126384354|NCT00244725|454700657|FG001|Overall Study|Withdrwal by participant|0|||
126384355|NCT00244725|454700658|FG002|Overall Study|Withdrwal by participant|0|||
126384356|NCT00244725|454700659|FG003|Overall Study|Withdrwal by participant|1|||
126384357|NCT00244725|454700656|FG000|Overall Study|Liver function test abnormality|2|||
126384358|NCT00244725|454700657|FG001|Overall Study|Liver function test abnormality|0|||
126384359|NCT00244725|454700658|FG002|Overall Study|Liver function test abnormality|0|||
126384360|NCT00244725|454700659|FG003|Overall Study|Liver function test abnormality|1|||
126384361|NCT00244725|454700656|FG000|Overall Study|Sponsor withdrew the participant|1|||
126384362|NCT00244725|454700657|FG001|Overall Study|Sponsor withdrew the participant|0|||
126048622|NCT01961609|453475229|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
126048623|NCT01961609|453475230|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
126384363|NCT00244725|454700658|FG002|Overall Study|Sponsor withdrew the participant|0|||
126384364|NCT00244725|454700659|FG003|Overall Study|Sponsor withdrew the participant|1|||
126384365|NCT00244725|454700656|FG000|Overall Study|Mediciation Error|0|||
126384366|NCT00244725|454700657|FG001|Overall Study|Mediciation Error|1|||
126384367|NCT00244725|454700658|FG002|Overall Study|Mediciation Error|0|||
126384368|NCT00244725|454700659|FG003|Overall Study|Mediciation Error|0|||
126384369|NCT00244725|454700656|FG000|Overall Study|Rehab Refused to allow participantion|0|||
126384370|NCT00244725|454700657|FG001|Overall Study|Rehab Refused to allow participantion|1|||
126384371|NCT00244725|454700658|FG002|Overall Study|Rehab Refused to allow participantion|0|||
126384372|NCT00244725|454700659|FG003|Overall Study|Rehab Refused to allow participantion|0|||
126384373|NCT00244725|454700656|FG000|Overall Study|Headache|0|||
126384374|NCT00244725|454700657|FG001|Overall Study|Headache|1|||
126384375|NCT00244725|454700658|FG002|Overall Study|Headache|0|||
126384376|NCT00244725|454700659|FG003|Overall Study|Headache|0|||
126384377|NCT00244725|454700656|FG000|Overall Study|Received prohibited medication|0|||
126384378|NCT00244725|454700657|FG001|Overall Study|Received prohibited medication|1|||
126384379|NCT00244725|454700658|FG002|Overall Study|Received prohibited medication|0|||
126384380|NCT00244725|454700659|FG003|Overall Study|Received prohibited medication|1|||
126384381|NCT00244725|454700656|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
126384382|NCT00244725|454700657|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
126384383|NCT00244725|454700658|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
126384384|NCT00244725|454700659|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
126384385|NCT00244725|454700656|FG000|Overall Study|Administrative reason|0|||
126384386|NCT00244725|454700657|FG001|Overall Study|Administrative reason|0|||
126384387|NCT00244725|454700658|FG002|Overall Study|Administrative reason|1|||
126384388|NCT00244725|454700659|FG003|Overall Study|Administrative reason|0|||
126384389|NCT00244725|454700656|FG000|Overall Study|Vomit|0|||
126384390|NCT00244725|454700657|FG001|Overall Study|Vomit|0|||
126384391|NCT00244725|454700658|FG002|Overall Study|Vomit|1|||
126384392|NCT00244725|454700659|FG003|Overall Study|Vomit|0|||
126384393|NCT00244725|454700656|FG000|Overall Study|Failed to follow-up|0|||
126384394|NCT00244725|454700657|FG001|Overall Study|Failed to follow-up|0|||
126384395|NCT00244725|454700658|FG002|Overall Study|Failed to follow-up|1|||
126384396|NCT00244725|454700659|FG003|Overall Study|Failed to follow-up|1|||
126384397|NCT02131311|454700660|FG000|Overall Study|Adverse Event|2|||
126384398|NCT02131311|454700660|FG000|Overall Study|Protocol Violation|1|||
126384399|NCT02131311|454700660|FG000|Overall Study|Lost to Follow-up|1|||
126384400|NCT00255723|454700662|FG000|Overall Study|Adverse Event|1|||
126384401|NCT00255723|454700663|FG001|Overall Study|Adverse Event|1|||
126384402|NCT00255723|454700662|FG000|Overall Study|Death|0|||
126384403|NCT00255723|454700663|FG001|Overall Study|Death|1|||
126384404|NCT00255723|454700662|FG000|Overall Study|Response Data Not Available|1|||
126384405|NCT00255723|454700663|FG001|Overall Study|Response Data Not Available|0|||
126384406|NCT01169701|454700668|FG000|Overall Study|Lost to Follow-up|1|||
126384407|NCT01169701|454700669|FG001|Overall Study|Lost to Follow-up|1|||
126384408|NCT01169701|454700668|FG000|Overall Study|Withdrawal by Subject|1|||
126384409|NCT01169701|454700669|FG001|Overall Study|Withdrawal by Subject|3|||
126384410|NCT01169701|454700668|FG000|Overall Study|Adverse Event|1|||
126384411|NCT01169701|454700669|FG001|Overall Study|Adverse Event|2|||
126384412|NCT01169701|454700668|FG000|Overall Study|Exclusion criteria|2|||
126384413|NCT01169701|454700669|FG001|Overall Study|Exclusion criteria|0|||
126384414|NCT01169701|454700668|FG000|Overall Study|Death|0|||
126384415|NCT01169701|454700669|FG001|Overall Study|Death|1|||
126384416|NCT01169701|454700668|FG000|Overall Study|Administrative problems|0|||
126384417|NCT01169701|454700669|FG001|Overall Study|Administrative problems|1|||
126048624|NCT01961609|453475231|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
126048625|NCT01961609|453475228|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
126048626|NCT01961609|453475229|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
126048627|NCT01961609|453475230|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
126048628|NCT01961609|453475231|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
126048629|NCT01961609|453475228|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
126048630|NCT01961609|453475229|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
126384418|NCT01169701|454700668|FG000|Overall Study|Serious adverse event|0|||
126384419|NCT01169701|454700669|FG001|Overall Study|Serious adverse event|1|||
126384420|NCT01169701|454700668|FG000|Overall Study|Sponsor decision|0|||
126384421|NCT01169701|454700669|FG001|Overall Study|Sponsor decision|1|||
126384422|NCT00553436|454700670|FG000|Overall Study|Conversion to another procedure|1|||
126384423|NCT01814046|454700671|FG000|Drug Administration|Death due to complications of RSV|1|||
126384424|NCT01814046|454700672|FG001|Drug Administration|Death due to complications of RSV|0|||
126384425|NCT01814046|454700673|FG002|Drug Administration|Death due to complications of RSV|0|||
126384426|NCT03146663|454700676|FG000|Overall Study|Did not receive study treatment|1|||
126384427|NCT03146663|454700677|FG001|Overall Study|Did not receive study treatment|1|||
126384428|NCT03089047|454700678|FG000|Overall Study|Lost to Follow-up|1|||
126384429|NCT03089047|454700679|FG001|Overall Study|Lost to Follow-up|0|||
126384430|NCT03599518|454700680|FG000|Overall Study|Clinical progression|0|||
126384431|NCT03599518|454700681|FG001|Overall Study|Clinical progression|0|||
126384432|NCT03599518|454700682|FG002|Overall Study|Clinical progression|0|||
126384433|NCT03599518|454700683|FG003|Overall Study|Clinical progression|0|||
126384434|NCT03599518|454700684|FG004|Overall Study|Clinical progression|1|||
126384435|NCT03599518|454700680|FG000|Overall Study|Adverse Event|0|||
126384436|NCT03599518|454700681|FG001|Overall Study|Adverse Event|0|||
126384437|NCT03599518|454700682|FG002|Overall Study|Adverse Event|0|||
126384438|NCT03599518|454700683|FG003|Overall Study|Adverse Event|0|||
126384439|NCT03599518|454700684|FG004|Overall Study|Adverse Event|1|||
126384440|NCT03599518|454700680|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
126384441|NCT03599518|454700681|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
126384442|NCT03599518|454700682|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
126384443|NCT03599518|454700683|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
126384444|NCT03599518|454700684|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
126384445|NCT03599518|454700680|FG000|Overall Study|Participant withdrawal from study treatment|0|||
126384446|NCT03599518|454700681|FG001|Overall Study|Participant withdrawal from study treatment|0|||
126384447|NCT03599518|454700682|FG002|Overall Study|Participant withdrawal from study treatment|1|||
126384448|NCT03599518|454700683|FG003|Overall Study|Participant withdrawal from study treatment|0|||
126384449|NCT03599518|454700684|FG004|Overall Study|Participant withdrawal from study treatment|0|||
126384450|NCT00429182|454700687|FG000|Overall Study|Not evaluable, Disease Progression|2|||
126384451|NCT00429182|454700687|FG000|Overall Study|Not eligible|5|||
126384452|NCT02311881|454700698|FG000|Overall Study|Did not meet the study criteria|2|||
126384453|NCT02311881|454700699|FG001|Overall Study|Did not meet the study criteria|2|||
126384454|NCT02311881|454700700|FG002|Overall Study|Did not meet the study criteria|0|||
126384455|NCT02311881|454700698|FG000|Overall Study|Adverse Event|7|||
126384456|NCT02311881|454700699|FG001|Overall Study|Adverse Event|15|||
126384457|NCT02311881|454700700|FG002|Overall Study|Adverse Event|8|||
126384458|NCT02311881|454700698|FG000|Overall Study|Lost to Follow-up|3|||
126384459|NCT02311881|454700699|FG001|Overall Study|Lost to Follow-up|3|||
126384460|NCT02311881|454700700|FG002|Overall Study|Lost to Follow-up|2|||
126384461|NCT02311881|454700698|FG000|Overall Study|Protocol Violation|1|||
126384462|NCT02311881|454700699|FG001|Overall Study|Protocol Violation|2|||
126384463|NCT02311881|454700700|FG002|Overall Study|Protocol Violation|3|||
126384464|NCT02311881|454700698|FG000|Overall Study|Withdrawal of consent|14|||
126384465|NCT02311881|454700699|FG001|Overall Study|Withdrawal of consent|16|||
126384466|NCT02311881|454700700|FG002|Overall Study|Withdrawal of consent|17|||
126384467|NCT02311881|454700698|FG000|Overall Study|Other|0|||
126384468|NCT02311881|454700699|FG001|Overall Study|Other|0|||
126384469|NCT02311881|454700700|FG002|Overall Study|Other|1|||
126384470|NCT02311881|454700698|FG000|Overall Study|Lack of Efficacy|1|||
126384471|NCT02311881|454700699|FG001|Overall Study|Lack of Efficacy|2|||
126384472|NCT02311881|454700700|FG002|Overall Study|Lack of Efficacy|0|||
126384473|NCT02311881|454700698|FG000|Overall Study|Subject has border line pregnancy test|1|||
126384474|NCT02311881|454700699|FG001|Overall Study|Subject has border line pregnancy test|0|||
126384475|NCT02311881|454700700|FG002|Overall Study|Subject has border line pregnancy test|0|||
126384476|NCT02311881|454700698|FG000|Overall Study|Withdrawal by Subject|3|||
126384477|NCT02311881|454700699|FG001|Overall Study|Withdrawal by Subject|1|||
126384478|NCT02311881|454700700|FG002|Overall Study|Withdrawal by Subject|4|||
126384479|NCT02311881|454700698|FG000|Overall Study|Sponsor Decision|1|||
126384480|NCT02311881|454700699|FG001|Overall Study|Sponsor Decision|1|||
126384481|NCT02311881|454700700|FG002|Overall Study|Sponsor Decision|1|||
126384482|NCT02311881|454700698|FG000|Overall Study|Protocol Deviation|1|||
126384483|NCT02311881|454700699|FG001|Overall Study|Protocol Deviation|0|||
126384484|NCT02311881|454700700|FG002|Overall Study|Protocol Deviation|0|||
126384485|NCT02311881|454700698|FG000|Overall Study|Non-Compliance|1|||
126384486|NCT02311881|454700699|FG001|Overall Study|Non-Compliance|0|||
126384487|NCT02311881|454700700|FG002|Overall Study|Non-Compliance|2|||
126384488|NCT02311881|454700698|FG000|Overall Study|Physician Decision|0|||
126384489|NCT02311881|454700699|FG001|Overall Study|Physician Decision|0|||
126384490|NCT02311881|454700700|FG002|Overall Study|Physician Decision|1|||
126384491|NCT02311881|454700698|FG000|Overall Study|Medical Monitor Discretion|0|||
126384492|NCT02311881|454700699|FG001|Overall Study|Medical Monitor Discretion|0|||
126384493|NCT02311881|454700700|FG002|Overall Study|Medical Monitor Discretion|1|||
126384494|NCT02311881|454700698|FG000|Overall Study|Participant taking another medication|0|||
126384495|NCT02311881|454700699|FG001|Overall Study|Participant taking another medication|0|||
126384496|NCT02311881|454700700|FG002|Overall Study|Participant taking another medication|1|||
126384497|NCT02311881|454700698|FG000|Overall Study|Serious Adverse Event|0|||
126384498|NCT02311881|454700699|FG001|Overall Study|Serious Adverse Event|1|||
126384499|NCT02311881|454700700|FG002|Overall Study|Serious Adverse Event|0|||
126384500|NCT00819156|454700701|FG000|Overall Study|Adverse Event|1|||
126384501|NCT00819156|454700702|FG001|Overall Study|Adverse Event|4|||
126384502|NCT00819156|454700703|FG002|Overall Study|Adverse Event|2|||
126384503|NCT00819156|454700704|FG003|Overall Study|Adverse Event|1|||
126384504|NCT00819156|454700705|FG004|Overall Study|Adverse Event|2|||
126384505|NCT00819156|454700706|FG005|Overall Study|Adverse Event|3|||
126384506|NCT00819156|454700701|FG000|Overall Study|Withdrawal by Subject|0|||
126384507|NCT00819156|454700702|FG001|Overall Study|Withdrawal by Subject|3|||
126384508|NCT00819156|454700703|FG002|Overall Study|Withdrawal by Subject|2|||
126384509|NCT00819156|454700704|FG003|Overall Study|Withdrawal by Subject|0|||
126384510|NCT00819156|454700705|FG004|Overall Study|Withdrawal by Subject|1|||
126384511|NCT00819156|454700706|FG005|Overall Study|Withdrawal by Subject|0|||
126384512|NCT00819156|454700701|FG000|Overall Study|Protocol Violation|1|||
126384513|NCT00819156|454700702|FG001|Overall Study|Protocol Violation|0|||
126384514|NCT00819156|454700703|FG002|Overall Study|Protocol Violation|1|||
126384515|NCT00819156|454700704|FG003|Overall Study|Protocol Violation|0|||
126384516|NCT00819156|454700705|FG004|Overall Study|Protocol Violation|0|||
126384517|NCT00819156|454700706|FG005|Overall Study|Protocol Violation|1|||
126384518|NCT00819156|454700701|FG000|Overall Study|Lost to Follow-up|0|||
126384519|NCT00819156|454700702|FG001|Overall Study|Lost to Follow-up|1|||
126384520|NCT00819156|454700703|FG002|Overall Study|Lost to Follow-up|0|||
126384521|NCT00819156|454700704|FG003|Overall Study|Lost to Follow-up|0|||
126384522|NCT00819156|454700705|FG004|Overall Study|Lost to Follow-up|0|||
126384523|NCT00819156|454700706|FG005|Overall Study|Lost to Follow-up|2|||
126384524|NCT00819156|454700701|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
126384525|NCT00819156|454700702|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
126384526|NCT00819156|454700703|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
126384527|NCT00819156|454700704|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
126384528|NCT00819156|454700705|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
126384529|NCT00819156|454700706|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
126384530|NCT00819156|454700701|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
126384531|NCT00819156|454700702|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
126384532|NCT00819156|454700703|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
126384533|NCT00819156|454700704|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
126384534|NCT00819156|454700705|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
126384535|NCT00819156|454700706|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
126384536|NCT00819156|454700701|FG000|Overall Study|Prostate-specific antigen progression|0|||
126384537|NCT00819156|454700702|FG001|Overall Study|Prostate-specific antigen progression|0|||
126384538|NCT00819156|454700703|FG002|Overall Study|Prostate-specific antigen progression|0|||
126384539|NCT00819156|454700704|FG003|Overall Study|Prostate-specific antigen progression|0|||
126384540|NCT00819156|454700705|FG004|Overall Study|Prostate-specific antigen progression|1|||
126384541|NCT00819156|454700706|FG005|Overall Study|Prostate-specific antigen progression|0|||
126384542|NCT00790582|454700707|FG000|Overall Study|Death|14|||
126384543|NCT00790582|454700708|FG001|Overall Study|Death|32|||
126384544|NCT00790582|454700707|FG000|Overall Study|Physician Decision|7|||
126384545|NCT00790582|454700708|FG001|Overall Study|Physician Decision|1|||
126384546|NCT00790582|454700707|FG000|Overall Study|Lost to Follow-up|3|||
126384547|NCT00790582|454700708|FG001|Overall Study|Lost to Follow-up|3|||
126384548|NCT00790582|454700707|FG000|Overall Study|Withdrawal by Subject|7|||
126384549|NCT00790582|454700708|FG001|Overall Study|Withdrawal by Subject|51|||
126384550|NCT01575808|454700711|FG000|Overall Study|Death|2|||
126384551|NCT01575808|454700712|FG001|Overall Study|Death|0|||
126384552|NCT01575808|454700711|FG000|Overall Study|Withdrawal by Subject|1|||
126384553|NCT01575808|454700712|FG001|Overall Study|Withdrawal by Subject|0|||
126384554|NCT05823974|454703052|FG000|Overall Study|Lost to Follow-up|0|||
126384555|NCT05823974|454703053|FG001|Overall Study|Lost to Follow-up|3|||
126384556|NCT05823974|454703054|FG002|Overall Study|Lost to Follow-up|1|||
126384557|NCT05823974|454703055|FG003|Overall Study|Lost to Follow-up|0|||
126384558|NCT05823974|454703056|FG004|Overall Study|Lost to Follow-up|1|||
126384559|NCT05823974|454703057|FG005|Overall Study|Lost to Follow-up|0|||
126384560|NCT05823974|454703058|FG006|Overall Study|Lost to Follow-up|1|||
126384561|NCT05823974|454703059|FG007|Overall Study|Lost to Follow-up|0|||
126384562|NCT05823974|454703060|FG008|Overall Study|Lost to Follow-up|0|||
126384563|NCT05823974|454703061|FG009|Overall Study|Lost to Follow-up|1|||
126384564|NCT05823974|454703062|FG010|Overall Study|Lost to Follow-up|1|||
126384565|NCT05823974|454703063|FG011|Overall Study|Lost to Follow-up|0|||
126384566|NCT05823974|454703064|FG012|Overall Study|Lost to Follow-up|1|||
126384567|NCT05823974|454703065|FG013|Overall Study|Lost to Follow-up|2|||
126384568|NCT05823974|454703066|FG014|Overall Study|Lost to Follow-up|1|||
126384569|NCT05823974|454703067|FG015|Overall Study|Lost to Follow-up|1|||
126384570|NCT05823974|454703068|FG016|Overall Study|Lost to Follow-up|1|||
126384571|NCT05823974|454703069|FG017|Overall Study|Lost to Follow-up|0|||
126384572|NCT05823974|454703070|FG018|Overall Study|Lost to Follow-up|0|||
126384573|NCT05823974|454703071|FG019|Overall Study|Lost to Follow-up|2|||
126384574|NCT05823974|454703072|FG020|Overall Study|Lost to Follow-up|0|||
126384575|NCT05823974|454703052|FG000|Overall Study|Physician Decision|0|||
126384576|NCT05823974|454703053|FG001|Overall Study|Physician Decision|0|||
126384577|NCT05823974|454703054|FG002|Overall Study|Physician Decision|0|||
126384578|NCT05823974|454703055|FG003|Overall Study|Physician Decision|0|||
126384579|NCT05823974|454703056|FG004|Overall Study|Physician Decision|0|||
126384580|NCT05823974|454703057|FG005|Overall Study|Physician Decision|0|||
126384581|NCT05823974|454703058|FG006|Overall Study|Physician Decision|0|||
126384582|NCT05823974|454703059|FG007|Overall Study|Physician Decision|0|||
126384583|NCT05823974|454703060|FG008|Overall Study|Physician Decision|0|||
126384584|NCT05823974|454703061|FG009|Overall Study|Physician Decision|0|||
126384585|NCT05823974|454703062|FG010|Overall Study|Physician Decision|0|||
126384586|NCT05823974|454703063|FG011|Overall Study|Physician Decision|0|||
126384587|NCT05823974|454703064|FG012|Overall Study|Physician Decision|0|||
126384588|NCT05823974|454703065|FG013|Overall Study|Physician Decision|0|||
126384589|NCT05823974|454703066|FG014|Overall Study|Physician Decision|0|||
126384590|NCT05823974|454703067|FG015|Overall Study|Physician Decision|1|||
126384591|NCT05823974|454703068|FG016|Overall Study|Physician Decision|0|||
126384592|NCT05823974|454703069|FG017|Overall Study|Physician Decision|1|||
126384593|NCT05823974|454703070|FG018|Overall Study|Physician Decision|1|||
126384594|NCT05823974|454703071|FG019|Overall Study|Physician Decision|0|||
126384595|NCT05823974|454703072|FG020|Overall Study|Physician Decision|0|||
126384596|NCT05823974|454703052|FG000|Overall Study|Withdrawal by Subject|1|||
126384597|NCT05823974|454703053|FG001|Overall Study|Withdrawal by Subject|1|||
126384598|NCT05823974|454703054|FG002|Overall Study|Withdrawal by Subject|2|||
126384599|NCT05823974|454703055|FG003|Overall Study|Withdrawal by Subject|0|||
126384600|NCT05823974|454703056|FG004|Overall Study|Withdrawal by Subject|2|||
126384601|NCT05823974|454703057|FG005|Overall Study|Withdrawal by Subject|3|||
126384602|NCT05823974|454703058|FG006|Overall Study|Withdrawal by Subject|1|||
126384603|NCT05823974|454703059|FG007|Overall Study|Withdrawal by Subject|1|||
126384604|NCT05823974|454703060|FG008|Overall Study|Withdrawal by Subject|2|||
126384605|NCT05823974|454703061|FG009|Overall Study|Withdrawal by Subject|1|||
126384606|NCT05823974|454703062|FG010|Overall Study|Withdrawal by Subject|1|||
126384607|NCT05823974|454703063|FG011|Overall Study|Withdrawal by Subject|0|||
126384608|NCT05823974|454703064|FG012|Overall Study|Withdrawal by Subject|0|||
126384609|NCT05823974|454703065|FG013|Overall Study|Withdrawal by Subject|1|||
126384610|NCT05823974|454703066|FG014|Overall Study|Withdrawal by Subject|1|||
126384611|NCT05823974|454703067|FG015|Overall Study|Withdrawal by Subject|3|||
126384612|NCT05823974|454703068|FG016|Overall Study|Withdrawal by Subject|0|||
126384613|NCT05823974|454703069|FG017|Overall Study|Withdrawal by Subject|2|||
126384614|NCT05823974|454703070|FG018|Overall Study|Withdrawal by Subject|2|||
126384615|NCT05823974|454703071|FG019|Overall Study|Withdrawal by Subject|0|||
126384616|NCT05823974|454703072|FG020|Overall Study|Withdrawal by Subject|1|||
126384617|NCT05823974|454703052|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384618|NCT05823974|454703053|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384619|NCT05823974|454703054|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126384620|NCT05823974|454703055|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384621|NCT05823974|454703056|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384622|NCT05823974|454703057|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384623|NCT05823974|454703058|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384624|NCT05823974|454703059|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384625|NCT05823974|454703060|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384626|NCT05823974|454703061|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384627|NCT05823974|454703062|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384628|NCT05823974|454703063|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384629|NCT05823974|454703064|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384630|NCT05823974|454703065|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384631|NCT05823974|454703066|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126384632|NCT05823974|454703067|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384633|NCT05823974|454703068|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384634|NCT05823974|454703069|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384635|NCT05823974|454703070|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126104202|NCT03057977|453675822|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
126384636|NCT05823974|454703071|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384637|NCT05823974|454703072|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384638|NCT05823974|454703052|FG000|Overall Study|Other|0|||
126384639|NCT05823974|454703053|FG001|Overall Study|Other|1|||
126384640|NCT05823974|454703054|FG002|Overall Study|Other|1|||
126384641|NCT05823974|454703055|FG003|Overall Study|Other|1|||
126384642|NCT05823974|454703056|FG004|Overall Study|Other|0|||
126384643|NCT05823974|454703057|FG005|Overall Study|Other|1|||
126384644|NCT05823974|454703058|FG006|Overall Study|Other|1|||
126384645|NCT05823974|454703059|FG007|Overall Study|Other|1|||
126384646|NCT05823974|454703060|FG008|Overall Study|Other|1|||
126384647|NCT05823974|454703061|FG009|Overall Study|Other|0|||
126384648|NCT05823974|454703062|FG010|Overall Study|Other|0|||
126384649|NCT05823974|454703063|FG011|Overall Study|Other|0|||
126384650|NCT05823974|454703064|FG012|Overall Study|Other|2|||
126384651|NCT05823974|454703065|FG013|Overall Study|Other|1|||
126384652|NCT05823974|454703066|FG014|Overall Study|Other|0|||
126384653|NCT05823974|454703067|FG015|Overall Study|Other|1|||
126384654|NCT05823974|454703068|FG016|Overall Study|Other|0|||
126384655|NCT05823974|454703069|FG017|Overall Study|Other|0|||
126384656|NCT05823974|454703070|FG018|Overall Study|Other|0|||
126384657|NCT05823974|454703071|FG019|Overall Study|Other|0|||
126384658|NCT05823974|454703072|FG020|Overall Study|Other|0|||
126384659|NCT00316706|454703073|FG000|Overall Study|Lost to Follow-up|38|||
126384660|NCT00316706|454703074|FG001|Overall Study|Lost to Follow-up|48|||
126384661|NCT03292874|454703078|FG000|Overall Study|Due to pandemic|5|||
126384662|NCT00485758|454703086|FG000|Overall Study|Adverse Event|102|||
126384663|NCT00485758|454703087|FG001|Overall Study|Adverse Event|31|||
126384664|NCT00485758|454703086|FG000|Overall Study|Death|0|||
126384665|NCT00485758|454703087|FG001|Overall Study|Death|1|||
126384666|NCT00485758|454703086|FG000|Overall Study|Lost to Follow-up|5|||
126384667|NCT00485758|454703087|FG001|Overall Study|Lost to Follow-up|1|||
126384668|NCT00485758|454703086|FG000|Overall Study|Physician Decision|3|||
126384669|NCT00485758|454703087|FG001|Overall Study|Physician Decision|3|||
126384670|NCT00485758|454703086|FG000|Overall Study|Protocol Violation|11|||
126384671|NCT00485758|454703087|FG001|Overall Study|Protocol Violation|2|||
126384672|NCT00485758|454703086|FG000|Overall Study|Withdrawal by Subject|32|||
126384673|NCT00485758|454703087|FG001|Overall Study|Withdrawal by Subject|27|||
126384674|NCT00485758|454703086|FG000|Overall Study|Study Terminated by Sponsor|3|||
126384675|NCT00485758|454703087|FG001|Overall Study|Study Terminated by Sponsor|0|||
126384676|NCT00654745|454703088|FG000|Overall Study|Adverse Event|12|||
126384677|NCT00654745|454703088|FG000|Overall Study|Lost to Follow-up|7|||
126384678|NCT00654745|454703088|FG000|Overall Study|Protocol Violation|11|||
126384679|NCT00654745|454703088|FG000|Overall Study|Withdrawal by Subject|10|||
126384680|NCT00654745|454703088|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
126384681|NCT01995526|454703089|FG000|Overall Study|Physician Decision|1|||
126384682|NCT00383331|454703090|FG000|Overall Study|Protocol Violation|0|||
126384683|NCT00383331|454703091|FG001|Overall Study|Protocol Violation|1|||
126384684|NCT02229825|454703099|FG000|Overall Study|Personal Reasons|0|||
126384685|NCT02229825|454703100|FG001|Overall Study|Personal Reasons|1|||
126384686|NCT02229825|454703099|FG000|Overall Study|Refused continuing medication|7|||
126384687|NCT02229825|454703100|FG001|Overall Study|Refused continuing medication|6|||
126384688|NCT02229825|454703099|FG000|Overall Study|Lost to Follow-up|1|||
126384689|NCT02229825|454703100|FG001|Overall Study|Lost to Follow-up|2|||
126384690|NCT02229825|454703099|FG000|Overall Study|Protocol Violation|1|||
126384691|NCT02229825|454703100|FG001|Overall Study|Protocol Violation|1|||
126384692|NCT02229825|454703099|FG000|Overall Study|Lack of Efficacy|4|||
126384693|NCT02229825|454703100|FG001|Overall Study|Lack of Efficacy|10|||
126384694|NCT02229825|454703099|FG000|Overall Study|Adverse Event|11|||
126384695|NCT02229825|454703100|FG001|Overall Study|Adverse Event|9|||
126384696|NCT02229825|454703099|FG000|Overall Study|Not treated|0|||
126384697|NCT02229825|454703100|FG001|Overall Study|Not treated|1|||
126048631|NCT01961609|453475230|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
126384698|NCT01532921|454703105|FG000|Overall Study|Death|3|||
126384699|NCT01532921|454703105|FG000|Overall Study|Withdrawal by Subject|2|||
126384700|NCT01532921|454703105|FG000|Overall Study|Lost to Follow-up|3|||
126384701|NCT01532921|454703105|FG000|Overall Study|Physician Decision|7|||
126048632|NCT01961609|453475231|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
126048633|NCT01961609|453475228|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
126048634|NCT01961609|453475229|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
126048635|NCT01961609|453475230|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
126048636|NCT01961609|453475231|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
126048637|NCT01961609|453475228|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
126384702|NCT01532921|454703105|FG000|Overall Study|Device was explanted during procedure|1|||
126384703|NCT00070109|454703106|FG000|Overall Study|Death|1|||
126384704|NCT00070109|454703107|FG001|Overall Study|Death|1|||
126384705|NCT00070109|454703108|FG002|Overall Study|Death|0|||
126384706|NCT00070109|454703109|FG003|Overall Study|Death|0|||
126384707|NCT00070109|454703110|FG004|Overall Study|Death|1|||
126384708|NCT00070109|454703106|FG000|Overall Study|Lack of Efficacy|6|||
126384709|NCT00070109|454703107|FG001|Overall Study|Lack of Efficacy|4|||
126384710|NCT00070109|454703108|FG002|Overall Study|Lack of Efficacy|5|||
126384711|NCT00070109|454703109|FG003|Overall Study|Lack of Efficacy|15|||
126384712|NCT00070109|454703110|FG004|Overall Study|Lack of Efficacy|5|||
126384713|NCT00070109|454703106|FG000|Overall Study|Physician Decision|1|||
126384714|NCT00070109|454703107|FG001|Overall Study|Physician Decision|0|||
126384715|NCT00070109|454703108|FG002|Overall Study|Physician Decision|0|||
126384716|NCT00070109|454703109|FG003|Overall Study|Physician Decision|0|||
126384717|NCT00070109|454703110|FG004|Overall Study|Physician Decision|0|||
126384718|NCT00070109|454703106|FG000|Overall Study|Withdrawal by Subject|0|||
126384719|NCT00070109|454703107|FG001|Overall Study|Withdrawal by Subject|1|||
126384720|NCT00070109|454703108|FG002|Overall Study|Withdrawal by Subject|1|||
126384721|NCT00070109|454703109|FG003|Overall Study|Withdrawal by Subject|0|||
126384722|NCT00070109|454703110|FG004|Overall Study|Withdrawal by Subject|0|||
126384723|NCT00070109|454703106|FG000|Overall Study|Adverse Event|0|||
126384724|NCT00070109|454703107|FG001|Overall Study|Adverse Event|0|||
126384725|NCT00070109|454703108|FG002|Overall Study|Adverse Event|2|||
126384726|NCT00070109|454703109|FG003|Overall Study|Adverse Event|4|||
126384727|NCT00070109|454703110|FG004|Overall Study|Adverse Event|2|||
126384728|NCT00070109|454703106|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
126384729|NCT00070109|454703107|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
126384730|NCT00070109|454703108|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
126384731|NCT00070109|454703109|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
126384732|NCT00070109|454703110|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
126384733|NCT00624468|454703116|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
126384734|NCT00624468|454703117|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
126384735|NCT00624468|454703118|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
126384736|NCT00624468|454703119|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
126384737|NCT00624468|454703116|FG000|Double-blind Period|Withdrew Prematurely|1|||
126384738|NCT00624468|454703117|FG001|Double-blind Period|Withdrew Prematurely|1|||
126384739|NCT00624468|454703118|FG002|Double-blind Period|Withdrew Prematurely|0|||
126384740|NCT00624468|454703119|FG003|Double-blind Period|Withdrew Prematurely|0|||
126384741|NCT00624468|454703116|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
126384742|NCT00624468|454703117|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
126384743|NCT00624468|454703118|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
126384744|NCT00624468|454703119|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
126384745|NCT00624468|454703116|FG000|Safety Follow-up (SFU) Period|Other|0|||
126384746|NCT00624468|454703117|FG001|Safety Follow-up (SFU) Period|Other|0|||
126384747|NCT00624468|454703118|FG002|Safety Follow-up (SFU) Period|Other|1|||
126384748|NCT00624468|454703119|FG003|Safety Follow-up (SFU) Period|Other|1|||
126384749|NCT01524224|454703122|FG000|Overall Study|Progressive Disease|1|||
126384750|NCT01524224|454703123|FG001|Overall Study|Progressive Disease|0|||
126384751|NCT01524224|454703124|FG002|Overall Study|Progressive Disease|2|||
126384752|NCT01524224|454703125|FG003|Overall Study|Progressive Disease|1|||
126384753|NCT01524224|454703126|FG004|Overall Study|Progressive Disease|2|||
126384754|NCT01524224|454703127|FG005|Overall Study|Progressive Disease|1|||
126384755|NCT01524224|454703128|FG006|Overall Study|Progressive Disease|1|||
126384756|NCT01524224|454703129|FG007|Overall Study|Progressive Disease|5|||
126048638|NCT01961609|453475229|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
126384757|NCT01524224|454703122|FG000|Overall Study|Withdrawal by Subject|2|||
126384758|NCT01524224|454703123|FG001|Overall Study|Withdrawal by Subject|0|||
126384759|NCT01524224|454703124|FG002|Overall Study|Withdrawal by Subject|0|||
126384760|NCT01524224|454703125|FG003|Overall Study|Withdrawal by Subject|0|||
126384761|NCT01524224|454703126|FG004|Overall Study|Withdrawal by Subject|0|||
126048639|NCT01961609|453475230|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
126048640|NCT01961609|453475231|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
126048641|NCT01961609|453475228|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
126048642|NCT01961609|453475229|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
126384762|NCT01524224|454703127|FG005|Overall Study|Withdrawal by Subject|0|||
126384763|NCT01524224|454703128|FG006|Overall Study|Withdrawal by Subject|2|||
126384764|NCT01524224|454703129|FG007|Overall Study|Withdrawal by Subject|0|||
126048643|NCT01961609|453475230|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
126048644|NCT01961609|453475231|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
126048645|NCT01961609|453475228|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
126384765|NCT01524224|454703122|FG000|Overall Study|Adverse Event|0|||
126384766|NCT01524224|454703123|FG001|Overall Study|Adverse Event|1|||
126384767|NCT01524224|454703124|FG002|Overall Study|Adverse Event|0|||
126384768|NCT01524224|454703125|FG003|Overall Study|Adverse Event|0|||
126384769|NCT01524224|454703126|FG004|Overall Study|Adverse Event|0|||
126384770|NCT01524224|454703127|FG005|Overall Study|Adverse Event|1|||
126384771|NCT01524224|454703128|FG006|Overall Study|Adverse Event|0|||
126384772|NCT01524224|454703129|FG007|Overall Study|Adverse Event|0|||
126048646|NCT01961609|453475229|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
126384773|NCT01524224|454703122|FG000|Overall Study|Physician Decision|0|||
126384774|NCT01524224|454703123|FG001|Overall Study|Physician Decision|0|||
126384775|NCT01524224|454703124|FG002|Overall Study|Physician Decision|0|||
126384776|NCT01524224|454703125|FG003|Overall Study|Physician Decision|1|||
126384777|NCT01524224|454703126|FG004|Overall Study|Physician Decision|1|||
126384778|NCT01524224|454703127|FG005|Overall Study|Physician Decision|0|||
126384779|NCT01524224|454703128|FG006|Overall Study|Physician Decision|0|||
126384780|NCT01524224|454703129|FG007|Overall Study|Physician Decision|1|||
126384781|NCT01524224|454703122|FG000|Overall Study|Sponsor Decision|0|||
126384782|NCT01524224|454703123|FG001|Overall Study|Sponsor Decision|0|||
126384783|NCT01524224|454703124|FG002|Overall Study|Sponsor Decision|0|||
126384784|NCT01524224|454703125|FG003|Overall Study|Sponsor Decision|0|||
126384785|NCT01524224|454703126|FG004|Overall Study|Sponsor Decision|1|||
126384786|NCT01524224|454703127|FG005|Overall Study|Sponsor Decision|0|||
126384787|NCT01524224|454703128|FG006|Overall Study|Sponsor Decision|0|||
126384788|NCT01524224|454703129|FG007|Overall Study|Sponsor Decision|0|||
126384789|NCT00803361|454703131|FG000|Overall Study|Adverse Event|13|||
126384790|NCT00803361|454703132|FG001|Overall Study|Adverse Event|3|||
126384791|NCT00803361|454703131|FG000|Overall Study|Lack of Efficacy|4|||
126048647|NCT01961609|453475230|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
126048648|NCT01961609|453475231|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
126048649|NCT01961609|453475228|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
126048650|NCT01961609|453475229|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
126048651|NCT01961609|453475230|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
126048652|NCT01961609|453475231|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
126048653|NCT01961609|453475228|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
126048654|NCT01961609|453475229|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
126048655|NCT01961609|453475230|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
126048656|NCT01961609|453475231|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
126048657|NCT01961609|453475228|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
126048658|NCT01961609|453475229|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
126048659|NCT01961609|453475230|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
126048660|NCT01961609|453475231|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
126048661|NCT01961609|453475228|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
126048662|NCT01961609|453475229|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
126048663|NCT01961609|453475230|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
126048664|NCT01961609|453475231|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
126048665|NCT01961609|453475228|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
126048666|NCT01961609|453475229|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
126048667|NCT01961609|453475230|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
126048668|NCT01961609|453475231|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
126048669|NCT00582972|453475233|FG000|Overall Study|Protocol Violation|2|||
126048670|NCT01211184|453475239|FG000|Overall Study|Withdrawal by Subject|0|||
126048671|NCT01211184|453475240|FG001|Overall Study|Withdrawal by Subject|2|||
126048672|NCT01211184|453475241|FG002|Overall Study|Withdrawal by Subject|1|||
126048673|NCT00822120|453475242|FG000|Initial Registration|Adverse Event|1|||
126384792|NCT00803361|454703132|FG001|Overall Study|Lack of Efficacy|13|||
126384793|NCT00803361|454703131|FG000|Overall Study|Lost to Follow-up|1|||
126384794|NCT00803361|454703132|FG001|Overall Study|Lost to Follow-up|2|||
126384795|NCT00803361|454703131|FG000|Overall Study|Physician Decision|1|||
126384796|NCT00803361|454703132|FG001|Overall Study|Physician Decision|0|||
126384797|NCT00803361|454703131|FG000|Overall Study|Protocol Violation|2|||
126384798|NCT00803361|454703132|FG001|Overall Study|Protocol Violation|4|||
126384799|NCT00803361|454703131|FG000|Overall Study|Withdrawal by Subject|5|||
126384800|NCT00803361|454703132|FG001|Overall Study|Withdrawal by Subject|6|||
126384801|NCT02858440|454703133|FG000|Overall Study|Lost to Follow-up|3|||
126048674|NCT00822120|453475243|FG001|Initial Registration|Adverse Event|0|||
126104203|NCT03057977|453675821|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
126104204|NCT03057977|453675822|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
126384802|NCT02858440|454703133|FG000|Overall Study|Protocol Violation|2|||
126384803|NCT02858440|454703133|FG000|Overall Study|Consent withdrawal|3|||
126384804|NCT02858440|454703133|FG000|Overall Study|Migrated/moved from study area|4|||
126384805|NCT01670279|454703134|FG000|Overall Study|Adverse Event|0|||
126384806|NCT01670279|454703135|FG001|Overall Study|Adverse Event|1|||
126384807|NCT01670279|454703136|FG002|Overall Study|Adverse Event|0|||
126384808|NCT01670279|454703137|FG003|Overall Study|Adverse Event|0|||
126384809|NCT01670279|454703134|FG000|Overall Study|Physician Decision|0|||
126384810|NCT01670279|454703135|FG001|Overall Study|Physician Decision|1|||
126048675|NCT00822120|453475244|FG002|Initial Registration|Adverse Event|0|||
126048676|NCT00822120|453475245|FG003|Initial Registration|Adverse Event|0|||
126048677|NCT00822120|453475246|FG004|Initial Registration|Adverse Event|0|||
126384811|NCT01670279|454703136|FG002|Overall Study|Physician Decision|0|||
126384812|NCT01670279|454703137|FG003|Overall Study|Physician Decision|0|||
126384813|NCT01670279|454703134|FG000|Overall Study|Participant met withdrawal criteria|0|||
126384814|NCT01670279|454703135|FG001|Overall Study|Participant met withdrawal criteria|0|||
126384815|NCT01670279|454703136|FG002|Overall Study|Participant met withdrawal criteria|0|||
126384816|NCT01670279|454703137|FG003|Overall Study|Participant met withdrawal criteria|1|||
126384817|NCT01901614|454703138|FG000|Overall Study|Adverse Event|0|||
126384818|NCT01901614|454703139|FG001|Overall Study|Adverse Event|1|||
126384819|NCT01901614|454703138|FG000|Overall Study|Lost to Follow-up|1|||
126384820|NCT01901614|454703139|FG001|Overall Study|Lost to Follow-up|0|||
126384821|NCT01901614|454703138|FG000|Overall Study|Screen Fail|1|||
126384822|NCT01901614|454703139|FG001|Overall Study|Screen Fail|0|||
126384823|NCT01823198|454703140|FG000|Overall Study|Physician Decision|0|||
126384824|NCT01823198|454703141|FG001|Overall Study|Physician Decision|1|||
126384825|NCT01823198|454703142|FG002|Overall Study|Physician Decision|0|||
126384826|NCT01823198|454703143|FG003|Overall Study|Physician Decision|0|||
126384827|NCT01823198|454703144|FG004|Overall Study|Physician Decision|0|||
126384828|NCT01823198|454703145|FG005|Overall Study|Physician Decision|3|||
126384829|NCT01823198|454703146|FG006|Overall Study|Physician Decision|3|||
126384830|NCT02674464|454703147|FG000|Overall Study|Death|10|||
126384831|NCT02674464|454703148|FG001|Overall Study|Death|21|||
126384832|NCT02674464|454703147|FG000|Overall Study|Withdrawal by Subject|24|||
126384833|NCT02674464|454703148|FG001|Overall Study|Withdrawal by Subject|44|||
126384834|NCT02674464|454703147|FG000|Overall Study|Lost to Follow-up|97|||
126384835|NCT02674464|454703148|FG001|Overall Study|Lost to Follow-up|92|||
126384836|NCT02674464|454703147|FG000|Overall Study|Outside survey window|6|||
126384837|NCT02674464|454703148|FG001|Overall Study|Outside survey window|3|||
126384838|NCT00783835|454703149|FG000|Overall Study|Adverse Event|3|||
126384839|NCT00783835|454703149|FG000|Overall Study|Medical Criteria|1|||
126384840|NCT00783835|454703149|FG000|Overall Study|Withdrawal by Subject|2|||
126384841|NCT00783835|454703149|FG000|Overall Study|Lost to Follow-up|1|||
126384842|NCT00783835|454703149|FG000|Overall Study|Participant not Adherent|3|||
126384843|NCT01262638|454703150|FG000|Overall Study|Adverse Event|3|||
126384844|NCT01262638|454703151|FG001|Overall Study|Adverse Event|4|||
126384845|NCT01262638|454703152|FG002|Overall Study|Adverse Event|3|||
126384846|NCT01262638|454703153|FG003|Overall Study|Adverse Event|4|||
126384847|NCT01262638|454703150|FG000|Overall Study|Protocol Violation|1|||
126384848|NCT01262638|454703151|FG001|Overall Study|Protocol Violation|0|||
126384849|NCT01262638|454703152|FG002|Overall Study|Protocol Violation|0|||
126384850|NCT01262638|454703153|FG003|Overall Study|Protocol Violation|1|||
126384851|NCT01262638|454703150|FG000|Overall Study|Withdrawal by Subject|2|||
126384852|NCT01262638|454703151|FG001|Overall Study|Withdrawal by Subject|1|||
126384853|NCT01262638|454703152|FG002|Overall Study|Withdrawal by Subject|0|||
126384854|NCT01262638|454703153|FG003|Overall Study|Withdrawal by Subject|1|||
126384855|NCT01262638|454703150|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
126384856|NCT01262638|454703151|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
126384857|NCT01262638|454703152|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
126384858|NCT01262638|454703153|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
126384859|NCT01262638|454703150|FG000|Overall Study|Lost to Follow-up|1|||
126384860|NCT01262638|454703151|FG001|Overall Study|Lost to Follow-up|1|||
126384861|NCT01262638|454703152|FG002|Overall Study|Lost to Follow-up|1|||
126384862|NCT01262638|454703153|FG003|Overall Study|Lost to Follow-up|1|||
126384863|NCT01262638|454703150|FG000|Overall Study|Participant Went Out of Town|0|||
126384864|NCT01262638|454703151|FG001|Overall Study|Participant Went Out of Town|0|||
126384865|NCT01262638|454703152|FG002|Overall Study|Participant Went Out of Town|1|||
126384866|NCT01262638|454703153|FG003|Overall Study|Participant Went Out of Town|0|||
126384867|NCT02243371|454703158|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
126384868|NCT02243371|454703159|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
126384869|NCT02243371|454703158|FG000|Overall Study|Death (unrelated)|2|||
126384870|NCT02243371|454703159|FG001|Overall Study|Death (unrelated)|4|||
126384871|NCT02243371|454703158|FG000|Overall Study|Adverse Event (unrelated)|0|||
126384872|NCT02243371|454703159|FG001|Overall Study|Adverse Event (unrelated)|1|||
126384873|NCT02243371|454703158|FG000|Overall Study|Lack of Clinical Benefit|0|||
126384874|NCT02243371|454703159|FG001|Overall Study|Lack of Clinical Benefit|1|||
126384875|NCT02243371|454703158|FG000|Overall Study|Withdrawal by Subject|0|||
126384876|NCT02243371|454703159|FG001|Overall Study|Withdrawal by Subject|2|||
126384877|NCT01369199|454703160|FG000|Overall Study|Withdrawal by Subject|1|||
126384878|NCT01369199|454703160|FG000|Overall Study|Lost to Follow-up|2|||
126384879|NCT01066104|454703161|FG000|Overall Study|Adverse Event|1|||
126384880|NCT01066104|454703162|FG001|Overall Study|Adverse Event|1|||
126384881|NCT01066104|454703161|FG000|Overall Study|Protocol Violation|1|||
126384882|NCT01066104|454703162|FG001|Overall Study|Protocol Violation|0|||
126384883|NCT02091362|454703170|FG000|Period 1|Protocol Violation|1|||
126384884|NCT02091362|454703171|FG001|Period 1|Protocol Violation|0|||
126384885|NCT02091362|454703170|FG000|Period 1|Withdrawal by Subject|2|||
126384886|NCT02091362|454703171|FG001|Period 1|Withdrawal by Subject|3|||
126384887|NCT02091362|454703170|FG000|Period 1|Lost to Follow-up|0|||
126384888|NCT02091362|454703171|FG001|Period 1|Lost to Follow-up|1|||
126384889|NCT02091362|454703170|FG000|Period 1|Adverse Event|2|||
126384890|NCT02091362|454703171|FG001|Period 1|Adverse Event|0|||
126384891|NCT02091362|454703170|FG000|Wash-out|Lost to Follow-up|1|||
126384892|NCT02091362|454703171|FG001|Wash-out|Lost to Follow-up|1|||
126384893|NCT02091362|454703170|FG000|Wash-out|Withdrawal by Subject|0|||
126384894|NCT02091362|454703171|FG001|Wash-out|Withdrawal by Subject|2|||
126384895|NCT02091362|454703170|FG000|Period 2|Adverse Event|1|||
126384896|NCT02091362|454703171|FG001|Period 2|Adverse Event|0|||
126384897|NCT02091362|454703170|FG000|Period 2|Lost to Follow-up|0|||
126384898|NCT02091362|454703171|FG001|Period 2|Lost to Follow-up|1|||
126384899|NCT02091362|454703170|FG000|Period 2|Withdrawal by Subject|1|||
126384900|NCT02091362|454703171|FG001|Period 2|Withdrawal by Subject|1|||
126384901|NCT00470262|454703172|FG000|Overall Study|Withdrawal by Subject|2|||
126384902|NCT00470262|454703173|FG001|Overall Study|Withdrawal by Subject|0|||
126384903|NCT03900728|454703174|FG000|Overall Study|No text responses|0|||
126384904|NCT03900728|454703175|FG001|Overall Study|No text responses|0|||
126384905|NCT03900728|454703176|FG002|Overall Study|No text responses|4|||
126384906|NCT03248167|454703185|FG000|Overall Study|Withdrawal by Subject|2|||
126384907|NCT03248167|454703186|FG001|Overall Study|Withdrawal by Subject|2|||
126384908|NCT03248167|454703185|FG000|Overall Study|Physician Decision|0|||
126384909|NCT03248167|454703186|FG001|Overall Study|Physician Decision|1|||
126384910|NCT03248167|454703185|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
126384911|NCT03248167|454703186|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
126384912|NCT03248167|454703185|FG000|Overall Study|Lost to Follow-up|1|||
126384913|NCT03248167|454703186|FG001|Overall Study|Lost to Follow-up|0|||
126384914|NCT02122146|454703187|FG000|Part 1: Dose Escalation|Death|0|||
126384915|NCT02122146|454703188|FG001|Part 1: Dose Escalation|Death|1|||
126384916|NCT02122146|454703189|FG002|Part 1: Dose Escalation|Death|1|||
126384917|NCT02122146|454703190|FG003|Part 1: Dose Escalation|Death|0|||
126384918|NCT02122146|454703191|FG004|Part 1: Dose Escalation|Death|0|||
126384919|NCT02122146|454703192|FG005|Part 1: Dose Escalation|Death|0|||
125886704|NCT00473382|452881819|FG000|Core Study|Subject non-compliance|5|||
125886705|NCT00473382|452881820|FG001|Core Study|Subject non-compliance|2|||
125886706|NCT00473382|452881821|FG002|Core Study|Subject non-compliance|1|||
125886707|NCT00473382|452881819|FG000|Core Study|Subject needed other treatment|1|||
125886708|NCT00473382|452881820|FG001|Core Study|Subject needed other treatment|3|||
125886709|NCT00473382|452881821|FG002|Core Study|Subject needed other treatment|2|||
125886710|NCT00473382|452881819|FG000|Core Study|Subject's decision|12|||
125886711|NCT00473382|452881820|FG001|Core Study|Subject's decision|11|||
126384920|NCT02122146|454703193|FG006|Part 1: Dose Escalation|Death|0|||
126384921|NCT02122146|454703194|FG007|Part 1: Dose Escalation|Death|0|||
126384922|NCT02122146|454703187|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384923|NCT02122146|454703188|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384924|NCT02122146|454703189|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
126384925|NCT02122146|454703190|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384926|NCT02122146|454703191|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
126384927|NCT02122146|454703192|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384928|NCT02122146|454703193|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384929|NCT02122146|454703194|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384930|NCT02122146|454703187|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384931|NCT02122146|454703188|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384932|NCT02122146|454703189|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384933|NCT02122146|454703190|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
126384934|NCT02122146|454703191|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384935|NCT02122146|454703192|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384936|NCT02122146|454703193|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384937|NCT02122146|454703194|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384938|NCT02122146|454703187|FG000|Part 1: Dose Escalation|Other|1|||
126384939|NCT02122146|454703188|FG001|Part 1: Dose Escalation|Other|0|||
126384940|NCT02122146|454703189|FG002|Part 1: Dose Escalation|Other|0|||
126384941|NCT02122146|454703190|FG003|Part 1: Dose Escalation|Other|0|||
126384942|NCT02122146|454703191|FG004|Part 1: Dose Escalation|Other|0|||
126384943|NCT02122146|454703192|FG005|Part 1: Dose Escalation|Other|1|||
126384944|NCT02122146|454703193|FG006|Part 1: Dose Escalation|Other|1|||
126384945|NCT02122146|454703194|FG007|Part 1: Dose Escalation|Other|2|||
126384946|NCT03835481|454703195|FG000|Double-blind Period|Other not stated below|0|||
126384947|NCT03835481|454703196|FG001|Double-blind Period|Other not stated below|0|||
126384948|NCT03835481|454703197|FG002|Double-blind Period|Other not stated below|0|||
126384949|NCT03835481|454703198|FG003|Double-blind Period|Other not stated below|1|||
126384950|NCT03835481|454703199|FG004|Double-blind Period|Other not stated below|1|||
126384951|NCT03835481|454703195|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
126384952|NCT03835481|454703196|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
126384953|NCT03835481|454703197|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
126104205|NCT03057977|453675821|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
126384954|NCT03835481|454703198|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
126384955|NCT03835481|454703199|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
126384956|NCT03835481|454703195|FG000|Double-blind Period|Withdrawal by Subject|0|||
125886712|NCT00473382|452881821|FG002|Core Study|Subject's decision|10|||
125886713|NCT00473382|452881819|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
126384957|NCT03835481|454703196|FG001|Double-blind Period|Withdrawal by Subject|0|||
126384958|NCT03835481|454703197|FG002|Double-blind Period|Withdrawal by Subject|1|||
126384959|NCT03835481|454703198|FG003|Double-blind Period|Withdrawal by Subject|0|||
126384960|NCT03835481|454703199|FG004|Double-blind Period|Withdrawal by Subject|5|||
126384961|NCT03835481|454703195|FG000|Double-blind Period|Lost to Follow-up|0|||
126384962|NCT03835481|454703196|FG001|Double-blind Period|Lost to Follow-up|0|||
126384963|NCT03835481|454703197|FG002|Double-blind Period|Lost to Follow-up|0|||
126384964|NCT03835481|454703198|FG003|Double-blind Period|Lost to Follow-up|1|||
126384965|NCT03835481|454703199|FG004|Double-blind Period|Lost to Follow-up|0|||
126384966|NCT03835481|454703195|FG000|Double-blind Period|Protocol Violation|0|||
126384967|NCT03835481|454703196|FG001|Double-blind Period|Protocol Violation|2|||
126384968|NCT03835481|454703197|FG002|Double-blind Period|Protocol Violation|0|||
126384969|NCT03835481|454703198|FG003|Double-blind Period|Protocol Violation|1|||
126384970|NCT03835481|454703199|FG004|Double-blind Period|Protocol Violation|0|||
126384971|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
126384972|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
126384973|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
126384974|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
126384975|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
126384976|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
126384977|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
126384978|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
126384979|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
126384980|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
126384981|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
126384982|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
126384983|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
126384984|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
126384985|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
126384986|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
126384987|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
126384988|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
126384989|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
126384990|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
126384991|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
126384992|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
126384993|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
126384994|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
126384995|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
126384996|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
126384997|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
126384998|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
126384999|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
126385000|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
126385001|NCT00191945|454703201|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
126385002|NCT00191945|454703202|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
126385003|NCT00191945|454703201|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
126385004|NCT00191945|454703202|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
126385005|NCT00191945|454703201|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
126385006|NCT00191945|454703202|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
126385007|NCT00191945|454703201|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
126385008|NCT00191945|454703202|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
126385009|NCT02725476|454703203|FG000|Overall Study|Physician Decision|2|||
126385010|NCT02725476|454703204|FG001|Overall Study|Physician Decision|0|||
126385011|NCT02725476|454703203|FG000|Overall Study|Adverse Event|1|||
126385012|NCT02725476|454703204|FG001|Overall Study|Adverse Event|1|||
126385013|NCT04188834|454703215|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
126385014|NCT01030952|454703216|FG000|Overall Study|Protocol Violation|0|||
126385015|NCT01030952|454703217|FG001|Overall Study|Protocol Violation|1|||
126385016|NCT01030952|454703216|FG000|Overall Study|Informed consent withdrawal|1|||
126385017|NCT01030952|454703217|FG001|Overall Study|Informed consent withdrawal|0|||
126385018|NCT01030952|454703216|FG000|Overall Study|Lost to Follow-up|0|||
126385019|NCT01030952|454703217|FG001|Overall Study|Lost to Follow-up|1|||
126385020|NCT01030952|454703216|FG000|Overall Study|Unexplained|1|||
126385021|NCT01030952|454703217|FG001|Overall Study|Unexplained|1|||
126385022|NCT00391430|454703218|FG000|Overall Study|Withdrawal by Subject|3|||
126385023|NCT00391430|454703219|FG001|Overall Study|Withdrawal by Subject|0|||
126385024|NCT00391430|454703220|FG002|Overall Study|Withdrawal by Subject|12|||
126385025|NCT00958347|454703224|FG000|Overall Study|Death|43|||
126385026|NCT00958347|454703224|FG000|Overall Study|Withdrawal by Subject|23|||
126104206|NCT03057977|453675822|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
126104207|NCT03057977|453675821|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
126104208|NCT03057977|453675822|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
126104209|NCT03057977|453675821|FG000|Discontinuation From Treatment|Not attending study visit|3|||
126104210|NCT03057977|453675822|FG001|Discontinuation From Treatment|Not attending study visit|10|||
126385027|NCT00958347|454703224|FG000|Overall Study|Lost to Follow-up|15|||
126385028|NCT00958347|454703224|FG000|Overall Study|revision/removal|10|||
126385029|NCT00958347|454703224|FG000|Overall Study|study termination|135|||
126385030|NCT02470585|454703232|FG000|Overall Study|Death|224|||
126385031|NCT02470585|454703233|FG001|Overall Study|Death|227|||
126385032|NCT02470585|454703234|FG002|Overall Study|Death|199|||
126385033|NCT02470585|454703232|FG000|Overall Study|Withdrew consent|21|||
126385034|NCT02470585|454703233|FG001|Overall Study|Withdrew consent|22|||
126385035|NCT02470585|454703234|FG002|Overall Study|Withdrew consent|31|||
126385036|NCT02470585|454703232|FG000|Overall Study|Lost to Follow-up|8|||
126385037|NCT02470585|454703233|FG001|Overall Study|Lost to Follow-up|15|||
126385038|NCT02470585|454703234|FG002|Overall Study|Lost to Follow-up|13|||
126385039|NCT02470585|454703232|FG000|Overall Study|Sponsor discontinued study|117|||
126385040|NCT02470585|454703233|FG001|Overall Study|Sponsor discontinued study|110|||
126385041|NCT02470585|454703234|FG002|Overall Study|Sponsor discontinued study|122|||
126385042|NCT02470585|454703232|FG000|Overall Study|Other, not specified|5|||
126385043|NCT02470585|454703233|FG001|Overall Study|Other, not specified|7|||
126385044|NCT02470585|454703234|FG002|Overall Study|Other, not specified|14|||
126385045|NCT02470585|454703232|FG000|Overall Study|Missing due to site non-compliance|0|||
126385046|NCT02470585|454703233|FG001|Overall Study|Missing due to site non-compliance|2|||
126385047|NCT02470585|454703234|FG002|Overall Study|Missing due to site non-compliance|3|||
126385048|NCT03497039|454703235|FG000|Overall Study|Withdrawal by Subject|1|||
126385049|NCT03497039|454703236|FG001|Overall Study|Withdrawal by Subject|0|||
126385050|NCT03497039|454703235|FG000|Overall Study|Protocol Violation|0|||
126385051|NCT03497039|454703236|FG001|Overall Study|Protocol Violation|1|||
126385052|NCT00465972|454703239|FG000|Overall Study|Withdrawal by Subject|2|||
126385053|NCT00465972|454703240|FG001|Overall Study|Withdrawal by Subject|1|||
126385054|NCT03292640|454703242|FG000|Overall Study|Withdrawal by Subject|17|||
126385055|NCT03292640|454703243|FG001|Overall Study|Withdrawal by Subject|16|||
126385056|NCT03292640|454703242|FG000|Overall Study|Adverse Event|20|||
126385057|NCT03292640|454703243|FG001|Overall Study|Adverse Event|2|||
126385058|NCT03292640|454703242|FG000|Overall Study|Lost to Follow-up|24|||
126385059|NCT03292640|454703243|FG001|Overall Study|Lost to Follow-up|24|||
126385060|NCT02218697|454703244|FG000|Overall Study|Adverse Event|0|||
126385061|NCT02218697|454703245|FG001|Overall Study|Adverse Event|2|||
126385062|NCT02218697|454703244|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
126385063|NCT02218697|454703245|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
126385064|NCT02218697|454703244|FG000|Overall Study|Withdrawal by Subject|2|||
126385065|NCT02218697|454703245|FG001|Overall Study|Withdrawal by Subject|3|||
126385066|NCT03306433|454703248|FG000|Overall Study|Lost to Follow-up|3|||
126385067|NCT03306433|454703248|FG000|Overall Study|Patient did not have teeth extracted|1|||
126385068|NCT03306433|454703248|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
126385069|NCT00294671|454704857|FG000|Overall Study|Lack of Efficacy|11|||
126385070|NCT00294671|454704858|FG001|Overall Study|Lack of Efficacy|23|||
126385071|NCT00294671|454704857|FG000|Overall Study|Liver transplant|7|||
126385072|NCT00294671|454704858|FG001|Overall Study|Liver transplant|9|||
126385073|NCT00294671|454704857|FG000|Overall Study|Drug related adverse event (AE)|4|||
126385074|NCT00294671|454704858|FG001|Overall Study|Drug related adverse event (AE)|2|||
126385075|NCT00294671|454704857|FG000|Overall Study|Non-drug related AE|3|||
126385076|NCT00294671|454704858|FG001|Overall Study|Non-drug related AE|2|||
126385077|NCT00294671|454704857|FG000|Overall Study|Lost to Follow-up|1|||
126385078|NCT00294671|454704858|FG001|Overall Study|Lost to Follow-up|3|||
126385079|NCT00294671|454704857|FG000|Overall Study|Non-compliance|1|||
126385080|NCT00294671|454704858|FG001|Overall Study|Non-compliance|0|||
126385081|NCT00294671|454704857|FG000|Overall Study|Death|0|||
126385082|NCT00294671|454704858|FG001|Overall Study|Death|1|||
126385083|NCT01893411|454704862|FG000|Overall Study|Protocol Violation|1|||
126385084|NCT01893411|454704863|FG001|Overall Study|Protocol Violation|0|||
126385085|NCT01893411|454704864|FG002|Overall Study|Protocol Violation|0|||
126385086|NCT01893411|454704862|FG000|Overall Study|Physician Decision|1|||
126385087|NCT01893411|454704863|FG001|Overall Study|Physician Decision|1|||
126385088|NCT01893411|454704864|FG002|Overall Study|Physician Decision|2|||
126385089|NCT01893411|454704862|FG000|Overall Study|Lack of Efficacy|2|||
126385090|NCT01893411|454704863|FG001|Overall Study|Lack of Efficacy|1|||
126385091|NCT01893411|454704864|FG002|Overall Study|Lack of Efficacy|0|||
126385092|NCT01893411|454704862|FG000|Overall Study|Other|3|||
126385093|NCT01893411|454704863|FG001|Overall Study|Other|1|||
126385094|NCT01893411|454704864|FG002|Overall Study|Other|3|||
126385095|NCT01893411|454704862|FG000|Overall Study|Adverse Event|1|||
126385096|NCT01893411|454704863|FG001|Overall Study|Adverse Event|0|||
126385097|NCT01893411|454704864|FG002|Overall Study|Adverse Event|0|||
126385098|NCT01893411|454704862|FG000|Overall Study|Withdrawal by Subject|7|||
126385099|NCT01893411|454704863|FG001|Overall Study|Withdrawal by Subject|4|||
126385100|NCT01893411|454704864|FG002|Overall Study|Withdrawal by Subject|3|||
126385101|NCT01893411|454704862|FG000|Overall Study|Lost to Follow-up|2|||
126385102|NCT01893411|454704863|FG001|Overall Study|Lost to Follow-up|0|||
126385103|NCT01893411|454704864|FG002|Overall Study|Lost to Follow-up|1|||
126385104|NCT02403817|454704867|FG000|Overall Study|Withdrawal by Subject|5|||
126385105|NCT02403817|454704868|FG001|Overall Study|Withdrawal by Subject|0|||
126385106|NCT03053440|454704869|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
126385107|NCT03053440|454704870|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
126385108|NCT03053440|454704869|FG000|Overall Study|Death|18|||
126385109|NCT03053440|454704870|FG001|Overall Study|Death|14|||
126385110|NCT03053440|454704869|FG000|Overall Study|Withdrawal by Subject|9|||
126385111|NCT03053440|454704870|FG001|Overall Study|Withdrawal by Subject|8|||
126385112|NCT03053440|454704869|FG000|Overall Study|Lost to Follow-up|1|||
126385113|NCT03053440|454704870|FG001|Overall Study|Lost to Follow-up|0|||
126385114|NCT03053440|454704869|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
126385115|NCT03053440|454704870|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
126385116|NCT03053440|454704869|FG000|Overall Study|Physician Decision|2|||
126385117|NCT03053440|454704870|FG001|Overall Study|Physician Decision|1|||
126385118|NCT03053440|454704869|FG000|Overall Study|Participant Randomized but died before dosing|1|||
126385119|NCT03053440|454704870|FG001|Overall Study|Participant Randomized but died before dosing|0|||
126385120|NCT00430989|454704871|FG000|Overall Study|Lost to Follow-up|2|||
126385121|NCT00430989|454704872|FG001|Overall Study|Lost to Follow-up|3|||
126385122|NCT00430989|454704871|FG000|Overall Study|Withdrawal by Subject|15|||
126385123|NCT00430989|454704872|FG001|Overall Study|Withdrawal by Subject|14|||
126385124|NCT00430989|454704871|FG000|Overall Study|Protocol Violation|30|||
126385125|NCT00430989|454704872|FG001|Overall Study|Protocol Violation|37|||
126385126|NCT00430989|454704871|FG000|Overall Study|Not eligible|13|||
126385127|NCT00430989|454704872|FG001|Overall Study|Not eligible|6|||
126385128|NCT01701362|454704873|FG000|Overall Study|Adverse events not related to study drug|1|||
126385129|NCT01701362|454704874|FG001|Overall Study|Adverse events not related to study drug|6|||
126385130|NCT01701362|454704873|FG000|Overall Study|Adverse events related to study drug|12|||
126385131|NCT01701362|454704874|FG001|Overall Study|Adverse events related to study drug|10|||
126385132|NCT01701362|454704873|FG000|Overall Study|Protocol Violation|5|||
126385133|NCT01701362|454704874|FG001|Overall Study|Protocol Violation|3|||
126385134|NCT01701362|454704873|FG000|Overall Study|No longer willing to participate|8|||
126385135|NCT01701362|454704874|FG001|Overall Study|No longer willing to participate|14|||
126385136|NCT01701362|454704873|FG000|Overall Study|Lost to Follow-up|6|||
126385137|NCT01701362|454704874|FG001|Overall Study|Lost to Follow-up|9|||
126385138|NCT01701362|454704873|FG000|Overall Study|Insufficient clinical response|6|||
126385139|NCT01701362|454704874|FG001|Overall Study|Insufficient clinical response|6|||
126385140|NCT01701362|454704873|FG000|Overall Study|Death|0|||
126385141|NCT01701362|454704874|FG001|Overall Study|Death|1|||
126385142|NCT01701362|454704873|FG000|Overall Study|Randomized but not treated|1|||
126385143|NCT01701362|454704874|FG001|Overall Study|Randomized but not treated|2|||
126385144|NCT01701362|454704873|FG000|Overall Study|Reasons other than those mentioned above|3|||
126385145|NCT01701362|454704874|FG001|Overall Study|Reasons other than those mentioned above|5|||
126385146|NCT00570778|454704875|FG000|Overall Study|Protocol deviation|2|||
126385147|NCT00570778|454704876|FG001|Overall Study|Protocol deviation|1|||
126385148|NCT00570778|454704877|FG002|Overall Study|Protocol deviation|2|||
126385149|NCT00570778|454704878|FG003|Overall Study|Protocol deviation|2|||
126385150|NCT00570778|454704875|FG000|Overall Study|Adverse Event|0|||
126385151|NCT00570778|454704876|FG001|Overall Study|Adverse Event|1|||
126385152|NCT00570778|454704877|FG002|Overall Study|Adverse Event|4|||
126385153|NCT00570778|454704878|FG003|Overall Study|Adverse Event|1|||
126385154|NCT00570778|454704875|FG000|Overall Study|Subject withdrew consent|0|||
126385155|NCT00570778|454704876|FG001|Overall Study|Subject withdrew consent|1|||
126385156|NCT00570778|454704877|FG002|Overall Study|Subject withdrew consent|0|||
126385157|NCT00570778|454704878|FG003|Overall Study|Subject withdrew consent|1|||
126385158|NCT00570778|454704875|FG000|Overall Study|Abnormal test procedure|1|||
126385159|NCT00570778|454704876|FG001|Overall Study|Abnormal test procedure|0|||
126385160|NCT00570778|454704877|FG002|Overall Study|Abnormal test procedure|0|||
126385161|NCT00570778|454704878|FG003|Overall Study|Abnormal test procedure|0|||
126385162|NCT00570778|454704875|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126385163|NCT00570778|454704876|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126385164|NCT00570778|454704877|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126385165|NCT00570778|454704878|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126385166|NCT00570778|454704875|FG000|Overall Study|Lost to Follow-up|0|||
126385167|NCT00570778|454704876|FG001|Overall Study|Lost to Follow-up|0|||
126385168|NCT00570778|454704877|FG002|Overall Study|Lost to Follow-up|1|||
126385169|NCT00570778|454704878|FG003|Overall Study|Lost to Follow-up|0|||
126385170|NCT00570778|454704875|FG000|Overall Study|Subject no longer requires study drug|0|||
126385171|NCT00570778|454704876|FG001|Overall Study|Subject no longer requires study drug|1|||
126385172|NCT00570778|454704877|FG002|Overall Study|Subject no longer requires study drug|0|||
126385173|NCT00570778|454704878|FG003|Overall Study|Subject no longer requires study drug|0|||
126385174|NCT02120781|454704883|FG000|Overall Study|Physician Decision|2|||
126385175|NCT02120781|454704884|FG001|Overall Study|Physician Decision|0|||
126385176|NCT02120781|454704883|FG000|Overall Study|Completion not documented|2|||
126385177|NCT02120781|454704884|FG001|Overall Study|Completion not documented|1|||
126385178|NCT00984165|454704885|FG000|Overall Study|Death on study|2|||
126385179|NCT00984165|454704886|FG001|Overall Study|Death on study|0|||
126385180|NCT00984165|454704887|FG002|Overall Study|Death on study|0|||
126385181|NCT00984165|454704888|FG003|Overall Study|Death on study|0|||
126385182|NCT00984165|454704885|FG000|Overall Study|Disease progression on study|5|||
126385183|NCT00984165|454704886|FG001|Overall Study|Disease progression on study|1|||
126385184|NCT00984165|454704887|FG002|Overall Study|Disease progression on study|0|||
126385185|NCT00984165|454704888|FG003|Overall Study|Disease progression on study|0|||
126385186|NCT00984165|454704885|FG000|Overall Study|Death of recipient|0|||
126385187|NCT00984165|454704886|FG001|Overall Study|Death of recipient|0|||
126385188|NCT00984165|454704887|FG002|Overall Study|Death of recipient|0|||
126385189|NCT00984165|454704888|FG003|Overall Study|Death of recipient|1|||
126385190|NCT00984165|454704885|FG000|Overall Study|New protocol|0|||
126385191|NCT00984165|454704886|FG001|Overall Study|New protocol|0|||
126385192|NCT00984165|454704887|FG002|Overall Study|New protocol|0|||
126385193|NCT00984165|454704888|FG003|Overall Study|New protocol|1|||
126048678|NCT00822120|453475247|FG005|Initial Registration|Adverse Event|0|||
126385194|NCT00984165|454704885|FG000|Overall Study|P+/donor pair removed from protocol|0|||
126385195|NCT00984165|454704886|FG001|Overall Study|P+/donor pair removed from protocol|0|||
126048679|NCT00822120|453475242|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
126048680|NCT00822120|453475243|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126385196|NCT00984165|454704887|FG002|Overall Study|P+/donor pair removed from protocol|0|||
126385197|NCT00984165|454704888|FG003|Overall Study|P+/donor pair removed from protocol|1|||
126385198|NCT00984165|454704885|FG000|Overall Study|removed with a pair recipient|0|||
126385199|NCT00984165|454704886|FG001|Overall Study|removed with a pair recipient|0|||
126385200|NCT00984165|454704887|FG002|Overall Study|removed with a pair recipient|0|||
126385201|NCT00984165|454704888|FG003|Overall Study|removed with a pair recipient|1|||
126385202|NCT00466947|454704889|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
126385203|NCT00466947|454704890|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
126385204|NCT00466947|454704889|FG000|Study End Analysis Period|Adverse Event|35|||
126385205|NCT00466947|454704890|FG001|Study End Analysis Period|Adverse Event|43|||
126385206|NCT00466947|454704889|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
126385207|NCT00466947|454704890|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
126385208|NCT00466947|454704889|FG000|Study End Analysis Period|Physician Decision|29|||
126385209|NCT00466947|454704890|FG001|Study End Analysis Period|Physician Decision|29|||
126385210|NCT00466947|454704889|FG000|Study End Analysis Period|Protocol Violation|9|||
126385211|NCT00466947|454704890|FG001|Study End Analysis Period|Protocol Violation|17|||
126385212|NCT00466947|454704889|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
126385213|NCT00466947|454704890|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
126385214|NCT00466947|454704889|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
126385215|NCT00466947|454704890|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
126385216|NCT00466947|454704889|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
126385217|NCT00466947|454704890|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
126385218|NCT00466947|454704889|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
126385219|NCT00466947|454704890|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
126385220|NCT03850093|454704891|FG000|Overall Study|Withdrawal by Subject|1|||
126385221|NCT03850093|454704892|FG001|Overall Study|Withdrawal by Subject|0|||
126385222|NCT03850093|454704893|FG002|Overall Study|Withdrawal by Subject|2|||
126385223|NCT03226249|454704894|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
126385224|NCT03226249|454704894|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
126385225|NCT03226249|454704894|FG000|Survival Follow-up|Patients still in follow-up.|30|||
126385226|NCT02096952|454704895|FG000|Overall Study|Adverse Event|1|||
126385227|NCT00066222|454704896|FG000|Overall Study|No protocol treatment received|1|||
126385228|NCT02684617|454704897|FG000|Overall Study|Adverse Event|1|||
126385229|NCT02684617|454704898|FG001|Overall Study|Adverse Event|0|||
126385230|NCT02684617|454704899|FG002|Overall Study|Adverse Event|1|||
126385231|NCT02684617|454704897|FG000|Overall Study|Death|8|||
126385232|NCT02684617|454704898|FG001|Overall Study|Death|16|||
126385233|NCT02684617|454704899|FG002|Overall Study|Death|28|||
126385234|NCT02684617|454704897|FG000|Overall Study|Withdrawal by Subject|2|||
126385235|NCT02684617|454704898|FG001|Overall Study|Withdrawal by Subject|0|||
126385236|NCT02684617|454704899|FG002|Overall Study|Withdrawal by Subject|4|||
126385237|NCT02684617|454704897|FG000|Overall Study|Screen Failure|1|||
126385238|NCT02684617|454704898|FG001|Overall Study|Screen Failure|0|||
126385239|NCT02684617|454704899|FG002|Overall Study|Screen Failure|2|||
126385240|NCT02684617|454704897|FG000|Overall Study|Study Terminated by Sponsor|6|||
126385241|NCT02684617|454704898|FG001|Overall Study|Study Terminated by Sponsor|1|||
126385242|NCT02684617|454704899|FG002|Overall Study|Study Terminated by Sponsor|5|||
126385243|NCT00615719|454704910|FG000|Overall Study|Physician Decision|5|||
126385244|NCT04482439|454704915|FG000|Overall Study|Lost to Follow-up|1|||
126385245|NCT04482439|454704915|FG000|Overall Study|Unrelated illness|1|||
126385246|NCT02318368|454704916|FG000|Overall Study|Withdrawal by Subject|2|||
126385247|NCT02318368|454704917|FG001|Overall Study|Withdrawal by Subject|0|||
126385248|NCT02318368|454704916|FG000|Overall Study|Study terminated by the sponsor|5|||
126385249|NCT02318368|454704917|FG001|Overall Study|Study terminated by the sponsor|2|||
126385250|NCT02318368|454704916|FG000|Overall Study|Death|0|||
126385251|NCT02318368|454704917|FG001|Overall Study|Death|1|||
126385252|NCT02201329|454704918|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
126385253|NCT02201329|454704918|FG000|Overall Study|Withdrawal by Subject|2|||
126385254|NCT03629223|454704919|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385255|NCT03629223|454704920|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385256|NCT03629223|454704921|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385257|NCT03629223|454704922|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
126385258|NCT03629223|454704923|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385259|NCT03629223|454704924|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385260|NCT03629223|454704919|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385261|NCT03629223|454704920|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385262|NCT03629223|454704921|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385263|NCT03629223|454704922|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
126385264|NCT03629223|454704923|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385265|NCT03629223|454704924|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385266|NCT03629223|454704919|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385267|NCT03629223|454704920|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
126385268|NCT03629223|454704921|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385269|NCT03629223|454704922|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385270|NCT03629223|454704923|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385271|NCT03629223|454704924|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385272|NCT03629223|454704919|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385273|NCT03629223|454704920|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
126385274|NCT03629223|454704921|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385275|NCT03629223|454704922|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385276|NCT03629223|454704923|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385277|NCT03629223|454704924|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385278|NCT03629223|454704919|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
126385279|NCT03629223|454704920|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385280|NCT03629223|454704921|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385281|NCT03629223|454704922|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385282|NCT03629223|454704923|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385283|NCT03629223|454704924|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385284|NCT01534351|454704925|FG000|Overall Study|Study Terminated Early|1|||
126385285|NCT01534351|454704926|FG001|Overall Study|Study Terminated Early|0|||
126385286|NCT01534351|454704927|FG002|Overall Study|Study Terminated Early|0|||
126385287|NCT02702609|454704928|FG000|Overall Study|Lost to Follow-up|8|||
126385288|NCT02702609|454704929|FG001|Overall Study|Lost to Follow-up|4|||
126385289|NCT02702609|454704928|FG000|Overall Study|Physician Decision|1|||
126385290|NCT02702609|454704929|FG001|Overall Study|Physician Decision|0|||
126385291|NCT04660552|454704931|FG000|Overall Study|Withdrawal by Subject|3|||
126385292|NCT04660552|454704932|FG001|Overall Study|Withdrawal by Subject|1|||
126385293|NCT00690430|454704933|FG000|Core Phase|Abnormal Laboratory value|0|||
126385294|NCT00690430|454704934|FG001|Core Phase|Abnormal Laboratory value|1|||
126385295|NCT00690430|454704935|FG002|Core Phase|Abnormal Laboratory value|0|||
126385296|NCT00690430|454704933|FG000|Core Phase|Adverse Event|5|||
126385297|NCT00690430|454704934|FG001|Core Phase|Adverse Event|1|||
126385298|NCT00690430|454704935|FG002|Core Phase|Adverse Event|0|||
126385299|NCT00690430|454704933|FG000|Core Phase|Death|0|||
126385300|NCT00690430|454704934|FG001|Core Phase|Death|2|||
126385301|NCT00690430|454704935|FG002|Core Phase|Death|0|||
126385302|NCT00690430|454704933|FG000|Core Phase|Protocol Violation|1|||
126385303|NCT00690430|454704934|FG001|Core Phase|Protocol Violation|0|||
126385304|NCT00690430|454704935|FG002|Core Phase|Protocol Violation|0|||
126385305|NCT00690430|454704933|FG000|Core Phase|Withdrawal by Subject|3|||
126385306|NCT00690430|454704934|FG001|Core Phase|Withdrawal by Subject|3|||
126385307|NCT00690430|454704935|FG002|Core Phase|Withdrawal by Subject|0|||
126385308|NCT00690430|454704933|FG000|Core Phase|Subject no longer requires study drug|1|||
126385309|NCT00690430|454704934|FG001|Core Phase|Subject no longer requires study drug|0|||
126385310|NCT00690430|454704935|FG002|Core Phase|Subject no longer requires study drug|0|||
126385311|NCT00690430|454704933|FG000|Core Phase|Lack of Efficacy|8|||
126385312|NCT00690430|454704934|FG001|Core Phase|Lack of Efficacy|10|||
126385313|NCT00690430|454704935|FG002|Core Phase|Lack of Efficacy|0|||
126385314|NCT00690430|454704933|FG000|Core Phase|Administrative Problems|0|||
126385315|NCT00690430|454704934|FG001|Core Phase|Administrative Problems|1|||
126385316|NCT00690430|454704935|FG002|Core Phase|Administrative Problems|0|||
126385317|NCT00690430|454704933|FG000|Core Phase|Early Termination|0|||
126385318|NCT00690430|454704934|FG001|Core Phase|Early Termination|5|||
126385319|NCT00690430|454704935|FG002|Core Phase|Early Termination|0|||
126385320|NCT00690430|454704933|FG000|Extension Phase|Lack of Efficacy|3|||
126385321|NCT00690430|454704934|FG001|Extension Phase|Lack of Efficacy|1|||
126385322|NCT00690430|454704935|FG002|Extension Phase|Lack of Efficacy|4|||
126385323|NCT00690430|454704933|FG000|Extension Phase|Abnormal Lab Values|1|||
126385324|NCT00690430|454704934|FG001|Extension Phase|Abnormal Lab Values|0|||
126385325|NCT00690430|454704935|FG002|Extension Phase|Abnormal Lab Values|0|||
126385326|NCT00690430|454704933|FG000|Extension Phase|Abnormal test procedure results|1|||
126385327|NCT00690430|454704934|FG001|Extension Phase|Abnormal test procedure results|0|||
126385328|NCT00690430|454704935|FG002|Extension Phase|Abnormal test procedure results|0|||
126385329|NCT00690430|454704933|FG000|Extension Phase|Administrative Problems|0|||
126385330|NCT00690430|454704934|FG001|Extension Phase|Administrative Problems|1|||
126385331|NCT00690430|454704935|FG002|Extension Phase|Administrative Problems|1|||
126385332|NCT00690430|454704933|FG000|Extension Phase|Adverse Event|2|||
126385333|NCT00690430|454704934|FG001|Extension Phase|Adverse Event|1|||
126385334|NCT00690430|454704935|FG002|Extension Phase|Adverse Event|2|||
126385335|NCT00690430|454704933|FG000|Extension Phase|Death|1|||
126385336|NCT00690430|454704934|FG001|Extension Phase|Death|1|||
126385337|NCT00690430|454704935|FG002|Extension Phase|Death|1|||
126385338|NCT00690430|454704933|FG000|Extension Phase|Withdrawal by Subject|0|||
126385339|NCT00690430|454704934|FG001|Extension Phase|Withdrawal by Subject|0|||
126385340|NCT00690430|454704935|FG002|Extension Phase|Withdrawal by Subject|2|||
126385341|NCT00690430|454704933|FG000|Extension Phase|Early Termination|10|||
126385342|NCT00690430|454704934|FG001|Extension Phase|Early Termination|1|||
126385343|NCT00690430|454704935|FG002|Extension Phase|Early Termination|3|||
126385344|NCT02125838|454704938|FG000|Overall Study|Lost to Follow-up|4|||
126385345|NCT02125838|454704939|FG001|Overall Study|Lost to Follow-up|4|||
126385346|NCT00787839|454704940|FG000|Overall Study|Failure to have the OGTT was most common|404|||
126385347|NCT00335738|454704943|FG000|Overall Study|Physician Decision|6|||
126385348|NCT00335738|454704944|FG001|Overall Study|Physician Decision|0|||
126385349|NCT00335738|454704943|FG000|Overall Study|Withdrawal by Subject|2|||
126385350|NCT00335738|454704944|FG001|Overall Study|Withdrawal by Subject|0|||
126385351|NCT00335738|454704943|FG000|Overall Study|Ineligible|3|||
126385352|NCT00335738|454704944|FG001|Overall Study|Ineligible|4|||
126385353|NCT01970241|454704951|FG000|Overall Study|Withdrawal by Subject|2|||
126385354|NCT01970241|454704952|FG001|Overall Study|Withdrawal by Subject|0|||
126385355|NCT01970241|454704951|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
126385356|NCT01970241|454704952|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
126385357|NCT00992056|454704955|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
126385358|NCT00992056|454704956|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
126385359|NCT00992056|454704955|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
126385360|NCT00992056|454704956|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
126385361|NCT00564902|454704959|FG000|Overall Study|Withdrawal by Subject|0|||
126385362|NCT00564902|454704960|FG001|Overall Study|Withdrawal by Subject|3|||
126385363|NCT00564902|454704961|FG002|Overall Study|Withdrawal by Subject|4|||
126385364|NCT00564902|454704959|FG000|Overall Study|Death|1|||
126385365|NCT00564902|454704960|FG001|Overall Study|Death|1|||
126385366|NCT00564902|454704961|FG002|Overall Study|Death|0|||
126385367|NCT00375505|454704964|FG000|Overall Study|Adverse Event|1|||
126385368|NCT00375505|454704965|FG001|Overall Study|Adverse Event|2|||
126385369|NCT02146131|454704966|FG000|Overall Study|Physician Decision|61|||
126385370|NCT02146131|454704967|FG001|Overall Study|Physician Decision|56|||
126385371|NCT02567799|454704968|FG000|Concurrent Chemoradiotherapy|Death|1|||
125886714|NCT00473382|452881820|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
125886715|NCT00473382|452881821|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
126385372|NCT02567799|454704969|FG001|Concurrent Chemoradiotherapy|Death|0|||
126385373|NCT02567799|454704970|FG002|Concurrent Chemoradiotherapy|Death|0|||
126385374|NCT02567799|454704968|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
126385375|NCT02567799|454704969|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
126385376|NCT02567799|454704970|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
126385377|NCT02567799|454704968|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
126385378|NCT02567799|454704969|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
126048681|NCT00822120|453475244|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126385379|NCT02567799|454704970|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
125886716|NCT00473382|452881819|FG000|Open-label Extension Through Month 48|Death|1|||
125886717|NCT00473382|452881820|FG001|Open-label Extension Through Month 48|Death|3|||
125886718|NCT00473382|452881821|FG002|Open-label Extension Through Month 48|Death|3|||
125886719|NCT00473382|452881819|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
125886720|NCT00473382|452881820|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
125886721|NCT00473382|452881821|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
125886722|NCT00473382|452881819|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
125886723|NCT00473382|452881820|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
125886724|NCT00473382|452881821|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
125886725|NCT00473382|452881819|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
125886726|NCT00473382|452881820|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
125886727|NCT00473382|452881821|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
125886728|NCT00473382|452881819|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
125886729|NCT00473382|452881820|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
125886730|NCT00473382|452881821|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
125886731|NCT00473382|452881819|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
125886732|NCT00473382|452881820|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
125886733|NCT00473382|452881821|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
125886734|NCT00473382|452881819|FG000|Open-label Extension Through Month 60|Death|1|||
125886735|NCT00473382|452881820|FG001|Open-label Extension Through Month 60|Death|7|||
125886736|NCT00473382|452881821|FG002|Open-label Extension Through Month 60|Death|4|||
125886737|NCT00473382|452881819|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
125886738|NCT00473382|452881820|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
125886739|NCT00473382|452881821|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
125886740|NCT00473382|452881819|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
125886741|NCT00473382|452881820|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
125886742|NCT00473382|452881821|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
125886743|NCT00473382|452881819|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
125886744|NCT00473382|452881820|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
125886745|NCT00473382|452881821|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
125886746|NCT00473382|452881819|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
125886747|NCT00473382|452881820|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
125886748|NCT00473382|452881821|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
125886749|NCT01189032|452881822|FG000|Overall Study|Adverse Event|1|||
125886750|NCT01189032|452881823|FG001|Overall Study|Adverse Event|3|||
125886751|NCT01189032|452881824|FG002|Overall Study|Adverse Event|4|||
125886752|NCT01189032|452881822|FG000|Overall Study|Lack of Efficacy|2|||
125886753|NCT01189032|452881823|FG001|Overall Study|Lack of Efficacy|3|||
125886754|NCT01189032|452881824|FG002|Overall Study|Lack of Efficacy|0|||
125886755|NCT01189032|452881822|FG000|Overall Study|Withdrawal by Subject|1|||
125886756|NCT01189032|452881823|FG001|Overall Study|Withdrawal by Subject|0|||
125886757|NCT01189032|452881824|FG002|Overall Study|Withdrawal by Subject|1|||
125886758|NCT01189032|452881822|FG000|Overall Study|Protocol Violation|1|||
125886759|NCT01189032|452881823|FG001|Overall Study|Protocol Violation|1|||
125886760|NCT01189032|452881824|FG002|Overall Study|Protocol Violation|1|||
125886761|NCT00275509|452881825|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
125886762|NCT00275509|452881826|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
125886763|NCT03388164|452881827|FG000|Overall Study|Withdrawal by Subject|3|||
125886764|NCT03388164|452881828|FG001|Overall Study|Withdrawal by Subject|1|||
125886765|NCT03967444|452881829|FG000|Overall Study|Lost to Follow-up|1|||
125886766|NCT03967444|452881830|FG001|Overall Study|Lost to Follow-up|2|||
125886767|NCT01821118|452881832|FG000|Overall Study|Death|0|||
125886768|NCT01821118|452881833|FG001|Overall Study|Death|1|||
125886769|NCT01605799|452881834|FG000|Overall Study|Withdrawal by Subject|2|||
125886770|NCT01605799|452881835|FG001|Overall Study|Withdrawal by Subject|1|||
125886771|NCT00345358|452881836|FG000|Primary Vaccination Phase|Other|0|||
126048682|NCT00822120|453475245|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126048683|NCT00822120|453475246|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126385380|NCT02567799|454704968|FG000|Follow-up|Death|1|||
126048684|NCT00822120|453475247|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126048685|NCT00822120|453475242|FG000|Initial Registration|Reasons not Protocol Specified|2|||
126385381|NCT02567799|454704969|FG001|Follow-up|Death|0|||
126385382|NCT02567799|454704970|FG002|Follow-up|Death|1|||
126385383|NCT02567799|454704968|FG000|Follow-up|Progressive Disease|1|||
126385384|NCT02567799|454704969|FG001|Follow-up|Progressive Disease|1|||
125886772|NCT00345358|452881837|FG001|Primary Vaccination Phase|Other|1|||
125886773|NCT00345358|452881838|FG002|Primary Vaccination Phase|Other|1|||
125886774|NCT00345358|452881839|FG003|Primary Vaccination Phase|Other|0|||
126385385|NCT02567799|454704970|FG002|Follow-up|Progressive Disease|3|||
126385386|NCT00349349|454704972|FG000|Overall Study|Adverse Event|5|||
125886775|NCT00345358|452881836|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
125886776|NCT00345358|452881837|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
125886777|NCT00345358|452881838|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
125886778|NCT00345358|452881839|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
125886779|NCT00345358|452881836|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
125886780|NCT00345358|452881837|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
125886781|NCT00345358|452881838|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
125886782|NCT00345358|452881839|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
125886783|NCT00345358|452881836|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
125886784|NCT00345358|452881837|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
125886785|NCT00345358|452881838|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
125886786|NCT00345358|452881839|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
125886787|NCT00345358|452881836|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
125886788|NCT00345358|452881837|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
125886789|NCT00345358|452881838|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
125886790|NCT00345358|452881839|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
125886791|NCT00345358|452881836|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
125886792|NCT00345358|452881837|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
125886793|NCT00345358|452881838|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
125886794|NCT00345358|452881839|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
125886795|NCT00499083|452881840|FG000|Overall Study|Not evaluable|3|||
125886796|NCT00686686|452881841|FG000|Overall Study|Non-compliance|1|||
125886797|NCT00686686|452881841|FG000|Overall Study|Adverse Event|2|||
125886798|NCT00686686|452881841|FG000|Overall Study|Lost to Follow-up|3|||
125886799|NCT00131248|452881845|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
125886800|NCT00131248|452881846|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
125886801|NCT00477386|452881847|FG000|Overall Study|Adverse Event|4|||
125886802|NCT00477386|452881848|FG001|Overall Study|Adverse Event|8|||
125886803|NCT00477386|452881847|FG000|Overall Study|Disease progression, relapse|3|||
125886804|NCT00477386|452881848|FG001|Overall Study|Disease progression, relapse|4|||
125886805|NCT00477386|452881847|FG000|Overall Study|Disease progression, refractory|1|||
125886806|NCT00477386|452881848|FG001|Overall Study|Disease progression, refractory|3|||
125886807|NCT00477386|452881847|FG000|Overall Study|Other|1|||
126048686|NCT00822120|453475243|FG001|Initial Registration|Reasons not Protocol Specified|0|||
125886808|NCT00477386|452881848|FG001|Overall Study|Other|2|||
125886809|NCT00477386|452881847|FG000|Overall Study|Physician Decision|1|||
125886810|NCT00477386|452881848|FG001|Overall Study|Physician Decision|0|||
125886811|NCT00477386|452881847|FG000|Overall Study|Withdrawal by Subject|1|||
125886812|NCT00477386|452881848|FG001|Overall Study|Withdrawal by Subject|0|||
125886813|NCT01254422|452881849|FG000|Overall Study|Protocol Violation|1|||
125886814|NCT01254422|452881850|FG001|Overall Study|Protocol Violation|0|||
125886815|NCT01254422|452881849|FG000|Overall Study|Adverse Event|1|||
125886816|NCT01254422|452881850|FG001|Overall Study|Adverse Event|0|||
125886817|NCT01254422|452881849|FG000|Overall Study|Serious adverse event|0|||
125886818|NCT01254422|452881850|FG001|Overall Study|Serious adverse event|1|||
125886819|NCT01254422|452881849|FG000|Overall Study|Lost to Follow-up|1|||
125886820|NCT01254422|452881850|FG001|Overall Study|Lost to Follow-up|0|||
125886821|NCT02207088|452881851|FG000|Overall Study|Adverse Event|2|||
125886822|NCT00643162|452881852|FG000|Overall Study|Withdrawal by Subject|1|||
125886823|NCT00643162|452881853|FG001|Overall Study|Withdrawal by Subject|1|||
125886824|NCT02284243|452881854|FG000|Overall Study|Lack of Efficacy|3|||
125886825|NCT02284243|452881855|FG001|Overall Study|Lack of Efficacy|3|||
125886826|NCT02284243|452881854|FG000|Overall Study|Adverse Event|1|||
125886827|NCT02284243|452881855|FG001|Overall Study|Adverse Event|0|||
125886828|NCT02699749|452881860|FG000|Overall Study|Other|0|||
125886829|NCT02699749|452881861|FG001|Overall Study|Other|0|||
125886830|NCT02699749|452881862|FG002|Overall Study|Other|2|||
125886831|NCT02699749|452881863|FG003|Overall Study|Other|0|||
125886832|NCT02699749|452881864|FG004|Overall Study|Other|0|||
125886833|NCT02699749|452881865|FG005|Overall Study|Other|1|||
125886834|NCT02699749|452881866|FG006|Overall Study|Other|1|||
125886835|NCT02699749|452881867|FG007|Overall Study|Other|0|||
126048687|NCT00822120|453475244|FG002|Initial Registration|Reasons not Protocol Specified|0|||
126048688|NCT00822120|453475245|FG003|Initial Registration|Reasons not Protocol Specified|0|||
126385387|NCT00349349|454704973|FG001|Overall Study|Adverse Event|6|||
126385388|NCT00349349|454704974|FG002|Overall Study|Adverse Event|2|||
126385389|NCT00349349|454704972|FG000|Overall Study|Withdrawal by Subject|5|||
126048689|NCT00822120|453475246|FG004|Initial Registration|Reasons not Protocol Specified|0|||
125886836|NCT02699749|452881868|FG008|Overall Study|Other|0|||
125886837|NCT02699749|452881869|FG009|Overall Study|Other|0|||
126048690|NCT00822120|453475247|FG005|Initial Registration|Reasons not Protocol Specified|0|||
125886838|NCT02699749|452881870|FG010|Overall Study|Other|1|||
125886839|NCT02699749|452881871|FG011|Overall Study|Other|0|||
125886840|NCT02699749|452881872|FG012|Overall Study|Other|0|||
125886841|NCT02699749|452881873|FG013|Overall Study|Other|0|||
126048691|NCT00822120|453475242|FG000|Initial Registration|Ineligible|22|||
126048692|NCT00822120|453475243|FG001|Initial Registration|Ineligible|1|||
126048693|NCT00822120|453475244|FG002|Initial Registration|Ineligible|0|||
126048694|NCT00822120|453475245|FG003|Initial Registration|Ineligible|0|||
126048695|NCT00822120|453475246|FG004|Initial Registration|Ineligible|0|||
126385390|NCT00349349|454704973|FG001|Overall Study|Withdrawal by Subject|2|||
126385391|NCT00349349|454704974|FG002|Overall Study|Withdrawal by Subject|1|||
126385392|NCT00349349|454704972|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
126385393|NCT00349349|454704973|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
126385394|NCT00349349|454704974|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
126385395|NCT00349349|454704972|FG000|Overall Study|Death|13|||
126385396|NCT00349349|454704973|FG001|Overall Study|Death|10|||
126385397|NCT00349349|454704974|FG002|Overall Study|Death|1|||
126385398|NCT00349349|454704972|FG000|Overall Study|Other Treatment Selected|2|||
126385399|NCT00349349|454704973|FG001|Overall Study|Other Treatment Selected|0|||
126385400|NCT00349349|454704974|FG002|Overall Study|Other Treatment Selected|0|||
126385401|NCT00349349|454704972|FG000|Overall Study|Participant Reduced General Condition|0|||
126385402|NCT00349349|454704973|FG001|Overall Study|Participant Reduced General Condition|1|||
126385403|NCT00349349|454704974|FG002|Overall Study|Participant Reduced General Condition|0|||
126385404|NCT00349349|454704972|FG000|Overall Study|Physician Decision|1|||
126385405|NCT00349349|454704973|FG001|Overall Study|Physician Decision|2|||
126385406|NCT00349349|454704974|FG002|Overall Study|Physician Decision|1|||
126385407|NCT00349349|454704972|FG000|Overall Study|No Response|0|||
126385408|NCT00349349|454704973|FG001|Overall Study|No Response|3|||
126385409|NCT00349349|454704974|FG002|Overall Study|No Response|0|||
126385410|NCT00349349|454704972|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
126385411|NCT00349349|454704973|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
126385412|NCT00349349|454704974|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
126385413|NCT00861692|454704975|FG000|Overall Study|Death|6|||
126385414|NCT05111002|454704980|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
126385415|NCT05111002|454704981|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
126385416|NCT05111002|454704980|FG000|Secondary Outcome|Lost to Follow-up|1|||
126385417|NCT05111002|454704981|FG001|Secondary Outcome|Lost to Follow-up|0|||
126385418|NCT04380753|454704982|FG000|Overall Study|Participants continuing study|4|||
126385419|NCT04380753|454704982|FG000|Overall Study|Death|2|||
126385420|NCT04776720|454704985|FG000|Overall Study|COVID Related|4|||
126385421|NCT04776720|454704986|FG001|Overall Study|COVID Related|2|||
126385422|NCT04776720|454704985|FG000|Overall Study|Adverse Event|2|||
126385423|NCT04776720|454704986|FG001|Overall Study|Adverse Event|0|||
126385424|NCT04776720|454704985|FG000|Overall Study|Serious Adverse Event|0|||
126385425|NCT04776720|454704986|FG001|Overall Study|Serious Adverse Event|1|||
126385426|NCT04776720|454704985|FG000|Overall Study|Too Busy|3|||
126385427|NCT04776720|454704986|FG001|Overall Study|Too Busy|1|||
126385428|NCT04776720|454704985|FG000|Overall Study|Lost to Follow-up|1|||
126385429|NCT04776720|454704986|FG001|Overall Study|Lost to Follow-up|2|||
126385430|NCT04776720|454704985|FG000|Overall Study|Family|2|||
126385431|NCT04776720|454704986|FG001|Overall Study|Family|2|||
126385432|NCT04776720|454704985|FG000|Overall Study|No remote technology access|0|||
126385433|NCT04776720|454704986|FG001|Overall Study|No remote technology access|1|||
126385434|NCT04776720|454704985|FG000|Overall Study|Withdrawal by Subject|1|||
126385435|NCT04776720|454704986|FG001|Overall Study|Withdrawal by Subject|0|||
126385436|NCT04776720|454704985|FG000|Overall Study|Cannot tolerate intervention|1|||
126385437|NCT04776720|454704986|FG001|Overall Study|Cannot tolerate intervention|0|||
126385438|NCT04776720|454704985|FG000|Overall Study|Incomplete outcome data|6|||
126385439|NCT04776720|454704986|FG001|Overall Study|Incomplete outcome data|1|||
126385440|NCT00972517|454704987|FG000|Overall Study|Adverse Event|0|||
126385441|NCT00972517|454704988|FG001|Overall Study|Adverse Event|0|||
126385442|NCT00972517|454704989|FG002|Overall Study|Adverse Event|0|||
126385443|NCT00972517|454704990|FG003|Overall Study|Adverse Event|1|||
126385444|NCT00972517|454704991|FG004|Overall Study|Adverse Event|0|||
126385445|NCT00972517|454704992|FG005|Overall Study|Adverse Event|0|||
126385446|NCT00972517|454704987|FG000|Overall Study|Withdrawal by Subject|0|||
126385447|NCT00972517|454704988|FG001|Overall Study|Withdrawal by Subject|1|||
126385448|NCT00972517|454704989|FG002|Overall Study|Withdrawal by Subject|0|||
126385449|NCT00972517|454704990|FG003|Overall Study|Withdrawal by Subject|2|||
126385450|NCT00972517|454704991|FG004|Overall Study|Withdrawal by Subject|1|||
126385451|NCT00972517|454704992|FG005|Overall Study|Withdrawal by Subject|0|||
126385452|NCT00984594|454704993|FG000|Overall Study|Lost to Follow-up|1|||
126385453|NCT00984594|454704994|FG001|Overall Study|Lost to Follow-up|0|||
126385454|NCT00984594|454704993|FG000|Overall Study|Withdrawal by Subject|0|||
126385455|NCT00984594|454704994|FG001|Overall Study|Withdrawal by Subject|1|||
126385456|NCT00803595|454704995|FG000|Overall Study|Adverse Event|3|||
126385457|NCT00803595|454704996|FG001|Overall Study|Adverse Event|4|||
126385458|NCT00803595|454704997|FG002|Overall Study|Adverse Event|1|||
126385459|NCT00803595|454704995|FG000|Overall Study|Protocol Violation|7|||
126385460|NCT00803595|454704996|FG001|Overall Study|Protocol Violation|2|||
126385461|NCT00803595|454704997|FG002|Overall Study|Protocol Violation|12|||
126385462|NCT00803595|454704995|FG000|Overall Study|Withdrawal by Subject|5|||
126385463|NCT00803595|454704996|FG001|Overall Study|Withdrawal by Subject|2|||
126385464|NCT00803595|454704997|FG002|Overall Study|Withdrawal by Subject|3|||
126385465|NCT00851890|454704998|FG000|Overall Study|Lost to Follow-up|0|||
126385466|NCT00851890|454704999|FG001|Overall Study|Lost to Follow-up|1|||
126385467|NCT00851890|454705000|FG002|Overall Study|Lost to Follow-up|0|||
126385468|NCT00851890|454705001|FG003|Overall Study|Lost to Follow-up|1|||
126385469|NCT03135431|454705002|FG000|Overall Study|Study Surgeon not available|2|||
126385470|NCT03135431|454705003|FG001|Overall Study|Study Surgeon not available|0|||
126104211|NCT03057977|453675821|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
126104212|NCT03057977|453675822|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
126385471|NCT02709577|454705004|FG000|Overall Study|non-accommodating anatomy|0|||
126385472|NCT02709577|454705005|FG001|Overall Study|non-accommodating anatomy|1|||
126385473|NCT02709577|454705006|FG002|Overall Study|non-accommodating anatomy|0|||
126385474|NCT02709577|454705007|FG003|Overall Study|non-accommodating anatomy|0|||
126385475|NCT02709577|454705004|FG000|Overall Study|procedural complication|0|||
126385476|NCT02709577|454705005|FG001|Overall Study|procedural complication|1|||
126385477|NCT02709577|454705006|FG002|Overall Study|procedural complication|0|||
126385478|NCT02709577|454705007|FG003|Overall Study|procedural complication|0|||
126385479|NCT02709577|454705004|FG000|Overall Study|Withdrawal by Subject|2|||
126385480|NCT02709577|454705005|FG001|Overall Study|Withdrawal by Subject|3|||
126385481|NCT02709577|454705006|FG002|Overall Study|Withdrawal by Subject|2|||
126385482|NCT02709577|454705007|FG003|Overall Study|Withdrawal by Subject|0|||
126385483|NCT00375674|454705008|FG000|Overall Study|Other|26|||
126385484|NCT00375674|454705009|FG001|Overall Study|Other|18|||
126385485|NCT00375674|454705008|FG000|Overall Study|Death|67|||
126385486|NCT00375674|454705009|FG001|Overall Study|Death|76|||
126385487|NCT00375674|454705008|FG000|Overall Study|Participants refused further follow-up|31|||
126385488|NCT00375674|454705009|FG001|Overall Study|Participants refused further follow-up|30|||
126385489|NCT00375674|454705008|FG000|Overall Study|Lost to Follow-up|17|||
126385490|NCT00375674|454705009|FG001|Overall Study|Lost to Follow-up|15|||
126385491|NCT00375674|454705008|FG000|Overall Study|Enrolled but not treated|3|||
126385492|NCT00375674|454705009|FG001|Overall Study|Enrolled but not treated|2|||
126385493|NCT03744910|454707461|FG000|Overall Study|Withdrew Consent|1|||
126385494|NCT03744910|454707462|FG001|Overall Study|Withdrew Consent|8|||
126385495|NCT03744910|454707461|FG000|Overall Study|Physician Decision|5|||
126385496|NCT03744910|454707462|FG001|Overall Study|Physician Decision|4|||
126385497|NCT03744910|454707461|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
125886842|NCT02699749|452881860|FG000|Overall Study|Progressive Disease|3|||
125886843|NCT02699749|452881861|FG001|Overall Study|Progressive Disease|3|||
125886844|NCT02699749|452881862|FG002|Overall Study|Progressive Disease|14|||
125886845|NCT02699749|452881863|FG003|Overall Study|Progressive Disease|3|||
126385498|NCT03744910|454707462|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
126385499|NCT03744910|454707461|FG000|Overall Study|Lost to Follow-up|0|||
126385500|NCT03744910|454707462|FG001|Overall Study|Lost to Follow-up|1|||
125886846|NCT02699749|452881864|FG004|Overall Study|Progressive Disease|3|||
125886847|NCT02699749|452881865|FG005|Overall Study|Progressive Disease|7|||
125886848|NCT02699749|452881866|FG006|Overall Study|Progressive Disease|5|||
125886849|NCT02699749|452881867|FG007|Overall Study|Progressive Disease|5|||
126048696|NCT00822120|453475247|FG005|Initial Registration|Ineligible|0|||
126385501|NCT03744910|454707461|FG000|Overall Study|Other-unspecified|4|||
126385502|NCT03744910|454707462|FG001|Overall Study|Other-unspecified|1|||
126385503|NCT00064259|454707463|FG000|Overall Study|Adverse Event|1|||
126385504|NCT00064259|454707464|FG001|Overall Study|Adverse Event|0|||
126385505|NCT00064259|454707465|FG002|Overall Study|Adverse Event|0|||
126385506|NCT00064259|454707466|FG003|Overall Study|Adverse Event|1|||
126385507|NCT01132651|454707469|FG000|Overall Study|Lost to Follow-up|1|||
126385508|NCT01132651|454707470|FG001|Overall Study|Lost to Follow-up|1|||
126385509|NCT00948857|454707471|FG000|Overall Study|Lost to Follow-up|1|||
126385510|NCT00948857|454707472|FG001|Overall Study|Lost to Follow-up|0|||
126385511|NCT03430843|454707475|FG000|Overall Study|Death|233|||
126385512|NCT03430843|454707476|FG001|Overall Study|Death|233|||
126385513|NCT03430843|454707475|FG000|Overall Study|Sponsor Decision|17|||
126385514|NCT03430843|454707476|FG001|Overall Study|Sponsor Decision|6|||
126385515|NCT03430843|454707475|FG000|Overall Study|Withdrawal by Subject|5|||
126385516|NCT03430843|454707476|FG001|Overall Study|Withdrawal by Subject|14|||
126385517|NCT03430843|454707475|FG000|Overall Study|Lost to Follow-up|1|||
126385518|NCT03430843|454707476|FG001|Overall Study|Lost to Follow-up|3|||
126385519|NCT03037476|454707485|FG000|Overall Study|Lost to Follow-up|63|||
126385520|NCT03037476|454707486|FG001|Overall Study|Lost to Follow-up|46|||
126385521|NCT01498692|454707489|FG000|Overall Study|Death|4|||
126385522|NCT01498692|454707489|FG000|Overall Study|Withdrawal by Subject|1|||
126385523|NCT01498692|454707489|FG000|Overall Study|Missed 12-month visit|3|||
126385524|NCT00590122|454707490|FG000|Overall Study|swallowed oral dissolving dose|1|||
126385525|NCT00590122|454707491|FG001|Overall Study|swallowed oral dissolving dose|0|||
126385526|NCT03050450|454707492|FG000|Overall Study|Physician Decision|1|||
126385527|NCT03050450|454707493|FG001|Overall Study|Physician Decision|0|||
126385528|NCT03050450|454707494|FG002|Overall Study|Physician Decision|0|||
126385529|NCT03050450|454707495|FG003|Overall Study|Physician Decision|0|||
126385530|NCT03050450|454707496|FG004|Overall Study|Physician Decision|0|||
126385531|NCT00711594|454707497|FG000|Overall Study|Progressive disease|2|||
126385532|NCT00711594|454707498|FG001|Overall Study|Progressive disease|2|||
126385533|NCT00711594|454707499|FG002|Overall Study|Progressive disease|6|||
126048697|NCT00822120|453475242|FG000|PET-directed Therapy|Adverse Event|0|||
126385534|NCT00711594|454707500|FG003|Overall Study|Progressive disease|44|||
126385535|NCT00711594|454707497|FG000|Overall Study|Other Adverse Event|1|||
126385536|NCT00711594|454707498|FG001|Overall Study|Other Adverse Event|0|||
126385537|NCT00711594|454707499|FG002|Overall Study|Other Adverse Event|0|||
126385538|NCT00711594|454707500|FG003|Overall Study|Other Adverse Event|16|||
126385539|NCT00711594|454707497|FG000|Overall Study|Withdrawal by Subject|0|||
126385540|NCT00711594|454707498|FG001|Overall Study|Withdrawal by Subject|1|||
126385541|NCT00711594|454707499|FG002|Overall Study|Withdrawal by Subject|0|||
126385542|NCT00711594|454707500|FG003|Overall Study|Withdrawal by Subject|2|||
126385543|NCT00443872|454707501|FG000|Overall Study|Protocol Violation|7|||
126385544|NCT00443872|454707501|FG000|Overall Study|Lost to Follow-up|2|||
126385545|NCT00443872|454707501|FG000|Overall Study|Adverse Event|8|||
126385546|NCT00135330|454707502|FG000|Overall Study|Adverse Event|2|||
126385547|NCT00135330|454707503|FG001|Overall Study|Adverse Event|5|||
126385548|NCT00135330|454707504|FG002|Overall Study|Adverse Event|1|||
126385549|NCT00135330|454707502|FG000|Overall Study|Lost to Follow-up|0|||
126385550|NCT00135330|454707503|FG001|Overall Study|Lost to Follow-up|2|||
125886850|NCT02699749|452881868|FG008|Overall Study|Progressive Disease|6|||
126385551|NCT00135330|454707504|FG002|Overall Study|Lost to Follow-up|3|||
125886851|NCT02699749|452881869|FG009|Overall Study|Progressive Disease|6|||
125886852|NCT02699749|452881870|FG010|Overall Study|Progressive Disease|5|||
125886853|NCT02699749|452881871|FG011|Overall Study|Progressive Disease|4|||
125886854|NCT02699749|452881872|FG012|Overall Study|Progressive Disease|3|||
125886855|NCT02699749|452881873|FG013|Overall Study|Progressive Disease|5|||
125886856|NCT02699749|452881860|FG000|Overall Study|Death|0|||
125886857|NCT02699749|452881861|FG001|Overall Study|Death|0|||
125886858|NCT02699749|452881862|FG002|Overall Study|Death|0|||
125886859|NCT02699749|452881863|FG003|Overall Study|Death|0|||
125886860|NCT02699749|452881864|FG004|Overall Study|Death|0|||
125886861|NCT02699749|452881865|FG005|Overall Study|Death|0|||
125886862|NCT02699749|452881866|FG006|Overall Study|Death|0|||
125886863|NCT02699749|452881867|FG007|Overall Study|Death|0|||
125886864|NCT02699749|452881868|FG008|Overall Study|Death|0|||
125886865|NCT02699749|452881869|FG009|Overall Study|Death|0|||
125886866|NCT02699749|452881870|FG010|Overall Study|Death|0|||
125886867|NCT02699749|452881871|FG011|Overall Study|Death|0|||
125886868|NCT02699749|452881872|FG012|Overall Study|Death|0|||
125886869|NCT02699749|452881873|FG013|Overall Study|Death|1|||
125886870|NCT02699749|452881860|FG000|Overall Study|Lost to Follow-up|0|||
125886871|NCT02699749|452881861|FG001|Overall Study|Lost to Follow-up|0|||
125886872|NCT02699749|452881862|FG002|Overall Study|Lost to Follow-up|0|||
125886873|NCT02699749|452881863|FG003|Overall Study|Lost to Follow-up|0|||
125886874|NCT02699749|452881864|FG004|Overall Study|Lost to Follow-up|0|||
125886875|NCT02699749|452881865|FG005|Overall Study|Lost to Follow-up|1|||
125886876|NCT02699749|452881866|FG006|Overall Study|Lost to Follow-up|0|||
125886877|NCT02699749|452881867|FG007|Overall Study|Lost to Follow-up|1|||
125886878|NCT02699749|452881868|FG008|Overall Study|Lost to Follow-up|0|||
125886879|NCT02699749|452881869|FG009|Overall Study|Lost to Follow-up|0|||
125886880|NCT02699749|452881870|FG010|Overall Study|Lost to Follow-up|0|||
126385552|NCT00135330|454707502|FG000|Overall Study|Physician Decision|1|||
126385553|NCT00135330|454707503|FG001|Overall Study|Physician Decision|1|||
125886881|NCT02699749|452881871|FG011|Overall Study|Lost to Follow-up|0|||
125886882|NCT02699749|452881872|FG012|Overall Study|Lost to Follow-up|0|||
125886883|NCT02699749|452881873|FG013|Overall Study|Lost to Follow-up|0|||
125886884|NCT02721966|452881875|FG000|Overall Study|Protocol Violation|1|||
125886885|NCT02721966|452881876|FG001|Overall Study|Protocol Violation|0|||
125886886|NCT02721966|452881877|FG002|Overall Study|Protocol Violation|0|||
125886887|NCT02721966|452881878|FG003|Overall Study|Protocol Violation|0|||
125886888|NCT02721966|452881879|FG004|Overall Study|Protocol Violation|0|||
125886889|NCT02721966|452881875|FG000|Overall Study|Withdrawal by Subject|9|||
126048698|NCT00822120|453475243|FG001|PET-directed Therapy|Adverse Event|0|||
126048699|NCT00822120|453475244|FG002|PET-directed Therapy|Adverse Event|0|||
126385554|NCT00135330|454707504|FG002|Overall Study|Physician Decision|0|||
126385555|NCT00135330|454707502|FG000|Overall Study|Protocol Violation|4|||
126385556|NCT00135330|454707503|FG001|Overall Study|Protocol Violation|3|||
126385557|NCT00135330|454707504|FG002|Overall Study|Protocol Violation|3|||
126385558|NCT00135330|454707502|FG000|Overall Study|Patient Decision|5|||
126385559|NCT00135330|454707503|FG001|Overall Study|Patient Decision|1|||
126385560|NCT00135330|454707504|FG002|Overall Study|Patient Decision|4|||
126385561|NCT00135330|454707502|FG000|Overall Study|Sponsor Decision|0|||
126385562|NCT00135330|454707503|FG001|Overall Study|Sponsor Decision|1|||
126385563|NCT00135330|454707504|FG002|Overall Study|Sponsor Decision|0|||
126385564|NCT00104416|454707508|FG000|Double-Blind Phase|Adverse Event|2|||
126385565|NCT00104416|454707509|FG001|Double-Blind Phase|Adverse Event|1|||
126385566|NCT00104416|454707510|FG002|Double-Blind Phase|Adverse Event|0|||
126385567|NCT00104416|454707511|FG003|Double-Blind Phase|Adverse Event|0|||
126385568|NCT00104416|454707512|FG004|Double-Blind Phase|Adverse Event|0|||
126385569|NCT00104416|454707508|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126048700|NCT00822120|453475245|FG003|PET-directed Therapy|Adverse Event|1|||
126048701|NCT00822120|453475246|FG004|PET-directed Therapy|Adverse Event|0|||
126048702|NCT00822120|453475247|FG005|PET-directed Therapy|Adverse Event|0|||
126048703|NCT00822120|453475242|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126048704|NCT00822120|453475243|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126385570|NCT00104416|454707509|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125886890|NCT02721966|452881876|FG001|Overall Study|Withdrawal by Subject|2|||
125886891|NCT02721966|452881877|FG002|Overall Study|Withdrawal by Subject|3|||
125886892|NCT02721966|452881878|FG003|Overall Study|Withdrawal by Subject|7|||
125886893|NCT02721966|452881879|FG004|Overall Study|Withdrawal by Subject|0|||
125886894|NCT02721966|452881875|FG000|Overall Study|Adverse Event|4|||
125886895|NCT02721966|452881876|FG001|Overall Study|Adverse Event|4|||
126385571|NCT00104416|454707510|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126385572|NCT00104416|454707511|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126385573|NCT00104416|454707512|FG004|Double-Blind Phase|Lost to Follow-up|0|||
126385574|NCT00104416|454707508|FG000|Double-Blind Phase|Protocol Violation|0|||
126385575|NCT00104416|454707509|FG001|Double-Blind Phase|Protocol Violation|1|||
125886896|NCT02721966|452881877|FG002|Overall Study|Adverse Event|3|||
125886897|NCT02721966|452881878|FG003|Overall Study|Adverse Event|0|||
125886898|NCT02721966|452881879|FG004|Overall Study|Adverse Event|0|||
126385576|NCT00104416|454707510|FG002|Double-Blind Phase|Protocol Violation|0|||
126385577|NCT00104416|454707511|FG003|Double-Blind Phase|Protocol Violation|0|||
126385578|NCT00104416|454707512|FG004|Double-Blind Phase|Protocol Violation|0|||
126385579|NCT00104416|454707508|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
126385580|NCT00104416|454707509|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
126385581|NCT00104416|454707510|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126385582|NCT00104416|454707511|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126385583|NCT00104416|454707512|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
126385584|NCT00104416|454707508|FG000|Double-Blind Phase|Pregnancy|1|||
126385585|NCT00104416|454707509|FG001|Double-Blind Phase|Pregnancy|0|||
126385586|NCT00104416|454707510|FG002|Double-Blind Phase|Pregnancy|0|||
126385587|NCT00104416|454707511|FG003|Double-Blind Phase|Pregnancy|0|||
126385588|NCT00104416|454707512|FG004|Double-Blind Phase|Pregnancy|0|||
126385589|NCT00104416|454707508|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
126385590|NCT00104416|454707509|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
126385591|NCT00104416|454707510|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
126385592|NCT00104416|454707511|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
126385593|NCT00104416|454707512|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
126385594|NCT00104416|454707508|FG000|Continuation Phase|Adverse Event|0|||
126385595|NCT00104416|454707509|FG001|Continuation Phase|Adverse Event|0|||
126385596|NCT00104416|454707510|FG002|Continuation Phase|Adverse Event|2|||
126385597|NCT00104416|454707511|FG003|Continuation Phase|Adverse Event|0|||
126385598|NCT00104416|454707512|FG004|Continuation Phase|Adverse Event|2|||
126385599|NCT00104416|454707508|FG000|Continuation Phase|Lost to Follow-up|0|||
126385600|NCT00104416|454707509|FG001|Continuation Phase|Lost to Follow-up|0|||
126385601|NCT00104416|454707510|FG002|Continuation Phase|Lost to Follow-up|1|||
126385602|NCT00104416|454707511|FG003|Continuation Phase|Lost to Follow-up|0|||
126385603|NCT00104416|454707512|FG004|Continuation Phase|Lost to Follow-up|1|||
126385604|NCT00104416|454707508|FG000|Continuation Phase|Withdrawal by Subject|0|||
126385605|NCT00104416|454707509|FG001|Continuation Phase|Withdrawal by Subject|0|||
126385606|NCT00104416|454707510|FG002|Continuation Phase|Withdrawal by Subject|2|||
126385607|NCT00104416|454707511|FG003|Continuation Phase|Withdrawal by Subject|1|||
126385608|NCT00104416|454707512|FG004|Continuation Phase|Withdrawal by Subject|1|||
126385609|NCT00104416|454707508|FG000|Continuation Phase|Pregnancy|0|||
126385610|NCT00104416|454707509|FG001|Continuation Phase|Pregnancy|0|||
126385611|NCT00104416|454707510|FG002|Continuation Phase|Pregnancy|1|||
126385612|NCT00104416|454707511|FG003|Continuation Phase|Pregnancy|1|||
126385613|NCT00104416|454707512|FG004|Continuation Phase|Pregnancy|0|||
126385614|NCT00104416|454707508|FG000|Continuation Phase|Non-compliance|0|||
126385615|NCT00104416|454707509|FG001|Continuation Phase|Non-compliance|0|||
126385616|NCT00104416|454707510|FG002|Continuation Phase|Non-compliance|0|||
126385617|NCT00104416|454707511|FG003|Continuation Phase|Non-compliance|0|||
126385618|NCT00104416|454707512|FG004|Continuation Phase|Non-compliance|1|||
126385619|NCT01309997|454707513|FG000|Overall Study|Adverse Event|1|||
126385620|NCT01309997|454707514|FG001|Overall Study|Adverse Event|0|||
126385621|NCT01309997|454707513|FG000|Overall Study|Death|1|||
126385622|NCT01309997|454707514|FG001|Overall Study|Death|3|||
126385623|NCT01309997|454707513|FG000|Overall Study|Lack of Efficacy|2|||
126385624|NCT01309997|454707514|FG001|Overall Study|Lack of Efficacy|2|||
126385625|NCT01309997|454707513|FG000|Overall Study|Withdrawal by Subject|1|||
126385626|NCT01309997|454707514|FG001|Overall Study|Withdrawal by Subject|1|||
126385627|NCT03462641|454707515|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
126385628|NCT03462641|454707516|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
126385629|NCT03462641|454707515|FG000|Visit 2|Withdrawal by Subject|0|||
126385630|NCT03462641|454707516|FG001|Visit 2|Withdrawal by Subject|1|||
126385631|NCT00372619|454707517|FG000|Overall Study|Ineligible|0|||
126385632|NCT00372619|454707518|FG001|Overall Study|Ineligible|0|||
126385633|NCT00372619|454707519|FG002|Overall Study|Ineligible|0|||
126385634|NCT00372619|454707520|FG003|Overall Study|Ineligible|0|||
126385635|NCT00372619|454707521|FG004|Overall Study|Ineligible|0|||
126385636|NCT00372619|454707522|FG005|Overall Study|Ineligible|2|||
126385637|NCT00372619|454707523|FG006|Overall Study|Ineligible|0|||
126385638|NCT00372619|454707517|FG000|Overall Study|Inevaluable|0|||
126385639|NCT00372619|454707518|FG001|Overall Study|Inevaluable|0|||
126385640|NCT00372619|454707519|FG002|Overall Study|Inevaluable|0|||
126385641|NCT00372619|454707520|FG003|Overall Study|Inevaluable|0|||
126385642|NCT00372619|454707521|FG004|Overall Study|Inevaluable|0|||
125886899|NCT02721966|452881875|FG000|Overall Study|Death|1|||
125886900|NCT02721966|452881876|FG001|Overall Study|Death|0|||
125886901|NCT02721966|452881877|FG002|Overall Study|Death|0|||
126385643|NCT00372619|454707522|FG005|Overall Study|Inevaluable|1|||
126385644|NCT00372619|454707523|FG006|Overall Study|Inevaluable|0|||
126385645|NCT03748706|454707528|FG000|Overall Study|Lost to Follow-up|1|||
126385646|NCT03517371|454707531|FG000|Overall Study|Adverse Event|8|||
126385647|NCT03517371|454707532|FG001|Overall Study|Adverse Event|9|||
126385648|NCT03517371|454707531|FG000|Overall Study|Lost to Follow-up|1|||
126385649|NCT03517371|454707532|FG001|Overall Study|Lost to Follow-up|2|||
126385650|NCT03517371|454707531|FG000|Overall Study|Withdrawal by Subject|4|||
126385651|NCT03517371|454707532|FG001|Overall Study|Withdrawal by Subject|4|||
126385652|NCT03517371|454707531|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
126385653|NCT03517371|454707532|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
126385654|NCT03517371|454707531|FG000|Overall Study|COVID restrictions|2|||
126385655|NCT03517371|454707532|FG001|Overall Study|COVID restrictions|0|||
126385656|NCT03517371|454707531|FG000|Overall Study|Receiving DBS Surgery|0|||
126385657|NCT03517371|454707532|FG001|Overall Study|Receiving DBS Surgery|1|||
125886902|NCT02721966|452881878|FG003|Overall Study|Death|0|||
125886903|NCT02721966|452881879|FG004|Overall Study|Death|0|||
125886904|NCT02721966|452881875|FG000|Overall Study|Lack of Efficacy|7|||
125886905|NCT02721966|452881876|FG001|Overall Study|Lack of Efficacy|4|||
125886906|NCT02721966|452881877|FG002|Overall Study|Lack of Efficacy|0|||
126048705|NCT00822120|453475244|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126048706|NCT00822120|453475245|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
126048707|NCT00822120|453475246|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126048708|NCT00822120|453475247|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126048709|NCT00822120|453475242|FG000|PET-directed Therapy|Death|0|||
126048710|NCT00822120|453475243|FG001|PET-directed Therapy|Death|0|||
126385658|NCT05420961|454707533|FG000|Overall Study|Withdrawal by Subject|2|||
126385659|NCT05420961|454707534|FG001|Overall Study|Withdrawal by Subject|1|||
126385660|NCT05420961|454707535|FG002|Overall Study|Withdrawal by Subject|1|||
126385661|NCT05420961|454707536|FG003|Overall Study|Withdrawal by Subject|0|||
126385662|NCT05420961|454707537|FG004|Overall Study|Withdrawal by Subject|0|||
126385663|NCT05420961|454707533|FG000|Overall Study|Lost to Follow-up|0|||
126385664|NCT05420961|454707534|FG001|Overall Study|Lost to Follow-up|0|||
126385665|NCT05420961|454707535|FG002|Overall Study|Lost to Follow-up|1|||
126385666|NCT05420961|454707536|FG003|Overall Study|Lost to Follow-up|0|||
126385667|NCT05420961|454707537|FG004|Overall Study|Lost to Follow-up|0|||
126385668|NCT05420961|454707533|FG000|Overall Study|Randomized by mistake without study treatment|0|||
126385669|NCT05420961|454707534|FG001|Overall Study|Randomized by mistake without study treatment|0|||
126385670|NCT05420961|454707535|FG002|Overall Study|Randomized by mistake without study treatment|1|||
126385671|NCT05420961|454707536|FG003|Overall Study|Randomized by mistake without study treatment|0|||
126385672|NCT05420961|454707537|FG004|Overall Study|Randomized by mistake without study treatment|1|||
126385673|NCT04283656|454707538|FG000|Overall Study|Adverse Event|1|||
126385674|NCT04283656|454707539|FG001|Overall Study|Adverse Event|0|||
126385675|NCT04283656|454707538|FG000|Overall Study|Lost to Follow-up|0|||
126385676|NCT04283656|454707539|FG001|Overall Study|Lost to Follow-up|1|||
126385677|NCT00935493|454707542|FG000|Overall Study|Lost to Follow-up|1|||
126385678|NCT00935493|454707543|FG001|Overall Study|Lost to Follow-up|1|||
126385679|NCT00935493|454707544|FG002|Overall Study|Lost to Follow-up|1|||
126385680|NCT00935493|454707542|FG000|Overall Study|Treatment Discontinued|0|||
126385681|NCT00935493|454707543|FG001|Overall Study|Treatment Discontinued|1|||
126385682|NCT00935493|454707544|FG002|Overall Study|Treatment Discontinued|0|||
126385683|NCT01555073|454707545|FG000|Overall Study|Lost to Follow-up|1|||
126385684|NCT01555073|454707546|FG001|Overall Study|Lost to Follow-up|2|||
126385685|NCT01555073|454707547|FG002|Overall Study|Lost to Follow-up|0|||
126385686|NCT01555073|454707548|FG003|Overall Study|Lost to Follow-up|5|||
126385687|NCT03490292|454707549|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
126385688|NCT03490292|454707550|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
126385689|NCT03490292|454707549|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
126385690|NCT03490292|454707550|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
126385691|NCT03490292|454707549|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
126385692|NCT03490292|454707550|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
126385693|NCT03490292|454707549|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
126385694|NCT03490292|454707550|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
126385695|NCT03490292|454707549|FG000|1 Year Follow Up Post Last Dose|Death|1|||
126385696|NCT03490292|454707550|FG001|1 Year Follow Up Post Last Dose|Death|1|||
126385697|NCT02565147|454707553|FG000|Overall Study|Withdrawal by Subject|5|||
126385698|NCT02565147|454707554|FG001|Overall Study|Withdrawal by Subject|1|||
126385699|NCT02565147|454707553|FG000|Overall Study|Lost to Follow-up|0|||
126385700|NCT02565147|454707554|FG001|Overall Study|Lost to Follow-up|1|||
126385701|NCT02565147|454707553|FG000|Overall Study|Death|1|||
126385702|NCT02565147|454707554|FG001|Overall Study|Death|1|||
126385703|NCT01001767|454707557|FG000|Overall Study|no baseline study performed|1|||
126385704|NCT01001767|454707558|FG001|Overall Study|no baseline study performed|0|||
126385705|NCT01001767|454707557|FG000|Overall Study|Protocol Violation|1|||
126385706|NCT01001767|454707558|FG001|Overall Study|Protocol Violation|0|||
126385707|NCT01001767|454707557|FG000|Overall Study|Lost to Follow-up|1|||
126385708|NCT01001767|454707558|FG001|Overall Study|Lost to Follow-up|0|||
126385709|NCT01001767|454707557|FG000|Overall Study|Physician Decision|1|||
126385710|NCT01001767|454707558|FG001|Overall Study|Physician Decision|0|||
126385711|NCT03098433|454707559|FG000|Overall Study|Withdrawal by Subject|10|||
126385712|NCT01667133|454707560|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
126385713|NCT01667133|454707561|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
126385714|NCT01667133|454707562|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
126385715|NCT01667133|454707563|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
126385716|NCT01667133|454707564|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
125886907|NCT02721966|452881878|FG003|Overall Study|Lack of Efficacy|0|||
126385717|NCT01667133|454707565|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
126385718|NCT01667133|454707566|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
126385719|NCT01667133|454707567|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
126385720|NCT01667133|454707568|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
126385721|NCT01667133|454707569|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
126385722|NCT01667133|454707570|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
126385723|NCT01667133|454707571|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
126385724|NCT01667133|454707560|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385725|NCT01667133|454707561|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125886908|NCT02721966|452881879|FG004|Overall Study|Lack of Efficacy|0|||
125886909|NCT02721966|452881875|FG000|Overall Study|Lost to Follow-up|0|||
125886910|NCT02721966|452881876|FG001|Overall Study|Lost to Follow-up|0|||
125886911|NCT02721966|452881877|FG002|Overall Study|Lost to Follow-up|3|||
125886912|NCT02721966|452881878|FG003|Overall Study|Lost to Follow-up|0|||
125886913|NCT02721966|452881879|FG004|Overall Study|Lost to Follow-up|0|||
125886914|NCT02721966|452881875|FG000|Overall Study|Physician Decision|1|||
125886915|NCT02721966|452881876|FG001|Overall Study|Physician Decision|1|||
125886916|NCT02721966|452881877|FG002|Overall Study|Physician Decision|0|||
125886917|NCT02721966|452881878|FG003|Overall Study|Physician Decision|0|||
125886918|NCT02721966|452881879|FG004|Overall Study|Physician Decision|0|||
125886919|NCT02721966|452881875|FG000|Overall Study|Pregnancy|1|||
125886920|NCT02721966|452881876|FG001|Overall Study|Pregnancy|0|||
125886921|NCT02721966|452881877|FG002|Overall Study|Pregnancy|0|||
125886922|NCT02721966|452881878|FG003|Overall Study|Pregnancy|0|||
126048711|NCT00822120|453475244|FG002|PET-directed Therapy|Death|0|||
126385726|NCT01667133|454707562|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
126385727|NCT01667133|454707563|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385728|NCT01667133|454707564|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385729|NCT01667133|454707565|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385730|NCT01667133|454707566|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385731|NCT01667133|454707567|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385732|NCT01667133|454707568|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385733|NCT01667133|454707569|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385734|NCT01667133|454707570|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385735|NCT01667133|454707571|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385736|NCT01667133|454707560|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
126385737|NCT01667133|454707561|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
126385738|NCT01667133|454707562|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
126385739|NCT01667133|454707563|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
126385740|NCT01667133|454707564|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
126385741|NCT01667133|454707565|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
126385742|NCT01667133|454707566|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
126385743|NCT01667133|454707567|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
126385744|NCT01667133|454707568|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
126385745|NCT01667133|454707569|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
126385746|NCT01667133|454707570|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
126385747|NCT01667133|454707571|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
126385748|NCT01667133|454707560|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385749|NCT01667133|454707561|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385750|NCT01667133|454707562|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385751|NCT01667133|454707563|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
126385752|NCT01667133|454707564|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385753|NCT01667133|454707565|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385754|NCT01667133|454707566|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125886923|NCT02721966|452881879|FG004|Overall Study|Pregnancy|0|||
126048712|NCT00822120|453475245|FG003|PET-directed Therapy|Death|2|||
126048713|NCT00822120|453475246|FG004|PET-directed Therapy|Death|0|||
126385755|NCT01667133|454707567|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385756|NCT01667133|454707568|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385757|NCT01667133|454707569|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385758|NCT01667133|454707570|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385759|NCT01667133|454707571|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385760|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
126385761|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
126385762|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
126385763|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
126385764|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
126385765|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
126385766|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
126385767|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
126385768|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
125886924|NCT02721966|452881875|FG000|Overall Study|Did not continue to period 2|5|||
125886925|NCT02721966|452881876|FG001|Overall Study|Did not continue to period 2|12|||
126048714|NCT00822120|453475247|FG005|PET-directed Therapy|Death|0|||
125886926|NCT02721966|452881877|FG002|Overall Study|Did not continue to period 2|0|||
126048715|NCT00822120|453475242|FG000|PET-directed Therapy|Protocol Violation|0|||
126048716|NCT00822120|453475243|FG001|PET-directed Therapy|Protocol Violation|0|||
126385769|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
126385770|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
126385771|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
126385772|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385773|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385774|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385775|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385776|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385777|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385778|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385779|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385780|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385781|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
126385782|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385783|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385784|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
126385785|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
126385786|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
126385787|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
126385788|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
126385789|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
126385790|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
126385791|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
126385792|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
126385793|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
126385794|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
126385795|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
126385796|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385797|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385798|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385799|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385800|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385801|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385802|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385803|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385804|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385805|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
126385806|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385807|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385808|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Death|0|||
126385809|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Death|0|||
126385810|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Death|0|||
126385811|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Death|0|||
126385812|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Death|0|||
126385813|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Death|0|||
126385814|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Death|0|||
126385815|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Death|0|||
126385816|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Death|0|||
126385817|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Death|1|||
126385818|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Death|0|||
126385819|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Death|0|||
126385820|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Other|0|||
126385821|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Other|0|||
126385822|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Other|0|||
126385823|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Other|0|||
126385824|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Other|0|||
126385825|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Other|0|||
126385826|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Other|0|||
126385827|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Other|0|||
126385828|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Other|0|||
126385829|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Other|0|||
126385830|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Other|0|||
126385831|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Other|1|||
126385832|NCT01104545|454707575|FG000|Overall Study|Adverse Event|0|||
126385833|NCT01104545|454707576|FG001|Overall Study|Adverse Event|1|||
126385834|NCT01104545|454707577|FG002|Overall Study|Adverse Event|2|||
126385835|NCT02676895|454707579|FG000|Overall Study|Administrative reason|1|||
126385836|NCT02676895|454707580|FG001|Overall Study|Administrative reason|0|||
126385837|NCT02676895|454707581|FG002|Overall Study|Administrative reason|0|||
126385838|NCT02676895|454707579|FG000|Overall Study|Protocol Violation|1|||
126385839|NCT02676895|454707580|FG001|Overall Study|Protocol Violation|0|||
126385840|NCT02676895|454707581|FG002|Overall Study|Protocol Violation|0|||
126385841|NCT02676895|454707579|FG000|Overall Study|Adverse Event|0|||
126385842|NCT02676895|454707580|FG001|Overall Study|Adverse Event|3|||
126385843|NCT02676895|454707581|FG002|Overall Study|Adverse Event|1|||
126385844|NCT02676895|454707579|FG000|Overall Study|Lost to Follow-up|0|||
126385845|NCT02676895|454707580|FG001|Overall Study|Lost to Follow-up|0|||
126385846|NCT02676895|454707581|FG002|Overall Study|Lost to Follow-up|1|||
126385847|NCT02676895|454707579|FG000|Overall Study|Withdrawal by Subject|0|||
126385848|NCT02676895|454707580|FG001|Overall Study|Withdrawal by Subject|0|||
126385849|NCT02676895|454707581|FG002|Overall Study|Withdrawal by Subject|1|||
126385850|NCT00289289|454707582|FG000|Overall Study|Withdrawal by Subject|5|||
126385851|NCT00289289|454707583|FG001|Overall Study|Withdrawal by Subject|3|||
126385852|NCT00289289|454707584|FG002|Overall Study|Withdrawal by Subject|15|||
126385853|NCT00289289|454707582|FG000|Overall Study|Lost to Follow-up|1|||
126385854|NCT00289289|454707583|FG001|Overall Study|Lost to Follow-up|0|||
126385855|NCT00289289|454707584|FG002|Overall Study|Lost to Follow-up|1|||
126385856|NCT00289289|454707582|FG000|Overall Study|Death|4|||
126385857|NCT00289289|454707583|FG001|Overall Study|Death|2|||
126385858|NCT00289289|454707584|FG002|Overall Study|Death|5|||
126385859|NCT00289289|454707582|FG000|Overall Study|No implant attempted|0|||
126385860|NCT00289289|454707583|FG001|Overall Study|No implant attempted|0|||
126385861|NCT00289289|454707584|FG002|Overall Study|No implant attempted|1|||
126385862|NCT00289289|454707582|FG000|Overall Study|Physician Decision|1|||
126385863|NCT00289289|454707583|FG001|Overall Study|Physician Decision|0|||
126385864|NCT00289289|454707584|FG002|Overall Study|Physician Decision|6|||
126385865|NCT00289289|454707582|FG000|Overall Study|Non-study device implanted|2|||
126385866|NCT00289289|454707583|FG001|Overall Study|Non-study device implanted|1|||
126385867|NCT00289289|454707584|FG002|Overall Study|Non-study device implanted|3|||
126385868|NCT00289289|454707582|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
126385869|NCT00289289|454707583|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
126385870|NCT00289289|454707584|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
126385871|NCT00289289|454707582|FG000|Overall Study|Other Exit Reason|6|||
126385872|NCT00289289|454707583|FG001|Overall Study|Other Exit Reason|4|||
126385873|NCT00289289|454707584|FG002|Overall Study|Other Exit Reason|12|||
126385874|NCT03028129|454707592|FG000|Overall Study|Adverse Event|13|||
126385875|NCT03028129|454707593|FG001|Overall Study|Adverse Event|2|||
126385876|NCT03028129|454707592|FG000|Overall Study|Lost to Follow-up|50|||
126385877|NCT03028129|454707593|FG001|Overall Study|Lost to Follow-up|38|||
126385878|NCT03028129|454707592|FG000|Overall Study|Physician Decision|0|||
126385879|NCT03028129|454707593|FG001|Overall Study|Physician Decision|1|||
126385880|NCT03028129|454707592|FG000|Overall Study|Protocol Violation|1|||
126385881|NCT03028129|454707593|FG001|Overall Study|Protocol Violation|1|||
126385882|NCT03028129|454707592|FG000|Overall Study|Withdrawal by Subject|62|||
126385883|NCT03028129|454707593|FG001|Overall Study|Withdrawal by Subject|45|||
126385884|NCT03583359|454707603|FG000|Overall Study|Withdrawal by Subject|15|||
126385885|NCT03583359|454707604|FG001|Overall Study|Withdrawal by Subject|6|||
126385886|NCT03583359|454707603|FG000|Overall Study|Lost to Follow-up|12|||
126385887|NCT03583359|454707604|FG001|Overall Study|Lost to Follow-up|3|||
126385888|NCT03583359|454707603|FG000|Overall Study|Adverse Event|0|||
126385889|NCT03583359|454707604|FG001|Overall Study|Adverse Event|1|||
126385890|NCT03583359|454707603|FG000|Overall Study|Protocol Violation|0|||
126385891|NCT03583359|454707604|FG001|Overall Study|Protocol Violation|1|||
126385892|NCT03583359|454707603|FG000|Overall Study|Other|2|||
126385893|NCT03583359|454707604|FG001|Overall Study|Other|1|||
126385894|NCT01831466|454707605|FG000|Overall Study|Protocol Violation|1|||
126385895|NCT01831466|454707606|FG001|Overall Study|Protocol Violation|1|||
126385896|NCT01831466|454707607|FG002|Overall Study|Protocol Violation|2|||
126048717|NCT00822120|453475244|FG002|PET-directed Therapy|Protocol Violation|0|||
126048718|NCT00822120|453475245|FG003|PET-directed Therapy|Protocol Violation|6|||
126048719|NCT00822120|453475246|FG004|PET-directed Therapy|Protocol Violation|0|||
126048720|NCT00822120|453475247|FG005|PET-directed Therapy|Protocol Violation|0|||
126048721|NCT01324310|453475248|FG000|Overall Study|Adverse Event|1|||
126048722|NCT01324310|453475248|FG000|Overall Study|Disease Progression|1|||
126048723|NCT04060212|453475250|FG000|Overall Study|Withdrawal by Subject|7|||
126385897|NCT01831466|454707608|FG003|Overall Study|Protocol Violation|0|||
126385898|NCT01831466|454707609|FG004|Overall Study|Protocol Violation|0|||
126385899|NCT01831466|454707610|FG005|Overall Study|Protocol Violation|1|||
126385900|NCT01831466|454707611|FG006|Overall Study|Protocol Violation|0|||
126385901|NCT01831466|454707612|FG007|Overall Study|Protocol Violation|0|||
126385902|NCT01831466|454707613|FG008|Overall Study|Protocol Violation|0|||
126385903|NCT01831466|454707614|FG009|Overall Study|Protocol Violation|0|||
126385904|NCT01831466|454707615|FG010|Overall Study|Protocol Violation|0|||
126385905|NCT01831466|454707616|FG011|Overall Study|Protocol Violation|0|||
126385906|NCT01831466|454707605|FG000|Overall Study|Other|2|||
126385907|NCT01831466|454707606|FG001|Overall Study|Other|3|||
126385908|NCT01831466|454707607|FG002|Overall Study|Other|2|||
126385909|NCT01831466|454707608|FG003|Overall Study|Other|2|||
126385910|NCT01831466|454707609|FG004|Overall Study|Other|2|||
126385911|NCT01831466|454707610|FG005|Overall Study|Other|1|||
126385912|NCT01831466|454707611|FG006|Overall Study|Other|0|||
126385913|NCT01831466|454707612|FG007|Overall Study|Other|0|||
126385914|NCT01831466|454707613|FG008|Overall Study|Other|0|||
126385915|NCT01831466|454707614|FG009|Overall Study|Other|0|||
126385916|NCT01831466|454707615|FG010|Overall Study|Other|0|||
126385917|NCT01831466|454707616|FG011|Overall Study|Other|0|||
126385918|NCT01831466|454707605|FG000|Overall Study|Non-compliance with study treatment|2|||
126385919|NCT01831466|454707606|FG001|Overall Study|Non-compliance with study treatment|1|||
126385920|NCT01831466|454707607|FG002|Overall Study|Non-compliance with study treatment|1|||
126385921|NCT01831466|454707608|FG003|Overall Study|Non-compliance with study treatment|0|||
126385922|NCT01831466|454707609|FG004|Overall Study|Non-compliance with study treatment|0|||
126385923|NCT01831466|454707610|FG005|Overall Study|Non-compliance with study treatment|1|||
126385924|NCT01831466|454707611|FG006|Overall Study|Non-compliance with study treatment|0|||
126385925|NCT01831466|454707612|FG007|Overall Study|Non-compliance with study treatment|0|||
126385926|NCT01831466|454707613|FG008|Overall Study|Non-compliance with study treatment|0|||
126385927|NCT01831466|454707614|FG009|Overall Study|Non-compliance with study treatment|0|||
126385928|NCT01831466|454707615|FG010|Overall Study|Non-compliance with study treatment|0|||
126385929|NCT01831466|454707616|FG011|Overall Study|Non-compliance with study treatment|0|||
126385930|NCT01831466|454707605|FG000|Overall Study|Death|0|||
126385931|NCT01831466|454707606|FG001|Overall Study|Death|1|||
126385932|NCT01831466|454707607|FG002|Overall Study|Death|0|||
126385933|NCT01831466|454707608|FG003|Overall Study|Death|0|||
126385934|NCT01831466|454707609|FG004|Overall Study|Death|0|||
126385935|NCT01831466|454707610|FG005|Overall Study|Death|0|||
126385936|NCT01831466|454707611|FG006|Overall Study|Death|0|||
126385937|NCT01831466|454707612|FG007|Overall Study|Death|0|||
126385938|NCT01831466|454707613|FG008|Overall Study|Death|0|||
126385939|NCT01831466|454707614|FG009|Overall Study|Death|0|||
126385940|NCT01831466|454707615|FG010|Overall Study|Death|0|||
126385941|NCT01831466|454707616|FG011|Overall Study|Death|0|||
126385942|NCT01831466|454707605|FG000|Overall Study|Withdrawal by Subject|6|||
126385943|NCT01831466|454707606|FG001|Overall Study|Withdrawal by Subject|3|||
126385944|NCT01831466|454707607|FG002|Overall Study|Withdrawal by Subject|3|||
126385945|NCT01831466|454707608|FG003|Overall Study|Withdrawal by Subject|3|||
126385946|NCT01831466|454707609|FG004|Overall Study|Withdrawal by Subject|3|||
126385947|NCT01831466|454707610|FG005|Overall Study|Withdrawal by Subject|5|||
126385948|NCT01831466|454707611|FG006|Overall Study|Withdrawal by Subject|0|||
126385949|NCT01831466|454707612|FG007|Overall Study|Withdrawal by Subject|0|||
126385950|NCT01831466|454707613|FG008|Overall Study|Withdrawal by Subject|0|||
126385951|NCT01831466|454707614|FG009|Overall Study|Withdrawal by Subject|1|||
126385952|NCT01831466|454707615|FG010|Overall Study|Withdrawal by Subject|0|||
126385953|NCT01831466|454707616|FG011|Overall Study|Withdrawal by Subject|1|||
126385954|NCT01831466|454707605|FG000|Overall Study|Lost to Follow-up|0|||
126385955|NCT01831466|454707606|FG001|Overall Study|Lost to Follow-up|1|||
126385956|NCT01831466|454707607|FG002|Overall Study|Lost to Follow-up|4|||
126385957|NCT01831466|454707608|FG003|Overall Study|Lost to Follow-up|2|||
126385958|NCT01831466|454707609|FG004|Overall Study|Lost to Follow-up|0|||
126385959|NCT01831466|454707610|FG005|Overall Study|Lost to Follow-up|3|||
126385960|NCT01831466|454707611|FG006|Overall Study|Lost to Follow-up|0|||
126385961|NCT01831466|454707612|FG007|Overall Study|Lost to Follow-up|0|||
126385962|NCT01831466|454707613|FG008|Overall Study|Lost to Follow-up|0|||
126385963|NCT01831466|454707614|FG009|Overall Study|Lost to Follow-up|1|||
126385964|NCT01831466|454707615|FG010|Overall Study|Lost to Follow-up|0|||
126385965|NCT01831466|454707616|FG011|Overall Study|Lost to Follow-up|1|||
126385966|NCT01831466|454707605|FG000|Overall Study|Lack of Efficacy|5|||
126385967|NCT01831466|454707606|FG001|Overall Study|Lack of Efficacy|8|||
126385968|NCT01831466|454707607|FG002|Overall Study|Lack of Efficacy|7|||
126385969|NCT01831466|454707608|FG003|Overall Study|Lack of Efficacy|6|||
126385970|NCT01831466|454707609|FG004|Overall Study|Lack of Efficacy|9|||
126385971|NCT01831466|454707610|FG005|Overall Study|Lack of Efficacy|8|||
126385972|NCT01831466|454707611|FG006|Overall Study|Lack of Efficacy|1|||
126385973|NCT01831466|454707612|FG007|Overall Study|Lack of Efficacy|1|||
126385974|NCT01831466|454707613|FG008|Overall Study|Lack of Efficacy|2|||
125886927|NCT02721966|452881878|FG003|Overall Study|Did not continue to period 2|0|||
126048724|NCT02787005|453475271|FG000|Overall Study|Adverse Event|24|||
125886928|NCT02721966|452881879|FG004|Overall Study|Did not continue to period 2|5|||
126048725|NCT02787005|453475272|FG001|Overall Study|Adverse Event|9|||
126048726|NCT02787005|453475273|FG002|Overall Study|Adverse Event|9|||
126385975|NCT01831466|454707614|FG009|Overall Study|Lack of Efficacy|2|||
126385976|NCT01831466|454707615|FG010|Overall Study|Lack of Efficacy|2|||
126385977|NCT01831466|454707616|FG011|Overall Study|Lack of Efficacy|0|||
125886929|NCT03857867|452881880|FG000|Overall Study|Physician Decision|1|||
125886930|NCT02157883|452881881|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
126385978|NCT01831466|454707605|FG000|Overall Study|Adverse Event|0|||
126385979|NCT01831466|454707606|FG001|Overall Study|Adverse Event|0|||
126385980|NCT01831466|454707607|FG002|Overall Study|Adverse Event|4|||
126385981|NCT01831466|454707608|FG003|Overall Study|Adverse Event|6|||
126385982|NCT01831466|454707609|FG004|Overall Study|Adverse Event|3|||
126385983|NCT01831466|454707610|FG005|Overall Study|Adverse Event|7|||
126385984|NCT01831466|454707611|FG006|Overall Study|Adverse Event|0|||
126385985|NCT01831466|454707612|FG007|Overall Study|Adverse Event|1|||
126385986|NCT01831466|454707613|FG008|Overall Study|Adverse Event|1|||
126385987|NCT01831466|454707614|FG009|Overall Study|Adverse Event|1|||
126385988|NCT01831466|454707615|FG010|Overall Study|Adverse Event|0|||
126385989|NCT01831466|454707616|FG011|Overall Study|Adverse Event|2|||
126385990|NCT05356910|454707617|FG000|Overall Study|Lost to Follow-up|10|||
126385991|NCT05356910|454707618|FG001|Overall Study|Lost to Follow-up|19|||
126385992|NCT05356910|454707619|FG002|Overall Study|Lost to Follow-up|0|||
126385993|NCT05356910|454707620|FG003|Overall Study|Lost to Follow-up|0|||
126385994|NCT05356910|454707617|FG000|Overall Study|Withdrawal by Subject|4|||
126385995|NCT05356910|454707618|FG001|Overall Study|Withdrawal by Subject|2|||
126385996|NCT05356910|454707619|FG002|Overall Study|Withdrawal by Subject|0|||
126385997|NCT05356910|454707620|FG003|Overall Study|Withdrawal by Subject|0|||
126385998|NCT03122145|454707621|FG000|Overall Study|Concurrent respiratory disease|3|||
126385999|NCT03122145|454707622|FG001|Overall Study|Concurrent respiratory disease|0|||
126386000|NCT01597908|454707623|FG000|Randomized Phase|Death|217|||
126386001|NCT01597908|454707624|FG001|Randomized Phase|Death|238|||
126386002|NCT01597908|454707625|FG002|Randomized Phase|Death|0|||
126386003|NCT01597908|454707623|FG000|Randomized Phase|Sponsor Decision|93|||
126386004|NCT01597908|454707624|FG001|Randomized Phase|Sponsor Decision|39|||
126386005|NCT01597908|454707625|FG002|Randomized Phase|Sponsor Decision|0|||
126386006|NCT01597908|454707623|FG000|Randomized Phase|Lost to Follow-up|9|||
126386007|NCT01597908|454707624|FG001|Randomized Phase|Lost to Follow-up|16|||
126386008|NCT01597908|454707625|FG002|Randomized Phase|Lost to Follow-up|0|||
126386009|NCT01597908|454707623|FG000|Randomized Phase|Physician Decision|6|||
126386010|NCT01597908|454707624|FG001|Randomized Phase|Physician Decision|3|||
126386011|NCT01597908|454707625|FG002|Randomized Phase|Physician Decision|0|||
126386012|NCT01597908|454707623|FG000|Randomized Phase|Withdrawal by Subject|26|||
126386013|NCT01597908|454707624|FG001|Randomized Phase|Withdrawal by Subject|22|||
126386014|NCT01597908|454707625|FG002|Randomized Phase|Withdrawal by Subject|0|||
126386015|NCT01597908|454707623|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
126386016|NCT01597908|454707624|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
126386017|NCT01597908|454707625|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
126386018|NCT01597908|454707623|FG000|Crossover Phase|Death|0|||
126386019|NCT01597908|454707624|FG001|Crossover Phase|Death|0|||
126386020|NCT01597908|454707625|FG002|Crossover Phase|Death|11|||
126386021|NCT01597908|454707623|FG000|Crossover Phase|Withdrawal by Subject|0|||
126386022|NCT01597908|454707624|FG001|Crossover Phase|Withdrawal by Subject|0|||
126386023|NCT01597908|454707625|FG002|Crossover Phase|Withdrawal by Subject|3|||
126386024|NCT01597908|454707623|FG000|Crossover Phase|Sponsor Decision|0|||
126048727|NCT02787005|453475274|FG003|Overall Study|Adverse Event|7|||
126048728|NCT02787005|453475275|FG004|Overall Study|Adverse Event|2|||
126386025|NCT01597908|454707624|FG001|Crossover Phase|Sponsor Decision|0|||
126386026|NCT01597908|454707625|FG002|Crossover Phase|Sponsor Decision|20|||
126386027|NCT00837161|454707628|FG000|Overall Study|refused hysterectomy|2|||
126386028|NCT01659996|454707631|FG000|Overall Study|Protocol Violation|3|||
126386029|NCT01659996|454707632|FG001|Overall Study|Protocol Violation|3|||
126386030|NCT01659996|454707633|FG002|Overall Study|Protocol Violation|3|||
126386031|NCT01659996|454707631|FG000|Overall Study|Lost to Follow-up|1|||
126386032|NCT01659996|454707632|FG001|Overall Study|Lost to Follow-up|3|||
126386033|NCT01659996|454707633|FG002|Overall Study|Lost to Follow-up|2|||
126386034|NCT01659996|454707631|FG000|Overall Study|Adverse Event|0|||
126386035|NCT01659996|454707632|FG001|Overall Study|Adverse Event|0|||
126386036|NCT01659996|454707633|FG002|Overall Study|Adverse Event|1|||
126386037|NCT01659996|454707631|FG000|Overall Study|Withdrawal by Subject|4|||
126386038|NCT01659996|454707632|FG001|Overall Study|Withdrawal by Subject|1|||
126386039|NCT01659996|454707633|FG002|Overall Study|Withdrawal by Subject|5|||
126048729|NCT02787005|453475271|FG000|Overall Study|Death|100|||
126048730|NCT02787005|453475272|FG001|Overall Study|Death|53|||
126048731|NCT02787005|453475273|FG002|Overall Study|Death|48|||
126048732|NCT02787005|453475274|FG003|Overall Study|Death|69|||
126048733|NCT02787005|453475275|FG004|Overall Study|Death|38|||
126386040|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Adverse Event|7|||
126386041|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Adverse Event|0|||
126386042|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Adverse Event|0|||
126386043|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
126386044|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
126386045|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
126386046|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
126386047|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
126386048|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
126386049|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
126386050|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
126386051|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
126386052|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
126386053|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
126386054|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
126386055|NCT01059864|454707640|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126386056|NCT01059864|454707641|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
126386057|NCT01059864|454707642|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
126386058|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Adverse Event|21|||
126386059|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Adverse Event|34|||
126386060|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Adverse Event|14|||
126386061|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Adverse Event|17|||
126386062|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Adverse Event|0|||
126386063|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
126386064|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
126386065|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
126386066|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
126386067|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
126386068|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
126386069|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
126386070|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
126386071|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
126386072|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
126386073|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Physician Decision|2|||
126386074|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Physician Decision|4|||
126386075|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Physician Decision|4|||
126386076|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Physician Decision|4|||
126386077|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Physician Decision|0|||
126386078|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
126386079|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
126386080|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
126386081|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
126386082|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
126386083|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
126386084|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
126386085|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
126386086|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
126386087|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
126386088|NCT03281629|454707656|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
126386089|NCT03281629|454707657|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
126386090|NCT03281629|454707656|FG000|Overall Study|Death|0|||
126386091|NCT03281629|454707657|FG001|Overall Study|Death|1|||
126386092|NCT03281629|454707656|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
126386093|NCT03281629|454707657|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
126386094|NCT02175277|454707659|FG000|Overall Study|Protocol-specified Criteria|1|||
126386095|NCT01905943|454709275|FG000|Overall Study|Withdrawal of consent|90|||
126386096|NCT01905943|454709275|FG000|Overall Study|Lost to Follow-up|16|||
126386097|NCT01905943|454709275|FG000|Overall Study|Investigator discretion|7|||
126386098|NCT01905943|454709275|FG000|Overall Study|Death|186|||
126386099|NCT01905943|454709275|FG000|Overall Study|Adverse Event|3|||
126386100|NCT01905943|454709275|FG000|Overall Study|Other|12|||
126386101|NCT02574078|454709276|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386102|NCT02574078|454709277|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386103|NCT02574078|454709278|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386104|NCT02574078|454709279|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386105|NCT02574078|454709280|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386106|NCT02574078|454709281|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126048734|NCT02787005|453475271|FG000|Overall Study|Sponsor Decision|7|||
126048735|NCT02787005|453475272|FG001|Overall Study|Sponsor Decision|4|||
126048736|NCT02787005|453475273|FG002|Overall Study|Sponsor Decision|0|||
126048737|NCT02787005|453475274|FG003|Overall Study|Sponsor Decision|4|||
126048738|NCT02787005|453475275|FG004|Overall Study|Sponsor Decision|5|||
126386107|NCT02574078|454709282|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
126048739|NCT02787005|453475271|FG000|Overall Study|Withdrawal by Subject|2|||
126048740|NCT02787005|453475272|FG001|Overall Study|Withdrawal by Subject|1|||
126386108|NCT02574078|454709283|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386109|NCT02574078|454709284|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126386110|NCT02574078|454709285|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386111|NCT02574078|454709286|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386112|NCT02574078|454709287|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386113|NCT02574078|454709288|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125886931|NCT02157883|452881881|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
125886932|NCT02157883|452881881|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
125886933|NCT02157883|452881881|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
125886934|NCT02157883|452881881|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
126386114|NCT02574078|454709276|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
126386115|NCT02574078|454709277|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126386116|NCT02574078|454709278|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
126386117|NCT02574078|454709279|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
126386118|NCT02574078|454709280|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
126386119|NCT02574078|454709281|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
126386120|NCT02574078|454709282|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
126386121|NCT02574078|454709283|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
126386122|NCT02574078|454709284|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
126386123|NCT02574078|454709285|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
126386124|NCT02574078|454709286|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
126386125|NCT02574078|454709287|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
126386126|NCT02574078|454709288|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
126386127|NCT02574078|454709276|FG000|Pre-Treatment Period|Other reasons|0|||
126386128|NCT02574078|454709277|FG001|Pre-Treatment Period|Other reasons|0|||
126386129|NCT02574078|454709278|FG002|Pre-Treatment Period|Other reasons|0|||
126386130|NCT02574078|454709279|FG003|Pre-Treatment Period|Other reasons|0|||
126386131|NCT02574078|454709280|FG004|Pre-Treatment Period|Other reasons|0|||
126386132|NCT02574078|454709281|FG005|Pre-Treatment Period|Other reasons|0|||
126386133|NCT02574078|454709282|FG006|Pre-Treatment Period|Other reasons|2|||
126386134|NCT02574078|454709283|FG007|Pre-Treatment Period|Other reasons|0|||
126386135|NCT02574078|454709284|FG008|Pre-Treatment Period|Other reasons|0|||
126386136|NCT02574078|454709285|FG009|Pre-Treatment Period|Other reasons|0|||
126386137|NCT02574078|454709286|FG010|Pre-Treatment Period|Other reasons|2|||
126386138|NCT02574078|454709287|FG011|Pre-Treatment Period|Other reasons|0|||
126386139|NCT02574078|454709288|FG012|Pre-Treatment Period|Other reasons|0|||
126386140|NCT02574078|454709276|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
126386141|NCT02574078|454709277|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
126386142|NCT02574078|454709278|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
126386143|NCT02574078|454709279|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
126386144|NCT02574078|454709280|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
126386145|NCT02574078|454709281|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
126386146|NCT02574078|454709282|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
126386147|NCT02574078|454709283|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
126386148|NCT02574078|454709284|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
126386149|NCT02574078|454709285|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
126386150|NCT02574078|454709286|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
126386151|NCT02574078|454709287|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
126386152|NCT02574078|454709288|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
126386153|NCT02574078|454709276|FG000|Treatment Period|Disease progression|6|||
126386154|NCT02574078|454709277|FG001|Treatment Period|Disease progression|4|||
126386155|NCT02574078|454709278|FG002|Treatment Period|Disease progression|7|||
126386156|NCT02574078|454709279|FG003|Treatment Period|Disease progression|18|||
126386157|NCT02574078|454709280|FG004|Treatment Period|Disease progression|16|||
126386158|NCT02574078|454709281|FG005|Treatment Period|Disease progression|26|||
126386159|NCT02574078|454709282|FG006|Treatment Period|Disease progression|5|||
126386160|NCT02574078|454709283|FG007|Treatment Period|Disease progression|9|||
126386161|NCT02574078|454709284|FG008|Treatment Period|Disease progression|8|||
126386162|NCT02574078|454709285|FG009|Treatment Period|Disease progression|5|||
126386163|NCT02574078|454709286|FG010|Treatment Period|Disease progression|20|||
126386164|NCT02574078|454709287|FG011|Treatment Period|Disease progression|29|||
126386165|NCT02574078|454709288|FG012|Treatment Period|Disease progression|2|||
126386166|NCT02574078|454709276|FG000|Treatment Period|Study drug toxicity|1|||
126386167|NCT02574078|454709277|FG001|Treatment Period|Study drug toxicity|1|||
126386168|NCT02574078|454709278|FG002|Treatment Period|Study drug toxicity|0|||
126386169|NCT02574078|454709279|FG003|Treatment Period|Study drug toxicity|5|||
126386170|NCT02574078|454709280|FG004|Treatment Period|Study drug toxicity|3|||
126386171|NCT02574078|454709281|FG005|Treatment Period|Study drug toxicity|1|||
126386172|NCT02574078|454709282|FG006|Treatment Period|Study drug toxicity|2|||
126386173|NCT02574078|454709283|FG007|Treatment Period|Study drug toxicity|0|||
126386174|NCT02574078|454709284|FG008|Treatment Period|Study drug toxicity|2|||
126386175|NCT02574078|454709285|FG009|Treatment Period|Study drug toxicity|1|||
126386176|NCT02574078|454709286|FG010|Treatment Period|Study drug toxicity|16|||
126386177|NCT02574078|454709287|FG011|Treatment Period|Study drug toxicity|2|||
126386178|NCT02574078|454709288|FG012|Treatment Period|Study drug toxicity|4|||
126386179|NCT02574078|454709276|FG000|Treatment Period|Death|2|||
126386180|NCT02574078|454709277|FG001|Treatment Period|Death|0|||
126386181|NCT02574078|454709278|FG002|Treatment Period|Death|0|||
126386182|NCT02574078|454709279|FG003|Treatment Period|Death|0|||
126386183|NCT02574078|454709280|FG004|Treatment Period|Death|1|||
126386184|NCT02574078|454709281|FG005|Treatment Period|Death|1|||
126386185|NCT02574078|454709282|FG006|Treatment Period|Death|1|||
126386186|NCT02574078|454709283|FG007|Treatment Period|Death|1|||
126386187|NCT02574078|454709284|FG008|Treatment Period|Death|7|||
126386188|NCT02574078|454709285|FG009|Treatment Period|Death|1|||
126386189|NCT02574078|454709286|FG010|Treatment Period|Death|0|||
126386190|NCT02574078|454709287|FG011|Treatment Period|Death|2|||
126386191|NCT02574078|454709288|FG012|Treatment Period|Death|1|||
126386192|NCT02574078|454709276|FG000|Treatment Period|Adverse event unrelated to drug|0|||
126386193|NCT02574078|454709277|FG001|Treatment Period|Adverse event unrelated to drug|0|||
126386194|NCT02574078|454709278|FG002|Treatment Period|Adverse event unrelated to drug|1|||
126386195|NCT02574078|454709279|FG003|Treatment Period|Adverse event unrelated to drug|0|||
126386196|NCT02574078|454709280|FG004|Treatment Period|Adverse event unrelated to drug|2|||
126386197|NCT02574078|454709281|FG005|Treatment Period|Adverse event unrelated to drug|3|||
126386198|NCT02574078|454709282|FG006|Treatment Period|Adverse event unrelated to drug|0|||
126386199|NCT02574078|454709283|FG007|Treatment Period|Adverse event unrelated to drug|0|||
126386200|NCT02574078|454709284|FG008|Treatment Period|Adverse event unrelated to drug|1|||
126386201|NCT02574078|454709285|FG009|Treatment Period|Adverse event unrelated to drug|2|||
126386202|NCT02574078|454709286|FG010|Treatment Period|Adverse event unrelated to drug|4|||
126386203|NCT02574078|454709287|FG011|Treatment Period|Adverse event unrelated to drug|1|||
126386204|NCT02574078|454709288|FG012|Treatment Period|Adverse event unrelated to drug|0|||
126386205|NCT02574078|454709276|FG000|Treatment Period|Administrative reason by Sponsor|0|||
126386206|NCT02574078|454709277|FG001|Treatment Period|Administrative reason by Sponsor|1|||
126386207|NCT02574078|454709278|FG002|Treatment Period|Administrative reason by Sponsor|0|||
126386208|NCT02574078|454709279|FG003|Treatment Period|Administrative reason by Sponsor|0|||
126386209|NCT02574078|454709280|FG004|Treatment Period|Administrative reason by Sponsor|0|||
126386210|NCT02574078|454709281|FG005|Treatment Period|Administrative reason by Sponsor|0|||
126386211|NCT02574078|454709282|FG006|Treatment Period|Administrative reason by Sponsor|1|||
126386212|NCT02574078|454709283|FG007|Treatment Period|Administrative reason by Sponsor|0|||
126386213|NCT02574078|454709284|FG008|Treatment Period|Administrative reason by Sponsor|0|||
126386214|NCT02574078|454709285|FG009|Treatment Period|Administrative reason by Sponsor|0|||
126386215|NCT02574078|454709286|FG010|Treatment Period|Administrative reason by Sponsor|0|||
126386216|NCT02574078|454709287|FG011|Treatment Period|Administrative reason by Sponsor|0|||
126386217|NCT02574078|454709288|FG012|Treatment Period|Administrative reason by Sponsor|3|||
126386218|NCT02574078|454709276|FG000|Treatment Period|Other reasons|1|||
126386219|NCT02574078|454709277|FG001|Treatment Period|Other reasons|0|||
126386220|NCT02574078|454709278|FG002|Treatment Period|Other reasons|1|||
126386221|NCT02574078|454709279|FG003|Treatment Period|Other reasons|3|||
126386222|NCT02574078|454709280|FG004|Treatment Period|Other reasons|3|||
126386223|NCT02574078|454709281|FG005|Treatment Period|Other reasons|1|||
126386224|NCT02574078|454709282|FG006|Treatment Period|Other reasons|2|||
126386225|NCT02574078|454709283|FG007|Treatment Period|Other reasons|1|||
126386226|NCT02574078|454709284|FG008|Treatment Period|Other reasons|3|||
126386227|NCT02574078|454709285|FG009|Treatment Period|Other reasons|1|||
126386228|NCT02574078|454709286|FG010|Treatment Period|Other reasons|1|||
126386229|NCT02574078|454709287|FG011|Treatment Period|Other reasons|3|||
126386230|NCT02574078|454709288|FG012|Treatment Period|Other reasons|1|||
126386231|NCT02574078|454709276|FG000|Treatment Period|Participant request to stop drug|0|||
126386232|NCT02574078|454709277|FG001|Treatment Period|Participant request to stop drug|0|||
126386233|NCT02574078|454709278|FG002|Treatment Period|Participant request to stop drug|0|||
126386234|NCT02574078|454709279|FG003|Treatment Period|Participant request to stop drug|2|||
126386235|NCT02574078|454709280|FG004|Treatment Period|Participant request to stop drug|4|||
126386236|NCT02574078|454709281|FG005|Treatment Period|Participant request to stop drug|0|||
126386237|NCT02574078|454709282|FG006|Treatment Period|Participant request to stop drug|1|||
126386238|NCT02574078|454709283|FG007|Treatment Period|Participant request to stop drug|0|||
126386239|NCT02574078|454709284|FG008|Treatment Period|Participant request to stop drug|3|||
126386240|NCT02574078|454709285|FG009|Treatment Period|Participant request to stop drug|2|||
126386241|NCT02574078|454709286|FG010|Treatment Period|Participant request to stop drug|2|||
126386242|NCT02574078|454709287|FG011|Treatment Period|Participant request to stop drug|4|||
126386243|NCT02574078|454709288|FG012|Treatment Period|Participant request to stop drug|1|||
126386244|NCT02574078|454709276|FG000|Treatment Period|Participant withdrew consent|0|||
126386245|NCT02574078|454709277|FG001|Treatment Period|Participant withdrew consent|0|||
126048741|NCT02787005|453475273|FG002|Overall Study|Withdrawal by Subject|1|||
126386246|NCT02574078|454709278|FG002|Treatment Period|Participant withdrew consent|0|||
126386247|NCT02574078|454709279|FG003|Treatment Period|Participant withdrew consent|0|||
126386248|NCT02574078|454709280|FG004|Treatment Period|Participant withdrew consent|1|||
126386249|NCT02574078|454709281|FG005|Treatment Period|Participant withdrew consent|1|||
126386250|NCT02574078|454709282|FG006|Treatment Period|Participant withdrew consent|0|||
126386251|NCT02574078|454709283|FG007|Treatment Period|Participant withdrew consent|1|||
126386252|NCT02574078|454709284|FG008|Treatment Period|Participant withdrew consent|0|||
126386253|NCT02574078|454709285|FG009|Treatment Period|Participant withdrew consent|2|||
126386254|NCT02574078|454709286|FG010|Treatment Period|Participant withdrew consent|1|||
126386255|NCT02574078|454709287|FG011|Treatment Period|Participant withdrew consent|4|||
125886935|NCT00888940|452881882|FG000|Overall Study|Adverse Event|12|||
125886936|NCT00888940|452881883|FG001|Overall Study|Adverse Event|3|||
125886937|NCT00888940|452881882|FG000|Overall Study|Lost to Follow-up|5|||
125886938|NCT00888940|452881883|FG001|Overall Study|Lost to Follow-up|5|||
125886939|NCT00888940|452881882|FG000|Overall Study|Randomized Not Treated|11|||
125886940|NCT00888940|452881883|FG001|Overall Study|Randomized Not Treated|13|||
125886941|NCT00750438|452881885|FG000|Overall Study|Protocol Violation|4|||
125886942|NCT00750438|452881886|FG001|Overall Study|Protocol Violation|1|||
125886943|NCT00750438|452881885|FG000|Overall Study|Physician Decision|2|||
125886944|NCT00750438|452881886|FG001|Overall Study|Physician Decision|2|||
125886945|NCT00750438|452881885|FG000|Overall Study|Withdrawal by Subject|1|||
125886946|NCT00750438|452881886|FG001|Overall Study|Withdrawal by Subject|1|||
125886947|NCT02736578|452881887|FG000|Overall Study|Adverse Event|1|||
125886948|NCT02736578|452881888|FG001|Overall Study|Adverse Event|0|||
125886949|NCT00354432|452881889|FG000|Overall Study|Adverse Event|3|||
125886950|NCT00354432|452881890|FG001|Overall Study|Adverse Event|1|||
125886951|NCT00354432|452881891|FG002|Overall Study|Adverse Event|5|||
125886952|NCT00354432|452881892|FG003|Overall Study|Adverse Event|5|||
125886953|NCT00354432|452881889|FG000|Overall Study|Off/Toxicity|3|||
126386256|NCT02574078|454709288|FG012|Treatment Period|Participant withdrew consent|1|||
126386257|NCT02574078|454709276|FG000|Treatment Period|Participant no longer meets criteria|0|||
126386258|NCT02574078|454709277|FG001|Treatment Period|Participant no longer meets criteria|0|||
126386259|NCT02574078|454709278|FG002|Treatment Period|Participant no longer meets criteria|0|||
126386260|NCT02574078|454709279|FG003|Treatment Period|Participant no longer meets criteria|0|||
126386261|NCT02574078|454709280|FG004|Treatment Period|Participant no longer meets criteria|1|||
126386262|NCT02574078|454709281|FG005|Treatment Period|Participant no longer meets criteria|0|||
126386263|NCT02574078|454709282|FG006|Treatment Period|Participant no longer meets criteria|0|||
126386264|NCT02574078|454709283|FG007|Treatment Period|Participant no longer meets criteria|0|||
126386265|NCT02574078|454709284|FG008|Treatment Period|Participant no longer meets criteria|0|||
126386266|NCT02574078|454709285|FG009|Treatment Period|Participant no longer meets criteria|1|||
126386267|NCT02574078|454709286|FG010|Treatment Period|Participant no longer meets criteria|1|||
126386268|NCT02574078|454709287|FG011|Treatment Period|Participant no longer meets criteria|1|||
126386269|NCT02574078|454709288|FG012|Treatment Period|Participant no longer meets criteria|0|||
126386270|NCT02574078|454709276|FG000|Treatment Period|Lost to Follow-up|0|||
125886954|NCT00354432|452881890|FG001|Overall Study|Off/Toxicity|7|||
125886955|NCT00354432|452881891|FG002|Overall Study|Off/Toxicity|5|||
126386271|NCT02574078|454709277|FG001|Treatment Period|Lost to Follow-up|0|||
126386272|NCT02574078|454709278|FG002|Treatment Period|Lost to Follow-up|0|||
126386273|NCT02574078|454709279|FG003|Treatment Period|Lost to Follow-up|0|||
126386274|NCT02574078|454709280|FG004|Treatment Period|Lost to Follow-up|0|||
126386275|NCT02574078|454709281|FG005|Treatment Period|Lost to Follow-up|0|||
126386276|NCT02574078|454709282|FG006|Treatment Period|Lost to Follow-up|0|||
126386277|NCT02574078|454709283|FG007|Treatment Period|Lost to Follow-up|0|||
126386278|NCT02574078|454709284|FG008|Treatment Period|Lost to Follow-up|0|||
126386279|NCT02574078|454709285|FG009|Treatment Period|Lost to Follow-up|1|||
126386280|NCT02574078|454709286|FG010|Treatment Period|Lost to Follow-up|0|||
126386281|NCT02574078|454709287|FG011|Treatment Period|Lost to Follow-up|1|||
126386282|NCT02574078|454709288|FG012|Treatment Period|Lost to Follow-up|0|||
126386283|NCT02574078|454709276|FG000|Treatment Period|Maximum clinical benefit|0|||
126386284|NCT02574078|454709277|FG001|Treatment Period|Maximum clinical benefit|0|||
126386285|NCT02574078|454709278|FG002|Treatment Period|Maximum clinical benefit|0|||
126386286|NCT02574078|454709279|FG003|Treatment Period|Maximum clinical benefit|0|||
126386287|NCT02574078|454709280|FG004|Treatment Period|Maximum clinical benefit|0|||
126386288|NCT02574078|454709281|FG005|Treatment Period|Maximum clinical benefit|0|||
126386289|NCT02574078|454709282|FG006|Treatment Period|Maximum clinical benefit|0|||
126386290|NCT02574078|454709283|FG007|Treatment Period|Maximum clinical benefit|0|||
126386291|NCT02574078|454709284|FG008|Treatment Period|Maximum clinical benefit|0|||
126386292|NCT02574078|454709285|FG009|Treatment Period|Maximum clinical benefit|1|||
126386293|NCT02574078|454709286|FG010|Treatment Period|Maximum clinical benefit|0|||
126386294|NCT02574078|454709287|FG011|Treatment Period|Maximum clinical benefit|0|||
126386295|NCT02574078|454709288|FG012|Treatment Period|Maximum clinical benefit|0|||
126386296|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Adverse Event|1|||
125886956|NCT00354432|452881892|FG003|Overall Study|Off/Toxicity|5|||
125886957|NCT02827877|452881893|FG000|Overall Study|Withdrawal by Subject|1|||
125886958|NCT01071798|452883051|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
125886959|NCT01071798|452883051|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
125886960|NCT01071798|452883051|FG000|Participants Who Received One Cycle|Patient requirement|20|||
125886961|NCT01071798|452883051|FG000|Participants Who Received One Cycle|Death|5|||
125886962|NCT01071798|452883051|FG000|Participants Who Received One Cycle|Change of therapy|6|||
126386297|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Adverse Event|0|||
126386298|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
126386299|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
126386300|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
126386301|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
126386302|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
126386303|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
126386304|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Other|1|||
126386305|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Other|4|||
126386306|NCT00301262|454709292|FG000|Open Label Phase (OL)|Adverse Event|1|||
126386307|NCT00301262|454709293|FG001|Open Label Phase (OL)|Adverse Event|0|||
126386308|NCT00301262|454709292|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
126386309|NCT00301262|454709293|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
126386310|NCT00301262|454709292|FG000|Open Label Phase (OL)|Other|2|||
126386311|NCT00301262|454709293|FG001|Open Label Phase (OL)|Other|0|||
126386312|NCT00368745|454709294|FG000|Double-blind Treatment Period|Adverse Event|6|||
126386313|NCT00368745|454709295|FG001|Double-blind Treatment Period|Adverse Event|6|||
126386314|NCT00368745|454709294|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
126386315|NCT00368745|454709295|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
126386316|NCT00368745|454709294|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
126386317|NCT00368745|454709295|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126386318|NCT00368745|454709294|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
126386319|NCT00368745|454709295|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
126386320|NCT00368745|454709294|FG000|Double-blind Treatment Period|Other|7|||
126386321|NCT00368745|454709295|FG001|Double-blind Treatment Period|Other|6|||
126386322|NCT01208324|454709296|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
126386323|NCT01208324|454709297|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
126386324|NCT01208324|454709298|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
126386325|NCT01208324|454709299|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
126386326|NCT02707965|454709300|FG000|Overall Study|Withdrawal by Subject|0|||
126386327|NCT02707965|454709301|FG001|Overall Study|Withdrawal by Subject|0|||
126386328|NCT02707965|454709302|FG002|Overall Study|Withdrawal by Subject|1|||
126386329|NCT02707965|454709303|FG003|Overall Study|Withdrawal by Subject|0|||
126386330|NCT02707965|454709304|FG004|Overall Study|Withdrawal by Subject|0|||
126386331|NCT02707965|454709305|FG005|Overall Study|Withdrawal by Subject|0|||
126386332|NCT02707965|454709306|FG006|Overall Study|Withdrawal by Subject|0|||
126386333|NCT02707965|454709307|FG007|Overall Study|Withdrawal by Subject|2|||
126386334|NCT02707965|454709308|FG008|Overall Study|Withdrawal by Subject|0|||
126386335|NCT02707965|454709309|FG009|Overall Study|Withdrawal by Subject|0|||
126386336|NCT02707965|454709310|FG010|Overall Study|Withdrawal by Subject|0|||
126386337|NCT02707965|454709311|FG011|Overall Study|Withdrawal by Subject|0|||
126386338|NCT02707965|454709312|FG012|Overall Study|Withdrawal by Subject|0|||
126386339|NCT02707965|454709313|FG013|Overall Study|Withdrawal by Subject|0|||
126386340|NCT02707965|454709314|FG014|Overall Study|Withdrawal by Subject|0|||
126386341|NCT02707965|454709315|FG015|Overall Study|Withdrawal by Subject|0|||
126386342|NCT02707965|454709300|FG000|Overall Study|PI decisions|0|||
126386343|NCT02707965|454709301|FG001|Overall Study|PI decisions|0|||
126386344|NCT02707965|454709302|FG002|Overall Study|PI decisions|0|||
126386345|NCT02707965|454709303|FG003|Overall Study|PI decisions|0|||
126386346|NCT02707965|454709304|FG004|Overall Study|PI decisions|0|||
126386347|NCT02707965|454709305|FG005|Overall Study|PI decisions|0|||
126386348|NCT02707965|454709306|FG006|Overall Study|PI decisions|0|||
126386349|NCT02707965|454709307|FG007|Overall Study|PI decisions|0|||
126386350|NCT02707965|454709308|FG008|Overall Study|PI decisions|0|||
126386351|NCT02707965|454709309|FG009|Overall Study|PI decisions|0|||
126386352|NCT02707965|454709310|FG010|Overall Study|PI decisions|0|||
126386353|NCT02707965|454709311|FG011|Overall Study|PI decisions|0|||
126386354|NCT02707965|454709312|FG012|Overall Study|PI decisions|0|||
126386355|NCT02707965|454709313|FG013|Overall Study|PI decisions|0|||
126386356|NCT02707965|454709314|FG014|Overall Study|PI decisions|2|||
126386357|NCT02707965|454709315|FG015|Overall Study|PI decisions|0|||
126386358|NCT02707965|454709300|FG000|Overall Study|Protocol deviation|1|||
126386359|NCT02707965|454709301|FG001|Overall Study|Protocol deviation|1|||
126386360|NCT02707965|454709302|FG002|Overall Study|Protocol deviation|0|||
126386361|NCT02707965|454709303|FG003|Overall Study|Protocol deviation|0|||
126386362|NCT02707965|454709304|FG004|Overall Study|Protocol deviation|0|||
126386363|NCT02707965|454709305|FG005|Overall Study|Protocol deviation|0|||
126386364|NCT02707965|454709306|FG006|Overall Study|Protocol deviation|0|||
126386365|NCT02707965|454709307|FG007|Overall Study|Protocol deviation|1|||
126386366|NCT02707965|454709308|FG008|Overall Study|Protocol deviation|0|||
126386367|NCT02707965|454709309|FG009|Overall Study|Protocol deviation|0|||
126386368|NCT02707965|454709310|FG010|Overall Study|Protocol deviation|0|||
126386369|NCT02707965|454709311|FG011|Overall Study|Protocol deviation|0|||
126386370|NCT02707965|454709312|FG012|Overall Study|Protocol deviation|0|||
126386371|NCT02707965|454709313|FG013|Overall Study|Protocol deviation|0|||
126386372|NCT02707965|454709314|FG014|Overall Study|Protocol deviation|0|||
126386373|NCT02707965|454709315|FG015|Overall Study|Protocol deviation|0|||
126386374|NCT00748618|454709317|FG000|Overall Study|Adverse Event|1|||
126386375|NCT00748618|454709318|FG001|Overall Study|Adverse Event|0|||
126386376|NCT02854436|454709319|FG000|Overall Study|Adverse Event|1|||
126386377|NCT02854436|454709319|FG000|Overall Study|Death|208|||
126386378|NCT02854436|454709319|FG000|Overall Study|Lost to Follow-up|5|||
125886963|NCT01071798|452883051|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
125886964|NCT01071798|452883051|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
125886965|NCT01071798|452883051|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
125886966|NCT01071798|452883051|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
125886967|NCT01071798|452883051|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
125886968|NCT00145158|452883054|FG000|Overall Study|premature withdrawal|2|||
125886969|NCT00145158|452883055|FG001|Overall Study|premature withdrawal|3|||
125886970|NCT01227018|452883059|FG000|Overall Study|Disease progression|9|||
125886971|NCT01227018|452883059|FG000|Overall Study|Toxicity|2|||
125886972|NCT01227018|452883059|FG000|Overall Study|Withdrew after beginning treatment|4|||
125886973|NCT00753649|452883060|FG000|Overall Study|Migrated/moved from study area|1|||
125886974|NCT00753649|452883061|FG001|Overall Study|Migrated/moved from study area|0|||
125886975|NCT00753649|452883060|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
125886976|NCT00753649|452883061|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
125886977|NCT00753649|452883060|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
125886978|NCT00753649|452883061|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
125886979|NCT00753649|452883060|FG000|Overall Study|Protocol Violation|2|||
125886980|NCT00753649|452883061|FG001|Overall Study|Protocol Violation|0|||
125886981|NCT00499616|452883062|FG000|Overall Study|Death|1|||
125886982|NCT00499616|452883063|FG001|Overall Study|Death|5|||
125886983|NCT00499616|452883064|FG002|Overall Study|Death|3|||
125886984|NCT00499616|452883065|FG003|Overall Study|Death|1|||
125886985|NCT00499616|452883062|FG000|Overall Study|Lack of Efficacy|5|||
125886986|NCT00499616|452883063|FG001|Overall Study|Lack of Efficacy|0|||
125886987|NCT00499616|452883064|FG002|Overall Study|Lack of Efficacy|19|||
125886988|NCT00499616|452883065|FG003|Overall Study|Lack of Efficacy|0|||
125886989|NCT00499616|452883062|FG000|Overall Study|Lost to Follow-up|0|||
125886990|NCT00499616|452883063|FG001|Overall Study|Lost to Follow-up|0|||
125886991|NCT00499616|452883064|FG002|Overall Study|Lost to Follow-up|1|||
125886992|NCT00499616|452883065|FG003|Overall Study|Lost to Follow-up|0|||
125886993|NCT00499616|452883062|FG000|Overall Study|Physician Decision|6|||
125886994|NCT00499616|452883063|FG001|Overall Study|Physician Decision|16|||
125886995|NCT00499616|452883064|FG002|Overall Study|Physician Decision|9|||
125886996|NCT00499616|452883065|FG003|Overall Study|Physician Decision|0|||
125886997|NCT00499616|452883062|FG000|Overall Study|Withdrawal by Subject|1|||
125886998|NCT00499616|452883063|FG001|Overall Study|Withdrawal by Subject|0|||
125886999|NCT00499616|452883064|FG002|Overall Study|Withdrawal by Subject|1|||
125887000|NCT00499616|452883065|FG003|Overall Study|Withdrawal by Subject|0|||
125887001|NCT00499616|452883062|FG000|Overall Study|Ineligible|1|||
125887002|NCT00499616|452883063|FG001|Overall Study|Ineligible|2|||
125887003|NCT00499616|452883064|FG002|Overall Study|Ineligible|0|||
125887004|NCT00499616|452883065|FG003|Overall Study|Ineligible|15|||
125887005|NCT00499616|452883062|FG000|Overall Study|Not evaluable|0|||
125887006|NCT00499616|452883063|FG001|Overall Study|Not evaluable|0|||
125887007|NCT00499616|452883064|FG002|Overall Study|Not evaluable|0|||
125887008|NCT00499616|452883065|FG003|Overall Study|Not evaluable|41|||
125887009|NCT00499616|452883062|FG000|Overall Study|Patient/Parent Refusal|1|||
125887010|NCT00499616|452883063|FG001|Overall Study|Patient/Parent Refusal|5|||
125887011|NCT00499616|452883064|FG002|Overall Study|Patient/Parent Refusal|3|||
125887012|NCT00499616|452883065|FG003|Overall Study|Patient/Parent Refusal|0|||
125887013|NCT01938716|452883073|FG000|Overall Study|Physician Decision|2|||
125887014|NCT01938716|452883073|FG000|Overall Study|Withdrawal by Subject|2|||
125887015|NCT00098813|452883074|FG000|Overall Study|Death|8|||
125887016|NCT00098813|452883074|FG000|Overall Study|Protocol Violation|1|||
126048742|NCT02787005|453475274|FG003|Overall Study|Withdrawal by Subject|0|||
126386379|NCT02854436|454709319|FG000|Overall Study|Withdrawal by Subject|24|||
126386380|NCT02854436|454709319|FG000|Overall Study|Other|45|||
126386381|NCT02854436|454709319|FG000|Overall Study|Physician Decision|6|||
126386382|NCT01977729|454709320|FG000|Overall Study|Study terminated|1|||
126386383|NCT01268046|454709321|FG000|Overall Study|Withdrawal by Subject|1|||
126386384|NCT01268046|454709322|FG001|Overall Study|Withdrawal by Subject|0|||
125887017|NCT00098813|452883074|FG000|Overall Study|Withdrawal by Subject|7|||
126048743|NCT02787005|453475275|FG004|Overall Study|Withdrawal by Subject|1|||
125887018|NCT00098813|452883074|FG000|Overall Study|Progression of Disease|1|||
126048744|NCT02787005|453475271|FG000|Overall Study|Screen Failure|0|||
125887019|NCT00098813|452883074|FG000|Overall Study|Other complicating disease|1|||
125887020|NCT00098813|452883074|FG000|Overall Study|Reversal of RAI resistance|1|||
125887021|NCT00433004|452883077|FG000|Overall Study|Lost to Follow-up|5|||
126048745|NCT02787005|453475272|FG001|Overall Study|Screen Failure|2|||
125887022|NCT00433004|452883078|FG001|Overall Study|Lost to Follow-up|7|||
126048746|NCT02787005|453475273|FG002|Overall Study|Screen Failure|0|||
126048747|NCT02787005|453475274|FG003|Overall Study|Screen Failure|0|||
125887023|NCT00220636|452883079|FG000|Overall Study|Withdrawal by Subject|4|||
125887024|NCT00330967|452883080|FG000|Overall Study|Withdrawal by Subject|0|||
126048748|NCT02787005|453475275|FG004|Overall Study|Screen Failure|1|||
126386385|NCT01268046|454709323|FG002|Overall Study|Withdrawal by Subject|0|||
126386386|NCT01268046|454709324|FG003|Overall Study|Withdrawal by Subject|1|||
126386387|NCT01268046|454709321|FG000|Overall Study|Lost to Follow-up|0|||
126386388|NCT01268046|454709322|FG001|Overall Study|Lost to Follow-up|0|||
126386389|NCT01268046|454709323|FG002|Overall Study|Lost to Follow-up|1|||
126386390|NCT01268046|454709324|FG003|Overall Study|Lost to Follow-up|0|||
126386391|NCT00224120|454709325|FG000|Overall Study|Adverse Event|10|||
126386392|NCT00224120|454709326|FG001|Overall Study|Adverse Event|4|||
126386393|NCT00224120|454709325|FG000|Overall Study|Protocol Violation|1|||
126386394|NCT00224120|454709326|FG001|Overall Study|Protocol Violation|0|||
126386395|NCT00224120|454709325|FG000|Overall Study|Withdrawal by Subject|5|||
126386396|NCT00224120|454709326|FG001|Overall Study|Withdrawal by Subject|10|||
126386397|NCT00224120|454709325|FG000|Overall Study|Lack of Efficacy|0|||
126386398|NCT00224120|454709326|FG001|Overall Study|Lack of Efficacy|2|||
126386399|NCT00224120|454709325|FG000|Overall Study|Lost to Follow-up|2|||
126386400|NCT00224120|454709326|FG001|Overall Study|Lost to Follow-up|3|||
126386401|NCT00224120|454709325|FG000|Overall Study|Other|4|||
126386402|NCT00224120|454709326|FG001|Overall Study|Other|5|||
126386403|NCT00282087|454709327|FG000|Overall Study|Death|1|||
126386404|NCT00338286|454709335|FG000|Overall Study|Withdrawal by Subject|50|||
126386405|NCT00338286|454709336|FG001|Overall Study|Withdrawal by Subject|54|||
126386406|NCT00338286|454709335|FG000|Overall Study|Lost to Follow-up|80|||
126386407|NCT00338286|454709336|FG001|Overall Study|Lost to Follow-up|66|||
126386408|NCT00338286|454709335|FG000|Overall Study|Other|103|||
126386409|NCT00338286|454709336|FG001|Overall Study|Other|93|||
126386410|NCT03248531|454709337|FG000|Overall Study|Adverse Event|0|||
126386411|NCT03248531|454709338|FG001|Overall Study|Adverse Event|0|||
126386412|NCT03248531|454709339|FG002|Overall Study|Adverse Event|1|||
126386413|NCT03248531|454709337|FG000|Overall Study|Lost to Follow-up|1|||
126386414|NCT03248531|454709338|FG001|Overall Study|Lost to Follow-up|0|||
126386415|NCT03248531|454709339|FG002|Overall Study|Lost to Follow-up|5|||
126386416|NCT03248531|454709337|FG000|Overall Study|Withdrawal by Subject|3|||
126386417|NCT03248531|454709338|FG001|Overall Study|Withdrawal by Subject|3|||
126386418|NCT03248531|454709339|FG002|Overall Study|Withdrawal by Subject|2|||
126386419|NCT03248531|454709337|FG000|Overall Study|Sponsor Request|0|||
126386420|NCT03248531|454709338|FG001|Overall Study|Sponsor Request|2|||
126386421|NCT03248531|454709339|FG002|Overall Study|Sponsor Request|0|||
126386422|NCT04075513|454709340|FG000|Overall Study|Withdrawal by Subject|2|||
126386423|NCT04075513|454709341|FG001|Overall Study|Withdrawal by Subject|2|||
126386424|NCT04075513|454709340|FG000|Overall Study|Lack of Efficacy|1|||
126386425|NCT04075513|454709341|FG001|Overall Study|Lack of Efficacy|0|||
126386426|NCT04075513|454709340|FG000|Overall Study|Lost to Follow-up|4|||
126386427|NCT04075513|454709341|FG001|Overall Study|Lost to Follow-up|2|||
126386428|NCT04075513|454709340|FG000|Overall Study|Switch to insulin pump|1|||
126386429|NCT04075513|454709341|FG001|Overall Study|Switch to insulin pump|0|||
126386430|NCT01035463|454709342|FG000|Overall Study|Adverse Event|0|||
126386431|NCT01035463|454709343|FG001|Overall Study|Adverse Event|0|||
126386432|NCT01035463|454709344|FG002|Overall Study|Adverse Event|4|||
126386433|NCT01035463|454709345|FG003|Overall Study|Adverse Event|1|||
126386434|NCT01035463|454709346|FG004|Overall Study|Adverse Event|5|||
126386435|NCT01035463|454709347|FG005|Overall Study|Adverse Event|7|||
126386436|NCT01035463|454709342|FG000|Overall Study|Withdrawal by Subject|0|||
126386437|NCT01035463|454709343|FG001|Overall Study|Withdrawal by Subject|2|||
126386438|NCT01035463|454709344|FG002|Overall Study|Withdrawal by Subject|1|||
126386439|NCT01035463|454709345|FG003|Overall Study|Withdrawal by Subject|0|||
126386440|NCT01035463|454709346|FG004|Overall Study|Withdrawal by Subject|1|||
126386441|NCT01035463|454709347|FG005|Overall Study|Withdrawal by Subject|4|||
126386442|NCT01035463|454709342|FG000|Overall Study|Disease progression|0|||
126386443|NCT01035463|454709343|FG001|Overall Study|Disease progression|0|||
126386444|NCT01035463|454709344|FG002|Overall Study|Disease progression|0|||
126386445|NCT01035463|454709345|FG003|Overall Study|Disease progression|0|||
126386446|NCT01035463|454709346|FG004|Overall Study|Disease progression|0|||
125887025|NCT00330967|452883081|FG001|Overall Study|Withdrawal by Subject|5|||
126386447|NCT01035463|454709347|FG005|Overall Study|Disease progression|3|||
125887026|NCT00330967|452883080|FG000|Overall Study|Physician Decision|0|||
125887027|NCT00330967|452883081|FG001|Overall Study|Physician Decision|9|||
125887028|NCT01470326|452883082|FG000|Overall Study|Protocol Violation|32|||
126386448|NCT01035463|454709342|FG000|Overall Study|Other Malignancy|0|||
126386449|NCT01035463|454709343|FG001|Overall Study|Other Malignancy|0|||
126386450|NCT01035463|454709344|FG002|Overall Study|Other Malignancy|0|||
126386451|NCT01035463|454709345|FG003|Overall Study|Other Malignancy|0|||
126386452|NCT01035463|454709346|FG004|Overall Study|Other Malignancy|0|||
126386453|NCT01035463|454709347|FG005|Overall Study|Other Malignancy|2|||
126386454|NCT01035463|454709342|FG000|Overall Study|Other|0|||
126386455|NCT01035463|454709343|FG001|Overall Study|Other|0|||
126386456|NCT01035463|454709344|FG002|Overall Study|Other|0|||
126386457|NCT01035463|454709345|FG003|Overall Study|Other|1|||
126386458|NCT01035463|454709346|FG004|Overall Study|Other|0|||
126386459|NCT01035463|454709347|FG005|Overall Study|Other|2|||
126386460|NCT04153981|454709355|FG000|Overall Study|Death|1|||
126386461|NCT04153981|454709355|FG000|Overall Study|Withdrawal by Subject|24|||
126386462|NCT04153981|454709355|FG000|Overall Study|Lost to Follow-up|1|||
126386463|NCT04153981|454709355|FG000|Overall Study|Physician Decision|1|||
126386464|NCT04153981|454709355|FG000|Overall Study|Due to Unavailable Glucometer|1|||
126386465|NCT04153981|454709355|FG000|Overall Study|Covid 19|52|||
126386466|NCT04153981|454709355|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
126386467|NCT04153981|454709355|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
126386468|NCT01355679|454709356|FG000|Overall Study|benign tumor types found at biopsy|2|||
126386469|NCT00964002|454709357|FG000|Overall Study|Protocol Violation|8|||
126386470|NCT00904670|454709360|FG000|Open Label Phase|Withdrawal by Subject|2|||
126386471|NCT00904670|454709361|FG001|Open Label Phase|Withdrawal by Subject|0|||
126386472|NCT00904670|454709360|FG000|Open Label Phase|Adverse Event|2|||
126386473|NCT00904670|454709361|FG001|Open Label Phase|Adverse Event|0|||
126386474|NCT00904670|454709360|FG000|Open Label Phase|Lack of Efficacy|1|||
126386475|NCT00904670|454709361|FG001|Open Label Phase|Lack of Efficacy|0|||
126386476|NCT00904670|454709360|FG000|Open Label Phase|Lost to Follow-up|1|||
126386477|NCT00904670|454709361|FG001|Open Label Phase|Lost to Follow-up|0|||
126386478|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
126386479|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
126386480|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
126386481|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
126386482|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Death|58|||
126386483|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Death|65|||
126386484|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Adverse Event|28|||
126386485|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Adverse Event|40|||
126386486|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Disease Progression|22|||
126386487|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Disease Progression|35|||
126386488|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Other|25|||
126386489|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Other|33|||
126386490|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
126386491|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
126386492|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Noncompliance|8|||
126386493|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Noncompliance|8|||
126386494|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
126386495|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
126386496|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
126386497|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
126386498|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
126386499|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
126386500|NCT00286091|454709362|FG000|Open-label Treatment Phase|Physician Decision|24|||
126386501|NCT00286091|454709363|FG001|Open-label Treatment Phase|Physician Decision|21|||
126386502|NCT00286091|454709362|FG000|Open-label Treatment Phase|Adverse Event|5|||
126386503|NCT00286091|454709363|FG001|Open-label Treatment Phase|Adverse Event|16|||
126386504|NCT00286091|454709362|FG000|Open-label Treatment Phase|Other|11|||
126386505|NCT00286091|454709363|FG001|Open-label Treatment Phase|Other|11|||
126386506|NCT00286091|454709362|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
126386507|NCT00286091|454709363|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
126386508|NCT00286091|454709362|FG000|Open-label Treatment Phase|Death|10|||
126386509|NCT00286091|454709363|FG001|Open-label Treatment Phase|Death|7|||
126386510|NCT00286091|454709362|FG000|Open-label Treatment Phase|Disease Progression|9|||
126386511|NCT00286091|454709363|FG001|Open-label Treatment Phase|Disease Progression|3|||
126386512|NCT00286091|454709362|FG000|Open-label Treatment Phase|Noncompliance|3|||
126386513|NCT00286091|454709363|FG001|Open-label Treatment Phase|Noncompliance|1|||
126386514|NCT00286091|454709362|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
126386515|NCT00286091|454709363|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
126386516|NCT00286091|454709362|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
126386517|NCT00286091|454709363|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
126386518|NCT00286091|454709362|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
126386519|NCT00286091|454709363|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
126386520|NCT03423238|454709364|FG000|Overall Study|Lost to Follow-up|1|||
126386521|NCT03423238|454709365|FG001|Overall Study|Lost to Follow-up|0|||
126386522|NCT03423238|454709364|FG000|Overall Study|Withdrawal by Subject|1|||
126104213|NCT03057977|453675821|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
126104214|NCT03057977|453675822|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
126386523|NCT03423238|454709365|FG001|Overall Study|Withdrawal by Subject|0|||
126386524|NCT02036580|454709366|FG000|Overall Study|Withdrawal by Subject|0|||
126386525|NCT02036580|454709367|FG001|Overall Study|Withdrawal by Subject|1|||
126386526|NCT02036580|454709368|FG002|Overall Study|Withdrawal by Subject|0|||
126386527|NCT02036580|454709366|FG000|Overall Study|Adverse Event|1|||
126386528|NCT02036580|454709367|FG001|Overall Study|Adverse Event|0|||
126386529|NCT02036580|454709368|FG002|Overall Study|Adverse Event|0|||
126386530|NCT02584452|454709369|FG000|Overall Study|Physician Decision|1|||
126386531|NCT02584452|454709370|FG001|Overall Study|Physician Decision|1|||
126386532|NCT02584452|454709369|FG000|Overall Study|Lost to Follow-up|1|||
126104215|NCT03057977|453675821|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
126386533|NCT02584452|454709370|FG001|Overall Study|Lost to Follow-up|1|||
126386534|NCT00923351|454709371|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
126386535|NCT00923351|454709372|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
126386536|NCT00923351|454709373|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
126386537|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
126386538|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
126386539|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
126386540|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
126386541|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
126386542|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
126386543|NCT01221753|454709375|FG000|Overall Study|Adverse Event|1|||
126386544|NCT04552288|454709379|FG000|Overall Study|Death|3|||
126386545|NCT04552288|454709379|FG000|Overall Study|Lost to Follow-up|6|||
126386546|NCT04552288|454709379|FG000|Overall Study|Physician Decision|3|||
126386547|NCT04552288|454709379|FG000|Overall Study|Protocol Violation|9|||
126386548|NCT04552288|454709379|FG000|Overall Study|Withdrawal by Subject|6|||
126386549|NCT04552288|454709379|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
126386550|NCT05285644|454709380|FG000|Overall Study|Adverse Event|3|||
126386551|NCT05285644|454709381|FG001|Overall Study|Adverse Event|3|||
126386552|NCT05285644|454709380|FG000|Overall Study|Withdrawal of Consent|2|||
126386553|NCT05285644|454709381|FG001|Overall Study|Withdrawal of Consent|5|||
126386554|NCT05285644|454709380|FG000|Overall Study|Noncompliance|0|||
126386555|NCT05285644|454709381|FG001|Overall Study|Noncompliance|4|||
126386556|NCT05285644|454709380|FG000|Overall Study|Lost to Follow-up|4|||
126386557|NCT05285644|454709381|FG001|Overall Study|Lost to Follow-up|6|||
126386558|NCT05285644|454709380|FG000|Overall Study|Disallowed Concurrent Medication|1|||
126386559|NCT05285644|454709381|FG001|Overall Study|Disallowed Concurrent Medication|1|||
126386560|NCT05285644|454709380|FG000|Overall Study|Investigator Decision|2|||
126386561|NCT05285644|454709381|FG001|Overall Study|Investigator Decision|0|||
126386562|NCT05285644|454709380|FG000|Overall Study|Protocol Deviation|1|||
126386563|NCT05285644|454709381|FG001|Overall Study|Protocol Deviation|0|||
126386564|NCT05285644|454709380|FG000|Overall Study|As specified in the Clinical Study Report|7|||
126386565|NCT05285644|454709381|FG001|Overall Study|As specified in the Clinical Study Report|3|||
126386566|NCT04532294|454709382|FG000|Overall Study|Withdrawal by Subject|0|||
126386567|NCT04532294|454709383|FG001|Overall Study|Withdrawal by Subject|0|||
126386568|NCT04532294|454709384|FG002|Overall Study|Withdrawal by Subject|1|||
126386569|NCT04532294|454709382|FG000|Overall Study|Participants Not Dosed|0|||
126386570|NCT04532294|454709383|FG001|Overall Study|Participants Not Dosed|0|||
126386571|NCT04532294|454709384|FG002|Overall Study|Participants Not Dosed|2|||
126386572|NCT04295759|454709385|FG000|Overall Study|Lack of Efficacy|9|||
126386573|NCT04295759|454709385|FG000|Overall Study|Death|1|||
126386574|NCT04295759|454709385|FG000|Overall Study|Withdrawal by Subject|2|||
126386575|NCT04295759|454709385|FG000|Overall Study|Deemed ineligible|1|||
126386576|NCT01696981|454709386|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
126386577|NCT01696981|454709387|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
126386578|NCT01696981|454709386|FG000|Overall Study|Died Before Randomization|3|||
126386579|NCT01696981|454709387|FG001|Overall Study|Died Before Randomization|8|||
126386580|NCT01696981|454709386|FG000|Overall Study|Died Before ASU (Control)|278|||
126386581|NCT01696981|454709387|FG001|Overall Study|Died Before ASU (Control)|0|||
126386582|NCT01696981|454709386|FG000|Overall Study|Refused ASU (Control)|920|||
126386583|NCT01696981|454709387|FG001|Overall Study|Refused ASU (Control)|0|||
126386584|NCT01696981|454709386|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
126386585|NCT01696981|454709387|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
126386586|NCT02798315|454709388|FG000|Overall Study|Failure to return|1|||
126386587|NCT03335150|454709390|FG000|Overall Study|Withdrawal by Subject|10|||
126386588|NCT03335150|454709391|FG001|Overall Study|Withdrawal by Subject|4|||
126386589|NCT03335150|454709390|FG000|Overall Study|Adverse Event|0|||
126386590|NCT03335150|454709391|FG001|Overall Study|Adverse Event|1|||
126386591|NCT02097719|454709392|FG000|Overall Study|Subject Withdrew Consent|1|||
126386592|NCT02097719|454709393|FG001|Overall Study|Subject Withdrew Consent|0|||
126386593|NCT02097719|454709392|FG000|Overall Study|Lost to Follow-up|0|||
126386594|NCT02097719|454709393|FG001|Overall Study|Lost to Follow-up|1|||
126386595|NCT02097719|454709392|FG000|Overall Study|Adverse Event|2|||
126386596|NCT02097719|454709393|FG001|Overall Study|Adverse Event|0|||
126386597|NCT03028415|454709394|FG000|Overall Study|Lost to Follow-up|6|||
126386598|NCT03028415|454709395|FG001|Overall Study|Lost to Follow-up|3|||
126386599|NCT03028415|454709394|FG000|Overall Study|Withdrawal by Subject|1|||
126386600|NCT03028415|454709395|FG001|Overall Study|Withdrawal by Subject|0|||
126386601|NCT03028415|454709394|FG000|Overall Study|Discontinued due to COVID-19|1|||
126386602|NCT03028415|454709395|FG001|Overall Study|Discontinued due to COVID-19|0|||
126386603|NCT02907216|454709396|FG000|Overall Study|No benefit to be obtained by continuing|0|||
126386604|NCT02907216|454709397|FG001|Overall Study|No benefit to be obtained by continuing|1|||
126386605|NCT02907216|454709396|FG000|Overall Study|Withdrawal by Subject|1|||
126386606|NCT02907216|454709397|FG001|Overall Study|Withdrawal by Subject|0|||
126386607|NCT01854775|454709398|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
126386608|NCT01854775|454709399|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
126386609|NCT01854775|454709400|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
126386610|NCT01854775|454709398|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
126386611|NCT01854775|454709399|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
126386612|NCT01854775|454709400|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
126386613|NCT01854775|454709398|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
126386614|NCT01854775|454709399|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
126386615|NCT01854775|454709400|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
126386616|NCT01854775|454709398|FG000|Extension Phase|Pregnancy|3|||
126386617|NCT01854775|454709399|FG001|Extension Phase|Pregnancy|0|||
126386618|NCT01854775|454709400|FG002|Extension Phase|Pregnancy|0|||
126386619|NCT01854775|454709398|FG000|Extension Phase|Investigator's Discretion|1|||
126386620|NCT01854775|454709399|FG001|Extension Phase|Investigator's Discretion|0|||
126386621|NCT01854775|454709400|FG002|Extension Phase|Investigator's Discretion|0|||
126386622|NCT01854775|454709398|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
126386623|NCT01854775|454709399|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
126386624|NCT01854775|454709400|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
126386625|NCT01854775|454709398|FG000|Extension Phase|Lost to Follow-up|2|||
126386626|NCT01854775|454709399|FG001|Extension Phase|Lost to Follow-up|0|||
126386627|NCT01854775|454709400|FG002|Extension Phase|Lost to Follow-up|0|||
126386628|NCT01854775|454709398|FG000|Extension Phase|Still on Study|32|||
126386629|NCT01854775|454709399|FG001|Extension Phase|Still on Study|47|||
126386630|NCT01854775|454709400|FG002|Extension Phase|Still on Study|18|||
126386631|NCT04601532|454709403|FG000|Overall Study|Lost to Follow-up|1|||
126386632|NCT04601532|454709404|FG001|Overall Study|Lost to Follow-up|2|||
126386633|NCT04601532|454709403|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
126386634|NCT04601532|454709404|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
126386635|NCT00281099|454709405|FG000|Overall Study|Death|46|||
126386636|NCT00281099|454709406|FG001|Overall Study|Death|57|||
126386637|NCT00281099|454709405|FG000|Overall Study|Lost to Follow-up|10|||
126386638|NCT00281099|454709406|FG001|Overall Study|Lost to Follow-up|19|||
126386639|NCT00281099|454709405|FG000|Overall Study|Withdrawal by Subject|65|||
126386640|NCT00281099|454709406|FG001|Overall Study|Withdrawal by Subject|70|||
126386641|NCT00281099|454709405|FG000|Overall Study|Physician Decision|79|||
126386642|NCT00281099|454709406|FG001|Overall Study|Physician Decision|72|||
126386643|NCT00281099|454709405|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
126386644|NCT00281099|454709406|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
126386645|NCT04621240|454709407|FG000|Overall Study|Withdrawal by Subject|36|||
126386646|NCT03108521|454709408|FG000|Overall Study|Lost to Follow-up|3|||
126386647|NCT03108521|454709409|FG001|Overall Study|Lost to Follow-up|0|||
126386648|NCT03108521|454709408|FG000|Overall Study|Lack of Efficacy|2|||
126386649|NCT03108521|454709409|FG001|Overall Study|Lack of Efficacy|0|||
126386650|NCT03108521|454709408|FG000|Overall Study|Physician Decision|4|||
126386651|NCT03108521|454709409|FG001|Overall Study|Physician Decision|0|||
126386652|NCT03108521|454709408|FG000|Overall Study|Adverse Event|3|||
126386653|NCT03108521|454709409|FG001|Overall Study|Adverse Event|0|||
126386654|NCT06899737|454709410|FG000|Overall Study|Lost to Follow-up|19|||
126386655|NCT06899737|454709411|FG001|Overall Study|Lost to Follow-up|7|||
126386656|NCT01945216|454711297|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
126386657|NCT01945216|454711297|FG000|Overall Study|Protocol Violation|42|||
126386658|NCT01945216|454711297|FG000|Overall Study|CRF not assured by investigators|5|||
126386659|NCT03062280|454711301|FG000|Overall Study|Adverse Event|1|||
126386660|NCT03062280|454711301|FG000|Overall Study|Death|1|||
126386661|NCT03062280|454711301|FG000|Overall Study|Fertility Treatment|2|||
126386662|NCT03062280|454711301|FG000|Overall Study|Physician Decision|2|||
126386663|NCT03062280|454711301|FG000|Overall Study|Pregnancy|5|||
126386664|NCT03062280|454711301|FG000|Overall Study|Withdrawal by Subject|11|||
126386665|NCT04299308|454711302|FG000|Overall Study|Withdrawal by Subject|1|||
126386666|NCT04299308|454711303|FG001|Overall Study|Withdrawal by Subject|0|||
126386667|NCT04299308|454711302|FG000|Overall Study|issue with PET image (1)|1|||
126386668|NCT04299308|454711303|FG001|Overall Study|issue with PET image (1)|0|||
126386669|NCT05258890|454711304|FG000|Overall Study|Patient withdrawal|6|||
126386670|NCT05258890|454711305|FG001|Overall Study|Patient withdrawal|7|||
126386671|NCT05258890|454711304|FG000|Overall Study|Patient lost to follow-up|10|||
126386672|NCT05258890|454711305|FG001|Overall Study|Patient lost to follow-up|3|||
126386673|NCT05258890|454711304|FG000|Overall Study|Social network member withdrawal|1|||
126386674|NCT05258890|454711305|FG001|Overall Study|Social network member withdrawal|0|||
126386675|NCT05258890|454711304|FG000|Overall Study|Social network member lost to follow-up|5|||
126386676|NCT05258890|454711305|FG001|Overall Study|Social network member lost to follow-up|0|||
126386677|NCT05959447|454711308|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
126386678|NCT05959447|454711309|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
126386679|NCT05959447|454711308|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
126386680|NCT05959447|454711309|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
126386681|NCT05959447|454711308|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
126386682|NCT05959447|454711309|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
126386683|NCT05959447|454711308|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
126386684|NCT05959447|454711309|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
126386685|NCT00249808|454711315|FG000|Overall Study|Other|27|||
126386686|NCT00249808|454711315|FG000|Overall Study|Protocol Violation|3|||
126386687|NCT00249808|454711315|FG000|Overall Study|Lost to Follow-up|8|||
126386688|NCT00249808|454711315|FG000|Overall Study|Adverse Event|81|||
126386689|NCT00249808|454711315|FG000|Overall Study|Lack of Efficacy|52|||
126386690|NCT00249808|454711315|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
126386691|NCT02789345|454711316|FG000|Overall Study|Adverse Event|0|||
126386692|NCT02789345|454711317|FG001|Overall Study|Adverse Event|0|||
126386693|NCT02789345|454711318|FG002|Overall Study|Adverse Event|1|||
126386694|NCT02789345|454711316|FG000|Overall Study|Death|0|||
126386695|NCT02789345|454711317|FG001|Overall Study|Death|0|||
126386696|NCT02789345|454711318|FG002|Overall Study|Death|1|||
126386697|NCT02789345|454711316|FG000|Overall Study|Physician Decision|2|||
126386698|NCT02789345|454711317|FG001|Overall Study|Physician Decision|0|||
126386699|NCT02789345|454711318|FG002|Overall Study|Physician Decision|1|||
126386700|NCT02789345|454711316|FG000|Overall Study|Progressive Disease|1|||
126386701|NCT02789345|454711317|FG001|Overall Study|Progressive Disease|3|||
126386702|NCT02789345|454711318|FG002|Overall Study|Progressive Disease|14|||
126386703|NCT01804049|454711319|FG000|Overall Study|Adverse Event|2|||
126386704|NCT01804049|454711320|FG001|Overall Study|Adverse Event|10|||
126386705|NCT01804049|454711319|FG000|Overall Study|Lost to Follow-up|2|||
126386706|NCT01804049|454711320|FG001|Overall Study|Lost to Follow-up|1|||
126386707|NCT01804049|454711319|FG000|Overall Study|Decreased interest/personal|4|||
126386708|NCT01804049|454711320|FG001|Overall Study|Decreased interest/personal|5|||
126386709|NCT01804049|454711319|FG000|Overall Study|Other health concerns|2|||
126386710|NCT01804049|454711320|FG001|Overall Study|Other health concerns|7|||
126386711|NCT01804049|454711319|FG000|Overall Study|Moved out of area|0|||
126386712|NCT01804049|454711320|FG001|Overall Study|Moved out of area|7|||
126386713|NCT01804049|454711319|FG000|Overall Study|other MD recommended|1|||
126386714|NCT01804049|454711320|FG001|Overall Study|other MD recommended|1|||
126386715|NCT01804049|454711319|FG000|Overall Study|Enrollment in dual studies|0|||
126386716|NCT01804049|454711320|FG001|Overall Study|Enrollment in dual studies|1|||
126386717|NCT01147250|454711321|FG000|Overall Study|Lost to Follow-up|14|||
126386718|NCT01147250|454711322|FG001|Overall Study|Lost to Follow-up|11|||
126386719|NCT01147250|454711321|FG000|Overall Study|Withdrawal by Subject|83|||
126386720|NCT01147250|454711322|FG001|Overall Study|Withdrawal by Subject|88|||
126386721|NCT01147250|454711321|FG000|Overall Study|Site termination by sponsor|13|||
126386722|NCT01147250|454711322|FG001|Overall Study|Site termination by sponsor|5|||
126386723|NCT01147250|454711321|FG000|Overall Study|Other than specified|0|||
126386724|NCT01147250|454711322|FG001|Overall Study|Other than specified|1|||
126386725|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386726|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
126386727|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386728|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386729|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386730|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386731|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
126386732|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
126386733|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126386734|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126386735|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126386736|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126386737|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
126386738|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
126386739|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126386740|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126386741|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126386742|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126048749|NCT02787005|453475271|FG000|Overall Study|Lost to Follow-up|0|||
126048750|NCT02787005|453475272|FG001|Overall Study|Lost to Follow-up|0|||
126386743|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
126048751|NCT02787005|453475273|FG002|Overall Study|Lost to Follow-up|0|||
126386744|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
126386745|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
126048752|NCT02787005|453475274|FG003|Overall Study|Lost to Follow-up|1|||
126048753|NCT02787005|453475275|FG004|Overall Study|Lost to Follow-up|0|||
126386746|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
126386747|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
126386748|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
126386749|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126048754|NCT02016872|453475279|FG000|Overall Study|Withdrawal by Subject|10|||
126048755|NCT02016872|453475279|FG000|Overall Study|Death Progression|2|||
126048756|NCT02016872|453475279|FG000|Overall Study|No FMISO scan|1|||
126048757|NCT02016872|453475279|FG000|Overall Study|Ineligible|2|||
126048758|NCT03593226|453475282|FG000|Overall Study|Disease progression|6|||
126048759|NCT03593226|453475283|FG001|Overall Study|Disease progression|13|||
126048760|NCT03593226|453475284|FG002|Overall Study|Disease progression|5|||
126048761|NCT03593226|453475285|FG003|Overall Study|Disease progression|6|||
126048762|NCT03593226|453475282|FG000|Overall Study|Adverse Event|0|||
126386750|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
126048763|NCT03593226|453475283|FG001|Overall Study|Adverse Event|1|||
126386751|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126386752|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126386753|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126386754|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126386755|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
126386756|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
126386757|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
126386758|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
126386759|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
126386760|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
126386761|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386762|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
126386763|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386764|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386765|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386766|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386767|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386768|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
126386769|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386770|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386771|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386772|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386773|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126048764|NCT03593226|453475284|FG002|Overall Study|Adverse Event|0|||
126048765|NCT03593226|453475285|FG003|Overall Study|Adverse Event|0|||
126048766|NCT03593226|453475282|FG000|Overall Study|Withdrawal by Subject|0|||
126048767|NCT03593226|453475283|FG001|Overall Study|Withdrawal by Subject|4|||
126048768|NCT03593226|453475284|FG002|Overall Study|Withdrawal by Subject|1|||
126048769|NCT03593226|453475285|FG003|Overall Study|Withdrawal by Subject|0|||
126104216|NCT03057977|453675822|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
126104217|NCT03057977|453675821|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
126104218|NCT03057977|453675822|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
126386774|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126386775|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
126386776|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
126386777|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
126386778|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
126386779|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126386780|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126386781|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
126386782|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
126386783|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
126386784|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
126386785|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
126386786|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
126386787|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
126386788|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
126386789|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
126386790|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
126386791|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126386792|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126048770|NCT03593226|453475282|FG000|Overall Study|Physician Decision|0|||
126048771|NCT03593226|453475283|FG001|Overall Study|Physician Decision|1|||
126048772|NCT03593226|453475284|FG002|Overall Study|Physician Decision|0|||
126386793|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126386794|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126386795|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126386796|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126386797|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
126386798|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
126386799|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
126386800|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
126386801|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
126386802|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
126386803|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
126386804|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
126386805|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
126386806|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
126386807|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
126386808|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
126386809|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
126386810|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
126386811|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
126386812|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
126386813|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
126386814|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
126386815|NCT00022763|454711334|FG000|Overall Study|Adverse Event|1|||
126386816|NCT00022763|454711335|FG001|Overall Study|Adverse Event|2|||
126386817|NCT00022763|454711334|FG000|Overall Study|Injection Site Reactions|0|||
126386818|NCT00022763|454711335|FG001|Overall Study|Injection Site Reactions|2|||
126386819|NCT00022763|454711334|FG000|Overall Study|Death|0|||
126386820|NCT00022763|454711335|FG001|Overall Study|Death|1|||
126386821|NCT00022763|454711334|FG000|Overall Study|Lost to Follow-up|0|||
126386822|NCT00022763|454711335|FG001|Overall Study|Lost to Follow-up|3|||
126386823|NCT00022763|454711334|FG000|Overall Study|Withdrawal by Subject|4|||
126386824|NCT00022763|454711335|FG001|Overall Study|Withdrawal by Subject|7|||
126386825|NCT00022763|454711334|FG000|Overall Study|Insufficient Therapy|1|||
126386826|NCT00022763|454711335|FG001|Overall Study|Insufficient Therapy|0|||
126386827|NCT00022763|454711334|FG000|Overall Study|Admin|3|||
126386828|NCT00022763|454711335|FG001|Overall Study|Admin|2|||
126386829|NCT00716482|454711336|FG000|Overall Study|Lost to Follow-up|6|||
126386830|NCT00716482|454711336|FG000|Overall Study|Inadequate acquisition or analysis|50|||
126386831|NCT00716482|454711336|FG000|Overall Study|no pathology obtained|10|||
126386832|NCT00716482|454711336|FG000|Overall Study|technical/machine error|28|||
126386833|NCT00716482|454711336|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
126386834|NCT01092780|454711337|FG000|Washout Period 1|Adverse Event|0|||
126048773|NCT03593226|453475285|FG003|Overall Study|Physician Decision|0|||
126048774|NCT03593226|453475282|FG000|Overall Study|Clinical disease progression|0|||
126048775|NCT03593226|453475283|FG001|Overall Study|Clinical disease progression|0|||
126048776|NCT03593226|453475284|FG002|Overall Study|Clinical disease progression|1|||
126386835|NCT01092780|454711338|FG001|Washout Period 1|Adverse Event|1|||
126386836|NCT01092780|454711339|FG002|Washout Period 1|Adverse Event|0|||
126386837|NCT01092780|454711340|FG003|Washout Period 1|Adverse Event|0|||
126386838|NCT01092780|454711337|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
126386839|NCT01092780|454711338|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
126386840|NCT01092780|454711339|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
126386841|NCT01092780|454711340|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
126386842|NCT01092780|454711337|FG000|Washout Period 2|Adverse Event|0|||
126386843|NCT01092780|454711338|FG001|Washout Period 2|Adverse Event|1|||
126048777|NCT03593226|453475285|FG003|Overall Study|Clinical disease progression|0|||
126048778|NCT00747565|453475286|FG000|Overall Study|Withdrawal by Subject|10|||
126048779|NCT00747565|453475287|FG001|Overall Study|Withdrawal by Subject|6|||
126048780|NCT00747565|453475286|FG000|Overall Study|Lost to Follow-up|4|||
126048781|NCT00747565|453475287|FG001|Overall Study|Lost to Follow-up|1|||
126048782|NCT00545545|453475288|FG000|Overall Study|Progressive Neoplastic Disease|1|||
126386844|NCT01092780|454711339|FG002|Washout Period 2|Adverse Event|1|||
126386845|NCT01092780|454711340|FG003|Washout Period 2|Adverse Event|0|||
126386846|NCT01864148|454711341|FG000|Overall Study|Other|2|||
126386847|NCT01864148|454711342|FG001|Overall Study|Other|1|||
126386848|NCT01864148|454711343|FG002|Overall Study|Other|1|||
126386849|NCT01864148|454711344|FG003|Overall Study|Other|3|||
126386850|NCT01864148|454711345|FG004|Overall Study|Other|1|||
126386851|NCT01864148|454711341|FG000|Overall Study|Death|0|||
126386852|NCT01864148|454711342|FG001|Overall Study|Death|0|||
126386853|NCT01864148|454711343|FG002|Overall Study|Death|0|||
126386854|NCT01864148|454711344|FG003|Overall Study|Death|1|||
126386855|NCT01864148|454711345|FG004|Overall Study|Death|0|||
126386856|NCT01864148|454711341|FG000|Overall Study|Investigator Decision|5|||
126386857|NCT01864148|454711342|FG001|Overall Study|Investigator Decision|0|||
126386858|NCT01864148|454711343|FG002|Overall Study|Investigator Decision|0|||
126386859|NCT01864148|454711344|FG003|Overall Study|Investigator Decision|4|||
126386860|NCT01864148|454711345|FG004|Overall Study|Investigator Decision|6|||
126386861|NCT01864148|454711341|FG000|Overall Study|Withdrawal by Subject|9|||
126386862|NCT01864148|454711342|FG001|Overall Study|Withdrawal by Subject|2|||
126386863|NCT01864148|454711343|FG002|Overall Study|Withdrawal by Subject|6|||
126386864|NCT01864148|454711344|FG003|Overall Study|Withdrawal by Subject|8|||
126386865|NCT01864148|454711345|FG004|Overall Study|Withdrawal by Subject|8|||
126386866|NCT01864148|454711341|FG000|Overall Study|Lost to Follow-up|0|||
126386867|NCT01864148|454711342|FG001|Overall Study|Lost to Follow-up|0|||
126386868|NCT01864148|454711343|FG002|Overall Study|Lost to Follow-up|0|||
126386869|NCT01864148|454711344|FG003|Overall Study|Lost to Follow-up|2|||
126386870|NCT01864148|454711345|FG004|Overall Study|Lost to Follow-up|1|||
126386871|NCT01864148|454711341|FG000|Overall Study|Adverse Event|4|||
126386872|NCT01864148|454711342|FG001|Overall Study|Adverse Event|2|||
126386873|NCT01864148|454711343|FG002|Overall Study|Adverse Event|4|||
126386874|NCT01864148|454711344|FG003|Overall Study|Adverse Event|7|||
126386875|NCT01864148|454711345|FG004|Overall Study|Adverse Event|7|||
126386876|NCT01864148|454711341|FG000|Overall Study|Not Dosed|0|||
126386877|NCT01864148|454711342|FG001|Overall Study|Not Dosed|0|||
126386878|NCT01864148|454711343|FG002|Overall Study|Not Dosed|0|||
126386879|NCT01864148|454711344|FG003|Overall Study|Not Dosed|1|||
126386880|NCT01864148|454711345|FG004|Overall Study|Not Dosed|0|||
126386881|NCT02936869|454711354|FG000|Overall Study|Lost to Follow-up|1|||
126386882|NCT02936869|454711355|FG001|Overall Study|Lost to Follow-up|3|||
126386883|NCT02936869|454711354|FG000|Overall Study|Death|0|||
126386884|NCT02936869|454711355|FG001|Overall Study|Death|1|||
126386885|NCT02936869|454711354|FG000|Overall Study|Legal Case|0|||
126386886|NCT02936869|454711355|FG001|Overall Study|Legal Case|1|||
126386887|NCT02936869|454711354|FG000|Overall Study|Protocol Violation|1|||
126386888|NCT02936869|454711355|FG001|Overall Study|Protocol Violation|0|||
126386889|NCT04004221|454711356|FG000|Overall Study|Death|89|||
126386890|NCT04004221|454711356|FG000|Overall Study|Withdrawal by Subject|5|||
126386891|NCT04004221|454711356|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
126386892|NCT04004221|454711356|FG000|Overall Study|Sponsor Decision|9|||
126386893|NCT04004221|454711356|FG000|Overall Study|Participant refused to enter LTE|1|||
126386894|NCT00506454|454711357|FG000|Overall Study|Withdrawal by Subject|1|||
126386895|NCT00506454|454711358|FG001|Overall Study|Withdrawal by Subject|1|||
126386896|NCT00851552|454711359|FG000|Overall Study|Death|2|||
126386897|NCT00851552|454711359|FG000|Overall Study|Adverse Event|1|||
126386898|NCT00851552|454711359|FG000|Overall Study|Disease Progression|4|||
126386899|NCT02689206|454711360|FG000|Overall Study|Adverse Event|0|||
126386900|NCT02689206|454711361|FG001|Overall Study|Adverse Event|0|||
126386901|NCT02689206|454711362|FG002|Overall Study|Adverse Event|1|||
126048783|NCT00545545|453475289|FG001|Overall Study|Progressive Neoplastic Disease|5|||
126048784|NCT00545545|453475290|FG002|Overall Study|Progressive Neoplastic Disease|0|||
126048785|NCT00545545|453475291|FG003|Overall Study|Progressive Neoplastic Disease|4|||
126048786|NCT00545545|453475292|FG004|Overall Study|Progressive Neoplastic Disease|8|||
126048787|NCT00545545|453475293|FG005|Overall Study|Progressive Neoplastic Disease|7|||
126048788|NCT00545545|453475288|FG000|Overall Study|Withdrawal by Subject|0|||
126048789|NCT00545545|453475289|FG001|Overall Study|Withdrawal by Subject|1|||
126048790|NCT00545545|453475290|FG002|Overall Study|Withdrawal by Subject|0|||
126048791|NCT00545545|453475291|FG003|Overall Study|Withdrawal by Subject|0|||
126048792|NCT00545545|453475292|FG004|Overall Study|Withdrawal by Subject|0|||
126048793|NCT00545545|453475293|FG005|Overall Study|Withdrawal by Subject|0|||
126386902|NCT02689206|454711363|FG003|Overall Study|Adverse Event|0|||
126386903|NCT02689206|454711364|FG004|Overall Study|Adverse Event|2|||
126386904|NCT02689206|454711360|FG000|Overall Study|Protocol Violation|1|||
126386905|NCT02689206|454711361|FG001|Overall Study|Protocol Violation|0|||
126386906|NCT02689206|454711362|FG002|Overall Study|Protocol Violation|0|||
126386907|NCT02689206|454711363|FG003|Overall Study|Protocol Violation|1|||
126386908|NCT02689206|454711364|FG004|Overall Study|Protocol Violation|2|||
126386909|NCT02689206|454711360|FG000|Overall Study|Other: Reached stopping criteria|0|||
126386910|NCT02689206|454711361|FG001|Overall Study|Other: Reached stopping criteria|1|||
126386911|NCT02689206|454711362|FG002|Overall Study|Other: Reached stopping criteria|2|||
126386912|NCT02689206|454711363|FG003|Overall Study|Other: Reached stopping criteria|3|||
126386913|NCT02689206|454711364|FG004|Overall Study|Other: Reached stopping criteria|4|||
126386914|NCT02689206|454711360|FG000|Overall Study|Physician Decision|1|||
125887029|NCT01470326|452883082|FG000|Overall Study|No Drug Administration Information|2|||
125887030|NCT01470326|452883082|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
125887031|NCT01166282|452883083|FG000|Open-label Period|Adverse Event|0|||
125887032|NCT01166282|452883084|FG001|Open-label Period|Adverse Event|0|||
125887033|NCT01166282|452883085|FG002|Open-label Period|Adverse Event|6|||
125887034|NCT01166282|452883083|FG000|Open-label Period|Withdrawal by Subject|0|||
125887035|NCT01166282|452883084|FG001|Open-label Period|Withdrawal by Subject|0|||
125887036|NCT01166282|452883085|FG002|Open-label Period|Withdrawal by Subject|4|||
126048794|NCT00545545|453475288|FG000|Overall Study|Physician Decision|1|||
126048795|NCT00545545|453475289|FG001|Overall Study|Physician Decision|0|||
126048796|NCT00545545|453475290|FG002|Overall Study|Physician Decision|0|||
126048797|NCT00545545|453475291|FG003|Overall Study|Physician Decision|0|||
126048798|NCT00545545|453475292|FG004|Overall Study|Physician Decision|0|||
126048799|NCT00545545|453475293|FG005|Overall Study|Physician Decision|1|||
126048800|NCT00545545|453475288|FG000|Overall Study|Irinotecan intolerance|1|||
126048801|NCT00545545|453475289|FG001|Overall Study|Irinotecan intolerance|1|||
126048802|NCT00545545|453475290|FG002|Overall Study|Irinotecan intolerance|0|||
126048803|NCT00545545|453475291|FG003|Overall Study|Irinotecan intolerance|0|||
126048804|NCT00545545|453475292|FG004|Overall Study|Irinotecan intolerance|0|||
126048805|NCT00545545|453475293|FG005|Overall Study|Irinotecan intolerance|0|||
126048806|NCT00545545|453475288|FG000|Overall Study|No target lesions to track post surgery|0|||
126386915|NCT02689206|454711361|FG001|Overall Study|Physician Decision|0|||
126386916|NCT02689206|454711362|FG002|Overall Study|Physician Decision|0|||
126386917|NCT02689206|454711363|FG003|Overall Study|Physician Decision|0|||
126386918|NCT02689206|454711364|FG004|Overall Study|Physician Decision|0|||
126386919|NCT02689206|454711360|FG000|Overall Study|Withdrawal by Subject|1|||
126386920|NCT02689206|454711361|FG001|Overall Study|Withdrawal by Subject|0|||
126386921|NCT02689206|454711362|FG002|Overall Study|Withdrawal by Subject|1|||
126386922|NCT02689206|454711363|FG003|Overall Study|Withdrawal by Subject|0|||
126386923|NCT02689206|454711364|FG004|Overall Study|Withdrawal by Subject|0|||
126386924|NCT01558596|454711367|FG000|Overall Study|Withdrawal by Subject|1|||
126386925|NCT01558596|454711368|FG001|Overall Study|Withdrawal by Subject|0|||
126386926|NCT01558596|454711367|FG000|Overall Study|surgery elsewhere or cancelled|1|||
126386927|NCT01558596|454711368|FG001|Overall Study|surgery elsewhere or cancelled|1|||
126386928|NCT01558596|454711367|FG000|Overall Study|Protocol Violation|1|||
126386929|NCT01558596|454711368|FG001|Overall Study|Protocol Violation|0|||
126386930|NCT01479764|454711370|FG000|Randomized|Adverse Event|1|||
126386931|NCT01479764|454711371|FG001|Randomized|Adverse Event|1|||
126386932|NCT01479764|454711370|FG000|Randomized|Withdrawal by Subject|1|||
126386933|NCT01479764|454711371|FG001|Randomized|Withdrawal by Subject|0|||
126386934|NCT01479764|454711370|FG000|Treated|Lost to Follow-up|0|||
126386935|NCT01479764|454711371|FG001|Treated|Lost to Follow-up|2|||
126386936|NCT00902850|454711373|FG000|Overall Study|Physician Decision|2|||
126386937|NCT00902850|454711374|FG001|Overall Study|Physician Decision|2|||
126386938|NCT00260832|454711375|FG000|Overall Study|Adverse Event|26|||
126386939|NCT00260832|454711376|FG001|Overall Study|Adverse Event|19|||
126386940|NCT00260832|454711375|FG000|Overall Study|Progression|116|||
126386941|NCT00260832|454711376|FG001|Overall Study|Progression|96|||
126386942|NCT00260832|454711375|FG000|Overall Study|Withdrawal by Subject|15|||
126386943|NCT00260832|454711376|FG001|Overall Study|Withdrawal by Subject|17|||
126386944|NCT00260832|454711375|FG000|Overall Study|Physician Decision|15|||
126386945|NCT00260832|454711376|FG001|Overall Study|Physician Decision|9|||
126386946|NCT00260832|454711375|FG000|Overall Study|Death|43|||
126386947|NCT00260832|454711376|FG001|Overall Study|Death|62|||
126386948|NCT00260832|454711375|FG000|Overall Study|Other|10|||
126386949|NCT00260832|454711376|FG001|Overall Study|Other|7|||
126386950|NCT00260832|454711375|FG000|Overall Study|Protocol Violation|3|||
126386951|NCT00260832|454711376|FG001|Overall Study|Protocol Violation|1|||
126386952|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
126386953|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
126386954|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
126386955|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126386956|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125887037|NCT01166282|452883083|FG000|Open-label Period|Lack of Efficacy|0|||
126048807|NCT00545545|453475289|FG001|Overall Study|No target lesions to track post surgery|0|||
126048808|NCT00545545|453475290|FG002|Overall Study|No target lesions to track post surgery|0|||
126386957|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125887038|NCT01166282|452883084|FG001|Open-label Period|Lack of Efficacy|0|||
126386958|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126386959|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
126386960|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386961|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386962|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386963|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386964|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386965|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126048809|NCT00545545|453475291|FG003|Overall Study|No target lesions to track post surgery|0|||
126048810|NCT00545545|453475292|FG004|Overall Study|No target lesions to track post surgery|1|||
126048811|NCT00545545|453475293|FG005|Overall Study|No target lesions to track post surgery|1|||
126048812|NCT00319020|453475305|FG000|Overall Study|Death|2|||
126048813|NCT00319020|453475306|FG001|Overall Study|Death|2|||
126386966|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
126386967|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
126386968|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
126386969|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126386970|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126386971|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126386972|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126386973|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
126048814|NCT00319020|453475305|FG000|Overall Study|Withdrawal by Subject|4|||
126048815|NCT00319020|453475306|FG001|Overall Study|Withdrawal by Subject|1|||
126048816|NCT00319020|453475305|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
126386974|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
126386975|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386976|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386977|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386978|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386979|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386980|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
126386981|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386982|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386983|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386984|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386985|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386986|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386987|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386988|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
126386989|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386990|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386991|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386992|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386993|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386994|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
126386995|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
126386996|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
126386997|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126386998|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126386999|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126387000|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126387001|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
126387002|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
126387003|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387004|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387005|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387006|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387007|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387008|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387009|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387010|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387011|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387012|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387013|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
126387014|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
126387015|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126387016|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126387017|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126387018|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
126387019|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126387020|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
126387021|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
126387022|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126387023|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126387024|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126387025|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
126387026|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
126387027|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
126387028|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
126387029|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387030|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387031|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387032|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387033|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
126387034|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
126387035|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387036|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387037|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387038|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387039|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387040|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387041|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
126387042|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387043|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126387044|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126387045|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126387046|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
126387047|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
126387048|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
126387049|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
126387050|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126387051|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126387052|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126048817|NCT00319020|453475306|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
126048818|NCT00319020|453475305|FG000|Overall Study|Administrative reason|0|||
126048819|NCT00319020|453475306|FG001|Overall Study|Administrative reason|5|||
126048820|NCT00319020|453475305|FG000|Overall Study|Disease progression|0|||
126048821|NCT00319020|453475306|FG001|Overall Study|Disease progression|2|||
126387053|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126387054|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126387055|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
126387056|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
126387057|NCT04470050|454711386|FG000|Double-blind Treatment Phase|Adverse Event|0|||
126387058|NCT04470050|454711387|FG001|Double-blind Treatment Phase|Adverse Event|0|||
126387059|NCT04470050|454711388|FG002|Double-blind Treatment Phase|Adverse Event|0|||
126387060|NCT04470050|454711389|FG003|Double-blind Treatment Phase|Adverse Event|1|||
126387061|NCT04470050|454711390|FG004|Double-blind Treatment Phase|Adverse Event|0|||
126387062|NCT04470050|454711391|FG005|Double-blind Treatment Phase|Adverse Event|0|||
126387063|NCT04470050|454711392|FG006|Double-blind Treatment Phase|Adverse Event|0|||
126387064|NCT04470050|454711386|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387065|NCT04470050|454711387|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387066|NCT04470050|454711388|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387067|NCT04470050|454711389|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387068|NCT04470050|454711390|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
126387069|NCT04470050|454711391|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387070|NCT04470050|454711392|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387071|NCT04470050|454711386|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
126387072|NCT04470050|454711387|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
126387073|NCT04470050|454711388|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
126387074|NCT04470050|454711389|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
126387075|NCT04470050|454711390|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
126387076|NCT04470050|454711391|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
126387077|NCT04470050|454711392|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
126387078|NCT03585764|454711395|FG000|Overall Study|Death|3|||
126387079|NCT03585764|454711396|FG001|Overall Study|Death|2|||
126387080|NCT03585764|454711397|FG002|Overall Study|Death|3|||
126387081|NCT03585764|454711398|FG003|Overall Study|Death|0|||
126387082|NCT03585764|454711395|FG000|Overall Study|Lost to Follow-up|0|||
126048822|NCT00319020|453475305|FG000|Overall Study|Transplant|0|||
126387083|NCT03585764|454711396|FG001|Overall Study|Lost to Follow-up|1|||
126387084|NCT03585764|454711397|FG002|Overall Study|Lost to Follow-up|0|||
126387085|NCT03585764|454711398|FG003|Overall Study|Lost to Follow-up|0|||
126387086|NCT03585764|454711395|FG000|Overall Study|Physician Decision|0|||
126387087|NCT03585764|454711396|FG001|Overall Study|Physician Decision|0|||
126387088|NCT03585764|454711397|FG002|Overall Study|Physician Decision|2|||
126387089|NCT03585764|454711398|FG003|Overall Study|Physician Decision|0|||
126387090|NCT03640507|454711399|FG000|Overall Study|Withdrawal by Subject|0|||
126387091|NCT03640507|454711400|FG001|Overall Study|Withdrawal by Subject|0|||
126387092|NCT03640507|454711401|FG002|Overall Study|Withdrawal by Subject|1|||
126387093|NCT03604172|454711402|FG000|Overall Study|Lost to Follow-up|1|||
126387094|NCT03604172|454711403|FG001|Overall Study|Lost to Follow-up|2|||
126387095|NCT01270880|454711407|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
126387096|NCT00976716|454711408|FG000|Overall Study|Adverse Event|1|||
126387097|NCT04222699|454711409|FG000|Overall Study|Lost to Follow-up|2|||
126387098|NCT01606176|454711410|FG000|Overall Study|Adverse Event|2|||
126387099|NCT01606176|454711411|FG001|Overall Study|Adverse Event|3|||
126387100|NCT01606176|454711410|FG000|Overall Study|Disease progression|1|||
126387101|NCT01606176|454711411|FG001|Overall Study|Disease progression|0|||
126387102|NCT01606176|454711410|FG000|Overall Study|Withdrawal by Subject|1|||
126387103|NCT01606176|454711411|FG001|Overall Study|Withdrawal by Subject|0|||
126387104|NCT01832493|454711412|FG000|Overall Study|Physician Decision|2|||
126387105|NCT01832493|454711412|FG000|Overall Study|Protocol Violation|4|||
126387106|NCT01832493|454711412|FG000|Overall Study|Unable to place LV lead|2|||
126387107|NCT02993822|454711413|FG000|Overall Study|Lack of Efficacy|1|||
126387108|NCT02993822|454711414|FG001|Overall Study|Lack of Efficacy|1|||
126387109|NCT02993822|454711415|FG002|Overall Study|Lack of Efficacy|0|||
126387110|NCT02993822|454711416|FG003|Overall Study|Lack of Efficacy|0|||
126387111|NCT02993822|454711413|FG000|Overall Study|Protocol Violation|1|||
126387112|NCT02993822|454711414|FG001|Overall Study|Protocol Violation|0|||
126387113|NCT02993822|454711415|FG002|Overall Study|Protocol Violation|0|||
126387114|NCT02993822|454711416|FG003|Overall Study|Protocol Violation|0|||
126387115|NCT02993822|454711413|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
126387116|NCT02993822|454711414|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
126387117|NCT02993822|454711415|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
126387118|NCT02993822|454711416|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
126387119|NCT02993822|454711413|FG000|Overall Study|Adverse Event|3|||
126387120|NCT02993822|454711414|FG001|Overall Study|Adverse Event|1|||
126387121|NCT02993822|454711415|FG002|Overall Study|Adverse Event|7|||
126387122|NCT02993822|454711416|FG003|Overall Study|Adverse Event|0|||
126387123|NCT02993822|454711413|FG000|Overall Study|Withdrawal by Subject|4|||
126387124|NCT02993822|454711414|FG001|Overall Study|Withdrawal by Subject|2|||
126387125|NCT02993822|454711415|FG002|Overall Study|Withdrawal by Subject|2|||
126387126|NCT02993822|454711416|FG003|Overall Study|Withdrawal by Subject|3|||
126387127|NCT02993822|454711413|FG000|Overall Study|Lost to Follow-up|1|||
126387128|NCT02993822|454711414|FG001|Overall Study|Lost to Follow-up|0|||
126387129|NCT02993822|454711415|FG002|Overall Study|Lost to Follow-up|1|||
126387130|NCT02993822|454711416|FG003|Overall Study|Lost to Follow-up|0|||
126387131|NCT01732510|454711417|FG000|Overall Study|Adverse Event|0|||
126387132|NCT01732510|454711418|FG001|Overall Study|Adverse Event|1|||
126387133|NCT01732510|454711419|FG002|Overall Study|Adverse Event|1|||
126387134|NCT01732510|454711420|FG003|Overall Study|Adverse Event|0|||
126387135|NCT01732510|454711421|FG004|Overall Study|Adverse Event|0|||
126387136|NCT01732510|454711422|FG005|Overall Study|Adverse Event|0|||
126387137|NCT01732510|454711423|FG006|Overall Study|Adverse Event|1|||
126387138|NCT01732510|454711417|FG000|Overall Study|Protocol Violation|0|||
126387139|NCT01732510|454711418|FG001|Overall Study|Protocol Violation|0|||
126387140|NCT01732510|454711419|FG002|Overall Study|Protocol Violation|0|||
126387141|NCT01732510|454711420|FG003|Overall Study|Protocol Violation|1|||
125887039|NCT01166282|452883085|FG002|Open-label Period|Lack of Efficacy|2|||
125887040|NCT01166282|452883083|FG000|Open-label Period|Remission|0|||
126387142|NCT01732510|454711421|FG004|Overall Study|Protocol Violation|0|||
126387143|NCT01732510|454711422|FG005|Overall Study|Protocol Violation|0|||
126387144|NCT01732510|454711423|FG006|Overall Study|Protocol Violation|0|||
126387145|NCT01732510|454711417|FG000|Overall Study|Withdrawal by Subject|1|||
126387146|NCT01732510|454711418|FG001|Overall Study|Withdrawal by Subject|3|||
126387147|NCT01732510|454711419|FG002|Overall Study|Withdrawal by Subject|2|||
126387148|NCT01732510|454711420|FG003|Overall Study|Withdrawal by Subject|1|||
126387149|NCT01732510|454711421|FG004|Overall Study|Withdrawal by Subject|5|||
126387150|NCT01732510|454711422|FG005|Overall Study|Withdrawal by Subject|0|||
126387151|NCT01732510|454711423|FG006|Overall Study|Withdrawal by Subject|1|||
126387152|NCT01732510|454711417|FG000|Overall Study|Lost to Follow-up|0|||
126387153|NCT01732510|454711418|FG001|Overall Study|Lost to Follow-up|0|||
126387154|NCT01732510|454711419|FG002|Overall Study|Lost to Follow-up|1|||
126387155|NCT01732510|454711420|FG003|Overall Study|Lost to Follow-up|1|||
126387156|NCT01732510|454711421|FG004|Overall Study|Lost to Follow-up|0|||
126387157|NCT01732510|454711422|FG005|Overall Study|Lost to Follow-up|1|||
126387158|NCT01732510|454711423|FG006|Overall Study|Lost to Follow-up|0|||
126387159|NCT01732510|454711417|FG000|Overall Study|Physician Decision|0|||
126387160|NCT01732510|454711418|FG001|Overall Study|Physician Decision|1|||
126387161|NCT01732510|454711419|FG002|Overall Study|Physician Decision|0|||
126387162|NCT01732510|454711420|FG003|Overall Study|Physician Decision|0|||
126387163|NCT01732510|454711421|FG004|Overall Study|Physician Decision|0|||
126387164|NCT01732510|454711422|FG005|Overall Study|Physician Decision|0|||
126387165|NCT01732510|454711423|FG006|Overall Study|Physician Decision|0|||
126387166|NCT01732510|454711417|FG000|Overall Study|Pregnancy|0|||
126387167|NCT01732510|454711418|FG001|Overall Study|Pregnancy|0|||
126387168|NCT01732510|454711419|FG002|Overall Study|Pregnancy|0|||
126387169|NCT01732510|454711420|FG003|Overall Study|Pregnancy|1|||
126387170|NCT01732510|454711421|FG004|Overall Study|Pregnancy|0|||
126387171|NCT01732510|454711422|FG005|Overall Study|Pregnancy|0|||
126387172|NCT01732510|454711423|FG006|Overall Study|Pregnancy|0|||
126387173|NCT01732510|454711417|FG000|Overall Study|Study Terminated By Sponsor|0|||
126387174|NCT01732510|454711418|FG001|Overall Study|Study Terminated By Sponsor|0|||
126387175|NCT01732510|454711419|FG002|Overall Study|Study Terminated By Sponsor|0|||
126387176|NCT01732510|454711420|FG003|Overall Study|Study Terminated By Sponsor|1|||
126387177|NCT01732510|454711421|FG004|Overall Study|Study Terminated By Sponsor|0|||
126387178|NCT01732510|454711422|FG005|Overall Study|Study Terminated By Sponsor|12|||
126387179|NCT01732510|454711423|FG006|Overall Study|Study Terminated By Sponsor|6|||
126387180|NCT00313144|454711424|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
126387181|NCT00313144|454711424|FG000|Overall Study|Death|7|||
126387182|NCT00313144|454711424|FG000|Overall Study|Lost to Follow-up|5|||
126387183|NCT00313144|454711424|FG000|Overall Study|Withdrawal by Subject|4|||
126387184|NCT00313144|454711424|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
126387185|NCT00313144|454711424|FG000|Overall Study|Physician Decision|4|||
126387186|NCT00313144|454711424|FG000|Overall Study|Adverse event - transient|5|||
126387187|NCT00313144|454711424|FG000|Overall Study|Liver transplant|1|||
126387188|NCT00313144|454711424|FG000|Overall Study|Insurance (homecare provider) change|1|||
126387189|NCT00313144|454711424|FG000|Overall Study|Change to different product|1|||
126387190|NCT00313144|454711424|FG000|Overall Study|Due to termination of the study|66|||
126387191|NCT01939977|454711426|FG000|Overall Study|Adverse Event|4|||
126387192|NCT01939977|454711427|FG001|Overall Study|Adverse Event|3|||
126387193|NCT01939977|454711426|FG000|Overall Study|Lack of Efficacy|3|||
126387194|NCT01939977|454711427|FG001|Overall Study|Lack of Efficacy|0|||
126387195|NCT01939977|454711426|FG000|Overall Study|Physician Decision|1|||
126387196|NCT01939977|454711427|FG001|Overall Study|Physician Decision|1|||
126387197|NCT01939977|454711426|FG000|Overall Study|Withdrawal by Subject|0|||
126387198|NCT01939977|454711427|FG001|Overall Study|Withdrawal by Subject|2|||
126387199|NCT01939977|454711426|FG000|Overall Study|Did not meet inclusion criteria|1|||
126387200|NCT01939977|454711427|FG001|Overall Study|Did not meet inclusion criteria|0|||
126387201|NCT01939977|454711426|FG000|Overall Study|Did not receive study medication|0|||
126387202|NCT01939977|454711427|FG001|Overall Study|Did not receive study medication|1|||
126387203|NCT01262560|454711431|FG000|Overall Study|Protocol Violation|0|||
126387204|NCT01262560|454711432|FG001|Overall Study|Protocol Violation|1|||
126387205|NCT01262560|454711433|FG002|Overall Study|Protocol Violation|2|||
126387206|NCT03213938|454711434|FG000|Overall Study|Lost to Follow-up|4|||
126387207|NCT03213938|454711435|FG001|Overall Study|Lost to Follow-up|3|||
126387208|NCT03213938|454711434|FG000|Overall Study|Lack of Efficacy|1|||
126387209|NCT03213938|454711435|FG001|Overall Study|Lack of Efficacy|0|||
126387210|NCT03213938|454711434|FG000|Overall Study|Decline to participate|5|||
126387211|NCT03213938|454711435|FG001|Overall Study|Decline to participate|4|||
126387212|NCT03213938|454711434|FG000|Overall Study|Without reason|4|||
126387213|NCT03213938|454711435|FG001|Overall Study|Without reason|5|||
126387214|NCT04238481|454711436|FG000|Overall Study|Miscellaneous|0|||
126387215|NCT04238481|454711437|FG001|Overall Study|Miscellaneous|1|||
126387216|NCT04238481|454711438|FG002|Overall Study|Miscellaneous|0|||
126387217|NCT04238481|454711439|FG003|Overall Study|Miscellaneous|0|||
126387218|NCT00673231|454711440|FG000|Overall Study|Withdrawal by Subject|14|||
126387219|NCT00673231|454711441|FG001|Overall Study|Withdrawal by Subject|10|||
126387220|NCT00673231|454711442|FG002|Overall Study|Withdrawal by Subject|8|||
126387221|NCT00673231|454711443|FG003|Overall Study|Withdrawal by Subject|6|||
126387222|NCT00673231|454711440|FG000|Overall Study|Adverse Event|6|||
126387223|NCT00673231|454711441|FG001|Overall Study|Adverse Event|5|||
126387224|NCT00673231|454711442|FG002|Overall Study|Adverse Event|9|||
126048823|NCT00319020|453475306|FG001|Overall Study|Transplant|1|||
126048824|NCT00319020|453475305|FG000|Overall Study|Treatment failure|0|||
126387225|NCT00673231|454711443|FG003|Overall Study|Adverse Event|6|||
126387226|NCT00673231|454711440|FG000|Overall Study|Lost to Follow-up|1|||
126387227|NCT00673231|454711441|FG001|Overall Study|Lost to Follow-up|2|||
126387228|NCT00673231|454711442|FG002|Overall Study|Lost to Follow-up|1|||
126387229|NCT00673231|454711443|FG003|Overall Study|Lost to Follow-up|2|||
126387230|NCT00673231|454711440|FG000|Overall Study|Death|0|||
126387231|NCT00673231|454711441|FG001|Overall Study|Death|0|||
126387232|NCT00673231|454711442|FG002|Overall Study|Death|1|||
126387233|NCT00673231|454711443|FG003|Overall Study|Death|0|||
126387234|NCT00673231|454711440|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
126387235|NCT00673231|454711441|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
126387236|NCT00673231|454711442|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
125887041|NCT01166282|452883084|FG001|Open-label Period|Remission|0|||
125887042|NCT01166282|452883085|FG002|Open-label Period|Remission|4|||
125887043|NCT01166282|452883083|FG000|Open-label Period|Irregular Compliance|0|||
125887044|NCT01166282|452883084|FG001|Open-label Period|Irregular Compliance|0|||
125887045|NCT01166282|452883085|FG002|Open-label Period|Irregular Compliance|1|||
125887046|NCT02577718|452883086|FG000|Overall Study|Death|6|||
125887047|NCT02577718|452883086|FG000|Overall Study|Withdrawal by Subject|2|||
125887048|NCT01995838|452883087|FG000|Overall Study|Lost to Follow-up|0|||
125887049|NCT01995838|452883088|FG001|Overall Study|Lost to Follow-up|1|||
125887050|NCT01995838|452883089|FG002|Overall Study|Lost to Follow-up|0|||
125887051|NCT01995838|452883090|FG003|Overall Study|Lost to Follow-up|0|||
125887052|NCT01995838|452883091|FG004|Overall Study|Lost to Follow-up|0|||
125887053|NCT01995838|452883092|FG005|Overall Study|Lost to Follow-up|0|||
125887054|NCT01995838|452883093|FG006|Overall Study|Lost to Follow-up|1|||
125887055|NCT01995838|452883087|FG000|Overall Study|Participant choice|2|||
125887056|NCT01995838|452883088|FG001|Overall Study|Participant choice|0|||
125887057|NCT01995838|452883089|FG002|Overall Study|Participant choice|0|||
125887058|NCT01995838|452883090|FG003|Overall Study|Participant choice|0|||
125887059|NCT01995838|452883091|FG004|Overall Study|Participant choice|0|||
125887060|NCT01995838|452883092|FG005|Overall Study|Participant choice|1|||
125887061|NCT01995838|452883093|FG006|Overall Study|Participant choice|1|||
125887062|NCT01995838|452883087|FG000|Overall Study|Adverse Event|0|||
125887063|NCT01995838|452883088|FG001|Overall Study|Adverse Event|0|||
126387237|NCT00673231|454711443|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
126387238|NCT03594747|454711444|FG000|Overall Study|Death|78|||
126387239|NCT03594747|454711445|FG001|Overall Study|Death|86|||
126387240|NCT03594747|454711446|FG002|Overall Study|Death|87|||
125887064|NCT01995838|452883089|FG002|Overall Study|Adverse Event|0|||
125887065|NCT01995838|452883090|FG003|Overall Study|Adverse Event|0|||
125887066|NCT01995838|452883091|FG004|Overall Study|Adverse Event|0|||
126048825|NCT00319020|453475306|FG001|Overall Study|Treatment failure|1|||
126387241|NCT03594747|454711444|FG000|Overall Study|Withdrawal by Subject|5|||
126387242|NCT03594747|454711445|FG001|Overall Study|Withdrawal by Subject|2|||
126387243|NCT03594747|454711446|FG002|Overall Study|Withdrawal by Subject|11|||
126387244|NCT03594747|454711444|FG000|Overall Study|Lost to Follow-up|4|||
126387245|NCT03594747|454711445|FG001|Overall Study|Lost to Follow-up|1|||
126387246|NCT03594747|454711446|FG002|Overall Study|Lost to Follow-up|1|||
126387247|NCT03594747|454711444|FG000|Overall Study|Physician Decision|0|||
126387248|NCT03594747|454711445|FG001|Overall Study|Physician Decision|1|||
126387249|NCT03594747|454711446|FG002|Overall Study|Physician Decision|0|||
126387250|NCT03594747|454711444|FG000|Overall Study|Sponsor decision|23|||
126387251|NCT03594747|454711445|FG001|Overall Study|Sponsor decision|17|||
126387252|NCT03594747|454711446|FG002|Overall Study|Sponsor decision|16|||
126387253|NCT03594747|454711444|FG000|Overall Study|Did not meet inclusion criteria|0|||
126387254|NCT03594747|454711445|FG001|Overall Study|Did not meet inclusion criteria|0|||
126387255|NCT03594747|454711446|FG002|Overall Study|Did not meet inclusion criteria|1|||
126387256|NCT03594747|454711444|FG000|Overall Study|Transfer to long term extension study|10|||
126387257|NCT03594747|454711445|FG001|Overall Study|Transfer to long term extension study|12|||
126387258|NCT03594747|454711446|FG002|Overall Study|Transfer to long term extension study|5|||
126387259|NCT02095873|454711449|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126387260|NCT02095873|454711450|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126387261|NCT02095873|454711449|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
126387262|NCT02095873|454711450|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
126387263|NCT02095873|454711449|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
126387264|NCT02095873|454711450|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
126387265|NCT00792740|454711451|FG000|Overall Study|Disease Worsening|3|||
126387266|NCT00792740|454711452|FG001|Overall Study|Disease Worsening|2|||
126387267|NCT00792740|454711451|FG000|Overall Study|Personal Reason|1|||
126387268|NCT00792740|454711452|FG001|Overall Study|Personal Reason|0|||
126387269|NCT00792740|454711451|FG000|Overall Study|Adverse Event|1|||
126387270|NCT00792740|454711452|FG001|Overall Study|Adverse Event|3|||
126387271|NCT00792740|454711451|FG000|Overall Study|Patient's withdrawal of consent|0|||
126387272|NCT00792740|454711452|FG001|Overall Study|Patient's withdrawal of consent|1|||
126387273|NCT00792740|454711451|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
125887067|NCT01995838|452883092|FG005|Overall Study|Adverse Event|0|||
125887068|NCT01995838|452883093|FG006|Overall Study|Adverse Event|1|||
125887069|NCT01995838|452883087|FG000|Overall Study|Withdrawal by Subject|0|||
126048826|NCT00319020|453475305|FG000|Overall Study|Adverse Event|0|||
126387274|NCT00792740|454711452|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
126387275|NCT00792740|454711451|FG000|Overall Study|Other reasons|0|||
126387276|NCT00792740|454711452|FG001|Overall Study|Other reasons|1|||
125887070|NCT01995838|452883088|FG001|Overall Study|Withdrawal by Subject|0|||
125887071|NCT01995838|452883089|FG002|Overall Study|Withdrawal by Subject|0|||
126387277|NCT01063062|454711453|FG000|Overall Study|Patient withdrew consent|0|||
126387278|NCT01063062|454711454|FG001|Overall Study|Patient withdrew consent|1|||
125887072|NCT01995838|452883090|FG003|Overall Study|Withdrawal by Subject|0|||
126048827|NCT00319020|453475306|FG001|Overall Study|Adverse Event|1|||
125887073|NCT01995838|452883091|FG004|Overall Study|Withdrawal by Subject|1|||
125887074|NCT01995838|452883092|FG005|Overall Study|Withdrawal by Subject|0|||
125887075|NCT01995838|452883093|FG006|Overall Study|Withdrawal by Subject|0|||
125887076|NCT01995838|452883087|FG000|Overall Study|Other|3|||
125887077|NCT01995838|452883088|FG001|Overall Study|Other|1|||
125887078|NCT01995838|452883089|FG002|Overall Study|Other|0|||
125887079|NCT01995838|452883090|FG003|Overall Study|Other|2|||
125887080|NCT01995838|452883091|FG004|Overall Study|Other|1|||
125887081|NCT01995838|452883092|FG005|Overall Study|Other|1|||
125887082|NCT01995838|452883093|FG006|Overall Study|Other|2|||
125887083|NCT01967576|452883094|FG000|Overall Study|Withdrawal by Subject|3|||
125887084|NCT01967576|452883094|FG000|Overall Study|Progressed/Removed from treatment|1|||
125887085|NCT01967576|452883094|FG000|Overall Study|Study closing at site|1|||
125887086|NCT01967576|452883094|FG000|Overall Study|Adverse Event|1|||
125887087|NCT01967576|452883094|FG000|Overall Study|Refused further treatment|1|||
125887088|NCT00380367|452883097|FG000|Overall Study|Lost to Follow-up|1|||
125887089|NCT00380367|452883097|FG000|Overall Study|Withdrawal by Subject|1|||
125887090|NCT00392769|452883101|FG000|Overall Study|Clinical Deterioration|9|||
125887091|NCT00392769|452883101|FG000|Overall Study|Adverse Event|1|||
125887092|NCT00060840|452883110|FG000|Overall Study|Change in surgical plan|2|||
125887093|NCT00060840|452883111|FG001|Overall Study|Change in surgical plan|6|||
125887094|NCT00060840|452883110|FG000|Overall Study|Death|0|||
125887095|NCT00060840|452883111|FG001|Overall Study|Death|1|||
125887096|NCT00060840|452883110|FG000|Overall Study|Withdrawal by Subject|0|||
125887097|NCT00060840|452883111|FG001|Overall Study|Withdrawal by Subject|1|||
125887098|NCT00060840|452883110|FG000|Overall Study|Subinvestigator unavailable|0|||
125887099|NCT00060840|452883111|FG001|Overall Study|Subinvestigator unavailable|1|||
125887100|NCT00060840|452883110|FG000|Overall Study|Physician Decision|1|||
125887101|NCT00060840|452883111|FG001|Overall Study|Physician Decision|0|||
125887102|NCT00060840|452883110|FG000|Overall Study|Other|1|||
125887103|NCT00060840|452883111|FG001|Overall Study|Other|0|||
125887104|NCT03710161|452883112|FG000|Overall Study|Study halted due to COVID pandemic|3|||
125887105|NCT03710161|452883113|FG001|Overall Study|Study halted due to COVID pandemic|2|||
125887106|NCT00541385|452883116|FG000|Overall Study|Adverse Event|6|||
125887107|NCT00541385|452883117|FG001|Overall Study|Adverse Event|3|||
125887108|NCT00541385|452883116|FG000|Overall Study|Withdrawal by Subject|2|||
125887109|NCT00541385|452883117|FG001|Overall Study|Withdrawal by Subject|2|||
125887110|NCT00541385|452883116|FG000|Overall Study|Lost to Follow-up|6|||
125887111|NCT00541385|452883117|FG001|Overall Study|Lost to Follow-up|1|||
125887112|NCT00541385|452883116|FG000|Overall Study|Parasite reappearance/malaria|67|||
125887113|NCT00541385|452883117|FG001|Overall Study|Parasite reappearance/malaria|32|||
125887114|NCT01499355|452883120|FG000|Run-In Period|Study Termination|15|||
125887115|NCT01499355|452883121|FG001|Run-In Period|Study Termination|0|||
125887116|NCT01499355|452883122|FG002|Run-In Period|Study Termination|0|||
125887117|NCT01499355|452883123|FG003|Run-In Period|Study Termination|0|||
125887118|NCT01499355|452883120|FG000|Run-In Period|Other|3|||
125887119|NCT01499355|452883121|FG001|Run-In Period|Other|0|||
125887120|NCT01499355|452883122|FG002|Run-In Period|Other|0|||
125887121|NCT01499355|452883123|FG003|Run-In Period|Other|0|||
125887122|NCT01499355|452883120|FG000|Run-In Period|Death|2|||
125887123|NCT01499355|452883121|FG001|Run-In Period|Death|0|||
125887124|NCT01499355|452883122|FG002|Run-In Period|Death|0|||
125887125|NCT01499355|452883123|FG003|Run-In Period|Death|0|||
125887126|NCT01499355|452883120|FG000|Run-In Period|Investigator Decision|2|||
125887127|NCT01499355|452883121|FG001|Run-In Period|Investigator Decision|0|||
125887128|NCT01499355|452883122|FG002|Run-In Period|Investigator Decision|0|||
125887129|NCT01499355|452883123|FG003|Run-In Period|Investigator Decision|0|||
125887130|NCT01499355|452883120|FG000|Run-In Period|Consent Withdrawn|1|||
125887131|NCT01499355|452883121|FG001|Run-In Period|Consent Withdrawn|0|||
125887132|NCT01499355|452883122|FG002|Run-In Period|Consent Withdrawn|0|||
125887133|NCT01499355|452883123|FG003|Run-In Period|Consent Withdrawn|0|||
125887134|NCT01499355|452883120|FG000|Run-In Period|Adverse Event|8|||
125887135|NCT01499355|452883121|FG001|Run-In Period|Adverse Event|0|||
125887136|NCT01499355|452883122|FG002|Run-In Period|Adverse Event|0|||
125887137|NCT01499355|452883123|FG003|Run-In Period|Adverse Event|0|||
125887138|NCT01499355|452883120|FG000|Double-Blind Period|Adverse Event|0|||
125887139|NCT01499355|452883121|FG001|Double-Blind Period|Adverse Event|2|||
125887140|NCT01499355|452883122|FG002|Double-Blind Period|Adverse Event|3|||
125887141|NCT01499355|452883123|FG003|Double-Blind Period|Adverse Event|2|||
125887142|NCT01499355|452883120|FG000|Double-Blind Period|Study Termination|0|||
125887143|NCT01499355|452883121|FG001|Double-Blind Period|Study Termination|18|||
126387279|NCT01063062|454711453|FG000|Overall Study|Adverse Event|2|||
125887144|NCT01499355|452883122|FG002|Double-Blind Period|Study Termination|16|||
125887145|NCT01499355|452883123|FG003|Double-Blind Period|Study Termination|14|||
126048828|NCT00227266|453475307|FG000|Overall Study|Withdrawal by Subject|0|||
125887146|NCT01499355|452883120|FG000|Double-Blind Period|Other|0|||
125887147|NCT01499355|452883121|FG001|Double-Blind Period|Other|1|||
125887148|NCT01499355|452883122|FG002|Double-Blind Period|Other|2|||
125887149|NCT01499355|452883123|FG003|Double-Blind Period|Other|2|||
125887150|NCT01499355|452883120|FG000|Double-Blind Period|Death|0|||
126387280|NCT01063062|454711454|FG001|Overall Study|Adverse Event|4|||
126387281|NCT01063062|454711453|FG000|Overall Study|Protocol Violation|5|||
126387282|NCT01063062|454711454|FG001|Overall Study|Protocol Violation|4|||
126387283|NCT01063062|454711453|FG000|Overall Study|Investigator's request|1|||
126387284|NCT01063062|454711454|FG001|Overall Study|Investigator's request|0|||
126387285|NCT01063062|454711453|FG000|Overall Study|Lost to Follow-up|0|||
126387286|NCT01063062|454711454|FG001|Overall Study|Lost to Follow-up|2|||
126387287|NCT01063062|454711453|FG000|Overall Study|Miscellaneous reason|0|||
126387288|NCT01063062|454711454|FG001|Overall Study|Miscellaneous reason|1|||
126387289|NCT02485639|454711459|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
126387290|NCT02485639|454711459|FG000|Overall Study|Early termination|4|||
126387291|NCT02485639|454711459|FG000|Overall Study|Withdrawal by Subject|4|||
126387292|NCT02015481|454711460|FG000|Overall Study|Death|1|||
126387293|NCT02597452|454711461|FG000|Overall Study|testing incomplete|30|||
126387294|NCT02566785|454711468|FG000|Overall Study|Lost to Follow-up|0|||
126387295|NCT02566785|454711469|FG001|Overall Study|Lost to Follow-up|2|||
126387296|NCT02566785|454711468|FG000|Overall Study|Worsening condition|1|||
126387297|NCT02566785|454711469|FG001|Overall Study|Worsening condition|1|||
126387298|NCT02147197|454711470|FG000|Overall Study|Adverse Event|1|||
126387299|NCT02147197|454711471|FG001|Overall Study|Adverse Event|0|||
126387300|NCT02147197|454711472|FG002|Overall Study|Adverse Event|0|||
126387301|NCT02147197|454711470|FG000|Overall Study|Withdrawal of Consent|4|||
126387302|NCT02147197|454711471|FG001|Overall Study|Withdrawal of Consent|3|||
126387303|NCT02147197|454711472|FG002|Overall Study|Withdrawal of Consent|2|||
126387304|NCT02147197|454711470|FG000|Overall Study|Lost to Follow-up|2|||
126387305|NCT02147197|454711471|FG001|Overall Study|Lost to Follow-up|3|||
126387306|NCT02147197|454711472|FG002|Overall Study|Lost to Follow-up|1|||
126387307|NCT02147197|454711470|FG000|Overall Study|Protocol Violation|1|||
126387308|NCT02147197|454711471|FG001|Overall Study|Protocol Violation|0|||
126387309|NCT02147197|454711472|FG002|Overall Study|Protocol Violation|3|||
126387310|NCT02147197|454711470|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126387311|NCT02147197|454711471|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126387312|NCT02147197|454711472|FG002|Overall Study|Other Miscellaneous Reasons|3|||
126387313|NCT02744612|454713621|FG000|Overall Study|Withdrawal by Subject|0|||
126387314|NCT02744612|454713622|FG001|Overall Study|Withdrawal by Subject|2|||
126387315|NCT02712983|454713624|FG000|Treatment Phase|Adverse Event|3|||
126387316|NCT02712983|454713625|FG001|Treatment Phase|Adverse Event|1|||
126387317|NCT02712983|454713626|FG002|Treatment Phase|Adverse Event|1|||
126387318|NCT02712983|454713627|FG003|Treatment Phase|Adverse Event|4|||
126387319|NCT02712983|454713628|FG004|Treatment Phase|Adverse Event|3|||
126387320|NCT02712983|454713629|FG005|Treatment Phase|Adverse Event|0|||
126387321|NCT02712983|454713630|FG006|Treatment Phase|Adverse Event|6|||
126387322|NCT02712983|454713631|FG007|Treatment Phase|Adverse Event|6|||
126387323|NCT02712983|454713632|FG008|Treatment Phase|Adverse Event|1|||
126387324|NCT02712983|454713624|FG000|Treatment Phase|Protocol Deviation|0|||
126387325|NCT02712983|454713625|FG001|Treatment Phase|Protocol Deviation|0|||
126387326|NCT02712983|454713626|FG002|Treatment Phase|Protocol Deviation|0|||
126387327|NCT02712983|454713627|FG003|Treatment Phase|Protocol Deviation|2|||
126387328|NCT02712983|454713628|FG004|Treatment Phase|Protocol Deviation|0|||
126387329|NCT02712983|454713629|FG005|Treatment Phase|Protocol Deviation|0|||
126387330|NCT02712983|454713630|FG006|Treatment Phase|Protocol Deviation|1|||
126387331|NCT02712983|454713631|FG007|Treatment Phase|Protocol Deviation|0|||
126387332|NCT02712983|454713632|FG008|Treatment Phase|Protocol Deviation|0|||
126387333|NCT02712983|454713624|FG000|Treatment Phase|Technical Problems|0|||
126387334|NCT02712983|454713625|FG001|Treatment Phase|Technical Problems|0|||
126387335|NCT02712983|454713626|FG002|Treatment Phase|Technical Problems|0|||
126387336|NCT02712983|454713627|FG003|Treatment Phase|Technical Problems|0|||
126387337|NCT02712983|454713628|FG004|Treatment Phase|Technical Problems|0|||
126387338|NCT02712983|454713629|FG005|Treatment Phase|Technical Problems|0|||
126387339|NCT02712983|454713630|FG006|Treatment Phase|Technical Problems|1|||
126387340|NCT02712983|454713631|FG007|Treatment Phase|Technical Problems|0|||
126387341|NCT02712983|454713632|FG008|Treatment Phase|Technical Problems|0|||
126387342|NCT02712983|454713624|FG000|Treatment Phase|Physician Decision|0|||
126387343|NCT02712983|454713625|FG001|Treatment Phase|Physician Decision|0|||
126387344|NCT02712983|454713626|FG002|Treatment Phase|Physician Decision|0|||
126387345|NCT02712983|454713627|FG003|Treatment Phase|Physician Decision|0|||
126387346|NCT02712983|454713628|FG004|Treatment Phase|Physician Decision|0|||
126387347|NCT02712983|454713629|FG005|Treatment Phase|Physician Decision|0|||
126387348|NCT02712983|454713630|FG006|Treatment Phase|Physician Decision|0|||
126387349|NCT02712983|454713631|FG007|Treatment Phase|Physician Decision|1|||
126387350|NCT02712983|454713632|FG008|Treatment Phase|Physician Decision|1|||
126387351|NCT02712983|454713624|FG000|Treatment Phase|Subject Decision|2|||
126387352|NCT02712983|454713625|FG001|Treatment Phase|Subject Decision|0|||
126387353|NCT02712983|454713626|FG002|Treatment Phase|Subject Decision|0|||
126387354|NCT02712983|454713627|FG003|Treatment Phase|Subject Decision|2|||
126387355|NCT02712983|454713628|FG004|Treatment Phase|Subject Decision|1|||
126387356|NCT02712983|454713629|FG005|Treatment Phase|Subject Decision|0|||
126048829|NCT00227266|453475308|FG001|Overall Study|Withdrawal by Subject|0|||
126048830|NCT00227266|453475309|FG002|Overall Study|Withdrawal by Subject|1|||
126048831|NCT00227266|453475307|FG000|Overall Study|Protocol Violation|1|||
126387357|NCT02712983|454713630|FG006|Treatment Phase|Subject Decision|1|||
126387358|NCT02712983|454713631|FG007|Treatment Phase|Subject Decision|2|||
126387359|NCT02712983|454713632|FG008|Treatment Phase|Subject Decision|0|||
126387360|NCT02712983|454713624|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387361|NCT02712983|454713625|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
126387362|NCT02712983|454713626|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387363|NCT02712983|454713627|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387364|NCT02712983|454713628|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387365|NCT02712983|454713629|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387366|NCT02712983|454713630|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
126387367|NCT02712983|454713631|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
126387368|NCT02712983|454713632|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387369|NCT02712983|454713624|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387370|NCT02712983|454713625|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387371|NCT02712983|454713626|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387372|NCT02712983|454713627|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
126387373|NCT02712983|454713628|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387374|NCT02712983|454713629|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387375|NCT02712983|454713630|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387376|NCT02712983|454713631|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387377|NCT02712983|454713632|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387378|NCT02712983|454713624|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387379|NCT02712983|454713625|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387380|NCT02712983|454713626|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387381|NCT02712983|454713627|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387382|NCT02712983|454713628|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
126387383|NCT02712983|454713629|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
126387384|NCT02712983|454713630|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
126387385|NCT02712983|454713631|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
126387386|NCT02712983|454713632|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387387|NCT02954406|454713633|FG000|Overall Study|Adverse Event|0|||
126387388|NCT02954406|454713634|FG001|Overall Study|Adverse Event|1|||
126387389|NCT02954406|454713635|FG002|Overall Study|Adverse Event|0|||
126387390|NCT02954406|454713636|FG003|Overall Study|Adverse Event|0|||
126387391|NCT02954406|454713637|FG004|Overall Study|Adverse Event|1|||
126387392|NCT02954406|454713638|FG005|Overall Study|Adverse Event|0|||
126387393|NCT02954406|454713639|FG006|Overall Study|Adverse Event|0|||
126387394|NCT02954406|454713640|FG007|Overall Study|Adverse Event|0|||
126387395|NCT02954406|454713641|FG008|Overall Study|Adverse Event|1|||
126387396|NCT02954406|454713642|FG009|Overall Study|Adverse Event|1|||
126387397|NCT02954406|454713643|FG010|Overall Study|Adverse Event|0|||
126387398|NCT02954406|454713633|FG000|Overall Study|Progressive Disease|3|||
126387399|NCT02954406|454713634|FG001|Overall Study|Progressive Disease|4|||
126387400|NCT02954406|454713635|FG002|Overall Study|Progressive Disease|3|||
126387401|NCT02954406|454713636|FG003|Overall Study|Progressive Disease|4|||
126387402|NCT02954406|454713637|FG004|Overall Study|Progressive Disease|3|||
126387403|NCT02954406|454713638|FG005|Overall Study|Progressive Disease|3|||
126387404|NCT02954406|454713639|FG006|Overall Study|Progressive Disease|2|||
126387405|NCT02954406|454713640|FG007|Overall Study|Progressive Disease|2|||
126387406|NCT02954406|454713641|FG008|Overall Study|Progressive Disease|1|||
126387407|NCT02954406|454713642|FG009|Overall Study|Progressive Disease|1|||
126387408|NCT02954406|454713643|FG010|Overall Study|Progressive Disease|0|||
126387409|NCT02954406|454713633|FG000|Overall Study|Symptomatic Deterioration|0|||
126387410|NCT02954406|454713634|FG001|Overall Study|Symptomatic Deterioration|1|||
126387411|NCT02954406|454713635|FG002|Overall Study|Symptomatic Deterioration|0|||
126387412|NCT02954406|454713636|FG003|Overall Study|Symptomatic Deterioration|0|||
126387413|NCT02954406|454713637|FG004|Overall Study|Symptomatic Deterioration|0|||
126387414|NCT02954406|454713638|FG005|Overall Study|Symptomatic Deterioration|0|||
126048832|NCT00227266|453475308|FG001|Overall Study|Protocol Violation|0|||
126048833|NCT00227266|453475309|FG002|Overall Study|Protocol Violation|1|||
126048834|NCT00227266|453475307|FG000|Overall Study|Excessive weight gain|0|||
126048835|NCT00227266|453475308|FG001|Overall Study|Excessive weight gain|0|||
126048836|NCT00227266|453475309|FG002|Overall Study|Excessive weight gain|2|||
126048837|NCT03978637|453475313|FG000|Overall Study|Death|0|||
126048838|NCT03978637|453475314|FG001|Overall Study|Death|2|||
126387415|NCT02954406|454713639|FG006|Overall Study|Symptomatic Deterioration|0|||
126387416|NCT02954406|454713640|FG007|Overall Study|Symptomatic Deterioration|0|||
126387417|NCT02954406|454713641|FG008|Overall Study|Symptomatic Deterioration|0|||
126387418|NCT02954406|454713642|FG009|Overall Study|Symptomatic Deterioration|0|||
126387419|NCT02954406|454713643|FG010|Overall Study|Symptomatic Deterioration|0|||
126387420|NCT02954406|454713633|FG000|Overall Study|Death|0|||
126387421|NCT02954406|454713634|FG001|Overall Study|Death|0|||
126387422|NCT02954406|454713635|FG002|Overall Study|Death|0|||
126387423|NCT02954406|454713636|FG003|Overall Study|Death|0|||
126387424|NCT02954406|454713637|FG004|Overall Study|Death|1|||
126387425|NCT02954406|454713638|FG005|Overall Study|Death|0|||
126387426|NCT02954406|454713639|FG006|Overall Study|Death|0|||
126387427|NCT02954406|454713640|FG007|Overall Study|Death|0|||
126387428|NCT02954406|454713641|FG008|Overall Study|Death|1|||
126387429|NCT02954406|454713642|FG009|Overall Study|Death|1|||
126387430|NCT02954406|454713643|FG010|Overall Study|Death|0|||
126387431|NCT02954406|454713633|FG000|Overall Study|Reason Not Specified|0|||
126387432|NCT02954406|454713634|FG001|Overall Study|Reason Not Specified|0|||
126387433|NCT02954406|454713635|FG002|Overall Study|Reason Not Specified|3|||
126387434|NCT02954406|454713636|FG003|Overall Study|Reason Not Specified|2|||
126387435|NCT02954406|454713637|FG004|Overall Study|Reason Not Specified|2|||
126387436|NCT02954406|454713638|FG005|Overall Study|Reason Not Specified|0|||
125887151|NCT01499355|452883121|FG001|Double-Blind Period|Death|1|||
125887152|NCT01499355|452883122|FG002|Double-Blind Period|Death|0|||
125887153|NCT01499355|452883123|FG003|Double-Blind Period|Death|0|||
125887154|NCT01499355|452883120|FG000|Double-Blind Period|Investigator Decision|0|||
125887155|NCT01499355|452883121|FG001|Double-Blind Period|Investigator Decision|0|||
125887156|NCT01499355|452883122|FG002|Double-Blind Period|Investigator Decision|3|||
125887157|NCT01499355|452883123|FG003|Double-Blind Period|Investigator Decision|3|||
125887158|NCT01499355|452883120|FG000|Double-Blind Period|Consent Withdrawn|0|||
125887159|NCT01499355|452883121|FG001|Double-Blind Period|Consent Withdrawn|0|||
125887160|NCT01499355|452883122|FG002|Double-Blind Period|Consent Withdrawn|1|||
125887161|NCT01499355|452883123|FG003|Double-Blind Period|Consent Withdrawn|2|||
126387437|NCT02954406|454713639|FG006|Overall Study|Reason Not Specified|1|||
126387438|NCT02954406|454713640|FG007|Overall Study|Reason Not Specified|0|||
126387439|NCT02954406|454713641|FG008|Overall Study|Reason Not Specified|1|||
126387440|NCT02954406|454713642|FG009|Overall Study|Reason Not Specified|0|||
126387441|NCT02954406|454713643|FG010|Overall Study|Reason Not Specified|0|||
126387442|NCT05360966|454713644|FG000|Overall Study|Adverse Event|5|||
126387443|NCT05360966|454713645|FG001|Overall Study|Adverse Event|5|||
126387444|NCT05360966|454713644|FG000|Overall Study|Withdrawal of Consent|5|||
126387445|NCT05360966|454713645|FG001|Overall Study|Withdrawal of Consent|3|||
126387446|NCT05360966|454713644|FG000|Overall Study|Noncompliance|2|||
126387447|NCT05360966|454713645|FG001|Overall Study|Noncompliance|1|||
126387448|NCT05360966|454713644|FG000|Overall Study|Lost to Follow-up|2|||
126387449|NCT05360966|454713645|FG001|Overall Study|Lost to Follow-up|3|||
126387450|NCT05360966|454713644|FG000|Overall Study|Protocol Deviation|2|||
126387451|NCT05360966|454713645|FG001|Overall Study|Protocol Deviation|1|||
126387452|NCT05360966|454713644|FG000|Overall Study|As specified in the Clinical Study Report|1|||
125887162|NCT01499355|452883120|FG000|Double-Blind Period|Lost to Follow-up|0|||
125887163|NCT01499355|452883121|FG001|Double-Blind Period|Lost to Follow-up|1|||
125887164|NCT01499355|452883122|FG002|Double-Blind Period|Lost to Follow-up|0|||
125887165|NCT01499355|452883123|FG003|Double-Blind Period|Lost to Follow-up|0|||
125887166|NCT01526733|452883124|FG000|Phase 1|Protocol Violation|1|||
125887167|NCT01526733|452883125|FG001|Phase 1|Protocol Violation|0|||
125887168|NCT01526733|452883124|FG000|Phase 1|Withdrawal by Subject|1|||
125887169|NCT01526733|452883125|FG001|Phase 1|Withdrawal by Subject|1|||
125887170|NCT01599637|452883126|FG000|Overall Study|administrative problems|0|||
126387453|NCT05360966|454713645|FG001|Overall Study|As specified in the Clinical Study Report|3|||
126387454|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
126387455|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387456|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387457|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387458|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387459|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387460|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387461|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387462|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387463|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387464|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387465|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387466|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387467|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
126048839|NCT03978637|453475315|FG002|Overall Study|Death|2|||
125887171|NCT01599637|452883127|FG001|Overall Study|administrative problems|2|||
125887172|NCT01599637|452883128|FG002|Overall Study|administrative problems|0|||
125887173|NCT01599637|452883126|FG000|Overall Study|Adverse Event|1|||
125887174|NCT01599637|452883127|FG001|Overall Study|Adverse Event|0|||
125887175|NCT01599637|452883128|FG002|Overall Study|Adverse Event|0|||
126048840|NCT03978637|453475316|FG003|Overall Study|Death|0|||
126048841|NCT03978637|453475313|FG000|Overall Study|Withdrawal by Subject|0|||
126387468|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387469|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387470|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387471|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387472|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387473|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387474|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387475|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387476|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387477|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387478|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387479|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387480|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
126387481|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387482|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387483|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387484|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387485|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126048842|NCT03978637|453475314|FG001|Overall Study|Withdrawal by Subject|0|||
126048843|NCT03978637|453475315|FG002|Overall Study|Withdrawal by Subject|1|||
126048844|NCT03978637|453475316|FG003|Overall Study|Withdrawal by Subject|0|||
126048845|NCT03978637|453475313|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
126048846|NCT03978637|453475314|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
126048847|NCT03978637|453475315|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
126048848|NCT03978637|453475316|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
126048849|NCT02549352|453475317|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
126048850|NCT02549352|453475318|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
126048851|NCT02549352|453475317|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
126104219|NCT03057977|453675821|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
126387486|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387487|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387488|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387489|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387490|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387491|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387492|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387493|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
126387494|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387495|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387496|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387497|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
126387498|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125887176|NCT02565108|452883129|FG000|Overall Study|Adverse Event|1|||
125887177|NCT02565108|452883130|FG001|Overall Study|Adverse Event|0|||
126387499|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387500|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387501|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387502|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387503|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387504|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387505|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387506|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387507|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387508|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387509|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387510|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
126387511|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387512|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387513|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387514|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387515|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387516|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387517|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126048852|NCT02549352|453475318|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
126048853|NCT02549352|453475317|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
126104220|NCT03057977|453675822|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
125887178|NCT02565108|452883129|FG000|Overall Study|Withdrew Consent|1|||
125887179|NCT02565108|452883130|FG001|Overall Study|Withdrew Consent|0|||
125887180|NCT01310075|452883131|FG000|Overall Study|Lost to Follow-up|1|||
125887181|NCT01310075|452883132|FG001|Overall Study|Lost to Follow-up|0|||
125887182|NCT01310075|452883131|FG000|Overall Study|Physician Decision|10|||
125887183|NCT01310075|452883132|FG001|Overall Study|Physician Decision|7|||
125887184|NCT01310075|452883131|FG000|Overall Study|Protocol Violation|2|||
125887185|NCT01310075|452883132|FG001|Overall Study|Protocol Violation|2|||
125887186|NCT01310075|452883131|FG000|Overall Study|Withdrawal by Subject|1|||
125887187|NCT01310075|452883132|FG001|Overall Study|Withdrawal by Subject|1|||
125887188|NCT02395081|452883133|FG000|Overall Study|Withdrawal by Subject|1|||
125887189|NCT02395081|452883134|FG001|Overall Study|Withdrawal by Subject|1|||
125887190|NCT02395081|452883135|FG002|Overall Study|Withdrawal by Subject|0|||
125887191|NCT02395081|452883133|FG000|Overall Study|Moved where blood couldn't be collected|4|||
125887192|NCT02395081|452883134|FG001|Overall Study|Moved where blood couldn't be collected|1|||
125887193|NCT02395081|452883135|FG002|Overall Study|Moved where blood couldn't be collected|3|||
125887194|NCT02395081|452883133|FG000|Overall Study|Fetal Loss|2|||
125887195|NCT02395081|452883134|FG001|Overall Study|Fetal Loss|3|||
125887196|NCT02395081|452883135|FG002|Overall Study|Fetal Loss|1|||
125887197|NCT02991040|452883136|FG000|Overall Study|Withdrawal by Subject|2|||
125887198|NCT02991040|452883136|FG000|Overall Study|Lost to Follow-up|2|||
125887199|NCT01286480|452883137|FG000|Overall Study|Withdrawal by Subject|5|||
125887200|NCT01286480|452883138|FG001|Overall Study|Withdrawal by Subject|3|||
125887201|NCT02536963|452883139|FG000|Overall Study|Withdrawal by Subject|18|||
126387518|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387519|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387520|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387521|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387522|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387523|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
126387524|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387525|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387526|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387527|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387528|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387529|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387530|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387531|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387532|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387533|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387534|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387535|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387536|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
126387537|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125887202|NCT02668393|452883141|FG000|Overall Study|Progressive disease|6|||
125887203|NCT02668393|452883142|FG001|Overall Study|Progressive disease|3|||
125887204|NCT02668393|452883141|FG000|Overall Study|Adverse Event|0|||
125887205|NCT02668393|452883142|FG001|Overall Study|Adverse Event|2|||
125887206|NCT02668393|452883141|FG000|Overall Study|Withdrawal from the trial|0|||
125887207|NCT02668393|452883142|FG001|Overall Study|Withdrawal from the trial|1|||
125887208|NCT02668393|452883141|FG000|Overall Study|Lack of benefit and side effects|1|||
125887209|NCT02668393|452883142|FG001|Overall Study|Lack of benefit and side effects|0|||
125887210|NCT02141204|452883143|FG000|Overall Study|Lost to Follow-up|2|||
125887211|NCT02141204|452883144|FG001|Overall Study|Lost to Follow-up|1|||
125887212|NCT02141204|452883143|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
125887213|NCT02141204|452883144|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
125887214|NCT02141204|452883143|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
125887215|NCT02141204|452883144|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
126048854|NCT02549352|453475318|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
126048855|NCT02549352|453475317|FG000|12-month Follow-up|Withdrawal by Subject|4|||
126048856|NCT02549352|453475318|FG001|12-month Follow-up|Withdrawal by Subject|5|||
126048857|NCT02549352|453475317|FG000|12-month Follow-up|Lost to Follow-up|3|||
126048858|NCT02549352|453475318|FG001|12-month Follow-up|Lost to Follow-up|2|||
126048859|NCT02549352|453475317|FG000|12-month Follow-up|Death|0|||
125887216|NCT02141204|452883143|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
125887217|NCT02141204|452883144|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
126048860|NCT02549352|453475318|FG001|12-month Follow-up|Death|1|||
126104221|NCT01650246|453675825|FG000|Overall Study|Adverse Event|23|||
125887218|NCT02963506|452883145|FG000|Double-Blind Period|Adverse Event|0|||
125887219|NCT02963506|452883146|FG001|Double-Blind Period|Adverse Event|0|||
125887220|NCT02963506|452883147|FG002|Double-Blind Period|Adverse Event|1|||
125887221|NCT02963506|452883148|FG003|Double-Blind Period|Adverse Event|0|||
125887222|NCT02963506|452883149|FG004|Double-Blind Period|Adverse Event|0|||
126048861|NCT02549352|453475317|FG000|12-month Follow-up|Protocol Violation|0|||
125887223|NCT02963506|452883150|FG005|Double-Blind Period|Adverse Event|0|||
125887224|NCT02963506|452883151|FG006|Double-Blind Period|Adverse Event|0|||
125887225|NCT02963506|452883152|FG007|Double-Blind Period|Adverse Event|0|||
125887226|NCT02963506|452883153|FG008|Double-Blind Period|Adverse Event|0|||
125887227|NCT02963506|452883154|FG009|Double-Blind Period|Adverse Event|0|||
125887228|NCT02963506|452883155|FG010|Double-Blind Period|Adverse Event|0|||
125887229|NCT02963506|452883156|FG011|Double-Blind Period|Adverse Event|0|||
125887230|NCT02963506|452883157|FG012|Double-Blind Period|Adverse Event|0|||
125887231|NCT02963506|452883145|FG000|Double-Blind Period|Death|0|||
125887232|NCT02963506|452883146|FG001|Double-Blind Period|Death|0|||
125887233|NCT02963506|452883147|FG002|Double-Blind Period|Death|0|||
125887234|NCT02963506|452883148|FG003|Double-Blind Period|Death|1|||
125887235|NCT02963506|452883149|FG004|Double-Blind Period|Death|0|||
125887236|NCT02963506|452883150|FG005|Double-Blind Period|Death|0|||
125887237|NCT02963506|452883151|FG006|Double-Blind Period|Death|0|||
125887238|NCT02963506|452883152|FG007|Double-Blind Period|Death|0|||
125887239|NCT02963506|452883153|FG008|Double-Blind Period|Death|0|||
125887240|NCT02963506|452883154|FG009|Double-Blind Period|Death|0|||
125887241|NCT02963506|452883155|FG010|Double-Blind Period|Death|0|||
125887242|NCT02963506|452883156|FG011|Double-Blind Period|Death|0|||
125887243|NCT02963506|452883157|FG012|Double-Blind Period|Death|0|||
125887244|NCT02963506|452883145|FG000|Double-Blind Period|Lost to Follow-up|0|||
125887245|NCT02963506|452883146|FG001|Double-Blind Period|Lost to Follow-up|1|||
125887246|NCT02963506|452883147|FG002|Double-Blind Period|Lost to Follow-up|0|||
125887247|NCT02963506|452883148|FG003|Double-Blind Period|Lost to Follow-up|0|||
125887248|NCT02963506|452883149|FG004|Double-Blind Period|Lost to Follow-up|0|||
125887249|NCT02963506|452883150|FG005|Double-Blind Period|Lost to Follow-up|0|||
125887250|NCT02963506|452883151|FG006|Double-Blind Period|Lost to Follow-up|0|||
125887251|NCT02963506|452883152|FG007|Double-Blind Period|Lost to Follow-up|0|||
125887252|NCT02963506|452883153|FG008|Double-Blind Period|Lost to Follow-up|0|||
125887253|NCT02963506|452883154|FG009|Double-Blind Period|Lost to Follow-up|0|||
125887254|NCT02963506|452883155|FG010|Double-Blind Period|Lost to Follow-up|0|||
125887255|NCT02963506|452883156|FG011|Double-Blind Period|Lost to Follow-up|0|||
125887256|NCT02963506|452883157|FG012|Double-Blind Period|Lost to Follow-up|0|||
125887257|NCT02963506|452883145|FG000|Double-Blind Period|Withdrawal by Subject|0|||
125887258|NCT02963506|452883146|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125887259|NCT02963506|452883147|FG002|Double-Blind Period|Withdrawal by Subject|1|||
125887260|NCT02963506|452883148|FG003|Double-Blind Period|Withdrawal by Subject|1|||
125887261|NCT02963506|452883149|FG004|Double-Blind Period|Withdrawal by Subject|0|||
125887262|NCT02963506|452883150|FG005|Double-Blind Period|Withdrawal by Subject|0|||
125887263|NCT02963506|452883151|FG006|Double-Blind Period|Withdrawal by Subject|0|||
125887264|NCT02963506|452883152|FG007|Double-Blind Period|Withdrawal by Subject|0|||
125887265|NCT02963506|452883153|FG008|Double-Blind Period|Withdrawal by Subject|0|||
125887266|NCT02963506|452883154|FG009|Double-Blind Period|Withdrawal by Subject|0|||
125887267|NCT02963506|452883155|FG010|Double-Blind Period|Withdrawal by Subject|0|||
125887268|NCT02963506|452883156|FG011|Double-Blind Period|Withdrawal by Subject|0|||
125887269|NCT02963506|452883157|FG012|Double-Blind Period|Withdrawal by Subject|0|||
125887270|NCT02963506|452883145|FG000|Double-Blind Period|No compliance|0|||
125887271|NCT02963506|452883146|FG001|Double-Blind Period|No compliance|1|||
125887272|NCT02963506|452883147|FG002|Double-Blind Period|No compliance|0|||
125887273|NCT02963506|452883148|FG003|Double-Blind Period|No compliance|0|||
125887274|NCT02963506|452883149|FG004|Double-Blind Period|No compliance|0|||
125887275|NCT02963506|452883150|FG005|Double-Blind Period|No compliance|0|||
125887276|NCT02963506|452883151|FG006|Double-Blind Period|No compliance|0|||
125887277|NCT02963506|452883152|FG007|Double-Blind Period|No compliance|0|||
125887278|NCT02963506|452883153|FG008|Double-Blind Period|No compliance|0|||
125887279|NCT02963506|452883154|FG009|Double-Blind Period|No compliance|0|||
125887280|NCT02963506|452883155|FG010|Double-Blind Period|No compliance|0|||
125887281|NCT02963506|452883156|FG011|Double-Blind Period|No compliance|0|||
125887282|NCT02963506|452883157|FG012|Double-Blind Period|No compliance|0|||
125887283|NCT02963506|452883145|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887284|NCT02963506|452883146|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
125887285|NCT02963506|452883147|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887286|NCT02963506|452883148|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887287|NCT02963506|452883149|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887288|NCT02963506|452883150|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887289|NCT02963506|452883151|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887290|NCT02963506|452883152|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887291|NCT02963506|452883153|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887292|NCT02963506|452883154|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887293|NCT02963506|452883155|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887294|NCT02963506|452883156|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887295|NCT02963506|452883157|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125887296|NCT02963506|452883145|FG000|Dose-Blind Period|Adverse Event|0|||
125887297|NCT02963506|452883146|FG001|Dose-Blind Period|Adverse Event|0|||
125887298|NCT02963506|452883147|FG002|Dose-Blind Period|Adverse Event|0|||
125887299|NCT02963506|452883148|FG003|Dose-Blind Period|Adverse Event|0|||
126387538|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387539|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387540|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
126387541|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387542|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387543|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387544|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387545|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387546|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387547|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387548|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387549|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387550|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387551|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387552|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387553|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
126387554|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387555|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387556|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387557|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387558|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387559|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387560|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387561|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387562|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387563|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387564|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387565|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387566|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
126387567|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387568|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387569|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387570|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387571|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387572|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387573|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387574|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387575|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387576|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387577|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387578|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387579|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
126387580|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387581|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387582|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387583|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387584|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387585|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387586|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387587|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387588|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387589|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387590|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387591|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387592|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387593|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387594|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387595|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387596|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387597|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387598|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387599|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387600|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387601|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387602|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387603|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387604|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387605|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387606|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387607|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387608|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387609|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
126387610|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387611|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126048862|NCT02549352|453475318|FG001|12-month Follow-up|Protocol Violation|1|||
126048863|NCT02549352|453475317|FG000|12-month Follow-up|Other|1|||
126048864|NCT02549352|453475318|FG001|12-month Follow-up|Other|3|||
126048865|NCT01268306|453476605|FG000|Overall Study|Lost to Follow-up|1|||
126387612|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387613|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387614|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387615|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387616|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387617|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387618|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387619|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387620|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387621|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387622|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
126387623|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387624|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387625|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387626|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387627|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387628|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387629|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387630|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125887300|NCT02963506|452883149|FG004|Dose-Blind Period|Adverse Event|0|||
125887301|NCT02963506|452883150|FG005|Dose-Blind Period|Adverse Event|1|||
125887302|NCT02963506|452883151|FG006|Dose-Blind Period|Adverse Event|3|||
125887303|NCT02963506|452883152|FG007|Dose-Blind Period|Adverse Event|2|||
125887304|NCT02963506|452883153|FG008|Dose-Blind Period|Adverse Event|2|||
125887305|NCT02963506|452883154|FG009|Dose-Blind Period|Adverse Event|2|||
125887306|NCT02963506|452883155|FG010|Dose-Blind Period|Adverse Event|1|||
125887307|NCT02963506|452883156|FG011|Dose-Blind Period|Adverse Event|1|||
125887308|NCT02963506|452883157|FG012|Dose-Blind Period|Adverse Event|6|||
126387631|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387632|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387633|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387634|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387635|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387636|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387637|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387638|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387639|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387640|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387641|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387642|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387643|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387644|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387645|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387646|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387647|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387648|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387649|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387650|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387651|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387652|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
125887309|NCT02963506|452883145|FG000|Dose-Blind Period|Lack of Efficacy|0|||
125887310|NCT02963506|452883146|FG001|Dose-Blind Period|Lack of Efficacy|0|||
125887311|NCT02963506|452883147|FG002|Dose-Blind Period|Lack of Efficacy|0|||
126387653|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387654|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125887312|NCT02963506|452883148|FG003|Dose-Blind Period|Lack of Efficacy|0|||
126048866|NCT04334317|453476606|FG000|Overall Study|Adverse Event|1|||
125887313|NCT02963506|452883149|FG004|Dose-Blind Period|Lack of Efficacy|0|||
125887314|NCT02963506|452883150|FG005|Dose-Blind Period|Lack of Efficacy|0|||
126387655|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387656|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387657|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387658|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387659|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387660|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387661|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387662|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387663|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387664|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387665|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387666|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387667|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387668|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387669|NCT05396014|454713646|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387670|NCT05396014|454713647|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387671|NCT05396014|454713648|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387672|NCT05396014|454713649|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387673|NCT05396014|454713650|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387674|NCT05396014|454713651|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387675|NCT05396014|454713652|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387676|NCT05396014|454713653|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387677|NCT05396014|454713654|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387678|NCT05396014|454713655|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387679|NCT05396014|454713656|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387680|NCT05396014|454713657|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387681|NCT05396014|454713658|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387682|NCT05396014|454713659|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
126387683|NCT05396014|454713660|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387684|NCT05396014|454713661|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387685|NCT05396014|454713662|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387686|NCT05396014|454713663|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387687|NCT05396014|454713664|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387688|NCT05396014|454713665|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387689|NCT05396014|454713666|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387690|NCT05396014|454713667|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387691|NCT05396014|454713668|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387692|NCT05396014|454713669|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387693|NCT05396014|454713670|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387694|NCT05396014|454713671|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387695|NCT05396014|454713672|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387696|NCT05396014|454713673|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387697|NCT05396014|454713674|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387698|NCT05396014|454713675|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387699|NCT05396014|454713676|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387700|NCT05396014|454713677|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387701|NCT05396014|454713678|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387702|NCT05396014|454713679|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387703|NCT05396014|454713680|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387704|NCT05396014|454713681|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387705|NCT05396014|454713682|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387706|NCT05396014|454713683|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387707|NCT05396014|454713684|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387708|NCT05396014|454713685|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387709|NCT05396014|454713686|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387710|NCT05396014|454713687|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387711|NCT05396014|454713688|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387712|NCT05396014|454713646|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
126387713|NCT05396014|454713647|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387714|NCT05396014|454713648|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387715|NCT05396014|454713649|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387716|NCT05396014|454713650|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387717|NCT05396014|454713651|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126048867|NCT04334317|453476607|FG001|Overall Study|Adverse Event|2|||
126048868|NCT04334317|453476608|FG002|Overall Study|Adverse Event|0|||
126048869|NCT04334317|453476609|FG003|Overall Study|Adverse Event|0|||
126048870|NCT04334317|453476606|FG000|Overall Study|Protocol Deviation|0|||
126048871|NCT04334317|453476607|FG001|Overall Study|Protocol Deviation|1|||
126048872|NCT04334317|453476608|FG002|Overall Study|Protocol Deviation|0|||
126387718|NCT05396014|454713652|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387719|NCT05396014|454713653|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387720|NCT05396014|454713654|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387721|NCT05396014|454713655|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387722|NCT05396014|454713656|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387723|NCT05396014|454713657|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387724|NCT05396014|454713658|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387725|NCT05396014|454713659|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
126387726|NCT05396014|454713660|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387727|NCT05396014|454713661|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387728|NCT05396014|454713662|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387729|NCT05396014|454713663|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387730|NCT05396014|454713664|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387731|NCT05396014|454713665|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387732|NCT05396014|454713666|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387733|NCT05396014|454713667|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387734|NCT05396014|454713668|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387735|NCT05396014|454713669|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387736|NCT05396014|454713670|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387737|NCT05396014|454713671|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387738|NCT05396014|454713672|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387739|NCT05396014|454713673|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387740|NCT05396014|454713674|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387741|NCT05396014|454713675|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387742|NCT05396014|454713676|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387743|NCT05396014|454713677|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387744|NCT05396014|454713678|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387745|NCT05396014|454713679|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387746|NCT05396014|454713680|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387747|NCT05396014|454713681|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387748|NCT05396014|454713682|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387749|NCT05396014|454713683|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387750|NCT05396014|454713684|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387751|NCT05396014|454713685|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
126387752|NCT05396014|454713686|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387753|NCT05396014|454713687|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387754|NCT05396014|454713688|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387755|NCT05396014|454713646|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
126387756|NCT05396014|454713647|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387757|NCT05396014|454713648|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387758|NCT05396014|454713649|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387759|NCT05396014|454713650|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387760|NCT05396014|454713651|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387761|NCT05396014|454713652|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387762|NCT05396014|454713653|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387763|NCT05396014|454713654|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387764|NCT05396014|454713655|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387765|NCT05396014|454713656|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387766|NCT05396014|454713657|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387767|NCT05396014|454713658|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387768|NCT05396014|454713659|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387769|NCT05396014|454713660|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387770|NCT05396014|454713661|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387771|NCT05396014|454713662|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387772|NCT05396014|454713663|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387773|NCT05396014|454713664|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387774|NCT05396014|454713665|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387775|NCT05396014|454713666|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126048873|NCT04334317|453476609|FG003|Overall Study|Protocol Deviation|0|||
126048874|NCT04334317|453476606|FG000|Overall Study|Withdrawal by Subject|2|||
126048875|NCT04334317|453476607|FG001|Overall Study|Withdrawal by Subject|2|||
126387776|NCT05396014|454713667|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387777|NCT05396014|454713668|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387778|NCT05396014|454713669|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387779|NCT05396014|454713670|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387780|NCT05396014|454713671|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387781|NCT05396014|454713672|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
126387782|NCT05396014|454713673|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387783|NCT05396014|454713674|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387784|NCT05396014|454713675|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387785|NCT05396014|454713676|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387786|NCT05396014|454713677|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387787|NCT05396014|454713678|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387788|NCT05396014|454713679|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387789|NCT05396014|454713680|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387790|NCT05396014|454713681|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387791|NCT05396014|454713682|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387792|NCT05396014|454713683|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387793|NCT05396014|454713684|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387794|NCT05396014|454713685|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387795|NCT05396014|454713686|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387796|NCT05396014|454713687|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387797|NCT05396014|454713688|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387798|NCT05396014|454713646|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387799|NCT05396014|454713647|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387800|NCT05396014|454713648|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387801|NCT05396014|454713649|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387802|NCT05396014|454713650|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387803|NCT05396014|454713651|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387804|NCT05396014|454713652|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387805|NCT05396014|454713653|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387806|NCT05396014|454713654|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387807|NCT05396014|454713655|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387808|NCT05396014|454713656|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387809|NCT05396014|454713657|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387810|NCT05396014|454713658|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387811|NCT05396014|454713659|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
126387812|NCT05396014|454713660|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387813|NCT05396014|454713661|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387814|NCT05396014|454713662|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387815|NCT05396014|454713663|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387816|NCT05396014|454713664|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387817|NCT05396014|454713665|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387818|NCT05396014|454713666|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387819|NCT05396014|454713667|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387820|NCT05396014|454713668|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387821|NCT05396014|454713669|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387822|NCT05396014|454713670|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387823|NCT05396014|454713671|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387824|NCT05396014|454713672|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387825|NCT05396014|454713673|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387826|NCT05396014|454713674|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387827|NCT05396014|454713675|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387828|NCT05396014|454713676|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387829|NCT05396014|454713677|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387830|NCT05396014|454713678|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387831|NCT05396014|454713679|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387832|NCT05396014|454713680|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387833|NCT05396014|454713681|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387834|NCT05396014|454713682|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387835|NCT05396014|454713683|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387836|NCT05396014|454713684|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387837|NCT05396014|454713685|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387838|NCT05396014|454713686|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387839|NCT05396014|454713687|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126104222|NCT01650246|453675825|FG000|Overall Study|Protocol Violation|5|||
126387840|NCT05396014|454713688|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387841|NCT05396014|454713646|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387842|NCT05396014|454713647|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387843|NCT05396014|454713648|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387844|NCT05396014|454713649|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
126387845|NCT05396014|454713650|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387846|NCT05396014|454713651|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387847|NCT05396014|454713652|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387848|NCT05396014|454713653|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387849|NCT05396014|454713654|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
126387850|NCT05396014|454713655|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387851|NCT05396014|454713656|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387852|NCT05396014|454713657|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387853|NCT05396014|454713658|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387854|NCT05396014|454713659|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387855|NCT05396014|454713660|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387856|NCT05396014|454713661|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387857|NCT05396014|454713662|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387858|NCT05396014|454713663|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387859|NCT05396014|454713664|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387860|NCT05396014|454713665|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387861|NCT05396014|454713666|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387862|NCT05396014|454713667|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387863|NCT05396014|454713668|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387864|NCT05396014|454713669|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387865|NCT05396014|454713670|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387866|NCT05396014|454713671|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
126387867|NCT05396014|454713672|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387868|NCT05396014|454713673|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387869|NCT05396014|454713674|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387870|NCT05396014|454713675|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387871|NCT05396014|454713676|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387872|NCT05396014|454713677|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387873|NCT05396014|454713678|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387874|NCT05396014|454713679|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387875|NCT05396014|454713680|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387876|NCT05396014|454713681|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387877|NCT05396014|454713682|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387878|NCT05396014|454713683|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387879|NCT05396014|454713684|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387880|NCT05396014|454713685|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387881|NCT05396014|454713686|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
126387882|NCT05396014|454713687|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
126387883|NCT05396014|454713688|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387884|NCT05396014|454713646|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387885|NCT05396014|454713647|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387886|NCT05396014|454713648|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387887|NCT05396014|454713649|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387888|NCT05396014|454713650|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387889|NCT05396014|454713651|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387890|NCT05396014|454713652|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387891|NCT05396014|454713653|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387892|NCT05396014|454713654|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
126387893|NCT05396014|454713655|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387894|NCT05396014|454713656|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387895|NCT05396014|454713657|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387896|NCT05396014|454713658|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387897|NCT05396014|454713659|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387898|NCT05396014|454713660|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387899|NCT05396014|454713661|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387900|NCT05396014|454713662|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387901|NCT05396014|454713663|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387902|NCT05396014|454713664|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387903|NCT05396014|454713665|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125887315|NCT02963506|452883151|FG006|Dose-Blind Period|Lack of Efficacy|0|||
126387904|NCT05396014|454713666|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387905|NCT05396014|454713667|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387906|NCT05396014|454713668|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
126387907|NCT05396014|454713669|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387908|NCT05396014|454713670|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387909|NCT05396014|454713671|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387910|NCT05396014|454713672|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387911|NCT05396014|454713673|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387912|NCT05396014|454713674|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387913|NCT05396014|454713675|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387914|NCT05396014|454713676|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387915|NCT05396014|454713677|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387916|NCT05396014|454713678|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387917|NCT05396014|454713679|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387918|NCT05396014|454713680|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387919|NCT05396014|454713681|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
126387920|NCT05396014|454713682|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387921|NCT05396014|454713683|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387922|NCT05396014|454713684|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387923|NCT05396014|454713685|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387924|NCT05396014|454713686|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387925|NCT05396014|454713687|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
126387926|NCT05396014|454713688|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387927|NCT05396014|454713646|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387928|NCT05396014|454713647|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387929|NCT05396014|454713648|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387930|NCT05396014|454713649|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387931|NCT05396014|454713650|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387932|NCT05396014|454713651|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387933|NCT05396014|454713652|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387934|NCT05396014|454713653|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387935|NCT05396014|454713654|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387936|NCT05396014|454713655|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387937|NCT05396014|454713656|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387938|NCT05396014|454713657|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387939|NCT05396014|454713658|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387940|NCT05396014|454713659|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
126387941|NCT05396014|454713660|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387942|NCT05396014|454713661|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387943|NCT05396014|454713662|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387944|NCT05396014|454713663|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387945|NCT05396014|454713664|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387946|NCT05396014|454713665|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387947|NCT05396014|454713666|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387948|NCT05396014|454713667|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387949|NCT05396014|454713668|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387950|NCT05396014|454713669|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387951|NCT05396014|454713670|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387952|NCT05396014|454713671|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126048876|NCT04334317|453476608|FG002|Overall Study|Withdrawal by Subject|0|||
126048877|NCT04334317|453476609|FG003|Overall Study|Withdrawal by Subject|0|||
126048878|NCT03621735|453476610|FG000|Overall Study|Withdrawal by Subject|13|||
126048879|NCT03621735|453476611|FG001|Overall Study|Withdrawal by Subject|13|||
126048880|NCT01128595|453476614|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126048881|NCT01128595|453476615|FG001|Treatment Period 3|Withdrawal by Subject|1|||
126387953|NCT05396014|454713672|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
126387954|NCT05396014|454713673|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387955|NCT05396014|454713674|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387956|NCT05396014|454713675|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387957|NCT05396014|454713676|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387958|NCT05396014|454713677|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387959|NCT05396014|454713678|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387960|NCT05396014|454713679|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387961|NCT05396014|454713680|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
126387962|NCT05396014|454713681|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387963|NCT05396014|454713682|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126048882|NCT01128595|453476616|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126048883|NCT01128595|453476617|FG003|Treatment Period 3|Withdrawal by Subject|0|||
126048884|NCT00605306|453476618|FG000|Overall Study|Adverse Event|0|||
126048885|NCT00605306|453476619|FG001|Overall Study|Adverse Event|1|||
126387964|NCT05396014|454713683|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387965|NCT05396014|454713684|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387966|NCT05396014|454713685|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387967|NCT05396014|454713686|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387968|NCT05396014|454713687|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387969|NCT05396014|454713688|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
126387970|NCT05396014|454713646|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387971|NCT05396014|454713647|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387972|NCT05396014|454713648|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387973|NCT05396014|454713649|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387974|NCT05396014|454713650|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387975|NCT05396014|454713651|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387976|NCT05396014|454713652|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387977|NCT05396014|454713653|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387978|NCT05396014|454713654|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387979|NCT05396014|454713655|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387980|NCT05396014|454713656|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387981|NCT05396014|454713657|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387982|NCT05396014|454713658|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387983|NCT05396014|454713659|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387984|NCT05396014|454713660|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387985|NCT05396014|454713661|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387986|NCT05396014|454713662|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387987|NCT05396014|454713663|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387988|NCT05396014|454713664|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387989|NCT05396014|454713665|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387990|NCT05396014|454713666|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387991|NCT05396014|454713667|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387992|NCT05396014|454713668|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387993|NCT05396014|454713669|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387994|NCT05396014|454713670|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387995|NCT05396014|454713671|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387996|NCT05396014|454713672|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
126387997|NCT05396014|454713673|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387998|NCT05396014|454713674|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387999|NCT05396014|454713675|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388000|NCT05396014|454713676|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388001|NCT05396014|454713677|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388002|NCT05396014|454713678|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388003|NCT05396014|454713679|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388004|NCT05396014|454713680|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388005|NCT05396014|454713681|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388006|NCT05396014|454713682|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388007|NCT05396014|454713683|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388008|NCT05396014|454713684|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388009|NCT05396014|454713685|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388010|NCT05396014|454713686|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388011|NCT05396014|454713687|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388012|NCT05396014|454713688|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388013|NCT03522246|454713696|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
126388014|NCT03522246|454713697|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
126388015|NCT03522246|454713698|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
126388016|NCT03522246|454713699|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
126388017|NCT03522246|454713700|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
126388018|NCT04683029|454713701|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
126388019|NCT04683029|454713702|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
126388020|NCT04683029|454713703|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
126388021|NCT04683029|454713704|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
126388022|NCT04683029|454713701|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
126388023|NCT04683029|454713702|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
126388024|NCT04683029|454713703|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
126388025|NCT04683029|454713704|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
126388026|NCT04683029|454713701|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
126388027|NCT04683029|454713702|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
126388028|NCT04683029|454713703|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
126048886|NCT00372775|453476620|FG000|Overall Study|Adverse Event|8|||
126388029|NCT04683029|454713704|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
126388030|NCT04493424|454713706|FG000|Overall Study|Termination of the trial by the sponsor|89|||
126388031|NCT04493424|454713706|FG000|Overall Study|Withdrawal by Subject|9|||
126388032|NCT04493424|454713706|FG000|Overall Study|Lost to Follow-up|2|||
126388033|NCT04493424|454713706|FG000|Overall Study|Lack of Efficacy|3|||
126388034|NCT04493424|454713706|FG000|Overall Study|Adverse Event|5|||
126388035|NCT00814580|454713707|FG000|Overall Study|Adverse Event|6|||
126388036|NCT00814580|454713708|FG001|Overall Study|Adverse Event|15|||
126388037|NCT00814580|454713707|FG000|Overall Study|Lack of Efficacy|18|||
126388038|NCT00814580|454713708|FG001|Overall Study|Lack of Efficacy|25|||
126388039|NCT00814580|454713707|FG000|Overall Study|Protocol Violation|2|||
126388040|NCT00814580|454713708|FG001|Overall Study|Protocol Violation|0|||
126388041|NCT00814580|454713707|FG000|Overall Study|Withdrawal by Subject|2|||
126388042|NCT00814580|454713708|FG001|Overall Study|Withdrawal by Subject|2|||
126388043|NCT00814580|454713707|FG000|Overall Study|Other|1|||
126388044|NCT00814580|454713708|FG001|Overall Study|Other|3|||
126388045|NCT00814580|454713707|FG000|Overall Study|Did Not Take Drug|2|||
126388046|NCT00814580|454713708|FG001|Overall Study|Did Not Take Drug|2|||
126388047|NCT02482428|454713709|FG000|Overall Study|Lost to Follow-up|4|||
126388048|NCT02482428|454713710|FG001|Overall Study|Lost to Follow-up|9|||
126388049|NCT02482428|454713711|FG002|Overall Study|Lost to Follow-up|1|||
126388050|NCT02482428|454713712|FG003|Overall Study|Lost to Follow-up|2|||
126388051|NCT02482428|454713713|FG004|Overall Study|Lost to Follow-up|4|||
126388052|NCT02482428|454713709|FG000|Overall Study|Physician Decision|0|||
126388053|NCT02482428|454713710|FG001|Overall Study|Physician Decision|0|||
126388054|NCT02482428|454713711|FG002|Overall Study|Physician Decision|0|||
126388055|NCT02482428|454713712|FG003|Overall Study|Physician Decision|0|||
126388056|NCT02482428|454713713|FG004|Overall Study|Physician Decision|1|||
126388057|NCT02482428|454713709|FG000|Overall Study|protocol deviation|1|||
126388058|NCT02482428|454713710|FG001|Overall Study|protocol deviation|1|||
126388059|NCT02482428|454713711|FG002|Overall Study|protocol deviation|0|||
126388060|NCT02482428|454713712|FG003|Overall Study|protocol deviation|0|||
126388061|NCT02482428|454713713|FG004|Overall Study|protocol deviation|0|||
126388062|NCT02482428|454713709|FG000|Overall Study|subject/guardian decision|4|||
126388063|NCT02482428|454713710|FG001|Overall Study|subject/guardian decision|2|||
126388064|NCT02482428|454713711|FG002|Overall Study|subject/guardian decision|0|||
126388065|NCT02482428|454713712|FG003|Overall Study|subject/guardian decision|0|||
126388066|NCT02482428|454713713|FG004|Overall Study|subject/guardian decision|2|||
126388067|NCT00516893|454713714|FG000|Overall Study|Lost to Follow-up|4|||
126388068|NCT00516893|454713714|FG000|Overall Study|Adverse Event|3|||
126388069|NCT00516893|454713714|FG000|Overall Study|Withdrawal by Subject|2|||
126388070|NCT00516893|454713714|FG000|Overall Study|Noncompliance|2|||
126388071|NCT00516893|454713714|FG000|Overall Study|Death|1|||
126388072|NCT00516893|454713714|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
126388073|NCT00516893|454713714|FG000|Overall Study|Relocated|1|||
126388074|NCT00516893|454713714|FG000|Overall Study|Pregnancy|1|||
126388075|NCT00516893|454713714|FG000|Overall Study|Received Medication From Another Study|1|||
126388076|NCT05924165|454713720|FG000|Overall Study|Physician Decision|2|||
126388077|NCT05924165|454713721|FG001|Overall Study|Physician Decision|3|||
126388078|NCT04075292|454713722|FG000|Overall Study|Withdrawal by Subject|1|||
126388079|NCT04075292|454713723|FG001|Overall Study|Withdrawal by Subject|9|||
126388080|NCT04075292|454713722|FG000|Overall Study|Death|2|||
126388081|NCT04075292|454713723|FG001|Overall Study|Death|5|||
126388082|NCT04075292|454713722|FG000|Overall Study|Remained on study at time of DCO|74|||
126388083|NCT04075292|454713723|FG001|Overall Study|Remained on study at time of DCO|64|||
126388084|NCT04308239|454713724|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
126388085|NCT04308239|454713725|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
126388086|NCT04308239|454713724|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
126388087|NCT04308239|454713725|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
126388088|NCT04308239|454713724|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
126388089|NCT04308239|454713725|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
126388090|NCT04308239|454713724|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
126388091|NCT04308239|454713725|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
126388092|NCT00459875|454713728|FG000|Overall Study|Ineligible participant|1|||
126388093|NCT00459875|454713728|FG000|Overall Study|Adverse Event|2|||
126048887|NCT00372775|453476620|FG000|Overall Study|Death|15|||
126048888|NCT00372775|453476620|FG000|Overall Study|Objective progression or relapse|30|||
126048889|NCT00372775|453476620|FG000|Overall Study|Global deterioration of health status|6|||
126048890|NCT00372775|453476620|FG000|Overall Study|Withdrawal by Subject|1|||
126048891|NCT00372775|453476620|FG000|Overall Study|Other|1|||
126048892|NCT00372775|453476620|FG000|Overall Study|Not Treated|2|||
126048893|NCT00336505|453476626|FG000|Overall Study|Adverse Event|10|||
126048894|NCT00336505|453476627|FG001|Overall Study|Adverse Event|9|||
126048895|NCT00336505|453476626|FG000|Overall Study|Lack of Efficacy|8|||
126388094|NCT01436656|454713729|FG000|Dose Escalation|Death|1|||
126388095|NCT01436656|454713730|FG001|Dose Escalation|Death|3|||
125887316|NCT02963506|452883152|FG007|Dose-Blind Period|Lack of Efficacy|1|||
125887317|NCT02963506|452883153|FG008|Dose-Blind Period|Lack of Efficacy|0|||
126048896|NCT00336505|453476627|FG001|Overall Study|Lack of Efficacy|4|||
126388096|NCT01436656|454713731|FG002|Dose Escalation|Death|1|||
126388097|NCT01436656|454713732|FG003|Dose Escalation|Death|0|||
126388098|NCT01436656|454713733|FG004|Dose Escalation|Death|2|||
126388099|NCT01436656|454713734|FG005|Dose Escalation|Death|1|||
126388100|NCT01436656|454713735|FG006|Dose Escalation|Death|1|||
126388101|NCT01436656|454713736|FG007|Dose Escalation|Death|1|||
126388102|NCT01436656|454713737|FG008|Dose Escalation|Death|1|||
126388103|NCT01436656|454713738|FG009|Dose Escalation|Death|0|||
126388104|NCT01436656|454713739|FG010|Dose Escalation|Death|0|||
126388105|NCT01436656|454713740|FG011|Dose Escalation|Death|0|||
126388106|NCT01436656|454713741|FG012|Dose Escalation|Death|0|||
126388107|NCT01436656|454713742|FG013|Dose Escalation|Death|0|||
126388108|NCT01436656|454713743|FG014|Dose Escalation|Death|0|||
126388109|NCT01436656|454713744|FG015|Dose Escalation|Death|0|||
126388110|NCT01436656|454713745|FG016|Dose Escalation|Death|0|||
126388111|NCT01436656|454713746|FG017|Dose Escalation|Death|0|||
126388112|NCT01436656|454713729|FG000|Dose Escalation|Protocol Violation|0|||
126388113|NCT01436656|454713730|FG001|Dose Escalation|Protocol Violation|0|||
126388114|NCT01436656|454713731|FG002|Dose Escalation|Protocol Violation|0|||
126388115|NCT01436656|454713732|FG003|Dose Escalation|Protocol Violation|0|||
126388116|NCT01436656|454713733|FG004|Dose Escalation|Protocol Violation|0|||
126388117|NCT01436656|454713734|FG005|Dose Escalation|Protocol Violation|1|||
126388118|NCT01436656|454713735|FG006|Dose Escalation|Protocol Violation|0|||
126388119|NCT01436656|454713736|FG007|Dose Escalation|Protocol Violation|0|||
126388120|NCT01436656|454713737|FG008|Dose Escalation|Protocol Violation|0|||
126388121|NCT01436656|454713738|FG009|Dose Escalation|Protocol Violation|0|||
126388122|NCT01436656|454713739|FG010|Dose Escalation|Protocol Violation|0|||
126388123|NCT01436656|454713740|FG011|Dose Escalation|Protocol Violation|0|||
126388124|NCT01436656|454713741|FG012|Dose Escalation|Protocol Violation|0|||
126388125|NCT01436656|454713742|FG013|Dose Escalation|Protocol Violation|0|||
126388126|NCT01436656|454713743|FG014|Dose Escalation|Protocol Violation|0|||
126388127|NCT01436656|454713744|FG015|Dose Escalation|Protocol Violation|0|||
126388128|NCT01436656|454713745|FG016|Dose Escalation|Protocol Violation|0|||
126388129|NCT01436656|454713746|FG017|Dose Escalation|Protocol Violation|0|||
126388130|NCT01436656|454713729|FG000|Dose Escalation|Withdrawal by Subject|0|||
126388131|NCT01436656|454713730|FG001|Dose Escalation|Withdrawal by Subject|0|||
126388132|NCT01436656|454713731|FG002|Dose Escalation|Withdrawal by Subject|0|||
126388133|NCT01436656|454713732|FG003|Dose Escalation|Withdrawal by Subject|0|||
126388134|NCT01436656|454713733|FG004|Dose Escalation|Withdrawal by Subject|1|||
126388135|NCT01436656|454713734|FG005|Dose Escalation|Withdrawal by Subject|0|||
126388136|NCT01436656|454713735|FG006|Dose Escalation|Withdrawal by Subject|0|||
126388137|NCT01436656|454713736|FG007|Dose Escalation|Withdrawal by Subject|2|||
126388138|NCT01436656|454713737|FG008|Dose Escalation|Withdrawal by Subject|0|||
126388139|NCT01436656|454713738|FG009|Dose Escalation|Withdrawal by Subject|1|||
126388140|NCT01436656|454713739|FG010|Dose Escalation|Withdrawal by Subject|1|||
126388141|NCT01436656|454713740|FG011|Dose Escalation|Withdrawal by Subject|0|||
126388142|NCT01436656|454713741|FG012|Dose Escalation|Withdrawal by Subject|0|||
126388143|NCT01436656|454713742|FG013|Dose Escalation|Withdrawal by Subject|0|||
126388144|NCT01436656|454713743|FG014|Dose Escalation|Withdrawal by Subject|0|||
126388145|NCT01436656|454713744|FG015|Dose Escalation|Withdrawal by Subject|0|||
126388146|NCT01436656|454713745|FG016|Dose Escalation|Withdrawal by Subject|0|||
126388147|NCT01436656|454713746|FG017|Dose Escalation|Withdrawal by Subject|0|||
126388148|NCT01436656|454713729|FG000|Dose Escalation|Administrative problems|0|||
126388149|NCT01436656|454713730|FG001|Dose Escalation|Administrative problems|1|||
126388150|NCT01436656|454713731|FG002|Dose Escalation|Administrative problems|0|||
126388151|NCT01436656|454713732|FG003|Dose Escalation|Administrative problems|0|||
126388152|NCT01436656|454713733|FG004|Dose Escalation|Administrative problems|0|||
126388153|NCT01436656|454713734|FG005|Dose Escalation|Administrative problems|0|||
126388154|NCT01436656|454713735|FG006|Dose Escalation|Administrative problems|0|||
126388155|NCT01436656|454713736|FG007|Dose Escalation|Administrative problems|0|||
126388156|NCT01436656|454713737|FG008|Dose Escalation|Administrative problems|0|||
126388157|NCT01436656|454713738|FG009|Dose Escalation|Administrative problems|0|||
126388158|NCT01436656|454713739|FG010|Dose Escalation|Administrative problems|0|||
126388159|NCT01436656|454713740|FG011|Dose Escalation|Administrative problems|0|||
126388160|NCT01436656|454713741|FG012|Dose Escalation|Administrative problems|0|||
126388161|NCT01436656|454713742|FG013|Dose Escalation|Administrative problems|0|||
125887318|NCT02963506|452883154|FG009|Dose-Blind Period|Lack of Efficacy|1|||
125887319|NCT02963506|452883155|FG010|Dose-Blind Period|Lack of Efficacy|0|||
126048897|NCT00336505|453476626|FG000|Overall Study|Lost to Follow-up|7|||
126388162|NCT01436656|454713743|FG014|Dose Escalation|Administrative problems|0|||
126388163|NCT01436656|454713744|FG015|Dose Escalation|Administrative problems|0|||
126388164|NCT01436656|454713745|FG016|Dose Escalation|Administrative problems|0|||
126388165|NCT01436656|454713746|FG017|Dose Escalation|Administrative problems|0|||
126388166|NCT01436656|454713729|FG000|Dose Escalation|Lost to Follow-up|1|||
126388167|NCT01436656|454713730|FG001|Dose Escalation|Lost to Follow-up|0|||
126388168|NCT01436656|454713731|FG002|Dose Escalation|Lost to Follow-up|0|||
126388169|NCT01436656|454713732|FG003|Dose Escalation|Lost to Follow-up|0|||
126388170|NCT01436656|454713733|FG004|Dose Escalation|Lost to Follow-up|1|||
126048898|NCT00336505|453476627|FG001|Overall Study|Lost to Follow-up|4|||
126048899|NCT00336505|453476626|FG000|Overall Study|Withdrawal by Subject|5|||
126048900|NCT00336505|453476627|FG001|Overall Study|Withdrawal by Subject|3|||
126048901|NCT00336505|453476626|FG000|Overall Study|Other|7|||
126048902|NCT00336505|453476627|FG001|Overall Study|Other|7|||
126048903|NCT01561300|453476628|FG000|Run in on Placebo|Adverse Event|1|||
126048904|NCT01561300|453476629|FG001|Run in on Placebo|Adverse Event|0|||
126048905|NCT00609869|453476630|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
126048906|NCT00609869|453476630|FG000|Overall Study|Severe hematologic toxicity|1|||
126048907|NCT00609869|453476630|FG000|Overall Study|Withdrawal by Subject|1|||
126048908|NCT00609869|453476630|FG000|Overall Study|Seizures|1|||
126048909|NCT00609869|453476630|FG000|Overall Study|Severe tumor flare reaction|1|||
126048910|NCT00609869|453476630|FG000|Overall Study|Hepatitis B infection|1|||
126048911|NCT00609869|453476630|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
126048912|NCT00609869|453476630|FG000|Overall Study|Mantle cell: not evaluable|4|||
126048913|NCT00890591|453476632|FG000|Overall Study|Lack of Efficacy|20|||
126048914|NCT00724126|453476635|FG000|Overall Study|Adverse Event|2|||
126048915|NCT00724126|453476636|FG001|Overall Study|Adverse Event|0|||
126048916|NCT00724126|453476635|FG000|Overall Study|Withdrawal by Subject|8|||
126048917|NCT00724126|453476636|FG001|Overall Study|Withdrawal by Subject|6|||
126048918|NCT00724126|453476635|FG000|Overall Study|Lost to Follow-up|6|||
126048919|NCT00724126|453476636|FG001|Overall Study|Lost to Follow-up|6|||
126048920|NCT00724126|453476635|FG000|Overall Study|Noncompliance|2|||
126048921|NCT00724126|453476636|FG001|Overall Study|Noncompliance|1|||
126048922|NCT00724126|453476635|FG000|Overall Study|Subject randomized although ineligible|1|||
126048923|NCT00724126|453476636|FG001|Overall Study|Subject randomized although ineligible|1|||
126048924|NCT00724126|453476635|FG000|Overall Study|Subject had to leave vicinity of site|0|||
126048925|NCT00724126|453476636|FG001|Overall Study|Subject had to leave vicinity of site|1|||
126388171|NCT01436656|454713734|FG005|Dose Escalation|Lost to Follow-up|0|||
126388172|NCT01436656|454713735|FG006|Dose Escalation|Lost to Follow-up|0|||
126388173|NCT01436656|454713736|FG007|Dose Escalation|Lost to Follow-up|0|||
126388174|NCT01436656|454713737|FG008|Dose Escalation|Lost to Follow-up|0|||
126388175|NCT01436656|454713738|FG009|Dose Escalation|Lost to Follow-up|0|||
126388176|NCT01436656|454713739|FG010|Dose Escalation|Lost to Follow-up|0|||
126388177|NCT01436656|454713740|FG011|Dose Escalation|Lost to Follow-up|0|||
126388178|NCT01436656|454713741|FG012|Dose Escalation|Lost to Follow-up|0|||
126388179|NCT01436656|454713742|FG013|Dose Escalation|Lost to Follow-up|0|||
126388180|NCT01436656|454713743|FG014|Dose Escalation|Lost to Follow-up|0|||
126388181|NCT01436656|454713744|FG015|Dose Escalation|Lost to Follow-up|0|||
126388182|NCT01436656|454713745|FG016|Dose Escalation|Lost to Follow-up|0|||
126388183|NCT01436656|454713746|FG017|Dose Escalation|Lost to Follow-up|0|||
126388184|NCT01436656|454713729|FG000|Dose Escalation|New anti-cancer therapy|1|||
126388185|NCT01436656|454713730|FG001|Dose Escalation|New anti-cancer therapy|0|||
126388186|NCT01436656|454713731|FG002|Dose Escalation|New anti-cancer therapy|0|||
126388187|NCT01436656|454713732|FG003|Dose Escalation|New anti-cancer therapy|0|||
126388188|NCT01436656|454713733|FG004|Dose Escalation|New anti-cancer therapy|0|||
126388189|NCT01436656|454713734|FG005|Dose Escalation|New anti-cancer therapy|0|||
126388190|NCT01436656|454713735|FG006|Dose Escalation|New anti-cancer therapy|0|||
126388191|NCT01436656|454713736|FG007|Dose Escalation|New anti-cancer therapy|0|||
126388192|NCT01436656|454713737|FG008|Dose Escalation|New anti-cancer therapy|1|||
126388193|NCT01436656|454713738|FG009|Dose Escalation|New anti-cancer therapy|1|||
126388194|NCT01436656|454713739|FG010|Dose Escalation|New anti-cancer therapy|0|||
126388195|NCT01436656|454713740|FG011|Dose Escalation|New anti-cancer therapy|0|||
126388196|NCT01436656|454713741|FG012|Dose Escalation|New anti-cancer therapy|0|||
126388197|NCT01436656|454713742|FG013|Dose Escalation|New anti-cancer therapy|0|||
126388198|NCT01436656|454713743|FG014|Dose Escalation|New anti-cancer therapy|0|||
126388199|NCT01436656|454713744|FG015|Dose Escalation|New anti-cancer therapy|0|||
126388200|NCT01436656|454713745|FG016|Dose Escalation|New anti-cancer therapy|0|||
126388201|NCT01436656|454713746|FG017|Dose Escalation|New anti-cancer therapy|0|||
126048926|NCT02502526|453476638|FG000|Overall Study|Lost to Follow-up|2|||
126388202|NCT01436656|454713729|FG000|Dose Expansion|Adverse Event|0|||
126388203|NCT01436656|454713730|FG001|Dose Expansion|Adverse Event|0|||
126048927|NCT02502526|453476639|FG001|Overall Study|Lost to Follow-up|2|||
126388204|NCT01436656|454713731|FG002|Dose Expansion|Adverse Event|0|||
126388205|NCT01436656|454713732|FG003|Dose Expansion|Adverse Event|0|||
126388206|NCT01436656|454713733|FG004|Dose Expansion|Adverse Event|0|||
126048928|NCT02502526|453476640|FG002|Overall Study|Lost to Follow-up|3|||
126048929|NCT02502526|453476638|FG000|Overall Study|Withdrawal by Subject|0|||
126048930|NCT02502526|453476639|FG001|Overall Study|Withdrawal by Subject|1|||
126048931|NCT02502526|453476640|FG002|Overall Study|Withdrawal by Subject|1|||
126388207|NCT01436656|454713734|FG005|Dose Expansion|Adverse Event|0|||
126388208|NCT01436656|454713735|FG006|Dose Expansion|Adverse Event|0|||
126388209|NCT01436656|454713736|FG007|Dose Expansion|Adverse Event|0|||
126388210|NCT01436656|454713737|FG008|Dose Expansion|Adverse Event|0|||
126388211|NCT01436656|454713738|FG009|Dose Expansion|Adverse Event|0|||
126388212|NCT01436656|454713739|FG010|Dose Expansion|Adverse Event|0|||
126388213|NCT01436656|454713740|FG011|Dose Expansion|Adverse Event|1|||
126388214|NCT01436656|454713741|FG012|Dose Expansion|Adverse Event|0|||
126388215|NCT01436656|454713742|FG013|Dose Expansion|Adverse Event|0|||
126388216|NCT01436656|454713743|FG014|Dose Expansion|Adverse Event|0|||
126388217|NCT01436656|454713744|FG015|Dose Expansion|Adverse Event|0|||
126388218|NCT01436656|454713745|FG016|Dose Expansion|Adverse Event|0|||
126388219|NCT01436656|454713746|FG017|Dose Expansion|Adverse Event|0|||
126388220|NCT01436656|454713729|FG000|Dose Expansion|Withdrawal by Subject|0|||
126388221|NCT01436656|454713730|FG001|Dose Expansion|Withdrawal by Subject|0|||
126388222|NCT01436656|454713731|FG002|Dose Expansion|Withdrawal by Subject|0|||
126388223|NCT01436656|454713732|FG003|Dose Expansion|Withdrawal by Subject|0|||
126388224|NCT01436656|454713733|FG004|Dose Expansion|Withdrawal by Subject|0|||
126388225|NCT01436656|454713734|FG005|Dose Expansion|Withdrawal by Subject|0|||
126388226|NCT01436656|454713735|FG006|Dose Expansion|Withdrawal by Subject|0|||
126388227|NCT01436656|454713736|FG007|Dose Expansion|Withdrawal by Subject|0|||
126388228|NCT01436656|454713737|FG008|Dose Expansion|Withdrawal by Subject|0|||
126388229|NCT01436656|454713738|FG009|Dose Expansion|Withdrawal by Subject|0|||
126388230|NCT01436656|454713739|FG010|Dose Expansion|Withdrawal by Subject|0|||
126388231|NCT01436656|454713740|FG011|Dose Expansion|Withdrawal by Subject|1|||
126388232|NCT01436656|454713741|FG012|Dose Expansion|Withdrawal by Subject|3|||
126388233|NCT01436656|454713742|FG013|Dose Expansion|Withdrawal by Subject|1|||
126388234|NCT01436656|454713743|FG014|Dose Expansion|Withdrawal by Subject|2|||
126388235|NCT01436656|454713744|FG015|Dose Expansion|Withdrawal by Subject|0|||
126388236|NCT01436656|454713745|FG016|Dose Expansion|Withdrawal by Subject|1|||
126388237|NCT01436656|454713746|FG017|Dose Expansion|Withdrawal by Subject|1|||
126388238|NCT01436656|454713729|FG000|Dose Expansion|Death|0|||
126388239|NCT01436656|454713730|FG001|Dose Expansion|Death|0|||
126388240|NCT01436656|454713731|FG002|Dose Expansion|Death|0|||
126388241|NCT01436656|454713732|FG003|Dose Expansion|Death|0|||
126388242|NCT01436656|454713733|FG004|Dose Expansion|Death|0|||
126388243|NCT01436656|454713734|FG005|Dose Expansion|Death|0|||
126388244|NCT01436656|454713735|FG006|Dose Expansion|Death|0|||
126388245|NCT01436656|454713736|FG007|Dose Expansion|Death|0|||
126388246|NCT01436656|454713737|FG008|Dose Expansion|Death|0|||
126388247|NCT01436656|454713738|FG009|Dose Expansion|Death|0|||
126388248|NCT01436656|454713739|FG010|Dose Expansion|Death|0|||
126388249|NCT01436656|454713740|FG011|Dose Expansion|Death|0|||
126388250|NCT01436656|454713741|FG012|Dose Expansion|Death|1|||
126388251|NCT01436656|454713742|FG013|Dose Expansion|Death|0|||
126388252|NCT01436656|454713743|FG014|Dose Expansion|Death|3|||
126388253|NCT01436656|454713744|FG015|Dose Expansion|Death|0|||
126388254|NCT01436656|454713745|FG016|Dose Expansion|Death|3|||
126388255|NCT01436656|454713746|FG017|Dose Expansion|Death|3|||
126388256|NCT01436656|454713729|FG000|Dose Expansion|Lost to Follow-up|0|||
126388257|NCT01436656|454713730|FG001|Dose Expansion|Lost to Follow-up|0|||
126388258|NCT01436656|454713731|FG002|Dose Expansion|Lost to Follow-up|0|||
126388259|NCT01436656|454713732|FG003|Dose Expansion|Lost to Follow-up|0|||
126388260|NCT01436656|454713733|FG004|Dose Expansion|Lost to Follow-up|0|||
125887320|NCT02963506|452883156|FG011|Dose-Blind Period|Lack of Efficacy|0|||
125887321|NCT02963506|452883157|FG012|Dose-Blind Period|Lack of Efficacy|0|||
125887322|NCT02963506|452883145|FG000|Dose-Blind Period|Lost to Follow-up|0|||
125887323|NCT02963506|452883146|FG001|Dose-Blind Period|Lost to Follow-up|0|||
126388261|NCT01436656|454713734|FG005|Dose Expansion|Lost to Follow-up|0|||
126388262|NCT01436656|454713735|FG006|Dose Expansion|Lost to Follow-up|0|||
126388263|NCT01436656|454713736|FG007|Dose Expansion|Lost to Follow-up|0|||
126388264|NCT01436656|454713737|FG008|Dose Expansion|Lost to Follow-up|0|||
126388265|NCT01436656|454713738|FG009|Dose Expansion|Lost to Follow-up|0|||
126388266|NCT01436656|454713739|FG010|Dose Expansion|Lost to Follow-up|0|||
126388267|NCT01436656|454713740|FG011|Dose Expansion|Lost to Follow-up|0|||
126388268|NCT01436656|454713741|FG012|Dose Expansion|Lost to Follow-up|0|||
126388269|NCT01436656|454713742|FG013|Dose Expansion|Lost to Follow-up|0|||
126388270|NCT01436656|454713743|FG014|Dose Expansion|Lost to Follow-up|0|||
126048932|NCT02502526|453476638|FG000|Overall Study|Disqualified due to cataract grading|0|||
126048933|NCT02502526|453476639|FG001|Overall Study|Disqualified due to cataract grading|0|||
126388271|NCT01436656|454713744|FG015|Dose Expansion|Lost to Follow-up|0|||
126388272|NCT01436656|454713745|FG016|Dose Expansion|Lost to Follow-up|0|||
126388273|NCT01436656|454713746|FG017|Dose Expansion|Lost to Follow-up|3|||
126388274|NCT01436656|454713729|FG000|Dose Expansion|Disease progression|0|||
126388275|NCT01436656|454713730|FG001|Dose Expansion|Disease progression|0|||
126388276|NCT01436656|454713731|FG002|Dose Expansion|Disease progression|0|||
126388277|NCT01436656|454713732|FG003|Dose Expansion|Disease progression|0|||
126388278|NCT01436656|454713733|FG004|Dose Expansion|Disease progression|0|||
126388279|NCT01436656|454713734|FG005|Dose Expansion|Disease progression|0|||
126388280|NCT01436656|454713735|FG006|Dose Expansion|Disease progression|0|||
126388281|NCT01436656|454713736|FG007|Dose Expansion|Disease progression|0|||
126388282|NCT01436656|454713737|FG008|Dose Expansion|Disease progression|0|||
126388283|NCT01436656|454713738|FG009|Dose Expansion|Disease progression|0|||
125887324|NCT02963506|452883147|FG002|Dose-Blind Period|Lost to Follow-up|0|||
126104223|NCT01650246|453675825|FG000|Overall Study|Sponsor terminated study|53|||
126388284|NCT01436656|454713739|FG010|Dose Expansion|Disease progression|0|||
126388285|NCT01436656|454713740|FG011|Dose Expansion|Disease progression|3|||
126388286|NCT01436656|454713741|FG012|Dose Expansion|Disease progression|1|||
126388287|NCT01436656|454713742|FG013|Dose Expansion|Disease progression|0|||
126388288|NCT01436656|454713743|FG014|Dose Expansion|Disease progression|1|||
126388289|NCT01436656|454713744|FG015|Dose Expansion|Disease progression|0|||
126388290|NCT01436656|454713745|FG016|Dose Expansion|Disease progression|0|||
126388291|NCT01436656|454713746|FG017|Dose Expansion|Disease progression|1|||
126388292|NCT01436656|454713729|FG000|Dose Expansion|New cancer therapy|0|||
126388293|NCT01436656|454713730|FG001|Dose Expansion|New cancer therapy|0|||
126388294|NCT01436656|454713731|FG002|Dose Expansion|New cancer therapy|0|||
126388295|NCT01436656|454713732|FG003|Dose Expansion|New cancer therapy|0|||
126388296|NCT01436656|454713733|FG004|Dose Expansion|New cancer therapy|0|||
126388297|NCT01436656|454713734|FG005|Dose Expansion|New cancer therapy|0|||
126388298|NCT01436656|454713735|FG006|Dose Expansion|New cancer therapy|0|||
126388299|NCT01436656|454713736|FG007|Dose Expansion|New cancer therapy|0|||
126388300|NCT01436656|454713737|FG008|Dose Expansion|New cancer therapy|0|||
126388301|NCT01436656|454713738|FG009|Dose Expansion|New cancer therapy|0|||
126388302|NCT01436656|454713739|FG010|Dose Expansion|New cancer therapy|0|||
126388303|NCT01436656|454713740|FG011|Dose Expansion|New cancer therapy|1|||
126388304|NCT01436656|454713741|FG012|Dose Expansion|New cancer therapy|1|||
126388305|NCT01436656|454713742|FG013|Dose Expansion|New cancer therapy|0|||
126388306|NCT01436656|454713743|FG014|Dose Expansion|New cancer therapy|2|||
126388307|NCT01436656|454713744|FG015|Dose Expansion|New cancer therapy|0|||
126388308|NCT01436656|454713745|FG016|Dose Expansion|New cancer therapy|0|||
126388309|NCT01436656|454713746|FG017|Dose Expansion|New cancer therapy|0|||
126388310|NCT04729972|454713747|FG000|Overall Study|Adverse Event|1|||
126388311|NCT00576628|454713749|FG000|Overall Study|Adverse Event|11|||
126388312|NCT00576628|454713749|FG000|Overall Study|Death|2|||
126388313|NCT00576628|454713749|FG000|Overall Study|Failure to return|1|||
126388314|NCT00576628|454713749|FG000|Overall Study|Refused Treatment|8|||
126388315|NCT00576628|454713749|FG000|Overall Study|Pregnancy|1|||
126388316|NCT00576628|454713749|FG000|Overall Study|RBC transfusion|1|||
126388317|NCT00576628|454713749|FG000|Overall Study|Progression of Kidney Disease|1|||
126388318|NCT00576628|454713749|FG000|Overall Study|Progression of Renal Failure|1|||
126388319|NCT00576628|454713749|FG000|Overall Study|The patient move into other town|1|||
126388320|NCT00576628|454713749|FG000|Overall Study|Transplantation|1|||
126388321|NCT00576628|454713749|FG000|Overall Study|Dialysis|15|||
126388322|NCT03206970|454713750|FG000|Overall Study|Death|21|||
126388323|NCT03206970|454713750|FG000|Overall Study|Withdrawal by Subject|13|||
126388324|NCT03206970|454713750|FG000|Overall Study|Lost to Follow-up|3|||
126388325|NCT03206970|454713750|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
126388326|NCT02516982|454713753|FG000|Overall Study|Called in to antenatal appointment|32|||
126388327|NCT02516982|454713754|FG001|Overall Study|Called in to antenatal appointment|35|||
126388328|NCT02516982|454713755|FG002|Overall Study|Called in to antenatal appointment|0|||
126388329|NCT02516982|454713756|FG003|Overall Study|Called in to antenatal appointment|0|||
126388330|NCT02516982|454713753|FG000|Overall Study|Withdrawal by Subject|0|||
126388331|NCT02516982|454713754|FG001|Overall Study|Withdrawal by Subject|0|||
126388332|NCT02516982|454713755|FG002|Overall Study|Withdrawal by Subject|1|||
126388333|NCT02516982|454713756|FG003|Overall Study|Withdrawal by Subject|2|||
126388334|NCT02516982|454713753|FG000|Overall Study|Protocol Violation|0|||
126388335|NCT02516982|454713754|FG001|Overall Study|Protocol Violation|0|||
126388336|NCT02516982|454713755|FG002|Overall Study|Protocol Violation|1|||
126388337|NCT02516982|454713756|FG003|Overall Study|Protocol Violation|1|||
126388338|NCT02516982|454713753|FG000|Overall Study|Did not install the app|0|||
126388339|NCT02516982|454713754|FG001|Overall Study|Did not install the app|0|||
126388340|NCT02516982|454713755|FG002|Overall Study|Did not install the app|46|||
126388341|NCT02516982|454713756|FG003|Overall Study|Did not install the app|47|||
126388342|NCT00962741|454713758|FG000|Overall Study|Failed to return|3|||
126388343|NCT00962741|454713758|FG000|Overall Study|Lost to Follow-up|2|||
126388344|NCT00962741|454713758|FG000|Overall Study|Withdrawal by Subject|1|||
126388345|NCT00962741|454713758|FG000|Overall Study|Lack of Efficacy|1|||
126388346|NCT00962741|454713758|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
126388347|NCT01814878|454713761|FG000|Overall Study|Adverse Event|16|||
126388348|NCT01814878|454713762|FG001|Overall Study|Adverse Event|5|||
126388349|NCT01814878|454713761|FG000|Overall Study|Withdrawal by Subject|20|||
126388350|NCT01814878|454713762|FG001|Overall Study|Withdrawal by Subject|16|||
126388351|NCT01814878|454713761|FG000|Overall Study|Protocol Violation|5|||
126388352|NCT01814878|454713762|FG001|Overall Study|Protocol Violation|5|||
126388353|NCT01814878|454713761|FG000|Overall Study|Physician Decision|3|||
125887325|NCT02963506|452883148|FG003|Dose-Blind Period|Lost to Follow-up|0|||
126104224|NCT01650246|453675825|FG000|Overall Study|Lost to Follow-up|5|||
126388354|NCT01814878|454713762|FG001|Overall Study|Physician Decision|1|||
126388355|NCT01814878|454713761|FG000|Overall Study|Screening failure (drop-out)|0|||
126388356|NCT01814878|454713762|FG001|Overall Study|Screening failure (drop-out)|3|||
126388357|NCT01814878|454713761|FG000|Overall Study|Other|2|||
126388358|NCT01814878|454713762|FG001|Overall Study|Other|0|||
126388359|NCT03645421|454713763|FG000|Overall Study|Adverse Event|0|||
126388360|NCT03645421|454713764|FG001|Overall Study|Adverse Event|0|||
126388361|NCT03645421|454713765|FG002|Overall Study|Adverse Event|4|||
126388362|NCT03645421|454713766|FG003|Overall Study|Adverse Event|1|||
126388363|NCT03645421|454713763|FG000|Overall Study|Withdrawal by patient|0|||
126388364|NCT03645421|454713764|FG001|Overall Study|Withdrawal by patient|0|||
126388365|NCT03645421|454713765|FG002|Overall Study|Withdrawal by patient|0|||
126388366|NCT03645421|454713766|FG003|Overall Study|Withdrawal by patient|3|||
126388367|NCT03645421|454713763|FG000|Overall Study|Study specific withdrawal criteria|0|||
126388368|NCT03645421|454713764|FG001|Overall Study|Study specific withdrawal criteria|0|||
126388369|NCT03645421|454713765|FG002|Overall Study|Study specific withdrawal criteria|1|||
126388370|NCT03645421|454713766|FG003|Overall Study|Study specific withdrawal criteria|0|||
126388371|NCT02253433|454713770|FG000|Overall Study|Unable to Contact|9|||
125887326|NCT02963506|452883149|FG004|Dose-Blind Period|Lost to Follow-up|0|||
125887327|NCT02963506|452883150|FG005|Dose-Blind Period|Lost to Follow-up|1|||
125887328|NCT02963506|452883151|FG006|Dose-Blind Period|Lost to Follow-up|0|||
125887329|NCT02963506|452883152|FG007|Dose-Blind Period|Lost to Follow-up|0|||
125887330|NCT02963506|452883153|FG008|Dose-Blind Period|Lost to Follow-up|1|||
125887331|NCT02963506|452883154|FG009|Dose-Blind Period|Lost to Follow-up|0|||
125887332|NCT02963506|452883155|FG010|Dose-Blind Period|Lost to Follow-up|0|||
125887333|NCT02963506|452883156|FG011|Dose-Blind Period|Lost to Follow-up|1|||
125887334|NCT02963506|452883157|FG012|Dose-Blind Period|Lost to Follow-up|0|||
125887335|NCT02963506|452883145|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
125887336|NCT02963506|452883146|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
125887337|NCT02963506|452883147|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
125887338|NCT02963506|452883148|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
125887339|NCT02963506|452883149|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
125887340|NCT02963506|452883150|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
125887341|NCT02963506|452883151|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
125887342|NCT02963506|452883152|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
125887343|NCT02963506|452883153|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
125887344|NCT02963506|452883154|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
125887345|NCT02963506|452883155|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
125887346|NCT02963506|452883156|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
125887347|NCT02963506|452883157|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
125887348|NCT02963506|452883145|FG000|Dose-Blind Period|Sponsor decision|0|||
125887349|NCT02963506|452883146|FG001|Dose-Blind Period|Sponsor decision|0|||
125887350|NCT02963506|452883147|FG002|Dose-Blind Period|Sponsor decision|0|||
126388372|NCT02253433|454713771|FG001|Overall Study|Unable to Contact|16|||
126388373|NCT02253433|454713770|FG000|Overall Study|Death|1|||
126388374|NCT02253433|454713771|FG001|Overall Study|Death|1|||
126388375|NCT02253433|454713770|FG000|Overall Study|No Longer Interested|3|||
126388376|NCT02253433|454713771|FG001|Overall Study|No Longer Interested|15|||
126388377|NCT02253433|454713770|FG000|Overall Study|Out of Study Area|2|||
126388378|NCT02253433|454713771|FG001|Overall Study|Out of Study Area|7|||
126388379|NCT02253433|454713770|FG000|Overall Study|Uncomfortable with home visitors|0|||
126388380|NCT02253433|454713771|FG001|Overall Study|Uncomfortable with home visitors|3|||
126388381|NCT02253433|454713770|FG000|Overall Study|Unstable Housing/Homeless|0|||
126388382|NCT02253433|454713771|FG001|Overall Study|Unstable Housing/Homeless|7|||
126388383|NCT02253433|454713770|FG000|Overall Study|Too Busy|0|||
126388384|NCT02253433|454713771|FG001|Overall Study|Too Busy|4|||
126388385|NCT02253433|454713770|FG000|Overall Study|Medical or Other Concerns|1|||
126388386|NCT02253433|454713771|FG001|Overall Study|Medical or Other Concerns|2|||
126388387|NCT00759876|454713779|FG000|Overall Study|Sponsor terminated study early|36|||
126388388|NCT02836717|454713780|FG000|Test Phase|Lack of Efficacy|14|||
126388389|NCT02836717|454713781|FG001|Test Phase|Lack of Efficacy|8|||
126388390|NCT02836717|454713782|FG002|Test Phase|Lack of Efficacy|0|||
126388391|NCT02836717|454713780|FG000|Study Phase|Adverse Event|2|||
126388392|NCT02836717|454713781|FG001|Study Phase|Adverse Event|0|||
126388393|NCT02836717|454713782|FG002|Study Phase|Adverse Event|0|||
125887351|NCT02963506|452883148|FG003|Dose-Blind Period|Sponsor decision|0|||
125887352|NCT02963506|452883149|FG004|Dose-Blind Period|Sponsor decision|0|||
125887353|NCT02963506|452883150|FG005|Dose-Blind Period|Sponsor decision|1|||
125887354|NCT02963506|452883151|FG006|Dose-Blind Period|Sponsor decision|0|||
125887355|NCT02963506|452883152|FG007|Dose-Blind Period|Sponsor decision|0|||
125887356|NCT02963506|452883153|FG008|Dose-Blind Period|Sponsor decision|0|||
125887357|NCT02963506|452883154|FG009|Dose-Blind Period|Sponsor decision|0|||
125887358|NCT02963506|452883155|FG010|Dose-Blind Period|Sponsor decision|0|||
126388394|NCT02836717|454713780|FG000|Study Phase|Lack of Efficacy|8|||
126388395|NCT02836717|454713781|FG001|Study Phase|Lack of Efficacy|6|||
126388396|NCT02836717|454713782|FG002|Study Phase|Lack of Efficacy|1|||
126388397|NCT02836717|454713780|FG000|Study Phase|Withdrawal by Subject|1|||
126388398|NCT02836717|454713781|FG001|Study Phase|Withdrawal by Subject|0|||
126388399|NCT02836717|454713782|FG002|Study Phase|Withdrawal by Subject|0|||
126388400|NCT02836717|454713780|FG000|Study Phase|Death|1|||
126388401|NCT02836717|454713781|FG001|Study Phase|Death|0|||
126388402|NCT02836717|454713782|FG002|Study Phase|Death|0|||
126388403|NCT02836717|454713780|FG000|Study Phase|abdominal surgeries|2|||
126388404|NCT02836717|454713781|FG001|Study Phase|abdominal surgeries|1|||
126388405|NCT02836717|454713782|FG002|Study Phase|abdominal surgeries|0|||
126388406|NCT03636893|454713783|FG000|Overall Study|Death|0|||
126388407|NCT03636893|454713784|FG001|Overall Study|Death|1|||
126388408|NCT03636893|454713783|FG000|Overall Study|Protocol Violation|0|||
126388409|NCT03636893|454713784|FG001|Overall Study|Protocol Violation|3|||
126388410|NCT03636893|454713783|FG000|Overall Study|Withdrawal by Subject|1|||
126388411|NCT03636893|454713784|FG001|Overall Study|Withdrawal by Subject|2|||
126388412|NCT03636893|454713783|FG000|Overall Study|Refusal to surgery|4|||
126388413|NCT03636893|454713784|FG001|Overall Study|Refusal to surgery|3|||
126388414|NCT03636893|454713783|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
126388415|NCT03636893|454713784|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
126388416|NCT03636893|454713783|FG000|Overall Study|Adverse Event|1|||
126388417|NCT03636893|454713784|FG001|Overall Study|Adverse Event|1|||
126388418|NCT00438360|454713785|FG000|Overall Study|Adverse Event|6|||
126388419|NCT00438360|454713786|FG001|Overall Study|Adverse Event|1|||
126388420|NCT00438360|454713785|FG000|Overall Study|Lack of Efficacy|42|||
126388421|NCT00438360|454713786|FG001|Overall Study|Lack of Efficacy|27|||
126388422|NCT00438360|454713785|FG000|Overall Study|Other|24|||
126388423|NCT00438360|454713786|FG001|Overall Study|Other|15|||
126388424|NCT04560816|454713788|FG000|Overall Study|Withdrawal by Subject|1|||
126388425|NCT04560816|454713789|FG001|Overall Study|Withdrawal by Subject|1|||
126388426|NCT04560816|454713790|FG002|Overall Study|Withdrawal by Subject|1|||
126388427|NCT04560816|454713791|FG003|Overall Study|Withdrawal by Subject|0|||
126388428|NCT04560816|454713792|FG004|Overall Study|Withdrawal by Subject|3|||
126388429|NCT04560816|454713793|FG005|Overall Study|Withdrawal by Subject|0|||
126388430|NCT04560816|454713788|FG000|Overall Study|Lost to Follow-up|1|||
126388431|NCT04560816|454713789|FG001|Overall Study|Lost to Follow-up|0|||
126388432|NCT04560816|454713790|FG002|Overall Study|Lost to Follow-up|0|||
126388433|NCT04560816|454713791|FG003|Overall Study|Lost to Follow-up|0|||
126388434|NCT04560816|454713792|FG004|Overall Study|Lost to Follow-up|0|||
126388435|NCT04560816|454713793|FG005|Overall Study|Lost to Follow-up|0|||
126388436|NCT04560816|454713788|FG000|Overall Study|Protocol Violation|1|||
126388437|NCT04560816|454713789|FG001|Overall Study|Protocol Violation|0|||
126388438|NCT04560816|454713790|FG002|Overall Study|Protocol Violation|0|||
126388439|NCT04560816|454713791|FG003|Overall Study|Protocol Violation|0|||
126388440|NCT04560816|454713792|FG004|Overall Study|Protocol Violation|0|||
126388441|NCT04560816|454713793|FG005|Overall Study|Protocol Violation|0|||
126388442|NCT02277691|454713794|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
126388443|NCT02277691|454713794|FG000|Overall Study|Voluntary Withdrawal|7|||
126388444|NCT02277691|454713794|FG000|Overall Study|Lack of Efficacy|5|||
126388445|NCT02277691|454713794|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
126388446|NCT03818607|454713795|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
126388447|NCT03818607|454713796|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
126388448|NCT03818607|454713795|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
126388449|NCT03818607|454713796|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
126388450|NCT03818607|454713795|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
126388451|NCT03818607|454713796|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
126388452|NCT05059301|454713798|FG000|Overall Study|Adverse Event|0|||
126388453|NCT05059301|454713799|FG001|Overall Study|Adverse Event|2|||
126388454|NCT05059301|454713800|FG002|Overall Study|Adverse Event|2|||
126388455|NCT05059301|454713798|FG000|Overall Study|Lost to Follow-up|2|||
126388456|NCT05059301|454713799|FG001|Overall Study|Lost to Follow-up|3|||
126388457|NCT05059301|454713800|FG002|Overall Study|Lost to Follow-up|3|||
126388458|NCT01164891|454713801|FG000|Overall Study|Disease Progression|5|||
126388459|NCT01164891|454713801|FG000|Overall Study|Adverse Event|1|||
126388460|NCT00441142|454713802|FG000|Overall Study|Adverse Event|2|||
126388461|NCT00441142|454713803|FG001|Overall Study|Adverse Event|3|||
126388462|NCT00441142|454713804|FG002|Overall Study|Adverse Event|3|||
126388463|NCT00441142|454713805|FG003|Overall Study|Adverse Event|22|||
126388464|NCT00441142|454713802|FG000|Overall Study|Lack of Efficacy|3|||
126388465|NCT00441142|454713803|FG001|Overall Study|Lack of Efficacy|3|||
126388466|NCT00441142|454713804|FG002|Overall Study|Lack of Efficacy|17|||
126388467|NCT00441142|454713805|FG003|Overall Study|Lack of Efficacy|32|||
126388468|NCT00441142|454713802|FG000|Overall Study|Withdrawal by Subject|0|||
126388469|NCT00441142|454713803|FG001|Overall Study|Withdrawal by Subject|0|||
126388470|NCT00441142|454713804|FG002|Overall Study|Withdrawal by Subject|2|||
126388471|NCT00441142|454713805|FG003|Overall Study|Withdrawal by Subject|10|||
126388472|NCT00441142|454713802|FG000|Overall Study|Patient still receiving active study tx|1|||
126388473|NCT00441142|454713803|FG001|Overall Study|Patient still receiving active study tx|0|||
126388474|NCT00441142|454713804|FG002|Overall Study|Patient still receiving active study tx|0|||
126388475|NCT00441142|454713805|FG003|Overall Study|Patient still receiving active study tx|2|||
126388476|NCT00441142|454713802|FG000|Overall Study|Physician Decision|0|||
126388477|NCT00441142|454713803|FG001|Overall Study|Physician Decision|1|||
126388478|NCT00441142|454713804|FG002|Overall Study|Physician Decision|0|||
126388479|NCT00441142|454713805|FG003|Overall Study|Physician Decision|1|||
126388480|NCT00441142|454713802|FG000|Overall Study|Death|0|||
126048934|NCT02502526|453476640|FG002|Overall Study|Disqualified due to cataract grading|1|||
126388481|NCT00441142|454713803|FG001|Overall Study|Death|0|||
126388482|NCT00441142|454713804|FG002|Overall Study|Death|0|||
126388483|NCT00441142|454713805|FG003|Overall Study|Death|1|||
126388484|NCT04952597|454713806|FG000|Overall Study|Death|12|||
126388485|NCT04952597|454713807|FG001|Overall Study|Death|13|||
126388486|NCT04952597|454713808|FG002|Overall Study|Death|14|||
126388487|NCT04952597|454713806|FG000|Overall Study|Withdrawal by Subject|1|||
126388488|NCT04952597|454713807|FG001|Overall Study|Withdrawal by Subject|0|||
126388489|NCT04952597|454713808|FG002|Overall Study|Withdrawal by Subject|3|||
126388490|NCT04952597|454713806|FG000|Overall Study|Lost to Follow-up|0|||
126388491|NCT04952597|454713807|FG001|Overall Study|Lost to Follow-up|1|||
126388492|NCT04952597|454713808|FG002|Overall Study|Lost to Follow-up|1|||
126388493|NCT05730335|454713809|FG000|Overall Study|Lost to Follow-up|8|||
126388494|NCT05730335|454713809|FG000|Overall Study|Withdrawal by Subject|6|||
126388495|NCT03249909|454713814|FG000|Overall Study|Withdrawal by Subject|3|||
126388496|NCT03249909|454713815|FG001|Overall Study|Withdrawal by Subject|0|||
126388497|NCT03249909|454713816|FG002|Overall Study|Withdrawal by Subject|0|||
126388498|NCT03249909|454713814|FG000|Overall Study|Adverse Event|3|||
126388499|NCT03249909|454713815|FG001|Overall Study|Adverse Event|0|||
126388500|NCT03249909|454713816|FG002|Overall Study|Adverse Event|0|||
126388501|NCT03249909|454713814|FG000|Overall Study|Lost to Follow-up|0|||
126388502|NCT03249909|454713815|FG001|Overall Study|Lost to Follow-up|1|||
126388503|NCT03249909|454713816|FG002|Overall Study|Lost to Follow-up|0|||
126388504|NCT05286658|454713820|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
126388505|NCT05286658|454713820|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
126388506|NCT05411822|454713821|FG000|Overall Study|Withdrawal by Subject|2|||
126388507|NCT05411822|454713822|FG001|Overall Study|Withdrawal by Subject|1|||
126388508|NCT01814397|454713825|FG000|Overall Study|Adverse Event|7|||
126388509|NCT01814397|454713825|FG000|Overall Study|Withdrawal by Subject|7|||
126388510|NCT02952313|454713835|FG000|Primary Endpoint|Lost to Follow-up|4|||
126388511|NCT02952313|454713835|FG000|Primary Endpoint|Withdrawal by Subject|1|||
126388512|NCT02952313|454713835|FG000|Primary Endpoint|Lack of Efficacy|1|||
126388513|NCT02952313|454713835|FG000|Primary Endpoint|Missed visit|1|||
126388514|NCT02952313|454713835|FG000|Long-term Follow-up|Lost to Follow-up|12|||
126388515|NCT02952313|454713835|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
126388516|NCT02952313|454713835|FG000|Long-term Follow-up|Lack of Efficacy|6|||
126388517|NCT02952313|454713835|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
126388518|NCT02952313|454713835|FG000|Long-term Follow-up|Physician Decision|1|||
126388519|NCT02952313|454713835|FG000|Long-term Follow-up|Death|1|||
126388520|NCT03206918|454713846|FG000|Overall Study|Death|11|||
126388521|NCT03206918|454713846|FG000|Overall Study|Withdrawal by Subject|5|||
126388522|NCT03206918|454713846|FG000|Overall Study|Study terminated by sponsor|12|||
126388523|NCT03206918|454713846|FG000|Overall Study|Lost to Follow-up|3|||
126388524|NCT03206918|454713846|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
126388525|NCT03823287|454713847|FG000|Overall Study|Withdrawal by Subject|25|||
126388526|NCT03823287|454713848|FG001|Overall Study|Withdrawal by Subject|17|||
126388527|NCT03823287|454713847|FG000|Overall Study|Death|13|||
126388528|NCT03823287|454713848|FG001|Overall Study|Death|7|||
126388529|NCT03823287|454713847|FG000|Overall Study|Lost to Follow-up|7|||
126388530|NCT03823287|454713848|FG001|Overall Study|Lost to Follow-up|8|||
126388531|NCT03823287|454713847|FG000|Overall Study|Adverse Event|6|||
126388532|NCT03823287|454713848|FG001|Overall Study|Adverse Event|8|||
126388533|NCT03823287|454713847|FG000|Overall Study|Physician Decision|5|||
126388534|NCT03823287|454713848|FG001|Overall Study|Physician Decision|2|||
126388535|NCT03823287|454713847|FG000|Overall Study|Lack of Efficacy|2|||
126388536|NCT03823287|454713848|FG001|Overall Study|Lack of Efficacy|0|||
126388537|NCT03823287|454713847|FG000|Overall Study|Other|2|||
126048935|NCT02502526|453476638|FG000|Overall Study|Enrollment suspension|4|||
126048936|NCT02502526|453476639|FG001|Overall Study|Enrollment suspension|1|||
126048937|NCT02502526|453476640|FG002|Overall Study|Enrollment suspension|1|||
126048938|NCT01952366|453476641|FG000|Overall Study|Death|22|||
126388538|NCT03823287|454713848|FG001|Overall Study|Other|4|||
126388539|NCT01170273|454713850|FG000|Overall Study|Lost to Follow-up|6|||
126388540|NCT01170273|454713851|FG001|Overall Study|Lost to Follow-up|8|||
126388541|NCT01170273|454713850|FG000|Overall Study|Protocol Violation|1|||
126388542|NCT01170273|454713851|FG001|Overall Study|Protocol Violation|0|||
126388543|NCT01170273|454713850|FG000|Overall Study|Death|1|||
126388544|NCT01170273|454713851|FG001|Overall Study|Death|0|||
126388545|NCT01170273|454713850|FG000|Overall Study|Adverse Event|0|||
126388546|NCT01170273|454713851|FG001|Overall Study|Adverse Event|1|||
126388547|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
126388548|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
126388549|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
126388550|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
126388551|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
126048939|NCT01952366|453476641|FG000|Overall Study|Withdrawal by Subject|9|||
126048940|NCT01988402|453476642|FG000|Overall Study|Adverse Event|1|||
126048941|NCT01988402|453476643|FG001|Overall Study|Adverse Event|2|||
126048942|NCT01988402|453476642|FG000|Overall Study|Withdrawal by Subject|1|||
126048943|NCT01988402|453476643|FG001|Overall Study|Withdrawal by Subject|0|||
126048944|NCT00571649|453476644|FG000|Treatment Period|Adverse Event|438|||
126048945|NCT00571649|453476645|FG001|Treatment Period|Adverse Event|385|||
126048946|NCT00571649|453476644|FG000|Treatment Period|Clinical endpoint reached|50|||
126048947|NCT00571649|453476645|FG001|Treatment Period|Clinical endpoint reached|56|||
126048948|NCT00571649|453476644|FG000|Treatment Period|Withdrawal by Subject|285|||
126048949|NCT00571649|453476645|FG001|Treatment Period|Withdrawal by Subject|255|||
126048950|NCT00571649|453476644|FG000|Treatment Period|Death|76|||
126048951|NCT00571649|453476645|FG001|Treatment Period|Death|59|||
126048952|NCT00571649|453476644|FG000|Treatment Period|Physician Decision|8|||
126048953|NCT00571649|453476645|FG001|Treatment Period|Physician Decision|9|||
126048954|NCT00571649|453476644|FG000|Treatment Period|Lost to Follow-up|43|||
126048955|NCT00571649|453476645|FG001|Treatment Period|Lost to Follow-up|41|||
126048956|NCT00571649|453476644|FG000|Treatment Period|Non-compliant with study medication|88|||
126048957|NCT00571649|453476645|FG001|Treatment Period|Non-compliant with study medication|89|||
126048958|NCT00571649|453476644|FG000|Treatment Period|Patient convenience|11|||
126048959|NCT00571649|453476645|FG001|Treatment Period|Patient convenience|13|||
126048960|NCT00571649|453476644|FG000|Treatment Period|Protocol Violation|90|||
126048961|NCT00571649|453476645|FG001|Treatment Period|Protocol Violation|92|||
126048962|NCT00571649|453476644|FG000|Treatment Period|Technical problems|3|||
126048963|NCT00571649|453476645|FG001|Treatment Period|Technical problems|5|||
126048964|NCT00571649|453476644|FG000|Follow-up Period|Adverse Event|46|||
126048965|NCT00571649|453476645|FG001|Follow-up Period|Adverse Event|40|||
126048966|NCT00571649|453476644|FG000|Follow-up Period|Clinical endpoint reached|5|||
126388552|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
126388553|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
126388554|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
126388555|NCT01673854|454713852|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
126388556|NCT01673854|454713852|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
126388557|NCT01673854|454713852|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
126388558|NCT01673854|454713852|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
126388559|NCT00334737|454713853|FG000|Hospital Phase|Death|1|||
126388560|NCT00334737|454713854|FG001|Hospital Phase|Death|2|||
126388561|NCT00334737|454713855|FG002|Hospital Phase|Death|3|||
126388562|NCT00334737|454713853|FG000|Hospital Phase|Withdrawal by Subject|0|||
126388563|NCT00334737|454713854|FG001|Hospital Phase|Withdrawal by Subject|0|||
126388564|NCT00334737|454713855|FG002|Hospital Phase|Withdrawal by Subject|1|||
126388565|NCT00334737|454713853|FG000|Hospital Phase|Did not receive study drug|1|||
126388566|NCT00334737|454713854|FG001|Hospital Phase|Did not receive study drug|0|||
126388567|NCT00334737|454713855|FG002|Hospital Phase|Did not receive study drug|0|||
126388568|NCT00334737|454713853|FG000|Follow up Phase|Lost to Follow-up|5|||
126388569|NCT00334737|454713854|FG001|Follow up Phase|Lost to Follow-up|3|||
126388570|NCT00334737|454713855|FG002|Follow up Phase|Lost to Follow-up|6|||
126388571|NCT00583752|454713856|FG000|Overall Study|Lost to Follow-up|5|||
126388572|NCT00583752|454713857|FG001|Overall Study|Lost to Follow-up|5|||
126048967|NCT00571649|453476645|FG001|Follow-up Period|Clinical endpoint reached|2|||
126048968|NCT00571649|453476644|FG000|Follow-up Period|Withdrawal by Subject|119|||
126048969|NCT00571649|453476645|FG001|Follow-up Period|Withdrawal by Subject|115|||
126048970|NCT00571649|453476644|FG000|Follow-up Period|Death|132|||
126048971|NCT00571649|453476645|FG001|Follow-up Period|Death|133|||
126048972|NCT00571649|453476644|FG000|Follow-up Period|Physician Decision|7|||
126048973|NCT00571649|453476645|FG001|Follow-up Period|Physician Decision|13|||
126048974|NCT00571649|453476644|FG000|Follow-up Period|Lost to Follow-up|95|||
126048975|NCT00571649|453476645|FG001|Follow-up Period|Lost to Follow-up|92|||
126048976|NCT00571649|453476644|FG000|Follow-up Period|Patient convenience|136|||
126048977|NCT00571649|453476645|FG001|Follow-up Period|Patient convenience|121|||
126048978|NCT00571649|453476644|FG000|Follow-up Period|Protocol Violation|5|||
126048979|NCT00571649|453476645|FG001|Follow-up Period|Protocol Violation|12|||
126048980|NCT01566890|453476646|FG000|Overall Study|Adverse Event|1|||
126388573|NCT02316353|454713858|FG000|Overall Study|Pregnancy|1|||
126388574|NCT02316353|454713859|FG001|Overall Study|Pregnancy|3|||
126048981|NCT01566890|453476647|FG001|Overall Study|Adverse Event|0|||
126048982|NCT01566890|453476648|FG002|Overall Study|Adverse Event|0|||
126048983|NCT01566890|453476649|FG003|Overall Study|Adverse Event|0|||
126048984|NCT01566890|453476650|FG004|Overall Study|Adverse Event|0|||
126048985|NCT01566890|453476646|FG000|Overall Study|Withdrawal by Subject|3|||
126048986|NCT01566890|453476647|FG001|Overall Study|Withdrawal by Subject|1|||
126048987|NCT01566890|453476648|FG002|Overall Study|Withdrawal by Subject|1|||
126388575|NCT02316353|454713858|FG000|Overall Study|Adverse Event|1|||
126388576|NCT02316353|454713859|FG001|Overall Study|Adverse Event|3|||
126388577|NCT02316353|454713858|FG000|Overall Study|Withdrawal by Subject|6|||
126388578|NCT02316353|454713859|FG001|Overall Study|Withdrawal by Subject|2|||
126388579|NCT00782171|454715329|FG000|Overall Study|Lost to Follow-up|2|||
126388580|NCT00782171|454715330|FG001|Overall Study|Lost to Follow-up|2|||
126388581|NCT00782171|454715329|FG000|Overall Study|Withdrawal by Subject|2|||
126388582|NCT00782171|454715330|FG001|Overall Study|Withdrawal by Subject|1|||
126388583|NCT00782171|454715329|FG000|Overall Study|complications|3|||
126388584|NCT00782171|454715330|FG001|Overall Study|complications|1|||
126388585|NCT00782171|454715329|FG000|Overall Study|others|7|||
126388586|NCT00782171|454715330|FG001|Overall Study|others|9|||
126388587|NCT00782171|454715329|FG000|Overall Study|not eligible|8|||
126388588|NCT00782171|454715330|FG001|Overall Study|not eligible|6|||
126388589|NCT05935878|454715331|FG000|Overall Study|Death|1|||
126388590|NCT05935878|454715332|FG001|Overall Study|Death|2|||
126388591|NCT05935878|454715331|FG000|Overall Study|Withdrawal by Subject|5|||
126388592|NCT05935878|454715332|FG001|Overall Study|Withdrawal by Subject|5|||
126388593|NCT05935878|454715331|FG000|Overall Study|Revision of implant|1|||
126388594|NCT05935878|454715332|FG001|Overall Study|Revision of implant|1|||
126388595|NCT05935878|454715331|FG000|Overall Study|Mobile bearing dislocation|0|||
126388596|NCT05935878|454715332|FG001|Overall Study|Mobile bearing dislocation|1|||
126388597|NCT01443364|454715339|FG000|Overall Study|Lack of Efficacy|14|||
126388598|NCT01443364|454715339|FG000|Overall Study|Lost to Follow-up|3|||
126388599|NCT01443364|454715339|FG000|Overall Study|Withdrawal by Subject|5|||
126388600|NCT01443364|454715339|FG000|Overall Study|Other Reason|4|||
126388601|NCT01443364|454715339|FG000|Overall Study|SAE, non-fatal|6|||
126388602|NCT01443364|454715339|FG000|Overall Study|AE, non-serious non-fatal|8|||
126388603|NCT01443364|454715339|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126388604|NCT00559845|454715340|FG000|Overall Study|Withdrew Consent|1|||
126388605|NCT00559845|454715340|FG000|Overall Study|Disease Progression|1|||
126388606|NCT00559845|454715340|FG000|Overall Study|Adverse Event|3|||
126388607|NCT00559845|454715340|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
126388608|NCT00559845|454715340|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
126388609|NCT01406938|454715343|FG000|Induction Period|Subject/guardian decision|6|||
126388610|NCT01406938|454715344|FG001|Induction Period|Subject/guardian decision|8|||
126388611|NCT01406938|454715345|FG002|Induction Period|Subject/guardian decision|0|||
126388612|NCT01406938|454715346|FG003|Induction Period|Subject/guardian decision|0|||
126388613|NCT01406938|454715347|FG004|Induction Period|Subject/guardian decision|0|||
126388614|NCT01406938|454715348|FG005|Induction Period|Subject/guardian decision|0|||
126388615|NCT01406938|454715343|FG000|Induction Period|Protocol deviation|1|||
126388616|NCT01406938|454715344|FG001|Induction Period|Protocol deviation|0|||
126388617|NCT01406938|454715345|FG002|Induction Period|Protocol deviation|0|||
126388618|NCT01406938|454715346|FG003|Induction Period|Protocol deviation|0|||
126388619|NCT01406938|454715347|FG004|Induction Period|Protocol deviation|0|||
126388620|NCT01406938|454715348|FG005|Induction Period|Protocol deviation|0|||
126388621|NCT01406938|454715343|FG000|Induction Period|Adverse Event|8|||
126388622|NCT01406938|454715344|FG001|Induction Period|Adverse Event|9|||
126388623|NCT01406938|454715345|FG002|Induction Period|Adverse Event|0|||
126388624|NCT01406938|454715346|FG003|Induction Period|Adverse Event|0|||
126388625|NCT01406938|454715347|FG004|Induction Period|Adverse Event|0|||
126388626|NCT01406938|454715348|FG005|Induction Period|Adverse Event|0|||
126388627|NCT01406938|454715343|FG000|Induction Period|Lack of Efficacy|1|||
126388628|NCT01406938|454715344|FG001|Induction Period|Lack of Efficacy|0|||
126388629|NCT01406938|454715345|FG002|Induction Period|Lack of Efficacy|0|||
126388630|NCT01406938|454715346|FG003|Induction Period|Lack of Efficacy|0|||
126388631|NCT01406938|454715347|FG004|Induction Period|Lack of Efficacy|0|||
126388632|NCT01406938|454715348|FG005|Induction Period|Lack of Efficacy|0|||
126388633|NCT01406938|454715343|FG000|Induction Period|Lost to Follow-up|2|||
126388634|NCT01406938|454715344|FG001|Induction Period|Lost to Follow-up|3|||
126388635|NCT01406938|454715345|FG002|Induction Period|Lost to Follow-up|0|||
126388636|NCT01406938|454715346|FG003|Induction Period|Lost to Follow-up|0|||
126388637|NCT01406938|454715347|FG004|Induction Period|Lost to Follow-up|0|||
126388638|NCT01406938|454715348|FG005|Induction Period|Lost to Follow-up|0|||
126388639|NCT01406938|454715343|FG000|Maintenance Period|Adverse Event|0|||
126388640|NCT01406938|454715344|FG001|Maintenance Period|Adverse Event|0|||
126048988|NCT01566890|453476649|FG003|Overall Study|Withdrawal by Subject|1|||
126048989|NCT01566890|453476650|FG004|Overall Study|Withdrawal by Subject|0|||
126048990|NCT01566890|453476646|FG000|Overall Study|Screen failure|6|||
126388641|NCT01406938|454715345|FG002|Maintenance Period|Adverse Event|2|||
126388642|NCT01406938|454715346|FG003|Maintenance Period|Adverse Event|8|||
126388643|NCT01406938|454715347|FG004|Maintenance Period|Adverse Event|4|||
126388644|NCT01406938|454715348|FG005|Maintenance Period|Adverse Event|2|||
126388645|NCT01406938|454715343|FG000|Maintenance Period|Death|0|||
126388646|NCT01406938|454715344|FG001|Maintenance Period|Death|0|||
126388647|NCT01406938|454715345|FG002|Maintenance Period|Death|0|||
126388648|NCT01406938|454715346|FG003|Maintenance Period|Death|0|||
126388649|NCT01406938|454715347|FG004|Maintenance Period|Death|1|||
126388650|NCT01406938|454715348|FG005|Maintenance Period|Death|0|||
126388651|NCT01406938|454715343|FG000|Maintenance Period|Subject/guardian decision|0|||
126388652|NCT01406938|454715344|FG001|Maintenance Period|Subject/guardian decision|0|||
126388653|NCT01406938|454715345|FG002|Maintenance Period|Subject/guardian decision|11|||
126388654|NCT01406938|454715346|FG003|Maintenance Period|Subject/guardian decision|7|||
126388655|NCT01406938|454715347|FG004|Maintenance Period|Subject/guardian decision|10|||
126388656|NCT01406938|454715348|FG005|Maintenance Period|Subject/guardian decision|7|||
126388657|NCT01406938|454715343|FG000|Maintenance Period|Protocol Violation|0|||
126388658|NCT01406938|454715344|FG001|Maintenance Period|Protocol Violation|0|||
126388659|NCT01406938|454715345|FG002|Maintenance Period|Protocol Violation|2|||
126388660|NCT01406938|454715346|FG003|Maintenance Period|Protocol Violation|2|||
126388661|NCT01406938|454715347|FG004|Maintenance Period|Protocol Violation|2|||
126388662|NCT01406938|454715348|FG005|Maintenance Period|Protocol Violation|2|||
126388663|NCT01406938|454715343|FG000|Maintenance Period|Pregnancy|0|||
126388664|NCT01406938|454715344|FG001|Maintenance Period|Pregnancy|0|||
126388665|NCT01406938|454715345|FG002|Maintenance Period|Pregnancy|0|||
126388666|NCT01406938|454715346|FG003|Maintenance Period|Pregnancy|0|||
126388667|NCT01406938|454715347|FG004|Maintenance Period|Pregnancy|1|||
126388668|NCT01406938|454715348|FG005|Maintenance Period|Pregnancy|0|||
126388669|NCT01406938|454715343|FG000|Maintenance Period|Lost to Follow-up|0|||
126388670|NCT01406938|454715344|FG001|Maintenance Period|Lost to Follow-up|0|||
126388671|NCT01406938|454715345|FG002|Maintenance Period|Lost to Follow-up|0|||
126388672|NCT01406938|454715346|FG003|Maintenance Period|Lost to Follow-up|0|||
126388673|NCT01406938|454715347|FG004|Maintenance Period|Lost to Follow-up|4|||
126388674|NCT01406938|454715348|FG005|Maintenance Period|Lost to Follow-up|0|||
126388675|NCT01406938|454715343|FG000|Maintenance Period|Lack of Efficacy|0|||
126388676|NCT01406938|454715344|FG001|Maintenance Period|Lack of Efficacy|0|||
126388677|NCT01406938|454715345|FG002|Maintenance Period|Lack of Efficacy|2|||
126388678|NCT01406938|454715346|FG003|Maintenance Period|Lack of Efficacy|1|||
126388679|NCT01406938|454715347|FG004|Maintenance Period|Lack of Efficacy|3|||
126388680|NCT01406938|454715348|FG005|Maintenance Period|Lack of Efficacy|5|||
126388681|NCT01406938|454715343|FG000|Follow up|Lack of Efficacy|3|||
126388682|NCT01406938|454715344|FG001|Follow up|Lack of Efficacy|2|||
126388683|NCT01406938|454715345|FG002|Follow up|Lack of Efficacy|1|||
126388684|NCT01406938|454715346|FG003|Follow up|Lack of Efficacy|0|||
126388685|NCT01406938|454715347|FG004|Follow up|Lack of Efficacy|0|||
126388686|NCT01406938|454715348|FG005|Follow up|Lack of Efficacy|0|||
126388687|NCT01406938|454715343|FG000|Follow up|Patient/guardian decision|4|||
126388688|NCT01406938|454715344|FG001|Follow up|Patient/guardian decision|2|||
126388689|NCT01406938|454715345|FG002|Follow up|Patient/guardian decision|4|||
126388690|NCT01406938|454715346|FG003|Follow up|Patient/guardian decision|2|||
126388691|NCT01406938|454715347|FG004|Follow up|Patient/guardian decision|4|||
126388692|NCT01406938|454715348|FG005|Follow up|Patient/guardian decision|1|||
126388693|NCT01406938|454715343|FG000|Follow up|Protocol Violation|0|||
126388694|NCT01406938|454715344|FG001|Follow up|Protocol Violation|0|||
126388695|NCT01406938|454715345|FG002|Follow up|Protocol Violation|1|||
126388696|NCT01406938|454715346|FG003|Follow up|Protocol Violation|0|||
126388697|NCT01406938|454715347|FG004|Follow up|Protocol Violation|0|||
126388698|NCT01406938|454715348|FG005|Follow up|Protocol Violation|0|||
126388699|NCT01406938|454715343|FG000|Follow up|Physician Decision|0|||
126388700|NCT01406938|454715344|FG001|Follow up|Physician Decision|0|||
126388701|NCT01406938|454715345|FG002|Follow up|Physician Decision|2|||
126388702|NCT01406938|454715346|FG003|Follow up|Physician Decision|0|||
126388703|NCT01406938|454715347|FG004|Follow up|Physician Decision|3|||
126388704|NCT01406938|454715348|FG005|Follow up|Physician Decision|1|||
126388705|NCT01406938|454715343|FG000|Follow up|Lost to Follow-up|1|||
126388706|NCT01406938|454715344|FG001|Follow up|Lost to Follow-up|1|||
126388707|NCT01406938|454715345|FG002|Follow up|Lost to Follow-up|0|||
126388708|NCT01406938|454715346|FG003|Follow up|Lost to Follow-up|1|||
126388709|NCT01406938|454715347|FG004|Follow up|Lost to Follow-up|2|||
126388710|NCT01406938|454715348|FG005|Follow up|Lost to Follow-up|1|||
126388711|NCT00878254|454715350|FG000|Overall Study|Physician Decision|1|||
126048991|NCT01566890|453476647|FG001|Overall Study|Screen failure|0|||
126048992|NCT01566890|453476648|FG002|Overall Study|Screen failure|1|||
126048993|NCT01566890|453476649|FG003|Overall Study|Screen failure|1|||
126048994|NCT01566890|453476650|FG004|Overall Study|Screen failure|0|||
126388712|NCT00878254|454715350|FG000|Overall Study|Death|1|||
126048995|NCT01566890|453476646|FG000|Overall Study|Incomplete CEU data|1|||
126388713|NCT00878254|454715350|FG000|Overall Study|Withdrawal by Subject|1|||
126388714|NCT03367403|454715353|FG000|Overall Study|Adverse Event|20|||
126388715|NCT03367403|454715354|FG001|Overall Study|Adverse Event|6|||
126388716|NCT03367403|454715355|FG002|Overall Study|Adverse Event|2|||
126388717|NCT03367403|454715353|FG000|Overall Study|Withdrawal by Subject|12|||
126388718|NCT03367403|454715354|FG001|Overall Study|Withdrawal by Subject|13|||
126388719|NCT03367403|454715355|FG002|Overall Study|Withdrawal by Subject|1|||
126388720|NCT03367403|454715353|FG000|Overall Study|Death|1|||
126048996|NCT01566890|453476647|FG001|Overall Study|Incomplete CEU data|3|||
126388721|NCT03367403|454715354|FG001|Overall Study|Death|2|||
126388722|NCT03367403|454715355|FG002|Overall Study|Death|0|||
126388723|NCT03367403|454715353|FG000|Overall Study|Physician Decision|0|||
126048997|NCT01566890|453476648|FG002|Overall Study|Incomplete CEU data|5|||
126048998|NCT01566890|453476649|FG003|Overall Study|Incomplete CEU data|8|||
126388724|NCT03367403|454715354|FG001|Overall Study|Physician Decision|1|||
126388725|NCT03367403|454715355|FG002|Overall Study|Physician Decision|0|||
126388726|NCT03367403|454715353|FG000|Overall Study|Protocol Violation|1|||
126388727|NCT03367403|454715354|FG001|Overall Study|Protocol Violation|1|||
126388728|NCT03367403|454715355|FG002|Overall Study|Protocol Violation|0|||
126388729|NCT03367403|454715353|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
126388730|NCT03367403|454715354|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
126388731|NCT03367403|454715355|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
126388732|NCT03367403|454715353|FG000|Overall Study|COVID-19|3|||
126388733|NCT03367403|454715354|FG001|Overall Study|COVID-19|6|||
126388734|NCT03367403|454715355|FG002|Overall Study|COVID-19|0|||
126388735|NCT03367403|454715353|FG000|Overall Study|Abuse of Alcohol Intake|0|||
126388736|NCT03367403|454715354|FG001|Overall Study|Abuse of Alcohol Intake|1|||
126388737|NCT03367403|454715355|FG002|Overall Study|Abuse of Alcohol Intake|0|||
126388738|NCT03367403|454715353|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
126388739|NCT03367403|454715354|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
126388740|NCT03367403|454715355|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
126388741|NCT00194077|454715356|FG000|Overall Study|Lack of Efficacy|22|||
126388742|NCT00194077|454715357|FG001|Overall Study|Lack of Efficacy|29|||
126388743|NCT00194077|454715356|FG000|Overall Study|Study nonadherence|1|||
126388744|NCT00194077|454715357|FG001|Overall Study|Study nonadherence|0|||
126388745|NCT00194077|454715356|FG000|Overall Study|Withdrawal by Subject|1|||
126388746|NCT00194077|454715357|FG001|Overall Study|Withdrawal by Subject|1|||
126388747|NCT03470194|454715360|FG000|Overall Study|Lost to Follow-up|11|||
126388748|NCT03470194|454715361|FG001|Overall Study|Lost to Follow-up|17|||
126388749|NCT03286543|454715362|FG000|Consented|Screen failure before randomization|2|||
126388750|NCT03286543|454715363|FG001|Consented|Screen failure before randomization|0|||
126388751|NCT03286543|454715364|FG002|Consented|Screen failure before randomization|0|||
126388752|NCT03286543|454715362|FG000|Consented|Screen failure before enrollment|4|||
126388753|NCT03286543|454715363|FG001|Consented|Screen failure before enrollment|0|||
126388754|NCT03286543|454715364|FG002|Consented|Screen failure before enrollment|0|||
126388755|NCT03286543|454715362|FG000|Consented|TKA cancelled after enrollment|1|||
126388756|NCT03286543|454715363|FG001|Consented|TKA cancelled after enrollment|0|||
126388757|NCT03286543|454715364|FG002|Consented|TKA cancelled after enrollment|0|||
126388758|NCT03286543|454715362|FG000|Consented|Withdrawn from study|12|||
126388759|NCT03286543|454715363|FG001|Consented|Withdrawn from study|0|||
126388760|NCT03286543|454715364|FG002|Consented|Withdrawn from study|0|||
126388761|NCT03286543|454715362|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
126388762|NCT03286543|454715363|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
126388763|NCT03286543|454715364|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
126388764|NCT03286543|454715362|FG000|Study Enrollment|Withdrawn from study|0|||
126388765|NCT03286543|454715363|FG001|Study Enrollment|Withdrawn from study|6|||
126388766|NCT03286543|454715364|FG002|Study Enrollment|Withdrawn from study|6|||
126388767|NCT00758069|454715365|FG000|Overall Study|Lack of Efficacy|0|||
126388768|NCT00758069|454715366|FG001|Overall Study|Lack of Efficacy|0|||
126388769|NCT00758069|454715367|FG002|Overall Study|Lack of Efficacy|1|||
126388770|NCT00758069|454715365|FG000|Overall Study|Incorrect Study Drug|1|||
126388771|NCT00758069|454715366|FG001|Overall Study|Incorrect Study Drug|0|||
126388772|NCT00758069|454715367|FG002|Overall Study|Incorrect Study Drug|0|||
126388773|NCT00588237|454715368|FG000|Overall Study|Evaluable for toxicity only|3|||
126388774|NCT00588237|454715368|FG000|Overall Study|Patien not treated|1|||
126388775|NCT04908865|454715372|FG000|Overall Study|Adverse Event|2|||
126388776|NCT04908865|454715372|FG000|Overall Study|Lack of Efficacy|5|||
126388777|NCT04908865|454715372|FG000|Overall Study|Lost to Follow-up|1|||
126388778|NCT00606034|454715377|FG000|Overall Study|incarceration|1|||
126388779|NCT02027311|454715378|FG000|Overall Study|Protocol Violation|3|||
126388780|NCT02027311|454715379|FG001|Overall Study|Protocol Violation|2|||
126388781|NCT02466425|454715382|FG000|Overall Study|Adverse Event|3|||
126388782|NCT02466425|454715383|FG001|Overall Study|Adverse Event|11|||
126388783|NCT02466425|454715382|FG000|Overall Study|Lack of Efficacy|4|||
126388784|NCT02466425|454715383|FG001|Overall Study|Lack of Efficacy|1|||
126388785|NCT02466425|454715382|FG000|Overall Study|Lost to Follow-up|3|||
126388786|NCT02466425|454715383|FG001|Overall Study|Lost to Follow-up|0|||
126388787|NCT02466425|454715382|FG000|Overall Study|Protocol Violation|1|||
126388788|NCT02466425|454715383|FG001|Overall Study|Protocol Violation|0|||
126388789|NCT02466425|454715382|FG000|Overall Study|Withdrawal by Subject|0|||
126388790|NCT02466425|454715383|FG001|Overall Study|Withdrawal by Subject|1|||
126388791|NCT02466425|454715382|FG000|Overall Study|Other|1|||
126388792|NCT02466425|454715383|FG001|Overall Study|Other|3|||
126388793|NCT02466425|454715382|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126388794|NCT02466425|454715383|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126388795|NCT01721486|454715388|FG000|Overall Study|Protocol Violation|1|||
126388796|NCT01721486|454715389|FG001|Overall Study|Protocol Violation|0|||
126388797|NCT01721486|454715388|FG000|Overall Study|Physician Decision|0|||
126388798|NCT01721486|454715389|FG001|Overall Study|Physician Decision|1|||
126388799|NCT00582712|454715390|FG000|Overall Study|Adverse Event|1|||
126388800|NCT00582712|454715390|FG000|Overall Study|Lack of Efficacy|1|||
126388801|NCT00582712|454715390|FG000|Overall Study|Withdrawal by Subject|1|||
126388802|NCT00582712|454715390|FG000|Overall Study|Complicating disease requiring treatment|1|||
126388803|NCT05141175|454715391|FG000|Overall Study|Withdrawal by Subject|1|||
126388804|NCT01901289|454715393|FG000|Overall Study|Death|32|||
126388805|NCT01901289|454715393|FG000|Overall Study|Lost to Follow-up|16|||
126388806|NCT01901289|454715393|FG000|Overall Study|Withdrawal by Subject|35|||
126388807|NCT01901289|454715393|FG000|Overall Study|Other type of endpoint met|2|||
126388808|NCT01813058|454715394|FG000|Overall Study|Withdrawal by Subject|5|||
126388809|NCT01813058|454715395|FG001|Overall Study|Withdrawal by Subject|4|||
126388810|NCT00182078|454715397|FG000|Overall Study|Withdrawal by Subject|1|||
126388811|NCT00182078|454715398|FG001|Overall Study|Withdrawal by Subject|0|||
126388812|NCT00395486|454715399|FG000|Overall Study|Adverse Event|1|||
126388813|NCT00395486|454715400|FG001|Overall Study|Adverse Event|2|||
126388814|NCT00395486|454715399|FG000|Overall Study|Withdrawal by Subject|5|||
126388815|NCT00395486|454715400|FG001|Overall Study|Withdrawal by Subject|2|||
126388816|NCT00395486|454715399|FG000|Overall Study|Lost to Follow-up|0|||
126388817|NCT00395486|454715400|FG001|Overall Study|Lost to Follow-up|1|||
126388818|NCT01076205|454715401|FG000|Overall Study|Adverse Drug Reaction|299|||
126388819|NCT01076205|454715401|FG000|Overall Study|Lack of Effectiveness|1423|||
126388820|NCT01076205|454715401|FG000|Overall Study|Other Reason|1075|||
126388821|NCT01076205|454715401|FG000|Overall Study|Unknown Reason|71|||
126388822|NCT01076205|454715401|FG000|Overall Study|Lost to Follow-up|3151|||
126388823|NCT04731298|454715408|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
126388824|NCT04731298|454715409|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
126388825|NCT02443116|454715414|FG000|Part 1|Adverse Event|2|||
126388826|NCT02443116|454715415|FG001|Part 1|Adverse Event|3|||
126388827|NCT02443116|454715416|FG002|Part 1|Adverse Event|0|||
126388828|NCT02443116|454715417|FG003|Part 1|Adverse Event|0|||
126388829|NCT02443116|454715418|FG004|Part 1|Adverse Event|0|||
126388830|NCT02443116|454715419|FG005|Part 1|Adverse Event|0|||
126388831|NCT02443116|454715420|FG006|Part 1|Adverse Event|0|||
126388832|NCT02443116|454715421|FG007|Part 1|Adverse Event|0|||
126388833|NCT02443116|454715422|FG008|Part 1|Adverse Event|0|||
126388834|NCT02443116|454715414|FG000|Part 1|Withdrew informed consent|0|||
126388835|NCT02443116|454715415|FG001|Part 1|Withdrew informed consent|1|||
126388836|NCT02443116|454715416|FG002|Part 1|Withdrew informed consent|0|||
126388837|NCT02443116|454715417|FG003|Part 1|Withdrew informed consent|0|||
126388838|NCT02443116|454715418|FG004|Part 1|Withdrew informed consent|0|||
126388839|NCT02443116|454715419|FG005|Part 1|Withdrew informed consent|0|||
126388840|NCT02443116|454715420|FG006|Part 1|Withdrew informed consent|0|||
126388841|NCT02443116|454715421|FG007|Part 1|Withdrew informed consent|0|||
126388842|NCT02443116|454715422|FG008|Part 1|Withdrew informed consent|0|||
126388843|NCT02443116|454715414|FG000|Part 1|Lost to Follow-up|0|||
126388844|NCT02443116|454715415|FG001|Part 1|Lost to Follow-up|0|||
126388845|NCT02443116|454715416|FG002|Part 1|Lost to Follow-up|2|||
126388846|NCT02443116|454715417|FG003|Part 1|Lost to Follow-up|0|||
126388847|NCT02443116|454715418|FG004|Part 1|Lost to Follow-up|0|||
126388848|NCT02443116|454715419|FG005|Part 1|Lost to Follow-up|0|||
126388849|NCT02443116|454715420|FG006|Part 1|Lost to Follow-up|0|||
126388850|NCT02443116|454715421|FG007|Part 1|Lost to Follow-up|0|||
126388851|NCT02443116|454715422|FG008|Part 1|Lost to Follow-up|0|||
126388852|NCT02443116|454715414|FG000|Part 1|Participant moved out of state|0|||
126388853|NCT02443116|454715415|FG001|Part 1|Participant moved out of state|0|||
126388854|NCT02443116|454715416|FG002|Part 1|Participant moved out of state|1|||
126388855|NCT02443116|454715417|FG003|Part 1|Participant moved out of state|0|||
126388856|NCT02443116|454715418|FG004|Part 1|Participant moved out of state|0|||
126388857|NCT02443116|454715419|FG005|Part 1|Participant moved out of state|0|||
126388858|NCT02443116|454715420|FG006|Part 1|Participant moved out of state|0|||
126388859|NCT02443116|454715421|FG007|Part 1|Participant moved out of state|0|||
126388860|NCT02443116|454715422|FG008|Part 1|Participant moved out of state|0|||
126388861|NCT02443116|454715414|FG000|Part 1|Participant enrolled in another clinical trial|0|||
126388862|NCT02443116|454715415|FG001|Part 1|Participant enrolled in another clinical trial|0|||
126388863|NCT02443116|454715416|FG002|Part 1|Participant enrolled in another clinical trial|1|||
126388864|NCT02443116|454715417|FG003|Part 1|Participant enrolled in another clinical trial|0|||
126388865|NCT02443116|454715418|FG004|Part 1|Participant enrolled in another clinical trial|0|||
126388866|NCT02443116|454715419|FG005|Part 1|Participant enrolled in another clinical trial|0|||
126388867|NCT02443116|454715420|FG006|Part 1|Participant enrolled in another clinical trial|0|||
126388868|NCT02443116|454715421|FG007|Part 1|Participant enrolled in another clinical trial|0|||
126388869|NCT02443116|454715422|FG008|Part 1|Participant enrolled in another clinical trial|0|||
126388870|NCT02443116|454715414|FG000|Part 2|Adverse Event|0|||
126388871|NCT02443116|454715415|FG001|Part 2|Adverse Event|0|||
126388872|NCT02443116|454715416|FG002|Part 2|Adverse Event|0|||
126388873|NCT02443116|454715417|FG003|Part 2|Adverse Event|0|||
126388874|NCT02443116|454715418|FG004|Part 2|Adverse Event|1|||
126388875|NCT02443116|454715419|FG005|Part 2|Adverse Event|1|||
126388876|NCT02443116|454715420|FG006|Part 2|Adverse Event|2|||
126388877|NCT02443116|454715421|FG007|Part 2|Adverse Event|0|||
126388878|NCT02443116|454715422|FG008|Part 2|Adverse Event|0|||
126388879|NCT02443116|454715414|FG000|Part 2|Withdrew informed consent|0|||
126388880|NCT02443116|454715415|FG001|Part 2|Withdrew informed consent|0|||
126388881|NCT02443116|454715416|FG002|Part 2|Withdrew informed consent|0|||
126388882|NCT02443116|454715417|FG003|Part 2|Withdrew informed consent|0|||
126388883|NCT02443116|454715418|FG004|Part 2|Withdrew informed consent|0|||
126388884|NCT02443116|454715419|FG005|Part 2|Withdrew informed consent|1|||
126388885|NCT02443116|454715420|FG006|Part 2|Withdrew informed consent|1|||
126388886|NCT02443116|454715421|FG007|Part 2|Withdrew informed consent|0|||
126388887|NCT02443116|454715422|FG008|Part 2|Withdrew informed consent|0|||
126388888|NCT02443116|454715414|FG000|Part 2|Inability to comply with protocol|0|||
126388889|NCT02443116|454715415|FG001|Part 2|Inability to comply with protocol|0|||
126388890|NCT02443116|454715416|FG002|Part 2|Inability to comply with protocol|0|||
126388891|NCT02443116|454715417|FG003|Part 2|Inability to comply with protocol|1|||
126388892|NCT02443116|454715418|FG004|Part 2|Inability to comply with protocol|0|||
126388893|NCT02443116|454715419|FG005|Part 2|Inability to comply with protocol|0|||
126388894|NCT02443116|454715420|FG006|Part 2|Inability to comply with protocol|0|||
126388895|NCT02443116|454715421|FG007|Part 2|Inability to comply with protocol|0|||
126388896|NCT02443116|454715422|FG008|Part 2|Inability to comply with protocol|0|||
126388897|NCT02443116|454715414|FG000|Part 2|Lost to Follow-up|0|||
126388898|NCT02443116|454715415|FG001|Part 2|Lost to Follow-up|0|||
126388899|NCT02443116|454715416|FG002|Part 2|Lost to Follow-up|0|||
126388900|NCT02443116|454715417|FG003|Part 2|Lost to Follow-up|1|||
126388901|NCT02443116|454715418|FG004|Part 2|Lost to Follow-up|0|||
126388902|NCT02443116|454715419|FG005|Part 2|Lost to Follow-up|0|||
126388903|NCT02443116|454715420|FG006|Part 2|Lost to Follow-up|0|||
126388904|NCT02443116|454715421|FG007|Part 2|Lost to Follow-up|0|||
126388905|NCT02443116|454715422|FG008|Part 2|Lost to Follow-up|0|||
126388906|NCT02443116|454715414|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388907|NCT02443116|454715415|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388908|NCT02443116|454715416|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388909|NCT02443116|454715417|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388910|NCT02443116|454715418|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388911|NCT02443116|454715419|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
126388912|NCT02443116|454715420|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388913|NCT02443116|454715421|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388914|NCT02443116|454715422|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388915|NCT02443116|454715414|FG000|Part 3|Adverse Event|0|||
126388916|NCT02443116|454715415|FG001|Part 3|Adverse Event|0|||
126388917|NCT02443116|454715416|FG002|Part 3|Adverse Event|0|||
126388918|NCT02443116|454715417|FG003|Part 3|Adverse Event|0|||
126388919|NCT02443116|454715418|FG004|Part 3|Adverse Event|0|||
126388920|NCT02443116|454715419|FG005|Part 3|Adverse Event|0|||
126388921|NCT02443116|454715420|FG006|Part 3|Adverse Event|0|||
126388922|NCT02443116|454715421|FG007|Part 3|Adverse Event|0|||
126388923|NCT02443116|454715422|FG008|Part 3|Adverse Event|1|||
126388924|NCT02443116|454715414|FG000|Part 3|Withdrew informed consent|0|||
126388925|NCT02443116|454715415|FG001|Part 3|Withdrew informed consent|0|||
126388926|NCT02443116|454715416|FG002|Part 3|Withdrew informed consent|0|||
126388927|NCT02443116|454715417|FG003|Part 3|Withdrew informed consent|0|||
126388928|NCT02443116|454715418|FG004|Part 3|Withdrew informed consent|0|||
126388929|NCT02443116|454715419|FG005|Part 3|Withdrew informed consent|0|||
126388930|NCT02443116|454715420|FG006|Part 3|Withdrew informed consent|0|||
126388931|NCT02443116|454715421|FG007|Part 3|Withdrew informed consent|3|||
126388932|NCT02443116|454715422|FG008|Part 3|Withdrew informed consent|2|||
126388933|NCT02443116|454715414|FG000|Part 3|Lost to Follow-up|0|||
126388934|NCT02443116|454715415|FG001|Part 3|Lost to Follow-up|0|||
126388935|NCT02443116|454715416|FG002|Part 3|Lost to Follow-up|0|||
126388936|NCT02443116|454715417|FG003|Part 3|Lost to Follow-up|0|||
126388937|NCT02443116|454715418|FG004|Part 3|Lost to Follow-up|0|||
126388938|NCT02443116|454715419|FG005|Part 3|Lost to Follow-up|0|||
126048999|NCT01566890|453476650|FG004|Overall Study|Incomplete CEU data|0|||
126388939|NCT02443116|454715420|FG006|Part 3|Lost to Follow-up|0|||
126049000|NCT01566890|453476646|FG000|Overall Study|Lost to Follow-up|0|||
126388940|NCT02443116|454715421|FG007|Part 3|Lost to Follow-up|1|||
126388941|NCT02443116|454715422|FG008|Part 3|Lost to Follow-up|2|||
126388942|NCT01932372|454715423|FG000|Overall Study|Not meeting eligibility criteria|33|||
126388943|NCT01932372|454715424|FG001|Overall Study|Not meeting eligibility criteria|179|||
126388944|NCT01917929|454715425|FG000|Overall Study|Death|8|||
126388945|NCT01917929|454715425|FG000|Overall Study|Lost to Follow-up|19|||
126388946|NCT01917929|454715425|FG000|Overall Study|Withdrawal by Subject|33|||
126388947|NCT01917929|454715425|FG000|Overall Study|Adverse Event|6|||
126388948|NCT01917929|454715425|FG000|Overall Study|Investigative Site Terminated|35|||
126388949|NCT01917929|454715425|FG000|Overall Study|Censored because study device not implanted|6|||
126388950|NCT01917929|454715425|FG000|Overall Study|Censored because surgery not performed|3|||
126049001|NCT01566890|453476647|FG001|Overall Study|Lost to Follow-up|0|||
126049002|NCT01566890|453476648|FG002|Overall Study|Lost to Follow-up|4|||
126049003|NCT01566890|453476649|FG003|Overall Study|Lost to Follow-up|4|||
126049004|NCT01566890|453476650|FG004|Overall Study|Lost to Follow-up|0|||
126388951|NCT01917929|454715425|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
126388952|NCT01917929|454715425|FG000|Overall Study|Sponsor terminated study|175|||
126388953|NCT02059499|454715434|FG000|Upto Week 20|Lost to Follow-up|2|||
126388954|NCT02059499|454715435|FG001|Upto Week 20|Lost to Follow-up|6|||
126388955|NCT02059499|454715436|FG002|Upto Week 20|Lost to Follow-up|0|||
126388956|NCT02059499|454715434|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
126388957|NCT02059499|454715435|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
126388958|NCT02059499|454715436|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
126388959|NCT02059499|454715434|FG000|Upto Week 20|Withdrawal by Subject|1|||
126388960|NCT02059499|454715435|FG001|Upto Week 20|Withdrawal by Subject|1|||
126388961|NCT02059499|454715436|FG002|Upto Week 20|Withdrawal by Subject|0|||
126388962|NCT02059499|454715434|FG000|Upto Week 20|No treatment per protocol criteria|0|||
126388963|NCT02059499|454715435|FG001|Upto Week 20|No treatment per protocol criteria|0|||
126388964|NCT02059499|454715436|FG002|Upto Week 20|No treatment per protocol criteria|5|||
126388965|NCT02059499|454715434|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
126388966|NCT02059499|454715435|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
126388967|NCT02059499|454715436|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
126388968|NCT02059499|454715434|FG000|Post-week 20|Lost to Follow-up|0|||
126388969|NCT02059499|454715435|FG001|Post-week 20|Lost to Follow-up|2|||
126388970|NCT02059499|454715436|FG002|Post-week 20|Lost to Follow-up|0|||
126388971|NCT02059499|454715434|FG000|Post-week 20|Withdrawal by Subject|0|||
126388972|NCT02059499|454715435|FG001|Post-week 20|Withdrawal by Subject|1|||
126388973|NCT02059499|454715436|FG002|Post-week 20|Withdrawal by Subject|0|||
126388974|NCT02059499|454715434|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
126388975|NCT02059499|454715435|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
126388976|NCT02059499|454715436|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
126388977|NCT00703846|454715437|FG000|Overall Study|Adverse Event|8|||
126388978|NCT00703846|454715437|FG000|Overall Study|Lost to Follow-up|55|||
126388979|NCT00703846|454715437|FG000|Overall Study|Lack of Efficacy|15|||
126388980|NCT00703846|454715437|FG000|Overall Study|Noncompliance with Study Treatment|2|||
126388981|NCT00703846|454715437|FG000|Overall Study|Withdrawal by Subject|40|||
126388982|NCT00703846|454715437|FG000|Overall Study|Death|1|||
126388983|NCT00703846|454715437|FG000|Overall Study|Other|14|||
126388984|NCT00703846|454715437|FG000|Overall Study|Did Not Receive Study Drug|2|||
126388985|NCT01700959|454715442|FG000|Overall Study|Adverse Event|0|||
126388986|NCT01700959|454715443|FG001|Overall Study|Adverse Event|1|||
126388987|NCT01700959|454715444|FG002|Overall Study|Adverse Event|1|||
126388988|NCT01700959|454715445|FG003|Overall Study|Adverse Event|2|||
126388989|NCT01700959|454715446|FG004|Overall Study|Adverse Event|0|||
126388990|NCT01700959|454715447|FG005|Overall Study|Adverse Event|2|||
126388991|NCT01700959|454715442|FG000|Overall Study|Withdrawal by Subject|15|||
126388992|NCT01700959|454715443|FG001|Overall Study|Withdrawal by Subject|9|||
126388993|NCT01700959|454715444|FG002|Overall Study|Withdrawal by Subject|12|||
126388994|NCT01700959|454715445|FG003|Overall Study|Withdrawal by Subject|11|||
126388995|NCT01700959|454715446|FG004|Overall Study|Withdrawal by Subject|8|||
126388996|NCT01700959|454715447|FG005|Overall Study|Withdrawal by Subject|12|||
126388997|NCT01700959|454715442|FG000|Overall Study|Ineligible|2|||
126388998|NCT01700959|454715443|FG001|Overall Study|Ineligible|1|||
126388999|NCT01700959|454715444|FG002|Overall Study|Ineligible|2|||
126389000|NCT01700959|454715445|FG003|Overall Study|Ineligible|0|||
126389001|NCT01700959|454715446|FG004|Overall Study|Ineligible|0|||
126389002|NCT01700959|454715447|FG005|Overall Study|Ineligible|1|||
126389003|NCT01700959|454715442|FG000|Overall Study|Noncompliant|9|||
126389004|NCT01700959|454715443|FG001|Overall Study|Noncompliant|9|||
126389005|NCT01700959|454715444|FG002|Overall Study|Noncompliant|17|||
126389006|NCT01700959|454715445|FG003|Overall Study|Noncompliant|18|||
126389007|NCT01700959|454715446|FG004|Overall Study|Noncompliant|15|||
126389008|NCT01700959|454715447|FG005|Overall Study|Noncompliant|9|||
126389009|NCT01700959|454715442|FG000|Overall Study|Side effects|1|||
126389010|NCT01700959|454715443|FG001|Overall Study|Side effects|4|||
126389011|NCT01700959|454715444|FG002|Overall Study|Side effects|8|||
126389012|NCT01700959|454715445|FG003|Overall Study|Side effects|4|||
126389013|NCT01700959|454715446|FG004|Overall Study|Side effects|4|||
126389014|NCT01700959|454715447|FG005|Overall Study|Side effects|1|||
126389015|NCT00830375|454715448|FG000|Overall Study|Lost to Follow-up|1|||
126389016|NCT02582814|454717356|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126389017|NCT02582814|454717357|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126389018|NCT02582814|454717356|FG000|Overall Study|Withdrawal by Subject|4|||
126389019|NCT02582814|454717357|FG001|Overall Study|Withdrawal by Subject|3|||
126389020|NCT02582814|454717356|FG000|Overall Study|Adverse Event|4|||
126389021|NCT02582814|454717357|FG001|Overall Study|Adverse Event|4|||
126389022|NCT03530995|454717358|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
126389023|NCT03530995|454717359|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
126049005|NCT01566890|453476646|FG000|Overall Study|Other|0|||
126389024|NCT03530995|454717358|FG000|Part 1 Period 3|Protocol Violation|1|||
126389025|NCT03530995|454717359|FG001|Part 1 Period 3|Protocol Violation|0|||
126389026|NCT03530995|454717358|FG000|Part 1 Period 4|Physician Decision|1|||
126389027|NCT03530995|454717359|FG001|Part 1 Period 4|Physician Decision|0|||
126389028|NCT03530995|454717358|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
126389029|NCT03530995|454717359|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
126389030|NCT01986231|454717363|FG000|Overall Study|Adverse Event|1|||
126389031|NCT00623233|454717364|FG000|Overall Study|Adverse Event|10|||
126389032|NCT00623233|454717364|FG000|Overall Study|Physician Decision|10|||
126389033|NCT00623233|454717364|FG000|Overall Study|Lost to Follow-up|1|||
126389034|NCT00623233|454717364|FG000|Overall Study|Withdrawal by Subject|3|||
126389035|NCT01751906|454717365|FG000|Overall Study|Lost to Follow-up|151|||
126389036|NCT01751906|454717366|FG001|Overall Study|Lost to Follow-up|68|||
126389037|NCT01751906|454717365|FG000|Overall Study|Withdrawal by Subject|22|||
126389038|NCT01751906|454717366|FG001|Overall Study|Withdrawal by Subject|18|||
126389039|NCT01751906|454717365|FG000|Overall Study|Physician Decision|5|||
126389040|NCT01751906|454717366|FG001|Overall Study|Physician Decision|2|||
126389041|NCT01751906|454717365|FG000|Overall Study|Death|84|||
126389042|NCT01751906|454717366|FG001|Overall Study|Death|43|||
126389043|NCT01751906|454717365|FG000|Overall Study|Denied on premises for follow-up by law|1|||
126389044|NCT01751906|454717366|FG001|Overall Study|Denied on premises for follow-up by law|0|||
126389045|NCT01110330|454717367|FG000|Overall Study|Adverse Event|0|||
126389046|NCT01110330|454717368|FG001|Overall Study|Adverse Event|4|||
126389047|NCT01110330|454717369|FG002|Overall Study|Adverse Event|3|||
126389048|NCT01110330|454717367|FG000|Overall Study|Lack of Efficacy|3|||
126389049|NCT01110330|454717368|FG001|Overall Study|Lack of Efficacy|1|||
126389050|NCT01110330|454717369|FG002|Overall Study|Lack of Efficacy|1|||
126389051|NCT01110330|454717367|FG000|Overall Study|Lost to Follow-up|9|||
126389052|NCT01110330|454717368|FG001|Overall Study|Lost to Follow-up|10|||
126389053|NCT01110330|454717369|FG002|Overall Study|Lost to Follow-up|15|||
126389054|NCT01110330|454717367|FG000|Overall Study|Physician Decision|0|||
126389055|NCT01110330|454717368|FG001|Overall Study|Physician Decision|1|||
126389056|NCT01110330|454717369|FG002|Overall Study|Physician Decision|0|||
126389057|NCT01110330|454717367|FG000|Overall Study|Protocol Violation|2|||
126389058|NCT01110330|454717368|FG001|Overall Study|Protocol Violation|0|||
126389059|NCT01110330|454717369|FG002|Overall Study|Protocol Violation|4|||
126389060|NCT01110330|454717367|FG000|Overall Study|Withdrawal by Subject|0|||
126389061|NCT01110330|454717368|FG001|Overall Study|Withdrawal by Subject|6|||
126389062|NCT01110330|454717369|FG002|Overall Study|Withdrawal by Subject|2|||
126389063|NCT01110330|454717367|FG000|Overall Study|Other|1|||
126389064|NCT01110330|454717368|FG001|Overall Study|Other|1|||
126389065|NCT01110330|454717369|FG002|Overall Study|Other|1|||
126389066|NCT02557100|454717370|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
126389067|NCT02557100|454717371|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
126389068|NCT02557100|454717372|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
126389069|NCT02557100|454717370|FG000|Single Blind Treatment Period|Death|0|||
126389070|NCT02557100|454717371|FG001|Single Blind Treatment Period|Death|1|||
126389071|NCT02557100|454717372|FG002|Single Blind Treatment Period|Death|0|||
126389072|NCT02557100|454717370|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
126389073|NCT02557100|454717371|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
126389074|NCT02557100|454717372|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
126389075|NCT02557100|454717370|FG000|Single Blind Treatment Period|Adverse Event|0|||
126389076|NCT02557100|454717371|FG001|Single Blind Treatment Period|Adverse Event|1|||
126389077|NCT02557100|454717372|FG002|Single Blind Treatment Period|Adverse Event|0|||
126389078|NCT02557100|454717370|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
126389079|NCT02557100|454717371|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
126389080|NCT02557100|454717372|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
126389081|NCT02557100|454717370|FG000|Cumulative Abatacept Period|Other Reasons|0|||
126389082|NCT02557100|454717371|FG001|Cumulative Abatacept Period|Other Reasons|0|||
126389083|NCT02557100|454717372|FG002|Cumulative Abatacept Period|Other Reasons|1|||
126389084|NCT02557100|454717370|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
126389085|NCT02557100|454717371|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
126389086|NCT02557100|454717372|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
126389087|NCT02557100|454717370|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
126389088|NCT02557100|454717371|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
126389089|NCT02557100|454717372|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
126389090|NCT02150057|454717380|FG000|Overall Study|Lost to Follow-up|6|||
126389091|NCT02150057|454717381|FG001|Overall Study|Lost to Follow-up|4|||
126389092|NCT00489424|454717382|FG000|Overall Study|Adverse Event|3|||
126389093|NCT00489424|454717383|FG001|Overall Study|Adverse Event|3|||
126389094|NCT00489424|454717384|FG002|Overall Study|Adverse Event|4|||
126389095|NCT00489424|454717382|FG000|Overall Study|Lack of Efficacy|1|||
126389096|NCT00489424|454717383|FG001|Overall Study|Lack of Efficacy|0|||
126389097|NCT00489424|454717384|FG002|Overall Study|Lack of Efficacy|0|||
126389098|NCT00489424|454717382|FG000|Overall Study|Administrative problems|0|||
126389099|NCT00489424|454717383|FG001|Overall Study|Administrative problems|2|||
125887359|NCT02963506|452883156|FG011|Dose-Blind Period|Sponsor decision|0|||
125887360|NCT02963506|452883157|FG012|Dose-Blind Period|Sponsor decision|0|||
125887361|NCT02963506|452883145|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887362|NCT02963506|452883146|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887363|NCT02963506|452883147|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887364|NCT02963506|452883148|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887365|NCT02963506|452883149|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887366|NCT02963506|452883150|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887367|NCT02963506|452883151|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887368|NCT02963506|452883152|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887369|NCT02963506|452883153|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887370|NCT02963506|452883154|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887371|NCT02963506|452883155|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887372|NCT02963506|452883156|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125887373|NCT02963506|452883157|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
125887374|NCT00928408|452883162|FG000|Overall Study|Other|2|||
125887375|NCT00928408|452883162|FG000|Overall Study|Withdrawal by Subject|4|||
125887376|NCT00928408|452883162|FG000|Overall Study|Death|5|||
125887377|NCT00928408|452883162|FG000|Overall Study|Lost to Follow-up|12|||
125887378|NCT00536744|452883163|FG000|Overall Study|Adverse Event|13|||
125887379|NCT00536744|452883164|FG001|Overall Study|Adverse Event|10|||
125887380|NCT00536744|452883163|FG000|Overall Study|Death|2|||
125887381|NCT00536744|452883164|FG001|Overall Study|Death|1|||
125887382|NCT00536744|452883163|FG000|Overall Study|Physician Decision|3|||
125887383|NCT00536744|452883164|FG001|Overall Study|Physician Decision|1|||
125887384|NCT00536744|452883163|FG000|Overall Study|Lost to Follow-up|3|||
125887385|NCT00536744|452883164|FG001|Overall Study|Lost to Follow-up|5|||
125887386|NCT00536744|452883163|FG000|Overall Study|Withdrawal by Subject|7|||
125887387|NCT00536744|452883164|FG001|Overall Study|Withdrawal by Subject|8|||
125887388|NCT00536744|452883163|FG000|Overall Study|PI tried alternative treatment|1|||
125887389|NCT00536744|452883164|FG001|Overall Study|PI tried alternative treatment|3|||
125887390|NCT00787644|452883165|FG000|Overall Study|Lost to Follow-up|1|||
125887391|NCT00787644|452883166|FG001|Overall Study|Lost to Follow-up|1|||
125887392|NCT00787644|452883165|FG000|Overall Study|Withdrawal by Subject|1|||
125887393|NCT00787644|452883166|FG001|Overall Study|Withdrawal by Subject|1|||
125887394|NCT02908672|452883167|FG000|Run-in Period|Death|12|||
125887395|NCT02908672|452883168|FG001|Run-in Period|Death|10|||
125887396|NCT02908672|452883169|FG002|Run-in Period|Death|0|||
125887397|NCT02908672|452883170|FG003|Run-in Period|Death|0|||
125887398|NCT02908672|452883167|FG000|Run-in Period|Lost to Follow-up|1|||
125887399|NCT02908672|452883168|FG001|Run-in Period|Lost to Follow-up|1|||
125887400|NCT02908672|452883169|FG002|Run-in Period|Lost to Follow-up|0|||
125887401|NCT02908672|452883170|FG003|Run-in Period|Lost to Follow-up|0|||
126389100|NCT00489424|454717384|FG002|Overall Study|Administrative problems|1|||
126389101|NCT00394251|454717385|FG000|Overall Study|Adverse Event|7|||
126389102|NCT00394251|454717386|FG001|Overall Study|Adverse Event|5|||
126389103|NCT00394251|454717385|FG000|Overall Study|Unacceptable Toxicity|20|||
126389104|NCT00394251|454717386|FG001|Overall Study|Unacceptable Toxicity|18|||
126389105|NCT00394251|454717385|FG000|Overall Study|Physician Decision|1|||
126389106|NCT00394251|454717386|FG001|Overall Study|Physician Decision|1|||
126389107|NCT00394251|454717385|FG000|Overall Study|Protocol Violation|0|||
126389108|NCT00394251|454717386|FG001|Overall Study|Protocol Violation|1|||
126389109|NCT00394251|454717385|FG000|Overall Study|Withdrawal by Subject|7|||
126389110|NCT00394251|454717386|FG001|Overall Study|Withdrawal by Subject|11|||
126389111|NCT00394251|454717385|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
125887402|NCT02908672|452883167|FG000|Run-in Period|Reason Not Specified|2|||
125887403|NCT02908672|452883168|FG001|Run-in Period|Reason Not Specified|0|||
125887404|NCT02908672|452883169|FG002|Run-in Period|Reason Not Specified|0|||
126049006|NCT01566890|453476647|FG001|Overall Study|Other|0|||
126049007|NCT01566890|453476648|FG002|Overall Study|Other|0|||
126049008|NCT01566890|453476649|FG003|Overall Study|Other|0|||
126049009|NCT01566890|453476650|FG004|Overall Study|Other|7|||
126049010|NCT01421667|453476657|FG000|Overall Study|Withdrawal by Subject|0|||
126049011|NCT01421667|453476658|FG001|Overall Study|Withdrawal by Subject|1|||
125887405|NCT02908672|452883170|FG003|Run-in Period|Reason Not Specified|0|||
125887406|NCT02908672|452883167|FG000|Run-in Period|Protocol Violation|1|||
125887407|NCT02908672|452883168|FG001|Run-in Period|Protocol Violation|1|||
125887408|NCT02908672|452883169|FG002|Run-in Period|Protocol Violation|0|||
125887409|NCT02908672|452883170|FG003|Run-in Period|Protocol Violation|0|||
125887410|NCT02908672|452883167|FG000|Run-in Period|Study Ended by Sponsor|5|||
125887411|NCT02908672|452883168|FG001|Run-in Period|Study Ended by Sponsor|1|||
125887412|NCT02908672|452883169|FG002|Run-in Period|Study Ended by Sponsor|0|||
125887413|NCT02908672|452883170|FG003|Run-in Period|Study Ended by Sponsor|0|||
125887414|NCT02908672|452883167|FG000|Run-in Period|Withdrawal by Subject|3|||
125887415|NCT02908672|452883168|FG001|Run-in Period|Withdrawal by Subject|9|||
126049012|NCT01421667|453476659|FG002|Overall Study|Withdrawal by Subject|2|||
126049013|NCT01421667|453476660|FG003|Overall Study|Withdrawal by Subject|1|||
126389112|NCT00394251|454717386|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
126389113|NCT01558115|454717387|FG000|Overall Study|Withdrawal by Subject|3|||
126389114|NCT01558115|454717387|FG000|Overall Study|Study closed due to poor enrollment|4|||
126389115|NCT01696994|454717388|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
126389116|NCT01696994|454717389|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
126389117|NCT01696994|454717388|FG000|Overall Study|Died Before Randomization|1|||
126389118|NCT01696994|454717389|FG001|Overall Study|Died Before Randomization|2|||
126389119|NCT01696994|454717388|FG000|Overall Study|Died Before ASU (Control)|73|||
126389120|NCT01696994|454717389|FG001|Overall Study|Died Before ASU (Control)|0|||
126389121|NCT01696994|454717388|FG000|Overall Study|No Ovaries at Baseline|4807|||
126389122|NCT01696994|454717389|FG001|Overall Study|No Ovaries at Baseline|4851|||
126389123|NCT01696994|454717388|FG000|Overall Study|Refused ASU (Control)|311|||
126389124|NCT01696994|454717389|FG001|Overall Study|Refused ASU (Control)|0|||
126389125|NCT01696994|454717388|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
126389126|NCT01696994|454717389|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
126389127|NCT04644276|454717390|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
126389128|NCT04644276|454717391|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
126389129|NCT04644276|454717392|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
126389130|NCT00705250|454717393|FG000|Overall Study|Withdrawal by Subject|1|||
126389131|NCT00705250|454717393|FG000|Overall Study|Patient died in car accident|1|||
126389132|NCT01576146|454717394|FG000|Extension Period 1|Adverse Event|2|||
126389133|NCT01576146|454717394|FG000|Extension Period 1|Death|2|||
126389134|NCT01576146|454717394|FG000|Extension Period 1|Physician Decision|2|||
126389135|NCT01576146|454717394|FG000|Extension Period 1|Withdrawal by Subject|1|||
126389136|NCT01576146|454717394|FG000|Extension Period 1|Lost to Follow-up|1|||
126389137|NCT01576146|454717394|FG000|Extension Period 1|Parathyroidectomy|1|||
126389138|NCT01576146|454717394|FG000|Extension Period 1|Renal Transplant|1|||
126389139|NCT01576146|454717394|FG000|Extension Period 2|Sponsor Decision|13|||
126389140|NCT01576146|454717394|FG000|Extension Period 2|Death|1|||
126389141|NCT01576146|454717394|FG000|Extension Period 2|Adverse Event|1|||
126389142|NCT01576146|454717394|FG000|Extension Period 2|Renal Transplant|1|||
126389143|NCT01576146|454717394|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
126389144|NCT01951586|454717401|FG000|Overall Study|Death|61|||
126389145|NCT01951586|454717402|FG001|Overall Study|Death|120|||
126389146|NCT01951586|454717401|FG000|Overall Study|Withdrawal by Subject|8|||
126389147|NCT01951586|454717402|FG001|Overall Study|Withdrawal by Subject|17|||
126389148|NCT01951586|454717401|FG000|Overall Study|Lost to Follow-up|0|||
126389149|NCT01951586|454717402|FG001|Overall Study|Lost to Follow-up|1|||
126389150|NCT01951586|454717401|FG000|Overall Study|Sponsor Decision|9|||
126389151|NCT01951586|454717402|FG001|Overall Study|Sponsor Decision|10|||
126389152|NCT01667224|454717405|FG000|Overall Study|Withdrawal by Subject|3|||
126389153|NCT01667224|454717406|FG001|Overall Study|Withdrawal by Subject|1|||
126389154|NCT01667224|454717405|FG000|Overall Study|Protocol Violation|1|||
126049014|NCT01421667|453476657|FG000|Overall Study|Lost to Follow-up|0|||
126049015|NCT01421667|453476658|FG001|Overall Study|Lost to Follow-up|1|||
126389155|NCT01667224|454717406|FG001|Overall Study|Protocol Violation|1|||
126389156|NCT04995419|454717411|FG000|Overall Study|Withdrawal by Subject|3|||
126389157|NCT04995419|454717411|FG000|Overall Study|Progressive Disease|19|||
126389158|NCT04995419|454717411|FG000|Overall Study|Adverse Event|2|||
126389159|NCT04995419|454717411|FG000|Overall Study|Ongoing|16|||
126389160|NCT01822899|454717412|FG000|Overall Study|Adverse Event|6|||
126389161|NCT01822899|454717413|FG001|Overall Study|Adverse Event|5|||
126389162|NCT01822899|454717412|FG000|Overall Study|Lack of Efficacy|6|||
126389163|NCT01822899|454717413|FG001|Overall Study|Lack of Efficacy|3|||
126389164|NCT01822899|454717412|FG000|Overall Study|Protocol Violation|6|||
126389165|NCT01822899|454717413|FG001|Overall Study|Protocol Violation|3|||
126389166|NCT01822899|454717412|FG000|Overall Study|Lost to Follow-up|1|||
126389167|NCT01822899|454717413|FG001|Overall Study|Lost to Follow-up|0|||
126389168|NCT01822899|454717412|FG000|Overall Study|Withdrawal by Subject|5|||
126389169|NCT01822899|454717413|FG001|Overall Study|Withdrawal by Subject|7|||
126389170|NCT05332392|454717414|FG000|Overall Study|Did not meet inclusion criteria|25|||
126389171|NCT05332392|454717414|FG000|Overall Study|Principal Investigator's decision|17|||
126389172|NCT05332392|454717414|FG000|Overall Study|Adverse Event|1|||
126389173|NCT05332392|454717414|FG000|Overall Study|Subject's decision|1|||
126389174|NCT02752633|454717416|FG000|Overall Study|Withdrawal by Subject|1|||
126389175|NCT02846389|454717417|FG000|Overall Study|Withdrawal by Subject|1|||
126389176|NCT02846389|454717418|FG001|Overall Study|Withdrawal by Subject|1|||
126389177|NCT00853242|454717420|FG000|Overall Study|Adverse Event|0|||
126389178|NCT00853242|454717421|FG001|Overall Study|Adverse Event|1|||
126389179|NCT00853242|454717422|FG002|Overall Study|Adverse Event|1|||
126389180|NCT00853242|454717423|FG003|Overall Study|Adverse Event|0|||
126389181|NCT00853242|454717424|FG004|Overall Study|Adverse Event|3|||
126389182|NCT00853242|454717425|FG005|Overall Study|Adverse Event|1|||
126389183|NCT00853242|454717426|FG006|Overall Study|Adverse Event|1|||
126049016|NCT01421667|453476659|FG002|Overall Study|Lost to Follow-up|0|||
126389184|NCT00853242|454717420|FG000|Overall Study|Noncompliant|0|||
126389185|NCT00853242|454717421|FG001|Overall Study|Noncompliant|0|||
126389186|NCT00853242|454717422|FG002|Overall Study|Noncompliant|0|||
126389187|NCT00853242|454717423|FG003|Overall Study|Noncompliant|0|||
126389188|NCT00853242|454717424|FG004|Overall Study|Noncompliant|1|||
126389189|NCT00853242|454717425|FG005|Overall Study|Noncompliant|0|||
126389190|NCT00853242|454717426|FG006|Overall Study|Noncompliant|0|||
126389191|NCT00853242|454717420|FG000|Overall Study|Withdrawal by Subject|1|||
126389192|NCT00853242|454717421|FG001|Overall Study|Withdrawal by Subject|2|||
126389193|NCT00853242|454717422|FG002|Overall Study|Withdrawal by Subject|0|||
126389194|NCT00853242|454717423|FG003|Overall Study|Withdrawal by Subject|4|||
125887416|NCT02908672|452883169|FG002|Run-in Period|Withdrawal by Subject|0|||
125887417|NCT02908672|452883170|FG003|Run-in Period|Withdrawal by Subject|0|||
125887418|NCT02908672|452883167|FG000|Triple Combination Period|Death|0|||
125887419|NCT02908672|452883168|FG001|Triple Combination Period|Death|0|||
125887420|NCT02908672|452883169|FG002|Triple Combination Period|Death|150|||
125887421|NCT02908672|452883170|FG003|Triple Combination Period|Death|127|||
125887422|NCT02908672|452883167|FG000|Triple Combination Period|Lost to Follow-up|0|||
126389195|NCT00853242|454717424|FG004|Overall Study|Withdrawal by Subject|0|||
126389196|NCT00853242|454717425|FG005|Overall Study|Withdrawal by Subject|0|||
126389197|NCT00853242|454717426|FG006|Overall Study|Withdrawal by Subject|2|||
126389198|NCT00853242|454717420|FG000|Overall Study|Other|2|||
126389199|NCT00853242|454717421|FG001|Overall Study|Other|0|||
126389200|NCT00853242|454717422|FG002|Overall Study|Other|2|||
126389201|NCT00853242|454717423|FG003|Overall Study|Other|0|||
126389202|NCT00853242|454717424|FG004|Overall Study|Other|0|||
126389203|NCT00853242|454717425|FG005|Overall Study|Other|1|||
126389204|NCT00853242|454717426|FG006|Overall Study|Other|2|||
126389205|NCT01265563|454717427|FG000|Overall Study|Withdrawal by Subject|0|||
125887423|NCT02908672|452883168|FG001|Triple Combination Period|Lost to Follow-up|0|||
125887424|NCT02908672|452883169|FG002|Triple Combination Period|Lost to Follow-up|6|||
126389206|NCT01265563|454717428|FG001|Overall Study|Withdrawal by Subject|1|||
126389207|NCT01265563|454717429|FG002|Overall Study|Withdrawal by Subject|1|||
125887425|NCT02908672|452883170|FG003|Triple Combination Period|Lost to Follow-up|8|||
125887426|NCT02908672|452883167|FG000|Triple Combination Period|Reason Not Specified|0|||
125887427|NCT02908672|452883168|FG001|Triple Combination Period|Reason Not Specified|0|||
125887428|NCT02908672|452883169|FG002|Triple Combination Period|Reason Not Specified|0|||
125887429|NCT02908672|452883170|FG003|Triple Combination Period|Reason Not Specified|1|||
125887430|NCT02908672|452883167|FG000|Triple Combination Period|Physician Decision|0|||
125887431|NCT02908672|452883168|FG001|Triple Combination Period|Physician Decision|0|||
125887432|NCT02908672|452883169|FG002|Triple Combination Period|Physician Decision|1|||
125887433|NCT02908672|452883170|FG003|Triple Combination Period|Physician Decision|1|||
125887434|NCT02908672|452883167|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
125887435|NCT02908672|452883168|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
125887436|NCT02908672|452883169|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
125887437|NCT02908672|452883170|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
125887438|NCT02908672|452883167|FG000|Triple Combination Period|Withdrawal by Subject|0|||
125887439|NCT02908672|452883168|FG001|Triple Combination Period|Withdrawal by Subject|0|||
125887440|NCT02908672|452883169|FG002|Triple Combination Period|Withdrawal by Subject|13|||
125887441|NCT02908672|452883170|FG003|Triple Combination Period|Withdrawal by Subject|16|||
125887442|NCT04163016|452883171|FG000|Enrollment|Adverse Event|1|||
125887443|NCT04163016|452883172|FG001|Enrollment|Adverse Event|0|||
125887444|NCT04163016|452883173|FG002|Enrollment|Adverse Event|0|||
125887445|NCT04163016|452883174|FG003|Enrollment|Adverse Event|0|||
125887446|NCT04163016|452883171|FG000|Treatment|Adverse Event|0|||
125887447|NCT04163016|452883172|FG001|Treatment|Adverse Event|1|||
125887448|NCT04163016|452883173|FG002|Treatment|Adverse Event|0|||
125887449|NCT04163016|452883174|FG003|Treatment|Adverse Event|0|||
125887450|NCT04163016|452883171|FG000|Treatment|Withdrawal by Subject|0|||
125887451|NCT04163016|452883172|FG001|Treatment|Withdrawal by Subject|2|||
126389208|NCT01265563|454717430|FG003|Overall Study|Withdrawal by Subject|0|||
125887452|NCT04163016|452883173|FG002|Treatment|Withdrawal by Subject|0|||
126049017|NCT01421667|453476660|FG003|Overall Study|Lost to Follow-up|0|||
126389209|NCT01265563|454717431|FG004|Overall Study|Withdrawal by Subject|2|||
126389210|NCT02141399|454717436|FG000|Overall Study|Adverse Event|158|||
126389211|NCT02141399|454717436|FG000|Overall Study|Lack of Efficacy|62|||
126389212|NCT02141399|454717436|FG000|Overall Study|Lost to Follow-up|151|||
126389213|NCT02141399|454717436|FG000|Overall Study|Non-compliance with study drug|18|||
126389214|NCT02141399|454717436|FG000|Overall Study|Other|45|||
125887453|NCT04163016|452883174|FG003|Treatment|Withdrawal by Subject|0|||
125887454|NCT04163016|452883171|FG000|Treatment|Indeterminate TB-test|0|||
125887455|NCT04163016|452883172|FG001|Treatment|Indeterminate TB-test|0|||
125887456|NCT04163016|452883173|FG002|Treatment|Indeterminate TB-test|0|||
126389215|NCT02141399|454717436|FG000|Overall Study|Physician Decision|17|||
125887457|NCT04163016|452883174|FG003|Treatment|Indeterminate TB-test|1|||
125887458|NCT04163016|452883171|FG000|Treatment|Participant did not want to continue in study|0|||
126049018|NCT00503906|453476661|FG000|Overall Study|Withdrawal by Subject|1|||
126389216|NCT02141399|454717436|FG000|Overall Study|Pregnancy|3|||
126389217|NCT02141399|454717436|FG000|Overall Study|Protocol Violation|38|||
126389218|NCT02141399|454717436|FG000|Overall Study|Withdrawal by Subject|238|||
126389219|NCT02141399|454717436|FG000|Overall Study|Failure to meet eligibility criteria|14|||
126389220|NCT01296711|454717437|FG000|Overall Study|Adverse Event|3|||
126389221|NCT01296711|454717438|FG001|Overall Study|Adverse Event|1|||
126389222|NCT01296711|454717439|FG002|Overall Study|Adverse Event|4|||
126389223|NCT01296711|454717440|FG003|Overall Study|Adverse Event|3|||
126389224|NCT01296711|454717441|FG004|Overall Study|Adverse Event|1|||
126389225|NCT01296711|454717442|FG005|Overall Study|Adverse Event|6|||
126389226|NCT01296711|454717443|FG006|Overall Study|Adverse Event|11|||
126389227|NCT01296711|454717444|FG007|Overall Study|Adverse Event|3|||
126389228|NCT01296711|454717437|FG000|Overall Study|Lack of Efficacy|1|||
126389229|NCT01296711|454717438|FG001|Overall Study|Lack of Efficacy|4|||
126389230|NCT01296711|454717439|FG002|Overall Study|Lack of Efficacy|1|||
126389231|NCT01296711|454717440|FG003|Overall Study|Lack of Efficacy|1|||
126389232|NCT01296711|454717441|FG004|Overall Study|Lack of Efficacy|1|||
126389233|NCT01296711|454717442|FG005|Overall Study|Lack of Efficacy|0|||
126389234|NCT01296711|454717443|FG006|Overall Study|Lack of Efficacy|2|||
126389235|NCT01296711|454717444|FG007|Overall Study|Lack of Efficacy|3|||
126389236|NCT01296711|454717437|FG000|Overall Study|Lost to Follow-up|0|||
126389237|NCT01296711|454717438|FG001|Overall Study|Lost to Follow-up|0|||
126389238|NCT01296711|454717439|FG002|Overall Study|Lost to Follow-up|1|||
126389239|NCT01296711|454717440|FG003|Overall Study|Lost to Follow-up|1|||
126389240|NCT01296711|454717441|FG004|Overall Study|Lost to Follow-up|2|||
126389241|NCT01296711|454717442|FG005|Overall Study|Lost to Follow-up|0|||
126389242|NCT01296711|454717443|FG006|Overall Study|Lost to Follow-up|4|||
126389243|NCT01296711|454717444|FG007|Overall Study|Lost to Follow-up|2|||
126389244|NCT01296711|454717437|FG000|Overall Study|Protocol Violation|0|||
126389245|NCT01296711|454717438|FG001|Overall Study|Protocol Violation|0|||
126389246|NCT01296711|454717439|FG002|Overall Study|Protocol Violation|0|||
126389247|NCT01296711|454717440|FG003|Overall Study|Protocol Violation|1|||
126389248|NCT01296711|454717441|FG004|Overall Study|Protocol Violation|1|||
126389249|NCT01296711|454717442|FG005|Overall Study|Protocol Violation|0|||
126389250|NCT01296711|454717443|FG006|Overall Study|Protocol Violation|0|||
126389251|NCT01296711|454717444|FG007|Overall Study|Protocol Violation|0|||
126389252|NCT01296711|454717437|FG000|Overall Study|Withdrawal by Subject|4|||
126389253|NCT01296711|454717438|FG001|Overall Study|Withdrawal by Subject|2|||
126389254|NCT01296711|454717439|FG002|Overall Study|Withdrawal by Subject|2|||
126389255|NCT01296711|454717440|FG003|Overall Study|Withdrawal by Subject|1|||
126389256|NCT01296711|454717441|FG004|Overall Study|Withdrawal by Subject|1|||
126389257|NCT01296711|454717442|FG005|Overall Study|Withdrawal by Subject|1|||
126389258|NCT01296711|454717443|FG006|Overall Study|Withdrawal by Subject|2|||
126389259|NCT01296711|454717444|FG007|Overall Study|Withdrawal by Subject|1|||
126389260|NCT01296711|454717437|FG000|Overall Study|Study termination|8|||
126389261|NCT01296711|454717438|FG001|Overall Study|Study termination|1|||
126389262|NCT01296711|454717439|FG002|Overall Study|Study termination|5|||
126389263|NCT01296711|454717440|FG003|Overall Study|Study termination|4|||
126389264|NCT01296711|454717441|FG004|Overall Study|Study termination|4|||
126389265|NCT01296711|454717442|FG005|Overall Study|Study termination|4|||
126389266|NCT01296711|454717443|FG006|Overall Study|Study termination|8|||
126389267|NCT01296711|454717444|FG007|Overall Study|Study termination|10|||
126389268|NCT01296711|454717437|FG000|Overall Study|Continued elevated liver enzymes|0|||
126389269|NCT01296711|454717438|FG001|Overall Study|Continued elevated liver enzymes|0|||
126389270|NCT01296711|454717439|FG002|Overall Study|Continued elevated liver enzymes|0|||
126389271|NCT01296711|454717440|FG003|Overall Study|Continued elevated liver enzymes|1|||
126389272|NCT01296711|454717441|FG004|Overall Study|Continued elevated liver enzymes|0|||
126389273|NCT01296711|454717442|FG005|Overall Study|Continued elevated liver enzymes|0|||
126389274|NCT01296711|454717443|FG006|Overall Study|Continued elevated liver enzymes|0|||
126389275|NCT01296711|454717444|FG007|Overall Study|Continued elevated liver enzymes|0|||
126389276|NCT01296711|454717437|FG000|Overall Study|Methotrexate discontinued|0|||
126389277|NCT01296711|454717438|FG001|Overall Study|Methotrexate discontinued|0|||
126389278|NCT01296711|454717439|FG002|Overall Study|Methotrexate discontinued|0|||
126389279|NCT01296711|454717440|FG003|Overall Study|Methotrexate discontinued|1|||
126389280|NCT01296711|454717441|FG004|Overall Study|Methotrexate discontinued|0|||
126389281|NCT01296711|454717442|FG005|Overall Study|Methotrexate discontinued|0|||
126389282|NCT01296711|454717443|FG006|Overall Study|Methotrexate discontinued|0|||
126389283|NCT01296711|454717444|FG007|Overall Study|Methotrexate discontinued|0|||
126389284|NCT01296711|454717437|FG000|Overall Study|Investigator discretion|0|||
126389285|NCT01296711|454717438|FG001|Overall Study|Investigator discretion|0|||
126389286|NCT01296711|454717439|FG002|Overall Study|Investigator discretion|0|||
126389287|NCT01296711|454717440|FG003|Overall Study|Investigator discretion|0|||
126389288|NCT01296711|454717441|FG004|Overall Study|Investigator discretion|0|||
126389289|NCT01296711|454717442|FG005|Overall Study|Investigator discretion|0|||
126389290|NCT01296711|454717443|FG006|Overall Study|Investigator discretion|1|||
126389291|NCT01296711|454717444|FG007|Overall Study|Investigator discretion|0|||
126389292|NCT01296711|454717437|FG000|Overall Study|Other|0|||
126389293|NCT01296711|454717438|FG001|Overall Study|Other|0|||
126389294|NCT01296711|454717439|FG002|Overall Study|Other|0|||
125887459|NCT04163016|452883172|FG001|Treatment|Participant did not want to continue in study|0|||
125887460|NCT04163016|452883173|FG002|Treatment|Participant did not want to continue in study|0|||
125887461|NCT04163016|452883174|FG003|Treatment|Participant did not want to continue in study|1|||
125887462|NCT00372593|452884453|FG000|Overall Study|Adverse Event|43|||
125887463|NCT00372593|452884454|FG001|Overall Study|Adverse Event|45|||
125887464|NCT00372593|452884455|FG002|Overall Study|Adverse Event|0|||
125887465|NCT00372593|452884453|FG000|Overall Study|Death|16|||
125887466|NCT00372593|452884454|FG001|Overall Study|Death|20|||
125887467|NCT00372593|452884455|FG002|Overall Study|Death|1|||
125887468|NCT00372593|452884453|FG000|Overall Study|Lack of Efficacy|82|||
125887469|NCT00372593|452884454|FG001|Overall Study|Lack of Efficacy|71|||
125887470|NCT00372593|452884455|FG002|Overall Study|Lack of Efficacy|2|||
125887471|NCT00372593|452884453|FG000|Overall Study|Lost to Follow-up|1|||
125887472|NCT00372593|452884454|FG001|Overall Study|Lost to Follow-up|0|||
125887473|NCT00372593|452884455|FG002|Overall Study|Lost to Follow-up|0|||
125887474|NCT00372593|452884453|FG000|Overall Study|Physician Decision|42|||
125887475|NCT00372593|452884454|FG001|Overall Study|Physician Decision|41|||
125887476|NCT00372593|452884455|FG002|Overall Study|Physician Decision|0|||
125887477|NCT00372593|452884453|FG000|Overall Study|Ineligible|20|||
125887478|NCT00372593|452884454|FG001|Overall Study|Ineligible|21|||
125887479|NCT00372593|452884455|FG002|Overall Study|Ineligible|1|||
125887480|NCT03534180|452884456|FG000|Overall Study|Withdrawal by Subject|1|||
125887481|NCT00790088|452884459|FG000|Overall Study|Protocol Violation|11|||
125887482|NCT00790088|452884459|FG000|Overall Study|Withdrawal by Subject|17|||
125887483|NCT00790088|452884459|FG000|Overall Study|Lost to Follow-up|7|||
125887484|NCT00790088|452884459|FG000|Overall Study|Physician Decision|4|||
125887485|NCT04329806|452884460|FG000|Overall Study|Physician Decision|3|||
125887486|NCT04329806|452884461|FG001|Overall Study|Physician Decision|4|||
125887487|NCT02636595|452884464|FG000|Overall Study|Lost to Follow-up|1|||
125887488|NCT02636595|452884464|FG000|Overall Study|Other|1|||
125887489|NCT02578706|452884468|FG000|Overall Study|Withdrawal by Subject|1|||
125887490|NCT02578706|452884469|FG001|Overall Study|Withdrawal by Subject|0|||
125887491|NCT02578706|452884470|FG002|Overall Study|Withdrawal by Subject|0|||
125887492|NCT02578706|452884468|FG000|Overall Study|Lost to Follow-up|0|||
125887493|NCT02578706|452884469|FG001|Overall Study|Lost to Follow-up|4|||
126049019|NCT01387516|453476662|FG000|Overall Study|Lost to Follow-up|4|||
126049020|NCT01387516|453476663|FG001|Overall Study|Lost to Follow-up|4|||
126049021|NCT01387516|453476664|FG002|Overall Study|Lost to Follow-up|2|||
126049022|NCT01387516|453476665|FG003|Overall Study|Lost to Follow-up|3|||
126049023|NCT01387516|453476662|FG000|Overall Study|Withdrawal by Subject|1|||
126049024|NCT01387516|453476663|FG001|Overall Study|Withdrawal by Subject|1|||
126049025|NCT01387516|453476664|FG002|Overall Study|Withdrawal by Subject|2|||
126049026|NCT01387516|453476665|FG003|Overall Study|Withdrawal by Subject|0|||
126049027|NCT01387516|453476662|FG000|Overall Study|Death|0|||
126049028|NCT01387516|453476663|FG001|Overall Study|Death|0|||
126389295|NCT01296711|454717440|FG003|Overall Study|Other|0|||
126389296|NCT01296711|454717441|FG004|Overall Study|Other|0|||
126389297|NCT01296711|454717442|FG005|Overall Study|Other|0|||
126389298|NCT01296711|454717443|FG006|Overall Study|Other|1|||
126389299|NCT01296711|454717444|FG007|Overall Study|Other|0|||
126389300|NCT01296711|454717437|FG000|Overall Study|Required restricted steroid injections|0|||
126389301|NCT01296711|454717438|FG001|Overall Study|Required restricted steroid injections|0|||
126389302|NCT01296711|454717439|FG002|Overall Study|Required restricted steroid injections|0|||
126389303|NCT01296711|454717440|FG003|Overall Study|Required restricted steroid injections|0|||
126389304|NCT01296711|454717441|FG004|Overall Study|Required restricted steroid injections|0|||
126389305|NCT01296711|454717442|FG005|Overall Study|Required restricted steroid injections|0|||
126389306|NCT01296711|454717443|FG006|Overall Study|Required restricted steroid injections|1|||
126389307|NCT01296711|454717444|FG007|Overall Study|Required restricted steroid injections|0|||
126389308|NCT01296711|454717437|FG000|Overall Study|Ongoing missed appointments|0|||
126389309|NCT01296711|454717438|FG001|Overall Study|Ongoing missed appointments|0|||
126389310|NCT01296711|454717439|FG002|Overall Study|Ongoing missed appointments|0|||
126389311|NCT01296711|454717440|FG003|Overall Study|Ongoing missed appointments|0|||
126049029|NCT01387516|453476664|FG002|Overall Study|Death|0|||
126104225|NCT01650246|453675825|FG000|Overall Study|Withdrawal by Subject|26|||
126389312|NCT01296711|454717441|FG004|Overall Study|Ongoing missed appointments|0|||
126389313|NCT01296711|454717442|FG005|Overall Study|Ongoing missed appointments|0|||
125887494|NCT02578706|452884470|FG002|Overall Study|Lost to Follow-up|0|||
125887495|NCT02578706|452884468|FG000|Overall Study|Physician Decision|0|||
125887496|NCT02578706|452884469|FG001|Overall Study|Physician Decision|1|||
125887497|NCT02578706|452884470|FG002|Overall Study|Physician Decision|0|||
125887498|NCT02015637|452884474|FG000|Overall Study|Lost to Follow-up|3|||
125887499|NCT02015637|452884475|FG001|Overall Study|Lost to Follow-up|5|||
125887500|NCT02015637|452884474|FG000|Overall Study|Adverse Event|3|||
125887501|NCT02015637|452884475|FG001|Overall Study|Adverse Event|0|||
125887502|NCT02015637|452884474|FG000|Overall Study|Did not take study drug|2|||
125887503|NCT02015637|452884475|FG001|Overall Study|Did not take study drug|0|||
125887504|NCT02223858|452884480|FG000|Overall Study|Death|1|||
126049030|NCT01387516|453476665|FG003|Overall Study|Death|1|||
126104226|NCT01650246|453675825|FG000|Overall Study|Death|1|||
126389314|NCT01296711|454717443|FG006|Overall Study|Ongoing missed appointments|1|||
126389315|NCT01296711|454717444|FG007|Overall Study|Ongoing missed appointments|0|||
126389316|NCT01296711|454717437|FG000|Overall Study|Failure to comply with visits|0|||
126389317|NCT01296711|454717438|FG001|Overall Study|Failure to comply with visits|0|||
126389318|NCT01296711|454717439|FG002|Overall Study|Failure to comply with visits|0|||
126389319|NCT01296711|454717440|FG003|Overall Study|Failure to comply with visits|0|||
126389320|NCT01296711|454717441|FG004|Overall Study|Failure to comply with visits|0|||
126389321|NCT01296711|454717442|FG005|Overall Study|Failure to comply with visits|0|||
126389322|NCT01296711|454717443|FG006|Overall Study|Failure to comply with visits|0|||
126389323|NCT01296711|454717444|FG007|Overall Study|Failure to comply with visits|1|||
126389324|NCT01296711|454717437|FG000|Overall Study|Patient decision due to transport|0|||
126389325|NCT01296711|454717438|FG001|Overall Study|Patient decision due to transport|0|||
126389326|NCT01296711|454717439|FG002|Overall Study|Patient decision due to transport|0|||
126389327|NCT01296711|454717440|FG003|Overall Study|Patient decision due to transport|0|||
126389328|NCT01296711|454717441|FG004|Overall Study|Patient decision due to transport|0|||
126389329|NCT01296711|454717442|FG005|Overall Study|Patient decision due to transport|0|||
126389330|NCT01296711|454717443|FG006|Overall Study|Patient decision due to transport|0|||
126389331|NCT01296711|454717444|FG007|Overall Study|Patient decision due to transport|1|||
126389332|NCT01126268|454717445|FG000|Overall Study|Adverse Event|1|||
126389333|NCT04026009|454717446|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126389334|NCT04026009|454717447|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126389335|NCT04026009|454717448|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126389336|NCT04026009|454717449|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
126389337|NCT04026009|454717450|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
126389338|NCT04026009|454717446|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
126389339|NCT04026009|454717447|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
126389340|NCT04026009|454717448|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
126389341|NCT04026009|454717449|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
126389342|NCT04026009|454717450|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
126389343|NCT01988662|454717451|FG000|Overall Study|Subject/guardian decision|1|||
126389344|NCT01988662|454717452|FG001|Overall Study|Subject/guardian decision|1|||
126389345|NCT01988662|454717451|FG000|Overall Study|Adverse Event|3|||
126389346|NCT01988662|454717452|FG001|Overall Study|Adverse Event|1|||
126389347|NCT00842153|454717456|FG000|Overall Study|Adverse Event|0|||
126389348|NCT00842153|454717457|FG001|Overall Study|Adverse Event|1|||
126389349|NCT00842153|454717456|FG000|Overall Study|Lost to Follow-up|1|||
126389350|NCT00842153|454717457|FG001|Overall Study|Lost to Follow-up|2|||
126389351|NCT00002540|454717458|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
126389352|NCT00002540|454717459|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
126389353|NCT00002540|454717458|FG000|Overall Study|Died Before Randomization|2|||
126389354|NCT00002540|454717459|FG001|Overall Study|Died Before Randomization|6|||
126389355|NCT00002540|454717458|FG000|Overall Study|Died Before ASU (Control)|202|||
126389356|NCT00002540|454717459|FG001|Overall Study|Died Before ASU (Control)|0|||
126389357|NCT00002540|454717458|FG000|Overall Study|Refused ASU (Control)|597|||
126389358|NCT00002540|454717459|FG001|Overall Study|Refused ASU (Control)|0|||
126389359|NCT00002540|454717458|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
126389360|NCT00002540|454717459|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
126389361|NCT01345929|454717460|FG000|Overall Study|Withdrawal by Subject|9|||
126389362|NCT01345929|454717461|FG001|Overall Study|Withdrawal by Subject|8|||
126389363|NCT01345929|454717460|FG000|Overall Study|Lost to Follow-up|9|||
126389364|NCT01345929|454717461|FG001|Overall Study|Lost to Follow-up|9|||
126389365|NCT01345929|454717460|FG000|Overall Study|Adverse Event|0|||
126389366|NCT01345929|454717461|FG001|Overall Study|Adverse Event|1|||
126389367|NCT01345929|454717460|FG000|Overall Study|Didn't meet eligibility criteria|2|||
126389368|NCT01345929|454717461|FG001|Overall Study|Didn't meet eligibility criteria|0|||
126389369|NCT01345929|454717460|FG000|Overall Study|40,000 CFU/ML|1|||
126389370|NCT01345929|454717461|FG001|Overall Study|40,000 CFU/ML|0|||
126389371|NCT01345929|454717460|FG000|Overall Study|Patient withdrawal|0|||
126389372|NCT01345929|454717461|FG001|Overall Study|Patient withdrawal|1|||
126389373|NCT02151903|454717462|FG000|Overall Study|Withdrawal by Subject|1|||
126389374|NCT02151903|454717463|FG001|Overall Study|Withdrawal by Subject|0|||
126389375|NCT02151903|454717462|FG000|Overall Study|Progressive disease|2|||
126389376|NCT02151903|454717463|FG001|Overall Study|Progressive disease|1|||
126389377|NCT01500252|454717466|FG000|Overall Study|Death|4|||
126389378|NCT01500252|454717467|FG001|Overall Study|Death|2|||
126389379|NCT01500252|454717466|FG000|Overall Study|Lost to Follow-up|5|||
126389380|NCT01500252|454717467|FG001|Overall Study|Lost to Follow-up|4|||
126389381|NCT05319600|454717468|FG000|Overall Study|Withdrawal by Subject|1|||
126389382|NCT05319600|454717469|FG001|Overall Study|Withdrawal by Subject|0|||
126389383|NCT05319600|454717468|FG000|Overall Study|Lost to Follow-up|0|||
126389384|NCT05319600|454717469|FG001|Overall Study|Lost to Follow-up|4|||
126389385|NCT03768089|454717473|FG000|Part A|Lost to Follow-up|0|||
126389386|NCT03768089|454717474|FG001|Part A|Lost to Follow-up|0|||
126389387|NCT03768089|454717475|FG002|Part A|Lost to Follow-up|0|||
126389388|NCT03768089|454717476|FG003|Part A|Lost to Follow-up|0|||
126389389|NCT03768089|454717477|FG004|Part A|Lost to Follow-up|1|||
126389390|NCT03768089|454717478|FG005|Part A|Lost to Follow-up|0|||
126389391|NCT03768089|454717479|FG006|Part A|Lost to Follow-up|0|||
126389392|NCT03768089|454717480|FG007|Part A|Lost to Follow-up|0|||
126389393|NCT03768089|454717481|FG008|Part A|Lost to Follow-up|0|||
126389394|NCT03768089|454717482|FG009|Part A|Lost to Follow-up|0|||
126389395|NCT03768089|454717483|FG010|Part A|Lost to Follow-up|0|||
126389396|NCT03768089|454717484|FG011|Part A|Lost to Follow-up|0|||
126389397|NCT03768089|454717485|FG012|Part A|Lost to Follow-up|0|||
126389398|NCT03768089|454717486|FG013|Part A|Lost to Follow-up|0|||
126389399|NCT03768089|454717487|FG014|Part A|Lost to Follow-up|0|||
126389400|NCT03768089|454717488|FG015|Part A|Lost to Follow-up|0|||
126389401|NCT03768089|454717489|FG016|Part A|Lost to Follow-up|0|||
126389402|NCT03768089|454717490|FG017|Part A|Lost to Follow-up|0|||
126389403|NCT03768089|454717473|FG000|Part C|Randomized, Never Dosed|0|||
126389404|NCT03768089|454717474|FG001|Part C|Randomized, Never Dosed|0|||
126389405|NCT03768089|454717475|FG002|Part C|Randomized, Never Dosed|0|||
126389406|NCT03768089|454717476|FG003|Part C|Randomized, Never Dosed|0|||
126389407|NCT03768089|454717477|FG004|Part C|Randomized, Never Dosed|0|||
126389408|NCT03768089|454717478|FG005|Part C|Randomized, Never Dosed|0|||
126389409|NCT03768089|454717479|FG006|Part C|Randomized, Never Dosed|0|||
126389410|NCT03768089|454717480|FG007|Part C|Randomized, Never Dosed|0|||
126389411|NCT03768089|454717481|FG008|Part C|Randomized, Never Dosed|0|||
126389412|NCT03768089|454717482|FG009|Part C|Randomized, Never Dosed|0|||
126389413|NCT03768089|454717483|FG010|Part C|Randomized, Never Dosed|0|||
126389414|NCT03768089|454717484|FG011|Part C|Randomized, Never Dosed|0|||
126389415|NCT03768089|454717485|FG012|Part C|Randomized, Never Dosed|0|||
126389416|NCT03768089|454717486|FG013|Part C|Randomized, Never Dosed|0|||
126389417|NCT03768089|454717487|FG014|Part C|Randomized, Never Dosed|1|||
126389418|NCT03768089|454717488|FG015|Part C|Randomized, Never Dosed|0|||
126389419|NCT03768089|454717489|FG016|Part C|Randomized, Never Dosed|0|||
126389420|NCT03768089|454717490|FG017|Part C|Randomized, Never Dosed|0|||
126389421|NCT02120300|454717493|FG000|Overall Study|Enrolled but Never Treated|2|||
126389422|NCT02120300|454717494|FG001|Overall Study|Enrolled but Never Treated|0|||
126389423|NCT02120300|454717495|FG002|Overall Study|Enrolled but Never Treated|0|||
126389424|NCT02120300|454717496|FG003|Overall Study|Enrolled but Never Treated|0|||
126389425|NCT02120300|454717493|FG000|Overall Study|Lack of Efficacy|0|||
126389426|NCT02120300|454717494|FG001|Overall Study|Lack of Efficacy|0|||
126389427|NCT02120300|454717495|FG002|Overall Study|Lack of Efficacy|0|||
126389428|NCT02120300|454717496|FG003|Overall Study|Lack of Efficacy|1|||
126389429|NCT02120300|454717493|FG000|Overall Study|Lost to Follow-up|1|||
126389430|NCT02120300|454717494|FG001|Overall Study|Lost to Follow-up|0|||
126389431|NCT02120300|454717495|FG002|Overall Study|Lost to Follow-up|0|||
126389432|NCT02120300|454717496|FG003|Overall Study|Lost to Follow-up|0|||
126389433|NCT00361231|454717500|FG000|Overall Study|Physician Decision|3|||
126389434|NCT00361231|454717500|FG000|Overall Study|Symptomatic deterioration|5|||
126389435|NCT00361231|454717500|FG000|Overall Study|Radiographic disease progression|16|||
126389436|NCT00361231|454717500|FG000|Overall Study|Withdrawal by Subject|4|||
126389437|NCT00361231|454717500|FG000|Overall Study|Adverse Event|6|||
126389438|NCT01208961|454717503|FG000|High-Fat Period III|Protocol Violation|1|||
126389439|NCT01208961|454717504|FG001|High-Fat Period III|Protocol Violation|0|||
126389440|NCT02241733|454717507|FG000|Overall Study|Lost to Follow-up|9|||
126389441|NCT02241733|454717508|FG001|Overall Study|Lost to Follow-up|4|||
126389442|NCT02241733|454717507|FG000|Overall Study|Physician Decision|6|||
126389443|NCT02241733|454717508|FG001|Overall Study|Physician Decision|2|||
126389444|NCT02241733|454717507|FG000|Overall Study|Withdrawal by Subject|0|||
126389445|NCT02241733|454717508|FG001|Overall Study|Withdrawal by Subject|2|||
126389446|NCT02241733|454717507|FG000|Overall Study|Death|0|||
126389447|NCT02241733|454717508|FG001|Overall Study|Death|2|||
126389448|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
126389449|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
126389450|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
126389451|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
126389452|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
126389453|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
126389454|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
126389455|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
126389456|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
126389457|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
126389458|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
126389459|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
126389460|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
126389461|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
126389462|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
126389463|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
125887505|NCT02223858|452884481|FG001|Overall Study|Death|1|||
125887506|NCT02223858|452884480|FG000|Overall Study|Lost to Follow-up|6|||
125887507|NCT02223858|452884481|FG001|Overall Study|Lost to Follow-up|11|||
125887508|NCT02223858|452884480|FG000|Overall Study|Withdrawal by Subject|8|||
125887509|NCT02223858|452884481|FG001|Overall Study|Withdrawal by Subject|5|||
125887510|NCT02223858|452884480|FG000|Overall Study|Refused|9|||
125887511|NCT02223858|452884481|FG001|Overall Study|Refused|9|||
125887512|NCT04455815|452884482|FG000|Randomisation Phase|Adverse Event|1|||
125887513|NCT04455815|452884483|FG001|Randomisation Phase|Adverse Event|0|||
125887514|NCT04455815|452884482|FG000|Treatment Phase|Adverse Event|0|||
125887515|NCT04455815|452884483|FG001|Treatment Phase|Adverse Event|1|||
125887516|NCT04455815|452884482|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
125887517|NCT04455815|452884483|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
125887518|NCT04455815|452884482|FG000|Treatment Phase|Withdrawal by Subject|1|||
125887519|NCT04455815|452884483|FG001|Treatment Phase|Withdrawal by Subject|1|||
125887520|NCT02106390|452884484|FG000|Overall Study|Withdrawal by Subject|15|||
126049031|NCT01738438|453476667|FG000|Overall Study|Disease Progression|32|||
126049032|NCT01738438|453476667|FG000|Overall Study|Adverse Event|3|||
126049033|NCT02928172|453476668|FG000|Overall Study|Device did not record data|1|||
126049034|NCT04066075|453476669|FG000|Overall Study|Lost to Follow-up|3|||
126389464|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
126389465|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
126389466|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
126389467|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
126389468|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
126389469|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
126389470|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
126389471|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
126389472|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
126389473|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
126389474|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
126389475|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
126389476|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
126389477|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
126389478|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
126389479|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
126389480|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
126389481|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
126389482|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
126389483|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
126389484|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
126389485|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
126389486|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
126389487|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
126389488|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
126389489|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
126389490|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
126389491|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
126389492|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Death|1|||
126389493|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Death|1|||
126389494|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Death|3|||
126389495|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Death|2|||
126389496|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
126389497|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
126389498|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
126389499|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
126389500|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
126389501|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
126389502|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
126389503|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
125887521|NCT02106390|452884485|FG001|Overall Study|Withdrawal by Subject|16|||
125887522|NCT02106390|452884486|FG002|Overall Study|Withdrawal by Subject|15|||
125887523|NCT02106390|452884484|FG000|Overall Study|Lost to Follow-up|25|||
126389504|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
126389505|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
125887524|NCT02106390|452884485|FG001|Overall Study|Lost to Follow-up|20|||
125887525|NCT02106390|452884486|FG002|Overall Study|Lost to Follow-up|13|||
126049035|NCT04066075|453476670|FG001|Overall Study|Lost to Follow-up|3|||
126389506|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
126389507|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
126389508|NCT04576455|454717514|FG000|Overall Study|Ongoing in the Study|48|||
126389509|NCT04576455|454717515|FG001|Overall Study|Ongoing in the Study|58|||
126389510|NCT04576455|454717514|FG000|Overall Study|Death|83|||
126389511|NCT04576455|454717515|FG001|Overall Study|Death|77|||
126389512|NCT04576455|454717514|FG000|Overall Study|Lost to Follow-up|4|||
126389513|NCT04576455|454717515|FG001|Overall Study|Lost to Follow-up|5|||
126389514|NCT04576455|454717514|FG000|Overall Study|Withdrawal by Subject|16|||
126389515|NCT04576455|454717515|FG001|Overall Study|Withdrawal by Subject|12|||
126389516|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
126389517|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389518|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389519|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389520|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389521|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389522|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
126389523|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
126389524|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126389525|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126389526|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126389527|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125887526|NCT02106390|452884484|FG000|Overall Study|Other: Administrative Reason|8|||
125887527|NCT02106390|452884485|FG001|Overall Study|Other: Administrative Reason|5|||
126389528|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
126389529|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
126389530|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
126389531|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
126389532|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
126389533|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
126389534|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
126389535|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
126389536|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126389537|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126389538|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126389539|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126389540|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
126389541|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
126389542|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
126389543|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
126389544|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
126389545|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
126389546|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
126389547|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389548|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389549|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389550|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389551|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389552|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
126389553|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
126389554|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
126389555|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
126389556|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
126389557|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
126389558|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126389559|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126389560|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
126389561|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
126049036|NCT04066075|453476669|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
126049037|NCT04066075|453476670|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
126049038|NCT04066075|453476669|FG000|Overall Study|Withdrawal by Subject|2|||
126049039|NCT04066075|453476670|FG001|Overall Study|Withdrawal by Subject|2|||
126049040|NCT00309166|453476671|FG000|Overall Study|Adverse event, non-fatal|1|||
126104227|NCT01650246|453675825|FG000|Overall Study|Lack of Efficacy|30|||
126104228|NCT00953407|453675826|FG000|Overall Study|Failed inclusion criteria|1|||
126104229|NCT00953407|453675827|FG001|Overall Study|Failed inclusion criteria|1|||
126104230|NCT00953407|453675828|FG002|Overall Study|Failed inclusion criteria|1|||
126389562|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
126389563|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
126389564|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126389565|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126389566|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
126389567|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
126389568|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
126389569|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
126389570|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126389571|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126389572|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
126389573|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
126389574|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
126389575|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
126389576|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126389577|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126389578|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126389579|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126389580|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
126389581|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126389582|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126389583|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126389584|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
126389585|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
126389586|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126389587|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
126389588|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
126389589|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
126389590|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
126389591|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
126389592|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
126389593|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
126389594|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
126389595|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
126389596|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
126389597|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
126389598|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
126389599|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
126389600|NCT01352221|454717522|FG000|Double-blind Phase|Adverse Event|6|||
126389601|NCT01352221|454717523|FG001|Double-blind Phase|Adverse Event|4|||
126389602|NCT01352221|454717524|FG002|Double-blind Phase|Adverse Event|0|||
126389603|NCT01352221|454717525|FG003|Double-blind Phase|Adverse Event|0|||
126389604|NCT01352221|454717522|FG000|Double-blind Phase|Withdrawal by Subject|3|||
126389605|NCT01352221|454717523|FG001|Double-blind Phase|Withdrawal by Subject|5|||
126389606|NCT01352221|454717524|FG002|Double-blind Phase|Withdrawal by Subject|0|||
126389607|NCT01352221|454717525|FG003|Double-blind Phase|Withdrawal by Subject|0|||
126389608|NCT01352221|454717522|FG000|Double-blind Phase|Lost to Follow-up|0|||
126389609|NCT01352221|454717523|FG001|Double-blind Phase|Lost to Follow-up|1|||
126389610|NCT01352221|454717524|FG002|Double-blind Phase|Lost to Follow-up|0|||
126389611|NCT01352221|454717525|FG003|Double-blind Phase|Lost to Follow-up|0|||
126389612|NCT01352221|454717522|FG000|Double-blind Phase|Protocol Violation|0|||
126389613|NCT01352221|454717523|FG001|Double-blind Phase|Protocol Violation|1|||
126389614|NCT01352221|454717524|FG002|Double-blind Phase|Protocol Violation|0|||
126389615|NCT01352221|454717525|FG003|Double-blind Phase|Protocol Violation|0|||
126389616|NCT01352221|454717522|FG000|Open-label Phase|Physician Decision|0|||
126389617|NCT01352221|454717523|FG001|Open-label Phase|Physician Decision|0|||
126389618|NCT01352221|454717524|FG002|Open-label Phase|Physician Decision|2|||
126389619|NCT01352221|454717525|FG003|Open-label Phase|Physician Decision|1|||
126389620|NCT01352221|454717522|FG000|Open-label Phase|Pregnancy|0|||
126389621|NCT01352221|454717523|FG001|Open-label Phase|Pregnancy|0|||
126389622|NCT01352221|454717524|FG002|Open-label Phase|Pregnancy|1|||
126389623|NCT01352221|454717525|FG003|Open-label Phase|Pregnancy|0|||
126389624|NCT01352221|454717522|FG000|Open-label Phase|Adverse Event|0|||
126389625|NCT01352221|454717523|FG001|Open-label Phase|Adverse Event|0|||
126389626|NCT01352221|454717524|FG002|Open-label Phase|Adverse Event|8|||
126104231|NCT00953407|453675829|FG003|Overall Study|Failed inclusion criteria|1|||
126104232|NCT00953407|453675830|FG004|Overall Study|Failed inclusion criteria|1|||
126104233|NCT00953407|453675826|FG000|Overall Study|Lost to Follow-up|0|||
126104234|NCT00953407|453675827|FG001|Overall Study|Lost to Follow-up|0|||
126104235|NCT00953407|453675828|FG002|Overall Study|Lost to Follow-up|0|||
126104236|NCT00953407|453675829|FG003|Overall Study|Lost to Follow-up|1|||
126104237|NCT00953407|453675830|FG004|Overall Study|Lost to Follow-up|0|||
126104238|NCT03435497|453675832|FG000|Overall Study|Lost to Follow-up|1|||
126389627|NCT01352221|454717525|FG003|Open-label Phase|Adverse Event|4|||
126389628|NCT01352221|454717522|FG000|Open-label Phase|Withdrawal by Subject|0|||
126389629|NCT01352221|454717523|FG001|Open-label Phase|Withdrawal by Subject|0|||
126389630|NCT01352221|454717524|FG002|Open-label Phase|Withdrawal by Subject|1|||
126389631|NCT01352221|454717525|FG003|Open-label Phase|Withdrawal by Subject|6|||
126389632|NCT01352221|454717522|FG000|Open-label Phase|Worsening of IBD|0|||
126389633|NCT01352221|454717523|FG001|Open-label Phase|Worsening of IBD|0|||
126389634|NCT01352221|454717524|FG002|Open-label Phase|Worsening of IBD|1|||
126389635|NCT01352221|454717525|FG003|Open-label Phase|Worsening of IBD|0|||
126389636|NCT02016716|454717526|FG000|Overall Study|Withdrawal by Subject|5|||
126389637|NCT02016716|454717527|FG001|Overall Study|Withdrawal by Subject|5|||
126389638|NCT02016716|454717528|FG002|Overall Study|Withdrawal by Subject|5|||
126389639|NCT02016716|454717526|FG000|Overall Study|Protocol-specified Criteria|0|||
126389640|NCT02016716|454717527|FG001|Overall Study|Protocol-specified Criteria|1|||
126389641|NCT02016716|454717528|FG002|Overall Study|Protocol-specified Criteria|0|||
126104239|NCT03435497|453675833|FG001|Overall Study|Lost to Follow-up|0|||
126389642|NCT02016716|454717526|FG000|Overall Study|Lost to Follow-up|1|||
126389643|NCT02016716|454717527|FG001|Overall Study|Lost to Follow-up|2|||
126389644|NCT02016716|454717528|FG002|Overall Study|Lost to Follow-up|1|||
126389645|NCT02248649|454717529|FG000|Overall Study|Death|7|||
126389646|NCT02248649|454717530|FG001|Overall Study|Death|11|||
126389647|NCT02248649|454717529|FG000|Overall Study|Lost to Follow-up|14|||
126389648|NCT02248649|454717530|FG001|Overall Study|Lost to Follow-up|10|||
126389649|NCT01439971|454717531|FG000|Overall Study|Required number in cohort dosed|0|||
126389650|NCT01439971|454717532|FG001|Overall Study|Required number in cohort dosed|1|||
126389651|NCT01439971|454717533|FG002|Overall Study|Required number in cohort dosed|2|||
126389652|NCT01439971|454717534|FG003|Overall Study|Required number in cohort dosed|0|||
126389653|NCT01439971|454717535|FG004|Overall Study|Required number in cohort dosed|1|||
126389654|NCT02628600|454717539|FG000|Overall Study|Death|2|||
126389655|NCT02628600|454717540|FG001|Overall Study|Death|1|||
126389656|NCT02628600|454717539|FG000|Overall Study|Adverse Event|3|||
126389657|NCT02628600|454717540|FG001|Overall Study|Adverse Event|20|||
126389658|NCT02628600|454717539|FG000|Overall Study|Protocol Violation|0|||
126389659|NCT02628600|454717540|FG001|Overall Study|Protocol Violation|1|||
126389660|NCT02628600|454717539|FG000|Overall Study|Lack of Efficacy|2|||
126389661|NCT02628600|454717540|FG001|Overall Study|Lack of Efficacy|0|||
126389662|NCT02628600|454717539|FG000|Overall Study|Withdrawal by Subject|13|||
126389663|NCT02628600|454717540|FG001|Overall Study|Withdrawal by Subject|8|||
126389664|NCT02628600|454717539|FG000|Overall Study|Lost to Follow-up|1|||
126389665|NCT02628600|454717540|FG001|Overall Study|Lost to Follow-up|0|||
126389666|NCT02628600|454717539|FG000|Overall Study|Physician Decision|2|||
126389667|NCT02628600|454717540|FG001|Overall Study|Physician Decision|2|||
126389668|NCT02628600|454717539|FG000|Overall Study|Other not specified|1|||
126389669|NCT02628600|454717540|FG001|Overall Study|Other not specified|0|||
126389670|NCT01221623|454717545|FG000|Overall Study|Withdrawal by Subject|19|||
126389671|NCT01221623|454717546|FG001|Overall Study|Withdrawal by Subject|8|||
126389672|NCT01221623|454717545|FG000|Overall Study|Lost to Follow-up|7|||
126389673|NCT01221623|454717546|FG001|Overall Study|Lost to Follow-up|1|||
126389674|NCT01221623|454717545|FG000|Overall Study|Adverse Event|6|||
126389675|NCT01221623|454717546|FG001|Overall Study|Adverse Event|3|||
126389676|NCT01221623|454717545|FG000|Overall Study|Death|1|||
126389677|NCT01221623|454717546|FG001|Overall Study|Death|0|||
126389678|NCT01221623|454717545|FG000|Overall Study|Other|5|||
126389679|NCT01221623|454717546|FG001|Overall Study|Other|2|||
126389680|NCT00661726|454717547|FG000|Overall Study|Adverse Event|1|||
126389681|NCT00875485|454720473|FG000|Challenge Dose Epoch|Pregnancy|1|||
126389682|NCT00875485|454720474|FG001|Challenge Dose Epoch|Pregnancy|0|||
126389683|NCT01271010|454720475|FG000|Overall Study|Reason not specified|11|||
126389684|NCT01271010|454720475|FG000|Overall Study|Start of new CLL therapy|1|||
126389685|NCT01271010|454720475|FG000|Overall Study|Protocol Violation|1|||
126389686|NCT01271010|454720475|FG000|Overall Study|Death|2|||
126389687|NCT01271010|454720475|FG000|Overall Study|Progression and relapse of disease|1|||
126389688|NCT01271010|454720475|FG000|Overall Study|Withdrawal by Subject|18|||
126389689|NCT01271010|454720475|FG000|Overall Study|Disease progression|27|||
126104240|NCT03435497|453675832|FG000|Overall Study|Death|1|||
126104241|NCT03435497|453675833|FG001|Overall Study|Death|0|||
126104242|NCT03435497|453675832|FG000|Overall Study|Withdrawal by Subject|0|||
126389690|NCT01631747|454720476|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
126389691|NCT01631747|454720477|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
126389692|NCT01631747|454720476|FG000|Live Birth|Pregnancy Termination|1|||
126389693|NCT01631747|454720477|FG001|Live Birth|Pregnancy Termination|0|||
126389694|NCT01631747|454720476|FG000|Live Birth|MIscarriage|2|||
126389695|NCT01631747|454720477|FG001|Live Birth|MIscarriage|0|||
126389696|NCT01631747|454720476|FG000|Live Birth|Stillbirth|1|||
126389697|NCT01631747|454720477|FG001|Live Birth|Stillbirth|1|||
126389698|NCT01631747|454720476|FG000|One Year Infant Outcomes|Patient Refused|13|||
126389699|NCT01631747|454720477|FG001|One Year Infant Outcomes|Patient Refused|9|||
126389700|NCT02908685|454720478|FG000|Part 1 OLE|Withdrawal by Subject|0|||
126389701|NCT02908685|454720479|FG001|Part 1 OLE|Withdrawal by Subject|0|||
126389702|NCT02908685|454720480|FG002|Part 1 OLE|Withdrawal by Subject|0|||
126389703|NCT02908685|454720481|FG003|Part 1 OLE|Withdrawal by Subject|0|||
126389704|NCT02908685|454720482|FG004|Part 1 OLE|Withdrawal by Subject|0|||
126389705|NCT02908685|454720483|FG005|Part 1 OLE|Withdrawal by Subject|0|||
126389706|NCT02908685|454720484|FG006|Part 1 OLE|Withdrawal by Subject|0|||
126389707|NCT02908685|454720485|FG007|Part 1 OLE|Withdrawal by Subject|0|||
126389708|NCT02908685|454720486|FG008|Part 1 OLE|Withdrawal by Subject|0|||
126389709|NCT02908685|454720487|FG009|Part 1 OLE|Withdrawal by Subject|0|||
126389710|NCT02908685|454720488|FG010|Part 1 OLE|Withdrawal by Subject|2|||
126389711|NCT02908685|454720489|FG011|Part 1 OLE|Withdrawal by Subject|1|||
126389712|NCT02908685|454720490|FG012|Part 1 OLE|Withdrawal by Subject|0|||
126389713|NCT02908685|454720491|FG013|Part 1 OLE|Withdrawal by Subject|0|||
126389714|NCT02908685|454720478|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389715|NCT02908685|454720479|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389716|NCT02908685|454720480|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389717|NCT02908685|454720481|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389718|NCT02908685|454720482|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389719|NCT02908685|454720483|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389720|NCT02908685|454720484|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389721|NCT02908685|454720485|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389722|NCT02908685|454720486|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389723|NCT02908685|454720487|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389724|NCT02908685|454720488|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389725|NCT02908685|454720489|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389726|NCT02908685|454720490|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
126389727|NCT02908685|454720491|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
126389728|NCT02908685|454720478|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389729|NCT02908685|454720479|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389730|NCT02908685|454720480|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389731|NCT02908685|454720481|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389732|NCT02908685|454720482|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389733|NCT02908685|454720483|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389734|NCT02908685|454720484|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389735|NCT02908685|454720485|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389736|NCT02908685|454720486|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389737|NCT02908685|454720487|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389738|NCT02908685|454720488|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389739|NCT02908685|454720489|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389740|NCT02908685|454720490|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
126389741|NCT02908685|454720491|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389742|NCT02908685|454720478|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389743|NCT02908685|454720479|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389744|NCT02908685|454720480|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389745|NCT02908685|454720481|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389746|NCT02908685|454720482|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389747|NCT02908685|454720483|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389748|NCT02908685|454720484|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389749|NCT02908685|454720485|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389750|NCT02908685|454720486|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389751|NCT02908685|454720487|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389752|NCT02908685|454720488|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389753|NCT02908685|454720489|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389754|NCT02908685|454720490|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
126389755|NCT02908685|454720491|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389756|NCT02908685|454720478|FG000|Part 2 OLE: > Month 24|Death|0|||
126389757|NCT02908685|454720479|FG001|Part 2 OLE: > Month 24|Death|0|||
126389758|NCT02908685|454720480|FG002|Part 2 OLE: > Month 24|Death|0|||
126049041|NCT00309166|453476672|FG001|Overall Study|Adverse event, non-fatal|0|||
126389759|NCT02908685|454720481|FG003|Part 2 OLE: > Month 24|Death|0|||
126389760|NCT02908685|454720482|FG004|Part 2 OLE: > Month 24|Death|0|||
126389761|NCT02908685|454720483|FG005|Part 2 OLE: > Month 24|Death|0|||
126389762|NCT02908685|454720484|FG006|Part 2 OLE: > Month 24|Death|0|||
126389763|NCT02908685|454720485|FG007|Part 2 OLE: > Month 24|Death|0|||
126389764|NCT02908685|454720486|FG008|Part 2 OLE: > Month 24|Death|0|||
126389765|NCT02908685|454720487|FG009|Part 2 OLE: > Month 24|Death|0|||
126389766|NCT02908685|454720488|FG010|Part 2 OLE: > Month 24|Death|0|||
126389767|NCT02908685|454720489|FG011|Part 2 OLE: > Month 24|Death|0|||
126389768|NCT02908685|454720490|FG012|Part 2 OLE: > Month 24|Death|1|||
126389769|NCT02908685|454720491|FG013|Part 2 OLE: > Month 24|Death|0|||
126389770|NCT02908685|454720478|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
126389771|NCT02908685|454720479|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
126389772|NCT02908685|454720480|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
126389773|NCT02908685|454720481|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
126389774|NCT02908685|454720482|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
126389775|NCT02908685|454720483|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
126389776|NCT02908685|454720484|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
126389777|NCT02908685|454720485|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
126389778|NCT02908685|454720486|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
126389779|NCT02908685|454720487|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
126389780|NCT02908685|454720488|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
126389781|NCT02908685|454720489|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
126389782|NCT02908685|454720490|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
126389783|NCT02908685|454720491|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
126389784|NCT02908685|454720478|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389785|NCT02908685|454720479|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389786|NCT02908685|454720480|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389787|NCT02908685|454720481|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389788|NCT02908685|454720482|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389789|NCT02908685|454720483|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389790|NCT02908685|454720484|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389791|NCT02908685|454720485|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389792|NCT02908685|454720486|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389793|NCT02908685|454720487|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389794|NCT02908685|454720488|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389795|NCT02908685|454720489|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389796|NCT02908685|454720490|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
126389797|NCT02908685|454720491|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
126389798|NCT02370537|454720494|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
126389799|NCT02370537|454720495|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
126389800|NCT02370537|454720496|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
126389801|NCT02370537|454720494|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
126389802|NCT02370537|454720495|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
126389803|NCT02370537|454720496|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
126389804|NCT02370537|454720494|FG000|Part B|Not randomised to receive treatment|1|||
126389805|NCT02370537|454720495|FG001|Part B|Not randomised to receive treatment|2|||
126389806|NCT02370537|454720496|FG002|Part B|Not randomised to receive treatment|259|||
126389807|NCT02370537|454720494|FG000|Part B|Withdrawal by Subject|0|||
126389808|NCT02370537|454720495|FG001|Part B|Withdrawal by Subject|1|||
126389809|NCT02370537|454720496|FG002|Part B|Withdrawal by Subject|0|||
126389810|NCT01691014|454720497|FG000|Overall Study|Premature Termination|1|||
126389811|NCT01691014|454720498|FG001|Overall Study|Premature Termination|6|||
126389812|NCT01691014|454720499|FG002|Overall Study|Premature Termination|0|||
126389813|NCT01691014|454720500|FG003|Overall Study|Premature Termination|3|||
126389814|NCT01691014|454720497|FG000|Overall Study|Other|0|||
126389815|NCT01691014|454720498|FG001|Overall Study|Other|0|||
126389816|NCT01691014|454720499|FG002|Overall Study|Other|2|||
126389817|NCT01691014|454720500|FG003|Overall Study|Other|0|||
126389818|NCT01691014|454720497|FG000|Overall Study|Withdrawal by Subject|0|||
126389819|NCT01691014|454720498|FG001|Overall Study|Withdrawal by Subject|1|||
126389820|NCT01691014|454720499|FG002|Overall Study|Withdrawal by Subject|1|||
126389821|NCT01691014|454720500|FG003|Overall Study|Withdrawal by Subject|1|||
126389822|NCT01691014|454720497|FG000|Overall Study|Adverse Event|0|||
126389823|NCT01691014|454720498|FG001|Overall Study|Adverse Event|5|||
126389824|NCT01691014|454720499|FG002|Overall Study|Adverse Event|1|||
126389825|NCT01691014|454720500|FG003|Overall Study|Adverse Event|1|||
126389826|NCT01691014|454720497|FG000|Overall Study|Lack of Efficacy|2|||
126389827|NCT01691014|454720498|FG001|Overall Study|Lack of Efficacy|3|||
126389828|NCT01691014|454720499|FG002|Overall Study|Lack of Efficacy|7|||
126389829|NCT01691014|454720500|FG003|Overall Study|Lack of Efficacy|0|||
126389830|NCT03100539|454720507|FG000|Overall Study|Lost to Follow-up|60|||
126389831|NCT03100539|454720508|FG001|Overall Study|Lost to Follow-up|54|||
126389832|NCT03100539|454720509|FG002|Overall Study|Lost to Follow-up|17|||
126389833|NCT03100539|454720507|FG000|Overall Study|Uncollected|8|||
126389834|NCT03100539|454720508|FG001|Overall Study|Uncollected|8|||
126389835|NCT03100539|454720509|FG002|Overall Study|Uncollected|0|||
126049042|NCT00309166|453476671|FG000|Overall Study|Withdrawal by Subject|4|||
126389836|NCT03100539|454720507|FG000|Overall Study|Ally Health|0|||
126389837|NCT03100539|454720508|FG001|Overall Study|Ally Health|0|||
126389838|NCT03100539|454720509|FG002|Overall Study|Ally Health|3|||
126389839|NCT03100539|454720507|FG000|Overall Study|Disinterest|0|||
126389840|NCT03100539|454720508|FG001|Overall Study|Disinterest|0|||
126389841|NCT03100539|454720509|FG002|Overall Study|Disinterest|22|||
126389842|NCT03100539|454720507|FG000|Overall Study|Veteran Health|0|||
126389843|NCT03100539|454720508|FG001|Overall Study|Veteran Health|0|||
126389844|NCT03100539|454720509|FG002|Overall Study|Veteran Health|8|||
126389845|NCT03100539|454720507|FG000|Overall Study|Moved|0|||
126389846|NCT03100539|454720508|FG001|Overall Study|Moved|0|||
126389847|NCT03100539|454720509|FG002|Overall Study|Moved|1|||
126389848|NCT03100539|454720507|FG000|Overall Study|Scheduling Conflicts|0|||
126389849|NCT03100539|454720508|FG001|Overall Study|Scheduling Conflicts|0|||
126389850|NCT03100539|454720509|FG002|Overall Study|Scheduling Conflicts|12|||
126389851|NCT05897242|454720510|FG000|Overall Study|Lost to Follow-up|6|||
126389852|NCT05897242|454720511|FG001|Overall Study|Lost to Follow-up|1|||
126389853|NCT05897242|454720510|FG000|Overall Study|Incomplete|1|||
126389854|NCT05897242|454720511|FG001|Overall Study|Incomplete|0|||
126389855|NCT05897242|454720510|FG000|Overall Study|Withdrawal by Subject|1|||
126389856|NCT05897242|454720511|FG001|Overall Study|Withdrawal by Subject|0|||
126389857|NCT00809835|454720512|FG000|Overall Study|Lost to Follow-up|7|||
126389858|NCT00809835|454720513|FG001|Overall Study|Lost to Follow-up|6|||
125887528|NCT02106390|452884486|FG002|Overall Study|Other: Administrative Reason|12|||
126389859|NCT00809835|454720514|FG002|Overall Study|Lost to Follow-up|10|||
126389860|NCT00809835|454720515|FG003|Overall Study|Lost to Follow-up|2|||
126389861|NCT00809835|454720512|FG000|Overall Study|Withdrawal by Subject|1|||
126389862|NCT00809835|454720513|FG001|Overall Study|Withdrawal by Subject|1|||
126389863|NCT00809835|454720514|FG002|Overall Study|Withdrawal by Subject|1|||
126389864|NCT00809835|454720515|FG003|Overall Study|Withdrawal by Subject|0|||
126389865|NCT00066703|454720516|FG000|Overall Study|Adverse Event|80|||
126389866|NCT00066703|454720517|FG001|Overall Study|Adverse Event|111|||
126389867|NCT00066703|454720516|FG000|Overall Study|Death|3|||
126389868|NCT00066703|454720517|FG001|Overall Study|Death|0|||
126389869|NCT00066703|454720516|FG000|Overall Study|Lack of Efficacy|114|||
126389870|NCT00066703|454720517|FG001|Overall Study|Lack of Efficacy|69|||
126389871|NCT00066703|454720516|FG000|Overall Study|Lost to Follow-up|31|||
126389872|NCT00066703|454720517|FG001|Overall Study|Lost to Follow-up|28|||
126389873|NCT00066703|454720516|FG000|Overall Study|Withdrawal by Subject|38|||
126389874|NCT00066703|454720517|FG001|Overall Study|Withdrawal by Subject|63|||
126389875|NCT00066703|454720516|FG000|Overall Study|Treatment ongoing|346|||
126389876|NCT00066703|454720517|FG001|Overall Study|Treatment ongoing|311|||
126389877|NCT01696968|454720518|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
126389878|NCT01696968|454720519|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
126389879|NCT01696968|454720518|FG000|Overall Study|Died Before Randomization|3|||
126389880|NCT01696968|454720519|FG001|Overall Study|Died Before Randomization|8|||
126389881|NCT01696968|454720518|FG000|Overall Study|Died Before ASU (Control)|278|||
126389882|NCT01696968|454720519|FG001|Overall Study|Died Before ASU (Control)|0|||
126389883|NCT01696968|454720518|FG000|Overall Study|Refused ASU (Control)|920|||
126389884|NCT01696968|454720519|FG001|Overall Study|Refused ASU (Control)|0|||
126389885|NCT01696968|454720518|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
126389886|NCT01696968|454720519|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
126389887|NCT05659719|454720520|FG000|Overall Study|At sponsor's request|0|||
126389888|NCT05659719|454720521|FG001|Overall Study|At sponsor's request|0|||
126389889|NCT05659719|454720522|FG002|Overall Study|At sponsor's request|0|||
126389890|NCT05659719|454720523|FG003|Overall Study|At sponsor's request|95|||
126389891|NCT05659719|454720520|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
126389892|NCT05659719|454720521|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
126389893|NCT05659719|454720522|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
126389894|NCT05659719|454720523|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
126389895|NCT05659719|454720520|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
126389896|NCT05659719|454720521|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
126389897|NCT05659719|454720522|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
126389898|NCT05659719|454720523|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
126389899|NCT05659719|454720520|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
126389900|NCT05659719|454720521|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
126389901|NCT05659719|454720522|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
126389902|NCT05659719|454720523|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
126389903|NCT05659719|454720520|FG000|Overall Study|Lost to Follow-up|0|||
126389904|NCT05659719|454720521|FG001|Overall Study|Lost to Follow-up|0|||
126389905|NCT05659719|454720522|FG002|Overall Study|Lost to Follow-up|0|||
126389906|NCT05659719|454720523|FG003|Overall Study|Lost to Follow-up|2|||
126389907|NCT05659719|454720520|FG000|Overall Study|Moved to another observational study|0|||
126389908|NCT05659719|454720521|FG001|Overall Study|Moved to another observational study|0|||
125887529|NCT02106390|452884484|FG000|Overall Study|Other: Unspecified|1|||
125887530|NCT02106390|452884485|FG001|Overall Study|Other: Unspecified|4|||
126389909|NCT05659719|454720522|FG002|Overall Study|Moved to another observational study|0|||
126389910|NCT05659719|454720523|FG003|Overall Study|Moved to another observational study|1|||
126389911|NCT05659719|454720520|FG000|Overall Study|The child was enrolled in an interventional study|0|||
125887531|NCT02106390|452884486|FG002|Overall Study|Other: Unspecified|2|||
125887532|NCT02106390|452884484|FG000|Overall Study|Adverse Event|0|||
125887533|NCT02106390|452884485|FG001|Overall Study|Adverse Event|2|||
125887534|NCT02106390|452884486|FG002|Overall Study|Adverse Event|1|||
125887535|NCT02106390|452884484|FG000|Overall Study|Protocol Violation|0|||
125887536|NCT02106390|452884485|FG001|Overall Study|Protocol Violation|1|||
125887537|NCT02106390|452884486|FG002|Overall Study|Protocol Violation|0|||
125887538|NCT03198507|452884487|FG000|Overall Study|Withdrawal by Subject|1|||
125887539|NCT03198507|452884488|FG001|Overall Study|Withdrawal by Subject|0|||
125887540|NCT00241839|452884493|FG000|Overall Study|Withdrawal by Subject|18|||
125887541|NCT00241839|452884494|FG001|Overall Study|Withdrawal by Subject|17|||
125887542|NCT00241839|452884493|FG000|Overall Study|Adverse Event|1|||
126049043|NCT00309166|453476672|FG001|Overall Study|Withdrawal by Subject|3|||
126049044|NCT03477175|453476677|FG000|Overall Study|Unable to travel due to COVID-19|0|||
126049045|NCT03477175|453476678|FG001|Overall Study|Unable to travel due to COVID-19|1|||
126049046|NCT03477175|453476677|FG000|Overall Study|Physician Decision|1|||
126049047|NCT03477175|453476678|FG001|Overall Study|Physician Decision|0|||
126049048|NCT03477175|453476677|FG000|Overall Study|Transitioned to commercial drug|6|||
126049049|NCT03477175|453476678|FG001|Overall Study|Transitioned to commercial drug|6|||
126049050|NCT03477175|453476677|FG000|Overall Study|Lost to Follow-up|1|||
126049051|NCT03477175|453476678|FG001|Overall Study|Lost to Follow-up|1|||
126049052|NCT03477175|453476677|FG000|Overall Study|Withdrawal by Subject|3|||
126049053|NCT03477175|453476678|FG001|Overall Study|Withdrawal by Subject|1|||
126049054|NCT03477175|453476677|FG000|Overall Study|Adverse Event|1|||
126049055|NCT03477175|453476678|FG001|Overall Study|Adverse Event|5|||
126049056|NCT03477175|453476677|FG000|Overall Study|Disease Progression|7|||
126049057|NCT03477175|453476678|FG001|Overall Study|Disease Progression|7|||
126049058|NCT04517435|453476695|FG000|Overall Study|Withdrawal by Subject|0|||
126049059|NCT04517435|453476696|FG001|Overall Study|Withdrawal by Subject|0|||
126049060|NCT04517435|453476697|FG002|Overall Study|Withdrawal by Subject|1|||
126049061|NCT04517435|453476695|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
126049062|NCT04517435|453476696|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
126049063|NCT04517435|453476697|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
126049064|NCT04882917|453476701|FG000|Overall Study|Adverse Event|0|||
126049065|NCT04882917|453476702|FG001|Overall Study|Adverse Event|1|||
126049066|NCT04882917|453476703|FG002|Overall Study|Adverse Event|2|||
126049067|NCT04882917|453476704|FG003|Overall Study|Adverse Event|2|||
126049068|NCT04882917|453476701|FG000|Overall Study|Withdrawal by Subject|1|||
126049069|NCT04882917|453476702|FG001|Overall Study|Withdrawal by Subject|0|||
126049070|NCT04882917|453476703|FG002|Overall Study|Withdrawal by Subject|2|||
126049071|NCT04882917|453476704|FG003|Overall Study|Withdrawal by Subject|1|||
126389912|NCT05659719|454720521|FG001|Overall Study|The child was enrolled in an interventional study|0|||
126389913|NCT05659719|454720522|FG002|Overall Study|The child was enrolled in an interventional study|0|||
126389914|NCT05659719|454720523|FG003|Overall Study|The child was enrolled in an interventional study|55|||
126389915|NCT05659719|454720520|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
126389916|NCT05659719|454720521|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
126389917|NCT05659719|454720522|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
126389918|NCT05659719|454720523|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
126389919|NCT05659719|454720520|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
125887543|NCT00241839|452884494|FG001|Overall Study|Adverse Event|1|||
125887544|NCT00439517|452884497|FG000|Overall Study|Subject on treatment|1|||
126049072|NCT04882917|453476701|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
126049073|NCT04882917|453476702|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
126049074|NCT04882917|453476703|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
126049075|NCT04882917|453476704|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
126049076|NCT02678689|453476705|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
126049077|NCT02678689|453476706|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
126049078|NCT03160885|453476707|FG000|Initial Treatment Period|Not dosed|2|||
126049079|NCT03160885|453476708|FG001|Initial Treatment Period|Not dosed|0|||
126049080|NCT03160885|453476709|FG002|Initial Treatment Period|Not dosed|0|||
125887545|NCT00439517|452884498|FG001|Overall Study|Subject on treatment|0|||
125887546|NCT00439517|452884497|FG000|Overall Study|Subject in survival follow-up|1|||
125887547|NCT00439517|452884498|FG001|Overall Study|Subject in survival follow-up|0|||
125887548|NCT02304367|452884501|FG000|Overall Study|Lack of Response to Bruosumab|1|||
125887549|NCT02304367|452884501|FG000|Overall Study|Sponsor Decision|3|||
125887550|NCT02304367|452884501|FG000|Overall Study|Death|2|||
125887551|NCT02304367|452884501|FG000|Overall Study|Physician Decision|1|||
125887552|NCT02304367|452884501|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
125887553|NCT00526071|452884502|FG000|Overall Study|Adverse Event|1|||
125887554|NCT00526071|452884502|FG000|Overall Study|Withdrawal by Subject|1|||
125887555|NCT00526071|452884502|FG000|Overall Study|Lack of Response to Study Drug|4|||
125887556|NCT00318643|452884508|FG000|Overall Study|Adverse Event|0|||
125887557|NCT00318643|452884509|FG001|Overall Study|Adverse Event|0|||
125887558|NCT00318643|452884510|FG002|Overall Study|Adverse Event|0|||
125887559|NCT00318643|452884511|FG003|Overall Study|Adverse Event|0|||
125887560|NCT00318643|452884512|FG004|Overall Study|Adverse Event|1|||
125887561|NCT00318643|452884508|FG000|Overall Study|Participant's Decision|0|||
125887562|NCT00318643|452884509|FG001|Overall Study|Participant's Decision|0|||
125887563|NCT00318643|452884510|FG002|Overall Study|Participant's Decision|0|||
125887564|NCT00318643|452884511|FG003|Overall Study|Participant's Decision|0|||
125887565|NCT00318643|452884512|FG004|Overall Study|Participant's Decision|1|||
125887566|NCT00318643|452884508|FG000|Overall Study|Investigator's Decision|0|||
125887567|NCT00318643|452884509|FG001|Overall Study|Investigator's Decision|0|||
125887568|NCT00318643|452884510|FG002|Overall Study|Investigator's Decision|0|||
125887569|NCT00318643|452884511|FG003|Overall Study|Investigator's Decision|0|||
125887570|NCT00318643|452884512|FG004|Overall Study|Investigator's Decision|1|||
125887571|NCT02500797|452884515|FG000|Overall Study|Cancel (rapid disease progression)|0|||
125887572|NCT02500797|452884516|FG001|Overall Study|Cancel (rapid disease progression)|0|||
125887573|NCT02500797|452884517|FG002|Overall Study|Cancel (rapid disease progression)|0|||
125887574|NCT02500797|452884518|FG003|Overall Study|Cancel (rapid disease progression)|0|||
125887575|NCT02500797|452884519|FG004|Overall Study|Cancel (rapid disease progression)|1|||
125887576|NCT02500797|452884520|FG005|Overall Study|Cancel (rapid disease progression)|1|||
125887577|NCT02500797|452884521|FG006|Overall Study|Cancel (rapid disease progression)|0|||
125887578|NCT02500797|452884522|FG007|Overall Study|Cancel (rapid disease progression)|0|||
125887579|NCT02500797|452884515|FG000|Overall Study|Withdrawal by Subject|1|||
125887580|NCT02500797|452884516|FG001|Overall Study|Withdrawal by Subject|0|||
125887581|NCT02500797|452884517|FG002|Overall Study|Withdrawal by Subject|0|||
125887582|NCT02500797|452884518|FG003|Overall Study|Withdrawal by Subject|0|||
125887583|NCT02500797|452884519|FG004|Overall Study|Withdrawal by Subject|0|||
125887584|NCT02500797|452884520|FG005|Overall Study|Withdrawal by Subject|0|||
126049081|NCT03160885|453476710|FG003|Initial Treatment Period|Not dosed|0|||
126049082|NCT03160885|453476711|FG004|Initial Treatment Period|Not dosed|0|||
126049083|NCT03160885|453476712|FG005|Initial Treatment Period|Not dosed|0|||
126049084|NCT03160885|453476713|FG006|Initial Treatment Period|Not dosed|0|||
126049085|NCT03160885|453476707|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
126049086|NCT03160885|453476708|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
126049087|NCT03160885|453476709|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126049088|NCT03160885|453476710|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126049089|NCT03160885|453476711|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126049090|NCT03160885|453476712|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126049091|NCT03160885|453476713|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126049092|NCT03160885|453476707|FG000|Open-label Treatment|Not dosed|0|||
126049093|NCT03160885|453476708|FG001|Open-label Treatment|Not dosed|0|||
126049094|NCT03160885|453476709|FG002|Open-label Treatment|Not dosed|0|||
126049095|NCT03160885|453476710|FG003|Open-label Treatment|Not dosed|0|||
126389920|NCT05659719|454720521|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
126389921|NCT05659719|454720522|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
126049096|NCT03160885|453476711|FG004|Open-label Treatment|Not dosed|0|||
126049097|NCT03160885|453476712|FG005|Open-label Treatment|Not dosed|0|||
126049098|NCT03160885|453476713|FG006|Open-label Treatment|Not dosed|2|||
126389922|NCT05659719|454720523|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
126389923|NCT01681186|454720524|FG000|Washout Period From Second Intervention|Adverse Event|0|||
126389924|NCT01681186|454720525|FG001|Washout Period From Second Intervention|Adverse Event|0|||
126389925|NCT01681186|454720526|FG002|Washout Period From Second Intervention|Adverse Event|0|||
126389926|NCT01681186|454720527|FG003|Washout Period From Second Intervention|Adverse Event|0|||
126389927|NCT01681186|454720528|FG004|Washout Period From Second Intervention|Adverse Event|0|||
126389928|NCT01681186|454720529|FG005|Washout Period From Second Intervention|Adverse Event|0|||
126389929|NCT01681186|454720530|FG006|Washout Period From Second Intervention|Adverse Event|1|||
125887585|NCT02500797|452884521|FG006|Overall Study|Withdrawal by Subject|0|||
125887586|NCT02500797|452884522|FG007|Overall Study|Withdrawal by Subject|0|||
125887587|NCT00357006|452884527|FG000|Overall Study|Lost to Follow-up|1|||
125887588|NCT00357006|452884528|FG001|Overall Study|Lost to Follow-up|2|||
125887589|NCT00357006|452884529|FG002|Overall Study|Lost to Follow-up|1|||
126104243|NCT03435497|453675833|FG001|Overall Study|Withdrawal by Subject|4|||
125887590|NCT00357006|452884527|FG000|Overall Study|Withdrawal by Subject|1|||
125887591|NCT00357006|452884528|FG001|Overall Study|Withdrawal by Subject|3|||
125887592|NCT00357006|452884529|FG002|Overall Study|Withdrawal by Subject|2|||
126389930|NCT01681186|454720531|FG007|Washout Period From Second Intervention|Adverse Event|0|||
126389931|NCT01681186|454720524|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
126389932|NCT01681186|454720525|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
126389933|NCT01681186|454720526|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
126389934|NCT01681186|454720527|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
126389935|NCT01681186|454720528|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
126389936|NCT01681186|454720529|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
126389937|NCT01681186|454720530|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
126389938|NCT01681186|454720531|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
126389939|NCT01681186|454720524|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389940|NCT01681186|454720525|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389941|NCT01681186|454720526|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389942|NCT01681186|454720527|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389943|NCT01681186|454720528|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389944|NCT01681186|454720529|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389945|NCT01681186|454720530|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
126389946|NCT01681186|454720531|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389947|NCT01681186|454720524|FG000|Fourth Intervention|Protocol Violation|0|||
126389948|NCT01681186|454720525|FG001|Fourth Intervention|Protocol Violation|0|||
126389949|NCT01681186|454720526|FG002|Fourth Intervention|Protocol Violation|0|||
126389950|NCT01681186|454720527|FG003|Fourth Intervention|Protocol Violation|0|||
126389951|NCT01681186|454720528|FG004|Fourth Intervention|Protocol Violation|0|||
126389952|NCT01681186|454720529|FG005|Fourth Intervention|Protocol Violation|0|||
126389953|NCT01681186|454720530|FG006|Fourth Intervention|Protocol Violation|0|||
126389954|NCT01681186|454720531|FG007|Fourth Intervention|Protocol Violation|1|||
126389955|NCT05160415|454720532|FG000|Overall Study|Withdrawal by Subject|3|||
126389956|NCT04848220|454720533|FG000|Overall Study|Unable to proceed to study procedure|0|||
126389957|NCT04848220|454720534|FG001|Overall Study|Unable to proceed to study procedure|1|||
126389958|NCT04848220|454720535|FG002|Overall Study|Unable to proceed to study procedure|0|||
126389959|NCT04848220|454720533|FG000|Overall Study|Fractional flow not significant|0|||
126389960|NCT04848220|454720534|FG001|Overall Study|Fractional flow not significant|1|||
126389961|NCT04848220|454720535|FG002|Overall Study|Fractional flow not significant|0|||
126389962|NCT02923830|454720536|FG000|Overall Study|Physician Decision|13|||
126389963|NCT02923830|454720537|FG001|Overall Study|Physician Decision|15|||
126389964|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
126389965|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
126389966|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
126104244|NCT03435497|453675832|FG000|Overall Study|Wrong survey administered|0|||
126104245|NCT03435497|453675833|FG001|Overall Study|Wrong survey administered|2|||
126104246|NCT00701779|453675834|FG000|Overall Study|Adverse Event|6|||
126104247|NCT00701779|453675834|FG000|Overall Study|Lost to Follow-up|1|||
126104248|NCT00701779|453675834|FG000|Overall Study|Withdrawal by Subject|2|||
126389967|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
126389968|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
126389969|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
126389970|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
126389971|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
126389972|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
126389973|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
126389974|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
126389975|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
126389976|NCT05791565|454720552|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
126389977|NCT05791565|454720553|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
126389978|NCT02388165|454720554|FG000|Overall Study|Study terminated by sponsor|5|||
126389979|NCT02388165|454720555|FG001|Overall Study|Study terminated by sponsor|5|||
126389980|NCT02388165|454720554|FG000|Overall Study|Other|11|||
126389981|NCT02388165|454720555|FG001|Overall Study|Other|13|||
126389982|NCT02388165|454720554|FG000|Overall Study|No longer meet eligibility criteria|40|||
126389983|NCT02388165|454720555|FG001|Overall Study|No longer meet eligibility criteria|43|||
126389984|NCT02388165|454720554|FG000|Overall Study|Withdrawal of consent|31|||
126389985|NCT02388165|454720555|FG001|Overall Study|Withdrawal of consent|32|||
126389986|NCT02388165|454720554|FG000|Overall Study|Lost to Follow-up|19|||
126389987|NCT02388165|454720555|FG001|Overall Study|Lost to Follow-up|20|||
126389988|NCT02388165|454720554|FG000|Overall Study|Death|13|||
126389989|NCT02388165|454720555|FG001|Overall Study|Death|10|||
126389990|NCT02388165|454720554|FG000|Overall Study|Adverse Event|3|||
126389991|NCT02388165|454720555|FG001|Overall Study|Adverse Event|5|||
126389992|NCT02388165|454720554|FG000|Overall Study|Did not meet entrance criteria|5|||
126389993|NCT02388165|454720555|FG001|Overall Study|Did not meet entrance criteria|2|||
126104249|NCT05220254|453675836|FG000|Overall Study|Withdrawal by Subject|4|||
125887593|NCT01216189|452884530|FG000|Overall Study|Lost to Follow-up|21|||
125887594|NCT01216189|452884531|FG001|Overall Study|Lost to Follow-up|3|||
125887595|NCT01216189|452884530|FG000|Overall Study|Death|4|||
125887596|NCT01216189|452884531|FG001|Overall Study|Death|2|||
125887597|NCT01469377|452884533|FG000|Overall Study|Protocol Deviation|7|||
125887598|NCT01469377|452884534|FG001|Overall Study|Protocol Deviation|10|||
125887599|NCT01469377|452884535|FG002|Overall Study|Protocol Deviation|10|||
125887600|NCT01469377|452884533|FG000|Overall Study|Lost to Follow-up|3|||
126389994|NCT00880269|454720556|FG000|Overall Study|Protocol Violation|1|||
126389995|NCT00880269|454720557|FG001|Overall Study|Protocol Violation|0|||
126389996|NCT00880269|454720556|FG000|Overall Study|Disease Progression|13|||
126389997|NCT00880269|454720557|FG001|Overall Study|Disease Progression|11|||
126389998|NCT00880269|454720556|FG000|Overall Study|New Cancer Therapy|1|||
126389999|NCT00880269|454720557|FG001|Overall Study|New Cancer Therapy|0|||
126390000|NCT00880269|454720556|FG000|Overall Study|Death|4|||
126390001|NCT00880269|454720557|FG001|Overall Study|Death|2|||
126390002|NCT00880269|454720556|FG000|Overall Study|Lost to Follow-up|0|||
126390003|NCT00880269|454720557|FG001|Overall Study|Lost to Follow-up|1|||
126390004|NCT00880269|454720556|FG000|Overall Study|Withdrawal by Subject|3|||
126390005|NCT00880269|454720557|FG001|Overall Study|Withdrawal by Subject|4|||
126390006|NCT00880269|454720556|FG000|Overall Study|Adverse Event|10|||
126390007|NCT00880269|454720557|FG001|Overall Study|Adverse Event|9|||
126390008|NCT00316225|454720564|FG000|Overall Study|Adverse Event|2|||
126390009|NCT00316225|454720564|FG000|Overall Study|Physician Decision|3|||
126390010|NCT00316225|454720564|FG000|Overall Study|Progressive Disease|15|||
126390011|NCT00316225|454720564|FG000|Overall Study|Withdrawal by Subject|3|||
126390012|NCT00316225|454720564|FG000|Overall Study|Death|2|||
126390013|NCT01811485|454720565|FG000|Overall Study|Adverse Event|1|||
126390014|NCT01811485|454720566|FG001|Overall Study|Adverse Event|3|||
126390015|NCT01811485|454720567|FG002|Overall Study|Adverse Event|2|||
126390016|NCT01811485|454720565|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126390017|NCT01811485|454720566|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126390018|NCT01811485|454720567|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
126390019|NCT01811485|454720565|FG000|Overall Study|Administrative problems|1|||
126390020|NCT01811485|454720566|FG001|Overall Study|Administrative problems|0|||
126390021|NCT01811485|454720567|FG002|Overall Study|Administrative problems|0|||
126390022|NCT01811485|454720565|FG000|Overall Study|Protocol Deviation|0|||
126390023|NCT01811485|454720566|FG001|Overall Study|Protocol Deviation|1|||
126390024|NCT01811485|454720567|FG002|Overall Study|Protocol Deviation|0|||
126390025|NCT01545934|454720568|FG000|Overall Study|Withdrawal by Subject|4|||
125887601|NCT01469377|452884534|FG001|Overall Study|Lost to Follow-up|2|||
125887602|NCT01469377|452884535|FG002|Overall Study|Lost to Follow-up|5|||
125887603|NCT01469377|452884533|FG000|Overall Study|Withdrawal of Consent|12|||
126390026|NCT01545934|454720569|FG001|Overall Study|Withdrawal by Subject|3|||
126390027|NCT01545934|454720568|FG000|Overall Study|Lost to Follow-up|1|||
126390028|NCT01545934|454720569|FG001|Overall Study|Lost to Follow-up|0|||
126390029|NCT03654404|454720570|FG000|Overall Study|Death|1|||
126390030|NCT03654404|454720570|FG000|Overall Study|Lost to Follow-up|2|||
126390031|NCT03654404|454720570|FG000|Overall Study|Withdrawal by Subject|5|||
126390032|NCT02003638|454720573|FG000|Overall Study|Withdrawal by Subject|1|||
126390033|NCT02003638|454720574|FG001|Overall Study|Withdrawal by Subject|0|||
126390034|NCT06004895|454720580|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
126390035|NCT06004895|454720580|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
126390036|NCT02314156|454720582|FG000|Overall Study|Adverse Event|1|||
126390037|NCT02314156|454720583|FG001|Overall Study|Adverse Event|0|||
126390038|NCT02314156|454720582|FG000|Overall Study|Withdrawal by Subject|1|||
126390039|NCT02314156|454720583|FG001|Overall Study|Withdrawal by Subject|0|||
126390040|NCT03497975|454720587|FG000|Overall Study|Withdrew Consent|34|||
126390041|NCT03497975|454720588|FG001|Overall Study|Withdrew Consent|35|||
126390042|NCT03497975|454720587|FG000|Overall Study|Lost to Follow-up|7|||
126390043|NCT03497975|454720588|FG001|Overall Study|Lost to Follow-up|7|||
126390044|NCT03497975|454720587|FG000|Overall Study|Physician Decision|4|||
126390045|NCT03497975|454720588|FG001|Overall Study|Physician Decision|5|||
126390046|NCT03497975|454720587|FG000|Overall Study|Discontinued|42|||
126390047|NCT03497975|454720588|FG001|Overall Study|Discontinued|39|||
126390048|NCT03497975|454720587|FG000|Overall Study|Reason Not Specified|15|||
126390049|NCT03497975|454720588|FG001|Overall Study|Reason Not Specified|14|||
126390050|NCT01257230|454720589|FG000|Overall Study|Not Treated|0|||
126390051|NCT01257230|454720590|FG001|Overall Study|Not Treated|0|||
126390052|NCT01257230|454720591|FG002|Overall Study|Not Treated|1|||
126390053|NCT01257230|454720589|FG000|Overall Study|Adverse Event|2|||
126390054|NCT01257230|454720590|FG001|Overall Study|Adverse Event|0|||
125887604|NCT01469377|452884534|FG001|Overall Study|Withdrawal of Consent|14|||
125887605|NCT01469377|452884535|FG002|Overall Study|Withdrawal of Consent|15|||
125887606|NCT01469377|452884533|FG000|Overall Study|Adverse Event|8|||
125887607|NCT01469377|452884534|FG001|Overall Study|Adverse Event|18|||
126390055|NCT01257230|454720591|FG002|Overall Study|Adverse Event|0|||
126390056|NCT01257230|454720589|FG000|Overall Study|Lack of Efficacy|0|||
126390057|NCT01257230|454720590|FG001|Overall Study|Lack of Efficacy|1|||
126390058|NCT01257230|454720591|FG002|Overall Study|Lack of Efficacy|0|||
126390059|NCT01257230|454720589|FG000|Overall Study|Protocol Violation|3|||
126390060|NCT01257230|454720590|FG001|Overall Study|Protocol Violation|0|||
126390061|NCT01257230|454720591|FG002|Overall Study|Protocol Violation|1|||
126390062|NCT01257230|454720589|FG000|Overall Study|Withdrawal by Subject|0|||
126390063|NCT01257230|454720590|FG001|Overall Study|Withdrawal by Subject|4|||
126390064|NCT01257230|454720591|FG002|Overall Study|Withdrawal by Subject|1|||
126390065|NCT01257230|454720589|FG000|Overall Study|Other reason not defined above|1|||
126390066|NCT01257230|454720590|FG001|Overall Study|Other reason not defined above|5|||
126390067|NCT01257230|454720591|FG002|Overall Study|Other reason not defined above|3|||
126390068|NCT01205061|454720594|FG000|Overall Study|Adverse Event|4|||
126390069|NCT01205061|454720594|FG000|Overall Study|Withdrawal by Subject|11|||
126390070|NCT01205061|454720594|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
126390071|NCT01205061|454720594|FG000|Overall Study|Lost to Follow-up|9|||
126390072|NCT01205061|454720594|FG000|Overall Study|Other|1|||
126390073|NCT00765037|454720595|FG000|Overall Study|Lost to Follow-up|5|||
126390074|NCT00765037|454720595|FG000|Overall Study|Adverse Event|1|||
126390075|NCT03070171|454720600|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
126390076|NCT03070171|454720601|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
126390077|NCT03070171|454720600|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
126390078|NCT03070171|454720601|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
126390079|NCT01471028|454720605|FG000|VTI-208|Adverse Event|39|||
126390080|NCT01471028|454720606|FG001|VTI-208|Adverse Event|41|||
126390081|NCT01471028|454720605|FG000|VTI-208|Withdrawal by Subject|0|||
126390082|NCT01471028|454720606|FG001|VTI-208|Withdrawal by Subject|2|||
126390083|NCT01471028|454720605|FG000|VTI-208|Lost to Follow-up|1|||
126390084|NCT01471028|454720606|FG001|VTI-208|Lost to Follow-up|1|||
126390085|NCT01471028|454720605|FG000|VTI-208E|Death|7|||
126390086|NCT01471028|454720606|FG001|VTI-208E|Death|10|||
126390087|NCT01471028|454720605|FG000|VTI-208E|Withdrawal by Subject|1|||
126390088|NCT01471028|454720606|FG001|VTI-208E|Withdrawal by Subject|0|||
126390089|NCT01471028|454720605|FG000|VTI-208E|Lost to Follow-up|0|||
126390090|NCT01471028|454720606|FG001|VTI-208E|Lost to Follow-up|2|||
126390091|NCT00610857|454720608|FG000|Overall Study|Not evaluable for response|2|||
126390092|NCT04826094|454720609|FG000|Overall Study|Lost to Follow-up|2|||
126390093|NCT04826094|454720610|FG001|Overall Study|Lost to Follow-up|1|||
126390094|NCT04826094|454720611|FG002|Overall Study|Lost to Follow-up|0|||
126390095|NCT04826094|454720612|FG003|Overall Study|Lost to Follow-up|0|||
126390096|NCT04826094|454720613|FG004|Overall Study|Lost to Follow-up|1|||
126390097|NCT04826094|454720614|FG005|Overall Study|Lost to Follow-up|3|||
126390098|NCT04826094|454720615|FG006|Overall Study|Lost to Follow-up|1|||
126390099|NCT04826094|454720616|FG007|Overall Study|Lost to Follow-up|1|||
126390100|NCT04826094|454720609|FG000|Overall Study|Participant withdrew consent|1|||
126390101|NCT04826094|454720610|FG001|Overall Study|Participant withdrew consent|0|||
126390102|NCT04826094|454720611|FG002|Overall Study|Participant withdrew consent|0|||
126390103|NCT04826094|454720612|FG003|Overall Study|Participant withdrew consent|1|||
126390104|NCT04826094|454720613|FG004|Overall Study|Participant withdrew consent|1|||
126390105|NCT04826094|454720614|FG005|Overall Study|Participant withdrew consent|1|||
126390106|NCT04826094|454720615|FG006|Overall Study|Participant withdrew consent|0|||
126390107|NCT04826094|454720616|FG007|Overall Study|Participant withdrew consent|1|||
126390108|NCT04826094|454720609|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
126390109|NCT04826094|454720610|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
126390110|NCT04826094|454720611|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
126390111|NCT04826094|454720612|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
126390112|NCT04826094|454720613|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
126390113|NCT04826094|454720614|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
126390114|NCT04826094|454720615|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
126390115|NCT04826094|454720616|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
126390116|NCT04826094|454720609|FG000|Overall Study|Withdrawn by Investigator|0|||
126390117|NCT04826094|454720610|FG001|Overall Study|Withdrawn by Investigator|0|||
126390118|NCT04826094|454720611|FG002|Overall Study|Withdrawn by Investigator|0|||
126390119|NCT04826094|454720612|FG003|Overall Study|Withdrawn by Investigator|0|||
126390120|NCT04826094|454720613|FG004|Overall Study|Withdrawn by Investigator|0|||
126390121|NCT04826094|454720614|FG005|Overall Study|Withdrawn by Investigator|1|||
126390122|NCT04826094|454720615|FG006|Overall Study|Withdrawn by Investigator|0|||
126390123|NCT04826094|454720616|FG007|Overall Study|Withdrawn by Investigator|1|||
126390124|NCT04826094|454720609|FG000|Overall Study|Other: Moved from area|1|||
126390125|NCT04826094|454720610|FG001|Overall Study|Other: Moved from area|1|||
126390126|NCT04826094|454720611|FG002|Overall Study|Other: Moved from area|1|||
126390127|NCT04826094|454720612|FG003|Overall Study|Other: Moved from area|0|||
126390128|NCT04826094|454720613|FG004|Overall Study|Other: Moved from area|0|||
126390129|NCT04826094|454720614|FG005|Overall Study|Other: Moved from area|0|||
126390130|NCT04826094|454720615|FG006|Overall Study|Other: Moved from area|0|||
126390131|NCT04826094|454720616|FG007|Overall Study|Other: Moved from area|0|||
126390132|NCT04826094|454720609|FG000|Overall Study|Other: Declined|0|||
126390133|NCT04826094|454720610|FG001|Overall Study|Other: Declined|0|||
126049099|NCT03160885|453476707|FG000|Open-label Treatment|Discontinued IMP|0|||
126390134|NCT04826094|454720611|FG002|Overall Study|Other: Declined|0|||
126390135|NCT04826094|454720612|FG003|Overall Study|Other: Declined|0|||
126390136|NCT04826094|454720613|FG004|Overall Study|Other: Declined|1|||
126390137|NCT04826094|454720614|FG005|Overall Study|Other: Declined|0|||
126390138|NCT04826094|454720615|FG006|Overall Study|Other: Declined|0|||
126390139|NCT04826094|454720616|FG007|Overall Study|Other: Declined|0|||
126390140|NCT04826094|454720609|FG000|Overall Study|Other: Vaccine not administered|0|||
126390141|NCT04826094|454720610|FG001|Overall Study|Other: Vaccine not administered|0|||
126390142|NCT04826094|454720611|FG002|Overall Study|Other: Vaccine not administered|1|||
126390143|NCT04826094|454720612|FG003|Overall Study|Other: Vaccine not administered|0|||
126049100|NCT03160885|453476708|FG001|Open-label Treatment|Discontinued IMP|0|||
126049101|NCT03160885|453476709|FG002|Open-label Treatment|Discontinued IMP|0|||
126049102|NCT03160885|453476710|FG003|Open-label Treatment|Discontinued IMP|0|||
126049103|NCT03160885|453476711|FG004|Open-label Treatment|Discontinued IMP|0|||
126104250|NCT05220254|453675836|FG000|Overall Study|Removed due to ineligibility|1|||
126049104|NCT03160885|453476712|FG005|Open-label Treatment|Discontinued IMP|0|||
126049105|NCT03160885|453476713|FG006|Open-label Treatment|Discontinued IMP|131|||
126049106|NCT03160885|453476707|FG000|Open-label Treatment|Completed Week 50|0|||
126049107|NCT03160885|453476708|FG001|Open-label Treatment|Completed Week 50|0|||
126049108|NCT03160885|453476709|FG002|Open-label Treatment|Completed Week 50|0|||
126049109|NCT03160885|453476710|FG003|Open-label Treatment|Completed Week 50|0|||
126049110|NCT03160885|453476711|FG004|Open-label Treatment|Completed Week 50|0|||
126049111|NCT03160885|453476712|FG005|Open-label Treatment|Completed Week 50|0|||
126049112|NCT03160885|453476713|FG006|Open-label Treatment|Completed Week 50|4|||
126049113|NCT03160885|453476707|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126049114|NCT03160885|453476708|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126049115|NCT03160885|453476709|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126049116|NCT03160885|453476710|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
126049117|NCT03160885|453476711|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126049118|NCT03160885|453476712|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126049119|NCT03160885|453476713|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126049120|NCT03160885|453476707|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
126049121|NCT03160885|453476708|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
126049122|NCT03160885|453476709|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
126049123|NCT03160885|453476710|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
126049124|NCT03160885|453476711|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
126049125|NCT03160885|453476712|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
126049126|NCT03160885|453476713|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
126049127|NCT03160885|453476707|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126049128|NCT03160885|453476708|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126049129|NCT03160885|453476709|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
126049130|NCT03160885|453476710|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
126049131|NCT03160885|453476711|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
126049132|NCT03160885|453476712|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
126049133|NCT03160885|453476713|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126049134|NCT03160885|453476707|FG000|Maintenance Treatment Period|Completed Week 50|0|||
126049135|NCT03160885|453476708|FG001|Maintenance Treatment Period|Completed Week 50|0|||
126049136|NCT03160885|453476709|FG002|Maintenance Treatment Period|Completed Week 50|1|||
126390144|NCT04826094|454720613|FG004|Overall Study|Other: Vaccine not administered|0|||
126390145|NCT04826094|454720614|FG005|Overall Study|Other: Vaccine not administered|1|||
126390146|NCT04826094|454720615|FG006|Overall Study|Other: Vaccine not administered|1|||
126390147|NCT04826094|454720616|FG007|Overall Study|Other: Vaccine not administered|3|||
126390148|NCT05312697|454720617|FG000|Overall Study|Sponsor Terminated Trial|2|||
126390149|NCT04445519|454720618|FG000|Overall Study|Due to adaptive design|3|||
126390150|NCT04445519|454720619|FG001|Overall Study|Due to adaptive design|0|||
126049137|NCT03160885|453476710|FG003|Maintenance Treatment Period|Completed Week 50|0|||
126104251|NCT05220254|453675836|FG000|Overall Study|Lost to Follow-up|7|||
126390151|NCT04445519|454720620|FG002|Overall Study|Due to adaptive design|0|||
126390152|NCT04445519|454720618|FG000|Overall Study|Lost to Follow-up|0|||
126390153|NCT04445519|454720619|FG001|Overall Study|Lost to Follow-up|1|||
126390154|NCT04445519|454720620|FG002|Overall Study|Lost to Follow-up|4|||
126390155|NCT04445519|454720618|FG000|Overall Study|Sponsor or IRB Decision|0|||
126390156|NCT04445519|454720619|FG001|Overall Study|Sponsor or IRB Decision|1|||
126390157|NCT04445519|454720620|FG002|Overall Study|Sponsor or IRB Decision|2|||
126390158|NCT04445519|454720618|FG000|Overall Study|Withdrawal by Subject|0|||
126390159|NCT04445519|454720619|FG001|Overall Study|Withdrawal by Subject|3|||
126049138|NCT03160885|453476711|FG004|Maintenance Treatment Period|Completed Week 50|0|||
126104252|NCT01557283|453675837|FG000|Overall Study|Lost to Follow-up|7|||
126390160|NCT04445519|454720620|FG002|Overall Study|Withdrawal by Subject|3|||
126390161|NCT04445519|454720618|FG000|Overall Study|Adverse Event|0|||
126390162|NCT04445519|454720619|FG001|Overall Study|Adverse Event|8|||
126390163|NCT04445519|454720620|FG002|Overall Study|Adverse Event|6|||
126390164|NCT04445519|454720618|FG000|Overall Study|Other Reason|0|||
126390165|NCT04445519|454720619|FG001|Overall Study|Other Reason|1|||
126390166|NCT04445519|454720620|FG002|Overall Study|Other Reason|1|||
126390167|NCT04445519|454720618|FG000|Overall Study|Protocol Violation|0|||
126390168|NCT04445519|454720619|FG001|Overall Study|Protocol Violation|0|||
126390169|NCT04445519|454720620|FG002|Overall Study|Protocol Violation|1|||
126390170|NCT00177294|454720627|FG000|Overall Study|Withdrawal by Subject|7|||
126390171|NCT00177294|454720628|FG001|Overall Study|Withdrawal by Subject|5|||
126390172|NCT04154605|454720629|FG000|Overall Study|Procedure Canceled|1|||
126390173|NCT04154605|454720630|FG001|Overall Study|Procedure Canceled|1|||
126390174|NCT04154605|454720629|FG000|Overall Study|Missed follow up|1|||
126390175|NCT04154605|454720630|FG001|Overall Study|Missed follow up|1|||
126390176|NCT04154605|454720629|FG000|Overall Study|Withdrawal by Subject|1|||
126390177|NCT04154605|454720630|FG001|Overall Study|Withdrawal by Subject|0|||
126390178|NCT00700882|454720631|FG000|Overall Study|Never received treatment|6|||
126390179|NCT00700882|454720631|FG000|Overall Study|Ineligible|2|||
126390180|NCT00700882|454720631|FG000|Overall Study|No KIT mutation|51|||
126390181|NCT04154293|454720635|FG000|Overall Study|Withdrawal by Subject|2|||
126390182|NCT04154293|454720636|FG001|Overall Study|Withdrawal by Subject|3|||
126390183|NCT04154293|454720637|FG002|Overall Study|Withdrawal by Subject|1|||
126390184|NCT04154293|454720635|FG000|Overall Study|Physician Decision|0|||
126390185|NCT04154293|454720636|FG001|Overall Study|Physician Decision|0|||
126390186|NCT04154293|454720637|FG002|Overall Study|Physician Decision|1|||
126390187|NCT03403361|454720638|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
126390188|NCT02152371|454720640|FG000|Overall Study|Adverse Event|6|||
126390189|NCT02152371|454720641|FG001|Overall Study|Adverse Event|2|||
126390190|NCT02152371|454720640|FG000|Overall Study|Withdrawal by Subject|3|||
126390191|NCT02152371|454720641|FG001|Overall Study|Withdrawal by Subject|7|||
126390192|NCT02152371|454720640|FG000|Overall Study|Protocol Violation|2|||
126390193|NCT02152371|454720641|FG001|Overall Study|Protocol Violation|3|||
126390194|NCT02152371|454720640|FG000|Overall Study|Lost to Follow-up|1|||
126390195|NCT02152371|454720641|FG001|Overall Study|Lost to Follow-up|0|||
126390196|NCT02152371|454720640|FG000|Overall Study|Lack of Efficacy|0|||
126390197|NCT02152371|454720641|FG001|Overall Study|Lack of Efficacy|1|||
126390198|NCT02152371|454720640|FG000|Overall Study|Physician Decision|0|||
126390199|NCT02152371|454720641|FG001|Overall Study|Physician Decision|2|||
126390200|NCT02152371|454720640|FG000|Overall Study|Reason Not Given|0|||
126390201|NCT02152371|454720641|FG001|Overall Study|Reason Not Given|1|||
126390202|NCT06359028|454720646|FG000|Overall Study|Adverse Event|1|||
126390203|NCT06359028|454720647|FG001|Overall Study|Adverse Event|0|||
126390204|NCT06359028|454720646|FG000|Overall Study|Withdrawal by Subject|1|||
126390205|NCT06359028|454720647|FG001|Overall Study|Withdrawal by Subject|0|||
126390206|NCT04382586|454720648|FG000|Overall Study|Death|3|||
126390207|NCT04382586|454720649|FG001|Overall Study|Death|4|||
126390208|NCT04382586|454720648|FG000|Overall Study|Lost to Follow-up|11|||
126390209|NCT04382586|454720649|FG001|Overall Study|Lost to Follow-up|8|||
126390210|NCT04382586|454720648|FG000|Overall Study|Withdrawal by Subject|3|||
126390211|NCT04382586|454720649|FG001|Overall Study|Withdrawal by Subject|1|||
126390212|NCT04382586|454720648|FG000|Overall Study|Physician Decision|0|||
126390213|NCT04382586|454720649|FG001|Overall Study|Physician Decision|3|||
126390214|NCT00107900|454720654|FG000|Overall Study|Adverse Event|3|||
126390215|NCT00107900|454720655|FG001|Overall Study|Adverse Event|2|||
126390216|NCT00107900|454720656|FG002|Overall Study|Adverse Event|10|||
126390217|NCT00107900|454720657|FG003|Overall Study|Adverse Event|3|||
126390218|NCT00107900|454720658|FG004|Overall Study|Adverse Event|5|||
126390219|NCT00107900|454720659|FG005|Overall Study|Adverse Event|3|||
126390220|NCT00107900|454720654|FG000|Overall Study|Death|0|||
126390221|NCT00107900|454720655|FG001|Overall Study|Death|0|||
126390222|NCT00107900|454720656|FG002|Overall Study|Death|0|||
126390223|NCT00107900|454720657|FG003|Overall Study|Death|0|||
126390224|NCT00107900|454720658|FG004|Overall Study|Death|1|||
126390225|NCT00107900|454720659|FG005|Overall Study|Death|0|||
126390226|NCT00107900|454720654|FG000|Overall Study|Lost to Follow-up|4|||
126390227|NCT00107900|454720655|FG001|Overall Study|Lost to Follow-up|1|||
126390228|NCT00107900|454720656|FG002|Overall Study|Lost to Follow-up|3|||
126390229|NCT00107900|454720657|FG003|Overall Study|Lost to Follow-up|2|||
126390230|NCT00107900|454720658|FG004|Overall Study|Lost to Follow-up|5|||
126390231|NCT00107900|454720659|FG005|Overall Study|Lost to Follow-up|5|||
126390232|NCT00107900|454720654|FG000|Overall Study|Protocol Violation|1|||
126390233|NCT00107900|454720655|FG001|Overall Study|Protocol Violation|0|||
126390234|NCT00107900|454720656|FG002|Overall Study|Protocol Violation|5|||
126390235|NCT00107900|454720657|FG003|Overall Study|Protocol Violation|5|||
126390236|NCT00107900|454720658|FG004|Overall Study|Protocol Violation|7|||
126390237|NCT00107900|454720659|FG005|Overall Study|Protocol Violation|0|||
126390238|NCT00107900|454720654|FG000|Overall Study|Withdrawal by Subject|1|||
126390239|NCT00107900|454720655|FG001|Overall Study|Withdrawal by Subject|0|||
126390240|NCT00107900|454720656|FG002|Overall Study|Withdrawal by Subject|5|||
126390241|NCT00107900|454720657|FG003|Overall Study|Withdrawal by Subject|0|||
126390242|NCT00107900|454720658|FG004|Overall Study|Withdrawal by Subject|1|||
126390243|NCT00107900|454720659|FG005|Overall Study|Withdrawal by Subject|1|||
126390244|NCT00107900|454720654|FG000|Overall Study|Administrative Reasons|1|||
126390245|NCT00107900|454720655|FG001|Overall Study|Administrative Reasons|0|||
126390246|NCT00107900|454720656|FG002|Overall Study|Administrative Reasons|2|||
126390247|NCT00107900|454720657|FG003|Overall Study|Administrative Reasons|2|||
126390248|NCT00107900|454720658|FG004|Overall Study|Administrative Reasons|2|||
126390249|NCT00107900|454720659|FG005|Overall Study|Administrative Reasons|0|||
126390250|NCT02109432|454722469|FG000|Overall Study|Withdrawal by Subject|1|||
126390251|NCT02920528|454722470|FG000|Overall Study|Incomplete Data|1|||
126390252|NCT02920528|454722471|FG001|Overall Study|Incomplete Data|1|||
126390253|NCT02920528|454722472|FG002|Overall Study|Incomplete Data|1|||
126390254|NCT02920528|454722470|FG000|Overall Study|Adverse Event|0|||
126390255|NCT02920528|454722471|FG001|Overall Study|Adverse Event|0|||
126390256|NCT02920528|454722472|FG002|Overall Study|Adverse Event|3|||
126390257|NCT02920528|454722470|FG000|Overall Study|Did not meet inclusion criteria|2|||
126390258|NCT02920528|454722471|FG001|Overall Study|Did not meet inclusion criteria|0|||
126390259|NCT02920528|454722472|FG002|Overall Study|Did not meet inclusion criteria|1|||
126390260|NCT03215758|454722484|FG000|Overall Study|Technical Problems|1|||
126390261|NCT03215758|454722485|FG001|Overall Study|Technical Problems|0|||
126390262|NCT03215758|454722484|FG000|Overall Study|Protocol deviation|0|||
126390263|NCT03215758|454722485|FG001|Overall Study|Protocol deviation|1|||
126390264|NCT03215758|454722484|FG000|Overall Study|Physician Decision|0|||
126390265|NCT03215758|454722485|FG001|Overall Study|Physician Decision|1|||
126390266|NCT03215758|454722484|FG000|Overall Study|Death|0|||
126390267|NCT03215758|454722485|FG001|Overall Study|Death|1|||
126390268|NCT03215758|454722484|FG000|Overall Study|Adverse Event|1|||
126390269|NCT03215758|454722485|FG001|Overall Study|Adverse Event|2|||
126390270|NCT03215758|454722484|FG000|Overall Study|Subject/Guardian Decision|3|||
126390271|NCT03215758|454722485|FG001|Overall Study|Subject/Guardian Decision|3|||
126390272|NCT04115748|454722486|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
126390273|NCT04115748|454722487|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
126390274|NCT04115748|454722488|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
126390275|NCT04115748|454722489|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
126390276|NCT04115748|454722490|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390277|NCT04115748|454722491|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390278|NCT04115748|454722492|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390279|NCT04115748|454722493|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390280|NCT04115748|454722494|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390281|NCT04115748|454722495|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390282|NCT04115748|454722486|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390283|NCT04115748|454722487|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390284|NCT04115748|454722488|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390285|NCT04115748|454722489|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
126390286|NCT04115748|454722490|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390287|NCT04115748|454722491|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390288|NCT04115748|454722492|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390289|NCT04115748|454722493|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390290|NCT04115748|454722494|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390291|NCT04115748|454722495|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390292|NCT04115748|454722486|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
126390293|NCT04115748|454722487|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
126390294|NCT04115748|454722488|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
126390295|NCT04115748|454722489|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
126390296|NCT04115748|454722490|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
126390297|NCT04115748|454722491|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
126390298|NCT04115748|454722492|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
126390299|NCT04115748|454722493|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
126390300|NCT04115748|454722494|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
126390301|NCT04115748|454722495|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
126390302|NCT04115748|454722486|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390303|NCT04115748|454722487|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390304|NCT04115748|454722488|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390305|NCT04115748|454722489|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390306|NCT04115748|454722490|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390307|NCT04115748|454722491|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390308|NCT04115748|454722492|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390309|NCT04115748|454722493|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390310|NCT04115748|454722494|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
126390311|NCT04115748|454722495|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390312|NCT00713349|454722496|FG000|Overall Study|Protocol Violation|1|||
126049139|NCT03160885|453476712|FG005|Maintenance Treatment Period|Completed Week 50|0|||
126390313|NCT03764631|454722497|FG000|Overall Study|Personal Reasons|3|||
126390314|NCT03764631|454722498|FG001|Overall Study|Personal Reasons|2|||
126390315|NCT03764631|454722497|FG000|Overall Study|Switching Therapy|3|||
126390316|NCT03764631|454722498|FG001|Overall Study|Switching Therapy|3|||
126390317|NCT03764631|454722497|FG000|Overall Study|Adverse Event|0|||
126390318|NCT03764631|454722498|FG001|Overall Study|Adverse Event|1|||
126390319|NCT03764631|454722497|FG000|Overall Study|Lost to Follow-up|33|||
126390320|NCT03764631|454722498|FG001|Overall Study|Lost to Follow-up|41|||
126390321|NCT03764631|454722497|FG000|Overall Study|No data as study site was closed|2|||
126390322|NCT03764631|454722498|FG001|Overall Study|No data as study site was closed|6|||
126390323|NCT01200407|454722499|FG000|Overall Study|Lost to Follow-up|56|||
126390324|NCT01200407|454722499|FG000|Overall Study|Adverse Event|3|||
126390325|NCT01200407|454722499|FG000|Overall Study|Withdrawal by Subject|4|||
126390326|NCT01200407|454722499|FG000|Overall Study|Other|19|||
126390327|NCT03299881|454722500|FG000|Overall Study|Study Termination|17|||
126390328|NCT03299881|454722501|FG001|Overall Study|Study Termination|13|||
126390329|NCT01549886|454722504|FG000|Overall Study|Sponsor's decision|2|||
126390330|NCT01549886|454722505|FG001|Overall Study|Sponsor's decision|3|||
126390331|NCT00473668|454722506|FG000|Overall Study|Withdrawal by Subject|0|||
126390332|NCT00473668|454722507|FG001|Overall Study|Withdrawal by Subject|2|||
126390333|NCT00473668|454722508|FG002|Overall Study|Withdrawal by Subject|0|||
126390334|NCT00473668|454722506|FG000|Overall Study|Migrated/moved from study area|3|||
126390335|NCT00473668|454722507|FG001|Overall Study|Migrated/moved from study area|2|||
126390336|NCT00473668|454722508|FG002|Overall Study|Migrated/moved from study area|0|||
126390337|NCT00473668|454722506|FG000|Overall Study|Lost to Follow-up|0|||
126390338|NCT00473668|454722507|FG001|Overall Study|Lost to Follow-up|4|||
126390339|NCT00473668|454722508|FG002|Overall Study|Lost to Follow-up|6|||
126390340|NCT00473668|454722506|FG000|Overall Study|Other|2|||
126390341|NCT00473668|454722507|FG001|Overall Study|Other|3|||
126390342|NCT00473668|454722508|FG002|Overall Study|Other|4|||
126390343|NCT03195660|454722509|FG000|Overall Study|The study was terminated|2|||
126390344|NCT05260073|454722511|FG000|Overall Study|Physician Decision|1|||
126390345|NCT05260073|454722511|FG000|Overall Study|Withdrawal by Subject|6|||
126390346|NCT05260073|454722511|FG000|Overall Study|Lost to Follow-up|14|||
126390347|NCT03458910|454722512|FG000|Overall Study|Withdrawal by Subject|7|||
126390348|NCT03458910|454722513|FG001|Overall Study|Withdrawal by Subject|8|||
126390349|NCT03458910|454722514|FG002|Overall Study|Withdrawal by Subject|6|||
126390350|NCT03458910|454722515|FG003|Overall Study|Withdrawal by Subject|4|||
126390351|NCT03458910|454722512|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
126390352|NCT03458910|454722513|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
126390353|NCT03458910|454722514|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
126390354|NCT03458910|454722515|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
126390355|NCT04484649|454722516|FG000|Overall Study|Lost to Follow-up|2|||
126390356|NCT04484649|454722517|FG001|Overall Study|Lost to Follow-up|1|||
126390357|NCT04484649|454722516|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
126390358|NCT04484649|454722517|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
126390359|NCT01450696|454722518|FG000|Overall Study|Never Treated|1|||
126390360|NCT01450696|454722519|FG001|Overall Study|Never Treated|1|||
126390361|NCT01450696|454722518|FG000|Overall Study|Death|77|||
126390362|NCT01450696|454722519|FG001|Overall Study|Death|84|||
126390363|NCT01450696|454722518|FG000|Overall Study|Lost to Follow-up|3|||
126390364|NCT01450696|454722519|FG001|Overall Study|Lost to Follow-up|3|||
126390365|NCT01450696|454722518|FG000|Overall Study|Non-Compliance|1|||
126390366|NCT01450696|454722519|FG001|Overall Study|Non-Compliance|0|||
126390367|NCT01450696|454722518|FG000|Overall Study|Withdrawal by Subject|13|||
126390368|NCT01450696|454722519|FG001|Overall Study|Withdrawal by Subject|2|||
126390369|NCT01450696|454722518|FG000|Overall Study|Study Terminated by Sponsor|53|||
126390370|NCT01450696|454722519|FG001|Overall Study|Study Terminated by Sponsor|58|||
126390371|NCT02249091|454722522|FG000|Overall Study|Lack of Efficacy|8|||
126390372|NCT02249091|454722523|FG001|Overall Study|Lack of Efficacy|3|||
126390373|NCT02249091|454722522|FG000|Overall Study|Physician Decision|4|||
126390374|NCT02249091|454722523|FG001|Overall Study|Physician Decision|1|||
126390375|NCT02249091|454722522|FG000|Overall Study|Withdrawal by Subject|2|||
126390376|NCT02249091|454722523|FG001|Overall Study|Withdrawal by Subject|2|||
126390377|NCT02249091|454722522|FG000|Overall Study|Death|3|||
126390378|NCT02249091|454722523|FG001|Overall Study|Death|4|||
126390379|NCT02249091|454722522|FG000|Overall Study|Adverse Event|1|||
126390380|NCT02249091|454722523|FG001|Overall Study|Adverse Event|0|||
126390381|NCT02249091|454722522|FG000|Overall Study|Stable disease with following SCT|0|||
126390382|NCT02249091|454722523|FG001|Overall Study|Stable disease with following SCT|1|||
126390383|NCT02249091|454722522|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
125887608|NCT01469377|452884535|FG002|Overall Study|Adverse Event|36|||
126049140|NCT03160885|453476713|FG006|Maintenance Treatment Period|Completed Week 50|0|||
126390384|NCT02249091|454722523|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
126390385|NCT02249091|454722522|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
126390386|NCT02249091|454722523|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
126390387|NCT02249091|454722522|FG000|Overall Study|Refractory AML|1|||
126390388|NCT02249091|454722523|FG001|Overall Study|Refractory AML|1|||
126390389|NCT00433966|454722524|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
126390390|NCT00433966|454722525|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
126390391|NCT00433966|454722526|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
126390392|NCT00433966|454722527|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
126390393|NCT00433966|454722524|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
126390394|NCT00433966|454722525|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
126390395|NCT00433966|454722526|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
126390396|NCT00433966|454722527|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
126390397|NCT00433966|454722524|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
126390398|NCT00433966|454722525|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
126390399|NCT00433966|454722526|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
126390400|NCT00433966|454722527|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
126390401|NCT00433966|454722524|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
126390402|NCT00433966|454722525|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
126390403|NCT00433966|454722526|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
126390404|NCT00433966|454722527|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
126390405|NCT00433966|454722524|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
126390406|NCT00433966|454722525|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
126390407|NCT00433966|454722526|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
126390408|NCT00433966|454722527|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
126390409|NCT02570152|454722528|FG000|Overall Study|Protocol Violation|2|||
126390410|NCT02570152|454722528|FG000|Overall Study|Migrated/moved from study area|13|||
126390411|NCT02957747|454722529|FG000|Overall Study|Withdrawal by Subject|0|||
125887609|NCT01469377|452884533|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125887610|NCT01469377|452884534|FG001|Overall Study|Insufficient Therapeutic Response|4|||
125887611|NCT01469377|452884535|FG002|Overall Study|Insufficient Therapeutic Response|0|||
125887612|NCT01469377|452884533|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125887613|NCT01469377|452884534|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125887614|NCT01469377|452884535|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125887615|NCT01733680|452884536|FG000|Overall Study|Withdrawal by Subject|0|||
125887616|NCT01733680|452884537|FG001|Overall Study|Withdrawal by Subject|1|||
125887617|NCT04139798|452884540|FG000|Overall Study|Withdrawal by Subject|6|||
125887618|NCT04139798|452884541|FG001|Overall Study|Withdrawal by Subject|5|||
125887619|NCT04139798|452884540|FG000|Overall Study|Lost to Follow-up|2|||
125887620|NCT04139798|452884541|FG001|Overall Study|Lost to Follow-up|5|||
125887621|NCT04139798|452884540|FG000|Overall Study|Discontinued|4|||
125887622|NCT04139798|452884541|FG001|Overall Study|Discontinued|2|||
125887623|NCT04139798|452884540|FG000|Overall Study|Adverse Event|1|||
125887624|NCT04139798|452884541|FG001|Overall Study|Adverse Event|3|||
125887625|NCT04139798|452884540|FG000|Overall Study|Protocol Violation|1|||
125887626|NCT04139798|452884541|FG001|Overall Study|Protocol Violation|0|||
125887627|NCT04269889|452884542|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
125887628|NCT04308291|452884545|FG000|Run-In Phase|Withdrawal by Subject|4|||
125887629|NCT04308291|452884545|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
125887630|NCT04308291|452884545|FG000|Study Phase 6-M|Physician Decision|2|||
125887631|NCT04308291|452884545|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
125887632|NCT04308291|452884545|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
125887633|NCT04308291|452884545|FG000|Study Phase 12-M|Physician Decision|2|||
125887634|NCT04308291|452884545|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
126049141|NCT02761187|453476714|FG000|Overall Study|Too ill to Participate|13|||
126049142|NCT02761187|453476715|FG001|Overall Study|Too ill to Participate|8|||
126390412|NCT02957747|454722530|FG001|Overall Study|Withdrawal by Subject|3|||
126390413|NCT02957747|454722529|FG000|Overall Study|Lost to Follow-up|10|||
126390414|NCT02957747|454722530|FG001|Overall Study|Lost to Follow-up|5|||
126390415|NCT00632827|454722531|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
126390416|NCT00632827|454722531|FG000|Overall Study|Death|2|||
126390417|NCT00632827|454722531|FG000|Overall Study|Adverse Event|5|||
126390418|NCT00632827|454722531|FG000|Overall Study|Lost to Follow-up|1|||
126390419|NCT01177553|454722534|FG000|Overall Study|babies not yet 6 months of age|1|||
126390420|NCT01177553|454722535|FG001|Overall Study|babies not yet 6 months of age|0|||
126390421|NCT03931382|454722536|FG000|Overall Study|Equipment malfunction|2|||
125887635|NCT00467753|452884547|FG000|Overall Study|Lost to Follow-up|1|||
125887636|NCT00467753|452884548|FG001|Overall Study|Lost to Follow-up|2|||
125887637|NCT00467753|452884547|FG000|Overall Study|Adverse Event|2|||
125887638|NCT00467753|452884548|FG001|Overall Study|Adverse Event|0|||
125887639|NCT01869764|452884549|FG000|Overall Study|Withdrawal by Subject|0|||
125887640|NCT01869764|452884550|FG001|Overall Study|Withdrawal by Subject|2|||
126049143|NCT02761187|453476714|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
126049144|NCT02761187|453476715|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
126049145|NCT02761187|453476714|FG000|Overall Study|Patient withdrew consent|64|||
126049146|NCT02761187|453476715|FG001|Overall Study|Patient withdrew consent|58|||
126049147|NCT02761187|453476714|FG000|Overall Study|Physician discretion|4|||
126049148|NCT02761187|453476715|FG001|Overall Study|Physician discretion|8|||
126049149|NCT02761187|453476714|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
126049150|NCT02761187|453476715|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
126049151|NCT02761187|453476714|FG000|Overall Study|On Hospice|20|||
126049152|NCT02761187|453476715|FG001|Overall Study|On Hospice|26|||
126049153|NCT02761187|453476714|FG000|Overall Study|Deceased|474|||
126049154|NCT02761187|453476715|FG001|Overall Study|Deceased|642|||
126049155|NCT02761187|453476714|FG000|Overall Study|Lost to Follow-up|73|||
126049156|NCT02761187|453476715|FG001|Overall Study|Lost to Follow-up|63|||
126390422|NCT03931382|454722537|FG001|Overall Study|Equipment malfunction|0|||
126390423|NCT03931382|454722538|FG002|Overall Study|Equipment malfunction|2|||
126390424|NCT03931382|454722536|FG000|Overall Study|Withdrawal by Subject|0|||
126390425|NCT03931382|454722537|FG001|Overall Study|Withdrawal by Subject|1|||
126390426|NCT03931382|454722538|FG002|Overall Study|Withdrawal by Subject|0|||
126390427|NCT00778375|454722544|FG000|Overall Study|Ineligible|3|||
126390428|NCT04590404|454722547|FG000|Overall Study|Death|16|||
126390429|NCT04590404|454722548|FG001|Overall Study|Death|17|||
126390430|NCT04590404|454722547|FG000|Overall Study|Withdrawal by Subject|7|||
126390431|NCT04590404|454722548|FG001|Overall Study|Withdrawal by Subject|2|||
126390432|NCT01581021|454722553|FG000|Overall Study|Lost to Follow-up|4|||
126390433|NCT01581021|454722554|FG001|Overall Study|Lost to Follow-up|6|||
126390434|NCT01581021|454722553|FG000|Overall Study|More than 2 hooks in thoracic|3|||
126390435|NCT01581021|454722554|FG001|Overall Study|More than 2 hooks in thoracic|0|||
126390436|NCT01581021|454722553|FG000|Overall Study|Neuromuscular|2|||
126390437|NCT01581021|454722554|FG001|Overall Study|Neuromuscular|1|||
126390438|NCT01581021|454722553|FG000|Overall Study|Not Randomized|1|||
126390439|NCT01581021|454722554|FG001|Overall Study|Not Randomized|2|||
126390440|NCT01581021|454722553|FG000|Overall Study|Lenke 6 Classification|0|||
126390441|NCT01581021|454722554|FG001|Overall Study|Lenke 6 Classification|1|||
126390442|NCT01581021|454722553|FG000|Overall Study|Lack of Efficacy|0|||
126390443|NCT01581021|454722554|FG001|Overall Study|Lack of Efficacy|1|||
126390444|NCT00675441|454722555|FG000|Overall Study|Withdrawal by Subject|2|||
126390445|NCT00675441|454722555|FG000|Overall Study|Death|1|||
126390446|NCT00054327|454722558|FG000|Overall Study|Engraftment failure|1|||
126390447|NCT00054327|454722559|FG001|Overall Study|Engraftment failure|0|||
126390448|NCT00054327|454722560|FG002|Overall Study|Engraftment failure|0|||
126390449|NCT00054327|454722561|FG003|Overall Study|Engraftment failure|0|||
126390450|NCT00054327|454722562|FG004|Overall Study|Engraftment failure|0|||
126390451|NCT00054327|454722563|FG005|Overall Study|Engraftment failure|0|||
126390452|NCT05596734|454722573|FG000|Substudy A|Withdrawal by Subject|1|||
126390453|NCT05596734|454722574|FG001|Substudy A|Withdrawal by Subject|0|||
126390454|NCT05596734|454722575|FG002|Substudy A|Withdrawal by Subject|0|||
126390455|NCT05596734|454722576|FG003|Substudy A|Withdrawal by Subject|0|||
126390456|NCT05596734|454722577|FG004|Substudy A|Withdrawal by Subject|0|||
126390457|NCT05596734|454722578|FG005|Substudy A|Withdrawal by Subject|0|||
126390458|NCT05596734|454722579|FG006|Substudy A|Withdrawal by Subject|1|||
126390459|NCT05596734|454722580|FG007|Substudy A|Withdrawal by Subject|0|||
126390460|NCT05596734|454722581|FG008|Substudy A|Withdrawal by Subject|0|||
126390461|NCT05596734|454722582|FG009|Substudy A|Withdrawal by Subject|0|||
126390462|NCT05596734|454722583|FG010|Substudy A|Withdrawal by Subject|0|||
126390463|NCT05596734|454722584|FG011|Substudy A|Withdrawal by Subject|0|||
126390464|NCT05596734|454722585|FG012|Substudy A|Withdrawal by Subject|0|||
126390465|NCT05596734|454722586|FG013|Substudy A|Withdrawal by Subject|0|||
126390466|NCT05596734|454722587|FG014|Substudy A|Withdrawal by Subject|0|||
126390467|NCT05596734|454722588|FG015|Substudy A|Withdrawal by Subject|0|||
126049157|NCT02761187|453476714|FG000|Overall Study|Due to study discontinued at site|100|||
126049158|NCT02761187|453476715|FG001|Overall Study|Due to study discontinued at site|85|||
126049159|NCT02761187|453476714|FG000|Overall Study|Reason not Specified|1484|||
126049160|NCT02761187|453476715|FG001|Overall Study|Reason not Specified|937|||
126390468|NCT05596734|454722589|FG016|Substudy A|Withdrawal by Subject|0|||
126390469|NCT05596734|454722590|FG017|Substudy A|Withdrawal by Subject|0|||
126390470|NCT05596734|454722591|FG018|Substudy A|Withdrawal by Subject|0|||
126390471|NCT05596734|454722592|FG019|Substudy A|Withdrawal by Subject|0|||
126390472|NCT05596734|454722593|FG020|Substudy A|Withdrawal by Subject|0|||
126390473|NCT05596734|454722594|FG021|Substudy A|Withdrawal by Subject|0|||
126390474|NCT05596734|454722595|FG022|Substudy A|Withdrawal by Subject|0|||
126390475|NCT05596734|454722596|FG023|Substudy A|Withdrawal by Subject|0|||
126390476|NCT05596734|454722573|FG000|Substudy A|Lost to Follow-up|1|||
126390477|NCT05596734|454722574|FG001|Substudy A|Lost to Follow-up|0|||
126049161|NCT02307682|453476716|FG000|Overall Study|Adverse Event|9|||
126049162|NCT02307682|453476717|FG001|Overall Study|Adverse Event|8|||
126049163|NCT02307682|453476718|FG002|Overall Study|Adverse Event|12|||
126390478|NCT05596734|454722575|FG002|Substudy A|Lost to Follow-up|1|||
126390479|NCT05596734|454722576|FG003|Substudy A|Lost to Follow-up|0|||
126390480|NCT05596734|454722577|FG004|Substudy A|Lost to Follow-up|0|||
126390481|NCT05596734|454722578|FG005|Substudy A|Lost to Follow-up|0|||
126390482|NCT05596734|454722579|FG006|Substudy A|Lost to Follow-up|0|||
126390483|NCT05596734|454722580|FG007|Substudy A|Lost to Follow-up|0|||
126390484|NCT05596734|454722581|FG008|Substudy A|Lost to Follow-up|0|||
126390485|NCT05596734|454722582|FG009|Substudy A|Lost to Follow-up|0|||
126390486|NCT05596734|454722583|FG010|Substudy A|Lost to Follow-up|0|||
126390487|NCT05596734|454722584|FG011|Substudy A|Lost to Follow-up|0|||
126390488|NCT05596734|454722585|FG012|Substudy A|Lost to Follow-up|0|||
126390489|NCT05596734|454722586|FG013|Substudy A|Lost to Follow-up|0|||
126390490|NCT05596734|454722587|FG014|Substudy A|Lost to Follow-up|0|||
126390491|NCT05596734|454722588|FG015|Substudy A|Lost to Follow-up|0|||
126390492|NCT05596734|454722589|FG016|Substudy A|Lost to Follow-up|0|||
126390493|NCT05596734|454722590|FG017|Substudy A|Lost to Follow-up|0|||
126390494|NCT05596734|454722591|FG018|Substudy A|Lost to Follow-up|0|||
126390495|NCT05596734|454722592|FG019|Substudy A|Lost to Follow-up|0|||
126390496|NCT05596734|454722593|FG020|Substudy A|Lost to Follow-up|0|||
126390497|NCT05596734|454722594|FG021|Substudy A|Lost to Follow-up|0|||
126390498|NCT05596734|454722595|FG022|Substudy A|Lost to Follow-up|0|||
126390499|NCT05596734|454722596|FG023|Substudy A|Lost to Follow-up|0|||
126390500|NCT05596734|454722573|FG000|Substudy B|Withdrawal by Subject|0|||
126390501|NCT05596734|454722574|FG001|Substudy B|Withdrawal by Subject|0|||
126390502|NCT05596734|454722575|FG002|Substudy B|Withdrawal by Subject|0|||
126390503|NCT05596734|454722576|FG003|Substudy B|Withdrawal by Subject|0|||
126390504|NCT05596734|454722577|FG004|Substudy B|Withdrawal by Subject|0|||
126390505|NCT05596734|454722578|FG005|Substudy B|Withdrawal by Subject|0|||
126390506|NCT05596734|454722579|FG006|Substudy B|Withdrawal by Subject|0|||
126390507|NCT05596734|454722580|FG007|Substudy B|Withdrawal by Subject|0|||
126390508|NCT05596734|454722581|FG008|Substudy B|Withdrawal by Subject|0|||
126390509|NCT05596734|454722582|FG009|Substudy B|Withdrawal by Subject|0|||
126390510|NCT05596734|454722583|FG010|Substudy B|Withdrawal by Subject|0|||
126390511|NCT05596734|454722584|FG011|Substudy B|Withdrawal by Subject|0|||
126390512|NCT05596734|454722585|FG012|Substudy B|Withdrawal by Subject|1|||
126390513|NCT05596734|454722586|FG013|Substudy B|Withdrawal by Subject|0|||
126390514|NCT05596734|454722587|FG014|Substudy B|Withdrawal by Subject|1|||
126390515|NCT05596734|454722588|FG015|Substudy B|Withdrawal by Subject|2|||
126390516|NCT05596734|454722589|FG016|Substudy B|Withdrawal by Subject|2|||
126390517|NCT05596734|454722590|FG017|Substudy B|Withdrawal by Subject|1|||
126390518|NCT05596734|454722591|FG018|Substudy B|Withdrawal by Subject|2|||
126390519|NCT05596734|454722592|FG019|Substudy B|Withdrawal by Subject|0|||
126390520|NCT05596734|454722593|FG020|Substudy B|Withdrawal by Subject|0|||
126390521|NCT05596734|454722594|FG021|Substudy B|Withdrawal by Subject|0|||
126390522|NCT05596734|454722595|FG022|Substudy B|Withdrawal by Subject|0|||
126390523|NCT05596734|454722596|FG023|Substudy B|Withdrawal by Subject|1|||
126390524|NCT05596734|454722573|FG000|Substudy B|Physician Decision|0|||
126390525|NCT05596734|454722574|FG001|Substudy B|Physician Decision|0|||
126390526|NCT05596734|454722575|FG002|Substudy B|Physician Decision|0|||
126390527|NCT05596734|454722576|FG003|Substudy B|Physician Decision|0|||
126390528|NCT05596734|454722577|FG004|Substudy B|Physician Decision|0|||
126390529|NCT05596734|454722578|FG005|Substudy B|Physician Decision|0|||
126390530|NCT05596734|454722579|FG006|Substudy B|Physician Decision|0|||
126390531|NCT05596734|454722580|FG007|Substudy B|Physician Decision|0|||
125887641|NCT01626872|452884551|FG000|Overall Study|Physician Decision|13|||
125887642|NCT01626872|452884552|FG001|Overall Study|Physician Decision|9|||
125887643|NCT01626872|452884553|FG002|Overall Study|Physician Decision|6|||
126390532|NCT05596734|454722581|FG008|Substudy B|Physician Decision|0|||
126390533|NCT05596734|454722582|FG009|Substudy B|Physician Decision|0|||
126390534|NCT05596734|454722583|FG010|Substudy B|Physician Decision|0|||
126390535|NCT05596734|454722584|FG011|Substudy B|Physician Decision|0|||
126390536|NCT05596734|454722585|FG012|Substudy B|Physician Decision|0|||
126390537|NCT05596734|454722586|FG013|Substudy B|Physician Decision|0|||
126390538|NCT05596734|454722587|FG014|Substudy B|Physician Decision|0|||
126390539|NCT05596734|454722588|FG015|Substudy B|Physician Decision|1|||
126390540|NCT05596734|454722589|FG016|Substudy B|Physician Decision|0|||
126390541|NCT05596734|454722590|FG017|Substudy B|Physician Decision|0|||
126390542|NCT05596734|454722591|FG018|Substudy B|Physician Decision|0|||
126390543|NCT05596734|454722592|FG019|Substudy B|Physician Decision|0|||
126390544|NCT05596734|454722593|FG020|Substudy B|Physician Decision|0|||
126104253|NCT01557283|453675837|FG000|Overall Study|Non-responder|19|||
126390545|NCT05596734|454722594|FG021|Substudy B|Physician Decision|0|||
126390546|NCT05596734|454722595|FG022|Substudy B|Physician Decision|0|||
125887644|NCT01626872|452884551|FG000|Overall Study|Withdrawal by Subject|19|||
126390547|NCT05596734|454722596|FG023|Substudy B|Physician Decision|0|||
126390548|NCT05596734|454722573|FG000|Substudy B|Lost to Follow-up|0|||
126390549|NCT05596734|454722574|FG001|Substudy B|Lost to Follow-up|0|||
126390550|NCT05596734|454722575|FG002|Substudy B|Lost to Follow-up|0|||
125887645|NCT01626872|452884552|FG001|Overall Study|Withdrawal by Subject|27|||
126390551|NCT05596734|454722576|FG003|Substudy B|Lost to Follow-up|0|||
126390552|NCT05596734|454722577|FG004|Substudy B|Lost to Follow-up|0|||
126390553|NCT05596734|454722578|FG005|Substudy B|Lost to Follow-up|0|||
126390554|NCT05596734|454722579|FG006|Substudy B|Lost to Follow-up|0|||
126390555|NCT05596734|454722580|FG007|Substudy B|Lost to Follow-up|0|||
126390556|NCT05596734|454722581|FG008|Substudy B|Lost to Follow-up|0|||
126390557|NCT05596734|454722582|FG009|Substudy B|Lost to Follow-up|0|||
126390558|NCT05596734|454722583|FG010|Substudy B|Lost to Follow-up|0|||
126390559|NCT05596734|454722584|FG011|Substudy B|Lost to Follow-up|0|||
126390560|NCT05596734|454722585|FG012|Substudy B|Lost to Follow-up|1|||
126390561|NCT05596734|454722586|FG013|Substudy B|Lost to Follow-up|0|||
126390562|NCT05596734|454722587|FG014|Substudy B|Lost to Follow-up|1|||
126390563|NCT05596734|454722588|FG015|Substudy B|Lost to Follow-up|1|||
126390564|NCT05596734|454722589|FG016|Substudy B|Lost to Follow-up|0|||
126390565|NCT05596734|454722590|FG017|Substudy B|Lost to Follow-up|0|||
126390566|NCT05596734|454722591|FG018|Substudy B|Lost to Follow-up|0|||
126390567|NCT05596734|454722592|FG019|Substudy B|Lost to Follow-up|0|||
126390568|NCT05596734|454722593|FG020|Substudy B|Lost to Follow-up|0|||
126390569|NCT05596734|454722594|FG021|Substudy B|Lost to Follow-up|0|||
126390570|NCT05596734|454722595|FG022|Substudy B|Lost to Follow-up|0|||
126390571|NCT05596734|454722596|FG023|Substudy B|Lost to Follow-up|0|||
126390572|NCT04113018|454722597|FG000|Overall Study|Death|2|||
126390573|NCT04113018|454722597|FG000|Overall Study|Lost to Follow-up|1|||
126390574|NCT04113018|454722597|FG000|Overall Study|Still On Study (on study treatment)|24|||
126390575|NCT04113018|454722597|FG000|Overall Study|Still On Study (in follow up)|12|||
126390576|NCT06099223|454722598|FG000|Overall Study|Preoperative surveys missed|0|||
126390577|NCT06099223|454722599|FG001|Overall Study|Preoperative surveys missed|1|||
126390578|NCT00079391|454722600|FG000|Overall Study|Withdrawal by Subject|1|||
126390579|NCT01802580|454722603|FG000|Overall Study|Physician Decision|1|||
126390580|NCT01802580|454722604|FG001|Overall Study|Physician Decision|0|||
126390581|NCT01802580|454722603|FG000|Overall Study|Protocol Violation|2|||
126390582|NCT01802580|454722604|FG001|Overall Study|Protocol Violation|0|||
126390583|NCT01802580|454722603|FG000|Overall Study|Withdrawal by Subject|5|||
126390584|NCT01802580|454722604|FG001|Overall Study|Withdrawal by Subject|6|||
126390585|NCT01802580|454722603|FG000|Overall Study|Other|1|||
126390586|NCT01802580|454722604|FG001|Overall Study|Other|3|||
126390587|NCT01802580|454722603|FG000|Overall Study|Lack of Efficacy|0|||
126390588|NCT01802580|454722604|FG001|Overall Study|Lack of Efficacy|2|||
126390589|NCT02791516|454722607|FG000|Overall Study|Withdrawal by Subject|1|||
126390590|NCT02791516|454722608|FG001|Overall Study|Withdrawal by Subject|1|||
126390591|NCT00211757|454722611|FG000|Overall Study|Withdrawal by Subject|1|||
126390592|NCT00211757|454722612|FG001|Overall Study|Withdrawal by Subject|1|||
126390593|NCT00211757|454722611|FG000|Overall Study|Lack of Efficacy|0|||
126390594|NCT00211757|454722612|FG001|Overall Study|Lack of Efficacy|1|||
126390595|NCT03479541|454722613|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
126390596|NCT03479541|454722614|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
126390597|NCT03479541|454722615|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
126390598|NCT03479541|454722616|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
126390599|NCT03479541|454722613|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
126390600|NCT03479541|454722614|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
126390601|NCT03479541|454722615|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
126390602|NCT03479541|454722616|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
126390603|NCT03479541|454722613|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
126390604|NCT03479541|454722614|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
126390605|NCT03479541|454722615|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
126390606|NCT03479541|454722616|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
126390607|NCT03479541|454722613|FG000|Home Monitoring|Lost to Follow-up|0|||
126390608|NCT03479541|454722614|FG001|Home Monitoring|Lost to Follow-up|0|||
126104254|NCT01557283|453675837|FG000|Overall Study|Adverse Event|7|||
126104255|NCT01557283|453675837|FG000|Overall Study|Lack of Efficacy|1|||
126104256|NCT01557283|453675837|FG000|Overall Study|Non-compliance|1|||
126104257|NCT01557283|453675837|FG000|Overall Study|Withdrawal by Subject|1|||
126104258|NCT01557283|453675837|FG000|Overall Study|Participant's weight too high for dose|1|||
126104259|NCT01557283|453675837|FG000|Overall Study|Worsening of psoriasis|1|||
126104260|NCT01557283|453675837|FG000|Overall Study|Other|6|||
126104261|NCT00120406|453675838|FG000|Overall Study|Death|9|||
126104262|NCT00120406|453675839|FG001|Overall Study|Death|4|||
126104263|NCT00120406|453675838|FG000|Overall Study|Withdrawal by Subject|5|||
126104264|NCT00120406|453675839|FG001|Overall Study|Withdrawal by Subject|7|||
126104265|NCT00120406|453675838|FG000|Overall Study|Lost to Follow-up|5|||
126104266|NCT00120406|453675839|FG001|Overall Study|Lost to Follow-up|2|||
126104267|NCT00120406|453675838|FG000|Overall Study|received non-study stent|0|||
126390609|NCT03479541|454722615|FG002|Home Monitoring|Lost to Follow-up|8|||
126390610|NCT03479541|454722616|FG003|Home Monitoring|Lost to Follow-up|12|||
126390611|NCT03479541|454722613|FG000|Home Monitoring|Withdrawal by Subject|0|||
126390612|NCT03479541|454722614|FG001|Home Monitoring|Withdrawal by Subject|0|||
126390613|NCT03479541|454722615|FG002|Home Monitoring|Withdrawal by Subject|17|||
126390614|NCT03479541|454722616|FG003|Home Monitoring|Withdrawal by Subject|30|||
126390615|NCT03479541|454722613|FG000|Home Monitoring|Early Termination - PI Decision|0|||
126390616|NCT03479541|454722614|FG001|Home Monitoring|Early Termination - PI Decision|0|||
126390617|NCT03479541|454722615|FG002|Home Monitoring|Early Termination - PI Decision|4|||
126390618|NCT03479541|454722616|FG003|Home Monitoring|Early Termination - PI Decision|6|||
126390619|NCT02644096|454722617|FG000|Overall Study|Withdrawal by Subject|28|||
126390620|NCT02644096|454722618|FG001|Overall Study|Withdrawal by Subject|25|||
126390621|NCT02461290|454722619|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
126390622|NCT02461290|454722619|FG000|Overall Study|Lost to Follow-up|3|||
126390623|NCT00526656|454722620|FG000|Overall Study|Death|1|||
126390624|NCT00526656|454722620|FG000|Overall Study|Refused surgery|1|||
126390625|NCT01456195|454724375|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126390626|NCT01456195|454724376|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
126390627|NCT01456195|454724377|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
126390628|NCT01456195|454724375|FG000|Overall Study|Lost to Follow-up|3|||
126390629|NCT01456195|454724376|FG001|Overall Study|Lost to Follow-up|1|||
126390630|NCT01456195|454724377|FG002|Overall Study|Lost to Follow-up|3|||
126390631|NCT01456195|454724375|FG000|Overall Study|Voluntary Withdrawal|5|||
126390632|NCT01456195|454724376|FG001|Overall Study|Voluntary Withdrawal|3|||
126390633|NCT01456195|454724377|FG002|Overall Study|Voluntary Withdrawal|7|||
126390634|NCT01456195|454724375|FG000|Overall Study|Lack of Efficacy|0|||
125887646|NCT01626872|452884553|FG002|Overall Study|Withdrawal by Subject|8|||
125887647|NCT01626872|452884551|FG000|Overall Study|Adverse Event (including Death)|20|||
125887648|NCT01626872|452884552|FG001|Overall Study|Adverse Event (including Death)|28|||
125887649|NCT01626872|452884553|FG002|Overall Study|Adverse Event (including Death)|8|||
125887650|NCT01626872|452884551|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
125887651|NCT01626872|452884552|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
125887652|NCT01626872|452884553|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
125887653|NCT00960999|452884554|FG000|Overall Study|Withdrawal by Subject|1|||
125887654|NCT00960999|452884555|FG001|Overall Study|Withdrawal by Subject|0|||
125887655|NCT00960999|452884554|FG000|Overall Study|Protocol Violation|5|||
125887656|NCT00960999|452884555|FG001|Overall Study|Protocol Violation|2|||
125887657|NCT00960999|452884554|FG000|Overall Study|RT dose constraints not met|2|||
125887658|NCT00960999|452884555|FG001|Overall Study|RT dose constraints not met|0|||
125887659|NCT01696188|452884556|FG000|Overall Study|Protocol Violation|1|||
125887660|NCT01696188|452884557|FG001|Overall Study|Protocol Violation|1|||
125887661|NCT01578486|452884558|FG000|Overall Study|Physician Decision|3|||
125887662|NCT01578486|452884558|FG000|Overall Study|Withdrawal by Subject|2|||
125887663|NCT01958164|452884559|FG000|Overall Study|Adverse Event|0|||
125887664|NCT01958164|452884560|FG001|Overall Study|Adverse Event|2|||
125887665|NCT01958164|452884559|FG000|Overall Study|Lost to Follow-up|2|||
125887666|NCT01958164|452884560|FG001|Overall Study|Lost to Follow-up|3|||
125887667|NCT00828204|452884563|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
125887668|NCT00828204|452884564|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
125887669|NCT00828204|452884563|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
125887670|NCT00828204|452884564|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
125887671|NCT00828204|452884563|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
125887672|NCT00828204|452884564|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
125887673|NCT00828204|452884563|FG000|Main Study: After Study Restart|Adverse Event|0|||
125887674|NCT00828204|452884564|FG001|Main Study: After Study Restart|Adverse Event|2|||
125887675|NCT00828204|452884563|FG000|Main Study: After Study Restart|Noncompliance|0|||
125887676|NCT00828204|452884564|FG001|Main Study: After Study Restart|Noncompliance|1|||
125887677|NCT00828204|452884563|FG000|Extension Study|Lost to Follow-up|0|||
125887678|NCT00828204|452884564|FG001|Extension Study|Lost to Follow-up|1|||
125887679|NCT00828204|452884563|FG000|Extension Study|Physician Decision|0|||
126390635|NCT01456195|454724376|FG001|Overall Study|Lack of Efficacy|1|||
126390636|NCT01456195|454724377|FG002|Overall Study|Lack of Efficacy|0|||
126390637|NCT01456195|454724375|FG000|Overall Study|Other Reasons|2|||
126390638|NCT01456195|454724376|FG001|Overall Study|Other Reasons|1|||
126390639|NCT01456195|454724377|FG002|Overall Study|Other Reasons|3|||
126390640|NCT02547038|454724378|FG000|Overall Study|Lost to Follow-up|3|||
126390641|NCT02547038|454724379|FG001|Overall Study|Lost to Follow-up|2|||
126390642|NCT01340625|454724380|FG000|First Intervention|Adverse Event|1|||
126390643|NCT01340625|454724381|FG001|First Intervention|Adverse Event|0|||
126390644|NCT01340625|454724380|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
126390645|NCT01340625|454724381|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
126390646|NCT00734604|454724388|FG000|Overall Study|Adverse Event|0|||
126390647|NCT00734604|454724389|FG001|Overall Study|Adverse Event|2|||
125887680|NCT00828204|452884564|FG001|Extension Study|Physician Decision|2|||
125887681|NCT02302339|452884567|FG000|Overall Study|Lost to Follow-up|1|||
125887682|NCT02302339|452884568|FG001|Overall Study|Lost to Follow-up|0|||
125887683|NCT02302339|452884569|FG002|Overall Study|Lost to Follow-up|0|||
125887684|NCT02302339|452884570|FG003|Overall Study|Lost to Follow-up|0|||
125887685|NCT02302339|452884567|FG000|Overall Study|Withdrawal by Subject|0|||
126390648|NCT00734604|454724390|FG002|Overall Study|Adverse Event|0|||
126390649|NCT00734604|454724391|FG003|Overall Study|Adverse Event|2|||
126390650|NCT00734604|454724392|FG004|Overall Study|Adverse Event|1|||
125887686|NCT02302339|452884568|FG001|Overall Study|Withdrawal by Subject|2|||
126390651|NCT00734604|454724393|FG005|Overall Study|Adverse Event|1|||
126390652|NCT00734604|454724388|FG000|Overall Study|Serious Adverse Event|1|||
126390653|NCT00734604|454724389|FG001|Overall Study|Serious Adverse Event|0|||
126390654|NCT00734604|454724390|FG002|Overall Study|Serious Adverse Event|1|||
126390655|NCT00734604|454724391|FG003|Overall Study|Serious Adverse Event|2|||
126390656|NCT00734604|454724392|FG004|Overall Study|Serious Adverse Event|0|||
126390657|NCT00734604|454724393|FG005|Overall Study|Serious Adverse Event|1|||
126390658|NCT00734604|454724388|FG000|Overall Study|Lost to Follow-up|1|||
126390659|NCT00734604|454724389|FG001|Overall Study|Lost to Follow-up|2|||
126390660|NCT00734604|454724390|FG002|Overall Study|Lost to Follow-up|2|||
126390661|NCT00734604|454724391|FG003|Overall Study|Lost to Follow-up|4|||
126390662|NCT00734604|454724392|FG004|Overall Study|Lost to Follow-up|2|||
126390663|NCT00734604|454724393|FG005|Overall Study|Lost to Follow-up|3|||
126390664|NCT00734604|454724388|FG000|Overall Study|Physician Decision|0|||
126390665|NCT00734604|454724389|FG001|Overall Study|Physician Decision|1|||
126390666|NCT00734604|454724390|FG002|Overall Study|Physician Decision|1|||
126390667|NCT00734604|454724391|FG003|Overall Study|Physician Decision|0|||
126390668|NCT00734604|454724392|FG004|Overall Study|Physician Decision|0|||
126390669|NCT00734604|454724393|FG005|Overall Study|Physician Decision|0|||
126390670|NCT00734604|454724388|FG000|Overall Study|Protocol Violation|0|||
126390671|NCT00734604|454724389|FG001|Overall Study|Protocol Violation|2|||
126390672|NCT00734604|454724390|FG002|Overall Study|Protocol Violation|0|||
126390673|NCT00734604|454724391|FG003|Overall Study|Protocol Violation|0|||
126390674|NCT00734604|454724392|FG004|Overall Study|Protocol Violation|1|||
126390675|NCT00734604|454724393|FG005|Overall Study|Protocol Violation|0|||
126390676|NCT00734604|454724388|FG000|Overall Study|Sponsor Decision|1|||
126390677|NCT00734604|454724389|FG001|Overall Study|Sponsor Decision|2|||
126390678|NCT00734604|454724390|FG002|Overall Study|Sponsor Decision|1|||
126390679|NCT00734604|454724391|FG003|Overall Study|Sponsor Decision|0|||
126390680|NCT00734604|454724392|FG004|Overall Study|Sponsor Decision|2|||
126390681|NCT00734604|454724393|FG005|Overall Study|Sponsor Decision|0|||
126390682|NCT00734604|454724388|FG000|Overall Study|Withdrawal by Subject|0|||
126390683|NCT00734604|454724389|FG001|Overall Study|Withdrawal by Subject|2|||
126390684|NCT00734604|454724390|FG002|Overall Study|Withdrawal by Subject|0|||
126390685|NCT00734604|454724391|FG003|Overall Study|Withdrawal by Subject|1|||
126390686|NCT00734604|454724392|FG004|Overall Study|Withdrawal by Subject|2|||
126390687|NCT00734604|454724393|FG005|Overall Study|Withdrawal by Subject|1|||
126390688|NCT00734604|454724388|FG000|Overall Study|Lack of Efficacy|0|||
126390689|NCT00734604|454724389|FG001|Overall Study|Lack of Efficacy|1|||
126390690|NCT00734604|454724390|FG002|Overall Study|Lack of Efficacy|1|||
126390691|NCT00734604|454724391|FG003|Overall Study|Lack of Efficacy|0|||
126390692|NCT00734604|454724392|FG004|Overall Study|Lack of Efficacy|0|||
126390693|NCT00734604|454724393|FG005|Overall Study|Lack of Efficacy|0|||
126390694|NCT02589665|454724394|FG000|Induction Period|Did not receive drug|0|||
126390695|NCT02589665|454724395|FG001|Induction Period|Did not receive drug|0|||
126390696|NCT02589665|454724396|FG002|Induction Period|Did not receive drug|0|||
126390697|NCT02589665|454724397|FG003|Induction Period|Did not receive drug|1|||
126390698|NCT02589665|454724398|FG004|Induction Period|Did not receive drug|0|||
126390699|NCT02589665|454724399|FG005|Induction Period|Did not receive drug|0|||
126390700|NCT02589665|454724400|FG006|Induction Period|Did not receive drug|0|||
126390701|NCT02589665|454724401|FG007|Induction Period|Did not receive drug|0|||
126390702|NCT02589665|454724402|FG008|Induction Period|Did not receive drug|0|||
126390703|NCT02589665|454724403|FG009|Induction Period|Did not receive drug|0|||
126390704|NCT02589665|454724394|FG000|Induction Period|Adverse Event|3|||
126390705|NCT02589665|454724395|FG001|Induction Period|Adverse Event|0|||
126390706|NCT02589665|454724396|FG002|Induction Period|Adverse Event|2|||
126390707|NCT02589665|454724397|FG003|Induction Period|Adverse Event|2|||
126390708|NCT02589665|454724398|FG004|Induction Period|Adverse Event|0|||
126390709|NCT02589665|454724399|FG005|Induction Period|Adverse Event|0|||
126390710|NCT02589665|454724400|FG006|Induction Period|Adverse Event|0|||
126390711|NCT02589665|454724401|FG007|Induction Period|Adverse Event|0|||
126390712|NCT02589665|454724402|FG008|Induction Period|Adverse Event|0|||
126390713|NCT02589665|454724403|FG009|Induction Period|Adverse Event|0|||
126390714|NCT02589665|454724394|FG000|Induction Period|Withdrawal by Subject|0|||
126390715|NCT02589665|454724395|FG001|Induction Period|Withdrawal by Subject|1|||
126390716|NCT02589665|454724396|FG002|Induction Period|Withdrawal by Subject|0|||
126390717|NCT02589665|454724397|FG003|Induction Period|Withdrawal by Subject|1|||
126390718|NCT02589665|454724398|FG004|Induction Period|Withdrawal by Subject|0|||
126390719|NCT02589665|454724399|FG005|Induction Period|Withdrawal by Subject|0|||
126390720|NCT02589665|454724400|FG006|Induction Period|Withdrawal by Subject|0|||
126390721|NCT02589665|454724401|FG007|Induction Period|Withdrawal by Subject|0|||
126390722|NCT02589665|454724402|FG008|Induction Period|Withdrawal by Subject|0|||
126390723|NCT02589665|454724403|FG009|Induction Period|Withdrawal by Subject|0|||
126390724|NCT02589665|454724394|FG000|Induction Period|Protocol Violation|0|||
126390725|NCT02589665|454724395|FG001|Induction Period|Protocol Violation|1|||
126390726|NCT02589665|454724396|FG002|Induction Period|Protocol Violation|0|||
126390727|NCT02589665|454724397|FG003|Induction Period|Protocol Violation|0|||
126390728|NCT02589665|454724398|FG004|Induction Period|Protocol Violation|0|||
126390729|NCT02589665|454724399|FG005|Induction Period|Protocol Violation|0|||
126390730|NCT02589665|454724400|FG006|Induction Period|Protocol Violation|0|||
126390731|NCT02589665|454724401|FG007|Induction Period|Protocol Violation|0|||
126390732|NCT02589665|454724402|FG008|Induction Period|Protocol Violation|0|||
126390733|NCT02589665|454724403|FG009|Induction Period|Protocol Violation|0|||
126390734|NCT02589665|454724394|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390735|NCT02589665|454724395|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390736|NCT02589665|454724396|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390737|NCT02589665|454724397|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390738|NCT02589665|454724398|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
126390739|NCT02589665|454724399|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
126390740|NCT02589665|454724400|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
126390741|NCT02589665|454724401|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390742|NCT02589665|454724402|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390743|NCT02589665|454724403|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390744|NCT02589665|454724394|FG000|Maintenance Period|Withdrawal by Subject|0|||
126390745|NCT02589665|454724395|FG001|Maintenance Period|Withdrawal by Subject|0|||
126390746|NCT02589665|454724396|FG002|Maintenance Period|Withdrawal by Subject|0|||
126390747|NCT02589665|454724397|FG003|Maintenance Period|Withdrawal by Subject|0|||
126390748|NCT02589665|454724398|FG004|Maintenance Period|Withdrawal by Subject|4|||
126390749|NCT02589665|454724399|FG005|Maintenance Period|Withdrawal by Subject|2|||
126390750|NCT02589665|454724400|FG006|Maintenance Period|Withdrawal by Subject|4|||
126390751|NCT02589665|454724401|FG007|Maintenance Period|Withdrawal by Subject|0|||
126390752|NCT02589665|454724402|FG008|Maintenance Period|Withdrawal by Subject|0|||
126390753|NCT02589665|454724403|FG009|Maintenance Period|Withdrawal by Subject|0|||
126390754|NCT02589665|454724394|FG000|Maintenance Period|Lack of Efficacy|0|||
126390755|NCT02589665|454724395|FG001|Maintenance Period|Lack of Efficacy|0|||
126390756|NCT02589665|454724396|FG002|Maintenance Period|Lack of Efficacy|0|||
126390757|NCT02589665|454724397|FG003|Maintenance Period|Lack of Efficacy|0|||
126390758|NCT02589665|454724398|FG004|Maintenance Period|Lack of Efficacy|2|||
126390759|NCT02589665|454724399|FG005|Maintenance Period|Lack of Efficacy|1|||
126390760|NCT02589665|454724400|FG006|Maintenance Period|Lack of Efficacy|0|||
126390761|NCT02589665|454724401|FG007|Maintenance Period|Lack of Efficacy|0|||
126390762|NCT02589665|454724402|FG008|Maintenance Period|Lack of Efficacy|0|||
126390763|NCT02589665|454724403|FG009|Maintenance Period|Lack of Efficacy|0|||
126390764|NCT02589665|454724394|FG000|Maintenance Period|Adverse Event|0|||
126390765|NCT02589665|454724395|FG001|Maintenance Period|Adverse Event|0|||
126390766|NCT02589665|454724396|FG002|Maintenance Period|Adverse Event|0|||
126390767|NCT02589665|454724397|FG003|Maintenance Period|Adverse Event|0|||
126390768|NCT02589665|454724398|FG004|Maintenance Period|Adverse Event|0|||
126390769|NCT02589665|454724399|FG005|Maintenance Period|Adverse Event|0|||
126390770|NCT02589665|454724400|FG006|Maintenance Period|Adverse Event|2|||
126390771|NCT02589665|454724401|FG007|Maintenance Period|Adverse Event|0|||
126390772|NCT02589665|454724402|FG008|Maintenance Period|Adverse Event|0|||
126390773|NCT02589665|454724403|FG009|Maintenance Period|Adverse Event|0|||
126390774|NCT02589665|454724394|FG000|Maintenance Period|Lost to Follow-up|0|||
126390775|NCT02589665|454724395|FG001|Maintenance Period|Lost to Follow-up|0|||
126390776|NCT02589665|454724396|FG002|Maintenance Period|Lost to Follow-up|0|||
126390777|NCT02589665|454724397|FG003|Maintenance Period|Lost to Follow-up|0|||
126390778|NCT02589665|454724398|FG004|Maintenance Period|Lost to Follow-up|0|||
126390779|NCT02589665|454724399|FG005|Maintenance Period|Lost to Follow-up|1|||
126390780|NCT02589665|454724400|FG006|Maintenance Period|Lost to Follow-up|0|||
126390781|NCT02589665|454724401|FG007|Maintenance Period|Lost to Follow-up|0|||
126390782|NCT02589665|454724402|FG008|Maintenance Period|Lost to Follow-up|0|||
126390783|NCT02589665|454724403|FG009|Maintenance Period|Lost to Follow-up|0|||
126390784|NCT02589665|454724394|FG000|Maintenance Period|Physician Decision|0|||
126390785|NCT02589665|454724395|FG001|Maintenance Period|Physician Decision|0|||
126390786|NCT02589665|454724396|FG002|Maintenance Period|Physician Decision|0|||
126390787|NCT02589665|454724397|FG003|Maintenance Period|Physician Decision|0|||
126390788|NCT02589665|454724398|FG004|Maintenance Period|Physician Decision|0|||
126390789|NCT02589665|454724399|FG005|Maintenance Period|Physician Decision|1|||
126390790|NCT02589665|454724400|FG006|Maintenance Period|Physician Decision|0|||
126390791|NCT02589665|454724401|FG007|Maintenance Period|Physician Decision|0|||
126390792|NCT02589665|454724402|FG008|Maintenance Period|Physician Decision|0|||
126390793|NCT02589665|454724403|FG009|Maintenance Period|Physician Decision|0|||
126390794|NCT02589665|454724394|FG000|Maintenance Period|Reason Not Collected|0|||
126390795|NCT02589665|454724395|FG001|Maintenance Period|Reason Not Collected|0|||
126390796|NCT02589665|454724396|FG002|Maintenance Period|Reason Not Collected|0|||
126390797|NCT02589665|454724397|FG003|Maintenance Period|Reason Not Collected|0|||
126390798|NCT02589665|454724398|FG004|Maintenance Period|Reason Not Collected|0|||
126390799|NCT02589665|454724399|FG005|Maintenance Period|Reason Not Collected|1|||
126390800|NCT02589665|454724400|FG006|Maintenance Period|Reason Not Collected|1|||
126390801|NCT02589665|454724401|FG007|Maintenance Period|Reason Not Collected|0|||
125887687|NCT02302339|452884569|FG002|Overall Study|Withdrawal by Subject|1|||
126049164|NCT02307682|453476716|FG000|Overall Study|Lack of Efficacy|1|||
126049165|NCT02307682|453476717|FG001|Overall Study|Lack of Efficacy|0|||
126049166|NCT02307682|453476718|FG002|Overall Study|Lack of Efficacy|1|||
126049167|NCT02307682|453476716|FG000|Overall Study|Physician Decision|2|||
126049168|NCT02307682|453476717|FG001|Overall Study|Physician Decision|2|||
126049169|NCT02307682|453476718|FG002|Overall Study|Physician Decision|8|||
126049170|NCT02307682|453476716|FG000|Overall Study|Progressive Disease|1|||
126049171|NCT02307682|453476717|FG001|Overall Study|Progressive Disease|0|||
126049172|NCT02307682|453476718|FG002|Overall Study|Progressive Disease|0|||
126049173|NCT02307682|453476716|FG000|Overall Study|Withdrawal by Subject|26|||
126049174|NCT02307682|453476717|FG001|Overall Study|Withdrawal by Subject|34|||
126049175|NCT02307682|453476718|FG002|Overall Study|Withdrawal by Subject|23|||
126049176|NCT02307682|453476716|FG000|Overall Study|Death|9|||
126049177|NCT02307682|453476717|FG001|Overall Study|Death|7|||
126049178|NCT02307682|453476718|FG002|Overall Study|Death|12|||
126049179|NCT02307682|453476716|FG000|Overall Study|Lost to Follow-up|1|||
126049180|NCT02307682|453476717|FG001|Overall Study|Lost to Follow-up|5|||
126049181|NCT02307682|453476718|FG002|Overall Study|Lost to Follow-up|6|||
126049182|NCT02307682|453476716|FG000|Overall Study|Protocol Deviation|0|||
126049183|NCT02307682|453476717|FG001|Overall Study|Protocol Deviation|0|||
126049184|NCT02307682|453476718|FG002|Overall Study|Protocol Deviation|2|||
126049185|NCT02307682|453476716|FG000|Overall Study|Other|1|||
126049186|NCT02307682|453476717|FG001|Overall Study|Other|1|||
126049187|NCT02307682|453476718|FG002|Overall Study|Other|0|||
126049188|NCT05630833|453476719|FG000|Overall Study|Adverse Event|3|||
126049189|NCT05630833|453476720|FG001|Overall Study|Adverse Event|0|||
126390802|NCT02589665|454724402|FG008|Maintenance Period|Reason Not Collected|0|||
126390803|NCT02589665|454724403|FG009|Maintenance Period|Reason Not Collected|0|||
126390804|NCT02589665|454724394|FG000|Induction Extension Period|Adverse Event|0|||
126390805|NCT02589665|454724395|FG001|Induction Extension Period|Adverse Event|0|||
126390806|NCT02589665|454724396|FG002|Induction Extension Period|Adverse Event|0|||
126049190|NCT05630833|453476719|FG000|Overall Study|Lack of Efficacy|0|||
126049191|NCT05630833|453476720|FG001|Overall Study|Lack of Efficacy|1|||
126049192|NCT05630833|453476719|FG000|Overall Study|Lost to Follow-up|1|||
126049193|NCT05630833|453476720|FG001|Overall Study|Lost to Follow-up|0|||
126049194|NCT05630833|453476719|FG000|Overall Study|Withdrawal by Subject|3|||
126049195|NCT05630833|453476720|FG001|Overall Study|Withdrawal by Subject|1|||
126049196|NCT03170349|453476722|FG000|From Implant to the 30-Day Visit|Death|1|||
126049197|NCT03170349|453476722|FG000|From 30-Day to 6-Month Visit|Death|3|||
126049198|NCT03170349|453476722|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
126049199|NCT03170349|453476722|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
126049200|NCT03170349|453476722|FG000|From 6-Month to 1-Year Visit|Death|6|||
126049201|NCT03170349|453476722|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
126049202|NCT03170349|453476722|FG000|From 1-Year to 2-Year Visit|Death|13|||
126049203|NCT03170349|453476722|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
126049204|NCT03170349|453476722|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
126049205|NCT03170349|453476722|FG000|From 2-Year to 3-Year Visit|Death|10|||
126049206|NCT03170349|453476722|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
126390807|NCT02589665|454724397|FG003|Induction Extension Period|Adverse Event|0|||
126049207|NCT03170349|453476722|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
126049208|NCT03170349|453476722|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
126049209|NCT04551066|453476723|FG000|Overall Study|Death|5|||
126049210|NCT04551066|453476724|FG001|Overall Study|Death|3|||
126049211|NCT04551066|453476723|FG000|Overall Study|Lost to Follow-up|1|||
126049212|NCT04551066|453476724|FG001|Overall Study|Lost to Follow-up|0|||
126049213|NCT04551066|453476723|FG000|Overall Study|Sponsor Decision|103|||
126049214|NCT04551066|453476724|FG001|Overall Study|Sponsor Decision|117|||
126049215|NCT04551066|453476723|FG000|Overall Study|Withdrawal by Subject|8|||
126049216|NCT04551066|453476724|FG001|Overall Study|Withdrawal by Subject|2|||
126049217|NCT04551066|453476723|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
126104268|NCT00120406|453675839|FG001|Overall Study|received non-study stent|2|||
126104269|NCT00120406|453675838|FG000|Overall Study|patient moved but has not withdrawn|0|||
126104270|NCT00120406|453675839|FG001|Overall Study|patient moved but has not withdrawn|1|||
126104271|NCT00250679|453675840|FG000|Overall Study|Adverse Event|12|||
126390808|NCT02589665|454724398|FG004|Induction Extension Period|Adverse Event|0|||
126390809|NCT02589665|454724399|FG005|Induction Extension Period|Adverse Event|0|||
126390810|NCT02589665|454724400|FG006|Induction Extension Period|Adverse Event|0|||
126390811|NCT02589665|454724401|FG007|Induction Extension Period|Adverse Event|0|||
126390812|NCT02589665|454724402|FG008|Induction Extension Period|Adverse Event|4|||
126049218|NCT04551066|453476724|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
126049219|NCT04551066|453476723|FG000|Overall Study|Adverse Event|2|||
126049220|NCT04551066|453476724|FG001|Overall Study|Adverse Event|0|||
126049221|NCT04551066|453476723|FG000|Overall Study|Physician Decision|2|||
126049222|NCT04551066|453476724|FG001|Overall Study|Physician Decision|0|||
126049223|NCT04551066|453476723|FG000|Overall Study|Protocol Violation|1|||
126049224|NCT04551066|453476724|FG001|Overall Study|Protocol Violation|0|||
126104272|NCT00250679|453675841|FG001|Overall Study|Adverse Event|15|||
126390813|NCT02589665|454724403|FG009|Induction Extension Period|Adverse Event|0|||
126390814|NCT02589665|454724394|FG000|Induction Extension Period|Lack of Efficacy|0|||
126390815|NCT02589665|454724395|FG001|Induction Extension Period|Lack of Efficacy|0|||
126390816|NCT02589665|454724396|FG002|Induction Extension Period|Lack of Efficacy|0|||
126390817|NCT02589665|454724397|FG003|Induction Extension Period|Lack of Efficacy|0|||
126390818|NCT02589665|454724398|FG004|Induction Extension Period|Lack of Efficacy|0|||
126390819|NCT02589665|454724399|FG005|Induction Extension Period|Lack of Efficacy|0|||
126390820|NCT02589665|454724400|FG006|Induction Extension Period|Lack of Efficacy|0|||
126390821|NCT02589665|454724401|FG007|Induction Extension Period|Lack of Efficacy|0|||
126390822|NCT02589665|454724402|FG008|Induction Extension Period|Lack of Efficacy|3|||
126390823|NCT02589665|454724403|FG009|Induction Extension Period|Lack of Efficacy|0|||
126390824|NCT02589665|454724394|FG000|Induction Extension Period|Withdrawal by Subject|0|||
126390825|NCT02589665|454724395|FG001|Induction Extension Period|Withdrawal by Subject|0|||
126390826|NCT02589665|454724396|FG002|Induction Extension Period|Withdrawal by Subject|0|||
126390827|NCT02589665|454724397|FG003|Induction Extension Period|Withdrawal by Subject|0|||
126390828|NCT02589665|454724398|FG004|Induction Extension Period|Withdrawal by Subject|0|||
126390829|NCT02589665|454724399|FG005|Induction Extension Period|Withdrawal by Subject|0|||
126390830|NCT02589665|454724400|FG006|Induction Extension Period|Withdrawal by Subject|0|||
126390831|NCT02589665|454724401|FG007|Induction Extension Period|Withdrawal by Subject|2|||
126390832|NCT02589665|454724402|FG008|Induction Extension Period|Withdrawal by Subject|3|||
126390833|NCT02589665|454724403|FG009|Induction Extension Period|Withdrawal by Subject|0|||
126390834|NCT02589665|454724394|FG000|Induction Extension Period|Physician Decision|0|||
126390835|NCT02589665|454724395|FG001|Induction Extension Period|Physician Decision|0|||
126390836|NCT02589665|454724396|FG002|Induction Extension Period|Physician Decision|0|||
126390837|NCT02589665|454724397|FG003|Induction Extension Period|Physician Decision|0|||
126390838|NCT02589665|454724398|FG004|Induction Extension Period|Physician Decision|0|||
126390839|NCT02589665|454724399|FG005|Induction Extension Period|Physician Decision|0|||
126390840|NCT02589665|454724400|FG006|Induction Extension Period|Physician Decision|0|||
126390841|NCT02589665|454724401|FG007|Induction Extension Period|Physician Decision|0|||
126390842|NCT02589665|454724402|FG008|Induction Extension Period|Physician Decision|1|||
126390843|NCT02589665|454724403|FG009|Induction Extension Period|Physician Decision|0|||
126390844|NCT02589665|454724394|FG000|Induction Extension Period|Reason Not Collected|0|||
126390845|NCT02589665|454724395|FG001|Induction Extension Period|Reason Not Collected|0|||
126390846|NCT02589665|454724396|FG002|Induction Extension Period|Reason Not Collected|0|||
126390847|NCT02589665|454724397|FG003|Induction Extension Period|Reason Not Collected|0|||
126390848|NCT02589665|454724398|FG004|Induction Extension Period|Reason Not Collected|0|||
126390849|NCT02589665|454724399|FG005|Induction Extension Period|Reason Not Collected|0|||
126390850|NCT02589665|454724400|FG006|Induction Extension Period|Reason Not Collected|0|||
126390851|NCT02589665|454724401|FG007|Induction Extension Period|Reason Not Collected|0|||
125887688|NCT02302339|452884570|FG003|Overall Study|Withdrawal by Subject|0|||
125887689|NCT01642589|452884574|FG000|Overall Study|Withdrawal by Subject|1|||
125887690|NCT01642589|452884575|FG001|Overall Study|Withdrawal by Subject|1|||
125887691|NCT01185080|452884580|FG000|Overall Study|Adverse Event|1|||
125887692|NCT01185080|452884581|FG001|Overall Study|Adverse Event|1|||
125887693|NCT01185080|452884582|FG002|Overall Study|Adverse Event|0|||
125887694|NCT01185080|452884580|FG000|Overall Study|Personal reasons|0|||
125887695|NCT01185080|452884581|FG001|Overall Study|Personal reasons|0|||
125887696|NCT01185080|452884582|FG002|Overall Study|Personal reasons|1|||
125887697|NCT01104311|452884587|FG000|Overall Study|Withdrawal by Subject|6|||
126390852|NCT02589665|454724402|FG008|Induction Extension Period|Reason Not Collected|1|||
126390853|NCT02589665|454724403|FG009|Induction Extension Period|Reason Not Collected|0|||
126390854|NCT02589665|454724394|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125887698|NCT01104311|452884588|FG001|Overall Study|Withdrawal by Subject|6|||
125887699|NCT01104311|452884587|FG000|Overall Study|Protocol Violation|0|||
125887700|NCT01104311|452884588|FG001|Overall Study|Protocol Violation|1|||
125887701|NCT01104311|452884587|FG000|Overall Study|Physician Decision|2|||
125887702|NCT01104311|452884588|FG001|Overall Study|Physician Decision|2|||
125887703|NCT01104311|452884587|FG000|Overall Study|low compliance|1|||
125887704|NCT01104311|452884588|FG001|Overall Study|low compliance|1|||
126390855|NCT02589665|454724395|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390856|NCT02589665|454724396|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390857|NCT02589665|454724397|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125887705|NCT01104311|452884587|FG000|Overall Study|Adverse Event|1|||
125887706|NCT01104311|452884588|FG001|Overall Study|Adverse Event|2|||
126390858|NCT02589665|454724398|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125887707|NCT00854113|452886534|FG000|Overall Study|Adverse Event|0|||
126390859|NCT02589665|454724399|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390860|NCT02589665|454724400|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125887708|NCT00854113|452886535|FG001|Overall Study|Adverse Event|0|||
125887709|NCT00854113|452886536|FG002|Overall Study|Adverse Event|0|||
125887710|NCT00854113|452886537|FG003|Overall Study|Adverse Event|0|||
126390861|NCT02589665|454724401|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390862|NCT02589665|454724402|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126049225|NCT04551066|453476723|FG000|Overall Study|Lack of Efficacy|0|||
126049226|NCT04551066|453476724|FG001|Overall Study|Lack of Efficacy|1|||
126049227|NCT04551066|453476723|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
126390863|NCT02589665|454724403|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
126390864|NCT02589665|454724394|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
126390865|NCT02589665|454724395|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
126390866|NCT02589665|454724396|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
126390867|NCT02589665|454724397|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
126390868|NCT02589665|454724398|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
126390869|NCT02589665|454724399|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
126390870|NCT02589665|454724400|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
126390871|NCT02589665|454724401|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
126390872|NCT02589665|454724402|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
126390873|NCT02589665|454724403|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
126390874|NCT02589665|454724394|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
126390875|NCT02589665|454724395|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
126390876|NCT02589665|454724396|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
126390877|NCT02589665|454724397|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
126390878|NCT02589665|454724398|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
126390879|NCT02589665|454724399|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
126390880|NCT02589665|454724400|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
126390881|NCT02589665|454724401|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
126390882|NCT02589665|454724402|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
126390883|NCT02589665|454724403|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
126390884|NCT02589665|454724394|FG000|Maintenance Extension Period|Adverse Event|0|||
126390885|NCT02589665|454724395|FG001|Maintenance Extension Period|Adverse Event|0|||
126390886|NCT02589665|454724396|FG002|Maintenance Extension Period|Adverse Event|0|||
126390887|NCT02589665|454724397|FG003|Maintenance Extension Period|Adverse Event|0|||
126390888|NCT02589665|454724398|FG004|Maintenance Extension Period|Adverse Event|0|||
126390889|NCT02589665|454724399|FG005|Maintenance Extension Period|Adverse Event|0|||
126390890|NCT02589665|454724400|FG006|Maintenance Extension Period|Adverse Event|0|||
126390891|NCT02589665|454724401|FG007|Maintenance Extension Period|Adverse Event|0|||
126390892|NCT02589665|454724402|FG008|Maintenance Extension Period|Adverse Event|0|||
126390893|NCT02589665|454724403|FG009|Maintenance Extension Period|Adverse Event|2|||
126390894|NCT02589665|454724394|FG000|Maintenance Extension Period|Non-responder|0|||
126390895|NCT02589665|454724395|FG001|Maintenance Extension Period|Non-responder|0|||
126390896|NCT02589665|454724396|FG002|Maintenance Extension Period|Non-responder|0|||
126390897|NCT02589665|454724397|FG003|Maintenance Extension Period|Non-responder|0|||
126390898|NCT02589665|454724398|FG004|Maintenance Extension Period|Non-responder|0|||
126390899|NCT02589665|454724399|FG005|Maintenance Extension Period|Non-responder|0|||
126390900|NCT02589665|454724400|FG006|Maintenance Extension Period|Non-responder|0|||
126390901|NCT02589665|454724401|FG007|Maintenance Extension Period|Non-responder|0|||
126390902|NCT02589665|454724402|FG008|Maintenance Extension Period|Non-responder|0|||
126390903|NCT02589665|454724403|FG009|Maintenance Extension Period|Non-responder|1|||
126390904|NCT00978380|454724404|FG000|Overall Study|Protocol Violation|2|||
126390905|NCT00978380|454724404|FG000|Overall Study|Withdrawal criteria|9|||
126390906|NCT00978380|454724404|FG000|Overall Study|Unclassified|8|||
126390907|NCT00327015|454724405|FG000|Overall Study|Lack of Efficacy|18|||
126390908|NCT00327015|454724406|FG001|Overall Study|Lack of Efficacy|18|||
126390909|NCT00327015|454724407|FG002|Overall Study|Lack of Efficacy|35|||
126390910|NCT00327015|454724408|FG003|Overall Study|Lack of Efficacy|29|||
126390911|NCT00327015|454724405|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
126390912|NCT00327015|454724406|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
126390913|NCT00327015|454724407|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
126390914|NCT00327015|454724408|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
126390915|NCT00327015|454724405|FG000|Overall Study|Lost to Follow-up|22|||
126390916|NCT00327015|454724406|FG001|Overall Study|Lost to Follow-up|23|||
126390917|NCT00327015|454724407|FG002|Overall Study|Lost to Follow-up|29|||
126390918|NCT00327015|454724408|FG003|Overall Study|Lost to Follow-up|22|||
126390919|NCT00327015|454724405|FG000|Overall Study|Adverse Event|14|||
126390920|NCT00327015|454724406|FG001|Overall Study|Adverse Event|10|||
126390921|NCT00327015|454724407|FG002|Overall Study|Adverse Event|14|||
126104273|NCT00250679|453675842|FG002|Overall Study|Adverse Event|16|||
126390922|NCT00327015|454724408|FG003|Overall Study|Adverse Event|14|||
126390923|NCT00327015|454724405|FG000|Overall Study|Subject no longer meets study criteria|4|||
126390924|NCT00327015|454724406|FG001|Overall Study|Subject no longer meets study criteria|2|||
126390925|NCT00327015|454724407|FG002|Overall Study|Subject no longer meets study criteria|8|||
126390926|NCT00327015|454724408|FG003|Overall Study|Subject no longer meets study criteria|7|||
126390927|NCT00327015|454724405|FG000|Overall Study|Poor/Noncompliance|11|||
126390928|NCT00327015|454724406|FG001|Overall Study|Poor/Noncompliance|8|||
126390929|NCT00327015|454724407|FG002|Overall Study|Poor/Noncompliance|4|||
126390930|NCT00327015|454724408|FG003|Overall Study|Poor/Noncompliance|5|||
126390931|NCT00327015|454724405|FG000|Overall Study|Physician Decision|0|||
126390932|NCT00327015|454724406|FG001|Overall Study|Physician Decision|1|||
126390933|NCT00327015|454724407|FG002|Overall Study|Physician Decision|3|||
126390934|NCT00327015|454724408|FG003|Overall Study|Physician Decision|2|||
126390935|NCT00327015|454724405|FG000|Overall Study|Death|1|||
126390936|NCT00327015|454724406|FG001|Overall Study|Death|2|||
126390937|NCT00327015|454724407|FG002|Overall Study|Death|2|||
126390938|NCT00327015|454724408|FG003|Overall Study|Death|3|||
126390939|NCT00327015|454724405|FG000|Overall Study|Pregnancy|0|||
126390940|NCT00327015|454724406|FG001|Overall Study|Pregnancy|2|||
126390941|NCT00327015|454724407|FG002|Overall Study|Pregnancy|1|||
126390942|NCT00327015|454724408|FG003|Overall Study|Pregnancy|1|||
126390943|NCT00327015|454724405|FG000|Overall Study|Administrative Reason by Sponsor|1|||
126390944|NCT00327015|454724406|FG001|Overall Study|Administrative Reason by Sponsor|2|||
126390945|NCT00327015|454724407|FG002|Overall Study|Administrative Reason by Sponsor|2|||
126390946|NCT00327015|454724408|FG003|Overall Study|Administrative Reason by Sponsor|1|||
126390947|NCT01519791|454724409|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
126390948|NCT01519791|454724410|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
126390949|NCT01519791|454724409|FG000|Overall Study|Protocol Violation|6|||
126390950|NCT01519791|454724410|FG001|Overall Study|Protocol Violation|19|||
126390951|NCT01519791|454724409|FG000|Overall Study|Other Reason|87|||
126390952|NCT01519791|454724410|FG001|Overall Study|Other Reason|222|||
126390953|NCT01519791|454724409|FG000|Overall Study|subjects randomized in error|2|||
126390954|NCT01519791|454724410|FG001|Overall Study|subjects randomized in error|0|||
126390955|NCT01519791|454724409|FG000|Overall Study|Lack of Efficacy|16|||
126390956|NCT01519791|454724410|FG001|Overall Study|Lack of Efficacy|20|||
126390957|NCT01519791|454724409|FG000|Overall Study|SAE, non-fatal|6|||
126390958|NCT01519791|454724410|FG001|Overall Study|SAE, non-fatal|22|||
126390959|NCT01519791|454724409|FG000|Overall Study|AE, serious fatal|0|||
126390960|NCT01519791|454724410|FG001|Overall Study|AE, serious fatal|1|||
125887711|NCT00854113|452886538|FG004|Overall Study|Adverse Event|0|||
125887712|NCT00854113|452886539|FG005|Overall Study|Adverse Event|0|||
126390961|NCT01519791|454724409|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
126390962|NCT01519791|454724410|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
126390963|NCT01519791|454724409|FG000|Overall Study|AE, non-serious non-fatal|12|||
126390964|NCT01519791|454724410|FG001|Overall Study|AE, non-serious non-fatal|31|||
126390965|NCT01519791|454724409|FG000|Overall Study|Withdrawal by Subject|15|||
126390966|NCT01519791|454724410|FG001|Overall Study|Withdrawal by Subject|37|||
126390967|NCT01519791|454724409|FG000|Overall Study|Lost to Follow-up|6|||
126390968|NCT01519791|454724410|FG001|Overall Study|Lost to Follow-up|14|||
126390969|NCT00837265|454724411|FG000|Pilot Phase|Withdrawal by Subject|0|||
126390970|NCT00837265|454724412|FG001|Pilot Phase|Withdrawal by Subject|2|||
126390971|NCT00837265|454724413|FG002|Pilot Phase|Withdrawal by Subject|3|||
126390972|NCT00837265|454724414|FG003|Pilot Phase|Withdrawal by Subject|2|||
126390973|NCT00837265|454724415|FG004|Pilot Phase|Withdrawal by Subject|0|||
126390974|NCT00837265|454724416|FG005|Pilot Phase|Withdrawal by Subject|0|||
126390975|NCT00837265|454724417|FG006|Pilot Phase|Withdrawal by Subject|0|||
126390976|NCT00837265|454724411|FG000|Pilot Phase|Decision of the investigator|2|||
126390977|NCT00837265|454724412|FG001|Pilot Phase|Decision of the investigator|1|||
126390978|NCT00837265|454724413|FG002|Pilot Phase|Decision of the investigator|0|||
126390979|NCT00837265|454724414|FG003|Pilot Phase|Decision of the investigator|0|||
126390980|NCT00837265|454724415|FG004|Pilot Phase|Decision of the investigator|0|||
126390981|NCT00837265|454724416|FG005|Pilot Phase|Decision of the investigator|0|||
126390982|NCT00837265|454724417|FG006|Pilot Phase|Decision of the investigator|0|||
126390983|NCT00837265|454724411|FG000|Pilot Phase|Adverse Event|1|||
126390984|NCT00837265|454724412|FG001|Pilot Phase|Adverse Event|0|||
126390985|NCT00837265|454724413|FG002|Pilot Phase|Adverse Event|0|||
126390986|NCT00837265|454724414|FG003|Pilot Phase|Adverse Event|0|||
126390987|NCT00837265|454724415|FG004|Pilot Phase|Adverse Event|0|||
126390988|NCT00837265|454724416|FG005|Pilot Phase|Adverse Event|0|||
126390989|NCT00837265|454724417|FG006|Pilot Phase|Adverse Event|0|||
126390990|NCT00837265|454724411|FG000|Pilot Phase|Disease progression|0|||
126390991|NCT00837265|454724412|FG001|Pilot Phase|Disease progression|0|||
126390992|NCT00837265|454724413|FG002|Pilot Phase|Disease progression|0|||
126390993|NCT00837265|454724414|FG003|Pilot Phase|Disease progression|1|||
126390994|NCT00837265|454724415|FG004|Pilot Phase|Disease progression|0|||
126390995|NCT00837265|454724416|FG005|Pilot Phase|Disease progression|0|||
126390996|NCT00837265|454724417|FG006|Pilot Phase|Disease progression|0|||
126390997|NCT00837265|454724411|FG000|Pilot Phase|Participant left the city|0|||
126390998|NCT00837265|454724412|FG001|Pilot Phase|Participant left the city|0|||
126390999|NCT00837265|454724413|FG002|Pilot Phase|Participant left the city|0|||
126391000|NCT00837265|454724414|FG003|Pilot Phase|Participant left the city|1|||
126391001|NCT00837265|454724415|FG004|Pilot Phase|Participant left the city|0|||
126391002|NCT00837265|454724416|FG005|Pilot Phase|Participant left the city|0|||
126391003|NCT00837265|454724417|FG006|Pilot Phase|Participant left the city|0|||
126391004|NCT00837265|454724411|FG000|Main Phase|Withdrawal by Subject|0|||
126391005|NCT00837265|454724412|FG001|Main Phase|Withdrawal by Subject|0|||
126391006|NCT00837265|454724413|FG002|Main Phase|Withdrawal by Subject|0|||
126391007|NCT00837265|454724414|FG003|Main Phase|Withdrawal by Subject|0|||
126391008|NCT00837265|454724415|FG004|Main Phase|Withdrawal by Subject|4|||
126391009|NCT00837265|454724416|FG005|Main Phase|Withdrawal by Subject|2|||
126391010|NCT00837265|454724417|FG006|Main Phase|Withdrawal by Subject|1|||
126391011|NCT00837265|454724411|FG000|Main Phase|Decision of the investigator|0|||
126391012|NCT00837265|454724412|FG001|Main Phase|Decision of the investigator|0|||
126391013|NCT00837265|454724413|FG002|Main Phase|Decision of the investigator|0|||
126391014|NCT00837265|454724414|FG003|Main Phase|Decision of the investigator|0|||
126391015|NCT00837265|454724415|FG004|Main Phase|Decision of the investigator|0|||
126391016|NCT00837265|454724416|FG005|Main Phase|Decision of the investigator|2|||
126391017|NCT00837265|454724417|FG006|Main Phase|Decision of the investigator|1|||
125887713|NCT00854113|452886540|FG006|Overall Study|Adverse Event|0|||
125887714|NCT00854113|452886541|FG007|Overall Study|Adverse Event|2|||
125887715|NCT00854113|452886542|FG008|Overall Study|Adverse Event|0|||
125887716|NCT00854113|452886543|FG009|Overall Study|Adverse Event|0|||
125887717|NCT00854113|452886544|FG010|Overall Study|Adverse Event|0|||
125887718|NCT00854113|452886534|FG000|Overall Study|Withdrawal by Subject|0|||
125887719|NCT00854113|452886535|FG001|Overall Study|Withdrawal by Subject|0|||
125887720|NCT00854113|452886536|FG002|Overall Study|Withdrawal by Subject|0|||
125887721|NCT00854113|452886537|FG003|Overall Study|Withdrawal by Subject|0|||
125887722|NCT00854113|452886538|FG004|Overall Study|Withdrawal by Subject|0|||
125887723|NCT00854113|452886539|FG005|Overall Study|Withdrawal by Subject|0|||
125887724|NCT00854113|452886540|FG006|Overall Study|Withdrawal by Subject|0|||
125887725|NCT00854113|452886541|FG007|Overall Study|Withdrawal by Subject|1|||
125887726|NCT00854113|452886542|FG008|Overall Study|Withdrawal by Subject|1|||
125887727|NCT00854113|452886543|FG009|Overall Study|Withdrawal by Subject|0|||
125887728|NCT00854113|452886544|FG010|Overall Study|Withdrawal by Subject|0|||
125887729|NCT02273596|452886548|FG000|24-Week Treatment Period|Adverse Event|3|||
125887730|NCT02273596|452886548|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
125887731|NCT02273596|452886548|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
125887732|NCT02273596|452886548|FG000|24-Week Treatment Period|Physician Decision|1|||
125887733|NCT02273596|452886548|FG000|24-Week Treatment Period|Protocol Deviation|1|||
125887734|NCT02273596|452886548|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
125887735|NCT02273596|452886548|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
125887736|NCT02273596|452886548|FG000|Extension Period|Lost to Follow-up|1|||
125887737|NCT02273596|452886548|FG000|Extension Period|Protocol Deviation|1|||
125887738|NCT02604160|452886549|FG000|Overall Study|Protocol Violation|0|||
125887739|NCT02604160|452886550|FG001|Overall Study|Protocol Violation|1|||
125887740|NCT02604160|452886549|FG000|Overall Study|Physician Decision|0|||
125887741|NCT02604160|452886550|FG001|Overall Study|Physician Decision|1|||
125887742|NCT01596062|452886551|FG000|Overall Study|Adverse Event|1|||
125887743|NCT01596062|452886552|FG001|Overall Study|Adverse Event|0|||
125887744|NCT01596062|452886553|FG002|Overall Study|Adverse Event|2|||
125887745|NCT01596062|452886551|FG000|Overall Study|Lack of Efficacy|0|||
125887746|NCT01596062|452886552|FG001|Overall Study|Lack of Efficacy|0|||
125887747|NCT01596062|452886553|FG002|Overall Study|Lack of Efficacy|1|||
125887748|NCT02139592|452886554|FG000|Overall Study|Case Report Forms Uncollected|8|||
125887749|NCT01413204|452886562|FG000|Overall Study|Adverse Event|1|||
125887750|NCT01413204|452886563|FG001|Overall Study|Adverse Event|2|||
125887751|NCT01413204|452886564|FG002|Overall Study|Adverse Event|2|||
125887752|NCT01413204|452886562|FG000|Overall Study|Physician Decision|3|||
125887753|NCT01413204|452886563|FG001|Overall Study|Physician Decision|0|||
125887754|NCT01413204|452886564|FG002|Overall Study|Physician Decision|2|||
125887755|NCT01413204|452886562|FG000|Overall Study|Withdrawal by Subject|1|||
125887756|NCT01413204|452886563|FG001|Overall Study|Withdrawal by Subject|4|||
125887757|NCT01413204|452886564|FG002|Overall Study|Withdrawal by Subject|4|||
125887758|NCT01413204|452886562|FG000|Overall Study|Clearly not eligible for the study|0|||
125887759|NCT01413204|452886563|FG001|Overall Study|Clearly not eligible for the study|0|||
125887760|NCT01413204|452886564|FG002|Overall Study|Clearly not eligible for the study|1|||
125887761|NCT01413204|452886562|FG000|Overall Study|Fasting plasma glucose level increased|1|||
125887762|NCT01413204|452886563|FG001|Overall Study|Fasting plasma glucose level increased|0|||
125887763|NCT01413204|452886564|FG002|Overall Study|Fasting plasma glucose level increased|10|||
126049228|NCT04551066|453476724|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
125887764|NCT00123422|452886565|FG000|Overall Study|Physician Decision|2|||
125887765|NCT00123422|452886566|FG001|Overall Study|Physician Decision|2|||
125887766|NCT00123422|452886567|FG002|Overall Study|Physician Decision|6|||
125887767|NCT00123422|452886565|FG000|Overall Study|Withdrawal by Subject|1|||
126391018|NCT00837265|454724411|FG000|Main Phase|Adverse Event|0|||
125887768|NCT00123422|452886566|FG001|Overall Study|Withdrawal by Subject|2|||
125887769|NCT00123422|452886567|FG002|Overall Study|Withdrawal by Subject|2|||
126391019|NCT00837265|454724412|FG001|Main Phase|Adverse Event|0|||
126391020|NCT00837265|454724413|FG002|Main Phase|Adverse Event|0|||
126391021|NCT00837265|454724414|FG003|Main Phase|Adverse Event|0|||
126391022|NCT00837265|454724415|FG004|Main Phase|Adverse Event|0|||
126391023|NCT00837265|454724416|FG005|Main Phase|Adverse Event|1|||
126391024|NCT00837265|454724417|FG006|Main Phase|Adverse Event|0|||
126391025|NCT00837265|454724411|FG000|Main Phase|Death|0|||
126391026|NCT00837265|454724412|FG001|Main Phase|Death|0|||
126391027|NCT00837265|454724413|FG002|Main Phase|Death|0|||
126391028|NCT00837265|454724414|FG003|Main Phase|Death|0|||
126391029|NCT00837265|454724415|FG004|Main Phase|Death|2|||
126391030|NCT00837265|454724416|FG005|Main Phase|Death|0|||
126391031|NCT00837265|454724417|FG006|Main Phase|Death|1|||
126391032|NCT00837265|454724411|FG000|Main Phase|Lost to Follow-up|0|||
126391033|NCT00837265|454724412|FG001|Main Phase|Lost to Follow-up|0|||
126391034|NCT00837265|454724413|FG002|Main Phase|Lost to Follow-up|0|||
126391035|NCT00837265|454724414|FG003|Main Phase|Lost to Follow-up|0|||
126391036|NCT00837265|454724415|FG004|Main Phase|Lost to Follow-up|1|||
126391037|NCT00837265|454724416|FG005|Main Phase|Lost to Follow-up|0|||
126391038|NCT00837265|454724417|FG006|Main Phase|Lost to Follow-up|0|||
126391039|NCT00837265|454724411|FG000|Main Phase|Principal investigator resignation|0|||
126391040|NCT00837265|454724412|FG001|Main Phase|Principal investigator resignation|0|||
126391041|NCT00837265|454724413|FG002|Main Phase|Principal investigator resignation|0|||
126391042|NCT00837265|454724414|FG003|Main Phase|Principal investigator resignation|0|||
126391043|NCT00837265|454724415|FG004|Main Phase|Principal investigator resignation|2|||
126391044|NCT00837265|454724416|FG005|Main Phase|Principal investigator resignation|0|||
126391045|NCT00837265|454724417|FG006|Main Phase|Principal investigator resignation|0|||
126391046|NCT00837265|454724411|FG000|Main Phase|Participant's personal reason|0|||
126391047|NCT00837265|454724412|FG001|Main Phase|Participant's personal reason|0|||
126391048|NCT00837265|454724413|FG002|Main Phase|Participant's personal reason|0|||
126391049|NCT00837265|454724414|FG003|Main Phase|Participant's personal reason|0|||
126391050|NCT00837265|454724415|FG004|Main Phase|Participant's personal reason|1|||
126391051|NCT00837265|454724416|FG005|Main Phase|Participant's personal reason|0|||
126391052|NCT00837265|454724417|FG006|Main Phase|Participant's personal reason|0|||
126391053|NCT01289353|454724418|FG000|Overall Study|Lost to Follow-up|2|||
126391054|NCT02226562|454724419|FG000|Overall Study|Lost to Follow-up|0|||
126391055|NCT02226562|454724420|FG001|Overall Study|Lost to Follow-up|1|||
126391056|NCT01474772|454724422|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
126391057|NCT01474772|454724423|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
126391058|NCT01474772|454724422|FG000|Period 1|AE not Related to Study Drug|1|||
126391059|NCT01474772|454724423|FG001|Period 1|AE not Related to Study Drug|0|||
126391060|NCT01474772|454724422|FG000|Period 1|Withdrawal by Subject|3|||
126391061|NCT01474772|454724423|FG001|Period 1|Withdrawal by Subject|1|||
126391062|NCT01474772|454724422|FG000|Period 1|Lost to Follow-up|1|||
126391063|NCT01474772|454724423|FG001|Period 1|Lost to Follow-up|0|||
126391064|NCT01474772|454724422|FG000|Period 1|Reason not Specified|1|||
126391065|NCT01474772|454724423|FG001|Period 1|Reason not Specified|1|||
126391066|NCT01474772|454724422|FG000|Washout|AE not Related to Study Drug|2|||
126391067|NCT01474772|454724423|FG001|Washout|AE not Related to Study Drug|0|||
126391068|NCT01474772|454724422|FG000|Washout|Withdrawal by Subject|1|||
126391069|NCT01474772|454724423|FG001|Washout|Withdrawal by Subject|0|||
126391070|NCT01474772|454724422|FG000|Washout|Lost to Follow-up|0|||
126391071|NCT01474772|454724423|FG001|Washout|Lost to Follow-up|1|||
126391072|NCT01474772|454724422|FG000|Washout|Reason not Specified|0|||
126391073|NCT01474772|454724423|FG001|Washout|Reason not Specified|1|||
126391074|NCT01474772|454724422|FG000|Period 2|Death|0|||
126391075|NCT01474772|454724423|FG001|Period 2|Death|1|||
126391076|NCT01474772|454724422|FG000|Period 2|AE Related to Study Drug|0|||
126391077|NCT01474772|454724423|FG001|Period 2|AE Related to Study Drug|1|||
126391078|NCT01474772|454724422|FG000|Period 2|AE not Related to Study Drug|4|||
126391079|NCT01474772|454724423|FG001|Period 2|AE not Related to Study Drug|1|||
126391080|NCT01474772|454724422|FG000|Period 2|Lack of Efficacy|1|||
126391081|NCT01474772|454724423|FG001|Period 2|Lack of Efficacy|0|||
126391082|NCT01474772|454724422|FG000|Period 2|Withdrawal by Subject|3|||
126391083|NCT01474772|454724423|FG001|Period 2|Withdrawal by Subject|4|||
126391084|NCT01474772|454724422|FG000|Period 2|Lost to Follow-up|1|||
126391085|NCT01474772|454724423|FG001|Period 2|Lost to Follow-up|1|||
126391086|NCT01474772|454724422|FG000|Period 2|Reason not Specified|0|||
126391087|NCT01474772|454724423|FG001|Period 2|Reason not Specified|2|||
126391088|NCT01474772|454724422|FG000|Follow-up|AE not Related to Study Drug|0|||
126391089|NCT01474772|454724423|FG001|Follow-up|AE not Related to Study Drug|1|||
126391090|NCT00223808|454724424|FG000|Overall Study|<5 hrs therapy before discharge|3|||
126391091|NCT00223808|454724425|FG001|Overall Study|<5 hrs therapy before discharge|5|||
126391092|NCT00223808|454724426|FG002|Overall Study|<5 hrs therapy before discharge|5|||
126391093|NCT00967694|454724429|FG000|Overall Study|Withdrawal by Subject|6|||
126391094|NCT02321319|454724430|FG000|Overall Study|Product discontinued|5|||
126391095|NCT00152477|454724431|FG000|Chemotherapy Period|Adverse Event|9|||
126391096|NCT00152477|454724432|FG001|Chemotherapy Period|Adverse Event|4|||
126391097|NCT00152477|454724433|FG002|Chemotherapy Period|Adverse Event|5|||
126391098|NCT00152477|454724431|FG000|Chemotherapy Period|Death|1|||
126391099|NCT00152477|454724432|FG001|Chemotherapy Period|Death|3|||
126391100|NCT00152477|454724433|FG002|Chemotherapy Period|Death|3|||
126391101|NCT00152477|454724431|FG000|Chemotherapy Period|Lack of Efficacy|4|||
126391102|NCT00152477|454724432|FG001|Chemotherapy Period|Lack of Efficacy|5|||
125887770|NCT00123422|452886565|FG000|Overall Study|Lost to Follow-up|1|||
125887771|NCT00123422|452886566|FG001|Overall Study|Lost to Follow-up|2|||
125887772|NCT00123422|452886567|FG002|Overall Study|Lost to Follow-up|2|||
125887773|NCT01255436|452886570|FG000|Overall Study|Lost to Follow-up|178|||
125887774|NCT01255436|452886571|FG001|Overall Study|Lost to Follow-up|191|||
125887775|NCT01255436|452886570|FG000|Overall Study|Death, stroke, or MI|4|||
125887776|NCT01255436|452886571|FG001|Overall Study|Death, stroke, or MI|3|||
125887777|NCT01358721|452886574|FG000|Overall Study|Withdrawal by Subject|0|||
125887778|NCT01358721|452886575|FG001|Overall Study|Withdrawal by Subject|0|||
125887779|NCT01358721|452886576|FG002|Overall Study|Withdrawal by Subject|0|||
125887780|NCT01358721|452886577|FG003|Overall Study|Withdrawal by Subject|1|||
125887781|NCT01358721|452886574|FG000|Overall Study|Death|0|||
125887782|NCT01358721|452886575|FG001|Overall Study|Death|2|||
125887783|NCT01358721|452886576|FG002|Overall Study|Death|0|||
125887784|NCT01358721|452886577|FG003|Overall Study|Death|0|||
125887785|NCT01358721|452886574|FG000|Overall Study|Study Drug Toxicity|1|||
125887786|NCT01358721|452886575|FG001|Overall Study|Study Drug Toxicity|3|||
125887787|NCT01358721|452886576|FG002|Overall Study|Study Drug Toxicity|4|||
125887788|NCT01358721|452886577|FG003|Overall Study|Study Drug Toxicity|5|||
125887789|NCT01358721|452886574|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
125887790|NCT01358721|452886575|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
125887791|NCT01358721|452886576|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
125887792|NCT01358721|452886577|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
125887793|NCT01358721|452886574|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125887794|NCT01358721|452886575|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
125887795|NCT01358721|452886576|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
125887796|NCT01358721|452886577|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
125887797|NCT01358721|452886574|FG000|Overall Study|Adverse Event related to study drug|1|||
125887798|NCT01358721|452886575|FG001|Overall Study|Adverse Event related to study drug|0|||
125887799|NCT01358721|452886576|FG002|Overall Study|Adverse Event related to study drug|0|||
125887800|NCT01358721|452886577|FG003|Overall Study|Adverse Event related to study drug|1|||
125887801|NCT01358721|452886574|FG000|Overall Study|Disease Progression|19|||
125887802|NCT01358721|452886575|FG001|Overall Study|Disease Progression|15|||
125887803|NCT01358721|452886576|FG002|Overall Study|Disease Progression|17|||
125887804|NCT01358721|452886577|FG003|Overall Study|Disease Progression|15|||
125887805|NCT01358721|452886574|FG000|Overall Study|Out of State/Unmet Criteria|0|||
125887806|NCT01358721|452886575|FG001|Overall Study|Out of State/Unmet Criteria|0|||
125887807|NCT01358721|452886576|FG002|Overall Study|Out of State/Unmet Criteria|1|||
125887808|NCT01358721|452886577|FG003|Overall Study|Out of State/Unmet Criteria|0|||
125887809|NCT01908803|452886578|FG000|Overall Study|Adverse Event|1|||
125887810|NCT01908803|452886579|FG001|Overall Study|Adverse Event|0|||
125887811|NCT01908803|452886578|FG000|Overall Study|Physician Decision|0|||
125887812|NCT01908803|452886579|FG001|Overall Study|Physician Decision|1|||
125887813|NCT01908803|452886578|FG000|Overall Study|Withdrawal by Subject|1|||
125887814|NCT01908803|452886579|FG001|Overall Study|Withdrawal by Subject|0|||
125887815|NCT01908803|452886578|FG000|Overall Study|Randomization Error|1|||
125887816|NCT01908803|452886579|FG001|Overall Study|Randomization Error|0|||
125887817|NCT01908803|452886578|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
126391103|NCT00152477|454724433|FG002|Chemotherapy Period|Lack of Efficacy|6|||
126391104|NCT00152477|454724431|FG000|Chemotherapy Period|Lost to Follow-up|1|||
126391105|NCT00152477|454724432|FG001|Chemotherapy Period|Lost to Follow-up|0|||
126391106|NCT00152477|454724433|FG002|Chemotherapy Period|Lost to Follow-up|1|||
126391107|NCT00152477|454724431|FG000|Chemotherapy Period|Protocol Violation|1|||
126391108|NCT00152477|454724432|FG001|Chemotherapy Period|Protocol Violation|1|||
126391109|NCT00152477|454724433|FG002|Chemotherapy Period|Protocol Violation|0|||
126391110|NCT00152477|454724431|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
126391111|NCT00152477|454724432|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
126391112|NCT00152477|454724433|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
126391113|NCT00152477|454724431|FG000|Chemotherapy Period|Progression of Disease|6|||
126391114|NCT00152477|454724432|FG001|Chemotherapy Period|Progression of Disease|8|||
126391115|NCT00152477|454724433|FG002|Chemotherapy Period|Progression of Disease|4|||
126391116|NCT00152477|454724431|FG000|Chemotherapy Period|Investigator decision|0|||
126391117|NCT00152477|454724432|FG001|Chemotherapy Period|Investigator decision|0|||
126391118|NCT00152477|454724433|FG002|Chemotherapy Period|Investigator decision|1|||
126391119|NCT00152477|454724431|FG000|Chemotherapy Period|Patient condition worsened|1|||
126391120|NCT00152477|454724432|FG001|Chemotherapy Period|Patient condition worsened|0|||
126391121|NCT00152477|454724433|FG002|Chemotherapy Period|Patient condition worsened|0|||
126391122|NCT00152477|454724431|FG000|Monotherapy Period|Adverse Event|1|||
126391123|NCT00152477|454724432|FG001|Monotherapy Period|Adverse Event|0|||
126391124|NCT00152477|454724433|FG002|Monotherapy Period|Adverse Event|5|||
126391125|NCT00152477|454724431|FG000|Monotherapy Period|Death|2|||
126391126|NCT00152477|454724432|FG001|Monotherapy Period|Death|0|||
126391127|NCT00152477|454724433|FG002|Monotherapy Period|Death|1|||
126391128|NCT00152477|454724431|FG000|Monotherapy Period|Lack of Efficacy|7|||
126391129|NCT00152477|454724432|FG001|Monotherapy Period|Lack of Efficacy|16|||
126391130|NCT00152477|454724433|FG002|Monotherapy Period|Lack of Efficacy|10|||
126391131|NCT00152477|454724431|FG000|Monotherapy Period|Protocol Violation|0|||
126391132|NCT00152477|454724432|FG001|Monotherapy Period|Protocol Violation|1|||
126391133|NCT00152477|454724433|FG002|Monotherapy Period|Protocol Violation|0|||
126391134|NCT00152477|454724431|FG000|Monotherapy Period|Withdrawal by Subject|0|||
126391135|NCT00152477|454724432|FG001|Monotherapy Period|Withdrawal by Subject|0|||
126391136|NCT00152477|454724433|FG002|Monotherapy Period|Withdrawal by Subject|4|||
126391137|NCT00152477|454724431|FG000|Monotherapy Period|Progression of Disease|5|||
126391138|NCT00152477|454724432|FG001|Monotherapy Period|Progression of Disease|11|||
126391139|NCT00152477|454724433|FG002|Monotherapy Period|Progression of Disease|12|||
126391140|NCT00152477|454724431|FG000|Monotherapy Period|Patient decision|0|||
126391141|NCT00152477|454724432|FG001|Monotherapy Period|Patient decision|1|||
126391142|NCT00152477|454724433|FG002|Monotherapy Period|Patient decision|1|||
126391143|NCT00152477|454724431|FG000|Monotherapy Period|Study personel decision|0|||
126391144|NCT00152477|454724432|FG001|Monotherapy Period|Study personel decision|0|||
126391145|NCT00152477|454724433|FG002|Monotherapy Period|Study personel decision|1|||
126391146|NCT00923975|454724434|FG000|Overall Study|Did not meet inclusion criteria|1|||
126391147|NCT01005316|454724435|FG000|Overall Study|Adverse Event|0|||
126391148|NCT01005316|454724436|FG001|Overall Study|Adverse Event|0|||
126391149|NCT01005316|454724437|FG002|Overall Study|Adverse Event|0|||
126391150|NCT01005316|454724438|FG003|Overall Study|Adverse Event|1|||
126391151|NCT01005316|454724435|FG000|Overall Study|Death|20|||
126391152|NCT01005316|454724436|FG001|Overall Study|Death|5|||
126391153|NCT01005316|454724437|FG002|Overall Study|Death|1|||
126391154|NCT01005316|454724438|FG003|Overall Study|Death|15|||
126391155|NCT01005316|454724435|FG000|Overall Study|Study Termination|5|||
126391156|NCT01005316|454724436|FG001|Overall Study|Study Termination|63|||
126391157|NCT01005316|454724437|FG002|Overall Study|Study Termination|9|||
126391158|NCT01005316|454724438|FG003|Overall Study|Study Termination|85|||
126391159|NCT01005316|454724435|FG000|Overall Study|Lost to Follow-up|1|||
126391160|NCT01005316|454724436|FG001|Overall Study|Lost to Follow-up|3|||
126391161|NCT01005316|454724437|FG002|Overall Study|Lost to Follow-up|0|||
126391162|NCT01005316|454724438|FG003|Overall Study|Lost to Follow-up|2|||
126391163|NCT01005316|454724435|FG000|Overall Study|Physician Decision|6|||
126391164|NCT01005316|454724436|FG001|Overall Study|Physician Decision|0|||
126391165|NCT01005316|454724437|FG002|Overall Study|Physician Decision|0|||
126391166|NCT01005316|454724438|FG003|Overall Study|Physician Decision|0|||
126391167|NCT01005316|454724435|FG000|Overall Study|Sponsor Decision|6|||
126391168|NCT01005316|454724436|FG001|Overall Study|Sponsor Decision|3|||
126391169|NCT01005316|454724437|FG002|Overall Study|Sponsor Decision|0|||
126391170|NCT01005316|454724438|FG003|Overall Study|Sponsor Decision|0|||
126391171|NCT01005316|454724435|FG000|Overall Study|Withdrawal by Subject|1|||
126391172|NCT01005316|454724436|FG001|Overall Study|Withdrawal by Subject|1|||
126104274|NCT00250679|453675840|FG000|Overall Study|Protocol Violation|2|||
126391173|NCT01005316|454724437|FG002|Overall Study|Withdrawal by Subject|0|||
126391174|NCT01005316|454724438|FG003|Overall Study|Withdrawal by Subject|2|||
126391175|NCT01005316|454724435|FG000|Overall Study|Consented to Another Study|2|||
126104275|NCT00250679|453675841|FG001|Overall Study|Protocol Violation|4|||
126104276|NCT00250679|453675842|FG002|Overall Study|Protocol Violation|3|||
126104277|NCT00250679|453675840|FG000|Overall Study|Withdrawal by Subject|15|||
126104278|NCT00250679|453675841|FG001|Overall Study|Withdrawal by Subject|18|||
126104279|NCT00250679|453675842|FG002|Overall Study|Withdrawal by Subject|15|||
126104280|NCT00250679|453675840|FG000|Overall Study|Lost to Follow-up|3|||
126104281|NCT00250679|453675841|FG001|Overall Study|Lost to Follow-up|4|||
126104282|NCT00250679|453675842|FG002|Overall Study|Lost to Follow-up|2|||
126104283|NCT00250679|453675840|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
126104284|NCT00250679|453675841|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
126104285|NCT00250679|453675842|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
126104286|NCT00250679|453675840|FG000|Overall Study|Lack of Efficacy|0|||
126104287|NCT00250679|453675841|FG001|Overall Study|Lack of Efficacy|1|||
126104288|NCT00250679|453675842|FG002|Overall Study|Lack of Efficacy|3|||
126104289|NCT00250679|453675840|FG000|Overall Study|Technical Holter issues|1|||
126391176|NCT01005316|454724436|FG001|Overall Study|Consented to Another Study|0|||
126391177|NCT01005316|454724437|FG002|Overall Study|Consented to Another Study|0|||
126391178|NCT01005316|454724438|FG003|Overall Study|Consented to Another Study|0|||
126391179|NCT01005316|454724435|FG000|Overall Study|Delisted|8|||
126391180|NCT01005316|454724436|FG001|Overall Study|Delisted|0|||
126391181|NCT01005316|454724437|FG002|Overall Study|Delisted|0|||
126391182|NCT01005316|454724438|FG003|Overall Study|Delisted|0|||
126391183|NCT01005316|454724435|FG000|Overall Study|Transferred Care|1|||
126391184|NCT01005316|454724436|FG001|Overall Study|Transferred Care|0|||
126391185|NCT01005316|454724437|FG002|Overall Study|Transferred Care|1|||
126391186|NCT01005316|454724438|FG003|Overall Study|Transferred Care|3|||
126391187|NCT01005316|454724435|FG000|Overall Study|Retransplanted|0|||
126391188|NCT01005316|454724436|FG001|Overall Study|Retransplanted|1|||
126391189|NCT01005316|454724437|FG002|Overall Study|Retransplanted|0|||
126391190|NCT01005316|454724438|FG003|Overall Study|Retransplanted|0|||
126391191|NCT00960011|454724439|FG000|Overall Study|Death|5|||
126391192|NCT00960011|454724440|FG001|Overall Study|Death|0|||
126391193|NCT00960011|454724439|FG000|Overall Study|Lost to Follow-up|6|||
126391194|NCT00960011|454724440|FG001|Overall Study|Lost to Follow-up|2|||
126391195|NCT00758264|454724441|FG000|Active Phase|Withdrawal by Subject|0|||
125887818|NCT01908803|452886579|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
125887819|NCT00867815|452886580|FG000|Overall Study|Lost to Follow-up|1|||
125887820|NCT01864603|452886581|FG000|Stage 2|DSMB design modification|86056|||
126049229|NCT05529992|453476725|FG000|Overall Study|Withdrawal by Subject|1|||
126049230|NCT01084694|453477614|FG000|Overall Study|Withdrawal by Subject|2|||
126049231|NCT01084694|453477615|FG001|Overall Study|Withdrawal by Subject|1|||
126049232|NCT01084694|453477614|FG000|Overall Study|Death|2|||
126049233|NCT01084694|453477615|FG001|Overall Study|Death|12|||
126049234|NCT01084694|453477614|FG000|Overall Study|eligibility not maintained|2|||
126049235|NCT01084694|453477615|FG001|Overall Study|eligibility not maintained|7|||
126049236|NCT00945321|453477618|FG000|Period 1|Adverse Event|0|||
126049237|NCT00945321|453477619|FG001|Period 1|Adverse Event|0|||
126049238|NCT00945321|453477620|FG002|Period 1|Adverse Event|0|||
126049239|NCT00945321|453477621|FG003|Period 1|Adverse Event|0|||
126049240|NCT00945321|453477622|FG004|Period 1|Adverse Event|1|||
126104290|NCT00250679|453675841|FG001|Overall Study|Technical Holter issues|0|||
126049241|NCT00945321|453477623|FG005|Period 1|Adverse Event|0|||
126391196|NCT00758264|454724442|FG001|Active Phase|Withdrawal by Subject|0|||
125887821|NCT01864603|452886582|FG001|Stage 2|DSMB design modification|92558|||
126104291|NCT00250679|453675842|FG002|Overall Study|Technical Holter issues|2|||
126391197|NCT00758264|454724443|FG002|Active Phase|Withdrawal by Subject|1|||
126391198|NCT00758264|454724441|FG000|Active Phase|Lost to Follow-up|1|||
126391199|NCT00758264|454724442|FG001|Active Phase|Lost to Follow-up|0|||
126049242|NCT00945321|453477618|FG000|Period 4|Lost to Follow-up|0|||
126049243|NCT00945321|453477619|FG001|Period 4|Lost to Follow-up|0|||
126049244|NCT00945321|453477620|FG002|Period 4|Lost to Follow-up|0|||
126049245|NCT00945321|453477621|FG003|Period 4|Lost to Follow-up|0|||
126049246|NCT00945321|453477622|FG004|Period 4|Lost to Follow-up|0|||
126049247|NCT00945321|453477623|FG005|Period 4|Lost to Follow-up|1|||
126049248|NCT02633215|453477624|FG000|Overall Study|Lost to Follow-up|2|||
126049249|NCT02633215|453477625|FG001|Overall Study|Lost to Follow-up|3|||
126049250|NCT04017611|453477626|FG000|Overall Study|Withdrawn prior to completion|1|||
126049251|NCT00692913|453477627|FG000|Overall Study|Adverse Event|8|||
126049252|NCT00692913|453477628|FG001|Overall Study|Adverse Event|4|||
126049253|NCT00692913|453477627|FG000|Overall Study|Lost to Follow-up|3|||
126049254|NCT00692913|453477628|FG001|Overall Study|Lost to Follow-up|5|||
126049255|NCT00692913|453477627|FG000|Overall Study|Physician Decision|2|||
126049256|NCT00692913|453477628|FG001|Overall Study|Physician Decision|0|||
126049257|NCT00692913|453477627|FG000|Overall Study|Protocol Violation|1|||
126049258|NCT00692913|453477628|FG001|Overall Study|Protocol Violation|1|||
126049259|NCT00692913|453477627|FG000|Overall Study|Withdrawal by Subject|15|||
126049260|NCT00692913|453477628|FG001|Overall Study|Withdrawal by Subject|20|||
126049261|NCT02291913|453477629|FG000|Overall Study|Progressive Disease|32|||
126049262|NCT02291913|453477629|FG000|Overall Study|Adverse Event|11|||
126391200|NCT00758264|454724443|FG002|Active Phase|Lost to Follow-up|0|||
126391201|NCT00758264|454724441|FG000|Active Phase|Other|0|||
126391202|NCT00758264|454724442|FG001|Active Phase|Other|0|||
126391203|NCT00758264|454724443|FG002|Active Phase|Other|4|||
126391204|NCT01626118|454724449|FG000|Overall Study|Lack of Efficacy|1|||
126391205|NCT01626118|454724450|FG001|Overall Study|Lack of Efficacy|0|||
126391206|NCT01626118|454724451|FG002|Overall Study|Lack of Efficacy|1|||
126391207|NCT01626118|454724452|FG003|Overall Study|Lack of Efficacy|3|||
126049263|NCT02291913|453477629|FG000|Overall Study|Death|2|||
126049264|NCT02291913|453477629|FG000|Overall Study|Physician Decision|1|||
126049265|NCT02291913|453477629|FG000|Overall Study|Withdrawal by Subject|1|||
126049266|NCT02291913|453477629|FG000|Overall Study|Protocol Violation|1|||
126049267|NCT04876417|453477640|FG000|Overall Study|Lost to Follow-up|5|||
126049268|NCT04876417|453477641|FG001|Overall Study|Lost to Follow-up|8|||
126049269|NCT04876417|453477642|FG002|Overall Study|Lost to Follow-up|0|||
126049270|NCT04876417|453477643|FG003|Overall Study|Lost to Follow-up|0|||
126049271|NCT02866942|453477644|FG000|Overall Study|Invalid consent|1|||
126049272|NCT03801148|453477645|FG000|Period 1 (2 Days)|Adverse Event|1|||
126049273|NCT03801148|453477646|FG001|Period 1 (2 Days)|Adverse Event|1|||
126049274|NCT03801148|453477647|FG002|Period 1 (2 Days)|Adverse Event|0|||
126049275|NCT03801148|453477648|FG003|Period 1 (2 Days)|Adverse Event|0|||
126049276|NCT03801148|453477645|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
126049277|NCT03801148|453477646|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
126049278|NCT03801148|453477647|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
126049279|NCT03801148|453477648|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
126049280|NCT03801148|453477645|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126049281|NCT03801148|453477646|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126049282|NCT03801148|453477647|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
126049283|NCT03801148|453477648|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126391208|NCT01626118|454724449|FG000|Overall Study|Lost to Follow-up|1|||
126049284|NCT03801148|453477645|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
125887822|NCT00001213|452886583|FG000|Overall Study|Death|18|||
126049285|NCT03801148|453477646|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
126391209|NCT01626118|454724450|FG001|Overall Study|Lost to Follow-up|0|||
126391210|NCT01626118|454724451|FG002|Overall Study|Lost to Follow-up|0|||
126391211|NCT01626118|454724452|FG003|Overall Study|Lost to Follow-up|0|||
126391212|NCT01626118|454724449|FG000|Overall Study|Adverse Event|0|||
126391213|NCT01626118|454724450|FG001|Overall Study|Adverse Event|1|||
126391214|NCT01626118|454724451|FG002|Overall Study|Adverse Event|1|||
126391215|NCT01626118|454724452|FG003|Overall Study|Adverse Event|0|||
126391216|NCT01626118|454724449|FG000|Overall Study|Investigator Decision|0|||
126391217|NCT01626118|454724450|FG001|Overall Study|Investigator Decision|1|||
126391218|NCT01626118|454724451|FG002|Overall Study|Investigator Decision|0|||
126391219|NCT01626118|454724452|FG003|Overall Study|Investigator Decision|0|||
126391220|NCT00888329|454724453|FG000|Overall Study|Physician Decision|6|||
126391221|NCT00888329|454724454|FG001|Overall Study|Physician Decision|9|||
126391222|NCT00939029|454724455|FG000|Overall Study|Withdrawal by Subject|3|||
126391223|NCT00939029|454724456|FG001|Overall Study|Withdrawal by Subject|7|||
126391224|NCT00939029|454724455|FG000|Overall Study|Lost to Follow-up|3|||
126391225|NCT00939029|454724456|FG001|Overall Study|Lost to Follow-up|4|||
126391226|NCT00939029|454724455|FG000|Overall Study|Adverse Event|0|||
126391227|NCT00939029|454724456|FG001|Overall Study|Adverse Event|1|||
126391228|NCT06003777|454724457|FG000|Period 1|Adverse Event|0|||
126391229|NCT06003777|454724458|FG001|Period 1|Adverse Event|0|||
126391230|NCT06003777|454724459|FG002|Period 1|Adverse Event|1|||
126391231|NCT06003777|454724460|FG003|Period 1|Adverse Event|0|||
126391232|NCT06003777|454724461|FG004|Period 1|Adverse Event|0|||
126391233|NCT06003777|454724462|FG005|Period 1|Adverse Event|0|||
126391234|NCT06003777|454724463|FG006|Period 1|Adverse Event|0|||
126391235|NCT06003777|454724464|FG007|Period 1|Adverse Event|0|||
126391236|NCT06003777|454724465|FG008|Period 1|Adverse Event|0|||
126391237|NCT06003777|454724466|FG009|Period 1|Adverse Event|0|||
126391238|NCT06003777|454724467|FG010|Period 1|Adverse Event|0|||
126391239|NCT06003777|454724468|FG011|Period 1|Adverse Event|0|||
126391240|NCT06003777|454724457|FG000|Period 1|Withdrawal by Subject|0|||
126391241|NCT06003777|454724458|FG001|Period 1|Withdrawal by Subject|0|||
126391242|NCT06003777|454724459|FG002|Period 1|Withdrawal by Subject|0|||
126391243|NCT06003777|454724460|FG003|Period 1|Withdrawal by Subject|0|||
126391244|NCT06003777|454724461|FG004|Period 1|Withdrawal by Subject|1|||
126049286|NCT03801148|453477647|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
126049287|NCT03801148|453477648|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
126049288|NCT00439270|453477649|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
126049289|NCT00439270|453477650|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
126049290|NCT00439270|453477651|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
126049291|NCT00439270|453477652|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
126049292|NCT00439270|453477653|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
126049293|NCT00439270|453477649|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
126049294|NCT00439270|453477650|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
126049295|NCT00439270|453477651|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
126049296|NCT00439270|453477652|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
126049297|NCT00439270|453477653|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
126049298|NCT00439270|453477649|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
126049299|NCT00439270|453477650|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
126049300|NCT00439270|453477651|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
126049301|NCT00439270|453477652|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
126049302|NCT00439270|453477653|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
126049303|NCT00439270|453477649|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
126049304|NCT00439270|453477650|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
126049305|NCT00439270|453477651|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
126049306|NCT00439270|453477652|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
126049307|NCT00439270|453477653|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
126049308|NCT00439270|453477649|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
126049309|NCT00439270|453477650|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
126049310|NCT00439270|453477651|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
126049311|NCT00439270|453477652|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
126049312|NCT00439270|453477653|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
126049313|NCT00439270|453477649|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
126049314|NCT00439270|453477650|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
126049315|NCT00439270|453477651|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
126049316|NCT00439270|453477652|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
126049317|NCT00439270|453477653|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
126049318|NCT00439270|453477649|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
126049319|NCT00439270|453477650|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
126391245|NCT06003777|454724462|FG005|Period 1|Withdrawal by Subject|0|||
126391246|NCT06003777|454724463|FG006|Period 1|Withdrawal by Subject|0|||
126391247|NCT06003777|454724464|FG007|Period 1|Withdrawal by Subject|0|||
126391248|NCT06003777|454724465|FG008|Period 1|Withdrawal by Subject|0|||
126391249|NCT06003777|454724466|FG009|Period 1|Withdrawal by Subject|0|||
126391250|NCT06003777|454724467|FG010|Period 1|Withdrawal by Subject|0|||
126391251|NCT06003777|454724468|FG011|Period 1|Withdrawal by Subject|0|||
126391252|NCT06003777|454724457|FG000|Period 2|Withdrawal by Subject|0|||
126391253|NCT06003777|454724458|FG001|Period 2|Withdrawal by Subject|0|||
126391254|NCT06003777|454724459|FG002|Period 2|Withdrawal by Subject|0|||
126391255|NCT06003777|454724460|FG003|Period 2|Withdrawal by Subject|0|||
126391256|NCT06003777|454724461|FG004|Period 2|Withdrawal by Subject|0|||
126391257|NCT06003777|454724462|FG005|Period 2|Withdrawal by Subject|0|||
126049320|NCT00439270|453477651|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
126049321|NCT00439270|453477652|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
126049322|NCT00439270|453477653|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
126049323|NCT00439270|453477649|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
126049324|NCT00439270|453477650|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
126049325|NCT00439270|453477651|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
126049326|NCT00439270|453477652|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
126049327|NCT00439270|453477653|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
126049328|NCT00439270|453477649|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
126049329|NCT00439270|453477650|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
126049330|NCT00439270|453477651|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
126049331|NCT00439270|453477652|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
126049332|NCT00439270|453477653|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
126049333|NCT00439270|453477649|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
126049334|NCT00439270|453477650|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
126049335|NCT00439270|453477651|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
126049336|NCT00439270|453477652|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
126049337|NCT00439270|453477653|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
126049338|NCT02568215|453477655|FG000|Overall Study|Death|1|||
126049339|NCT02568215|453477656|FG001|Overall Study|Death|2|||
126049340|NCT02568215|453477657|FG002|Overall Study|Death|0|||
126049341|NCT02568215|453477655|FG000|Overall Study|Physician Decision|2|||
126049342|NCT02568215|453477656|FG001|Overall Study|Physician Decision|2|||
126049343|NCT02568215|453477657|FG002|Overall Study|Physician Decision|2|||
126049344|NCT02568215|453477655|FG000|Overall Study|Lost to Follow-up|29|||
126049345|NCT02568215|453477656|FG001|Overall Study|Lost to Follow-up|32|||
126049346|NCT02568215|453477657|FG002|Overall Study|Lost to Follow-up|41|||
126049347|NCT02568215|453477655|FG000|Overall Study|Withdrawal by Subject|21|||
126049348|NCT02568215|453477656|FG001|Overall Study|Withdrawal by Subject|19|||
126049349|NCT02568215|453477657|FG002|Overall Study|Withdrawal by Subject|22|||
126049350|NCT02568215|453477655|FG000|Overall Study|Protocol Violation|1|||
126049351|NCT02568215|453477656|FG001|Overall Study|Protocol Violation|1|||
126049352|NCT02568215|453477657|FG002|Overall Study|Protocol Violation|0|||
126049353|NCT02568215|453477655|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
126049354|NCT02568215|453477656|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
126049355|NCT02568215|453477657|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
126049356|NCT02568215|453477655|FG000|Overall Study|Other|0|||
126049357|NCT02568215|453477656|FG001|Overall Study|Other|1|||
126049358|NCT02568215|453477657|FG002|Overall Study|Other|4|||
126049359|NCT00246805|453477658|FG000|Phase 1|Lost to Follow-up|1|||
126049360|NCT00246805|453477659|FG001|Phase 1|Lost to Follow-up|0|||
126049361|NCT02964741|453477660|FG000|Overall Study|Protocol Violation|1|||
126049362|NCT02964741|453477661|FG001|Overall Study|Protocol Violation|0|||
126049363|NCT02964741|453477662|FG002|Overall Study|Protocol Violation|0|||
126049364|NCT02964741|453477660|FG000|Overall Study|Withdrawal by Subject|0|||
126049365|NCT02964741|453477661|FG001|Overall Study|Withdrawal by Subject|1|||
126049366|NCT02964741|453477662|FG002|Overall Study|Withdrawal by Subject|0|||
126049367|NCT02964741|453477660|FG000|Overall Study|claustrophobia|1|||
126049368|NCT02964741|453477661|FG001|Overall Study|claustrophobia|0|||
126049369|NCT02964741|453477662|FG002|Overall Study|claustrophobia|0|||
126049370|NCT01500200|453477663|FG000|Stage 1|Adverse Event|1|||
126049371|NCT01500200|453477664|FG001|Stage 1|Adverse Event|4|||
126049372|NCT01500200|453477665|FG002|Stage 1|Adverse Event|5|||
126049373|NCT01500200|453477666|FG003|Stage 1|Adverse Event|0|||
126049374|NCT01500200|453477667|FG004|Stage 1|Adverse Event|0|||
126049375|NCT01500200|453477668|FG005|Stage 1|Adverse Event|0|||
126049376|NCT01500200|453477663|FG000|Stage 1|Lost to Follow-up|2|||
126049377|NCT01500200|453477664|FG001|Stage 1|Lost to Follow-up|2|||
126049378|NCT01500200|453477665|FG002|Stage 1|Lost to Follow-up|1|||
126049379|NCT01500200|453477666|FG003|Stage 1|Lost to Follow-up|0|||
126049380|NCT01500200|453477667|FG004|Stage 1|Lost to Follow-up|0|||
126049381|NCT01500200|453477668|FG005|Stage 1|Lost to Follow-up|0|||
126049382|NCT01500200|453477663|FG000|Stage 1|Withdrawal by Subject|3|||
126049383|NCT01500200|453477664|FG001|Stage 1|Withdrawal by Subject|0|||
126049384|NCT01500200|453477665|FG002|Stage 1|Withdrawal by Subject|0|||
126049385|NCT01500200|453477666|FG003|Stage 1|Withdrawal by Subject|0|||
126049386|NCT01500200|453477667|FG004|Stage 1|Withdrawal by Subject|0|||
126049387|NCT01500200|453477668|FG005|Stage 1|Withdrawal by Subject|0|||
126049388|NCT01500200|453477663|FG000|Stage 1|Noncompliance with Study Drug|1|||
126049389|NCT01500200|453477664|FG001|Stage 1|Noncompliance with Study Drug|0|||
126049390|NCT01500200|453477665|FG002|Stage 1|Noncompliance with Study Drug|0|||
126049391|NCT01500200|453477666|FG003|Stage 1|Noncompliance with Study Drug|0|||
126049392|NCT01500200|453477667|FG004|Stage 1|Noncompliance with Study Drug|0|||
126049393|NCT01500200|453477668|FG005|Stage 1|Noncompliance with Study Drug|0|||
126049394|NCT01500200|453477663|FG000|Stage 1|Physician Decision|1|||
126049395|NCT01500200|453477664|FG001|Stage 1|Physician Decision|0|||
126049396|NCT01500200|453477665|FG002|Stage 1|Physician Decision|0|||
126049397|NCT01500200|453477666|FG003|Stage 1|Physician Decision|0|||
126049398|NCT01500200|453477667|FG004|Stage 1|Physician Decision|0|||
126049399|NCT01500200|453477668|FG005|Stage 1|Physician Decision|0|||
126049400|NCT01500200|453477663|FG000|Stage 2|Adverse Event|0|||
126049401|NCT01500200|453477664|FG001|Stage 2|Adverse Event|0|||
126049402|NCT01500200|453477665|FG002|Stage 2|Adverse Event|0|||
126049403|NCT01500200|453477666|FG003|Stage 2|Adverse Event|0|||
126049404|NCT01500200|453477667|FG004|Stage 2|Adverse Event|5|||
126049405|NCT01500200|453477668|FG005|Stage 2|Adverse Event|4|||
126049406|NCT01212744|453477675|FG000|Overall Study|Withdrawal by Subject|1|||
126049407|NCT02167451|453477676|FG000|Overall Study|Withdrawal by Subject|1|||
126049408|NCT00293397|453477677|FG000|Overall Study|Death|2|||
126049409|NCT01218009|453477678|FG000|Overall Study|Protocol Violation|2|||
126049410|NCT01218009|453477679|FG001|Overall Study|Protocol Violation|1|||
126049411|NCT01218009|453477678|FG000|Overall Study|Withdrawal by Subject|3|||
126049412|NCT01218009|453477679|FG001|Overall Study|Withdrawal by Subject|1|||
126049413|NCT01218009|453477678|FG000|Overall Study|Sponsor terminated study|161|||
126049414|NCT01218009|453477679|FG001|Overall Study|Sponsor terminated study|163|||
126049415|NCT00174252|453477680|FG000|Overall Study|Protocol Violation|2|||
126049416|NCT03170882|453477681|FG000|Overall Study|Death|17|||
126049417|NCT03170882|453477682|FG001|Overall Study|Death|29|||
126049418|NCT03170882|453477681|FG000|Overall Study|Lost to Follow-up|0|||
126049419|NCT03170882|453477682|FG001|Overall Study|Lost to Follow-up|1|||
126049420|NCT03170882|453477681|FG000|Overall Study|Withdrawal by Subject|4|||
126049421|NCT03170882|453477682|FG001|Overall Study|Withdrawal by Subject|7|||
126049422|NCT03170882|453477681|FG000|Overall Study|Reason not Specified|28|||
126049423|NCT03170882|453477682|FG001|Overall Study|Reason not Specified|36|||
126049424|NCT03802994|453477683|FG000|Overall Study|Lost to Follow-up|0|||
126049425|NCT03802994|453477684|FG001|Overall Study|Lost to Follow-up|2|||
126049426|NCT03802994|453477685|FG002|Overall Study|Lost to Follow-up|3|||
126049427|NCT03802994|453477686|FG003|Overall Study|Lost to Follow-up|2|||
126049428|NCT03802994|453477687|FG004|Overall Study|Lost to Follow-up|2|||
126049429|NCT02029235|453477690|FG000|Overall Study|Non-compliance with study meds or diary|4|||
126049430|NCT02029235|453477691|FG001|Overall Study|Non-compliance with study meds or diary|1|||
126049431|NCT02415127|453477692|FG000|Overall Study|Adverse Event|1|||
126049432|NCT02415127|453477693|FG001|Overall Study|Adverse Event|0|||
126049433|NCT03789110|453477694|FG000|Overall Study|Adverse Event|2|||
126049434|NCT03789110|453477694|FG000|Overall Study|Physician Decision|1|||
126049435|NCT03789110|453477694|FG000|Overall Study|Withdrawal by Subject|2|||
126049436|NCT03789110|453477694|FG000|Overall Study|Lack of Efficacy|22|||
126049437|NCT03789110|453477694|FG000|Overall Study|still on treatment|3|||
126049438|NCT01855750|453477695|FG000|Overall Study|Death|78|||
126049439|NCT01855750|453477696|FG001|Overall Study|Death|78|||
126049440|NCT01855750|453477695|FG000|Overall Study|Lost to Follow-up|9|||
126049441|NCT01855750|453477696|FG001|Overall Study|Lost to Follow-up|23|||
126049442|NCT01855750|453477695|FG000|Overall Study|Withdrawal by Subject|35|||
126049443|NCT01855750|453477696|FG001|Overall Study|Withdrawal by Subject|28|||
126049444|NCT01855750|453477695|FG000|Overall Study|Sponsor ends the study|297|||
126049445|NCT01855750|453477696|FG001|Overall Study|Sponsor ends the study|290|||
126049446|NCT04300023|453477697|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
126049447|NCT04300023|453477698|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
126049448|NCT05525572|453477699|FG000|Overall Study|Lost to Follow-up|2|||
126049449|NCT04057131|453477700|FG000|Overall Study|Protocol Violation|24|||
126049450|NCT03425682|453477701|FG000|Overall Study|Lost to Follow-up|2|||
126049451|NCT03425682|453477702|FG001|Overall Study|Lost to Follow-up|4|||
126049452|NCT03425682|453477701|FG000|Overall Study|Withdrawal by Subject|0|||
126049453|NCT03425682|453477702|FG001|Overall Study|Withdrawal by Subject|3|||
126049454|NCT03425682|453477701|FG000|Overall Study|Subject did not meet I/E|4|||
126049455|NCT03425682|453477702|FG001|Overall Study|Subject did not meet I/E|10|||
126049456|NCT03277989|453477706|FG000|Overall Study|Lost to Follow-up|6|||
126049457|NCT03277989|453477706|FG000|Overall Study|Adverse Event|6|||
126049458|NCT03277989|453477706|FG000|Overall Study|Withdrawal by Subject|3|||
126049459|NCT03277989|453477706|FG000|Overall Study|Didn't Receive Study Device|7|||
126049460|NCT03277989|453477706|FG000|Overall Study|Site Closure|26|||
126049461|NCT03277989|453477706|FG000|Overall Study|Sponsor Closure|107|||
126049462|NCT05704725|453477709|FG000|Overall Study|Lost to Follow-up|0|||
126049463|NCT05704725|453477710|FG001|Overall Study|Lost to Follow-up|1|||
126049464|NCT05704725|453477709|FG000|Overall Study|Withdrawal by Subject|1|||
126049465|NCT05704725|453477710|FG001|Overall Study|Withdrawal by Subject|0|||
126049466|NCT03227861|453477711|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
126049467|NCT03227861|453477711|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
126049468|NCT03227861|453477711|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
126049469|NCT03227861|453477711|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
126049470|NCT03227861|453477711|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
126049471|NCT03227861|453477711|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
126049472|NCT03227861|453477711|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
126049473|NCT03227861|453477711|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
126049474|NCT03227861|453477711|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
126049475|NCT03227861|453477711|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
126049476|NCT03516942|453477712|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
126049477|NCT03516942|453477712|FG000|Registration Through Baseline Survey Com|Death|8|||
125887823|NCT01554241|452886585|FG000|Overall Study|Death|3|||
125887824|NCT01554241|452886586|FG001|Overall Study|Death|1|||
125887825|NCT01554241|452886587|FG002|Overall Study|Death|1|||
125887826|NCT01554241|452886588|FG003|Overall Study|Death|0|||
125887827|NCT01554241|452886585|FG000|Overall Study|protocol specified renal stone|0|||
125887828|NCT01554241|452886586|FG001|Overall Study|protocol specified renal stone|0|||
125887829|NCT01554241|452886587|FG002|Overall Study|protocol specified renal stone|0|||
125887830|NCT01554241|452886588|FG003|Overall Study|protocol specified renal stone|1|||
125887831|NCT01554241|452886585|FG000|Overall Study|protocol specified change in eGFR|0|||
125887832|NCT01554241|452886586|FG001|Overall Study|protocol specified change in eGFR|0|||
125887833|NCT01554241|452886587|FG002|Overall Study|protocol specified change in eGFR|1|||
125887834|NCT01554241|452886588|FG003|Overall Study|protocol specified change in eGFR|0|||
125887835|NCT01554241|452886585|FG000|Overall Study|Withdrawal by Subject|0|||
125887836|NCT01554241|452886586|FG001|Overall Study|Withdrawal by Subject|0|||
125887837|NCT01554241|452886587|FG002|Overall Study|Withdrawal by Subject|2|||
125887838|NCT01554241|452886588|FG003|Overall Study|Withdrawal by Subject|0|||
125887839|NCT05661409|452886593|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
125887840|NCT05661409|452886594|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
125887841|NCT05661409|452886595|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
125887842|NCT05661409|452886596|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
125887843|NCT05661409|452886597|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
125887844|NCT05661409|452886598|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
126049478|NCT03516942|453477712|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
126049479|NCT03516942|453477712|FG000|T0: Baseline|LOST|13|||
126049480|NCT03516942|453477712|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
126049481|NCT03516942|453477712|FG000|T1: 3 Months Survey|Death|10|||
126049482|NCT03516942|453477712|FG000|T1: 3 Months Survey|Lost|163|||
126049483|NCT03516942|453477712|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
126049484|NCT03516942|453477712|FG000|T2: 6 Month Survey|Death|14|||
126049485|NCT03516942|453477712|FG000|T2: 6 Month Survey|Lost|180|||
126049486|NCT03516942|453477712|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
126049487|NCT03516942|453477712|FG000|T3: 12 Month Survey|Death|19|||
126049488|NCT03516942|453477712|FG000|T3: 12 Month Survey|Lost|209|||
126049489|NCT02798471|453477715|FG000|Overall Study|Adverse Event|7|||
126049490|NCT02798471|453477716|FG001|Overall Study|Adverse Event|2|||
126049491|NCT02798471|453477715|FG000|Overall Study|Physician Decision|3|||
126049492|NCT02798471|453477716|FG001|Overall Study|Physician Decision|7|||
126049493|NCT02798471|453477715|FG000|Overall Study|Death|2|||
126049494|NCT02798471|453477716|FG001|Overall Study|Death|3|||
126049495|NCT02798471|453477715|FG000|Overall Study|Lost to Follow-up|0|||
126049496|NCT02798471|453477716|FG001|Overall Study|Lost to Follow-up|1|||
126049497|NCT02798471|453477715|FG000|Overall Study|Other|5|||
126049498|NCT02798471|453477716|FG001|Overall Study|Other|3|||
126049499|NCT02798471|453477715|FG000|Overall Study|Subject withdrew consent|0|||
126049500|NCT02798471|453477716|FG001|Overall Study|Subject withdrew consent|6|||
126049501|NCT02798471|453477715|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
126049502|NCT02798471|453477716|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
126049503|NCT02798471|453477715|FG000|Overall Study|Randomized, but not treated|0|||
126049504|NCT02798471|453477716|FG001|Overall Study|Randomized, but not treated|2|||
126049505|NCT05293717|453477717|FG000|Overall Study|Physician Decision|1|||
126049506|NCT03762850|453478984|FG000|Overall Study|Death|0|||
126049507|NCT03762850|453478985|FG001|Overall Study|Death|1|||
126049508|NCT03762850|453478984|FG000|Overall Study|Lost to Follow-up|0|||
126049509|NCT03762850|453478985|FG001|Overall Study|Lost to Follow-up|1|||
126049510|NCT03762850|453478984|FG000|Overall Study|Physician Decision|0|||
125887845|NCT05661409|452886593|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
126049511|NCT03762850|453478985|FG001|Overall Study|Physician Decision|1|||
126049512|NCT03762850|453478984|FG000|Overall Study|Withdrawal by Subject|4|||
126049513|NCT03762850|453478985|FG001|Overall Study|Withdrawal by Subject|9|||
125887846|NCT05661409|452886594|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
125887847|NCT05661409|452886595|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
125887848|NCT05661409|452886596|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
125887849|NCT05661409|452886597|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
126049514|NCT03083366|453478986|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
126049515|NCT03083366|453478987|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
126104292|NCT00250679|453675840|FG000|Overall Study|Moved|1|||
126104293|NCT00250679|453675841|FG001|Overall Study|Moved|1|||
126104294|NCT00250679|453675842|FG002|Overall Study|Moved|0|||
126104295|NCT00250679|453675840|FG000|Overall Study|Non-compliance|1|||
126104296|NCT00250679|453675841|FG001|Overall Study|Non-compliance|1|||
126104297|NCT00250679|453675842|FG002|Overall Study|Non-compliance|0|||
126104298|NCT00250679|453675840|FG000|Overall Study|various single events: hip surgery,diary|3|||
126104299|NCT00250679|453675841|FG001|Overall Study|various single events: hip surgery,diary|1|||
126104300|NCT00250679|453675842|FG002|Overall Study|various single events: hip surgery,diary|1|||
126104301|NCT03603028|453675843|FG000|Overall Study|Withdrawal by Subject|1|||
126104302|NCT00842985|453675848|FG000|Screening|Did not meet entrance requirements|27|||
126104303|NCT00842985|453675848|FG000|First Intervention|Withdrawal by Subject|3|||
126104304|NCT00842985|453675848|FG000|First Intervention|Protocol Violation|3|||
126104305|NCT00842985|453675848|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
126104306|NCT00842985|453675848|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
126104307|NCT01037244|453675849|FG000|Overall Study|Adverse Event|3|||
126104308|NCT01037244|453675850|FG001|Overall Study|Adverse Event|2|||
126104309|NCT01037244|453675851|FG002|Overall Study|Adverse Event|6|||
126104310|NCT01037244|453675852|FG003|Overall Study|Adverse Event|3|||
126104311|NCT01037244|453675849|FG000|Overall Study|Lack of Efficacy|1|||
126104312|NCT01037244|453675850|FG001|Overall Study|Lack of Efficacy|1|||
126104313|NCT01037244|453675851|FG002|Overall Study|Lack of Efficacy|0|||
126104314|NCT01037244|453675852|FG003|Overall Study|Lack of Efficacy|1|||
126104315|NCT01037244|453675849|FG000|Overall Study|Lost to Follow-up|3|||
126391258|NCT06003777|454724463|FG006|Period 2|Withdrawal by Subject|0|||
126391259|NCT06003777|454724464|FG007|Period 2|Withdrawal by Subject|0|||
126391260|NCT06003777|454724465|FG008|Period 2|Withdrawal by Subject|1|||
125887850|NCT05661409|452886598|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
126104316|NCT01037244|453675850|FG001|Overall Study|Lost to Follow-up|3|||
126104317|NCT01037244|453675851|FG002|Overall Study|Lost to Follow-up|4|||
126104318|NCT01037244|453675852|FG003|Overall Study|Lost to Follow-up|4|||
126391261|NCT06003777|454724466|FG009|Period 2|Withdrawal by Subject|0|||
126391262|NCT06003777|454724467|FG010|Period 2|Withdrawal by Subject|0|||
126391263|NCT06003777|454724468|FG011|Period 2|Withdrawal by Subject|0|||
126104319|NCT01037244|453675849|FG000|Overall Study|Withdrawal by Subject|1|||
126391264|NCT06003777|454724457|FG000|Period 3|Adverse Event|0|||
125887851|NCT05661409|452886593|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
126104320|NCT01037244|453675850|FG001|Overall Study|Withdrawal by Subject|5|||
126104321|NCT01037244|453675851|FG002|Overall Study|Withdrawal by Subject|3|||
126104322|NCT01037244|453675852|FG003|Overall Study|Withdrawal by Subject|5|||
126104323|NCT01037244|453675849|FG000|Overall Study|Partner Withdrew Consent|2|||
126391265|NCT06003777|454724458|FG001|Period 3|Adverse Event|0|||
126104324|NCT01037244|453675850|FG001|Overall Study|Partner Withdrew Consent|1|||
126104325|NCT01037244|453675851|FG002|Overall Study|Partner Withdrew Consent|0|||
126104326|NCT01037244|453675852|FG003|Overall Study|Partner Withdrew Consent|0|||
126104327|NCT01037244|453675849|FG000|Overall Study|Various|3|||
126391266|NCT06003777|454724459|FG002|Period 3|Adverse Event|0|||
126391267|NCT06003777|454724460|FG003|Period 3|Adverse Event|0|||
126391268|NCT06003777|454724461|FG004|Period 3|Adverse Event|0|||
126391269|NCT06003777|454724462|FG005|Period 3|Adverse Event|0|||
126049516|NCT03083366|453478986|FG000|Enrollment Period|Lack of Efficacy|1|||
126049517|NCT03083366|453478987|FG001|Enrollment Period|Lack of Efficacy|0|||
126049518|NCT00536120|453478993|FG000|Overall Study|Lost to Follow-up|1|||
126049519|NCT00536120|453478994|FG001|Overall Study|Lost to Follow-up|0|||
126049520|NCT00536120|453478993|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
126049521|NCT00536120|453478994|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
126049522|NCT00536120|453478993|FG000|Overall Study|Non-compliance|1|||
126049523|NCT00536120|453478994|FG001|Overall Study|Non-compliance|0|||
126049524|NCT00536120|453478993|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
126049525|NCT00536120|453478994|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
126049526|NCT00536120|453478993|FG000|Overall Study|Steroid Use|0|||
126049527|NCT00536120|453478994|FG001|Overall Study|Steroid Use|2|||
126049528|NCT00536120|453478993|FG000|Overall Study|Missed Study Visit|0|||
126049529|NCT00536120|453478994|FG001|Overall Study|Missed Study Visit|1|||
126049530|NCT04989816|453478995|FG000|Overall Study|Death|77|||
126049531|NCT04989816|453478995|FG000|Overall Study|Lost to Follow-up|3|||
126049532|NCT01982682|453478996|FG000|Overall Study|Physician Decision|1|||
126049533|NCT02760654|453478997|FG000|Overall Study|Lost to Follow-up|3|||
126049534|NCT02760654|453478998|FG001|Overall Study|Lost to Follow-up|3|||
126049535|NCT02760654|453478997|FG000|Overall Study|Withdrawal by Subject|4|||
126049536|NCT02760654|453478998|FG001|Overall Study|Withdrawal by Subject|3|||
126049537|NCT00210106|453478999|FG000|Overall Study|Death|1|||
126049538|NCT00210106|453478999|FG000|Overall Study|Protocol Violation|13|||
126049539|NCT00065182|453479008|FG000|Overall Study|Adverse Event|24|||
126049540|NCT00065182|453479009|FG001|Overall Study|Adverse Event|17|||
126049541|NCT00065182|453479008|FG000|Overall Study|Lost to Follow-up|0|||
126049542|NCT00065182|453479009|FG001|Overall Study|Lost to Follow-up|4|||
126049543|NCT00065182|453479008|FG000|Overall Study|Protocol Violation|3|||
126049544|NCT00065182|453479009|FG001|Overall Study|Protocol Violation|4|||
126049545|NCT00065182|453479008|FG000|Overall Study|Serious adverse events (SAE)|1|||
126049546|NCT00065182|453479009|FG001|Overall Study|Serious adverse events (SAE)|0|||
126049547|NCT00065182|453479008|FG000|Overall Study|Sponsor Decision|11|||
126049548|NCT00065182|453479009|FG001|Overall Study|Sponsor Decision|7|||
126391270|NCT06003777|454724463|FG006|Period 3|Adverse Event|1|||
126391271|NCT06003777|454724464|FG007|Period 3|Adverse Event|0|||
126391272|NCT06003777|454724465|FG008|Period 3|Adverse Event|0|||
126391273|NCT06003777|454724466|FG009|Period 3|Adverse Event|0|||
126391274|NCT06003777|454724467|FG010|Period 3|Adverse Event|0|||
126391275|NCT06003777|454724468|FG011|Period 3|Adverse Event|0|||
126391276|NCT06003777|454724457|FG000|Period 4|No longer met eligibility criteria|0|||
126391277|NCT06003777|454724458|FG001|Period 4|No longer met eligibility criteria|0|||
126391278|NCT06003777|454724459|FG002|Period 4|No longer met eligibility criteria|1|||
126391279|NCT06003777|454724460|FG003|Period 4|No longer met eligibility criteria|0|||
126391280|NCT06003777|454724461|FG004|Period 4|No longer met eligibility criteria|0|||
126391281|NCT06003777|454724462|FG005|Period 4|No longer met eligibility criteria|0|||
126391282|NCT06003777|454724463|FG006|Period 4|No longer met eligibility criteria|0|||
126391283|NCT06003777|454724464|FG007|Period 4|No longer met eligibility criteria|0|||
125887852|NCT05661409|452886594|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
126049549|NCT00065182|453479008|FG000|Overall Study|Withdrawal by Subject|8|||
126049550|NCT00065182|453479009|FG001|Overall Study|Withdrawal by Subject|3|||
126049551|NCT00065182|453479008|FG000|Overall Study|No clinical benefit|1|||
126049552|NCT00065182|453479009|FG001|Overall Study|No clinical benefit|0|||
126104328|NCT01037244|453675850|FG001|Overall Study|Various|2|||
126104329|NCT01037244|453675851|FG002|Overall Study|Various|1|||
126391284|NCT06003777|454724465|FG008|Period 4|No longer met eligibility criteria|0|||
126391285|NCT06003777|454724466|FG009|Period 4|No longer met eligibility criteria|0|||
126391286|NCT06003777|454724467|FG010|Period 4|No longer met eligibility criteria|0|||
126391287|NCT06003777|454724468|FG011|Period 4|No longer met eligibility criteria|0|||
126391288|NCT06003777|454724457|FG000|Period 4|Withdrawal by Subject|0|||
126391289|NCT06003777|454724458|FG001|Period 4|Withdrawal by Subject|1|||
125887853|NCT05661409|452886595|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
125887854|NCT05661409|452886596|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
125887855|NCT05661409|452886597|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
125887856|NCT05661409|452886598|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
125887857|NCT05661409|452886593|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
125887858|NCT05661409|452886594|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
125887859|NCT05661409|452886595|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
125887860|NCT05661409|452886596|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
125887861|NCT05661409|452886597|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
125887862|NCT05661409|452886598|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
125887863|NCT05661409|452886593|FG000|Overall Study|Miscommu-nication about administration|0|||
125887864|NCT05661409|452886594|FG001|Overall Study|Miscommu-nication about administration|0|||
125887865|NCT05661409|452886595|FG002|Overall Study|Miscommu-nication about administration|0|||
125887866|NCT05661409|452886596|FG003|Overall Study|Miscommu-nication about administration|0|||
125887867|NCT05661409|452886597|FG004|Overall Study|Miscommu-nication about administration|0|||
125887868|NCT05661409|452886598|FG005|Overall Study|Miscommu-nication about administration|1|||
126391290|NCT06003777|454724459|FG002|Period 4|Withdrawal by Subject|0|||
126391291|NCT06003777|454724460|FG003|Period 4|Withdrawal by Subject|0|||
126391292|NCT06003777|454724461|FG004|Period 4|Withdrawal by Subject|0|||
126391293|NCT06003777|454724462|FG005|Period 4|Withdrawal by Subject|0|||
126391294|NCT06003777|454724463|FG006|Period 4|Withdrawal by Subject|0|||
126391295|NCT06003777|454724464|FG007|Period 4|Withdrawal by Subject|0|||
126391296|NCT06003777|454724465|FG008|Period 4|Withdrawal by Subject|0|||
126391297|NCT06003777|454724466|FG009|Period 4|Withdrawal by Subject|0|||
126391298|NCT06003777|454724467|FG010|Period 4|Withdrawal by Subject|0|||
126391299|NCT06003777|454724468|FG011|Period 4|Withdrawal by Subject|0|||
126391300|NCT01106651|454724469|FG000|Overall Study|Adverse Event|17|||
126391301|NCT01106651|454724470|FG001|Overall Study|Adverse Event|9|||
126391302|NCT01106651|454724471|FG002|Overall Study|Adverse Event|23|||
126391303|NCT01106651|454724469|FG000|Overall Study|Lost to Follow-up|8|||
126391304|NCT01106651|454724470|FG001|Overall Study|Lost to Follow-up|2|||
126391305|NCT01106651|454724471|FG002|Overall Study|Lost to Follow-up|6|||
126391306|NCT01106651|454724469|FG000|Overall Study|Physician Decision|4|||
126391307|NCT01106651|454724470|FG001|Overall Study|Physician Decision|3|||
126391308|NCT01106651|454724471|FG002|Overall Study|Physician Decision|1|||
126391309|NCT01106651|454724469|FG000|Overall Study|Protocol Violation|1|||
126391310|NCT01106651|454724470|FG001|Overall Study|Protocol Violation|2|||
126391311|NCT01106651|454724471|FG002|Overall Study|Protocol Violation|1|||
126391312|NCT01106651|454724469|FG000|Overall Study|Withdrawal by Subject|14|||
126391313|NCT01106651|454724470|FG001|Overall Study|Withdrawal by Subject|7|||
126391314|NCT01106651|454724471|FG002|Overall Study|Withdrawal by Subject|4|||
126391315|NCT01106651|454724469|FG000|Overall Study|Noncompliance with study drug|1|||
126391316|NCT01106651|454724470|FG001|Overall Study|Noncompliance with study drug|0|||
126391317|NCT01106651|454724471|FG002|Overall Study|Noncompliance with study drug|2|||
126391318|NCT01106651|454724469|FG000|Overall Study|Other|34|||
126391319|NCT01106651|454724470|FG001|Overall Study|Other|31|||
126391320|NCT01106651|454724471|FG002|Overall Study|Other|21|||
126391321|NCT01106651|454724469|FG000|Overall Study|Death|0|||
126391322|NCT01106651|454724470|FG001|Overall Study|Death|3|||
126391323|NCT01106651|454724471|FG002|Overall Study|Death|0|||
126391324|NCT00613327|454724475|FG000|Overall Study|Adverse Event|38|||
126391325|NCT00613327|454724475|FG000|Overall Study|Lost to Follow-up|8|||
126391326|NCT00613327|454724475|FG000|Overall Study|Withdrawal by Subject|6|||
126391327|NCT00613327|454724475|FG000|Overall Study|Protocol Violation|2|||
125887869|NCT04439136|452886599|FG000|Overall Study|Ineligible|1|||
125887870|NCT04439136|452886599|FG000|Overall Study|Never Started Treatment|2|||
125887871|NCT04439136|452886599|FG000|Overall Study|Adverse Event|4|||
125887872|NCT04439136|452886599|FG000|Overall Study|Death|3|||
125887873|NCT04439136|452886599|FG000|Overall Study|Disease Progression|27|||
125887874|NCT04439136|452886599|FG000|Overall Study|Alternative Therapy|1|||
125887875|NCT04439136|452886599|FG000|Overall Study|Increased Tumor Burden|1|||
125887876|NCT04439136|452886599|FG000|Overall Study|Symptomatic Detrioration|1|||
126391328|NCT00613327|454724475|FG000|Overall Study|Other|47|||
126391329|NCT00344318|454724476|FG000|Overall Study|Adverse Event|0|||
126391330|NCT00344318|454724477|FG001|Overall Study|Adverse Event|3|||
126391331|NCT00344318|454724478|FG002|Overall Study|Adverse Event|0|||
126391332|NCT00344318|454724479|FG003|Overall Study|Adverse Event|1|||
126391333|NCT00344318|454724476|FG000|Overall Study|Withdrawal by Subject|2|||
126391334|NCT00344318|454724477|FG001|Overall Study|Withdrawal by Subject|2|||
126391335|NCT00344318|454724478|FG002|Overall Study|Withdrawal by Subject|0|||
126391336|NCT00344318|454724479|FG003|Overall Study|Withdrawal by Subject|2|||
126391337|NCT00344318|454724476|FG000|Overall Study|Lost to Follow-up|2|||
126391338|NCT00344318|454724477|FG001|Overall Study|Lost to Follow-up|0|||
126391339|NCT00344318|454724478|FG002|Overall Study|Lost to Follow-up|1|||
126391340|NCT00344318|454724479|FG003|Overall Study|Lost to Follow-up|0|||
126391341|NCT03832322|454724482|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
125887877|NCT03682770|452886600|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125887878|NCT03682770|452886601|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
126049553|NCT00065182|453479008|FG000|Overall Study|Death|0|||
126049554|NCT00065182|453479009|FG001|Overall Study|Death|1|||
126049555|NCT00065182|453479008|FG000|Overall Study|Decline in Status|0|||
126049556|NCT00065182|453479009|FG001|Overall Study|Decline in Status|1|||
126049557|NCT00754325|453479010|FG000|Initial Treatment|Continuing Active Treatment|4|||
126049558|NCT00754325|453479011|FG001|Initial Treatment|Continuing Active Treatment|5|||
126049559|NCT00754325|453479010|FG000|Initial Treatment|Adverse Event|7|||
126049560|NCT00754325|453479011|FG001|Initial Treatment|Adverse Event|6|||
126049561|NCT00754325|453479010|FG000|Initial Treatment|Withdrawal by Subject|2|||
126049562|NCT00754325|453479011|FG001|Initial Treatment|Withdrawal by Subject|2|||
126049563|NCT00754325|453479010|FG000|Initial Treatment|Physician Decision|2|||
126049564|NCT00754325|453479011|FG001|Initial Treatment|Physician Decision|0|||
126049565|NCT00754325|453479010|FG000|Initial Treatment|Sponsor Request|0|||
126049566|NCT00754325|453479011|FG001|Initial Treatment|Sponsor Request|1|||
126049567|NCT00754325|453479010|FG000|Initial Treatment|Disease Progression|35|||
126049568|NCT00754325|453479011|FG001|Initial Treatment|Disease Progression|35|||
126049569|NCT01750684|453479016|FG000|Overall Study|Death|1|||
126049570|NCT01750684|453479017|FG001|Overall Study|Death|0|||
126049571|NCT01750684|453479016|FG000|Overall Study|Non-compliance with Study Drug|0|||
126049572|NCT01750684|453479017|FG001|Overall Study|Non-compliance with Study Drug|1|||
126049573|NCT01750684|453479016|FG000|Overall Study|Withdrawn by Sponsor|0|||
126049574|NCT01750684|453479017|FG001|Overall Study|Withdrawn by Sponsor|1|||
126049575|NCT01750684|453479016|FG000|Overall Study|Protocol Violation|1|||
126049576|NCT01750684|453479017|FG001|Overall Study|Protocol Violation|0|||
126049577|NCT02185794|453479019|FG000|Overall Study|Enrolled but Never Dosed|1|||
126049578|NCT02185794|453479020|FG001|Overall Study|Enrolled but Never Dosed|6|||
126049579|NCT02185794|453479021|FG002|Overall Study|Enrolled but Never Dosed|3|||
126049580|NCT02185794|453479022|FG003|Overall Study|Enrolled but Never Dosed|1|||
126049581|NCT02185794|453479023|FG004|Overall Study|Enrolled but Never Dosed|1|||
126049582|NCT02185794|453479024|FG005|Overall Study|Enrolled but Never Dosed|0|||
126049583|NCT02185794|453479019|FG000|Overall Study|Investigator's Discretion|1|||
126049584|NCT02185794|453479020|FG001|Overall Study|Investigator's Discretion|0|||
126049585|NCT02185794|453479021|FG002|Overall Study|Investigator's Discretion|1|||
126049586|NCT02185794|453479022|FG003|Overall Study|Investigator's Discretion|2|||
126049587|NCT02185794|453479023|FG004|Overall Study|Investigator's Discretion|2|||
126049588|NCT02185794|453479024|FG005|Overall Study|Investigator's Discretion|15|||
126049589|NCT02185794|453479019|FG000|Overall Study|Withdrew Consent|2|||
126049590|NCT02185794|453479020|FG001|Overall Study|Withdrew Consent|5|||
126049591|NCT02185794|453479021|FG002|Overall Study|Withdrew Consent|10|||
126049592|NCT02185794|453479022|FG003|Overall Study|Withdrew Consent|2|||
126049593|NCT02185794|453479023|FG004|Overall Study|Withdrew Consent|0|||
126049594|NCT02185794|453479024|FG005|Overall Study|Withdrew Consent|0|||
126049595|NCT02185794|453479019|FG000|Overall Study|Lost to Follow-up|1|||
126049596|NCT02185794|453479020|FG001|Overall Study|Lost to Follow-up|2|||
126049597|NCT02185794|453479021|FG002|Overall Study|Lost to Follow-up|2|||
126049598|NCT02185794|453479022|FG003|Overall Study|Lost to Follow-up|3|||
126049599|NCT02185794|453479023|FG004|Overall Study|Lost to Follow-up|0|||
126049600|NCT02185794|453479024|FG005|Overall Study|Lost to Follow-up|1|||
126049601|NCT01092416|453479025|FG000|Enrollment|Atherectomy device not inserted|3|||
126049602|NCT01092416|453479025|FG000|30-Day Follow-up|Death|2|||
126049603|NCT01092416|453479025|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
126049604|NCT01092416|453479025|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
126049605|NCT01092416|453479025|FG000|12-Month Follow-up|Death|16|||
126049606|NCT01092416|453479025|FG000|12-Month Follow-up|Lost to Follow-up|4|||
126049607|NCT01092416|453479025|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
126049608|NCT01092416|453479025|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
126049609|NCT01092416|453479025|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
126049610|NCT00366249|453479026|FG000|Overall Study|Adverse Event|53|||
126049611|NCT00366249|453479027|FG001|Overall Study|Adverse Event|28|||
126391342|NCT03832322|454724483|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
126391343|NCT01923363|454724484|FG000|Overall Study|Protocol Violation|1|||
126391344|NCT00290771|454724487|FG000|Overall Study|Disease progression|95|||
126391345|NCT00290771|454724488|FG001|Overall Study|Disease progression|73|||
126391346|NCT00290771|454724487|FG000|Overall Study|Death|11|||
126391347|NCT00290771|454724488|FG001|Overall Study|Death|10|||
126391348|NCT00290771|454724487|FG000|Overall Study|Adverse Event|12|||
126391349|NCT00290771|454724488|FG001|Overall Study|Adverse Event|6|||
126391350|NCT00290771|454724487|FG000|Overall Study|Withdrawal by Subject|5|||
126391351|NCT00290771|454724488|FG001|Overall Study|Withdrawal by Subject|6|||
126049612|NCT00366249|453479026|FG000|Overall Study|Death|0|||
126049613|NCT00366249|453479027|FG001|Overall Study|Death|1|||
126049614|NCT00366249|453479026|FG000|Overall Study|Physician Decision|5|||
126049615|NCT00366249|453479027|FG001|Overall Study|Physician Decision|2|||
126049616|NCT00366249|453479026|FG000|Overall Study|Lost to Follow-up|2|||
126049617|NCT00366249|453479027|FG001|Overall Study|Lost to Follow-up|0|||
126049618|NCT00366249|453479026|FG000|Overall Study|Protocol Violation|1|||
126049619|NCT00366249|453479027|FG001|Overall Study|Protocol Violation|2|||
126049620|NCT00366249|453479026|FG000|Overall Study|Withdrawal by Subject|18|||
126049621|NCT00366249|453479027|FG001|Overall Study|Withdrawal by Subject|4|||
126049622|NCT00366249|453479026|FG000|Overall Study|Lack of Efficacy|21|||
126049623|NCT00366249|453479027|FG001|Overall Study|Lack of Efficacy|21|||
126049624|NCT00366249|453479026|FG000|Overall Study|Most due to osteomylitis status|31|||
126049625|NCT00366249|453479027|FG001|Overall Study|Most due to osteomylitis status|20|||
126049626|NCT00777049|453479028|FG000|Overall Study|Withdrawal by Subject|1|||
126049627|NCT00777049|453479029|FG001|Overall Study|Withdrawal by Subject|0|||
126049628|NCT00777049|453479028|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
126049629|NCT00777049|453479029|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
126049630|NCT03478969|453479030|FG000|Overall Study|Withdrawal by Subject|4|||
126049631|NCT03478969|453479031|FG001|Overall Study|Withdrawal by Subject|7|||
126049632|NCT03478969|453479032|FG002|Overall Study|Withdrawal by Subject|6|||
126049633|NCT03478969|453479030|FG000|Overall Study|Adverse Event|2|||
126049634|NCT03478969|453479031|FG001|Overall Study|Adverse Event|0|||
126049635|NCT03478969|453479032|FG002|Overall Study|Adverse Event|1|||
126049636|NCT03478969|453479030|FG000|Overall Study|Pregnancy|1|||
126049637|NCT03478969|453479031|FG001|Overall Study|Pregnancy|0|||
126049638|NCT03478969|453479032|FG002|Overall Study|Pregnancy|0|||
126049639|NCT03478969|453479030|FG000|Overall Study|Personal Reasons|1|||
126049640|NCT03478969|453479031|FG001|Overall Study|Personal Reasons|0|||
126049641|NCT03478969|453479032|FG002|Overall Study|Personal Reasons|1|||
126049642|NCT03478969|453479030|FG000|Overall Study|Covid-19|1|||
126049643|NCT03478969|453479031|FG001|Overall Study|Covid-19|4|||
126049644|NCT03478969|453479032|FG002|Overall Study|Covid-19|3|||
126049645|NCT03478969|453479030|FG000|Overall Study|Multiple Reasons|0|||
126049646|NCT03478969|453479031|FG001|Overall Study|Multiple Reasons|1|||
126049647|NCT03478969|453479032|FG002|Overall Study|Multiple Reasons|1|||
126049648|NCT03478969|453479030|FG000|Overall Study|Eligibility Criteria|0|||
126049649|NCT03478969|453479031|FG001|Overall Study|Eligibility Criteria|0|||
126049650|NCT03478969|453479032|FG002|Overall Study|Eligibility Criteria|5|||
126049651|NCT03478969|453479030|FG000|Overall Study|Lost to Follow-up|0|||
126049652|NCT03478969|453479031|FG001|Overall Study|Lost to Follow-up|0|||
126049653|NCT03478969|453479032|FG002|Overall Study|Lost to Follow-up|1|||
126049654|NCT01185600|453479033|FG000|Overall Study|Adverse Event|1|||
126049655|NCT01185600|453479034|FG001|Overall Study|Adverse Event|1|||
126049656|NCT01185600|453479033|FG000|Overall Study|Death|0|||
126049657|NCT01185600|453479034|FG001|Overall Study|Death|1|||
126049658|NCT01185600|453479033|FG000|Overall Study|Lost to Follow-up|0|||
126049659|NCT01185600|453479034|FG001|Overall Study|Lost to Follow-up|5|||
126049660|NCT01185600|453479033|FG000|Overall Study|Physician Decision|29|||
126049661|NCT01185600|453479034|FG001|Overall Study|Physician Decision|35|||
126049662|NCT01185600|453479033|FG000|Overall Study|Withdrawal by Subject|1|||
126049663|NCT01185600|453479034|FG001|Overall Study|Withdrawal by Subject|1|||
126391352|NCT00290771|454724487|FG000|Overall Study|Administrative problems|2|||
126049664|NCT01185600|453479033|FG000|Overall Study|Hold by DSMB|1|||
126049665|NCT01185600|453479034|FG001|Overall Study|Hold by DSMB|2|||
126049666|NCT02941549|453479035|FG000|Overall Study|Adverse Event|1|||
126049667|NCT02941549|453479036|FG001|Overall Study|Adverse Event|0|||
126049668|NCT02941549|453479037|FG002|Overall Study|Adverse Event|0|||
126049669|NCT02941549|453479035|FG000|Overall Study|Withdrawal by Subject|2|||
126104330|NCT01037244|453675852|FG003|Overall Study|Various|1|||
126391353|NCT00290771|454724488|FG001|Overall Study|Administrative problems|1|||
126391354|NCT00290771|454724487|FG000|Overall Study|Protocol Violation|2|||
126049670|NCT02941549|453479036|FG001|Overall Study|Withdrawal by Subject|1|||
126049671|NCT02941549|453479037|FG002|Overall Study|Withdrawal by Subject|2|||
126104331|NCT00690820|453675853|FG000|Period 1|Withdrawal by Subject|0|||
126391355|NCT00290771|454724488|FG001|Overall Study|Protocol Violation|0|||
126049672|NCT01436175|453479038|FG000|Overall Study|Adverse Event|111|||
126049673|NCT01436175|453479038|FG000|Overall Study|Protocol Violation|49|||
126049674|NCT01436175|453479038|FG000|Overall Study|Withdrawal by Subject|108|||
126391356|NCT00290771|454724487|FG000|Overall Study|Lost to Follow-up|0|||
126104332|NCT00690820|453675854|FG001|Period 1|Withdrawal by Subject|1|||
126104333|NCT01768117|453675856|FG000|Overall Study|Lost to Follow-up|1|||
126104334|NCT01768117|453675856|FG000|Overall Study|Withdrawal by Subject|2|||
126104335|NCT01768117|453675856|FG000|Overall Study|Protocol Violation|3|||
126104336|NCT01249274|453675859|FG000|Overall Study|Lost to Follow-up|3|||
126104337|NCT01249274|453675860|FG001|Overall Study|Lost to Follow-up|4|||
126104338|NCT01249274|453675859|FG000|Overall Study|Received inpatient substance treatment|1|||
126104339|NCT01249274|453675860|FG001|Overall Study|Received inpatient substance treatment|2|||
126104340|NCT01000636|453675861|FG000|Overall Study|Withdrawal by Subject|1|||
126104341|NCT01000636|453675861|FG000|Overall Study|Adverse Event|1|||
126104342|NCT03451162|453675862|FG000|Overall Study|Lost to Follow-up|1|||
126104343|NCT03451162|453675863|FG001|Overall Study|Lost to Follow-up|0|||
126104344|NCT03451162|453675864|FG002|Overall Study|Lost to Follow-up|0|||
126104345|NCT03451162|453675865|FG003|Overall Study|Lost to Follow-up|0|||
126104346|NCT03451162|453675866|FG004|Overall Study|Lost to Follow-up|0|||
126104347|NCT03451162|453675862|FG000|Overall Study|Physician Decision|0|||
126104348|NCT03451162|453675863|FG001|Overall Study|Physician Decision|1|||
126104349|NCT03451162|453675864|FG002|Overall Study|Physician Decision|0|||
126104350|NCT03451162|453675865|FG003|Overall Study|Physician Decision|0|||
126104351|NCT03451162|453675866|FG004|Overall Study|Physician Decision|0|||
126104352|NCT03451162|453675862|FG000|Overall Study|Withdrawal by Subject|1|||
126104353|NCT03451162|453675863|FG001|Overall Study|Withdrawal by Subject|1|||
126104354|NCT03451162|453675864|FG002|Overall Study|Withdrawal by Subject|0|||
126104355|NCT03451162|453675865|FG003|Overall Study|Withdrawal by Subject|0|||
126104356|NCT03451162|453675866|FG004|Overall Study|Withdrawal by Subject|0|||
126104357|NCT01127139|453675867|FG000|Overall Study|Adverse Event|40|||
126104358|NCT01127139|453675867|FG000|Overall Study|Incompliance|12|||
126104359|NCT01127139|453675867|FG000|Overall Study|Lack of Efficacy|4|||
126104360|NCT01127139|453675867|FG000|Overall Study|Reason not specified|1|||
126104361|NCT01498653|453675869|FG000|Overall Study|Adverse Event|2|||
126104362|NCT01498653|453675870|FG001|Overall Study|Adverse Event|2|||
126104363|NCT01498653|453675869|FG000|Overall Study|Lack of Efficacy|12|||
126104364|NCT01498653|453675870|FG001|Overall Study|Lack of Efficacy|26|||
126104365|NCT01498653|453675869|FG000|Overall Study|Protocol Violation|0|||
126104366|NCT01498653|453675870|FG001|Overall Study|Protocol Violation|4|||
126104367|NCT01498653|453675869|FG000|Overall Study|Lost to Follow-up|1|||
126104368|NCT01498653|453675870|FG001|Overall Study|Lost to Follow-up|0|||
126104369|NCT01498653|453675869|FG000|Overall Study|Physician Decision|2|||
126104370|NCT01498653|453675870|FG001|Overall Study|Physician Decision|0|||
126104371|NCT01498653|453675869|FG000|Overall Study|Withdrawal by Subject|2|||
126104372|NCT01498653|453675870|FG001|Overall Study|Withdrawal by Subject|3|||
126104373|NCT02216357|453675872|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
126104374|NCT02216357|453675873|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
126104375|NCT04964414|453675875|FG000|Overall Study|Lost to Follow-up|10|||
126104376|NCT04964414|453675876|FG001|Overall Study|Lost to Follow-up|8|||
126104377|NCT04964414|453675875|FG000|Overall Study|Withdrawal by Subject|1|||
126104378|NCT04964414|453675876|FG001|Overall Study|Withdrawal by Subject|1|||
126104379|NCT02076178|453675885|FG000|Oral Phase|Adverse Event|0|||
126104380|NCT02076178|453675886|FG001|Oral Phase|Adverse Event|7|||
126104381|NCT02076178|453675885|FG000|Oral Phase|Withdrawal by Subject|0|||
126391357|NCT00290771|454724488|FG001|Overall Study|Lost to Follow-up|1|||
126391358|NCT00244933|454724491|FG000|Overall Study|Not response evaluable|2|||
126391359|NCT02487654|454724494|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
126391360|NCT02487654|454724495|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
126391361|NCT02487654|454724494|FG000|Overall Study|Withdrawal by Subject|3|||
126391362|NCT02487654|454724495|FG001|Overall Study|Withdrawal by Subject|7|||
126391363|NCT02247011|454724496|FG000|Overall Study|Poor quality of radiological results|125|||
126391364|NCT00656058|454724497|FG000|Overall Study|Withdrawal by Subject|2|||
126391365|NCT00656058|454724497|FG000|Overall Study|Withdrawal by Subject|4|||
126391366|NCT03718884|454724498|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
126391367|NCT03718884|454724499|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
126391368|NCT03718884|454724498|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
126391369|NCT03718884|454724499|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
126391370|NCT04700540|454724500|FG000|Overall Study|Withdrawal by Subject|12|||
126391371|NCT04700540|454724501|FG001|Overall Study|Withdrawal by Subject|8|||
126104382|NCT02076178|453675886|FG001|Oral Phase|Withdrawal by Subject|4|||
126104383|NCT02076178|453675885|FG000|Oral Phase|Physician Decision|0|||
126104384|NCT02076178|453675886|FG001|Oral Phase|Physician Decision|1|||
126104385|NCT02076178|453675885|FG000|Injection Phase|Protocol defined stopping criteria|1|||
126104386|NCT02076178|453675886|FG001|Injection Phase|Protocol defined stopping criteria|0|||
126391372|NCT04700540|454724500|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
126104387|NCT02076178|453675885|FG000|Injection Phase|Withdrawal by Subject|0|||
126104388|NCT02076178|453675886|FG001|Injection Phase|Withdrawal by Subject|3|||
126104389|NCT02076178|453675885|FG000|Injection Phase|Physician Decision|0|||
126104390|NCT02076178|453675886|FG001|Injection Phase|Physician Decision|3|||
126104391|NCT02076178|453675885|FG000|Injection Phase|Lost to Follow-up|0|||
126104392|NCT02076178|453675886|FG001|Injection Phase|Lost to Follow-up|1|||
126104393|NCT02434939|453675894|FG000|Overall Study|Lack of Efficacy|34|||
126104394|NCT02434939|453675895|FG001|Overall Study|Lack of Efficacy|48|||
126104395|NCT02434939|453675894|FG000|Overall Study|Withdrawal by Subject|3|||
126104396|NCT02434939|453675895|FG001|Overall Study|Withdrawal by Subject|0|||
126104397|NCT02434939|453675894|FG000|Overall Study|Adverse Event|0|||
126049675|NCT01436175|453479038|FG000|Overall Study|Lost to Follow-up|89|||
126049676|NCT01436175|453479038|FG000|Overall Study|Lack of Efficacy|24|||
126049677|NCT01436175|453479038|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
126049678|NCT01436175|453479038|FG000|Overall Study|Other|826|||
126049679|NCT05405244|453479040|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
126049680|NCT05405244|453479041|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
126049681|NCT05405244|453479040|FG000|Washout (2 Weeks)|Adverse Event|2|||
126049682|NCT05405244|453479041|FG001|Washout (2 Weeks)|Adverse Event|0|||
126049683|NCT05405244|453479040|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
126049684|NCT05405244|453479041|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
126049685|NCT00739934|453479044|FG000|Voriconazole IV|Adverse Event|6|||
126049686|NCT00739934|453479044|FG000|Voriconazole Oral|Other|3|||
126049687|NCT03418922|453479045|FG000|Overall Study|Withdrawal by Subject|0|||
126049688|NCT03418922|453479046|FG001|Overall Study|Withdrawal by Subject|2|||
126049689|NCT03418922|453479045|FG000|Overall Study|Adverse Event|2|||
126049690|NCT03418922|453479046|FG001|Overall Study|Adverse Event|2|||
126049691|NCT03418922|453479045|FG000|Overall Study|Death|0|||
126049692|NCT03418922|453479046|FG001|Overall Study|Death|1|||
126049693|NCT03418922|453479045|FG000|Overall Study|Physician Decision|0|||
126049694|NCT03418922|453479046|FG001|Overall Study|Physician Decision|1|||
126049695|NCT03577106|453479047|FG000|Overall Study|Withdrawal by Subject|3|||
126049696|NCT03451422|453479048|FG000|Overall Study|Lost to Follow-up|0|||
126049697|NCT03451422|453479049|FG001|Overall Study|Lost to Follow-up|0|||
126049698|NCT03451422|453479050|FG002|Overall Study|Lost to Follow-up|0|||
126049699|NCT03451422|453479051|FG003|Overall Study|Lost to Follow-up|0|||
126049700|NCT03451422|453479052|FG004|Overall Study|Lost to Follow-up|0|||
126049701|NCT03451422|453479053|FG005|Overall Study|Lost to Follow-up|1|||
126049702|NCT03451422|453479048|FG000|Overall Study|Decision by sponsor|1|||
126049703|NCT03451422|453479049|FG001|Overall Study|Decision by sponsor|0|||
126049704|NCT03451422|453479050|FG002|Overall Study|Decision by sponsor|1|||
126049705|NCT03451422|453479051|FG003|Overall Study|Decision by sponsor|0|||
126049706|NCT03451422|453479052|FG004|Overall Study|Decision by sponsor|0|||
126049707|NCT03451422|453479053|FG005|Overall Study|Decision by sponsor|0|||
126049708|NCT03451422|453479048|FG000|Overall Study|Withdrawal by Subject|0|||
126049709|NCT03451422|453479049|FG001|Overall Study|Withdrawal by Subject|0|||
126049710|NCT03451422|453479050|FG002|Overall Study|Withdrawal by Subject|2|||
126049711|NCT03451422|453479051|FG003|Overall Study|Withdrawal by Subject|3|||
126049712|NCT03451422|453479052|FG004|Overall Study|Withdrawal by Subject|2|||
126049713|NCT03451422|453479053|FG005|Overall Study|Withdrawal by Subject|1|||
126049714|NCT03601715|453479056|FG000|Second Intervention|Lost to Follow-up|1|||
126049715|NCT03601715|453479057|FG001|Second Intervention|Lost to Follow-up|1|||
126049716|NCT03601715|453479058|FG002|Second Intervention|Lost to Follow-up|0|||
126049717|NCT00918333|453479061|FG000|Overall Study|Drug not taken per protocol|1|||
126049718|NCT00918333|453479062|FG001|Overall Study|Drug not taken per protocol|0|||
126049719|NCT00918333|453479061|FG000|Overall Study|Inadequate amount of drugs provided|1|||
126049720|NCT00918333|453479062|FG001|Overall Study|Inadequate amount of drugs provided|4|||
126049721|NCT00918333|453479061|FG000|Overall Study|Ineligible|1|||
126049722|NCT00918333|453479062|FG001|Overall Study|Ineligible|0|||
126049723|NCT00918333|453479061|FG000|Overall Study|Withdrawal by Subject|0|||
126104398|NCT02434939|453675895|FG001|Overall Study|Adverse Event|1|||
126104399|NCT01536015|453675896|FG000|Overall Study|Adverse Event|1|||
126104400|NCT01536015|453675897|FG001|Overall Study|Adverse Event|4|||
126049724|NCT00918333|453479062|FG001|Overall Study|Withdrawal by Subject|1|||
126049725|NCT00263757|453479064|FG000|Overall Study|Withdrawal by Subject|5|||
126049726|NCT00263757|453479065|FG001|Overall Study|Withdrawal by Subject|4|||
126049727|NCT00263757|453479064|FG000|Overall Study|Screen failure|0|||
125887879|NCT03682770|452886602|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126049728|NCT00263757|453479065|FG001|Overall Study|Screen failure|1|||
126391373|NCT04700540|454724501|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
126391374|NCT03515551|454724502|FG000|Overall Study|Death|4|||
126391375|NCT03515551|454724503|FG001|Overall Study|Death|1|||
126391376|NCT03515551|454724504|FG002|Overall Study|Death|2|||
126391377|NCT03515551|454724505|FG003|Overall Study|Death|2|||
126391378|NCT03515551|454724506|FG004|Overall Study|Death|2|||
126391379|NCT03515551|454724507|FG005|Overall Study|Death|4|||
126391380|NCT03515551|454724508|FG006|Overall Study|Death|1|||
126391381|NCT03515551|454724502|FG000|Overall Study|Lost to Follow-up|0|||
126391382|NCT03515551|454724503|FG001|Overall Study|Lost to Follow-up|0|||
126391383|NCT03515551|454724504|FG002|Overall Study|Lost to Follow-up|1|||
126391384|NCT03515551|454724505|FG003|Overall Study|Lost to Follow-up|0|||
126391385|NCT03515551|454724506|FG004|Overall Study|Lost to Follow-up|0|||
126391386|NCT03515551|454724507|FG005|Overall Study|Lost to Follow-up|0|||
126391387|NCT03515551|454724508|FG006|Overall Study|Lost to Follow-up|0|||
126391388|NCT03515551|454724502|FG000|Overall Study|Withdrawal by Subject|0|||
126391389|NCT03515551|454724503|FG001|Overall Study|Withdrawal by Subject|1|||
126391390|NCT03515551|454724504|FG002|Overall Study|Withdrawal by Subject|0|||
126391391|NCT03515551|454724505|FG003|Overall Study|Withdrawal by Subject|0|||
126391392|NCT03515551|454724506|FG004|Overall Study|Withdrawal by Subject|0|||
126391393|NCT03515551|454724507|FG005|Overall Study|Withdrawal by Subject|0|||
126391394|NCT03515551|454724508|FG006|Overall Study|Withdrawal by Subject|1|||
126391395|NCT03515551|454724502|FG000|Overall Study|Study ended by sponsor|0|||
126391396|NCT03515551|454724503|FG001|Overall Study|Study ended by sponsor|0|||
126391397|NCT03515551|454724504|FG002|Overall Study|Study ended by sponsor|2|||
126391398|NCT03515551|454724505|FG003|Overall Study|Study ended by sponsor|1|||
126391399|NCT03515551|454724506|FG004|Overall Study|Study ended by sponsor|3|||
126391400|NCT03515551|454724507|FG005|Overall Study|Study ended by sponsor|0|||
126391401|NCT03515551|454724508|FG006|Overall Study|Study ended by sponsor|3|||
126391402|NCT03515551|454724502|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391403|NCT03515551|454724503|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
126391404|NCT03515551|454724504|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391405|NCT03515551|454724505|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391406|NCT03515551|454724506|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391407|NCT03515551|454724507|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391408|NCT03515551|454724508|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391409|NCT00920387|454724515|FG000|Stage 1|Adverse Event|1|||
126391410|NCT00920387|454724516|FG001|Stage 1|Adverse Event|0|||
126391411|NCT00920387|454724517|FG002|Stage 1|Adverse Event|0|||
126391412|NCT02265536|454724528|FG000|Overall Study|Adverse Event|1|||
126391413|NCT02265536|454724529|FG001|Overall Study|Adverse Event|0|||
126391414|NCT02265536|454724530|FG002|Overall Study|Adverse Event|0|||
126391415|NCT02265536|454724531|FG003|Overall Study|Adverse Event|0|||
126391416|NCT02265536|454724532|FG004|Overall Study|Adverse Event|1|||
126391417|NCT02265536|454724533|FG005|Overall Study|Adverse Event|0|||
126391418|NCT02265536|454724528|FG000|Overall Study|Physician Decision|0|||
126391419|NCT02265536|454724529|FG001|Overall Study|Physician Decision|0|||
126391420|NCT02265536|454724530|FG002|Overall Study|Physician Decision|0|||
126391421|NCT02265536|454724531|FG003|Overall Study|Physician Decision|0|||
126391422|NCT02265536|454724532|FG004|Overall Study|Physician Decision|2|||
126391423|NCT02265536|454724533|FG005|Overall Study|Physician Decision|0|||
126391424|NCT02265536|454724528|FG000|Overall Study|Withdrawal by Subject|0|||
126391425|NCT02265536|454724529|FG001|Overall Study|Withdrawal by Subject|3|||
126391426|NCT02265536|454724530|FG002|Overall Study|Withdrawal by Subject|0|||
126391427|NCT02265536|454724531|FG003|Overall Study|Withdrawal by Subject|0|||
126391428|NCT02265536|454724532|FG004|Overall Study|Withdrawal by Subject|0|||
126391429|NCT02265536|454724533|FG005|Overall Study|Withdrawal by Subject|0|||
126391430|NCT03268954|454724534|FG000|Overall Study|Ongoing|23|||
126391431|NCT03268954|454724535|FG001|Overall Study|Ongoing|31|||
126391432|NCT03268954|454724534|FG000|Overall Study|Adverse Event|53|||
126391433|NCT03268954|454724535|FG001|Overall Study|Adverse Event|62|||
126391434|NCT03268954|454724534|FG000|Overall Study|Withdrawal by Subject|25|||
126391435|NCT03268954|454724535|FG001|Overall Study|Withdrawal by Subject|16|||
126391436|NCT03268954|454724534|FG000|Overall Study|Progressive Disease|61|||
126391437|NCT03268954|454724535|FG001|Overall Study|Progressive Disease|48|||
126391438|NCT03268954|454724534|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
126391439|NCT03268954|454724535|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
126391440|NCT03268954|454724534|FG000|Overall Study|Reason not Specified|40|||
126391441|NCT03268954|454724535|FG001|Overall Study|Reason not Specified|40|||
126391442|NCT03802630|454724536|FG000|Overall Study|Study terminated by sponsor|130|||
126391443|NCT03802630|454724537|FG001|Overall Study|Study terminated by sponsor|134|||
126391444|NCT03802630|454724536|FG000|Overall Study|Subject decision|16|||
126391445|NCT03802630|454724537|FG001|Overall Study|Subject decision|9|||
126391446|NCT03802630|454724536|FG000|Overall Study|Adverse Event|3|||
126391447|NCT03802630|454724537|FG001|Overall Study|Adverse Event|1|||
126391448|NCT03802630|454724536|FG000|Overall Study|Lost to Follow-up|2|||
126391449|NCT03802630|454724537|FG001|Overall Study|Lost to Follow-up|2|||
126391450|NCT03802630|454724536|FG000|Overall Study|Physician Decision|2|||
126391451|NCT03802630|454724537|FG001|Overall Study|Physician Decision|0|||
126391452|NCT03802630|454724536|FG000|Overall Study|Death|0|||
126391453|NCT03802630|454724537|FG001|Overall Study|Death|2|||
126391454|NCT05005013|454724538|FG000|Overall Study|Withdrawal by Subject|5|||
126391455|NCT05005013|454724539|FG001|Overall Study|Withdrawal by Subject|1|||
126391456|NCT05005013|454724538|FG000|Overall Study|Lost to Follow-up|3|||
126391457|NCT05005013|454724539|FG001|Overall Study|Lost to Follow-up|1|||
126391458|NCT05005013|454724538|FG000|Overall Study|Ineligibility|1|||
126391459|NCT05005013|454724539|FG001|Overall Study|Ineligibility|1|||
126391460|NCT04210245|454724540|FG000|Overall Study|Adverse Event|0|||
126391461|NCT04210245|454724541|FG001|Overall Study|Adverse Event|3|||
126391462|NCT04210245|454724542|FG002|Overall Study|Adverse Event|6|||
126391463|NCT04210245|454724543|FG003|Overall Study|Adverse Event|0|||
126391464|NCT04210245|454724540|FG000|Overall Study|Withdrawal by Subject|0|||
126391465|NCT04210245|454724541|FG001|Overall Study|Withdrawal by Subject|1|||
126391466|NCT04210245|454724542|FG002|Overall Study|Withdrawal by Subject|4|||
126391467|NCT04210245|454724543|FG003|Overall Study|Withdrawal by Subject|4|||
126391468|NCT04210245|454724540|FG000|Overall Study|Lost to Follow-up|0|||
126391469|NCT04210245|454724541|FG001|Overall Study|Lost to Follow-up|1|||
126391470|NCT04210245|454724542|FG002|Overall Study|Lost to Follow-up|1|||
126391471|NCT04210245|454724543|FG003|Overall Study|Lost to Follow-up|1|||
126391472|NCT04210245|454724540|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
126391473|NCT04210245|454724541|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
126391474|NCT04210245|454724542|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
126391475|NCT04210245|454724543|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
126391476|NCT04091581|454724544|FG000|Overall Study|Lost to Follow-up|0|||
126391477|NCT04091581|454724545|FG001|Overall Study|Lost to Follow-up|1|||
126391478|NCT03724981|454726245|FG000|First Device|Protocol Violation|1|||
126391479|NCT03724981|454726246|FG001|First Device|Protocol Violation|1|||
126391480|NCT04439539|454726250|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
126391481|NCT04439539|454726251|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
126391482|NCT04439539|454726252|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
126391483|NCT04439539|454726250|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
126391484|NCT04439539|454726251|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
126391485|NCT04439539|454726252|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
126391486|NCT04439539|454726250|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
126391487|NCT04439539|454726251|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
126391488|NCT04439539|454726252|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
126391489|NCT03596047|454726253|FG000|Overall Study|Withdrawal by Subject|7|||
126391490|NCT03596047|454726254|FG001|Overall Study|Withdrawal by Subject|4|||
126391491|NCT03596047|454726253|FG000|Overall Study|Lost to Follow-up|0|||
126391492|NCT03596047|454726254|FG001|Overall Study|Lost to Follow-up|2|||
126391493|NCT03727646|454726255|FG000|Overall Study|Adverse Event|1|||
126391494|NCT03727646|454726256|FG001|Overall Study|Adverse Event|0|||
126391495|NCT02290691|454726259|FG000|Overall Study|Noncompliance|0|||
126391496|NCT02290691|454726260|FG001|Overall Study|Noncompliance|1|||
126391497|NCT02290691|454726259|FG000|Overall Study|Withdrawal by Subject|1|||
126391498|NCT02290691|454726260|FG001|Overall Study|Withdrawal by Subject|1|||
126391499|NCT02290691|454726259|FG000|Overall Study|Lost to Follow-up|7|||
126391500|NCT02290691|454726260|FG001|Overall Study|Lost to Follow-up|7|||
126391501|NCT01843673|454726262|FG000|Overall Study|Lack of Efficacy|2|||
126391502|NCT01843673|454726262|FG000|Overall Study|Withdrawal by Subject|4|||
126391503|NCT01328535|454726266|FG000|Overall Study|Ineligible|1|||
126391504|NCT04417218|454726267|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
126391505|NCT04417218|454726268|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
126391506|NCT00873041|454726271|FG000|Core Study|Adverse Event|2|||
126391507|NCT00873041|454726272|FG001|Core Study|Adverse Event|3|||
126391508|NCT00873041|454726273|FG002|Core Study|Adverse Event|1|||
126391509|NCT00873041|454726271|FG000|Core Study|Withdrawal by Subject|1|||
126391510|NCT00873041|454726272|FG001|Core Study|Withdrawal by Subject|2|||
126391511|NCT00873041|454726273|FG002|Core Study|Withdrawal by Subject|2|||
126391512|NCT00873041|454726271|FG000|Core Study|Lost to Follow-up|3|||
126391513|NCT00873041|454726272|FG001|Core Study|Lost to Follow-up|1|||
126391514|NCT00873041|454726273|FG002|Core Study|Lost to Follow-up|0|||
126391515|NCT00873041|454726271|FG000|Core Study|Abnormal laboratory value|0|||
126391516|NCT00873041|454726272|FG001|Core Study|Abnormal laboratory value|0|||
126391517|NCT00873041|454726273|FG002|Core Study|Abnormal laboratory value|1|||
126391518|NCT00873041|454726271|FG000|Core Study|Protocol deviation|1|||
126391519|NCT00873041|454726272|FG001|Core Study|Protocol deviation|0|||
126391520|NCT00873041|454726273|FG002|Core Study|Protocol deviation|1|||
126049729|NCT00263757|453479064|FG000|Overall Study|Adverse Event|3|||
126049730|NCT00263757|453479065|FG001|Overall Study|Adverse Event|3|||
126049731|NCT01342367|453479066|FG000|Overall Study|Death|1|||
126049732|NCT01342367|453479067|FG001|Overall Study|Death|0|||
126049733|NCT01342367|453479066|FG000|Overall Study|Withdrawal by Subject|1|||
126049734|NCT01342367|453479067|FG001|Overall Study|Withdrawal by Subject|2|||
126049735|NCT00640159|453479068|FG000|Overall Study|Lost to Follow-up|2|||
126049736|NCT04860505|453479075|FG000|Overall Study|Lost to Follow-up|2|||
126049737|NCT01218659|453479078|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
126049738|NCT01218659|453479079|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
126049739|NCT01218659|453479080|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
126049740|NCT01218659|453479078|FG000|18-Month Randomized Period|Did not receive study drug|0|||
126049741|NCT01218659|453479079|FG001|18-Month Randomized Period|Did not receive study drug|3|||
126049742|NCT01218659|453479080|FG002|18-Month Randomized Period|Did not receive study drug|0|||
126049743|NCT01218659|453479078|FG000|12-Month OLE|Withdrawal by Subject|0|||
126049744|NCT01218659|453479079|FG001|12-Month OLE|Withdrawal by Subject|0|||
126049745|NCT01218659|453479080|FG002|12-Month OLE|Withdrawal by Subject|2|||
126049746|NCT01218659|453479078|FG000|12-Month OLE|Physician Decision|0|||
126049747|NCT01218659|453479079|FG001|12-Month OLE|Physician Decision|0|||
126049748|NCT01218659|453479080|FG002|12-Month OLE|Physician Decision|1|||
126049749|NCT01218659|453479078|FG000|12-Month OLE|Lost to Follow-up|0|||
126049750|NCT01218659|453479079|FG001|12-Month OLE|Lost to Follow-up|0|||
126049751|NCT01218659|453479080|FG002|12-Month OLE|Lost to Follow-up|1|||
126049752|NCT01218659|453479078|FG000|12-Month OLE|Pregnancy|0|||
126049753|NCT01218659|453479079|FG001|12-Month OLE|Pregnancy|0|||
126049754|NCT01218659|453479080|FG002|12-Month OLE|Pregnancy|1|||
126391521|NCT00873041|454726271|FG000|Extension Study|Adverse Event|1|||
126049755|NCT01218659|453479078|FG000|12-Month OLE|Lack of Efficacy|0|||
126049756|NCT01218659|453479079|FG001|12-Month OLE|Lack of Efficacy|0|||
126049757|NCT01218659|453479080|FG002|12-Month OLE|Lack of Efficacy|1|||
126049758|NCT01218659|453479078|FG000|12-Month OLE|Declined to participate in the OLE|0|||
126049759|NCT01218659|453479079|FG001|12-Month OLE|Declined to participate in the OLE|0|||
126049760|NCT01218659|453479080|FG002|12-Month OLE|Declined to participate in the OLE|4|||
126049761|NCT03066609|453479085|FG000|INDUCTION|Pregnancy|0|||
126049762|NCT03066609|453479086|FG001|INDUCTION|Pregnancy|0|||
126049763|NCT03066609|453479087|FG002|INDUCTION|Pregnancy|1|||
126049764|NCT03066609|453479088|FG003|INDUCTION|Pregnancy|0|||
126049765|NCT03066609|453479085|FG000|INDUCTION|Lack of Efficacy|0|||
126049766|NCT03066609|453479086|FG001|INDUCTION|Lack of Efficacy|0|||
126049767|NCT03066609|453479087|FG002|INDUCTION|Lack of Efficacy|1|||
126391522|NCT00873041|454726272|FG001|Extension Study|Adverse Event|0|||
126391523|NCT00873041|454726273|FG002|Extension Study|Adverse Event|1|||
126391524|NCT00873041|454726271|FG000|Extension Study|Administrative reasons|0|||
126391525|NCT00873041|454726272|FG001|Extension Study|Administrative reasons|0|||
126391526|NCT00873041|454726273|FG002|Extension Study|Administrative reasons|1|||
126391527|NCT01734395|454726276|FG000|Overall Study|Other|65|||
126391528|NCT01734395|454726276|FG000|Overall Study|Lost to Follow-up|287|||
126391529|NCT01734395|454726276|FG000|Overall Study|Lack of Efficacy|5|||
126049768|NCT03066609|453479088|FG003|INDUCTION|Lack of Efficacy|0|||
126049769|NCT03066609|453479085|FG000|INDUCTION|Adverse Event|2|||
126391530|NCT01734395|454726276|FG000|Overall Study|Adverse Event|40|||
126391531|NCT01734395|454726276|FG000|Overall Study|Withdrawal by Subject|10|||
126391532|NCT01734395|454726276|FG000|Overall Study|Missing the reasons for not completed|3|||
126391533|NCT01032291|454726277|FG000|Safety Lead-in|Adverse Event|1|||
126391534|NCT01032291|454726278|FG001|Safety Lead-in|Adverse Event|0|||
126049770|NCT03066609|453479086|FG001|INDUCTION|Adverse Event|2|||
126049771|NCT03066609|453479087|FG002|INDUCTION|Adverse Event|0|||
126049772|NCT03066609|453479088|FG003|INDUCTION|Adverse Event|0|||
126391535|NCT01032291|454726279|FG002|Safety Lead-in|Adverse Event|0|||
126391536|NCT01032291|454726277|FG000|Safety Lead-in|Death|1|||
126391537|NCT01032291|454726278|FG001|Safety Lead-in|Death|0|||
126391538|NCT01032291|454726279|FG002|Safety Lead-in|Death|0|||
126391539|NCT01032291|454726277|FG000|Proof of Concept|Adverse Event|0|||
126391540|NCT01032291|454726278|FG001|Proof of Concept|Adverse Event|5|||
126391541|NCT01032291|454726279|FG002|Proof of Concept|Adverse Event|1|||
126391542|NCT01032291|454726277|FG000|Proof of Concept|Death|0|||
126391543|NCT01032291|454726278|FG001|Proof of Concept|Death|1|||
126391544|NCT01032291|454726279|FG002|Proof of Concept|Death|2|||
126391545|NCT01032291|454726277|FG000|Proof of Concept|Lack of Efficacy|0|||
126391546|NCT01032291|454726278|FG001|Proof of Concept|Lack of Efficacy|1|||
126391547|NCT01032291|454726279|FG002|Proof of Concept|Lack of Efficacy|0|||
126391548|NCT01032291|454726277|FG000|Proof of Concept|Never Received Study Drug|0|||
126391549|NCT01032291|454726278|FG001|Proof of Concept|Never Received Study Drug|1|||
126391550|NCT01032291|454726279|FG002|Proof of Concept|Never Received Study Drug|0|||
126391551|NCT00313313|454726280|FG000|Overall Study|Lack of Efficacy|14|||
126391552|NCT00313313|454726281|FG001|Overall Study|Lack of Efficacy|9|||
126391553|NCT00313313|454726282|FG002|Overall Study|Lack of Efficacy|20|||
126391554|NCT00313313|454726280|FG000|Overall Study|Withdrawal of consent by subject|18|||
126391555|NCT00313313|454726281|FG001|Overall Study|Withdrawal of consent by subject|17|||
126391556|NCT00313313|454726282|FG002|Overall Study|Withdrawal of consent by subject|31|||
126391557|NCT00313313|454726280|FG000|Overall Study|Lost to Follow-up|10|||
126391558|NCT00313313|454726281|FG001|Overall Study|Lost to Follow-up|7|||
126391559|NCT00313313|454726282|FG002|Overall Study|Lost to Follow-up|9|||
126391560|NCT00313313|454726280|FG000|Overall Study|Adverse Event|15|||
126391561|NCT00313313|454726281|FG001|Overall Study|Adverse Event|16|||
126391562|NCT00313313|454726282|FG002|Overall Study|Adverse Event|12|||
126391563|NCT00313313|454726280|FG000|Overall Study|Physician Decision|2|||
126391564|NCT00313313|454726281|FG001|Overall Study|Physician Decision|6|||
126391565|NCT00313313|454726282|FG002|Overall Study|Physician Decision|4|||
126391566|NCT00313313|454726280|FG000|Overall Study|Poor/Noncompliance|3|||
126391567|NCT00313313|454726281|FG001|Overall Study|Poor/Noncompliance|6|||
126391568|NCT00313313|454726282|FG002|Overall Study|Poor/Noncompliance|2|||
126391569|NCT00313313|454726280|FG000|Overall Study|Pregnancy|1|||
126391570|NCT00313313|454726281|FG001|Overall Study|Pregnancy|2|||
126391571|NCT00313313|454726282|FG002|Overall Study|Pregnancy|0|||
126391572|NCT00313313|454726280|FG000|Overall Study|Death|0|||
126391573|NCT00313313|454726281|FG001|Overall Study|Death|0|||
126391574|NCT00313313|454726282|FG002|Overall Study|Death|2|||
126391575|NCT00313313|454726280|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
126391576|NCT00313313|454726281|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
126391577|NCT00313313|454726282|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
126391578|NCT03425006|454726285|FG000|Overall Study|Withdrawal by Subject|1|||
126391579|NCT03425006|454726285|FG000|Overall Study|Physician Decision|1|||
126391580|NCT03425006|454726285|FG000|Overall Study|Death|1|||
126391581|NCT02300558|454726288|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
126391582|NCT02300558|454726288|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
126391583|NCT02300558|454726288|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
126391584|NCT02300558|454726288|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
126391585|NCT00695955|454726289|FG000|Cohort 1|Adverse Event|26|||
126391586|NCT00695955|454726289|FG000|Cohort 1|Protocol Violation|2|||
126391587|NCT00695955|454726289|FG000|Cohort 1|Lost to Follow-up|30|||
126391588|NCT00695955|454726289|FG000|Cohort 1|Withdrawal by Subject|25|||
126391589|NCT00695955|454726289|FG000|Cohort 1|Lack of Efficacy|3|||
126391590|NCT00695955|454726289|FG000|Cohort 1|Other|16|||
126391591|NCT00695955|454726289|FG000|Cohort 2|Adverse Event|24|||
126391592|NCT00695955|454726289|FG000|Cohort 2|Protocol Violation|5|||
126391593|NCT00695955|454726289|FG000|Cohort 2|Lost to Follow-up|38|||
126391594|NCT00695955|454726289|FG000|Cohort 2|Withdrawal by Subject|28|||
126391595|NCT00695955|454726289|FG000|Cohort 2|Lack of Efficacy|4|||
126391596|NCT00695955|454726289|FG000|Cohort 2|Other|5|||
126391597|NCT03888235|454726292|FG000|Overall Study|Lost to Follow-up|1|||
126391598|NCT03888235|454726293|FG001|Overall Study|Lost to Follow-up|1|||
126391599|NCT03888235|454726294|FG002|Overall Study|Lost to Follow-up|0|||
126391600|NCT01054560|454726295|FG000|Overall Study|Death|10|||
126391601|NCT01054560|454726296|FG001|Overall Study|Death|21|||
126391602|NCT01054560|454726295|FG000|Overall Study|Lost to Follow-up|2|||
126391603|NCT01054560|454726296|FG001|Overall Study|Lost to Follow-up|5|||
126391604|NCT01054560|454726295|FG000|Overall Study|Withdrawal by Subject|0|||
126391605|NCT01054560|454726296|FG001|Overall Study|Withdrawal by Subject|2|||
126391606|NCT01054560|454726295|FG000|Overall Study|Physician Decision|1|||
126391607|NCT01054560|454726296|FG001|Overall Study|Physician Decision|0|||
126391608|NCT01421303|454726297|FG000|Overall Study|Lost to Follow-up|13|||
126391609|NCT01421303|454726297|FG000|Overall Study|Non compliance with study procedure|1|||
126391610|NCT01421303|454726297|FG000|Overall Study|Other|7|||
126391611|NCT01421303|454726297|FG000|Overall Study|Withdrawal by Subject|1|||
126104401|NCT01536015|453675896|FG000|Overall Study|Lost to Follow-up|0|||
126104402|NCT01536015|453675897|FG001|Overall Study|Lost to Follow-up|1|||
126104403|NCT01536015|453675896|FG000|Overall Study|Inclusion Criterion not met|2|||
126104404|NCT01536015|453675897|FG001|Overall Study|Inclusion Criterion not met|0|||
126104405|NCT01536015|453675896|FG000|Overall Study|Study closure|5|||
126104406|NCT01536015|453675897|FG001|Overall Study|Study closure|5|||
126104407|NCT00585195|453675909|FG000|Overall Study|Adverse Event|0|||
126104408|NCT00585195|453675910|FG001|Overall Study|Adverse Event|0|||
126104409|NCT00585195|453675911|FG002|Overall Study|Adverse Event|0|||
126104410|NCT00585195|453675912|FG003|Overall Study|Adverse Event|0|||
126104411|NCT00585195|453675913|FG004|Overall Study|Adverse Event|2|||
126104412|NCT00585195|453675914|FG005|Overall Study|Adverse Event|1|||
126104413|NCT00585195|453675915|FG006|Overall Study|Adverse Event|0|||
126104414|NCT00585195|453675916|FG007|Overall Study|Adverse Event|1|||
126104415|NCT00585195|453675917|FG008|Overall Study|Adverse Event|0|||
126104416|NCT00585195|453675918|FG009|Overall Study|Adverse Event|0|||
126104417|NCT00585195|453675919|FG010|Overall Study|Adverse Event|3|||
126104418|NCT00585195|453675920|FG011|Overall Study|Adverse Event|0|||
126104419|NCT00585195|453675921|FG012|Overall Study|Adverse Event|8|||
126104420|NCT00585195|453675922|FG013|Overall Study|Adverse Event|6|||
126104421|NCT00585195|453675923|FG014|Overall Study|Adverse Event|4|||
126104422|NCT00585195|453675924|FG015|Overall Study|Adverse Event|1|||
126104423|NCT00585195|453675925|FG016|Overall Study|Adverse Event|14|||
126104424|NCT00585195|453675926|FG017|Overall Study|Adverse Event|9|||
126104425|NCT00585195|453675927|FG018|Overall Study|Adverse Event|2|||
126104426|NCT00585195|453675928|FG019|Overall Study|Adverse Event|3|||
126104427|NCT00585195|453675929|FG020|Overall Study|Adverse Event|1|||
126104428|NCT00585195|453675909|FG000|Overall Study|Progressive Disease|2|||
126104429|NCT00585195|453675910|FG001|Overall Study|Progressive Disease|2|||
126104430|NCT00585195|453675911|FG002|Overall Study|Progressive Disease|5|||
126104431|NCT00585195|453675912|FG003|Overall Study|Progressive Disease|4|||
126104432|NCT00585195|453675913|FG004|Overall Study|Progressive Disease|6|||
126104433|NCT00585195|453675914|FG005|Overall Study|Progressive Disease|4|||
126104434|NCT00585195|453675915|FG006|Overall Study|Progressive Disease|6|||
126104435|NCT00585195|453675916|FG007|Overall Study|Progressive Disease|3|||
126104436|NCT00585195|453675917|FG008|Overall Study|Progressive Disease|0|||
126104437|NCT00585195|453675918|FG009|Overall Study|Progressive Disease|5|||
126104438|NCT00585195|453675919|FG010|Overall Study|Progressive Disease|2|||
126104439|NCT00585195|453675920|FG011|Overall Study|Progressive Disease|25|||
126104440|NCT00585195|453675921|FG012|Overall Study|Progressive Disease|29|||
126104441|NCT00585195|453675922|FG013|Overall Study|Progressive Disease|26|||
126104442|NCT00585195|453675923|FG014|Overall Study|Progressive Disease|21|||
126104443|NCT00585195|453675924|FG015|Overall Study|Progressive Disease|12|||
126104444|NCT00585195|453675925|FG016|Overall Study|Progressive Disease|94|||
126104445|NCT00585195|453675926|FG017|Overall Study|Progressive Disease|42|||
126104446|NCT00585195|453675927|FG018|Overall Study|Progressive Disease|4|||
126104447|NCT00585195|453675928|FG019|Overall Study|Progressive Disease|9|||
126104448|NCT00585195|453675929|FG020|Overall Study|Progressive Disease|8|||
126104449|NCT00585195|453675909|FG000|Overall Study|Withdrawal by Subject|1|||
126104450|NCT00585195|453675910|FG001|Overall Study|Withdrawal by Subject|1|||
126104451|NCT00585195|453675911|FG002|Overall Study|Withdrawal by Subject|2|||
126104452|NCT00585195|453675912|FG003|Overall Study|Withdrawal by Subject|2|||
126104453|NCT00585195|453675913|FG004|Overall Study|Withdrawal by Subject|0|||
126104454|NCT00585195|453675914|FG005|Overall Study|Withdrawal by Subject|0|||
126104455|NCT00585195|453675915|FG006|Overall Study|Withdrawal by Subject|0|||
126104456|NCT00585195|453675916|FG007|Overall Study|Withdrawal by Subject|1|||
126104457|NCT00585195|453675917|FG008|Overall Study|Withdrawal by Subject|0|||
126104458|NCT00585195|453675918|FG009|Overall Study|Withdrawal by Subject|0|||
126104459|NCT00585195|453675919|FG010|Overall Study|Withdrawal by Subject|3|||
126104460|NCT00585195|453675920|FG011|Overall Study|Withdrawal by Subject|8|||
126391612|NCT00712725|454726299|FG000|Overall Study|Adverse Event|1|||
126391613|NCT00712725|454726300|FG001|Overall Study|Adverse Event|0|||
126391614|NCT00712725|454726301|FG002|Overall Study|Adverse Event|0|||
126391615|NCT00712725|454726302|FG003|Overall Study|Adverse Event|1|||
126391616|NCT00712725|454726303|FG004|Overall Study|Adverse Event|0|||
126391617|NCT00712725|454726304|FG005|Overall Study|Adverse Event|0|||
126391618|NCT00712725|454726305|FG006|Overall Study|Adverse Event|0|||
126391619|NCT00712725|454726306|FG007|Overall Study|Adverse Event|0|||
126391620|NCT00712725|454726299|FG000|Overall Study|Lost to Follow-up|3|||
126391621|NCT00712725|454726300|FG001|Overall Study|Lost to Follow-up|2|||
126104461|NCT00585195|453675921|FG012|Overall Study|Withdrawal by Subject|15|||
126104462|NCT00585195|453675922|FG013|Overall Study|Withdrawal by Subject|0|||
126104463|NCT00585195|453675923|FG014|Overall Study|Withdrawal by Subject|3|||
126391622|NCT00712725|454726301|FG002|Overall Study|Lost to Follow-up|1|||
126104464|NCT00585195|453675924|FG015|Overall Study|Withdrawal by Subject|0|||
126104465|NCT00585195|453675925|FG016|Overall Study|Withdrawal by Subject|7|||
126104466|NCT00585195|453675926|FG017|Overall Study|Withdrawal by Subject|1|||
126104467|NCT00585195|453675927|FG018|Overall Study|Withdrawal by Subject|2|||
126391623|NCT00712725|454726302|FG003|Overall Study|Lost to Follow-up|1|||
126391624|NCT00712725|454726303|FG004|Overall Study|Lost to Follow-up|2|||
126049773|NCT03066609|453479085|FG000|MAINTENANCE|Adverse Event|0|||
126049774|NCT03066609|453479086|FG001|MAINTENANCE|Adverse Event|0|||
126049775|NCT03066609|453479087|FG002|MAINTENANCE|Adverse Event|0|||
126049776|NCT03066609|453479088|FG003|MAINTENANCE|Adverse Event|1|||
126049777|NCT03066609|453479085|FG000|MAINTENANCE|Withdrawal by Subject|4|||
126049778|NCT03066609|453479086|FG001|MAINTENANCE|Withdrawal by Subject|2|||
126049779|NCT03066609|453479087|FG002|MAINTENANCE|Withdrawal by Subject|1|||
126049780|NCT03066609|453479088|FG003|MAINTENANCE|Withdrawal by Subject|1|||
126049781|NCT03066609|453479085|FG000|MAINTENANCE|Lost to Follow-up|0|||
126049782|NCT03066609|453479086|FG001|MAINTENANCE|Lost to Follow-up|1|||
126049783|NCT03066609|453479087|FG002|MAINTENANCE|Lost to Follow-up|1|||
126049784|NCT03066609|453479088|FG003|MAINTENANCE|Lost to Follow-up|0|||
126049785|NCT03066609|453479085|FG000|MAINTENANCE|Pregnancy|1|||
126049786|NCT03066609|453479086|FG001|MAINTENANCE|Pregnancy|0|||
126049787|NCT03066609|453479087|FG002|MAINTENANCE|Pregnancy|0|||
126049788|NCT03066609|453479088|FG003|MAINTENANCE|Pregnancy|0|||
126049789|NCT03066609|453479085|FG000|MAINTENANCE|Lack of Efficacy|2|||
126049790|NCT03066609|453479086|FG001|MAINTENANCE|Lack of Efficacy|1|||
126049791|NCT03066609|453479087|FG002|MAINTENANCE|Lack of Efficacy|0|||
126049792|NCT03066609|453479088|FG003|MAINTENANCE|Lack of Efficacy|1|||
126049793|NCT03066609|453479085|FG000|OVERALL STUDY|Adverse Event|2|||
126049794|NCT03066609|453479086|FG001|OVERALL STUDY|Adverse Event|2|||
126049795|NCT03066609|453479087|FG002|OVERALL STUDY|Adverse Event|0|||
126049796|NCT03066609|453479088|FG003|OVERALL STUDY|Adverse Event|1|||
126049797|NCT03066609|453479085|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
126049798|NCT03066609|453479086|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
126049799|NCT03066609|453479087|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
126049800|NCT03066609|453479088|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
126049801|NCT03066609|453479085|FG000|OVERALL STUDY|Lost to Follow-up|1|||
126049802|NCT03066609|453479086|FG001|OVERALL STUDY|Lost to Follow-up|1|||
126049803|NCT03066609|453479087|FG002|OVERALL STUDY|Lost to Follow-up|1|||
126049804|NCT03066609|453479088|FG003|OVERALL STUDY|Lost to Follow-up|1|||
126049805|NCT03066609|453479085|FG000|OVERALL STUDY|Pregnancy|1|||
126049806|NCT03066609|453479086|FG001|OVERALL STUDY|Pregnancy|0|||
126049807|NCT03066609|453479087|FG002|OVERALL STUDY|Pregnancy|1|||
126049808|NCT03066609|453479088|FG003|OVERALL STUDY|Pregnancy|0|||
126391625|NCT00712725|454726304|FG005|Overall Study|Lost to Follow-up|2|||
126391626|NCT00712725|454726305|FG006|Overall Study|Lost to Follow-up|3|||
126391627|NCT00712725|454726306|FG007|Overall Study|Lost to Follow-up|1|||
126391628|NCT00712725|454726299|FG000|Overall Study|Physician Decision|2|||
126391629|NCT00712725|454726300|FG001|Overall Study|Physician Decision|0|||
126391630|NCT00712725|454726301|FG002|Overall Study|Physician Decision|0|||
126391631|NCT00712725|454726302|FG003|Overall Study|Physician Decision|0|||
126391632|NCT00712725|454726303|FG004|Overall Study|Physician Decision|1|||
126391633|NCT00712725|454726304|FG005|Overall Study|Physician Decision|0|||
126391634|NCT00712725|454726305|FG006|Overall Study|Physician Decision|2|||
126391635|NCT00712725|454726306|FG007|Overall Study|Physician Decision|0|||
126391636|NCT00712725|454726299|FG000|Overall Study|Pregnancy|0|||
126391637|NCT00712725|454726300|FG001|Overall Study|Pregnancy|1|||
126391638|NCT00712725|454726301|FG002|Overall Study|Pregnancy|0|||
126391639|NCT00712725|454726302|FG003|Overall Study|Pregnancy|0|||
126391640|NCT00712725|454726303|FG004|Overall Study|Pregnancy|1|||
126391641|NCT00712725|454726304|FG005|Overall Study|Pregnancy|0|||
126391642|NCT00712725|454726305|FG006|Overall Study|Pregnancy|2|||
126391643|NCT00712725|454726306|FG007|Overall Study|Pregnancy|0|||
126391644|NCT00712725|454726299|FG000|Overall Study|Protocol Violation|2|||
126391645|NCT00712725|454726300|FG001|Overall Study|Protocol Violation|0|||
126391646|NCT00712725|454726301|FG002|Overall Study|Protocol Violation|1|||
126391647|NCT00712725|454726302|FG003|Overall Study|Protocol Violation|3|||
126391648|NCT00712725|454726303|FG004|Overall Study|Protocol Violation|2|||
126049809|NCT03066609|453479085|FG000|OVERALL STUDY|Lack of Efficacy|2|||
126049810|NCT03066609|453479086|FG001|OVERALL STUDY|Lack of Efficacy|1|||
126049811|NCT03066609|453479087|FG002|OVERALL STUDY|Lack of Efficacy|1|||
126049812|NCT03066609|453479088|FG003|OVERALL STUDY|Lack of Efficacy|1|||
126049813|NCT03066609|453479085|FG000|OVERALL STUDY|discontinued follow up|0|||
126049814|NCT03066609|453479086|FG001|OVERALL STUDY|discontinued follow up|2|||
126049815|NCT03066609|453479087|FG002|OVERALL STUDY|discontinued follow up|0|||
126049816|NCT03066609|453479088|FG003|OVERALL STUDY|discontinued follow up|0|||
126049817|NCT00523419|453479093|FG000|Overall Study|Adverse Event|1|||
126049818|NCT00523419|453479093|FG000|Overall Study|Withdrawal by Subject|1|||
126049819|NCT00523419|453479093|FG000|Overall Study|Physician Decision|2|||
126391649|NCT00712725|454726304|FG005|Overall Study|Protocol Violation|0|||
126391650|NCT00712725|454726305|FG006|Overall Study|Protocol Violation|1|||
126391651|NCT00712725|454726306|FG007|Overall Study|Protocol Violation|1|||
126391652|NCT00712725|454726299|FG000|Overall Study|Withdrawal by Subject|2|||
126049820|NCT00523419|453479093|FG000|Overall Study|Progressive Disease|22|||
126049821|NCT00523419|453479093|FG000|Overall Study|Death due to Study Disease|4|||
126049822|NCT00523419|453479093|FG000|Overall Study|Death due to Adverse Event|2|||
126049823|NCT01437319|453479096|FG000|Phase I|Lost to Follow-up|2|||
126391653|NCT00712725|454726300|FG001|Overall Study|Withdrawal by Subject|1|||
126391654|NCT00712725|454726301|FG002|Overall Study|Withdrawal by Subject|1|||
126391655|NCT00712725|454726302|FG003|Overall Study|Withdrawal by Subject|2|||
125887880|NCT03682770|452886603|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125887881|NCT03682770|452886604|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126049824|NCT01437319|453479097|FG001|Phase I|Lost to Follow-up|0|||
126049825|NCT01437319|453479098|FG002|Phase I|Lost to Follow-up|0|||
126049826|NCT01437319|453479096|FG000|Phase I|Protocol Violation|1|||
126049827|NCT01437319|453479097|FG001|Phase I|Protocol Violation|0|||
126049828|NCT01437319|453479098|FG002|Phase I|Protocol Violation|0|||
126049829|NCT01437319|453479096|FG000|Phase I|Study related symptoms/complaints|27|||
126049830|NCT01437319|453479097|FG001|Phase I|Study related symptoms/complaints|0|||
126391656|NCT00712725|454726303|FG004|Overall Study|Withdrawal by Subject|1|||
126391657|NCT00712725|454726304|FG005|Overall Study|Withdrawal by Subject|1|||
126391658|NCT00712725|454726305|FG006|Overall Study|Withdrawal by Subject|1|||
126391659|NCT00712725|454726306|FG007|Overall Study|Withdrawal by Subject|2|||
126391660|NCT00712725|454726299|FG000|Overall Study|Lack of Qualifying Event|16|||
126391661|NCT00712725|454726300|FG001|Overall Study|Lack of Qualifying Event|2|||
126391662|NCT00712725|454726301|FG002|Overall Study|Lack of Qualifying Event|6|||
126391663|NCT00712725|454726302|FG003|Overall Study|Lack of Qualifying Event|8|||
126391664|NCT00712725|454726303|FG004|Overall Study|Lack of Qualifying Event|11|||
126391665|NCT00712725|454726304|FG005|Overall Study|Lack of Qualifying Event|13|||
126391666|NCT00712725|454726305|FG006|Overall Study|Lack of Qualifying Event|11|||
125887882|NCT03682770|452886605|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126049831|NCT01437319|453479098|FG002|Phase I|Study related symptoms/complaints|0|||
126049832|NCT01437319|453479096|FG000|Phase I|Withdrawal by Subject|25|||
126049833|NCT01437319|453479097|FG001|Phase I|Withdrawal by Subject|0|||
126391667|NCT00712725|454726306|FG007|Overall Study|Lack of Qualifying Event|6|||
126391668|NCT00712725|454726299|FG000|Overall Study|Protocol Specified Criteria|3|||
126391669|NCT00712725|454726300|FG001|Overall Study|Protocol Specified Criteria|0|||
126391670|NCT00712725|454726301|FG002|Overall Study|Protocol Specified Criteria|1|||
126391671|NCT00712725|454726302|FG003|Overall Study|Protocol Specified Criteria|2|||
126391672|NCT00712725|454726303|FG004|Overall Study|Protocol Specified Criteria|1|||
126391673|NCT00712725|454726304|FG005|Overall Study|Protocol Specified Criteria|0|||
126391674|NCT00712725|454726305|FG006|Overall Study|Protocol Specified Criteria|2|||
126391675|NCT00712725|454726306|FG007|Overall Study|Protocol Specified Criteria|1|||
126391676|NCT03466099|454726307|FG000|Overall Study|Adverse Event|1|||
126391677|NCT03466099|454726308|FG001|Overall Study|Adverse Event|1|||
126391678|NCT03466099|454726309|FG002|Overall Study|Adverse Event|1|||
126391679|NCT03466099|454726307|FG000|Overall Study|Withdrawal by Subject|2|||
126391680|NCT03466099|454726308|FG001|Overall Study|Withdrawal by Subject|3|||
126391681|NCT03466099|454726309|FG002|Overall Study|Withdrawal by Subject|1|||
126391682|NCT03466099|454726307|FG000|Overall Study|Use of rescue medication|8|||
126391683|NCT03466099|454726308|FG001|Overall Study|Use of rescue medication|9|||
126391684|NCT03466099|454726309|FG002|Overall Study|Use of rescue medication|13|||
125887883|NCT03682770|452886606|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125887884|NCT03682770|452886600|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
126049834|NCT01437319|453479098|FG002|Phase I|Withdrawal by Subject|0|||
126049835|NCT01437319|453479096|FG000|Phase II|Withdrawal by Subject|0|||
126049836|NCT01437319|453479097|FG001|Phase II|Withdrawal by Subject|8|||
126049837|NCT01437319|453479098|FG002|Phase II|Withdrawal by Subject|16|||
126049838|NCT01437319|453479096|FG000|Phase II|Lost to Follow-up|0|||
126049839|NCT01437319|453479097|FG001|Phase II|Lost to Follow-up|7|||
126049840|NCT01437319|453479098|FG002|Phase II|Lost to Follow-up|2|||
126049841|NCT01437319|453479096|FG000|Phase II|Study related symptoms/complaints|0|||
126391685|NCT03466099|454726307|FG000|Overall Study|Rescued without meeting criteria|4|||
126391686|NCT03466099|454726308|FG001|Overall Study|Rescued without meeting criteria|1|||
126391687|NCT03466099|454726309|FG002|Overall Study|Rescued without meeting criteria|1|||
126391688|NCT03466099|454726307|FG000|Overall Study|Subject compliance|2|||
126391689|NCT03466099|454726308|FG001|Overall Study|Subject compliance|0|||
126391690|NCT03466099|454726309|FG002|Overall Study|Subject compliance|0|||
126391691|NCT03466099|454726307|FG000|Overall Study|Worsening disease|0|||
126104468|NCT00585195|453675928|FG019|Overall Study|Withdrawal by Subject|2|||
126104469|NCT00585195|453675929|FG020|Overall Study|Withdrawal by Subject|0|||
126104470|NCT00585195|453675909|FG000|Overall Study|Other|0|||
126104471|NCT00585195|453675910|FG001|Overall Study|Other|1|||
126104472|NCT00585195|453675911|FG002|Overall Study|Other|1|||
126104473|NCT00585195|453675912|FG003|Overall Study|Other|1|||
126104474|NCT00585195|453675913|FG004|Overall Study|Other|0|||
126104475|NCT00585195|453675914|FG005|Overall Study|Other|1|||
126104476|NCT00585195|453675915|FG006|Overall Study|Other|0|||
126104477|NCT00585195|453675916|FG007|Overall Study|Other|0|||
126104478|NCT00585195|453675917|FG008|Overall Study|Other|2|||
126391692|NCT03466099|454726308|FG001|Overall Study|Worsening disease|0|||
126391693|NCT03466099|454726309|FG002|Overall Study|Worsening disease|1|||
126104479|NCT00585195|453675918|FG009|Overall Study|Other|1|||
126104480|NCT00585195|453675919|FG010|Overall Study|Other|0|||
126104481|NCT00585195|453675920|FG011|Overall Study|Other|19|||
126104482|NCT00585195|453675921|FG012|Overall Study|Other|24|||
126104483|NCT00585195|453675922|FG013|Overall Study|Other|7|||
126104484|NCT00585195|453675923|FG014|Overall Study|Other|11|||
126104485|NCT00585195|453675924|FG015|Overall Study|Other|3|||
126104486|NCT00585195|453675925|FG016|Overall Study|Other|28|||
126104487|NCT00585195|453675926|FG017|Overall Study|Other|12|||
126104488|NCT00585195|453675927|FG018|Overall Study|Other|10|||
126104489|NCT00585195|453675928|FG019|Overall Study|Other|4|||
126104490|NCT00585195|453675929|FG020|Overall Study|Other|2|||
126104491|NCT00585195|453675909|FG000|Overall Study|Randomized not treated|0|||
126104492|NCT00585195|453675910|FG001|Overall Study|Randomized not treated|0|||
126104493|NCT00585195|453675911|FG002|Overall Study|Randomized not treated|1|||
126104494|NCT00585195|453675912|FG003|Overall Study|Randomized not treated|0|||
126104495|NCT00585195|453675913|FG004|Overall Study|Randomized not treated|1|||
126104496|NCT00585195|453675914|FG005|Overall Study|Randomized not treated|0|||
126104497|NCT00585195|453675915|FG006|Overall Study|Randomized not treated|1|||
126104498|NCT00585195|453675916|FG007|Overall Study|Randomized not treated|0|||
126104499|NCT00585195|453675917|FG008|Overall Study|Randomized not treated|0|||
126104500|NCT00585195|453675918|FG009|Overall Study|Randomized not treated|0|||
126104501|NCT00585195|453675919|FG010|Overall Study|Randomized not treated|2|||
126104502|NCT00585195|453675920|FG011|Overall Study|Randomized not treated|0|||
126104503|NCT00585195|453675921|FG012|Overall Study|Randomized not treated|0|||
126104504|NCT00585195|453675922|FG013|Overall Study|Randomized not treated|0|||
126104505|NCT00585195|453675923|FG014|Overall Study|Randomized not treated|0|||
126104506|NCT00585195|453675924|FG015|Overall Study|Randomized not treated|1|||
126104507|NCT00585195|453675925|FG016|Overall Study|Randomized not treated|0|||
126104508|NCT00585195|453675926|FG017|Overall Study|Randomized not treated|1|||
126104509|NCT00585195|453675927|FG018|Overall Study|Randomized not treated|3|||
126104510|NCT00585195|453675928|FG019|Overall Study|Randomized not treated|0|||
126104511|NCT00585195|453675929|FG020|Overall Study|Randomized not treated|2|||
126104512|NCT00585195|453675909|FG000|Overall Study|Death|0|||
126104513|NCT00585195|453675910|FG001|Overall Study|Death|0|||
126104514|NCT00585195|453675911|FG002|Overall Study|Death|0|||
126391694|NCT00616018|454726314|FG000|Overall Study|Protocol Violation|3|||
126104515|NCT00585195|453675912|FG003|Overall Study|Death|0|||
126104516|NCT00585195|453675913|FG004|Overall Study|Death|0|||
126104517|NCT00585195|453675914|FG005|Overall Study|Death|0|||
126104518|NCT00585195|453675915|FG006|Overall Study|Death|0|||
126104519|NCT00585195|453675916|FG007|Overall Study|Death|0|||
126104520|NCT00585195|453675917|FG008|Overall Study|Death|1|||
126104521|NCT00585195|453675918|FG009|Overall Study|Death|0|||
126391695|NCT00404755|454726316|FG000|Phase I (Bupropion)|Adverse Event|3|||
126391696|NCT00404755|454726316|FG000|Phase I (Bupropion)|Other|1|||
126104522|NCT00585195|453675919|FG010|Overall Study|Death|1|||
126104523|NCT00585195|453675920|FG011|Overall Study|Death|1|||
126104524|NCT00585195|453675921|FG012|Overall Study|Death|7|||
126104525|NCT00585195|453675922|FG013|Overall Study|Death|2|||
126391697|NCT00404755|454726316|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
126391698|NCT00350870|454726317|FG000|Overall Study|Withdrawal by Subject|21|||
126391699|NCT00350870|454726318|FG001|Overall Study|Withdrawal by Subject|17|||
126391700|NCT00350870|454726319|FG002|Overall Study|Withdrawal by Subject|15|||
126391701|NCT00350870|454726320|FG003|Overall Study|Withdrawal by Subject|14|||
126391702|NCT00350870|454726317|FG000|Overall Study|Physician Decision|1|||
126391703|NCT00350870|454726318|FG001|Overall Study|Physician Decision|0|||
126391704|NCT00350870|454726319|FG002|Overall Study|Physician Decision|1|||
126104526|NCT00585195|453675923|FG014|Overall Study|Death|8|||
126104527|NCT00585195|453675924|FG015|Overall Study|Death|2|||
126104528|NCT00585195|453675925|FG016|Overall Study|Death|11|||
126104529|NCT00585195|453675926|FG017|Overall Study|Death|0|||
126104530|NCT00585195|453675927|FG018|Overall Study|Death|0|||
126104531|NCT00585195|453675928|FG019|Overall Study|Death|0|||
126104532|NCT00585195|453675929|FG020|Overall Study|Death|1|||
126104533|NCT00585195|453675909|FG000|Overall Study|Lost to Follow-up|0|||
126104534|NCT00585195|453675910|FG001|Overall Study|Lost to Follow-up|0|||
126391705|NCT00350870|454726320|FG003|Overall Study|Physician Decision|1|||
126049842|NCT01437319|453479097|FG001|Phase II|Study related symptoms/complaints|28|||
126049843|NCT01437319|453479098|FG002|Phase II|Study related symptoms/complaints|19|||
126049844|NCT01437319|453479096|FG000|Phase II|Protocol Violation|0|||
126049845|NCT01437319|453479097|FG001|Phase II|Protocol Violation|1|||
126049846|NCT01437319|453479098|FG002|Phase II|Protocol Violation|0|||
126049847|NCT01499849|453479099|FG000|Overall Study|Adverse Event|28|||
126049848|NCT01499849|453479100|FG001|Overall Study|Adverse Event|32|||
126049849|NCT01499849|453479099|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
126049850|NCT01499849|453479100|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
126049851|NCT01499849|453479099|FG000|Overall Study|Withdrawal by Subject|43|||
126049852|NCT01499849|453479100|FG001|Overall Study|Withdrawal by Subject|43|||
126049853|NCT01499849|453479099|FG000|Overall Study|Death|5|||
126049854|NCT01499849|453479100|FG001|Overall Study|Death|7|||
126049855|NCT01499849|453479099|FG000|Overall Study|Disease Progression|11|||
126049856|NCT01499849|453479100|FG001|Overall Study|Disease Progression|10|||
126049857|NCT01499849|453479099|FG000|Overall Study|Protocol Violation|11|||
126049858|NCT01499849|453479100|FG001|Overall Study|Protocol Violation|11|||
126049859|NCT01499849|453479099|FG000|Overall Study|Physician Decision|20|||
126049860|NCT01499849|453479100|FG001|Overall Study|Physician Decision|19|||
126049861|NCT01499849|453479099|FG000|Overall Study|Lack of Efficacy|3|||
126049862|NCT01499849|453479100|FG001|Overall Study|Lack of Efficacy|4|||
126049863|NCT01499849|453479099|FG000|Overall Study|Lost to Follow-up|6|||
126049864|NCT01499849|453479100|FG001|Overall Study|Lost to Follow-up|3|||
126049865|NCT01499849|453479099|FG000|Overall Study|Other Reasons|27|||
126049866|NCT01499849|453479100|FG001|Overall Study|Other Reasons|30|||
126049867|NCT00811941|453479101|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
126049868|NCT00811941|453479102|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
126049869|NCT00811941|453479101|FG000|All Treated Patients|Adverse Event|2|||
126049870|NCT00811941|453479102|FG001|All Treated Patients|Adverse Event|43|||
126049871|NCT00811941|453479101|FG000|All Treated Patients|Lack of Efficacy|2|||
126049872|NCT00811941|453479102|FG001|All Treated Patients|Lack of Efficacy|3|||
126049873|NCT00811941|453479101|FG000|All Treated Patients|Non-compliance|1|||
126049874|NCT00811941|453479102|FG001|All Treated Patients|Non-compliance|8|||
126049875|NCT00811941|453479101|FG000|All Treated Patients|Protocol Violation|5|||
126049876|NCT00811941|453479102|FG001|All Treated Patients|Protocol Violation|17|||
126049877|NCT00811941|453479101|FG000|All Treated Patients|Withdrawal by Subject|35|||
126049878|NCT00811941|453479102|FG001|All Treated Patients|Withdrawal by Subject|94|||
126049879|NCT00811941|453479101|FG000|All Treated Patients|Lost to Follow-up|3|||
126049880|NCT00811941|453479102|FG001|All Treated Patients|Lost to Follow-up|12|||
126049881|NCT00811941|453479101|FG000|All Treated Patients|Other Reason|4|||
126049882|NCT00811941|453479102|FG001|All Treated Patients|Other Reason|14|||
126049883|NCT00622700|453479105|FG000|Core Treatment Period|Randomized but Not Treated|0|||
126049884|NCT00622700|453479106|FG001|Core Treatment Period|Randomized but Not Treated|2|||
126049885|NCT00622700|453479107|FG002|Core Treatment Period|Randomized but Not Treated|2|||
126049886|NCT00622700|453479108|FG003|Core Treatment Period|Randomized but Not Treated|0|||
126049887|NCT00622700|453479109|FG004|Core Treatment Period|Randomized but Not Treated|0|||
126049888|NCT00622700|453479110|FG005|Core Treatment Period|Randomized but Not Treated|0|||
126049889|NCT00622700|453479111|FG006|Core Treatment Period|Randomized but Not Treated|0|||
126049890|NCT00622700|453479105|FG000|Core Treatment Period|Adverse Event|18|||
126049891|NCT00622700|453479106|FG001|Core Treatment Period|Adverse Event|25|||
126049892|NCT00622700|453479107|FG002|Core Treatment Period|Adverse Event|18|||
126049893|NCT00622700|453479108|FG003|Core Treatment Period|Adverse Event|0|||
126049894|NCT00622700|453479109|FG004|Core Treatment Period|Adverse Event|0|||
126049895|NCT00622700|453479110|FG005|Core Treatment Period|Adverse Event|0|||
126049896|NCT00622700|453479111|FG006|Core Treatment Period|Adverse Event|0|||
126049897|NCT00622700|453479105|FG000|Core Treatment Period|Lack of Efficacy|19|||
126049898|NCT00622700|453479106|FG001|Core Treatment Period|Lack of Efficacy|6|||
126049899|NCT00622700|453479107|FG002|Core Treatment Period|Lack of Efficacy|12|||
126391706|NCT03194568|454726321|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
126049900|NCT00622700|453479108|FG003|Core Treatment Period|Lack of Efficacy|0|||
126049901|NCT00622700|453479109|FG004|Core Treatment Period|Lack of Efficacy|0|||
126049902|NCT00622700|453479110|FG005|Core Treatment Period|Lack of Efficacy|0|||
126049903|NCT00622700|453479111|FG006|Core Treatment Period|Lack of Efficacy|0|||
126049904|NCT00622700|453479105|FG000|Core Treatment Period|Lost to Follow-up|1|||
126049905|NCT00622700|453479106|FG001|Core Treatment Period|Lost to Follow-up|1|||
126049906|NCT00622700|453479107|FG002|Core Treatment Period|Lost to Follow-up|1|||
126049907|NCT00622700|453479108|FG003|Core Treatment Period|Lost to Follow-up|0|||
126049908|NCT00622700|453479109|FG004|Core Treatment Period|Lost to Follow-up|0|||
126049909|NCT00622700|453479110|FG005|Core Treatment Period|Lost to Follow-up|0|||
126049910|NCT00622700|453479111|FG006|Core Treatment Period|Lost to Follow-up|0|||
126049911|NCT00622700|453479105|FG000|Core Treatment Period|Death|1|||
126049912|NCT00622700|453479106|FG001|Core Treatment Period|Death|0|||
126049913|NCT00622700|453479107|FG002|Core Treatment Period|Death|0|||
126049914|NCT00622700|453479108|FG003|Core Treatment Period|Death|0|||
126049915|NCT00622700|453479109|FG004|Core Treatment Period|Death|0|||
126049916|NCT00622700|453479110|FG005|Core Treatment Period|Death|0|||
126049917|NCT00622700|453479111|FG006|Core Treatment Period|Death|0|||
126049918|NCT00622700|453479105|FG000|Core Treatment Period|Progressive Disease|3|||
126049919|NCT00622700|453479106|FG001|Core Treatment Period|Progressive Disease|1|||
126049920|NCT00622700|453479107|FG002|Core Treatment Period|Progressive Disease|0|||
126049921|NCT00622700|453479108|FG003|Core Treatment Period|Progressive Disease|0|||
126049922|NCT00622700|453479109|FG004|Core Treatment Period|Progressive Disease|0|||
126049923|NCT00622700|453479110|FG005|Core Treatment Period|Progressive Disease|0|||
126049924|NCT00622700|453479111|FG006|Core Treatment Period|Progressive Disease|0|||
126049925|NCT00622700|453479105|FG000|Core Treatment Period|Withdrawal by Subject|12|||
126049926|NCT00622700|453479106|FG001|Core Treatment Period|Withdrawal by Subject|18|||
126049927|NCT00622700|453479107|FG002|Core Treatment Period|Withdrawal by Subject|15|||
126049928|NCT00622700|453479108|FG003|Core Treatment Period|Withdrawal by Subject|0|||
126049929|NCT00622700|453479109|FG004|Core Treatment Period|Withdrawal by Subject|0|||
126049930|NCT00622700|453479110|FG005|Core Treatment Period|Withdrawal by Subject|0|||
126049931|NCT00622700|453479111|FG006|Core Treatment Period|Withdrawal by Subject|0|||
126049932|NCT00622700|453479105|FG000|Core Treatment Period|Other than specified above|2|||
126049933|NCT00622700|453479106|FG001|Core Treatment Period|Other than specified above|2|||
126049934|NCT00622700|453479107|FG002|Core Treatment Period|Other than specified above|5|||
126049935|NCT00622700|453479108|FG003|Core Treatment Period|Other than specified above|0|||
126049936|NCT00622700|453479109|FG004|Core Treatment Period|Other than specified above|0|||
126049937|NCT00622700|453479110|FG005|Core Treatment Period|Other than specified above|0|||
126049938|NCT00622700|453479111|FG006|Core Treatment Period|Other than specified above|0|||
126049939|NCT00622700|453479105|FG000|Extension Treatment Period|Adverse Event|0|||
126049940|NCT00622700|453479106|FG001|Extension Treatment Period|Adverse Event|0|||
126049941|NCT00622700|453479107|FG002|Extension Treatment Period|Adverse Event|0|||
126049942|NCT00622700|453479108|FG003|Extension Treatment Period|Adverse Event|5|||
126049943|NCT00622700|453479109|FG004|Extension Treatment Period|Adverse Event|9|||
126049944|NCT00622700|453479110|FG005|Extension Treatment Period|Adverse Event|6|||
126049945|NCT00622700|453479111|FG006|Extension Treatment Period|Adverse Event|8|||
126049946|NCT00622700|453479105|FG000|Extension Treatment Period|Lack of Efficacy|0|||
126049947|NCT00622700|453479106|FG001|Extension Treatment Period|Lack of Efficacy|0|||
126049948|NCT00622700|453479107|FG002|Extension Treatment Period|Lack of Efficacy|0|||
126049949|NCT00622700|453479108|FG003|Extension Treatment Period|Lack of Efficacy|2|||
126049950|NCT00622700|453479109|FG004|Extension Treatment Period|Lack of Efficacy|8|||
126049951|NCT00622700|453479110|FG005|Extension Treatment Period|Lack of Efficacy|1|||
126049952|NCT00622700|453479111|FG006|Extension Treatment Period|Lack of Efficacy|9|||
126049953|NCT00622700|453479105|FG000|Extension Treatment Period|Protocol Violation|0|||
126391707|NCT05248997|454726322|FG000|Overall Study|Lost to Follow-up|1|||
126391708|NCT05248997|454726323|FG001|Overall Study|Lost to Follow-up|1|||
126391709|NCT05248997|454726322|FG000|Overall Study|Randomized but not treated|32|||
126391710|NCT05248997|454726323|FG001|Overall Study|Randomized but not treated|25|||
126391711|NCT01453205|454726324|FG000|Overall Study|Lost to Follow-up|3|||
126391712|NCT01453205|454726325|FG001|Overall Study|Lost to Follow-up|0|||
126391713|NCT01453205|454726326|FG002|Overall Study|Lost to Follow-up|1|||
126391714|NCT01453205|454726324|FG000|Overall Study|Withdrawal by Subject|8|||
126391715|NCT01453205|454726325|FG001|Overall Study|Withdrawal by Subject|3|||
126391716|NCT01453205|454726326|FG002|Overall Study|Withdrawal by Subject|0|||
126391717|NCT01453205|454726324|FG000|Overall Study|Death|24|||
126391718|NCT01453205|454726325|FG001|Overall Study|Death|22|||
126391719|NCT01453205|454726326|FG002|Overall Study|Death|18|||
126391720|NCT01453205|454726324|FG000|Overall Study|Other|45|||
126391721|NCT01453205|454726325|FG001|Overall Study|Other|27|||
126391722|NCT01453205|454726326|FG002|Overall Study|Other|35|||
126391723|NCT02602275|454726331|FG000|Day 1|Physician Decision|0|||
126391724|NCT02602275|454726332|FG001|Day 1|Physician Decision|1|||
126391725|NCT04262882|454726333|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
126391726|NCT04262882|454726334|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
126391727|NCT04262882|454726333|FG000|Overall Study|Lost to Follow-up|1|||
126391728|NCT04262882|454726334|FG001|Overall Study|Lost to Follow-up|0|||
126391729|NCT01301066|454726335|FG000|Overall Study|Lost to Follow-up|5|||
126391730|NCT01301066|454726336|FG001|Overall Study|Lost to Follow-up|11|||
126049954|NCT00622700|453479106|FG001|Extension Treatment Period|Protocol Violation|0|||
126049955|NCT00622700|453479107|FG002|Extension Treatment Period|Protocol Violation|0|||
126049956|NCT00622700|453479108|FG003|Extension Treatment Period|Protocol Violation|0|||
126049957|NCT00622700|453479109|FG004|Extension Treatment Period|Protocol Violation|0|||
126049958|NCT00622700|453479110|FG005|Extension Treatment Period|Protocol Violation|2|||
126049959|NCT00622700|453479111|FG006|Extension Treatment Period|Protocol Violation|0|||
126049960|NCT00622700|453479105|FG000|Extension Treatment Period|Lost to Follow-up|0|||
126049961|NCT00622700|453479106|FG001|Extension Treatment Period|Lost to Follow-up|0|||
126049962|NCT00622700|453479107|FG002|Extension Treatment Period|Lost to Follow-up|0|||
126049963|NCT00622700|453479108|FG003|Extension Treatment Period|Lost to Follow-up|0|||
126049964|NCT00622700|453479109|FG004|Extension Treatment Period|Lost to Follow-up|1|||
126049965|NCT00622700|453479110|FG005|Extension Treatment Period|Lost to Follow-up|0|||
126049966|NCT00622700|453479111|FG006|Extension Treatment Period|Lost to Follow-up|0|||
126049967|NCT00622700|453479105|FG000|Extension Treatment Period|Progressive Disease|0|||
126049968|NCT00622700|453479106|FG001|Extension Treatment Period|Progressive Disease|0|||
126049969|NCT00622700|453479107|FG002|Extension Treatment Period|Progressive Disease|0|||
126049970|NCT00622700|453479108|FG003|Extension Treatment Period|Progressive Disease|1|||
126049971|NCT00622700|453479109|FG004|Extension Treatment Period|Progressive Disease|2|||
126104535|NCT00585195|453675911|FG002|Overall Study|Lost to Follow-up|0|||
126391731|NCT01301066|454726335|FG000|Overall Study|Protocol Violation|8|||
126391732|NCT01301066|454726336|FG001|Overall Study|Protocol Violation|7|||
126391733|NCT01301066|454726335|FG000|Overall Study|Withdrawal by Subject|4|||
126391734|NCT01301066|454726336|FG001|Overall Study|Withdrawal by Subject|9|||
126391735|NCT01301066|454726335|FG000|Overall Study|Adverse Event|6|||
126391736|NCT01301066|454726336|FG001|Overall Study|Adverse Event|6|||
126391737|NCT01301066|454726335|FG000|Overall Study|Sponsor Decision|2|||
126391738|NCT01301066|454726336|FG001|Overall Study|Sponsor Decision|1|||
126391739|NCT01301066|454726335|FG000|Overall Study|Physician Decision|0|||
126391740|NCT01301066|454726336|FG001|Overall Study|Physician Decision|1|||
126391741|NCT01301066|454726335|FG000|Overall Study|Other|2|||
126391742|NCT01301066|454726336|FG001|Overall Study|Other|0|||
126391743|NCT01108731|454726343|FG000|Overall Study|Withdrawal by Subject|1|||
126391744|NCT01108731|454726344|FG001|Overall Study|Withdrawal by Subject|1|||
126391745|NCT01108731|454726343|FG000|Overall Study|Adverse Event|3|||
126391746|NCT01108731|454726344|FG001|Overall Study|Adverse Event|3|||
126391747|NCT01892722|454726345|FG000|Overall Study|Protocol deviation|0|||
126391748|NCT01892722|454726346|FG001|Overall Study|Protocol deviation|1|||
126391749|NCT01892722|454726345|FG000|Overall Study|Administrative problems|0|||
126391750|NCT01892722|454726346|FG001|Overall Study|Administrative problems|1|||
126391751|NCT01892722|454726345|FG000|Overall Study|Patient/guardian decision|0|||
126391752|NCT01892722|454726346|FG001|Overall Study|Patient/guardian decision|2|||
126391753|NCT01892722|454726345|FG000|Overall Study|Physician Decision|1|||
126391754|NCT01892722|454726346|FG001|Overall Study|Physician Decision|2|||
126391755|NCT01892722|454726345|FG000|Overall Study|Adverse Event|3|||
126391756|NCT01892722|454726346|FG001|Overall Study|Adverse Event|2|||
126391757|NCT01892722|454726345|FG000|Overall Study|Lack of Efficacy|0|||
126391758|NCT01892722|454726346|FG001|Overall Study|Lack of Efficacy|7|||
126391759|NCT01892722|454726345|FG000|Overall Study|Withdrawal by Subject|3|||
126391760|NCT01892722|454726346|FG001|Overall Study|Withdrawal by Subject|5|||
126391761|NCT01252186|454726347|FG000|Overall Study|Adverse Event|9|||
126391762|NCT01252186|454726348|FG001|Overall Study|Adverse Event|6|||
126391763|NCT01252186|454726349|FG002|Overall Study|Adverse Event|8|||
126391764|NCT01252186|454726347|FG000|Overall Study|Withdrawal by Subject|2|||
126391765|NCT01252186|454726348|FG001|Overall Study|Withdrawal by Subject|5|||
126391766|NCT01252186|454726349|FG002|Overall Study|Withdrawal by Subject|2|||
126391767|NCT01252186|454726347|FG000|Overall Study|Physician Decision|0|||
126391768|NCT01252186|454726348|FG001|Overall Study|Physician Decision|0|||
126391769|NCT01252186|454726349|FG002|Overall Study|Physician Decision|1|||
126391770|NCT01252186|454726347|FG000|Overall Study|Non-compliance|0|||
126391771|NCT01252186|454726348|FG001|Overall Study|Non-compliance|3|||
126391772|NCT01252186|454726349|FG002|Overall Study|Non-compliance|4|||
126391773|NCT01252186|454726347|FG000|Overall Study|Protocol Violation|0|||
126391774|NCT01252186|454726348|FG001|Overall Study|Protocol Violation|0|||
126391775|NCT01252186|454726349|FG002|Overall Study|Protocol Violation|1|||
126391776|NCT01252186|454726347|FG000|Overall Study|Pregnancy|2|||
126391777|NCT01252186|454726348|FG001|Overall Study|Pregnancy|2|||
126391778|NCT01252186|454726349|FG002|Overall Study|Pregnancy|0|||
126391779|NCT01252186|454726347|FG000|Overall Study|Sponsor Request|2|||
126104536|NCT00585195|453675912|FG003|Overall Study|Lost to Follow-up|0|||
126104537|NCT00585195|453675913|FG004|Overall Study|Lost to Follow-up|0|||
126104538|NCT00585195|453675914|FG005|Overall Study|Lost to Follow-up|0|||
126104539|NCT00585195|453675915|FG006|Overall Study|Lost to Follow-up|0|||
126104540|NCT00585195|453675916|FG007|Overall Study|Lost to Follow-up|0|||
126104541|NCT00585195|453675917|FG008|Overall Study|Lost to Follow-up|0|||
126104542|NCT00585195|453675918|FG009|Overall Study|Lost to Follow-up|0|||
126104543|NCT00585195|453675919|FG010|Overall Study|Lost to Follow-up|0|||
126104544|NCT00585195|453675920|FG011|Overall Study|Lost to Follow-up|0|||
126104545|NCT00585195|453675921|FG012|Overall Study|Lost to Follow-up|1|||
126104546|NCT00585195|453675922|FG013|Overall Study|Lost to Follow-up|0|||
126104547|NCT00585195|453675923|FG014|Overall Study|Lost to Follow-up|0|||
126104548|NCT00585195|453675924|FG015|Overall Study|Lost to Follow-up|0|||
126104549|NCT00585195|453675925|FG016|Overall Study|Lost to Follow-up|0|||
126104550|NCT00585195|453675926|FG017|Overall Study|Lost to Follow-up|2|||
126104551|NCT00585195|453675927|FG018|Overall Study|Lost to Follow-up|0|||
126104552|NCT00585195|453675928|FG019|Overall Study|Lost to Follow-up|0|||
126104553|NCT00585195|453675929|FG020|Overall Study|Lost to Follow-up|0|||
126104554|NCT00585195|453675909|FG000|Overall Study|Site Terminated by Sponsor|0|||
126104555|NCT00585195|453675910|FG001|Overall Study|Site Terminated by Sponsor|0|||
126104556|NCT00585195|453675911|FG002|Overall Study|Site Terminated by Sponsor|0|||
126104557|NCT00585195|453675912|FG003|Overall Study|Site Terminated by Sponsor|0|||
126104558|NCT00585195|453675913|FG004|Overall Study|Site Terminated by Sponsor|0|||
126104559|NCT00585195|453675914|FG005|Overall Study|Site Terminated by Sponsor|0|||
126104560|NCT00585195|453675915|FG006|Overall Study|Site Terminated by Sponsor|0|||
126104561|NCT00585195|453675916|FG007|Overall Study|Site Terminated by Sponsor|0|||
126391780|NCT01252186|454726348|FG001|Overall Study|Sponsor Request|1|||
126391781|NCT01252186|454726349|FG002|Overall Study|Sponsor Request|0|||
126391782|NCT01252186|454726347|FG000|Overall Study|Lost to Follow-up|10|||
126391783|NCT01252186|454726348|FG001|Overall Study|Lost to Follow-up|10|||
126391784|NCT01252186|454726349|FG002|Overall Study|Lost to Follow-up|11|||
126391785|NCT01252186|454726347|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
126391786|NCT01252186|454726348|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
126391787|NCT01252186|454726349|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
126391788|NCT04283994|454726356|FG000|Overall Study|Death|11|||
126391789|NCT04283994|454726357|FG001|Overall Study|Death|20|||
126391790|NCT04283994|454726358|FG002|Overall Study|Death|11|||
126391791|NCT04283994|454726359|FG003|Overall Study|Death|0|||
126391792|NCT04283994|454726360|FG004|Overall Study|Death|0|||
126391793|NCT04283994|454726361|FG005|Overall Study|Death|0|||
126391794|NCT04283994|454726362|FG006|Overall Study|Death|0|||
126391795|NCT04283994|454726356|FG000|Overall Study|Withdrawal by Subject|16|||
126391796|NCT04283994|454726357|FG001|Overall Study|Withdrawal by Subject|4|||
126391797|NCT04283994|454726358|FG002|Overall Study|Withdrawal by Subject|6|||
126391798|NCT04283994|454726359|FG003|Overall Study|Withdrawal by Subject|1|||
126391799|NCT04283994|454726360|FG004|Overall Study|Withdrawal by Subject|0|||
126391800|NCT04283994|454726361|FG005|Overall Study|Withdrawal by Subject|1|||
126391801|NCT04283994|454726362|FG006|Overall Study|Withdrawal by Subject|0|||
126391802|NCT03763656|454726363|FG000|Overall Study|Physician Decision|1|||
126391803|NCT03763656|454726363|FG000|Overall Study|Protocol Violation|1|||
126391804|NCT03763656|454726363|FG000|Overall Study|Withdrawal by Subject|7|||
126391805|NCT00487942|454726364|FG000|Overall Study|Adverse Event|1|||
126391806|NCT00487942|454726365|FG001|Overall Study|Adverse Event|1|||
126391807|NCT00487942|454726366|FG002|Overall Study|Adverse Event|1|||
126391808|NCT00487942|454726367|FG003|Overall Study|Adverse Event|1|||
126391809|NCT00487942|454726364|FG000|Overall Study|Lost to Follow-up|1|||
126391810|NCT00487942|454726365|FG001|Overall Study|Lost to Follow-up|0|||
125887885|NCT03682770|452886601|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
126104562|NCT00585195|453675917|FG008|Overall Study|Site Terminated by Sponsor|0|||
126104563|NCT00585195|453675918|FG009|Overall Study|Site Terminated by Sponsor|0|||
126391811|NCT00487942|454726366|FG002|Overall Study|Lost to Follow-up|0|||
126391812|NCT00487942|454726367|FG003|Overall Study|Lost to Follow-up|1|||
126391813|NCT00487942|454726364|FG000|Overall Study|Protocol Violation|1|||
126391814|NCT00487942|454726365|FG001|Overall Study|Protocol Violation|1|||
126391815|NCT00487942|454726366|FG002|Overall Study|Protocol Violation|0|||
126391816|NCT00487942|454726367|FG003|Overall Study|Protocol Violation|0|||
126391817|NCT00487942|454726364|FG000|Overall Study|Withdrawal by Subject|0|||
126104564|NCT00585195|453675919|FG010|Overall Study|Site Terminated by Sponsor|0|||
126104565|NCT00585195|453675920|FG011|Overall Study|Site Terminated by Sponsor|0|||
126104566|NCT00585195|453675921|FG012|Overall Study|Site Terminated by Sponsor|1|||
125887886|NCT03682770|452886602|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125887887|NCT03682770|452886603|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125887888|NCT03682770|452886604|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125887889|NCT03682770|452886605|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
126104567|NCT00585195|453675922|FG013|Overall Study|Site Terminated by Sponsor|0|||
126391818|NCT00487942|454726365|FG001|Overall Study|Withdrawal by Subject|1|||
126391819|NCT00487942|454726366|FG002|Overall Study|Withdrawal by Subject|2|||
126391820|NCT00487942|454726367|FG003|Overall Study|Withdrawal by Subject|0|||
126391821|NCT00322452|454726368|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126391822|NCT00322452|454726369|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126391823|NCT00322452|454726368|FG000|Overall Study|Lost to Follow-up|5|||
126391824|NCT00322452|454726369|FG001|Overall Study|Lost to Follow-up|2|||
126391825|NCT00322452|454726368|FG000|Overall Study|Withdrawal by Subject|19|||
126391826|NCT00322452|454726369|FG001|Overall Study|Withdrawal by Subject|46|||
126391827|NCT00322452|454726368|FG000|Overall Study|Death|223|||
126391828|NCT00322452|454726369|FG001|Overall Study|Death|227|||
126391829|NCT00197145|454727756|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
126391830|NCT00197145|454727757|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
126391831|NCT00197145|454727756|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
126391832|NCT00197145|454727757|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
126391833|NCT00197145|454727756|FG000|Period 1: Randomized Treatment Phase|Other|2|||
126391834|NCT00197145|454727757|FG001|Period 1: Randomized Treatment Phase|Other|2|||
126391835|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
126391836|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
126391837|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
126391838|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
126391839|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
126391840|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
126391841|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
126391842|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
126391843|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Other|1|||
126391844|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Other|0|||
126391845|NCT03372551|454727764|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
126391846|NCT03372551|454727765|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
126391847|NCT03285958|454727770|FG000|Overall Study|Lost to Follow-up|1|||
126391848|NCT03285958|454727771|FG001|Overall Study|Lost to Follow-up|1|||
126391849|NCT03285958|454727770|FG000|Overall Study|Withdrawal by Subject|1|||
126391850|NCT03285958|454727771|FG001|Overall Study|Withdrawal by Subject|0|||
126391851|NCT03285958|454727770|FG000|Overall Study|Not able to attend required orientation|3|||
126391852|NCT03285958|454727771|FG001|Overall Study|Not able to attend required orientation|0|||
126391853|NCT02578680|454727772|FG000|Overall Study|Death|329|||
126391854|NCT02578680|454727773|FG001|Overall Study|Death|181|||
126391855|NCT02578680|454727772|FG000|Overall Study|Lost to Follow-up|3|||
126391856|NCT02578680|454727773|FG001|Overall Study|Lost to Follow-up|1|||
126391857|NCT02578680|454727772|FG000|Overall Study|Physician Decision|0|||
126391858|NCT02578680|454727773|FG001|Overall Study|Physician Decision|1|||
126391859|NCT02578680|454727772|FG000|Overall Study|Protocol Violation|1|||
126391860|NCT02578680|454727773|FG001|Overall Study|Protocol Violation|1|||
126391861|NCT02578680|454727772|FG000|Overall Study|Sponsor Decision|64|||
126391862|NCT02578680|454727773|FG001|Overall Study|Sponsor Decision|13|||
126391863|NCT02578680|454727772|FG000|Overall Study|Withdrawal by Subject|13|||
126391864|NCT02578680|454727773|FG001|Overall Study|Withdrawal by Subject|9|||
126391865|NCT03116828|454727774|FG000|Overall Study|Adverse Event|1|||
126391866|NCT03116828|454727775|FG001|Overall Study|Adverse Event|10|||
126391867|NCT03116828|454727774|FG000|Overall Study|Withdrawal by Subject|4|||
126391868|NCT03116828|454727775|FG001|Overall Study|Withdrawal by Subject|8|||
126391869|NCT03116828|454727774|FG000|Overall Study|OTHER|3|||
126391870|NCT03116828|454727775|FG001|Overall Study|OTHER|3|||
126391871|NCT00176488|454727777|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
126391872|NCT00591149|454727793|FG000|Overall Study|Adverse Event|4|||
126391873|NCT00591149|454727793|FG000|Overall Study|Withdrawal by Subject|1|||
126391874|NCT00470093|454727794|FG000|Overall Study|Adverse Event|2|||
126391875|NCT00664560|454727795|FG000|Overall Study|Adverse Event|19|||
126391876|NCT00664560|454727796|FG001|Overall Study|Adverse Event|16|||
126391877|NCT00664560|454727797|FG002|Overall Study|Adverse Event|7|||
126391878|NCT00664560|454727795|FG000|Overall Study|Withdrawal by Subject|9|||
126391879|NCT00664560|454727796|FG001|Overall Study|Withdrawal by Subject|13|||
126391880|NCT00664560|454727797|FG002|Overall Study|Withdrawal by Subject|7|||
126391881|NCT00664560|454727795|FG000|Overall Study|Lost to Follow-up|0|||
125887890|NCT03682770|452886606|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
126049972|NCT00622700|453479110|FG005|Extension Treatment Period|Progressive Disease|0|||
126049973|NCT00622700|453479111|FG006|Extension Treatment Period|Progressive Disease|2|||
126049974|NCT00622700|453479105|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
126049975|NCT00622700|453479106|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126049976|NCT00622700|453479107|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
126049977|NCT00622700|453479108|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
126049978|NCT00622700|453479109|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
126049979|NCT00622700|453479110|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
126049980|NCT00622700|453479111|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
126049981|NCT00622700|453479105|FG000|Extension Treatment Period|Missing|0|||
126049982|NCT00622700|453479106|FG001|Extension Treatment Period|Missing|0|||
126049983|NCT00622700|453479107|FG002|Extension Treatment Period|Missing|0|||
126049984|NCT00622700|453479108|FG003|Extension Treatment Period|Missing|2|||
126049985|NCT00622700|453479109|FG004|Extension Treatment Period|Missing|3|||
126049986|NCT00622700|453479110|FG005|Extension Treatment Period|Missing|1|||
126049987|NCT00622700|453479111|FG006|Extension Treatment Period|Missing|0|||
126049988|NCT00622700|453479105|FG000|Extension Treatment Period|Other than specified above|0|||
126049989|NCT00622700|453479106|FG001|Extension Treatment Period|Other than specified above|0|||
126049990|NCT00622700|453479107|FG002|Extension Treatment Period|Other than specified above|0|||
126049991|NCT00622700|453479108|FG003|Extension Treatment Period|Other than specified above|0|||
126049992|NCT00622700|453479109|FG004|Extension Treatment Period|Other than specified above|0|||
126049993|NCT00622700|453479110|FG005|Extension Treatment Period|Other than specified above|1|||
126049994|NCT00622700|453479111|FG006|Extension Treatment Period|Other than specified above|1|||
126049995|NCT01753999|453479112|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
126049996|NCT01753999|453479113|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
126049997|NCT01753999|453479112|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
126049998|NCT01753999|453479113|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
126049999|NCT01753999|453479112|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
126050000|NCT01753999|453479113|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
126391882|NCT00664560|454727796|FG001|Overall Study|Lost to Follow-up|2|||
126391883|NCT00664560|454727797|FG002|Overall Study|Lost to Follow-up|0|||
126391884|NCT00664560|454727795|FG000|Overall Study|Other|11|||
126391885|NCT00664560|454727796|FG001|Overall Study|Other|4|||
126391886|NCT00664560|454727797|FG002|Overall Study|Other|5|||
126391887|NCT02456636|454727798|FG000|Overall Study|Death|0|||
126391888|NCT02456636|454727799|FG001|Overall Study|Death|3|||
126391889|NCT02456636|454727800|FG002|Overall Study|Death|0|||
126391890|NCT02456636|454727798|FG000|Overall Study|Pregnancy|1|||
126391891|NCT02456636|454727799|FG001|Overall Study|Pregnancy|3|||
126391892|NCT02456636|454727800|FG002|Overall Study|Pregnancy|5|||
126391893|NCT02456636|454727798|FG000|Overall Study|Physician Decision|4|||
126391894|NCT02456636|454727799|FG001|Overall Study|Physician Decision|5|||
126391895|NCT02456636|454727800|FG002|Overall Study|Physician Decision|4|||
126391896|NCT02456636|454727798|FG000|Overall Study|Withdrawal by Subject|13|||
126391897|NCT02456636|454727799|FG001|Overall Study|Withdrawal by Subject|14|||
126391898|NCT02456636|454727800|FG002|Overall Study|Withdrawal by Subject|16|||
126391899|NCT02456636|454727798|FG000|Overall Study|Lost to Follow-up|50|||
126391900|NCT02456636|454727799|FG001|Overall Study|Lost to Follow-up|44|||
126391901|NCT02456636|454727800|FG002|Overall Study|Lost to Follow-up|50|||
126391902|NCT03350035|454727801|FG000|Overall Study|Lack of Efficacy|2|||
126391903|NCT03350035|454727802|FG001|Overall Study|Lack of Efficacy|0|||
126391904|NCT03350035|454727803|FG002|Overall Study|Lack of Efficacy|0|||
126391905|NCT03350035|454727801|FG000|Overall Study|Subject discharged to hospice|0|||
126391906|NCT03350035|454727802|FG001|Overall Study|Subject discharged to hospice|0|||
126391907|NCT03350035|454727803|FG002|Overall Study|Subject discharged to hospice|1|||
126391908|NCT03576066|454727804|FG000|Overall Study|Noncompliance with study drug|0|||
126391909|NCT03576066|454727805|FG001|Overall Study|Noncompliance with study drug|1|||
126391910|NCT00006164|454727806|FG000|Overall Study|Withdrew or lost to follow-up|70|||
126391911|NCT00006164|454727807|FG001|Overall Study|Withdrew or lost to follow-up|81|||
126391912|NCT00633074|454727810|FG000|Overall Study|Adverse Event|1|||
126391913|NCT00633074|454727811|FG001|Overall Study|Adverse Event|0|||
126391914|NCT00365105|454727812|FG000|Overall Study|Protocol Violation|5|||
126391915|NCT00365105|454727813|FG001|Overall Study|Protocol Violation|8|||
126391916|NCT00608023|454727814|FG000|Overall Study|Withdrawal by Subject|8|||
126391917|NCT00608023|454727815|FG001|Overall Study|Withdrawal by Subject|10|||
126391918|NCT00608023|454727816|FG002|Overall Study|Withdrawal by Subject|7|||
126391919|NCT00608023|454727814|FG000|Overall Study|Adverse Event|1|||
126391920|NCT00608023|454727815|FG001|Overall Study|Adverse Event|4|||
126391921|NCT00608023|454727816|FG002|Overall Study|Adverse Event|5|||
126391922|NCT00608023|454727814|FG000|Overall Study|Lost to Follow-up|2|||
126391923|NCT00608023|454727815|FG001|Overall Study|Lost to Follow-up|2|||
126391924|NCT00608023|454727816|FG002|Overall Study|Lost to Follow-up|1|||
126391925|NCT00608023|454727814|FG000|Overall Study|Protocol Violation|1|||
126391926|NCT00608023|454727815|FG001|Overall Study|Protocol Violation|3|||
125887891|NCT03682770|452886600|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125887892|NCT03682770|452886601|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125887893|NCT03682770|452886602|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
125887894|NCT03682770|452886603|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
125887895|NCT03682770|452886604|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125887896|NCT03682770|452886605|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125887897|NCT03682770|452886606|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125887898|NCT03682770|452886600|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125887899|NCT03682770|452886601|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125887900|NCT03682770|452886602|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125887901|NCT03682770|452886603|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
125887902|NCT03682770|452886604|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125887903|NCT03682770|452886605|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125887904|NCT03682770|452886606|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125887905|NCT03682770|452886600|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125887906|NCT03682770|452886601|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125887907|NCT03682770|452886602|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
125887908|NCT03682770|452886603|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
125887909|NCT03682770|452886604|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125887910|NCT03682770|452886605|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125887911|NCT03682770|452886606|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125887912|NCT03682770|452886600|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125887913|NCT03682770|452886601|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125887914|NCT03682770|452886602|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
125887915|NCT03682770|452886603|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125887916|NCT03682770|452886604|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125887917|NCT03682770|452886605|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125887918|NCT03682770|452886606|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125887919|NCT03682770|452886600|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125887920|NCT03682770|452886601|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125887921|NCT03682770|452886602|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
125887922|NCT03682770|452886603|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125887923|NCT03682770|452886604|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125887924|NCT03682770|452886605|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125887925|NCT03682770|452886606|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125887926|NCT03682770|452886600|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125887927|NCT03682770|452886601|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125887928|NCT03682770|452886602|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125887929|NCT03682770|452886603|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
125887930|NCT03682770|452886604|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125887931|NCT03682770|452886605|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125887932|NCT03682770|452886606|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125887933|NCT03682770|452886600|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125887934|NCT03682770|452886601|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125887935|NCT03682770|452886602|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125887936|NCT03682770|452886603|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125887937|NCT03682770|452886604|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
125887938|NCT03682770|452886605|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
125887939|NCT03682770|452886606|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
125887940|NCT03682770|452886600|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125887941|NCT03682770|452886601|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125887942|NCT03682770|452886602|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125887943|NCT03682770|452886603|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125887944|NCT03682770|452886604|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
125887945|NCT03682770|452886605|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125887946|NCT03682770|452886606|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125887947|NCT03682770|452886600|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125887948|NCT03682770|452886601|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125887949|NCT03682770|452886602|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125887950|NCT03682770|452886603|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
126050001|NCT01753999|453479112|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
126050002|NCT01753999|453479113|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
126391927|NCT00608023|454727816|FG002|Overall Study|Protocol Violation|1|||
126391928|NCT00608023|454727814|FG000|Overall Study|Unknown reason|0|||
126391929|NCT00608023|454727815|FG001|Overall Study|Unknown reason|3|||
126391930|NCT00608023|454727816|FG002|Overall Study|Unknown reason|0|||
126050003|NCT01753999|453479112|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
126050004|NCT01753999|453479113|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
126050005|NCT01753999|453479112|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
126050006|NCT01753999|453479113|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
126050007|NCT02392234|453479114|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
126050008|NCT02392234|453479115|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
126391931|NCT06422364|454727817|FG000|Overall Study|Withdrawn due to study closure|0|||
126391932|NCT06422364|454727818|FG001|Overall Study|Withdrawn due to study closure|2|||
126391933|NCT01681069|454727820|FG000|Overall Study|Withdrawal by Subject|4|||
126050009|NCT02392234|453479116|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
126391934|NCT01681069|454727821|FG001|Overall Study|Withdrawal by Subject|5|||
126391935|NCT01681069|454727820|FG000|Overall Study|Protocol Violation|1|||
126391936|NCT01681069|454727821|FG001|Overall Study|Protocol Violation|1|||
126391937|NCT01681069|454727820|FG000|Overall Study|Adverse Event|0|||
126391938|NCT01681069|454727821|FG001|Overall Study|Adverse Event|1|||
126391939|NCT01463696|454727822|FG000|Overall Study|Adverse Event|0|||
126391940|NCT01463696|454727823|FG001|Overall Study|Adverse Event|1|||
126391941|NCT01463696|454727824|FG002|Overall Study|Adverse Event|0|||
126391942|NCT01463696|454727825|FG003|Overall Study|Adverse Event|2|||
126391943|NCT01463696|454727826|FG004|Overall Study|Adverse Event|0|||
126391944|NCT01463696|454727827|FG005|Overall Study|Adverse Event|1|||
126391945|NCT01463696|454727828|FG006|Overall Study|Adverse Event|3|||
126391946|NCT01463696|454727829|FG007|Overall Study|Adverse Event|2|||
126391947|NCT01463696|454727822|FG000|Overall Study|Lost to Follow-up|0|||
126391948|NCT01463696|454727823|FG001|Overall Study|Lost to Follow-up|0|||
126391949|NCT01463696|454727824|FG002|Overall Study|Lost to Follow-up|1|||
126391950|NCT01463696|454727825|FG003|Overall Study|Lost to Follow-up|0|||
126391951|NCT01463696|454727826|FG004|Overall Study|Lost to Follow-up|0|||
126391952|NCT01463696|454727827|FG005|Overall Study|Lost to Follow-up|0|||
126391953|NCT01463696|454727828|FG006|Overall Study|Lost to Follow-up|0|||
126391954|NCT01463696|454727829|FG007|Overall Study|Lost to Follow-up|0|||
126391955|NCT01463696|454727822|FG000|Overall Study|Progressive Disease|0|||
126391956|NCT01463696|454727823|FG001|Overall Study|Progressive Disease|1|||
126391957|NCT01463696|454727824|FG002|Overall Study|Progressive Disease|0|||
126391958|NCT01463696|454727825|FG003|Overall Study|Progressive Disease|1|||
126391959|NCT01463696|454727826|FG004|Overall Study|Progressive Disease|0|||
126050010|NCT02392234|453479117|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
126104568|NCT00585195|453675923|FG014|Overall Study|Site Terminated by Sponsor|0|||
126391960|NCT01463696|454727827|FG005|Overall Study|Progressive Disease|1|||
126391961|NCT01463696|454727828|FG006|Overall Study|Progressive Disease|4|||
126391962|NCT01463696|454727829|FG007|Overall Study|Progressive Disease|2|||
126391963|NCT01463696|454727822|FG000|Overall Study|Withdrawal by Subject|0|||
126391964|NCT01463696|454727823|FG001|Overall Study|Withdrawal by Subject|0|||
126391965|NCT01463696|454727824|FG002|Overall Study|Withdrawal by Subject|0|||
126391966|NCT01463696|454727825|FG003|Overall Study|Withdrawal by Subject|1|||
126391967|NCT01463696|454727826|FG004|Overall Study|Withdrawal by Subject|1|||
126391968|NCT01463696|454727827|FG005|Overall Study|Withdrawal by Subject|1|||
126391969|NCT01463696|454727828|FG006|Overall Study|Withdrawal by Subject|2|||
126391970|NCT01463696|454727829|FG007|Overall Study|Withdrawal by Subject|0|||
126391971|NCT01463696|454727822|FG000|Overall Study|Not Treated|0|||
126391972|NCT01463696|454727823|FG001|Overall Study|Not Treated|0|||
126391973|NCT01463696|454727824|FG002|Overall Study|Not Treated|0|||
126391974|NCT01463696|454727825|FG003|Overall Study|Not Treated|0|||
126391975|NCT01463696|454727826|FG004|Overall Study|Not Treated|0|||
126391976|NCT01463696|454727827|FG005|Overall Study|Not Treated|0|||
126391977|NCT01463696|454727828|FG006|Overall Study|Not Treated|1|||
126391978|NCT01463696|454727829|FG007|Overall Study|Not Treated|0|||
126391979|NCT03883165|454727831|FG000|Overall Study|Withdrawal by Subject|4|||
126391980|NCT03883165|454727832|FG001|Overall Study|Withdrawal by Subject|3|||
126391981|NCT00245050|454727836|FG000|Overall Study|Adverse Event|3|||
126391982|NCT00245050|454727837|FG001|Overall Study|Adverse Event|2|||
126391983|NCT00425698|454727838|FG000|Overall Study|Adverse Event|3|||
126391984|NCT00425698|454727839|FG001|Overall Study|Adverse Event|1|||
126391985|NCT00425698|454727838|FG000|Overall Study|Withdrawal by Subject|0|||
126391986|NCT00425698|454727839|FG001|Overall Study|Withdrawal by Subject|1|||
126391987|NCT03275246|454727846|FG000|Overall Study|Protocol Violation|5|||
126391988|NCT03275246|454727846|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
126391989|NCT03905265|454727849|FG000|Overall Study|Withdrawal by Subject|1|||
126391990|NCT03905265|454727850|FG001|Overall Study|Withdrawal by Subject|1|||
126391991|NCT03905265|454727851|FG002|Overall Study|Withdrawal by Subject|0|||
126391992|NCT03905265|454727852|FG003|Overall Study|Withdrawal by Subject|0|||
126391993|NCT02516098|454727853|FG000|Period 1|Protocol Violation|1|||
126391994|NCT02516098|454727854|FG001|Period 1|Protocol Violation|0|||
126391995|NCT02516098|454727853|FG000|Washout After Period 1|Adverse Event|0|||
126391996|NCT02516098|454727854|FG001|Washout After Period 1|Adverse Event|1|||
126391997|NCT02516098|454727853|FG000|Period 2|Withdrawal by Subject|0|||
126391998|NCT02516098|454727854|FG001|Period 2|Withdrawal by Subject|1|||
126391999|NCT01973387|454727855|FG000|Overall Study|Adverse Event|14|||
126392000|NCT01973387|454727856|FG001|Overall Study|Adverse Event|4|||
126392001|NCT01973387|454727855|FG000|Overall Study|Withdrawal by Subject|7|||
126392002|NCT01973387|454727856|FG001|Overall Study|Withdrawal by Subject|4|||
126392003|NCT01973387|454727855|FG000|Overall Study|Study terminated by sponsor|63|||
126392004|NCT01973387|454727856|FG001|Overall Study|Study terminated by sponsor|0|||
126392005|NCT01973387|454727855|FG000|Overall Study|Progressive disease or relapse|16|||
126392006|NCT01973387|454727856|FG001|Overall Study|Progressive disease or relapse|5|||
126392007|NCT01973387|454727855|FG000|Overall Study|Death|4|||
126392008|NCT01973387|454727856|FG001|Overall Study|Death|3|||
126392009|NCT01973387|454727855|FG000|Overall Study|Randomized, not treated|2|||
126392010|NCT01973387|454727856|FG001|Overall Study|Randomized, not treated|2|||
126392011|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
126392012|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
126392013|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
126392014|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
126392015|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
126392016|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
126392017|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
126392018|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
126392019|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
126392020|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
126392021|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
126392022|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
126392023|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
126392024|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
126392025|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
126392026|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
126392027|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
126392028|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392029|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392030|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392031|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392032|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392033|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392034|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392035|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392036|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392037|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392038|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392039|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392040|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392041|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
126392042|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
126392043|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
126392044|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
126392045|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
126392046|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
126392047|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
126392048|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
126392049|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
126392050|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
126392051|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
126392052|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
126392053|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
126392054|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
126392055|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
126392056|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
126392057|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
126392058|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
126392059|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
126392060|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
126392061|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
126392062|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
126392063|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
126392064|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
126392065|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
126392066|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
126392067|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
126392068|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
126392069|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
126392070|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
126392071|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
126392072|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
126392073|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
126392074|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
126392075|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392076|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392077|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392078|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392079|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392080|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392081|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392082|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392083|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392084|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392085|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392086|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
126392087|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
126392088|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
126392089|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
126392090|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392091|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392092|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392093|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392094|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392095|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392096|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392097|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392098|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392099|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392100|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392101|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392102|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392103|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392104|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
126392105|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392106|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392107|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392108|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392109|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392110|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392111|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392112|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392113|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392114|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392115|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392116|NCT03831191|454727859|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
126392117|NCT03831191|454727860|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
126392118|NCT03831191|454727861|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
126392119|NCT03831191|454727862|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
126392120|NCT03831191|454727863|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
126392121|NCT03831191|454727864|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
126392122|NCT03831191|454727865|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
126392123|NCT03831191|454727866|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
126392124|NCT03831191|454727867|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
126392125|NCT03831191|454727868|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
126392126|NCT03831191|454727869|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
126392127|NCT03831191|454727870|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
126392128|NCT03831191|454727871|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
126392129|NCT03831191|454727872|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
126392130|NCT03831191|454727873|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
126392131|NCT03831191|454727859|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392132|NCT03831191|454727860|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392133|NCT03831191|454727861|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392134|NCT03831191|454727862|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392135|NCT03831191|454727863|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392136|NCT03831191|454727864|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392137|NCT03831191|454727865|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392138|NCT03831191|454727866|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392139|NCT03831191|454727867|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392140|NCT03831191|454727868|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392141|NCT03831191|454727869|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392142|NCT03831191|454727870|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392143|NCT03831191|454727871|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392144|NCT03831191|454727872|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392145|NCT03831191|454727873|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
126392146|NCT03831191|454727859|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392147|NCT03831191|454727860|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392148|NCT03831191|454727861|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392149|NCT03831191|454727862|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392150|NCT03831191|454727863|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392151|NCT03831191|454727864|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126050011|NCT02392234|453479118|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
126392152|NCT03831191|454727865|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392153|NCT03831191|454727866|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392154|NCT03831191|454727867|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126050012|NCT02392234|453479119|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
126050013|NCT02392234|453479114|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126050014|NCT02392234|453479115|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126392155|NCT03831191|454727868|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392156|NCT03831191|454727869|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392157|NCT03831191|454727870|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392158|NCT03831191|454727871|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392159|NCT03831191|454727872|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392160|NCT03831191|454727873|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
126392161|NCT01562314|454727874|FG000|Overall Study|Adverse Event|10|||
126392162|NCT01562314|454727875|FG001|Overall Study|Adverse Event|5|||
126392163|NCT01562314|454727874|FG000|Overall Study|Met Withdrawal Criteria|3|||
126392164|NCT01562314|454727875|FG001|Overall Study|Met Withdrawal Criteria|2|||
126392165|NCT01562314|454727874|FG000|Overall Study|Withdrawal by Subject|0|||
126392166|NCT01562314|454727875|FG001|Overall Study|Withdrawal by Subject|1|||
126392167|NCT03655054|454727876|FG000|Overall Study|Lost to Follow-up|1|||
126392168|NCT02256384|454727885|FG000|Overall Study|Withdrawal by Subject|12|||
126392169|NCT02256384|454727885|FG000|Overall Study|Equipment not capturing data|2|||
126392170|NCT03703817|454727898|FG000|Overall Study|Not meeting eligibility criteria|7|||
126392171|NCT03703817|454727899|FG001|Overall Study|Not meeting eligibility criteria|4|||
126392172|NCT00349921|454727900|FG000|First Spinal Injection|Physician Decision|1|||
126392173|NCT00349921|454727901|FG001|First Spinal Injection|Physician Decision|0|||
126392174|NCT00349921|454727902|FG002|First Spinal Injection|Physician Decision|0|||
126392175|NCT00349921|454727903|FG003|First Spinal Injection|Physician Decision|0|||
126392176|NCT00349921|454727900|FG000|First Spinal Injection|Adverse Event|0|||
126392177|NCT00349921|454727901|FG001|First Spinal Injection|Adverse Event|0|||
126392178|NCT00349921|454727902|FG002|First Spinal Injection|Adverse Event|1|||
126392179|NCT00349921|454727903|FG003|First Spinal Injection|Adverse Event|0|||
126392180|NCT00157196|454727904|FG000|Overall Study|Ongoing at data cut-off|9|||
126392181|NCT02524275|454727905|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
126392182|NCT00778258|454727906|FG000|Overall Study|Adverse Event|1|||
126392183|NCT00778258|454727907|FG001|Overall Study|Adverse Event|0|||
126392184|NCT00778258|454727908|FG002|Overall Study|Adverse Event|0|||
126392185|NCT00778258|454727909|FG003|Overall Study|Adverse Event|0|||
126392186|NCT00778258|454727910|FG004|Overall Study|Adverse Event|0|||
126392187|NCT00778258|454727911|FG005|Overall Study|Adverse Event|1|||
126392188|NCT00778258|454727912|FG006|Overall Study|Adverse Event|0|||
126392189|NCT00778258|454727913|FG007|Overall Study|Adverse Event|0|||
126392190|NCT00778258|454727914|FG008|Overall Study|Adverse Event|0|||
126392191|NCT00778258|454727906|FG000|Overall Study|Lost to Follow-up|0|||
126392192|NCT00778258|454727907|FG001|Overall Study|Lost to Follow-up|0|||
126392193|NCT00778258|454727908|FG002|Overall Study|Lost to Follow-up|2|||
126392194|NCT00778258|454727909|FG003|Overall Study|Lost to Follow-up|0|||
126392195|NCT00778258|454727910|FG004|Overall Study|Lost to Follow-up|0|||
126392196|NCT00778258|454727911|FG005|Overall Study|Lost to Follow-up|3|||
126392197|NCT00778258|454727912|FG006|Overall Study|Lost to Follow-up|2|||
125887951|NCT03682770|452886604|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125887952|NCT03682770|452886605|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
125887953|NCT03682770|452886606|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
126050015|NCT02392234|453479116|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126392198|NCT00778258|454727913|FG007|Overall Study|Lost to Follow-up|2|||
126392199|NCT00778258|454727914|FG008|Overall Study|Lost to Follow-up|0|||
126392200|NCT00778258|454727906|FG000|Overall Study|Withdrawal by Subject|6|||
126392201|NCT00778258|454727907|FG001|Overall Study|Withdrawal by Subject|2|||
126392202|NCT00778258|454727908|FG002|Overall Study|Withdrawal by Subject|8|||
126392203|NCT00778258|454727909|FG003|Overall Study|Withdrawal by Subject|2|||
126392204|NCT00778258|454727910|FG004|Overall Study|Withdrawal by Subject|0|||
126392205|NCT00778258|454727911|FG005|Overall Study|Withdrawal by Subject|6|||
126392206|NCT00778258|454727912|FG006|Overall Study|Withdrawal by Subject|12|||
126392207|NCT00778258|454727913|FG007|Overall Study|Withdrawal by Subject|12|||
126392208|NCT00778258|454727914|FG008|Overall Study|Withdrawal by Subject|4|||
126392209|NCT00778258|454727906|FG000|Overall Study|New Contraindication|0|||
126392210|NCT00778258|454727907|FG001|Overall Study|New Contraindication|0|||
126392211|NCT00778258|454727908|FG002|Overall Study|New Contraindication|0|||
126392212|NCT00778258|454727909|FG003|Overall Study|New Contraindication|0|||
126392213|NCT00778258|454727910|FG004|Overall Study|New Contraindication|0|||
126392214|NCT00778258|454727911|FG005|Overall Study|New Contraindication|0|||
126392215|NCT00778258|454727912|FG006|Overall Study|New Contraindication|0|||
126392216|NCT00778258|454727913|FG007|Overall Study|New Contraindication|1|||
126392217|NCT00778258|454727914|FG008|Overall Study|New Contraindication|0|||
126392218|NCT00778258|454727906|FG000|Overall Study|Non-compliance|0|||
126392219|NCT00778258|454727907|FG001|Overall Study|Non-compliance|0|||
126392220|NCT00778258|454727908|FG002|Overall Study|Non-compliance|0|||
126392221|NCT00778258|454727909|FG003|Overall Study|Non-compliance|1|||
126392222|NCT00778258|454727910|FG004|Overall Study|Non-compliance|0|||
126392223|NCT00778258|454727911|FG005|Overall Study|Non-compliance|0|||
126392224|NCT00778258|454727912|FG006|Overall Study|Non-compliance|0|||
126392225|NCT00778258|454727913|FG007|Overall Study|Non-compliance|0|||
126392226|NCT00778258|454727914|FG008|Overall Study|Non-compliance|0|||
126392227|NCT00778258|454727906|FG000|Overall Study|Other|0|||
126392228|NCT00778258|454727907|FG001|Overall Study|Other|0|||
126392229|NCT00778258|454727908|FG002|Overall Study|Other|0|||
126392230|NCT00778258|454727909|FG003|Overall Study|Other|0|||
126392231|NCT00778258|454727910|FG004|Overall Study|Other|0|||
126392232|NCT00778258|454727911|FG005|Overall Study|Other|0|||
126392233|NCT00778258|454727912|FG006|Overall Study|Other|1|||
126392234|NCT00778258|454727913|FG007|Overall Study|Other|0|||
126392235|NCT00778258|454727914|FG008|Overall Study|Other|0|||
126392236|NCT00780143|454727923|FG000|Overall Study|Progressive disease|1|||
126392237|NCT00780143|454727923|FG000|Overall Study|Toxicity|1|||
126392238|NCT00780143|454727923|FG000|Overall Study|Adverse Event|1|||
126392239|NCT00082368|454727926|FG000|Overall Study|Not treated-pt had poor IV access|1|||
125887954|NCT03682770|452886600|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125887955|NCT03682770|452886601|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125887956|NCT03682770|452886602|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
126392240|NCT01331837|454727929|FG000|Overall Study|Death|30|||
126392241|NCT01331837|454727930|FG001|Overall Study|Death|34|||
126392242|NCT01331837|454727929|FG000|Overall Study|Lost to Follow-up|3|||
126392243|NCT01331837|454727930|FG001|Overall Study|Lost to Follow-up|1|||
126392244|NCT01331837|454727929|FG000|Overall Study|Info not recorded|10|||
126392245|NCT01331837|454727930|FG001|Overall Study|Info not recorded|16|||
126392246|NCT01331837|454727929|FG000|Overall Study|Withdrawal by Subject|13|||
126392247|NCT01331837|454727930|FG001|Overall Study|Withdrawal by Subject|16|||
126392248|NCT01380535|454729904|FG000|Overall Study|Adverse Event|3|||
126392249|NCT01380535|454729905|FG001|Overall Study|Adverse Event|3|||
126392250|NCT01380535|454729904|FG000|Overall Study|Death|3|||
126392251|NCT01380535|454729905|FG001|Overall Study|Death|0|||
126392252|NCT01380535|454729904|FG000|Overall Study|Study site closed|0|||
126392253|NCT01380535|454729905|FG001|Overall Study|Study site closed|5|||
126392254|NCT01380535|454729904|FG000|Overall Study|Withdrawal by Subject|1|||
126392255|NCT01380535|454729905|FG001|Overall Study|Withdrawal by Subject|2|||
126392256|NCT01380535|454729904|FG000|Overall Study|Protocol Violation|0|||
126392257|NCT01380535|454729905|FG001|Overall Study|Protocol Violation|2|||
126392258|NCT01380535|454729904|FG000|Overall Study|Lack of Efficacy|0|||
126392259|NCT01380535|454729905|FG001|Overall Study|Lack of Efficacy|3|||
126392260|NCT00882583|454729906|FG000|Overall Study|Physician Decision|1|||
126392261|NCT00882583|454729907|FG001|Overall Study|Physician Decision|0|||
126392262|NCT00882583|454729906|FG000|Overall Study|Adverse Event|0|||
126392263|NCT00882583|454729907|FG001|Overall Study|Adverse Event|1|||
126392264|NCT04753658|454729908|FG000|Overall Study|Progressive disease|7|||
126392265|NCT04753658|454729908|FG000|Overall Study|Other|7|||
126392266|NCT04753658|454729908|FG000|Overall Study|Adverse Event|1|||
126392267|NCT00218634|454729909|FG000|Overall Study|Lost to Follow-up|8|||
126392268|NCT00218634|454729910|FG001|Overall Study|Lost to Follow-up|15|||
126392269|NCT05243745|454729911|FG000|Overall Study|Withdrawal by Subject|0|||
126392270|NCT05243745|454729912|FG001|Overall Study|Withdrawal by Subject|0|||
126392271|NCT05243745|454729913|FG002|Overall Study|Withdrawal by Subject|0|||
126392272|NCT05243745|454729914|FG003|Overall Study|Withdrawal by Subject|1|||
126392273|NCT05243745|454729911|FG000|Overall Study|Unable to Attend Visit 6|0|||
126392274|NCT05243745|454729912|FG001|Overall Study|Unable to Attend Visit 6|0|||
126392275|NCT05243745|454729913|FG002|Overall Study|Unable to Attend Visit 6|1|||
126392276|NCT05243745|454729914|FG003|Overall Study|Unable to Attend Visit 6|0|||
126050016|NCT02392234|453479117|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126050017|NCT02392234|453479118|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
126050018|NCT02392234|453479119|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126050019|NCT02392234|453479114|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126050020|NCT02392234|453479115|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126050021|NCT02392234|453479116|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126050022|NCT02392234|453479117|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126050023|NCT02392234|453479118|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126050024|NCT02392234|453479119|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
126050025|NCT02392234|453479114|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
126104569|NCT00585195|453675924|FG015|Overall Study|Site Terminated by Sponsor|0|||
126104570|NCT00585195|453675925|FG016|Overall Study|Site Terminated by Sponsor|0|||
126104571|NCT00585195|453675926|FG017|Overall Study|Site Terminated by Sponsor|0|||
126104572|NCT00585195|453675927|FG018|Overall Study|Site Terminated by Sponsor|0|||
126104573|NCT00585195|453675928|FG019|Overall Study|Site Terminated by Sponsor|0|||
126104574|NCT00585195|453675929|FG020|Overall Study|Site Terminated by Sponsor|0|||
126104575|NCT00585195|453675909|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
126104576|NCT00585195|453675910|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
126104577|NCT00585195|453675911|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
126104578|NCT00585195|453675912|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
126104579|NCT00585195|453675913|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
126104580|NCT00585195|453675914|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
126104581|NCT00585195|453675915|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
126104582|NCT00585195|453675916|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
126104583|NCT00585195|453675917|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
126104584|NCT00585195|453675918|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
126104585|NCT00585195|453675919|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
126104586|NCT00585195|453675920|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
126104587|NCT00585195|453675921|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
126104588|NCT00585195|453675922|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
126104589|NCT00585195|453675923|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
126104590|NCT00585195|453675924|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
126104591|NCT00585195|453675925|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
126050026|NCT02392234|453479115|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
126050027|NCT02392234|453479116|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
126104592|NCT00585195|453675926|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
126104593|NCT00585195|453675927|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
126104594|NCT00585195|453675928|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
126392277|NCT03842969|454729925|FG000|Overall Study|Participant declined follow-up visit|0|||
126392278|NCT03842969|454729926|FG001|Overall Study|Participant declined follow-up visit|1|||
126392279|NCT03842969|454729927|FG002|Overall Study|Participant declined follow-up visit|0|||
126392280|NCT03842969|454729925|FG000|Overall Study|Sponsor's decision|12|||
126392281|NCT03842969|454729926|FG001|Overall Study|Sponsor's decision|99|||
126392282|NCT03842969|454729927|FG002|Overall Study|Sponsor's decision|61|||
126392283|NCT03842969|454729925|FG000|Overall Study|Pregnancy|0|||
126392284|NCT03842969|454729926|FG001|Overall Study|Pregnancy|0|||
126392285|NCT03842969|454729927|FG002|Overall Study|Pregnancy|1|||
126392286|NCT03842969|454729925|FG000|Overall Study|Death|1|||
126392287|NCT03842969|454729926|FG001|Overall Study|Death|0|||
126392288|NCT03842969|454729927|FG002|Overall Study|Death|1|||
126392289|NCT03842969|454729925|FG000|Overall Study|Withdrawal by Subject|3|||
126392290|NCT03842969|454729926|FG001|Overall Study|Withdrawal by Subject|30|||
126392291|NCT03842969|454729927|FG002|Overall Study|Withdrawal by Subject|18|||
126392292|NCT03842969|454729925|FG000|Overall Study|Protocol Violation|1|||
126392293|NCT03842969|454729926|FG001|Overall Study|Protocol Violation|1|||
126392294|NCT03842969|454729927|FG002|Overall Study|Protocol Violation|0|||
126392295|NCT03842969|454729925|FG000|Overall Study|Physician Decision|0|||
126392296|NCT03842969|454729926|FG001|Overall Study|Physician Decision|3|||
126392297|NCT03842969|454729927|FG002|Overall Study|Physician Decision|0|||
126392298|NCT03842969|454729925|FG000|Overall Study|Lost to Follow-up|0|||
126392299|NCT03842969|454729926|FG001|Overall Study|Lost to Follow-up|2|||
126392300|NCT03842969|454729927|FG002|Overall Study|Lost to Follow-up|0|||
126392301|NCT03842969|454729925|FG000|Overall Study|Adverse Event|0|||
126392302|NCT03842969|454729926|FG001|Overall Study|Adverse Event|2|||
126392303|NCT03842969|454729927|FG002|Overall Study|Adverse Event|0|||
126392304|NCT01044745|454729928|FG000|Overall Study|Ineiligible|2|||
126392305|NCT01159171|454729930|FG000|Overall Study|Adverse Event|11|||
126392306|NCT01159171|454729930|FG000|Overall Study|Progression of Disease|28|||
126392307|NCT01159171|454729930|FG000|Overall Study|Protocol Violation|1|||
126392308|NCT01159171|454729930|FG000|Overall Study|Need for Surgery|5|||
126392309|NCT01159171|454729930|FG000|Overall Study|Medical Decision|4|||
126392310|NCT01159171|454729930|FG000|Overall Study|Death|1|||
126392311|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Adverse Event|76|||
126392312|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Adverse Event|0|||
126392313|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Adverse Event|0|||
126392314|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Death|3|||
126392315|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Death|0|||
126392316|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Death|0|||
126392317|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
126392318|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
126392319|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
126392320|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Physician Decision|9|||
126392321|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Physician Decision|0|||
126392322|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Physician Decision|0|||
126392323|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
126392324|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
126392325|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
126392326|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Disease progression|45|||
126392327|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Disease progression|0|||
126392328|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Disease progression|0|||
126392329|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
126392330|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
126392331|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
126392332|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
126392333|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
126392334|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
126392335|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
126392336|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
126392337|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
126392338|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
126392339|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
126392340|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
126392341|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
126392342|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
126392343|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
126392344|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
126392345|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
126392346|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
126392347|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
126392348|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
126392349|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
126392350|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
126392351|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
126392352|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
126392353|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
126392354|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
126392355|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
126392356|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Promotor request|1|||
126392357|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Promotor request|0|||
126392358|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Promotor request|0|||
126392359|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
126392360|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
126392361|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
126392362|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
126392363|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
126392364|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
126392365|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Death|3|||
126392366|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Death|0|||
126392367|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Death|0|||
126392368|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
126392369|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
126392370|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
126392371|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
126392372|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
126392373|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
126392374|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Diseases progression|91|||
126392375|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Diseases progression|0|||
126392376|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Diseases progression|0|||
126392377|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Adverse Event|70|||
126392378|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Adverse Event|0|||
126392379|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Adverse Event|0|||
126392380|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Physician Decision|9|||
126392381|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Physician Decision|0|||
126392382|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Physician Decision|0|||
126392383|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
126392384|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
126392385|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
126392386|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
126050028|NCT02392234|453479117|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
126392387|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
126392388|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
126392389|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
126392390|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
126392391|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
126392392|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Not compliant|1|||
126392393|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Not compliant|0|||
126392394|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Not compliant|0|||
126392395|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
126392396|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
126392397|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
126392398|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Adverse Event|0|||
126392399|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Adverse Event|2|||
126392400|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Adverse Event|0|||
126392401|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Death|0|||
126392402|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Death|10|||
126392403|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Death|8|||
126392404|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Physician Decision|0|||
126392405|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Physician Decision|0|||
126392406|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Physician Decision|4|||
126392407|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
126392408|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
126392409|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
126392410|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Moved to another town|0|||
126392411|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Moved to another town|1|||
126392412|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Moved to another town|0|||
126392413|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Disease progression|0|||
126392414|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Disease progression|0|||
126392415|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Disease progression|3|||
126392416|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
126392417|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
126392418|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
126392419|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
126392420|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
126392421|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
126392422|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
126392423|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
126392424|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
126392425|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
126392426|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
126392427|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
126392428|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
126392429|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
126392430|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
126392431|NCT01892436|454729936|FG000|Overall Study|Withdrawal by Subject|8|||
126392432|NCT01892436|454729937|FG001|Overall Study|Withdrawal by Subject|15|||
126392433|NCT01892436|454729938|FG002|Overall Study|Withdrawal by Subject|4|||
126392434|NCT01892436|454729939|FG003|Overall Study|Withdrawal by Subject|4|||
126392435|NCT01892436|454729936|FG000|Overall Study|Death|1|||
126392436|NCT01892436|454729937|FG001|Overall Study|Death|1|||
126392437|NCT01892436|454729938|FG002|Overall Study|Death|0|||
126392438|NCT01892436|454729939|FG003|Overall Study|Death|0|||
126392439|NCT01892436|454729936|FG000|Overall Study|Physician Decision|2|||
126392440|NCT01892436|454729937|FG001|Overall Study|Physician Decision|1|||
126392441|NCT01892436|454729938|FG002|Overall Study|Physician Decision|0|||
126392442|NCT01892436|454729939|FG003|Overall Study|Physician Decision|1|||
126392443|NCT01892436|454729936|FG000|Overall Study|Pregnancy|0|||
126392444|NCT01892436|454729937|FG001|Overall Study|Pregnancy|2|||
126392445|NCT01892436|454729938|FG002|Overall Study|Pregnancy|1|||
126392446|NCT01892436|454729939|FG003|Overall Study|Pregnancy|0|||
126392447|NCT01892436|454729936|FG000|Overall Study|Technical problems|2|||
126392448|NCT01892436|454729937|FG001|Overall Study|Technical problems|1|||
126104595|NCT00585195|453675929|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
126392449|NCT01892436|454729938|FG002|Overall Study|Technical problems|1|||
126392450|NCT01892436|454729939|FG003|Overall Study|Technical problems|1|||
126392451|NCT01892436|454729936|FG000|Overall Study|Lack of Efficacy|1|||
126392452|NCT01892436|454729937|FG001|Overall Study|Lack of Efficacy|2|||
126392453|NCT01892436|454729938|FG002|Overall Study|Lack of Efficacy|2|||
126392454|NCT01892436|454729939|FG003|Overall Study|Lack of Efficacy|2|||
126392455|NCT01892436|454729936|FG000|Overall Study|Lost to Follow-up|1|||
126392456|NCT01892436|454729937|FG001|Overall Study|Lost to Follow-up|1|||
126392457|NCT01892436|454729938|FG002|Overall Study|Lost to Follow-up|1|||
126392458|NCT01892436|454729939|FG003|Overall Study|Lost to Follow-up|3|||
126392459|NCT01892436|454729936|FG000|Overall Study|non-compliance with treatment|1|||
126104596|NCT02796560|453675930|FG000|Overall Study|Adverse Event|2|||
126392460|NCT01892436|454729937|FG001|Overall Study|non-compliance with treatment|0|||
126392461|NCT01892436|454729938|FG002|Overall Study|non-compliance with treatment|0|||
126392462|NCT01892436|454729939|FG003|Overall Study|non-compliance with treatment|0|||
126392463|NCT01892436|454729936|FG000|Overall Study|Adverse Event|7|||
126392464|NCT01892436|454729937|FG001|Overall Study|Adverse Event|6|||
126392465|NCT01892436|454729938|FG002|Overall Study|Adverse Event|2|||
126392466|NCT01892436|454729939|FG003|Overall Study|Adverse Event|3|||
126392467|NCT00733291|454729947|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
126050029|NCT02392234|453479118|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
126050030|NCT02392234|453479119|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
126050031|NCT02392234|453479114|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126050032|NCT02392234|453479115|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126050033|NCT02392234|453479116|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126050034|NCT02392234|453479117|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126392468|NCT00733291|454729948|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
126392469|NCT00733291|454729949|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
126392470|NCT00733291|454729950|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
126392471|NCT02242435|454729955|FG000|Overall Study|Lost to Follow-up|3|||
126392472|NCT02242435|454729956|FG001|Overall Study|Lost to Follow-up|4|||
126392473|NCT02242435|454729955|FG000|Overall Study|Adverse Event|3|||
126392474|NCT02242435|454729956|FG001|Overall Study|Adverse Event|2|||
126392475|NCT02242435|454729955|FG000|Overall Study|Withdrawal by Subject|13|||
126392476|NCT02242435|454729956|FG001|Overall Study|Withdrawal by Subject|8|||
126392477|NCT02242435|454729955|FG000|Overall Study|Death|0|||
126392478|NCT02242435|454729956|FG001|Overall Study|Death|1|||
126392479|NCT02242435|454729955|FG000|Overall Study|Protocol Violation|1|||
126392480|NCT02242435|454729956|FG001|Overall Study|Protocol Violation|0|||
126392481|NCT02242435|454729955|FG000|Overall Study|Physician Decision|0|||
126392482|NCT02242435|454729956|FG001|Overall Study|Physician Decision|1|||
126392483|NCT03895086|454729958|FG000|Overall Study|Early termination study|1|||
126392484|NCT03895086|454729959|FG001|Overall Study|Early termination study|0|||
126392485|NCT01089413|454729963|FG000|Overall Study|Lost to Follow-up|1|||
126392486|NCT01089413|454729963|FG000|Overall Study|Progressive Disease|93|||
126392487|NCT01089413|454729963|FG000|Overall Study|Participant Withdrew Consent|1|||
126392488|NCT01089413|454729963|FG000|Overall Study|Unacceptable Toxicity|12|||
126392489|NCT01089413|454729963|FG000|Overall Study|Death|10|||
126392490|NCT01089413|454729963|FG000|Overall Study|Metastasectomy|13|||
126392491|NCT01089413|454729963|FG000|Overall Study|Other|71|||
126392492|NCT00420004|454729974|FG000|Overall Study|Adverse Event|4|||
126392493|NCT00420004|454729975|FG001|Overall Study|Adverse Event|1|||
126392494|NCT00420004|454729976|FG002|Overall Study|Adverse Event|1|||
126392495|NCT00420004|454729974|FG000|Overall Study|Lack of Efficacy|5|||
126392496|NCT00420004|454729975|FG001|Overall Study|Lack of Efficacy|4|||
126392497|NCT00420004|454729976|FG002|Overall Study|Lack of Efficacy|1|||
126392498|NCT00420004|454729974|FG000|Overall Study|Lost to Follow-up|31|||
126392499|NCT00420004|454729975|FG001|Overall Study|Lost to Follow-up|12|||
126392500|NCT00420004|454729976|FG002|Overall Study|Lost to Follow-up|10|||
126392501|NCT00420004|454729974|FG000|Overall Study|Entry Criteria Not Met|0|||
126392502|NCT00420004|454729975|FG001|Overall Study|Entry Criteria Not Met|1|||
126392503|NCT00420004|454729976|FG002|Overall Study|Entry Criteria Not Met|0|||
126392504|NCT00420004|454729974|FG000|Overall Study|Physician Decision|14|||
126392505|NCT00420004|454729975|FG001|Overall Study|Physician Decision|4|||
126392506|NCT00420004|454729976|FG002|Overall Study|Physician Decision|2|||
126392507|NCT00420004|454729974|FG000|Overall Study|Protocol Violation|5|||
126392508|NCT00420004|454729975|FG001|Overall Study|Protocol Violation|4|||
126392509|NCT00420004|454729976|FG002|Overall Study|Protocol Violation|3|||
126392510|NCT00420004|454729974|FG000|Overall Study|Withdrawal by Subject|67|||
126392511|NCT00420004|454729975|FG001|Overall Study|Withdrawal by Subject|42|||
126392512|NCT00420004|454729976|FG002|Overall Study|Withdrawal by Subject|14|||
126392513|NCT00420004|454729974|FG000|Overall Study|Sponsor Decision|3|||
126392514|NCT00420004|454729975|FG001|Overall Study|Sponsor Decision|3|||
126392515|NCT00420004|454729976|FG002|Overall Study|Sponsor Decision|1|||
126392516|NCT02379221|454729977|FG000|Overall Study|Lost to Follow-up|1|||
126392517|NCT01610557|454729978|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
126392518|NCT01610557|454729979|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
126392519|NCT01610557|454729980|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
126392520|NCT01610557|454729981|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
126392521|NCT01610557|454729982|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
126392522|NCT01610557|454729978|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
126392523|NCT01610557|454729979|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
126392524|NCT01610557|454729980|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
126392525|NCT01610557|454729981|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
126392526|NCT01610557|454729982|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
126050035|NCT02392234|453479118|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126050036|NCT02392234|453479119|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
126392527|NCT00519376|454729983|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392528|NCT00519376|454729984|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392529|NCT00519376|454729985|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392530|NCT00519376|454729986|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392531|NCT00519376|454729987|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392532|NCT00519376|454729988|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392533|NCT00519376|454729989|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392534|NCT00519376|454729990|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392535|NCT00519376|454729991|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392536|NCT00519376|454729992|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392537|NCT00519376|454729993|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392538|NCT00519376|454729994|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392539|NCT00519376|454729995|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
126392540|NCT00519376|454729996|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392541|NCT00519376|454729997|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392542|NCT00519376|454729998|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392543|NCT00519376|454729983|FG000|Treatment Period 4|Lost to Follow-up|0|||
126392544|NCT00519376|454729984|FG001|Treatment Period 4|Lost to Follow-up|0|||
126392545|NCT00519376|454729985|FG002|Treatment Period 4|Lost to Follow-up|1|||
126392546|NCT00519376|454729986|FG003|Treatment Period 4|Lost to Follow-up|0|||
126392547|NCT00519376|454729987|FG004|Treatment Period 4|Lost to Follow-up|0|||
126392548|NCT00519376|454729988|FG005|Treatment Period 4|Lost to Follow-up|0|||
126392549|NCT00519376|454729989|FG006|Treatment Period 4|Lost to Follow-up|0|||
126392550|NCT00519376|454729990|FG007|Treatment Period 4|Lost to Follow-up|0|||
126392551|NCT00519376|454729991|FG008|Treatment Period 4|Lost to Follow-up|0|||
126050037|NCT02392234|453479114|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
126050038|NCT02392234|453479115|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
126050039|NCT02392234|453479116|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
126050040|NCT02392234|453479117|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
126050041|NCT02392234|453479118|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
126050042|NCT02392234|453479119|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
126050043|NCT02392234|453479114|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
126050044|NCT02392234|453479115|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
126050045|NCT02392234|453479116|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
126050046|NCT02392234|453479117|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
126050047|NCT02392234|453479118|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
126392552|NCT00519376|454729992|FG009|Treatment Period 4|Lost to Follow-up|0|||
126392553|NCT00519376|454729993|FG010|Treatment Period 4|Lost to Follow-up|0|||
126050048|NCT02392234|453479119|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
126050049|NCT02392234|453479114|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
126392554|NCT00519376|454729994|FG011|Treatment Period 4|Lost to Follow-up|0|||
126392555|NCT00519376|454729995|FG012|Treatment Period 4|Lost to Follow-up|0|||
126392556|NCT00519376|454729996|FG013|Treatment Period 4|Lost to Follow-up|0|||
126392557|NCT00519376|454729997|FG014|Treatment Period 4|Lost to Follow-up|0|||
126392558|NCT00519376|454729998|FG015|Treatment Period 4|Lost to Follow-up|0|||
126392559|NCT02039219|454730001|FG000|Treatment|Withdrawal by Subject|1|||
126392560|NCT02039219|454730002|FG001|Treatment|Withdrawal by Subject|0|||
126392561|NCT02039219|454730001|FG000|Treatment|Adverse Event|0|||
126392562|NCT02039219|454730002|FG001|Treatment|Adverse Event|1|||
126392563|NCT02039219|454730001|FG000|Treatment|Physician Decision|1|||
126392564|NCT02039219|454730002|FG001|Treatment|Physician Decision|0|||
126392565|NCT02039219|454730001|FG000|Treatment|Lost to Follow-up|0|||
126392566|NCT02039219|454730002|FG001|Treatment|Lost to Follow-up|1|||
126392567|NCT02039219|454730001|FG000|Treatment|Protocol Violation|1|||
126392568|NCT02039219|454730002|FG001|Treatment|Protocol Violation|0|||
126392569|NCT02039219|454730001|FG000|Treatment|Death|1|||
126392570|NCT02039219|454730002|FG001|Treatment|Death|0|||
126392571|NCT02039219|454730001|FG000|Follow up|Adverse Event|0|||
126392572|NCT02039219|454730002|FG001|Follow up|Adverse Event|1|||
126392573|NCT02974855|454730003|FG000|Overall Study|Adverse Event|0|||
126392574|NCT02974855|454730004|FG001|Overall Study|Adverse Event|1|||
126392575|NCT02974855|454730005|FG002|Overall Study|Adverse Event|0|||
126392576|NCT02974855|454730006|FG003|Overall Study|Adverse Event|1|||
126392577|NCT00129701|454730007|FG000|Overall Study|Withdrawal by Subject|33|||
126392578|NCT02750345|454730008|FG000|Intervention 1|Adverse Event|0|||
126392579|NCT02750345|454730009|FG001|Intervention 1|Adverse Event|0|||
126392580|NCT02750345|454730010|FG002|Intervention 1|Adverse Event|0|||
126392581|NCT02750345|454730011|FG003|Intervention 1|Adverse Event|0|||
126392582|NCT02750345|454730012|FG004|Intervention 1|Adverse Event|1|||
126392583|NCT02750345|454730013|FG005|Intervention 1|Adverse Event|0|||
126392584|NCT02650128|454730014|FG000|Overall Study|Death|2|||
126392585|NCT01801436|454730035|FG000|Overall Study|Withdrawal by Subject|3|||
126392586|NCT01801436|454730035|FG000|Overall Study|Adverse Event|2|||
126392587|NCT01801436|454730035|FG000|Overall Study|Progressive disease|4|||
126392588|NCT01126437|454730040|FG000|Overall Study|Not treated|11|||
126392589|NCT01126437|454730041|FG001|Overall Study|Not treated|18|||
126392590|NCT01126437|454730042|FG002|Overall Study|Not treated|19|||
126392591|NCT01126437|454730040|FG000|Overall Study|Sites with data irregularities/fraud|6|||
126392592|NCT01126437|454730041|FG001|Overall Study|Sites with data irregularities/fraud|6|||
126392593|NCT01126437|454730042|FG002|Overall Study|Sites with data irregularities/fraud|7|||
126392594|NCT01126437|454730040|FG000|Overall Study|Adverse Event|602|||
126392595|NCT01126437|454730041|FG001|Overall Study|Adverse Event|606|||
126392596|NCT01126437|454730042|FG002|Overall Study|Adverse Event|635|||
126392597|NCT01126437|454730040|FG000|Overall Study|Lack of Efficacy|65|||
126392598|NCT01126437|454730041|FG001|Overall Study|Lack of Efficacy|60|||
126392599|NCT01126437|454730042|FG002|Overall Study|Lack of Efficacy|59|||
126392600|NCT01126437|454730040|FG000|Overall Study|Protocol Violation|64|||
126392601|NCT01126437|454730041|FG001|Overall Study|Protocol Violation|66|||
126392602|NCT01126437|454730042|FG002|Overall Study|Protocol Violation|41|||
126392603|NCT01126437|454730040|FG000|Overall Study|Lost to Follow-up|52|||
126392604|NCT01126437|454730041|FG001|Overall Study|Lost to Follow-up|63|||
126392605|NCT01126437|454730042|FG002|Overall Study|Lost to Follow-up|55|||
126392606|NCT01126437|454730040|FG000|Overall Study|Withdrawal by Subject|331|||
126392607|NCT01126437|454730041|FG001|Overall Study|Withdrawal by Subject|335|||
126392608|NCT01126437|454730042|FG002|Overall Study|Withdrawal by Subject|319|||
126392609|NCT01126437|454730040|FG000|Overall Study|Other reason not specified|210|||
126392610|NCT01126437|454730041|FG001|Overall Study|Other reason not specified|176|||
126392611|NCT01126437|454730042|FG002|Overall Study|Other reason not specified|178|||
126392612|NCT01846663|454730053|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
126392613|NCT01846663|454730054|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
126392614|NCT01846663|454730053|FG000|Overall Study|Withdrawal by Subject|1|||
126392615|NCT01846663|454730054|FG001|Overall Study|Withdrawal by Subject|0|||
126392616|NCT01846663|454730053|FG000|Overall Study|Adverse Event|1|||
126392617|NCT01846663|454730054|FG001|Overall Study|Adverse Event|2|||
126392618|NCT02851797|454730060|FG000|Overall Study|Withdrawal by Subject|4|||
126392619|NCT02851797|454730061|FG001|Overall Study|Withdrawal by Subject|2|||
126392620|NCT02851797|454730060|FG000|Overall Study|Adverse Event|3|||
126392621|NCT02851797|454730061|FG001|Overall Study|Adverse Event|0|||
126392622|NCT00813865|454730062|FG000|Overall Study|Failure to Respond|3|||
126392623|NCT00813865|454730062|FG000|Overall Study|Lost to Follow-up|3|||
126392624|NCT00813865|454730062|FG000|Overall Study|Withdrawal by Subject|1|||
126392625|NCT04295681|454730063|FG000|Overall Study|Eligibility error|1|||
126392626|NCT04295681|454730064|FG001|Overall Study|Eligibility error|3|||
126392627|NCT02135029|454730073|FG000|Overall Study|Adverse Event|2|||
126392628|NCT02135029|454730074|FG001|Overall Study|Adverse Event|2|||
126392629|NCT02135029|454730075|FG002|Overall Study|Adverse Event|2|||
126392630|NCT02135029|454730073|FG000|Overall Study|Lost to Follow-up|0|||
126392631|NCT02135029|454730074|FG001|Overall Study|Lost to Follow-up|1|||
126392632|NCT02135029|454730075|FG002|Overall Study|Lost to Follow-up|0|||
126392633|NCT02135029|454730073|FG000|Overall Study|Withdrawal by Subject|2|||
126392634|NCT02135029|454730074|FG001|Overall Study|Withdrawal by Subject|0|||
126392635|NCT02135029|454730075|FG002|Overall Study|Withdrawal by Subject|1|||
126392636|NCT02135029|454730073|FG000|Overall Study|Other|0|||
126392637|NCT02135029|454730074|FG001|Overall Study|Other|1|||
126392638|NCT02135029|454730075|FG002|Overall Study|Other|0|||
126392639|NCT02135029|454730073|FG000|Overall Study|Death|0|||
126392640|NCT02135029|454730074|FG001|Overall Study|Death|1|||
126392641|NCT02135029|454730075|FG002|Overall Study|Death|0|||
126392642|NCT03525600|454730076|FG000|Overall Study|Adverse Event|9|||
126392643|NCT03525600|454730077|FG001|Overall Study|Adverse Event|6|||
126392644|NCT03525600|454730078|FG002|Overall Study|Adverse Event|5|||
126392645|NCT03525600|454730079|FG003|Overall Study|Adverse Event|3|||
126392646|NCT03525600|454730076|FG000|Overall Study|Lost to Follow-up|2|||
126392647|NCT03525600|454730077|FG001|Overall Study|Lost to Follow-up|4|||
126392648|NCT03525600|454730078|FG002|Overall Study|Lost to Follow-up|4|||
126392649|NCT03525600|454730079|FG003|Overall Study|Lost to Follow-up|0|||
126392650|NCT03525600|454730076|FG000|Overall Study|Physician Decision|1|||
126392651|NCT03525600|454730077|FG001|Overall Study|Physician Decision|0|||
126392652|NCT03525600|454730078|FG002|Overall Study|Physician Decision|2|||
126392653|NCT03525600|454730079|FG003|Overall Study|Physician Decision|0|||
126392654|NCT03525600|454730076|FG000|Overall Study|Consent withdrawal|36|||
126392655|NCT03525600|454730077|FG001|Overall Study|Consent withdrawal|20|||
126392656|NCT03525600|454730078|FG002|Overall Study|Consent withdrawal|6|||
126392657|NCT03525600|454730079|FG003|Overall Study|Consent withdrawal|13|||
126392658|NCT03525600|454730076|FG000|Overall Study|Death|7|||
126392659|NCT03525600|454730077|FG001|Overall Study|Death|6|||
126392660|NCT03525600|454730078|FG002|Overall Study|Death|4|||
126392661|NCT03525600|454730079|FG003|Overall Study|Death|3|||
126392662|NCT03525600|454730076|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
126392663|NCT03525600|454730077|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
126392664|NCT03525600|454730078|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
126392665|NCT03525600|454730079|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
126392666|NCT03525600|454730076|FG000|Overall Study|Other|0|||
126392667|NCT03525600|454730077|FG001|Overall Study|Other|1|||
126392668|NCT03525600|454730078|FG002|Overall Study|Other|0|||
126392669|NCT03525600|454730079|FG003|Overall Study|Other|0|||
126392670|NCT03255967|454730082|FG000|Overall Study|Adverse Event|26|||
126392671|NCT03255967|454730083|FG001|Overall Study|Adverse Event|30|||
126392672|NCT03255967|454730082|FG000|Overall Study|Withdrawal by Subject|6|||
126392673|NCT03255967|454730083|FG001|Overall Study|Withdrawal by Subject|6|||
126392674|NCT03255967|454730082|FG000|Overall Study|Schedule conflict|6|||
126392675|NCT03255967|454730083|FG001|Overall Study|Schedule conflict|4|||
126392676|NCT03255967|454730082|FG000|Overall Study|POA did not sign consent form|2|||
126392677|NCT03255967|454730083|FG001|Overall Study|POA did not sign consent form|0|||
126392678|NCT01202188|454730084|FG000|Overall Study|Protocol deviation|14|||
126392679|NCT01202188|454730085|FG001|Overall Study|Protocol deviation|8|||
126392680|NCT01202188|454730086|FG002|Overall Study|Protocol deviation|12|||
126392681|NCT01202188|454730087|FG003|Overall Study|Protocol deviation|10|||
126392682|NCT01202188|454730088|FG004|Overall Study|Protocol deviation|11|||
126392683|NCT01202188|454730084|FG000|Overall Study|Subject withdrew consent|12|||
126392684|NCT01202188|454730085|FG001|Overall Study|Subject withdrew consent|13|||
126392685|NCT01202188|454730086|FG002|Overall Study|Subject withdrew consent|22|||
126392686|NCT01202188|454730087|FG003|Overall Study|Subject withdrew consent|11|||
126392687|NCT01202188|454730088|FG004|Overall Study|Subject withdrew consent|13|||
126392688|NCT01202188|454730084|FG000|Overall Study|Adverse Event|5|||
126392689|NCT01202188|454730085|FG001|Overall Study|Adverse Event|23|||
126392690|NCT01202188|454730086|FG002|Overall Study|Adverse Event|13|||
126392691|NCT01202188|454730087|FG003|Overall Study|Adverse Event|10|||
126392692|NCT01202188|454730088|FG004|Overall Study|Adverse Event|10|||
126392693|NCT01202188|454730084|FG000|Overall Study|Administrative problems|3|||
126392694|NCT01202188|454730085|FG001|Overall Study|Administrative problems|2|||
126392695|NCT01202188|454730086|FG002|Overall Study|Administrative problems|1|||
126392696|NCT01202188|454730087|FG003|Overall Study|Administrative problems|1|||
126392697|NCT01202188|454730088|FG004|Overall Study|Administrative problems|2|||
126392698|NCT01202188|454730084|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126392699|NCT01202188|454730085|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126392700|NCT01202188|454730086|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126392701|NCT01202188|454730087|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
126392702|NCT01202188|454730088|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
126392703|NCT01202188|454730084|FG000|Overall Study|Lost to Follow-up|1|||
126392704|NCT01202188|454730085|FG001|Overall Study|Lost to Follow-up|1|||
126392705|NCT01202188|454730086|FG002|Overall Study|Lost to Follow-up|0|||
126392706|NCT01202188|454730087|FG003|Overall Study|Lost to Follow-up|4|||
126392707|NCT01202188|454730088|FG004|Overall Study|Lost to Follow-up|1|||
126392708|NCT01202188|454730084|FG000|Overall Study|Death|1|||
126392709|NCT01202188|454730085|FG001|Overall Study|Death|1|||
126392710|NCT01202188|454730086|FG002|Overall Study|Death|1|||
126392711|NCT01202188|454730087|FG003|Overall Study|Death|1|||
126392712|NCT01202188|454730088|FG004|Overall Study|Death|0|||
126392713|NCT01202188|454730084|FG000|Overall Study|Abnormal test procedure result (s)|0|||
126392714|NCT01202188|454730085|FG001|Overall Study|Abnormal test procedure result (s)|0|||
126392715|NCT01202188|454730086|FG002|Overall Study|Abnormal test procedure result (s)|2|||
126104597|NCT02796560|453675931|FG001|Overall Study|Adverse Event|0|||
126392716|NCT01202188|454730087|FG003|Overall Study|Abnormal test procedure result (s)|0|||
126392717|NCT01202188|454730088|FG004|Overall Study|Abnormal test procedure result (s)|0|||
126392718|NCT02438384|454730090|FG000|Overall Study|Lost to Follow-up|8|||
126392719|NCT02438384|454730091|FG001|Overall Study|Lost to Follow-up|6|||
126392720|NCT02438384|454730092|FG002|Overall Study|Lost to Follow-up|4|||
126392721|NCT03319953|454730093|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
126392722|NCT03319953|454730094|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
126392723|NCT03319953|454730095|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
126392724|NCT03319953|454730096|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
126392725|NCT03319953|454730093|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
126392726|NCT03319953|454730094|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
126392727|NCT03319953|454730095|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
126392728|NCT03319953|454730096|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
126392729|NCT01795495|454730097|FG000|Overall Study|Protocol Violation|1|||
126392730|NCT01795495|454730098|FG001|Overall Study|Protocol Violation|0|||
126392731|NCT01795495|454730099|FG002|Overall Study|Protocol Violation|1|||
126392732|NCT01795495|454730097|FG000|Overall Study|Physician Decision|0|||
126392733|NCT01795495|454730098|FG001|Overall Study|Physician Decision|0|||
126392734|NCT01795495|454730099|FG002|Overall Study|Physician Decision|1|||
126392735|NCT03315793|454730100|FG000|Overall Study|Adverse Event|4|||
126392736|NCT03315793|454730101|FG001|Overall Study|Adverse Event|2|||
126392737|NCT03315793|454730100|FG000|Overall Study|Protocol Deviation|1|||
126392738|NCT03315793|454730101|FG001|Overall Study|Protocol Deviation|0|||
126392739|NCT03315793|454730100|FG000|Overall Study|Difficult for regular visit|0|||
126392740|NCT03315793|454730101|FG001|Overall Study|Difficult for regular visit|1|||
126392741|NCT02640625|454732059|FG000|Overall Study|Adverse Event|1|||
126392742|NCT00511433|454732060|FG000|Overall Study|Adverse Event|5|||
126392743|NCT00511433|454732061|FG001|Overall Study|Adverse Event|0|||
126392744|NCT00511433|454732060|FG000|Overall Study|Other Reason|1|||
126392745|NCT00511433|454732061|FG001|Overall Study|Other Reason|1|||
126392746|NCT01740089|454732062|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
126392747|NCT01740089|454732063|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
126392748|NCT01740089|454732064|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
126392749|NCT01740089|454732062|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
126392750|NCT01740089|454732063|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
126392751|NCT01740089|454732064|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
126050050|NCT02392234|453479115|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126050051|NCT02392234|453479116|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126050052|NCT02392234|453479117|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126050053|NCT02392234|453479118|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126050054|NCT02392234|453479119|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126050055|NCT00701701|453479124|FG000|Overall Study|Withdrawal by Subject|0|||
126050056|NCT00701701|453479125|FG001|Overall Study|Withdrawal by Subject|1|||
126050057|NCT00701701|453479124|FG000|Overall Study|Adverse Event|0|||
126050058|NCT00701701|453479125|FG001|Overall Study|Adverse Event|1|||
126104598|NCT02796560|453675930|FG000|Overall Study|Withdrawal by Subject|2|||
126104599|NCT02796560|453675931|FG001|Overall Study|Withdrawal by Subject|2|||
126392752|NCT01740089|454732062|FG000|After 12 Weeks|Lack of Efficacy|3|||
126392753|NCT01740089|454732063|FG001|After 12 Weeks|Lack of Efficacy|1|||
126392754|NCT01740089|454732064|FG002|After 12 Weeks|Lack of Efficacy|4|||
126392755|NCT01740089|454732062|FG000|After 12 Weeks|Adverse Event|2|||
126392756|NCT01740089|454732063|FG001|After 12 Weeks|Adverse Event|0|||
126392757|NCT01740089|454732064|FG002|After 12 Weeks|Adverse Event|5|||
125887957|NCT03682770|452886603|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
126392758|NCT01740089|454732062|FG000|After 12 Weeks|Protocol Violation|1|||
126392759|NCT01740089|454732063|FG001|After 12 Weeks|Protocol Violation|1|||
126392760|NCT01740089|454732064|FG002|After 12 Weeks|Protocol Violation|1|||
126050059|NCT02078648|453479126|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
126050060|NCT02078648|453479127|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
126050061|NCT02078648|453479126|FG000|Overall Study|Adverse Event|0|||
126392761|NCT01740089|454732062|FG000|After 12 Weeks|Withdrawal by Subject|1|||
126392762|NCT01740089|454732063|FG001|After 12 Weeks|Withdrawal by Subject|1|||
126392763|NCT01740089|454732064|FG002|After 12 Weeks|Withdrawal by Subject|1|||
126392764|NCT00790868|454732065|FG000|Overall Study|Withdrawal by Subject|4|||
126392765|NCT00790868|454732066|FG001|Overall Study|Withdrawal by Subject|5|||
126392766|NCT00790868|454732065|FG000|Overall Study|Lost to Follow-up|2|||
126392767|NCT00790868|454732066|FG001|Overall Study|Lost to Follow-up|12|||
126392768|NCT02013206|454732067|FG000|Overall Study|Progressive disease (PD)|14|||
126392769|NCT02013206|454732068|FG001|Overall Study|Progressive disease (PD)|17|||
126392770|NCT02013206|454732067|FG000|Overall Study|Symptomatic deterioration|3|||
126392771|NCT02013206|454732068|FG001|Overall Study|Symptomatic deterioration|1|||
126392772|NCT02013206|454732067|FG000|Overall Study|Adverse Event|1|||
126392773|NCT02013206|454732068|FG001|Overall Study|Adverse Event|0|||
126392774|NCT02013206|454732067|FG000|Overall Study|Patient refusal|2|||
126392775|NCT02013206|454732068|FG001|Overall Study|Patient refusal|0|||
126392776|NCT02013206|454732067|FG000|Overall Study|Patient non-compliance|1|||
126392777|NCT02013206|454732068|FG001|Overall Study|Patient non-compliance|0|||
126392778|NCT02013206|454732067|FG000|Overall Study|Death|1|||
126392779|NCT02013206|454732068|FG001|Overall Study|Death|2|||
126392780|NCT02013206|454732067|FG000|Overall Study|Other reasons off treatment|5|||
126392781|NCT02013206|454732068|FG001|Overall Study|Other reasons off treatment|2|||
126392782|NCT02791191|454732069|FG000|Overall Study|Adverse Event|2|||
126392783|NCT02791191|454732070|FG001|Overall Study|Adverse Event|4|||
126392784|NCT02791191|454732071|FG002|Overall Study|Adverse Event|5|||
126392785|NCT02791191|454732069|FG000|Overall Study|Lack of Efficacy|0|||
126392786|NCT02791191|454732070|FG001|Overall Study|Lack of Efficacy|1|||
126392787|NCT02791191|454732071|FG002|Overall Study|Lack of Efficacy|0|||
126392788|NCT02791191|454732069|FG000|Overall Study|Study Drug Non-Compliance|0|||
126392789|NCT02791191|454732070|FG001|Overall Study|Study Drug Non-Compliance|2|||
126392790|NCT02791191|454732071|FG002|Overall Study|Study Drug Non-Compliance|0|||
126392791|NCT02791191|454732069|FG000|Overall Study|Site Closed by Sponsor|1|||
126392792|NCT02791191|454732070|FG001|Overall Study|Site Closed by Sponsor|1|||
126392793|NCT02791191|454732071|FG002|Overall Study|Site Closed by Sponsor|3|||
126392794|NCT02791191|454732069|FG000|Overall Study|Progressive Disease|1|||
126392795|NCT02791191|454732070|FG001|Overall Study|Progressive Disease|0|||
126392796|NCT02791191|454732071|FG002|Overall Study|Progressive Disease|0|||
126392797|NCT02791191|454732069|FG000|Overall Study|Study Terminated by Sponsor|29|||
126392798|NCT02791191|454732070|FG001|Overall Study|Study Terminated by Sponsor|101|||
126392799|NCT02791191|454732071|FG002|Overall Study|Study Terminated by Sponsor|109|||
126392800|NCT02791191|454732069|FG000|Overall Study|Withdrawal by Subject|3|||
126392801|NCT02791191|454732070|FG001|Overall Study|Withdrawal by Subject|1|||
126392802|NCT02791191|454732071|FG002|Overall Study|Withdrawal by Subject|3|||
126392803|NCT02791191|454732069|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
126392804|NCT02791191|454732070|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
126392805|NCT02791191|454732071|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
126392806|NCT01952665|454732072|FG000|Overall Study|Physician Decision|3|||
126392807|NCT01952665|454732073|FG001|Overall Study|Physician Decision|2|||
126392808|NCT01952665|454732072|FG000|Overall Study|Lost to Follow-up|1|||
126392809|NCT01952665|454732073|FG001|Overall Study|Lost to Follow-up|2|||
126392810|NCT01952665|454732072|FG000|Overall Study|Adverse Event|2|||
126392811|NCT01952665|454732073|FG001|Overall Study|Adverse Event|1|||
126392812|NCT01952665|454732072|FG000|Overall Study|Protocol Violation|0|||
126392813|NCT01952665|454732073|FG001|Overall Study|Protocol Violation|1|||
126392814|NCT01537081|454732074|FG000|Overall Study|Adverse Event|5|||
126392815|NCT01537081|454732075|FG001|Overall Study|Adverse Event|2|||
126392816|NCT01537081|454732076|FG002|Overall Study|Adverse Event|2|||
126392817|NCT01537081|454732074|FG000|Overall Study|Lack of Efficacy|2|||
126392818|NCT01537081|454732075|FG001|Overall Study|Lack of Efficacy|1|||
126392819|NCT01537081|454732076|FG002|Overall Study|Lack of Efficacy|0|||
126392820|NCT01537081|454732074|FG000|Overall Study|Lost to Follow-up|17|||
126392821|NCT01537081|454732075|FG001|Overall Study|Lost to Follow-up|15|||
126392822|NCT01537081|454732076|FG002|Overall Study|Lost to Follow-up|9|||
126050062|NCT02078648|453479127|FG001|Overall Study|Adverse Event|1|||
126050063|NCT02078648|453479126|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
126088964|NCT01399697|453620041|FG002|Overall Study|Withdrawal by Subject|0|||
126392823|NCT01537081|454732074|FG000|Overall Study|Protocol Violation|3|||
126392824|NCT01537081|454732075|FG001|Overall Study|Protocol Violation|2|||
126392825|NCT01537081|454732076|FG002|Overall Study|Protocol Violation|2|||
126392826|NCT01537081|454732074|FG000|Overall Study|Withdrawal by Subject|6|||
126392827|NCT01537081|454732075|FG001|Overall Study|Withdrawal by Subject|11|||
126392828|NCT01537081|454732076|FG002|Overall Study|Withdrawal by Subject|3|||
126392829|NCT01537081|454732074|FG000|Overall Study|Physician Decision|5|||
126392830|NCT01537081|454732075|FG001|Overall Study|Physician Decision|6|||
126392831|NCT01537081|454732076|FG002|Overall Study|Physician Decision|0|||
126104600|NCT04002401|453675932|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
126392832|NCT01537081|454732074|FG000|Overall Study|Sponsor decision|0|||
126104601|NCT04002401|453675932|FG000|Overall Study|Death|10|||
126392833|NCT01537081|454732075|FG001|Overall Study|Sponsor decision|1|||
126392834|NCT01537081|454732076|FG002|Overall Study|Sponsor decision|0|||
126392835|NCT01537081|454732074|FG000|Overall Study|Assigned but never dosed|1|||
126392836|NCT01537081|454732075|FG001|Overall Study|Assigned but never dosed|0|||
126392837|NCT01537081|454732076|FG002|Overall Study|Assigned but never dosed|0|||
126392838|NCT01463111|454732079|FG000|Overall Study|Withdrawal by Subject|2|||
126392839|NCT01463111|454732079|FG000|Overall Study|Lost to Follow-up|5|||
126392840|NCT01463111|454732079|FG000|Overall Study|Physician Decision|2|||
126392841|NCT02596958|454732082|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
126392842|NCT02596958|454732082|FG000|Overall Study|Cancer Progression|441|||
126392843|NCT02596958|454732082|FG000|Overall Study|Death From Cancer|112|||
126392844|NCT02596958|454732082|FG000|Overall Study|Death From Other Cause|33|||
126392845|NCT02596958|454732082|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
126392846|NCT02596958|454732082|FG000|Overall Study|Administrative Reasons/Other|231|||
126392847|NCT02596958|454732082|FG000|Overall Study|Lost to Follow-up|33|||
126392848|NCT02596958|454732082|FG000|Overall Study|Missing|32|||
126392849|NCT02596958|454732082|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
126392850|NCT01559259|454732083|FG000|Overall Study|Withdrawal by Subject|0|||
126392851|NCT01559259|454732084|FG001|Overall Study|Withdrawal by Subject|0|||
126392852|NCT01559259|454732085|FG002|Overall Study|Withdrawal by Subject|0|||
126392853|NCT01559259|454732086|FG003|Overall Study|Withdrawal by Subject|1|||
126392854|NCT01559259|454732087|FG004|Overall Study|Withdrawal by Subject|0|||
126392855|NCT01559259|454732083|FG000|Overall Study|Adverse Event|0|||
126392856|NCT01559259|454732084|FG001|Overall Study|Adverse Event|1|||
126392857|NCT01559259|454732085|FG002|Overall Study|Adverse Event|1|||
126392858|NCT01559259|454732086|FG003|Overall Study|Adverse Event|0|||
126392859|NCT01559259|454732087|FG004|Overall Study|Adverse Event|0|||
126392860|NCT05425732|454732088|FG000|Overall Study|Death|4|||
126392861|NCT05425732|454732089|FG001|Overall Study|Death|2|||
126392862|NCT05425732|454732090|FG002|Overall Study|Death|0|||
126392863|NCT05425732|454732091|FG003|Overall Study|Death|0|||
126392864|NCT05425732|454732088|FG000|Overall Study|Lost to Follow-up|10|||
126392865|NCT05425732|454732089|FG001|Overall Study|Lost to Follow-up|15|||
126392866|NCT05425732|454732090|FG002|Overall Study|Lost to Follow-up|5|||
126392867|NCT05425732|454732091|FG003|Overall Study|Lost to Follow-up|3|||
126151349|NCT00356915|453841966|FG000|Overall Study|Miscellaneous reasons|11|||
126392868|NCT05425732|454732088|FG000|Overall Study|Physician Decision|0|||
126392869|NCT05425732|454732089|FG001|Overall Study|Physician Decision|2|||
126392870|NCT05425732|454732090|FG002|Overall Study|Physician Decision|0|||
126392871|NCT05425732|454732091|FG003|Overall Study|Physician Decision|0|||
126392872|NCT05425732|454732088|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126392873|NCT05425732|454732089|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
126392874|NCT05425732|454732090|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126392875|NCT05425732|454732091|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126392876|NCT05425732|454732088|FG000|Overall Study|Withdrawal by Subject|4|||
126392877|NCT05425732|454732089|FG001|Overall Study|Withdrawal by Subject|8|||
126392878|NCT05425732|454732090|FG002|Overall Study|Withdrawal by Subject|1|||
126392879|NCT05425732|454732091|FG003|Overall Study|Withdrawal by Subject|1|||
126392880|NCT05425732|454732088|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
126392881|NCT05425732|454732089|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
126392882|NCT05425732|454732090|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
126392883|NCT05425732|454732091|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
126392884|NCT00306293|454732093|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
126392885|NCT00306293|454732094|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
126392886|NCT00306293|454732093|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
126392887|NCT00306293|454732094|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
126392888|NCT00306293|454732093|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
126392889|NCT00306293|454732094|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
126392890|NCT00306293|454732093|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
126392891|NCT00306293|454732094|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
126392892|NCT00306293|454732093|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
126392893|NCT00306293|454732094|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
126392894|NCT00306293|454732093|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
126392895|NCT00306293|454732094|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
126392896|NCT00306293|454732093|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
126392897|NCT00306293|454732094|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
126392898|NCT00306293|454732093|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
126392899|NCT00306293|454732094|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
126392900|NCT00185380|454732095|FG000|Overall Study|Adverse Event|41|||
126392901|NCT00185380|454732096|FG001|Overall Study|Adverse Event|43|||
126392902|NCT00185380|454732097|FG002|Overall Study|Adverse Event|48|||
126392903|NCT00185380|454732095|FG000|Overall Study|Lost to Follow-up|0|||
126392904|NCT00185380|454732096|FG001|Overall Study|Lost to Follow-up|4|||
126392905|NCT00185380|454732097|FG002|Overall Study|Lost to Follow-up|3|||
126392906|NCT00185380|454732095|FG000|Overall Study|Pregnancy|1|||
126392907|NCT00185380|454732096|FG001|Overall Study|Pregnancy|4|||
126392908|NCT00185380|454732097|FG002|Overall Study|Pregnancy|0|||
126392909|NCT00185380|454732095|FG000|Overall Study|Protocol Violation|2|||
126392910|NCT00185380|454732096|FG001|Overall Study|Protocol Violation|2|||
126392911|NCT00185380|454732097|FG002|Overall Study|Protocol Violation|1|||
126392912|NCT00185380|454732095|FG000|Overall Study|Withdrawal by Subject|1|||
126392913|NCT00185380|454732096|FG001|Overall Study|Withdrawal by Subject|2|||
126392914|NCT00185380|454732097|FG002|Overall Study|Withdrawal by Subject|0|||
126392915|NCT00185380|454732095|FG000|Overall Study|Failed insertion|1|||
126392916|NCT00185380|454732096|FG001|Overall Study|Failed insertion|1|||
126392917|NCT00185380|454732097|FG002|Overall Study|Failed insertion|2|||
126392918|NCT00185380|454732095|FG000|Overall Study|Planned pregnancy|9|||
126392919|NCT00185380|454732096|FG001|Overall Study|Planned pregnancy|12|||
126392920|NCT00185380|454732097|FG002|Overall Study|Planned pregnancy|12|||
126392921|NCT00185380|454732095|FG000|Overall Study|No need for contraception|3|||
126392922|NCT00185380|454732096|FG001|Overall Study|No need for contraception|3|||
126392923|NCT00185380|454732097|FG002|Overall Study|No need for contraception|3|||
126392924|NCT00185380|454732095|FG000|Overall Study|Could not attend visits|2|||
126392925|NCT00185380|454732096|FG001|Overall Study|Could not attend visits|0|||
126392926|NCT00185380|454732097|FG002|Overall Study|Could not attend visits|4|||
126392927|NCT00185380|454732095|FG000|Overall Study|personal reason|6|||
126392928|NCT00185380|454732096|FG001|Overall Study|personal reason|1|||
126392929|NCT00185380|454732097|FG002|Overall Study|personal reason|1|||
126392930|NCT02199314|454732100|FG000|Overall Study|Withdrawal by Subject|6|||
126392931|NCT02199314|454732100|FG000|Overall Study|Physician Decision|10|||
126392932|NCT04187144|454732101|FG000|Overall Study|Lost to Follow-up|12|||
126392933|NCT04187144|454732102|FG001|Overall Study|Lost to Follow-up|11|||
126392934|NCT04187144|454732101|FG000|Overall Study|Withdrawal by Subject|20|||
126392935|NCT04187144|454732102|FG001|Overall Study|Withdrawal by Subject|18|||
126392936|NCT04187144|454732101|FG000|Overall Study|Adverse Event|19|||
126392937|NCT04187144|454732102|FG001|Overall Study|Adverse Event|4|||
126392938|NCT04187144|454732101|FG000|Overall Study|Physician Decision|5|||
126392939|NCT04187144|454732102|FG001|Overall Study|Physician Decision|3|||
126392940|NCT04187144|454732101|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
126050064|NCT02078648|453479127|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
126050065|NCT02078648|453479126|FG000|Overall Study|Withdrawal by Subject|3|||
126050066|NCT02078648|453479127|FG001|Overall Study|Withdrawal by Subject|1|||
126050067|NCT02078648|453479126|FG000|Overall Study|Investigator Decision|5|||
126050068|NCT02078648|453479127|FG001|Overall Study|Investigator Decision|7|||
126050069|NCT02078648|453479126|FG000|Overall Study|Death|1|||
126392941|NCT04187144|454732102|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
126392942|NCT04187144|454732101|FG000|Overall Study|Protocol Deviation|1|||
126392943|NCT04187144|454732102|FG001|Overall Study|Protocol Deviation|4|||
126392944|NCT02650804|454732103|FG000|Overall Study|Adverse Event|3|||
126392945|NCT02650804|454732104|FG001|Overall Study|Adverse Event|2|||
126392946|NCT02650804|454732103|FG000|Overall Study|Death|1|||
126392947|NCT02650804|454732104|FG001|Overall Study|Death|2|||
126392948|NCT02650804|454732103|FG000|Overall Study|Progressive Disease|7|||
126392949|NCT02650804|454732104|FG001|Overall Study|Progressive Disease|10|||
126392950|NCT02650804|454732103|FG000|Overall Study|Physician Decision|0|||
126392951|NCT02650804|454732104|FG001|Overall Study|Physician Decision|2|||
126392952|NCT02650804|454732103|FG000|Overall Study|Withdrawal by Subject|1|||
126392953|NCT02650804|454732104|FG001|Overall Study|Withdrawal by Subject|4|||
126392954|NCT02650804|454732103|FG000|Overall Study|Symptomatic deterioration|5|||
126392955|NCT02650804|454732104|FG001|Overall Study|Symptomatic deterioration|7|||
126392956|NCT02650804|454732103|FG000|Overall Study|Protocol Violation|0|||
126392957|NCT02650804|454732104|FG001|Overall Study|Protocol Violation|1|||
126392958|NCT02759107|454732105|FG000|Overall Study|Adverse Event|0|||
126392959|NCT02759107|454732106|FG001|Overall Study|Adverse Event|0|||
126392960|NCT02759107|454732107|FG002|Overall Study|Adverse Event|0|||
126392961|NCT02759107|454732108|FG003|Overall Study|Adverse Event|0|||
126392962|NCT02759107|454732109|FG004|Overall Study|Adverse Event|0|||
126392963|NCT02759107|454732110|FG005|Overall Study|Adverse Event|0|||
126392964|NCT02759107|454732111|FG006|Overall Study|Adverse Event|0|||
126392965|NCT02759107|454732112|FG007|Overall Study|Adverse Event|0|||
126392966|NCT02759107|454732113|FG008|Overall Study|Adverse Event|0|||
126392967|NCT02759107|454732114|FG009|Overall Study|Adverse Event|0|||
126392968|NCT02759107|454732115|FG010|Overall Study|Adverse Event|0|||
126392969|NCT02759107|454732116|FG011|Overall Study|Adverse Event|0|||
126392970|NCT02759107|454732117|FG012|Overall Study|Adverse Event|2|||
126392971|NCT02759107|454732118|FG013|Overall Study|Adverse Event|0|||
126392972|NCT02759107|454732119|FG014|Overall Study|Adverse Event|0|||
126392973|NCT02759107|454732120|FG015|Overall Study|Adverse Event|1|||
126392974|NCT02759107|454732121|FG016|Overall Study|Adverse Event|0|||
126392975|NCT02759107|454732122|FG017|Overall Study|Adverse Event|2|||
126392976|NCT02759107|454732105|FG000|Overall Study|Scheduling Conflict|0|||
126392977|NCT02759107|454732106|FG001|Overall Study|Scheduling Conflict|0|||
126392978|NCT02759107|454732107|FG002|Overall Study|Scheduling Conflict|0|||
126392979|NCT02759107|454732108|FG003|Overall Study|Scheduling Conflict|0|||
126392980|NCT02759107|454732109|FG004|Overall Study|Scheduling Conflict|0|||
126392981|NCT02759107|454732110|FG005|Overall Study|Scheduling Conflict|0|||
126392982|NCT02759107|454732111|FG006|Overall Study|Scheduling Conflict|0|||
126392983|NCT02759107|454732112|FG007|Overall Study|Scheduling Conflict|0|||
126392984|NCT02759107|454732113|FG008|Overall Study|Scheduling Conflict|0|||
126392985|NCT02759107|454732114|FG009|Overall Study|Scheduling Conflict|1|||
126392986|NCT02759107|454732115|FG010|Overall Study|Scheduling Conflict|0|||
126392987|NCT02759107|454732116|FG011|Overall Study|Scheduling Conflict|0|||
126392988|NCT02759107|454732117|FG012|Overall Study|Scheduling Conflict|0|||
126392989|NCT02759107|454732118|FG013|Overall Study|Scheduling Conflict|0|||
126392990|NCT02759107|454732119|FG014|Overall Study|Scheduling Conflict|0|||
126392991|NCT02759107|454732120|FG015|Overall Study|Scheduling Conflict|0|||
126392992|NCT02759107|454732121|FG016|Overall Study|Scheduling Conflict|0|||
126392993|NCT02759107|454732122|FG017|Overall Study|Scheduling Conflict|0|||
126392994|NCT02513485|454732126|FG000|Overall Study|Adverse Event|1|||
126392995|NCT02513485|454732127|FG001|Overall Study|Adverse Event|0|||
126392996|NCT02526524|454732128|FG000|Overall Study|Withdrawal by Subject|3|||
126392997|NCT02526524|454732129|FG001|Overall Study|Withdrawal by Subject|3|||
126392998|NCT02526524|454732130|FG002|Overall Study|Withdrawal by Subject|6|||
126392999|NCT02526524|454732131|FG003|Overall Study|Withdrawal by Subject|1|||
126393000|NCT02526524|454732132|FG004|Overall Study|Withdrawal by Subject|9|||
126393001|NCT02526524|454732133|FG005|Overall Study|Withdrawal by Subject|5|||
126050070|NCT02078648|453479127|FG001|Overall Study|Death|1|||
126393002|NCT02526524|454732128|FG000|Overall Study|Adverse Event|3|||
126393003|NCT02526524|454732129|FG001|Overall Study|Adverse Event|2|||
126393004|NCT02526524|454732130|FG002|Overall Study|Adverse Event|4|||
126393005|NCT02526524|454732131|FG003|Overall Study|Adverse Event|2|||
126393006|NCT02526524|454732132|FG004|Overall Study|Adverse Event|6|||
126393007|NCT02526524|454732133|FG005|Overall Study|Adverse Event|8|||
126393008|NCT02526524|454732128|FG000|Overall Study|Lost to Follow-up|2|||
126393009|NCT02526524|454732129|FG001|Overall Study|Lost to Follow-up|3|||
126393010|NCT02526524|454732130|FG002|Overall Study|Lost to Follow-up|8|||
126393011|NCT02526524|454732131|FG003|Overall Study|Lost to Follow-up|1|||
126393012|NCT02526524|454732132|FG004|Overall Study|Lost to Follow-up|2|||
126393013|NCT02526524|454732133|FG005|Overall Study|Lost to Follow-up|5|||
126393014|NCT02526524|454732128|FG000|Overall Study|Protocol Violation|3|||
126393015|NCT02526524|454732129|FG001|Overall Study|Protocol Violation|1|||
126393016|NCT02526524|454732130|FG002|Overall Study|Protocol Violation|5|||
126393017|NCT02526524|454732131|FG003|Overall Study|Protocol Violation|3|||
126393018|NCT02526524|454732132|FG004|Overall Study|Protocol Violation|4|||
126393019|NCT02526524|454732133|FG005|Overall Study|Protocol Violation|3|||
126393020|NCT02526524|454732128|FG000|Overall Study|Loss of Glucose Control|0|||
126393021|NCT02526524|454732129|FG001|Overall Study|Loss of Glucose Control|0|||
126393022|NCT02526524|454732130|FG002|Overall Study|Loss of Glucose Control|3|||
126393023|NCT02526524|454732131|FG003|Overall Study|Loss of Glucose Control|0|||
126393024|NCT02526524|454732132|FG004|Overall Study|Loss of Glucose Control|2|||
126393025|NCT02526524|454732133|FG005|Overall Study|Loss of Glucose Control|0|||
126393026|NCT02526524|454732128|FG000|Overall Study|Physician Decision|0|||
126393027|NCT02526524|454732129|FG001|Overall Study|Physician Decision|0|||
126393028|NCT02526524|454732130|FG002|Overall Study|Physician Decision|0|||
126393029|NCT02526524|454732131|FG003|Overall Study|Physician Decision|0|||
126393030|NCT02526524|454732132|FG004|Overall Study|Physician Decision|1|||
126393031|NCT02526524|454732133|FG005|Overall Study|Physician Decision|0|||
126393032|NCT02526524|454732128|FG000|Overall Study|Sponsor Decision|1|||
126393033|NCT02526524|454732129|FG001|Overall Study|Sponsor Decision|0|||
126393034|NCT02526524|454732130|FG002|Overall Study|Sponsor Decision|0|||
126393035|NCT02526524|454732131|FG003|Overall Study|Sponsor Decision|0|||
126393036|NCT02526524|454732132|FG004|Overall Study|Sponsor Decision|0|||
126393037|NCT02526524|454732133|FG005|Overall Study|Sponsor Decision|0|||
126393038|NCT05312632|454732138|FG000|Overall Study|Adverse Event|12|||
126393039|NCT05312632|454732138|FG000|Overall Study|Withdrawal by Subject|10|||
126393040|NCT05312632|454732138|FG000|Overall Study|Lack of Efficacy|4|||
126393041|NCT05312632|454732138|FG000|Overall Study|Non-compliance with study procedures|9|||
126393042|NCT05312632|454732138|FG000|Overall Study|Other|4|||
126393043|NCT02019108|454732139|FG000|Overall Study|Lost to Follow-up|5|||
126393044|NCT02019108|454732140|FG001|Overall Study|Lost to Follow-up|7|||
126393045|NCT04569136|454732146|FG000|Overall Study|Lost to Follow-up|2|||
126393046|NCT04569136|454732147|FG001|Overall Study|Lost to Follow-up|0|||
126393047|NCT04569136|454732148|FG002|Overall Study|Lost to Follow-up|1|||
126393048|NCT01466660|454732153|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
126393049|NCT01466660|454732154|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
126393050|NCT01466660|454732153|FG000|Overall Study|Worsening of underlying cancer disease|5|||
126393051|NCT01466660|454732154|FG001|Overall Study|Worsening of underlying cancer disease|2|||
126393052|NCT01466660|454732153|FG000|Overall Study|Other adverse event|19|||
126393053|NCT01466660|454732154|FG001|Overall Study|Other adverse event|18|||
126393054|NCT01466660|454732153|FG000|Overall Study|Protocol Violation|2|||
126393055|NCT01466660|454732154|FG001|Overall Study|Protocol Violation|1|||
126393056|NCT01466660|454732153|FG000|Overall Study|Refused continuation of trial medication|4|||
126393057|NCT01466660|454732154|FG001|Overall Study|Refused continuation of trial medication|3|||
126393058|NCT01466660|454732153|FG000|Overall Study|Other reason not defined above|10|||
126393059|NCT01466660|454732154|FG001|Overall Study|Other reason not defined above|8|||
126393060|NCT00191724|454732155|FG000|Overall Study|Adverse Event|0|||
126393061|NCT00191724|454732156|FG001|Overall Study|Adverse Event|0|||
126393062|NCT00191724|454732157|FG002|Overall Study|Adverse Event|1|||
126393063|NCT00191724|454732158|FG003|Overall Study|Adverse Event|0|||
126393064|NCT00191724|454732159|FG004|Overall Study|Adverse Event|0|||
126393065|NCT00191724|454732155|FG000|Overall Study|Lost to Follow-up|1|||
126393066|NCT00191724|454732156|FG001|Overall Study|Lost to Follow-up|1|||
126393067|NCT00191724|454732157|FG002|Overall Study|Lost to Follow-up|0|||
126393068|NCT00191724|454732158|FG003|Overall Study|Lost to Follow-up|2|||
126393069|NCT00191724|454732159|FG004|Overall Study|Lost to Follow-up|3|||
126393070|NCT00191724|454732155|FG000|Overall Study|Withdrawal by Subject|0|||
126393071|NCT00191724|454732156|FG001|Overall Study|Withdrawal by Subject|0|||
126393072|NCT00191724|454732157|FG002|Overall Study|Withdrawal by Subject|0|||
126393073|NCT00191724|454732158|FG003|Overall Study|Withdrawal by Subject|1|||
126393074|NCT00191724|454732159|FG004|Overall Study|Withdrawal by Subject|0|||
126393075|NCT02301546|454732160|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
126393076|NCT02301546|454732161|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
126393077|NCT02301546|454732160|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
126393078|NCT02301546|454732161|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
126393079|NCT02301546|454732160|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
126393080|NCT02301546|454732161|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
126393081|NCT02301546|454732160|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
126393082|NCT02301546|454732161|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
126393083|NCT02301546|454732160|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
126393084|NCT02301546|454732161|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
126393085|NCT02301546|454732160|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
126393086|NCT02301546|454732161|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
126393087|NCT02301546|454732160|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
126393088|NCT02301546|454732161|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
126393089|NCT02447250|454732164|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
126393090|NCT02447250|454732164|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
126393091|NCT02447250|454732164|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
126393092|NCT01885208|454732167|FG000|Overall Study|Unclassified|32|||
126393093|NCT01885208|454732168|FG001|Overall Study|Unclassified|38|||
126393094|NCT03224507|454732174|FG000|Overall Study|Death|3|||
126393095|NCT03224507|454732175|FG001|Overall Study|Death|0|||
126393096|NCT03224507|454732174|FG000|Overall Study|Lack of Efficacy|6|||
126393097|NCT03224507|454732175|FG001|Overall Study|Lack of Efficacy|0|||
126393098|NCT03224507|454732174|FG000|Overall Study|Withdrawal by Subject|6|||
126393099|NCT03224507|454732175|FG001|Overall Study|Withdrawal by Subject|0|||
126393100|NCT01498575|454732176|FG000|Overall Sample|Withdrawal by Subject|60|||
126393101|NCT01498575|454732177|FG001|Overall Sample|Withdrawal by Subject|14|||
126393102|NCT01498575|454732176|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
126393103|NCT01498575|454732177|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
126393104|NCT01498575|454732176|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
126393105|NCT01498575|454732177|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
126393106|NCT01972308|454732179|FG000|Overall Study|Withdrawal by Subject|0|||
126393107|NCT01972308|454732180|FG001|Overall Study|Withdrawal by Subject|1|||
126393108|NCT01972308|454732179|FG000|Overall Study|Lost to Follow-up|4|||
126393109|NCT01972308|454732180|FG001|Overall Study|Lost to Follow-up|6|||
126393110|NCT01972308|454732179|FG000|Overall Study|Death|4|||
126393111|NCT01972308|454732180|FG001|Overall Study|Death|1|||
126393112|NCT00543803|454732181|FG000|Overall Study|Adverse Event|14|||
126393113|NCT00543803|454732181|FG000|Overall Study|Lack of Efficacy|22|||
126393114|NCT00543803|454732181|FG000|Overall Study|Lost to Follow-up|20|||
126393115|NCT00543803|454732181|FG000|Overall Study|Other|86|||
126393116|NCT05129449|454732195|FG000|Overall Study|Protocol Violation|1|||
126393117|NCT02839720|454732198|FG000|Overall Study|Adverse Event|2|||
126393118|NCT02839720|454732198|FG000|Overall Study|Non-compliance|2|||
126393119|NCT02839720|454732198|FG000|Overall Study|Intercurrent Illness|1|||
126393120|NCT02839720|454732198|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
126393121|NCT00503581|454732199|FG000|Overall Study|Study closed|3|||
126393122|NCT00503581|454732200|FG001|Overall Study|Study closed|4|||
126393123|NCT00503581|454732201|FG002|Overall Study|Study closed|2|||
126393124|NCT06107803|454732207|FG000|Overall Study|Adverse Event|1|||
126393125|NCT06107803|454732207|FG000|Overall Study|Withdrawal by Subject|2|||
126393126|NCT06107803|454732207|FG000|Overall Study|Protocol Violation|1|||
126393127|NCT02378298|454732209|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
126393128|NCT02378298|454732210|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
126393129|NCT02378298|454732211|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
126393130|NCT02378298|454732209|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
126393131|NCT02378298|454732210|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
126393132|NCT02378298|454732211|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
126393133|NCT02378298|454732209|FG000|Surveillance (19-68 Weeks)|Death|1|||
126050071|NCT02078648|453479126|FG000|Overall Study|Undefined|0|||
126050072|NCT02078648|453479127|FG001|Overall Study|Undefined|1|||
126393134|NCT02378298|454732210|FG001|Surveillance (19-68 Weeks)|Death|0|||
126393135|NCT02378298|454732211|FG002|Surveillance (19-68 Weeks)|Death|0|||
126393136|NCT04730635|454732212|FG000|Overall Study|Lost to Follow-up|1|||
126393137|NCT04730635|454732213|FG001|Overall Study|Lost to Follow-up|0|||
126393138|NCT04730635|454732212|FG000|Overall Study|Withdrawal by Subject|0|||
126393139|NCT04730635|454732213|FG001|Overall Study|Withdrawal by Subject|1|||
126393140|NCT04934800|454732214|FG000|Overall Study|Other|1|||
126393141|NCT04934800|454732214|FG000|Overall Study|Withdrawal by Subject|5|||
126050073|NCT04088227|453479128|FG000|Overall Study|Withdrawal by Subject|1|||
126393142|NCT04934800|454732214|FG000|Overall Study|Lack of Efficacy|1|||
126393143|NCT04934800|454732214|FG000|Overall Study|Adverse Event|9|||
126393144|NCT04934800|454732214|FG000|Overall Study|Lost to Follow-up|5|||
126393145|NCT04934800|454732214|FG000|Overall Study|Enrolled but not treated|1|||
126393146|NCT00516906|454732215|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
126393147|NCT00516906|454732216|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
126393148|NCT01974206|454732219|FG000|Overall Study|Did Not Take Study Drug|0|||
126050074|NCT04088227|453479129|FG001|Overall Study|Withdrawal by Subject|0|||
126393149|NCT01974206|454732220|FG001|Overall Study|Did Not Take Study Drug|1|||
126393150|NCT01974206|454732219|FG000|Overall Study|Physician Decision|1|||
126393151|NCT01974206|454732220|FG001|Overall Study|Physician Decision|0|||
126393152|NCT01974206|454732219|FG000|Overall Study|Withdrawal by Subject|3|||
126393153|NCT01974206|454732220|FG001|Overall Study|Withdrawal by Subject|0|||
126393154|NCT01974206|454732219|FG000|Overall Study|Lost to Follow-up|1|||
126393155|NCT01974206|454732220|FG001|Overall Study|Lost to Follow-up|0|||
126393156|NCT01974206|454732219|FG000|Overall Study|Death|1|||
126393157|NCT01974206|454732220|FG001|Overall Study|Death|0|||
126393158|NCT03219034|454732228|FG000|Overall Study|Lost to Follow-up|9|||
126393159|NCT03219034|454732229|FG001|Overall Study|Lost to Follow-up|13|||
126393160|NCT03219034|454732228|FG000|Overall Study|Additional dental work needed|1|||
126393161|NCT03219034|454732229|FG001|Overall Study|Additional dental work needed|0|||
126393162|NCT03219034|454732228|FG000|Overall Study|UPPP Surgery|1|||
126393163|NCT03219034|454732229|FG001|Overall Study|UPPP Surgery|0|||
126393164|NCT03219034|454732228|FG000|Overall Study|Dental sensitivity|0|||
126393165|NCT03219034|454732229|FG001|Overall Study|Dental sensitivity|1|||
126393166|NCT03219034|454732228|FG000|Overall Study|Death in family|0|||
126393167|NCT03219034|454732229|FG001|Overall Study|Death in family|1|||
126393168|NCT02438683|454732230|FG000|Overall Study|Adverse Event|1|||
126393169|NCT02438683|454732231|FG001|Overall Study|Adverse Event|0|||
126393170|NCT02438683|454732232|FG002|Overall Study|Adverse Event|0|||
126393171|NCT02438683|454732233|FG003|Overall Study|Adverse Event|0|||
126393172|NCT02438683|454732234|FG004|Overall Study|Adverse Event|0|||
126393173|NCT02438683|454732235|FG005|Overall Study|Adverse Event|0|||
126393174|NCT04669262|454732241|FG000|Overall Study|Withdrawal by Subject|0|||
126393175|NCT04669262|454732242|FG001|Overall Study|Withdrawal by Subject|0|||
126393176|NCT04669262|454732243|FG002|Overall Study|Withdrawal by Subject|0|||
126393177|NCT04669262|454732244|FG003|Overall Study|Withdrawal by Subject|1|||
126393178|NCT04669262|454732241|FG000|Overall Study|Randomized but Not Treated|0|||
126393179|NCT04669262|454732242|FG001|Overall Study|Randomized but Not Treated|1|||
126393180|NCT04669262|454732243|FG002|Overall Study|Randomized but Not Treated|0|||
126393181|NCT04669262|454732244|FG003|Overall Study|Randomized but Not Treated|0|||
126393182|NCT01638013|454732245|FG000|Overall Study|Adverse Event|36|||
126393183|NCT01638013|454732246|FG001|Overall Study|Adverse Event|29|||
126393184|NCT01638013|454732247|FG002|Overall Study|Adverse Event|48|||
126393185|NCT01638013|454732245|FG000|Overall Study|Lack of Efficacy|39|||
126393186|NCT01638013|454732246|FG001|Overall Study|Lack of Efficacy|11|||
126393187|NCT01638013|454732247|FG002|Overall Study|Lack of Efficacy|14|||
126393188|NCT01638013|454732245|FG000|Overall Study|Protocol Violation|10|||
126393189|NCT01638013|454732246|FG001|Overall Study|Protocol Violation|7|||
126393190|NCT01638013|454732247|FG002|Overall Study|Protocol Violation|11|||
126393191|NCT01638013|454732245|FG000|Overall Study|Met discontinuation criteria|4|||
126393192|NCT01638013|454732246|FG001|Overall Study|Met discontinuation criteria|0|||
126393193|NCT01638013|454732247|FG002|Overall Study|Met discontinuation criteria|7|||
126393194|NCT01638013|454732245|FG000|Overall Study|Subject Lost to Follow up|1|||
126393195|NCT01638013|454732246|FG001|Overall Study|Subject Lost to Follow up|0|||
126393196|NCT01638013|454732247|FG002|Overall Study|Subject Lost to Follow up|1|||
126393197|NCT01638013|454732245|FG000|Overall Study|Miscellaneous|25|||
126393198|NCT01638013|454732246|FG001|Overall Study|Miscellaneous|19|||
126393199|NCT01638013|454732247|FG002|Overall Study|Miscellaneous|23|||
126393200|NCT01638013|454732245|FG000|Overall Study|Withdrawal of Consent|16|||
126393201|NCT01638013|454732246|FG001|Overall Study|Withdrawal of Consent|12|||
126393202|NCT01638013|454732247|FG002|Overall Study|Withdrawal of Consent|16|||
126393203|NCT01638013|454732245|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
126393204|NCT01638013|454732246|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
126393205|NCT01638013|454732247|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
126393206|NCT05463744|454732248|FG000|Treatment Period|Withdrawal by Subject|19|||
126393207|NCT05463744|454732249|FG001|Treatment Period|Withdrawal by Subject|16|||
126393208|NCT05463744|454732248|FG000|Treatment Period|Adverse Event|4|||
126393209|NCT05463744|454732249|FG001|Treatment Period|Adverse Event|4|||
126393210|NCT05463744|454732248|FG000|Treatment Period|Pregnancy|0|||
126393211|NCT05463744|454732249|FG001|Treatment Period|Pregnancy|3|||
126393212|NCT05463744|454732248|FG000|Treatment Period|Lost to Follow-up|1|||
126393213|NCT05463744|454732249|FG001|Treatment Period|Lost to Follow-up|3|||
126393214|NCT05463744|454732248|FG000|Treatment Period|Inadvertent enrollment|2|||
126393215|NCT05463744|454732249|FG001|Treatment Period|Inadvertent enrollment|1|||
126393216|NCT05463744|454732248|FG000|Treatment Period|Death|0|||
126393217|NCT05463744|454732249|FG001|Treatment Period|Death|1|||
126393218|NCT05463744|454732248|FG000|Treatment Period|Non-compliance with Study Drug|1|||
126393219|NCT05463744|454732249|FG001|Treatment Period|Non-compliance with Study Drug|0|||
126393220|NCT05463744|454732248|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
126393221|NCT05463744|454732249|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
126393222|NCT05463744|454732248|FG000|Treatment Period|Physician Decision|0|||
126393223|NCT05463744|454732249|FG001|Treatment Period|Physician Decision|1|||
126393224|NCT05463744|454732248|FG000|Follow-Up Period|Withdrawal by Subject|3|||
126393225|NCT05463744|454732249|FG001|Follow-Up Period|Withdrawal by Subject|1|||
126393226|NCT05463744|454732248|FG000|Follow-Up Period|Lost to Follow-up|1|||
126393227|NCT05463744|454732249|FG001|Follow-Up Period|Lost to Follow-up|1|||
125887958|NCT03682770|452886604|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125887959|NCT03682770|452886605|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
125887960|NCT03682770|452886606|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
125887961|NCT02362282|452886607|FG000|Overall Study|Withdrawal by Subject|1|||
125887962|NCT02362282|452886608|FG001|Overall Study|Withdrawal by Subject|0|||
125887963|NCT03599089|452886613|FG000|Overall Study|Lost to Follow-up|1|||
125887964|NCT03599089|452886614|FG001|Overall Study|Lost to Follow-up|0|||
125887965|NCT03599089|452886615|FG002|Overall Study|Lost to Follow-up|0|||
125887966|NCT03599089|452886616|FG003|Overall Study|Lost to Follow-up|0|||
125887967|NCT03599089|452886613|FG000|Overall Study|Withdrawal by Subject|2|||
125887968|NCT03599089|452886614|FG001|Overall Study|Withdrawal by Subject|1|||
125887969|NCT03599089|452886615|FG002|Overall Study|Withdrawal by Subject|0|||
125887970|NCT03599089|452886616|FG003|Overall Study|Withdrawal by Subject|0|||
125887971|NCT03599089|452886613|FG000|Overall Study|Lack of Efficacy|0|||
125887972|NCT03599089|452886614|FG001|Overall Study|Lack of Efficacy|0|||
125887973|NCT03599089|452886615|FG002|Overall Study|Lack of Efficacy|1|||
125887974|NCT03599089|452886616|FG003|Overall Study|Lack of Efficacy|2|||
125887975|NCT03214666|452886617|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125887976|NCT03214666|452886618|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125887977|NCT03214666|452886619|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125887978|NCT03214666|452886620|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125887979|NCT03214666|452886621|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
125887980|NCT03214666|452886622|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125887981|NCT00470275|452886623|FG000|Overall Study|Death|1|||
125887982|NCT00470275|452886623|FG000|Overall Study|Lack of Efficacy|7|||
125887983|NCT00470275|452886623|FG000|Overall Study|Withdrawal by Subject|2|||
125887984|NCT01519921|452886624|FG000|Overall Study|Adverse Event|10|||
125887985|NCT01519921|452886625|FG001|Overall Study|Adverse Event|9|||
126393228|NCT01579565|454734029|FG000|Randomized|Adverse Event|1|||
126393229|NCT01579565|454734030|FG001|Randomized|Adverse Event|3|||
126393230|NCT01579565|454734029|FG000|Randomized|Withdrawal by Subject|3|||
126393231|NCT01579565|454734030|FG001|Randomized|Withdrawal by Subject|0|||
126393232|NCT01579565|454734029|FG000|Randomized|inadequate preoperative pupil dilation|0|||
126393233|NCT01579565|454734030|FG001|Randomized|inadequate preoperative pupil dilation|1|||
126393234|NCT01579565|454734029|FG000|Randomized|prohibited preoperative eating|1|||
126393235|NCT01579565|454734030|FG001|Randomized|prohibited preoperative eating|0|||
126393236|NCT01579565|454734029|FG000|Randomized|prohibited preoperative medication|0|||
126393237|NCT01579565|454734030|FG001|Randomized|prohibited preoperative medication|1|||
126393238|NCT01579565|454734029|FG000|Treated|Physician Decision|0|||
126393239|NCT01579565|454734030|FG001|Treated|Physician Decision|1|||
126393240|NCT01579565|454734029|FG000|Treated|Lost to Follow-up|2|||
126393241|NCT01579565|454734030|FG001|Treated|Lost to Follow-up|1|||
126393242|NCT01579565|454734029|FG000|Treated|declined to return for final visit|0|||
126393243|NCT01579565|454734030|FG001|Treated|declined to return for final visit|1|||
126393244|NCT02867813|454734031|FG000|Overall Study|Withdrawal by Subject|57|||
126393245|NCT02867813|454734032|FG001|Overall Study|Withdrawal by Subject|56|||
126393246|NCT02867813|454734031|FG000|Overall Study|Decision by Sponsor|7|||
126393247|NCT02867813|454734032|FG001|Overall Study|Decision by Sponsor|7|||
126393248|NCT02867813|454734031|FG000|Overall Study|Lost to Follow-up|91|||
126393249|NCT02867813|454734032|FG001|Overall Study|Lost to Follow-up|78|||
126393250|NCT02867813|454734031|FG000|Overall Study|Missing|2|||
126393251|NCT02867813|454734032|FG001|Overall Study|Missing|1|||
126393252|NCT02867813|454734031|FG000|Overall Study|Death|294|||
126393253|NCT02867813|454734032|FG001|Overall Study|Death|268|||
126393254|NCT01448824|454734033|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393255|NCT01448824|454734034|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393256|NCT01448824|454734035|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393257|NCT01448824|454734036|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393258|NCT01448824|454734037|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393259|NCT01448824|454734038|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393260|NCT01448824|454734039|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
125887986|NCT01519921|452886624|FG000|Overall Study|Lack of Efficacy|4|||
125887987|NCT01519921|452886625|FG001|Overall Study|Lack of Efficacy|3|||
126050075|NCT04088227|453479128|FG000|Overall Study|Surgery postponed >5weeks|1|||
126050076|NCT04088227|453479129|FG001|Overall Study|Surgery postponed >5weeks|0|||
126393261|NCT01448824|454734040|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393262|NCT01448824|454734033|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126393263|NCT01448824|454734034|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125887988|NCT01519921|452886624|FG000|Overall Study|Withdrawal by Subject|3|||
125887989|NCT01519921|452886625|FG001|Overall Study|Withdrawal by Subject|0|||
126050077|NCT00490139|453479131|FG000|Overall Study|Lost to Follow-up|249|||
126050078|NCT00490139|453479132|FG001|Overall Study|Lost to Follow-up|216|||
126393264|NCT01448824|454734035|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126393265|NCT01448824|454734036|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
126393266|NCT01448824|454734037|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
126393267|NCT01448824|454734038|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
126393268|NCT01448824|454734039|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126393269|NCT01448824|454734040|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126393270|NCT01448824|454734033|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393271|NCT01448824|454734034|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393272|NCT01448824|454734035|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393273|NCT01448824|454734036|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393274|NCT01448824|454734037|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393275|NCT01448824|454734038|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
126393276|NCT01448824|454734039|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393277|NCT01448824|454734040|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393278|NCT01448824|454734033|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
126393279|NCT01448824|454734034|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
126393280|NCT01448824|454734035|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
126393281|NCT01448824|454734036|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
126393282|NCT01448824|454734037|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
126393283|NCT01448824|454734038|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
126393284|NCT01448824|454734039|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
126393285|NCT01448824|454734040|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
126393286|NCT01448824|454734033|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393287|NCT01448824|454734034|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393288|NCT01448824|454734035|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393289|NCT01448824|454734036|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393290|NCT01448824|454734037|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393291|NCT01448824|454734038|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393292|NCT01448824|454734039|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393293|NCT01448824|454734040|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
126393294|NCT01448824|454734033|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393295|NCT01448824|454734034|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393296|NCT01448824|454734035|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393297|NCT01448824|454734036|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393298|NCT01448824|454734037|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393299|NCT01448824|454734038|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393300|NCT01448824|454734039|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393301|NCT01448824|454734040|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
126393302|NCT01448824|454734033|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393303|NCT01448824|454734034|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393304|NCT01448824|454734035|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393305|NCT01448824|454734036|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393306|NCT01448824|454734037|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393307|NCT01448824|454734038|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393308|NCT01448824|454734039|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393309|NCT01448824|454734040|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
126393310|NCT01448824|454734033|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393311|NCT01448824|454734034|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393312|NCT01448824|454734035|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393313|NCT01448824|454734036|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393314|NCT01448824|454734037|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393315|NCT01448824|454734038|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393316|NCT01448824|454734039|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393317|NCT01448824|454734040|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
126393318|NCT01995669|454734052|FG000|Overall Study|Progression|2|||
126393319|NCT01995669|454734053|FG001|Overall Study|Progression|1|||
126393320|NCT01995669|454734054|FG002|Overall Study|Progression|1|||
126393321|NCT01995669|454734055|FG003|Overall Study|Progression|13|||
126393322|NCT01995669|454734052|FG000|Overall Study|Adverse Event|0|||
126393323|NCT01995669|454734053|FG001|Overall Study|Adverse Event|0|||
126393324|NCT01995669|454734054|FG002|Overall Study|Adverse Event|0|||
126393325|NCT01995669|454734055|FG003|Overall Study|Adverse Event|3|||
126393326|NCT01995669|454734052|FG000|Overall Study|Death|0|||
126393327|NCT01995669|454734053|FG001|Overall Study|Death|0|||
126393328|NCT01995669|454734054|FG002|Overall Study|Death|0|||
126393329|NCT01995669|454734055|FG003|Overall Study|Death|6|||
126393330|NCT01995669|454734052|FG000|Overall Study|Withdrawal by Subject|0|||
126050079|NCT00490139|453479133|FG002|Overall Study|Lost to Follow-up|205|||
126050080|NCT00490139|453479134|FG003|Overall Study|Lost to Follow-up|229|||
126050081|NCT00490139|453479131|FG000|Overall Study|Withdrawal by Subject|333|||
126393331|NCT01995669|454734053|FG001|Overall Study|Withdrawal by Subject|0|||
126393332|NCT01995669|454734054|FG002|Overall Study|Withdrawal by Subject|0|||
126393333|NCT01995669|454734055|FG003|Overall Study|Withdrawal by Subject|6|||
126393334|NCT01995669|454734052|FG000|Overall Study|Insurance Expired|0|||
126393335|NCT01995669|454734053|FG001|Overall Study|Insurance Expired|0|||
126393336|NCT01995669|454734054|FG002|Overall Study|Insurance Expired|0|||
126393337|NCT01995669|454734055|FG003|Overall Study|Insurance Expired|1|||
126393338|NCT02998203|454734056|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
126393339|NCT02998203|454734057|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
126393340|NCT02998203|454734056|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
126393341|NCT02998203|454734057|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
126393342|NCT04085458|454734058|FG000|Overall Study|Other|1|||
126393343|NCT04085458|454734058|FG000|Overall Study|Withdrawal by Subject|2|||
126393344|NCT04085458|454734058|FG000|Overall Study|Adverse Event|2|||
126393345|NCT03632993|454734059|FG000|Overall Study|Withdrawal by Subject|1|||
126050082|NCT00490139|453479132|FG001|Overall Study|Withdrawal by Subject|322|||
126393346|NCT03632993|454734060|FG001|Overall Study|Withdrawal by Subject|0|||
126393347|NCT03632993|454734061|FG002|Overall Study|Withdrawal by Subject|0|||
126393348|NCT03632993|454734062|FG003|Overall Study|Withdrawal by Subject|0|||
126393349|NCT03632993|454734063|FG004|Overall Study|Withdrawal by Subject|0|||
126393350|NCT03632993|454734064|FG005|Overall Study|Withdrawal by Subject|0|||
126393351|NCT03632993|454734065|FG006|Overall Study|Withdrawal by Subject|0|||
126393352|NCT03632993|454734066|FG007|Overall Study|Withdrawal by Subject|0|||
126393353|NCT03632993|454734067|FG008|Overall Study|Withdrawal by Subject|0|||
126393354|NCT03632993|454734068|FG009|Overall Study|Withdrawal by Subject|1|||
126393355|NCT03632993|454734059|FG000|Overall Study|Protocol Non-compliance|0|||
126393356|NCT03632993|454734060|FG001|Overall Study|Protocol Non-compliance|1|||
126393357|NCT03632993|454734061|FG002|Overall Study|Protocol Non-compliance|0|||
126393358|NCT03632993|454734062|FG003|Overall Study|Protocol Non-compliance|0|||
126393359|NCT03632993|454734063|FG004|Overall Study|Protocol Non-compliance|0|||
126393360|NCT03632993|454734064|FG005|Overall Study|Protocol Non-compliance|0|||
126393361|NCT03632993|454734065|FG006|Overall Study|Protocol Non-compliance|0|||
126393362|NCT03632993|454734066|FG007|Overall Study|Protocol Non-compliance|0|||
126393363|NCT03632993|454734067|FG008|Overall Study|Protocol Non-compliance|0|||
126393364|NCT03632993|454734068|FG009|Overall Study|Protocol Non-compliance|0|||
126393365|NCT03632993|454734059|FG000|Overall Study|Lost to Follow-up|0|||
126393366|NCT03632993|454734060|FG001|Overall Study|Lost to Follow-up|0|||
126050083|NCT00490139|453479133|FG002|Overall Study|Withdrawal by Subject|396|||
126393367|NCT03632993|454734061|FG002|Overall Study|Lost to Follow-up|0|||
126393368|NCT03632993|454734062|FG003|Overall Study|Lost to Follow-up|0|||
126393369|NCT03632993|454734063|FG004|Overall Study|Lost to Follow-up|0|||
126393370|NCT03632993|454734064|FG005|Overall Study|Lost to Follow-up|1|||
126393371|NCT03632993|454734065|FG006|Overall Study|Lost to Follow-up|0|||
126393372|NCT03632993|454734066|FG007|Overall Study|Lost to Follow-up|1|||
125887990|NCT01519921|452886624|FG000|Overall Study|Lost to Follow-up|2|||
126393373|NCT03632993|454734067|FG008|Overall Study|Lost to Follow-up|0|||
126393374|NCT03632993|454734068|FG009|Overall Study|Lost to Follow-up|0|||
126393375|NCT03632993|454734059|FG000|Overall Study|Adverse Event|0|||
126393376|NCT03632993|454734060|FG001|Overall Study|Adverse Event|0|||
126393377|NCT03632993|454734061|FG002|Overall Study|Adverse Event|0|||
126393378|NCT03632993|454734062|FG003|Overall Study|Adverse Event|0|||
126393379|NCT03632993|454734063|FG004|Overall Study|Adverse Event|0|||
126393380|NCT03632993|454734064|FG005|Overall Study|Adverse Event|1|||
126393381|NCT03632993|454734065|FG006|Overall Study|Adverse Event|0|||
126393382|NCT03632993|454734066|FG007|Overall Study|Adverse Event|1|||
126393383|NCT03632993|454734067|FG008|Overall Study|Adverse Event|0|||
126393384|NCT03632993|454734068|FG009|Overall Study|Adverse Event|0|||
126393385|NCT02743949|454734069|FG000|Overall Study|Adverse Event|0|||
126393386|NCT02743949|454734070|FG001|Overall Study|Adverse Event|0|||
126393387|NCT02743949|454734071|FG002|Overall Study|Adverse Event|2|||
126393388|NCT02743949|454734069|FG000|Overall Study|Significant Protocol Deviation|2|||
126393389|NCT02743949|454734070|FG001|Overall Study|Significant Protocol Deviation|0|||
126393390|NCT02743949|454734071|FG002|Overall Study|Significant Protocol Deviation|1|||
126393391|NCT02743949|454734069|FG000|Overall Study|Voluntary Withdrawal|2|||
126393392|NCT02743949|454734070|FG001|Overall Study|Voluntary Withdrawal|1|||
126393393|NCT02743949|454734071|FG002|Overall Study|Voluntary Withdrawal|0|||
126393394|NCT03389555|454734072|FG000|Overall Study|Protocol Violation|1|||
126393395|NCT03389555|454734073|FG001|Overall Study|Protocol Violation|3|||
126393396|NCT03389555|454734072|FG000|Overall Study|Death|1|||
126393397|NCT03389555|454734073|FG001|Overall Study|Death|0|||
126393398|NCT00920218|454734074|FG000|Overall Study|Serious Adverse Event|2|||
126393399|NCT00920218|454734075|FG001|Overall Study|Serious Adverse Event|0|||
126393400|NCT00920218|454734076|FG002|Overall Study|Serious Adverse Event|2|||
126393401|NCT00920218|454734077|FG003|Overall Study|Serious Adverse Event|1|||
126393402|NCT00920218|454734074|FG000|Overall Study|Withdrawal by Subject|0|||
126393403|NCT00920218|454734075|FG001|Overall Study|Withdrawal by Subject|3|||
126393404|NCT00920218|454734076|FG002|Overall Study|Withdrawal by Subject|2|||
126393405|NCT00920218|454734077|FG003|Overall Study|Withdrawal by Subject|0|||
126393406|NCT00920218|454734074|FG000|Overall Study|Migrated/moved from study area|0|||
126393407|NCT00920218|454734075|FG001|Overall Study|Migrated/moved from study area|0|||
126393408|NCT00920218|454734076|FG002|Overall Study|Migrated/moved from study area|1|||
126393409|NCT00920218|454734077|FG003|Overall Study|Migrated/moved from study area|0|||
126393410|NCT00920218|454734074|FG000|Overall Study|Lost to Follow-up|0|||
126393411|NCT00920218|454734075|FG001|Overall Study|Lost to Follow-up|1|||
126393412|NCT00920218|454734076|FG002|Overall Study|Lost to Follow-up|0|||
126393413|NCT00920218|454734077|FG003|Overall Study|Lost to Follow-up|3|||
126393414|NCT00920218|454734074|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
126393415|NCT00920218|454734075|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
126393416|NCT00920218|454734076|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
126393417|NCT00920218|454734077|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
126393418|NCT00920218|454734074|FG000|Overall Study|Other|0|||
126393419|NCT00920218|454734075|FG001|Overall Study|Other|0|||
126393420|NCT00920218|454734076|FG002|Overall Study|Other|1|||
126050084|NCT00490139|453479134|FG003|Overall Study|Withdrawal by Subject|295|||
126050085|NCT00490139|453479131|FG000|Overall Study|Patient did not sign ICF 12|169|||
126393421|NCT00920218|454734077|FG003|Overall Study|Other|0|||
126393422|NCT01007435|454734078|FG000|Overall Study|Adverse Event|16|||
126393423|NCT01007435|454734079|FG001|Overall Study|Adverse Event|25|||
126393424|NCT01007435|454734080|FG002|Overall Study|Adverse Event|47|||
126393425|NCT01007435|454734081|FG003|Overall Study|Adverse Event|31|||
126393426|NCT01007435|454734078|FG000|Overall Study|Death|2|||
126393427|NCT01007435|454734079|FG001|Overall Study|Death|4|||
126393428|NCT01007435|454734080|FG002|Overall Study|Death|2|||
126393429|NCT01007435|454734081|FG003|Overall Study|Death|1|||
126393430|NCT01007435|454734078|FG000|Overall Study|Insufficient Therapeutic Response|21|||
126393431|NCT01007435|454734079|FG001|Overall Study|Insufficient Therapeutic Response|7|||
126393432|NCT01007435|454734080|FG002|Overall Study|Insufficient Therapeutic Response|2|||
126393433|NCT01007435|454734081|FG003|Overall Study|Insufficient Therapeutic Response|9|||
126393434|NCT01007435|454734078|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
126393435|NCT01007435|454734079|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
126393436|NCT01007435|454734080|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
126393437|NCT01007435|454734081|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
126393438|NCT01007435|454734078|FG000|Overall Study|Other Protocol Violation|2|||
126393439|NCT01007435|454734079|FG001|Overall Study|Other Protocol Violation|0|||
126393440|NCT01007435|454734080|FG002|Overall Study|Other Protocol Violation|1|||
126393441|NCT01007435|454734081|FG003|Overall Study|Other Protocol Violation|0|||
126393442|NCT01007435|454734078|FG000|Overall Study|Refused Treatment|13|||
126393443|NCT01007435|454734079|FG001|Overall Study|Refused Treatment|13|||
126393444|NCT01007435|454734080|FG002|Overall Study|Refused Treatment|5|||
126393445|NCT01007435|454734081|FG003|Overall Study|Refused Treatment|8|||
126393446|NCT01007435|454734078|FG000|Overall Study|Failure to Return|5|||
126393447|NCT01007435|454734079|FG001|Overall Study|Failure to Return|4|||
126393448|NCT01007435|454734080|FG002|Overall Study|Failure to Return|3|||
126393449|NCT01007435|454734081|FG003|Overall Study|Failure to Return|6|||
126393450|NCT01007435|454734078|FG000|Overall Study|Reason not Specified|1|||
126393451|NCT01007435|454734079|FG001|Overall Study|Reason not Specified|1|||
126393452|NCT01007435|454734080|FG002|Overall Study|Reason not Specified|2|||
126393453|NCT01007435|454734081|FG003|Overall Study|Reason not Specified|1|||
126393454|NCT01345591|454734084|FG000|Overall Study|Lost to Follow-up|1|||
126393455|NCT00847665|454734091|FG000|Overall Study|Withdrawal by Subject|1|||
126393456|NCT00847665|454734092|FG001|Overall Study|Withdrawal by Subject|0|||
126393457|NCT00624585|454734093|FG000|Overall Study|Death|3|||
126393458|NCT00624585|454734093|FG000|Overall Study|Disease Progression|6|||
126393459|NCT00624585|454734093|FG000|Overall Study|Adverse Event|3|||
126393460|NCT00676520|454734095|FG000|Overall Study|Withdrawal by Subject|163|||
126393461|NCT00676520|454734095|FG000|Overall Study|Lost to Follow-up|162|||
126393462|NCT00676520|454734095|FG000|Overall Study|Death|159|||
126393463|NCT00676520|454734095|FG000|Overall Study|Physician Decision|20|||
126393464|NCT00676520|454734095|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
126393465|NCT00676520|454734095|FG000|Overall Study|Other Reason|18|||
126393466|NCT01425359|454734096|FG000|Overall Study|Randomized but Not Treated|2|||
126393467|NCT01425359|454734097|FG001|Overall Study|Randomized but Not Treated|3|||
126393468|NCT01425359|454734096|FG000|Overall Study|Adverse Event|9|||
126393469|NCT01425359|454734097|FG001|Overall Study|Adverse Event|8|||
126393470|NCT01425359|454734096|FG000|Overall Study|Revascularization|0|||
126393471|NCT01425359|454734097|FG001|Overall Study|Revascularization|1|||
126393472|NCT01425359|454734096|FG000|Overall Study|Death|0|||
126393473|NCT01425359|454734097|FG001|Overall Study|Death|1|||
126393474|NCT01425359|454734096|FG000|Overall Study|Unsatisfactory Response|1|||
126393475|NCT01425359|454734097|FG001|Overall Study|Unsatisfactory Response|0|||
126393476|NCT01425359|454734096|FG000|Overall Study|Protocol Violation|1|||
126393477|NCT01425359|454734097|FG001|Overall Study|Protocol Violation|2|||
126393478|NCT01425359|454734096|FG000|Overall Study|Subject Withdrew Consent|1|||
126393479|NCT01425359|454734097|FG001|Overall Study|Subject Withdrew Consent|2|||
126393480|NCT01425359|454734096|FG000|Overall Study|Investigator's Discretion|2|||
126393481|NCT01425359|454734097|FG001|Overall Study|Investigator's Discretion|0|||
126393482|NCT01425359|454734096|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
126393483|NCT01425359|454734097|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
126393484|NCT03172325|454734098|FG000|Overall Study|Adverse Event|2|||
126393485|NCT03172325|454734099|FG001|Overall Study|Adverse Event|3|||
126393486|NCT03172325|454734098|FG000|Overall Study|Positive PPD|1|||
126393487|NCT03172325|454734099|FG001|Overall Study|Positive PPD|0|||
126393488|NCT03172325|454734098|FG000|Overall Study|Poor Compliance|1|||
126393489|NCT03172325|454734099|FG001|Overall Study|Poor Compliance|1|||
126393490|NCT03305419|454734104|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393491|NCT03305419|454734105|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
126393492|NCT03305419|454734106|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393493|NCT03305419|454734107|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393494|NCT03305419|454734108|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393495|NCT03305419|454734109|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393496|NCT03305419|454734110|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393497|NCT03305419|454734111|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393498|NCT03305419|454734104|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
126393499|NCT03305419|454734105|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393500|NCT03305419|454734106|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126050086|NCT00490139|453479132|FG001|Overall Study|Patient did not sign ICF 12|176|||
126393501|NCT03305419|454734107|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393502|NCT03305419|454734108|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126050087|NCT00490139|453479133|FG002|Overall Study|Patient did not sign ICF 12|139|||
126050088|NCT00490139|453479134|FG003|Overall Study|Patient did not sign ICF 12|167|||
126393503|NCT03305419|454734109|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393504|NCT03305419|454734110|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393505|NCT03305419|454734111|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393506|NCT03305419|454734104|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
126393507|NCT03305419|454734105|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393508|NCT03305419|454734106|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393509|NCT03305419|454734107|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393510|NCT03305419|454734108|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393511|NCT03305419|454734109|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393512|NCT03305419|454734110|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393513|NCT03305419|454734111|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393514|NCT03305419|454734104|FG000|Part B (14 Days)|Adverse Event|0|||
126393515|NCT03305419|454734105|FG001|Part B (14 Days)|Adverse Event|0|||
126393516|NCT03305419|454734106|FG002|Part B (14 Days)|Adverse Event|0|||
126393517|NCT03305419|454734107|FG003|Part B (14 Days)|Adverse Event|0|||
126393518|NCT03305419|454734108|FG004|Part B (14 Days)|Adverse Event|1|||
126393519|NCT03305419|454734109|FG005|Part B (14 Days)|Adverse Event|2|||
126393520|NCT03305419|454734110|FG006|Part B (14 Days)|Adverse Event|4|||
126393521|NCT03305419|454734111|FG007|Part B (14 Days)|Adverse Event|0|||
126393522|NCT03305419|454734104|FG000|Part B (14 Days)|Physician Decision|0|||
126393523|NCT03305419|454734105|FG001|Part B (14 Days)|Physician Decision|0|||
126393524|NCT03305419|454734106|FG002|Part B (14 Days)|Physician Decision|0|||
126393525|NCT03305419|454734107|FG003|Part B (14 Days)|Physician Decision|0|||
126393526|NCT03305419|454734108|FG004|Part B (14 Days)|Physician Decision|2|||
126393527|NCT03305419|454734109|FG005|Part B (14 Days)|Physician Decision|8|||
126393528|NCT03305419|454734110|FG006|Part B (14 Days)|Physician Decision|1|||
126393529|NCT03305419|454734111|FG007|Part B (14 Days)|Physician Decision|0|||
126393530|NCT00075946|454734112|FG000|Overall Study|Path ineligible: undetermined histology|0|||
126393531|NCT00075946|454734113|FG001|Overall Study|Path ineligible: undetermined histology|0|||
126393532|NCT00075946|454734114|FG002|Overall Study|Path ineligible: undetermined histology|0|||
126393533|NCT00075946|454734115|FG003|Overall Study|Path ineligible: undetermined histology|0|||
126393534|NCT00075946|454734116|FG004|Overall Study|Path ineligible: undetermined histology|6|||
126393535|NCT00075946|454734112|FG000|Overall Study|Did not achieve response after induction|0|||
126393536|NCT00075946|454734113|FG001|Overall Study|Did not achieve response after induction|0|||
126393537|NCT00075946|454734114|FG002|Overall Study|Did not achieve response after induction|0|||
126393538|NCT00075946|454734115|FG003|Overall Study|Did not achieve response after induction|0|||
125887991|NCT01519921|452886625|FG001|Overall Study|Lost to Follow-up|1|||
125887992|NCT01519921|452886624|FG000|Overall Study|Treatment refusal|2|||
125887993|NCT01519921|452886625|FG001|Overall Study|Treatment refusal|1|||
125887994|NCT01519921|452886624|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
125887995|NCT01519921|452886625|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
125887996|NCT01415882|452886628|FG000|Overall Study|Ineligible|1|||
125887997|NCT01415882|452886629|FG001|Overall Study|Ineligible|0|||
125887998|NCT01415882|452886630|FG002|Overall Study|Ineligible|0|||
125887999|NCT01415882|452886631|FG003|Overall Study|Ineligible|3|||
126393539|NCT00075946|454734116|FG004|Overall Study|Did not achieve response after induction|182|||
126393540|NCT00075946|454734112|FG000|Overall Study|Incorrectly randomized (no response)|5|||
126393541|NCT00075946|454734113|FG001|Overall Study|Incorrectly randomized (no response)|5|||
126393542|NCT00075946|454734114|FG002|Overall Study|Incorrectly randomized (no response)|5|||
125888000|NCT01415882|452886632|FG004|Overall Study|Ineligible|0|||
125888001|NCT01415882|452886628|FG000|Overall Study|Withdrawal by Subject|0|||
126393543|NCT00075946|454734115|FG003|Overall Study|Incorrectly randomized (no response)|1|||
126393544|NCT00075946|454734116|FG004|Overall Study|Incorrectly randomized (no response)|0|||
126393545|NCT00075946|454734112|FG000|Overall Study|Adverse Event|2|||
126393546|NCT00075946|454734113|FG001|Overall Study|Adverse Event|10|||
126393547|NCT00075946|454734114|FG002|Overall Study|Adverse Event|0|||
126393548|NCT00075946|454734115|FG003|Overall Study|Adverse Event|2|||
126393549|NCT00075946|454734116|FG004|Overall Study|Adverse Event|0|||
126393550|NCT00075946|454734112|FG000|Overall Study|Death|0|||
126393551|NCT00075946|454734113|FG001|Overall Study|Death|1|||
126393552|NCT00075946|454734114|FG002|Overall Study|Death|0|||
126393553|NCT00075946|454734115|FG003|Overall Study|Death|0|||
126393554|NCT00075946|454734116|FG004|Overall Study|Death|0|||
126393555|NCT00075946|454734112|FG000|Overall Study|Withdrawal by Subject|23|||
126393556|NCT00075946|454734113|FG001|Overall Study|Withdrawal by Subject|58|||
126393557|NCT00075946|454734114|FG002|Overall Study|Withdrawal by Subject|4|||
126393558|NCT00075946|454734115|FG003|Overall Study|Withdrawal by Subject|9|||
126393559|NCT00075946|454734116|FG004|Overall Study|Withdrawal by Subject|0|||
126393560|NCT00075946|454734112|FG000|Overall Study|Alternative therapy|16|||
126393561|NCT00075946|454734113|FG001|Overall Study|Alternative therapy|2|||
126393562|NCT00075946|454734114|FG002|Overall Study|Alternative therapy|5|||
126393563|NCT00075946|454734115|FG003|Overall Study|Alternative therapy|0|||
126393564|NCT00075946|454734116|FG004|Overall Study|Alternative therapy|0|||
126393565|NCT00075946|454734112|FG000|Overall Study|Other complicating disease|7|||
126393566|NCT00075946|454734113|FG001|Overall Study|Other complicating disease|13|||
126393567|NCT00075946|454734114|FG002|Overall Study|Other complicating disease|1|||
126393568|NCT00075946|454734115|FG003|Overall Study|Other complicating disease|4|||
126393569|NCT00075946|454734116|FG004|Overall Study|Other complicating disease|0|||
126393570|NCT00075946|454734112|FG000|Overall Study|No response to retreatment|23|||
126393571|NCT00075946|454734113|FG001|Overall Study|No response to retreatment|0|||
126393572|NCT00075946|454734114|FG002|Overall Study|No response to retreatment|2|||
126393573|NCT00075946|454734115|FG003|Overall Study|No response to retreatment|0|||
126393574|NCT00075946|454734116|FG004|Overall Study|No response to retreatment|0|||
126393575|NCT00075946|454734112|FG000|Overall Study|Time to progression less than 6 months|15|||
126393576|NCT00075946|454734113|FG001|Overall Study|Time to progression less than 6 months|30|||
126393577|NCT00075946|454734114|FG002|Overall Study|Time to progression less than 6 months|8|||
126050089|NCT00490139|453479131|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
126393578|NCT00075946|454734115|FG003|Overall Study|Time to progression less than 6 months|3|||
126393579|NCT00075946|454734116|FG004|Overall Study|Time to progression less than 6 months|0|||
126393580|NCT00075946|454734112|FG000|Overall Study|Other|57|||
126393581|NCT00075946|454734113|FG001|Overall Study|Other|32|||
126393582|NCT00075946|454734114|FG002|Overall Study|Other|3|||
126393583|NCT00075946|454734115|FG003|Overall Study|Other|11|||
126393584|NCT00075946|454734116|FG004|Overall Study|Other|0|||
126393585|NCT00889603|454734119|FG000|Overall Study|Adverse Event|7|||
126393586|NCT00889603|454734119|FG000|Overall Study|Death|3|||
126393587|NCT00889603|454734119|FG000|Overall Study|Lost to Follow-up|19|||
126393588|NCT00889603|454734119|FG000|Overall Study|No longer willing to participant in stud|4|||
126393589|NCT00889603|454734119|FG000|Overall Study|Other|4|||
126393590|NCT01229254|454734120|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
126393591|NCT01229254|454734121|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
126393592|NCT01229254|454734122|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
126393593|NCT01229254|454734120|FG000|Overall Study|Adverse Event|4|||
126393594|NCT01229254|454734121|FG001|Overall Study|Adverse Event|5|||
126393595|NCT01229254|454734122|FG002|Overall Study|Adverse Event|3|||
126393596|NCT01229254|454734120|FG000|Overall Study|Lost to Follow-up|3|||
126393597|NCT01229254|454734121|FG001|Overall Study|Lost to Follow-up|0|||
126050090|NCT00490139|453479132|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
126393598|NCT01229254|454734122|FG002|Overall Study|Lost to Follow-up|1|||
126393599|NCT01229254|454734120|FG000|Overall Study|Physician Decision|0|||
126393600|NCT01229254|454734121|FG001|Overall Study|Physician Decision|3|||
126393601|NCT01229254|454734122|FG002|Overall Study|Physician Decision|0|||
126393602|NCT01229254|454734120|FG000|Overall Study|Protocol Violation|4|||
126393603|NCT01229254|454734121|FG001|Overall Study|Protocol Violation|6|||
126393604|NCT01229254|454734122|FG002|Overall Study|Protocol Violation|5|||
126393605|NCT01229254|454734120|FG000|Overall Study|Withdrawal by Subject|1|||
126393606|NCT01229254|454734121|FG001|Overall Study|Withdrawal by Subject|0|||
126393607|NCT01229254|454734122|FG002|Overall Study|Withdrawal by Subject|1|||
126393608|NCT01229254|454734120|FG000|Overall Study|Non-compliance with Study Drug|0|||
126393609|NCT01229254|454734121|FG001|Overall Study|Non-compliance with Study Drug|1|||
126393610|NCT01229254|454734122|FG002|Overall Study|Non-compliance with Study Drug|1|||
126393611|NCT02231892|454734123|FG000|Overall Study|Lost to Follow-up|1|||
126393612|NCT02231892|454734124|FG001|Overall Study|Lost to Follow-up|0|||
126393613|NCT02231892|454734125|FG002|Overall Study|Lost to Follow-up|3|||
126393614|NCT02231892|454734123|FG000|Overall Study|Withdrawal by Subject|4|||
126393615|NCT02231892|454734124|FG001|Overall Study|Withdrawal by Subject|3|||
126393616|NCT02231892|454734125|FG002|Overall Study|Withdrawal by Subject|15|||
126393617|NCT02231892|454734123|FG000|Overall Study|Physician Decision|0|||
126393618|NCT02231892|454734124|FG001|Overall Study|Physician Decision|2|||
126393619|NCT02231892|454734125|FG002|Overall Study|Physician Decision|4|||
126393620|NCT02231892|454734123|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
126393621|NCT02231892|454734124|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
126393622|NCT02231892|454734125|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
126393623|NCT02231892|454734123|FG000|Overall Study|Participant motor threshold was >83%|0|||
126393624|NCT02231892|454734124|FG001|Overall Study|Participant motor threshold was >83%|0|||
126393625|NCT02231892|454734125|FG002|Overall Study|Participant motor threshold was >83%|9|||
126050091|NCT00490139|453479133|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
126050092|NCT00490139|453479134|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
126393626|NCT02231892|454734123|FG000|Overall Study|Could not find motor threshold|2|||
126393627|NCT02231892|454734124|FG001|Overall Study|Could not find motor threshold|0|||
126393628|NCT02231892|454734125|FG002|Overall Study|Could not find motor threshold|1|||
126393629|NCT02231892|454734123|FG000|Overall Study|Could not find reliable motor hotspot|0|||
126393630|NCT02231892|454734124|FG001|Overall Study|Could not find reliable motor hotspot|0|||
126393631|NCT02231892|454734125|FG002|Overall Study|Could not find reliable motor hotspot|1|||
126393632|NCT01694121|454734128|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
126393633|NCT01694121|454734129|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
126393634|NCT02680041|454734130|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
126393635|NCT02680041|454734130|FG000|Overall Study|Lost to Follow-up|2|||
126393636|NCT00521599|454734131|FG000|Overall Study|Adverse Event|5|||
126393637|NCT00521599|454734132|FG001|Overall Study|Adverse Event|7|||
126393638|NCT00521599|454734133|FG002|Overall Study|Adverse Event|6|||
126393639|NCT00521599|454734131|FG000|Overall Study|Treatment Failure|8|||
126393640|NCT00521599|454734132|FG001|Overall Study|Treatment Failure|9|||
126393641|NCT00521599|454734133|FG002|Overall Study|Treatment Failure|22|||
126393642|NCT00521599|454734131|FG000|Overall Study|Lost to Follow-up|2|||
126393643|NCT00521599|454734132|FG001|Overall Study|Lost to Follow-up|1|||
126393644|NCT00521599|454734133|FG002|Overall Study|Lost to Follow-up|2|||
126393645|NCT00521599|454734131|FG000|Overall Study|Withdrawal by Subject|3|||
126393646|NCT00521599|454734132|FG001|Overall Study|Withdrawal by Subject|5|||
126393647|NCT00521599|454734133|FG002|Overall Study|Withdrawal by Subject|1|||
126393648|NCT00521599|454734131|FG000|Overall Study|Withdrawal by subject treatment related|3|||
126393649|NCT00521599|454734132|FG001|Overall Study|Withdrawal by subject treatment related|1|||
126393650|NCT00521599|454734133|FG002|Overall Study|Withdrawal by subject treatment related|2|||
126393651|NCT00521599|454734131|FG000|Overall Study|Protocol Violation|2|||
126393652|NCT00521599|454734132|FG001|Overall Study|Protocol Violation|4|||
126393653|NCT00521599|454734133|FG002|Overall Study|Protocol Violation|2|||
126393654|NCT00521599|454734131|FG000|Overall Study|Did not meet protocol eligibility|2|||
126393655|NCT00521599|454734132|FG001|Overall Study|Did not meet protocol eligibility|2|||
126393656|NCT00521599|454734133|FG002|Overall Study|Did not meet protocol eligibility|1|||
126393657|NCT02186652|454734134|FG000|Overall Study|Lost to Follow-up|2|||
126393658|NCT02186652|454734135|FG001|Overall Study|Lost to Follow-up|0|||
126393659|NCT00744978|454734136|FG000|Period 1|Lost to Follow-up|1|||
126393660|NCT00744978|454734137|FG001|Period 1|Lost to Follow-up|0|||
126393661|NCT00744978|454734136|FG000|Period 1|Withdrawal by Subject|0|||
126393662|NCT00744978|454734137|FG001|Period 1|Withdrawal by Subject|2|||
126393663|NCT00744978|454734136|FG000|Period 1|Other|0|||
126393664|NCT00744978|454734137|FG001|Period 1|Other|2|||
126393665|NCT00744978|454734136|FG000|Period 1|Adverse Event|4|||
126050093|NCT00490139|453479131|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
126050094|NCT00490139|453479132|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
126050095|NCT00490139|453479133|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
126050096|NCT00490139|453479134|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
126050097|NCT00490139|453479131|FG000|Overall Study|Other reasons as defined per protocol|98|||
126050098|NCT00490139|453479132|FG001|Overall Study|Other reasons as defined per protocol|84|||
126050099|NCT00490139|453479133|FG002|Overall Study|Other reasons as defined per protocol|82|||
126050100|NCT00490139|453479134|FG003|Overall Study|Other reasons as defined per protocol|105|||
126050101|NCT02036970|453480999|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
126050102|NCT02036970|453481000|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
126050103|NCT02036970|453481001|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
126050104|NCT02036970|453481002|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
126050105|NCT02036970|453481003|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
126050106|NCT02036970|453481004|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
126050107|NCT02036970|453481005|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
126050108|NCT02036970|453481006|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
126050109|NCT02036970|453481007|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
126050110|NCT02036970|453481008|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
126050111|NCT02036970|453480999|FG000|Part 1: Day 1 Through Week 16|Death|0|||
126104602|NCT04002401|453675932|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
126393666|NCT00744978|454734137|FG001|Period 1|Adverse Event|0|||
126393667|NCT00744978|454734136|FG000|Period 1|Randomized but not Treated|1|||
126393668|NCT00744978|454734137|FG001|Period 1|Randomized but not Treated|1|||
126393669|NCT00744978|454734136|FG000|Period 2|Adverse Event|0|||
126393670|NCT00744978|454734137|FG001|Period 2|Adverse Event|1|||
126393671|NCT00866047|454734141|FG000|Treatment Period|Progressive disease|13|||
126393672|NCT00866047|454734141|FG000|Treatment Period|Adverse Event|16|||
126393673|NCT00866047|454734141|FG000|Treatment Period|Physician Decision|14|||
126393674|NCT00866047|454734141|FG000|Treatment Period|Withdrawal by Subject|5|||
126393675|NCT00866047|454734141|FG000|Follow-up Period|Lost to Follow-up|5|||
126050112|NCT02036970|453481000|FG001|Part 1: Day 1 Through Week 16|Death|0|||
126050113|NCT02036970|453481001|FG002|Part 1: Day 1 Through Week 16|Death|0|||
126050114|NCT02036970|453481002|FG003|Part 1: Day 1 Through Week 16|Death|0|||
126393676|NCT02928029|454734142|FG000|Overall Study|Withdrawal by Subject|0|||
126393677|NCT02928029|454734143|FG001|Overall Study|Withdrawal by Subject|1|||
126393678|NCT02928029|454734142|FG000|Overall Study|Radiological progression|1|||
126050115|NCT02036970|453481003|FG004|Part 1: Day 1 Through Week 16|Death|0|||
126050116|NCT02036970|453481004|FG005|Part 1: Day 1 Through Week 16|Death|0|||
126050117|NCT02036970|453481005|FG006|Part 1: Day 1 Through Week 16|Death|0|||
126050118|NCT02036970|453481006|FG007|Part 1: Day 1 Through Week 16|Death|0|||
126050119|NCT02036970|453481007|FG008|Part 1: Day 1 Through Week 16|Death|1|||
126050120|NCT02036970|453481008|FG009|Part 1: Day 1 Through Week 16|Death|0|||
126050121|NCT02036970|453480999|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
126050122|NCT02036970|453481000|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126050123|NCT02036970|453481001|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
126050124|NCT02036970|453481002|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126050125|NCT02036970|453481003|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126050126|NCT02036970|453481004|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126050127|NCT02036970|453481005|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126050128|NCT02036970|453481006|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126050129|NCT02036970|453481007|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
126050130|NCT02036970|453481008|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126050131|NCT02036970|453480999|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126050132|NCT02036970|453481000|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126050133|NCT02036970|453481001|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126050134|NCT02036970|453481002|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126050135|NCT02036970|453481003|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
126050136|NCT02036970|453481004|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126050137|NCT02036970|453481005|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126050138|NCT02036970|453481006|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126050139|NCT02036970|453481007|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
126050140|NCT02036970|453481008|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
126050141|NCT02036970|453480999|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050142|NCT02036970|453481000|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050143|NCT02036970|453481001|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050144|NCT02036970|453481002|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
126050145|NCT02036970|453481003|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050146|NCT02036970|453481004|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050147|NCT02036970|453481005|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050148|NCT02036970|453481006|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050149|NCT02036970|453481007|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050150|NCT02036970|453481008|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126050151|NCT02036970|453480999|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
126050152|NCT02036970|453481000|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
126050153|NCT02036970|453481001|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
126050154|NCT02036970|453481002|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
126050155|NCT02036970|453481003|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
126393679|NCT02928029|454734143|FG001|Overall Study|Radiological progression|0|||
126393680|NCT02928029|454734142|FG000|Overall Study|Clinical progression|1|||
126393681|NCT02928029|454734143|FG001|Overall Study|Clinical progression|2|||
126393682|NCT02928029|454734142|FG000|Overall Study|AE not related to clinical progression|1|||
126393683|NCT02928029|454734143|FG001|Overall Study|AE not related to clinical progression|1|||
126393684|NCT00515294|454734144|FG000|Overall Study|Lost to Follow-up|3|||
126393685|NCT00515294|454734145|FG001|Overall Study|Lost to Follow-up|2|||
126393686|NCT00515294|454734146|FG002|Overall Study|Lost to Follow-up|3|||
126393687|NCT00515294|454734147|FG003|Overall Study|Lost to Follow-up|1|||
126393688|NCT00515294|454734144|FG000|Overall Study|Driver simulator problems|1|||
126393689|NCT00515294|454734145|FG001|Overall Study|Driver simulator problems|1|||
126393690|NCT00515294|454734146|FG002|Overall Study|Driver simulator problems|1|||
126393691|NCT00515294|454734147|FG003|Overall Study|Driver simulator problems|3|||
126393692|NCT00515294|454734144|FG000|Overall Study|Caffeine amount inaccurate|5|||
126393693|NCT00515294|454734145|FG001|Overall Study|Caffeine amount inaccurate|0|||
126393694|NCT00515294|454734146|FG002|Overall Study|Caffeine amount inaccurate|7|||
126050156|NCT02036970|453481004|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
126050157|NCT02036970|453481005|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
126050158|NCT02036970|453481006|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
126050159|NCT02036970|453481007|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
126104603|NCT04002401|453675932|FG000|Overall Study|Enrolled but Never Treated|1|||
126104604|NCT04002401|453675932|FG000|Overall Study|Lost to Follow-up|1|||
126393695|NCT00515294|454734147|FG003|Overall Study|Caffeine amount inaccurate|0|||
126393696|NCT02778555|454734148|FG000|Overall Study|Withdrawal by Subject|55|||
126050160|NCT02036970|453481008|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
126050161|NCT02036970|453480999|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
126050162|NCT02036970|453481000|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
126050163|NCT02036970|453481001|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
126050164|NCT02036970|453481002|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
126050165|NCT02036970|453481003|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
126050166|NCT02036970|453481004|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
126393697|NCT02778555|454734149|FG001|Overall Study|Withdrawal by Subject|32|||
126393698|NCT02778555|454734150|FG002|Overall Study|Withdrawal by Subject|107|||
126050167|NCT02036970|453481005|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
126050168|NCT02036970|453481006|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
126050169|NCT02036970|453481007|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
126393699|NCT04659174|454734155|FG000|Overall Study|Sponsor decision to discontinue study|0|||
126393700|NCT04659174|454734156|FG001|Overall Study|Sponsor decision to discontinue study|2|||
126393701|NCT04659174|454734155|FG000|Overall Study|Lost to Follow-up|9|||
126393702|NCT04659174|454734156|FG001|Overall Study|Lost to Follow-up|11|||
126393703|NCT04659174|454734155|FG000|Overall Study|Adverse Event|8|||
126393704|NCT04659174|454734156|FG001|Overall Study|Adverse Event|5|||
126393705|NCT04659174|454734155|FG000|Overall Study|Withdrawal by Subject|17|||
126393706|NCT04659174|454734156|FG001|Overall Study|Withdrawal by Subject|33|||
126393707|NCT04659174|454734155|FG000|Overall Study|Progressive disease|0|||
126393708|NCT04659174|454734156|FG001|Overall Study|Progressive disease|2|||
126393709|NCT04659174|454734155|FG000|Overall Study|Other reasons|0|||
126393710|NCT04659174|454734156|FG001|Overall Study|Other reasons|2|||
126393711|NCT04659174|454734155|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
126393712|NCT04659174|454734156|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
126393713|NCT04659174|454734155|FG000|Overall Study|Alcohol or illegal drug use|0|||
126393714|NCT04659174|454734156|FG001|Overall Study|Alcohol or illegal drug use|3|||
126393715|NCT04659174|454734155|FG000|Overall Study|Violation of entry criteria|1|||
126393716|NCT04659174|454734156|FG001|Overall Study|Violation of entry criteria|0|||
126393717|NCT04659174|454734155|FG000|Overall Study|Death|0|||
126393718|NCT04659174|454734156|FG001|Overall Study|Death|1|||
126393719|NCT01818258|454734163|FG000|Overall Study|Death|3|||
126393720|NCT01818258|454734164|FG001|Overall Study|Death|0|||
126393721|NCT01818258|454734163|FG000|Overall Study|Withdrawal by Subject|0|||
126393722|NCT01818258|454734164|FG001|Overall Study|Withdrawal by Subject|1|||
126050170|NCT02036970|453481008|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
126050171|NCT02036970|453480999|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126050172|NCT02036970|453481000|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
126050173|NCT02036970|453481001|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
126050174|NCT02036970|453481002|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126393723|NCT01818258|454734163|FG000|Overall Study|Lost to Follow-up|0|||
126393724|NCT01818258|454734164|FG001|Overall Study|Lost to Follow-up|1|||
126393725|NCT01818258|454734163|FG000|Overall Study|Unable to Travel to Clinic|0|||
126393726|NCT01818258|454734164|FG001|Overall Study|Unable to Travel to Clinic|1|||
126393727|NCT02099344|454734165|FG000|Overall Study|Physician Decision|1|||
126393728|NCT02099344|454734166|FG001|Overall Study|Physician Decision|0|||
126393729|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
126393730|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
126393731|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
126393732|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
126393733|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
126393734|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
126393735|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
126393736|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
126393737|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
126393738|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
126393739|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
126393740|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
126393741|NCT01639339|454734172|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
126393742|NCT01639339|454734173|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
126050175|NCT02036970|453481003|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126393743|NCT01639339|454734172|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
126393744|NCT01639339|454734173|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
126393745|NCT01639339|454734172|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
126393746|NCT01639339|454734173|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
126393747|NCT01639339|454734172|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
126393748|NCT01639339|454734173|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
126393749|NCT02649218|454734174|FG000|Overall Study|Adverse Event|8|||
126393750|NCT02649218|454734174|FG000|Overall Study|Lack of Efficacy|8|||
126393751|NCT02649218|454734174|FG000|Overall Study|Pregnancy|3|||
126393752|NCT02649218|454734174|FG000|Overall Study|Protocol Violation|3|||
126393753|NCT02649218|454734174|FG000|Overall Study|Physician Decision|1|||
126393754|NCT02649218|454734174|FG000|Overall Study|Withdrawal by Subject|2|||
126393755|NCT03022097|454734176|FG000|Overall Study|Adverse Event|3|||
126050176|NCT02036970|453481004|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126050177|NCT02036970|453481005|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126393756|NCT03022097|454734177|FG001|Overall Study|Adverse Event|4|||
126393757|NCT03022097|454734178|FG002|Overall Study|Adverse Event|1|||
126393758|NCT03022097|454734179|FG003|Overall Study|Adverse Event|3|||
126050178|NCT02036970|453481006|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126050179|NCT02036970|453481007|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
126050180|NCT02036970|453481008|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126050181|NCT02036970|453480999|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
126393759|NCT03022097|454734176|FG000|Overall Study|Progressive Disease|2|||
126393760|NCT03022097|454734177|FG001|Overall Study|Progressive Disease|0|||
126393761|NCT03022097|454734178|FG002|Overall Study|Progressive Disease|5|||
126393762|NCT03022097|454734179|FG003|Overall Study|Progressive Disease|2|||
126393763|NCT03022097|454734176|FG000|Overall Study|Lack of Efficacy|0|||
126393764|NCT03022097|454734177|FG001|Overall Study|Lack of Efficacy|0|||
126393765|NCT03022097|454734178|FG002|Overall Study|Lack of Efficacy|3|||
126393766|NCT03022097|454734179|FG003|Overall Study|Lack of Efficacy|3|||
126393767|NCT03022097|454734176|FG000|Overall Study|Protocol Violation|1|||
126393768|NCT03022097|454734177|FG001|Overall Study|Protocol Violation|0|||
126393769|NCT03022097|454734178|FG002|Overall Study|Protocol Violation|1|||
126393770|NCT03022097|454734179|FG003|Overall Study|Protocol Violation|0|||
126393771|NCT03022097|454734176|FG000|Overall Study|Withdrawal by Subject|11|||
126393772|NCT03022097|454734177|FG001|Overall Study|Withdrawal by Subject|13|||
126393773|NCT03022097|454734178|FG002|Overall Study|Withdrawal by Subject|15|||
126393774|NCT03022097|454734179|FG003|Overall Study|Withdrawal by Subject|21|||
126393775|NCT03022097|454734176|FG000|Overall Study|Lost to Follow-up|0|||
126393776|NCT03022097|454734177|FG001|Overall Study|Lost to Follow-up|0|||
126393777|NCT03022097|454734178|FG002|Overall Study|Lost to Follow-up|1|||
126393778|NCT03022097|454734179|FG003|Overall Study|Lost to Follow-up|1|||
126393779|NCT03022097|454734176|FG000|Overall Study|Other|4|||
126393780|NCT03022097|454734177|FG001|Overall Study|Other|1|||
126393781|NCT03022097|454734178|FG002|Overall Study|Other|6|||
126393782|NCT03022097|454734179|FG003|Overall Study|Other|4|||
126393783|NCT03022097|454734176|FG000|Overall Study|Due to COVID-19 pandemic|0|||
126393784|NCT03022097|454734177|FG001|Overall Study|Due to COVID-19 pandemic|1|||
126393785|NCT03022097|454734178|FG002|Overall Study|Due to COVID-19 pandemic|0|||
126393786|NCT03022097|454734179|FG003|Overall Study|Due to COVID-19 pandemic|0|||
126393787|NCT01451931|454734182|FG000|Overall Study|Lost to Follow-up|17|||
126393788|NCT01451931|454734183|FG001|Overall Study|Lost to Follow-up|36|||
126393789|NCT01451931|454734184|FG002|Overall Study|Lost to Follow-up|21|||
126393790|NCT01451931|454734182|FG000|Overall Study|Withdrawal by Subject|16|||
126393791|NCT01451931|454734183|FG001|Overall Study|Withdrawal by Subject|22|||
126393792|NCT01451931|454734184|FG002|Overall Study|Withdrawal by Subject|22|||
126393793|NCT01349322|454734185|FG000|Overall Study|Protocol Violation|45|||
126393794|NCT01349322|454734186|FG001|Overall Study|Protocol Violation|47|||
126393795|NCT04470908|454734191|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
126393796|NCT02118766|454734192|FG000|Overall Study|Adverse Event|7|||
126393797|NCT02118766|454734193|FG001|Overall Study|Adverse Event|2|||
126393798|NCT02118766|454734192|FG000|Overall Study|Withdrawal by Subject|3|||
126393799|NCT02118766|454734193|FG001|Overall Study|Withdrawal by Subject|6|||
126393800|NCT02118766|454734192|FG000|Overall Study|Lost to Follow-up|5|||
126393801|NCT02118766|454734193|FG001|Overall Study|Lost to Follow-up|4|||
126393802|NCT02118766|454734192|FG000|Overall Study|Withdrawal by parent/guardian|12|||
126393803|NCT02118766|454734193|FG001|Overall Study|Withdrawal by parent/guardian|18|||
126393804|NCT02118766|454734192|FG000|Overall Study|Other|3|||
126393805|NCT02118766|454734193|FG001|Overall Study|Other|1|||
126393806|NCT01846299|454734196|FG000|Overall Study|Physician Decision|4|||
126393807|NCT01846299|454734197|FG001|Overall Study|Physician Decision|2|||
126393808|NCT01846299|454734196|FG000|Overall Study|Protocol deviation|1|||
126393809|NCT01846299|454734197|FG001|Overall Study|Protocol deviation|0|||
126393810|NCT01846299|454734196|FG000|Overall Study|Death|1|||
126393811|NCT01846299|454734197|FG001|Overall Study|Death|2|||
126393812|NCT01846299|454734196|FG000|Overall Study|Lost to Follow-up|3|||
126393813|NCT01846299|454734197|FG001|Overall Study|Lost to Follow-up|0|||
126393814|NCT01846299|454734196|FG000|Overall Study|Withdrawal by Subject|1|||
126393815|NCT01846299|454734197|FG001|Overall Study|Withdrawal by Subject|6|||
126050182|NCT02036970|453481000|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
126050183|NCT02036970|453481001|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
126393816|NCT01846299|454734196|FG000|Overall Study|Adverse Event|2|||
126393817|NCT01846299|454734197|FG001|Overall Study|Adverse Event|0|||
126393818|NCT00496483|454736401|FG000|Overall Study|Not dosed|9|||
126393819|NCT00496483|454736401|FG000|Overall Study|Adverse Event|2|||
126393820|NCT00496483|454736401|FG000|Overall Study|Lack of Efficacy|1|||
126393821|NCT03095027|454736404|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
126393822|NCT03095027|454736405|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
126393823|NCT02264665|454736406|FG000|Overall Study|Other|0|||
126393824|NCT02264665|454736407|FG001|Overall Study|Other|0|||
126393825|NCT02264665|454736408|FG002|Overall Study|Other|3|||
126393826|NCT02264665|454736409|FG003|Overall Study|Other|0|||
126393827|NCT02264665|454736410|FG004|Overall Study|Other|0|||
126393828|NCT02264665|454736411|FG005|Overall Study|Other|0|||
126393829|NCT02264665|454736412|FG006|Overall Study|Other|0|||
126393830|NCT02264665|454736406|FG000|Overall Study|Death|9|||
126393831|NCT02264665|454736407|FG001|Overall Study|Death|8|||
126393832|NCT02264665|454736408|FG002|Overall Study|Death|13|||
126393833|NCT02264665|454736409|FG003|Overall Study|Death|5|||
126393834|NCT02264665|454736410|FG004|Overall Study|Death|0|||
126393835|NCT02264665|454736411|FG005|Overall Study|Death|0|||
126393836|NCT02264665|454736412|FG006|Overall Study|Death|1|||
126393837|NCT02264665|454736406|FG000|Overall Study|Lost to Follow-up|1|||
126393838|NCT02264665|454736407|FG001|Overall Study|Lost to Follow-up|0|||
126393839|NCT02264665|454736408|FG002|Overall Study|Lost to Follow-up|2|||
126393840|NCT02264665|454736409|FG003|Overall Study|Lost to Follow-up|1|||
126393841|NCT02264665|454736410|FG004|Overall Study|Lost to Follow-up|0|||
126393842|NCT02264665|454736411|FG005|Overall Study|Lost to Follow-up|0|||
126393843|NCT02264665|454736412|FG006|Overall Study|Lost to Follow-up|0|||
126393844|NCT02264665|454736406|FG000|Overall Study|Participant decision|0|||
126393845|NCT02264665|454736407|FG001|Overall Study|Participant decision|0|||
126393846|NCT02264665|454736408|FG002|Overall Study|Participant decision|0|||
126393847|NCT02264665|454736409|FG003|Overall Study|Participant decision|1|||
126393848|NCT02264665|454736410|FG004|Overall Study|Participant decision|0|||
126393849|NCT02264665|454736411|FG005|Overall Study|Participant decision|0|||
126393850|NCT02264665|454736412|FG006|Overall Study|Participant decision|0|||
126393851|NCT02264665|454736406|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
126393852|NCT02264665|454736407|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
126393853|NCT02264665|454736408|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
126393854|NCT02264665|454736409|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
126393855|NCT02264665|454736410|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
126393856|NCT02264665|454736411|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
126393857|NCT02264665|454736412|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
126393858|NCT02264665|454736406|FG000|Overall Study|Data Missing|0|||
126393859|NCT02264665|454736407|FG001|Overall Study|Data Missing|0|||
126393860|NCT02264665|454736408|FG002|Overall Study|Data Missing|1|||
126393861|NCT02264665|454736409|FG003|Overall Study|Data Missing|0|||
126393862|NCT02264665|454736410|FG004|Overall Study|Data Missing|0|||
126393863|NCT02264665|454736411|FG005|Overall Study|Data Missing|0|||
126393864|NCT02264665|454736412|FG006|Overall Study|Data Missing|0|||
126393865|NCT01962987|454736413|FG000|Overall Study|Adverse Event|4|||
126393866|NCT01962987|454736414|FG001|Overall Study|Adverse Event|4|||
126393867|NCT01962987|454736415|FG002|Overall Study|Adverse Event|0|||
126393868|NCT01962987|454736413|FG000|Overall Study|Lost to Follow-up|0|||
126393869|NCT01962987|454736414|FG001|Overall Study|Lost to Follow-up|0|||
126393870|NCT01962987|454736415|FG002|Overall Study|Lost to Follow-up|1|||
126393871|NCT01962987|454736413|FG000|Overall Study|Non compliance with dosing requirements|4|||
126393872|NCT01962987|454736414|FG001|Overall Study|Non compliance with dosing requirements|2|||
126393873|NCT01962987|454736415|FG002|Overall Study|Non compliance with dosing requirements|0|||
126393874|NCT01962987|454736413|FG000|Overall Study|Miscellaneous|1|||
126393875|NCT01962987|454736414|FG001|Overall Study|Miscellaneous|9|||
126393876|NCT01962987|454736415|FG002|Overall Study|Miscellaneous|2|||
126393877|NCT01962987|454736413|FG000|Overall Study|Restricted medication|5|||
126393878|NCT01962987|454736414|FG001|Overall Study|Restricted medication|1|||
126050184|NCT02036970|453481002|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
126393879|NCT01962987|454736415|FG002|Overall Study|Restricted medication|1|||
126393880|NCT01962987|454736413|FG000|Overall Study|Serious Adverse Event|1|||
126393881|NCT01962987|454736414|FG001|Overall Study|Serious Adverse Event|0|||
126393882|NCT01962987|454736415|FG002|Overall Study|Serious Adverse Event|0|||
126393883|NCT01962987|454736413|FG000|Overall Study|Withdrawal by Subject|11|||
126393884|NCT01962987|454736414|FG001|Overall Study|Withdrawal by Subject|10|||
126393885|NCT01962987|454736415|FG002|Overall Study|Withdrawal by Subject|6|||
126393886|NCT01962987|454736413|FG000|Overall Study|Randomized in Error|4|||
126393887|NCT01962987|454736414|FG001|Overall Study|Randomized in Error|2|||
126393888|NCT01962987|454736415|FG002|Overall Study|Randomized in Error|2|||
126393889|NCT00789581|454736421|FG000|AC Therapy|Adverse Event|2|||
126393890|NCT00789581|454736422|FG001|AC Therapy|Adverse Event|3|||
126393891|NCT00789581|454736421|FG000|AC Therapy|Withdrawal by Subject|4|||
126393892|NCT00789581|454736422|FG001|AC Therapy|Withdrawal by Subject|7|||
126393893|NCT00789581|454736421|FG000|AC Therapy|Disease recurrence|3|||
126393894|NCT00789581|454736422|FG001|AC Therapy|Disease recurrence|1|||
126393895|NCT00789581|454736421|FG000|AC Therapy|Intercurrent Illness|1|||
126393896|NCT00789581|454736422|FG001|AC Therapy|Intercurrent Illness|0|||
126393897|NCT00789581|454736421|FG000|AC Therapy|Never Treated|1|||
126393898|NCT00789581|454736422|FG001|AC Therapy|Never Treated|4|||
126393899|NCT00789581|454736421|FG000|AC Therapy|Other|0|||
126393900|NCT00789581|454736422|FG001|AC Therapy|Other|2|||
126393901|NCT00789581|454736421|FG000|Adjuvant Therapy|Never treated|2|||
126393902|NCT00789581|454736422|FG001|Adjuvant Therapy|Never treated|2|||
126393903|NCT00789581|454736421|FG000|Adjuvant Therapy|Adverse Event|20|||
126393904|NCT00789581|454736422|FG001|Adjuvant Therapy|Adverse Event|44|||
126393905|NCT00789581|454736421|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
126393906|NCT00789581|454736422|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
126393907|NCT00789581|454736421|FG000|Adjuvant Therapy|Disease recurrence|2|||
126393908|NCT00789581|454736422|FG001|Adjuvant Therapy|Disease recurrence|1|||
126393909|NCT00789581|454736421|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
126393910|NCT00789581|454736422|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
126393911|NCT00789581|454736421|FG000|Adjuvant Therapy|Protocol Violation|1|||
126393912|NCT00789581|454736422|FG001|Adjuvant Therapy|Protocol Violation|1|||
126393913|NCT00789581|454736421|FG000|Adjuvant Therapy|Other|0|||
126393914|NCT00789581|454736422|FG001|Adjuvant Therapy|Other|1|||
126393915|NCT04021524|454736423|FG000|Overall Study|Change in surgical intervention|0|||
126393916|NCT04021524|454736424|FG001|Overall Study|Change in surgical intervention|1|||
126393917|NCT05275010|454736425|FG000|Overall Study|Reason Not Specified|4|||
126393918|NCT05275010|454736426|FG001|Overall Study|Reason Not Specified|1|||
126393919|NCT05275010|454736425|FG000|Overall Study|Withdrawal by Subject|1|||
126393920|NCT05275010|454736426|FG001|Overall Study|Withdrawal by Subject|0|||
126393921|NCT05275010|454736425|FG000|Overall Study|Lost to Follow-up|0|||
126393922|NCT05275010|454736426|FG001|Overall Study|Lost to Follow-up|1|||
126393923|NCT00730041|454736427|FG000|Overall Study|Lost to Follow-up|0|||
126393924|NCT00730041|454736428|FG001|Overall Study|Lost to Follow-up|2|||
126393925|NCT05526781|454736429|FG000|Overall Study|Lost to Follow-up|1|||
126393926|NCT03327220|454736430|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
126393927|NCT03327220|454736431|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
126393928|NCT03327220|454736430|FG000|Overall Study|Investigator Decision|2|||
126393929|NCT03327220|454736431|FG001|Overall Study|Investigator Decision|0|||
126393930|NCT03327220|454736430|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
126393931|NCT03327220|454736431|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
126393932|NCT03327220|454736430|FG000|Overall Study|Fungal infection|1|||
126393933|NCT03327220|454736431|FG001|Overall Study|Fungal infection|0|||
126393934|NCT03327220|454736430|FG000|Overall Study|Discharged to Rehabilitation|0|||
126393935|NCT03327220|454736431|FG001|Overall Study|Discharged to Rehabilitation|1|||
126393936|NCT03327220|454736430|FG000|Overall Study|Missing|1|||
126393937|NCT03327220|454736431|FG001|Overall Study|Missing|0|||
126393938|NCT00523705|454736434|FG000|Overall Study|No time for study.|0|||
126393939|NCT00523705|454736435|FG001|Overall Study|No time for study.|1|||
126393940|NCT00368836|454736436|FG000|Phase II|Screen Failure|1|||
126393941|NCT00368836|454736436|FG000|Phase II|Withdrawal by Subject|1|||
126393942|NCT00368836|454736436|FG000|Phase II|unable to collect blood and/or breath|17|||
126393943|NCT00368836|454736436|FG000|Phase II|Protocol Violation|2|||
126393944|NCT02442310|454736437|FG000|Overall Study|Adverse Event|2|||
126393945|NCT02442310|454736437|FG000|Overall Study|Withdrawal by Subject|1|||
126393946|NCT03176472|454736438|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
126393947|NCT03176472|454736439|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
126393948|NCT03176472|454736438|FG000|Double Blind Treatment Period|Adverse Event|0|||
126393949|NCT03176472|454736439|FG001|Double Blind Treatment Period|Adverse Event|5|||
126393950|NCT03176472|454736438|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
126393951|NCT03176472|454736439|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126393952|NCT03176472|454736438|FG000|Double Blind Treatment Period|Physician Decision|0|||
126050185|NCT02036970|453481003|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
126050186|NCT02036970|453481004|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
126393953|NCT03176472|454736439|FG001|Double Blind Treatment Period|Physician Decision|1|||
126393954|NCT03176472|454736438|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126393955|NCT03176472|454736439|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126393956|NCT03176472|454736438|FG000|Double Blind Treatment Period|Not Provided|1|||
126393957|NCT03176472|454736439|FG001|Double Blind Treatment Period|Not Provided|0|||
126393958|NCT03176472|454736438|FG000|Open Label Extension|Withdrawal by Subject|3|||
126393959|NCT03176472|454736439|FG001|Open Label Extension|Withdrawal by Subject|4|||
126393960|NCT03176472|454736438|FG000|Open Label Extension|Adverse Event|2|||
126393961|NCT03176472|454736439|FG001|Open Label Extension|Adverse Event|4|||
126050187|NCT02036970|453481005|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
126393962|NCT03176472|454736438|FG000|Open Label Extension|Lost to Follow-up|1|||
126393963|NCT03176472|454736439|FG001|Open Label Extension|Lost to Follow-up|2|||
126393964|NCT03176472|454736438|FG000|Open Label Extension|Protocol Violation|0|||
126393965|NCT03176472|454736439|FG001|Open Label Extension|Protocol Violation|1|||
126393966|NCT03176472|454736438|FG000|Open Label Extension|Not Provided|2|||
126393967|NCT03176472|454736439|FG001|Open Label Extension|Not Provided|1|||
126393968|NCT03077438|454736440|FG000|Overall Study|Protocol Violation|3|||
126393969|NCT03077438|454736441|FG001|Overall Study|Protocol Violation|5|||
126393970|NCT03077438|454736440|FG000|Overall Study|Withdrawal by Subject|3|||
126393971|NCT03077438|454736441|FG001|Overall Study|Withdrawal by Subject|6|||
126393972|NCT03077438|454736440|FG000|Overall Study|Lost to Follow-up|6|||
126393973|NCT03077438|454736441|FG001|Overall Study|Lost to Follow-up|3|||
126393974|NCT01190475|454736442|FG000|Overall Study|Withdrawal by Subject|0|||
126393975|NCT01190475|454736443|FG001|Overall Study|Withdrawal by Subject|0|||
126393976|NCT01190475|454736444|FG002|Overall Study|Withdrawal by Subject|1|||
126393977|NCT04154345|454736447|FG000|Overall Study|Covid-19 pandemic|4|||
126393978|NCT03622112|454736460|FG000|Overall Study|Withdrawal by Subject|6|||
126393979|NCT03622112|454736461|FG001|Overall Study|Withdrawal by Subject|2|||
126393980|NCT03622112|454736462|FG002|Overall Study|Withdrawal by Subject|4|||
126393981|NCT03622112|454736463|FG003|Overall Study|Withdrawal by Subject|2|||
126393982|NCT03622112|454736464|FG004|Overall Study|Withdrawal by Subject|1|||
126393983|NCT03622112|454736465|FG005|Overall Study|Withdrawal by Subject|2|||
126393984|NCT03622112|454736466|FG006|Overall Study|Withdrawal by Subject|2|||
126393985|NCT03622112|454736460|FG000|Overall Study|Death|0|||
126393986|NCT03622112|454736461|FG001|Overall Study|Death|0|||
126393987|NCT03622112|454736462|FG002|Overall Study|Death|0|||
126393988|NCT03622112|454736463|FG003|Overall Study|Death|1|||
126393989|NCT03622112|454736464|FG004|Overall Study|Death|0|||
126393990|NCT03622112|454736465|FG005|Overall Study|Death|0|||
126393991|NCT03622112|454736466|FG006|Overall Study|Death|0|||
126393992|NCT03622112|454736460|FG000|Overall Study|Lost to Follow-up|1|||
126393993|NCT03622112|454736461|FG001|Overall Study|Lost to Follow-up|1|||
126393994|NCT03622112|454736462|FG002|Overall Study|Lost to Follow-up|0|||
126393995|NCT03622112|454736463|FG003|Overall Study|Lost to Follow-up|0|||
126393996|NCT03622112|454736464|FG004|Overall Study|Lost to Follow-up|0|||
126393997|NCT03622112|454736465|FG005|Overall Study|Lost to Follow-up|0|||
126393998|NCT03622112|454736466|FG006|Overall Study|Lost to Follow-up|0|||
126393999|NCT03622112|454736460|FG000|Overall Study|Study-specific withdrawal criteria|10|||
126394000|NCT03622112|454736461|FG001|Overall Study|Study-specific withdrawal criteria|8|||
126394001|NCT03622112|454736462|FG002|Overall Study|Study-specific withdrawal criteria|7|||
126394002|NCT03622112|454736463|FG003|Overall Study|Study-specific withdrawal criteria|6|||
126394003|NCT03622112|454736464|FG004|Overall Study|Study-specific withdrawal criteria|4|||
126394004|NCT03622112|454736465|FG005|Overall Study|Study-specific withdrawal criteria|18|||
126394005|NCT03622112|454736466|FG006|Overall Study|Study-specific withdrawal criteria|4|||
126394006|NCT03622112|454736460|FG000|Overall Study|Protocol Violation|2|||
126394007|NCT03622112|454736461|FG001|Overall Study|Protocol Violation|0|||
126394008|NCT03622112|454736462|FG002|Overall Study|Protocol Violation|1|||
126394009|NCT03622112|454736463|FG003|Overall Study|Protocol Violation|1|||
126394010|NCT03622112|454736464|FG004|Overall Study|Protocol Violation|0|||
126394011|NCT03622112|454736465|FG005|Overall Study|Protocol Violation|0|||
126394012|NCT03622112|454736466|FG006|Overall Study|Protocol Violation|0|||
126394013|NCT03622112|454736460|FG000|Overall Study|Adverse Event|6|||
126394014|NCT03622112|454736461|FG001|Overall Study|Adverse Event|8|||
126394015|NCT03622112|454736462|FG002|Overall Study|Adverse Event|4|||
126394016|NCT03622112|454736463|FG003|Overall Study|Adverse Event|11|||
126394017|NCT03622112|454736464|FG004|Overall Study|Adverse Event|4|||
126394018|NCT03622112|454736465|FG005|Overall Study|Adverse Event|20|||
126394019|NCT03622112|454736466|FG006|Overall Study|Adverse Event|2|||
126394020|NCT03622112|454736460|FG000|Overall Study|Reason not specified|0|||
126394021|NCT03622112|454736461|FG001|Overall Study|Reason not specified|1|||
126394022|NCT03622112|454736462|FG002|Overall Study|Reason not specified|0|||
126394023|NCT03622112|454736463|FG003|Overall Study|Reason not specified|1|||
126394024|NCT03622112|454736464|FG004|Overall Study|Reason not specified|1|||
126394025|NCT03622112|454736465|FG005|Overall Study|Reason not specified|2|||
126394026|NCT03622112|454736466|FG006|Overall Study|Reason not specified|1|||
126394027|NCT03773133|454736467|FG000|Overall Study|Screen Failure|8|||
126394028|NCT01610713|454736468|FG000|Overall Study|Adverse Event|3|||
126394029|NCT01610713|454736469|FG001|Overall Study|Adverse Event|0|||
126394030|NCT01610713|454736468|FG000|Overall Study|Lack of Efficacy|1|||
126394031|NCT01610713|454736469|FG001|Overall Study|Lack of Efficacy|0|||
126394032|NCT01610713|454736468|FG000|Overall Study|low mood and poor motivation|1|||
126394033|NCT01610713|454736469|FG001|Overall Study|low mood and poor motivation|0|||
126394034|NCT01610713|454736468|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
126394035|NCT01610713|454736469|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
126394036|NCT01610713|454736468|FG000|Overall Study|Lost to Follow-up|0|||
126394037|NCT01610713|454736469|FG001|Overall Study|Lost to Follow-up|1|||
126394038|NCT03943550|454736473|FG000|Overall Study|Adverse Event|0|||
126394039|NCT03943550|454736474|FG001|Overall Study|Adverse Event|0|||
126394040|NCT03943550|454736475|FG002|Overall Study|Adverse Event|1|||
126394041|NCT03943550|454736473|FG000|Overall Study|Lost to Follow-up|0|||
126394042|NCT03943550|454736474|FG001|Overall Study|Lost to Follow-up|0|||
126394043|NCT03943550|454736475|FG002|Overall Study|Lost to Follow-up|1|||
126394044|NCT03943550|454736473|FG000|Overall Study|Progressive Disease|0|||
126394045|NCT03943550|454736474|FG001|Overall Study|Progressive Disease|0|||
126394046|NCT03943550|454736475|FG002|Overall Study|Progressive Disease|2|||
126394047|NCT03943550|454736473|FG000|Overall Study|Participant Moved Out of the Country|0|||
126394048|NCT03943550|454736474|FG001|Overall Study|Participant Moved Out of the Country|1|||
126394049|NCT03943550|454736475|FG002|Overall Study|Participant Moved Out of the Country|0|||
126394050|NCT03359785|454736476|FG000|Overall Study|Protocol Violation|0|||
126394051|NCT03359785|454736477|FG001|Overall Study|Protocol Violation|1|||
126394052|NCT03359785|454736478|FG002|Overall Study|Protocol Violation|0|||
126394053|NCT03359785|454736479|FG003|Overall Study|Protocol Violation|0|||
126394054|NCT03359785|454736476|FG000|Overall Study|Early study termination due to study pause|0|||
126394055|NCT03359785|454736477|FG001|Overall Study|Early study termination due to study pause|0|||
126394056|NCT03359785|454736478|FG002|Overall Study|Early study termination due to study pause|2|||
126394057|NCT03359785|454736479|FG003|Overall Study|Early study termination due to study pause|0|||
126394058|NCT03359785|454736476|FG000|Overall Study|Withdrawal by Subject|2|||
126394059|NCT03359785|454736477|FG001|Overall Study|Withdrawal by Subject|2|||
126394060|NCT03359785|454736478|FG002|Overall Study|Withdrawal by Subject|0|||
126394061|NCT03359785|454736479|FG003|Overall Study|Withdrawal by Subject|0|||
126394062|NCT01895543|454736480|FG000|Overall Study|Withdrawal by Subject|43|||
126394063|NCT01895543|454736480|FG000|Overall Study|Lost to Follow-up|25|||
126394064|NCT01895543|454736480|FG000|Overall Study|Adverse Event|28|||
126394065|NCT01895543|454736480|FG000|Overall Study|Subject's substantial non-compliance|6|||
126394066|NCT01895543|454736480|FG000|Overall Study|Protocol Violation|1|||
126394067|NCT01895543|454736480|FG000|Overall Study|Physician Decision|2|||
126394068|NCT01895543|454736480|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
126394069|NCT03650803|454736484|FG000|Overall Study|Lost to Follow-up|6|||
126394070|NCT02901054|454736487|FG000|Overall Study|Physician Decision|1|||
126394071|NCT02901054|454736487|FG000|Overall Study|Withdrawal by Subject|3|||
126394072|NCT01534260|454736488|FG000|Overall Study|Adverse Event|1|||
126394073|NCT01534260|454736489|FG001|Overall Study|Adverse Event|8|||
126394074|NCT01534260|454736488|FG000|Overall Study|Death|2|||
126394075|NCT01534260|454736489|FG001|Overall Study|Death|0|||
126394076|NCT01534260|454736488|FG000|Overall Study|Lack of Efficacy|1|||
126394077|NCT01534260|454736489|FG001|Overall Study|Lack of Efficacy|1|||
126394078|NCT01534260|454736488|FG000|Overall Study|Withdrawal by Subject|1|||
126394079|NCT01534260|454736489|FG001|Overall Study|Withdrawal by Subject|3|||
126394080|NCT01534260|454736488|FG000|Overall Study|Disease Progression|8|||
126394081|NCT01534260|454736489|FG001|Overall Study|Disease Progression|6|||
126394082|NCT01534260|454736488|FG000|Overall Study|Physician Decision|3|||
126394083|NCT01534260|454736489|FG001|Overall Study|Physician Decision|1|||
126394084|NCT01534260|454736488|FG000|Overall Study|No treatment, per protocol|0|||
126394085|NCT01534260|454736489|FG001|Overall Study|No treatment, per protocol|1|||
126394086|NCT05145322|454736493|FG000|Overall Study|Lost to Follow-up|4|||
126394087|NCT05145322|454736494|FG001|Overall Study|Lost to Follow-up|5|||
126394088|NCT04376684|454736495|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
126394089|NCT04376684|454736496|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
126394090|NCT04376684|454736497|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
126394091|NCT04376684|454736498|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
126394092|NCT04376684|454736495|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
126394093|NCT04376684|454736496|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
126394094|NCT04376684|454736497|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
126394095|NCT04376684|454736498|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
126394096|NCT04376684|454736495|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
126050188|NCT02036970|453481006|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
126050189|NCT02036970|453481007|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
126050190|NCT02036970|453481008|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
126050191|NCT02386098|453481011|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
126050192|NCT02386098|453481012|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
126394097|NCT04376684|454736496|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
126394098|NCT04376684|454736497|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
126394099|NCT04376684|454736498|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
126394100|NCT04376684|454736495|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
126394101|NCT04376684|454736496|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
126394102|NCT04376684|454736497|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
126394103|NCT04376684|454736498|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
126394104|NCT04376684|454736495|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
126394105|NCT04376684|454736496|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
126394106|NCT04376684|454736497|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
126394107|NCT04376684|454736498|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
126394108|NCT04376684|454736495|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
126394109|NCT04376684|454736496|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
126394110|NCT04376684|454736497|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
126394111|NCT04376684|454736498|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
126394112|NCT04376684|454736495|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
126394113|NCT04376684|454736496|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
126394114|NCT04376684|454736497|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
126394115|NCT04376684|454736498|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
126394116|NCT02979093|454736502|FG000|First Scan Session|Scanning data problems|1|||
126394117|NCT02979093|454736503|FG001|First Scan Session|Scanning data problems|2|||
126394118|NCT02979093|454736504|FG002|First Scan Session|Scanning data problems|2|||
126394119|NCT02979093|454736505|FG003|First Scan Session|Scanning data problems|0|||
126394120|NCT02979093|454736502|FG000|Second Scan Session|Scanning data problems|3|||
126394121|NCT02979093|454736503|FG001|Second Scan Session|Scanning data problems|0|||
126394122|NCT02979093|454736504|FG002|Second Scan Session|Scanning data problems|1|||
126394123|NCT02979093|454736505|FG003|Second Scan Session|Scanning data problems|3|||
126394124|NCT03099174|454736506|FG000|Overall Study|Withdrawal by Subject|0|||
126394125|NCT03099174|454736507|FG001|Overall Study|Withdrawal by Subject|0|||
126394126|NCT03099174|454736508|FG002|Overall Study|Withdrawal by Subject|1|||
126394127|NCT03099174|454736509|FG003|Overall Study|Withdrawal by Subject|0|||
126394128|NCT03099174|454736510|FG004|Overall Study|Withdrawal by Subject|2|||
126394129|NCT03099174|454736511|FG005|Overall Study|Withdrawal by Subject|2|||
126394130|NCT03099174|454736512|FG006|Overall Study|Withdrawal by Subject|1|||
126394131|NCT03099174|454736513|FG007|Overall Study|Withdrawal by Subject|4|||
126394132|NCT03099174|454736506|FG000|Overall Study|Adverse Event|0|||
126394133|NCT03099174|454736507|FG001|Overall Study|Adverse Event|1|||
126394134|NCT03099174|454736508|FG002|Overall Study|Adverse Event|1|||
126394135|NCT03099174|454736509|FG003|Overall Study|Adverse Event|2|||
126394136|NCT03099174|454736510|FG004|Overall Study|Adverse Event|5|||
126394137|NCT03099174|454736511|FG005|Overall Study|Adverse Event|3|||
126394138|NCT03099174|454736512|FG006|Overall Study|Adverse Event|6|||
126394139|NCT03099174|454736513|FG007|Overall Study|Adverse Event|4|||
126394140|NCT03099174|454736506|FG000|Overall Study|Other than listed|6|||
126394141|NCT03099174|454736507|FG001|Overall Study|Other than listed|6|||
126394142|NCT03099174|454736508|FG002|Overall Study|Other than listed|5|||
126394143|NCT03099174|454736509|FG003|Overall Study|Other than listed|6|||
126394144|NCT03099174|454736510|FG004|Overall Study|Other than listed|19|||
126394145|NCT03099174|454736511|FG005|Overall Study|Other than listed|10|||
126394146|NCT03099174|454736512|FG006|Overall Study|Other than listed|26|||
126394147|NCT03099174|454736513|FG007|Overall Study|Other than listed|23|||
126050193|NCT02386098|453481013|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
126050194|NCT02386098|453481014|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
126050195|NCT02386098|453481015|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
126394148|NCT04173260|454736514|FG000|Overall Study|Early termination|4|||
126394149|NCT01096368|454736515|FG000|Overall Study|Death|0|||
126394150|NCT01096368|454736516|FG001|Overall Study|Death|1|||
126394151|NCT01096368|454736517|FG002|Overall Study|Death|0|||
126394152|NCT01096368|454736518|FG003|Overall Study|Death|0|||
126394153|NCT01096368|454736519|FG004|Overall Study|Death|0|||
126394154|NCT01096368|454736515|FG000|Overall Study|Physician Decision|0|||
126394155|NCT01096368|454736516|FG001|Overall Study|Physician Decision|13|||
126394156|NCT01096368|454736517|FG002|Overall Study|Physician Decision|2|||
126394157|NCT01096368|454736518|FG003|Overall Study|Physician Decision|4|||
126394158|NCT01096368|454736519|FG004|Overall Study|Physician Decision|6|||
126394159|NCT01096368|454736515|FG000|Overall Study|Withdrawal by Subject|0|||
126394160|NCT01096368|454736516|FG001|Overall Study|Withdrawal by Subject|52|||
126394161|NCT01096368|454736517|FG002|Overall Study|Withdrawal by Subject|0|||
126394162|NCT01096368|454736518|FG003|Overall Study|Withdrawal by Subject|10|||
126394163|NCT01096368|454736519|FG004|Overall Study|Withdrawal by Subject|14|||
126394164|NCT01096368|454736515|FG000|Overall Study|Ineligible|0|||
126394165|NCT01096368|454736516|FG001|Overall Study|Ineligible|3|||
126394166|NCT01096368|454736517|FG002|Overall Study|Ineligible|2|||
126394167|NCT01096368|454736518|FG003|Overall Study|Ineligible|0|||
126394168|NCT01096368|454736519|FG004|Overall Study|Ineligible|25|||
126394169|NCT01096368|454736515|FG000|Overall Study|Did not start treatment|0|||
126394170|NCT01096368|454736516|FG001|Overall Study|Did not start treatment|4|||
126394171|NCT01096368|454736517|FG002|Overall Study|Did not start treatment|4|||
126050196|NCT02386098|453481011|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
126394172|NCT01096368|454736518|FG003|Overall Study|Did not start treatment|0|||
126394173|NCT01096368|454736519|FG004|Overall Study|Did not start treatment|0|||
126394174|NCT01096368|454736515|FG000|Overall Study|Progressive disease|0|||
126394175|NCT01096368|454736516|FG001|Overall Study|Progressive disease|6|||
126394176|NCT01096368|454736517|FG002|Overall Study|Progressive disease|0|||
126394177|NCT01096368|454736518|FG003|Overall Study|Progressive disease|10|||
126394178|NCT01096368|454736519|FG004|Overall Study|Progressive disease|3|||
126394179|NCT01096368|454736515|FG000|Overall Study|Other|0|||
126394180|NCT01096368|454736516|FG001|Overall Study|Other|0|||
126394181|NCT01096368|454736517|FG002|Overall Study|Other|1|||
126394182|NCT01096368|454736518|FG003|Overall Study|Other|0|||
126394183|NCT01096368|454736519|FG004|Overall Study|Other|0|||
126394184|NCT01096368|454736515|FG000|Overall Study|Treated with institutional review|0|||
126394185|NCT01096368|454736516|FG001|Overall Study|Treated with institutional review|0|||
126394186|NCT01096368|454736517|FG002|Overall Study|Treated with institutional review|0|||
126394187|NCT01096368|454736518|FG003|Overall Study|Treated with institutional review|0|||
126394188|NCT01096368|454736519|FG004|Overall Study|Treated with institutional review|1|||
126394189|NCT03070223|454736520|FG000|Overall Study|Lost to Follow-up|34|||
126394190|NCT03070223|454736521|FG001|Overall Study|Lost to Follow-up|27|||
126394191|NCT03070223|454736520|FG000|Overall Study|Withdrawal by Subject|12|||
126394192|NCT03070223|454736521|FG001|Overall Study|Withdrawal by Subject|22|||
126394193|NCT03070223|454736520|FG000|Overall Study|Protocol Violation|0|||
126394194|NCT03070223|454736521|FG001|Overall Study|Protocol Violation|1|||
126394195|NCT02308163|454736522|FG000|Overall Study|Not fulfill eligible criteria|1|||
126394196|NCT02308163|454736523|FG001|Overall Study|Not fulfill eligible criteria|2|||
126394197|NCT02308163|454736524|FG002|Overall Study|Not fulfill eligible criteria|0|||
126394198|NCT02308163|454736525|FG003|Overall Study|Not fulfill eligible criteria|1|||
126394199|NCT02308163|454736526|FG004|Overall Study|Not fulfill eligible criteria|1|||
126394200|NCT02308163|454736522|FG000|Overall Study|Adverse Event|9|||
126394201|NCT02308163|454736523|FG001|Overall Study|Adverse Event|5|||
126394202|NCT02308163|454736524|FG002|Overall Study|Adverse Event|2|||
126394203|NCT02308163|454736525|FG003|Overall Study|Adverse Event|2|||
126394204|NCT02308163|454736526|FG004|Overall Study|Adverse Event|11|||
126394205|NCT02308163|454736522|FG000|Overall Study|Lack of Efficacy|11|||
126394206|NCT02308163|454736523|FG001|Overall Study|Lack of Efficacy|3|||
126394207|NCT02308163|454736524|FG002|Overall Study|Lack of Efficacy|8|||
126394208|NCT02308163|454736525|FG003|Overall Study|Lack of Efficacy|4|||
126394209|NCT02308163|454736526|FG004|Overall Study|Lack of Efficacy|6|||
126394210|NCT02308163|454736522|FG000|Overall Study|Withdrawal of consent|2|||
126394211|NCT02308163|454736523|FG001|Overall Study|Withdrawal of consent|3|||
126394212|NCT02308163|454736524|FG002|Overall Study|Withdrawal of consent|0|||
126394213|NCT02308163|454736525|FG003|Overall Study|Withdrawal of consent|2|||
126394214|NCT02308163|454736526|FG004|Overall Study|Withdrawal of consent|6|||
126394215|NCT02308163|454736522|FG000|Overall Study|Protocol Violation|3|||
126394216|NCT02308163|454736523|FG001|Overall Study|Protocol Violation|3|||
126394217|NCT02308163|454736524|FG002|Overall Study|Protocol Violation|3|||
126394218|NCT02308163|454736525|FG003|Overall Study|Protocol Violation|2|||
126394219|NCT02308163|454736526|FG004|Overall Study|Protocol Violation|5|||
126394220|NCT02308163|454736522|FG000|Overall Study|Lab data met discontinuation criteria|3|||
126394221|NCT02308163|454736523|FG001|Overall Study|Lab data met discontinuation criteria|0|||
126394222|NCT02308163|454736524|FG002|Overall Study|Lab data met discontinuation criteria|0|||
126394223|NCT02308163|454736525|FG003|Overall Study|Lab data met discontinuation criteria|2|||
126394224|NCT02308163|454736526|FG004|Overall Study|Lab data met discontinuation criteria|0|||
126394225|NCT02308163|454736522|FG000|Overall Study|Miscellaneous|2|||
126394226|NCT02308163|454736523|FG001|Overall Study|Miscellaneous|2|||
126394227|NCT02308163|454736524|FG002|Overall Study|Miscellaneous|1|||
126394228|NCT02308163|454736525|FG003|Overall Study|Miscellaneous|0|||
126394229|NCT02308163|454736526|FG004|Overall Study|Miscellaneous|5|||
126394230|NCT03941964|454736529|FG000|Overall Study|Adverse Event|1|||
126394231|NCT03941964|454736530|FG001|Overall Study|Adverse Event|8|||
126394232|NCT03941964|454736529|FG000|Overall Study|Progressive disease|7|||
126394233|NCT03941964|454736530|FG001|Overall Study|Progressive disease|3|||
126394234|NCT03941964|454736529|FG000|Overall Study|Lack of Efficacy|0|||
126394235|NCT03941964|454736530|FG001|Overall Study|Lack of Efficacy|1|||
126394236|NCT03941964|454736529|FG000|Overall Study|Death|3|||
126394237|NCT03941964|454736530|FG001|Overall Study|Death|1|||
126394238|NCT03941964|454736529|FG000|Overall Study|Withdrew consent|1|||
126394239|NCT03941964|454736530|FG001|Overall Study|Withdrew consent|3|||
126394240|NCT03941964|454736529|FG000|Overall Study|Physician Decision|9|||
126394241|NCT03941964|454736530|FG001|Overall Study|Physician Decision|2|||
126394242|NCT03941964|454736529|FG000|Overall Study|Other, not specified|2|||
126394243|NCT03941964|454736530|FG001|Overall Study|Other, not specified|1|||
126394244|NCT02136680|454736535|FG000|Overall Study|No Longer Interested|1|||
126394245|NCT02136680|454736536|FG001|Overall Study|No Longer Interested|1|||
126394246|NCT02136680|454736535|FG000|Overall Study|No longer receiving care at clinic|3|||
126394247|NCT02136680|454736536|FG001|Overall Study|No longer receiving care at clinic|5|||
126394248|NCT02136680|454736535|FG000|Overall Study|Moved away|5|||
126394249|NCT02136680|454736536|FG001|Overall Study|Moved away|4|||
126394250|NCT02136680|454736535|FG000|Overall Study|Unable to schedule|17|||
126394251|NCT02136680|454736536|FG001|Overall Study|Unable to schedule|16|||
126394252|NCT02136680|454736535|FG000|Overall Study|Study ended before interview due|6|||
126394253|NCT02136680|454736536|FG001|Overall Study|Study ended before interview due|3|||
126394254|NCT05151445|454736537|FG000|Overall Study|Withdrawal by Subject|3|||
126394255|NCT02298179|454736538|FG000|Overall Study|Lost to Follow-up|0|||
126394256|NCT02298179|454736539|FG001|Overall Study|Lost to Follow-up|0|||
126394257|NCT02298179|454736540|FG002|Overall Study|Lost to Follow-up|1|||
126394258|NCT02298179|454736541|FG003|Overall Study|Lost to Follow-up|0|||
126394259|NCT02298179|454736542|FG004|Overall Study|Lost to Follow-up|0|||
126394260|NCT02298179|454736543|FG005|Overall Study|Lost to Follow-up|0|||
126394261|NCT02298179|454736544|FG006|Overall Study|Lost to Follow-up|0|||
126394262|NCT02298179|454736545|FG007|Overall Study|Lost to Follow-up|1|||
126394263|NCT02298179|454736546|FG008|Overall Study|Lost to Follow-up|0|||
126394264|NCT02298179|454736547|FG009|Overall Study|Lost to Follow-up|0|||
126394265|NCT02298179|454736548|FG010|Overall Study|Lost to Follow-up|0|||
126394266|NCT02298179|454736549|FG011|Overall Study|Lost to Follow-up|0|||
126394267|NCT03559517|454736552|FG000|Overall Study|Withdrawal by Subject|1|||
126394268|NCT03559517|454736553|FG001|Overall Study|Withdrawal by Subject|0|||
126394269|NCT03559517|454736554|FG002|Overall Study|Withdrawal by Subject|0|||
126394270|NCT01457014|454736555|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
126394271|NCT01457014|454736556|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
126394272|NCT01457014|454736557|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
126394273|NCT01457014|454736558|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
126394274|NCT01457014|454736555|FG000|First Night|Withdrawal by Subject|3|||
126394275|NCT01457014|454736556|FG001|First Night|Withdrawal by Subject|0|||
126394276|NCT01457014|454736557|FG002|First Night|Withdrawal by Subject|0|||
126394277|NCT01457014|454736558|FG003|First Night|Withdrawal by Subject|0|||
126394278|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Death|5|||
126394279|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Death|0|||
126394280|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Death|0|||
126394281|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
126394282|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
126394283|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
126394284|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
126394285|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
126394286|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
126394287|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
126394288|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
126394289|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
126394290|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
126394291|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
126394292|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
126394293|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
126394294|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
126394295|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
126394296|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
126394297|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
126394298|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
126394299|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
126394300|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
126394301|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
126394302|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
126394303|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
126394304|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
126394305|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
126394306|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
126050197|NCT02386098|453481012|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
126394307|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
126394308|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
126394309|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
126394310|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
126050198|NCT02386098|453481013|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
126050199|NCT02386098|453481014|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
126050200|NCT02386098|453481015|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
126050201|NCT02386098|453481011|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
126050202|NCT02386098|453481012|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
126050203|NCT02386098|453481013|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
126050204|NCT02386098|453481014|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
126050205|NCT02386098|453481015|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
126050206|NCT02386098|453481011|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
126050207|NCT02386098|453481012|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
126050208|NCT02386098|453481013|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
126050209|NCT02386098|453481014|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
126104605|NCT00423930|453675933|FG000|Overall Study|Withdrawal by Subject|2|||
126394311|NCT02825420|454736563|FG000|Overall Study|Death|30|||
126394312|NCT02825420|454736564|FG001|Overall Study|Death|12|||
126394313|NCT02825420|454736563|FG000|Overall Study|Progressive disease|6|||
126394314|NCT02825420|454736564|FG001|Overall Study|Progressive disease|1|||
126394315|NCT02825420|454736563|FG000|Overall Study|Lost to Follow-up|2|||
126394316|NCT02825420|454736564|FG001|Overall Study|Lost to Follow-up|2|||
126394317|NCT02825420|454736563|FG000|Overall Study|Withdrawal by Subject|1|||
126394318|NCT02825420|454736564|FG001|Overall Study|Withdrawal by Subject|1|||
126394319|NCT02825420|454736563|FG000|Overall Study|Protocol amendment not signed|1|||
126394320|NCT02825420|454736564|FG001|Overall Study|Protocol amendment not signed|1|||
126394321|NCT02825420|454736563|FG000|Overall Study|Physician Decision|1|||
126394322|NCT02825420|454736564|FG001|Overall Study|Physician Decision|0|||
126394323|NCT02825420|454736563|FG000|Overall Study|Did not receive PLD|2|||
126394324|NCT02825420|454736564|FG001|Overall Study|Did not receive PLD|0|||
126394325|NCT04027049|454736565|FG000|Overall Study|Withdrawn by family|1|||
126394326|NCT04027049|454736566|FG001|Overall Study|Withdrawn by family|0|||
126394327|NCT04027049|454736565|FG000|Overall Study|Participant safety|1|||
126394328|NCT04027049|454736566|FG001|Overall Study|Participant safety|0|||
126394329|NCT02226198|454738019|FG000|Lead-in Phase|Protocol Violation|1|||
126394330|NCT02226198|454738020|FG001|Lead-in Phase|Protocol Violation|0|||
126394331|NCT02226198|454738021|FG002|Lead-in Phase|Protocol Violation|0|||
126394332|NCT02226198|454738019|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
126394333|NCT02226198|454738020|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
126394334|NCT02226198|454738021|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
126394335|NCT01288612|454738023|FG000|Overall Study|Unable to contact|11|||
126394336|NCT01288612|454738024|FG001|Overall Study|Unable to contact|16|||
126394337|NCT01288612|454738025|FG002|Overall Study|Unable to contact|20|||
126394338|NCT01288612|454738023|FG000|Overall Study|Declined|78|||
126394339|NCT01288612|454738024|FG001|Overall Study|Declined|63|||
126394340|NCT01288612|454738025|FG002|Overall Study|Declined|62|||
126394341|NCT01288612|454738023|FG000|Overall Study|Unable to intubate|0|||
126394342|NCT01288612|454738024|FG001|Overall Study|Unable to intubate|3|||
126394343|NCT01288612|454738025|FG002|Overall Study|Unable to intubate|0|||
126394344|NCT00871923|454738026|FG000|Overall Study|Death|1|||
126394345|NCT00871923|454738026|FG000|Overall Study|Withdrawal by Subject|1|||
126394346|NCT05599451|454738027|FG000|Overall Study|Not randomized|11|||
126394347|NCT05599451|454738028|FG001|Overall Study|Not randomized|0|||
126394348|NCT05599451|454738029|FG002|Overall Study|Not randomized|0|||
126394349|NCT05599451|454738030|FG003|Overall Study|Not randomized|0|||
126394350|NCT05599451|454738031|FG004|Overall Study|Not randomized|0|||
126394351|NCT05599451|454738027|FG000|Overall Study|Physician Decision|0|||
126394352|NCT05599451|454738028|FG001|Overall Study|Physician Decision|0|||
126394353|NCT05599451|454738029|FG002|Overall Study|Physician Decision|0|||
126394354|NCT05599451|454738030|FG003|Overall Study|Physician Decision|1|||
126394355|NCT05599451|454738031|FG004|Overall Study|Physician Decision|0|||
126394356|NCT01730339|454738032|FG000|Overall Study|Withdrawal by Subject|3|||
126394357|NCT01730339|454738033|FG001|Overall Study|Withdrawal by Subject|2|||
126394358|NCT01730339|454738032|FG000|Overall Study|Lost to Follow-up|1|||
126104606|NCT01009580|453675938|FG000|Overall Study|Adverse Event|4|||
126104607|NCT01009580|453675939|FG001|Overall Study|Adverse Event|4|||
126104608|NCT01009580|453675938|FG000|Overall Study|Lack of Efficacy|0|||
126394359|NCT01730339|454738033|FG001|Overall Study|Lost to Follow-up|1|||
126394360|NCT01730339|454738032|FG000|Overall Study|Un-specified|1|||
126394361|NCT01730339|454738033|FG001|Overall Study|Un-specified|0|||
126394362|NCT01145352|454738034|FG000|Overall Study|Found to have been registered twice|6|||
126394363|NCT01145352|454738034|FG000|Overall Study|Treated before marketing approval|4|||
126394364|NCT01145352|454738034|FG000|Overall Study|Syringe formulation was used|1|||
126394365|NCT04143217|454738035|FG000|Overall Study|Withdrawal by Subject|42|||
126394366|NCT04143217|454738035|FG000|Overall Study|Adverse Event|29|||
126394367|NCT04143217|454738035|FG000|Overall Study|Lost to Follow-up|29|||
126394368|NCT04143217|454738035|FG000|Overall Study|Lack of Efficacy|15|||
126050210|NCT02386098|453481015|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
126394369|NCT04143217|454738035|FG000|Overall Study|Physician Decision|1|||
126394370|NCT04143217|454738035|FG000|Overall Study|Non-Compliance With Study Drug|6|||
126050211|NCT02386098|453481011|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
126050212|NCT02386098|453481012|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
126050213|NCT02386098|453481013|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
126050214|NCT02386098|453481014|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
126050215|NCT02386098|453481015|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
126050216|NCT02386098|453481011|FG000|Stage 1 (96 Weeks)|Other|1|||
126050217|NCT02386098|453481012|FG001|Stage 1 (96 Weeks)|Other|0|||
126050218|NCT02386098|453481013|FG002|Stage 1 (96 Weeks)|Other|0|||
126050219|NCT02386098|453481014|FG003|Stage 1 (96 Weeks)|Other|0|||
126050220|NCT02386098|453481015|FG004|Stage 1 (96 Weeks)|Other|0|||
126050221|NCT02386098|453481011|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
126050222|NCT02386098|453481012|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
126050223|NCT02386098|453481013|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
126050224|NCT02386098|453481014|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
126050225|NCT02386098|453481015|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
126050226|NCT04503681|453481018|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
126050227|NCT04503681|453481019|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
126050228|NCT03352713|453481020|FG000|Overall Study|Lost to Follow-up|8|||
126050229|NCT03352713|453481020|FG000|Overall Study|Withdrawn by investigator|5|||
126050230|NCT03352713|453481020|FG000|Overall Study|Completed 0 EMAs|8|||
126050231|NCT03352713|453481020|FG000|Overall Study|Device incompatible/stolen|5|||
126050232|NCT01812759|453481021|FG000|Overall Study|Physician Decision|0|||
126050233|NCT01812759|453481022|FG001|Overall Study|Physician Decision|0|||
126050234|NCT01812759|453481023|FG002|Overall Study|Physician Decision|1|||
126050235|NCT00360269|453481024|FG000|Overall Study|Lost to Follow-up|7|||
126050236|NCT00360269|453481025|FG001|Overall Study|Lost to Follow-up|9|||
126050237|NCT00360269|453481024|FG000|Overall Study|Physician Decision|1|||
126050238|NCT00360269|453481025|FG001|Overall Study|Physician Decision|2|||
126050239|NCT00360269|453481024|FG000|Overall Study|Adverse Event|1|||
126050240|NCT00360269|453481025|FG001|Overall Study|Adverse Event|0|||
126050241|NCT00360269|453481024|FG000|Overall Study|Withdrawal by Subject|1|||
126050242|NCT00360269|453481025|FG001|Overall Study|Withdrawal by Subject|1|||
126050243|NCT03437733|453481031|FG000|Overall Study|Eligibility criteria not met|0|||
126050244|NCT03437733|453481032|FG001|Overall Study|Eligibility criteria not met|3|||
126050245|NCT01313884|453481033|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
126050246|NCT04191824|453481036|FG000|Overall Study|Death|13|||
126050247|NCT04191824|453481037|FG001|Overall Study|Death|12|||
126050248|NCT04191824|453481036|FG000|Overall Study|Lost to Follow-up|456|||
126050249|NCT04191824|453481037|FG001|Overall Study|Lost to Follow-up|435|||
126050250|NCT04191824|453481036|FG000|Overall Study|Physician Decision|2|||
126050251|NCT04191824|453481037|FG001|Overall Study|Physician Decision|1|||
126050252|NCT04191824|453481036|FG000|Overall Study|Protocol Violation|0|||
126050253|NCT04191824|453481037|FG001|Overall Study|Protocol Violation|2|||
126050254|NCT04191824|453481036|FG000|Overall Study|Withdrawal by Subject|16|||
126050255|NCT04191824|453481037|FG001|Overall Study|Withdrawal by Subject|18|||
126050256|NCT04191824|453481036|FG000|Overall Study|Early site closure|24|||
126050257|NCT04191824|453481037|FG001|Overall Study|Early site closure|22|||
126050258|NCT03611556|453481042|FG000|Overall Study|Death|7|||
126050259|NCT03611556|453481043|FG001|Overall Study|Death|7|||
126050260|NCT03611556|453481044|FG002|Overall Study|Death|3|||
126050261|NCT03611556|453481045|FG003|Overall Study|Death|8|||
126050262|NCT03611556|453481046|FG004|Overall Study|Death|47|||
126050263|NCT03611556|453481047|FG005|Overall Study|Death|32|||
126050264|NCT03611556|453481048|FG006|Overall Study|Death|53|||
126050265|NCT03611556|453481042|FG000|Overall Study|Withdrawal by Subject|0|||
126050266|NCT03611556|453481043|FG001|Overall Study|Withdrawal by Subject|0|||
126050267|NCT03611556|453481044|FG002|Overall Study|Withdrawal by Subject|0|||
126050268|NCT03611556|453481045|FG003|Overall Study|Withdrawal by Subject|0|||
126050269|NCT03611556|453481046|FG004|Overall Study|Withdrawal by Subject|4|||
126050270|NCT03611556|453481047|FG005|Overall Study|Withdrawal by Subject|2|||
126050271|NCT03611556|453481048|FG006|Overall Study|Withdrawal by Subject|4|||
126050272|NCT03611556|453481042|FG000|Overall Study|Sponsor decision|0|||
126050273|NCT03611556|453481043|FG001|Overall Study|Sponsor decision|0|||
126050274|NCT03611556|453481044|FG002|Overall Study|Sponsor decision|0|||
126050275|NCT03611556|453481045|FG003|Overall Study|Sponsor decision|0|||
126050276|NCT03611556|453481046|FG004|Overall Study|Sponsor decision|9|||
126050277|NCT03611556|453481047|FG005|Overall Study|Sponsor decision|4|||
126050278|NCT03611556|453481048|FG006|Overall Study|Sponsor decision|12|||
126050279|NCT03611556|453481042|FG000|Overall Study|Reasons|0|||
126050280|NCT03611556|453481043|FG001|Overall Study|Reasons|0|||
126050281|NCT03611556|453481044|FG002|Overall Study|Reasons|0|||
126050282|NCT03611556|453481045|FG003|Overall Study|Reasons|0|||
126050283|NCT03611556|453481046|FG004|Overall Study|Reasons|2|||
126050284|NCT03611556|453481047|FG005|Overall Study|Reasons|0|||
126050285|NCT03611556|453481048|FG006|Overall Study|Reasons|1|||
126050286|NCT02646618|453481051|FG000|Overall Study|Lost to Follow-up|10|||
126050287|NCT02646618|453481052|FG001|Overall Study|Lost to Follow-up|14|||
126050288|NCT00390884|453481053|FG000|Overall Study|Withdrawal by Subject|2|||
126104609|NCT01009580|453675939|FG001|Overall Study|Lack of Efficacy|1|||
125888002|NCT01415882|452886629|FG001|Overall Study|Withdrawal by Subject|1|||
125888003|NCT01415882|452886630|FG002|Overall Study|Withdrawal by Subject|0|||
125888004|NCT01415882|452886631|FG003|Overall Study|Withdrawal by Subject|1|||
125888005|NCT01415882|452886632|FG004|Overall Study|Withdrawal by Subject|0|||
125888006|NCT00976560|452886633|FG000|Overall Study|Adverse Event|5|||
125888007|NCT00976560|452886634|FG001|Overall Study|Adverse Event|5|||
125888008|NCT00976560|452886633|FG000|Overall Study|Lack of Efficacy|3|||
125888009|NCT00976560|452886634|FG001|Overall Study|Lack of Efficacy|5|||
125888010|NCT00976560|452886633|FG000|Overall Study|Protocol Violation|1|||
125888011|NCT00976560|452886634|FG001|Overall Study|Protocol Violation|0|||
125888012|NCT00976560|452886633|FG000|Overall Study|Lost to Follow-up|1|||
125888013|NCT00976560|452886634|FG001|Overall Study|Lost to Follow-up|0|||
125888014|NCT00976560|452886633|FG000|Overall Study|Physician Decision|2|||
125888015|NCT00976560|452886634|FG001|Overall Study|Physician Decision|0|||
125888016|NCT00976560|452886633|FG000|Overall Study|Withdrawal by Subject|2|||
125888017|NCT00976560|452886634|FG001|Overall Study|Withdrawal by Subject|3|||
125888018|NCT00125164|452886637|FG000|Overall Study|Adverse Event|0|||
125888019|NCT00125164|452886638|FG001|Overall Study|Adverse Event|0|||
125888020|NCT00125164|452886639|FG002|Overall Study|Adverse Event|2|||
125888021|NCT00125164|452886640|FG003|Overall Study|Adverse Event|4|||
125888022|NCT00125164|452886637|FG000|Overall Study|Lost to Follow-up|0|||
125888023|NCT00125164|452886638|FG001|Overall Study|Lost to Follow-up|0|||
125888024|NCT00125164|452886639|FG002|Overall Study|Lost to Follow-up|1|||
125888025|NCT00125164|452886640|FG003|Overall Study|Lost to Follow-up|1|||
126394371|NCT04143217|454738035|FG000|Overall Study|Other, Multiple Categories|11|||
126394372|NCT01328041|454738040|FG000|Overall Study|Adverse Event|7|||
126394373|NCT01328041|454738040|FG000|Overall Study|Lack of Efficacy|27|||
126394374|NCT01328041|454738040|FG000|Overall Study|Protocol Violation|7|||
126394375|NCT01328041|454738040|FG000|Overall Study|Lost to Follow-up|7|||
126394376|NCT01328041|454738040|FG000|Overall Study|Physician Decision|2|||
126394377|NCT01328041|454738040|FG000|Overall Study|Withdrawal by Subject|7|||
126394378|NCT02688088|454738044|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
126394379|NCT02688088|454738045|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
126394380|NCT02688088|454738046|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
126394381|NCT02688088|454738047|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
126394382|NCT02688088|454738048|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
126394383|NCT02688088|454738044|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
126394384|NCT02688088|454738045|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
126394385|NCT02688088|454738046|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125888026|NCT00125164|452886637|FG000|Overall Study|Withdrawal by Subject|2|||
125888027|NCT00125164|452886638|FG001|Overall Study|Withdrawal by Subject|0|||
125888028|NCT00125164|452886639|FG002|Overall Study|Withdrawal by Subject|1|||
125888029|NCT00125164|452886640|FG003|Overall Study|Withdrawal by Subject|1|||
125888030|NCT01339052|452886641|FG000|Overall Study|Disease progression|13|||
125888031|NCT01339052|452886642|FG001|Overall Study|Disease progression|46|||
125888032|NCT01339052|452886641|FG000|Overall Study|Adverse Event|1|||
125888033|NCT01339052|452886642|FG001|Overall Study|Adverse Event|1|||
125888034|NCT01339052|452886641|FG000|Overall Study|Withdrawal by Subject|0|||
125888035|NCT01339052|452886642|FG001|Overall Study|Withdrawal by Subject|3|||
125888036|NCT01339052|452886641|FG000|Overall Study|Physician Decision|1|||
125888037|NCT01339052|452886642|FG001|Overall Study|Physician Decision|0|||
125888038|NCT02637037|452886643|FG000|Overall Study|Positive drug screen at admission|1|||
125888039|NCT02637037|452886644|FG001|Overall Study|Positive drug screen at admission|0|||
125888040|NCT02637037|452886643|FG000|Overall Study|Withdrawal by Subject|2|||
126394386|NCT02688088|454738047|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
126394387|NCT02688088|454738048|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
126394388|NCT02688088|454738044|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
126394389|NCT02688088|454738045|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
126394390|NCT02688088|454738046|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
126394391|NCT02688088|454738047|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
126394392|NCT02688088|454738048|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
126394393|NCT02688088|454738044|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
126394394|NCT02688088|454738045|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
126394395|NCT02688088|454738046|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
126394396|NCT02688088|454738047|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
126394397|NCT02688088|454738048|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
126394398|NCT02688088|454738044|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
126394399|NCT02688088|454738045|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
126394400|NCT02688088|454738046|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
126394401|NCT02688088|454738047|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
126394402|NCT02688088|454738048|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
126394403|NCT02688088|454738044|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
126394404|NCT02688088|454738045|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
126394405|NCT02688088|454738046|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
126394406|NCT02688088|454738047|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
126394407|NCT02688088|454738048|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
126394408|NCT02688088|454738044|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
126394409|NCT02688088|454738045|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
126394410|NCT02688088|454738046|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
126394411|NCT02688088|454738047|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
125888041|NCT02637037|452886644|FG001|Overall Study|Withdrawal by Subject|1|||
125888042|NCT02637037|452886643|FG000|Overall Study|Adverse Event|1|||
125888043|NCT02637037|452886644|FG001|Overall Study|Adverse Event|0|||
125888044|NCT03339219|452886645|FG000|Overall Study|Death|12|||
126394412|NCT02688088|454738048|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
126394413|NCT02688088|454738044|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
126394414|NCT02688088|454738045|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
126394415|NCT02688088|454738046|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125888045|NCT03339219|452886645|FG000|Overall Study|Site Terminated by Sponsor|22|||
125888046|NCT03339219|452886645|FG000|Overall Study|Withdrawal by Subject|1|||
125888047|NCT03610269|452886649|FG000|Overall Study|Physician Decision|10|||
125888048|NCT03610269|452886649|FG000|Overall Study|Protocol Violation|1|||
125888049|NCT03610269|452886649|FG000|Overall Study|Unable to draw blood|1|||
125888050|NCT03610269|452886649|FG000|Overall Study|Screen fail|4|||
125888051|NCT04411667|452886652|FG000|Overall Study|Physician Decision|1|||
125888052|NCT04411667|452886653|FG001|Overall Study|Physician Decision|0|||
125888053|NCT00067002|452886654|FG000|Overall Study|Early Death|1|||
125888054|NCT00067002|452886655|FG001|Overall Study|Early Death|2|||
125888055|NCT00067002|452886654|FG000|Overall Study|Delayed|1|||
125888056|NCT00067002|452886655|FG001|Overall Study|Delayed|1|||
125888057|NCT00067002|452886654|FG000|Overall Study|Graft Failure|5|||
125888058|NCT00067002|452886655|FG001|Overall Study|Graft Failure|6|||
126394416|NCT02688088|454738047|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
126394417|NCT02688088|454738048|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125888059|NCT01354314|452886660|FG000|Overall Study|Lost to Follow-up|1|||
125888060|NCT01354314|452886661|FG001|Overall Study|Lost to Follow-up|0|||
125888061|NCT01354314|452886662|FG002|Overall Study|Lost to Follow-up|1|||
125888062|NCT01354314|452886663|FG003|Overall Study|Lost to Follow-up|1|||
125888063|NCT01354314|452886660|FG000|Overall Study|Withdrawal by Subject|0|||
126394418|NCT02688088|454738044|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
126394419|NCT02688088|454738045|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
126394420|NCT02688088|454738046|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
126394421|NCT02688088|454738047|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
126394422|NCT02688088|454738048|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
126394423|NCT01921218|454738051|FG000|Overall Study|Death|2|||
126394424|NCT01921218|454738052|FG001|Overall Study|Death|1|||
126394425|NCT01921218|454738051|FG000|Overall Study|Withdrawal by Subject|0|||
126394426|NCT01921218|454738052|FG001|Overall Study|Withdrawal by Subject|2|||
126394427|NCT01921218|454738051|FG000|Overall Study|Kidney transplant|1|||
126394428|NCT01921218|454738052|FG001|Overall Study|Kidney transplant|1|||
126394429|NCT02449889|454738053|FG000|Overall Study|Adverse Event|1|||
126394430|NCT02449889|454738054|FG001|Overall Study|Adverse Event|2|||
126394431|NCT02449889|454738055|FG002|Overall Study|Adverse Event|0|||
126394432|NCT02449889|454738053|FG000|Overall Study|Protocol Violation|0|||
126394433|NCT02449889|454738054|FG001|Overall Study|Protocol Violation|4|||
126394434|NCT02449889|454738055|FG002|Overall Study|Protocol Violation|1|||
126394435|NCT00090142|454738057|FG000|Treatment Period I|Lost to Follow-up|1|||
126394436|NCT00090142|454738058|FG001|Treatment Period I|Lost to Follow-up|2|||
126394437|NCT00090142|454738057|FG000|Treatment Period I|Protocol Violation|2|||
126394438|NCT00090142|454738058|FG001|Treatment Period I|Protocol Violation|0|||
126394439|NCT00090142|454738057|FG000|Treatment Period I|Withdrawal by Subject|2|||
126394440|NCT00090142|454738058|FG001|Treatment Period I|Withdrawal by Subject|0|||
126394441|NCT00090142|454738057|FG000|Treatment Period I|Other|0|||
126394442|NCT00090142|454738058|FG001|Treatment Period I|Other|1|||
126394443|NCT00090142|454738057|FG000|Treatment Period II|Other|1|||
126050289|NCT00390884|453481054|FG001|Overall Study|Withdrawal by Subject|2|||
126394444|NCT00090142|454738058|FG001|Treatment Period II|Other|0|||
126394445|NCT00688324|454738059|FG000|Overall Study|Withdrawal by Subject|2|||
126394446|NCT00688324|454738059|FG000|Overall Study|Physician Decision|5|||
126394447|NCT00688324|454738059|FG000|Overall Study|Lost to Follow-up|1|||
126050290|NCT04035447|453481055|FG000|Treatment Period|Lost to Follow-up|6|||
126050291|NCT04035447|453481056|FG001|Treatment Period|Lost to Follow-up|5|||
126050292|NCT04035447|453481055|FG000|Treatment Period|Physician Decision|0|||
126050293|NCT04035447|453481056|FG001|Treatment Period|Physician Decision|2|||
126050294|NCT03304587|453481057|FG000|Overall Study|Headache after intervention|0|||
126050295|NCT03304587|453481058|FG001|Overall Study|Headache after intervention|1|||
126050296|NCT03304587|453481057|FG000|Overall Study|Withdrawal by Subject|1|||
126050297|NCT03304587|453481058|FG001|Overall Study|Withdrawal by Subject|0|||
126050298|NCT01458366|453481060|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
126050299|NCT01458366|453481061|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
126050300|NCT01458366|453481062|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
126050301|NCT01458366|453481063|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
126050302|NCT01458366|453481064|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
126050303|NCT01458366|453481060|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
126050304|NCT01458366|453481061|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
126050305|NCT01458366|453481062|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
126050306|NCT01458366|453481063|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
126050307|NCT01458366|453481064|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
126050308|NCT02397096|453481065|FG000|Day 1 to Week 24|Adverse Event|7|||
126050309|NCT02397096|453481066|FG001|Day 1 to Week 24|Adverse Event|1|||
126050310|NCT02397096|453481065|FG000|Day 1 to Week 24|Death|1|||
126050311|NCT02397096|453481066|FG001|Day 1 to Week 24|Death|0|||
126050312|NCT02397096|453481065|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
126050313|NCT02397096|453481066|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
126050314|NCT02397096|453481065|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
126050315|NCT02397096|453481066|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
126050316|NCT02397096|453481065|FG000|Day 1 to Week 24|Physician Decision|2|||
126050317|NCT02397096|453481066|FG001|Day 1 to Week 24|Physician Decision|3|||
126050318|NCT02397096|453481065|FG000|Day 1 to Week 24|Protocol Violation|1|||
126050319|NCT02397096|453481066|FG001|Day 1 to Week 24|Protocol Violation|4|||
126050320|NCT02397096|453481065|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
126050321|NCT02397096|453481066|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
126050322|NCT02397096|453481065|FG000|Day 1 to Week 24|Randomized, not treated|3|||
126394448|NCT00006046|454738060|FG000|Overall Study|Adverse Event|3|||
126394449|NCT00006046|454738061|FG001|Overall Study|Adverse Event|0|||
126394450|NCT00006046|454738062|FG002|Overall Study|Adverse Event|0|||
126050323|NCT02397096|453481066|FG001|Day 1 to Week 24|Randomized, not treated|0|||
126050324|NCT02397096|453481065|FG000|Week 24 to Week 48|Adverse Event|6|||
126050325|NCT02397096|453481066|FG001|Week 24 to Week 48|Adverse Event|2|||
126050326|NCT02397096|453481065|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
126394451|NCT00006046|454738063|FG003|Overall Study|Adverse Event|0|||
126050327|NCT02397096|453481066|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
126104610|NCT01009580|453675938|FG000|Overall Study|Protocol Violation|2|||
126394452|NCT00006046|454738064|FG004|Overall Study|Adverse Event|0|||
126394453|NCT00006046|454738060|FG000|Overall Study|Disease Progression|2|||
126394454|NCT00006046|454738061|FG001|Overall Study|Disease Progression|0|||
126394455|NCT00006046|454738062|FG002|Overall Study|Disease Progression|0|||
126394456|NCT00006046|454738063|FG003|Overall Study|Disease Progression|0|||
126394457|NCT00006046|454738064|FG004|Overall Study|Disease Progression|0|||
126394458|NCT00596154|454738065|FG000|Overall Study|Not Evaluable|2|||
126394459|NCT00642369|454738066|FG000|Overall Study|Adverse Event|2|||
126394460|NCT00642369|454738067|FG001|Overall Study|Adverse Event|3|||
126394461|NCT00642369|454738066|FG000|Overall Study|Withdrawal by Subject|1|||
126394462|NCT00642369|454738067|FG001|Overall Study|Withdrawal by Subject|0|||
126394463|NCT00642369|454738066|FG000|Overall Study|misdiagnosis|0|||
126394464|NCT00642369|454738067|FG001|Overall Study|misdiagnosis|1|||
126394465|NCT00642369|454738066|FG000|Overall Study|Lack of Efficacy|2|||
126394466|NCT00642369|454738067|FG001|Overall Study|Lack of Efficacy|2|||
126394467|NCT00585546|454738074|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
126394468|NCT00585546|454738074|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
126394469|NCT01535599|454738075|FG000|Overall Study|Adverse Event|6|||
126394470|NCT01535599|454738076|FG001|Overall Study|Adverse Event|15|||
126394471|NCT01535599|454738075|FG000|Overall Study|Lost to Follow-up|3|||
126394472|NCT01535599|454738076|FG001|Overall Study|Lost to Follow-up|4|||
126394473|NCT01535599|454738075|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
126394474|NCT01535599|454738076|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
126394475|NCT01535599|454738075|FG000|Overall Study|Treatment Failure|33|||
126394476|NCT01535599|454738076|FG001|Overall Study|Treatment Failure|66|||
126394477|NCT01535599|454738075|FG000|Overall Study|BL Culture + for Group A Strep|0|||
126394478|NCT01535599|454738076|FG001|Overall Study|BL Culture + for Group A Strep|1|||
126394479|NCT01535599|454738075|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
126394480|NCT01535599|454738076|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
126394481|NCT01535599|454738075|FG000|Overall Study|Randomized in Error|2|||
126394482|NCT01535599|454738076|FG001|Overall Study|Randomized in Error|4|||
126394483|NCT01535599|454738075|FG000|Overall Study|Did not use product|1|||
126394484|NCT01535599|454738076|FG001|Overall Study|Did not use product|0|||
126394485|NCT01535599|454738075|FG000|Overall Study|Other|1|||
126394486|NCT01535599|454738076|FG001|Overall Study|Other|0|||
126394487|NCT01535599|454738075|FG000|Overall Study|Stopped medication|0|||
126394488|NCT01535599|454738076|FG001|Overall Study|Stopped medication|1|||
126394489|NCT01535599|454738075|FG000|Overall Study|Noncompliance|0|||
126394490|NCT01535599|454738076|FG001|Overall Study|Noncompliance|1|||
126394491|NCT01165320|454738077|FG000|Overall Study|Clinical adverse experience|2|||
126394492|NCT01165320|454738078|FG001|Overall Study|Clinical adverse experience|1|||
126394493|NCT01165320|454738079|FG002|Overall Study|Clinical adverse experience|0|||
126394494|NCT01165320|454738077|FG000|Overall Study|Laboratory adverse experience|1|||
126394495|NCT01165320|454738078|FG001|Overall Study|Laboratory adverse experience|0|||
126394496|NCT01165320|454738079|FG002|Overall Study|Laboratory adverse experience|0|||
126394497|NCT01165320|454738077|FG000|Overall Study|Lack of Efficacy|0|||
126394498|NCT01165320|454738078|FG001|Overall Study|Lack of Efficacy|2|||
126394499|NCT01165320|454738079|FG002|Overall Study|Lack of Efficacy|0|||
126394500|NCT01165320|454738077|FG000|Overall Study|Reason unknown|0|||
126394501|NCT01165320|454738078|FG001|Overall Study|Reason unknown|1|||
126394502|NCT01165320|454738079|FG002|Overall Study|Reason unknown|0|||
126394503|NCT00385944|454738080|FG000|1st Maintenance Dose Period|Physician Decision|1|||
126394504|NCT00385944|454738081|FG001|1st Maintenance Dose Period|Physician Decision|0|||
126394505|NCT00385944|454738082|FG002|1st Maintenance Dose Period|Physician Decision|0|||
126394506|NCT00385944|454738080|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
126394507|NCT00385944|454738081|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
126394508|NCT00385944|454738082|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
126394509|NCT00385944|454738080|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
126394510|NCT00385944|454738081|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
126394511|NCT00385944|454738082|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
126394512|NCT00385944|454738080|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
126394513|NCT00385944|454738081|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
126394514|NCT00385944|454738082|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
126394515|NCT00590824|454738086|FG000|Overall Study|Disease could not be resected|0|||
126394516|NCT00590824|454738087|FG001|Overall Study|Disease could not be resected|2|||
126394517|NCT00590824|454738088|FG002|Overall Study|Disease could not be resected|1|||
126394518|NCT00590824|454738089|FG003|Overall Study|Disease could not be resected|0|||
126394519|NCT00590824|454738086|FG000|Overall Study|Adverse Event|0|||
126394520|NCT00590824|454738087|FG001|Overall Study|Adverse Event|0|||
125888064|NCT01354314|452886661|FG001|Overall Study|Withdrawal by Subject|0|||
125888065|NCT01354314|452886662|FG002|Overall Study|Withdrawal by Subject|1|||
125888066|NCT01354314|452886663|FG003|Overall Study|Withdrawal by Subject|0|||
125888067|NCT01354314|452886660|FG000|Overall Study|Adverse Event|0|||
125888068|NCT01354314|452886661|FG001|Overall Study|Adverse Event|0|||
125888069|NCT01354314|452886662|FG002|Overall Study|Adverse Event|0|||
125888070|NCT01354314|452886663|FG003|Overall Study|Adverse Event|1|||
126394521|NCT00590824|454738088|FG002|Overall Study|Adverse Event|0|||
125888071|NCT01354314|452886660|FG000|Overall Study|Protocol Violation|1|||
125888072|NCT01354314|452886661|FG001|Overall Study|Protocol Violation|1|||
125888073|NCT01354314|452886662|FG002|Overall Study|Protocol Violation|0|||
125888074|NCT01354314|452886663|FG003|Overall Study|Protocol Violation|0|||
125888075|NCT01354314|452886660|FG000|Overall Study|Less than 90% Adherence|4|||
126394522|NCT00590824|454738089|FG003|Overall Study|Adverse Event|1|||
126394523|NCT00791479|454738095|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394524|NCT00791479|454738096|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394525|NCT00791479|454738097|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394526|NCT00791479|454738098|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394527|NCT00791479|454738099|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
126394528|NCT00791479|454738100|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394529|NCT00791479|454738095|FG000|Overall Study|Adverse Event|0|||
126394530|NCT00791479|454738096|FG001|Overall Study|Adverse Event|1|||
126394531|NCT00791479|454738097|FG002|Overall Study|Adverse Event|0|||
126394532|NCT00791479|454738098|FG003|Overall Study|Adverse Event|2|||
126394533|NCT00791479|454738099|FG004|Overall Study|Adverse Event|0|||
126394534|NCT00791479|454738100|FG005|Overall Study|Adverse Event|1|||
126394535|NCT00791479|454738095|FG000|Overall Study|Lost to Follow-up|0|||
126394536|NCT00791479|454738096|FG001|Overall Study|Lost to Follow-up|1|||
125888076|NCT01354314|452886661|FG001|Overall Study|Less than 90% Adherence|2|||
125888077|NCT01354314|452886662|FG002|Overall Study|Less than 90% Adherence|6|||
125888078|NCT01354314|452886663|FG003|Overall Study|Less than 90% Adherence|4|||
125888079|NCT00478023|452886664|FG000|Overall Study|Adverse Event|11|||
125888080|NCT00478023|452886665|FG001|Overall Study|Adverse Event|7|||
125888081|NCT00478023|452886666|FG002|Overall Study|Adverse Event|8|||
125888082|NCT00478023|452886667|FG003|Overall Study|Adverse Event|14|||
125888083|NCT00478023|452886668|FG004|Overall Study|Adverse Event|6|||
125888084|NCT00478023|452886664|FG000|Overall Study|Death|1|||
125888085|NCT00478023|452886665|FG001|Overall Study|Death|0|||
125888086|NCT00478023|452886666|FG002|Overall Study|Death|0|||
125888087|NCT00478023|452886667|FG003|Overall Study|Death|0|||
125888088|NCT00478023|452886668|FG004|Overall Study|Death|0|||
125888089|NCT00478023|452886664|FG000|Overall Study|Lack of Efficacy|11|||
125888090|NCT00478023|452886665|FG001|Overall Study|Lack of Efficacy|10|||
125888091|NCT00478023|452886666|FG002|Overall Study|Lack of Efficacy|4|||
125888092|NCT00478023|452886667|FG003|Overall Study|Lack of Efficacy|5|||
125888093|NCT00478023|452886668|FG004|Overall Study|Lack of Efficacy|41|||
125888094|NCT00478023|452886664|FG000|Overall Study|Lost to Follow-up|3|||
125888095|NCT00478023|452886665|FG001|Overall Study|Lost to Follow-up|1|||
125888096|NCT00478023|452886666|FG002|Overall Study|Lost to Follow-up|1|||
126394537|NCT00791479|454738097|FG002|Overall Study|Lost to Follow-up|0|||
126394538|NCT00791479|454738098|FG003|Overall Study|Lost to Follow-up|0|||
126394539|NCT00791479|454738099|FG004|Overall Study|Lost to Follow-up|0|||
126394540|NCT00791479|454738100|FG005|Overall Study|Lost to Follow-up|1|||
126394541|NCT00791479|454738095|FG000|Overall Study|Protocol Violation|2|||
126394542|NCT00791479|454738096|FG001|Overall Study|Protocol Violation|1|||
126394543|NCT00791479|454738097|FG002|Overall Study|Protocol Violation|0|||
126394544|NCT00791479|454738098|FG003|Overall Study|Protocol Violation|1|||
126394545|NCT00791479|454738099|FG004|Overall Study|Protocol Violation|0|||
126394546|NCT00791479|454738100|FG005|Overall Study|Protocol Violation|0|||
126394547|NCT00791479|454738095|FG000|Overall Study|Withdrawal by Subject|0|||
126394548|NCT00791479|454738096|FG001|Overall Study|Withdrawal by Subject|0|||
126394549|NCT00791479|454738097|FG002|Overall Study|Withdrawal by Subject|0|||
126394550|NCT00791479|454738098|FG003|Overall Study|Withdrawal by Subject|1|||
126394551|NCT00791479|454738099|FG004|Overall Study|Withdrawal by Subject|0|||
125888097|NCT00478023|452886667|FG003|Overall Study|Lost to Follow-up|1|||
125888098|NCT00478023|452886668|FG004|Overall Study|Lost to Follow-up|0|||
125888099|NCT00478023|452886664|FG000|Overall Study|Withdrawal by Subject|2|||
125888100|NCT00478023|452886665|FG001|Overall Study|Withdrawal by Subject|3|||
126050328|NCT02397096|453481065|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
126050329|NCT02397096|453481066|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
125888101|NCT00478023|452886666|FG002|Overall Study|Withdrawal by Subject|2|||
125888102|NCT00478023|452886667|FG003|Overall Study|Withdrawal by Subject|4|||
126104611|NCT01009580|453675939|FG001|Overall Study|Protocol Violation|3|||
125888103|NCT00478023|452886668|FG004|Overall Study|Withdrawal by Subject|5|||
126394552|NCT00791479|454738100|FG005|Overall Study|Withdrawal by Subject|1|||
126394553|NCT01778049|454738101|FG000|Open Label Treatment Period|Adverse Event|5|||
126394554|NCT01778049|454738102|FG001|Open Label Treatment Period|Adverse Event|15|||
126394555|NCT01778049|454738103|FG002|Open Label Treatment Period|Adverse Event|0|||
126394556|NCT01778049|454738104|FG003|Open Label Treatment Period|Adverse Event|0|||
126394557|NCT01778049|454738105|FG004|Open Label Treatment Period|Adverse Event|0|||
126394558|NCT01778049|454738106|FG005|Open Label Treatment Period|Adverse Event|0|||
126394559|NCT01778049|454738101|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
126394560|NCT01778049|454738102|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
126394561|NCT01778049|454738103|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
126394562|NCT01778049|454738104|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
126394563|NCT01778049|454738105|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
126394564|NCT01778049|454738106|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
126394565|NCT01778049|454738101|FG000|Open Label Treatment Period|Protocol Violation|5|||
126394566|NCT01778049|454738102|FG001|Open Label Treatment Period|Protocol Violation|5|||
126394567|NCT01778049|454738103|FG002|Open Label Treatment Period|Protocol Violation|0|||
126394568|NCT01778049|454738104|FG003|Open Label Treatment Period|Protocol Violation|0|||
126394569|NCT01778049|454738105|FG004|Open Label Treatment Period|Protocol Violation|0|||
126394570|NCT01778049|454738106|FG005|Open Label Treatment Period|Protocol Violation|0|||
126394571|NCT01778049|454738101|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
126394572|NCT01778049|454738102|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
126394573|NCT01778049|454738103|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
126394574|NCT01778049|454738104|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
126394575|NCT01778049|454738105|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
126394576|NCT01778049|454738106|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
126394577|NCT01778049|454738101|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
126394578|NCT01778049|454738102|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
126394579|NCT01778049|454738103|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
126394580|NCT01778049|454738104|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
126394581|NCT01778049|454738105|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
126394582|NCT01778049|454738106|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
126394583|NCT01778049|454738101|FG000|Open Label Treatment Period|Not treated|2|||
126394584|NCT01778049|454738102|FG001|Open Label Treatment Period|Not treated|1|||
126394585|NCT01778049|454738103|FG002|Open Label Treatment Period|Not treated|0|||
126394586|NCT01778049|454738104|FG003|Open Label Treatment Period|Not treated|0|||
126394587|NCT01778049|454738105|FG004|Open Label Treatment Period|Not treated|0|||
126394588|NCT01778049|454738106|FG005|Open Label Treatment Period|Not treated|0|||
126394589|NCT01778049|454738101|FG000|Open Label Treatment Period|Other reason not defined above|77|||
126394590|NCT01778049|454738102|FG001|Open Label Treatment Period|Other reason not defined above|94|||
126394591|NCT01778049|454738103|FG002|Open Label Treatment Period|Other reason not defined above|0|||
126394592|NCT01778049|454738104|FG003|Open Label Treatment Period|Other reason not defined above|0|||
126394593|NCT01778049|454738105|FG004|Open Label Treatment Period|Other reason not defined above|0|||
126394594|NCT01778049|454738106|FG005|Open Label Treatment Period|Other reason not defined above|0|||
126394595|NCT01778049|454738101|FG000|Double Blind Treatment Period|Adverse Event|0|||
126394596|NCT01778049|454738102|FG001|Double Blind Treatment Period|Adverse Event|0|||
126394597|NCT01778049|454738103|FG002|Double Blind Treatment Period|Adverse Event|4|||
126394598|NCT01778049|454738104|FG003|Double Blind Treatment Period|Adverse Event|5|||
126394599|NCT01778049|454738105|FG004|Double Blind Treatment Period|Adverse Event|3|||
126394600|NCT01778049|454738106|FG005|Double Blind Treatment Period|Adverse Event|2|||
126394601|NCT01778049|454738101|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
126394602|NCT01778049|454738102|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
126394603|NCT01778049|454738103|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
126394604|NCT01778049|454738104|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
126394605|NCT01778049|454738105|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
126394606|NCT01778049|454738106|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
126394607|NCT01778049|454738101|FG000|Double Blind Treatment Period|Protocol Violation|0|||
126394608|NCT01778049|454738102|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126394609|NCT01778049|454738103|FG002|Double Blind Treatment Period|Protocol Violation|2|||
126394610|NCT01778049|454738104|FG003|Double Blind Treatment Period|Protocol Violation|0|||
126394611|NCT01778049|454738105|FG004|Double Blind Treatment Period|Protocol Violation|0|||
126394612|NCT01778049|454738106|FG005|Double Blind Treatment Period|Protocol Violation|0|||
126394613|NCT01778049|454738101|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
126394614|NCT01778049|454738102|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126394615|NCT01778049|454738103|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
126394616|NCT01778049|454738104|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
126394617|NCT01778049|454738105|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
125888104|NCT00478023|452886664|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
125888105|NCT00478023|452886665|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
125888106|NCT00478023|452886666|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
125888107|NCT00478023|452886667|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
126104612|NCT01009580|453675938|FG000|Overall Study|Withdrawal Criteria|4|||
126394618|NCT01778049|454738106|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
126394619|NCT01778049|454738101|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
126394620|NCT01778049|454738102|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
126394621|NCT01778049|454738103|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
126394622|NCT01778049|454738104|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
126394623|NCT01778049|454738105|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
126394624|NCT01778049|454738106|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
126394625|NCT01778049|454738101|FG000|Double Blind Treatment Period|Not treated|0|||
126394626|NCT01778049|454738102|FG001|Double Blind Treatment Period|Not treated|0|||
126394627|NCT01778049|454738103|FG002|Double Blind Treatment Period|Not treated|0|||
126394628|NCT01778049|454738104|FG003|Double Blind Treatment Period|Not treated|2|||
126394629|NCT01778049|454738105|FG004|Double Blind Treatment Period|Not treated|2|||
126394630|NCT01778049|454738106|FG005|Double Blind Treatment Period|Not treated|0|||
126394631|NCT01778049|454738101|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
126394632|NCT01778049|454738102|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
126394633|NCT01778049|454738103|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
126394634|NCT01778049|454738104|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
126394635|NCT01778049|454738105|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
126394636|NCT01778049|454738106|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
126394637|NCT03770728|454738107|FG000|Overall Study|Adverse Event|1|||
126394638|NCT03770728|454738108|FG001|Overall Study|Adverse Event|0|||
126394639|NCT03770728|454738109|FG002|Overall Study|Adverse Event|1|||
126394640|NCT03770728|454738110|FG003|Overall Study|Adverse Event|0|||
126394641|NCT03770728|454738107|FG000|Overall Study|Poor compliance to protocol|0|||
126394642|NCT03770728|454738108|FG001|Overall Study|Poor compliance to protocol|0|||
126394643|NCT03770728|454738109|FG002|Overall Study|Poor compliance to protocol|1|||
126394644|NCT03770728|454738110|FG003|Overall Study|Poor compliance to protocol|0|||
126394645|NCT03770728|454738107|FG000|Overall Study|Withdrawal by Subject|13|||
126394646|NCT03770728|454738108|FG001|Overall Study|Withdrawal by Subject|8|||
126394647|NCT03770728|454738109|FG002|Overall Study|Withdrawal by Subject|9|||
126394648|NCT03770728|454738110|FG003|Overall Study|Withdrawal by Subject|13|||
126394649|NCT03770728|454738107|FG000|Overall Study|Other than specified|24|||
126394650|NCT03770728|454738108|FG001|Overall Study|Other than specified|23|||
126394651|NCT03770728|454738109|FG002|Overall Study|Other than specified|21|||
126394652|NCT03770728|454738110|FG003|Overall Study|Other than specified|22|||
126394653|NCT00503776|454738111|FG000|Overall Study|Withdrawal by Subject|1|||
126394654|NCT00503776|454738112|FG001|Overall Study|Withdrawal by Subject|0|||
126394655|NCT00503776|454738113|FG002|Overall Study|Withdrawal by Subject|1|||
126394656|NCT00503776|454738114|FG003|Overall Study|Withdrawal by Subject|1|||
126394657|NCT00503776|454738111|FG000|Overall Study|Physician Decision|0|||
126394658|NCT00503776|454738112|FG001|Overall Study|Physician Decision|0|||
126394659|NCT00503776|454738113|FG002|Overall Study|Physician Decision|1|||
126394660|NCT00503776|454738114|FG003|Overall Study|Physician Decision|1|||
126394661|NCT02379988|454738115|FG000|Overall Study|Not eligible|1|||
126394662|NCT00107315|454738116|FG000|Overall Study|Disease Progression|9|||
126394663|NCT00107315|454738116|FG000|Overall Study|Adverse Event|4|||
126394664|NCT00107315|454738116|FG000|Overall Study|Withdrawal by Subject|2|||
126394665|NCT02509039|454738119|FG000|Overall Study|Adverse Event|0|||
126394666|NCT02509039|454738120|FG001|Overall Study|Adverse Event|1|||
126394667|NCT02509039|454738121|FG002|Overall Study|Adverse Event|1|||
126394668|NCT02509039|454738122|FG003|Overall Study|Adverse Event|1|||
126394669|NCT02509039|454738119|FG000|Overall Study|Withdrawal by Subject|0|||
126394670|NCT02509039|454738120|FG001|Overall Study|Withdrawal by Subject|0|||
126394671|NCT02509039|454738121|FG002|Overall Study|Withdrawal by Subject|1|||
126394672|NCT02509039|454738122|FG003|Overall Study|Withdrawal by Subject|0|||
126394673|NCT02509039|454738119|FG000|Overall Study|Progressive disease|2|||
126394674|NCT02509039|454738120|FG001|Overall Study|Progressive disease|2|||
126394675|NCT02509039|454738121|FG002|Overall Study|Progressive disease|1|||
126394676|NCT02509039|454738122|FG003|Overall Study|Progressive disease|5|||
126394677|NCT02509039|454738119|FG000|Overall Study|Study terminated by Sponsor|1|||
126394678|NCT02509039|454738120|FG001|Overall Study|Study terminated by Sponsor|0|||
126394679|NCT02509039|454738121|FG002|Overall Study|Study terminated by Sponsor|0|||
126394680|NCT02509039|454738122|FG003|Overall Study|Study terminated by Sponsor|0|||
126394681|NCT05427539|454738127|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
126050330|NCT02397096|453481065|FG000|Week 24 to Week 48|Physician Decision|2|||
126394682|NCT05427539|454738128|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
126394683|NCT05427539|454738127|FG000|Period 1|Withdrawal by Subject|1|||
126394684|NCT05427539|454738128|FG001|Period 1|Withdrawal by Subject|0|||
126394685|NCT00543296|454738129|FG000|Overall Study|Physician Decision|7|||
126394686|NCT00934947|454738130|FG000|Overall Study|Adverse Event|0|||
126050331|NCT02397096|453481066|FG001|Week 24 to Week 48|Physician Decision|1|||
126394687|NCT00934947|454738131|FG001|Overall Study|Adverse Event|2|||
126394688|NCT03276026|454738134|FG000|Overall Study|Protocol Violation|1|||
126394689|NCT03276026|454738135|FG001|Overall Study|Protocol Violation|0|||
126394690|NCT04049266|454738136|FG000|Overall Study|Adverse Event|16|||
126394691|NCT04049266|454738137|FG001|Overall Study|Adverse Event|9|||
126394692|NCT04049266|454738136|FG000|Overall Study|Non-compliance with study drug|0|||
126394693|NCT04049266|454738137|FG001|Overall Study|Non-compliance with study drug|3|||
126394694|NCT04049266|454738136|FG000|Overall Study|Withdrawal by Subject|6|||
126394695|NCT04049266|454738137|FG001|Overall Study|Withdrawal by Subject|10|||
126394696|NCT04049266|454738136|FG000|Overall Study|Lost to Follow-up|2|||
126394697|NCT04049266|454738137|FG001|Overall Study|Lost to Follow-up|2|||
126394698|NCT04049266|454738136|FG000|Overall Study|Progressive disease|11|||
126394699|NCT04049266|454738137|FG001|Overall Study|Progressive disease|2|||
126394700|NCT04049266|454738136|FG000|Overall Study|Physician Decision|1|||
126394701|NCT04049266|454738137|FG001|Overall Study|Physician Decision|0|||
126394702|NCT04049266|454738136|FG000|Overall Study|Patient moved out of state|1|||
126394703|NCT04049266|454738137|FG001|Overall Study|Patient moved out of state|0|||
126394704|NCT01703208|454738138|FG000|Overall Study|Death|61|||
126394705|NCT01703208|454738139|FG001|Overall Study|Death|48|||
126394706|NCT01703208|454738138|FG000|Overall Study|Lack of Efficacy|1|||
126394707|NCT01703208|454738139|FG001|Overall Study|Lack of Efficacy|2|||
126394708|NCT01703208|454738138|FG000|Overall Study|Lost to Follow-up|68|||
126394709|NCT01703208|454738139|FG001|Overall Study|Lost to Follow-up|62|||
126104613|NCT01009580|453675939|FG001|Overall Study|Withdrawal Criteria|6|||
126394710|NCT01703208|454738138|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126104614|NCT01009580|453675938|FG000|Overall Study|Unclassified|17|||
126104615|NCT01009580|453675939|FG001|Overall Study|Unclassified|21|||
126394711|NCT01703208|454738139|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126394712|NCT01703208|454738138|FG000|Overall Study|Excluded Medication|1|||
126394713|NCT01703208|454738139|FG001|Overall Study|Excluded Medication|2|||
126394714|NCT01703208|454738138|FG000|Overall Study|Site Discontinued Study Participation|23|||
126394715|NCT01703208|454738139|FG001|Overall Study|Site Discontinued Study Participation|27|||
126394716|NCT01703208|454738138|FG000|Overall Study|Physician Decision|11|||
126394717|NCT01703208|454738139|FG001|Overall Study|Physician Decision|13|||
126394718|NCT01703208|454738138|FG000|Overall Study|Progressive disease|2|||
126394719|NCT01703208|454738139|FG001|Overall Study|Progressive disease|2|||
126394720|NCT01703208|454738138|FG000|Overall Study|Protocol Violation|1|||
126394721|NCT01703208|454738139|FG001|Overall Study|Protocol Violation|1|||
126394722|NCT01703208|454738138|FG000|Overall Study|Study Terminated by Sponsor|1710|||
126394723|NCT01703208|454738139|FG001|Overall Study|Study Terminated by Sponsor|1716|||
126394724|NCT01703208|454738138|FG000|Overall Study|Withdrawal by Subject|205|||
126394725|NCT01703208|454738139|FG001|Overall Study|Withdrawal by Subject|209|||
126394726|NCT01703208|454738138|FG000|Overall Study|Adverse Event|14|||
126394727|NCT01703208|454738139|FG001|Overall Study|Adverse Event|19|||
126394728|NCT01703208|454738138|FG000|Overall Study|Technical Problems|0|||
126394729|NCT01703208|454738139|FG001|Overall Study|Technical Problems|1|||
126394730|NCT01703208|454738138|FG000|Overall Study|Protocol Deviation|2|||
126394731|NCT01703208|454738139|FG001|Overall Study|Protocol Deviation|0|||
126394732|NCT01271712|454738147|FG000|Double Blind Treatment|Death|2|||
126394733|NCT01271712|454738148|FG001|Double Blind Treatment|Death|0|||
126394734|NCT01271712|454738147|FG000|Double Blind Treatment|Lack of Efficacy|1|||
126394735|NCT01271712|454738148|FG001|Double Blind Treatment|Lack of Efficacy|0|||
126394736|NCT01271712|454738147|FG000|Double Blind Treatment|Adverse Event|9|||
126394737|NCT01271712|454738148|FG001|Double Blind Treatment|Adverse Event|4|||
126394738|NCT01271712|454738147|FG000|Double Blind Treatment|Progressive disease|23|||
126394739|NCT01271712|454738148|FG001|Double Blind Treatment|Progressive disease|3|||
126394740|NCT01271712|454738147|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
126394741|NCT01271712|454738148|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
126394742|NCT01271712|454738147|FG000|Double Blind Treatment|Non compliance with study drug|2|||
126394743|NCT01271712|454738148|FG001|Double Blind Treatment|Non compliance with study drug|0|||
126394744|NCT01271712|454738147|FG000|Double Blind Treatment|receive no study drug|1|||
126050332|NCT02397096|453481065|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
126050333|NCT02397096|453481066|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
126394745|NCT01271712|454738148|FG001|Double Blind Treatment|receive no study drug|0|||
126394746|NCT01271712|454738147|FG000|Open Label Treatment|Death|6|||
126394747|NCT01271712|454738148|FG001|Open Label Treatment|Death|5|||
126394748|NCT01271712|454738147|FG000|Open Label Treatment|Withdrawal by Subject|6|||
126394749|NCT01271712|454738148|FG001|Open Label Treatment|Withdrawal by Subject|11|||
126394750|NCT01271712|454738147|FG000|Open Label Treatment|Physician Decision|2|||
126394751|NCT01271712|454738148|FG001|Open Label Treatment|Physician Decision|0|||
126394752|NCT01271712|454738147|FG000|Open Label Treatment|Adverse Event|14|||
126394753|NCT01271712|454738148|FG001|Open Label Treatment|Adverse Event|8|||
126394754|NCT01271712|454738147|FG000|Open Label Treatment|Progressive disease|59|||
126394755|NCT01271712|454738148|FG001|Open Label Treatment|Progressive disease|32|||
126394756|NCT01271712|454738147|FG000|Open Label Treatment|transferred to rollover study|1|||
126394757|NCT01271712|454738148|FG001|Open Label Treatment|transferred to rollover study|0|||
126394758|NCT01271712|454738147|FG000|Open Label Treatment|Non-compliance with study drug|1|||
126394759|NCT01271712|454738148|FG001|Open Label Treatment|Non-compliance with study drug|0|||
126394760|NCT01271712|454738147|FG000|Open Label Treatment|Protocol Violation|0|||
126394761|NCT01271712|454738148|FG001|Open Label Treatment|Protocol Violation|1|||
126394762|NCT01271712|454738147|FG000|Open Label Treatment|Switching to other therapy|2|||
126394763|NCT01271712|454738148|FG001|Open Label Treatment|Switching to other therapy|1|||
126394764|NCT01271712|454738147|FG000|Safety Follow-up|Death|11|||
126394765|NCT01271712|454738148|FG001|Safety Follow-up|Death|7|||
126394766|NCT01271712|454738147|FG000|Safety Follow-up|Withdrawal by Subject|4|||
126394767|NCT01271712|454738148|FG001|Safety Follow-up|Withdrawal by Subject|2|||
126394768|NCT01271712|454738147|FG000|Safety Follow-up|Protocol Violation|1|||
126394769|NCT01271712|454738148|FG001|Safety Follow-up|Protocol Violation|1|||
126394770|NCT01271712|454738147|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
126394771|NCT01271712|454738148|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
126394772|NCT01271712|454738147|FG000|Safety Follow-up|No follow-up|1|||
126394773|NCT01271712|454738148|FG001|Safety Follow-up|No follow-up|1|||
126394774|NCT01271712|454738147|FG000|Safety Follow-up|Progressive disease|1|||
126394775|NCT01271712|454738148|FG001|Safety Follow-up|Progressive disease|0|||
126394776|NCT01271712|454738147|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
126394777|NCT01271712|454738148|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
126394778|NCT05593913|454738149|FG000|Overall Study|Insufficient image quality|39|||
126394779|NCT02684058|454738157|FG000|Treatment Period|Progressive disease|4|||
126394780|NCT02684058|454738158|FG001|Treatment Period|Progressive disease|10|||
126394781|NCT02684058|454738159|FG002|Treatment Period|Progressive disease|19|||
126394782|NCT02684058|454738157|FG000|Treatment Period|Adverse Event|3|||
126394783|NCT02684058|454738158|FG001|Treatment Period|Adverse Event|8|||
126394784|NCT02684058|454738159|FG002|Treatment Period|Adverse Event|1|||
126394785|NCT02684058|454738157|FG000|Treatment Period|Physician Decision|5|||
126394786|NCT02684058|454738158|FG001|Treatment Period|Physician Decision|1|||
126394787|NCT02684058|454738159|FG002|Treatment Period|Physician Decision|2|||
126394788|NCT02684058|454738157|FG000|Treatment Period|New therapy for study indication|1|||
126394789|NCT02684058|454738158|FG001|Treatment Period|New therapy for study indication|0|||
126394790|NCT02684058|454738159|FG002|Treatment Period|New therapy for study indication|0|||
126394791|NCT02684058|454738157|FG000|Treatment Period|Protocol deviation|0|||
126394792|NCT02684058|454738158|FG001|Treatment Period|Protocol deviation|1|||
126394793|NCT02684058|454738159|FG002|Treatment Period|Protocol deviation|0|||
126394794|NCT02684058|454738157|FG000|Treatment Period|Subject/guardian decision|4|||
126394795|NCT02684058|454738158|FG001|Treatment Period|Subject/guardian decision|3|||
126394796|NCT02684058|454738159|FG002|Treatment Period|Subject/guardian decision|0|||
126394797|NCT02684058|454738157|FG000|Treatment Period|Death|0|||
126394798|NCT02684058|454738158|FG001|Treatment Period|Death|0|||
126394799|NCT02684058|454738159|FG002|Treatment Period|Death|2|||
126394800|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126394801|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
126394802|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
126394803|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
126394804|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
126394805|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
126394806|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
126394807|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
126394808|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
126394809|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|Death|0|||
126394810|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|Death|0|||
126394811|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|Death|3|||
126394812|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
126394813|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
126394814|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
125888108|NCT00478023|452886668|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
125888109|NCT00714870|452886670|FG000|Overall Study|Lost to Follow-up|22|||
125888110|NCT00714870|452886671|FG001|Overall Study|Lost to Follow-up|5|||
125888111|NCT00714870|452886670|FG000|Overall Study|patient unable to come b/c back pain|1|||
125888112|NCT00714870|452886671|FG001|Overall Study|patient unable to come b/c back pain|0|||
125888113|NCT00714870|452886670|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
125888114|NCT00714870|452886671|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
125888115|NCT02357368|452886672|FG000|Overall Study|Lost to Follow-up|0|||
125888116|NCT02357368|452886673|FG001|Overall Study|Lost to Follow-up|0|||
125888117|NCT02357368|452886674|FG002|Overall Study|Lost to Follow-up|0|||
126394815|NCT02684058|454738157|FG000|Post-treatment Survival Follow-up|Death|0|||
126394816|NCT02684058|454738158|FG001|Post-treatment Survival Follow-up|Death|0|||
126394817|NCT02684058|454738159|FG002|Post-treatment Survival Follow-up|Death|7|||
126394818|NCT02684058|454738157|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
126394819|NCT02684058|454738158|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
126394820|NCT02684058|454738159|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
126394821|NCT02684058|454738157|FG000|Crossover Treatment Period|Progressive disease|0|||
126394822|NCT02684058|454738158|FG001|Crossover Treatment Period|Progressive disease|1|||
126394823|NCT02684058|454738159|FG002|Crossover Treatment Period|Progressive disease|0|||
125888118|NCT02357368|452886675|FG003|Overall Study|Lost to Follow-up|1|||
125888119|NCT02357368|452886672|FG000|Overall Study|Pregnancy|3|||
125888120|NCT02357368|452886673|FG001|Overall Study|Pregnancy|2|||
125888121|NCT02357368|452886674|FG002|Overall Study|Pregnancy|0|||
125888122|NCT02357368|452886675|FG003|Overall Study|Pregnancy|0|||
125888123|NCT02357368|452886672|FG000|Overall Study|Withdrawal by Subject|3|||
125888124|NCT02357368|452886673|FG001|Overall Study|Withdrawal by Subject|1|||
125888125|NCT02357368|452886674|FG002|Overall Study|Withdrawal by Subject|1|||
125888126|NCT02357368|452886675|FG003|Overall Study|Withdrawal by Subject|2|||
125888127|NCT02377817|452886676|FG000|Overall Study|Transportation/childcare barriers.|2|||
125888128|NCT02377817|452886677|FG001|Overall Study|Transportation/childcare barriers.|0|||
125888129|NCT02377817|452886676|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
125888130|NCT02377817|452886677|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
125888131|NCT03895840|452886678|FG000|Overall Study|Withdrawal by Subject|21|||
125888132|NCT01147874|452886682|FG000|Overall Study|Adverse Event|5|||
125888133|NCT01147874|452886682|FG000|Overall Study|Investigator's Request|1|||
125888134|NCT01147874|452886682|FG000|Overall Study|Lost to Follow-up|25|||
126050334|NCT02397096|453481065|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
126050335|NCT02397096|453481066|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
126050336|NCT02397096|453481065|FG000|Study Extension 1|Adverse Event|7|||
126050337|NCT02397096|453481066|FG001|Study Extension 1|Adverse Event|5|||
126050338|NCT02397096|453481065|FG000|Study Extension 1|Death|1|||
126050339|NCT02397096|453481066|FG001|Study Extension 1|Death|0|||
126394824|NCT00443053|454738163|FG000|Overall Study|Adverse Event|2|||
126394825|NCT00443053|454738164|FG001|Overall Study|Adverse Event|1|||
126394826|NCT00443053|454738163|FG000|Overall Study|Withdrawal by Subject|9|||
125888135|NCT01147874|452886682|FG000|Overall Study|Other|5|||
125888136|NCT01147874|452886682|FG000|Overall Study|Protocol Violation|5|||
126050340|NCT02397096|453481065|FG000|Study Extension 1|Lack of Efficacy|2|||
126050341|NCT02397096|453481066|FG001|Study Extension 1|Lack of Efficacy|5|||
126050342|NCT02397096|453481065|FG000|Study Extension 1|Lost to Follow-up|2|||
125888137|NCT01147874|452886682|FG000|Overall Study|Sponsor's Decision|2|||
125888138|NCT01147874|452886682|FG000|Overall Study|Withdrawal by Subject|24|||
126394827|NCT00443053|454738164|FG001|Overall Study|Withdrawal by Subject|18|||
125888139|NCT02175030|452886683|FG000|Overall Study|Failed screen after consent|7|||
126050343|NCT02397096|453481066|FG001|Study Extension 1|Lost to Follow-up|3|||
126050344|NCT02397096|453481065|FG000|Study Extension 1|Non-compliance with study drug|3|||
126050345|NCT02397096|453481066|FG001|Study Extension 1|Non-compliance with study drug|0|||
126394828|NCT00443053|454738163|FG000|Overall Study|Lost to Follow-up|4|||
126394829|NCT00443053|454738164|FG001|Overall Study|Lost to Follow-up|5|||
126394830|NCT00443053|454738163|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
126394831|NCT00443053|454738164|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
126394832|NCT00443053|454738163|FG000|Overall Study|Noncompliance|2|||
126394833|NCT00443053|454738164|FG001|Overall Study|Noncompliance|1|||
126394834|NCT00443053|454738163|FG000|Overall Study|Other|3|||
126394835|NCT00443053|454738164|FG001|Overall Study|Other|4|||
126394836|NCT00443053|454738163|FG000|Overall Study|Physician Decision|0|||
126394837|NCT00443053|454738164|FG001|Overall Study|Physician Decision|4|||
126394838|NCT01330628|454738166|FG000|Overall Study|Death|2|||
126394839|NCT01330628|454738167|FG001|Overall Study|Death|3|||
126394840|NCT01330628|454738166|FG000|Overall Study|Lost to Follow-up|5|||
126394841|NCT01330628|454738167|FG001|Overall Study|Lost to Follow-up|6|||
126394842|NCT01330628|454738166|FG000|Overall Study|Adverse Event|44|||
126394843|NCT01330628|454738167|FG001|Overall Study|Adverse Event|25|||
126394844|NCT01330628|454738166|FG000|Overall Study|Withdrawn|18|||
126394845|NCT01330628|454738167|FG001|Overall Study|Withdrawn|6|||
126394846|NCT01330628|454738166|FG000|Overall Study|Didn't receive study treatment|1|||
126394847|NCT01330628|454738167|FG001|Overall Study|Didn't receive study treatment|0|||
126394848|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
126394849|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
126394850|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Death|1|||
126394851|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Death|0|||
126394852|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
126394853|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
126394854|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
126394855|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
126394856|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
126394857|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
126394858|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
126394859|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
126394860|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
126394861|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
126394862|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
126394863|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
126394864|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
126394865|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
126394866|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
126394867|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
126394868|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
126394869|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
126394870|NCT01440517|454739420|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
126394871|NCT01468207|454739421|FG000|Treatment Period 1|Adverse Event|1|||
126394872|NCT01468207|454739422|FG001|Treatment Period 1|Adverse Event|0|||
126394873|NCT01468207|454739423|FG002|Treatment Period 1|Adverse Event|0|||
126394874|NCT01468207|454739424|FG003|Treatment Period 1|Adverse Event|0|||
126394875|NCT01468207|454739425|FG004|Treatment Period 1|Adverse Event|0|||
126394876|NCT01468207|454739426|FG005|Treatment Period 1|Adverse Event|0|||
126394877|NCT01468207|454739421|FG000|Treatment Period 1|Protocol Violation|1|||
126394878|NCT01468207|454739422|FG001|Treatment Period 1|Protocol Violation|1|||
126394879|NCT01468207|454739423|FG002|Treatment Period 1|Protocol Violation|0|||
126394880|NCT01468207|454739424|FG003|Treatment Period 1|Protocol Violation|0|||
126394881|NCT01468207|454739425|FG004|Treatment Period 1|Protocol Violation|0|||
126394882|NCT01468207|454739426|FG005|Treatment Period 1|Protocol Violation|0|||
126394883|NCT01468207|454739421|FG000|Treatment Period 1|Withdrawal by Subject|5|||
126394884|NCT01468207|454739422|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126394885|NCT01468207|454739423|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126394886|NCT01468207|454739424|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126394887|NCT01468207|454739425|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126394888|NCT01468207|454739426|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126394889|NCT01468207|454739421|FG000|Treatment Period 1|Lost to Follow-up|2|||
126394890|NCT01468207|454739422|FG001|Treatment Period 1|Lost to Follow-up|1|||
126394891|NCT01468207|454739423|FG002|Treatment Period 1|Lost to Follow-up|0|||
125888140|NCT02175030|452886684|FG001|Overall Study|Failed screen after consent|6|||
125888141|NCT02175030|452886683|FG000|Overall Study|Failed IUD Insertion|20|||
126050346|NCT02397096|453481065|FG000|Study Extension 1|Physician Decision|4|||
126394892|NCT01468207|454739424|FG003|Treatment Period 1|Lost to Follow-up|0|||
126394893|NCT01468207|454739425|FG004|Treatment Period 1|Lost to Follow-up|0|||
126394894|NCT01468207|454739426|FG005|Treatment Period 1|Lost to Follow-up|0|||
126394895|NCT01468207|454739421|FG000|Treatment Period 1|Other|0|||
126394896|NCT01468207|454739422|FG001|Treatment Period 1|Other|2|||
126394897|NCT01468207|454739423|FG002|Treatment Period 1|Other|0|||
126050347|NCT02397096|453481066|FG001|Study Extension 1|Physician Decision|2|||
125888142|NCT02175030|452886684|FG001|Overall Study|Failed IUD Insertion|21|||
126394898|NCT01468207|454739424|FG003|Treatment Period 1|Other|0|||
126394899|NCT01468207|454739425|FG004|Treatment Period 1|Other|0|||
126394900|NCT01468207|454739426|FG005|Treatment Period 1|Other|0|||
126394901|NCT01468207|454739421|FG000|Treatment Period 2|Adverse Event|0|||
126394902|NCT01468207|454739422|FG001|Treatment Period 2|Adverse Event|0|||
126394903|NCT01468207|454739423|FG002|Treatment Period 2|Adverse Event|6|||
126394904|NCT01468207|454739424|FG003|Treatment Period 2|Adverse Event|1|||
126394905|NCT01468207|454739425|FG004|Treatment Period 2|Adverse Event|2|||
126394906|NCT01468207|454739426|FG005|Treatment Period 2|Adverse Event|1|||
126394907|NCT01468207|454739421|FG000|Treatment Period 2|Lack of Efficacy|0|||
126394908|NCT01468207|454739422|FG001|Treatment Period 2|Lack of Efficacy|0|||
126394909|NCT01468207|454739423|FG002|Treatment Period 2|Lack of Efficacy|1|||
126394910|NCT01468207|454739424|FG003|Treatment Period 2|Lack of Efficacy|1|||
126394911|NCT01468207|454739425|FG004|Treatment Period 2|Lack of Efficacy|0|||
126394912|NCT01468207|454739426|FG005|Treatment Period 2|Lack of Efficacy|2|||
126394913|NCT01468207|454739421|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126394914|NCT01468207|454739422|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126394915|NCT01468207|454739423|FG002|Treatment Period 2|Withdrawal by Subject|5|||
126394916|NCT01468207|454739424|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126394917|NCT01468207|454739425|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126394918|NCT01468207|454739426|FG005|Treatment Period 2|Withdrawal by Subject|2|||
126394919|NCT01468207|454739421|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
126394920|NCT01468207|454739422|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
126394921|NCT01468207|454739423|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
126394922|NCT01468207|454739424|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
126394923|NCT01468207|454739425|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
126394924|NCT01468207|454739426|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
126394925|NCT01468207|454739421|FG000|Treatment Period 2|Lost to Follow-up|0|||
126394926|NCT01468207|454739422|FG001|Treatment Period 2|Lost to Follow-up|0|||
126394927|NCT01468207|454739423|FG002|Treatment Period 2|Lost to Follow-up|5|||
125888143|NCT02175030|452886683|FG000|Overall Study|Physician Decision|1|||
125888144|NCT02175030|452886684|FG001|Overall Study|Physician Decision|1|||
125888145|NCT02175030|452886683|FG000|Overall Study|Lost to Follow-up|6|||
125888146|NCT02175030|452886684|FG001|Overall Study|Lost to Follow-up|6|||
125888147|NCT02175030|452886683|FG000|Overall Study|Withdrawal by Subject|1|||
125888148|NCT02175030|452886684|FG001|Overall Study|Withdrawal by Subject|4|||
125888149|NCT00885534|452886685|FG000|Overall Study|Patient deemed ineligible|1|||
125888150|NCT02817464|452886686|FG000|Overall Study|Lost to Follow-up|1|||
125888151|NCT02817464|452886687|FG001|Overall Study|Lost to Follow-up|0|||
125888152|NCT02817464|452886686|FG000|Overall Study|Discontinued early due to personal decision|1|||
126394928|NCT01468207|454739424|FG003|Treatment Period 2|Lost to Follow-up|1|||
126394929|NCT01468207|454739425|FG004|Treatment Period 2|Lost to Follow-up|0|||
126394930|NCT01468207|454739426|FG005|Treatment Period 2|Lost to Follow-up|0|||
126394931|NCT01468207|454739421|FG000|Treatment Period 2|Other|0|||
126394932|NCT01468207|454739422|FG001|Treatment Period 2|Other|0|||
126394933|NCT01468207|454739423|FG002|Treatment Period 2|Other|5|||
126394934|NCT01468207|454739424|FG003|Treatment Period 2|Other|1|||
126394935|NCT01468207|454739425|FG004|Treatment Period 2|Other|1|||
126394936|NCT01468207|454739426|FG005|Treatment Period 2|Other|2|||
126394937|NCT00539513|454739427|FG000|Overall Study|Withdrawal by Subject|2|||
126394938|NCT00539513|454739428|FG001|Overall Study|Withdrawal by Subject|1|||
126394939|NCT00539513|454739427|FG000|Overall Study|Lost to Follow-up|0|||
125888153|NCT02817464|452886687|FG001|Overall Study|Discontinued early due to personal decision|1|||
125888154|NCT02453711|452886688|FG000|Overall Study|Withdrawal by Subject|5|||
125888155|NCT02453711|452886689|FG001|Overall Study|Withdrawal by Subject|4|||
125888156|NCT02453711|452886690|FG002|Overall Study|Withdrawal by Subject|6|||
125888157|NCT02453711|452886691|FG003|Overall Study|Withdrawal by Subject|4|||
125888158|NCT02453711|452886692|FG004|Overall Study|Withdrawal by Subject|1|||
125888159|NCT02453711|452886693|FG005|Overall Study|Withdrawal by Subject|1|||
125888160|NCT02453711|452886694|FG006|Overall Study|Withdrawal by Subject|0|||
125888161|NCT02453711|452886695|FG007|Overall Study|Withdrawal by Subject|1|||
125888162|NCT02453711|452886696|FG008|Overall Study|Withdrawal by Subject|7|||
125888163|NCT02453711|452886688|FG000|Overall Study|Lost to Follow-up|5|||
125888164|NCT02453711|452886689|FG001|Overall Study|Lost to Follow-up|3|||
125888165|NCT02453711|452886690|FG002|Overall Study|Lost to Follow-up|2|||
125888166|NCT02453711|452886691|FG003|Overall Study|Lost to Follow-up|3|||
125888167|NCT02453711|452886692|FG004|Overall Study|Lost to Follow-up|1|||
125888168|NCT02453711|452886693|FG005|Overall Study|Lost to Follow-up|5|||
125888169|NCT02453711|452886694|FG006|Overall Study|Lost to Follow-up|2|||
125888170|NCT02453711|452886695|FG007|Overall Study|Lost to Follow-up|6|||
125888171|NCT02453711|452886696|FG008|Overall Study|Lost to Follow-up|6|||
125888172|NCT02453711|452886688|FG000|Overall Study|Death|0|||
125888173|NCT02453711|452886689|FG001|Overall Study|Death|0|||
125888174|NCT02453711|452886690|FG002|Overall Study|Death|0|||
125888175|NCT02453711|452886691|FG003|Overall Study|Death|0|||
125888176|NCT02453711|452886692|FG004|Overall Study|Death|0|||
125888177|NCT02453711|452886693|FG005|Overall Study|Death|0|||
125888178|NCT02453711|452886694|FG006|Overall Study|Death|1|||
125888179|NCT02453711|452886695|FG007|Overall Study|Death|0|||
125888180|NCT02453711|452886696|FG008|Overall Study|Death|0|||
125888181|NCT02453711|452886688|FG000|Overall Study|Unclassified|1|||
125888182|NCT02453711|452886689|FG001|Overall Study|Unclassified|0|||
125888183|NCT02453711|452886690|FG002|Overall Study|Unclassified|1|||
125888184|NCT02453711|452886691|FG003|Overall Study|Unclassified|0|||
125888185|NCT02453711|452886692|FG004|Overall Study|Unclassified|0|||
125888186|NCT02453711|452886693|FG005|Overall Study|Unclassified|0|||
125888187|NCT02453711|452886694|FG006|Overall Study|Unclassified|0|||
125888188|NCT02453711|452886695|FG007|Overall Study|Unclassified|0|||
125888189|NCT02453711|452886696|FG008|Overall Study|Unclassified|0|||
125888190|NCT01273519|452886699|FG000|Overall Study|Adverse Event|3|||
125888191|NCT01273519|452886700|FG001|Overall Study|Adverse Event|0|||
125888192|NCT01273519|452886701|FG002|Overall Study|Adverse Event|0|||
125888193|NCT01273519|452886699|FG000|Overall Study|Lost to Follow-up|2|||
125888194|NCT01273519|452886700|FG001|Overall Study|Lost to Follow-up|1|||
125888195|NCT01273519|452886701|FG002|Overall Study|Lost to Follow-up|3|||
125888196|NCT01273519|452886699|FG000|Overall Study|Lack of Efficacy|8|||
125888197|NCT01273519|452886700|FG001|Overall Study|Lack of Efficacy|3|||
125888198|NCT01273519|452886701|FG002|Overall Study|Lack of Efficacy|4|||
125888199|NCT01273519|452886699|FG000|Overall Study|Other|6|||
125888200|NCT01273519|452886700|FG001|Overall Study|Other|1|||
125888201|NCT01273519|452886701|FG002|Overall Study|Other|1|||
125888202|NCT04292899|452886702|FG000|Overall Study|Death|21|||
125888203|NCT04292899|452886703|FG001|Overall Study|Death|28|||
125888204|NCT04292899|452886704|FG002|Overall Study|Death|188|||
125888205|NCT04292899|452886705|FG003|Overall Study|Death|371|||
125888206|NCT04292899|452886702|FG000|Overall Study|Lost to Follow-up|8|||
125888207|NCT04292899|452886703|FG001|Overall Study|Lost to Follow-up|4|||
125888208|NCT04292899|452886704|FG002|Overall Study|Lost to Follow-up|22|||
125888209|NCT04292899|452886705|FG003|Overall Study|Lost to Follow-up|235|||
125888210|NCT04292899|452886702|FG000|Overall Study|Withdrew consent|1|||
125888211|NCT04292899|452886703|FG001|Overall Study|Withdrew consent|0|||
125888212|NCT04292899|452886704|FG002|Overall Study|Withdrew consent|11|||
125888213|NCT04292899|452886705|FG003|Overall Study|Withdrew consent|32|||
125888214|NCT04292899|452886702|FG000|Overall Study|Adverse Event|2|||
125888215|NCT04292899|452886703|FG001|Overall Study|Adverse Event|1|||
125888216|NCT04292899|452886704|FG002|Overall Study|Adverse Event|2|||
125888217|NCT04292899|452886705|FG003|Overall Study|Adverse Event|2|||
125888218|NCT04292899|452886702|FG000|Overall Study|Investigator's Discretion|0|||
126104616|NCT02390245|453675940|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
126104617|NCT02390245|453675941|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
125888219|NCT04292899|452886703|FG001|Overall Study|Investigator's Discretion|0|||
126104618|NCT02390245|453675942|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
126104619|NCT02390245|453675940|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
126104620|NCT02390245|453675941|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
125888220|NCT04292899|452886704|FG002|Overall Study|Investigator's Discretion|0|||
125888221|NCT04292899|452886705|FG003|Overall Study|Investigator's Discretion|3|||
125888222|NCT04292899|452886702|FG000|Overall Study|Non-compliance With Study Drug|0|||
125888223|NCT04292899|452886703|FG001|Overall Study|Non-compliance With Study Drug|0|||
125888224|NCT04292899|452886704|FG002|Overall Study|Non-compliance With Study Drug|0|||
125888225|NCT04292899|452886705|FG003|Overall Study|Non-compliance With Study Drug|1|||
125888226|NCT04292899|452886702|FG000|Overall Study|Protocol Violation|0|||
125888227|NCT04292899|452886703|FG001|Overall Study|Protocol Violation|0|||
125888228|NCT04292899|452886704|FG002|Overall Study|Protocol Violation|0|||
125888229|NCT04292899|452886705|FG003|Overall Study|Protocol Violation|1|||
126050348|NCT02397096|453481065|FG000|Study Extension 1|Pregnancy|1|||
126050349|NCT02397096|453481066|FG001|Study Extension 1|Pregnancy|0|||
126050350|NCT02397096|453481065|FG000|Study Extension 1|Protocol Violation|0|||
126050351|NCT02397096|453481066|FG001|Study Extension 1|Protocol Violation|1|||
126394940|NCT00539513|454739428|FG001|Overall Study|Lost to Follow-up|1|||
126394941|NCT00908115|454739431|FG000|Overall Study|Other|14|||
126394942|NCT01728077|454739432|FG000|Overall Study|Lack of Efficacy|3|||
126394943|NCT01728077|454739433|FG001|Overall Study|Lack of Efficacy|1|||
126394944|NCT01728077|454739432|FG000|Overall Study|Lost to Follow-up|1|||
126394945|NCT01728077|454739433|FG001|Overall Study|Lost to Follow-up|0|||
126394946|NCT01728077|454739432|FG000|Overall Study|Subject choice|2|||
126394947|NCT01728077|454739433|FG001|Overall Study|Subject choice|3|||
126394948|NCT01728077|454739432|FG000|Overall Study|Death|0|||
126394949|NCT01728077|454739433|FG001|Overall Study|Death|1|||
126394950|NCT01728077|454739432|FG000|Overall Study|Patient moving|1|||
126394951|NCT01728077|454739433|FG001|Overall Study|Patient moving|0|||
126394952|NCT01728077|454739432|FG000|Overall Study|Non compliance|1|||
126394953|NCT01728077|454739433|FG001|Overall Study|Non compliance|0|||
126394954|NCT00347438|454739437|FG000|Overall Study|Withdrawal by Subject|1|||
126394955|NCT00347438|454739437|FG000|Overall Study|Physician Decision|1|||
126394956|NCT00322023|454739438|FG000|Overall Study|various|0|||
126394957|NCT00322023|454739439|FG001|Overall Study|various|2|||
126394958|NCT00322023|454739440|FG002|Overall Study|various|6|||
126394959|NCT00693017|454739441|FG000|Overall Study|Sponsor Decision|2|||
126394960|NCT00693017|454739442|FG001|Overall Study|Sponsor Decision|1|||
126394961|NCT00693017|454739441|FG000|Overall Study|Death|0|||
126394962|NCT00693017|454739442|FG001|Overall Study|Death|1|||
126394963|NCT01082874|454739443|FG000|Overall Study|Lost to Follow-up|10|||
126394964|NCT01082874|454739444|FG001|Overall Study|Lost to Follow-up|10|||
126394965|NCT01082874|454739445|FG002|Overall Study|Lost to Follow-up|6|||
126394966|NCT01082874|454739446|FG003|Overall Study|Lost to Follow-up|10|||
126394967|NCT01082874|454739443|FG000|Overall Study|Withdrawal by Subject|1|||
126394968|NCT01082874|454739444|FG001|Overall Study|Withdrawal by Subject|2|||
126394969|NCT01082874|454739445|FG002|Overall Study|Withdrawal by Subject|5|||
126394970|NCT01082874|454739446|FG003|Overall Study|Withdrawal by Subject|3|||
126394971|NCT01685801|454739464|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
126394972|NCT01685801|454739465|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
126394973|NCT01685801|454739466|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
126394974|NCT01685801|454739467|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
126394975|NCT01685801|454739464|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
126394976|NCT01685801|454739465|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
126394977|NCT01685801|454739466|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
126394978|NCT01685801|454739467|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
126394979|NCT00113399|454739468|FG000|Overall Study|Death|1|||
126394980|NCT00113399|454739469|FG001|Overall Study|Death|1|||
126394981|NCT00113399|454739468|FG000|Overall Study|Withdrawal by Subject|1|||
126394982|NCT00113399|454739469|FG001|Overall Study|Withdrawal by Subject|2|||
126394983|NCT00113399|454739468|FG000|Overall Study|Complete Response|0|||
126394984|NCT00113399|454739469|FG001|Overall Study|Complete Response|1|||
126394985|NCT00113399|454739468|FG000|Overall Study|Other|0|||
126394986|NCT00113399|454739469|FG001|Overall Study|Other|1|||
126050352|NCT02397096|453481065|FG000|Study Extension 1|Withdrawal by Subject|21|||
126394987|NCT00396136|454739470|FG000|Overall Study|Death|43|||
126394988|NCT00396136|454739470|FG000|Overall Study|Withdrawal by Subject|59|||
126050353|NCT02397096|453481066|FG001|Study Extension 1|Withdrawal by Subject|7|||
126050354|NCT02397096|453481065|FG000|Study Extension 2|Adverse Event|3|||
126394989|NCT00396136|454739470|FG000|Overall Study|Lost to Follow-up|15|||
126394990|NCT00396136|454739470|FG000|Overall Study|Study device explanted|8|||
126394991|NCT04686084|454739472|FG000|Overall Study|Lost to Follow-up|1|||
126394992|NCT01779856|454739473|FG000|Overall Study|Withdrawal by Subject|15|||
126394993|NCT01779856|454739473|FG000|Overall Study|Death|3|||
126394994|NCT01779856|454739473|FG000|Overall Study|Physician Decision|1|||
126394995|NCT01779856|454739473|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
126394996|NCT01779856|454739473|FG000|Overall Study|Delays in scheduling implant|1|||
126050355|NCT02397096|453481066|FG001|Study Extension 2|Adverse Event|3|||
126394997|NCT01779856|454739473|FG000|Overall Study|Subject ineligible for Implant|2|||
126394998|NCT03350256|454739475|FG000|Overall Study|Inclusion/exclusion violation|4|||
126394999|NCT03350256|454739475|FG000|Overall Study|Recommended for other therapies|2|||
126395000|NCT03350256|454739475|FG000|Overall Study|Protocol Violation|3|||
126395001|NCT03350256|454739475|FG000|Overall Study|Non compliance|2|||
126395002|NCT03350256|454739475|FG000|Overall Study|Denial by insurance|1|||
126395003|NCT03350256|454739475|FG000|Overall Study|Adverse Event|2|||
126395004|NCT03350256|454739475|FG000|Overall Study|Trial failure|12|||
126395005|NCT03350256|454739475|FG000|Overall Study|Did not proceed to permanent implant|3|||
126395006|NCT03350256|454739475|FG000|Overall Study|Withdrawal by Subject|3|||
126395007|NCT03350256|454739475|FG000|Overall Study|Subject moving out of state|1|||
126395008|NCT03350256|454739475|FG000|Overall Study|Lost to Follow-up|1|||
126395009|NCT03350256|454739475|FG000|Overall Study|Lack of Efficacy|2|||
126395010|NCT04043234|454739478|FG000|Overall Study|Lost to Follow-up|1|||
126395011|NCT04043234|454739478|FG000|Overall Study|Withdrawal by Subject|1|||
126395012|NCT01155466|454739479|FG000|Overall Study|Adverse Event|13|||
126395013|NCT01155466|454739480|FG001|Overall Study|Adverse Event|15|||
126395014|NCT01155466|454739481|FG002|Overall Study|Adverse Event|6|||
126395015|NCT01155466|454739482|FG003|Overall Study|Adverse Event|17|||
126395016|NCT01155466|454739483|FG004|Overall Study|Adverse Event|18|||
126395017|NCT01155466|454739479|FG000|Overall Study|Lost to Follow-up|0|||
126395018|NCT01155466|454739480|FG001|Overall Study|Lost to Follow-up|0|||
126395019|NCT01155466|454739481|FG002|Overall Study|Lost to Follow-up|0|||
126395020|NCT01155466|454739482|FG003|Overall Study|Lost to Follow-up|0|||
126395021|NCT01155466|454739483|FG004|Overall Study|Lost to Follow-up|2|||
126395022|NCT01155466|454739479|FG000|Overall Study|Withdrawal by Subject|7|||
126395023|NCT01155466|454739480|FG001|Overall Study|Withdrawal by Subject|5|||
126395024|NCT01155466|454739481|FG002|Overall Study|Withdrawal by Subject|9|||
126395025|NCT01155466|454739482|FG003|Overall Study|Withdrawal by Subject|4|||
126395026|NCT01155466|454739483|FG004|Overall Study|Withdrawal by Subject|4|||
126395027|NCT01155466|454739479|FG000|Overall Study|Protocol Violation|0|||
126395028|NCT01155466|454739480|FG001|Overall Study|Protocol Violation|0|||
126395029|NCT01155466|454739481|FG002|Overall Study|Protocol Violation|2|||
126395030|NCT01155466|454739482|FG003|Overall Study|Protocol Violation|0|||
126395031|NCT01155466|454739483|FG004|Overall Study|Protocol Violation|1|||
126395032|NCT01155466|454739479|FG000|Overall Study|Administrative|0|||
126395033|NCT01155466|454739480|FG001|Overall Study|Administrative|3|||
126395034|NCT01155466|454739481|FG002|Overall Study|Administrative|0|||
126395035|NCT01155466|454739482|FG003|Overall Study|Administrative|0|||
126395036|NCT01155466|454739483|FG004|Overall Study|Administrative|0|||
126395037|NCT01155466|454739479|FG000|Overall Study|Randomized not treated|2|||
126395038|NCT01155466|454739480|FG001|Overall Study|Randomized not treated|2|||
126395039|NCT01155466|454739481|FG002|Overall Study|Randomized not treated|3|||
126395040|NCT01155466|454739482|FG003|Overall Study|Randomized not treated|0|||
126395041|NCT01155466|454739483|FG004|Overall Study|Randomized not treated|2|||
126395042|NCT02210689|454739484|FG000|Overall Study|Withdrawal by Subject|7|||
126395043|NCT02210689|454739485|FG001|Overall Study|Withdrawal by Subject|4|||
126395044|NCT02210689|454739486|FG002|Overall Study|Withdrawal by Subject|2|||
126395045|NCT02210689|454739484|FG000|Overall Study|Adverse Event|0|||
126395046|NCT02210689|454739485|FG001|Overall Study|Adverse Event|1|||
126395047|NCT02210689|454739486|FG002|Overall Study|Adverse Event|0|||
126395048|NCT02210689|454739484|FG000|Overall Study|Protocol Violation|1|||
126395049|NCT02210689|454739485|FG001|Overall Study|Protocol Violation|0|||
126395050|NCT02210689|454739486|FG002|Overall Study|Protocol Violation|0|||
126395051|NCT02210689|454739484|FG000|Overall Study|Lost to Follow-up|11|||
126395052|NCT02210689|454739485|FG001|Overall Study|Lost to Follow-up|9|||
126395053|NCT02210689|454739486|FG002|Overall Study|Lost to Follow-up|5|||
126395054|NCT02210689|454739484|FG000|Overall Study|Pregnancy|0|||
126395055|NCT02210689|454739485|FG001|Overall Study|Pregnancy|1|||
126395056|NCT02210689|454739486|FG002|Overall Study|Pregnancy|0|||
126395057|NCT02210689|454739484|FG000|Overall Study|Lack of Efficacy|0|||
126395058|NCT02210689|454739485|FG001|Overall Study|Lack of Efficacy|1|||
126395059|NCT02210689|454739486|FG002|Overall Study|Lack of Efficacy|5|||
126395060|NCT02210689|454739484|FG000|Overall Study|Prohibited medication|2|||
126395061|NCT02210689|454739485|FG001|Overall Study|Prohibited medication|8|||
126395062|NCT02210689|454739486|FG002|Overall Study|Prohibited medication|1|||
126395063|NCT02210689|454739484|FG000|Overall Study|Negative Nugent score at baseline|6|||
126395064|NCT02210689|454739485|FG001|Overall Study|Negative Nugent score at baseline|2|||
126395065|NCT02210689|454739486|FG002|Overall Study|Negative Nugent score at baseline|2|||
126395066|NCT02210689|454739484|FG000|Overall Study|Other|25|||
126395067|NCT02210689|454739485|FG001|Overall Study|Other|21|||
126395068|NCT02210689|454739486|FG002|Overall Study|Other|8|||
126395069|NCT00223977|454739493|FG000|Overall Study|Adverse Event|7|||
126395070|NCT00223977|454739494|FG001|Overall Study|Adverse Event|10|||
126395071|NCT00223977|454739495|FG002|Overall Study|Adverse Event|0|||
126395072|NCT00223977|454739493|FG000|Overall Study|Protocol Violation|0|||
126395073|NCT00223977|454739494|FG001|Overall Study|Protocol Violation|0|||
126395074|NCT00223977|454739495|FG002|Overall Study|Protocol Violation|1|||
126395075|NCT00223977|454739493|FG000|Overall Study|Withdrawal by Subject|1|||
125888230|NCT03695367|452886706|FG000|Overall Study|Missed the Day 28 visit.|1|||
125888231|NCT03695367|452886707|FG001|Overall Study|Missed the Day 28 visit.|0|||
125888232|NCT03695367|452886706|FG000|Overall Study|Lost to Follow-up|0|||
125888233|NCT03695367|452886707|FG001|Overall Study|Lost to Follow-up|1|||
125888234|NCT03695367|452886706|FG000|Overall Study|Withdrawal by Subject|0|||
125888235|NCT03695367|452886707|FG001|Overall Study|Withdrawal by Subject|1|||
125888236|NCT03695367|452886706|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
125888237|NCT03695367|452886707|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
125888238|NCT01209325|452886711|FG000|Overall Study|Lost to Follow-up|24|||
126050356|NCT02397096|453481065|FG000|Study Extension 2|Availability of study medication locally|152|||
126050357|NCT02397096|453481066|FG001|Study Extension 2|Availability of study medication locally|64|||
126050358|NCT02397096|453481065|FG000|Study Extension 2|Death|2|||
126050359|NCT02397096|453481066|FG001|Study Extension 2|Death|0|||
126050360|NCT02397096|453481065|FG000|Study Extension 2|Lack of Efficacy|1|||
126050361|NCT02397096|453481066|FG001|Study Extension 2|Lack of Efficacy|0|||
126050362|NCT02397096|453481065|FG000|Study Extension 2|Lost to Follow-up|2|||
126050363|NCT02397096|453481066|FG001|Study Extension 2|Lost to Follow-up|1|||
126050364|NCT02397096|453481065|FG000|Study Extension 2|Non-compliance with study drug|1|||
126050365|NCT02397096|453481066|FG001|Study Extension 2|Non-compliance with study drug|0|||
126050366|NCT02397096|453481065|FG000|Study Extension 2|Physician Decision|2|||
126395076|NCT00223977|454739494|FG001|Overall Study|Withdrawal by Subject|1|||
126395077|NCT00223977|454739495|FG002|Overall Study|Withdrawal by Subject|2|||
126395078|NCT00223977|454739493|FG000|Overall Study|Other|1|||
126395079|NCT00223977|454739494|FG001|Overall Study|Other|0|||
126395080|NCT00223977|454739495|FG002|Overall Study|Other|0|||
126395081|NCT03136497|454739496|FG000|Overall Study|Screen Failure|1|||
126395082|NCT03136497|454739497|FG001|Overall Study|Screen Failure|0|||
126395083|NCT03136497|454739498|FG002|Overall Study|Screen Failure|0|||
126395084|NCT00557310|454739501|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
126395085|NCT00557310|454739501|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
126395086|NCT00557310|454739501|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
126395087|NCT00557310|454739501|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
126395088|NCT00557310|454739501|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
126395089|NCT00557310|454739501|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
126395090|NCT00367744|454739504|FG000|Overall Study|Lost to Follow-up|4|||
126395091|NCT00367744|454739505|FG001|Overall Study|Lost to Follow-up|5|||
126395092|NCT00096226|454739507|FG000|Overall Study|Ineligible|2|||
126395093|NCT00096226|454739507|FG000|Overall Study|Protocol treatment not started|1|||
126395094|NCT01666119|454739508|FG000|Overall Study|Adverse Event|6|||
126395095|NCT01666119|454739508|FG000|Overall Study|Withdrawal by Subject|16|||
126395096|NCT01666119|454739508|FG000|Overall Study|Lost to Follow-up|7|||
126395097|NCT01666119|454739508|FG000|Overall Study|non compliance with study medication, pa|18|||
126395098|NCT01666119|454739508|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
126395099|NCT05479097|454739514|FG000|Overall Study|Withdrawal by Subject|2|||
126395100|NCT04003207|454739517|FG000|Overall Study|Protocol Violation|1|||
126395101|NCT03894969|454739520|FG000|Overall Study|Adverse Event|0|||
126395102|NCT03894969|454739521|FG001|Overall Study|Adverse Event|2|||
126395103|NCT03894969|454739522|FG002|Overall Study|Adverse Event|0|||
126395104|NCT03894969|454739523|FG003|Overall Study|Adverse Event|1|||
126395105|NCT03894969|454739524|FG004|Overall Study|Adverse Event|2|||
126395106|NCT03894969|454739520|FG000|Overall Study|Lost to Follow-up|3|||
126395107|NCT03894969|454739521|FG001|Overall Study|Lost to Follow-up|1|||
126395108|NCT03894969|454739522|FG002|Overall Study|Lost to Follow-up|1|||
126395109|NCT03894969|454739523|FG003|Overall Study|Lost to Follow-up|0|||
126395110|NCT03894969|454739524|FG004|Overall Study|Lost to Follow-up|0|||
126395111|NCT03894969|454739520|FG000|Overall Study|Withdrawal by Subject|2|||
126395112|NCT03894969|454739521|FG001|Overall Study|Withdrawal by Subject|1|||
126395113|NCT03894969|454739522|FG002|Overall Study|Withdrawal by Subject|3|||
126395114|NCT03894969|454739523|FG003|Overall Study|Withdrawal by Subject|4|||
126395115|NCT03894969|454739524|FG004|Overall Study|Withdrawal by Subject|8|||
126395116|NCT03894969|454739520|FG000|Overall Study|Other|0|||
126395117|NCT03894969|454739521|FG001|Overall Study|Other|0|||
126395118|NCT03894969|454739522|FG002|Overall Study|Other|0|||
126395119|NCT03894969|454739523|FG003|Overall Study|Other|0|||
126395120|NCT03894969|454739524|FG004|Overall Study|Other|3|||
125888239|NCT01209325|452886711|FG000|Overall Study|Adverse Event|1|||
125888240|NCT01209325|452886711|FG000|Overall Study|Relocated|3|||
125888241|NCT01209325|452886711|FG000|Overall Study|Refusal after starting therapy|8|||
126050367|NCT02397096|453481066|FG001|Study Extension 2|Physician Decision|5|||
126395121|NCT03894969|454739520|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
126395122|NCT03894969|454739521|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
126395123|NCT03894969|454739522|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
126395124|NCT03894969|454739523|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
126395125|NCT03894969|454739524|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
126395126|NCT03894969|454739520|FG000|Overall Study|Solicited Adverse Event|0|||
125888242|NCT01209325|452886711|FG000|Overall Study|Protocol Violation|4|||
125888243|NCT01209325|452886711|FG000|Overall Study|Refusal prior to therapy|1|||
125888244|NCT01209325|452886711|FG000|Overall Study|Incarceration|2|||
125888245|NCT00396253|452886712|FG000|Overall Study|Protocol Violation|1|||
125888246|NCT00396253|452886712|FG000|Overall Study|Withdrawal by Subject|7|||
125888247|NCT00396253|452886712|FG000|Overall Study|Death|3|||
125888248|NCT00396253|452886712|FG000|Overall Study|Physician Decision|1|||
126395127|NCT03894969|454739521|FG001|Overall Study|Solicited Adverse Event|1|||
126395128|NCT03894969|454739522|FG002|Overall Study|Solicited Adverse Event|0|||
126395129|NCT03894969|454739523|FG003|Overall Study|Solicited Adverse Event|0|||
126395130|NCT03894969|454739524|FG004|Overall Study|Solicited Adverse Event|0|||
126395131|NCT00468676|454739528|FG000|Overall Study|Lost to Follow-up|14|||
126395132|NCT00468676|454739529|FG001|Overall Study|Lost to Follow-up|11|||
126395133|NCT00468676|454739528|FG000|Overall Study|Death|2|||
126395134|NCT00468676|454739529|FG001|Overall Study|Death|1|||
126395135|NCT00118846|454739533|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
126395136|NCT00118846|454739534|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
126395137|NCT00118846|454739533|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
126395138|NCT00118846|454739534|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
126395139|NCT00118846|454739533|FG000|Overall Study|Physician Decision|1|||
126395140|NCT00118846|454739534|FG001|Overall Study|Physician Decision|0|||
126395141|NCT00118846|454739533|FG000|Overall Study|Medical condition|2|||
126395142|NCT00118846|454739534|FG001|Overall Study|Medical condition|2|||
126395143|NCT00118846|454739533|FG000|Overall Study|Lost to Follow-up|0|||
126395144|NCT00118846|454739534|FG001|Overall Study|Lost to Follow-up|2|||
126395145|NCT00118846|454739533|FG000|Overall Study|Personal reason|4|||
126395146|NCT00118846|454739534|FG001|Overall Study|Personal reason|5|||
126395147|NCT01327053|454739535|FG000|Overall Study|Adverse Event|23|||
126395148|NCT01327053|454739536|FG001|Overall Study|Adverse Event|57|||
126395149|NCT01327053|454739535|FG000|Overall Study|Patient/guardian decision|11|||
126395150|NCT01327053|454739536|FG001|Overall Study|Patient/guardian decision|35|||
126395151|NCT01327053|454739535|FG000|Overall Study|Physician Decision|10|||
126395152|NCT01327053|454739536|FG001|Overall Study|Physician Decision|14|||
126395153|NCT01327053|454739535|FG000|Overall Study|Death|1|||
126395154|NCT01327053|454739536|FG001|Overall Study|Death|5|||
126395155|NCT01327053|454739535|FG000|Overall Study|Lost to Follow-up|2|||
126395156|NCT01327053|454739536|FG001|Overall Study|Lost to Follow-up|4|||
126395157|NCT01327053|454739535|FG000|Overall Study|Non-compliance with study treatment|0|||
126395158|NCT01327053|454739536|FG001|Overall Study|Non-compliance with study treatment|5|||
126395159|NCT01327053|454739535|FG000|Overall Study|Study terminated by Sponsor|1|||
126395160|NCT01327053|454739536|FG001|Overall Study|Study terminated by Sponsor|3|||
126395161|NCT01327053|454739535|FG000|Overall Study|Progressive disease|31|||
126395162|NCT01327053|454739536|FG001|Overall Study|Progressive disease|26|||
126395163|NCT01327053|454739535|FG000|Overall Study|Protocol Violation|0|||
126395164|NCT01327053|454739536|FG001|Overall Study|Protocol Violation|1|||
126395165|NCT01327053|454739535|FG000|Overall Study|Untreated|0|||
126395166|NCT01327053|454739536|FG001|Overall Study|Untreated|1|||
126395167|NCT01574157|454739537|FG000|Overall Study|Withdrawal by Subject|4|||
126395168|NCT01574157|454739538|FG001|Overall Study|Withdrawal by Subject|5|||
126395169|NCT01574157|454739537|FG000|Overall Study|Lost to Follow-up|0|||
126395170|NCT01574157|454739538|FG001|Overall Study|Lost to Follow-up|3|||
126395171|NCT00721578|454739539|FG000|Overall Study|Death|1|||
126395172|NCT00721578|454739540|FG001|Overall Study|Death|1|||
126395173|NCT00721578|454739539|FG000|Overall Study|Withdrawal by Subject|1|||
126395174|NCT00721578|454739540|FG001|Overall Study|Withdrawal by Subject|1|||
126395175|NCT02910401|454739544|FG000|Overall Study|Study closure Study closure|0|||
126395176|NCT02910401|454739545|FG001|Overall Study|Study closure Study closure|0|||
126395177|NCT02910401|454739546|FG002|Overall Study|Study closure Study closure|2|||
126395178|NCT02910401|454739544|FG000|Overall Study|Physician Decision|1|||
126395179|NCT02910401|454739545|FG001|Overall Study|Physician Decision|0|||
126395180|NCT02910401|454739546|FG002|Overall Study|Physician Decision|0|||
126395181|NCT03300024|454739549|FG000|Overall Study|Physician Decision|4|||
126395182|NCT03300024|454739550|FG001|Overall Study|Physician Decision|6|||
126395183|NCT00570037|454739555|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
126395184|NCT00570037|454739556|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
126395185|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
126395186|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
126395187|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Death|0|||
125888249|NCT00396253|452886712|FG000|Overall Study|Change in eligibility status|1|||
125888250|NCT05340478|452886714|FG000|Overall Study|Scheduling Issues|10|||
125888251|NCT05340478|452886715|FG001|Overall Study|Scheduling Issues|4|||
126395188|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Death|0|||
126395189|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
126395190|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
126395191|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
126395192|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
126395193|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
126050368|NCT02397096|453481065|FG000|Study Extension 2|Pregnancy|1|||
126050369|NCT02397096|453481066|FG001|Study Extension 2|Pregnancy|0|||
126050370|NCT02397096|453481065|FG000|Study Extension 2|Withdrawal by Subject|10|||
126050371|NCT02397096|453481066|FG001|Study Extension 2|Withdrawal by Subject|3|||
126050372|NCT02397096|453481065|FG000|Study Extension 3|Adverse Event|1|||
126050373|NCT02397096|453481066|FG001|Study Extension 3|Adverse Event|0|||
126050374|NCT02397096|453481065|FG000|Study Extension 3|Availability of study medication locally|11|||
126050375|NCT02397096|453481066|FG001|Study Extension 3|Availability of study medication locally|3|||
126050376|NCT02397096|453481065|FG000|Study Extension 3|Lost to Follow-up|1|||
126050377|NCT02397096|453481066|FG001|Study Extension 3|Lost to Follow-up|0|||
126050378|NCT02397096|453481065|FG000|Study Extension 3|Withdrawal by Subject|2|||
126050379|NCT02397096|453481066|FG001|Study Extension 3|Withdrawal by Subject|1|||
126050380|NCT05580003|453481067|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050381|NCT05580003|453481068|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050382|NCT05580003|453481069|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050383|NCT05580003|453481070|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050384|NCT05580003|453481071|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050385|NCT05580003|453481072|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050386|NCT05580003|453481073|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
126050387|NCT05580003|453481074|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050388|NCT05580003|453481075|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050389|NCT05580003|453481076|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050390|NCT05580003|453481077|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050391|NCT05580003|453481078|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050392|NCT05580003|453481079|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050393|NCT05580003|453481080|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050394|NCT05580003|453481081|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050395|NCT05580003|453481082|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050396|NCT05580003|453481083|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050397|NCT05580003|453481084|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050398|NCT05580003|453481085|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050399|NCT05580003|453481086|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050400|NCT05580003|453481087|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050401|NCT05580003|453481088|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050402|NCT05580003|453481089|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050403|NCT05580003|453481090|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050404|NCT05580003|453481091|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050405|NCT05580003|453481092|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050406|NCT05580003|453481093|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050407|NCT05580003|453481094|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126050408|NCT05580003|453481067|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050409|NCT05580003|453481068|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050410|NCT05580003|453481069|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050411|NCT05580003|453481070|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050412|NCT05580003|453481071|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050413|NCT05580003|453481072|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
126050414|NCT05580003|453481073|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050415|NCT05580003|453481074|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050416|NCT05580003|453481075|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050417|NCT05580003|453481076|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050418|NCT05580003|453481077|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050419|NCT05580003|453481078|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050420|NCT05580003|453481079|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050421|NCT05580003|453481080|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050422|NCT05580003|453481081|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050423|NCT05580003|453481082|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050424|NCT05580003|453481083|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050425|NCT05580003|453481084|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050426|NCT05580003|453481085|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050427|NCT05580003|453481086|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050428|NCT05580003|453481087|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050429|NCT05580003|453481088|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050430|NCT05580003|453481089|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050431|NCT05580003|453481090|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050432|NCT05580003|453481091|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126395194|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
126395195|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
126395196|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
126395197|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
126395198|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
126395199|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
126395200|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
126395201|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
126395202|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
126395203|NCT00433160|454739557|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
126395204|NCT00433160|454739558|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
126395205|NCT00433160|454739557|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
126395206|NCT00433160|454739558|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
126395207|NCT00433160|454739557|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
126395208|NCT00433160|454739558|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
126395209|NCT00433160|454739557|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
126395210|NCT00433160|454739558|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
126395211|NCT00433160|454739557|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
126395212|NCT00433160|454739558|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
126395213|NCT00433160|454739557|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
126395214|NCT00433160|454739558|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
126395215|NCT00433160|454739557|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
126395216|NCT00433160|454739558|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
126395217|NCT02499900|454739563|FG000|Core Study Period|Other|1|||
126395218|NCT02499900|454739564|FG001|Core Study Period|Other|4|||
126395219|NCT02499900|454739563|FG000|Core Study Period|Lost to Follow-up|1|||
126395220|NCT02499900|454739564|FG001|Core Study Period|Lost to Follow-up|2|||
126395221|NCT02499900|454739563|FG000|Core Study Period|Per sponsor request|0|||
126395222|NCT02499900|454739564|FG001|Core Study Period|Per sponsor request|1|||
126395223|NCT02499900|454739563|FG000|Core Study Period|Pregnancy|1|||
126395224|NCT02499900|454739564|FG001|Core Study Period|Pregnancy|0|||
126395225|NCT02499900|454739563|FG000|Core Study Period|Protocol Violation|3|||
126395226|NCT02499900|454739564|FG001|Core Study Period|Protocol Violation|0|||
126395227|NCT02499900|454739563|FG000|Core Study Period|Withdrawal by Subject|11|||
126395228|NCT02499900|454739564|FG001|Core Study Period|Withdrawal by Subject|10|||
126395229|NCT02499900|454739563|FG000|Core Study Period|Adverse Event|18|||
126395230|NCT02499900|454739564|FG001|Core Study Period|Adverse Event|14|||
126395231|NCT02499900|454739563|FG000|Core Study Period|Death|0|||
126395232|NCT02499900|454739564|FG001|Core Study Period|Death|1|||
126395233|NCT02499900|454739563|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
126395234|NCT02499900|454739564|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
126395235|NCT02499900|454739563|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
126395236|NCT02499900|454739564|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
126395237|NCT02499900|454739563|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
126104621|NCT02390245|453675942|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
126104622|NCT04281004|453676982|FG000|Overall Study|Physician Decision|1|||
126104623|NCT04281004|453676983|FG001|Overall Study|Physician Decision|0|||
126104624|NCT03628898|453676984|FG000|Overall Study|Device deficiency|1|||
126104625|NCT03442985|453676985|FG000|Overall Study|Sponsor Request|55|||
126104626|NCT03442985|453676986|FG001|Overall Study|Sponsor Request|60|||
126104627|NCT03442985|453676987|FG002|Overall Study|Sponsor Request|54|||
126104628|NCT03442985|453676985|FG000|Overall Study|Lost to Follow-up|5|||
126104629|NCT03442985|453676986|FG001|Overall Study|Lost to Follow-up|2|||
126104630|NCT03442985|453676987|FG002|Overall Study|Lost to Follow-up|7|||
126104631|NCT03442985|453676985|FG000|Overall Study|Withdrawal by Subject|2|||
126104632|NCT03442985|453676986|FG001|Overall Study|Withdrawal by Subject|3|||
126104633|NCT03442985|453676987|FG002|Overall Study|Withdrawal by Subject|4|||
126104634|NCT03442985|453676985|FG000|Overall Study|Adverse Event|0|||
126104635|NCT03442985|453676986|FG001|Overall Study|Adverse Event|1|||
126104636|NCT03442985|453676987|FG002|Overall Study|Adverse Event|0|||
126104637|NCT01217957|453676988|FG000|Phase 1|Withdrawal by Patient|1|||
126104638|NCT01217957|453676989|FG001|Phase 1|Withdrawal by Patient|0|||
126395238|NCT02499900|454739564|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
126395239|NCT02499900|454739563|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
126395240|NCT02499900|454739564|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
126395241|NCT02499900|454739563|FG000|Extension Study Period|Adverse Event|2|||
126104639|NCT01217957|453676990|FG002|Phase 1|Withdrawal by Patient|1|||
126104640|NCT01217957|453676991|FG003|Phase 1|Withdrawal by Patient|1|||
126104641|NCT01217957|453676992|FG004|Phase 1|Withdrawal by Patient|0|||
126050433|NCT05580003|453481092|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050434|NCT05580003|453481093|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050435|NCT05580003|453481094|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126050436|NCT05580003|453481067|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050437|NCT05580003|453481068|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050438|NCT05580003|453481069|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125888252|NCT05340478|452886714|FG000|Overall Study|Neither member of dyad started treatment|2|||
125888253|NCT05340478|452886715|FG001|Overall Study|Neither member of dyad started treatment|2|||
125888254|NCT05340478|452886714|FG000|Overall Study|Withdrawn from study|2|||
125888255|NCT05340478|452886715|FG001|Overall Study|Withdrawn from study|2|||
125888256|NCT05340478|452886714|FG000|Overall Study|Lost to Follow-up|1|||
125888257|NCT05340478|452886715|FG001|Overall Study|Lost to Follow-up|4|||
125888258|NCT00092443|452886718|FG000|Overall Study|Adverse Event|9|||
125888259|NCT00092443|452886719|FG001|Overall Study|Adverse Event|13|||
125888260|NCT00092443|452886718|FG000|Overall Study|Lost to Follow-up|7|||
125888261|NCT00092443|452886719|FG001|Overall Study|Lost to Follow-up|3|||
125888262|NCT00092443|452886718|FG000|Overall Study|Protocol Violation|11|||
125888263|NCT00092443|452886719|FG001|Overall Study|Protocol Violation|9|||
126050439|NCT05580003|453481070|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
126050440|NCT05580003|453481071|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050441|NCT05580003|453481072|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050442|NCT05580003|453481073|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050443|NCT05580003|453481074|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050444|NCT05580003|453481075|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050445|NCT05580003|453481076|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050446|NCT05580003|453481077|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050447|NCT05580003|453481078|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050448|NCT05580003|453481079|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050449|NCT05580003|453481080|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050450|NCT05580003|453481081|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050451|NCT05580003|453481082|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050452|NCT05580003|453481083|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050453|NCT05580003|453481084|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050454|NCT05580003|453481085|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050455|NCT05580003|453481086|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050456|NCT05580003|453481087|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050457|NCT05580003|453481088|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050458|NCT05580003|453481089|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050459|NCT05580003|453481090|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050460|NCT05580003|453481091|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050461|NCT05580003|453481092|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050462|NCT05580003|453481093|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050463|NCT05580003|453481094|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126050464|NCT05580003|453481067|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050465|NCT05580003|453481068|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
126050466|NCT05580003|453481069|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050467|NCT05580003|453481070|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050468|NCT05580003|453481071|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050469|NCT05580003|453481072|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050470|NCT05580003|453481073|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050471|NCT05580003|453481074|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050472|NCT05580003|453481075|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050473|NCT05580003|453481076|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050474|NCT05580003|453481077|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050475|NCT05580003|453481078|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050476|NCT05580003|453481079|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050477|NCT05580003|453481080|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050478|NCT05580003|453481081|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050479|NCT05580003|453481082|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050480|NCT05580003|453481083|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050481|NCT05580003|453481084|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050482|NCT05580003|453481085|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050483|NCT05580003|453481086|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050484|NCT05580003|453481087|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050485|NCT05580003|453481088|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050486|NCT05580003|453481089|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050487|NCT05580003|453481090|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050488|NCT05580003|453481091|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050489|NCT05580003|453481092|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050490|NCT05580003|453481093|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050491|NCT05580003|453481094|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126050492|NCT05580003|453481067|FG000|Part 2 (up to 10 Days)|Other|0|||
125888264|NCT00092443|452886718|FG000|Overall Study|Withdrawal by Subject|9|||
125888265|NCT00092443|452886719|FG001|Overall Study|Withdrawal by Subject|11|||
126050493|NCT05580003|453481068|FG001|Part 2 (up to 10 Days)|Other|0|||
126050494|NCT05580003|453481069|FG002|Part 2 (up to 10 Days)|Other|0|||
125888266|NCT00092443|452886718|FG000|Overall Study|Moved|5|||
125888267|NCT00092443|452886719|FG001|Overall Study|Moved|5|||
126395242|NCT02499900|454739564|FG001|Extension Study Period|Adverse Event|4|||
126395243|NCT02499900|454739563|FG000|Extension Study Period|Withdrawal by Subject|5|||
126395244|NCT02499900|454739564|FG001|Extension Study Period|Withdrawal by Subject|2|||
126395245|NCT02499900|454739563|FG000|Extension Study Period|Physician Decision|2|||
126395246|NCT02499900|454739564|FG001|Extension Study Period|Physician Decision|5|||
126395247|NCT02499900|454739563|FG000|Extension Study Period|Pregnancy|1|||
126395248|NCT02499900|454739564|FG001|Extension Study Period|Pregnancy|2|||
126395249|NCT02499900|454739563|FG000|Extension Study Period|Lost to Follow-up|2|||
126395250|NCT02499900|454739564|FG001|Extension Study Period|Lost to Follow-up|5|||
126395251|NCT02499900|454739563|FG000|Extension Study Period|Other|0|||
126395252|NCT02499900|454739564|FG001|Extension Study Period|Other|2|||
126395253|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
126395254|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
126395255|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
126395256|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
126395257|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
126395258|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
126395259|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
126395260|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
126395261|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
126395262|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
126395263|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
126395264|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
126395265|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
126395266|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
126395267|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
125888268|NCT00092443|452886718|FG000|Overall Study|Other|17|||
125888269|NCT00092443|452886719|FG001|Overall Study|Other|13|||
125888270|NCT03207763|452887968|FG000|Overall Study|Lost to Follow-up|1|||
125888271|NCT03207763|452887969|FG001|Overall Study|Lost to Follow-up|0|||
125888272|NCT02605122|452887970|FG000|Overall Study|Withdrawal by Subject|4|||
125888273|NCT02605122|452887971|FG001|Overall Study|Withdrawal by Subject|1|||
125888274|NCT02605122|452887970|FG000|Overall Study|Lost to Follow-up|1|||
125888275|NCT02605122|452887971|FG001|Overall Study|Lost to Follow-up|1|||
125888276|NCT00807001|452887979|FG000|Overall Study|Non-compliance|0|||
125888277|NCT00807001|452887980|FG001|Overall Study|Non-compliance|1|||
125888278|NCT00807001|452887981|FG002|Overall Study|Non-compliance|0|||
125888279|NCT00807001|452887982|FG003|Overall Study|Non-compliance|0|||
125888280|NCT00807001|452887983|FG004|Overall Study|Non-compliance|0|||
125888281|NCT03180840|452887984|FG000|Overall Study|Withdrawal by Subject|1|||
125888282|NCT04555616|452887987|FG000|Overall Study|Death|1|||
125888283|NCT04555616|452887988|FG001|Overall Study|Death|0|||
125888284|NCT04555616|452887989|FG002|Overall Study|Death|1|||
125888285|NCT04555616|452887987|FG000|Overall Study|Withdrawal by Subject|2|||
125888286|NCT04555616|452887988|FG001|Overall Study|Withdrawal by Subject|1|||
125888287|NCT04555616|452887989|FG002|Overall Study|Withdrawal by Subject|0|||
125888288|NCT04816669|452887990|FG000|Part 1|Adverse Event|1|||
125888289|NCT04816669|452887991|FG001|Part 1|Adverse Event|1|||
125888290|NCT04816669|452887992|FG002|Part 1|Adverse Event|0|||
125888291|NCT04816669|452887993|FG003|Part 1|Adverse Event|0|||
125888292|NCT04816669|452887990|FG000|Part 1|Lost to Follow-up|2|||
125888293|NCT04816669|452887991|FG001|Part 1|Lost to Follow-up|2|||
125888294|NCT04816669|452887992|FG002|Part 1|Lost to Follow-up|0|||
125888295|NCT04816669|452887993|FG003|Part 1|Lost to Follow-up|0|||
125888296|NCT04816669|452887990|FG000|Part 1|Protocol Violation|0|||
125888297|NCT04816669|452887991|FG001|Part 1|Protocol Violation|1|||
125888298|NCT04816669|452887992|FG002|Part 1|Protocol Violation|0|||
125888299|NCT04816669|452887993|FG003|Part 1|Protocol Violation|0|||
125888300|NCT04816669|452887990|FG000|Part 1|Withdrawal by Subject|1|||
125888301|NCT04816669|452887991|FG001|Part 1|Withdrawal by Subject|2|||
125888302|NCT04816669|452887992|FG002|Part 1|Withdrawal by Subject|0|||
125888303|NCT04816669|452887993|FG003|Part 1|Withdrawal by Subject|0|||
125888304|NCT04816669|452887990|FG000|Part 2|Other|0|||
125888305|NCT04816669|452887991|FG001|Part 2|Other|0|||
125888306|NCT04816669|452887992|FG002|Part 2|Other|1|||
125888307|NCT04816669|452887993|FG003|Part 2|Other|0|||
125888308|NCT04816669|452887990|FG000|Part 2|Withdrawal by Subject|0|||
125888309|NCT04816669|452887991|FG001|Part 2|Withdrawal by Subject|0|||
125888310|NCT04816669|452887992|FG002|Part 2|Withdrawal by Subject|0|||
125888311|NCT04816669|452887993|FG003|Part 2|Withdrawal by Subject|1|||
125888312|NCT04816669|452887990|FG000|Part 2|Lost to Follow-up|0|||
125888313|NCT04816669|452887991|FG001|Part 2|Lost to Follow-up|0|||
125888314|NCT04816669|452887992|FG002|Part 2|Lost to Follow-up|1|||
125888315|NCT04816669|452887993|FG003|Part 2|Lost to Follow-up|0|||
125888316|NCT01229267|452887994|FG000|Overall Study|Adverse Event|4|||
125888317|NCT01229267|452887995|FG001|Overall Study|Adverse Event|6|||
125888318|NCT01229267|452887996|FG002|Overall Study|Adverse Event|3|||
125888319|NCT01229267|452887997|FG003|Overall Study|Adverse Event|2|||
125888320|NCT01229267|452887998|FG004|Overall Study|Adverse Event|10|||
125888321|NCT01229267|452887994|FG000|Overall Study|Death|40|||
125888322|NCT01229267|452887995|FG001|Overall Study|Death|37|||
126395268|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
126395269|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
126395270|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
126395271|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
126395272|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
126395273|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
126395274|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
126395275|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
126395276|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
126395277|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
126395278|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
126395279|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
126395280|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
126395281|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
126395282|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
126395283|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
125888323|NCT01229267|452887996|FG002|Overall Study|Death|35|||
125888324|NCT01229267|452887997|FG003|Overall Study|Death|13|||
125888325|NCT01229267|452887998|FG004|Overall Study|Death|103|||
125888326|NCT01229267|452887994|FG000|Overall Study|Withdrawal by Subject|23|||
125888327|NCT01229267|452887995|FG001|Overall Study|Withdrawal by Subject|22|||
125888328|NCT01229267|452887996|FG002|Overall Study|Withdrawal by Subject|32|||
126050495|NCT05580003|453481070|FG003|Part 2 (up to 10 Days)|Other|0|||
126050496|NCT05580003|453481071|FG004|Part 2 (up to 10 Days)|Other|0|||
126050497|NCT05580003|453481072|FG005|Part 2 (up to 10 Days)|Other|0|||
126050498|NCT05580003|453481073|FG006|Part 2 (up to 10 Days)|Other|0|||
126050499|NCT05580003|453481074|FG007|Part 2 (up to 10 Days)|Other|0|||
126050500|NCT05580003|453481075|FG008|Part 2 (up to 10 Days)|Other|0|||
126050501|NCT05580003|453481076|FG009|Part 2 (up to 10 Days)|Other|1|||
126050502|NCT05580003|453481077|FG010|Part 2 (up to 10 Days)|Other|0|||
126050503|NCT05580003|453481078|FG011|Part 2 (up to 10 Days)|Other|0|||
126050504|NCT05580003|453481079|FG012|Part 2 (up to 10 Days)|Other|0|||
126050505|NCT05580003|453481080|FG013|Part 2 (up to 10 Days)|Other|0|||
126050506|NCT05580003|453481081|FG014|Part 2 (up to 10 Days)|Other|0|||
126050507|NCT05580003|453481082|FG015|Part 2 (up to 10 Days)|Other|0|||
126050508|NCT05580003|453481083|FG016|Part 2 (up to 10 Days)|Other|0|||
126050509|NCT05580003|453481084|FG017|Part 2 (up to 10 Days)|Other|0|||
126050510|NCT05580003|453481085|FG018|Part 2 (up to 10 Days)|Other|0|||
126050511|NCT05580003|453481086|FG019|Part 2 (up to 10 Days)|Other|0|||
126050512|NCT05580003|453481087|FG020|Part 2 (up to 10 Days)|Other|0|||
126050513|NCT05580003|453481088|FG021|Part 2 (up to 10 Days)|Other|0|||
126050514|NCT05580003|453481089|FG022|Part 2 (up to 10 Days)|Other|0|||
126050515|NCT05580003|453481090|FG023|Part 2 (up to 10 Days)|Other|0|||
126050516|NCT05580003|453481091|FG024|Part 2 (up to 10 Days)|Other|0|||
126050517|NCT05580003|453481092|FG025|Part 2 (up to 10 Days)|Other|0|||
126050518|NCT05580003|453481093|FG026|Part 2 (up to 10 Days)|Other|0|||
126050519|NCT05580003|453481094|FG027|Part 2 (up to 10 Days)|Other|0|||
126050520|NCT05580003|453481067|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050521|NCT05580003|453481068|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050522|NCT05580003|453481069|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050523|NCT05580003|453481070|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050524|NCT05580003|453481071|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050525|NCT05580003|453481072|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050526|NCT05580003|453481073|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050527|NCT05580003|453481074|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050528|NCT05580003|453481075|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050529|NCT05580003|453481076|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050530|NCT05580003|453481077|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050531|NCT05580003|453481078|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050532|NCT05580003|453481079|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050533|NCT05580003|453481080|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050534|NCT05580003|453481081|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050535|NCT05580003|453481082|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050536|NCT05580003|453481083|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050537|NCT05580003|453481084|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050538|NCT05580003|453481085|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050539|NCT05580003|453481086|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
126050540|NCT05580003|453481087|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050541|NCT05580003|453481088|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050542|NCT05580003|453481089|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050543|NCT05580003|453481090|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050544|NCT05580003|453481091|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125888329|NCT01229267|452887997|FG003|Overall Study|Withdrawal by Subject|14|||
125888330|NCT01229267|452887998|FG004|Overall Study|Withdrawal by Subject|59|||
125888331|NCT01229267|452887994|FG000|Overall Study|Protocol Violation|0|||
126050545|NCT05580003|453481092|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050546|NCT05580003|453481093|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126395284|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
126050547|NCT05580003|453481094|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126050548|NCT05580003|453481067|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050549|NCT05580003|453481068|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126395285|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
126395286|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
126395287|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
126395288|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
126395289|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
126395290|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
126395291|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
126395292|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
126395293|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
126395294|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
126395295|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
126395296|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
126395297|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
126395298|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
126395299|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
126395300|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
126395301|NCT02080481|454739571|FG000|Overall Study|Never received a block.|1|||
126395302|NCT02080481|454739572|FG001|Overall Study|Never received a block.|0|||
126050550|NCT05580003|453481069|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050551|NCT05580003|453481070|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125888332|NCT01229267|452887995|FG001|Overall Study|Protocol Violation|1|||
126104642|NCT01217957|453676988|FG000|Phase 2|Withdrawal by Patient|0|||
126050552|NCT05580003|453481071|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050553|NCT05580003|453481072|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050554|NCT05580003|453481073|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050555|NCT05580003|453481074|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126395303|NCT02723006|454741874|FG000|Overall Study|Withdrawal by Subject|0|||
126395304|NCT02723006|454741875|FG001|Overall Study|Withdrawal by Subject|1|||
126395305|NCT02723006|454741876|FG002|Overall Study|Withdrawal by Subject|1|||
126395306|NCT02723006|454741874|FG000|Overall Study|Study Terminated by Sponsor|1|||
126395307|NCT02723006|454741875|FG001|Overall Study|Study Terminated by Sponsor|6|||
126395308|NCT02723006|454741876|FG002|Overall Study|Study Terminated by Sponsor|6|||
126395309|NCT04258995|454741877|FG000|Overall Study|Lost to Follow-up|1|||
126395310|NCT04258995|454741878|FG001|Overall Study|Lost to Follow-up|1|||
126395311|NCT00983515|454741881|FG000|Ritonavir Alone|liver panel out of range|6|||
126395312|NCT00983515|454741881|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
126395313|NCT00316693|454741882|FG000|Overall Study|Adverse Event|6|||
126395314|NCT00316693|454741883|FG001|Overall Study|Adverse Event|1|||
126395315|NCT00316693|454741882|FG000|Overall Study|Protocol Violation|1|||
126395316|NCT00316693|454741883|FG001|Overall Study|Protocol Violation|0|||
126395317|NCT00316693|454741882|FG000|Overall Study|Withdrawal by Subject|6|||
126395318|NCT00316693|454741883|FG001|Overall Study|Withdrawal by Subject|6|||
126395319|NCT00316693|454741882|FG000|Overall Study|Lost to Follow-up|26|||
126395320|NCT00316693|454741883|FG001|Overall Study|Lost to Follow-up|34|||
126395321|NCT00316693|454741882|FG000|Overall Study|Other|38|||
126395322|NCT00316693|454741883|FG001|Overall Study|Other|44|||
126395323|NCT01967823|454741884|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
126395324|NCT03002818|454741885|FG000|Overall Study|Decision of the investigator|1|||
126395325|NCT00711113|454741889|FG000|Overall Study|Lost to Follow-up|9|||
126395326|NCT00711113|454741889|FG000|Overall Study|Implant lost|2|||
126395327|NCT01606787|454741896|FG000|Overall Study|Withdrawal by Subject|4|||
126395328|NCT01606787|454741897|FG001|Overall Study|Withdrawal by Subject|5|||
126395329|NCT01606787|454741896|FG000|Overall Study|Surgery canceled|0|||
126395330|NCT01606787|454741897|FG001|Overall Study|Surgery canceled|2|||
126395331|NCT00413894|454741898|FG000|Overall Study|Withdrawal by Subject|10|||
126395332|NCT00413894|454741898|FG000|Overall Study|Administrative Reasons|1|||
126395333|NCT00413894|454741898|FG000|Overall Study|Hb <10 grams/deciliter|12|||
126395334|NCT00413894|454741898|FG000|Overall Study|Adverse Event|28|||
126395335|NCT00413894|454741898|FG000|Overall Study|Protocol Violation|11|||
126395336|NCT00413894|454741898|FG000|Overall Study|Other|18|||
126395337|NCT04225676|454741899|FG000|Overall Study|Physician Decision|1|||
126395338|NCT04225676|454741899|FG000|Overall Study|Lack of Efficacy|1|||
126395339|NCT04225676|454741899|FG000|Overall Study|Study terminated by sponsor|3|||
126395340|NCT03245736|454741900|FG000|Overall Study|Adverse Event|1|||
126395341|NCT03245736|454741900|FG000|Overall Study|Progressive Disease|4|||
126395342|NCT01942161|454741901|FG000|Overall Study|Adverse Event|1|||
126395343|NCT01942161|454741902|FG001|Overall Study|Adverse Event|2|||
126395344|NCT01942161|454741903|FG002|Overall Study|Adverse Event|5|||
126395345|NCT01942161|454741901|FG000|Overall Study|Physician Decision|3|||
126395346|NCT01942161|454741902|FG001|Overall Study|Physician Decision|1|||
126395347|NCT01942161|454741903|FG002|Overall Study|Physician Decision|0|||
126395348|NCT01942161|454741901|FG000|Overall Study|Protocol Violation|1|||
126395349|NCT01942161|454741902|FG001|Overall Study|Protocol Violation|0|||
126050556|NCT05580003|453481075|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126395350|NCT01942161|454741903|FG002|Overall Study|Protocol Violation|0|||
126395351|NCT01942161|454741901|FG000|Overall Study|Withdrawal by Subject|3|||
126395352|NCT01942161|454741902|FG001|Overall Study|Withdrawal by Subject|3|||
126395353|NCT01942161|454741903|FG002|Overall Study|Withdrawal by Subject|1|||
126395354|NCT05289271|454741906|FG000|Overall Study|Mistakenly allocated, untreated|1|||
126395355|NCT05289271|454741907|FG001|Overall Study|Mistakenly allocated, untreated|0|||
125888333|NCT01229267|452887996|FG002|Overall Study|Protocol Violation|0|||
126395356|NCT01257568|454741908|FG000|Overall Study|Lost to Follow-up|2|||
126395357|NCT01257568|454741908|FG000|Overall Study|Withdrawal by Subject|6|||
125888334|NCT01229267|452887997|FG003|Overall Study|Protocol Violation|0|||
125888335|NCT01229267|452887998|FG004|Overall Study|Protocol Violation|0|||
125888336|NCT01229267|452887994|FG000|Overall Study|Progressive disease|0|||
125888337|NCT01229267|452887995|FG001|Overall Study|Progressive disease|0|||
125888338|NCT01229267|452887996|FG002|Overall Study|Progressive disease|0|||
125888339|NCT01229267|452887997|FG003|Overall Study|Progressive disease|0|||
125888340|NCT01229267|452887998|FG004|Overall Study|Progressive disease|1|||
125888341|NCT01229267|452887994|FG000|Overall Study|Physician Decision|8|||
126395358|NCT01257568|454741908|FG000|Overall Study|Terminated|1|||
126395359|NCT01257568|454741908|FG000|Overall Study|Component Revision|24|||
126395360|NCT03392883|454741911|FG000|Overall Study|Lost to Follow-up|122|||
126395361|NCT03392883|454741912|FG001|Overall Study|Lost to Follow-up|13|||
126395362|NCT03392883|454741913|FG002|Overall Study|Lost to Follow-up|9|||
126395363|NCT03392883|454741911|FG000|Overall Study|Death|4|||
126395364|NCT03392883|454741912|FG001|Overall Study|Death|0|||
126395365|NCT03392883|454741913|FG002|Overall Study|Death|0|||
126395366|NCT03392883|454741911|FG000|Overall Study|Lack of Efficacy|29|||
126395367|NCT03392883|454741912|FG001|Overall Study|Lack of Efficacy|0|||
126395368|NCT03392883|454741913|FG002|Overall Study|Lack of Efficacy|0|||
126395369|NCT03392883|454741911|FG000|Overall Study|Withdrawal by Subject|180|||
126395370|NCT03392883|454741912|FG001|Overall Study|Withdrawal by Subject|0|||
126395371|NCT03392883|454741913|FG002|Overall Study|Withdrawal by Subject|0|||
126395372|NCT03392883|454741911|FG000|Overall Study|Adverse Event|1|||
126395373|NCT03392883|454741912|FG001|Overall Study|Adverse Event|0|||
126395374|NCT03392883|454741913|FG002|Overall Study|Adverse Event|0|||
126395375|NCT00132691|454741923|FG000|Overall Study|Lost to Follow-up|5|||
126395376|NCT00132691|454741924|FG001|Overall Study|Lost to Follow-up|8|||
126395377|NCT00132691|454741923|FG000|Overall Study|Missed 2-year visit|4|||
126395378|NCT00132691|454741924|FG001|Overall Study|Missed 2-year visit|4|||
126395379|NCT00132691|454741923|FG000|Overall Study|Death|2|||
126395380|NCT00132691|454741924|FG001|Overall Study|Death|0|||
126395381|NCT01739933|454741925|FG000|Overall Study|Death|89|||
126395382|NCT01739933|454741926|FG001|Overall Study|Death|86|||
126395383|NCT01739933|454741925|FG000|Overall Study|Withdrawal by Subject|10|||
126395384|NCT01739933|454741926|FG001|Overall Study|Withdrawal by Subject|8|||
126395385|NCT01739933|454741925|FG000|Overall Study|Lost to Follow-up|3|||
126395386|NCT01739933|454741926|FG001|Overall Study|Lost to Follow-up|10|||
126395387|NCT01739933|454741925|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
126395388|NCT01739933|454741926|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
126395389|NCT04098367|454741927|FG000|Overall Study|Adverse Event|0|||
126395390|NCT04098367|454741928|FG001|Overall Study|Adverse Event|0|||
126395391|NCT04098367|454741929|FG002|Overall Study|Adverse Event|1|||
126395392|NCT04098367|454741927|FG000|Overall Study|Lost to Follow-up|1|||
126395393|NCT04098367|454741928|FG001|Overall Study|Lost to Follow-up|5|||
126395394|NCT04098367|454741929|FG002|Overall Study|Lost to Follow-up|2|||
126395395|NCT04098367|454741927|FG000|Overall Study|Withdrawal by Subject|0|||
126395396|NCT04098367|454741928|FG001|Overall Study|Withdrawal by Subject|0|||
126395397|NCT04098367|454741929|FG002|Overall Study|Withdrawal by Subject|1|||
126395398|NCT04098367|454741927|FG000|Overall Study|Sick . Could not attend visit|1|||
126395399|NCT04098367|454741928|FG001|Overall Study|Sick . Could not attend visit|0|||
126395400|NCT04098367|454741929|FG002|Overall Study|Sick . Could not attend visit|0|||
126395401|NCT01231321|454741936|FG000|Overall Study|Adverse Event|3|||
126395402|NCT01231321|454741936|FG000|Overall Study|Lack of Efficacy|2|||
126395403|NCT00354107|454741938|FG000|Overall Study|Adverse Event|2|||
126395404|NCT00354107|454741938|FG000|Overall Study|Physician Decision|2|||
126395405|NCT00354107|454741938|FG000|Overall Study|Withdrawal by Subject|1|||
126395406|NCT03575065|454741941|FG000|Overall Study|Death|31|||
126395407|NCT03575065|454741942|FG001|Overall Study|Death|12|||
126395408|NCT03575065|454741941|FG000|Overall Study|Sponsor's Decision|28|||
126395409|NCT03575065|454741942|FG001|Overall Study|Sponsor's Decision|13|||
126395410|NCT03575065|454741941|FG000|Overall Study|Withdrawal by Subject|2|||
126395411|NCT03575065|454741942|FG001|Overall Study|Withdrawal by Subject|1|||
126395412|NCT03575065|454741941|FG000|Overall Study|Lost to Follow-up|1|||
126395413|NCT03575065|454741942|FG001|Overall Study|Lost to Follow-up|0|||
126395414|NCT03960580|454741943|FG000|Overall Study|Adverse Event|2|||
126395415|NCT03960580|454741944|FG001|Overall Study|Adverse Event|1|||
126395416|NCT03960580|454741945|FG002|Overall Study|Adverse Event|1|||
126395417|NCT03960580|454741943|FG000|Overall Study|Lost to Follow-up|1|||
126395418|NCT03960580|454741944|FG001|Overall Study|Lost to Follow-up|0|||
126395419|NCT03960580|454741945|FG002|Overall Study|Lost to Follow-up|0|||
126395420|NCT03960580|454741943|FG000|Overall Study|Lack of Efficacy|2|||
126395421|NCT03960580|454741944|FG001|Overall Study|Lack of Efficacy|1|||
126395422|NCT03960580|454741945|FG002|Overall Study|Lack of Efficacy|0|||
126395423|NCT03960580|454741943|FG000|Overall Study|Protocol Violation|0|||
126395424|NCT03960580|454741944|FG001|Overall Study|Protocol Violation|0|||
125888342|NCT01229267|452887995|FG001|Overall Study|Physician Decision|11|||
125888343|NCT01229267|452887996|FG002|Overall Study|Physician Decision|8|||
126395425|NCT03960580|454741945|FG002|Overall Study|Protocol Violation|1|||
126395426|NCT03960580|454741943|FG000|Overall Study|Withdrawal by Subject|1|||
126395427|NCT03960580|454741944|FG001|Overall Study|Withdrawal by Subject|1|||
126050557|NCT05580003|453481076|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050558|NCT05580003|453481077|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050559|NCT05580003|453481078|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050560|NCT05580003|453481079|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050561|NCT05580003|453481080|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050562|NCT05580003|453481081|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050563|NCT05580003|453481082|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050564|NCT05580003|453481083|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050565|NCT05580003|453481084|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050566|NCT05580003|453481085|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126395428|NCT03960580|454741945|FG002|Overall Study|Withdrawal by Subject|1|||
126050567|NCT05580003|453481086|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050568|NCT05580003|453481087|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
126050569|NCT05580003|453481088|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050570|NCT05580003|453481089|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050571|NCT05580003|453481090|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050572|NCT05580003|453481091|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050573|NCT05580003|453481092|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050574|NCT05580003|453481093|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050575|NCT05580003|453481094|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126050576|NCT05580003|453481067|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050577|NCT05580003|453481068|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050578|NCT05580003|453481069|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050579|NCT05580003|453481070|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050580|NCT05580003|453481071|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050581|NCT05580003|453481072|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050582|NCT05580003|453481073|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050583|NCT05580003|453481074|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050584|NCT05580003|453481075|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050585|NCT05580003|453481076|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050586|NCT05580003|453481077|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050587|NCT05580003|453481078|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050588|NCT05580003|453481079|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050589|NCT05580003|453481080|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050590|NCT05580003|453481081|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050591|NCT05580003|453481082|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050592|NCT05580003|453481083|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050593|NCT05580003|453481084|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050594|NCT05580003|453481085|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050595|NCT05580003|453481086|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050596|NCT05580003|453481087|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050597|NCT05580003|453481088|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
126050598|NCT05580003|453481089|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050599|NCT05580003|453481090|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050600|NCT05580003|453481091|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050601|NCT05580003|453481092|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050602|NCT05580003|453481093|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050603|NCT05580003|453481094|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126050604|NCT05580003|453481067|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050605|NCT05580003|453481068|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050606|NCT05580003|453481069|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050607|NCT05580003|453481070|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050608|NCT05580003|453481071|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050609|NCT05580003|453481072|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050610|NCT05580003|453481073|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126395429|NCT03960580|454741943|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
126395430|NCT03960580|454741944|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
126395431|NCT03960580|454741945|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
126395432|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
126395433|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
126395434|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
126395435|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
126395436|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
126395437|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
126395438|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
125888344|NCT01229267|452887997|FG003|Overall Study|Physician Decision|3|||
126395439|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395440|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395441|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395442|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
126395443|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
126395444|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395445|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395446|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395447|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395448|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395449|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395450|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
126395451|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395452|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
126395453|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395454|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395455|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
126395456|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125888345|NCT01229267|452887998|FG004|Overall Study|Physician Decision|25|||
125888346|NCT01229267|452887994|FG000|Overall Study|Lost to Follow-up|6|||
126050611|NCT05580003|453481074|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050612|NCT05580003|453481075|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050613|NCT05580003|453481076|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050614|NCT05580003|453481077|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050615|NCT05580003|453481078|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050616|NCT05580003|453481079|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050617|NCT05580003|453481080|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050618|NCT05580003|453481081|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050619|NCT05580003|453481082|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050620|NCT05580003|453481083|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050621|NCT05580003|453481084|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050622|NCT05580003|453481085|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050623|NCT05580003|453481086|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050624|NCT05580003|453481087|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050625|NCT05580003|453481088|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050626|NCT05580003|453481089|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050627|NCT05580003|453481090|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050628|NCT05580003|453481091|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050629|NCT05580003|453481092|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050630|NCT05580003|453481093|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126050631|NCT05580003|453481094|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
126050632|NCT05580003|453481067|FG000|Part 6 Period 2 (Day 1)|Other|0|||
126050633|NCT05580003|453481068|FG001|Part 6 Period 2 (Day 1)|Other|0|||
126050634|NCT05580003|453481069|FG002|Part 6 Period 2 (Day 1)|Other|0|||
126050635|NCT05580003|453481070|FG003|Part 6 Period 2 (Day 1)|Other|0|||
126050636|NCT05580003|453481071|FG004|Part 6 Period 2 (Day 1)|Other|0|||
126050637|NCT05580003|453481072|FG005|Part 6 Period 2 (Day 1)|Other|0|||
126050638|NCT05580003|453481073|FG006|Part 6 Period 2 (Day 1)|Other|0|||
126050639|NCT05580003|453481074|FG007|Part 6 Period 2 (Day 1)|Other|0|||
126050640|NCT05580003|453481075|FG008|Part 6 Period 2 (Day 1)|Other|0|||
126050641|NCT05580003|453481076|FG009|Part 6 Period 2 (Day 1)|Other|0|||
126050642|NCT05580003|453481077|FG010|Part 6 Period 2 (Day 1)|Other|0|||
126050643|NCT05580003|453481078|FG011|Part 6 Period 2 (Day 1)|Other|0|||
126050644|NCT05580003|453481079|FG012|Part 6 Period 2 (Day 1)|Other|0|||
126050645|NCT05580003|453481080|FG013|Part 6 Period 2 (Day 1)|Other|0|||
126050646|NCT05580003|453481081|FG014|Part 6 Period 2 (Day 1)|Other|0|||
126050647|NCT05580003|453481082|FG015|Part 6 Period 2 (Day 1)|Other|0|||
126050648|NCT05580003|453481083|FG016|Part 6 Period 2 (Day 1)|Other|0|||
126050649|NCT05580003|453481084|FG017|Part 6 Period 2 (Day 1)|Other|0|||
126050650|NCT05580003|453481085|FG018|Part 6 Period 2 (Day 1)|Other|0|||
126050651|NCT05580003|453481086|FG019|Part 6 Period 2 (Day 1)|Other|0|||
126050652|NCT05580003|453481087|FG020|Part 6 Period 2 (Day 1)|Other|0|||
126050653|NCT05580003|453481088|FG021|Part 6 Period 2 (Day 1)|Other|0|||
125888347|NCT01229267|452887995|FG001|Overall Study|Lost to Follow-up|5|||
125888348|NCT01229267|452887996|FG002|Overall Study|Lost to Follow-up|8|||
125888349|NCT01229267|452887997|FG003|Overall Study|Lost to Follow-up|3|||
125888350|NCT01229267|452887998|FG004|Overall Study|Lost to Follow-up|22|||
125888351|NCT02446899|452887999|FG000|Overall Study|Adverse Event|4|||
125888352|NCT02446899|452888000|FG001|Overall Study|Adverse Event|7|||
125888353|NCT02446899|452887999|FG000|Overall Study|Condition Under Investigation Worsened|1|||
125888354|NCT02446899|452888000|FG001|Overall Study|Condition Under Investigation Worsened|4|||
125888355|NCT02446899|452887999|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
125888356|NCT02446899|452888000|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
125888357|NCT02446899|452887999|FG000|Overall Study|Lack of Efficacy|2|||
125888358|NCT02446899|452888000|FG001|Overall Study|Lack of Efficacy|8|||
125888359|NCT02446899|452887999|FG000|Overall Study|Lost to Follow-up|1|||
125888360|NCT02446899|452888000|FG001|Overall Study|Lost to Follow-up|3|||
125888361|NCT02446899|452887999|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
125888362|NCT02446899|452888000|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
125888363|NCT02446899|452887999|FG000|Overall Study|Withdrawal by Subject|11|||
125888364|NCT02446899|452888000|FG001|Overall Study|Withdrawal by Subject|19|||
126050654|NCT05580003|453481089|FG022|Part 6 Period 2 (Day 1)|Other|0|||
126050655|NCT05580003|453481090|FG023|Part 6 Period 2 (Day 1)|Other|0|||
126050656|NCT05580003|453481091|FG024|Part 6 Period 2 (Day 1)|Other|1|||
126050657|NCT05580003|453481092|FG025|Part 6 Period 2 (Day 1)|Other|0|||
126050658|NCT05580003|453481093|FG026|Part 6 Period 2 (Day 1)|Other|0|||
126050659|NCT05580003|453481094|FG027|Part 6 Period 2 (Day 1)|Other|0|||
126050660|NCT04795167|453481095|FG000|Overall Study|Death|1|||
126050661|NCT04795167|453481096|FG001|Overall Study|Death|18|||
126050662|NCT04795167|453481097|FG002|Overall Study|Death|1|||
126050663|NCT04795167|453481095|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
126050664|NCT04795167|453481096|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
126050665|NCT04795167|453481097|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
125888365|NCT02446899|452887999|FG000|Overall Study|Miscellaneous|5|||
125888366|NCT02446899|452888000|FG001|Overall Study|Miscellaneous|4|||
126050666|NCT02052440|453481099|FG000|Overall Study|Withdrawal by Subject|0|||
126050667|NCT02052440|453481100|FG001|Overall Study|Withdrawal by Subject|1|||
126050668|NCT02130557|453481102|FG000|Overall Study|Withdrawal by Subject|12|||
126050669|NCT02130557|453481103|FG001|Overall Study|Withdrawal by Subject|12|||
126050670|NCT02130557|453481102|FG000|Overall Study|Investigator Request|0|||
126050671|NCT02130557|453481103|FG001|Overall Study|Investigator Request|2|||
126050672|NCT02130557|453481102|FG000|Overall Study|Deceased|14|||
126050673|NCT02130557|453481103|FG001|Overall Study|Deceased|14|||
126050674|NCT02130557|453481102|FG000|Overall Study|Lost to Follow-up|6|||
126050675|NCT02130557|453481103|FG001|Overall Study|Lost to Follow-up|7|||
126050676|NCT02130557|453481102|FG000|Overall Study|Other|2|||
126395457|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395458|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395459|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395460|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395461|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395462|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395463|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395464|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395465|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395466|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395467|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395468|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395469|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395470|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
126395471|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395472|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395473|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395474|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395475|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395476|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395477|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125888367|NCT02446899|452887999|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125888368|NCT02446899|452888000|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
125888369|NCT04050202|452888001|FG000|Overall Study|Lost to Follow-up|2|||
125888370|NCT02974543|452888002|FG000|Overall Study|Withdrawal by Subject|1|||
125888371|NCT02974543|452888003|FG001|Overall Study|Withdrawal by Subject|0|||
126050677|NCT02130557|453481103|FG001|Overall Study|Other|1|||
126050678|NCT02130557|453481102|FG000|Overall Study|Missing|2|||
126050679|NCT02130557|453481103|FG001|Overall Study|Missing|1|||
126104643|NCT01217957|453676989|FG001|Phase 2|Withdrawal by Patient|0|||
126395478|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395479|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395480|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395481|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395482|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395483|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395484|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395485|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395486|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395487|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395488|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
126395489|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126050680|NCT02408887|453481104|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
126050681|NCT02408887|453481105|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
126050682|NCT02408887|453481104|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
126050683|NCT02408887|453481105|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
126050684|NCT03333109|453481106|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
126395490|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395491|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395492|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395493|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395494|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395495|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126050685|NCT03333109|453481107|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
126050686|NCT03333109|453481108|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
126104644|NCT01217957|453676990|FG002|Phase 2|Withdrawal by Patient|0|||
126104645|NCT01217957|453676991|FG003|Phase 2|Withdrawal by Patient|0|||
126395496|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395497|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395498|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395499|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126050687|NCT03333109|453481106|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126050688|NCT03333109|453481107|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126050689|NCT03333109|453481108|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
126050690|NCT03333109|453481106|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
126050691|NCT03333109|453481107|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
126050692|NCT03333109|453481108|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
126050693|NCT03333109|453481106|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
126050694|NCT03333109|453481107|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
126050695|NCT03333109|453481108|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
126050696|NCT03333109|453481106|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
126050697|NCT03333109|453481107|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
126050698|NCT03333109|453481108|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
126050699|NCT03333109|453481106|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
126050700|NCT03333109|453481107|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
126050701|NCT03333109|453481108|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
126050702|NCT03333109|453481106|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
126050703|NCT03333109|453481107|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
126050704|NCT03333109|453481108|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
126050705|NCT03333109|453481106|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
126050706|NCT03333109|453481107|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
126050707|NCT03333109|453481108|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
126050708|NCT00918203|453481112|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
126050709|NCT00918203|453481113|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
126050710|NCT00918203|453481114|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
126050711|NCT00918203|453481112|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
126050712|NCT00918203|453481113|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
126050713|NCT00918203|453481114|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
126050714|NCT00918203|453481112|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
126050715|NCT00918203|453481113|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
126050716|NCT00918203|453481114|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
126050717|NCT00918203|453481112|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
126050718|NCT00918203|453481113|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
126050719|NCT00918203|453481114|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
126050720|NCT00589875|453481117|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
126050721|NCT00589875|453481117|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
126050722|NCT03488719|453481120|FG000|Overall Study|Adverse Event|0|||
126050723|NCT03488719|453481121|FG001|Overall Study|Adverse Event|4|||
126050724|NCT03488719|453481122|FG002|Overall Study|Adverse Event|2|||
126050725|NCT03488719|453481120|FG000|Overall Study|Other|0|||
126050726|NCT03488719|453481121|FG001|Overall Study|Other|0|||
126050727|NCT03488719|453481122|FG002|Overall Study|Other|5|||
126050728|NCT01675492|453481125|FG000|Overall Study|study completed early - product approval|42|||
126050729|NCT05025384|453481126|FG000|Overall Study|Physician Decision|5|||
126050730|NCT05025384|453481127|FG001|Overall Study|Physician Decision|6|||
126050731|NCT03610581|453481128|FG000|Overall Study|Study terminated by sponsor|2|||
126050732|NCT03610581|453481129|FG001|Overall Study|Study terminated by sponsor|0|||
126050733|NCT03610581|453481128|FG000|Overall Study|Other|0|||
126050734|NCT03610581|453481129|FG001|Overall Study|Other|1|||
126050735|NCT03610581|453481128|FG000|Overall Study|Withdrawal by Subject|1|||
126050736|NCT03610581|453481129|FG001|Overall Study|Withdrawal by Subject|0|||
126050737|NCT05485805|453481137|FG000|Overall Study|Withdrawal by Subject|1|||
126050738|NCT05485805|453481138|FG001|Overall Study|Withdrawal by Subject|2|||
126050739|NCT05485805|453481139|FG002|Overall Study|Withdrawal by Subject|2|||
126050740|NCT05485805|453481140|FG003|Overall Study|Withdrawal by Subject|0|||
126050741|NCT05485805|453481141|FG004|Overall Study|Withdrawal by Subject|2|||
126050742|NCT05485805|453481137|FG000|Overall Study|Adverse Event|0|||
126104646|NCT01217957|453676992|FG004|Phase 2|Withdrawal by Patient|1|||
126395500|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126050743|NCT05485805|453481138|FG001|Overall Study|Adverse Event|1|||
126050744|NCT05485805|453481139|FG002|Overall Study|Adverse Event|0|||
126050745|NCT05485805|453481140|FG003|Overall Study|Adverse Event|0|||
126050746|NCT05485805|453481141|FG004|Overall Study|Adverse Event|0|||
126050747|NCT05485805|453481137|FG000|Overall Study|Lost to Follow-up|1|||
126050748|NCT05485805|453481138|FG001|Overall Study|Lost to Follow-up|1|||
126395501|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395502|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126050749|NCT05485805|453481139|FG002|Overall Study|Lost to Follow-up|3|||
126050750|NCT05485805|453481140|FG003|Overall Study|Lost to Follow-up|1|||
126050751|NCT05485805|453481141|FG004|Overall Study|Lost to Follow-up|0|||
126050752|NCT04218357|453481142|FG000|1st Allocation|Withdrawal by Subject|1|||
126050753|NCT04218357|453481143|FG001|1st Allocation|Withdrawal by Subject|0|||
126050754|NCT05349838|453481144|FG000|Overall Study|Virological Failure|1|||
125888372|NCT00742235|452888004|FG000|Overall Study|Lost to Follow-up|0|||
126050755|NCT05349838|453481145|FG001|Overall Study|Virological Failure|2|||
126050756|NCT05349838|453481144|FG000|Overall Study|Withdrawal by Subject|2|||
126050757|NCT05349838|453481145|FG001|Overall Study|Withdrawal by Subject|3|||
126050758|NCT05349838|453481144|FG000|Overall Study|Adverse Event|3|||
126050759|NCT05349838|453481145|FG001|Overall Study|Adverse Event|1|||
126050760|NCT05349838|453481144|FG000|Overall Study|Lost to Follow-up|1|||
126050761|NCT05349838|453481145|FG001|Overall Study|Lost to Follow-up|2|||
126050762|NCT05349838|453481144|FG000|Overall Study|Other reasons|5|||
126050763|NCT05349838|453481145|FG001|Overall Study|Other reasons|1|||
126395503|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395504|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395505|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395506|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395507|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395508|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395509|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395510|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395511|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395512|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395513|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125888373|NCT00742235|452888005|FG001|Overall Study|Lost to Follow-up|31|||
125888374|NCT01237899|452888006|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
126050764|NCT04484623|453481147|FG000|Overall Study|Lost to Follow-up|0|||
126050765|NCT04484623|453481148|FG001|Overall Study|Lost to Follow-up|1|||
126050766|NCT04484623|453481147|FG000|Overall Study|Protocol Deviation|1|||
126050767|NCT04484623|453481148|FG001|Overall Study|Protocol Deviation|0|||
126050768|NCT04484623|453481147|FG000|Overall Study|Physician Decision|1|||
126050769|NCT04484623|453481148|FG001|Overall Study|Physician Decision|0|||
126050770|NCT04484623|453481147|FG000|Overall Study|Withdrawal by Subject|11|||
126050771|NCT04484623|453481148|FG001|Overall Study|Withdrawal by Subject|8|||
126050772|NCT04484623|453481147|FG000|Overall Study|Ongoing|94|||
126050773|NCT04484623|453481148|FG001|Overall Study|Ongoing|84|||
126050774|NCT02488408|453481149|FG000|Part A|Adverse Event|2|||
126050775|NCT02488408|453481150|FG001|Part A|Adverse Event|0|||
126050776|NCT02488408|453481151|FG002|Part A|Adverse Event|0|||
126050777|NCT02488408|453481152|FG003|Part A|Adverse Event|0|||
126050778|NCT02488408|453481153|FG004|Part A|Adverse Event|0|||
126050779|NCT02488408|453481154|FG005|Part A|Adverse Event|0|||
126050780|NCT02488408|453481155|FG006|Part A|Adverse Event|0|||
126050781|NCT02488408|453481156|FG007|Part A|Adverse Event|0|||
126050782|NCT02488408|453481157|FG008|Part A|Adverse Event|0|||
126050783|NCT02488408|453481158|FG009|Part A|Adverse Event|0|||
126050784|NCT02488408|453481149|FG000|Part A|Death|1|||
126050785|NCT02488408|453481150|FG001|Part A|Death|5|||
126050786|NCT02488408|453481151|FG002|Part A|Death|0|||
126050787|NCT02488408|453481152|FG003|Part A|Death|0|||
126050788|NCT02488408|453481153|FG004|Part A|Death|3|||
126050789|NCT02488408|453481154|FG005|Part A|Death|0|||
126050790|NCT02488408|453481155|FG006|Part A|Death|0|||
126050791|NCT02488408|453481156|FG007|Part A|Death|0|||
126050792|NCT02488408|453481157|FG008|Part A|Death|0|||
126050793|NCT02488408|453481158|FG009|Part A|Death|0|||
126050794|NCT02488408|453481149|FG000|Part A|Disease Progression|2|||
126050795|NCT02488408|453481150|FG001|Part A|Disease Progression|8|||
126050796|NCT02488408|453481151|FG002|Part A|Disease Progression|2|||
126050797|NCT02488408|453481152|FG003|Part A|Disease Progression|3|||
126050798|NCT02488408|453481153|FG004|Part A|Disease Progression|4|||
126050799|NCT02488408|453481154|FG005|Part A|Disease Progression|0|||
126050800|NCT02488408|453481155|FG006|Part A|Disease Progression|0|||
126050801|NCT02488408|453481156|FG007|Part A|Disease Progression|0|||
126050802|NCT02488408|453481157|FG008|Part A|Disease Progression|0|||
126050803|NCT02488408|453481158|FG009|Part A|Disease Progression|0|||
126050804|NCT02488408|453481149|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
126050805|NCT02488408|453481150|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
126050806|NCT02488408|453481151|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
126104647|NCT01716117|453676998|FG000|Overall Study|Death|5|||
126104648|NCT01716117|453676999|FG001|Overall Study|Death|2|||
126104649|NCT01716117|453676998|FG000|Overall Study|Withdrawal by Subject|2|||
126395514|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
126395515|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126104650|NCT01716117|453676999|FG001|Overall Study|Withdrawal by Subject|0|||
126395516|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395517|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395518|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395519|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395520|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395521|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395522|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395523|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395524|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395525|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
126395526|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126050807|NCT02488408|453481152|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
126050808|NCT02488408|453481153|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
126050809|NCT02488408|453481154|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
126050810|NCT02488408|453481155|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
126050811|NCT02488408|453481156|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
126050812|NCT02488408|453481157|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
126050813|NCT02488408|453481158|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
126050814|NCT02488408|453481149|FG000|Part A|Investigator Decision|0|||
126050815|NCT02488408|453481150|FG001|Part A|Investigator Decision|1|||
126050816|NCT02488408|453481151|FG002|Part A|Investigator Decision|1|||
126050817|NCT02488408|453481152|FG003|Part A|Investigator Decision|0|||
126050818|NCT02488408|453481153|FG004|Part A|Investigator Decision|0|||
126050819|NCT02488408|453481154|FG005|Part A|Investigator Decision|0|||
126050820|NCT02488408|453481155|FG006|Part A|Investigator Decision|0|||
126050821|NCT02488408|453481156|FG007|Part A|Investigator Decision|0|||
126050822|NCT02488408|453481157|FG008|Part A|Investigator Decision|0|||
126050823|NCT02488408|453481158|FG009|Part A|Investigator Decision|0|||
126050824|NCT02488408|453481149|FG000|Part A|Withdrawal by Subject|0|||
126050825|NCT02488408|453481150|FG001|Part A|Withdrawal by Subject|0|||
126050826|NCT02488408|453481151|FG002|Part A|Withdrawal by Subject|2|||
126050827|NCT02488408|453481152|FG003|Part A|Withdrawal by Subject|0|||
126050828|NCT02488408|453481153|FG004|Part A|Withdrawal by Subject|0|||
126050829|NCT02488408|453481154|FG005|Part A|Withdrawal by Subject|0|||
126050830|NCT02488408|453481155|FG006|Part A|Withdrawal by Subject|0|||
126050831|NCT02488408|453481156|FG007|Part A|Withdrawal by Subject|0|||
126050832|NCT02488408|453481157|FG008|Part A|Withdrawal by Subject|0|||
126050833|NCT02488408|453481158|FG009|Part A|Withdrawal by Subject|0|||
126050834|NCT02488408|453481149|FG000|Part A|Other|1|||
126050835|NCT02488408|453481150|FG001|Part A|Other|0|||
126050836|NCT02488408|453481151|FG002|Part A|Other|0|||
126104651|NCT03645057|453677000|FG000|Randomization to Baseline|Lost to Follow-up|1|||
126104652|NCT03645057|453677001|FG001|Randomization to Baseline|Lost to Follow-up|0|||
126395527|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
126395528|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395529|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395530|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395531|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395532|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395533|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395534|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395535|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395536|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395537|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395538|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395539|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395540|NCT02359045|454741966|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
126395541|NCT02359045|454741967|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126395542|NCT02359045|454741966|FG000|Overall Study|Lost to Follow-up|1|||
126395543|NCT02359045|454741967|FG001|Overall Study|Lost to Follow-up|1|||
126395544|NCT02359045|454741966|FG000|Overall Study|Adverse Event|0|||
126395545|NCT02359045|454741967|FG001|Overall Study|Adverse Event|1|||
126395546|NCT04600076|454741970|FG000|Overall Study|Lost to Follow-up|3|||
126395547|NCT00541866|454741971|FG000|Overall Study|Adverse Event|3|||
126395548|NCT00541866|454741972|FG001|Overall Study|Adverse Event|0|||
126395549|NCT00541866|454741973|FG002|Overall Study|Adverse Event|0|||
126395550|NCT00541866|454741974|FG003|Overall Study|Adverse Event|0|||
126395551|NCT00541866|454741975|FG004|Overall Study|Adverse Event|0|||
126395552|NCT00541866|454741971|FG000|Overall Study|Death|1|||
126395553|NCT00541866|454741972|FG001|Overall Study|Death|0|||
126395554|NCT00541866|454741973|FG002|Overall Study|Death|0|||
126395555|NCT00541866|454741974|FG003|Overall Study|Death|0|||
126395556|NCT00541866|454741975|FG004|Overall Study|Death|0|||
126395557|NCT00541866|454741971|FG000|Overall Study|Lack of Efficacy|19|||
126395558|NCT00541866|454741972|FG001|Overall Study|Lack of Efficacy|15|||
126395559|NCT00541866|454741973|FG002|Overall Study|Lack of Efficacy|10|||
126395560|NCT00541866|454741974|FG003|Overall Study|Lack of Efficacy|12|||
126395561|NCT00541866|454741975|FG004|Overall Study|Lack of Efficacy|14|||
126395562|NCT00541866|454741971|FG000|Overall Study|Not Reported or Other|11|||
126395563|NCT00541866|454741972|FG001|Overall Study|Not Reported or Other|3|||
126395564|NCT00541866|454741973|FG002|Overall Study|Not Reported or Other|3|||
126395565|NCT00541866|454741974|FG003|Overall Study|Not Reported or Other|3|||
126395566|NCT00541866|454741975|FG004|Overall Study|Not Reported or Other|1|||
126395567|NCT00541866|454741971|FG000|Overall Study|Physician Decision|0|||
126395568|NCT00541866|454741972|FG001|Overall Study|Physician Decision|0|||
126395569|NCT00541866|454741973|FG002|Overall Study|Physician Decision|2|||
126395570|NCT00541866|454741974|FG003|Overall Study|Physician Decision|1|||
126395571|NCT00541866|454741975|FG004|Overall Study|Physician Decision|0|||
126395572|NCT00957944|454741976|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
126395573|NCT00957944|454741977|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
126050837|NCT02488408|453481152|FG003|Part A|Other|0|||
126050838|NCT02488408|453481153|FG004|Part A|Other|0|||
126050839|NCT02488408|453481154|FG005|Part A|Other|0|||
126050840|NCT02488408|453481155|FG006|Part A|Other|0|||
126050841|NCT02488408|453481156|FG007|Part A|Other|0|||
126104653|NCT03645057|453677002|FG002|Randomization to Baseline|Lost to Follow-up|1|||
126104654|NCT03645057|453677003|FG003|Randomization to Baseline|Lost to Follow-up|0|||
126104655|NCT03645057|453677000|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
126104656|NCT03645057|453677001|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
126104657|NCT03645057|453677002|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
126104658|NCT03645057|453677003|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
126104659|NCT03645057|453677000|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
126104660|NCT03645057|453677001|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
126104661|NCT03645057|453677002|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
126104662|NCT03645057|453677003|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
126104663|NCT03645057|453677000|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
126104664|NCT03645057|453677001|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
126104665|NCT03645057|453677002|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
126104666|NCT03645057|453677003|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
126104667|NCT01873495|453677004|FG000|Overall Study|Withdrawal by Subject|1|||
126104668|NCT01873495|453677004|FG000|Overall Study|Physician Decision|3|||
126104669|NCT01873495|453677004|FG000|Overall Study|Adverse Event|1|||
126104670|NCT01873495|453677004|FG000|Overall Study|Removed for Transplantation|1|||
126104671|NCT01873495|453677004|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
126395574|NCT01482169|454741982|FG000|Overall Study|Physician Decision|2|||
126395575|NCT00522418|454741983|FG000|Overall Study|Local IRB Consent Violation|5|||
126395576|NCT00522418|454741984|FG001|Overall Study|Local IRB Consent Violation|5|||
126395577|NCT00522418|454741983|FG000|Overall Study|Early Study Termination|46|||
126395578|NCT00522418|454741984|FG001|Overall Study|Early Study Termination|47|||
126395579|NCT00522418|454741983|FG000|Overall Study|Noncompliance|2|||
126395580|NCT00522418|454741984|FG001|Overall Study|Noncompliance|2|||
126395581|NCT00522418|454741983|FG000|Overall Study|Reason Not Specified|3|||
126395582|NCT00522418|454741984|FG001|Overall Study|Reason Not Specified|1|||
126395583|NCT00522418|454741983|FG000|Overall Study|Consent Withdraw|1|||
126395584|NCT00522418|454741984|FG001|Overall Study|Consent Withdraw|2|||
126395585|NCT00522418|454741983|FG000|Overall Study|Lack of Efficacy|0|||
126395586|NCT00522418|454741984|FG001|Overall Study|Lack of Efficacy|1|||
126104672|NCT01206777|453677005|FG000|Overall Study|Death|1|||
126104673|NCT01206777|453677005|FG000|Overall Study|Adverse Event|1|||
126104674|NCT02986334|453677006|FG000|Overall Study|Withdrawal by Subject|0|||
126104675|NCT02986334|453677007|FG001|Overall Study|Withdrawal by Subject|1|||
125888375|NCT01237899|452888007|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
125888376|NCT01237899|452888008|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
125888377|NCT01237899|452888009|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
125888378|NCT01237899|452888010|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
125888379|NCT01237899|452888011|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
125888380|NCT01237899|452888012|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
125888381|NCT01237899|452888013|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
125888382|NCT01237899|452888014|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
125888383|NCT01237899|452888015|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
125888384|NCT01237899|452888016|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
125888385|NCT02141438|452888018|FG000|Overall Study|Death|1308|||
125888386|NCT02141438|452888018|FG000|Overall Study|Lost to Follow-up|84|||
125888387|NCT02141438|452888018|FG000|Overall Study|Withdrawal by Subject|52|||
126395587|NCT01944098|454741985|FG000|Overall Study|Physician Decision|1|||
126395588|NCT01944098|454741986|FG001|Overall Study|Physician Decision|0|||
126395589|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
126395590|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
126395591|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
126395592|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
126395593|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
126395594|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
126395595|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
126395596|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
126395597|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
126395598|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
126395599|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
126395600|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
126395601|NCT00737568|454741987|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
126395602|NCT00737568|454741988|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
126395603|NCT00737568|454741987|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
126395604|NCT00737568|454741988|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
126395605|NCT00737568|454741987|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
126395606|NCT00737568|454741988|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
126395607|NCT00855933|454741989|FG000|Overall Study|Withdrawal by Subject|0|||
126395608|NCT00855933|454741990|FG001|Overall Study|Withdrawal by Subject|1|||
126395609|NCT00951080|454741991|FG000|Overall Study|Adverse Event|3|||
126395610|NCT00951080|454741992|FG001|Overall Study|Adverse Event|3|||
126395611|NCT00951080|454741991|FG000|Overall Study|Lost to Follow-up|0|||
126395612|NCT00951080|454741992|FG001|Overall Study|Lost to Follow-up|1|||
125888388|NCT02141438|452888018|FG000|Overall Study|Physician Decision|1|||
126395613|NCT00951080|454741991|FG000|Overall Study|Physician Decision|4|||
126395614|NCT00951080|454741992|FG001|Overall Study|Physician Decision|1|||
126395615|NCT00951080|454741991|FG000|Overall Study|Other|19|||
126050842|NCT02488408|453481157|FG008|Part A|Other|0|||
126050843|NCT02488408|453481158|FG009|Part A|Other|0|||
126395616|NCT00951080|454741992|FG001|Overall Study|Other|22|||
126395617|NCT01960998|454741993|FG000|Overall Study|Lost to Follow-up|3|||
126395618|NCT01960998|454741994|FG001|Overall Study|Lost to Follow-up|7|||
126395619|NCT01960998|454741993|FG000|Overall Study|Death|0|||
126395620|NCT01960998|454741994|FG001|Overall Study|Death|1|||
126395621|NCT01960998|454741993|FG000|Overall Study|Withdrawal by Subject|8|||
126395622|NCT01960998|454741994|FG001|Overall Study|Withdrawal by Subject|2|||
126395623|NCT01960998|454741993|FG000|Overall Study|lost computer access|0|||
126395624|NCT01960998|454741994|FG001|Overall Study|lost computer access|1|||
126395625|NCT01939002|454742000|FG000|Overall Study|Adverse Event|13|||
126395626|NCT01939002|454742001|FG001|Overall Study|Adverse Event|13|||
126395627|NCT01939002|454742000|FG000|Overall Study|Withdrawal by Subject|5|||
126395628|NCT01939002|454742001|FG001|Overall Study|Withdrawal by Subject|3|||
126395629|NCT01939002|454742000|FG000|Overall Study|Other|1|||
126395630|NCT01939002|454742001|FG001|Overall Study|Other|2|||
126395631|NCT03372460|454742003|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
126395632|NCT03372460|454742004|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
126395633|NCT01170065|454742007|FG000|Overall Study|Adverse Event|17|||
126395634|NCT01170065|454742008|FG001|Overall Study|Adverse Event|50|||
126395635|NCT01170065|454742009|FG002|Overall Study|Adverse Event|10|||
126395636|NCT01170065|454742007|FG000|Overall Study|Lost to Follow-up|1|||
126395637|NCT01170065|454742008|FG001|Overall Study|Lost to Follow-up|4|||
126395638|NCT01170065|454742009|FG002|Overall Study|Lost to Follow-up|1|||
126395639|NCT01170065|454742007|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
126395640|NCT01170065|454742008|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
126395641|NCT01170065|454742009|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
126395642|NCT01170065|454742007|FG000|Overall Study|Reason other than specified|3|||
126395643|NCT01170065|454742008|FG001|Overall Study|Reason other than specified|8|||
126395644|NCT01170065|454742009|FG002|Overall Study|Reason other than specified|3|||
126395645|NCT01170065|454742007|FG000|Overall Study|Ongoing after planned observation time|5|||
126395646|NCT01170065|454742008|FG001|Overall Study|Ongoing after planned observation time|26|||
126395647|NCT01170065|454742009|FG002|Overall Study|Ongoing after planned observation time|10|||
126395648|NCT00840060|454744362|FG000|Overall Study|Withdrawal by Subject|1|||
126395649|NCT00840060|454744363|FG001|Overall Study|Withdrawal by Subject|0|||
126395650|NCT00840060|454744362|FG000|Overall Study|Change in emotional/behavioral status|0|||
126395651|NCT00840060|454744363|FG001|Overall Study|Change in emotional/behavioral status|1|||
126395652|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
126395653|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
126395654|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
126395655|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
126395656|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
126395657|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
126395658|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
126395659|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
126395660|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
126395661|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
126395662|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
126395663|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
126395664|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
126395665|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
126395666|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
126395667|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
126050844|NCT02488408|453481149|FG000|Part B|Adverse Event|0|||
126104676|NCT02986334|453677008|FG002|Overall Study|Withdrawal by Subject|2|||
126104677|NCT02986334|453677006|FG000|Overall Study|Lost to Follow-up|1|||
126104678|NCT02986334|453677007|FG001|Overall Study|Lost to Follow-up|2|||
126104679|NCT02986334|453677008|FG002|Overall Study|Lost to Follow-up|1|||
126104680|NCT02986334|453677006|FG000|Overall Study|Adverse Event|0|||
126104681|NCT02986334|453677007|FG001|Overall Study|Adverse Event|2|||
126104682|NCT02986334|453677008|FG002|Overall Study|Adverse Event|1|||
126104683|NCT02986334|453677006|FG000|Overall Study|non compliance in phone ratings|2|||
126104684|NCT02986334|453677007|FG001|Overall Study|non compliance in phone ratings|1|||
126104685|NCT02986334|453677008|FG002|Overall Study|non compliance in phone ratings|2|||
126104686|NCT02986334|453677006|FG000|Overall Study|undisclosed comorbidities|0|||
126104687|NCT02986334|453677007|FG001|Overall Study|undisclosed comorbidities|1|||
126104688|NCT02986334|453677008|FG002|Overall Study|undisclosed comorbidities|1|||
126104689|NCT00762970|453677009|FG000|Overall Study|Withdrawal by Subject|7|||
126104690|NCT00762970|453677010|FG001|Overall Study|Withdrawal by Subject|4|||
126104691|NCT00762970|453677011|FG002|Overall Study|Withdrawal by Subject|0|||
126104692|NCT00762970|453677009|FG000|Overall Study|Protocol Violation|3|||
126104693|NCT00762970|453677010|FG001|Overall Study|Protocol Violation|1|||
126104694|NCT00762970|453677011|FG002|Overall Study|Protocol Violation|1|||
126104695|NCT00762970|453677009|FG000|Overall Study|Lost to Follow-up|1|||
126104696|NCT00762970|453677010|FG001|Overall Study|Lost to Follow-up|2|||
126104697|NCT00762970|453677011|FG002|Overall Study|Lost to Follow-up|0|||
126104698|NCT00762970|453677009|FG000|Overall Study|Difficulty of handling lens|1|||
126104699|NCT00762970|453677010|FG001|Overall Study|Difficulty of handling lens|2|||
126104700|NCT00762970|453677011|FG002|Overall Study|Difficulty of handling lens|0|||
126104701|NCT03864146|453677012|FG000|Overall Study|Lost to Follow-up|14|||
126104702|NCT03864146|453677013|FG001|Overall Study|Lost to Follow-up|23|||
126104703|NCT03864146|453677012|FG000|Overall Study|Withdrawal by Subject|3|||
126104704|NCT03864146|453677013|FG001|Overall Study|Withdrawal by Subject|2|||
126104705|NCT01313637|453677019|FG000|Overall Study|Adverse Event|17|||
126104706|NCT01313637|453677020|FG001|Overall Study|Adverse Event|24|||
126104707|NCT01313637|453677021|FG002|Overall Study|Adverse Event|25|||
126104708|NCT01313637|453677022|FG003|Overall Study|Adverse Event|18|||
126104709|NCT01313637|453677019|FG000|Overall Study|Lack of Efficacy|44|||
126104710|NCT01313637|453677020|FG001|Overall Study|Lack of Efficacy|38|||
126104711|NCT01313637|453677021|FG002|Overall Study|Lack of Efficacy|37|||
126104712|NCT01313637|453677022|FG003|Overall Study|Lack of Efficacy|24|||
126104713|NCT01313637|453677019|FG000|Overall Study|Protocol Violation|4|||
126104714|NCT01313637|453677020|FG001|Overall Study|Protocol Violation|3|||
126104715|NCT01313637|453677021|FG002|Overall Study|Protocol Violation|11|||
126395668|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
126395669|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
126395670|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
126395671|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
126395672|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
126395673|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
126395674|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
126395675|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
126395676|NCT00303446|454744367|FG000|Overall Study|Withdrawal by Subject|2|||
126395677|NCT00303446|454744368|FG001|Overall Study|Withdrawal by Subject|2|||
126395678|NCT00303446|454744367|FG000|Overall Study|Death|0|||
126395679|NCT00303446|454744368|FG001|Overall Study|Death|1|||
126104716|NCT01313637|453677022|FG003|Overall Study|Protocol Violation|5|||
126104717|NCT01313637|453677019|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
126104718|NCT01313637|453677020|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
126104719|NCT01313637|453677021|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
126104720|NCT01313637|453677022|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
126104721|NCT01313637|453677019|FG000|Overall Study|Lost to Follow-up|0|||
126104722|NCT01313637|453677020|FG001|Overall Study|Lost to Follow-up|2|||
126104723|NCT01313637|453677021|FG002|Overall Study|Lost to Follow-up|1|||
126104724|NCT01313637|453677022|FG003|Overall Study|Lost to Follow-up|3|||
126104725|NCT01313637|453677019|FG000|Overall Study|Withdrawal by Subject|11|||
126395680|NCT00303446|454744367|FG000|Overall Study|Physician Decision|0|||
126395681|NCT00303446|454744368|FG001|Overall Study|Physician Decision|1|||
126395682|NCT00428220|454744369|FG000|Overall Study|Participant died|8|||
126395683|NCT00428220|454744369|FG000|Overall Study|Global deterioration of health status|7|||
126104726|NCT01313637|453677020|FG001|Overall Study|Withdrawal by Subject|13|||
126104727|NCT01313637|453677021|FG002|Overall Study|Withdrawal by Subject|18|||
126104728|NCT01313637|453677022|FG003|Overall Study|Withdrawal by Subject|15|||
126104729|NCT00846391|453677024|FG000|Overall Study|Physician Decision|0|||
126104730|NCT00846391|453677025|FG001|Overall Study|Physician Decision|0|||
126104731|NCT00846391|453677026|FG002|Overall Study|Physician Decision|1|||
126104732|NCT00846391|453677024|FG000|Overall Study|Study Terminated by Sponsor|1|||
126104733|NCT00846391|453677025|FG001|Overall Study|Study Terminated by Sponsor|2|||
126395684|NCT00428220|454744369|FG000|Overall Study|Lost to Follow-up|4|||
126104734|NCT00846391|453677026|FG002|Overall Study|Study Terminated by Sponsor|2|||
126050845|NCT02488408|453481150|FG001|Part B|Adverse Event|0|||
126050846|NCT02488408|453481151|FG002|Part B|Adverse Event|0|||
126050847|NCT02488408|453481152|FG003|Part B|Adverse Event|0|||
126050848|NCT02488408|453481153|FG004|Part B|Adverse Event|0|||
126050849|NCT02488408|453481154|FG005|Part B|Adverse Event|2|||
126050850|NCT02488408|453481155|FG006|Part B|Adverse Event|2|||
126050851|NCT02488408|453481156|FG007|Part B|Adverse Event|7|||
126050852|NCT02488408|453481157|FG008|Part B|Adverse Event|2|||
126050853|NCT02488408|453481158|FG009|Part B|Adverse Event|2|||
126050854|NCT02488408|453481149|FG000|Part B|Death|0|||
126050855|NCT02488408|453481150|FG001|Part B|Death|0|||
126050856|NCT02488408|453481151|FG002|Part B|Death|0|||
126050857|NCT02488408|453481152|FG003|Part B|Death|0|||
126050858|NCT02488408|453481153|FG004|Part B|Death|0|||
126050859|NCT02488408|453481154|FG005|Part B|Death|3|||
126050860|NCT02488408|453481155|FG006|Part B|Death|1|||
126050861|NCT02488408|453481156|FG007|Part B|Death|2|||
126050862|NCT02488408|453481157|FG008|Part B|Death|2|||
126050863|NCT02488408|453481158|FG009|Part B|Death|2|||
126050864|NCT02488408|453481149|FG000|Part B|Death due to Disease Progression|0|||
126050865|NCT02488408|453481150|FG001|Part B|Death due to Disease Progression|0|||
126050866|NCT02488408|453481151|FG002|Part B|Death due to Disease Progression|0|||
126050867|NCT02488408|453481152|FG003|Part B|Death due to Disease Progression|0|||
126050868|NCT02488408|453481153|FG004|Part B|Death due to Disease Progression|0|||
126050869|NCT02488408|453481154|FG005|Part B|Death due to Disease Progression|2|||
126050870|NCT02488408|453481155|FG006|Part B|Death due to Disease Progression|2|||
126050871|NCT02488408|453481156|FG007|Part B|Death due to Disease Progression|1|||
126050872|NCT02488408|453481157|FG008|Part B|Death due to Disease Progression|1|||
126050873|NCT02488408|453481158|FG009|Part B|Death due to Disease Progression|1|||
126050874|NCT02488408|453481149|FG000|Part B|Disease Progression|0|||
126050875|NCT02488408|453481150|FG001|Part B|Disease Progression|0|||
126050876|NCT02488408|453481151|FG002|Part B|Disease Progression|0|||
126050877|NCT02488408|453481152|FG003|Part B|Disease Progression|0|||
126050878|NCT02488408|453481153|FG004|Part B|Disease Progression|0|||
126050879|NCT02488408|453481154|FG005|Part B|Disease Progression|6|||
126050880|NCT02488408|453481155|FG006|Part B|Disease Progression|9|||
126050881|NCT02488408|453481156|FG007|Part B|Disease Progression|7|||
126050882|NCT02488408|453481157|FG008|Part B|Disease Progression|9|||
126050883|NCT02488408|453481158|FG009|Part B|Disease Progression|11|||
126050884|NCT02488408|453481149|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
126050885|NCT02488408|453481150|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
126050886|NCT02488408|453481151|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
126050887|NCT02488408|453481152|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
126050888|NCT02488408|453481153|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
126050889|NCT02488408|453481154|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
126050890|NCT02488408|453481155|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
126050891|NCT02488408|453481156|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
126050892|NCT02488408|453481157|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
126050893|NCT02488408|453481158|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
126050894|NCT02488408|453481149|FG000|Part B|Investigator Decision|0|||
126050895|NCT02488408|453481150|FG001|Part B|Investigator Decision|0|||
126050896|NCT02488408|453481151|FG002|Part B|Investigator Decision|0|||
126050897|NCT02488408|453481152|FG003|Part B|Investigator Decision|0|||
126050898|NCT02488408|453481153|FG004|Part B|Investigator Decision|0|||
126050899|NCT02488408|453481154|FG005|Part B|Investigator Decision|0|||
126050900|NCT02488408|453481155|FG006|Part B|Investigator Decision|1|||
126050901|NCT02488408|453481156|FG007|Part B|Investigator Decision|0|||
126050902|NCT02488408|453481157|FG008|Part B|Investigator Decision|2|||
126050903|NCT02488408|453481158|FG009|Part B|Investigator Decision|1|||
126050904|NCT03664804|453481162|FG000|Overall Study|Withdrawal by Subject|7|||
126050905|NCT04701203|453481163|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
126050906|NCT04701203|453481164|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
126050907|NCT04701203|453481165|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
126050908|NCT04701203|453481163|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
126050909|NCT04701203|453481164|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
126050910|NCT04701203|453481165|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
126050911|NCT04701203|453481163|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
126050912|NCT04701203|453481164|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
126050913|NCT04701203|453481165|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
126050914|NCT04701203|453481163|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
126395685|NCT00428220|454744369|FG000|Overall Study|Objective progression or relapse|123|||
126395686|NCT00428220|454744369|FG000|Overall Study|Participant refused continued treatment|7|||
126395687|NCT00428220|454744369|FG000|Overall Study|Adverse Event|51|||
126395688|NCT00428220|454744369|FG000|Overall Study|Other|23|||
126395689|NCT00642174|454744378|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
126395690|NCT00642174|454744379|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
126395691|NCT00896363|454744380|FG000|Overall Study|Adverse Event|3|||
126395692|NCT00896363|454744381|FG001|Overall Study|Adverse Event|4|||
126395693|NCT00896363|454744382|FG002|Overall Study|Adverse Event|2|||
126395694|NCT00896363|454744380|FG000|Overall Study|Lack of Efficacy|0|||
126395695|NCT00896363|454744381|FG001|Overall Study|Lack of Efficacy|2|||
126395696|NCT00896363|454744382|FG002|Overall Study|Lack of Efficacy|1|||
126395697|NCT00896363|454744380|FG000|Overall Study|Withdrawal by Subject|3|||
125888389|NCT02141438|452888018|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
126050915|NCT04701203|453481164|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
126050916|NCT04701203|453481165|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
126050917|NCT06140290|453481166|FG000|Period 1|Adverse Event|1|||
126050918|NCT06140290|453481167|FG001|Period 1|Adverse Event|0|||
126395698|NCT00896363|454744381|FG001|Overall Study|Withdrawal by Subject|5|||
126395699|NCT00896363|454744382|FG002|Overall Study|Withdrawal by Subject|5|||
126395700|NCT02982018|454744387|FG000|Overall Study|Incorrect Lens Dispensed|1|||
126395701|NCT02982018|454744388|FG001|Overall Study|Incorrect Lens Dispensed|0|||
126050919|NCT06140290|453481166|FG000|Period 2|Assigned but not treated|0|||
126050920|NCT06140290|453481167|FG001|Period 2|Assigned but not treated|1|||
126050921|NCT06140290|453481166|FG000|Period 2|Withdrawal by Subject|0|||
126050922|NCT06140290|453481167|FG001|Period 2|Withdrawal by Subject|1|||
126050923|NCT03752684|453482296|FG000|Overall Study|Lost to Follow-up|4|||
126050924|NCT02722434|453482299|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
126050925|NCT02722434|453482300|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
126050926|NCT02722434|453482299|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
126050927|NCT02722434|453482300|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
126050928|NCT02200705|453482301|FG000|Overall Study|Excluded|12|||
126050929|NCT02200705|453482301|FG000|Overall Study|Death|21|||
126050930|NCT02200705|453482301|FG000|Overall Study|Withdrawal by Subject|22|||
126050931|NCT02200705|453482301|FG000|Overall Study|Lost to Follow-up|13|||
126050932|NCT02200705|453482301|FG000|Overall Study|Physician Decision|5|||
126050933|NCT02200705|453482301|FG000|Overall Study|Adverse Event|2|||
126050934|NCT00786864|453482302|FG000|Overall Study|Lost to Follow-up|0|||
126050935|NCT00786864|453482303|FG001|Overall Study|Lost to Follow-up|1|||
126050936|NCT00786864|453482302|FG000|Overall Study|Sustained serious back injury|1|||
126050937|NCT00786864|453482303|FG001|Overall Study|Sustained serious back injury|0|||
126050938|NCT03442777|453482307|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
126050939|NCT03442777|453482308|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
126050940|NCT03442777|453482309|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
126050941|NCT00442104|453482311|FG000|Overall Study|Adverse Event|5|||
126050942|NCT00442104|453482311|FG000|Overall Study|Death|2|||
126050943|NCT00442104|453482311|FG000|Overall Study|Lost to Follow-up|3|||
126050944|NCT00442104|453482311|FG000|Overall Study|Withdrawal by Subject|5|||
126050945|NCT00442104|453482311|FG000|Overall Study|Insufficient Clinical Response|10|||
126050946|NCT00442104|453482311|FG000|Overall Study|Other|21|||
126395702|NCT02982018|454744387|FG000|Overall Study|Protocol Violation|1|||
126395703|NCT02982018|454744388|FG001|Overall Study|Protocol Violation|1|||
126395704|NCT02982018|454744387|FG000|Overall Study|Adverse Event|1|||
126395705|NCT02982018|454744388|FG001|Overall Study|Adverse Event|1|||
126395706|NCT02982018|454744387|FG000|Overall Study|Lens Discomfort|2|||
126395707|NCT02982018|454744388|FG001|Overall Study|Lens Discomfort|0|||
126395708|NCT02982018|454744387|FG000|Overall Study|Withdrawal by Subject|0|||
126395709|NCT02982018|454744388|FG001|Overall Study|Withdrawal by Subject|1|||
126395710|NCT00378599|454744394|FG000|Overall Study|Adverse Event|38|||
126395711|NCT00378599|454744394|FG000|Overall Study|Protocol Violation|2|||
126395712|NCT00378599|454744394|FG000|Overall Study|Treatment failure|7|||
126395713|NCT00378599|454744394|FG000|Overall Study|Withdrawal by Subject|5|||
126395714|NCT00416715|454744395|FG000|Overall Study|Not evaluable for joint aches|7|||
126395715|NCT00416715|454744395|FG000|Overall Study|Vitamin D levels not evaluable|8|||
126395716|NCT03812185|454744399|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
126395717|NCT03334851|454744414|FG000|Overall Study|Other|0|||
126395718|NCT03334851|454744415|FG001|Overall Study|Other|0|||
126395719|NCT03334851|454744416|FG002|Overall Study|Other|0|||
126395720|NCT03334851|454744417|FG003|Overall Study|Other|0|||
126395721|NCT03334851|454744418|FG004|Overall Study|Other|0|||
126395722|NCT03334851|454744419|FG005|Overall Study|Other|0|||
126395723|NCT03334851|454744420|FG006|Overall Study|Other|0|||
126395724|NCT03334851|454744421|FG007|Overall Study|Other|1|||
126395725|NCT03334851|454744422|FG008|Overall Study|Other|0|||
126395726|NCT03334851|454744423|FG009|Overall Study|Other|0|||
125888390|NCT05782179|452888019|FG000|Overall Study|Adverse Event|0|||
125888391|NCT05782179|452888020|FG001|Overall Study|Adverse Event|0|||
125888392|NCT05782179|452888021|FG002|Overall Study|Adverse Event|2|||
125888393|NCT05782179|452888022|FG003|Overall Study|Adverse Event|0|||
125888394|NCT05782179|452888023|FG004|Overall Study|Adverse Event|0|||
125888395|NCT05782179|452888024|FG005|Overall Study|Adverse Event|0|||
125888396|NCT03675321|452888025|FG000|Overall Study|Lack of Efficacy|2|||
125888397|NCT03675321|452888026|FG001|Overall Study|Lack of Efficacy|2|||
125888398|NCT03675321|452888025|FG000|Overall Study|Withdrawal by Subject|1|||
125888399|NCT03675321|452888026|FG001|Overall Study|Withdrawal by Subject|3|||
125888400|NCT02999672|452888034|FG000|Overall Study|Death|0|||
126050947|NCT00442104|453482311|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
126050948|NCT00463229|453482317|FG000|Overall Study|Lost to Follow-up|5|||
126050949|NCT00463229|453482318|FG001|Overall Study|Lost to Follow-up|7|||
126050950|NCT00463229|453482317|FG000|Overall Study|Death|4|||
126050951|NCT00463229|453482318|FG001|Overall Study|Death|3|||
126050952|NCT01932970|453482319|FG000|Overall Study|Withdrawal by Subject|5|||
126050953|NCT01932970|453482319|FG000|Overall Study|Death|1|||
126050954|NCT01932970|453482319|FG000|Overall Study|Lost to Follow-up|2|||
126395727|NCT03334851|454744424|FG010|Overall Study|Other|0|||
126395728|NCT03334851|454744425|FG011|Overall Study|Other|0|||
126050955|NCT01932970|453482319|FG000|Overall Study|Protocol Specified Criteria|10|||
126395729|NCT03334851|454744426|FG012|Overall Study|Other|0|||
126395730|NCT03334851|454744414|FG000|Overall Study|Adverse Event|0|||
125888401|NCT02999672|452888035|FG001|Overall Study|Death|1|||
125888402|NCT02999672|452888034|FG000|Overall Study|Study Terminated by Sponsor|0|||
126395731|NCT03334851|454744415|FG001|Overall Study|Adverse Event|0|||
126395732|NCT03334851|454744416|FG002|Overall Study|Adverse Event|0|||
126395733|NCT03334851|454744417|FG003|Overall Study|Adverse Event|0|||
126395734|NCT03334851|454744418|FG004|Overall Study|Adverse Event|0|||
126395735|NCT03334851|454744419|FG005|Overall Study|Adverse Event|0|||
126395736|NCT03334851|454744420|FG006|Overall Study|Adverse Event|0|||
126395737|NCT03334851|454744421|FG007|Overall Study|Adverse Event|1|||
126395738|NCT03334851|454744422|FG008|Overall Study|Adverse Event|0|||
126395739|NCT03334851|454744423|FG009|Overall Study|Adverse Event|0|||
126395740|NCT03334851|454744424|FG010|Overall Study|Adverse Event|0|||
126395741|NCT03334851|454744425|FG011|Overall Study|Adverse Event|0|||
126395742|NCT03334851|454744426|FG012|Overall Study|Adverse Event|0|||
126395743|NCT03334851|454744414|FG000|Overall Study|Withdrawal by Subject|0|||
126395744|NCT03334851|454744415|FG001|Overall Study|Withdrawal by Subject|0|||
126395745|NCT03334851|454744416|FG002|Overall Study|Withdrawal by Subject|0|||
126395746|NCT03334851|454744417|FG003|Overall Study|Withdrawal by Subject|0|||
126395747|NCT03334851|454744418|FG004|Overall Study|Withdrawal by Subject|0|||
126395748|NCT03334851|454744419|FG005|Overall Study|Withdrawal by Subject|0|||
126395749|NCT03334851|454744420|FG006|Overall Study|Withdrawal by Subject|0|||
126395750|NCT03334851|454744421|FG007|Overall Study|Withdrawal by Subject|0|||
126395751|NCT03334851|454744422|FG008|Overall Study|Withdrawal by Subject|0|||
126395752|NCT03334851|454744423|FG009|Overall Study|Withdrawal by Subject|0|||
126395753|NCT03334851|454744424|FG010|Overall Study|Withdrawal by Subject|1|||
126395754|NCT03334851|454744425|FG011|Overall Study|Withdrawal by Subject|0|||
126395755|NCT03334851|454744426|FG012|Overall Study|Withdrawal by Subject|1|||
126395756|NCT03334851|454744414|FG000|Overall Study|Lost to Follow-up|0|||
126395757|NCT03334851|454744415|FG001|Overall Study|Lost to Follow-up|0|||
126395758|NCT03334851|454744416|FG002|Overall Study|Lost to Follow-up|0|||
126395759|NCT03334851|454744417|FG003|Overall Study|Lost to Follow-up|0|||
126395760|NCT03334851|454744418|FG004|Overall Study|Lost to Follow-up|0|||
126395761|NCT03334851|454744419|FG005|Overall Study|Lost to Follow-up|0|||
126395762|NCT03334851|454744420|FG006|Overall Study|Lost to Follow-up|0|||
126395763|NCT03334851|454744421|FG007|Overall Study|Lost to Follow-up|0|||
126395764|NCT03334851|454744422|FG008|Overall Study|Lost to Follow-up|0|||
126395765|NCT03334851|454744423|FG009|Overall Study|Lost to Follow-up|0|||
126395766|NCT03334851|454744424|FG010|Overall Study|Lost to Follow-up|2|||
126395767|NCT03334851|454744425|FG011|Overall Study|Lost to Follow-up|1|||
126395768|NCT03334851|454744426|FG012|Overall Study|Lost to Follow-up|0|||
126395769|NCT01691885|454744427|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
126395770|NCT01691885|454744428|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
126395771|NCT01691885|454744427|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
126395772|NCT01691885|454744428|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
126395773|NCT03555981|454744429|FG000|Overall Study|Lost to Follow-up|0|||
126395774|NCT03555981|454744430|FG001|Overall Study|Lost to Follow-up|2|||
126395775|NCT02754141|454744434|FG000|Overall Study|Disease progression|11|||
126050956|NCT01767467|453482320|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
126050957|NCT01767467|453482321|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
126050958|NCT01767467|453482320|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
126395776|NCT02754141|454744435|FG001|Overall Study|Disease progression|7|||
126395777|NCT02754141|454744436|FG002|Overall Study|Disease progression|8|||
126395778|NCT02754141|454744437|FG003|Overall Study|Disease progression|5|||
126395779|NCT02754141|454744438|FG004|Overall Study|Disease progression|7|||
126395780|NCT02754141|454744439|FG005|Overall Study|Disease progression|7|||
126395781|NCT02754141|454744440|FG006|Overall Study|Disease progression|7|||
126395782|NCT02754141|454744441|FG007|Overall Study|Disease progression|6|||
126395783|NCT02754141|454744442|FG008|Overall Study|Disease progression|11|||
126395784|NCT02754141|454744443|FG009|Overall Study|Disease progression|16|||
126395785|NCT02754141|454744444|FG010|Overall Study|Disease progression|18|||
126395786|NCT02754141|454744445|FG011|Overall Study|Disease progression|13|||
126395787|NCT02754141|454744446|FG012|Overall Study|Disease progression|10|||
126395788|NCT02754141|454744447|FG013|Overall Study|Disease progression|12|||
126395789|NCT02754141|454744448|FG014|Overall Study|Disease progression|12|||
126050959|NCT01767467|453482321|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
126050960|NCT01767467|453482320|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
126050961|NCT01767467|453482321|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
126395790|NCT02754141|454744449|FG015|Overall Study|Disease progression|14|||
126395791|NCT02754141|454744450|FG016|Overall Study|Disease progression|0|||
126395792|NCT02754141|454744451|FG017|Overall Study|Disease progression|1|||
126395793|NCT02754141|454744434|FG000|Overall Study|Study drug toxicity|1|||
126395794|NCT02754141|454744435|FG001|Overall Study|Study drug toxicity|1|||
126395795|NCT02754141|454744436|FG002|Overall Study|Study drug toxicity|0|||
126395796|NCT02754141|454744437|FG003|Overall Study|Study drug toxicity|0|||
126395797|NCT02754141|454744438|FG004|Overall Study|Study drug toxicity|0|||
126395798|NCT02754141|454744439|FG005|Overall Study|Study drug toxicity|0|||
126395799|NCT02754141|454744440|FG006|Overall Study|Study drug toxicity|0|||
126395800|NCT02754141|454744441|FG007|Overall Study|Study drug toxicity|0|||
126395801|NCT02754141|454744442|FG008|Overall Study|Study drug toxicity|0|||
126395802|NCT02754141|454744443|FG009|Overall Study|Study drug toxicity|0|||
126395803|NCT02754141|454744444|FG010|Overall Study|Study drug toxicity|2|||
126395804|NCT02754141|454744445|FG011|Overall Study|Study drug toxicity|1|||
126395805|NCT02754141|454744446|FG012|Overall Study|Study drug toxicity|1|||
126395806|NCT02754141|454744447|FG013|Overall Study|Study drug toxicity|0|||
126395807|NCT02754141|454744448|FG014|Overall Study|Study drug toxicity|0|||
126395808|NCT02754141|454744449|FG015|Overall Study|Study drug toxicity|0|||
126395809|NCT02754141|454744450|FG016|Overall Study|Study drug toxicity|0|||
126395810|NCT02754141|454744451|FG017|Overall Study|Study drug toxicity|0|||
126395811|NCT02754141|454744434|FG000|Overall Study|AE unrelated to study drug|1|||
126395812|NCT02754141|454744435|FG001|Overall Study|AE unrelated to study drug|1|||
126395813|NCT02754141|454744436|FG002|Overall Study|AE unrelated to study drug|0|||
126395814|NCT02754141|454744437|FG003|Overall Study|AE unrelated to study drug|1|||
126395815|NCT02754141|454744438|FG004|Overall Study|AE unrelated to study drug|3|||
126395816|NCT02754141|454744439|FG005|Overall Study|AE unrelated to study drug|2|||
126395817|NCT02754141|454744440|FG006|Overall Study|AE unrelated to study drug|1|||
126395818|NCT02754141|454744441|FG007|Overall Study|AE unrelated to study drug|0|||
126395819|NCT02754141|454744442|FG008|Overall Study|AE unrelated to study drug|0|||
126395820|NCT02754141|454744443|FG009|Overall Study|AE unrelated to study drug|0|||
126395821|NCT02754141|454744444|FG010|Overall Study|AE unrelated to study drug|0|||
126395822|NCT02754141|454744445|FG011|Overall Study|AE unrelated to study drug|0|||
126395823|NCT02754141|454744446|FG012|Overall Study|AE unrelated to study drug|0|||
126395824|NCT02754141|454744447|FG013|Overall Study|AE unrelated to study drug|0|||
126395825|NCT02754141|454744448|FG014|Overall Study|AE unrelated to study drug|0|||
126395826|NCT02754141|454744449|FG015|Overall Study|AE unrelated to study drug|0|||
126395827|NCT02754141|454744450|FG016|Overall Study|AE unrelated to study drug|0|||
126395828|NCT02754141|454744451|FG017|Overall Study|AE unrelated to study drug|0|||
126395829|NCT02754141|454744434|FG000|Overall Study|Request to discontinue|0|||
126395830|NCT02754141|454744435|FG001|Overall Study|Request to discontinue|0|||
126395831|NCT02754141|454744436|FG002|Overall Study|Request to discontinue|0|||
126395832|NCT02754141|454744437|FG003|Overall Study|Request to discontinue|0|||
126395833|NCT02754141|454744438|FG004|Overall Study|Request to discontinue|0|||
126395834|NCT02754141|454744439|FG005|Overall Study|Request to discontinue|0|||
126395835|NCT02754141|454744440|FG006|Overall Study|Request to discontinue|0|||
126395836|NCT02754141|454744441|FG007|Overall Study|Request to discontinue|0|||
126395837|NCT02754141|454744442|FG008|Overall Study|Request to discontinue|1|||
126395838|NCT02754141|454744443|FG009|Overall Study|Request to discontinue|0|||
126395839|NCT02754141|454744444|FG010|Overall Study|Request to discontinue|0|||
126395840|NCT02754141|454744445|FG011|Overall Study|Request to discontinue|0|||
126395841|NCT02754141|454744446|FG012|Overall Study|Request to discontinue|0|||
126395842|NCT02754141|454744447|FG013|Overall Study|Request to discontinue|1|||
126395843|NCT02754141|454744448|FG014|Overall Study|Request to discontinue|1|||
126395844|NCT02754141|454744449|FG015|Overall Study|Request to discontinue|0|||
126395845|NCT02754141|454744450|FG016|Overall Study|Request to discontinue|0|||
126395846|NCT02754141|454744451|FG017|Overall Study|Request to discontinue|0|||
126395847|NCT02754141|454744434|FG000|Overall Study|Withdrew consent|0|||
126395848|NCT02754141|454744435|FG001|Overall Study|Withdrew consent|0|||
126395849|NCT02754141|454744436|FG002|Overall Study|Withdrew consent|0|||
126395850|NCT02754141|454744437|FG003|Overall Study|Withdrew consent|0|||
126395851|NCT02754141|454744438|FG004|Overall Study|Withdrew consent|0|||
126395852|NCT02754141|454744439|FG005|Overall Study|Withdrew consent|0|||
126395853|NCT02754141|454744440|FG006|Overall Study|Withdrew consent|0|||
126395854|NCT02754141|454744441|FG007|Overall Study|Withdrew consent|0|||
126395855|NCT02754141|454744442|FG008|Overall Study|Withdrew consent|0|||
126395856|NCT02754141|454744443|FG009|Overall Study|Withdrew consent|1|||
126395857|NCT02754141|454744444|FG010|Overall Study|Withdrew consent|0|||
126395858|NCT02754141|454744445|FG011|Overall Study|Withdrew consent|0|||
126395859|NCT02754141|454744446|FG012|Overall Study|Withdrew consent|0|||
126395860|NCT02754141|454744447|FG013|Overall Study|Withdrew consent|0|||
126395861|NCT02754141|454744448|FG014|Overall Study|Withdrew consent|0|||
126395862|NCT02754141|454744449|FG015|Overall Study|Withdrew consent|0|||
126395863|NCT02754141|454744450|FG016|Overall Study|Withdrew consent|0|||
126395864|NCT02754141|454744451|FG017|Overall Study|Withdrew consent|0|||
126395865|NCT02754141|454744434|FG000|Overall Study|Maximum clinical benefit|0|||
126395866|NCT02754141|454744435|FG001|Overall Study|Maximum clinical benefit|0|||
126395867|NCT02754141|454744436|FG002|Overall Study|Maximum clinical benefit|0|||
126395868|NCT02754141|454744437|FG003|Overall Study|Maximum clinical benefit|1|||
126395869|NCT02754141|454744438|FG004|Overall Study|Maximum clinical benefit|0|||
126395870|NCT02754141|454744439|FG005|Overall Study|Maximum clinical benefit|0|||
126395871|NCT02754141|454744440|FG006|Overall Study|Maximum clinical benefit|0|||
126395872|NCT02754141|454744441|FG007|Overall Study|Maximum clinical benefit|0|||
126395873|NCT02754141|454744442|FG008|Overall Study|Maximum clinical benefit|0|||
126395874|NCT02754141|454744443|FG009|Overall Study|Maximum clinical benefit|0|||
126395875|NCT02754141|454744444|FG010|Overall Study|Maximum clinical benefit|0|||
126395876|NCT02754141|454744445|FG011|Overall Study|Maximum clinical benefit|0|||
126395877|NCT02754141|454744446|FG012|Overall Study|Maximum clinical benefit|0|||
126395878|NCT02754141|454744447|FG013|Overall Study|Maximum clinical benefit|0|||
126395879|NCT02754141|454744448|FG014|Overall Study|Maximum clinical benefit|0|||
126395880|NCT02754141|454744449|FG015|Overall Study|Maximum clinical benefit|0|||
126395881|NCT02754141|454744450|FG016|Overall Study|Maximum clinical benefit|0|||
126395882|NCT02754141|454744451|FG017|Overall Study|Maximum clinical benefit|0|||
126395883|NCT02754141|454744434|FG000|Overall Study|No longer meets study criteria|0|||
126395884|NCT02754141|454744435|FG001|Overall Study|No longer meets study criteria|0|||
126395885|NCT02754141|454744436|FG002|Overall Study|No longer meets study criteria|0|||
126395886|NCT02754141|454744437|FG003|Overall Study|No longer meets study criteria|1|||
126395887|NCT02754141|454744438|FG004|Overall Study|No longer meets study criteria|0|||
126395888|NCT02754141|454744439|FG005|Overall Study|No longer meets study criteria|0|||
126395889|NCT02754141|454744440|FG006|Overall Study|No longer meets study criteria|0|||
126395890|NCT02754141|454744441|FG007|Overall Study|No longer meets study criteria|0|||
126395891|NCT02754141|454744442|FG008|Overall Study|No longer meets study criteria|0|||
126395892|NCT02754141|454744443|FG009|Overall Study|No longer meets study criteria|0|||
126395893|NCT02754141|454744444|FG010|Overall Study|No longer meets study criteria|0|||
126395894|NCT02754141|454744445|FG011|Overall Study|No longer meets study criteria|0|||
126395895|NCT02754141|454744446|FG012|Overall Study|No longer meets study criteria|0|||
126395896|NCT02754141|454744447|FG013|Overall Study|No longer meets study criteria|0|||
126395897|NCT02754141|454744448|FG014|Overall Study|No longer meets study criteria|0|||
126395898|NCT02754141|454744449|FG015|Overall Study|No longer meets study criteria|0|||
126395899|NCT02754141|454744450|FG016|Overall Study|No longer meets study criteria|0|||
126395900|NCT02754141|454744451|FG017|Overall Study|No longer meets study criteria|0|||
126395901|NCT02754141|454744434|FG000|Overall Study|Other reasons|0|||
126050962|NCT01767467|453482320|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
126050963|NCT01767467|453482321|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
126050964|NCT01767467|453482320|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
126050965|NCT01767467|453482321|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
126050966|NCT01767467|453482320|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
126050967|NCT01767467|453482321|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
126050968|NCT01767467|453482320|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
126050969|NCT01767467|453482321|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
126050970|NCT01767467|453482320|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
126050971|NCT01767467|453482321|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
126050972|NCT01767467|453482320|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
126050973|NCT01767467|453482321|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
126050974|NCT01767467|453482320|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
126050975|NCT01767467|453482321|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
126104735|NCT04634825|453677028|FG000|Overall Study|Death|10|||
126395902|NCT02754141|454744435|FG001|Overall Study|Other reasons|0|||
126395903|NCT02754141|454744436|FG002|Overall Study|Other reasons|0|||
126395904|NCT02754141|454744437|FG003|Overall Study|Other reasons|0|||
126395905|NCT02754141|454744438|FG004|Overall Study|Other reasons|0|||
126395906|NCT02754141|454744439|FG005|Overall Study|Other reasons|0|||
126395907|NCT02754141|454744440|FG006|Overall Study|Other reasons|0|||
126395908|NCT02754141|454744441|FG007|Overall Study|Other reasons|1|||
126395909|NCT02754141|454744442|FG008|Overall Study|Other reasons|0|||
126395910|NCT02754141|454744443|FG009|Overall Study|Other reasons|0|||
126395911|NCT02754141|454744444|FG010|Overall Study|Other reasons|0|||
126395912|NCT02754141|454744445|FG011|Overall Study|Other reasons|0|||
126395913|NCT02754141|454744446|FG012|Overall Study|Other reasons|2|||
126395914|NCT02754141|454744447|FG013|Overall Study|Other reasons|0|||
125888403|NCT02999672|452888035|FG001|Overall Study|Study Terminated by Sponsor|1|||
125888404|NCT02999672|452888034|FG000|Overall Study|Progressive Disease|9|||
125888405|NCT02999672|452888035|FG001|Overall Study|Progressive Disease|5|||
125888406|NCT02999672|452888034|FG000|Overall Study|Adverse Event|4|||
125888407|NCT02999672|452888035|FG001|Overall Study|Adverse Event|0|||
125888408|NCT03565497|452888036|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
125888409|NCT03565497|452888037|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
125888410|NCT03565497|452888038|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
125888411|NCT03565497|452888036|FG000|Overall Study|Lost to Follow-up|1|||
125888412|NCT03565497|452888037|FG001|Overall Study|Lost to Follow-up|1|||
125888413|NCT03565497|452888038|FG002|Overall Study|Lost to Follow-up|2|||
125888414|NCT03565497|452888036|FG000|Overall Study|Withdrawal by Subject|1|||
125888415|NCT03565497|452888037|FG001|Overall Study|Withdrawal by Subject|1|||
125888416|NCT03565497|452888038|FG002|Overall Study|Withdrawal by Subject|1|||
125888417|NCT02194985|452888041|FG000|Overall Study|Adverse Event|1|||
125888418|NCT02194985|452888041|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
125888419|NCT02194985|452888041|FG000|Overall Study|Physician Decision|4|||
125888420|NCT02194985|452888041|FG000|Overall Study|Lost to Follow-up|1|||
125888421|NCT02194985|452888041|FG000|Overall Study|Withdrawal by Subject|2|||
125888422|NCT02561832|452888042|FG000|Overall Study|Withdrawal by Subject|1|||
125888423|NCT02561832|452888043|FG001|Overall Study|Withdrawal by Subject|1|||
125888424|NCT02561832|452888042|FG000|Overall Study|Adverse Event|3|||
125888425|NCT02561832|452888043|FG001|Overall Study|Adverse Event|0|||
125888426|NCT02561832|452888042|FG000|Overall Study|Disease progression|3|||
125888427|NCT02561832|452888043|FG001|Overall Study|Disease progression|3|||
125888428|NCT03048578|452888045|FG000|Overall Study|Withdrawal by Subject|5|||
125888429|NCT03048578|452888046|FG001|Overall Study|Withdrawal by Subject|6|||
125888430|NCT03048578|452888045|FG000|Overall Study|Lost to Follow-up|22|||
125888431|NCT03048578|452888046|FG001|Overall Study|Lost to Follow-up|10|||
125888432|NCT03048578|452888045|FG000|Overall Study|Adverse Event|1|||
125888433|NCT03048578|452888046|FG001|Overall Study|Adverse Event|2|||
125888434|NCT03048578|452888045|FG000|Overall Study|Terminated|3|||
125888435|NCT03048578|452888046|FG001|Overall Study|Terminated|2|||
125888436|NCT00996333|452888051|FG000|Overall Study|Screen failure|1|||
125888437|NCT00996333|452888051|FG000|Overall Study|Withdrawal by Subject|1|||
125888438|NCT00996333|452888051|FG000|Overall Study|Death|4|||
125888439|NCT00996333|452888051|FG000|Overall Study|Adverse Event|1|||
125888440|NCT00996333|452888051|FG000|Overall Study|Physician Decision|1|||
125888441|NCT00996333|452888051|FG000|Overall Study|Other|5|||
125888442|NCT01301027|452888053|FG000|Overall Study|Physician Decision|2|||
125888443|NCT01301027|452888054|FG001|Overall Study|Physician Decision|0|||
125888444|NCT01301027|452888053|FG000|Overall Study|Withdrawal by Subject|2|||
126050976|NCT01767467|453482320|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
126050977|NCT01767467|453482321|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
126050978|NCT01767467|453482320|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
126050979|NCT01767467|453482321|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
126050980|NCT01767467|453482320|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
126050981|NCT01767467|453482321|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
126050982|NCT01767467|453482320|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
126050983|NCT01767467|453482321|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
126050984|NCT01640951|453482322|FG000|Overall Study|Adverse Event|8|||
126050985|NCT01640951|453482323|FG001|Overall Study|Adverse Event|3|||
126050986|NCT01640951|453482324|FG002|Overall Study|Adverse Event|10|||
126050987|NCT01640951|453482325|FG003|Overall Study|Adverse Event|6|||
126050988|NCT01640951|453482326|FG004|Overall Study|Adverse Event|1|||
126050989|NCT01640951|453482327|FG005|Overall Study|Adverse Event|11|||
126050990|NCT01640951|453482328|FG006|Overall Study|Adverse Event|1|||
126050991|NCT01640951|453482329|FG007|Overall Study|Adverse Event|3|||
126050992|NCT01640951|453482322|FG000|Overall Study|Lack of Efficacy|20|||
126050993|NCT01640951|453482323|FG001|Overall Study|Lack of Efficacy|1|||
126050994|NCT01640951|453482324|FG002|Overall Study|Lack of Efficacy|7|||
126050995|NCT01640951|453482325|FG003|Overall Study|Lack of Efficacy|14|||
125888445|NCT01301027|452888054|FG001|Overall Study|Withdrawal by Subject|3|||
125888446|NCT01301027|452888053|FG000|Overall Study|Adverse Event|0|||
125888447|NCT01301027|452888054|FG001|Overall Study|Adverse Event|2|||
126050996|NCT01640951|453482326|FG004|Overall Study|Lack of Efficacy|0|||
126050997|NCT01640951|453482327|FG005|Overall Study|Lack of Efficacy|6|||
126104736|NCT04634825|453677029|FG001|Overall Study|Death|3|||
126395915|NCT02754141|454744448|FG014|Overall Study|Other reasons|0|||
126395916|NCT02754141|454744449|FG015|Overall Study|Other reasons|0|||
125888448|NCT01301027|452888053|FG000|Overall Study|Fracture|1|||
125888449|NCT01301027|452888054|FG001|Overall Study|Fracture|3|||
125888450|NCT01301027|452888053|FG000|Overall Study|Transplant|0|||
125888451|NCT01301027|452888054|FG001|Overall Study|Transplant|2|||
125888452|NCT01301027|452888053|FG000|Overall Study|Volume Overload|3|||
125888453|NCT01301027|452888054|FG001|Overall Study|Volume Overload|0|||
125888454|NCT01932437|452888055|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125888455|NCT01932437|452888056|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125888456|NCT01932437|452888057|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125888457|NCT01932437|452888058|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125888458|NCT01932437|452888059|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125888459|NCT01932437|452888060|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
125888460|NCT00074490|452888061|FG000|Overall Study|Progressive malignancy|0|||
125888461|NCT00074490|452888062|FG001|Overall Study|Progressive malignancy|7|||
125888462|NCT00074490|452888063|FG002|Overall Study|Progressive malignancy|0|||
125888463|NCT00074490|452888064|FG003|Overall Study|Progressive malignancy|0|||
125888464|NCT00074490|452888065|FG004|Overall Study|Progressive malignancy|3|||
125888465|NCT00074490|452888066|FG005|Overall Study|Progressive malignancy|0|||
125888466|NCT02722499|452888067|FG000|Overall Study|Lost to Follow-up|2|||
125888467|NCT02722499|452888068|FG001|Overall Study|Lost to Follow-up|0|||
125888468|NCT02722499|452888069|FG002|Overall Study|Lost to Follow-up|1|||
125888469|NCT03566485|452888080|FG000|Overall Study|Disease progression|5|||
125888470|NCT03566485|452888081|FG001|Overall Study|Disease progression|4|||
125888471|NCT03566485|452888080|FG000|Overall Study|Clinical progression|0|||
125888472|NCT03566485|452888081|FG001|Overall Study|Clinical progression|1|||
125888473|NCT03566485|452888080|FG000|Overall Study|Toxicity|0|||
125888474|NCT03566485|452888081|FG001|Overall Study|Toxicity|2|||
125888475|NCT04999852|452888082|FG000|Overall Study|Withdrawal by Subject|11|||
125888476|NCT04999852|452888083|FG001|Overall Study|Withdrawal by Subject|1|||
125888477|NCT04999852|452888082|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
126050998|NCT01640951|453482328|FG006|Overall Study|Lack of Efficacy|5|||
126050999|NCT01640951|453482329|FG007|Overall Study|Lack of Efficacy|6|||
126051000|NCT01640951|453482322|FG000|Overall Study|Lost to Follow-up|1|||
126051001|NCT01640951|453482323|FG001|Overall Study|Lost to Follow-up|0|||
126051002|NCT01640951|453482324|FG002|Overall Study|Lost to Follow-up|6|||
126051003|NCT01640951|453482325|FG003|Overall Study|Lost to Follow-up|2|||
126051004|NCT01640951|453482326|FG004|Overall Study|Lost to Follow-up|2|||
126051005|NCT01640951|453482327|FG005|Overall Study|Lost to Follow-up|3|||
126051006|NCT01640951|453482328|FG006|Overall Study|Lost to Follow-up|1|||
126051007|NCT01640951|453482329|FG007|Overall Study|Lost to Follow-up|1|||
126051008|NCT01640951|453482322|FG000|Overall Study|Non-compliance with study treatment|0|||
126051009|NCT01640951|453482323|FG001|Overall Study|Non-compliance with study treatment|0|||
126051010|NCT01640951|453482324|FG002|Overall Study|Non-compliance with study treatment|1|||
126051011|NCT01640951|453482325|FG003|Overall Study|Non-compliance with study treatment|1|||
126051012|NCT01640951|453482326|FG004|Overall Study|Non-compliance with study treatment|1|||
126051013|NCT01640951|453482327|FG005|Overall Study|Non-compliance with study treatment|4|||
126051014|NCT01640951|453482328|FG006|Overall Study|Non-compliance with study treatment|1|||
126051015|NCT01640951|453482329|FG007|Overall Study|Non-compliance with study treatment|0|||
126051016|NCT01640951|453482322|FG000|Overall Study|Physician Decision|2|||
126051017|NCT01640951|453482323|FG001|Overall Study|Physician Decision|5|||
126051018|NCT01640951|453482324|FG002|Overall Study|Physician Decision|2|||
126051019|NCT01640951|453482325|FG003|Overall Study|Physician Decision|2|||
126051020|NCT01640951|453482326|FG004|Overall Study|Physician Decision|2|||
126051021|NCT01640951|453482327|FG005|Overall Study|Physician Decision|3|||
126051022|NCT01640951|453482328|FG006|Overall Study|Physician Decision|3|||
126051023|NCT01640951|453482329|FG007|Overall Study|Physician Decision|0|||
126051024|NCT01640951|453482322|FG000|Overall Study|Pregnancy|3|||
126051025|NCT01640951|453482323|FG001|Overall Study|Pregnancy|0|||
126051026|NCT01640951|453482324|FG002|Overall Study|Pregnancy|0|||
126051027|NCT01640951|453482325|FG003|Overall Study|Pregnancy|4|||
126051028|NCT01640951|453482326|FG004|Overall Study|Pregnancy|0|||
126051029|NCT01640951|453482327|FG005|Overall Study|Pregnancy|0|||
126051030|NCT01640951|453482328|FG006|Overall Study|Pregnancy|2|||
126051031|NCT01640951|453482329|FG007|Overall Study|Pregnancy|0|||
126051032|NCT01640951|453482322|FG000|Overall Study|Protocol Deviation|0|||
126051033|NCT01640951|453482323|FG001|Overall Study|Protocol Deviation|1|||
126051034|NCT01640951|453482324|FG002|Overall Study|Protocol Deviation|2|||
126051035|NCT01640951|453482325|FG003|Overall Study|Protocol Deviation|1|||
126051036|NCT01640951|453482326|FG004|Overall Study|Protocol Deviation|0|||
126051037|NCT01640951|453482327|FG005|Overall Study|Protocol Deviation|1|||
126051038|NCT01640951|453482328|FG006|Overall Study|Protocol Deviation|0|||
126051039|NCT01640951|453482329|FG007|Overall Study|Protocol Deviation|0|||
126051040|NCT01640951|453482322|FG000|Overall Study|Subject/Guardian decision|12|||
126051041|NCT01640951|453482323|FG001|Overall Study|Subject/Guardian decision|4|||
126051042|NCT01640951|453482324|FG002|Overall Study|Subject/Guardian decision|13|||
126051043|NCT01640951|453482325|FG003|Overall Study|Subject/Guardian decision|15|||
126051044|NCT01640951|453482326|FG004|Overall Study|Subject/Guardian decision|7|||
126051045|NCT01640951|453482327|FG005|Overall Study|Subject/Guardian decision|19|||
126051046|NCT01640951|453482328|FG006|Overall Study|Subject/Guardian decision|5|||
126051047|NCT01640951|453482329|FG007|Overall Study|Subject/Guardian decision|4|||
126051048|NCT01640951|453482322|FG000|Overall Study|Death|0|||
126051049|NCT01640951|453482323|FG001|Overall Study|Death|1|||
126051050|NCT01640951|453482324|FG002|Overall Study|Death|1|||
126051051|NCT01640951|453482325|FG003|Overall Study|Death|0|||
126051052|NCT01640951|453482326|FG004|Overall Study|Death|0|||
126051053|NCT01640951|453482327|FG005|Overall Study|Death|0|||
126051054|NCT01640951|453482328|FG006|Overall Study|Death|0|||
126051055|NCT01640951|453482329|FG007|Overall Study|Death|2|||
126051056|NCT03355573|453482330|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
126051057|NCT03355573|453482330|FG000|Overall Study|Sponsor's decision|1|||
126051058|NCT03355573|453482330|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
126051059|NCT03355573|453482330|FG000|Overall Study|PI's decision|2|||
126051060|NCT03355573|453482330|FG000|Overall Study|Withdrawal by Subject|23|||
126051061|NCT03355573|453482330|FG000|Overall Study|Lost to Follow-up|4|||
126051062|NCT03355573|453482330|FG000|Overall Study|Lack of Efficacy|2|||
126051063|NCT03355573|453482330|FG000|Overall Study|Adverse Event, non-fatal|17|||
126051064|NCT03355573|453482330|FG000|Overall Study|Adverse Event, serious fatal|2|||
126051065|NCT03631407|453482333|FG000|Overall Study|Withdrawal by Subject|3|||
126051066|NCT03631407|453482334|FG001|Overall Study|Withdrawal by Subject|2|||
126051067|NCT03631407|453482333|FG000|Overall Study|Sponsor Decision|0|||
126051068|NCT03631407|453482334|FG001|Overall Study|Sponsor Decision|2|||
126051069|NCT03631407|453482333|FG000|Overall Study|Death|16|||
126051070|NCT03631407|453482334|FG001|Overall Study|Death|16|||
126051071|NCT03631407|453482333|FG000|Overall Study|Randomized by mistake without study treatment|1|||
126051072|NCT03631407|453482334|FG001|Overall Study|Randomized by mistake without study treatment|0|||
126051073|NCT00942266|453482335|FG000|Overall Study|Withdrawal by Subject|1|||
126051074|NCT00942266|453482336|FG001|Overall Study|Withdrawal by Subject|0|||
126104737|NCT04634825|453677028|FG000|Overall Study|Lost to Follow-up|1|||
126104738|NCT04634825|453677029|FG001|Overall Study|Lost to Follow-up|0|||
126104739|NCT04634825|453677028|FG000|Overall Study|Study terminated by sponsor|35|||
126104740|NCT04634825|453677029|FG001|Overall Study|Study terminated by sponsor|11|||
126104741|NCT04634825|453677028|FG000|Overall Study|Withdrawal by Subject|2|||
126104742|NCT04634825|453677029|FG001|Overall Study|Withdrawal by Subject|0|||
126104743|NCT05116046|453677037|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126104744|NCT05116046|453677038|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126104745|NCT05116046|453677039|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126104746|NCT05116046|453677037|FG000|Overall Study|Study terminated by sponsor|14|||
126104747|NCT05116046|453677038|FG001|Overall Study|Study terminated by sponsor|16|||
126104748|NCT05116046|453677039|FG002|Overall Study|Study terminated by sponsor|1|||
126104749|NCT01745848|453677045|FG000|Overall Study|Adverse Event|6|||
126104750|NCT00679627|453677046|FG000|Overall Study|Death|41|||
126104751|NCT00679627|453677047|FG001|Overall Study|Death|29|||
126104752|NCT00679627|453677046|FG000|Overall Study|Adverse Event|43|||
126104753|NCT00679627|453677047|FG001|Overall Study|Adverse Event|53|||
126104754|NCT00679627|453677046|FG000|Overall Study|Withdrawal by Subject|168|||
126104755|NCT00679627|453677047|FG001|Overall Study|Withdrawal by Subject|172|||
126104756|NCT00679627|453677046|FG000|Overall Study|Lost to Follow-up|22|||
126104757|NCT00679627|453677047|FG001|Overall Study|Lost to Follow-up|26|||
126104758|NCT00679627|453677046|FG000|Overall Study|Early Study Closure|425|||
126104759|NCT00679627|453677047|FG001|Overall Study|Early Study Closure|405|||
126104760|NCT01886378|453677048|FG000|Overall Study|Adverse Event|1|||
126104761|NCT01886378|453677048|FG000|Overall Study|Withdrawal by Subject|4|||
126104762|NCT03021954|453677052|FG000|Overall Study|Lost to Follow-up|10|||
126104763|NCT03021954|453677053|FG001|Overall Study|Lost to Follow-up|43|||
126104764|NCT03021954|453677052|FG000|Overall Study|Subjects had avulsion trauma|4|||
126104765|NCT03021954|453677053|FG001|Overall Study|Subjects had avulsion trauma|1|||
126104766|NCT00069238|453677054|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
126104767|NCT00069238|453677055|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
126104768|NCT00069238|453677056|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
126104769|NCT00069238|453677054|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
126104770|NCT00069238|453677055|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
126104771|NCT00069238|453677056|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
126104772|NCT00069238|453677054|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
126104773|NCT00069238|453677055|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
126104774|NCT00069238|453677056|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
126104775|NCT01001832|453677057|FG000|Short-term Period|Adverse Event|2|||
126104776|NCT01001832|453677058|FG001|Short-term Period|Adverse Event|3|||
126104777|NCT01001832|453677057|FG000|Long-term Period|Adverse Event|2|||
126104778|NCT01001832|453677058|FG001|Long-term Period|Adverse Event|1|||
126104779|NCT01001832|453677057|FG000|Long-term Period|Withdrawal by Subject|1|||
126104780|NCT01001832|453677058|FG001|Long-term Period|Withdrawal by Subject|0|||
126104781|NCT01001832|453677057|FG000|Long-term Period|Lack of Efficacy|0|||
126104782|NCT01001832|453677058|FG001|Long-term Period|Lack of Efficacy|2|||
126104783|NCT01001832|453677057|FG000|Long-term Period|Other|1|||
126104784|NCT01001832|453677058|FG001|Long-term Period|Other|2|||
126104785|NCT01001832|453677057|FG000|Follow-up Period|Withdrawal by Subject|1|||
126104786|NCT01001832|453677058|FG001|Follow-up Period|Withdrawal by Subject|0|||
126104787|NCT01001832|453677057|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
126104788|NCT01001832|453677058|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
126395917|NCT02754141|454744450|FG016|Overall Study|Other reasons|0|||
126395918|NCT02754141|454744451|FG017|Overall Study|Other reasons|0|||
126395919|NCT02754141|454744434|FG000|Overall Study|Completed treatment as per protocol|0|||
126395920|NCT02754141|454744435|FG001|Overall Study|Completed treatment as per protocol|1|||
126395921|NCT02754141|454744436|FG002|Overall Study|Completed treatment as per protocol|0|||
126395922|NCT02754141|454744437|FG003|Overall Study|Completed treatment as per protocol|0|||
126395923|NCT02754141|454744438|FG004|Overall Study|Completed treatment as per protocol|0|||
126395924|NCT02754141|454744439|FG005|Overall Study|Completed treatment as per protocol|0|||
126104789|NCT01001832|453677057|FG000|Follow-up Period|Other|2|||
126104790|NCT01001832|453677058|FG001|Follow-up Period|Other|1|||
126104791|NCT00807235|453677065|FG000|Overall Study|Adverse Event|1|||
126104792|NCT00807235|453677066|FG001|Overall Study|Adverse Event|0|||
126104793|NCT01765179|453677067|FG000|Overall Study|Adverse Event|3|||
126395925|NCT02754141|454744440|FG006|Overall Study|Completed treatment as per protocol|0|||
126395926|NCT02754141|454744441|FG007|Overall Study|Completed treatment as per protocol|0|||
126395927|NCT02754141|454744442|FG008|Overall Study|Completed treatment as per protocol|0|||
126395928|NCT02754141|454744443|FG009|Overall Study|Completed treatment as per protocol|0|||
126395929|NCT02754141|454744444|FG010|Overall Study|Completed treatment as per protocol|0|||
126395930|NCT02754141|454744445|FG011|Overall Study|Completed treatment as per protocol|0|||
126395931|NCT02754141|454744446|FG012|Overall Study|Completed treatment as per protocol|1|||
126395932|NCT02754141|454744447|FG013|Overall Study|Completed treatment as per protocol|0|||
126395933|NCT02754141|454744448|FG014|Overall Study|Completed treatment as per protocol|0|||
126395934|NCT02754141|454744449|FG015|Overall Study|Completed treatment as per protocol|0|||
126395935|NCT02754141|454744450|FG016|Overall Study|Completed treatment as per protocol|0|||
126395936|NCT02754141|454744451|FG017|Overall Study|Completed treatment as per protocol|0|||
126395937|NCT02754141|454744434|FG000|Overall Study|Not completing monotherapy|0|||
126395938|NCT02754141|454744435|FG001|Overall Study|Not completing monotherapy|0|||
126395939|NCT02754141|454744436|FG002|Overall Study|Not completing monotherapy|0|||
126395940|NCT02754141|454744437|FG003|Overall Study|Not completing monotherapy|0|||
126395941|NCT02754141|454744438|FG004|Overall Study|Not completing monotherapy|0|||
126395942|NCT02754141|454744439|FG005|Overall Study|Not completing monotherapy|0|||
126395943|NCT02754141|454744440|FG006|Overall Study|Not completing monotherapy|0|||
126395944|NCT02754141|454744441|FG007|Overall Study|Not completing monotherapy|0|||
125888478|NCT04999852|452888083|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
125888479|NCT04638660|452888084|FG000|Overall Study|Withdrawal by Subject|2|||
125888480|NCT04638660|452888085|FG001|Overall Study|Withdrawal by Subject|0|||
125888481|NCT04638660|452888084|FG000|Overall Study|Lost to Follow-up|1|||
125888482|NCT04638660|452888085|FG001|Overall Study|Lost to Follow-up|0|||
125888483|NCT04939415|452888086|FG000|Overall Study|Withdrawal by Subject|1|||
125888484|NCT04939415|452888087|FG001|Overall Study|Withdrawal by Subject|3|||
125888485|NCT04939415|452888086|FG000|Overall Study|Lost to Follow-up|0|||
125888486|NCT04939415|452888087|FG001|Overall Study|Lost to Follow-up|2|||
126104794|NCT01765179|453677067|FG000|Overall Study|Lost to Follow-up|5|||
126104795|NCT01765179|453677067|FG000|Overall Study|Non-compliance with study drug|2|||
126395945|NCT02754141|454744442|FG008|Overall Study|Not completing monotherapy|0|||
126395946|NCT02754141|454744443|FG009|Overall Study|Not completing monotherapy|0|||
126395947|NCT02754141|454744444|FG010|Overall Study|Not completing monotherapy|0|||
126395948|NCT02754141|454744445|FG011|Overall Study|Not completing monotherapy|0|||
126395949|NCT02754141|454744446|FG012|Overall Study|Not completing monotherapy|0|||
126395950|NCT02754141|454744447|FG013|Overall Study|Not completing monotherapy|1|||
126395951|NCT02754141|454744448|FG014|Overall Study|Not completing monotherapy|0|||
126395952|NCT02754141|454744449|FG015|Overall Study|Not completing monotherapy|0|||
126395953|NCT02754141|454744450|FG016|Overall Study|Not completing monotherapy|0|||
126395954|NCT02754141|454744451|FG017|Overall Study|Not completing monotherapy|0|||
126395955|NCT03361189|454744452|FG000|Overall Study|Received heart transplant|1|||
126395956|NCT03361189|454744453|FG001|Overall Study|Received heart transplant|0|||
126395957|NCT03361189|454744452|FG000|Overall Study|Pacemake replacement|0|||
126395958|NCT03361189|454744453|FG001|Overall Study|Pacemake replacement|1|||
126395959|NCT03344549|454744458|FG000|Overall Study|Withdrawal by Subject|3|||
126395960|NCT03344549|454744459|FG001|Overall Study|Withdrawal by Subject|2|||
126395961|NCT03344549|454744458|FG000|Overall Study|Dialysis|2|||
126395962|NCT03344549|454744459|FG001|Overall Study|Dialysis|0|||
126395963|NCT03344549|454744458|FG000|Overall Study|Cancer|1|||
126395964|NCT03344549|454744459|FG001|Overall Study|Cancer|0|||
126395965|NCT03344549|454744458|FG000|Overall Study|Lack of electronic device|1|||
126395966|NCT03344549|454744459|FG001|Overall Study|Lack of electronic device|0|||
126395967|NCT03344549|454744458|FG000|Overall Study|Transportation difficulty|0|||
126395968|NCT03344549|454744459|FG001|Overall Study|Transportation difficulty|13|||
126395969|NCT02323126|454744460|FG000|Overall Study|Patient / guardian decision|0|||
126395970|NCT02323126|454744461|FG001|Overall Study|Patient / guardian decision|1|||
126395971|NCT02323126|454744462|FG002|Overall Study|Patient / guardian decision|2|||
126395972|NCT02323126|454744460|FG000|Overall Study|Progressive disease|14|||
126395973|NCT02323126|454744461|FG001|Overall Study|Progressive disease|8|||
126395974|NCT02323126|454744462|FG002|Overall Study|Progressive disease|14|||
126395975|NCT02323126|454744460|FG000|Overall Study|Physician Decision|0|||
126395976|NCT02323126|454744461|FG001|Overall Study|Physician Decision|1|||
126395977|NCT02323126|454744462|FG002|Overall Study|Physician Decision|3|||
126104796|NCT01765179|453677067|FG000|Overall Study|Protocol Violation|1|||
126395978|NCT02323126|454744460|FG000|Overall Study|Death|1|||
126395979|NCT02323126|454744461|FG001|Overall Study|Death|1|||
126395980|NCT02323126|454744462|FG002|Overall Study|Death|4|||
126395981|NCT02323126|454744460|FG000|Overall Study|Adverse Event|3|||
126395982|NCT02323126|454744461|FG001|Overall Study|Adverse Event|5|||
126395983|NCT02323126|454744462|FG002|Overall Study|Adverse Event|7|||
126395984|NCT03333252|454744463|FG000|Overall Study|Adverse Event|10|||
126395985|NCT03333252|454744464|FG001|Overall Study|Adverse Event|6|||
126395986|NCT03333252|454744465|FG002|Overall Study|Adverse Event|5|||
126395987|NCT03333252|454744466|FG003|Overall Study|Adverse Event|2|||
126395988|NCT03333252|454744463|FG000|Overall Study|Death|1|||
126395989|NCT03333252|454744464|FG001|Overall Study|Death|3|||
126395990|NCT03333252|454744465|FG002|Overall Study|Death|0|||
126395991|NCT03333252|454744466|FG003|Overall Study|Death|0|||
126104797|NCT01765179|453677067|FG000|Overall Study|Withdrawal by Subject|8|||
126104798|NCT01765179|453677067|FG000|Overall Study|Hematocrit >54%|3|||
126104799|NCT01765179|453677067|FG000|Overall Study|prohibited med|1|||
126104800|NCT01765179|453677067|FG000|Overall Study|Out of country unable to finish study|1|||
126104801|NCT01765179|453677067|FG000|Overall Study|lack of venous access|1|||
126104802|NCT01765179|453677067|FG000|Overall Study|work conflict|1|||
126104803|NCT01765179|453677067|FG000|Overall Study|Ca elevated 10.6|1|||
126104804|NCT03581825|453677069|FG000|Period 1|Lens Discomfort|1|||
126104805|NCT03581825|453677070|FG001|Period 1|Lens Discomfort|0|||
126104806|NCT03581825|453677069|FG000|Period 2|Unsatisfactory Vision to Test|0|||
126104807|NCT03581825|453677070|FG001|Period 2|Unsatisfactory Vision to Test|1|||
126104808|NCT01668667|453677071|FG000|Overall Study|Adverse Event|3|||
126104809|NCT01668667|453677072|FG001|Overall Study|Adverse Event|6|||
126104810|NCT01668667|453677073|FG002|Overall Study|Adverse Event|4|||
126104811|NCT01668667|453677074|FG003|Overall Study|Adverse Event|4|||
126104812|NCT01668667|453677071|FG000|Overall Study|Lack of Efficacy|3|||
126104813|NCT01668667|453677072|FG001|Overall Study|Lack of Efficacy|2|||
126104814|NCT01668667|453677073|FG002|Overall Study|Lack of Efficacy|2|||
126104815|NCT01668667|453677074|FG003|Overall Study|Lack of Efficacy|3|||
126104816|NCT01668667|453677071|FG000|Overall Study|Protocol Violation|6|||
126104817|NCT01668667|453677072|FG001|Overall Study|Protocol Violation|10|||
126104818|NCT01668667|453677073|FG002|Overall Study|Protocol Violation|12|||
126104819|NCT01668667|453677074|FG003|Overall Study|Protocol Violation|5|||
126104820|NCT01668667|453677071|FG000|Overall Study|Lost to Follow-up|9|||
126104821|NCT01668667|453677072|FG001|Overall Study|Lost to Follow-up|4|||
126104822|NCT01668667|453677073|FG002|Overall Study|Lost to Follow-up|7|||
126104823|NCT01668667|453677074|FG003|Overall Study|Lost to Follow-up|6|||
126104824|NCT01668667|453677071|FG000|Overall Study|Physician Decision|3|||
126104825|NCT01668667|453677072|FG001|Overall Study|Physician Decision|0|||
126104826|NCT01668667|453677073|FG002|Overall Study|Physician Decision|1|||
126104827|NCT01668667|453677074|FG003|Overall Study|Physician Decision|0|||
126104828|NCT01668667|453677071|FG000|Overall Study|Withdrawal by Subject|7|||
126104829|NCT01668667|453677072|FG001|Overall Study|Withdrawal by Subject|4|||
126104830|NCT01668667|453677073|FG002|Overall Study|Withdrawal by Subject|5|||
126104831|NCT01668667|453677074|FG003|Overall Study|Withdrawal by Subject|5|||
126104832|NCT00511901|453677075|FG000|Overall Study|Withdrawal by Subject|1|||
126104833|NCT00511901|453677076|FG001|Overall Study|Withdrawal by Subject|3|||
126104834|NCT00178126|453677077|FG000|Overall Study|Lost to Follow-up|21|||
126104835|NCT00178126|453677078|FG001|Overall Study|Lost to Follow-up|21|||
126104836|NCT00178126|453677077|FG000|Overall Study|did not receive intervention|4|||
126104837|NCT00178126|453677078|FG001|Overall Study|did not receive intervention|6|||
126104838|NCT02447172|453677079|FG000|Overall Study|Adverse Event|11|||
126104839|NCT02447172|453677080|FG001|Overall Study|Adverse Event|8|||
126104840|NCT02447172|453677081|FG002|Overall Study|Adverse Event|7|||
126104841|NCT02447172|453677079|FG000|Overall Study|Death|3|||
126104842|NCT02447172|453677080|FG001|Overall Study|Death|1|||
126104843|NCT02447172|453677081|FG002|Overall Study|Death|0|||
126104844|NCT02447172|453677079|FG000|Overall Study|Protocol Violation|2|||
126104845|NCT02447172|453677080|FG001|Overall Study|Protocol Violation|1|||
126104846|NCT02447172|453677081|FG002|Overall Study|Protocol Violation|2|||
126104847|NCT02447172|453677079|FG000|Overall Study|Lost to Follow-up|7|||
126104848|NCT02447172|453677080|FG001|Overall Study|Lost to Follow-up|4|||
126104849|NCT02447172|453677081|FG002|Overall Study|Lost to Follow-up|4|||
126104850|NCT02447172|453677079|FG000|Overall Study|Withdrawal by Subject|5|||
126104851|NCT02447172|453677080|FG001|Overall Study|Withdrawal by Subject|1|||
126104852|NCT02447172|453677081|FG002|Overall Study|Withdrawal by Subject|3|||
126104853|NCT02447172|453677079|FG000|Overall Study|protocol specific treatment unrelated|3|||
126104854|NCT02447172|453677080|FG001|Overall Study|protocol specific treatment unrelated|0|||
126104855|NCT02447172|453677081|FG002|Overall Study|protocol specific treatment unrelated|2|||
126104856|NCT00427895|453677084|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126104857|NCT00427895|453677085|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126104858|NCT00427895|453677086|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126104859|NCT00427895|453677087|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
126104860|NCT00427895|453677088|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126395992|NCT03333252|454744463|FG000|Overall Study|Lack of Efficacy|8|||
126395993|NCT03333252|454744464|FG001|Overall Study|Lack of Efficacy|4|||
126395994|NCT03333252|454744465|FG002|Overall Study|Lack of Efficacy|0|||
126395995|NCT03333252|454744466|FG003|Overall Study|Lack of Efficacy|7|||
126395996|NCT03333252|454744463|FG000|Overall Study|Lost to Follow-up|0|||
126395997|NCT03333252|454744464|FG001|Overall Study|Lost to Follow-up|5|||
126395998|NCT03333252|454744465|FG002|Overall Study|Lost to Follow-up|9|||
126395999|NCT03333252|454744466|FG003|Overall Study|Lost to Follow-up|3|||
126396000|NCT03333252|454744463|FG000|Overall Study|Withdrawal by Subject|14|||
126396001|NCT03333252|454744464|FG001|Overall Study|Withdrawal by Subject|24|||
126396002|NCT03333252|454744465|FG002|Overall Study|Withdrawal by Subject|11|||
126396003|NCT03333252|454744466|FG003|Overall Study|Withdrawal by Subject|17|||
126396004|NCT00666588|454744470|FG000|Overall Study|ineligible|2|||
126396005|NCT00666588|454744471|FG001|Overall Study|ineligible|0|||
126396006|NCT00666588|454744472|FG002|Overall Study|ineligible|0|||
126396007|NCT00666588|454744473|FG003|Overall Study|ineligible|2|||
126396008|NCT00666588|454744470|FG000|Overall Study|inevaluable|2|||
126396009|NCT00666588|454744471|FG001|Overall Study|inevaluable|0|||
126396010|NCT00666588|454744472|FG002|Overall Study|inevaluable|0|||
126396011|NCT00666588|454744473|FG003|Overall Study|inevaluable|0|||
126396012|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
126396013|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
126051075|NCT00942266|453482335|FG000|Overall Study|Adverse Event|2|||
126396014|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
126396015|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
126396016|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
126396017|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
126396018|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
126396019|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
126396020|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
126396021|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
126051076|NCT00942266|453482336|FG001|Overall Study|Adverse Event|1|||
126396022|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Other|1|||
126396023|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Other|1|||
126396024|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
126396025|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
126396026|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
126396027|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
126396028|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
126051077|NCT00942266|453482335|FG000|Overall Study|Disease Progression|38|||
126051078|NCT00942266|453482336|FG001|Overall Study|Disease Progression|11|||
126051079|NCT00942266|453482335|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
126051080|NCT00942266|453482336|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
126051081|NCT00942266|453482335|FG000|Overall Study|Intercurrent illness|0|||
126051082|NCT00942266|453482336|FG001|Overall Study|Intercurrent illness|1|||
126051083|NCT00942266|453482335|FG000|Overall Study|Physician Decision|2|||
126051084|NCT00942266|453482336|FG001|Overall Study|Physician Decision|0|||
126051085|NCT00942266|453482335|FG000|Overall Study|medical deterioration (pneumonia)|0|||
126051086|NCT00942266|453482336|FG001|Overall Study|medical deterioration (pneumonia)|1|||
126051087|NCT00756574|453482340|FG000|Overall Study|Withdrawal by Subject|9|||
126051088|NCT00756574|453482341|FG001|Overall Study|Withdrawal by Subject|7|||
126051089|NCT00756574|453482340|FG000|Overall Study|Lost to Follow-up|4|||
126051090|NCT00756574|453482341|FG001|Overall Study|Lost to Follow-up|4|||
126051091|NCT01588951|453482342|FG000|Overall Study|Ineligible in retrospect|0|||
126051092|NCT01588951|453482343|FG001|Overall Study|Ineligible in retrospect|0|||
126051093|NCT01588951|453482344|FG002|Overall Study|Ineligible in retrospect|1|||
126051094|NCT02517268|453482356|FG000|Overall Study|Withdrawal by Subject|1|||
126051095|NCT02517268|453482357|FG001|Overall Study|Withdrawal by Subject|0|||
126051096|NCT04912856|453482363|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
126051097|NCT04912856|453482364|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
126051098|NCT04912856|453482363|FG000|Overall Study|Not reported in synoptic CSR.|0|||
126051099|NCT04912856|453482364|FG001|Overall Study|Not reported in synoptic CSR.|1|||
126051100|NCT05613907|453482365|FG000|Overall Study|Lost to Follow-up|5|||
126051101|NCT05613907|453482365|FG000|Overall Study|Death|3|||
126051102|NCT05613907|453482365|FG000|Overall Study|Withdrawal by Subject|2|||
126051103|NCT00748709|453482368|FG000|Overall Study|Progressive disease|15|||
126051104|NCT00748709|453482368|FG000|Overall Study|Drug reducing Toxity|2|||
126396029|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
126396030|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
126396031|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
126396032|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
126396033|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
126396034|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
126396035|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
126396036|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Other|1|||
126396037|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Other|2|||
126396038|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
126396039|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
126396040|NCT04195438|454744483|FG000|Overall Study|Withdrawal by Subject|1|||
126396041|NCT03006458|454744489|FG000|First Intervention|Unsatisfied Vision|0|||
126396042|NCT03006458|454744490|FG001|First Intervention|Unsatisfied Vision|3|||
126396043|NCT00457821|454744491|FG000|Part 2|Withdrawal by Subject|0|||
126396044|NCT00457821|454744492|FG001|Part 2|Withdrawal by Subject|0|||
126396045|NCT00457821|454744493|FG002|Part 2|Withdrawal by Subject|0|||
126396046|NCT00457821|454744494|FG003|Part 2|Withdrawal by Subject|0|||
126396047|NCT00457821|454744495|FG004|Part 2|Withdrawal by Subject|0|||
126396048|NCT00457821|454744496|FG005|Part 2|Withdrawal by Subject|0|||
126396049|NCT00457821|454744497|FG006|Part 2|Withdrawal by Subject|0|||
126396050|NCT00457821|454744498|FG007|Part 2|Withdrawal by Subject|1|||
126396051|NCT00578877|454744501|FG000|Overall Study|Lost to Follow-up|8|||
126396052|NCT00578877|454744502|FG001|Overall Study|Lost to Follow-up|10|||
126396053|NCT00578877|454744501|FG000|Overall Study|early discontinue|61|||
126396054|NCT00578877|454744502|FG001|Overall Study|early discontinue|101|||
126396055|NCT00578877|454744501|FG000|Overall Study|did not provide follow-up data|12|||
126396056|NCT00578877|454744502|FG001|Overall Study|did not provide follow-up data|17|||
126396057|NCT02437409|454744507|FG000|Overall Study|Withdrawal by Subject|3|||
126396058|NCT02437409|454744507|FG000|Overall Study|Screening failure|12|||
126396059|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
126396060|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
126396061|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
126396062|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
126051105|NCT00748709|453482368|FG000|Overall Study|Other Adverse Event|1|||
126051106|NCT00748709|453482368|FG000|Overall Study|Withdrawal by Subject|1|||
126051107|NCT00748709|453482368|FG000|Overall Study|Other Reasons|1|||
126051108|NCT02751528|453482373|FG000|Overall Study|Withdrawal by Subject|1|||
126051109|NCT02751528|453482373|FG000|Overall Study|Adverse Event|1|||
126051110|NCT05071430|453482376|FG000|Overall Study|Adverse Event|1|||
126051111|NCT05071430|453482377|FG001|Overall Study|Adverse Event|2|||
126051112|NCT05071430|453482376|FG000|Overall Study|Lost to Follow-up|4|||
126051113|NCT05071430|453482377|FG001|Overall Study|Lost to Follow-up|4|||
126051114|NCT05071430|453482376|FG000|Overall Study|Protocol Violation|1|||
126051115|NCT05071430|453482377|FG001|Overall Study|Protocol Violation|0|||
126051116|NCT05071430|453482376|FG000|Overall Study|Withdrawal by Subject|3|||
126051117|NCT05071430|453482377|FG001|Overall Study|Withdrawal by Subject|2|||
126051118|NCT05071430|453482376|FG000|Overall Study|Other|1|||
126051119|NCT05071430|453482377|FG001|Overall Study|Other|1|||
126051120|NCT01958021|453482378|FG000|Treatment|Progressive disease|206|||
126051121|NCT01958021|453482379|FG001|Treatment|Progressive disease|265|||
126051122|NCT01958021|453482378|FG000|Treatment|Adverse Event|38|||
126051123|NCT01958021|453482379|FG001|Treatment|Adverse Event|10|||
126051124|NCT01958021|453482378|FG000|Treatment|Subject/guardian decision|29|||
126051125|NCT01958021|453482379|FG001|Treatment|Subject/guardian decision|25|||
126051126|NCT01958021|453482378|FG000|Treatment|Physician Decision|28|||
126051127|NCT01958021|453482379|FG001|Treatment|Physician Decision|21|||
126051128|NCT01958021|453482378|FG000|Treatment|Death|6|||
126051129|NCT01958021|453482379|FG001|Treatment|Death|1|||
126051130|NCT01958021|453482378|FG000|Treatment|Protocol deviation|3|||
126051131|NCT01958021|453482379|FG001|Treatment|Protocol deviation|1|||
126051132|NCT01958021|453482378|FG000|Treatment|Sponsor decision|24|||
126396063|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
126396064|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
126396065|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
126051133|NCT01958021|453482379|FG001|Treatment|Sponsor decision|11|||
126051134|NCT01958021|453482378|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
126051135|NCT01958021|453482379|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126051136|NCT01958021|453482378|FG000|Post-treatment Efficacy Follow-up|Death|1|||
126051137|NCT01958021|453482379|FG001|Post-treatment Efficacy Follow-up|Death|0|||
126051138|NCT01958021|453482378|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
126051139|NCT01958021|453482379|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126051140|NCT01958021|453482378|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126051141|NCT01958021|453482379|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
126396066|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
126396067|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
126396068|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
126051142|NCT01958021|453482378|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
126051143|NCT01958021|453482379|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
126051144|NCT01958021|453482378|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
126051145|NCT01958021|453482379|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
126051146|NCT01958021|453482378|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
126051147|NCT01958021|453482379|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
126051148|NCT04649047|453482380|FG000|Overall Study|Withdrawal by Subject|3|||
126051149|NCT00719888|453482381|FG000|Overall Study|Death|24|||
126051150|NCT00719888|453482382|FG001|Overall Study|Death|9|||
126051151|NCT00719888|453482381|FG000|Overall Study|Relapse|8|||
126051152|NCT00719888|453482382|FG001|Overall Study|Relapse|3|||
126051153|NCT00719888|453482381|FG000|Overall Study|Physician Decision|1|||
126051154|NCT00719888|453482382|FG001|Overall Study|Physician Decision|0|||
126051155|NCT00719888|453482381|FG000|Overall Study|Withdrawal by Subject|1|||
126051156|NCT00719888|453482382|FG001|Overall Study|Withdrawal by Subject|0|||
126051157|NCT05037513|453482383|FG000|Intervention Period|Lost to Follow-up|1|||
126051158|NCT05037513|453482384|FG001|Intervention Period|Lost to Follow-up|2|||
126051159|NCT05037513|453482383|FG000|Follow Up Period|Lost to Follow-up|16|||
126051160|NCT05037513|453482384|FG001|Follow Up Period|Lost to Follow-up|21|||
126051161|NCT05037513|453482383|FG000|Follow Up Period|Death|0|||
126051162|NCT05037513|453482384|FG001|Follow Up Period|Death|1|||
126051163|NCT05037513|453482383|FG000|Follow Up Period|Incarcerated|4|||
126051164|NCT05037513|453482384|FG001|Follow Up Period|Incarcerated|2|||
126051165|NCT05886777|453482385|FG000|Overall Study|Lost to Follow-up|1|||
126051166|NCT05886777|453482386|FG001|Overall Study|Lost to Follow-up|0|||
126051167|NCT05886777|453482387|FG002|Overall Study|Lost to Follow-up|2|||
126051168|NCT05886777|453482388|FG003|Overall Study|Lost to Follow-up|1|||
126051169|NCT05886777|453482389|FG004|Overall Study|Lost to Follow-up|0|||
126051170|NCT05886777|453482390|FG005|Overall Study|Lost to Follow-up|2|||
126051171|NCT05886777|453482391|FG006|Overall Study|Lost to Follow-up|0|||
126051172|NCT05886777|453482385|FG000|Overall Study|Other|0|||
126051173|NCT05886777|453482386|FG001|Overall Study|Other|2|||
126051174|NCT05886777|453482387|FG002|Overall Study|Other|1|||
126051175|NCT05886777|453482388|FG003|Overall Study|Other|0|||
126051176|NCT05886777|453482389|FG004|Overall Study|Other|0|||
126051177|NCT05886777|453482390|FG005|Overall Study|Other|0|||
126051178|NCT05886777|453482391|FG006|Overall Study|Other|0|||
126051179|NCT05886777|453482385|FG000|Overall Study|Withdrawal by Subject|1|||
126051180|NCT05886777|453482386|FG001|Overall Study|Withdrawal by Subject|0|||
126051181|NCT05886777|453482387|FG002|Overall Study|Withdrawal by Subject|1|||
126051182|NCT05886777|453482388|FG003|Overall Study|Withdrawal by Subject|4|||
126051183|NCT05886777|453482389|FG004|Overall Study|Withdrawal by Subject|3|||
126051184|NCT05886777|453482390|FG005|Overall Study|Withdrawal by Subject|1|||
126051185|NCT05886777|453482391|FG006|Overall Study|Withdrawal by Subject|1|||
126051186|NCT05886777|453482385|FG000|Overall Study|Protocol Violation|0|||
126051187|NCT05886777|453482386|FG001|Overall Study|Protocol Violation|0|||
126051188|NCT05886777|453482387|FG002|Overall Study|Protocol Violation|1|||
126051189|NCT05886777|453482388|FG003|Overall Study|Protocol Violation|0|||
126051190|NCT05886777|453482389|FG004|Overall Study|Protocol Violation|0|||
126051191|NCT05886777|453482390|FG005|Overall Study|Protocol Violation|0|||
126051192|NCT05886777|453482391|FG006|Overall Study|Protocol Violation|0|||
126051193|NCT05886777|453482385|FG000|Overall Study|No longer met eligibility criteria|0|||
126051194|NCT05886777|453482386|FG001|Overall Study|No longer met eligibility criteria|1|||
126051195|NCT05886777|453482387|FG002|Overall Study|No longer met eligibility criteria|0|||
126051196|NCT05886777|453482388|FG003|Overall Study|No longer met eligibility criteria|0|||
126051197|NCT05886777|453482389|FG004|Overall Study|No longer met eligibility criteria|0|||
126051198|NCT05886777|453482390|FG005|Overall Study|No longer met eligibility criteria|0|||
126051199|NCT05886777|453482391|FG006|Overall Study|No longer met eligibility criteria|0|||
126051200|NCT00048932|453483865|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
126051201|NCT00048932|453483866|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
126051202|NCT00048932|453483867|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
126051203|NCT00048932|453483865|FG000|Double Blind Period (DB)|Adverse Event|51|||
126051204|NCT00048932|453483866|FG001|Double Blind Period (DB)|Adverse Event|19|||
126051205|NCT00048932|453483867|FG002|Double Blind Period (DB)|Adverse Event|0|||
126051206|NCT00048932|453483865|FG000|Double Blind Period (DB)|Death|5|||
126051207|NCT00048932|453483866|FG001|Double Blind Period (DB)|Death|3|||
126051208|NCT00048932|453483867|FG002|Double Blind Period (DB)|Death|0|||
126051209|NCT00048932|453483865|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
126051210|NCT00048932|453483866|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
126051211|NCT00048932|453483867|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
126051212|NCT00048932|453483865|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
126051213|NCT00048932|453483866|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
126051214|NCT00048932|453483867|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
126051215|NCT00048932|453483865|FG000|Double Blind Period (DB)|Relocation|1|||
126051216|NCT00048932|453483866|FG001|Double Blind Period (DB)|Relocation|0|||
126051217|NCT00048932|453483867|FG002|Double Blind Period (DB)|Relocation|0|||
126051218|NCT00048932|453483865|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
126104861|NCT00427895|453677089|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126104862|NCT00427895|453677090|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126104863|NCT00427895|453677091|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126104864|NCT00427895|453677084|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126104865|NCT00427895|453677085|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126104866|NCT00427895|453677086|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126104867|NCT00427895|453677087|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126104868|NCT00427895|453677088|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126104869|NCT00427895|453677089|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126104870|NCT00427895|453677090|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126104871|NCT00427895|453677091|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
126104872|NCT00427895|453677084|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
126104873|NCT00427895|453677085|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
126104874|NCT00427895|453677086|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
126104875|NCT00427895|453677087|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
126104876|NCT00427895|453677088|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
126104877|NCT00427895|453677089|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
126104878|NCT00427895|453677090|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
126104879|NCT00427895|453677091|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
126104880|NCT00427895|453677084|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
126104881|NCT00427895|453677085|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
126104882|NCT00427895|453677086|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
126104883|NCT00427895|453677087|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
126104884|NCT00427895|453677088|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
126104885|NCT00427895|453677089|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
126104886|NCT00427895|453677090|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
126104887|NCT00427895|453677091|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
126104888|NCT00427895|453677084|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126104889|NCT00427895|453677085|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
126104890|NCT00427895|453677086|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
126104891|NCT00427895|453677087|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
126104892|NCT00427895|453677088|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126104893|NCT00427895|453677089|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126104894|NCT00427895|453677090|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126104895|NCT00427895|453677091|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126104896|NCT00427895|453677084|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
126104897|NCT00427895|453677085|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126104898|NCT00427895|453677086|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
126104899|NCT00427895|453677087|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
126104900|NCT00427895|453677088|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126104901|NCT00427895|453677089|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126104902|NCT00427895|453677090|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126104903|NCT00427895|453677091|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126104904|NCT00427895|453677084|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
126104905|NCT00427895|453677085|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
126104906|NCT00427895|453677086|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125888487|NCT03399552|452888089|FG000|Overall Study|No evidence of disease|1|||
126104907|NCT00427895|453677087|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126104908|NCT00427895|453677088|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126104909|NCT00427895|453677089|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126104910|NCT00427895|453677090|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126396069|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
126396070|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
126396071|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
126396072|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
126396073|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
126396074|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
126396075|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
126396076|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
126396077|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
126396078|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
126396079|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
126396080|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
126396081|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
126104911|NCT00427895|453677091|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126396082|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
126396083|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
126396084|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
126396085|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
126051219|NCT00048932|453483866|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
126051220|NCT00048932|453483867|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
126051221|NCT00048932|453483865|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
126051222|NCT00048932|453483866|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
126051223|NCT00048932|453483867|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
126051224|NCT00048932|453483865|FG000|Double Blind Period (DB)|Pregnancy|1|||
126051225|NCT00048932|453483866|FG001|Double Blind Period (DB)|Pregnancy|0|||
126051226|NCT00048932|453483867|FG002|Double Blind Period (DB)|Pregnancy|0|||
126051227|NCT00048932|453483865|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
126051228|NCT00048932|453483866|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
126051229|NCT00048932|453483867|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
126051230|NCT00048932|453483865|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
126051231|NCT00048932|453483866|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
126051232|NCT00048932|453483867|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
126051233|NCT00048932|453483865|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
126051234|NCT00048932|453483866|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
126051235|NCT00048932|453483867|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
126051236|NCT00048932|453483865|FG000|Open Label Period (OL)|Death|0|||
126051237|NCT00048932|453483866|FG001|Open Label Period (OL)|Death|0|||
126051238|NCT00048932|453483867|FG002|Open Label Period (OL)|Death|25|||
126051239|NCT00048932|453483865|FG000|Open Label Period (OL)|Adverse Event|0|||
126051240|NCT00048932|453483866|FG001|Open Label Period (OL)|Adverse Event|0|||
126051241|NCT00048932|453483867|FG002|Open Label Period (OL)|Adverse Event|103|||
126051242|NCT00048932|453483865|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
126051243|NCT00048932|453483866|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
126051244|NCT00048932|453483867|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
126051245|NCT00048932|453483865|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
126051246|NCT00048932|453483866|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
126051247|NCT00048932|453483867|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
126051248|NCT00048932|453483865|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
126051249|NCT00048932|453483866|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
126051250|NCT00048932|453483867|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
126051251|NCT00048932|453483865|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
126051252|NCT00048932|453483866|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
126051253|NCT00048932|453483867|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
126051254|NCT00048932|453483865|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
126051255|NCT00048932|453483866|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
126051256|NCT00048932|453483867|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
126051257|NCT00048932|453483865|FG000|Open Label Period (OL)|Pregnancy|0|||
126051258|NCT00048932|453483866|FG001|Open Label Period (OL)|Pregnancy|0|||
126051259|NCT00048932|453483867|FG002|Open Label Period (OL)|Pregnancy|6|||
126051260|NCT00048932|453483865|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
126051261|NCT00048932|453483866|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
126051262|NCT00048932|453483867|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
126051263|NCT00048932|453483865|FG000|Open Label Period (OL)|Investigator Retiring|0|||
126051264|NCT00048932|453483866|FG001|Open Label Period (OL)|Investigator Retiring|0|||
126051265|NCT00048932|453483867|FG002|Open Label Period (OL)|Investigator Retiring|2|||
126051266|NCT00048932|453483865|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
126051267|NCT00048932|453483866|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
126104912|NCT00427895|453677084|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
126104913|NCT00427895|453677085|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
126104914|NCT00427895|453677086|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
126104915|NCT00427895|453677087|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
126104916|NCT00427895|453677088|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
126104917|NCT00427895|453677089|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
126104918|NCT00427895|453677090|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
126104919|NCT00427895|453677091|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
126104920|NCT00427895|453677084|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126104921|NCT00427895|453677085|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126104922|NCT00427895|453677086|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126051268|NCT00048932|453483867|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
126051269|NCT00048932|453483865|FG000|Open Label Period (OL)|Participant Relocated|0|||
126051270|NCT00048932|453483866|FG001|Open Label Period (OL)|Participant Relocated|0|||
126051271|NCT00048932|453483867|FG002|Open Label Period (OL)|Participant Relocated|6|||
126051272|NCT00048932|453483865|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
126051273|NCT00048932|453483866|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
126051274|NCT00048932|453483867|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
126051275|NCT00048932|453483865|FG000|Open Label Period (OL)|Site Closure|0|||
126051276|NCT00048932|453483866|FG001|Open Label Period (OL)|Site Closure|0|||
126051277|NCT00048932|453483867|FG002|Open Label Period (OL)|Site Closure|3|||
126051278|NCT00048932|453483865|FG000|Open Label Period (OL)|Trial Terminated|0|||
126051279|NCT00048932|453483866|FG001|Open Label Period (OL)|Trial Terminated|0|||
126051280|NCT00048932|453483867|FG002|Open Label Period (OL)|Trial Terminated|1|||
126051281|NCT00048932|453483865|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
126051282|NCT00048932|453483866|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
126051283|NCT00048932|453483867|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
126051284|NCT00048932|453483865|FG000|Open Label Period (OL)|Patient Decision|0|||
126051285|NCT00048932|453483866|FG001|Open Label Period (OL)|Patient Decision|0|||
126051286|NCT00048932|453483867|FG002|Open Label Period (OL)|Patient Decision|4|||
126051287|NCT00048932|453483865|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
126051288|NCT00048932|453483866|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
126051289|NCT00048932|453483867|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
126051290|NCT00048932|453483865|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
126051291|NCT00048932|453483866|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
126051292|NCT00048932|453483867|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
126051293|NCT00048932|453483865|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
126051294|NCT00048932|453483866|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
126051295|NCT00048932|453483867|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
126051296|NCT00048932|453483865|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
126051297|NCT00048932|453483866|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
126051298|NCT00048932|453483867|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
126051299|NCT00048932|453483865|FG000|Open Label Period (OL)|Investigator Decision|0|||
126051300|NCT00048932|453483866|FG001|Open Label Period (OL)|Investigator Decision|0|||
126051301|NCT00048932|453483867|FG002|Open Label Period (OL)|Investigator Decision|4|||
126051302|NCT00048932|453483865|FG000|Open Label Period (OL)|Site Staff Issues|0|||
126051303|NCT00048932|453483866|FG001|Open Label Period (OL)|Site Staff Issues|0|||
126051304|NCT00048932|453483867|FG002|Open Label Period (OL)|Site Staff Issues|2|||
126051305|NCT00048932|453483865|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
126051306|NCT00048932|453483866|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
126051307|NCT00048932|453483867|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
126051308|NCT00048932|453483865|FG000|Open Label Period (OL)|Participant Surgery|0|||
126051309|NCT00048932|453483866|FG001|Open Label Period (OL)|Participant Surgery|0|||
126051310|NCT00048932|453483867|FG002|Open Label Period (OL)|Participant Surgery|1|||
126051311|NCT02232737|453483868|FG000|Overall Study|Lost to Follow-up|18|||
126051312|NCT02232737|453483869|FG001|Overall Study|Lost to Follow-up|28|||
126051313|NCT02232737|453483870|FG002|Overall Study|Lost to Follow-up|33|||
126051314|NCT02232737|453483868|FG000|Overall Study|Personal reasons|7|||
126051315|NCT02232737|453483869|FG001|Overall Study|Personal reasons|8|||
126051316|NCT02232737|453483870|FG002|Overall Study|Personal reasons|14|||
126051317|NCT02232737|453483868|FG000|Overall Study|Adverse Event|6|||
126051318|NCT02232737|453483869|FG001|Overall Study|Adverse Event|3|||
126051319|NCT02232737|453483870|FG002|Overall Study|Adverse Event|8|||
126051320|NCT02232737|453483868|FG000|Overall Study|Incarcerated|2|||
126051321|NCT02232737|453483869|FG001|Overall Study|Incarcerated|1|||
126051322|NCT02232737|453483870|FG002|Overall Study|Incarcerated|2|||
126051323|NCT02232737|453483868|FG000|Overall Study|Withdrawal by Subject|0|||
126051324|NCT02232737|453483869|FG001|Overall Study|Withdrawal by Subject|1|||
126051325|NCT02232737|453483870|FG002|Overall Study|Withdrawal by Subject|2|||
126051326|NCT02232737|453483868|FG000|Overall Study|Death|0|||
126051327|NCT02232737|453483869|FG001|Overall Study|Death|1|||
126051328|NCT02232737|453483870|FG002|Overall Study|Death|1|||
126051329|NCT02232737|453483868|FG000|Overall Study|Physician Decision|1|||
126051330|NCT02232737|453483869|FG001|Overall Study|Physician Decision|3|||
126051331|NCT02232737|453483870|FG002|Overall Study|Physician Decision|1|||
126051332|NCT02232737|453483868|FG000|Overall Study|Protocol Violation|1|||
126051333|NCT02232737|453483869|FG001|Overall Study|Protocol Violation|0|||
126051334|NCT02232737|453483870|FG002|Overall Study|Protocol Violation|1|||
126051335|NCT02232737|453483868|FG000|Overall Study|Reason unknown|1|||
126051336|NCT02232737|453483869|FG001|Overall Study|Reason unknown|0|||
126051337|NCT02232737|453483870|FG002|Overall Study|Reason unknown|0|||
126051338|NCT04559698|453483871|FG000|Overall Study|Lost to Follow-up|14|||
126051339|NCT04559698|453483872|FG001|Overall Study|Lost to Follow-up|15|||
126051340|NCT04559698|453483871|FG000|Overall Study|Withdrawal by Subject|0|||
126051341|NCT04559698|453483872|FG001|Overall Study|Withdrawal by Subject|1|||
126051342|NCT01641900|453483886|FG000|Overall Study|Withdrawal by Subject|2|||
126051343|NCT01641900|453483887|FG001|Overall Study|Withdrawal by Subject|2|||
126051344|NCT03220724|453483893|FG000|Overall Study|Lost to Follow-up|2|||
126051345|NCT03220724|453483894|FG001|Overall Study|Lost to Follow-up|2|||
126051346|NCT03220724|453483895|FG002|Overall Study|Lost to Follow-up|0|||
126051347|NCT03220724|453483896|FG003|Overall Study|Lost to Follow-up|3|||
126051348|NCT03220724|453483897|FG004|Overall Study|Lost to Follow-up|1|||
126051349|NCT03220724|453483898|FG005|Overall Study|Lost to Follow-up|0|||
126051350|NCT03220724|453483899|FG006|Overall Study|Lost to Follow-up|2|||
126051351|NCT03220724|453483900|FG007|Overall Study|Lost to Follow-up|1|||
126051352|NCT03220724|453483901|FG008|Overall Study|Lost to Follow-up|0|||
126051353|NCT03220724|453483893|FG000|Overall Study|Withdrawal by Subject|1|||
126051354|NCT03220724|453483894|FG001|Overall Study|Withdrawal by Subject|0|||
126051355|NCT03220724|453483895|FG002|Overall Study|Withdrawal by Subject|1|||
126051356|NCT03220724|453483896|FG003|Overall Study|Withdrawal by Subject|0|||
126051357|NCT03220724|453483897|FG004|Overall Study|Withdrawal by Subject|0|||
126051358|NCT03220724|453483898|FG005|Overall Study|Withdrawal by Subject|0|||
126051359|NCT03220724|453483899|FG006|Overall Study|Withdrawal by Subject|0|||
126051360|NCT03220724|453483900|FG007|Overall Study|Withdrawal by Subject|0|||
126051361|NCT03220724|453483901|FG008|Overall Study|Withdrawal by Subject|0|||
126051362|NCT02463448|453483910|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
126051363|NCT02463448|453483910|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
126051364|NCT02463448|453483910|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
126051365|NCT02463448|453483910|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
126051366|NCT01359150|453483911|FG000|Overall Study|Lack of Efficacy|1|||
126051367|NCT01359150|453483912|FG001|Overall Study|Lack of Efficacy|1|||
126051368|NCT01359150|453483911|FG000|Overall Study|Withdrawal by Subject|1|||
126051369|NCT01359150|453483912|FG001|Overall Study|Withdrawal by Subject|1|||
126051370|NCT01359150|453483911|FG000|Overall Study|Adverse Event|4|||
126051371|NCT01359150|453483912|FG001|Overall Study|Adverse Event|3|||
126051372|NCT01359150|453483911|FG000|Overall Study|Other|1|||
126051373|NCT01359150|453483912|FG001|Overall Study|Other|0|||
126051374|NCT00857766|453483913|FG000|Overall Study|Adverse Event|13|||
126051375|NCT00857766|453483914|FG001|Overall Study|Adverse Event|12|||
126051376|NCT00857766|453483913|FG000|Overall Study|Protocol Violation|11|||
126051377|NCT00857766|453483914|FG001|Overall Study|Protocol Violation|11|||
126051378|NCT00857766|453483913|FG000|Overall Study|Lost to Follow-up|1|||
126051379|NCT00857766|453483914|FG001|Overall Study|Lost to Follow-up|0|||
126051380|NCT00857766|453483913|FG000|Overall Study|Investigator Discretion|2|||
126051381|NCT00857766|453483914|FG001|Overall Study|Investigator Discretion|3|||
126051382|NCT00857766|453483913|FG000|Overall Study|Participant Withdrew Consent|4|||
126051383|NCT00857766|453483914|FG001|Overall Study|Participant Withdrew Consent|4|||
126051384|NCT03113409|453483915|FG000|Overall Study|Withdrawal by Subject|5|||
126051385|NCT03113409|453483916|FG001|Overall Study|Withdrawal by Subject|0|||
126051386|NCT03113409|453483917|FG002|Overall Study|Withdrawal by Subject|0|||
126051387|NCT01787032|453483924|FG000|Overall Study|Protocol Violation|0|||
126051388|NCT01787032|453483925|FG001|Overall Study|Protocol Violation|0|||
126051389|NCT01787032|453483926|FG002|Overall Study|Protocol Violation|0|||
126051390|NCT01787032|453483927|FG003|Overall Study|Protocol Violation|0|||
126051391|NCT01787032|453483928|FG004|Overall Study|Protocol Violation|1|||
126051392|NCT01787032|453483929|FG005|Overall Study|Protocol Violation|1|||
126051393|NCT00776009|453483930|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
126051394|NCT00776009|453483931|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
126051395|NCT00776009|453483932|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
126051396|NCT00776009|453483933|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
126051397|NCT00776009|453483934|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
126051398|NCT00776009|453483935|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
126051399|NCT00776009|453483930|FG000|Period 1: First Intervention|Protocol Violation|0|||
126051400|NCT00776009|453483931|FG001|Period 1: First Intervention|Protocol Violation|1|||
126104923|NCT00427895|453677087|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
126104924|NCT00427895|453677088|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126104925|NCT00427895|453677089|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126104926|NCT00427895|453677090|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
125888488|NCT03399552|452888089|FG000|Overall Study|Unevaluable|1|||
125888489|NCT02506244|452888090|FG000|Overall Study|Did not undergo active monitoring|458|||
125888490|NCT02506244|452888091|FG001|Overall Study|Did not undergo active monitoring|459|||
125888491|NCT02506244|452888092|FG002|Overall Study|Did not undergo active monitoring|0|||
126104927|NCT00427895|453677091|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126104928|NCT00427895|453677084|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
126104929|NCT00427895|453677085|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
126104930|NCT00427895|453677086|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
126104931|NCT00427895|453677087|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
126104932|NCT00427895|453677088|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
126104933|NCT00427895|453677089|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
126104934|NCT00427895|453677090|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
126104935|NCT00427895|453677091|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
126104936|NCT00427895|453677084|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126104937|NCT00427895|453677085|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126104938|NCT00427895|453677086|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
126396086|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
126396087|NCT05032690|454744518|FG000|Period 1|Adverse Event|0|||
126396088|NCT05032690|454744519|FG001|Period 1|Adverse Event|1|||
126396089|NCT05032690|454744520|FG002|Period 1|Adverse Event|0|||
126396090|NCT05032690|454744521|FG003|Period 1|Adverse Event|0|||
126396091|NCT05032690|454744518|FG000|Period 1|Withdrawal by Subject|1|||
126396092|NCT05032690|454744519|FG001|Period 1|Withdrawal by Subject|0|||
126396093|NCT05032690|454744520|FG002|Period 1|Withdrawal by Subject|0|||
126396094|NCT05032690|454744521|FG003|Period 1|Withdrawal by Subject|0|||
126396095|NCT05032690|454744518|FG000|Period 1|No longer meets eligibility criteria|0|||
126396096|NCT05032690|454744519|FG001|Period 1|No longer meets eligibility criteria|1|||
126396097|NCT05032690|454744520|FG002|Period 1|No longer meets eligibility criteria|0|||
126396098|NCT05032690|454744521|FG003|Period 1|No longer meets eligibility criteria|0|||
126396099|NCT05032690|454744518|FG000|Period 2|Adverse Event|1|||
126396100|NCT05032690|454744519|FG001|Period 2|Adverse Event|0|||
126396101|NCT05032690|454744520|FG002|Period 2|Adverse Event|0|||
126396102|NCT05032690|454744521|FG003|Period 2|Adverse Event|0|||
126396103|NCT05032690|454744518|FG000|Period 2|Withdrawal by Subject|0|||
126396104|NCT05032690|454744519|FG001|Period 2|Withdrawal by Subject|1|||
126396105|NCT05032690|454744520|FG002|Period 2|Withdrawal by Subject|0|||
126396106|NCT05032690|454744521|FG003|Period 2|Withdrawal by Subject|0|||
126396107|NCT05032690|454744518|FG000|Period 2|No longer meets eligibility criteria|0|||
126396108|NCT05032690|454744519|FG001|Period 2|No longer meets eligibility criteria|1|||
126396109|NCT05032690|454744520|FG002|Period 2|No longer meets eligibility criteria|0|||
126396110|NCT05032690|454744521|FG003|Period 2|No longer meets eligibility criteria|0|||
126396111|NCT05032690|454744518|FG000|Period 3|Adverse Event|0|||
126396112|NCT05032690|454744519|FG001|Period 3|Adverse Event|1|||
126396113|NCT05032690|454744520|FG002|Period 3|Adverse Event|0|||
126396114|NCT05032690|454744521|FG003|Period 3|Adverse Event|0|||
126396115|NCT00759356|454744524|FG000|Overall Study|Adverse Event|0|||
126396116|NCT00759356|454744525|FG001|Overall Study|Adverse Event|1|||
126396117|NCT00759356|454744524|FG000|Overall Study|Withdrawal by Subject|0|||
126396118|NCT00759356|454744525|FG001|Overall Study|Withdrawal by Subject|2|||
126396119|NCT00759356|454744524|FG000|Overall Study|Subject was unable to return|1|||
126396120|NCT00759356|454744525|FG001|Overall Study|Subject was unable to return|0|||
126396121|NCT01713283|454744526|FG000|Overall Study|Lack of Efficacy|10|||
126396122|NCT01713283|454744527|FG001|Overall Study|Lack of Efficacy|2|||
126396123|NCT01713283|454744526|FG000|Overall Study|Lost to Follow-up|1|||
126396124|NCT01713283|454744527|FG001|Overall Study|Lost to Follow-up|1|||
126396125|NCT02403635|454744528|FG000|Overall Study|Not eligible|9|||
126396126|NCT01904149|454744534|FG000|Overall Study|Adverse Event|3|||
126396127|NCT01904149|454744535|FG001|Overall Study|Adverse Event|4|||
126396128|NCT01904149|454744536|FG002|Overall Study|Adverse Event|0|||
126396129|NCT01904149|454744537|FG003|Overall Study|Adverse Event|1|||
126396130|NCT01904149|454744538|FG004|Overall Study|Adverse Event|1|||
126396131|NCT01904149|454744539|FG005|Overall Study|Adverse Event|2|||
126396132|NCT01904149|454744534|FG000|Overall Study|Lack of Efficacy|0|||
126396133|NCT01904149|454744535|FG001|Overall Study|Lack of Efficacy|3|||
126396134|NCT01904149|454744536|FG002|Overall Study|Lack of Efficacy|1|||
126396135|NCT01904149|454744537|FG003|Overall Study|Lack of Efficacy|3|||
126396136|NCT01904149|454744538|FG004|Overall Study|Lack of Efficacy|3|||
126396137|NCT01904149|454744539|FG005|Overall Study|Lack of Efficacy|1|||
126396138|NCT01904149|454744534|FG000|Overall Study|Withdrawal by Subject|1|||
126396139|NCT01904149|454744535|FG001|Overall Study|Withdrawal by Subject|3|||
126396140|NCT01904149|454744536|FG002|Overall Study|Withdrawal by Subject|1|||
126396141|NCT01904149|454744537|FG003|Overall Study|Withdrawal by Subject|0|||
125888492|NCT02840461|452888101|FG000|Overall Study|Adverse Event|1|||
125888493|NCT02840461|452888102|FG001|Overall Study|Adverse Event|5|||
125888494|NCT02840461|452888103|FG002|Overall Study|Adverse Event|3|||
125888495|NCT02840461|452888101|FG000|Overall Study|Lost to Follow-up|10|||
125888496|NCT02840461|452888102|FG001|Overall Study|Lost to Follow-up|7|||
125888497|NCT02840461|452888103|FG002|Overall Study|Lost to Follow-up|6|||
125888498|NCT02840461|452888101|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
125888499|NCT02840461|452888102|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
125888500|NCT02840461|452888103|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
126396142|NCT01904149|454744538|FG004|Overall Study|Withdrawal by Subject|1|||
126396143|NCT01904149|454744539|FG005|Overall Study|Withdrawal by Subject|0|||
126396144|NCT01904149|454744534|FG000|Overall Study|Protocol Violation|0|||
126396145|NCT01904149|454744535|FG001|Overall Study|Protocol Violation|1|||
126396146|NCT01904149|454744536|FG002|Overall Study|Protocol Violation|0|||
126396147|NCT01904149|454744537|FG003|Overall Study|Protocol Violation|0|||
126396148|NCT01904149|454744538|FG004|Overall Study|Protocol Violation|0|||
126396149|NCT01904149|454744539|FG005|Overall Study|Protocol Violation|0|||
126396150|NCT01904149|454744534|FG000|Overall Study|non compliance with study drug|1|||
126396151|NCT01904149|454744535|FG001|Overall Study|non compliance with study drug|0|||
126396152|NCT01904149|454744536|FG002|Overall Study|non compliance with study drug|0|||
126396153|NCT01904149|454744537|FG003|Overall Study|non compliance with study drug|0|||
126396154|NCT01904149|454744538|FG004|Overall Study|non compliance with study drug|0|||
126396155|NCT01904149|454744539|FG005|Overall Study|non compliance with study drug|0|||
125888501|NCT02840461|452888101|FG000|Overall Study|Protocol Violation|2|||
125888502|NCT02840461|452888102|FG001|Overall Study|Protocol Violation|3|||
125888503|NCT02840461|452888103|FG002|Overall Study|Protocol Violation|1|||
125888504|NCT02840461|452888101|FG000|Overall Study|Withdrawal by Subject|10|||
125888505|NCT02840461|452888102|FG001|Overall Study|Withdrawal by Subject|6|||
125888506|NCT02840461|452888103|FG002|Overall Study|Withdrawal by Subject|2|||
125888507|NCT02840461|452888101|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
125888508|NCT02840461|452888102|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
125888509|NCT02840461|452888103|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
125888510|NCT01737502|452888104|FG000|Phase I|Disease progression|2|||
125888511|NCT01737502|452888105|FG001|Phase I|Disease progression|3|||
125888512|NCT01737502|452888104|FG000|Phase I|Complicating disease|1|||
125888513|NCT01737502|452888105|FG001|Phase I|Complicating disease|0|||
125888514|NCT01737502|452888104|FG000|Phase II|Adverse Event|0|||
125888515|NCT01737502|452888105|FG001|Phase II|Adverse Event|3|||
125888516|NCT01737502|452888104|FG000|Phase II|Disease progression|0|||
125888517|NCT01737502|452888105|FG001|Phase II|Disease progression|18|||
126396156|NCT00835640|454744540|FG000|Second Intervention|Protocol Violation|1|||
126396157|NCT00835640|454744541|FG001|Second Intervention|Protocol Violation|0|||
125888518|NCT01737502|452888104|FG000|Phase II|Death|0|||
125888519|NCT01737502|452888105|FG001|Phase II|Death|1|||
126051401|NCT00776009|453483932|FG002|Period 1: First Intervention|Protocol Violation|0|||
126051402|NCT00776009|453483933|FG003|Period 1: First Intervention|Protocol Violation|0|||
126051403|NCT00776009|453483934|FG004|Period 1: First Intervention|Protocol Violation|1|||
126051404|NCT00776009|453483935|FG005|Period 1: First Intervention|Protocol Violation|0|||
126051405|NCT00776009|453483930|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
126051406|NCT00776009|453483931|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
126051407|NCT00776009|453483932|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
126051408|NCT00776009|453483933|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
126051409|NCT00776009|453483934|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
126051410|NCT00776009|453483935|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
126051411|NCT00776009|453483930|FG000|Period 2: Second Intervention|Protocol Violation|1|||
126051412|NCT00776009|453483931|FG001|Period 2: Second Intervention|Protocol Violation|0|||
126051413|NCT00776009|453483932|FG002|Period 2: Second Intervention|Protocol Violation|1|||
126051414|NCT00776009|453483933|FG003|Period 2: Second Intervention|Protocol Violation|0|||
126051415|NCT00776009|453483934|FG004|Period 2: Second Intervention|Protocol Violation|0|||
126051416|NCT00776009|453483935|FG005|Period 2: Second Intervention|Protocol Violation|0|||
126051417|NCT00776009|453483930|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
126051418|NCT00776009|453483931|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
126051419|NCT00776009|453483932|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
126051420|NCT00776009|453483933|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
126051421|NCT00776009|453483934|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
126051422|NCT00776009|453483935|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
126051423|NCT02040870|453483936|FG000|Overall Study|Completed treatment phase|6|||
126051424|NCT02040870|453483936|FG000|Overall Study|Adverse Event|7|||
126051425|NCT02040870|453483936|FG000|Overall Study|Progressive disease|58|||
126051426|NCT02040870|453483936|FG000|Overall Study|Physician Decision|6|||
126051427|NCT02040870|453483936|FG000|Overall Study|Subject/guardian decision|10|||
126051428|NCT02040870|453483936|FG000|Overall Study|Lost to Follow-up|3|||
126051429|NCT02040870|453483936|FG000|Overall Study|Death|13|||
126051430|NCT01536093|453483937|FG000|Overall Study|Death|1|||
126051431|NCT01536093|453483938|FG001|Overall Study|Death|2|||
126396158|NCT00068250|454744542|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
126396159|NCT00068250|454744543|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
126396160|NCT00068250|454744544|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
126396161|NCT00068250|454744545|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
126396162|NCT00812006|454744546|FG000|Overall Study|Lost to Follow-up|0|||
126396163|NCT00812006|454744547|FG001|Overall Study|Lost to Follow-up|0|||
126396164|NCT00812006|454744548|FG002|Overall Study|Lost to Follow-up|2|||
126396165|NCT00812006|454744546|FG000|Overall Study|Physician Decision|0|||
126396166|NCT00812006|454744547|FG001|Overall Study|Physician Decision|0|||
126396167|NCT00812006|454744548|FG002|Overall Study|Physician Decision|1|||
126396168|NCT00812006|454744546|FG000|Overall Study|Withdrawal by Subject|2|||
126396169|NCT00812006|454744547|FG001|Overall Study|Withdrawal by Subject|1|||
126396170|NCT00812006|454744548|FG002|Overall Study|Withdrawal by Subject|1|||
126396171|NCT00812006|454744546|FG000|Overall Study|Lack of Qualifying Event|4|||
126396172|NCT00812006|454744547|FG001|Overall Study|Lack of Qualifying Event|2|||
126396173|NCT00812006|454744548|FG002|Overall Study|Lack of Qualifying Event|2|||
126396174|NCT00235391|454744549|FG000|Overall Study|Adverse Event|4|||
126396175|NCT00235391|454744550|FG001|Overall Study|Adverse Event|5|||
126396176|NCT00235391|454744551|FG002|Overall Study|Adverse Event|10|||
126396177|NCT00235391|454744552|FG003|Overall Study|Adverse Event|72|||
126396178|NCT00235391|454744553|FG004|Overall Study|Adverse Event|5|||
126396179|NCT00235391|454744554|FG005|Overall Study|Adverse Event|2|||
126396180|NCT00235391|454744549|FG000|Overall Study|Abnormal laboratory value(s)|3|||
126396181|NCT00235391|454744550|FG001|Overall Study|Abnormal laboratory value(s)|5|||
126396182|NCT00235391|454744551|FG002|Overall Study|Abnormal laboratory value(s)|4|||
126396183|NCT00235391|454744552|FG003|Overall Study|Abnormal laboratory value(s)|27|||
126396184|NCT00235391|454744553|FG004|Overall Study|Abnormal laboratory value(s)|1|||
126396185|NCT00235391|454744554|FG005|Overall Study|Abnormal laboratory value(s)|2|||
126396186|NCT00235391|454744549|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126396187|NCT00235391|454744550|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125888520|NCT01737502|452888104|FG000|Phase II|Transition to hospice care|0|||
125888521|NCT01737502|452888105|FG001|Phase II|Transition to hospice care|1|||
126051432|NCT01536093|453483937|FG000|Overall Study|absence of maternal colostrum|2|||
126051433|NCT01536093|453483938|FG001|Overall Study|absence of maternal colostrum|0|||
126396188|NCT00235391|454744551|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126396189|NCT00235391|454744552|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
126396190|NCT00235391|454744553|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
126396191|NCT00235391|454744554|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
126396192|NCT00235391|454744549|FG000|Overall Study|Condition no longer requires treatment|3|||
126396193|NCT00235391|454744550|FG001|Overall Study|Condition no longer requires treatment|0|||
126396194|NCT00235391|454744551|FG002|Overall Study|Condition no longer requires treatment|0|||
126396195|NCT00235391|454744552|FG003|Overall Study|Condition no longer requires treatment|11|||
126396196|NCT00235391|454744553|FG004|Overall Study|Condition no longer requires treatment|1|||
126396197|NCT00235391|454744554|FG005|Overall Study|Condition no longer requires treatment|0|||
126396198|NCT00235391|454744549|FG000|Overall Study|Protocol deviation|0|||
126396199|NCT00235391|454744550|FG001|Overall Study|Protocol deviation|0|||
126396200|NCT00235391|454744551|FG002|Overall Study|Protocol deviation|1|||
126396201|NCT00235391|454744552|FG003|Overall Study|Protocol deviation|11|||
126396202|NCT00235391|454744553|FG004|Overall Study|Protocol deviation|0|||
126396203|NCT00235391|454744554|FG005|Overall Study|Protocol deviation|0|||
126396204|NCT00235391|454744549|FG000|Overall Study|Withdrawal by Subject|2|||
126396205|NCT00235391|454744550|FG001|Overall Study|Withdrawal by Subject|3|||
126396206|NCT00235391|454744551|FG002|Overall Study|Withdrawal by Subject|3|||
126396207|NCT00235391|454744552|FG003|Overall Study|Withdrawal by Subject|61|||
126396208|NCT00235391|454744553|FG004|Overall Study|Withdrawal by Subject|5|||
125888522|NCT04672655|452888109|FG000|Overall Study|Lost to Follow-up|12|||
126051434|NCT01536093|453483937|FG000|Overall Study|Withdrawal by Subject|0|||
126051435|NCT01536093|453483938|FG001|Overall Study|Withdrawal by Subject|1|||
126051436|NCT04971733|453483939|FG000|Overall Study|Adverse Event|1|||
126051437|NCT04971733|453483940|FG001|Overall Study|Adverse Event|1|||
126051438|NCT04971733|453483939|FG000|Overall Study|Subject choice|2|||
126051439|NCT04971733|453483940|FG001|Overall Study|Subject choice|0|||
126051440|NCT04971733|453483939|FG000|Overall Study|Withdrawal by Subject|1|||
126051441|NCT04971733|453483940|FG001|Overall Study|Withdrawal by Subject|0|||
126051442|NCT04971733|453483939|FG000|Overall Study|Other|1|||
126051443|NCT04971733|453483940|FG001|Overall Study|Other|0|||
126051444|NCT02275611|453483943|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
126051445|NCT02275611|453483944|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
126051446|NCT02275611|453483945|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
126051447|NCT02275611|453483946|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
126051448|NCT02406092|453483950|FG000|Overall Study|Screen failure|10|||
126051449|NCT02406092|453483951|FG001|Overall Study|Screen failure|7|||
126051450|NCT02406092|453483950|FG000|Overall Study|Death|22|||
126051451|NCT02406092|453483951|FG001|Overall Study|Death|5|||
126051452|NCT02406092|453483950|FG000|Overall Study|Lost to Follow-up|4|||
126051453|NCT02406092|453483951|FG001|Overall Study|Lost to Follow-up|1|||
126051454|NCT02406092|453483950|FG000|Overall Study|Adverse Event|1|||
126051455|NCT02406092|453483951|FG001|Overall Study|Adverse Event|0|||
126051456|NCT02406092|453483950|FG000|Overall Study|Withdrawal by Subject|1|||
126051457|NCT02406092|453483951|FG001|Overall Study|Withdrawal by Subject|0|||
126051458|NCT01759862|453483954|FG000|Overall Study|Physician Decision|3|||
126051459|NCT01759862|453483955|FG001|Overall Study|Physician Decision|1|||
126051460|NCT01759862|453483954|FG000|Overall Study|Adverse Event|0|||
126051461|NCT01759862|453483955|FG001|Overall Study|Adverse Event|1|||
126051462|NCT03041233|453483956|FG000|Overall Study|Death|5|||
126051463|NCT03041233|453483956|FG000|Overall Study|Physician Decision|1|||
126051464|NCT03041233|453483956|FG000|Overall Study|Lost to Follow-up|16|||
126051465|NCT03041233|453483956|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
126051466|NCT03041233|453483956|FG000|Overall Study|Sponsor Request|1|||
126051467|NCT03041233|453483956|FG000|Overall Study|Duplicate subject|1|||
126051468|NCT03041233|453483956|FG000|Overall Study|Re-ablation|1|||
126051469|NCT00274261|453483959|FG000|Overall Study|Adverse Event|19|||
126051470|NCT00274261|453483960|FG001|Overall Study|Adverse Event|11|||
126051471|NCT00274261|453483959|FG000|Overall Study|Pregnancy|114|||
126051472|NCT00274261|453483960|FG001|Overall Study|Pregnancy|83|||
126051473|NCT00274261|453483959|FG000|Overall Study|Withdrawal by Subject|179|||
126051474|NCT00274261|453483960|FG001|Overall Study|Withdrawal by Subject|126|||
126051475|NCT00274261|453483959|FG000|Overall Study|Protocol Violation|71|||
126051476|NCT00274261|453483960|FG001|Overall Study|Protocol Violation|42|||
126051477|NCT00274261|453483959|FG000|Overall Study|Lost to Follow-up|106|||
126051478|NCT00274261|453483960|FG001|Overall Study|Lost to Follow-up|75|||
126051479|NCT02816398|453483966|FG000|Overall Study|Death|5|||
126051480|NCT02816398|453483966|FG000|Overall Study|Lack of Efficacy|8|||
126051481|NCT02816398|453483966|FG000|Overall Study|Lost to Follow-up|1|||
126051482|NCT01367236|453483971|FG000|Overall Study|Withdrawal by Subject|3|||
126051483|NCT01367236|453483972|FG001|Overall Study|Withdrawal by Subject|1|||
126051484|NCT02628626|453483973|FG000|Overall Study|Withdrawal by Subject|2|||
126051485|NCT02628626|453483974|FG001|Overall Study|Withdrawal by Subject|2|||
126051486|NCT01593020|453483975|FG000|Overall Study|Adverse Event|1|||
126051487|NCT01593020|453483976|FG001|Overall Study|Adverse Event|1|||
126051488|NCT01593020|453483975|FG000|Overall Study|Death|0|||
126051489|NCT01593020|453483976|FG001|Overall Study|Death|1|||
126051490|NCT01593020|453483975|FG000|Overall Study|Ineligible|1|||
126051491|NCT01593020|453483976|FG001|Overall Study|Ineligible|0|||
126396209|NCT00235391|454744554|FG005|Overall Study|Withdrawal by Subject|0|||
126396210|NCT00235391|454744549|FG000|Overall Study|Lost to Follow-up|0|||
126396211|NCT00235391|454744550|FG001|Overall Study|Lost to Follow-up|3|||
126396212|NCT00235391|454744551|FG002|Overall Study|Lost to Follow-up|3|||
126051492|NCT02063659|453483977|FG000|Double-Blind Treatment Period|Adverse Event|1|||
126051493|NCT02063659|453483978|FG001|Double-Blind Treatment Period|Adverse Event|2|||
126051494|NCT02063659|453483979|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126051495|NCT02063659|453483980|FG003|Double-Blind Treatment Period|Adverse Event|0|||
126396213|NCT00235391|454744552|FG003|Overall Study|Lost to Follow-up|16|||
126396214|NCT00235391|454744553|FG004|Overall Study|Lost to Follow-up|0|||
126396215|NCT00235391|454744554|FG005|Overall Study|Lost to Follow-up|0|||
126396216|NCT00235391|454744549|FG000|Overall Study|Administrative problems|0|||
126396217|NCT00235391|454744550|FG001|Overall Study|Administrative problems|0|||
126396218|NCT00235391|454744551|FG002|Overall Study|Administrative problems|0|||
126396219|NCT00235391|454744552|FG003|Overall Study|Administrative problems|1|||
126396220|NCT00235391|454744553|FG004|Overall Study|Administrative problems|0|||
126396221|NCT00235391|454744554|FG005|Overall Study|Administrative problems|0|||
126396222|NCT00235391|454744549|FG000|Overall Study|Death|0|||
126396223|NCT00235391|454744550|FG001|Overall Study|Death|0|||
126396224|NCT00235391|454744551|FG002|Overall Study|Death|1|||
126396225|NCT00235391|454744552|FG003|Overall Study|Death|4|||
126396226|NCT00235391|454744553|FG004|Overall Study|Death|0|||
126396227|NCT00235391|454744554|FG005|Overall Study|Death|0|||
126051496|NCT02063659|453483977|FG000|Double-Blind Treatment Period|Physician Decision|1|||
126396228|NCT03349645|454744555|FG000|Overall Study|Sponsor Terminated Study|75|||
126396229|NCT03349645|454744555|FG000|Overall Study|Withdrawal by Subject|4|||
126396230|NCT03349645|454744555|FG000|Overall Study|Protocol Violation|1|||
125888523|NCT04672655|452888110|FG001|Overall Study|Lost to Follow-up|17|||
125888524|NCT04672655|452888109|FG000|Overall Study|Withdrawal by Subject|1|||
125888525|NCT04672655|452888110|FG001|Overall Study|Withdrawal by Subject|0|||
126396231|NCT03349645|454744555|FG000|Overall Study|Other|2|||
126396232|NCT00580034|454744556|FG000|Overall Study|Toxicity|10|||
126396233|NCT00580034|454744557|FG001|Overall Study|Toxicity|0|||
126396234|NCT00098748|454744560|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
126396235|NCT00098748|454744561|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
126396236|NCT00098748|454744562|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
126396237|NCT00098748|454744560|FG000|Received Study Treatment|Death|2|||
126396238|NCT00098748|454744561|FG001|Received Study Treatment|Death|1|||
126396239|NCT00098748|454744562|FG002|Received Study Treatment|Death|2|||
126396240|NCT00098748|454744560|FG000|Received Study Treatment|Adverse Event|1|||
126396241|NCT00098748|454744561|FG001|Received Study Treatment|Adverse Event|2|||
126396242|NCT00098748|454744562|FG002|Received Study Treatment|Adverse Event|5|||
126396243|NCT00098748|454744560|FG000|Received Study Treatment|Lack of Efficacy|40|||
126396244|NCT00098748|454744561|FG001|Received Study Treatment|Lack of Efficacy|27|||
126396245|NCT00098748|454744562|FG002|Received Study Treatment|Lack of Efficacy|27|||
126396246|NCT00098748|454744560|FG000|Received Study Treatment|Other|2|||
126396247|NCT00098748|454744561|FG001|Received Study Treatment|Other|2|||
126396248|NCT00098748|454744562|FG002|Received Study Treatment|Other|6|||
126396249|NCT00098748|454744560|FG000|Received Study Treatment|Subject defaulted|3|||
126396250|NCT00098748|454744561|FG001|Received Study Treatment|Subject defaulted|4|||
126396251|NCT00098748|454744562|FG002|Received Study Treatment|Subject defaulted|4|||
126396252|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
126396253|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
126396254|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
126396255|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
126396256|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
126396257|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
126396258|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
126396259|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
126396260|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
126396261|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
126396262|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
126396263|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
126396264|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
126396265|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
126396266|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
126396267|NCT02439450|454744566|FG000|Overall Study|Adverse Event|4|||
126396268|NCT02439450|454744567|FG001|Overall Study|Adverse Event|1|||
126396269|NCT02439450|454744568|FG002|Overall Study|Adverse Event|0|||
126396270|NCT02439450|454744569|FG003|Overall Study|Adverse Event|0|||
126396271|NCT02439450|454744566|FG000|Overall Study|Withdrawal by Subject|1|||
126396272|NCT02439450|454744567|FG001|Overall Study|Withdrawal by Subject|2|||
126396273|NCT02439450|454744568|FG002|Overall Study|Withdrawal by Subject|0|||
126396274|NCT02439450|454744569|FG003|Overall Study|Withdrawal by Subject|0|||
126396275|NCT02439450|454744566|FG000|Overall Study|Death|3|||
126396276|NCT02439450|454744567|FG001|Overall Study|Death|0|||
126396277|NCT02439450|454744568|FG002|Overall Study|Death|0|||
126396278|NCT02439450|454744569|FG003|Overall Study|Death|1|||
126396279|NCT02439450|454744566|FG000|Overall Study|Progressive Disease|18|||
126396280|NCT02439450|454744567|FG001|Overall Study|Progressive Disease|41|||
126396281|NCT02439450|454744568|FG002|Overall Study|Progressive Disease|2|||
126396282|NCT02439450|454744569|FG003|Overall Study|Progressive Disease|3|||
126396283|NCT01081301|454744572|FG000|Overall Study|Bereaved|3|||
126396284|NCT01081301|454744572|FG000|Overall Study|Too busy|5|||
126396285|NCT01081301|454744572|FG000|Overall Study|Patient too ill|2|||
126396286|NCT01081301|454744572|FG000|Overall Study|Lost to Follow-up|4|||
126396287|NCT03551665|454744575|FG000|Overall Study|Lost to Follow-up|11|||
126396288|NCT03551665|454744576|FG001|Overall Study|Lost to Follow-up|2|||
126396289|NCT00549900|454745888|FG000|Overall Study|Adverse Event|1|||
126396290|NCT03283098|454745889|FG000|Overall Study|Withdrawal by Subject|0|||
126396291|NCT03283098|454745890|FG001|Overall Study|Withdrawal by Subject|1|||
126396292|NCT02251717|454745893|FG000|Overall Study|Adverse Event|0|||
126396293|NCT02251717|454745894|FG001|Overall Study|Adverse Event|1|||
126396294|NCT02251717|454745893|FG000|Overall Study|Withdrew Consent|1|||
126396295|NCT02251717|454745894|FG001|Overall Study|Withdrew Consent|0|||
125888526|NCT04672655|452888109|FG000|Overall Study|Withdrawal by Study|1|||
126396296|NCT03356977|454745895|FG000|Overall Study|Lost to Follow-up|3|||
126396297|NCT03356977|454745895|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126396298|NCT00445939|454745900|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
126396299|NCT00445939|454745901|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
125888527|NCT04672655|452888110|FG001|Overall Study|Withdrawal by Study|0|||
126396300|NCT00445939|454745902|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
125888528|NCT00494676|452888111|FG000|Allocation|Withdrawal by Subject|2|||
125888529|NCT00494676|452888112|FG001|Allocation|Withdrawal by Subject|4|||
125888530|NCT00494676|452888111|FG000|First Intervention|Withdrawal by Subject|1|||
125888531|NCT00494676|452888112|FG001|First Intervention|Withdrawal by Subject|3|||
125888532|NCT00494676|452888111|FG000|Second Intervention|Withdrawal by Subject|1|||
125888533|NCT00494676|452888112|FG001|Second Intervention|Withdrawal by Subject|1|||
125888534|NCT01788358|452889721|FG000|Overall Study|Other|11|||
125888535|NCT01788358|452889721|FG000|Overall Study|Logistical difficulties|1|||
125888536|NCT01788358|452889721|FG000|Overall Study|Lost to Follow-up|5|||
125888537|NCT01788358|452889721|FG000|Overall Study|Protocol Violation|3|||
125888538|NCT01788358|452889721|FG000|Overall Study|Withdrawal by Subject|26|||
126104939|NCT00427895|453677087|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
126104940|NCT00427895|453677088|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126104941|NCT00427895|453677089|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126104942|NCT00427895|453677090|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126104943|NCT00427895|453677091|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126104944|NCT00427895|453677084|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126104945|NCT00427895|453677085|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
126104946|NCT00427895|453677086|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
126104947|NCT00427895|453677087|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
126104948|NCT00427895|453677088|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126104949|NCT00427895|453677089|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126104950|NCT00427895|453677090|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126104951|NCT00427895|453677091|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126104952|NCT00427895|453677084|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
126104953|NCT00427895|453677085|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
126396301|NCT00445939|454745903|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
126396302|NCT00445939|454745900|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
126396303|NCT00445939|454745901|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
126396304|NCT00445939|454745902|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
126396305|NCT00445939|454745903|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
126396306|NCT00798317|454745904|FG000|Overall Study|Physician Decision|0|||
126396307|NCT00798317|454745905|FG001|Overall Study|Physician Decision|1|||
126396308|NCT00798317|454745904|FG000|Overall Study|Withdrawal by Subject|5|||
126396309|NCT00798317|454745905|FG001|Overall Study|Withdrawal by Subject|4|||
126396310|NCT00798317|454745904|FG000|Overall Study|Lost to Follow-up|2|||
126396311|NCT00798317|454745905|FG001|Overall Study|Lost to Follow-up|2|||
126396312|NCT00798317|454745904|FG000|Overall Study|Adverse Event|2|||
126396313|NCT00798317|454745905|FG001|Overall Study|Adverse Event|0|||
126396314|NCT00798317|454745904|FG000|Overall Study|Death|1|||
126396315|NCT00798317|454745905|FG001|Overall Study|Death|0|||
126396316|NCT00489736|454745906|FG000|Overall Study|Lack of Efficacy|53|||
126396317|NCT00489736|454745907|FG001|Overall Study|Lack of Efficacy|14|||
126396318|NCT00489736|454745906|FG000|Overall Study|Adverse Event|32|||
126396319|NCT00489736|454745907|FG001|Overall Study|Adverse Event|45|||
126396320|NCT00489736|454745906|FG000|Overall Study|Poor compliance|6|||
126396321|NCT00489736|454745907|FG001|Overall Study|Poor compliance|2|||
126396322|NCT00489736|454745906|FG000|Overall Study|Not coded/ Not pre-specified|5|||
126396323|NCT00489736|454745907|FG001|Overall Study|Not coded/ Not pre-specified|8|||
126396324|NCT02576535|454745908|FG000|Overall Study|Withdrawal by Subject|2|||
126396325|NCT02545517|454745909|FG000|Overall Study|Death|2|||
126396326|NCT02545517|454745910|FG001|Overall Study|Death|2|||
126396327|NCT02545517|454745911|FG002|Overall Study|Death|1|||
126396328|NCT02545517|454745909|FG000|Overall Study|Lost to Follow-up|14|||
126396329|NCT02545517|454745910|FG001|Overall Study|Lost to Follow-up|13|||
126396330|NCT02545517|454745911|FG002|Overall Study|Lost to Follow-up|17|||
126396331|NCT02545517|454745909|FG000|Overall Study|Protocol Violation|0|||
126396332|NCT02545517|454745910|FG001|Overall Study|Protocol Violation|1|||
126396333|NCT02545517|454745911|FG002|Overall Study|Protocol Violation|1|||
126396334|NCT02545517|454745909|FG000|Overall Study|Withdrawal by Subject|5|||
126396335|NCT02545517|454745910|FG001|Overall Study|Withdrawal by Subject|8|||
126396336|NCT02545517|454745911|FG002|Overall Study|Withdrawal by Subject|9|||
126396337|NCT02545517|454745909|FG000|Overall Study|Administrative reason|5|||
126396338|NCT02545517|454745910|FG001|Overall Study|Administrative reason|6|||
126396339|NCT02545517|454745911|FG002|Overall Study|Administrative reason|10|||
126396340|NCT02545517|454745909|FG000|Overall Study|Other|2|||
126396341|NCT02545517|454745910|FG001|Overall Study|Other|4|||
126396342|NCT02545517|454745911|FG002|Overall Study|Other|3|||
126396343|NCT01529515|454745914|FG000|TRANSITION PHASE|Adverse Event|16|||
125888539|NCT01788358|452889721|FG000|Overall Study|Lack of Efficacy|1|||
125888540|NCT01788358|452889721|FG000|Overall Study|Adverse Event|51|||
126104954|NCT00427895|453677086|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
125888541|NCT02873702|452889722|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
126396344|NCT01529515|454745915|FG001|TRANSITION PHASE|Adverse Event|0|||
126396345|NCT01529515|454745916|FG002|TRANSITION PHASE|Adverse Event|0|||
126396346|NCT01529515|454745917|FG003|TRANSITION PHASE|Adverse Event|0|||
126396347|NCT01529515|454745914|FG000|TRANSITION PHASE|Death|1|||
126396348|NCT01529515|454745915|FG001|TRANSITION PHASE|Death|0|||
126396349|NCT01529515|454745916|FG002|TRANSITION PHASE|Death|0|||
126396350|NCT01529515|454745917|FG003|TRANSITION PHASE|Death|0|||
126396351|NCT01529515|454745914|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
126396352|NCT01529515|454745915|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
126396353|NCT01529515|454745916|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
126396354|NCT01529515|454745917|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
126396355|NCT01529515|454745914|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
126396356|NCT01529515|454745915|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
126396357|NCT01529515|454745916|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
126396358|NCT01529515|454745917|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
126396359|NCT01529515|454745914|FG000|TRANSITION PHASE|Protocol Violation|4|||
126396360|NCT01529515|454745915|FG001|TRANSITION PHASE|Protocol Violation|0|||
126396361|NCT01529515|454745916|FG002|TRANSITION PHASE|Protocol Violation|0|||
126396362|NCT01529515|454745917|FG003|TRANSITION PHASE|Protocol Violation|0|||
126396363|NCT01529515|454745914|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
126396364|NCT01529515|454745915|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
126396365|NCT01529515|454745916|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
126396366|NCT01529515|454745917|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
126396367|NCT01529515|454745914|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
126396368|NCT01529515|454745915|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
126396369|NCT01529515|454745916|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
126396370|NCT01529515|454745917|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
126396371|NCT01529515|454745914|FG000|TRANSITION PHASE|Other|9|||
126396372|NCT01529515|454745915|FG001|TRANSITION PHASE|Other|0|||
126396373|NCT01529515|454745916|FG002|TRANSITION PHASE|Other|0|||
126396374|NCT01529515|454745917|FG003|TRANSITION PHASE|Other|0|||
126396375|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Adverse Event|0|||
126396376|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Adverse Event|10|||
126396377|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Adverse Event|0|||
126396378|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Adverse Event|0|||
126396379|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
126396380|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
126396381|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
126396382|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
126396383|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
126396384|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
126396385|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
126396386|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
126396387|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
126396388|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
126051497|NCT02063659|453483978|FG001|Double-Blind Treatment Period|Physician Decision|0|||
126051498|NCT02063659|453483979|FG002|Double-Blind Treatment Period|Physician Decision|0|||
126051499|NCT02063659|453483980|FG003|Double-Blind Treatment Period|Physician Decision|0|||
126051500|NCT02063659|453483977|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
126051501|NCT02063659|453483978|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
126051502|NCT02063659|453483979|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
126051503|NCT02063659|453483980|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
126051504|NCT02063659|453483977|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
126051505|NCT02063659|453483978|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
126051506|NCT02063659|453483979|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
126051507|NCT02063659|453483980|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
126051508|NCT02063659|453483977|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126051509|NCT02063659|453483978|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126051510|NCT02063659|453483979|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126051511|NCT02063659|453483980|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
126051512|NCT02063659|453483977|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126051513|NCT02063659|453483978|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126051514|NCT02063659|453483979|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126051515|NCT02063659|453483980|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
126051516|NCT02063659|453483977|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
126051517|NCT02063659|453483978|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
126051518|NCT02063659|453483979|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
126051519|NCT02063659|453483980|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
126051520|NCT02063659|453483977|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126051521|NCT02063659|453483978|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126051522|NCT02063659|453483979|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126051523|NCT02063659|453483980|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
126051524|NCT02972359|453483981|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
126396389|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
126396390|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
126396391|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
126396392|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
126396393|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
126396394|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
126396395|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
126396396|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
126396397|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
126396398|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
126396399|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Other|0|||
126396400|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Other|10|||
126396401|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Other|0|||
126396402|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Other|0|||
126396403|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
126396404|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
126396405|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
126396406|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
126396407|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
126396408|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
126396409|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
126396410|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
126396411|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
126396412|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
126396413|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
126396414|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
126396415|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
126396416|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
126396417|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
126396418|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
126396419|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
125888542|NCT02873702|452889723|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
125888543|NCT02873702|452889724|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
125888544|NCT02873702|452889725|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
125888545|NCT02873702|452889722|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125888546|NCT02873702|452889723|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
125888547|NCT02873702|452889724|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125888548|NCT02873702|452889725|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125888549|NCT02873702|452889722|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
125888550|NCT02873702|452889723|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
125888551|NCT02873702|452889724|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
125888552|NCT02873702|452889725|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
125888553|NCT02873702|452889722|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
126051525|NCT02972359|453483981|FG000|Overall Study|Lack of Efficacy|1|||
126051526|NCT02972359|453483981|FG000|Overall Study|Adverse Event|4|||
126051527|NCT02972359|453483981|FG000|Overall Study|Death|1|||
126051528|NCT02972359|453483981|FG000|Overall Study|Withdrawal by Subject|30|||
126051529|NCT02972359|453483981|FG000|Overall Study|Protocol Violation|1|||
126051530|NCT02972359|453483981|FG000|Overall Study|Lost to Follow-up|26|||
126051531|NCT02972359|453483981|FG000|Overall Study|Other reasons|5|||
126051532|NCT02972359|453483981|FG000|Overall Study|Missing|1|||
126051533|NCT01532999|453483982|FG000|Overall Study|Lost to Follow-up|14|||
126051534|NCT01532999|453483983|FG001|Overall Study|Lost to Follow-up|8|||
126051535|NCT01532999|453483982|FG000|Overall Study|Physician Decision|1|||
126051536|NCT01532999|453483983|FG001|Overall Study|Physician Decision|2|||
126051537|NCT01532999|453483982|FG000|Overall Study|Withdrawal by Subject|5|||
126051538|NCT01532999|453483983|FG001|Overall Study|Withdrawal by Subject|0|||
126051539|NCT01532999|453483982|FG000|Overall Study|Relocated|2|||
126051540|NCT01532999|453483983|FG001|Overall Study|Relocated|0|||
126051541|NCT01532999|453483982|FG000|Overall Study|should not have been randomized|1|||
126051542|NCT01532999|453483983|FG001|Overall Study|should not have been randomized|0|||
126051543|NCT01532999|453483982|FG000|Overall Study|substantial noncompliance|2|||
126051544|NCT01532999|453483983|FG001|Overall Study|substantial noncompliance|0|||
126051545|NCT01532999|453483982|FG000|Overall Study|no show for week 9 assessments|6|||
126051546|NCT01532999|453483983|FG001|Overall Study|no show for week 9 assessments|4|||
126051547|NCT01532999|453483982|FG000|Overall Study|Adverse Event|0|||
126051548|NCT01532999|453483983|FG001|Overall Study|Adverse Event|1|||
126051549|NCT01532999|453483982|FG000|Overall Study|incarcerated|0|||
126051550|NCT01532999|453483983|FG001|Overall Study|incarcerated|1|||
126396420|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
126396421|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
126396422|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
126396423|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Other|0|||
126396424|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Other|0|||
126396425|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Other|9|||
126396426|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Other|2|||
125888554|NCT02873702|452889723|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
125888555|NCT02873702|452889724|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
126051551|NCT01532999|453483982|FG000|Overall Study|New job|0|||
126396427|NCT03920293|454745919|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
126396428|NCT03920293|454745920|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
126051552|NCT01532999|453483983|FG001|Overall Study|New job|2|||
126051553|NCT00914966|453483984|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
126051554|NCT00914966|453483984|FG000|Step 1: 1500 Units|Physician Decision|1|||
126051555|NCT00914966|453483984|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
126051556|NCT03598907|453483991|FG000|Overall Study|Physician Decision|14|||
126051557|NCT03598907|453483992|FG001|Overall Study|Physician Decision|19|||
126051558|NCT05251363|453483993|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
126051559|NCT05251363|453483993|FG000|Overall Study After Implant Period|Death|9|||
126051560|NCT05251363|453483993|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
126051561|NCT05251363|453483993|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
126051562|NCT05251363|453483993|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
126051563|NCT05251363|453483993|FG000|Overall Study After Implant Period|Physician Decision|1|||
126051564|NCT05251363|453483993|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
126051565|NCT03835754|453483996|FG000|Overall Study|Death|4|||
126051566|NCT02830204|453483997|FG000|Overall Study|Death|9|||
126051567|NCT02830204|453483997|FG000|Overall Study|Withdrawal by Subject|1|||
125888556|NCT02873702|452889725|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
126051568|NCT01690624|453484000|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
126051569|NCT01690624|453484001|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
126051570|NCT01690624|453484002|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
126051571|NCT01690624|453484003|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
126051572|NCT01690624|453484000|FG000|Overall Study|Adverse event (other than DLT)|3|||
126051573|NCT01690624|453484001|FG001|Overall Study|Adverse event (other than DLT)|1|||
126051574|NCT01690624|453484002|FG002|Overall Study|Adverse event (other than DLT)|1|||
126051575|NCT01690624|453484003|FG003|Overall Study|Adverse event (other than DLT)|1|||
126051576|NCT01690624|453484000|FG000|Overall Study|Withdrawal by Subject|0|||
126051577|NCT01690624|453484001|FG001|Overall Study|Withdrawal by Subject|0|||
126051578|NCT01690624|453484002|FG002|Overall Study|Withdrawal by Subject|1|||
126051579|NCT01690624|453484003|FG003|Overall Study|Withdrawal by Subject|0|||
126051580|NCT01690624|453484000|FG000|Overall Study|Sponsor is ending trial|0|||
126051581|NCT01690624|453484001|FG001|Overall Study|Sponsor is ending trial|0|||
126051582|NCT01690624|453484002|FG002|Overall Study|Sponsor is ending trial|0|||
126051583|NCT01690624|453484003|FG003|Overall Study|Sponsor is ending trial|1|||
126051584|NCT01690624|453484000|FG000|Overall Study|Physician Decision|0|||
126051585|NCT01690624|453484001|FG001|Overall Study|Physician Decision|0|||
126051586|NCT01690624|453484002|FG002|Overall Study|Physician Decision|0|||
126051587|NCT01690624|453484003|FG003|Overall Study|Physician Decision|1|||
126051588|NCT01690624|453484000|FG000|Overall Study|Withdrawal by Subject|0|||
126051589|NCT01690624|453484001|FG001|Overall Study|Withdrawal by Subject|1|||
126051590|NCT01690624|453484002|FG002|Overall Study|Withdrawal by Subject|0|||
126051591|NCT01690624|453484003|FG003|Overall Study|Withdrawal by Subject|0|||
126051592|NCT01690624|453484000|FG000|Overall Study|Lack of Efficacy|1|||
126051593|NCT01690624|453484001|FG001|Overall Study|Lack of Efficacy|1|||
126051594|NCT01690624|453484002|FG002|Overall Study|Lack of Efficacy|3|||
126396429|NCT03920293|454745919|FG000|Randomized-Controlled Period|Physician Decision|1|||
126396430|NCT03920293|454745920|FG001|Randomized-Controlled Period|Physician Decision|2|||
126396431|NCT03920293|454745919|FG000|Randomized-Controlled Period|Adverse Event|0|||
126396432|NCT03920293|454745920|FG001|Randomized-Controlled Period|Adverse Event|2|||
126396433|NCT03920293|454745919|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
126396434|NCT03920293|454745920|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
126396435|NCT03920293|454745919|FG000|Randomized-Controlled Period|Death|2|||
126396436|NCT03920293|454745920|FG001|Randomized-Controlled Period|Death|0|||
126396437|NCT03920293|454745919|FG000|Randomized-Controlled Period|Protocol Violation|1|||
126396438|NCT03920293|454745920|FG001|Randomized-Controlled Period|Protocol Violation|0|||
126396439|NCT03920293|454745919|FG000|Randomized-Controlled Period|Noncompliance|1|||
126396440|NCT03920293|454745920|FG001|Randomized-Controlled Period|Noncompliance|0|||
126396441|NCT03920293|454745919|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
126396442|NCT03920293|454745920|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
126396443|NCT03920293|454745919|FG000|Open- Label Extension Period|Death|3|||
126396444|NCT03920293|454745920|FG001|Open- Label Extension Period|Death|3|||
126396445|NCT03920293|454745919|FG000|Open- Label Extension Period|Physician Decision|5|||
126396446|NCT03920293|454745920|FG001|Open- Label Extension Period|Physician Decision|3|||
126396447|NCT03920293|454745919|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
126396448|NCT03920293|454745920|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
126396449|NCT01069861|454745921|FG000|Overall Study|Death|1|||
126396450|NCT01069861|454745921|FG000|Overall Study|Adverse Event|1|||
126396451|NCT01069861|454745921|FG000|Overall Study|Did not meet entrance criteria|1|||
126396452|NCT03272828|454745923|FG000|Overall Study|Lost to Follow-up|7|||
126396453|NCT03272828|454745924|FG001|Overall Study|Lost to Follow-up|7|||
126396454|NCT03272828|454745923|FG000|Overall Study|Withdrawal by Subject|2|||
126396455|NCT03272828|454745924|FG001|Overall Study|Withdrawal by Subject|0|||
126396456|NCT03272828|454745923|FG000|Overall Study|Deceased|1|||
126051595|NCT01690624|453484003|FG003|Overall Study|Lack of Efficacy|0|||
126051596|NCT04686266|453484005|FG000|Overall Study|Withdrawal by Subject|0|||
126051597|NCT04686266|453484006|FG001|Overall Study|Withdrawal by Subject|1|||
126051598|NCT04306367|453484011|FG000|Overall Study|Progression of Disease|9|||
126051599|NCT04306367|453484011|FG000|Overall Study|Adverse Event|3|||
126051600|NCT04306367|453484011|FG000|Overall Study|Withdrawal by Subject|1|||
126051601|NCT02401815|453484012|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051602|NCT02401815|453484013|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051603|NCT02401815|453484014|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051604|NCT02401815|453484015|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
126051605|NCT02401815|453484016|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051606|NCT02401815|453484017|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051607|NCT02401815|453484018|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051608|NCT02401815|453484019|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051609|NCT02401815|453484020|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051610|NCT02401815|453484021|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126051611|NCT02401815|453484012|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
126051612|NCT02401815|453484013|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126051613|NCT02401815|453484014|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126051614|NCT02401815|453484015|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
126051615|NCT02401815|453484016|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126051616|NCT02401815|453484017|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126051617|NCT02401815|453484018|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126051618|NCT02401815|453484019|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126051619|NCT02401815|453484020|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126051620|NCT02401815|453484021|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126051621|NCT02401815|453484012|FG000|Dose Escalation (up to 670 Days)|Death|1|||
126051622|NCT02401815|453484013|FG001|Dose Escalation (up to 670 Days)|Death|2|||
126051623|NCT02401815|453484014|FG002|Dose Escalation (up to 670 Days)|Death|3|||
126104955|NCT00427895|453677087|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
126104956|NCT00427895|453677088|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126104957|NCT00427895|453677089|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126104958|NCT00427895|453677090|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126104959|NCT00427895|453677091|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126104960|NCT00427895|453677084|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
126104961|NCT00427895|453677085|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
126104962|NCT00427895|453677086|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
126104963|NCT00427895|453677087|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
126104964|NCT00427895|453677088|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
126104965|NCT00427895|453677089|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
126104966|NCT00427895|453677090|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
126104967|NCT00427895|453677091|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
126104968|NCT00427895|453677084|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126104969|NCT00427895|453677085|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
126104970|NCT00427895|453677086|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126104971|NCT00427895|453677087|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126104972|NCT00427895|453677088|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126104973|NCT00427895|453677089|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126104974|NCT00427895|453677090|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126104975|NCT00427895|453677091|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
125888557|NCT02873702|452889722|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
125888558|NCT02873702|452889723|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
126051624|NCT02401815|453484015|FG003|Dose Escalation (up to 670 Days)|Death|5|||
126051625|NCT02401815|453484016|FG004|Dose Escalation (up to 670 Days)|Death|4|||
126051626|NCT02401815|453484017|FG005|Dose Escalation (up to 670 Days)|Death|0|||
126051627|NCT02401815|453484018|FG006|Dose Escalation (up to 670 Days)|Death|0|||
126051628|NCT02401815|453484019|FG007|Dose Escalation (up to 670 Days)|Death|0|||
126051629|NCT02401815|453484020|FG008|Dose Escalation (up to 670 Days)|Death|0|||
126051630|NCT02401815|453484021|FG009|Dose Escalation (up to 670 Days)|Death|0|||
126051631|NCT02401815|453484012|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126051632|NCT02401815|453484013|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
126051633|NCT02401815|453484014|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126051634|NCT02401815|453484015|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126051635|NCT02401815|453484016|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
126051636|NCT02401815|453484017|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126051637|NCT02401815|453484018|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126051638|NCT02401815|453484019|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126051639|NCT02401815|453484020|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126051640|NCT02401815|453484021|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126051641|NCT02401815|453484012|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
126051642|NCT02401815|453484013|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126051643|NCT02401815|453484014|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126051644|NCT02401815|453484015|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126051645|NCT02401815|453484016|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
126051646|NCT02401815|453484017|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126051647|NCT02401815|453484018|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126051648|NCT02401815|453484019|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126051649|NCT02401815|453484020|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126051650|NCT02401815|453484021|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126051651|NCT02401815|453484012|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051652|NCT02401815|453484013|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051653|NCT02401815|453484014|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051654|NCT02401815|453484015|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051655|NCT02401815|453484016|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051656|NCT02401815|453484017|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
126051657|NCT02401815|453484018|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051658|NCT02401815|453484019|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051659|NCT02401815|453484020|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051660|NCT02401815|453484021|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126051661|NCT02401815|453484012|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051662|NCT02401815|453484013|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126104976|NCT00427895|453677084|FG000|Vax 1/Year 1 Follow-up|Death|1|||
126104977|NCT00427895|453677085|FG001|Vax 1/Year 1 Follow-up|Death|0|||
126104978|NCT00427895|453677086|FG002|Vax 1/Year 1 Follow-up|Death|0|||
126104979|NCT00427895|453677087|FG003|Vax 1/Year 1 Follow-up|Death|0|||
126104980|NCT00427895|453677088|FG004|Vax 1/Year 1 Follow-up|Death|0|||
126051663|NCT02401815|453484014|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051664|NCT02401815|453484015|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051665|NCT02401815|453484016|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051666|NCT02401815|453484017|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051667|NCT02401815|453484018|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
126051668|NCT02401815|453484019|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126104981|NCT00427895|453677089|FG005|Vax 1/Year 1 Follow-up|Death|0|||
126104982|NCT00427895|453677090|FG006|Vax 1/Year 1 Follow-up|Death|0|||
126104983|NCT00427895|453677091|FG007|Vax 1/Year 1 Follow-up|Death|0|||
126104984|NCT00427895|453677084|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126104985|NCT00427895|453677085|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126104986|NCT00427895|453677086|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
126104987|NCT00427895|453677087|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
126104988|NCT00427895|453677088|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126104989|NCT00427895|453677089|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126104990|NCT00427895|453677090|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126104991|NCT00427895|453677091|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126104992|NCT00427895|453677084|FG000|Vax 1/Year 1 Follow-up|Other|0|||
126104993|NCT00427895|453677085|FG001|Vax 1/Year 1 Follow-up|Other|0|||
126104994|NCT00427895|453677086|FG002|Vax 1/Year 1 Follow-up|Other|0|||
126104995|NCT00427895|453677087|FG003|Vax 1/Year 1 Follow-up|Other|2|||
126104996|NCT00427895|453677088|FG004|Vax 1/Year 1 Follow-up|Other|0|||
126104997|NCT00427895|453677089|FG005|Vax 1/Year 1 Follow-up|Other|0|||
126104998|NCT00427895|453677090|FG006|Vax 1/Year 1 Follow-up|Other|0|||
126104999|NCT00427895|453677091|FG007|Vax 1/Year 1 Follow-up|Other|0|||
126105000|NCT00427895|453677084|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
126105001|NCT00427895|453677085|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
126105002|NCT00427895|453677086|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
126105003|NCT00427895|453677087|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
126105004|NCT00427895|453677088|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
126105005|NCT00427895|453677089|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
126105006|NCT00427895|453677090|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
126105007|NCT00427895|453677091|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
126105008|NCT02533570|453677092|FG000|Overall Study|Adverse Event|0|||
126105009|NCT02533570|453677093|FG001|Overall Study|Adverse Event|1|||
126105010|NCT02533570|453677094|FG002|Overall Study|Adverse Event|1|||
126105011|NCT02881957|453677103|FG000|Overall Study|Comfort care|0|||
126105012|NCT02881957|453677104|FG001|Overall Study|Comfort care|1|||
126105013|NCT02881957|453677103|FG000|Overall Study|Concurrent trial enrollment|0|||
126105014|NCT02881957|453677104|FG001|Overall Study|Concurrent trial enrollment|1|||
126105015|NCT02881957|453677103|FG000|Overall Study|Discharged within 48 hours|0|||
126105016|NCT02881957|453677104|FG001|Overall Study|Discharged within 48 hours|1|||
126105017|NCT02881957|453677103|FG000|Overall Study|Withdrawal by Subject|2|||
126105018|NCT02881957|453677104|FG001|Overall Study|Withdrawal by Subject|1|||
126105019|NCT02881957|453677103|FG000|Overall Study|Protocol Violation|1|||
126105020|NCT02881957|453677104|FG001|Overall Study|Protocol Violation|0|||
126105021|NCT00081497|453677105|FG000|Overall Study|Adverse Event|2|||
126105022|NCT00081497|453677106|FG001|Overall Study|Adverse Event|0|||
126105023|NCT00081497|453677105|FG000|Overall Study|Death|0|||
126105024|NCT00081497|453677106|FG001|Overall Study|Death|1|||
126105025|NCT00081497|453677105|FG000|Overall Study|Withdrawal by Subject|1|||
126105026|NCT00081497|453677106|FG001|Overall Study|Withdrawal by Subject|0|||
126105027|NCT00081497|453677105|FG000|Overall Study|Non-compliance|0|||
126105028|NCT00081497|453677106|FG001|Overall Study|Non-compliance|1|||
126105029|NCT00345293|453677107|FG000|Overall Study|Unable to access line for sample|1|||
126105030|NCT00345293|453677108|FG001|Overall Study|Unable to access line for sample|0|||
126105031|NCT00345293|453677107|FG000|Overall Study|Withdrawal by Subject|1|||
126105032|NCT00345293|453677108|FG001|Overall Study|Withdrawal by Subject|0|||
126105033|NCT01328717|453678527|FG000|Overall Study|Adverse Event|1|||
126105034|NCT03440320|453678528|FG000|Overall Study|Withdrawal by Subject|0|||
126396457|NCT03272828|454745924|FG001|Overall Study|Deceased|1|||
126396458|NCT03272828|454745923|FG000|Overall Study|Failed implant|1|||
126396459|NCT03272828|454745924|FG001|Overall Study|Failed implant|2|||
126396460|NCT00996281|454745926|FG000|Overall Study|Adverse Event|75|||
126396461|NCT00996281|454745927|FG001|Overall Study|Adverse Event|37|||
126105035|NCT03440320|453678529|FG001|Overall Study|Withdrawal by Subject|1|||
126105036|NCT01786174|453678532|FG000|Overall Study|Discontinued Study Drug|2|||
126105037|NCT01786174|453678533|FG001|Overall Study|Discontinued Study Drug|0|||
126105038|NCT01009203|453678542|FG000|Overall Study|Withdrawal by Subject|1|||
126105039|NCT01009203|453678542|FG000|Overall Study|Adverse Event|5|||
126105040|NCT01009203|453678542|FG000|Overall Study|Treatment-unrelated death|1|||
126396462|NCT00996281|454745926|FG000|Overall Study|Major Protocol Deviation|6|||
126396463|NCT00996281|454745927|FG001|Overall Study|Major Protocol Deviation|7|||
126051669|NCT02401815|453484020|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126396464|NCT00996281|454745926|FG000|Overall Study|Lost to Follow-up|14|||
126396465|NCT00996281|454745927|FG001|Overall Study|Lost to Follow-up|16|||
126396466|NCT00996281|454745926|FG000|Overall Study|Withdrawal by Subject|31|||
126396467|NCT00996281|454745927|FG001|Overall Study|Withdrawal by Subject|20|||
126396468|NCT00996281|454745926|FG000|Overall Study|Lack of Efficacy|0|||
126396469|NCT00996281|454745927|FG001|Overall Study|Lack of Efficacy|2|||
126396470|NCT00996281|454745926|FG000|Overall Study|Other|5|||
126396471|NCT00996281|454745927|FG001|Overall Study|Other|7|||
126396472|NCT01920568|454745930|FG000|Overall Study|Adverse Event|27|||
126396473|NCT01920568|454745931|FG001|Overall Study|Adverse Event|8|||
126396474|NCT01920568|454745930|FG000|Overall Study|Protocol Violation|5|||
126051670|NCT02401815|453484021|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051671|NCT02401815|453484012|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126051672|NCT02401815|453484013|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126051673|NCT02401815|453484014|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126051674|NCT02401815|453484015|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126051675|NCT02401815|453484016|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126051676|NCT02401815|453484017|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
126051677|NCT02401815|453484018|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
126051678|NCT02401815|453484019|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126051679|NCT02401815|453484020|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126051680|NCT02401815|453484021|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126051681|NCT02401815|453484012|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051682|NCT02401815|453484013|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051683|NCT02401815|453484014|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051684|NCT02401815|453484015|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051685|NCT02401815|453484016|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051686|NCT02401815|453484017|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
126051687|NCT02401815|453484018|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051688|NCT02401815|453484019|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051689|NCT02401815|453484020|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051690|NCT02401815|453484021|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126051691|NCT02401815|453484012|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126051692|NCT02401815|453484013|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126051693|NCT02401815|453484014|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126051694|NCT02401815|453484015|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126051695|NCT02401815|453484016|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126051696|NCT02401815|453484017|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126051697|NCT02401815|453484018|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126051698|NCT02401815|453484019|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
126051699|NCT02401815|453484020|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
126051700|NCT02401815|453484021|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
126051701|NCT02401815|453484012|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051702|NCT02401815|453484013|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051703|NCT02401815|453484014|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051704|NCT02401815|453484015|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051705|NCT02401815|453484016|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051706|NCT02401815|453484017|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051707|NCT02401815|453484018|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051708|NCT02401815|453484019|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126051709|NCT02401815|453484020|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
126051710|NCT02401815|453484021|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
126051711|NCT02401815|453484012|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126051712|NCT02401815|453484013|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126051713|NCT02401815|453484014|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126051714|NCT02401815|453484015|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126051715|NCT02401815|453484016|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126051716|NCT02401815|453484017|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126051717|NCT02401815|453484018|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126105041|NCT00892723|453678543|FG000|Overall Study|Lost to Follow-up|1|||
126105042|NCT00892723|453678544|FG001|Overall Study|Lost to Follow-up|3|||
126396475|NCT01920568|454745931|FG001|Overall Study|Protocol Violation|3|||
126396476|NCT01920568|454745930|FG000|Overall Study|Lost to Follow-up|2|||
126396477|NCT01920568|454745931|FG001|Overall Study|Lost to Follow-up|2|||
126396478|NCT01920568|454745930|FG000|Overall Study|Physician Decision|13|||
125888559|NCT02873702|452889724|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
125888560|NCT02873702|452889725|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
126105043|NCT00892723|453678545|FG002|Overall Study|Lost to Follow-up|1|||
126105044|NCT00892723|453678543|FG000|Overall Study|Withdrawal by Subject|1|||
126105045|NCT00892723|453678544|FG001|Overall Study|Withdrawal by Subject|1|||
126105046|NCT00892723|453678545|FG002|Overall Study|Withdrawal by Subject|1|||
126105047|NCT01007448|453678547|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
126105048|NCT01007448|453678548|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
126396479|NCT01920568|454745931|FG001|Overall Study|Physician Decision|4|||
126396480|NCT01920568|454745930|FG000|Overall Study|Withdrawal by Subject|79|||
126396481|NCT01920568|454745931|FG001|Overall Study|Withdrawal by Subject|55|||
126105049|NCT01007448|453678547|FG000|Overall Study|Staph Skin Infection Flare|1|||
126105050|NCT01007448|453678548|FG001|Overall Study|Staph Skin Infection Flare|0|||
126105051|NCT01007448|453678547|FG000|Overall Study|Participant Leaving the Country|1|||
126105052|NCT01007448|453678548|FG001|Overall Study|Participant Leaving the Country|0|||
126105053|NCT01007448|453678547|FG000|Overall Study|Participant Given Prohibited Medication|1|||
126105054|NCT01007448|453678548|FG001|Overall Study|Participant Given Prohibited Medication|0|||
126105055|NCT01007448|453678547|FG000|Overall Study|Progressive Disease|1|||
126105056|NCT01007448|453678548|FG001|Overall Study|Progressive Disease|2|||
126105057|NCT01007448|453678547|FG000|Overall Study|Lack of Efficacy|2|||
126105058|NCT01007448|453678548|FG001|Overall Study|Lack of Efficacy|0|||
126105059|NCT01007448|453678547|FG000|Overall Study|Withdrawal by Subject|2|||
126105060|NCT01007448|453678548|FG001|Overall Study|Withdrawal by Subject|3|||
126105061|NCT01007448|453678547|FG000|Overall Study|Adverse Event|1|||
126105062|NCT01007448|453678548|FG001|Overall Study|Adverse Event|4|||
126105063|NCT01337115|453678549|FG000|Overall Study|Protocol Violation|2|||
126105064|NCT01337115|453678550|FG001|Overall Study|Protocol Violation|0|||
126105065|NCT00448123|453678551|FG000|Overall Study|Lost to Follow-up|9|||
126105066|NCT00448123|453678552|FG001|Overall Study|Lost to Follow-up|6|||
126105067|NCT00448123|453678551|FG000|Overall Study|Physician Decision|6|||
126105068|NCT00448123|453678552|FG001|Overall Study|Physician Decision|6|||
126105069|NCT02027623|453678554|FG000|Overall Study|Lost to Follow-up|3|||
126105070|NCT02027623|453678555|FG001|Overall Study|Lost to Follow-up|3|||
126105071|NCT02027623|453678554|FG000|Overall Study|Withdrawal by Subject|6|||
126105072|NCT02027623|453678555|FG001|Overall Study|Withdrawal by Subject|9|||
126105073|NCT00406653|453678559|FG000|Induction Period|Adverse Event|1|||
126105074|NCT00406653|453678560|FG001|Induction Period|Adverse Event|10|||
126105075|NCT00406653|453678561|FG002|Induction Period|Adverse Event|4|||
126105076|NCT00406653|453678562|FG003|Induction Period|Adverse Event|11|||
126105077|NCT00406653|453678563|FG004|Induction Period|Adverse Event|0|||
126105078|NCT00406653|453678564|FG005|Induction Period|Adverse Event|0|||
126105079|NCT00406653|453678565|FG006|Induction Period|Adverse Event|0|||
126105080|NCT00406653|453678559|FG000|Induction Period|Lack of Efficacy|11|||
126105081|NCT00406653|453678560|FG001|Induction Period|Lack of Efficacy|14|||
126105082|NCT00406653|453678561|FG002|Induction Period|Lack of Efficacy|8|||
126105083|NCT00406653|453678562|FG003|Induction Period|Lack of Efficacy|10|||
126105084|NCT00406653|453678563|FG004|Induction Period|Lack of Efficacy|0|||
126105085|NCT00406653|453678564|FG005|Induction Period|Lack of Efficacy|0|||
126396482|NCT01920568|454745930|FG000|Overall Study|Death due to disease progression|25|||
126396483|NCT01920568|454745931|FG001|Overall Study|Death due to disease progression|12|||
126396484|NCT02891681|454745935|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
126396485|NCT02891681|454745936|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
126396486|NCT02891681|454745937|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
126105086|NCT00406653|453678565|FG006|Induction Period|Lack of Efficacy|0|||
126105087|NCT00406653|453678559|FG000|Induction Period|Lost to Follow-up|0|||
126105088|NCT00406653|453678560|FG001|Induction Period|Lost to Follow-up|2|||
126105089|NCT00406653|453678561|FG002|Induction Period|Lost to Follow-up|0|||
126105090|NCT00406653|453678562|FG003|Induction Period|Lost to Follow-up|0|||
126105091|NCT00406653|453678563|FG004|Induction Period|Lost to Follow-up|0|||
126105092|NCT00406653|453678564|FG005|Induction Period|Lost to Follow-up|0|||
126105093|NCT00406653|453678565|FG006|Induction Period|Lost to Follow-up|0|||
126105094|NCT00406653|453678559|FG000|Induction Period|Withdrawal of Consent|2|||
126396487|NCT02891681|454745935|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
126396488|NCT02891681|454745936|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
126396489|NCT02891681|454745937|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
126396490|NCT02891681|454745935|FG000|Overall Study|Taken off study after first imaging appointment|1|||
126396491|NCT02891681|454745936|FG001|Overall Study|Taken off study after first imaging appointment|0|||
126396492|NCT02891681|454745937|FG002|Overall Study|Taken off study after first imaging appointment|0|||
126396493|NCT03664674|454745940|FG000|Overall Study|Adverse Event|1|||
126396494|NCT03664674|454745941|FG001|Overall Study|Adverse Event|1|||
126396495|NCT03664674|454745940|FG000|Overall Study|Physician Decision|0|||
126396496|NCT03664674|454745941|FG001|Overall Study|Physician Decision|1|||
126051718|NCT02401815|453484019|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126051719|NCT02401815|453484020|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126051720|NCT02401815|453484021|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
126051721|NCT02401815|453484012|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051722|NCT02401815|453484013|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051723|NCT02401815|453484014|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051724|NCT02401815|453484015|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051725|NCT02401815|453484016|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051726|NCT02401815|453484017|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051727|NCT02401815|453484018|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051728|NCT02401815|453484019|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051729|NCT02401815|453484020|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
126051730|NCT02401815|453484021|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126051731|NCT02401815|453484012|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126051732|NCT02401815|453484013|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126051733|NCT02401815|453484014|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126051734|NCT02401815|453484015|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126051735|NCT02401815|453484016|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126051736|NCT02401815|453484017|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126051737|NCT02401815|453484018|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126051738|NCT02401815|453484019|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
126051739|NCT02401815|453484020|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126051740|NCT02401815|453484021|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
126051741|NCT03773107|453484035|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
126051742|NCT03773107|453484036|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
126051743|NCT03773107|453484037|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
126051744|NCT03773107|453484038|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
126051745|NCT01563185|453484041|FG000|Overall Study|Withdrawal by Subject|1|||
126051746|NCT01563185|453484041|FG000|Overall Study|Non-Compliance with study drug|1|||
126051747|NCT05864209|453485870|FG000|Overall Study|Lost to Follow-up|2|||
126051748|NCT05864209|453485871|FG001|Overall Study|Lost to Follow-up|3|||
126051749|NCT00092534|453485874|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
126051750|NCT00092534|453485875|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
126051751|NCT00092534|453485876|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126051752|NCT00092534|453485877|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126051753|NCT00092534|453485878|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126051754|NCT00092534|453485874|FG000|Base Study Vaccination Period|Adverse Event|3|||
126051755|NCT00092534|453485875|FG001|Base Study Vaccination Period|Adverse Event|1|||
126051756|NCT00092534|453485876|FG002|Base Study Vaccination Period|Adverse Event|0|||
126051757|NCT00092534|453485877|FG003|Base Study Vaccination Period|Adverse Event|0|||
126051758|NCT00092534|453485878|FG004|Base Study Vaccination Period|Adverse Event|0|||
126051759|NCT00092534|453485874|FG000|Base Study Vaccination Period|Death|5|||
126051760|NCT00092534|453485875|FG001|Base Study Vaccination Period|Death|4|||
126051761|NCT00092534|453485876|FG002|Base Study Vaccination Period|Death|0|||
126051762|NCT00092534|453485877|FG003|Base Study Vaccination Period|Death|0|||
126051763|NCT00092534|453485878|FG004|Base Study Vaccination Period|Death|0|||
126051764|NCT00092534|453485874|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
126051765|NCT00092534|453485875|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
126051766|NCT00092534|453485876|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
126051767|NCT00092534|453485877|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
126105095|NCT00406653|453678560|FG001|Induction Period|Withdrawal of Consent|5|||
126105096|NCT00406653|453678561|FG002|Induction Period|Withdrawal of Consent|1|||
126105097|NCT00406653|453678562|FG003|Induction Period|Withdrawal of Consent|2|||
126105098|NCT00406653|453678563|FG004|Induction Period|Withdrawal of Consent|0|||
126105099|NCT00406653|453678564|FG005|Induction Period|Withdrawal of Consent|0|||
126105100|NCT00406653|453678565|FG006|Induction Period|Withdrawal of Consent|0|||
126105101|NCT00406653|453678559|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
126105102|NCT00406653|453678560|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
126105103|NCT00406653|453678561|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
126105104|NCT00406653|453678562|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
126105105|NCT00406653|453678563|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
126105106|NCT00406653|453678564|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
126105107|NCT00406653|453678565|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
126105108|NCT00406653|453678559|FG000|Induction Period|Pregnancy|1|||
126105109|NCT00406653|453678560|FG001|Induction Period|Pregnancy|0|||
126105110|NCT00406653|453678561|FG002|Induction Period|Pregnancy|0|||
126105111|NCT00406653|453678562|FG003|Induction Period|Pregnancy|0|||
126105112|NCT00406653|453678563|FG004|Induction Period|Pregnancy|0|||
126105113|NCT00406653|453678564|FG005|Induction Period|Pregnancy|0|||
126105114|NCT00406653|453678565|FG006|Induction Period|Pregnancy|0|||
126396497|NCT03664674|454745940|FG000|Overall Study|Withdrawal by Subject|2|||
126396498|NCT03664674|454745941|FG001|Overall Study|Withdrawal by Subject|0|||
126396499|NCT02174523|454745942|FG000|Overall Study|Withdrawal by Subject|1|||
126396500|NCT02174523|454745943|FG001|Overall Study|Withdrawal by Subject|0|||
126396501|NCT00794365|454745944|FG000|Overall Study|Lost to Follow-up|38|||
126396502|NCT00794365|454745944|FG000|Overall Study|Other|17|||
126396503|NCT00794365|454745944|FG000|Overall Study|Poor Compliance|11|||
126396504|NCT00794365|454745944|FG000|Overall Study|Adverse Event|10|||
126396505|NCT00794365|454745944|FG000|Overall Study|Lack of Efficacy|3|||
126396506|NCT00856206|454745945|FG000|Overall Study|Protocol Violation|6|||
126396507|NCT00856206|454745946|FG001|Overall Study|Protocol Violation|18|||
126396508|NCT00856206|454745945|FG000|Overall Study|Adverse Event|10|||
126396509|NCT00856206|454745946|FG001|Overall Study|Adverse Event|46|||
126396510|NCT00856206|454745945|FG000|Overall Study|Lack of Efficacy|1|||
126396511|NCT00856206|454745946|FG001|Overall Study|Lack of Efficacy|2|||
126396512|NCT00856206|454745945|FG000|Overall Study|Withdrawal by Subject|15|||
126396513|NCT00856206|454745946|FG001|Overall Study|Withdrawal by Subject|36|||
126396514|NCT00856206|454745945|FG000|Overall Study|Lost to Follow-up|13|||
126396515|NCT00856206|454745946|FG001|Overall Study|Lost to Follow-up|39|||
126396516|NCT00856206|454745945|FG000|Overall Study|Death|2|||
126396517|NCT00856206|454745946|FG001|Overall Study|Death|2|||
126396518|NCT00856206|454745945|FG000|Overall Study|Decision by the Sponsor|4|||
126396519|NCT00856206|454745946|FG001|Overall Study|Decision by the Sponsor|8|||
126396520|NCT00856206|454745945|FG000|Overall Study|Other than specified above|3|||
126396521|NCT00856206|454745946|FG001|Overall Study|Other than specified above|10|||
126396522|NCT04584346|454745947|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
126396523|NCT04584346|454745948|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
126396524|NCT02780856|454745955|FG000|Overall Study|Lost to Follow-up|1|||
126396525|NCT03640052|454745956|FG000|Overall Study|Lost to Follow-up|0|||
126396526|NCT03640052|454745957|FG001|Overall Study|Lost to Follow-up|1|||
126396527|NCT03640052|454745958|FG002|Overall Study|Lost to Follow-up|0|||
126396528|NCT03640052|454745959|FG003|Overall Study|Lost to Follow-up|0|||
126396529|NCT03640052|454745960|FG004|Overall Study|Lost to Follow-up|0|||
126396530|NCT04422561|454745961|FG000|Overall Study|Lost to Follow-up|25|||
126396531|NCT04422561|454745962|FG001|Overall Study|Lost to Follow-up|11|||
126396532|NCT04239222|454745965|FG000|Baseline|Withdrawal by Subject|0|||
126396533|NCT04239222|454745966|FG001|Baseline|Withdrawal by Subject|0|||
126396534|NCT04239222|454745967|FG002|Baseline|Withdrawal by Subject|1|||
126396535|NCT04239222|454745968|FG003|Baseline|Withdrawal by Subject|1|||
126396536|NCT04239222|454745965|FG000|First Foot Assignment|Withdrawal by Subject|0|||
126396537|NCT04239222|454745966|FG001|First Foot Assignment|Withdrawal by Subject|0|||
126396538|NCT04239222|454745967|FG002|First Foot Assignment|Withdrawal by Subject|1|||
126396539|NCT04239222|454745968|FG003|First Foot Assignment|Withdrawal by Subject|0|||
126396540|NCT04239222|454745965|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
126396541|NCT04239222|454745966|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
126396542|NCT04239222|454745967|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
126396543|NCT04239222|454745968|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
126396544|NCT01468233|454745974|FG000|Treatment Period 1|Adverse Event|5|||
126396545|NCT01468233|454745975|FG001|Treatment Period 1|Adverse Event|3|||
126396546|NCT01468233|454745976|FG002|Treatment Period 1|Adverse Event|0|||
126105115|NCT00406653|453678559|FG000|Induction Period|Declined participation but followup done|0|||
126105116|NCT00406653|453678560|FG001|Induction Period|Declined participation but followup done|2|||
126105117|NCT00406653|453678561|FG002|Induction Period|Declined participation but followup done|1|||
126105118|NCT00406653|453678562|FG003|Induction Period|Declined participation but followup done|1|||
126105119|NCT00406653|453678563|FG004|Induction Period|Declined participation but followup done|0|||
126051768|NCT00092534|453485878|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
126051769|NCT00092534|453485874|FG000|Base Study Vaccination Period|Physician Decision|1|||
126051770|NCT00092534|453485875|FG001|Base Study Vaccination Period|Physician Decision|0|||
126051771|NCT00092534|453485876|FG002|Base Study Vaccination Period|Physician Decision|0|||
126051772|NCT00092534|453485877|FG003|Base Study Vaccination Period|Physician Decision|0|||
126051773|NCT00092534|453485878|FG004|Base Study Vaccination Period|Physician Decision|0|||
126051774|NCT00092534|453485874|FG000|Base Study Vaccination Period|Pregnancy|9|||
126051775|NCT00092534|453485875|FG001|Base Study Vaccination Period|Pregnancy|7|||
126051776|NCT00092534|453485876|FG002|Base Study Vaccination Period|Pregnancy|0|||
126051777|NCT00092534|453485877|FG003|Base Study Vaccination Period|Pregnancy|0|||
126051778|NCT00092534|453485878|FG004|Base Study Vaccination Period|Pregnancy|0|||
126051779|NCT00092534|453485874|FG000|Base Study Vaccination Period|Protocol Violation|2|||
126051780|NCT00092534|453485875|FG001|Base Study Vaccination Period|Protocol Violation|1|||
126051781|NCT00092534|453485876|FG002|Base Study Vaccination Period|Protocol Violation|0|||
126051782|NCT00092534|453485877|FG003|Base Study Vaccination Period|Protocol Violation|0|||
126051783|NCT00092534|453485878|FG004|Base Study Vaccination Period|Protocol Violation|0|||
126051784|NCT00092534|453485874|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
126051785|NCT00092534|453485875|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
126051786|NCT00092534|453485876|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
126105120|NCT00406653|453678564|FG005|Induction Period|Declined participation but followup done|0|||
126396547|NCT01468233|454745977|FG003|Treatment Period 1|Adverse Event|0|||
126396548|NCT01468233|454745978|FG004|Treatment Period 1|Adverse Event|0|||
126396549|NCT01468233|454745979|FG005|Treatment Period 1|Adverse Event|0|||
126396550|NCT01468233|454745974|FG000|Treatment Period 1|Withdrawal by Subject|3|||
126396551|NCT01468233|454745975|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126396552|NCT01468233|454745976|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126396553|NCT01468233|454745977|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126396554|NCT01468233|454745978|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126396555|NCT01468233|454745979|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126396556|NCT01468233|454745974|FG000|Treatment Period 1|Lost to Follow-up|3|||
126396557|NCT01468233|454745975|FG001|Treatment Period 1|Lost to Follow-up|0|||
126396558|NCT01468233|454745976|FG002|Treatment Period 1|Lost to Follow-up|0|||
126396559|NCT01468233|454745977|FG003|Treatment Period 1|Lost to Follow-up|0|||
126396560|NCT01468233|454745978|FG004|Treatment Period 1|Lost to Follow-up|0|||
126396561|NCT01468233|454745979|FG005|Treatment Period 1|Lost to Follow-up|0|||
126396562|NCT01468233|454745974|FG000|Treatment Period 1|Other|1|||
126396563|NCT01468233|454745975|FG001|Treatment Period 1|Other|1|||
126396564|NCT01468233|454745976|FG002|Treatment Period 1|Other|0|||
126396565|NCT01468233|454745977|FG003|Treatment Period 1|Other|0|||
126396566|NCT01468233|454745978|FG004|Treatment Period 1|Other|0|||
126396567|NCT01468233|454745979|FG005|Treatment Period 1|Other|0|||
126396568|NCT01468233|454745974|FG000|Treatment Period 2|Adverse Event|0|||
126396569|NCT01468233|454745975|FG001|Treatment Period 2|Adverse Event|0|||
126396570|NCT01468233|454745976|FG002|Treatment Period 2|Adverse Event|3|||
126105121|NCT00406653|453678565|FG006|Induction Period|Declined participation but followup done|0|||
126396571|NCT01468233|454745977|FG003|Treatment Period 2|Adverse Event|0|||
126396572|NCT01468233|454745978|FG004|Treatment Period 2|Adverse Event|2|||
126396573|NCT01468233|454745979|FG005|Treatment Period 2|Adverse Event|1|||
126396574|NCT01468233|454745974|FG000|Treatment Period 2|Lack of Efficacy|0|||
126396575|NCT01468233|454745975|FG001|Treatment Period 2|Lack of Efficacy|0|||
126396576|NCT01468233|454745976|FG002|Treatment Period 2|Lack of Efficacy|9|||
126396577|NCT01468233|454745977|FG003|Treatment Period 2|Lack of Efficacy|2|||
126051787|NCT00092534|453485877|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
126051788|NCT00092534|453485878|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
126051789|NCT00092534|453485874|FG000|Base Study Vaccination Period|Moved|14|||
126051790|NCT00092534|453485875|FG001|Base Study Vaccination Period|Moved|12|||
126051791|NCT00092534|453485876|FG002|Base Study Vaccination Period|Moved|0|||
126051792|NCT00092534|453485877|FG003|Base Study Vaccination Period|Moved|0|||
126051793|NCT00092534|453485878|FG004|Base Study Vaccination Period|Moved|0|||
126051794|NCT00092534|453485874|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
126051795|NCT00092534|453485875|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
126051796|NCT00092534|453485876|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
126051797|NCT00092534|453485877|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
126051798|NCT00092534|453485878|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
126051799|NCT00092534|453485874|FG000|Base Study Vaccination Period|Travel|1|||
126051800|NCT00092534|453485875|FG001|Base Study Vaccination Period|Travel|0|||
126396578|NCT01468233|454745978|FG004|Treatment Period 2|Lack of Efficacy|0|||
126396579|NCT01468233|454745979|FG005|Treatment Period 2|Lack of Efficacy|1|||
126396580|NCT01468233|454745974|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126396581|NCT01468233|454745975|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126396582|NCT01468233|454745976|FG002|Treatment Period 2|Withdrawal by Subject|9|||
126396583|NCT01468233|454745977|FG003|Treatment Period 2|Withdrawal by Subject|1|||
126396584|NCT01468233|454745978|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126396585|NCT01468233|454745979|FG005|Treatment Period 2|Withdrawal by Subject|1|||
126396586|NCT01468233|454745974|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
126396587|NCT01468233|454745975|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
126396588|NCT01468233|454745976|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
126396589|NCT01468233|454745977|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
126396590|NCT01468233|454745978|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
126396591|NCT01468233|454745979|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
126396592|NCT01468233|454745974|FG000|Treatment Period 2|Lost to Follow-up|0|||
126396593|NCT01468233|454745975|FG001|Treatment Period 2|Lost to Follow-up|0|||
126396594|NCT01468233|454745976|FG002|Treatment Period 2|Lost to Follow-up|3|||
126396595|NCT01468233|454745977|FG003|Treatment Period 2|Lost to Follow-up|0|||
126396596|NCT01468233|454745978|FG004|Treatment Period 2|Lost to Follow-up|2|||
126396597|NCT01468233|454745979|FG005|Treatment Period 2|Lost to Follow-up|0|||
126396598|NCT01468233|454745974|FG000|Treatment Period 2|Other|0|||
126396599|NCT01468233|454745975|FG001|Treatment Period 2|Other|0|||
126396600|NCT01468233|454745976|FG002|Treatment Period 2|Other|3|||
126396601|NCT01468233|454745977|FG003|Treatment Period 2|Other|0|||
126396602|NCT01468233|454745978|FG004|Treatment Period 2|Other|1|||
126396603|NCT01468233|454745979|FG005|Treatment Period 2|Other|0|||
126396604|NCT00790647|454745987|FG000|Overall Study|Adverse Event|1|||
126396605|NCT04926831|454745989|FG000|Overall Study|Withdrawal by Subject|2|||
126396606|NCT04926831|454745989|FG000|Overall Study|Adverse Event|2|||
126396607|NCT02701777|454745990|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
126396608|NCT02701777|454745991|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
126396609|NCT02701777|454745992|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
126396610|NCT02701777|454745993|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
126396611|NCT02701777|454745990|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
126396612|NCT02701777|454745991|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
126396613|NCT02701777|454745992|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
126396614|NCT02701777|454745993|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
126396615|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
126396616|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
126396617|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
126396618|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
126396619|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
126396620|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
126396621|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
126396622|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
126396623|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
126396624|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
126396625|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
126396626|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
126396627|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
126396628|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
126051801|NCT00092534|453485876|FG002|Base Study Vaccination Period|Travel|0|||
126105122|NCT00406653|453678559|FG000|Induction Period|Given prohibited drug|0|||
126396629|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
126396630|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
126051802|NCT00092534|453485877|FG003|Base Study Vaccination Period|Travel|0|||
126051803|NCT00092534|453485878|FG004|Base Study Vaccination Period|Travel|0|||
126051804|NCT00092534|453485874|FG000|Base Study Vaccination Period|Site Closed|0|||
126051805|NCT00092534|453485875|FG001|Base Study Vaccination Period|Site Closed|1|||
126051806|NCT00092534|453485876|FG002|Base Study Vaccination Period|Site Closed|0|||
126051807|NCT00092534|453485877|FG003|Base Study Vaccination Period|Site Closed|0|||
126051808|NCT00092534|453485878|FG004|Base Study Vaccination Period|Site Closed|0|||
126051809|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Adverse Event|2|||
126051810|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Adverse Event|4|||
126051811|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Adverse Event|0|||
126051812|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Adverse Event|0|||
126051813|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Adverse Event|0|||
126051814|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Death|2|||
126051815|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Death|1|||
126051816|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Death|0|||
126051817|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Death|0|||
126051818|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Death|0|||
126051819|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
126051820|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
126051821|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
126051822|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
126051823|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
126051824|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Pregnancy|6|||
126051825|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Pregnancy|10|||
126051826|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Pregnancy|0|||
126051827|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Pregnancy|0|||
126051828|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Pregnancy|0|||
126051829|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
126051830|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
126051831|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
126051832|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
126051833|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
126396631|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
126396632|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
126396633|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
126396634|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
126396635|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
126396636|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
126396637|NCT01133626|454745999|FG000|Overall Study|Adverse Event|0|||
126396638|NCT01133626|454746000|FG001|Overall Study|Adverse Event|1|||
126396639|NCT01133626|454746001|FG002|Overall Study|Adverse Event|0|||
126396640|NCT01133626|454745999|FG000|Overall Study|Withdrawal by Subject|1|||
126396641|NCT01133626|454746000|FG001|Overall Study|Withdrawal by Subject|2|||
126396642|NCT01133626|454746001|FG002|Overall Study|Withdrawal by Subject|2|||
126396643|NCT01133626|454745999|FG000|Overall Study|Other|0|||
126396644|NCT01133626|454746000|FG001|Overall Study|Other|2|||
126396645|NCT01133626|454746001|FG002|Overall Study|Other|0|||
126396646|NCT03298984|454746004|FG000|Overall Study|Physician Decision|1|||
126396647|NCT03298984|454746005|FG001|Overall Study|Physician Decision|0|||
126396648|NCT03298984|454746006|FG002|Overall Study|Physician Decision|0|||
126396649|NCT03298984|454746007|FG003|Overall Study|Physician Decision|6|||
126396650|NCT03298984|454746004|FG000|Overall Study|Lack of Efficacy|0|||
126396651|NCT03298984|454746005|FG001|Overall Study|Lack of Efficacy|1|||
126396652|NCT03298984|454746006|FG002|Overall Study|Lack of Efficacy|1|||
126396653|NCT03298984|454746007|FG003|Overall Study|Lack of Efficacy|4|||
126396654|NCT03298984|454746004|FG000|Overall Study|Relapsed disease (following remission)|0|||
126396655|NCT03298984|454746005|FG001|Overall Study|Relapsed disease (following remission)|0|||
126396656|NCT03298984|454746006|FG002|Overall Study|Relapsed disease (following remission)|1|||
126396657|NCT03298984|454746007|FG003|Overall Study|Relapsed disease (following remission)|1|||
126396658|NCT03298984|454746004|FG000|Overall Study|Adverse Event|0|||
126396659|NCT03298984|454746005|FG001|Overall Study|Adverse Event|0|||
126051834|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
126051835|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
126051836|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
126051837|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
126051838|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
126051839|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Moved|62|||
126051840|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Moved|58|||
126051841|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Moved|0|||
126051842|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Moved|0|||
126051843|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Moved|0|||
126051844|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Travel|10|||
126051845|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Travel|7|||
126051846|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Travel|0|||
126051847|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Travel|0|||
126051848|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Travel|0|||
126051849|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Site Closed|0|||
126051850|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Site Closed|2|||
126051851|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Site Closed|0|||
126051852|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Site Closed|0|||
126051853|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Site Closed|0|||
126051854|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
126051855|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
126051856|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
126051857|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
126051858|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
126051859|NCT00092534|453485874|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
126051860|NCT00092534|453485875|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
126051861|NCT00092534|453485876|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
126051862|NCT00092534|453485877|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
126051863|NCT00092534|453485878|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
126051864|NCT00092534|453485874|FG000|Base Study EXT|Lost to Follow-up|0|||
126051865|NCT00092534|453485875|FG001|Base Study EXT|Lost to Follow-up|0|||
126051866|NCT00092534|453485876|FG002|Base Study EXT|Lost to Follow-up|41|||
126051867|NCT00092534|453485877|FG003|Base Study EXT|Lost to Follow-up|0|||
126051868|NCT00092534|453485878|FG004|Base Study EXT|Lost to Follow-up|0|||
126051869|NCT00092534|453485874|FG000|Base Study EXT|Physician Decision|0|||
126051870|NCT00092534|453485875|FG001|Base Study EXT|Physician Decision|0|||
126051871|NCT00092534|453485876|FG002|Base Study EXT|Physician Decision|1|||
126051872|NCT00092534|453485877|FG003|Base Study EXT|Physician Decision|0|||
126051873|NCT00092534|453485878|FG004|Base Study EXT|Physician Decision|0|||
126051874|NCT00092534|453485874|FG000|Base Study EXT|Pregnancy|0|||
126051875|NCT00092534|453485875|FG001|Base Study EXT|Pregnancy|0|||
126051876|NCT00092534|453485876|FG002|Base Study EXT|Pregnancy|12|||
126051877|NCT00092534|453485877|FG003|Base Study EXT|Pregnancy|0|||
126051878|NCT00092534|453485878|FG004|Base Study EXT|Pregnancy|0|||
126051879|NCT00092534|453485874|FG000|Base Study EXT|Withdrawal by Subject|0|||
126051880|NCT00092534|453485875|FG001|Base Study EXT|Withdrawal by Subject|0|||
126051881|NCT00092534|453485876|FG002|Base Study EXT|Withdrawal by Subject|18|||
126051882|NCT00092534|453485877|FG003|Base Study EXT|Withdrawal by Subject|0|||
126051883|NCT00092534|453485878|FG004|Base Study EXT|Withdrawal by Subject|0|||
126051884|NCT00092534|453485874|FG000|Base Study EXT|Participant moved|0|||
126051885|NCT00092534|453485875|FG001|Base Study EXT|Participant moved|0|||
126051886|NCT00092534|453485876|FG002|Base Study EXT|Participant moved|6|||
126051887|NCT00092534|453485877|FG003|Base Study EXT|Participant moved|0|||
126051888|NCT00092534|453485878|FG004|Base Study EXT|Participant moved|0|||
126051889|NCT00092534|453485874|FG000|Base Study EXT|Travel|0|||
126051890|NCT00092534|453485875|FG001|Base Study EXT|Travel|0|||
126051891|NCT00092534|453485876|FG002|Base Study EXT|Travel|2|||
126051892|NCT00092534|453485877|FG003|Base Study EXT|Travel|0|||
126051893|NCT00092534|453485878|FG004|Base Study EXT|Travel|0|||
126051894|NCT00092534|453485874|FG000|Base Study EXT|Site closed|0|||
126051895|NCT00092534|453485875|FG001|Base Study EXT|Site closed|0|||
126051896|NCT00092534|453485876|FG002|Base Study EXT|Site closed|21|||
126051897|NCT00092534|453485877|FG003|Base Study EXT|Site closed|0|||
126051898|NCT00092534|453485878|FG004|Base Study EXT|Site closed|0|||
126105123|NCT00406653|453678560|FG001|Induction Period|Given prohibited drug|1|||
126051899|NCT00092534|453485874|FG000|Base Study EXT|Study ended|0|||
126051900|NCT00092534|453485875|FG001|Base Study EXT|Study ended|0|||
126105124|NCT00406653|453678561|FG002|Induction Period|Given prohibited drug|2|||
126396660|NCT03298984|454746006|FG002|Overall Study|Adverse Event|0|||
126396661|NCT03298984|454746007|FG003|Overall Study|Adverse Event|1|||
126051901|NCT00092534|453485876|FG002|Base Study EXT|Study ended|29|||
126051902|NCT00092534|453485877|FG003|Base Study EXT|Study ended|0|||
126051903|NCT00092534|453485878|FG004|Base Study EXT|Study ended|0|||
126051904|NCT00092534|453485874|FG000|Base Study EXT|Protocol Violation|0|||
126105125|NCT00406653|453678562|FG003|Induction Period|Given prohibited drug|0|||
126051905|NCT00092534|453485875|FG001|Base Study EXT|Protocol Violation|0|||
126051906|NCT00092534|453485876|FG002|Base Study EXT|Protocol Violation|15|||
126051907|NCT00092534|453485877|FG003|Base Study EXT|Protocol Violation|0|||
126051908|NCT00092534|453485878|FG004|Base Study EXT|Protocol Violation|0|||
126051909|NCT00092534|453485874|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
126051910|NCT00092534|453485875|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
126105126|NCT00406653|453678563|FG004|Induction Period|Given prohibited drug|0|||
126105127|NCT00406653|453678564|FG005|Induction Period|Given prohibited drug|0|||
126105128|NCT00406653|453678565|FG006|Induction Period|Given prohibited drug|0|||
126105129|NCT00406653|453678559|FG000|Induction Period|Incarcerated|0|||
126105130|NCT00406653|453678560|FG001|Induction Period|Incarcerated|0|||
126105131|NCT00406653|453678561|FG002|Induction Period|Incarcerated|1|||
126105132|NCT00406653|453678562|FG003|Induction Period|Incarcerated|0|||
126105133|NCT00406653|453678563|FG004|Induction Period|Incarcerated|0|||
126105134|NCT00406653|453678564|FG005|Induction Period|Incarcerated|0|||
126105135|NCT00406653|453678565|FG006|Induction Period|Incarcerated|0|||
126105136|NCT00406653|453678559|FG000|Induction Period|Patient relocated|0|||
126105137|NCT00406653|453678560|FG001|Induction Period|Patient relocated|0|||
126105138|NCT00406653|453678561|FG002|Induction Period|Patient relocated|1|||
126105139|NCT00406653|453678562|FG003|Induction Period|Patient relocated|0|||
126105140|NCT00406653|453678563|FG004|Induction Period|Patient relocated|0|||
126396662|NCT03298984|454746004|FG000|Overall Study|Death|0|||
126396663|NCT03298984|454746005|FG001|Overall Study|Death|0|||
126396664|NCT03298984|454746006|FG002|Overall Study|Death|0|||
126396665|NCT03298984|454746007|FG003|Overall Study|Death|2|||
126396666|NCT03298984|454746004|FG000|Overall Study|Insurance Company Decision|0|||
126396667|NCT03298984|454746005|FG001|Overall Study|Insurance Company Decision|0|||
126396668|NCT03298984|454746006|FG002|Overall Study|Insurance Company Decision|0|||
126396669|NCT03298984|454746007|FG003|Overall Study|Insurance Company Decision|1|||
126396670|NCT02851407|454746008|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126396671|NCT02851407|454746009|FG001|Overall Study|Withdrawal by parent/guardian|7|||
126396672|NCT02851407|454746008|FG000|Overall Study|Protocol deviation|0|||
126396673|NCT02851407|454746009|FG001|Overall Study|Protocol deviation|1|||
126396674|NCT02851407|454746008|FG000|Overall Study|Transferred to another hospital to continue|1|||
126396675|NCT02851407|454746009|FG001|Overall Study|Transferred to another hospital to continue|0|||
126396676|NCT02851407|454746008|FG000|Overall Study|Other Death|30|||
126396677|NCT02851407|454746009|FG001|Overall Study|Other Death|20|||
126396678|NCT02851407|454746008|FG000|Overall Study|Adverse event, serious fatal|6|||
126396679|NCT02851407|454746009|FG001|Overall Study|Adverse event, serious fatal|8|||
126396680|NCT02851407|454746008|FG000|Overall Study|Consent withdrawn by participant|5|||
126396681|NCT02851407|454746009|FG001|Overall Study|Consent withdrawn by participant|3|||
126396682|NCT02851407|454746008|FG000|Overall Study|Screen failure|2|||
126396683|NCT02851407|454746009|FG001|Overall Study|Screen failure|1|||
126396684|NCT02851407|454746008|FG000|Overall Study|Disease relapse|9|||
126396685|NCT02851407|454746009|FG001|Overall Study|Disease relapse|6|||
126396686|NCT02851407|454746008|FG000|Overall Study|Physician Decision|7|||
126396687|NCT02851407|454746009|FG001|Overall Study|Physician Decision|6|||
126396688|NCT02851407|454746008|FG000|Overall Study|Transferred to hospital closer to home|0|||
126105141|NCT00406653|453678564|FG005|Induction Period|Patient relocated|0|||
126396689|NCT02851407|454746009|FG001|Overall Study|Transferred to hospital closer to home|1|||
126396690|NCT02851407|454746008|FG000|Overall Study|Enrolled in an investigational study|0|||
126396691|NCT02851407|454746009|FG001|Overall Study|Enrolled in an investigational study|1|||
126396692|NCT02851407|454746008|FG000|Overall Study|Early recovery|1|||
126396693|NCT02851407|454746009|FG001|Overall Study|Early recovery|0|||
126396694|NCT02851407|454746008|FG000|Overall Study|Adverse event, non-fatal|7|||
126396695|NCT02851407|454746009|FG001|Overall Study|Adverse event, non-fatal|5|||
126396696|NCT02851407|454746008|FG000|Overall Study|Lost to Follow-up|0|||
126396697|NCT02851407|454746009|FG001|Overall Study|Lost to Follow-up|2|||
126396698|NCT00294645|454746010|FG000|Overall Study|Death|10|||
126396699|NCT00294645|454746011|FG001|Overall Study|Death|18|||
126396700|NCT00294645|454746010|FG000|Overall Study|Lost to Follow-up|1|||
126396701|NCT00294645|454746011|FG001|Overall Study|Lost to Follow-up|10|||
126396702|NCT00294645|454746010|FG000|Overall Study|Withdrawal by Subject|18|||
126396703|NCT00294645|454746011|FG001|Overall Study|Withdrawal by Subject|34|||
126396704|NCT00294645|454746010|FG000|Overall Study|Physician Decision|15|||
126396705|NCT00294645|454746011|FG001|Overall Study|Physician Decision|20|||
126396706|NCT00294645|454746010|FG000|Overall Study|Other|4|||
126396707|NCT00294645|454746011|FG001|Overall Study|Other|10|||
126396708|NCT00075725|454746012|FG000|Overall Study|Adverse Event|6|||
126396709|NCT00075725|454746013|FG001|Overall Study|Adverse Event|6|||
126396710|NCT00075725|454746014|FG002|Overall Study|Adverse Event|20|||
126396711|NCT00075725|454746015|FG003|Overall Study|Adverse Event|8|||
126396712|NCT00075725|454746016|FG004|Overall Study|Adverse Event|4|||
126396713|NCT00075725|454746017|FG005|Overall Study|Adverse Event|38|||
126396714|NCT00075725|454746018|FG006|Overall Study|Adverse Event|3|||
126105142|NCT00406653|453678565|FG006|Induction Period|Patient relocated|0|||
126105143|NCT00406653|453678559|FG000|Maintenance Period|Adverse Event|0|||
126105144|NCT00406653|453678560|FG001|Maintenance Period|Adverse Event|0|||
126105145|NCT00406653|453678561|FG002|Maintenance Period|Adverse Event|0|||
126396715|NCT00075725|454746019|FG007|Overall Study|Adverse Event|51|||
126396716|NCT00075725|454746020|FG008|Overall Study|Adverse Event|15|||
126396717|NCT00075725|454746021|FG009|Overall Study|Adverse Event|4|||
126396718|NCT00075725|454746022|FG010|Overall Study|Adverse Event|2|||
126396719|NCT00075725|454746023|FG011|Overall Study|Adverse Event|2|||
126396720|NCT00075725|454746012|FG000|Overall Study|Death|3|||
126396721|NCT00075725|454746013|FG001|Overall Study|Death|5|||
126396722|NCT00075725|454746014|FG002|Overall Study|Death|10|||
126396723|NCT00075725|454746015|FG003|Overall Study|Death|2|||
126396724|NCT00075725|454746016|FG004|Overall Study|Death|3|||
126396725|NCT00075725|454746017|FG005|Overall Study|Death|25|||
126396726|NCT00075725|454746018|FG006|Overall Study|Death|4|||
126396727|NCT00075725|454746019|FG007|Overall Study|Death|22|||
126396728|NCT00075725|454746020|FG008|Overall Study|Death|14|||
126396729|NCT00075725|454746021|FG009|Overall Study|Death|4|||
126396730|NCT00075725|454746022|FG010|Overall Study|Death|3|||
126396731|NCT00075725|454746023|FG011|Overall Study|Death|0|||
126396732|NCT00075725|454746012|FG000|Overall Study|Lost to Follow-up|1|||
126396733|NCT00075725|454746013|FG001|Overall Study|Lost to Follow-up|1|||
126396734|NCT00075725|454746014|FG002|Overall Study|Lost to Follow-up|4|||
126396735|NCT00075725|454746015|FG003|Overall Study|Lost to Follow-up|1|||
126396736|NCT00075725|454746016|FG004|Overall Study|Lost to Follow-up|0|||
126396737|NCT00075725|454746017|FG005|Overall Study|Lost to Follow-up|13|||
126396738|NCT00075725|454746018|FG006|Overall Study|Lost to Follow-up|2|||
126396739|NCT00075725|454746019|FG007|Overall Study|Lost to Follow-up|4|||
126396740|NCT00075725|454746020|FG008|Overall Study|Lost to Follow-up|1|||
126396741|NCT00075725|454746021|FG009|Overall Study|Lost to Follow-up|0|||
126396742|NCT00075725|454746022|FG010|Overall Study|Lost to Follow-up|0|||
126396743|NCT00075725|454746023|FG011|Overall Study|Lost to Follow-up|0|||
126396744|NCT00075725|454746012|FG000|Overall Study|Physician Decision|2|||
126396745|NCT00075725|454746013|FG001|Overall Study|Physician Decision|6|||
126396746|NCT00075725|454746014|FG002|Overall Study|Physician Decision|5|||
126396747|NCT00075725|454746015|FG003|Overall Study|Physician Decision|8|||
126396748|NCT00075725|454746016|FG004|Overall Study|Physician Decision|4|||
126396749|NCT00075725|454746017|FG005|Overall Study|Physician Decision|19|||
126396750|NCT00075725|454746018|FG006|Overall Study|Physician Decision|3|||
126396751|NCT00075725|454746019|FG007|Overall Study|Physician Decision|17|||
126396752|NCT00075725|454746020|FG008|Overall Study|Physician Decision|5|||
126396753|NCT00075725|454746021|FG009|Overall Study|Physician Decision|0|||
126396754|NCT00075725|454746022|FG010|Overall Study|Physician Decision|1|||
126396755|NCT00075725|454746023|FG011|Overall Study|Physician Decision|0|||
126396756|NCT00075725|454746012|FG000|Overall Study|Pregnancy|0|||
126396757|NCT00075725|454746013|FG001|Overall Study|Pregnancy|0|||
126396758|NCT00075725|454746014|FG002|Overall Study|Pregnancy|0|||
126396759|NCT00075725|454746015|FG003|Overall Study|Pregnancy|0|||
126396760|NCT00075725|454746016|FG004|Overall Study|Pregnancy|0|||
126396761|NCT00075725|454746017|FG005|Overall Study|Pregnancy|1|||
126396762|NCT00075725|454746018|FG006|Overall Study|Pregnancy|0|||
126396763|NCT00075725|454746019|FG007|Overall Study|Pregnancy|1|||
126396764|NCT00075725|454746020|FG008|Overall Study|Pregnancy|0|||
126396765|NCT00075725|454746021|FG009|Overall Study|Pregnancy|0|||
126396766|NCT00075725|454746022|FG010|Overall Study|Pregnancy|0|||
126396767|NCT00075725|454746023|FG011|Overall Study|Pregnancy|0|||
126396768|NCT00075725|454746012|FG000|Overall Study|Protocol Violation|1|||
126396769|NCT00075725|454746013|FG001|Overall Study|Protocol Violation|1|||
126396770|NCT00075725|454746014|FG002|Overall Study|Protocol Violation|0|||
126396771|NCT00075725|454746015|FG003|Overall Study|Protocol Violation|3|||
126396772|NCT00075725|454746016|FG004|Overall Study|Protocol Violation|3|||
126396773|NCT00075725|454746017|FG005|Overall Study|Protocol Violation|2|||
126396774|NCT00075725|454746018|FG006|Overall Study|Protocol Violation|1|||
126396775|NCT00075725|454746019|FG007|Overall Study|Protocol Violation|2|||
126051911|NCT00092534|453485876|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
126396776|NCT00075725|454746020|FG008|Overall Study|Protocol Violation|3|||
126396777|NCT00075725|454746021|FG009|Overall Study|Protocol Violation|0|||
126051912|NCT00092534|453485877|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
126396778|NCT00075725|454746022|FG010|Overall Study|Protocol Violation|0|||
126396779|NCT00075725|454746023|FG011|Overall Study|Protocol Violation|1|||
126396780|NCT00075725|454746012|FG000|Overall Study|Withdrawal by Subject|12|||
126396781|NCT00075725|454746013|FG001|Overall Study|Withdrawal by Subject|3|||
126396782|NCT00075725|454746014|FG002|Overall Study|Withdrawal by Subject|6|||
126396783|NCT00075725|454746015|FG003|Overall Study|Withdrawal by Subject|10|||
126396784|NCT00075725|454746016|FG004|Overall Study|Withdrawal by Subject|6|||
126396785|NCT00075725|454746017|FG005|Overall Study|Withdrawal by Subject|27|||
126396786|NCT00075725|454746018|FG006|Overall Study|Withdrawal by Subject|7|||
126051913|NCT00092534|453485878|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
126051914|NCT05029284|453485879|FG000|Overall Study|Lost to Follow-up|1|||
126051915|NCT04001829|453485880|FG000|Overall Study|Never start protocol therapy|5|||
126051916|NCT04001829|453485881|FG001|Overall Study|Never start protocol therapy|5|||
126051917|NCT04001829|453485880|FG000|Overall Study|Adverse Event|11|||
126051918|NCT04001829|453485881|FG001|Overall Study|Adverse Event|7|||
126051919|NCT04001829|453485880|FG000|Overall Study|Alternative therapy|1|||
126051920|NCT04001829|453485881|FG001|Overall Study|Alternative therapy|2|||
126051921|NCT04001829|453485880|FG000|Overall Study|Disease progression/relapse|2|||
126051922|NCT04001829|453485881|FG001|Overall Study|Disease progression/relapse|1|||
126051923|NCT04001829|453485880|FG000|Overall Study|Other complicating disease|1|||
126051924|NCT04001829|453485881|FG001|Overall Study|Other complicating disease|0|||
126396787|NCT00075725|454746019|FG007|Overall Study|Withdrawal by Subject|31|||
126396788|NCT00075725|454746020|FG008|Overall Study|Withdrawal by Subject|10|||
126396789|NCT00075725|454746021|FG009|Overall Study|Withdrawal by Subject|2|||
126396790|NCT00075725|454746022|FG010|Overall Study|Withdrawal by Subject|0|||
126396791|NCT00075725|454746023|FG011|Overall Study|Withdrawal by Subject|0|||
126396792|NCT00075725|454746012|FG000|Overall Study|Disease Progression, all other reasons|17|||
126396793|NCT00075725|454746013|FG001|Overall Study|Disease Progression, all other reasons|5|||
126396794|NCT00075725|454746014|FG002|Overall Study|Disease Progression, all other reasons|33|||
126396795|NCT00075725|454746015|FG003|Overall Study|Disease Progression, all other reasons|6|||
126396796|NCT00075725|454746016|FG004|Overall Study|Disease Progression, all other reasons|21|||
126396797|NCT00075725|454746017|FG005|Overall Study|Disease Progression, all other reasons|59|||
126396798|NCT00075725|454746018|FG006|Overall Study|Disease Progression, all other reasons|20|||
126396799|NCT00075725|454746019|FG007|Overall Study|Disease Progression, all other reasons|46|||
126396800|NCT00075725|454746020|FG008|Overall Study|Disease Progression, all other reasons|21|||
126396801|NCT00075725|454746021|FG009|Overall Study|Disease Progression, all other reasons|4|||
126396802|NCT00075725|454746022|FG010|Overall Study|Disease Progression, all other reasons|0|||
126396803|NCT00075725|454746023|FG011|Overall Study|Disease Progression, all other reasons|5|||
126396804|NCT00075725|454746012|FG000|Overall Study|Patient off treatment|0|||
126396805|NCT00075725|454746013|FG001|Overall Study|Patient off treatment|0|||
126396806|NCT00075725|454746014|FG002|Overall Study|Patient off treatment|1|||
126396807|NCT00075725|454746015|FG003|Overall Study|Patient off treatment|2|||
126396808|NCT00075725|454746016|FG004|Overall Study|Patient off treatment|1|||
126396809|NCT00075725|454746017|FG005|Overall Study|Patient off treatment|0|||
126396810|NCT00075725|454746018|FG006|Overall Study|Patient off treatment|0|||
126396811|NCT00075725|454746019|FG007|Overall Study|Patient off treatment|2|||
126396812|NCT00075725|454746020|FG008|Overall Study|Patient off treatment|1|||
126396813|NCT00075725|454746021|FG009|Overall Study|Patient off treatment|0|||
126396814|NCT00075725|454746022|FG010|Overall Study|Patient off treatment|0|||
126396815|NCT00075725|454746023|FG011|Overall Study|Patient off treatment|0|||
126051925|NCT04001829|453485880|FG000|Overall Study|Withdrawal by Subject|1|||
126051926|NCT04001829|453485881|FG001|Overall Study|Withdrawal by Subject|4|||
126051927|NCT04001829|453485880|FG000|Overall Study|Ineligible|2|||
126051928|NCT04001829|453485881|FG001|Overall Study|Ineligible|2|||
126051929|NCT04001829|453485880|FG000|Overall Study|Reason missing due to delinquent data|1|||
126051930|NCT04001829|453485881|FG001|Overall Study|Reason missing due to delinquent data|0|||
126051931|NCT03678688|453485882|FG000|Overall Study|Reason not Specified|0|||
126051932|NCT03678688|453485883|FG001|Overall Study|Reason not Specified|0|||
126051933|NCT03678688|453485884|FG002|Overall Study|Reason not Specified|3|||
126051934|NCT03678688|453485885|FG003|Overall Study|Reason not Specified|0|||
126051935|NCT03678688|453485886|FG004|Overall Study|Reason not Specified|1|||
126051936|NCT03678688|453485887|FG005|Overall Study|Reason not Specified|0|||
126051937|NCT03678688|453485888|FG006|Overall Study|Reason not Specified|0|||
126396816|NCT00075725|454746012|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
126396817|NCT00075725|454746013|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
126396818|NCT00075725|454746014|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
126396819|NCT00075725|454746015|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
126396820|NCT00075725|454746016|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
126396821|NCT00075725|454746017|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
126396822|NCT00075725|454746018|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
126396823|NCT00075725|454746019|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
126396824|NCT00075725|454746020|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
126396825|NCT00075725|454746021|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
126396826|NCT00075725|454746022|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
126051938|NCT03678688|453485889|FG007|Overall Study|Reason not Specified|0|||
126051939|NCT03678688|453485890|FG008|Overall Study|Reason not Specified|0|||
126396827|NCT00075725|454746023|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
126051940|NCT03678688|453485882|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
126105146|NCT00406653|453678562|FG003|Maintenance Period|Adverse Event|0|||
126396828|NCT00075725|454746012|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
126396829|NCT00075725|454746013|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
126051941|NCT03678688|453485883|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
126051942|NCT03678688|453485884|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
126051943|NCT03678688|453485885|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
126051944|NCT03678688|453485886|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
126051945|NCT03678688|453485887|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
126396830|NCT00075725|454746014|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
126396831|NCT00075725|454746015|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
126396832|NCT00075725|454746016|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
126396833|NCT00075725|454746017|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
126396834|NCT00075725|454746018|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
126396835|NCT00075725|454746019|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
126396836|NCT00075725|454746020|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
126396837|NCT00075725|454746021|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
126396838|NCT00075725|454746022|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
126396839|NCT00075725|454746023|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
126396840|NCT00075725|454746012|FG000|Overall Study|Pt non compliant with therapy|2|||
126396841|NCT00075725|454746013|FG001|Overall Study|Pt non compliant with therapy|1|||
126396842|NCT00075725|454746014|FG002|Overall Study|Pt non compliant with therapy|1|||
126396843|NCT00075725|454746015|FG003|Overall Study|Pt non compliant with therapy|0|||
126396844|NCT00075725|454746016|FG004|Overall Study|Pt non compliant with therapy|2|||
126396845|NCT00075725|454746017|FG005|Overall Study|Pt non compliant with therapy|14|||
126396846|NCT00075725|454746018|FG006|Overall Study|Pt non compliant with therapy|2|||
126396847|NCT00075725|454746019|FG007|Overall Study|Pt non compliant with therapy|5|||
126396848|NCT00075725|454746020|FG008|Overall Study|Pt non compliant with therapy|3|||
126396849|NCT00075725|454746021|FG009|Overall Study|Pt non compliant with therapy|0|||
126396850|NCT00075725|454746022|FG010|Overall Study|Pt non compliant with therapy|0|||
126396851|NCT00075725|454746023|FG011|Overall Study|Pt non compliant with therapy|0|||
126396852|NCT00075725|454746012|FG000|Overall Study|Pt age out of range for treatment|0|||
126396853|NCT00075725|454746013|FG001|Overall Study|Pt age out of range for treatment|1|||
126396854|NCT00075725|454746014|FG002|Overall Study|Pt age out of range for treatment|0|||
126396855|NCT00075725|454746015|FG003|Overall Study|Pt age out of range for treatment|0|||
126396856|NCT00075725|454746016|FG004|Overall Study|Pt age out of range for treatment|0|||
126396857|NCT00075725|454746017|FG005|Overall Study|Pt age out of range for treatment|1|||
126396858|NCT00075725|454746018|FG006|Overall Study|Pt age out of range for treatment|0|||
126396859|NCT00075725|454746019|FG007|Overall Study|Pt age out of range for treatment|1|||
126396860|NCT00075725|454746020|FG008|Overall Study|Pt age out of range for treatment|0|||
126396861|NCT00075725|454746021|FG009|Overall Study|Pt age out of range for treatment|0|||
126396862|NCT00075725|454746022|FG010|Overall Study|Pt age out of range for treatment|0|||
126396863|NCT00075725|454746023|FG011|Overall Study|Pt age out of range for treatment|0|||
126396864|NCT00075725|454746012|FG000|Overall Study|Insurance issues|0|||
126396865|NCT00075725|454746013|FG001|Overall Study|Insurance issues|1|||
126396866|NCT00075725|454746014|FG002|Overall Study|Insurance issues|0|||
126396867|NCT00075725|454746015|FG003|Overall Study|Insurance issues|1|||
126396868|NCT00075725|454746016|FG004|Overall Study|Insurance issues|1|||
126396869|NCT00075725|454746017|FG005|Overall Study|Insurance issues|1|||
126396870|NCT00075725|454746018|FG006|Overall Study|Insurance issues|0|||
126396871|NCT00075725|454746019|FG007|Overall Study|Insurance issues|1|||
126396872|NCT00075725|454746020|FG008|Overall Study|Insurance issues|0|||
126396873|NCT00075725|454746021|FG009|Overall Study|Insurance issues|0|||
126396874|NCT00075725|454746022|FG010|Overall Study|Insurance issues|0|||
126396875|NCT00075725|454746023|FG011|Overall Study|Insurance issues|0|||
126396876|NCT00075725|454746012|FG000|Overall Study|MRD positive after extended ind|0|||
126396877|NCT00075725|454746013|FG001|Overall Study|MRD positive after extended ind|1|||
126396878|NCT00075725|454746014|FG002|Overall Study|MRD positive after extended ind|1|||
126396879|NCT00075725|454746015|FG003|Overall Study|MRD positive after extended ind|0|||
126396880|NCT00075725|454746016|FG004|Overall Study|MRD positive after extended ind|1|||
126396881|NCT00075725|454746017|FG005|Overall Study|MRD positive after extended ind|2|||
126396882|NCT00075725|454746018|FG006|Overall Study|MRD positive after extended ind|0|||
126396883|NCT00075725|454746019|FG007|Overall Study|MRD positive after extended ind|1|||
126396884|NCT00075725|454746020|FG008|Overall Study|MRD positive after extended ind|0|||
126396885|NCT00075725|454746021|FG009|Overall Study|MRD positive after extended ind|0|||
126396886|NCT00075725|454746022|FG010|Overall Study|MRD positive after extended ind|0|||
126051946|NCT03678688|453485888|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
126396887|NCT00075725|454746023|FG011|Overall Study|MRD positive after extended ind|0|||
126396888|NCT00075725|454746012|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
126396889|NCT00075725|454746013|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
126396890|NCT00075725|454746014|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
126396891|NCT00075725|454746015|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
126396892|NCT00075725|454746016|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
126051947|NCT03678688|453485889|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
126396893|NCT00075725|454746017|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
126396894|NCT00075725|454746018|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
126396895|NCT00075725|454746019|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
126396896|NCT00075725|454746020|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
126396897|NCT00075725|454746021|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
126396898|NCT00075725|454746022|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
126396899|NCT00075725|454746023|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
126396900|NCT00075725|454746012|FG000|Overall Study|Inevaluable|1|||
126396901|NCT00075725|454746013|FG001|Overall Study|Inevaluable|1|||
126396902|NCT00075725|454746014|FG002|Overall Study|Inevaluable|4|||
126396903|NCT00075725|454746015|FG003|Overall Study|Inevaluable|2|||
126396904|NCT00075725|454746016|FG004|Overall Study|Inevaluable|2|||
126396905|NCT00075725|454746017|FG005|Overall Study|Inevaluable|9|||
126396906|NCT00075725|454746018|FG006|Overall Study|Inevaluable|1|||
126396907|NCT00075725|454746019|FG007|Overall Study|Inevaluable|11|||
126396908|NCT00075725|454746020|FG008|Overall Study|Inevaluable|2|||
126396909|NCT00075725|454746021|FG009|Overall Study|Inevaluable|0|||
126396910|NCT00075725|454746022|FG010|Overall Study|Inevaluable|1|||
126396911|NCT00075725|454746023|FG011|Overall Study|Inevaluable|0|||
126396912|NCT00075725|454746012|FG000|Overall Study|Other|4|||
126396913|NCT00075725|454746013|FG001|Overall Study|Other|2|||
126396914|NCT00075725|454746014|FG002|Overall Study|Other|1|||
126396915|NCT00075725|454746015|FG003|Overall Study|Other|1|||
126396916|NCT00075725|454746016|FG004|Overall Study|Other|1|||
126396917|NCT00075725|454746017|FG005|Overall Study|Other|4|||
126396918|NCT00075725|454746018|FG006|Overall Study|Other|2|||
126396919|NCT00075725|454746019|FG007|Overall Study|Other|9|||
126396920|NCT00075725|454746020|FG008|Overall Study|Other|2|||
126396921|NCT00075725|454746021|FG009|Overall Study|Other|1|||
126396922|NCT00075725|454746022|FG010|Overall Study|Other|0|||
126396923|NCT00075725|454746023|FG011|Overall Study|Other|3|||
126396924|NCT00075725|454746012|FG000|Overall Study|Pt trying to find a BM donor|0|||
126396925|NCT00075725|454746013|FG001|Overall Study|Pt trying to find a BM donor|1|||
126396926|NCT00075725|454746014|FG002|Overall Study|Pt trying to find a BM donor|0|||
126396927|NCT00075725|454746015|FG003|Overall Study|Pt trying to find a BM donor|0|||
126396928|NCT00075725|454746016|FG004|Overall Study|Pt trying to find a BM donor|0|||
126396929|NCT00075725|454746017|FG005|Overall Study|Pt trying to find a BM donor|0|||
126396930|NCT00075725|454746018|FG006|Overall Study|Pt trying to find a BM donor|0|||
126396931|NCT00075725|454746019|FG007|Overall Study|Pt trying to find a BM donor|0|||
126396932|NCT00075725|454746020|FG008|Overall Study|Pt trying to find a BM donor|0|||
126396933|NCT00075725|454746021|FG009|Overall Study|Pt trying to find a BM donor|0|||
126396934|NCT00075725|454746022|FG010|Overall Study|Pt trying to find a BM donor|0|||
126396935|NCT00075725|454746023|FG011|Overall Study|Pt trying to find a BM donor|0|||
126396936|NCT00075725|454746012|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
126396937|NCT00075725|454746013|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
126396938|NCT00075725|454746014|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
126396939|NCT00075725|454746015|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
126396940|NCT00075725|454746016|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
126396941|NCT00075725|454746017|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
126396942|NCT00075725|454746018|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
126396943|NCT00075725|454746019|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
126396944|NCT00075725|454746020|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
126396945|NCT00075725|454746021|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
126396946|NCT00075725|454746022|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
126396947|NCT00075725|454746023|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
126396948|NCT00075725|454746012|FG000|Overall Study|Unsuccessful institutional transfer|0|||
126396949|NCT00075725|454746013|FG001|Overall Study|Unsuccessful institutional transfer|0|||
126396950|NCT00075725|454746014|FG002|Overall Study|Unsuccessful institutional transfer|2|||
126396951|NCT00075725|454746015|FG003|Overall Study|Unsuccessful institutional transfer|0|||
126396952|NCT00075725|454746016|FG004|Overall Study|Unsuccessful institutional transfer|0|||
126396953|NCT00075725|454746017|FG005|Overall Study|Unsuccessful institutional transfer|0|||
126105147|NCT00406653|453678563|FG004|Maintenance Period|Adverse Event|1|||
126396954|NCT00075725|454746018|FG006|Overall Study|Unsuccessful institutional transfer|0|||
126396955|NCT00075725|454746019|FG007|Overall Study|Unsuccessful institutional transfer|0|||
126396956|NCT00075725|454746020|FG008|Overall Study|Unsuccessful institutional transfer|0|||
126396957|NCT00075725|454746021|FG009|Overall Study|Unsuccessful institutional transfer|1|||
126396958|NCT00075725|454746022|FG010|Overall Study|Unsuccessful institutional transfer|0|||
126396959|NCT00075725|454746023|FG011|Overall Study|Unsuccessful institutional transfer|0|||
126396960|NCT00075725|454746012|FG000|Overall Study|specimen(s) not submitted|0|||
126396961|NCT00075725|454746013|FG001|Overall Study|specimen(s) not submitted|0|||
126396962|NCT00075725|454746014|FG002|Overall Study|specimen(s) not submitted|2|||
126105148|NCT00406653|453678564|FG005|Maintenance Period|Adverse Event|1|||
126396963|NCT00075725|454746015|FG003|Overall Study|specimen(s) not submitted|0|||
126396964|NCT00075725|454746016|FG004|Overall Study|specimen(s) not submitted|0|||
126396965|NCT00075725|454746017|FG005|Overall Study|specimen(s) not submitted|0|||
126396966|NCT00075725|454746018|FG006|Overall Study|specimen(s) not submitted|0|||
126396967|NCT00075725|454746019|FG007|Overall Study|specimen(s) not submitted|0|||
126396968|NCT00075725|454746020|FG008|Overall Study|specimen(s) not submitted|0|||
126396969|NCT00075725|454746021|FG009|Overall Study|specimen(s) not submitted|0|||
126396970|NCT00075725|454746022|FG010|Overall Study|specimen(s) not submitted|0|||
126396971|NCT00075725|454746023|FG011|Overall Study|specimen(s) not submitted|0|||
125888561|NCT01039376|452889728|FG000|Overall Study|Lost to Follow-up|5|||
125888562|NCT01039376|452889729|FG001|Overall Study|Lost to Follow-up|12|||
126396972|NCT00075725|454746012|FG000|Overall Study|Pt went to transplant|0|||
126396973|NCT00075725|454746013|FG001|Overall Study|Pt went to transplant|0|||
126396974|NCT00075725|454746014|FG002|Overall Study|Pt went to transplant|0|||
126396975|NCT00075725|454746015|FG003|Overall Study|Pt went to transplant|1|||
126396976|NCT00075725|454746016|FG004|Overall Study|Pt went to transplant|0|||
126396977|NCT00075725|454746017|FG005|Overall Study|Pt went to transplant|1|||
126396978|NCT00075725|454746018|FG006|Overall Study|Pt went to transplant|0|||
126396979|NCT00075725|454746019|FG007|Overall Study|Pt went to transplant|0|||
126396980|NCT00075725|454746020|FG008|Overall Study|Pt went to transplant|0|||
126396981|NCT00075725|454746021|FG009|Overall Study|Pt went to transplant|0|||
126396982|NCT00075725|454746022|FG010|Overall Study|Pt went to transplant|0|||
126396983|NCT00075725|454746023|FG011|Overall Study|Pt went to transplant|0|||
126051948|NCT03678688|453485890|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
126051949|NCT03678688|453485882|FG000|Overall Study|Covid Related Adverse Event|0|||
126051950|NCT03678688|453485883|FG001|Overall Study|Covid Related Adverse Event|0|||
126051951|NCT03678688|453485884|FG002|Overall Study|Covid Related Adverse Event|0|||
126051952|NCT03678688|453485885|FG003|Overall Study|Covid Related Adverse Event|0|||
126051953|NCT03678688|453485886|FG004|Overall Study|Covid Related Adverse Event|0|||
126051954|NCT03678688|453485887|FG005|Overall Study|Covid Related Adverse Event|3|||
126051955|NCT03678688|453485888|FG006|Overall Study|Covid Related Adverse Event|1|||
126051956|NCT03678688|453485889|FG007|Overall Study|Covid Related Adverse Event|1|||
126051957|NCT03678688|453485890|FG008|Overall Study|Covid Related Adverse Event|0|||
126051958|NCT03678688|453485882|FG000|Overall Study|Physician Decision|0|||
126051959|NCT03678688|453485883|FG001|Overall Study|Physician Decision|0|||
126051960|NCT03678688|453485884|FG002|Overall Study|Physician Decision|0|||
126051961|NCT03678688|453485885|FG003|Overall Study|Physician Decision|0|||
126051962|NCT03678688|453485886|FG004|Overall Study|Physician Decision|0|||
126051963|NCT03678688|453485887|FG005|Overall Study|Physician Decision|1|||
126051964|NCT03678688|453485888|FG006|Overall Study|Physician Decision|0|||
126051965|NCT03678688|453485889|FG007|Overall Study|Physician Decision|0|||
126051966|NCT03678688|453485890|FG008|Overall Study|Physician Decision|0|||
126051967|NCT03678688|453485882|FG000|Overall Study|Withdrawal by Subject|0|||
126051968|NCT03678688|453485883|FG001|Overall Study|Withdrawal by Subject|0|||
126051969|NCT03678688|453485884|FG002|Overall Study|Withdrawal by Subject|0|||
126051970|NCT03678688|453485885|FG003|Overall Study|Withdrawal by Subject|0|||
126051971|NCT03678688|453485886|FG004|Overall Study|Withdrawal by Subject|0|||
126051972|NCT03678688|453485887|FG005|Overall Study|Withdrawal by Subject|0|||
126051973|NCT03678688|453485888|FG006|Overall Study|Withdrawal by Subject|2|||
126051974|NCT03678688|453485889|FG007|Overall Study|Withdrawal by Subject|1|||
126051975|NCT03678688|453485890|FG008|Overall Study|Withdrawal by Subject|0|||
126051976|NCT03002194|453485896|FG000|Overall Study|Lost to Follow-up|6|||
126051977|NCT03002194|453485896|FG000|Overall Study|Adverse Event|1|||
126051978|NCT03002194|453485896|FG000|Overall Study|Lack of Efficacy|1|||
126051979|NCT03002194|453485896|FG000|Overall Study|Withdrawal by Subject|2|||
126051980|NCT00985088|453485897|FG000|Overall Study|Serious Adverse Event|1|||
126051981|NCT00985088|453485898|FG001|Overall Study|Serious Adverse Event|1|||
126051982|NCT00985088|453485899|FG002|Overall Study|Serious Adverse Event|0|||
126051983|NCT00985088|453485900|FG003|Overall Study|Serious Adverse Event|0|||
126051984|NCT00985088|453485901|FG004|Overall Study|Serious Adverse Event|0|||
126051985|NCT00985088|453485902|FG005|Overall Study|Serious Adverse Event|0|||
126051986|NCT00985088|453485903|FG006|Overall Study|Serious Adverse Event|0|||
126051987|NCT00985088|453485904|FG007|Overall Study|Serious Adverse Event|1|||
126051988|NCT00985088|453485897|FG000|Overall Study|Adverse Event|0|||
126051989|NCT00985088|453485898|FG001|Overall Study|Adverse Event|0|||
126051990|NCT00985088|453485899|FG002|Overall Study|Adverse Event|1|||
126051991|NCT00985088|453485900|FG003|Overall Study|Adverse Event|0|||
126051992|NCT00985088|453485901|FG004|Overall Study|Adverse Event|0|||
126051993|NCT00985088|453485902|FG005|Overall Study|Adverse Event|0|||
126396984|NCT00075725|454746012|FG000|Overall Study|Pt received additional steroids|0|||
126396985|NCT00075725|454746013|FG001|Overall Study|Pt received additional steroids|0|||
126396986|NCT00075725|454746014|FG002|Overall Study|Pt received additional steroids|0|||
126396987|NCT00075725|454746015|FG003|Overall Study|Pt received additional steroids|1|||
126396988|NCT00075725|454746016|FG004|Overall Study|Pt received additional steroids|0|||
126396989|NCT00075725|454746017|FG005|Overall Study|Pt received additional steroids|0|||
126396990|NCT00075725|454746018|FG006|Overall Study|Pt received additional steroids|0|||
126396991|NCT00075725|454746019|FG007|Overall Study|Pt received additional steroids|0|||
126396992|NCT00075725|454746020|FG008|Overall Study|Pt received additional steroids|0|||
126396993|NCT00075725|454746021|FG009|Overall Study|Pt received additional steroids|0|||
126396994|NCT00075725|454746022|FG010|Overall Study|Pt received additional steroids|0|||
126396995|NCT00075725|454746023|FG011|Overall Study|Pt received additional steroids|0|||
126396996|NCT00075725|454746012|FG000|Overall Study|Pt relocated|0|||
126396997|NCT00075725|454746013|FG001|Overall Study|Pt relocated|0|||
126396998|NCT00075725|454746014|FG002|Overall Study|Pt relocated|0|||
126051994|NCT00985088|453485903|FG006|Overall Study|Adverse Event|0|||
126051995|NCT00985088|453485904|FG007|Overall Study|Adverse Event|0|||
126051996|NCT00985088|453485897|FG000|Overall Study|Withdrawal by Subject|4|||
126051997|NCT00985088|453485898|FG001|Overall Study|Withdrawal by Subject|0|||
126051998|NCT00985088|453485899|FG002|Overall Study|Withdrawal by Subject|0|||
126051999|NCT00985088|453485900|FG003|Overall Study|Withdrawal by Subject|1|||
126396999|NCT00075725|454746015|FG003|Overall Study|Pt relocated|2|||
126397000|NCT00075725|454746016|FG004|Overall Study|Pt relocated|0|||
126052000|NCT00985088|453485901|FG004|Overall Study|Withdrawal by Subject|3|||
126052001|NCT00985088|453485902|FG005|Overall Study|Withdrawal by Subject|2|||
126052002|NCT00985088|453485903|FG006|Overall Study|Withdrawal by Subject|1|||
126052003|NCT00985088|453485904|FG007|Overall Study|Withdrawal by Subject|2|||
126052004|NCT00985088|453485897|FG000|Overall Study|Migrated/moved from study area|0|||
126052005|NCT00985088|453485898|FG001|Overall Study|Migrated/moved from study area|0|||
126052006|NCT00985088|453485899|FG002|Overall Study|Migrated/moved from study area|1|||
126397001|NCT00075725|454746017|FG005|Overall Study|Pt relocated|1|||
126397002|NCT00075725|454746018|FG006|Overall Study|Pt relocated|1|||
126397003|NCT00075725|454746019|FG007|Overall Study|Pt relocated|2|||
126397004|NCT00075725|454746020|FG008|Overall Study|Pt relocated|1|||
126397005|NCT00075725|454746021|FG009|Overall Study|Pt relocated|0|||
126397006|NCT00075725|454746022|FG010|Overall Study|Pt relocated|0|||
126397007|NCT00075725|454746023|FG011|Overall Study|Pt relocated|0|||
126397008|NCT00075725|454746012|FG000|Overall Study|Institution Terminated|0|||
126397009|NCT00075725|454746013|FG001|Overall Study|Institution Terminated|0|||
126397010|NCT00075725|454746014|FG002|Overall Study|Institution Terminated|0|||
126397011|NCT00075725|454746015|FG003|Overall Study|Institution Terminated|0|||
126397012|NCT00075725|454746016|FG004|Overall Study|Institution Terminated|1|||
126397013|NCT00075725|454746017|FG005|Overall Study|Institution Terminated|0|||
126397014|NCT00075725|454746018|FG006|Overall Study|Institution Terminated|0|||
126397015|NCT00075725|454746019|FG007|Overall Study|Institution Terminated|3|||
126397016|NCT00075725|454746020|FG008|Overall Study|Institution Terminated|0|||
126397017|NCT00075725|454746021|FG009|Overall Study|Institution Terminated|0|||
126397018|NCT00075725|454746022|FG010|Overall Study|Institution Terminated|0|||
126397019|NCT00075725|454746023|FG011|Overall Study|Institution Terminated|0|||
126397020|NCT00075725|454746012|FG000|Overall Study|Study Closure|1|||
126397021|NCT00075725|454746013|FG001|Overall Study|Study Closure|0|||
126397022|NCT00075725|454746014|FG002|Overall Study|Study Closure|0|||
126397023|NCT00075725|454746015|FG003|Overall Study|Study Closure|0|||
126397024|NCT00075725|454746016|FG004|Overall Study|Study Closure|1|||
126397025|NCT00075725|454746017|FG005|Overall Study|Study Closure|3|||
126397026|NCT00075725|454746018|FG006|Overall Study|Study Closure|0|||
126397027|NCT00075725|454746019|FG007|Overall Study|Study Closure|1|||
126397028|NCT00075725|454746020|FG008|Overall Study|Study Closure|0|||
126397029|NCT00075725|454746021|FG009|Overall Study|Study Closure|0|||
126397030|NCT00075725|454746022|FG010|Overall Study|Study Closure|0|||
126397031|NCT00075725|454746023|FG011|Overall Study|Study Closure|0|||
126397032|NCT00075725|454746012|FG000|Overall Study|Other complications|0|||
126397033|NCT00075725|454746013|FG001|Overall Study|Other complications|0|||
126397034|NCT00075725|454746014|FG002|Overall Study|Other complications|0|||
126397035|NCT00075725|454746015|FG003|Overall Study|Other complications|0|||
126397036|NCT00075725|454746016|FG004|Overall Study|Other complications|0|||
126397037|NCT00075725|454746017|FG005|Overall Study|Other complications|1|||
126397038|NCT00075725|454746018|FG006|Overall Study|Other complications|0|||
126397039|NCT00075725|454746019|FG007|Overall Study|Other complications|0|||
126397040|NCT00075725|454746020|FG008|Overall Study|Other complications|0|||
126397041|NCT00075725|454746021|FG009|Overall Study|Other complications|0|||
126397042|NCT00075725|454746022|FG010|Overall Study|Other complications|0|||
126397043|NCT00075725|454746023|FG011|Overall Study|Other complications|0|||
126397044|NCT00075725|454746012|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
126397045|NCT00075725|454746013|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
126397046|NCT00075725|454746014|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
126397047|NCT00075725|454746015|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
126397048|NCT00075725|454746016|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
126397049|NCT00075725|454746017|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
126397050|NCT00075725|454746018|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
126397051|NCT00075725|454746019|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
126397052|NCT00075725|454746020|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
126397053|NCT00075725|454746021|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
126397054|NCT00075725|454746022|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
126052007|NCT00985088|453485900|FG003|Overall Study|Migrated/moved from study area|0|||
126052008|NCT00985088|453485901|FG004|Overall Study|Migrated/moved from study area|0|||
126052009|NCT00985088|453485902|FG005|Overall Study|Migrated/moved from study area|0|||
126052010|NCT00985088|453485903|FG006|Overall Study|Migrated/moved from study area|0|||
126052011|NCT00985088|453485904|FG007|Overall Study|Migrated/moved from study area|1|||
126052012|NCT00985088|453485897|FG000|Overall Study|Lost to Follow-up|6|||
126052013|NCT00985088|453485898|FG001|Overall Study|Lost to Follow-up|1|||
126052014|NCT00985088|453485899|FG002|Overall Study|Lost to Follow-up|2|||
126052015|NCT00985088|453485900|FG003|Overall Study|Lost to Follow-up|6|||
126397055|NCT00075725|454746023|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
126397056|NCT00075725|454746012|FG000|Overall Study|Pt incarcerated|0|||
126397057|NCT00075725|454746013|FG001|Overall Study|Pt incarcerated|0|||
126397058|NCT00075725|454746014|FG002|Overall Study|Pt incarcerated|0|||
126397059|NCT00075725|454746015|FG003|Overall Study|Pt incarcerated|0|||
126397060|NCT00075725|454746016|FG004|Overall Study|Pt incarcerated|0|||
126052016|NCT00985088|453485901|FG004|Overall Study|Lost to Follow-up|6|||
126397061|NCT00075725|454746017|FG005|Overall Study|Pt incarcerated|0|||
126052017|NCT00985088|453485902|FG005|Overall Study|Lost to Follow-up|5|||
126052018|NCT00985088|453485903|FG006|Overall Study|Lost to Follow-up|3|||
126052019|NCT00985088|453485904|FG007|Overall Study|Lost to Follow-up|2|||
126052020|NCT01278030|453485907|FG000|Overall Study|Withdrawal by Subject|8|||
126052021|NCT01278030|453485908|FG001|Overall Study|Withdrawal by Subject|4|||
126052022|NCT00458783|453485910|FG000|Overall Study|Protocol Violation|1228|||
126052023|NCT00458783|453485911|FG001|Overall Study|Protocol Violation|1220|||
126052024|NCT01737398|453485912|FG000|Overall Study|Adverse event or SAE|16|||
126052025|NCT01737398|453485913|FG001|Overall Study|Adverse event or SAE|1|||
126052026|NCT01737398|453485912|FG000|Overall Study|Stopping rule met|2|||
126052027|NCT01737398|453485913|FG001|Overall Study|Stopping rule met|1|||
126052028|NCT01737398|453485912|FG000|Overall Study|Voluntary withdrawal|2|||
126052029|NCT01737398|453485913|FG001|Overall Study|Voluntary withdrawal|3|||
126052030|NCT01737398|453485912|FG000|Overall Study|Ineligibility|1|||
126052031|NCT01737398|453485913|FG001|Overall Study|Ineligibility|0|||
126052032|NCT01737398|453485912|FG000|Overall Study|Liver transplant|1|||
126052033|NCT01737398|453485913|FG001|Overall Study|Liver transplant|0|||
126052034|NCT01737398|453485912|FG000|Overall Study|Disease progression|2|||
126052035|NCT01737398|453485913|FG001|Overall Study|Disease progression|3|||
126052036|NCT01737398|453485912|FG000|Overall Study|Sponsor's decision|2|||
126052037|NCT01737398|453485913|FG001|Overall Study|Sponsor's decision|0|||
126052038|NCT02962284|453485915|FG000|Overall Study|Death|2|||
126052039|NCT02962284|453485916|FG001|Overall Study|Death|0|||
126052040|NCT02962284|453485915|FG000|Overall Study|Progressive disease|2|||
126052041|NCT02962284|453485916|FG001|Overall Study|Progressive disease|3|||
126052042|NCT02962284|453485915|FG000|Overall Study|Withdrawal by Subject|1|||
126052043|NCT02962284|453485916|FG001|Overall Study|Withdrawal by Subject|0|||
126052044|NCT00357994|453485919|FG000|Overall Study|Adverse Event|1|||
126052045|NCT00357994|453485920|FG001|Overall Study|Adverse Event|2|||
126052046|NCT00357994|453485919|FG000|Overall Study|Lack of Efficacy|0|||
126052047|NCT00357994|453485920|FG001|Overall Study|Lack of Efficacy|1|||
126052048|NCT00357994|453485919|FG000|Overall Study|Protocol Violation|1|||
126052049|NCT00357994|453485920|FG001|Overall Study|Protocol Violation|0|||
126397062|NCT00075725|454746018|FG006|Overall Study|Pt incarcerated|0|||
126397063|NCT00075725|454746019|FG007|Overall Study|Pt incarcerated|1|||
126397064|NCT00075725|454746020|FG008|Overall Study|Pt incarcerated|0|||
126397065|NCT00075725|454746021|FG009|Overall Study|Pt incarcerated|0|||
126397066|NCT00075725|454746022|FG010|Overall Study|Pt incarcerated|0|||
126397067|NCT00075725|454746023|FG011|Overall Study|Pt incarcerated|0|||
126397068|NCT01444027|454746026|FG000|Overall Study|Withdrawal by Subject|4|||
126397069|NCT01444027|454746027|FG001|Overall Study|Withdrawal by Subject|10|||
126397070|NCT01444027|454746028|FG002|Overall Study|Withdrawal by Subject|24|||
126397071|NCT01444027|454746026|FG000|Overall Study|Lost to Follow-up|26|||
126397072|NCT01444027|454746027|FG001|Overall Study|Lost to Follow-up|20|||
126397073|NCT01444027|454746028|FG002|Overall Study|Lost to Follow-up|14|||
126397074|NCT00737711|454746030|FG000|Overall Study|Adverse Event|2|||
126397075|NCT00737711|454746030|FG000|Overall Study|Death|8|||
126397076|NCT00737711|454746030|FG000|Overall Study|Failure to return|4|||
126397077|NCT00737711|454746030|FG000|Overall Study|Protocol Violation|1|||
126397078|NCT00737711|454746030|FG000|Overall Study|Withdrawal by Subject|5|||
126397079|NCT00737711|454746030|FG000|Overall Study|Blood transfusion|6|||
126397080|NCT00737711|454746030|FG000|Overall Study|Other|5|||
126397081|NCT04035564|454748076|FG000|Overall Study|Protocol Violation|1|||
126397082|NCT04035564|454748077|FG001|Overall Study|Protocol Violation|2|||
126052050|NCT04162210|453485925|FG000|Overall Study|Lost to Follow-up|4|||
126052051|NCT04162210|453485926|FG001|Overall Study|Lost to Follow-up|1|||
126052052|NCT04162210|453485925|FG000|Overall Study|Withdrawal by Subject|17|||
126052053|NCT04162210|453485926|FG001|Overall Study|Withdrawal by Subject|9|||
126052054|NCT04162210|453485925|FG000|Overall Study|Ongoing|113|||
126052055|NCT04162210|453485926|FG001|Overall Study|Ongoing|59|||
126052056|NCT03244800|453485927|FG000|Overall Study|Adverse Event|0|||
126052057|NCT03244800|453485928|FG001|Overall Study|Adverse Event|1|||
126052058|NCT03244800|453485929|FG002|Overall Study|Adverse Event|0|||
126052059|NCT03244800|453485930|FG003|Overall Study|Adverse Event|1|||
126052060|NCT03244800|453485927|FG000|Overall Study|Withdrew treatment|0|||
126105149|NCT00406653|453678565|FG006|Maintenance Period|Adverse Event|0|||
126397083|NCT04035564|454748076|FG000|Overall Study|No laboratory available|2|||
126397084|NCT04035564|454748077|FG001|Overall Study|No laboratory available|2|||
126397085|NCT04035564|454748076|FG000|Overall Study|Guardian declined consent|1|||
126397086|NCT04035564|454748077|FG001|Overall Study|Guardian declined consent|2|||
126397087|NCT03505788|454748078|FG000|Overall Study|Lost to Follow-up|2|||
126397088|NCT03505788|454748079|FG001|Overall Study|Lost to Follow-up|1|||
126052061|NCT03244800|453485928|FG001|Overall Study|Withdrew treatment|0|||
126052062|NCT03244800|453485929|FG002|Overall Study|Withdrew treatment|0|||
126052063|NCT03244800|453485930|FG003|Overall Study|Withdrew treatment|1|||
126052064|NCT00371345|453485933|FG000|Overall Study|Disease Progression|21|||
126052065|NCT00371345|453485934|FG001|Overall Study|Disease Progression|35|||
126052066|NCT00371345|453485933|FG000|Overall Study|Study Drug Toxicity|1|||
126052067|NCT00371345|453485934|FG001|Overall Study|Study Drug Toxicity|7|||
126397089|NCT03505788|454748078|FG000|Overall Study|Withdrawal by Subject|1|||
126397090|NCT03505788|454748079|FG001|Overall Study|Withdrawal by Subject|3|||
126397091|NCT03505788|454748078|FG000|Overall Study|Physician Decision|0|||
126397092|NCT03505788|454748079|FG001|Overall Study|Physician Decision|1|||
126397093|NCT01007123|454748084|FG000|Overall Study|Adverse Event|3|||
126397094|NCT01007123|454748085|FG001|Overall Study|Adverse Event|4|||
126397095|NCT01007123|454748086|FG002|Overall Study|Adverse Event|7|||
126397096|NCT01007123|454748087|FG003|Overall Study|Adverse Event|1|||
126397097|NCT01007123|454748084|FG000|Overall Study|Lack of Efficacy|1|||
126397098|NCT01007123|454748085|FG001|Overall Study|Lack of Efficacy|0|||
126397099|NCT01007123|454748086|FG002|Overall Study|Lack of Efficacy|1|||
126397100|NCT01007123|454748087|FG003|Overall Study|Lack of Efficacy|4|||
126397101|NCT01007123|454748084|FG000|Overall Study|Protocol Violation|1|||
126397102|NCT01007123|454748085|FG001|Overall Study|Protocol Violation|1|||
126397103|NCT01007123|454748086|FG002|Overall Study|Protocol Violation|2|||
126397104|NCT01007123|454748087|FG003|Overall Study|Protocol Violation|1|||
126397105|NCT01007123|454748084|FG000|Overall Study|Withdrawal by Subject|1|||
126397106|NCT01007123|454748085|FG001|Overall Study|Withdrawal by Subject|0|||
126397107|NCT01007123|454748086|FG002|Overall Study|Withdrawal by Subject|1|||
126397108|NCT01007123|454748087|FG003|Overall Study|Withdrawal by Subject|0|||
126397109|NCT01007123|454748084|FG000|Overall Study|Lost to Follow-up|0|||
126397110|NCT01007123|454748085|FG001|Overall Study|Lost to Follow-up|1|||
126397111|NCT01007123|454748086|FG002|Overall Study|Lost to Follow-up|0|||
126397112|NCT01007123|454748087|FG003|Overall Study|Lost to Follow-up|0|||
126397113|NCT00149994|454748088|FG000|Overall Study|Administrative problems:|1|||
126397114|NCT00149994|454748089|FG001|Overall Study|Administrative problems:|0|||
126397115|NCT00149994|454748088|FG000|Overall Study|Protocol Violation|0|||
126397116|NCT00149994|454748089|FG001|Overall Study|Protocol Violation|1|||
126397117|NCT02324205|454748092|FG000|Overall Study|Withdrawal by Subject|37|||
126397118|NCT01774097|454748093|FG000|Overall Study|Withdrawal by Subject|1|||
126397119|NCT01774097|454748094|FG001|Overall Study|Withdrawal by Subject|1|||
126397120|NCT01774097|454748093|FG000|Overall Study|Adverse Event|1|||
126397121|NCT01774097|454748094|FG001|Overall Study|Adverse Event|1|||
126397122|NCT00937404|454748096|FG000|Overall Study|Protocol Violation|1|||
126397123|NCT00937404|454748096|FG000|Overall Study|Withdrawal by Subject|1|||
126397124|NCT00230282|454748097|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
126397125|NCT00230282|454748097|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
126397126|NCT00230282|454748097|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
126397127|NCT00230282|454748097|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
126397128|NCT00090233|454748100|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
126397129|NCT00090233|454748101|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
126397130|NCT00090233|454748100|FG000|Overall Study|Adverse Event|214|||
126397131|NCT00090233|454748101|FG001|Overall Study|Adverse Event|198|||
126397132|NCT00090233|454748100|FG000|Overall Study|Lost to Follow-up|68|||
126397133|NCT00090233|454748101|FG001|Overall Study|Lost to Follow-up|95|||
126397134|NCT00090233|454748100|FG000|Overall Study|Protocol Violation|960|||
126397135|NCT00090233|454748101|FG001|Overall Study|Protocol Violation|1022|||
126397136|NCT00090233|454748100|FG000|Overall Study|Withdrawal by Subject|182|||
126397137|NCT00090233|454748101|FG001|Overall Study|Withdrawal by Subject|211|||
126397138|NCT00090233|454748100|FG000|Overall Study|Moved|203|||
126397139|NCT00090233|454748101|FG001|Overall Study|Moved|189|||
126052068|NCT00371345|453485933|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
126052069|NCT00371345|453485934|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
126052070|NCT00371345|453485933|FG000|Overall Study|Participant Request|1|||
126052071|NCT00371345|453485934|FG001|Overall Study|Participant Request|1|||
126397140|NCT00090233|454748100|FG000|Overall Study|Other|1211|||
126397141|NCT00090233|454748101|FG001|Overall Study|Other|1160|||
126397142|NCT00090233|454748100|FG000|Overall Study|Data not available at data cut-off point|1552|||
126397143|NCT00090233|454748101|FG001|Overall Study|Data not available at data cut-off point|1563|||
126397144|NCT04863248|454748102|FG000|Overall Study|Sponsor Terminated|4|||
126397145|NCT04863248|454748103|FG001|Overall Study|Sponsor Terminated|1|||
126397146|NCT04863248|454748102|FG000|Overall Study|Death|0|||
126397147|NCT04863248|454748103|FG001|Overall Study|Death|1|||
126052072|NCT00371345|453485933|FG000|Overall Study|Participant Withdrew Consent|0|||
126397148|NCT04863248|454748102|FG000|Overall Study|Withdrawal by Subject|0|||
126397149|NCT04863248|454748103|FG001|Overall Study|Withdrawal by Subject|1|||
126397150|NCT01691105|454748104|FG000|1 Month Follow-up|Lost to Follow-up|41|||
126397151|NCT01691105|454748105|FG001|1 Month Follow-up|Lost to Follow-up|38|||
126397152|NCT01691105|454748104|FG000|1 Month Follow-up|Death|2|||
126397153|NCT01691105|454748105|FG001|1 Month Follow-up|Death|3|||
126397154|NCT01691105|454748104|FG000|6 Month Follow-up|Lost to Follow-up|39|||
126397155|NCT01691105|454748105|FG001|6 Month Follow-up|Lost to Follow-up|58|||
126397156|NCT01691105|454748104|FG000|6 Month Follow-up|Death|13|||
126397157|NCT01691105|454748105|FG001|6 Month Follow-up|Death|13|||
126397158|NCT01691105|454748104|FG000|12 Month Follow-up|Lost to Follow-up|50|||
126397159|NCT01691105|454748105|FG001|12 Month Follow-up|Lost to Follow-up|71|||
126397160|NCT01691105|454748104|FG000|12 Month Follow-up|Death|22|||
126397161|NCT01691105|454748105|FG001|12 Month Follow-up|Death|30|||
126397162|NCT01691105|454748104|FG000|12 Month Biochemical Verification|Death|22|||
126397163|NCT01691105|454748105|FG001|12 Month Biochemical Verification|Death|30|||
126397164|NCT01691105|454748104|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
126397165|NCT01691105|454748105|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
126397166|NCT01691105|454748104|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
126397167|NCT01691105|454748105|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
126397168|NCT03263923|454748106|FG000|Overall Study|Withdrawal by Subject|10|||
126397169|NCT03263923|454748107|FG001|Overall Study|Withdrawal by Subject|8|||
126397170|NCT03263923|454748106|FG000|Overall Study|Lost to Follow-up|15|||
126397171|NCT03263923|454748107|FG001|Overall Study|Lost to Follow-up|13|||
126397172|NCT03362931|454748108|FG000|Overall Study|Adverse Event|1|||
126397173|NCT03362931|454748108|FG000|Overall Study|Death|2|||
126397174|NCT02229214|454748117|FG000|Overall Study|Adverse Event|2|||
126397175|NCT02229214|454748118|FG001|Overall Study|Adverse Event|0|||
126397176|NCT02229214|454748117|FG000|Overall Study|Withdrawal by Subject|4|||
126397177|NCT02229214|454748118|FG001|Overall Study|Withdrawal by Subject|0|||
126397178|NCT00969761|454748119|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
126397179|NCT00969761|454748120|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397180|NCT00969761|454748121|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397181|NCT00969761|454748122|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
126397182|NCT00969761|454748123|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397183|NCT00969761|454748124|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397184|NCT00969761|454748125|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397185|NCT00969761|454748126|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397186|NCT00969761|454748127|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
126397187|NCT00969761|454748128|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
126397188|NCT00969761|454748129|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397189|NCT00969761|454748130|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397190|NCT00969761|454748119|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397191|NCT00969761|454748120|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397192|NCT00969761|454748121|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
126397193|NCT00969761|454748122|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397194|NCT00969761|454748123|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397195|NCT00969761|454748124|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397196|NCT00969761|454748125|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397197|NCT00969761|454748126|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397198|NCT00969761|454748127|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397199|NCT00969761|454748128|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397200|NCT00969761|454748129|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397201|NCT00969761|454748130|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397202|NCT00969761|454748119|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397203|NCT00969761|454748120|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397204|NCT00969761|454748121|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
126397205|NCT00969761|454748122|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397206|NCT00969761|454748123|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397207|NCT00969761|454748124|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397208|NCT00969761|454748125|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397209|NCT00969761|454748126|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397210|NCT00969761|454748127|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397211|NCT00969761|454748128|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397212|NCT00969761|454748129|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397213|NCT00969761|454748130|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397214|NCT00969761|454748119|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397215|NCT00969761|454748120|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397216|NCT00969761|454748121|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397217|NCT00969761|454748122|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397218|NCT00969761|454748123|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397219|NCT00969761|454748124|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397220|NCT00969761|454748125|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125888563|NCT01039376|452889728|FG000|Overall Study|Physician Decision|15|||
125888564|NCT01039376|452889729|FG001|Overall Study|Physician Decision|10|||
126397221|NCT00969761|454748126|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397222|NCT00969761|454748127|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
126397223|NCT00969761|454748128|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397224|NCT00969761|454748129|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397225|NCT00969761|454748130|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397226|NCT00969761|454748119|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
126397227|NCT00969761|454748120|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397228|NCT00969761|454748121|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
126397229|NCT00969761|454748122|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397230|NCT00969761|454748123|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
126397231|NCT00969761|454748124|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397232|NCT00969761|454748125|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397233|NCT00969761|454748126|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
126397234|NCT00969761|454748127|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
126397235|NCT00969761|454748128|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
126397236|NCT00969761|454748129|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397237|NCT00969761|454748130|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397238|NCT00969761|454748119|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397239|NCT00969761|454748120|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397240|NCT00969761|454748121|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397241|NCT00969761|454748122|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
126397242|NCT00969761|454748123|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
126397243|NCT00969761|454748124|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397244|NCT00969761|454748125|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397245|NCT00969761|454748126|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397246|NCT00969761|454748127|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
126397247|NCT00969761|454748128|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397248|NCT00969761|454748129|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397249|NCT00969761|454748130|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397250|NCT02927925|454748137|FG000|Overall Study|Death|16|||
126397251|NCT02927925|454748137|FG000|Overall Study|Physician Decision|1|||
126397252|NCT02927925|454748137|FG000|Overall Study|Withdrawal by Subject|11|||
126397253|NCT02927925|454748137|FG000|Overall Study|Other|3|||
126397254|NCT02927925|454748137|FG000|Overall Study|Disease progression at clinical cutoff|1|||
126397255|NCT03305081|454748140|FG000|Overall Study|Lost to Follow-up|10|||
126397256|NCT03305081|454748141|FG001|Overall Study|Lost to Follow-up|15|||
126397257|NCT01571284|454748148|FG000|Overall Study|Participant's decision|84|||
126397258|NCT01571284|454748148|FG000|Overall Study|Lost to Follow-up|3|||
126397259|NCT01571284|454748148|FG000|Overall Study|Enrolled but not treated|2|||
126397260|NCT01571284|454748148|FG000|Overall Study|Other than specified above|80|||
126397261|NCT04065074|454748149|FG000|Overall Study|Adverse Event|1|||
126397262|NCT04065074|454748149|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
126397263|NCT00871117|454748150|FG000|Overall Study|Lost to Follow-up|5|||
126397264|NCT00871117|454748151|FG001|Overall Study|Lost to Follow-up|6|||
126397265|NCT00871117|454748150|FG000|Overall Study|Other|0|||
126397266|NCT00871117|454748151|FG001|Overall Study|Other|4|||
126397267|NCT03385265|454748155|FG000|Overall Study|Withdrawal by Subject|5|||
126397268|NCT03385265|454748156|FG001|Overall Study|Withdrawal by Subject|2|||
126397269|NCT03385265|454748157|FG002|Overall Study|Withdrawal by Subject|5|||
126397270|NCT03385265|454748158|FG003|Overall Study|Withdrawal by Subject|2|||
126397271|NCT01560637|454748159|FG000|Overall Study|Adverse Event|63|||
126397272|NCT01560637|454748159|FG000|Overall Study|Death|69|||
126397273|NCT01560637|454748159|FG000|Overall Study|Lost to Follow-up|8|||
126397274|NCT01560637|454748159|FG000|Overall Study|Protocol Violation|8|||
126397275|NCT01560637|454748159|FG000|Overall Study|Withdrawal by Subject|24|||
126397276|NCT01560637|454748159|FG000|Overall Study|Progressive Disease|20|||
126052073|NCT00371345|453485934|FG001|Overall Study|Participant Withdrew Consent|1|||
126052074|NCT01478594|453485935|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
126052075|NCT01478594|453485936|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
126052076|NCT01478594|453485935|FG000|Overall Study|Death|45|||
126397277|NCT01560637|454748159|FG000|Overall Study|Other Reason Not Specified|6|||
126397278|NCT02323204|454748165|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
126397279|NCT02323204|454748166|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
126397280|NCT02323204|454748167|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
126397281|NCT02323204|454748168|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
126397282|NCT02323204|454748165|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
126397283|NCT02323204|454748166|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
126397284|NCT02323204|454748167|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
126397285|NCT02323204|454748168|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
126397286|NCT02323204|454748165|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
126052077|NCT01478594|453485936|FG001|Overall Study|Death|18|||
126397287|NCT02323204|454748166|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
126397288|NCT02323204|454748167|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
126397289|NCT02323204|454748168|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
126397290|NCT02323204|454748165|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
126397291|NCT02323204|454748166|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
126397292|NCT02323204|454748167|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
126397293|NCT02323204|454748168|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
126397294|NCT02323204|454748165|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
126397295|NCT02323204|454748166|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
126397296|NCT02323204|454748167|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
126397297|NCT02323204|454748168|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
126397298|NCT02323204|454748165|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
126397299|NCT02323204|454748166|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
126397300|NCT02323204|454748167|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
126397301|NCT02323204|454748168|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
126397302|NCT02323204|454748165|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
126397303|NCT02323204|454748166|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
126397304|NCT02323204|454748167|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
126397305|NCT02323204|454748168|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
126397306|NCT02323204|454748165|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
126397307|NCT02323204|454748166|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
126397308|NCT02323204|454748167|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
126397309|NCT02323204|454748168|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
126397310|NCT02323204|454748165|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
126397311|NCT02323204|454748166|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
126397312|NCT02323204|454748167|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
126397313|NCT02323204|454748168|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
126397314|NCT03831880|454748169|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
126397315|NCT03831880|454748170|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
126397316|NCT03831880|454748169|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
126397317|NCT03831880|454748170|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
126397318|NCT01852825|454748171|FG000|Overall Study|Withdrawal by Subject|2|||
126397319|NCT01852825|454748172|FG001|Overall Study|Withdrawal by Subject|0|||
126397320|NCT01852825|454748173|FG002|Overall Study|Withdrawal by Subject|0|||
126397321|NCT00724854|454748175|FG000|Overall Study|Lack of Efficacy|187|||
126397322|NCT00724854|454748176|FG001|Overall Study|Lack of Efficacy|13|||
126397323|NCT00724854|454748175|FG000|Overall Study|Lost to Follow-up|87|||
126397324|NCT00724854|454748176|FG001|Overall Study|Lost to Follow-up|10|||
126397325|NCT00724854|454748175|FG000|Overall Study|Adverse Event|62|||
126397326|NCT00724854|454748176|FG001|Overall Study|Adverse Event|4|||
126397327|NCT00724854|454748175|FG000|Overall Study|Other|42|||
126397328|NCT00724854|454748176|FG001|Overall Study|Other|3|||
126397329|NCT00724854|454748175|FG000|Overall Study|Death|11|||
126397330|NCT00724854|454748176|FG001|Overall Study|Death|0|||
126397331|NCT00724854|454748175|FG000|Overall Study|Change of treatment|7|||
126397332|NCT00724854|454748176|FG001|Overall Study|Change of treatment|0|||
126052078|NCT01478594|453485935|FG000|Overall Study|Lost to Follow-up|3|||
126052079|NCT01478594|453485936|FG001|Overall Study|Lost to Follow-up|1|||
126397333|NCT00724854|454748175|FG000|Overall Study|Withdrawal by Subject|5|||
126397334|NCT00724854|454748176|FG001|Overall Study|Withdrawal by Subject|0|||
126397335|NCT00724854|454748175|FG000|Overall Study|Adverse event + lack of efficacy|2|||
126397336|NCT00724854|454748176|FG001|Overall Study|Adverse event + lack of efficacy|1|||
126397337|NCT01095653|454748177|FG000|Overall Study|Lack of Efficacy|3|||
126397338|NCT01095653|454748178|FG001|Overall Study|Lack of Efficacy|0|||
126397339|NCT01095653|454748179|FG002|Overall Study|Lack of Efficacy|0|||
126397340|NCT01095653|454748177|FG000|Overall Study|Adverse Event|1|||
126397341|NCT01095653|454748178|FG001|Overall Study|Adverse Event|4|||
126397342|NCT01095653|454748179|FG002|Overall Study|Adverse Event|4|||
126397343|NCT01095653|454748177|FG000|Overall Study|Lost to Follow-up|1|||
126397344|NCT01095653|454748178|FG001|Overall Study|Lost to Follow-up|0|||
126397345|NCT01095653|454748179|FG002|Overall Study|Lost to Follow-up|4|||
126397346|NCT01095653|454748177|FG000|Overall Study|Withdrawal by Subject|4|||
126397347|NCT01095653|454748178|FG001|Overall Study|Withdrawal by Subject|5|||
126397348|NCT01095653|454748179|FG002|Overall Study|Withdrawal by Subject|3|||
126397349|NCT01095653|454748177|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
126397350|NCT01095653|454748178|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
126397351|NCT01095653|454748179|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
126397352|NCT00171925|454748180|FG000|Overall Study|Adverse Event|10|||
126397353|NCT00171925|454748181|FG001|Overall Study|Adverse Event|6|||
126397354|NCT00171925|454748180|FG000|Overall Study|Protocol Violation|1|||
126397355|NCT00171925|454748181|FG001|Overall Study|Protocol Violation|1|||
126052080|NCT01478594|453485935|FG000|Overall Study|Withdrawal by Subject|9|||
126397356|NCT00171925|454748180|FG000|Overall Study|Withdrawal by Subject|6|||
126397357|NCT00171925|454748181|FG001|Overall Study|Withdrawal by Subject|9|||
126397358|NCT00171925|454748180|FG000|Overall Study|Lost to Follow-up|2|||
126397359|NCT00171925|454748181|FG001|Overall Study|Lost to Follow-up|2|||
126397360|NCT00171925|454748180|FG000|Overall Study|Administrative problems|10|||
126397361|NCT00171925|454748181|FG001|Overall Study|Administrative problems|11|||
126397362|NCT00171925|454748180|FG000|Overall Study|Death|1|||
126397363|NCT00171925|454748181|FG001|Overall Study|Death|2|||
126397364|NCT02692040|454748182|FG000|Overall Study|Protocol Violation|0|||
126397365|NCT02692040|454748183|FG001|Overall Study|Protocol Violation|0|||
126397366|NCT02692040|454748184|FG002|Overall Study|Protocol Violation|0|||
126397367|NCT02692040|454748185|FG003|Overall Study|Protocol Violation|0|||
126397368|NCT02692040|454748186|FG004|Overall Study|Protocol Violation|0|||
126397369|NCT02692040|454748187|FG005|Overall Study|Protocol Violation|0|||
126397370|NCT02692040|454748188|FG006|Overall Study|Protocol Violation|0|||
126397371|NCT02692040|454748189|FG007|Overall Study|Protocol Violation|0|||
126397372|NCT02692040|454748190|FG008|Overall Study|Protocol Violation|0|||
126397373|NCT02692040|454748191|FG009|Overall Study|Protocol Violation|0|||
126397374|NCT02692040|454748192|FG010|Overall Study|Protocol Violation|0|||
126397375|NCT02692040|454748193|FG011|Overall Study|Protocol Violation|0|||
126397376|NCT02692040|454748194|FG012|Overall Study|Protocol Violation|1|||
126397377|NCT02692040|454748195|FG013|Overall Study|Protocol Violation|0|||
126397378|NCT02692040|454748196|FG014|Overall Study|Protocol Violation|0|||
126397379|NCT02692040|454748197|FG015|Overall Study|Protocol Violation|0|||
126397380|NCT02692040|454748198|FG016|Overall Study|Protocol Violation|0|||
126397381|NCT02692040|454748182|FG000|Overall Study|Adverse Event|0|||
126397382|NCT02692040|454748183|FG001|Overall Study|Adverse Event|0|||
126397383|NCT02692040|454748184|FG002|Overall Study|Adverse Event|0|||
126397384|NCT02692040|454748185|FG003|Overall Study|Adverse Event|0|||
126397385|NCT02692040|454748186|FG004|Overall Study|Adverse Event|0|||
126397386|NCT02692040|454748187|FG005|Overall Study|Adverse Event|0|||
126397387|NCT02692040|454748188|FG006|Overall Study|Adverse Event|0|||
126397388|NCT02692040|454748189|FG007|Overall Study|Adverse Event|0|||
126397389|NCT02692040|454748190|FG008|Overall Study|Adverse Event|0|||
126397390|NCT02692040|454748191|FG009|Overall Study|Adverse Event|0|||
126397391|NCT02692040|454748192|FG010|Overall Study|Adverse Event|0|||
126397392|NCT02692040|454748193|FG011|Overall Study|Adverse Event|0|||
126397393|NCT02692040|454748194|FG012|Overall Study|Adverse Event|0|||
126397394|NCT02692040|454748195|FG013|Overall Study|Adverse Event|3|||
126397395|NCT02692040|454748196|FG014|Overall Study|Adverse Event|1|||
126397396|NCT02692040|454748197|FG015|Overall Study|Adverse Event|1|||
126397397|NCT02692040|454748198|FG016|Overall Study|Adverse Event|0|||
126397398|NCT02752958|454748199|FG000|Overall Study|Adverse Event|3|||
126397399|NCT02752958|454748199|FG000|Overall Study|Lost to Follow-up|1|||
126397400|NCT02752958|454748199|FG000|Overall Study|Protocol Violation|1|||
126397401|NCT02752958|454748199|FG000|Overall Study|Withdrawal by Subject|2|||
126397402|NCT02752958|454748199|FG000|Overall Study|Other (Reason not specified)|2|||
126397403|NCT00853125|454748200|FG000|Overall Study|Study participant's donor was CMV +|1|||
126397404|NCT03746600|454748206|FG000|Overall Study|Withdrawal by Subject|3|||
126397405|NCT03746600|454748207|FG001|Overall Study|Withdrawal by Subject|3|||
126397406|NCT03746600|454748206|FG000|Overall Study|dismissed from study|1|||
126397407|NCT03746600|454748207|FG001|Overall Study|dismissed from study|0|||
126397408|NCT03746600|454748206|FG000|Overall Study|Lost to Follow-up|1|||
126397409|NCT03746600|454748207|FG001|Overall Study|Lost to Follow-up|0|||
126397410|NCT03023826|454748208|FG000|Period 1|Withdrawal by Subject|0|||
126397411|NCT03023826|454748209|FG001|Period 1|Withdrawal by Subject|0|||
126397412|NCT03023826|454748210|FG002|Period 1|Withdrawal by Subject|0|||
126397413|NCT03023826|454748211|FG003|Period 1|Withdrawal by Subject|0|||
126052081|NCT01478594|453485936|FG001|Overall Study|Withdrawal by Subject|3|||
126052082|NCT01478594|453485935|FG000|Overall Study|Study Closed by Sponsor|8|||
126397414|NCT03023826|454748212|FG004|Period 1|Withdrawal by Subject|1|||
126397415|NCT03023826|454748213|FG005|Period 1|Withdrawal by Subject|0|||
126397416|NCT00977938|454748214|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
126397417|NCT00977938|454748215|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
126397418|NCT00977938|454748216|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
126397419|NCT00977938|454748217|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
126397420|NCT00977938|454748214|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
126397421|NCT00977938|454748215|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
126397422|NCT00977938|454748216|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
126397423|NCT00977938|454748217|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
125888565|NCT01039376|452889728|FG000|Overall Study|Withdrawal by Subject|20|||
125888566|NCT01039376|452889729|FG001|Overall Study|Withdrawal by Subject|32|||
125888567|NCT01039376|452889728|FG000|Overall Study|Study terminated by Sponsor|90|||
126397424|NCT00977938|454748214|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
126397425|NCT00977938|454748215|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
126397426|NCT00977938|454748216|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
126397427|NCT00977938|454748217|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
126397428|NCT00977938|454748214|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
126397429|NCT00977938|454748215|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
126397430|NCT00977938|454748216|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
126397431|NCT00977938|454748217|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
126397432|NCT00977938|454748214|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
126397433|NCT00977938|454748215|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
126397434|NCT00977938|454748216|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
126397435|NCT00977938|454748217|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
126397436|NCT00977938|454748214|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
126397437|NCT00977938|454748215|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
126397438|NCT00977938|454748216|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
126397439|NCT00977938|454748217|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
126397440|NCT02142283|454748222|FG000|Overall Study|Death|20|||
126397441|NCT02142283|454748223|FG001|Overall Study|Death|18|||
126397442|NCT02142283|454748222|FG000|Overall Study|Withdrawal by Subject|1|||
126397443|NCT02142283|454748223|FG001|Overall Study|Withdrawal by Subject|3|||
126397444|NCT02460783|454748224|FG000|Overall Study|Withdrawal by Subject|1|||
126397445|NCT02460783|454748225|FG001|Overall Study|Withdrawal by Subject|3|||
126397446|NCT02460783|454748224|FG000|Overall Study|Lost to Follow-up|1|||
126397447|NCT02460783|454748225|FG001|Overall Study|Lost to Follow-up|1|||
126397448|NCT01646645|454748226|FG000|Overall Study|No Treated|1|||
126397449|NCT01646645|454748226|FG000|Overall Study|Inevaluable Donor|29|||
126397450|NCT00884039|454748235|FG000|Overall Study|Withdrawal by Subject|0|||
126397451|NCT00884039|454748236|FG001|Overall Study|Withdrawal by Subject|1|||
126397452|NCT00884039|454748235|FG000|Overall Study|Lack of Efficacy|2|||
126397453|NCT00884039|454748236|FG001|Overall Study|Lack of Efficacy|0|||
126397454|NCT00717522|454748237|FG000|Overall Study|Disease Progression|5|||
126397455|NCT00717522|454748237|FG000|Overall Study|Adverse Event|1|||
126397456|NCT00717522|454748237|FG000|Overall Study|Death|1|||
126397457|NCT02182440|454748238|FG000|Overall Study|Adverse Event|0|||
126397458|NCT02182440|454748239|FG001|Overall Study|Adverse Event|1|||
126397459|NCT02182440|454748240|FG002|Overall Study|Adverse Event|0|||
126397460|NCT02182440|454748241|FG003|Overall Study|Adverse Event|0|||
126397461|NCT02182440|454748238|FG000|Overall Study|Death|31|||
126397462|NCT02182440|454748239|FG001|Overall Study|Death|8|||
126397463|NCT02182440|454748240|FG002|Overall Study|Death|5|||
126397464|NCT02182440|454748241|FG003|Overall Study|Death|16|||
126397465|NCT02182440|454748238|FG000|Overall Study|Protocol Violation|0|||
126397466|NCT02182440|454748239|FG001|Overall Study|Protocol Violation|1|||
126397467|NCT02182440|454748240|FG002|Overall Study|Protocol Violation|0|||
126397468|NCT02182440|454748241|FG003|Overall Study|Protocol Violation|0|||
126397469|NCT02182440|454748238|FG000|Overall Study|Physician Decision|1|||
126397470|NCT02182440|454748239|FG001|Overall Study|Physician Decision|0|||
126397471|NCT02182440|454748240|FG002|Overall Study|Physician Decision|0|||
126397472|NCT02182440|454748241|FG003|Overall Study|Physician Decision|0|||
125888568|NCT01039376|452889729|FG001|Overall Study|Study terminated by Sponsor|72|||
126397473|NCT02182440|454748238|FG000|Overall Study|Withdrawal by Subject|1|||
126052083|NCT01478594|453485936|FG001|Overall Study|Study Closed by Sponsor|5|||
126052084|NCT00713596|453485937|FG000|Overall Study|Study was terminated|2|||
126397474|NCT02182440|454748239|FG001|Overall Study|Withdrawal by Subject|1|||
126397475|NCT02182440|454748240|FG002|Overall Study|Withdrawal by Subject|3|||
126397476|NCT02182440|454748241|FG003|Overall Study|Withdrawal by Subject|4|||
126397477|NCT02182440|454748238|FG000|Overall Study|different, e.g adm other hospital|12|||
126397478|NCT02182440|454748239|FG001|Overall Study|different, e.g adm other hospital|3|||
126397479|NCT02182440|454748240|FG002|Overall Study|different, e.g adm other hospital|3|||
126397480|NCT02182440|454748241|FG003|Overall Study|different, e.g adm other hospital|10|||
126397481|NCT00072293|454748242|FG000|Overall Study|Lost to Follow-up|1|||
126397482|NCT00072293|454748243|FG001|Overall Study|Lost to Follow-up|1|||
126397483|NCT00072293|454748242|FG000|Overall Study|Withdrawal by Subject|0|||
126397484|NCT00072293|454748243|FG001|Overall Study|Withdrawal by Subject|1|||
126397485|NCT01166958|454748244|FG000|Overall Study|Withdrawal by Subject|1|||
126397486|NCT01166958|454748245|FG001|Overall Study|Withdrawal by Subject|0|||
126397487|NCT02981407|454748250|FG000|Overall Study|Withdrawal by Subject|2|||
126397488|NCT02981407|454748251|FG001|Overall Study|Withdrawal by Subject|0|||
126397489|NCT00355342|454748254|FG000|Overall Study|Adverse Event|13|||
126397490|NCT00355342|454748255|FG001|Overall Study|Adverse Event|15|||
126397491|NCT00355342|454748254|FG000|Overall Study|Lost to Follow-up|4|||
126397492|NCT00355342|454748255|FG001|Overall Study|Lost to Follow-up|2|||
126397493|NCT00355342|454748254|FG000|Overall Study|Withdrawal by Subject|14|||
126397494|NCT00355342|454748255|FG001|Overall Study|Withdrawal by Subject|11|||
126397495|NCT00355342|454748254|FG000|Overall Study|Sponsor terminated study|2|||
126397496|NCT00355342|454748255|FG001|Overall Study|Sponsor terminated study|2|||
126397497|NCT00355342|454748254|FG000|Overall Study|Overcompliant-PI discretion|1|||
126397498|NCT00355342|454748255|FG001|Overall Study|Overcompliant-PI discretion|0|||
126397499|NCT00355342|454748254|FG000|Overall Study|Use of prohibited medication|1|||
126397500|NCT00355342|454748255|FG001|Overall Study|Use of prohibited medication|0|||
126397501|NCT00355342|454748254|FG000|Overall Study|COPD exacerbation|1|||
126397502|NCT00355342|454748255|FG001|Overall Study|COPD exacerbation|1|||
126397503|NCT00355342|454748254|FG000|Overall Study|Dispensed wrong study drug kit|1|||
126397504|NCT00355342|454748255|FG001|Overall Study|Dispensed wrong study drug kit|0|||
126397505|NCT00355342|454748254|FG000|Overall Study|Non-compliance with Dexa scans|1|||
126397506|NCT00355342|454748255|FG001|Overall Study|Non-compliance with Dexa scans|0|||
126397507|NCT00355342|454748254|FG000|Overall Study|Withdrawal by participant and physician|1|||
126052085|NCT00713596|453485938|FG001|Overall Study|Study was terminated|3|||
126052086|NCT00713596|453485939|FG002|Overall Study|Study was terminated|2|||
126052087|NCT04545619|453485940|FG000|Overall Study|due to equipment challenges|1|||
126397508|NCT00355342|454748255|FG001|Overall Study|Withdrawal by participant and physician|0|||
126397509|NCT00355342|454748254|FG000|Overall Study|Participant relocated|0|||
126397510|NCT00355342|454748255|FG001|Overall Study|Participant relocated|1|||
126397511|NCT00355342|454748254|FG000|Overall Study|Participant discontinued study drug|0|||
126397512|NCT00355342|454748255|FG001|Overall Study|Participant discontinued study drug|1|||
126052088|NCT03712371|453485943|FG000|Overall Study|Lack of Efficacy|0|||
126052089|NCT03712371|453485944|FG001|Overall Study|Lack of Efficacy|0|||
126397513|NCT00355342|454748254|FG000|Overall Study|Study management|0|||
126397514|NCT00355342|454748255|FG001|Overall Study|Study management|1|||
126397515|NCT00355342|454748254|FG000|Overall Study|Protocol Violation|0|||
126397516|NCT00355342|454748255|FG001|Overall Study|Protocol Violation|1|||
126397517|NCT00355342|454748254|FG000|Overall Study|Use of protocol excluded medication|0|||
126397518|NCT00355342|454748255|FG001|Overall Study|Use of protocol excluded medication|1|||
126397519|NCT01416441|454748256|FG000|Overall Study|Lost to Follow-up|5|||
126397520|NCT01416441|454748256|FG000|Overall Study|Adverse Event|6|||
126397521|NCT01416441|454748256|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
126397522|NCT01416441|454748256|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
126397523|NCT01416441|454748256|FG000|Overall Study|Investigator Withdrew Subject|2|||
126397524|NCT01416441|454748256|FG000|Overall Study|Subject Withdrew Consent|12|||
126397525|NCT01416441|454748256|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
126397526|NCT02653495|454748261|FG000|Overall Study|Lost to Follow-up|2|||
126397527|NCT02653495|454748262|FG001|Overall Study|Lost to Follow-up|0|||
126397528|NCT02653495|454748261|FG000|Overall Study|Screening Failure|10|||
125888569|NCT03252925|452889730|FG000|Overall Study|Withdrawal by Subject|1|||
125888570|NCT03252925|452889731|FG001|Overall Study|Withdrawal by Subject|0|||
125888571|NCT03252925|452889730|FG000|Overall Study|Protocol Violation|6|||
125888572|NCT03252925|452889731|FG001|Overall Study|Protocol Violation|0|||
126397529|NCT02653495|454748262|FG001|Overall Study|Screening Failure|0|||
126397530|NCT00953680|454748263|FG000|Period 1|Withdrawal by Subject|0|||
126397531|NCT00953680|454748264|FG001|Period 1|Withdrawal by Subject|1|||
126397532|NCT01360398|454748265|FG000|Overall Study|Withdrawal by Subject|14|||
125888573|NCT03252925|452889730|FG000|Overall Study|Adverse Event|1|||
125888574|NCT03252925|452889731|FG001|Overall Study|Adverse Event|0|||
125888575|NCT03252925|452889730|FG000|Overall Study|Lost to Follow-up|6|||
125888576|NCT03252925|452889731|FG001|Overall Study|Lost to Follow-up|6|||
125888577|NCT01499277|452889739|FG000|Overall Study|Adverse Event|3|||
125888578|NCT01499277|452889740|FG001|Overall Study|Adverse Event|6|||
125888579|NCT01499277|452889739|FG000|Overall Study|Death|3|||
125888580|NCT01499277|452889740|FG001|Overall Study|Death|2|||
125888581|NCT01499277|452889739|FG000|Overall Study|Lost to Follow-up|15|||
125888582|NCT01499277|452889740|FG001|Overall Study|Lost to Follow-up|8|||
125888583|NCT01499277|452889739|FG000|Overall Study|Protocol Violation|2|||
125888584|NCT01499277|452889740|FG001|Overall Study|Protocol Violation|3|||
125888585|NCT01499277|452889739|FG000|Overall Study|Withdrawal by Subject|16|||
126052090|NCT03712371|453485945|FG002|Overall Study|Lack of Efficacy|0|||
126052091|NCT03712371|453485946|FG003|Overall Study|Lack of Efficacy|1|||
126052092|NCT02788981|453485947|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
126052093|NCT02788981|453485948|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
126052094|NCT00229658|453485949|FG000|Overall Study|Administrative|2|||
126052095|NCT00229658|453485950|FG001|Overall Study|Administrative|1|||
126052096|NCT00229658|453485949|FG000|Overall Study|Investigator decision|13|||
126052097|NCT00229658|453485950|FG001|Overall Study|Investigator decision|10|||
126052098|NCT00229658|453485949|FG000|Overall Study|Other|80|||
126052099|NCT00229658|453485950|FG001|Overall Study|Other|60|||
126052100|NCT00229658|453485949|FG000|Overall Study|Lost to Follow-up|82|||
126052101|NCT00229658|453485950|FG001|Overall Study|Lost to Follow-up|55|||
126397533|NCT01360398|454748265|FG000|Overall Study|Other|7|||
126397534|NCT01360398|454748265|FG000|Overall Study|Migrated/moved from study area|1|||
126397535|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
126397536|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
126397537|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
126397538|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
126397539|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
126397540|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
126397541|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
126397542|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
126397543|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
126397544|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
126397545|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
126397546|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
126397547|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
126397548|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
126397549|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
126397550|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
125888586|NCT01499277|452889740|FG001|Overall Study|Withdrawal by Subject|6|||
125888587|NCT01499277|452889739|FG000|Overall Study|Lack of therapeutic response and other|8|||
125888588|NCT01499277|452889740|FG001|Overall Study|Lack of therapeutic response and other|7|||
125888589|NCT04730271|452889741|FG000|Overall Study|Adverse Event|0|||
125888590|NCT04730271|452889742|FG001|Overall Study|Adverse Event|2|||
126052102|NCT00229658|453485949|FG000|Overall Study|Serious Adverse Event|2|||
126052103|NCT00229658|453485950|FG001|Overall Study|Serious Adverse Event|2|||
125888591|NCT04730271|452889741|FG000|Overall Study|Withdrawal by Subject|1|||
125888592|NCT04730271|452889742|FG001|Overall Study|Withdrawal by Subject|1|||
125888593|NCT04730271|452889741|FG000|Overall Study|Protocol Violation|7|||
125888594|NCT04730271|452889742|FG001|Overall Study|Protocol Violation|13|||
125888595|NCT04730271|452889741|FG000|Overall Study|Lost to Follow-up|3|||
125888596|NCT04730271|452889742|FG001|Overall Study|Lost to Follow-up|3|||
125888597|NCT04730271|452889741|FG000|Overall Study|Death|1|||
125888598|NCT04730271|452889742|FG001|Overall Study|Death|0|||
125888599|NCT02023697|452889745|FG000|Treatment Period|Radiological progression|13|||
125888600|NCT02023697|452889746|FG001|Treatment Period|Radiological progression|17|||
125888601|NCT02023697|452889747|FG002|Treatment Period|Radiological progression|26|||
125888602|NCT02023697|452889745|FG000|Treatment Period|Never Treated|5|||
125888603|NCT02023697|452889746|FG001|Treatment Period|Never Treated|6|||
125888604|NCT02023697|452889747|FG002|Treatment Period|Never Treated|10|||
125888605|NCT02023697|452889745|FG000|Treatment Period|Adverse Event|13|||
125888606|NCT02023697|452889746|FG001|Treatment Period|Adverse Event|25|||
125888607|NCT02023697|452889747|FG002|Treatment Period|Adverse Event|23|||
125888608|NCT02023697|452889745|FG000|Treatment Period|Logistical difficulties|1|||
125888609|NCT02023697|452889746|FG001|Treatment Period|Logistical difficulties|1|||
125888610|NCT02023697|452889747|FG002|Treatment Period|Logistical difficulties|1|||
125888611|NCT02023697|452889745|FG000|Treatment Period|Clinical progression|10|||
125888612|NCT02023697|452889746|FG001|Treatment Period|Clinical progression|8|||
125888613|NCT02023697|452889747|FG002|Treatment Period|Clinical progression|28|||
125888614|NCT02023697|452889745|FG000|Treatment Period|Withdrawal by Subject|4|||
125888615|NCT02023697|452889746|FG001|Treatment Period|Withdrawal by Subject|5|||
125888616|NCT02023697|452889747|FG002|Treatment Period|Withdrawal by Subject|13|||
125888617|NCT02023697|452889745|FG000|Treatment Period|Safety outcome reached|0|||
125888618|NCT02023697|452889746|FG001|Treatment Period|Safety outcome reached|1|||
125888619|NCT02023697|452889747|FG002|Treatment Period|Safety outcome reached|0|||
125888620|NCT02023697|452889745|FG000|Treatment Period|Physician Decision|0|||
125888621|NCT02023697|452889746|FG001|Treatment Period|Physician Decision|0|||
125888622|NCT02023697|452889747|FG002|Treatment Period|Physician Decision|1|||
125888623|NCT02023697|452889745|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
125888624|NCT02023697|452889746|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
125888625|NCT02023697|452889747|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
125888626|NCT02023697|452889745|FG000|Active Follow-up Period|Lost to Follow-up|1|||
125888627|NCT02023697|452889746|FG001|Active Follow-up Period|Lost to Follow-up|1|||
125888628|NCT02023697|452889747|FG002|Active Follow-up Period|Lost to Follow-up|1|||
125888629|NCT02023697|452889745|FG000|Active Follow-up Period|Deterioration of general condition|1|||
125888630|NCT02023697|452889746|FG001|Active Follow-up Period|Deterioration of general condition|1|||
125888631|NCT02023697|452889747|FG002|Active Follow-up Period|Deterioration of general condition|1|||
125888632|NCT02023697|452889745|FG000|Active Follow-up Period|Other unspecified|2|||
125888633|NCT02023697|452889746|FG001|Active Follow-up Period|Other unspecified|0|||
125888634|NCT02023697|452889747|FG002|Active Follow-up Period|Other unspecified|1|||
125888635|NCT02023697|452889745|FG000|Active Follow-up Period|Clinical progression|0|||
125888636|NCT02023697|452889746|FG001|Active Follow-up Period|Clinical progression|2|||
125888637|NCT02023697|452889747|FG002|Active Follow-up Period|Clinical progression|1|||
125888638|NCT02023697|452889745|FG000|Active Follow-up Period|Radiological progression|0|||
125888639|NCT02023697|452889746|FG001|Active Follow-up Period|Radiological progression|0|||
125888640|NCT02023697|452889747|FG002|Active Follow-up Period|Radiological progression|1|||
125888641|NCT02023697|452889745|FG000|Active Follow-up Period|Death|83|||
125888642|NCT02023697|452889746|FG001|Active Follow-up Period|Death|82|||
126052104|NCT00229658|453485949|FG000|Overall Study|Withdrawal of consent|46|||
126052105|NCT00229658|453485950|FG001|Overall Study|Withdrawal of consent|39|||
126052106|NCT00249769|453485951|FG000|Overall Study|Withdrawal by Subject|1|||
126052107|NCT00249769|453485952|FG001|Overall Study|Withdrawal by Subject|10|||
126052108|NCT00249769|453485953|FG002|Overall Study|Withdrawal by Subject|6|||
126052109|NCT00249769|453485951|FG000|Overall Study|Migration from Study Area|1|||
126052110|NCT00249769|453485952|FG001|Overall Study|Migration from Study Area|3|||
126052111|NCT00249769|453485953|FG002|Overall Study|Migration from Study Area|14|||
126052112|NCT00249769|453485951|FG000|Overall Study|Miscellaneous|0|||
126052113|NCT00249769|453485952|FG001|Overall Study|Miscellaneous|2|||
126052114|NCT00249769|453485953|FG002|Overall Study|Miscellaneous|2|||
126052115|NCT00249769|453485951|FG000|Overall Study|Adverse Event|0|||
126052116|NCT00249769|453485952|FG001|Overall Study|Adverse Event|0|||
126052117|NCT00249769|453485953|FG002|Overall Study|Adverse Event|1|||
126052118|NCT00249769|453485951|FG000|Overall Study|Physician Decision|0|||
126052119|NCT00249769|453485952|FG001|Overall Study|Physician Decision|0|||
126052120|NCT00249769|453485953|FG002|Overall Study|Physician Decision|2|||
126052121|NCT00249769|453485951|FG000|Overall Study|Lost to Follow-up|0|||
126052122|NCT00249769|453485952|FG001|Overall Study|Lost to Follow-up|0|||
126052123|NCT00249769|453485953|FG002|Overall Study|Lost to Follow-up|3|||
126052124|NCT01953224|453485954|FG000|Overall Study|Lost to Follow-up|1|||
126052125|NCT01953224|453485955|FG001|Overall Study|Lost to Follow-up|1|||
126052126|NCT01953224|453485954|FG000|Overall Study|Withdrawal by Subject|1|||
126052127|NCT01953224|453485955|FG001|Overall Study|Withdrawal by Subject|2|||
126052128|NCT03229408|453485964|FG000|Overall Study|Withdrawal by Subject|4|||
126052129|NCT03229408|453485965|FG001|Overall Study|Withdrawal by Subject|1|||
126052130|NCT03229408|453485964|FG000|Overall Study|Adverse Event|2|||
126052131|NCT03229408|453485965|FG001|Overall Study|Adverse Event|0|||
126052132|NCT03229408|453485964|FG000|Overall Study|Pregnancy|0|||
126052133|NCT03229408|453485965|FG001|Overall Study|Pregnancy|1|||
126052134|NCT03229408|453485964|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
126052135|NCT03229408|453485965|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
126052136|NCT04541589|453485966|FG000|Treatment Period|Adverse Event|8|||
126052137|NCT04541589|453485967|FG001|Treatment Period|Adverse Event|2|||
126052138|NCT04541589|453485966|FG000|Treatment Period|Physician Decision|3|||
126052139|NCT04541589|453485967|FG001|Treatment Period|Physician Decision|1|||
126052140|NCT04541589|453485966|FG000|Treatment Period|Subject decision|7|||
126052141|NCT04541589|453485967|FG001|Treatment Period|Subject decision|4|||
126052142|NCT04541589|453485966|FG000|Treatment Period|Withdrawal by Subject|1|||
126052143|NCT04541589|453485967|FG001|Treatment Period|Withdrawal by Subject|0|||
126052144|NCT04541589|453485966|FG000|Safety Follow-up Period|Adverse Event|2|||
126052145|NCT04541589|453485967|FG001|Safety Follow-up Period|Adverse Event|1|||
126052146|NCT04541589|453485966|FG000|Safety Follow-up Period|Physician Decision|1|||
126052147|NCT04541589|453485967|FG001|Safety Follow-up Period|Physician Decision|0|||
126052148|NCT04541589|453485966|FG000|Safety Follow-up Period|Subject decision|5|||
126052149|NCT04541589|453485967|FG001|Safety Follow-up Period|Subject decision|3|||
126052150|NCT04541589|453485966|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
126052151|NCT04541589|453485967|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
126052152|NCT03890289|453485968|FG000|Overall Study|Adverse Event|1|||
126052153|NCT03890289|453485968|FG000|Overall Study|Physician Decision|1|||
126052154|NCT03890289|453485968|FG000|Overall Study|Lack of Efficacy|2|||
126052155|NCT02426138|453485969|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126052156|NCT02426138|453485970|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126052157|NCT03362190|453485977|FG000|Overall Study|Adverse Event|0|||
126052158|NCT03362190|453485978|FG001|Overall Study|Adverse Event|0|||
126052159|NCT03362190|453485979|FG002|Overall Study|Adverse Event|0|||
126052160|NCT03362190|453485980|FG003|Overall Study|Adverse Event|1|||
126052161|NCT03362190|453485977|FG000|Overall Study|Withdrawal by Subject|0|||
126052162|NCT03362190|453485978|FG001|Overall Study|Withdrawal by Subject|0|||
126052163|NCT03362190|453485979|FG002|Overall Study|Withdrawal by Subject|0|||
126052164|NCT03362190|453485980|FG003|Overall Study|Withdrawal by Subject|1|||
126052165|NCT00687219|453485981|FG000|Overall Study|Adverse Event|8|||
126052166|NCT00687219|453485981|FG000|Overall Study|Discontinuance criteria met|7|||
126052167|NCT00687219|453485981|FG000|Overall Study|HCV-RNA positive conversion|34|||
126052168|NCT00687219|453485981|FG000|Overall Study|Withdrawal by Subject|1|||
126052169|NCT00687219|453485981|FG000|Overall Study|Lack of Efficacy|1|||
126052170|NCT02350634|453485984|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
126052171|NCT01400958|453485993|FG000|Overall Study|Physician Decision|0|||
126052172|NCT01400958|453485994|FG001|Overall Study|Physician Decision|1|||
126052173|NCT01400958|453485993|FG000|Overall Study|Withdrawal by Subject|0|||
126052174|NCT01400958|453485994|FG001|Overall Study|Withdrawal by Subject|1|||
126052175|NCT01400958|453485993|FG000|Overall Study|Adverse Event|1|||
126052176|NCT01400958|453485994|FG001|Overall Study|Adverse Event|0|||
126052177|NCT04021862|453485998|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126052178|NCT04021862|453485999|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
126052179|NCT04021862|453486000|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126052180|NCT04021862|453486001|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126052181|NCT04021862|453486002|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126052182|NCT04021862|453486003|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126052183|NCT04021862|453485998|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
126052184|NCT04021862|453485999|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126052185|NCT04021862|453486000|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126052186|NCT04021862|453486001|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126397551|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
126397552|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
126397553|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
126397554|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
126397555|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
126397556|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
126397557|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
126397558|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
126397559|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
126052187|NCT04021862|453486002|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126052188|NCT04021862|453486003|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126052189|NCT04021862|453485998|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126052190|NCT04021862|453485999|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126052191|NCT04021862|453486000|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
126052192|NCT04021862|453486001|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126052193|NCT04021862|453486002|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126052194|NCT04021862|453486003|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126052195|NCT04021862|453485998|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
126052196|NCT04021862|453485999|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
126052197|NCT04021862|453486000|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
126052198|NCT04021862|453486001|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
126397560|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
126397561|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
126397562|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
126397563|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
126397564|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
126397565|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
126397566|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
126397567|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
126397568|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
126397569|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
126397570|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
126397571|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
126052199|NCT04021862|453486002|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
126052200|NCT04021862|453486003|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
126052201|NCT04021862|453485998|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126052202|NCT04021862|453485999|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126052203|NCT04021862|453486000|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126052204|NCT04021862|453486001|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
126052205|NCT04021862|453486002|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126052206|NCT04021862|453486003|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126052207|NCT04445831|453486004|FG000|Overall Study|Withdrawal by Subject|2|||
126052208|NCT04445831|453486005|FG001|Overall Study|Withdrawal by Subject|1|||
126052209|NCT04445831|453486006|FG002|Overall Study|Withdrawal by Subject|1|||
126052210|NCT04445831|453486007|FG003|Overall Study|Withdrawal by Subject|0|||
126052211|NCT04445831|453486008|FG004|Overall Study|Withdrawal by Subject|0|||
126052212|NCT04445831|453486009|FG005|Overall Study|Withdrawal by Subject|0|||
126052213|NCT04445831|453486010|FG006|Overall Study|Withdrawal by Subject|0|||
126052214|NCT04445831|453486004|FG000|Overall Study|Subject withdrawal by caregiver|0|||
126052215|NCT04445831|453486005|FG001|Overall Study|Subject withdrawal by caregiver|1|||
126052216|NCT04445831|453486006|FG002|Overall Study|Subject withdrawal by caregiver|0|||
126052217|NCT04445831|453486007|FG003|Overall Study|Subject withdrawal by caregiver|0|||
126052218|NCT04445831|453486008|FG004|Overall Study|Subject withdrawal by caregiver|0|||
126052219|NCT04445831|453486009|FG005|Overall Study|Subject withdrawal by caregiver|0|||
126397572|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
126397573|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
126397574|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
126397575|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
126397576|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
126105150|NCT00406653|453678559|FG000|Maintenance Period|Lack of Efficacy|0|||
126105151|NCT00406653|453678560|FG001|Maintenance Period|Lack of Efficacy|0|||
126105152|NCT00406653|453678561|FG002|Maintenance Period|Lack of Efficacy|0|||
126105153|NCT00406653|453678562|FG003|Maintenance Period|Lack of Efficacy|0|||
126105154|NCT00406653|453678563|FG004|Maintenance Period|Lack of Efficacy|20|||
126105155|NCT00406653|453678564|FG005|Maintenance Period|Lack of Efficacy|26|||
126105156|NCT00406653|453678565|FG006|Maintenance Period|Lack of Efficacy|0|||
126105157|NCT00406653|453678559|FG000|Maintenance Period|Lost to Follow-up|0|||
126105158|NCT00406653|453678560|FG001|Maintenance Period|Lost to Follow-up|0|||
126105159|NCT00406653|453678561|FG002|Maintenance Period|Lost to Follow-up|0|||
126105160|NCT00406653|453678562|FG003|Maintenance Period|Lost to Follow-up|0|||
126397577|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
126397578|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
126397579|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
126397580|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
126397581|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
126397582|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
126397583|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
126397584|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
126397585|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
126397586|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
126397587|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
126397588|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
126397589|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
126397590|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
126397591|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
126397592|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
126397593|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
126397594|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
126397595|NCT00624780|454748269|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
126397596|NCT00624780|454748270|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
126397597|NCT00624780|454748271|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
126397598|NCT00624780|454748272|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
126397599|NCT00624780|454748273|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
126397600|NCT00624780|454748274|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
126397601|NCT00624780|454748269|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
126397602|NCT00624780|454748270|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397603|NCT00624780|454748271|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397604|NCT00624780|454748272|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397605|NCT00624780|454748273|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397606|NCT00624780|454748274|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397607|NCT00624780|454748269|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397608|NCT00624780|454748270|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397609|NCT00624780|454748271|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
126397610|NCT00624780|454748272|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397611|NCT00624780|454748273|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397612|NCT00624780|454748274|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397613|NCT00624780|454748269|FG000|Follow-up (Week 26)|Death|0|||
126397614|NCT00624780|454748270|FG001|Follow-up (Week 26)|Death|0|||
126397615|NCT00624780|454748271|FG002|Follow-up (Week 26)|Death|1|||
126397616|NCT00624780|454748272|FG003|Follow-up (Week 26)|Death|0|||
126397617|NCT00624780|454748273|FG004|Follow-up (Week 26)|Death|0|||
126397618|NCT00624780|454748274|FG005|Follow-up (Week 26)|Death|0|||
126397619|NCT00624780|454748269|FG000|Follow-up (Week 26)|Adverse Event|0|||
126397620|NCT00624780|454748270|FG001|Follow-up (Week 26)|Adverse Event|0|||
126397621|NCT00624780|454748271|FG002|Follow-up (Week 26)|Adverse Event|0|||
126397622|NCT00624780|454748272|FG003|Follow-up (Week 26)|Adverse Event|0|||
126397623|NCT00624780|454748273|FG004|Follow-up (Week 26)|Adverse Event|1|||
126397624|NCT00624780|454748274|FG005|Follow-up (Week 26)|Adverse Event|0|||
126397625|NCT00624780|454748269|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
126397626|NCT00624780|454748270|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
126397627|NCT00624780|454748271|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
126397628|NCT00624780|454748272|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
126397629|NCT00624780|454748273|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
126397630|NCT00624780|454748274|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
126397631|NCT00624780|454748269|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
126397632|NCT00624780|454748270|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
126397633|NCT00624780|454748271|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
126397634|NCT00624780|454748272|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
126105161|NCT00406653|453678563|FG004|Maintenance Period|Lost to Follow-up|2|||
126105162|NCT00406653|453678564|FG005|Maintenance Period|Lost to Follow-up|1|||
126397635|NCT00624780|454748273|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
126105163|NCT00406653|453678565|FG006|Maintenance Period|Lost to Follow-up|0|||
126105164|NCT00406653|453678559|FG000|Maintenance Period|Withdrawal of Consent|0|||
126105165|NCT00406653|453678560|FG001|Maintenance Period|Withdrawal of Consent|0|||
126105166|NCT00406653|453678561|FG002|Maintenance Period|Withdrawal of Consent|0|||
126105167|NCT00406653|453678562|FG003|Maintenance Period|Withdrawal of Consent|0|||
126105168|NCT00406653|453678563|FG004|Maintenance Period|Withdrawal of Consent|2|||
126105169|NCT00406653|453678564|FG005|Maintenance Period|Withdrawal of Consent|0|||
126105170|NCT00406653|453678565|FG006|Maintenance Period|Withdrawal of Consent|0|||
126105171|NCT00406653|453678559|FG000|Maintenance Period|Pregnancy|0|||
126105172|NCT00406653|453678560|FG001|Maintenance Period|Pregnancy|0|||
126105173|NCT00406653|453678561|FG002|Maintenance Period|Pregnancy|0|||
126105174|NCT00406653|453678562|FG003|Maintenance Period|Pregnancy|0|||
126105175|NCT00406653|453678563|FG004|Maintenance Period|Pregnancy|0|||
126105176|NCT00406653|453678564|FG005|Maintenance Period|Pregnancy|1|||
126105177|NCT00406653|453678565|FG006|Maintenance Period|Pregnancy|0|||
126105178|NCT00406653|453678559|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
126105179|NCT00406653|453678560|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
126105180|NCT00406653|453678561|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
126105181|NCT00406653|453678562|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
126105182|NCT00406653|453678563|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
126105183|NCT00406653|453678564|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
126105184|NCT00406653|453678565|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
126105185|NCT00406653|453678559|FG000|Maintenance Period|Error in disease score evaluation|0|||
126105186|NCT00406653|453678560|FG001|Maintenance Period|Error in disease score evaluation|0|||
126105187|NCT00406653|453678561|FG002|Maintenance Period|Error in disease score evaluation|0|||
126105188|NCT00406653|453678562|FG003|Maintenance Period|Error in disease score evaluation|0|||
126105189|NCT00406653|453678563|FG004|Maintenance Period|Error in disease score evaluation|1|||
126105190|NCT00406653|453678564|FG005|Maintenance Period|Error in disease score evaluation|0|||
125888643|NCT02023697|452889747|FG002|Active Follow-up Period|Death|87|||
125888644|NCT02023697|452889745|FG000|Long-term Follow-up Period|Death|9|||
126105191|NCT00406653|453678565|FG006|Maintenance Period|Error in disease score evaluation|0|||
126105192|NCT00406653|453678559|FG000|Open-Label Period|Death|0|||
126105193|NCT00406653|453678560|FG001|Open-Label Period|Death|0|||
126105194|NCT00406653|453678561|FG002|Open-Label Period|Death|0|||
126105195|NCT00406653|453678562|FG003|Open-Label Period|Death|0|||
126105196|NCT00406653|453678563|FG004|Open-Label Period|Death|0|||
126105197|NCT00406653|453678564|FG005|Open-Label Period|Death|0|||
126105198|NCT00406653|453678565|FG006|Open-Label Period|Death|1|||
126105199|NCT00406653|453678559|FG000|Open-Label Period|Adverse Event|0|||
126105200|NCT00406653|453678560|FG001|Open-Label Period|Adverse Event|0|||
126105201|NCT00406653|453678561|FG002|Open-Label Period|Adverse Event|0|||
126105202|NCT00406653|453678562|FG003|Open-Label Period|Adverse Event|0|||
126105203|NCT00406653|453678563|FG004|Open-Label Period|Adverse Event|0|||
126105204|NCT00406653|453678564|FG005|Open-Label Period|Adverse Event|0|||
126105205|NCT00406653|453678565|FG006|Open-Label Period|Adverse Event|18|||
126105206|NCT00406653|453678559|FG000|Open-Label Period|Lack of Efficacy|0|||
126105207|NCT00406653|453678560|FG001|Open-Label Period|Lack of Efficacy|0|||
126105208|NCT00406653|453678561|FG002|Open-Label Period|Lack of Efficacy|0|||
126105209|NCT00406653|453678562|FG003|Open-Label Period|Lack of Efficacy|0|||
126105210|NCT00406653|453678563|FG004|Open-Label Period|Lack of Efficacy|0|||
126105211|NCT00406653|453678564|FG005|Open-Label Period|Lack of Efficacy|0|||
126105212|NCT00406653|453678565|FG006|Open-Label Period|Lack of Efficacy|160|||
126105213|NCT00406653|453678559|FG000|Open-Label Period|Lost to Follow-up|0|||
126105214|NCT00406653|453678560|FG001|Open-Label Period|Lost to Follow-up|0|||
126105215|NCT00406653|453678561|FG002|Open-Label Period|Lost to Follow-up|0|||
126105216|NCT00406653|453678562|FG003|Open-Label Period|Lost to Follow-up|0|||
126105217|NCT00406653|453678563|FG004|Open-Label Period|Lost to Follow-up|0|||
126105218|NCT00406653|453678564|FG005|Open-Label Period|Lost to Follow-up|0|||
126105219|NCT00406653|453678565|FG006|Open-Label Period|Lost to Follow-up|6|||
126105220|NCT00406653|453678559|FG000|Open-Label Period|Withdrawal of Consent|0|||
126105221|NCT00406653|453678560|FG001|Open-Label Period|Withdrawal of Consent|0|||
126105222|NCT00406653|453678561|FG002|Open-Label Period|Withdrawal of Consent|0|||
126105223|NCT00406653|453678562|FG003|Open-Label Period|Withdrawal of Consent|0|||
126105224|NCT00406653|453678563|FG004|Open-Label Period|Withdrawal of Consent|0|||
126105225|NCT00406653|453678564|FG005|Open-Label Period|Withdrawal of Consent|0|||
126105226|NCT00406653|453678565|FG006|Open-Label Period|Withdrawal of Consent|11|||
126105227|NCT00406653|453678559|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126105228|NCT00406653|453678560|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126105229|NCT00406653|453678561|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126105230|NCT00406653|453678562|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126105231|NCT00406653|453678563|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126105232|NCT00406653|453678564|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126105233|NCT00406653|453678565|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
126105234|NCT00406653|453678559|FG000|Open-Label Period|Pregnancy|0|||
126105235|NCT00406653|453678560|FG001|Open-Label Period|Pregnancy|0|||
126105236|NCT00406653|453678561|FG002|Open-Label Period|Pregnancy|0|||
126105237|NCT00406653|453678562|FG003|Open-Label Period|Pregnancy|0|||
126105238|NCT00406653|453678563|FG004|Open-Label Period|Pregnancy|0|||
126105239|NCT00406653|453678564|FG005|Open-Label Period|Pregnancy|0|||
126105240|NCT00406653|453678565|FG006|Open-Label Period|Pregnancy|2|||
126105241|NCT00406653|453678559|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
126105242|NCT00406653|453678560|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
126105243|NCT00406653|453678561|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
126105244|NCT00406653|453678562|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
126105245|NCT00406653|453678563|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
126105246|NCT00406653|453678564|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
126105247|NCT00406653|453678565|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
126105248|NCT00406653|453678559|FG000|Open-Label Period|Declined participation but followup done|0|||
126105249|NCT00406653|453678560|FG001|Open-Label Period|Declined participation but followup done|0|||
126105250|NCT00406653|453678561|FG002|Open-Label Period|Declined participation but followup done|0|||
126105251|NCT00406653|453678562|FG003|Open-Label Period|Declined participation but followup done|0|||
126105252|NCT00406653|453678563|FG004|Open-Label Period|Declined participation but followup done|0|||
126105253|NCT00406653|453678564|FG005|Open-Label Period|Declined participation but followup done|0|||
126105254|NCT00406653|453678565|FG006|Open-Label Period|Declined participation but followup done|8|||
126105255|NCT00406653|453678559|FG000|Open-Label Period|Discontinued by Sponsor|0|||
126105256|NCT00406653|453678560|FG001|Open-Label Period|Discontinued by Sponsor|0|||
126105257|NCT00406653|453678561|FG002|Open-Label Period|Discontinued by Sponsor|0|||
126105258|NCT00406653|453678562|FG003|Open-Label Period|Discontinued by Sponsor|0|||
126105259|NCT00406653|453678563|FG004|Open-Label Period|Discontinued by Sponsor|0|||
126105260|NCT00406653|453678564|FG005|Open-Label Period|Discontinued by Sponsor|0|||
126105261|NCT00406653|453678565|FG006|Open-Label Period|Discontinued by Sponsor|1|||
126105262|NCT00406653|453678559|FG000|Open-Label Period|Refused followup|0|||
126105263|NCT00406653|453678560|FG001|Open-Label Period|Refused followup|0|||
126105264|NCT00406653|453678561|FG002|Open-Label Period|Refused followup|0|||
126105265|NCT00406653|453678562|FG003|Open-Label Period|Refused followup|0|||
126105266|NCT00406653|453678563|FG004|Open-Label Period|Refused followup|0|||
126397636|NCT00624780|454748274|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
126397637|NCT00624780|454748269|FG000|Follow-up (Week 26)|Other|1|||
126397638|NCT00624780|454748270|FG001|Follow-up (Week 26)|Other|1|||
126397639|NCT00624780|454748271|FG002|Follow-up (Week 26)|Other|0|||
126397640|NCT00624780|454748272|FG003|Follow-up (Week 26)|Other|0|||
126397641|NCT00624780|454748273|FG004|Follow-up (Week 26)|Other|0|||
126397642|NCT00624780|454748274|FG005|Follow-up (Week 26)|Other|0|||
126397643|NCT01514240|454750255|FG000|Overall Study|Adverse Event|4|||
126397644|NCT01514240|454750256|FG001|Overall Study|Adverse Event|4|||
126397645|NCT01514240|454750255|FG000|Overall Study|Subject Decision|2|||
126397646|NCT01514240|454750256|FG001|Overall Study|Subject Decision|7|||
126397647|NCT01103063|454750258|FG000|Overall Study|Adverse Event|3|||
126397648|NCT01103063|454750259|FG001|Overall Study|Adverse Event|1|||
126397649|NCT01103063|454750258|FG000|Overall Study|Lost to Follow-up|68|||
126397650|NCT01103063|454750259|FG001|Overall Study|Lost to Follow-up|51|||
126397651|NCT01103063|454750258|FG000|Overall Study|Withdrawal by Subject|60|||
126397652|NCT01103063|454750259|FG001|Overall Study|Withdrawal by Subject|15|||
126397653|NCT01103063|454750258|FG000|Overall Study|Other|16|||
126397654|NCT01103063|454750259|FG001|Overall Study|Other|11|||
126397655|NCT01103063|454750258|FG000|Overall Study|Protocol Violation|1|||
126397656|NCT01103063|454750259|FG001|Overall Study|Protocol Violation|0|||
126397657|NCT01103063|454750258|FG000|Overall Study|Study terminated by Sponsor|326|||
126397658|NCT01103063|454750259|FG001|Overall Study|Study terminated by Sponsor|342|||
126397659|NCT01103063|454750258|FG000|Overall Study|Death|3|||
126397660|NCT01103063|454750259|FG001|Overall Study|Death|1|||
126105267|NCT00406653|453678564|FG005|Open-Label Period|Refused followup|0|||
126105268|NCT00406653|453678565|FG006|Open-Label Period|Refused followup|1|||
126105269|NCT00818649|453678566|FG000|Overall Study|Declining performance status|2|||
126105270|NCT00818649|453678566|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
126105271|NCT00818649|453678566|FG000|Overall Study|Adverse Event|1|||
126105272|NCT03513588|453678567|FG000|Overall Study|Lost to Follow-up|0|||
126105273|NCT03513588|453678568|FG001|Overall Study|Lost to Follow-up|1|||
126105274|NCT03513588|453678569|FG002|Overall Study|Lost to Follow-up|1|||
126105275|NCT03513588|453678567|FG000|Overall Study|Study dosing paused by sponsor|1|||
126105276|NCT03513588|453678568|FG001|Overall Study|Study dosing paused by sponsor|1|||
126105277|NCT03513588|453678569|FG002|Overall Study|Study dosing paused by sponsor|0|||
126105278|NCT03513588|453678567|FG000|Overall Study|Death|0|||
126105279|NCT03513588|453678568|FG001|Overall Study|Death|0|||
126105280|NCT03513588|453678569|FG002|Overall Study|Death|1|||
126105281|NCT00940108|453678573|FG000|Overall Study|Adverse Event|2|||
126105282|NCT00940108|453678574|FG001|Overall Study|Adverse Event|4|||
126105283|NCT00940108|453678575|FG002|Overall Study|Adverse Event|0|||
125888645|NCT02023697|452889746|FG001|Long-term Follow-up Period|Death|6|||
125888646|NCT02023697|452889747|FG002|Long-term Follow-up Period|Death|4|||
125888647|NCT02023697|452889745|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
125888648|NCT02023697|452889746|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
125888649|NCT02023697|452889747|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
125888650|NCT02023697|452889745|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
125888651|NCT02023697|452889746|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
125888652|NCT02023697|452889747|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
125888653|NCT02023697|452889745|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
125888654|NCT02023697|452889746|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
125888655|NCT02023697|452889747|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
125888656|NCT02023697|452889745|FG000|Long-term Follow-up Period|Technical problems|0|||
125888657|NCT02023697|452889746|FG001|Long-term Follow-up Period|Technical problems|0|||
125888658|NCT02023697|452889747|FG002|Long-term Follow-up Period|Technical problems|1|||
125888659|NCT02023697|452889745|FG000|Long-term Follow-up Period|Other unspecified|6|||
125888660|NCT02023697|452889746|FG001|Long-term Follow-up Period|Other unspecified|3|||
125888661|NCT02023697|452889747|FG002|Long-term Follow-up Period|Other unspecified|5|||
125888662|NCT00845897|452889748|FG000|Overall Study|Lost to Follow-up|1|||
125888663|NCT00845897|452889749|FG001|Overall Study|Lost to Follow-up|1|||
125888664|NCT00845897|452889750|FG002|Overall Study|Lost to Follow-up|0|||
125888665|NCT00845897|452889748|FG000|Overall Study|Withdrawal by Subject|0|||
125888666|NCT00845897|452889749|FG001|Overall Study|Withdrawal by Subject|3|||
125888667|NCT00845897|452889750|FG002|Overall Study|Withdrawal by Subject|2|||
125888668|NCT00845897|452889748|FG000|Overall Study|Ulcer did not heal|1|||
125888669|NCT00845897|452889749|FG001|Overall Study|Ulcer did not heal|0|||
125888670|NCT00845897|452889750|FG002|Overall Study|Ulcer did not heal|1|||
125888671|NCT00845897|452889748|FG000|Overall Study|Too ill to participate|0|||
125888672|NCT00845897|452889749|FG001|Overall Study|Too ill to participate|1|||
125888673|NCT00845897|452889750|FG002|Overall Study|Too ill to participate|0|||
125888674|NCT01931566|452889751|FG000|Overall Study|Randomized But Not Treated|6|||
125888675|NCT01931566|452889752|FG001|Overall Study|Randomized But Not Treated|9|||
125888676|NCT01931566|452889753|FG002|Overall Study|Randomized But Not Treated|14|||
125888677|NCT01931566|452889751|FG000|Overall Study|Adverse Event|37|||
125888678|NCT01931566|452889752|FG001|Overall Study|Adverse Event|167|||
125888679|NCT01931566|452889753|FG002|Overall Study|Adverse Event|132|||
125888680|NCT01931566|452889751|FG000|Overall Study|Major Protocol Deviation|5|||
125888681|NCT01931566|452889752|FG001|Overall Study|Major Protocol Deviation|14|||
125888682|NCT01931566|452889753|FG002|Overall Study|Major Protocol Deviation|21|||
125888683|NCT01931566|452889751|FG000|Overall Study|Lost to Follow-up|3|||
125888684|NCT01931566|452889752|FG001|Overall Study|Lost to Follow-up|26|||
125888685|NCT01931566|452889753|FG002|Overall Study|Lost to Follow-up|23|||
125888686|NCT01931566|452889751|FG000|Overall Study|Voluntary Withdrawal|78|||
125888687|NCT01931566|452889752|FG001|Overall Study|Voluntary Withdrawal|245|||
125888688|NCT01931566|452889753|FG002|Overall Study|Voluntary Withdrawal|225|||
125888689|NCT01931566|452889751|FG000|Overall Study|Study Termination|289|||
125888690|NCT01931566|452889752|FG001|Overall Study|Study Termination|968|||
125888691|NCT01931566|452889753|FG002|Overall Study|Study Termination|1037|||
125888692|NCT01931566|452889751|FG000|Overall Study|Reason Not Specified|11|||
125888693|NCT01931566|452889752|FG001|Overall Study|Reason Not Specified|47|||
125888694|NCT01931566|452889753|FG002|Overall Study|Reason Not Specified|53|||
125888695|NCT01931566|452889751|FG000|Overall Study|Missing|0|||
125888696|NCT01931566|452889752|FG001|Overall Study|Missing|0|||
125888697|NCT01931566|452889753|FG002|Overall Study|Missing|1|||
125888698|NCT05019521|452889757|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
125888699|NCT05019521|452889758|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
125888700|NCT05019521|452889759|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
125888701|NCT05019521|452889760|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
125888702|NCT05019521|452889761|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125888703|NCT05019521|452889762|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125888704|NCT05019521|452889763|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125888705|NCT05019521|452889757|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125888706|NCT05019521|452889758|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125888707|NCT05019521|452889759|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125888708|NCT05019521|452889760|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
125888709|NCT05019521|452889761|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125888710|NCT05019521|452889762|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125888711|NCT05019521|452889763|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125888712|NCT05019521|452889757|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
125888713|NCT05019521|452889758|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
126052220|NCT04445831|453486010|FG006|Overall Study|Subject withdrawal by caregiver|0|||
126052221|NCT05470114|453486011|FG000|Overall Study|Withdrawal by Subject|1|||
126052222|NCT05470114|453486012|FG001|Overall Study|Withdrawal by Subject|0|||
125888714|NCT05019521|452889759|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
125888715|NCT05019521|452889760|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
125888716|NCT05019521|452889761|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125888717|NCT05019521|452889762|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125888718|NCT05019521|452889763|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125888719|NCT05019521|452889757|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
125888720|NCT05019521|452889758|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125888721|NCT05019521|452889759|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
125888722|NCT05019521|452889760|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125888723|NCT05019521|452889761|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125888724|NCT05019521|452889762|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125888725|NCT05019521|452889763|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125888726|NCT05019521|452889757|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
125888727|NCT05019521|452889758|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
125888728|NCT05019521|452889759|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
125888729|NCT05019521|452889760|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
125888730|NCT05019521|452889761|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
125888731|NCT05019521|452889762|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
125888732|NCT05019521|452889763|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
125888733|NCT05019521|452889757|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
125888734|NCT05019521|452889758|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888735|NCT05019521|452889759|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888736|NCT05019521|452889760|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888737|NCT05019521|452889761|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888738|NCT05019521|452889762|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888739|NCT05019521|452889763|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888740|NCT05019521|452889757|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125888741|NCT05019521|452889758|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125888742|NCT05019521|452889759|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125888743|NCT05019521|452889760|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
125888744|NCT05019521|452889761|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125888745|NCT05019521|452889762|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125888746|NCT05019521|452889763|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125888747|NCT05019521|452889757|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
125888748|NCT05019521|452889758|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
125888749|NCT05019521|452889759|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
125888750|NCT05019521|452889760|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125888751|NCT05019521|452889761|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125888752|NCT05019521|452889762|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125888753|NCT05019521|452889763|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
125888754|NCT05019521|452889757|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125888755|NCT05019521|452889758|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
125888756|NCT05019521|452889759|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125888757|NCT05019521|452889760|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125888758|NCT05019521|452889761|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125888759|NCT05019521|452889762|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125888760|NCT05019521|452889763|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125888761|NCT05019521|452889757|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
125888762|NCT05019521|452889758|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125888763|NCT05019521|452889759|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125888764|NCT05019521|452889760|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125888765|NCT05019521|452889761|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
125888766|NCT05019521|452889762|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
125888767|NCT05019521|452889763|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
125888768|NCT05019521|452889757|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125888769|NCT05019521|452889758|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
125888770|NCT05019521|452889759|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
125888771|NCT05019521|452889760|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125888772|NCT05019521|452889761|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125888773|NCT05019521|452889762|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125888774|NCT05019521|452889763|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125888775|NCT05019521|452889757|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
125888776|NCT05019521|452889758|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
126052223|NCT05470114|453486011|FG000|Overall Study|Lost to Follow-up|1|||
125888777|NCT05019521|452889759|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
125888778|NCT05019521|452889760|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
126052224|NCT05470114|453486012|FG001|Overall Study|Lost to Follow-up|0|||
125888779|NCT05019521|452889761|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
125888780|NCT05019521|452889762|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
125888781|NCT05019521|452889763|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
125888782|NCT05019521|452889757|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888783|NCT05019521|452889758|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888784|NCT05019521|452889759|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888785|NCT05019521|452889760|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888786|NCT05019521|452889761|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888787|NCT05019521|452889762|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
125888788|NCT05019521|452889763|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125888789|NCT05019521|452889757|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125888790|NCT05019521|452889758|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
125888791|NCT05019521|452889759|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125888792|NCT05019521|452889760|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125888793|NCT05019521|452889761|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125888794|NCT05019521|452889762|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
125888795|NCT05019521|452889763|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125888796|NCT05019521|452889757|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
125888797|NCT05019521|452889758|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
125888798|NCT05019521|452889759|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
125888799|NCT05019521|452889760|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
126397661|NCT01187446|454750262|FG000|Overall Study|Patient started non-protocol therapy|0|||
126397662|NCT01187446|454750263|FG001|Overall Study|Patient started non-protocol therapy|1|||
126397663|NCT00613925|454750264|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
126397664|NCT00613925|454750265|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
126397665|NCT00252694|454750268|FG000|Overall Study|Withdrawal by Subject|83|||
125888800|NCT05019521|452889761|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
125888801|NCT05019521|452889762|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
125888802|NCT05019521|452889763|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
125888803|NCT00611026|452889764|FG000|Randomized to Double-blind Treatment|Not treated|2|||
125888804|NCT00611026|452889765|FG001|Randomized to Double-blind Treatment|Not treated|1|||
125888805|NCT00611026|452889766|FG002|Randomized to Double-blind Treatment|Not treated|3|||
125888806|NCT00611026|452889764|FG000|Double-blind Treatment Period|Death|1|||
125888807|NCT00611026|452889765|FG001|Double-blind Treatment Period|Death|0|||
125888808|NCT00611026|452889766|FG002|Double-blind Treatment Period|Death|0|||
125888809|NCT00611026|452889764|FG000|Double-blind Treatment Period|Adverse Event|9|||
125888810|NCT00611026|452889765|FG001|Double-blind Treatment Period|Adverse Event|28|||
125888811|NCT00611026|452889766|FG002|Double-blind Treatment Period|Adverse Event|46|||
125888812|NCT00611026|452889764|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
125888813|NCT00611026|452889765|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
125888814|NCT00611026|452889766|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
125888815|NCT00611026|452889764|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
125888816|NCT00611026|452889765|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
125888817|NCT00611026|452889766|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
125888818|NCT00611026|452889764|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
125888819|NCT00611026|452889765|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
125888820|NCT00611026|452889766|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
125888821|NCT00611026|452889764|FG000|Double-blind Treatment Period|Other|13|||
125888822|NCT00611026|452889765|FG001|Double-blind Treatment Period|Other|20|||
125888823|NCT00611026|452889766|FG002|Double-blind Treatment Period|Other|18|||
125888824|NCT00760617|452889767|FG000|Overall Study|Adverse Event|5|||
125888825|NCT00760617|452889768|FG001|Overall Study|Adverse Event|2|||
125888826|NCT00760617|452889769|FG002|Overall Study|Adverse Event|0|||
125888827|NCT00760617|452889767|FG000|Overall Study|Lost to Follow-up|0|||
125888828|NCT00760617|452889768|FG001|Overall Study|Lost to Follow-up|0|||
125888829|NCT00760617|452889769|FG002|Overall Study|Lost to Follow-up|5|||
125888830|NCT04625101|452889770|FG000|Overall Study|Withdrawal by Subject|0|||
125888831|NCT04625101|452889771|FG001|Overall Study|Withdrawal by Subject|1|||
125888832|NCT04625101|452889770|FG000|Overall Study|Protocol Deviation|1|||
125888833|NCT04625101|452889771|FG001|Overall Study|Protocol Deviation|0|||
125888834|NCT02533453|452889779|FG000|Overall Study|Adverse Event|6|||
125888835|NCT02533453|452889779|FG000|Overall Study|Protocol Violation|1|||
125888836|NCT02533453|452889779|FG000|Overall Study|Withdrawal by Subject|2|||
125888837|NCT00068419|452889785|FG000|Overall Study|Adverse Event|3|||
125888838|NCT00068419|452889785|FG000|Overall Study|Lack of Efficacy|24|||
125888839|NCT00068419|452889785|FG000|Overall Study|Lost to Follow-up|1|||
125888840|NCT00068419|452889785|FG000|Overall Study|Physician Decision|7|||
125888841|NCT00068419|452889785|FG000|Overall Study|Withdrawal by Subject|14|||
126397666|NCT00252694|454750269|FG001|Overall Study|Withdrawal by Subject|91|||
126397667|NCT00252694|454750268|FG000|Overall Study|Death|36|||
126397668|NCT00252694|454750269|FG001|Overall Study|Death|34|||
126397669|NCT00252694|454750268|FG000|Overall Study|Mostly Lost to Follow Up|8|||
126397670|NCT00252694|454750269|FG001|Overall Study|Mostly Lost to Follow Up|13|||
126397671|NCT00252694|454750268|FG000|Overall Study|Patient Moving|17|||
126397672|NCT00252694|454750269|FG001|Overall Study|Patient Moving|16|||
126397673|NCT01342965|454750270|FG000|Overall Study|Death|58|||
126105284|NCT00940108|453678576|FG003|Overall Study|Adverse Event|2|||
126397674|NCT01342965|454750271|FG001|Overall Study|Death|57|||
125888842|NCT00068419|452889785|FG000|Overall Study|Ineligible|11|||
125888843|NCT01160822|452889794|FG000|Overall Study|Adverse Event|0|||
125888844|NCT01160822|452889795|FG001|Overall Study|Adverse Event|0|||
125888845|NCT01160822|452889796|FG002|Overall Study|Adverse Event|0|||
125888846|NCT01160822|452889797|FG003|Overall Study|Adverse Event|0|||
125888847|NCT01160822|452889798|FG004|Overall Study|Adverse Event|1|||
125888848|NCT01160822|452889799|FG005|Overall Study|Adverse Event|2|||
125888849|NCT01160822|452889800|FG006|Overall Study|Adverse Event|5|||
125888850|NCT01160822|452889794|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125888851|NCT01160822|452889795|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125888852|NCT01160822|452889796|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125888853|NCT01160822|452889797|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125888854|NCT01160822|452889798|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
125888855|NCT01160822|452889799|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
125888856|NCT01160822|452889800|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
125888857|NCT01160822|452889794|FG000|Overall Study|Withdrawal by Subject|0|||
125888858|NCT01160822|452889795|FG001|Overall Study|Withdrawal by Subject|0|||
125888859|NCT01160822|452889796|FG002|Overall Study|Withdrawal by Subject|0|||
125888860|NCT01160822|452889797|FG003|Overall Study|Withdrawal by Subject|0|||
125888861|NCT01160822|452889798|FG004|Overall Study|Withdrawal by Subject|0|||
125888862|NCT01160822|452889799|FG005|Overall Study|Withdrawal by Subject|0|||
125888863|NCT01160822|452889800|FG006|Overall Study|Withdrawal by Subject|1|||
125888864|NCT01160822|452889794|FG000|Overall Study|Lost to Follow-up|0|||
125888865|NCT01160822|452889795|FG001|Overall Study|Lost to Follow-up|0|||
125888866|NCT01160822|452889796|FG002|Overall Study|Lost to Follow-up|0|||
125888867|NCT01160822|452889797|FG003|Overall Study|Lost to Follow-up|0|||
125888868|NCT01160822|452889798|FG004|Overall Study|Lost to Follow-up|1|||
125888869|NCT01160822|452889799|FG005|Overall Study|Lost to Follow-up|0|||
125888870|NCT01160822|452889800|FG006|Overall Study|Lost to Follow-up|0|||
125888871|NCT01160822|452889794|FG000|Overall Study|Administrative problems|0|||
125888872|NCT01160822|452889795|FG001|Overall Study|Administrative problems|0|||
125888873|NCT01160822|452889796|FG002|Overall Study|Administrative problems|0|||
125888874|NCT01160822|452889797|FG003|Overall Study|Administrative problems|0|||
125888875|NCT01160822|452889798|FG004|Overall Study|Administrative problems|1|||
125888876|NCT01160822|452889799|FG005|Overall Study|Administrative problems|0|||
125888877|NCT01160822|452889800|FG006|Overall Study|Administrative problems|0|||
125888878|NCT01160822|452889794|FG000|Overall Study|Protocol deviation|0|||
125888879|NCT01160822|452889795|FG001|Overall Study|Protocol deviation|0|||
125888880|NCT01160822|452889796|FG002|Overall Study|Protocol deviation|0|||
125888881|NCT01160822|452889797|FG003|Overall Study|Protocol deviation|0|||
125888882|NCT01160822|452889798|FG004|Overall Study|Protocol deviation|2|||
125888883|NCT01160822|452889799|FG005|Overall Study|Protocol deviation|0|||
125888884|NCT01160822|452889800|FG006|Overall Study|Protocol deviation|0|||
125888885|NCT04717336|452889804|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
125888886|NCT04717336|452889805|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
125888887|NCT04717336|452889804|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
125888888|NCT04717336|452889805|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
125888889|NCT02039843|452889810|FG000|Randomization and Observation Period|Adverse Event|2|||
125888890|NCT02039843|452889811|FG001|Randomization and Observation Period|Adverse Event|0|||
125888891|NCT02039843|452889810|FG000|Randomization and Observation Period|Death|1|||
125888892|NCT02039843|452889811|FG001|Randomization and Observation Period|Death|0|||
125888893|NCT02039843|452889810|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
125888894|NCT02039843|452889811|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
125888895|NCT02039843|452889810|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
125888896|NCT02039843|452889811|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
125888897|NCT02039843|452889810|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
125888898|NCT02039843|452889811|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
125888899|NCT02039843|452889810|FG000|Pairing With a Study Dog|Death|1|||
125888900|NCT02039843|452889811|FG001|Pairing With a Study Dog|Death|0|||
125888901|NCT02039843|452889810|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
125888902|NCT02039843|452889811|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
125888903|NCT02039843|452889810|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
125888904|NCT02039843|452889811|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
125888905|NCT02039843|452889810|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
125888906|NCT02039843|452889811|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
125888907|NCT01500720|452889812|FG000|Overall Study|Randomized But Not Treated|1|||
125888908|NCT01500720|452889813|FG001|Overall Study|Randomized But Not Treated|1|||
125888909|NCT01500720|452889812|FG000|Overall Study|Other|4|||
125888910|NCT01500720|452889813|FG001|Overall Study|Other|8|||
125888911|NCT02527421|452889814|FG000|Overall Study|Withdrawal by Subject|1|||
125888912|NCT02527421|452889815|FG001|Overall Study|Withdrawal by Subject|0|||
125888913|NCT02116205|452889816|FG000|Overall Study|Withdrawal by Subject|2|||
125888914|NCT02116205|452889817|FG001|Overall Study|Withdrawal by Subject|4|||
125888915|NCT02116205|452889818|FG002|Overall Study|Withdrawal by Subject|1|||
125888916|NCT02116205|452889819|FG003|Overall Study|Withdrawal by Subject|3|||
125888917|NCT02116205|452889816|FG000|Overall Study|Lost to Follow-up|0|||
125888918|NCT02116205|452889817|FG001|Overall Study|Lost to Follow-up|2|||
125888919|NCT02116205|452889818|FG002|Overall Study|Lost to Follow-up|1|||
125888920|NCT02116205|452889819|FG003|Overall Study|Lost to Follow-up|2|||
125888921|NCT02116205|452889816|FG000|Overall Study|Physician Decision|0|||
125888922|NCT02116205|452889817|FG001|Overall Study|Physician Decision|1|||
125888923|NCT02116205|452889818|FG002|Overall Study|Physician Decision|1|||
125888924|NCT02116205|452889819|FG003|Overall Study|Physician Decision|1|||
125888925|NCT02116205|452889816|FG000|Overall Study|Exclusion criteria|0|||
125888926|NCT02116205|452889817|FG001|Overall Study|Exclusion criteria|0|||
125888927|NCT02116205|452889818|FG002|Overall Study|Exclusion criteria|1|||
125888928|NCT02116205|452889819|FG003|Overall Study|Exclusion criteria|0|||
125888929|NCT02541604|452889820|FG000|Overall Study|Death|6|||
126397675|NCT01342965|454750270|FG000|Overall Study|Lost to Follow-up|5|||
126397676|NCT01342965|454750271|FG001|Overall Study|Lost to Follow-up|3|||
126397677|NCT01342965|454750270|FG000|Overall Study|Other Reasons- Unspecified|44|||
126397678|NCT01342965|454750271|FG001|Overall Study|Other Reasons- Unspecified|38|||
126397679|NCT01342965|454750270|FG000|Overall Study|Withdrawal by Subject|2|||
126397680|NCT01342965|454750271|FG001|Overall Study|Withdrawal by Subject|9|||
126397681|NCT03538444|454750282|FG000|Overall Study|opioid withdrawal|1|||
126397682|NCT03538444|454750283|FG001|Overall Study|opioid withdrawal|0|||
126397683|NCT04644237|454750297|FG000|Overall Study|Death|3|||
126397684|NCT04644237|454750298|FG001|Overall Study|Death|2|||
126397685|NCT04644237|454750297|FG000|Overall Study|Adverse Event|15|||
126397686|NCT04644237|454750298|FG001|Overall Study|Adverse Event|12|||
126397687|NCT04644237|454750297|FG000|Overall Study|Progressive Disease|47|||
126397688|NCT04644237|454750298|FG001|Overall Study|Progressive Disease|19|||
126397689|NCT04644237|454750297|FG000|Overall Study|Clinical Progression|4|||
126397690|NCT04644237|454750298|FG001|Overall Study|Clinical Progression|1|||
125888930|NCT02541604|452889821|FG001|Overall Study|Death|5|||
125888931|NCT02541604|452889822|FG002|Overall Study|Death|7|||
125888932|NCT02541604|452889823|FG003|Overall Study|Death|2|||
125888933|NCT02541604|452889824|FG004|Overall Study|Death|9|||
125888934|NCT02541604|452889825|FG005|Overall Study|Death|8|||
125888935|NCT02541604|452889826|FG006|Overall Study|Death|9|||
125888936|NCT02541604|452889827|FG007|Overall Study|Death|9|||
125888937|NCT02541604|452889828|FG008|Overall Study|Death|3|||
125888938|NCT02541604|452889829|FG009|Overall Study|Death|4|||
125888939|NCT02541604|452889830|FG010|Overall Study|Death|2|||
125888940|NCT02541604|452889831|FG011|Overall Study|Death|3|||
125888941|NCT02541604|452889820|FG000|Overall Study|Lost to Follow-up|2|||
125888942|NCT02541604|452889821|FG001|Overall Study|Lost to Follow-up|0|||
125888943|NCT02541604|452889822|FG002|Overall Study|Lost to Follow-up|1|||
125888944|NCT02541604|452889823|FG003|Overall Study|Lost to Follow-up|0|||
125888945|NCT02541604|452889824|FG004|Overall Study|Lost to Follow-up|0|||
125888946|NCT02541604|452889825|FG005|Overall Study|Lost to Follow-up|1|||
125888947|NCT02541604|452889826|FG006|Overall Study|Lost to Follow-up|1|||
125888948|NCT02541604|452889827|FG007|Overall Study|Lost to Follow-up|0|||
125888949|NCT02541604|452889828|FG008|Overall Study|Lost to Follow-up|0|||
125888950|NCT02541604|452889829|FG009|Overall Study|Lost to Follow-up|0|||
125888951|NCT02541604|452889830|FG010|Overall Study|Lost to Follow-up|0|||
125888952|NCT02541604|452889831|FG011|Overall Study|Lost to Follow-up|0|||
125888953|NCT02541604|452889820|FG000|Overall Study|Withdrawal by Subject|2|||
125888954|NCT02541604|452889821|FG001|Overall Study|Withdrawal by Subject|0|||
125888955|NCT02541604|452889822|FG002|Overall Study|Withdrawal by Subject|1|||
125888956|NCT02541604|452889823|FG003|Overall Study|Withdrawal by Subject|0|||
125888957|NCT02541604|452889824|FG004|Overall Study|Withdrawal by Subject|1|||
125888958|NCT02541604|452889825|FG005|Overall Study|Withdrawal by Subject|1|||
125888959|NCT02541604|452889826|FG006|Overall Study|Withdrawal by Subject|0|||
125888960|NCT02541604|452889827|FG007|Overall Study|Withdrawal by Subject|0|||
125888961|NCT02541604|452889828|FG008|Overall Study|Withdrawal by Subject|1|||
125888962|NCT02541604|452889829|FG009|Overall Study|Withdrawal by Subject|0|||
125888963|NCT02541604|452889830|FG010|Overall Study|Withdrawal by Subject|0|||
125888964|NCT02541604|452889831|FG011|Overall Study|Withdrawal by Subject|0|||
125888965|NCT02541604|452889820|FG000|Overall Study|Study Terminated by Sponsor|1|||
126105285|NCT00940108|453678573|FG000|Overall Study|Withdrew Consent|2|||
126397691|NCT04644237|454750297|FG000|Overall Study|Withdrawal by Subject|1|||
126397692|NCT04644237|454750298|FG001|Overall Study|Withdrawal by Subject|2|||
126397693|NCT04644237|454750297|FG000|Overall Study|Physician Decision|3|||
125888966|NCT02541604|452889821|FG001|Overall Study|Study Terminated by Sponsor|4|||
125888967|NCT02541604|452889822|FG002|Overall Study|Study Terminated by Sponsor|2|||
125888968|NCT02541604|452889823|FG003|Overall Study|Study Terminated by Sponsor|1|||
125888969|NCT02541604|452889824|FG004|Overall Study|Study Terminated by Sponsor|0|||
125888970|NCT02541604|452889825|FG005|Overall Study|Study Terminated by Sponsor|0|||
125888971|NCT02541604|452889826|FG006|Overall Study|Study Terminated by Sponsor|0|||
125888972|NCT02541604|452889827|FG007|Overall Study|Study Terminated by Sponsor|0|||
125888973|NCT02541604|452889828|FG008|Overall Study|Study Terminated by Sponsor|0|||
125888974|NCT02541604|452889829|FG009|Overall Study|Study Terminated by Sponsor|0|||
126397694|NCT04644237|454750298|FG001|Overall Study|Physician Decision|0|||
125888975|NCT02541604|452889830|FG010|Overall Study|Study Terminated by Sponsor|0|||
125888976|NCT02541604|452889831|FG011|Overall Study|Study Terminated by Sponsor|0|||
125888977|NCT02541604|452889820|FG000|Overall Study|Medical condition may jeopardize safety|0|||
125888978|NCT02541604|452889821|FG001|Overall Study|Medical condition may jeopardize safety|0|||
125888979|NCT02541604|452889822|FG002|Overall Study|Medical condition may jeopardize safety|0|||
125888980|NCT02541604|452889823|FG003|Overall Study|Medical condition may jeopardize safety|0|||
125888981|NCT02541604|452889824|FG004|Overall Study|Medical condition may jeopardize safety|0|||
125888982|NCT02541604|452889825|FG005|Overall Study|Medical condition may jeopardize safety|0|||
125888983|NCT02541604|452889826|FG006|Overall Study|Medical condition may jeopardize safety|0|||
125888984|NCT02541604|452889827|FG007|Overall Study|Medical condition may jeopardize safety|1|||
125888985|NCT02541604|452889828|FG008|Overall Study|Medical condition may jeopardize safety|0|||
125888986|NCT02541604|452889829|FG009|Overall Study|Medical condition may jeopardize safety|0|||
125888987|NCT02541604|452889830|FG010|Overall Study|Medical condition may jeopardize safety|0|||
125888988|NCT02541604|452889831|FG011|Overall Study|Medical condition may jeopardize safety|0|||
125888989|NCT00806819|452889832|FG000|Overall Study|progressive disease (modified RECIST )|217|||
125888990|NCT00806819|452889833|FG001|Overall Study|progressive disease (modified RECIST )|216|||
125888991|NCT00806819|452889832|FG000|Overall Study|Worsening or AE of underlying disease|18|||
125888992|NCT00806819|452889833|FG001|Overall Study|Worsening or AE of underlying disease|25|||
125888993|NCT00806819|452889832|FG000|Overall Study|Other AE|38|||
125888994|NCT00806819|452889833|FG001|Overall Study|Other AE|40|||
125888995|NCT00806819|452889832|FG000|Overall Study|Protocol Violation|9|||
125888996|NCT00806819|452889833|FG001|Overall Study|Protocol Violation|4|||
125888997|NCT00806819|452889832|FG000|Overall Study|Lost to Follow-up|1|||
125888998|NCT00806819|452889833|FG001|Overall Study|Lost to Follow-up|0|||
125888999|NCT00806819|452889832|FG000|Overall Study|Withdrawal by Subject|32|||
125889000|NCT00806819|452889833|FG001|Overall Study|Withdrawal by Subject|29|||
126397695|NCT04644237|454750297|FG000|Overall Study|Other|1|||
126397696|NCT04644237|454750298|FG001|Overall Study|Other|0|||
126397697|NCT04644237|454750297|FG000|Overall Study|Randomized but not Treated|1|||
126397698|NCT04644237|454750298|FG001|Overall Study|Randomized but not Treated|0|||
126397699|NCT01779869|454750299|FG000|Overall Study|Physician Decision|2|||
126397700|NCT02233738|454750301|FG000|Overall Study|Lost to Follow-up|5|||
126397701|NCT02233738|454750302|FG001|Overall Study|Lost to Follow-up|12|||
126397702|NCT02233738|454750301|FG000|Overall Study|Death|0|||
126397703|NCT02233738|454750302|FG001|Overall Study|Death|1|||
126397704|NCT02233738|454750301|FG000|Overall Study|Withdrawal by Subject|0|||
126397705|NCT02233738|454750302|FG001|Overall Study|Withdrawal by Subject|1|||
126397706|NCT02233738|454750301|FG000|Overall Study|Did not return after Baseline|3|||
126397707|NCT02233738|454750302|FG001|Overall Study|Did not return after Baseline|2|||
126397708|NCT00096174|454750303|FG000|Overall Study|Lack of Efficacy|9|||
126397709|NCT00096174|454750303|FG000|Overall Study|Adverse Event|15|||
126397710|NCT00096174|454750303|FG000|Overall Study|Death|6|||
126397711|NCT00096174|454750303|FG000|Overall Study|Withdrawal by Subject|15|||
126397712|NCT00096174|454750303|FG000|Overall Study|Not started protocol therapy|3|||
126397713|NCT00096174|454750303|FG000|Overall Study|Ineligible|6|||
126397714|NCT00096174|454750303|FG000|Overall Study|other reason|8|||
126397715|NCT00027378|454750307|FG000|Overall Study|Physician Decision|0|||
126397716|NCT00027378|454750308|FG001|Overall Study|Physician Decision|3|||
126397717|NCT05605691|454750309|FG000|Overall Study|Lost to Follow-up|1|||
125889001|NCT00806819|452889832|FG000|Overall Study|Not treated|6|||
126397718|NCT03199053|454750312|FG000|ST Period|Withdrawal by Subject|2|||
125889002|NCT00806819|452889833|FG001|Overall Study|Not treated|3|||
125889003|NCT00806819|452889832|FG000|Overall Study|Reasons other than stated above|25|||
125889004|NCT00806819|452889833|FG001|Overall Study|Reasons other than stated above|41|||
125889005|NCT02752165|452889839|FG000|Overall Study|Withdrawal by Subject|6|||
126397719|NCT03199053|454750313|FG001|ST Period|Withdrawal by Subject|4|||
126397720|NCT03199053|454750314|FG002|ST Period|Withdrawal by Subject|6|||
126397721|NCT03199053|454750312|FG000|ST Period|Withdrawal by parent/guardian|1|||
126397722|NCT03199053|454750313|FG001|ST Period|Withdrawal by parent/guardian|1|||
125889006|NCT02752165|452889840|FG001|Overall Study|Withdrawal by Subject|6|||
125889007|NCT02752165|452889839|FG000|Overall Study|Protocol Violation|6|||
125889008|NCT02752165|452889840|FG001|Overall Study|Protocol Violation|5|||
126397723|NCT03199053|454750314|FG002|ST Period|Withdrawal by parent/guardian|1|||
126397724|NCT03199053|454750312|FG000|ST Period|Lost to Follow-up|2|||
126397725|NCT03199053|454750313|FG001|ST Period|Lost to Follow-up|0|||
126397726|NCT03199053|454750314|FG002|ST Period|Lost to Follow-up|1|||
126397727|NCT03199053|454750312|FG000|LT Period|Withdrawal by Subject|1|||
125889009|NCT02752165|452889839|FG000|Overall Study|Lost to Follow-up|33|||
125889010|NCT02752165|452889840|FG001|Overall Study|Lost to Follow-up|38|||
125889011|NCT01704599|452889841|FG000|Overall Study|Adverse Event|1|||
125889012|NCT03843541|452889849|FG000|Overall Study|Adverse Event|4|||
125889013|NCT03843541|452889850|FG001|Overall Study|Adverse Event|2|||
125889014|NCT03843541|452889851|FG002|Overall Study|Adverse Event|3|||
125889015|NCT03843541|452889849|FG000|Overall Study|Death|1|||
125889016|NCT03843541|452889850|FG001|Overall Study|Death|0|||
125889017|NCT03843541|452889851|FG002|Overall Study|Death|0|||
125889018|NCT03843541|452889849|FG000|Overall Study|Lack of adherence to study medication|0|||
125889019|NCT03843541|452889850|FG001|Overall Study|Lack of adherence to study medication|0|||
125889020|NCT03843541|452889851|FG002|Overall Study|Lack of adherence to study medication|1|||
125889021|NCT03843541|452889849|FG000|Overall Study|Physician Decision|1|||
125889022|NCT03843541|452889850|FG001|Overall Study|Physician Decision|2|||
125889023|NCT03843541|452889851|FG002|Overall Study|Physician Decision|2|||
125889024|NCT03843541|452889849|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
125889025|NCT03843541|452889850|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
125889026|NCT03843541|452889851|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
125889027|NCT03843541|452889849|FG000|Overall Study|Withdrawal by Subject|6|||
125889028|NCT03843541|452889850|FG001|Overall Study|Withdrawal by Subject|9|||
125889029|NCT03843541|452889851|FG002|Overall Study|Withdrawal by Subject|7|||
125889030|NCT03843541|452889849|FG000|Overall Study|Administration of rescue mucolytic|0|||
125889031|NCT03843541|452889850|FG001|Overall Study|Administration of rescue mucolytic|0|||
125889032|NCT03843541|452889851|FG002|Overall Study|Administration of rescue mucolytic|1|||
125889033|NCT03843541|452889849|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
125889034|NCT03843541|452889850|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
125889035|NCT03843541|452889851|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
125889036|NCT05767749|452889861|FG000|Overall Study|Withdrawal by Subject|0|||
125889037|NCT05767749|452889862|FG001|Overall Study|Withdrawal by Subject|0|||
125889038|NCT05767749|452889863|FG002|Overall Study|Withdrawal by Subject|2|||
125889039|NCT05767749|452889864|FG003|Overall Study|Withdrawal by Subject|2|||
125889040|NCT05767749|452889865|FG004|Overall Study|Withdrawal by Subject|2|||
125889041|NCT05767749|452889866|FG005|Overall Study|Withdrawal by Subject|2|||
125889042|NCT01077050|452891635|FG000|Overall Study|Subjects signed ICF could not be located|1|||
125889043|NCT01077050|452891635|FG000|Overall Study|Screen failure|8|||
125889044|NCT00684060|452891636|FG000|Overall Study|Lost to Follow-up|1|||
125889045|NCT00684060|452891637|FG001|Overall Study|Lost to Follow-up|0|||
125889046|NCT00684060|452891636|FG000|Overall Study|New stenosis identified|1|||
125889047|NCT00684060|452891637|FG001|Overall Study|New stenosis identified|0|||
125889048|NCT00684060|452891636|FG000|Overall Study|Unable to collect MRI|1|||
125889049|NCT00684060|452891637|FG001|Overall Study|Unable to collect MRI|2|||
125889050|NCT00684060|452891636|FG000|Overall Study|Death|0|||
125889051|NCT00684060|452891637|FG001|Overall Study|Death|1|||
125889052|NCT03751657|452891638|FG000|Overall Study|Physician Decision|0|||
125889053|NCT03751657|452891639|FG001|Overall Study|Physician Decision|1|||
125889054|NCT03751657|452891638|FG000|Overall Study|Withdrawal by Subject|1|||
125889055|NCT03751657|452891639|FG001|Overall Study|Withdrawal by Subject|1|||
125889056|NCT03751657|452891638|FG000|Overall Study|Lost to Follow-up|2|||
125889057|NCT03751657|452891639|FG001|Overall Study|Lost to Follow-up|1|||
125889058|NCT03894813|452891640|FG000|Overall Study|Adverse Event|1|||
125889059|NCT03894813|452891641|FG001|Overall Study|Adverse Event|1|||
125889060|NCT03894813|452891640|FG000|Overall Study|Lack of Efficacy|3|||
125889061|NCT03894813|452891641|FG001|Overall Study|Lack of Efficacy|3|||
125889062|NCT03894813|452891640|FG000|Overall Study|Lost to Follow-up|1|||
125889063|NCT03894813|452891641|FG001|Overall Study|Lost to Follow-up|0|||
125889064|NCT03894813|452891640|FG000|Overall Study|Pregnancy|2|||
125889065|NCT03894813|452891641|FG001|Overall Study|Pregnancy|1|||
125889066|NCT03894813|452891640|FG000|Overall Study|Protocol Violation|3|||
125889067|NCT03894813|452891641|FG001|Overall Study|Protocol Violation|7|||
125889068|NCT03894813|452891640|FG000|Overall Study|Withdrawal by Subject|1|||
125889069|NCT03894813|452891641|FG001|Overall Study|Withdrawal by Subject|3|||
125889070|NCT03894813|452891640|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
126397728|NCT03199053|454750313|FG001|LT Period|Withdrawal by Subject|3|||
126397729|NCT03199053|454750314|FG002|LT Period|Withdrawal by Subject|3|||
126397730|NCT03199053|454750312|FG000|LT Period|Withdrawal by parent/guardian|0|||
125889071|NCT03894813|452891641|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
126397731|NCT03199053|454750313|FG001|LT Period|Withdrawal by parent/guardian|0|||
126397732|NCT03199053|454750314|FG002|LT Period|Withdrawal by parent/guardian|1|||
125889072|NCT03083873|452891643|FG000|Overall Study|Death|6|||
125889073|NCT03083873|452891644|FG001|Overall Study|Death|15|||
126397733|NCT03199053|454750312|FG000|LT Period|Lost to Follow-up|0|||
126397734|NCT03199053|454750313|FG001|LT Period|Lost to Follow-up|1|||
126397735|NCT03199053|454750314|FG002|LT Period|Lost to Follow-up|1|||
126397736|NCT03199053|454750312|FG000|LT Period|Miscellaneous|0|||
126397737|NCT03199053|454750313|FG001|LT Period|Miscellaneous|0|||
126397738|NCT03199053|454750314|FG002|LT Period|Miscellaneous|2|||
126397739|NCT03199053|454750312|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
126397740|NCT03199053|454750313|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
126397741|NCT03199053|454750314|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
126397742|NCT03199053|454750312|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
126397743|NCT03199053|454750313|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
126105286|NCT00940108|453678574|FG001|Overall Study|Withdrew Consent|1|||
126397744|NCT03199053|454750314|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
126397745|NCT03199053|454750312|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
126397746|NCT03199053|454750313|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
126052320|NCT02328014|453487733|FG000|Overall Study|Adverse Event|1|||
126052321|NCT02328014|453487734|FG001|Overall Study|Adverse Event|0|||
126052322|NCT02328014|453487735|FG002|Overall Study|Adverse Event|0|||
126052323|NCT02328014|453487736|FG003|Overall Study|Adverse Event|1|||
126052324|NCT02328014|453487733|FG000|Overall Study|Death|0|||
126052325|NCT02328014|453487734|FG001|Overall Study|Death|0|||
126052326|NCT02328014|453487735|FG002|Overall Study|Death|0|||
126052327|NCT02328014|453487736|FG003|Overall Study|Death|4|||
126052328|NCT02328014|453487733|FG000|Overall Study|Physician Decision|0|||
126052329|NCT02328014|453487734|FG001|Overall Study|Physician Decision|0|||
126052330|NCT02328014|453487735|FG002|Overall Study|Physician Decision|0|||
126052331|NCT02328014|453487736|FG003|Overall Study|Physician Decision|1|||
126052332|NCT02328014|453487733|FG000|Overall Study|Disease Progression|1|||
126052333|NCT02328014|453487734|FG001|Overall Study|Disease Progression|0|||
126052334|NCT02328014|453487735|FG002|Overall Study|Disease Progression|1|||
125889074|NCT03083873|452891645|FG002|Overall Study|Death|13|||
125889075|NCT03083873|452891646|FG003|Overall Study|Death|9|||
126052335|NCT02328014|453487736|FG003|Overall Study|Disease Progression|3|||
126052336|NCT02328014|453487733|FG000|Overall Study|Study Terminated by Sponsor|4|||
126052337|NCT02328014|453487734|FG001|Overall Study|Study Terminated by Sponsor|1|||
126052338|NCT02328014|453487735|FG002|Overall Study|Study Terminated by Sponsor|1|||
126397747|NCT03199053|454750314|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
125889076|NCT03083873|452891647|FG004|Overall Study|Death|0|||
125889077|NCT03083873|452891643|FG000|Overall Study|Sponsor Terminated Study|0|||
125889078|NCT03083873|452891644|FG001|Overall Study|Sponsor Terminated Study|1|||
126052339|NCT02328014|453487736|FG003|Overall Study|Study Terminated by Sponsor|0|||
126052340|NCT02328014|453487733|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
126052341|NCT02328014|453487734|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
126052342|NCT02328014|453487735|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
126397748|NCT03199053|454750312|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
126397749|NCT03199053|454750313|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
126397750|NCT03199053|454750314|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
126397751|NCT01824823|454750317|FG000|Overall Study|Lack of Efficacy|1|||
126397752|NCT01824823|454750318|FG001|Overall Study|Lack of Efficacy|1|||
126397753|NCT01824823|454750317|FG000|Overall Study|Off-treatment reason not submitted|1|||
126397754|NCT01824823|454750318|FG001|Overall Study|Off-treatment reason not submitted|0|||
126397755|NCT02098369|454750319|FG000|Overall Study|Withdrawal by Subject|1|||
126397756|NCT02098369|454750320|FG001|Overall Study|Withdrawal by Subject|5|||
126397757|NCT02098369|454750321|FG002|Overall Study|Withdrawal by Subject|0|||
126397758|NCT02098369|454750319|FG000|Overall Study|Lost to Follow-up|5|||
126397759|NCT02098369|454750320|FG001|Overall Study|Lost to Follow-up|1|||
126397760|NCT02098369|454750321|FG002|Overall Study|Lost to Follow-up|3|||
126397761|NCT02098369|454750319|FG000|Overall Study|Death|1|||
126397762|NCT02098369|454750320|FG001|Overall Study|Death|1|||
126397763|NCT02098369|454750321|FG002|Overall Study|Death|1|||
126397764|NCT02098369|454750319|FG000|Overall Study|Other|0|||
126397765|NCT02098369|454750320|FG001|Overall Study|Other|2|||
126397766|NCT02098369|454750321|FG002|Overall Study|Other|1|||
126397767|NCT00246025|454750322|FG000|Overall Study|Adverse Event|7|||
126397768|NCT00246025|454750323|FG001|Overall Study|Adverse Event|9|||
126397769|NCT00246025|454750324|FG002|Overall Study|Adverse Event|9|||
126397770|NCT00246025|454750325|FG003|Overall Study|Adverse Event|10|||
126397771|NCT00246025|454750322|FG000|Overall Study|Withdrawal by Subject|3|||
126397772|NCT00246025|454750323|FG001|Overall Study|Withdrawal by Subject|0|||
126397773|NCT00246025|454750324|FG002|Overall Study|Withdrawal by Subject|1|||
126397774|NCT00246025|454750325|FG003|Overall Study|Withdrawal by Subject|2|||
126397775|NCT00246025|454750322|FG000|Overall Study|unsuitable medical history was found|0|||
126397776|NCT00246025|454750323|FG001|Overall Study|unsuitable medical history was found|0|||
126397777|NCT00246025|454750324|FG002|Overall Study|unsuitable medical history was found|0|||
126397778|NCT00246025|454750325|FG003|Overall Study|unsuitable medical history was found|1|||
126397779|NCT03444766|454750330|FG000|Overall Study|Other Reasons|2|||
126397780|NCT03444766|454750330|FG000|Overall Study|Participant Withdrew Consent|5|||
126397781|NCT03444766|454750330|FG000|Overall Study|Lost to Follow-up|2|||
126397782|NCT03444766|454750330|FG000|Overall Study|Death|2|||
126397783|NCT03444766|454750330|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
126397784|NCT03444766|454750330|FG000|Overall Study|Disease Progression|49|||
126397785|NCT02374814|454750334|FG000|Overall Study|Lost to Follow-up|1|||
126397786|NCT02374814|454750335|FG001|Overall Study|Lost to Follow-up|1|||
126397787|NCT02374814|454750336|FG002|Overall Study|Lost to Follow-up|0|||
126397788|NCT02374814|454750337|FG003|Overall Study|Lost to Follow-up|1|||
126397789|NCT02374814|454750338|FG004|Overall Study|Lost to Follow-up|0|||
126397790|NCT02374814|454750339|FG005|Overall Study|Lost to Follow-up|0|||
126397791|NCT02374814|454750334|FG000|Overall Study|Withdrawal by Subject|0|||
126397792|NCT02374814|454750335|FG001|Overall Study|Withdrawal by Subject|0|||
126397793|NCT02374814|454750336|FG002|Overall Study|Withdrawal by Subject|1|||
126397794|NCT02374814|454750337|FG003|Overall Study|Withdrawal by Subject|1|||
126397795|NCT02374814|454750338|FG004|Overall Study|Withdrawal by Subject|0|||
126397796|NCT02374814|454750339|FG005|Overall Study|Withdrawal by Subject|0|||
126397797|NCT04209114|454750342|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
126397798|NCT04209114|454750343|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
126397799|NCT04209114|454750344|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
126397800|NCT04209114|454750342|FG000|Pre-Treatment Phase|Other reasons|0|||
126397801|NCT04209114|454750343|FG001|Pre-Treatment Phase|Other reasons|0|||
126397802|NCT04209114|454750344|FG002|Pre-Treatment Phase|Other reasons|1|||
126397803|NCT04209114|454750342|FG000|Pre-Treatment Phase|Death|0|||
126397804|NCT04209114|454750343|FG001|Pre-Treatment Phase|Death|0|||
126397805|NCT04209114|454750344|FG002|Pre-Treatment Phase|Death|1|||
126397806|NCT04209114|454750342|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
126397807|NCT04209114|454750343|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
126397808|NCT04209114|454750344|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
126397809|NCT04209114|454750342|FG000|Treatment Phase|Other reasons|5|||
126397810|NCT04209114|454750343|FG001|Treatment Phase|Other reasons|3|||
126397811|NCT04209114|454750344|FG002|Treatment Phase|Other reasons|0|||
126397812|NCT04209114|454750342|FG000|Treatment Phase|Lost to Follow-up|1|||
126397813|NCT04209114|454750343|FG001|Treatment Phase|Lost to Follow-up|0|||
126397814|NCT04209114|454750344|FG002|Treatment Phase|Lost to Follow-up|0|||
126397815|NCT04209114|454750342|FG000|Treatment Phase|Participant withdrew consent|1|||
126397816|NCT04209114|454750343|FG001|Treatment Phase|Participant withdrew consent|0|||
126397817|NCT04209114|454750344|FG002|Treatment Phase|Participant withdrew consent|0|||
126397818|NCT04209114|454750342|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
126397819|NCT04209114|454750343|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
126397820|NCT04209114|454750344|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
126397821|NCT04209114|454750342|FG000|Treatment Phase|Death|4|||
126397822|NCT04209114|454750343|FG001|Treatment Phase|Death|1|||
126397823|NCT04209114|454750344|FG002|Treatment Phase|Death|0|||
126397824|NCT04209114|454750342|FG000|Treatment Phase|Study drug toxicity|4|||
126052343|NCT02328014|453487736|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
126052344|NCT02328014|453487733|FG000|Overall Study|Withdrawal by Subject|0|||
126052345|NCT02328014|453487734|FG001|Overall Study|Withdrawal by Subject|0|||
126052346|NCT02328014|453487735|FG002|Overall Study|Withdrawal by Subject|0|||
126052347|NCT02328014|453487736|FG003|Overall Study|Withdrawal by Subject|1|||
126052350|NCT01274338|453487739|FG000|Overall Study|Lack of Efficacy|72|||
126052351|NCT01274338|453487740|FG001|Overall Study|Lack of Efficacy|108|||
126052352|NCT01274338|453487741|FG002|Overall Study|Lack of Efficacy|116|||
126052353|NCT01274338|453487742|FG003|Overall Study|Lack of Efficacy|0|||
126052354|NCT01274338|453487743|FG004|Overall Study|Lack of Efficacy|0|||
126052355|NCT01274338|453487744|FG005|Overall Study|Lack of Efficacy|0|||
126052356|NCT01274338|453487739|FG000|Overall Study|Adverse Event|272|||
126052357|NCT01274338|453487740|FG001|Overall Study|Adverse Event|105|||
126052358|NCT01274338|453487741|FG002|Overall Study|Adverse Event|180|||
126052359|NCT01274338|453487742|FG003|Overall Study|Adverse Event|1|||
126052360|NCT01274338|453487743|FG004|Overall Study|Adverse Event|0|||
126052361|NCT01274338|453487744|FG005|Overall Study|Adverse Event|0|||
126052362|NCT01274338|453487739|FG000|Overall Study|Death|8|||
126052363|NCT01274338|453487740|FG001|Overall Study|Death|1|||
126052364|NCT01274338|453487741|FG002|Overall Study|Death|0|||
126052365|NCT01274338|453487742|FG003|Overall Study|Death|0|||
126052366|NCT01274338|453487743|FG004|Overall Study|Death|0|||
126052367|NCT01274338|453487744|FG005|Overall Study|Death|0|||
126052368|NCT01274338|453487739|FG000|Overall Study|Withdrawal by Subject|27|||
126052369|NCT01274338|453487740|FG001|Overall Study|Withdrawal by Subject|99|||
126052370|NCT01274338|453487741|FG002|Overall Study|Withdrawal by Subject|17|||
126052371|NCT01274338|453487742|FG003|Overall Study|Withdrawal by Subject|0|||
126052372|NCT01274338|453487743|FG004|Overall Study|Withdrawal by Subject|0|||
126052373|NCT01274338|453487744|FG005|Overall Study|Withdrawal by Subject|0|||
126052374|NCT01274338|453487739|FG000|Overall Study|Did not start treatment|8|||
126052375|NCT01274338|453487740|FG001|Overall Study|Did not start treatment|116|||
126052376|NCT01274338|453487741|FG002|Overall Study|Did not start treatment|7|||
126052377|NCT01274338|453487742|FG003|Overall Study|Did not start treatment|0|||
126052378|NCT01274338|453487743|FG004|Overall Study|Did not start treatment|0|||
126052379|NCT01274338|453487744|FG005|Overall Study|Did not start treatment|0|||
126052380|NCT01274338|453487739|FG000|Overall Study|Alternative therapy|0|||
126052381|NCT01274338|453487740|FG001|Overall Study|Alternative therapy|1|||
126052382|NCT01274338|453487741|FG002|Overall Study|Alternative therapy|0|||
126052383|NCT01274338|453487742|FG003|Overall Study|Alternative therapy|0|||
126052384|NCT01274338|453487743|FG004|Overall Study|Alternative therapy|0|||
126052385|NCT01274338|453487744|FG005|Overall Study|Alternative therapy|0|||
126052386|NCT01274338|453487739|FG000|Overall Study|Other complicating diseases|0|||
126052387|NCT01274338|453487740|FG001|Overall Study|Other complicating diseases|3|||
126052388|NCT01274338|453487741|FG002|Overall Study|Other complicating diseases|1|||
126052389|NCT01274338|453487742|FG003|Overall Study|Other complicating diseases|0|||
126052390|NCT01274338|453487743|FG004|Overall Study|Other complicating diseases|0|||
126052391|NCT01274338|453487744|FG005|Overall Study|Other complicating diseases|0|||
126052392|NCT01274338|453487739|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
126052393|NCT01274338|453487740|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
126052394|NCT01274338|453487741|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
126052395|NCT01274338|453487742|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
126052396|NCT01274338|453487743|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
126052397|NCT01274338|453487744|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
126052398|NCT01274338|453487739|FG000|Overall Study|Pregnancy|0|||
126052399|NCT01274338|453487740|FG001|Overall Study|Pregnancy|0|||
126052400|NCT01274338|453487741|FG002|Overall Study|Pregnancy|1|||
126052401|NCT01274338|453487742|FG003|Overall Study|Pregnancy|0|||
126052402|NCT01274338|453487743|FG004|Overall Study|Pregnancy|0|||
126052403|NCT01274338|453487744|FG005|Overall Study|Pregnancy|0|||
126052404|NCT01274338|453487739|FG000|Overall Study|Reason not reported|12|||
126052405|NCT01274338|453487740|FG001|Overall Study|Reason not reported|21|||
126052406|NCT01274338|453487741|FG002|Overall Study|Reason not reported|3|||
126052407|NCT01274338|453487742|FG003|Overall Study|Reason not reported|0|||
126052408|NCT01274338|453487743|FG004|Overall Study|Reason not reported|1|||
126052409|NCT01274338|453487744|FG005|Overall Study|Reason not reported|0|||
126052438|NCT05422339|453487757|FG000|Overall Study|Withdrawal by Subject|17|||
126052439|NCT05422339|453487758|FG001|Overall Study|Withdrawal by Subject|15|||
126397825|NCT04209114|454750343|FG001|Treatment Phase|Study drug toxicity|6|||
126397826|NCT04209114|454750344|FG002|Treatment Phase|Study drug toxicity|0|||
126397827|NCT04209114|454750342|FG000|Treatment Phase|Disease progression|6|||
126397828|NCT04209114|454750343|FG001|Treatment Phase|Disease progression|9|||
126397829|NCT04209114|454750344|FG002|Treatment Phase|Disease progression|0|||
126397830|NCT00624819|454750347|FG000|Follow-up Period: Year 4|Parents decision|0|||
126397831|NCT00624819|454750348|FG001|Follow-up Period: Year 4|Parents decision|0|||
126397832|NCT00624819|454750349|FG002|Follow-up Period: Year 4|Parents decision|1|||
126397833|NCT00624819|454750350|FG003|Follow-up Period: Year 4|Parents decision|0|||
126397834|NCT00624819|454750347|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
126397835|NCT00624819|454750348|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
126397836|NCT00624819|454750349|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
126397837|NCT00624819|454750350|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
125889079|NCT03083873|452891645|FG002|Overall Study|Sponsor Terminated Study|2|||
125889080|NCT03083873|452891646|FG003|Overall Study|Sponsor Terminated Study|3|||
125889081|NCT03083873|452891647|FG004|Overall Study|Sponsor Terminated Study|0|||
125889082|NCT03083873|452891643|FG000|Overall Study|Lost to Follow-up|0|||
125889083|NCT03083873|452891644|FG001|Overall Study|Lost to Follow-up|1|||
125889084|NCT03083873|452891645|FG002|Overall Study|Lost to Follow-up|1|||
125889085|NCT03083873|452891646|FG003|Overall Study|Lost to Follow-up|0|||
125889086|NCT03083873|452891647|FG004|Overall Study|Lost to Follow-up|0|||
125889087|NCT03083873|452891643|FG000|Overall Study|Withdrawal by Subject|2|||
125889088|NCT03083873|452891644|FG001|Overall Study|Withdrawal by Subject|0|||
125889089|NCT03083873|452891645|FG002|Overall Study|Withdrawal by Subject|0|||
125889090|NCT03083873|452891646|FG003|Overall Study|Withdrawal by Subject|0|||
125889091|NCT03083873|452891647|FG004|Overall Study|Withdrawal by Subject|0|||
125889092|NCT03083873|452891643|FG000|Overall Study|Did Not Receive TIL|2|||
125889093|NCT03083873|452891644|FG001|Overall Study|Did Not Receive TIL|5|||
125889094|NCT03083873|452891645|FG002|Overall Study|Did Not Receive TIL|3|||
125889095|NCT03083873|452891646|FG003|Overall Study|Did Not Receive TIL|1|||
125889096|NCT03083873|452891647|FG004|Overall Study|Did Not Receive TIL|0|||
125889097|NCT01677377|452891648|FG000|Overall Study|Protocol Violation|1|||
125889098|NCT01677377|452891649|FG001|Overall Study|Protocol Violation|0|||
125889099|NCT01677377|452891650|FG002|Overall Study|Protocol Violation|0|||
125889100|NCT01677377|452891648|FG000|Overall Study|Lost to Follow-up|0|||
125889101|NCT01677377|452891649|FG001|Overall Study|Lost to Follow-up|1|||
125889102|NCT01677377|452891650|FG002|Overall Study|Lost to Follow-up|1|||
125889103|NCT01677377|452891648|FG000|Overall Study|Withdrawal by Subject|0|||
125889104|NCT01677377|452891649|FG001|Overall Study|Withdrawal by Subject|0|||
125889105|NCT01677377|452891650|FG002|Overall Study|Withdrawal by Subject|3|||
125889106|NCT01677377|452891648|FG000|Overall Study|Lack of Efficacy|0|||
125889107|NCT01677377|452891649|FG001|Overall Study|Lack of Efficacy|0|||
125889108|NCT01677377|452891650|FG002|Overall Study|Lack of Efficacy|1|||
125889109|NCT01677377|452891648|FG000|Overall Study|Pregnancy|0|||
125889110|NCT01677377|452891649|FG001|Overall Study|Pregnancy|0|||
125889111|NCT01677377|452891650|FG002|Overall Study|Pregnancy|1|||
125889112|NCT02656693|452891664|FG000|Overall Study|Pregnancy|1|||
125889113|NCT02656693|452891665|FG001|Overall Study|Pregnancy|1|||
125889114|NCT02656693|452891666|FG002|Overall Study|Pregnancy|1|||
125889115|NCT02656693|452891664|FG000|Overall Study|Bariatric surgery|0|||
125889116|NCT02656693|452891665|FG001|Overall Study|Bariatric surgery|1|||
125889117|NCT02656693|452891666|FG002|Overall Study|Bariatric surgery|2|||
125889118|NCT02269267|452891668|FG000|Overall Study|Death|5|||
125889119|NCT03773796|452891669|FG000|Overall Study|Adverse Event|1|||
125889120|NCT03773796|452891669|FG000|Overall Study|Withdrawal by Subject|1|||
125889121|NCT03773796|452891669|FG000|Overall Study|Lack of Efficacy|1|||
125889122|NCT03805659|452891671|FG000|Overall Study|Withdrawal by Subject|0|||
125889123|NCT03805659|452891672|FG001|Overall Study|Withdrawal by Subject|1|||
125889124|NCT00796419|452891673|FG000|Overall Study|Death|0|||
125889125|NCT00796419|452891674|FG001|Overall Study|Death|1|||
125889126|NCT01250145|452891675|FG000|Overall Study|Adverse Event|2|||
125889127|NCT01250145|452891676|FG001|Overall Study|Adverse Event|1|||
125889128|NCT01250145|452891675|FG000|Overall Study|Withdrawal by Subject|0|||
125889129|NCT01250145|452891676|FG001|Overall Study|Withdrawal by Subject|4|||
125889130|NCT01069900|452891677|FG000|Overall Study|Technical problems|0|||
125889131|NCT01069900|452891678|FG001|Overall Study|Technical problems|1|||
125889132|NCT01069900|452891677|FG000|Overall Study|Lost to Follow-up|7|||
125889133|NCT01069900|452891678|FG001|Overall Study|Lost to Follow-up|1|||
125889134|NCT01069900|452891677|FG000|Overall Study|Withdrawal by Subject|6|||
125889135|NCT01069900|452891678|FG001|Overall Study|Withdrawal by Subject|1|||
125889136|NCT01069900|452891677|FG000|Overall Study|Protocol Violation|4|||
125889137|NCT01069900|452891678|FG001|Overall Study|Protocol Violation|1|||
125889138|NCT01069900|452891677|FG000|Overall Study|Insufficient Therapeutic effect|1|||
125889139|NCT01069900|452891678|FG001|Overall Study|Insufficient Therapeutic effect|0|||
125889140|NCT02687191|452891680|FG000|Overall Study|Death|0|||
125889141|NCT02687191|452891681|FG001|Overall Study|Death|1|||
125889142|NCT02687191|452891682|FG002|Overall Study|Death|1|||
125889143|NCT02687191|452891683|FG003|Overall Study|Death|0|||
125889144|NCT02687191|452891684|FG004|Overall Study|Death|1|||
125889145|NCT02687191|452891685|FG005|Overall Study|Death|1|||
125889146|NCT02687191|452891680|FG000|Overall Study|Withdrawal by Subject|0|||
125889147|NCT02687191|452891681|FG001|Overall Study|Withdrawal by Subject|0|||
125889148|NCT02687191|452891682|FG002|Overall Study|Withdrawal by Subject|0|||
125889149|NCT02687191|452891683|FG003|Overall Study|Withdrawal by Subject|1|||
125889150|NCT02687191|452891684|FG004|Overall Study|Withdrawal by Subject|0|||
125889151|NCT02687191|452891685|FG005|Overall Study|Withdrawal by Subject|0|||
125889152|NCT01168219|452891688|FG000|Overall Study|off study before starting treatment|2|||
125889153|NCT01168219|452891688|FG000|Overall Study|withdrew before transplant|1|||
125889154|NCT01168219|452891688|FG000|Overall Study|ineligible due to CML|2|||
125889155|NCT02600819|452891691|FG000|GEN Phase|Adverse Event|2|||
125889156|NCT02600819|452891692|FG001|GEN Phase|Adverse Event|0|||
125889157|NCT02600819|452891691|FG000|GEN Phase|Death|2|||
125889158|NCT02600819|452891692|FG001|GEN Phase|Death|0|||
125889159|NCT02600819|452891691|FG000|GEN Phase|Investigator's Discretion|4|||
125889160|NCT02600819|452891692|FG001|GEN Phase|Investigator's Discretion|0|||
125889161|NCT02600819|452891691|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
125889162|NCT02600819|452891692|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
125889163|NCT02600819|452891691|FG000|GEN Phase|Withdrew Consent|5|||
125889164|NCT02600819|452891692|FG001|GEN Phase|Withdrew Consent|0|||
125889165|NCT02600819|452891691|FG000|GEN Phase|Lost to Follow-up|2|||
125889166|NCT02600819|452891692|FG001|GEN Phase|Lost to Follow-up|0|||
125889167|NCT02736890|452891693|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
125889168|NCT02736890|452891694|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
125889169|NCT02736890|452891693|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
125889170|NCT02736890|452891694|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
125889171|NCT01027273|452891695|FG000|Overall Study|Lost to Follow-up|57|||
125889172|NCT01027273|452891696|FG001|Overall Study|Lost to Follow-up|31|||
125889173|NCT01027273|452891695|FG000|Overall Study|Death|2|||
125889174|NCT01027273|452891696|FG001|Overall Study|Death|2|||
125889175|NCT02904954|452891698|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
125889176|NCT02904954|452891699|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
125889177|NCT02904954|452891698|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
125889178|NCT02904954|452891699|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
125889179|NCT02904954|452891698|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
125889180|NCT02904954|452891699|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
125889181|NCT02904954|452891698|FG000|Adjuvant Durvalumab|Recurrence|2|||
125889182|NCT02904954|452891699|FG001|Adjuvant Durvalumab|Recurrence|0|||
125889183|NCT02904954|452891698|FG000|Adjuvant Durvalumab|Adverse Event|2|||
125889184|NCT02904954|452891699|FG001|Adjuvant Durvalumab|Adverse Event|6|||
125889185|NCT02904954|452891698|FG000|Adjuvant Durvalumab|Participant wishes|12|||
126052542|NCT06056310|453487788|FG000|Overall Study|Other Reasons|2|||
126052543|NCT06056310|453487788|FG000|Overall Study|Sponsor Request|16|||
126397838|NCT02826421|454750355|FG000|Overall Study|Adverse Event|1|||
125889186|NCT02904954|452891699|FG001|Adjuvant Durvalumab|Participant wishes|7|||
125889187|NCT02904954|452891698|FG000|Adjuvant Durvalumab|Physician Decision|2|||
125889188|NCT02904954|452891699|FG001|Adjuvant Durvalumab|Physician Decision|1|||
125889189|NCT02904954|452891698|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
125889190|NCT02904954|452891699|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
125889191|NCT02904954|452891698|FG000|Adjuvant Durvalumab|Death|0|||
125889192|NCT02904954|452891699|FG001|Adjuvant Durvalumab|Death|1|||
125889193|NCT02904954|452891698|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
125889194|NCT02904954|452891699|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
125889195|NCT05097963|452891700|FG000|Overall Study|Protocol Violation|13|||
126105287|NCT00940108|453678575|FG002|Overall Study|Withdrew Consent|0|||
126397839|NCT02826421|454750356|FG001|Overall Study|Adverse Event|0|||
126397840|NCT02826421|454750357|FG002|Overall Study|Adverse Event|0|||
126397841|NCT02826421|454750358|FG003|Overall Study|Adverse Event|1|||
126397842|NCT02826421|454750355|FG000|Overall Study|Withdrawal by Subject|1|||
126397843|NCT02826421|454750356|FG001|Overall Study|Withdrawal by Subject|3|||
126397844|NCT02826421|454750357|FG002|Overall Study|Withdrawal by Subject|1|||
126397845|NCT02826421|454750358|FG003|Overall Study|Withdrawal by Subject|1|||
126397846|NCT02826421|454750355|FG000|Overall Study|Reason not given|1|||
126397847|NCT02826421|454750356|FG001|Overall Study|Reason not given|0|||
126397848|NCT02826421|454750357|FG002|Overall Study|Reason not given|1|||
126397849|NCT02826421|454750358|FG003|Overall Study|Reason not given|0|||
126397850|NCT02210221|454750361|FG000|Overall Study|Lack of Efficacy|7|||
126397851|NCT02210221|454750361|FG000|Overall Study|Withdrawal by Subject|43|||
126397852|NCT02141490|454750364|FG000|Overall Study|Screening failures|4|||
126397853|NCT02141490|454750365|FG001|Overall Study|Screening failures|0|||
125889196|NCT05097963|452891700|FG000|Overall Study|Withdrawal by Subject|21|||
126105288|NCT00940108|453678576|FG003|Overall Study|Withdrew Consent|1|||
126397854|NCT02141490|454750366|FG002|Overall Study|Screening failures|0|||
126397855|NCT00405964|454750367|FG000|Overall Study|Treatment Failure|17|||
126397856|NCT00405964|454750368|FG001|Overall Study|Treatment Failure|45|||
125889197|NCT03830892|452891701|FG000|Overall Study|Physician Decision|2|||
125889198|NCT03830892|452891702|FG001|Overall Study|Physician Decision|3|||
125889199|NCT03830892|452891701|FG000|Overall Study|Study terminated due to COVID|4|||
125889200|NCT03830892|452891702|FG001|Overall Study|Study terminated due to COVID|0|||
125889201|NCT03830892|452891701|FG000|Overall Study|Protocol Violation|0|||
125889202|NCT03830892|452891702|FG001|Overall Study|Protocol Violation|1|||
125889203|NCT03830892|452891701|FG000|Overall Study|Withdrawal by Subject|0|||
125889204|NCT03830892|452891702|FG001|Overall Study|Withdrawal by Subject|2|||
125889205|NCT04661579|452891703|FG000|Overall Study|Lost to Follow-up|19|||
125889206|NCT04661579|452891704|FG001|Overall Study|Lost to Follow-up|10|||
125889207|NCT04661579|452891705|FG002|Overall Study|Lost to Follow-up|2|||
125889208|NCT04661579|452891706|FG003|Overall Study|Lost to Follow-up|7|||
125889209|NCT04661579|452891707|FG004|Overall Study|Lost to Follow-up|11|||
125889210|NCT04661579|452891703|FG000|Overall Study|Physician Decision|2|||
125889211|NCT04661579|452891704|FG001|Overall Study|Physician Decision|0|||
125889212|NCT04661579|452891705|FG002|Overall Study|Physician Decision|0|||
125889213|NCT04661579|452891706|FG003|Overall Study|Physician Decision|1|||
125889214|NCT04661579|452891707|FG004|Overall Study|Physician Decision|0|||
125889215|NCT04661579|452891703|FG000|Overall Study|Withdrawal by Subject|1|||
125889216|NCT04661579|452891704|FG001|Overall Study|Withdrawal by Subject|4|||
125889217|NCT04661579|452891705|FG002|Overall Study|Withdrawal by Subject|0|||
125889218|NCT04661579|452891706|FG003|Overall Study|Withdrawal by Subject|2|||
125889219|NCT04661579|452891707|FG004|Overall Study|Withdrawal by Subject|0|||
125889220|NCT04661579|452891703|FG000|Overall Study|Death|1|||
125889221|NCT04661579|452891704|FG001|Overall Study|Death|0|||
125889222|NCT04661579|452891705|FG002|Overall Study|Death|0|||
125889223|NCT04661579|452891706|FG003|Overall Study|Death|0|||
125889224|NCT04661579|452891707|FG004|Overall Study|Death|0|||
125889225|NCT04661579|452891703|FG000|Overall Study|Other|1|||
126397857|NCT00405964|454750367|FG000|Overall Study|Adverse Event|7|||
126397858|NCT00405964|454750368|FG001|Overall Study|Adverse Event|16|||
126397859|NCT00405964|454750367|FG000|Overall Study|Lost to Follow-up|5|||
126397860|NCT00405964|454750368|FG001|Overall Study|Lost to Follow-up|5|||
126397861|NCT00405964|454750367|FG000|Overall Study|Withdrawal by Subject|19|||
126397862|NCT00405964|454750368|FG001|Overall Study|Withdrawal by Subject|23|||
126397863|NCT00405964|454750367|FG000|Overall Study|Protocol Violation|11|||
126397864|NCT00405964|454750368|FG001|Overall Study|Protocol Violation|6|||
126397865|NCT03271047|454750376|FG000|Phase 1b: Dose Finding Period|Death|8|||
126397866|NCT03271047|454750377|FG001|Phase 1b: Dose Finding Period|Death|8|||
126397867|NCT03271047|454750378|FG002|Phase 1b: Dose Finding Period|Death|0|||
126397868|NCT03271047|454750379|FG003|Phase 1b: Dose Finding Period|Death|0|||
126397869|NCT03271047|454750376|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
126397870|NCT03271047|454750377|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
126397871|NCT03271047|454750378|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
126397872|NCT03271047|454750379|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
126397873|NCT03271047|454750376|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
126397874|NCT03271047|454750377|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
126397875|NCT03271047|454750378|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
126397876|NCT03271047|454750379|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
126397877|NCT03271047|454750376|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
126397878|NCT03271047|454750377|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
126397879|NCT03271047|454750378|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
126397880|NCT03271047|454750379|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
126397881|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Other|0|||
126397882|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Other|0|||
126397883|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Other|0|||
126397884|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Other|1|||
126397885|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Death|0|||
126397886|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Death|0|||
126397887|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Death|20|||
126397888|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Death|21|||
126397889|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
126397890|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
126397891|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
126397892|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
126397893|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
126397894|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
126397895|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
126397896|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
126397897|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
126397898|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
126397899|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
125889226|NCT04661579|452891704|FG001|Overall Study|Other|2|||
125889227|NCT04661579|452891705|FG002|Overall Study|Other|1|||
125889228|NCT04661579|452891706|FG003|Overall Study|Other|1|||
126052641|NCT05250115|453487850|FG000|Overall Study|Premature study end|40|||
126105289|NCT00940108|453678573|FG000|Overall Study|Dose 2 contraindicated|1|||
126105290|NCT00940108|453678574|FG001|Overall Study|Dose 2 contraindicated|1|||
126397900|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
126397901|NCT00434759|454750380|FG000|Overall Study|Lack of Efficacy|5|||
126397902|NCT00434759|454750381|FG001|Overall Study|Lack of Efficacy|4|||
126397903|NCT00434759|454750380|FG000|Overall Study|Withdrawal by Subject|17|||
126397904|NCT00434759|454750381|FG001|Overall Study|Withdrawal by Subject|1|||
126397905|NCT00434759|454750380|FG000|Overall Study|family affairs|2|||
126397906|NCT00434759|454750381|FG001|Overall Study|family affairs|0|||
126397907|NCT02436408|454750383|FG000|Overall Study|Death|1|||
126397908|NCT01300819|454750384|FG000|Overall Study|Adverse Event|9|||
126397909|NCT01300819|454750385|FG001|Overall Study|Adverse Event|27|||
126397910|NCT01300819|454750384|FG000|Overall Study|Lack of Efficacy|2|||
126397911|NCT01300819|454750385|FG001|Overall Study|Lack of Efficacy|1|||
126397912|NCT01300819|454750384|FG000|Overall Study|Withdrawal by Subject|10|||
126397913|NCT01300819|454750385|FG001|Overall Study|Withdrawal by Subject|12|||
126397914|NCT01300819|454750384|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
126397915|NCT01300819|454750385|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
126397916|NCT01300819|454750384|FG000|Overall Study|Refusal to down titrate study drug|0|||
126397917|NCT01300819|454750385|FG001|Overall Study|Refusal to down titrate study drug|1|||
126397918|NCT01300819|454750384|FG000|Overall Study|Administrative reason|0|||
126397919|NCT01300819|454750385|FG001|Overall Study|Administrative reason|1|||
126397920|NCT01300819|454750384|FG000|Overall Study|Safety follow up not done by mistake|0|||
126397921|NCT01300819|454750385|FG001|Overall Study|Safety follow up not done by mistake|1|||
126397922|NCT01300819|454750384|FG000|Overall Study|Follow up call was not done|1|||
126397923|NCT01300819|454750385|FG001|Overall Study|Follow up call was not done|0|||
126397924|NCT02649855|454750386|FG000|Overall Study|Refused further treatment|2|||
126397925|NCT02649855|454750387|FG001|Overall Study|Refused further treatment|1|||
126397926|NCT02649855|454750388|FG002|Overall Study|Refused further treatment|1|||
126397927|NCT02649855|454750386|FG000|Overall Study|Withdrew consent|0|||
126397928|NCT02649855|454750387|FG001|Overall Study|Withdrew consent|1|||
126397929|NCT02649855|454750388|FG002|Overall Study|Withdrew consent|0|||
126397930|NCT02649855|454750386|FG000|Overall Study|Switched to alternative treatment|0|||
126397931|NCT02649855|454750387|FG001|Overall Study|Switched to alternative treatment|1|||
126397932|NCT02649855|454750388|FG002|Overall Study|Switched to alternative treatment|1|||
126397933|NCT02649855|454750386|FG000|Overall Study|Principal investigator discretion|0|||
126397934|NCT02649855|454750387|FG001|Overall Study|Principal investigator discretion|1|||
126397935|NCT02649855|454750388|FG002|Overall Study|Principal investigator discretion|1|||
126397936|NCT02649855|454750386|FG000|Overall Study|No treatment, per protocol|1|||
126397937|NCT02649855|454750387|FG001|Overall Study|No treatment, per protocol|0|||
126397938|NCT02649855|454750388|FG002|Overall Study|No treatment, per protocol|0|||
126397939|NCT02649855|454750386|FG000|Overall Study|Initiate new treatment|1|||
126397940|NCT02649855|454750387|FG001|Overall Study|Initiate new treatment|0|||
126397941|NCT02649855|454750388|FG002|Overall Study|Initiate new treatment|0|||
126052642|NCT05250115|453487850|FG000|Overall Study|Adverse Event|8|||
126052643|NCT05250115|453487850|FG000|Overall Study|Lost to Follow-up|7|||
126052644|NCT05250115|453487850|FG000|Overall Study|Withdrawal by Subject|6|||
126052645|NCT05250115|453487850|FG000|Overall Study|Withdrawal of informed consent|1|||
126052646|NCT05250115|453487850|FG000|Overall Study|Other|7|||
126052647|NCT04401267|453487852|FG000|Overall Study|Death|0|||
126052648|NCT04401267|453487853|FG001|Overall Study|Death|1|||
126052649|NCT04401267|453487852|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
126052650|NCT04401267|453487853|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
126052651|NCT04401267|453487852|FG000|Overall Study|Found to be Ineligible|1|||
126052652|NCT04401267|453487853|FG001|Overall Study|Found to be Ineligible|0|||
126397942|NCT01319721|454750392|FG000|Overall Study|Lost to Follow-up|1|||
126397943|NCT01319721|454750393|FG001|Overall Study|Lost to Follow-up|6|||
126397944|NCT00461305|454750394|FG000|Treatment|Adverse Event|26|||
126397945|NCT00461305|454750395|FG001|Treatment|Adverse Event|3|||
126397946|NCT00461305|454750394|FG000|Treatment|Lost to Follow-up|4|||
126397947|NCT00461305|454750395|FG001|Treatment|Lost to Follow-up|2|||
126397948|NCT00461305|454750394|FG000|Treatment|Protocol Violation|13|||
126397949|NCT00461305|454750395|FG001|Treatment|Protocol Violation|2|||
126397950|NCT00461305|454750394|FG000|Treatment|Withdrawal by Subject|48|||
126397951|NCT00461305|454750395|FG001|Treatment|Withdrawal by Subject|2|||
126397952|NCT00461305|454750394|FG000|Treatment|Never dispensed|5|||
126397953|NCT00461305|454750395|FG001|Treatment|Never dispensed|0|||
126397954|NCT00461305|454750394|FG000|Treatment|Study drug not taken|1|||
126397955|NCT00461305|454750395|FG001|Treatment|Study drug not taken|0|||
126397956|NCT00461305|454750394|FG000|Treatment|Partially missing diary|2|||
126397957|NCT00461305|454750395|FG001|Treatment|Partially missing diary|0|||
126397958|NCT00461305|454750394|FG000|Treatment|Other (missing drug etc)|2|||
126397959|NCT00461305|454750395|FG001|Treatment|Other (missing drug etc)|0|||
126397960|NCT00461305|454750394|FG000|Continued Treatment|Adverse Event|26|||
126397961|NCT00461305|454750395|FG001|Continued Treatment|Adverse Event|0|||
126397962|NCT00461305|454750394|FG000|Continued Treatment|Lost to Follow-up|4|||
126397963|NCT00461305|454750395|FG001|Continued Treatment|Lost to Follow-up|0|||
126397964|NCT00461305|454750394|FG000|Continued Treatment|Protocol Violation|13|||
126397965|NCT00461305|454750395|FG001|Continued Treatment|Protocol Violation|0|||
126397966|NCT00461305|454750394|FG000|Continued Treatment|Withdrawal by Subject|48|||
126397967|NCT00461305|454750395|FG001|Continued Treatment|Withdrawal by Subject|0|||
126397968|NCT00461305|454750394|FG000|Continued Treatment|Partially missing diary|2|||
126397969|NCT00461305|454750395|FG001|Continued Treatment|Partially missing diary|0|||
126397970|NCT00461305|454750394|FG000|Continued Treatment|Other (missing drug etc)|2|||
126052677|NCT05815342|453487866|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
126052678|NCT05815342|453487866|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
126052679|NCT05815342|453487866|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
126397971|NCT00461305|454750395|FG001|Continued Treatment|Other (missing drug etc)|0|||
126397972|NCT00496197|454752998|FG000|Overall Study|Discontinued study due to death|43|||
126397973|NCT00496197|454752998|FG000|Overall Study|Adverse Event|13|||
126397974|NCT00496197|454752998|FG000|Overall Study|Does not meet entrance criteria|5|||
126397975|NCT00496197|454752998|FG000|Overall Study|Insufficient clinical response|3|||
126397976|NCT00496197|454752998|FG000|Overall Study|Insufficient bacteriological response|10|||
126397977|NCT00496197|454752998|FG000|Overall Study|Lost to Follow-up|11|||
126397978|NCT00496197|454752998|FG000|Overall Study|Withdrawal by Subject|11|||
125889229|NCT04661579|452891707|FG004|Overall Study|Other|1|||
125889230|NCT04661579|452891703|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
125889231|NCT04661579|452891704|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
125889232|NCT04661579|452891705|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
125889233|NCT04661579|452891706|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
125889234|NCT04661579|452891707|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
125889235|NCT00859456|452891709|FG000|Overall Study|Adverse Event|3|||
125889236|NCT00859456|452891709|FG000|Overall Study|Progressive disease|2|||
125889237|NCT00859456|452891709|FG000|Overall Study|Non-compliance|3|||
125889238|NCT00337675|452891710|FG000|Overall Study|Adverse Event|10|||
125889239|NCT00337675|452891711|FG001|Overall Study|Adverse Event|9|||
125889240|NCT00337675|452891712|FG002|Overall Study|Adverse Event|19|||
125889241|NCT00337675|452891710|FG000|Overall Study|Lack of Efficacy|10|||
125889242|NCT00337675|452891711|FG001|Overall Study|Lack of Efficacy|7|||
126052680|NCT05815342|453487866|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
126397979|NCT00496197|454752998|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
126397980|NCT00496197|454752998|FG000|Overall Study|Other|14|||
126397981|NCT00496197|454752998|FG000|Overall Study|Protocol Violation|8|||
126397982|NCT01344538|454752999|FG000|Overall Study|Adverse Event|1|||
126397983|NCT01344538|454753000|FG001|Overall Study|Adverse Event|1|||
126397984|NCT01344538|454752999|FG000|Overall Study|Lost to Follow-up|1|||
126397985|NCT01344538|454753000|FG001|Overall Study|Lost to Follow-up|0|||
126397986|NCT01655381|454753001|FG000|Overall Study|Investigator Decision|1|||
126397987|NCT01655381|454753001|FG000|Overall Study|Moved to Another City|1|||
126397988|NCT01655381|454753001|FG000|Overall Study|Insufficient Treatment Response|1|||
126397989|NCT00320255|454753002|FG000|Overall Study|Lack of Efficacy|1|||
126397990|NCT00320255|454753003|FG001|Overall Study|Lack of Efficacy|0|||
126397991|NCT00320255|454753004|FG002|Overall Study|Lack of Efficacy|0|||
126397992|NCT00320255|454753005|FG003|Overall Study|Lack of Efficacy|0|||
126397993|NCT00320255|454753006|FG004|Overall Study|Lack of Efficacy|0|||
126397994|NCT00320255|454753007|FG005|Overall Study|Lack of Efficacy|0|||
126397995|NCT00320255|454753002|FG000|Overall Study|Adverse Event|5|||
126397996|NCT00320255|454753003|FG001|Overall Study|Adverse Event|2|||
126397997|NCT00320255|454753004|FG002|Overall Study|Adverse Event|3|||
126397998|NCT00320255|454753005|FG003|Overall Study|Adverse Event|2|||
126397999|NCT00320255|454753006|FG004|Overall Study|Adverse Event|0|||
126398000|NCT00320255|454753007|FG005|Overall Study|Adverse Event|0|||
126398001|NCT00320255|454753002|FG000|Overall Study|Withdrawal by Subject|1|||
126398002|NCT00320255|454753003|FG001|Overall Study|Withdrawal by Subject|2|||
126398003|NCT00320255|454753004|FG002|Overall Study|Withdrawal by Subject|2|||
126398004|NCT00320255|454753005|FG003|Overall Study|Withdrawal by Subject|4|||
126398005|NCT00320255|454753006|FG004|Overall Study|Withdrawal by Subject|0|||
126398006|NCT00320255|454753007|FG005|Overall Study|Withdrawal by Subject|0|||
126398007|NCT00320255|454753002|FG000|Overall Study|Poor compliance/noncompliance|1|||
126398008|NCT00320255|454753003|FG001|Overall Study|Poor compliance/noncompliance|1|||
126398009|NCT00320255|454753004|FG002|Overall Study|Poor compliance/noncompliance|0|||
126398010|NCT00320255|454753005|FG003|Overall Study|Poor compliance/noncompliance|1|||
126398011|NCT00320255|454753006|FG004|Overall Study|Poor compliance/noncompliance|0|||
126398012|NCT00320255|454753007|FG005|Overall Study|Poor compliance/noncompliance|0|||
126398013|NCT00320255|454753002|FG000|Overall Study|No longer meets study criteria|0|||
126398014|NCT00320255|454753003|FG001|Overall Study|No longer meets study criteria|0|||
126398015|NCT00320255|454753004|FG002|Overall Study|No longer meets study criteria|0|||
126398016|NCT00320255|454753005|FG003|Overall Study|No longer meets study criteria|1|||
126398017|NCT00320255|454753006|FG004|Overall Study|No longer meets study criteria|0|||
126398018|NCT00320255|454753007|FG005|Overall Study|No longer meets study criteria|0|||
126398019|NCT00320255|454753002|FG000|Overall Study|Other|3|||
126398020|NCT00320255|454753003|FG001|Overall Study|Other|2|||
126398021|NCT00320255|454753004|FG002|Overall Study|Other|1|||
126398022|NCT00320255|454753005|FG003|Overall Study|Other|0|||
126398023|NCT00320255|454753006|FG004|Overall Study|Other|0|||
126398024|NCT00320255|454753007|FG005|Overall Study|Other|0|||
125889243|NCT00337675|452891712|FG002|Overall Study|Lack of Efficacy|9|||
126052681|NCT05815342|453487866|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
126398025|NCT03405935|454753009|FG000|Overall Study|Adverse Event|3|||
126398026|NCT03405935|454753009|FG000|Overall Study|Death|2|||
126398027|NCT03405935|454753009|FG000|Overall Study|Withdrawal by Subject|1|||
126398028|NCT03405935|454753009|FG000|Overall Study|Lost to Follow-up|2|||
126398029|NCT04979897|454753010|FG000|Overall Study|Death|1|||
126398030|NCT04979897|454753011|FG001|Overall Study|Death|8|||
125889244|NCT00337675|452891710|FG000|Overall Study|Lost to Follow-up|22|||
125889245|NCT00337675|452891711|FG001|Overall Study|Lost to Follow-up|19|||
126398031|NCT04979897|454753010|FG000|Overall Study|Lost to Follow-up|111|||
126398032|NCT04979897|454753011|FG001|Overall Study|Lost to Follow-up|56|||
126398033|NCT04979897|454753010|FG000|Overall Study|Withdrawal by Subject|7|||
126398034|NCT04979897|454753011|FG001|Overall Study|Withdrawal by Subject|2|||
126398035|NCT02781792|454753018|FG000|Overall Study|Adverse Event|1|||
126398036|NCT02781792|454753019|FG001|Overall Study|Adverse Event|2|||
125889246|NCT00337675|452891712|FG002|Overall Study|Lost to Follow-up|17|||
125889247|NCT00337675|452891710|FG000|Overall Study|Physician Decision|9|||
125889248|NCT00337675|452891711|FG001|Overall Study|Physician Decision|17|||
125889249|NCT00337675|452891712|FG002|Overall Study|Physician Decision|14|||
125889250|NCT00337675|452891710|FG000|Overall Study|Protocol Violation|21|||
125889251|NCT00337675|452891711|FG001|Overall Study|Protocol Violation|24|||
125889252|NCT00337675|452891712|FG002|Overall Study|Protocol Violation|19|||
125889253|NCT00337675|452891710|FG000|Overall Study|Withdrawal by Subject|25|||
125889254|NCT00337675|452891711|FG001|Overall Study|Withdrawal by Subject|25|||
125889255|NCT00337675|452891712|FG002|Overall Study|Withdrawal by Subject|19|||
125889256|NCT00337675|452891710|FG000|Overall Study|Progressive Disease|0|||
125889257|NCT00337675|452891711|FG001|Overall Study|Progressive Disease|2|||
125889258|NCT00337675|452891712|FG002|Overall Study|Progressive Disease|0|||
125889259|NCT00337675|452891710|FG000|Overall Study|Trial Terminated|0|||
125889260|NCT00337675|452891711|FG001|Overall Study|Trial Terminated|0|||
125889261|NCT00337675|452891712|FG002|Overall Study|Trial Terminated|2|||
125889262|NCT01491607|452891719|FG000|Overall Study|Lost to Follow-up|7|||
125889263|NCT01491607|452891719|FG000|Overall Study|Withdrawal by Subject|3|||
125889264|NCT01317277|452891720|FG000|Overall Study|Lost to Follow-up|3|||
125889265|NCT01317277|452891721|FG001|Overall Study|Lost to Follow-up|1|||
125889266|NCT01317277|452891720|FG000|Overall Study|Lost MEMS|1|||
125889267|NCT01317277|452891721|FG001|Overall Study|Lost MEMS|1|||
126398037|NCT02781792|454753018|FG000|Overall Study|Withdrawal by Subject|3|||
126398038|NCT02781792|454753019|FG001|Overall Study|Withdrawal by Subject|1|||
126398039|NCT02781792|454753018|FG000|Overall Study|Lack of Efficacy|1|||
126398040|NCT02781792|454753019|FG001|Overall Study|Lack of Efficacy|1|||
126398041|NCT02781792|454753018|FG000|Overall Study|Hospice|0|||
126398042|NCT02781792|454753019|FG001|Overall Study|Hospice|1|||
126398043|NCT01703117|454753020|FG000|Overall Study|Adverse Event|4|||
126398044|NCT01703117|454753021|FG001|Overall Study|Adverse Event|3|||
126398045|NCT01703117|454753020|FG000|Overall Study|Withdrawal by Subject|0|||
126398046|NCT01703117|454753021|FG001|Overall Study|Withdrawal by Subject|1|||
126398047|NCT00683917|454753022|FG000|Overall Study|Study prematurely terminated|10|||
126398048|NCT01170598|454753027|FG000|Overall Study|Withdrawal by Subject|1|||
126398049|NCT01170598|454753027|FG000|Overall Study|Death|3|||
126398050|NCT01170598|454753027|FG000|Overall Study|Lost to Follow-up|1|||
126398051|NCT01170598|454753027|FG000|Overall Study|Refused|1|||
126398052|NCT02119156|454753028|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
126398053|NCT02119156|454753029|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
126398054|NCT02119156|454753030|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
126398055|NCT02119156|454753028|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
126398056|NCT02119156|454753029|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
126398057|NCT02119156|454753030|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
126398058|NCT02119156|454753028|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
126398059|NCT02119156|454753029|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
126398060|NCT02119156|454753030|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
126398061|NCT02119156|454753028|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
126398062|NCT02119156|454753029|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
126398063|NCT02119156|454753030|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
126398064|NCT02119156|454753028|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
126398065|NCT02119156|454753029|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
126398066|NCT02119156|454753030|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
126398067|NCT02685748|454753031|FG000|Overall Study|Withdrawal by Subject|3|||
126398068|NCT02685748|454753032|FG001|Overall Study|Withdrawal by Subject|2|||
126398069|NCT02536300|454753036|FG000|Overall Study|Investigator's Discretion|17|||
126398070|NCT02536300|454753037|FG001|Overall Study|Investigator's Discretion|11|||
126398071|NCT02536300|454753038|FG002|Overall Study|Investigator's Discretion|2|||
126398072|NCT02536300|454753036|FG000|Overall Study|Progressive Disease|11|||
126398073|NCT02536300|454753037|FG001|Overall Study|Progressive Disease|7|||
126398074|NCT02536300|454753038|FG002|Overall Study|Progressive Disease|6|||
126398075|NCT02536300|454753036|FG000|Overall Study|Study Terminated by Sponsor|6|||
126398076|NCT02536300|454753037|FG001|Overall Study|Study Terminated by Sponsor|4|||
126398077|NCT02536300|454753038|FG002|Overall Study|Study Terminated by Sponsor|7|||
126398078|NCT02536300|454753036|FG000|Overall Study|Death|7|||
125889268|NCT01317277|452891720|FG000|Overall Study|Unable to comply with intervention|1|||
125889269|NCT01317277|452891721|FG001|Overall Study|Unable to comply with intervention|0|||
125889270|NCT01317277|452891720|FG000|Overall Study|Withdrawal by Subject|1|||
125889271|NCT01317277|452891721|FG001|Overall Study|Withdrawal by Subject|0|||
125889272|NCT01317277|452891720|FG000|Overall Study|Adverse Event|1|||
125889273|NCT01317277|452891721|FG001|Overall Study|Adverse Event|0|||
126398079|NCT02536300|454753037|FG001|Overall Study|Death|0|||
126398080|NCT02536300|454753038|FG002|Overall Study|Death|5|||
126398081|NCT02536300|454753036|FG000|Overall Study|Withdrew Consent|4|||
126398082|NCT02536300|454753037|FG001|Overall Study|Withdrew Consent|2|||
126398083|NCT02536300|454753038|FG002|Overall Study|Withdrew Consent|0|||
126398084|NCT02536300|454753036|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
126398085|NCT02536300|454753037|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
125889274|NCT00774566|452891722|FG000|Overall Study|Protocol Violation|18|||
125889275|NCT00774566|452891723|FG001|Overall Study|Protocol Violation|15|||
126398086|NCT02536300|454753038|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
126398087|NCT02536300|454753036|FG000|Overall Study|Enrolled but Never Treated|0|||
126398088|NCT02536300|454753037|FG001|Overall Study|Enrolled but Never Treated|0|||
126398089|NCT02536300|454753038|FG002|Overall Study|Enrolled but Never Treated|1|||
126398090|NCT02536300|454753036|FG000|Overall Study|Non-compliance With Study Drug|1|||
126398091|NCT02536300|454753037|FG001|Overall Study|Non-compliance With Study Drug|0|||
126398092|NCT02536300|454753038|FG002|Overall Study|Non-compliance With Study Drug|0|||
126398093|NCT02536300|454753036|FG000|Overall Study|Protocol Violation|0|||
126398094|NCT02536300|454753037|FG001|Overall Study|Protocol Violation|1|||
126398095|NCT02536300|454753038|FG002|Overall Study|Protocol Violation|0|||
126398096|NCT04706273|454753039|FG000|Overall Study|Withdrawal by Subject|27|||
126398097|NCT04706273|454753039|FG000|Overall Study|Physician Decision|1|||
125889276|NCT01075685|452891726|FG000|Overall Study|Protocol Violation|9|||
125889277|NCT01075685|452891727|FG001|Overall Study|Protocol Violation|1|||
125889278|NCT01075685|452891726|FG000|Overall Study|Withdrawal by Subject|20|||
125889279|NCT01075685|452891727|FG001|Overall Study|Withdrawal by Subject|5|||
125889280|NCT01075685|452891726|FG000|Overall Study|Lost to Follow-up|563|||
125889281|NCT01075685|452891727|FG001|Overall Study|Lost to Follow-up|220|||
125889282|NCT02858362|452891728|FG000|Overall Study|Protocol Violation|0|||
125889283|NCT02858362|452891729|FG001|Overall Study|Protocol Violation|1|||
125889284|NCT02858362|452891730|FG002|Overall Study|Protocol Violation|0|||
125889285|NCT02858362|452891728|FG000|Overall Study|Withdrawal by Subject|1|||
125889286|NCT02858362|452891729|FG001|Overall Study|Withdrawal by Subject|0|||
125889287|NCT02858362|452891730|FG002|Overall Study|Withdrawal by Subject|0|||
125889288|NCT02858362|452891728|FG000|Overall Study|Early Study Termination|0|||
125889289|NCT02858362|452891729|FG001|Overall Study|Early Study Termination|0|||
125889290|NCT02858362|452891730|FG002|Overall Study|Early Study Termination|3|||
125889291|NCT02858362|452891728|FG000|Overall Study|Lost to Follow-up|1|||
125889292|NCT02858362|452891729|FG001|Overall Study|Lost to Follow-up|0|||
125889293|NCT02858362|452891730|FG002|Overall Study|Lost to Follow-up|0|||
125889294|NCT01262989|452891731|FG000|Period 1|Lost to Follow-up|1|||
125889295|NCT01262989|452891732|FG001|Period 1|Lost to Follow-up|1|||
125889296|NCT01262989|452891731|FG000|Period 1|Intercurrent disease|0|||
125889297|NCT01262989|452891732|FG001|Period 1|Intercurrent disease|1|||
125889298|NCT01262989|452891731|FG000|Period 1|Positive answer for exclusion criteria|0|||
125889299|NCT01262989|452891732|FG001|Period 1|Positive answer for exclusion criteria|1|||
125889300|NCT01262989|452891731|FG000|Period 2|Intercurrent disease|0|||
125889301|NCT01262989|452891732|FG001|Period 2|Intercurrent disease|1|||
125889302|NCT02813577|452891733|FG000|Overall Study|Study terminated|4|||
125889303|NCT00775593|452891739|FG000|Overall Study|Unmet eligibility criteria|6|||
126398098|NCT04706273|454753039|FG000|Overall Study|Lost to Follow-up|42|||
126398099|NCT04706273|454753039|FG000|Overall Study|Death|85|||
126398100|NCT04706273|454753039|FG000|Overall Study|Amputation that removes study device|2|||
126398101|NCT04706273|454753039|FG000|Overall Study|Surgical bypass|3|||
126398102|NCT04706273|454753039|FG000|Overall Study|Changing hospital|23|||
126398103|NCT04706273|454753039|FG000|Overall Study|Unable to attend hospital|2|||
126398104|NCT01080768|454753045|FG000|Overall Study|Protocol Deviation|2|||
126398105|NCT01080768|454753046|FG001|Overall Study|Protocol Deviation|1|||
126398106|NCT03054350|454753051|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
126398107|NCT03054350|454753052|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
126398108|NCT03054350|454753053|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
126398109|NCT03054350|454753054|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
126398110|NCT03054350|454753055|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
126398111|NCT03054350|454753056|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
126398112|NCT03054350|454753051|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126398113|NCT03054350|454753052|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126398114|NCT03054350|454753053|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
126398115|NCT03054350|454753054|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126398116|NCT03054350|454753055|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125889304|NCT00775593|452891739|FG000|Overall Study|Death|1|||
125889305|NCT02067676|452891740|FG000|Overall Study|Withdrawal by Subject|1|||
125889306|NCT02067676|452891741|FG001|Overall Study|Withdrawal by Subject|0|||
125889307|NCT02067676|452891742|FG002|Overall Study|Withdrawal by Subject|0|||
125889308|NCT02067676|452891743|FG003|Overall Study|Withdrawal by Subject|0|||
126398117|NCT03054350|454753056|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126398118|NCT03054350|454753051|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
126398119|NCT03054350|454753052|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
126398120|NCT03054350|454753053|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
126398121|NCT03054350|454753054|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
126398122|NCT03054350|454753055|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
126398123|NCT03054350|454753056|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
126398124|NCT03054350|454753051|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126398125|NCT03054350|454753052|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126398126|NCT03054350|454753053|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
126398127|NCT03054350|454753054|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125889309|NCT02067676|452891744|FG004|Overall Study|Withdrawal by Subject|0|||
125889310|NCT02067676|452891745|FG005|Overall Study|Withdrawal by Subject|0|||
126398128|NCT03054350|454753055|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126398129|NCT03054350|454753056|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126398130|NCT00931723|454753057|FG000|Overall Study|Withdrawal by Subject|11|||
126398131|NCT00931723|454753058|FG001|Overall Study|Withdrawal by Subject|13|||
126398132|NCT00931723|454753057|FG000|Overall Study|Adverse Event|6|||
126398133|NCT00931723|454753058|FG001|Overall Study|Adverse Event|13|||
126398134|NCT00931723|454753057|FG000|Overall Study|Lithium found in blood|0|||
126398135|NCT00931723|454753058|FG001|Overall Study|Lithium found in blood|1|||
126398136|NCT00931723|454753057|FG000|Overall Study|Condition under investigation worsened|1|||
126398137|NCT00931723|454753058|FG001|Overall Study|Condition under investigation worsened|2|||
126398138|NCT00931723|454753057|FG000|Overall Study|Lost to Follow-up|1|||
126398139|NCT00931723|454753058|FG001|Overall Study|Lost to Follow-up|2|||
126398140|NCT00931723|454753057|FG000|Overall Study|Study-specific discontinuation criteria|1|||
126398141|NCT00931723|454753058|FG001|Overall Study|Study-specific discontinuation criteria|1|||
126398142|NCT00931723|454753057|FG000|Overall Study|Severe non-compliance to protocol|2|||
126398143|NCT00931723|454753058|FG001|Overall Study|Severe non-compliance to protocol|0|||
126398144|NCT00931723|454753057|FG000|Overall Study|Safety reasons|0|||
126398145|NCT00931723|454753058|FG001|Overall Study|Safety reasons|1|||
126398146|NCT00931723|454753057|FG000|Overall Study|Took prohibited concomitant medication|0|||
126398147|NCT00931723|454753058|FG001|Overall Study|Took prohibited concomitant medication|1|||
126398148|NCT00931723|454753057|FG000|Overall Study|Lack or insufficient theraputic response|2|||
126398149|NCT00931723|454753058|FG001|Overall Study|Lack or insufficient theraputic response|5|||
126398150|NCT00931723|454753057|FG000|Overall Study|Sponsor decision|1|||
126398151|NCT00931723|454753058|FG001|Overall Study|Sponsor decision|0|||
126398152|NCT00931723|454753057|FG000|Overall Study|Late hospital discharge|1|||
126398153|NCT00931723|454753058|FG001|Overall Study|Late hospital discharge|0|||
126398154|NCT01643850|454753062|FG000|Overall Study|Withdrawal by Subject|0|||
126398155|NCT01643850|454753063|FG001|Overall Study|Withdrawal by Subject|0|||
126398156|NCT01643850|454753064|FG002|Overall Study|Withdrawal by Subject|0|||
126398157|NCT01643850|454753065|FG003|Overall Study|Withdrawal by Subject|0|||
126398158|NCT01643850|454753066|FG004|Overall Study|Withdrawal by Subject|1|||
126398159|NCT01643850|454753067|FG005|Overall Study|Withdrawal by Subject|0|||
126398160|NCT01643850|454753068|FG006|Overall Study|Withdrawal by Subject|0|||
126398161|NCT01643850|454753069|FG007|Overall Study|Withdrawal by Subject|0|||
126398162|NCT01643850|454753070|FG008|Overall Study|Withdrawal by Subject|0|||
126398163|NCT01643850|454753062|FG000|Overall Study|Lost to Follow-up|0|||
126398164|NCT01643850|454753063|FG001|Overall Study|Lost to Follow-up|0|||
126398165|NCT01643850|454753064|FG002|Overall Study|Lost to Follow-up|0|||
126398166|NCT01643850|454753065|FG003|Overall Study|Lost to Follow-up|0|||
126398167|NCT01643850|454753066|FG004|Overall Study|Lost to Follow-up|0|||
126398168|NCT01643850|454753067|FG005|Overall Study|Lost to Follow-up|0|||
126398169|NCT01643850|454753068|FG006|Overall Study|Lost to Follow-up|1|||
126398170|NCT01643850|454753069|FG007|Overall Study|Lost to Follow-up|0|||
126398171|NCT01643850|454753070|FG008|Overall Study|Lost to Follow-up|1|||
126398172|NCT01643850|454753062|FG000|Overall Study|Adverse Event|0|||
126398173|NCT01643850|454753063|FG001|Overall Study|Adverse Event|0|||
125889311|NCT03904693|452891753|FG000|Overall Study|Death|0|||
126398174|NCT01643850|454753064|FG002|Overall Study|Adverse Event|0|||
126398175|NCT01643850|454753065|FG003|Overall Study|Adverse Event|0|||
125889312|NCT03904693|452891754|FG001|Overall Study|Death|0|||
126398176|NCT01643850|454753066|FG004|Overall Study|Adverse Event|1|||
126398177|NCT01643850|454753067|FG005|Overall Study|Adverse Event|0|||
126398178|NCT01643850|454753068|FG006|Overall Study|Adverse Event|0|||
126398179|NCT01643850|454753069|FG007|Overall Study|Adverse Event|0|||
126398180|NCT01643850|454753070|FG008|Overall Study|Adverse Event|0|||
125889313|NCT03904693|452891755|FG002|Overall Study|Death|3|||
126398181|NCT01643850|454753062|FG000|Overall Study|Administrative Problems|0|||
126398182|NCT01643850|454753063|FG001|Overall Study|Administrative Problems|0|||
126398183|NCT01643850|454753064|FG002|Overall Study|Administrative Problems|1|||
126398184|NCT01643850|454753065|FG003|Overall Study|Administrative Problems|0|||
126398185|NCT01643850|454753066|FG004|Overall Study|Administrative Problems|1|||
126398186|NCT01643850|454753067|FG005|Overall Study|Administrative Problems|0|||
126398187|NCT01643850|454753068|FG006|Overall Study|Administrative Problems|0|||
126398188|NCT01643850|454753069|FG007|Overall Study|Administrative Problems|0|||
126398189|NCT01643850|454753070|FG008|Overall Study|Administrative Problems|0|||
126398190|NCT01133405|454753071|FG000|Period 1|Withdrawal by Subject|0|||
126398191|NCT01133405|454753072|FG001|Period 1|Withdrawal by Subject|1|||
126398192|NCT01133405|454753073|FG002|Period 1|Withdrawal by Subject|0|||
126398193|NCT01133405|454753074|FG003|Period 1|Withdrawal by Subject|1|||
126398194|NCT01133405|454753075|FG004|Period 1|Withdrawal by Subject|0|||
126398195|NCT01133405|454753076|FG005|Period 1|Withdrawal by Subject|1|||
126398196|NCT01133405|454753077|FG006|Period 1|Withdrawal by Subject|0|||
126398197|NCT01133405|454753078|FG007|Period 1|Withdrawal by Subject|0|||
126398198|NCT01133405|454753079|FG008|Period 1|Withdrawal by Subject|0|||
126398199|NCT01133405|454753080|FG009|Period 1|Withdrawal by Subject|0|||
126398200|NCT01133405|454753071|FG000|Period 1|Physician Decision|0|||
126398201|NCT01133405|454753072|FG001|Period 1|Physician Decision|0|||
126398202|NCT01133405|454753073|FG002|Period 1|Physician Decision|0|||
126398203|NCT01133405|454753074|FG003|Period 1|Physician Decision|1|||
126398204|NCT01133405|454753075|FG004|Period 1|Physician Decision|0|||
126398205|NCT01133405|454753076|FG005|Period 1|Physician Decision|0|||
126398206|NCT01133405|454753077|FG006|Period 1|Physician Decision|0|||
126398207|NCT01133405|454753078|FG007|Period 1|Physician Decision|0|||
126398208|NCT01133405|454753079|FG008|Period 1|Physician Decision|0|||
126398209|NCT01133405|454753080|FG009|Period 1|Physician Decision|0|||
126398210|NCT01133405|454753071|FG000|Period 1|Discontinued after randomization|1|||
126398211|NCT01133405|454753072|FG001|Period 1|Discontinued after randomization|0|||
126398212|NCT01133405|454753073|FG002|Period 1|Discontinued after randomization|0|||
126398213|NCT01133405|454753074|FG003|Period 1|Discontinued after randomization|0|||
126398214|NCT01133405|454753075|FG004|Period 1|Discontinued after randomization|0|||
126398215|NCT01133405|454753076|FG005|Period 1|Discontinued after randomization|0|||
126398216|NCT01133405|454753077|FG006|Period 1|Discontinued after randomization|1|||
126398217|NCT01133405|454753078|FG007|Period 1|Discontinued after randomization|0|||
126398218|NCT01133405|454753079|FG008|Period 1|Discontinued after randomization|0|||
126398219|NCT01133405|454753080|FG009|Period 1|Discontinued after randomization|0|||
126398220|NCT01133405|454753071|FG000|Period 1|Received drug only in period 2|0|||
126398221|NCT01133405|454753072|FG001|Period 1|Received drug only in period 2|1|||
126398222|NCT01133405|454753073|FG002|Period 1|Received drug only in period 2|0|||
126398223|NCT01133405|454753074|FG003|Period 1|Received drug only in period 2|2|||
126398224|NCT01133405|454753075|FG004|Period 1|Received drug only in period 2|0|||
126398225|NCT01133405|454753076|FG005|Period 1|Received drug only in period 2|1|||
126398226|NCT01133405|454753077|FG006|Period 1|Received drug only in period 2|0|||
126398227|NCT01133405|454753078|FG007|Period 1|Received drug only in period 2|0|||
126398228|NCT01133405|454753079|FG008|Period 1|Received drug only in period 2|0|||
126398229|NCT01133405|454753080|FG009|Period 1|Received drug only in period 2|0|||
126398230|NCT01133405|454753071|FG000|Period 1|Received drug only in period 3|0|||
126398231|NCT01133405|454753072|FG001|Period 1|Received drug only in period 3|1|||
126398232|NCT01133405|454753073|FG002|Period 1|Received drug only in period 3|1|||
126398233|NCT01133405|454753074|FG003|Period 1|Received drug only in period 3|0|||
126398234|NCT01133405|454753075|FG004|Period 1|Received drug only in period 3|0|||
126398235|NCT01133405|454753076|FG005|Period 1|Received drug only in period 3|0|||
126398236|NCT01133405|454753077|FG006|Period 1|Received drug only in period 3|0|||
126398237|NCT01133405|454753078|FG007|Period 1|Received drug only in period 3|0|||
126398238|NCT01133405|454753079|FG008|Period 1|Received drug only in period 3|0|||
126398239|NCT01133405|454753080|FG009|Period 1|Received drug only in period 3|0|||
126398240|NCT01133405|454753071|FG000|Period 2|Adverse Event|0|||
126398241|NCT01133405|454753072|FG001|Period 2|Adverse Event|0|||
126398242|NCT01133405|454753073|FG002|Period 2|Adverse Event|1|||
126398243|NCT01133405|454753074|FG003|Period 2|Adverse Event|0|||
126398244|NCT01133405|454753075|FG004|Period 2|Adverse Event|0|||
126398245|NCT01133405|454753076|FG005|Period 2|Adverse Event|0|||
126398246|NCT01133405|454753077|FG006|Period 2|Adverse Event|0|||
125889314|NCT03904693|452891753|FG000|Overall Study|Physician Decision|0|||
125889315|NCT03904693|452891754|FG001|Overall Study|Physician Decision|0|||
125889316|NCT03904693|452891755|FG002|Overall Study|Physician Decision|2|||
125889317|NCT03904693|452891753|FG000|Overall Study|Withdrawal by Subject|0|||
125889318|NCT03904693|452891754|FG001|Overall Study|Withdrawal by Subject|1|||
125889319|NCT03904693|452891755|FG002|Overall Study|Withdrawal by Subject|4|||
125889320|NCT00314795|452891758|FG000|Overall Study|Adverse Event|8|||
125889321|NCT00314795|452891758|FG000|Overall Study|Death|4|||
125889322|NCT00314795|452891758|FG000|Overall Study|Reason not Specified|3|||
125889323|NCT00314795|452891758|FG000|Overall Study|Renal Transplant|3|||
125889324|NCT00314795|452891758|FG000|Overall Study|Participants Withdrew Consent|2|||
125889325|NCT02624986|452891759|FG000|Overall Study|Death|0|||
125889326|NCT02624986|452891760|FG001|Overall Study|Death|1|||
125889327|NCT02624986|452891761|FG002|Overall Study|Death|2|||
125889328|NCT02624986|452891762|FG003|Overall Study|Death|2|||
125889329|NCT02624986|452891763|FG004|Overall Study|Death|2|||
125889330|NCT02624986|452891764|FG005|Overall Study|Death|0|||
125889331|NCT02624986|452891765|FG006|Overall Study|Death|0|||
125889332|NCT02624986|452891766|FG007|Overall Study|Death|1|||
125889333|NCT02624986|452891759|FG000|Overall Study|Study Terminated by Sponsor|1|||
125889334|NCT02624986|452891760|FG001|Overall Study|Study Terminated by Sponsor|1|||
125889335|NCT02624986|452891761|FG002|Overall Study|Study Terminated by Sponsor|0|||
126398247|NCT01133405|454753078|FG007|Period 2|Adverse Event|0|||
126398248|NCT01133405|454753079|FG008|Period 2|Adverse Event|0|||
126398249|NCT01133405|454753080|FG009|Period 2|Adverse Event|0|||
126398250|NCT01133405|454753071|FG000|Period 2|Withdrawal by Subject|0|||
126398251|NCT01133405|454753072|FG001|Period 2|Withdrawal by Subject|0|||
126398252|NCT01133405|454753073|FG002|Period 2|Withdrawal by Subject|0|||
126398253|NCT01133405|454753074|FG003|Period 2|Withdrawal by Subject|1|||
126398254|NCT01133405|454753075|FG004|Period 2|Withdrawal by Subject|0|||
126398255|NCT01133405|454753076|FG005|Period 2|Withdrawal by Subject|1|||
126398256|NCT01133405|454753077|FG006|Period 2|Withdrawal by Subject|0|||
126398257|NCT01133405|454753078|FG007|Period 2|Withdrawal by Subject|0|||
126398258|NCT01133405|454753079|FG008|Period 2|Withdrawal by Subject|0|||
126398259|NCT01133405|454753080|FG009|Period 2|Withdrawal by Subject|0|||
126398260|NCT01133405|454753071|FG000|Period 2|Entry Criteria Not Met|0|||
126398261|NCT01133405|454753072|FG001|Period 2|Entry Criteria Not Met|1|||
126398262|NCT01133405|454753073|FG002|Period 2|Entry Criteria Not Met|0|||
126398263|NCT01133405|454753074|FG003|Period 2|Entry Criteria Not Met|0|||
126398264|NCT01133405|454753075|FG004|Period 2|Entry Criteria Not Met|0|||
126398265|NCT01133405|454753076|FG005|Period 2|Entry Criteria Not Met|0|||
126398266|NCT01133405|454753077|FG006|Period 2|Entry Criteria Not Met|0|||
126398267|NCT01133405|454753078|FG007|Period 2|Entry Criteria Not Met|0|||
126398268|NCT01133405|454753079|FG008|Period 2|Entry Criteria Not Met|0|||
126398269|NCT01133405|454753080|FG009|Period 2|Entry Criteria Not Met|0|||
126398270|NCT01133405|454753071|FG000|Period 2|Physician Decision|0|||
126398271|NCT01133405|454753072|FG001|Period 2|Physician Decision|0|||
126398272|NCT01133405|454753073|FG002|Period 2|Physician Decision|0|||
126398273|NCT01133405|454753074|FG003|Period 2|Physician Decision|0|||
126398274|NCT01133405|454753075|FG004|Period 2|Physician Decision|0|||
126398275|NCT01133405|454753076|FG005|Period 2|Physician Decision|1|||
126398276|NCT01133405|454753077|FG006|Period 2|Physician Decision|0|||
126398277|NCT01133405|454753078|FG007|Period 2|Physician Decision|0|||
126398278|NCT01133405|454753079|FG008|Period 2|Physician Decision|0|||
126398279|NCT01133405|454753080|FG009|Period 2|Physician Decision|0|||
126398280|NCT01238835|454753083|FG000|Overall Study|Death|124|||
126398281|NCT01238835|454753083|FG000|Overall Study|Withdrawal by Subject|9|||
126398282|NCT01238835|454753083|FG000|Overall Study|Lost to Follow-up|1|||
126398283|NCT01238835|454753083|FG000|Overall Study|Site early discontinuation|2|||
126398284|NCT01774253|454753084|FG000|Overall Study|Lack of Efficacy|4|||
126398285|NCT01774253|454753084|FG000|Overall Study|Physician Decision|2|||
126398286|NCT01774253|454753084|FG000|Overall Study|Withdrawal by Subject|2|||
126398287|NCT01774253|454753084|FG000|Overall Study|Death|1|||
126398288|NCT00772369|454753085|FG000|Overall Study|Did not return record release form|1|||
126398289|NCT00554619|454753086|FG000|Overall Study|Adverse Event|1|||
126398290|NCT00554619|454753086|FG000|Overall Study|Physician Decision|1|||
125889336|NCT02624986|452891762|FG003|Overall Study|Study Terminated by Sponsor|1|||
125889337|NCT02624986|452891763|FG004|Overall Study|Study Terminated by Sponsor|2|||
126105291|NCT00940108|453678575|FG002|Overall Study|Dose 2 contraindicated|0|||
125889338|NCT02624986|452891764|FG005|Overall Study|Study Terminated by Sponsor|2|||
126398291|NCT00554619|454753086|FG000|Overall Study|Liver Function Test Abnormality|1|||
126398292|NCT02240368|454753090|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
126398293|NCT02240368|454753091|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
126398294|NCT02240368|454753092|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
126398295|NCT02240368|454753090|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
126398296|NCT02240368|454753091|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
126398297|NCT02240368|454753092|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
125889339|NCT02624986|452891765|FG006|Overall Study|Study Terminated by Sponsor|4|||
126398298|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Death|1|||
125889340|NCT02624986|452891766|FG007|Overall Study|Study Terminated by Sponsor|3|||
125889341|NCT02624986|452891759|FG000|Overall Study|Progressive Disease|0|||
125889342|NCT02624986|452891760|FG001|Overall Study|Progressive Disease|1|||
125889343|NCT02624986|452891761|FG002|Overall Study|Progressive Disease|0|||
125889344|NCT02624986|452891762|FG003|Overall Study|Progressive Disease|0|||
125889345|NCT02624986|452891763|FG004|Overall Study|Progressive Disease|0|||
125889346|NCT02624986|452891764|FG005|Overall Study|Progressive Disease|0|||
125889347|NCT02624986|452891765|FG006|Overall Study|Progressive Disease|0|||
125889348|NCT02624986|452891766|FG007|Overall Study|Progressive Disease|0|||
125889349|NCT02624986|452891759|FG000|Overall Study|Protocol Violation|1|||
125889350|NCT02624986|452891760|FG001|Overall Study|Protocol Violation|0|||
125889351|NCT02624986|452891761|FG002|Overall Study|Protocol Violation|0|||
125889352|NCT02624986|452891762|FG003|Overall Study|Protocol Violation|0|||
125889353|NCT02624986|452891763|FG004|Overall Study|Protocol Violation|0|||
125889354|NCT02624986|452891764|FG005|Overall Study|Protocol Violation|0|||
125889355|NCT02624986|452891765|FG006|Overall Study|Protocol Violation|0|||
125889356|NCT02624986|452891766|FG007|Overall Study|Protocol Violation|0|||
125889357|NCT02624986|452891759|FG000|Overall Study|Withdrawal by Subject|0|||
125889358|NCT02624986|452891760|FG001|Overall Study|Withdrawal by Subject|0|||
125889359|NCT02624986|452891761|FG002|Overall Study|Withdrawal by Subject|0|||
125889360|NCT02624986|452891762|FG003|Overall Study|Withdrawal by Subject|0|||
125889361|NCT02624986|452891763|FG004|Overall Study|Withdrawal by Subject|0|||
125889362|NCT02624986|452891764|FG005|Overall Study|Withdrawal by Subject|0|||
125889363|NCT02624986|452891765|FG006|Overall Study|Withdrawal by Subject|0|||
125889364|NCT02624986|452891766|FG007|Overall Study|Withdrawal by Subject|1|||
125889365|NCT00560352|452891769|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125889366|NCT00560352|452891770|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125889367|NCT00560352|452891771|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125889368|NCT00560352|452891769|FG000|Overall Study|Study drug toxicity|3|||
125889369|NCT00560352|452891770|FG001|Overall Study|Study drug toxicity|0|||
125889370|NCT00560352|452891771|FG002|Overall Study|Study drug toxicity|1|||
125889371|NCT00560352|452891769|FG000|Overall Study|Disease progression|0|||
125889372|NCT00560352|452891770|FG001|Overall Study|Disease progression|1|||
125889373|NCT00560352|452891771|FG002|Overall Study|Disease progression|1|||
125889374|NCT00560352|452891769|FG000|Overall Study|Withdrawal by Subject|1|||
125889375|NCT00560352|452891770|FG001|Overall Study|Withdrawal by Subject|1|||
125889376|NCT00560352|452891771|FG002|Overall Study|Withdrawal by Subject|1|||
125889377|NCT00560352|452891769|FG000|Overall Study|Maximum clinical benefit|1|||
125889378|NCT00560352|452891770|FG001|Overall Study|Maximum clinical benefit|0|||
125889379|NCT00560352|452891771|FG002|Overall Study|Maximum clinical benefit|0|||
125889380|NCT04434937|452891772|FG000|Overall Study|Death|4|||
125889381|NCT04434937|452891772|FG000|Overall Study|Withdrawal by Subject|1|||
125889382|NCT04434937|452891772|FG000|Overall Study|Transitioned to Rollover Study|19|||
125889383|NCT04434937|452891772|FG000|Overall Study|Progressive Disease|18|||
125889384|NCT00924027|452891773|FG000|Overall Study|Lost to Further Follow-Up|4|||
125889385|NCT00924027|452891774|FG001|Overall Study|Lost to Further Follow-Up|0|||
125889386|NCT00924027|452891775|FG002|Overall Study|Lost to Further Follow-Up|0|||
125889387|NCT00924027|452891776|FG003|Overall Study|Lost to Further Follow-Up|0|||
125889388|NCT00924027|452891773|FG000|Overall Study|Physician Decision|1|||
125889389|NCT00924027|452891774|FG001|Overall Study|Physician Decision|0|||
125889390|NCT00924027|452891775|FG002|Overall Study|Physician Decision|0|||
125889391|NCT00924027|452891776|FG003|Overall Study|Physician Decision|1|||
125889392|NCT00924027|452891773|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
125889393|NCT00924027|452891774|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
125889394|NCT00924027|452891775|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
125889395|NCT00924027|452891776|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
125889396|NCT00924027|452891773|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
125889397|NCT00924027|452891774|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
125889398|NCT00924027|452891775|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
125889399|NCT00924027|452891776|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
125889400|NCT00924027|452891773|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
125889401|NCT00924027|452891774|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
125889402|NCT00924027|452891775|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
125889403|NCT00924027|452891776|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
126398299|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Death|1|||
126398300|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Death|0|||
126398301|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Death|0|||
126398302|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Death|1|||
126398303|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Death|0|||
125889404|NCT04695977|452891777|FG000|Overall Study|Sponsor Decision|9|||
125889405|NCT04695977|452891778|FG001|Overall Study|Sponsor Decision|4|||
125889406|NCT04695977|452891777|FG000|Overall Study|Death|2|||
125889407|NCT04695977|452891778|FG001|Overall Study|Death|5|||
125889408|NCT03474965|452891779|FG000|Overall Study|Pregnancy|1|||
125889409|NCT03474965|452891780|FG001|Overall Study|Pregnancy|0|||
125889410|NCT03474965|452891781|FG002|Overall Study|Pregnancy|0|||
125889411|NCT03474965|452891782|FG003|Overall Study|Pregnancy|0|||
125889412|NCT03474965|452891779|FG000|Overall Study|Lost to Follow-up|0|||
125889413|NCT03474965|452891780|FG001|Overall Study|Lost to Follow-up|0|||
125889414|NCT03474965|452891781|FG002|Overall Study|Lost to Follow-up|1|||
125889415|NCT03474965|452891782|FG003|Overall Study|Lost to Follow-up|0|||
125889416|NCT03474965|452891779|FG000|Overall Study|Death|1|||
125889417|NCT03474965|452891780|FG001|Overall Study|Death|0|||
125889418|NCT03474965|452891781|FG002|Overall Study|Death|0|||
125889419|NCT03474965|452891782|FG003|Overall Study|Death|0|||
125889420|NCT03474965|452891779|FG000|Overall Study|Adverse Event|1|||
125889421|NCT03474965|452891780|FG001|Overall Study|Adverse Event|0|||
125889422|NCT03474965|452891781|FG002|Overall Study|Adverse Event|0|||
125889423|NCT03474965|452891782|FG003|Overall Study|Adverse Event|1|||
125889424|NCT03474965|452891779|FG000|Overall Study|Physician Decision|3|||
125889425|NCT03474965|452891780|FG001|Overall Study|Physician Decision|1|||
125889426|NCT03474965|452891781|FG002|Overall Study|Physician Decision|2|||
125889427|NCT03474965|452891782|FG003|Overall Study|Physician Decision|0|||
125889428|NCT03474965|452891779|FG000|Overall Study|Participant Decision|7|||
125889429|NCT03474965|452891780|FG001|Overall Study|Participant Decision|0|||
125889430|NCT03474965|452891781|FG002|Overall Study|Participant Decision|1|||
125889431|NCT03474965|452891782|FG003|Overall Study|Participant Decision|0|||
125889432|NCT03474965|452891779|FG000|Overall Study|Guardian Decision|4|||
125889433|NCT03474965|452891780|FG001|Overall Study|Guardian Decision|2|||
125889434|NCT03474965|452891781|FG002|Overall Study|Guardian Decision|7|||
125889435|NCT03474965|452891782|FG003|Overall Study|Guardian Decision|2|||
125889436|NCT00702715|452893607|FG000|Overall Study|Lost to Follow-up|1|||
125889437|NCT00702715|452893608|FG001|Overall Study|Lost to Follow-up|0|||
125889438|NCT02840799|452893615|FG000|Phase 1|Physician Decision|1|||
125889439|NCT02840799|452893616|FG001|Phase 1|Physician Decision|3|||
125889440|NCT02840799|452893615|FG000|Phase 1|Withdrawal by Subject|4|||
125889441|NCT02840799|452893616|FG001|Phase 1|Withdrawal by Subject|0|||
125889442|NCT02840799|452893615|FG000|Phase 2 (Crossover)|Adverse Event|0|||
125889443|NCT02840799|452893616|FG001|Phase 2 (Crossover)|Adverse Event|1|||
125889444|NCT02840799|452893615|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
125889445|NCT02840799|452893616|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
125889446|NCT02164461|452893622|FG000|Overall Study|Adverse Event|0|||
125889447|NCT02164461|452893623|FG001|Overall Study|Adverse Event|0|||
125889448|NCT02164461|452893624|FG002|Overall Study|Adverse Event|1|||
125889449|NCT02164461|452893622|FG000|Overall Study|Disease Progression|1|||
125889450|NCT02164461|452893623|FG001|Overall Study|Disease Progression|3|||
125889451|NCT02164461|452893624|FG002|Overall Study|Disease Progression|4|||
125889452|NCT02164461|452893622|FG000|Overall Study|Withdrawal by Subject|0|||
125889453|NCT02164461|452893623|FG001|Overall Study|Withdrawal by Subject|3|||
125889454|NCT02164461|452893624|FG002|Overall Study|Withdrawal by Subject|0|||
125889455|NCT02100696|452893626|FG000|Induction Phase|Adverse Event|0|||
125889456|NCT02100696|452893627|FG001|Induction Phase|Adverse Event|0|||
125889457|NCT02100696|452893628|FG002|Induction Phase|Adverse Event|1|||
125889458|NCT02100696|452893629|FG003|Induction Phase|Adverse Event|0|||
125889459|NCT02100696|452893630|FG004|Induction Phase|Adverse Event|0|||
125889460|NCT02100696|452893631|FG005|Induction Phase|Adverse Event|0|||
125889461|NCT02100696|452893626|FG000|Induction Phase|Lost to Follow-up|1|||
125889462|NCT02100696|452893627|FG001|Induction Phase|Lost to Follow-up|0|||
125889463|NCT02100696|452893628|FG002|Induction Phase|Lost to Follow-up|1|||
125889464|NCT02100696|452893629|FG003|Induction Phase|Lost to Follow-up|0|||
125889465|NCT02100696|452893630|FG004|Induction Phase|Lost to Follow-up|0|||
125889466|NCT02100696|452893631|FG005|Induction Phase|Lost to Follow-up|0|||
125889467|NCT02100696|452893626|FG000|Induction Phase|Protocol Violation|0|||
125889468|NCT02100696|452893627|FG001|Induction Phase|Protocol Violation|1|||
125889469|NCT02100696|452893628|FG002|Induction Phase|Protocol Violation|1|||
125889470|NCT02100696|452893629|FG003|Induction Phase|Protocol Violation|0|||
125889471|NCT02100696|452893630|FG004|Induction Phase|Protocol Violation|0|||
125889472|NCT02100696|452893631|FG005|Induction Phase|Protocol Violation|0|||
125889473|NCT02100696|452893626|FG000|Induction Phase|Withdrawal by Subject|8|||
125889474|NCT02100696|452893627|FG001|Induction Phase|Withdrawal by Subject|2|||
125889475|NCT02100696|452893628|FG002|Induction Phase|Withdrawal by Subject|13|||
125889476|NCT02100696|452893629|FG003|Induction Phase|Withdrawal by Subject|0|||
125889477|NCT02100696|452893630|FG004|Induction Phase|Withdrawal by Subject|0|||
125889478|NCT02100696|452893631|FG005|Induction Phase|Withdrawal by Subject|0|||
125889479|NCT02100696|452893626|FG000|Induction Phase|Physician Decision|1|||
125889480|NCT02100696|452893627|FG001|Induction Phase|Physician Decision|0|||
125889481|NCT02100696|452893628|FG002|Induction Phase|Physician Decision|2|||
125889482|NCT02100696|452893629|FG003|Induction Phase|Physician Decision|0|||
125889483|NCT02100696|452893630|FG004|Induction Phase|Physician Decision|0|||
125889484|NCT02100696|452893631|FG005|Induction Phase|Physician Decision|0|||
125889485|NCT02100696|452893626|FG000|Induction Phase|Multiple Reasons|5|||
125889486|NCT02100696|452893627|FG001|Induction Phase|Multiple Reasons|2|||
125889487|NCT02100696|452893628|FG002|Induction Phase|Multiple Reasons|8|||
125889488|NCT02100696|452893629|FG003|Induction Phase|Multiple Reasons|0|||
125889489|NCT02100696|452893630|FG004|Induction Phase|Multiple Reasons|0|||
126398304|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Death|0|||
126398305|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Death|0|||
126398306|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Death|0|||
126398307|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Death|0|||
126398308|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
126398309|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
126398310|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
126398311|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398312|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
126398313|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398314|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398315|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398316|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398317|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398318|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398319|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398320|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398321|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398322|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
126398323|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398324|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398325|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398326|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398327|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398328|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
126398329|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398330|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398331|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398332|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398333|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125889490|NCT02100696|452893631|FG005|Induction Phase|Multiple Reasons|0|||
125889491|NCT02100696|452893626|FG000|Maintenance Phase|Adverse Event|0|||
125889492|NCT02100696|452893627|FG001|Maintenance Phase|Adverse Event|0|||
125889493|NCT02100696|452893628|FG002|Maintenance Phase|Adverse Event|0|||
125889494|NCT02100696|452893629|FG003|Maintenance Phase|Adverse Event|0|||
125889495|NCT02100696|452893630|FG004|Maintenance Phase|Adverse Event|0|||
125889496|NCT02100696|452893631|FG005|Maintenance Phase|Adverse Event|2|||
125889497|NCT02100696|452893626|FG000|Maintenance Phase|Lost to Follow-up|0|||
125889498|NCT02100696|452893627|FG001|Maintenance Phase|Lost to Follow-up|0|||
125889499|NCT02100696|452893628|FG002|Maintenance Phase|Lost to Follow-up|0|||
125889500|NCT02100696|452893629|FG003|Maintenance Phase|Lost to Follow-up|0|||
125889501|NCT02100696|452893630|FG004|Maintenance Phase|Lost to Follow-up|1|||
125889502|NCT02100696|452893631|FG005|Maintenance Phase|Lost to Follow-up|0|||
125889503|NCT02100696|452893626|FG000|Maintenance Phase|Protocol Violation|0|||
125889504|NCT02100696|452893627|FG001|Maintenance Phase|Protocol Violation|0|||
125889505|NCT02100696|452893628|FG002|Maintenance Phase|Protocol Violation|0|||
125889506|NCT02100696|452893629|FG003|Maintenance Phase|Protocol Violation|0|||
125889507|NCT02100696|452893630|FG004|Maintenance Phase|Protocol Violation|1|||
125889508|NCT02100696|452893631|FG005|Maintenance Phase|Protocol Violation|0|||
125889509|NCT02100696|452893626|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125889510|NCT02100696|452893627|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125889511|NCT02100696|452893628|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125889512|NCT02100696|452893629|FG003|Maintenance Phase|Withdrawal by Subject|1|||
125889513|NCT02100696|452893630|FG004|Maintenance Phase|Withdrawal by Subject|4|||
125889514|NCT02100696|452893631|FG005|Maintenance Phase|Withdrawal by Subject|2|||
125889515|NCT02100696|452893626|FG000|Maintenance Phase|Physician Decision|0|||
125889516|NCT02100696|452893627|FG001|Maintenance Phase|Physician Decision|0|||
125889517|NCT02100696|452893628|FG002|Maintenance Phase|Physician Decision|0|||
125889518|NCT02100696|452893629|FG003|Maintenance Phase|Physician Decision|0|||
125889519|NCT02100696|452893630|FG004|Maintenance Phase|Physician Decision|1|||
125889520|NCT02100696|452893631|FG005|Maintenance Phase|Physician Decision|0|||
125889521|NCT02100696|452893626|FG000|Maintenance Phase|Multiple Reasons|0|||
125889522|NCT02100696|452893627|FG001|Maintenance Phase|Multiple Reasons|0|||
125889523|NCT02100696|452893628|FG002|Maintenance Phase|Multiple Reasons|0|||
125889524|NCT02100696|452893629|FG003|Maintenance Phase|Multiple Reasons|0|||
125889525|NCT02100696|452893630|FG004|Maintenance Phase|Multiple Reasons|2|||
125889526|NCT02100696|452893631|FG005|Maintenance Phase|Multiple Reasons|1|||
125889527|NCT03865381|452893634|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
125889528|NCT03865381|452893634|FG000|Overall Study|Withdrawal by Subject|2|||
125889529|NCT05626322|452893635|FG000|Overall Study|Death|2|||
125889530|NCT05626322|452893636|FG001|Overall Study|Death|0|||
125889531|NCT05626322|452893637|FG002|Overall Study|Death|0|||
125889532|NCT05626322|452893635|FG000|Overall Study|Physician Decision|1|||
125889533|NCT05626322|452893636|FG001|Overall Study|Physician Decision|0|||
125889534|NCT05626322|452893637|FG002|Overall Study|Physician Decision|0|||
125889535|NCT05626322|452893635|FG000|Overall Study|Progressive Disease|0|||
125889536|NCT05626322|452893636|FG001|Overall Study|Progressive Disease|1|||
125889537|NCT05626322|452893637|FG002|Overall Study|Progressive Disease|1|||
125889538|NCT05626322|452893635|FG000|Overall Study|Study terminated by sponsor|0|||
125889539|NCT05626322|452893636|FG001|Overall Study|Study terminated by sponsor|1|||
125889540|NCT05626322|452893637|FG002|Overall Study|Study terminated by sponsor|0|||
125889541|NCT00369265|452893638|FG000|Overall Study|Study terminated|4|||
125889542|NCT00369265|452893639|FG001|Overall Study|Study terminated|7|||
125889543|NCT00048074|452893642|FG000|Overall Study|Adverse Event|46|||
125889544|NCT00048074|452893643|FG001|Overall Study|Adverse Event|41|||
125889545|NCT00048074|452893644|FG002|Overall Study|Adverse Event|53|||
125889546|NCT00048074|452893642|FG000|Overall Study|Death|3|||
125889547|NCT00048074|452893643|FG001|Overall Study|Death|3|||
125889548|NCT00048074|452893644|FG002|Overall Study|Death|2|||
125889549|NCT00048074|452893642|FG000|Overall Study|Lost to Follow-up|2|||
125889550|NCT00048074|452893643|FG001|Overall Study|Lost to Follow-up|6|||
125889551|NCT00048074|452893644|FG002|Overall Study|Lost to Follow-up|6|||
125889552|NCT00048074|452893642|FG000|Overall Study|Withdrawal by Subject|28|||
125889553|NCT00048074|452893643|FG001|Overall Study|Withdrawal by Subject|30|||
125889554|NCT00048074|452893644|FG002|Overall Study|Withdrawal by Subject|35|||
125889555|NCT00048074|452893642|FG000|Overall Study|Protocol Violation|1|||
125889556|NCT00048074|452893643|FG001|Overall Study|Protocol Violation|3|||
125889557|NCT00048074|452893644|FG002|Overall Study|Protocol Violation|0|||
125889558|NCT00048074|452893642|FG000|Overall Study|Study participation was terminated|0|||
125889559|NCT00048074|452893643|FG001|Overall Study|Study participation was terminated|1|||
125889560|NCT00048074|452893644|FG002|Overall Study|Study participation was terminated|0|||
125889561|NCT00048074|452893642|FG000|Overall Study|Husband ill|0|||
125889562|NCT00048074|452893643|FG001|Overall Study|Husband ill|1|||
125889563|NCT00048074|452893644|FG002|Overall Study|Husband ill|0|||
125889564|NCT00048074|452893642|FG000|Overall Study|Poor compliance|0|||
125889565|NCT00048074|452893643|FG001|Overall Study|Poor compliance|1|||
125889566|NCT00048074|452893644|FG002|Overall Study|Poor compliance|0|||
125889567|NCT00048074|452893642|FG000|Overall Study|Out of station|0|||
125889568|NCT00048074|452893643|FG001|Overall Study|Out of station|1|||
125889569|NCT00048074|452893644|FG002|Overall Study|Out of station|1|||
125889570|NCT00048074|452893642|FG000|Overall Study|Social reasons|1|||
125889571|NCT00048074|452893643|FG001|Overall Study|Social reasons|0|||
125889572|NCT00048074|452893644|FG002|Overall Study|Social reasons|0|||
125889573|NCT02873377|452893645|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
125889574|NCT02873377|452893646|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
125889575|NCT02873377|452893645|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
125889576|NCT02873377|452893646|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
125889577|NCT01032889|452893652|FG000|Overall Study|Adverse Event|2|||
125889578|NCT01032889|452893653|FG001|Overall Study|Adverse Event|2|||
125889579|NCT01032889|452893654|FG002|Overall Study|Adverse Event|0|||
125889580|NCT01032889|452893652|FG000|Overall Study|Withdrawal of Consent|1|||
125889581|NCT01032889|452893653|FG001|Overall Study|Withdrawal of Consent|2|||
125889582|NCT01032889|452893654|FG002|Overall Study|Withdrawal of Consent|1|||
125889583|NCT01032889|452893652|FG000|Overall Study|Patient Request|0|||
125889584|NCT01032889|452893653|FG001|Overall Study|Patient Request|1|||
125889585|NCT01032889|452893654|FG002|Overall Study|Patient Request|0|||
125889586|NCT01032889|452893652|FG000|Overall Study|Lost to Follow-up|1|||
125889587|NCT01032889|452893653|FG001|Overall Study|Lost to Follow-up|1|||
125889588|NCT01032889|452893654|FG002|Overall Study|Lost to Follow-up|0|||
125889589|NCT01032889|452893652|FG000|Overall Study|Lack of Submental Fat|2|||
125889590|NCT01032889|452893653|FG001|Overall Study|Lack of Submental Fat|8|||
125889591|NCT01032889|452893654|FG002|Overall Study|Lack of Submental Fat|1|||
125889592|NCT01032889|452893652|FG000|Overall Study|Miscellaneous Reasons|2|||
125889593|NCT01032889|452893653|FG001|Overall Study|Miscellaneous Reasons|1|||
125889594|NCT01032889|452893654|FG002|Overall Study|Miscellaneous Reasons|1|||
125889595|NCT00740857|452893659|FG000|Overall Study|Withdrawal by Subject|1|||
125889596|NCT00740857|452893660|FG001|Overall Study|Withdrawal by Subject|0|||
125889597|NCT00740857|452893661|FG002|Overall Study|Withdrawal by Subject|0|||
125889598|NCT03532451|452893665|FG000|Overall Study|Withdrawal by Subject|0|||
125889599|NCT03532451|452893666|FG001|Overall Study|Withdrawal by Subject|1|||
125889600|NCT03532451|452893665|FG000|Overall Study|Did not undergo surgery|1|||
125889601|NCT03532451|452893666|FG001|Overall Study|Did not undergo surgery|1|||
125889602|NCT01519167|452893667|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
125889603|NCT01519167|452893668|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
125889604|NCT01519167|452893667|FG000|Overall Study|Adverse Event|0|||
125889605|NCT01519167|452893668|FG001|Overall Study|Adverse Event|1|||
125889606|NCT01519167|452893667|FG000|Overall Study|Lack of Efficacy|0|||
125889607|NCT01519167|452893668|FG001|Overall Study|Lack of Efficacy|1|||
125889608|NCT01519167|452893667|FG000|Overall Study|Medical condition changes&deep sedation|0|||
125889609|NCT01519167|452893668|FG001|Overall Study|Medical condition changes&deep sedation|2|||
125889610|NCT01519167|452893667|FG000|Overall Study|Physician Decision|0|||
125889611|NCT01519167|452893668|FG001|Overall Study|Physician Decision|1|||
125889612|NCT04200352|452893679|FG000|Overall Study|Death|1|||
125889613|NCT04200352|452893679|FG000|Overall Study|Adverse Event|6|||
125889614|NCT04200352|452893679|FG000|Overall Study|Withdrawal by parent/guardian|6|||
125889615|NCT04200352|452893679|FG000|Overall Study|Lack of Efficacy|1|||
125889616|NCT04200352|452893679|FG000|Overall Study|Other than specified|6|||
125889617|NCT00993148|452893680|FG000|Overall Study|Lost to Follow-up|2|||
125889618|NCT00993148|452893680|FG000|Overall Study|never initiated treatment|1|||
125889619|NCT00233064|452893681|FG000|Overall Study|Lost to Follow-up|7|||
125889620|NCT00233064|452893682|FG001|Overall Study|Lost to Follow-up|7|||
125889621|NCT00233064|452893681|FG000|Overall Study|Withdrawal by Subject|5|||
125889622|NCT00233064|452893682|FG001|Overall Study|Withdrawal by Subject|3|||
125889623|NCT00233064|452893681|FG000|Overall Study|Death|0|||
125889624|NCT00233064|452893682|FG001|Overall Study|Death|1|||
125889625|NCT00233064|452893681|FG000|Overall Study|Relocation|0|||
125889626|NCT00233064|452893682|FG001|Overall Study|Relocation|1|||
125889627|NCT00233064|452893681|FG000|Overall Study|Protocol Violation|1|||
125889628|NCT00233064|452893682|FG001|Overall Study|Protocol Violation|0|||
125889629|NCT00233064|452893681|FG000|Overall Study|Moved to Dom. Republic|1|||
125889630|NCT00233064|452893682|FG001|Overall Study|Moved to Dom. Republic|0|||
125889631|NCT01120964|452893689|FG000|Overall Study|Did not receive full treatment|1|||
125889632|NCT01120964|452893690|FG001|Overall Study|Did not receive full treatment|0|||
125889633|NCT04237116|452893694|FG000|Overall Study|Adverse Event|0|||
125889634|NCT04237116|452893695|FG001|Overall Study|Adverse Event|1|||
125889635|NCT04237116|452893694|FG000|Overall Study|Study terminated by Sponsor|4|||
125889636|NCT04237116|452893695|FG001|Overall Study|Study terminated by Sponsor|1|||
125889637|NCT00472030|452893696|FG000|Overall Study|Physician Decision|1|||
125889638|NCT00472030|452893697|FG001|Overall Study|Physician Decision|0|||
125889639|NCT00829504|452893698|FG000|First Intervention|Adverse Event|1|||
125889640|NCT00829504|452893699|FG001|First Intervention|Adverse Event|0|||
125889641|NCT00829504|452893698|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125889642|NCT00829504|452893699|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125889643|NCT00829504|452893698|FG000|Second Intervention|Physician Decision|1|||
125889644|NCT00829504|452893699|FG001|Second Intervention|Physician Decision|0|||
126398334|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126052837|NCT04885998|453487890|FG000|Overall Study|Withdrawal by Subject|0|||
126052838|NCT04885998|453487891|FG001|Overall Study|Withdrawal by Subject|2|||
126052839|NCT04885998|453487892|FG002|Overall Study|Withdrawal by Subject|0|||
126052840|NCT04885998|453487893|FG003|Overall Study|Withdrawal by Subject|3|||
126052841|NCT04885998|453487890|FG000|Overall Study|Lost to Follow-up|1|||
126052842|NCT04885998|453487891|FG001|Overall Study|Lost to Follow-up|1|||
126052843|NCT04885998|453487892|FG002|Overall Study|Lost to Follow-up|0|||
126052844|NCT04885998|453487893|FG003|Overall Study|Lost to Follow-up|0|||
125889645|NCT03212144|452893700|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
125889646|NCT03212144|452893701|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
125889647|NCT03212144|452893700|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
125889648|NCT03212144|452893701|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
125889649|NCT00599339|452893702|FG000|Overall Study|Adverse Event|79|||
125889650|NCT00599339|452893702|FG000|Overall Study|Withdrawal by Subject|137|||
125889651|NCT00599339|452893702|FG000|Overall Study|Other Reason|179|||
125889652|NCT00599339|452893702|FG000|Overall Study|Lost to Follow-up|221|||
125889653|NCT00599339|452893702|FG000|Overall Study|No valid data consent|36|||
125889654|NCT00599339|452893702|FG000|Overall Study|Study Termination Status Unknown|12|||
125889655|NCT00912197|452893705|FG000|Overall Study|Withdrawal by Subject|3|||
125889656|NCT00912197|452893706|FG001|Overall Study|Withdrawal by Subject|3|||
125889657|NCT01615029|452893712|FG000|Overall Study|Adverse Event|0|||
125889658|NCT01615029|452893713|FG001|Overall Study|Adverse Event|0|||
125889659|NCT01615029|452893714|FG002|Overall Study|Adverse Event|0|||
125889660|NCT01615029|452893715|FG003|Overall Study|Adverse Event|0|||
125889661|NCT01615029|452893716|FG004|Overall Study|Adverse Event|1|||
125889662|NCT01615029|452893712|FG000|Overall Study|Death|0|||
125889663|NCT01615029|452893713|FG001|Overall Study|Death|0|||
125889664|NCT01615029|452893714|FG002|Overall Study|Death|0|||
125889665|NCT01615029|452893715|FG003|Overall Study|Death|0|||
125889666|NCT01615029|452893716|FG004|Overall Study|Death|1|||
125889667|NCT01615029|452893712|FG000|Overall Study|Lost to Follow-up|0|||
125889668|NCT01615029|452893713|FG001|Overall Study|Lost to Follow-up|0|||
126052845|NCT04885998|453487890|FG000|Overall Study|Death|2|||
126052846|NCT04885998|453487891|FG001|Overall Study|Death|1|||
126052847|NCT04885998|453487892|FG002|Overall Study|Death|2|||
126052848|NCT04885998|453487893|FG003|Overall Study|Death|2|||
126052849|NCT04885998|453487890|FG000|Overall Study|Decision by sponsor|1|||
126052850|NCT04885998|453487891|FG001|Overall Study|Decision by sponsor|1|||
126052851|NCT04885998|453487892|FG002|Overall Study|Decision by sponsor|0|||
126052852|NCT04885998|453487893|FG003|Overall Study|Decision by sponsor|0|||
126052883|NCT02362035|453489403|FG000|Overall Study|Death|67|||
126052884|NCT02362035|453489403|FG000|Overall Study|Lost to Follow-up|3|||
126052885|NCT02362035|453489403|FG000|Overall Study|Adverse Event|1|||
126052886|NCT02362035|453489403|FG000|Overall Study|Physician Decision|1|||
126052887|NCT02362035|453489403|FG000|Overall Study|Subject started another cancer therapy|10|||
126052888|NCT02362035|453489403|FG000|Overall Study|Study terminated by sponsor|45|||
125889669|NCT01615029|452893714|FG002|Overall Study|Lost to Follow-up|0|||
125889670|NCT01615029|452893715|FG003|Overall Study|Lost to Follow-up|0|||
126052889|NCT02362035|453489403|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
126052890|NCT02362035|453489403|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
126052891|NCT02362035|453489403|FG000|Overall Study|Disease progression|11|||
125889671|NCT01615029|452893716|FG004|Overall Study|Lost to Follow-up|1|||
126052892|NCT02362035|453489403|FG000|Overall Study|Withdrawal by Subject|20|||
125889672|NCT01615029|452893712|FG000|Overall Study|Progressive disease|2|||
125889673|NCT01615029|452893713|FG001|Overall Study|Progressive disease|1|||
125889674|NCT01615029|452893714|FG002|Overall Study|Progressive disease|1|||
125889675|NCT01615029|452893715|FG003|Overall Study|Progressive disease|1|||
125889676|NCT01615029|452893716|FG004|Overall Study|Progressive disease|5|||
125889677|NCT01615029|452893712|FG000|Overall Study|Physician Decision|0|||
125889678|NCT01615029|452893713|FG001|Overall Study|Physician Decision|0|||
125889679|NCT01615029|452893714|FG002|Overall Study|Physician Decision|0|||
125889680|NCT01615029|452893715|FG003|Overall Study|Physician Decision|0|||
125889681|NCT01615029|452893716|FG004|Overall Study|Physician Decision|1|||
125889682|NCT01615029|452893712|FG000|Overall Study|Ongoing|1|||
125889683|NCT01615029|452893713|FG001|Overall Study|Ongoing|2|||
125889684|NCT01615029|452893714|FG002|Overall Study|Ongoing|3|||
125889685|NCT01615029|452893715|FG003|Overall Study|Ongoing|2|||
125889686|NCT01615029|452893716|FG004|Overall Study|Ongoing|23|||
125889687|NCT01326104|452893717|FG000|Overall Study|progressed prior to vaccine|0|||
125889688|NCT01326104|452893718|FG001|Overall Study|progressed prior to vaccine|2|||
125889689|NCT01326104|452893717|FG000|Overall Study|unable to make vaccine|0|||
125889690|NCT01326104|452893718|FG001|Overall Study|unable to make vaccine|2|||
125889691|NCT01287741|452893719|FG000|Overall Study|Withdrawal by Subject|35|||
125889692|NCT01287741|452893720|FG001|Overall Study|Withdrawal by Subject|38|||
125889693|NCT01287741|452893719|FG000|Overall Study|Protocol Violation|2|||
125889694|NCT01287741|452893720|FG001|Overall Study|Protocol Violation|0|||
125889695|NCT01287741|452893719|FG000|Overall Study|Physician Decision|15|||
125889696|NCT01287741|452893720|FG001|Overall Study|Physician Decision|23|||
125889697|NCT01287741|452893719|FG000|Overall Study|Non-compliance|8|||
125889698|NCT01287741|452893720|FG001|Overall Study|Non-compliance|6|||
125889699|NCT01287741|452893719|FG000|Overall Study|Lost to Follow-up|10|||
125889700|NCT01287741|452893720|FG001|Overall Study|Lost to Follow-up|8|||
125889701|NCT01287741|452893719|FG000|Overall Study|Death|32|||
125889702|NCT01287741|452893720|FG001|Overall Study|Death|44|||
125889703|NCT01287741|452893719|FG000|Overall Study|Adverse Event|4|||
125889704|NCT01287741|452893720|FG001|Overall Study|Adverse Event|6|||
125889705|NCT01287741|452893719|FG000|Overall Study|Study terminated by Sponsor|307|||
125889706|NCT01287741|452893720|FG001|Overall Study|Study terminated by Sponsor|315|||
125889707|NCT01287741|452893719|FG000|Overall Study|Progressive disease|190|||
125889708|NCT01287741|452893720|FG001|Overall Study|Progressive disease|166|||
126398335|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398336|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125889709|NCT01287741|452893719|FG000|Overall Study|Reason not specified|23|||
125889710|NCT01287741|452893720|FG001|Overall Study|Reason not specified|9|||
126052911|NCT04250194|453489412|FG000|Overall Study|Declined to schedule biopsy|6|||
126052912|NCT04250194|453489413|FG001|Overall Study|Declined to schedule biopsy|10|||
126052913|NCT04250194|453489412|FG000|Overall Study|Medically Unfit for Biopsy|2|||
126052914|NCT04250194|453489413|FG001|Overall Study|Medically Unfit for Biopsy|1|||
126052915|NCT04250194|453489412|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
126052916|NCT04250194|453489413|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
126052917|NCT04250194|453489412|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
126052918|NCT04250194|453489413|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
125889711|NCT04421027|452893721|FG000|Treatment Period|Adverse Event|5|||
126052919|NCT04250194|453489412|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
126052920|NCT04250194|453489413|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
125889712|NCT04421027|452893722|FG001|Treatment Period|Adverse Event|3|||
125889713|NCT04421027|452893723|FG002|Treatment Period|Adverse Event|0|||
125889714|NCT04421027|452893724|FG003|Treatment Period|Adverse Event|0|||
125889715|NCT04421027|452893721|FG000|Treatment Period|Death|98|||
125889716|NCT04421027|452893722|FG001|Treatment Period|Death|61|||
125889717|NCT04421027|452893723|FG002|Treatment Period|Death|0|||
125889718|NCT04421027|452893724|FG003|Treatment Period|Death|0|||
125889719|NCT04421027|452893721|FG000|Treatment Period|Lost to Follow-up|22|||
126398337|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398338|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
126398339|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398340|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398341|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
126398342|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
126398343|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398344|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398345|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398346|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125889720|NCT04421027|452893722|FG001|Treatment Period|Lost to Follow-up|20|||
125889721|NCT04421027|452893723|FG002|Treatment Period|Lost to Follow-up|0|||
125889722|NCT04421027|452893724|FG003|Treatment Period|Lost to Follow-up|0|||
125889723|NCT04421027|452893721|FG000|Treatment Period|Other-Unknown|15|||
125889724|NCT04421027|452893722|FG001|Treatment Period|Other-Unknown|9|||
125889725|NCT04421027|452893723|FG002|Treatment Period|Other-Unknown|0|||
125889726|NCT04421027|452893724|FG003|Treatment Period|Other-Unknown|0|||
125889727|NCT04421027|452893721|FG000|Treatment Period|Physician Decision|1|||
125889728|NCT04421027|452893722|FG001|Treatment Period|Physician Decision|1|||
125889729|NCT04421027|452893723|FG002|Treatment Period|Physician Decision|0|||
125889730|NCT04421027|452893724|FG003|Treatment Period|Physician Decision|0|||
125889731|NCT04421027|452893721|FG000|Treatment Period|Withdrawal by Subject|7|||
125889732|NCT04421027|452893722|FG001|Treatment Period|Withdrawal by Subject|12|||
125889733|NCT04421027|452893723|FG002|Treatment Period|Withdrawal by Subject|0|||
125889734|NCT04421027|452893724|FG003|Treatment Period|Withdrawal by Subject|0|||
125889735|NCT04421027|452893721|FG000|Treatment Period|Randomized Not Dosed|9|||
125889736|NCT04421027|452893722|FG001|Treatment Period|Randomized Not Dosed|14|||
125889737|NCT04421027|452893723|FG002|Treatment Period|Randomized Not Dosed|0|||
125889738|NCT04421027|452893724|FG003|Treatment Period|Randomized Not Dosed|0|||
125889739|NCT04421027|452893721|FG000|Follow-Up Period|Adverse Event|0|||
125889740|NCT04421027|452893722|FG001|Follow-Up Period|Adverse Event|0|||
125889741|NCT04421027|452893723|FG002|Follow-Up Period|Adverse Event|0|||
125889742|NCT04421027|452893724|FG003|Follow-Up Period|Adverse Event|3|||
125889743|NCT04421027|452893721|FG000|Follow-Up Period|Death|0|||
125889744|NCT04421027|452893722|FG001|Follow-Up Period|Death|0|||
125889745|NCT04421027|452893723|FG002|Follow-Up Period|Death|16|||
125889746|NCT04421027|452893724|FG003|Follow-Up Period|Death|17|||
125889747|NCT04421027|452893721|FG000|Follow-Up Period|Lost to Follow-up|0|||
126398347|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125889748|NCT04421027|452893722|FG001|Follow-Up Period|Lost to Follow-up|0|||
125889749|NCT04421027|452893723|FG002|Follow-Up Period|Lost to Follow-up|7|||
126398348|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
126398349|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398350|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398351|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
126398352|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398353|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398354|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398355|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398356|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398357|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398358|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
126398359|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
126398360|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
126398361|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
126398362|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
126398363|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126398364|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126398365|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125889750|NCT04421027|452893724|FG003|Follow-Up Period|Lost to Follow-up|7|||
126398366|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126398367|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126398368|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
126398369|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
126398370|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
126398371|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398372|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
125889751|NCT04421027|452893721|FG000|Follow-Up Period|Protocol Deviation|0|||
125889752|NCT04421027|452893722|FG001|Follow-Up Period|Protocol Deviation|0|||
125889753|NCT04421027|452893723|FG002|Follow-Up Period|Protocol Deviation|1|||
126398373|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398374|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398375|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398376|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398377|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398378|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
126398379|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398380|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398381|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
126398382|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
126398383|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398384|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398385|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398386|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125889754|NCT04421027|452893724|FG003|Follow-Up Period|Protocol Deviation|0|||
125889755|NCT04421027|452893721|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125889756|NCT04421027|452893722|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125889757|NCT04421027|452893723|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
125889758|NCT04421027|452893724|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125889759|NCT04421027|452893721|FG000|Follow-Up Period|Left message, participant did not call back|0|||
125889760|NCT04421027|452893722|FG001|Follow-Up Period|Left message, participant did not call back|0|||
125889761|NCT04421027|452893723|FG002|Follow-Up Period|Left message, participant did not call back|0|||
125889762|NCT04421027|452893724|FG003|Follow-Up Period|Left message, participant did not call back|1|||
125889763|NCT04421027|452893721|FG000|Follow-Up Period|Participant died|0|||
125889764|NCT04421027|452893722|FG001|Follow-Up Period|Participant died|0|||
125889765|NCT04421027|452893723|FG002|Follow-Up Period|Participant died|0|||
125889766|NCT04421027|452893724|FG003|Follow-Up Period|Participant died|1|||
125889767|NCT04421027|452893721|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125889768|NCT04421027|452893722|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125889769|NCT04421027|452893723|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125889770|NCT04421027|452893724|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
125889771|NCT00802945|452893725|FG000|Overall Study|Death|27|||
125889772|NCT00802945|452893726|FG001|Overall Study|Death|23|||
125889773|NCT00802945|452893725|FG000|Overall Study|Terminated by sponsor|8|||
125889774|NCT00802945|452893726|FG001|Overall Study|Terminated by sponsor|12|||
125889775|NCT05307692|452893729|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125889776|NCT05307692|452893730|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
125889777|NCT05307692|452893731|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125889778|NCT05307692|452893732|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125889779|NCT05307692|452893729|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125889780|NCT05307692|452893730|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
125889781|NCT05307692|452893731|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125889782|NCT05307692|452893732|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125889783|NCT05307692|452893729|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
125889784|NCT05307692|452893730|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
125889785|NCT05307692|452893731|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
125889786|NCT05307692|452893732|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
125889787|NCT05307692|452893729|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
125889788|NCT05307692|452893730|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
125889789|NCT05307692|452893731|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
125889790|NCT05307692|452893732|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
125889791|NCT05307692|452893729|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125889792|NCT05307692|452893730|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
125889793|NCT05307692|452893731|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125889794|NCT05307692|452893732|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125889795|NCT05307692|452893729|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
125889796|NCT05307692|452893730|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
125889797|NCT05307692|452893731|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
125889798|NCT05307692|452893732|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
125889799|NCT05307692|452893729|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125889800|NCT05307692|452893730|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125889801|NCT05307692|452893731|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125889802|NCT05307692|452893732|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
125889803|NCT05307692|452893729|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125889804|NCT05307692|452893730|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125889805|NCT05307692|452893731|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125889806|NCT05307692|452893732|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
126398387|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398388|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398389|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125889807|NCT02003924|452893739|FG000|Double-blind Phase|Lost to Follow-up|2|||
125889808|NCT02003924|452893740|FG001|Double-blind Phase|Lost to Follow-up|1|||
125889809|NCT02003924|452893741|FG002|Double-blind Phase|Lost to Follow-up|0|||
125889810|NCT02003924|452893739|FG000|Double-blind Phase|Protocol Violation|1|||
126105292|NCT00940108|453678576|FG003|Overall Study|Dose 2 contraindicated|1|||
126105293|NCT00940108|453678573|FG000|Overall Study|Declined further vaccination|0|||
126398390|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398391|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398392|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398393|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398394|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398395|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398396|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398397|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398398|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398399|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398400|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
126398401|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398402|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
126398403|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398404|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398405|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398406|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398407|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398408|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
126398409|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
126398410|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
126398411|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
126398412|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
126398413|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398414|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398415|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398416|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398417|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398418|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398419|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398420|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398421|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
126398422|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
126398423|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398424|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398425|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398426|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126053004|NCT05014412|453489432|FG000|Overall Study|Death|11|||
126053005|NCT05014412|453489433|FG001|Overall Study|Death|7|||
126053006|NCT05014412|453489434|FG002|Overall Study|Death|4|||
126053007|NCT05014412|453489435|FG003|Overall Study|Death|7|||
126053008|NCT05014412|453489432|FG000|Overall Study|Withdrawal by Subject|1|||
126053009|NCT05014412|453489433|FG001|Overall Study|Withdrawal by Subject|1|||
126053010|NCT05014412|453489434|FG002|Overall Study|Withdrawal by Subject|1|||
125889811|NCT02003924|452893740|FG001|Double-blind Phase|Protocol Violation|2|||
125889812|NCT02003924|452893741|FG002|Double-blind Phase|Protocol Violation|0|||
125889813|NCT02003924|452893739|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
125889814|NCT02003924|452893740|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
125889815|NCT02003924|452893741|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
125889816|NCT02003924|452893739|FG000|Double-blind Phase|Disease Progression|229|||
125889817|NCT02003924|452893740|FG001|Double-blind Phase|Disease Progression|247|||
126053011|NCT05014412|453489435|FG003|Overall Study|Withdrawal by Subject|2|||
126053012|NCT05014412|453489432|FG000|Overall Study|Ongoing|21|||
126053013|NCT05014412|453489433|FG001|Overall Study|Ongoing|4|||
126053014|NCT05014412|453489434|FG002|Overall Study|Ongoing|6|||
126053015|NCT05014412|453489435|FG003|Overall Study|Ongoing|20|||
125889818|NCT02003924|452893741|FG002|Double-blind Phase|Disease Progression|0|||
125889819|NCT02003924|452893739|FG000|Double-blind Phase|Adverse Event|120|||
125889820|NCT02003924|452893740|FG001|Double-blind Phase|Adverse Event|31|||
125889821|NCT02003924|452893741|FG002|Double-blind Phase|Adverse Event|0|||
125889822|NCT02003924|452893739|FG000|Double-blind Phase|Randomized But not Treated|3|||
125889823|NCT02003924|452893740|FG001|Double-blind Phase|Randomized But not Treated|3|||
125889824|NCT02003924|452893741|FG002|Double-blind Phase|Randomized But not Treated|0|||
125889825|NCT02003924|452893739|FG000|Double-blind Phase|Other|29|||
125889826|NCT02003924|452893740|FG001|Double-blind Phase|Other|50|||
125889827|NCT02003924|452893741|FG002|Double-blind Phase|Other|0|||
125889828|NCT02003924|452893739|FG000|Open-label Phase|Lost to Follow-up|0|||
125889829|NCT02003924|452893740|FG001|Open-label Phase|Lost to Follow-up|0|||
125889830|NCT02003924|452893741|FG002|Open-label Phase|Lost to Follow-up|1|||
125889831|NCT02003924|452893739|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
125889832|NCT02003924|452893740|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
125889833|NCT02003924|452893741|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
125889834|NCT02003924|452893739|FG000|Open-label Phase|Disease Progression|59|||
125889835|NCT02003924|452893740|FG001|Open-label Phase|Disease Progression|0|||
125889836|NCT02003924|452893741|FG002|Open-label Phase|Disease Progression|5|||
125889837|NCT02003924|452893739|FG000|Open-label Phase|Adverse Event|25|||
125889838|NCT02003924|452893740|FG001|Open-label Phase|Adverse Event|0|||
125889839|NCT02003924|452893741|FG002|Open-label Phase|Adverse Event|10|||
125889840|NCT02003924|452893739|FG000|Open-label Phase|Other|7|||
125889841|NCT02003924|452893740|FG001|Open-label Phase|Other|0|||
125889842|NCT02003924|452893741|FG002|Open-label Phase|Other|0|||
125889843|NCT02003924|452893739|FG000|Long-term Follow-up Phase|Death|288|||
125889844|NCT02003924|452893740|FG001|Long-term Follow-up Phase|Death|174|||
125889845|NCT02003924|452893741|FG002|Long-term Follow-up Phase|Death|4|||
125889846|NCT02003924|452893739|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
125889847|NCT02003924|452893740|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
125889848|NCT02003924|452893741|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
125889849|NCT02003924|452893739|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
125889850|NCT02003924|452893740|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
125889851|NCT02003924|452893741|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
125889852|NCT02003924|452893739|FG000|Long-term Follow-up Phase|Other|5|||
125889853|NCT02003924|452893740|FG001|Long-term Follow-up Phase|Other|2|||
125889854|NCT02003924|452893741|FG002|Long-term Follow-up Phase|Other|1|||
125889855|NCT02930018|452893745|FG000|Overall Study|Lost to Follow-up|1|||
125889856|NCT02930018|452893746|FG001|Overall Study|Lost to Follow-up|1|||
125889857|NCT02930018|452893745|FG000|Overall Study|Withdrawal by Subject|5|||
125889858|NCT02930018|452893746|FG001|Overall Study|Withdrawal by Subject|2|||
125889859|NCT00114517|452893750|FG000|Overall Study|Adverse Event|6|||
125889860|NCT00114517|452893751|FG001|Overall Study|Adverse Event|1|||
125889861|NCT00114517|452893752|FG002|Overall Study|Adverse Event|6|||
125889862|NCT00114517|452893753|FG003|Overall Study|Adverse Event|3|||
125889863|NCT00114517|452893750|FG000|Overall Study|Lost to Follow-up|2|||
125889864|NCT00114517|452893751|FG001|Overall Study|Lost to Follow-up|2|||
125889865|NCT00114517|452893752|FG002|Overall Study|Lost to Follow-up|2|||
125889866|NCT00114517|452893753|FG003|Overall Study|Lost to Follow-up|1|||
125889867|NCT00114517|452893750|FG000|Overall Study|Too busy|3|||
125889868|NCT00114517|452893751|FG001|Overall Study|Too busy|1|||
125889869|NCT00114517|452893752|FG002|Overall Study|Too busy|1|||
125889870|NCT00114517|452893753|FG003|Overall Study|Too busy|2|||
125889871|NCT00114517|452893750|FG000|Overall Study|Moved from area|0|||
125889872|NCT00114517|452893751|FG001|Overall Study|Moved from area|3|||
125889873|NCT00114517|452893752|FG002|Overall Study|Moved from area|2|||
125889874|NCT00114517|452893753|FG003|Overall Study|Moved from area|1|||
125889875|NCT00114517|452893750|FG000|Overall Study|Did not want estradiol|1|||
125889876|NCT00114517|452893751|FG001|Overall Study|Did not want estradiol|1|||
125889877|NCT00114517|452893752|FG002|Overall Study|Did not want estradiol|0|||
125889878|NCT00114517|452893753|FG003|Overall Study|Did not want estradiol|0|||
125889879|NCT00114517|452893750|FG000|Overall Study|Armed-services duty|0|||
125889880|NCT00114517|452893751|FG001|Overall Study|Armed-services duty|1|||
126398427|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398428|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125889881|NCT00114517|452893752|FG002|Overall Study|Armed-services duty|0|||
125889882|NCT00114517|452893753|FG003|Overall Study|Armed-services duty|1|||
125889883|NCT00114517|452893750|FG000|Overall Study|Competing family issue|0|||
125889884|NCT00114517|452893751|FG001|Overall Study|Competing family issue|1|||
125889885|NCT00114517|452893752|FG002|Overall Study|Competing family issue|0|||
125889886|NCT00114517|452893753|FG003|Overall Study|Competing family issue|1|||
125889887|NCT00114517|452893750|FG000|Overall Study|Physician Decision|0|||
125889888|NCT00114517|452893751|FG001|Overall Study|Physician Decision|1|||
125889889|NCT00114517|452893752|FG002|Overall Study|Physician Decision|0|||
125889890|NCT00114517|452893753|FG003|Overall Study|Physician Decision|0|||
125889891|NCT00114517|452893750|FG000|Overall Study|Lost interest|0|||
125889892|NCT00114517|452893751|FG001|Overall Study|Lost interest|0|||
125889893|NCT00114517|452893752|FG002|Overall Study|Lost interest|1|||
125889894|NCT00114517|452893753|FG003|Overall Study|Lost interest|0|||
125889895|NCT00114517|452893750|FG000|Overall Study|Weight increase|0|||
125889896|NCT00114517|452893751|FG001|Overall Study|Weight increase|0|||
125889897|NCT00114517|452893752|FG002|Overall Study|Weight increase|1|||
125889898|NCT00114517|452893753|FG003|Overall Study|Weight increase|0|||
125889899|NCT00114517|452893750|FG000|Overall Study|Concern about blood clots|0|||
125889900|NCT00114517|452893751|FG001|Overall Study|Concern about blood clots|0|||
125889901|NCT00114517|452893752|FG002|Overall Study|Concern about blood clots|1|||
125889902|NCT00114517|452893753|FG003|Overall Study|Concern about blood clots|0|||
125889903|NCT00114517|452893750|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125889904|NCT00114517|452893751|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125889905|NCT00114517|452893752|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125889906|NCT00114517|452893753|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
125889907|NCT00539864|452895367|FG000|Overall Study|Lost to Follow-up|0|||
125889908|NCT00539864|452895368|FG001|Overall Study|Lost to Follow-up|1|||
125889909|NCT00539864|452895367|FG000|Overall Study|Withdrawal by Subject|1|||
125889910|NCT00539864|452895368|FG001|Overall Study|Withdrawal by Subject|1|||
125889911|NCT02565784|452895369|FG000|First Treatment|Adverse Event|1|||
125889912|NCT02565784|452895369|FG000|First Treatment|Withdrawal by Subject|1|||
125889913|NCT02565784|452895369|FG000|Second Treatment|Withdrawal by Subject|2|||
125889914|NCT00552188|452895372|FG000|Overall Study|Adverse Event|0|||
125889915|NCT00552188|452895373|FG001|Overall Study|Adverse Event|2|||
125889916|NCT00552188|452895372|FG000|Overall Study|Lost to Follow-up|2|||
125889917|NCT00552188|452895373|FG001|Overall Study|Lost to Follow-up|1|||
125889918|NCT00552188|452895372|FG000|Overall Study|Withdrawal of consent|0|||
125889919|NCT00552188|452895373|FG001|Overall Study|Withdrawal of consent|1|||
125889920|NCT00552188|452895372|FG000|Overall Study|Subject returned to home country|0|||
125889921|NCT00552188|452895373|FG001|Overall Study|Subject returned to home country|1|||
125889922|NCT03887702|452895374|FG000|Overall Study|Study terminated|0|||
125889923|NCT03887702|452895375|FG001|Overall Study|Study terminated|0|||
125889924|NCT03887702|452895376|FG002|Overall Study|Study terminated|2|||
125889925|NCT03887702|452895377|FG003|Overall Study|Study terminated|2|||
125889926|NCT01193257|452895378|FG000|Overall Study|Death|202|||
125889927|NCT01193257|452895379|FG001|Overall Study|Death|391|||
125889928|NCT01193257|452895378|FG000|Overall Study|Study termination by sponsor|0|||
125889929|NCT01193257|452895379|FG001|Overall Study|Study termination by sponsor|3|||
125889930|NCT01193257|452895378|FG000|Overall Study|Withdrawal by Subject|26|||
125889931|NCT01193257|452895379|FG001|Overall Study|Withdrawal by Subject|86|||
126398429|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398430|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125889932|NCT01193257|452895378|FG000|Overall Study|Lost to Follow-up|2|||
125889933|NCT01193257|452895379|FG001|Overall Study|Lost to Follow-up|3|||
125889934|NCT01193257|452895378|FG000|Overall Study|Unblinded due to futility|135|||
125889935|NCT01193257|452895379|FG001|Overall Study|Unblinded due to futility|251|||
125889936|NCT01675544|452895380|FG000|Overall Study|Withdrawal by Subject|2|||
125889937|NCT00476008|452895386|FG000|Overall Study|Adverse Event|4|||
126398431|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125889938|NCT00476008|452895387|FG001|Overall Study|Adverse Event|4|||
125889939|NCT00476008|452895386|FG000|Overall Study|Placebo concerns|2|||
125889940|NCT00476008|452895387|FG001|Overall Study|Placebo concerns|2|||
125889941|NCT00476008|452895386|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
125889942|NCT00476008|452895387|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
126398432|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
126398433|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398434|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398435|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398436|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398437|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398438|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
126398439|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125889943|NCT00476008|452895386|FG000|Overall Study|Withdrawal by Subject|0|||
125889944|NCT00476008|452895387|FG001|Overall Study|Withdrawal by Subject|1|||
125889945|NCT00476008|452895386|FG000|Overall Study|Death|1|||
125889946|NCT00476008|452895387|FG001|Overall Study|Death|0|||
125889947|NCT00792571|452895394|FG000|Overall Study|Death|1|||
125889948|NCT00792571|452895394|FG000|Overall Study|Adverse Event|4|||
125889949|NCT00792571|452895394|FG000|Overall Study|Withdrawal by Subject|1|||
125889950|NCT00792571|452895394|FG000|Overall Study|Other|4|||
125889951|NCT01621802|452895396|FG000|Overall Study|Protocol Violation|0|||
125889952|NCT01621802|452895397|FG001|Overall Study|Protocol Violation|0|||
125889953|NCT01621802|452895398|FG002|Overall Study|Protocol Violation|0|||
125889954|NCT01621802|452895399|FG003|Overall Study|Protocol Violation|0|||
125889955|NCT01621802|452895400|FG004|Overall Study|Protocol Violation|0|||
125889956|NCT01621802|452895401|FG005|Overall Study|Protocol Violation|1|||
125889957|NCT01621802|452895396|FG000|Overall Study|Withdrawal by Subject|8|||
125889958|NCT01621802|452895397|FG001|Overall Study|Withdrawal by Subject|4|||
125889959|NCT01621802|452895398|FG002|Overall Study|Withdrawal by Subject|4|||
125889960|NCT01621802|452895399|FG003|Overall Study|Withdrawal by Subject|2|||
126398440|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398441|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398442|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
126398443|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398444|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398445|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398446|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398447|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398448|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398449|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398450|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398451|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398452|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
126398453|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398454|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398455|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126053136|NCT02101775|453489451|FG000|Overall Study|Adverse Event|4|||
126053137|NCT02101775|453489452|FG001|Overall Study|Adverse Event|0|||
126053138|NCT02101775|453489453|FG002|Overall Study|Adverse Event|0|||
126053139|NCT02101775|453489451|FG000|Overall Study|Admission to Hospital|0|||
126053140|NCT02101775|453489452|FG001|Overall Study|Admission to Hospital|1|||
126053141|NCT02101775|453489453|FG002|Overall Study|Admission to Hospital|0|||
126105294|NCT00940108|453678574|FG001|Overall Study|Declined further vaccination|1|||
125889961|NCT01621802|452895400|FG004|Overall Study|Withdrawal by Subject|2|||
125889962|NCT01621802|452895401|FG005|Overall Study|Withdrawal by Subject|0|||
125889963|NCT01621802|452895396|FG000|Overall Study|Migrated/moved from study area|0|||
125889964|NCT01621802|452895397|FG001|Overall Study|Migrated/moved from study area|0|||
125889965|NCT01621802|452895398|FG002|Overall Study|Migrated/moved from study area|2|||
125889966|NCT01621802|452895399|FG003|Overall Study|Migrated/moved from study area|0|||
125889967|NCT01621802|452895400|FG004|Overall Study|Migrated/moved from study area|1|||
125889968|NCT01621802|452895401|FG005|Overall Study|Migrated/moved from study area|0|||
125889969|NCT01621802|452895396|FG000|Overall Study|Others|3|||
125889970|NCT01621802|452895397|FG001|Overall Study|Others|3|||
125889971|NCT01621802|452895398|FG002|Overall Study|Others|3|||
125889972|NCT01621802|452895399|FG003|Overall Study|Others|2|||
125889973|NCT01621802|452895400|FG004|Overall Study|Others|1|||
125889974|NCT01621802|452895401|FG005|Overall Study|Others|0|||
125889975|NCT01621802|452895396|FG000|Overall Study|Lost to Follow-up|36|||
125889976|NCT01621802|452895397|FG001|Overall Study|Lost to Follow-up|16|||
125889977|NCT01621802|452895398|FG002|Overall Study|Lost to Follow-up|24|||
125889978|NCT01621802|452895399|FG003|Overall Study|Lost to Follow-up|7|||
125889979|NCT01621802|452895400|FG004|Overall Study|Lost to Follow-up|31|||
126398456|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398457|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398458|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398459|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
126398460|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398461|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398462|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
126398463|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398464|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398465|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398466|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398467|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398468|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
126398469|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398470|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398471|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398472|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
126398473|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398474|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398475|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398476|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398477|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398478|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
126398479|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398480|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
126398481|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398482|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
126398483|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398484|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398485|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398486|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398487|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398488|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Other|5|||
126398489|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Other|1|||
126398490|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Other|0|||
126398491|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Other|3|||
126398492|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Other|0|||
126398493|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Other|0|||
126398494|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Other|0|||
126398495|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Other|0|||
126398496|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Other|0|||
126398497|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Other|0|||
125889980|NCT01621802|452895401|FG005|Overall Study|Lost to Follow-up|11|||
126398498|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398499|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398500|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398501|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398502|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
126398503|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398504|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
125889981|NCT02948634|452895402|FG000|Overall Study|Lack of efficacy and study suspended|10|||
125889982|NCT02948634|452895403|FG001|Overall Study|Lack of efficacy and study suspended|2|||
126398505|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398506|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398507|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398508|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Death|0|||
126398509|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Death|0|||
126398510|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Death|0|||
126398511|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Death|0|||
126398512|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Death|0|||
126398513|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Death|1|||
126398514|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Death|0|||
126398515|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Death|1|||
126398516|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Death|1|||
126398517|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Death|1|||
126398518|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398519|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398520|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398521|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398522|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398523|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
126398524|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398525|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398526|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398527|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398528|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398529|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398530|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398531|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398532|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398533|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398534|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398535|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398536|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
126398537|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398538|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398539|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398540|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398541|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398542|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398543|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
126398544|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
126398545|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
126398546|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
126398547|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
126398548|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398549|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398550|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398551|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398552|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398553|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
126398554|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398555|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
126398556|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
126398557|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
126398558|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398559|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398560|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398561|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398562|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398563|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398564|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398565|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398566|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398567|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398568|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398569|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398570|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398571|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398572|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398573|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
126398574|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398575|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
126398576|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
126398577|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
126398578|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398579|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398580|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398581|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398582|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398583|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398584|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398585|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398586|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
126398587|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
126398588|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398589|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398590|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398591|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398592|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398593|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398594|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398595|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
126398596|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398597|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398598|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398599|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398600|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398601|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398602|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398603|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398604|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398605|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
126398606|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398607|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398608|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398609|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398610|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398611|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398612|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398613|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398614|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398615|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
126398616|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
126398617|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398618|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398619|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398620|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398621|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398622|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398623|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
126398624|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398625|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398626|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
126398627|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398628|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398629|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398630|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398631|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398632|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398633|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398634|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398635|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398636|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398637|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
126398638|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398639|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398640|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398641|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398642|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398643|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398644|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398645|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398646|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
126398647|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
126398648|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398649|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398650|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398651|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126105295|NCT00940108|453678575|FG002|Overall Study|Declined further vaccination|3|||
126398652|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398653|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398654|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398655|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
126398656|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
126398657|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398658|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Other|0|||
126398659|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Other|0|||
126398660|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Other|0|||
126398661|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Other|0|||
126398662|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Other|0|||
126398663|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Other|0|||
126398664|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Other|0|||
126398665|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Other|1|||
126398666|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Other|0|||
126398667|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Other|0|||
126398668|NCT00907803|454753103|FG000|Overall Study|Withdrawal of consent - long commute|1|||
126398669|NCT00907803|454753104|FG001|Overall Study|Withdrawal of consent - long commute|0|||
126398670|NCT00907803|454753105|FG002|Overall Study|Withdrawal of consent - long commute|0|||
126398671|NCT00907803|454753103|FG000|Overall Study|Adverse Event|2|||
126398672|NCT00907803|454753104|FG001|Overall Study|Adverse Event|0|||
126398673|NCT00907803|454753105|FG002|Overall Study|Adverse Event|0|||
126398674|NCT00907803|454753103|FG000|Overall Study|Withdrawal by Subject|0|||
126398675|NCT00907803|454753104|FG001|Overall Study|Withdrawal by Subject|1|||
126398676|NCT00907803|454753105|FG002|Overall Study|Withdrawal by Subject|0|||
126398677|NCT00907803|454753103|FG000|Overall Study|Lost to Follow-up|0|||
126398678|NCT00907803|454753104|FG001|Overall Study|Lost to Follow-up|1|||
126398679|NCT00907803|454753105|FG002|Overall Study|Lost to Follow-up|0|||
126398680|NCT00907803|454753103|FG000|Overall Study|Protocol Violation|0|||
126398681|NCT00907803|454753104|FG001|Overall Study|Protocol Violation|1|||
126398682|NCT00907803|454753105|FG002|Overall Study|Protocol Violation|0|||
126398683|NCT03510468|454753106|FG000|Overall Study|Lost to Follow-up|1|||
126398684|NCT03510468|454753106|FG000|Overall Study|Adverse Event|5|||
126398685|NCT03510468|454753106|FG000|Overall Study|Physician Decision|1|||
126398686|NCT03510468|454753106|FG000|Overall Study|non-compliant with treatment|2|||
126398687|NCT03510468|454753106|FG000|Overall Study|Missed visit|1|||
126398688|NCT04612842|454753107|FG000|Overall Study|Lost to Follow-up|20|||
126398689|NCT04612842|454753108|FG001|Overall Study|Lost to Follow-up|11|||
126398690|NCT04612842|454753107|FG000|Overall Study|Withdrawal by Subject|26|||
126398691|NCT04612842|454753108|FG001|Overall Study|Withdrawal by Subject|15|||
126398692|NCT04612842|454753107|FG000|Overall Study|Death|2|||
126398693|NCT04612842|454753108|FG001|Overall Study|Death|2|||
126398694|NCT02419131|454753109|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
126398695|NCT02419131|454753110|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
126398696|NCT02419131|454753111|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
126398697|NCT02419131|454753109|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
126398698|NCT02419131|454753110|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
126398699|NCT02419131|454753111|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
126398700|NCT05426031|454753112|FG000|Overall Study|Circulatory Arrest|3|||
126398701|NCT05426031|454753113|FG001|Overall Study|Circulatory Arrest|2|||
126398702|NCT04677660|454753114|FG000|Overall Study|Lost to Follow-up|0|||
126398703|NCT04677660|454753115|FG001|Overall Study|Lost to Follow-up|2|||
126398704|NCT04677660|454753114|FG000|Overall Study|Withdrawal by Subject|0|||
126398705|NCT04677660|454753115|FG001|Overall Study|Withdrawal by Subject|1|||
126398706|NCT04677660|454753114|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
126398707|NCT04677660|454753115|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
126398708|NCT00089986|454753116|FG000|Overall Study|Adverse Event|6|||
126398709|NCT00089986|454753117|FG001|Overall Study|Adverse Event|9|||
126398710|NCT00089986|454753118|FG002|Overall Study|Adverse Event|6|||
126398711|NCT00089986|454753116|FG000|Overall Study|Lost to Follow-up|3|||
126398712|NCT00089986|454753117|FG001|Overall Study|Lost to Follow-up|1|||
126398713|NCT00089986|454753118|FG002|Overall Study|Lost to Follow-up|1|||
126398714|NCT00089986|454753116|FG000|Overall Study|Protocol Violation|0|||
126398715|NCT00089986|454753117|FG001|Overall Study|Protocol Violation|1|||
126398716|NCT00089986|454753118|FG002|Overall Study|Protocol Violation|0|||
126398717|NCT00089986|454753116|FG000|Overall Study|Patient transferred to another hospital|2|||
126398718|NCT00089986|454753117|FG001|Overall Study|Patient transferred to another hospital|1|||
126398719|NCT00089986|454753118|FG002|Overall Study|Patient transferred to another hospital|0|||
126398720|NCT00089986|454753116|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
126398721|NCT00089986|454753117|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
126398722|NCT00089986|454753118|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
126398723|NCT00089986|454753116|FG000|Overall Study|Hemohlobin stopping rule|0|||
126398724|NCT00089986|454753117|FG001|Overall Study|Hemohlobin stopping rule|1|||
126398725|NCT00089986|454753118|FG002|Overall Study|Hemohlobin stopping rule|0|||
125971373|NCT04723576|453182811|FG000|Overall Study|Withdrawal by Subject|2133|||
126105296|NCT00940108|453678576|FG003|Overall Study|Declined further vaccination|0|||
126105297|NCT00940108|453678573|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
126398726|NCT00089986|454753116|FG000|Overall Study|Investigator decision to withdrew|0|||
126398727|NCT00089986|454753117|FG001|Overall Study|Investigator decision to withdrew|1|||
126398728|NCT00089986|454753118|FG002|Overall Study|Investigator decision to withdrew|0|||
126398729|NCT00089986|454753116|FG000|Overall Study|Enrollment in another study|0|||
126398730|NCT00089986|454753117|FG001|Overall Study|Enrollment in another study|1|||
126398731|NCT00089986|454753118|FG002|Overall Study|Enrollment in another study|0|||
126398732|NCT00089986|454753116|FG000|Overall Study|Family decision|0|||
126398733|NCT00089986|454753117|FG001|Overall Study|Family decision|1|||
126398734|NCT00089986|454753118|FG002|Overall Study|Family decision|0|||
126398735|NCT00089986|454753116|FG000|Overall Study|Do not resuscitate (DNR)|0|||
126398736|NCT00089986|454753117|FG001|Overall Study|Do not resuscitate (DNR)|0|||
126398737|NCT00089986|454753118|FG002|Overall Study|Do not resuscitate (DNR)|1|||
126398738|NCT00089986|454753116|FG000|Overall Study|Withdrawal by Subject|3|||
126398739|NCT00089986|454753117|FG001|Overall Study|Withdrawal by Subject|6|||
126398740|NCT00089986|454753118|FG002|Overall Study|Withdrawal by Subject|2|||
126398741|NCT02334683|454753125|FG000|First 12 Week Period|Lost to Follow-up|1|||
126398742|NCT02334683|454753126|FG001|First 12 Week Period|Lost to Follow-up|0|||
126398743|NCT02334683|454753125|FG000|Second 12 Week Period|Adverse Event|0|||
126398744|NCT02334683|454753126|FG001|Second 12 Week Period|Adverse Event|1|||
126398745|NCT00916058|454753127|FG000|Phase 1|Screen Failure|0|||
126398746|NCT00916058|454753128|FG001|Phase 1|Screen Failure|0|||
126398747|NCT00916058|454753129|FG002|Phase 1|Screen Failure|0|||
126398748|NCT00916058|454753130|FG003|Phase 1|Screen Failure|0|||
126398749|NCT00916058|454753131|FG004|Phase 1|Screen Failure|0|||
126398750|NCT00916058|454753132|FG005|Phase 1|Screen Failure|1|||
126398751|NCT00916058|454753133|FG006|Phase 1|Screen Failure|0|||
126398752|NCT00916058|454753127|FG000|Phase 2|Screen Failure|0|||
126398753|NCT00916058|454753128|FG001|Phase 2|Screen Failure|0|||
126398754|NCT00916058|454753129|FG002|Phase 2|Screen Failure|0|||
126398755|NCT00916058|454753130|FG003|Phase 2|Screen Failure|0|||
126398756|NCT00916058|454753131|FG004|Phase 2|Screen Failure|0|||
126398757|NCT00916058|454753132|FG005|Phase 2|Screen Failure|0|||
126398758|NCT00916058|454753133|FG006|Phase 2|Screen Failure|3|||
126398759|NCT01218100|454753134|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
126398760|NCT01218100|454753135|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
126398761|NCT01218100|454753136|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
126398762|NCT01218100|454753137|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
126398763|NCT01218100|454753134|FG000|Overall Study|Adverse Event|4|||
126398764|NCT01218100|454753135|FG001|Overall Study|Adverse Event|6|||
126398765|NCT01218100|454753136|FG002|Overall Study|Adverse Event|6|||
125971374|NCT04723576|453182812|FG001|Overall Study|Withdrawal by Subject|3234|||
125971375|NCT02097472|453182813|FG000|Received Vaccination 2|Adverse Event|0|||
125971376|NCT02097472|453182814|FG001|Received Vaccination 2|Adverse Event|0|||
125971377|NCT02097472|453182815|FG002|Received Vaccination 2|Adverse Event|0|||
125971378|NCT02097472|453182816|FG003|Received Vaccination 2|Adverse Event|0|||
125971379|NCT02097472|453182817|FG004|Received Vaccination 2|Adverse Event|0|||
125971380|NCT02097472|453182818|FG005|Received Vaccination 2|Adverse Event|0|||
125971381|NCT02097472|453182819|FG006|Received Vaccination 2|Adverse Event|1|||
125971382|NCT02097472|453182820|FG007|Received Vaccination 2|Adverse Event|0|||
125971383|NCT03966157|453182821|FG000|Overall Study|Physician Decision|1|||
125971384|NCT03966157|453182822|FG001|Overall Study|Physician Decision|0|||
125971385|NCT03305016|453182823|FG000|Overall Study|Withdrawal by Subject|2|||
125971386|NCT02119416|453182824|FG000|Overall Study|Protocol Violation|1|||
125971387|NCT02119416|453182825|FG001|Overall Study|Protocol Violation|1|||
125971388|NCT02119416|453182826|FG002|Overall Study|Protocol Violation|1|||
125971389|NCT02119416|453182824|FG000|Overall Study|wrong pubertal stage|1|||
125971390|NCT02119416|453182825|FG001|Overall Study|wrong pubertal stage|0|||
125971391|NCT02119416|453182826|FG002|Overall Study|wrong pubertal stage|1|||
126398766|NCT01218100|454753137|FG003|Overall Study|Adverse Event|7|||
126398767|NCT01218100|454753134|FG000|Overall Study|Lack of Efficacy|9|||
126398768|NCT01218100|454753135|FG001|Overall Study|Lack of Efficacy|6|||
126398769|NCT01218100|454753136|FG002|Overall Study|Lack of Efficacy|5|||
126398770|NCT01218100|454753137|FG003|Overall Study|Lack of Efficacy|12|||
126398771|NCT01218100|454753134|FG000|Overall Study|Protocol Violation|0|||
126398772|NCT01218100|454753135|FG001|Overall Study|Protocol Violation|0|||
126398773|NCT01218100|454753136|FG002|Overall Study|Protocol Violation|1|||
126398774|NCT01218100|454753137|FG003|Overall Study|Protocol Violation|1|||
126398775|NCT01218100|454753134|FG000|Overall Study|Withdrawal by Subject|5|||
126398776|NCT01218100|454753135|FG001|Overall Study|Withdrawal by Subject|2|||
126398777|NCT01218100|454753136|FG002|Overall Study|Withdrawal by Subject|6|||
126398778|NCT01218100|454753137|FG003|Overall Study|Withdrawal by Subject|7|||
126398779|NCT01218100|454753134|FG000|Overall Study|Lost to Follow-up|3|||
126398780|NCT01218100|454753135|FG001|Overall Study|Lost to Follow-up|8|||
126398781|NCT01218100|454753136|FG002|Overall Study|Lost to Follow-up|2|||
126398782|NCT01218100|454753137|FG003|Overall Study|Lost to Follow-up|1|||
126398783|NCT01218100|454753134|FG000|Overall Study|Other Reason|2|||
126398784|NCT01218100|454753135|FG001|Overall Study|Other Reason|2|||
126398785|NCT01218100|454753136|FG002|Overall Study|Other Reason|6|||
126398786|NCT01218100|454753137|FG003|Overall Study|Other Reason|4|||
126398787|NCT02437305|454753138|FG000|Overall Study|Lost to Follow-up|18|||
126398788|NCT02437305|454753139|FG001|Overall Study|Lost to Follow-up|12|||
126398789|NCT02434354|454753160|FG000|Overall Study|screen fail|3|||
126398790|NCT00413920|454753161|FG000|Overall Study|Adverse Event|9|||
126398791|NCT00413920|454753162|FG001|Overall Study|Adverse Event|11|||
126398792|NCT00413920|454753161|FG000|Overall Study|Lack of Efficacy|11|||
126398793|NCT00413920|454753162|FG001|Overall Study|Lack of Efficacy|9|||
126398794|NCT00413920|454753161|FG000|Overall Study|Death|3|||
126398795|NCT00413920|454753162|FG001|Overall Study|Death|5|||
126398796|NCT00413920|454753161|FG000|Overall Study|Graft Loss|5|||
126398797|NCT00413920|454753162|FG001|Overall Study|Graft Loss|3|||
126398798|NCT01071200|454753163|FG000|Overall Study|Lack of ovarian response|1|||
126398799|NCT01071200|454753164|FG001|Overall Study|Lack of ovarian response|1|||
126398800|NCT01071200|454753163|FG000|Overall Study|No fertilization|4|||
126398801|NCT01071200|454753164|FG001|Overall Study|No fertilization|0|||
126398802|NCT01071200|454753163|FG000|Overall Study|No oocytes retrieved|1|||
126398803|NCT01071200|454753164|FG001|Overall Study|No oocytes retrieved|1|||
126398804|NCT01071200|454753163|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
126398805|NCT01071200|454753164|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
126398806|NCT01071200|454753163|FG000|Overall Study|No viable embryos|0|||
126398807|NCT01071200|454753164|FG001|Overall Study|No viable embryos|1|||
126398808|NCT03730961|454753165|FG000|Overall Study|Adverse Event|0|||
125889983|NCT03790696|452895404|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
125889984|NCT03790696|452895405|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
125889985|NCT01149148|452895406|FG000|Overall Study|Lost to Follow-up|1|||
126398809|NCT03730961|454753166|FG001|Overall Study|Adverse Event|1|||
126398810|NCT04465877|454753172|FG000|Overall Study|Noncompliant with study requirements|0|||
126398811|NCT04465877|454753173|FG001|Overall Study|Noncompliant with study requirements|0|||
126398812|NCT04465877|454753174|FG002|Overall Study|Noncompliant with study requirements|1|||
126398813|NCT04465877|454753175|FG003|Overall Study|Noncompliant with study requirements|0|||
126398814|NCT03762616|454753176|FG000|Overall Study|Protocol Violation|2|||
126398815|NCT03576755|454753177|FG000|Overall Study|Withdrawal by Subject|1|||
126398816|NCT03576755|454753178|FG001|Overall Study|Withdrawal by Subject|0|||
126398817|NCT03576755|454753179|FG002|Overall Study|Withdrawal by Subject|0|||
126398818|NCT03576755|454753180|FG003|Overall Study|Withdrawal by Subject|0|||
126398819|NCT04962230|454753181|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
126398820|NCT04962230|454753181|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
126398821|NCT03958656|454753184|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
126398822|NCT03958656|454753185|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
126398823|NCT03958656|454753186|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
126398824|NCT03958656|454753187|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
126398825|NCT03958656|454753184|FG000|Overall Study|No longer meets eligibility criteria|0|||
126398826|NCT03958656|454753185|FG001|Overall Study|No longer meets eligibility criteria|0|||
126398827|NCT03958656|454753186|FG002|Overall Study|No longer meets eligibility criteria|1|||
126398828|NCT03958656|454753187|FG003|Overall Study|No longer meets eligibility criteria|0|||
126398829|NCT03958656|454753184|FG000|Overall Study|Started anti-cancer treatment|0|||
126398830|NCT03958656|454753185|FG001|Overall Study|Started anti-cancer treatment|0|||
126398831|NCT03958656|454753186|FG002|Overall Study|Started anti-cancer treatment|1|||
126398832|NCT03958656|454753187|FG003|Overall Study|Started anti-cancer treatment|0|||
126398833|NCT01767493|454753188|FG000|Overall Study|screen failures|3|||
126398834|NCT01598753|454753189|FG000|Overall Study|Adverse Event|1|||
126398835|NCT01598753|454753190|FG001|Overall Study|Adverse Event|9|||
126398836|NCT01598753|454753191|FG002|Overall Study|Adverse Event|1|||
126398837|NCT01598753|454753192|FG003|Overall Study|Adverse Event|7|||
126398838|NCT01598753|454753189|FG000|Overall Study|Lost to Follow-up|4|||
126398839|NCT01598753|454753190|FG001|Overall Study|Lost to Follow-up|3|||
126398840|NCT01598753|454753191|FG002|Overall Study|Lost to Follow-up|7|||
126398841|NCT01598753|454753192|FG003|Overall Study|Lost to Follow-up|5|||
126398842|NCT01598753|454753189|FG000|Overall Study|Physician Decision|0|||
126398843|NCT01598753|454753190|FG001|Overall Study|Physician Decision|1|||
126398844|NCT01598753|454753191|FG002|Overall Study|Physician Decision|0|||
126398845|NCT01598753|454753192|FG003|Overall Study|Physician Decision|2|||
126398846|NCT01598753|454753189|FG000|Overall Study|Withdrawal by Subject|7|||
126053246|NCT01886872|453489474|FG000|Overall Study|Ineligible|7|||
126053247|NCT01886872|453489475|FG001|Overall Study|Ineligible|4|||
126398847|NCT01598753|454753190|FG001|Overall Study|Withdrawal by Subject|2|||
126398848|NCT01598753|454753191|FG002|Overall Study|Withdrawal by Subject|0|||
126398849|NCT01598753|454753192|FG003|Overall Study|Withdrawal by Subject|1|||
126398850|NCT03158012|454753193|FG000|Overall Study|Withdrawal by Subject|0|||
126398851|NCT03158012|454753194|FG001|Overall Study|Withdrawal by Subject|1|||
126398852|NCT04346108|454753195|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
126398853|NCT04346108|454753196|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
126398854|NCT04346108|454753197|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
126398855|NCT04346108|454753195|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
126398856|NCT04346108|454753196|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
126398857|NCT04346108|454753197|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
126398858|NCT02788201|454753198|FG000|Overall Study|Death|1|||
126398859|NCT02788201|454753199|FG001|Overall Study|Death|1|||
126398860|NCT02788201|454753200|FG002|Overall Study|Death|1|||
126398861|NCT02788201|454753201|FG003|Overall Study|Death|1|||
126398862|NCT02788201|454753202|FG004|Overall Study|Death|0|||
126398863|NCT02788201|454753203|FG005|Overall Study|Death|1|||
126398864|NCT02788201|454753198|FG000|Overall Study|Ineligible|0|||
126398865|NCT02788201|454753199|FG001|Overall Study|Ineligible|0|||
126398866|NCT02788201|454753200|FG002|Overall Study|Ineligible|0|||
126398867|NCT02788201|454753201|FG003|Overall Study|Ineligible|0|||
126398868|NCT02788201|454753202|FG004|Overall Study|Ineligible|0|||
126398869|NCT02788201|454753203|FG005|Overall Study|Ineligible|1|||
126398870|NCT02788201|454753198|FG000|Overall Study|Withdrawal by Subject|0|||
125889986|NCT01149148|452895407|FG001|Overall Study|Lost to Follow-up|2|||
125889987|NCT01149148|452895406|FG000|Overall Study|Death|1|||
126398871|NCT02788201|454753199|FG001|Overall Study|Withdrawal by Subject|0|||
126398872|NCT02788201|454753200|FG002|Overall Study|Withdrawal by Subject|0|||
126398873|NCT02788201|454753201|FG003|Overall Study|Withdrawal by Subject|0|||
126398874|NCT02788201|454753202|FG004|Overall Study|Withdrawal by Subject|0|||
126398875|NCT02788201|454753203|FG005|Overall Study|Withdrawal by Subject|1|||
126398876|NCT02446418|454753208|FG000|Overall Study|Adverse Event|4|||
126398877|NCT02446418|454753209|FG001|Overall Study|Adverse Event|8|||
126398878|NCT02446418|454753208|FG000|Overall Study|Physician Decision|5|||
126398879|NCT02446418|454753209|FG001|Overall Study|Physician Decision|1|||
126398880|NCT02446418|454753208|FG000|Overall Study|Withdrawal by Subject|3|||
126398881|NCT02446418|454753209|FG001|Overall Study|Withdrawal by Subject|3|||
126398882|NCT02446418|454753208|FG000|Overall Study|Lost to Follow-up|2|||
126398883|NCT02446418|454753209|FG001|Overall Study|Lost to Follow-up|2|||
126398884|NCT02446418|454753208|FG000|Overall Study|Protocol Violation|1|||
126398885|NCT02446418|454753209|FG001|Overall Study|Protocol Violation|2|||
126398886|NCT02446418|454753208|FG000|Overall Study|Lack of Efficacy|2|||
126398887|NCT02446418|454753209|FG001|Overall Study|Lack of Efficacy|0|||
126398888|NCT02446418|454753208|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
126398889|NCT02446418|454753209|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
126398890|NCT04508751|454753210|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
126398891|NCT04508751|454753211|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
126398892|NCT04508751|454753212|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
126398893|NCT02014480|454753215|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398894|NCT02014480|454753216|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398895|NCT02014480|454753217|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
126398896|NCT02014480|454753218|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398897|NCT02014480|454753219|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398898|NCT02014480|454753220|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398899|NCT02014480|454753215|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126398900|NCT02014480|454753216|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125889988|NCT01149148|452895407|FG001|Overall Study|Death|0|||
125889989|NCT00950859|452895410|FG000|Overall Study|Adverse Event|3|||
125889990|NCT00950859|452895411|FG001|Overall Study|Adverse Event|3|||
125889991|NCT00950859|452895410|FG000|Overall Study|Insufficient Viral Load Response|12|||
125889992|NCT00950859|452895411|FG001|Overall Study|Insufficient Viral Load Response|3|||
125889993|NCT00950859|452895410|FG000|Overall Study|Protocol Violation|1|||
125889994|NCT00950859|452895411|FG001|Overall Study|Protocol Violation|1|||
125889995|NCT00950859|452895410|FG000|Overall Study|Lost to Follow-up|0|||
125889996|NCT00950859|452895411|FG001|Overall Study|Lost to Follow-up|3|||
125889997|NCT04896086|452895412|FG000|Overall Study|Lost to Follow-up|0|||
125889998|NCT04896086|452895413|FG001|Overall Study|Lost to Follow-up|2|||
125889999|NCT04896086|452895414|FG002|Overall Study|Lost to Follow-up|1|||
125890000|NCT04896086|452895415|FG003|Overall Study|Lost to Follow-up|0|||
125890001|NCT04896086|452895416|FG004|Overall Study|Lost to Follow-up|0|||
125890002|NCT04896086|452895412|FG000|Overall Study|Physician Decision|0|||
125890003|NCT04896086|452895413|FG001|Overall Study|Physician Decision|1|||
125890004|NCT04896086|452895414|FG002|Overall Study|Physician Decision|0|||
125890005|NCT04896086|452895415|FG003|Overall Study|Physician Decision|0|||
125890006|NCT04896086|452895416|FG004|Overall Study|Physician Decision|0|||
125971392|NCT03593655|453182829|FG000|First Product Use Period|Withdrawal by Subject|1|||
126398901|NCT02014480|454753217|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126398902|NCT02014480|454753218|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
126398903|NCT02014480|454753219|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126398904|NCT02014480|454753220|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126398905|NCT02014480|454753215|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398906|NCT02014480|454753216|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398907|NCT02014480|454753217|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
126398908|NCT02014480|454753218|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398909|NCT02014480|454753219|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398910|NCT02014480|454753220|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398911|NCT02014480|454753215|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126398912|NCT02014480|454753216|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126398913|NCT02014480|454753217|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
126398914|NCT02014480|454753218|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126398915|NCT02014480|454753219|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126398916|NCT02014480|454753220|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126398917|NCT02014480|454753215|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398918|NCT02014480|454753216|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
126398919|NCT02014480|454753217|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398920|NCT02014480|454753218|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398921|NCT02014480|454753219|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398922|NCT02014480|454753220|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398923|NCT02014480|454753215|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
126398924|NCT02014480|454753216|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
126398925|NCT02014480|454753217|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
126398926|NCT02014480|454753218|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
126398927|NCT02014480|454753219|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
126398928|NCT02014480|454753220|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
126398929|NCT02014480|454753215|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398930|NCT02014480|454753216|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398931|NCT02014480|454753217|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398932|NCT02014480|454753218|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398933|NCT02014480|454753219|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398934|NCT02014480|454753220|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
126398935|NCT01865812|454753221|FG000|Primary Treatment Phase|Adverse Event|2|||
126398936|NCT01865812|454753222|FG001|Primary Treatment Phase|Adverse Event|0|||
126398937|NCT01865812|454753221|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
126398938|NCT01865812|454753222|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
126398939|NCT01865812|454753221|FG000|Long-term Safety Extension Phase|Pruritus|0|||
126398940|NCT01865812|454753222|FG001|Long-term Safety Extension Phase|Pruritus|3|||
126398941|NCT01865812|454753221|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
126398942|NCT01865812|454753222|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
126398943|NCT01865812|454753221|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
126398944|NCT01865812|454753222|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
126398945|NCT01338610|454753223|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
126398946|NCT01338610|454753224|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
126398947|NCT01338610|454753225|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
126398948|NCT01338610|454753223|FG000|Overall Study|Protocol Violation|1|||
126398949|NCT01338610|454753224|FG001|Overall Study|Protocol Violation|0|||
126398950|NCT01338610|454753225|FG002|Overall Study|Protocol Violation|1|||
126398951|NCT01338610|454753223|FG000|Overall Study|Adverse Event|3|||
126398952|NCT01338610|454753224|FG001|Overall Study|Adverse Event|0|||
126398953|NCT01338610|454753225|FG002|Overall Study|Adverse Event|0|||
126398954|NCT01414205|454753226|FG000|Overall Study|Death|5|||
126398955|NCT01414205|454753227|FG001|Overall Study|Death|1|||
126398956|NCT01414205|454753226|FG000|Overall Study|Lost to Follow-up|1|||
126398957|NCT01414205|454753227|FG001|Overall Study|Lost to Follow-up|4|||
126398958|NCT01414205|454753226|FG000|Overall Study|Physician Decision|0|||
126398959|NCT01414205|454753227|FG001|Overall Study|Physician Decision|1|||
126398960|NCT01414205|454753226|FG000|Overall Study|Randomized but not Treated|1|||
126398961|NCT01414205|454753227|FG001|Overall Study|Randomized but not Treated|1|||
126398962|NCT02046226|454753230|FG000|Overall Study|Lost to Follow-up|7|||
126398963|NCT01166373|454753233|FG000|Overall Study|Lost to Follow-up|3|||
126398964|NCT01166373|454753234|FG001|Overall Study|Lost to Follow-up|2|||
126398965|NCT01166373|454753235|FG002|Overall Study|Lost to Follow-up|2|||
126398966|NCT01166373|454753236|FG003|Overall Study|Lost to Follow-up|2|||
126398967|NCT01166373|454753233|FG000|Overall Study|Withdrawal by Subject|1|||
126398968|NCT01166373|454753234|FG001|Overall Study|Withdrawal by Subject|2|||
126398969|NCT01166373|454753235|FG002|Overall Study|Withdrawal by Subject|2|||
126398970|NCT01166373|454753236|FG003|Overall Study|Withdrawal by Subject|3|||
125890007|NCT04896086|452895412|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
126398971|NCT01166373|454753233|FG000|Overall Study|Physician Decision|1|||
126398972|NCT01166373|454753234|FG001|Overall Study|Physician Decision|0|||
126398973|NCT01166373|454753235|FG002|Overall Study|Physician Decision|0|||
126398974|NCT01166373|454753236|FG003|Overall Study|Physician Decision|0|||
126398975|NCT01819129|454753237|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
126398976|NCT01819129|454753238|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
126398977|NCT01819129|454753237|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
126398978|NCT01819129|454753238|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
126398979|NCT01819129|454753237|FG000|Overall Study|Other, Subject moved out of the country|0|||
126398980|NCT01819129|454753238|FG001|Overall Study|Other, Subject moved out of the country|1|||
126398981|NCT01819129|454753237|FG000|Overall Study|Withdrawal by Subject|15|||
126398982|NCT01819129|454753238|FG001|Overall Study|Withdrawal by Subject|15|||
126398983|NCT01819129|454753237|FG000|Overall Study|Lost to Follow-up|5|||
126398984|NCT01819129|454753238|FG001|Overall Study|Lost to Follow-up|2|||
126398985|NCT01819129|454753237|FG000|Overall Study|Lack of Efficacy|0|||
126398986|NCT01819129|454753238|FG001|Overall Study|Lack of Efficacy|1|||
126398987|NCT01819129|454753237|FG000|Overall Study|Adverse Event|1|||
126398988|NCT01819129|454753238|FG001|Overall Study|Adverse Event|4|||
126398989|NCT01819129|454753237|FG000|Overall Study|Death|1|||
126398990|NCT01819129|454753238|FG001|Overall Study|Death|1|||
126398991|NCT01819129|454753237|FG000|Overall Study|Withdrawal Criteria|20|||
126398992|NCT01819129|454753238|FG001|Overall Study|Withdrawal Criteria|15|||
126398993|NCT02836873|454753239|FG000|Overall Study|Protocol Violation|0|||
126398994|NCT02836873|454753240|FG001|Overall Study|Protocol Violation|1|||
126398995|NCT02836873|454753239|FG000|Overall Study|Adverse Event|1|||
126398996|NCT02836873|454753240|FG001|Overall Study|Adverse Event|4|||
126398997|NCT02836873|454753239|FG000|Overall Study|Withdrawal by Subject|2|||
126398998|NCT02836873|454753240|FG001|Overall Study|Withdrawal by Subject|2|||
126398999|NCT02836873|454753239|FG000|Overall Study|Lost to Follow-up|1|||
126399000|NCT02836873|454753240|FG001|Overall Study|Lost to Follow-up|3|||
126399001|NCT02836873|454753239|FG000|Overall Study|Physician Decision|0|||
126399002|NCT02836873|454753240|FG001|Overall Study|Physician Decision|1|||
126399003|NCT02836873|454753239|FG000|Overall Study|Other|1|||
126399004|NCT02836873|454753240|FG001|Overall Study|Other|0|||
126399005|NCT02914548|454753243|FG000|Overall Study|Adverse Event|15|||
126399006|NCT02914548|454753244|FG001|Overall Study|Adverse Event|7|||
126399007|NCT02914548|454753245|FG002|Overall Study|Adverse Event|15|||
126399008|NCT02914548|454753243|FG000|Overall Study|Physician Decision|2|||
126399009|NCT02914548|454753244|FG001|Overall Study|Physician Decision|2|||
126399010|NCT02914548|454753245|FG002|Overall Study|Physician Decision|0|||
126399011|NCT02914548|454753243|FG000|Overall Study|Protocol Violation|1|||
126399012|NCT02914548|454753244|FG001|Overall Study|Protocol Violation|0|||
126399013|NCT02914548|454753245|FG002|Overall Study|Protocol Violation|0|||
126399014|NCT02914548|454753243|FG000|Overall Study|Withdrawal by Subject|3|||
126399015|NCT02914548|454753244|FG001|Overall Study|Withdrawal by Subject|4|||
126399016|NCT02914548|454753245|FG002|Overall Study|Withdrawal by Subject|4|||
126399017|NCT02914548|454753243|FG000|Overall Study|>40% of body surface area|0|||
126399018|NCT02914548|454753244|FG001|Overall Study|>40% of body surface area|1|||
126399019|NCT02914548|454753245|FG002|Overall Study|>40% of body surface area|1|||
126399020|NCT02214225|454753246|FG000|Overall Study|Lost to Follow-up|46|||
126399021|NCT02214225|454753247|FG001|Overall Study|Lost to Follow-up|18|||
126399022|NCT02214225|454753248|FG002|Overall Study|Lost to Follow-up|18|||
126399023|NCT02214225|454753246|FG000|Overall Study|Withdrawal by Subject|2|||
126399024|NCT02214225|454753247|FG001|Overall Study|Withdrawal by Subject|0|||
126399025|NCT02214225|454753248|FG002|Overall Study|Withdrawal by Subject|2|||
126399026|NCT02214225|454753246|FG000|Overall Study|Death|5|||
126399027|NCT02214225|454753247|FG001|Overall Study|Death|0|||
126399028|NCT02214225|454753248|FG002|Overall Study|Death|1|||
126399029|NCT02214225|454753246|FG000|Overall Study|randomized in error, not vaccinated|2|||
126399030|NCT02214225|454753247|FG001|Overall Study|randomized in error, not vaccinated|1|||
126399031|NCT02214225|454753248|FG002|Overall Study|randomized in error, not vaccinated|1|||
126399032|NCT01253265|454753249|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
126399033|NCT01253265|454753250|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
126399034|NCT01253265|454753251|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
126399035|NCT01253265|454753252|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
126399036|NCT01253265|454753253|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
126399037|NCT01253265|454753249|FG000|Overall Study|Withdrawal by Subject|0|||
126399038|NCT01253265|454753250|FG001|Overall Study|Withdrawal by Subject|0|||
126399039|NCT01253265|454753251|FG002|Overall Study|Withdrawal by Subject|0|||
126399040|NCT01253265|454753252|FG003|Overall Study|Withdrawal by Subject|0|||
126399041|NCT01253265|454753253|FG004|Overall Study|Withdrawal by Subject|1|||
126399042|NCT00495521|454753254|FG000|Overall Study|Physician Decision|0|||
126399043|NCT00495521|454753255|FG001|Overall Study|Physician Decision|1|||
126399044|NCT02395055|454753260|FG000|Overall Study|Withdrawal by Subject|7|||
126399045|NCT02395055|454753261|FG001|Overall Study|Withdrawal by Subject|3|||
126399046|NCT00787930|454753262|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
126399047|NCT01896271|454753263|FG000|Overall Study|Physician Decision|10|||
126399048|NCT00823212|454755191|FG000|Overall Study|Death|8|||
126399049|NCT00823212|454755192|FG001|Overall Study|Death|10|||
126399050|NCT00823212|454755191|FG000|Overall Study|Withdrawal by Subject|6|||
126399051|NCT00823212|454755192|FG001|Overall Study|Withdrawal by Subject|1|||
126399052|NCT00823212|454755191|FG000|Overall Study|Incarcerated|0|||
126399053|NCT00823212|454755192|FG001|Overall Study|Incarcerated|1|||
126399054|NCT00823212|454755191|FG000|Overall Study|Missed 12-month visit|21|||
126399055|NCT00823212|454755192|FG001|Overall Study|Missed 12-month visit|21|||
126399056|NCT04126564|454755193|FG000|Overall Study|Withdrawal by Subject|0|||
126399057|NCT04126564|454755194|FG001|Overall Study|Withdrawal by Subject|2|||
126399058|NCT04126564|454755193|FG000|Overall Study|Lost to Follow-up|0|||
126399059|NCT04126564|454755194|FG001|Overall Study|Lost to Follow-up|1|||
126399060|NCT03500172|454755195|FG000|Period 1: Baseline Randomization|Death|0|||
126399061|NCT03500172|454755196|FG001|Period 1: Baseline Randomization|Death|0|||
126399062|NCT03500172|454755197|FG002|Period 1: Baseline Randomization|Death|0|||
126399063|NCT03500172|454755198|FG003|Period 1: Baseline Randomization|Death|0|||
126399064|NCT03500172|454755199|FG004|Period 1: Baseline Randomization|Death|0|||
126399065|NCT03500172|454755200|FG005|Period 1: Baseline Randomization|Death|0|||
126399066|NCT03500172|454755201|FG006|Period 1: Baseline Randomization|Death|0|||
126399067|NCT03500172|454755202|FG007|Period 1: Baseline Randomization|Death|0|||
126399068|NCT03500172|454755203|FG008|Period 1: Baseline Randomization|Death|0|||
126399069|NCT03500172|454755204|FG009|Period 1: Baseline Randomization|Death|2|||
126399070|NCT03500172|454755205|FG010|Period 1: Baseline Randomization|Death|0|||
126399071|NCT03500172|454755195|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
126399072|NCT03500172|454755196|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
126399073|NCT03500172|454755197|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
126399074|NCT03500172|454755198|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
126399075|NCT03500172|454755199|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
126399076|NCT03500172|454755200|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
126399077|NCT03500172|454755201|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
126399078|NCT03500172|454755202|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
126399079|NCT03500172|454755203|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
126399080|NCT03500172|454755204|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
126399081|NCT03500172|454755205|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
126399082|NCT03500172|454755195|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
126399083|NCT03500172|454755196|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
126399084|NCT03500172|454755197|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
126399085|NCT03500172|454755198|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
126399086|NCT03500172|454755199|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
126399087|NCT03500172|454755200|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
126399088|NCT03500172|454755201|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
126399089|NCT03500172|454755202|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
126399090|NCT03500172|454755203|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
126399091|NCT03500172|454755204|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
126399092|NCT03500172|454755205|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
126399093|NCT03500172|454755195|FG000|Period 2: Re-Randomization|Death|0|||
126399094|NCT03500172|454755196|FG001|Period 2: Re-Randomization|Death|0|||
126399095|NCT03500172|454755197|FG002|Period 2: Re-Randomization|Death|0|||
126399096|NCT03500172|454755198|FG003|Period 2: Re-Randomization|Death|4|||
126399097|NCT03500172|454755199|FG004|Period 2: Re-Randomization|Death|2|||
126399098|NCT03500172|454755200|FG005|Period 2: Re-Randomization|Death|0|||
126399099|NCT03500172|454755201|FG006|Period 2: Re-Randomization|Death|5|||
126399100|NCT03500172|454755202|FG007|Period 2: Re-Randomization|Death|2|||
126399101|NCT03500172|454755203|FG008|Period 2: Re-Randomization|Death|0|||
125890008|NCT04896086|452895413|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125890009|NCT04896086|452895414|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
126053248|NCT01886872|453489476|FG002|Overall Study|Ineligible|12|||
126399102|NCT03500172|454755204|FG009|Period 2: Re-Randomization|Death|0|||
126399103|NCT03500172|454755205|FG010|Period 2: Re-Randomization|Death|0|||
126399104|NCT02435680|454755211|FG000|Overall Study|Physician Decision|3|||
126399105|NCT02435680|454755212|FG001|Overall Study|Physician Decision|0|||
126399106|NCT02435680|454755213|FG002|Overall Study|Physician Decision|0|||
126399107|NCT02435680|454755211|FG000|Overall Study|subject / guardian decision|0|||
126399108|NCT02435680|454755212|FG001|Overall Study|subject / guardian decision|3|||
126399109|NCT02435680|454755213|FG002|Overall Study|subject / guardian decision|2|||
126399110|NCT02435680|454755211|FG000|Overall Study|Adverse Event|8|||
126399111|NCT02435680|454755212|FG001|Overall Study|Adverse Event|3|||
126399112|NCT02435680|454755213|FG002|Overall Study|Adverse Event|2|||
126399113|NCT02435680|454755211|FG000|Overall Study|progressive disease|10|||
126399114|NCT02435680|454755212|FG001|Overall Study|progressive disease|7|||
126399115|NCT02435680|454755213|FG002|Overall Study|progressive disease|11|||
126399116|NCT02435680|454755211|FG000|Overall Study|not treated|0|||
126399117|NCT02435680|454755212|FG001|Overall Study|not treated|0|||
126399118|NCT02435680|454755213|FG002|Overall Study|not treated|1|||
126399119|NCT00445848|454755214|FG000|Overall Study|Adverse Event|14|||
126399120|NCT00445848|454755214|FG000|Overall Study|Withdrawal by Subject|4|||
126399121|NCT00445848|454755214|FG000|Overall Study|Progression|62|||
126399122|NCT00445848|454755214|FG000|Overall Study|Other-Not protocol specified|5|||
126399123|NCT02585830|454755217|FG000|Overall Study|Withdrawal by Subject|3|||
126399124|NCT02509052|454755218|FG000|Overall Study|Non compliance|0|||
126399125|NCT02509052|454755219|FG001|Overall Study|Non compliance|0|||
126399126|NCT02509052|454755220|FG002|Overall Study|Non compliance|1|||
126399127|NCT01323270|454755223|FG000|Overall Study|Withdrawal by Subject|19|||
126399128|NCT01323270|454755224|FG001|Overall Study|Withdrawal by Subject|10|||
126399129|NCT01323270|454755223|FG000|Overall Study|Protocol Violation|9|||
126399130|NCT01323270|454755224|FG001|Overall Study|Protocol Violation|7|||
126399131|NCT01323270|454755223|FG000|Overall Study|Lost to Follow-up|4|||
126399132|NCT01323270|454755224|FG001|Overall Study|Lost to Follow-up|6|||
126399133|NCT01323270|454755223|FG000|Overall Study|Adverse Event|8|||
126399134|NCT01323270|454755224|FG001|Overall Study|Adverse Event|0|||
126399135|NCT01323270|454755223|FG000|Overall Study|Other|0|||
126399136|NCT01323270|454755224|FG001|Overall Study|Other|3|||
126399137|NCT01323270|454755223|FG000|Overall Study|Physician Decision|0|||
126399138|NCT01323270|454755224|FG001|Overall Study|Physician Decision|2|||
126399139|NCT01323270|454755223|FG000|Overall Study|Not eligible|1|||
126399140|NCT01323270|454755224|FG001|Overall Study|Not eligible|1|||
126399141|NCT01323270|454755223|FG000|Overall Study|Death|1|||
126399142|NCT01323270|454755224|FG001|Overall Study|Death|0|||
126399143|NCT01323270|454755223|FG000|Overall Study|Randomized, but not vaccinated|1|||
126399144|NCT01323270|454755224|FG001|Overall Study|Randomized, but not vaccinated|0|||
126399145|NCT03761394|454755228|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
126399146|NCT03761394|454755229|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
126399147|NCT03761394|454755230|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
126399148|NCT03761394|454755231|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
126399149|NCT03761394|454755228|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
126399150|NCT03761394|454755229|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
126399151|NCT03761394|454755230|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
126399152|NCT03761394|454755231|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
126399153|NCT03761394|454755228|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
126399154|NCT03761394|454755229|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
126399155|NCT03761394|454755230|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
126399156|NCT03761394|454755231|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
126399157|NCT03761394|454755228|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
126399158|NCT03761394|454755229|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
126399159|NCT03761394|454755230|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
126399160|NCT03761394|454755231|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
126399161|NCT03242772|454755240|FG000|Overall Study|Lost to Follow-up|2|||
126399162|NCT03242772|454755241|FG001|Overall Study|Lost to Follow-up|0|||
126399163|NCT03242772|454755240|FG000|Overall Study|Physician Decision|0|||
126399164|NCT03242772|454755241|FG001|Overall Study|Physician Decision|1|||
126399165|NCT03242772|454755240|FG000|Overall Study|Withdrawal by Subject|1|||
126399166|NCT03242772|454755241|FG001|Overall Study|Withdrawal by Subject|0|||
126399167|NCT01062841|454755245|FG000|Overall Study|Indwelling Device Removed|41|||
126399168|NCT01062841|454755246|FG001|Overall Study|Indwelling Device Removed|48|||
126399169|NCT01062841|454755245|FG000|Overall Study|Death|3|||
126399170|NCT01062841|454755246|FG001|Overall Study|Death|5|||
126399171|NCT01062841|454755245|FG000|Overall Study|Withdrawal by Subject|2|||
126399172|NCT01062841|454755246|FG001|Overall Study|Withdrawal by Subject|0|||
126399173|NCT01062841|454755245|FG000|Overall Study|Withdrawal by Study|3|||
126399174|NCT01062841|454755246|FG001|Overall Study|Withdrawal by Study|0|||
126399175|NCT01118520|454755247|FG000|Overall Study|AAA repair|9|||
126399176|NCT01118520|454755248|FG001|Overall Study|AAA repair|7|||
126399177|NCT01118520|454755249|FG002|Overall Study|AAA repair|9|||
126399178|NCT01118520|454755247|FG000|Overall Study|Adverse Event|3|||
125890010|NCT04896086|452895415|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
126399179|NCT01118520|454755248|FG001|Overall Study|Adverse Event|3|||
126399180|NCT01118520|454755249|FG002|Overall Study|Adverse Event|3|||
126399181|NCT01118520|454755247|FG000|Overall Study|Withdrawal by Subject|8|||
126399182|NCT01118520|454755248|FG001|Overall Study|Withdrawal by Subject|13|||
126399183|NCT01118520|454755249|FG002|Overall Study|Withdrawal by Subject|8|||
126399184|NCT01089023|454755252|FG000|Overall Study|Lost to Follow-up|3|||
126399185|NCT01089023|454755252|FG000|Overall Study|Adverse Event|1|||
126399186|NCT01089023|454755252|FG000|Overall Study|Withdrawal by Subject|1|||
126399187|NCT01089023|454755252|FG000|Overall Study|Protocol Violation|1|||
126399188|NCT01089023|454755252|FG000|Overall Study|Lack of Efficacy|1|||
126399189|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
126399190|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
126399191|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
126399192|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
126399193|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
126399194|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
126399195|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
126399196|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
126399197|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
126399198|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
126399199|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
126399200|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
126399201|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Adverse Event|1|||
126399202|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Adverse Event|0|||
126399203|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Adverse Event|2|||
126399204|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Adverse Event|0|||
126399205|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
126399206|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
126399207|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
126399208|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
125890011|NCT04896086|452895416|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125890012|NCT04896086|452895412|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
125890013|NCT04896086|452895413|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
125890014|NCT04896086|452895414|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
125890015|NCT04896086|452895415|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
125890016|NCT04896086|452895416|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
125890017|NCT03052400|452895421|FG000|Overall Study|Lost to Follow-up|1|||
125890018|NCT03052400|452895422|FG001|Overall Study|Lost to Follow-up|0|||
126399209|NCT01185964|454755256|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
125890019|NCT03052400|452895421|FG000|Overall Study|Withdrawal by Subject|0|||
126105298|NCT00940108|453678574|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
126399210|NCT01185964|454755257|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
126399211|NCT01185964|454755258|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
126399212|NCT01185964|454755259|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
126399213|NCT01185964|454755256|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
126399214|NCT01185964|454755257|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
126399215|NCT01185964|454755258|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
126399216|NCT01185964|454755259|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
126399217|NCT01185964|454755256|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
126399218|NCT01185964|454755257|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
126399219|NCT01185964|454755258|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
126399220|NCT01185964|454755259|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
126399221|NCT01920893|454755260|FG000|Overall Study|Adverse Event|5|||
126399222|NCT01920893|454755261|FG001|Overall Study|Adverse Event|2|||
126399223|NCT01920893|454755260|FG000|Overall Study|Lack of Efficacy|2|||
126399224|NCT01920893|454755261|FG001|Overall Study|Lack of Efficacy|0|||
126399225|NCT03440918|454755265|FG000|Overall Study|Protocol Violation|0|||
126399226|NCT03440918|454755266|FG001|Overall Study|Protocol Violation|16|||
126399227|NCT01396265|454755278|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
126399228|NCT02275117|454755281|FG000|Overall Study|Adverse Event|0|||
126399229|NCT02275117|454755282|FG001|Overall Study|Adverse Event|0|||
126399230|NCT02275117|454755283|FG002|Overall Study|Adverse Event|0|||
126399231|NCT02275117|454755284|FG003|Overall Study|Adverse Event|0|||
126399232|NCT02275117|454755285|FG004|Overall Study|Adverse Event|1|||
126399233|NCT02275117|454755281|FG000|Overall Study|Lack of Efficacy|6|||
126399234|NCT02275117|454755282|FG001|Overall Study|Lack of Efficacy|7|||
126399235|NCT02275117|454755283|FG002|Overall Study|Lack of Efficacy|5|||
126399236|NCT02275117|454755284|FG003|Overall Study|Lack of Efficacy|2|||
126399237|NCT02275117|454755285|FG004|Overall Study|Lack of Efficacy|10|||
126399238|NCT02275117|454755281|FG000|Overall Study|Lost to Follow-up|11|||
126399239|NCT02275117|454755282|FG001|Overall Study|Lost to Follow-up|16|||
126399240|NCT02275117|454755283|FG002|Overall Study|Lost to Follow-up|15|||
126399241|NCT02275117|454755284|FG003|Overall Study|Lost to Follow-up|16|||
126399242|NCT02275117|454755285|FG004|Overall Study|Lost to Follow-up|8|||
126399243|NCT02275117|454755281|FG000|Overall Study|Physician Decision|0|||
126399244|NCT02275117|454755282|FG001|Overall Study|Physician Decision|1|||
126399245|NCT02275117|454755283|FG002|Overall Study|Physician Decision|1|||
126399246|NCT02275117|454755284|FG003|Overall Study|Physician Decision|0|||
126399247|NCT02275117|454755285|FG004|Overall Study|Physician Decision|1|||
126399248|NCT02275117|454755281|FG000|Overall Study|Protocol Violation|1|||
126399249|NCT02275117|454755282|FG001|Overall Study|Protocol Violation|0|||
126399250|NCT02275117|454755283|FG002|Overall Study|Protocol Violation|1|||
126399251|NCT02275117|454755284|FG003|Overall Study|Protocol Violation|1|||
126399252|NCT02275117|454755285|FG004|Overall Study|Protocol Violation|0|||
126399253|NCT02275117|454755281|FG000|Overall Study|Withdrawal by Subject|6|||
126399254|NCT02275117|454755282|FG001|Overall Study|Withdrawal by Subject|4|||
126399255|NCT02275117|454755283|FG002|Overall Study|Withdrawal by Subject|7|||
126399256|NCT02275117|454755284|FG003|Overall Study|Withdrawal by Subject|3|||
126399257|NCT02275117|454755285|FG004|Overall Study|Withdrawal by Subject|3|||
126399258|NCT02275117|454755281|FG000|Overall Study|Terminated by Sponsor|4|||
126399259|NCT02275117|454755282|FG001|Overall Study|Terminated by Sponsor|4|||
126399260|NCT02275117|454755283|FG002|Overall Study|Terminated by Sponsor|4|||
126399261|NCT02275117|454755284|FG003|Overall Study|Terminated by Sponsor|6|||
126399262|NCT02275117|454755285|FG004|Overall Study|Terminated by Sponsor|4|||
126399263|NCT02275117|454755281|FG000|Overall Study|Worsening of Study Indication|0|||
126399264|NCT02275117|454755282|FG001|Overall Study|Worsening of Study Indication|1|||
126399265|NCT02275117|454755283|FG002|Overall Study|Worsening of Study Indication|2|||
126399266|NCT02275117|454755284|FG003|Overall Study|Worsening of Study Indication|0|||
126399267|NCT02275117|454755285|FG004|Overall Study|Worsening of Study Indication|0|||
126399268|NCT02275117|454755281|FG000|Overall Study|Study Burden|5|||
126399269|NCT02275117|454755282|FG001|Overall Study|Study Burden|4|||
126399270|NCT02275117|454755283|FG002|Overall Study|Study Burden|7|||
126399271|NCT02275117|454755284|FG003|Overall Study|Study Burden|5|||
126399272|NCT02275117|454755285|FG004|Overall Study|Study Burden|7|||
126399273|NCT02275117|454755281|FG000|Overall Study|Other|1|||
126399274|NCT02275117|454755282|FG001|Overall Study|Other|0|||
126399275|NCT02275117|454755283|FG002|Overall Study|Other|0|||
126399276|NCT02275117|454755284|FG003|Overall Study|Other|0|||
126399277|NCT02275117|454755285|FG004|Overall Study|Other|2|||
126399278|NCT03754582|454755291|FG000|Treatment Phase|Adverse Event|0|||
126399279|NCT03754582|454755292|FG001|Treatment Phase|Adverse Event|1|||
126399280|NCT03754582|454755293|FG002|Treatment Phase|Adverse Event|0|||
126399281|NCT03754582|454755291|FG000|Follow-up Phase|Other|0|||
126399282|NCT03754582|454755292|FG001|Follow-up Phase|Other|0|||
126399283|NCT03754582|454755293|FG002|Follow-up Phase|Other|1|||
126399284|NCT02680574|454755294|FG000|Overall Study|Death|137|||
126399285|NCT02680574|454755295|FG001|Overall Study|Death|137|||
126399286|NCT02680574|454755294|FG000|Overall Study|Withdrawal by Subject|17|||
126399287|NCT02680574|454755295|FG001|Overall Study|Withdrawal by Subject|9|||
126399288|NCT02680574|454755294|FG000|Overall Study|Lost to Follow-up|4|||
126399289|NCT02680574|454755295|FG001|Overall Study|Lost to Follow-up|6|||
126399290|NCT02847858|454755296|FG000|Overall Study|Lost to Follow-up|401|||
126399291|NCT02847858|454755297|FG001|Overall Study|Lost to Follow-up|269|||
126399292|NCT00066469|454755299|FG000|Overall Study|Death|3|||
126399293|NCT00066469|454755299|FG000|Overall Study|Lack of Efficacy|9|||
126399294|NCT00066469|454755299|FG000|Overall Study|Lost to Follow-up|1|||
126399295|NCT00066469|454755299|FG000|Overall Study|Physician Decision|1|||
126399296|NCT00066469|454755299|FG000|Overall Study|Withdrawal by Subject|1|||
126399297|NCT00066469|454755299|FG000|Overall Study|ineligible|1|||
126399298|NCT00711802|454755300|FG000|Overall Study|Not treated (no further detail)|2|||
126399299|NCT00711802|454755301|FG001|Overall Study|Not treated (no further detail)|1|||
126399300|NCT00711802|454755302|FG002|Overall Study|Not treated (no further detail)|2|||
126399301|NCT00711802|454755303|FG003|Overall Study|Not treated (no further detail)|0|||
126399302|NCT00711802|454755304|FG004|Overall Study|Not treated (no further detail)|2|||
126399303|NCT00711802|454755305|FG005|Overall Study|Not treated (no further detail)|0|||
126399304|NCT00711802|454755306|FG006|Overall Study|Not treated (no further detail)|0|||
126399305|NCT00711802|454755307|FG007|Overall Study|Not treated (no further detail)|0|||
126399306|NCT00711802|454755300|FG000|Overall Study|Adverse Event|0|||
126399307|NCT00711802|454755301|FG001|Overall Study|Adverse Event|0|||
126399308|NCT00711802|454755302|FG002|Overall Study|Adverse Event|0|||
126399309|NCT00711802|454755303|FG003|Overall Study|Adverse Event|0|||
126399310|NCT00711802|454755304|FG004|Overall Study|Adverse Event|1|||
126399311|NCT00711802|454755305|FG005|Overall Study|Adverse Event|1|||
126399312|NCT00711802|454755306|FG006|Overall Study|Adverse Event|0|||
126399313|NCT00711802|454755307|FG007|Overall Study|Adverse Event|0|||
126399314|NCT00711802|454755300|FG000|Overall Study|Microbiological failure|0|||
126399315|NCT00711802|454755301|FG001|Overall Study|Microbiological failure|1|||
126399316|NCT00711802|454755302|FG002|Overall Study|Microbiological failure|0|||
126399317|NCT00711802|454755303|FG003|Overall Study|Microbiological failure|0|||
126399318|NCT00711802|454755304|FG004|Overall Study|Microbiological failure|0|||
126399319|NCT00711802|454755305|FG005|Overall Study|Microbiological failure|1|||
126399320|NCT00711802|454755306|FG006|Overall Study|Microbiological failure|0|||
126399321|NCT00711802|454755307|FG007|Overall Study|Microbiological failure|0|||
126399322|NCT00711802|454755300|FG000|Overall Study|Protocol Violation|0|||
126399323|NCT00711802|454755301|FG001|Overall Study|Protocol Violation|0|||
126399324|NCT00711802|454755302|FG002|Overall Study|Protocol Violation|0|||
126399325|NCT00711802|454755303|FG003|Overall Study|Protocol Violation|1|||
126399326|NCT00711802|454755304|FG004|Overall Study|Protocol Violation|0|||
126399327|NCT00711802|454755305|FG005|Overall Study|Protocol Violation|0|||
126399328|NCT00711802|454755306|FG006|Overall Study|Protocol Violation|0|||
126399329|NCT00711802|454755307|FG007|Overall Study|Protocol Violation|0|||
126399330|NCT00711802|454755300|FG000|Overall Study|Physician Decision|0|||
126399331|NCT00711802|454755301|FG001|Overall Study|Physician Decision|2|||
126399332|NCT00711802|454755302|FG002|Overall Study|Physician Decision|0|||
126399333|NCT00711802|454755303|FG003|Overall Study|Physician Decision|0|||
126399334|NCT00711802|454755304|FG004|Overall Study|Physician Decision|0|||
126399335|NCT00711802|454755305|FG005|Overall Study|Physician Decision|0|||
126399336|NCT00711802|454755306|FG006|Overall Study|Physician Decision|0|||
126399337|NCT00711802|454755307|FG007|Overall Study|Physician Decision|0|||
126399338|NCT00711802|454755300|FG000|Overall Study|Withdrawal by Subject|0|||
126399339|NCT00711802|454755301|FG001|Overall Study|Withdrawal by Subject|1|||
126399340|NCT00711802|454755302|FG002|Overall Study|Withdrawal by Subject|0|||
126399341|NCT00711802|454755303|FG003|Overall Study|Withdrawal by Subject|1|||
126399342|NCT00711802|454755304|FG004|Overall Study|Withdrawal by Subject|0|||
126399343|NCT00711802|454755305|FG005|Overall Study|Withdrawal by Subject|0|||
126399344|NCT00711802|454755306|FG006|Overall Study|Withdrawal by Subject|0|||
126399345|NCT00711802|454755307|FG007|Overall Study|Withdrawal by Subject|0|||
126399346|NCT00711802|454755300|FG000|Overall Study|Lost to Follow-up|0|||
126399347|NCT00711802|454755301|FG001|Overall Study|Lost to Follow-up|0|||
126399348|NCT00711802|454755302|FG002|Overall Study|Lost to Follow-up|3|||
126399349|NCT00711802|454755303|FG003|Overall Study|Lost to Follow-up|1|||
126399350|NCT00711802|454755304|FG004|Overall Study|Lost to Follow-up|10|||
126399351|NCT00711802|454755305|FG005|Overall Study|Lost to Follow-up|6|||
126399352|NCT00711802|454755306|FG006|Overall Study|Lost to Follow-up|4|||
126399353|NCT00711802|454755307|FG007|Overall Study|Lost to Follow-up|2|||
126399354|NCT00711802|454755300|FG000|Overall Study|Reason not reported|0|||
126399355|NCT00711802|454755301|FG001|Overall Study|Reason not reported|1|||
126399356|NCT00711802|454755302|FG002|Overall Study|Reason not reported|1|||
126399357|NCT00711802|454755303|FG003|Overall Study|Reason not reported|0|||
126399358|NCT00711802|454755304|FG004|Overall Study|Reason not reported|1|||
126399359|NCT00711802|454755305|FG005|Overall Study|Reason not reported|0|||
126399360|NCT00711802|454755306|FG006|Overall Study|Reason not reported|1|||
126399361|NCT00711802|454755307|FG007|Overall Study|Reason not reported|0|||
126399362|NCT02305849|454755309|FG000|Overall Study|Adverse Event|10|||
126399363|NCT02305849|454755310|FG001|Overall Study|Adverse Event|12|||
126399364|NCT02305849|454755311|FG002|Overall Study|Adverse Event|7|||
126399365|NCT02305849|454755312|FG003|Overall Study|Adverse Event|3|||
126399366|NCT02305849|454755309|FG000|Overall Study|Lack of Efficacy|10|||
126399367|NCT02305849|454755310|FG001|Overall Study|Lack of Efficacy|6|||
126399368|NCT02305849|454755311|FG002|Overall Study|Lack of Efficacy|3|||
126399369|NCT02305849|454755312|FG003|Overall Study|Lack of Efficacy|9|||
126399370|NCT02305849|454755309|FG000|Overall Study|Withdrawal by Subject|2|||
126399371|NCT02305849|454755310|FG001|Overall Study|Withdrawal by Subject|2|||
126399372|NCT02305849|454755311|FG002|Overall Study|Withdrawal by Subject|1|||
126399373|NCT02305849|454755312|FG003|Overall Study|Withdrawal by Subject|4|||
126399374|NCT02305849|454755309|FG000|Overall Study|Lost to Follow-up|0|||
126399375|NCT02305849|454755310|FG001|Overall Study|Lost to Follow-up|2|||
126399376|NCT02305849|454755311|FG002|Overall Study|Lost to Follow-up|0|||
126399377|NCT02305849|454755312|FG003|Overall Study|Lost to Follow-up|0|||
126399378|NCT02305849|454755309|FG000|Overall Study|Protocol Violation|3|||
126399379|NCT02305849|454755310|FG001|Overall Study|Protocol Violation|2|||
125890020|NCT03052400|452895422|FG001|Overall Study|Withdrawal by Subject|1|||
125890021|NCT00555061|452895423|FG000|Overall Study|Adverse Event|3|||
126399380|NCT02305849|454755311|FG002|Overall Study|Protocol Violation|1|||
126399381|NCT02305849|454755312|FG003|Overall Study|Protocol Violation|1|||
126399382|NCT02305849|454755309|FG000|Overall Study|Lab data met discontinuation criteria|0|||
126399383|NCT02305849|454755310|FG001|Overall Study|Lab data met discontinuation criteria|1|||
126399384|NCT02305849|454755311|FG002|Overall Study|Lab data met discontinuation criteria|2|||
126399385|NCT02305849|454755312|FG003|Overall Study|Lab data met discontinuation criteria|1|||
126399386|NCT02305849|454755309|FG000|Overall Study|Miscellaneous|1|||
126399387|NCT02305849|454755310|FG001|Overall Study|Miscellaneous|2|||
126399388|NCT02305849|454755311|FG002|Overall Study|Miscellaneous|4|||
126399389|NCT02305849|454755312|FG003|Overall Study|Miscellaneous|1|||
126399390|NCT02305849|454755309|FG000|Overall Study|Not fulfill eligibility criteria|1|||
126399391|NCT02305849|454755310|FG001|Overall Study|Not fulfill eligibility criteria|1|||
126399392|NCT02305849|454755311|FG002|Overall Study|Not fulfill eligibility criteria|0|||
126399393|NCT02305849|454755312|FG003|Overall Study|Not fulfill eligibility criteria|0|||
126399394|NCT02410824|454755317|FG000|First Intervention (One Week)|Headache|0|||
126399395|NCT02410824|454755318|FG001|First Intervention (One Week)|Headache|1|||
126399396|NCT00392808|454755319|FG000|Overall Study|Lost to Follow-up|3|||
126399397|NCT00392808|454755320|FG001|Overall Study|Lost to Follow-up|2|||
126399398|NCT00392808|454755321|FG002|Overall Study|Lost to Follow-up|1|||
126399399|NCT00392808|454755322|FG003|Overall Study|Lost to Follow-up|2|||
126399400|NCT00392808|454755319|FG000|Overall Study|Unable to withdraw blood|3|||
126399401|NCT00392808|454755320|FG001|Overall Study|Unable to withdraw blood|1|||
126399402|NCT00392808|454755321|FG002|Overall Study|Unable to withdraw blood|1|||
126399403|NCT00392808|454755322|FG003|Overall Study|Unable to withdraw blood|2|||
126399404|NCT02782325|454755323|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
126399405|NCT02782325|454755324|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
126399406|NCT02782325|454755325|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
126399407|NCT02782325|454755323|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
126399408|NCT02782325|454755324|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
126399409|NCT02782325|454755325|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
126399410|NCT02818036|454755328|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
126399411|NCT02818036|454755329|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
126399412|NCT02818036|454755328|FG000|Overall Study|Withdrawal by Subject|1|||
126399413|NCT02818036|454755329|FG001|Overall Study|Withdrawal by Subject|0|||
126399414|NCT01038713|454755330|FG000|Overall Study|Patient to hospice|1|||
126399415|NCT01038713|454755331|FG001|Overall Study|Patient to hospice|1|||
126399416|NCT01038713|454755332|FG002|Overall Study|Patient to hospice|1|||
126399417|NCT01038713|454755330|FG000|Overall Study|Lost to Follow-up|3|||
126399418|NCT01038713|454755331|FG001|Overall Study|Lost to Follow-up|0|||
126399419|NCT01038713|454755332|FG002|Overall Study|Lost to Follow-up|0|||
126399420|NCT01038713|454755330|FG000|Overall Study|Neuroendocrine Tumor|0|||
126399421|NCT01038713|454755331|FG001|Overall Study|Neuroendocrine Tumor|1|||
126399422|NCT01038713|454755332|FG002|Overall Study|Neuroendocrine Tumor|0|||
126399423|NCT01038713|454755330|FG000|Overall Study|died from PEP|0|||
126399424|NCT01038713|454755331|FG001|Overall Study|died from PEP|1|||
126399425|NCT01038713|454755332|FG002|Overall Study|died from PEP|0|||
126399426|NCT01038713|454755330|FG000|Overall Study|Autoimmune Pancreatitis|1|||
126399427|NCT01038713|454755331|FG001|Overall Study|Autoimmune Pancreatitis|0|||
126399428|NCT01038713|454755332|FG002|Overall Study|Autoimmune Pancreatitis|0|||
126399429|NCT01154283|454755333|FG000|0-6 Weeks|Withdrawal by Subject|7|||
126399430|NCT01154283|454755334|FG001|0-6 Weeks|Withdrawal by Subject|2|||
126399431|NCT01154283|454755333|FG000|0-6 Weeks|Death|0|||
126399432|NCT01154283|454755334|FG001|0-6 Weeks|Death|1|||
126399433|NCT01154283|454755333|FG000|7-12 Weeks|Death|1|||
126399434|NCT01154283|454755334|FG001|7-12 Weeks|Death|0|||
126399435|NCT01154283|454755333|FG000|7-12 Weeks|Withdrawal by Subject|0|||
126399436|NCT01154283|454755334|FG001|7-12 Weeks|Withdrawal by Subject|1|||
126399437|NCT03777917|454755335|FG000|Overall Study|Withdrawal by Subject|1|||
126399438|NCT03777917|454755336|FG001|Overall Study|Withdrawal by Subject|0|||
126399439|NCT03777917|454755335|FG000|Overall Study|Physician Decision|1|||
126399440|NCT03777917|454755336|FG001|Overall Study|Physician Decision|0|||
126399441|NCT03777917|454755335|FG000|Overall Study|Lost to Follow-up|6|||
126399442|NCT03777917|454755336|FG001|Overall Study|Lost to Follow-up|2|||
126399443|NCT03777917|454755335|FG000|Overall Study|Other|1|||
126399444|NCT03777917|454755336|FG001|Overall Study|Other|0|||
126399445|NCT00042432|454755337|FG000|Overall Study|Adverse Event|4|||
126399446|NCT00042432|454755338|FG001|Overall Study|Adverse Event|1|||
126399447|NCT00042432|454755337|FG000|Overall Study|Withdrawal by Subject|1|||
126399448|NCT00042432|454755338|FG001|Overall Study|Withdrawal by Subject|3|||
126399449|NCT00042432|454755337|FG000|Overall Study|Death|0|||
126399450|NCT00042432|454755338|FG001|Overall Study|Death|2|||
126399451|NCT00042432|454755337|FG000|Overall Study|Ineligibility determined|1|||
126399452|NCT00042432|454755338|FG001|Overall Study|Ineligibility determined|0|||
126399453|NCT00042432|454755337|FG000|Overall Study|Initiation of maintenance dialysis|1|||
126399454|NCT00042432|454755338|FG001|Overall Study|Initiation of maintenance dialysis|1|||
126399455|NCT00042432|454755337|FG000|Overall Study|Other|2|||
126399456|NCT00042432|454755338|FG001|Overall Study|Other|0|||
126399457|NCT01853072|454755339|FG000|Overall Study|Adverse event prior to treatment|0|||
126399458|NCT01853072|454755340|FG001|Overall Study|Adverse event prior to treatment|1|||
126399459|NCT01853072|454755339|FG000|Overall Study|Adverse Event|0|||
126399460|NCT01853072|454755340|FG001|Overall Study|Adverse Event|3|||
126399461|NCT01853072|454755339|FG000|Overall Study|Death|1|||
126399462|NCT01853072|454755340|FG001|Overall Study|Death|4|||
126399463|NCT01853072|454755339|FG000|Overall Study|Lost to Follow-up|0|||
126399464|NCT01853072|454755340|FG001|Overall Study|Lost to Follow-up|3|||
126399465|NCT01853072|454755339|FG000|Overall Study|Non-compliance with study drug|0|||
126399466|NCT01853072|454755340|FG001|Overall Study|Non-compliance with study drug|1|||
126399467|NCT01853072|454755339|FG000|Overall Study|Physician Decision|1|||
126399468|NCT01853072|454755340|FG001|Overall Study|Physician Decision|1|||
126399469|NCT01853072|454755339|FG000|Overall Study|Withdrawal by Subject|1|||
126399470|NCT01853072|454755340|FG001|Overall Study|Withdrawal by Subject|2|||
126399471|NCT01853072|454755339|FG000|Overall Study|Reason not specified|9|||
126399472|NCT01853072|454755340|FG001|Overall Study|Reason not specified|6|||
126399473|NCT01816906|454755341|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
126399474|NCT01816906|454755342|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
126399475|NCT01816906|454755341|FG000|Six Months|Lost to Follow-up|14|||
126399476|NCT01816906|454755342|FG001|Six Months|Lost to Follow-up|16|||
126399477|NCT01816906|454755341|FG000|12 Months|Adverse Event|2|||
126399478|NCT01816906|454755342|FG001|12 Months|Adverse Event|2|||
126399479|NCT01816906|454755341|FG000|12 Months|Death|0|||
126399480|NCT01816906|454755342|FG001|12 Months|Death|2|||
126399481|NCT01816906|454755341|FG000|12 Months|Lost to Follow-up|2|||
126399482|NCT01816906|454755342|FG001|12 Months|Lost to Follow-up|1|||
126399483|NCT01527383|454755343|FG000|Overall Study|Adverse Event|5|||
126399484|NCT01527383|454755344|FG001|Overall Study|Adverse Event|0|||
126399485|NCT01527383|454755343|FG000|Overall Study|Lost to Follow-up|3|||
126399486|NCT01527383|454755344|FG001|Overall Study|Lost to Follow-up|0|||
126399487|NCT01527383|454755343|FG000|Overall Study|Physician Decision|2|||
126399488|NCT01527383|454755344|FG001|Overall Study|Physician Decision|0|||
126399489|NCT01527383|454755343|FG000|Overall Study|Pregnancy|1|||
126399490|NCT01527383|454755344|FG001|Overall Study|Pregnancy|0|||
126399491|NCT01527383|454755343|FG000|Overall Study|Protocol Violation|1|||
126399492|NCT01527383|454755344|FG001|Overall Study|Protocol Violation|0|||
126399493|NCT01527383|454755343|FG000|Overall Study|Screen failure|1|||
126399494|NCT01527383|454755344|FG001|Overall Study|Screen failure|0|||
126399495|NCT01527383|454755343|FG000|Overall Study|Participant moved|0|||
126399496|NCT01527383|454755344|FG001|Overall Study|Participant moved|1|||
126399497|NCT01527383|454755343|FG000|Overall Study|Withdrawal by Subject|2|||
126399498|NCT01527383|454755344|FG001|Overall Study|Withdrawal by Subject|3|||
126399499|NCT00746733|454755345|FG000|Second Intervention|Adverse Event|1|||
126399500|NCT00746733|454755346|FG001|Second Intervention|Adverse Event|0|||
126399501|NCT00746733|454755345|FG000|Third Intervention|Withdrawal by Subject|1|||
126399502|NCT00746733|454755346|FG001|Third Intervention|Withdrawal by Subject|1|||
126399503|NCT03412604|454755347|FG000|Overall Study|Withdrawal by Subject|1|||
126399504|NCT00930969|454755349|FG000|Overall Study|Death|5|||
126399505|NCT00930969|454755349|FG000|Overall Study|Lost to Follow-up|1|||
126399506|NCT00930969|454755349|FG000|Overall Study|Physician Decision|13|||
126399507|NCT00930969|454755349|FG000|Overall Study|Withdrawal by Subject|19|||
126399508|NCT01287221|454755350|FG000|Overall Study|Lack of Perceived Benefit|1|||
126399509|NCT01287221|454755351|FG001|Overall Study|Lack of Perceived Benefit|1|||
126399510|NCT01287221|454755350|FG000|Overall Study|Adverse Event|3|||
126399511|NCT01287221|454755351|FG001|Overall Study|Adverse Event|3|||
126399512|NCT01287221|454755350|FG000|Overall Study|Withdrawal by Subject|0|||
126399513|NCT01287221|454755351|FG001|Overall Study|Withdrawal by Subject|1|||
126399514|NCT00657150|454755352|FG000|Overall Study|Adverse Event|19|||
126399515|NCT00657150|454755353|FG001|Overall Study|Adverse Event|10|||
126399516|NCT00657150|454755352|FG000|Overall Study|Non-compliant with protocol|5|||
126399517|NCT00657150|454755353|FG001|Overall Study|Non-compliant with protocol|9|||
126399518|NCT00657150|454755352|FG000|Overall Study|Lost to Follow-up|2|||
126399519|NCT00657150|454755353|FG001|Overall Study|Lost to Follow-up|0|||
126399520|NCT00657150|454755352|FG000|Overall Study|Withdrawal by Subject|51|||
126399521|NCT00657150|454755353|FG001|Overall Study|Withdrawal by Subject|36|||
126399522|NCT00657150|454755352|FG000|Overall Study|Other|38|||
126399523|NCT00657150|454755353|FG001|Overall Study|Other|38|||
126399524|NCT00657150|454755352|FG000|Treatment|Adverse Event|60|||
126399525|NCT00657150|454755353|FG001|Treatment|Adverse Event|53|||
126399526|NCT00657150|454755352|FG000|Treatment|Non-compliant with protocol|10|||
126399527|NCT00657150|454755353|FG001|Treatment|Non-compliant with protocol|9|||
126399528|NCT00657150|454755352|FG000|Treatment|Lost to Follow-up|1|||
126399529|NCT00657150|454755353|FG001|Treatment|Lost to Follow-up|0|||
126399530|NCT00657150|454755352|FG000|Treatment|Withdrawal by Subject|23|||
126399531|NCT00657150|454755353|FG001|Treatment|Withdrawal by Subject|20|||
126399532|NCT00657150|454755352|FG000|Treatment|Other|13|||
126399533|NCT00657150|454755353|FG001|Treatment|Other|15|||
126399534|NCT02966795|454755354|FG000|Overall Study|Patient Left the Country|0|||
126399535|NCT02966795|454755355|FG001|Overall Study|Patient Left the Country|1|||
126399536|NCT00787137|454755371|FG000|Overall Study|Study Termination|0|||
126399537|NCT00787137|454755372|FG001|Overall Study|Study Termination|0|||
126399538|NCT00787137|454755373|FG002|Overall Study|Study Termination|1|||
126399539|NCT01367704|454755380|FG000|Overall Study|Lost to Follow-up|47|||
126399540|NCT01367704|454755381|FG001|Overall Study|Lost to Follow-up|161|||
126399541|NCT00526110|454755382|FG000|Overall Study|Adverse Event|2|||
126399542|NCT00526110|454755383|FG001|Overall Study|Adverse Event|9|||
126399543|NCT00526110|454755382|FG000|Overall Study|Disease Progression|0|||
126399544|NCT00526110|454755383|FG001|Overall Study|Disease Progression|19|||
126399545|NCT00526110|454755382|FG000|Overall Study|Maximal Response|0|||
126399546|NCT00526110|454755383|FG001|Overall Study|Maximal Response|6|||
126399547|NCT00526110|454755382|FG000|Overall Study|Withdrawal by Subject|0|||
126399548|NCT00526110|454755383|FG001|Overall Study|Withdrawal by Subject|2|||
126399549|NCT00526110|454755382|FG000|Overall Study|Poor Tolerance|0|||
126399550|NCT00526110|454755383|FG001|Overall Study|Poor Tolerance|5|||
126399551|NCT02193087|454755384|FG000|Overall Study|Adverse Event|2|||
126399552|NCT02193087|454755385|FG001|Overall Study|Adverse Event|0|||
126399553|NCT02193087|454755386|FG002|Overall Study|Adverse Event|0|||
126399554|NCT02193087|454755387|FG003|Overall Study|Adverse Event|11|||
126399555|NCT02193087|454755384|FG000|Overall Study|Lost to Follow-up|14|||
126399556|NCT02193087|454755385|FG001|Overall Study|Lost to Follow-up|6|||
126399557|NCT02193087|454755386|FG002|Overall Study|Lost to Follow-up|4|||
126399558|NCT02193087|454755387|FG003|Overall Study|Lost to Follow-up|37|||
126399559|NCT02193087|454755384|FG000|Overall Study|Protocol Violation|2|||
126399560|NCT02193087|454755385|FG001|Overall Study|Protocol Violation|0|||
126399561|NCT02193087|454755386|FG002|Overall Study|Protocol Violation|1|||
126399562|NCT02193087|454755387|FG003|Overall Study|Protocol Violation|2|||
126399563|NCT02193087|454755384|FG000|Overall Study|Withdrawal by Subject|10|||
126399564|NCT02193087|454755385|FG001|Overall Study|Withdrawal by Subject|3|||
126399565|NCT02193087|454755386|FG002|Overall Study|Withdrawal by Subject|1|||
126399566|NCT02193087|454755387|FG003|Overall Study|Withdrawal by Subject|19|||
126399567|NCT02193087|454755384|FG000|Overall Study|Other Reason Not Specified|7|||
126399568|NCT02193087|454755385|FG001|Overall Study|Other Reason Not Specified|2|||
126399569|NCT02193087|454755386|FG002|Overall Study|Other Reason Not Specified|1|||
126399570|NCT02193087|454755387|FG003|Overall Study|Other Reason Not Specified|9|||
126399571|NCT02193087|454755384|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
126399572|NCT02193087|454755385|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
126399573|NCT02193087|454755386|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
126399574|NCT02193087|454755387|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
126399575|NCT04096820|454755388|FG000|Overall Study|Did not return for intervention|2|||
126399576|NCT04096820|454755388|FG000|Overall Study|Death|1|||
126399577|NCT04030247|454757224|FG000|Overall Study|Withdrawal by Subject|4|||
126399578|NCT04030247|454757224|FG000|Overall Study|Lost to Follow-up|13|||
126399579|NCT00509093|454757225|FG000|Overall Study|Adverse Event|10|||
126399580|NCT00509093|454757225|FG000|Overall Study|Disease Progression|9|||
126399581|NCT00509093|454757225|FG000|Overall Study|Transformed into MDS|1|||
126399582|NCT00509093|454757225|FG000|Overall Study|Withdrawal by Subject|3|||
126399583|NCT00509093|454757225|FG000|Overall Study|Physician Decision|1|||
126399584|NCT05438602|454757227|FG000|Treatment (15 Days)|Adverse Event|2|||
126399585|NCT05438602|454757228|FG001|Treatment (15 Days)|Adverse Event|1|||
126399586|NCT05438602|454757229|FG002|Treatment (15 Days)|Adverse Event|3|||
126399587|NCT05438602|454757227|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
126399588|NCT05438602|454757228|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
126399589|NCT05438602|454757229|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
126399590|NCT05438602|454757227|FG000|Treatment (15 Days)|Other|0|||
126399591|NCT05438602|454757228|FG001|Treatment (15 Days)|Other|0|||
126399592|NCT05438602|454757229|FG002|Treatment (15 Days)|Other|1|||
126399593|NCT05438602|454757227|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
126399594|NCT05438602|454757228|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
126399595|NCT05438602|454757229|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
126399596|NCT05438602|454757227|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
126399597|NCT05438602|454757228|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
126399598|NCT05438602|454757229|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
126399599|NCT05438602|454757227|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
126399600|NCT05438602|454757228|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
126399601|NCT05438602|454757229|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
126399602|NCT05438602|454757227|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
126399603|NCT05438602|454757228|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
126399604|NCT05438602|454757229|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
126399605|NCT05438602|454757227|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
126399606|NCT05438602|454757228|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
126399607|NCT05438602|454757229|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
126399608|NCT05438602|454757227|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
126399609|NCT05438602|454757228|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
126399610|NCT05438602|454757229|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
126399611|NCT05438602|454757227|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
126399612|NCT05438602|454757228|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
126399613|NCT05438602|454757229|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
126399614|NCT04431713|454757232|FG000|Overall Study|Withdrawal by Subject|2|||
126399615|NCT04431713|454757233|FG001|Overall Study|Withdrawal by Subject|0|||
126399616|NCT04431713|454757232|FG000|Overall Study|Death|2|||
126399617|NCT04431713|454757233|FG001|Overall Study|Death|2|||
126399618|NCT03383783|454757236|FG000|Overall Study|Withdrawal by Subject|2|||
126399619|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
126399620|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
126399621|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
126399622|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
126399623|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
126399624|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
126399625|NCT01224821|454757240|FG000|Long-Term Follow-Up|Death|2|||
126399626|NCT01224821|454757240|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
126399627|NCT01340937|454757241|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
126399628|NCT01340937|454757242|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
126399629|NCT01340937|454757243|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
126399630|NCT01340937|454757244|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
126399631|NCT01340937|454757241|FG000|Period 1: Infant Series|Adverse Event|0|||
126399632|NCT01340937|454757242|FG001|Period 1: Infant Series|Adverse Event|1|||
126399633|NCT01340937|454757243|FG002|Period 1: Infant Series|Adverse Event|4|||
126399634|NCT01340937|454757244|FG003|Period 1: Infant Series|Adverse Event|0|||
126399635|NCT01340937|454757241|FG000|Period 1: Infant Series|Death|2|||
126399636|NCT01340937|454757242|FG001|Period 1: Infant Series|Death|0|||
126399637|NCT01340937|454757243|FG002|Period 1: Infant Series|Death|2|||
126399638|NCT01340937|454757244|FG003|Period 1: Infant Series|Death|0|||
126399639|NCT01340937|454757241|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
126399640|NCT01340937|454757242|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
126399641|NCT01340937|454757243|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
126399642|NCT01340937|454757244|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
126399643|NCT01340937|454757241|FG000|Period 1: Infant Series|Physician Decision|2|||
126399644|NCT01340937|454757242|FG001|Period 1: Infant Series|Physician Decision|3|||
126399645|NCT01340937|454757243|FG002|Period 1: Infant Series|Physician Decision|1|||
126399646|NCT01340937|454757244|FG003|Period 1: Infant Series|Physician Decision|0|||
126399647|NCT01340937|454757241|FG000|Period 1: Infant Series|Protocol Violation|1|||
126399648|NCT01340937|454757242|FG001|Period 1: Infant Series|Protocol Violation|4|||
126399649|NCT01340937|454757243|FG002|Period 1: Infant Series|Protocol Violation|4|||
126399650|NCT01340937|454757244|FG003|Period 1: Infant Series|Protocol Violation|3|||
126399651|NCT01340937|454757241|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
126399652|NCT01340937|454757242|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
126399653|NCT01340937|454757243|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
126399654|NCT01340937|454757244|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
126399655|NCT01340937|454757241|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
126399656|NCT01340937|454757242|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
126399657|NCT01340937|454757243|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
126399658|NCT01340937|454757244|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
126399659|NCT01340937|454757241|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
126399660|NCT01340937|454757242|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
126399661|NCT01340937|454757243|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
126399662|NCT01340937|454757244|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
126399663|NCT01340937|454757241|FG000|Period 2: Interim Period|Adverse Event|1|||
126399664|NCT01340937|454757242|FG001|Period 2: Interim Period|Adverse Event|0|||
126399665|NCT01340937|454757243|FG002|Period 2: Interim Period|Adverse Event|1|||
126399666|NCT01340937|454757244|FG003|Period 2: Interim Period|Adverse Event|0|||
126399667|NCT01340937|454757241|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
126399668|NCT01340937|454757242|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
126399669|NCT01340937|454757243|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
126399670|NCT01340937|454757244|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
126399671|NCT01340937|454757241|FG000|Period 2: Interim Period|Physician Decision|0|||
126399672|NCT01340937|454757242|FG001|Period 2: Interim Period|Physician Decision|1|||
126399673|NCT01340937|454757243|FG002|Period 2: Interim Period|Physician Decision|1|||
126399674|NCT01340937|454757244|FG003|Period 2: Interim Period|Physician Decision|0|||
126399675|NCT01340937|454757241|FG000|Period 2: Interim Period|Protocol Violation|5|||
126399676|NCT01340937|454757242|FG001|Period 2: Interim Period|Protocol Violation|3|||
126399677|NCT01340937|454757243|FG002|Period 2: Interim Period|Protocol Violation|6|||
126399678|NCT01340937|454757244|FG003|Period 2: Interim Period|Protocol Violation|3|||
126399679|NCT01340937|454757241|FG000|Period 2: Interim Period|Technical problems|4|||
126399680|NCT01340937|454757242|FG001|Period 2: Interim Period|Technical problems|4|||
126399681|NCT01340937|454757243|FG002|Period 2: Interim Period|Technical problems|6|||
126399682|NCT01340937|454757244|FG003|Period 2: Interim Period|Technical problems|3|||
126399683|NCT01340937|454757241|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
126399684|NCT01340937|454757242|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
126399685|NCT01340937|454757243|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
126399686|NCT01340937|454757244|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
126053255|NCT04941482|453489479|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
126053256|NCT04941482|453489480|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
126399687|NCT01340937|454757241|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
126399688|NCT01340937|454757242|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
126399689|NCT01340937|454757243|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
126399690|NCT01340937|454757244|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
126399691|NCT01340937|454757241|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
126399692|NCT01340937|454757242|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
126399693|NCT01340937|454757243|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
126399694|NCT01340937|454757244|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
126399695|NCT01340937|454757241|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
126399696|NCT01340937|454757242|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
125890022|NCT00555061|452895423|FG000|Overall Study|Protocol Violation|1|||
126399697|NCT01340937|454757243|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
126399698|NCT01340937|454757244|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
126399699|NCT02469415|454757248|FG000|Overall Study|Withdrawal by Subject|1|||
126399700|NCT02469415|454757248|FG000|Overall Study|Investigational agent placed on hold|2|||
125890023|NCT00555061|452895423|FG000|Overall Study|Lost to Follow-up|2|||
126399701|NCT00350623|454757251|FG000|Overall Study|Lost to Follow-up|8|||
126399702|NCT00350623|454757252|FG001|Overall Study|Lost to Follow-up|3|||
126399703|NCT00350623|454757253|FG002|Overall Study|Lost to Follow-up|4|||
126399704|NCT00350623|454757251|FG000|Overall Study|Withdrawal by Subject|0|||
126399705|NCT00350623|454757252|FG001|Overall Study|Withdrawal by Subject|1|||
126399706|NCT00350623|454757253|FG002|Overall Study|Withdrawal by Subject|1|||
126399707|NCT00350623|454757251|FG000|Overall Study|patient traveling outside the country|0|||
126399708|NCT00350623|454757252|FG001|Overall Study|patient traveling outside the country|0|||
126399709|NCT00350623|454757253|FG002|Overall Study|patient traveling outside the country|1|||
126399710|NCT00623545|454757254|FG000|Overall Study|Adverse Event|6|||
126399711|NCT00623545|454757254|FG000|Overall Study|Withdrawal by Subject|4|||
126399712|NCT01974752|454757259|FG000|Overall Study|Death|33|||
126399713|NCT01974752|454757260|FG001|Overall Study|Death|11|||
126399714|NCT01974752|454757259|FG000|Overall Study|Lost to Follow-up|2|||
126399715|NCT01974752|454757260|FG001|Overall Study|Lost to Follow-up|0|||
126399716|NCT01974752|454757259|FG000|Overall Study|Withdrawal by Subject|2|||
126399717|NCT01974752|454757260|FG001|Overall Study|Withdrawal by Subject|3|||
126399718|NCT01974752|454757259|FG000|Overall Study|Other Eligibility Criteria|0|||
126399719|NCT01974752|454757260|FG001|Overall Study|Other Eligibility Criteria|1|||
126399720|NCT00330928|454757266|FG000|Overall Study|Lost to Follow-up|6|||
126399721|NCT00330928|454757266|FG000|Overall Study|Physician Decision|9|||
126399722|NCT00330928|454757266|FG000|Overall Study|Death|1|||
126399723|NCT00330928|454757266|FG000|Overall Study|IVUS could not be performed.|1|||
126399724|NCT03028480|454757267|FG000|Overall Study|No revisit after the first prescription date|2|||
126399725|NCT03028480|454757267|FG000|Overall Study|Did not use the drug|1|||
126399726|NCT03028480|454757267|FG000|Overall Study|Violation of the enrollment deadline|10|||
126399727|NCT03028480|454757267|FG000|Overall Study|Case report forms were not collected|21|||
126399728|NCT02279719|454757272|FG000|Overall Study|Patients randomized but never treated|0|||
126399729|NCT02279719|454757273|FG001|Overall Study|Patients randomized but never treated|0|||
126399730|NCT02279719|454757274|FG002|Overall Study|Patients randomized but never treated|0|||
126399731|NCT02279719|454757275|FG003|Overall Study|Patients randomized but never treated|0|||
126399732|NCT02279719|454757276|FG004|Overall Study|Patients randomized but never treated|3|||
126399733|NCT02279719|454757277|FG005|Overall Study|Patients randomized but never treated|0|||
126399734|NCT02279719|454757278|FG006|Overall Study|Patients randomized but never treated|3|||
126399735|NCT03541187|454757279|FG000|Overall Study|Lost to Follow-up|2|||
126399736|NCT03541187|454757280|FG001|Overall Study|Lost to Follow-up|6|||
126399737|NCT03541187|454757279|FG000|Overall Study|Pregnancy|0|||
126399738|NCT03541187|454757280|FG001|Overall Study|Pregnancy|1|||
126399739|NCT03541187|454757279|FG000|Overall Study|Withdrawal by Subject|6|||
126399740|NCT03541187|454757280|FG001|Overall Study|Withdrawal by Subject|2|||
126399741|NCT03541187|454757279|FG000|Overall Study|Moved out of town|1|||
126399742|NCT03541187|454757280|FG001|Overall Study|Moved out of town|0|||
126399743|NCT03541187|454757279|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
126399744|NCT03541187|454757280|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
126399745|NCT03541187|454757279|FG000|Overall Study|Did not meet randomization criteria|1|||
126399746|NCT03541187|454757280|FG001|Overall Study|Did not meet randomization criteria|1|||
126399747|NCT03541187|454757279|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
126399748|NCT03541187|454757280|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
126399749|NCT03541187|454757279|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
126399750|NCT03541187|454757280|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
126399751|NCT00869050|454757283|FG000|Overall Study|Screen Failure|3|||
126399752|NCT01369680|454757287|FG000|Overall Study|Lost to Follow-up|0|||
126399753|NCT01369680|454757288|FG001|Overall Study|Lost to Follow-up|0|||
126399754|NCT01369680|454757289|FG002|Overall Study|Lost to Follow-up|1|||
126399755|NCT01369680|454757290|FG003|Overall Study|Lost to Follow-up|2|||
126399756|NCT00585221|454757293|FG000|Overall Study|Protocol Violation|8|||
126399757|NCT01145053|454757294|FG000|Overall Study|Adverse Event|22|||
126399758|NCT01145053|454757294|FG000|Overall Study|Lost to Follow-up|28|||
126399759|NCT01145053|454757294|FG000|Overall Study|Withdrawal by Subject|25|||
126399760|NCT01145053|454757294|FG000|Overall Study|Other|18|||
126399761|NCT03060512|454757295|FG000|Overall Study|Adverse Event|4|||
126399762|NCT03060512|454757296|FG001|Overall Study|Adverse Event|6|||
126399763|NCT03060512|454757295|FG000|Overall Study|Lost to Follow-up|1|||
126399764|NCT03060512|454757296|FG001|Overall Study|Lost to Follow-up|1|||
126399765|NCT03060512|454757295|FG000|Overall Study|Withdrawal by Subject|1|||
126105299|NCT00940108|453678575|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
126399766|NCT03060512|454757296|FG001|Overall Study|Withdrawal by Subject|0|||
126399767|NCT03060512|454757295|FG000|Overall Study|Non-compliance with study medication|1|||
126399768|NCT03060512|454757296|FG001|Overall Study|Non-compliance with study medication|2|||
126399769|NCT03220581|454757299|FG000|Overall Study|Withdrawal by Subject|0|||
126399770|NCT03220581|454757300|FG001|Overall Study|Withdrawal by Subject|1|||
126399771|NCT03220581|454757299|FG000|Overall Study|Lost to Follow-up|3|||
126399772|NCT03220581|454757300|FG001|Overall Study|Lost to Follow-up|6|||
126399773|NCT03421743|454757302|FG000|Overall Study|Lack of Efficacy|1|||
126399774|NCT03421743|454757303|FG001|Overall Study|Lack of Efficacy|0|||
126399775|NCT03421743|454757302|FG000|Overall Study|Adverse Event|2|||
126399776|NCT03421743|454757303|FG001|Overall Study|Adverse Event|1|||
126399777|NCT03421743|454757302|FG000|Overall Study|Withdrawal by Subject|0|||
126399778|NCT03421743|454757303|FG001|Overall Study|Withdrawal by Subject|1|||
126399779|NCT00681564|454757307|FG000|Overall Study|Lost to Follow-up|6|||
126399780|NCT00681564|454757308|FG001|Overall Study|Lost to Follow-up|6|||
126399781|NCT00681564|454757307|FG000|Overall Study|Withdrawal by Subject|0|||
126399782|NCT00681564|454757308|FG001|Overall Study|Withdrawal by Subject|1|||
126399783|NCT00681564|454757307|FG000|Overall Study|Death|0|||
126399784|NCT00681564|454757308|FG001|Overall Study|Death|1|||
126399785|NCT01009346|454757311|FG000|Overall Study|Adverse Event|4|||
126399786|NCT00541099|454757315|FG000|Overall Study|Ineligible|3|||
126399787|NCT00432744|454757316|FG000|Months 0-6|Withdrawal by Subject|4|||
126399788|NCT00432744|454757317|FG001|Months 0-6|Withdrawal by Subject|4|||
126399789|NCT00432744|454757316|FG000|Months 0-6|Too disabled to score|1|||
126399790|NCT00432744|454757317|FG001|Months 0-6|Too disabled to score|0|||
126399791|NCT00432744|454757316|FG000|Months 7 - 12|Withdrawal by Subject|1|||
126399792|NCT00432744|454757317|FG001|Months 7 - 12|Withdrawal by Subject|0|||
126399793|NCT00432744|454757316|FG000|Months 7 - 12|Too disabled to score|0|||
126399794|NCT00432744|454757317|FG001|Months 7 - 12|Too disabled to score|1|||
126399795|NCT00468845|454757322|FG000|Overall Study|Adverse Event|9|||
126399796|NCT00468845|454757323|FG001|Overall Study|Adverse Event|14|||
126399797|NCT00468845|454757324|FG002|Overall Study|Adverse Event|11|||
126399798|NCT00468845|454757322|FG000|Overall Study|Lost to Follow-up|2|||
126399799|NCT00468845|454757323|FG001|Overall Study|Lost to Follow-up|1|||
126399800|NCT00468845|454757324|FG002|Overall Study|Lost to Follow-up|2|||
126399801|NCT00468845|454757322|FG000|Overall Study|Other|4|||
126399802|NCT00468845|454757323|FG001|Overall Study|Other|9|||
126399803|NCT00468845|454757324|FG002|Overall Study|Other|5|||
126399804|NCT00468845|454757322|FG000|Overall Study|No longer willing to participate|5|||
126399805|NCT00468845|454757323|FG001|Overall Study|No longer willing to participate|6|||
126399806|NCT00468845|454757324|FG002|Overall Study|No longer willing to participate|10|||
126399807|NCT00468845|454757322|FG000|Overall Study|Randomized, not treated|1|||
126399808|NCT00468845|454757323|FG001|Overall Study|Randomized, not treated|4|||
126399809|NCT00468845|454757324|FG002|Overall Study|Randomized, not treated|2|||
126399810|NCT02759315|454757325|FG000|Overall Study|Adverse Event|0|||
126399811|NCT02759315|454757326|FG001|Overall Study|Adverse Event|0|||
126399812|NCT02759315|454757327|FG002|Overall Study|Adverse Event|0|||
126399813|NCT02759315|454757328|FG003|Overall Study|Adverse Event|1|||
126399814|NCT02759315|454757329|FG004|Overall Study|Adverse Event|0|||
126399815|NCT02759315|454757325|FG000|Overall Study|Death|0|||
126399816|NCT02759315|454757326|FG001|Overall Study|Death|0|||
126399817|NCT02759315|454757327|FG002|Overall Study|Death|1|||
126399818|NCT02759315|454757328|FG003|Overall Study|Death|0|||
126399819|NCT02759315|454757329|FG004|Overall Study|Death|0|||
126399820|NCT02759315|454757325|FG000|Overall Study|Lost to Follow-up|2|||
126399821|NCT02759315|454757326|FG001|Overall Study|Lost to Follow-up|0|||
126399822|NCT02759315|454757327|FG002|Overall Study|Lost to Follow-up|4|||
126399823|NCT02759315|454757328|FG003|Overall Study|Lost to Follow-up|0|||
126399824|NCT02759315|454757329|FG004|Overall Study|Lost to Follow-up|0|||
126399825|NCT02759315|454757325|FG000|Overall Study|Protocol Violation|0|||
126399826|NCT02759315|454757326|FG001|Overall Study|Protocol Violation|1|||
126399827|NCT02759315|454757327|FG002|Overall Study|Protocol Violation|0|||
126399828|NCT02759315|454757328|FG003|Overall Study|Protocol Violation|0|||
126399829|NCT02759315|454757329|FG004|Overall Study|Protocol Violation|0|||
126399830|NCT02759315|454757325|FG000|Overall Study|Study terminated prior to completion|2|||
126399831|NCT02759315|454757326|FG001|Overall Study|Study terminated prior to completion|0|||
126399832|NCT02759315|454757327|FG002|Overall Study|Study terminated prior to completion|5|||
126399833|NCT02759315|454757328|FG003|Overall Study|Study terminated prior to completion|0|||
126399834|NCT02759315|454757329|FG004|Overall Study|Study terminated prior to completion|1|||
126399835|NCT02761694|454757330|FG000|Overall Study|Lack of Efficacy|0|||
126399836|NCT02761694|454757331|FG001|Overall Study|Lack of Efficacy|0|||
126399837|NCT02761694|454757332|FG002|Overall Study|Lack of Efficacy|0|||
126399838|NCT02761694|454757333|FG003|Overall Study|Lack of Efficacy|0|||
126399839|NCT02761694|454757334|FG004|Overall Study|Lack of Efficacy|0|||
126399840|NCT02761694|454757335|FG005|Overall Study|Lack of Efficacy|0|||
126399841|NCT02761694|454757336|FG006|Overall Study|Lack of Efficacy|6|||
126399842|NCT02761694|454757337|FG007|Overall Study|Lack of Efficacy|0|||
126399843|NCT02761694|454757338|FG008|Overall Study|Lack of Efficacy|0|||
126399844|NCT02761694|454757339|FG009|Overall Study|Lack of Efficacy|1|||
126399845|NCT02761694|454757340|FG010|Overall Study|Lack of Efficacy|1|||
126399846|NCT02761694|454757341|FG011|Overall Study|Lack of Efficacy|4|||
126399847|NCT02761694|454757330|FG000|Overall Study|Death|0|||
126399848|NCT02761694|454757331|FG001|Overall Study|Death|0|||
126399849|NCT02761694|454757332|FG002|Overall Study|Death|0|||
126399850|NCT02761694|454757333|FG003|Overall Study|Death|0|||
126399851|NCT02761694|454757334|FG004|Overall Study|Death|0|||
126399852|NCT02761694|454757335|FG005|Overall Study|Death|0|||
126399853|NCT02761694|454757336|FG006|Overall Study|Death|2|||
126399854|NCT02761694|454757337|FG007|Overall Study|Death|0|||
126399855|NCT02761694|454757338|FG008|Overall Study|Death|2|||
126399856|NCT02761694|454757339|FG009|Overall Study|Death|2|||
126399857|NCT02761694|454757340|FG010|Overall Study|Death|1|||
126399858|NCT02761694|454757341|FG011|Overall Study|Death|0|||
126399859|NCT02761694|454757330|FG000|Overall Study|Physician Decision|0|||
126399860|NCT02761694|454757331|FG001|Overall Study|Physician Decision|0|||
126399861|NCT02761694|454757332|FG002|Overall Study|Physician Decision|0|||
126399862|NCT02761694|454757333|FG003|Overall Study|Physician Decision|0|||
126399863|NCT02761694|454757334|FG004|Overall Study|Physician Decision|0|||
126399864|NCT02761694|454757335|FG005|Overall Study|Physician Decision|0|||
126399865|NCT02761694|454757336|FG006|Overall Study|Physician Decision|1|||
126399866|NCT02761694|454757337|FG007|Overall Study|Physician Decision|0|||
126399867|NCT02761694|454757338|FG008|Overall Study|Physician Decision|0|||
126399868|NCT02761694|454757339|FG009|Overall Study|Physician Decision|0|||
126399869|NCT02761694|454757340|FG010|Overall Study|Physician Decision|0|||
126399870|NCT02761694|454757341|FG011|Overall Study|Physician Decision|0|||
126399871|NCT02761694|454757330|FG000|Overall Study|Withdrawal by Subject|0|||
126399872|NCT02761694|454757331|FG001|Overall Study|Withdrawal by Subject|0|||
126399873|NCT02761694|454757332|FG002|Overall Study|Withdrawal by Subject|0|||
126399874|NCT02761694|454757333|FG003|Overall Study|Withdrawal by Subject|1|||
126399875|NCT02761694|454757334|FG004|Overall Study|Withdrawal by Subject|0|||
126399876|NCT02761694|454757335|FG005|Overall Study|Withdrawal by Subject|0|||
126399877|NCT02761694|454757336|FG006|Overall Study|Withdrawal by Subject|4|||
126399878|NCT02761694|454757337|FG007|Overall Study|Withdrawal by Subject|0|||
126399879|NCT02761694|454757338|FG008|Overall Study|Withdrawal by Subject|2|||
126399880|NCT02761694|454757339|FG009|Overall Study|Withdrawal by Subject|1|||
126399881|NCT02761694|454757340|FG010|Overall Study|Withdrawal by Subject|0|||
126399882|NCT02761694|454757341|FG011|Overall Study|Withdrawal by Subject|0|||
126399883|NCT02761694|454757330|FG000|Overall Study|Lost to Follow-up|0|||
126399884|NCT02761694|454757331|FG001|Overall Study|Lost to Follow-up|0|||
126399885|NCT02761694|454757332|FG002|Overall Study|Lost to Follow-up|0|||
126399886|NCT02761694|454757333|FG003|Overall Study|Lost to Follow-up|0|||
126399887|NCT02761694|454757334|FG004|Overall Study|Lost to Follow-up|0|||
126399888|NCT02761694|454757335|FG005|Overall Study|Lost to Follow-up|0|||
126399889|NCT02761694|454757336|FG006|Overall Study|Lost to Follow-up|1|||
126399890|NCT02761694|454757337|FG007|Overall Study|Lost to Follow-up|0|||
126399891|NCT02761694|454757338|FG008|Overall Study|Lost to Follow-up|0|||
126399892|NCT02761694|454757339|FG009|Overall Study|Lost to Follow-up|0|||
126399893|NCT02761694|454757340|FG010|Overall Study|Lost to Follow-up|0|||
126399894|NCT02761694|454757341|FG011|Overall Study|Lost to Follow-up|1|||
126399895|NCT02761694|454757330|FG000|Overall Study|Adverse Event|0|||
126399896|NCT02761694|454757331|FG001|Overall Study|Adverse Event|0|||
126399897|NCT02761694|454757332|FG002|Overall Study|Adverse Event|0|||
126399898|NCT02761694|454757333|FG003|Overall Study|Adverse Event|0|||
126399899|NCT02761694|454757334|FG004|Overall Study|Adverse Event|0|||
126399900|NCT02761694|454757335|FG005|Overall Study|Adverse Event|0|||
126399901|NCT02761694|454757336|FG006|Overall Study|Adverse Event|1|||
126399902|NCT02761694|454757337|FG007|Overall Study|Adverse Event|0|||
126088965|NCT01399697|453620039|FG000|Overall Study|Investigator Decisión|1|||
126399903|NCT02761694|454757338|FG008|Overall Study|Adverse Event|1|||
126399904|NCT02761694|454757339|FG009|Overall Study|Adverse Event|0|||
126399905|NCT02761694|454757340|FG010|Overall Study|Adverse Event|0|||
126399906|NCT02761694|454757341|FG011|Overall Study|Adverse Event|1|||
126399907|NCT02761694|454757330|FG000|Overall Study|Other|4|||
126399908|NCT02761694|454757331|FG001|Overall Study|Other|4|||
126088966|NCT01399697|453620040|FG001|Overall Study|Investigator Decisión|0|||
126399909|NCT02761694|454757332|FG002|Overall Study|Other|1|||
126399910|NCT02761694|454757333|FG003|Overall Study|Other|2|||
126399911|NCT02761694|454757334|FG004|Overall Study|Other|3|||
126399912|NCT02761694|454757335|FG005|Overall Study|Other|3|||
126399913|NCT02761694|454757336|FG006|Overall Study|Other|18|||
126399914|NCT02761694|454757337|FG007|Overall Study|Other|8|||
126399915|NCT02761694|454757338|FG008|Overall Study|Other|0|||
126399916|NCT02761694|454757339|FG009|Overall Study|Other|1|||
126399917|NCT02761694|454757340|FG010|Overall Study|Other|1|||
126399918|NCT02761694|454757341|FG011|Overall Study|Other|0|||
126399919|NCT03464422|454757348|FG000|Overall Study|Lost to Follow-up|2|||
126399920|NCT03464422|454757348|FG000|Overall Study|Withdrawal by Subject|2|||
126399921|NCT01628367|454757353|FG000|Overall Study|Adverse Event|1|||
126399922|NCT01628367|454757354|FG001|Overall Study|Adverse Event|0|||
126399923|NCT02513823|454757355|FG000|Overall Study|Lost to Follow-up|4|||
126399924|NCT02513823|454757355|FG000|Overall Study|Physician Decision|1|||
126399925|NCT03353922|454757356|FG000|Overall Study|Withdrawal by Subject|1|||
126399926|NCT03353922|454757357|FG001|Overall Study|Withdrawal by Subject|0|||
126399927|NCT03353922|454757358|FG002|Overall Study|Withdrawal by Subject|1|||
126399928|NCT03353922|454757359|FG003|Overall Study|Withdrawal by Subject|1|||
126399929|NCT03353922|454757360|FG004|Overall Study|Withdrawal by Subject|0|||
126399930|NCT03353922|454757361|FG005|Overall Study|Withdrawal by Subject|0|||
126399931|NCT03353922|454757356|FG000|Overall Study|Adverse Event|0|||
126399932|NCT03353922|454757357|FG001|Overall Study|Adverse Event|1|||
126399933|NCT03353922|454757358|FG002|Overall Study|Adverse Event|0|||
126399934|NCT03353922|454757359|FG003|Overall Study|Adverse Event|0|||
126399935|NCT03353922|454757360|FG004|Overall Study|Adverse Event|0|||
126399936|NCT03353922|454757361|FG005|Overall Study|Adverse Event|0|||
126399937|NCT00740714|454757362|FG000|Overall Study|Withdrawal by Subject|17|||
126399938|NCT00740714|454757363|FG001|Overall Study|Withdrawal by Subject|19|||
126399939|NCT00740714|454757364|FG002|Overall Study|Withdrawal by Subject|29|||
126399940|NCT03688555|454757365|FG000|Treatment Period|Adverse Event|0|||
126399941|NCT03688555|454757366|FG001|Treatment Period|Adverse Event|0|||
126399942|NCT03688555|454757367|FG002|Treatment Period|Adverse Event|1|||
126399943|NCT00886119|454757368|FG000|Period 1|Did not meet inclusion criteria|1|||
126399944|NCT00886119|454757369|FG001|Period 1|Did not meet inclusion criteria|0|||
126399945|NCT02743780|454757370|FG000|Part 3 (7 Days)|Adverse Event|0|||
126399946|NCT02743780|454757371|FG001|Part 3 (7 Days)|Adverse Event|0|||
126399947|NCT02743780|454757372|FG002|Part 3 (7 Days)|Adverse Event|1|||
126399948|NCT02743780|454757373|FG003|Part 3 (7 Days)|Adverse Event|0|||
126399949|NCT02743780|454757374|FG004|Part 3 (7 Days)|Adverse Event|0|||
126399950|NCT01294462|454757375|FG000|Overall Study|Lost to Follow-up|1|||
126399951|NCT01294462|454757376|FG001|Overall Study|Lost to Follow-up|0|||
126399952|NCT01294462|454757375|FG000|Overall Study|Withdrawal by Subject|65|||
126399953|NCT01294462|454757376|FG001|Overall Study|Withdrawal by Subject|63|||
126399954|NCT01140568|454757383|FG000|Overall Study|disease progression|31|||
126399955|NCT01140568|454757383|FG000|Overall Study|Withdrawal by Subject|1|||
126399956|NCT01140568|454757383|FG000|Overall Study|Screen Fail|4|||
126399957|NCT01400243|454757384|FG000|Overall Study|Protocol Violation|8|||
126399958|NCT01400243|454757385|FG001|Overall Study|Protocol Violation|11|||
126399959|NCT02279498|454757388|FG000|Overall Study|Adverse Event|3|||
126399960|NCT02279498|454757389|FG001|Overall Study|Adverse Event|0|||
126399961|NCT02279498|454757388|FG000|Overall Study|Lack of Efficacy|4|||
126399962|NCT02279498|454757389|FG001|Overall Study|Lack of Efficacy|0|||
126399963|NCT02279498|454757388|FG000|Overall Study|Lost to Follow-up|0|||
126399964|NCT02279498|454757389|FG001|Overall Study|Lost to Follow-up|1|||
126399965|NCT02279498|454757388|FG000|Overall Study|Withdrawal by Subject|9|||
126399966|NCT02279498|454757389|FG001|Overall Study|Withdrawal by Subject|2|||
126399967|NCT02279498|454757388|FG000|Overall Study|Undefined|2|||
126399968|NCT02279498|454757389|FG001|Overall Study|Undefined|1|||
126399969|NCT01048866|454757390|FG000|Overall Study|Adverse Event|1|||
126399970|NCT01048866|454757391|FG001|Overall Study|Adverse Event|0|||
126399971|NCT01048866|454757390|FG000|Overall Study|Protocol Violation|1|||
126399972|NCT01048866|454757391|FG001|Overall Study|Protocol Violation|0|||
126399973|NCT01048866|454757390|FG000|Overall Study|Physician Decision|1|||
126399974|NCT01048866|454757391|FG001|Overall Study|Physician Decision|0|||
126399975|NCT01048866|454757390|FG000|Overall Study|Withdrawal by Subject|0|||
126399976|NCT01048866|454757391|FG001|Overall Study|Withdrawal by Subject|2|||
126399977|NCT01048866|454757390|FG000|Overall Study|Lost to Follow-up|0|||
126399978|NCT01048866|454757391|FG001|Overall Study|Lost to Follow-up|2|||
126399979|NCT01048866|454757390|FG000|Overall Study|Other|1|||
126399980|NCT01048866|454757391|FG001|Overall Study|Other|1|||
126399981|NCT05320393|454759461|FG000|Overall Study|Withdrawal by Subject|1|||
126399982|NCT05320393|454759462|FG001|Overall Study|Withdrawal by Subject|0|||
126399983|NCT05320393|454759463|FG002|Overall Study|Withdrawal by Subject|2|||
126399984|NCT05320393|454759461|FG000|Overall Study|Lost to Follow-up|1|||
126399985|NCT05320393|454759462|FG001|Overall Study|Lost to Follow-up|2|||
126399986|NCT05320393|454759463|FG002|Overall Study|Lost to Follow-up|1|||
126399987|NCT05320393|454759461|FG000|Overall Study|Moved; too much driving|0|||
126399988|NCT05320393|454759462|FG001|Overall Study|Moved; too much driving|0|||
126399989|NCT05320393|454759463|FG002|Overall Study|Moved; too much driving|2|||
126399990|NCT05320393|454759461|FG000|Overall Study|Did not receive treatment|0|||
126399991|NCT05320393|454759462|FG001|Overall Study|Did not receive treatment|0|||
126399992|NCT05320393|454759463|FG002|Overall Study|Did not receive treatment|1|||
126399993|NCT03187834|454759466|FG000|Overall Study|Lost to Follow-up|0|||
126399994|NCT03187834|454759467|FG001|Overall Study|Lost to Follow-up|1|||
126399995|NCT03187834|454759468|FG002|Overall Study|Lost to Follow-up|2|||
126399996|NCT03187834|454759469|FG003|Overall Study|Lost to Follow-up|2|||
126399997|NCT03187834|454759466|FG000|Overall Study|Had invalid anthropometric measurements|5|||
126399998|NCT03187834|454759467|FG001|Overall Study|Had invalid anthropometric measurements|3|||
126399999|NCT03187834|454759468|FG002|Overall Study|Had invalid anthropometric measurements|4|||
126400000|NCT03187834|454759469|FG003|Overall Study|Had invalid anthropometric measurements|2|||
126400001|NCT03559699|454759470|FG000|Overall Study|Withdrawal by Subject|6|||
126400002|NCT03559699|454759470|FG000|Overall Study|Lost to Follow-up|1|||
126400003|NCT01930890|454759477|FG000|Overall Study|Study Termination|14|||
126400004|NCT01930890|454759478|FG001|Overall Study|Study Termination|28|||
126400005|NCT01930890|454759479|FG002|Overall Study|Study Termination|13|||
126400006|NCT01930890|454759480|FG003|Overall Study|Study Termination|25|||
126400007|NCT01930890|454759477|FG000|Overall Study|Death|0|||
126400008|NCT01930890|454759478|FG001|Overall Study|Death|0|||
126400009|NCT01930890|454759479|FG002|Overall Study|Death|0|||
126400010|NCT01930890|454759480|FG003|Overall Study|Death|1|||
126400011|NCT01930890|454759477|FG000|Overall Study|Investigator Decision|0|||
126400012|NCT01930890|454759478|FG001|Overall Study|Investigator Decision|1|||
126400013|NCT01930890|454759479|FG002|Overall Study|Investigator Decision|0|||
126400014|NCT01930890|454759480|FG003|Overall Study|Investigator Decision|0|||
126400015|NCT01930890|454759477|FG000|Overall Study|Consent Withdrawn|0|||
126400016|NCT01930890|454759478|FG001|Overall Study|Consent Withdrawn|3|||
126400017|NCT01930890|454759479|FG002|Overall Study|Consent Withdrawn|0|||
126400018|NCT01930890|454759480|FG003|Overall Study|Consent Withdrawn|1|||
126400019|NCT01930890|454759477|FG000|Overall Study|Adverse Event|0|||
126400020|NCT01930890|454759478|FG001|Overall Study|Adverse Event|1|||
126400021|NCT01930890|454759479|FG002|Overall Study|Adverse Event|0|||
126400022|NCT01930890|454759480|FG003|Overall Study|Adverse Event|0|||
126400023|NCT02091284|454759481|FG000|Overall Study|Withdrawal by Subject|2|||
126400024|NCT02091284|454759482|FG001|Overall Study|Withdrawal by Subject|1|||
126400025|NCT02091284|454759481|FG000|Overall Study|unreliable data|1|||
126400026|NCT02091284|454759482|FG001|Overall Study|unreliable data|0|||
126400027|NCT01278407|454759483|FG000|Confirmatory Phase|Adverse Event|5|||
126400028|NCT01278407|454759484|FG001|Confirmatory Phase|Adverse Event|10|||
126400029|NCT01278407|454759485|FG002|Confirmatory Phase|Adverse Event|1|||
126400030|NCT01278407|454759486|FG003|Confirmatory Phase|Adverse Event|0|||
126400031|NCT01278407|454759487|FG004|Confirmatory Phase|Adverse Event|0|||
126400032|NCT01278407|454759483|FG000|Confirmatory Phase|Participant's Choice|3|||
126400033|NCT01278407|454759484|FG001|Confirmatory Phase|Participant's Choice|5|||
126400034|NCT01278407|454759485|FG002|Confirmatory Phase|Participant's Choice|3|||
126400035|NCT01278407|454759486|FG003|Confirmatory Phase|Participant's Choice|0|||
126400036|NCT01278407|454759487|FG004|Confirmatory Phase|Participant's Choice|0|||
126400037|NCT01278407|454759483|FG000|Confirmatory Phase|Other|1|||
126400038|NCT01278407|454759484|FG001|Confirmatory Phase|Other|1|||
126400039|NCT01278407|454759485|FG002|Confirmatory Phase|Other|2|||
126400040|NCT01278407|454759486|FG003|Confirmatory Phase|Other|0|||
126400041|NCT01278407|454759487|FG004|Confirmatory Phase|Other|0|||
126400042|NCT01278407|454759483|FG000|Extension Phase|Adverse Event|0|||
126400043|NCT01278407|454759484|FG001|Extension Phase|Adverse Event|0|||
126400044|NCT01278407|454759485|FG002|Extension Phase|Adverse Event|0|||
126400045|NCT01278407|454759486|FG003|Extension Phase|Adverse Event|7|||
126400046|NCT01278407|454759487|FG004|Extension Phase|Adverse Event|16|||
126400047|NCT01278407|454759483|FG000|Extension Phase|Participant's Choice|0|||
126400048|NCT01278407|454759484|FG001|Extension Phase|Participant's Choice|0|||
126400049|NCT01278407|454759485|FG002|Extension Phase|Participant's Choice|0|||
126400050|NCT01278407|454759486|FG003|Extension Phase|Participant's Choice|4|||
126400051|NCT01278407|454759487|FG004|Extension Phase|Participant's Choice|11|||
126400052|NCT01278407|454759483|FG000|Extension Phase|Other|0|||
126400053|NCT01278407|454759484|FG001|Extension Phase|Other|0|||
126400054|NCT01278407|454759485|FG002|Extension Phase|Other|0|||
126400055|NCT01278407|454759486|FG003|Extension Phase|Other|1|||
126400056|NCT01278407|454759487|FG004|Extension Phase|Other|3|||
126400057|NCT02534935|454759488|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
126400058|NCT02534935|454759489|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
126400059|NCT02534935|454759490|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
126400060|NCT02534935|454759488|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
126400061|NCT02534935|454759489|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
126400062|NCT02534935|454759490|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
126400063|NCT02534935|454759488|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
126400064|NCT02534935|454759489|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
126400065|NCT02534935|454759490|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
126400066|NCT02534935|454759488|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
126400067|NCT02534935|454759489|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
126400068|NCT02534935|454759490|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
126400069|NCT02534935|454759488|FG000|Stage 1: 24 Months|Adverse Event|0|||
126400070|NCT02534935|454759489|FG001|Stage 1: 24 Months|Adverse Event|2|||
126400071|NCT02534935|454759490|FG002|Stage 1: 24 Months|Adverse Event|0|||
126400072|NCT02534935|454759488|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
126400073|NCT02534935|454759489|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
126400074|NCT02534935|454759490|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
126400075|NCT02534935|454759488|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
126400076|NCT02534935|454759489|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
126400077|NCT02534935|454759490|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
126400078|NCT01460719|454759491|FG000|Overall Study|Adverse Event|1|||
126400079|NCT01460719|454759491|FG000|Overall Study|Withdrawal by Subject|1|||
126400080|NCT02838901|454759492|FG000|Overall Study|Withdrawal by Subject|1|||
126400081|NCT02838901|454759493|FG001|Overall Study|Withdrawal by Subject|1|||
126400082|NCT02838901|454759492|FG000|Overall Study|Lost to Follow-up|1|||
126400083|NCT02838901|454759493|FG001|Overall Study|Lost to Follow-up|1|||
126400084|NCT00076336|454759494|FG000|Overall Study|Death|13|||
126400085|NCT00076336|454759495|FG001|Overall Study|Death|17|||
126400086|NCT00076336|454759494|FG000|Overall Study|Adverse Event|4|||
126400087|NCT00076336|454759495|FG001|Overall Study|Adverse Event|4|||
126400088|NCT00076336|454759494|FG000|Overall Study|Lost to Follow-up|4|||
126400089|NCT00076336|454759495|FG001|Overall Study|Lost to Follow-up|4|||
126400090|NCT00076336|454759494|FG000|Overall Study|Non-Compliance|2|||
126400091|NCT00076336|454759495|FG001|Overall Study|Non-Compliance|0|||
126400092|NCT00076336|454759494|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
126400093|NCT00076336|454759495|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
126400094|NCT00076336|454759494|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
126400095|NCT00076336|454759495|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
126400096|NCT00076336|454759494|FG000|Overall Study|Liver Transplantation|3|||
126400097|NCT00076336|454759495|FG001|Overall Study|Liver Transplantation|3|||
126400098|NCT00076336|454759494|FG000|Overall Study|Virologic Breakthrough|14|||
126400099|NCT00076336|454759495|FG001|Overall Study|Virologic Breakthrough|16|||
126400100|NCT00076336|454759494|FG000|Overall Study|Treatment failure|4|||
126400101|NCT00076336|454759495|FG001|Overall Study|Treatment failure|5|||
126400102|NCT02285114|454759496|FG000|Main Phase|Investigator's Discretion|0|||
126400103|NCT02285114|454759497|FG001|Main Phase|Investigator's Discretion|2|||
126400104|NCT02285114|454759498|FG002|Main Phase|Investigator's Discretion|0|||
126400105|NCT02285114|454759499|FG003|Main Phase|Investigator's Discretion|0|||
126400106|NCT02285114|454759500|FG004|Main Phase|Investigator's Discretion|0|||
126400107|NCT02285114|454759501|FG005|Main Phase|Investigator's Discretion|0|||
126400108|NCT02285114|454759496|FG000|Main Phase|Enrolled but Never Treated|1|||
126400109|NCT02285114|454759497|FG001|Main Phase|Enrolled but Never Treated|0|||
126400110|NCT02285114|454759498|FG002|Main Phase|Enrolled but Never Treated|0|||
126400111|NCT02285114|454759499|FG003|Main Phase|Enrolled but Never Treated|0|||
126400112|NCT02285114|454759500|FG004|Main Phase|Enrolled but Never Treated|0|||
126400113|NCT02285114|454759501|FG005|Main Phase|Enrolled but Never Treated|0|||
126400114|NCT02285114|454759496|FG000|Main Phase|Withdrew Consent|0|||
126400115|NCT02285114|454759497|FG001|Main Phase|Withdrew Consent|0|||
126400116|NCT02285114|454759498|FG002|Main Phase|Withdrew Consent|1|||
126400117|NCT02285114|454759499|FG003|Main Phase|Withdrew Consent|0|||
126400118|NCT02285114|454759500|FG004|Main Phase|Withdrew Consent|0|||
126400119|NCT02285114|454759501|FG005|Main Phase|Withdrew Consent|0|||
126400120|NCT02285114|454759496|FG000|Extension Phase|Investigator's Discretion|0|||
126400121|NCT02285114|454759497|FG001|Extension Phase|Investigator's Discretion|0|||
126400122|NCT02285114|454759498|FG002|Extension Phase|Investigator's Discretion|0|||
126400123|NCT02285114|454759499|FG003|Extension Phase|Investigator's Discretion|14|||
126400124|NCT02285114|454759500|FG004|Extension Phase|Investigator's Discretion|1|||
126400125|NCT02285114|454759501|FG005|Extension Phase|Investigator's Discretion|0|||
126400126|NCT02285114|454759496|FG000|Extension Phase|Lost to Follow-up|0|||
126400127|NCT02285114|454759497|FG001|Extension Phase|Lost to Follow-up|0|||
126400128|NCT02285114|454759498|FG002|Extension Phase|Lost to Follow-up|0|||
126400129|NCT02285114|454759499|FG003|Extension Phase|Lost to Follow-up|1|||
126400130|NCT02285114|454759500|FG004|Extension Phase|Lost to Follow-up|1|||
126400131|NCT02285114|454759501|FG005|Extension Phase|Lost to Follow-up|0|||
126400132|NCT02285114|454759496|FG000|Extension Phase|Non-compliance with Study Drug|0|||
126400133|NCT02285114|454759497|FG001|Extension Phase|Non-compliance with Study Drug|0|||
126400134|NCT02285114|454759498|FG002|Extension Phase|Non-compliance with Study Drug|0|||
126400135|NCT02285114|454759499|FG003|Extension Phase|Non-compliance with Study Drug|2|||
126400136|NCT02285114|454759500|FG004|Extension Phase|Non-compliance with Study Drug|0|||
126400137|NCT02285114|454759501|FG005|Extension Phase|Non-compliance with Study Drug|0|||
126400138|NCT02285114|454759496|FG000|Extension Phase|Pregnancy|0|||
126400139|NCT02285114|454759497|FG001|Extension Phase|Pregnancy|0|||
126400140|NCT02285114|454759498|FG002|Extension Phase|Pregnancy|0|||
126400141|NCT02285114|454759499|FG003|Extension Phase|Pregnancy|1|||
126400142|NCT02285114|454759500|FG004|Extension Phase|Pregnancy|0|||
126400143|NCT02285114|454759501|FG005|Extension Phase|Pregnancy|0|||
126400144|NCT01156389|454759507|FG000|Overall Study|Elevated liver enzymes|4|||
126400145|NCT01156389|454759508|FG001|Overall Study|Elevated liver enzymes|0|||
126400146|NCT01156389|454759507|FG000|Overall Study|Vomiting|0|||
126400147|NCT01156389|454759508|FG001|Overall Study|Vomiting|1|||
126400148|NCT04599166|454759509|FG000|Overall Study|Technological failure connecting to study app|80|||
126400149|NCT01777542|454759510|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
126400150|NCT01777542|454759511|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
126400151|NCT00953524|454759513|FG000|Overall Study|Adverse Event|2|||
126400152|NCT00953524|454759514|FG001|Overall Study|Adverse Event|0|||
126400153|NCT00953524|454759515|FG002|Overall Study|Adverse Event|1|||
126400154|NCT00953524|454759516|FG003|Overall Study|Adverse Event|2|||
126400155|NCT00953524|454759513|FG000|Overall Study|Protocol Violation|18|||
126400156|NCT00953524|454759514|FG001|Overall Study|Protocol Violation|10|||
126400157|NCT00953524|454759515|FG002|Overall Study|Protocol Violation|11|||
126400158|NCT00953524|454759516|FG003|Overall Study|Protocol Violation|6|||
126400159|NCT00953524|454759513|FG000|Overall Study|Lost to Follow-up|0|||
126400160|NCT00953524|454759514|FG001|Overall Study|Lost to Follow-up|1|||
126400161|NCT00953524|454759515|FG002|Overall Study|Lost to Follow-up|1|||
126400162|NCT00953524|454759516|FG003|Overall Study|Lost to Follow-up|0|||
126400163|NCT00953524|454759513|FG000|Overall Study|Withdrawal by Subject|2|||
126400164|NCT00953524|454759514|FG001|Overall Study|Withdrawal by Subject|4|||
126400165|NCT00953524|454759515|FG002|Overall Study|Withdrawal by Subject|1|||
126400166|NCT00953524|454759516|FG003|Overall Study|Withdrawal by Subject|0|||
126400167|NCT03276052|454759518|FG000|Overall Study|Withdrawal by Subject|5|||
126400168|NCT03276052|454759518|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
126400169|NCT01994863|454759519|FG000|Period 1|Adverse Event|4|||
126400170|NCT01994863|454759520|FG001|Period 1|Adverse Event|0|||
126400171|NCT01994863|454759519|FG000|Period 1|Withdrawal by Subject|1|||
126400172|NCT01994863|454759520|FG001|Period 1|Withdrawal by Subject|0|||
126400173|NCT01994863|454759519|FG000|Period 1|Trial stopped by sponsor|1|||
126400174|NCT01994863|454759520|FG001|Period 1|Trial stopped by sponsor|3|||
126400175|NCT01994863|454759519|FG000|Period 1|Lack of Efficacy|1|||
126400176|NCT01994863|454759520|FG001|Period 1|Lack of Efficacy|0|||
126400177|NCT01994863|454759519|FG000|Period 2|Adverse Event|0|||
126400178|NCT01994863|454759520|FG001|Period 2|Adverse Event|1|||
126400179|NCT01994863|454759519|FG000|Period 2|Lack of Efficacy|0|||
126400180|NCT01994863|454759520|FG001|Period 2|Lack of Efficacy|2|||
126400181|NCT01994863|454759519|FG000|Period 2|Withdrawal by Subject|1|||
126400182|NCT01994863|454759520|FG001|Period 2|Withdrawal by Subject|1|||
126400183|NCT03946124|454759521|FG000|Overall Study|Withdrawal by Subject|19|||
126400184|NCT00919867|454759523|FG000|First Intervention|Withdrawal by Subject|0|||
126400185|NCT00919867|454759524|FG001|First Intervention|Withdrawal by Subject|0|||
126400186|NCT00919867|454759525|FG002|First Intervention|Withdrawal by Subject|1|||
126400187|NCT00919867|454759526|FG003|First Intervention|Withdrawal by Subject|0|||
126400188|NCT00919867|454759527|FG004|First Intervention|Withdrawal by Subject|0|||
126400189|NCT00919867|454759528|FG005|First Intervention|Withdrawal by Subject|0|||
126400190|NCT00919867|454759523|FG000|First Intervention|Physician Decision|0|||
126400191|NCT00919867|454759524|FG001|First Intervention|Physician Decision|0|||
126400192|NCT00919867|454759525|FG002|First Intervention|Physician Decision|0|||
126400193|NCT00919867|454759526|FG003|First Intervention|Physician Decision|0|||
126400194|NCT00919867|454759527|FG004|First Intervention|Physician Decision|0|||
126400195|NCT00919867|454759528|FG005|First Intervention|Physician Decision|1|||
126400196|NCT01765426|454759531|FG000|Overall Study|Lost to Follow-up|0|||
126400197|NCT01765426|454759532|FG001|Overall Study|Lost to Follow-up|1|||
126400198|NCT01765426|454759533|FG002|Overall Study|Lost to Follow-up|0|||
126400199|NCT01765426|454759534|FG003|Overall Study|Lost to Follow-up|0|||
126400200|NCT01510184|454759535|FG000|Overall Study|Sponsor discretion|28|||
126400201|NCT01510184|454759536|FG001|Overall Study|Sponsor discretion|28|||
126400202|NCT01510184|454759535|FG000|Overall Study|Death|1|||
126400203|NCT01510184|454759536|FG001|Overall Study|Death|2|||
126400204|NCT01510184|454759535|FG000|Overall Study|Withdrawal by Subject|1|||
126400205|NCT01510184|454759536|FG001|Overall Study|Withdrawal by Subject|4|||
126400206|NCT01510184|454759535|FG000|Overall Study|Other|0|||
126400207|NCT01510184|454759536|FG001|Overall Study|Other|1|||
126400208|NCT00694096|454759545|FG000|Overall Study|Withdrawal by Subject|5|||
126400209|NCT02498067|454759554|FG000|Overall Study|Lost to Follow-up|22|||
126400210|NCT02498067|454759554|FG000|Overall Study|Did not meet inclusion criteria|11|||
126400211|NCT01484834|454759555|FG000|Overall Study|Lost to Follow-up|5|||
126400212|NCT01484834|454759556|FG001|Overall Study|Lost to Follow-up|8|||
126400213|NCT01484834|454759557|FG002|Overall Study|Lost to Follow-up|1|||
126400214|NCT01484834|454759558|FG003|Overall Study|Lost to Follow-up|4|||
126400215|NCT00747344|454759559|FG000|Controlled Period|Adverse Event|3|||
126400216|NCT00747344|454759560|FG001|Controlled Period|Adverse Event|0|||
126400217|NCT00747344|454759561|FG002|Controlled Period|Adverse Event|0|||
126400218|NCT00747344|454759562|FG003|Controlled Period|Adverse Event|0|||
126400219|NCT00747344|454759559|FG000|Controlled Period|Lack of Efficacy|2|||
126400220|NCT00747344|454759560|FG001|Controlled Period|Lack of Efficacy|1|||
126400221|NCT00747344|454759561|FG002|Controlled Period|Lack of Efficacy|0|||
126400222|NCT00747344|454759562|FG003|Controlled Period|Lack of Efficacy|0|||
126400223|NCT00747344|454759559|FG000|Controlled Period|Other|0|||
126400224|NCT00747344|454759560|FG001|Controlled Period|Other|3|||
126400225|NCT00747344|454759561|FG002|Controlled Period|Other|0|||
126400226|NCT00747344|454759562|FG003|Controlled Period|Other|0|||
126400227|NCT00747344|454759559|FG000|After Controlled Period|Adverse Event|0|||
126400228|NCT00747344|454759560|FG001|After Controlled Period|Adverse Event|0|||
126400229|NCT00747344|454759561|FG002|After Controlled Period|Adverse Event|0|||
126400230|NCT00747344|454759562|FG003|After Controlled Period|Adverse Event|1|||
126400231|NCT00765882|454759563|FG000|Overall Study|Adverse Event|10|||
126400232|NCT00765882|454759564|FG001|Overall Study|Adverse Event|21|||
126400233|NCT00765882|454759565|FG002|Overall Study|Adverse Event|20|||
126400234|NCT00765882|454759563|FG000|Overall Study|Lack of Efficacy|4|||
126400235|NCT00765882|454759564|FG001|Overall Study|Lack of Efficacy|0|||
126400236|NCT00765882|454759565|FG002|Overall Study|Lack of Efficacy|1|||
126400237|NCT00765882|454759563|FG000|Overall Study|Protocol Violation|4|||
126400238|NCT00765882|454759564|FG001|Overall Study|Protocol Violation|3|||
126400239|NCT00765882|454759565|FG002|Overall Study|Protocol Violation|1|||
126400240|NCT00765882|454759563|FG000|Overall Study|Withdrawal by Subject|2|||
126400241|NCT00765882|454759564|FG001|Overall Study|Withdrawal by Subject|6|||
126400242|NCT00765882|454759565|FG002|Overall Study|Withdrawal by Subject|6|||
126400243|NCT00765882|454759563|FG000|Overall Study|Lost to Follow-up|1|||
126400244|NCT00765882|454759564|FG001|Overall Study|Lost to Follow-up|9|||
126400245|NCT00765882|454759565|FG002|Overall Study|Lost to Follow-up|6|||
126400246|NCT00765882|454759563|FG000|Overall Study|Other Reason|3|||
126400247|NCT00765882|454759564|FG001|Overall Study|Other Reason|1|||
126400248|NCT00765882|454759565|FG002|Overall Study|Other Reason|2|||
126400249|NCT02231762|454759569|FG000|Combination Phase|Adverse Event|10|||
126400250|NCT02231762|454759570|FG001|Combination Phase|Adverse Event|0|||
126400251|NCT02231762|454759571|FG002|Combination Phase|Adverse Event|0|||
126400252|NCT02231762|454759572|FG003|Combination Phase|Adverse Event|0|||
126400253|NCT02231762|454759569|FG000|Combination Phase|Withdrawal by Subject|2|||
126400254|NCT02231762|454759570|FG001|Combination Phase|Withdrawal by Subject|0|||
126400255|NCT02231762|454759571|FG002|Combination Phase|Withdrawal by Subject|0|||
126400256|NCT02231762|454759572|FG003|Combination Phase|Withdrawal by Subject|0|||
126400257|NCT02231762|454759569|FG000|Combination Phase|Disease Progression|6|||
126400258|NCT02231762|454759570|FG001|Combination Phase|Disease Progression|0|||
126400259|NCT02231762|454759571|FG002|Combination Phase|Disease Progression|0|||
126400260|NCT02231762|454759572|FG003|Combination Phase|Disease Progression|0|||
126400261|NCT02231762|454759569|FG000|Combination Phase|Did not meet inclusion criteria|1|||
126400262|NCT02231762|454759570|FG001|Combination Phase|Did not meet inclusion criteria|0|||
126400263|NCT02231762|454759571|FG002|Combination Phase|Did not meet inclusion criteria|0|||
126400264|NCT02231762|454759572|FG003|Combination Phase|Did not meet inclusion criteria|0|||
126400265|NCT02231762|454759569|FG000|Combination Phase|Protocol Violation|1|||
126400266|NCT02231762|454759570|FG001|Combination Phase|Protocol Violation|0|||
126400267|NCT02231762|454759571|FG002|Combination Phase|Protocol Violation|0|||
126400268|NCT02231762|454759572|FG003|Combination Phase|Protocol Violation|0|||
126400269|NCT02231762|454759569|FG000|Maintenance Phase|Disease progression|0|||
126400270|NCT02231762|454759570|FG001|Maintenance Phase|Disease progression|3|||
126400271|NCT02231762|454759571|FG002|Maintenance Phase|Disease progression|4|||
126400272|NCT02231762|454759572|FG003|Maintenance Phase|Disease progression|3|||
126400273|NCT02231762|454759569|FG000|Maintenance Phase|Adverse Event|0|||
126400274|NCT02231762|454759570|FG001|Maintenance Phase|Adverse Event|0|||
126400275|NCT02231762|454759571|FG002|Maintenance Phase|Adverse Event|1|||
126400276|NCT02231762|454759572|FG003|Maintenance Phase|Adverse Event|2|||
126400277|NCT01799239|454759577|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
126400278|NCT01799239|454759578|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
126400279|NCT01799239|454759577|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
126400280|NCT01799239|454759578|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
126400281|NCT01799239|454759577|FG000|Period 1 (7 Days)|Protocol Violation|0|||
126400282|NCT01799239|454759578|FG001|Period 1 (7 Days)|Protocol Violation|1|||
126400283|NCT01799239|454759577|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
126400284|NCT01799239|454759578|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
126400285|NCT01799239|454759577|FG000|Period 2 (7 Days)|Protocol Violation|1|||
126400286|NCT01799239|454759578|FG001|Period 2 (7 Days)|Protocol Violation|0|||
126400287|NCT02813668|454759581|FG000|Overall Study|Death|4|||
126400288|NCT02813668|454759581|FG000|Overall Study|Lost to Follow-up|509|||
126400289|NCT02813668|454759581|FG000|Overall Study|Withdrawal by Subject|148|||
126400290|NCT02813668|454759581|FG000|Overall Study|No longer at worksite|85|||
126400291|NCT02813668|454759581|FG000|Overall Study|Medical reasons not related to the study|4|||
126400292|NCT01286987|454759583|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
126400293|NCT01286987|454759584|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
126400294|NCT01286987|454759585|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
126400295|NCT01286987|454759586|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
126400296|NCT01286987|454759587|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
126400297|NCT01286987|454759588|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
126400298|NCT01286987|454759589|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
126400299|NCT01286987|454759590|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
126400300|NCT01286987|454759591|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
126400301|NCT01286987|454759592|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
126400302|NCT01286987|454759593|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
126400303|NCT01286987|454759594|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
126400304|NCT01286987|454759595|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
126400305|NCT01286987|454759596|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
126400306|NCT01286987|454759597|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
126400307|NCT01286987|454759583|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
126400308|NCT01286987|454759584|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
126400309|NCT01286987|454759585|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
126400310|NCT01286987|454759586|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
126400311|NCT01286987|454759587|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
126400312|NCT01286987|454759588|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
126400313|NCT01286987|454759589|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
126400314|NCT01286987|454759590|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
126400315|NCT01286987|454759591|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
126400316|NCT01286987|454759592|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
126400317|NCT01286987|454759593|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
126400318|NCT01286987|454759594|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
126400319|NCT01286987|454759595|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
126400320|NCT01286987|454759596|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
126400321|NCT01286987|454759597|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
126400322|NCT01286987|454759583|FG000|Part 1: Dose Escalation|Physician Decision|0|||
126400323|NCT01286987|454759584|FG001|Part 1: Dose Escalation|Physician Decision|0|||
126400324|NCT01286987|454759585|FG002|Part 1: Dose Escalation|Physician Decision|0|||
126400325|NCT01286987|454759586|FG003|Part 1: Dose Escalation|Physician Decision|0|||
126400326|NCT01286987|454759587|FG004|Part 1: Dose Escalation|Physician Decision|1|||
126400327|NCT01286987|454759588|FG005|Part 1: Dose Escalation|Physician Decision|0|||
126400328|NCT01286987|454759589|FG006|Part 1: Dose Escalation|Physician Decision|0|||
126400329|NCT01286987|454759590|FG007|Part 1: Dose Escalation|Physician Decision|0|||
126400330|NCT01286987|454759591|FG008|Part 1: Dose Escalation|Physician Decision|0|||
126400331|NCT01286987|454759592|FG009|Part 1: Dose Escalation|Physician Decision|0|||
126400332|NCT01286987|454759593|FG010|Part 1: Dose Escalation|Physician Decision|0|||
126400333|NCT01286987|454759594|FG011|Part 1: Dose Escalation|Physician Decision|0|||
126400334|NCT01286987|454759595|FG012|Part 1: Dose Escalation|Physician Decision|0|||
126400335|NCT01286987|454759596|FG013|Part 1: Dose Escalation|Physician Decision|0|||
126400336|NCT01286987|454759597|FG014|Part 1: Dose Escalation|Physician Decision|0|||
126400337|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Death|0|||
126400338|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Death|0|||
126400339|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Death|0|||
126400340|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Death|0|||
126400341|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Death|0|||
126400342|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Death|0|||
126400343|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Death|0|||
126400344|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Death|0|||
126400345|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Death|0|||
126400346|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Death|0|||
126400347|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Death|0|||
126400348|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Death|0|||
126400349|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Death|1|||
126400350|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Death|1|||
126400351|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Death|0|||
126400352|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Physician Decision|0|||
126400353|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Physician Decision|0|||
126400354|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Physician Decision|0|||
126400355|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Physician Decision|0|||
126400356|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Physician Decision|0|||
126400357|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Physician Decision|0|||
126400358|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Physician Decision|0|||
126400359|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Physician Decision|0|||
126400360|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Physician Decision|0|||
126400361|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Physician Decision|0|||
126400362|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Physician Decision|1|||
126400363|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Physician Decision|1|||
126400364|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Physician Decision|0|||
126400365|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Physician Decision|1|||
126400366|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Physician Decision|0|||
126400367|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Other|0|||
126400368|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Other|0|||
126400369|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Other|0|||
126400370|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Other|0|||
126400371|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Other|0|||
126400372|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Other|0|||
126400373|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Other|0|||
126400374|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Other|0|||
126400375|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Other|0|||
126400376|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Other|0|||
126400377|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Other|0|||
126400378|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Other|0|||
126400379|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Other|0|||
126400380|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Other|1|||
126400381|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Other|0|||
126400382|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
126400383|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
126400384|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
126400385|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
126400386|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
126400387|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
126400388|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
126400389|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
126400390|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
126400391|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
126400392|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
126400393|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
126400394|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
126400395|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
126400396|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
126400397|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
126400398|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
126400399|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
126400400|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
126400401|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
126400402|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
126400403|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
126400404|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
126400405|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
126400406|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
126400407|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
126400408|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
126400409|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
126400410|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
126400411|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
126400412|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400413|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400414|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400415|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400416|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400417|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400418|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400419|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400420|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400421|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400422|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
126400423|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400424|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400425|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400426|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400427|NCT02594098|454759598|FG000|Overall Study|Lack of Efficacy|17|||
126400428|NCT02594098|454759599|FG001|Overall Study|Lack of Efficacy|6|||
126400429|NCT02594098|454759598|FG000|Overall Study|Withdrawal by Subject|1|||
126400430|NCT02594098|454759599|FG001|Overall Study|Withdrawal by Subject|3|||
126400431|NCT02594098|454759598|FG000|Overall Study|Terminated participation|6|||
126400432|NCT02594098|454759599|FG001|Overall Study|Terminated participation|2|||
126400433|NCT02594098|454759598|FG000|Overall Study|Seek alternative treatment|2|||
126400434|NCT02594098|454759599|FG001|Overall Study|Seek alternative treatment|1|||
126400435|NCT02594098|454759598|FG000|Overall Study|Other|0|||
126400436|NCT02594098|454759599|FG001|Overall Study|Other|1|||
126400437|NCT00033540|454759600|FG000|Overall Study|Adverse Event|14|||
126400438|NCT00033540|454759600|FG000|Overall Study|Death|1|||
126400439|NCT00033540|454759600|FG000|Overall Study|Progression|26|||
126400440|NCT00033540|454759600|FG000|Overall Study|Withdrawal by Subject|6|||
126400441|NCT00033540|454759600|FG000|Overall Study|Other|5|||
126400442|NCT00033540|454759600|FG000|Overall Study|Ineligible|3|||
126400443|NCT00033540|454759600|FG000|Overall Study|Never received treatment|2|||
126400444|NCT03366103|454759601|FG000|Overall Study|Disease Progression|3|||
126400445|NCT03366103|454759602|FG001|Overall Study|Disease Progression|1|||
126400446|NCT03366103|454759603|FG002|Overall Study|Disease Progression|0|||
126400447|NCT03366103|454759601|FG000|Overall Study|Adverse Event|0|||
126400448|NCT03366103|454759602|FG001|Overall Study|Adverse Event|1|||
126400449|NCT03366103|454759603|FG002|Overall Study|Adverse Event|0|||
126400450|NCT01036529|454759604|FG000|Overall Study|Adverse Event|0|||
126400451|NCT01036529|454759605|FG001|Overall Study|Adverse Event|1|||
126400452|NCT01036529|454759604|FG000|Overall Study|Lost to Follow-up|0|||
126400453|NCT01036529|454759605|FG001|Overall Study|Lost to Follow-up|1|||
126400454|NCT01036529|454759604|FG000|Overall Study|Physician Decision|1|||
126400455|NCT01036529|454759605|FG001|Overall Study|Physician Decision|0|||
126400456|NCT01036529|454759604|FG000|Overall Study|Withdrawal by Subject|1|||
126400457|NCT01036529|454759605|FG001|Overall Study|Withdrawal by Subject|1|||
126400458|NCT01036529|454759604|FG000|Overall Study|Sponsor study termination|11|||
126400459|NCT01036529|454759605|FG001|Overall Study|Sponsor study termination|12|||
126400460|NCT01945775|454759606|FG000|Overall Study|Death|214|||
126400461|NCT01945775|454759607|FG001|Overall Study|Death|98|||
126400462|NCT01945775|454759606|FG000|Overall Study|Lost to Follow-up|12|||
126400463|NCT01945775|454759607|FG001|Overall Study|Lost to Follow-up|7|||
126400464|NCT01945775|454759606|FG000|Overall Study|Withdrawal by Subject|11|||
126400465|NCT01945775|454759607|FG001|Overall Study|Withdrawal by Subject|21|||
126400466|NCT01945775|454759606|FG000|Overall Study|Other|50|||
126400467|NCT01945775|454759607|FG001|Overall Study|Other|18|||
126400468|NCT02876328|454759608|FG000|Overall Study|Death|2|||
126400469|NCT02876328|454759609|FG001|Overall Study|Death|1|||
126400470|NCT02876328|454759610|FG002|Overall Study|Death|3|||
126400471|NCT02876328|454759611|FG003|Overall Study|Death|0|||
126400472|NCT02876328|454759612|FG004|Overall Study|Death|0|||
126400473|NCT02876328|454759613|FG005|Overall Study|Death|0|||
126400474|NCT02876328|454759614|FG006|Overall Study|Death|1|||
126400475|NCT02876328|454759615|FG007|Overall Study|Death|3|||
126400476|NCT02876328|454759616|FG008|Overall Study|Death|0|||
126400477|NCT02876328|454759617|FG009|Overall Study|Death|1|||
126400478|NCT02876328|454759618|FG010|Overall Study|Death|1|||
126400479|NCT02876328|454759619|FG011|Overall Study|Death|0|||
126400480|NCT02876328|454759620|FG012|Overall Study|Death|0|||
126400481|NCT02876328|454759621|FG013|Overall Study|Death|0|||
126400482|NCT02876328|454759622|FG014|Overall Study|Death|0|||
126400483|NCT02876328|454759623|FG015|Overall Study|Death|0|||
126400484|NCT02876328|454759624|FG016|Overall Study|Death|1|||
126400485|NCT02876328|454759625|FG017|Overall Study|Death|1|||
126400486|NCT02876328|454759626|FG018|Overall Study|Death|0|||
126400487|NCT02876328|454759627|FG019|Overall Study|Death|0|||
126400488|NCT02876328|454759628|FG020|Overall Study|Death|0|||
126400489|NCT02876328|454759629|FG021|Overall Study|Death|1|||
126400490|NCT02876328|454759630|FG022|Overall Study|Death|0|||
126400491|NCT02876328|454759631|FG023|Overall Study|Death|0|||
126400492|NCT02876328|454759608|FG000|Overall Study|Withdrawal by Subject|0|||
126400493|NCT02876328|454759609|FG001|Overall Study|Withdrawal by Subject|2|||
126400494|NCT02876328|454759610|FG002|Overall Study|Withdrawal by Subject|3|||
126400495|NCT02876328|454759611|FG003|Overall Study|Withdrawal by Subject|3|||
126400496|NCT02876328|454759612|FG004|Overall Study|Withdrawal by Subject|0|||
126400497|NCT02876328|454759613|FG005|Overall Study|Withdrawal by Subject|1|||
126400498|NCT02876328|454759614|FG006|Overall Study|Withdrawal by Subject|0|||
126400499|NCT02876328|454759615|FG007|Overall Study|Withdrawal by Subject|1|||
126400500|NCT02876328|454759616|FG008|Overall Study|Withdrawal by Subject|1|||
126400501|NCT02876328|454759617|FG009|Overall Study|Withdrawal by Subject|2|||
126400502|NCT02876328|454759618|FG010|Overall Study|Withdrawal by Subject|0|||
126400503|NCT02876328|454759619|FG011|Overall Study|Withdrawal by Subject|0|||
126400504|NCT02876328|454759620|FG012|Overall Study|Withdrawal by Subject|0|||
126400505|NCT02876328|454759621|FG013|Overall Study|Withdrawal by Subject|0|||
126400506|NCT02876328|454759622|FG014|Overall Study|Withdrawal by Subject|0|||
126400507|NCT02876328|454759623|FG015|Overall Study|Withdrawal by Subject|0|||
126400508|NCT02876328|454759624|FG016|Overall Study|Withdrawal by Subject|1|||
126400509|NCT02876328|454759625|FG017|Overall Study|Withdrawal by Subject|3|||
126400510|NCT02876328|454759626|FG018|Overall Study|Withdrawal by Subject|0|||
126400511|NCT02876328|454759627|FG019|Overall Study|Withdrawal by Subject|0|||
126400512|NCT02876328|454759628|FG020|Overall Study|Withdrawal by Subject|1|||
126400513|NCT02876328|454759629|FG021|Overall Study|Withdrawal by Subject|0|||
126400514|NCT02876328|454759630|FG022|Overall Study|Withdrawal by Subject|0|||
126400515|NCT02876328|454759631|FG023|Overall Study|Withdrawal by Subject|0|||
126400516|NCT02876328|454759608|FG000|Overall Study|Missed 12 Month Visit|15|||
126400517|NCT02876328|454759609|FG001|Overall Study|Missed 12 Month Visit|10|||
126400518|NCT02876328|454759610|FG002|Overall Study|Missed 12 Month Visit|11|||
126400519|NCT02876328|454759611|FG003|Overall Study|Missed 12 Month Visit|6|||
126400520|NCT02876328|454759612|FG004|Overall Study|Missed 12 Month Visit|10|||
126400521|NCT02876328|454759613|FG005|Overall Study|Missed 12 Month Visit|14|||
126400522|NCT02876328|454759614|FG006|Overall Study|Missed 12 Month Visit|3|||
126400523|NCT02876328|454759615|FG007|Overall Study|Missed 12 Month Visit|8|||
126400524|NCT02876328|454759616|FG008|Overall Study|Missed 12 Month Visit|9|||
126400525|NCT02876328|454759617|FG009|Overall Study|Missed 12 Month Visit|5|||
126400526|NCT02876328|454759618|FG010|Overall Study|Missed 12 Month Visit|4|||
126400527|NCT02876328|454759619|FG011|Overall Study|Missed 12 Month Visit|1|||
126400528|NCT02876328|454759620|FG012|Overall Study|Missed 12 Month Visit|5|||
126400529|NCT02876328|454759621|FG013|Overall Study|Missed 12 Month Visit|4|||
126400530|NCT02876328|454759622|FG014|Overall Study|Missed 12 Month Visit|4|||
126400531|NCT02876328|454759623|FG015|Overall Study|Missed 12 Month Visit|4|||
126400532|NCT02876328|454759624|FG016|Overall Study|Missed 12 Month Visit|3|||
126400533|NCT02876328|454759625|FG017|Overall Study|Missed 12 Month Visit|6|||
126400534|NCT02876328|454759626|FG018|Overall Study|Missed 12 Month Visit|2|||
126400535|NCT02876328|454759627|FG019|Overall Study|Missed 12 Month Visit|2|||
126105300|NCT00940108|453678576|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
126400536|NCT02876328|454759628|FG020|Overall Study|Missed 12 Month Visit|11|||
126400537|NCT02876328|454759629|FG021|Overall Study|Missed 12 Month Visit|7|||
126400538|NCT02876328|454759630|FG022|Overall Study|Missed 12 Month Visit|1|||
126400539|NCT02876328|454759631|FG023|Overall Study|Missed 12 Month Visit|0|||
126400540|NCT03515941|454759632|FG000|Overall Study|Adverse Event|1|||
126400541|NCT03515941|454759633|FG001|Overall Study|Adverse Event|0|||
126400542|NCT00334282|454759636|FG000|Overall Study|Lost to Follow-up|11|||
126400543|NCT00334282|454759637|FG001|Overall Study|Lost to Follow-up|5|||
126400544|NCT00334282|454759636|FG000|Overall Study|Withdrawal by Subject|17|||
126400545|NCT00334282|454759637|FG001|Overall Study|Withdrawal by Subject|3|||
126400546|NCT00334282|454759636|FG000|Overall Study|Death|194|||
126400547|NCT00334282|454759637|FG001|Overall Study|Death|100|||
126400548|NCT04342689|454759644|FG000|Overall Study|Withdrawal by Subject|32|||
126400549|NCT04342689|454759645|FG001|Overall Study|Withdrawal by Subject|33|||
126400550|NCT04342689|454759644|FG000|Overall Study|Lost to Follow-up|10|||
126400551|NCT04342689|454759645|FG001|Overall Study|Lost to Follow-up|12|||
126400552|NCT01460407|454759646|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
126400553|NCT01460407|454759647|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
126400554|NCT00844805|454759652|FG000|Treatment Phase|Adverse Event|5|||
126400555|NCT00844805|454759653|FG001|Treatment Phase|Adverse Event|1|||
126400556|NCT00844805|454759654|FG002|Treatment Phase|Adverse Event|0|||
126400557|NCT00844805|454759655|FG003|Treatment Phase|Adverse Event|0|||
126400558|NCT00844805|454759652|FG000|Treatment Phase|Withdrawal by Subject|3|||
126400559|NCT00844805|454759653|FG001|Treatment Phase|Withdrawal by Subject|4|||
126400560|NCT00844805|454759654|FG002|Treatment Phase|Withdrawal by Subject|0|||
126400561|NCT00844805|454759655|FG003|Treatment Phase|Withdrawal by Subject|0|||
126400562|NCT00844805|454759652|FG000|Treatment Phase|Noncompliance With Protocol|1|||
126400563|NCT00844805|454759653|FG001|Treatment Phase|Noncompliance With Protocol|0|||
126400564|NCT00844805|454759654|FG002|Treatment Phase|Noncompliance With Protocol|0|||
126400565|NCT00844805|454759655|FG003|Treatment Phase|Noncompliance With Protocol|0|||
126400566|NCT00844805|454759652|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
126400567|NCT00844805|454759653|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
126400568|NCT00844805|454759654|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
126400569|NCT00844805|454759655|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
126400570|NCT00844805|454759652|FG000|Follow-Up Phase|Adverse Event|0|||
126400571|NCT00844805|454759653|FG001|Follow-Up Phase|Adverse Event|0|||
126400572|NCT00844805|454759654|FG002|Follow-Up Phase|Adverse Event|1|||
126400573|NCT00844805|454759655|FG003|Follow-Up Phase|Adverse Event|0|||
126400574|NCT00844805|454759652|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
126400575|NCT00844805|454759653|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
126400576|NCT00844805|454759654|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
126400577|NCT00844805|454759655|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
126400578|NCT00844805|454759652|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
126400579|NCT00844805|454759653|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
126400580|NCT00844805|454759654|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
126400581|NCT00844805|454759655|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
126400582|NCT00844805|454759652|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
126400583|NCT00844805|454759653|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
126400584|NCT00844805|454759654|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
126400585|NCT00844805|454759655|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
126400586|NCT00844805|454759652|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
126400587|NCT00844805|454759653|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
126400588|NCT00844805|454759654|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
126400589|NCT00844805|454759655|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
126400590|NCT04070326|454759656|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
126400591|NCT04070326|454759657|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
126400592|NCT03618628|454759661|FG000|Overall Study|Death|1|||
126400593|NCT03618628|454759661|FG000|Overall Study|Lost to Follow-up|1|||
126400594|NCT01741532|454759663|FG000|Overall Study|Adverse Event|4|||
126400595|NCT01741532|454759664|FG001|Overall Study|Adverse Event|0|||
126400596|NCT01741532|454759663|FG000|Overall Study|Withdrawal by Subject|1|||
126400597|NCT01741532|454759664|FG001|Overall Study|Withdrawal by Subject|1|||
126400598|NCT01741532|454759663|FG000|Overall Study|Protocol Violation|0|||
126400599|NCT01741532|454759664|FG001|Overall Study|Protocol Violation|1|||
126400600|NCT01741532|454759663|FG000|Overall Study|Worsening of the disease|3|||
126400601|NCT01741532|454759664|FG001|Overall Study|Worsening of the disease|1|||
126400602|NCT01741532|454759663|FG000|Overall Study|Sponsor decision|1|||
126400603|NCT01741532|454759664|FG001|Overall Study|Sponsor decision|0|||
126400604|NCT01741532|454759663|FG000|Overall Study|Medical event|1|||
126400605|NCT01741532|454759664|FG001|Overall Study|Medical event|0|||
126400606|NCT00475865|454759665|FG000|Overall Study|Adverse Event|0|||
126400607|NCT00475865|454759666|FG001|Overall Study|Adverse Event|3|||
126400608|NCT00475865|454759667|FG002|Overall Study|Adverse Event|4|||
126400609|NCT00475865|454759665|FG000|Overall Study|Lack of Efficacy|1|||
126400610|NCT00475865|454759666|FG001|Overall Study|Lack of Efficacy|0|||
126400611|NCT00475865|454759667|FG002|Overall Study|Lack of Efficacy|0|||
126400612|NCT00475865|454759665|FG000|Overall Study|Progressive disease|0|||
126400613|NCT00475865|454759666|FG001|Overall Study|Progressive disease|1|||
126400614|NCT00475865|454759667|FG002|Overall Study|Progressive disease|2|||
126400615|NCT00475865|454759665|FG000|Overall Study|Participant did not wish to continue|1|||
126400616|NCT00475865|454759666|FG001|Overall Study|Participant did not wish to continue|0|||
126400617|NCT00475865|454759667|FG002|Overall Study|Participant did not wish to continue|0|||
126400618|NCT00475865|454759665|FG000|Overall Study|Other than above|0|||
126400619|NCT00475865|454759666|FG001|Overall Study|Other than above|1|||
126400620|NCT00475865|454759667|FG002|Overall Study|Other than above|0|||
126400621|NCT01498185|454759669|FG000|Overall Study|Adverse Event|0|||
126400622|NCT01498185|454759670|FG001|Overall Study|Adverse Event|0|||
126105301|NCT00940108|453678573|FG000|Overall Study|Viral illness after Dose 1|0|||
126400623|NCT01498185|454759671|FG002|Overall Study|Adverse Event|0|||
126400624|NCT01498185|454759672|FG003|Overall Study|Adverse Event|1|||
126400625|NCT01498185|454759673|FG004|Overall Study|Adverse Event|0|||
126400626|NCT01498185|454759669|FG000|Overall Study|Withdrawal by Subject|1|||
126400627|NCT01498185|454759670|FG001|Overall Study|Withdrawal by Subject|1|||
126400628|NCT01498185|454759671|FG002|Overall Study|Withdrawal by Subject|0|||
126400629|NCT01498185|454759672|FG003|Overall Study|Withdrawal by Subject|2|||
126400630|NCT01498185|454759673|FG004|Overall Study|Withdrawal by Subject|1|||
126400631|NCT01498185|454759669|FG000|Overall Study|No longer met criteria, etc|0|||
126400632|NCT01498185|454759670|FG001|Overall Study|No longer met criteria, etc|0|||
126400633|NCT01498185|454759671|FG002|Overall Study|No longer met criteria, etc|0|||
126400634|NCT01498185|454759672|FG003|Overall Study|No longer met criteria, etc|0|||
126400635|NCT01498185|454759673|FG004|Overall Study|No longer met criteria, etc|2|||
126400636|NCT00946322|454759674|FG000|Pre-treatment|participant failure to follow up|1|||
126400637|NCT00946322|454759674|FG000|Post-treatment|participant failure to follow up|2|||
126400638|NCT01453946|454759675|FG000|Overall Study|Did not receive drug for the taper phase|1|||
126400639|NCT01453946|454759675|FG000|Overall Study|Protocol Violation|2|||
126400640|NCT01453946|454759675|FG000|Overall Study|Lack of Efficacy|3|||
126400641|NCT01453946|454759675|FG000|Overall Study|Adverse Event|3|||
126400642|NCT02153346|454759676|FG000|Overall Study|Lost to Follow-up|11|||
126400643|NCT00846040|454759677|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
126400644|NCT00846040|454759678|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
126400645|NCT00846040|454759679|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
126400646|NCT00846040|454759677|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
126400647|NCT00846040|454759678|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
126400648|NCT00846040|454759679|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
126400649|NCT03158272|454759683|FG000|Overall Study|Disease progression|3|||
126400650|NCT03158272|454759684|FG001|Overall Study|Disease progression|3|||
126400651|NCT03158272|454759685|FG002|Overall Study|Disease progression|4|||
126400652|NCT03158272|454759686|FG003|Overall Study|Disease progression|6|||
126400653|NCT03158272|454759683|FG000|Overall Study|Death|0|||
126400654|NCT03158272|454759684|FG001|Overall Study|Death|0|||
126400655|NCT03158272|454759685|FG002|Overall Study|Death|1|||
126400656|NCT03158272|454759686|FG003|Overall Study|Death|0|||
126400657|NCT03158272|454759683|FG000|Overall Study|Other reasons|0|||
126400658|NCT03158272|454759684|FG001|Overall Study|Other reasons|0|||
126400659|NCT03158272|454759685|FG002|Overall Study|Other reasons|1|||
126400660|NCT03158272|454759686|FG003|Overall Study|Other reasons|0|||
126400661|NCT03158272|454759683|FG000|Overall Study|Adverse event unrelated to the drug|0|||
126400662|NCT03158272|454759684|FG001|Overall Study|Adverse event unrelated to the drug|1|||
126400663|NCT03158272|454759685|FG002|Overall Study|Adverse event unrelated to the drug|0|||
126400664|NCT03158272|454759686|FG003|Overall Study|Adverse event unrelated to the drug|0|||
126400665|NCT01822535|454759687|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
126400666|NCT01822535|454759688|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
126400667|NCT01822535|454759687|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
126400668|NCT01822535|454759688|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
126400669|NCT01822535|454759687|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
126400670|NCT01822535|454759688|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
126400671|NCT02278614|454759691|FG000|Overall Study|Withdrawal by Subject|3|||
126400672|NCT02278614|454759692|FG001|Overall Study|Withdrawal by Subject|5|||
126400673|NCT02278614|454759691|FG000|Overall Study|Adverse Event|1|||
126400674|NCT02278614|454759692|FG001|Overall Study|Adverse Event|0|||
125890024|NCT00555061|452895423|FG000|Overall Study|Withdrawal by Subject|2|||
126400675|NCT02278614|454759691|FG000|Overall Study|left eye was not eligible|1|||
126400676|NCT02278614|454759692|FG001|Overall Study|left eye was not eligible|0|||
126400677|NCT03582813|454759695|FG000|Overall Study|Lost to Follow-up|18|||
126400678|NCT03582813|454759696|FG001|Overall Study|Lost to Follow-up|21|||
126400679|NCT03582813|454759695|FG000|Overall Study|Withdrawal by Subject|1|||
126400680|NCT03582813|454759696|FG001|Overall Study|Withdrawal by Subject|0|||
126400681|NCT02366767|454759699|FG000|Overall Study|left for home after 1 day at camp|1|||
126400682|NCT02366767|454759700|FG001|Overall Study|left for home after 1 day at camp|0|||
126400683|NCT02558400|454759703|FG000|Overall Study|Adverse Event|47|||
126400684|NCT02558400|454759704|FG001|Overall Study|Adverse Event|53|||
126400685|NCT02558400|454759705|FG002|Overall Study|Adverse Event|4|||
126400686|NCT02558400|454759703|FG000|Overall Study|Withdrawal by Subject|13|||
126400687|NCT02558400|454759704|FG001|Overall Study|Withdrawal by Subject|9|||
126400688|NCT02558400|454759705|FG002|Overall Study|Withdrawal by Subject|8|||
126400689|NCT02558400|454759703|FG000|Overall Study|Non-Compliant|0|||
126400690|NCT02558400|454759704|FG001|Overall Study|Non-Compliant|1|||
126400691|NCT02558400|454759705|FG002|Overall Study|Non-Compliant|3|||
126400692|NCT02558400|454759703|FG000|Overall Study|Lost to Follow-up|5|||
126400693|NCT02558400|454759704|FG001|Overall Study|Lost to Follow-up|5|||
126400694|NCT02558400|454759705|FG002|Overall Study|Lost to Follow-up|4|||
126400695|NCT02558400|454759703|FG000|Overall Study|Lack of Efficacy|0|||
126400696|NCT02558400|454759704|FG001|Overall Study|Lack of Efficacy|13|||
126400697|NCT02558400|454759705|FG002|Overall Study|Lack of Efficacy|1|||
126400698|NCT02558400|454759703|FG000|Overall Study|Disallowed Concurrent Medication|6|||
126400699|NCT02558400|454759704|FG001|Overall Study|Disallowed Concurrent Medication|7|||
126400700|NCT02558400|454759705|FG002|Overall Study|Disallowed Concurrent Medication|5|||
126400701|NCT02558400|454759703|FG000|Overall Study|Physician Decision|2|||
126400702|NCT02558400|454759704|FG001|Overall Study|Physician Decision|2|||
126400703|NCT02558400|454759705|FG002|Overall Study|Physician Decision|0|||
126400704|NCT02558400|454759703|FG000|Overall Study|Protocol Violation|6|||
126400705|NCT02558400|454759704|FG001|Overall Study|Protocol Violation|3|||
126400706|NCT02558400|454759705|FG002|Overall Study|Protocol Violation|8|||
126400707|NCT02558400|454759703|FG000|Overall Study|Death|0|||
126400708|NCT02558400|454759704|FG001|Overall Study|Death|1|||
126400709|NCT02558400|454759705|FG002|Overall Study|Death|0|||
126400710|NCT02558400|454759703|FG000|Overall Study|Ineligible for the study|0|||
126400711|NCT02558400|454759704|FG001|Overall Study|Ineligible for the study|2|||
126400712|NCT02558400|454759705|FG002|Overall Study|Ineligible for the study|0|||
126400713|NCT02230683|454759706|FG000|Overall Study|Adverse Event|1|||
126400714|NCT00260065|454759707|FG000|Overall Study|Progressive Disease|22|||
126400715|NCT00260065|454759707|FG000|Overall Study|Adverse Event|17|||
126400716|NCT00260065|454759707|FG000|Overall Study|Death|13|||
126400717|NCT00260065|454759707|FG000|Overall Study|Withdrawal by Subject|13|||
126400718|NCT00260065|454759707|FG000|Overall Study|Physician Decision|19|||
126400719|NCT00260065|454759707|FG000|Overall Study|Not otherwise specified|8|||
126400720|NCT00260065|454759707|FG000|Overall Study|Medication Noncompliance|1|||
126400721|NCT04068519|454759708|FG000|Dose Verification|Death|15|||
126400722|NCT04068519|454759708|FG000|Dose Verification|Withdrawal by Subject|1|||
126400723|NCT04068519|454759708|FG000|Pharmacokinetic Sub-study|Death|35|||
126400724|NCT04068519|454759708|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
126400725|NCT04068519|454759708|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
126400726|NCT04068519|454759708|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
126400727|NCT04068519|454759708|FG000|Indication Expansion|Death|152|||
126400728|NCT04068519|454759708|FG000|Indication Expansion|Withdrawal by Subject|10|||
126400729|NCT04068519|454759708|FG000|Indication Expansion|Lost to Follow-up|7|||
126400730|NCT03959982|454761277|FG000|Overall Study|Withdrawal by Subject|1|||
126400731|NCT03959982|454761278|FG001|Overall Study|Withdrawal by Subject|0|||
126400732|NCT03959982|454761277|FG000|Overall Study|Physician Decision|2|||
126400733|NCT03959982|454761278|FG001|Overall Study|Physician Decision|0|||
126400734|NCT03959982|454761277|FG000|Overall Study|Lost to Follow-up|1|||
126400735|NCT03959982|454761278|FG001|Overall Study|Lost to Follow-up|0|||
126400736|NCT00758589|454761279|FG000|Overall Study|Adverse Event|3|||
126400737|NCT00758589|454761280|FG001|Overall Study|Adverse Event|2|||
126400738|NCT00758589|454761281|FG002|Overall Study|Adverse Event|5|||
126400739|NCT00758589|454761282|FG003|Overall Study|Adverse Event|4|||
126400740|NCT00758589|454761279|FG000|Overall Study|Withdrawal by Subject|0|||
126400741|NCT00758589|454761280|FG001|Overall Study|Withdrawal by Subject|1|||
126400742|NCT00758589|454761281|FG002|Overall Study|Withdrawal by Subject|1|||
126400743|NCT00758589|454761282|FG003|Overall Study|Withdrawal by Subject|1|||
126400744|NCT00758589|454761279|FG000|Overall Study|Palm stopped to work|0|||
126400745|NCT00758589|454761280|FG001|Overall Study|Palm stopped to work|0|||
126400746|NCT00758589|454761281|FG002|Overall Study|Palm stopped to work|0|||
126400747|NCT00758589|454761282|FG003|Overall Study|Palm stopped to work|1|||
126400748|NCT04639219|454761291|FG000|Overall Study|Withdrawal by Subject|8|||
126400749|NCT04639219|454761291|FG000|Overall Study|Lost to Follow-up|6|||
126400750|NCT04639219|454761291|FG000|Overall Study|Death|55|||
126400751|NCT03554772|454761296|FG000|Overall Study|Lost to Follow-up|0|||
126400752|NCT03554772|454761297|FG001|Overall Study|Lost to Follow-up|0|||
126400753|NCT03554772|454761298|FG002|Overall Study|Lost to Follow-up|0|||
126400754|NCT03554772|454761299|FG003|Overall Study|Lost to Follow-up|2|||
126400755|NCT05136898|454761300|FG000|Overall Study|Adverse Event|2|||
126400756|NCT03784846|454761301|FG000|Pre-COVID Study|Lost to Follow-up|3|||
126400757|NCT03784846|454761302|FG001|Pre-COVID Study|Lost to Follow-up|3|||
126400758|NCT03784846|454761303|FG002|Pre-COVID Study|Lost to Follow-up|2|||
126400759|NCT03784846|454761301|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
126400760|NCT03784846|454761302|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
126400761|NCT03784846|454761303|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
126400762|NCT03784846|454761301|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
126400763|NCT03784846|454761302|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
126400764|NCT03784846|454761303|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
126400765|NCT03784846|454761301|FG000|Post-COVID Study|Lost to Follow-up|3|||
126400766|NCT03784846|454761302|FG001|Post-COVID Study|Lost to Follow-up|5|||
126400767|NCT03784846|454761303|FG002|Post-COVID Study|Lost to Follow-up|1|||
126400768|NCT03784846|454761301|FG000|Post-COVID Study|Withdrawal by Subject|1|||
126400769|NCT03784846|454761302|FG001|Post-COVID Study|Withdrawal by Subject|2|||
126400770|NCT03784846|454761303|FG002|Post-COVID Study|Withdrawal by Subject|0|||
126400771|NCT00867087|454761304|FG000|Overall Study|Other|1|||
126400772|NCT00867087|454761304|FG000|Overall Study|Withdrawal by Subject|4|||
126400773|NCT00867087|454761304|FG000|Overall Study|Death|37|||
126400774|NCT02088073|454761306|FG000|Acute Phase|Withdrawal by Subject|5|||
126400775|NCT02088073|454761307|FG001|Acute Phase|Withdrawal by Subject|0|||
126400776|NCT02088073|454761308|FG002|Acute Phase|Withdrawal by Subject|0|||
126400777|NCT02088073|454761309|FG003|Acute Phase|Withdrawal by Subject|0|||
126400778|NCT02088073|454761310|FG004|Acute Phase|Withdrawal by Subject|0|||
126400779|NCT02088073|454761306|FG000|Acute Phase|Hyperkalemia|2|||
126400780|NCT02088073|454761307|FG001|Acute Phase|Hyperkalemia|0|||
126400781|NCT02088073|454761308|FG002|Acute Phase|Hyperkalemia|0|||
126400782|NCT02088073|454761309|FG003|Acute Phase|Hyperkalemia|0|||
126400783|NCT02088073|454761310|FG004|Acute Phase|Hyperkalemia|0|||
126400784|NCT02088073|454761306|FG000|Maintanance Phase|Withdrawal by Subject|0|||
126400785|NCT02088073|454761307|FG001|Maintanance Phase|Withdrawal by Subject|2|||
126400786|NCT02088073|454761308|FG002|Maintanance Phase|Withdrawal by Subject|0|||
126400787|NCT02088073|454761309|FG003|Maintanance Phase|Withdrawal by Subject|0|||
126400788|NCT02088073|454761310|FG004|Maintanance Phase|Withdrawal by Subject|0|||
126400789|NCT02088073|454761306|FG000|Maintanance Phase|Adverse Event|0|||
126400790|NCT02088073|454761307|FG001|Maintanance Phase|Adverse Event|0|||
126400791|NCT02088073|454761308|FG002|Maintanance Phase|Adverse Event|3|||
126400792|NCT02088073|454761309|FG003|Maintanance Phase|Adverse Event|0|||
126400793|NCT02088073|454761310|FG004|Maintanance Phase|Adverse Event|1|||
126400794|NCT02088073|454761306|FG000|Maintanance Phase|Physician Decision|0|||
126400795|NCT02088073|454761307|FG001|Maintanance Phase|Physician Decision|0|||
126400796|NCT02088073|454761308|FG002|Maintanance Phase|Physician Decision|0|||
126400797|NCT02088073|454761309|FG003|Maintanance Phase|Physician Decision|0|||
126400798|NCT02088073|454761310|FG004|Maintanance Phase|Physician Decision|1|||
126400799|NCT02088073|454761306|FG000|Maintanance Phase|Sponsor's decision|0|||
126400800|NCT02088073|454761307|FG001|Maintanance Phase|Sponsor's decision|2|||
126400801|NCT02088073|454761308|FG002|Maintanance Phase|Sponsor's decision|0|||
126400802|NCT02088073|454761309|FG003|Maintanance Phase|Sponsor's decision|2|||
126400803|NCT02088073|454761310|FG004|Maintanance Phase|Sponsor's decision|1|||
126400804|NCT02088073|454761306|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
126400805|NCT02088073|454761307|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
126400806|NCT02088073|454761308|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
126400807|NCT02088073|454761309|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
126400808|NCT02088073|454761310|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
126400809|NCT02088073|454761306|FG000|Maintanance Phase|Miscellaneous|0|||
126400810|NCT02088073|454761307|FG001|Maintanance Phase|Miscellaneous|2|||
126400811|NCT02088073|454761308|FG002|Maintanance Phase|Miscellaneous|1|||
126400812|NCT02088073|454761309|FG003|Maintanance Phase|Miscellaneous|2|||
126400813|NCT02088073|454761310|FG004|Maintanance Phase|Miscellaneous|1|||
126400814|NCT02088073|454761306|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
126400815|NCT02088073|454761307|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
126400816|NCT02088073|454761308|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
126400817|NCT02088073|454761309|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
126400818|NCT02088073|454761310|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
126400819|NCT02088073|454761306|FG000|Maintanance Phase|Subject compliance|0|||
126400820|NCT02088073|454761307|FG001|Maintanance Phase|Subject compliance|1|||
126400821|NCT02088073|454761308|FG002|Maintanance Phase|Subject compliance|0|||
126400822|NCT02088073|454761309|FG003|Maintanance Phase|Subject compliance|0|||
126400823|NCT02088073|454761310|FG004|Maintanance Phase|Subject compliance|0|||
126400824|NCT00241631|454761311|FG000|Run in (2 Weeks)|Physician Decision|3|||
126400825|NCT00241631|454761312|FG001|Run in (2 Weeks)|Physician Decision|3|||
126400826|NCT00241631|454761311|FG000|Phase 1 (4 Weeks)|sore throat|1|||
126400827|NCT00241631|454761312|FG001|Phase 1 (4 Weeks)|sore throat|0|||
126400828|NCT00241631|454761311|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
126400829|NCT00241631|454761312|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
126400830|NCT00241631|454761311|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
126400831|NCT00241631|454761312|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
126400832|NCT00241631|454761311|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
126400833|NCT00241631|454761312|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
126400834|NCT03883113|454761313|FG000|Overall Study|Physician Decision|4|||
126400835|NCT03883113|454761314|FG001|Overall Study|Physician Decision|2|||
126400836|NCT03883113|454761313|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
126400837|NCT03883113|454761314|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
126400838|NCT03883113|454761313|FG000|Overall Study|Pregnancy|1|||
126400839|NCT03883113|454761314|FG001|Overall Study|Pregnancy|0|||
126400840|NCT03883113|454761313|FG000|Overall Study|Adverse Event|0|||
126400841|NCT03883113|454761314|FG001|Overall Study|Adverse Event|1|||
126400842|NCT03883113|454761313|FG000|Overall Study|Withdrawal by Subject|1|||
126400843|NCT03883113|454761314|FG001|Overall Study|Withdrawal by Subject|2|||
126400844|NCT03883113|454761313|FG000|Overall Study|Lost to Follow-up|1|||
126400845|NCT03883113|454761314|FG001|Overall Study|Lost to Follow-up|0|||
126400846|NCT01457950|454761322|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
126400847|NCT01457950|454761323|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
126400848|NCT01457950|454761324|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
126400849|NCT01457950|454761325|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
126400850|NCT01457950|454761322|FG000|Double-Blind Phase|Protocol Violation|2|||
126400851|NCT01457950|454761323|FG001|Double-Blind Phase|Protocol Violation|1|||
126400852|NCT01457950|454761324|FG002|Double-Blind Phase|Protocol Violation|0|||
126400853|NCT01457950|454761325|FG003|Double-Blind Phase|Protocol Violation|0|||
126400854|NCT01457950|454761322|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
126400855|NCT01457950|454761323|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
126400856|NCT01457950|454761324|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126400857|NCT01457950|454761325|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126400858|NCT01457950|454761322|FG000|Open-Label Phase|Adverse Event|0|||
126400859|NCT01457950|454761323|FG001|Open-Label Phase|Adverse Event|0|||
126400860|NCT01457950|454761324|FG002|Open-Label Phase|Adverse Event|0|||
126400861|NCT01457950|454761325|FG003|Open-Label Phase|Adverse Event|1|||
126400862|NCT01457950|454761322|FG000|Open-Label Phase|Protocol Violation|0|||
126400863|NCT01457950|454761323|FG001|Open-Label Phase|Protocol Violation|0|||
126400864|NCT01457950|454761324|FG002|Open-Label Phase|Protocol Violation|0|||
126400865|NCT01457950|454761325|FG003|Open-Label Phase|Protocol Violation|1|||
126400866|NCT01457950|454761322|FG000|Open-Label Phase|Withdrawal by Subject|0|||
126400867|NCT01457950|454761323|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126400868|NCT01457950|454761324|FG002|Open-Label Phase|Withdrawal by Subject|2|||
126400869|NCT01457950|454761325|FG003|Open-Label Phase|Withdrawal by Subject|0|||
126400870|NCT00435162|454761326|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
126400871|NCT00435162|454761327|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
126400872|NCT00435162|454761328|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
126400873|NCT00435162|454761329|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
126400874|NCT00435162|454761330|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
126400875|NCT00435162|454761331|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
126400876|NCT03351114|454761332|FG000|Overall Study|Withdrawal by Subject|1|||
126400877|NCT01665430|454761333|FG000|Overall Study|Adverse Event|1|||
126400878|NCT01665430|454761333|FG000|Overall Study|Withdrawal by Subject|6|||
126400879|NCT01665430|454761333|FG000|Overall Study|Other Unspecified|2|||
126400880|NCT02310230|454761334|FG000|Overall Study|Physician Decision|1|||
126400881|NCT02310230|454761335|FG001|Overall Study|Physician Decision|3|||
126400882|NCT02310230|454761334|FG000|Overall Study|monitor baseline taken after induction|2|||
126400883|NCT02310230|454761335|FG001|Overall Study|monitor baseline taken after induction|7|||
126400884|NCT02310230|454761334|FG000|Overall Study|Poor signal quality|5|||
126400885|NCT02310230|454761335|FG001|Overall Study|Poor signal quality|8|||
126400886|NCT02310230|454761334|FG000|Overall Study|Case cancelled|1|||
126400887|NCT02310230|454761335|FG001|Overall Study|Case cancelled|0|||
126400888|NCT01371643|454761336|FG000|Overall Study|Withdrawal by Subject|3|||
126105302|NCT00940108|453678574|FG001|Overall Study|Viral illness after Dose 1|1|||
126400889|NCT01371643|454761337|FG001|Overall Study|Withdrawal by Subject|0|||
126400890|NCT03249935|454761338|FG000|Overall Study|Discharged from facility early|36|||
126400891|NCT03249935|454761338|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
126400892|NCT03249935|454761338|FG000|Overall Study|Protocol Violation|5|||
126400893|NCT03593681|454761341|FG000|Overall Study|Inadequate sample collected|12|||
126400894|NCT03593681|454761341|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
126400895|NCT03593681|454761341|FG000|Overall Study|Protocol Violation|3|||
126400896|NCT03593681|454761341|FG000|Overall Study|Withdrawal by Subject|3|||
126400897|NCT03593681|454761341|FG000|Overall Study|Procedure not attempted|3|||
126400898|NCT03593681|454761341|FG000|Overall Study|Adverse Event|2|||
126400899|NCT03593681|454761341|FG000|Overall Study|Physician Decision|1|||
126400900|NCT03987932|454761346|FG000|Overall Study|Lost to Follow-up|2|||
126400901|NCT03987932|454761347|FG001|Overall Study|Lost to Follow-up|1|||
126400902|NCT03987932|454761348|FG002|Overall Study|Lost to Follow-up|1|||
126400903|NCT03987932|454761346|FG000|Overall Study|Non-study related elective surgery|0|||
126400904|NCT03987932|454761347|FG001|Overall Study|Non-study related elective surgery|0|||
126400905|NCT03987932|454761348|FG002|Overall Study|Non-study related elective surgery|1|||
126400906|NCT01669421|454761349|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
126400907|NCT01669421|454761349|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
126400908|NCT01561755|454761357|FG000|Overall Study|Lost to Follow-up|0|||
126400909|NCT01561755|454761358|FG001|Overall Study|Lost to Follow-up|1|||
126400910|NCT04662073|454761360|FG000|Overall Study|Withdrawal by Subject|1|||
126400911|NCT04662073|454761361|FG001|Overall Study|Withdrawal by Subject|0|||
126400912|NCT02961790|454761362|FG000|Overall Study|Canceled|4|||
126400913|NCT02961790|454761363|FG001|Overall Study|Canceled|5|||
126400914|NCT02961790|454761364|FG002|Overall Study|Canceled|1|||
126400915|NCT02961790|454761365|FG003|Overall Study|Canceled|4|||
126400916|NCT02961790|454761362|FG000|Overall Study|without baseline data|4|||
126400917|NCT02961790|454761363|FG001|Overall Study|without baseline data|0|||
126400918|NCT02961790|454761364|FG002|Overall Study|without baseline data|1|||
126400919|NCT02961790|454761365|FG003|Overall Study|without baseline data|0|||
126400920|NCT02961790|454761362|FG000|Overall Study|without post baseline data|7|||
126400921|NCT02961790|454761363|FG001|Overall Study|without post baseline data|6|||
126400922|NCT02961790|454761364|FG002|Overall Study|without post baseline data|4|||
126400923|NCT02961790|454761365|FG003|Overall Study|without post baseline data|1|||
126400924|NCT02185014|454761366|FG000|Overall Study|Adverse Event|18|||
126400925|NCT02185014|454761366|FG000|Overall Study|Withdrew Consent|8|||
126400926|NCT02185014|454761366|FG000|Overall Study|Lost to Follow-up|4|||
126400927|NCT02185014|454761366|FG000|Overall Study|Lack of Efficacy|14|||
126400928|NCT02185014|454761366|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
126400929|NCT02185014|454761366|FG000|Overall Study|Subject Noncompliance|1|||
126400930|NCT02185014|454761366|FG000|Overall Study|Other|4|||
126400931|NCT01479595|454761373|FG000|Overall Study|Protocol deviation|0|||
126400932|NCT01479595|454761374|FG001|Overall Study|Protocol deviation|1|||
126400933|NCT01479595|454761373|FG000|Overall Study|Adverse Event|2|||
126400934|NCT01479595|454761374|FG001|Overall Study|Adverse Event|1|||
126400935|NCT02370641|454761375|FG000|Overall Study|dropped study|4|||
126400936|NCT02370641|454761376|FG001|Overall Study|dropped study|2|||
126400937|NCT02255565|454761381|FG000|Overall Study|Withdrawal by Subject|0|||
126400938|NCT02255565|454761382|FG001|Overall Study|Withdrawal by Subject|1|||
126400939|NCT02255565|454761383|FG002|Overall Study|Withdrawal by Subject|0|||
126400940|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
126400941|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
126400942|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
126400943|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
126400944|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
126400945|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
126400946|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
126400947|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
126400948|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
126400949|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
126400950|NCT03906656|454761384|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
126400951|NCT03906656|454761385|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
126400952|NCT03906656|454761384|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
126400953|NCT03906656|454761385|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
126400954|NCT03906656|454761384|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
126400955|NCT03906656|454761385|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
126400956|NCT03906656|454761384|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
126400957|NCT03906656|454761385|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
126400958|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
126400959|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
126400960|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
126400961|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
126400962|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
126400963|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
126400964|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
126400965|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
126400966|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
126400967|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
126400968|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
126400969|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
126400970|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
126400971|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
126400972|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
126400973|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
126400974|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Death|2|||
126400975|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Death|0|||
126400976|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
126400977|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
126400978|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
126400979|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
126400980|NCT00343915|454761386|FG000|Primary Study|Withdrawal by Subject|1|||
126400981|NCT00343915|454761387|FG001|Primary Study|Withdrawal by Subject|0|||
126400982|NCT00343915|454761386|FG000|Primary Study|Lost to Follow-up|2|||
126400983|NCT00343915|454761387|FG001|Primary Study|Lost to Follow-up|3|||
126400984|NCT00343915|454761386|FG000|Primary Study|Other|1|||
126400985|NCT00343915|454761387|FG001|Primary Study|Other|0|||
126400986|NCT00882908|454761388|FG000|Overall Study|Adverse Event|0|||
126400987|NCT00882908|454761389|FG001|Overall Study|Adverse Event|0|||
126400988|NCT00882908|454761390|FG002|Overall Study|Adverse Event|1|||
126400989|NCT00882908|454761391|FG003|Overall Study|Adverse Event|0|||
126400990|NCT00882908|454761392|FG004|Overall Study|Adverse Event|1|||
126400991|NCT00882908|454761388|FG000|Overall Study|Lost to Follow-up|3|||
126400992|NCT00882908|454761389|FG001|Overall Study|Lost to Follow-up|5|||
126400993|NCT00882908|454761390|FG002|Overall Study|Lost to Follow-up|3|||
126400994|NCT00882908|454761391|FG003|Overall Study|Lost to Follow-up|1|||
126400995|NCT00882908|454761392|FG004|Overall Study|Lost to Follow-up|2|||
126400996|NCT00882908|454761388|FG000|Overall Study|Protocol Violation|0|||
126400997|NCT00882908|454761389|FG001|Overall Study|Protocol Violation|1|||
126400998|NCT00882908|454761390|FG002|Overall Study|Protocol Violation|0|||
126400999|NCT00882908|454761391|FG003|Overall Study|Protocol Violation|0|||
126401000|NCT00882908|454761392|FG004|Overall Study|Protocol Violation|0|||
126401001|NCT00882908|454761388|FG000|Overall Study|Withdrawal by Subject|0|||
126401002|NCT00882908|454761389|FG001|Overall Study|Withdrawal by Subject|0|||
126401003|NCT00882908|454761390|FG002|Overall Study|Withdrawal by Subject|3|||
126401004|NCT00882908|454761391|FG003|Overall Study|Withdrawal by Subject|5|||
126401005|NCT00882908|454761392|FG004|Overall Study|Withdrawal by Subject|2|||
126401006|NCT00882908|454761388|FG000|Overall Study|Subject reached a virologic endpoint|0|||
126401007|NCT00882908|454761389|FG001|Overall Study|Subject reached a virologic endpoint|0|||
126401008|NCT00882908|454761390|FG002|Overall Study|Subject reached a virologic endpoint|0|||
126401009|NCT00882908|454761391|FG003|Overall Study|Subject reached a virologic endpoint|0|||
126401010|NCT00882908|454761392|FG004|Overall Study|Subject reached a virologic endpoint|1|||
126401011|NCT00882908|454761388|FG000|Overall Study|Study terminated in error|0|||
126401012|NCT00882908|454761389|FG001|Overall Study|Study terminated in error|0|||
126401013|NCT00882908|454761390|FG002|Overall Study|Study terminated in error|0|||
126401014|NCT00882908|454761391|FG003|Overall Study|Study terminated in error|1|||
126401015|NCT00882908|454761392|FG004|Overall Study|Study terminated in error|0|||
126401016|NCT05291936|454761393|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
126401017|NCT05291936|454761394|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
126401018|NCT05291936|454761393|FG000|Period 1|Withdrew Consent during study|1|||
126401019|NCT05291936|454761394|FG001|Period 1|Withdrew Consent during study|0|||
126401020|NCT05291936|454761393|FG000|Period 2|Adverse Event|0|||
126401021|NCT05291936|454761394|FG001|Period 2|Adverse Event|1|||
126401022|NCT05291936|454761393|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
126401023|NCT05291936|454761394|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126401024|NCT02370095|454761395|FG000|Overall Study|Withdrawal by Subject|0|||
126401025|NCT02370095|454761396|FG001|Overall Study|Withdrawal by Subject|1|||
126401026|NCT01667562|454761400|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
126401027|NCT01667562|454761401|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
126401028|NCT01667562|454761400|FG000|Erlotinib Phase|Lost to Follow-up|0|||
126401029|NCT01667562|454761401|FG001|Erlotinib Phase|Lost to Follow-up|1|||
126401030|NCT01667562|454761400|FG000|Erlotinib Phase|Adverse Event|0|||
126401031|NCT01667562|454761401|FG001|Erlotinib Phase|Adverse Event|1|||
126401032|NCT01667562|454761400|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
126401033|NCT01667562|454761401|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
126401034|NCT02130986|454761402|FG000|Overall Study|Withdrawal by Subject|4|||
126401035|NCT02130986|454761403|FG001|Overall Study|Withdrawal by Subject|4|||
126401036|NCT02130986|454761402|FG000|Overall Study|Lost to Follow-up|151|||
126401037|NCT02130986|454761403|FG001|Overall Study|Lost to Follow-up|160|||
126401038|NCT01129882|454761404|FG000|Overall Study|Adverse Event|39|||
126401039|NCT01129882|454761404|FG000|Overall Study|Death|6|||
126401040|NCT01129882|454761404|FG000|Overall Study|Lack of Efficacy|5|||
126401041|NCT01129882|454761404|FG000|Overall Study|Lost to Follow-up|13|||
126401042|NCT01129882|454761404|FG000|Overall Study|Physician Decision|27|||
126401043|NCT01129882|454761404|FG000|Overall Study|Protocol Deviation|3|||
126401044|NCT01129882|454761404|FG000|Overall Study|Withdrawal Criteria Met|19|||
126401045|NCT01129882|454761404|FG000|Overall Study|Trial Termination by Sponsor|6|||
126401046|NCT01129882|454761404|FG000|Overall Study|Withdrawal by Subject|160|||
126401047|NCT00993499|454761408|FG000|Run-in Period (8 Days)|Adverse Event|0|||
126401048|NCT00993499|454761409|FG001|Run-in Period (8 Days)|Adverse Event|1|||
126401049|NCT00993499|454761410|FG002|Run-in Period (8 Days)|Adverse Event|0|||
126401050|NCT00993499|454761411|FG003|Run-in Period (8 Days)|Adverse Event|0|||
126401051|NCT00993499|454761412|FG004|Run-in Period (8 Days)|Adverse Event|0|||
126401052|NCT00993499|454761413|FG005|Run-in Period (8 Days)|Adverse Event|0|||
126401053|NCT00993499|454761408|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
126401054|NCT00993499|454761409|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401055|NCT00993499|454761410|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401056|NCT00993499|454761411|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401057|NCT00993499|454761412|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401058|NCT00993499|454761413|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401059|NCT00993499|454761408|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
126401060|NCT00993499|454761409|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
126401061|NCT00993499|454761410|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
126401062|NCT00993499|454761411|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
126401063|NCT00993499|454761412|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
126401064|NCT00993499|454761413|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
126401065|NCT00993499|454761408|FG000|Run-in Period (8 Days)|Progressive disease|0|||
126401066|NCT00993499|454761409|FG001|Run-in Period (8 Days)|Progressive disease|1|||
126401067|NCT00993499|454761410|FG002|Run-in Period (8 Days)|Progressive disease|1|||
126401068|NCT00993499|454761411|FG003|Run-in Period (8 Days)|Progressive disease|0|||
126401069|NCT00993499|454761412|FG004|Run-in Period (8 Days)|Progressive disease|0|||
126401070|NCT00993499|454761413|FG005|Run-in Period (8 Days)|Progressive disease|0|||
126401071|NCT00993499|454761408|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
126401072|NCT00993499|454761409|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
126401073|NCT00993499|454761410|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
126401074|NCT00993499|454761411|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
126401075|NCT00993499|454761412|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
126401076|NCT00993499|454761413|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
126401077|NCT00993499|454761408|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
126401078|NCT00993499|454761409|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
126401079|NCT00993499|454761410|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
126401080|NCT00993499|454761411|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
126401081|NCT00993499|454761412|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
126401082|NCT00993499|454761413|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
126401083|NCT00993499|454761408|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
126401084|NCT00993499|454761409|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
126401085|NCT00993499|454761410|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
126401086|NCT00993499|454761411|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
126401087|NCT00993499|454761412|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
126401088|NCT00993499|454761413|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
126401089|NCT00993499|454761408|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401090|NCT00993499|454761409|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401091|NCT00993499|454761410|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
126401092|NCT00993499|454761411|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401093|NCT00993499|454761412|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401094|NCT00993499|454761413|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401095|NCT00993499|454761408|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401096|NCT00993499|454761409|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
126401097|NCT00993499|454761410|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401098|NCT00993499|454761411|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401099|NCT00993499|454761412|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401100|NCT00993499|454761413|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401101|NCT00993499|454761408|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
126401102|NCT00993499|454761409|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
126401103|NCT00993499|454761410|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
126401104|NCT00993499|454761411|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
126401105|NCT00993499|454761412|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
126401106|NCT00993499|454761413|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
126401107|NCT00993499|454761408|FG000|Discontinued After Starting Course 3|DLT|1|||
126401108|NCT00993499|454761409|FG001|Discontinued After Starting Course 3|DLT|0|||
126401109|NCT00993499|454761410|FG002|Discontinued After Starting Course 3|DLT|2|||
126401110|NCT00993499|454761411|FG003|Discontinued After Starting Course 3|DLT|1|||
126401111|NCT00993499|454761412|FG004|Discontinued After Starting Course 3|DLT|0|||
126401112|NCT00993499|454761413|FG005|Discontinued After Starting Course 3|DLT|0|||
126401113|NCT00993499|454761408|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
125890025|NCT00555061|452895423|FG000|Overall Study|Participant enrolled, but never treated|1|||
125890026|NCT00485134|452895425|FG000|Overall Study|Lost to Follow-up|1|||
125890027|NCT00485134|452895426|FG001|Overall Study|Lost to Follow-up|0|||
125890028|NCT00485134|452895427|FG002|Overall Study|Lost to Follow-up|0|||
125890029|NCT00485134|452895428|FG003|Overall Study|Lost to Follow-up|0|||
125890030|NCT00485134|452895429|FG004|Overall Study|Lost to Follow-up|0|||
125890031|NCT00485134|452895430|FG005|Overall Study|Lost to Follow-up|0|||
125890032|NCT00485134|452895431|FG006|Overall Study|Lost to Follow-up|0|||
125890033|NCT00485134|452895432|FG007|Overall Study|Lost to Follow-up|0|||
125890034|NCT00485134|452895425|FG000|Overall Study|Withdrawal by Subject|0|||
125890035|NCT00485134|452895426|FG001|Overall Study|Withdrawal by Subject|1|||
125890036|NCT00485134|452895427|FG002|Overall Study|Withdrawal by Subject|0|||
126401114|NCT00993499|454761409|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
125890037|NCT00485134|452895428|FG003|Overall Study|Withdrawal by Subject|0|||
125890038|NCT00485134|452895429|FG004|Overall Study|Withdrawal by Subject|0|||
125890039|NCT00485134|452895430|FG005|Overall Study|Withdrawal by Subject|0|||
125890040|NCT00485134|452895431|FG006|Overall Study|Withdrawal by Subject|0|||
125890041|NCT00485134|452895432|FG007|Overall Study|Withdrawal by Subject|0|||
125890042|NCT00485134|452895425|FG000|Overall Study|Change in health status|0|||
125890043|NCT00485134|452895426|FG001|Overall Study|Change in health status|1|||
125890044|NCT00485134|452895427|FG002|Overall Study|Change in health status|2|||
125890045|NCT00485134|452895428|FG003|Overall Study|Change in health status|1|||
125890046|NCT00485134|452895429|FG004|Overall Study|Change in health status|0|||
125890047|NCT00485134|452895430|FG005|Overall Study|Change in health status|1|||
125890048|NCT00485134|452895431|FG006|Overall Study|Change in health status|0|||
125890049|NCT00485134|452895432|FG007|Overall Study|Change in health status|0|||
125890050|NCT00485134|452895425|FG000|Overall Study|Withdrew for adverse event|0|||
125890051|NCT00485134|452895426|FG001|Overall Study|Withdrew for adverse event|0|||
125890052|NCT00485134|452895427|FG002|Overall Study|Withdrew for adverse event|1|||
125890053|NCT00485134|452895428|FG003|Overall Study|Withdrew for adverse event|0|||
125890054|NCT00485134|452895429|FG004|Overall Study|Withdrew for adverse event|0|||
126105303|NCT00940108|453678575|FG002|Overall Study|Viral illness after Dose 1|0|||
126401115|NCT00993499|454761410|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
126401116|NCT00993499|454761411|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
126401117|NCT00993499|454761412|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
126401118|NCT00993499|454761413|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
126401119|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
126401120|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
126401121|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
126401122|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
126401123|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
126401124|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
126401125|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
126401126|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
126401127|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
126401128|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
126401129|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Other|4|||
126401130|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Other|0|||
125890055|NCT00485134|452895430|FG005|Overall Study|Withdrew for adverse event|0|||
126105304|NCT00940108|453678576|FG003|Overall Study|Viral illness after Dose 1|0|||
125890056|NCT00485134|452895431|FG006|Overall Study|Withdrew for adverse event|0|||
125890057|NCT00485134|452895432|FG007|Overall Study|Withdrew for adverse event|0|||
125890058|NCT00485134|452895425|FG000|Overall Study|Positive drug test|0|||
125890059|NCT00485134|452895426|FG001|Overall Study|Positive drug test|0|||
126401131|NCT01352741|454761414|FG000|Double-blind Comparative Period|Protocol Violation|2|||
126401132|NCT01352741|454761415|FG001|Double-blind Comparative Period|Protocol Violation|0|||
126401133|NCT01352741|454761414|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
126401134|NCT01352741|454761415|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
126401135|NCT01352741|454761414|FG000|Double-blind Comparative Period|Adverse Event|16|||
126401136|NCT01352741|454761415|FG001|Double-blind Comparative Period|Adverse Event|17|||
126401137|NCT01352741|454761414|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
126401138|NCT01352741|454761415|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
126401139|NCT01352741|454761414|FG000|Double-blind Comparative Period|Death|0|||
126401140|NCT01352741|454761415|FG001|Double-blind Comparative Period|Death|1|||
126401141|NCT01352741|454761414|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
126401142|NCT01352741|454761415|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
126401143|NCT01352741|454761414|FG000|Double-blind Comparative Period|Other|1|||
126401144|NCT01352741|454761415|FG001|Double-blind Comparative Period|Other|2|||
126401145|NCT01352741|454761414|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
126401146|NCT01352741|454761415|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
126401147|NCT01352741|454761414|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
126401148|NCT01352741|454761415|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
126105305|NCT00940108|453678573|FG000|Overall Study|Diagnosed with H1N1|0|||
126105306|NCT00940108|453678574|FG001|Overall Study|Diagnosed with H1N1|0|||
126105307|NCT00940108|453678575|FG002|Overall Study|Diagnosed with H1N1|0|||
126105308|NCT00940108|453678576|FG003|Overall Study|Diagnosed with H1N1|1|||
126105309|NCT02075541|453678577|FG000|Overall Study|Serious Adverse Event|1|||
126105310|NCT02075541|453678578|FG001|Overall Study|Serious Adverse Event|4|||
126105311|NCT02075541|453678577|FG000|Overall Study|Protocol Violation|1|||
126105312|NCT02075541|453678578|FG001|Overall Study|Protocol Violation|0|||
126105313|NCT02075541|453678577|FG000|Overall Study|Withdrawal by Subject|1|||
126105314|NCT02075541|453678578|FG001|Overall Study|Withdrawal by Subject|3|||
126105315|NCT02075541|453678577|FG000|Overall Study|Sponsor study termination|0|||
126105316|NCT02075541|453678578|FG001|Overall Study|Sponsor study termination|1|||
126105317|NCT02075541|453678577|FG000|Overall Study|Other- unable to perform study procedure|1|||
126105318|NCT02075541|453678578|FG001|Overall Study|Other- unable to perform study procedure|0|||
126105319|NCT01142596|453678580|FG000|Overall Study|Withdrawal by Subject|9|||
126105320|NCT01142596|453678581|FG001|Overall Study|Withdrawal by Subject|35|||
126105321|NCT01142596|453678580|FG000|Overall Study|Adverse Event|8|||
126105322|NCT01142596|453678581|FG001|Overall Study|Adverse Event|35|||
126105323|NCT01142596|453678580|FG000|Overall Study|Lack of Efficacy|5|||
126105324|NCT01142596|453678581|FG001|Overall Study|Lack of Efficacy|9|||
126105325|NCT01142596|453678580|FG000|Overall Study|Lost to Follow-up|2|||
126105326|NCT01142596|453678581|FG001|Overall Study|Lost to Follow-up|3|||
126105327|NCT01142596|453678580|FG000|Overall Study|Other reason (not specified)|5|||
126105328|NCT01142596|453678581|FG001|Overall Study|Other reason (not specified)|4|||
126105329|NCT01054846|453678582|FG000|Overall Study|Lost to Follow-up|76|||
126105330|NCT01054846|453678583|FG001|Overall Study|Lost to Follow-up|17|||
126105331|NCT02446886|453678584|FG000|Overall Study|Adverse Event|1|||
126105332|NCT02446886|453678585|FG001|Overall Study|Adverse Event|3|||
126105333|NCT02446886|453678584|FG000|Overall Study|Withdrawal by Subject|1|||
126105334|NCT02446886|453678585|FG001|Overall Study|Withdrawal by Subject|1|||
126105335|NCT00928447|453678586|FG000|Overall Study|Withdrawal by Subject|1|||
126105336|NCT00928447|453678586|FG000|Overall Study|Investigator's decision|1|||
126105337|NCT01259284|453678587|FG000|Overall Study|Study Termination|2|||
126105338|NCT01259284|453678588|FG001|Overall Study|Study Termination|0|||
126105339|NCT01259284|453678589|FG002|Overall Study|Study Termination|0|||
126105340|NCT02988622|453678590|FG000|Overall Study|Lost to Follow-up|17|||
126105341|NCT01204398|453678594|FG000|Overall Study|Adverse Event|1|||
126105342|NCT03562247|453678595|FG000|Overall Study|Lost to Follow-up|3|||
126105343|NCT03562247|453678596|FG001|Overall Study|Lost to Follow-up|1|||
126401149|NCT01352741|454761414|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
126401150|NCT01352741|454761415|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
126401151|NCT01352741|454761414|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
126401152|NCT01352741|454761415|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
126401153|NCT00645528|454761416|FG000|Overall Study|Did not show up for Visit 2|7|||
126401154|NCT02725593|454761419|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
126401155|NCT02725593|454761420|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
126401156|NCT02725593|454761419|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
126401157|NCT02725593|454761420|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
126401158|NCT02725593|454761419|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
126401159|NCT02725593|454761420|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
126401160|NCT02725593|454761419|FG000|Long Term Extension|Withdrawal by Subject|1|||
126401161|NCT02725593|454761420|FG001|Long Term Extension|Withdrawal by Subject|3|||
126401162|NCT03654885|454762920|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
126401163|NCT03654885|454762921|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
126401164|NCT03654885|454762920|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
126401165|NCT03654885|454762921|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
126401166|NCT03654885|454762920|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
126401167|NCT03654885|454762921|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
126401168|NCT03654885|454762920|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
126401169|NCT03654885|454762921|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
126401170|NCT03654885|454762920|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
126401171|NCT03654885|454762921|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
126401172|NCT03654885|454762920|FG000|Overall Study|Adverse Event in Study Eye|3|||
126401173|NCT03654885|454762921|FG001|Overall Study|Adverse Event in Study Eye|0|||
126401174|NCT03654885|454762920|FG000|Overall Study|Consent Withdrawn|1|||
126401175|NCT03654885|454762921|FG001|Overall Study|Consent Withdrawn|0|||
126401176|NCT03654885|454762920|FG000|Overall Study|Death|3|||
126401177|NCT03654885|454762921|FG001|Overall Study|Death|1|||
126401178|NCT03654885|454762920|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
126401179|NCT03654885|454762921|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
126401180|NCT03654885|454762920|FG000|Overall Study|Lost to Follow-up|3|||
126401181|NCT03654885|454762921|FG001|Overall Study|Lost to Follow-up|3|||
126401182|NCT05275582|454762922|FG000|Overall Study|Lost to Follow-up|1|||
126401183|NCT05275582|454762923|FG001|Overall Study|Lost to Follow-up|0|||
126401184|NCT05275582|454762922|FG000|Overall Study|Withdrawal by Subject|0|||
126401185|NCT05275582|454762923|FG001|Overall Study|Withdrawal by Subject|2|||
126401186|NCT05275582|454762922|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
126401187|NCT05275582|454762923|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
126401188|NCT05275582|454762922|FG000|Overall Study|Death|1|||
126401189|NCT05275582|454762923|FG001|Overall Study|Death|0|||
126401190|NCT05275582|454762922|FG000|Overall Study|Protocol Violation|1|||
126401191|NCT05275582|454762923|FG001|Overall Study|Protocol Violation|0|||
126401192|NCT04411420|454762924|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
126401193|NCT04411420|454762925|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
126401194|NCT04411420|454762924|FG000|Survey Subset|Lost to Follow-up|134|||
126401195|NCT04411420|454762925|FG001|Survey Subset|Lost to Follow-up|120|||
126401196|NCT03899064|454762926|FG000|Overall Study|Lost to Follow-up|1|||
126401197|NCT03899064|454762926|FG000|Overall Study|Protocol Violation|2|||
126401198|NCT03899064|454762926|FG000|Overall Study|Withdrawal by Subject|2|||
126401199|NCT03899064|454762926|FG000|Overall Study|Other|2|||
126401200|NCT00031460|454762931|FG000|Overall Study|Lost to Follow-up|0|||
126401201|NCT00031460|454762932|FG001|Overall Study|Lost to Follow-up|1|||
126401202|NCT00031460|454762931|FG000|Overall Study|Withdrawal by Subject|1|||
126401203|NCT00031460|454762932|FG001|Overall Study|Withdrawal by Subject|1|||
126401204|NCT00031460|454762931|FG000|Overall Study|Non-Compliant|1|||
126401205|NCT00031460|454762932|FG001|Overall Study|Non-Compliant|1|||
126401206|NCT00031460|454762931|FG000|Overall Study|Death|0|||
126401207|NCT00031460|454762932|FG001|Overall Study|Death|1|||
126401208|NCT00031460|454762931|FG000|Overall Study|Reactivation of Disease|5|||
126401209|NCT00031460|454762932|FG001|Overall Study|Reactivation of Disease|9|||
126401210|NCT00031460|454762931|FG000|Overall Study|Disruption of blinded drug supply|2|||
126401211|NCT00031460|454762932|FG001|Overall Study|Disruption of blinded drug supply|0|||
126401212|NCT00031460|454762931|FG000|Overall Study|Confirmed unevaluable|0|||
126401213|NCT00031460|454762932|FG001|Overall Study|Confirmed unevaluable|1|||
126401214|NCT02210832|454762933|FG000|Overall Study|Pregnancy termination .|3|||
126401215|NCT02210832|454762934|FG001|Overall Study|Pregnancy termination .|4|||
126401216|NCT02210832|454762935|FG002|Overall Study|Pregnancy termination .|1|||
126401217|NCT02210832|454762933|FG000|Overall Study|Lost to Follow-up|26|||
126401218|NCT02210832|454762934|FG001|Overall Study|Lost to Follow-up|32|||
126401219|NCT02210832|454762935|FG002|Overall Study|Lost to Follow-up|17|||
126401220|NCT02080260|454762939|FG000|Overall Study|Death|18|||
126401221|NCT02080260|454762939|FG000|Overall Study|Withdrawal by Subject|1|||
126401222|NCT00471887|454762943|FG000|Overall Study|Adverse Event|9|||
126401223|NCT00524589|454762953|FG000|Overall Study|Withdrawal by Subject|2|||
126401224|NCT00524589|454762953|FG000|Overall Study|Disease Progression|16|||
126401225|NCT01030874|454762955|FG000|Overall Study|Withdrawal by Subject|1|||
126401226|NCT01030874|454762956|FG001|Overall Study|Withdrawal by Subject|0|||
126401227|NCT01030874|454762955|FG000|Overall Study|Discharged in first 2 weeks|17|||
126401228|NCT01030874|454762956|FG001|Overall Study|Discharged in first 2 weeks|16|||
126401229|NCT01998893|454762957|FG000|Overall Study|Adverse Event|2|||
126401230|NCT01998893|454762957|FG000|Overall Study|Death|1|||
126401231|NCT01998893|454762957|FG000|Overall Study|Lost to Follow-up|8|||
126401232|NCT01998893|454762957|FG000|Overall Study|Physician Decision|2|||
126401233|NCT01998893|454762957|FG000|Overall Study|Protocol Violation|2|||
126401234|NCT01998893|454762957|FG000|Overall Study|Withdrawal by Subject|1|||
126401235|NCT01998893|454762957|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
126401236|NCT02046174|454762958|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
126401237|NCT02046174|454762959|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
126401238|NCT02118597|454762960|FG000|Overall Study|Sponsor terminated the study|14|||
126401239|NCT02118597|454762960|FG000|Overall Study|Serious Adverse Event|1|||
126401240|NCT02118597|454762960|FG000|Overall Study|Investigator's decision|1|||
126401241|NCT01891344|454762961|FG000|Overall Study|Ongoing|6|||
126401242|NCT01891344|454762962|FG001|Overall Study|Ongoing|2|||
126401243|NCT01891344|454762963|FG002|Overall Study|Ongoing|0|||
126401244|NCT01891344|454762964|FG003|Overall Study|Ongoing|1|||
126401245|NCT01891344|454762965|FG004|Overall Study|Ongoing|4|||
126401246|NCT01891344|454762966|FG005|Overall Study|Ongoing|1|||
126401247|NCT01891344|454762967|FG006|Overall Study|Ongoing|0|||
126401248|NCT01891344|454762968|FG007|Overall Study|Ongoing|0|||
126401249|NCT02969590|454762969|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
126401250|NCT02969590|454762970|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
126401251|NCT02969590|454762971|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
126401252|NCT00186537|454762972|FG000|Overall Study|Withdrawal by Subject|4|||
126401253|NCT00186537|454762973|FG001|Overall Study|Withdrawal by Subject|0|||
126401254|NCT00186537|454762974|FG002|Overall Study|Withdrawal by Subject|3|||
126401255|NCT00186537|454762972|FG000|Overall Study|ALT > 1.5 x ULN|3|||
126401256|NCT00186537|454762973|FG001|Overall Study|ALT > 1.5 x ULN|0|||
126401257|NCT00186537|454762974|FG002|Overall Study|ALT > 1.5 x ULN|0|||
126401258|NCT03294135|454762975|FG000|Overall Study|Serious Adverse Event|1|||
126401259|NCT03294135|454762976|FG001|Overall Study|Serious Adverse Event|0|||
126401260|NCT03294135|454762977|FG002|Overall Study|Serious Adverse Event|0|||
126401261|NCT03294135|454762975|FG000|Overall Study|Lost to Follow-up|1|||
126401262|NCT03294135|454762976|FG001|Overall Study|Lost to Follow-up|0|||
126401263|NCT03294135|454762977|FG002|Overall Study|Lost to Follow-up|1|||
126401264|NCT03294135|454762975|FG000|Overall Study|Withdrawal by Subject|0|||
126401265|NCT03294135|454762976|FG001|Overall Study|Withdrawal by Subject|0|||
126401266|NCT03294135|454762977|FG002|Overall Study|Withdrawal by Subject|1|||
126401267|NCT03294135|454762975|FG000|Overall Study|Other|2|||
126401268|NCT03294135|454762976|FG001|Overall Study|Other|0|||
126401269|NCT03294135|454762977|FG002|Overall Study|Other|0|||
126401270|NCT02590562|454762978|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
126401271|NCT02763254|454762979|FG000|Overall Study|Adverse Event|1|||
126401272|NCT03684304|454762980|FG000|Overall Study|Lost to Follow-up|19|||
126401273|NCT03684304|454762981|FG001|Overall Study|Lost to Follow-up|17|||
126401274|NCT00054691|454762982|FG000|Overall Study|Unmeasurable Disease|2|||
126401275|NCT00054691|454762982|FG000|Overall Study|Noncompliant|1|||
126401276|NCT02078102|454762987|FG000|Overall Study|Adverse Event|1|||
126401277|NCT02078102|454762988|FG001|Overall Study|Adverse Event|0|||
126401278|NCT02078102|454762987|FG000|Overall Study|Withdrawal by Subject|1|||
126401279|NCT02078102|454762988|FG001|Overall Study|Withdrawal by Subject|0|||
126401280|NCT02078102|454762987|FG000|Overall Study|Physician Decision|0|||
126401281|NCT02078102|454762988|FG001|Overall Study|Physician Decision|1|||
126401282|NCT00598078|454762991|FG000|Period 2 (Day 2)|Adverse Event|1|||
126401283|NCT00598078|454762992|FG001|Period 2 (Day 2)|Adverse Event|0|||
126401284|NCT02387164|454762995|FG000|Overall Study|Lost to Follow-up|2|||
126401285|NCT02387164|454762996|FG001|Overall Study|Lost to Follow-up|0|||
126401286|NCT02387164|454762995|FG000|Overall Study|Diagnosed|1|||
126401287|NCT02387164|454762996|FG001|Overall Study|Diagnosed|2|||
126401288|NCT02133664|454762997|FG000|Overall Study|Lost to Follow-up|2|||
126401289|NCT02133664|454762998|FG001|Overall Study|Lost to Follow-up|1|||
126401290|NCT02133664|454762997|FG000|Overall Study|Adverse Event|3|||
126401291|NCT02133664|454762998|FG001|Overall Study|Adverse Event|6|||
126401292|NCT02120365|454763005|FG000|Overall Study|Withdrawal by Subject|0|||
126401293|NCT02120365|454763006|FG001|Overall Study|Withdrawal by Subject|0|||
126401294|NCT02120365|454763007|FG002|Overall Study|Withdrawal by Subject|2|||
126401295|NCT02120365|454763008|FG003|Overall Study|Withdrawal by Subject|4|||
126401296|NCT02120365|454763009|FG004|Overall Study|Withdrawal by Subject|0|||
126401297|NCT02120365|454763010|FG005|Overall Study|Withdrawal by Subject|2|||
126401298|NCT01719003|454763013|FG000|Overall Study|Non compliant with protocol|1|||
126401299|NCT01719003|454763014|FG001|Overall Study|Non compliant with protocol|1|||
126401300|NCT01719003|454763015|FG002|Overall Study|Non compliant with protocol|0|||
126401301|NCT01719003|454763016|FG003|Overall Study|Non compliant with protocol|1|||
126401302|NCT01719003|454763017|FG004|Overall Study|Non compliant with protocol|2|||
126401303|NCT01719003|454763018|FG005|Overall Study|Non compliant with protocol|1|||
126401304|NCT01719003|454763019|FG006|Overall Study|Non compliant with protocol|2|||
126401305|NCT01719003|454763020|FG007|Overall Study|Non compliant with protocol|3|||
126401306|NCT01719003|454763021|FG008|Overall Study|Non compliant with protocol|0|||
126401307|NCT01719003|454763013|FG000|Overall Study|Adverse Event|6|||
126401308|NCT01719003|454763014|FG001|Overall Study|Adverse Event|5|||
126401309|NCT01719003|454763015|FG002|Overall Study|Adverse Event|4|||
126401310|NCT01719003|454763016|FG003|Overall Study|Adverse Event|3|||
126401311|NCT01719003|454763017|FG004|Overall Study|Adverse Event|4|||
126401312|NCT01719003|454763018|FG005|Overall Study|Adverse Event|3|||
126401313|NCT01719003|454763019|FG006|Overall Study|Adverse Event|6|||
126401314|NCT01719003|454763020|FG007|Overall Study|Adverse Event|5|||
126401315|NCT01719003|454763021|FG008|Overall Study|Adverse Event|0|||
126401316|NCT01719003|454763013|FG000|Overall Study|Lost to Follow-up|0|||
126401317|NCT01719003|454763014|FG001|Overall Study|Lost to Follow-up|6|||
126401318|NCT01719003|454763015|FG002|Overall Study|Lost to Follow-up|7|||
126401319|NCT01719003|454763016|FG003|Overall Study|Lost to Follow-up|2|||
126401320|NCT01719003|454763017|FG004|Overall Study|Lost to Follow-up|3|||
126401321|NCT01719003|454763018|FG005|Overall Study|Lost to Follow-up|4|||
126401322|NCT01719003|454763019|FG006|Overall Study|Lost to Follow-up|3|||
126401323|NCT01719003|454763020|FG007|Overall Study|Lost to Follow-up|2|||
126401324|NCT01719003|454763021|FG008|Overall Study|Lost to Follow-up|2|||
126401325|NCT01719003|454763013|FG000|Overall Study|Refusal to continue, not due to AE|2|||
126401326|NCT01719003|454763014|FG001|Overall Study|Refusal to continue, not due to AE|5|||
126401327|NCT01719003|454763015|FG002|Overall Study|Refusal to continue, not due to AE|4|||
126401328|NCT01719003|454763016|FG003|Overall Study|Refusal to continue, not due to AE|4|||
126401329|NCT01719003|454763017|FG004|Overall Study|Refusal to continue, not due to AE|4|||
126401330|NCT01719003|454763018|FG005|Overall Study|Refusal to continue, not due to AE|3|||
126401331|NCT01719003|454763019|FG006|Overall Study|Refusal to continue, not due to AE|8|||
126401332|NCT01719003|454763020|FG007|Overall Study|Refusal to continue, not due to AE|7|||
126401333|NCT01719003|454763021|FG008|Overall Study|Refusal to continue, not due to AE|1|||
126401334|NCT01719003|454763013|FG000|Overall Study|Reason other than those specified|0|||
126401335|NCT01719003|454763014|FG001|Overall Study|Reason other than those specified|0|||
126401336|NCT01719003|454763015|FG002|Overall Study|Reason other than those specified|2|||
126401337|NCT01719003|454763016|FG003|Overall Study|Reason other than those specified|3|||
126401338|NCT01719003|454763017|FG004|Overall Study|Reason other than those specified|4|||
126401339|NCT01719003|454763018|FG005|Overall Study|Reason other than those specified|1|||
126401340|NCT01719003|454763019|FG006|Overall Study|Reason other than those specified|0|||
126401341|NCT01719003|454763020|FG007|Overall Study|Reason other than those specified|3|||
126401342|NCT01719003|454763021|FG008|Overall Study|Reason other than those specified|1|||
126401343|NCT01719003|454763013|FG000|Overall Study|Lack of Efficacy|0|||
126401344|NCT01719003|454763014|FG001|Overall Study|Lack of Efficacy|0|||
126401345|NCT01719003|454763015|FG002|Overall Study|Lack of Efficacy|0|||
126401346|NCT01719003|454763016|FG003|Overall Study|Lack of Efficacy|0|||
126401347|NCT01719003|454763017|FG004|Overall Study|Lack of Efficacy|0|||
126401348|NCT01719003|454763018|FG005|Overall Study|Lack of Efficacy|0|||
126401349|NCT01719003|454763019|FG006|Overall Study|Lack of Efficacy|1|||
126401350|NCT01719003|454763020|FG007|Overall Study|Lack of Efficacy|0|||
126401351|NCT01719003|454763021|FG008|Overall Study|Lack of Efficacy|0|||
126401352|NCT00581828|454763022|FG000|Overall Study|Protocol Violation|1|||
126401353|NCT02525939|454763023|FG000|Overall Study|Lost to Follow-up|27|||
126401354|NCT02525939|454763024|FG001|Overall Study|Lost to Follow-up|24|||
126401355|NCT02525939|454763023|FG000|Overall Study|Physician Decision|0|||
126401356|NCT02525939|454763024|FG001|Overall Study|Physician Decision|1|||
126401357|NCT02525939|454763023|FG000|Overall Study|Withdrawal by Subject|24|||
126401358|NCT02525939|454763024|FG001|Overall Study|Withdrawal by Subject|39|||
126401359|NCT02525939|454763023|FG000|Overall Study|Death|180|||
126401360|NCT02525939|454763024|FG001|Overall Study|Death|179|||
126401361|NCT01996592|454763035|FG000|Overall Study|no response to text/no diary entry|32|||
126401362|NCT01996592|454763035|FG000|Overall Study|change in surgical date|4|||
126401363|NCT01996592|454763035|FG000|Overall Study|Withdrawal by Subject|5|||
126401364|NCT01996592|454763035|FG000|Overall Study|change in mode of delivery|4|||
126401365|NCT01406015|454763036|FG000|Overall Study|Withdrawal by Subject|3|||
126401366|NCT01406015|454763037|FG001|Overall Study|Withdrawal by Subject|3|||
126401367|NCT00394901|454763038|FG000|Baseline Phase|Protocol Violation|0|||
126401368|NCT00394901|454763039|FG001|Baseline Phase|Protocol Violation|0|||
126401369|NCT00394901|454763040|FG002|Baseline Phase|Protocol Violation|1|||
126401370|NCT00394901|454763041|FG003|Baseline Phase|Protocol Violation|0|||
126401371|NCT00394901|454763038|FG000|Double-blind Phase|Adverse Event|5|||
126401372|NCT00394901|454763039|FG001|Double-blind Phase|Adverse Event|7|||
126401373|NCT00394901|454763040|FG002|Double-blind Phase|Adverse Event|16|||
126401374|NCT00394901|454763041|FG003|Double-blind Phase|Adverse Event|20|||
126401375|NCT00394901|454763038|FG000|Double-blind Phase|Lack of Efficacy|6|||
126401376|NCT00394901|454763039|FG001|Double-blind Phase|Lack of Efficacy|4|||
126401377|NCT00394901|454763040|FG002|Double-blind Phase|Lack of Efficacy|1|||
126401378|NCT00394901|454763041|FG003|Double-blind Phase|Lack of Efficacy|3|||
126401379|NCT00394901|454763038|FG000|Double-blind Phase|Withdrawal by Subject|2|||
126401380|NCT00394901|454763039|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126401381|NCT00394901|454763040|FG002|Double-blind Phase|Withdrawal by Subject|0|||
126401382|NCT00394901|454763041|FG003|Double-blind Phase|Withdrawal by Subject|0|||
126401383|NCT00394901|454763038|FG000|Double-blind Phase|Lost to Follow-up|0|||
126401384|NCT00394901|454763039|FG001|Double-blind Phase|Lost to Follow-up|0|||
126401385|NCT00394901|454763040|FG002|Double-blind Phase|Lost to Follow-up|0|||
126401386|NCT00394901|454763041|FG003|Double-blind Phase|Lost to Follow-up|1|||
126401387|NCT00394901|454763038|FG000|Double-blind Phase|Protocol Violation|0|||
126401388|NCT00394901|454763039|FG001|Double-blind Phase|Protocol Violation|0|||
126401389|NCT00394901|454763040|FG002|Double-blind Phase|Protocol Violation|0|||
126401390|NCT00394901|454763041|FG003|Double-blind Phase|Protocol Violation|1|||
126401391|NCT00394901|454763038|FG000|Double-blind Phase|Death|1|||
126401392|NCT00394901|454763039|FG001|Double-blind Phase|Death|0|||
126401393|NCT00394901|454763040|FG002|Double-blind Phase|Death|0|||
126401394|NCT00394901|454763041|FG003|Double-blind Phase|Death|0|||
126401395|NCT00394901|454763038|FG000|Double-blind Phase|Subject's Personal Reason|1|||
126401396|NCT00394901|454763039|FG001|Double-blind Phase|Subject's Personal Reason|0|||
126401397|NCT00394901|454763040|FG002|Double-blind Phase|Subject's Personal Reason|0|||
126401398|NCT00394901|454763041|FG003|Double-blind Phase|Subject's Personal Reason|1|||
126401399|NCT00394901|454763038|FG000|Double-blind Phase|Lack of Compliance|0|||
126401400|NCT00394901|454763039|FG001|Double-blind Phase|Lack of Compliance|3|||
126401401|NCT00394901|454763040|FG002|Double-blind Phase|Lack of Compliance|0|||
126401402|NCT00394901|454763041|FG003|Double-blind Phase|Lack of Compliance|0|||
126401403|NCT00394901|454763038|FG000|Double-blind Phase|Entry into another study was found|0|||
126401404|NCT00394901|454763039|FG001|Double-blind Phase|Entry into another study was found|0|||
126401405|NCT00394901|454763040|FG002|Double-blind Phase|Entry into another study was found|1|||
126401406|NCT00394901|454763041|FG003|Double-blind Phase|Entry into another study was found|0|||
126401407|NCT00394901|454763038|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
126401408|NCT00394901|454763039|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
126401409|NCT00394901|454763040|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
126401410|NCT00394901|454763041|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
126401411|NCT05028517|454763042|FG000|Overall Study|Lost to Follow-up|13|||
126401412|NCT05028517|454763043|FG001|Overall Study|Lost to Follow-up|20|||
126401413|NCT05028517|454763044|FG002|Overall Study|Lost to Follow-up|12|||
126401414|NCT05028517|454763042|FG000|Overall Study|Withdrawal by Subject|0|||
126401415|NCT05028517|454763043|FG001|Overall Study|Withdrawal by Subject|0|||
126401416|NCT05028517|454763044|FG002|Overall Study|Withdrawal by Subject|1|||
126401417|NCT00259298|454763046|FG000|Overall Study|Withdrawal by Subject|1|||
126401418|NCT00259298|454763046|FG000|Overall Study|Physician Decision|2|||
126401419|NCT01886690|454763047|FG000|Overall Study|Protocol Violation|0|||
126401420|NCT01886690|454763048|FG001|Overall Study|Protocol Violation|1|||
126401421|NCT01886690|454763047|FG000|Overall Study|Personal Reasons|0|||
126401422|NCT01886690|454763048|FG001|Overall Study|Personal Reasons|1|||
126401423|NCT02360293|454763051|FG000|Overall Study|Lost to Follow-up|73|||
126401424|NCT02360293|454763052|FG001|Overall Study|Lost to Follow-up|95|||
126401425|NCT02360293|454763051|FG000|Overall Study|Withdrawal by Subject|2|||
126401426|NCT02360293|454763052|FG001|Overall Study|Withdrawal by Subject|1|||
126401427|NCT02360293|454763051|FG000|Overall Study|Excluded|1|||
126401428|NCT02360293|454763052|FG001|Overall Study|Excluded|0|||
126401429|NCT04316741|454763053|FG000|Baseline Enrollment|Lost to Follow-up|1|||
126401430|NCT04316741|454763054|FG001|Baseline Enrollment|Lost to Follow-up|1|||
126401431|NCT04316741|454763053|FG000|Immediate Post-Test|Lost to Follow-up|5|||
126401432|NCT04316741|454763054|FG001|Immediate Post-Test|Lost to Follow-up|1|||
126401433|NCT04316741|454763053|FG000|1-month Post-test|Lost to Follow-up|7|||
126401434|NCT04316741|454763054|FG001|1-month Post-test|Lost to Follow-up|2|||
126401435|NCT04316741|454763053|FG000|3-month Follow-up|Lost to Follow-up|10|||
126401436|NCT04316741|454763054|FG001|3-month Follow-up|Lost to Follow-up|2|||
126401437|NCT01510145|454763055|FG000|Overall Study|Adverse Event|6|||
126401438|NCT01510145|454763055|FG000|Overall Study|Lost to Follow-up|5|||
126401439|NCT01510145|454763055|FG000|Overall Study|Withdrawal by Subject|6|||
126401440|NCT01510145|454763055|FG000|Overall Study|Relative reported subject withdrew|1|||
126401441|NCT02312219|454763056|FG000|Overall Study|Withdrawal by Subject|1|||
126401442|NCT02312219|454763057|FG001|Overall Study|Withdrawal by Subject|2|||
126401443|NCT02312219|454763056|FG000|Overall Study|could not schedule imaging in time|0|||
126401444|NCT02312219|454763057|FG001|Overall Study|could not schedule imaging in time|2|||
126401445|NCT02312219|454763056|FG000|Overall Study|Other|0|||
126401446|NCT02312219|454763057|FG001|Overall Study|Other|1|||
126401447|NCT02312219|454763056|FG000|Overall Study|Not randomized. Ineligible|0|||
126401448|NCT02312219|454763057|FG001|Overall Study|Not randomized. Ineligible|1|||
126401449|NCT01827332|454763059|FG000|Overall Study|Lost to Follow-up|2|||
126401450|NCT01827332|454763060|FG001|Overall Study|Lost to Follow-up|1|||
126401451|NCT00546260|454763061|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
126401452|NCT00546260|454763062|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
126401453|NCT03734029|454763065|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
126401454|NCT03734029|454763066|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
126401455|NCT03734029|454763065|FG000|Overall Study|Adverse Event|60|||
126401456|NCT03734029|454763066|FG001|Overall Study|Adverse Event|14|||
126401457|NCT03734029|454763065|FG000|Overall Study|Withdrawal by Subject|12|||
126401458|NCT03734029|454763066|FG001|Overall Study|Withdrawal by Subject|11|||
126401459|NCT03734029|454763065|FG000|Overall Study|Clinical progression by investigator|10|||
126401460|NCT03734029|454763066|FG001|Overall Study|Clinical progression by investigator|8|||
126401461|NCT03734029|454763065|FG000|Overall Study|Death|5|||
126401462|NCT03734029|454763066|FG001|Overall Study|Death|2|||
126401463|NCT03734029|454763065|FG000|Overall Study|Physician Decision|4|||
126401464|NCT03734029|454763066|FG001|Overall Study|Physician Decision|3|||
126401465|NCT03734029|454763065|FG000|Overall Study|Other|2|||
126401466|NCT03734029|454763066|FG001|Overall Study|Other|0|||
126401467|NCT03734029|454763065|FG000|Overall Study|Lost to Follow-up|0|||
126401468|NCT03734029|454763066|FG001|Overall Study|Lost to Follow-up|1|||
126401469|NCT03734029|454763065|FG000|Overall Study|Randomized, but not treated|2|||
126401470|NCT03734029|454763066|FG001|Overall Study|Randomized, but not treated|12|||
126401471|NCT03081858|454764860|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
126401472|NCT03081858|454764861|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
126401473|NCT03081858|454764862|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
126401474|NCT03081858|454764863|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
125890060|NCT00485134|452895427|FG002|Overall Study|Positive drug test|0|||
126401475|NCT00262847|454764866|FG000|Overall Study|Disease Progression|309|||
126401476|NCT00262847|454764867|FG001|Overall Study|Disease Progression|274|||
126401477|NCT00262847|454764868|FG002|Overall Study|Disease Progression|195|||
126401478|NCT00262847|454764866|FG000|Overall Study|Patient Refusal|41|||
126401479|NCT00262847|454764867|FG001|Overall Study|Patient Refusal|52|||
126401480|NCT00262847|454764868|FG002|Overall Study|Patient Refusal|47|||
126401481|NCT00262847|454764866|FG000|Overall Study|Adverse Event|74|||
126401482|NCT00262847|454764867|FG001|Overall Study|Adverse Event|88|||
126401483|NCT00262847|454764868|FG002|Overall Study|Adverse Event|108|||
126401484|NCT00262847|454764866|FG000|Overall Study|Death|8|||
126401485|NCT00262847|454764867|FG001|Overall Study|Death|8|||
126401486|NCT00262847|454764868|FG002|Overall Study|Death|11|||
126401487|NCT00262847|454764866|FG000|Overall Study|Concomitant disease|3|||
126401488|NCT00262847|454764867|FG001|Overall Study|Concomitant disease|2|||
126401489|NCT00262847|454764868|FG002|Overall Study|Concomitant disease|4|||
126401490|NCT00262847|454764866|FG000|Overall Study|Other Reasons|79|||
126401491|NCT00262847|454764867|FG001|Overall Study|Other Reasons|88|||
126401492|NCT00262847|454764868|FG002|Overall Study|Other Reasons|27|||
126401493|NCT00262847|454764866|FG000|Overall Study|Did not receive study treatment|4|||
126401494|NCT00262847|454764867|FG001|Overall Study|Did not receive study treatment|1|||
126401495|NCT00262847|454764868|FG002|Overall Study|Did not receive study treatment|4|||
126401496|NCT03966885|454764869|FG000|Overall Study|Death|1|||
126401497|NCT03966885|454764870|FG001|Overall Study|Death|0|||
126401498|NCT03966885|454764869|FG000|Overall Study|Lost to Follow-up|1|||
126401499|NCT03966885|454764870|FG001|Overall Study|Lost to Follow-up|2|||
126401500|NCT03966885|454764869|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
126401501|NCT03966885|454764870|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
126401502|NCT03966885|454764869|FG000|Overall Study|Moved from study area.|0|||
126401503|NCT03966885|454764870|FG001|Overall Study|Moved from study area.|2|||
126401504|NCT00289198|454764897|FG000|Overall Study|Adverse Event|0|||
126401505|NCT00289198|454764898|FG001|Overall Study|Adverse Event|2|||
126401506|NCT00289198|454764897|FG000|Overall Study|Protocol Violation|2|||
126401507|NCT00289198|454764898|FG001|Overall Study|Protocol Violation|1|||
126401508|NCT00289198|454764897|FG000|Overall Study|Withdrawal by Subject|4|||
126401509|NCT00289198|454764898|FG001|Overall Study|Withdrawal by Subject|1|||
126401510|NCT00289198|454764897|FG000|Overall Study|Lack of Efficacy|2|||
126401511|NCT00289198|454764898|FG001|Overall Study|Lack of Efficacy|0|||
126401512|NCT00289198|454764897|FG000|Overall Study|Other: Low compliance|0|||
126401513|NCT00289198|454764898|FG001|Overall Study|Other: Low compliance|1|||
126401514|NCT00289198|454764897|FG000|Overall Study|Other: Physician's decision|0|||
126401515|NCT00289198|454764898|FG001|Overall Study|Other: Physician's decision|1|||
126401516|NCT00289198|454764897|FG000|Overall Study|Other: Unable to attend on schedule|2|||
126401517|NCT00289198|454764898|FG001|Overall Study|Other: Unable to attend on schedule|1|||
126401518|NCT00289198|454764897|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
126401519|NCT00289198|454764898|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
126401520|NCT00289198|454764897|FG000|Overall Study|Other: Impossible to come on visit|0|||
126401521|NCT00289198|454764898|FG001|Overall Study|Other: Impossible to come on visit|1|||
126401522|NCT01176565|454764899|FG000|Overall Study|Lost to Follow-up|12|||
126401523|NCT01176565|454764900|FG001|Overall Study|Lost to Follow-up|16|||
126401524|NCT01176565|454764899|FG000|Overall Study|Withdrawal by Subject|7|||
126401525|NCT01176565|454764900|FG001|Overall Study|Withdrawal by Subject|1|||
126401526|NCT01176565|454764899|FG000|Overall Study|Not Analyzed (any other reason)|1|||
126401527|NCT01176565|454764900|FG001|Overall Study|Not Analyzed (any other reason)|2|||
126401528|NCT03602885|454764901|FG000|Overall Study|Lost to Follow-up|3|||
126401529|NCT03602885|454764902|FG001|Overall Study|Lost to Follow-up|0|||
126401530|NCT01062061|454764905|FG000|Overall Study|Enrolled more than once|2|||
126401531|NCT01062061|454764905|FG000|Overall Study|Investigated before study start|13|||
126401532|NCT01062061|454764905|FG000|Overall Study|Outside chief indications|10|||
126401533|NCT01062061|454764905|FG000|Overall Study|Failed to meet inclusion criteria|2|||
126401534|NCT01143051|454764912|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
126401535|NCT01143051|454764913|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
126401536|NCT01143051|454764914|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
126401537|NCT01143051|454764915|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
126401538|NCT01143051|454764916|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
126401539|NCT01143051|454764917|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
126401540|NCT01143051|454764912|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
126401541|NCT01143051|454764913|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
126401542|NCT01143051|454764914|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
126401543|NCT01143051|454764915|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
126401544|NCT01143051|454764916|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
126401545|NCT01143051|454764917|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
126401546|NCT01605227|454764918|FG000|Overall Study|Did not receive study treatment|2|||
126401547|NCT01605227|454764919|FG001|Overall Study|Did not receive study treatment|3|||
126401548|NCT01605227|454764918|FG000|Overall Study|Adverse Event|228|||
126401549|NCT01605227|454764919|FG001|Overall Study|Adverse Event|42|||
126401550|NCT01605227|454764918|FG000|Overall Study|Progressive Disease|132|||
126401551|NCT01605227|454764919|FG001|Overall Study|Progressive Disease|128|||
126401552|NCT01605227|454764918|FG000|Overall Study|Clinical Deterioration|227|||
126401553|NCT01605227|454764919|FG001|Overall Study|Clinical Deterioration|133|||
126401554|NCT01605227|454764918|FG000|Overall Study|Lost to Follow-up|1|||
126401555|NCT01605227|454764919|FG001|Overall Study|Lost to Follow-up|0|||
126401556|NCT01605227|454764918|FG000|Overall Study|Protocol Violation|1|||
126401557|NCT01605227|454764919|FG001|Overall Study|Protocol Violation|0|||
126401558|NCT01605227|454764918|FG000|Overall Study|Physician Decision|9|||
126401559|NCT01605227|454764919|FG001|Overall Study|Physician Decision|7|||
126401560|NCT01605227|454764918|FG000|Overall Study|Withdrawal by Subject|18|||
126401561|NCT01605227|454764919|FG001|Overall Study|Withdrawal by Subject|14|||
126401562|NCT01605227|454764918|FG000|Overall Study|Sponsor Decision|2|||
126401563|NCT01605227|454764919|FG001|Overall Study|Sponsor Decision|0|||
126401564|NCT01605227|454764918|FG000|Overall Study|Started New Therapy|1|||
126401565|NCT01605227|454764919|FG001|Overall Study|Started New Therapy|0|||
126401566|NCT01605227|454764918|FG000|Overall Study|Subject Decision|0|||
126401567|NCT01605227|454764919|FG001|Overall Study|Subject Decision|1|||
126401568|NCT01605227|454764918|FG000|Overall Study|Dose Held >6 weeks|0|||
126401569|NCT01605227|454764919|FG001|Overall Study|Dose Held >6 weeks|1|||
126401570|NCT03093974|454764920|FG000|Overall Study|Withdrawal by Subject|32|||
126401571|NCT03093974|454764921|FG001|Overall Study|Withdrawal by Subject|27|||
126401572|NCT03093974|454764920|FG000|Overall Study|Adverse Event|17|||
126401573|NCT03093974|454764921|FG001|Overall Study|Adverse Event|24|||
126401574|NCT03093974|454764920|FG000|Overall Study|Death|0|||
126401575|NCT03093974|454764921|FG001|Overall Study|Death|1|||
126401576|NCT03093974|454764920|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126401577|NCT03093974|454764921|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126401578|NCT03093974|454764920|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
126401579|NCT03093974|454764921|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
126401580|NCT03093974|454764920|FG000|Overall Study|Lost to Follow-up|0|||
126401581|NCT03093974|454764921|FG001|Overall Study|Lost to Follow-up|1|||
126401582|NCT03093974|454764920|FG000|Overall Study|Other|1|||
126401583|NCT03093974|454764921|FG001|Overall Study|Other|2|||
126401584|NCT01866423|454764925|FG000|Overall Study|Lack of Efficacy|3|||
126401585|NCT01866423|454764925|FG000|Overall Study|Sponsor Decision|1|||
126401586|NCT01813721|454764926|FG000|Overall Study|Ineligibility determined|63|||
126401587|NCT01813721|454764926|FG000|Overall Study|Withdrawal by Subject|1|||
126401588|NCT00810901|454764927|FG000|Overall Study|Lost to Follow-up|88|||
126401589|NCT00810901|454764928|FG001|Overall Study|Lost to Follow-up|58|||
126401590|NCT00900146|454764929|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
126401591|NCT00900146|454764930|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
126401592|NCT00900146|454764931|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
126401593|NCT00900146|454764932|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
126401594|NCT00900146|454764933|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
126401595|NCT00900146|454764929|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
126401596|NCT00900146|454764930|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
126401597|NCT00900146|454764931|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
126401598|NCT00900146|454764932|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
126401599|NCT00900146|454764933|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
126401600|NCT00900146|454764929|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
126401601|NCT00900146|454764930|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
126401602|NCT00900146|454764931|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
126401603|NCT00900146|454764932|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
126401604|NCT00900146|454764933|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
126401605|NCT00900146|454764929|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
126401606|NCT00900146|454764930|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
126401607|NCT00900146|454764931|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
126401608|NCT00900146|454764932|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
126401609|NCT00900146|454764933|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
126401610|NCT00900146|454764929|FG000|Intermediate: Period III|Lost to Follow-up|2|||
126401611|NCT00900146|454764930|FG001|Intermediate: Period III|Lost to Follow-up|0|||
126401612|NCT00900146|454764931|FG002|Intermediate: Period III|Lost to Follow-up|0|||
126401613|NCT00900146|454764932|FG003|Intermediate: Period III|Lost to Follow-up|0|||
126401614|NCT00900146|454764933|FG004|Intermediate: Period III|Lost to Follow-up|1|||
126401615|NCT00900146|454764929|FG000|Intermediate: Period III|Administrative problems|85|||
126401616|NCT00900146|454764930|FG001|Intermediate: Period III|Administrative problems|92|||
126401617|NCT00900146|454764931|FG002|Intermediate: Period III|Administrative problems|84|||
126401618|NCT00900146|454764932|FG003|Intermediate: Period III|Administrative problems|90|||
126401619|NCT00900146|454764933|FG004|Intermediate: Period III|Administrative problems|163|||
126401620|NCT01133275|454764934|FG000|Overall Study|Withdrawal by Subject|1|||
126401621|NCT01133275|454764934|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
126401622|NCT00700102|454764935|FG000|Overall Study|Died|394|||
126401623|NCT00700102|454764936|FG001|Overall Study|Died|385|||
126401624|NCT00700102|454764935|FG000|Overall Study|Lost to Follow-up|8|||
126401625|NCT00700102|454764936|FG001|Overall Study|Lost to Follow-up|10|||
126401626|NCT01028716|454764941|FG000|Overall Study|Physician Decision|1|||
126401627|NCT05590000|454764942|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
126401628|NCT00536874|454764943|FG000|Overall Study|Adverse Event|1|||
126401629|NCT00536874|454764943|FG000|Overall Study|Death|2|||
126401630|NCT00536874|454764943|FG000|Overall Study|Withdrawal by Subject|1|||
126401631|NCT00762996|454764944|FG000|Period One|Protocol Violation|0|||
126401632|NCT00762996|454764945|FG001|Period One|Protocol Violation|0|||
126401633|NCT00762996|454764946|FG002|Period One|Protocol Violation|1|||
126401634|NCT00762996|454764947|FG003|Period One|Protocol Violation|0|||
126401635|NCT00762996|454764944|FG000|Period One|ineligible|0|||
126401636|NCT00762996|454764945|FG001|Period One|ineligible|0|||
126401637|NCT00762996|454764946|FG002|Period One|ineligible|1|||
126401638|NCT00762996|454764947|FG003|Period One|ineligible|1|||
126401639|NCT00762996|454764944|FG000|Period One|Adverse Event|0|||
126401640|NCT00762996|454764945|FG001|Period One|Adverse Event|0|||
126401641|NCT00762996|454764946|FG002|Period One|Adverse Event|1|||
126401642|NCT00762996|454764947|FG003|Period One|Adverse Event|0|||
126401643|NCT00762996|454764944|FG000|Period One|Withdrawal by Subject|0|||
126401644|NCT00762996|454764945|FG001|Period One|Withdrawal by Subject|0|||
126401645|NCT00762996|454764946|FG002|Period One|Withdrawal by Subject|1|||
126401646|NCT00762996|454764947|FG003|Period One|Withdrawal by Subject|0|||
126401647|NCT02689076|454764948|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
126401648|NCT02689076|454764949|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
126401649|NCT02689076|454764950|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
126401650|NCT02689076|454764948|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
126401651|NCT02689076|454764949|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
126401652|NCT02689076|454764950|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
126401653|NCT02689076|454764948|FG000|Overall Study|Did not have an HIE match|2|||
126401654|NCT02689076|454764949|FG001|Overall Study|Did not have an HIE match|0|||
126401655|NCT02689076|454764950|FG002|Overall Study|Did not have an HIE match|0|||
126401656|NCT02689076|454764948|FG000|Overall Study|Death during non-VA encounter|2|||
126401657|NCT02689076|454764949|FG001|Overall Study|Death during non-VA encounter|5|||
126401658|NCT02689076|454764950|FG002|Overall Study|Death during non-VA encounter|0|||
126401659|NCT02689076|454764948|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
126401660|NCT02689076|454764949|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
126401661|NCT02689076|454764950|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
126401662|NCT02689076|454764948|FG000|Overall Study|Participant no longer active in VA system|1|||
126401663|NCT02689076|454764949|FG001|Overall Study|Participant no longer active in VA system|0|||
126401664|NCT02689076|454764950|FG002|Overall Study|Participant no longer active in VA system|0|||
126401665|NCT02689076|454764948|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
126401666|NCT02689076|454764949|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
126401667|NCT02689076|454764950|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
126401668|NCT01143896|454764952|FG000|Overall Study|Did not complete Baseline Interview|5|||
126401669|NCT01143896|454764953|FG001|Overall Study|Did not complete Baseline Interview|4|||
126401670|NCT01143896|454764952|FG000|Overall Study|Lost to Follow-up|18|||
126401671|NCT01143896|454764953|FG001|Overall Study|Lost to Follow-up|13|||
126401672|NCT01143896|454764952|FG000|Overall Study|Withdrawal by Subject|13|||
126401673|NCT01143896|454764953|FG001|Overall Study|Withdrawal by Subject|5|||
126401674|NCT01143896|454764952|FG000|Overall Study|Death|6|||
126401675|NCT01143896|454764953|FG001|Overall Study|Death|3|||
126401676|NCT02084238|454764954|FG000|Overall Study|Lost to Follow-up|2|||
126401677|NCT00320372|454764955|FG000|Overall Study|Physician Decision|4|||
126401678|NCT00320372|454764956|FG001|Overall Study|Physician Decision|7|||
126401679|NCT00320372|454764955|FG000|Overall Study|Death|7|||
126401680|NCT00320372|454764956|FG001|Overall Study|Death|8|||
126401681|NCT00320372|454764955|FG000|Overall Study|Withdrawal by Subject|55|||
126401682|NCT00320372|454764956|FG001|Overall Study|Withdrawal by Subject|37|||
126401683|NCT00320372|454764955|FG000|Overall Study|Non-Compliance|40|||
126401684|NCT00320372|454764956|FG001|Overall Study|Non-Compliance|39|||
126401685|NCT00320372|454764955|FG000|Overall Study|Did not Meet (I/E)|3|||
125890061|NCT00485134|452895428|FG003|Overall Study|Positive drug test|0|||
126401686|NCT00320372|454764956|FG001|Overall Study|Did not Meet (I/E)|1|||
126401687|NCT00320372|454764955|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
126401688|NCT00320372|454764956|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
126401689|NCT00849875|454764957|FG000|Overall Study|Death|28|||
126401690|NCT00849875|454764957|FG000|Overall Study|Ongoing (unknown completion status)|11|||
126401691|NCT00849875|454764957|FG000|Overall Study|Others|6|||
126401692|NCT00849875|454764957|FG000|Overall Study|Lost to Follow-up|2|||
126401693|NCT00086502|454764958|FG000|Overall Study|Adverse Event|11|||
126401694|NCT00086502|454764959|FG001|Overall Study|Adverse Event|2|||
126401695|NCT00086502|454764958|FG000|Overall Study|Lack of Efficacy|0|||
126401696|NCT00086502|454764959|FG001|Overall Study|Lack of Efficacy|2|||
126401697|NCT00086502|454764958|FG000|Overall Study|Lost to Follow-up|3|||
126401698|NCT00086502|454764959|FG001|Overall Study|Lost to Follow-up|1|||
126401699|NCT00086502|454764958|FG000|Overall Study|Physician Decision|1|||
126401700|NCT00086502|454764959|FG001|Overall Study|Physician Decision|1|||
126401701|NCT00086502|454764958|FG000|Overall Study|Pregnancy|0|||
126401702|NCT00086502|454764959|FG001|Overall Study|Pregnancy|1|||
126401703|NCT00086502|454764958|FG000|Overall Study|Protocol Violation|3|||
126401704|NCT00086502|454764959|FG001|Overall Study|Protocol Violation|3|||
126401705|NCT00086502|454764958|FG000|Overall Study|Withdrawal by Subject|5|||
126401706|NCT00086502|454764959|FG001|Overall Study|Withdrawal by Subject|6|||
126401707|NCT00086502|454764958|FG000|Overall Study|Patient Moved|1|||
126401708|NCT00086502|454764959|FG001|Overall Study|Patient Moved|1|||
126401709|NCT00086502|454764958|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
126401710|NCT00086502|454764959|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
126401711|NCT00086502|454764958|FG000|Overall Study|Patient Accidentally Unblinded|1|||
126401712|NCT00086502|454764959|FG001|Overall Study|Patient Accidentally Unblinded|0|||
126401713|NCT01304329|454764960|FG000|Third Intervention (3 Days)|Adverse Event|0|||
126401714|NCT01304329|454764961|FG001|Third Intervention (3 Days)|Adverse Event|1|||
126401715|NCT01304329|454764962|FG002|Third Intervention (3 Days)|Adverse Event|0|||
126401716|NCT01304329|454764963|FG003|Third Intervention (3 Days)|Adverse Event|0|||
126401717|NCT01304329|454764964|FG004|Third Intervention (3 Days)|Adverse Event|0|||
126401718|NCT01304329|454764965|FG005|Third Intervention (3 Days)|Adverse Event|0|||
126401719|NCT02068118|454764973|FG000|18-month Comparative Study Period|Death|90|||
126401720|NCT02068118|454764974|FG001|18-month Comparative Study Period|Death|97|||
126401721|NCT02068118|454764973|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
126401722|NCT02068118|454764974|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
126401723|NCT02068118|454764973|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
126401724|NCT02068118|454764974|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
126401725|NCT02068118|454764973|FG000|18-month Comparative Study Period|Heart transplant|9|||
126401726|NCT02068118|454764974|FG001|18-month Comparative Study Period|Heart transplant|15|||
126401727|NCT02068118|454764973|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
126401728|NCT02068118|454764974|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
126401729|NCT02068118|454764973|FG000|18-month Comparative Study Period|Hemiplegia|0|||
126401730|NCT02068118|454764974|FG001|18-month Comparative Study Period|Hemiplegia|1|||
126401731|NCT02068118|454764973|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
126401732|NCT02068118|454764974|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
126401733|NCT02068118|454764973|FG000|18-month Comparative Study Period|Move|0|||
126401734|NCT02068118|454764974|FG001|18-month Comparative Study Period|Move|1|||
126401735|NCT02068118|454764973|FG000|18-month Comparative Study Period|Hearing loss|0|||
126401736|NCT02068118|454764974|FG001|18-month Comparative Study Period|Hearing loss|1|||
126401737|NCT02068118|454764973|FG000|Extension Period|Death|0|||
126401738|NCT02068118|454764974|FG001|Extension Period|Death|2|||
126401739|NCT02068118|454764973|FG000|Extension Period|Withdrawal by Subject|1|||
126401740|NCT02068118|454764974|FG001|Extension Period|Withdrawal by Subject|0|||
126401741|NCT02068118|454764973|FG000|Extension Period|Heart transplant|1|||
126401742|NCT02068118|454764974|FG001|Extension Period|Heart transplant|0|||
126401743|NCT02068118|454764973|FG000|Extension Period|Wrong device use|0|||
126401744|NCT02068118|454764974|FG001|Extension Period|Wrong device use|1|||
126401745|NCT00283868|454764975|FG000|Overall Study|Lost to Follow-up|7|||
126401746|NCT00283868|454764976|FG001|Overall Study|Lost to Follow-up|8|||
126105344|NCT03562247|453678597|FG002|Overall Study|Lost to Follow-up|1|||
126401747|NCT01515475|454764977|FG000|Overall Study|Lost to Follow-up|20|||
126401748|NCT01515475|454764978|FG001|Overall Study|Lost to Follow-up|15|||
126401749|NCT01515475|454764979|FG002|Overall Study|Lost to Follow-up|12|||
126401750|NCT01515475|454764980|FG003|Overall Study|Lost to Follow-up|12|||
126401751|NCT01420627|454764981|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
126401752|NCT00837876|454764982|FG000|Overall Study|Death|2|||
126401753|NCT00837876|454764982|FG000|Overall Study|Adverse Event|7|||
126401754|NCT00837876|454764982|FG000|Overall Study|Physician Decision|1|||
126401755|NCT00837876|454764982|FG000|Overall Study|Withdrawal by Subject|3|||
126401756|NCT00837876|454764982|FG000|Overall Study|disease progression|24|||
126401757|NCT02075632|454764985|FG000|Overall Study|Adverse Event|1|||
126401758|NCT02075632|454764986|FG001|Overall Study|Adverse Event|1|||
126401759|NCT02075632|454764985|FG000|Overall Study|Lost to Follow-up|0|||
126401760|NCT02075632|454764986|FG001|Overall Study|Lost to Follow-up|3|||
126401761|NCT02075632|454764985|FG000|Overall Study|Withdrawal by Subject|0|||
126401762|NCT02075632|454764986|FG001|Overall Study|Withdrawal by Subject|1|||
126401763|NCT02256267|454764987|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
126401764|NCT02256267|454764987|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
126401765|NCT01969500|454764997|FG000|Overall Study|Death|0|||
126401766|NCT01969500|454764998|FG001|Overall Study|Death|1|||
126401767|NCT01969500|454764997|FG000|Overall Study|extended hospitalization|1|||
126401768|NCT01969500|454764998|FG001|Overall Study|extended hospitalization|1|||
126401769|NCT00613080|454764999|FG000|Overall Study|Ineligible / no protocol treatment|11|||
126401770|NCT03757130|454765000|FG000|Overall Study|Lost to Follow-up|0|||
126401771|NCT03757130|454765001|FG001|Overall Study|Lost to Follow-up|0|||
126401772|NCT03757130|454765002|FG002|Overall Study|Lost to Follow-up|0|||
126401773|NCT03757130|454765003|FG003|Overall Study|Lost to Follow-up|1|||
126401774|NCT03757130|454765004|FG004|Overall Study|Lost to Follow-up|0|||
126401775|NCT03757130|454765005|FG005|Overall Study|Lost to Follow-up|0|||
126401776|NCT03757130|454765006|FG006|Overall Study|Lost to Follow-up|0|||
126401777|NCT03757130|454765007|FG007|Overall Study|Lost to Follow-up|1|||
126401778|NCT03757130|454765000|FG000|Overall Study|Withdrawal by Subject|0|||
126401779|NCT03757130|454765001|FG001|Overall Study|Withdrawal by Subject|0|||
126401780|NCT03757130|454765002|FG002|Overall Study|Withdrawal by Subject|0|||
126401781|NCT03757130|454765003|FG003|Overall Study|Withdrawal by Subject|0|||
126401782|NCT03757130|454765004|FG004|Overall Study|Withdrawal by Subject|0|||
126401783|NCT03757130|454765005|FG005|Overall Study|Withdrawal by Subject|0|||
126401784|NCT03757130|454765006|FG006|Overall Study|Withdrawal by Subject|1|||
126401785|NCT03757130|454765007|FG007|Overall Study|Withdrawal by Subject|0|||
126401786|NCT02226549|454765008|FG000|Overall Study|Randomized but Never Treated|1|||
126401787|NCT02226549|454765009|FG001|Overall Study|Randomized but Never Treated|0|||
126401788|NCT02226549|454765008|FG000|Overall Study|Lost to Follow-up|0|||
126401789|NCT02226549|454765009|FG001|Overall Study|Lost to Follow-up|1|||
126401790|NCT02726880|454765010|FG000|Overall Study|Withdrawal by Subject|2|||
126401791|NCT02726880|454765011|FG001|Overall Study|Withdrawal by Subject|0|||
126401792|NCT02726880|454765010|FG000|Overall Study|Lost to Follow-up|1|||
126401793|NCT02726880|454765011|FG001|Overall Study|Lost to Follow-up|3|||
126401794|NCT01269385|454765012|FG000|Overall Study|Adverse Event|1|||
126401795|NCT01269385|454765013|FG001|Overall Study|Adverse Event|1|||
126401796|NCT01269385|454765014|FG002|Overall Study|Adverse Event|0|||
126401797|NCT01269385|454765015|FG003|Overall Study|Adverse Event|0|||
126401798|NCT04941807|454765016|FG000|Overall Study|Lost to Follow-up|1|||
126401799|NCT04941807|454765017|FG001|Overall Study|Lost to Follow-up|1|||
126401800|NCT03553498|454765018|FG000|Overall Study|Missing primary outcome|1|||
126401801|NCT03553498|454765019|FG001|Overall Study|Missing primary outcome|2|||
126401802|NCT01100567|454765020|FG000|Overall Study|Withdrawal by Subject|5|||
126401803|NCT01100567|454765021|FG001|Overall Study|Withdrawal by Subject|8|||
126401804|NCT01100567|454765020|FG000|Overall Study|Early Hospital Discharge|6|||
126401805|NCT01100567|454765021|FG001|Overall Study|Early Hospital Discharge|4|||
126401806|NCT01100567|454765020|FG000|Overall Study|Lost to Follow-up|1|||
126401807|NCT01100567|454765021|FG001|Overall Study|Lost to Follow-up|2|||
126401808|NCT01100567|454765020|FG000|Overall Study|Physician Decision|0|||
126401809|NCT01100567|454765021|FG001|Overall Study|Physician Decision|1|||
126401810|NCT01100567|454765020|FG000|Overall Study|Deemed ineligible after consent|0|||
126401811|NCT01100567|454765021|FG001|Overall Study|Deemed ineligible after consent|1|||
126401812|NCT02741570|454765022|FG000|Pre-Treatment Period|Other reasons|0|||
126401813|NCT02741570|454765023|FG001|Pre-Treatment Period|Other reasons|3|||
126401814|NCT02741570|454765022|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
126401815|NCT02741570|454765023|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
126401816|NCT02741570|454765022|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
126401817|NCT02741570|454765023|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
126401818|NCT02741570|454765022|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
126401819|NCT02741570|454765023|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
126401820|NCT02741570|454765022|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
126401821|NCT02741570|454765023|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
126401822|NCT02741570|454765022|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
126401823|NCT02741570|454765023|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
126401824|NCT02741570|454765022|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
126401825|NCT02741570|454765023|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126401826|NCT02741570|454765022|FG000|Pre-Treatment Period|Death|0|||
126401827|NCT02741570|454765023|FG001|Pre-Treatment Period|Death|1|||
126401828|NCT02741570|454765022|FG000|Pre-Treatment Period|Disease progression|0|||
126401829|NCT02741570|454765023|FG001|Pre-Treatment Period|Disease progression|1|||
126401830|NCT02741570|454765022|FG000|Treatment Period|Other reasons|47|||
126401831|NCT02741570|454765023|FG001|Treatment Period|Other reasons|12|||
126401832|NCT02741570|454765022|FG000|Treatment Period|Poor/non-compliance|0|||
126401833|NCT02741570|454765023|FG001|Treatment Period|Poor/non-compliance|2|||
126401834|NCT02741570|454765022|FG000|Treatment Period|Maximum clinical benefit|4|||
126401835|NCT02741570|454765023|FG001|Treatment Period|Maximum clinical benefit|6|||
126401836|NCT02741570|454765022|FG000|Treatment Period|Lost to Follow-up|1|||
126401837|NCT02741570|454765023|FG001|Treatment Period|Lost to Follow-up|3|||
126401838|NCT02741570|454765022|FG000|Treatment Period|Participant withdrew consent|9|||
126401839|NCT02741570|454765023|FG001|Treatment Period|Participant withdrew consent|13|||
126401840|NCT02741570|454765022|FG000|Treatment Period|Participant request to discontinue treatment|8|||
126401841|NCT02741570|454765023|FG001|Treatment Period|Participant request to discontinue treatment|23|||
126401842|NCT02741570|454765022|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
126401843|NCT02741570|454765023|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
126401844|NCT02741570|454765022|FG000|Treatment Period|Death|9|||
126401845|NCT02741570|454765023|FG001|Treatment Period|Death|7|||
126401846|NCT02741570|454765022|FG000|Treatment Period|Study drug toxicity|55|||
126401847|NCT02741570|454765023|FG001|Treatment Period|Study drug toxicity|47|||
126401848|NCT02741570|454765022|FG000|Treatment Period|Disease progression|294|||
126401849|NCT02741570|454765023|FG001|Treatment Period|Disease progression|301|||
126401850|NCT02741570|454765022|FG000|Treatment Period|Administrative reason by sponsor|0|||
126401851|NCT02741570|454765023|FG001|Treatment Period|Administrative reason by sponsor|1|||
126401852|NCT03697993|454765035|FG000|Overall Study|Became Ineligible after Enrollment|1|||
126401853|NCT03697993|454765036|FG001|Overall Study|Became Ineligible after Enrollment|3|||
126401854|NCT03697993|454765035|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
126401855|NCT03697993|454765036|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
126401856|NCT03697993|454765035|FG000|Overall Study|Lost to Follow-up|3|||
126401857|NCT03697993|454765036|FG001|Overall Study|Lost to Follow-up|0|||
126401858|NCT03697993|454765035|FG000|Overall Study|Physician Decision|4|||
126401859|NCT03697993|454765036|FG001|Overall Study|Physician Decision|0|||
126401860|NCT03697993|454765035|FG000|Overall Study|Initial Urine Culture Negative|0|||
126401861|NCT03697993|454765036|FG001|Overall Study|Initial Urine Culture Negative|1|||
126401862|NCT03759041|454765037|FG000|Overall Study|Withdrawal by Subject|4|||
126401863|NCT03759041|454765038|FG001|Overall Study|Withdrawal by Subject|10|||
126401864|NCT03759041|454765039|FG002|Overall Study|Withdrawal by Subject|10|||
126401865|NCT03759041|454765037|FG000|Overall Study|Adverse Event|1|||
126401866|NCT03759041|454765038|FG001|Overall Study|Adverse Event|3|||
126401867|NCT03759041|454765039|FG002|Overall Study|Adverse Event|4|||
126401868|NCT03759041|454765037|FG000|Overall Study|Lack of Efficacy|0|||
126401869|NCT03759041|454765038|FG001|Overall Study|Lack of Efficacy|0|||
126401870|NCT03759041|454765039|FG002|Overall Study|Lack of Efficacy|1|||
126401871|NCT03759041|454765037|FG000|Overall Study|Study Terminated by Sponsor|15|||
126401872|NCT03759041|454765038|FG001|Overall Study|Study Terminated by Sponsor|16|||
126401873|NCT03759041|454765039|FG002|Overall Study|Study Terminated by Sponsor|10|||
126401874|NCT03759041|454765037|FG000|Overall Study|Other reason for discontinuation|0|||
126401875|NCT03759041|454765038|FG001|Overall Study|Other reason for discontinuation|2|||
126401876|NCT03759041|454765039|FG002|Overall Study|Other reason for discontinuation|1|||
126401877|NCT03759041|454765037|FG000|Overall Study|Lost to Follow-up|7|||
126401878|NCT03759041|454765038|FG001|Overall Study|Lost to Follow-up|2|||
126401879|NCT03759041|454765039|FG002|Overall Study|Lost to Follow-up|2|||
126401880|NCT03759041|454765037|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
126401881|NCT03759041|454765038|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
126401882|NCT03759041|454765039|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
126401883|NCT04384107|454765040|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
126401884|NCT04384107|454765041|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
126401885|NCT04384107|454765040|FG000|Overall Study|Lost to Follow-up|1|||
126401886|NCT04384107|454765041|FG001|Overall Study|Lost to Follow-up|0|||
126401887|NCT00276614|454765042|FG000|Overall Study|Progression of disease under study|3|||
126401888|NCT01522404|454765045|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
126401889|NCT01522404|454765046|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
126401890|NCT01522404|454765045|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
126401891|NCT01522404|454765046|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
126401892|NCT01522404|454765045|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
126401893|NCT01522404|454765046|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
126401894|NCT02698371|454765047|FG000|All Participants Flow|Lost to Follow-up|3|||
126401895|NCT02698371|454765047|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
126401896|NCT02698371|454765047|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
126401897|NCT02698371|454765047|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
126401898|NCT02698371|454765047|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
126401899|NCT02698371|454765047|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
126401900|NCT02698371|454765047|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
126401901|NCT01591863|454765048|FG000|Overall Study|Adverse Event|3|||
126401902|NCT01591863|454765048|FG000|Overall Study|Withdrawal by Subject|1|||
126401903|NCT01591863|454765048|FG000|Overall Study|recurrence|9|||
126401904|NCT01591863|454765048|FG000|Overall Study|Lack of Efficacy|1|||
126401905|NCT03204890|454766398|FG000|Overall Study|Withdrawal by Subject|1|||
126401906|NCT01549873|454766399|FG000|Overall Study|Physician Decision|0|||
126401907|NCT01549873|454766400|FG001|Overall Study|Physician Decision|1|||
126401908|NCT03769311|454766401|FG000|Overall Study|Withdrawal by Subject|1|||
126401909|NCT01596335|454766402|FG000|Overall Study|exacerbation of primary disease|5|||
126401910|NCT01596335|454766403|FG001|Overall Study|exacerbation of primary disease|9|||
126401911|NCT00098722|454766404|FG000|Double Blind Phase|Adverse Event|7|||
126401912|NCT00098722|454766405|FG001|Double Blind Phase|Adverse Event|7|||
126401913|NCT00098722|454766406|FG002|Double Blind Phase|Adverse Event|3|||
126401914|NCT00098722|454766407|FG003|Double Blind Phase|Adverse Event|0|||
126401915|NCT00098722|454766408|FG004|Double Blind Phase|Adverse Event|0|||
126401916|NCT00098722|454766409|FG005|Double Blind Phase|Adverse Event|0|||
126401917|NCT00098722|454766410|FG006|Double Blind Phase|Adverse Event|0|||
126401918|NCT00098722|454766404|FG000|Double Blind Phase|Death|2|||
126401919|NCT00098722|454766405|FG001|Double Blind Phase|Death|5|||
126401920|NCT00098722|454766406|FG002|Double Blind Phase|Death|0|||
126401921|NCT00098722|454766407|FG003|Double Blind Phase|Death|0|||
126401922|NCT00098722|454766408|FG004|Double Blind Phase|Death|0|||
126401923|NCT00098722|454766409|FG005|Double Blind Phase|Death|0|||
126401924|NCT00098722|454766410|FG006|Double Blind Phase|Death|0|||
126401925|NCT00098722|454766404|FG000|Double Blind Phase|Lack of Efficacy|21|||
126401926|NCT00098722|454766405|FG001|Double Blind Phase|Lack of Efficacy|23|||
126401927|NCT00098722|454766406|FG002|Double Blind Phase|Lack of Efficacy|15|||
126401928|NCT00098722|454766407|FG003|Double Blind Phase|Lack of Efficacy|0|||
126401929|NCT00098722|454766408|FG004|Double Blind Phase|Lack of Efficacy|0|||
126401930|NCT00098722|454766409|FG005|Double Blind Phase|Lack of Efficacy|0|||
126401931|NCT00098722|454766410|FG006|Double Blind Phase|Lack of Efficacy|0|||
126401932|NCT00098722|454766404|FG000|Double Blind Phase|Participant defaulted|16|||
126401933|NCT00098722|454766405|FG001|Double Blind Phase|Participant defaulted|11|||
126401934|NCT00098722|454766406|FG002|Double Blind Phase|Participant defaulted|9|||
126401935|NCT00098722|454766407|FG003|Double Blind Phase|Participant defaulted|0|||
126401936|NCT00098722|454766408|FG004|Double Blind Phase|Participant defaulted|0|||
126401937|NCT00098722|454766409|FG005|Double Blind Phase|Participant defaulted|0|||
126401938|NCT00098722|454766410|FG006|Double Blind Phase|Participant defaulted|0|||
126401939|NCT00098722|454766404|FG000|Double Blind Phase|Pregnancy|1|||
126401940|NCT00098722|454766405|FG001|Double Blind Phase|Pregnancy|0|||
126401941|NCT00098722|454766406|FG002|Double Blind Phase|Pregnancy|0|||
126401942|NCT00098722|454766407|FG003|Double Blind Phase|Pregnancy|0|||
126401943|NCT00098722|454766408|FG004|Double Blind Phase|Pregnancy|0|||
126401944|NCT00098722|454766409|FG005|Double Blind Phase|Pregnancy|0|||
126401945|NCT00098722|454766410|FG006|Double Blind Phase|Pregnancy|0|||
126401946|NCT00098722|454766404|FG000|Double Blind Phase|Randomized, not treated|4|||
126401947|NCT00098722|454766405|FG001|Double Blind Phase|Randomized, not treated|3|||
126401948|NCT00098722|454766406|FG002|Double Blind Phase|Randomized, not treated|3|||
126401949|NCT00098722|454766407|FG003|Double Blind Phase|Randomized, not treated|0|||
126401950|NCT00098722|454766408|FG004|Double Blind Phase|Randomized, not treated|0|||
126401951|NCT00098722|454766409|FG005|Double Blind Phase|Randomized, not treated|0|||
126401952|NCT00098722|454766410|FG006|Double Blind Phase|Randomized, not treated|0|||
126401953|NCT00098722|454766404|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
126401954|NCT00098722|454766405|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
126401955|NCT00098722|454766406|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
126401956|NCT00098722|454766407|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
126401957|NCT00098722|454766408|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
126401958|NCT00098722|454766409|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
126401959|NCT00098722|454766410|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
126401960|NCT00098722|454766404|FG000|Double Blind Phase|Other|7|||
126401961|NCT00098722|454766405|FG001|Double Blind Phase|Other|8|||
126401962|NCT00098722|454766406|FG002|Double Blind Phase|Other|7|||
126401963|NCT00098722|454766407|FG003|Double Blind Phase|Other|0|||
126401964|NCT00098722|454766408|FG004|Double Blind Phase|Other|0|||
126401965|NCT00098722|454766409|FG005|Double Blind Phase|Other|0|||
126401966|NCT00098722|454766410|FG006|Double Blind Phase|Other|0|||
126401967|NCT00098722|454766404|FG000|Open Label Phase|Adverse Event|0|||
126401968|NCT00098722|454766405|FG001|Open Label Phase|Adverse Event|0|||
126401969|NCT00098722|454766406|FG002|Open Label Phase|Adverse Event|0|||
126401970|NCT00098722|454766407|FG003|Open Label Phase|Adverse Event|5|||
126401971|NCT00098722|454766408|FG004|Open Label Phase|Adverse Event|0|||
126401972|NCT00098722|454766409|FG005|Open Label Phase|Adverse Event|0|||
126401973|NCT00098722|454766410|FG006|Open Label Phase|Adverse Event|0|||
126401974|NCT00098722|454766404|FG000|Open Label Phase|Death|0|||
126401975|NCT00098722|454766405|FG001|Open Label Phase|Death|0|||
126401976|NCT00098722|454766406|FG002|Open Label Phase|Death|0|||
126401977|NCT00098722|454766407|FG003|Open Label Phase|Death|2|||
126401978|NCT00098722|454766408|FG004|Open Label Phase|Death|0|||
126401979|NCT00098722|454766409|FG005|Open Label Phase|Death|0|||
126401980|NCT00098722|454766410|FG006|Open Label Phase|Death|0|||
126401981|NCT00098722|454766404|FG000|Open Label Phase|Lack of Efficacy|0|||
126401982|NCT00098722|454766405|FG001|Open Label Phase|Lack of Efficacy|0|||
126401983|NCT00098722|454766406|FG002|Open Label Phase|Lack of Efficacy|0|||
126401984|NCT00098722|454766407|FG003|Open Label Phase|Lack of Efficacy|8|||
126401985|NCT00098722|454766408|FG004|Open Label Phase|Lack of Efficacy|0|||
126401986|NCT00098722|454766409|FG005|Open Label Phase|Lack of Efficacy|0|||
126401987|NCT00098722|454766410|FG006|Open Label Phase|Lack of Efficacy|0|||
126401988|NCT00098722|454766404|FG000|Open Label Phase|Pregnancy|0|||
126401989|NCT00098722|454766405|FG001|Open Label Phase|Pregnancy|0|||
126401990|NCT00098722|454766406|FG002|Open Label Phase|Pregnancy|0|||
126401991|NCT00098722|454766407|FG003|Open Label Phase|Pregnancy|1|||
126401992|NCT00098722|454766408|FG004|Open Label Phase|Pregnancy|0|||
126401993|NCT00098722|454766409|FG005|Open Label Phase|Pregnancy|0|||
126401994|NCT00098722|454766410|FG006|Open Label Phase|Pregnancy|0|||
126401995|NCT00098722|454766404|FG000|Open Label Phase|Participant defaulted|0|||
126401996|NCT00098722|454766405|FG001|Open Label Phase|Participant defaulted|0|||
126401997|NCT00098722|454766406|FG002|Open Label Phase|Participant defaulted|0|||
126401998|NCT00098722|454766407|FG003|Open Label Phase|Participant defaulted|18|||
126401999|NCT00098722|454766408|FG004|Open Label Phase|Participant defaulted|0|||
126402000|NCT00098722|454766409|FG005|Open Label Phase|Participant defaulted|0|||
126402001|NCT00098722|454766410|FG006|Open Label Phase|Participant defaulted|0|||
126402002|NCT00098722|454766404|FG000|Open Label Phase|Ongoing at cut-off date|0|||
126402003|NCT00098722|454766405|FG001|Open Label Phase|Ongoing at cut-off date|0|||
126402004|NCT00098722|454766406|FG002|Open Label Phase|Ongoing at cut-off date|0|||
126402005|NCT00098722|454766407|FG003|Open Label Phase|Ongoing at cut-off date|220|||
126402006|NCT00098722|454766408|FG004|Open Label Phase|Ongoing at cut-off date|50|||
126402007|NCT00098722|454766409|FG005|Open Label Phase|Ongoing at cut-off date|0|||
126402008|NCT00098722|454766410|FG006|Open Label Phase|Ongoing at cut-off date|0|||
126402009|NCT00098722|454766404|FG000|Open Label Phase|Other|0|||
126402010|NCT00098722|454766405|FG001|Open Label Phase|Other|0|||
126402011|NCT00098722|454766406|FG002|Open Label Phase|Other|0|||
126402012|NCT00098722|454766407|FG003|Open Label Phase|Other|18|||
126402013|NCT00098722|454766408|FG004|Open Label Phase|Other|0|||
126402014|NCT00098722|454766409|FG005|Open Label Phase|Other|0|||
126402015|NCT00098722|454766410|FG006|Open Label Phase|Other|0|||
126402016|NCT00098722|454766404|FG000|Observation Phase|Death|0|||
126402017|NCT00098722|454766405|FG001|Observation Phase|Death|0|||
126402018|NCT00098722|454766406|FG002|Observation Phase|Death|0|||
126402019|NCT00098722|454766407|FG003|Observation Phase|Death|0|||
126402020|NCT00098722|454766408|FG004|Observation Phase|Death|0|||
126402021|NCT00098722|454766409|FG005|Observation Phase|Death|5|||
126402022|NCT00098722|454766410|FG006|Observation Phase|Death|3|||
126402023|NCT00098722|454766404|FG000|Observation Phase|Lack of Efficacy|0|||
126402024|NCT00098722|454766405|FG001|Observation Phase|Lack of Efficacy|0|||
126402025|NCT00098722|454766406|FG002|Observation Phase|Lack of Efficacy|0|||
126402026|NCT00098722|454766407|FG003|Observation Phase|Lack of Efficacy|0|||
126402027|NCT00098722|454766408|FG004|Observation Phase|Lack of Efficacy|0|||
126402028|NCT00098722|454766409|FG005|Observation Phase|Lack of Efficacy|2|||
125890062|NCT00485134|452895429|FG004|Overall Study|Positive drug test|2|||
126402029|NCT00098722|454766410|FG006|Observation Phase|Lack of Efficacy|0|||
126402030|NCT00098722|454766404|FG000|Observation Phase|Participant defaulted|0|||
126402031|NCT00098722|454766405|FG001|Observation Phase|Participant defaulted|0|||
126402032|NCT00098722|454766406|FG002|Observation Phase|Participant defaulted|0|||
126402033|NCT00098722|454766407|FG003|Observation Phase|Participant defaulted|0|||
126402034|NCT00098722|454766408|FG004|Observation Phase|Participant defaulted|0|||
126402035|NCT00098722|454766409|FG005|Observation Phase|Participant defaulted|17|||
126402036|NCT00098722|454766410|FG006|Observation Phase|Participant defaulted|4|||
126402037|NCT00098722|454766404|FG000|Observation Phase|Other|0|||
126402038|NCT00098722|454766405|FG001|Observation Phase|Other|0|||
126402039|NCT00098722|454766406|FG002|Observation Phase|Other|0|||
126402040|NCT00098722|454766407|FG003|Observation Phase|Other|0|||
126402041|NCT00098722|454766408|FG004|Observation Phase|Other|0|||
126402042|NCT00098722|454766409|FG005|Observation Phase|Other|21|||
126402043|NCT00098722|454766410|FG006|Observation Phase|Other|10|||
126402044|NCT02351349|454766411|FG000|Overall Study|Withdrawal by Subject|2|||
126402045|NCT02351349|454766412|FG001|Overall Study|Withdrawal by Subject|3|||
126402046|NCT00440310|454766413|FG000|Overall Study|Lost to Follow-up|4|||
126402047|NCT00440310|454766414|FG001|Overall Study|Lost to Follow-up|5|||
126402048|NCT00440310|454766413|FG000|Overall Study|Protocol Violation|0|||
126402049|NCT00440310|454766414|FG001|Overall Study|Protocol Violation|1|||
126402050|NCT00440310|454766413|FG000|Overall Study|Withdrawal by Subject|15|||
126402051|NCT00440310|454766414|FG001|Overall Study|Withdrawal by Subject|14|||
126402052|NCT00440310|454766413|FG000|Overall Study|No Reply at EOS|7|||
126402053|NCT00440310|454766414|FG001|Overall Study|No Reply at EOS|7|||
126402054|NCT00440310|454766413|FG000|Overall Study|Other|1|||
126402055|NCT00440310|454766414|FG001|Overall Study|Other|0|||
126402056|NCT00440310|454766413|FG000|Overall Study|Status Unknown|1|||
126402057|NCT00440310|454766414|FG001|Overall Study|Status Unknown|3|||
126402058|NCT01610596|454766421|FG000|Overall Study|Lost to Follow-up|0|||
126402059|NCT01610596|454766422|FG001|Overall Study|Lost to Follow-up|1|||
126402060|NCT01519674|454766423|FG000|Overall Study|Adverse Event|3|||
126402061|NCT01519674|454766424|FG001|Overall Study|Adverse Event|3|||
126402062|NCT01519674|454766425|FG002|Overall Study|Adverse Event|0|||
126402063|NCT01519674|454766423|FG000|Overall Study|Lack of Efficacy|1|||
126402064|NCT01519674|454766424|FG001|Overall Study|Lack of Efficacy|1|||
126402065|NCT01519674|454766425|FG002|Overall Study|Lack of Efficacy|1|||
126402066|NCT01519674|454766423|FG000|Overall Study|Protocol Violation|0|||
126402067|NCT01519674|454766424|FG001|Overall Study|Protocol Violation|3|||
126402068|NCT01519674|454766425|FG002|Overall Study|Protocol Violation|1|||
126402069|NCT01519674|454766423|FG000|Overall Study|Withdrawal Criteria|7|||
126402070|NCT01519674|454766424|FG001|Overall Study|Withdrawal Criteria|2|||
126402071|NCT01519674|454766425|FG002|Overall Study|Withdrawal Criteria|7|||
126402072|NCT01519674|454766423|FG000|Overall Study|Unsclassified|10|||
126402073|NCT01519674|454766424|FG001|Overall Study|Unsclassified|4|||
126402074|NCT01519674|454766425|FG002|Overall Study|Unsclassified|3|||
126402075|NCT00799591|454766426|FG000|Overall Study|De-escalation of doses|20|||
126402076|NCT00799591|454766426|FG000|Overall Study|Death|14|||
126402077|NCT00799591|454766426|FG000|Overall Study|Technical failure|12|||
126402078|NCT00799591|454766426|FG000|Overall Study|Resistant germ|11|||
126402079|NCT00799591|454766426|FG000|Overall Study|New infection|4|||
126402080|NCT00799591|454766426|FG000|Overall Study|Resistance germ and technical failure|2|||
126402081|NCT00799591|454766426|FG000|Overall Study|Persistance of fever undetermined origin|1|||
126402082|NCT00799591|454766426|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
126402083|NCT00799591|454766426|FG000|Overall Study|Infectious origin not probable|1|||
126402084|NCT03106415|454766429|FG000|Phase 1|Withdrawal by Subject|1|||
126402085|NCT03106415|454766430|FG001|Phase 1|Withdrawal by Subject|0|||
126402086|NCT03106415|454766431|FG002|Phase 1|Withdrawal by Subject|0|||
126402087|NCT03106415|454766429|FG000|Phase 1|Adverse Event|1|||
126402088|NCT03106415|454766430|FG001|Phase 1|Adverse Event|1|||
126402089|NCT03106415|454766431|FG002|Phase 1|Adverse Event|0|||
126402090|NCT03106415|454766429|FG000|Phase 1|Protocol Violation|0|||
126402091|NCT03106415|454766430|FG001|Phase 1|Protocol Violation|1|||
126402092|NCT03106415|454766431|FG002|Phase 1|Protocol Violation|0|||
126402093|NCT00293709|454766432|FG000|Overall Study|Other|47|||
126402094|NCT02785458|454766433|FG000|1 Month|Withdrawal by Subject|2|||
126402095|NCT02785458|454766434|FG001|1 Month|Withdrawal by Subject|1|||
126402096|NCT02785458|454766433|FG000|1 Month|Lost to Follow-up|38|||
126402097|NCT02785458|454766434|FG001|1 Month|Lost to Follow-up|31|||
126402098|NCT02785458|454766433|FG000|1 Month|Deemed Ineligible|1|||
126402099|NCT02785458|454766434|FG001|1 Month|Deemed Ineligible|0|||
126402100|NCT02785458|454766433|FG000|1 Month|Completed Evaluation by Baseline|42|||
126402101|NCT02785458|454766434|FG001|1 Month|Completed Evaluation by Baseline|39|||
126402102|NCT02785458|454766433|FG000|1 Month|Partial Interview|0|||
126402103|NCT02785458|454766434|FG001|1 Month|Partial Interview|4|||
126402104|NCT02785458|454766433|FG000|3 Months|Withdrawal by Subject|3|||
126402105|NCT02785458|454766434|FG001|3 Months|Withdrawal by Subject|1|||
126402106|NCT02785458|454766433|FG000|3 Months|Lost to Follow-up|25|||
126402107|NCT02785458|454766434|FG001|3 Months|Lost to Follow-up|21|||
126402108|NCT02785458|454766433|FG000|3 Months|Completed Evaluation at 1 Month|100|||
126402109|NCT02785458|454766434|FG001|3 Months|Completed Evaluation at 1 Month|89|||
126402110|NCT01804582|454766435|FG000|Overall Study|Lost to Follow-up|47|||
126402111|NCT01804582|454766436|FG001|Overall Study|Lost to Follow-up|56|||
126402112|NCT01804582|454766435|FG000|Overall Study|Physician Decision|2|||
126402113|NCT01804582|454766436|FG001|Overall Study|Physician Decision|0|||
126402114|NCT00520013|454766437|FG000|Overall Study|Withdrawal by Subject|0|||
126402115|NCT00520013|454766438|FG001|Overall Study|Withdrawal by Subject|0|||
126402116|NCT00520013|454766439|FG002|Overall Study|Withdrawal by Subject|1|||
126402117|NCT00520013|454766437|FG000|Overall Study|Adverse Event|2|||
126402118|NCT00520013|454766438|FG001|Overall Study|Adverse Event|10|||
126402119|NCT00520013|454766439|FG002|Overall Study|Adverse Event|7|||
126402120|NCT00520013|454766437|FG000|Overall Study|Progressive Disease|7|||
126402121|NCT00520013|454766438|FG001|Overall Study|Progressive Disease|3|||
126402122|NCT00520013|454766439|FG002|Overall Study|Progressive Disease|0|||
126402123|NCT00520013|454766437|FG000|Overall Study|Clinical Progression|3|||
126402124|NCT00520013|454766438|FG001|Overall Study|Clinical Progression|1|||
126402125|NCT00520013|454766439|FG002|Overall Study|Clinical Progression|0|||
126402126|NCT00520013|454766437|FG000|Overall Study|Death|0|||
126402127|NCT00520013|454766438|FG001|Overall Study|Death|1|||
126402128|NCT00520013|454766439|FG002|Overall Study|Death|0|||
126402129|NCT00520013|454766437|FG000|Overall Study|Physician Decision|0|||
126402130|NCT00520013|454766438|FG001|Overall Study|Physician Decision|0|||
126402131|NCT00520013|454766439|FG002|Overall Study|Physician Decision|3|||
126402132|NCT02677844|454766440|FG000|Period 3|Withdrawal by Subject|0|||
126402133|NCT02677844|454766441|FG001|Period 3|Withdrawal by Subject|0|||
126402134|NCT02677844|454766442|FG002|Period 3|Withdrawal by Subject|0|||
125890063|NCT00485134|452895430|FG005|Overall Study|Positive drug test|1|||
126402135|NCT02677844|454766443|FG003|Period 3|Withdrawal by Subject|1|||
126402136|NCT02677844|454766444|FG004|Period 3|Withdrawal by Subject|0|||
126402137|NCT02677844|454766445|FG005|Period 3|Withdrawal by Subject|0|||
126402138|NCT02677844|454766446|FG006|Period 3|Withdrawal by Subject|0|||
126402139|NCT01697462|454766447|FG000|Overall Study|Disease Progression|1|||
126402140|NCT01697462|454766447|FG000|Overall Study|Adverse Event|6|||
126402141|NCT01697462|454766447|FG000|Overall Study|Lost to Follow-up|21|||
126402142|NCT01697462|454766447|FG000|Overall Study|Withdrawal by Subject|12|||
126402143|NCT01697462|454766447|FG000|Overall Study|Investigator Decision|21|||
126402144|NCT01697462|454766447|FG000|Overall Study|Death|1|||
126402145|NCT01697462|454766447|FG000|Overall Study|Other|10|||
126402146|NCT01697462|454766447|FG000|Overall Study|Missing|5|||
126402147|NCT03630302|454766448|FG000|Surgery|hardware issue prevented LFP recordings|1|||
126402148|NCT03630302|454766448|FG000|3 Month Visit|Adverse Event|2|||
126402149|NCT03630302|454766448|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
126402150|NCT01135914|454766451|FG000|Overall Study|Withdrawal by Subject|1|||
126402151|NCT01135914|454766452|FG001|Overall Study|Withdrawal by Subject|3|||
126402152|NCT01135914|454766453|FG002|Overall Study|Withdrawal by Subject|6|||
126402153|NCT01135914|454766451|FG000|Overall Study|Lost to Follow-up|1|||
126402154|NCT01135914|454766452|FG001|Overall Study|Lost to Follow-up|0|||
126402155|NCT01135914|454766453|FG002|Overall Study|Lost to Follow-up|1|||
126402156|NCT01135914|454766451|FG000|Overall Study|Protocol Violation|0|||
126402157|NCT01135914|454766452|FG001|Overall Study|Protocol Violation|0|||
126402158|NCT01135914|454766453|FG002|Overall Study|Protocol Violation|3|||
126402159|NCT01135914|454766451|FG000|Overall Study|Lack of Efficacy|2|||
126402160|NCT01135914|454766452|FG001|Overall Study|Lack of Efficacy|1|||
126402161|NCT01135914|454766453|FG002|Overall Study|Lack of Efficacy|10|||
126402162|NCT01135914|454766451|FG000|Overall Study|Adverse Event|0|||
126402163|NCT01135914|454766452|FG001|Overall Study|Adverse Event|1|||
126402164|NCT01135914|454766453|FG002|Overall Study|Adverse Event|2|||
126402165|NCT03532932|454766454|FG000|Overall Study|Protocol Deviation|33|||
126402166|NCT03532932|454766455|FG001|Overall Study|Protocol Deviation|31|||
126402167|NCT03532932|454766454|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
126402168|NCT03532932|454766455|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
126402169|NCT03532932|454766454|FG000|Overall Study|Withdrawal by Subject|2|||
126402170|NCT03532932|454766455|FG001|Overall Study|Withdrawal by Subject|0|||
126402171|NCT03532932|454766454|FG000|Overall Study|Lost to Follow-up|15|||
126402172|NCT03532932|454766455|FG001|Overall Study|Lost to Follow-up|9|||
126402173|NCT03532932|454766454|FG000|Overall Study|Adverse Event|4|||
126402174|NCT03532932|454766455|FG001|Overall Study|Adverse Event|3|||
126402175|NCT03532932|454766454|FG000|Overall Study|Death|0|||
126402176|NCT03532932|454766455|FG001|Overall Study|Death|2|||
126402177|NCT03532932|454766454|FG000|Overall Study|Other|11|||
126402178|NCT03532932|454766455|FG001|Overall Study|Other|16|||
126402179|NCT02699450|454766456|FG000|Overall Study|Death|2|||
126402180|NCT02699450|454766457|FG001|Overall Study|Death|1|||
126402181|NCT02699450|454766458|FG002|Overall Study|Death|2|||
126402182|NCT02699450|454766456|FG000|Overall Study|Met Criteria for Study Exit|0|||
126402183|NCT02699450|454766457|FG001|Overall Study|Met Criteria for Study Exit|0|||
126402184|NCT02699450|454766458|FG002|Overall Study|Met Criteria for Study Exit|1|||
126402185|NCT02699450|454766456|FG000|Overall Study|Protocol Violation|4|||
126402186|NCT02699450|454766457|FG001|Overall Study|Protocol Violation|3|||
126402187|NCT02699450|454766458|FG002|Overall Study|Protocol Violation|5|||
126402188|NCT02699450|454766456|FG000|Overall Study|Lost to Follow-up|3|||
126402189|NCT02699450|454766457|FG001|Overall Study|Lost to Follow-up|0|||
126402190|NCT02699450|454766458|FG002|Overall Study|Lost to Follow-up|5|||
126402191|NCT02699450|454766456|FG000|Overall Study|Physician Decision|2|||
126402192|NCT02699450|454766457|FG001|Overall Study|Physician Decision|0|||
126402193|NCT02699450|454766458|FG002|Overall Study|Physician Decision|0|||
126402194|NCT02699450|454766456|FG000|Overall Study|Withdrawal by Subject|3|||
126402195|NCT02699450|454766457|FG001|Overall Study|Withdrawal by Subject|1|||
126402196|NCT02699450|454766458|FG002|Overall Study|Withdrawal by Subject|2|||
126402197|NCT02699450|454766456|FG000|Overall Study|Adverse Event|1|||
126402198|NCT02699450|454766457|FG001|Overall Study|Adverse Event|0|||
126402199|NCT02699450|454766458|FG002|Overall Study|Adverse Event|0|||
126402200|NCT01344629|454766459|FG000|Crossover Period 2|Withdrawal by Subject|0|||
126402201|NCT01344629|454766460|FG001|Crossover Period 2|Withdrawal by Subject|1|||
126402202|NCT00693472|454766462|FG000|Part 1|Adverse Event|1|||
126402203|NCT00693472|454766463|FG001|Part 1|Adverse Event|1|||
126402204|NCT00693472|454766464|FG002|Part 1|Adverse Event|0|||
126402205|NCT00693472|454766465|FG003|Part 1|Adverse Event|0|||
126402206|NCT00693472|454766462|FG000|Part 1|Lost to Follow-up|0|||
126402207|NCT00693472|454766463|FG001|Part 1|Lost to Follow-up|1|||
126402208|NCT00693472|454766464|FG002|Part 1|Lost to Follow-up|0|||
126402209|NCT00693472|454766465|FG003|Part 1|Lost to Follow-up|0|||
126402210|NCT00693472|454766462|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
126402211|NCT00693472|454766463|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
126402212|NCT00693472|454766464|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
126402213|NCT00693472|454766465|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
126402214|NCT00693472|454766462|FG000|Part 2|Adverse Event|0|||
126402215|NCT00693472|454766463|FG001|Part 2|Adverse Event|0|||
126402216|NCT00693472|454766464|FG002|Part 2|Adverse Event|1|||
126402217|NCT00693472|454766465|FG003|Part 2|Adverse Event|0|||
126402218|NCT00693472|454766462|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
126402219|NCT00693472|454766463|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
126402220|NCT00693472|454766464|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
126402221|NCT00693472|454766465|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
126402222|NCT04063787|454766468|FG000|Overall Study|Inadequate Doppler data|4|||
126402223|NCT04063787|454766468|FG000|Overall Study|Lost to Follow-up|2|||
126402224|NCT04063787|454766468|FG000|Overall Study|Death|3|||
126402225|NCT05545644|454766469|FG000|Overall Study|Lost to Follow-up|4|||
126402226|NCT05545644|454766470|FG001|Overall Study|Lost to Follow-up|3|||
126402227|NCT00453973|454766475|FG000|Overall Study|Adverse Event|4|||
126402228|NCT00453973|454766476|FG001|Overall Study|Adverse Event|9|||
126402229|NCT00453973|454766475|FG000|Overall Study|Withdrawal by Subject|7|||
126402230|NCT00453973|454766476|FG001|Overall Study|Withdrawal by Subject|6|||
126402231|NCT00453973|454766475|FG000|Overall Study|PI Decision|0|||
126402232|NCT00453973|454766476|FG001|Overall Study|PI Decision|2|||
126402233|NCT00453973|454766475|FG000|Overall Study|Relocation|1|||
126402234|NCT00453973|454766476|FG001|Overall Study|Relocation|0|||
126402235|NCT00453973|454766475|FG000|Overall Study|Renal transplant|1|||
126402236|NCT00453973|454766476|FG001|Overall Study|Renal transplant|1|||
126402237|NCT00453973|454766475|FG000|Overall Study|Site closed by sponsor|3|||
126402238|NCT00453973|454766476|FG001|Overall Study|Site closed by sponsor|0|||
126402239|NCT00453973|454766475|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
126402240|NCT00453973|454766476|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
126402241|NCT00276094|454766477|FG000|Overall Study|Adverse Event|15|||
126402242|NCT00276094|454766478|FG001|Overall Study|Adverse Event|13|||
126402243|NCT00276094|454766479|FG002|Overall Study|Adverse Event|11|||
126402244|NCT00276094|454766477|FG000|Overall Study|Withdrawal by Subject|14|||
126402245|NCT00276094|454766478|FG001|Overall Study|Withdrawal by Subject|14|||
126402246|NCT00276094|454766479|FG002|Overall Study|Withdrawal by Subject|12|||
126402247|NCT00276094|454766477|FG000|Overall Study|Protocol Violation|16|||
126402248|NCT00276094|454766478|FG001|Overall Study|Protocol Violation|7|||
126402249|NCT00276094|454766479|FG002|Overall Study|Protocol Violation|10|||
126402250|NCT00276094|454766477|FG000|Overall Study|Lost to Follow-up|8|||
126402251|NCT00276094|454766478|FG001|Overall Study|Lost to Follow-up|6|||
126402252|NCT00276094|454766479|FG002|Overall Study|Lost to Follow-up|4|||
126402253|NCT00276094|454766477|FG000|Overall Study|Other-Subject moved out of country|1|||
126402254|NCT00276094|454766478|FG001|Overall Study|Other-Subject moved out of country|0|||
126402255|NCT00276094|454766479|FG002|Overall Study|Other-Subject moved out of country|0|||
126402256|NCT00276094|454766477|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
126402257|NCT00276094|454766478|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
126402258|NCT00276094|454766479|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
126402259|NCT00276094|454766477|FG000|Overall Study|Other-Lack of efficacy|1|||
126402260|NCT00276094|454766478|FG001|Overall Study|Other-Lack of efficacy|0|||
126402261|NCT00276094|454766479|FG002|Overall Study|Other-Lack of efficacy|0|||
126402262|NCT00276094|454766477|FG000|Overall Study|Other-Refused follow-up visit|1|||
126402263|NCT00276094|454766478|FG001|Overall Study|Other-Refused follow-up visit|0|||
126402264|NCT00276094|454766479|FG002|Overall Study|Other-Refused follow-up visit|0|||
126402265|NCT00276094|454766477|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
126402266|NCT00276094|454766478|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
126402267|NCT00276094|454766479|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
126402268|NCT00276094|454766477|FG000|Overall Study|Other-Relocation|0|||
126402269|NCT00276094|454766478|FG001|Overall Study|Other-Relocation|1|||
126402270|NCT00276094|454766479|FG002|Overall Study|Other-Relocation|0|||
126402271|NCT00276094|454766477|FG000|Overall Study|Other-Study medication lost|0|||
126402272|NCT00276094|454766478|FG001|Overall Study|Other-Study medication lost|0|||
126402273|NCT00276094|454766479|FG002|Overall Study|Other-Study medication lost|1|||
126402274|NCT03002623|454766482|FG000|Overall Study|Lost to Follow-up|1|||
126402275|NCT03002623|454766483|FG001|Overall Study|Lost to Follow-up|0|||
126402276|NCT03002623|454766482|FG000|Overall Study|Physician Decision|1|||
126402277|NCT03002623|454766483|FG001|Overall Study|Physician Decision|1|||
126402278|NCT00493636|454766485|FG000|Overall Study|Withdrawal by Subject|1|||
126402279|NCT00493636|454766486|FG001|Overall Study|Withdrawal by Subject|0|||
126402280|NCT00493636|454766485|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
126402281|NCT00493636|454766486|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
126402282|NCT00493636|454766485|FG000|Overall Study|Mis-randomization|1|||
126402283|NCT00493636|454766486|FG001|Overall Study|Mis-randomization|1|||
126402284|NCT01873729|454766493|FG000|Overall Study|Withdrawal by Subject|1|||
126402285|NCT02463032|454766494|FG000|Overall Study|Lack of Efficacy|61|||
126402286|NCT02463032|454766495|FG001|Overall Study|Lack of Efficacy|50|||
126402287|NCT02463032|454766494|FG000|Overall Study|Death|8|||
126402288|NCT02463032|454766495|FG001|Overall Study|Death|8|||
126402289|NCT02463032|454766494|FG000|Overall Study|Adverse Event|2|||
126402290|NCT02463032|454766495|FG001|Overall Study|Adverse Event|6|||
126402291|NCT01066780|454766496|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
126402292|NCT01066780|454766497|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
126402293|NCT00160199|454766502|FG000|Overall Study|Adverse Event|5|||
126402294|NCT00160199|454766503|FG001|Overall Study|Adverse Event|14|||
126402295|NCT00160199|454766502|FG000|Overall Study|Lack of Efficacy|0|||
126402296|NCT00160199|454766503|FG001|Overall Study|Lack of Efficacy|1|||
126402297|NCT00160199|454766502|FG000|Overall Study|Lost to Follow-up|7|||
126402298|NCT00160199|454766503|FG001|Overall Study|Lost to Follow-up|7|||
126402299|NCT00160199|454766502|FG000|Overall Study|Withdrawal by Subject|4|||
126402300|NCT00160199|454766503|FG001|Overall Study|Withdrawal by Subject|6|||
126402301|NCT00160199|454766502|FG000|Overall Study|Administrative|0|||
126402302|NCT00160199|454766503|FG001|Overall Study|Administrative|1|||
126402303|NCT00160199|454766502|FG000|Overall Study|Protocol Violation|8|||
126402304|NCT00160199|454766503|FG001|Overall Study|Protocol Violation|8|||
126402305|NCT03352453|454766504|FG000|Overall Study|Miscellaneous Reasons|1|||
126402306|NCT03352453|454766505|FG001|Overall Study|Miscellaneous Reasons|2|||
126402307|NCT03352453|454766504|FG000|Overall Study|Lack of Efficacy|1|||
126402308|NCT03352453|454766505|FG001|Overall Study|Lack of Efficacy|0|||
126402309|NCT03352453|454766504|FG000|Overall Study|Withdrawal by Subject|8|||
126402310|NCT03352453|454766505|FG001|Overall Study|Withdrawal by Subject|14|||
126402311|NCT03352453|454766504|FG000|Overall Study|Study Terminated by Sponsor|2|||
126402312|NCT03352453|454766505|FG001|Overall Study|Study Terminated by Sponsor|1|||
126402313|NCT03352453|454766504|FG000|Overall Study|Protocol Deviation|1|||
126402314|NCT03352453|454766505|FG001|Overall Study|Protocol Deviation|0|||
126402315|NCT03352453|454766504|FG000|Overall Study|Lost to Follow-up|7|||
126402316|NCT03352453|454766505|FG001|Overall Study|Lost to Follow-up|6|||
126402317|NCT03352453|454766504|FG000|Overall Study|Adverse Event|2|||
126402318|NCT03352453|454766505|FG001|Overall Study|Adverse Event|9|||
126402319|NCT01241760|454766508|FG000|Overall Study|Adverse Event|1|||
126402320|NCT01241760|454766509|FG001|Overall Study|Adverse Event|0|||
126402321|NCT01241760|454766508|FG000|Overall Study|Lost to Follow-up|18|||
126402322|NCT01241760|454766509|FG001|Overall Study|Lost to Follow-up|22|||
126402323|NCT01241760|454766508|FG000|Overall Study|Withdrawal by Subject|13|||
126402324|NCT01241760|454766509|FG001|Overall Study|Withdrawal by Subject|13|||
126402325|NCT01241760|454766508|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
126402326|NCT01241760|454766509|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
126402327|NCT01241760|454766508|FG000|Overall Study|Other|1|||
126402328|NCT01241760|454766509|FG001|Overall Study|Other|1|||
126402329|NCT03089944|454766510|FG000|Overall Study|Lost to Follow-up|8|||
126402330|NCT03089944|454766510|FG000|Overall Study|Withdrew Consent|2|||
126402331|NCT03089944|454766510|FG000|Overall Study|Adverse Event|1|||
126402332|NCT03089944|454766510|FG000|Overall Study|Other|1|||
126402333|NCT03780959|454766511|FG000|Part 1|Adverse Event|1|||
126402334|NCT03780959|454766512|FG001|Part 1|Adverse Event|0|||
126402335|NCT03780959|454766513|FG002|Part 1|Adverse Event|0|||
126402336|NCT03780959|454766511|FG000|Part 1|Withdrawal by Subject|1|||
126402337|NCT03780959|454766512|FG001|Part 1|Withdrawal by Subject|0|||
126402338|NCT03780959|454766513|FG002|Part 1|Withdrawal by Subject|0|||
126402339|NCT03780959|454766511|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
126402340|NCT03780959|454766512|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
126402341|NCT03780959|454766513|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
126402342|NCT03780959|454766511|FG000|Part 1|Response Status|2|||
126402343|NCT03780959|454766512|FG001|Part 1|Response Status|0|||
126402344|NCT03780959|454766513|FG002|Part 1|Response Status|0|||
126402345|NCT03780959|454766511|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
126402346|NCT03780959|454766512|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
126402347|NCT03780959|454766513|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
126402348|NCT03780959|454766511|FG000|Part 2|Response Status|0|||
126402349|NCT03780959|454766512|FG001|Part 2|Response Status|18|||
126402350|NCT03780959|454766513|FG002|Part 2|Response Status|6|||
126402351|NCT01636713|454766514|FG000|Overall Study|Adverse Event|16|||
126402352|NCT01636713|454766515|FG001|Overall Study|Adverse Event|16|||
126402353|NCT01636713|454766516|FG002|Overall Study|Adverse Event|7|||
126402354|NCT01636713|454766514|FG000|Overall Study|Lack of Efficacy|6|||
126402355|NCT01636713|454766515|FG001|Overall Study|Lack of Efficacy|6|||
126402356|NCT01636713|454766516|FG002|Overall Study|Lack of Efficacy|2|||
126402357|NCT01636713|454766514|FG000|Overall Study|Protocol Violation|3|||
126402358|NCT01636713|454766515|FG001|Overall Study|Protocol Violation|0|||
126402359|NCT01636713|454766516|FG002|Overall Study|Protocol Violation|1|||
126402360|NCT01636713|454766514|FG000|Overall Study|Lost to Follow-up|0|||
126402361|NCT01636713|454766515|FG001|Overall Study|Lost to Follow-up|0|||
126402362|NCT01636713|454766516|FG002|Overall Study|Lost to Follow-up|1|||
126402363|NCT01636713|454766514|FG000|Overall Study|Withdrawal by Subject|5|||
126402364|NCT01636713|454766515|FG001|Overall Study|Withdrawal by Subject|4|||
126402365|NCT01636713|454766516|FG002|Overall Study|Withdrawal by Subject|8|||
126402366|NCT01636713|454766514|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
126402367|NCT01636713|454766515|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
126402368|NCT01636713|454766516|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
126402369|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
126402370|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
126402371|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
126402372|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
126402373|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
126402374|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
125890064|NCT00485134|452895431|FG006|Overall Study|Positive drug test|0|||
125890065|NCT00485134|452895432|FG007|Overall Study|Positive drug test|0|||
125890066|NCT00485134|452895425|FG000|Overall Study|Non-compliance|0|||
125890067|NCT00485134|452895426|FG001|Overall Study|Non-compliance|0|||
125890068|NCT00485134|452895427|FG002|Overall Study|Non-compliance|0|||
125890069|NCT00485134|452895428|FG003|Overall Study|Non-compliance|0|||
125890070|NCT00485134|452895429|FG004|Overall Study|Non-compliance|1|||
125890071|NCT00485134|452895430|FG005|Overall Study|Non-compliance|2|||
125890072|NCT00485134|452895431|FG006|Overall Study|Non-compliance|2|||
125890073|NCT00485134|452895432|FG007|Overall Study|Non-compliance|0|||
125890074|NCT00485134|452895425|FG000|Overall Study|Unable to comply with study schedule|0|||
125890075|NCT00485134|452895426|FG001|Overall Study|Unable to comply with study schedule|0|||
125890076|NCT00485134|452895427|FG002|Overall Study|Unable to comply with study schedule|0|||
125890077|NCT00485134|452895428|FG003|Overall Study|Unable to comply with study schedule|0|||
125890078|NCT00485134|452895429|FG004|Overall Study|Unable to comply with study schedule|0|||
125890079|NCT00485134|452895430|FG005|Overall Study|Unable to comply with study schedule|0|||
125890080|NCT00485134|452895431|FG006|Overall Study|Unable to comply with study schedule|0|||
125890081|NCT00485134|452895432|FG007|Overall Study|Unable to comply with study schedule|1|||
125890082|NCT00485134|452895425|FG000|Overall Study|Pregnancy|0|||
125890083|NCT00485134|452895426|FG001|Overall Study|Pregnancy|0|||
125890084|NCT00485134|452895427|FG002|Overall Study|Pregnancy|0|||
125890085|NCT00485134|452895428|FG003|Overall Study|Pregnancy|0|||
125890086|NCT00485134|452895429|FG004|Overall Study|Pregnancy|0|||
125890087|NCT00485134|452895430|FG005|Overall Study|Pregnancy|0|||
125890088|NCT00485134|452895431|FG006|Overall Study|Pregnancy|1|||
125890089|NCT00485134|452895432|FG007|Overall Study|Pregnancy|0|||
125890090|NCT00970684|452895433|FG000|Overall Study|Lack of Efficacy|5|||
125890091|NCT00970684|452895433|FG000|Overall Study|Adverse Event|4|||
125890092|NCT00970684|452895433|FG000|Overall Study|Withdrawal by Subject|1|||
125890093|NCT00481091|452895434|FG000|Overall Study|Withdrawal by Subject|0|||
125890094|NCT00481091|452895435|FG001|Overall Study|Withdrawal by Subject|1|||
125890095|NCT00481091|452895436|FG002|Overall Study|Withdrawal by Subject|1|||
125890096|NCT00481091|452895437|FG003|Overall Study|Withdrawal by Subject|0|||
125890097|NCT00481091|452895438|FG004|Overall Study|Withdrawal by Subject|0|||
125890098|NCT00481091|452895439|FG005|Overall Study|Withdrawal by Subject|0|||
125890099|NCT00481091|452895440|FG006|Overall Study|Withdrawal by Subject|0|||
125890100|NCT00481091|452895441|FG007|Overall Study|Withdrawal by Subject|0|||
125890101|NCT00481091|452895442|FG008|Overall Study|Withdrawal by Subject|1|||
125890102|NCT00481091|452895443|FG009|Overall Study|Withdrawal by Subject|6|||
125890103|NCT00481091|452895434|FG000|Overall Study|Other, Not Specified|0|||
126402375|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
125890104|NCT00481091|452895435|FG001|Overall Study|Other, Not Specified|1|||
125890105|NCT00481091|452895436|FG002|Overall Study|Other, Not Specified|1|||
125890106|NCT00481091|452895437|FG003|Overall Study|Other, Not Specified|0|||
125890107|NCT00481091|452895438|FG004|Overall Study|Other, Not Specified|0|||
125890108|NCT00481091|452895439|FG005|Overall Study|Other, Not Specified|1|||
125890109|NCT00481091|452895440|FG006|Overall Study|Other, Not Specified|0|||
126402376|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
126402377|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
126402378|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
126402379|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
126402380|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
126402381|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
126402382|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
126402383|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
126402384|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
126402385|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
126402386|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
126402387|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
126402388|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
126402389|NCT03689244|454766521|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
126402390|NCT03689244|454766522|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
126402391|NCT03689244|454766523|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
126402392|NCT03689244|454766524|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
126402393|NCT03689244|454766521|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
126402394|NCT03689244|454766522|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
126402395|NCT03689244|454766523|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
126402396|NCT03689244|454766524|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
126402397|NCT03689244|454766521|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
126402398|NCT03689244|454766522|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
126402399|NCT03689244|454766523|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
126402400|NCT03689244|454766524|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
126402401|NCT01565564|454766525|FG000|Overall Study|Lost to Follow-up|5|||
126402402|NCT01565564|454766526|FG001|Overall Study|Lost to Follow-up|1|||
126402403|NCT00969436|454766528|FG000|Overall Study|Protocol Violation|1|||
126402404|NCT00969436|454766529|FG001|Overall Study|Protocol Violation|3|||
126402405|NCT00969436|454766530|FG002|Overall Study|Protocol Violation|0|||
126402406|NCT00969436|454766528|FG000|Overall Study|Migrated/moved from study area|12|||
126402407|NCT00969436|454766529|FG001|Overall Study|Migrated/moved from study area|10|||
126402408|NCT00969436|454766530|FG002|Overall Study|Migrated/moved from study area|2|||
126402409|NCT00969436|454766528|FG000|Overall Study|Father - serious health problem|0|||
126402410|NCT00969436|454766529|FG001|Overall Study|Father - serious health problem|0|||
126402411|NCT00969436|454766530|FG002|Overall Study|Father - serious health problem|1|||
126402412|NCT00969436|454766528|FG000|Overall Study|Parents personal problem|0|||
126402413|NCT00969436|454766529|FG001|Overall Study|Parents personal problem|0|||
126402414|NCT00969436|454766530|FG002|Overall Study|Parents personal problem|1|||
126402415|NCT00969436|454766528|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
126402416|NCT00969436|454766529|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
126402417|NCT00969436|454766530|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
126402418|NCT00969436|454766528|FG000|Overall Study|Withdrawal by Subject|3|||
126402419|NCT00969436|454766529|FG001|Overall Study|Withdrawal by Subject|0|||
126402420|NCT00969436|454766530|FG002|Overall Study|Withdrawal by Subject|2|||
126402421|NCT00969436|454766528|FG000|Overall Study|Lost to Follow-up|8|||
126402422|NCT00969436|454766529|FG001|Overall Study|Lost to Follow-up|8|||
126402423|NCT00969436|454766530|FG002|Overall Study|Lost to Follow-up|5|||
126402424|NCT00459537|454766540|FG000|Overall Study|Adverse Event|1|||
126402425|NCT00459537|454766541|FG001|Overall Study|Adverse Event|6|||
126402426|NCT00459537|454766540|FG000|Overall Study|Lack of Efficacy|10|||
126402427|NCT00459537|454766541|FG001|Overall Study|Lack of Efficacy|11|||
126402428|NCT00459537|454766540|FG000|Overall Study|Withdrawal by Subject|20|||
126402429|NCT00459537|454766541|FG001|Overall Study|Withdrawal by Subject|26|||
126402430|NCT00459537|454766540|FG000|Overall Study|Lost to Follow-up|27|||
126402431|NCT00459537|454766541|FG001|Overall Study|Lost to Follow-up|30|||
126402432|NCT00459537|454766540|FG000|Overall Study|Administrative problems|3|||
126402433|NCT00459537|454766541|FG001|Overall Study|Administrative problems|0|||
126402434|NCT00459537|454766540|FG000|Overall Study|Protocol Violation|4|||
126402435|NCT00459537|454766541|FG001|Overall Study|Protocol Violation|3|||
126402436|NCT00459537|454766540|FG000|Overall Study|Missing|1|||
126402437|NCT00459537|454766541|FG001|Overall Study|Missing|0|||
126402438|NCT03159104|454766542|FG000|Overall Study|Violation of inclusion criteria|1|||
126402439|NCT03159104|454766543|FG001|Overall Study|Violation of inclusion criteria|2|||
126402440|NCT00456599|454766544|FG000|Overall Study|Non-compliance|1|||
126402441|NCT00456599|454766544|FG000|Overall Study|Withdrawal by Subject|2|||
126402442|NCT01999218|454766545|FG000|Overall Study|Hyperglycemia|18|||
126402443|NCT01999218|454766546|FG001|Overall Study|Hyperglycemia|17|||
126402444|NCT01999218|454766547|FG002|Overall Study|Hyperglycemia|17|||
126402445|NCT01999218|454766545|FG000|Overall Study|Lack of Efficacy|1|||
126402446|NCT01999218|454766546|FG001|Overall Study|Lack of Efficacy|0|||
126402447|NCT01999218|454766547|FG002|Overall Study|Lack of Efficacy|1|||
126402448|NCT01999218|454766545|FG000|Overall Study|Lost to Follow-up|22|||
126402449|NCT01999218|454766546|FG001|Overall Study|Lost to Follow-up|17|||
126402450|NCT01999218|454766547|FG002|Overall Study|Lost to Follow-up|18|||
126402451|NCT01999218|454766545|FG000|Overall Study|Non-Compliance With Study Drug|6|||
126402452|NCT01999218|454766546|FG001|Overall Study|Non-Compliance With Study Drug|4|||
126402453|NCT01999218|454766547|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126402454|NCT01999218|454766545|FG000|Overall Study|Physician Decision|1|||
126402455|NCT01999218|454766546|FG001|Overall Study|Physician Decision|4|||
126402456|NCT01999218|454766547|FG002|Overall Study|Physician Decision|6|||
126402457|NCT01999218|454766545|FG000|Overall Study|Protocol Violation|4|||
126402458|NCT01999218|454766546|FG001|Overall Study|Protocol Violation|5|||
126402459|NCT01999218|454766547|FG002|Overall Study|Protocol Violation|4|||
126402460|NCT01999218|454766545|FG000|Overall Study|Screen failure|0|||
126402461|NCT01999218|454766546|FG001|Overall Study|Screen failure|1|||
126402462|NCT01999218|454766547|FG002|Overall Study|Screen failure|0|||
126402463|NCT01999218|454766545|FG000|Overall Study|Study Terminated By Sponsor|7|||
126402464|NCT01999218|454766546|FG001|Overall Study|Study Terminated By Sponsor|5|||
126402465|NCT01999218|454766547|FG002|Overall Study|Study Terminated By Sponsor|12|||
126402466|NCT01999218|454766545|FG000|Overall Study|Participant moves|2|||
126402467|NCT01999218|454766546|FG001|Overall Study|Participant moves|5|||
126402468|NCT01999218|454766547|FG002|Overall Study|Participant moves|3|||
126402469|NCT01999218|454766545|FG000|Overall Study|Withdrawal by Subject|28|||
126402470|NCT01999218|454766546|FG001|Overall Study|Withdrawal by Subject|29|||
126402471|NCT01999218|454766547|FG002|Overall Study|Withdrawal by Subject|34|||
126402472|NCT01999218|454766545|FG000|Overall Study|Creatinine/eGFR|0|||
126402473|NCT01999218|454766546|FG001|Overall Study|Creatinine/eGFR|0|||
126402474|NCT01999218|454766547|FG002|Overall Study|Creatinine/eGFR|1|||
126402475|NCT01999218|454766545|FG000|Overall Study|Death|7|||
126402476|NCT01999218|454766546|FG001|Overall Study|Death|1|||
126402477|NCT01999218|454766547|FG002|Overall Study|Death|2|||
126402478|NCT01999218|454766545|FG000|Overall Study|Excluded Medication|1|||
126402479|NCT01999218|454766546|FG001|Overall Study|Excluded Medication|1|||
126402480|NCT01999218|454766547|FG002|Overall Study|Excluded Medication|2|||
126402481|NCT01999218|454766545|FG000|Overall Study|Adverse Event|9|||
126402482|NCT01999218|454766546|FG001|Overall Study|Adverse Event|7|||
126402483|NCT01999218|454766547|FG002|Overall Study|Adverse Event|7|||
126402484|NCT01999218|454766545|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
126402485|NCT01999218|454766546|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
126402486|NCT01999218|454766547|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
126402487|NCT00664326|454768371|FG000|Overall Study|Adverse Event|14|||
126053447|NCT03745313|453489518|FG000|At 30 Days Follow-up|Death|2|||
126053448|NCT03745313|453489518|FG000|At 6 Months Follow-up|Death|1|||
126053449|NCT03745313|453489518|FG000|At 6 Months Follow-up|Missed Visit|1|||
126053450|NCT03745313|453489518|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
126053451|NCT03745313|453489518|FG000|At 1 Year Follow-up|Death|2|||
126053452|NCT03745313|453489518|FG000|At 1 Year Follow-up|Missed Visit|2|||
126053453|NCT03745313|453489518|FG000|At 2 Year Follow-up|Missed Visit|1|||
126402488|NCT00664326|454768371|FG000|Overall Study|Noncompliance with study medication|3|||
126402489|NCT00664326|454768371|FG000|Overall Study|Withdrawal by Subject|1|||
126402490|NCT00664326|454768371|FG000|Overall Study|Physician Decision|1|||
126402491|NCT00664326|454768371|FG000|Overall Study|Other Reasons|3|||
126402492|NCT00664326|454768371|FG000|Overall Study|Death|2|||
126402493|NCT00664326|454768371|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
126402494|NCT00387647|454768372|FG000|Overall Study|Death|18|||
126402495|NCT02032407|454768373|FG000|Overall Study|Lost to Follow-up|2|||
126402496|NCT02032407|454768373|FG000|Overall Study|Pregnancy|1|||
126402497|NCT02032407|454768373|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126402498|NCT02191605|454768374|FG000|Overall Study|Lost to Follow-up|9|||
126402499|NCT02191605|454768375|FG001|Overall Study|Lost to Follow-up|4|||
126402500|NCT02191605|454768376|FG002|Overall Study|Lost to Follow-up|7|||
126402501|NCT02191605|454768377|FG003|Overall Study|Lost to Follow-up|3|||
126402502|NCT02191605|454768378|FG004|Overall Study|Lost to Follow-up|4|||
126402503|NCT01309269|454768381|FG000|Overall Study|Adverse Event|56|||
126402504|NCT01309269|454768381|FG000|Overall Study|Withdrawal by Subject|25|||
126402505|NCT01309269|454768381|FG000|Overall Study|Lack of Acceptance|15|||
126402506|NCT01309269|454768381|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
126402507|NCT01309269|454768381|FG000|Overall Study|Kidney Transplant|25|||
126402508|NCT01309269|454768381|FG000|Overall Study|Administrative Problems|141|||
126402509|NCT01309269|454768381|FG000|Overall Study|Other|256|||
126402510|NCT01309269|454768381|FG000|Overall Study|Other|1|||
126402511|NCT01309269|454768381|FG000|Overall Study|Study Completion Data Not Recorded|95|||
126402512|NCT01309269|454768381|FG000|Overall Study|Enrolled but not Treated|107|||
126402513|NCT03647267|454768385|FG000|Overall Study|Lost to Follow-up|1|||
126402514|NCT03647267|454768386|FG001|Overall Study|Lost to Follow-up|0|||
126402515|NCT01350115|454768387|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
126402516|NCT01350115|454768388|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
126402517|NCT01350115|454768387|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
126402518|NCT01350115|454768388|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
126402519|NCT01350115|454768387|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
126402520|NCT01350115|454768388|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
126402521|NCT05079477|454768389|FG000|Overall Study|Lost to Follow-up|2|||
126402522|NCT05079477|454768390|FG001|Overall Study|Lost to Follow-up|0|||
126402523|NCT05079477|454768389|FG000|Overall Study|Withdrawal by Subject|1|||
126402524|NCT05079477|454768390|FG001|Overall Study|Withdrawal by Subject|0|||
126402525|NCT05079477|454768389|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
126402526|NCT05079477|454768390|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
126402527|NCT05079477|454768389|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
126402528|NCT05079477|454768390|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
126402529|NCT05013424|454768393|FG000|Overall Study|Lost to Follow-up|1|||
126402530|NCT05013424|454768394|FG001|Overall Study|Lost to Follow-up|1|||
126402531|NCT05013424|454768395|FG002|Overall Study|Lost to Follow-up|1|||
126402532|NCT05013424|454768393|FG000|Overall Study|Withdrawal by Subject|0|||
126402533|NCT05013424|454768394|FG001|Overall Study|Withdrawal by Subject|1|||
126402534|NCT05013424|454768395|FG002|Overall Study|Withdrawal by Subject|0|||
126402535|NCT00240110|454768397|FG000|Overall Study|Lost to Follow-up|6|||
126402536|NCT00240110|454768398|FG001|Overall Study|Lost to Follow-up|7|||
126402537|NCT00583791|454768399|FG000|Overall Study|Other|67|||
126402538|NCT00583791|454768399|FG000|Overall Study|Death|6|||
126402539|NCT03323736|454768400|FG000|Overall Study|Screen Failure|14|||
126402540|NCT03323736|454768401|FG001|Overall Study|Screen Failure|9|||
126402541|NCT03323736|454768402|FG002|Overall Study|Screen Failure|1|||
126402542|NCT03323736|454768400|FG000|Overall Study|Withdrawal Before Treatment|3|||
126402543|NCT03323736|454768401|FG001|Overall Study|Withdrawal Before Treatment|1|||
126402544|NCT03323736|454768402|FG002|Overall Study|Withdrawal Before Treatment|1|||
126402545|NCT03323736|454768400|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
126402546|NCT03323736|454768401|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
126402547|NCT03323736|454768402|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
126402548|NCT02654236|454768406|FG000|Overall Study|Withdrawal by Subject|0|||
126402549|NCT02654236|454768407|FG001|Overall Study|Withdrawal by Subject|0|||
126402550|NCT02654236|454768408|FG002|Overall Study|Withdrawal by Subject|2|||
126402551|NCT03710876|454768409|FG000|Overall Study|Death|0|||
126402552|NCT03710876|454768410|FG001|Overall Study|Death|2|||
126402553|NCT03710876|454768409|FG000|Overall Study|Withdrawal by Subject|0|||
126402554|NCT03710876|454768410|FG001|Overall Study|Withdrawal by Subject|2|||
126402555|NCT03627065|454768411|FG000|Overall Study|Study Terminated by sponsor|1|||
126402556|NCT03627065|454768411|FG000|Overall Study|Withdrawal by Subject|2|||
126402557|NCT04524455|454768413|FG000|Overall Study|Death|3|||
126402558|NCT04524455|454768414|FG001|Overall Study|Death|3|||
126402559|NCT04524455|454768413|FG000|Overall Study|Decision by Sponsor|0|||
126402560|NCT04524455|454768414|FG001|Overall Study|Decision by Sponsor|2|||
126402561|NCT04524455|454768413|FG000|Overall Study|Withdrawal of Consent From Study|1|||
126402562|NCT04524455|454768414|FG001|Overall Study|Withdrawal of Consent From Study|0|||
126402563|NCT04524455|454768413|FG000|Overall Study|Lost to Follow-up|0|||
126402564|NCT04524455|454768414|FG001|Overall Study|Lost to Follow-up|1|||
126402565|NCT01688739|454768417|FG000|Overall Study|Administrative Decision|1|||
126402566|NCT01688739|454768418|FG001|Overall Study|Administrative Decision|0|||
126402567|NCT01688739|454768419|FG002|Overall Study|Administrative Decision|0|||
126402568|NCT01688739|454768420|FG003|Overall Study|Administrative Decision|0|||
126402569|NCT01688739|454768421|FG004|Overall Study|Administrative Decision|0|||
126402570|NCT01688739|454768422|FG005|Overall Study|Administrative Decision|0|||
126402571|NCT01688739|454768423|FG006|Overall Study|Administrative Decision|0|||
126402572|NCT01688739|454768424|FG007|Overall Study|Administrative Decision|0|||
126402573|NCT01688739|454768425|FG008|Overall Study|Administrative Decision|0|||
126402574|NCT01688739|454768426|FG009|Overall Study|Administrative Decision|0|||
126402575|NCT00996801|454768427|FG000|Overall Study|Adverse Event|6|||
126402576|NCT00996801|454768428|FG001|Overall Study|Adverse Event|4|||
126402577|NCT00996801|454768429|FG002|Overall Study|Adverse Event|12|||
126402578|NCT00996801|454768430|FG003|Overall Study|Adverse Event|17|||
126402579|NCT00996801|454768431|FG004|Overall Study|Adverse Event|31|||
126402580|NCT00996801|454768432|FG005|Overall Study|Adverse Event|3|||
126402581|NCT00996801|454768427|FG000|Overall Study|Lack of Efficacy|3|||
126402582|NCT00996801|454768428|FG001|Overall Study|Lack of Efficacy|0|||
126402583|NCT00996801|454768429|FG002|Overall Study|Lack of Efficacy|1|||
126402584|NCT00996801|454768430|FG003|Overall Study|Lack of Efficacy|3|||
126402585|NCT00996801|454768431|FG004|Overall Study|Lack of Efficacy|0|||
126402586|NCT00996801|454768432|FG005|Overall Study|Lack of Efficacy|1|||
126402587|NCT00996801|454768427|FG000|Overall Study|Lost to Follow-up|0|||
126402588|NCT00996801|454768428|FG001|Overall Study|Lost to Follow-up|0|||
126402589|NCT00996801|454768429|FG002|Overall Study|Lost to Follow-up|0|||
126402590|NCT00996801|454768430|FG003|Overall Study|Lost to Follow-up|3|||
126402591|NCT00996801|454768431|FG004|Overall Study|Lost to Follow-up|3|||
126402592|NCT00996801|454768432|FG005|Overall Study|Lost to Follow-up|2|||
126402593|NCT00996801|454768427|FG000|Overall Study|Physician Decision|0|||
126402594|NCT00996801|454768428|FG001|Overall Study|Physician Decision|0|||
126402595|NCT00996801|454768429|FG002|Overall Study|Physician Decision|0|||
126402596|NCT00996801|454768430|FG003|Overall Study|Physician Decision|1|||
126402597|NCT00996801|454768431|FG004|Overall Study|Physician Decision|0|||
126402598|NCT00996801|454768432|FG005|Overall Study|Physician Decision|0|||
126402599|NCT00996801|454768427|FG000|Overall Study|Progressive Disease|0|||
126402600|NCT00996801|454768428|FG001|Overall Study|Progressive Disease|1|||
126402601|NCT00996801|454768429|FG002|Overall Study|Progressive Disease|0|||
126402602|NCT00996801|454768430|FG003|Overall Study|Progressive Disease|0|||
126402603|NCT00996801|454768431|FG004|Overall Study|Progressive Disease|0|||
126402604|NCT00996801|454768432|FG005|Overall Study|Progressive Disease|0|||
126402605|NCT00996801|454768427|FG000|Overall Study|Protocol Violation|3|||
126402606|NCT00996801|454768428|FG001|Overall Study|Protocol Violation|4|||
126402607|NCT00996801|454768429|FG002|Overall Study|Protocol Violation|1|||
126402608|NCT00996801|454768430|FG003|Overall Study|Protocol Violation|2|||
126402609|NCT00996801|454768431|FG004|Overall Study|Protocol Violation|3|||
126402610|NCT00996801|454768432|FG005|Overall Study|Protocol Violation|4|||
126402611|NCT00996801|454768427|FG000|Overall Study|Study Terminated by Sponsor|0|||
126402612|NCT00996801|454768428|FG001|Overall Study|Study Terminated by Sponsor|1|||
126402613|NCT00996801|454768429|FG002|Overall Study|Study Terminated by Sponsor|0|||
126402614|NCT00996801|454768430|FG003|Overall Study|Study Terminated by Sponsor|0|||
126402615|NCT00996801|454768431|FG004|Overall Study|Study Terminated by Sponsor|46|||
126402616|NCT00996801|454768432|FG005|Overall Study|Study Terminated by Sponsor|0|||
126402617|NCT00996801|454768427|FG000|Overall Study|Withdrawal by Subject|8|||
126402618|NCT00996801|454768428|FG001|Overall Study|Withdrawal by Subject|6|||
126402619|NCT00996801|454768429|FG002|Overall Study|Withdrawal by Subject|9|||
126402620|NCT00996801|454768430|FG003|Overall Study|Withdrawal by Subject|5|||
126402621|NCT00996801|454768431|FG004|Overall Study|Withdrawal by Subject|5|||
126402622|NCT00996801|454768432|FG005|Overall Study|Withdrawal by Subject|9|||
126402623|NCT02804750|454768433|FG000|Period 1|Adverse Event|0|||
126402624|NCT02804750|454768434|FG001|Period 1|Adverse Event|2|||
125890110|NCT00481091|452895441|FG007|Overall Study|Other, Not Specified|0|||
126402625|NCT02804750|454768433|FG000|Period 1|Withdrawal by Subject|0|||
126402626|NCT02804750|454768434|FG001|Period 1|Withdrawal by Subject|1|||
126402627|NCT02804750|454768433|FG000|Period 2|Adverse Event|1|||
125890111|NCT00481091|452895442|FG008|Overall Study|Other, Not Specified|0|||
125890112|NCT00481091|452895443|FG009|Overall Study|Other, Not Specified|4|||
126402628|NCT02804750|454768434|FG001|Period 2|Adverse Event|0|||
126402629|NCT02804750|454768433|FG000|Period 3|Adverse Event|0|||
126402630|NCT02804750|454768434|FG001|Period 3|Adverse Event|2|||
126402631|NCT02804750|454768433|FG000|Period 4|Adverse Event|0|||
126402632|NCT02804750|454768434|FG001|Period 4|Adverse Event|5|||
126402633|NCT02559414|454768435|FG000|Overall Study|Lost to Follow-up|0|||
126402634|NCT02559414|454768436|FG001|Overall Study|Lost to Follow-up|1|||
126402635|NCT02559414|454768437|FG002|Overall Study|Lost to Follow-up|0|||
126402636|NCT02559414|454768435|FG000|Overall Study|Withdrawal by Subject|1|||
126402637|NCT02559414|454768436|FG001|Overall Study|Withdrawal by Subject|0|||
126402638|NCT02559414|454768437|FG002|Overall Study|Withdrawal by Subject|1|||
126402639|NCT02559414|454768435|FG000|Overall Study|Other|0|||
126402640|NCT02559414|454768436|FG001|Overall Study|Other|1|||
126402641|NCT02559414|454768437|FG002|Overall Study|Other|1|||
126402642|NCT03369431|454768438|FG000|Overall Study|Lost to Follow-up|1|||
126402643|NCT03369431|454768439|FG001|Overall Study|Lost to Follow-up|3|||
126402644|NCT03369431|454768438|FG000|Overall Study|Withdrawal by Subject|2|||
126402645|NCT03369431|454768439|FG001|Overall Study|Withdrawal by Subject|3|||
126402646|NCT03369431|454768438|FG000|Overall Study|Protocol Violation|1|||
126402647|NCT03369431|454768439|FG001|Overall Study|Protocol Violation|1|||
126402648|NCT00046930|454768444|FG000|Overall Study|Ineligible|12|||
126402649|NCT00046930|454768445|FG001|Overall Study|Ineligible|4|||
126402650|NCT01113580|454768446|FG000|Overall Study|Protocol Violation|1|||
126402651|NCT01113580|454768447|FG001|Overall Study|Protocol Violation|0|||
126402652|NCT02317809|454768452|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
126402653|NCT02317809|454768453|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
126402654|NCT02317809|454768452|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
126402655|NCT02317809|454768453|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
126402656|NCT04912895|454768457|FG000|Overall Study|Unable to provide specimen|2|||
126402657|NCT04912895|454768458|FG001|Overall Study|Unable to provide specimen|0|||
126402658|NCT04912895|454768459|FG002|Overall Study|Unable to provide specimen|0|||
126402659|NCT03458702|454768460|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
126402660|NCT03458702|454768461|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
126402661|NCT03458702|454768460|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
126402662|NCT03458702|454768461|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
126402663|NCT01390779|454768462|FG000|Overall Study|Physician Decision|1|||
126402664|NCT00168103|454768465|FG000|Overall Study|Withdrawal by Subject|1|||
126402665|NCT00168103|454768466|FG001|Overall Study|Withdrawal by Subject|2|||
126402666|NCT00168103|454768467|FG002|Overall Study|Withdrawal by Subject|1|||
126402667|NCT00168103|454768468|FG003|Overall Study|Withdrawal by Subject|0|||
126402668|NCT00168103|454768465|FG000|Overall Study|Lost to Follow-up|1|||
126402669|NCT00168103|454768466|FG001|Overall Study|Lost to Follow-up|3|||
126402670|NCT00168103|454768467|FG002|Overall Study|Lost to Follow-up|0|||
126402671|NCT00168103|454768468|FG003|Overall Study|Lost to Follow-up|0|||
126402672|NCT00545532|454768469|FG000|Overall Study|Withdrawal by Subject|1|||
126402673|NCT00545532|454768470|FG001|Overall Study|Withdrawal by Subject|3|||
126402674|NCT00545532|454768469|FG000|Overall Study|Lost to Follow-up|5|||
126402675|NCT00545532|454768470|FG001|Overall Study|Lost to Follow-up|6|||
126402676|NCT00545532|454768469|FG000|Overall Study|Death|0|||
126402677|NCT00545532|454768470|FG001|Overall Study|Death|1|||
126402678|NCT01149486|454768473|FG000|First Intervention|Adverse Event|0|||
126402679|NCT01149486|454768474|FG001|First Intervention|Adverse Event|1|||
126402680|NCT00931801|454768483|FG000|Overall Study|Adverse Event|0|||
126402681|NCT00931801|454768484|FG001|Overall Study|Adverse Event|0|||
126402682|NCT00931801|454768485|FG002|Overall Study|Adverse Event|1|||
126402683|NCT00931801|454768483|FG000|Overall Study|Lost to Follow-up|0|||
126402684|NCT00931801|454768484|FG001|Overall Study|Lost to Follow-up|1|||
126402685|NCT00931801|454768485|FG002|Overall Study|Lost to Follow-up|0|||
126402686|NCT00931801|454768483|FG000|Overall Study|Withdrawal by Subject|1|||
126402687|NCT00931801|454768484|FG001|Overall Study|Withdrawal by Subject|0|||
126402688|NCT00931801|454768485|FG002|Overall Study|Withdrawal by Subject|0|||
126402689|NCT00931801|454768483|FG000|Overall Study|Confirmed Virologic Failure|0|||
126402690|NCT00931801|454768484|FG001|Overall Study|Confirmed Virologic Failure|0|||
126402691|NCT00931801|454768485|FG002|Overall Study|Confirmed Virologic Failure|3|||
126402692|NCT01635764|454768487|FG000|Overall Study|Adverse Event|46|||
126402693|NCT01635764|454768487|FG000|Overall Study|Lack of Efficacy|76|||
126402694|NCT01635764|454768487|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
125890113|NCT00481091|452895434|FG000|Overall Study|Adverse Event|1|||
125890114|NCT00481091|452895435|FG001|Overall Study|Adverse Event|2|||
125890115|NCT00481091|452895436|FG002|Overall Study|Adverse Event|0|||
125890116|NCT00481091|452895437|FG003|Overall Study|Adverse Event|1|||
125890117|NCT00481091|452895438|FG004|Overall Study|Adverse Event|1|||
125890118|NCT00481091|452895439|FG005|Overall Study|Adverse Event|1|||
125890119|NCT00481091|452895440|FG006|Overall Study|Adverse Event|2|||
125890120|NCT00481091|452895441|FG007|Overall Study|Adverse Event|1|||
125890121|NCT00481091|452895442|FG008|Overall Study|Adverse Event|1|||
126402695|NCT01635764|454768487|FG000|Overall Study|Protocol Deviation|1|||
126402696|NCT01635764|454768487|FG000|Overall Study|Withdrew Consent|67|||
126402697|NCT01635764|454768487|FG000|Overall Study|Lost to Follow-up|53|||
126402698|NCT01635764|454768487|FG000|Overall Study|Other|28|||
126402699|NCT00933244|454768488|FG000|Overall Study|Withdrawal by Subject|5|||
126402700|NCT00933244|454768489|FG001|Overall Study|Withdrawal by Subject|1|||
126402701|NCT00933244|454768490|FG002|Overall Study|Withdrawal by Subject|3|||
126402702|NCT01174004|454768491|FG000|Overall Study|Adverse Event|2|||
126402703|NCT01174004|454768492|FG001|Overall Study|Adverse Event|10|||
126402704|NCT01174004|454768491|FG000|Overall Study|Withdrawal by Subject|2|||
126402705|NCT01174004|454768492|FG001|Overall Study|Withdrawal by Subject|3|||
126402706|NCT01174004|454768491|FG000|Overall Study|At Discretion of Sponsor|2|||
126402707|NCT01174004|454768492|FG001|Overall Study|At Discretion of Sponsor|2|||
126402708|NCT01174004|454768491|FG000|Overall Study|Protocol Violation|0|||
126402709|NCT01174004|454768492|FG001|Overall Study|Protocol Violation|1|||
126402710|NCT01174004|454768491|FG000|Overall Study|Physician Decision|1|||
126402711|NCT01174004|454768492|FG001|Overall Study|Physician Decision|0|||
126402712|NCT02266875|454768496|FG000|Overall Study|Withdrawal by Subject|9|||
126402713|NCT02266875|454768497|FG001|Overall Study|Withdrawal by Subject|0|||
126402714|NCT02266875|454768496|FG000|Overall Study|Lost to Follow-up|2|||
126402715|NCT02266875|454768497|FG001|Overall Study|Lost to Follow-up|0|||
126402716|NCT02956850|454768501|FG000|Overall Study|Withdrawal by Subject|0|||
126402717|NCT02956850|454768502|FG001|Overall Study|Withdrawal by Subject|0|||
126402718|NCT02956850|454768503|FG002|Overall Study|Withdrawal by Subject|0|||
126402719|NCT02956850|454768504|FG003|Overall Study|Withdrawal by Subject|0|||
126402720|NCT02956850|454768505|FG004|Overall Study|Withdrawal by Subject|0|||
126402721|NCT02956850|454768506|FG005|Overall Study|Withdrawal by Subject|0|||
126402722|NCT02956850|454768507|FG006|Overall Study|Withdrawal by Subject|0|||
126402723|NCT02956850|454768508|FG007|Overall Study|Withdrawal by Subject|0|||
126402724|NCT02956850|454768509|FG008|Overall Study|Withdrawal by Subject|0|||
126402725|NCT02956850|454768510|FG009|Overall Study|Withdrawal by Subject|0|||
126402726|NCT02956850|454768511|FG010|Overall Study|Withdrawal by Subject|0|||
126402727|NCT02956850|454768512|FG011|Overall Study|Withdrawal by Subject|0|||
126402728|NCT02956850|454768513|FG012|Overall Study|Withdrawal by Subject|0|||
126402729|NCT02956850|454768514|FG013|Overall Study|Withdrawal by Subject|0|||
126402730|NCT02956850|454768515|FG014|Overall Study|Withdrawal by Subject|0|||
126402731|NCT02956850|454768516|FG015|Overall Study|Withdrawal by Subject|0|||
126402732|NCT02956850|454768517|FG016|Overall Study|Withdrawal by Subject|0|||
126402733|NCT02956850|454768518|FG017|Overall Study|Withdrawal by Subject|1|||
126402734|NCT00391391|454768521|FG000|Overall Study|Adverse Event|0|||
126402735|NCT00391391|454768522|FG001|Overall Study|Adverse Event|0|||
126402736|NCT00391391|454768523|FG002|Overall Study|Adverse Event|0|||
126402737|NCT00391391|454768524|FG003|Overall Study|Adverse Event|1|||
126402738|NCT00391391|454768521|FG000|Overall Study|Lost to Follow-up|1|||
126402739|NCT00391391|454768522|FG001|Overall Study|Lost to Follow-up|3|||
126402740|NCT00391391|454768523|FG002|Overall Study|Lost to Follow-up|7|||
126402741|NCT00391391|454768524|FG003|Overall Study|Lost to Follow-up|4|||
126402742|NCT00391391|454768521|FG000|Overall Study|Protocol Violation|2|||
126402743|NCT00391391|454768522|FG001|Overall Study|Protocol Violation|3|||
126402744|NCT00391391|454768523|FG002|Overall Study|Protocol Violation|6|||
126402745|NCT00391391|454768524|FG003|Overall Study|Protocol Violation|7|||
126402746|NCT00391391|454768521|FG000|Overall Study|Withdrawal by Subject|6|||
125890122|NCT00481091|452895443|FG009|Overall Study|Adverse Event|6|||
125890123|NCT00481091|452895434|FG000|Overall Study|Progressive disease clinical|0|||
126402747|NCT00391391|454768522|FG001|Overall Study|Withdrawal by Subject|4|||
126402748|NCT00391391|454768523|FG002|Overall Study|Withdrawal by Subject|10|||
126402749|NCT00391391|454768524|FG003|Overall Study|Withdrawal by Subject|7|||
126402750|NCT04375397|454768527|FG000|Overall Study|Death|1|||
126402751|NCT04375397|454768528|FG001|Overall Study|Death|1|||
126402752|NCT04375397|454768527|FG000|Overall Study|Withdrew consent|2|||
126402753|NCT04375397|454768528|FG001|Overall Study|Withdrew consent|0|||
126053481|NCT03516812|453489531|FG000|Overall Study|Adverse Event|4|||
126053482|NCT03516812|453489531|FG000|Overall Study|Lack of Efficacy|2|||
126402754|NCT04375397|454768527|FG000|Overall Study|Lost to Follow-up|6|||
126402755|NCT04375397|454768528|FG001|Overall Study|Lost to Follow-up|4|||
126402756|NCT04375397|454768527|FG000|Overall Study|Other, not specified|0|||
126402757|NCT04375397|454768528|FG001|Overall Study|Other, not specified|1|||
126402758|NCT00610441|454768531|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
126402759|NCT00610441|454768532|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
126402760|NCT00610441|454768533|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
126402761|NCT00610441|454768534|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
126402762|NCT00610441|454768531|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
126402763|NCT00610441|454768532|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
126402764|NCT00610441|454768533|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
126402765|NCT00610441|454768534|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
126402766|NCT00610441|454768531|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
126402767|NCT00610441|454768532|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
126402768|NCT00610441|454768533|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
126402769|NCT00610441|454768534|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
126402770|NCT00610441|454768531|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
126402771|NCT00610441|454768532|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
126402772|NCT00610441|454768533|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
126402773|NCT00610441|454768534|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
126402774|NCT00610441|454768531|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
126402775|NCT00610441|454768532|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
126402776|NCT00610441|454768533|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
126402777|NCT00610441|454768534|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
126402778|NCT00610441|454768531|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
126402779|NCT00610441|454768532|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
126402780|NCT00610441|454768533|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
126402781|NCT00610441|454768534|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
126402782|NCT00610441|454768531|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
126402783|NCT00610441|454768532|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
126402784|NCT00610441|454768533|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
126402785|NCT00610441|454768534|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
126402786|NCT00610441|454768531|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
126402787|NCT00610441|454768532|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
126402788|NCT00610441|454768533|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
126402789|NCT00610441|454768534|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
126402790|NCT00610441|454768531|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
126402791|NCT00610441|454768532|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
126402792|NCT00610441|454768533|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
126402793|NCT00610441|454768534|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
126402794|NCT01995552|454768537|FG000|Overall Study|Protocol Violation|1|||
126402795|NCT01995552|454768537|FG000|Overall Study|Lack of Efficacy|15|||
126402796|NCT01995552|454768537|FG000|Overall Study|Death|1|||
126402797|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
126402798|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
126402799|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
126402800|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
126402801|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
126402802|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
126402803|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
126402804|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
126402805|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
126402806|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
126402807|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
126402808|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
126402809|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
126402810|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
126402811|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
126402812|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
126402813|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
126402814|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
126402815|NCT00554099|454768538|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
126402816|NCT00554099|454768539|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
126402817|NCT00554099|454768540|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
126402818|NCT00554099|454768538|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
126402819|NCT00554099|454768539|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
126402820|NCT00554099|454768540|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
126402821|NCT00554099|454768538|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
126402822|NCT00554099|454768539|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
126402823|NCT00554099|454768540|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
126402824|NCT01011933|454768541|FG000|Overall Study|Wrong cell type|1|||
126402825|NCT01011933|454768541|FG000|Overall Study|Improper pre-protocol Rx|1|||
126402826|NCT01011933|454768541|FG000|Overall Study|Inadequate pathology|1|||
126402827|NCT01011933|454768541|FG000|Overall Study|Never treated|1|||
126402828|NCT01439074|454768542|FG000|Overall Study|Lost to Follow-up|3|||
126402829|NCT01439074|454768543|FG001|Overall Study|Lost to Follow-up|4|||
126402830|NCT01439074|454768542|FG000|Overall Study|Subject shedding|1|||
126402831|NCT01439074|454768543|FG001|Overall Study|Subject shedding|0|||
126402832|NCT01439074|454768542|FG000|Overall Study|Withdrawal by Subject|1|||
126402833|NCT01439074|454768543|FG001|Overall Study|Withdrawal by Subject|5|||
126402834|NCT01439074|454768542|FG000|Overall Study|Other|4|||
126402835|NCT01439074|454768543|FG001|Overall Study|Other|4|||
126402836|NCT02639338|454768544|FG000|Overall Study|Lost to Follow-up|2|||
126402837|NCT02639338|454768545|FG001|Overall Study|Lost to Follow-up|2|||
126402838|NCT02639338|454768544|FG000|Overall Study|Withdrew Consent|1|||
126402839|NCT02639338|454768545|FG001|Overall Study|Withdrew Consent|2|||
126402840|NCT02639338|454768544|FG000|Overall Study|Death|1|||
126402841|NCT02639338|454768545|FG001|Overall Study|Death|0|||
126402842|NCT02639338|454768544|FG000|Overall Study|Randomized but Not Treated|0|||
126402843|NCT02639338|454768545|FG001|Overall Study|Randomized but Not Treated|1|||
126402844|NCT00514020|454768546|FG000|Overall Study|Adverse Event|6|||
126402845|NCT00514020|454768546|FG000|Overall Study|Withdrawal by Subject|3|||
126402846|NCT00514020|454768546|FG000|Overall Study|Physician Decision|1|||
126402847|NCT00514020|454768546|FG000|Overall Study|disease progression|9|||
126402848|NCT00514020|454768546|FG000|Overall Study|other complicating disease|2|||
126402849|NCT00514020|454768546|FG000|Overall Study|patient went to radiation treatment|1|||
126402850|NCT00514020|454768546|FG000|Overall Study|"patients moved to the no tx group"|6|||
126402851|NCT01688921|454768547|FG000|Overall Study|Lost to Follow-up|7|||
126402852|NCT01688921|454768548|FG001|Overall Study|Lost to Follow-up|13|||
126402853|NCT01688921|454768547|FG000|Overall Study|Physician Decision|6|||
126402854|NCT01688921|454768548|FG001|Overall Study|Physician Decision|1|||
126402855|NCT01688921|454768547|FG000|Overall Study|Protocol Violation|0|||
126402856|NCT01688921|454768548|FG001|Overall Study|Protocol Violation|1|||
126402857|NCT01688921|454768547|FG000|Overall Study|informed consent|3|||
126402858|NCT01688921|454768548|FG001|Overall Study|informed consent|0|||
126402859|NCT00831701|454768549|FG000|Overall Study|Withdrawal by Subject|2|||
126402860|NCT00831701|454768550|FG001|Overall Study|Withdrawal by Subject|0|||
126402861|NCT00831701|454768549|FG000|Overall Study|Stone expulsion before first medication|2|||
126402862|NCT00831701|454768550|FG001|Overall Study|Stone expulsion before first medication|2|||
126402863|NCT00831701|454768549|FG000|Overall Study|Lost to Follow-up|1|||
126402864|NCT00831701|454768550|FG001|Overall Study|Lost to Follow-up|3|||
126402865|NCT03131596|454770416|FG000|Overall Study|Protocol Violation|3|||
126402866|NCT03131596|454770417|FG001|Overall Study|Protocol Violation|3|||
126402867|NCT03131596|454770416|FG000|Overall Study|Lost to Follow-up|3|||
126402868|NCT03131596|454770417|FG001|Overall Study|Lost to Follow-up|0|||
126402869|NCT00734071|454770418|FG000|Overall Study|Adverse Event|4|||
126402870|NCT00734071|454770419|FG001|Overall Study|Adverse Event|3|||
126402871|NCT00734071|454770418|FG000|Overall Study|Lack of Efficacy|3|||
126402872|NCT00734071|454770419|FG001|Overall Study|Lack of Efficacy|1|||
126402873|NCT00734071|454770418|FG000|Overall Study|Noncompliance|2|||
126402874|NCT00734071|454770419|FG001|Overall Study|Noncompliance|2|||
126402875|NCT00734071|454770418|FG000|Overall Study|Protocol Deviations|3|||
126402876|NCT00734071|454770419|FG001|Overall Study|Protocol Deviations|4|||
126402877|NCT00734071|454770418|FG000|Overall Study|Voluntary Withdrawal|9|||
126402878|NCT00734071|454770419|FG001|Overall Study|Voluntary Withdrawal|7|||
126402879|NCT00734071|454770418|FG000|Overall Study|Lost to Follow-up|16|||
126402880|NCT00734071|454770419|FG001|Overall Study|Lost to Follow-up|8|||
126402881|NCT00734071|454770418|FG000|Overall Study|Other|1|||
126402882|NCT00734071|454770419|FG001|Overall Study|Other|2|||
126402883|NCT00151372|454770420|FG000|Overall Study|Death|12|||
126402884|NCT00151372|454770421|FG001|Overall Study|Death|11|||
126402885|NCT00151372|454770420|FG000|Overall Study|Lost to Follow-up|5|||
126402886|NCT00151372|454770421|FG001|Overall Study|Lost to Follow-up|5|||
126402887|NCT00151372|454770420|FG000|Overall Study|Too sick medically to continue|5|||
126402888|NCT00151372|454770421|FG001|Overall Study|Too sick medically to continue|6|||
126402889|NCT00151372|454770420|FG000|Overall Study|Withdrawal by Subject|7|||
126402890|NCT00151372|454770421|FG001|Overall Study|Withdrawal by Subject|7|||
126402891|NCT00541346|454770422|FG000|Follow-up|Adverse Event|1|||
126402892|NCT04732949|454770423|FG000|Overall Study|Withdrawal by Subject|23|||
126402893|NCT04732949|454770424|FG001|Overall Study|Withdrawal by Subject|27|||
126402894|NCT04732949|454770423|FG000|Overall Study|Protocol Violation|0|||
126402895|NCT04732949|454770424|FG001|Overall Study|Protocol Violation|1|||
126402896|NCT04732949|454770423|FG000|Overall Study|Non-compliance|0|||
126402897|NCT04732949|454770424|FG001|Overall Study|Non-compliance|2|||
126402898|NCT04732949|454770423|FG000|Overall Study|Physician Decision|2|||
126402899|NCT04732949|454770424|FG001|Overall Study|Physician Decision|1|||
126402900|NCT04732949|454770423|FG000|Overall Study|Serious adverse event (Fatal)|16|||
126402901|NCT04732949|454770424|FG001|Overall Study|Serious adverse event (Fatal)|18|||
126402902|NCT04732949|454770423|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
126402903|NCT04732949|454770424|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
126402904|NCT04732949|454770423|FG000|Overall Study|Non-serious adverse event|1|||
126402905|NCT04732949|454770424|FG001|Overall Study|Non-serious adverse event|3|||
126402906|NCT04732949|454770423|FG000|Overall Study|Lost to Follow-up|26|||
126402907|NCT04732949|454770424|FG001|Overall Study|Lost to Follow-up|27|||
126402908|NCT04732949|454770423|FG000|Overall Study|Other|6|||
126402909|NCT04732949|454770424|FG001|Overall Study|Other|3|||
126402910|NCT02853435|454770427|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402911|NCT02853435|454770428|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402912|NCT02853435|454770429|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402913|NCT02853435|454770430|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402914|NCT02853435|454770431|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
126402915|NCT02853435|454770432|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402916|NCT03747120|454770435|FG000|Overall Study|treatment related toxicity|3|||
126402917|NCT03747120|454770436|FG001|Overall Study|treatment related toxicity|0|||
126402918|NCT03747120|454770437|FG002|Overall Study|treatment related toxicity|0|||
126402919|NCT03747120|454770435|FG000|Overall Study|Withdrawal by Subject|0|||
126402920|NCT03747120|454770436|FG001|Overall Study|Withdrawal by Subject|1|||
126402921|NCT03747120|454770437|FG002|Overall Study|Withdrawal by Subject|2|||
126402922|NCT01266317|454770446|FG000|Overall Study|Withdrawal by Subject|2|||
126402923|NCT00490776|454770447|FG000|Overall Study|Withdrawal by Subject|1|||
126402924|NCT00490776|454770447|FG000|Overall Study|Administrative Problems|1|||
126402925|NCT00490776|454770447|FG000|Overall Study|Death|1|||
126402926|NCT00490776|454770447|FG000|Overall Study|New Cancer Therapy|1|||
126402927|NCT00490776|454770447|FG000|Overall Study|Disease Progression|5|||
126402928|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Death|1|||
126402929|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Death|0|||
126402930|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Death|0|||
126402931|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Death|0|||
126402932|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
126402933|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
126402934|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
126402935|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
126402936|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
126402937|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
126402938|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
126402939|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
126402940|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
126402941|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
126402942|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
126402943|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
126402944|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Other|8|||
126402945|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Other|5|||
126402946|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Other|0|||
126402947|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Other|0|||
126402948|NCT04271475|454770459|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
126402949|NCT04271475|454770460|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
126402950|NCT04271475|454770461|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
126402951|NCT04271475|454770462|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
126402952|NCT04271475|454770459|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
126402953|NCT04271475|454770460|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
126402954|NCT04271475|454770461|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
126402955|NCT04271475|454770462|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
126402956|NCT00159913|454770466|FG000|Overall Study|Adverse Event|1|||
126402957|NCT00159913|454770467|FG001|Overall Study|Adverse Event|0|||
126402958|NCT00159913|454770468|FG002|Overall Study|Adverse Event|1|||
126402959|NCT00159913|454770469|FG003|Overall Study|Adverse Event|0|||
126402960|NCT00159913|454770466|FG000|Overall Study|Withdrawal by Subject|0|||
126402961|NCT00159913|454770467|FG001|Overall Study|Withdrawal by Subject|0|||
126402962|NCT00159913|454770468|FG002|Overall Study|Withdrawal by Subject|0|||
126402963|NCT00159913|454770469|FG003|Overall Study|Withdrawal by Subject|1|||
126402964|NCT00159913|454770466|FG000|Overall Study|Lost to Follow-up|0|||
126402965|NCT00159913|454770467|FG001|Overall Study|Lost to Follow-up|0|||
126402966|NCT00159913|454770468|FG002|Overall Study|Lost to Follow-up|0|||
126402967|NCT00159913|454770469|FG003|Overall Study|Lost to Follow-up|1|||
126402968|NCT00159913|454770466|FG000|Overall Study|Protocol Violation|1|||
126402969|NCT00159913|454770467|FG001|Overall Study|Protocol Violation|0|||
126402970|NCT00159913|454770468|FG002|Overall Study|Protocol Violation|1|||
126402971|NCT00159913|454770469|FG003|Overall Study|Protocol Violation|0|||
126402972|NCT00824005|454770470|FG000|Overall Study|Death|0|||
126402973|NCT00824005|454770471|FG001|Overall Study|Death|1|||
126402974|NCT00824005|454770470|FG000|Overall Study|Lost to Follow-up|0|||
126402975|NCT00824005|454770471|FG001|Overall Study|Lost to Follow-up|1|||
126402976|NCT01874275|454770472|FG000|Overall Study|Lost to Follow-up|1|||
126402977|NCT01874275|454770473|FG001|Overall Study|Lost to Follow-up|0|||
126402978|NCT00989235|454770474|FG000|Overall Study|Death|0|||
126402979|NCT00989235|454770475|FG001|Overall Study|Death|1|||
126402980|NCT00989235|454770474|FG000|Overall Study|Adverse Event|0|||
126402981|NCT00989235|454770475|FG001|Overall Study|Adverse Event|1|||
126402982|NCT00989235|454770474|FG000|Overall Study|Lack of Efficacy|1|||
126402983|NCT00989235|454770475|FG001|Overall Study|Lack of Efficacy|0|||
126402984|NCT00989235|454770474|FG000|Overall Study|Withdrawal of Consent|1|||
126402985|NCT00989235|454770475|FG001|Overall Study|Withdrawal of Consent|1|||
126402986|NCT00989235|454770474|FG000|Overall Study|Desire to Become Pregnant|1|||
126402987|NCT00989235|454770475|FG001|Overall Study|Desire to Become Pregnant|0|||
126402988|NCT00989235|454770474|FG000|Overall Study|Randomized by Mistake|0|||
126402989|NCT00989235|454770475|FG001|Overall Study|Randomized by Mistake|2|||
126402990|NCT00989235|454770474|FG000|Overall Study|Lost to Follow-up|0|||
126402991|NCT00989235|454770475|FG001|Overall Study|Lost to Follow-up|1|||
126402992|NCT00875056|454770476|FG000|Overall Study|Adverse Event|6|||
126402993|NCT00875056|454770477|FG001|Overall Study|Adverse Event|1|||
126402994|NCT00875056|454770478|FG002|Overall Study|Adverse Event|2|||
126402995|NCT00875056|454770476|FG000|Overall Study|Progressive Disease|14|||
126402996|NCT00875056|454770477|FG001|Overall Study|Progressive Disease|8|||
126402997|NCT00875056|454770478|FG002|Overall Study|Progressive Disease|3|||
126402998|NCT00875056|454770476|FG000|Overall Study|Withdrawal by Subject|3|||
126402999|NCT00875056|454770477|FG001|Overall Study|Withdrawal by Subject|0|||
126403000|NCT00875056|454770478|FG002|Overall Study|Withdrawal by Subject|1|||
126403001|NCT01318070|454770479|FG000|Overall Study|Adverse Event|1|||
126403002|NCT01318070|454770480|FG001|Overall Study|Adverse Event|1|||
126403003|NCT01318070|454770481|FG002|Overall Study|Adverse Event|5|||
126403004|NCT01318070|454770479|FG000|Overall Study|Withdrawal by Subject|0|||
126403005|NCT01318070|454770480|FG001|Overall Study|Withdrawal by Subject|1|||
126403006|NCT01318070|454770481|FG002|Overall Study|Withdrawal by Subject|1|||
126403007|NCT01318070|454770479|FG000|Overall Study|Lack of Efficacy|0|||
126403008|NCT01318070|454770480|FG001|Overall Study|Lack of Efficacy|0|||
126403009|NCT01318070|454770481|FG002|Overall Study|Lack of Efficacy|1|||
126403010|NCT01318070|454770479|FG000|Overall Study|Principal Investigator Discretion|1|||
126403011|NCT01318070|454770480|FG001|Overall Study|Principal Investigator Discretion|0|||
126403012|NCT01318070|454770481|FG002|Overall Study|Principal Investigator Discretion|0|||
126403013|NCT01920152|454770482|FG000|Overall Study|Withdrawal by Subject|1|||
126403014|NCT01920152|454770483|FG001|Overall Study|Withdrawal by Subject|2|||
126403015|NCT00353873|454770485|FG000|Overall Study|Protocol Violation|1|||
126403016|NCT00353873|454770486|FG001|Overall Study|Protocol Violation|2|||
126403017|NCT00353873|454770485|FG000|Overall Study|Exacerbation|1|||
126403018|NCT00353873|454770486|FG001|Overall Study|Exacerbation|0|||
126403019|NCT00353873|454770485|FG000|Overall Study|Adverse Event|1|||
126403020|NCT00353873|454770486|FG001|Overall Study|Adverse Event|0|||
126403021|NCT00353873|454770485|FG000|Overall Study|Physician Decision|2|||
126403022|NCT00353873|454770486|FG001|Overall Study|Physician Decision|0|||
125890124|NCT00481091|452895435|FG001|Overall Study|Progressive disease clinical|0|||
125890125|NCT00481091|452895436|FG002|Overall Study|Progressive disease clinical|0|||
125890126|NCT00481091|452895437|FG003|Overall Study|Progressive disease clinical|0|||
126403023|NCT00353873|454770485|FG000|Overall Study|Withdrawal by Subject|1|||
126403024|NCT00353873|454770486|FG001|Overall Study|Withdrawal by Subject|1|||
126403025|NCT00870194|454770489|FG000|Overall Study|Adverse Event|10|||
126403026|NCT00870194|454770490|FG001|Overall Study|Adverse Event|5|||
126403027|NCT00870194|454770489|FG000|Overall Study|Lack of Efficacy|0|||
126403028|NCT00870194|454770490|FG001|Overall Study|Lack of Efficacy|1|||
126403029|NCT00870194|454770489|FG000|Overall Study|Lost to Follow-up|2|||
126403030|NCT00870194|454770490|FG001|Overall Study|Lost to Follow-up|0|||
126403031|NCT00870194|454770489|FG000|Overall Study|Physician Decision|3|||
126403032|NCT00870194|454770490|FG001|Overall Study|Physician Decision|1|||
126403033|NCT00870194|454770489|FG000|Overall Study|Protocol Violation|3|||
126403034|NCT00870194|454770490|FG001|Overall Study|Protocol Violation|3|||
126403035|NCT00870194|454770489|FG000|Overall Study|Entry Criteria Not Met|1|||
126403036|NCT00870194|454770490|FG001|Overall Study|Entry Criteria Not Met|2|||
126403037|NCT00870194|454770489|FG000|Overall Study|Subject Decision|7|||
126403038|NCT00870194|454770490|FG001|Overall Study|Subject Decision|2|||
126403039|NCT02717130|454770491|FG000|Overall Study|Withdrawal by Subject|1|||
126403040|NCT02717130|454770491|FG000|Overall Study|Adverse Event|1|||
126403041|NCT02717130|454770491|FG000|Overall Study|Physician Decision|1|||
126403042|NCT02717130|454770491|FG000|Overall Study|Study Closure|4|||
126403043|NCT00106691|454770492|FG000|Overall Study|Adverse Event|60|||
126403044|NCT00106691|454770493|FG001|Overall Study|Adverse Event|64|||
126403045|NCT00106691|454770492|FG000|Overall Study|Lost to Follow-up|23|||
126403046|NCT00106691|454770493|FG001|Overall Study|Lost to Follow-up|18|||
126403047|NCT00106691|454770492|FG000|Overall Study|Physician Decision|18|||
126403048|NCT00106691|454770493|FG001|Overall Study|Physician Decision|21|||
126403049|NCT00106691|454770492|FG000|Overall Study|Protocol Violation|13|||
126403050|NCT00106691|454770493|FG001|Overall Study|Protocol Violation|18|||
126403051|NCT00106691|454770492|FG000|Overall Study|Withdrawal by Subject|75|||
126403052|NCT00106691|454770493|FG001|Overall Study|Withdrawal by Subject|70|||
126403053|NCT00106691|454770492|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
126403054|NCT00106691|454770493|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
126403055|NCT00106691|454770492|FG000|Overall Study|QTc>480|3|||
126403056|NCT00106691|454770493|FG001|Overall Study|QTc>480|1|||
126403057|NCT00106691|454770492|FG000|Overall Study|mililtary deployment|2|||
126403058|NCT00106691|454770493|FG001|Overall Study|mililtary deployment|0|||
126403059|NCT00106691|454770492|FG000|Overall Study|Study Site Closing/PI Moved|1|||
126403060|NCT00106691|454770493|FG001|Overall Study|Study Site Closing/PI Moved|2|||
126403061|NCT00106691|454770492|FG000|Overall Study|Cardiologist recommendation|1|||
126403062|NCT00106691|454770493|FG001|Overall Study|Cardiologist recommendation|0|||
126403063|NCT00106691|454770492|FG000|Overall Study|Pt. moved to another state|1|||
126403064|NCT00106691|454770493|FG001|Overall Study|Pt. moved to another state|0|||
126403065|NCT00106691|454770492|FG000|Overall Study|Taking exclusionary avodart|1|||
126403066|NCT00106691|454770493|FG001|Overall Study|Taking exclusionary avodart|0|||
126403067|NCT00106691|454770492|FG000|Overall Study|Not able to discontinue plavix|0|||
126403068|NCT00106691|454770493|FG001|Overall Study|Not able to discontinue plavix|1|||
126403069|NCT02322190|454770495|FG000|Overall Study|Death on study|1|||
126403070|NCT02322190|454770496|FG001|Overall Study|Death on study|0|||
126403071|NCT01685983|454770500|FG000|Overall Study|Adverse Event|7|||
126403072|NCT01685983|454770500|FG000|Overall Study|Death|1|||
126403073|NCT01685983|454770500|FG000|Overall Study|Withdrawal by Subject|19|||
126403074|NCT01685983|454770500|FG000|Overall Study|Protocol Violation|2|||
126403075|NCT01685983|454770500|FG000|Overall Study|Physician Decision|13|||
126403076|NCT01685983|454770500|FG000|Overall Study|Other|7|||
126403077|NCT01685983|454770500|FG000|Overall Study|Progressive Disease|32|||
126403078|NCT01685983|454770500|FG000|Overall Study|Noncompliance with Study Drug|1|||
126403079|NCT01443130|454770501|FG000|Overall Study|Lost to Follow-up|44|||
126403080|NCT01443130|454770502|FG001|Overall Study|Lost to Follow-up|42|||
126403081|NCT01443130|454770503|FG002|Overall Study|Lost to Follow-up|50|||
126403082|NCT01443130|454770504|FG003|Overall Study|Lost to Follow-up|23|||
126403083|NCT01443130|454770505|FG004|Overall Study|Lost to Follow-up|25|||
126403084|NCT01443130|454770506|FG005|Overall Study|Lost to Follow-up|21|||
126403085|NCT01443130|454770501|FG000|Overall Study|Death|0|||
126403086|NCT01443130|454770502|FG001|Overall Study|Death|1|||
126403087|NCT01443130|454770503|FG002|Overall Study|Death|0|||
126403088|NCT01443130|454770504|FG003|Overall Study|Death|7|||
126403089|NCT01443130|454770505|FG004|Overall Study|Death|10|||
126403090|NCT01443130|454770506|FG005|Overall Study|Death|8|||
126403091|NCT01443130|454770501|FG000|Overall Study|Adverse Event|2|||
126403092|NCT01443130|454770502|FG001|Overall Study|Adverse Event|1|||
126403093|NCT01443130|454770503|FG002|Overall Study|Adverse Event|1|||
126403094|NCT01443130|454770504|FG003|Overall Study|Adverse Event|0|||
126403095|NCT01443130|454770505|FG004|Overall Study|Adverse Event|0|||
126403096|NCT01443130|454770506|FG005|Overall Study|Adverse Event|0|||
126403097|NCT01443130|454770501|FG000|Overall Study|Protocol Violation|2|||
126403098|NCT01443130|454770502|FG001|Overall Study|Protocol Violation|1|||
126403099|NCT01443130|454770503|FG002|Overall Study|Protocol Violation|3|||
126403100|NCT01443130|454770504|FG003|Overall Study|Protocol Violation|2|||
126403101|NCT01443130|454770505|FG004|Overall Study|Protocol Violation|2|||
126403102|NCT01443130|454770506|FG005|Overall Study|Protocol Violation|3|||
126403103|NCT01443130|454770501|FG000|Overall Study|Withdrawal by Subject|15|||
126403104|NCT01443130|454770502|FG001|Overall Study|Withdrawal by Subject|14|||
126403105|NCT01443130|454770503|FG002|Overall Study|Withdrawal by Subject|12|||
126403106|NCT01443130|454770504|FG003|Overall Study|Withdrawal by Subject|7|||
126403107|NCT01443130|454770505|FG004|Overall Study|Withdrawal by Subject|7|||
126403108|NCT01443130|454770506|FG005|Overall Study|Withdrawal by Subject|2|||
126403109|NCT01443130|454770501|FG000|Overall Study|Death of Subject's Infant|5|||
126403110|NCT01443130|454770502|FG001|Overall Study|Death of Subject's Infant|10|||
126403111|NCT01443130|454770503|FG002|Overall Study|Death of Subject's Infant|11|||
126403112|NCT01443130|454770504|FG003|Overall Study|Death of Subject's Infant|0|||
126403113|NCT01443130|454770505|FG004|Overall Study|Death of Subject's Infant|0|||
126403114|NCT01443130|454770506|FG005|Overall Study|Death of Subject's Infant|0|||
126403115|NCT01167907|454770508|FG000|Overall Study|Protocol Violation|1|||
126403116|NCT01167907|454770509|FG001|Overall Study|Protocol Violation|0|||
126403117|NCT01167907|454770508|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
125890127|NCT00481091|452895438|FG004|Overall Study|Progressive disease clinical|0|||
125890128|NCT00481091|452895439|FG005|Overall Study|Progressive disease clinical|0|||
126403118|NCT01167907|454770509|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
126403119|NCT03461406|454770510|FG000|Overall Study|Death|1|||
126403120|NCT03461406|454770511|FG001|Overall Study|Death|2|||
126403121|NCT03461406|454770510|FG000|Overall Study|Consent Withdrawn by Participant|0|||
126403122|NCT03461406|454770511|FG001|Overall Study|Consent Withdrawn by Participant|1|||
126403123|NCT03461406|454770510|FG000|Overall Study|Screen Failure|3|||
126403124|NCT03461406|454770511|FG001|Overall Study|Screen Failure|1|||
125890129|NCT00481091|452895440|FG006|Overall Study|Progressive disease clinical|0|||
126403125|NCT03461406|454770510|FG000|Overall Study|Reason not Specified|1|||
126403126|NCT03461406|454770511|FG001|Overall Study|Reason not Specified|3|||
126403127|NCT03461406|454770510|FG000|Overall Study|Lost to Follow-up|3|||
126403128|NCT03461406|454770511|FG001|Overall Study|Lost to Follow-up|0|||
126403129|NCT00973102|454770514|FG000|Overall Study|Protocol Violation|1|||
126403130|NCT00973102|454770515|FG001|Overall Study|Protocol Violation|0|||
126403131|NCT00973102|454770514|FG000|Overall Study|Prisoner|0|||
126403132|NCT00973102|454770515|FG001|Overall Study|Prisoner|1|||
126403133|NCT00612508|454770518|FG000|Overall Study|Withdrawal by Subject|3|||
126403134|NCT00612508|454770519|FG001|Overall Study|Withdrawal by Subject|4|||
126403135|NCT02012686|454770520|FG000|Overall Study|muscle contraction|0|||
126403136|NCT02012686|454770521|FG001|Overall Study|muscle contraction|1|||
126403137|NCT02012686|454770520|FG000|Overall Study|electrocardiography monitoring noise|0|||
126403138|NCT02012686|454770521|FG001|Overall Study|electrocardiography monitoring noise|1|||
126403139|NCT00787202|454770522|FG000|Overall Study|Adverse Event|3|||
126403140|NCT00787202|454770523|FG001|Overall Study|Adverse Event|2|||
126403141|NCT00787202|454770524|FG002|Overall Study|Adverse Event|0|||
126403142|NCT00787202|454770525|FG003|Overall Study|Adverse Event|0|||
126403143|NCT00787202|454770526|FG004|Overall Study|Adverse Event|2|||
126403144|NCT00787202|454770522|FG000|Overall Study|Lack of Efficacy|5|||
126403145|NCT00787202|454770523|FG001|Overall Study|Lack of Efficacy|6|||
126403146|NCT00787202|454770524|FG002|Overall Study|Lack of Efficacy|5|||
126403147|NCT00787202|454770525|FG003|Overall Study|Lack of Efficacy|2|||
126403148|NCT00787202|454770526|FG004|Overall Study|Lack of Efficacy|1|||
126403149|NCT00787202|454770522|FG000|Overall Study|Lost to Follow-up|1|||
126403150|NCT00787202|454770523|FG001|Overall Study|Lost to Follow-up|0|||
126403151|NCT00787202|454770524|FG002|Overall Study|Lost to Follow-up|0|||
126403152|NCT00787202|454770525|FG003|Overall Study|Lost to Follow-up|0|||
126403153|NCT00787202|454770526|FG004|Overall Study|Lost to Follow-up|0|||
126403154|NCT00787202|454770522|FG000|Overall Study|Withdrawal by Subject|2|||
126403155|NCT00787202|454770523|FG001|Overall Study|Withdrawal by Subject|2|||
126403156|NCT00787202|454770524|FG002|Overall Study|Withdrawal by Subject|2|||
126403157|NCT00787202|454770525|FG003|Overall Study|Withdrawal by Subject|0|||
126403158|NCT00787202|454770526|FG004|Overall Study|Withdrawal by Subject|0|||
126403159|NCT00787202|454770522|FG000|Overall Study|Protocol Violation|2|||
126403160|NCT00787202|454770523|FG001|Overall Study|Protocol Violation|1|||
126403161|NCT00787202|454770524|FG002|Overall Study|Protocol Violation|0|||
126403162|NCT00787202|454770525|FG003|Overall Study|Protocol Violation|0|||
126403163|NCT00787202|454770526|FG004|Overall Study|Protocol Violation|1|||
126403164|NCT00787202|454770522|FG000|Overall Study|Randomized, not treated|1|||
126403165|NCT00787202|454770523|FG001|Overall Study|Randomized, not treated|0|||
126403166|NCT00787202|454770524|FG002|Overall Study|Randomized, not treated|0|||
126403167|NCT00787202|454770525|FG003|Overall Study|Randomized, not treated|0|||
126403168|NCT00787202|454770526|FG004|Overall Study|Randomized, not treated|0|||
126403169|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
126403170|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
126403171|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
126403172|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
126403173|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
126403174|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
126403175|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
126403176|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
126403177|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
126403178|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
126403179|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
126403180|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
126403181|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
126403182|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
126403183|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
126403184|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
126403185|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
126403186|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
126403187|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
126403188|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
126403189|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
126403190|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
126403191|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
126403192|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
126403193|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
126403194|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
126403195|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
126403196|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
126403197|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
126403198|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
126403199|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
126403200|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
126403201|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
126403202|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
126403203|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
126403204|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
126403205|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
126403206|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
126403207|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
126403208|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
126403209|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
126403210|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
126403211|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
126403212|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
126403213|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
126403214|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
126403215|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
126403216|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
126403217|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
126403218|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
126403219|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
126403220|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
126403221|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
126403222|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
126403223|NCT02008357|454770527|FG000|Open-label Extension Period|Adverse Event|8|||
126403224|NCT02008357|454770528|FG001|Open-label Extension Period|Adverse Event|7|||
126403225|NCT02008357|454770527|FG000|Open-label Extension Period|Death|7|||
126403226|NCT02008357|454770528|FG001|Open-label Extension Period|Death|4|||
126403227|NCT02008357|454770527|FG000|Open-label Extension Period|Lack of Efficacy|9|||
126403228|NCT02008357|454770528|FG001|Open-label Extension Period|Lack of Efficacy|5|||
126403229|NCT02008357|454770527|FG000|Open-label Extension Period|Lost to Follow-up|2|||
126403230|NCT02008357|454770528|FG001|Open-label Extension Period|Lost to Follow-up|2|||
126403231|NCT02008357|454770527|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
126403232|NCT02008357|454770528|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
126403233|NCT02008357|454770527|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
126403234|NCT02008357|454770528|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
126403235|NCT02008357|454770527|FG000|Open-label Extension Period|Safety Risk|2|||
126403236|NCT02008357|454770528|FG001|Open-label Extension Period|Safety Risk|1|||
126403237|NCT02008357|454770527|FG000|Open-label Extension Period|Non-Compliance|0|||
126403238|NCT02008357|454770528|FG001|Open-label Extension Period|Non-Compliance|1|||
126403239|NCT02008357|454770527|FG000|Open-label Extension Period|Investigator Recommendation|0|||
126403240|NCT02008357|454770528|FG001|Open-label Extension Period|Investigator Recommendation|1|||
126403241|NCT02008357|454770527|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
126403242|NCT02008357|454770528|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
126403243|NCT02008357|454770527|FG000|Open-label Extension Period|Coordinating Center Request|2|||
126403244|NCT02008357|454770528|FG001|Open-label Extension Period|Coordinating Center Request|4|||
126403245|NCT02008357|454770527|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
126403246|NCT02008357|454770528|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
126403247|NCT02008357|454770527|FG000|Open-label Extension Period|Study Ended|20|||
126403248|NCT02008357|454770528|FG001|Open-label Extension Period|Study Ended|25|||
126403249|NCT02008357|454770527|FG000|Open-label Extension Period|Personal Reasons|0|||
126403250|NCT02008357|454770528|FG001|Open-label Extension Period|Personal Reasons|1|||
126403251|NCT02008357|454770527|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
126403252|NCT02008357|454770528|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
126403253|NCT02008357|454770527|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
126403254|NCT02008357|454770528|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
126403255|NCT02008357|454770527|FG000|Open-label Extension Period|Other|2|||
126403256|NCT02008357|454770528|FG001|Open-label Extension Period|Other|0|||
126403257|NCT01442064|454770529|FG000|Overall Study|Adverse Event|2|||
126403258|NCT01442064|454770530|FG001|Overall Study|Adverse Event|2|||
126403259|NCT01442064|454770531|FG002|Overall Study|Adverse Event|2|||
126403260|NCT01442064|454770532|FG003|Overall Study|Adverse Event|1|||
126403261|NCT01442064|454770533|FG004|Overall Study|Adverse Event|2|||
126403262|NCT01442064|454770534|FG005|Overall Study|Adverse Event|0|||
126403263|NCT01442064|454770529|FG000|Overall Study|Death|0|||
126403264|NCT01442064|454770530|FG001|Overall Study|Death|1|||
126403265|NCT01442064|454770531|FG002|Overall Study|Death|3|||
126403266|NCT01442064|454770532|FG003|Overall Study|Death|3|||
126403267|NCT01442064|454770533|FG004|Overall Study|Death|1|||
126403268|NCT01442064|454770534|FG005|Overall Study|Death|3|||
126403269|NCT01442064|454770529|FG000|Overall Study|Lost to Follow-up|5|||
126403270|NCT01442064|454770530|FG001|Overall Study|Lost to Follow-up|5|||
126403271|NCT01442064|454770531|FG002|Overall Study|Lost to Follow-up|1|||
126403272|NCT01442064|454770532|FG003|Overall Study|Lost to Follow-up|1|||
126403273|NCT01442064|454770533|FG004|Overall Study|Lost to Follow-up|3|||
126403274|NCT01442064|454770534|FG005|Overall Study|Lost to Follow-up|3|||
126403275|NCT01442064|454770529|FG000|Overall Study|Physician Decision|1|||
126403276|NCT01442064|454770530|FG001|Overall Study|Physician Decision|1|||
126403277|NCT01442064|454770531|FG002|Overall Study|Physician Decision|2|||
126403278|NCT01442064|454770532|FG003|Overall Study|Physician Decision|3|||
126403279|NCT01442064|454770533|FG004|Overall Study|Physician Decision|3|||
126403280|NCT01442064|454770534|FG005|Overall Study|Physician Decision|1|||
126403281|NCT01442064|454770529|FG000|Overall Study|Withdrawal by Subject|6|||
126403282|NCT01442064|454770530|FG001|Overall Study|Withdrawal by Subject|3|||
126403283|NCT01442064|454770531|FG002|Overall Study|Withdrawal by Subject|2|||
126403284|NCT01442064|454770532|FG003|Overall Study|Withdrawal by Subject|2|||
126403285|NCT01442064|454770533|FG004|Overall Study|Withdrawal by Subject|2|||
126403286|NCT01442064|454770534|FG005|Overall Study|Withdrawal by Subject|1|||
126403287|NCT01442064|454770529|FG000|Overall Study|Sponsor decision|82|||
126403288|NCT01442064|454770530|FG001|Overall Study|Sponsor decision|88|||
126403289|NCT01442064|454770531|FG002|Overall Study|Sponsor decision|92|||
126403290|NCT01442064|454770532|FG003|Overall Study|Sponsor decision|88|||
126403291|NCT01442064|454770533|FG004|Overall Study|Sponsor decision|95|||
126403292|NCT01442064|454770534|FG005|Overall Study|Sponsor decision|87|||
126403293|NCT01442064|454770529|FG000|Overall Study|Subject non-compliance|0|||
126403294|NCT01442064|454770530|FG001|Overall Study|Subject non-compliance|0|||
126403295|NCT01442064|454770531|FG002|Overall Study|Subject non-compliance|0|||
126403296|NCT01442064|454770532|FG003|Overall Study|Subject non-compliance|0|||
126403297|NCT01442064|454770533|FG004|Overall Study|Subject non-compliance|0|||
126403298|NCT01442064|454770534|FG005|Overall Study|Subject non-compliance|2|||
126403299|NCT01442064|454770529|FG000|Overall Study|Condition mandated other intervention|1|||
126403300|NCT01442064|454770530|FG001|Overall Study|Condition mandated other intervention|1|||
126403301|NCT01442064|454770531|FG002|Overall Study|Condition mandated other intervention|2|||
126403302|NCT01442064|454770532|FG003|Overall Study|Condition mandated other intervention|0|||
126403303|NCT01442064|454770533|FG004|Overall Study|Condition mandated other intervention|0|||
126403304|NCT01442064|454770534|FG005|Overall Study|Condition mandated other intervention|2|||
126403305|NCT00966719|454770535|FG000|Overall Study|Lost to Follow-up|6|||
126403306|NCT00966719|454770536|FG001|Overall Study|Lost to Follow-up|11|||
126403307|NCT01703065|454770537|FG000|Overall Study|Lack of Efficacy|1|||
126403308|NCT01703065|454770538|FG001|Overall Study|Lack of Efficacy|0|||
126403309|NCT01710527|454770539|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
126403310|NCT01710527|454770540|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
126403311|NCT02635347|454770543|FG000|Overall Study|Failed screening|20|||
126403312|NCT02635347|454770544|FG001|Overall Study|Failed screening|7|||
126403313|NCT02124772|454770546|FG000|Overall Study|Lack of Efficacy|2|||
126403314|NCT02124772|454770547|FG001|Overall Study|Lack of Efficacy|0|||
126403315|NCT02124772|454770548|FG002|Overall Study|Lack of Efficacy|0|||
126403316|NCT02124772|454770549|FG003|Overall Study|Lack of Efficacy|1|||
126403317|NCT02124772|454770550|FG004|Overall Study|Lack of Efficacy|2|||
126403318|NCT02124772|454770551|FG005|Overall Study|Lack of Efficacy|3|||
126403319|NCT02124772|454770552|FG006|Overall Study|Lack of Efficacy|0|||
126403320|NCT02124772|454770553|FG007|Overall Study|Lack of Efficacy|2|||
126403321|NCT02124772|454770554|FG008|Overall Study|Lack of Efficacy|0|||
126403322|NCT02124772|454770555|FG009|Overall Study|Lack of Efficacy|1|||
126403323|NCT02124772|454770556|FG010|Overall Study|Lack of Efficacy|0|||
126403324|NCT02124772|454770557|FG011|Overall Study|Lack of Efficacy|0|||
126403325|NCT02124772|454770558|FG012|Overall Study|Lack of Efficacy|1|||
126403326|NCT02124772|454770546|FG000|Overall Study|Adverse Event|1|||
126403327|NCT02124772|454770547|FG001|Overall Study|Adverse Event|4|||
126403328|NCT02124772|454770548|FG002|Overall Study|Adverse Event|1|||
126403329|NCT02124772|454770549|FG003|Overall Study|Adverse Event|5|||
126403330|NCT02124772|454770550|FG004|Overall Study|Adverse Event|2|||
126403331|NCT02124772|454770551|FG005|Overall Study|Adverse Event|1|||
126403332|NCT02124772|454770552|FG006|Overall Study|Adverse Event|1|||
126403333|NCT02124772|454770553|FG007|Overall Study|Adverse Event|5|||
126403334|NCT02124772|454770554|FG008|Overall Study|Adverse Event|0|||
126403335|NCT02124772|454770555|FG009|Overall Study|Adverse Event|3|||
126403336|NCT02124772|454770556|FG010|Overall Study|Adverse Event|1|||
126403337|NCT02124772|454770557|FG011|Overall Study|Adverse Event|3|||
126403338|NCT02124772|454770558|FG012|Overall Study|Adverse Event|1|||
126403339|NCT02124772|454770546|FG000|Overall Study|Withdrawal consent|0|||
126403340|NCT02124772|454770547|FG001|Overall Study|Withdrawal consent|1|||
126403341|NCT02124772|454770548|FG002|Overall Study|Withdrawal consent|1|||
126403342|NCT02124772|454770549|FG003|Overall Study|Withdrawal consent|1|||
126403343|NCT02124772|454770550|FG004|Overall Study|Withdrawal consent|0|||
126403344|NCT02124772|454770551|FG005|Overall Study|Withdrawal consent|1|||
126403345|NCT02124772|454770552|FG006|Overall Study|Withdrawal consent|1|||
126403346|NCT02124772|454770553|FG007|Overall Study|Withdrawal consent|0|||
126403347|NCT02124772|454770554|FG008|Overall Study|Withdrawal consent|0|||
126403348|NCT02124772|454770555|FG009|Overall Study|Withdrawal consent|1|||
126403349|NCT02124772|454770556|FG010|Overall Study|Withdrawal consent|0|||
126403350|NCT02124772|454770557|FG011|Overall Study|Withdrawal consent|1|||
126403351|NCT02124772|454770558|FG012|Overall Study|Withdrawal consent|0|||
126403352|NCT02124772|454770546|FG000|Overall Study|Investigator discretion|0|||
126403353|NCT02124772|454770547|FG001|Overall Study|Investigator discretion|2|||
126403354|NCT02124772|454770548|FG002|Overall Study|Investigator discretion|2|||
126403355|NCT02124772|454770549|FG003|Overall Study|Investigator discretion|1|||
126403356|NCT02124772|454770550|FG004|Overall Study|Investigator discretion|1|||
126403357|NCT02124772|454770551|FG005|Overall Study|Investigator discretion|0|||
126403358|NCT02124772|454770552|FG006|Overall Study|Investigator discretion|1|||
126403359|NCT02124772|454770553|FG007|Overall Study|Investigator discretion|0|||
126403360|NCT02124772|454770554|FG008|Overall Study|Investigator discretion|0|||
126403361|NCT02124772|454770555|FG009|Overall Study|Investigator discretion|1|||
126403362|NCT02124772|454770556|FG010|Overall Study|Investigator discretion|0|||
126403363|NCT02124772|454770557|FG011|Overall Study|Investigator discretion|1|||
126403364|NCT02124772|454770558|FG012|Overall Study|Investigator discretion|0|||
126403365|NCT02124772|454770546|FG000|Overall Study|Progressive disease|0|||
126403366|NCT02124772|454770547|FG001|Overall Study|Progressive disease|0|||
126403367|NCT02124772|454770548|FG002|Overall Study|Progressive disease|0|||
126403368|NCT02124772|454770549|FG003|Overall Study|Progressive disease|0|||
126403369|NCT02124772|454770550|FG004|Overall Study|Progressive disease|0|||
126403370|NCT02124772|454770551|FG005|Overall Study|Progressive disease|0|||
126403371|NCT02124772|454770552|FG006|Overall Study|Progressive disease|1|||
126403372|NCT02124772|454770553|FG007|Overall Study|Progressive disease|1|||
126403373|NCT02124772|454770554|FG008|Overall Study|Progressive disease|0|||
126403374|NCT02124772|454770555|FG009|Overall Study|Progressive disease|0|||
126403375|NCT02124772|454770556|FG010|Overall Study|Progressive disease|0|||
126403376|NCT02124772|454770557|FG011|Overall Study|Progressive disease|0|||
126403377|NCT02124772|454770558|FG012|Overall Study|Progressive disease|0|||
126403378|NCT02124772|454770546|FG000|Overall Study|Other|0|||
126403379|NCT02124772|454770547|FG001|Overall Study|Other|7|||
126403380|NCT02124772|454770548|FG002|Overall Study|Other|2|||
126403381|NCT02124772|454770549|FG003|Overall Study|Other|5|||
126403382|NCT02124772|454770550|FG004|Overall Study|Other|4|||
126403383|NCT02124772|454770551|FG005|Overall Study|Other|3|||
126403384|NCT02124772|454770552|FG006|Overall Study|Other|4|||
126403385|NCT02124772|454770553|FG007|Overall Study|Other|1|||
126403386|NCT02124772|454770554|FG008|Overall Study|Other|1|||
126403387|NCT02124772|454770555|FG009|Overall Study|Other|1|||
126403388|NCT02124772|454770556|FG010|Overall Study|Other|1|||
126403389|NCT02124772|454770557|FG011|Overall Study|Other|1|||
126403390|NCT02124772|454770558|FG012|Overall Study|Other|0|||
126403391|NCT00780273|454770561|FG000|Overall Study|Death|1|||
126403392|NCT00780273|454770561|FG000|Overall Study|Lost to Follow-up|1|||
126403393|NCT00940485|454771632|FG000|Overall Study|HBeAb positive at Baseline|3|||
126403394|NCT00940485|454771633|FG001|Overall Study|HBeAb positive at Baseline|2|||
126403395|NCT00940485|454771632|FG000|Overall Study|Lost to Follow-up|2|||
126403396|NCT00940485|454771633|FG001|Overall Study|Lost to Follow-up|3|||
126403397|NCT00940485|454771632|FG000|Overall Study|Adverse Event|8|||
126403398|NCT00940485|454771633|FG001|Overall Study|Adverse Event|0|||
126403399|NCT00940485|454771632|FG000|Overall Study|Withdrawal by Subject|1|||
126403400|NCT00940485|454771633|FG001|Overall Study|Withdrawal by Subject|1|||
126403401|NCT00940485|454771632|FG000|Overall Study|Others|1|||
126403402|NCT00940485|454771633|FG001|Overall Study|Others|1|||
126403403|NCT03921554|454771635|FG000|Overall Study|Adverse Event|2|||
126403404|NCT03921554|454771635|FG000|Overall Study|Withdrawal by Subject|1|||
126403405|NCT03921554|454771635|FG000|Overall Study|Death|3|||
126403406|NCT03283150|454771642|FG000|Overall Study|Withdrawal by Subject|6|||
126403407|NCT03283150|454771643|FG001|Overall Study|Withdrawal by Subject|0|||
126403408|NCT03283150|454771644|FG002|Overall Study|Withdrawal by Subject|0|||
126403409|NCT01299571|454771647|FG000|Overall Study|Protocol Violation|107|||
126403410|NCT00864851|454771648|FG000|Overall Study|Withdrawal by Subject|0|||
126403411|NCT00864851|454771649|FG001|Overall Study|Withdrawal by Subject|1|||
126403412|NCT00864851|454771650|FG002|Overall Study|Withdrawal by Subject|0|||
126403413|NCT00864851|454771648|FG000|Overall Study|Physician Decision|1|||
126403414|NCT00864851|454771649|FG001|Overall Study|Physician Decision|0|||
126403415|NCT00864851|454771650|FG002|Overall Study|Physician Decision|0|||
126403416|NCT00864851|454771648|FG000|Overall Study|Death|1|||
126403417|NCT00864851|454771649|FG001|Overall Study|Death|0|||
126403418|NCT00864851|454771650|FG002|Overall Study|Death|0|||
126403419|NCT00864851|454771648|FG000|Overall Study|Patient uncooperative|1|||
126403420|NCT00864851|454771649|FG001|Overall Study|Patient uncooperative|0|||
126403421|NCT00864851|454771650|FG002|Overall Study|Patient uncooperative|0|||
126403422|NCT01842581|454771654|FG000|Overall Study|Adverse Event|6|||
126403423|NCT01842581|454771655|FG001|Overall Study|Adverse Event|4|||
126403424|NCT01842581|454771654|FG000|Overall Study|HE breakthrough|26|||
126403425|NCT01842581|454771655|FG001|Overall Study|HE breakthrough|13|||
126403426|NCT01842581|454771654|FG000|Overall Study|Liver transplant|2|||
126403427|NCT01842581|454771655|FG001|Overall Study|Liver transplant|0|||
126403428|NCT01842581|454771654|FG000|Overall Study|Lost to Follow-up|2|||
126403429|NCT01842581|454771655|FG001|Overall Study|Lost to Follow-up|5|||
126403430|NCT01842581|454771654|FG000|Overall Study|Withdrawal by Subject|5|||
126403431|NCT01842581|454771655|FG001|Overall Study|Withdrawal by Subject|7|||
126403432|NCT01842581|454771654|FG000|Overall Study|Other than specified|3|||
126403433|NCT01842581|454771655|FG001|Overall Study|Other than specified|1|||
126403434|NCT01287195|454771658|FG000|Overall Study|Withdrawal by Subject|2|||
126403435|NCT02006069|454771661|FG000|Overall Study|MPP other programming|239|||
126403436|NCT02006069|454771662|FG001|Overall Study|MPP other programming|0|||
126403437|NCT02006069|454771661|FG000|Overall Study|RV only pacing|0|||
126403438|NCT02006069|454771662|FG001|Overall Study|RV only pacing|3|||
126403439|NCT00530920|454771663|FG000|Overall Study|Randomized but not treated|0|||
126403440|NCT00530920|454771664|FG001|Overall Study|Randomized but not treated|2|||
126403441|NCT00530920|454771665|FG002|Overall Study|Randomized but not treated|0|||
126403442|NCT00530920|454771663|FG000|Overall Study|Adverse Event|0|||
126403443|NCT00530920|454771664|FG001|Overall Study|Adverse Event|0|||
126403444|NCT00530920|454771665|FG002|Overall Study|Adverse Event|3|||
126403445|NCT00530920|454771663|FG000|Overall Study|Withdrawal by Subject|0|||
126403446|NCT00530920|454771664|FG001|Overall Study|Withdrawal by Subject|0|||
126403447|NCT00530920|454771665|FG002|Overall Study|Withdrawal by Subject|1|||
126403448|NCT04957758|454771666|FG000|Overall Study|Adverse Event|1|||
126403449|NCT04957758|454771667|FG001|Overall Study|Adverse Event|0|||
126403450|NCT04957758|454771666|FG000|Overall Study|Lost to Follow-up|0|||
126403451|NCT04957758|454771667|FG001|Overall Study|Lost to Follow-up|2|||
126403452|NCT04957758|454771666|FG000|Overall Study|Withdrawal by Subject|4|||
126403453|NCT04957758|454771667|FG001|Overall Study|Withdrawal by Subject|2|||
126403454|NCT04957758|454771666|FG000|Overall Study|Protocol Violation|0|||
126403455|NCT04957758|454771667|FG001|Overall Study|Protocol Violation|1|||
126403456|NCT00707746|454771668|FG000|Treatment Period|Adverse Event|2|||
126403457|NCT00707746|454771669|FG001|Treatment Period|Adverse Event|4|||
126403458|NCT00707746|454771668|FG000|Treatment Period|Ineligibility|0|||
126403459|NCT00707746|454771669|FG001|Treatment Period|Ineligibility|1|||
126403460|NCT00685373|454771671|FG000|Overall Study|Adverse Event|3|||
126403461|NCT00685373|454771671|FG000|Overall Study|Withdrawal by Subject|5|||
126403462|NCT00685373|454771671|FG000|Overall Study|Lack of Efficacy|3|||
126403463|NCT00685373|454771671|FG000|Overall Study|Condition no longer requires study drug|1|||
126403464|NCT00685373|454771671|FG000|Overall Study|Lost to Follow-up|2|||
126403465|NCT00685373|454771671|FG000|Overall Study|Protocol Violation|1|||
126403466|NCT02642965|454771672|FG000|Overall Study|Lack of Efficacy|4|||
126403467|NCT02642965|454771672|FG000|Overall Study|Physician Decision|9|||
126403468|NCT00857948|454771673|FG000|Overall Study|Withdrawal by Subject|2|||
126403469|NCT00857948|454771674|FG001|Overall Study|Withdrawal by Subject|0|||
126403470|NCT00857948|454771675|FG002|Overall Study|Withdrawal by Subject|0|||
126403471|NCT00857948|454771676|FG003|Overall Study|Withdrawal by Subject|0|||
126403472|NCT00857948|454771673|FG000|Overall Study|Protocol Violation|1|||
126403473|NCT00857948|454771674|FG001|Overall Study|Protocol Violation|0|||
126403474|NCT00857948|454771675|FG002|Overall Study|Protocol Violation|1|||
126403475|NCT00857948|454771676|FG003|Overall Study|Protocol Violation|0|||
126403476|NCT03077698|454771679|FG000|Progestin Monotherapy|Stable Disease|8|||
126403477|NCT03077698|454771680|FG001|Progestin Monotherapy|Stable Disease|0|||
126403478|NCT03077698|454771679|FG000|Progestin Monotherapy|Adverse Event|1|||
126403479|NCT03077698|454771680|FG001|Progestin Monotherapy|Adverse Event|0|||
126403480|NCT03077698|454771679|FG000|Progestin Monotherapy|Death|1|||
126403481|NCT03077698|454771680|FG001|Progestin Monotherapy|Death|0|||
126403482|NCT03077698|454771679|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
126403483|NCT03077698|454771680|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
126403484|NCT03077698|454771679|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
126403485|NCT03077698|454771680|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
126403486|NCT03077698|454771679|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
126403487|NCT03077698|454771680|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
126403488|NCT03077698|454771679|FG000|Safety Follow Up|Withdrawal by Subject|2|||
126403489|NCT03077698|454771680|FG001|Safety Follow Up|Withdrawal by Subject|1|||
126403490|NCT03077698|454771679|FG000|Safety Follow Up|Transfer of care to hospice|1|||
126403491|NCT03077698|454771680|FG001|Safety Follow Up|Transfer of care to hospice|0|||
126403492|NCT03099148|454771683|FG000|Wash-out|scheduling conflict|0|||
126403493|NCT03099148|454771684|FG001|Wash-out|scheduling conflict|1|||
126403494|NCT03099148|454771685|FG002|Wash-out|scheduling conflict|0|||
126403495|NCT03099148|454771686|FG003|Wash-out|scheduling conflict|0|||
126403496|NCT03099148|454771683|FG000|Wash-out|Adverse Event|0|||
126403497|NCT03099148|454771684|FG001|Wash-out|Adverse Event|1|||
126403498|NCT03099148|454771685|FG002|Wash-out|Adverse Event|0|||
126403499|NCT03099148|454771686|FG003|Wash-out|Adverse Event|0|||
126403500|NCT01439126|454771687|FG000|Overall Study|Adverse Event|2|||
126403501|NCT01439126|454771688|FG001|Overall Study|Adverse Event|0|||
126403502|NCT01439126|454771687|FG000|Overall Study|Withdrawal by Subject|5|||
126403503|NCT01439126|454771688|FG001|Overall Study|Withdrawal by Subject|21|||
126403504|NCT01439126|454771687|FG000|Overall Study|Protocol Violation|6|||
126403505|NCT01439126|454771688|FG001|Overall Study|Protocol Violation|4|||
126403506|NCT01439126|454771687|FG000|Overall Study|Lost to Follow-up|6|||
126403507|NCT01439126|454771688|FG001|Overall Study|Lost to Follow-up|3|||
126403508|NCT01439126|454771687|FG000|Overall Study|Other-Use of prohibited treatment|0|||
126403509|NCT01439126|454771688|FG001|Overall Study|Other-Use of prohibited treatment|2|||
126403510|NCT01439126|454771687|FG000|Overall Study|Other-Miscellaneous|12|||
126403511|NCT01439126|454771688|FG001|Overall Study|Other-Miscellaneous|12|||
126403512|NCT01617447|454771689|FG000|Overall Study|Adverse Event|0|||
126403513|NCT01617447|454771690|FG001|Overall Study|Adverse Event|1|||
126403514|NCT01617447|454771689|FG000|Overall Study|Physician Decision|0|||
126403515|NCT01617447|454771690|FG001|Overall Study|Physician Decision|2|||
126403516|NCT02713529|454771692|FG000|Overall Study|Withdrawal by Subject|3|||
126403517|NCT02713529|454771693|FG001|Overall Study|Withdrawal by Subject|1|||
126403518|NCT02713529|454771694|FG002|Overall Study|Withdrawal by Subject|4|||
126403519|NCT02713529|454771695|FG003|Overall Study|Withdrawal by Subject|2|||
126403520|NCT02713529|454771696|FG004|Overall Study|Withdrawal by Subject|0|||
126403521|NCT02713529|454771697|FG005|Overall Study|Withdrawal by Subject|1|||
126403522|NCT02713529|454771698|FG006|Overall Study|Withdrawal by Subject|1|||
126403523|NCT02713529|454771692|FG000|Overall Study|Lost to Follow-up|1|||
126403524|NCT02713529|454771693|FG001|Overall Study|Lost to Follow-up|0|||
126403525|NCT02713529|454771694|FG002|Overall Study|Lost to Follow-up|1|||
126403526|NCT02713529|454771695|FG003|Overall Study|Lost to Follow-up|0|||
126403527|NCT02713529|454771696|FG004|Overall Study|Lost to Follow-up|0|||
126403528|NCT02713529|454771697|FG005|Overall Study|Lost to Follow-up|0|||
126403529|NCT02713529|454771698|FG006|Overall Study|Lost to Follow-up|0|||
126403530|NCT02713529|454771692|FG000|Overall Study|Death|3|||
126403531|NCT02713529|454771693|FG001|Overall Study|Death|3|||
126403532|NCT02713529|454771694|FG002|Overall Study|Death|26|||
126403533|NCT02713529|454771695|FG003|Overall Study|Death|27|||
126403534|NCT02713529|454771696|FG004|Overall Study|Death|3|||
126403535|NCT02713529|454771697|FG005|Overall Study|Death|13|||
126403536|NCT02713529|454771698|FG006|Overall Study|Death|3|||
126403537|NCT02827500|454771699|FG000|Overall Study|Death|7|||
126403538|NCT02827500|454771700|FG001|Overall Study|Death|3|||
126403539|NCT02827500|454771699|FG000|Overall Study|Lost to Follow-up|1|||
126403540|NCT02827500|454771700|FG001|Overall Study|Lost to Follow-up|1|||
126403541|NCT02827500|454771699|FG000|Overall Study|Withdrawal by Subject|3|||
126403542|NCT02827500|454771700|FG001|Overall Study|Withdrawal by Subject|1|||
126403543|NCT02827500|454771699|FG000|Overall Study|Missing primary endpoint data|3|||
126403544|NCT02827500|454771700|FG001|Overall Study|Missing primary endpoint data|1|||
126403545|NCT02827500|454771699|FG000|Overall Study|Other|5|||
126403546|NCT02827500|454771700|FG001|Overall Study|Other|1|||
126403547|NCT02358044|454771701|FG000|Overall Study|Adverse Event|0|||
126403548|NCT02358044|454771702|FG001|Overall Study|Adverse Event|1|||
126403549|NCT02358044|454771701|FG000|Overall Study|Lost to Follow-up|2|||
126403550|NCT02358044|454771702|FG001|Overall Study|Lost to Follow-up|1|||
126403551|NCT02358044|454771701|FG000|Overall Study|Physician Decision|0|||
126403552|NCT02358044|454771702|FG001|Overall Study|Physician Decision|1|||
126403553|NCT02358044|454771701|FG000|Overall Study|Withdrawal by Subject|0|||
126403554|NCT02358044|454771702|FG001|Overall Study|Withdrawal by Subject|4|||
126403555|NCT01739803|454771703|FG000|Overall Study|Lost to Follow-up|9|||
126403556|NCT01739803|454771704|FG001|Overall Study|Lost to Follow-up|6|||
126403557|NCT02525094|454771712|FG000|Overall Study|Lost to Follow-up|2|||
126403558|NCT02525094|454771713|FG001|Overall Study|Lost to Follow-up|1|||
126403559|NCT02525094|454771712|FG000|Overall Study|Withdrawal by Subject|5|||
126403560|NCT02525094|454771713|FG001|Overall Study|Withdrawal by Subject|6|||
126403561|NCT02525094|454771712|FG000|Overall Study|Not Treated|1|||
126403562|NCT02525094|454771713|FG001|Overall Study|Not Treated|1|||
126403563|NCT01751776|454771715|FG000|Overall Study|Adverse Event|0|||
126403564|NCT01751776|454771716|FG001|Overall Study|Adverse Event|0|||
126403565|NCT01751776|454771717|FG002|Overall Study|Adverse Event|0|||
126403566|NCT01751776|454771718|FG003|Overall Study|Adverse Event|0|||
126403567|NCT01751776|454771719|FG004|Overall Study|Adverse Event|0|||
126403568|NCT01751776|454771720|FG005|Overall Study|Adverse Event|0|||
126403569|NCT01751776|454771721|FG006|Overall Study|Adverse Event|4|||
126403570|NCT01751776|454771722|FG007|Overall Study|Adverse Event|2|||
126403571|NCT01751776|454771715|FG000|Overall Study|Consent withdrawn|0|||
126403572|NCT01751776|454771716|FG001|Overall Study|Consent withdrawn|0|||
126403573|NCT01751776|454771717|FG002|Overall Study|Consent withdrawn|0|||
126403574|NCT01751776|454771718|FG003|Overall Study|Consent withdrawn|0|||
126403575|NCT01751776|454771719|FG004|Overall Study|Consent withdrawn|0|||
126403576|NCT01751776|454771720|FG005|Overall Study|Consent withdrawn|0|||
126403577|NCT01751776|454771721|FG006|Overall Study|Consent withdrawn|0|||
126403578|NCT01751776|454771722|FG007|Overall Study|Consent withdrawn|1|||
126403579|NCT01751776|454771715|FG000|Overall Study|Other reason not specified above|0|||
126403580|NCT01751776|454771716|FG001|Overall Study|Other reason not specified above|0|||
126403581|NCT01751776|454771717|FG002|Overall Study|Other reason not specified above|0|||
126403582|NCT01751776|454771718|FG003|Overall Study|Other reason not specified above|0|||
126403583|NCT01751776|454771719|FG004|Overall Study|Other reason not specified above|0|||
126403584|NCT01751776|454771720|FG005|Overall Study|Other reason not specified above|0|||
126403585|NCT01751776|454771721|FG006|Overall Study|Other reason not specified above|0|||
126403586|NCT01751776|454771722|FG007|Overall Study|Other reason not specified above|1|||
126403587|NCT05219669|454771723|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403588|NCT05219669|454771724|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403589|NCT05219669|454771725|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
126403590|NCT05219669|454771726|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403591|NCT05219669|454771727|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403592|NCT05219669|454771728|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403593|NCT02242981|454771733|FG000|Overall Study|Withdrawal by Subject|1|||
126403594|NCT03474081|454771734|FG000|Overall Study|Adverse Event|6|||
126403595|NCT03474081|454771735|FG001|Overall Study|Adverse Event|3|||
126403596|NCT03474081|454771734|FG000|Overall Study|Lost to Follow-up|2|||
126403597|NCT03474081|454771735|FG001|Overall Study|Lost to Follow-up|1|||
126403598|NCT03474081|454771734|FG000|Overall Study|Physician Decision|3|||
126403599|NCT03474081|454771735|FG001|Overall Study|Physician Decision|2|||
126403600|NCT03474081|454771734|FG000|Overall Study|Withdrawal by Subject|5|||
126403601|NCT03474081|454771735|FG001|Overall Study|Withdrawal by Subject|7|||
126403602|NCT03474081|454771734|FG000|Overall Study|Investigator site closed|1|||
126403603|NCT03474081|454771735|FG001|Overall Study|Investigator site closed|0|||
126403604|NCT02210091|454771738|FG000|Overall Study|Physician Decision|0|||
126403605|NCT02210091|454771739|FG001|Overall Study|Physician Decision|1|||
126403606|NCT02210091|454771738|FG000|Overall Study|Withdrawal by Sponsor|0|||
126403607|NCT02210091|454771739|FG001|Overall Study|Withdrawal by Sponsor|1|||
126403608|NCT02290938|454771740|FG000|Overall Study|Lost to Follow-up|14|||
126403609|NCT02290938|454771741|FG001|Overall Study|Lost to Follow-up|43|||
126403610|NCT01831817|454771742|FG000|Overall Study|Lost to Follow-up|1|||
126403611|NCT01831817|454771743|FG001|Overall Study|Lost to Follow-up|0|||
126403612|NCT01831817|454771744|FG002|Overall Study|Lost to Follow-up|0|||
126403613|NCT01831817|454771745|FG003|Overall Study|Lost to Follow-up|0|||
126403614|NCT01831817|454771742|FG000|Overall Study|Withdrawl of Consent|3|||
126403615|NCT01831817|454771743|FG001|Overall Study|Withdrawl of Consent|0|||
126403616|NCT01831817|454771744|FG002|Overall Study|Withdrawl of Consent|0|||
126403617|NCT01831817|454771745|FG003|Overall Study|Withdrawl of Consent|0|||
126403618|NCT02198235|454771747|FG000|Overall Study|Lost to Follow-up|3|||
126403619|NCT02198235|454771748|FG001|Overall Study|Lost to Follow-up|2|||
126403620|NCT02198235|454771749|FG002|Overall Study|Lost to Follow-up|2|||
126403621|NCT05065190|454773583|FG000|Overall Study|Other than listed|2|||
126403622|NCT05065190|454773584|FG001|Overall Study|Other than listed|12|||
126403623|NCT05065190|454773583|FG000|Overall Study|Lack of Efficacy|4|||
126403624|NCT05065190|454773584|FG001|Overall Study|Lack of Efficacy|0|||
126403625|NCT05065190|454773583|FG000|Overall Study|Adverse Event|1|||
126403626|NCT05065190|454773584|FG001|Overall Study|Adverse Event|10|||
126403627|NCT05565937|454773585|FG000|Overall Study|Adverse Event|0|||
126403628|NCT05565937|454773586|FG001|Overall Study|Adverse Event|1|||
126403629|NCT05565937|454773585|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
126403630|NCT05565937|454773586|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
126403631|NCT05565937|454773585|FG000|Overall Study|Lost to Follow-up|2|||
126403632|NCT05565937|454773586|FG001|Overall Study|Lost to Follow-up|0|||
126403633|NCT05565937|454773585|FG000|Overall Study|Pregnancy|0|||
126403634|NCT05565937|454773586|FG001|Overall Study|Pregnancy|2|||
126403635|NCT05565937|454773585|FG000|Overall Study|Anisometropia|0|||
126403636|NCT05565937|454773586|FG001|Overall Study|Anisometropia|1|||
126403637|NCT02783170|454773589|FG000|Overall Study|Randomized but not Vaccinated|1|||
126403638|NCT02783170|454773590|FG001|Overall Study|Randomized but not Vaccinated|0|||
126403639|NCT04938037|454773591|FG000|Overall Study|Lost to Follow-up|4|||
126403640|NCT04938037|454773592|FG001|Overall Study|Lost to Follow-up|3|||
126403641|NCT03320330|454773595|FG000|Overall Study|Lack of Efficacy|5|||
126403642|NCT03320330|454773596|FG001|Overall Study|Lack of Efficacy|5|||
126403643|NCT03320330|454773597|FG002|Overall Study|Lack of Efficacy|14|||
126403644|NCT03320330|454773595|FG000|Overall Study|Physician Decision|1|||
126403645|NCT03320330|454773596|FG001|Overall Study|Physician Decision|0|||
126403646|NCT03320330|454773597|FG002|Overall Study|Physician Decision|0|||
126403647|NCT00203021|454773598|FG000|Overall Study|Death|4|||
126403648|NCT00203021|454773599|FG001|Overall Study|Death|1|||
126403649|NCT00203021|454773598|FG000|Overall Study|Adverse Event|10|||
126403650|NCT00203021|454773599|FG001|Overall Study|Adverse Event|5|||
126403651|NCT00203021|454773598|FG000|Overall Study|Withdrawal by Subject|45|||
126403652|NCT00203021|454773599|FG001|Overall Study|Withdrawal by Subject|48|||
126403653|NCT00203021|454773598|FG000|Overall Study|Lost to Follow-up|9|||
126403654|NCT00203021|454773599|FG001|Overall Study|Lost to Follow-up|7|||
126403655|NCT00203021|454773598|FG000|Overall Study|Other than specified|11|||
126403656|NCT00203021|454773599|FG001|Overall Study|Other than specified|16|||
126403657|NCT01282294|454773602|FG000|Overall Study|Lost to Follow-up|14|||
126403658|NCT01282294|454773602|FG000|Overall Study|Screening failure|1|||
126403659|NCT01282294|454773602|FG000|Overall Study|Adverse Event|1|||
126403660|NCT01282294|454773602|FG000|Overall Study|Patient non-compliance|2|||
126403661|NCT01282294|454773602|FG000|Overall Study|Physician Decision|1|||
126403662|NCT04692077|454773603|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
126403663|NCT01657760|454773610|FG000|Overall Study|Withdrawal by Subject|0|||
126403664|NCT01657760|454773611|FG001|Overall Study|Withdrawal by Subject|0|||
126403665|NCT01657760|454773612|FG002|Overall Study|Withdrawal by Subject|0|||
126403666|NCT01657760|454773613|FG003|Overall Study|Withdrawal by Subject|1|||
126403667|NCT01657760|454773610|FG000|Overall Study|Physician Decision|1|||
126403668|NCT01657760|454773611|FG001|Overall Study|Physician Decision|1|||
126403669|NCT01657760|454773612|FG002|Overall Study|Physician Decision|1|||
126403670|NCT01657760|454773613|FG003|Overall Study|Physician Decision|2|||
126403671|NCT06250738|454773626|FG000|Overall Study|Lost to Follow-up|1|||
126403672|NCT02936284|454773628|FG000|Overall Study|Withdrawal by Subject|3|||
126403673|NCT02936284|454773629|FG001|Overall Study|Withdrawal by Subject|1|||
126403674|NCT02936284|454773628|FG000|Overall Study|Lost to Follow-up|7|||
126403675|NCT02936284|454773629|FG001|Overall Study|Lost to Follow-up|8|||
126403676|NCT01068249|454773632|FG000|Overall Study|Death|1|||
126403677|NCT01068249|454773632|FG000|Overall Study|Withdrawal by Subject|3|||
126403678|NCT04284813|454773633|FG000|Overall Study|Withdrawal by Subject|1|||
126403679|NCT01146652|454773638|FG000|Overall Study|Adverse Event|506|||
126403680|NCT01146652|454773639|FG001|Overall Study|Adverse Event|15|||
126403681|NCT01146652|454773638|FG000|Overall Study|Lack of Efficacy|91|||
126403682|NCT01146652|454773639|FG001|Overall Study|Lack of Efficacy|7|||
126403683|NCT01146652|454773638|FG000|Overall Study|Poor compliance to protocol|38|||
126403684|NCT01146652|454773639|FG001|Overall Study|Poor compliance to protocol|1|||
126403685|NCT01146652|454773638|FG000|Overall Study|Other unspecified reasons|314|||
126403686|NCT01146652|454773639|FG001|Overall Study|Other unspecified reasons|22|||
126403687|NCT01146652|454773638|FG000|Overall Study|Enrolled but not treated|2|||
126403688|NCT01146652|454773639|FG001|Overall Study|Enrolled but not treated|0|||
126403689|NCT01300351|454773643|FG000|Overall Study|Did not receive treatment|2|||
126403690|NCT01300351|454773644|FG001|Overall Study|Did not receive treatment|0|||
126403691|NCT01300351|454773643|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
126403692|NCT01300351|454773644|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
126403693|NCT01300351|454773643|FG000|Overall Study|Lost to Follow-up|0|||
126403694|NCT01300351|454773644|FG001|Overall Study|Lost to Follow-up|1|||
126403695|NCT01300351|454773643|FG000|Overall Study|Adverse Event|0|||
126403696|NCT01300351|454773644|FG001|Overall Study|Adverse Event|4|||
126403697|NCT01300351|454773643|FG000|Overall Study|Withdrawal by Subject|7|||
126403698|NCT01300351|454773644|FG001|Overall Study|Withdrawal by Subject|10|||
126403699|NCT00431951|454773645|FG000|Overall Study|Inability to follow study procedures|1|||
126403700|NCT00431951|454773646|FG001|Overall Study|Inability to follow study procedures|0|||
126403701|NCT00431951|454773647|FG002|Overall Study|Inability to follow study procedures|1|||
126403702|NCT00431951|454773648|FG003|Overall Study|Inability to follow study procedures|2|||
126403703|NCT00431951|454773645|FG000|Overall Study|Lost to Follow-up|0|||
126403704|NCT00431951|454773646|FG001|Overall Study|Lost to Follow-up|1|||
126403705|NCT00431951|454773647|FG002|Overall Study|Lost to Follow-up|0|||
126403706|NCT00431951|454773648|FG003|Overall Study|Lost to Follow-up|0|||
126403707|NCT00431951|454773645|FG000|Overall Study|Withdrawal by Subject|0|||
126403708|NCT00431951|454773646|FG001|Overall Study|Withdrawal by Subject|1|||
126403709|NCT00431951|454773647|FG002|Overall Study|Withdrawal by Subject|0|||
126403710|NCT00431951|454773648|FG003|Overall Study|Withdrawal by Subject|0|||
126403711|NCT00431951|454773645|FG000|Overall Study|Adverse Event|0|||
126403712|NCT00431951|454773646|FG001|Overall Study|Adverse Event|0|||
126403713|NCT00431951|454773647|FG002|Overall Study|Adverse Event|1|||
126403714|NCT00431951|454773648|FG003|Overall Study|Adverse Event|0|||
126403715|NCT00096018|454773651|FG000|Overall Study|Became Ineligible (not treated)|0|||
126403716|NCT00096018|454773652|FG001|Overall Study|Became Ineligible (not treated)|3|||
126403717|NCT00096018|454773651|FG000|Overall Study|Miscellaneous (not treated)|0|||
126403718|NCT00096018|454773652|FG001|Overall Study|Miscellaneous (not treated)|2|||
126403719|NCT00096018|454773651|FG000|Overall Study|Adverse Event|0|||
126403720|NCT00096018|454773652|FG001|Overall Study|Adverse Event|5|||
126403721|NCT00096018|454773651|FG000|Overall Study|Death|0|||
126403722|NCT00096018|454773652|FG001|Overall Study|Death|1|||
126403723|NCT00096018|454773651|FG000|Overall Study|Withdrawal by Subject|0|||
126403724|NCT00096018|454773652|FG001|Overall Study|Withdrawal by Subject|2|||
126403725|NCT00096018|454773651|FG000|Overall Study|Miscellaneous|2|||
126403726|NCT00096018|454773652|FG001|Overall Study|Miscellaneous|1|||
126403727|NCT00673881|454773653|FG000|Overall Study|Withdrawal by Subject|1|||
126403728|NCT00689793|454773654|FG000|Overall Study|Lost to Follow-up|4|||
126403729|NCT00689793|454773655|FG001|Overall Study|Lost to Follow-up|5|||
126403730|NCT01100528|454773656|FG000|Overall Study|Death|1|||
126403731|NCT01100528|454773656|FG000|Overall Study|Withdrawal by Subject|2|||
126403732|NCT03968159|454773657|FG000|Overall Study|Adverse Event|4|||
126403733|NCT03968159|454773658|FG001|Overall Study|Adverse Event|4|||
126403734|NCT03968159|454773657|FG000|Overall Study|Lost to Follow-up|1|||
126403735|NCT03968159|454773658|FG001|Overall Study|Lost to Follow-up|1|||
126403736|NCT03968159|454773657|FG000|Overall Study|Use of prohibited medication|0|||
126403737|NCT03968159|454773658|FG001|Overall Study|Use of prohibited medication|1|||
126403738|NCT03968159|454773657|FG000|Overall Study|Protocol Violation|2|||
126403739|NCT03968159|454773658|FG001|Overall Study|Protocol Violation|2|||
126403740|NCT03968159|454773657|FG000|Overall Study|Withdrawal by Subject|4|||
126403741|NCT03968159|454773658|FG001|Overall Study|Withdrawal by Subject|6|||
126403742|NCT03968159|454773657|FG000|Overall Study|Lack of Efficacy|0|||
126403743|NCT03968159|454773658|FG001|Overall Study|Lack of Efficacy|1|||
126403744|NCT03968159|454773657|FG000|Overall Study|Not further specified|2|||
126403745|NCT03968159|454773658|FG001|Overall Study|Not further specified|0|||
126403746|NCT02308488|454773666|FG000|Overall Study|Withdrawal by Subject|2|||
126403747|NCT01541917|454773667|FG000|Overall Study|Lost to Follow-up|2|||
126403748|NCT01541917|454773668|FG001|Overall Study|Lost to Follow-up|2|||
126403749|NCT01541917|454773667|FG000|Overall Study|Withdrawal by Subject|13|||
126403750|NCT01541917|454773668|FG001|Overall Study|Withdrawal by Subject|7|||
126403751|NCT00094107|454773673|FG000|Overall Study|Lack of Efficacy|23|||
126403752|NCT00094107|454773673|FG000|Overall Study|Death|5|||
126403753|NCT00094107|454773673|FG000|Overall Study|Adverse Event|3|||
126403754|NCT00094107|454773673|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
126403755|NCT00525824|454773674|FG000|Overall Study|Adverse Event|7|||
126403756|NCT00525824|454773675|FG001|Overall Study|Adverse Event|11|||
126403757|NCT00525824|454773676|FG002|Overall Study|Adverse Event|6|||
126403758|NCT00525824|454773677|FG003|Overall Study|Adverse Event|7|||
126403759|NCT00525824|454773674|FG000|Overall Study|Withdrawal by Subject|5|||
126403760|NCT00525824|454773675|FG001|Overall Study|Withdrawal by Subject|9|||
126403761|NCT00525824|454773676|FG002|Overall Study|Withdrawal by Subject|3|||
126403762|NCT00525824|454773677|FG003|Overall Study|Withdrawal by Subject|4|||
126403763|NCT00525824|454773674|FG000|Overall Study|Lost to Follow-up|4|||
126403764|NCT00525824|454773675|FG001|Overall Study|Lost to Follow-up|2|||
126403765|NCT00525824|454773676|FG002|Overall Study|Lost to Follow-up|4|||
126403766|NCT00525824|454773677|FG003|Overall Study|Lost to Follow-up|0|||
126403767|NCT00525824|454773674|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
126403768|NCT00525824|454773675|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
126403769|NCT00525824|454773676|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
126403770|NCT00525824|454773677|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
126403771|NCT00525824|454773674|FG000|Overall Study|Severe non-compliance|0|||
126403772|NCT00525824|454773675|FG001|Overall Study|Severe non-compliance|1|||
126403773|NCT00525824|454773676|FG002|Overall Study|Severe non-compliance|1|||
126403774|NCT00525824|454773677|FG003|Overall Study|Severe non-compliance|1|||
125890130|NCT00481091|452895441|FG007|Overall Study|Progressive disease clinical|0|||
125890131|NCT00481091|452895442|FG008|Overall Study|Progressive disease clinical|1|||
125890132|NCT00481091|452895443|FG009|Overall Study|Progressive disease clinical|7|||
125890133|NCT00481091|452895434|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125890134|NCT00481091|452895435|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125890135|NCT00481091|452895436|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
126403775|NCT00525824|454773674|FG000|Overall Study|Safety reasons|1|||
126403776|NCT00525824|454773675|FG001|Overall Study|Safety reasons|0|||
126403777|NCT00525824|454773676|FG002|Overall Study|Safety reasons|1|||
126403778|NCT00525824|454773677|FG003|Overall Study|Safety reasons|0|||
126403779|NCT00525824|454773674|FG000|Overall Study|Other|1|||
126403780|NCT00525824|454773675|FG001|Overall Study|Other|3|||
126403781|NCT00525824|454773676|FG002|Overall Study|Other|3|||
126403782|NCT00525824|454773677|FG003|Overall Study|Other|1|||
126403783|NCT01378429|454773681|FG000|Overall Study|Noncompliance with study drug|1|||
126403784|NCT01378429|454773682|FG001|Overall Study|Noncompliance with study drug|0|||
126403785|NCT01490294|454773685|FG000|Overall Study|Prematurely discontinuation|4|||
126403786|NCT01490294|454773686|FG001|Overall Study|Prematurely discontinuation|0|||
126403787|NCT01490294|454773687|FG002|Overall Study|Prematurely discontinuation|1|||
126403788|NCT01490294|454773688|FG003|Overall Study|Prematurely discontinuation|1|||
126403789|NCT01490294|454773685|FG000|Overall Study|Adverse Event|1|||
125890136|NCT00481091|452895437|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125890137|NCT00481091|452895438|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125890138|NCT00481091|452895439|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125890139|NCT00481091|452895440|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125890140|NCT00481091|452895441|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125890141|NCT00481091|452895442|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125890142|NCT00481091|452895443|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125890143|NCT00481091|452895434|FG000|Overall Study|Progressive disease other|1|||
125890144|NCT00481091|452895435|FG001|Overall Study|Progressive disease other|1|||
125890145|NCT00481091|452895436|FG002|Overall Study|Progressive disease other|0|||
125890146|NCT00481091|452895437|FG003|Overall Study|Progressive disease other|1|||
125890147|NCT00481091|452895438|FG004|Overall Study|Progressive disease other|1|||
125890148|NCT00481091|452895439|FG005|Overall Study|Progressive disease other|1|||
126403790|NCT01490294|454773686|FG001|Overall Study|Adverse Event|0|||
126403791|NCT01490294|454773687|FG002|Overall Study|Adverse Event|0|||
126403792|NCT01490294|454773688|FG003|Overall Study|Adverse Event|0|||
126403793|NCT02404649|454773689|FG000|Overall Study|Adverse Event|1|||
126403794|NCT02404649|454773690|FG001|Overall Study|Adverse Event|2|||
126403795|NCT00330668|454773694|FG000|BID Dosing Period|Adverse Event|1|||
126403796|NCT00330668|454773694|FG000|BID Dosing Period|Lost to Follow-up|7|||
126403797|NCT00330668|454773694|FG000|BID Dosing Period|Non-Compliance|5|||
126403798|NCT00330668|454773694|FG000|BID Dosing Period|Withdrawal by Subject|19|||
125890149|NCT00481091|452895440|FG006|Overall Study|Progressive disease other|0|||
125890150|NCT00481091|452895441|FG007|Overall Study|Progressive disease other|2|||
125890151|NCT00481091|452895442|FG008|Overall Study|Progressive disease other|0|||
125890152|NCT00481091|452895443|FG009|Overall Study|Progressive disease other|0|||
125890153|NCT00481091|452895434|FG000|Overall Study|No reason given|0|||
125890154|NCT00481091|452895435|FG001|Overall Study|No reason given|0|||
125890155|NCT00481091|452895436|FG002|Overall Study|No reason given|1|||
125890156|NCT00481091|452895437|FG003|Overall Study|No reason given|1|||
125890157|NCT00481091|452895438|FG004|Overall Study|No reason given|1|||
125890158|NCT00481091|452895439|FG005|Overall Study|No reason given|0|||
125890159|NCT00481091|452895440|FG006|Overall Study|No reason given|1|||
125890160|NCT00481091|452895441|FG007|Overall Study|No reason given|1|||
125890161|NCT00481091|452895442|FG008|Overall Study|No reason given|1|||
125890162|NCT00481091|452895443|FG009|Overall Study|No reason given|4|||
125890163|NCT04294680|452895444|FG000|Overall Study|Withdrawal by Subject|2|||
125890164|NCT04294680|452895445|FG001|Overall Study|Withdrawal by Subject|1|||
126403799|NCT00330668|454773694|FG000|BID Dosing Period|Sponsor's decision|1|||
126403800|NCT00330668|454773694|FG000|BID Dosing Period|Other|3|||
126403801|NCT00330668|454773694|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
126403802|NCT00330668|454773694|FG000|QD Dosing Period|Other|1|||
126403803|NCT00330668|454773694|FG000|QD Dosing Period|Withdrawal by Subject|1|||
126403804|NCT00330668|454773694|FG000|QD Dosing Period|Lost to Follow-up|2|||
126403805|NCT01839656|454773695|FG000|Overall Study|Withdrawal by Subject|1|||
126403806|NCT01839656|454773696|FG001|Overall Study|Withdrawal by Subject|1|||
126403807|NCT01839656|454773695|FG000|Overall Study|Adverse event, serious fatal|1|||
126403808|NCT01839656|454773696|FG001|Overall Study|Adverse event, serious fatal|4|||
126403809|NCT01839656|454773695|FG000|Overall Study|Early study closure|0|||
126403810|NCT01839656|454773696|FG001|Overall Study|Early study closure|11|||
126403811|NCT01839656|454773695|FG000|Overall Study|Adverse Event|1|||
125890165|NCT04294680|452895444|FG000|Overall Study|Follow-up visits completed outside of window|1|||
125890166|NCT04294680|452895445|FG001|Overall Study|Follow-up visits completed outside of window|0|||
125890167|NCT01296672|452895446|FG000|Overall Study|Lost to Follow-up|73|||
125890168|NCT01296672|452895447|FG001|Overall Study|Lost to Follow-up|18|||
125890169|NCT04027608|452895448|FG000|Overall Study|Withdrawal by Subject|13|||
126403812|NCT01839656|454773696|FG001|Overall Study|Adverse Event|0|||
126403813|NCT02621073|454773706|FG000|Overall Study|Lost to Follow-up|0|||
126403814|NCT02621073|454773707|FG001|Overall Study|Lost to Follow-up|1|||
126403815|NCT02621073|454773706|FG000|Overall Study|Physician Decision|3|||
126403816|NCT02621073|454773707|FG001|Overall Study|Physician Decision|2|||
126403817|NCT01595581|454773708|FG000|Overall Study|Withdrawal by Subject|1|||
126403818|NCT01595581|454773709|FG001|Overall Study|Withdrawal by Subject|0|||
126403819|NCT01440881|454773710|FG000|Overall Study|Death|0|||
126403820|NCT01440881|454773711|FG001|Overall Study|Death|1|||
126403821|NCT02920957|454773714|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
126403822|NCT02920957|454773715|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
126403823|NCT02920957|454773714|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
126403824|NCT02920957|454773715|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
126403825|NCT02920957|454773714|FG000|First Intervention : 1 Month|Adverse Event|1|||
126403826|NCT02920957|454773715|FG001|First Intervention : 1 Month|Adverse Event|0|||
126403827|NCT02920957|454773714|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
126403828|NCT02920957|454773715|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
126403829|NCT02644356|454773719|FG000|Overall Study|Withdrawal by Subject|2|||
126403830|NCT02739321|454773726|FG000|Overall Study|Lack of Efficacy|1|||
126403831|NCT02739321|454773727|FG001|Overall Study|Lack of Efficacy|1|||
126403832|NCT02739321|454773726|FG000|Overall Study|Lost to Follow-up|1|||
126403833|NCT02739321|454773727|FG001|Overall Study|Lost to Follow-up|1|||
126403834|NCT02739321|454773726|FG000|Overall Study|Withdrawal by Subject|1|||
126403835|NCT02739321|454773727|FG001|Overall Study|Withdrawal by Subject|2|||
126403836|NCT01711866|454773728|FG000|Overall Study|Noncompliant|3|||
126403837|NCT01711866|454773728|FG000|Overall Study|Withdrawal by Subject|3|||
126403838|NCT01711866|454773728|FG000|Overall Study|Adverse Event|2|||
125890170|NCT04027608|452895449|FG001|Overall Study|Withdrawal by Subject|2|||
125890171|NCT04027608|452895448|FG000|Overall Study|Protocol Violation|2|||
125890172|NCT04027608|452895449|FG001|Overall Study|Protocol Violation|1|||
125890173|NCT04027608|452895448|FG000|Overall Study|Physician Decision|1|||
125890174|NCT04027608|452895449|FG001|Overall Study|Physician Decision|0|||
125890175|NCT04027608|452895448|FG000|Overall Study|Lost to Follow-up|20|||
125890176|NCT04027608|452895449|FG001|Overall Study|Lost to Follow-up|4|||
125890177|NCT01386970|452895451|FG000|Overall Study|Withdrawal by Subject|0|||
125890178|NCT01386970|452895452|FG001|Overall Study|Withdrawal by Subject|1|||
125890179|NCT01386970|452895451|FG000|Overall Study|Adverse Event|4|||
125890180|NCT01386970|452895452|FG001|Overall Study|Adverse Event|1|||
125890181|NCT04881942|452895453|FG000|Overall Study|Adverse Event|0|||
125890182|NCT04881942|452895454|FG001|Overall Study|Adverse Event|0|||
125890183|NCT04881942|452895455|FG002|Overall Study|Adverse Event|0|||
125890184|NCT04881942|452895456|FG003|Overall Study|Adverse Event|0|||
125890185|NCT04881942|452895457|FG004|Overall Study|Adverse Event|1|||
125890186|NCT04881942|452895453|FG000|Overall Study|Alternates|0|||
125890187|NCT04881942|452895454|FG001|Overall Study|Alternates|0|||
125890188|NCT04881942|452895455|FG002|Overall Study|Alternates|0|||
125890189|NCT04881942|452895456|FG003|Overall Study|Alternates|0|||
126403839|NCT01345682|454773729|FG000|Overall Study|Progressive disease per RECIST|226|||
126403840|NCT01345682|454773730|FG001|Overall Study|Progressive disease per RECIST|93|||
126403841|NCT01345682|454773729|FG000|Overall Study|Worsening of underlying cancer disease|23|||
125890190|NCT04881942|452895457|FG004|Overall Study|Alternates|2|||
125890191|NCT01349959|452895458|FG000|Overall Study|Adverse Event|7|||
125890192|NCT02675634|452895459|FG000|Test Period 1|Adverse Event|0|||
125890193|NCT02675634|452895460|FG001|Test Period 1|Adverse Event|1|||
125890194|NCT02675634|452895461|FG002|Test Period 1|Adverse Event|0|||
125890195|NCT02675634|452895462|FG003|Test Period 1|Adverse Event|1|||
126403842|NCT01345682|454773730|FG001|Overall Study|Worsening of underlying cancer disease|12|||
126403843|NCT01345682|454773729|FG000|Overall Study|Adverse Event|51|||
126403844|NCT01345682|454773730|FG001|Overall Study|Adverse Event|41|||
126403845|NCT01345682|454773729|FG000|Overall Study|Non-compliance with protocol|0|||
126403846|NCT01345682|454773730|FG001|Overall Study|Non-compliance with protocol|1|||
126403847|NCT01345682|454773729|FG000|Overall Study|Lost to Follow-up|0|||
126403848|NCT01345682|454773730|FG001|Overall Study|Lost to Follow-up|1|||
126403849|NCT01345682|454773729|FG000|Overall Study|Refused to continue trial medication|16|||
126403850|NCT01345682|454773730|FG001|Overall Study|Refused to continue trial medication|9|||
126403851|NCT01345682|454773729|FG000|Overall Study|Not treated|2|||
126403852|NCT01345682|454773730|FG001|Overall Study|Not treated|1|||
126403853|NCT01345682|454773729|FG000|Overall Study|Reason other than those specified above|4|||
126403854|NCT01345682|454773730|FG001|Overall Study|Reason other than those specified above|3|||
126403855|NCT00897390|454773733|FG000|Overall Study|Adverse Event|2|||
126403856|NCT00897390|454773733|FG000|Overall Study|No Longer Met Study Criteria|1|||
126403857|NCT00897390|454773733|FG000|Overall Study|Personal Reasons|1|||
126403858|NCT00897390|454773733|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
126403859|NCT00958217|454773737|FG000|Overall Study|Death|2|||
126403860|NCT00958217|454773738|FG001|Overall Study|Death|1|||
126403861|NCT00958217|454773737|FG000|Overall Study|Withdrawal by Subject|4|||
126403862|NCT00958217|454773738|FG001|Overall Study|Withdrawal by Subject|3|||
126403863|NCT00958217|454773737|FG000|Overall Study|Lost to Follow-up|17|||
126403864|NCT00958217|454773738|FG001|Overall Study|Lost to Follow-up|19|||
126403865|NCT00958217|454773737|FG000|Overall Study|Moved out of area|1|||
126403866|NCT00958217|454773738|FG001|Overall Study|Moved out of area|1|||
126403867|NCT00958217|454773737|FG000|Overall Study|Inpatient hospitalization|0|||
126403868|NCT00958217|454773738|FG001|Overall Study|Inpatient hospitalization|1|||
126403869|NCT01075984|454773741|FG000|Treatment Phase|Adverse Event|0|||
126403870|NCT01075984|454773742|FG001|Treatment Phase|Adverse Event|1|||
126403871|NCT01075984|454773743|FG002|Treatment Phase|Adverse Event|3|||
126403872|NCT01075984|454773744|FG003|Treatment Phase|Adverse Event|7|||
126403873|NCT01075984|454773745|FG004|Treatment Phase|Adverse Event|35|||
126403874|NCT01075984|454773741|FG000|Treatment Phase|Protocol Violation|0|||
126403875|NCT01075984|454773742|FG001|Treatment Phase|Protocol Violation|0|||
126403876|NCT01075984|454773743|FG002|Treatment Phase|Protocol Violation|1|||
126403877|NCT01075984|454773744|FG003|Treatment Phase|Protocol Violation|0|||
126403878|NCT01075984|454773745|FG004|Treatment Phase|Protocol Violation|3|||
126403879|NCT01075984|454773741|FG000|Treatment Phase|Withdrawal by Subject|0|||
126403880|NCT01075984|454773742|FG001|Treatment Phase|Withdrawal by Subject|0|||
126403881|NCT01075984|454773743|FG002|Treatment Phase|Withdrawal by Subject|2|||
126403882|NCT01075984|454773744|FG003|Treatment Phase|Withdrawal by Subject|0|||
126403883|NCT01075984|454773745|FG004|Treatment Phase|Withdrawal by Subject|15|||
126403884|NCT01075984|454773741|FG000|Treatment Phase|Treatment Failure|0|||
126403885|NCT01075984|454773742|FG001|Treatment Phase|Treatment Failure|0|||
126403886|NCT01075984|454773743|FG002|Treatment Phase|Treatment Failure|1|||
126403887|NCT01075984|454773744|FG003|Treatment Phase|Treatment Failure|0|||
126403888|NCT01075984|454773745|FG004|Treatment Phase|Treatment Failure|5|||
126403889|NCT01075984|454773741|FG000|Treatment Phase|Progression of disease|0|||
126403890|NCT01075984|454773742|FG001|Treatment Phase|Progression of disease|0|||
126403891|NCT01075984|454773743|FG002|Treatment Phase|Progression of disease|0|||
126403892|NCT01075984|454773744|FG003|Treatment Phase|Progression of disease|0|||
126403893|NCT01075984|454773745|FG004|Treatment Phase|Progression of disease|2|||
126403894|NCT01075984|454773741|FG000|Follow-up Phase|Protocol Violation|0|||
126403895|NCT01075984|454773742|FG001|Follow-up Phase|Protocol Violation|0|||
126403896|NCT01075984|454773743|FG002|Follow-up Phase|Protocol Violation|1|||
126403897|NCT01075984|454773744|FG003|Follow-up Phase|Protocol Violation|0|||
126403898|NCT01075984|454773745|FG004|Follow-up Phase|Protocol Violation|3|||
126403899|NCT01075984|454773741|FG000|Follow-up Phase|Adverse Event|0|||
126403900|NCT01075984|454773742|FG001|Follow-up Phase|Adverse Event|0|||
126403901|NCT01075984|454773743|FG002|Follow-up Phase|Adverse Event|0|||
126403902|NCT01075984|454773744|FG003|Follow-up Phase|Adverse Event|2|||
126403903|NCT01075984|454773745|FG004|Follow-up Phase|Adverse Event|27|||
126403904|NCT01075984|454773741|FG000|Follow-up Phase|Administrative|0|||
126403905|NCT01075984|454773742|FG001|Follow-up Phase|Administrative|0|||
126403906|NCT01075984|454773743|FG002|Follow-up Phase|Administrative|0|||
126403907|NCT01075984|454773744|FG003|Follow-up Phase|Administrative|0|||
126403908|NCT01075984|454773745|FG004|Follow-up Phase|Administrative|1|||
126403909|NCT01075984|454773741|FG000|Follow-up Phase|Withdrawal by Subject|0|||
126403910|NCT01075984|454773742|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126403911|NCT01075984|454773743|FG002|Follow-up Phase|Withdrawal by Subject|0|||
126403912|NCT01075984|454773744|FG003|Follow-up Phase|Withdrawal by Subject|0|||
126403913|NCT01075984|454773745|FG004|Follow-up Phase|Withdrawal by Subject|10|||
126403914|NCT01075984|454773741|FG000|Follow-up Phase|Progression of disease|0|||
126403915|NCT01075984|454773742|FG001|Follow-up Phase|Progression of disease|0|||
126403916|NCT01075984|454773743|FG002|Follow-up Phase|Progression of disease|0|||
126403917|NCT01075984|454773744|FG003|Follow-up Phase|Progression of disease|0|||
126403918|NCT01075984|454773745|FG004|Follow-up Phase|Progression of disease|2|||
126403919|NCT01075984|454773741|FG000|Follow-up Phase|Treatment failure|0|||
126403920|NCT01075984|454773742|FG001|Follow-up Phase|Treatment failure|0|||
126403921|NCT01075984|454773743|FG002|Follow-up Phase|Treatment failure|0|||
126403922|NCT01075984|454773744|FG003|Follow-up Phase|Treatment failure|0|||
126403923|NCT01075984|454773745|FG004|Follow-up Phase|Treatment failure|4|||
126403924|NCT02440789|454773746|FG000|Overall Study|Withdrawal by Subject|3|||
126403925|NCT02440789|454773746|FG000|Overall Study|Not willing to adhere to reqs|1|||
126403926|NCT04573881|454773748|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
126403927|NCT02564978|454773751|FG000|Overall Study|Adverse Event|8|||
126403928|NCT02564978|454773751|FG000|Overall Study|Death|1|||
126403929|NCT02564978|454773751|FG000|Overall Study|Lost to Follow-up|1|||
126403930|NCT02564978|454773751|FG000|Overall Study|Withdrawal by Subject|15|||
126403931|NCT02564978|454773751|FG000|Overall Study|Early Study Closure|2|||
126403932|NCT02564978|454773751|FG000|Overall Study|Other Reason|5|||
126403933|NCT03684694|454773752|FG000|Phase 1|Withdrawal by Subject|1|||
126403934|NCT03684694|454773753|FG001|Phase 1|Withdrawal by Subject|0|||
126403935|NCT03684694|454773754|FG002|Phase 1|Withdrawal by Subject|0|||
126403936|NCT03684694|454773755|FG003|Phase 1|Withdrawal by Subject|0|||
126403937|NCT03684694|454773756|FG004|Phase 1|Withdrawal by Subject|0|||
126403938|NCT03684694|454773757|FG005|Phase 1|Withdrawal by Subject|0|||
126403939|NCT03684694|454773752|FG000|Phase 1|Investigator/Sponsor Decision|12|||
126403940|NCT03684694|454773753|FG001|Phase 1|Investigator/Sponsor Decision|2|||
126403941|NCT03684694|454773754|FG002|Phase 1|Investigator/Sponsor Decision|1|||
126403942|NCT03684694|454773755|FG003|Phase 1|Investigator/Sponsor Decision|0|||
126403943|NCT03684694|454773756|FG004|Phase 1|Investigator/Sponsor Decision|0|||
126403944|NCT03684694|454773757|FG005|Phase 1|Investigator/Sponsor Decision|0|||
126403945|NCT03684694|454773752|FG000|Phase 1|Death|24|||
126403946|NCT03684694|454773753|FG001|Phase 1|Death|0|||
126403947|NCT03684694|454773754|FG002|Phase 1|Death|3|||
126403948|NCT03684694|454773755|FG003|Phase 1|Death|0|||
126403949|NCT03684694|454773756|FG004|Phase 1|Death|0|||
126403950|NCT03684694|454773757|FG005|Phase 1|Death|0|||
126403951|NCT03684694|454773752|FG000|Phase 1|Lost to Follow-up|0|||
126403952|NCT03684694|454773753|FG001|Phase 1|Lost to Follow-up|0|||
126403953|NCT03684694|454773754|FG002|Phase 1|Lost to Follow-up|1|||
126403954|NCT03684694|454773755|FG003|Phase 1|Lost to Follow-up|0|||
126403955|NCT03684694|454773756|FG004|Phase 1|Lost to Follow-up|0|||
126403956|NCT03684694|454773757|FG005|Phase 1|Lost to Follow-up|0|||
126403957|NCT03684694|454773752|FG000|Phase 1|Miscellaneous|0|||
126403958|NCT03684694|454773753|FG001|Phase 1|Miscellaneous|1|||
126403959|NCT03684694|454773754|FG002|Phase 1|Miscellaneous|0|||
126403960|NCT03684694|454773755|FG003|Phase 1|Miscellaneous|0|||
126403961|NCT03684694|454773756|FG004|Phase 1|Miscellaneous|0|||
126403962|NCT03684694|454773757|FG005|Phase 1|Miscellaneous|0|||
126403963|NCT03684694|454773752|FG000|Phase 2|Withdrawal by Subject|0|||
126403964|NCT03684694|454773753|FG001|Phase 2|Withdrawal by Subject|0|||
126403965|NCT03684694|454773754|FG002|Phase 2|Withdrawal by Subject|0|||
126403966|NCT03684694|454773755|FG003|Phase 2|Withdrawal by Subject|0|||
126403967|NCT03684694|454773756|FG004|Phase 2|Withdrawal by Subject|0|||
126403968|NCT03684694|454773757|FG005|Phase 2|Withdrawal by Subject|1|||
126403969|NCT03684694|454773752|FG000|Phase 2|Investigator/Sponsor Decision|0|||
126403970|NCT03684694|454773753|FG001|Phase 2|Investigator/Sponsor Decision|0|||
126403971|NCT03684694|454773754|FG002|Phase 2|Investigator/Sponsor Decision|0|||
126403972|NCT03684694|454773755|FG003|Phase 2|Investigator/Sponsor Decision|17|||
126403973|NCT03684694|454773756|FG004|Phase 2|Investigator/Sponsor Decision|16|||
126403974|NCT03684694|454773757|FG005|Phase 2|Investigator/Sponsor Decision|6|||
126403975|NCT03684694|454773752|FG000|Phase 2|Death|0|||
126403976|NCT03684694|454773753|FG001|Phase 2|Death|0|||
126403977|NCT03684694|454773754|FG002|Phase 2|Death|0|||
126403978|NCT03684694|454773755|FG003|Phase 2|Death|28|||
126403979|NCT03684694|454773756|FG004|Phase 2|Death|14|||
126403980|NCT03684694|454773757|FG005|Phase 2|Death|3|||
126403981|NCT03684694|454773752|FG000|Phase 2|Lost to Follow-up|0|||
126403982|NCT03684694|454773753|FG001|Phase 2|Lost to Follow-up|0|||
126403983|NCT03684694|454773754|FG002|Phase 2|Lost to Follow-up|0|||
126403984|NCT03684694|454773755|FG003|Phase 2|Lost to Follow-up|1|||
126403985|NCT03684694|454773756|FG004|Phase 2|Lost to Follow-up|0|||
126403986|NCT03684694|454773757|FG005|Phase 2|Lost to Follow-up|0|||
126403987|NCT03684694|454773752|FG000|Phase 2|Miscellaneous|0|||
126403988|NCT03684694|454773753|FG001|Phase 2|Miscellaneous|0|||
126403989|NCT03684694|454773754|FG002|Phase 2|Miscellaneous|0|||
126403990|NCT03684694|454773755|FG003|Phase 2|Miscellaneous|3|||
126403991|NCT03684694|454773756|FG004|Phase 2|Miscellaneous|0|||
126403992|NCT03684694|454773757|FG005|Phase 2|Miscellaneous|0|||
126403993|NCT01825941|454775560|FG000|Overall Study|Lost to Follow-up|4|||
126403994|NCT01825941|454775561|FG001|Overall Study|Lost to Follow-up|1|||
126403995|NCT00528996|454775562|FG000|Overall Study|Other reasons than listing|6|||
126403996|NCT00528996|454775563|FG001|Overall Study|Other reasons than listing|7|||
126403997|NCT00528996|454775564|FG002|Overall Study|Other reasons than listing|14|||
126403998|NCT00528996|454775565|FG003|Overall Study|Other reasons than listing|11|||
126403999|NCT00528996|454775566|FG004|Overall Study|Other reasons than listing|5|||
126404000|NCT00528996|454775562|FG000|Overall Study|Refused continue medication|16|||
126404001|NCT00528996|454775563|FG001|Overall Study|Refused continue medication|0|||
126404002|NCT00528996|454775564|FG002|Overall Study|Refused continue medication|3|||
126404003|NCT00528996|454775565|FG003|Overall Study|Refused continue medication|3|||
126404004|NCT00528996|454775566|FG004|Overall Study|Refused continue medication|6|||
126404005|NCT00528996|454775562|FG000|Overall Study|Lost to Follow-up|2|||
126404006|NCT00528996|454775563|FG001|Overall Study|Lost to Follow-up|0|||
126404007|NCT00528996|454775564|FG002|Overall Study|Lost to Follow-up|4|||
126404008|NCT00528996|454775565|FG003|Overall Study|Lost to Follow-up|1|||
126404009|NCT00528996|454775566|FG004|Overall Study|Lost to Follow-up|3|||
126404010|NCT00528996|454775562|FG000|Overall Study|Protocol Violation|1|||
126404011|NCT00528996|454775563|FG001|Overall Study|Protocol Violation|2|||
126404012|NCT00528996|454775564|FG002|Overall Study|Protocol Violation|3|||
126404013|NCT00528996|454775565|FG003|Overall Study|Protocol Violation|3|||
126404014|NCT00528996|454775566|FG004|Overall Study|Protocol Violation|2|||
126404015|NCT00528996|454775562|FG000|Overall Study|Lack of Efficacy|7|||
126404016|NCT00528996|454775563|FG001|Overall Study|Lack of Efficacy|2|||
126404017|NCT00528996|454775564|FG002|Overall Study|Lack of Efficacy|1|||
126404018|NCT00528996|454775565|FG003|Overall Study|Lack of Efficacy|3|||
126404019|NCT00528996|454775566|FG004|Overall Study|Lack of Efficacy|3|||
126404020|NCT00528996|454775562|FG000|Overall Study|Adverse Event|32|||
126404021|NCT00528996|454775563|FG001|Overall Study|Adverse Event|13|||
126404022|NCT00528996|454775564|FG002|Overall Study|Adverse Event|18|||
126404023|NCT00528996|454775565|FG003|Overall Study|Adverse Event|29|||
126404024|NCT00528996|454775566|FG004|Overall Study|Adverse Event|18|||
126404025|NCT01022424|454775570|FG000|Overall Study|Adverse Event|1|||
126404026|NCT01022424|454775570|FG000|Overall Study|Physician Decision|1|||
126404027|NCT01022424|454775570|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
126404028|NCT01806064|454775573|FG000|Overall Study|Randomized Not Enrolled|0|||
126404029|NCT01806064|454775574|FG001|Overall Study|Randomized Not Enrolled|0|||
126404030|NCT01806064|454775575|FG002|Overall Study|Randomized Not Enrolled|0|||
126404031|NCT01806064|454775576|FG003|Overall Study|Randomized Not Enrolled|1|||
126404032|NCT01806064|454775577|FG004|Overall Study|Randomized Not Enrolled|2|||
126404033|NCT05160766|454775580|FG000|Overall Study|Adverse Event|0|||
126404034|NCT05160766|454775581|FG001|Overall Study|Adverse Event|1|||
126404035|NCT05160766|454775582|FG002|Overall Study|Adverse Event|0|||
126404036|NCT05160766|454775583|FG003|Overall Study|Adverse Event|0|||
126404037|NCT05160766|454775580|FG000|Overall Study|COVID-19 infection|0|||
126404038|NCT05160766|454775581|FG001|Overall Study|COVID-19 infection|1|||
126404039|NCT05160766|454775582|FG002|Overall Study|COVID-19 infection|0|||
126404040|NCT05160766|454775583|FG003|Overall Study|COVID-19 infection|0|||
126404041|NCT05160766|454775580|FG000|Overall Study|travel time|1|||
126404042|NCT05160766|454775581|FG001|Overall Study|travel time|0|||
126404043|NCT05160766|454775582|FG002|Overall Study|travel time|0|||
126404044|NCT05160766|454775583|FG003|Overall Study|travel time|1|||
126404045|NCT05160766|454775580|FG000|Overall Study|Withdrawal by Subject|3|||
126404046|NCT05160766|454775581|FG001|Overall Study|Withdrawal by Subject|5|||
126404047|NCT05160766|454775582|FG002|Overall Study|Withdrawal by Subject|4|||
125890196|NCT02675634|452895463|FG004|Test Period 1|Adverse Event|0|||
126404048|NCT05160766|454775583|FG003|Overall Study|Withdrawal by Subject|2|||
126404049|NCT05160766|454775580|FG000|Overall Study|Death|0|||
126404050|NCT05160766|454775581|FG001|Overall Study|Death|0|||
126404051|NCT05160766|454775582|FG002|Overall Study|Death|2|||
126404052|NCT05160766|454775583|FG003|Overall Study|Death|5|||
126404053|NCT05160766|454775580|FG000|Overall Study|Lost to Follow-up|0|||
126404054|NCT05160766|454775581|FG001|Overall Study|Lost to Follow-up|0|||
126404055|NCT05160766|454775582|FG002|Overall Study|Lost to Follow-up|1|||
125890197|NCT02675634|452895464|FG005|Test Period 1|Adverse Event|0|||
126404056|NCT05160766|454775583|FG003|Overall Study|Lost to Follow-up|2|||
126404057|NCT05160766|454775580|FG000|Overall Study|No show|0|||
126404058|NCT05160766|454775581|FG001|Overall Study|No show|0|||
126404059|NCT05160766|454775582|FG002|Overall Study|No show|1|||
126404060|NCT05160766|454775583|FG003|Overall Study|No show|1|||
126404061|NCT05160766|454775580|FG000|Overall Study|Physician Decision|0|||
126404062|NCT05160766|454775581|FG001|Overall Study|Physician Decision|0|||
126404063|NCT05160766|454775582|FG002|Overall Study|Physician Decision|0|||
126404064|NCT05160766|454775583|FG003|Overall Study|Physician Decision|1|||
126404065|NCT05160766|454775580|FG000|Overall Study|Protocol Violation|0|||
126404066|NCT05160766|454775581|FG001|Overall Study|Protocol Violation|0|||
126404067|NCT05160766|454775582|FG002|Overall Study|Protocol Violation|1|||
126404068|NCT05160766|454775583|FG003|Overall Study|Protocol Violation|0|||
126404069|NCT02943915|454775584|FG000|Overall Study|Withdrawal by Subject|2|||
126404070|NCT02943915|454775585|FG001|Overall Study|Withdrawal by Subject|1|||
126404071|NCT02943915|454775586|FG002|Overall Study|Withdrawal by Subject|0|||
126404072|NCT02943915|454775587|FG003|Overall Study|Withdrawal by Subject|0|||
126404073|NCT02943915|454775584|FG000|Overall Study|Lost to Follow-up|3|||
126404074|NCT02943915|454775585|FG001|Overall Study|Lost to Follow-up|1|||
126404075|NCT02943915|454775586|FG002|Overall Study|Lost to Follow-up|0|||
126404076|NCT02943915|454775587|FG003|Overall Study|Lost to Follow-up|0|||
126404077|NCT02943915|454775584|FG000|Overall Study|excluded|0|||
126404078|NCT02943915|454775585|FG001|Overall Study|excluded|1|||
126404079|NCT02943915|454775586|FG002|Overall Study|excluded|0|||
126404080|NCT02943915|454775587|FG003|Overall Study|excluded|0|||
126404081|NCT00004445|454775589|FG000|Overall Study|Physician Decision|2|||
126404082|NCT00004445|454775589|FG000|Overall Study|Withdrawal by Subject|1|||
126404083|NCT02753127|454775590|FG000|Overall Study|Lost to Follow-up|13|||
126404084|NCT02753127|454775591|FG001|Overall Study|Lost to Follow-up|11|||
126404085|NCT02753127|454775590|FG000|Overall Study|Withdrawal by Subject|37|||
126404086|NCT02753127|454775591|FG001|Overall Study|Withdrawal by Subject|47|||
126404087|NCT02753127|454775590|FG000|Overall Study|Other|3|||
126404088|NCT02753127|454775591|FG001|Overall Study|Other|8|||
126404089|NCT02753127|454775590|FG000|Overall Study|Hospice|0|||
126404090|NCT02753127|454775591|FG001|Overall Study|Hospice|2|||
126404091|NCT03826342|454775592|FG000|Overall Study|Withdrawal by Subject|8|||
126404092|NCT03826342|454775593|FG001|Overall Study|Withdrawal by Subject|1|||
126404093|NCT03826342|454775592|FG000|Overall Study|Lost to Follow-up|7|||
126404094|NCT03826342|454775593|FG001|Overall Study|Lost to Follow-up|7|||
126404095|NCT03826342|454775592|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
126404096|NCT03826342|454775593|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
126404097|NCT01818284|454775594|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
126404098|NCT01818284|454775595|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
126404099|NCT01818284|454775594|FG000|Overall Study|Death|0|||
126404100|NCT01818284|454775595|FG001|Overall Study|Death|2|||
126404101|NCT03681678|454775596|FG000|Overall Study|Lost to Follow-up|20|||
126404102|NCT04030962|454775598|FG000|Stage 2|Adverse Event|0|||
126404103|NCT04030962|454775599|FG001|Stage 2|Adverse Event|0|||
126404104|NCT04030962|454775600|FG002|Stage 2|Adverse Event|0|||
126404105|NCT04030962|454775601|FG003|Stage 2|Adverse Event|0|||
126404106|NCT04030962|454775602|FG004|Stage 2|Adverse Event|0|||
126404107|NCT04030962|454775603|FG005|Stage 2|Adverse Event|0|||
126404108|NCT04030962|454775604|FG006|Stage 2|Adverse Event|0|||
126404109|NCT04030962|454775605|FG007|Stage 2|Adverse Event|0|||
126404110|NCT04030962|454775606|FG008|Stage 2|Adverse Event|1|||
126404111|NCT04030962|454775607|FG009|Stage 2|Adverse Event|0|||
126404112|NCT04030962|454775608|FG010|Stage 2|Adverse Event|1|||
126404113|NCT04030962|454775609|FG011|Stage 2|Adverse Event|1|||
126404114|NCT04030962|454775610|FG012|Stage 2|Adverse Event|1|||
126404115|NCT04030962|454775598|FG000|Stage 2|Withdrawal by Subject|0|||
126404116|NCT04030962|454775599|FG001|Stage 2|Withdrawal by Subject|0|||
126404117|NCT04030962|454775600|FG002|Stage 2|Withdrawal by Subject|0|||
126404118|NCT04030962|454775601|FG003|Stage 2|Withdrawal by Subject|0|||
126404119|NCT04030962|454775602|FG004|Stage 2|Withdrawal by Subject|0|||
126404120|NCT04030962|454775603|FG005|Stage 2|Withdrawal by Subject|0|||
126404121|NCT04030962|454775604|FG006|Stage 2|Withdrawal by Subject|0|||
126404122|NCT04030962|454775605|FG007|Stage 2|Withdrawal by Subject|0|||
126404123|NCT04030962|454775606|FG008|Stage 2|Withdrawal by Subject|1|||
126404124|NCT04030962|454775607|FG009|Stage 2|Withdrawal by Subject|0|||
126404125|NCT04030962|454775608|FG010|Stage 2|Withdrawal by Subject|0|||
125890198|NCT02675634|452895459|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
125890199|NCT02675634|452895460|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
126404126|NCT04030962|454775609|FG011|Stage 2|Withdrawal by Subject|2|||
126404127|NCT04030962|454775610|FG012|Stage 2|Withdrawal by Subject|1|||
126404128|NCT04030962|454775598|FG000|Stage 2|Lost to Follow-up|0|||
125890200|NCT02675634|452895461|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
126404129|NCT04030962|454775599|FG001|Stage 2|Lost to Follow-up|0|||
126404130|NCT04030962|454775600|FG002|Stage 2|Lost to Follow-up|0|||
126404131|NCT04030962|454775601|FG003|Stage 2|Lost to Follow-up|0|||
126404132|NCT04030962|454775602|FG004|Stage 2|Lost to Follow-up|0|||
126404133|NCT04030962|454775603|FG005|Stage 2|Lost to Follow-up|0|||
126404134|NCT04030962|454775604|FG006|Stage 2|Lost to Follow-up|0|||
126404135|NCT04030962|454775605|FG007|Stage 2|Lost to Follow-up|0|||
126404136|NCT04030962|454775606|FG008|Stage 2|Lost to Follow-up|1|||
126404137|NCT04030962|454775607|FG009|Stage 2|Lost to Follow-up|0|||
126404138|NCT04030962|454775608|FG010|Stage 2|Lost to Follow-up|0|||
126404139|NCT04030962|454775609|FG011|Stage 2|Lost to Follow-up|0|||
126404140|NCT04030962|454775610|FG012|Stage 2|Lost to Follow-up|0|||
126404141|NCT04030962|454775598|FG000|Stage 2|Technical Problems|0|||
126404142|NCT04030962|454775599|FG001|Stage 2|Technical Problems|0|||
126404143|NCT04030962|454775600|FG002|Stage 2|Technical Problems|0|||
126404144|NCT04030962|454775601|FG003|Stage 2|Technical Problems|0|||
126404145|NCT04030962|454775602|FG004|Stage 2|Technical Problems|0|||
126404146|NCT04030962|454775603|FG005|Stage 2|Technical Problems|0|||
126404147|NCT04030962|454775604|FG006|Stage 2|Technical Problems|0|||
126404148|NCT04030962|454775605|FG007|Stage 2|Technical Problems|0|||
126404149|NCT04030962|454775606|FG008|Stage 2|Technical Problems|0|||
126404150|NCT04030962|454775607|FG009|Stage 2|Technical Problems|0|||
126404151|NCT04030962|454775608|FG010|Stage 2|Technical Problems|0|||
126404152|NCT04030962|454775609|FG011|Stage 2|Technical Problems|1|||
126404153|NCT04030962|454775610|FG012|Stage 2|Technical Problems|0|||
126404154|NCT05288166|454775611|FG000|Overall Study|Adverse Event|1|||
126404155|NCT05288166|454775612|FG001|Overall Study|Adverse Event|0|||
126404156|NCT05288166|454775611|FG000|Overall Study|Lost to Follow-up|2|||
126404157|NCT05288166|454775612|FG001|Overall Study|Lost to Follow-up|0|||
126404158|NCT05288166|454775611|FG000|Overall Study|Physician Decision|0|||
126404159|NCT05288166|454775612|FG001|Overall Study|Physician Decision|2|||
126404160|NCT05288166|454775611|FG000|Overall Study|Screen Failure|1|||
126404161|NCT05288166|454775612|FG001|Overall Study|Screen Failure|1|||
126404162|NCT05288166|454775611|FG000|Overall Study|Withdrawal by Subject|4|||
126404163|NCT05288166|454775612|FG001|Overall Study|Withdrawal by Subject|2|||
126404164|NCT05288166|454775611|FG000|Overall Study|On Study Treatment|408|||
126404165|NCT05288166|454775612|FG001|Overall Study|On Study Treatment|418|||
126404166|NCT01114360|454775613|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
126404167|NCT01114360|454775614|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
126404168|NCT03007745|454775615|FG000|Overall Study|Sleep test negative for OSA|53|||
126404169|NCT03007745|454775616|FG001|Overall Study|Sleep test negative for OSA|49|||
126404170|NCT03007745|454775615|FG000|Overall Study|Physician Decision|6|||
126404171|NCT03007745|454775616|FG001|Overall Study|Physician Decision|9|||
126404172|NCT03007745|454775615|FG000|Overall Study|Withdrawal by Subject|38|||
126404173|NCT03007745|454775616|FG001|Overall Study|Withdrawal by Subject|16|||
126404174|NCT03007745|454775615|FG000|Overall Study|Lost to Follow-up|19|||
126404175|NCT03007745|454775616|FG001|Overall Study|Lost to Follow-up|25|||
126404176|NCT03007745|454775615|FG000|Overall Study|Unable to login to website|17|||
126404177|NCT03007745|454775616|FG001|Overall Study|Unable to login to website|4|||
126404178|NCT01146288|454775618|FG000|First Intervention(1 Day)|Adverse Event|0|||
125890201|NCT02675634|452895462|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
126404179|NCT01146288|454775619|FG001|First Intervention(1 Day)|Adverse Event|1|||
126404180|NCT00385723|454775620|FG000|Overall Study|Lost to Follow-up|1|||
126404181|NCT00385723|454775621|FG001|Overall Study|Lost to Follow-up|1|||
126404182|NCT00385723|454775622|FG002|Overall Study|Lost to Follow-up|0|||
126404183|NCT00385723|454775620|FG000|Overall Study|Withdrawal by Subject|1|||
126404184|NCT00385723|454775621|FG001|Overall Study|Withdrawal by Subject|0|||
126404185|NCT00385723|454775622|FG002|Overall Study|Withdrawal by Subject|2|||
126404186|NCT03455829|454775623|FG000|Overall Study|Death|2|||
126404187|NCT03455829|454775624|FG001|Overall Study|Death|3|||
126404188|NCT03455829|454775625|FG002|Overall Study|Death|2|||
126404189|NCT03455829|454775626|FG003|Overall Study|Death|4|||
126404190|NCT03455829|454775627|FG004|Overall Study|Death|2|||
126404191|NCT03455829|454775623|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
126404192|NCT03455829|454775624|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
126404193|NCT03455829|454775625|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
126404194|NCT03455829|454775626|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
126404195|NCT03455829|454775627|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
126404196|NCT03455829|454775623|FG000|Overall Study|Disease progression|0|||
126404197|NCT03455829|454775624|FG001|Overall Study|Disease progression|0|||
126404198|NCT03455829|454775625|FG002|Overall Study|Disease progression|0|||
126404199|NCT03455829|454775626|FG003|Overall Study|Disease progression|1|||
126404200|NCT03455829|454775627|FG004|Overall Study|Disease progression|1|||
126404201|NCT05824936|454775629|FG000|Overall Study|Lost to Follow-up|1|||
126404202|NCT03689712|454775630|FG000|Overall Study|Adverse Event|1|||
126404203|NCT03689712|454775631|FG001|Overall Study|Adverse Event|0|||
126404204|NCT03689712|454775630|FG000|Overall Study|Death|20|||
126404205|NCT03689712|454775631|FG001|Overall Study|Death|10|||
126404206|NCT03689712|454775630|FG000|Overall Study|Lost to Follow-up|6|||
126404207|NCT03689712|454775631|FG001|Overall Study|Lost to Follow-up|6|||
126404208|NCT03689712|454775630|FG000|Overall Study|Other|1|||
126404209|NCT03689712|454775631|FG001|Overall Study|Other|0|||
126404210|NCT03689712|454775630|FG000|Overall Study|Patient Non-Compliance|0|||
126404211|NCT03689712|454775631|FG001|Overall Study|Patient Non-Compliance|1|||
126404212|NCT03689712|454775630|FG000|Overall Study|Withdrawal by Subject|20|||
126404213|NCT03689712|454775631|FG001|Overall Study|Withdrawal by Subject|4|||
126404214|NCT03689712|454775630|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
126404215|NCT03689712|454775631|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
126404216|NCT03689712|454775630|FG000|Overall Study|Randomized but not Treated|13|||
126404217|NCT03689712|454775631|FG001|Overall Study|Randomized but not Treated|7|||
126404218|NCT03689712|454775630|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
126404219|NCT03689712|454775631|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
126404220|NCT01533922|454775635|FG000|Overall Study|Adverse Event|5|||
126404221|NCT01533922|454775636|FG001|Overall Study|Adverse Event|8|||
126404222|NCT01533922|454775637|FG002|Overall Study|Adverse Event|6|||
126404223|NCT01533922|454775638|FG003|Overall Study|Adverse Event|3|||
126404224|NCT01533922|454775639|FG004|Overall Study|Adverse Event|4|||
126404225|NCT01533922|454775635|FG000|Overall Study|Lack of Efficacy|0|||
126404226|NCT01533922|454775636|FG001|Overall Study|Lack of Efficacy|0|||
126404227|NCT01533922|454775637|FG002|Overall Study|Lack of Efficacy|1|||
126404228|NCT01533922|454775638|FG003|Overall Study|Lack of Efficacy|0|||
126404229|NCT01533922|454775639|FG004|Overall Study|Lack of Efficacy|0|||
126404230|NCT01533922|454775635|FG000|Overall Study|Protocol Violation|0|||
126404231|NCT01533922|454775636|FG001|Overall Study|Protocol Violation|3|||
126404232|NCT01533922|454775637|FG002|Overall Study|Protocol Violation|0|||
126404233|NCT01533922|454775638|FG003|Overall Study|Protocol Violation|0|||
126404234|NCT01533922|454775639|FG004|Overall Study|Protocol Violation|1|||
126404235|NCT01533922|454775635|FG000|Overall Study|Withdrawal by Subject|3|||
126404236|NCT01533922|454775636|FG001|Overall Study|Withdrawal by Subject|1|||
126404237|NCT01533922|454775637|FG002|Overall Study|Withdrawal by Subject|2|||
126404238|NCT01533922|454775638|FG003|Overall Study|Withdrawal by Subject|2|||
126404239|NCT01533922|454775639|FG004|Overall Study|Withdrawal by Subject|1|||
126404240|NCT01533922|454775635|FG000|Overall Study|Other reason not defined above|2|||
126404241|NCT01533922|454775636|FG001|Overall Study|Other reason not defined above|0|||
126404242|NCT01533922|454775637|FG002|Overall Study|Other reason not defined above|1|||
126404243|NCT01533922|454775638|FG003|Overall Study|Other reason not defined above|0|||
126404244|NCT01533922|454775639|FG004|Overall Study|Other reason not defined above|0|||
126404245|NCT02634606|454775640|FG000|Overall Study|unable to obtain the drug at start|13|||
126404246|NCT00286221|454775641|FG000|Overall Study|Protocol Violation|2|||
126404247|NCT00286221|454775642|FG001|Overall Study|Protocol Violation|1|||
126404248|NCT00286221|454775643|FG002|Overall Study|Protocol Violation|6|||
126404249|NCT00286221|454775644|FG003|Overall Study|Protocol Violation|4|||
126404250|NCT00286221|454775641|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
126404251|NCT00286221|454775642|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
126404252|NCT00286221|454775643|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
126404253|NCT00286221|454775644|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
126404254|NCT00286221|454775641|FG000|Overall Study|Inability to trigger PCA|2|||
126404255|NCT00286221|454775642|FG001|Overall Study|Inability to trigger PCA|0|||
126404256|NCT00286221|454775643|FG002|Overall Study|Inability to trigger PCA|0|||
126404257|NCT00286221|454775644|FG003|Overall Study|Inability to trigger PCA|0|||
126404258|NCT00286221|454775641|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
126404259|NCT00286221|454775642|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
126404260|NCT00286221|454775643|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
126404261|NCT00286221|454775644|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
126404262|NCT02553538|454775646|FG000|Overall Study|Could Not Reach by Telephone|133|||
126404263|NCT02553538|454775647|FG001|Overall Study|Could Not Reach by Telephone|0|||
126404264|NCT02553538|454775646|FG000|Overall Study|Died or Left Network|54|||
126404265|NCT02553538|454775647|FG001|Overall Study|Died or Left Network|56|||
126404266|NCT02276547|454775648|FG000|Overall Study|Death|2|||
126404267|NCT02276547|454775648|FG000|Overall Study|Explant|2|||
126404268|NCT01754194|454775649|FG000|Overall Study|Lost to Follow-up|39|||
126404269|NCT01754194|454775650|FG001|Overall Study|Lost to Follow-up|14|||
126404270|NCT01754194|454775649|FG000|Overall Study|Withdrawal by Subject|4|||
126404271|NCT01754194|454775650|FG001|Overall Study|Withdrawal by Subject|5|||
126404272|NCT01754194|454775649|FG000|Overall Study|Other|9|||
126404273|NCT01754194|454775650|FG001|Overall Study|Other|8|||
126404274|NCT02066129|454775652|FG000|Overall Study|Lost to Follow-up|13|||
126404275|NCT02066129|454775653|FG001|Overall Study|Lost to Follow-up|12|||
126404276|NCT02066129|454775652|FG000|Overall Study|Withdrawal by Subject|7|||
126404277|NCT02066129|454775653|FG001|Overall Study|Withdrawal by Subject|10|||
126404278|NCT02066129|454775652|FG000|Overall Study|Lack of Efficacy|8|||
126404279|NCT02066129|454775653|FG001|Overall Study|Lack of Efficacy|10|||
126404280|NCT02066129|454775652|FG000|Overall Study|Physician Decision|1|||
126404281|NCT02066129|454775653|FG001|Overall Study|Physician Decision|1|||
126404282|NCT03344640|454775654|FG000|Overall Study|Adverse Event|1|||
126404283|NCT03344640|454775655|FG001|Overall Study|Adverse Event|0|||
126404284|NCT03344640|454775654|FG000|Overall Study|Physician Decision|1|||
126404285|NCT03344640|454775655|FG001|Overall Study|Physician Decision|1|||
126404286|NCT03344640|454775654|FG000|Overall Study|Withdrawal by Subject|1|||
126404287|NCT03344640|454775655|FG001|Overall Study|Withdrawal by Subject|2|||
126404288|NCT03344640|454775654|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
126404289|NCT03344640|454775655|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
126404290|NCT00357656|454775656|FG000|Overall Study|Other, No surgery performed|0|||
126404291|NCT00357656|454775657|FG001|Overall Study|Other, No surgery performed|3|||
126404292|NCT02573246|454775658|FG000|Overall Study|Lost to Follow-up|2|||
126404293|NCT02573246|454775659|FG001|Overall Study|Lost to Follow-up|0|||
126404294|NCT02573246|454775660|FG002|Overall Study|Lost to Follow-up|0|||
126404295|NCT02573246|454775661|FG003|Overall Study|Lost to Follow-up|0|||
126404296|NCT02573246|454775662|FG004|Overall Study|Lost to Follow-up|1|||
126404297|NCT02573246|454775658|FG000|Overall Study|Withdrawal by Subject|0|||
126404298|NCT02573246|454775659|FG001|Overall Study|Withdrawal by Subject|0|||
126404299|NCT02573246|454775660|FG002|Overall Study|Withdrawal by Subject|0|||
126404300|NCT02573246|454775661|FG003|Overall Study|Withdrawal by Subject|0|||
126404301|NCT02573246|454775662|FG004|Overall Study|Withdrawal by Subject|1|||
126404302|NCT02573246|454775658|FG000|Overall Study|Physician Decision|1|||
126404303|NCT02573246|454775659|FG001|Overall Study|Physician Decision|1|||
126404304|NCT02573246|454775660|FG002|Overall Study|Physician Decision|3|||
126404305|NCT02573246|454775661|FG003|Overall Study|Physician Decision|2|||
126404306|NCT02573246|454775662|FG004|Overall Study|Physician Decision|2|||
126404307|NCT01219933|454775663|FG000|Overall Study|Adverse Event|8|||
126404308|NCT01219933|454775663|FG000|Overall Study|No LDA reached|5|||
126404309|NCT01219933|454775663|FG000|Overall Study|No LDA maintained|7|||
126404310|NCT01219933|454775663|FG000|Overall Study|Lost to Follow-up|3|||
126404311|NCT01219933|454775663|FG000|Overall Study|GC free|1|||
126404312|NCT01219933|454775663|FG000|Overall Study|Withdrawal by Subject|5|||
126404313|NCT01219933|454775663|FG000|Overall Study|Protocol Violation|8|||
126404314|NCT01219933|454775663|FG000|Overall Study|Lack of Efficacy|1|||
126404315|NCT01902888|454775667|FG000|Overall Study|Study Terminated|3|||
126404316|NCT00316888|454775668|FG000|Overall Study|Adverse Event|4|||
126404317|NCT00316888|454775669|FG001|Overall Study|Adverse Event|5|||
126404318|NCT00316888|454775668|FG000|Overall Study|Withdrawal by Subject|2|||
126404319|NCT00316888|454775669|FG001|Overall Study|Withdrawal by Subject|2|||
126404320|NCT00316888|454775668|FG000|Overall Study|Not start protocol therapy|0|||
126404321|NCT00316888|454775669|FG001|Overall Study|Not start protocol therapy|1|||
126404322|NCT03149003|454775670|FG000|Overall Study|Randomized but not treated|0|||
126404323|NCT03149003|454775671|FG001|Overall Study|Randomized but not treated|1|||
126404324|NCT03149003|454775672|FG002|Overall Study|Randomized but not treated|18|||
126404325|NCT00815191|454775673|FG000|Overall Study|Protocol Violation|1|||
126404326|NCT00815191|454775674|FG001|Overall Study|Protocol Violation|1|||
126404327|NCT01814670|454775677|FG000|Overall Study|Protocol Violation|12|||
126404328|NCT01565941|454775678|FG000|Overall Study|Withdrawn by parent/guardian|3|||
126404329|NCT01565941|454775679|FG001|Overall Study|Withdrawn by parent/guardian|2|||
126404330|NCT01565941|454775678|FG000|Overall Study|Randomized; did not receive intevention|8|||
126404331|NCT01565941|454775679|FG001|Overall Study|Randomized; did not receive intevention|2|||
126404332|NCT04047420|454775680|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
126404333|NCT04047420|454775680|FG000|Washout Period|Refused Participation|2|||
126404334|NCT03443427|454775681|FG000|Overall Study|Adverse Event|2|||
126404335|NCT03443427|454775682|FG001|Overall Study|Adverse Event|3|||
126404336|NCT03443427|454775681|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
126404337|NCT03443427|454775682|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
126404338|NCT03443427|454775681|FG000|Overall Study|Other|4|||
126404339|NCT03443427|454775682|FG001|Overall Study|Other|6|||
126404340|NCT02576860|454775683|FG000|Overall Study|Adverse Event|6|||
126404341|NCT02576860|454775684|FG001|Overall Study|Adverse Event|6|||
126404342|NCT02576860|454775683|FG000|Overall Study|Lost to Follow-up|5|||
126404343|NCT02576860|454775684|FG001|Overall Study|Lost to Follow-up|7|||
126404344|NCT02576860|454775683|FG000|Overall Study|Physician Decision|0|||
126404345|NCT02576860|454775684|FG001|Overall Study|Physician Decision|1|||
126404346|NCT02576860|454775683|FG000|Overall Study|Protocol Violation|0|||
126404347|NCT02576860|454775684|FG001|Overall Study|Protocol Violation|2|||
126404348|NCT02576860|454775683|FG000|Overall Study|Withdrawal by Subject|13|||
126404349|NCT02576860|454775684|FG001|Overall Study|Withdrawal by Subject|8|||
126404350|NCT02576860|454775683|FG000|Overall Study|Disallowed medication|1|||
126404351|NCT02576860|454775684|FG001|Overall Study|Disallowed medication|0|||
126404352|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
126404353|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
126404354|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
126404355|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
126404356|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
126404357|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
126404358|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
126404359|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
126404360|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
126404361|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
126404362|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
126404363|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
126404364|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
126404365|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
126404366|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
126404367|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
126404368|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
126404369|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
126404370|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
126404371|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
126404372|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
126404373|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
126404374|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
126404375|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
126404376|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
126404377|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
126404378|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
126404379|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
126404380|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
126404381|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
126404382|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Other Reason|1|||
126404383|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Other Reason|0|||
126404384|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Other Reason|0|||
126404385|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Other Reason|0|||
126404386|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Other Reason|0|||
126404387|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
126404388|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
126404389|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
126404390|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
126404391|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
126404392|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
126404393|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
126404394|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
126404395|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
126404396|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
126404397|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
126404398|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
126404399|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
126404400|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
126404401|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
126404402|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
126404403|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
126404404|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
126404405|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
126404406|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
126404407|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
126404408|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
126404409|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
126404410|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
126404411|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
126404412|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
126404413|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
126404414|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
126404415|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
126404416|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
126404417|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
126404418|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
126404419|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
126404420|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
126404421|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
126404422|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
126404423|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
126404424|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
126404425|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
126404426|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
126404427|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Death|0|||
126404428|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Death|0|||
126404429|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Death|0|||
126404430|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Death|1|||
126404431|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Death|0|||
126404432|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Missing|0|||
126404433|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Missing|0|||
126404434|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Missing|1|||
126404435|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Missing|0|||
126404436|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Missing|0|||
126404437|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
126404438|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
126404439|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
126404440|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
126404441|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
126404442|NCT02356887|454775737|FG000|Overall Study|poor compliance|2|||
126404443|NCT00199888|454775740|FG000|Overall Study|Lost to Follow-up|1|||
126404444|NCT02544373|454775744|FG000|Overall Study|Lost to Follow-up|5|||
126404445|NCT02544373|454775745|FG001|Overall Study|Lost to Follow-up|3|||
126404446|NCT02544373|454775744|FG000|Overall Study|Withdrawal by Subject|8|||
126404447|NCT02544373|454775745|FG001|Overall Study|Withdrawal by Subject|2|||
126404448|NCT03172130|454776729|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
126404449|NCT03172130|454776730|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
126404450|NCT02831933|454776734|FG000|Overall Study|Physician Decision|11|||
126404451|NCT04619004|454776741|FG000|Overall Study|Death|114|||
126404452|NCT04619004|454776742|FG001|Overall Study|Death|28|||
126404453|NCT04619004|454776741|FG000|Overall Study|Lost to Follow-up|1|||
126404454|NCT04619004|454776742|FG001|Overall Study|Lost to Follow-up|1|||
126404455|NCT04619004|454776741|FG000|Overall Study|Withdrawal by Subject|24|||
126404456|NCT04619004|454776742|FG001|Overall Study|Withdrawal by Subject|7|||
126404457|NCT04619004|454776741|FG000|Overall Study|Other - Not specified|0|||
126404458|NCT04619004|454776742|FG001|Overall Study|Other - Not specified|1|||
126404459|NCT05601102|454776744|FG000|Overall Study|Death|1|||
126404460|NCT05601102|454776745|FG001|Overall Study|Death|2|||
126404461|NCT05601102|454776744|FG000|Overall Study|Withdrawal by Subject|1|||
126404462|NCT05601102|454776745|FG001|Overall Study|Withdrawal by Subject|1|||
126404463|NCT05601102|454776744|FG000|Overall Study|Lost to Follow-up|0|||
126404464|NCT05601102|454776745|FG001|Overall Study|Lost to Follow-up|2|||
126404465|NCT02981524|454776747|FG000|Overall Study|Progressive Disease|14|||
126404466|NCT02981524|454776747|FG000|Overall Study|Death (unrelated)|1|||
126404467|NCT02981524|454776747|FG000|Overall Study|Treatment Related Toxicity|1|||
126404468|NCT02981524|454776747|FG000|Overall Study|Withdrawal by Subject|1|||
126404469|NCT00483041|454776748|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
126404470|NCT00483041|454776749|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
126404471|NCT02258529|454776752|FG000|Overall Study|Study Terminated by Sponsor|9|||
126404472|NCT02258529|454776752|FG000|Overall Study|Adverse Event|1|||
126404473|NCT00413010|454776753|FG000|Overall Study|Adverse Event|8|||
126404474|NCT00413010|454776754|FG001|Overall Study|Adverse Event|4|||
126404475|NCT00413010|454776753|FG000|Overall Study|Laboratory abnormality|0|||
126404476|NCT00413010|454776754|FG001|Overall Study|Laboratory abnormality|2|||
126404477|NCT00413010|454776753|FG000|Overall Study|Lack of Efficacy|0|||
126404478|NCT00413010|454776754|FG001|Overall Study|Lack of Efficacy|3|||
126404479|NCT00413010|454776753|FG000|Overall Study|Lost to Follow-up|3|||
126404480|NCT00413010|454776754|FG001|Overall Study|Lost to Follow-up|0|||
126404481|NCT00413010|454776753|FG000|Overall Study|Withdrawal by Subject|7|||
126404482|NCT00413010|454776754|FG001|Overall Study|Withdrawal by Subject|2|||
126404483|NCT00413010|454776753|FG000|Overall Study|Due to termination of the study|54|||
126404484|NCT00413010|454776754|FG001|Overall Study|Due to termination of the study|52|||
126404485|NCT00708734|454776757|FG000|Overall Study|scheduling conflict|2|||
126404486|NCT00708734|454776757|FG000|Overall Study|moved|1|||
126404487|NCT00708734|454776757|FG000|Overall Study|leg injury|1|||
126404488|NCT00708734|454776757|FG000|Overall Study|knee replacement|1|||
126404489|NCT00708734|454776757|FG000|Overall Study|vertigo|1|||
126404490|NCT00708734|454776757|FG000|Overall Study|leg fracture|1|||
126404491|NCT05432167|454776758|FG000|Overall Study|Adverse Event|0|||
126404492|NCT05432167|454776759|FG001|Overall Study|Adverse Event|2|||
126404493|NCT05432167|454776760|FG002|Overall Study|Adverse Event|1|||
126404494|NCT05432167|454776758|FG000|Overall Study|Lost to Follow-up|3|||
126404495|NCT05432167|454776759|FG001|Overall Study|Lost to Follow-up|3|||
126404496|NCT05432167|454776760|FG002|Overall Study|Lost to Follow-up|2|||
126404497|NCT05432167|454776758|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
126404498|NCT05432167|454776759|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
126404499|NCT05432167|454776760|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
126404500|NCT05432167|454776758|FG000|Overall Study|Physician Decision|1|||
126404501|NCT05432167|454776759|FG001|Overall Study|Physician Decision|0|||
126404502|NCT05432167|454776760|FG002|Overall Study|Physician Decision|0|||
126404503|NCT05432167|454776758|FG000|Overall Study|Withdrawal by Subject|7|||
126404504|NCT05432167|454776759|FG001|Overall Study|Withdrawal by Subject|4|||
126404505|NCT05432167|454776760|FG002|Overall Study|Withdrawal by Subject|11|||
126404506|NCT05432167|454776758|FG000|Overall Study|Other|0|||
126404507|NCT05432167|454776759|FG001|Overall Study|Other|0|||
126404508|NCT05432167|454776760|FG002|Overall Study|Other|1|||
126404509|NCT01267175|454776762|FG000|Overall Study|Withdrawal by Subject|1|||
126404510|NCT01267175|454776762|FG000|Overall Study|Lost to Follow-up|1|||
126404511|NCT00895661|454776763|FG000|Overall Study|Death|1|||
126404512|NCT00895661|454776763|FG000|Overall Study|reason unknown|2|||
126404513|NCT04094584|454776766|FG000|Overall Study|No interest in study|88|||
126404514|NCT04094584|454776766|FG000|Overall Study|Unwilling to undergo screening tests|36|||
126404515|NCT04094584|454776766|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
126404516|NCT04094584|454776766|FG000|Overall Study|Opioid use|7|||
126404517|NCT04094584|454776766|FG000|Overall Study|Need for major surgery in study period|4|||
126404518|NCT04094584|454776766|FG000|Overall Study|eligible but declined enrollment|4|||
126404519|NCT04094584|454776766|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
126404520|NCT04094584|454776766|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
126404521|NCT04094584|454776766|FG000|Overall Study|Lost to Follow-up|3|||
126404522|NCT04094584|454776766|FG000|Overall Study|Withdrawal by Subject|2|||
126404523|NCT02690649|454776767|FG000|Overall Study|Withdrawal by Subject|1|||
126404524|NCT02690649|454776768|FG001|Overall Study|Withdrawal by Subject|1|||
126404525|NCT02690649|454776767|FG000|Overall Study|Protocol Violation|0|||
126404526|NCT02690649|454776768|FG001|Overall Study|Protocol Violation|3|||
126404527|NCT00907296|454776769|FG000|Overall Study|Ineligibility Determined|1|||
126404528|NCT00907296|454776770|FG001|Overall Study|Ineligibility Determined|0|||
126404529|NCT00907296|454776771|FG002|Overall Study|Ineligibility Determined|0|||
126404530|NCT00907296|454776772|FG003|Overall Study|Ineligibility Determined|1|||
126404531|NCT00907296|454776773|FG004|Overall Study|Ineligibility Determined|0|||
126404532|NCT00907296|454776774|FG005|Overall Study|Ineligibility Determined|0|||
126404533|NCT00907296|454776775|FG006|Overall Study|Ineligibility Determined|0|||
126404534|NCT00907296|454776776|FG007|Overall Study|Ineligibility Determined|1|||
126404535|NCT00907296|454776777|FG008|Overall Study|Ineligibility Determined|0|||
126404536|NCT00907296|454776778|FG009|Overall Study|Ineligibility Determined|0|||
126404537|NCT00907296|454776769|FG000|Overall Study|Protocol Deviation|0|||
126404538|NCT00907296|454776770|FG001|Overall Study|Protocol Deviation|1|||
126404539|NCT00907296|454776771|FG002|Overall Study|Protocol Deviation|0|||
126404540|NCT00907296|454776772|FG003|Overall Study|Protocol Deviation|0|||
126404541|NCT00907296|454776773|FG004|Overall Study|Protocol Deviation|0|||
126404542|NCT00907296|454776774|FG005|Overall Study|Protocol Deviation|0|||
126404543|NCT00907296|454776775|FG006|Overall Study|Protocol Deviation|0|||
126404544|NCT00907296|454776776|FG007|Overall Study|Protocol Deviation|0|||
126404545|NCT00907296|454776777|FG008|Overall Study|Protocol Deviation|0|||
126404546|NCT00907296|454776778|FG009|Overall Study|Protocol Deviation|0|||
126404547|NCT00907296|454776769|FG000|Overall Study|Noncompliance|1|||
126404548|NCT00907296|454776770|FG001|Overall Study|Noncompliance|1|||
126404549|NCT00907296|454776771|FG002|Overall Study|Noncompliance|1|||
126404550|NCT00907296|454776772|FG003|Overall Study|Noncompliance|0|||
126404551|NCT00907296|454776773|FG004|Overall Study|Noncompliance|0|||
126404552|NCT00907296|454776774|FG005|Overall Study|Noncompliance|1|||
126404553|NCT00907296|454776775|FG006|Overall Study|Noncompliance|0|||
126404554|NCT00907296|454776776|FG007|Overall Study|Noncompliance|2|||
126404555|NCT00907296|454776777|FG008|Overall Study|Noncompliance|0|||
126404556|NCT00907296|454776778|FG009|Overall Study|Noncompliance|0|||
126404557|NCT00907296|454776769|FG000|Overall Study|Adverse Event|2|||
126404558|NCT00907296|454776770|FG001|Overall Study|Adverse Event|0|||
126404559|NCT00907296|454776771|FG002|Overall Study|Adverse Event|0|||
126404560|NCT00907296|454776772|FG003|Overall Study|Adverse Event|0|||
126404561|NCT00907296|454776773|FG004|Overall Study|Adverse Event|0|||
126404562|NCT00907296|454776774|FG005|Overall Study|Adverse Event|0|||
126404563|NCT00907296|454776775|FG006|Overall Study|Adverse Event|1|||
126404564|NCT00907296|454776776|FG007|Overall Study|Adverse Event|0|||
126404565|NCT00907296|454776777|FG008|Overall Study|Adverse Event|0|||
126404566|NCT00907296|454776778|FG009|Overall Study|Adverse Event|1|||
126404567|NCT00907296|454776769|FG000|Overall Study|Withdrawal by Subject|7|||
126404568|NCT00907296|454776770|FG001|Overall Study|Withdrawal by Subject|2|||
126404569|NCT00907296|454776771|FG002|Overall Study|Withdrawal by Subject|1|||
126404570|NCT00907296|454776772|FG003|Overall Study|Withdrawal by Subject|1|||
126404571|NCT00907296|454776773|FG004|Overall Study|Withdrawal by Subject|1|||
126404572|NCT00907296|454776774|FG005|Overall Study|Withdrawal by Subject|5|||
126404573|NCT00907296|454776775|FG006|Overall Study|Withdrawal by Subject|3|||
126404574|NCT00907296|454776776|FG007|Overall Study|Withdrawal by Subject|2|||
126404575|NCT00907296|454776777|FG008|Overall Study|Withdrawal by Subject|4|||
126404576|NCT00907296|454776778|FG009|Overall Study|Withdrawal by Subject|2|||
126404577|NCT00907296|454776769|FG000|Overall Study|Lost to Follow-up|9|||
126404578|NCT00907296|454776770|FG001|Overall Study|Lost to Follow-up|1|||
126404579|NCT00907296|454776771|FG002|Overall Study|Lost to Follow-up|0|||
126404580|NCT00907296|454776772|FG003|Overall Study|Lost to Follow-up|2|||
126404581|NCT00907296|454776773|FG004|Overall Study|Lost to Follow-up|0|||
126404582|NCT00907296|454776774|FG005|Overall Study|Lost to Follow-up|3|||
126404583|NCT00907296|454776775|FG006|Overall Study|Lost to Follow-up|2|||
126404584|NCT00907296|454776776|FG007|Overall Study|Lost to Follow-up|2|||
126404585|NCT00907296|454776777|FG008|Overall Study|Lost to Follow-up|0|||
126404586|NCT00907296|454776778|FG009|Overall Study|Lost to Follow-up|4|||
126404587|NCT00791557|454776779|FG000|Overall Study|Adverse Event|1|||
126404588|NCT04135859|454776782|FG000|Overall Study|Withdrawal by Subject|1|||
126404589|NCT04135859|454776783|FG001|Overall Study|Withdrawal by Subject|0|||
126404590|NCT04135859|454776782|FG000|Overall Study|Withdrawal due to screening failure|1|||
126404591|NCT04135859|454776783|FG001|Overall Study|Withdrawal due to screening failure|2|||
126404592|NCT04135859|454776782|FG000|Overall Study|Did not complete stress test|3|||
125890202|NCT02675634|452895463|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
125890203|NCT02675634|452895464|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
125890204|NCT02675634|452895459|FG000|Test Period 2|Lack of Efficacy|1|||
125890205|NCT02675634|452895460|FG001|Test Period 2|Lack of Efficacy|0|||
125890206|NCT02675634|452895461|FG002|Test Period 2|Lack of Efficacy|0|||
125890207|NCT02675634|452895462|FG003|Test Period 2|Lack of Efficacy|0|||
125890208|NCT02675634|452895463|FG004|Test Period 2|Lack of Efficacy|0|||
125890209|NCT02675634|452895464|FG005|Test Period 2|Lack of Efficacy|0|||
125890210|NCT02675634|452895459|FG000|Test Period 2|Adverse Event|0|||
125890211|NCT02675634|452895460|FG001|Test Period 2|Adverse Event|0|||
125890212|NCT02675634|452895461|FG002|Test Period 2|Adverse Event|0|||
125890213|NCT02675634|452895462|FG003|Test Period 2|Adverse Event|0|||
125890214|NCT02675634|452895463|FG004|Test Period 2|Adverse Event|0|||
125890215|NCT02675634|452895464|FG005|Test Period 2|Adverse Event|1|||
125890216|NCT01652534|452895465|FG000|Overall Study|Lack of Efficacy|1|||
125890217|NCT01652534|452895466|FG001|Overall Study|Lack of Efficacy|0|||
125890218|NCT03860259|452895467|FG000|Overall Study|Lost to Follow-up|5|||
125890219|NCT03860259|452895468|FG001|Overall Study|Lost to Follow-up|5|||
125890220|NCT03860259|452895467|FG000|Overall Study|Protocol Violation|1|||
125890221|NCT03860259|452895468|FG001|Overall Study|Protocol Violation|0|||
125890222|NCT00811018|452895469|FG000|Overall Study|Additional Chronic Treatment|31|||
125890223|NCT00811018|452895469|FG000|Overall Study|Adverse Event|79|||
125890224|NCT00811018|452895469|FG000|Overall Study|Death|147|||
125890225|NCT00811018|452895469|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
125890226|NCT00811018|452895469|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
125890227|NCT00811018|452895469|FG000|Overall Study|Investigator Decision|57|||
126404593|NCT04135859|454776783|FG001|Overall Study|Did not complete stress test|3|||
125890228|NCT00811018|452895469|FG000|Overall Study|Lost to Follow-up|19|||
125890229|NCT00811018|452895469|FG000|Overall Study|Pregnancy|6|||
125890230|NCT00811018|452895469|FG000|Overall Study|Sponsor Decision|450|||
125890231|NCT00811018|452895469|FG000|Overall Study|Withdrawal by Subject|70|||
125890232|NCT00811018|452895469|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
125890233|NCT00811018|452895469|FG000|Overall Study|Other|26|||
125890234|NCT00934362|452895473|FG000|Overall Study|Adverse Event|1|||
126404594|NCT04135859|454776782|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
125890235|NCT00934362|452895474|FG001|Overall Study|Adverse Event|0|||
125890236|NCT03527732|452895475|FG000|Overall Study|Lost to Follow-up|21|||
125890237|NCT03527732|452895476|FG001|Overall Study|Lost to Follow-up|23|||
125890238|NCT03527732|452895477|FG002|Overall Study|Lost to Follow-up|80|||
126404595|NCT04135859|454776783|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
126404596|NCT03242018|454776784|FG000|Overall Study|Adverse Event|7|||
126404597|NCT03242018|454776785|FG001|Overall Study|Adverse Event|7|||
126404598|NCT03242018|454776786|FG002|Overall Study|Adverse Event|6|||
126404599|NCT03242018|454776784|FG000|Overall Study|Lost to Follow-up|2|||
126404600|NCT03242018|454776785|FG001|Overall Study|Lost to Follow-up|2|||
126404601|NCT03242018|454776786|FG002|Overall Study|Lost to Follow-up|2|||
126404602|NCT03242018|454776784|FG000|Overall Study|At the Participant's Own Request|5|||
126404603|NCT03242018|454776785|FG001|Overall Study|At the Participant's Own Request|1|||
126404604|NCT03242018|454776786|FG002|Overall Study|At the Participant's Own Request|4|||
126404605|NCT03242018|454776784|FG000|Overall Study|Reason Not Specified|3|||
126404606|NCT03242018|454776785|FG001|Overall Study|Reason Not Specified|4|||
126404607|NCT03242018|454776786|FG002|Overall Study|Reason Not Specified|1|||
126404608|NCT03242018|454776784|FG000|Overall Study|Study Terminated by Sponsor|1|||
126404609|NCT03242018|454776785|FG001|Overall Study|Study Terminated by Sponsor|0|||
126404610|NCT03242018|454776786|FG002|Overall Study|Study Terminated by Sponsor|1|||
126404611|NCT03262116|454776787|FG000|Overall Study|Physician Decision|0|||
126404612|NCT03262116|454776788|FG001|Overall Study|Physician Decision|2|||
126404613|NCT03262116|454776789|FG002|Overall Study|Physician Decision|1|||
126404614|NCT03262116|454776790|FG003|Overall Study|Physician Decision|1|||
126404615|NCT03262116|454776791|FG004|Overall Study|Physician Decision|1|||
126404616|NCT03262116|454776792|FG005|Overall Study|Physician Decision|2|||
126404617|NCT02365285|454776793|FG000|Overall Study|Physician Decision|0|||
126404618|NCT02365285|454776794|FG001|Overall Study|Physician Decision|1|||
126404619|NCT02365285|454776795|FG002|Overall Study|Physician Decision|1|||
126404620|NCT02365285|454776796|FG003|Overall Study|Physician Decision|0|||
126404621|NCT02365285|454776793|FG000|Overall Study|Adverse Event|0|||
126404622|NCT02365285|454776794|FG001|Overall Study|Adverse Event|0|||
126404623|NCT02365285|454776795|FG002|Overall Study|Adverse Event|0|||
126404624|NCT02365285|454776796|FG003|Overall Study|Adverse Event|2|||
126404625|NCT02608450|454776799|FG000|Overall Study|Lost to Follow-up|39|||
126404626|NCT02608450|454776800|FG001|Overall Study|Lost to Follow-up|32|||
126404627|NCT02608450|454776799|FG000|Overall Study|Withdrawal by Subject|21|||
126404628|NCT02608450|454776800|FG001|Overall Study|Withdrawal by Subject|15|||
126404629|NCT02608450|454776799|FG000|Overall Study|Adverse Event|3|||
126404630|NCT02608450|454776800|FG001|Overall Study|Adverse Event|6|||
126404631|NCT02608450|454776799|FG000|Overall Study|Withdrawal by parent|2|||
126404632|NCT02608450|454776800|FG001|Overall Study|Withdrawal by parent|3|||
126404633|NCT02608450|454776799|FG000|Overall Study|Lack of Efficacy|0|||
126404634|NCT02608450|454776800|FG001|Overall Study|Lack of Efficacy|3|||
126404635|NCT02608450|454776799|FG000|Overall Study|Noncompliance with study drug|0|||
126404636|NCT02608450|454776800|FG001|Overall Study|Noncompliance with study drug|2|||
126404637|NCT02608450|454776799|FG000|Overall Study|Physician Decision|0|||
126404638|NCT02608450|454776800|FG001|Overall Study|Physician Decision|1|||
126404639|NCT02608450|454776799|FG000|Overall Study|Pregnancy|0|||
126404640|NCT02608450|454776800|FG001|Overall Study|Pregnancy|1|||
126404641|NCT02608450|454776799|FG000|Overall Study|Progressive disease|1|||
126404642|NCT02608450|454776800|FG001|Overall Study|Progressive disease|0|||
125890239|NCT03527732|452895478|FG003|Overall Study|Lost to Follow-up|62|||
125890240|NCT03527732|452895479|FG004|Overall Study|Lost to Follow-up|12|||
125890241|NCT03527732|452895480|FG005|Overall Study|Lost to Follow-up|20|||
125890242|NCT02280408|452895481|FG000|Overall Study|Lost to Follow-up|0|||
125890243|NCT02280408|452895482|FG001|Overall Study|Lost to Follow-up|2|||
125890244|NCT02280408|452895483|FG002|Overall Study|Lost to Follow-up|0|||
125890245|NCT02280408|452895484|FG003|Overall Study|Lost to Follow-up|0|||
125890246|NCT01092117|452895485|FG000|Index Procedure to 1 Month|Death|1|||
125890247|NCT01092117|452895485|FG000|1 Month|Death|1|||
125890248|NCT01092117|452895485|FG000|1 Month|Withdrawal by Subject|1|||
125890249|NCT01092117|452895485|FG000|1 Month|Lost to Follow-up|1|||
125890250|NCT01092117|452895485|FG000|6 Months|Death|2|||
125890251|NCT01092117|452895485|FG000|6 Months|Withdrawal by Subject|3|||
125890252|NCT01092117|452895485|FG000|12 Month|Death|11|||
125890253|NCT01092117|452895485|FG000|12 Month|Withdrawal by Subject|2|||
126404643|NCT02608450|454776799|FG000|Overall Study|Multiple reasons|0|||
125890254|NCT01092117|452895485|FG000|12 Month|Lost to Follow-up|1|||
126404644|NCT02608450|454776800|FG001|Overall Study|Multiple reasons|2|||
126404645|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
126404646|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
126404647|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
126404648|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
126404649|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
126404650|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
126404651|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
126404652|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
125890255|NCT01092117|452895485|FG000|Year 2|Death|5|||
125890256|NCT01092117|452895485|FG000|Year 2|Withdrawal by Subject|4|||
125890257|NCT01092117|452895485|FG000|Year 2|Lost to Follow-up|1|||
125890258|NCT01092117|452895485|FG000|Year 3|Death|7|||
125890259|NCT01092117|452895485|FG000|Year 3|Withdrawal by Subject|9|||
126404653|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
126404654|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
126404655|NCT02636946|454776801|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
126404656|NCT02636946|454776802|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
126404657|NCT00477269|454776803|FG000|Core Study|Adverse Event|6|||
126404658|NCT00477269|454776804|FG001|Core Study|Adverse Event|4|||
126404659|NCT00477269|454776805|FG002|Core Study|Adverse Event|0|||
126404660|NCT00477269|454776803|FG000|Core Study|Death|3|||
126404661|NCT00477269|454776804|FG001|Core Study|Death|3|||
126404662|NCT00477269|454776805|FG002|Core Study|Death|0|||
126404663|NCT00477269|454776803|FG000|Core Study|Withdrawn Consent|0|||
126404664|NCT00477269|454776804|FG001|Core Study|Withdrawn Consent|1|||
126404665|NCT00477269|454776805|FG002|Core Study|Withdrawn Consent|0|||
126404666|NCT00477269|454776803|FG000|Open Label Extension|Adverse Event|0|||
126404667|NCT00477269|454776804|FG001|Open Label Extension|Adverse Event|0|||
126404668|NCT00477269|454776805|FG002|Open Label Extension|Adverse Event|4|||
126053556|NCT03389802|453489555|FG000|Overall Study|Lack of Efficacy|3|||
126053557|NCT03389802|453489556|FG001|Overall Study|Lack of Efficacy|3|||
126404669|NCT00477269|454776803|FG000|Open Label Extension|Abnormal laboratory values|0|||
126404670|NCT00477269|454776804|FG001|Open Label Extension|Abnormal laboratory values|0|||
126404671|NCT00477269|454776805|FG002|Open Label Extension|Abnormal laboratory values|1|||
126404672|NCT00477269|454776803|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
126404673|NCT00477269|454776804|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
126404674|NCT00477269|454776805|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
126404675|NCT00477269|454776803|FG000|Open Label Extension|Adminiatrative problems|0|||
126404676|NCT00477269|454776804|FG001|Open Label Extension|Adminiatrative problems|0|||
126404677|NCT00477269|454776805|FG002|Open Label Extension|Adminiatrative problems|2|||
126404678|NCT00477269|454776803|FG000|Open Label Extension|Death|0|||
126404679|NCT00477269|454776804|FG001|Open Label Extension|Death|0|||
126404680|NCT00477269|454776805|FG002|Open Label Extension|Death|4|||
126404681|NCT01792518|454776806|FG000|Overall Study|Adverse Event|3|||
126404682|NCT01792518|454776807|FG001|Overall Study|Adverse Event|4|||
126404683|NCT01792518|454776806|FG000|Overall Study|Protocol Violation|0|||
126404684|NCT01792518|454776807|FG001|Overall Study|Protocol Violation|1|||
126404685|NCT01792518|454776806|FG000|Overall Study|Lost to Follow-up|3|||
126404686|NCT01792518|454776807|FG001|Overall Study|Lost to Follow-up|1|||
126404687|NCT01792518|454776806|FG000|Overall Study|Withdrawal by Subject|2|||
126404688|NCT01792518|454776807|FG001|Overall Study|Withdrawal by Subject|0|||
126404689|NCT01792518|454776806|FG000|Overall Study|Other Reason|0|||
126404690|NCT01792518|454776807|FG001|Overall Study|Other Reason|1|||
126404691|NCT00249613|454776811|FG000|12 Month Follow-up|Death|1|||
126404692|NCT00249613|454776812|FG001|12 Month Follow-up|Death|1|||
126404693|NCT00249613|454776811|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
126053558|NCT03389802|453489557|FG002|Overall Study|Lack of Efficacy|13|||
126053559|NCT03389802|453489558|FG003|Overall Study|Lack of Efficacy|6|||
126053560|NCT03389802|453489559|FG004|Overall Study|Lack of Efficacy|1|||
126053561|NCT03389802|453489555|FG000|Overall Study|Adverse Event|0|||
126053562|NCT03389802|453489556|FG001|Overall Study|Adverse Event|0|||
126404694|NCT00249613|454776812|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
126404695|NCT00249613|454776811|FG000|12 Month Follow-up|Lost to Follow-up|10|||
126404696|NCT00249613|454776812|FG001|12 Month Follow-up|Lost to Follow-up|8|||
126404697|NCT00806442|454776814|FG000|Overall Study|Lost to Follow-up|3|||
126404698|NCT00806442|454776815|FG001|Overall Study|Lost to Follow-up|2|||
126404699|NCT00806442|454776814|FG000|Overall Study|Withdrawal by Subject|1|||
126404700|NCT00806442|454776815|FG001|Overall Study|Withdrawal by Subject|5|||
126404701|NCT00654004|454776816|FG000|Overall Study|Lost to Follow-up|1|||
126404702|NCT00654004|454776817|FG001|Overall Study|Lost to Follow-up|0|||
126404703|NCT01264770|454776818|FG000|Overall Study|Not reported|0|||
126404704|NCT01264770|454776819|FG001|Overall Study|Not reported|0|||
126404705|NCT01264770|454776820|FG002|Overall Study|Not reported|1|||
126404706|NCT01264770|454776821|FG003|Overall Study|Not reported|0|||
126404707|NCT01264770|454776822|FG004|Overall Study|Not reported|0|||
126404708|NCT01264770|454776823|FG005|Overall Study|Not reported|0|||
126404709|NCT01264770|454776818|FG000|Overall Study|e.g., change in circumstances|8|||
126404710|NCT01264770|454776819|FG001|Overall Study|e.g., change in circumstances|3|||
126053563|NCT03389802|453489557|FG002|Overall Study|Adverse Event|1|||
126053564|NCT03389802|453489558|FG003|Overall Study|Adverse Event|0|||
126053565|NCT03389802|453489559|FG004|Overall Study|Adverse Event|4|||
126053566|NCT03389802|453489555|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
126053567|NCT03389802|453489556|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
126053568|NCT03389802|453489557|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
126053569|NCT03389802|453489558|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
126404711|NCT01264770|454776820|FG002|Overall Study|e.g., change in circumstances|3|||
126404712|NCT01264770|454776821|FG003|Overall Study|e.g., change in circumstances|3|||
126404713|NCT01264770|454776822|FG004|Overall Study|e.g., change in circumstances|4|||
126404714|NCT01264770|454776823|FG005|Overall Study|e.g., change in circumstances|4|||
126404715|NCT01264770|454776818|FG000|Overall Study|Severe non-compliance to protocol|0|||
126404716|NCT01264770|454776819|FG001|Overall Study|Severe non-compliance to protocol|0|||
126404717|NCT01264770|454776820|FG002|Overall Study|Severe non-compliance to protocol|1|||
126404718|NCT01264770|454776821|FG003|Overall Study|Severe non-compliance to protocol|1|||
126404719|NCT01264770|454776822|FG004|Overall Study|Severe non-compliance to protocol|0|||
126404720|NCT01264770|454776823|FG005|Overall Study|Severe non-compliance to protocol|0|||
126404721|NCT01264770|454776818|FG000|Overall Study|Lack of therapeutic response|1|||
126404722|NCT01264770|454776819|FG001|Overall Study|Lack of therapeutic response|0|||
126404723|NCT01264770|454776820|FG002|Overall Study|Lack of therapeutic response|2|||
126404724|NCT01264770|454776821|FG003|Overall Study|Lack of therapeutic response|1|||
126404725|NCT01264770|454776822|FG004|Overall Study|Lack of therapeutic response|1|||
126404726|NCT01264770|454776823|FG005|Overall Study|Lack of therapeutic response|0|||
126404727|NCT01264770|454776818|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
126404728|NCT01264770|454776819|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
126404729|NCT01264770|454776820|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
126404730|NCT01264770|454776821|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
126404731|NCT01264770|454776822|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
126404732|NCT01264770|454776823|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
126404733|NCT01264770|454776818|FG000|Overall Study|Lost to Follow-up|0|||
126404734|NCT01264770|454776819|FG001|Overall Study|Lost to Follow-up|0|||
126404735|NCT01264770|454776820|FG002|Overall Study|Lost to Follow-up|1|||
126404736|NCT01264770|454776821|FG003|Overall Study|Lost to Follow-up|1|||
126053570|NCT03389802|453489559|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
125890260|NCT01092117|452895485|FG000|Year 3|Lost to Follow-up|3|||
126404737|NCT01264770|454776822|FG004|Overall Study|Lost to Follow-up|0|||
126404738|NCT01264770|454776823|FG005|Overall Study|Lost to Follow-up|0|||
126404739|NCT01264770|454776818|FG000|Overall Study|Adverse Event|7|||
126404740|NCT01264770|454776819|FG001|Overall Study|Adverse Event|7|||
126404741|NCT01264770|454776820|FG002|Overall Study|Adverse Event|8|||
126404742|NCT01264770|454776821|FG003|Overall Study|Adverse Event|0|||
126404743|NCT01264770|454776822|FG004|Overall Study|Adverse Event|2|||
126404744|NCT01264770|454776823|FG005|Overall Study|Adverse Event|1|||
126404745|NCT00424190|454776825|FG000|Overall Study|Withdrew consent|3|||
126404746|NCT00424190|454776826|FG001|Overall Study|Withdrew consent|4|||
126404747|NCT00424190|454776825|FG000|Overall Study|Death|3|||
126404748|NCT00424190|454776826|FG001|Overall Study|Death|0|||
126404749|NCT00424190|454776825|FG000|Overall Study|Noncompliance|1|||
125890261|NCT01092117|452895485|FG000|Year 4|Death|8|||
125890262|NCT01092117|452895485|FG000|Year 4|Withdrawal by Subject|4|||
125890263|NCT01092117|452895485|FG000|Year 4|Lost to Follow-up|4|||
125890264|NCT03710083|452895486|FG000|Overall Study|Withdrawal by Subject|2|||
125890265|NCT03710083|452895486|FG000|Overall Study|Unsuccessful Procedure|1|||
126404750|NCT00424190|454776826|FG001|Overall Study|Noncompliance|2|||
126404751|NCT00424190|454776825|FG000|Overall Study|Request of sponsor or investigator|0|||
125890266|NCT05300763|452895487|FG000|Overall Study|Adverse Event|0|||
126404752|NCT00424190|454776826|FG001|Overall Study|Request of sponsor or investigator|2|||
126404753|NCT00424190|454776825|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
126404754|NCT00424190|454776826|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
126404755|NCT00424190|454776825|FG000|Overall Study|Other|15|||
126404756|NCT00424190|454776826|FG001|Overall Study|Other|21|||
126404757|NCT00351273|454776827|FG000|Overall Study|Lost to Follow-up|1|||
126404758|NCT00351273|454776828|FG001|Overall Study|Lost to Follow-up|2|||
126404759|NCT00351273|454776829|FG002|Overall Study|Lost to Follow-up|5|||
126404760|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
126404761|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
126404762|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
126404763|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
126404764|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
126404765|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
126404766|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
126404767|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
126404768|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
126404769|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
126404770|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
126404771|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
126404772|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
126404773|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
126404774|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
126404775|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
126404776|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
126404777|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
126404778|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
126404779|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
126404780|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
126404781|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
126404782|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
126404783|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
126404784|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
126404785|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
126404786|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
126404787|NCT01672866|454776830|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
126404788|NCT01672866|454776831|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
126404789|NCT01672866|454776832|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
126404790|NCT01672866|454776830|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
126404791|NCT01672866|454776831|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
126404792|NCT01672866|454776832|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
126404793|NCT01672866|454776830|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
126404794|NCT01672866|454776831|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
126404795|NCT01672866|454776832|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
126404796|NCT01672866|454776830|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
126404797|NCT01672866|454776831|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
126404798|NCT01672866|454776832|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
126404799|NCT02241187|454776833|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
126404800|NCT00160654|454776836|FG000|Overall Study|Adverse Event|14|||
126404801|NCT00160654|454776836|FG000|Overall Study|Lack of Efficacy|4|||
126404802|NCT00160654|454776836|FG000|Overall Study|Lost to Follow-up|2|||
126404803|NCT00160654|454776836|FG000|Overall Study|Intake of expired drug|7|||
126404804|NCT00160654|454776836|FG000|Overall Study|Psychological trauma|1|||
126404805|NCT00160654|454776836|FG000|Overall Study|Sponsor decision|1|||
126404806|NCT00160654|454776836|FG000|Overall Study|Patient met exclusion criteria|1|||
126404807|NCT00160654|454776836|FG000|Overall Study|Patient decision|1|||
126404808|NCT00160654|454776836|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
126404809|NCT00160654|454776836|FG000|Overall Study|Met exclusion criteria|1|||
126404810|NCT02383433|454776839|FG000|Overall Study|Disease progression|2|||
126404811|NCT02535416|454776840|FG000|Overall Study|Family bereavement overseas|1|||
126404812|NCT02535416|454776841|FG001|Overall Study|Family bereavement overseas|0|||
126404813|NCT02535416|454776842|FG002|Overall Study|Family bereavement overseas|0|||
126404814|NCT02535416|454776843|FG003|Overall Study|Family bereavement overseas|0|||
126404815|NCT02535416|454776844|FG004|Overall Study|Family bereavement overseas|0|||
126404816|NCT02535416|454776845|FG005|Overall Study|Family bereavement overseas|0|||
126404817|NCT02535416|454776846|FG006|Overall Study|Family bereavement overseas|0|||
126404818|NCT02535416|454776847|FG007|Overall Study|Family bereavement overseas|0|||
126088967|NCT01399697|453620041|FG002|Overall Study|Investigator Decisión|2|||
126404819|NCT02535416|454776848|FG008|Overall Study|Family bereavement overseas|0|||
126404820|NCT04544683|454778064|FG000|Overall Study|Lost to Follow-up|2|||
126404821|NCT04544683|454778064|FG000|Overall Study|Underwent cervical spine surgery|6|||
126404822|NCT01073930|454778065|FG000|Overall Study|Withdrawal by Subject|3|||
126404823|NCT01073930|454778066|FG001|Overall Study|Withdrawal by Subject|2|||
126404824|NCT01073930|454778065|FG000|Overall Study|Lost to Follow-up|0|||
126404825|NCT01073930|454778066|FG001|Overall Study|Lost to Follow-up|1|||
126404826|NCT01073930|454778065|FG000|Overall Study|Adverse Event|0|||
126404827|NCT01073930|454778066|FG001|Overall Study|Adverse Event|1|||
126404828|NCT01073930|454778065|FG000|Overall Study|Noncompliance with study drug|0|||
126404829|NCT01073930|454778066|FG001|Overall Study|Noncompliance with study drug|1|||
126404830|NCT01073930|454778065|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
126404831|NCT01073930|454778066|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
126404832|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Adverse Event|3|||
126404833|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Adverse Event|0|||
126404834|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
126404835|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
126404836|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Physician Decision|1|||
126404837|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Physician Decision|0|||
126404838|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
126404839|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
126404840|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
126404841|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
126404842|NCT02081599|454778067|FG000|Period 1：Double-blind Period|stopping criteria|1|||
126404843|NCT02081599|454778068|FG001|Period 1：Double-blind Period|stopping criteria|0|||
126404844|NCT02081599|454778067|FG000|Period 2：Open-label Period|Adverse Event|1|||
126404845|NCT02081599|454778068|FG001|Period 2：Open-label Period|Adverse Event|0|||
126404846|NCT02081599|454778067|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
126404847|NCT02081599|454778068|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
126404848|NCT02081599|454778067|FG000|Period 2：Open-label Period|Physician Decision|1|||
126404849|NCT02081599|454778068|FG001|Period 2：Open-label Period|Physician Decision|0|||
126404850|NCT02081599|454778067|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
126404851|NCT02081599|454778068|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
126404852|NCT01266590|454778069|FG000|Overall Study|Adverse Event|3|||
126404853|NCT01266590|454778069|FG000|Overall Study|Lost to Follow-up|1|||
126404854|NCT01266590|454778069|FG000|Overall Study|Withdrawal by Subject|1|||
126404855|NCT01266590|454778069|FG000|Overall Study|Physician Decision|1|||
126404856|NCT00720343|454778072|FG000|Overall Study|Lost to Follow-up|1|||
126404857|NCT00720343|454778073|FG001|Overall Study|Lost to Follow-up|0|||
126404858|NCT00720343|454778072|FG000|Overall Study|Protocol Violation|0|||
126404859|NCT00720343|454778073|FG001|Overall Study|Protocol Violation|2|||
126404860|NCT02008773|454778074|FG000|Overall Study|Adverse Event|3|||
126404861|NCT02008773|454778075|FG001|Overall Study|Adverse Event|3|||
126404862|NCT02008773|454778076|FG002|Overall Study|Adverse Event|1|||
126404863|NCT02008773|454778077|FG003|Overall Study|Adverse Event|2|||
126404864|NCT02008773|454778074|FG000|Overall Study|Medication Non-compliance|2|||
126404865|NCT02008773|454778075|FG001|Overall Study|Medication Non-compliance|1|||
126404866|NCT02008773|454778076|FG002|Overall Study|Medication Non-compliance|3|||
126404867|NCT02008773|454778077|FG003|Overall Study|Medication Non-compliance|2|||
126404868|NCT02008773|454778074|FG000|Overall Study|Withdrawal by Subject|8|||
126404869|NCT02008773|454778075|FG001|Overall Study|Withdrawal by Subject|4|||
126404870|NCT02008773|454778076|FG002|Overall Study|Withdrawal by Subject|7|||
126404871|NCT02008773|454778077|FG003|Overall Study|Withdrawal by Subject|6|||
126404872|NCT02008773|454778074|FG000|Overall Study|Lost to Follow-up|0|||
126404873|NCT02008773|454778075|FG001|Overall Study|Lost to Follow-up|1|||
126404874|NCT02008773|454778076|FG002|Overall Study|Lost to Follow-up|3|||
126404875|NCT02008773|454778077|FG003|Overall Study|Lost to Follow-up|2|||
126404876|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
126404877|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
126404878|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
126404879|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
126404880|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
125890267|NCT05300763|452895488|FG001|Overall Study|Adverse Event|1|||
125890268|NCT05300763|452895487|FG000|Overall Study|Major Protocol Deviation|1|||
126404881|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
126404882|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
126404883|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
126404884|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
126404885|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
126404886|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
126404887|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
126404888|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
126404889|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
126404890|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
126404891|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
126404892|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
126404893|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
126404894|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
126404895|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
126404896|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
126404897|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
126404898|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
126404899|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
126404900|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
126404901|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
126404902|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
126404903|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
126404904|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
126404905|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
126404906|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
126404907|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
126404908|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
126404909|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
126404910|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
126404911|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
126404912|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
126404913|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
126404914|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
126404915|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
126404916|NCT02198794|454778078|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
126404917|NCT02198794|454778079|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
126404918|NCT02198794|454778080|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
126404919|NCT02198794|454778081|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
126404920|NCT02198794|454778078|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
126404921|NCT02198794|454778079|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
126404922|NCT02198794|454778080|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
126404923|NCT02198794|454778081|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
126404924|NCT02198794|454778078|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
126404925|NCT02198794|454778079|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
126404926|NCT02198794|454778080|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
126404927|NCT02198794|454778081|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
126404928|NCT02198794|454778078|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
126404929|NCT02198794|454778079|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
126404930|NCT02198794|454778080|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
126404931|NCT02198794|454778081|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
126404932|NCT02198794|454778078|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
126404933|NCT02198794|454778079|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
126404934|NCT02198794|454778080|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
126404935|NCT02198794|454778081|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
126404936|NCT00701805|454778082|FG000|Overall Study|Withdrawal by Subject|3|||
126404937|NCT00701805|454778083|FG001|Overall Study|Withdrawal by Subject|1|||
126404938|NCT00701805|454778084|FG002|Overall Study|Withdrawal by Subject|4|||
126404939|NCT00701805|454778085|FG003|Overall Study|Withdrawal by Subject|3|||
126404940|NCT00701805|454778082|FG000|Overall Study|Adverse Event|0|||
126404941|NCT00701805|454778083|FG001|Overall Study|Adverse Event|1|||
126404942|NCT00701805|454778084|FG002|Overall Study|Adverse Event|1|||
126404943|NCT00701805|454778085|FG003|Overall Study|Adverse Event|0|||
126404944|NCT00701805|454778082|FG000|Overall Study|Missed 7 consecutive doses|0|||
126404945|NCT00701805|454778083|FG001|Overall Study|Missed 7 consecutive doses|1|||
126404946|NCT00701805|454778084|FG002|Overall Study|Missed 7 consecutive doses|0|||
126404947|NCT00701805|454778085|FG003|Overall Study|Missed 7 consecutive doses|0|||
126404948|NCT00701805|454778082|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
126404949|NCT00701805|454778083|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
126404950|NCT00701805|454778084|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
126404951|NCT00701805|454778085|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
126404952|NCT00701805|454778082|FG000|Overall Study|Physician decision, change of therapy|0|||
126404953|NCT00701805|454778083|FG001|Overall Study|Physician decision, change of therapy|0|||
126404954|NCT00701805|454778084|FG002|Overall Study|Physician decision, change of therapy|0|||
126404955|NCT00701805|454778085|FG003|Overall Study|Physician decision, change of therapy|1|||
126404956|NCT00701805|454778082|FG000|Overall Study|Difficult to travel to dialysis site|0|||
126404957|NCT00701805|454778083|FG001|Overall Study|Difficult to travel to dialysis site|0|||
126404958|NCT00701805|454778084|FG002|Overall Study|Difficult to travel to dialysis site|1|||
126404959|NCT00701805|454778085|FG003|Overall Study|Difficult to travel to dialysis site|0|||
126404960|NCT00701805|454778082|FG000|Overall Study|Resumption criteria were not met|0|||
126404961|NCT00701805|454778083|FG001|Overall Study|Resumption criteria were not met|1|||
126404962|NCT00701805|454778084|FG002|Overall Study|Resumption criteria were not met|0|||
126404963|NCT00701805|454778085|FG003|Overall Study|Resumption criteria were not met|0|||
126404964|NCT02252965|454778089|FG000|Overall Study|Adverse Event|9|||
126404965|NCT02252965|454778090|FG001|Overall Study|Adverse Event|14|||
126404966|NCT02252965|454778089|FG000|Overall Study|Lost to Follow-up|16|||
126404967|NCT02252965|454778090|FG001|Overall Study|Lost to Follow-up|8|||
126404968|NCT02252965|454778089|FG000|Overall Study|Protocol Violation|4|||
126404969|NCT02252965|454778090|FG001|Overall Study|Protocol Violation|5|||
126404970|NCT02252965|454778089|FG000|Overall Study|Lack of Efficacy|0|||
126404971|NCT02252965|454778090|FG001|Overall Study|Lack of Efficacy|2|||
126404972|NCT02252965|454778089|FG000|Overall Study|Withdrawal by Subject|7|||
126404973|NCT02252965|454778090|FG001|Overall Study|Withdrawal by Subject|9|||
126404974|NCT02252965|454778089|FG000|Overall Study|Other|4|||
126404975|NCT02252965|454778090|FG001|Overall Study|Other|5|||
125890269|NCT05300763|452895488|FG001|Overall Study|Major Protocol Deviation|0|||
126088968|NCT01399697|453620039|FG000|Overall Study|Lack of Efficacy|9|||
126404976|NCT04435600|454778094|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404977|NCT04435600|454778095|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404978|NCT04435600|454778096|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
126404979|NCT04435600|454778097|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404980|NCT04435600|454778098|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404981|NCT04435600|454778099|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404982|NCT04435600|454778100|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404983|NCT04435600|454778101|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404984|NCT04435600|454778102|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404985|NCT04435600|454778103|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404986|NCT04435600|454778094|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404987|NCT04435600|454778095|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404988|NCT04435600|454778096|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404989|NCT04435600|454778097|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404990|NCT04435600|454778098|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404991|NCT04435600|454778099|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404992|NCT04435600|454778100|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404993|NCT04435600|454778101|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404994|NCT04435600|454778102|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404995|NCT04435600|454778103|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
126404996|NCT04435600|454778094|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126404997|NCT04435600|454778095|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126404998|NCT04435600|454778096|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126404999|NCT04435600|454778097|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405000|NCT04435600|454778098|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405001|NCT04435600|454778099|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405002|NCT04435600|454778100|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405003|NCT04435600|454778101|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405004|NCT04435600|454778102|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405005|NCT04435600|454778103|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
126405006|NCT04435600|454778094|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405007|NCT04435600|454778095|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405008|NCT04435600|454778096|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405009|NCT04435600|454778097|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405010|NCT04435600|454778098|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405011|NCT04435600|454778099|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405012|NCT04435600|454778100|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405013|NCT04435600|454778101|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405014|NCT04435600|454778102|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405015|NCT04435600|454778103|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
126405016|NCT02797184|454778105|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
126405017|NCT02797184|454778106|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
126405018|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
126405019|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
126405020|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
126405021|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
126405022|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
126405023|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
126405024|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
126405025|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
126405026|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
126405027|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
126405028|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
126405029|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
126405030|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
126405031|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
126405032|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
126405033|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
126405034|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
126405035|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
126405036|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
126405037|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
126405038|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
126405039|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
126405040|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
126405041|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
126405042|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
126405043|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
126405044|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
126405045|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
126405046|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126405047|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126405048|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
126405049|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
126405050|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126405051|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126405052|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
126405053|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
126405054|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126405055|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126405056|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
126405057|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126405058|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
126405059|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
126405060|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
126405061|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
126405062|NCT03199391|454778115|FG000|Overall Study|Death|1|||
126405063|NCT03199391|454778115|FG000|Overall Study|Lost to Follow-up|3|||
126405064|NCT03199391|454778115|FG000|Overall Study|Adverse Event|2|||
126405065|NCT03199391|454778115|FG000|Overall Study|Withdrawal by Subject|10|||
126405066|NCT04736628|454778116|FG000|Overall Study|Not treated|0|||
126405067|NCT04736628|454778117|FG001|Overall Study|Not treated|0|||
126405068|NCT04736628|454778118|FG002|Overall Study|Not treated|0|||
126405069|NCT04736628|454778119|FG003|Overall Study|Not treated|2|||
126405070|NCT04736628|454778116|FG000|Overall Study|Other reason than listed|1|||
126405071|NCT04736628|454778117|FG001|Overall Study|Other reason than listed|2|||
126405072|NCT04736628|454778118|FG002|Overall Study|Other reason than listed|2|||
126405073|NCT04736628|454778119|FG003|Overall Study|Other reason than listed|3|||
126405074|NCT04736628|454778116|FG000|Overall Study|Protocol deviation|0|||
126405075|NCT04736628|454778117|FG001|Overall Study|Protocol deviation|0|||
126405076|NCT04736628|454778118|FG002|Overall Study|Protocol deviation|0|||
125890270|NCT05300763|452895487|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
126405077|NCT04736628|454778119|FG003|Overall Study|Protocol deviation|1|||
126405078|NCT04736628|454778116|FG000|Overall Study|Burden of study procedures|1|||
126405079|NCT04736628|454778117|FG001|Overall Study|Burden of study procedures|0|||
126405080|NCT04736628|454778118|FG002|Overall Study|Burden of study procedures|0|||
126405081|NCT04736628|454778119|FG003|Overall Study|Burden of study procedures|1|||
126405082|NCT04736628|454778116|FG000|Overall Study|Change of residence|0|||
126405083|NCT04736628|454778117|FG001|Overall Study|Change of residence|1|||
126405084|NCT04736628|454778118|FG002|Overall Study|Change of residence|0|||
126405085|NCT04736628|454778119|FG003|Overall Study|Change of residence|0|||
126405086|NCT04736628|454778116|FG000|Overall Study|Perceived lack of efficacy|1|||
126405087|NCT04736628|454778117|FG001|Overall Study|Perceived lack of efficacy|0|||
126405088|NCT04736628|454778118|FG002|Overall Study|Perceived lack of efficacy|0|||
126405089|NCT04736628|454778119|FG003|Overall Study|Perceived lack of efficacy|1|||
126405090|NCT04736628|454778116|FG000|Overall Study|Adverse Event|3|||
126405091|NCT04736628|454778117|FG001|Overall Study|Adverse Event|2|||
126405092|NCT04736628|454778118|FG002|Overall Study|Adverse Event|4|||
126405093|NCT04736628|454778119|FG003|Overall Study|Adverse Event|3|||
126405094|NCT02046070|454778128|FG000|Overall Study|Progressive Disease|18|||
126405095|NCT02046070|454778129|FG001|Overall Study|Progressive Disease|11|||
126405096|NCT02046070|454778130|FG002|Overall Study|Progressive Disease|40|||
126405097|NCT02046070|454778128|FG000|Overall Study|Adverse Event|8|||
126405098|NCT02046070|454778129|FG001|Overall Study|Adverse Event|10|||
126405099|NCT02046070|454778130|FG002|Overall Study|Adverse Event|17|||
126405100|NCT02046070|454778128|FG000|Overall Study|Withdrawal by Subject|1|||
126405101|NCT02046070|454778129|FG001|Overall Study|Withdrawal by Subject|2|||
126405102|NCT02046070|454778130|FG002|Overall Study|Withdrawal by Subject|6|||
126405103|NCT02046070|454778128|FG000|Overall Study|Study Terminated by Sponsor|1|||
126405104|NCT02046070|454778129|FG001|Overall Study|Study Terminated by Sponsor|1|||
126405105|NCT02046070|454778130|FG002|Overall Study|Study Terminated by Sponsor|1|||
126405106|NCT02046070|454778128|FG000|Overall Study|Reason not Specified|4|||
126405107|NCT02046070|454778129|FG001|Overall Study|Reason not Specified|4|||
126405108|NCT02046070|454778130|FG002|Overall Study|Reason not Specified|6|||
126405109|NCT02616393|454778143|FG000|Overall Study|Death|5|||
126405110|NCT02616393|454778144|FG001|Overall Study|Death|12|||
126405111|NCT02616393|454778145|FG002|Overall Study|Death|1|||
126405112|NCT02616393|454778143|FG000|Overall Study|Termination by Sponsor|4|||
126405113|NCT02616393|454778144|FG001|Overall Study|Termination by Sponsor|5|||
126405114|NCT02616393|454778145|FG002|Overall Study|Termination by Sponsor|2|||
126405115|NCT02616393|454778143|FG000|Overall Study|Other|3|||
126405116|NCT02616393|454778144|FG001|Overall Study|Other|0|||
126405117|NCT02616393|454778145|FG002|Overall Study|Other|0|||
126405118|NCT02616393|454778143|FG000|Overall Study|Withdrawal by Subject|1|||
126405119|NCT02616393|454778144|FG001|Overall Study|Withdrawal by Subject|1|||
126405120|NCT02616393|454778145|FG002|Overall Study|Withdrawal by Subject|0|||
126405121|NCT02616393|454778143|FG000|Overall Study|Lost to Follow-up|0|||
126405122|NCT02616393|454778144|FG001|Overall Study|Lost to Follow-up|2|||
126405123|NCT02616393|454778145|FG002|Overall Study|Lost to Follow-up|0|||
126405124|NCT02758301|454778147|FG000|Overall Study|Death|12|||
126405125|NCT02758301|454778148|FG001|Overall Study|Death|0|||
126405126|NCT02758301|454778147|FG000|Overall Study|Physician Decision|10|||
126405127|NCT02758301|454778148|FG001|Overall Study|Physician Decision|1|||
126405128|NCT02758301|454778147|FG000|Overall Study|Withdrawal by Subject|5|||
126405129|NCT02758301|454778148|FG001|Overall Study|Withdrawal by Subject|6|||
126405130|NCT02758301|454778147|FG000|Overall Study|Lost to Follow-up|7|||
126405131|NCT02758301|454778148|FG001|Overall Study|Lost to Follow-up|0|||
126405132|NCT02758301|454778147|FG000|Overall Study|Protocol Violation|0|||
126405133|NCT02758301|454778148|FG001|Overall Study|Protocol Violation|1|||
126405134|NCT00364533|454778149|FG000|Overall Study|Adverse Event|8|||
126405135|NCT00364533|454778150|FG001|Overall Study|Adverse Event|7|||
126405136|NCT00364533|454778151|FG002|Overall Study|Adverse Event|15|||
126405137|NCT00364533|454778152|FG003|Overall Study|Adverse Event|5|||
126405138|NCT00364533|454778153|FG004|Overall Study|Adverse Event|2|||
126405139|NCT00364533|454778149|FG000|Overall Study|Withdrawal by Subject|4|||
126405140|NCT00364533|454778150|FG001|Overall Study|Withdrawal by Subject|8|||
126405141|NCT00364533|454778151|FG002|Overall Study|Withdrawal by Subject|6|||
126405142|NCT00364533|454778152|FG003|Overall Study|Withdrawal by Subject|6|||
126405143|NCT00364533|454778153|FG004|Overall Study|Withdrawal by Subject|6|||
126405144|NCT00364533|454778149|FG000|Overall Study|Lack of Efficacy|22|||
126405145|NCT00364533|454778150|FG001|Overall Study|Lack of Efficacy|22|||
126405146|NCT00364533|454778151|FG002|Overall Study|Lack of Efficacy|21|||
126405147|NCT00364533|454778152|FG003|Overall Study|Lack of Efficacy|17|||
126405148|NCT00364533|454778153|FG004|Overall Study|Lack of Efficacy|42|||
126405149|NCT00364533|454778149|FG000|Overall Study|Subject discharged from hospital|4|||
126405150|NCT00364533|454778150|FG001|Overall Study|Subject discharged from hospital|1|||
126405151|NCT00364533|454778151|FG002|Overall Study|Subject discharged from hospital|2|||
126405152|NCT00364533|454778152|FG003|Overall Study|Subject discharged from hospital|3|||
126405153|NCT00364533|454778153|FG004|Overall Study|Subject discharged from hospital|1|||
126405154|NCT00364533|454778149|FG000|Overall Study|Variations in drug compliance|2|||
126405155|NCT00364533|454778150|FG001|Overall Study|Variations in drug compliance|1|||
126405156|NCT00364533|454778151|FG002|Overall Study|Variations in drug compliance|1|||
126405157|NCT00364533|454778152|FG003|Overall Study|Variations in drug compliance|0|||
126405158|NCT00364533|454778153|FG004|Overall Study|Variations in drug compliance|0|||
126405159|NCT00364533|454778149|FG000|Overall Study|Non-compliance|1|||
126405160|NCT00364533|454778150|FG001|Overall Study|Non-compliance|0|||
126405161|NCT00364533|454778151|FG002|Overall Study|Non-compliance|0|||
126405162|NCT00364533|454778152|FG003|Overall Study|Non-compliance|0|||
126405163|NCT00364533|454778153|FG004|Overall Study|Non-compliance|0|||
126405164|NCT00364533|454778149|FG000|Overall Study|Protocol Violation|1|||
126405165|NCT00364533|454778150|FG001|Overall Study|Protocol Violation|1|||
126405166|NCT00364533|454778151|FG002|Overall Study|Protocol Violation|0|||
126405167|NCT00364533|454778152|FG003|Overall Study|Protocol Violation|0|||
126405168|NCT00364533|454778153|FG004|Overall Study|Protocol Violation|0|||
126405169|NCT00652899|454778154|FG000|Overall Study|Death|1|||
126405170|NCT00652899|454778154|FG000|Overall Study|Treating physician decision|1|||
126405171|NCT02900170|454778157|FG000|Overall Study|Lost to Follow-up|8|||
126405172|NCT00551291|454778158|FG000|Overall Study|Physician Decision|1|||
126405173|NCT01943552|454778159|FG000|Overall Study|Adverse Event|3|||
126405174|NCT01943552|454778160|FG001|Overall Study|Adverse Event|2|||
126405175|NCT01943552|454778159|FG000|Overall Study|Withdrawal by Subject|6|||
126405176|NCT01943552|454778160|FG001|Overall Study|Withdrawal by Subject|6|||
126405177|NCT01943552|454778159|FG000|Overall Study|Other Reasons|16|||
126405178|NCT01943552|454778160|FG001|Overall Study|Other Reasons|17|||
126405179|NCT01600053|454778161|FG000|Overall Study|Adverse Event|2|||
126405180|NCT01600053|454778161|FG000|Overall Study|trial will not meet the interim endpoint|9|||
126405181|NCT02445573|454778162|FG000|Overall Study|Withdrawal by Subject|1|||
126405182|NCT02445573|454778163|FG001|Overall Study|Withdrawal by Subject|1|||
126405183|NCT02445573|454778162|FG000|Overall Study|Lost to Follow-up|0|||
126405184|NCT02445573|454778163|FG001|Overall Study|Lost to Follow-up|1|||
126405185|NCT02855944|454778164|FG000|Period 1: Treatment|Ongoing|14|||
126405186|NCT02855944|454778165|FG001|Period 1: Treatment|Ongoing|0|||
126405187|NCT02855944|454778164|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
126405188|NCT02855944|454778165|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
126405189|NCT02855944|454778164|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
126405190|NCT02855944|454778165|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
126405191|NCT01475162|454778172|FG000|Overall Study|Physician Decision|1|||
126405192|NCT01475162|454778172|FG000|Overall Study|Death|10|||
126405193|NCT01475162|454778172|FG000|Overall Study|Study closed for safety|3|||
126405194|NCT00490022|454778173|FG000|Overall Study|Adverse Event|0|||
126405195|NCT00490022|454778174|FG001|Overall Study|Adverse Event|2|||
126405196|NCT00490022|454778173|FG000|Overall Study|Withdrawal by Subject|1|||
126405197|NCT00490022|454778174|FG001|Overall Study|Withdrawal by Subject|0|||
126405198|NCT00490022|454778173|FG000|Overall Study|Subject failed to disclose concommitant|0|||
126405199|NCT00490022|454778174|FG001|Overall Study|Subject failed to disclose concommitant|1|||
126405200|NCT01283542|454778175|FG000|Main Phase|Acute or progressive vision loss|1|||
126405201|NCT01283542|454778175|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
126405202|NCT01283542|454778175|FG000|Main Phase|abnormal laboratory values|5|||
126405203|NCT01283542|454778175|FG000|Extension Phase|Physician Decision|1|||
126405204|NCT01283542|454778175|FG000|Extension Phase|Adverse Event|1|||
126405205|NCT01283542|454778175|FG000|Extension Phase|Administrative problems|1|||
126405206|NCT00576472|454778177|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405207|NCT00576472|454778178|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405208|NCT00576472|454778179|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405209|NCT00576472|454778180|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
126405210|NCT00576472|454778181|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405211|NCT00576472|454778182|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405212|NCT00576472|454778183|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405213|NCT00576472|454778184|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405214|NCT00576472|454778185|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405215|NCT00576472|454778186|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405216|NCT00576472|454778187|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405217|NCT00576472|454778188|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405218|NCT00576472|454778189|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405219|NCT00576472|454778190|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405220|NCT00576472|454778191|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405221|NCT00576472|454778177|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
126405222|NCT00576472|454778178|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
126405223|NCT00576472|454778179|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
126405224|NCT00576472|454778180|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
126405225|NCT00576472|454778181|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
126405226|NCT00576472|454778182|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
126405227|NCT00576472|454778183|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
126405228|NCT00576472|454778184|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
126405229|NCT00576472|454778185|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
126405230|NCT00576472|454778186|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
126405231|NCT00576472|454778187|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
126405232|NCT00576472|454778188|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
126405233|NCT00576472|454778189|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
126405234|NCT00576472|454778190|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
126405235|NCT00576472|454778191|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
126405236|NCT00576472|454778177|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405237|NCT00576472|454778178|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405238|NCT00576472|454778179|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405239|NCT00576472|454778180|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
126405240|NCT00576472|454778181|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405241|NCT00576472|454778182|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405242|NCT00576472|454778183|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405243|NCT00576472|454778184|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405244|NCT00576472|454778185|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405245|NCT00576472|454778186|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405246|NCT00576472|454778187|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405247|NCT00576472|454778188|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405248|NCT00576472|454778189|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405249|NCT00576472|454778190|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405250|NCT00576472|454778191|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405251|NCT00576472|454778177|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
126405252|NCT00576472|454778178|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
126405253|NCT00576472|454778179|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
126405254|NCT00576472|454778180|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
126405255|NCT00576472|454778181|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
126405256|NCT00576472|454778182|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
126405257|NCT00576472|454778183|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
126405258|NCT00576472|454778184|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
126405259|NCT00576472|454778185|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
126405260|NCT00576472|454778186|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
126405261|NCT00576472|454778187|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
126405262|NCT00576472|454778188|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
126405263|NCT00576472|454778189|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
126405264|NCT00576472|454778190|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
126405265|NCT00576472|454778191|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
126405266|NCT00576472|454778177|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405267|NCT00576472|454778178|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405268|NCT00576472|454778179|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405269|NCT00576472|454778180|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
126405270|NCT00576472|454778181|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405271|NCT00576472|454778182|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405272|NCT00576472|454778183|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405273|NCT00576472|454778184|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405274|NCT00576472|454778185|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405275|NCT00576472|454778186|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405276|NCT00576472|454778187|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405277|NCT00576472|454778188|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405278|NCT00576472|454778189|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405279|NCT00576472|454778190|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405280|NCT00576472|454778191|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405281|NCT00576472|454778177|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405282|NCT00576472|454778178|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405283|NCT00576472|454778179|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405284|NCT00576472|454778180|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405285|NCT00576472|454778181|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405286|NCT00576472|454778182|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405287|NCT00576472|454778183|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
126405288|NCT00576472|454778184|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405289|NCT00576472|454778185|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405290|NCT00576472|454778186|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405291|NCT00576472|454778187|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405292|NCT00576472|454778188|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405293|NCT00576472|454778189|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405294|NCT00576472|454778190|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405295|NCT00576472|454778191|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405296|NCT00576472|454778177|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
126405297|NCT00576472|454778178|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
126405298|NCT00576472|454778179|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
126405299|NCT00576472|454778180|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
126405300|NCT00576472|454778181|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
126405301|NCT00576472|454778182|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
126405302|NCT00576472|454778183|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
126405303|NCT00576472|454778184|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
126405304|NCT00576472|454778185|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
126405305|NCT00576472|454778186|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
126405306|NCT00576472|454778187|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
126405307|NCT00576472|454778188|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
126405308|NCT00576472|454778189|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
126405309|NCT00576472|454778190|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
126405310|NCT00576472|454778191|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
126405311|NCT00576472|454778177|FG000|MPH Cross Over Phase|Physician Decision|0|||
126405312|NCT00576472|454778178|FG001|MPH Cross Over Phase|Physician Decision|0|||
126405313|NCT00576472|454778179|FG002|MPH Cross Over Phase|Physician Decision|0|||
126405314|NCT00576472|454778180|FG003|MPH Cross Over Phase|Physician Decision|0|||
126405315|NCT00576472|454778181|FG004|MPH Cross Over Phase|Physician Decision|0|||
126405316|NCT00576472|454778182|FG005|MPH Cross Over Phase|Physician Decision|0|||
126405317|NCT00576472|454778183|FG006|MPH Cross Over Phase|Physician Decision|4|||
126405318|NCT00576472|454778184|FG007|MPH Cross Over Phase|Physician Decision|0|||
126405319|NCT00576472|454778185|FG008|MPH Cross Over Phase|Physician Decision|0|||
126405320|NCT00576472|454778186|FG009|MPH Cross Over Phase|Physician Decision|0|||
126405321|NCT00576472|454778187|FG010|MPH Cross Over Phase|Physician Decision|0|||
126405322|NCT00576472|454778188|FG011|MPH Cross Over Phase|Physician Decision|0|||
126405323|NCT00576472|454778189|FG012|MPH Cross Over Phase|Physician Decision|0|||
126405324|NCT00576472|454778190|FG013|MPH Cross Over Phase|Physician Decision|0|||
126405325|NCT00576472|454778191|FG014|MPH Cross Over Phase|Physician Decision|0|||
126405326|NCT00576472|454778177|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405327|NCT00576472|454778178|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405328|NCT00576472|454778179|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405329|NCT00576472|454778180|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405330|NCT00576472|454778181|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405331|NCT00576472|454778182|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405332|NCT00576472|454778183|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405333|NCT00576472|454778184|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405334|NCT00576472|454778185|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
126405335|NCT00576472|454778186|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405336|NCT00576472|454778187|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
126405337|NCT00576472|454778188|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
126405338|NCT00576472|454778189|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405339|NCT00576472|454778190|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405340|NCT00576472|454778191|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405341|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405342|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405343|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405344|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405345|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405346|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405347|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405348|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405349|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405350|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405351|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405352|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405353|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405354|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
126405355|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405356|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
126405357|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
126405358|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
126405359|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
126405360|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
126405361|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
126405362|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
126405363|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
126405364|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
126405365|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
126405366|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
126405367|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
126405368|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
126405369|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
126405370|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
126405371|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
126405372|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
126405373|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
126405374|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
126405375|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
126405376|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
126405377|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
126405378|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
126405379|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
126405380|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
126405381|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
126405382|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
126405383|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
126405384|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
126405385|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
126405386|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Side effects|0|||
126405387|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Side effects|0|||
126405388|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Side effects|0|||
126405389|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Side effects|0|||
126405390|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Side effects|0|||
126405391|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Side effects|0|||
126405392|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Side effects|0|||
126405393|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Side effects|0|||
126405394|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Side effects|0|||
126405395|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Side effects|0|||
126405396|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Side effects|0|||
126405397|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Side effects|0|||
126405398|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Side effects|0|||
126405399|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Side effects|0|||
126405400|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Side effects|8|||
126405401|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405402|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405403|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405404|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405405|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405406|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405407|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405408|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405409|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405410|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405411|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405412|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405413|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405414|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405415|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
126405416|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
126405417|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
126405418|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
126405419|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
126405420|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
126405421|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
126405422|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
126405423|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
126405424|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
126405425|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
126405426|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
126405427|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
126405428|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
126405429|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
126405430|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
126405431|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405432|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405433|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405434|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405435|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125890271|NCT05300763|452895488|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125890272|NCT00441064|452895493|FG000|Overall Study|Adverse Event|1|||
125890273|NCT00441064|452895494|FG001|Overall Study|Adverse Event|0|||
125890274|NCT00441064|452895493|FG000|Overall Study|Abnormal laboratory values|0|||
125890275|NCT00441064|452895494|FG001|Overall Study|Abnormal laboratory values|2|||
125890276|NCT00441064|452895493|FG000|Overall Study|Abnormal test procedure results|0|||
125890277|NCT00441064|452895494|FG001|Overall Study|Abnormal test procedure results|1|||
125890278|NCT00441064|452895493|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125890279|NCT00441064|452895494|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125890280|NCT00441064|452895493|FG000|Overall Study|Protocol Deviation|3|||
125890281|NCT00441064|452895494|FG001|Overall Study|Protocol Deviation|2|||
125890282|NCT00441064|452895493|FG000|Overall Study|Patient withdrew consent|5|||
125890283|NCT00441064|452895494|FG001|Overall Study|Patient withdrew consent|2|||
125890284|NCT00953056|452895495|FG000|Overall Study|Withdrew Consent|0|||
125890285|NCT00953056|452895496|FG001|Overall Study|Withdrew Consent|0|||
125890286|NCT00953056|452895497|FG002|Overall Study|Withdrew Consent|0|||
125890287|NCT00953056|452895498|FG003|Overall Study|Withdrew Consent|0|||
125890288|NCT00953056|452895499|FG004|Overall Study|Withdrew Consent|2|||
125890289|NCT00953056|452895500|FG005|Overall Study|Withdrew Consent|3|||
125890290|NCT00953056|452895495|FG000|Overall Study|Serious Adverse Event|0|||
125890291|NCT00953056|452895496|FG001|Overall Study|Serious Adverse Event|0|||
125890292|NCT00953056|452895497|FG002|Overall Study|Serious Adverse Event|0|||
125890293|NCT00953056|452895498|FG003|Overall Study|Serious Adverse Event|0|||
125890294|NCT00953056|452895499|FG004|Overall Study|Serious Adverse Event|0|||
125890295|NCT00953056|452895500|FG005|Overall Study|Serious Adverse Event|1|||
125890296|NCT03962504|452895501|FG000|Overall Study|Other|11|||
125890297|NCT03962504|452895502|FG001|Overall Study|Other|32|||
125890298|NCT01077076|452895503|FG000|First Intervention|Withdrawal by Subject|1|||
125890299|NCT01077076|452895504|FG001|First Intervention|Withdrawal by Subject|0|||
125890300|NCT01077076|452895505|FG002|First Intervention|Withdrawal by Subject|0|||
125890301|NCT01077076|452895506|FG003|First Intervention|Withdrawal by Subject|0|||
125890302|NCT01077076|452895507|FG004|First Intervention|Withdrawal by Subject|0|||
125890303|NCT01077076|452895508|FG005|First Intervention|Withdrawal by Subject|0|||
125890304|NCT01077076|452895503|FG000|Third Intervention|Death in the participant's family|0|||
125890305|NCT01077076|452895504|FG001|Third Intervention|Death in the participant's family|0|||
125890306|NCT01077076|452895505|FG002|Third Intervention|Death in the participant's family|0|||
125890307|NCT01077076|452895506|FG003|Third Intervention|Death in the participant's family|0|||
125890308|NCT01077076|452895507|FG004|Third Intervention|Death in the participant's family|0|||
125890309|NCT01077076|452895508|FG005|Third Intervention|Death in the participant's family|1|||
125890310|NCT01976741|452895509|FG000|Overall Study|Withdrawal by Subject|1|||
125890311|NCT01976741|452895510|FG001|Overall Study|Withdrawal by Subject|0|||
125890312|NCT01976741|452895511|FG002|Overall Study|Withdrawal by Subject|1|||
125890313|NCT01976741|452895512|FG003|Overall Study|Withdrawal by Subject|1|||
125890314|NCT01976741|452895513|FG004|Overall Study|Withdrawal by Subject|0|||
125890315|NCT01976741|452895514|FG005|Overall Study|Withdrawal by Subject|0|||
125890316|NCT01976741|452895515|FG006|Overall Study|Withdrawal by Subject|1|||
125890317|NCT01976741|452895516|FG007|Overall Study|Withdrawal by Subject|4|||
125890318|NCT01976741|452895517|FG008|Overall Study|Withdrawal by Subject|0|||
125890319|NCT01976741|452895518|FG009|Overall Study|Withdrawal by Subject|0|||
125890320|NCT01976741|452895509|FG000|Overall Study|Adverse Event|0|||
125890321|NCT01976741|452895510|FG001|Overall Study|Adverse Event|0|||
125890322|NCT01976741|452895511|FG002|Overall Study|Adverse Event|2|||
125890323|NCT01976741|452895512|FG003|Overall Study|Adverse Event|0|||
125890324|NCT01976741|452895513|FG004|Overall Study|Adverse Event|0|||
125890325|NCT01976741|452895514|FG005|Overall Study|Adverse Event|0|||
125890326|NCT01976741|452895515|FG006|Overall Study|Adverse Event|3|||
125890327|NCT01976741|452895516|FG007|Overall Study|Adverse Event|8|||
125890328|NCT01976741|452895517|FG008|Overall Study|Adverse Event|1|||
126405436|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405437|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405438|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125890329|NCT01976741|452895518|FG009|Overall Study|Adverse Event|4|||
125890330|NCT00889720|452895519|FG000|Overall Study|Withdrawal by Subject|4|||
125890331|NCT00889720|452895519|FG000|Overall Study|Other|4|||
125890332|NCT00670306|452895520|FG000|Overall Study|Adverse Event|8|||
125890333|NCT00670306|452895520|FG000|Overall Study|Lack of Efficacy|10|||
125890334|NCT00670306|452895520|FG000|Overall Study|Withdrawal by Subject|9|||
125890335|NCT00670306|452895520|FG000|Overall Study|Physician Decision|1|||
125890336|NCT00670306|452895520|FG000|Overall Study|Lost to Follow-up|8|||
125890337|NCT00670306|452895520|FG000|Overall Study|incl/excl criterias did not meet|19|||
125890338|NCT01327482|452895521|FG000|Overall Study|Adverse Event|1|||
125890339|NCT00476229|452895522|FG000|Overall Study|Progressive shortness of breath|1|||
125890340|NCT04193189|452895524|FG000|Overall Study|Lost to Follow-up|9|||
126405439|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405440|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405441|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405442|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405443|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405444|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405445|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
126405446|NCT03263780|454778194|FG000|Overall Study|Withdrawal by Subject|3|||
126405447|NCT03263780|454778194|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
126405448|NCT01504204|454778197|FG000|Overall Study|Lost to Follow-up|1|||
126405449|NCT01504204|454778198|FG001|Overall Study|Lost to Follow-up|1|||
126405450|NCT00903331|454778199|FG000|Overall Study|Death|4|||
126405451|NCT00903331|454778200|FG001|Overall Study|Death|8|||
126405452|NCT00903331|454778199|FG000|Overall Study|Withdrawal of consent|1|||
126405453|NCT00903331|454778200|FG001|Overall Study|Withdrawal of consent|8|||
126405454|NCT00903331|454778199|FG000|Overall Study|Lung transplant|0|||
126405455|NCT00903331|454778200|FG001|Overall Study|Lung transplant|2|||
126405456|NCT02723175|454778201|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
126405457|NCT02723175|454778202|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
126405458|NCT02723175|454778201|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
126405459|NCT02723175|454778202|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
126405460|NCT00257660|454778205|FG000|Overall Study|Lack of Efficacy|5|||
126405461|NCT00257660|454778206|FG001|Overall Study|Lack of Efficacy|23|||
126405462|NCT00257660|454778205|FG000|Overall Study|Withdrawal by Subject|2|||
126405463|NCT00257660|454778206|FG001|Overall Study|Withdrawal by Subject|0|||
126405464|NCT00257660|454778205|FG000|Overall Study|Lost to Follow-up|1|||
126405465|NCT00257660|454778206|FG001|Overall Study|Lost to Follow-up|0|||
126405466|NCT00257660|454778205|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
126405467|NCT00257660|454778206|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
126405468|NCT00257660|454778205|FG000|Overall Study|No longer wanted to do blood draws|1|||
126405469|NCT00257660|454778206|FG001|Overall Study|No longer wanted to do blood draws|0|||
126405470|NCT01977690|454778209|FG000|Overall Study|Withdrawal by Subject|0|||
126405471|NCT01977690|454778210|FG001|Overall Study|Withdrawal by Subject|4|||
126405472|NCT00447122|454778211|FG000|Overall Study|worsening medical condition -came off|0|||
126405473|NCT00447122|454778212|FG001|Overall Study|worsening medical condition -came off|1|||
126405474|NCT00447122|454778213|FG002|Overall Study|worsening medical condition -came off|0|||
126405475|NCT00447122|454778214|FG003|Overall Study|worsening medical condition -came off|0|||
126405476|NCT01174173|454778219|FG000|Overall Study|drug-drug interaction|1|||
126405477|NCT03938324|454779427|FG000|Overall Study|Lost to Follow-up|42|||
126405478|NCT03938324|454779428|FG001|Overall Study|Lost to Follow-up|21|||
126405479|NCT03938324|454779427|FG000|Overall Study|Withdrawal by Subject|6|||
126405480|NCT03938324|454779428|FG001|Overall Study|Withdrawal by Subject|1|||
126405481|NCT02769962|454779429|FG000|Overall Study|Physician Decision|0|||
126405482|NCT02769962|454779430|FG001|Overall Study|Physician Decision|0|||
126405483|NCT02769962|454779431|FG002|Overall Study|Physician Decision|0|||
126405484|NCT02769962|454779432|FG003|Overall Study|Physician Decision|0|||
126405485|NCT02769962|454779433|FG004|Overall Study|Physician Decision|0|||
126405486|NCT02769962|454779434|FG005|Overall Study|Physician Decision|1|||
126405487|NCT02769962|454779435|FG006|Overall Study|Physician Decision|0|||
126405488|NCT02769962|454779436|FG007|Overall Study|Physician Decision|1|||
126405489|NCT02769962|454779429|FG000|Overall Study|Refused further treatment|0|||
126405490|NCT02769962|454779430|FG001|Overall Study|Refused further treatment|0|||
126405491|NCT02769962|454779431|FG002|Overall Study|Refused further treatment|0|||
126405492|NCT02769962|454779432|FG003|Overall Study|Refused further treatment|0|||
126405493|NCT02769962|454779433|FG004|Overall Study|Refused further treatment|0|||
126405494|NCT02769962|454779434|FG005|Overall Study|Refused further treatment|1|||
126405495|NCT02769962|454779435|FG006|Overall Study|Refused further treatment|1|||
126405496|NCT02769962|454779436|FG007|Overall Study|Refused further treatment|0|||
126405497|NCT00837759|454779437|FG000|Overall Study|Protocol Violation|3|||
126405498|NCT00837759|454779437|FG000|Overall Study|Lost to Follow-up|1|||
126405499|NCT01918332|454779438|FG000|Overall Study|Adverse Event|0|||
126405500|NCT01918332|454779439|FG001|Overall Study|Adverse Event|0|||
126405501|NCT01918332|454779440|FG002|Overall Study|Adverse Event|0|||
126405502|NCT01918332|454779441|FG003|Overall Study|Adverse Event|1|||
126405503|NCT01918332|454779438|FG000|Overall Study|Withdrawal by Subject|2|||
126405504|NCT01918332|454779439|FG001|Overall Study|Withdrawal by Subject|3|||
126405505|NCT01918332|454779440|FG002|Overall Study|Withdrawal by Subject|2|||
126405506|NCT01918332|454779441|FG003|Overall Study|Withdrawal by Subject|3|||
126405507|NCT01918332|454779438|FG000|Overall Study|Protocol Violation|6|||
126405508|NCT01918332|454779439|FG001|Overall Study|Protocol Violation|2|||
126405509|NCT01918332|454779440|FG002|Overall Study|Protocol Violation|6|||
126405510|NCT01918332|454779441|FG003|Overall Study|Protocol Violation|3|||
126405511|NCT01918332|454779438|FG000|Overall Study|lipid result by central lab did not meet|0|||
126405512|NCT01918332|454779439|FG001|Overall Study|lipid result by central lab did not meet|0|||
126405513|NCT01918332|454779440|FG002|Overall Study|lipid result by central lab did not meet|1|||
125890341|NCT04193189|452895525|FG001|Overall Study|Lost to Follow-up|7|||
126405514|NCT01918332|454779441|FG003|Overall Study|lipid result by central lab did not meet|0|||
126405515|NCT02408523|454779442|FG000|Overall Study|Adverse Event|4|||
126405516|NCT02408523|454779443|FG001|Overall Study|Adverse Event|10|||
126405517|NCT02408523|454779442|FG000|Overall Study|Lack of Efficacy|0|||
126405518|NCT02408523|454779443|FG001|Overall Study|Lack of Efficacy|1|||
126405519|NCT02408523|454779442|FG000|Overall Study|Protocol Violation|1|||
126405520|NCT02408523|454779443|FG001|Overall Study|Protocol Violation|2|||
126405521|NCT02408523|454779442|FG000|Overall Study|Lost to Follow-up|2|||
126405522|NCT02408523|454779443|FG001|Overall Study|Lost to Follow-up|3|||
126405523|NCT02408523|454779442|FG000|Overall Study|Withdrawal by Subject|3|||
126405524|NCT02408523|454779443|FG001|Overall Study|Withdrawal by Subject|1|||
126405525|NCT02408523|454779442|FG000|Overall Study|Sponsor request|1|||
126405526|NCT02408523|454779443|FG001|Overall Study|Sponsor request|0|||
126405527|NCT02408523|454779442|FG000|Overall Study|Did not satisfy extension conditions|0|||
126405528|NCT02408523|454779443|FG001|Overall Study|Did not satisfy extension conditions|1|||
126405529|NCT05063539|454779444|FG000|Overall Study|Adverse Event|1|||
126405530|NCT05063539|454779445|FG001|Overall Study|Adverse Event|2|||
126405531|NCT05063539|454779446|FG002|Overall Study|Adverse Event|1|||
126405532|NCT05063539|454779444|FG000|Overall Study|Death|0|||
126405533|NCT05063539|454779445|FG001|Overall Study|Death|1|||
126405534|NCT05063539|454779446|FG002|Overall Study|Death|1|||
126405535|NCT05063539|454779444|FG000|Overall Study|Lost to Follow-up|0|||
126405536|NCT05063539|454779445|FG001|Overall Study|Lost to Follow-up|1|||
126405537|NCT05063539|454779446|FG002|Overall Study|Lost to Follow-up|0|||
126405538|NCT05063539|454779444|FG000|Overall Study|Physician Decision|4|||
126405539|NCT05063539|454779445|FG001|Overall Study|Physician Decision|3|||
126405540|NCT05063539|454779446|FG002|Overall Study|Physician Decision|1|||
126405541|NCT05063539|454779444|FG000|Overall Study|Progressive Disease|0|||
126405542|NCT05063539|454779445|FG001|Overall Study|Progressive Disease|2|||
126405543|NCT05063539|454779446|FG002|Overall Study|Progressive Disease|0|||
126405544|NCT05063539|454779444|FG000|Overall Study|Withdrawal by Subject|17|||
126405545|NCT05063539|454779445|FG001|Overall Study|Withdrawal by Subject|26|||
126405546|NCT05063539|454779446|FG002|Overall Study|Withdrawal by Subject|14|||
126405547|NCT05063539|454779444|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
126405548|NCT05063539|454779445|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
126405549|NCT05063539|454779446|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
126405550|NCT05063539|454779444|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
126405551|NCT05063539|454779445|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
126405552|NCT05063539|454779446|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
126405553|NCT05063539|454779444|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
126405554|NCT05063539|454779445|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
126405555|NCT05063539|454779446|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
126405556|NCT05063539|454779444|FG000|Overall Study|Discontinued due to Common Close Design|0|||
126405557|NCT05063539|454779445|FG001|Overall Study|Discontinued due to Common Close Design|1|||
126405558|NCT05063539|454779446|FG002|Overall Study|Discontinued due to Common Close Design|0|||
126405559|NCT05063539|454779444|FG000|Overall Study|Participant not co-operative|0|||
126405560|NCT05063539|454779445|FG001|Overall Study|Participant not co-operative|1|||
126405561|NCT05063539|454779446|FG002|Overall Study|Participant not co-operative|0|||
126405562|NCT05063539|454779444|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
126405563|NCT05063539|454779445|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
126405564|NCT05063539|454779446|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
126405565|NCT05063539|454779444|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
126405566|NCT05063539|454779445|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
126405567|NCT05063539|454779446|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
126405568|NCT04256512|454779447|FG000|Overall Study|Withdrawal by Subject|1|||
126405569|NCT01751139|454779448|FG000|Overall Study|Other|135|||
126405570|NCT01751139|454779448|FG000|Overall Study|Sponsor study termination|1609|||
126405571|NCT01751139|454779448|FG000|Overall Study|Lost to Follow-up|240|||
126405572|NCT01751139|454779448|FG000|Overall Study|Withdrawal by Subject|251|||
126405573|NCT01751139|454779448|FG000|Overall Study|Adverse Event|1|||
126405574|NCT01751139|454779448|FG000|Overall Study|Death|31|||
126405575|NCT01867086|454779449|FG000|Overall Study|Disease Progression|1|||
126405576|NCT04279613|454779450|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125890342|NCT04193189|452895526|FG002|Overall Study|Lost to Follow-up|9|||
126405577|NCT04279613|454779451|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
126405578|NCT04279613|454779452|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
126405579|NCT04279613|454779453|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
126405580|NCT04279613|454779454|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
126405581|NCT04279613|454779450|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
126405582|NCT04279613|454779451|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
126405583|NCT04279613|454779452|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
126405584|NCT04279613|454779453|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
126405585|NCT04279613|454779454|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
126405586|NCT04279613|454779450|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
126405587|NCT04279613|454779451|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
126405588|NCT04279613|454779452|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
126405589|NCT04279613|454779453|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
126405590|NCT04279613|454779454|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
126405591|NCT04279613|454779450|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
126405592|NCT04279613|454779451|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
126405593|NCT04279613|454779452|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
126405594|NCT04279613|454779453|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
126405595|NCT04279613|454779454|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
126405596|NCT04279613|454779450|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
126405597|NCT04279613|454779451|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
126405598|NCT04279613|454779452|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
126405599|NCT04279613|454779453|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
126405600|NCT04279613|454779454|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
126405601|NCT04428151|454779455|FG000|Overall Study|Death|100|||
126405602|NCT04428151|454779456|FG001|Overall Study|Death|86|||
126405603|NCT04428151|454779457|FG002|Overall Study|Death|57|||
126405604|NCT04428151|454779455|FG000|Overall Study|Lost to Follow-up|1|||
126405605|NCT04428151|454779456|FG001|Overall Study|Lost to Follow-up|1|||
126405606|NCT04428151|454779457|FG002|Overall Study|Lost to Follow-up|0|||
126405607|NCT04428151|454779455|FG000|Overall Study|Withdrawal by Subject|2|||
126405608|NCT04428151|454779456|FG001|Overall Study|Withdrawal by Subject|2|||
126405609|NCT04428151|454779457|FG002|Overall Study|Withdrawal by Subject|3|||
126405610|NCT04428151|454779455|FG000|Overall Study|Participant Ongoing in Study|41|||
126405611|NCT04428151|454779456|FG001|Overall Study|Participant Ongoing in Study|53|||
126405612|NCT04428151|454779457|FG002|Overall Study|Participant Ongoing in Study|28|||
126405613|NCT02704689|454779458|FG000|Overall Study|Physician Decision|1|||
126405614|NCT02704689|454779458|FG000|Overall Study|Study device not implanted|2|||
126405615|NCT02212678|454779461|FG000|Overall Study|Adverse Event|1|||
126405616|NCT02337634|454779462|FG000|Overall Study|Protocol Violation|3|||
126405617|NCT02337634|454779463|FG001|Overall Study|Protocol Violation|1|||
126405618|NCT02337634|454779462|FG000|Overall Study|Lost to Follow-up|1|||
126405619|NCT02337634|454779463|FG001|Overall Study|Lost to Follow-up|0|||
126405620|NCT04068610|454779464|FG000|Overall Study|Death|4|||
126405621|NCT04068610|454779465|FG001|Overall Study|Death|8|||
126405622|NCT04068610|454779466|FG002|Overall Study|Death|13|||
126405623|NCT04068610|454779464|FG000|Overall Study|Lost to Follow-up|0|||
126405624|NCT04068610|454779465|FG001|Overall Study|Lost to Follow-up|2|||
126405625|NCT04068610|454779466|FG002|Overall Study|Lost to Follow-up|0|||
126405626|NCT04068610|454779464|FG000|Overall Study|Withdrawal by Subject|0|||
126405627|NCT04068610|454779465|FG001|Overall Study|Withdrawal by Subject|4|||
126405628|NCT04068610|454779466|FG002|Overall Study|Withdrawal by Subject|2|||
126405629|NCT04068610|454779464|FG000|Overall Study|Other|3|||
126405630|NCT04068610|454779465|FG001|Overall Study|Other|12|||
126405631|NCT04068610|454779466|FG002|Overall Study|Other|11|||
126405632|NCT02428205|454779467|FG000|Overall Study|Lack of Efficacy|1|||
126405633|NCT02428205|454779468|FG001|Overall Study|Lack of Efficacy|0|||
126405634|NCT02428205|454779467|FG000|Overall Study|Lost to Follow-up|1|||
126405635|NCT02428205|454779468|FG001|Overall Study|Lost to Follow-up|1|||
126405636|NCT02428205|454779467|FG000|Overall Study|Worse behavior|0|||
126405637|NCT02428205|454779468|FG001|Overall Study|Worse behavior|1|||
126405638|NCT00527319|454779469|FG000|Overall Study|Withdrawal by Subject|5|||
126405639|NCT00527319|454779470|FG001|Overall Study|Withdrawal by Subject|0|||
126405640|NCT00527319|454779471|FG002|Overall Study|Withdrawal by Subject|1|||
126405641|NCT00527319|454779469|FG000|Overall Study|Lost to Follow-up|1|||
126405642|NCT00527319|454779470|FG001|Overall Study|Lost to Follow-up|0|||
126405643|NCT00527319|454779471|FG002|Overall Study|Lost to Follow-up|0|||
126405644|NCT00527319|454779469|FG000|Overall Study|Death|0|||
126405645|NCT00527319|454779470|FG001|Overall Study|Death|3|||
126405646|NCT00527319|454779471|FG002|Overall Study|Death|1|||
126405647|NCT00527319|454779469|FG000|Overall Study|Intercurrent Medical Illness|0|||
126405648|NCT00527319|454779470|FG001|Overall Study|Intercurrent Medical Illness|1|||
125890343|NCT04193189|452895527|FG003|Overall Study|Lost to Follow-up|0|||
126405649|NCT00527319|454779471|FG002|Overall Study|Intercurrent Medical Illness|3|||
126405650|NCT00527319|454779469|FG000|Overall Study|Adverse Event|0|||
126405651|NCT00527319|454779470|FG001|Overall Study|Adverse Event|0|||
125890344|NCT04193189|452895524|FG000|Overall Study|Withdrawal by Subject|1|||
126053707|NCT04745676|453490674|FG000|Overall Study|Death|1|||
126053708|NCT04745676|453490675|FG001|Overall Study|Death|0|||
126053709|NCT04745676|453490676|FG002|Overall Study|Death|0|||
126405652|NCT00527319|454779471|FG002|Overall Study|Adverse Event|1|||
126405653|NCT00680368|454779477|FG000|Overall Study|not supervised, not eligible|15|||
126405654|NCT00443781|454779482|FG000|Overall Study|Lost to Follow-up|10|||
126405655|NCT00443781|454779482|FG000|Overall Study|Physician Decision|2|||
126405656|NCT00443781|454779482|FG000|Overall Study|Protocol Violation|1|||
126405657|NCT00443781|454779482|FG000|Overall Study|Withdrawal by Subject|6|||
126405658|NCT00443781|454779482|FG000|Overall Study|Unable to comply with study follow up|2|||
126405659|NCT00443781|454779482|FG000|Overall Study|Investigator terminated participation|1|||
126405660|NCT00443781|454779482|FG000|Overall Study|Insurance not covered|2|||
126405661|NCT00443781|454779482|FG000|Overall Study|PD/FAD not done|1|||
126405662|NCT02066415|454779483|FG000|Overall Study|Decision by Sponsor|5|||
126405663|NCT02066415|454779484|FG001|Overall Study|Decision by Sponsor|4|||
126405664|NCT02066415|454779485|FG002|Overall Study|Decision by Sponsor|2|||
126405665|NCT02066415|454779483|FG000|Overall Study|Withdrawal by Subject|9|||
126405666|NCT02066415|454779484|FG001|Overall Study|Withdrawal by Subject|1|||
126405667|NCT02066415|454779485|FG002|Overall Study|Withdrawal by Subject|4|||
126405668|NCT02066415|454779483|FG000|Overall Study|Lost to Follow-up|7|||
126405669|NCT02066415|454779484|FG001|Overall Study|Lost to Follow-up|2|||
126405670|NCT02066415|454779485|FG002|Overall Study|Lost to Follow-up|2|||
126405671|NCT00430937|454779486|FG000|Overall Study|Adverse Event|3|||
126405672|NCT00430937|454779487|FG001|Overall Study|Adverse Event|8|||
126405673|NCT00430937|454779486|FG000|Overall Study|Death|0|||
126405674|NCT00430937|454779487|FG001|Overall Study|Death|1|||
126405675|NCT00430937|454779486|FG000|Overall Study|Lost to Follow-up|6|||
126405676|NCT00430937|454779487|FG001|Overall Study|Lost to Follow-up|6|||
126405677|NCT00430937|454779486|FG000|Overall Study|Withdrawal by Subject|5|||
126405678|NCT00430937|454779487|FG001|Overall Study|Withdrawal by Subject|2|||
126405679|NCT00430937|454779486|FG000|Overall Study|Protocol Violation|3|||
126405680|NCT00430937|454779487|FG001|Overall Study|Protocol Violation|2|||
126405681|NCT00430937|454779486|FG000|Overall Study|Lack of Efficacy|6|||
126405682|NCT00430937|454779487|FG001|Overall Study|Lack of Efficacy|5|||
126405683|NCT00430937|454779486|FG000|Overall Study|Inappropriate enrollment|2|||
126405684|NCT00430937|454779487|FG001|Overall Study|Inappropriate enrollment|1|||
126405685|NCT00430937|454779486|FG000|Overall Study|Administrative reasons|1|||
126405686|NCT00430937|454779487|FG001|Overall Study|Administrative reasons|0|||
126405687|NCT00430937|454779486|FG000|Overall Study|Protocol discontinuation criteria met|1|||
126405688|NCT00430937|454779487|FG001|Overall Study|Protocol discontinuation criteria met|2|||
126405689|NCT00430937|454779486|FG000|Overall Study|Unable to classify|0|||
126405690|NCT00430937|454779487|FG001|Overall Study|Unable to classify|1|||
126405691|NCT00582738|454779490|FG000|Overall Study|Administrative Problems|7|||
126405692|NCT00582738|454779491|FG001|Overall Study|Administrative Problems|8|||
126405693|NCT00582738|454779490|FG000|Overall Study|Adverse Event|0|||
126405694|NCT00582738|454779491|FG001|Overall Study|Adverse Event|5|||
126405695|NCT00582738|454779490|FG000|Overall Study|Graft Lost|0|||
126405696|NCT00582738|454779491|FG001|Overall Study|Graft Lost|1|||
126405697|NCT00582738|454779490|FG000|Overall Study|Other|1|||
126405698|NCT00582738|454779491|FG001|Overall Study|Other|0|||
126405699|NCT00582738|454779490|FG000|Overall Study|Protocol Violation|1|||
126405700|NCT00582738|454779491|FG001|Overall Study|Protocol Violation|1|||
126405701|NCT00582738|454779490|FG000|Overall Study|Withdrawal by Subject|0|||
126405702|NCT00582738|454779491|FG001|Overall Study|Withdrawal by Subject|3|||
126405703|NCT01639755|454779492|FG000|Overall Study|Study Ongoing|15|||
126405704|NCT01639755|454779492|FG000|Overall Study|Patient had device explantation|4|||
126405705|NCT05059977|454779498|FG000|Overall Study|Withdrawal by Subject|0|||
126405706|NCT05059977|454779499|FG001|Overall Study|Withdrawal by Subject|0|||
126405707|NCT05059977|454779500|FG002|Overall Study|Withdrawal by Subject|1|||
126405708|NCT04109976|454779509|FG000|Overall Study|Withdrawal by Subject|1|||
126405709|NCT04109976|454779510|FG001|Overall Study|Withdrawal by Subject|0|||
126405710|NCT02449018|454779513|FG000|Overall Study|Abnormal laboratory value|0|||
126405711|NCT02449018|454779514|FG001|Overall Study|Abnormal laboratory value|1|||
126405712|NCT02449018|454779513|FG000|Overall Study|Administrative problems|1|||
126405713|NCT02449018|454779514|FG001|Overall Study|Administrative problems|0|||
126405714|NCT02449018|454779513|FG000|Overall Study|Adverse Event|5|||
126405715|NCT02449018|454779514|FG001|Overall Study|Adverse Event|1|||
126405716|NCT02449018|454779513|FG000|Overall Study|Protocol deviation|4|||
126405717|NCT02449018|454779514|FG001|Overall Study|Protocol deviation|0|||
126405718|NCT02449018|454779513|FG000|Overall Study|Patient decision|2|||
126405719|NCT02449018|454779514|FG001|Overall Study|Patient decision|0|||
126405720|NCT03995355|454779515|FG000|Overall Study|Adverse Event|1|||
126405721|NCT03995355|454779516|FG001|Overall Study|Adverse Event|0|||
126405722|NCT03995355|454779515|FG000|Overall Study|Withdrawal by Subject|1|||
126405723|NCT03995355|454779516|FG001|Overall Study|Withdrawal by Subject|0|||
126405724|NCT03995355|454779515|FG000|Overall Study|Scheduling Issues|0|||
126405725|NCT03995355|454779516|FG001|Overall Study|Scheduling Issues|1|||
126405726|NCT03426631|454779517|FG000|Overall Study|Lost to Follow-up|0|||
126405727|NCT03426631|454779518|FG001|Overall Study|Lost to Follow-up|1|||
126405728|NCT03831945|454779519|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
126405729|NCT03831945|454779520|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
126405730|NCT03831945|454779519|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
126405731|NCT03831945|454779520|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
126405732|NCT03831945|454779519|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
126405733|NCT03831945|454779520|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
126405734|NCT00710385|454779529|FG000|Overall Study|Did not qualify|1|||
126405735|NCT00710385|454779529|FG000|Overall Study|Withdrawal by Subject|1|||
126405736|NCT00710385|454779529|FG000|Overall Study|Undisclosed back pain|1|||
126405737|NCT00710385|454779529|FG000|Overall Study|Physician Decision|1|||
126405738|NCT00710385|454779529|FG000|Overall Study|Undisclosed excessive methadone use|1|||
126405739|NCT03691779|454779534|FG000|Part B (24 Weeks)|Adverse Event|0|||
126405740|NCT03691779|454779535|FG001|Part B (24 Weeks)|Adverse Event|1|||
126405741|NCT03691779|454779534|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
126405742|NCT03691779|454779535|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
126405743|NCT00267150|454779538|FG000|Overall Study|Adverse Event|1|||
126405744|NCT00521222|454779540|FG000|Overall Study|Lost to Follow-up|0|||
126405745|NCT00521222|454779541|FG001|Overall Study|Lost to Follow-up|0|||
126405746|NCT00521222|454779542|FG002|Overall Study|Lost to Follow-up|1|||
126405747|NCT00521222|454779543|FG003|Overall Study|Lost to Follow-up|1|||
126405748|NCT00521222|454779540|FG000|Overall Study|Withdrawal by Subject|0|||
126405749|NCT00521222|454779541|FG001|Overall Study|Withdrawal by Subject|0|||
126405750|NCT00521222|454779542|FG002|Overall Study|Withdrawal by Subject|2|||
126405751|NCT00521222|454779543|FG003|Overall Study|Withdrawal by Subject|0|||
126405752|NCT00521222|454779540|FG000|Overall Study|Physician Decision|0|||
126405753|NCT00521222|454779541|FG001|Overall Study|Physician Decision|1|||
126405754|NCT00521222|454779542|FG002|Overall Study|Physician Decision|0|||
126405755|NCT00521222|454779543|FG003|Overall Study|Physician Decision|1|||
126405756|NCT03332160|454779546|FG000|Overall Study|Withdrawal by Subject|1|||
126405757|NCT03332160|454779547|FG001|Overall Study|Withdrawal by Subject|1|||
126405758|NCT03332160|454779546|FG000|Overall Study|Adverse Event|0|||
126405759|NCT03332160|454779547|FG001|Overall Study|Adverse Event|1|||
126405760|NCT03332160|454779546|FG000|Overall Study|Developed Exclusion Criteria|0|||
126405761|NCT03332160|454779547|FG001|Overall Study|Developed Exclusion Criteria|1|||
126405762|NCT03332160|454779546|FG000|Overall Study|Non-adherence to treatment|0|||
126405763|NCT03332160|454779547|FG001|Overall Study|Non-adherence to treatment|2|||
126405764|NCT01561963|454779548|FG000|Overall Study|Adverse Event|1|||
126405765|NCT04208087|454779551|FG000|Overall Study|Adverse Event|1|||
126405766|NCT04208087|454779552|FG001|Overall Study|Adverse Event|0|||
126405767|NCT04208087|454779553|FG002|Overall Study|Adverse Event|0|||
126405768|NCT04208087|454779554|FG003|Overall Study|Adverse Event|0|||
126405769|NCT04208087|454779555|FG004|Overall Study|Adverse Event|0|||
126405770|NCT04208087|454779551|FG000|Overall Study|Withdrawal by Subject|0|||
126405771|NCT04208087|454779552|FG001|Overall Study|Withdrawal by Subject|0|||
126405772|NCT04208087|454779553|FG002|Overall Study|Withdrawal by Subject|1|||
126405773|NCT04208087|454779554|FG003|Overall Study|Withdrawal by Subject|0|||
126405774|NCT04208087|454779555|FG004|Overall Study|Withdrawal by Subject|0|||
126405775|NCT04208087|454779551|FG000|Overall Study|Other|0|||
126405776|NCT04208087|454779552|FG001|Overall Study|Other|0|||
126405777|NCT04208087|454779553|FG002|Overall Study|Other|0|||
126405778|NCT04208087|454779554|FG003|Overall Study|Other|0|||
126405779|NCT04208087|454779555|FG004|Overall Study|Other|1|||
126405780|NCT00952614|454779556|FG000|Overall Study|Death|3|||
126405781|NCT00952614|454779556|FG000|Overall Study|Lost to Follow-up|3|||
126405782|NCT00952614|454779556|FG000|Overall Study|other reason|1|||
126405783|NCT04023682|454779557|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
126405784|NCT00637572|454779559|FG000|Overall Study|Adverse Event|1|||
126405785|NCT00637572|454779560|FG001|Overall Study|Adverse Event|2|||
126405786|NCT00637572|454779559|FG000|Overall Study|Death|0|||
126405787|NCT00637572|454779560|FG001|Overall Study|Death|1|||
126405788|NCT00637572|454779559|FG000|Overall Study|Lost to Follow-up|0|||
126405789|NCT00637572|454779560|FG001|Overall Study|Lost to Follow-up|1|||
126405790|NCT00637572|454779559|FG000|Overall Study|Physician Decision|1|||
126405791|NCT00637572|454779560|FG001|Overall Study|Physician Decision|1|||
126405792|NCT00637572|454779559|FG000|Overall Study|Withdrawal by Subject|0|||
126405793|NCT00637572|454779560|FG001|Overall Study|Withdrawal by Subject|2|||
126405794|NCT00637572|454779559|FG000|Overall Study|Illicit Drug Use|1|||
126405795|NCT00637572|454779560|FG001|Overall Study|Illicit Drug Use|0|||
126405796|NCT04268745|454779568|FG000|Overall Study|Lost to Follow-up|2|||
126405797|NCT04268745|454779569|FG001|Overall Study|Lost to Follow-up|3|||
126405798|NCT04268745|454779568|FG000|Overall Study|Withdrawal by Subject|4|||
126405799|NCT04268745|454779569|FG001|Overall Study|Withdrawal by Subject|2|||
126405800|NCT04268745|454779568|FG000|Overall Study|Death in the family|1|||
126405801|NCT04268745|454779569|FG001|Overall Study|Death in the family|0|||
126405802|NCT02540291|454779571|FG000|Overall Study|Death|7|||
126405803|NCT02540291|454779572|FG001|Overall Study|Death|7|||
126405804|NCT02540291|454779573|FG002|Overall Study|Death|5|||
126088969|NCT01399697|453620040|FG001|Overall Study|Lack of Efficacy|0|||
126405805|NCT02540291|454779574|FG003|Overall Study|Death|7|||
126405806|NCT02540291|454779571|FG000|Overall Study|Lost to Follow-up|0|||
126405807|NCT02540291|454779572|FG001|Overall Study|Lost to Follow-up|0|||
126405808|NCT02540291|454779573|FG002|Overall Study|Lost to Follow-up|1|||
126405809|NCT02540291|454779574|FG003|Overall Study|Lost to Follow-up|0|||
126405810|NCT02540291|454779571|FG000|Overall Study|Withdrawal Of Consent|0|||
126405811|NCT02540291|454779572|FG001|Overall Study|Withdrawal Of Consent|1|||
126405812|NCT02540291|454779573|FG002|Overall Study|Withdrawal Of Consent|0|||
126405813|NCT02540291|454779574|FG003|Overall Study|Withdrawal Of Consent|0|||
126405814|NCT02540291|454779571|FG000|Overall Study|Study Terminated By Sponsor|1|||
126405815|NCT02540291|454779572|FG001|Overall Study|Study Terminated By Sponsor|0|||
126405816|NCT02540291|454779573|FG002|Overall Study|Study Terminated By Sponsor|0|||
126405817|NCT02540291|454779574|FG003|Overall Study|Study Terminated By Sponsor|0|||
126405818|NCT02540291|454779571|FG000|Overall Study|Other|0|||
126405819|NCT02540291|454779572|FG001|Overall Study|Other|0|||
126405820|NCT02540291|454779573|FG002|Overall Study|Other|1|||
126405821|NCT02540291|454779574|FG003|Overall Study|Other|0|||
126405822|NCT00707954|454781206|FG000|Overall Study|Physician Decision|0|||
126405823|NCT00707954|454781207|FG001|Overall Study|Physician Decision|0|||
126405824|NCT00707954|454781208|FG002|Overall Study|Physician Decision|0|||
126405825|NCT00707954|454781209|FG003|Overall Study|Physician Decision|0|||
126405826|NCT00707954|454781210|FG004|Overall Study|Physician Decision|1|||
126405827|NCT01306656|454781211|FG000|Overall Study|Lost to Follow-up|1|||
126405828|NCT01306656|454781212|FG001|Overall Study|Lost to Follow-up|0|||
126405829|NCT01286077|454781213|FG000|Overall Study|Adverse Event|2|||
126405830|NCT01286077|454781214|FG001|Overall Study|Adverse Event|0|||
126405831|NCT01286077|454781213|FG000|Overall Study|Death|1|||
126405832|NCT01286077|454781214|FG001|Overall Study|Death|0|||
126405833|NCT01286077|454781213|FG000|Overall Study|Protocol Violation|1|||
126405834|NCT01286077|454781214|FG001|Overall Study|Protocol Violation|1|||
126405835|NCT01286077|454781213|FG000|Overall Study|Withdrawal by Subject|0|||
126405836|NCT01286077|454781214|FG001|Overall Study|Withdrawal by Subject|2|||
126405837|NCT01286077|454781213|FG000|Overall Study|Intercurrent illness|1|||
126405838|NCT01286077|454781214|FG001|Overall Study|Intercurrent illness|0|||
126405839|NCT01286077|454781213|FG000|Overall Study|Non-compliance|1|||
126405840|NCT01286077|454781214|FG001|Overall Study|Non-compliance|0|||
126405841|NCT01286077|454781213|FG000|Overall Study|The subject starts with alternative MMY|0|||
126405842|NCT01286077|454781214|FG001|Overall Study|The subject starts with alternative MMY|3|||
126405843|NCT01286077|454781213|FG000|Overall Study|Patient's decision to stop treatment|3|||
126405844|NCT01286077|454781214|FG001|Overall Study|Patient's decision to stop treatment|0|||
126405845|NCT01286077|454781213|FG000|Overall Study|Progression of disease|0|||
126405846|NCT01286077|454781214|FG001|Overall Study|Progression of disease|1|||
126405847|NCT01286077|454781213|FG000|Overall Study|refill medication not received in time|1|||
126405848|NCT01286077|454781214|FG001|Overall Study|refill medication not received in time|0|||
126405849|NCT01571232|454781215|FG000|Overall Study|Lost to Follow-up|0|||
126405850|NCT01571232|454781216|FG001|Overall Study|Lost to Follow-up|1|||
126405851|NCT01571232|454781215|FG000|Overall Study|Withdrawal by Subject|1|||
126405852|NCT01571232|454781216|FG001|Overall Study|Withdrawal by Subject|0|||
126405853|NCT01646203|454781217|FG000|Overall Study|Adverse Event|2|||
126405854|NCT01646203|454781218|FG001|Overall Study|Adverse Event|0|||
126405855|NCT01646203|454781219|FG002|Overall Study|Adverse Event|1|||
126405856|NCT01646203|454781217|FG000|Overall Study|Withdrawal by Subject|0|||
126405857|NCT01646203|454781218|FG001|Overall Study|Withdrawal by Subject|1|||
126405858|NCT01646203|454781219|FG002|Overall Study|Withdrawal by Subject|0|||
126405859|NCT01646203|454781217|FG000|Overall Study|Physician's Decision|0|||
126405860|NCT01646203|454781218|FG001|Overall Study|Physician's Decision|1|||
126405861|NCT01646203|454781219|FG002|Overall Study|Physician's Decision|0|||
126405862|NCT03242252|454781221|FG000|Overall Study|At the Participant's own Request|18|||
126405863|NCT03242252|454781222|FG001|Overall Study|At the Participant's own Request|10|||
126405864|NCT03242252|454781223|FG002|Overall Study|At the Participant's own Request|15|||
126405865|NCT03242252|454781221|FG000|Overall Study|Adverse Event|8|||
126405866|NCT03242252|454781222|FG001|Overall Study|Adverse Event|6|||
126405867|NCT03242252|454781223|FG002|Overall Study|Adverse Event|9|||
126405868|NCT03242252|454781221|FG000|Overall Study|Poor Compliance to Protocol|0|||
126405869|NCT03242252|454781222|FG001|Overall Study|Poor Compliance to Protocol|2|||
126405870|NCT03242252|454781223|FG002|Overall Study|Poor Compliance to Protocol|3|||
126405871|NCT03242252|454781221|FG000|Overall Study|Study Terminated by Sponsor|1|||
126405872|NCT03242252|454781222|FG001|Overall Study|Study Terminated by Sponsor|0|||
126405873|NCT03242252|454781223|FG002|Overall Study|Study Terminated by Sponsor|0|||
126405874|NCT03242252|454781221|FG000|Overall Study|Reason not Specified|4|||
126405875|NCT03242252|454781222|FG001|Overall Study|Reason not Specified|4|||
126405876|NCT03242252|454781223|FG002|Overall Study|Reason not Specified|1|||
126405877|NCT03242252|454781221|FG000|Overall Study|Lost to Follow-up|5|||
126405878|NCT03242252|454781222|FG001|Overall Study|Lost to Follow-up|1|||
126405879|NCT03242252|454781223|FG002|Overall Study|Lost to Follow-up|4|||
126405880|NCT01659255|454781224|FG000|Overall Study|Adverse Event|0|||
126405881|NCT01659255|454781225|FG001|Overall Study|Adverse Event|0|||
126405882|NCT01659255|454781226|FG002|Overall Study|Adverse Event|0|||
126405883|NCT01659255|454781227|FG003|Overall Study|Adverse Event|0|||
126405884|NCT01659255|454781228|FG004|Overall Study|Adverse Event|0|||
126405885|NCT01659255|454781229|FG005|Overall Study|Adverse Event|1|||
126405886|NCT01659255|454781230|FG006|Overall Study|Adverse Event|1|||
126405887|NCT01659255|454781231|FG007|Overall Study|Adverse Event|0|||
126405888|NCT01659255|454781232|FG008|Overall Study|Adverse Event|0|||
126405889|NCT01659255|454781233|FG009|Overall Study|Adverse Event|1|||
126405890|NCT01659255|454781234|FG010|Overall Study|Adverse Event|0|||
126405891|NCT01659255|454781235|FG011|Overall Study|Adverse Event|1|||
126405892|NCT01659255|454781236|FG012|Overall Study|Adverse Event|0|||
126405893|NCT01659255|454781237|FG013|Overall Study|Adverse Event|2|||
126405894|NCT01659255|454781238|FG014|Overall Study|Adverse Event|0|||
126405895|NCT01659255|454781239|FG015|Overall Study|Adverse Event|1|||
126405896|NCT01659255|454781240|FG016|Overall Study|Adverse Event|0|||
126405897|NCT01659255|454781224|FG000|Overall Study|Death|0|||
126405898|NCT01659255|454781225|FG001|Overall Study|Death|1|||
126405899|NCT01659255|454781226|FG002|Overall Study|Death|0|||
126405900|NCT01659255|454781227|FG003|Overall Study|Death|0|||
126405901|NCT01659255|454781228|FG004|Overall Study|Death|0|||
126405902|NCT01659255|454781229|FG005|Overall Study|Death|0|||
126405903|NCT01659255|454781230|FG006|Overall Study|Death|0|||
126405904|NCT01659255|454781231|FG007|Overall Study|Death|1|||
126405905|NCT01659255|454781232|FG008|Overall Study|Death|1|||
126405906|NCT01659255|454781233|FG009|Overall Study|Death|0|||
126405907|NCT01659255|454781234|FG010|Overall Study|Death|0|||
126405908|NCT01659255|454781235|FG011|Overall Study|Death|0|||
126405909|NCT01659255|454781236|FG012|Overall Study|Death|1|||
126405910|NCT01659255|454781237|FG013|Overall Study|Death|1|||
126405911|NCT01659255|454781238|FG014|Overall Study|Death|2|||
126405912|NCT01659255|454781239|FG015|Overall Study|Death|1|||
126405913|NCT01659255|454781240|FG016|Overall Study|Death|0|||
126405914|NCT01659255|454781224|FG000|Overall Study|Progressive Disease|2|||
126405915|NCT01659255|454781225|FG001|Overall Study|Progressive Disease|0|||
126405916|NCT01659255|454781226|FG002|Overall Study|Progressive Disease|0|||
126405917|NCT01659255|454781227|FG003|Overall Study|Progressive Disease|0|||
126405918|NCT01659255|454781228|FG004|Overall Study|Progressive Disease|0|||
126405919|NCT01659255|454781229|FG005|Overall Study|Progressive Disease|0|||
126405920|NCT01659255|454781230|FG006|Overall Study|Progressive Disease|0|||
126405921|NCT01659255|454781231|FG007|Overall Study|Progressive Disease|1|||
126405922|NCT01659255|454781232|FG008|Overall Study|Progressive Disease|0|||
126405923|NCT01659255|454781233|FG009|Overall Study|Progressive Disease|2|||
126405924|NCT01659255|454781234|FG010|Overall Study|Progressive Disease|2|||
126405925|NCT01659255|454781235|FG011|Overall Study|Progressive Disease|3|||
126405926|NCT01659255|454781236|FG012|Overall Study|Progressive Disease|5|||
126405927|NCT01659255|454781237|FG013|Overall Study|Progressive Disease|13|||
126405928|NCT01659255|454781238|FG014|Overall Study|Progressive Disease|6|||
126405929|NCT01659255|454781239|FG015|Overall Study|Progressive Disease|2|||
126405930|NCT01659255|454781240|FG016|Overall Study|Progressive Disease|3|||
126405931|NCT01659255|454781224|FG000|Overall Study|Withdrew Consent|0|||
126405932|NCT01659255|454781225|FG001|Overall Study|Withdrew Consent|0|||
126405933|NCT01659255|454781226|FG002|Overall Study|Withdrew Consent|0|||
126405934|NCT01659255|454781227|FG003|Overall Study|Withdrew Consent|0|||
126405935|NCT01659255|454781228|FG004|Overall Study|Withdrew Consent|0|||
126405936|NCT01659255|454781229|FG005|Overall Study|Withdrew Consent|0|||
126405937|NCT01659255|454781230|FG006|Overall Study|Withdrew Consent|0|||
126405938|NCT01659255|454781231|FG007|Overall Study|Withdrew Consent|0|||
126405939|NCT01659255|454781232|FG008|Overall Study|Withdrew Consent|0|||
126405940|NCT01659255|454781233|FG009|Overall Study|Withdrew Consent|0|||
126405941|NCT01659255|454781234|FG010|Overall Study|Withdrew Consent|1|||
126405942|NCT01659255|454781235|FG011|Overall Study|Withdrew Consent|0|||
126405943|NCT01659255|454781236|FG012|Overall Study|Withdrew Consent|0|||
126405944|NCT01659255|454781237|FG013|Overall Study|Withdrew Consent|1|||
126405945|NCT01659255|454781238|FG014|Overall Study|Withdrew Consent|0|||
126405946|NCT01659255|454781239|FG015|Overall Study|Withdrew Consent|0|||
126405947|NCT01659255|454781240|FG016|Overall Study|Withdrew Consent|0|||
126405948|NCT01659255|454781224|FG000|Overall Study|Investigator Decision|0|||
126405949|NCT01659255|454781225|FG001|Overall Study|Investigator Decision|0|||
126405950|NCT01659255|454781226|FG002|Overall Study|Investigator Decision|0|||
126405951|NCT01659255|454781227|FG003|Overall Study|Investigator Decision|0|||
126405952|NCT01659255|454781228|FG004|Overall Study|Investigator Decision|0|||
126405953|NCT01659255|454781229|FG005|Overall Study|Investigator Decision|0|||
126405954|NCT01659255|454781230|FG006|Overall Study|Investigator Decision|0|||
126405955|NCT01659255|454781231|FG007|Overall Study|Investigator Decision|0|||
126405956|NCT01659255|454781232|FG008|Overall Study|Investigator Decision|0|||
126405957|NCT01659255|454781233|FG009|Overall Study|Investigator Decision|0|||
126405958|NCT01659255|454781234|FG010|Overall Study|Investigator Decision|0|||
126405959|NCT01659255|454781235|FG011|Overall Study|Investigator Decision|0|||
126405960|NCT01659255|454781236|FG012|Overall Study|Investigator Decision|1|||
126405961|NCT01659255|454781237|FG013|Overall Study|Investigator Decision|1|||
126405962|NCT01659255|454781238|FG014|Overall Study|Investigator Decision|0|||
125890345|NCT04193189|452895525|FG001|Overall Study|Withdrawal by Subject|2|||
126405963|NCT01659255|454781239|FG015|Overall Study|Investigator Decision|0|||
126405964|NCT01659255|454781240|FG016|Overall Study|Investigator Decision|0|||
126405965|NCT01659255|454781224|FG000|Overall Study|Sponsor's Decision|0|||
126405966|NCT01659255|454781225|FG001|Overall Study|Sponsor's Decision|0|||
126405967|NCT01659255|454781226|FG002|Overall Study|Sponsor's Decision|0|||
126405968|NCT01659255|454781227|FG003|Overall Study|Sponsor's Decision|0|||
126405969|NCT01659255|454781228|FG004|Overall Study|Sponsor's Decision|0|||
126405970|NCT01659255|454781229|FG005|Overall Study|Sponsor's Decision|0|||
126405971|NCT01659255|454781230|FG006|Overall Study|Sponsor's Decision|1|||
126405972|NCT01659255|454781231|FG007|Overall Study|Sponsor's Decision|0|||
126405973|NCT01659255|454781232|FG008|Overall Study|Sponsor's Decision|0|||
126405974|NCT01659255|454781233|FG009|Overall Study|Sponsor's Decision|0|||
126405975|NCT01659255|454781234|FG010|Overall Study|Sponsor's Decision|0|||
126405976|NCT01659255|454781235|FG011|Overall Study|Sponsor's Decision|0|||
126405977|NCT01659255|454781236|FG012|Overall Study|Sponsor's Decision|0|||
126405978|NCT01659255|454781237|FG013|Overall Study|Sponsor's Decision|0|||
126405979|NCT01659255|454781238|FG014|Overall Study|Sponsor's Decision|0|||
126405980|NCT01659255|454781239|FG015|Overall Study|Sponsor's Decision|0|||
126405981|NCT01659255|454781240|FG016|Overall Study|Sponsor's Decision|0|||
126405982|NCT01659255|454781224|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405983|NCT01659255|454781225|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405984|NCT01659255|454781226|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405985|NCT01659255|454781227|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405986|NCT01659255|454781228|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405987|NCT01659255|454781229|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405988|NCT01659255|454781230|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405989|NCT01659255|454781231|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405990|NCT01659255|454781232|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405991|NCT01659255|454781233|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405992|NCT01659255|454781234|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405993|NCT01659255|454781235|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405994|NCT01659255|454781236|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405995|NCT01659255|454781237|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405996|NCT01659255|454781238|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405997|NCT01659255|454781239|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
126405998|NCT01659255|454781240|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405999|NCT01659255|454781224|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
126406000|NCT01659255|454781225|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
126406001|NCT01659255|454781226|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
126406002|NCT01659255|454781227|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
126406003|NCT01659255|454781228|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
126406004|NCT01659255|454781229|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
126406005|NCT01659255|454781230|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
126406006|NCT01659255|454781231|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
126406007|NCT01659255|454781232|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
126406008|NCT01659255|454781233|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
126406009|NCT01659255|454781234|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
126406010|NCT01659255|454781235|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
126406011|NCT01659255|454781236|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
126406012|NCT01659255|454781237|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
126406013|NCT01659255|454781238|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
126406014|NCT01659255|454781239|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
126406015|NCT01659255|454781240|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
126406016|NCT01116427|454781241|FG000|Core Phase|Adverse Event|0|||
126406017|NCT01116427|454781242|FG001|Core Phase|Adverse Event|1|||
126406018|NCT01116427|454781241|FG000|Core Phase|Lost to Follow-up|1|||
126406019|NCT01116427|454781242|FG001|Core Phase|Lost to Follow-up|0|||
126406020|NCT01116427|454781241|FG000|Core Phase|Withdrawal by Subject|3|||
126406021|NCT01116427|454781242|FG001|Core Phase|Withdrawal by Subject|0|||
126406022|NCT01116427|454781241|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
126406023|NCT01116427|454781242|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
126406024|NCT01116427|454781241|FG000|Extension Phase|Adverse Event|1|||
126406025|NCT01116427|454781242|FG001|Extension Phase|Adverse Event|1|||
126406026|NCT01116427|454781241|FG000|Extension Phase|Lost to Follow-up|2|||
126406027|NCT01116427|454781242|FG001|Extension Phase|Lost to Follow-up|0|||
126406028|NCT01116427|454781241|FG000|Extension Phase|Withdrawal by Subject|5|||
126406029|NCT01116427|454781242|FG001|Extension Phase|Withdrawal by Subject|1|||
126406030|NCT01116427|454781241|FG000|Extension Phase|Not using appropriate birth control|1|||
126406031|NCT01116427|454781242|FG001|Extension Phase|Not using appropriate birth control|0|||
126406032|NCT02989805|454781243|FG000|Overall Study|invalid consent|6|||
126406033|NCT02989805|454781244|FG001|Overall Study|invalid consent|4|||
126406034|NCT02211313|454781245|FG000|Overall Study|Treatment Failure|5|||
126406035|NCT02211313|454781246|FG001|Overall Study|Treatment Failure|2|||
126406036|NCT02211313|454781245|FG000|Overall Study|No Follow up Questionnaires|1|||
126406037|NCT02211313|454781246|FG001|Overall Study|No Follow up Questionnaires|1|||
126406038|NCT02648217|454781249|FG000|Overall Study|Adverse Event|0|||
126406039|NCT02648217|454781250|FG001|Overall Study|Adverse Event|1|||
126406040|NCT02648217|454781249|FG000|Overall Study|Lost to Follow-up|1|||
126406041|NCT02648217|454781250|FG001|Overall Study|Lost to Follow-up|1|||
126406042|NCT02648217|454781249|FG000|Overall Study|Withdrawal by Subject|4|||
126406043|NCT02648217|454781250|FG001|Overall Study|Withdrawal by Subject|3|||
126406044|NCT02648217|454781249|FG000|Overall Study|Unclassified|5|||
126406045|NCT02648217|454781250|FG001|Overall Study|Unclassified|0|||
126406046|NCT03316950|454781251|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
126406047|NCT03316950|454781252|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
126406048|NCT03316950|454781253|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
126406049|NCT03316950|454781254|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
126406050|NCT03316950|454781251|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
126406051|NCT03316950|454781252|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
126406052|NCT03316950|454781253|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
126406053|NCT03316950|454781254|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
126406054|NCT03316950|454781251|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
126406055|NCT03316950|454781252|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
126406056|NCT03316950|454781253|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
126406057|NCT03316950|454781254|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
126406058|NCT02392403|454781255|FG000|Overall Study|Adverse Event|1|||
126406059|NCT02392403|454781255|FG000|Overall Study|Death|1|||
126406060|NCT02392403|454781255|FG000|Overall Study|Withdrawal by Subject|1|||
126406061|NCT02335424|454781259|FG000|Overall Study|Withdrawal by Subject|19|||
126406062|NCT02335424|454781259|FG000|Overall Study|Adverse Event|25|||
126406063|NCT02335424|454781259|FG000|Overall Study|Death|273|||
126406064|NCT02335424|454781259|FG000|Overall Study|Lost to Follow-up|3|||
126406065|NCT02335424|454781259|FG000|Overall Study|Physician Decision|13|||
126406066|NCT02335424|454781259|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
126406067|NCT02335424|454781259|FG000|Overall Study|Protocol Violation|1|||
126406068|NCT02335424|454781259|FG000|Overall Study|Screen failure|1|||
126406069|NCT02776033|454781262|FG000|Overall Study|Withdrawal by Subject|0|||
126406070|NCT02776033|454781263|FG001|Overall Study|Withdrawal by Subject|0|||
126406071|NCT02776033|454781264|FG002|Overall Study|Withdrawal by Subject|2|||
126406072|NCT02776033|454781262|FG000|Overall Study|Physician Decision|2|||
126406073|NCT02776033|454781263|FG001|Overall Study|Physician Decision|0|||
126406074|NCT02776033|454781264|FG002|Overall Study|Physician Decision|0|||
126406075|NCT02776033|454781262|FG000|Overall Study|Lost to Follow-up|1|||
126406076|NCT02776033|454781263|FG001|Overall Study|Lost to Follow-up|0|||
126406077|NCT02776033|454781264|FG002|Overall Study|Lost to Follow-up|0|||
126406078|NCT02776033|454781262|FG000|Overall Study|Adverse Event|1|||
126406079|NCT02776033|454781263|FG001|Overall Study|Adverse Event|2|||
126406080|NCT02776033|454781264|FG002|Overall Study|Adverse Event|0|||
126406081|NCT00657371|454781265|FG000|Overall Study|Poor bowel preparation|15|||
126406082|NCT00657371|454781265|FG000|Overall Study|Unable to intubate the cecum|5|||
126406083|NCT00657371|454781265|FG000|Overall Study|Protocol Violation|2|||
126406084|NCT00657371|454781265|FG000|Overall Study|Device- related reasons|13|||
126406085|NCT00657371|454781265|FG000|Overall Study|Pre-existing medical condition|4|||
126406086|NCT02712424|454781266|FG000|Overall Study|Lost to Follow-up|34|||
126406087|NCT02712424|454781267|FG001|Overall Study|Lost to Follow-up|32|||
126406088|NCT02713867|454781273|FG000|Randomization|Other Reason|2|||
126406089|NCT02713867|454781274|FG001|Randomization|Other Reason|1|||
126406090|NCT02713867|454781273|FG000|Randomization|Participant Withdrew consent|0|||
126406091|NCT02713867|454781274|FG001|Randomization|Participant Withdrew consent|2|||
126406092|NCT02713867|454781273|FG000|Treatment Period|Other Reasons|22|||
126406093|NCT02713867|454781274|FG001|Treatment Period|Other Reasons|28|||
126406094|NCT02713867|454781273|FG000|Treatment Period|Administrative reason by sponsor|21|||
126406095|NCT02713867|454781274|FG001|Treatment Period|Administrative reason by sponsor|16|||
126406096|NCT02713867|454781273|FG000|Treatment Period|No longer meets study criteria|2|||
126406097|NCT02713867|454781274|FG001|Treatment Period|No longer meets study criteria|1|||
126406098|NCT02713867|454781273|FG000|Treatment Period|Poor/Non Compliance|1|||
126406099|NCT02713867|454781274|FG001|Treatment Period|Poor/Non Compliance|0|||
126406100|NCT02713867|454781273|FG000|Treatment Period|Maximum Clinical Benefit|5|||
126406101|NCT02713867|454781274|FG001|Treatment Period|Maximum Clinical Benefit|6|||
126406102|NCT02713867|454781273|FG000|Treatment Period|Withdrew consent|3|||
126406103|NCT02713867|454781274|FG001|Treatment Period|Withdrew consent|6|||
126406104|NCT02713867|454781273|FG000|Treatment Period|Requested to Discontinue|8|||
126406105|NCT02713867|454781274|FG001|Treatment Period|Requested to Discontinue|8|||
126406106|NCT02713867|454781273|FG000|Treatment Period|AE unrelated to Study Drug|11|||
126406107|NCT02713867|454781274|FG001|Treatment Period|AE unrelated to Study Drug|10|||
126406108|NCT02713867|454781273|FG000|Treatment Period|Death|7|||
126406109|NCT02713867|454781274|FG001|Treatment Period|Death|3|||
126406110|NCT02713867|454781273|FG000|Treatment Period|Study Drug Toxicity|16|||
126406111|NCT02713867|454781274|FG001|Treatment Period|Study Drug Toxicity|19|||
126406112|NCT02713867|454781273|FG000|Treatment Period|Disease Progression|82|||
126406113|NCT02713867|454781274|FG001|Treatment Period|Disease Progression|83|||
126406114|NCT02715726|454781278|FG000|Overall Study|Adverse Event|2|||
126406115|NCT02715726|454781279|FG001|Overall Study|Adverse Event|6|||
126406116|NCT02715726|454781278|FG000|Overall Study|Protocol Violation|1|||
126406117|NCT02715726|454781279|FG001|Overall Study|Protocol Violation|0|||
126406118|NCT02715726|454781278|FG000|Overall Study|Death|2|||
126406119|NCT02715726|454781279|FG001|Overall Study|Death|1|||
126406120|NCT02715726|454781278|FG000|Overall Study|Participant moved|1|||
126406121|NCT02715726|454781279|FG001|Overall Study|Participant moved|3|||
126406122|NCT02715726|454781278|FG000|Overall Study|Other than specified above|11|||
126406123|NCT02715726|454781279|FG001|Overall Study|Other than specified above|15|||
126406124|NCT02715726|454781278|FG000|Overall Study|Randomized but not treated|1|||
126406125|NCT02715726|454781279|FG001|Overall Study|Randomized but not treated|2|||
126406126|NCT03230292|454781280|FG000|Overall Study|Adverse Event|1|||
126406127|NCT03230292|454781280|FG000|Overall Study|Protocol Violation|1|||
126406128|NCT03230292|454781280|FG000|Overall Study|Lost to Follow-up|1|||
126406129|NCT03230292|454781280|FG000|Overall Study|Withdrawal by Subject|3|||
126406130|NCT03629912|454781281|FG000|Overall Study|Lost to Follow-up|19|||
126406131|NCT03629912|454781282|FG001|Overall Study|Lost to Follow-up|7|||
126406132|NCT03629912|454781283|FG002|Overall Study|Lost to Follow-up|5|||
126406133|NCT03629912|454781284|FG003|Overall Study|Lost to Follow-up|1|||
126406134|NCT03629912|454781281|FG000|Overall Study|Withdrawal by Subject|6|||
126406135|NCT03629912|454781282|FG001|Overall Study|Withdrawal by Subject|0|||
126406136|NCT03629912|454781283|FG002|Overall Study|Withdrawal by Subject|1|||
126406137|NCT03629912|454781284|FG003|Overall Study|Withdrawal by Subject|2|||
126406138|NCT03629912|454781281|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
126406139|NCT03629912|454781282|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
126406140|NCT03629912|454781283|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
126406141|NCT03629912|454781284|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
126406142|NCT03629912|454781281|FG000|Overall Study|Death|1|||
126406143|NCT03629912|454781282|FG001|Overall Study|Death|0|||
126406144|NCT03629912|454781283|FG002|Overall Study|Death|0|||
126406145|NCT03629912|454781284|FG003|Overall Study|Death|0|||
126406146|NCT02598128|454781293|FG000|Period A: Days -7 to -1|Adverse Event|1|||
126406147|NCT02598128|454781294|FG001|Period A: Days -7 to -1|Adverse Event|0|||
126406148|NCT02598128|454781295|FG002|Period A: Days -7 to -1|Adverse Event|0|||
126406149|NCT02598128|454781296|FG003|Period A: Days -7 to -1|Adverse Event|0|||
126406150|NCT01459913|454781297|FG000|Overall Study|Adverse Event|0|||
126406151|NCT01459913|454781298|FG001|Overall Study|Adverse Event|0|||
126406152|NCT01459913|454781299|FG002|Overall Study|Adverse Event|0|||
126406153|NCT01459913|454781300|FG003|Overall Study|Adverse Event|3|||
126406154|NCT01459913|454781297|FG000|Overall Study|Withdrawal by Subject|4|||
126406155|NCT01459913|454781298|FG001|Overall Study|Withdrawal by Subject|0|||
126406156|NCT01459913|454781299|FG002|Overall Study|Withdrawal by Subject|0|||
126406157|NCT01459913|454781300|FG003|Overall Study|Withdrawal by Subject|5|||
126406158|NCT01459913|454781297|FG000|Overall Study|Lost to Follow-up|7|||
126406159|NCT01459913|454781298|FG001|Overall Study|Lost to Follow-up|4|||
126406160|NCT01459913|454781299|FG002|Overall Study|Lost to Follow-up|1|||
126406161|NCT01459913|454781300|FG003|Overall Study|Lost to Follow-up|8|||
126406162|NCT01459913|454781297|FG000|Overall Study|Death|0|||
126406163|NCT01459913|454781298|FG001|Overall Study|Death|0|||
126406164|NCT01459913|454781299|FG002|Overall Study|Death|0|||
126406165|NCT01459913|454781300|FG003|Overall Study|Death|1|||
126406166|NCT01459913|454781297|FG000|Overall Study|Non- Compliance|0|||
126406167|NCT01459913|454781298|FG001|Overall Study|Non- Compliance|0|||
126406168|NCT01459913|454781299|FG002|Overall Study|Non- Compliance|0|||
126406169|NCT01459913|454781300|FG003|Overall Study|Non- Compliance|3|||
126406170|NCT01459913|454781297|FG000|Overall Study|Physician Decision|0|||
126406171|NCT01459913|454781298|FG001|Overall Study|Physician Decision|1|||
126406172|NCT01459913|454781299|FG002|Overall Study|Physician Decision|0|||
126406173|NCT01459913|454781300|FG003|Overall Study|Physician Decision|0|||
126406174|NCT01459913|454781297|FG000|Overall Study|Study Terminated by Sponsor|30|||
126406175|NCT01459913|454781298|FG001|Overall Study|Study Terminated by Sponsor|15|||
126406176|NCT01459913|454781299|FG002|Overall Study|Study Terminated by Sponsor|9|||
126406177|NCT01459913|454781300|FG003|Overall Study|Study Terminated by Sponsor|11|||
126406178|NCT01459913|454781297|FG000|Overall Study|Other|0|||
126406179|NCT01459913|454781298|FG001|Overall Study|Other|0|||
126406180|NCT01459913|454781299|FG002|Overall Study|Other|3|||
126406181|NCT01459913|454781300|FG003|Overall Study|Other|1|||
126406182|NCT01459913|454781297|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
126406183|NCT01459913|454781298|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
126406184|NCT01459913|454781299|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
126406185|NCT01459913|454781300|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
126406186|NCT01064687|454781303|FG000|Overall Study|Adverse Event|9|||
126406187|NCT01064687|454781304|FG001|Overall Study|Adverse Event|4|||
126406188|NCT01064687|454781305|FG002|Overall Study|Adverse Event|10|||
126406189|NCT01064687|454781306|FG003|Overall Study|Adverse Event|3|||
125890346|NCT04193189|452895526|FG002|Overall Study|Withdrawal by Subject|2|||
126406190|NCT01064687|454781303|FG000|Overall Study|Death|1|||
126406191|NCT01064687|454781304|FG001|Overall Study|Death|1|||
126406192|NCT01064687|454781305|FG002|Overall Study|Death|0|||
126406193|NCT01064687|454781306|FG003|Overall Study|Death|0|||
126406194|NCT01064687|454781303|FG000|Overall Study|Entry Criteria Not Met|3|||
126406195|NCT01064687|454781304|FG001|Overall Study|Entry Criteria Not Met|0|||
126406196|NCT01064687|454781305|FG002|Overall Study|Entry Criteria Not Met|0|||
126406197|NCT01064687|454781306|FG003|Overall Study|Entry Criteria Not Met|0|||
126406198|NCT01064687|454781303|FG000|Overall Study|Lack of Efficacy|1|||
126406199|NCT01064687|454781304|FG001|Overall Study|Lack of Efficacy|0|||
126406200|NCT01064687|454781305|FG002|Overall Study|Lack of Efficacy|2|||
126406201|NCT01064687|454781306|FG003|Overall Study|Lack of Efficacy|3|||
126406202|NCT01064687|454781303|FG000|Overall Study|Lost to Follow-up|7|||
126406203|NCT01064687|454781304|FG001|Overall Study|Lost to Follow-up|10|||
126406204|NCT01064687|454781305|FG002|Overall Study|Lost to Follow-up|13|||
126406205|NCT01064687|454781306|FG003|Overall Study|Lost to Follow-up|5|||
126406206|NCT01064687|454781303|FG000|Overall Study|Physician Decision|2|||
126406207|NCT01064687|454781304|FG001|Overall Study|Physician Decision|2|||
126406208|NCT01064687|454781305|FG002|Overall Study|Physician Decision|0|||
126406209|NCT01064687|454781306|FG003|Overall Study|Physician Decision|0|||
126406210|NCT01064687|454781303|FG000|Overall Study|Protocol Violation|1|||
126406211|NCT01064687|454781304|FG001|Overall Study|Protocol Violation|1|||
126406212|NCT01064687|454781305|FG002|Overall Study|Protocol Violation|0|||
126406213|NCT01064687|454781306|FG003|Overall Study|Protocol Violation|1|||
126406214|NCT01064687|454781303|FG000|Overall Study|Sponsor Decision|0|||
126406215|NCT01064687|454781304|FG001|Overall Study|Sponsor Decision|0|||
126406216|NCT01064687|454781305|FG002|Overall Study|Sponsor Decision|3|||
126406217|NCT01064687|454781306|FG003|Overall Study|Sponsor Decision|0|||
126406218|NCT01064687|454781303|FG000|Overall Study|Withdrawal by Subject|9|||
126406219|NCT01064687|454781304|FG001|Overall Study|Withdrawal by Subject|7|||
126406220|NCT01064687|454781305|FG002|Overall Study|Withdrawal by Subject|12|||
126406221|NCT01064687|454781306|FG003|Overall Study|Withdrawal by Subject|5|||
126406222|NCT01064687|454781303|FG000|Overall Study|Treatment Noncompliance|1|||
126406223|NCT01064687|454781304|FG001|Overall Study|Treatment Noncompliance|1|||
126406224|NCT01064687|454781305|FG002|Overall Study|Treatment Noncompliance|1|||
126406225|NCT01064687|454781306|FG003|Overall Study|Treatment Noncompliance|0|||
126406226|NCT03134183|454781309|FG000|Overall Study|Withdrawal by Subject|1|||
126406227|NCT03134183|454781310|FG001|Overall Study|Withdrawal by Subject|1|||
126406228|NCT00845065|454781311|FG000|Overall Study|Adverse Event|3|||
126406229|NCT00845065|454781312|FG001|Overall Study|Adverse Event|23|||
126406230|NCT00845065|454781311|FG000|Overall Study|Lack of Efficacy|43|||
126406231|NCT00845065|454781312|FG001|Overall Study|Lack of Efficacy|21|||
126406232|NCT00845065|454781311|FG000|Overall Study|Non-Medical Reasons|1|||
126406233|NCT00845065|454781312|FG001|Overall Study|Non-Medical Reasons|11|||
126406234|NCT02299076|454781313|FG000|Overall Study|Fraudulent Entries|20|||
126406235|NCT02299076|454781314|FG001|Overall Study|Fraudulent Entries|14|||
126406236|NCT00162266|454781315|FG000|Double-Blind Period|Adverse Event|5|||
126406237|NCT00162266|454781316|FG001|Double-Blind Period|Adverse Event|9|||
126406238|NCT00162266|454781317|FG002|Double-Blind Period|Adverse Event|11|||
126406239|NCT00162266|454781318|FG003|Double-Blind Period|Adverse Event|0|||
126406240|NCT00162266|454781315|FG000|Double-Blind Period|Death|0|||
126406241|NCT00162266|454781316|FG001|Double-Blind Period|Death|1|||
126406242|NCT00162266|454781317|FG002|Double-Blind Period|Death|0|||
126406243|NCT00162266|454781318|FG003|Double-Blind Period|Death|0|||
126406244|NCT00162266|454781315|FG000|Double-Blind Period|Lost to Follow-up|1|||
126406245|NCT00162266|454781316|FG001|Double-Blind Period|Lost to Follow-up|2|||
126406246|NCT00162266|454781317|FG002|Double-Blind Period|Lost to Follow-up|0|||
126406247|NCT00162266|454781318|FG003|Double-Blind Period|Lost to Follow-up|0|||
126406248|NCT00162266|454781315|FG000|Double-Blind Period|Other Reason|1|||
126406249|NCT00162266|454781316|FG001|Double-Blind Period|Other Reason|0|||
126406250|NCT00162266|454781317|FG002|Double-Blind Period|Other Reason|1|||
126406251|NCT00162266|454781318|FG003|Double-Blind Period|Other Reason|0|||
126406252|NCT00162266|454781315|FG000|Double-Blind Period|Lack of Efficacy|13|||
126406253|NCT00162266|454781316|FG001|Double-Blind Period|Lack of Efficacy|17|||
126406254|NCT00162266|454781317|FG002|Double-Blind Period|Lack of Efficacy|30|||
126406255|NCT00162266|454781318|FG003|Double-Blind Period|Lack of Efficacy|0|||
126406256|NCT00162266|454781315|FG000|Double-Blind Period|Withdrawal by Subject|5|||
126406257|NCT00162266|454781316|FG001|Double-Blind Period|Withdrawal by Subject|2|||
126406258|NCT00162266|454781317|FG002|Double-Blind Period|Withdrawal by Subject|6|||
126406259|NCT00162266|454781318|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126406260|NCT00162266|454781315|FG000|Open-Label Period|Death|0|||
126406261|NCT00162266|454781316|FG001|Open-Label Period|Death|0|||
126406262|NCT00162266|454781317|FG002|Open-Label Period|Death|0|||
126406263|NCT00162266|454781318|FG003|Open-Label Period|Death|7|||
126406264|NCT00162266|454781315|FG000|Open-Label Period|Adverse Event|0|||
126406265|NCT00162266|454781316|FG001|Open-Label Period|Adverse Event|0|||
126406266|NCT00162266|454781317|FG002|Open-Label Period|Adverse Event|0|||
126406267|NCT00162266|454781318|FG003|Open-Label Period|Adverse Event|46|||
126406268|NCT00162266|454781315|FG000|Open-Label Period|Lack of Efficacy|0|||
126406269|NCT00162266|454781316|FG001|Open-Label Period|Lack of Efficacy|0|||
126406270|NCT00162266|454781317|FG002|Open-Label Period|Lack of Efficacy|0|||
126406271|NCT00162266|454781318|FG003|Open-Label Period|Lack of Efficacy|26|||
126406272|NCT00162266|454781315|FG000|Open-Label Period|Lost to Follow-up|0|||
126406273|NCT00162266|454781316|FG001|Open-Label Period|Lost to Follow-up|0|||
126406274|NCT00162266|454781317|FG002|Open-Label Period|Lost to Follow-up|0|||
126406275|NCT00162266|454781318|FG003|Open-Label Period|Lost to Follow-up|3|||
126406276|NCT00162266|454781315|FG000|Open-Label Period|Withdrawal by Subject|0|||
126406277|NCT00162266|454781316|FG001|Open-Label Period|Withdrawal by Subject|0|||
126406278|NCT00162266|454781317|FG002|Open-Label Period|Withdrawal by Subject|0|||
126406279|NCT00162266|454781318|FG003|Open-Label Period|Withdrawal by Subject|31|||
126406280|NCT00162266|454781315|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
126406281|NCT00162266|454781316|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
126406282|NCT00162266|454781317|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
126406283|NCT00162266|454781318|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
126406284|NCT00162266|454781315|FG000|Open-Label Period|Other Reasons|0|||
126406285|NCT00162266|454781316|FG001|Open-Label Period|Other Reasons|0|||
126406286|NCT00162266|454781317|FG002|Open-Label Period|Other Reasons|0|||
126406287|NCT00162266|454781318|FG003|Open-Label Period|Other Reasons|15|||
126406288|NCT01969721|454781319|FG000|Overall Study|Adverse Event|3|||
126406289|NCT01969721|454781320|FG001|Overall Study|Adverse Event|8|||
126406290|NCT01969721|454781321|FG002|Overall Study|Adverse Event|3|||
126406291|NCT01969721|454781322|FG003|Overall Study|Adverse Event|2|||
126406292|NCT01969721|454781319|FG000|Overall Study|Lack of Efficacy|0|||
126406293|NCT01969721|454781320|FG001|Overall Study|Lack of Efficacy|0|||
126406294|NCT01969721|454781321|FG002|Overall Study|Lack of Efficacy|1|||
126406295|NCT01969721|454781322|FG003|Overall Study|Lack of Efficacy|0|||
126406296|NCT01969721|454781319|FG000|Overall Study|Non compliant with protocol|1|||
126406297|NCT01969721|454781320|FG001|Overall Study|Non compliant with protocol|1|||
126406298|NCT01969721|454781321|FG002|Overall Study|Non compliant with protocol|0|||
126406299|NCT01969721|454781322|FG003|Overall Study|Non compliant with protocol|2|||
126406300|NCT01969721|454781319|FG000|Overall Study|Other not defined above|0|||
126406301|NCT01969721|454781320|FG001|Overall Study|Other not defined above|2|||
126406302|NCT01969721|454781321|FG002|Overall Study|Other not defined above|0|||
126406303|NCT01969721|454781322|FG003|Overall Study|Other not defined above|0|||
126406304|NCT01969721|454781319|FG000|Overall Study|Discontinued during washout periods.|0|||
126406305|NCT01969721|454781320|FG001|Overall Study|Discontinued during washout periods.|1|||
126406306|NCT01969721|454781321|FG002|Overall Study|Discontinued during washout periods.|1|||
126406307|NCT01969721|454781322|FG003|Overall Study|Discontinued during washout periods.|2|||
126406308|NCT01012323|454781324|FG000|Overall Study|Investigator Judgment|1|||
126406309|NCT00495755|454781325|FG000|Overall Study|Adverse Event|3|||
126406310|NCT02117349|454781326|FG000|Overall Study|Withdrawal by Subject|1|||
126406311|NCT02117349|454781327|FG001|Overall Study|Withdrawal by Subject|0|||
126406312|NCT02117349|454781326|FG000|Overall Study|Lost to Follow-up|1|||
126406313|NCT02117349|454781327|FG001|Overall Study|Lost to Follow-up|1|||
126406314|NCT02117349|454781326|FG000|Overall Study|Death|1|||
126406315|NCT02117349|454781327|FG001|Overall Study|Death|0|||
126406316|NCT02265796|454781328|FG000|Overall Study|Death|1|||
126406317|NCT02265796|454781329|FG001|Overall Study|Death|0|||
126406318|NCT02265796|454781328|FG000|Overall Study|started on excluded medication|1|||
126406319|NCT02265796|454781329|FG001|Overall Study|started on excluded medication|0|||
126406320|NCT02265796|454781328|FG000|Overall Study|Withdrawal by Subject|1|||
126406321|NCT02265796|454781329|FG001|Overall Study|Withdrawal by Subject|1|||
126406322|NCT02477553|454781330|FG000|Overall Study|Screening up-to-date|12|||
126406323|NCT02477553|454781331|FG001|Overall Study|Screening up-to-date|13|||
126406324|NCT02477553|454781330|FG000|Overall Study|No MD visit|1|||
126406325|NCT02477553|454781331|FG001|Overall Study|No MD visit|1|||
126406326|NCT02477553|454781330|FG000|Overall Study|Workup consistent w/CRC|1|||
126406327|NCT02477553|454781331|FG001|Overall Study|Workup consistent w/CRC|1|||
126406328|NCT02477553|454781330|FG000|Overall Study|Technical issues with intervention|2|||
126406329|NCT02477553|454781331|FG001|Overall Study|Technical issues with intervention|0|||
126406330|NCT02477553|454781330|FG000|Overall Study|Elevated risk for CRC|2|||
126406331|NCT02477553|454781331|FG001|Overall Study|Elevated risk for CRC|2|||
126406332|NCT02477553|454781330|FG000|Overall Study|MD advised against screening|1|||
126406333|NCT02477553|454781331|FG001|Overall Study|MD advised against screening|3|||
126406334|NCT02477553|454781330|FG000|Overall Study|patient deceased|1|||
126406335|NCT02477553|454781331|FG001|Overall Study|patient deceased|0|||
126406336|NCT02963701|454781332|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
126406337|NCT02963701|454781333|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
126406338|NCT00896649|454781336|FG000|Overall Study|Physician Decision|1|||
126406339|NCT00896649|454781336|FG000|Overall Study|Pregnancy|1|||
126406340|NCT00896649|454781336|FG000|Overall Study|missing documentation|1|||
126406341|NCT00896649|454781336|FG000|Overall Study|technical difficulties|2|||
126406342|NCT03652675|454781337|FG000|Overall Study|Lost to Follow-up|4|||
126406343|NCT03652675|454781338|FG001|Overall Study|Lost to Follow-up|4|||
126406344|NCT01638559|454781339|FG000|Overall Study|Lost to Follow-up|1|||
126406345|NCT01638559|454781339|FG000|Overall Study|Withdrawal by Subject|1|||
126406346|NCT01638559|454781339|FG000|Overall Study|Subject declined to travel for biopsy|1|||
126406347|NCT00483002|454781342|FG000|Overall Study|Adverse Event|68|||
126406348|NCT00483002|454781342|FG000|Overall Study|Lack of Efficacy|555|||
126406349|NCT00483002|454781342|FG000|Overall Study|Lost to Follow-up|962|||
126406350|NCT00483002|454781342|FG000|Overall Study|Other|2|||
126406351|NCT00483002|454781342|FG000|Overall Study|Other|967|||
126406352|NCT03442296|454781343|FG000|3 Month Follow-up|Death|3|||
126406353|NCT03442296|454781344|FG001|3 Month Follow-up|Death|1|||
126406354|NCT03442296|454781343|FG000|3 Month Follow-up|Lost to Follow-up|1|||
126406355|NCT03442296|454781344|FG001|3 Month Follow-up|Lost to Follow-up|1|||
126406356|NCT03442296|454781343|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
126406357|NCT03442296|454781344|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
126406358|NCT03442296|454781343|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
126406359|NCT03442296|454781344|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
126406360|NCT03442296|454781343|FG000|12 Month Follow-up|Incomplete measurement|1|||
126406361|NCT03442296|454781344|FG001|12 Month Follow-up|Incomplete measurement|1|||
126406362|NCT01403116|454781345|FG000|Overall Study|Adverse Event|7|||
126406363|NCT01403116|454781346|FG001|Overall Study|Adverse Event|4|||
126406364|NCT01403116|454781345|FG000|Overall Study|Lost to Follow-up|7|||
126406365|NCT01403116|454781346|FG001|Overall Study|Lost to Follow-up|5|||
126406366|NCT01403116|454781345|FG000|Overall Study|Withdrawal by Subject|12|||
126406367|NCT01403116|454781346|FG001|Overall Study|Withdrawal by Subject|15|||
126406368|NCT01403116|454781345|FG000|Overall Study|Non-compliance of study drug|3|||
126406369|NCT01403116|454781346|FG001|Overall Study|Non-compliance of study drug|0|||
126406370|NCT01403116|454781345|FG000|Overall Study|Protocol Violation|0|||
126406371|NCT01403116|454781346|FG001|Overall Study|Protocol Violation|1|||
126406372|NCT01403116|454781345|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
126406373|NCT01403116|454781346|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
126406374|NCT01403116|454781345|FG000|Overall Study|Hct >54%|2|||
126406375|NCT01403116|454781346|FG001|Overall Study|Hct >54%|0|||
126406376|NCT01403116|454781345|FG000|Overall Study|unable to keep appointments|0|||
126406377|NCT01403116|454781346|FG001|Overall Study|unable to keep appointments|2|||
126406378|NCT01895309|454781347|FG000|Overall Study|Adverse Event|13|||
126406379|NCT01895309|454781348|FG001|Overall Study|Adverse Event|17|||
126406380|NCT01895309|454781347|FG000|Overall Study|Protocol Violation|1|||
126406381|NCT01895309|454781348|FG001|Overall Study|Protocol Violation|0|||
126406382|NCT01895309|454781347|FG000|Overall Study|Lack of Efficacy|1|||
126406383|NCT01895309|454781348|FG001|Overall Study|Lack of Efficacy|3|||
126406384|NCT01895309|454781347|FG000|Overall Study|Lost to Follow-up|1|||
126406385|NCT01895309|454781348|FG001|Overall Study|Lost to Follow-up|3|||
126406386|NCT01895309|454781347|FG000|Overall Study|Physician Decision|15|||
126406387|NCT01895309|454781348|FG001|Overall Study|Physician Decision|10|||
126406388|NCT01895309|454781347|FG000|Overall Study|Withdrawal by Subject|9|||
126406389|NCT01895309|454781348|FG001|Overall Study|Withdrawal by Subject|18|||
126406390|NCT03517969|454783076|FG000|Overall Study|Never started protocol treatment|3|||
125890347|NCT04193189|452895527|FG003|Overall Study|Withdrawal by Subject|0|||
126406391|NCT03517969|454783077|FG001|Overall Study|Never started protocol treatment|5|||
126406392|NCT03517969|454783076|FG000|Overall Study|Disease progression|11|||
126406393|NCT03517969|454783077|FG001|Overall Study|Disease progression|16|||
126406394|NCT03517969|454783076|FG000|Overall Study|PSA progression|8|||
126406395|NCT03517969|454783077|FG001|Overall Study|PSA progression|1|||
126406396|NCT03517969|454783076|FG000|Overall Study|Clinical progression|4|||
126406397|NCT03517969|454783077|FG001|Overall Study|Clinical progression|2|||
126406398|NCT03517969|454783076|FG000|Overall Study|Adverse Event|5|||
126406399|NCT03517969|454783077|FG001|Overall Study|Adverse Event|4|||
126406400|NCT03517969|454783076|FG000|Overall Study|Intercurrent illness|1|||
126406401|NCT03517969|454783077|FG001|Overall Study|Intercurrent illness|2|||
126406402|NCT03517969|454783076|FG000|Overall Study|Death|1|||
126406403|NCT03517969|454783077|FG001|Overall Study|Death|1|||
126406404|NCT03517969|454783076|FG000|Overall Study|Withdrawal by Subject|1|||
126406405|NCT03517969|454783077|FG001|Overall Study|Withdrawal by Subject|2|||
126406406|NCT03517969|454783076|FG000|Overall Study|Physician Decision|1|||
126406407|NCT03517969|454783077|FG001|Overall Study|Physician Decision|1|||
126406408|NCT03517969|454783076|FG000|Overall Study|No clinical benefit|1|||
126406409|NCT03517969|454783077|FG001|Overall Study|No clinical benefit|0|||
126406410|NCT03517969|454783076|FG000|Overall Study|Delayed treatment for dental treatment|1|||
126406411|NCT03517969|454783077|FG001|Overall Study|Delayed treatment for dental treatment|0|||
126406412|NCT03517969|454783076|FG000|Overall Study|Difficult to maintain appointment|0|||
126406413|NCT03517969|454783077|FG001|Overall Study|Difficult to maintain appointment|1|||
126406414|NCT03517969|454783076|FG000|Overall Study|Protocol Violation|0|||
126406415|NCT03517969|454783077|FG001|Overall Study|Protocol Violation|1|||
126406416|NCT04051827|454783082|FG000|Overall Study|Death|1|||
126406417|NCT04051827|454783082|FG000|Overall Study|Withdrawal by Subject|4|||
126406418|NCT04051827|454783082|FG000|Overall Study|Progressive disease|16|||
126406419|NCT04051827|454783082|FG000|Overall Study|Physician Decision|1|||
126406420|NCT04051827|454783082|FG000|Overall Study|Other|4|||
126406421|NCT03344172|454783085|FG000|Overall Study|Received <1 dose of treatment|1|||
126406422|NCT03344172|454783086|FG001|Overall Study|Received <1 dose of treatment|0|||
126406423|NCT03779503|454783087|FG000|First Intervention|Adverse Event|0|||
126406424|NCT03779503|454783088|FG001|First Intervention|Adverse Event|1|||
126406425|NCT03779503|454783087|FG000|First Intervention|Withdrawal by Subject|1|||
126406426|NCT03779503|454783088|FG001|First Intervention|Withdrawal by Subject|0|||
126406427|NCT01177969|454783089|FG000|Overall Study|Protocol Violation|2|||
126406428|NCT01177969|454783090|FG001|Overall Study|Protocol Violation|1|||
126406429|NCT01177969|454783089|FG000|Overall Study|Withdrawal by Subject|1|||
126406430|NCT01177969|454783090|FG001|Overall Study|Withdrawal by Subject|2|||
126406431|NCT00687609|454783091|FG000|Overall Study|Physician Decision|1|||
126406432|NCT00687609|454783091|FG000|Overall Study|Withdrawal by Subject|2|||
126406433|NCT00908037|454783092|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406434|NCT00908037|454783093|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406435|NCT00908037|454783094|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406436|NCT00908037|454783095|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406437|NCT00908037|454783096|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
126406438|NCT00908037|454783097|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406439|NCT00908037|454783098|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
126406440|NCT00908037|454783099|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406441|NCT00908037|454783100|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
126406442|NCT00908037|454783101|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406443|NCT00908037|454783102|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406444|NCT00908037|454783103|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406445|NCT00908037|454783092|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406446|NCT00908037|454783093|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406447|NCT00908037|454783094|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406448|NCT00908037|454783095|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126053792|NCT04827732|453490727|FG000|Overall Study|Did not start treatment|0|||
126053793|NCT04827732|453490728|FG001|Overall Study|Did not start treatment|1|||
126053794|NCT04827732|453490729|FG002|Overall Study|Did not start treatment|0|||
126053795|NCT04827732|453490730|FG003|Overall Study|Did not start treatment|1|||
126406449|NCT00908037|454783096|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
126406450|NCT00908037|454783097|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406451|NCT00908037|454783098|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406452|NCT00908037|454783099|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406453|NCT00908037|454783100|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
126406454|NCT00908037|454783101|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406455|NCT00908037|454783102|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406456|NCT00908037|454783103|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406457|NCT00908037|454783092|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406458|NCT00908037|454783093|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125890348|NCT04193189|452895524|FG000|Overall Study|Death|1|||
125890349|NCT04193189|452895525|FG001|Overall Study|Death|1|||
125890350|NCT04193189|452895526|FG002|Overall Study|Death|0|||
125890351|NCT04193189|452895527|FG003|Overall Study|Death|0|||
125890352|NCT04193189|452895524|FG000|Overall Study|Protocol Violation|0|||
125890353|NCT04193189|452895525|FG001|Overall Study|Protocol Violation|0|||
125890354|NCT04193189|452895526|FG002|Overall Study|Protocol Violation|0|||
126406459|NCT00908037|454783094|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406460|NCT00908037|454783095|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
126406461|NCT00908037|454783096|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406462|NCT00908037|454783097|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406463|NCT00908037|454783098|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
126406464|NCT00908037|454783099|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406465|NCT00908037|454783100|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406466|NCT00908037|454783101|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406467|NCT00908037|454783102|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406468|NCT00908037|454783103|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406469|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406470|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406471|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406472|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406473|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406474|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406475|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406476|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406477|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406478|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406479|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406480|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
126406481|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406482|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406483|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406484|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406485|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406486|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406487|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406488|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406489|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406490|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
126406491|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406492|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
126406493|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406494|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406495|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406496|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406497|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406498|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406499|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406500|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406501|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406502|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
126406503|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406504|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406505|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406506|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406507|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406508|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406509|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406510|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406511|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406512|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406513|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406514|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125890355|NCT04193189|452895527|FG003|Overall Study|Protocol Violation|1|||
125890356|NCT00943072|452897079|FG000|Overall Study|Adverse Event|0|||
126406515|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
126406516|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406517|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406518|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406519|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406520|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406521|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406522|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406523|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406524|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406525|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406526|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
126406527|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406528|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406529|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406530|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406531|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406532|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406533|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406534|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406535|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406536|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406537|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406538|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125890357|NCT00943072|452897080|FG001|Overall Study|Adverse Event|3|||
125890358|NCT00943072|452897079|FG000|Overall Study|Death|0|||
125890359|NCT00943072|452897080|FG001|Overall Study|Death|2|||
125890360|NCT00943072|452897079|FG000|Overall Study|Withdrawal by Subject|3|||
125890361|NCT00943072|452897080|FG001|Overall Study|Withdrawal by Subject|1|||
125890362|NCT00943072|452897079|FG000|Overall Study|Protocol Violation|0|||
125890363|NCT00943072|452897080|FG001|Overall Study|Protocol Violation|1|||
125890364|NCT00943072|452897079|FG000|Overall Study|Lost to Follow-up|1|||
125890365|NCT00943072|452897080|FG001|Overall Study|Lost to Follow-up|2|||
125890366|NCT00943072|452897079|FG000|Overall Study|Lack of Efficacy|0|||
125890367|NCT00943072|452897080|FG001|Overall Study|Lack of Efficacy|4|||
125890368|NCT00943072|452897079|FG000|Overall Study|Other|1|||
125890369|NCT00943072|452897080|FG001|Overall Study|Other|1|||
125890370|NCT03436082|452897084|FG000|Overall Study|Did not undergo procedure|1|||
126406539|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
126406540|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406541|NCT00869401|454783105|FG000|Overall Study|Withdrawal by Subject|0|||
125890371|NCT03436082|452897085|FG001|Overall Study|Did not undergo procedure|0|||
125890372|NCT02249832|452897086|FG000|Overall Study|Withdrawal by Subject|3|||
125890373|NCT02249832|452897086|FG000|Overall Study|Lost to Follow-up|10|||
125890374|NCT02563067|452897093|FG000|Overall Study|Subject/guardian decision|14|||
125890375|NCT02563067|452897094|FG001|Overall Study|Subject/guardian decision|20|||
125890376|NCT02563067|452897095|FG002|Overall Study|Subject/guardian decision|16|||
125890377|NCT02563067|452897093|FG000|Overall Study|Physician Decision|0|||
125890378|NCT02563067|452897094|FG001|Overall Study|Physician Decision|1|||
125890379|NCT02563067|452897095|FG002|Overall Study|Physician Decision|3|||
125890380|NCT02563067|452897093|FG000|Overall Study|Lost to Follow-up|1|||
125890381|NCT02563067|452897094|FG001|Overall Study|Lost to Follow-up|2|||
125890382|NCT02563067|452897095|FG002|Overall Study|Lost to Follow-up|0|||
125890383|NCT02563067|452897093|FG000|Overall Study|Technical problems|0|||
125890384|NCT02563067|452897094|FG001|Overall Study|Technical problems|1|||
125890385|NCT02563067|452897095|FG002|Overall Study|Technical problems|0|||
125890386|NCT02563067|452897093|FG000|Overall Study|Lack of Efficacy|1|||
125890387|NCT02563067|452897094|FG001|Overall Study|Lack of Efficacy|0|||
125890388|NCT02563067|452897095|FG002|Overall Study|Lack of Efficacy|0|||
125890389|NCT02563067|452897093|FG000|Overall Study|Death|0|||
125890390|NCT02563067|452897094|FG001|Overall Study|Death|1|||
125890391|NCT02563067|452897095|FG002|Overall Study|Death|1|||
125890392|NCT02563067|452897093|FG000|Overall Study|Adverse Event|2|||
125890393|NCT02563067|452897094|FG001|Overall Study|Adverse Event|1|||
125890394|NCT02563067|452897095|FG002|Overall Study|Adverse Event|0|||
125890395|NCT02563067|452897093|FG000|Overall Study|Death post Treatment/safety period|1|||
125890396|NCT02563067|452897094|FG001|Overall Study|Death post Treatment/safety period|0|||
125890397|NCT02563067|452897095|FG002|Overall Study|Death post Treatment/safety period|0|||
126406542|NCT00869401|454783106|FG001|Overall Study|Withdrawal by Subject|0|||
126406543|NCT00869401|454783107|FG002|Overall Study|Withdrawal by Subject|0|||
126406544|NCT00869401|454783108|FG003|Overall Study|Withdrawal by Subject|5|||
126406545|NCT00869401|454783109|FG004|Overall Study|Withdrawal by Subject|3|||
126406546|NCT01147900|454783110|FG000|At Year 10|Lost to Follow-up|0|||
126406547|NCT01147900|454783111|FG001|At Year 10|Lost to Follow-up|1|||
126406548|NCT01147900|454783112|FG002|At Year 10|Lost to Follow-up|0|||
126406549|NCT00581360|454783115|FG000|Overall Study|Withdrawal by Subject|1|||
126406550|NCT04405245|454783116|FG000|Overall Study|Adverse Event|0|||
126406551|NCT04405245|454783117|FG001|Overall Study|Adverse Event|1|||
126406552|NCT04405245|454783118|FG002|Overall Study|Adverse Event|0|||
126406553|NCT02391961|454783119|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
126406554|NCT02391961|454783120|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
126406555|NCT02391961|454783119|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
126406556|NCT02391961|454783120|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
126406557|NCT02391961|454783119|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126406558|NCT02391961|454783120|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126406559|NCT00491608|454783124|FG000|Overall Study|Death|2|||
126406560|NCT00491608|454783124|FG000|Overall Study|Withdrawal by Subject|1|||
126406561|NCT00025155|454783125|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
126406562|NCT00025155|454783125|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
126406563|NCT00413374|454783126|FG000|Overall Study|Ineligible due to screening criteria.|3|||
126406564|NCT00413374|454783127|FG001|Overall Study|Ineligible due to screening criteria.|0|||
126406565|NCT00413374|454783126|FG000|Overall Study|Adverse Event|1|||
126406566|NCT00413374|454783127|FG001|Overall Study|Adverse Event|0|||
126406567|NCT00413374|454783126|FG000|Overall Study|Lost to Follow-up|1|||
126406568|NCT00413374|454783127|FG001|Overall Study|Lost to Follow-up|0|||
126406569|NCT00413374|454783126|FG000|Overall Study|Surgery|1|||
126406570|NCT00413374|454783127|FG001|Overall Study|Surgery|0|||
126406571|NCT00552760|454783128|FG000|Overall Study|Adverse Event|3|||
126406572|NCT00552760|454783129|FG001|Overall Study|Adverse Event|5|||
126406573|NCT00552760|454783128|FG000|Overall Study|Relapsed- Depressed Event|10|||
126406574|NCT00552760|454783129|FG001|Overall Study|Relapsed- Depressed Event|16|||
126406575|NCT00552760|454783128|FG000|Overall Study|Relapse- Manic Event|3|||
126406576|NCT00552760|454783129|FG001|Overall Study|Relapse- Manic Event|3|||
126406577|NCT00552760|454783128|FG000|Overall Study|Relapsed- Mixed Event|3|||
126406578|NCT00552760|454783129|FG001|Overall Study|Relapsed- Mixed Event|5|||
126406579|NCT00552760|454783128|FG000|Overall Study|Protocol Violation|0|||
126406580|NCT00552760|454783129|FG001|Overall Study|Protocol Violation|1|||
126406581|NCT00552760|454783128|FG000|Overall Study|Lost to Follow-up|1|||
126406582|NCT00552760|454783129|FG001|Overall Study|Lost to Follow-up|1|||
126406583|NCT00552760|454783128|FG000|Overall Study|Non-compliance|1|||
126406584|NCT00552760|454783129|FG001|Overall Study|Non-compliance|1|||
126406585|NCT00552760|454783128|FG000|Overall Study|Medical Condition|1|||
126406586|NCT00552760|454783129|FG001|Overall Study|Medical Condition|1|||
126406587|NCT00552760|454783128|FG000|Overall Study|Withdrawal by Subject|3|||
126406588|NCT00552760|454783129|FG001|Overall Study|Withdrawal by Subject|0|||
126406589|NCT00552760|454783128|FG000|Overall Study|Medication Change|1|||
126406590|NCT00552760|454783129|FG001|Overall Study|Medication Change|0|||
126406591|NCT00924404|454783133|FG000|Overall Study|Lost to Follow-up|6|||
126406592|NCT00924404|454783134|FG001|Overall Study|Lost to Follow-up|4|||
126406593|NCT02613169|454783135|FG000|Overall Study|Withdrawal by Subject|4|||
126406594|NCT02613169|454783136|FG001|Overall Study|Withdrawal by Subject|1|||
126406595|NCT02613169|454783135|FG000|Overall Study|Lost to Follow-up|0|||
126406596|NCT02613169|454783136|FG001|Overall Study|Lost to Follow-up|5|||
126406597|NCT02613169|454783135|FG000|Overall Study|HIV|0|||
126406598|NCT02613169|454783136|FG001|Overall Study|HIV|2|||
126406599|NCT02613169|454783135|FG000|Overall Study|No TB infection endpoint|14|||
126406600|NCT02613169|454783136|FG001|Overall Study|No TB infection endpoint|9|||
126406601|NCT00343382|454783137|FG000|Overall Study|Adverse Event|2|||
126406602|NCT00343382|454783138|FG001|Overall Study|Adverse Event|10|||
126406603|NCT00343382|454783139|FG002|Overall Study|Adverse Event|7|||
126406604|NCT00343382|454783137|FG000|Overall Study|Withdrawal by Subject|1|||
126406605|NCT00343382|454783138|FG001|Overall Study|Withdrawal by Subject|2|||
126406606|NCT00343382|454783139|FG002|Overall Study|Withdrawal by Subject|6|||
126406607|NCT00343382|454783137|FG000|Overall Study|Other Reason Not Specified|1|||
126406608|NCT00343382|454783138|FG001|Overall Study|Other Reason Not Specified|2|||
126406609|NCT00343382|454783139|FG002|Overall Study|Other Reason Not Specified|4|||
126406610|NCT01985360|454783140|FG000|Overall Study|Withdrawal by Subject|4|||
126406611|NCT01985360|454783141|FG001|Overall Study|Withdrawal by Subject|0|||
126406612|NCT01985360|454783140|FG000|Overall Study|Lost to Follow-up|5|||
126406613|NCT01985360|454783141|FG001|Overall Study|Lost to Follow-up|3|||
126406614|NCT02976103|454783142|FG000|Overall Study|Withdrawal by Subject|1|||
126406615|NCT02976103|454783143|FG001|Overall Study|Withdrawal by Subject|0|||
126406616|NCT02976103|454783142|FG000|Overall Study|Lost to Follow-up|12|||
125890398|NCT03544333|452897101|FG000|Overall Study|Withdrawal by Subject|1|||
125890399|NCT03544333|452897102|FG001|Overall Study|Withdrawal by Subject|0|||
125890400|NCT01039519|452897107|FG000|Treatment|Progressive disease|20|||
125890401|NCT01039519|452897107|FG000|Treatment|Treatment failure|2|||
125890402|NCT01039519|452897107|FG000|Treatment|Adverse Event|3|||
125890403|NCT01039519|452897107|FG000|Treatment|Physician Decision|2|||
125890404|NCT01039519|452897107|FG000|Survival Follow-up|Death|23|||
125890405|NCT01039519|452897107|FG000|Survival Follow-up|Sponsor decision|4|||
125890406|NCT00808080|452897111|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
125890407|NCT00423917|452897114|FG000|Overall Study|Cancel|2|||
125890408|NCT00423917|452897114|FG000|Overall Study|Ineligible|1|||
125890409|NCT01396447|452897117|FG000|Overall Study|Did Not Receive Treatment|3|||
125890410|NCT01396447|452897118|FG001|Overall Study|Did Not Receive Treatment|2|||
125890411|NCT01396447|452897119|FG002|Overall Study|Did Not Receive Treatment|1|||
125890412|NCT01396447|452897120|FG003|Overall Study|Did Not Receive Treatment|0|||
125890413|NCT01396447|452897117|FG000|Overall Study|Adverse Event|15|||
125890414|NCT01396447|452897118|FG001|Overall Study|Adverse Event|12|||
125890415|NCT01396447|452897119|FG002|Overall Study|Adverse Event|12|||
125890416|NCT01396447|452897120|FG003|Overall Study|Adverse Event|17|||
125890417|NCT01396447|452897117|FG000|Overall Study|Insufficient Therapeutic Response|5|||
125890418|NCT01396447|452897118|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125890419|NCT01396447|452897119|FG002|Overall Study|Insufficient Therapeutic Response|2|||
125890420|NCT01396447|452897120|FG003|Overall Study|Insufficient Therapeutic Response|4|||
125890421|NCT01396447|452897117|FG000|Overall Study|Protocol Violation|5|||
125890422|NCT01396447|452897118|FG001|Overall Study|Protocol Violation|2|||
125890423|NCT01396447|452897119|FG002|Overall Study|Protocol Violation|3|||
125890424|NCT01396447|452897120|FG003|Overall Study|Protocol Violation|7|||
125890425|NCT01396447|452897117|FG000|Overall Study|Withdrawal of Consent|11|||
125890426|NCT01396447|452897118|FG001|Overall Study|Withdrawal of Consent|9|||
125890427|NCT01396447|452897119|FG002|Overall Study|Withdrawal of Consent|4|||
125890428|NCT01396447|452897120|FG003|Overall Study|Withdrawal of Consent|15|||
125890429|NCT01396447|452897117|FG000|Overall Study|Lost to Follow-up|4|||
125890430|NCT01396447|452897118|FG001|Overall Study|Lost to Follow-up|8|||
125890431|NCT01396447|452897119|FG002|Overall Study|Lost to Follow-up|7|||
125890432|NCT01396447|452897120|FG003|Overall Study|Lost to Follow-up|9|||
125890433|NCT01396447|452897117|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125890434|NCT01396447|452897118|FG001|Overall Study|Other Miscellaneous Reasons|2|||
125890435|NCT01396447|452897119|FG002|Overall Study|Other Miscellaneous Reasons|1|||
125890436|NCT01396447|452897120|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125890437|NCT00578292|452897121|FG000|Overall Study|Death|1|||
125890438|NCT00578292|452897121|FG000|Overall Study|Graft failure|2|||
125890439|NCT00856518|452897125|FG000|Overall Study|Lost to Follow-up|4|||
125890440|NCT00856518|452897126|FG001|Overall Study|Lost to Follow-up|2|||
125890441|NCT00947193|452897127|FG000|Overall Study|Lost to Follow-up|1|||
125890442|NCT00947193|452897128|FG001|Overall Study|Lost to Follow-up|0|||
125890443|NCT00947193|452897127|FG000|Overall Study|Withdrawal by Subject|1|||
125890444|NCT00947193|452897128|FG001|Overall Study|Withdrawal by Subject|0|||
125890445|NCT00947193|452897127|FG000|Overall Study|Factor VIII >1%|1|||
125890446|NCT00947193|452897128|FG001|Overall Study|Factor VIII >1%|0|||
125890447|NCT04849559|452897129|FG000|Overall Study|Withdrawal by Subject|2|||
125890448|NCT04849559|452897130|FG001|Overall Study|Withdrawal by Subject|1|||
125890449|NCT02105961|452897131|FG000|Overall Study|Adverse Event|18|||
125890450|NCT02105961|452897132|FG001|Overall Study|Adverse Event|7|||
125890451|NCT02105961|452897133|FG002|Overall Study|Adverse Event|13|||
125890452|NCT02105961|452897131|FG000|Overall Study|Lack of Efficacy|3|||
125890453|NCT02105961|452897132|FG001|Overall Study|Lack of Efficacy|0|||
125890454|NCT02105961|452897133|FG002|Overall Study|Lack of Efficacy|3|||
125890455|NCT02105961|452897131|FG000|Overall Study|Lost to Follow-up|2|||
125890456|NCT02105961|452897132|FG001|Overall Study|Lost to Follow-up|0|||
125890457|NCT02105961|452897133|FG002|Overall Study|Lost to Follow-up|1|||
125890458|NCT02105961|452897131|FG000|Overall Study|Physician Decision|3|||
125890459|NCT02105961|452897132|FG001|Overall Study|Physician Decision|3|||
125890460|NCT02105961|452897133|FG002|Overall Study|Physician Decision|2|||
125890461|NCT02105961|452897131|FG000|Overall Study|Withdrawal by Subject|15|||
125890462|NCT02105961|452897132|FG001|Overall Study|Withdrawal by Subject|7|||
125890463|NCT02105961|452897133|FG002|Overall Study|Withdrawal by Subject|11|||
125890464|NCT04154189|452897134|FG000|Overall Study|Withdrawal by Subject|4|||
125890465|NCT04154189|452897135|FG001|Overall Study|Withdrawal by Subject|6|||
125890466|NCT04154189|452897134|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
125890467|NCT04154189|452897135|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
125890468|NCT04154189|452897134|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
125890469|NCT04154189|452897135|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
125890470|NCT04154189|452897134|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
125890471|NCT04154189|452897135|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
125890472|NCT04154189|452897134|FG000|Overall Study|Death|25|||
125890473|NCT04154189|452897135|FG001|Overall Study|Death|25|||
125890474|NCT02147561|452897138|FG000|Overall Study|Lost to Follow-up|3|||
125890475|NCT02147561|452897138|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
125890476|NCT01191762|452897139|FG000|Overall Study|Adverse Event|1|||
125890477|NCT01191762|452897140|FG001|Overall Study|Adverse Event|0|||
125890478|NCT00459186|452897143|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
126406617|NCT02976103|454783143|FG001|Overall Study|Lost to Follow-up|8|||
126406618|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
126406619|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
125890479|NCT00459186|452897143|FG000|PET Imaging and Assessment|Adverse Event|3|||
125890480|NCT01485172|452897144|FG000|Overall Study|Adverse Event|2|||
125890481|NCT01485172|452897145|FG001|Overall Study|Adverse Event|1|||
125890482|NCT01485172|452897146|FG002|Overall Study|Adverse Event|2|||
125890483|NCT01485172|452897147|FG003|Overall Study|Adverse Event|2|||
125890484|NCT01485172|452897148|FG004|Overall Study|Adverse Event|1|||
125890485|NCT01485172|452897149|FG005|Overall Study|Adverse Event|2|||
125890486|NCT01485172|452897144|FG000|Overall Study|Lack of Efficacy|2|||
125890487|NCT01485172|452897145|FG001|Overall Study|Lack of Efficacy|0|||
125890488|NCT01485172|452897146|FG002|Overall Study|Lack of Efficacy|0|||
125890489|NCT01485172|452897147|FG003|Overall Study|Lack of Efficacy|0|||
125890490|NCT01485172|452897148|FG004|Overall Study|Lack of Efficacy|0|||
125890491|NCT01485172|452897149|FG005|Overall Study|Lack of Efficacy|0|||
125890492|NCT01485172|452897144|FG000|Overall Study|Protocol Violation|0|||
125890493|NCT01485172|452897145|FG001|Overall Study|Protocol Violation|0|||
125890494|NCT01485172|452897146|FG002|Overall Study|Protocol Violation|4|||
125890495|NCT01485172|452897147|FG003|Overall Study|Protocol Violation|5|||
125890496|NCT01485172|452897148|FG004|Overall Study|Protocol Violation|1|||
125890497|NCT01485172|452897149|FG005|Overall Study|Protocol Violation|0|||
125890498|NCT01485172|452897144|FG000|Overall Study|Protocol defined stopping criteria|1|||
125890499|NCT01485172|452897145|FG001|Overall Study|Protocol defined stopping criteria|0|||
125890500|NCT01485172|452897146|FG002|Overall Study|Protocol defined stopping criteria|0|||
125890501|NCT01485172|452897147|FG003|Overall Study|Protocol defined stopping criteria|0|||
125890502|NCT01485172|452897148|FG004|Overall Study|Protocol defined stopping criteria|1|||
125890503|NCT01485172|452897149|FG005|Overall Study|Protocol defined stopping criteria|0|||
125890504|NCT01485172|452897144|FG000|Overall Study|Lost to Follow-up|0|||
125890505|NCT01485172|452897145|FG001|Overall Study|Lost to Follow-up|0|||
125890506|NCT01485172|452897146|FG002|Overall Study|Lost to Follow-up|1|||
125890507|NCT01485172|452897147|FG003|Overall Study|Lost to Follow-up|0|||
125890508|NCT01485172|452897148|FG004|Overall Study|Lost to Follow-up|0|||
125890509|NCT01485172|452897149|FG005|Overall Study|Lost to Follow-up|1|||
125890510|NCT01485172|452897144|FG000|Overall Study|Physician Decision|0|||
125890511|NCT01485172|452897145|FG001|Overall Study|Physician Decision|0|||
125890512|NCT01485172|452897146|FG002|Overall Study|Physician Decision|0|||
125890513|NCT01485172|452897147|FG003|Overall Study|Physician Decision|0|||
126406620|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
126406621|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
126406622|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
126406623|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
126406624|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126406625|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126406626|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126406627|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125890514|NCT01485172|452897148|FG004|Overall Study|Physician Decision|1|||
125890515|NCT01485172|452897149|FG005|Overall Study|Physician Decision|0|||
125890516|NCT01485172|452897144|FG000|Overall Study|Withdrawal by Subject|2|||
125890517|NCT01485172|452897145|FG001|Overall Study|Withdrawal by Subject|0|||
125890518|NCT01485172|452897146|FG002|Overall Study|Withdrawal by Subject|0|||
125890519|NCT01485172|452897147|FG003|Overall Study|Withdrawal by Subject|1|||
125890520|NCT01485172|452897148|FG004|Overall Study|Withdrawal by Subject|1|||
126406628|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126406629|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
126406630|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
125890521|NCT01485172|452897149|FG005|Overall Study|Withdrawal by Subject|1|||
125890522|NCT02283762|452897150|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
125890523|NCT02283762|452897151|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
126406631|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
126406632|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406633|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
126406634|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
126406635|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406636|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406637|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406638|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406639|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406640|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406641|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
126406642|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
126406643|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
126406644|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
126406645|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
126406646|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406647|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406648|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406649|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406650|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406651|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
126406652|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
126406653|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
126406654|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406655|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
126406656|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
126406657|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406658|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406659|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406660|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406661|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406662|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406663|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406664|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
126406665|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406666|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406667|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
126406668|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406669|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406670|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406671|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406672|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406673|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
126406674|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406675|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406676|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406677|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406678|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406679|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406680|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406681|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406682|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406683|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406684|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406685|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406686|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
126406687|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406688|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406689|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406690|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406691|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406692|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406693|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406694|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126053859|NCT03414684|453491258|FG000|First-course Treatment|Complete response|0|||
126053860|NCT03414684|453491259|FG001|First-course Treatment|Complete response|1|||
126053861|NCT03414684|453491258|FG000|First-course Treatment|Intercurrent illness|1|||
126053862|NCT03414684|453491259|FG001|First-course Treatment|Intercurrent illness|0|||
126053863|NCT03414684|453491258|FG000|First-course Treatment|Progressive Disease|31|||
126053864|NCT03414684|453491259|FG001|First-course Treatment|Progressive Disease|32|||
126053865|NCT03414684|453491258|FG000|First-course Treatment|Adverse Event|1|||
126053866|NCT03414684|453491259|FG001|First-course Treatment|Adverse Event|2|||
126053867|NCT03414684|453491258|FG000|First-course Treatment|Physician Decision|0|||
126053868|NCT03414684|453491259|FG001|First-course Treatment|Physician Decision|1|||
126053869|NCT03414684|453491258|FG000|First-course Treatment|Withdrawal by Subject|0|||
126053870|NCT03414684|453491259|FG001|First-course Treatment|Withdrawal by Subject|1|||
126053871|NCT03414684|453491258|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
126053872|NCT03414684|453491259|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
126053873|NCT03414684|453491258|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
126053874|NCT03414684|453491259|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
126053875|NCT03414684|453491258|FG000|First-course Treatment|Still on treatment|3|||
126053876|NCT03414684|453491259|FG001|First-course Treatment|Still on treatment|0|||
126053877|NCT03414684|453491258|FG000|First-course Treatment|Never started protocol therapy|2|||
126053878|NCT03414684|453491259|FG001|First-course Treatment|Never started protocol therapy|1|||
126053879|NCT03414684|453491258|FG000|Crossover Treatment|Progressive disease|0|||
126406695|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
126406696|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406697|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
126406698|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
126406699|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
126406700|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
126406701|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406702|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406703|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406704|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406705|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406706|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406707|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406708|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406709|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406710|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406711|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406712|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
126406713|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
126406714|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
126406715|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
126406716|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
126406717|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406718|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406719|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406720|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406721|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406722|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406723|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
126406724|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
126406725|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
126406726|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
126406727|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
126406728|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406729|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406730|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406731|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406732|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406733|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406734|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
126406735|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
126406736|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
126406737|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
126406738|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
126406739|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406740|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406741|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406742|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406743|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125890524|NCT02283762|452897150|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
126406744|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406745|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
126406746|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406747|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
126406748|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406749|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
126406750|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406751|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406752|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406753|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406754|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406755|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406756|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
126406757|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406758|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
126406759|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
126406760|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
126406761|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406762|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406763|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406764|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406765|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406766|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406767|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
126406768|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406769|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
126406770|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406771|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406772|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406773|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406774|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406775|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406776|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406777|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406778|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406779|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406780|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
126406781|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406782|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406783|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406784|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406785|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406786|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406787|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406788|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406789|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
126406790|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406791|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406792|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406793|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406794|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406795|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406796|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406797|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406798|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406799|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406800|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406801|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406802|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
125890525|NCT02283762|452897151|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
125890526|NCT02283762|452897150|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
126406803|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
126406804|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
125890527|NCT02283762|452897151|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
126406805|NCT01455220|454783157|FG000|Overall Study|screen fail|30|||
126406806|NCT04881747|454783158|FG000|Period 2 Washout|Adverse Event|1|||
126406807|NCT04881747|454783159|FG001|Period 2 Washout|Adverse Event|0|||
126406808|NCT04881747|454783160|FG002|Period 2 Washout|Adverse Event|0|||
126406809|NCT04881747|454783161|FG003|Period 2 Washout|Adverse Event|0|||
126406810|NCT04881747|454783162|FG004|Period 2 Washout|Adverse Event|1|||
126406811|NCT04881747|454783163|FG005|Period 2 Washout|Adverse Event|0|||
126406812|NCT04881747|454783158|FG000|Period 2 Washout|Withdrawal by Subject|1|||
126406813|NCT04881747|454783159|FG001|Period 2 Washout|Withdrawal by Subject|0|||
126406814|NCT04881747|454783160|FG002|Period 2 Washout|Withdrawal by Subject|0|||
126406815|NCT04881747|454783161|FG003|Period 2 Washout|Withdrawal by Subject|1|||
126406816|NCT04881747|454783162|FG004|Period 2 Washout|Withdrawal by Subject|0|||
126406817|NCT04881747|454783163|FG005|Period 2 Washout|Withdrawal by Subject|0|||
126406818|NCT04598269|454783164|FG000|Overall Study|Adverse Event|0|||
126406819|NCT04598269|454783165|FG001|Overall Study|Adverse Event|3|||
126406820|NCT04598269|454783164|FG000|Overall Study|Withdrawal by Subject|1|||
126406821|NCT04598269|454783165|FG001|Overall Study|Withdrawal by Subject|4|||
126406822|NCT04598269|454783164|FG000|Overall Study|Lost to Follow-up|1|||
126406823|NCT04598269|454783165|FG001|Overall Study|Lost to Follow-up|0|||
126406824|NCT04598269|454783164|FG000|Overall Study|Not Treated|2|||
126406825|NCT04598269|454783165|FG001|Overall Study|Not Treated|0|||
126406826|NCT03869333|454783166|FG000|Overall Study|Lost to Follow-up|1|||
126406827|NCT03869333|454783167|FG001|Overall Study|Lost to Follow-up|0|||
126406828|NCT03869333|454783168|FG002|Overall Study|Lost to Follow-up|0|||
126406829|NCT03869333|454783169|FG003|Overall Study|Lost to Follow-up|0|||
126406830|NCT03869333|454783166|FG000|Overall Study|Pregnancy|1|||
126406831|NCT03869333|454783167|FG001|Overall Study|Pregnancy|0|||
126406832|NCT03869333|454783168|FG002|Overall Study|Pregnancy|0|||
126406833|NCT03869333|454783169|FG003|Overall Study|Pregnancy|0|||
125890528|NCT02283762|452897150|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
125890529|NCT02283762|452897151|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
125890530|NCT02283762|452897150|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
125890531|NCT02283762|452897151|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
125890532|NCT02283762|452897150|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
126053880|NCT03414684|453491259|FG001|Crossover Treatment|Progressive disease|12|||
126053881|NCT03414684|453491258|FG000|Crossover Treatment|Adverse Event|0|||
126053882|NCT03414684|453491259|FG001|Crossover Treatment|Adverse Event|3|||
126053883|NCT03414684|453491258|FG000|Crossover Treatment|Physician Decision|0|||
126053884|NCT03414684|453491259|FG001|Crossover Treatment|Physician Decision|1|||
126053885|NCT03414684|453491258|FG000|Crossover Treatment|Still on treatment|0|||
126053886|NCT03414684|453491259|FG001|Crossover Treatment|Still on treatment|2|||
126053887|NCT04038580|453491260|FG000|Washout 1|Death|0|||
126053888|NCT04038580|453491261|FG001|Washout 1|Death|0|||
126053889|NCT04038580|453491262|FG002|Washout 1|Death|0|||
126053890|NCT04038580|453491263|FG003|Washout 1|Death|1|||
126053891|NCT04038580|453491264|FG004|Washout 1|Death|0|||
126053892|NCT04038580|453491265|FG005|Washout 1|Death|0|||
126053893|NCT04038580|453491260|FG000|Washout 1|Withdrawal by Subject|0|||
126053894|NCT04038580|453491261|FG001|Washout 1|Withdrawal by Subject|0|||
126053895|NCT04038580|453491262|FG002|Washout 1|Withdrawal by Subject|0|||
126053896|NCT04038580|453491263|FG003|Washout 1|Withdrawal by Subject|0|||
126053897|NCT04038580|453491264|FG004|Washout 1|Withdrawal by Subject|1|||
126053898|NCT04038580|453491265|FG005|Washout 1|Withdrawal by Subject|0|||
126053899|NCT04038580|453491260|FG000|Wash-out 2|Withdrawal by Subject|1|||
126053900|NCT04038580|453491261|FG001|Wash-out 2|Withdrawal by Subject|0|||
126406834|NCT03869333|454783166|FG000|Overall Study|Physician Decision|0|||
126406835|NCT03869333|454783167|FG001|Overall Study|Physician Decision|1|||
126406836|NCT03869333|454783168|FG002|Overall Study|Physician Decision|0|||
126406837|NCT03869333|454783169|FG003|Overall Study|Physician Decision|0|||
126406838|NCT01927055|454783170|FG000|Open-label|Adverse Event|6|||
126053901|NCT04038580|453491262|FG002|Wash-out 2|Withdrawal by Subject|0|||
126053902|NCT04038580|453491263|FG003|Wash-out 2|Withdrawal by Subject|2|||
126053903|NCT04038580|453491264|FG004|Wash-out 2|Withdrawal by Subject|0|||
126406839|NCT01927055|454783171|FG001|Open-label|Adverse Event|0|||
126406840|NCT01927055|454783172|FG002|Open-label|Adverse Event|0|||
126053904|NCT04038580|453491265|FG005|Wash-out 2|Withdrawal by Subject|1|||
126406841|NCT01927055|454783170|FG000|Open-label|Withdrawal by Subject|1|||
126406842|NCT01927055|454783171|FG001|Open-label|Withdrawal by Subject|0|||
126406843|NCT01927055|454783172|FG002|Open-label|Withdrawal by Subject|0|||
126406844|NCT01927055|454783170|FG000|Open-label|Study Stopped|4|||
126406845|NCT01927055|454783171|FG001|Open-label|Study Stopped|0|||
126406846|NCT01927055|454783172|FG002|Open-label|Study Stopped|0|||
126406847|NCT01927055|454783170|FG000|Open-label|Supine Hypertension|4|||
126406848|NCT01927055|454783171|FG001|Open-label|Supine Hypertension|0|||
126406849|NCT01927055|454783172|FG002|Open-label|Supine Hypertension|0|||
126406850|NCT01927055|454783170|FG000|Open-label|Difficulty attending study visits|1|||
126406851|NCT01927055|454783171|FG001|Open-label|Difficulty attending study visits|0|||
126406852|NCT01927055|454783172|FG002|Open-label|Difficulty attending study visits|0|||
126406853|NCT01927055|454783170|FG000|Double-Blind|Adverse Event|0|||
126406854|NCT01927055|454783171|FG001|Double-Blind|Adverse Event|1|||
126406855|NCT01927055|454783172|FG002|Double-Blind|Adverse Event|1|||
126406856|NCT01927055|454783170|FG000|Double-Blind|Protocol Violation|0|||
126406857|NCT01927055|454783171|FG001|Double-Blind|Protocol Violation|0|||
126406858|NCT01927055|454783172|FG002|Double-Blind|Protocol Violation|1|||
126406859|NCT01927055|454783170|FG000|Double-Blind|Withdrawal by Subject|0|||
126406860|NCT01927055|454783171|FG001|Double-Blind|Withdrawal by Subject|2|||
126406861|NCT01927055|454783172|FG002|Double-Blind|Withdrawal by Subject|3|||
126406862|NCT01927055|454783170|FG000|Double-Blind|Study Stopped|0|||
126406863|NCT01927055|454783171|FG001|Double-Blind|Study Stopped|7|||
126406864|NCT01927055|454783172|FG002|Double-Blind|Study Stopped|7|||
126406865|NCT01927055|454783170|FG000|Double-Blind|Supine Hypertension|0|||
126406866|NCT01927055|454783171|FG001|Double-Blind|Supine Hypertension|0|||
126406867|NCT01927055|454783172|FG002|Double-Blind|Supine Hypertension|1|||
126406868|NCT01927055|454783170|FG000|Double-Blind|Extended Vacation|0|||
126406869|NCT01927055|454783171|FG001|Double-Blind|Extended Vacation|1|||
126406870|NCT01927055|454783172|FG002|Double-Blind|Extended Vacation|0|||
126406871|NCT02966015|454783175|FG000|Inclusion Visit|did not answer questionnaire|8|||
126406872|NCT02966015|454783176|FG001|Inclusion Visit|did not answer questionnaire|3|||
126406873|NCT00619489|454783177|FG000|Overall Study|Adverse Event|0|||
126406874|NCT00619489|454783178|FG001|Overall Study|Adverse Event|7|||
126406875|NCT00619489|454783177|FG000|Overall Study|Withdrawal by Subject|1|||
126406876|NCT00619489|454783178|FG001|Overall Study|Withdrawal by Subject|1|||
126406877|NCT00619489|454783177|FG000|Overall Study|Lack of Efficacy|0|||
126406878|NCT00619489|454783178|FG001|Overall Study|Lack of Efficacy|11|||
126406879|NCT00619489|454783177|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
126406880|NCT00619489|454783178|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
126406881|NCT01198509|454783185|FG000|Overall Study|Withdrawal by Subject|1|||
126406882|NCT01198509|454783186|FG001|Overall Study|Withdrawal by Subject|0|||
126406883|NCT01198509|454783187|FG002|Overall Study|Withdrawal by Subject|0|||
126406884|NCT01198509|454783188|FG003|Overall Study|Withdrawal by Subject|0|||
126406885|NCT01198509|454783189|FG004|Overall Study|Withdrawal by Subject|0|||
126406886|NCT01198509|454783190|FG005|Overall Study|Withdrawal by Subject|0|||
126406887|NCT00499746|454783191|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
126406888|NCT00499746|454783191|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
126406889|NCT00499746|454783191|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
126406890|NCT00499746|454783191|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
126406891|NCT02745535|454783193|FG000|Overall Study|Death|1|||
126406892|NCT02745535|454783193|FG000|Overall Study|Adverse Event|3|||
126406893|NCT02745535|454783193|FG000|Overall Study|Lost to Follow-up|2|||
126406894|NCT01291277|454783194|FG000|Overall Study|Death|2|||
126406895|NCT01291277|454783195|FG001|Overall Study|Death|2|||
126406896|NCT01291277|454783194|FG000|Overall Study|Lost to Follow-up|3|||
126406897|NCT01291277|454783195|FG001|Overall Study|Lost to Follow-up|1|||
126406898|NCT00849108|454783196|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
126406899|NCT00849108|454783197|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
126406900|NCT00849108|454783196|FG000|Cohort 2 Efficacy|Adverse Event|0|||
126406901|NCT00849108|454783197|FG001|Cohort 2 Efficacy|Adverse Event|1|||
126406902|NCT00849108|454783196|FG000|Cohort 2 Efficacy|Other|0|||
126406903|NCT00849108|454783197|FG001|Cohort 2 Efficacy|Other|9|||
126406904|NCT03480009|454783198|FG000|Overall Study|Lost to Follow-up|4|||
126406905|NCT03480009|454783199|FG001|Overall Study|Lost to Follow-up|5|||
126406906|NCT03480009|454783200|FG002|Overall Study|Lost to Follow-up|4|||
126406907|NCT03480009|454783201|FG003|Overall Study|Lost to Follow-up|0|||
126406908|NCT01563172|454783202|FG000|Overall Study|Adverse Event|5|||
126406909|NCT01563172|454783202|FG000|Overall Study|Lost to Follow-up|2|||
126406910|NCT01563172|454783202|FG000|Overall Study|Other (Protocol deviation)|5|||
126406911|NCT01563172|454783202|FG000|Overall Study|Other (Not specified)|1|||
126053905|NCT04038580|453491260|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
126406912|NCT01105377|454783203|FG000|Overall Study|Withdrawal by Subject|0|||
126406913|NCT01105377|454783204|FG001|Overall Study|Withdrawal by Subject|1|||
126406914|NCT02014584|454783212|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406915|NCT02014584|454783213|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
126406916|NCT02014584|454783214|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406917|NCT02014584|454783215|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406918|NCT02014584|454783216|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406919|NCT02014584|454783217|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406920|NCT02014584|454783212|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
126406921|NCT02014584|454783213|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
126406922|NCT02014584|454783214|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126406923|NCT02014584|454783215|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126406924|NCT02014584|454783216|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126406925|NCT02014584|454783217|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126406926|NCT02014584|454783212|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406927|NCT02014584|454783213|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406928|NCT02014584|454783214|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
126406929|NCT02014584|454783215|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406930|NCT02014584|454783216|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406931|NCT02014584|454783217|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406932|NCT02014584|454783212|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
126406933|NCT02014584|454783213|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
126406934|NCT02014584|454783214|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
126406935|NCT02014584|454783215|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
126406936|NCT02014584|454783216|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
126406937|NCT02014584|454783217|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
126406938|NCT02014584|454783212|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406939|NCT02014584|454783213|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406940|NCT02014584|454783214|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406941|NCT02014584|454783215|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406942|NCT02014584|454783216|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
126406943|NCT02014584|454783217|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406944|NCT01624090|454783218|FG000|Overall Study|DLT, taken off therapy|0|||
126406945|NCT01624090|454783219|FG001|Overall Study|DLT, taken off therapy|1|||
126406946|NCT01624090|454783220|FG002|Overall Study|DLT, taken off therapy|0|||
126406947|NCT01624090|454783221|FG003|Overall Study|DLT, taken off therapy|0|||
126406948|NCT01624090|454783218|FG000|Overall Study|Withdrew prior to treatment|0|||
126406949|NCT01624090|454783219|FG001|Overall Study|Withdrew prior to treatment|1|||
126406950|NCT01624090|454783220|FG002|Overall Study|Withdrew prior to treatment|0|||
126406951|NCT01624090|454783221|FG003|Overall Study|Withdrew prior to treatment|0|||
126406952|NCT01624090|454783218|FG000|Overall Study|Died on study|0|||
126406953|NCT01624090|454783219|FG001|Overall Study|Died on study|0|||
126406954|NCT01624090|454783220|FG002|Overall Study|Died on study|2|||
126406955|NCT01624090|454783221|FG003|Overall Study|Died on study|0|||
126406956|NCT01624090|454783218|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
126406957|NCT01624090|454783219|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
126406958|NCT01624090|454783220|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
125890533|NCT02283762|452897151|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
126406959|NCT01624090|454783221|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
126406960|NCT01624090|454783218|FG000|Overall Study|Dose escalated|0|||
126406961|NCT01624090|454783219|FG001|Overall Study|Dose escalated|0|||
126406962|NCT01624090|454783220|FG002|Overall Study|Dose escalated|3|||
126406963|NCT01624090|454783221|FG003|Overall Study|Dose escalated|0|||
125890534|NCT02283762|452897150|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
125890535|NCT02283762|452897151|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
125890536|NCT02283762|452897150|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
126406964|NCT00772109|454783222|FG000|Overall Study|Serious adverse event|1|||
126406965|NCT00772109|454783223|FG001|Overall Study|Serious adverse event|0|||
126406966|NCT00772109|454783224|FG002|Overall Study|Serious adverse event|1|||
126406967|NCT00772109|454783225|FG003|Overall Study|Serious adverse event|0|||
126406968|NCT00772109|454783222|FG000|Overall Study|Protocol Violation|5|||
126406969|NCT00772109|454783223|FG001|Overall Study|Protocol Violation|8|||
126406970|NCT00772109|454783224|FG002|Overall Study|Protocol Violation|7|||
126406971|NCT00772109|454783225|FG003|Overall Study|Protocol Violation|6|||
126406972|NCT00772109|454783222|FG000|Overall Study|Lost to Follow-up|7|||
126406973|NCT00772109|454783223|FG001|Overall Study|Lost to Follow-up|3|||
126406974|NCT00772109|454783224|FG002|Overall Study|Lost to Follow-up|5|||
126406975|NCT00772109|454783225|FG003|Overall Study|Lost to Follow-up|9|||
126406976|NCT00772109|454783222|FG000|Overall Study|Withdrawal by Subject|8|||
126406977|NCT00772109|454783223|FG001|Overall Study|Withdrawal by Subject|8|||
126406978|NCT00772109|454783224|FG002|Overall Study|Withdrawal by Subject|6|||
126406979|NCT00772109|454783225|FG003|Overall Study|Withdrawal by Subject|16|||
126406980|NCT00752726|454783226|FG000|Overall Study|Lost to Follow-up|2|||
126406981|NCT00752726|454783227|FG001|Overall Study|Lost to Follow-up|1|||
126406982|NCT00752726|454783226|FG000|Overall Study|Adverse Event|3|||
126406983|NCT00752726|454783227|FG001|Overall Study|Adverse Event|0|||
126406984|NCT00752726|454783226|FG000|Overall Study|Withdrawal by Subject|5|||
126406985|NCT00752726|454783227|FG001|Overall Study|Withdrawal by Subject|10|||
126406986|NCT00752726|454783226|FG000|Overall Study|Other Reason|1|||
126406987|NCT00752726|454783227|FG001|Overall Study|Other Reason|2|||
126406988|NCT00042666|454783228|FG000|Overall Study|Adverse Event|2|||
126406989|NCT00042666|454783228|FG000|Overall Study|Death|4|||
126406990|NCT00042666|454783228|FG000|Overall Study|Protocol Violation|1|||
126406991|NCT00042666|454783228|FG000|Overall Study|Participant/Physician Perception|1|||
126406992|NCT00042666|454783228|FG000|Overall Study|Progressive Disease|41|||
126406993|NCT00042666|454783228|FG000|Overall Study|Other|1|||
126406994|NCT00042666|454783228|FG000|Overall Study|Other|4|||
126406995|NCT04232215|454783229|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126406996|NCT04232215|454783230|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
126406997|NCT01555125|454783233|FG000|Induction Period|Lost to Follow-up|0|||
126406998|NCT01555125|454783234|FG001|Induction Period|Lost to Follow-up|2|||
126406999|NCT01555125|454783235|FG002|Induction Period|Lost to Follow-up|0|||
126407000|NCT01555125|454783236|FG003|Induction Period|Lost to Follow-up|0|||
126407001|NCT01555125|454783237|FG004|Induction Period|Lost to Follow-up|0|||
126407002|NCT01555125|454783233|FG000|Induction Period|Adverse Event|0|||
126407003|NCT01555125|454783234|FG001|Induction Period|Adverse Event|1|||
126407004|NCT01555125|454783235|FG002|Induction Period|Adverse Event|0|||
126407005|NCT01555125|454783236|FG003|Induction Period|Adverse Event|0|||
126407006|NCT01555125|454783237|FG004|Induction Period|Adverse Event|1|||
126407007|NCT01555125|454783233|FG000|Induction Period|Subject / guardian decision|0|||
126407008|NCT01555125|454783234|FG001|Induction Period|Subject / guardian decision|0|||
126407009|NCT01555125|454783235|FG002|Induction Period|Subject / guardian decision|0|||
126407010|NCT01555125|454783236|FG003|Induction Period|Subject / guardian decision|0|||
126407011|NCT01555125|454783237|FG004|Induction Period|Subject / guardian decision|2|||
126407012|NCT01555125|454783233|FG000|Induction Period|Death|1|||
126407013|NCT01555125|454783234|FG001|Induction Period|Death|0|||
126407014|NCT01555125|454783235|FG002|Induction Period|Death|0|||
126407015|NCT01555125|454783236|FG003|Induction Period|Death|0|||
126407016|NCT01555125|454783237|FG004|Induction Period|Death|0|||
126407017|NCT01555125|454783233|FG000|Maintenance Period|Adverse Event|1|||
126407018|NCT01555125|454783234|FG001|Maintenance Period|Adverse Event|1|||
126407019|NCT01555125|454783235|FG002|Maintenance Period|Adverse Event|0|||
126407020|NCT01555125|454783236|FG003|Maintenance Period|Adverse Event|0|||
126407021|NCT01555125|454783237|FG004|Maintenance Period|Adverse Event|0|||
126407022|NCT01555125|454783233|FG000|Maintenance Period|Subject / guardian decision|1|||
126407023|NCT01555125|454783234|FG001|Maintenance Period|Subject / guardian decision|2|||
126407024|NCT01555125|454783235|FG002|Maintenance Period|Subject / guardian decision|0|||
126407025|NCT01555125|454783236|FG003|Maintenance Period|Subject / guardian decision|0|||
126407026|NCT01555125|454783237|FG004|Maintenance Period|Subject / guardian decision|0|||
126407027|NCT01555125|454783233|FG000|Maintenance Period|Lost to Follow-up|2|||
126407028|NCT01555125|454783234|FG001|Maintenance Period|Lost to Follow-up|0|||
126407029|NCT01555125|454783235|FG002|Maintenance Period|Lost to Follow-up|0|||
126407030|NCT01555125|454783236|FG003|Maintenance Period|Lost to Follow-up|1|||
126407031|NCT01555125|454783237|FG004|Maintenance Period|Lost to Follow-up|0|||
126407032|NCT01555125|454783233|FG000|Maintenance Period|Lack of Efficacy|6|||
126407033|NCT01555125|454783234|FG001|Maintenance Period|Lack of Efficacy|1|||
126407034|NCT01555125|454783235|FG002|Maintenance Period|Lack of Efficacy|3|||
126407035|NCT01555125|454783236|FG003|Maintenance Period|Lack of Efficacy|0|||
126407036|NCT01555125|454783237|FG004|Maintenance Period|Lack of Efficacy|0|||
126407037|NCT01555125|454783233|FG000|Maintenance Period|Physician Decision|0|||
126407038|NCT01555125|454783234|FG001|Maintenance Period|Physician Decision|0|||
126407039|NCT01555125|454783235|FG002|Maintenance Period|Physician Decision|1|||
126407040|NCT01555125|454783236|FG003|Maintenance Period|Physician Decision|0|||
126407041|NCT01555125|454783237|FG004|Maintenance Period|Physician Decision|0|||
126407042|NCT01555125|454783233|FG000|Maintenance Period|Death|0|||
126407043|NCT01555125|454783234|FG001|Maintenance Period|Death|0|||
126407044|NCT01555125|454783235|FG002|Maintenance Period|Death|0|||
126407045|NCT01555125|454783236|FG003|Maintenance Period|Death|1|||
126407046|NCT01555125|454783237|FG004|Maintenance Period|Death|0|||
126407047|NCT01555125|454783233|FG000|Extension|Adverse Event|1|||
126407048|NCT01555125|454783234|FG001|Extension|Adverse Event|2|||
126407049|NCT01555125|454783235|FG002|Extension|Adverse Event|1|||
126407050|NCT01555125|454783236|FG003|Extension|Adverse Event|1|||
126407051|NCT01555125|454783237|FG004|Extension|Adverse Event|0|||
126407052|NCT01555125|454783233|FG000|Extension|Protocol deviation|1|||
126407053|NCT01555125|454783234|FG001|Extension|Protocol deviation|0|||
126407054|NCT01555125|454783235|FG002|Extension|Protocol deviation|0|||
126407055|NCT01555125|454783236|FG003|Extension|Protocol deviation|0|||
126407056|NCT01555125|454783237|FG004|Extension|Protocol deviation|0|||
126407057|NCT01555125|454783233|FG000|Extension|Lack of Efficacy|7|||
126407058|NCT01555125|454783234|FG001|Extension|Lack of Efficacy|6|||
126407059|NCT01555125|454783235|FG002|Extension|Lack of Efficacy|3|||
126407060|NCT01555125|454783236|FG003|Extension|Lack of Efficacy|0|||
126407061|NCT01555125|454783237|FG004|Extension|Lack of Efficacy|0|||
126407062|NCT01555125|454783233|FG000|Extension|Lost to Follow-up|2|||
126407063|NCT01555125|454783234|FG001|Extension|Lost to Follow-up|1|||
126407064|NCT01555125|454783235|FG002|Extension|Lost to Follow-up|2|||
126407065|NCT01555125|454783236|FG003|Extension|Lost to Follow-up|0|||
126407066|NCT01555125|454783237|FG004|Extension|Lost to Follow-up|0|||
126407067|NCT01555125|454783233|FG000|Extension|Study terminated by sponsor|32|||
126407068|NCT01555125|454783234|FG001|Extension|Study terminated by sponsor|33|||
126407069|NCT01555125|454783235|FG002|Extension|Study terminated by sponsor|16|||
126407070|NCT01555125|454783236|FG003|Extension|Study terminated by sponsor|20|||
126407071|NCT01555125|454783237|FG004|Extension|Study terminated by sponsor|0|||
126407072|NCT01555125|454783233|FG000|Extension|Subject/guardian decision|1|||
126407073|NCT01555125|454783234|FG001|Extension|Subject/guardian decision|9|||
126407074|NCT01555125|454783235|FG002|Extension|Subject/guardian decision|1|||
126407075|NCT01555125|454783236|FG003|Extension|Subject/guardian decision|0|||
126407076|NCT01555125|454783237|FG004|Extension|Subject/guardian decision|0|||
126407077|NCT01555125|454783233|FG000|Extension|Technical Problems|1|||
126407078|NCT01555125|454783234|FG001|Extension|Technical Problems|0|||
126407079|NCT01555125|454783235|FG002|Extension|Technical Problems|0|||
126407080|NCT01555125|454783236|FG003|Extension|Technical Problems|1|||
126407081|NCT01555125|454783237|FG004|Extension|Technical Problems|0|||
126407082|NCT01555125|454783233|FG000|Follow-Up Period|Lost to Follow-up|1|||
126407083|NCT01555125|454783234|FG001|Follow-Up Period|Lost to Follow-up|0|||
126407084|NCT01555125|454783235|FG002|Follow-Up Period|Lost to Follow-up|0|||
126407085|NCT01555125|454783236|FG003|Follow-Up Period|Lost to Follow-up|0|||
126407086|NCT01555125|454783237|FG004|Follow-Up Period|Lost to Follow-up|0|||
126407087|NCT01555125|454783233|FG000|Follow-Up Period|Subject / guardian decision|3|||
126407088|NCT01555125|454783234|FG001|Follow-Up Period|Subject / guardian decision|1|||
126407089|NCT01555125|454783235|FG002|Follow-Up Period|Subject / guardian decision|1|||
126407090|NCT01555125|454783236|FG003|Follow-Up Period|Subject / guardian decision|1|||
126407091|NCT01555125|454783237|FG004|Follow-Up Period|Subject / guardian decision|0|||
126407092|NCT02651220|454783238|FG000|Overall Study|Adverse Event|1|||
126407093|NCT02651220|454783239|FG001|Overall Study|Adverse Event|5|||
126407094|NCT02651220|454783240|FG002|Overall Study|Adverse Event|1|||
126407095|NCT02651220|454783238|FG000|Overall Study|Lost to Follow-up|8|||
126407096|NCT02651220|454783239|FG001|Overall Study|Lost to Follow-up|14|||
126407097|NCT02651220|454783240|FG002|Overall Study|Lost to Follow-up|14|||
126407098|NCT02651220|454783238|FG000|Overall Study|Non-Compliance with Study Drug|4|||
126407099|NCT02651220|454783239|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126407100|NCT02651220|454783240|FG002|Overall Study|Non-Compliance with Study Drug|1|||
126407101|NCT02651220|454783238|FG000|Overall Study|Pregnancy|1|||
126407102|NCT02651220|454783239|FG001|Overall Study|Pregnancy|0|||
126407103|NCT02651220|454783240|FG002|Overall Study|Pregnancy|1|||
126407104|NCT02651220|454783238|FG000|Overall Study|Protocol Violation|0|||
126407105|NCT02651220|454783239|FG001|Overall Study|Protocol Violation|0|||
126407106|NCT02651220|454783240|FG002|Overall Study|Protocol Violation|1|||
126407107|NCT02651220|454783238|FG000|Overall Study|Withdrawal by Subject|5|||
126407108|NCT02651220|454783239|FG001|Overall Study|Withdrawal by Subject|6|||
126407109|NCT02651220|454783240|FG002|Overall Study|Withdrawal by Subject|8|||
126407110|NCT02651220|454783238|FG000|Overall Study|Miscellaneous|4|||
126407111|NCT02651220|454783239|FG001|Overall Study|Miscellaneous|1|||
126407112|NCT02651220|454783240|FG002|Overall Study|Miscellaneous|2|||
126407113|NCT02651220|454783238|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126407114|NCT02651220|454783239|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126407115|NCT02651220|454783240|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
126407116|NCT04046250|454783256|FG000|Overall Study|Death|0|||
126407117|NCT04046250|454783257|FG001|Overall Study|Death|1|||
126407118|NCT04046250|454783256|FG000|Overall Study|Withdrawal by Subject|3|||
126407119|NCT04046250|454783257|FG001|Overall Study|Withdrawal by Subject|3|||
126407120|NCT04576897|454783262|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
126407121|NCT00527332|454783263|FG000|Overall Study|Protocol Violation|4|||
126407122|NCT00527332|454783264|FG001|Overall Study|Protocol Violation|8|||
126407123|NCT00527332|454783263|FG000|Overall Study|Withdrew consent|5|||
126407124|NCT00527332|454783264|FG001|Overall Study|Withdrew consent|1|||
126407125|NCT02666105|454783265|FG000|Overall Study|Death|1|||
126407126|NCT01078168|454783266|FG000|Overall Study|Physician Decision|0|||
126407127|NCT01078168|454783267|FG001|Overall Study|Physician Decision|1|||
126407128|NCT01264419|454783269|FG000|Overall Study|Lost to Follow-up|3|||
126407129|NCT02720692|454785752|FG000|Overall Study|Withdrawal by Subject|3|||
126407130|NCT02720692|454785753|FG001|Overall Study|Withdrawal by Subject|0|||
126407131|NCT02720692|454785752|FG000|Overall Study|Physician Decision|1|||
126407132|NCT02720692|454785753|FG001|Overall Study|Physician Decision|0|||
126407133|NCT02720692|454785752|FG000|Overall Study|Lost to Follow-up|8|||
126407134|NCT02720692|454785753|FG001|Overall Study|Lost to Follow-up|3|||
126407135|NCT02720692|454785752|FG000|Overall Study|Subject unable to return for visit|1|||
126407136|NCT02720692|454785753|FG001|Overall Study|Subject unable to return for visit|0|||
126407137|NCT05011513|454785754|FG000|Overall Study|Death|0|||
126407138|NCT05011513|454785755|FG001|Overall Study|Death|1|||
126407139|NCT05011513|454785754|FG000|Overall Study|Lost to Follow-up|4|||
126407140|NCT05011513|454785755|FG001|Overall Study|Lost to Follow-up|0|||
126407141|NCT05011513|454785754|FG000|Overall Study|Withdrawal by Subject|18|||
126407142|NCT05011513|454785755|FG001|Overall Study|Withdrawal by Subject|17|||
126407143|NCT05011513|454785754|FG000|Overall Study|Other|4|||
126407144|NCT05011513|454785755|FG001|Overall Study|Other|2|||
126407145|NCT03878758|454785756|FG000|Overall Study|Withdrawal by Subject|1|||
126407146|NCT03878758|454785756|FG000|Overall Study|Protocol defined|2|||
126053906|NCT04038580|453491261|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
126053907|NCT04038580|453491262|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
126053908|NCT04038580|453491263|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
126053909|NCT04038580|453491264|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
126053910|NCT04038580|453491265|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
126053911|NCT04038580|453491260|FG000|Wash-out 3|Withdrawal by Subject|1|||
126053912|NCT04038580|453491261|FG001|Wash-out 3|Withdrawal by Subject|0|||
126053913|NCT04038580|453491262|FG002|Wash-out 3|Withdrawal by Subject|2|||
126053914|NCT04038580|453491263|FG003|Wash-out 3|Withdrawal by Subject|0|||
126053915|NCT04038580|453491264|FG004|Wash-out 3|Withdrawal by Subject|0|||
126053916|NCT04038580|453491265|FG005|Wash-out 3|Withdrawal by Subject|0|||
126407147|NCT03878758|454785756|FG000|Overall Study|Improper consent documentation|1|||
126407148|NCT02315560|454785757|FG000|Overall Study|noncompliance by subjects|3|||
126407149|NCT00358436|454785759|FG000|Overall Study|Adverse Event|29|||
126407150|NCT00358436|454785760|FG001|Overall Study|Adverse Event|13|||
126407151|NCT00358436|454785759|FG000|Overall Study|Lack of Efficacy|34|||
126407152|NCT00358436|454785760|FG001|Overall Study|Lack of Efficacy|36|||
126407153|NCT00358436|454785759|FG000|Overall Study|Lost to Follow-up|11|||
126407154|NCT00358436|454785760|FG001|Overall Study|Lost to Follow-up|6|||
126407155|NCT00358436|454785759|FG000|Overall Study|Protocol Violation|8|||
126407156|NCT00358436|454785760|FG001|Overall Study|Protocol Violation|3|||
126407157|NCT00358436|454785759|FG000|Overall Study|Withdrawal by Subject|40|||
126407158|NCT00358436|454785760|FG001|Overall Study|Withdrawal by Subject|17|||
126407159|NCT00358436|454785759|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
126407160|NCT00358436|454785760|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
126407161|NCT00358436|454785759|FG000|Overall Study|COPD exacerbation|22|||
126407162|NCT00358436|454785760|FG001|Overall Study|COPD exacerbation|10|||
126407163|NCT00358436|454785759|FG000|Overall Study|Other|6|||
126407164|NCT00358436|454785760|FG001|Overall Study|Other|1|||
126407165|NCT02905006|454785764|FG000|Overall Study|Adverse Event|1|||
126407166|NCT02905006|454785765|FG001|Overall Study|Adverse Event|1|||
126407167|NCT02905006|454785766|FG002|Overall Study|Adverse Event|1|||
126407168|NCT02905006|454785767|FG003|Overall Study|Adverse Event|1|||
126407169|NCT02905006|454785768|FG004|Overall Study|Adverse Event|0|||
126407170|NCT02905006|454785769|FG005|Overall Study|Adverse Event|1|||
126407171|NCT02905006|454785764|FG000|Overall Study|Lack of Efficacy|1|||
126407172|NCT02905006|454785765|FG001|Overall Study|Lack of Efficacy|0|||
126407173|NCT02905006|454785766|FG002|Overall Study|Lack of Efficacy|0|||
126407174|NCT02905006|454785767|FG003|Overall Study|Lack of Efficacy|0|||
126407175|NCT02905006|454785768|FG004|Overall Study|Lack of Efficacy|0|||
126407176|NCT02905006|454785769|FG005|Overall Study|Lack of Efficacy|0|||
126407177|NCT02905006|454785764|FG000|Overall Study|Protocol Violation|2|||
126407178|NCT02905006|454785765|FG001|Overall Study|Protocol Violation|0|||
126407179|NCT02905006|454785766|FG002|Overall Study|Protocol Violation|0|||
126407180|NCT02905006|454785767|FG003|Overall Study|Protocol Violation|0|||
126407181|NCT02905006|454785768|FG004|Overall Study|Protocol Violation|0|||
126407182|NCT02905006|454785769|FG005|Overall Study|Protocol Violation|0|||
126407183|NCT02905006|454785764|FG000|Overall Study|Lost to Follow-up|0|||
126407184|NCT02905006|454785765|FG001|Overall Study|Lost to Follow-up|0|||
126407185|NCT02905006|454785766|FG002|Overall Study|Lost to Follow-up|0|||
126407186|NCT02905006|454785767|FG003|Overall Study|Lost to Follow-up|1|||
126407187|NCT02905006|454785768|FG004|Overall Study|Lost to Follow-up|1|||
126407188|NCT02905006|454785769|FG005|Overall Study|Lost to Follow-up|0|||
126407189|NCT02905006|454785764|FG000|Overall Study|Withdrawal by Subject|0|||
126407190|NCT02905006|454785765|FG001|Overall Study|Withdrawal by Subject|0|||
126407191|NCT02905006|454785766|FG002|Overall Study|Withdrawal by Subject|1|||
126407192|NCT02905006|454785767|FG003|Overall Study|Withdrawal by Subject|1|||
126407193|NCT02905006|454785768|FG004|Overall Study|Withdrawal by Subject|0|||
126407194|NCT02905006|454785769|FG005|Overall Study|Withdrawal by Subject|1|||
126407195|NCT02905006|454785764|FG000|Overall Study|Screening exclusion criteria met|1|||
126407196|NCT02905006|454785765|FG001|Overall Study|Screening exclusion criteria met|0|||
126407197|NCT02905006|454785766|FG002|Overall Study|Screening exclusion criteria met|0|||
126407198|NCT02905006|454785767|FG003|Overall Study|Screening exclusion criteria met|0|||
126407199|NCT02905006|454785768|FG004|Overall Study|Screening exclusion criteria met|0|||
126407200|NCT02905006|454785769|FG005|Overall Study|Screening exclusion criteria met|0|||
126407201|NCT02905006|454785764|FG000|Overall Study|Lab withdrawal criterion met|0|||
126407202|NCT02905006|454785765|FG001|Overall Study|Lab withdrawal criterion met|1|||
126407203|NCT02905006|454785766|FG002|Overall Study|Lab withdrawal criterion met|2|||
126407204|NCT02905006|454785767|FG003|Overall Study|Lab withdrawal criterion met|2|||
126407205|NCT02905006|454785768|FG004|Overall Study|Lab withdrawal criterion met|2|||
126407206|NCT02905006|454785769|FG005|Overall Study|Lab withdrawal criterion met|1|||
126407207|NCT02905006|454785764|FG000|Overall Study|Positive for Tuberculosis|0|||
126407208|NCT02905006|454785765|FG001|Overall Study|Positive for Tuberculosis|1|||
126053948|NCT03147287|453491346|FG000|Overall Study|Randomized Not Treated|2|||
126407209|NCT02905006|454785766|FG002|Overall Study|Positive for Tuberculosis|0|||
126407210|NCT02905006|454785767|FG003|Overall Study|Positive for Tuberculosis|0|||
126407211|NCT02905006|454785768|FG004|Overall Study|Positive for Tuberculosis|0|||
126407212|NCT02905006|454785769|FG005|Overall Study|Positive for Tuberculosis|0|||
126407213|NCT02905006|454785764|FG000|Overall Study|Subject positive for Hep B|0|||
126407214|NCT02905006|454785765|FG001|Overall Study|Subject positive for Hep B|0|||
126407215|NCT02905006|454785766|FG002|Overall Study|Subject positive for Hep B|1|||
126407216|NCT02905006|454785767|FG003|Overall Study|Subject positive for Hep B|0|||
126407217|NCT02905006|454785768|FG004|Overall Study|Subject positive for Hep B|0|||
126407218|NCT02905006|454785769|FG005|Overall Study|Subject positive for Hep B|0|||
126407219|NCT02905006|454785764|FG000|Overall Study|Patient moved abroad|0|||
126407220|NCT02905006|454785765|FG001|Overall Study|Patient moved abroad|0|||
126407221|NCT02905006|454785766|FG002|Overall Study|Patient moved abroad|0|||
126407222|NCT02905006|454785767|FG003|Overall Study|Patient moved abroad|1|||
126407223|NCT02905006|454785768|FG004|Overall Study|Patient moved abroad|0|||
126407224|NCT02905006|454785769|FG005|Overall Study|Patient moved abroad|0|||
126407225|NCT02905006|454785764|FG000|Overall Study|Patient randomized by mistake|0|||
126407226|NCT02905006|454785765|FG001|Overall Study|Patient randomized by mistake|0|||
126407227|NCT02905006|454785766|FG002|Overall Study|Patient randomized by mistake|0|||
126407228|NCT02905006|454785767|FG003|Overall Study|Patient randomized by mistake|0|||
126407229|NCT02905006|454785768|FG004|Overall Study|Patient randomized by mistake|0|||
126407230|NCT02905006|454785769|FG005|Overall Study|Patient randomized by mistake|1|||
126407231|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
126407232|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
126407233|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
126407234|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
126407235|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
126407236|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
126407237|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
126407238|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
126407239|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
126407240|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
126407241|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
126407242|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
126407243|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
126407244|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
126407245|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
126407246|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
126407247|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
126407248|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
126407249|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
126407250|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
126407251|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
126407252|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
126407253|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
126407254|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
126407255|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
126407256|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
126407257|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
126407258|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
126407259|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
126407260|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
126407261|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
126407262|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
126407263|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
126407264|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
126407265|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
126407266|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
126407267|NCT04201093|454785776|FG000|Overall Study|Adverse Event|6|||
126053949|NCT03147287|453491347|FG001|Overall Study|Randomized Not Treated|1|||
126053950|NCT03147287|453491348|FG002|Overall Study|Randomized Not Treated|1|||
126407268|NCT04201093|454785777|FG001|Overall Study|Adverse Event|29|||
126407269|NCT04201093|454785778|FG002|Overall Study|Adverse Event|35|||
126407270|NCT04201093|454785776|FG000|Overall Study|Death|2|||
126407271|NCT04201093|454785777|FG001|Overall Study|Death|1|||
126407272|NCT04201093|454785778|FG002|Overall Study|Death|0|||
126407273|NCT04201093|454785776|FG000|Overall Study|Lack of Efficacy|5|||
126407274|NCT04201093|454785777|FG001|Overall Study|Lack of Efficacy|1|||
126407275|NCT04201093|454785778|FG002|Overall Study|Lack of Efficacy|2|||
126407276|NCT04201093|454785776|FG000|Overall Study|Lost to Follow-up|0|||
126407277|NCT04201093|454785777|FG001|Overall Study|Lost to Follow-up|0|||
126407278|NCT04201093|454785778|FG002|Overall Study|Lost to Follow-up|1|||
126053951|NCT03147287|453491346|FG000|Overall Study|Progressive Disease RECIST|31|||
126053952|NCT03147287|453491347|FG001|Overall Study|Progressive Disease RECIST|72|||
126053953|NCT03147287|453491348|FG002|Overall Study|Progressive Disease RECIST|32|||
126053954|NCT03147287|453491346|FG000|Overall Study|Progressive Disease not RECIST|13|||
126407279|NCT04201093|454785776|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
126407280|NCT04201093|454785777|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
126407281|NCT04201093|454785778|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
126407282|NCT04201093|454785776|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
126407283|NCT04201093|454785777|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
126407284|NCT04201093|454785778|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
126407285|NCT04201093|454785776|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
126407286|NCT04201093|454785777|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
126407287|NCT04201093|454785778|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
126407288|NCT04201093|454785776|FG000|Overall Study|Physician Decision|1|||
126407289|NCT04201093|454785777|FG001|Overall Study|Physician Decision|0|||
126407290|NCT04201093|454785778|FG002|Overall Study|Physician Decision|0|||
126105345|NCT00983931|453678598|FG000|14 Day Washout Period|Physician Decision|1|||
126105346|NCT01281969|453678601|FG000|Overall Study|not randomized didn't meet criteria|0|||
126105347|NCT01281969|453678602|FG001|Overall Study|not randomized didn't meet criteria|0|||
126105348|NCT01281969|453678603|FG002|Overall Study|not randomized didn't meet criteria|7|||
126407291|NCT04201093|454785776|FG000|Overall Study|Protocol Deviation|1|||
126407292|NCT04201093|454785777|FG001|Overall Study|Protocol Deviation|0|||
126407293|NCT04201093|454785778|FG002|Overall Study|Protocol Deviation|0|||
126407294|NCT04201093|454785776|FG000|Overall Study|Site Terminated by Sponsor|5|||
126407295|NCT04201093|454785777|FG001|Overall Study|Site Terminated by Sponsor|3|||
126407296|NCT04201093|454785778|FG002|Overall Study|Site Terminated by Sponsor|1|||
126407297|NCT04201093|454785776|FG000|Overall Study|Withdrawal by Subject|7|||
126407298|NCT04201093|454785777|FG001|Overall Study|Withdrawal by Subject|8|||
126407299|NCT04201093|454785778|FG002|Overall Study|Withdrawal by Subject|15|||
126407300|NCT04201093|454785776|FG000|Overall Study|Other|0|||
126407301|NCT04201093|454785777|FG001|Overall Study|Other|1|||
126407302|NCT04201093|454785778|FG002|Overall Study|Other|2|||
126407303|NCT00881504|454785779|FG000|Overall Study|Withdrawal by Subject|1|||
126407304|NCT00007020|454785780|FG000|Overall Study|Death|16|||
126407305|NCT00007020|454785780|FG000|Overall Study|Lost to Follow-up|13|||
126407306|NCT00007020|454785780|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
126407307|NCT00007020|454785780|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
126407308|NCT00007020|454785780|FG000|Overall Study|Pt cared for by outside physician|4|||
126407309|NCT00007020|454785780|FG000|Overall Study|No evidence of treatment|6|||
126407310|NCT01276223|454785781|FG000|Overall Study|Adverse Event|7|||
126407311|NCT01276223|454785782|FG001|Overall Study|Adverse Event|4|||
126407312|NCT01276223|454785783|FG002|Overall Study|Adverse Event|1|||
126407313|NCT01276223|454785781|FG000|Overall Study|Lost to Follow-up|0|||
126407314|NCT01276223|454785782|FG001|Overall Study|Lost to Follow-up|0|||
126407315|NCT01276223|454785783|FG002|Overall Study|Lost to Follow-up|1|||
126407316|NCT01276223|454785781|FG000|Overall Study|Other|0|||
126407317|NCT01276223|454785782|FG001|Overall Study|Other|0|||
126407318|NCT01276223|454785783|FG002|Overall Study|Other|1|||
126407319|NCT01276223|454785781|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
126407320|NCT01276223|454785782|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
126053955|NCT03147287|453491347|FG001|Overall Study|Progressive Disease not RECIST|21|||
126053956|NCT03147287|453491348|FG002|Overall Study|Progressive Disease not RECIST|13|||
126053957|NCT03147287|453491346|FG000|Overall Study|Physician Decision|1|||
126053958|NCT03147287|453491347|FG001|Overall Study|Physician Decision|2|||
126053959|NCT03147287|453491348|FG002|Overall Study|Physician Decision|1|||
126053960|NCT03147287|453491346|FG000|Overall Study|Intercurrent illness|0|||
126053961|NCT03147287|453491347|FG001|Overall Study|Intercurrent illness|1|||
126105349|NCT01281969|453678601|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
126407321|NCT01276223|454785783|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
126407322|NCT01276223|454785781|FG000|Overall Study|Protocol Violation|1|||
126407323|NCT01276223|454785782|FG001|Overall Study|Protocol Violation|0|||
126407324|NCT01276223|454785783|FG002|Overall Study|Protocol Violation|0|||
126407325|NCT05856227|454785784|FG000|Overall Study|Adverse Event|0|||
126407326|NCT05856227|454785785|FG001|Overall Study|Adverse Event|1|||
126407327|NCT05856227|454785784|FG000|Overall Study|Due to Investigator absence|1|||
126407328|NCT05856227|454785785|FG001|Overall Study|Due to Investigator absence|0|||
126053962|NCT03147287|453491348|FG002|Overall Study|Intercurrent illness|0|||
126407329|NCT05856227|454785784|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
126407330|NCT05856227|454785785|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
126407331|NCT00771615|454785787|FG000|Overall Study|Withdrawal by Subject|0|||
126407332|NCT00771615|454785788|FG001|Overall Study|Withdrawal by Subject|1|||
126407333|NCT00771615|454785789|FG002|Overall Study|Withdrawal by Subject|0|||
126407334|NCT00771615|454785790|FG003|Overall Study|Withdrawal by Subject|0|||
126407335|NCT00771615|454785791|FG004|Overall Study|Withdrawal by Subject|0|||
126407336|NCT00771615|454785792|FG005|Overall Study|Withdrawal by Subject|0|||
126407337|NCT00771615|454785793|FG006|Overall Study|Withdrawal by Subject|0|||
126407338|NCT00771615|454785794|FG007|Overall Study|Withdrawal by Subject|1|||
126407339|NCT00771615|454785795|FG008|Overall Study|Withdrawal by Subject|0|||
126407340|NCT00771615|454785787|FG000|Overall Study|Lost to Follow-up|1|||
126407341|NCT00771615|454785788|FG001|Overall Study|Lost to Follow-up|1|||
126407342|NCT00771615|454785789|FG002|Overall Study|Lost to Follow-up|1|||
126407343|NCT00771615|454785790|FG003|Overall Study|Lost to Follow-up|1|||
126407344|NCT00771615|454785791|FG004|Overall Study|Lost to Follow-up|0|||
126407345|NCT00771615|454785792|FG005|Overall Study|Lost to Follow-up|1|||
126407346|NCT00771615|454785793|FG006|Overall Study|Lost to Follow-up|1|||
126407347|NCT00771615|454785794|FG007|Overall Study|Lost to Follow-up|0|||
126407348|NCT00771615|454785795|FG008|Overall Study|Lost to Follow-up|0|||
126407349|NCT02455076|454785796|FG000|Inpatient|Withdrawal by Subject|1|||
126407350|NCT02455076|454785797|FG001|Inpatient|Withdrawal by Subject|0|||
126407351|NCT02455076|454785798|FG002|Inpatient|Withdrawal by Subject|0|||
126407352|NCT02455076|454785799|FG003|Inpatient|Withdrawal by Subject|0|||
126407353|NCT02455076|454785800|FG004|Inpatient|Withdrawal by Subject|0|||
126407354|NCT02455076|454785796|FG000|Inpatient|Discharged <24 h after admission|0|||
126407355|NCT02455076|454785797|FG001|Inpatient|Discharged <24 h after admission|1|||
126407356|NCT02455076|454785798|FG002|Inpatient|Discharged <24 h after admission|0|||
126407357|NCT02455076|454785799|FG003|Inpatient|Discharged <24 h after admission|0|||
126407358|NCT02455076|454785800|FG004|Inpatient|Discharged <24 h after admission|0|||
126407359|NCT02455076|454785796|FG000|Inpatient|Adverse Event|3|||
126407360|NCT02455076|454785797|FG001|Inpatient|Adverse Event|0|||
126407361|NCT02455076|454785798|FG002|Inpatient|Adverse Event|0|||
126407362|NCT02455076|454785799|FG003|Inpatient|Adverse Event|0|||
126407363|NCT02455076|454785800|FG004|Inpatient|Adverse Event|0|||
126407364|NCT02455076|454785796|FG000|Outpatient|Adverse Event|0|||
126407365|NCT02455076|454785797|FG001|Outpatient|Adverse Event|0|||
126407366|NCT02455076|454785798|FG002|Outpatient|Adverse Event|0|||
126407367|NCT02455076|454785799|FG003|Outpatient|Adverse Event|5|||
126407368|NCT02455076|454785800|FG004|Outpatient|Adverse Event|0|||
126407369|NCT02455076|454785796|FG000|Outpatient|Lost to Follow-up|0|||
126407370|NCT02455076|454785797|FG001|Outpatient|Lost to Follow-up|0|||
126407371|NCT02455076|454785798|FG002|Outpatient|Lost to Follow-up|0|||
126407372|NCT02455076|454785799|FG003|Outpatient|Lost to Follow-up|1|||
126407373|NCT02455076|454785800|FG004|Outpatient|Lost to Follow-up|12|||
126407374|NCT03743064|454785805|FG000|Overall Study|Adverse Event|7|||
126407375|NCT03743064|454785806|FG001|Overall Study|Adverse Event|9|||
126407376|NCT03743064|454785805|FG000|Overall Study|Death|25|||
126407377|NCT03743064|454785806|FG001|Overall Study|Death|28|||
126407378|NCT03743064|454785805|FG000|Overall Study|Lost to Follow-up|3|||
126407379|NCT03743064|454785806|FG001|Overall Study|Lost to Follow-up|6|||
126407380|NCT03743064|454785805|FG000|Overall Study|Withdrawal by Subject|28|||
126407381|NCT03743064|454785806|FG001|Overall Study|Withdrawal by Subject|25|||
126407382|NCT03743064|454785805|FG000|Overall Study|Physician Decision|2|||
126407383|NCT03743064|454785806|FG001|Overall Study|Physician Decision|4|||
126407384|NCT03743064|454785805|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
126407385|NCT03743064|454785806|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
126407386|NCT02771626|454785809|FG000|Overall Study|Adverse Event|1|||
126407387|NCT02771626|454785810|FG001|Overall Study|Adverse Event|5|||
126407388|NCT02771626|454785811|FG002|Overall Study|Adverse Event|3|||
125890537|NCT02283762|452897151|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
125890538|NCT02283762|452897150|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
125890539|NCT02283762|452897151|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
125890540|NCT02283762|452897150|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
125890541|NCT02283762|452897151|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
125890542|NCT02283762|452897150|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
125890543|NCT02283762|452897151|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
125890544|NCT02283762|452897150|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
125890545|NCT02283762|452897151|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
125890546|NCT00202878|452897155|FG000|Overall Study|Death|964|||
125890547|NCT00202878|452897156|FG001|Overall Study|Death|968|||
125890548|NCT00202878|452897155|FG000|Overall Study|Only Vital Status Known|357|||
125890549|NCT00202878|452897156|FG001|Overall Study|Only Vital Status Known|356|||
125890550|NCT00202878|452897155|FG000|Overall Study|Lost to Follow-up|44|||
125890551|NCT00202878|452897156|FG001|Overall Study|Lost to Follow-up|49|||
125890552|NCT00202878|452897155|FG000|Overall Study|Site Closure|39|||
125890553|NCT00202878|452897156|FG001|Overall Study|Site Closure|36|||
125890554|NCT00202878|452897155|FG000|Overall Study|Withdrawal by Subject|795|||
125890555|NCT00202878|452897156|FG001|Overall Study|Withdrawal by Subject|808|||
125890556|NCT02920242|452897157|FG000|Overall Study|Withdrawal by Subject|1|||
125890557|NCT02920242|452897158|FG001|Overall Study|Withdrawal by Subject|0|||
125890558|NCT02920242|452897159|FG002|Overall Study|Withdrawal by Subject|1|||
125890559|NCT02920242|452897157|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
125890560|NCT02920242|452897158|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
125890561|NCT02920242|452897159|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
125890562|NCT01587014|452897160|FG000|Overall Study|Death|2|||
125890563|NCT03801031|452897165|FG000|Overall Study|Lost to Follow-up|1|||
125890564|NCT03801031|452897166|FG001|Overall Study|Lost to Follow-up|0|||
125890565|NCT03801031|452897165|FG000|Overall Study|Unable to comply|1|||
125890566|NCT03801031|452897166|FG001|Overall Study|Unable to comply|0|||
125890567|NCT03801031|452897165|FG000|Overall Study|Withdrawal by Subject|0|||
125890568|NCT03801031|452897166|FG001|Overall Study|Withdrawal by Subject|1|||
126407389|NCT02771626|454785812|FG003|Overall Study|Adverse Event|0|||
126407390|NCT02771626|454785813|FG004|Overall Study|Adverse Event|1|||
126407391|NCT02771626|454785814|FG005|Overall Study|Adverse Event|1|||
126407392|NCT02771626|454785809|FG000|Overall Study|Radiologic Disease Progression|6|||
125890569|NCT02948088|452897167|FG000|Overall Study|Lost to Follow-up|8|||
125890570|NCT02948088|452897167|FG000|Overall Study|Death|1|||
125890571|NCT02948088|452897167|FG000|Overall Study|Withdrawal by Subject|4|||
126053963|NCT03147287|453491346|FG000|Overall Study|Withdrawal by Subject|2|||
126053964|NCT03147287|453491347|FG001|Overall Study|Withdrawal by Subject|3|||
126407393|NCT02771626|454785810|FG001|Overall Study|Radiologic Disease Progression|13|||
126407394|NCT02771626|454785811|FG002|Overall Study|Radiologic Disease Progression|10|||
126407395|NCT02771626|454785812|FG003|Overall Study|Radiologic Disease Progression|7|||
126407396|NCT02771626|454785813|FG004|Overall Study|Radiologic Disease Progression|28|||
126407397|NCT02771626|454785814|FG005|Overall Study|Radiologic Disease Progression|15|||
126407398|NCT02771626|454785809|FG000|Overall Study|Symptomatic Deterioration|0|||
126407399|NCT02771626|454785810|FG001|Overall Study|Symptomatic Deterioration|4|||
125890572|NCT02948088|452897167|FG000|Overall Study|Other|2|||
126407400|NCT02771626|454785811|FG002|Overall Study|Symptomatic Deterioration|2|||
126407401|NCT02771626|454785812|FG003|Overall Study|Symptomatic Deterioration|0|||
126407402|NCT02771626|454785813|FG004|Overall Study|Symptomatic Deterioration|5|||
126407403|NCT02771626|454785814|FG005|Overall Study|Symptomatic Deterioration|2|||
126407404|NCT02771626|454785809|FG000|Overall Study|Participant Request|0|||
126407405|NCT02771626|454785810|FG001|Overall Study|Participant Request|1|||
126407406|NCT02771626|454785811|FG002|Overall Study|Participant Request|0|||
126407407|NCT02771626|454785812|FG003|Overall Study|Participant Request|2|||
126407408|NCT02771626|454785813|FG004|Overall Study|Participant Request|0|||
126407409|NCT02771626|454785814|FG005|Overall Study|Participant Request|1|||
126407410|NCT02771626|454785809|FG000|Overall Study|Investigator Decision|0|||
126407411|NCT02771626|454785810|FG001|Overall Study|Investigator Decision|1|||
126407412|NCT02771626|454785811|FG002|Overall Study|Investigator Decision|0|||
126407413|NCT02771626|454785812|FG003|Overall Study|Investigator Decision|0|||
126407414|NCT02771626|454785813|FG004|Overall Study|Investigator Decision|1|||
126407415|NCT02771626|454785814|FG005|Overall Study|Investigator Decision|0|||
126407416|NCT02771626|454785809|FG000|Overall Study|Study Termination by Sponsor|0|||
126407417|NCT02771626|454785810|FG001|Overall Study|Study Termination by Sponsor|2|||
126407418|NCT02771626|454785811|FG002|Overall Study|Study Termination by Sponsor|1|||
126407419|NCT02771626|454785812|FG003|Overall Study|Study Termination by Sponsor|0|||
126407420|NCT02771626|454785813|FG004|Overall Study|Study Termination by Sponsor|1|||
126407421|NCT02771626|454785814|FG005|Overall Study|Study Termination by Sponsor|0|||
126407422|NCT02771626|454785809|FG000|Overall Study|Informed Consent Withdrawn|0|||
126407423|NCT02771626|454785810|FG001|Overall Study|Informed Consent Withdrawn|0|||
126407424|NCT02771626|454785811|FG002|Overall Study|Informed Consent Withdrawn|1|||
126407425|NCT02771626|454785812|FG003|Overall Study|Informed Consent Withdrawn|0|||
126407426|NCT02771626|454785813|FG004|Overall Study|Informed Consent Withdrawn|1|||
126407427|NCT02771626|454785814|FG005|Overall Study|Informed Consent Withdrawn|1|||
126407428|NCT02771626|454785809|FG000|Overall Study|Other, Not Specified|1|||
126407429|NCT02771626|454785810|FG001|Overall Study|Other, Not Specified|0|||
126407430|NCT02771626|454785811|FG002|Overall Study|Other, Not Specified|0|||
126407431|NCT02771626|454785812|FG003|Overall Study|Other, Not Specified|0|||
126407432|NCT02771626|454785813|FG004|Overall Study|Other, Not Specified|0|||
126407433|NCT02771626|454785814|FG005|Overall Study|Other, Not Specified|1|||
126407434|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
126407435|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
126407436|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
126407437|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
126407438|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
126407439|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
126407440|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
126407441|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
126407442|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
126407443|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
126407444|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
126407445|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
126407446|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
126407447|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
126407448|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
126407449|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
126407450|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
126407451|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
126407452|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
126407453|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
126407454|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
126407455|NCT01302054|454785815|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
126407456|NCT01302054|454785816|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
126407457|NCT01302054|454785817|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
126407458|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126407459|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
126407460|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
126407461|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126407462|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
126407463|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126407464|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126407465|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
126407466|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
126407467|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
126407468|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
126407469|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
126407470|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126407471|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
126407472|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
126407473|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
126407474|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
126407475|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
126407476|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Other|0|||
126407477|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Other|4|||
126407478|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Other|9|||
126407479|NCT02809053|454785818|FG000|Overall Study|Death|0|||
126407480|NCT02809053|454785819|FG001|Overall Study|Death|1|||
126407481|NCT02809053|454785818|FG000|Overall Study|Lost to Follow-up|3|||
126407482|NCT02809053|454785819|FG001|Overall Study|Lost to Follow-up|1|||
126407483|NCT02809053|454785818|FG000|Overall Study|Withdrawal by Subject|2|||
126407484|NCT02809053|454785819|FG001|Overall Study|Withdrawal by Subject|3|||
126407485|NCT02809053|454785818|FG000|Overall Study|Disease Progression|2|||
126407486|NCT02809053|454785819|FG001|Overall Study|Disease Progression|1|||
126407487|NCT02565810|454785823|FG000|Overall Study|Withdrawal by Subject|1|||
126407488|NCT00635089|454785824|FG000|Overall Study|Adverse Event|7|||
126407489|NCT00635089|454785824|FG000|Overall Study|Lack of Efficacy|28|||
126407490|NCT00635089|454785824|FG000|Overall Study|Protocol Deviation|4|||
126407491|NCT00635089|454785824|FG000|Overall Study|Lost to Follow-up|8|||
126407492|NCT00635089|454785824|FG000|Overall Study|Other|31|||
126407493|NCT00444067|454785829|FG000|Overall Study|Lost to Follow-up|0|||
126407494|NCT00444067|454785830|FG001|Overall Study|Lost to Follow-up|1|||
126407495|NCT01300455|454785831|FG000|Washout|Withdrawal by Subject|1|||
126407496|NCT01300455|454785832|FG001|Washout|Withdrawal by Subject|0|||
126407497|NCT00084487|454785833|FG000|Overall Study|Death|1|||
126407498|NCT02528357|454785834|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407499|NCT02528357|454785835|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
126407500|NCT02528357|454785836|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407501|NCT02528357|454785837|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407502|NCT02528357|454785838|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407503|NCT02528357|454785839|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407504|NCT02528357|454785840|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407505|NCT02528357|454785841|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407506|NCT02528357|454785842|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407507|NCT02528357|454785843|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407508|NCT02528357|454785844|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407509|NCT02528357|454785845|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407510|NCT02528357|454785846|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407511|NCT02528357|454785847|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407512|NCT02528357|454785848|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407513|NCT02528357|454785849|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407514|NCT02528357|454785850|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407515|NCT02528357|454785851|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407516|NCT02528357|454785852|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407517|NCT02528357|454785834|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407518|NCT02528357|454785835|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407519|NCT02528357|454785836|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407520|NCT02528357|454785837|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
126407521|NCT02528357|454785838|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407522|NCT02528357|454785839|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
126407523|NCT02528357|454785840|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407524|NCT02528357|454785841|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
126407525|NCT02528357|454785842|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407526|NCT02528357|454785843|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125890573|NCT01942733|452897168|FG000|Overall Study|Lost to Follow-up|1|||
126407527|NCT02528357|454785844|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407528|NCT02528357|454785845|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407529|NCT02528357|454785846|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407530|NCT02528357|454785847|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407531|NCT02528357|454785848|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407532|NCT02528357|454785849|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407533|NCT02528357|454785850|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407534|NCT02528357|454785851|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407535|NCT02528357|454785852|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407536|NCT02528357|454785834|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407537|NCT02528357|454785835|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407538|NCT02528357|454785836|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
126407539|NCT02528357|454785837|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407540|NCT02528357|454785838|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
126407541|NCT02528357|454785839|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407542|NCT02528357|454785840|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
126407543|NCT02528357|454785841|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
126407544|NCT02528357|454785842|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407545|NCT02528357|454785843|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407546|NCT02528357|454785844|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407547|NCT02528357|454785845|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407548|NCT02528357|454785846|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407549|NCT02528357|454785847|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407550|NCT02528357|454785848|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407551|NCT02528357|454785849|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407552|NCT02528357|454785850|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407553|NCT02528357|454785851|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407554|NCT02528357|454785852|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407555|NCT02528357|454785834|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407556|NCT02528357|454785835|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407557|NCT02528357|454785836|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407558|NCT02528357|454785837|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407559|NCT02528357|454785838|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407560|NCT02528357|454785839|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407561|NCT02528357|454785840|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407562|NCT02528357|454785841|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407563|NCT02528357|454785842|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407564|NCT02528357|454785843|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407565|NCT02528357|454785844|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407566|NCT02528357|454785845|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407567|NCT02528357|454785846|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407568|NCT02528357|454785847|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407569|NCT02528357|454785848|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407570|NCT02528357|454785849|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407571|NCT02528357|454785850|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407572|NCT02528357|454785851|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407573|NCT02528357|454785852|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407574|NCT02528357|454785834|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407575|NCT02528357|454785835|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407576|NCT02528357|454785836|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407577|NCT02528357|454785837|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407578|NCT02528357|454785838|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407579|NCT02528357|454785839|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407580|NCT02528357|454785840|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126053965|NCT03147287|453491348|FG002|Overall Study|Withdrawal by Subject|2|||
126407581|NCT02528357|454785841|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407582|NCT02528357|454785842|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407583|NCT02528357|454785843|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407584|NCT02528357|454785844|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407585|NCT02528357|454785845|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407586|NCT02528357|454785846|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407587|NCT02528357|454785847|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
126407588|NCT02528357|454785848|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
126407589|NCT02528357|454785849|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407590|NCT02528357|454785850|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407591|NCT02528357|454785851|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407592|NCT02528357|454785852|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407593|NCT02528357|454785834|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407594|NCT02528357|454785835|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407595|NCT02528357|454785836|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407596|NCT02528357|454785837|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407597|NCT02528357|454785838|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407598|NCT02528357|454785839|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407599|NCT02528357|454785840|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407600|NCT02528357|454785841|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407601|NCT02528357|454785842|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407602|NCT02528357|454785843|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407603|NCT02528357|454785844|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407604|NCT02528357|454785845|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407605|NCT02528357|454785846|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407606|NCT02528357|454785847|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
126407607|NCT02528357|454785848|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407608|NCT02528357|454785849|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407609|NCT02528357|454785850|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407610|NCT02528357|454785851|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407611|NCT02528357|454785852|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407612|NCT02528357|454785834|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407613|NCT02528357|454785835|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407614|NCT02528357|454785836|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407615|NCT02528357|454785837|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407616|NCT02528357|454785838|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407617|NCT02528357|454785839|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407618|NCT02528357|454785840|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407619|NCT02528357|454785841|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407620|NCT02528357|454785842|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407621|NCT02528357|454785843|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407622|NCT02528357|454785844|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
126407623|NCT02528357|454785845|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407624|NCT02528357|454785846|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
126407625|NCT02528357|454785847|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
126407626|NCT02528357|454785848|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
126407627|NCT02528357|454785849|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407628|NCT02528357|454785850|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407629|NCT02528357|454785851|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407630|NCT02528357|454785852|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407631|NCT02528357|454785834|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407632|NCT02528357|454785835|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407633|NCT02528357|454785836|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407634|NCT02528357|454785837|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407635|NCT02528357|454785838|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407636|NCT02528357|454785839|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407637|NCT02528357|454785840|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126053966|NCT03147287|453491346|FG000|Overall Study|Patient Non-Compliance|0|||
126053967|NCT03147287|453491347|FG001|Overall Study|Patient Non-Compliance|2|||
126407638|NCT02528357|454785841|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407639|NCT02528357|454785842|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407640|NCT02528357|454785843|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407641|NCT02528357|454785844|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407642|NCT02528357|454785845|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
126407643|NCT02528357|454785846|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
126407644|NCT02528357|454785847|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407645|NCT02528357|454785848|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407646|NCT02528357|454785849|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407647|NCT02528357|454785850|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407648|NCT02528357|454785851|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407649|NCT02528357|454785852|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407650|NCT02528357|454785834|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407651|NCT02528357|454785835|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407652|NCT02528357|454785836|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407653|NCT02528357|454785837|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407654|NCT02528357|454785838|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407655|NCT02528357|454785839|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407656|NCT02528357|454785840|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407657|NCT02528357|454785841|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407658|NCT02528357|454785842|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407659|NCT02528357|454785843|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407660|NCT02528357|454785844|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407661|NCT02528357|454785845|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407662|NCT02528357|454785846|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407663|NCT02528357|454785847|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407664|NCT02528357|454785848|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407665|NCT02528357|454785849|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407666|NCT02528357|454785850|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
126407667|NCT02528357|454785851|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407668|NCT02528357|454785852|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407669|NCT02528357|454785834|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407670|NCT02528357|454785835|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407671|NCT02528357|454785836|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407672|NCT02528357|454785837|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407673|NCT02528357|454785838|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407674|NCT02528357|454785839|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407675|NCT02528357|454785840|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407676|NCT02528357|454785841|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407677|NCT02528357|454785842|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407678|NCT02528357|454785843|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407679|NCT02528357|454785844|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407680|NCT02528357|454785845|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407681|NCT02528357|454785846|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126053968|NCT03147287|453491348|FG002|Overall Study|Patient Non-Compliance|0|||
126053969|NCT03147287|453491346|FG000|Overall Study|Patient moved|0|||
126053970|NCT03147287|453491347|FG001|Overall Study|Patient moved|1|||
126053971|NCT03147287|453491348|FG002|Overall Study|Patient moved|0|||
126053972|NCT03147287|453491346|FG000|Overall Study|Arm A crossover without PD|1|||
126053973|NCT03147287|453491347|FG001|Overall Study|Arm A crossover without PD|0|||
126053974|NCT03147287|453491348|FG002|Overall Study|Arm A crossover without PD|0|||
126053975|NCT03147287|453491346|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
126407682|NCT02528357|454785847|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407683|NCT02528357|454785848|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407684|NCT02528357|454785849|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407685|NCT02528357|454785850|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407686|NCT02528357|454785851|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
126407687|NCT02528357|454785852|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
126407688|NCT02438813|454785858|FG000|Overall Study|Patient Decision|59|||
126407689|NCT02438813|454785858|FG000|Overall Study|Patient Lost to Follow-Up|137|||
126407690|NCT02438813|454785858|FG000|Overall Study|Study Ended by Sponsor|80|||
126407691|NCT02438813|454785858|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
126407692|NCT03040986|454785860|FG000|Overall Study|Hospice|1|||
126407693|NCT03040986|454785861|FG001|Overall Study|Hospice|0|||
126407694|NCT03040986|454785860|FG000|Overall Study|Adverse Event|2|||
126407695|NCT03040986|454785861|FG001|Overall Study|Adverse Event|1|||
126407696|NCT03040986|454785860|FG000|Overall Study|Disease progression on study|3|||
126407697|NCT03040986|454785861|FG001|Overall Study|Disease progression on study|1|||
126407698|NCT01183468|454785864|FG000|Overall Study|Lost to Follow-up|2|||
126407699|NCT01183468|454785865|FG001|Overall Study|Lost to Follow-up|1|||
126407700|NCT01183468|454785866|FG002|Overall Study|Lost to Follow-up|0|||
126407701|NCT01183468|454785867|FG003|Overall Study|Lost to Follow-up|0|||
126407702|NCT01183468|454785864|FG000|Overall Study|Physician Decision|1|||
126407703|NCT01183468|454785865|FG001|Overall Study|Physician Decision|0|||
126407704|NCT01183468|454785866|FG002|Overall Study|Physician Decision|0|||
126407705|NCT01183468|454785867|FG003|Overall Study|Physician Decision|0|||
126407706|NCT01183468|454785864|FG000|Overall Study|Withdrawal by Subject|0|||
126407707|NCT01183468|454785865|FG001|Overall Study|Withdrawal by Subject|1|||
126407708|NCT01183468|454785866|FG002|Overall Study|Withdrawal by Subject|0|||
126407709|NCT01183468|454785867|FG003|Overall Study|Withdrawal by Subject|0|||
126407710|NCT02228096|454785876|FG000|Overall Study|Study terminated by Sponsor|24|||
126407711|NCT02228096|454785876|FG000|Overall Study|Lack of Efficacy|18|||
126407712|NCT02228096|454785876|FG000|Overall Study|Death|12|||
126407713|NCT02228096|454785876|FG000|Overall Study|Physician Decision|3|||
126407714|NCT02228096|454785876|FG000|Overall Study|Subject/guardian decision|2|||
126407715|NCT02228096|454785876|FG000|Overall Study|New therapy for study indication|1|||
126407716|NCT02228096|454785876|FG000|Overall Study|Enrolled, not infused|11|||
126407717|NCT02273960|454785877|FG000|Short Term Period|Lost to Follow-up|1|||
126407718|NCT02273960|454785878|FG001|Short Term Period|Lost to Follow-up|0|||
126407719|NCT02273960|454785879|FG002|Short Term Period|Lost to Follow-up|0|||
126407720|NCT02273960|454785880|FG003|Short Term Period|Lost to Follow-up|0|||
126407721|NCT02273960|454785877|FG000|Short Term Period|Lack of Efficacy|0|||
126407722|NCT02273960|454785878|FG001|Short Term Period|Lack of Efficacy|0|||
126407723|NCT02273960|454785879|FG002|Short Term Period|Lack of Efficacy|0|||
126407724|NCT02273960|454785880|FG003|Short Term Period|Lack of Efficacy|1|||
126407725|NCT02273960|454785877|FG000|Short Term Period|ST complete, not entering LTE|4|||
126407726|NCT02273960|454785878|FG001|Short Term Period|ST complete, not entering LTE|6|||
126407727|NCT02273960|454785879|FG002|Short Term Period|ST complete, not entering LTE|4|||
126407728|NCT02273960|454785880|FG003|Short Term Period|ST complete, not entering LTE|5|||
126407729|NCT02273960|454785877|FG000|Long Term Extension|Death|0|||
126407730|NCT02273960|454785878|FG001|Long Term Extension|Death|0|||
126407731|NCT02273960|454785879|FG002|Long Term Extension|Death|0|||
126407732|NCT02273960|454785880|FG003|Long Term Extension|Death|1|||
126407733|NCT00558272|454785881|FG000|Overall Study|Adverse Event|10|||
126407734|NCT00558272|454785882|FG001|Overall Study|Adverse Event|0|||
126407735|NCT00558272|454785881|FG000|Overall Study|Death|1|||
126407736|NCT00558272|454785882|FG001|Overall Study|Death|0|||
126407737|NCT00558272|454785881|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
126407738|NCT00558272|454785882|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
126407739|NCT00558272|454785881|FG000|Overall Study|AZ study team decision|0|||
126407740|NCT00558272|454785882|FG001|Overall Study|AZ study team decision|1|||
126407741|NCT00558272|454785881|FG000|Overall Study|Incorrectly enrolled|1|||
126053976|NCT03147287|453491347|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
126053977|NCT03147287|453491348|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
126407742|NCT00558272|454785882|FG001|Overall Study|Incorrectly enrolled|0|||
126407743|NCT00558272|454785881|FG000|Overall Study|Withdrawal by Subject|0|||
126407744|NCT00558272|454785882|FG001|Overall Study|Withdrawal by Subject|1|||
126407745|NCT00454649|454785883|FG000|Overall Study|Lack of Efficacy|2|||
126407746|NCT00454649|454785884|FG001|Overall Study|Lack of Efficacy|2|||
126407747|NCT00454649|454785885|FG002|Overall Study|Lack of Efficacy|10|||
126407748|NCT00454649|454785886|FG003|Overall Study|Lack of Efficacy|3|||
126407749|NCT00454649|454785887|FG004|Overall Study|Lack of Efficacy|0|||
126407750|NCT00454649|454785888|FG005|Overall Study|Lack of Efficacy|4|||
126407751|NCT00454649|454785889|FG006|Overall Study|Lack of Efficacy|5|||
126407752|NCT00454649|454785890|FG007|Overall Study|Lack of Efficacy|13|||
126407753|NCT00454649|454785891|FG008|Overall Study|Lack of Efficacy|10|||
126407754|NCT00454649|454785892|FG009|Overall Study|Lack of Efficacy|2|||
126407755|NCT00454649|454785883|FG000|Overall Study|Adverse Event|0|||
126407756|NCT00454649|454785884|FG001|Overall Study|Adverse Event|1|||
126407757|NCT00454649|454785885|FG002|Overall Study|Adverse Event|3|||
126407758|NCT00454649|454785886|FG003|Overall Study|Adverse Event|0|||
126407759|NCT00454649|454785887|FG004|Overall Study|Adverse Event|1|||
126407760|NCT00454649|454785888|FG005|Overall Study|Adverse Event|2|||
126407761|NCT00454649|454785889|FG006|Overall Study|Adverse Event|3|||
126407762|NCT00454649|454785890|FG007|Overall Study|Adverse Event|4|||
126407763|NCT00454649|454785891|FG008|Overall Study|Adverse Event|6|||
126407764|NCT00454649|454785892|FG009|Overall Study|Adverse Event|2|||
126407765|NCT00454649|454785883|FG000|Overall Study|Lost to Follow-up|0|||
126407766|NCT00454649|454785884|FG001|Overall Study|Lost to Follow-up|0|||
126407767|NCT00454649|454785885|FG002|Overall Study|Lost to Follow-up|1|||
126407768|NCT00454649|454785886|FG003|Overall Study|Lost to Follow-up|0|||
126407769|NCT00454649|454785887|FG004|Overall Study|Lost to Follow-up|0|||
126407770|NCT00454649|454785888|FG005|Overall Study|Lost to Follow-up|0|||
126407771|NCT00454649|454785889|FG006|Overall Study|Lost to Follow-up|1|||
126407772|NCT00454649|454785890|FG007|Overall Study|Lost to Follow-up|0|||
126407773|NCT00454649|454785891|FG008|Overall Study|Lost to Follow-up|0|||
126407774|NCT00454649|454785892|FG009|Overall Study|Lost to Follow-up|0|||
126407775|NCT00454649|454785883|FG000|Overall Study|Other|1|||
126407776|NCT00454649|454785884|FG001|Overall Study|Other|1|||
126407777|NCT00454649|454785885|FG002|Overall Study|Other|5|||
126407778|NCT00454649|454785886|FG003|Overall Study|Other|3|||
126407779|NCT00454649|454785887|FG004|Overall Study|Other|0|||
126407780|NCT00454649|454785888|FG005|Overall Study|Other|0|||
126407781|NCT00454649|454785889|FG006|Overall Study|Other|0|||
126407782|NCT00454649|454785890|FG007|Overall Study|Other|0|||
126407783|NCT00454649|454785891|FG008|Overall Study|Other|3|||
126407784|NCT00454649|454785892|FG009|Overall Study|Other|1|||
126407785|NCT00454649|454785883|FG000|Overall Study|Withdrawal by Subject|0|||
126407786|NCT00454649|454785884|FG001|Overall Study|Withdrawal by Subject|0|||
126407787|NCT00454649|454785885|FG002|Overall Study|Withdrawal by Subject|0|||
126407788|NCT00454649|454785886|FG003|Overall Study|Withdrawal by Subject|0|||
126407789|NCT00454649|454785887|FG004|Overall Study|Withdrawal by Subject|0|||
126407790|NCT00454649|454785888|FG005|Overall Study|Withdrawal by Subject|1|||
126407791|NCT00454649|454785889|FG006|Overall Study|Withdrawal by Subject|0|||
126407792|NCT00454649|454785890|FG007|Overall Study|Withdrawal by Subject|2|||
126407793|NCT00454649|454785891|FG008|Overall Study|Withdrawal by Subject|1|||
126407794|NCT00454649|454785892|FG009|Overall Study|Withdrawal by Subject|0|||
126407795|NCT01789606|454785893|FG000|Overall Study|Participant not Purchased the Product|0|||
126407796|NCT01789606|454785894|FG001|Overall Study|Participant not Purchased the Product|20|||
126407797|NCT01789606|454785893|FG000|Overall Study|Withdrawal by Subject|0|||
126407798|NCT01789606|454785894|FG001|Overall Study|Withdrawal by Subject|1|||
126407799|NCT01789606|454785893|FG000|Overall Study|Ineligible|6|||
126407800|NCT01789606|454785894|FG001|Overall Study|Ineligible|2|||
126407801|NCT01789606|454785893|FG000|Overall Study|Administrative Reasons|17|||
126407802|NCT01789606|454785894|FG001|Overall Study|Administrative Reasons|6|||
126407803|NCT01789606|454785893|FG000|Overall Study|No Study Medication Taken|0|||
126407804|NCT01789606|454785894|FG001|Overall Study|No Study Medication Taken|1|||
126407805|NCT01789606|454785893|FG000|Overall Study|Protocol Violation|0|||
126407806|NCT01789606|454785894|FG001|Overall Study|Protocol Violation|55|||
126407807|NCT01789606|454785893|FG000|Overall Study|Adverse Event|0|||
126407808|NCT01789606|454785894|FG001|Overall Study|Adverse Event|3|||
126407809|NCT01789606|454785893|FG000|Overall Study|Lost to Follow-up|0|||
126407810|NCT01789606|454785894|FG001|Overall Study|Lost to Follow-up|14|||
126407811|NCT01789606|454785893|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
126407812|NCT01789606|454785894|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
126407813|NCT00279812|454785900|FG000|Overall Study|Protocol Violation|1|||
126407814|NCT00279812|454785901|FG001|Overall Study|Protocol Violation|1|||
126407815|NCT00279812|454785902|FG002|Overall Study|Protocol Violation|0|||
126407816|NCT00279812|454785903|FG003|Overall Study|Protocol Violation|0|||
126407817|NCT00279812|454785904|FG004|Overall Study|Protocol Violation|1|||
126407818|NCT00279812|454785905|FG005|Overall Study|Protocol Violation|0|||
126407819|NCT00279812|454785900|FG000|Overall Study|Withdrawal by Subject|0|||
126407820|NCT00279812|454785901|FG001|Overall Study|Withdrawal by Subject|4|||
126407821|NCT00279812|454785902|FG002|Overall Study|Withdrawal by Subject|2|||
126407822|NCT00279812|454785903|FG003|Overall Study|Withdrawal by Subject|0|||
126105350|NCT01281969|453678602|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
126407823|NCT00279812|454785904|FG004|Overall Study|Withdrawal by Subject|0|||
126407824|NCT00279812|454785905|FG005|Overall Study|Withdrawal by Subject|0|||
126407825|NCT00279812|454785900|FG000|Overall Study|Adverse Event|0|||
126407826|NCT00279812|454785901|FG001|Overall Study|Adverse Event|1|||
126407827|NCT00279812|454785902|FG002|Overall Study|Adverse Event|1|||
126407828|NCT00279812|454785903|FG003|Overall Study|Adverse Event|0|||
126407829|NCT00279812|454785904|FG004|Overall Study|Adverse Event|2|||
126407830|NCT00279812|454785905|FG005|Overall Study|Adverse Event|1|||
126407831|NCT01274429|454785906|FG000|Overall Study|Study closed do to lack of funding|5|||
126407832|NCT01879072|454785914|FG000|Overall Study|Withdrawal by Subject|121|||
126407833|NCT01879072|454785914|FG000|Overall Study|Not Transplanted|30|||
126407834|NCT05327361|454785915|FG000|Overall Study|Lost to Follow-up|4|||
126407835|NCT01439373|454785925|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
126407836|NCT01439373|454785926|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
126407837|NCT01439373|454785925|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
126407838|NCT01439373|454785926|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
126407839|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
126407840|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
126407841|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
126407842|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
126407843|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
126407844|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
126407845|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
126407846|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
126407847|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Death|0|||
126407848|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Death|1|||
126407849|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
126407850|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
126407851|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Other|0|||
126407852|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Other|2|||
126407853|NCT03281304|454785927|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
126407854|NCT03281304|454785928|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
126407855|NCT00626405|454785929|FG000|Overall Study|Deemed Ineligible|1|||
126407856|NCT00626405|454785930|FG001|Overall Study|Deemed Ineligible|0|||
126407857|NCT00626405|454785929|FG000|Overall Study|Withdrawal by Subject|0|||
126407858|NCT00626405|454785930|FG001|Overall Study|Withdrawal by Subject|1|||
126407859|NCT03834220|454785931|FG000|Overall Study|Adverse Event|1|||
126407860|NCT03834220|454785932|FG001|Overall Study|Adverse Event|0|||
126407861|NCT03834220|454785933|FG002|Overall Study|Adverse Event|0|||
126407862|NCT03834220|454785931|FG000|Overall Study|Death|8|||
126407863|NCT03834220|454785932|FG001|Overall Study|Death|1|||
126407864|NCT03834220|454785933|FG002|Overall Study|Death|17|||
126407865|NCT03834220|454785931|FG000|Overall Study|Reason not Specified|9|||
126407866|NCT03834220|454785932|FG001|Overall Study|Reason not Specified|0|||
126407867|NCT03834220|454785933|FG002|Overall Study|Reason not Specified|6|||
126407868|NCT03834220|454785931|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
126407869|NCT03834220|454785932|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
126407870|NCT03834220|454785933|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
126407871|NCT03834220|454785931|FG000|Overall Study|Withdrawal of Consent|2|||
126407872|NCT03834220|454785932|FG001|Overall Study|Withdrawal of Consent|2|||
126407873|NCT03834220|454785933|FG002|Overall Study|Withdrawal of Consent|2|||
126407874|NCT02593318|454785934|FG000|Overall Study|Withdrawal by Subject|1|||
126407875|NCT02593318|454785935|FG001|Overall Study|Withdrawal by Subject|1|||
126407876|NCT02100969|454787248|FG000|Overall Study|Did not pass screening phase|1|||
126407877|NCT01629953|454787249|FG000|Overall Study|Death|3|||
126407878|NCT01629953|454787250|FG001|Overall Study|Death|1|||
126407879|NCT01629953|454787249|FG000|Overall Study|Lost to Follow-up|10|||
126407880|NCT01629953|454787250|FG001|Overall Study|Lost to Follow-up|14|||
126407881|NCT06359080|454787251|FG000|Overall Study|Withdrawal by Subject|3|||
126407882|NCT00306527|454787252|FG000|Overall Study|Lost to Follow-up|3|||
126407883|NCT00306527|454787253|FG001|Overall Study|Lost to Follow-up|4|||
126407884|NCT00306527|454787254|FG002|Overall Study|Lost to Follow-up|3|||
126407885|NCT00306527|454787255|FG003|Overall Study|Lost to Follow-up|0|||
126407886|NCT00306527|454787252|FG000|Overall Study|Withdrawal by Subject|2|||
126407887|NCT00306527|454787253|FG001|Overall Study|Withdrawal by Subject|3|||
126407888|NCT00306527|454787254|FG002|Overall Study|Withdrawal by Subject|0|||
126407889|NCT00306527|454787255|FG003|Overall Study|Withdrawal by Subject|3|||
126407890|NCT00306527|454787252|FG000|Overall Study|Adverse Event|0|||
126407891|NCT00306527|454787253|FG001|Overall Study|Adverse Event|0|||
126407892|NCT00306527|454787254|FG002|Overall Study|Adverse Event|1|||
126407893|NCT00306527|454787255|FG003|Overall Study|Adverse Event|1|||
126407894|NCT00306527|454787252|FG000|Overall Study|Death|1|||
126407895|NCT00306527|454787253|FG001|Overall Study|Death|0|||
126407896|NCT00306527|454787254|FG002|Overall Study|Death|1|||
126407897|NCT00306527|454787255|FG003|Overall Study|Death|2|||
126407898|NCT04037254|454787256|FG000|Overall Study|Protocol Violation|1|||
126407899|NCT04037254|454787257|FG001|Overall Study|Protocol Violation|0|||
126407900|NCT04037254|454787258|FG002|Overall Study|Protocol Violation|0|||
126407901|NCT04037254|454787259|FG003|Overall Study|Protocol Violation|0|||
126407902|NCT04037254|454787260|FG004|Overall Study|Protocol Violation|0|||
126407903|NCT04037254|454787256|FG000|Overall Study|Withdrawal by Subject|0|||
126407904|NCT04037254|454787257|FG001|Overall Study|Withdrawal by Subject|0|||
126407905|NCT04037254|454787258|FG002|Overall Study|Withdrawal by Subject|1|||
126407906|NCT04037254|454787259|FG003|Overall Study|Withdrawal by Subject|0|||
126407907|NCT04037254|454787260|FG004|Overall Study|Withdrawal by Subject|0|||
126407908|NCT04037254|454787256|FG000|Overall Study|Delayed or incomplete treatment|0|||
126407909|NCT04037254|454787257|FG001|Overall Study|Delayed or incomplete treatment|2|||
126407910|NCT04037254|454787258|FG002|Overall Study|Delayed or incomplete treatment|1|||
126407911|NCT04037254|454787259|FG003|Overall Study|Delayed or incomplete treatment|0|||
126407912|NCT04037254|454787260|FG004|Overall Study|Delayed or incomplete treatment|0|||
126407913|NCT00417963|454787264|FG000|Overall Study|Lost to Follow-up|3|||
126407914|NCT00417963|454787264|FG000|Overall Study|Withdrawal by Subject|18|||
126407915|NCT00417963|454787264|FG000|Overall Study|Death|17|||
126407916|NCT00417963|454787264|FG000|Overall Study|Study device could not be deployed|3|||
126407917|NCT00477152|454787278|FG000|Overall Study|Parent withdrew consent|2|||
126407918|NCT00477152|454787278|FG000|Overall Study|Adverse Event|1|||
126407919|NCT01023672|454787279|FG000|Overall Study|Worsening disease|2|||
126407920|NCT01023672|454787279|FG000|Overall Study|Death|1|||
126407921|NCT02504580|454787280|FG000|Overall Study|Other|1|||
126407922|NCT02504580|454787281|FG001|Overall Study|Other|0|||
126407923|NCT02504580|454787282|FG002|Overall Study|Other|0|||
126407924|NCT02504580|454787283|FG003|Overall Study|Other|2|||
126407925|NCT02504580|454787284|FG004|Overall Study|Other|1|||
126407926|NCT02504580|454787285|FG005|Overall Study|Other|1|||
126407927|NCT02504580|454787286|FG006|Overall Study|Other|1|||
126407928|NCT02504580|454787287|FG007|Overall Study|Other|2|||
126407929|NCT02504580|454787288|FG008|Overall Study|Other|0|||
126407930|NCT02504580|454787289|FG009|Overall Study|Other|0|||
126407931|NCT02504580|454787290|FG010|Overall Study|Other|0|||
126407932|NCT02504580|454787291|FG011|Overall Study|Other|2|||
126407933|NCT02504580|454787280|FG000|Overall Study|Subject refusal to continue|0|||
126407934|NCT02504580|454787281|FG001|Overall Study|Subject refusal to continue|1|||
126407935|NCT02504580|454787282|FG002|Overall Study|Subject refusal to continue|0|||
126407936|NCT02504580|454787283|FG003|Overall Study|Subject refusal to continue|0|||
126407937|NCT02504580|454787284|FG004|Overall Study|Subject refusal to continue|0|||
126407938|NCT02504580|454787285|FG005|Overall Study|Subject refusal to continue|0|||
126407939|NCT02504580|454787286|FG006|Overall Study|Subject refusal to continue|0|||
126407940|NCT02504580|454787287|FG007|Overall Study|Subject refusal to continue|0|||
126407941|NCT02504580|454787288|FG008|Overall Study|Subject refusal to continue|0|||
126407942|NCT02504580|454787289|FG009|Overall Study|Subject refusal to continue|0|||
126407943|NCT02504580|454787290|FG010|Overall Study|Subject refusal to continue|0|||
126407944|NCT02504580|454787291|FG011|Overall Study|Subject refusal to continue|0|||
126407945|NCT00448747|454787293|FG000|Overall Study|collapsed veins|1|||
126407946|NCT00448747|454787294|FG001|Overall Study|collapsed veins|0|||
126407947|NCT02166463|454787297|FG000|Overall Study|Lost to Follow-up|0|||
126407948|NCT02166463|454787298|FG001|Overall Study|Lost to Follow-up|1|||
126407949|NCT02166463|454787297|FG000|Overall Study|Physician Decision|10|||
126407950|NCT02166463|454787298|FG001|Overall Study|Physician Decision|10|||
126407951|NCT02166463|454787297|FG000|Overall Study|Ineligible|11|||
126407952|NCT02166463|454787298|FG001|Overall Study|Ineligible|2|||
126407953|NCT02166463|454787297|FG000|Overall Study|Progressive Disease|9|||
126407954|NCT02166463|454787298|FG001|Overall Study|Progressive Disease|6|||
126407955|NCT02166463|454787297|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
126407956|NCT02166463|454787298|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
126407957|NCT02166463|454787297|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
126407958|NCT02166463|454787298|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
126407959|NCT02166463|454787297|FG000|Overall Study|Refusal of further protocol therapy|5|||
126407960|NCT02166463|454787298|FG001|Overall Study|Refusal of further protocol therapy|6|||
126407961|NCT02478164|454787299|FG000|Overall Study|Lack of Efficacy|13|||
126407962|NCT02478164|454787299|FG000|Overall Study|Adverse Event|1|||
126407963|NCT02478164|454787299|FG000|Overall Study|Withdrawal by Subject|1|||
126407964|NCT04588389|454787300|FG000|Overall Study|Issues with anesthesia during surgery|2|||
126407965|NCT04588389|454787301|FG001|Overall Study|Issues with anesthesia during surgery|0|||
126407966|NCT04588389|454787302|FG002|Overall Study|Issues with anesthesia during surgery|0|||
126407967|NCT05779007|454787303|FG000|Overall Study|not meeting eligibility criteria|3517|||
126407968|NCT05779007|454787304|FG001|Overall Study|not meeting eligibility criteria|2009|||
126407969|NCT01424566|454787305|FG000|Single-blind Treatment|Adverse Event|71|||
126407970|NCT01424566|454787306|FG001|Single-blind Treatment|Adverse Event|0|||
126407971|NCT01424566|454787307|FG002|Single-blind Treatment|Adverse Event|0|||
126407972|NCT01424566|454787305|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
126407973|NCT01424566|454787306|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
126407974|NCT01424566|454787307|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
126407975|NCT01424566|454787305|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
126407976|NCT01424566|454787306|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
126407977|NCT01424566|454787307|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
126407978|NCT01424566|454787305|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
126407979|NCT01424566|454787306|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
126407980|NCT01424566|454787307|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
126407981|NCT01424566|454787305|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
126407982|NCT01424566|454787306|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
126407983|NCT01424566|454787307|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
126407984|NCT01424566|454787305|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
126407985|NCT01424566|454787306|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
126407986|NCT01424566|454787307|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
126407987|NCT01424566|454787305|FG000|Double-blind Treatment|Adverse Event|0|||
126407988|NCT01424566|454787306|FG001|Double-blind Treatment|Adverse Event|21|||
126407989|NCT01424566|454787307|FG002|Double-blind Treatment|Adverse Event|13|||
126407990|NCT01424566|454787305|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
126407991|NCT01424566|454787306|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
126407992|NCT01424566|454787307|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
126407993|NCT01424566|454787305|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
126407994|NCT01424566|454787306|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
126407995|NCT01424566|454787307|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
126407996|NCT01424566|454787305|FG000|Double-blind Treatment|Lack of Efficacy|0|||
126407997|NCT01424566|454787306|FG001|Double-blind Treatment|Lack of Efficacy|1|||
126407998|NCT01424566|454787307|FG002|Double-blind Treatment|Lack of Efficacy|1|||
126407999|NCT05147662|454787320|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126408000|NCT05147662|454787320|FG000|Overall Study|Assigned to treatment but never treated|1|||
126408001|NCT04676867|454787321|FG000|Overall Study|Screen failure|0|||
126408002|NCT04676867|454787322|FG001|Overall Study|Screen failure|0|||
126408003|NCT04676867|454787323|FG002|Overall Study|Screen failure|6|||
126408004|NCT04676867|454787324|FG003|Overall Study|Screen failure|2|||
126408005|NCT04676867|454787321|FG000|Overall Study|Death|0|||
126408006|NCT04676867|454787322|FG001|Overall Study|Death|0|||
126408007|NCT04676867|454787323|FG002|Overall Study|Death|1|||
126408008|NCT04676867|454787324|FG003|Overall Study|Death|0|||
126408009|NCT04676867|454787321|FG000|Overall Study|Withdrawal by Subject|2|||
126408010|NCT04676867|454787322|FG001|Overall Study|Withdrawal by Subject|2|||
126408011|NCT04676867|454787323|FG002|Overall Study|Withdrawal by Subject|4|||
126408012|NCT04676867|454787324|FG003|Overall Study|Withdrawal by Subject|4|||
126408013|NCT04676867|454787321|FG000|Overall Study|Lost to Follow-up|1|||
126408014|NCT04676867|454787322|FG001|Overall Study|Lost to Follow-up|0|||
126408015|NCT04676867|454787323|FG002|Overall Study|Lost to Follow-up|0|||
126408016|NCT04676867|454787324|FG003|Overall Study|Lost to Follow-up|0|||
126408017|NCT00549770|454787325|FG000|Overall Study|Protocol deviation|1|||
126088970|NCT01399697|453620041|FG002|Overall Study|Lack of Efficacy|1|||
126088971|NCT01399697|453620039|FG000|Overall Study|Protocol Violation|2|||
126088972|NCT01399697|453620040|FG001|Overall Study|Protocol Violation|0|||
126088973|NCT01399697|453620041|FG002|Overall Study|Protocol Violation|0|||
126088974|NCT01399697|453620039|FG000|Overall Study|Non-Compliant|1|||
126088975|NCT01399697|453620040|FG001|Overall Study|Non-Compliant|0|||
126088976|NCT01399697|453620041|FG002|Overall Study|Non-Compliant|0|||
126088977|NCT01399697|453620039|FG000|Overall Study|Inclusion Error|2|||
126088978|NCT01399697|453620040|FG001|Overall Study|Inclusion Error|0|||
126088979|NCT01399697|453620041|FG002|Overall Study|Inclusion Error|0|||
126088980|NCT01399697|453620039|FG000|Overall Study|Positive result for hepatitis B|1|||
126088981|NCT01399697|453620040|FG001|Overall Study|Positive result for hepatitis B|0|||
126088982|NCT01399697|453620041|FG002|Overall Study|Positive result for hepatitis B|0|||
126088983|NCT01399697|453620039|FG000|Overall Study|Clinical RA remission|1|||
126088984|NCT01399697|453620040|FG001|Overall Study|Clinical RA remission|0|||
126088985|NCT01399697|453620041|FG002|Overall Study|Clinical RA remission|0|||
126088986|NCT01399697|453620039|FG000|Overall Study|Sponsor Decision|1|||
126088987|NCT01399697|453620040|FG001|Overall Study|Sponsor Decision|0|||
126088988|NCT01399697|453620041|FG002|Overall Study|Sponsor Decision|0|||
126088989|NCT04313608|453620042|FG000|Overall Study|Death|12|||
126088990|NCT04313608|453620043|FG001|Overall Study|Death|3|||
126088991|NCT03019640|453620045|FG000|Overall Study|Screen Failures|4|||
126408018|NCT00549770|454787326|FG001|Overall Study|Protocol deviation|1|||
126408019|NCT00549770|454787327|FG002|Overall Study|Protocol deviation|1|||
126408020|NCT00549770|454787328|FG003|Overall Study|Protocol deviation|2|||
126408021|NCT00549770|454787329|FG004|Overall Study|Protocol deviation|2|||
126408022|NCT00549770|454787330|FG005|Overall Study|Protocol deviation|2|||
126088992|NCT03019640|453620045|FG000|Overall Study|Adverse Event|3|||
126408023|NCT00549770|454787331|FG006|Overall Study|Protocol deviation|1|||
126408024|NCT00549770|454787332|FG007|Overall Study|Protocol deviation|2|||
126408025|NCT00549770|454787325|FG000|Overall Study|Administrative problems|0|||
126088993|NCT03019640|453620045|FG000|Overall Study|Participant Relapsed|1|||
126088994|NCT01327846|453620048|FG000|Core Phase|Subject decision (vital status: missing)|1|||
126088995|NCT01327846|453620049|FG001|Core Phase|Subject decision (vital status: missing)|2|||
126088996|NCT01327846|453620050|FG002|Core Phase|Subject decision (vital status: missing)|2|||
126088997|NCT01327846|453620051|FG003|Core Phase|Subject decision (vital status: missing)|1|||
126088998|NCT01327846|453620048|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
126408026|NCT00549770|454787326|FG001|Overall Study|Administrative problems|1|||
126408027|NCT00549770|454787327|FG002|Overall Study|Administrative problems|0|||
126088999|NCT01327846|453620049|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
126408028|NCT00549770|454787328|FG003|Overall Study|Administrative problems|0|||
126408029|NCT00549770|454787329|FG004|Overall Study|Administrative problems|0|||
126408030|NCT00549770|454787330|FG005|Overall Study|Administrative problems|0|||
126408031|NCT00549770|454787331|FG006|Overall Study|Administrative problems|0|||
126408032|NCT00549770|454787332|FG007|Overall Study|Administrative problems|1|||
126408033|NCT00549770|454787325|FG000|Overall Study|Lost to Follow-up|0|||
126408034|NCT00549770|454787326|FG001|Overall Study|Lost to Follow-up|0|||
126408035|NCT00549770|454787327|FG002|Overall Study|Lost to Follow-up|2|||
126408036|NCT00549770|454787328|FG003|Overall Study|Lost to Follow-up|2|||
126408037|NCT00549770|454787329|FG004|Overall Study|Lost to Follow-up|3|||
126408038|NCT00549770|454787330|FG005|Overall Study|Lost to Follow-up|2|||
126408039|NCT00549770|454787331|FG006|Overall Study|Lost to Follow-up|0|||
126408040|NCT00549770|454787332|FG007|Overall Study|Lost to Follow-up|0|||
126408041|NCT00549770|454787325|FG000|Overall Study|Withdrawal by Subject|4|||
126408042|NCT00549770|454787326|FG001|Overall Study|Withdrawal by Subject|6|||
126408043|NCT00549770|454787327|FG002|Overall Study|Withdrawal by Subject|4|||
126408044|NCT00549770|454787328|FG003|Overall Study|Withdrawal by Subject|5|||
126408045|NCT00549770|454787329|FG004|Overall Study|Withdrawal by Subject|6|||
126408046|NCT00549770|454787330|FG005|Overall Study|Withdrawal by Subject|6|||
126408047|NCT00549770|454787331|FG006|Overall Study|Withdrawal by Subject|4|||
126408048|NCT00549770|454787332|FG007|Overall Study|Withdrawal by Subject|9|||
126408049|NCT00549770|454787325|FG000|Overall Study|Lack of Efficacy|1|||
126408050|NCT00549770|454787326|FG001|Overall Study|Lack of Efficacy|0|||
126408051|NCT00549770|454787327|FG002|Overall Study|Lack of Efficacy|2|||
126408052|NCT00549770|454787328|FG003|Overall Study|Lack of Efficacy|3|||
126408053|NCT00549770|454787329|FG004|Overall Study|Lack of Efficacy|5|||
126408054|NCT00549770|454787330|FG005|Overall Study|Lack of Efficacy|1|||
126408055|NCT00549770|454787331|FG006|Overall Study|Lack of Efficacy|3|||
126408056|NCT00549770|454787332|FG007|Overall Study|Lack of Efficacy|8|||
126408057|NCT00549770|454787325|FG000|Overall Study|Abnormal test procedure results|0|||
126408058|NCT00549770|454787326|FG001|Overall Study|Abnormal test procedure results|0|||
126408059|NCT00549770|454787327|FG002|Overall Study|Abnormal test procedure results|0|||
126408060|NCT00549770|454787328|FG003|Overall Study|Abnormal test procedure results|2|||
126408061|NCT00549770|454787329|FG004|Overall Study|Abnormal test procedure results|0|||
126408062|NCT00549770|454787330|FG005|Overall Study|Abnormal test procedure results|1|||
126408063|NCT00549770|454787331|FG006|Overall Study|Abnormal test procedure results|1|||
126408064|NCT00549770|454787332|FG007|Overall Study|Abnormal test procedure results|1|||
126408065|NCT00549770|454787325|FG000|Overall Study|Abnormal laboratory values|0|||
126408066|NCT00549770|454787326|FG001|Overall Study|Abnormal laboratory values|0|||
126408067|NCT00549770|454787327|FG002|Overall Study|Abnormal laboratory values|0|||
126408068|NCT00549770|454787328|FG003|Overall Study|Abnormal laboratory values|0|||
126408069|NCT00549770|454787329|FG004|Overall Study|Abnormal laboratory values|0|||
126408070|NCT00549770|454787330|FG005|Overall Study|Abnormal laboratory values|1|||
126408071|NCT00549770|454787331|FG006|Overall Study|Abnormal laboratory values|0|||
126408072|NCT00549770|454787332|FG007|Overall Study|Abnormal laboratory values|0|||
126408073|NCT00549770|454787325|FG000|Overall Study|Adverse Event|1|||
126408074|NCT00549770|454787326|FG001|Overall Study|Adverse Event|3|||
126408075|NCT00549770|454787327|FG002|Overall Study|Adverse Event|1|||
126408076|NCT00549770|454787328|FG003|Overall Study|Adverse Event|2|||
126408077|NCT00549770|454787329|FG004|Overall Study|Adverse Event|1|||
126408078|NCT00549770|454787330|FG005|Overall Study|Adverse Event|0|||
126408079|NCT00549770|454787331|FG006|Overall Study|Adverse Event|5|||
126408080|NCT00549770|454787332|FG007|Overall Study|Adverse Event|4|||
126408081|NCT01079936|454787333|FG000|Phase I: MTD|First Remission Status|2|||
126408082|NCT01079936|454787334|FG001|Phase I: MTD|First Remission Status|0|||
126408083|NCT01079936|454787335|FG002|Phase I: MTD|First Remission Status|0|||
126408084|NCT01079936|454787336|FG003|Phase I: MTD|First Remission Status|0|||
126408085|NCT01079936|454787337|FG004|Phase I: MTD|First Remission Status|0|||
126408086|NCT01079936|454787333|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
126408087|NCT01079936|454787334|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
126408088|NCT01079936|454787335|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
126408089|NCT01079936|454787336|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
126408090|NCT01079936|454787337|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
126408091|NCT01079936|454787333|FG000|Phase II|Adverse Event|0|||
126408092|NCT01079936|454787334|FG001|Phase II|Adverse Event|0|||
126408093|NCT01079936|454787335|FG002|Phase II|Adverse Event|1|||
126408094|NCT01079936|454787336|FG003|Phase II|Adverse Event|0|||
126408095|NCT01079936|454787337|FG004|Phase II|Adverse Event|0|||
126408096|NCT01079936|454787333|FG000|Phase II|Insurance Issue|0|||
126408097|NCT01079936|454787334|FG001|Phase II|Insurance Issue|0|||
126408098|NCT01079936|454787335|FG002|Phase II|Insurance Issue|0|||
126408099|NCT01079936|454787336|FG003|Phase II|Insurance Issue|0|||
126408100|NCT01079936|454787337|FG004|Phase II|Insurance Issue|1|||
126408101|NCT02294734|454787338|FG000|Overall Study|Adverse Event|5|||
126408102|NCT02294734|454787339|FG001|Overall Study|Adverse Event|5|||
126408103|NCT02294734|454787338|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
126408104|NCT02294734|454787339|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
125890574|NCT01942733|452897168|FG000|Overall Study|Non-compliance with IMP|1|||
125890575|NCT01942733|452897168|FG000|Overall Study|Administrative|1|||
126408105|NCT02294734|454787338|FG000|Overall Study|Lost to Follow-up|2|||
126408106|NCT02294734|454787339|FG001|Overall Study|Lost to Follow-up|0|||
126408107|NCT02294734|454787338|FG000|Overall Study|Physician Decision|2|||
126408108|NCT02294734|454787339|FG001|Overall Study|Physician Decision|1|||
126408109|NCT02294734|454787338|FG000|Overall Study|Withdrawal by Subject|4|||
126408110|NCT02294734|454787339|FG001|Overall Study|Withdrawal by Subject|2|||
126408111|NCT00548717|454787340|FG000|Overall Study|Death|5|||
126408112|NCT00548717|454787341|FG001|Overall Study|Death|2|||
126408113|NCT00548717|454787340|FG000|Overall Study|Relapse|3|||
126408114|NCT00548717|454787341|FG001|Overall Study|Relapse|0|||
126408115|NCT00548717|454787340|FG000|Overall Study|Alternative treatment for GVHD|1|||
126408116|NCT00548717|454787341|FG001|Overall Study|Alternative treatment for GVHD|0|||
126408117|NCT03157583|454787342|FG000|Overall Study|Other (did not meet study criteria)|1|||
126408118|NCT00847015|454787346|FG000|Overall Study|Withdrawal by Subject|1|||
126408119|NCT00847015|454787346|FG000|Overall Study|declined any surgery|1|||
126408120|NCT00847015|454787346|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
126408121|NCT01141478|454787347|FG000|Overall Study|Withdrawal by Subject|1|||
126408122|NCT01141478|454787348|FG001|Overall Study|Withdrawal by Subject|1|||
126408123|NCT01732913|454787356|FG000|Overall Study|Study Terminated by Sponsor|105|||
126408124|NCT01732913|454787357|FG001|Overall Study|Study Terminated by Sponsor|55|||
126408125|NCT01732913|454787356|FG000|Overall Study|Withdrawal by Subject|27|||
126408126|NCT01732913|454787357|FG001|Overall Study|Withdrawal by Subject|4|||
126408127|NCT01732913|454787356|FG000|Overall Study|Physician Decision|14|||
126408128|NCT01732913|454787357|FG001|Overall Study|Physician Decision|7|||
126408129|NCT01732913|454787356|FG000|Overall Study|Other|7|||
126408130|NCT01732913|454787357|FG001|Overall Study|Other|1|||
126408131|NCT01732913|454787356|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
126408132|NCT01732913|454787357|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
126408133|NCT02925741|454787358|FG000|Overall Study|Withdrawal by Subject|11|||
126408134|NCT02925741|454787359|FG001|Overall Study|Withdrawal by Subject|0|||
126408135|NCT05086510|454787360|FG000|Overall Study|Lost to Follow-up|0|||
126408136|NCT05086510|454787361|FG001|Overall Study|Lost to Follow-up|2|||
126408137|NCT05086510|454787360|FG000|Overall Study|Death|0|||
126408138|NCT05086510|454787361|FG001|Overall Study|Death|2|||
126408139|NCT03022981|454787362|FG000|Overall Study|Adverse Event|0|||
126408140|NCT03022981|454787363|FG001|Overall Study|Adverse Event|1|||
126408141|NCT03022981|454787364|FG002|Overall Study|Adverse Event|0|||
126408142|NCT03022981|454787362|FG000|Overall Study|Investigator's Discretion|0|||
126408143|NCT03022981|454787363|FG001|Overall Study|Investigator's Discretion|1|||
126408144|NCT03022981|454787364|FG002|Overall Study|Investigator's Discretion|2|||
126408145|NCT03022981|454787362|FG000|Overall Study|Lost to Follow-up|6|||
126408146|NCT03022981|454787363|FG001|Overall Study|Lost to Follow-up|2|||
126408147|NCT03022981|454787364|FG002|Overall Study|Lost to Follow-up|1|||
126408148|NCT03022981|454787362|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126408149|NCT03022981|454787363|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126408150|NCT03022981|454787364|FG002|Overall Study|Non-Compliance With Study Drug|2|||
126408151|NCT03022981|454787362|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
126408152|NCT03022981|454787363|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
126408153|NCT03022981|454787364|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
125890576|NCT01409811|452897169|FG000|Overall Study|Insurance denial|1|||
126408154|NCT00295932|454787365|FG000|Overall Study|Not Treated|0|||
126053986|NCT03214081|453492186|FG000|Overall Study|Case Report Forms Uncollected|9|||
126053987|NCT03214081|453492186|FG000|Overall Study|Protocol Deviation|54|||
126053988|NCT01372085|453492189|FG000|Washout Period 2|Physician Decision|0|||
126053989|NCT01372085|453492190|FG001|Washout Period 2|Physician Decision|0|||
126053990|NCT01372085|453492191|FG002|Washout Period 2|Physician Decision|0|||
126053991|NCT01372085|453492192|FG003|Washout Period 2|Physician Decision|0|||
126053992|NCT01372085|453492193|FG004|Washout Period 2|Physician Decision|1|||
126053993|NCT01372085|453492194|FG005|Washout Period 2|Physician Decision|0|||
126053994|NCT01372085|453492195|FG006|Washout Period 2|Physician Decision|0|||
126053995|NCT01372085|453492196|FG007|Washout Period 2|Physician Decision|0|||
126053996|NCT01372085|453492197|FG008|Washout Period 2|Physician Decision|0|||
126053997|NCT01372085|453492198|FG009|Washout Period 2|Physician Decision|0|||
126053998|NCT01372085|453492189|FG000|Washout Period 3|Withdrawal by Subject|0|||
126053999|NCT01372085|453492190|FG001|Washout Period 3|Withdrawal by Subject|0|||
126054000|NCT01372085|453492191|FG002|Washout Period 3|Withdrawal by Subject|0|||
126054001|NCT01372085|453492192|FG003|Washout Period 3|Withdrawal by Subject|0|||
126054002|NCT01372085|453492193|FG004|Washout Period 3|Withdrawal by Subject|0|||
126054003|NCT01372085|453492194|FG005|Washout Period 3|Withdrawal by Subject|2|||
126054004|NCT01372085|453492195|FG006|Washout Period 3|Withdrawal by Subject|0|||
126054005|NCT01372085|453492196|FG007|Washout Period 3|Withdrawal by Subject|0|||
126054006|NCT01372085|453492197|FG008|Washout Period 3|Withdrawal by Subject|0|||
126054007|NCT01372085|453492198|FG009|Washout Period 3|Withdrawal by Subject|0|||
126054008|NCT00790569|453492199|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
126054009|NCT00790569|453492200|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
126054010|NCT00790569|453492201|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
126054011|NCT00790569|453492199|FG000|End of Treatment (6 Month Interview)|Death|0|||
126054012|NCT00790569|453492200|FG001|End of Treatment (6 Month Interview)|Death|2|||
126054013|NCT00790569|453492201|FG002|End of Treatment (6 Month Interview)|Death|1|||
126054014|NCT00790569|453492199|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
126054015|NCT00790569|453492200|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
126054016|NCT00790569|453492201|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
126054017|NCT00790569|453492199|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
126054018|NCT00790569|453492200|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
126054019|NCT00790569|453492201|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
126054020|NCT00790569|453492199|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
126054021|NCT00790569|453492200|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
126408155|NCT00295932|454787366|FG001|Overall Study|Not Treated|0|||
126408156|NCT00295932|454787367|FG002|Overall Study|Not Treated|0|||
126408157|NCT00295932|454787368|FG003|Overall Study|Not Treated|0|||
126408158|NCT00295932|454787369|FG004|Overall Study|Not Treated|0|||
126408159|NCT00295932|454787370|FG005|Overall Study|Not Treated|0|||
126408160|NCT00295932|454787371|FG006|Overall Study|Not Treated|0|||
126408161|NCT00295932|454787372|FG007|Overall Study|Not Treated|0|||
126408162|NCT00295932|454787373|FG008|Overall Study|Not Treated|0|||
126408163|NCT00295932|454787374|FG009|Overall Study|Not Treated|0|||
126408164|NCT00295932|454787375|FG010|Overall Study|Not Treated|1|||
126408165|NCT04891107|454787376|FG000|Overall Study|Physician Decision|1|||
126054022|NCT00790569|453492201|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
126054023|NCT00790569|453492199|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
126054024|NCT00790569|453492200|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
126054025|NCT00790569|453492201|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
126054026|NCT00705406|453492205|FG000|Overall Study|Lost to Follow-up|3|||
126408166|NCT04891107|454787376|FG000|Overall Study|Withdrawal by Subject|1|||
126408167|NCT04891107|454787376|FG000|Overall Study|Screen failure after consent|1|||
126408168|NCT01571453|454787377|FG000|Overall Study|Adverse Event|14|||
126408169|NCT01571453|454787378|FG001|Overall Study|Adverse Event|32|||
126408170|NCT01571453|454787377|FG000|Overall Study|Lack of Efficacy|8|||
126408171|NCT01571453|454787378|FG001|Overall Study|Lack of Efficacy|3|||
126054027|NCT00705406|453492206|FG001|Overall Study|Lost to Follow-up|3|||
126408172|NCT01571453|454787377|FG000|Overall Study|Non-compliance|2|||
126408173|NCT01571453|454787378|FG001|Overall Study|Non-compliance|4|||
126408174|NCT01571453|454787377|FG000|Overall Study|Protocol Violation|1|||
126408175|NCT01571453|454787378|FG001|Overall Study|Protocol Violation|5|||
126408176|NCT01571453|454787377|FG000|Overall Study|Withdrawal of consent|5|||
126408177|NCT01571453|454787378|FG001|Overall Study|Withdrawal of consent|13|||
126408178|NCT01571453|454787377|FG000|Overall Study|Lost to Follow-up|4|||
126408179|NCT01571453|454787378|FG001|Overall Study|Lost to Follow-up|2|||
126408180|NCT01571453|454787377|FG000|Overall Study|Administrative or other reason(s)|4|||
126408181|NCT01571453|454787378|FG001|Overall Study|Administrative or other reason(s)|3|||
126408182|NCT04033068|454787385|FG000|Overall Study|Withdrawal by Subject|0|||
126408183|NCT04033068|454787386|FG001|Overall Study|Withdrawal by Subject|0|||
126408184|NCT04033068|454787387|FG002|Overall Study|Withdrawal by Subject|1|||
126408185|NCT04033068|454787388|FG003|Overall Study|Withdrawal by Subject|0|||
126408186|NCT04033068|454787385|FG000|Overall Study|Lost to Follow-up|0|||
126408187|NCT04033068|454787386|FG001|Overall Study|Lost to Follow-up|1|||
126408188|NCT04033068|454787387|FG002|Overall Study|Lost to Follow-up|0|||
126408189|NCT04033068|454787388|FG003|Overall Study|Lost to Follow-up|0|||
126408190|NCT04033068|454787385|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
126408191|NCT04033068|454787386|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
126408192|NCT04033068|454787387|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
126408193|NCT04033068|454787388|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
126408194|NCT02039856|454787389|FG000|Overall Study|Death|5|||
126408195|NCT02039856|454787390|FG001|Overall Study|Death|3|||
126408196|NCT02039856|454787389|FG000|Overall Study|Partial survey completion|61|||
126408197|NCT02039856|454787390|FG001|Overall Study|Partial survey completion|26|||
126408198|NCT02039856|454787389|FG000|Overall Study|Lost to Follow-up|388|||
126408199|NCT02039856|454787390|FG001|Overall Study|Lost to Follow-up|206|||
126408200|NCT02039856|454787389|FG000|Overall Study|Withdrawal by Subject|1573|||
126408201|NCT02039856|454787390|FG001|Overall Study|Withdrawal by Subject|618|||
126408202|NCT02409342|454787393|FG000|Overall Study|Death|211|||
126408203|NCT02409342|454787394|FG001|Overall Study|Death|201|||
126408204|NCT02409342|454787393|FG000|Overall Study|Withdrawal by Subject|24|||
126408205|NCT02409342|454787394|FG001|Overall Study|Withdrawal by Subject|17|||
126408206|NCT02409342|454787393|FG000|Overall Study|Study Terminated By Sponsor|48|||
126408207|NCT02409342|454787394|FG001|Overall Study|Study Terminated By Sponsor|59|||
126408208|NCT02409342|454787393|FG000|Overall Study|Lost to Follow-up|3|||
126408209|NCT02409342|454787394|FG001|Overall Study|Lost to Follow-up|5|||
126408210|NCT02409342|454787393|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
126408211|NCT02409342|454787394|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
126408212|NCT02409342|454787393|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
126408213|NCT02409342|454787394|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
126408214|NCT02409342|454787393|FG000|Overall Study|Sponsor Decision|1|||
126408215|NCT02409342|454787394|FG001|Overall Study|Sponsor Decision|0|||
126408216|NCT03908970|454787395|FG000|Overall Study|Adverse Event|7|||
126408217|NCT03908970|454787396|FG001|Overall Study|Adverse Event|21|||
126408218|NCT03908970|454787395|FG000|Overall Study|Physician Decision|1|||
126408219|NCT03908970|454787396|FG001|Overall Study|Physician Decision|4|||
126408220|NCT03908970|454787395|FG000|Overall Study|Withdrawal by Subject|9|||
126408221|NCT03908970|454787396|FG001|Overall Study|Withdrawal by Subject|22|||
126408222|NCT04327024|454789719|FG000|Overall Study|Death|1|||
126408223|NCT04327024|454789720|FG001|Overall Study|Death|2|||
126408224|NCT04327024|454789721|FG002|Overall Study|Death|1|||
126408225|NCT04327024|454789719|FG000|Overall Study|Non-compliance with study drug|0|||
126408226|NCT04327024|454789720|FG001|Overall Study|Non-compliance with study drug|1|||
126408227|NCT04327024|454789721|FG002|Overall Study|Non-compliance with study drug|0|||
126408228|NCT04327024|454789719|FG000|Overall Study|Withdrawal by Subject|1|||
126408229|NCT04327024|454789720|FG001|Overall Study|Withdrawal by Subject|1|||
126408230|NCT04327024|454789721|FG002|Overall Study|Withdrawal by Subject|2|||
126408231|NCT01192568|454789725|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
126408232|NCT01192568|454789726|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
126408233|NCT01192568|454789727|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
126408234|NCT01192568|454789728|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
126408235|NCT01192568|454789725|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
126408236|NCT01192568|454789726|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
126408237|NCT01192568|454789727|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
126408238|NCT01192568|454789728|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
126408239|NCT00652951|454789729|FG000|Booster Phase|Adverse event, non-fatal|0|||
126408240|NCT00652951|454789730|FG001|Booster Phase|Adverse event, non-fatal|1|||
126408241|NCT00652951|454789731|FG002|Booster Phase|Adverse event, non-fatal|0|||
126408242|NCT00652951|454789729|FG000|Booster Phase|Other|1|||
126408243|NCT00652951|454789730|FG001|Booster Phase|Other|0|||
126408244|NCT00652951|454789731|FG002|Booster Phase|Other|0|||
126408245|NCT01206582|454789732|FG000|Overall Study|Withdrew prior to study|1|||
126408246|NCT01206582|454789733|FG001|Overall Study|Withdrew prior to study|0|||
126054028|NCT00705406|453492205|FG000|Overall Study|Did not receive study drug|1|||
126054029|NCT00705406|453492206|FG001|Overall Study|Did not receive study drug|2|||
126408247|NCT01206582|454789732|FG000|Overall Study|Discontinued intervention before week 8|1|||
126408248|NCT01206582|454789733|FG001|Overall Study|Discontinued intervention before week 8|2|||
126408249|NCT00387725|454789736|FG000|Overall Study|Adverse Event|0|||
126408250|NCT00387725|454789737|FG001|Overall Study|Adverse Event|0|||
126408251|NCT00387725|454789738|FG002|Overall Study|Adverse Event|0|||
126408252|NCT00387725|454789739|FG003|Overall Study|Adverse Event|1|||
126408253|NCT00387725|454789736|FG000|Overall Study|Protocol Violation|0|||
126408254|NCT00387725|454789737|FG001|Overall Study|Protocol Violation|1|||
126408255|NCT00387725|454789738|FG002|Overall Study|Protocol Violation|0|||
126408256|NCT00387725|454789739|FG003|Overall Study|Protocol Violation|0|||
126408257|NCT00387725|454789736|FG000|Overall Study|Withdrawal by Subject|1|||
126408258|NCT00387725|454789737|FG001|Overall Study|Withdrawal by Subject|0|||
126408259|NCT00387725|454789738|FG002|Overall Study|Withdrawal by Subject|1|||
126408260|NCT00387725|454789739|FG003|Overall Study|Withdrawal by Subject|0|||
126408261|NCT00387725|454789736|FG000|Overall Study|Parent/legal guardian request|0|||
126408262|NCT00387725|454789737|FG001|Overall Study|Parent/legal guardian request|0|||
126408263|NCT00387725|454789738|FG002|Overall Study|Parent/legal guardian request|1|||
126408264|NCT00387725|454789739|FG003|Overall Study|Parent/legal guardian request|1|||
126408265|NCT00568126|454789740|FG000|Overall Study|Adverse Event|3|||
126054030|NCT02357966|453492207|FG000|Overall Study|Death|0|||
126054031|NCT02357966|453492208|FG001|Overall Study|Death|0|||
126054032|NCT02357966|453492209|FG002|Overall Study|Death|1|||
126054033|NCT02357966|453492210|FG003|Overall Study|Death|0|||
126408266|NCT00568126|454789741|FG001|Overall Study|Adverse Event|0|||
126408267|NCT00568126|454789740|FG000|Overall Study|Withdrawal by Subject|2|||
126408268|NCT00568126|454789741|FG001|Overall Study|Withdrawal by Subject|3|||
126408269|NCT00568126|454789740|FG000|Overall Study|Lost to Follow-up|4|||
126408270|NCT00568126|454789741|FG001|Overall Study|Lost to Follow-up|3|||
126408271|NCT00568126|454789740|FG000|Overall Study|Lack of Efficacy|0|||
126408272|NCT00568126|454789741|FG001|Overall Study|Lack of Efficacy|1|||
126408273|NCT00568126|454789740|FG000|Overall Study|Physician Decision|2|||
126408274|NCT00568126|454789741|FG001|Overall Study|Physician Decision|2|||
126408275|NCT02615691|454789742|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
126408276|NCT02615691|454789742|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
126408277|NCT02615691|454789742|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
126408278|NCT02615691|454789742|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
126408279|NCT02017522|454789743|FG000|Overall Study|Withdrawal by Subject|1|||
126408280|NCT01272869|454789744|FG000|Period 2 (14 Days)|Adverse Event|1|||
126408281|NCT01272869|454789745|FG001|Period 2 (14 Days)|Adverse Event|0|||
126408282|NCT00859937|454789747|FG000|Overall Study|Protocol Violation|1|||
126408283|NCT00859937|454789748|FG001|Overall Study|Protocol Violation|0|||
126408284|NCT00615030|454789749|FG000|Period I|Administrative problem|0|||
126408285|NCT00615030|454789750|FG001|Period I|Administrative problem|0|||
126408286|NCT00615030|454789751|FG002|Period I|Administrative problem|0|||
126408287|NCT00615030|454789752|FG003|Period I|Administrative problem|0|||
126408288|NCT00615030|454789753|FG004|Period I|Administrative problem|1|||
126408289|NCT00615030|454789754|FG005|Period I|Administrative problem|0|||
126408290|NCT00615030|454789755|FG006|Period I|Administrative problem|0|||
126408291|NCT00615030|454789756|FG007|Period I|Administrative problem|0|||
126408292|NCT00615030|454789757|FG008|Period I|Administrative problem|0|||
126408293|NCT00615030|454789758|FG009|Period I|Administrative problem|0|||
126408294|NCT00615030|454789759|FG010|Period I|Administrative problem|0|||
126408295|NCT00615030|454789760|FG011|Period I|Administrative problem|0|||
126408296|NCT00615030|454789749|FG000|Period I|Protocol deviation|1|||
126408297|NCT00615030|454789750|FG001|Period I|Protocol deviation|0|||
126408298|NCT00615030|454789751|FG002|Period I|Protocol deviation|0|||
126408299|NCT00615030|454789752|FG003|Period I|Protocol deviation|0|||
126408300|NCT00615030|454789753|FG004|Period I|Protocol deviation|0|||
126408301|NCT00615030|454789754|FG005|Period I|Protocol deviation|0|||
126408302|NCT00615030|454789755|FG006|Period I|Protocol deviation|0|||
126408303|NCT00615030|454789756|FG007|Period I|Protocol deviation|0|||
126408304|NCT00615030|454789757|FG008|Period I|Protocol deviation|0|||
126408305|NCT00615030|454789758|FG009|Period I|Protocol deviation|0|||
126408306|NCT00615030|454789759|FG010|Period I|Protocol deviation|0|||
126408307|NCT00615030|454789760|FG011|Period I|Protocol deviation|0|||
126408308|NCT00615030|454789749|FG000|Period I|Subject withdrew consent|0|||
126408309|NCT00615030|454789750|FG001|Period I|Subject withdrew consent|0|||
126408310|NCT00615030|454789751|FG002|Period I|Subject withdrew consent|0|||
126408311|NCT00615030|454789752|FG003|Period I|Subject withdrew consent|0|||
126408312|NCT00615030|454789753|FG004|Period I|Subject withdrew consent|0|||
126408313|NCT00615030|454789754|FG005|Period I|Subject withdrew consent|0|||
126408314|NCT00615030|454789755|FG006|Period I|Subject withdrew consent|0|||
126408315|NCT00615030|454789756|FG007|Period I|Subject withdrew consent|0|||
126408316|NCT00615030|454789757|FG008|Period I|Subject withdrew consent|1|||
126408317|NCT00615030|454789758|FG009|Period I|Subject withdrew consent|0|||
126408318|NCT00615030|454789759|FG010|Period I|Subject withdrew consent|1|||
126408319|NCT00615030|454789760|FG011|Period I|Subject withdrew consent|1|||
126408320|NCT00615030|454789749|FG000|Period I|Abnormal laboratory value(s)|0|||
126408321|NCT00615030|454789750|FG001|Period I|Abnormal laboratory value(s)|0|||
126408322|NCT00615030|454789751|FG002|Period I|Abnormal laboratory value(s)|0|||
126408323|NCT00615030|454789752|FG003|Period I|Abnormal laboratory value(s)|0|||
126408324|NCT00615030|454789753|FG004|Period I|Abnormal laboratory value(s)|0|||
126408325|NCT00615030|454789754|FG005|Period I|Abnormal laboratory value(s)|1|||
126408326|NCT00615030|454789755|FG006|Period I|Abnormal laboratory value(s)|0|||
126408327|NCT00615030|454789756|FG007|Period I|Abnormal laboratory value(s)|0|||
126408328|NCT00615030|454789757|FG008|Period I|Abnormal laboratory value(s)|0|||
126408329|NCT00615030|454789758|FG009|Period I|Abnormal laboratory value(s)|0|||
126408330|NCT00615030|454789759|FG010|Period I|Abnormal laboratory value(s)|0|||
126408331|NCT00615030|454789760|FG011|Period I|Abnormal laboratory value(s)|0|||
126408332|NCT00615030|454789749|FG000|Period II|Adverse Event|0|||
126408333|NCT00615030|454789750|FG001|Period II|Adverse Event|0|||
126408334|NCT00615030|454789751|FG002|Period II|Adverse Event|1|||
126408335|NCT00615030|454789752|FG003|Period II|Adverse Event|0|||
125890577|NCT00634101|452897170|FG000|Overall Study|Study Terminated|3|||
125890578|NCT00634101|452897171|FG001|Overall Study|Study Terminated|3|||
126408336|NCT00615030|454789753|FG004|Period II|Adverse Event|0|||
126408337|NCT00615030|454789754|FG005|Period II|Adverse Event|0|||
126408338|NCT00615030|454789755|FG006|Period II|Adverse Event|0|||
126408339|NCT00615030|454789756|FG007|Period II|Adverse Event|0|||
126408340|NCT00615030|454789757|FG008|Period II|Adverse Event|1|||
126408341|NCT00615030|454789758|FG009|Period II|Adverse Event|0|||
126408342|NCT00615030|454789759|FG010|Period II|Adverse Event|0|||
126408343|NCT00615030|454789760|FG011|Period II|Adverse Event|0|||
126408344|NCT00615030|454789749|FG000|Period II|Subject withdrew consent|0|||
126408345|NCT00615030|454789750|FG001|Period II|Subject withdrew consent|0|||
126408346|NCT00615030|454789751|FG002|Period II|Subject withdrew consent|0|||
126408347|NCT00615030|454789752|FG003|Period II|Subject withdrew consent|1|||
126408348|NCT00615030|454789753|FG004|Period II|Subject withdrew consent|0|||
126408349|NCT00615030|454789754|FG005|Period II|Subject withdrew consent|0|||
126408350|NCT00615030|454789755|FG006|Period II|Subject withdrew consent|1|||
126408351|NCT00615030|454789756|FG007|Period II|Subject withdrew consent|0|||
126408352|NCT00615030|454789757|FG008|Period II|Subject withdrew consent|0|||
126408353|NCT00615030|454789758|FG009|Period II|Subject withdrew consent|0|||
126408354|NCT00615030|454789759|FG010|Period II|Subject withdrew consent|0|||
125890579|NCT00634101|452897170|FG000|Overall Study|Lost to Follow-up|2|||
125890580|NCT00634101|452897171|FG001|Overall Study|Lost to Follow-up|0|||
125890581|NCT00838513|452897173|FG000|Screening Period|Screen Failure|3|||
126054034|NCT02357966|453492211|FG004|Overall Study|Death|2|||
126054035|NCT02357966|453492212|FG005|Overall Study|Death|0|||
126054036|NCT02357966|453492207|FG000|Overall Study|Physician Decision|1|||
126054037|NCT02357966|453492208|FG001|Overall Study|Physician Decision|0|||
126054038|NCT02357966|453492209|FG002|Overall Study|Physician Decision|0|||
126054039|NCT02357966|453492210|FG003|Overall Study|Physician Decision|0|||
126408355|NCT00615030|454789760|FG011|Period II|Subject withdrew consent|0|||
126408356|NCT00615030|454789749|FG000|Period III|Administrative problems|1|||
126408357|NCT00615030|454789750|FG001|Period III|Administrative problems|0|||
126408358|NCT00615030|454789751|FG002|Period III|Administrative problems|0|||
126408359|NCT00615030|454789752|FG003|Period III|Administrative problems|1|||
126408360|NCT00615030|454789753|FG004|Period III|Administrative problems|0|||
126408361|NCT00615030|454789754|FG005|Period III|Administrative problems|0|||
126408362|NCT00615030|454789755|FG006|Period III|Administrative problems|0|||
126408363|NCT00615030|454789756|FG007|Period III|Administrative problems|0|||
126408364|NCT00615030|454789757|FG008|Period III|Administrative problems|0|||
125890582|NCT00838513|452897173|FG000|Extension Treatment Period|Death|1|||
126054040|NCT02357966|453492211|FG004|Overall Study|Physician Decision|1|||
126054041|NCT02357966|453492212|FG005|Overall Study|Physician Decision|0|||
126408365|NCT00615030|454789758|FG009|Period III|Administrative problems|0|||
126408366|NCT00615030|454789759|FG010|Period III|Administrative problems|0|||
126408367|NCT00615030|454789760|FG011|Period III|Administrative problems|0|||
126408368|NCT00151476|454789761|FG000|FAP Identified Subjects|Protocol Violation|0|||
126408369|NCT00151476|454789762|FG001|FAP Identified Subjects|Protocol Violation|1|||
126408370|NCT00151476|454789761|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
126408371|NCT00151476|454789762|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
126408372|NCT00151476|454789761|FG000|FAP Analyzed Subjects|Other study participation|0|||
126408373|NCT00151476|454789762|FG001|FAP Analyzed Subjects|Other study participation|1|||
126408374|NCT03908476|454789770|FG000|Overall Study|Death|3|||
126408375|NCT03908476|454789771|FG001|Overall Study|Death|0|||
126408376|NCT03908476|454789770|FG000|Overall Study|Lost to Follow-up|3|||
126408377|NCT03908476|454789771|FG001|Overall Study|Lost to Follow-up|1|||
126408378|NCT03908476|454789770|FG000|Overall Study|Withdrawal by Subject|7|||
126408379|NCT03908476|454789771|FG001|Overall Study|Withdrawal by Subject|1|||
126408380|NCT03908476|454789770|FG000|Overall Study|Physician Decision|2|||
126408381|NCT03908476|454789771|FG001|Overall Study|Physician Decision|0|||
126408382|NCT03908476|454789770|FG000|Overall Study|System Explanted and not Replaced|4|||
126408383|NCT03908476|454789771|FG001|Overall Study|System Explanted and not Replaced|0|||
126408384|NCT03908476|454789770|FG000|Overall Study|Intrathecal Pump|1|||
126408385|NCT03908476|454789771|FG001|Overall Study|Intrathecal Pump|0|||
126408386|NCT03908476|454789770|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
126408387|NCT03908476|454789771|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
126408388|NCT05194267|454789772|FG000|Overall Study|Withdrawal by Subject|2|||
126408389|NCT00802893|454789773|FG000|Overall Study|study terminated|3|||
126408390|NCT02868229|454789774|FG000|Overall Study|Adverse Event|1|||
126408391|NCT02868229|454789775|FG001|Overall Study|Adverse Event|0|||
126408392|NCT02868229|454789776|FG002|Overall Study|Adverse Event|0|||
126408393|NCT02868229|454789777|FG003|Overall Study|Adverse Event|1|||
126408394|NCT02868229|454789774|FG000|Overall Study|Death|0|||
126408395|NCT02868229|454789775|FG001|Overall Study|Death|0|||
126408396|NCT02868229|454789776|FG002|Overall Study|Death|1|||
126408397|NCT02868229|454789777|FG003|Overall Study|Death|1|||
126408398|NCT02868229|454789774|FG000|Overall Study|Missed dose|0|||
126408399|NCT02868229|454789775|FG001|Overall Study|Missed dose|0|||
126408400|NCT02868229|454789776|FG002|Overall Study|Missed dose|0|||
126408401|NCT02868229|454789777|FG003|Overall Study|Missed dose|3|||
126408402|NCT06151288|454789778|FG000|Overall Study|Lost to Follow-up|4|||
126408403|NCT06151288|454789779|FG001|Overall Study|Lost to Follow-up|2|||
126408404|NCT06151288|454789780|FG002|Overall Study|Lost to Follow-up|4|||
126408405|NCT06151288|454789781|FG003|Overall Study|Lost to Follow-up|3|||
126408406|NCT06151288|454789778|FG000|Overall Study|Withdrawal by Subject|4|||
126408407|NCT06151288|454789779|FG001|Overall Study|Withdrawal by Subject|5|||
126408408|NCT06151288|454789780|FG002|Overall Study|Withdrawal by Subject|1|||
126408409|NCT06151288|454789781|FG003|Overall Study|Withdrawal by Subject|1|||
126408410|NCT02911142|454789782|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
126408411|NCT02911142|454789782|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
126408412|NCT02911142|454789782|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
126408413|NCT02911142|454789782|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
126408414|NCT02883062|454789783|FG000|Overall Study|Withdrawal by Subject|6|||
126408415|NCT02883062|454789784|FG001|Overall Study|Withdrawal by Subject|0|||
126408416|NCT02888743|454789785|FG000|Overall Study|Withdrawal by Subject|1|||
126408417|NCT02888743|454789786|FG001|Overall Study|Withdrawal by Subject|2|||
126408418|NCT02888743|454789787|FG002|Overall Study|Withdrawal by Subject|2|||
126408419|NCT02888743|454789788|FG003|Overall Study|Withdrawal by Subject|0|||
126408420|NCT02888743|454789789|FG004|Overall Study|Withdrawal by Subject|1|||
126408421|NCT02888743|454789785|FG000|Overall Study|Disease progression before treatment|2|||
126408422|NCT02888743|454789786|FG001|Overall Study|Disease progression before treatment|0|||
126408423|NCT02888743|454789787|FG002|Overall Study|Disease progression before treatment|2|||
126408424|NCT02888743|454789788|FG003|Overall Study|Disease progression before treatment|0|||
126408425|NCT02888743|454789789|FG004|Overall Study|Disease progression before treatment|0|||
126408426|NCT02888743|454789785|FG000|Overall Study|Patient ineligible|1|||
126408427|NCT02888743|454789786|FG001|Overall Study|Patient ineligible|2|||
126408428|NCT02888743|454789787|FG002|Overall Study|Patient ineligible|0|||
126408429|NCT02888743|454789788|FG003|Overall Study|Patient ineligible|0|||
126408430|NCT02888743|454789789|FG004|Overall Study|Patient ineligible|0|||
126408431|NCT04816721|454789790|FG000|Overall Study|Withdrawal by Subject|0|||
126408432|NCT04816721|454789791|FG001|Overall Study|Withdrawal by Subject|2|||
126408433|NCT04816721|454789792|FG002|Overall Study|Withdrawal by Subject|0|||
126408434|NCT04816721|454789793|FG003|Overall Study|Withdrawal by Subject|1|||
126408435|NCT04816721|454789794|FG004|Overall Study|Withdrawal by Subject|1|||
126408436|NCT04816721|454789795|FG005|Overall Study|Withdrawal by Subject|0|||
126408437|NCT04816721|454789796|FG006|Overall Study|Withdrawal by Subject|0|||
126408438|NCT04816721|454789797|FG007|Overall Study|Withdrawal by Subject|0|||
126408439|NCT04816721|454789790|FG000|Overall Study|Miscellaneous|0|||
126408440|NCT04816721|454789791|FG001|Overall Study|Miscellaneous|0|||
126408441|NCT04816721|454789792|FG002|Overall Study|Miscellaneous|0|||
126408442|NCT04816721|454789793|FG003|Overall Study|Miscellaneous|0|||
126408443|NCT04816721|454789794|FG004|Overall Study|Miscellaneous|0|||
126408444|NCT04816721|454789795|FG005|Overall Study|Miscellaneous|1|||
126408445|NCT04816721|454789796|FG006|Overall Study|Miscellaneous|0|||
126408446|NCT04816721|454789797|FG007|Overall Study|Miscellaneous|0|||
126408447|NCT04816721|454789790|FG000|Overall Study|Lost to Follow-up|0|||
126408448|NCT04816721|454789791|FG001|Overall Study|Lost to Follow-up|0|||
126408449|NCT04816721|454789792|FG002|Overall Study|Lost to Follow-up|0|||
126408450|NCT04816721|454789793|FG003|Overall Study|Lost to Follow-up|1|||
126408451|NCT04816721|454789794|FG004|Overall Study|Lost to Follow-up|0|||
126408452|NCT04816721|454789795|FG005|Overall Study|Lost to Follow-up|0|||
126408453|NCT04816721|454789796|FG006|Overall Study|Lost to Follow-up|0|||
126408454|NCT04816721|454789797|FG007|Overall Study|Lost to Follow-up|0|||
126408455|NCT00026312|454789798|FG000|Overall Study|Adverse Event|0|||
126408456|NCT00026312|454789799|FG001|Overall Study|Adverse Event|32|||
126408457|NCT00026312|454789798|FG000|Overall Study|Death|1|||
126408458|NCT00026312|454789799|FG001|Overall Study|Death|7|||
126408459|NCT00026312|454789798|FG000|Overall Study|Lack of Efficacy|19|||
126408460|NCT00026312|454789799|FG001|Overall Study|Lack of Efficacy|114|||
126408461|NCT00026312|454789798|FG000|Overall Study|Lost to Follow-up|0|||
126408462|NCT00026312|454789799|FG001|Overall Study|Lost to Follow-up|5|||
126408463|NCT00026312|454789798|FG000|Overall Study|Physician Decision|1|||
126408464|NCT00026312|454789799|FG001|Overall Study|Physician Decision|37|||
126408465|NCT00026312|454789798|FG000|Overall Study|Protocol Violation|0|||
126408466|NCT00026312|454789799|FG001|Overall Study|Protocol Violation|3|||
126408467|NCT00026312|454789798|FG000|Overall Study|Withdrawal by Subject|1|||
126408468|NCT00026312|454789799|FG001|Overall Study|Withdrawal by Subject|6|||
126408469|NCT00026312|454789798|FG000|Overall Study|Ineligible|4|||
126408470|NCT00026312|454789799|FG001|Overall Study|Ineligible|5|||
126408471|NCT00026312|454789798|FG000|Overall Study|Entry onto another COG study|0|||
126408472|NCT00026312|454789799|FG001|Overall Study|Entry onto another COG study|1|||
126408473|NCT00026312|454789798|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
126408474|NCT00026312|454789799|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
126408475|NCT01638546|454789800|FG000|Overall Study|Adverse Event|1|||
126408476|NCT01638546|454789801|FG001|Overall Study|Adverse Event|3|||
126408477|NCT03194438|454789804|FG000|Overall Study|Withdrawal by Subject|2|||
126408478|NCT02250664|454789811|FG000|Overall Study|Lost to Follow-up|18|||
126408479|NCT02250664|454789812|FG001|Overall Study|Lost to Follow-up|28|||
126408480|NCT02250664|454789813|FG002|Overall Study|Lost to Follow-up|33|||
126408481|NCT02250664|454789811|FG000|Overall Study|Personal Reasons|7|||
126408482|NCT02250664|454789812|FG001|Overall Study|Personal Reasons|8|||
126408483|NCT02250664|454789813|FG002|Overall Study|Personal Reasons|14|||
126408484|NCT02250664|454789811|FG000|Overall Study|Adverse Event|6|||
126408485|NCT02250664|454789812|FG001|Overall Study|Adverse Event|3|||
126408486|NCT02250664|454789813|FG002|Overall Study|Adverse Event|8|||
126408487|NCT02250664|454789811|FG000|Overall Study|Incarcerated|2|||
126408488|NCT02250664|454789812|FG001|Overall Study|Incarcerated|1|||
126054042|NCT03732807|453492213|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
126054043|NCT03732807|453492214|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
126054044|NCT03732807|453492215|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
126054045|NCT03732807|453492216|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
126408489|NCT02250664|454789813|FG002|Overall Study|Incarcerated|2|||
126408490|NCT02250664|454789811|FG000|Overall Study|Withdrawal by Subject|0|||
126408491|NCT02250664|454789812|FG001|Overall Study|Withdrawal by Subject|1|||
126408492|NCT02250664|454789813|FG002|Overall Study|Withdrawal by Subject|2|||
126408493|NCT02250664|454789811|FG000|Overall Study|Death|0|||
126408494|NCT02250664|454789812|FG001|Overall Study|Death|1|||
126408495|NCT02250664|454789813|FG002|Overall Study|Death|1|||
126408496|NCT02250664|454789811|FG000|Overall Study|Physician Decision|1|||
126408497|NCT02250664|454789812|FG001|Overall Study|Physician Decision|3|||
126408498|NCT02250664|454789813|FG002|Overall Study|Physician Decision|1|||
126408499|NCT02250664|454789811|FG000|Overall Study|Protocol Violation|1|||
126408500|NCT02250664|454789812|FG001|Overall Study|Protocol Violation|0|||
126408501|NCT02250664|454789813|FG002|Overall Study|Protocol Violation|1|||
126408502|NCT02250664|454789811|FG000|Overall Study|Reason unknown|1|||
126408503|NCT02250664|454789812|FG001|Overall Study|Reason unknown|0|||
126408504|NCT02250664|454789813|FG002|Overall Study|Reason unknown|0|||
126408505|NCT03847909|454789814|FG000|Overall Study|Withdrawal by Subject|1|||
126408506|NCT03847909|454789815|FG001|Overall Study|Withdrawal by Subject|1|||
126408507|NCT00117793|454789816|FG000|Overall Study|Withdrawal by Subject|12|||
126408508|NCT04268173|454789817|FG000|Overall Study|Lost to Follow-up|75|||
126408509|NCT04268173|454789818|FG001|Overall Study|Lost to Follow-up|108|||
126408510|NCT00975143|454789819|FG000|Overall Study|Adverse Event|19|||
126408511|NCT00975143|454789820|FG001|Overall Study|Adverse Event|15|||
126408512|NCT00975143|454789819|FG000|Overall Study|Withdrawal by Subject|15|||
126408513|NCT00975143|454789820|FG001|Overall Study|Withdrawal by Subject|15|||
126408514|NCT00975143|454789819|FG000|Overall Study|Lost to Follow-up|20|||
126408515|NCT00975143|454789820|FG001|Overall Study|Lost to Follow-up|16|||
126408516|NCT00975143|454789819|FG000|Overall Study|Non-compliance|5|||
126408517|NCT00975143|454789820|FG001|Overall Study|Non-compliance|8|||
126408518|NCT00975143|454789819|FG000|Overall Study|Physician Decision|1|||
126408519|NCT00975143|454789820|FG001|Overall Study|Physician Decision|2|||
126408520|NCT00975143|454789819|FG000|Overall Study|Details not available|10|||
126408521|NCT00975143|454789820|FG001|Overall Study|Details not available|4|||
126408522|NCT01375608|454789821|FG000|Overall Study|Withdrawal by Subject|2|||
126408523|NCT00545103|454789822|FG000|Overall Study|Lack of Efficacy|48|||
126408524|NCT00545103|454789823|FG001|Overall Study|Lack of Efficacy|45|||
126408525|NCT00545103|454789824|FG002|Overall Study|Lack of Efficacy|31|||
126408526|NCT00545103|454789825|FG003|Overall Study|Lack of Efficacy|27|||
126408527|NCT00545103|454789822|FG000|Overall Study|Withdrawal by Subject|6|||
126408528|NCT00545103|454789823|FG001|Overall Study|Withdrawal by Subject|10|||
126408529|NCT00545103|454789824|FG002|Overall Study|Withdrawal by Subject|18|||
126054046|NCT03732807|453492217|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
126408530|NCT00545103|454789825|FG003|Overall Study|Withdrawal by Subject|22|||
126408531|NCT00545103|454789822|FG000|Overall Study|Adverse Event|11|||
126408532|NCT00545103|454789823|FG001|Overall Study|Adverse Event|12|||
126408533|NCT00545103|454789824|FG002|Overall Study|Adverse Event|17|||
126408534|NCT00545103|454789825|FG003|Overall Study|Adverse Event|10|||
126408535|NCT00545103|454789822|FG000|Overall Study|Lost to Follow-up|4|||
126408536|NCT00545103|454789823|FG001|Overall Study|Lost to Follow-up|6|||
126408537|NCT00545103|454789824|FG002|Overall Study|Lost to Follow-up|3|||
126408538|NCT00545103|454789825|FG003|Overall Study|Lost to Follow-up|4|||
126408539|NCT00545103|454789822|FG000|Overall Study|Protocol Violation|1|||
126408540|NCT00545103|454789823|FG001|Overall Study|Protocol Violation|2|||
126054047|NCT03732807|453492218|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
126408541|NCT00545103|454789824|FG002|Overall Study|Protocol Violation|3|||
126408542|NCT00545103|454789825|FG003|Overall Study|Protocol Violation|0|||
126408543|NCT00545103|454789822|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
126408544|NCT00545103|454789823|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
126408545|NCT00545103|454789824|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
126408546|NCT00545103|454789825|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
126408547|NCT00545103|454789822|FG000|Overall Study|Difficult to open package|0|||
126408548|NCT00545103|454789823|FG001|Overall Study|Difficult to open package|0|||
126408549|NCT00545103|454789824|FG002|Overall Study|Difficult to open package|0|||
126408550|NCT00545103|454789825|FG003|Overall Study|Difficult to open package|1|||
126408551|NCT00545103|454789822|FG000|Overall Study|Investigational product not taken|1|||
126408552|NCT00545103|454789823|FG001|Overall Study|Investigational product not taken|0|||
126408553|NCT00545103|454789824|FG002|Overall Study|Investigational product not taken|0|||
126408554|NCT00545103|454789825|FG003|Overall Study|Investigational product not taken|1|||
126408555|NCT00545103|454789822|FG000|Overall Study|Wish to start a family|0|||
126408556|NCT00545103|454789823|FG001|Overall Study|Wish to start a family|0|||
126408557|NCT00545103|454789824|FG002|Overall Study|Wish to start a family|0|||
126408558|NCT00545103|454789825|FG003|Overall Study|Wish to start a family|1|||
126408559|NCT00545103|454789822|FG000|Overall Study|Diverticulitis crisis|0|||
126408560|NCT00545103|454789823|FG001|Overall Study|Diverticulitis crisis|0|||
126408561|NCT00545103|454789824|FG002|Overall Study|Diverticulitis crisis|0|||
126408562|NCT00545103|454789825|FG003|Overall Study|Diverticulitis crisis|1|||
126408563|NCT00545103|454789822|FG000|Overall Study|Personal reasons|1|||
126408564|NCT00545103|454789823|FG001|Overall Study|Personal reasons|0|||
126408565|NCT00545103|454789824|FG002|Overall Study|Personal reasons|0|||
126408566|NCT00545103|454789825|FG003|Overall Study|Personal reasons|0|||
126408567|NCT00545103|454789822|FG000|Overall Study|Subject's decision|1|||
126408568|NCT00545103|454789823|FG001|Overall Study|Subject's decision|0|||
126408569|NCT00545103|454789824|FG002|Overall Study|Subject's decision|0|||
126408570|NCT00545103|454789825|FG003|Overall Study|Subject's decision|0|||
126408571|NCT00545103|454789822|FG000|Overall Study|Noncompliance|0|||
126408572|NCT00545103|454789823|FG001|Overall Study|Noncompliance|1|||
126408573|NCT00545103|454789824|FG002|Overall Study|Noncompliance|0|||
126408574|NCT00545103|454789825|FG003|Overall Study|Noncompliance|0|||
126408575|NCT00545103|454789822|FG000|Overall Study|Investigator decision|0|||
126408576|NCT00545103|454789823|FG001|Overall Study|Investigator decision|0|||
126408577|NCT00545103|454789824|FG002|Overall Study|Investigator decision|1|||
126408578|NCT00545103|454789825|FG003|Overall Study|Investigator decision|0|||
126408579|NCT00545103|454789822|FG000|Overall Study|Subject moved|0|||
126408580|NCT00545103|454789823|FG001|Overall Study|Subject moved|1|||
126408581|NCT00545103|454789824|FG002|Overall Study|Subject moved|0|||
126408582|NCT00545103|454789825|FG003|Overall Study|Subject moved|0|||
126408583|NCT00545103|454789822|FG000|Overall Study|Use of prohibited medication|0|||
126408584|NCT00545103|454789823|FG001|Overall Study|Use of prohibited medication|0|||
126408585|NCT00545103|454789824|FG002|Overall Study|Use of prohibited medication|1|||
126408586|NCT00545103|454789825|FG003|Overall Study|Use of prohibited medication|0|||
126408587|NCT00545103|454789822|FG000|Overall Study|Does not want to take study drug anymore|1|||
126408588|NCT00545103|454789823|FG001|Overall Study|Does not want to take study drug anymore|0|||
126408589|NCT00545103|454789824|FG002|Overall Study|Does not want to take study drug anymore|1|||
126408590|NCT00545103|454789825|FG003|Overall Study|Does not want to take study drug anymore|0|||
126408591|NCT00545103|454789822|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
126408592|NCT00545103|454789823|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
126408593|NCT00545103|454789824|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
126408594|NCT00545103|454789825|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
126408595|NCT00545103|454789822|FG000|Overall Study|Death|0|||
126408596|NCT00545103|454789823|FG001|Overall Study|Death|1|||
126408597|NCT00545103|454789824|FG002|Overall Study|Death|0|||
126408598|NCT00545103|454789825|FG003|Overall Study|Death|0|||
126408599|NCT01953913|454789826|FG000|Overall Study|Disease Progression|349|||
126408600|NCT01953913|454789826|FG000|Overall Study|Worsening of underlying cancer|22|||
126408601|NCT01953913|454789826|FG000|Overall Study|Adverse Event|20|||
126408602|NCT01953913|454789826|FG000|Overall Study|Protocol Violation|6|||
126408603|NCT01953913|454789826|FG000|Overall Study|Lost to Follow-up|4|||
126408604|NCT01953913|454789826|FG000|Overall Study|Withdrawal by Subject|32|||
126408605|NCT01953913|454789826|FG000|Overall Study|Other than listed|108|||
126408606|NCT01953913|454789826|FG000|Overall Study|Not Treated|1|||
126408607|NCT00082381|454789827|FG000|Overall Study|Adverse Event|27|||
126408608|NCT00082381|454789828|FG001|Overall Study|Adverse Event|2|||
126408609|NCT00082381|454789827|FG000|Overall Study|Lost to Follow-up|5|||
126408610|NCT00082381|454789828|FG001|Overall Study|Lost to Follow-up|7|||
126408611|NCT00082381|454789827|FG000|Overall Study|Patient Decision|8|||
126408612|NCT00082381|454789828|FG001|Overall Study|Patient Decision|4|||
126408613|NCT00082381|454789827|FG000|Overall Study|Physician Decision|1|||
126408614|NCT00082381|454789828|FG001|Overall Study|Physician Decision|2|||
126408615|NCT00082381|454789827|FG000|Overall Study|Protocol Violation|10|||
126408616|NCT00082381|454789828|FG001|Overall Study|Protocol Violation|11|||
126408617|NCT00082381|454789827|FG000|Overall Study|Loss of Glucose Control|4|||
126408618|NCT00082381|454789828|FG001|Overall Study|Loss of Glucose Control|0|||
126408619|NCT02049138|454789829|FG000|Overall Study|Adverse Event|46|||
126408620|NCT02049138|454789830|FG001|Overall Study|Adverse Event|25|||
126408621|NCT02049138|454789831|FG002|Overall Study|Adverse Event|1|||
126408622|NCT02049138|454789829|FG000|Overall Study|Withdrawal by Subject|57|||
126408623|NCT02049138|454789830|FG001|Overall Study|Withdrawal by Subject|21|||
126408624|NCT02049138|454789831|FG002|Overall Study|Withdrawal by Subject|5|||
126408625|NCT02049138|454789829|FG000|Overall Study|Lost to Follow-up|18|||
126408626|NCT02049138|454789830|FG001|Overall Study|Lost to Follow-up|5|||
126408627|NCT02049138|454789831|FG002|Overall Study|Lost to Follow-up|1|||
126408628|NCT02049138|454789829|FG000|Overall Study|Lack of Efficacy|10|||
126408629|NCT02049138|454789830|FG001|Overall Study|Lack of Efficacy|26|||
126408630|NCT02049138|454789831|FG002|Overall Study|Lack of Efficacy|1|||
126408631|NCT02049138|454789829|FG000|Overall Study|Non-Compliance|15|||
126408632|NCT02049138|454789830|FG001|Overall Study|Non-Compliance|6|||
126408633|NCT02049138|454789831|FG002|Overall Study|Non-Compliance|0|||
126408634|NCT02049138|454789829|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
126408635|NCT02049138|454789830|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
126408636|NCT02049138|454789831|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
126408637|NCT02049138|454789829|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
126408638|NCT02049138|454789830|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126408639|NCT02049138|454789831|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126408640|NCT02049138|454789829|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
126408641|NCT02049138|454789830|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
126408642|NCT02049138|454789831|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
126408643|NCT02049138|454789829|FG000|Overall Study|Other|15|||
126408644|NCT02049138|454789830|FG001|Overall Study|Other|13|||
126408645|NCT02049138|454789831|FG002|Overall Study|Other|0|||
126408646|NCT02049138|454789829|FG000|Overall Study|Missing|0|||
126408647|NCT02049138|454789830|FG001|Overall Study|Missing|1|||
126408648|NCT02049138|454789831|FG002|Overall Study|Missing|0|||
126408649|NCT00109577|454789832|FG000|Overall Study|Withdrawal by Subject|3|||
126408650|NCT00109577|454789833|FG001|Overall Study|Withdrawal by Subject|3|||
126408651|NCT00884832|454789834|FG000|Overall Study|Withdrawal by Subject|0|||
126408652|NCT00884832|454789835|FG001|Overall Study|Withdrawal by Subject|1|||
126408653|NCT02096263|454789836|FG000|Overall Study|Adverse Event|1|||
126408654|NCT02096263|454789837|FG001|Overall Study|Adverse Event|0|||
126408655|NCT02096263|454789838|FG002|Overall Study|Adverse Event|1|||
126408656|NCT02096263|454789836|FG000|Overall Study|Lost to Follow-up|14|||
126408657|NCT02096263|454789837|FG001|Overall Study|Lost to Follow-up|18|||
126408658|NCT02096263|454789838|FG002|Overall Study|Lost to Follow-up|15|||
126408659|NCT02096263|454789836|FG000|Overall Study|Other|7|||
126408660|NCT02096263|454789837|FG001|Overall Study|Other|9|||
126408661|NCT02096263|454789838|FG002|Overall Study|Other|6|||
126408662|NCT02096263|454789836|FG000|Overall Study|Sponsor study termination|0|||
126408663|NCT02096263|454789837|FG001|Overall Study|Sponsor study termination|0|||
126408664|NCT02096263|454789838|FG002|Overall Study|Sponsor study termination|1|||
126408665|NCT02096263|454789836|FG000|Overall Study|Protocol Violation|7|||
126408666|NCT02096263|454789837|FG001|Overall Study|Protocol Violation|2|||
126408667|NCT02096263|454789838|FG002|Overall Study|Protocol Violation|8|||
126408668|NCT02096263|454789836|FG000|Overall Study|Withdrawal by Subject|5|||
126408669|NCT02096263|454789837|FG001|Overall Study|Withdrawal by Subject|7|||
126408670|NCT02096263|454789838|FG002|Overall Study|Withdrawal by Subject|8|||
126408671|NCT03322423|454789839|FG000|Period 1|Subject no longer eligible|0|||
126408672|NCT03322423|454789840|FG001|Period 1|Subject no longer eligible|1|||
126408673|NCT03322423|454789839|FG000|Period 1|Withdrawal by Subject|0|||
126408674|NCT03322423|454789840|FG001|Period 1|Withdrawal by Subject|1|||
126408675|NCT03322423|454789839|FG000|Period 1|Incorrect Lens Dispensed|1|||
126408676|NCT03322423|454789840|FG001|Period 1|Incorrect Lens Dispensed|0|||
126408677|NCT03322423|454789839|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
126408678|NCT03322423|454789840|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
126408679|NCT03322423|454789839|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
126408680|NCT03322423|454789840|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
126408681|NCT03322423|454789839|FG000|Period 2|Protocol Violation|1|||
126408682|NCT03322423|454789840|FG001|Period 2|Protocol Violation|0|||
126408683|NCT03322423|454789839|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
126408684|NCT03322423|454789840|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
126408685|NCT02337725|454789841|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
126408686|NCT02337725|454789842|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
126408687|NCT02337725|454789841|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
126408688|NCT02337725|454789842|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
126408689|NCT02337725|454789841|FG000|Overall Study|Major Protocol Deviation|0|||
126408690|NCT02337725|454789842|FG001|Overall Study|Major Protocol Deviation|1|||
126408691|NCT02337725|454789841|FG000|Overall Study|Voluntary Withdrawal|14|||
126408692|NCT02337725|454789842|FG001|Overall Study|Voluntary Withdrawal|3|||
126408693|NCT02337725|454789841|FG000|Overall Study|Lack of Efficacy|4|||
126408694|NCT02337725|454789842|FG001|Overall Study|Lack of Efficacy|0|||
126408695|NCT02453555|454789843|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
126408696|NCT02453555|454789844|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
126408697|NCT02453555|454789845|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
126408698|NCT02453555|454789846|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
126408699|NCT02453555|454789847|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
126408700|NCT02453555|454789848|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
126408701|NCT02453555|454789843|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
126408702|NCT02453555|454789844|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408703|NCT02453555|454789845|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408704|NCT02453555|454789846|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408705|NCT02453555|454789847|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408706|NCT02453555|454789848|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408707|NCT02453555|454789843|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
126408708|NCT02453555|454789844|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
126408709|NCT02453555|454789845|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126408710|NCT02453555|454789846|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126408711|NCT02453555|454789847|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126408712|NCT02453555|454789848|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126408713|NCT02453555|454789843|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
126408714|NCT02453555|454789844|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
126408715|NCT02453555|454789845|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
126408716|NCT02453555|454789846|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
126408717|NCT02453555|454789847|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
126408718|NCT02453555|454789848|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
126408719|NCT02453555|454789843|FG000|Extension Period|Adverse Event|0|||
126408720|NCT02453555|454789844|FG001|Extension Period|Adverse Event|0|||
126408721|NCT02453555|454789845|FG002|Extension Period|Adverse Event|1|||
126408722|NCT02453555|454789846|FG003|Extension Period|Adverse Event|2|||
126408723|NCT02453555|454789847|FG004|Extension Period|Adverse Event|1|||
126408724|NCT02453555|454789848|FG005|Extension Period|Adverse Event|1|||
126408725|NCT02453555|454789843|FG000|Extension Period|Protocol Violation|0|||
126408726|NCT02453555|454789844|FG001|Extension Period|Protocol Violation|0|||
126408727|NCT02453555|454789845|FG002|Extension Period|Protocol Violation|1|||
126408728|NCT02453555|454789846|FG003|Extension Period|Protocol Violation|0|||
126408729|NCT02453555|454789847|FG004|Extension Period|Protocol Violation|0|||
126408730|NCT02453555|454789848|FG005|Extension Period|Protocol Violation|0|||
126408731|NCT02453555|454789843|FG000|Extension Period|Withdrawal by Subject|0|||
126408732|NCT02453555|454789844|FG001|Extension Period|Withdrawal by Subject|0|||
126408733|NCT02453555|454789845|FG002|Extension Period|Withdrawal by Subject|1|||
126408734|NCT02453555|454789846|FG003|Extension Period|Withdrawal by Subject|0|||
126408735|NCT02453555|454789847|FG004|Extension Period|Withdrawal by Subject|0|||
126408736|NCT02453555|454789848|FG005|Extension Period|Withdrawal by Subject|0|||
126408737|NCT00500760|454789849|FG000|Overall Study|Death|32|||
126408738|NCT00500760|454789850|FG001|Overall Study|Death|15|||
126408739|NCT00500760|454789849|FG000|Overall Study|Withdrawal by Subject|5|||
126408740|NCT00500760|454789850|FG001|Overall Study|Withdrawal by Subject|7|||
126408741|NCT00500760|454789849|FG000|Overall Study|Administrative decision|2|||
126408742|NCT00500760|454789850|FG001|Overall Study|Administrative decision|0|||
126408743|NCT00500760|454789849|FG000|Overall Study|Lost to Follow-up|3|||
126408744|NCT00500760|454789850|FG001|Overall Study|Lost to Follow-up|0|||
126408745|NCT00500760|454789849|FG000|Overall Study|Other|1|||
126408746|NCT00500760|454789850|FG001|Overall Study|Other|2|||
126408747|NCT00129961|454789852|FG000|Overall Study|Adverse Event|1|||
126408748|NCT00129961|454789853|FG001|Overall Study|Adverse Event|0|||
126408749|NCT00129961|454789852|FG000|Overall Study|Death|1|||
126408750|NCT00129961|454789853|FG001|Overall Study|Death|1|||
126408751|NCT00129961|454789852|FG000|Overall Study|Withdrawal by Sponsor|14|||
126408752|NCT00129961|454789853|FG001|Overall Study|Withdrawal by Sponsor|20|||
126408753|NCT00129961|454789852|FG000|Overall Study|Physician Decision|1|||
126408754|NCT00129961|454789853|FG001|Overall Study|Physician Decision|0|||
126408755|NCT00129961|454789852|FG000|Overall Study|Withdrawal by Subject|2|||
126408756|NCT00129961|454789853|FG001|Overall Study|Withdrawal by Subject|1|||
126408757|NCT00129961|454789852|FG000|Overall Study|Missing Record|0|||
126408758|NCT00129961|454789853|FG001|Overall Study|Missing Record|1|||
126408759|NCT03178669|454789854|FG000|Overall Study|Adverse Event|4|||
126408760|NCT03178669|454789855|FG001|Overall Study|Adverse Event|1|||
126408761|NCT03178669|454789856|FG002|Overall Study|Adverse Event|4|||
126408762|NCT03178669|454789857|FG003|Overall Study|Adverse Event|2|||
126408763|NCT03178669|454789858|FG004|Overall Study|Adverse Event|2|||
126408764|NCT03178669|454789854|FG000|Overall Study|Lack of Efficacy|0|||
126408765|NCT03178669|454789855|FG001|Overall Study|Lack of Efficacy|0|||
126408766|NCT03178669|454789856|FG002|Overall Study|Lack of Efficacy|2|||
126408767|NCT03178669|454789857|FG003|Overall Study|Lack of Efficacy|0|||
126408768|NCT03178669|454789858|FG004|Overall Study|Lack of Efficacy|1|||
126408769|NCT03178669|454789854|FG000|Overall Study|Physician Decision|0|||
126408770|NCT03178669|454789855|FG001|Overall Study|Physician Decision|0|||
126408771|NCT03178669|454789856|FG002|Overall Study|Physician Decision|0|||
126408772|NCT03178669|454789857|FG003|Overall Study|Physician Decision|0|||
126408773|NCT03178669|454789858|FG004|Overall Study|Physician Decision|1|||
126408774|NCT03178669|454789854|FG000|Overall Study|Withdrawal by Subject|1|||
126408775|NCT03178669|454789855|FG001|Overall Study|Withdrawal by Subject|0|||
126408776|NCT03178669|454789856|FG002|Overall Study|Withdrawal by Subject|1|||
126408777|NCT03178669|454789857|FG003|Overall Study|Withdrawal by Subject|1|||
126408778|NCT03178669|454789858|FG004|Overall Study|Withdrawal by Subject|0|||
126408779|NCT03178669|454789854|FG000|Overall Study|Lost to Follow-up|0|||
126408780|NCT03178669|454789855|FG001|Overall Study|Lost to Follow-up|0|||
126408781|NCT03178669|454789856|FG002|Overall Study|Lost to Follow-up|0|||
126408782|NCT03178669|454789857|FG003|Overall Study|Lost to Follow-up|1|||
126408783|NCT03178669|454789858|FG004|Overall Study|Lost to Follow-up|0|||
126408784|NCT01600092|454789859|FG000|Overall Study|Adverse Event|2|||
126408785|NCT01600092|454789860|FG001|Overall Study|Adverse Event|0|||
126408786|NCT01600092|454789859|FG000|Overall Study|Lost to Follow-up|4|||
126408787|NCT01600092|454789860|FG001|Overall Study|Lost to Follow-up|6|||
126408788|NCT01600092|454789859|FG000|Overall Study|Withdrawal by parent/guardian|8|||
126408789|NCT01600092|454789860|FG001|Overall Study|Withdrawal by parent/guardian|6|||
126408790|NCT01600092|454789859|FG000|Overall Study|Physician Decision|1|||
126408791|NCT01600092|454789860|FG001|Overall Study|Physician Decision|1|||
126408792|NCT01600092|454789859|FG000|Overall Study|Randomized but not vaccinated|3|||
126408793|NCT01600092|454789860|FG001|Overall Study|Randomized but not vaccinated|3|||
126408794|NCT00079677|454789861|FG000|Overall Study|Adverse Event|5|||
126408795|NCT00079677|454789862|FG001|Overall Study|Adverse Event|6|||
126408796|NCT00079677|454789861|FG000|Overall Study|Lack of Efficacy|1|||
126408797|NCT00079677|454789862|FG001|Overall Study|Lack of Efficacy|0|||
126408798|NCT00079677|454789861|FG000|Overall Study|Lost to Follow-up|2|||
126408799|NCT00079677|454789862|FG001|Overall Study|Lost to Follow-up|2|||
126408800|NCT00079677|454789861|FG000|Overall Study|Physician Decision|3|||
126408801|NCT00079677|454789862|FG001|Overall Study|Physician Decision|0|||
126408802|NCT00079677|454789861|FG000|Overall Study|Protocol Violation|2|||
126408803|NCT00079677|454789862|FG001|Overall Study|Protocol Violation|3|||
126408804|NCT00079677|454789861|FG000|Overall Study|Withdrawal by Subject|5|||
126408805|NCT00079677|454789862|FG001|Overall Study|Withdrawal by Subject|3|||
126408806|NCT00079677|454789861|FG000|Overall Study|Miscellaneous|2|||
126408807|NCT00079677|454789862|FG001|Overall Study|Miscellaneous|0|||
126408808|NCT00565136|454789863|FG000|Overall Study|Lost to Follow-up|1|||
126408809|NCT00565136|454789863|FG000|Overall Study|Withdrawal by Subject|1|||
126408810|NCT00565136|454789863|FG000|Overall Study|Protocol Violation|1|||
126408811|NCT04284774|454789865|FG000|Overall Study|Progressive disease|5|||
126408812|NCT01270256|454789866|FG000|Overall Study|Withdrawal by Subject|1|||
126408813|NCT01270256|454789867|FG001|Overall Study|Withdrawal by Subject|0|||
126408814|NCT02879578|454789868|FG000|Overall Study|Adverse Event|1|||
126408815|NCT02879578|454789869|FG001|Overall Study|Adverse Event|2|||
126408816|NCT02879578|454789870|FG002|Overall Study|Adverse Event|14|||
126408817|NCT02879578|454789868|FG000|Overall Study|Protocol Violation|0|||
126408818|NCT02879578|454789869|FG001|Overall Study|Protocol Violation|1|||
126408819|NCT02879578|454789870|FG002|Overall Study|Protocol Violation|1|||
126408820|NCT02879578|454789868|FG000|Overall Study|Withdrawal by Subject|8|||
126408821|NCT02879578|454789869|FG001|Overall Study|Withdrawal by Subject|6|||
126408822|NCT02879578|454789870|FG002|Overall Study|Withdrawal by Subject|9|||
126408823|NCT02879578|454789868|FG000|Overall Study|Lost to Follow-up|1|||
126408824|NCT02879578|454789869|FG001|Overall Study|Lost to Follow-up|0|||
126408825|NCT02879578|454789870|FG002|Overall Study|Lost to Follow-up|4|||
126408826|NCT02879578|454789868|FG000|Overall Study|Physician Decision|0|||
126408827|NCT02879578|454789869|FG001|Overall Study|Physician Decision|0|||
126408828|NCT02879578|454789870|FG002|Overall Study|Physician Decision|4|||
126408829|NCT02925728|454789876|FG000|Overall Study|Death|3|||
126408830|NCT02925728|454789877|FG001|Overall Study|Death|5|||
126408831|NCT02925728|454789876|FG000|Overall Study|Physician Decision|1|||
126408832|NCT02925728|454789877|FG001|Overall Study|Physician Decision|0|||
126408833|NCT02925728|454789876|FG000|Overall Study|Withdrawal by Subject|1|||
126408834|NCT02925728|454789877|FG001|Overall Study|Withdrawal by Subject|0|||
126408835|NCT05098509|454789878|FG000|Overall Study|Withdrawal by Subject|0|||
126408836|NCT05098509|454789879|FG001|Overall Study|Withdrawal by Subject|0|||
126408837|NCT05098509|454789880|FG002|Overall Study|Withdrawal by Subject|1|||
126408838|NCT05098509|454789881|FG003|Overall Study|Withdrawal by Subject|0|||
126408839|NCT05098509|454789878|FG000|Overall Study|Early study termination|1|||
126408840|NCT05098509|454789879|FG001|Overall Study|Early study termination|1|||
126408841|NCT05098509|454789880|FG002|Overall Study|Early study termination|1|||
126408842|NCT05098509|454789881|FG003|Overall Study|Early study termination|0|||
126408843|NCT02986854|454789883|FG000|Overall Study|Withdrawal by Subject|0|||
126408844|NCT02986854|454789884|FG001|Overall Study|Withdrawal by Subject|1|||
126408845|NCT02986854|454789885|FG002|Overall Study|Withdrawal by Subject|1|||
126408846|NCT02986854|454789883|FG000|Overall Study|Lost to Follow-up|3|||
126408847|NCT02986854|454789884|FG001|Overall Study|Lost to Follow-up|11|||
126408848|NCT02986854|454789885|FG002|Overall Study|Lost to Follow-up|2|||
126408849|NCT00324233|454789886|FG000|First Period|unable to insert catheter|1|||
126408850|NCT00324233|454789887|FG001|First Period|unable to insert catheter|0|||
126408851|NCT00324233|454789886|FG000|Second Period|unable to insert catheter|1|||
126408852|NCT00324233|454789887|FG001|Second Period|unable to insert catheter|1|||
126408853|NCT00324233|454789886|FG000|Second Period|Protocol Violation|4|||
126408854|NCT00324233|454789887|FG001|Second Period|Protocol Violation|6|||
126408855|NCT00086411|454789899|FG000|Overall Study|Lost to Follow-up|11|||
126408856|NCT00086411|454789900|FG001|Overall Study|Lost to Follow-up|11|||
126408857|NCT00086411|454789901|FG002|Overall Study|Lost to Follow-up|13|||
126408858|NCT00086411|454789902|FG003|Overall Study|Lost to Follow-up|12|||
126408859|NCT01740401|454791683|FG000|Overall Study|Progression of disease|6|||
126408860|NCT01740401|454791683|FG000|Overall Study|Adverse Event|2|||
126408861|NCT01740401|454791683|FG000|Overall Study|Did not reach primary endpoint|2|||
126408862|NCT03667690|454791684|FG000|Overall Study|Adverse Event|0|||
126408863|NCT03667690|454791685|FG001|Overall Study|Adverse Event|3|||
126408864|NCT03667690|454791684|FG000|Overall Study|Death|22|||
126408865|NCT03667690|454791685|FG001|Overall Study|Death|21|||
126408866|NCT03667690|454791684|FG000|Overall Study|Lost to Follow-up|4|||
126408867|NCT03667690|454791685|FG001|Overall Study|Lost to Follow-up|5|||
126408868|NCT03667690|454791684|FG000|Overall Study|Withdrawal by Subject|7|||
126408869|NCT03667690|454791685|FG001|Overall Study|Withdrawal by Subject|8|||
126408870|NCT03667690|454791684|FG000|Overall Study|Subject could not return for additional investigational product|1|||
126408871|NCT03667690|454791685|FG001|Overall Study|Subject could not return for additional investigational product|0|||
126408872|NCT03667690|454791684|FG000|Overall Study|Subject discharged to hospice care|2|||
126408873|NCT03667690|454791685|FG001|Overall Study|Subject discharged to hospice care|0|||
126408874|NCT03667690|454791684|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
126408875|NCT03667690|454791685|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
126408876|NCT03667690|454791684|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
126408877|NCT03667690|454791685|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
126408878|NCT03667690|454791684|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
126408879|NCT03667690|454791685|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
126408880|NCT03667690|454791684|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
126408881|NCT03667690|454791685|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
126408882|NCT03667690|454791684|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
126408883|NCT03667690|454791685|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
126408884|NCT03495102|454791686|FG000|Overall Study|Adverse Event|5|||
126408885|NCT03495102|454791687|FG001|Overall Study|Adverse Event|7|||
126408886|NCT03495102|454791688|FG002|Overall Study|Adverse Event|10|||
126408887|NCT03495102|454791686|FG000|Overall Study|Death|3|||
126408888|NCT03495102|454791687|FG001|Overall Study|Death|4|||
126408889|NCT03495102|454791688|FG002|Overall Study|Death|4|||
126408890|NCT03495102|454791686|FG000|Overall Study|Lost to Follow-up|15|||
126408891|NCT03495102|454791687|FG001|Overall Study|Lost to Follow-up|16|||
126408892|NCT03495102|454791688|FG002|Overall Study|Lost to Follow-up|17|||
126408893|NCT03495102|454791686|FG000|Overall Study|Physician Decision|2|||
126408894|NCT03495102|454791687|FG001|Overall Study|Physician Decision|0|||
126408895|NCT03495102|454791688|FG002|Overall Study|Physician Decision|2|||
126408896|NCT03495102|454791686|FG000|Overall Study|Withdrawal by Subject|25|||
126408897|NCT03495102|454791687|FG001|Overall Study|Withdrawal by Subject|36|||
126408898|NCT03495102|454791688|FG002|Overall Study|Withdrawal by Subject|18|||
126408899|NCT03495102|454791686|FG000|Overall Study|Protocol Violation|1|||
126408900|NCT03495102|454791687|FG001|Overall Study|Protocol Violation|1|||
126408901|NCT03495102|454791688|FG002|Overall Study|Protocol Violation|0|||
126408902|NCT03495102|454791686|FG000|Overall Study|Site Closure|3|||
126408903|NCT03495102|454791687|FG001|Overall Study|Site Closure|1|||
126408904|NCT03495102|454791688|FG002|Overall Study|Site Closure|2|||
126408905|NCT03495102|454791686|FG000|Overall Study|Non-compliance|1|||
126408906|NCT03495102|454791687|FG001|Overall Study|Non-compliance|0|||
126408907|NCT03495102|454791688|FG002|Overall Study|Non-compliance|0|||
126408908|NCT03495102|454791686|FG000|Overall Study|Participant Duplicated at Another Site|0|||
126408909|NCT03495102|454791687|FG001|Overall Study|Participant Duplicated at Another Site|0|||
126408910|NCT03495102|454791688|FG002|Overall Study|Participant Duplicated at Another Site|1|||
126408911|NCT03495102|454791686|FG000|Overall Study|Primary Care Physician Recommendation|0|||
126408912|NCT03495102|454791687|FG001|Overall Study|Primary Care Physician Recommendation|1|||
126408913|NCT03495102|454791688|FG002|Overall Study|Primary Care Physician Recommendation|0|||
126408914|NCT03495102|454791686|FG000|Overall Study|Relocated to Another Country|0|||
126408915|NCT03495102|454791687|FG001|Overall Study|Relocated to Another Country|1|||
126408916|NCT03495102|454791688|FG002|Overall Study|Relocated to Another Country|0|||
126408917|NCT03495102|454791686|FG000|Overall Study|Participant was in Rehabilitation|1|||
126408918|NCT03495102|454791687|FG001|Overall Study|Participant was in Rehabilitation|0|||
126408919|NCT03495102|454791688|FG002|Overall Study|Participant was in Rehabilitation|0|||
126408920|NCT01161537|454791690|FG000|Part B|Withdrawal by Subject|2|||
126408921|NCT00321464|454791693|FG000|Overall Study|Death|169|||
126408922|NCT00321464|454791694|FG001|Overall Study|Death|174|||
126408923|NCT00321464|454791693|FG000|Overall Study|Disease progression|124|||
126408924|NCT00321464|454791694|FG001|Overall Study|Disease progression|124|||
126408925|NCT00321464|454791693|FG000|Overall Study|Withdrawal by Subject|117|||
126408926|NCT00321464|454791694|FG001|Overall Study|Withdrawal by Subject|118|||
126408927|NCT00321464|454791693|FG000|Overall Study|Participant request|57|||
126408928|NCT00321464|454791694|FG001|Overall Study|Participant request|61|||
126408929|NCT00321464|454791693|FG000|Overall Study|Adverse Event|43|||
126408930|NCT00321464|454791694|FG001|Overall Study|Adverse Event|28|||
126408931|NCT00321464|454791693|FG000|Overall Study|Physician Decision|15|||
126408932|NCT00321464|454791694|FG001|Overall Study|Physician Decision|14|||
126408933|NCT00321464|454791693|FG000|Overall Study|Noncompliance|4|||
126408934|NCT00321464|454791694|FG001|Overall Study|Noncompliance|10|||
126408935|NCT00321464|454791693|FG000|Overall Study|Lost to Follow-up|7|||
126408936|NCT00321464|454791694|FG001|Overall Study|Lost to Follow-up|8|||
126408937|NCT00321464|454791693|FG000|Overall Study|Protocol deviation|0|||
126408938|NCT00321464|454791694|FG001|Overall Study|Protocol deviation|2|||
126408939|NCT00321464|454791693|FG000|Overall Study|Ineligibility determined|2|||
126408940|NCT00321464|454791694|FG001|Overall Study|Ineligibility determined|1|||
126408941|NCT00321464|454791693|FG000|Overall Study|Other|21|||
126408942|NCT00321464|454791694|FG001|Overall Study|Other|18|||
126408943|NCT02593825|454791695|FG000|Intervention|Lost to Follow-up|10|||
125890583|NCT00838513|452897173|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
125890584|NCT00139477|452897177|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
125890585|NCT00139477|452897178|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
125890586|NCT00139477|452897177|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
125890587|NCT00139477|452897178|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
125890588|NCT00139477|452897177|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
125890589|NCT00139477|452897178|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
125890590|NCT00139477|452897177|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
125890591|NCT00139477|452897178|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
125890592|NCT00139477|452897177|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
125890593|NCT00139477|452897178|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
125890594|NCT00139477|452897177|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
125890595|NCT00139477|452897178|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
125890596|NCT00139477|452897177|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
125890597|NCT00139477|452897178|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
125890598|NCT00573144|452897182|FG000|Overall Study|Withdrawal by Subject|2|||
125890599|NCT00573144|452897183|FG001|Overall Study|Withdrawal by Subject|3|||
126408944|NCT02593825|454791696|FG001|Intervention|Lost to Follow-up|12|||
126408945|NCT02522325|454791697|FG000|Overall Study|Adverse Event|0|||
126408946|NCT02522325|454791698|FG001|Overall Study|Adverse Event|1|||
126408947|NCT01209078|454791699|FG000|Overall Study|Adverse Event|5|||
126408948|NCT01209078|454791700|FG001|Overall Study|Adverse Event|0|||
126408949|NCT01209078|454791699|FG000|Overall Study|Lost to Follow-up|4|||
126408950|NCT01209078|454791700|FG001|Overall Study|Lost to Follow-up|0|||
126408951|NCT01209078|454791699|FG000|Overall Study|Physician Decision|5|||
126408952|NCT01209078|454791700|FG001|Overall Study|Physician Decision|2|||
126408953|NCT01209078|454791699|FG000|Overall Study|Withdrawal by Subject|2|||
126408954|NCT01209078|454791700|FG001|Overall Study|Withdrawal by Subject|1|||
126408955|NCT00924508|454791701|FG000|Overall Study|Withdrawal by Subject|3|||
126408956|NCT00495625|454791704|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
126408957|NCT01912339|454791705|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
126408958|NCT01912339|454791706|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
126408959|NCT01912339|454791707|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
126408960|NCT01912339|454791705|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
126408961|NCT01912339|454791706|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
126408962|NCT01912339|454791707|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
126408963|NCT01912339|454791705|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
126408964|NCT01912339|454791706|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
126408965|NCT01912339|454791707|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
126408966|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
126408967|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
126408968|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
126408969|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
126408970|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
126408971|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
126105351|NCT01281969|453678603|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
126408972|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
126408973|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
126054048|NCT03732807|453492219|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
126054049|NCT03732807|453492213|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
126054050|NCT03732807|453492214|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
126054051|NCT03732807|453492215|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
126054052|NCT03732807|453492216|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
126054053|NCT03732807|453492217|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
126408974|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
126408975|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
126408976|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
126408977|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
126408978|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
126408979|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
126408980|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
126408981|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
126408982|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
126408983|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
126408984|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
126408985|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
126408986|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
126408987|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
126408988|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
126408989|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
126408990|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
126408991|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
126408992|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
126408993|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
126408994|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
126408995|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
126408996|NCT01754493|454791709|FG000|Overall Study|Adverse Event|1|||
126408997|NCT01754493|454791709|FG000|Overall Study|Lost to Follow-up|3|||
126408998|NCT01754493|454791709|FG000|Overall Study|Withdrawal by Subject|1|||
126408999|NCT01754493|454791709|FG000|Overall Study|Moved out of town|1|||
126409000|NCT01754493|454791709|FG000|Overall Study|Scheduling conflict|1|||
126409001|NCT03464019|454791710|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
126409002|NCT03464019|454791711|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
126409003|NCT03464019|454791712|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
126409004|NCT03464019|454791710|FG000|NODE-301 Part 1|Ablation|0|||
126409005|NCT03464019|454791711|FG001|NODE-301 Part 1|Ablation|0|||
126409006|NCT03464019|454791712|FG002|NODE-301 Part 1|Ablation|16|||
126409007|NCT03464019|454791710|FG000|NODE-301 Part 1|Test Dose Failure|0|||
126409008|NCT03464019|454791711|FG001|NODE-301 Part 1|Test Dose Failure|0|||
126409009|NCT03464019|454791712|FG002|NODE-301 Part 1|Test Dose Failure|8|||
126409010|NCT03464019|454791710|FG000|NODE-301 Part 1|Adverse Event|0|||
126409011|NCT03464019|454791711|FG001|NODE-301 Part 1|Adverse Event|0|||
126409012|NCT03464019|454791712|FG002|NODE-301 Part 1|Adverse Event|5|||
126409013|NCT03464019|454791710|FG000|NODE-301 Part 1|Physician Decision|0|||
126409014|NCT03464019|454791711|FG001|NODE-301 Part 1|Physician Decision|0|||
126409015|NCT03464019|454791712|FG002|NODE-301 Part 1|Physician Decision|4|||
126409016|NCT03464019|454791710|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
126409017|NCT03464019|454791711|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
126409018|NCT03464019|454791712|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
126409019|NCT03464019|454791710|FG000|NODE-301 Part 1|Protocol Violation|0|||
126409020|NCT03464019|454791711|FG001|NODE-301 Part 1|Protocol Violation|0|||
126054054|NCT03732807|453492218|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
126054055|NCT03732807|453492219|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
126054056|NCT03732807|453492213|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
126054057|NCT03732807|453492214|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
126054058|NCT03732807|453492215|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
126054059|NCT03732807|453492216|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
126409021|NCT03464019|454791712|FG002|NODE-301 Part 1|Protocol Violation|2|||
126409022|NCT03464019|454791710|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
126409023|NCT03464019|454791711|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
126409024|NCT03464019|454791712|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
126409025|NCT03464019|454791710|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
126409026|NCT03464019|454791711|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
126409027|NCT03464019|454791712|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
126409028|NCT03464019|454791710|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
126409029|NCT03464019|454791711|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
126409030|NCT03464019|454791712|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
126409031|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
126409032|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
126409033|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
126409034|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
126409035|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
126409036|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
126409037|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
126409038|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
126409039|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
126409040|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
126409041|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
126409042|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
126409043|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
126409044|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
126409045|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
126409046|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
126409047|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
126409048|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
126409049|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
126409050|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
126409051|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
126409052|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
126409053|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
126409054|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
126409055|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
126409056|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
126409057|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
126409058|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
126409059|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
126409060|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
126409061|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
126409062|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
126409063|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
126409064|NCT00511134|454791713|FG000|Overall Study|Withdrawal by Subject|0|||
126409065|NCT00511134|454791714|FG001|Overall Study|Withdrawal by Subject|2|||
126409066|NCT01949090|454791715|FG000|Overall Study|Serious Adverse Event|0|||
126409067|NCT01949090|454791716|FG001|Overall Study|Serious Adverse Event|1|||
126409068|NCT01949090|454791717|FG002|Overall Study|Serious Adverse Event|2|||
126409069|NCT01949090|454791718|FG003|Overall Study|Serious Adverse Event|0|||
126409070|NCT01949090|454791719|FG004|Overall Study|Serious Adverse Event|1|||
126409071|NCT01949090|454791715|FG000|Overall Study|Withdrawal by Subject|2|||
126409072|NCT01949090|454791716|FG001|Overall Study|Withdrawal by Subject|0|||
126409073|NCT01949090|454791717|FG002|Overall Study|Withdrawal by Subject|0|||
126409074|NCT01949090|454791718|FG003|Overall Study|Withdrawal by Subject|0|||
126409075|NCT01949090|454791719|FG004|Overall Study|Withdrawal by Subject|1|||
126409076|NCT01949090|454791715|FG000|Overall Study|Protocol non-compliance|0|||
126409077|NCT01949090|454791716|FG001|Overall Study|Protocol non-compliance|0|||
126409078|NCT01949090|454791717|FG002|Overall Study|Protocol non-compliance|0|||
126409079|NCT01949090|454791718|FG003|Overall Study|Protocol non-compliance|0|||
126409080|NCT01949090|454791719|FG004|Overall Study|Protocol non-compliance|1|||
126409081|NCT01949090|454791715|FG000|Overall Study|Lost to Follow-up|2|||
126409082|NCT01949090|454791716|FG001|Overall Study|Lost to Follow-up|1|||
126409083|NCT01949090|454791717|FG002|Overall Study|Lost to Follow-up|0|||
126409084|NCT01949090|454791718|FG003|Overall Study|Lost to Follow-up|1|||
126409085|NCT01949090|454791719|FG004|Overall Study|Lost to Follow-up|1|||
126409086|NCT03459365|454791720|FG000|Overall Study|Withdrawal by Subject|6|||
126409087|NCT03459365|454791720|FG000|Overall Study|Protocol Violation|8|||
126409088|NCT01543776|454791721|FG000|Overall Study|Withdrawal by Subject|2|||
126409089|NCT01543776|454791722|FG001|Overall Study|Withdrawal by Subject|2|||
126409090|NCT00785980|454791725|FG000|7 Day Washout Period|Protocol Violation|3|||
126409091|NCT03055013|454791726|FG000|Overall Study|Adverse Event|78|||
126409092|NCT03055013|454791727|FG001|Overall Study|Adverse Event|0|||
126409093|NCT03055013|454791726|FG000|Overall Study|Death|6|||
126409094|NCT03055013|454791727|FG001|Overall Study|Death|0|||
126409095|NCT03055013|454791726|FG000|Overall Study|Disease relapse|33|||
126409096|NCT03055013|454791727|FG001|Overall Study|Disease relapse|0|||
126409097|NCT03055013|454791726|FG000|Overall Study|Withdrawal by Subject|28|||
126409098|NCT03055013|454791727|FG001|Overall Study|Withdrawal by Subject|0|||
126409099|NCT03055013|454791726|FG000|Overall Study|Other complicating disease|5|||
126409100|NCT03055013|454791727|FG001|Overall Study|Other complicating disease|0|||
125890600|NCT00975780|452897184|FG000|Follow Up|Death|88|||
126409101|NCT03055013|454791726|FG000|Overall Study|Physician Decision|1|||
126409102|NCT03055013|454791727|FG001|Overall Study|Physician Decision|0|||
126409103|NCT03055013|454791726|FG000|Overall Study|Benign mass/non-RCC|4|||
126409104|NCT03055013|454791727|FG001|Overall Study|Benign mass/non-RCC|0|||
126409105|NCT03055013|454791726|FG000|Overall Study|Enrolled in another trial|1|||
126409106|NCT03055013|454791727|FG001|Overall Study|Enrolled in another trial|0|||
126409107|NCT03055013|454791726|FG000|Overall Study|Non-protocol therapy|1|||
126409108|NCT03055013|454791727|FG001|Overall Study|Non-protocol therapy|0|||
126409109|NCT03055013|454791726|FG000|Overall Study|Incompliance|1|||
126409110|NCT03055013|454791727|FG001|Overall Study|Incompliance|0|||
126409111|NCT03055013|454791726|FG000|Overall Study|Insurance issues|1|||
126409112|NCT03055013|454791727|FG001|Overall Study|Insurance issues|0|||
126409113|NCT03055013|454791726|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
126409114|NCT03055013|454791727|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
126409115|NCT03055013|454791726|FG000|Overall Study|Did not receive nivolumab|10|||
126409116|NCT03055013|454791727|FG001|Overall Study|Did not receive nivolumab|0|||
126409117|NCT03055013|454791726|FG000|Overall Study|Did not receive surgery|0|||
126409118|NCT03055013|454791727|FG001|Overall Study|Did not receive surgery|28|||
126409119|NCT00528801|454791728|FG000|Overall Study|Withdrawal by Subject|1|||
126409120|NCT00528801|454791729|FG001|Overall Study|Withdrawal by Subject|1|||
126409121|NCT00528801|454791728|FG000|Overall Study|Protocol Violation|11|||
126409122|NCT00528801|454791729|FG001|Overall Study|Protocol Violation|5|||
126409123|NCT00528801|454791728|FG000|Overall Study|Lost to Follow-up|15|||
126409124|NCT00528801|454791729|FG001|Overall Study|Lost to Follow-up|4|||
126409125|NCT00528801|454791728|FG000|Overall Study|Administrative Reasons|0|||
126409126|NCT00528801|454791729|FG001|Overall Study|Administrative Reasons|1|||
126409127|NCT00344500|454791730|FG000|Overall Study|Adverse Event|6|||
126409128|NCT00344500|454791731|FG001|Overall Study|Adverse Event|2|||
126409129|NCT00344500|454791732|FG002|Overall Study|Adverse Event|0|||
126409130|NCT00344500|454791730|FG000|Overall Study|Lost to Follow-up|5|||
126409131|NCT00344500|454791731|FG001|Overall Study|Lost to Follow-up|13|||
126409132|NCT00344500|454791732|FG002|Overall Study|Lost to Follow-up|1|||
126409133|NCT00344500|454791730|FG000|Overall Study|Withdrawal by Subject|7|||
126409134|NCT00344500|454791731|FG001|Overall Study|Withdrawal by Subject|10|||
126409135|NCT00344500|454791732|FG002|Overall Study|Withdrawal by Subject|0|||
126409136|NCT00344500|454791730|FG000|Overall Study|Protocol Violation|4|||
126409137|NCT00344500|454791731|FG001|Overall Study|Protocol Violation|7|||
126409138|NCT00344500|454791732|FG002|Overall Study|Protocol Violation|1|||
126409139|NCT00344500|454791730|FG000|Overall Study|Not Noted|1|||
126409140|NCT00344500|454791731|FG001|Overall Study|Not Noted|3|||
126409141|NCT00344500|454791732|FG002|Overall Study|Not Noted|0|||
126409142|NCT02207491|454791733|FG000|Overall Study|Adverse Event|20|||
126409143|NCT02207491|454791734|FG001|Overall Study|Adverse Event|4|||
126409144|NCT02207491|454791733|FG000|Overall Study|Withdrawal by Subject|3|||
126409145|NCT02207491|454791734|FG001|Overall Study|Withdrawal by Subject|2|||
126409146|NCT02207491|454791733|FG000|Overall Study|Non-compliant|0|||
126409147|NCT02207491|454791734|FG001|Overall Study|Non-compliant|1|||
126409148|NCT02207491|454791733|FG000|Overall Study|Lost to Follow-up|0|||
126409149|NCT02207491|454791734|FG001|Overall Study|Lost to Follow-up|1|||
126409150|NCT02207491|454791733|FG000|Overall Study|Lack of Efficacy|3|||
126409151|NCT02207491|454791734|FG001|Overall Study|Lack of Efficacy|0|||
126409152|NCT02207491|454791733|FG000|Overall Study|Physician Decision|2|||
126409153|NCT02207491|454791734|FG001|Overall Study|Physician Decision|0|||
126409154|NCT02207491|454791733|FG000|Overall Study|Protocol Violation|3|||
126409155|NCT02207491|454791734|FG001|Overall Study|Protocol Violation|5|||
126409156|NCT00126776|454791735|FG000|Overall Study|follow up complete on all patients|0|||
126409157|NCT00126776|454791736|FG001|Overall Study|follow up complete on all patients|0|||
126409158|NCT00599755|454791737|FG000|Overall Study|Adverse Event|11|||
126409159|NCT00599755|454791737|FG000|Overall Study|Withdrawal by Subject|2|||
126409160|NCT00599755|454791737|FG000|Overall Study|Progression of Disease|3|||
126054060|NCT03732807|453492217|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
126054061|NCT03732807|453492218|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
126409161|NCT00599755|454791737|FG000|Overall Study|Other Reason|2|||
126409162|NCT00599755|454791737|FG000|Overall Study|No data available|1|||
126054062|NCT03732807|453492219|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
126054063|NCT03732807|453492213|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
126054064|NCT03732807|453492214|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
126054065|NCT03732807|453492215|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
126409163|NCT03626545|454791741|FG000|Overall Study|Progressive disease|3|||
126409164|NCT03626545|454791742|FG001|Overall Study|Progressive disease|82|||
126409165|NCT03626545|454791743|FG002|Overall Study|Progressive disease|85|||
126409166|NCT03626545|454791741|FG000|Overall Study|Adverse Event|3|||
126409167|NCT03626545|454791742|FG001|Overall Study|Adverse Event|13|||
126409168|NCT03626545|454791743|FG002|Overall Study|Adverse Event|10|||
126409169|NCT03626545|454791741|FG000|Overall Study|Physician Decision|1|||
126409170|NCT03626545|454791742|FG001|Overall Study|Physician Decision|18|||
126409171|NCT03626545|454791743|FG002|Overall Study|Physician Decision|14|||
126409172|NCT03626545|454791741|FG000|Overall Study|Subject Decision|0|||
126409173|NCT03626545|454791742|FG001|Overall Study|Subject Decision|5|||
126409174|NCT03626545|454791743|FG002|Overall Study|Subject Decision|5|||
126409175|NCT03626545|454791741|FG000|Overall Study|Death|1|||
126409176|NCT03626545|454791742|FG001|Overall Study|Death|1|||
126409177|NCT03626545|454791743|FG002|Overall Study|Death|1|||
126409178|NCT03626545|454791741|FG000|Overall Study|Protocol Deviation|0|||
126409179|NCT03626545|454791742|FG001|Overall Study|Protocol Deviation|1|||
126409180|NCT03626545|454791743|FG002|Overall Study|Protocol Deviation|1|||
126409181|NCT03626545|454791741|FG000|Overall Study|Guardian Decision|0|||
126409182|NCT03626545|454791742|FG001|Overall Study|Guardian Decision|0|||
126409183|NCT03626545|454791743|FG002|Overall Study|Guardian Decision|1|||
126409184|NCT01939366|454791745|FG000|Overall Study|Adverse Event|8|||
126409185|NCT01939366|454791746|FG001|Overall Study|Adverse Event|17|||
126409186|NCT01939366|454791747|FG002|Overall Study|Adverse Event|30|||
126409187|NCT01939366|454791748|FG003|Overall Study|Adverse Event|8|||
126409188|NCT01939366|454791749|FG004|Overall Study|Adverse Event|5|||
126409189|NCT01939366|454791745|FG000|Overall Study|Lack of Efficacy|2|||
126409190|NCT01939366|454791746|FG001|Overall Study|Lack of Efficacy|1|||
126409191|NCT01939366|454791747|FG002|Overall Study|Lack of Efficacy|1|||
126409192|NCT01939366|454791748|FG003|Overall Study|Lack of Efficacy|1|||
126409193|NCT01939366|454791749|FG004|Overall Study|Lack of Efficacy|3|||
126409194|NCT01939366|454791745|FG000|Overall Study|Lost to Follow-up|1|||
126409195|NCT01939366|454791746|FG001|Overall Study|Lost to Follow-up|1|||
126409196|NCT01939366|454791747|FG002|Overall Study|Lost to Follow-up|0|||
126409197|NCT01939366|454791748|FG003|Overall Study|Lost to Follow-up|0|||
126409198|NCT01939366|454791749|FG004|Overall Study|Lost to Follow-up|0|||
126409199|NCT01939366|454791745|FG000|Overall Study|Withdrawal by Subject|1|||
126409200|NCT01939366|454791746|FG001|Overall Study|Withdrawal by Subject|0|||
126409201|NCT01939366|454791747|FG002|Overall Study|Withdrawal by Subject|2|||
126409202|NCT01939366|454791748|FG003|Overall Study|Withdrawal by Subject|2|||
126409203|NCT01939366|454791749|FG004|Overall Study|Withdrawal by Subject|3|||
126409204|NCT01939366|454791745|FG000|Overall Study|Inclusion criteria not met|0|||
126409205|NCT01939366|454791746|FG001|Overall Study|Inclusion criteria not met|1|||
126409206|NCT01939366|454791747|FG002|Overall Study|Inclusion criteria not met|1|||
126409207|NCT01939366|454791748|FG003|Overall Study|Inclusion criteria not met|0|||
126409208|NCT01939366|454791749|FG004|Overall Study|Inclusion criteria not met|1|||
126409209|NCT01939366|454791745|FG000|Overall Study|Other|0|||
126409210|NCT01939366|454791746|FG001|Overall Study|Other|0|||
126409211|NCT01939366|454791747|FG002|Overall Study|Other|2|||
126409212|NCT01939366|454791748|FG003|Overall Study|Other|2|||
126409213|NCT01939366|454791749|FG004|Overall Study|Other|1|||
126409214|NCT01939366|454791745|FG000|Overall Study|Protocol Violation|0|||
126409215|NCT01939366|454791746|FG001|Overall Study|Protocol Violation|0|||
126409216|NCT01939366|454791747|FG002|Overall Study|Protocol Violation|0|||
126409217|NCT01939366|454791748|FG003|Overall Study|Protocol Violation|1|||
126409218|NCT01939366|454791749|FG004|Overall Study|Protocol Violation|0|||
126409219|NCT01939366|454791745|FG000|Overall Study|Sponsor decision|0|||
126409220|NCT01939366|454791746|FG001|Overall Study|Sponsor decision|0|||
126409221|NCT01939366|454791747|FG002|Overall Study|Sponsor decision|0|||
126409222|NCT01939366|454791748|FG003|Overall Study|Sponsor decision|0|||
126409223|NCT01939366|454791749|FG004|Overall Study|Sponsor decision|2|||
126409224|NCT01939366|454791745|FG000|Overall Study|GCP non-compliance at site|2|||
126409225|NCT01939366|454791746|FG001|Overall Study|GCP non-compliance at site|3|||
126409226|NCT01939366|454791747|FG002|Overall Study|GCP non-compliance at site|2|||
126409227|NCT01939366|454791748|FG003|Overall Study|GCP non-compliance at site|3|||
126409228|NCT01939366|454791749|FG004|Overall Study|GCP non-compliance at site|3|||
126409229|NCT03909152|454791754|FG000|Overall Study|Adverse Event|14|||
126409230|NCT03909152|454791755|FG001|Overall Study|Adverse Event|5|||
126409231|NCT03909152|454791756|FG002|Overall Study|Adverse Event|1|||
126409232|NCT03909152|454791757|FG003|Overall Study|Adverse Event|14|||
126409233|NCT02702414|454791758|FG000|Overall Study|Death|96|||
126409234|NCT02702414|454791759|FG001|Overall Study|Death|42|||
126409235|NCT02702414|454791758|FG000|Overall Study|Lost to Follow-up|0|||
126409236|NCT02702414|454791759|FG001|Overall Study|Lost to Follow-up|1|||
126409237|NCT02702414|454791758|FG000|Overall Study|Withdrawal by Subject|0|||
126409238|NCT02702414|454791759|FG001|Overall Study|Withdrawal by Subject|1|||
126409239|NCT02702414|454791758|FG000|Overall Study|Protocol Violation|1|||
126054066|NCT03732807|453492216|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
126054067|NCT03732807|453492217|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
126409240|NCT02702414|454791759|FG001|Overall Study|Protocol Violation|0|||
126409241|NCT02702414|454791758|FG000|Overall Study|Sponsor Decision|8|||
126409242|NCT02702414|454791759|FG001|Overall Study|Sponsor Decision|7|||
126409243|NCT02596230|454791760|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
126409244|NCT02596230|454791761|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
126409245|NCT02596230|454791762|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
126409246|NCT02596230|454791763|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
126409247|NCT02596230|454791764|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
126409248|NCT02596230|454791760|FG000|Objective 2, One Year|Lost to Follow-up|0|||
126409249|NCT02596230|454791761|FG001|Objective 2, One Year|Lost to Follow-up|41|||
126409250|NCT02596230|454791762|FG002|Objective 2, One Year|Lost to Follow-up|41|||
126409251|NCT02596230|454791763|FG003|Objective 2, One Year|Lost to Follow-up|32|||
126409252|NCT02596230|454791764|FG004|Objective 2, One Year|Lost to Follow-up|46|||
126409253|NCT02596230|454791760|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
126409254|NCT02596230|454791761|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
126409255|NCT02596230|454791762|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
126409256|NCT02596230|454791763|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
126409257|NCT02596230|454791764|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
126409258|NCT02596230|454791760|FG000|Objective 2, One Year|Adverse drug reaction|0|||
126409259|NCT02596230|454791761|FG001|Objective 2, One Year|Adverse drug reaction|1|||
126409260|NCT02596230|454791762|FG002|Objective 2, One Year|Adverse drug reaction|0|||
126409261|NCT02596230|454791763|FG003|Objective 2, One Year|Adverse drug reaction|0|||
126409262|NCT02596230|454791764|FG004|Objective 2, One Year|Adverse drug reaction|0|||
126409263|NCT02596230|454791760|FG000|Objective 2, One Year|Death|0|||
126409264|NCT02596230|454791761|FG001|Objective 2, One Year|Death|12|||
126409265|NCT02596230|454791762|FG002|Objective 2, One Year|Death|41|||
126409266|NCT02596230|454791763|FG003|Objective 2, One Year|Death|21|||
126409267|NCT02596230|454791764|FG004|Objective 2, One Year|Death|30|||
126409268|NCT02596230|454791760|FG000|Objective 2, One Year|Other|0|||
126409269|NCT02596230|454791761|FG001|Objective 2, One Year|Other|3|||
126409270|NCT02596230|454791762|FG002|Objective 2, One Year|Other|2|||
126409271|NCT02596230|454791763|FG003|Objective 2, One Year|Other|0|||
126409272|NCT02596230|454791764|FG004|Objective 2, One Year|Other|0|||
126409273|NCT02271945|454791765|FG000|Overall Study|Death|3|||
126409274|NCT02271945|454791766|FG001|Overall Study|Death|3|||
126409275|NCT02271945|454791765|FG000|Overall Study|Withdrawal by Subject|1|||
126409276|NCT02271945|454791766|FG001|Overall Study|Withdrawal by Subject|1|||
126409277|NCT02271945|454791765|FG000|Overall Study|Other|1|||
126409278|NCT02271945|454791766|FG001|Overall Study|Other|1|||
126409279|NCT03446456|454791767|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
126409280|NCT03446456|454791768|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
126409281|NCT03446456|454791767|FG000|Overall Study|Lost to Follow-up|1|||
126409282|NCT03446456|454791768|FG001|Overall Study|Lost to Follow-up|3|||
126409283|NCT03446456|454791767|FG000|Overall Study|Participant failed the toxicology test|1|||
126409284|NCT03446456|454791768|FG001|Overall Study|Participant failed the toxicology test|0|||
126409285|NCT03446456|454791767|FG000|Overall Study|Break down of the experimental equipment|1|||
126409286|NCT03446456|454791768|FG001|Overall Study|Break down of the experimental equipment|0|||
126409287|NCT04099511|454791770|FG000|Overall Study|Lost to Follow-up|2|||
126409288|NCT04099511|454791771|FG001|Overall Study|Lost to Follow-up|2|||
126409289|NCT04099511|454791770|FG000|Overall Study|Withdrawal by Subject|8|||
126409290|NCT04099511|454791771|FG001|Overall Study|Withdrawal by Subject|4|||
126409291|NCT03002311|454791774|FG000|Overall Study|Lost to Follow-up|13|||
126409292|NCT03002311|454791775|FG001|Overall Study|Lost to Follow-up|26|||
126409293|NCT03002311|454791774|FG000|Overall Study|Referral provider called to schedule app|3|||
126409294|NCT03002311|454791775|FG001|Overall Study|Referral provider called to schedule app|3|||
126409295|NCT03002311|454791774|FG000|Overall Study|Physician Decision|3|||
126409296|NCT03002311|454791775|FG001|Overall Study|Physician Decision|1|||
125890601|NCT00975780|452897185|FG001|Follow Up|Death|122|||
125890602|NCT00975780|452897184|FG000|Follow Up|Facility Withdrawal|7|||
125890603|NCT00975780|452897185|FG001|Follow Up|Facility Withdrawal|23|||
125890604|NCT00975780|452897184|FG000|Follow Up|Discharged from Facility|7|||
125890605|NCT00975780|452897185|FG001|Follow Up|Discharged from Facility|12|||
125890606|NCT02625909|452897188|FG000|Overall Study|Death|2|||
125890607|NCT02625909|452897189|FG001|Overall Study|Death|0|||
125890608|NCT02625909|452897188|FG000|Overall Study|Lost to Follow-up|3|||
126409297|NCT00320424|454791776|FG000|Overall Study|Adverse Event|3|||
126409298|NCT00320424|454791776|FG000|Overall Study|Other|3|||
126409299|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
126409300|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
126409301|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
126409302|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
126409303|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
126409304|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
125890609|NCT02625909|452897189|FG001|Overall Study|Lost to Follow-up|5|||
125890610|NCT02625909|452897188|FG000|Overall Study|Lack of Efficacy|9|||
126409305|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Death|1|||
126409306|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Death|4|||
126409307|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
126409308|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
126409309|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Not eligible|1|||
126409310|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Not eligible|2|||
126409311|NCT00658814|454791777|FG000|Consolidation Therapy|Not protocol specified|0|||
126409312|NCT00658814|454791778|FG001|Consolidation Therapy|Not protocol specified|1|||
126409313|NCT00658814|454791777|FG000|Consolidation Therapy|Not eligible|2|||
126409314|NCT00658814|454791778|FG001|Consolidation Therapy|Not eligible|2|||
126409315|NCT00658814|454791777|FG000|Maintenance Therapy|Adverse Event|1|||
126409316|NCT00658814|454791778|FG001|Maintenance Therapy|Adverse Event|1|||
126409317|NCT00658814|454791777|FG000|Maintenance Therapy|Not protocol specified|1|||
126409318|NCT00658814|454791778|FG001|Maintenance Therapy|Not protocol specified|0|||
126409319|NCT00658814|454791777|FG000|Maintenance Therapy|Not eligible|1|||
126409320|NCT00658814|454791778|FG001|Maintenance Therapy|Not eligible|0|||
126409321|NCT02708485|454791786|FG000|Overall Study|Withdrawal by Subject|3|||
126409322|NCT02708485|454791787|FG001|Overall Study|Withdrawal by Subject|2|||
126409323|NCT00231413|454791788|FG000|Overall Study|Non-serious AE|0|||
126409324|NCT00231413|454791789|FG001|Overall Study|Non-serious AE|0|||
126409325|NCT00231413|454791790|FG002|Overall Study|Non-serious AE|1|||
126409326|NCT00231413|454791791|FG003|Overall Study|Non-serious AE|0|||
126409327|NCT00231413|454791792|FG004|Overall Study|Non-serious AE|0|||
126409328|NCT00231413|454791793|FG005|Overall Study|Non-serious AE|0|||
126409329|NCT00231413|454791794|FG006|Overall Study|Non-serious AE|1|||
126409330|NCT00231413|454791788|FG000|Overall Study|Withdrawal by Subject|3|||
126409331|NCT00231413|454791789|FG001|Overall Study|Withdrawal by Subject|1|||
126409332|NCT00231413|454791790|FG002|Overall Study|Withdrawal by Subject|4|||
126409333|NCT00231413|454791791|FG003|Overall Study|Withdrawal by Subject|2|||
126409334|NCT00231413|454791792|FG004|Overall Study|Withdrawal by Subject|2|||
126409335|NCT00231413|454791793|FG005|Overall Study|Withdrawal by Subject|0|||
126409336|NCT00231413|454791794|FG006|Overall Study|Withdrawal by Subject|3|||
126409337|NCT00231413|454791788|FG000|Overall Study|Migrated/moved from study area|0|||
126409338|NCT00231413|454791789|FG001|Overall Study|Migrated/moved from study area|0|||
126409339|NCT00231413|454791790|FG002|Overall Study|Migrated/moved from study area|1|||
126409340|NCT00231413|454791791|FG003|Overall Study|Migrated/moved from study area|0|||
126409341|NCT00231413|454791792|FG004|Overall Study|Migrated/moved from study area|0|||
126409342|NCT00231413|454791793|FG005|Overall Study|Migrated/moved from study area|1|||
126409343|NCT00231413|454791794|FG006|Overall Study|Migrated/moved from study area|0|||
126409344|NCT00231413|454791788|FG000|Overall Study|Lost to Follow-up|4|||
126409345|NCT00231413|454791789|FG001|Overall Study|Lost to Follow-up|4|||
126409346|NCT00231413|454791790|FG002|Overall Study|Lost to Follow-up|1|||
126409347|NCT00231413|454791791|FG003|Overall Study|Lost to Follow-up|1|||
126409348|NCT00231413|454791792|FG004|Overall Study|Lost to Follow-up|1|||
126409349|NCT00231413|454791793|FG005|Overall Study|Lost to Follow-up|4|||
126409350|NCT00231413|454791794|FG006|Overall Study|Lost to Follow-up|0|||
126409351|NCT00231413|454791788|FG000|Overall Study|Pregnancy|1|||
126409352|NCT00231413|454791789|FG001|Overall Study|Pregnancy|0|||
126409353|NCT00231413|454791790|FG002|Overall Study|Pregnancy|0|||
126409354|NCT00231413|454791791|FG003|Overall Study|Pregnancy|0|||
126409355|NCT00231413|454791792|FG004|Overall Study|Pregnancy|0|||
126409356|NCT00231413|454791793|FG005|Overall Study|Pregnancy|0|||
126409357|NCT00231413|454791794|FG006|Overall Study|Pregnancy|0|||
126409358|NCT03266172|454791795|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
125890611|NCT02625909|452897189|FG001|Overall Study|Lack of Efficacy|2|||
125890612|NCT02625909|452897188|FG000|Overall Study|Reinfection|3|||
125890613|NCT02625909|452897189|FG001|Overall Study|Reinfection|2|||
125890614|NCT02367833|452897190|FG000|Overall Study|Withdrawal by Subject|1|||
125890615|NCT02367833|452897191|FG001|Overall Study|Withdrawal by Subject|1|||
126054068|NCT03732807|453492218|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
126409359|NCT03266172|454791796|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
126409360|NCT03266172|454791797|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
126409361|NCT03266172|454791795|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
126054069|NCT03732807|453492219|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
126054070|NCT03732807|453492213|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
126409362|NCT03266172|454791796|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
126409363|NCT03266172|454791797|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
126409364|NCT03266172|454791795|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
126409365|NCT03266172|454791796|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
126409366|NCT03266172|454791797|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
126409367|NCT03266172|454791795|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
126409368|NCT03266172|454791796|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
126409369|NCT03266172|454791797|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
126409370|NCT03266172|454791795|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
126409371|NCT03266172|454791796|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
126409372|NCT03266172|454791797|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
126409373|NCT03266172|454791795|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
126409374|NCT03266172|454791796|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
126409375|NCT03266172|454791797|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
126409376|NCT01554514|454791800|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
126409377|NCT01554514|454791800|FG000|Overall Study|Physician Decision|1|||
126409378|NCT05222555|454791801|FG000|Overall Study|Ongoing|2|||
126409379|NCT05222555|454791802|FG001|Overall Study|Ongoing|18|||
126409380|NCT05222555|454791801|FG000|Overall Study|Adverse Event|1|||
126409381|NCT05222555|454791802|FG001|Overall Study|Adverse Event|1|||
126409382|NCT05222555|454791801|FG000|Overall Study|Death|0|||
126409383|NCT05222555|454791802|FG001|Overall Study|Death|6|||
126409384|NCT05222555|454791801|FG000|Overall Study|Withdrawal by Subject|0|||
126409385|NCT05222555|454791802|FG001|Overall Study|Withdrawal by Subject|11|||
126409386|NCT00300365|454791803|FG000|Overall Study|Lost to Follow-up|1|||
126409387|NCT00300365|454791804|FG001|Overall Study|Lost to Follow-up|0|||
126409388|NCT00300365|454791803|FG000|Overall Study|Physician Decision|2|||
126409389|NCT00300365|454791804|FG001|Overall Study|Physician Decision|0|||
126409390|NCT00300365|454791803|FG000|Overall Study|Withdrawal by Subject|1|||
126409391|NCT00300365|454791804|FG001|Overall Study|Withdrawal by Subject|0|||
126409392|NCT00300365|454791803|FG000|Overall Study|Adverse Event|0|||
126409393|NCT00300365|454791804|FG001|Overall Study|Adverse Event|2|||
126409394|NCT01422824|454791805|FG000|Overall Study|Case record form not evaluated|1|||
126409395|NCT01422824|454791805|FG000|Overall Study|Lost to Follow-up|37|||
126409396|NCT01581619|454791806|FG000|Overall Study|Withdrawal by Subject|1|||
126409397|NCT01581619|454791806|FG000|Overall Study|Lost to Follow-up|1|||
126409398|NCT01818492|454791807|FG000|Overall Study|Adverse Event|2|||
126409399|NCT01818492|454791807|FG000|Overall Study|Death|3|||
126409400|NCT01818492|454791807|FG000|Overall Study|Withdrawal by Subject|1|||
126409401|NCT01818492|454791807|FG000|Overall Study|Additional therapy when not allowed PP|4|||
126409402|NCT00587847|454791809|FG000|Overall Study|Lack of Efficacy|5|||
126409403|NCT00587847|454791809|FG000|Overall Study|Adverse Event|2|||
126409404|NCT01972789|454791810|FG000|Overall Study|Adverse Event|11|||
126409405|NCT01972789|454791811|FG001|Overall Study|Adverse Event|4|||
126409406|NCT01972789|454791810|FG000|Overall Study|Subject withdrew consent|14|||
126409407|NCT01972789|454791811|FG001|Overall Study|Subject withdrew consent|12|||
126409408|NCT01972789|454791810|FG000|Overall Study|Lost to Follow-up|4|||
126409409|NCT01972789|454791811|FG001|Overall Study|Lost to Follow-up|7|||
126409410|NCT01972789|454791810|FG000|Overall Study|Death|7|||
126409411|NCT01972789|454791811|FG001|Overall Study|Death|5|||
126409412|NCT01972789|454791810|FG000|Overall Study|Protocol deviation|1|||
126409413|NCT01972789|454791811|FG001|Overall Study|Protocol deviation|0|||
126409414|NCT01972789|454791810|FG000|Overall Study|Physician Decision|3|||
126409415|NCT01972789|454791811|FG001|Overall Study|Physician Decision|2|||
126409416|NCT04407234|454791814|FG000|Overall Study|Adverse Event|3|||
126409417|NCT04407234|454791815|FG001|Overall Study|Adverse Event|3|||
126409418|NCT00727558|454791818|FG000|Overall Study|Lens issue|0|||
126409419|NCT00727558|454791819|FG001|Overall Study|Lens issue|1|||
126409420|NCT00727558|454791818|FG000|Overall Study|Adverse Event|0|||
126409421|NCT00727558|454791819|FG001|Overall Study|Adverse Event|1|||
126409422|NCT00727558|454791818|FG000|Overall Study|Subject unable to return for follow-up|1|||
126409423|NCT00727558|454791819|FG001|Overall Study|Subject unable to return for follow-up|1|||
126409424|NCT00727558|454791818|FG000|Overall Study|Lost to Follow-up|1|||
126409425|NCT00727558|454791819|FG001|Overall Study|Lost to Follow-up|0|||
126409426|NCT03268941|454793694|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126054071|NCT03732807|453492214|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
126054072|NCT03732807|453492215|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
126409427|NCT03268941|454793695|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409428|NCT03268941|454793696|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409429|NCT03268941|454793697|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
126409430|NCT03268941|454793698|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409431|NCT03268941|454793699|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409432|NCT03268941|454793700|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409433|NCT03268941|454793694|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409434|NCT03268941|454793695|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409435|NCT03268941|454793696|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409436|NCT03268941|454793697|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
126409437|NCT03268941|454793698|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409438|NCT03268941|454793699|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409439|NCT03268941|454793700|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409440|NCT03268941|454793694|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
126409441|NCT03268941|454793695|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409442|NCT03268941|454793696|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409443|NCT03268941|454793697|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409444|NCT03268941|454793698|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409445|NCT03268941|454793699|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409446|NCT03268941|454793700|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409447|NCT03268941|454793694|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
126409448|NCT03268941|454793695|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
126409449|NCT03268941|454793696|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
126409450|NCT03268941|454793697|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
126409451|NCT03268941|454793698|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
126409452|NCT03268941|454793699|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
126409453|NCT03268941|454793700|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
126409454|NCT03268941|454793694|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409455|NCT03268941|454793695|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409456|NCT03268941|454793696|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409457|NCT03268941|454793697|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409458|NCT03268941|454793698|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409459|NCT03268941|454793699|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409460|NCT03268941|454793700|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
126409461|NCT01216683|454793701|FG000|Induction|Never started treatment|0|||
126409462|NCT01216683|454793702|FG001|Induction|Never started treatment|6|||
126409463|NCT01216683|454793703|FG002|Induction|Never started treatment|3|||
126409464|NCT01216683|454793701|FG000|Induction|Lack of Efficacy|4|||
126409465|NCT01216683|454793702|FG001|Induction|Lack of Efficacy|3|||
126409466|NCT01216683|454793703|FG002|Induction|Lack of Efficacy|7|||
126409467|NCT01216683|454793701|FG000|Induction|Adverse Event|0|||
126409468|NCT01216683|454793702|FG001|Induction|Adverse Event|5|||
126409469|NCT01216683|454793703|FG002|Induction|Adverse Event|5|||
126409470|NCT01216683|454793701|FG000|Induction|Death|0|||
126409471|NCT01216683|454793702|FG001|Induction|Death|0|||
126409472|NCT01216683|454793703|FG002|Induction|Death|2|||
126409473|NCT01216683|454793701|FG000|Induction|Withdrawal by Subject|0|||
126409474|NCT01216683|454793702|FG001|Induction|Withdrawal by Subject|4|||
126409475|NCT01216683|454793703|FG002|Induction|Withdrawal by Subject|2|||
126409476|NCT01216683|454793701|FG000|Induction|Other disease|0|||
126409477|NCT01216683|454793702|FG001|Induction|Other disease|1|||
126409478|NCT01216683|454793703|FG002|Induction|Other disease|2|||
126409479|NCT01216683|454793701|FG000|Continuation|Lack of Efficacy|3|||
126409480|NCT01216683|454793702|FG001|Continuation|Lack of Efficacy|2|||
126409481|NCT01216683|454793703|FG002|Continuation|Lack of Efficacy|7|||
126409482|NCT01216683|454793701|FG000|Continuation|Adverse Event|5|||
126409483|NCT01216683|454793702|FG001|Continuation|Adverse Event|3|||
126409484|NCT01216683|454793703|FG002|Continuation|Adverse Event|16|||
126409485|NCT01216683|454793701|FG000|Continuation|Death|1|||
126409486|NCT01216683|454793702|FG001|Continuation|Death|0|||
126409487|NCT01216683|454793703|FG002|Continuation|Death|2|||
126409488|NCT01216683|454793701|FG000|Continuation|Withdrawal by Subject|4|||
126409489|NCT01216683|454793702|FG001|Continuation|Withdrawal by Subject|5|||
126409490|NCT01216683|454793703|FG002|Continuation|Withdrawal by Subject|9|||
126409491|NCT01216683|454793701|FG000|Continuation|Other diseases|0|||
126409492|NCT01216683|454793702|FG001|Continuation|Other diseases|2|||
126409493|NCT01216683|454793703|FG002|Continuation|Other diseases|1|||
126409494|NCT01216683|454793701|FG000|Continuation|Physician Decision|1|||
126409495|NCT01216683|454793702|FG001|Continuation|Physician Decision|0|||
126409496|NCT01216683|454793703|FG002|Continuation|Physician Decision|1|||
126409497|NCT01216683|454793701|FG000|Continuation|Non-compliance|1|||
126409498|NCT01216683|454793702|FG001|Continuation|Non-compliance|0|||
126409499|NCT01216683|454793703|FG002|Continuation|Non-compliance|1|||
126409500|NCT01216683|454793701|FG000|Continuation|Insurance change|0|||
126409501|NCT01216683|454793702|FG001|Continuation|Insurance change|1|||
126409502|NCT01216683|454793703|FG002|Continuation|Insurance change|0|||
126409503|NCT01216683|454793701|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
126409504|NCT01216683|454793702|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
126409505|NCT01216683|454793703|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
126409506|NCT01216683|454793701|FG000|Continuation|Not reported|0|||
126409507|NCT01216683|454793702|FG001|Continuation|Not reported|0|||
126409508|NCT01216683|454793703|FG002|Continuation|Not reported|1|||
126409509|NCT01216683|454793701|FG000|Continuation|Never started treatment|0|||
126409510|NCT01216683|454793702|FG001|Continuation|Never started treatment|1|||
126409511|NCT01216683|454793703|FG002|Continuation|Never started treatment|5|||
126409512|NCT02503501|454793705|FG000|Overall Study|Physician Decision|1|||
126409513|NCT02503501|454793706|FG001|Overall Study|Physician Decision|0|||
126409514|NCT02503501|454793705|FG000|Overall Study|Protocol Violation|0|||
126409515|NCT02503501|454793706|FG001|Overall Study|Protocol Violation|1|||
126409516|NCT02503501|454793705|FG000|Overall Study|Withdrawal by Subject|0|||
126409517|NCT02503501|454793706|FG001|Overall Study|Withdrawal by Subject|2|||
126409518|NCT02806960|454793707|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
126409519|NCT02806960|454793708|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
126409520|NCT02806960|454793709|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
126409521|NCT02806960|454793710|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
126409522|NCT02702180|454793716|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126409523|NCT02702180|454793717|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126409524|NCT02702180|454793718|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126409525|NCT02702180|454793716|FG000|Double-blind Treatment Period|Adverse Event|0|||
126409526|NCT02702180|454793717|FG001|Double-blind Treatment Period|Adverse Event|0|||
126409527|NCT02702180|454793718|FG002|Double-blind Treatment Period|Adverse Event|1|||
126409528|NCT02702180|454793716|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126409529|NCT02702180|454793717|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
126409530|NCT02702180|454793718|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
126409531|NCT02702180|454793716|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126409532|NCT02702180|454793717|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126409533|NCT02702180|454793718|FG002|Double-blind Treatment Period|Protocol Violation|2|||
126409534|NCT02702180|454793716|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
126409535|NCT02702180|454793717|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
126409536|NCT02702180|454793718|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
126409537|NCT02702180|454793716|FG000|Open-label Treatment Period|Withdrawn in error|0|||
126409538|NCT02702180|454793717|FG001|Open-label Treatment Period|Withdrawn in error|0|||
126409539|NCT02702180|454793718|FG002|Open-label Treatment Period|Withdrawn in error|1|||
126409540|NCT00567359|454793719|FG000|Overall Study|Withdrawal by Subject|1|||
126409541|NCT04680975|454793720|FG000|Overall Study|Adverse Event|3|||
126409542|NCT04680975|454793720|FG000|Overall Study|Death|1|||
126409543|NCT04680975|454793720|FG000|Overall Study|Progressive Disease|1|||
126409544|NCT04680975|454793720|FG000|Overall Study|Withdrawal by Subject|1|||
126409545|NCT03270891|454793725|FG000|Overall Study|Lost to Follow-up|3|||
126409546|NCT03270891|454793726|FG001|Overall Study|Lost to Follow-up|6|||
126409547|NCT03270891|454793727|FG002|Overall Study|Lost to Follow-up|0|||
126409548|NCT03270891|454793725|FG000|Overall Study|Withdrawal by Subject|1|||
126409549|NCT03270891|454793726|FG001|Overall Study|Withdrawal by Subject|0|||
126409550|NCT03270891|454793727|FG002|Overall Study|Withdrawal by Subject|0|||
126409551|NCT03270891|454793725|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
126409552|NCT03270891|454793726|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
126409553|NCT03270891|454793727|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
126409554|NCT02540668|454793728|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
126409555|NCT02540668|454793729|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
126409556|NCT00290498|454793731|FG000|Overall Study|Death|2|||
126409557|NCT00290498|454793732|FG001|Overall Study|Death|0|||
126409558|NCT00290498|454793731|FG000|Overall Study|Physician Decision|1|||
126409559|NCT00290498|454793732|FG001|Overall Study|Physician Decision|0|||
126409560|NCT00290498|454793731|FG000|Overall Study|Withdrawal by Subject|1|||
126409561|NCT00290498|454793732|FG001|Overall Study|Withdrawal by Subject|0|||
126409562|NCT00290498|454793731|FG000|Overall Study|Ineligible|3|||
126409563|NCT00290498|454793732|FG001|Overall Study|Ineligible|0|||
126409564|NCT00290498|454793731|FG000|Overall Study|Non-Compliance|1|||
126409565|NCT00290498|454793732|FG001|Overall Study|Non-Compliance|0|||
126409566|NCT01716104|454793734|FG000|Overall Study|Do not meet inclusion criteria|6|||
126409567|NCT01716104|454793735|FG001|Overall Study|Do not meet inclusion criteria|7|||
126409568|NCT01753401|454793738|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
126409569|NCT01753401|454793739|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
126409570|NCT01753401|454793740|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
126409571|NCT01753401|454793741|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
126409572|NCT01753401|454793738|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
126409573|NCT01753401|454793739|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
126054073|NCT03732807|453492216|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
126054074|NCT03732807|453492217|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
126409574|NCT01753401|454793740|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
126054075|NCT03732807|453492218|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
126409575|NCT01753401|454793741|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
126409576|NCT01753401|454793738|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
126409577|NCT01753401|454793739|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
126409578|NCT01753401|454793740|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
126409579|NCT01753401|454793741|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
126409580|NCT01753401|454793738|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
126409581|NCT01753401|454793739|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
126409582|NCT01753401|454793740|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
126409583|NCT01753401|454793741|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
126409584|NCT01753401|454793738|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
126409585|NCT01753401|454793739|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
126409586|NCT01753401|454793740|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
126409587|NCT01753401|454793741|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
126409588|NCT01753401|454793738|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
126409589|NCT01753401|454793739|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
126409590|NCT01753401|454793740|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
126409591|NCT01753401|454793741|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
126409592|NCT01753401|454793738|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
126409593|NCT01753401|454793739|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
126409594|NCT01753401|454793740|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
126409595|NCT01753401|454793741|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
126409596|NCT03129360|454793742|FG000|Overall Study|Did not meet entry criteria|0|||
126409597|NCT03129360|454793743|FG001|Overall Study|Did not meet entry criteria|2|||
126409598|NCT03129360|454793744|FG002|Overall Study|Did not meet entry criteria|1|||
126409599|NCT03129360|454793742|FG000|Overall Study|Excluded due to motion in scanner|1|||
126409600|NCT03129360|454793743|FG001|Overall Study|Excluded due to motion in scanner|0|||
126409601|NCT03129360|454793744|FG002|Overall Study|Excluded due to motion in scanner|0|||
126409602|NCT03006887|454793745|FG000|Overall Study|Adverse Event|1|||
126409603|NCT05026853|454793746|FG000|Overall Study|Cancelled appointment|1|||
126409604|NCT05026853|454793747|FG001|Overall Study|Cancelled appointment|0|||
126409605|NCT05026853|454793746|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
126409606|NCT05026853|454793747|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
126409607|NCT05026853|454793746|FG000|Overall Study|Did not complete 12-week survey|16|||
126409608|NCT05026853|454793747|FG001|Overall Study|Did not complete 12-week survey|16|||
126409609|NCT03836677|454793748|FG000|Period 1|Adverse Event|0|||
126409610|NCT03836677|454793749|FG001|Period 1|Adverse Event|1|||
126409611|NCT03836677|454793748|FG000|Period 2|Severe non-compliance to protocol|1|||
126409612|NCT03836677|454793749|FG001|Period 2|Severe non-compliance to protocol|0|||
126409613|NCT01353911|454793750|FG000|Overall Study|Lost to Follow-up|2|||
126409614|NCT01353911|454793751|FG001|Overall Study|Lost to Follow-up|6|||
126409615|NCT01353911|454793752|FG002|Overall Study|Lost to Follow-up|4|||
126409616|NCT01353911|454793753|FG003|Overall Study|Lost to Follow-up|0|||
126409617|NCT01353911|454793754|FG004|Overall Study|Lost to Follow-up|4|||
126409618|NCT01353911|454793755|FG005|Overall Study|Lost to Follow-up|4|||
126409619|NCT01353911|454793756|FG006|Overall Study|Lost to Follow-up|3|||
126409620|NCT01353911|454793757|FG007|Overall Study|Lost to Follow-up|6|||
126409621|NCT01353911|454793750|FG000|Overall Study|Withdrawal by Subject|2|||
126409622|NCT01353911|454793751|FG001|Overall Study|Withdrawal by Subject|3|||
126409623|NCT01353911|454793752|FG002|Overall Study|Withdrawal by Subject|4|||
126409624|NCT01353911|454793753|FG003|Overall Study|Withdrawal by Subject|2|||
126409625|NCT01353911|454793754|FG004|Overall Study|Withdrawal by Subject|2|||
126409626|NCT01353911|454793755|FG005|Overall Study|Withdrawal by Subject|3|||
126409627|NCT01353911|454793756|FG006|Overall Study|Withdrawal by Subject|3|||
126409628|NCT01353911|454793757|FG007|Overall Study|Withdrawal by Subject|9|||
126409629|NCT01353911|454793750|FG000|Overall Study|Status Not Recorded|4|||
126409630|NCT01353911|454793751|FG001|Overall Study|Status Not Recorded|0|||
126409631|NCT01353911|454793752|FG002|Overall Study|Status Not Recorded|1|||
126409632|NCT01353911|454793753|FG003|Overall Study|Status Not Recorded|0|||
126409633|NCT01353911|454793754|FG004|Overall Study|Status Not Recorded|0|||
126409634|NCT01353911|454793755|FG005|Overall Study|Status Not Recorded|0|||
126409635|NCT01353911|454793756|FG006|Overall Study|Status Not Recorded|0|||
126409636|NCT01353911|454793757|FG007|Overall Study|Status Not Recorded|0|||
126409637|NCT00462748|454793762|FG000|Overall Study|Adverse Event|7|||
126409638|NCT00462748|454793763|FG001|Overall Study|Adverse Event|5|||
126409639|NCT00462748|454793764|FG002|Overall Study|Adverse Event|9|||
126409640|NCT00462748|454793762|FG000|Overall Study|Protocol Violation|0|||
126409641|NCT00462748|454793763|FG001|Overall Study|Protocol Violation|2|||
126409642|NCT00462748|454793764|FG002|Overall Study|Protocol Violation|1|||
126409643|NCT00462748|454793762|FG000|Overall Study|Withdrew consent|3|||
126409644|NCT00462748|454793763|FG001|Overall Study|Withdrew consent|3|||
126409645|NCT00462748|454793764|FG002|Overall Study|Withdrew consent|0|||
126409646|NCT00462748|454793762|FG000|Overall Study|Lost to Follow-up|1|||
126409647|NCT00462748|454793763|FG001|Overall Study|Lost to Follow-up|1|||
125890616|NCT02367833|452897192|FG002|Overall Study|Withdrawal by Subject|0|||
125890617|NCT00035932|452897197|FG000|Overall Study|Adverse Event|10|||
125890618|NCT00035932|452897198|FG001|Overall Study|Adverse Event|9|||
125890619|NCT00035932|452897199|FG002|Overall Study|Adverse Event|9|||
125890620|NCT00035932|452897197|FG000|Overall Study|Death|0|||
125890621|NCT00035932|452897198|FG001|Overall Study|Death|0|||
125890622|NCT00035932|452897199|FG002|Overall Study|Death|1|||
125890623|NCT00035932|452897197|FG000|Overall Study|Disease Progression / Relapse|1|||
125890624|NCT00035932|452897198|FG001|Overall Study|Disease Progression / Relapse|1|||
125890625|NCT00035932|452897199|FG002|Overall Study|Disease Progression / Relapse|0|||
125890626|NCT00035932|452897197|FG000|Overall Study|Lost to Follow-up|4|||
125890627|NCT00035932|452897198|FG001|Overall Study|Lost to Follow-up|4|||
125890628|NCT00035932|452897199|FG002|Overall Study|Lost to Follow-up|3|||
125890629|NCT00035932|452897197|FG000|Overall Study|Noncompliance|6|||
125890630|NCT00035932|452897198|FG001|Overall Study|Noncompliance|7|||
125890631|NCT00035932|452897199|FG002|Overall Study|Noncompliance|6|||
125890632|NCT00035932|452897197|FG000|Overall Study|Protocol Violation While on Study|0|||
125890633|NCT00035932|452897198|FG001|Overall Study|Protocol Violation While on Study|1|||
125890634|NCT00035932|452897199|FG002|Overall Study|Protocol Violation While on Study|2|||
125890635|NCT00035932|452897197|FG000|Overall Study|Withdrawal by Subject|1|||
125890636|NCT00035932|452897198|FG001|Overall Study|Withdrawal by Subject|5|||
125890637|NCT00035932|452897199|FG002|Overall Study|Withdrawal by Subject|0|||
125890638|NCT00035932|452897197|FG000|Overall Study|Study Termination by Sponsor|1|||
125890639|NCT00035932|452897198|FG001|Overall Study|Study Termination by Sponsor|0|||
125890640|NCT00035932|452897199|FG002|Overall Study|Study Termination by Sponsor|0|||
125890641|NCT00035932|452897197|FG000|Overall Study|Lack of Efficacy|33|||
125890642|NCT00035932|452897198|FG001|Overall Study|Lack of Efficacy|33|||
125890643|NCT00035932|452897199|FG002|Overall Study|Lack of Efficacy|28|||
125890644|NCT04080167|452897202|FG000|Overall Study|Lost to Follow-up-Patients|7|||
125890645|NCT04080167|452897203|FG001|Overall Study|Lost to Follow-up-Patients|14|||
125890646|NCT04080167|452897204|FG002|Overall Study|Lost to Follow-up-Patients|0|||
125890647|NCT04080167|452897202|FG000|Overall Study|Lost to Follow-up-Providers|2|||
125890648|NCT04080167|452897203|FG001|Overall Study|Lost to Follow-up-Providers|2|||
125890649|NCT04080167|452897204|FG002|Overall Study|Lost to Follow-up-Providers|0|||
125890650|NCT04080167|452897202|FG000|Overall Study|Withdrawal by Subject|1|||
125890651|NCT04080167|452897203|FG001|Overall Study|Withdrawal by Subject|2|||
125890652|NCT04080167|452897204|FG002|Overall Study|Withdrawal by Subject|0|||
125890653|NCT04080167|452897202|FG000|Overall Study|Withdrawal by Provider|0|||
125890654|NCT04080167|452897203|FG001|Overall Study|Withdrawal by Provider|0|||
125890655|NCT04080167|452897204|FG002|Overall Study|Withdrawal by Provider|4|||
125890656|NCT04080167|452897202|FG000|Overall Study|Death-Patient|2|||
125890657|NCT04080167|452897203|FG001|Overall Study|Death-Patient|1|||
126409648|NCT00462748|454793764|FG002|Overall Study|Lost to Follow-up|1|||
126409649|NCT00462748|454793762|FG000|Overall Study|Discontinued after 41 days Rx|1|||
126409650|NCT00462748|454793763|FG001|Overall Study|Discontinued after 41 days Rx|0|||
126409651|NCT00462748|454793764|FG002|Overall Study|Discontinued after 41 days Rx|0|||
126409652|NCT03233438|454793765|FG000|Overall Study|Lost to Follow-up|4|||
126409653|NCT03233438|454793766|FG001|Overall Study|Lost to Follow-up|9|||
126409654|NCT03233438|454793765|FG000|Overall Study|Withdrawal by Subject|2|||
126409655|NCT03233438|454793766|FG001|Overall Study|Withdrawal by Subject|1|||
126409656|NCT03233438|454793765|FG000|Overall Study|No recording of dalbavancin|0|||
126409657|NCT03233438|454793766|FG001|Overall Study|No recording of dalbavancin|1|||
126409658|NCT03429543|454793767|FG000|Overall Study|Adverse Event|1|||
126409659|NCT03429543|454793768|FG001|Overall Study|Adverse Event|1|||
125890658|NCT04080167|452897204|FG002|Overall Study|Death-Patient|0|||
126409660|NCT03429543|454793769|FG002|Overall Study|Adverse Event|0|||
126409661|NCT03429543|454793770|FG003|Overall Study|Adverse Event|0|||
126409662|NCT03429543|454793771|FG004|Overall Study|Adverse Event|0|||
126409663|NCT03429543|454793772|FG005|Overall Study|Adverse Event|2|||
126409664|NCT03429543|454793773|FG006|Overall Study|Adverse Event|0|||
126409665|NCT03429543|454793767|FG000|Overall Study|Lost to Follow-up|1|||
126409666|NCT03429543|454793768|FG001|Overall Study|Lost to Follow-up|0|||
126409667|NCT03429543|454793769|FG002|Overall Study|Lost to Follow-up|0|||
125890659|NCT04080167|452897202|FG000|Overall Study|Hydroxyurea New Starts|0|||
125890660|NCT04080167|452897203|FG001|Overall Study|Hydroxyurea New Starts|0|||
126409668|NCT03429543|454793770|FG003|Overall Study|Lost to Follow-up|0|||
126409669|NCT03429543|454793771|FG004|Overall Study|Lost to Follow-up|1|||
126409670|NCT03429543|454793772|FG005|Overall Study|Lost to Follow-up|0|||
126409671|NCT03429543|454793773|FG006|Overall Study|Lost to Follow-up|0|||
126409672|NCT03429543|454793767|FG000|Overall Study|Withdrawal by Subject|5|||
126409673|NCT03429543|454793768|FG001|Overall Study|Withdrawal by Subject|0|||
125890661|NCT04080167|452897204|FG002|Overall Study|Hydroxyurea New Starts|1|||
125890662|NCT04080167|452897202|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
125890663|NCT04080167|452897203|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
125890664|NCT04080167|452897204|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
126409674|NCT03429543|454793769|FG002|Overall Study|Withdrawal by Subject|1|||
126409675|NCT03429543|454793770|FG003|Overall Study|Withdrawal by Subject|2|||
126409676|NCT03429543|454793771|FG004|Overall Study|Withdrawal by Subject|6|||
126409677|NCT03429543|454793772|FG005|Overall Study|Withdrawal by Subject|3|||
126409678|NCT03429543|454793773|FG006|Overall Study|Withdrawal by Subject|1|||
126409679|NCT03429543|454793767|FG000|Overall Study|Other reason than listed|0|||
126409680|NCT03429543|454793768|FG001|Overall Study|Other reason than listed|1|||
126409681|NCT03429543|454793769|FG002|Overall Study|Other reason than listed|0|||
126409682|NCT03429543|454793770|FG003|Overall Study|Other reason than listed|0|||
126409683|NCT03429543|454793771|FG004|Overall Study|Other reason than listed|4|||
126409684|NCT03429543|454793772|FG005|Overall Study|Other reason than listed|4|||
126409685|NCT03429543|454793773|FG006|Overall Study|Other reason than listed|0|||
126409686|NCT03429543|454793767|FG000|Overall Study|Not treated|0|||
125890665|NCT01459497|452897205|FG000|Overall Study|Inability to meet trial constraints.|1|||
125890666|NCT01459497|452897206|FG001|Overall Study|Inability to meet trial constraints.|0|||
125890667|NCT01459497|452897205|FG000|Overall Study|Physician Decision|1|||
125890668|NCT01459497|452897206|FG001|Overall Study|Physician Decision|1|||
125890669|NCT01459497|452897205|FG000|Overall Study|Hospitalization.|0|||
125890670|NCT01459497|452897206|FG001|Overall Study|Hospitalization.|3|||
126409687|NCT03429543|454793768|FG001|Overall Study|Not treated|0|||
126409688|NCT03429543|454793769|FG002|Overall Study|Not treated|0|||
126409689|NCT03429543|454793770|FG003|Overall Study|Not treated|0|||
126409690|NCT03429543|454793771|FG004|Overall Study|Not treated|1|||
126409691|NCT03429543|454793772|FG005|Overall Study|Not treated|0|||
126409692|NCT03429543|454793773|FG006|Overall Study|Not treated|0|||
126409693|NCT01729208|454793774|FG000|Baseline|Physician Decision|5|||
126409694|NCT01729208|454793775|FG001|Baseline|Physician Decision|4|||
126409695|NCT01729208|454793774|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
126409696|NCT01729208|454793775|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
126409697|NCT01729208|454793774|FG000|12 Months Follow-up|Lost to Follow-up|3|||
126409698|NCT01729208|454793775|FG001|12 Months Follow-up|Lost to Follow-up|3|||
126409699|NCT01729208|454793774|FG000|24 Months Follow-up|Lost to Follow-up|3|||
126409700|NCT01729208|454793775|FG001|24 Months Follow-up|Lost to Follow-up|0|||
126409701|NCT01729208|454793774|FG000|36 Months Follow-up|Physician Decision|1|||
126409702|NCT01729208|454793775|FG001|36 Months Follow-up|Physician Decision|0|||
126409703|NCT01729208|454793774|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
126409704|NCT01729208|454793775|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
126409705|NCT02428413|454793777|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
126409706|NCT02428413|454793778|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
126409707|NCT02428413|454793777|FG000|Overall Study|Protocol Violation|1|||
126409708|NCT02428413|454793778|FG001|Overall Study|Protocol Violation|2|||
126409709|NCT02428413|454793777|FG000|Overall Study|Case Cancelled|2|||
126409710|NCT02428413|454793778|FG001|Overall Study|Case Cancelled|0|||
126409711|NCT02428413|454793777|FG000|Overall Study|Missed Cases|1|||
126409712|NCT02428413|454793778|FG001|Overall Study|Missed Cases|2|||
126409713|NCT02428413|454793777|FG000|Overall Study|Nurse Refusal|1|||
126409714|NCT02428413|454793778|FG001|Overall Study|Nurse Refusal|0|||
126409715|NCT03688100|454793783|FG000|Overall Study|Lost to Follow-up|21|||
126409716|NCT03688100|454793784|FG001|Overall Study|Lost to Follow-up|15|||
126409717|NCT03688100|454793785|FG002|Overall Study|Lost to Follow-up|15|||
126409718|NCT03688100|454793786|FG003|Overall Study|Lost to Follow-up|18|||
126409719|NCT03688100|454793783|FG000|Overall Study|Withdrawal by Subject|19|||
126409720|NCT03688100|454793784|FG001|Overall Study|Withdrawal by Subject|16|||
126409721|NCT03688100|454793785|FG002|Overall Study|Withdrawal by Subject|0|||
126409722|NCT03688100|454793786|FG003|Overall Study|Withdrawal by Subject|0|||
126409723|NCT03688100|454793783|FG000|Overall Study|Death|36|||
126409724|NCT03688100|454793784|FG001|Overall Study|Death|27|||
126409725|NCT03688100|454793785|FG002|Overall Study|Death|0|||
126409726|NCT03688100|454793786|FG003|Overall Study|Death|0|||
126409727|NCT02345330|454793787|FG000|Overall Study|Death|1|||
126409728|NCT02345330|454793787|FG000|Overall Study|Progressive Disease|2|||
126409729|NCT00494507|454793788|FG000|Double-Blind Phase|Adverse Event|2|||
126409730|NCT00494507|454793789|FG001|Double-Blind Phase|Adverse Event|0|||
126409731|NCT00494507|454793790|FG002|Double-Blind Phase|Adverse Event|1|||
126409732|NCT00494507|454793791|FG003|Double-Blind Phase|Adverse Event|0|||
126409733|NCT00494507|454793788|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
126409734|NCT00494507|454793789|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
126409735|NCT00494507|454793790|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126409736|NCT00494507|454793791|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126409737|NCT00494507|454793788|FG000|Double-Blind Phase|Subject Non-compliance|0|||
126409738|NCT00494507|454793789|FG001|Double-Blind Phase|Subject Non-compliance|0|||
126409739|NCT00494507|454793790|FG002|Double-Blind Phase|Subject Non-compliance|1|||
126409740|NCT00494507|454793791|FG003|Double-Blind Phase|Subject Non-compliance|0|||
126409741|NCT00494507|454793788|FG000|Double-Blind Phase|Negative DNA test|0|||
126409742|NCT00494507|454793789|FG001|Double-Blind Phase|Negative DNA test|0|||
126409743|NCT00494507|454793790|FG002|Double-Blind Phase|Negative DNA test|0|||
126409744|NCT00494507|454793791|FG003|Double-Blind Phase|Negative DNA test|1|||
126409745|NCT00494507|454793788|FG000|Open-Label Phase|Adverse Event|0|||
126409746|NCT00494507|454793789|FG001|Open-Label Phase|Adverse Event|1|||
126409747|NCT00494507|454793790|FG002|Open-Label Phase|Adverse Event|5|||
126409748|NCT00494507|454793791|FG003|Open-Label Phase|Adverse Event|3|||
126409749|NCT00494507|454793788|FG000|Open-Label Phase|Worsening Disease|0|||
126409750|NCT00494507|454793789|FG001|Open-Label Phase|Worsening Disease|0|||
126409751|NCT00494507|454793790|FG002|Open-Label Phase|Worsening Disease|0|||
126409752|NCT00494507|454793791|FG003|Open-Label Phase|Worsening Disease|2|||
126409753|NCT03615066|454793792|FG000|Main Study|Withdrew Consent|0|||
126409754|NCT03615066|454793793|FG001|Main Study|Withdrew Consent|1|||
126409755|NCT03615066|454793794|FG002|Main Study|Withdrew Consent|1|||
126409756|NCT03615066|454793792|FG000|Main Study|Lost to Follow-up|0|||
126409757|NCT03615066|454793793|FG001|Main Study|Lost to Follow-up|0|||
126409758|NCT03615066|454793794|FG002|Main Study|Lost to Follow-up|1|||
126409759|NCT03615066|454793792|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
126409760|NCT03615066|454793793|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
126409761|NCT03615066|454793794|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
126409762|NCT03615066|454793792|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
126409763|NCT03615066|454793793|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
126409764|NCT03615066|454793794|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
126409765|NCT03615066|454793792|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
126409766|NCT03615066|454793793|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
126409767|NCT03615066|454793794|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
126409768|NCT02437084|454793795|FG000|Overall Study|Withdrawal by Subject|2|||
126409769|NCT02437084|454793795|FG000|Overall Study|Physician Decision|1|||
126409770|NCT03729245|454793796|FG000|Overall Study|Lost to Follow-up|5|||
126409771|NCT03729245|454793797|FG001|Overall Study|Lost to Follow-up|6|||
126409772|NCT03729245|454793796|FG000|Overall Study|Withdrawal by Subject|16|||
126409773|NCT03729245|454793797|FG001|Overall Study|Withdrawal by Subject|19|||
126409774|NCT03729245|454793796|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
125890671|NCT01459497|452897205|FG000|Overall Study|Disease progression.|0|||
125890672|NCT01459497|452897206|FG001|Overall Study|Disease progression.|1|||
125890673|NCT01192191|452897207|FG000|Overall Study|Adverse Event|7|||
125890674|NCT01192191|452897208|FG001|Overall Study|Adverse Event|12|||
125890675|NCT01192191|452897207|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
125890676|NCT01192191|452897208|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
126409775|NCT03729245|454793797|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
126409776|NCT00989781|454793807|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
126409777|NCT00989781|454793808|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
126409778|NCT00694304|454793809|FG000|Overall Study|Adverse Event|42|||
126409779|NCT00694304|454793809|FG000|Overall Study|Lack of Efficacy|35|||
126409780|NCT00694304|454793809|FG000|Overall Study|Non-compliance With Study Product|16|||
126409781|NCT00694304|454793809|FG000|Overall Study|Protocol Violation|6|||
126409782|NCT00694304|454793809|FG000|Overall Study|Withdrawal of Consent|61|||
126409783|NCT00694304|454793809|FG000|Overall Study|Lost to Follow-up|15|||
126409784|NCT00694304|454793809|FG000|Overall Study|Administrative or Other Reasons|32|||
126409785|NCT03517566|454793812|FG000|Overall Study|Adverse Event|5|||
126409786|NCT03517566|454793813|FG001|Overall Study|Adverse Event|2|||
126409787|NCT03517566|454793814|FG002|Overall Study|Adverse Event|2|||
126409788|NCT03517566|454793815|FG003|Overall Study|Adverse Event|8|||
126409789|NCT03517566|454793816|FG004|Overall Study|Adverse Event|7|||
125890677|NCT01192191|452897207|FG000|Overall Study|Lost to Follow-up|0|||
125890678|NCT01192191|452897208|FG001|Overall Study|Lost to Follow-up|1|||
125890679|NCT01192191|452897207|FG000|Overall Study|Withdrawal by Subject|1|||
125890680|NCT01192191|452897208|FG001|Overall Study|Withdrawal by Subject|6|||
125890681|NCT03179319|452897209|FG000|Overall Study|Lost to Follow-up|6|||
125890682|NCT03179319|452897210|FG001|Overall Study|Lost to Follow-up|0|||
125890683|NCT04393454|452897213|FG000|Overall Study|Death|1|||
125890684|NCT04393454|452897213|FG000|Overall Study|Lost to Follow-up|1|||
125890685|NCT02260180|452899558|FG000|Overall Study|Adverse Event|2|||
125890686|NCT02260180|452899559|FG001|Overall Study|Adverse Event|0|||
125890687|NCT02260180|452899560|FG002|Overall Study|Adverse Event|1|||
125890688|NCT03860818|452899571|FG000|Overall Study|Death|144|||
125890689|NCT03860818|452899572|FG001|Overall Study|Death|195|||
125890690|NCT03860818|452899571|FG000|Overall Study|Graft Loss|32|||
125890691|NCT03860818|452899572|FG001|Overall Study|Graft Loss|45|||
125890692|NCT03126344|452899573|FG000|Overall Study|Lost to Follow-up|0|||
125890693|NCT03126344|452899574|FG001|Overall Study|Lost to Follow-up|0|||
125890694|NCT03126344|452899575|FG002|Overall Study|Lost to Follow-up|5|||
125890695|NCT05367492|452899576|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
125890696|NCT05367492|452899577|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
125890697|NCT05367492|452899578|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
125890698|NCT05367492|452899576|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
125890699|NCT05367492|452899577|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
125890700|NCT05367492|452899578|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
125890701|NCT05367492|452899576|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
125890702|NCT05367492|452899577|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
125890703|NCT05367492|452899578|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
125890704|NCT05367492|452899576|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
125890705|NCT05367492|452899577|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
125890706|NCT05367492|452899578|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
125890707|NCT01088048|452899579|FG000|Overall Study|Adverse Event|7|||
125890708|NCT01088048|452899580|FG001|Overall Study|Adverse Event|9|||
125890709|NCT01088048|452899581|FG002|Overall Study|Adverse Event|7|||
125890710|NCT01088048|452899582|FG003|Overall Study|Adverse Event|5|||
125890711|NCT01088048|452899583|FG004|Overall Study|Adverse Event|6|||
125890712|NCT01088048|452899584|FG005|Overall Study|Adverse Event|3|||
125890713|NCT01088048|452899585|FG006|Overall Study|Adverse Event|3|||
125890714|NCT01088048|452899586|FG007|Overall Study|Adverse Event|0|||
125890715|NCT01088048|452899587|FG008|Overall Study|Adverse Event|2|||
125890716|NCT01088048|452899588|FG009|Overall Study|Adverse Event|2|||
125890717|NCT01088048|452899579|FG000|Overall Study|Withdrew Consent|1|||
125890718|NCT01088048|452899580|FG001|Overall Study|Withdrew Consent|1|||
125890719|NCT01088048|452899581|FG002|Overall Study|Withdrew Consent|1|||
125890720|NCT01088048|452899582|FG003|Overall Study|Withdrew Consent|1|||
125890721|NCT01088048|452899583|FG004|Overall Study|Withdrew Consent|2|||
126409790|NCT03517566|454793812|FG000|Overall Study|Lack of Efficacy|3|||
126409791|NCT03517566|454793813|FG001|Overall Study|Lack of Efficacy|2|||
125890722|NCT01088048|452899584|FG005|Overall Study|Withdrew Consent|1|||
125890723|NCT01088048|452899585|FG006|Overall Study|Withdrew Consent|0|||
125890724|NCT01088048|452899586|FG007|Overall Study|Withdrew Consent|2|||
125890725|NCT01088048|452899587|FG008|Overall Study|Withdrew Consent|2|||
125890726|NCT01088048|452899588|FG009|Overall Study|Withdrew Consent|1|||
125890727|NCT01088048|452899579|FG000|Overall Study|Concomitant Medication Prohibited|1|||
125890728|NCT01088048|452899580|FG001|Overall Study|Concomitant Medication Prohibited|0|||
126409792|NCT03517566|454793814|FG002|Overall Study|Lack of Efficacy|1|||
126409793|NCT03517566|454793815|FG003|Overall Study|Lack of Efficacy|1|||
126409794|NCT03517566|454793816|FG004|Overall Study|Lack of Efficacy|4|||
126409795|NCT03517566|454793812|FG000|Overall Study|Lost to Follow-up|3|||
126409796|NCT03517566|454793813|FG001|Overall Study|Lost to Follow-up|1|||
126409797|NCT03517566|454793814|FG002|Overall Study|Lost to Follow-up|1|||
126409798|NCT03517566|454793815|FG003|Overall Study|Lost to Follow-up|1|||
126409799|NCT03517566|454793816|FG004|Overall Study|Lost to Follow-up|0|||
126409800|NCT03517566|454793812|FG000|Overall Study|Physician Decision|1|||
126409801|NCT03517566|454793813|FG001|Overall Study|Physician Decision|1|||
126409802|NCT03517566|454793814|FG002|Overall Study|Physician Decision|0|||
126409803|NCT03517566|454793815|FG003|Overall Study|Physician Decision|1|||
126409804|NCT03517566|454793816|FG004|Overall Study|Physician Decision|0|||
126409805|NCT03517566|454793812|FG000|Overall Study|Pregnancy|0|||
126409806|NCT03517566|454793813|FG001|Overall Study|Pregnancy|1|||
126409807|NCT03517566|454793814|FG002|Overall Study|Pregnancy|0|||
126409808|NCT03517566|454793815|FG003|Overall Study|Pregnancy|0|||
126409809|NCT03517566|454793816|FG004|Overall Study|Pregnancy|0|||
126409810|NCT03517566|454793812|FG000|Overall Study|Protocol Deviation|0|||
126409811|NCT03517566|454793813|FG001|Overall Study|Protocol Deviation|1|||
126409812|NCT03517566|454793814|FG002|Overall Study|Protocol Deviation|0|||
126409813|NCT03517566|454793815|FG003|Overall Study|Protocol Deviation|1|||
126409814|NCT03517566|454793816|FG004|Overall Study|Protocol Deviation|1|||
126409815|NCT03517566|454793812|FG000|Overall Study|Study terminated by Sponsor|11|||
126409816|NCT03517566|454793813|FG001|Overall Study|Study terminated by Sponsor|5|||
126409817|NCT03517566|454793814|FG002|Overall Study|Study terminated by Sponsor|6|||
126409818|NCT03517566|454793815|FG003|Overall Study|Study terminated by Sponsor|14|||
126409819|NCT03517566|454793816|FG004|Overall Study|Study terminated by Sponsor|12|||
126409820|NCT03517566|454793812|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
126409821|NCT03517566|454793813|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
126409822|NCT03517566|454793814|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
126409823|NCT03517566|454793815|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
126409824|NCT03517566|454793816|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
126409825|NCT04566692|454793817|FG000|Overall Study|Adverse Event|2|||
126409826|NCT04566692|454793818|FG001|Overall Study|Adverse Event|0|||
126409827|NCT04566692|454793817|FG000|Overall Study|Withdrawal by Subject|1|||
126409828|NCT04566692|454793818|FG001|Overall Study|Withdrawal by Subject|1|||
126409829|NCT00671437|454793819|FG000|Overall Study|Progressive disease before C1 week 8|8|||
126409830|NCT00671437|454793819|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
126409831|NCT00671437|454793819|FG000|Overall Study|Adverse Event|3|||
126409832|NCT00671437|454793819|FG000|Overall Study|Ineligible post-hoc|1|||
126409833|NCT04311463|454793822|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
126409834|NCT04311463|454793823|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
126409835|NCT04311463|454793822|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
126409836|NCT04311463|454793823|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
126409837|NCT04311463|454793822|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
126409838|NCT04311463|454793823|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
126409839|NCT03203291|454793828|FG000|Overall Study|Withdrawal by Subject|1|||
126409840|NCT00737633|454793830|FG000|Overall Study|Study terminated by sponsor|44|||
126409841|NCT00737633|454793831|FG001|Overall Study|Study terminated by sponsor|55|||
126409842|NCT00737633|454793830|FG000|Overall Study|Lost to Follow-up|0|||
126409843|NCT00737633|454793831|FG001|Overall Study|Lost to Follow-up|1|||
126409844|NCT00737633|454793830|FG000|Overall Study|protocol non-compliance|0|||
126409845|NCT00737633|454793831|FG001|Overall Study|protocol non-compliance|1|||
126409846|NCT01300260|454793836|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
126409847|NCT01300260|454793837|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
126409848|NCT01300260|454793836|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
126409849|NCT01300260|454793837|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
126054076|NCT03732807|453492219|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
126409850|NCT01300260|454793836|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
126409851|NCT01300260|454793837|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
126409852|NCT00377364|454793838|FG000|Overall Study|Lost to Follow-up|1|||
126409853|NCT00377364|454793839|FG001|Overall Study|Lost to Follow-up|0|||
126409854|NCT00377364|454793838|FG000|Overall Study|Withdrawal by Subject|1|||
126054077|NCT03732807|453492213|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
126409855|NCT00377364|454793839|FG001|Overall Study|Withdrawal by Subject|0|||
126409856|NCT02540265|454793847|FG000|Overall Study|Lost to Follow-up|0|||
126409857|NCT02540265|454793848|FG001|Overall Study|Lost to Follow-up|0|||
126409858|NCT02540265|454793849|FG002|Overall Study|Lost to Follow-up|1|||
126409859|NCT03157037|454793855|FG000|Overall Study|Death|1|||
126409860|NCT02102399|454793856|FG000|Overall Study|Withdrawal by Subject|6|||
126409861|NCT02102399|454793857|FG001|Overall Study|Withdrawal by Subject|4|||
126409862|NCT03101085|454793858|FG000|Overall Study|Lost to Follow-up|0|||
126409863|NCT03101085|454793859|FG001|Overall Study|Lost to Follow-up|1|||
126409864|NCT00695864|454793860|FG000|Placebo|Withdrawal by Subject|1|||
126409865|NCT00695864|454793860|FG000|Placebo|Physician Decision|4|||
126409866|NCT01704456|454793861|FG000|Overall Study|Lost to Follow-up|8|||
126409867|NCT01704456|454793862|FG001|Overall Study|Lost to Follow-up|14|||
126409868|NCT00718770|454793863|FG000|Overall Study|Adverse Event|1|||
126409869|NCT00718770|454793863|FG000|Overall Study|Lack of Efficacy|1|||
126409870|NCT00718770|454793863|FG000|Overall Study|Lack of Efficacy|1|||
126409871|NCT00718770|454793863|FG000|Overall Study|Adverse Event|1|||
126409872|NCT00718770|454793863|FG000|Overall Study|Lack of Efficacy|1|||
126409873|NCT00718770|454793863|FG000|Overall Study|Adverse Event|1|||
126409874|NCT00718770|454793863|FG000|Overall Study|Lack of Efficacy|1|||
126409875|NCT00718770|454793863|FG000|Overall Study|Adverse Event|1|||
126409876|NCT00498355|454793864|FG000|Overall Study|Lost to Follow-up|1|||
126409877|NCT04583956|454793865|FG000|Overall Study|Death|9|||
126409878|NCT04583956|454793866|FG001|Overall Study|Death|11|||
126409879|NCT04583956|454793865|FG000|Overall Study|Lost to Follow-up|7|||
126409880|NCT04583956|454793866|FG001|Overall Study|Lost to Follow-up|9|||
126409881|NCT04583956|454793865|FG000|Overall Study|Protocol Violation|2|||
126409882|NCT04583956|454793866|FG001|Overall Study|Protocol Violation|0|||
126409883|NCT04583956|454793865|FG000|Overall Study|Withdrawal by Subject|0|||
126409884|NCT04583956|454793866|FG001|Overall Study|Withdrawal by Subject|2|||
126409885|NCT04583956|454793865|FG000|Overall Study|Randomized but not dosed|2|||
126409886|NCT04583956|454793866|FG001|Overall Study|Randomized but not dosed|3|||
126409887|NCT04583956|454793865|FG000|Overall Study|Withdrawal of consent before product administration|1|||
126409888|NCT04583956|454793866|FG001|Overall Study|Withdrawal of consent before product administration|0|||
126409889|NCT02100475|454795433|FG000|Overall Study|Unclassified|1|||
126409890|NCT02100475|454795434|FG001|Overall Study|Unclassified|2|||
126409891|NCT02100475|454795433|FG000|Overall Study|Withdrawal criteria|1|||
126409892|NCT02100475|454795434|FG001|Overall Study|Withdrawal criteria|0|||
126409893|NCT04599465|454795435|FG000|Overall Study|Physician Decision|1|||
126409894|NCT04599465|454795435|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
126409895|NCT00765063|454795436|FG000|Overall Study|Lack of Efficacy|5|||
126409896|NCT00765063|454795436|FG000|Overall Study|Withdrawal by Subject|1|||
126409897|NCT00765063|454795436|FG000|Overall Study|Other|16|||
126409898|NCT00765063|454795436|FG000|Overall Study|Protocol Violation|6|||
126409899|NCT00765063|454795436|FG000|Overall Study|Adverse Event|4|||
126409900|NCT01041287|454795439|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
126409901|NCT01041287|454795440|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
126409902|NCT01041287|454795439|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
126409903|NCT01041287|454795440|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
126409904|NCT02814175|454795441|FG000|Part 1|Adverse Event|2|||
126409905|NCT02814175|454795442|FG001|Part 1|Adverse Event|3|||
126409906|NCT02814175|454795443|FG002|Part 1|Adverse Event|0|||
126409907|NCT02814175|454795444|FG003|Part 1|Adverse Event|0|||
126409908|NCT02814175|454795445|FG004|Part 1|Adverse Event|0|||
126409909|NCT02814175|454795446|FG005|Part 1|Adverse Event|0|||
126409910|NCT02814175|454795441|FG000|Part 1|Withdrawal Consent|8|||
126409911|NCT02814175|454795442|FG001|Part 1|Withdrawal Consent|1|||
126409912|NCT02814175|454795443|FG002|Part 1|Withdrawal Consent|0|||
126409913|NCT02814175|454795444|FG003|Part 1|Withdrawal Consent|0|||
126409914|NCT02814175|454795445|FG004|Part 1|Withdrawal Consent|0|||
126409915|NCT02814175|454795446|FG005|Part 1|Withdrawal Consent|0|||
126409916|NCT02814175|454795441|FG000|Part 1|Lost to Follow-up|1|||
126409917|NCT02814175|454795442|FG001|Part 1|Lost to Follow-up|0|||
126409918|NCT02814175|454795443|FG002|Part 1|Lost to Follow-up|0|||
126409919|NCT02814175|454795444|FG003|Part 1|Lost to Follow-up|0|||
126409920|NCT02814175|454795445|FG004|Part 1|Lost to Follow-up|0|||
126409921|NCT02814175|454795446|FG005|Part 1|Lost to Follow-up|0|||
126409922|NCT02814175|454795441|FG000|Part 1|Lack of Efficacy|1|||
126409923|NCT02814175|454795442|FG001|Part 1|Lack of Efficacy|2|||
126409924|NCT02814175|454795443|FG002|Part 1|Lack of Efficacy|0|||
126409925|NCT02814175|454795444|FG003|Part 1|Lack of Efficacy|0|||
126409926|NCT02814175|454795445|FG004|Part 1|Lack of Efficacy|0|||
126409927|NCT02814175|454795446|FG005|Part 1|Lack of Efficacy|0|||
126409928|NCT02814175|454795441|FG000|Part 2|Adverse Event|0|||
126409929|NCT02814175|454795442|FG001|Part 2|Adverse Event|0|||
126409930|NCT02814175|454795443|FG002|Part 2|Adverse Event|0|||
126409931|NCT02814175|454795444|FG003|Part 2|Adverse Event|1|||
126409932|NCT02814175|454795445|FG004|Part 2|Adverse Event|1|||
126409933|NCT02814175|454795446|FG005|Part 2|Adverse Event|2|||
126409934|NCT02814175|454795441|FG000|Part 2|Withdrawal Consent|0|||
126409935|NCT02814175|454795442|FG001|Part 2|Withdrawal Consent|0|||
126409936|NCT02814175|454795443|FG002|Part 2|Withdrawal Consent|0|||
126409937|NCT02814175|454795444|FG003|Part 2|Withdrawal Consent|2|||
126409938|NCT02814175|454795445|FG004|Part 2|Withdrawal Consent|1|||
126409939|NCT02814175|454795446|FG005|Part 2|Withdrawal Consent|1|||
126409940|NCT02814175|454795441|FG000|Part 2|Lost to Follow-up|0|||
126409941|NCT02814175|454795442|FG001|Part 2|Lost to Follow-up|0|||
126409942|NCT02814175|454795443|FG002|Part 2|Lost to Follow-up|0|||
126409943|NCT02814175|454795444|FG003|Part 2|Lost to Follow-up|1|||
126409944|NCT02814175|454795445|FG004|Part 2|Lost to Follow-up|0|||
126409945|NCT02814175|454795446|FG005|Part 2|Lost to Follow-up|0|||
126409946|NCT02814175|454795441|FG000|Part 2|Lack of Efficacy|0|||
126409947|NCT02814175|454795442|FG001|Part 2|Lack of Efficacy|0|||
126409948|NCT02814175|454795443|FG002|Part 2|Lack of Efficacy|0|||
126409949|NCT02814175|454795444|FG003|Part 2|Lack of Efficacy|0|||
126409950|NCT02814175|454795445|FG004|Part 2|Lack of Efficacy|0|||
126409951|NCT02814175|454795446|FG005|Part 2|Lack of Efficacy|3|||
126409952|NCT01673620|454795447|FG000|Overall Study|Adverse Event|1|||
126409953|NCT01673620|454795448|FG001|Overall Study|Adverse Event|0|||
126409954|NCT03416127|454795449|FG000|Overall Study|Withdrawal by Subject|0|||
126409955|NCT03416127|454795450|FG001|Overall Study|Withdrawal by Subject|1|||
126409956|NCT03416127|454795451|FG002|Overall Study|Withdrawal by Subject|1|||
126409957|NCT02397057|454795452|FG000|Overall Study|Withdrawal by Subject|6|||
126409958|NCT02397057|454795453|FG001|Overall Study|Withdrawal by Subject|7|||
126409959|NCT02397057|454795452|FG000|Overall Study|Lost to Follow-up|4|||
126409960|NCT02397057|454795453|FG001|Overall Study|Lost to Follow-up|3|||
126409961|NCT02397057|454795452|FG000|Overall Study|Death|1|||
126409962|NCT02397057|454795453|FG001|Overall Study|Death|0|||
126409963|NCT02397057|454795452|FG000|Overall Study|Adverse Event|0|||
126409964|NCT02397057|454795453|FG001|Overall Study|Adverse Event|1|||
126409965|NCT02397057|454795452|FG000|Overall Study|Physician Decision|0|||
126409966|NCT02397057|454795453|FG001|Overall Study|Physician Decision|1|||
126409967|NCT02397057|454795452|FG000|Overall Study|Subject did not receive study drug|0|||
126409968|NCT02397057|454795453|FG001|Overall Study|Subject did not receive study drug|1|||
126409969|NCT00753454|454795458|FG000|Overall Study|Adverse Event|4|||
126409970|NCT00753454|454795458|FG000|Overall Study|Lack of Efficacy|1|||
126409971|NCT00753454|454795458|FG000|Overall Study|Lost to Follow-up|3|||
126409972|NCT00753454|454795458|FG000|Overall Study|Withdrawal by Subject|5|||
126409973|NCT00753454|454795458|FG000|Overall Study|Investigator Decision|1|||
126409974|NCT03927144|454795459|FG000|Core Phase|Adverse Event|9|||
126409975|NCT03927144|454795460|FG001|Core Phase|Adverse Event|5|||
126409976|NCT03927144|454795459|FG000|Core Phase|Lost to Follow-up|3|||
126409977|NCT03927144|454795460|FG001|Core Phase|Lost to Follow-up|2|||
126409978|NCT03927144|454795459|FG000|Core Phase|New Therapy for Study Indication|0|||
126409979|NCT03927144|454795460|FG001|Core Phase|New Therapy for Study Indication|1|||
126409980|NCT03927144|454795459|FG000|Core Phase|No Longer Clinically Benefiting|4|||
126409981|NCT03927144|454795460|FG001|Core Phase|No Longer Clinically Benefiting|4|||
126409982|NCT03927144|454795459|FG000|Core Phase|Physician Decision|2|||
126409983|NCT03927144|454795460|FG001|Core Phase|Physician Decision|8|||
126409984|NCT03927144|454795459|FG000|Core Phase|Protocol Violation|2|||
126409985|NCT03927144|454795460|FG001|Core Phase|Protocol Violation|2|||
126409986|NCT03927144|454795459|FG000|Core Phase|Withdrawal by Subject|16|||
126409987|NCT03927144|454795460|FG001|Core Phase|Withdrawal by Subject|40|||
126409988|NCT03927144|454795459|FG000|Extension Phase|Adverse Event|2|||
126409989|NCT03927144|454795460|FG001|Extension Phase|Adverse Event|1|||
126409990|NCT03927144|454795459|FG000|Extension Phase|No longer clinically benefiting|4|||
126409991|NCT03927144|454795460|FG001|Extension Phase|No longer clinically benefiting|5|||
126409992|NCT03927144|454795459|FG000|Extension Phase|Pregnancy|1|||
126409993|NCT03927144|454795460|FG001|Extension Phase|Pregnancy|0|||
126409994|NCT03927144|454795459|FG000|Extension Phase|Protocol Violation|0|||
126409995|NCT03927144|454795460|FG001|Extension Phase|Protocol Violation|1|||
126409996|NCT03927144|454795459|FG000|Extension Phase|Withdrawal by Subject|8|||
126409997|NCT03927144|454795460|FG001|Extension Phase|Withdrawal by Subject|3|||
126409998|NCT01452919|454795467|FG000|Open-Label Treatment|Adverse Event|5|||
126409999|NCT01452919|454795468|FG001|Open-Label Treatment|Adverse Event|0|||
126410000|NCT01452919|454795469|FG002|Open-Label Treatment|Adverse Event|0|||
126410001|NCT01452919|454795467|FG000|Open-Label Treatment|Lost to Follow-up|4|||
126410002|NCT01452919|454795468|FG001|Open-Label Treatment|Lost to Follow-up|0|||
126410003|NCT01452919|454795469|FG002|Open-Label Treatment|Lost to Follow-up|0|||
126410004|NCT01452919|454795467|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
126410005|NCT01452919|454795468|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
126410006|NCT01452919|454795469|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
126410007|NCT01452919|454795467|FG000|Open-Label Treatment|Protocol Violation|4|||
126410008|NCT01452919|454795468|FG001|Open-Label Treatment|Protocol Violation|0|||
126410009|NCT01452919|454795469|FG002|Open-Label Treatment|Protocol Violation|0|||
126410010|NCT01452919|454795467|FG000|Open-Label Treatment|Sponsor Decision|1|||
126410011|NCT01452919|454795468|FG001|Open-Label Treatment|Sponsor Decision|0|||
126410012|NCT01452919|454795469|FG002|Open-Label Treatment|Sponsor Decision|0|||
126410013|NCT01452919|454795467|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
126410014|NCT01452919|454795468|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
126410015|NCT01452919|454795469|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
126410016|NCT01452919|454795467|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
126410017|NCT01452919|454795468|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
126410018|NCT01452919|454795469|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
126410019|NCT01452919|454795467|FG000|Randomization Treatment|Adverse Event|0|||
126410020|NCT01452919|454795468|FG001|Randomization Treatment|Adverse Event|0|||
126410021|NCT01452919|454795469|FG002|Randomization Treatment|Adverse Event|2|||
126410022|NCT01452919|454795467|FG000|Randomization Treatment|Sponsor Decision|0|||
126410023|NCT01452919|454795468|FG001|Randomization Treatment|Sponsor Decision|1|||
126410024|NCT01452919|454795469|FG002|Randomization Treatment|Sponsor Decision|0|||
126410025|NCT01452919|454795467|FG000|Randomization Treatment|Withdrawal by Subject|0|||
126410026|NCT01452919|454795468|FG001|Randomization Treatment|Withdrawal by Subject|1|||
126410027|NCT01452919|454795469|FG002|Randomization Treatment|Withdrawal by Subject|0|||
126410028|NCT01452919|454795467|FG000|Randomization Treatment|Subject is moving or has moved|0|||
126410029|NCT01452919|454795468|FG001|Randomization Treatment|Subject is moving or has moved|1|||
126410030|NCT01452919|454795469|FG002|Randomization Treatment|Subject is moving or has moved|0|||
126410031|NCT01192412|454795470|FG000|Overall Study|Lost to Follow-up|2|||
126410032|NCT01192412|454795471|FG001|Overall Study|Lost to Follow-up|1|||
126410033|NCT01192412|454795470|FG000|Overall Study|Withdrawal by Subject|2|||
126410034|NCT01192412|454795471|FG001|Overall Study|Withdrawal by Subject|1|||
126410035|NCT02421588|454795472|FG000|Overall Study|Non-treatment-related AE|8|||
126410036|NCT02421588|454795473|FG001|Overall Study|Non-treatment-related AE|8|||
126410037|NCT02421588|454795472|FG000|Overall Study|Progressive disease|152|||
126410038|NCT02421588|454795473|FG001|Overall Study|Progressive disease|135|||
126410039|NCT02421588|454795472|FG000|Overall Study|Death|11|||
126410040|NCT02421588|454795473|FG001|Overall Study|Death|3|||
126410041|NCT02421588|454795472|FG000|Overall Study|Physician Decision|8|||
126410042|NCT02421588|454795473|FG001|Overall Study|Physician Decision|17|||
126410043|NCT02421588|454795472|FG000|Overall Study|Other reason not specified|3|||
126410044|NCT02421588|454795473|FG001|Overall Study|Other reason not specified|1|||
126054078|NCT03732807|453492214|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
126410045|NCT02421588|454795472|FG000|Overall Study|Symptomatic deterioration|13|||
126410046|NCT02421588|454795473|FG001|Overall Study|Symptomatic deterioration|19|||
126410047|NCT02421588|454795472|FG000|Overall Study|Treatment-related AE|10|||
126410048|NCT02421588|454795473|FG001|Overall Study|Treatment-related AE|14|||
126410049|NCT02421588|454795472|FG000|Overall Study|Withdrawal by Subject|14|||
126410050|NCT02421588|454795473|FG001|Overall Study|Withdrawal by Subject|16|||
126410051|NCT02421588|454795472|FG000|Overall Study|Not treated|2|||
126410052|NCT02421588|454795473|FG001|Overall Study|Not treated|8|||
126410053|NCT01359943|454795474|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
126410054|NCT01359943|454795475|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
126410055|NCT01359943|454795476|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
126410056|NCT01359943|454795474|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
126410057|NCT01359943|454795475|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
126410058|NCT01359943|454795476|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
126410059|NCT01359943|454795474|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
126410060|NCT01359943|454795475|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
126410061|NCT01359943|454795476|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
126410062|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
126410063|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
126410064|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
126410065|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
126410066|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
126410067|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
126410068|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
126410069|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
126410070|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
126410071|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
126410072|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
126410073|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
126410074|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
126410075|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
126410076|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
126410077|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
126410078|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
126410079|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
126410080|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
126410081|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
126410082|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
126410083|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
126410084|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
126410085|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
126410086|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
126410087|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
126410088|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
126410089|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
126410090|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
126410091|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
126410092|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
126410093|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
126410094|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
126410095|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
126410096|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
126410097|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
126410098|NCT03194646|454795486|FG000|Overall Study|Adverse Event|24|||
126410099|NCT03194646|454795487|FG001|Overall Study|Adverse Event|25|||
126410100|NCT03194646|454795488|FG002|Overall Study|Adverse Event|14|||
126410101|NCT03194646|454795489|FG003|Overall Study|Adverse Event|17|||
126410102|NCT03194646|454795486|FG000|Overall Study|Lack of Efficacy|4|||
126410103|NCT03194646|454795487|FG001|Overall Study|Lack of Efficacy|2|||
126410104|NCT03194646|454795488|FG002|Overall Study|Lack of Efficacy|2|||
126410105|NCT03194646|454795489|FG003|Overall Study|Lack of Efficacy|12|||
126410106|NCT03194646|454795486|FG000|Overall Study|Lost to Follow-up|30|||
126410107|NCT03194646|454795487|FG001|Overall Study|Lost to Follow-up|22|||
126410108|NCT03194646|454795488|FG002|Overall Study|Lost to Follow-up|12|||
126410109|NCT03194646|454795489|FG003|Overall Study|Lost to Follow-up|35|||
126410110|NCT03194646|454795486|FG000|Overall Study|Non-compliance with study drug|4|||
126410111|NCT03194646|454795487|FG001|Overall Study|Non-compliance with study drug|0|||
126410112|NCT03194646|454795488|FG002|Overall Study|Non-compliance with study drug|1|||
126410113|NCT03194646|454795489|FG003|Overall Study|Non-compliance with study drug|1|||
126410114|NCT03194646|454795486|FG000|Overall Study|Other|89|||
126410115|NCT03194646|454795487|FG001|Overall Study|Other|68|||
126410116|NCT03194646|454795488|FG002|Overall Study|Other|34|||
126410117|NCT03194646|454795489|FG003|Overall Study|Other|31|||
126410118|NCT03194646|454795486|FG000|Overall Study|Physician Decision|7|||
126410119|NCT03194646|454795487|FG001|Overall Study|Physician Decision|9|||
126410120|NCT03194646|454795488|FG002|Overall Study|Physician Decision|5|||
126410121|NCT03194646|454795489|FG003|Overall Study|Physician Decision|4|||
126410122|NCT03194646|454795486|FG000|Overall Study|Pregnancy|4|||
126410123|NCT03194646|454795487|FG001|Overall Study|Pregnancy|5|||
126410124|NCT03194646|454795488|FG002|Overall Study|Pregnancy|1|||
126410125|NCT03194646|454795489|FG003|Overall Study|Pregnancy|2|||
126410126|NCT03194646|454795486|FG000|Overall Study|Protocol Violation|4|||
126410127|NCT03194646|454795487|FG001|Overall Study|Protocol Violation|2|||
126410128|NCT03194646|454795488|FG002|Overall Study|Protocol Violation|1|||
126410129|NCT03194646|454795489|FG003|Overall Study|Protocol Violation|1|||
126410130|NCT03194646|454795486|FG000|Overall Study|Site terminated by sponsor|0|||
126410131|NCT03194646|454795487|FG001|Overall Study|Site terminated by sponsor|0|||
126410132|NCT03194646|454795488|FG002|Overall Study|Site terminated by sponsor|2|||
126410133|NCT03194646|454795489|FG003|Overall Study|Site terminated by sponsor|0|||
126410134|NCT03194646|454795486|FG000|Overall Study|Study terminated by sponsor|62|||
126410135|NCT03194646|454795487|FG001|Overall Study|Study terminated by sponsor|61|||
126410136|NCT03194646|454795488|FG002|Overall Study|Study terminated by sponsor|30|||
126410137|NCT03194646|454795489|FG003|Overall Study|Study terminated by sponsor|34|||
126410138|NCT03194646|454795486|FG000|Overall Study|Withdrawal by Subject|75|||
126410139|NCT03194646|454795487|FG001|Overall Study|Withdrawal by Subject|74|||
126410140|NCT03194646|454795488|FG002|Overall Study|Withdrawal by Subject|36|||
126410141|NCT03194646|454795489|FG003|Overall Study|Withdrawal by Subject|131|||
126410142|NCT03194646|454795486|FG000|Overall Study|Missing|1|||
126410143|NCT03194646|454795487|FG001|Overall Study|Missing|0|||
126410144|NCT03194646|454795488|FG002|Overall Study|Missing|1|||
126410145|NCT03194646|454795489|FG003|Overall Study|Missing|12|||
126410146|NCT02649894|454795490|FG000|Overall Study|Adverse Event|1|||
126410147|NCT02649894|454795491|FG001|Overall Study|Adverse Event|0|||
126410148|NCT02649894|454795490|FG000|Overall Study|Physician Decision|0|||
126410149|NCT02649894|454795491|FG001|Overall Study|Physician Decision|1|||
126410150|NCT02649894|454795490|FG000|Overall Study|Withdrawal by Subject|5|||
126410151|NCT02649894|454795491|FG001|Overall Study|Withdrawal by Subject|2|||
126410152|NCT02649894|454795490|FG000|Overall Study|Lost to Follow-up|2|||
126410153|NCT02649894|454795491|FG001|Overall Study|Lost to Follow-up|1|||
126410154|NCT02649894|454795490|FG000|Overall Study|Death|30|||
126410155|NCT02649894|454795491|FG001|Overall Study|Death|7|||
126410156|NCT02649894|454795490|FG000|Overall Study|Other, not specified|6|||
126410157|NCT02649894|454795491|FG001|Overall Study|Other, not specified|0|||
126410158|NCT00719680|454795492|FG000|Overall Study|Adverse Event|1|||
126410159|NCT00719680|454795492|FG000|Overall Study|Lost to Follow-up|1|||
126410160|NCT00719680|454795492|FG000|Overall Study|Withdrawal by Subject|3|||
126410161|NCT02141360|454795493|FG000|Overall Study|Withdrawal by Subject|6|||
126410162|NCT02141360|454795494|FG001|Overall Study|Withdrawal by Subject|0|||
126410163|NCT02141360|454795495|FG002|Overall Study|Withdrawal by Subject|0|||
126410164|NCT02141360|454795493|FG000|Overall Study|Study Terminated before Visit|1|||
126410165|NCT02141360|454795494|FG001|Overall Study|Study Terminated before Visit|0|||
126410166|NCT02141360|454795495|FG002|Overall Study|Study Terminated before Visit|0|||
126410167|NCT04071158|454795496|FG000|Overall Study|Lost to Follow-up|1|||
126410168|NCT04071158|454795497|FG001|Overall Study|Lost to Follow-up|2|||
126410169|NCT04071158|454795498|FG002|Overall Study|Lost to Follow-up|3|||
126410170|NCT04071158|454795499|FG003|Overall Study|Lost to Follow-up|3|||
126410171|NCT04071158|454795500|FG004|Overall Study|Lost to Follow-up|5|||
126410172|NCT04071158|454795496|FG000|Overall Study|Randomized but not treated|2|||
126410173|NCT04071158|454795497|FG001|Overall Study|Randomized but not treated|2|||
126410174|NCT04071158|454795498|FG002|Overall Study|Randomized but not treated|0|||
126410175|NCT04071158|454795499|FG003|Overall Study|Randomized but not treated|0|||
126410176|NCT04071158|454795500|FG004|Overall Study|Randomized but not treated|0|||
126410177|NCT01178099|454795501|FG000|Overall Study|Physician Decision|0|||
126410178|NCT01178099|454795502|FG001|Overall Study|Physician Decision|1|||
126410179|NCT02516592|454795503|FG000|Overall Study|Patient withdrew consent|5|||
126410180|NCT02516592|454795504|FG001|Overall Study|Patient withdrew consent|2|||
126410181|NCT02516592|454795503|FG000|Overall Study|Protocol deviation|4|||
126410182|NCT02516592|454795504|FG001|Overall Study|Protocol deviation|4|||
126410183|NCT02516592|454795503|FG000|Overall Study|Lost to Follow-up|2|||
126410184|NCT02516592|454795504|FG001|Overall Study|Lost to Follow-up|3|||
126410185|NCT02516592|454795503|FG000|Overall Study|Patient/guardian decision|2|||
126410186|NCT02516592|454795504|FG001|Overall Study|Patient/guardian decision|1|||
126410187|NCT02516592|454795503|FG000|Overall Study|Adverse Event|1|||
126410188|NCT02516592|454795504|FG001|Overall Study|Adverse Event|2|||
126410189|NCT02516592|454795503|FG000|Overall Study|Abnormal test procedure result|1|||
126410190|NCT02516592|454795504|FG001|Overall Study|Abnormal test procedure result|0|||
126410191|NCT02516592|454795503|FG000|Overall Study|Death|1|||
126410192|NCT02516592|454795504|FG001|Overall Study|Death|1|||
126410193|NCT01286740|454795505|FG000|Overall Study|Enrolled but not treated|1|||
126410194|NCT01286740|454795505|FG000|Overall Study|Protocol Violation|1|||
126410195|NCT01110382|454795507|FG000|Overall Study|Withdrawal by Subject|0|||
126410196|NCT01110382|454795508|FG001|Overall Study|Withdrawal by Subject|1|||
126410197|NCT01110382|454795507|FG000|Overall Study|Protocol Violation|0|||
126410198|NCT01110382|454795508|FG001|Overall Study|Protocol Violation|1|||
126410199|NCT00902174|454795510|FG000|Overall Study|Adverse Event|27|||
126410200|NCT00902174|454795511|FG001|Overall Study|Adverse Event|7|||
126410201|NCT00902174|454795510|FG000|Overall Study|Lack of Efficacy|1|||
126410202|NCT00902174|454795511|FG001|Overall Study|Lack of Efficacy|5|||
126410203|NCT00902174|454795510|FG000|Overall Study|Death|2|||
126410204|NCT00902174|454795511|FG001|Overall Study|Death|2|||
126410205|NCT00902174|454795510|FG000|Overall Study|Withdrawal by Subject|2|||
126410206|NCT00902174|454795511|FG001|Overall Study|Withdrawal by Subject|1|||
126410207|NCT00902174|454795510|FG000|Overall Study|Abnormal labs|1|||
126410208|NCT00902174|454795511|FG001|Overall Study|Abnormal labs|1|||
126410209|NCT00902174|454795510|FG000|Overall Study|Protocol Violation|1|||
126410210|NCT00902174|454795511|FG001|Overall Study|Protocol Violation|1|||
126410211|NCT00902174|454795510|FG000|Overall Study|Administration problem|0|||
126410212|NCT00902174|454795511|FG001|Overall Study|Administration problem|1|||
126410213|NCT00576576|454795519|FG000|Overall Study|Lost to Follow-up|6|||
126410214|NCT00576576|454795519|FG000|Overall Study|Protocol Violation|1|||
126410215|NCT01805037|454795525|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
126410216|NCT01805037|454795526|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
126410217|NCT01805037|454795525|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
126410218|NCT01805037|454795526|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
126410219|NCT01805037|454795525|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
126410220|NCT01805037|454795526|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
126410221|NCT01805037|454795525|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
126410222|NCT01805037|454795526|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
126410223|NCT01805037|454795525|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
126410224|NCT01805037|454795526|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
126410225|NCT01805037|454795525|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
126410226|NCT01805037|454795526|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
126410227|NCT01805037|454795525|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
126410228|NCT01805037|454795526|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
126410229|NCT01805037|454795525|FG000|Follow Up (up to 3 Years)|Death|0|||
126410230|NCT01805037|454795526|FG001|Follow Up (up to 3 Years)|Death|2|||
126410231|NCT01805037|454795525|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
126410232|NCT01805037|454795526|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
126410233|NCT01805037|454795525|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
126410234|NCT01805037|454795526|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
126410235|NCT02177838|454795527|FG000|Overall Study|Withdrawal by Subject|1|||
126410236|NCT02177838|454795527|FG000|Overall Study|Physician Decision|1|||
126410237|NCT02177838|454795527|FG000|Overall Study|Death|1|||
126410238|NCT03927404|454795533|FG000|Overall Study|Withdrawal by Subject|1|||
126410239|NCT00293020|454795537|FG000|Overall Study|Withdrawal by Subject|34|||
126410240|NCT00293020|454795537|FG000|Overall Study|Adverse Event|30|||
126410241|NCT00293020|454795537|FG000|Overall Study|Death|32|||
126410242|NCT00293020|454795537|FG000|Overall Study|Lack of Efficacy|12|||
126410243|NCT00293020|454795537|FG000|Overall Study|Lost to Follow-up|4|||
126410244|NCT00293020|454795537|FG000|Overall Study|Protocol Violation|6|||
126410245|NCT00293020|454795537|FG000|Overall Study|Physician Decision|21|||
126410246|NCT00293020|454795537|FG000|Overall Study|Other Reason|22|||
126410247|NCT00293020|454795537|FG000|Overall Study|No dose taken|1|||
126410248|NCT01147848|454795538|FG000|Run-in Period|Screen Failure|623|||
126410249|NCT01147848|454795539|FG001|Run-in Period|Screen Failure|0|||
126410250|NCT01147848|454795540|FG002|Run-in Period|Screen Failure|0|||
126410251|NCT01147848|454795538|FG000|Run-in Period|Run-in Failure|135|||
126410252|NCT01147848|454795539|FG001|Run-in Period|Run-in Failure|0|||
126410253|NCT01147848|454795540|FG002|Run-in Period|Run-in Failure|0|||
126410254|NCT01147848|454795538|FG000|Randomized Phase|Adverse Event|0|||
126410255|NCT01147848|454795539|FG001|Randomized Phase|Adverse Event|6|||
126410256|NCT01147848|454795540|FG002|Randomized Phase|Adverse Event|8|||
126410257|NCT01147848|454795538|FG000|Randomized Phase|Lack of Efficacy|0|||
126410258|NCT01147848|454795539|FG001|Randomized Phase|Lack of Efficacy|20|||
126410259|NCT01147848|454795540|FG002|Randomized Phase|Lack of Efficacy|11|||
126410260|NCT01147848|454795538|FG000|Randomized Phase|Protocol Violation|0|||
126410261|NCT01147848|454795539|FG001|Randomized Phase|Protocol Violation|7|||
126410262|NCT01147848|454795540|FG002|Randomized Phase|Protocol Violation|10|||
126410263|NCT01147848|454795538|FG000|Randomized Phase|Lost to Follow-up|0|||
126410264|NCT01147848|454795539|FG001|Randomized Phase|Lost to Follow-up|5|||
126410265|NCT01147848|454795540|FG002|Randomized Phase|Lost to Follow-up|7|||
126410266|NCT01147848|454795538|FG000|Randomized Phase|Physician Decision|0|||
125890729|NCT01088048|452899581|FG002|Overall Study|Concomitant Medication Prohibited|0|||
126410267|NCT01147848|454795539|FG001|Randomized Phase|Physician Decision|0|||
126410268|NCT01147848|454795540|FG002|Randomized Phase|Physician Decision|1|||
125890730|NCT01088048|452899582|FG003|Overall Study|Concomitant Medication Prohibited|0|||
126410269|NCT01147848|454795538|FG000|Randomized Phase|Withdrawal by Subject|0|||
126410270|NCT01147848|454795539|FG001|Randomized Phase|Withdrawal by Subject|7|||
126410271|NCT01147848|454795540|FG002|Randomized Phase|Withdrawal by Subject|9|||
126410272|NCT03180307|454795541|FG000|Overall Study|Lost to Follow-up|2|||
126410273|NCT03180307|454795542|FG001|Overall Study|Lost to Follow-up|0|||
126410274|NCT03180307|454795541|FG000|Overall Study|Death|1|||
126410275|NCT03180307|454795542|FG001|Overall Study|Death|0|||
126410276|NCT03180307|454795541|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
126410277|NCT03180307|454795542|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
126410278|NCT04349033|454795544|FG000|Overall Study|Lost to Follow-up|3|||
126410279|NCT04349033|454795545|FG001|Overall Study|Lost to Follow-up|1|||
126410280|NCT04349033|454795546|FG002|Overall Study|Lost to Follow-up|1|||
126410281|NCT03596450|454795547|FG000|Overall Study|Death|9|||
126410282|NCT03596450|454795548|FG001|Overall Study|Death|9|||
126410283|NCT03596450|454795547|FG000|Overall Study|Protocol Violation|18|||
126410284|NCT03596450|454795548|FG001|Overall Study|Protocol Violation|26|||
126410285|NCT03596450|454795547|FG000|Overall Study|Lost to Follow-up|50|||
126410286|NCT03596450|454795548|FG001|Overall Study|Lost to Follow-up|56|||
126410287|NCT03596450|454795547|FG000|Overall Study|Adverse Event|14|||
126410288|NCT03596450|454795548|FG001|Overall Study|Adverse Event|7|||
126410289|NCT03596450|454795547|FG000|Overall Study|Withdrawal by Subject|38|||
126410290|NCT03596450|454795548|FG001|Overall Study|Withdrawal by Subject|36|||
126410291|NCT03596450|454795547|FG000|Overall Study|Accidentally Randomized|2|||
126410292|NCT03596450|454795548|FG001|Overall Study|Accidentally Randomized|0|||
126410293|NCT03596450|454795547|FG000|Overall Study|Other reasons|48|||
126410294|NCT03596450|454795548|FG001|Overall Study|Other reasons|53|||
126410295|NCT03596450|454795547|FG000|Overall Study|Pregnancy|2|||
126410296|NCT03596450|454795548|FG001|Overall Study|Pregnancy|0|||
126410297|NCT02332291|454795549|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
126410298|NCT02332291|454795550|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
126410299|NCT02332291|454795549|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
126410300|NCT02332291|454795550|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
126410301|NCT02332291|454795549|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
126410302|NCT02332291|454795550|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
126410303|NCT02332291|454795549|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
126410304|NCT02332291|454795550|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
126410305|NCT02332291|454795549|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
126410306|NCT02332291|454795550|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
126410307|NCT02332291|454795549|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
126410308|NCT02332291|454795550|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
126410309|NCT02220712|454795551|FG000|Overall Study|Adverse Event|1|||
126410310|NCT02220712|454795551|FG000|Overall Study|Withdrawal by Subject|2|||
126054079|NCT03732807|453492215|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
126410311|NCT02220712|454795551|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
126410312|NCT03624127|454795552|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
126410313|NCT03624127|454795553|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
126410314|NCT03624127|454795554|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
126410315|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
126410316|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
126410317|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
126410318|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Death|0|||
126410319|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Death|1|||
125890731|NCT01088048|452899583|FG004|Overall Study|Concomitant Medication Prohibited|0|||
125890732|NCT01088048|452899584|FG005|Overall Study|Concomitant Medication Prohibited|0|||
125890733|NCT01088048|452899585|FG006|Overall Study|Concomitant Medication Prohibited|0|||
125890734|NCT01088048|452899586|FG007|Overall Study|Concomitant Medication Prohibited|0|||
125890735|NCT01088048|452899587|FG008|Overall Study|Concomitant Medication Prohibited|0|||
125890736|NCT01088048|452899588|FG009|Overall Study|Concomitant Medication Prohibited|0|||
125890737|NCT01088048|452899579|FG000|Overall Study|Investigator Request|2|||
125890738|NCT01088048|452899580|FG001|Overall Study|Investigator Request|2|||
126410320|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Death|0|||
126410321|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
126410322|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
126410323|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
126410324|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
126410325|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
126410326|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
126410327|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
126410328|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
126410329|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
126410330|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
126410331|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
126410332|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
126410333|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
126410334|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
126410335|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
126410336|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
126410337|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
126410338|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
126410339|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
126410340|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
126410341|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
126410342|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
126410343|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
126410344|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
126410345|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
126410346|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
126410347|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
126410348|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
126410349|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
126410350|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
126410351|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
126410352|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
126410353|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
126410354|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
126410355|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
126410356|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
126410357|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
126410358|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
126410359|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
126410360|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
126410361|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
126410362|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
126410363|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
126410364|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
126410365|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
126410366|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
126410367|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
126410368|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
126410369|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
126410370|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
126410371|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
126410372|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
126410373|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
126410374|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
126410375|NCT02607228|454795555|FG000|Overall Study|Progressive Disease|4|||
126410376|NCT02607228|454795556|FG001|Overall Study|Progressive Disease|3|||
126410377|NCT02607228|454795557|FG002|Overall Study|Progressive Disease|1|||
126410378|NCT02607228|454795558|FG003|Overall Study|Progressive Disease|5|||
126410379|NCT02607228|454795559|FG004|Overall Study|Progressive Disease|4|||
126410380|NCT02607228|454795560|FG005|Overall Study|Progressive Disease|3|||
126410381|NCT02607228|454795561|FG006|Overall Study|Progressive Disease|1|||
126410382|NCT02607228|454795555|FG000|Overall Study|Adverse Event|1|||
126410383|NCT02607228|454795556|FG001|Overall Study|Adverse Event|0|||
126410384|NCT02607228|454795557|FG002|Overall Study|Adverse Event|1|||
126410385|NCT02607228|454795558|FG003|Overall Study|Adverse Event|0|||
126410386|NCT02607228|454795559|FG004|Overall Study|Adverse Event|1|||
126410387|NCT02607228|454795560|FG005|Overall Study|Adverse Event|1|||
125890739|NCT01088048|452899581|FG002|Overall Study|Investigator Request|0|||
125890740|NCT01088048|452899582|FG003|Overall Study|Investigator Request|0|||
125890741|NCT01088048|452899583|FG004|Overall Study|Investigator Request|3|||
125890742|NCT01088048|452899584|FG005|Overall Study|Investigator Request|1|||
125890743|NCT01088048|452899585|FG006|Overall Study|Investigator Request|1|||
125890744|NCT01088048|452899586|FG007|Overall Study|Investigator Request|0|||
125890745|NCT01088048|452899587|FG008|Overall Study|Investigator Request|0|||
125890746|NCT01088048|452899588|FG009|Overall Study|Investigator Request|0|||
125890747|NCT01088048|452899579|FG000|Overall Study|Patient Non-compliance|0|||
126410388|NCT02607228|454795561|FG006|Overall Study|Adverse Event|1|||
126410389|NCT02607228|454795555|FG000|Overall Study|Investigator's Discretion|0|||
126410390|NCT02607228|454795556|FG001|Overall Study|Investigator's Discretion|0|||
125890748|NCT01088048|452899580|FG001|Overall Study|Patient Non-compliance|1|||
125890749|NCT01088048|452899581|FG002|Overall Study|Patient Non-compliance|0|||
126410391|NCT02607228|454795557|FG002|Overall Study|Investigator's Discretion|1|||
126410392|NCT02607228|454795558|FG003|Overall Study|Investigator's Discretion|0|||
125890750|NCT01088048|452899582|FG003|Overall Study|Patient Non-compliance|0|||
126410393|NCT02607228|454795559|FG004|Overall Study|Investigator's Discretion|0|||
126410394|NCT02607228|454795560|FG005|Overall Study|Investigator's Discretion|1|||
126410395|NCT02607228|454795561|FG006|Overall Study|Investigator's Discretion|0|||
126410396|NCT02607228|454795555|FG000|Overall Study|Withdrew Consent|0|||
126410397|NCT02607228|454795556|FG001|Overall Study|Withdrew Consent|1|||
126410398|NCT02607228|454795557|FG002|Overall Study|Withdrew Consent|0|||
126410399|NCT02607228|454795558|FG003|Overall Study|Withdrew Consent|0|||
126410400|NCT02607228|454795559|FG004|Overall Study|Withdrew Consent|0|||
126410401|NCT02607228|454795560|FG005|Overall Study|Withdrew Consent|1|||
126410402|NCT02607228|454795561|FG006|Overall Study|Withdrew Consent|0|||
126410403|NCT02607228|454795555|FG000|Overall Study|Study Terminated by Sponsor|0|||
126410404|NCT02607228|454795556|FG001|Overall Study|Study Terminated by Sponsor|0|||
126410405|NCT02607228|454795557|FG002|Overall Study|Study Terminated by Sponsor|0|||
126410406|NCT02607228|454795558|FG003|Overall Study|Study Terminated by Sponsor|1|||
126410407|NCT02607228|454795559|FG004|Overall Study|Study Terminated by Sponsor|0|||
126410408|NCT02607228|454795560|FG005|Overall Study|Study Terminated by Sponsor|0|||
126410409|NCT02607228|454795561|FG006|Overall Study|Study Terminated by Sponsor|0|||
126410410|NCT01990859|454795562|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
126410411|NCT01990859|454795562|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
126410412|NCT02262754|454795564|FG000|Overall Study|Adverse Event|3|||
126410413|NCT02262754|454795565|FG001|Overall Study|Adverse Event|4|||
126410414|NCT02262754|454795566|FG002|Overall Study|Adverse Event|0|||
126410415|NCT02262754|454795564|FG000|Overall Study|Lack of Efficacy|2|||
126410416|NCT02262754|454795565|FG001|Overall Study|Lack of Efficacy|0|||
126410417|NCT02262754|454795566|FG002|Overall Study|Lack of Efficacy|1|||
126410418|NCT02262754|454795564|FG000|Overall Study|Lost to Follow-up|0|||
126410419|NCT02262754|454795565|FG001|Overall Study|Lost to Follow-up|0|||
126410420|NCT02262754|454795566|FG002|Overall Study|Lost to Follow-up|1|||
126410421|NCT02262754|454795564|FG000|Overall Study|No longer meets eligibility criteria|0|||
126410422|NCT02262754|454795565|FG001|Overall Study|No longer meets eligibility criteria|1|||
126410423|NCT02262754|454795566|FG002|Overall Study|No longer meets eligibility criteria|0|||
126410424|NCT02262754|454795564|FG000|Overall Study|Study terminated by sponsor|5|||
126410425|NCT02262754|454795565|FG001|Overall Study|Study terminated by sponsor|4|||
126410426|NCT02262754|454795566|FG002|Overall Study|Study terminated by sponsor|4|||
126410427|NCT02262754|454795564|FG000|Overall Study|Protocol Violation|1|||
126410428|NCT02262754|454795565|FG001|Overall Study|Protocol Violation|0|||
126410429|NCT02262754|454795566|FG002|Overall Study|Protocol Violation|0|||
126410430|NCT02262754|454795564|FG000|Overall Study|Withdrawal by Subject|1|||
126410431|NCT02262754|454795565|FG001|Overall Study|Withdrawal by Subject|0|||
126410432|NCT02262754|454795566|FG002|Overall Study|Withdrawal by Subject|1|||
126410433|NCT02262754|454795564|FG000|Overall Study|Other|4|||
126410434|NCT02262754|454795565|FG001|Overall Study|Other|0|||
126410435|NCT02262754|454795566|FG002|Overall Study|Other|2|||
126410436|NCT02577016|454795567|FG000|Overall Study|Adverse Event|2|||
126410437|NCT02577016|454795568|FG001|Overall Study|Adverse Event|1|||
126410438|NCT02577016|454795567|FG000|Overall Study|Physician Decision|0|||
126410439|NCT02577016|454795568|FG001|Overall Study|Physician Decision|1|||
126410440|NCT02126839|454795569|FG000|Overall Study|Adverse Event|0|||
126410441|NCT02126839|454795570|FG001|Overall Study|Adverse Event|1|||
126410442|NCT02126839|454795569|FG000|Overall Study|Withdrawal by Subject|1|||
126410443|NCT02126839|454795570|FG001|Overall Study|Withdrawal by Subject|0|||
126410444|NCT02126839|454795569|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126410445|NCT02126839|454795570|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126410446|NCT02126839|454795569|FG000|Overall Study|Protocol Violation|2|||
126410447|NCT02126839|454795570|FG001|Overall Study|Protocol Violation|3|||
126410448|NCT02126839|454795569|FG000|Overall Study|Sponsor request|0|||
126410449|NCT02126839|454795570|FG001|Overall Study|Sponsor request|1|||
126410450|NCT02126839|454795569|FG000|Overall Study|Lost to Follow-up|1|||
126410451|NCT02126839|454795570|FG001|Overall Study|Lost to Follow-up|4|||
126410452|NCT02126839|454795569|FG000|Overall Study|Other|5|||
126410453|NCT02126839|454795570|FG001|Overall Study|Other|5|||
126410454|NCT00812565|454795571|FG000|Overall Study|Did Not Receive Study Medication|1|||
126410455|NCT00812565|454795572|FG001|Overall Study|Did Not Receive Study Medication|1|||
126410456|NCT00812565|454795573|FG002|Overall Study|Did Not Receive Study Medication|0|||
126410457|NCT00812565|454795574|FG003|Overall Study|Did Not Receive Study Medication|0|||
126410458|NCT00812565|454795575|FG004|Overall Study|Did Not Receive Study Medication|0|||
126410459|NCT00812565|454795576|FG005|Overall Study|Did Not Receive Study Medication|0|||
126410460|NCT00812565|454795577|FG006|Overall Study|Did Not Receive Study Medication|0|||
126410461|NCT00812565|454795578|FG007|Overall Study|Did Not Receive Study Medication|0|||
126410462|NCT00812565|454795571|FG000|Overall Study|Adverse Event|0|||
126410463|NCT00812565|454795572|FG001|Overall Study|Adverse Event|0|||
126410464|NCT00812565|454795573|FG002|Overall Study|Adverse Event|0|||
126410465|NCT00812565|454795574|FG003|Overall Study|Adverse Event|2|||
126410466|NCT00812565|454795575|FG004|Overall Study|Adverse Event|0|||
126410467|NCT00812565|454795576|FG005|Overall Study|Adverse Event|0|||
126410468|NCT00812565|454795577|FG006|Overall Study|Adverse Event|0|||
126410469|NCT00812565|454795578|FG007|Overall Study|Adverse Event|1|||
126410470|NCT00812565|454795571|FG000|Overall Study|Did Not Come to Study Visit|1|||
126410471|NCT00812565|454795572|FG001|Overall Study|Did Not Come to Study Visit|0|||
126410472|NCT00812565|454795573|FG002|Overall Study|Did Not Come to Study Visit|0|||
126410473|NCT00812565|454795574|FG003|Overall Study|Did Not Come to Study Visit|0|||
126410474|NCT00812565|454795575|FG004|Overall Study|Did Not Come to Study Visit|0|||
126410475|NCT00812565|454795576|FG005|Overall Study|Did Not Come to Study Visit|0|||
126410476|NCT00812565|454795577|FG006|Overall Study|Did Not Come to Study Visit|0|||
126410477|NCT00812565|454795578|FG007|Overall Study|Did Not Come to Study Visit|0|||
126410478|NCT00812565|454795571|FG000|Overall Study|Withdrawal of Consent|1|||
126410479|NCT00812565|454795572|FG001|Overall Study|Withdrawal of Consent|0|||
126410480|NCT00812565|454795573|FG002|Overall Study|Withdrawal of Consent|0|||
126410481|NCT00812565|454795574|FG003|Overall Study|Withdrawal of Consent|0|||
126410482|NCT00812565|454795575|FG004|Overall Study|Withdrawal of Consent|1|||
126410483|NCT00812565|454795576|FG005|Overall Study|Withdrawal of Consent|0|||
126410484|NCT00812565|454795577|FG006|Overall Study|Withdrawal of Consent|0|||
126410485|NCT00812565|454795578|FG007|Overall Study|Withdrawal of Consent|0|||
126410486|NCT00812565|454795571|FG000|Overall Study|Reason Not Specified|0|||
126410487|NCT00812565|454795572|FG001|Overall Study|Reason Not Specified|0|||
126410488|NCT00812565|454795573|FG002|Overall Study|Reason Not Specified|0|||
126410489|NCT00812565|454795574|FG003|Overall Study|Reason Not Specified|0|||
126410490|NCT00812565|454795575|FG004|Overall Study|Reason Not Specified|0|||
126410491|NCT00812565|454795576|FG005|Overall Study|Reason Not Specified|1|||
126410492|NCT00812565|454795577|FG006|Overall Study|Reason Not Specified|0|||
126410493|NCT00812565|454795578|FG007|Overall Study|Reason Not Specified|0|||
126410494|NCT03614325|454797933|FG000|Overall Study|Withdrawal by Subject|0|||
126410495|NCT03614325|454797934|FG001|Overall Study|Withdrawal by Subject|2|||
126410496|NCT03614325|454797933|FG000|Overall Study|Surgery Cancelled|2|||
126410497|NCT03614325|454797934|FG001|Overall Study|Surgery Cancelled|1|||
126410498|NCT03614325|454797933|FG000|Overall Study|Lost to Follow-up|2|||
126410499|NCT03614325|454797934|FG001|Overall Study|Lost to Follow-up|1|||
126410500|NCT03614325|454797933|FG000|Overall Study|Surgery never scheduled|1|||
126410501|NCT03614325|454797934|FG001|Overall Study|Surgery never scheduled|0|||
126410502|NCT01597635|454797941|FG000|Part A|Adverse Event|3|||
126410503|NCT01597635|454797942|FG001|Part A|Adverse Event|0|||
126410504|NCT01597635|454797943|FG002|Part A|Adverse Event|0|||
126410505|NCT01597635|454797941|FG000|Part B|Adverse Event|0|||
126410506|NCT01597635|454797942|FG001|Part B|Adverse Event|0|||
126410507|NCT01597635|454797943|FG002|Part B|Adverse Event|1|||
126410508|NCT01597635|454797941|FG000|Part B|Protocol Violation|0|||
126410509|NCT01597635|454797942|FG001|Part B|Protocol Violation|1|||
126410510|NCT01597635|454797943|FG002|Part B|Protocol Violation|0|||
126410511|NCT01597635|454797941|FG000|Part B|Protocol-defined stopping criteria|0|||
126410512|NCT01597635|454797942|FG001|Part B|Protocol-defined stopping criteria|4|||
126410513|NCT01597635|454797943|FG002|Part B|Protocol-defined stopping criteria|3|||
126410514|NCT01597635|454797941|FG000|Part B|Withdrawal by Subject|0|||
126410515|NCT01597635|454797942|FG001|Part B|Withdrawal by Subject|1|||
126410516|NCT01597635|454797943|FG002|Part B|Withdrawal by Subject|0|||
126410517|NCT01363661|454797944|FG000|Overall Study|Adverse Event|9|||
126410518|NCT01363661|454797945|FG001|Overall Study|Adverse Event|2|||
126410519|NCT01363661|454797944|FG000|Overall Study|Withdrawal by Subject|1|||
126410520|NCT01363661|454797945|FG001|Overall Study|Withdrawal by Subject|1|||
126410521|NCT01363661|454797944|FG000|Overall Study|Protocol Violation|1|||
126410522|NCT01363661|454797945|FG001|Overall Study|Protocol Violation|0|||
126410523|NCT01363661|454797944|FG000|Overall Study|Lost to Follow-up|3|||
126410524|NCT01363661|454797945|FG001|Overall Study|Lost to Follow-up|1|||
126410525|NCT01971008|454797946|FG000|Overall Study|Protocol Violation|2|||
126410526|NCT01971008|454797947|FG001|Overall Study|Protocol Violation|1|||
126410527|NCT03775512|454797948|FG000|Overall Study|Death|1|||
126410528|NCT03775512|454797949|FG001|Overall Study|Death|1|||
126410529|NCT03775512|454797948|FG000|Overall Study|Withdrawal by Subject|7|||
126410530|NCT03775512|454797949|FG001|Overall Study|Withdrawal by Subject|4|||
126410531|NCT03775512|454797948|FG000|Overall Study|Lost to Follow-up|5|||
126410532|NCT03775512|454797949|FG001|Overall Study|Lost to Follow-up|5|||
126410533|NCT03775512|454797948|FG000|Overall Study|Excluded before Catheter insertion|14|||
126410534|NCT03775512|454797949|FG001|Overall Study|Excluded before Catheter insertion|5|||
126410535|NCT03775512|454797948|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
126410536|NCT03775512|454797949|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
126410537|NCT03775512|454797948|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
126410538|NCT03775512|454797949|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
126410539|NCT01378325|454797950|FG000|Overall Study|Protocol Violation|0|||
126410540|NCT01378325|454797951|FG001|Overall Study|Protocol Violation|1|||
126410541|NCT00767806|454797954|FG000|Overall Study|Adverse Event|30|||
126410542|NCT00767806|454797955|FG001|Overall Study|Adverse Event|11|||
126410543|NCT00767806|454797954|FG000|Overall Study|Withdrawal by Subject|8|||
125890751|NCT01088048|452899583|FG004|Overall Study|Patient Non-compliance|0|||
125890752|NCT01088048|452899584|FG005|Overall Study|Patient Non-compliance|0|||
125890753|NCT01088048|452899585|FG006|Overall Study|Patient Non-compliance|0|||
125890754|NCT01088048|452899586|FG007|Overall Study|Patient Non-compliance|0|||
126410544|NCT00767806|454797955|FG001|Overall Study|Withdrawal by Subject|13|||
126410545|NCT00767806|454797954|FG000|Overall Study|Protocol Violation|6|||
126410546|NCT00767806|454797955|FG001|Overall Study|Protocol Violation|5|||
125890755|NCT01088048|452899587|FG008|Overall Study|Patient Non-compliance|0|||
125890756|NCT01088048|452899588|FG009|Overall Study|Patient Non-compliance|0|||
126410547|NCT00767806|454797954|FG000|Overall Study|Lack of Efficacy|1|||
126410548|NCT00767806|454797955|FG001|Overall Study|Lack of Efficacy|9|||
126410549|NCT00767806|454797954|FG000|Overall Study|Physician Decision|4|||
126410550|NCT00767806|454797955|FG001|Overall Study|Physician Decision|3|||
126410551|NCT00767806|454797954|FG000|Overall Study|Lost to Follow-up|1|||
126410552|NCT00767806|454797955|FG001|Overall Study|Lost to Follow-up|4|||
126410553|NCT00767806|454797954|FG000|Overall Study|Entry Criteria Not Met|1|||
126410554|NCT00767806|454797955|FG001|Overall Study|Entry Criteria Not Met|1|||
126410555|NCT00767806|454797954|FG000|Overall Study|Sponsor Decision|0|||
126410556|NCT00767806|454797955|FG001|Overall Study|Sponsor Decision|1|||
126410557|NCT02489942|454797956|FG000|Overall Study|Request by patient|602|||
126410558|NCT02489942|454797956|FG000|Overall Study|Improvement/remission|157|||
126410559|NCT02489942|454797956|FG000|Overall Study|No change/Progressive disease|263|||
126410560|NCT02489942|454797956|FG000|Overall Study|Adverse Event|522|||
126410561|NCT02489942|454797956|FG000|Overall Study|Other personal reasons|1218|||
126410562|NCT02489942|454797956|FG000|Overall Study|Lost to Follow-up|456|||
126410563|NCT02489942|454797956|FG000|Overall Study|Not continuously investigated|7|||
126410564|NCT02489942|454797956|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
126410565|NCT02489942|454797956|FG000|Overall Study|Multiple registration|1|||
126410566|NCT02489942|454797956|FG000|Overall Study|No patient visit after entry|100|||
126410567|NCT02489942|454797956|FG000|Overall Study|No treatment with Jardiance|2|||
126410568|NCT02489942|454797956|FG000|Overall Study|Patient received Jardiance before registration|1|||
126410569|NCT02489942|454797956|FG000|Overall Study|No CRF collected|86|||
126410570|NCT00858208|454797957|FG000|Overall Study|Adverse Event|3|||
126410571|NCT00858208|454797957|FG000|Overall Study|Lost to Follow-up|26|||
126410572|NCT00858208|454797957|FG000|Overall Study|Participant refused|40|||
126410573|NCT00858208|454797957|FG000|Overall Study|Other|10|||
126410574|NCT01393639|454797958|FG000|Overall Study|Protocol Violation|0|||
126105352|NCT01281969|453678601|FG000|Overall Study|not randomized, child consent not given|0|||
126410575|NCT01393639|454797959|FG001|Overall Study|Protocol Violation|0|||
126410576|NCT01393639|454797960|FG002|Overall Study|Protocol Violation|0|||
126410577|NCT01393639|454797961|FG003|Overall Study|Protocol Violation|1|||
126410578|NCT01393639|454797962|FG004|Overall Study|Protocol Violation|0|||
126410579|NCT01393639|454797963|FG005|Overall Study|Protocol Violation|0|||
126410580|NCT01393639|454797964|FG006|Overall Study|Protocol Violation|0|||
126410581|NCT01393639|454797958|FG000|Overall Study|Other|0|||
126410582|NCT01393639|454797959|FG001|Overall Study|Other|2|||
126410583|NCT01393639|454797960|FG002|Overall Study|Other|0|||
126410584|NCT01393639|454797961|FG003|Overall Study|Other|2|||
126410585|NCT01393639|454797962|FG004|Overall Study|Other|1|||
126410586|NCT01393639|454797963|FG005|Overall Study|Other|0|||
126410587|NCT01393639|454797964|FG006|Overall Study|Other|1|||
126410588|NCT01393639|454797958|FG000|Overall Study|Withdrawal by Subject|1|||
126410589|NCT01393639|454797959|FG001|Overall Study|Withdrawal by Subject|1|||
126410590|NCT01393639|454797960|FG002|Overall Study|Withdrawal by Subject|0|||
126054080|NCT03732807|453492216|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
126054081|NCT03732807|453492217|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
126410591|NCT01393639|454797961|FG003|Overall Study|Withdrawal by Subject|0|||
126410592|NCT01393639|454797962|FG004|Overall Study|Withdrawal by Subject|0|||
126410593|NCT01393639|454797963|FG005|Overall Study|Withdrawal by Subject|0|||
126410594|NCT01393639|454797964|FG006|Overall Study|Withdrawal by Subject|1|||
126410595|NCT01393639|454797958|FG000|Overall Study|Medication error without associated AE|0|||
126410596|NCT01393639|454797959|FG001|Overall Study|Medication error without associated AE|0|||
126410597|NCT01393639|454797960|FG002|Overall Study|Medication error without associated AE|0|||
126410598|NCT01393639|454797961|FG003|Overall Study|Medication error without associated AE|0|||
126410599|NCT01393639|454797962|FG004|Overall Study|Medication error without associated AE|0|||
126410600|NCT01393639|454797963|FG005|Overall Study|Medication error without associated AE|0|||
126410601|NCT01393639|454797964|FG006|Overall Study|Medication error without associated AE|1|||
126410602|NCT01393639|454797958|FG000|Overall Study|Lost to Follow-up|0|||
126410603|NCT01393639|454797959|FG001|Overall Study|Lost to Follow-up|1|||
126410604|NCT01393639|454797960|FG002|Overall Study|Lost to Follow-up|0|||
126410605|NCT01393639|454797961|FG003|Overall Study|Lost to Follow-up|0|||
126410606|NCT01393639|454797962|FG004|Overall Study|Lost to Follow-up|0|||
126410607|NCT01393639|454797963|FG005|Overall Study|Lost to Follow-up|0|||
126410608|NCT01393639|454797964|FG006|Overall Study|Lost to Follow-up|1|||
126410609|NCT01393639|454797958|FG000|Overall Study|Lack of Efficacy|0|||
126410610|NCT01393639|454797959|FG001|Overall Study|Lack of Efficacy|0|||
126410611|NCT01393639|454797960|FG002|Overall Study|Lack of Efficacy|0|||
126410612|NCT01393639|454797961|FG003|Overall Study|Lack of Efficacy|0|||
126410613|NCT01393639|454797962|FG004|Overall Study|Lack of Efficacy|0|||
126410614|NCT01393639|454797963|FG005|Overall Study|Lack of Efficacy|0|||
126410615|NCT01393639|454797964|FG006|Overall Study|Lack of Efficacy|1|||
126410616|NCT01393639|454797958|FG000|Overall Study|Adverse Event|2|||
126410617|NCT01393639|454797959|FG001|Overall Study|Adverse Event|3|||
126410618|NCT01393639|454797960|FG002|Overall Study|Adverse Event|1|||
126410619|NCT01393639|454797961|FG003|Overall Study|Adverse Event|2|||
126410620|NCT01393639|454797962|FG004|Overall Study|Adverse Event|0|||
126410621|NCT01393639|454797963|FG005|Overall Study|Adverse Event|2|||
126410622|NCT01393639|454797964|FG006|Overall Study|Adverse Event|3|||
126410623|NCT00679172|454797965|FG000|Overall Study|Non-compliance|1|||
126410624|NCT00679172|454797966|FG001|Overall Study|Non-compliance|1|||
126410625|NCT00679172|454797967|FG002|Overall Study|Non-compliance|0|||
126410626|NCT00679172|454797968|FG003|Overall Study|Non-compliance|1|||
126410627|NCT00679172|454797969|FG004|Overall Study|Non-compliance|0|||
126410628|NCT00679172|454797965|FG000|Overall Study|Other not specified|0|||
126410629|NCT00679172|454797966|FG001|Overall Study|Other not specified|0|||
126410630|NCT00679172|454797967|FG002|Overall Study|Other not specified|1|||
126410631|NCT00679172|454797968|FG003|Overall Study|Other not specified|0|||
126410632|NCT00679172|454797969|FG004|Overall Study|Other not specified|0|||
126410633|NCT00793325|454797970|FG000|Overall Study|Protocol Violation|18|||
126410634|NCT00793325|454797970|FG000|Overall Study|Lost to Follow-up|1|||
126410635|NCT01815840|454797971|FG000|Overall Study|Missing|1|||
126410636|NCT01815840|454797972|FG001|Overall Study|Missing|0|||
126410637|NCT01815840|454797971|FG000|Overall Study|Withdrew Consent|31|||
126410638|NCT01815840|454797972|FG001|Overall Study|Withdrew Consent|30|||
126410639|NCT01815840|454797971|FG000|Overall Study|Administrative/Other|1|||
126410640|NCT01815840|454797972|FG001|Overall Study|Administrative/Other|3|||
126410641|NCT01815840|454797971|FG000|Overall Study|Adverse Event|10|||
126410642|NCT01815840|454797972|FG001|Overall Study|Adverse Event|16|||
126410643|NCT01815840|454797971|FG000|Overall Study|Death|2|||
126410644|NCT01815840|454797972|FG001|Overall Study|Death|2|||
126410645|NCT01815840|454797971|FG000|Overall Study|Disease progression|3|||
126410646|NCT01815840|454797972|FG001|Overall Study|Disease progression|2|||
126410647|NCT01815840|454797971|FG000|Overall Study|Investigators Decision|2|||
126410648|NCT01815840|454797972|FG001|Overall Study|Investigators Decision|3|||
126410649|NCT01815840|454797971|FG000|Overall Study|Lost to Follow-up|3|||
126410650|NCT01815840|454797972|FG001|Overall Study|Lost to Follow-up|6|||
126410651|NCT01815840|454797971|FG000|Overall Study|Refused Treatment|5|||
126410652|NCT01815840|454797972|FG001|Overall Study|Refused Treatment|1|||
126410653|NCT01815840|454797971|FG000|Overall Study|Sponsor Termination Treatment|1|||
126410654|NCT01815840|454797972|FG001|Overall Study|Sponsor Termination Treatment|0|||
126410655|NCT03221842|454797973|FG000|Period 1 (Open-label)|Adverse Event|4|||
126410656|NCT03221842|454797974|FG001|Period 1 (Open-label)|Adverse Event|0|||
126410657|NCT03221842|454797973|FG000|Period 1 (Open-label)|Physician Decision|2|||
126410658|NCT03221842|454797974|FG001|Period 1 (Open-label)|Physician Decision|0|||
126410659|NCT03221842|454797973|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
126410660|NCT03221842|454797974|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
126410661|NCT03221842|454797973|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
126410662|NCT03221842|454797974|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
126410663|NCT03221842|454797973|FG000|Period 1 (Open-label)|Other|2|||
126410664|NCT03221842|454797974|FG001|Period 1 (Open-label)|Other|0|||
126410665|NCT03221842|454797973|FG000|Period 2 (Randomized, Blinded)|Death|0|||
126410666|NCT03221842|454797974|FG001|Period 2 (Randomized, Blinded)|Death|1|||
126410667|NCT03221842|454797973|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
126410668|NCT03221842|454797974|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
126410669|NCT00704288|454797976|FG000|Overall Treatment Period|Adverse Event|11|||
126410670|NCT00704288|454797977|FG001|Overall Treatment Period|Adverse Event|8|||
126410671|NCT00704288|454797978|FG002|Overall Treatment Period|Adverse Event|22|||
126410672|NCT00704288|454797976|FG000|Overall Treatment Period|Death|0|||
126410673|NCT00704288|454797977|FG001|Overall Treatment Period|Death|0|||
126410674|NCT00704288|454797978|FG002|Overall Treatment Period|Death|1|||
126410675|NCT00704288|454797976|FG000|Overall Treatment Period|Physician Decision|0|||
126410676|NCT00704288|454797977|FG001|Overall Treatment Period|Physician Decision|2|||
126410677|NCT00704288|454797978|FG002|Overall Treatment Period|Physician Decision|0|||
126410678|NCT00704288|454797976|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
126410679|NCT00704288|454797977|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
126054082|NCT03732807|453492218|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
126054083|NCT03732807|453492219|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
126410680|NCT00704288|454797978|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
126410681|NCT00704288|454797976|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
126410682|NCT00704288|454797977|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
126410683|NCT00704288|454797978|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
126410684|NCT00704288|454797976|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
126410685|NCT00704288|454797977|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
126410686|NCT00704288|454797978|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
126410687|NCT00704288|454797976|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
126410688|NCT00704288|454797977|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
126410689|NCT00704288|454797978|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
126410690|NCT00704288|454797976|FG000|Overall Treatment Period|Roll-over to another study|1|||
126410691|NCT00704288|454797977|FG001|Overall Treatment Period|Roll-over to another study|0|||
126410692|NCT00704288|454797978|FG002|Overall Treatment Period|Roll-over to another study|4|||
126410693|NCT00704288|454797976|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
126410694|NCT00704288|454797977|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
126410695|NCT00704288|454797978|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
126410696|NCT00704288|454797976|FG000|Extended Post Treatment Follow Up Period|Death|41|||
126410697|NCT00704288|454797977|FG001|Extended Post Treatment Follow Up Period|Death|50|||
126410698|NCT00704288|454797978|FG002|Extended Post Treatment Follow Up Period|Death|93|||
126410699|NCT00704288|454797976|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
126410700|NCT00704288|454797977|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
126410701|NCT00704288|454797978|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
126410702|NCT00704288|454797976|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
126410703|NCT00704288|454797977|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
126410704|NCT00704288|454797978|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
126410705|NCT00704288|454797976|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
126410706|NCT00704288|454797977|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
126410707|NCT00704288|454797978|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
126410708|NCT04395690|454797979|FG000|Overall Study|Lost to Follow-up|1|||
126410709|NCT04395690|454797980|FG001|Overall Study|Lost to Follow-up|1|||
126410710|NCT03387020|454797982|FG000|Overall Study|Adverse Event|0|||
126410711|NCT03387020|454797983|FG001|Overall Study|Adverse Event|2|||
126410712|NCT03387020|454797984|FG002|Overall Study|Adverse Event|0|||
126410713|NCT03387020|454797982|FG000|Overall Study|Withdrawal by Subject|2|||
126410714|NCT03387020|454797983|FG001|Overall Study|Withdrawal by Subject|0|||
126410715|NCT03387020|454797984|FG002|Overall Study|Withdrawal by Subject|0|||
126410716|NCT00434642|454797985|FG000|Blinded Treatment Phase|Adverse Event|12|||
126410717|NCT00434642|454797986|FG001|Blinded Treatment Phase|Adverse Event|58|||
126410718|NCT00434642|454797985|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
126410719|NCT00434642|454797986|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
126410720|NCT00434642|454797985|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
126410721|NCT00434642|454797986|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
126410722|NCT00434642|454797985|FG000|Blinded Treatment Phase|Physician Decision|19|||
126410723|NCT00434642|454797986|FG001|Blinded Treatment Phase|Physician Decision|27|||
126410724|NCT00434642|454797985|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
126410725|NCT00434642|454797986|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
126410726|NCT00434642|454797985|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
126410727|NCT00434642|454797986|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
126410728|NCT00434642|454797985|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
126410729|NCT00434642|454797986|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
126410730|NCT00434642|454797985|FG000|Open-label Treatment Phase|Adverse Event|0|||
126410731|NCT00434642|454797986|FG001|Open-label Treatment Phase|Adverse Event|5|||
126410732|NCT00434642|454797985|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
126410733|NCT00434642|454797986|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
126410734|NCT04512976|454797991|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410735|NCT04512976|454797992|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410736|NCT04512976|454797993|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410737|NCT04512976|454797994|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410738|NCT04512976|454797995|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410739|NCT04512976|454797996|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
126410740|NCT00527982|454797997|FG000|Overall Study|Physician Decision|1|||
126410741|NCT00527982|454797998|FG001|Overall Study|Physician Decision|0|||
126410742|NCT02241343|454798003|FG000|Overall Study|Adverse Event|1|||
126410743|NCT04541628|454798005|FG000|Overall Study|Study Terminated|1|||
126410744|NCT04541628|454798006|FG001|Overall Study|Study Terminated|1|||
126410745|NCT04541628|454798007|FG002|Overall Study|Study Terminated|1|||
126410746|NCT05011058|454798008|FG000|Overall Study|Sponsor Decision|2|||
126410747|NCT05011058|454798009|FG001|Overall Study|Sponsor Decision|0|||
126410748|NCT05011058|454798010|FG002|Overall Study|Sponsor Decision|14|||
126410749|NCT05011058|454798011|FG003|Overall Study|Sponsor Decision|0|||
126410750|NCT05011058|454798012|FG004|Overall Study|Sponsor Decision|0|||
126410751|NCT05011058|454798013|FG005|Overall Study|Sponsor Decision|1|||
126410752|NCT05011058|454798014|FG006|Overall Study|Sponsor Decision|0|||
126410753|NCT05011058|454798015|FG007|Overall Study|Sponsor Decision|5|||
126410754|NCT00308074|454798019|FG000|Overall Study|Withdrawal by Subject|1|||
126410755|NCT01329939|454798022|FG000|Overall Study|Lost to Follow-up|3|||
126410756|NCT01329939|454798023|FG001|Overall Study|Lost to Follow-up|0|||
126410757|NCT01329939|454798024|FG002|Overall Study|Lost to Follow-up|1|||
126410758|NCT01329939|454798025|FG003|Overall Study|Lost to Follow-up|2|||
126410759|NCT01329939|454798022|FG000|Overall Study|Withdrawal by Subject|0|||
126410760|NCT01329939|454798023|FG001|Overall Study|Withdrawal by Subject|1|||
126410761|NCT01329939|454798024|FG002|Overall Study|Withdrawal by Subject|0|||
126410762|NCT01329939|454798025|FG003|Overall Study|Withdrawal by Subject|0|||
126410763|NCT01329939|454798022|FG000|Overall Study|Adverse Event|0|||
126410764|NCT01329939|454798023|FG001|Overall Study|Adverse Event|0|||
126410765|NCT01329939|454798024|FG002|Overall Study|Adverse Event|0|||
126410766|NCT01329939|454798025|FG003|Overall Study|Adverse Event|3|||
126410767|NCT02942485|454798026|FG000|Overall Study|Lost to Follow-up|1|||
126410768|NCT02942485|454798027|FG001|Overall Study|Lost to Follow-up|0|||
126410769|NCT04369950|454798029|FG000|Overall Study|Protocol Violation|2|||
126410770|NCT04369950|454798030|FG001|Overall Study|Protocol Violation|2|||
126410771|NCT00989963|454798031|FG000|Overall Study|Adverse Event|1|||
126410772|NCT00989963|454798032|FG001|Overall Study|Adverse Event|1|||
126410773|NCT00989963|454798033|FG002|Overall Study|Adverse Event|1|||
126410774|NCT01240200|454798034|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
126410775|NCT01240200|454798035|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
126410776|NCT01529034|454798038|FG000|Overall Study|Discontinued prior to study treatment|14|||
126410777|NCT01529034|454798038|FG000|Overall Study|Site closure|62|||
126410778|NCT01529034|454798038|FG000|Overall Study|Study termination|29|||
126410779|NCT01529034|454798038|FG000|Overall Study|Withdrawal by Subject|25|||
126410780|NCT01529034|454798038|FG000|Overall Study|No treated SCs within protocol window|13|||
126410781|NCT01529034|454798038|FG000|Overall Study|Noncompliance|8|||
126410782|NCT01529034|454798038|FG000|Overall Study|Caregiver no longer available|7|||
126410783|NCT01529034|454798038|FG000|Overall Study|Adverse Event|4|||
126410784|NCT01529034|454798038|FG000|Overall Study|Protocol Violation|4|||
126410785|NCT01529034|454798038|FG000|Overall Study|Lack of Efficacy|4|||
126410786|NCT01529034|454798038|FG000|Overall Study|Investigator no longer available|2|||
126410787|NCT01529034|454798038|FG000|Overall Study|Study drug not available|2|||
126410788|NCT00646399|454798040|FG000|Overall Study|Death|63|||
126410789|NCT00646399|454798041|FG001|Overall Study|Death|53|||
126410790|NCT00646399|454798040|FG000|Overall Study|Withdrawal by Subject|9|||
126410791|NCT00646399|454798041|FG001|Overall Study|Withdrawal by Subject|10|||
126410792|NCT00646399|454798040|FG000|Overall Study|Other Reason|11|||
126410793|NCT00646399|454798041|FG001|Overall Study|Other Reason|11|||
126410794|NCT02473367|454798044|FG000|Wait 1|Withdrawal by Subject|1|||
126410795|NCT02473367|454798044|FG000|Period 4|Lost to Follow-up|1|||
126410796|NCT02678923|454798045|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
126410797|NCT02678923|454798046|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
126410798|NCT02678923|454798045|FG000|Overall Study|Withdrawal by Subject|3|||
126410799|NCT02678923|454798046|FG001|Overall Study|Withdrawal by Subject|2|||
126410800|NCT02678923|454798045|FG000|Overall Study|Lost to Follow-up|1|||
126410801|NCT02678923|454798046|FG001|Overall Study|Lost to Follow-up|0|||
126410802|NCT02678923|454798045|FG000|Overall Study|Did Not Return for Study Visits|1|||
126410803|NCT02678923|454798046|FG001|Overall Study|Did Not Return for Study Visits|0|||
126410804|NCT00455143|454798047|FG000|Overall Study|Physician Decision|1|||
126410805|NCT00455143|454798047|FG000|Overall Study|Withdrawal by Subject|1|||
126410806|NCT00455143|454798047|FG000|Overall Study|Staff was not avail to follow patient|2|||
126410807|NCT00455143|454798047|FG000|Overall Study|No longer met Inclusion Criteria|1|||
126410808|NCT00455143|454798047|FG000|Overall Study|Surgical time, staff not available|1|||
126410809|NCT01966445|454798048|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410810|NCT01966445|454798049|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410811|NCT01966445|454798050|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410812|NCT01966445|454798051|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
126410813|NCT01966445|454798052|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410814|NCT01966445|454798053|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
126054084|NCT03732807|453492213|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126054085|NCT03732807|453492214|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126054086|NCT03732807|453492215|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126054087|NCT03732807|453492216|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126054088|NCT03732807|453492217|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126410815|NCT01966445|454798054|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410816|NCT01966445|454798048|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
126410817|NCT01966445|454798049|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
126410818|NCT01966445|454798050|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
126410819|NCT01966445|454798051|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
126410820|NCT01966445|454798052|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
126410821|NCT01966445|454798053|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
126410822|NCT01966445|454798054|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
126410823|NCT01966445|454798048|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
126410824|NCT01966445|454798049|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
126054089|NCT03732807|453492218|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
126054090|NCT03732807|453492219|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126410825|NCT01966445|454798050|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
126410826|NCT01966445|454798051|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
126410827|NCT01966445|454798052|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
126410828|NCT01966445|454798053|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
126410829|NCT01966445|454798054|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
126410830|NCT01966445|454798048|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410831|NCT01966445|454798049|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410832|NCT01966445|454798050|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410833|NCT01966445|454798051|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410834|NCT01966445|454798052|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410835|NCT01966445|454798053|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410836|NCT01966445|454798054|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
126410837|NCT01966445|454798048|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410838|NCT01966445|454798049|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410839|NCT01966445|454798050|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410840|NCT01966445|454798051|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410841|NCT01966445|454798052|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410842|NCT01966445|454798053|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410843|NCT01966445|454798054|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
126410844|NCT01641822|454798055|FG000|Run-in Phase|Noncompliance with study drug|1|||
126410845|NCT01641822|454798056|FG001|Run-in Phase|Noncompliance with study drug|0|||
126410846|NCT01641822|454798057|FG002|Run-in Phase|Noncompliance with study drug|0|||
126410847|NCT01641822|454798055|FG000|Run-in Phase|Adverse Event|3|||
126410848|NCT01641822|454798056|FG001|Run-in Phase|Adverse Event|0|||
126410849|NCT01641822|454798057|FG002|Run-in Phase|Adverse Event|0|||
126410850|NCT01641822|454798055|FG000|Run-in Phase|Withdrew consent|1|||
126410851|NCT01641822|454798056|FG001|Run-in Phase|Withdrew consent|0|||
126410852|NCT01641822|454798057|FG002|Run-in Phase|Withdrew consent|0|||
126410853|NCT01641822|454798055|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
126410854|NCT01641822|454798056|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
126410855|NCT01641822|454798057|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
126410856|NCT01641822|454798055|FG000|Comparative Phase|Noncompliance with study drug|0|||
126410857|NCT01641822|454798056|FG001|Comparative Phase|Noncompliance with study drug|1|||
126410858|NCT01641822|454798057|FG002|Comparative Phase|Noncompliance with study drug|0|||
126410859|NCT01641822|454798055|FG000|Comparative Phase|Investigator's discretion|0|||
126410860|NCT01641822|454798056|FG001|Comparative Phase|Investigator's discretion|0|||
126410861|NCT01641822|454798057|FG002|Comparative Phase|Investigator's discretion|1|||
126410862|NCT01641822|454798055|FG000|Comparative Phase|Pregnancy|0|||
126410863|NCT01641822|454798056|FG001|Comparative Phase|Pregnancy|0|||
126410864|NCT01641822|454798057|FG002|Comparative Phase|Pregnancy|1|||
126410865|NCT01641822|454798055|FG000|Comparative Phase|Adverse event, serious fatal|0|||
126410866|NCT01641822|454798056|FG001|Comparative Phase|Adverse event, serious fatal|1|||
126410867|NCT01641822|454798057|FG002|Comparative Phase|Adverse event, serious fatal|0|||
126410868|NCT01641822|454798055|FG000|Comparative Phase|Withdrew consent|0|||
126410869|NCT01641822|454798056|FG001|Comparative Phase|Withdrew consent|3|||
126410870|NCT01641822|454798057|FG002|Comparative Phase|Withdrew consent|7|||
126410871|NCT01641822|454798055|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
125890757|NCT01088048|452899579|FG000|Overall Study|Disease Progression|7|||
125890758|NCT01088048|452899580|FG001|Overall Study|Disease Progression|4|||
126410872|NCT01641822|454798056|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
126410873|NCT01641822|454798057|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
126410874|NCT00454584|454798058|FG000|Controlled Period|Adverse Event|5|||
126410875|NCT00454584|454798059|FG001|Controlled Period|Adverse Event|2|||
126410876|NCT00454584|454798060|FG002|Controlled Period|Adverse Event|1|||
126410877|NCT00454584|454798061|FG003|Controlled Period|Adverse Event|0|||
126410878|NCT00454584|454798062|FG004|Controlled Period|Adverse Event|0|||
126410879|NCT00454584|454798063|FG005|Controlled Period|Adverse Event|0|||
126410880|NCT00454584|454798058|FG000|Controlled Period|Lost to Follow-up|1|||
126410881|NCT00454584|454798059|FG001|Controlled Period|Lost to Follow-up|2|||
125890759|NCT01088048|452899581|FG002|Overall Study|Disease Progression|3|||
125890760|NCT01088048|452899582|FG003|Overall Study|Disease Progression|5|||
125890761|NCT01088048|452899583|FG004|Overall Study|Disease Progression|3|||
126410882|NCT00454584|454798060|FG002|Controlled Period|Lost to Follow-up|2|||
126410883|NCT00454584|454798061|FG003|Controlled Period|Lost to Follow-up|0|||
125890762|NCT01088048|452899584|FG005|Overall Study|Disease Progression|3|||
126410884|NCT00454584|454798062|FG004|Controlled Period|Lost to Follow-up|0|||
126410885|NCT00454584|454798063|FG005|Controlled Period|Lost to Follow-up|0|||
126410886|NCT00454584|454798058|FG000|Controlled Period|Other|5|||
126410887|NCT00454584|454798059|FG001|Controlled Period|Other|4|||
125890763|NCT01088048|452899585|FG006|Overall Study|Disease Progression|2|||
126410888|NCT00454584|454798060|FG002|Controlled Period|Other|2|||
126410889|NCT00454584|454798061|FG003|Controlled Period|Other|0|||
126410890|NCT00454584|454798062|FG004|Controlled Period|Other|0|||
126410891|NCT00454584|454798063|FG005|Controlled Period|Other|0|||
126410892|NCT00454584|454798058|FG000|After Controlled Period|Adverse Event|0|||
126410893|NCT00454584|454798059|FG001|After Controlled Period|Adverse Event|0|||
126410894|NCT00454584|454798060|FG002|After Controlled Period|Adverse Event|0|||
126410895|NCT00454584|454798061|FG003|After Controlled Period|Adverse Event|9|||
126410896|NCT00454584|454798062|FG004|After Controlled Period|Adverse Event|3|||
126410897|NCT00454584|454798063|FG005|After Controlled Period|Adverse Event|9|||
126410898|NCT00454584|454798058|FG000|After Controlled Period|Lack of Efficacy|0|||
126410899|NCT00454584|454798059|FG001|After Controlled Period|Lack of Efficacy|0|||
126410900|NCT00454584|454798060|FG002|After Controlled Period|Lack of Efficacy|0|||
126410901|NCT00454584|454798061|FG003|After Controlled Period|Lack of Efficacy|1|||
126410902|NCT00454584|454798062|FG004|After Controlled Period|Lack of Efficacy|0|||
126410903|NCT00454584|454798063|FG005|After Controlled Period|Lack of Efficacy|0|||
126410904|NCT00454584|454798058|FG000|After Controlled Period|Lost to Follow-up|0|||
126410905|NCT00454584|454798059|FG001|After Controlled Period|Lost to Follow-up|0|||
126410906|NCT00454584|454798060|FG002|After Controlled Period|Lost to Follow-up|0|||
126410907|NCT00454584|454798061|FG003|After Controlled Period|Lost to Follow-up|2|||
126410908|NCT00454584|454798062|FG004|After Controlled Period|Lost to Follow-up|4|||
126410909|NCT00454584|454798063|FG005|After Controlled Period|Lost to Follow-up|6|||
126410910|NCT00454584|454798058|FG000|After Controlled Period|Other|0|||
126410911|NCT00454584|454798059|FG001|After Controlled Period|Other|0|||
126410912|NCT00454584|454798060|FG002|After Controlled Period|Other|0|||
126410913|NCT00454584|454798061|FG003|After Controlled Period|Other|1|||
126410914|NCT00454584|454798062|FG004|After Controlled Period|Other|0|||
126410915|NCT00454584|454798063|FG005|After Controlled Period|Other|0|||
126410916|NCT00454584|454798058|FG000|After Controlled Period|Other|0|||
126410917|NCT00454584|454798059|FG001|After Controlled Period|Other|0|||
126410918|NCT00454584|454798060|FG002|After Controlled Period|Other|0|||
126410919|NCT00454584|454798061|FG003|After Controlled Period|Other|13|||
126410920|NCT00454584|454798062|FG004|After Controlled Period|Other|5|||
126410921|NCT00454584|454798063|FG005|After Controlled Period|Other|17|||
126410922|NCT02421601|454798064|FG000|Overall Study|Adverse Event|4|||
126410923|NCT02421601|454798064|FG000|Overall Study|Lack of Efficacy|5|||
126410924|NCT02421601|454798064|FG000|Overall Study|Physician Decision|1|||
126410925|NCT02421601|454798064|FG000|Overall Study|Withdrawal by Subject|31|||
126410926|NCT02421601|454798064|FG000|Overall Study|Others|41|||
126410927|NCT00470418|454798065|FG000|Overall Study|Withdrawal by Subject|1|||
126410928|NCT00470418|454798066|FG001|Overall Study|Withdrawal by Subject|0|||
126410929|NCT00599638|454798067|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
126410930|NCT00599638|454798068|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
126410931|NCT00599638|454798069|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
126410932|NCT00599638|454798070|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
126410933|NCT00599638|454798067|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
126410934|NCT00599638|454798068|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
126410935|NCT00599638|454798069|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
126410936|NCT00599638|454798070|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
126410937|NCT00599638|454798067|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
126410938|NCT00599638|454798068|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
126410939|NCT00599638|454798069|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
126410940|NCT00599638|454798070|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
126410941|NCT00599638|454798067|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
126410942|NCT00599638|454798068|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
126410943|NCT00599638|454798069|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
126410944|NCT00599638|454798070|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
126410945|NCT00599638|454798067|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
126410946|NCT00599638|454798068|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
126410947|NCT00599638|454798069|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
126410948|NCT00599638|454798070|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
126410949|NCT00599638|454798067|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
126410950|NCT00599638|454798068|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
126410951|NCT00599638|454798069|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
126410952|NCT00599638|454798070|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
126054091|NCT03732807|453492213|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
126410953|NCT00599638|454798067|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
126410954|NCT00599638|454798068|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
126410955|NCT00599638|454798069|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
126410956|NCT00599638|454798070|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
126410957|NCT00599638|454798067|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
126410958|NCT00599638|454798068|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
125890764|NCT01088048|452899586|FG007|Overall Study|Disease Progression|1|||
126410959|NCT00599638|454798069|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
126410960|NCT00599638|454798070|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
126410961|NCT00599638|454798067|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
126410962|NCT00599638|454798068|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
126410963|NCT00599638|454798069|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
126410964|NCT00599638|454798070|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
126410965|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
126410966|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
126410967|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
126410968|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
126410969|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
126410970|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
126410971|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
126410972|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
126410973|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
126410974|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
126410975|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
126410976|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
126410977|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
126410978|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
126410979|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
126410980|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
126410981|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
126410982|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
126410983|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
126410984|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
126410985|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
126410986|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
126410987|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
126410988|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
126410989|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
126410990|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
126410991|NCT01532869|454798074|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
126410992|NCT01532869|454798075|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
126410993|NCT01532869|454798074|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
126410994|NCT01532869|454798075|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
126410995|NCT01532869|454798074|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
126410996|NCT01532869|454798075|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
126410997|NCT01532869|454798074|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
126410998|NCT01532869|454798075|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
126410999|NCT00409344|454798076|FG000|Overall Study|no enrollment|0|||
126411000|NCT00409344|454798077|FG001|Overall Study|no enrollment|0|||
126411001|NCT01424228|454798078|FG000|Overall Study|Withdrawal by Subject|27|||
126411002|NCT01424228|454798079|FG001|Overall Study|Withdrawal by Subject|11|||
126411003|NCT01424228|454798078|FG000|Overall Study|Adverse Event|10|||
126411004|NCT01424228|454798079|FG001|Overall Study|Adverse Event|14|||
126411005|NCT01424228|454798078|FG000|Overall Study|Sponsor's decision|9|||
126411006|NCT01424228|454798079|FG001|Overall Study|Sponsor's decision|12|||
126411007|NCT01424228|454798078|FG000|Overall Study|Lack of Efficacy|5|||
126411008|NCT01424228|454798079|FG001|Overall Study|Lack of Efficacy|7|||
126411009|NCT01424228|454798078|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
126411010|NCT01424228|454798079|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
126411011|NCT01424228|454798078|FG000|Overall Study|Non-compliance|2|||
126411012|NCT01424228|454798079|FG001|Overall Study|Non-compliance|0|||
126411013|NCT01424228|454798078|FG000|Overall Study|Worsening of symptoms|1|||
126411014|NCT01424228|454798079|FG001|Overall Study|Worsening of symptoms|0|||
126411015|NCT01424228|454798078|FG000|Overall Study|Unplanned journey|0|||
126411016|NCT01424228|454798079|FG001|Overall Study|Unplanned journey|1|||
126411017|NCT00410605|454798093|FG000|Overall Study|Adverse Event|12|||
126411018|NCT00410605|454798093|FG000|Overall Study|Physician Decision|3|||
126411019|NCT00410605|454798093|FG000|Overall Study|Withdrawal by Subject|5|||
126411020|NCT00410605|454798093|FG000|Overall Study|Started Non-Protocol Therapy|3|||
126411021|NCT00410605|454798093|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
126411022|NCT00410605|454798093|FG000|Overall Study|Transferred to another Institution|1|||
126411023|NCT04058886|454798094|FG000|Overall Study|Withdrawal by Subject|4|||
126411024|NCT04058886|454798094|FG000|Overall Study|Inadequate deafness interpreter service|1|||
126411025|NCT00760838|454798098|FG000|Overall Study|Adverse Event|1|||
126411026|NCT00760838|454798099|FG001|Overall Study|Adverse Event|1|||
126411027|NCT00760838|454798098|FG000|Overall Study|Lack of Efficacy|1|||
126411028|NCT00760838|454798099|FG001|Overall Study|Lack of Efficacy|0|||
126411029|NCT00760838|454798098|FG000|Overall Study|Lost to Follow-up|2|||
126411030|NCT00760838|454798099|FG001|Overall Study|Lost to Follow-up|0|||
126411031|NCT00760838|454798098|FG000|Overall Study|Withdrawal by Subject|1|||
126411032|NCT00760838|454798099|FG001|Overall Study|Withdrawal by Subject|1|||
126411033|NCT02999633|454798100|FG000|Overall Study|Adverse Event|2|||
126411034|NCT02999633|454798100|FG000|Overall Study|Progressive disease|12|||
126411035|NCT04356040|454798103|FG000|Overall Study|Death|2|||
126411036|NCT04356040|454798104|FG001|Overall Study|Death|0|||
126411037|NCT04356040|454798103|FG000|Overall Study|Lost to Follow-up|1|||
126411038|NCT04356040|454798104|FG001|Overall Study|Lost to Follow-up|0|||
126411039|NCT04356040|454798103|FG000|Overall Study|Physician Decision|0|||
126411040|NCT04356040|454798104|FG001|Overall Study|Physician Decision|1|||
126411041|NCT04356040|454798103|FG000|Overall Study|Withdrawal by Subject|13|||
126411042|NCT04356040|454798104|FG001|Overall Study|Withdrawal by Subject|1|||
126411043|NCT04356040|454798103|FG000|Overall Study|Enrollment Pause|10|||
126411044|NCT04356040|454798104|FG001|Overall Study|Enrollment Pause|0|||
126411045|NCT04356040|454798103|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
126411046|NCT04356040|454798104|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
126411047|NCT04356040|454798103|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
126411048|NCT04356040|454798104|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
126411049|NCT04356040|454798103|FG000|Overall Study|PI left institution|3|||
126411050|NCT04356040|454798104|FG001|Overall Study|PI left institution|0|||
126411051|NCT00788710|454798105|FG000|Overall Study|Adverse Event|1|||
126411052|NCT00788710|454798106|FG001|Overall Study|Adverse Event|3|||
126411053|NCT00788710|454798107|FG002|Overall Study|Adverse Event|4|||
126411054|NCT00788710|454798105|FG000|Overall Study|Lack of Efficacy|0|||
126411055|NCT00788710|454798106|FG001|Overall Study|Lack of Efficacy|0|||
126411056|NCT00788710|454798107|FG002|Overall Study|Lack of Efficacy|1|||
126411057|NCT00788710|454798105|FG000|Overall Study|Lost to Follow-up|0|||
126411058|NCT00788710|454798106|FG001|Overall Study|Lost to Follow-up|1|||
126411059|NCT00788710|454798107|FG002|Overall Study|Lost to Follow-up|0|||
126411060|NCT00788710|454798105|FG000|Overall Study|Physician Decision|2|||
126411061|NCT00788710|454798106|FG001|Overall Study|Physician Decision|1|||
126411062|NCT00788710|454798107|FG002|Overall Study|Physician Decision|0|||
126411063|NCT00788710|454798105|FG000|Overall Study|Protocol Violation|0|||
126411064|NCT00788710|454798106|FG001|Overall Study|Protocol Violation|1|||
126411065|NCT00788710|454798107|FG002|Overall Study|Protocol Violation|1|||
126411066|NCT00788710|454798105|FG000|Overall Study|Withdrawal by Subject|2|||
126411067|NCT00788710|454798106|FG001|Overall Study|Withdrawal by Subject|2|||
126411068|NCT00788710|454798107|FG002|Overall Study|Withdrawal by Subject|0|||
126411069|NCT01717326|454798108|FG000|Overall Study|Death|0|||
126411070|NCT01717326|454798109|FG001|Overall Study|Death|0|||
126411071|NCT01717326|454798110|FG002|Overall Study|Death|0|||
126411072|NCT01717326|454798111|FG003|Overall Study|Death|0|||
126411073|NCT01717326|454798112|FG004|Overall Study|Death|0|||
126411074|NCT01717326|454798113|FG005|Overall Study|Death|0|||
126411075|NCT01717326|454798114|FG006|Overall Study|Death|0|||
126411076|NCT01717326|454798115|FG007|Overall Study|Death|0|||
126411077|NCT01717326|454798116|FG008|Overall Study|Death|0|||
126411078|NCT01717326|454798117|FG009|Overall Study|Death|0|||
126411079|NCT01717326|454798118|FG010|Overall Study|Death|1|||
126411080|NCT01717326|454798119|FG011|Overall Study|Death|0|||
126411081|NCT01717326|454798120|FG012|Overall Study|Death|0|||
126411082|NCT01717326|454798121|FG013|Overall Study|Death|0|||
126411083|NCT01717326|454798122|FG014|Overall Study|Death|0|||
126411084|NCT01717326|454798123|FG015|Overall Study|Death|0|||
126411085|NCT01717326|454798124|FG016|Overall Study|Death|0|||
126411086|NCT01717326|454798125|FG017|Overall Study|Death|0|||
126411087|NCT01717326|454798126|FG018|Overall Study|Death|0|||
126411088|NCT01717326|454798127|FG019|Overall Study|Death|0|||
126411089|NCT01717326|454798108|FG000|Overall Study|Lost to Follow-up|3|||
126411090|NCT01717326|454798109|FG001|Overall Study|Lost to Follow-up|0|||
126411091|NCT01717326|454798110|FG002|Overall Study|Lost to Follow-up|0|||
126411092|NCT01717326|454798111|FG003|Overall Study|Lost to Follow-up|2|||
126411093|NCT01717326|454798112|FG004|Overall Study|Lost to Follow-up|1|||
126411094|NCT01717326|454798113|FG005|Overall Study|Lost to Follow-up|0|||
126411095|NCT01717326|454798114|FG006|Overall Study|Lost to Follow-up|1|||
126411096|NCT01717326|454798115|FG007|Overall Study|Lost to Follow-up|0|||
126411097|NCT01717326|454798116|FG008|Overall Study|Lost to Follow-up|0|||
126411098|NCT01717326|454798117|FG009|Overall Study|Lost to Follow-up|0|||
126411099|NCT01717326|454798118|FG010|Overall Study|Lost to Follow-up|1|||
126411100|NCT01717326|454798119|FG011|Overall Study|Lost to Follow-up|0|||
126411101|NCT01717326|454798120|FG012|Overall Study|Lost to Follow-up|0|||
126411102|NCT01717326|454798121|FG013|Overall Study|Lost to Follow-up|0|||
126411103|NCT01717326|454798122|FG014|Overall Study|Lost to Follow-up|0|||
126411104|NCT01717326|454798123|FG015|Overall Study|Lost to Follow-up|2|||
126411105|NCT01717326|454798124|FG016|Overall Study|Lost to Follow-up|1|||
126411106|NCT01717326|454798125|FG017|Overall Study|Lost to Follow-up|0|||
126411107|NCT01717326|454798126|FG018|Overall Study|Lost to Follow-up|2|||
126411108|NCT01717326|454798127|FG019|Overall Study|Lost to Follow-up|3|||
126411109|NCT01717326|454798108|FG000|Overall Study|Physician Decision|0|||
126411110|NCT01717326|454798109|FG001|Overall Study|Physician Decision|0|||
126411111|NCT01717326|454798110|FG002|Overall Study|Physician Decision|0|||
126411112|NCT01717326|454798111|FG003|Overall Study|Physician Decision|0|||
126411113|NCT01717326|454798112|FG004|Overall Study|Physician Decision|0|||
126411114|NCT01717326|454798113|FG005|Overall Study|Physician Decision|0|||
126411115|NCT01717326|454798114|FG006|Overall Study|Physician Decision|0|||
125890765|NCT01088048|452899587|FG008|Overall Study|Disease Progression|0|||
126411116|NCT01717326|454798115|FG007|Overall Study|Physician Decision|0|||
126411117|NCT01717326|454798116|FG008|Overall Study|Physician Decision|0|||
125890766|NCT01088048|452899588|FG009|Overall Study|Disease Progression|0|||
125890767|NCT01088048|452899579|FG000|Overall Study|Death|1|||
125890768|NCT01088048|452899580|FG001|Overall Study|Death|5|||
126411118|NCT01717326|454798117|FG009|Overall Study|Physician Decision|1|||
126411119|NCT01717326|454798118|FG010|Overall Study|Physician Decision|0|||
126411120|NCT01717326|454798119|FG011|Overall Study|Physician Decision|0|||
126411121|NCT01717326|454798120|FG012|Overall Study|Physician Decision|0|||
125890769|NCT01088048|452899581|FG002|Overall Study|Death|3|||
126411122|NCT01717326|454798121|FG013|Overall Study|Physician Decision|0|||
126411123|NCT01717326|454798122|FG014|Overall Study|Physician Decision|0|||
126411124|NCT01717326|454798123|FG015|Overall Study|Physician Decision|0|||
126411125|NCT01717326|454798124|FG016|Overall Study|Physician Decision|0|||
126411126|NCT01717326|454798125|FG017|Overall Study|Physician Decision|0|||
126411127|NCT01717326|454798126|FG018|Overall Study|Physician Decision|0|||
126411128|NCT01717326|454798127|FG019|Overall Study|Physician Decision|0|||
126411129|NCT01717326|454798108|FG000|Overall Study|Protocol Violation|0|||
126411130|NCT01717326|454798109|FG001|Overall Study|Protocol Violation|0|||
126411131|NCT01717326|454798110|FG002|Overall Study|Protocol Violation|0|||
126411132|NCT01717326|454798111|FG003|Overall Study|Protocol Violation|0|||
126411133|NCT01717326|454798112|FG004|Overall Study|Protocol Violation|1|||
126411134|NCT01717326|454798113|FG005|Overall Study|Protocol Violation|0|||
126411135|NCT01717326|454798114|FG006|Overall Study|Protocol Violation|0|||
126411136|NCT01717326|454798115|FG007|Overall Study|Protocol Violation|0|||
126411137|NCT01717326|454798116|FG008|Overall Study|Protocol Violation|0|||
126411138|NCT01717326|454798117|FG009|Overall Study|Protocol Violation|0|||
126411139|NCT01717326|454798118|FG010|Overall Study|Protocol Violation|0|||
126411140|NCT01717326|454798119|FG011|Overall Study|Protocol Violation|0|||
126411141|NCT01717326|454798120|FG012|Overall Study|Protocol Violation|0|||
126411142|NCT01717326|454798121|FG013|Overall Study|Protocol Violation|0|||
126411143|NCT01717326|454798122|FG014|Overall Study|Protocol Violation|0|||
126411144|NCT01717326|454798123|FG015|Overall Study|Protocol Violation|0|||
126411145|NCT01717326|454798124|FG016|Overall Study|Protocol Violation|0|||
126411146|NCT01717326|454798125|FG017|Overall Study|Protocol Violation|0|||
126411147|NCT01717326|454798126|FG018|Overall Study|Protocol Violation|0|||
126411148|NCT01717326|454798127|FG019|Overall Study|Protocol Violation|0|||
126411149|NCT01717326|454798108|FG000|Overall Study|Withdrawal by Subject|0|||
126411150|NCT01717326|454798109|FG001|Overall Study|Withdrawal by Subject|1|||
126411151|NCT01717326|454798110|FG002|Overall Study|Withdrawal by Subject|0|||
126411152|NCT01717326|454798111|FG003|Overall Study|Withdrawal by Subject|0|||
126411153|NCT01717326|454798112|FG004|Overall Study|Withdrawal by Subject|0|||
126411154|NCT01717326|454798113|FG005|Overall Study|Withdrawal by Subject|0|||
126411155|NCT01717326|454798114|FG006|Overall Study|Withdrawal by Subject|0|||
126411156|NCT01717326|454798115|FG007|Overall Study|Withdrawal by Subject|0|||
126411157|NCT01717326|454798116|FG008|Overall Study|Withdrawal by Subject|0|||
126411158|NCT01717326|454798117|FG009|Overall Study|Withdrawal by Subject|1|||
126411159|NCT01717326|454798118|FG010|Overall Study|Withdrawal by Subject|0|||
126411160|NCT01717326|454798119|FG011|Overall Study|Withdrawal by Subject|0|||
126411161|NCT01717326|454798120|FG012|Overall Study|Withdrawal by Subject|1|||
126411162|NCT01717326|454798121|FG013|Overall Study|Withdrawal by Subject|0|||
126411163|NCT01717326|454798122|FG014|Overall Study|Withdrawal by Subject|0|||
126411164|NCT01717326|454798123|FG015|Overall Study|Withdrawal by Subject|1|||
126411165|NCT01717326|454798124|FG016|Overall Study|Withdrawal by Subject|0|||
126411166|NCT01717326|454798125|FG017|Overall Study|Withdrawal by Subject|0|||
126411167|NCT01717326|454798126|FG018|Overall Study|Withdrawal by Subject|2|||
126411168|NCT01717326|454798127|FG019|Overall Study|Withdrawal by Subject|3|||
126411169|NCT00605345|454798132|FG000|Overall Study|Withdrawal by Subject|1|||
126411170|NCT00605345|454798133|FG001|Overall Study|Withdrawal by Subject|0|||
126411171|NCT00605345|454798132|FG000|Overall Study|Adverse Event|0|||
126411172|NCT00605345|454798133|FG001|Overall Study|Adverse Event|1|||
126411173|NCT00605345|454798132|FG000|Overall Study|Protocol Violation|0|||
126411174|NCT00605345|454798133|FG001|Overall Study|Protocol Violation|2|||
126411175|NCT02596945|454798136|FG000|Overall Study|No documentation of study drug dosing|3|||
126411176|NCT02596945|454798136|FG000|Overall Study|Other|32|||
126411177|NCT02596945|454798136|FG000|Overall Study|Change to hemodialysis|15|||
126411178|NCT02596945|454798136|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
126411179|NCT02596945|454798136|FG000|Overall Study|Withdrawal by Subject|1|||
126411180|NCT02596945|454798136|FG000|Overall Study|Missing|1|||
126411181|NCT00422383|454798137|FG000|Overall Study|Adverse Event|5|||
126411182|NCT00422383|454798138|FG001|Overall Study|Adverse Event|3|||
126411183|NCT00422383|454798139|FG002|Overall Study|Adverse Event|1|||
126411184|NCT00422383|454798140|FG003|Overall Study|Adverse Event|1|||
126411185|NCT00422383|454798141|FG004|Overall Study|Adverse Event|0|||
126411186|NCT00422383|454798137|FG000|Overall Study|Lack of Efficacy|4|||
126411187|NCT00422383|454798138|FG001|Overall Study|Lack of Efficacy|4|||
126411188|NCT00422383|454798139|FG002|Overall Study|Lack of Efficacy|2|||
126411189|NCT00422383|454798140|FG003|Overall Study|Lack of Efficacy|1|||
126411190|NCT00422383|454798141|FG004|Overall Study|Lack of Efficacy|1|||
126411191|NCT00422383|454798137|FG000|Overall Study|Lost to Follow-up|0|||
126411192|NCT00422383|454798138|FG001|Overall Study|Lost to Follow-up|1|||
126411193|NCT00422383|454798139|FG002|Overall Study|Lost to Follow-up|0|||
126411194|NCT00422383|454798140|FG003|Overall Study|Lost to Follow-up|0|||
126411195|NCT00422383|454798141|FG004|Overall Study|Lost to Follow-up|1|||
126411196|NCT00422383|454798137|FG000|Overall Study|Protocol Violation|1|||
126411197|NCT00422383|454798138|FG001|Overall Study|Protocol Violation|1|||
126411198|NCT00422383|454798139|FG002|Overall Study|Protocol Violation|1|||
126411199|NCT00422383|454798140|FG003|Overall Study|Protocol Violation|0|||
126411200|NCT00422383|454798141|FG004|Overall Study|Protocol Violation|0|||
126411201|NCT00422383|454798137|FG000|Overall Study|Withdrawal by Subject|5|||
126411202|NCT00422383|454798138|FG001|Overall Study|Withdrawal by Subject|5|||
126411203|NCT00422383|454798139|FG002|Overall Study|Withdrawal by Subject|0|||
126411204|NCT00422383|454798140|FG003|Overall Study|Withdrawal by Subject|0|||
126411205|NCT00422383|454798141|FG004|Overall Study|Withdrawal by Subject|1|||
126411206|NCT05066165|454799641|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
126411207|NCT05066165|454799642|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
126411208|NCT05066165|454799641|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
126411209|NCT05066165|454799642|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
126411210|NCT03738618|454799643|FG000|Overall Study|Protocol deviation|23|||
126411211|NCT03738618|454799644|FG001|Overall Study|Protocol deviation|0|||
126411212|NCT03738618|454799643|FG000|Overall Study|Adverse Event|4|||
126411213|NCT03738618|454799644|FG001|Overall Study|Adverse Event|0|||
126411214|NCT03738618|454799643|FG000|Overall Study|Lost to Follow-up|2|||
126411215|NCT03738618|454799644|FG001|Overall Study|Lost to Follow-up|0|||
126411216|NCT03738618|454799643|FG000|Overall Study|Randomization failure|1|||
126411217|NCT03738618|454799644|FG001|Overall Study|Randomization failure|0|||
126411218|NCT03738618|454799643|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
126411219|NCT03738618|454799644|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
126411220|NCT03738618|454799643|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
126411221|NCT03738618|454799644|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
126411222|NCT00649428|454799645|FG000|Overall Study|Adverse Event|2|||
126411223|NCT00649428|454799646|FG001|Overall Study|Adverse Event|2|||
126411224|NCT00649428|454799645|FG000|Overall Study|Withdrawal by Subject|6|||
126411225|NCT00649428|454799646|FG001|Overall Study|Withdrawal by Subject|6|||
126411226|NCT00649428|454799645|FG000|Overall Study|Lost to Follow-up|1|||
126411227|NCT00649428|454799646|FG001|Overall Study|Lost to Follow-up|3|||
126411228|NCT00649428|454799645|FG000|Overall Study|Insufficient manufacturing yield|5|||
126411229|NCT00649428|454799646|FG001|Overall Study|Insufficient manufacturing yield|1|||
126411230|NCT00649428|454799645|FG000|Overall Study|Protocol Violation|6|||
126411231|NCT00649428|454799646|FG001|Overall Study|Protocol Violation|2|||
126411232|NCT00649428|454799645|FG000|Overall Study|Physician Decision|0|||
126411233|NCT00649428|454799646|FG001|Overall Study|Physician Decision|1|||
126411234|NCT00742417|454799647|FG000|Randomized|Withdrawal by legal representative|0|||
126411235|NCT00742417|454799648|FG001|Randomized|Withdrawal by legal representative|1|||
126411236|NCT00742417|454799647|FG000|Randomized|Withdrawal by Subject|1|||
126411237|NCT00742417|454799648|FG001|Randomized|Withdrawal by Subject|0|||
126411238|NCT00742417|454799647|FG000|Randomized|Physician Decision|1|||
126411239|NCT00742417|454799648|FG001|Randomized|Physician Decision|0|||
126411240|NCT00742417|454799647|FG000|Intensive Period|Withdrawal by Subject|1|||
126411241|NCT00742417|454799648|FG001|Intensive Period|Withdrawal by Subject|1|||
126411242|NCT00742417|454799647|FG000|Intensive Period|Adverse Event|2|||
126411243|NCT00742417|454799648|FG001|Intensive Period|Adverse Event|0|||
126411244|NCT04566601|454799653|FG000|Overall Study|Other than listed|13|||
126411245|NCT04566601|454799654|FG001|Overall Study|Other than listed|4|||
126411246|NCT04566601|454799655|FG002|Overall Study|Other than listed|2|||
126411247|NCT04566601|454799656|FG003|Overall Study|Other than listed|1|||
126411248|NCT04566601|454799657|FG004|Overall Study|Other than listed|4|||
126411249|NCT04566601|454799653|FG000|Overall Study|Protocol deviation|3|||
126411250|NCT04566601|454799654|FG001|Overall Study|Protocol deviation|0|||
126411251|NCT04566601|454799655|FG002|Overall Study|Protocol deviation|1|||
126411252|NCT04566601|454799656|FG003|Overall Study|Protocol deviation|1|||
126411253|NCT04566601|454799657|FG004|Overall Study|Protocol deviation|1|||
126411254|NCT04566601|454799653|FG000|Overall Study|Technical problems|0|||
126411255|NCT04566601|454799654|FG001|Overall Study|Technical problems|0|||
126411256|NCT04566601|454799655|FG002|Overall Study|Technical problems|1|||
126411257|NCT04566601|454799656|FG003|Overall Study|Technical problems|0|||
126411258|NCT04566601|454799657|FG004|Overall Study|Technical problems|0|||
126411259|NCT04566601|454799653|FG000|Overall Study|No reason available|3|||
126411260|NCT04566601|454799654|FG001|Overall Study|No reason available|2|||
126411261|NCT04566601|454799655|FG002|Overall Study|No reason available|7|||
126411262|NCT04566601|454799656|FG003|Overall Study|No reason available|1|||
126411263|NCT04566601|454799657|FG004|Overall Study|No reason available|5|||
126411264|NCT04566601|454799653|FG000|Overall Study|Burden of study procedures|3|||
126411265|NCT04566601|454799654|FG001|Overall Study|Burden of study procedures|0|||
126411266|NCT04566601|454799655|FG002|Overall Study|Burden of study procedures|0|||
126411267|NCT04566601|454799656|FG003|Overall Study|Burden of study procedures|3|||
126411268|NCT04566601|454799657|FG004|Overall Study|Burden of study procedures|1|||
126411269|NCT04566601|454799653|FG000|Overall Study|Change of residence|2|||
126411270|NCT04566601|454799654|FG001|Overall Study|Change of residence|2|||
126411271|NCT04566601|454799655|FG002|Overall Study|Change of residence|0|||
126411272|NCT04566601|454799656|FG003|Overall Study|Change of residence|1|||
126411273|NCT04566601|454799657|FG004|Overall Study|Change of residence|2|||
126411274|NCT04566601|454799653|FG000|Overall Study|Perceived lack of efficacy|2|||
126411275|NCT04566601|454799654|FG001|Overall Study|Perceived lack of efficacy|0|||
126411276|NCT04566601|454799655|FG002|Overall Study|Perceived lack of efficacy|1|||
126411277|NCT04566601|454799656|FG003|Overall Study|Perceived lack of efficacy|1|||
126411278|NCT04566601|454799657|FG004|Overall Study|Perceived lack of efficacy|2|||
126411279|NCT04566601|454799653|FG000|Overall Study|Adverse Event|7|||
126411280|NCT04566601|454799654|FG001|Overall Study|Adverse Event|4|||
126411281|NCT04566601|454799655|FG002|Overall Study|Adverse Event|6|||
126411282|NCT04566601|454799656|FG003|Overall Study|Adverse Event|5|||
126411283|NCT04566601|454799657|FG004|Overall Study|Adverse Event|12|||
126411284|NCT01450098|454799658|FG000|Period 3|Protocol Violation|0|||
126411285|NCT01450098|454799659|FG001|Period 3|Protocol Violation|1|||
126411286|NCT01450098|454799658|FG000|Period 3|Withdrawal by Subject|0|||
126411287|NCT01450098|454799659|FG001|Period 3|Withdrawal by Subject|2|||
126411288|NCT01272635|454799662|FG000|Overall Study|Lost to Follow-up|31|||
126411289|NCT01272635|454799663|FG001|Overall Study|Lost to Follow-up|20|||
126411290|NCT01272635|454799664|FG002|Overall Study|Lost to Follow-up|31|||
126411291|NCT01272635|454799665|FG003|Overall Study|Lost to Follow-up|23|||
126411292|NCT00372697|454799668|FG000|Overall Study|Protocol Violation|1|||
126411293|NCT00372697|454799669|FG001|Overall Study|Protocol Violation|1|||
126411294|NCT01832155|454799670|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
126411295|NCT01832155|454799671|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
126411296|NCT01832155|454799670|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
126411297|NCT01832155|454799671|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
126411298|NCT01055314|454799672|FG000|Overall Study|Adverse Event|7|||
126411299|NCT01055314|454799673|FG001|Overall Study|Adverse Event|4|||
126411300|NCT01055314|454799672|FG000|Overall Study|Death|2|||
125890770|NCT01088048|452899582|FG003|Overall Study|Death|3|||
125890771|NCT01088048|452899583|FG004|Overall Study|Death|1|||
125890772|NCT01088048|452899584|FG005|Overall Study|Death|3|||
125890773|NCT01088048|452899585|FG006|Overall Study|Death|0|||
125890774|NCT01088048|452899586|FG007|Overall Study|Death|0|||
126411301|NCT01055314|454799673|FG001|Overall Study|Death|1|||
126411302|NCT01055314|454799672|FG000|Overall Study|Lack of Efficacy|11|||
126411303|NCT01055314|454799673|FG001|Overall Study|Lack of Efficacy|19|||
126411304|NCT01055314|454799672|FG000|Overall Study|Physician Decision|10|||
126411305|NCT01055314|454799673|FG001|Overall Study|Physician Decision|5|||
126411306|NCT01055314|454799672|FG000|Overall Study|Withdrawal by Subject|1|||
126411307|NCT01055314|454799673|FG001|Overall Study|Withdrawal by Subject|0|||
126411308|NCT01055314|454799672|FG000|Overall Study|Ineligible|3|||
126411309|NCT01055314|454799673|FG001|Overall Study|Ineligible|5|||
125890775|NCT01088048|452899587|FG008|Overall Study|Death|3|||
125890776|NCT01088048|452899588|FG009|Overall Study|Death|1|||
125890777|NCT01088048|452899579|FG000|Overall Study|Other|3|||
125890778|NCT01088048|452899580|FG001|Overall Study|Other|5|||
126411310|NCT01055314|454799672|FG000|Overall Study|Refusal of further protocol therapy|10|||
126411311|NCT01055314|454799673|FG001|Overall Study|Refusal of further protocol therapy|4|||
126411312|NCT01055314|454799672|FG000|Overall Study|No treatment|1|||
126411313|NCT01055314|454799673|FG001|Overall Study|No treatment|0|||
126411314|NCT01279616|454799674|FG000|Overall Study|donor could not be located|5|||
126411315|NCT01279616|454799674|FG000|Overall Study|no signs of sickle cell disease|2|||
126411316|NCT02462720|454799675|FG000|Part 2|Withdrawal by Subject|1|||
126411317|NCT02462720|454799676|FG001|Part 2|Withdrawal by Subject|0|||
126411318|NCT02462720|454799675|FG000|Part 2|Protocol Violation|0|||
126411319|NCT02462720|454799676|FG001|Part 2|Protocol Violation|1|||
126411320|NCT00183625|454799679|FG000|Overall Study|Withdrawal by Subject|18|||
126411321|NCT00183625|454799680|FG001|Overall Study|Withdrawal by Subject|18|||
126411322|NCT00183625|454799681|FG002|Overall Study|Withdrawal by Subject|19|||
126411323|NCT00183625|454799682|FG003|Overall Study|Withdrawal by Subject|14|||
126411324|NCT05249569|454799685|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
126411325|NCT03722524|454799686|FG000|Overall Study|Protocol Violation|86|||
126411326|NCT03722524|454799686|FG000|Overall Study|Adverse Event|7|||
126411327|NCT03722524|454799686|FG000|Overall Study|Lost to Follow-up|1|||
126411328|NCT03722524|454799686|FG000|Overall Study|Reason is not stated|1|||
126411329|NCT03722524|454799686|FG000|Overall Study|Physician Decision|1|||
126411330|NCT03722524|454799686|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
126411331|NCT01423916|454799689|FG000|Overall Study|Adverse Event|5|||
126411332|NCT01423916|454799690|FG001|Overall Study|Adverse Event|9|||
126411333|NCT01423916|454799691|FG002|Overall Study|Adverse Event|2|||
126411334|NCT01423916|454799689|FG000|Overall Study|Met Withdrawal Criteria|1|||
126411335|NCT01423916|454799690|FG001|Overall Study|Met Withdrawal Criteria|1|||
126411336|NCT01423916|454799691|FG002|Overall Study|Met Withdrawal Criteria|1|||
126411337|NCT01423916|454799689|FG000|Overall Study|Physician Decision|1|||
126411338|NCT01423916|454799690|FG001|Overall Study|Physician Decision|0|||
126411339|NCT01423916|454799691|FG002|Overall Study|Physician Decision|1|||
126411340|NCT01423916|454799689|FG000|Overall Study|Withdrawal by Subject|3|||
126411341|NCT01423916|454799690|FG001|Overall Study|Withdrawal by Subject|10|||
126411342|NCT01423916|454799691|FG002|Overall Study|Withdrawal by Subject|3|||
126411343|NCT01423916|454799689|FG000|Overall Study|Protocol Deviation|1|||
126411344|NCT01423916|454799690|FG001|Overall Study|Protocol Deviation|0|||
126411345|NCT01423916|454799691|FG002|Overall Study|Protocol Deviation|0|||
126411346|NCT01374178|454799696|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
126411347|NCT01374178|454799697|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
126411348|NCT01374178|454799696|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
126411349|NCT01374178|454799697|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
126411350|NCT04856904|454799700|FG000|Overall Study|Physician Decision|1|||
126411351|NCT04856904|454799701|FG001|Overall Study|Physician Decision|1|||
126411352|NCT04856904|454799700|FG000|Overall Study|Withdrawal by Subject|13|||
126411353|NCT04856904|454799701|FG001|Overall Study|Withdrawal by Subject|13|||
126411354|NCT04856904|454799700|FG000|Overall Study|Adverse Event|1|||
126411355|NCT04856904|454799701|FG001|Overall Study|Adverse Event|1|||
126411356|NCT04856904|454799700|FG000|Overall Study|Non-compliance with study drug|1|||
126411357|NCT04856904|454799701|FG001|Overall Study|Non-compliance with study drug|1|||
126411358|NCT04856904|454799700|FG000|Overall Study|Lost to Follow-up|4|||
126411359|NCT04856904|454799701|FG001|Overall Study|Lost to Follow-up|4|||
126411360|NCT04856904|454799700|FG000|Overall Study|Withdrawal by Subject|1|||
126411361|NCT04856904|454799701|FG001|Overall Study|Withdrawal by Subject|1|||
126411362|NCT04856904|454799700|FG000|Overall Study|Protocol Violation|1|||
126411363|NCT04856904|454799701|FG001|Overall Study|Protocol Violation|1|||
126411364|NCT00077649|454799702|FG000|Overall Study|Adverse Event|5|||
126411365|NCT00077649|454799703|FG001|Overall Study|Adverse Event|1|||
126411366|NCT00077649|454799704|FG002|Overall Study|Adverse Event|7|||
126411367|NCT00077649|454799705|FG003|Overall Study|Adverse Event|9|||
126411368|NCT00077649|454799702|FG000|Overall Study|Lack of Efficacy|5|||
126411369|NCT00077649|454799703|FG001|Overall Study|Lack of Efficacy|3|||
126411370|NCT00077649|454799704|FG002|Overall Study|Lack of Efficacy|3|||
126411371|NCT00077649|454799705|FG003|Overall Study|Lack of Efficacy|2|||
126411372|NCT00077649|454799702|FG000|Overall Study|Withdrawal by Subject|0|||
126411373|NCT00077649|454799703|FG001|Overall Study|Withdrawal by Subject|1|||
126411374|NCT00077649|454799704|FG002|Overall Study|Withdrawal by Subject|1|||
126411375|NCT00077649|454799705|FG003|Overall Study|Withdrawal by Subject|2|||
126411376|NCT00077649|454799702|FG000|Overall Study|Lost to Follow-up|2|||
126411377|NCT00077649|454799703|FG001|Overall Study|Lost to Follow-up|2|||
126054092|NCT03732807|453492214|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
126411378|NCT00077649|454799704|FG002|Overall Study|Lost to Follow-up|3|||
126411379|NCT00077649|454799705|FG003|Overall Study|Lost to Follow-up|2|||
126411380|NCT00077649|454799702|FG000|Overall Study|Abnormality of Laboratory Test|1|||
126411381|NCT00077649|454799703|FG001|Overall Study|Abnormality of Laboratory Test|2|||
126411382|NCT00077649|454799704|FG002|Overall Study|Abnormality of Laboratory Test|1|||
126411383|NCT00077649|454799705|FG003|Overall Study|Abnormality of Laboratory Test|2|||
126411384|NCT00077649|454799702|FG000|Overall Study|Randomized but never dosed|1|||
126411385|NCT00077649|454799703|FG001|Overall Study|Randomized but never dosed|0|||
126411386|NCT00077649|454799704|FG002|Overall Study|Randomized but never dosed|0|||
126411387|NCT00077649|454799705|FG003|Overall Study|Randomized but never dosed|0|||
126054093|NCT03732807|453492215|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
126054094|NCT03732807|453492216|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
126054095|NCT03732807|453492217|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
126054096|NCT03732807|453492218|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
126054097|NCT03732807|453492219|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
126411388|NCT02895945|454799706|FG000|Overall Study|Physician Decision|2|||
126411389|NCT02895945|454799707|FG001|Overall Study|Physician Decision|1|||
126411390|NCT00454181|454799711|FG000|Overall Study|Adverse Event|1|||
126411391|NCT00454181|454799712|FG001|Overall Study|Adverse Event|1|||
126411392|NCT00454181|454799711|FG000|Overall Study|Lost to Follow-up|11|||
126411393|NCT00454181|454799712|FG001|Overall Study|Lost to Follow-up|1|||
126411394|NCT00454181|454799711|FG000|Overall Study|Protocol Violation|1|||
126411395|NCT00454181|454799712|FG001|Overall Study|Protocol Violation|1|||
126411396|NCT00454181|454799711|FG000|Overall Study|Withdrawal by Subject|2|||
126411397|NCT00454181|454799712|FG001|Overall Study|Withdrawal by Subject|0|||
126411398|NCT04032080|454799713|FG000|Overall Study|Death|6|||
126411399|NCT02409719|454799725|FG000|Overall Study|Lost to Follow-up|3|||
126411400|NCT02409719|454799726|FG001|Overall Study|Lost to Follow-up|3|||
126411401|NCT03689855|454799727|FG000|Overall Study|Adverse Event|3|||
126411402|NCT03689855|454799727|FG000|Overall Study|Withdrawal by Subject|1|||
126411403|NCT02479139|454799728|FG000|Overall Study|Lost to Follow-up|2|||
126411404|NCT02479139|454799729|FG001|Overall Study|Lost to Follow-up|4|||
126411405|NCT02479139|454799730|FG002|Overall Study|Lost to Follow-up|4|||
126411406|NCT02479139|454799731|FG003|Overall Study|Lost to Follow-up|2|||
126411407|NCT02479139|454799732|FG004|Overall Study|Lost to Follow-up|3|||
126411408|NCT02479139|454799733|FG005|Overall Study|Lost to Follow-up|5|||
126411409|NCT02479139|454799728|FG000|Overall Study|Withdrew Consent|5|||
126411410|NCT02479139|454799729|FG001|Overall Study|Withdrew Consent|6|||
126411411|NCT02479139|454799730|FG002|Overall Study|Withdrew Consent|1|||
126411412|NCT02479139|454799731|FG003|Overall Study|Withdrew Consent|4|||
126411413|NCT02479139|454799732|FG004|Overall Study|Withdrew Consent|1|||
126411414|NCT02479139|454799733|FG005|Overall Study|Withdrew Consent|1|||
126411415|NCT02479139|454799728|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411416|NCT02479139|454799729|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411417|NCT02479139|454799730|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
126411418|NCT02479139|454799731|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411419|NCT02479139|454799732|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411420|NCT02479139|454799733|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411421|NCT02479139|454799728|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126411422|NCT02479139|454799729|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126411423|NCT02479139|454799730|FG002|Overall Study|Other Miscellaneous Reasons|1|||
126411424|NCT02479139|454799731|FG003|Overall Study|Other Miscellaneous Reasons|1|||
126411425|NCT02479139|454799732|FG004|Overall Study|Other Miscellaneous Reasons|1|||
126411426|NCT02479139|454799733|FG005|Overall Study|Other Miscellaneous Reasons|0|||
126411427|NCT00764673|454799734|FG000|Overall Study|Death|1|||
126411428|NCT00764673|454799734|FG000|Overall Study|Lost to Follow-up|3|||
126411429|NCT00764673|454799734|FG000|Overall Study|Withdrawal by Subject|6|||
126411430|NCT00764673|454799734|FG000|Overall Study|Revision of Device|2|||
126411431|NCT01438177|454799735|FG000|Overall Study|Withdrawal by Subject|1|||
126411432|NCT01438177|454799735|FG000|Overall Study|Initiation of new therapy|1|||
126411433|NCT01727336|454799738|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
126411434|NCT01727336|454799739|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
126411435|NCT01727336|454799740|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
126411436|NCT01727336|454799741|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
126411437|NCT01727336|454799742|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
126411438|NCT01727336|454799743|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
126411439|NCT01727336|454799738|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
126411440|NCT01727336|454799739|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
126054098|NCT03732807|453492213|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
126411441|NCT01727336|454799740|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
126411442|NCT01727336|454799741|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
126411443|NCT01727336|454799742|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
126054099|NCT03732807|453492214|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
126411444|NCT01727336|454799743|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
126411445|NCT01727336|454799738|FG000|Part 2 Blinded|Death|0|||
126411446|NCT01727336|454799739|FG001|Part 2 Blinded|Death|0|||
126054100|NCT03732807|453492215|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
126054101|NCT03732807|453492216|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
126411447|NCT01727336|454799740|FG002|Part 2 Blinded|Death|0|||
126411448|NCT01727336|454799741|FG003|Part 2 Blinded|Death|0|||
126411449|NCT01727336|454799742|FG004|Part 2 Blinded|Death|20|||
126411450|NCT01727336|454799743|FG005|Part 2 Blinded|Death|16|||
126411451|NCT01727336|454799738|FG000|Part 2 Blinded|Lack of Efficacy|0|||
126411452|NCT01727336|454799739|FG001|Part 2 Blinded|Lack of Efficacy|0|||
126411453|NCT01727336|454799740|FG002|Part 2 Blinded|Lack of Efficacy|0|||
126054102|NCT03732807|453492217|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
126054103|NCT03732807|453492218|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
126054104|NCT03732807|453492219|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
126054105|NCT03732807|453492213|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
126054106|NCT03732807|453492214|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
126054107|NCT03732807|453492215|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
126054108|NCT03732807|453492216|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
126411454|NCT01727336|454799741|FG003|Part 2 Blinded|Lack of Efficacy|0|||
126411455|NCT01727336|454799742|FG004|Part 2 Blinded|Lack of Efficacy|42|||
126411456|NCT01727336|454799743|FG005|Part 2 Blinded|Lack of Efficacy|44|||
126411457|NCT01727336|454799738|FG000|Part 2 Blinded|Lost to Follow-up|0|||
126411458|NCT01727336|454799739|FG001|Part 2 Blinded|Lost to Follow-up|0|||
126411459|NCT01727336|454799740|FG002|Part 2 Blinded|Lost to Follow-up|0|||
126411460|NCT01727336|454799741|FG003|Part 2 Blinded|Lost to Follow-up|0|||
126411461|NCT01727336|454799742|FG004|Part 2 Blinded|Lost to Follow-up|0|||
126411462|NCT01727336|454799743|FG005|Part 2 Blinded|Lost to Follow-up|1|||
126411463|NCT01727336|454799738|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
126411464|NCT01727336|454799739|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
126411465|NCT01727336|454799740|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
126411466|NCT01727336|454799741|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
126411467|NCT01727336|454799742|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
126411468|NCT01727336|454799743|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
126411469|NCT01727336|454799738|FG000|Part 2 Blinded|use of prohibited medications|0|||
126411470|NCT01727336|454799739|FG001|Part 2 Blinded|use of prohibited medications|0|||
126411471|NCT01727336|454799740|FG002|Part 2 Blinded|use of prohibited medications|0|||
126411472|NCT01727336|454799741|FG003|Part 2 Blinded|use of prohibited medications|0|||
126411473|NCT01727336|454799742|FG004|Part 2 Blinded|use of prohibited medications|1|||
126411474|NCT01727336|454799743|FG005|Part 2 Blinded|use of prohibited medications|3|||
126411475|NCT00619099|454799744|FG000|Overall Study|Progressive Disease|7|||
126411476|NCT00619099|454799745|FG001|Overall Study|Progressive Disease|5|||
126411477|NCT00619099|454799744|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
126411478|NCT00619099|454799745|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
126411479|NCT00619099|454799744|FG000|Overall Study|Adverse Event|4|||
126411480|NCT00619099|454799745|FG001|Overall Study|Adverse Event|3|||
126411481|NCT00619099|454799744|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
126411482|NCT00619099|454799745|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
126411483|NCT00619099|454799744|FG000|Overall Study|Withdrawal by Subject|10|||
126411484|NCT00619099|454799745|FG001|Overall Study|Withdrawal by Subject|2|||
126411485|NCT00619099|454799744|FG000|Overall Study|Physician Decision|9|||
126411486|NCT00619099|454799745|FG001|Overall Study|Physician Decision|6|||
126411487|NCT00885482|454799746|FG000|Overall Study|Pregnancy|1|||
126411488|NCT00885482|454799746|FG000|Overall Study|Lack of Efficacy|1|||
126411489|NCT00885482|454799746|FG000|Overall Study|Death|1|||
126411490|NCT00885482|454799746|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
126411491|NCT00084656|454799747|FG000|Overall Study|Other reasons|0|||
126411492|NCT00084656|454799748|FG001|Overall Study|Other reasons|12|||
126411493|NCT00084656|454799749|FG002|Overall Study|Other reasons|11|||
126411494|NCT00084656|454799747|FG000|Overall Study|Withdrawal by Subject|15|||
126411495|NCT00084656|454799748|FG001|Overall Study|Withdrawal by Subject|4|||
126411496|NCT00084656|454799749|FG002|Overall Study|Withdrawal by Subject|4|||
126411497|NCT00084656|454799747|FG000|Overall Study|Disease relapse|0|||
126411498|NCT00084656|454799748|FG001|Overall Study|Disease relapse|9|||
126411499|NCT00084656|454799749|FG002|Overall Study|Disease relapse|10|||
126411500|NCT00084656|454799747|FG000|Overall Study|Disease progression|9|||
126411501|NCT00084656|454799748|FG001|Overall Study|Disease progression|0|||
126411502|NCT00084656|454799749|FG002|Overall Study|Disease progression|0|||
126411503|NCT00084656|454799747|FG000|Overall Study|Lost to Follow-up|1|||
126411504|NCT00084656|454799748|FG001|Overall Study|Lost to Follow-up|0|||
126411505|NCT00084656|454799749|FG002|Overall Study|Lost to Follow-up|1|||
126411506|NCT02772978|454799750|FG000|Overall Study|Withdrawal by Subject|1|||
126411507|NCT02772978|454799751|FG001|Overall Study|Withdrawal by Subject|1|||
126411508|NCT00129467|454799752|FG000|Received Intervention|Death|1|||
126411509|NCT00129467|454799753|FG001|Received Intervention|Death|1|||
126411510|NCT00129467|454799752|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
126411511|NCT00129467|454799753|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
126411512|NCT00129467|454799752|FG000|Received Intervention|Delirium|2|||
126411513|NCT00129467|454799753|FG001|Received Intervention|Delirium|0|||
126411514|NCT00129467|454799752|FG000|Received Intervention|Withdrawal by Subject|1|||
126411515|NCT00129467|454799753|FG001|Received Intervention|Withdrawal by Subject|0|||
126411516|NCT00129467|454799752|FG000|Received Intervention|Nausea|1|||
126411517|NCT00129467|454799753|FG001|Received Intervention|Nausea|0|||
126411518|NCT00129467|454799752|FG000|Received Intervention|Intolerance to citalopram|0|||
126411519|NCT00129467|454799753|FG001|Received Intervention|Intolerance to citalopram|1|||
126411520|NCT00129467|454799752|FG000|Received Intervention|Dizzyness, fatigue|0|||
126411521|NCT00129467|454799753|FG001|Received Intervention|Dizzyness, fatigue|1|||
125890779|NCT01088048|452899581|FG002|Overall Study|Other|0|||
125890780|NCT01088048|452899582|FG003|Overall Study|Other|0|||
125890781|NCT01088048|452899583|FG004|Overall Study|Other|2|||
125890782|NCT01088048|452899584|FG005|Overall Study|Other|0|||
125890783|NCT01088048|452899585|FG006|Overall Study|Other|0|||
125890784|NCT01088048|452899586|FG007|Overall Study|Other|2|||
126411522|NCT00129467|454799752|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
126411523|NCT00129467|454799753|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
126411524|NCT00129467|454799752|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
126411525|NCT00129467|454799753|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
126411526|NCT01331291|454799754|FG000|Overall Study|Lack of Efficacy|2|||
126411527|NCT01331291|454799755|FG001|Overall Study|Lack of Efficacy|8|||
126411528|NCT01331291|454799754|FG000|Overall Study|Death|0|||
126411529|NCT01331291|454799755|FG001|Overall Study|Death|1|||
126411530|NCT01026220|454799756|FG000|Induction|Death|1|||
126411531|NCT01026220|454799757|FG001|Induction|Death|0|||
126411532|NCT01026220|454799758|FG002|Induction|Death|0|||
126411533|NCT01026220|454799756|FG000|Induction|Lack of Efficacy|2|||
126411534|NCT01026220|454799757|FG001|Induction|Lack of Efficacy|0|||
126411535|NCT01026220|454799758|FG002|Induction|Lack of Efficacy|0|||
126411536|NCT01026220|454799756|FG000|Induction|Physician Decision|12|||
126411537|NCT01026220|454799757|FG001|Induction|Physician Decision|0|||
126411538|NCT01026220|454799758|FG002|Induction|Physician Decision|0|||
126411539|NCT01026220|454799756|FG000|Induction|Withdrawal by Subject|9|||
126411540|NCT01026220|454799757|FG001|Induction|Withdrawal by Subject|0|||
126411541|NCT01026220|454799758|FG002|Induction|Withdrawal by Subject|0|||
126411542|NCT01026220|454799756|FG000|Induction|Ineligible|1|||
126411543|NCT01026220|454799757|FG001|Induction|Ineligible|0|||
126411544|NCT01026220|454799758|FG002|Induction|Ineligible|0|||
126411545|NCT01026220|454799756|FG000|Consolidation Maintenance|Death|0|||
126411546|NCT01026220|454799757|FG001|Consolidation Maintenance|Death|1|||
126411547|NCT01026220|454799758|FG002|Consolidation Maintenance|Death|0|||
126411548|NCT01026220|454799756|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
126411549|NCT01026220|454799757|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
126411550|NCT01026220|454799758|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
126411551|NCT01026220|454799756|FG000|Consolidation Maintenance|Physician Decision|0|||
126411552|NCT01026220|454799757|FG001|Consolidation Maintenance|Physician Decision|2|||
126411553|NCT01026220|454799758|FG002|Consolidation Maintenance|Physician Decision|7|||
126411554|NCT01026220|454799756|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
126411555|NCT01026220|454799757|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
126411556|NCT01026220|454799758|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
126411557|NCT00778895|454799759|FG000|Active Phase|Adverse Event|3|||
126411558|NCT00778895|454799760|FG001|Active Phase|Adverse Event|1|||
126411559|NCT00778895|454799761|FG002|Active Phase|Adverse Event|0|||
125890785|NCT01088048|452899587|FG008|Overall Study|Other|0|||
125890786|NCT01088048|452899588|FG009|Overall Study|Other|0|||
126411560|NCT00778895|454799759|FG000|Active Phase|Withdrawal by Subject|1|||
126411561|NCT00778895|454799760|FG001|Active Phase|Withdrawal by Subject|4|||
126411562|NCT00778895|454799761|FG002|Active Phase|Withdrawal by Subject|0|||
126411563|NCT00778895|454799759|FG000|Active Phase|Lost to Follow-up|1|||
126411564|NCT00778895|454799760|FG001|Active Phase|Lost to Follow-up|1|||
126411565|NCT00778895|454799761|FG002|Active Phase|Lost to Follow-up|0|||
126411566|NCT00778895|454799759|FG000|Active Phase|Other|2|||
126411567|NCT00778895|454799760|FG001|Active Phase|Other|0|||
125890787|NCT01330108|452899592|FG000|Overall Study|Withdrawal by Subject|4|||
126411568|NCT00778895|454799761|FG002|Active Phase|Other|0|||
126411569|NCT00778895|454799759|FG000|ESFU Phase|Adverse Event|2|||
126411570|NCT00778895|454799760|FG001|ESFU Phase|Adverse Event|1|||
125890788|NCT00243269|452899593|FG000|Overall Study|Protocol Violation|2|||
125890789|NCT00243269|452899594|FG001|Overall Study|Protocol Violation|1|||
126411571|NCT00778895|454799761|FG002|ESFU Phase|Adverse Event|0|||
126411572|NCT00778895|454799759|FG000|ESFU Phase|Withdrawal by Subject|1|||
126411573|NCT00778895|454799760|FG001|ESFU Phase|Withdrawal by Subject|4|||
126411574|NCT00778895|454799761|FG002|ESFU Phase|Withdrawal by Subject|0|||
126411575|NCT00778895|454799759|FG000|ESFU Phase|Lost to Follow-up|6|||
126411576|NCT00778895|454799760|FG001|ESFU Phase|Lost to Follow-up|7|||
126411577|NCT00778895|454799761|FG002|ESFU Phase|Lost to Follow-up|2|||
126411578|NCT00778895|454799759|FG000|ESFU Phase|Other|2|||
126411579|NCT00778895|454799760|FG001|ESFU Phase|Other|0|||
126411580|NCT00778895|454799761|FG002|ESFU Phase|Other|0|||
126411581|NCT02540993|454799763|FG000|Overall Study|Lost to Follow-up|5|||
126411582|NCT02540993|454799764|FG001|Overall Study|Lost to Follow-up|3|||
126411583|NCT02540993|454799763|FG000|Overall Study|Withdrawal by Subject|4|||
126411584|NCT02540993|454799764|FG001|Overall Study|Withdrawal by Subject|6|||
126411585|NCT02540993|454799763|FG000|Overall Study|GCP violations|33|||
126411586|NCT02540993|454799764|FG001|Overall Study|GCP violations|27|||
126411587|NCT03550404|454799765|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
126411588|NCT03550404|454799766|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
126411589|NCT03550404|454799767|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
126411590|NCT03550404|454799765|FG000|Phase 2|Vacated position|1|||
126411591|NCT03550404|454799766|FG001|Phase 2|Vacated position|0|||
126411592|NCT03550404|454799767|FG002|Phase 2|Vacated position|0|||
126411593|NCT01009086|454799769|FG000|Overall Study|Lack of Efficacy|16|||
126411594|NCT01009086|454799770|FG001|Overall Study|Lack of Efficacy|15|||
126411595|NCT01009086|454799771|FG002|Overall Study|Lack of Efficacy|9|||
126411596|NCT01009086|454799769|FG000|Overall Study|Lost to Follow-up|4|||
126411597|NCT01009086|454799770|FG001|Overall Study|Lost to Follow-up|5|||
126411598|NCT01009086|454799771|FG002|Overall Study|Lost to Follow-up|3|||
126411599|NCT01009086|454799769|FG000|Overall Study|Adverse Event|12|||
126411600|NCT01009086|454799770|FG001|Overall Study|Adverse Event|11|||
126411601|NCT01009086|454799771|FG002|Overall Study|Adverse Event|8|||
126411602|NCT01009086|454799769|FG000|Overall Study|Withdrawal by Subject|9|||
126411603|NCT01009086|454799770|FG001|Overall Study|Withdrawal by Subject|11|||
126411604|NCT01009086|454799771|FG002|Overall Study|Withdrawal by Subject|13|||
126411605|NCT01009086|454799769|FG000|Overall Study|Other|3|||
126411606|NCT01009086|454799770|FG001|Overall Study|Other|5|||
126411607|NCT01009086|454799771|FG002|Overall Study|Other|1|||
126411608|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
126411609|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
126411610|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
126411611|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
126411612|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
126411613|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
126411614|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
126411615|NCT01389323|454799772|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
126411616|NCT01389323|454799772|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
126411617|NCT01389323|454799772|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
126411618|NCT01389323|454799772|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
126411619|NCT00590577|454799774|FG000|Overall Study|Lack of Efficacy|31|||
126411620|NCT00590577|454799775|FG001|Overall Study|Lack of Efficacy|28|||
126411621|NCT00590577|454799776|FG002|Overall Study|Lack of Efficacy|23|||
126411622|NCT00590577|454799777|FG003|Overall Study|Lack of Efficacy|45|||
126411623|NCT00590577|454799774|FG000|Overall Study|Withdrawal by Subject|23|||
126411624|NCT00590577|454799775|FG001|Overall Study|Withdrawal by Subject|28|||
126411625|NCT00590577|454799776|FG002|Overall Study|Withdrawal by Subject|30|||
126411626|NCT00590577|454799777|FG003|Overall Study|Withdrawal by Subject|26|||
126411627|NCT00590577|454799774|FG000|Overall Study|Adverse Event|10|||
126411628|NCT00590577|454799775|FG001|Overall Study|Adverse Event|10|||
126411629|NCT00590577|454799776|FG002|Overall Study|Adverse Event|13|||
126411630|NCT00590577|454799777|FG003|Overall Study|Adverse Event|11|||
126411631|NCT00590577|454799774|FG000|Overall Study|Lost to Follow-up|12|||
126411632|NCT00590577|454799775|FG001|Overall Study|Lost to Follow-up|6|||
126411633|NCT00590577|454799776|FG002|Overall Study|Lost to Follow-up|6|||
126411634|NCT00590577|454799777|FG003|Overall Study|Lost to Follow-up|9|||
126411635|NCT00590577|454799774|FG000|Overall Study|Pregnancy|0|||
126411636|NCT00590577|454799775|FG001|Overall Study|Pregnancy|1|||
126411637|NCT00590577|454799776|FG002|Overall Study|Pregnancy|0|||
126411638|NCT00590577|454799777|FG003|Overall Study|Pregnancy|0|||
126411639|NCT00590577|454799774|FG000|Overall Study|Various reasons|1|||
126411640|NCT00590577|454799775|FG001|Overall Study|Various reasons|3|||
126411641|NCT00590577|454799776|FG002|Overall Study|Various reasons|1|||
126411642|NCT00590577|454799777|FG003|Overall Study|Various reasons|2|||
126411643|NCT00844558|454799778|FG000|Overall Study|Withdrawal by Subject|9|||
126411644|NCT00844558|454799779|FG001|Overall Study|Withdrawal by Subject|2|||
125890790|NCT00243269|452899595|FG002|Overall Study|Protocol Violation|0|||
126411645|NCT00844558|454799778|FG000|Overall Study|Death|1|||
126411646|NCT00844558|454799779|FG001|Overall Study|Death|0|||
126411647|NCT00844558|454799778|FG000|Overall Study|Protocol Violation|1|||
126411648|NCT00844558|454799779|FG001|Overall Study|Protocol Violation|1|||
126411649|NCT00844558|454799778|FG000|Overall Study|Lost to Follow-up|0|||
126411650|NCT00844558|454799779|FG001|Overall Study|Lost to Follow-up|1|||
126411651|NCT00844558|454799778|FG000|Overall Study|Physician Decision|1|||
126411652|NCT00844558|454799779|FG001|Overall Study|Physician Decision|0|||
126411653|NCT01229449|454799780|FG000|Overall Study|Withdrawal by Subject|0|||
126411654|NCT01229449|454799781|FG001|Overall Study|Withdrawal by Subject|3|||
126411655|NCT01229449|454799782|FG002|Overall Study|Withdrawal by Subject|0|||
126411656|NCT01229449|454799783|FG003|Overall Study|Withdrawal by Subject|1|||
126411657|NCT01229449|454799784|FG004|Overall Study|Withdrawal by Subject|1|||
126411658|NCT01229449|454799780|FG000|Overall Study|Lost to Follow-up|1|||
126411659|NCT01229449|454799781|FG001|Overall Study|Lost to Follow-up|1|||
126411660|NCT01229449|454799782|FG002|Overall Study|Lost to Follow-up|1|||
126411661|NCT01229449|454799783|FG003|Overall Study|Lost to Follow-up|0|||
126411662|NCT01229449|454799784|FG004|Overall Study|Lost to Follow-up|0|||
126411663|NCT01229449|454799780|FG000|Overall Study|Physician Decision|0|||
126411664|NCT01229449|454799781|FG001|Overall Study|Physician Decision|0|||
126411665|NCT01229449|454799782|FG002|Overall Study|Physician Decision|1|||
126411666|NCT01229449|454799783|FG003|Overall Study|Physician Decision|0|||
126411667|NCT01229449|454799784|FG004|Overall Study|Physician Decision|0|||
126411668|NCT01894022|454799785|FG000|Overall Study|Death|1|||
126411669|NCT01894022|454799786|FG001|Overall Study|Death|0|||
126411670|NCT01894022|454799785|FG000|Overall Study|Adverse Event, non-fatal|1|||
126411671|NCT01894022|454799786|FG001|Overall Study|Adverse Event, non-fatal|0|||
126411672|NCT01894022|454799785|FG000|Overall Study|Study Closed/terminated|7|||
126411673|NCT01894022|454799786|FG001|Overall Study|Study Closed/terminated|10|||
126411674|NCT04496453|454799788|FG000|Overall Study|Lost to Follow-up|6|||
126411675|NCT03235089|454799796|FG000|Overall Study|Lost to Follow-up|1|||
126411676|NCT03235089|454799797|FG001|Overall Study|Lost to Follow-up|1|||
126411677|NCT03235089|454799796|FG000|Overall Study|Physician Decision|2|||
126411678|NCT03235089|454799797|FG001|Overall Study|Physician Decision|2|||
126411679|NCT03238924|454799798|FG000|Overall Study|Withdrawal by Subject|2|||
126411680|NCT03238924|454799799|FG001|Overall Study|Withdrawal by Subject|2|||
126411681|NCT03576716|454799800|FG000|Overall Study|Withdrawal by Subject|0|||
126411682|NCT03576716|454799801|FG001|Overall Study|Withdrawal by Subject|1|||
126411683|NCT02516228|454799804|FG000|Overall Study|Lost to Follow-up|1|||
126411684|NCT02516228|454799804|FG000|Overall Study|Withdrawal by Subject|1|||
126411685|NCT02516228|454799804|FG000|Overall Study|Physician Decision|1|||
126411686|NCT03916484|454799805|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126411687|NCT03916484|454799806|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
126411688|NCT03916484|454799807|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126411689|NCT03916484|454799808|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126411690|NCT03916484|454799805|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
126411691|NCT03916484|454799806|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
126411692|NCT03916484|454799807|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
126411693|NCT03916484|454799808|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
126411694|NCT01769196|454801799|FG000|Overall Study|Adverse Event|24|||
126411695|NCT01769196|454801800|FG001|Overall Study|Adverse Event|20|||
126411696|NCT01769196|454801799|FG000|Overall Study|Death|21|||
126411697|NCT01769196|454801800|FG001|Overall Study|Death|26|||
126411698|NCT01769196|454801799|FG000|Overall Study|Investigator Discretion|7|||
126411699|NCT01769196|454801800|FG001|Overall Study|Investigator Discretion|3|||
126411700|NCT01769196|454801799|FG000|Overall Study|Lack of Efficacy|3|||
126411701|NCT01769196|454801800|FG001|Overall Study|Lack of Efficacy|2|||
126411702|NCT01769196|454801799|FG000|Overall Study|Progressive disease|11|||
126411703|NCT01769196|454801800|FG001|Overall Study|Progressive disease|6|||
126411704|NCT01769196|454801799|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
126411705|NCT01769196|454801800|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
126411706|NCT01769196|454801799|FG000|Overall Study|Protocol Violation|0|||
126411707|NCT01769196|454801800|FG001|Overall Study|Protocol Violation|3|||
126411708|NCT01769196|454801799|FG000|Overall Study|Study terminated by sponsor|160|||
126411709|NCT01769196|454801800|FG001|Overall Study|Study terminated by sponsor|161|||
126411710|NCT01769196|454801799|FG000|Overall Study|Participant never dosed with study drug|1|||
126411711|NCT01769196|454801800|FG001|Overall Study|Participant never dosed with study drug|0|||
126411712|NCT01769196|454801799|FG000|Overall Study|Withdrew consent|36|||
126411713|NCT01769196|454801800|FG001|Overall Study|Withdrew consent|40|||
126411714|NCT00655629|454801803|FG000|Overall Study|Adverse Event|4|||
126411715|NCT00655629|454801804|FG001|Overall Study|Adverse Event|1|||
126411716|NCT00655629|454801803|FG000|Overall Study|Lack of Efficacy|2|||
126411717|NCT00655629|454801804|FG001|Overall Study|Lack of Efficacy|12|||
126411718|NCT00655629|454801803|FG000|Overall Study|Lost to Follow-up|4|||
126411719|NCT00655629|454801804|FG001|Overall Study|Lost to Follow-up|3|||
126411720|NCT00655629|454801803|FG000|Overall Study|Protocol Violation|5|||
126411721|NCT00655629|454801804|FG001|Overall Study|Protocol Violation|3|||
126411722|NCT00655629|454801803|FG000|Overall Study|consent withdrawn|6|||
126411723|NCT00655629|454801804|FG001|Overall Study|consent withdrawn|4|||
126411724|NCT00705367|454801805|FG000|Long-term Extension Period|Adverse Event|2|||
126411725|NCT00705367|454801806|FG001|Long-term Extension Period|Adverse Event|0|||
126411726|NCT00705367|454801805|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
126411727|NCT00705367|454801806|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
126411728|NCT00705367|454801805|FG000|Long-term Extension Period|Lack of Efficacy|1|||
126411729|NCT00705367|454801806|FG001|Long-term Extension Period|Lack of Efficacy|0|||
126411730|NCT00705367|454801805|FG000|Long-term Extension Period|No longer met study criteria|1|||
126411731|NCT00705367|454801806|FG001|Long-term Extension Period|No longer met study criteria|0|||
126411732|NCT00705367|454801805|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
126411733|NCT00705367|454801806|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
126411734|NCT05096312|454801807|FG000|Overall Study|Lost to Follow-up|2|||
126411735|NCT05096312|454801808|FG001|Overall Study|Lost to Follow-up|4|||
126411736|NCT05096312|454801807|FG000|Overall Study|Adverse Event|1|||
126411737|NCT05096312|454801808|FG001|Overall Study|Adverse Event|0|||
126411738|NCT03135210|454801809|FG000|Overall Study|Death|0|||
126411739|NCT03135210|454801810|FG001|Overall Study|Death|1|||
126411740|NCT00820222|454801812|FG000|Overall Study|Lost to Follow-up|10|||
126411741|NCT00820222|454801813|FG001|Overall Study|Lost to Follow-up|9|||
126411742|NCT00820222|454801812|FG000|Overall Study|Withdrawal by Subject|19|||
126411743|NCT00820222|454801813|FG001|Overall Study|Withdrawal by Subject|21|||
126411744|NCT00820222|454801812|FG000|Overall Study|Physician Decision|93|||
126411745|NCT00820222|454801813|FG001|Overall Study|Physician Decision|88|||
126411746|NCT00820222|454801812|FG000|Overall Study|Sponsor Terminated Study|43|||
126411747|NCT00820222|454801813|FG001|Overall Study|Sponsor Terminated Study|65|||
126411748|NCT00820222|454801812|FG000|Overall Study|Unkown|11|||
126411749|NCT00820222|454801813|FG001|Overall Study|Unkown|7|||
126411750|NCT00699335|454801830|FG000|Overall Study|Combination of multiple reasons|176|||
126411751|NCT00699335|454801830|FG000|Overall Study|Missing data|52|||
126411752|NCT01887353|454801831|FG000|Overall Study|Study stopped early|4|||
126411753|NCT01887353|454801832|FG001|Overall Study|Study stopped early|3|||
126411754|NCT01069705|454801833|FG000|Overall Study|Adverse Event|1|||
126411755|NCT01069705|454801833|FG000|Overall Study|Withdrawal by Subject|2|||
126411756|NCT02726022|454801834|FG000|Overall Study|Adverse Event|14|||
126411757|NCT02726022|454801834|FG000|Overall Study|Treatment Failure|8|||
126411758|NCT02726022|454801834|FG000|Overall Study|Poor Compliance|13|||
126411759|NCT02726022|454801834|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
126411760|NCT01545050|454801835|FG000|Overall Study|Lack of Efficacy|0|||
126411761|NCT01545050|454801836|FG001|Overall Study|Lack of Efficacy|0|||
126411762|NCT01545050|454801837|FG002|Overall Study|Lack of Efficacy|0|||
126411763|NCT01545050|454801838|FG003|Overall Study|Lack of Efficacy|3|||
126411764|NCT01545050|454801839|FG004|Overall Study|Lack of Efficacy|2|||
126411765|NCT01545050|454801835|FG000|Overall Study|Adverse Event|1|||
126411766|NCT01545050|454801836|FG001|Overall Study|Adverse Event|1|||
126411767|NCT01545050|454801837|FG002|Overall Study|Adverse Event|2|||
126411768|NCT01545050|454801838|FG003|Overall Study|Adverse Event|2|||
126411769|NCT01545050|454801839|FG004|Overall Study|Adverse Event|0|||
126411770|NCT01545050|454801835|FG000|Overall Study|Discontinued study treatment|1|||
126411771|NCT01545050|454801836|FG001|Overall Study|Discontinued study treatment|0|||
126411772|NCT01545050|454801837|FG002|Overall Study|Discontinued study treatment|0|||
126411773|NCT01545050|454801838|FG003|Overall Study|Discontinued study treatment|0|||
126411774|NCT01545050|454801839|FG004|Overall Study|Discontinued study treatment|0|||
126411775|NCT01545050|454801835|FG000|Overall Study|Withdrawal by Subject|1|||
126411776|NCT01545050|454801836|FG001|Overall Study|Withdrawal by Subject|0|||
126411777|NCT01545050|454801837|FG002|Overall Study|Withdrawal by Subject|0|||
126411778|NCT01545050|454801838|FG003|Overall Study|Withdrawal by Subject|2|||
126411779|NCT01545050|454801839|FG004|Overall Study|Withdrawal by Subject|1|||
126411780|NCT01545050|454801835|FG000|Overall Study|Participant no longer meets study criteria|0|||
126411781|NCT01545050|454801836|FG001|Overall Study|Participant no longer meets study criteria|2|||
126411782|NCT01545050|454801837|FG002|Overall Study|Participant no longer meets study criteria|0|||
126411783|NCT01545050|454801838|FG003|Overall Study|Participant no longer meets study criteria|0|||
126411784|NCT01545050|454801839|FG004|Overall Study|Participant no longer meets study criteria|1|||
126411785|NCT01545050|454801835|FG000|Overall Study|Administrative reason by sponsor|4|||
126411786|NCT01545050|454801836|FG001|Overall Study|Administrative reason by sponsor|2|||
126411787|NCT01545050|454801837|FG002|Overall Study|Administrative reason by sponsor|3|||
126411788|NCT01545050|454801838|FG003|Overall Study|Administrative reason by sponsor|5|||
126411789|NCT01545050|454801839|FG004|Overall Study|Administrative reason by sponsor|5|||
126411790|NCT03262441|454801840|FG000|Overall Study|Withdrawal by Subject|1|||
126411791|NCT00559988|454801844|FG000|Overall Study|Death|147|||
126411792|NCT00559988|454801845|FG001|Overall Study|Death|140|||
126411793|NCT00559988|454801844|FG000|Overall Study|Withdrawal by Subject|152|||
126411794|NCT00559988|454801845|FG001|Overall Study|Withdrawal by Subject|139|||
126411795|NCT00559988|454801844|FG000|Overall Study|Lost to Follow-up|42|||
126411796|NCT00559988|454801845|FG001|Overall Study|Lost to Follow-up|56|||
126411797|NCT00559988|454801844|FG000|Overall Study|ICD device explanted|10|||
126411798|NCT00559988|454801845|FG001|Overall Study|ICD device explanted|17|||
126411799|NCT02249182|454801846|FG000|Treatment Phase|Lost to Follow-up|4|||
126411800|NCT02249182|454801847|FG001|Treatment Phase|Lost to Follow-up|0|||
126411801|NCT02249182|454801848|FG002|Treatment Phase|Lost to Follow-up|0|||
126411802|NCT02249182|454801849|FG003|Treatment Phase|Lost to Follow-up|0|||
126411803|NCT02249182|454801850|FG004|Treatment Phase|Lost to Follow-up|0|||
126411804|NCT01455194|454801851|FG000|Overall Study|Screen Failure|20|||
126411805|NCT01455194|454801852|FG001|Overall Study|Screen Failure|0|||
126411806|NCT01455194|454801853|FG002|Overall Study|Screen Failure|0|||
126411807|NCT01455194|454801854|FG003|Overall Study|Screen Failure|0|||
126411808|NCT01455194|454801851|FG000|Overall Study|Randomisation Failure|90|||
126411809|NCT01455194|454801852|FG001|Overall Study|Randomisation Failure|0|||
126411810|NCT01455194|454801853|FG002|Overall Study|Randomisation Failure|0|||
126411811|NCT01455194|454801854|FG003|Overall Study|Randomisation Failure|0|||
126411812|NCT01455194|454801851|FG000|Overall Study|Deterioration in asthma|12|||
126411813|NCT01455194|454801852|FG001|Overall Study|Deterioration in asthma|6|||
126411814|NCT01455194|454801853|FG002|Overall Study|Deterioration in asthma|14|||
126411815|NCT01455194|454801854|FG003|Overall Study|Deterioration in asthma|9|||
126411816|NCT01455194|454801851|FG000|Overall Study|Adverse Event|1|||
126411817|NCT01455194|454801852|FG001|Overall Study|Adverse Event|1|||
126411818|NCT01455194|454801853|FG002|Overall Study|Adverse Event|1|||
126411819|NCT01455194|454801854|FG003|Overall Study|Adverse Event|3|||
126411820|NCT01455194|454801851|FG000|Overall Study|Withdrawal by Subject|21|||
126411821|NCT01455194|454801852|FG001|Overall Study|Withdrawal by Subject|16|||
126411822|NCT01455194|454801853|FG002|Overall Study|Withdrawal by Subject|12|||
126411823|NCT01455194|454801854|FG003|Overall Study|Withdrawal by Subject|9|||
126411824|NCT01455194|454801851|FG000|Overall Study|Lost to Follow-up|2|||
125890791|NCT00243269|452899596|FG003|Overall Study|Protocol Violation|1|||
126411825|NCT01455194|454801852|FG001|Overall Study|Lost to Follow-up|0|||
126411826|NCT01455194|454801853|FG002|Overall Study|Lost to Follow-up|1|||
126411827|NCT01455194|454801854|FG003|Overall Study|Lost to Follow-up|1|||
126411828|NCT01455194|454801851|FG000|Overall Study|Pregnancy|0|||
126411829|NCT01455194|454801852|FG001|Overall Study|Pregnancy|1|||
126411830|NCT01455194|454801853|FG002|Overall Study|Pregnancy|1|||
126411831|NCT01455194|454801854|FG003|Overall Study|Pregnancy|0|||
125890792|NCT00243269|452899593|FG000|Overall Study|Lost to Follow-up|1|||
125890793|NCT00243269|452899594|FG001|Overall Study|Lost to Follow-up|0|||
125890794|NCT00243269|452899595|FG002|Overall Study|Lost to Follow-up|1|||
125890795|NCT00243269|452899596|FG003|Overall Study|Lost to Follow-up|3|||
125890796|NCT03085797|452899597|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
126054109|NCT03732807|453492217|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
126054110|NCT03732807|453492218|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
126411832|NCT01455194|454801851|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
126411833|NCT01455194|454801852|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
126411834|NCT01455194|454801853|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
126411835|NCT01455194|454801854|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
126411836|NCT01455194|454801851|FG000|Overall Study|Miscellaneous|4|||
126411837|NCT01455194|454801852|FG001|Overall Study|Miscellaneous|5|||
126411838|NCT01455194|454801853|FG002|Overall Study|Miscellaneous|1|||
126411839|NCT01455194|454801854|FG003|Overall Study|Miscellaneous|4|||
126411840|NCT00504894|454801857|FG000|Overall Study|fMRI technical problems|1|||
126411841|NCT00504894|454801858|FG001|Overall Study|fMRI technical problems|1|||
126411842|NCT00504894|454801859|FG002|Overall Study|fMRI technical problems|0|||
126411843|NCT00504894|454801857|FG000|Overall Study|Withdrawal by Subject|0|||
126411844|NCT00504894|454801858|FG001|Overall Study|Withdrawal by Subject|1|||
126411845|NCT00504894|454801859|FG002|Overall Study|Withdrawal by Subject|0|||
126411846|NCT00504894|454801857|FG000|Overall Study|Infusion technical problems|0|||
126411847|NCT00504894|454801858|FG001|Overall Study|Infusion technical problems|1|||
126411848|NCT00504894|454801859|FG002|Overall Study|Infusion technical problems|0|||
126411849|NCT00504894|454801857|FG000|Overall Study|poor subject data|2|||
126411850|NCT00504894|454801858|FG001|Overall Study|poor subject data|0|||
126411851|NCT00504894|454801859|FG002|Overall Study|poor subject data|0|||
126411852|NCT01196416|454801860|FG000|Overall Study|Withdrawal by Subject|2|||
126411853|NCT02673684|454801861|FG000|Overall Study|Study not completed d/t loss of funding|9|||
126411854|NCT02673684|454801862|FG001|Overall Study|Study not completed d/t loss of funding|8|||
126411855|NCT01092663|454801863|FG000|Overall Study|Withdrawal by Subject|3|||
126411856|NCT01092663|454801864|FG001|Overall Study|Withdrawal by Subject|2|||
126411857|NCT01092663|454801863|FG000|Overall Study|Glucose >300mg/dL|1|||
126411858|NCT01092663|454801864|FG001|Overall Study|Glucose >300mg/dL|0|||
126411859|NCT01092663|454801863|FG000|Overall Study|High fasting triglyceride|2|||
126411860|NCT01092663|454801864|FG001|Overall Study|High fasting triglyceride|0|||
126411861|NCT01092663|454801863|FG000|Overall Study|Adverse Event|1|||
126411862|NCT01092663|454801864|FG001|Overall Study|Adverse Event|1|||
126411863|NCT01092663|454801863|FG000|Overall Study|Protocol Violation|0|||
126411864|NCT01092663|454801864|FG001|Overall Study|Protocol Violation|1|||
126411865|NCT03688620|454801865|FG000|Overall Study|Other|0|||
126411866|NCT03688620|454801866|FG001|Overall Study|Other|0|||
126411867|NCT03688620|454801867|FG002|Overall Study|Other|1|||
126411868|NCT03688620|454801865|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
126411869|NCT03688620|454801866|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
126411870|NCT03688620|454801867|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
126411871|NCT03688620|454801865|FG000|Overall Study|Lost to Follow-up|16|||
126411872|NCT03688620|454801866|FG001|Overall Study|Lost to Follow-up|0|||
126411873|NCT03688620|454801867|FG002|Overall Study|Lost to Follow-up|1|||
126411874|NCT03688620|454801865|FG000|Overall Study|Withdrawal by Subject|0|||
126411875|NCT03688620|454801866|FG001|Overall Study|Withdrawal by Subject|0|||
126411876|NCT03688620|454801867|FG002|Overall Study|Withdrawal by Subject|6|||
126411877|NCT01008904|454801868|FG000|Overall Study|Lost to Follow-up|1|||
126411878|NCT01008904|454801868|FG000|Overall Study|Adverse Event|2|||
126411879|NCT01008904|454801868|FG000|Overall Study|unexpected unrelated surgery|1|||
126411880|NCT01183065|454801869|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
126411881|NCT02456857|454801870|FG000|Overall Study|Disease Progression|4|||
126411882|NCT00781859|454801871|FG000|Overall Study|Adverse Event|2|||
126411883|NCT00781859|454801872|FG001|Overall Study|Adverse Event|2|||
126411884|NCT00781859|454801871|FG000|Overall Study|Withdrawal by Subject|8|||
126411885|NCT00781859|454801872|FG001|Overall Study|Withdrawal by Subject|4|||
126411886|NCT00781859|454801871|FG000|Overall Study|Lost to Follow-up|6|||
126411887|NCT00781859|454801872|FG001|Overall Study|Lost to Follow-up|3|||
126411888|NCT00781859|454801871|FG000|Overall Study|Death|3|||
126411889|NCT00781859|454801872|FG001|Overall Study|Death|0|||
126411890|NCT01983774|454801876|FG000|Overall Study|Lung Transplant|0|||
126411891|NCT01983774|454801877|FG001|Overall Study|Lung Transplant|1|||
126054111|NCT03732807|453492219|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
126054112|NCT03732807|453492213|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126411892|NCT01983774|454801876|FG000|Overall Study|Lost to Follow-up|1|||
126411893|NCT01983774|454801877|FG001|Overall Study|Lost to Follow-up|0|||
126411894|NCT01008449|454801878|FG000|Overall Study|Lost to Follow-up|29|||
126411895|NCT01008449|454801879|FG001|Overall Study|Lost to Follow-up|19|||
126411896|NCT01220180|454801880|FG000|Overall Study|Lost to Follow-up|76|||
125890797|NCT03085797|452899598|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
126411897|NCT01220180|454801880|FG000|Overall Study|Other|72|||
126411898|NCT01220180|454801880|FG000|Overall Study|Adverse Event|35|||
126411899|NCT01220180|454801880|FG000|Overall Study|Lack of Efficacy|22|||
126411900|NCT01220180|454801880|FG000|Overall Study|Death|1|||
126411901|NCT01220180|454801880|FG000|Overall Study|Randomized but not treated|1|||
125890798|NCT03085797|452899597|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
125890799|NCT03085797|452899598|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
125890800|NCT03085797|452899597|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
125890801|NCT03085797|452899598|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
125890802|NCT00545272|452899600|FG000|Overall Study|Protocol deviation|0|||
125890803|NCT00545272|452899601|FG001|Overall Study|Protocol deviation|1|||
125890804|NCT00545272|452899602|FG002|Overall Study|Protocol deviation|0|||
125890805|NCT00545272|452899603|FG003|Overall Study|Protocol deviation|1|||
125890806|NCT00545272|452899604|FG004|Overall Study|Protocol deviation|0|||
125890807|NCT00545272|452899605|FG005|Overall Study|Protocol deviation|1|||
125890808|NCT00545272|452899600|FG000|Overall Study|Adverse Event|0|||
125890809|NCT00545272|452899601|FG001|Overall Study|Adverse Event|0|||
125890810|NCT00545272|452899602|FG002|Overall Study|Adverse Event|1|||
125890811|NCT00545272|452899603|FG003|Overall Study|Adverse Event|0|||
125890812|NCT00545272|452899604|FG004|Overall Study|Adverse Event|0|||
125890813|NCT00545272|452899605|FG005|Overall Study|Adverse Event|1|||
125890814|NCT00545272|452899600|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125890815|NCT00545272|452899601|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125890816|NCT00545272|452899602|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125890817|NCT00545272|452899603|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125890818|NCT00545272|452899604|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125890819|NCT00545272|452899605|FG005|Overall Study|Abnormal laboratory value(s)|1|||
125890820|NCT00545272|452899600|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125890821|NCT00545272|452899601|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125890822|NCT00545272|452899602|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125890823|NCT00545272|452899603|FG003|Overall Study|Abnormal test procedure result(s)|0|||
125890824|NCT00545272|452899604|FG004|Overall Study|Abnormal test procedure result(s)|1|||
125890825|NCT00545272|452899605|FG005|Overall Study|Abnormal test procedure result(s)|0|||
126411902|NCT01067469|454801886|FG000|Overall Study|Withdrawal by Subject|0|||
126411903|NCT01067469|454801887|FG001|Overall Study|Withdrawal by Subject|1|||
126411904|NCT01067469|454801886|FG000|Overall Study|Disease Progression|0|||
126411905|NCT01067469|454801887|FG001|Overall Study|Disease Progression|1|||
126411906|NCT01299116|454801889|FG000|Overall Study|Lost to Follow-up|65|||
126411907|NCT01299116|454801890|FG001|Overall Study|Lost to Follow-up|9|||
126411908|NCT01299116|454801891|FG002|Overall Study|Lost to Follow-up|11|||
126411909|NCT01123707|454801893|FG000|Overall Study|Lost to Follow-up|3|||
126411910|NCT01123707|454801894|FG001|Overall Study|Lost to Follow-up|1|||
126411911|NCT01123707|454801895|FG002|Overall Study|Lost to Follow-up|3|||
126411912|NCT01123707|454801896|FG003|Overall Study|Lost to Follow-up|2|||
126411913|NCT01123707|454801893|FG000|Overall Study|Adverse Event|5|||
126411914|NCT01123707|454801894|FG001|Overall Study|Adverse Event|7|||
126411915|NCT01123707|454801895|FG002|Overall Study|Adverse Event|5|||
126411916|NCT01123707|454801896|FG003|Overall Study|Adverse Event|3|||
126411917|NCT01123707|454801893|FG000|Overall Study|Sponsor Discontinued Study|30|||
126411918|NCT01123707|454801894|FG001|Overall Study|Sponsor Discontinued Study|24|||
125890826|NCT00545272|452899600|FG000|Overall Study|Lost to Follow-up|0|||
126054113|NCT03732807|453492214|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
126411919|NCT01123707|454801895|FG002|Overall Study|Sponsor Discontinued Study|25|||
126411920|NCT01123707|454801896|FG003|Overall Study|Sponsor Discontinued Study|40|||
126411921|NCT01123707|454801893|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
126411922|NCT01123707|454801894|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
126411923|NCT01123707|454801895|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
126411924|NCT01123707|454801896|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
125890827|NCT00545272|452899601|FG001|Overall Study|Lost to Follow-up|0|||
125890828|NCT00545272|452899602|FG002|Overall Study|Lost to Follow-up|0|||
125890829|NCT00545272|452899603|FG003|Overall Study|Lost to Follow-up|0|||
125890830|NCT00545272|452899604|FG004|Overall Study|Lost to Follow-up|1|||
125890831|NCT00545272|452899605|FG005|Overall Study|Lost to Follow-up|0|||
125890832|NCT01837823|452899606|FG000|Overall Study|Lost to Follow-up|6|||
126054114|NCT03732807|453492215|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126411925|NCT01123707|454801893|FG000|Overall Study|Investigator Withdrew Participant|0|||
126411926|NCT01123707|454801894|FG001|Overall Study|Investigator Withdrew Participant|1|||
126411927|NCT01123707|454801895|FG002|Overall Study|Investigator Withdrew Participant|1|||
126411928|NCT01123707|454801896|FG003|Overall Study|Investigator Withdrew Participant|1|||
126411929|NCT01123707|454801893|FG000|Overall Study|Subject Withdrew Consent|4|||
126411930|NCT01123707|454801894|FG001|Overall Study|Subject Withdrew Consent|5|||
126411931|NCT01123707|454801895|FG002|Overall Study|Subject Withdrew Consent|1|||
126411932|NCT01123707|454801896|FG003|Overall Study|Subject Withdrew Consent|2|||
126411933|NCT01123707|454801893|FG000|Overall Study|Lack of Efficacy|1|||
126411934|NCT01123707|454801894|FG001|Overall Study|Lack of Efficacy|2|||
126411935|NCT01123707|454801895|FG002|Overall Study|Lack of Efficacy|1|||
126411936|NCT01123707|454801896|FG003|Overall Study|Lack of Efficacy|0|||
126411937|NCT01123707|454801893|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
126411938|NCT01123707|454801894|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
126411939|NCT01123707|454801895|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
126411940|NCT01123707|454801896|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
126411941|NCT04378114|454801897|FG000|Overall Study|Withdrawal by Subject|5|||
126411942|NCT01959243|454801900|FG000|Overall Study|Investigator Decision|3|||
126411943|NCT01959243|454801901|FG001|Overall Study|Investigator Decision|0|||
126411944|NCT01959243|454801900|FG000|Overall Study|Adverse Event|5|||
126411945|NCT01959243|454801901|FG001|Overall Study|Adverse Event|2|||
126411946|NCT01959243|454801900|FG000|Overall Study|Administrative reasons|2|||
126411947|NCT01959243|454801901|FG001|Overall Study|Administrative reasons|1|||
126411948|NCT01959243|454801900|FG000|Overall Study|Lost to Follow-up|3|||
126054115|NCT03732807|453492216|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126054116|NCT03732807|453492217|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126054117|NCT03732807|453492218|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126054118|NCT03732807|453492219|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126411949|NCT01959243|454801901|FG001|Overall Study|Lost to Follow-up|1|||
126411950|NCT00629798|454801904|FG000|Overall Study|Not Treated|4|||
126411951|NCT02554981|454801905|FG000|Overall Study|Adverse Event|1|||
126411952|NCT02554981|454801905|FG000|Overall Study|Administrative Reasons|1|||
126411953|NCT02554981|454801905|FG000|Overall Study|Other Miscellaneous Reasons|3|||
126411954|NCT01114438|454801906|FG000|Overall Study|Adverse Event|10|||
126411955|NCT01114438|454801906|FG000|Overall Study|concomitant medication|1|||
126411956|NCT01114438|454801906|FG000|Overall Study|Physician Decision|1|||
126411957|NCT01114438|454801906|FG000|Overall Study|Withdrawal by Subject|2|||
126411958|NCT00428844|454801907|FG000|Completed Study Drug Treatment|Adverse Event|2|||
126411959|NCT00428844|454801908|FG001|Completed Study Drug Treatment|Adverse Event|4|||
126411960|NCT00428844|454801909|FG002|Completed Study Drug Treatment|Adverse Event|4|||
126411961|NCT00428844|454801907|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
126411962|NCT00428844|454801908|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
126411963|NCT00428844|454801909|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
126411964|NCT00428844|454801907|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
126411965|NCT00428844|454801908|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
126411966|NCT00428844|454801909|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
126411967|NCT00428844|454801907|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
126411968|NCT00428844|454801908|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
126411969|NCT00428844|454801909|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
126411970|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
126054119|NCT03732807|453492213|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
126054120|NCT03732807|453492214|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
126054121|NCT03732807|453492215|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
126411971|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
126411972|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
126411973|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
126411974|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
126411975|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
126411976|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
126411977|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
126411978|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
126411979|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
126411980|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
126411981|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
126411982|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
126411983|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
126411984|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
126411985|NCT00488826|454801912|FG000|Overall Study|Withdrawal by Subject|40|||
126411986|NCT00488826|454801913|FG001|Overall Study|Withdrawal by Subject|35|||
126411987|NCT00488826|454801914|FG002|Overall Study|Withdrawal by Subject|19|||
126411988|NCT00488826|454801912|FG000|Overall Study|Protocol Violation|0|||
126411989|NCT00488826|454801913|FG001|Overall Study|Protocol Violation|0|||
126411990|NCT00488826|454801914|FG002|Overall Study|Protocol Violation|2|||
126411991|NCT00488826|454801912|FG000|Overall Study|Adverse Event|9|||
126411992|NCT00488826|454801913|FG001|Overall Study|Adverse Event|15|||
126411993|NCT00488826|454801914|FG002|Overall Study|Adverse Event|4|||
126411994|NCT00488826|454801912|FG000|Overall Study|Lost to Follow-up|5|||
126411995|NCT00488826|454801913|FG001|Overall Study|Lost to Follow-up|1|||
126411996|NCT00488826|454801914|FG002|Overall Study|Lost to Follow-up|0|||
126411997|NCT00488826|454801912|FG000|Overall Study|Protocol Deviations|2|||
126411998|NCT00488826|454801913|FG001|Overall Study|Protocol Deviations|1|||
126411999|NCT00488826|454801914|FG002|Overall Study|Protocol Deviations|1|||
126412000|NCT02292706|454801915|FG000|Overall Study|Lost to Follow-up|20|||
126412001|NCT02292706|454801916|FG001|Overall Study|Lost to Follow-up|44|||
126412002|NCT02292706|454801917|FG002|Overall Study|Lost to Follow-up|24|||
126412003|NCT02292706|454801918|FG003|Overall Study|Lost to Follow-up|61|||
126412004|NCT02292706|454801919|FG004|Overall Study|Lost to Follow-up|21|||
126412005|NCT02292706|454801920|FG005|Overall Study|Lost to Follow-up|52|||
126412006|NCT02292706|454801921|FG006|Overall Study|Lost to Follow-up|25|||
126412007|NCT02292706|454801922|FG007|Overall Study|Lost to Follow-up|0|||
126412008|NCT02292706|454801915|FG000|Overall Study|Withdrew consent|15|||
126412009|NCT02292706|454801916|FG001|Overall Study|Withdrew consent|56|||
126412010|NCT02292706|454801917|FG002|Overall Study|Withdrew consent|43|||
126412011|NCT02292706|454801918|FG003|Overall Study|Withdrew consent|36|||
126412012|NCT02292706|454801919|FG004|Overall Study|Withdrew consent|13|||
126412013|NCT02292706|454801920|FG005|Overall Study|Withdrew consent|51|||
126412014|NCT02292706|454801921|FG006|Overall Study|Withdrew consent|20|||
126412015|NCT02292706|454801922|FG007|Overall Study|Withdrew consent|0|||
126412016|NCT02292706|454801915|FG000|Overall Study|Death|3|||
126412017|NCT02292706|454801916|FG001|Overall Study|Death|11|||
126412018|NCT02292706|454801917|FG002|Overall Study|Death|16|||
126412019|NCT02292706|454801918|FG003|Overall Study|Death|22|||
126412020|NCT02292706|454801919|FG004|Overall Study|Death|8|||
126412021|NCT02292706|454801920|FG005|Overall Study|Death|17|||
126412022|NCT02292706|454801921|FG006|Overall Study|Death|3|||
126412023|NCT02292706|454801922|FG007|Overall Study|Death|0|||
126412024|NCT02292706|454801915|FG000|Overall Study|Study terminated by sponsor|0|||
126412025|NCT02292706|454801916|FG001|Overall Study|Study terminated by sponsor|9|||
126412026|NCT02292706|454801917|FG002|Overall Study|Study terminated by sponsor|4|||
126412027|NCT02292706|454801918|FG003|Overall Study|Study terminated by sponsor|21|||
126412028|NCT02292706|454801919|FG004|Overall Study|Study terminated by sponsor|11|||
126412029|NCT02292706|454801920|FG005|Overall Study|Study terminated by sponsor|13|||
126412030|NCT02292706|454801921|FG006|Overall Study|Study terminated by sponsor|3|||
126412031|NCT02292706|454801922|FG007|Overall Study|Study terminated by sponsor|0|||
125890833|NCT00436345|452899611|FG000|Overall Study|ICU resident beyond follow-up period|3|||
126412032|NCT02292706|454801915|FG000|Overall Study|Investigator's discretion|4|||
125890834|NCT00436345|452899612|FG001|Overall Study|ICU resident beyond follow-up period|0|||
126412033|NCT02292706|454801916|FG001|Overall Study|Investigator's discretion|9|||
126412034|NCT02292706|454801917|FG002|Overall Study|Investigator's discretion|7|||
126412035|NCT02292706|454801918|FG003|Overall Study|Investigator's discretion|11|||
126412036|NCT02292706|454801919|FG004|Overall Study|Investigator's discretion|4|||
126412037|NCT02292706|454801920|FG005|Overall Study|Investigator's discretion|10|||
126412038|NCT02292706|454801921|FG006|Overall Study|Investigator's discretion|1|||
126412039|NCT02292706|454801922|FG007|Overall Study|Investigator's discretion|0|||
126412040|NCT02292706|454801915|FG000|Overall Study|Liver transplant|1|||
126412041|NCT02292706|454801916|FG001|Overall Study|Liver transplant|1|||
126412042|NCT02292706|454801917|FG002|Overall Study|Liver transplant|11|||
126412043|NCT02292706|454801918|FG003|Overall Study|Liver transplant|16|||
126412044|NCT02292706|454801919|FG004|Overall Study|Liver transplant|5|||
126412045|NCT02292706|454801920|FG005|Overall Study|Liver transplant|6|||
126412046|NCT02292706|454801921|FG006|Overall Study|Liver transplant|5|||
126412047|NCT02292706|454801922|FG007|Overall Study|Liver transplant|0|||
126412048|NCT02292706|454801915|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
126412049|NCT02292706|454801916|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
126412050|NCT02292706|454801917|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
126412051|NCT02292706|454801918|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
126412052|NCT02292706|454801919|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
126412053|NCT02292706|454801920|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
126412054|NCT02292706|454801921|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
126412055|NCT02292706|454801922|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
126412056|NCT02292706|454801915|FG000|Overall Study|Subject terminated by sponsor|1|||
126412057|NCT02292706|454801916|FG001|Overall Study|Subject terminated by sponsor|0|||
126412058|NCT02292706|454801917|FG002|Overall Study|Subject terminated by sponsor|0|||
126412059|NCT02292706|454801918|FG003|Overall Study|Subject terminated by sponsor|2|||
126412060|NCT02292706|454801919|FG004|Overall Study|Subject terminated by sponsor|1|||
126412061|NCT02292706|454801920|FG005|Overall Study|Subject terminated by sponsor|0|||
126412062|NCT02292706|454801921|FG006|Overall Study|Subject terminated by sponsor|0|||
126412063|NCT02292706|454801922|FG007|Overall Study|Subject terminated by sponsor|0|||
126412064|NCT02292706|454801915|FG000|Overall Study|Missing|0|||
126412065|NCT02292706|454801916|FG001|Overall Study|Missing|0|||
126412066|NCT02292706|454801917|FG002|Overall Study|Missing|1|||
126412067|NCT02292706|454801918|FG003|Overall Study|Missing|1|||
126412068|NCT02292706|454801919|FG004|Overall Study|Missing|0|||
126412069|NCT02292706|454801920|FG005|Overall Study|Missing|1|||
126412070|NCT02292706|454801921|FG006|Overall Study|Missing|0|||
126412071|NCT02292706|454801922|FG007|Overall Study|Missing|0|||
126412072|NCT02292706|454801915|FG000|Overall Study|Virologic relapse or reinfection|1|||
126412073|NCT02292706|454801916|FG001|Overall Study|Virologic relapse or reinfection|0|||
126412074|NCT02292706|454801917|FG002|Overall Study|Virologic relapse or reinfection|0|||
126412075|NCT02292706|454801918|FG003|Overall Study|Virologic relapse or reinfection|1|||
126412076|NCT02292706|454801919|FG004|Overall Study|Virologic relapse or reinfection|0|||
126412077|NCT02292706|454801920|FG005|Overall Study|Virologic relapse or reinfection|1|||
126412078|NCT02292706|454801921|FG006|Overall Study|Virologic relapse or reinfection|0|||
126412079|NCT02292706|454801922|FG007|Overall Study|Virologic relapse or reinfection|0|||
126412080|NCT02725866|454801925|FG000|Overall Study|Failure to return|6|||
126412081|NCT02725866|454801925|FG000|Overall Study|Withdrew consent|3|||
126412082|NCT02725866|454801925|FG000|Overall Study|Insufficient virological response|1|||
126412083|NCT02725866|454801925|FG000|Overall Study|Other, not specified|4|||
125890835|NCT01175083|452899613|FG000|Primary Epoch|Withdrawal by Subject|0|||
125890836|NCT01175083|452899614|FG001|Primary Epoch|Withdrawal by Subject|0|||
126054122|NCT03732807|453492216|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
126054123|NCT03732807|453492217|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
126412084|NCT04667104|454801932|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
126412085|NCT04667104|454801933|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
126412086|NCT04667104|454801934|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
126412087|NCT03043651|454801935|FG000|Overall Study|Death|1|||
126412088|NCT03043651|454801935|FG000|Overall Study|Progressive Disease|2|||
126412089|NCT03043651|454801935|FG000|Overall Study|Adverse Event|2|||
126412090|NCT03043651|454801935|FG000|Overall Study|Withdrawal by Subject|4|||
126412091|NCT03043651|454801935|FG000|Overall Study|Study Terminated by Sponsor|39|||
126412092|NCT01630889|454801936|FG000|Overall Study|Death|2|||
126412093|NCT01630889|454801936|FG000|Overall Study|Withdrawal by Subject|1|||
126412094|NCT01630889|454801936|FG000|Overall Study|Other than Specified|2|||
126412095|NCT01630889|454801936|FG000|Overall Study|Lost to Follow-up|4|||
126412096|NCT01630889|454801936|FG000|Overall Study|Other|1|||
126412097|NCT03208088|454801941|FG000|Period 2|Withdrawal by Subject|0|||
126412098|NCT03208088|454801942|FG001|Period 2|Withdrawal by Subject|0|||
126412099|NCT03208088|454801943|FG002|Period 2|Withdrawal by Subject|0|||
126412100|NCT03208088|454801944|FG003|Period 2|Withdrawal by Subject|0|||
126412101|NCT03208088|454801945|FG004|Period 2|Withdrawal by Subject|0|||
126412102|NCT03208088|454801946|FG005|Period 2|Withdrawal by Subject|0|||
126412103|NCT03208088|454801947|FG006|Period 2|Withdrawal by Subject|0|||
126412104|NCT03208088|454801948|FG007|Period 2|Withdrawal by Subject|0|||
126412105|NCT03208088|454801949|FG008|Period 2|Withdrawal by Subject|1|||
126412106|NCT03208088|454801950|FG009|Period 2|Withdrawal by Subject|0|||
126054124|NCT03732807|453492218|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
126054125|NCT03732807|453492219|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
126054126|NCT03732807|453492213|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
126412107|NCT03208088|454801941|FG000|Period 3|Unsatisfactory Test Article|0|||
126054127|NCT03732807|453492214|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
126412108|NCT03208088|454801942|FG001|Period 3|Unsatisfactory Test Article|0|||
126412109|NCT03208088|454801943|FG002|Period 3|Unsatisfactory Test Article|0|||
126412110|NCT03208088|454801944|FG003|Period 3|Unsatisfactory Test Article|1|||
126412111|NCT03208088|454801945|FG004|Period 3|Unsatisfactory Test Article|0|||
126412112|NCT03208088|454801946|FG005|Period 3|Unsatisfactory Test Article|0|||
126412113|NCT03208088|454801947|FG006|Period 3|Unsatisfactory Test Article|0|||
126412114|NCT03208088|454801948|FG007|Period 3|Unsatisfactory Test Article|0|||
126412115|NCT03208088|454801949|FG008|Period 3|Unsatisfactory Test Article|0|||
126412116|NCT03208088|454801950|FG009|Period 3|Unsatisfactory Test Article|0|||
126412117|NCT03208088|454801941|FG000|Period 4|Unsatisfactory Test Article|0|||
126412118|NCT03208088|454801942|FG001|Period 4|Unsatisfactory Test Article|0|||
126412119|NCT03208088|454801943|FG002|Period 4|Unsatisfactory Test Article|0|||
126412120|NCT03208088|454801944|FG003|Period 4|Unsatisfactory Test Article|1|||
126412121|NCT03208088|454801945|FG004|Period 4|Unsatisfactory Test Article|0|||
126412122|NCT03208088|454801946|FG005|Period 4|Unsatisfactory Test Article|0|||
126412123|NCT03208088|454801947|FG006|Period 4|Unsatisfactory Test Article|0|||
126412124|NCT03208088|454801948|FG007|Period 4|Unsatisfactory Test Article|0|||
126412125|NCT03208088|454801949|FG008|Period 4|Unsatisfactory Test Article|0|||
126412126|NCT03208088|454801950|FG009|Period 4|Unsatisfactory Test Article|0|||
126412127|NCT00566254|454801951|FG000|Overall Study|Adverse Event|3|||
126412128|NCT00566254|454801952|FG001|Overall Study|Adverse Event|1|||
126412129|NCT00566254|454801951|FG000|Overall Study|Protocol Violation|1|||
126412130|NCT00566254|454801952|FG001|Overall Study|Protocol Violation|3|||
126412131|NCT00566254|454801951|FG000|Overall Study|Withdrawal by Subject|1|||
126412132|NCT00566254|454801952|FG001|Overall Study|Withdrawal by Subject|2|||
126412133|NCT00566254|454801951|FG000|Overall Study|Lack of Efficacy|5|||
126412134|NCT00566254|454801952|FG001|Overall Study|Lack of Efficacy|6|||
126412135|NCT00566254|454801951|FG000|Overall Study|Other|0|||
126412136|NCT00566254|454801952|FG001|Overall Study|Other|2|||
126412137|NCT00238238|454801953|FG000|Overall Study|Withdrawal by Subject|0|||
126412138|NCT00238238|454801954|FG001|Overall Study|Withdrawal by Subject|3|||
126412139|NCT00238238|454801955|FG002|Overall Study|Withdrawal by Subject|0|||
126412140|NCT01345669|454801956|FG000|Overall Study|Primary tumour recurrence|53|||
126412141|NCT01345669|454801957|FG001|Overall Study|Primary tumour recurrence|32|||
126412142|NCT01345669|454801956|FG000|Overall Study|Second primary tumour|4|||
126412143|NCT01345669|454801957|FG001|Overall Study|Second primary tumour|3|||
126412144|NCT01345669|454801956|FG000|Overall Study|Adverse Event|63|||
126412145|NCT01345669|454801957|FG001|Overall Study|Adverse Event|9|||
126412146|NCT01345669|454801956|FG000|Overall Study|Protocol Violation|3|||
126412147|NCT01345669|454801957|FG001|Overall Study|Protocol Violation|1|||
126412148|NCT01345669|454801956|FG000|Overall Study|Lost to Follow-up|1|||
126412149|NCT01345669|454801957|FG001|Overall Study|Lost to Follow-up|1|||
126412150|NCT01345669|454801956|FG000|Overall Study|Withdrawal by Subject|52|||
126412151|NCT01345669|454801957|FG001|Overall Study|Withdrawal by Subject|13|||
126412152|NCT01345669|454801956|FG000|Overall Study|Other Reasons|111|||
126412153|NCT01345669|454801957|FG001|Overall Study|Other Reasons|60|||
126412154|NCT01793883|454801958|FG000|Overall Study|Withdrawal by Subject|3|||
126412155|NCT01793883|454801959|FG001|Overall Study|Withdrawal by Subject|7|||
126412156|NCT01793883|454801960|FG002|Overall Study|Withdrawal by Subject|3|||
126412157|NCT01793883|454801958|FG000|Overall Study|Subject noncompliance|0|||
126412158|NCT01793883|454801959|FG001|Overall Study|Subject noncompliance|1|||
126412159|NCT01793883|454801960|FG002|Overall Study|Subject noncompliance|1|||
126412160|NCT01793883|454801958|FG000|Overall Study|Lost to Follow-up|5|||
126412161|NCT01793883|454801959|FG001|Overall Study|Lost to Follow-up|1|||
126412162|NCT01793883|454801960|FG002|Overall Study|Lost to Follow-up|3|||
126412163|NCT01793883|454801958|FG000|Overall Study|Randomized in error|1|||
126412164|NCT01793883|454801959|FG001|Overall Study|Randomized in error|0|||
126412165|NCT01793883|454801960|FG002|Overall Study|Randomized in error|0|||
126412166|NCT01793883|454801958|FG000|Overall Study|Unable to complete spriometry|1|||
126412167|NCT01793883|454801959|FG001|Overall Study|Unable to complete spriometry|0|||
126412168|NCT01793883|454801960|FG002|Overall Study|Unable to complete spriometry|0|||
126412169|NCT01793883|454801958|FG000|Overall Study|Unable to complete measurements|1|||
126412170|NCT01793883|454801959|FG001|Overall Study|Unable to complete measurements|0|||
126412171|NCT01793883|454801960|FG002|Overall Study|Unable to complete measurements|0|||
126412172|NCT01793883|454801958|FG000|Overall Study|Met exclusion criteria|1|||
126412173|NCT01793883|454801959|FG001|Overall Study|Met exclusion criteria|0|||
126412174|NCT01793883|454801960|FG002|Overall Study|Met exclusion criteria|0|||
126412175|NCT01793883|454801958|FG000|Overall Study|Dosing error|0|||
126412176|NCT01793883|454801959|FG001|Overall Study|Dosing error|1|||
126412177|NCT01793883|454801960|FG002|Overall Study|Dosing error|0|||
126412178|NCT01793883|454801958|FG000|Overall Study|Respiratory distress during spirometry|0|||
126412179|NCT01793883|454801959|FG001|Overall Study|Respiratory distress during spirometry|0|||
126412180|NCT01793883|454801960|FG002|Overall Study|Respiratory distress during spirometry|1|||
126412181|NCT02478255|454801961|FG000|Overall Study|Physician Decision|6|||
126412182|NCT02478255|454801962|FG001|Overall Study|Physician Decision|0|||
126412183|NCT02478255|454801961|FG000|Overall Study|Withdrawal by Subject|2|||
126412184|NCT02478255|454801962|FG001|Overall Study|Withdrawal by Subject|0|||
126412185|NCT00761527|454801964|FG000|Overall Study|Adverse Event|3|||
126412186|NCT00761527|454801964|FG000|Overall Study|Poor Compliance|8|||
126412187|NCT00761527|454801964|FG000|Overall Study|Lost to Follow-up|9|||
126412188|NCT00761527|454801964|FG000|Overall Study|Unknown reason|2|||
126412189|NCT01730586|454801965|FG000|Overall Study|Progressive Disease|2|||
126412190|NCT01730586|454801965|FG000|Overall Study|Inadequate Trial|8|||
126412191|NCT01730586|454801965|FG000|Overall Study|Adverse Event|2|||
126412192|NCT01730586|454801965|FG000|Overall Study|Hospice|1|||
126412193|NCT00061633|454801966|FG000|Overall Study|Adverse Event|1|||
126412194|NCT00061633|454801967|FG001|Overall Study|Adverse Event|2|||
126412195|NCT00061633|454801966|FG000|Overall Study|Withdrawal by Subject|2|||
126412196|NCT00061633|454801967|FG001|Overall Study|Withdrawal by Subject|2|||
126412197|NCT00061633|454801966|FG000|Overall Study|Lost to Follow-up|1|||
126412198|NCT00061633|454801967|FG001|Overall Study|Lost to Follow-up|4|||
126412199|NCT00061633|454801966|FG000|Overall Study|Other|1|||
126412200|NCT00061633|454801967|FG001|Overall Study|Other|1|||
126412201|NCT00061633|454801966|FG000|Overall Study|Never received study treatment|0|||
126412202|NCT00061633|454801967|FG001|Overall Study|Never received study treatment|2|||
126412203|NCT01431963|454801968|FG000|Overall Study|Adverse Event|18|||
126412204|NCT01431963|454801968|FG000|Overall Study|Lack of Efficacy|7|||
126412205|NCT01431963|454801968|FG000|Overall Study|Protocol Violation|1|||
126412206|NCT01431963|454801968|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
126412207|NCT01431963|454801968|FG000|Overall Study|Physician Decision|4|||
126054128|NCT03732807|453492215|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
126054129|NCT03732807|453492216|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
126054130|NCT03732807|453492217|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
126054131|NCT03732807|453492218|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
126412208|NCT01431963|454801968|FG000|Overall Study|Withdrawal by Subject|3|||
126412209|NCT02921087|454801971|FG000|Overall Study|Withdrawal by Subject|0|||
126412210|NCT02921087|454801972|FG001|Overall Study|Withdrawal by Subject|1|||
126412211|NCT00687531|454801973|FG000|Overall Study|Did not meet protocol eligibility|104|||
126412212|NCT00687531|454801973|FG000|Overall Study|Adverse Event|5|||
126412213|NCT00687531|454801973|FG000|Overall Study|Lost to Follow-up|26|||
126412214|NCT03848949|454801974|FG000|Overall Study|Lost to Follow-up|5|||
126412215|NCT03848949|454801975|FG001|Overall Study|Lost to Follow-up|7|||
126412216|NCT02353728|454801976|FG000|Overall Study|Subject non-compliance|1|||
126412217|NCT00619307|454801979|FG000|Overall Study|Adverse Event|0|||
126412218|NCT00619307|454801980|FG001|Overall Study|Adverse Event|1|||
126412219|NCT00619307|454801979|FG000|Overall Study|Lost to Follow-up|0|||
126412220|NCT00619307|454801980|FG001|Overall Study|Lost to Follow-up|1|||
126412221|NCT00619307|454801979|FG000|Overall Study|Protocol Violation|3|||
126412222|NCT00619307|454801980|FG001|Overall Study|Protocol Violation|0|||
126412223|NCT00619307|454801979|FG000|Overall Study|Withdrew consent|1|||
126412224|NCT00619307|454801980|FG001|Overall Study|Withdrew consent|0|||
126412225|NCT00619307|454801979|FG000|Overall Study|Severe migraine|0|||
126412226|NCT00619307|454801980|FG001|Overall Study|Severe migraine|1|||
126412227|NCT00619307|454801979|FG000|Overall Study|MS attack plus steroids|0|||
126412228|NCT00619307|454801980|FG001|Overall Study|MS attack plus steroids|1|||
126412229|NCT00547521|454801981|FG000|Short Term Study (4 Months)|Adverse Event|1|||
126412230|NCT00547521|454801982|FG001|Short Term Study (4 Months)|Adverse Event|0|||
126412231|NCT00547521|454801981|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
126412232|NCT00547521|454801982|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
126412233|NCT00547521|454801981|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
126412234|NCT00547521|454801982|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
126412235|NCT00547521|454801981|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
126412236|NCT00547521|454801982|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
126412237|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
126412238|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
126412239|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
126412240|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
126412241|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
126412242|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
126412243|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
126412244|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
126412245|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Other|0|||
126412246|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Other|2|||
126412247|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
126412248|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
126412249|NCT03109184|454803739|FG000|Overall Study|Lost to Follow-up|6|||
126412250|NCT03109184|454803740|FG001|Overall Study|Lost to Follow-up|6|||
126412251|NCT03109184|454803739|FG000|Overall Study|Withdrawal by Subject|1|||
126412252|NCT03109184|454803740|FG001|Overall Study|Withdrawal by Subject|1|||
126412253|NCT00602420|454803741|FG000|Overall Study|Death|1|||
126412254|NCT00602420|454803742|FG001|Overall Study|Death|4|||
126054132|NCT03732807|453492219|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
126412255|NCT00602420|454803741|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
126412256|NCT00602420|454803742|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
126412257|NCT00602420|454803741|FG000|Overall Study|Withdrawal by Subject|18|||
126412258|NCT00602420|454803742|FG001|Overall Study|Withdrawal by Subject|17|||
126412259|NCT00602420|454803741|FG000|Overall Study|Adverse Event|1|||
126412260|NCT00602420|454803742|FG001|Overall Study|Adverse Event|0|||
126412261|NCT00703924|454803745|FG000|Overall Study|Withdrawal by Subject|1|||
126412262|NCT00703924|454803746|FG001|Overall Study|Withdrawal by Subject|1|||
126412263|NCT02008227|454803747|FG000|Overall Study|Lost to Follow-up|7|||
126412264|NCT02008227|454803748|FG001|Overall Study|Lost to Follow-up|9|||
126412265|NCT02008227|454803747|FG000|Overall Study|Death|494|||
126412266|NCT02008227|454803748|FG001|Overall Study|Death|485|||
126412267|NCT02008227|454803747|FG000|Overall Study|Withdrawal by Subject|67|||
126412268|NCT02008227|454803748|FG001|Overall Study|Withdrawal by Subject|36|||
126412269|NCT02008227|454803747|FG000|Overall Study|Study Terminated By Sponsor|44|||
126412270|NCT02008227|454803748|FG001|Overall Study|Study Terminated By Sponsor|83|||
126412271|NCT03499314|454803749|FG000|Overall Study|Time Commitment|1|||
126412272|NCT03499314|454803750|FG001|Overall Study|Time Commitment|2|||
126412273|NCT03499314|454803749|FG000|Overall Study|Medical issue unrelated to research study|1|||
126412274|NCT03499314|454803750|FG001|Overall Study|Medical issue unrelated to research study|1|||
126412275|NCT01271725|454803751|FG000|Part A|Progressive disease according to RECIST|8|||
126412276|NCT01271725|454803752|FG001|Part A|Progressive disease according to RECIST|0|||
126412277|NCT01271725|454803751|FG000|Part A|Clinical signs/symptoms of progression|2|||
126412278|NCT01271725|454803752|FG001|Part A|Clinical signs/symptoms of progression|0|||
126412279|NCT01271725|454803751|FG000|Part A|Other Adverse Event|8|||
126412280|NCT01271725|454803752|FG001|Part A|Other Adverse Event|0|||
126412281|NCT01271725|454803751|FG000|Part A|Lost to Follow-up|1|||
126412282|NCT01271725|454803752|FG001|Part A|Lost to Follow-up|0|||
126412283|NCT01271725|454803751|FG000|Part A|Withdrawal by Subject|12|||
126412284|NCT01271725|454803752|FG001|Part A|Withdrawal by Subject|0|||
126412285|NCT01271725|454803751|FG000|Part A|Other than specified|3|||
126412286|NCT01271725|454803752|FG001|Part A|Other than specified|0|||
126412287|NCT01271725|454803751|FG000|Part A|Protocol Violation|1|||
126412288|NCT01271725|454803752|FG001|Part A|Protocol Violation|0|||
126412289|NCT01271725|454803751|FG000|Part B|Other than specified|0|||
126412290|NCT01271725|454803752|FG001|Part B|Other than specified|2|||
126412291|NCT01271725|454803751|FG000|Part B|Clinical signs/symptoms of progression|0|||
126412292|NCT01271725|454803752|FG001|Part B|Clinical signs/symptoms of progression|2|||
126412293|NCT01271725|454803751|FG000|Part B|Other Adverse Event|0|||
126412294|NCT01271725|454803752|FG001|Part B|Other Adverse Event|1|||
126412295|NCT01271725|454803751|FG000|Part B|Protocol Violation|0|||
126412296|NCT01271725|454803752|FG001|Part B|Protocol Violation|1|||
126412297|NCT01271725|454803751|FG000|Part B|Withdrawal by Subject|0|||
126412298|NCT01271725|454803752|FG001|Part B|Withdrawal by Subject|6|||
126412299|NCT01702025|454803753|FG000|Overall Study|Equipment failure|1|||
126412300|NCT01702025|454803754|FG001|Overall Study|Equipment failure|0|||
126412301|NCT01702025|454803755|FG002|Overall Study|Equipment failure|0|||
126412302|NCT01702025|454803756|FG003|Overall Study|Equipment failure|0|||
126412303|NCT01702025|454803753|FG000|Overall Study|Adverse Event|1|||
126412304|NCT01702025|454803754|FG001|Overall Study|Adverse Event|1|||
126412305|NCT01702025|454803755|FG002|Overall Study|Adverse Event|1|||
126412306|NCT01702025|454803756|FG003|Overall Study|Adverse Event|0|||
126412307|NCT03354273|454803757|FG000|Overall Study|Adverse Event|5|||
126412308|NCT03354273|454803757|FG000|Overall Study|Screen Failure|21|||
126412309|NCT03354273|454803757|FG000|Overall Study|Withdrawal by Subject|34|||
126412310|NCT03354273|454803757|FG000|Overall Study|Technical Problems|30|||
126412311|NCT03354273|454803757|FG000|Overall Study|Lost to Follow-up|4|||
126412312|NCT03354273|454803757|FG000|Overall Study|Investigator Decision|3|||
126412313|NCT03354273|454803757|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
126412314|NCT03354273|454803757|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
126412315|NCT03354273|454803757|FG000|Overall Study|COVID-19 Restrictions|9|||
126412316|NCT03354273|454803757|FG000|Overall Study|Other|5|||
126412317|NCT03149055|454803764|FG000|Overall Study|Not treated|4|||
126412318|NCT04440813|454803765|FG000|Overall Study|Lost to Follow-up|5|||
126412319|NCT04440813|454803766|FG001|Overall Study|Lost to Follow-up|5|||
126412320|NCT02629822|454803767|FG000|Base Study|Lost to Follow-up|2|||
126412321|NCT02629822|454803767|FG000|Base Study|Non-Compliance With Study Drug|1|||
126412322|NCT02629822|454803767|FG000|Extension Study|Adverse Event|1|||
126412323|NCT02629822|454803767|FG000|Extension Study|Lost to Follow-up|1|||
126412324|NCT00741013|454803768|FG000|Overall Study|Adverse Event|1|||
126412325|NCT00741013|454803769|FG001|Overall Study|Adverse Event|0|||
126412326|NCT00741013|454803770|FG002|Overall Study|Adverse Event|0|||
126412327|NCT00741013|454803768|FG000|Overall Study|Withdrawal by Subject|0|||
126412328|NCT00741013|454803769|FG001|Overall Study|Withdrawal by Subject|0|||
126412329|NCT00741013|454803770|FG002|Overall Study|Withdrawal by Subject|1|||
126412330|NCT00741013|454803768|FG000|Overall Study|Discovered failed screen after enrolled|0|||
126412331|NCT00741013|454803769|FG001|Overall Study|Discovered failed screen after enrolled|2|||
126412332|NCT00741013|454803770|FG002|Overall Study|Discovered failed screen after enrolled|0|||
126412333|NCT00193180|454803774|FG000|Overall Study|Lack of Efficacy|1|||
126412334|NCT00193180|454803774|FG000|Overall Study|Adverse Event|8|||
126412335|NCT00193180|454803774|FG000|Overall Study|Protocol Violation|1|||
126412336|NCT00539305|454803775|FG000|Overall Study|Adverse Event|1|||
126412337|NCT00539305|454803776|FG001|Overall Study|Adverse Event|0|||
126412338|NCT00539305|454803775|FG000|Overall Study|Substance Use|0|||
126412339|NCT00539305|454803776|FG001|Overall Study|Substance Use|1|||
126412340|NCT00539305|454803775|FG000|Overall Study|Withdrawal by Subject|0|||
126054133|NCT03732807|453492213|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
126054134|NCT03732807|453492214|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
126054135|NCT03732807|453492215|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
126054136|NCT03732807|453492216|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
126054137|NCT03732807|453492217|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
126054138|NCT03732807|453492218|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
126412341|NCT00539305|454803776|FG001|Overall Study|Withdrawal by Subject|1|||
126412342|NCT00239928|454803782|FG000|Overall Study|Lack of Efficacy|1|||
126412343|NCT00239928|454803782|FG000|Overall Study|Adverse Event|4|||
126412344|NCT00239928|454803782|FG000|Overall Study|Not need to continue study|3|||
126412345|NCT00239928|454803782|FG000|Overall Study|Withdrawal by Subject|2|||
126412346|NCT00774800|454803785|FG000|Intervention 4|Withdrawal by Subject|1|||
126412347|NCT01331109|454803790|FG000|Overall Study|Adverse Event|6|||
126412348|NCT01331109|454803790|FG000|Overall Study|Lack of Efficacy|2|||
126412349|NCT01331109|454803790|FG000|Overall Study|Protocol Violation|3|||
126412350|NCT01331109|454803790|FG000|Overall Study|Withdrawal by Subject|7|||
126412351|NCT01331109|454803790|FG000|Overall Study|Lost to Follow-up|1|||
126412352|NCT01331109|454803790|FG000|Overall Study|Study Terminated by Sponsor|38|||
126412353|NCT00479856|454803791|FG000|Overall Study|Adverse Event|1|||
126412354|NCT00479856|454803791|FG000|Overall Study|Withdrawal by Subject|1|||
126412355|NCT00479856|454803791|FG000|Overall Study|Physician Decision|1|||
126412356|NCT00661622|454803794|FG000|Overall Study|Protocol Violation|1|||
126412357|NCT00661622|454803795|FG001|Overall Study|Protocol Violation|0|||
126412358|NCT00098306|454803801|FG000|Double Blind|Randomized, not treated|9|||
126412359|NCT00098306|454803802|FG001|Double Blind|Randomized, not treated|5|||
126412360|NCT00098306|454803803|FG002|Double Blind|Randomized, not treated|2|||
126412361|NCT00098306|454803804|FG003|Double Blind|Randomized, not treated|0|||
126412362|NCT00098306|454803805|FG004|Double Blind|Randomized, not treated|0|||
126412363|NCT00098306|454803806|FG005|Double Blind|Randomized, not treated|0|||
126412364|NCT00098306|454803807|FG006|Double Blind|Randomized, not treated|0|||
126412365|NCT00098306|454803801|FG000|Double Blind|Ongoing at cut-off date|151|||
126412366|NCT00098306|454803802|FG001|Double Blind|Ongoing at cut-off date|166|||
126412367|NCT00098306|454803803|FG002|Double Blind|Ongoing at cut-off date|72|||
126412368|NCT00098306|454803804|FG003|Double Blind|Ongoing at cut-off date|0|||
126412369|NCT00098306|454803805|FG004|Double Blind|Ongoing at cut-off date|0|||
126412370|NCT00098306|454803806|FG005|Double Blind|Ongoing at cut-off date|0|||
126412371|NCT00098306|454803807|FG006|Double Blind|Ongoing at cut-off date|0|||
126412372|NCT00098306|454803801|FG000|Double Blind|Adverse Event|11|||
126412373|NCT00098306|454803802|FG001|Double Blind|Adverse Event|10|||
126412374|NCT00098306|454803803|FG002|Double Blind|Adverse Event|6|||
126412375|NCT00098306|454803804|FG003|Double Blind|Adverse Event|0|||
126412376|NCT00098306|454803805|FG004|Double Blind|Adverse Event|0|||
126412377|NCT00098306|454803806|FG005|Double Blind|Adverse Event|0|||
126412378|NCT00098306|454803807|FG006|Double Blind|Adverse Event|0|||
126412379|NCT00098306|454803801|FG000|Double Blind|Lack of Efficacy|43|||
126412380|NCT00098306|454803802|FG001|Double Blind|Lack of Efficacy|34|||
126412381|NCT00098306|454803803|FG002|Double Blind|Lack of Efficacy|17|||
126412382|NCT00098306|454803804|FG003|Double Blind|Lack of Efficacy|0|||
126412383|NCT00098306|454803805|FG004|Double Blind|Lack of Efficacy|0|||
126412384|NCT00098306|454803806|FG005|Double Blind|Lack of Efficacy|0|||
126412385|NCT00098306|454803807|FG006|Double Blind|Lack of Efficacy|0|||
126412386|NCT00098306|454803801|FG000|Double Blind|Death|1|||
126412387|NCT00098306|454803802|FG001|Double Blind|Death|4|||
126412388|NCT00098306|454803803|FG002|Double Blind|Death|1|||
126412389|NCT00098306|454803804|FG003|Double Blind|Death|0|||
126412390|NCT00098306|454803805|FG004|Double Blind|Death|0|||
126412391|NCT00098306|454803806|FG005|Double Blind|Death|0|||
126412392|NCT00098306|454803807|FG006|Double Blind|Death|0|||
126412393|NCT00098306|454803801|FG000|Double Blind|Participant defaulted|19|||
126412394|NCT00098306|454803802|FG001|Double Blind|Participant defaulted|18|||
126412395|NCT00098306|454803803|FG002|Double Blind|Participant defaulted|11|||
126412396|NCT00098306|454803804|FG003|Double Blind|Participant defaulted|0|||
126412397|NCT00098306|454803805|FG004|Double Blind|Participant defaulted|0|||
126412398|NCT00098306|454803806|FG005|Double Blind|Participant defaulted|0|||
126412399|NCT00098306|454803807|FG006|Double Blind|Participant defaulted|0|||
126412400|NCT00098306|454803801|FG000|Double Blind|Un-specified|7|||
126412401|NCT00098306|454803802|FG001|Double Blind|Un-specified|3|||
126412402|NCT00098306|454803803|FG002|Double Blind|Un-specified|11|||
126412403|NCT00098306|454803804|FG003|Double Blind|Un-specified|0|||
126412404|NCT00098306|454803805|FG004|Double Blind|Un-specified|0|||
126054139|NCT03732807|453492219|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
126054140|NCT00975585|453492221|FG000|Overall Study|Adverse Event|0|||
126412405|NCT00098306|454803806|FG005|Double Blind|Un-specified|0|||
126412406|NCT00098306|454803807|FG006|Double Blind|Un-specified|0|||
126412407|NCT00098306|454803801|FG000|Open Label|Lack of Efficacy|0|||
126412408|NCT00098306|454803802|FG001|Open Label|Lack of Efficacy|0|||
126412409|NCT00098306|454803803|FG002|Open Label|Lack of Efficacy|0|||
126412410|NCT00098306|454803804|FG003|Open Label|Lack of Efficacy|13|||
126412411|NCT00098306|454803805|FG004|Open Label|Lack of Efficacy|0|||
126412412|NCT00098306|454803806|FG005|Open Label|Lack of Efficacy|0|||
126412413|NCT00098306|454803807|FG006|Open Label|Lack of Efficacy|0|||
126412414|NCT00098306|454803801|FG000|Open Label|Adverse Event|0|||
126412415|NCT00098306|454803802|FG001|Open Label|Adverse Event|0|||
126412416|NCT00098306|454803803|FG002|Open Label|Adverse Event|0|||
126412417|NCT00098306|454803804|FG003|Open Label|Adverse Event|2|||
126412418|NCT00098306|454803805|FG004|Open Label|Adverse Event|0|||
126412419|NCT00098306|454803806|FG005|Open Label|Adverse Event|0|||
126412420|NCT00098306|454803807|FG006|Open Label|Adverse Event|0|||
126412421|NCT00098306|454803801|FG000|Open Label|Death|0|||
126412422|NCT00098306|454803802|FG001|Open Label|Death|0|||
126412423|NCT00098306|454803803|FG002|Open Label|Death|0|||
126412424|NCT00098306|454803804|FG003|Open Label|Death|4|||
126412425|NCT00098306|454803805|FG004|Open Label|Death|0|||
126412426|NCT00098306|454803806|FG005|Open Label|Death|0|||
126412427|NCT00098306|454803807|FG006|Open Label|Death|0|||
126412428|NCT00098306|454803801|FG000|Open Label|Participant defaulted|0|||
126412429|NCT00098306|454803802|FG001|Open Label|Participant defaulted|0|||
126412430|NCT00098306|454803803|FG002|Open Label|Participant defaulted|0|||
126412431|NCT00098306|454803804|FG003|Open Label|Participant defaulted|24|||
126412432|NCT00098306|454803805|FG004|Open Label|Participant defaulted|0|||
126412433|NCT00098306|454803806|FG005|Open Label|Participant defaulted|0|||
126412434|NCT00098306|454803807|FG006|Open Label|Participant defaulted|0|||
126412435|NCT00098306|454803801|FG000|Open Label|Un-specified|0|||
126412436|NCT00098306|454803802|FG001|Open Label|Un-specified|0|||
126412437|NCT00098306|454803803|FG002|Open Label|Un-specified|0|||
126412438|NCT00098306|454803804|FG003|Open Label|Un-specified|15|||
126412439|NCT00098306|454803805|FG004|Open Label|Un-specified|0|||
126412440|NCT00098306|454803806|FG005|Open Label|Un-specified|0|||
126412441|NCT00098306|454803807|FG006|Open Label|Un-specified|0|||
126412442|NCT00098306|454803801|FG000|Open Label|Ongoing at cut-off date|0|||
126412443|NCT00098306|454803802|FG001|Open Label|Ongoing at cut-off date|0|||
126412444|NCT00098306|454803803|FG002|Open Label|Ongoing at cut-off date|0|||
126412445|NCT00098306|454803804|FG003|Open Label|Ongoing at cut-off date|269|||
126412446|NCT00098306|454803805|FG004|Open Label|Ongoing at cut-off date|62|||
126412447|NCT00098306|454803806|FG005|Open Label|Ongoing at cut-off date|0|||
126412448|NCT00098306|454803807|FG006|Open Label|Ongoing at cut-off date|0|||
126412449|NCT00098306|454803801|FG000|Observational Phase|Death|0|||
126412450|NCT00098306|454803802|FG001|Observational Phase|Death|0|||
126412451|NCT00098306|454803803|FG002|Observational Phase|Death|0|||
126412452|NCT00098306|454803804|FG003|Observational Phase|Death|0|||
126412453|NCT00098306|454803805|FG004|Observational Phase|Death|0|||
126412454|NCT00098306|454803806|FG005|Observational Phase|Death|5|||
126412455|NCT00098306|454803807|FG006|Observational Phase|Death|4|||
126412456|NCT00098306|454803801|FG000|Observational Phase|Participant defaulted|0|||
126412457|NCT00098306|454803802|FG001|Observational Phase|Participant defaulted|0|||
126412458|NCT00098306|454803803|FG002|Observational Phase|Participant defaulted|0|||
126412459|NCT00098306|454803804|FG003|Observational Phase|Participant defaulted|0|||
125890837|NCT01175083|452899615|FG002|Primary Epoch|Withdrawal by Subject|0|||
125890838|NCT01175083|452899616|FG003|Primary Epoch|Withdrawal by Subject|0|||
125890839|NCT01175083|452899617|FG004|Primary Epoch|Withdrawal by Subject|0|||
125890840|NCT01175083|452899618|FG005|Primary Epoch|Withdrawal by Subject|2|||
126412460|NCT00098306|454803805|FG004|Observational Phase|Participant defaulted|0|||
126412461|NCT00098306|454803806|FG005|Observational Phase|Participant defaulted|34|||
126412462|NCT00098306|454803807|FG006|Observational Phase|Participant defaulted|18|||
126412463|NCT00098306|454803801|FG000|Observational Phase|Un-specified|0|||
126412464|NCT00098306|454803802|FG001|Observational Phase|Un-specified|0|||
126412465|NCT00098306|454803803|FG002|Observational Phase|Un-specified|0|||
126412466|NCT00098306|454803804|FG003|Observational Phase|Un-specified|0|||
126412467|NCT00098306|454803805|FG004|Observational Phase|Un-specified|0|||
126412468|NCT00098306|454803806|FG005|Observational Phase|Un-specified|7|||
126412469|NCT00098306|454803807|FG006|Observational Phase|Un-specified|4|||
126412470|NCT02760810|454803808|FG000|Overall Study|Protocol Violation|1|||
126412471|NCT00932165|454803809|FG000|Overall Study|Lost to Follow-up|1|||
126412472|NCT00588094|454803810|FG000|Overall Study|Adverse Event|3|||
126412473|NCT00588094|454803810|FG000|Overall Study|Progression of Disease|2|||
126412474|NCT01336023|454803811|FG000|Week 0 to Week 26|Adverse Event|8|||
126412475|NCT01336023|454803812|FG001|Week 0 to Week 26|Adverse Event|10|||
126412476|NCT01336023|454803813|FG002|Week 0 to Week 26|Adverse Event|24|||
126412477|NCT01336023|454803811|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
126412478|NCT01336023|454803812|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
126412479|NCT01336023|454803813|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
126412480|NCT01336023|454803811|FG000|Week 0 to Week 26|Protocol Violation|1|||
126412481|NCT01336023|454803812|FG001|Week 0 to Week 26|Protocol Violation|2|||
126412482|NCT01336023|454803813|FG002|Week 0 to Week 26|Protocol Violation|0|||
126412483|NCT01336023|454803811|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
126412484|NCT01336023|454803812|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
126412485|NCT01336023|454803813|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
126412486|NCT01336023|454803811|FG000|Week 0 to Week 26|Unclassified|5|||
126412487|NCT01336023|454803812|FG001|Week 0 to Week 26|Unclassified|16|||
126412488|NCT01336023|454803813|FG002|Week 0 to Week 26|Unclassified|9|||
126412489|NCT01336023|454803811|FG000|Week 27 to 52|Adverse Event|1|||
126412490|NCT01336023|454803812|FG001|Week 27 to 52|Adverse Event|5|||
126412491|NCT01336023|454803813|FG002|Week 27 to 52|Adverse Event|2|||
126412492|NCT01336023|454803811|FG000|Week 27 to 52|Protocol Violation|0|||
126412493|NCT01336023|454803812|FG001|Week 27 to 52|Protocol Violation|2|||
126412494|NCT01336023|454803813|FG002|Week 27 to 52|Protocol Violation|1|||
126412495|NCT01336023|454803811|FG000|Week 27 to 52|Withdrawal Criteria|14|||
126412496|NCT01336023|454803812|FG001|Week 27 to 52|Withdrawal Criteria|19|||
126412497|NCT01336023|454803813|FG002|Week 27 to 52|Withdrawal Criteria|16|||
126412498|NCT01336023|454803811|FG000|Week 27 to 52|Unclassified|13|||
126412499|NCT01336023|454803812|FG001|Week 27 to 52|Unclassified|18|||
126412500|NCT01336023|454803813|FG002|Week 27 to 52|Unclassified|9|||
126412501|NCT00391625|454803819|FG000|Month 14|Withdrawal by Subject|1|||
126412502|NCT00391625|454803819|FG000|Month 50|Physician Decision|1|||
126412503|NCT01361178|454803820|FG000|Overall Study|Death|13|||
126412504|NCT01361178|454803821|FG001|Overall Study|Death|0|||
126412505|NCT03997825|454803822|FG000|Overall Study|Death|3|||
126412506|NCT03997825|454803822|FG000|Overall Study|Lost to Follow-up|10|||
126412507|NCT03997825|454803822|FG000|Overall Study|Withdrawal by Subject|3|||
126412508|NCT03997825|454803822|FG000|Overall Study|Refused participation|1|||
126412509|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
126412510|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
126412511|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
126412512|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
126412513|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
126412514|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
126412515|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
126412516|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
126412517|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
126412518|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
126412519|NCT00383162|454803823|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
126412520|NCT00383162|454803824|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
126412521|NCT00383162|454803823|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
126412522|NCT00383162|454803824|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
126412523|NCT00383162|454803823|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
126412524|NCT00383162|454803824|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
126412525|NCT00383162|454803823|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
125890841|NCT01175083|452899613|FG000|Primary Epoch|Lost to Follow-up|0|||
125890842|NCT01175083|452899614|FG001|Primary Epoch|Lost to Follow-up|0|||
126412526|NCT00383162|454803824|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
126412527|NCT00767819|454803825|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
125890843|NCT01175083|452899615|FG002|Primary Epoch|Lost to Follow-up|0|||
126412528|NCT00767819|454803826|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
126412529|NCT00767819|454803827|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126412530|NCT00767819|454803825|FG000|Overall Study|Withdrawal by Subject|1|||
126412531|NCT00767819|454803826|FG001|Overall Study|Withdrawal by Subject|1|||
126412532|NCT00767819|454803827|FG002|Overall Study|Withdrawal by Subject|0|||
126412533|NCT00767819|454803825|FG000|Overall Study|Administrative problems|0|||
126412534|NCT00767819|454803826|FG001|Overall Study|Administrative problems|1|||
126412535|NCT00767819|454803827|FG002|Overall Study|Administrative problems|0|||
126412536|NCT00767819|454803825|FG000|Overall Study|Death|2|||
126412537|NCT00767819|454803826|FG001|Overall Study|Death|3|||
126412538|NCT00767819|454803827|FG002|Overall Study|Death|0|||
126412539|NCT00767819|454803825|FG000|Overall Study|Adverse Event|2|||
126412540|NCT00767819|454803826|FG001|Overall Study|Adverse Event|0|||
126412541|NCT00767819|454803827|FG002|Overall Study|Adverse Event|0|||
126412542|NCT00767819|454803825|FG000|Overall Study|Abnormal lab values|1|||
126412543|NCT00767819|454803826|FG001|Overall Study|Abnormal lab values|0|||
126412544|NCT00767819|454803827|FG002|Overall Study|Abnormal lab values|0|||
126412545|NCT00767819|454803825|FG000|Overall Study|Lost to Follow-up|1|||
126412546|NCT00767819|454803826|FG001|Overall Study|Lost to Follow-up|0|||
126412547|NCT00767819|454803827|FG002|Overall Study|Lost to Follow-up|0|||
126412548|NCT05392803|454803828|FG000|Overall Study|Lost to Follow-up|0|||
126412549|NCT05392803|454803829|FG001|Overall Study|Lost to Follow-up|2|||
126412550|NCT04294147|454803830|FG000|Overall Study|Protocol Violation|2|||
126412551|NCT04294147|454803831|FG001|Overall Study|Protocol Violation|0|||
126412552|NCT00915551|454803832|FG000|Overall Study|Withdrawal by Subject|0|||
126412553|NCT00915551|454803833|FG001|Overall Study|Withdrawal by Subject|1|||
126412554|NCT00235716|454803834|FG000|Overall Study|Death|26|||
126412555|NCT00235716|454803835|FG001|Overall Study|Death|39|||
126412556|NCT00235716|454803836|FG002|Overall Study|Death|32|||
126412557|NCT00235716|454803837|FG003|Overall Study|Death|31|||
126412558|NCT00235716|454803834|FG000|Overall Study|Withdrawal by Subject|23|||
126412559|NCT00235716|454803835|FG001|Overall Study|Withdrawal by Subject|19|||
126412560|NCT00235716|454803836|FG002|Overall Study|Withdrawal by Subject|17|||
126412561|NCT00235716|454803837|FG003|Overall Study|Withdrawal by Subject|18|||
126412562|NCT00235716|454803834|FG000|Overall Study|Lost to Follow-up|12|||
126412563|NCT00235716|454803835|FG001|Overall Study|Lost to Follow-up|7|||
126412564|NCT00235716|454803836|FG002|Overall Study|Lost to Follow-up|14|||
126412565|NCT00235716|454803837|FG003|Overall Study|Lost to Follow-up|10|||
126412566|NCT00235716|454803834|FG000|Overall Study|Adverse Event|1|||
126412567|NCT00235716|454803835|FG001|Overall Study|Adverse Event|1|||
126054141|NCT00975585|453492222|FG001|Overall Study|Adverse Event|4|||
126054142|NCT00975585|453492221|FG000|Overall Study|Lost to Follow-up|3|||
126054143|NCT00975585|453492222|FG001|Overall Study|Lost to Follow-up|5|||
126054144|NCT00975585|453492221|FG000|Overall Study|Withdrawal by Subject|2|||
126054145|NCT00975585|453492222|FG001|Overall Study|Withdrawal by Subject|1|||
126054146|NCT00975585|453492221|FG000|Overall Study|Lens issue|2|||
126054147|NCT00975585|453492222|FG001|Overall Study|Lens issue|2|||
126054148|NCT00683800|453492224|FG000|Overall Study|Adverse Event|195|||
126054149|NCT00683800|453492225|FG001|Overall Study|Adverse Event|102|||
126054150|NCT00683800|453492224|FG000|Overall Study|Death|0|||
126412568|NCT00235716|454803836|FG002|Overall Study|Adverse Event|1|||
126412569|NCT00235716|454803837|FG003|Overall Study|Adverse Event|0|||
126412570|NCT00235716|454803834|FG000|Overall Study|Physician Decision|0|||
126412571|NCT00235716|454803835|FG001|Overall Study|Physician Decision|1|||
126412572|NCT00235716|454803836|FG002|Overall Study|Physician Decision|1|||
126412573|NCT00235716|454803837|FG003|Overall Study|Physician Decision|3|||
126412574|NCT04390841|454803838|FG000|Overall Study|Withdrawal by Subject|2|||
126412575|NCT02188849|454803849|FG000|Overall Study|Lost to Follow-up|3|||
126412576|NCT02188849|454803850|FG001|Overall Study|Lost to Follow-up|8|||
126412577|NCT05090852|454803857|FG000|Overall Study|Physician Decision|5|||
126412578|NCT00148941|454803861|FG000|Overall Study|Lost to Follow-up|17|||
126412579|NCT00148941|454803862|FG001|Overall Study|Lost to Follow-up|24|||
126412580|NCT00148941|454803863|FG002|Overall Study|Lost to Follow-up|18|||
126412581|NCT00148941|454803864|FG003|Overall Study|Lost to Follow-up|22|||
126412582|NCT00148941|454803861|FG000|Overall Study|Withdrawal by Subject|1|||
126412583|NCT00148941|454803862|FG001|Overall Study|Withdrawal by Subject|0|||
126412584|NCT00148941|454803863|FG002|Overall Study|Withdrawal by Subject|1|||
126412585|NCT00148941|454803864|FG003|Overall Study|Withdrawal by Subject|0|||
126412586|NCT00148941|454803861|FG000|Overall Study|Other|0|||
125890844|NCT01175083|452899616|FG003|Primary Epoch|Lost to Follow-up|0|||
126054151|NCT00683800|453492225|FG001|Overall Study|Death|1|||
126412587|NCT00148941|454803862|FG001|Overall Study|Other|0|||
126412588|NCT00148941|454803863|FG002|Overall Study|Other|1|||
126412589|NCT00148941|454803864|FG003|Overall Study|Other|2|||
126412590|NCT03244826|454803865|FG000|Overall Study|Withdrawal by Subject|2|||
126412591|NCT03244826|454803866|FG001|Overall Study|Withdrawal by Subject|0|||
125890845|NCT01175083|452899617|FG004|Primary Epoch|Lost to Follow-up|0|||
126054152|NCT00683800|453492224|FG000|Overall Study|Lost to Follow-up|57|||
126054153|NCT00683800|453492225|FG001|Overall Study|Lost to Follow-up|44|||
126054154|NCT00683800|453492224|FG000|Overall Study|Other|5|||
126412592|NCT03244826|454803865|FG000|Overall Study|Transplant delayed or withdrawn|12|||
126412593|NCT03244826|454803866|FG001|Overall Study|Transplant delayed or withdrawn|10|||
126412594|NCT00416455|454803872|FG000|Overall Study|PET / CT not done|3|||
126412595|NCT00416455|454803873|FG001|Overall Study|PET / CT not done|5|||
126412596|NCT00416455|454803872|FG000|Overall Study|PET / CT poor quality|2|||
126412597|NCT00416455|454803873|FG001|Overall Study|PET / CT poor quality|1|||
126412598|NCT00416455|454803872|FG000|Overall Study|Inadequate pathology|11|||
126412599|NCT00416455|454803873|FG001|Overall Study|Inadequate pathology|2|||
126412600|NCT01620944|454803875|FG000|Overall Study|Early termination of Study|2|||
126412601|NCT01620944|454803876|FG001|Overall Study|Early termination of Study|1|||
126412602|NCT04079114|454803877|FG000|Overall Study|Study prematuely terminated.|166|||
126412603|NCT01364389|454803879|FG000|Overall Study|Withdrawal by Subject|0|||
126412604|NCT01364389|454803880|FG001|Overall Study|Withdrawal by Subject|1|||
126412605|NCT01364389|454803881|FG002|Overall Study|Withdrawal by Subject|0|||
126412606|NCT01364389|454803879|FG000|Overall Study|Protocol deviation|0|||
126412607|NCT01364389|454803880|FG001|Overall Study|Protocol deviation|0|||
126412608|NCT01364389|454803881|FG002|Overall Study|Protocol deviation|1|||
126412609|NCT01364389|454803879|FG000|Overall Study|Administrative problems|1|||
126412610|NCT01364389|454803880|FG001|Overall Study|Administrative problems|0|||
126412611|NCT01364389|454803881|FG002|Overall Study|Administrative problems|0|||
126412612|NCT01364389|454803879|FG000|Overall Study|Adverse Event|1|||
126412613|NCT01364389|454803880|FG001|Overall Study|Adverse Event|0|||
126412614|NCT01364389|454803881|FG002|Overall Study|Adverse Event|0|||
126412615|NCT02687581|454803882|FG000|Overall Study|Withdrawal by Subject|1|||
126412616|NCT02687581|454803883|FG001|Overall Study|Withdrawal by Subject|0|||
126412617|NCT02687581|454803884|FG002|Overall Study|Withdrawal by Subject|0|||
126412618|NCT02687581|454803885|FG003|Overall Study|Withdrawal by Subject|1|||
126412619|NCT02687581|454803882|FG000|Overall Study|Lost to Follow-up|2|||
126412620|NCT02687581|454803883|FG001|Overall Study|Lost to Follow-up|2|||
126412621|NCT02687581|454803884|FG002|Overall Study|Lost to Follow-up|0|||
126412622|NCT02687581|454803885|FG003|Overall Study|Lost to Follow-up|0|||
126412623|NCT02687581|454803882|FG000|Overall Study|the device is too small for the patient.|1|||
126412624|NCT02687581|454803883|FG001|Overall Study|the device is too small for the patient.|0|||
126412625|NCT02687581|454803884|FG002|Overall Study|the device is too small for the patient.|0|||
126412626|NCT02687581|454803885|FG003|Overall Study|the device is too small for the patient.|0|||
126412627|NCT00991406|454803898|FG000|Overall Study|One participant did not respond to FES.|1|||
126412628|NCT02160145|454803899|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
126412629|NCT02160145|454803900|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
126412630|NCT02160145|454803901|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
126412631|NCT02160145|454803899|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
126412632|NCT02160145|454803900|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
126412633|NCT02160145|454803901|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
126412634|NCT02160145|454803899|FG000|Randomized Double-blind Period|Subject decision|0|||
126412635|NCT02160145|454803900|FG001|Randomized Double-blind Period|Subject decision|21|||
126412636|NCT02160145|454803901|FG002|Randomized Double-blind Period|Subject decision|20|||
126412637|NCT02160145|454803899|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
126412638|NCT02160145|454803900|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
126412639|NCT02160145|454803901|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
126412640|NCT02160145|454803899|FG000|Randomized Double-blind Period|Physician Decision|0|||
126412641|NCT02160145|454803900|FG001|Randomized Double-blind Period|Physician Decision|7|||
126412642|NCT02160145|454803901|FG002|Randomized Double-blind Period|Physician Decision|5|||
126412643|NCT03597061|454803902|FG000|Overall Study|Lost to Follow-up|1|||
126412644|NCT03597061|454803903|FG001|Overall Study|Lost to Follow-up|0|||
126412645|NCT03597061|454803902|FG000|Overall Study|Protocol Violation|0|||
126412646|NCT03597061|454803903|FG001|Overall Study|Protocol Violation|1|||
126412647|NCT00375518|454803904|FG000|Overall Study|Withdrawal by Subject|2|||
126412648|NCT00375518|454803905|FG001|Overall Study|Withdrawal by Subject|10|||
126412649|NCT00375518|454803904|FG000|Overall Study|Patient Not Treated|6|||
126412650|NCT00375518|454803905|FG001|Overall Study|Patient Not Treated|6|||
126412651|NCT00375518|454803904|FG000|Overall Study|Death|0|||
126412652|NCT00375518|454803905|FG001|Overall Study|Death|1|||
126412653|NCT04699461|454803906|FG000|Overall Study|Withdrawal by Subject|1|||
126412654|NCT04699461|454803907|FG001|Overall Study|Withdrawal by Subject|0|||
126412655|NCT04699461|454803906|FG000|Overall Study|Study termination by sponsor|2|||
126412656|NCT04699461|454803907|FG001|Overall Study|Study termination by sponsor|1|||
126412657|NCT04699461|454803906|FG000|Overall Study|Death|1|||
126412658|NCT04699461|454803907|FG001|Overall Study|Death|0|||
126412659|NCT04699461|454803906|FG000|Overall Study|Radiographic progression|0|||
126412660|NCT04699461|454803907|FG001|Overall Study|Radiographic progression|1|||
126412661|NCT03068767|454803908|FG000|Overall Study|Lost to Follow-up|7|||
126412662|NCT03068767|454803909|FG001|Overall Study|Lost to Follow-up|3|||
126412663|NCT03068767|454803908|FG000|Overall Study|Protocol Violation|3|||
126412664|NCT03068767|454803909|FG001|Overall Study|Protocol Violation|0|||
126412665|NCT02301624|454803910|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
126412666|NCT02301624|454803911|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
126412667|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
126412668|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
126412669|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Adverse Event|2|||
126412670|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Adverse Event|5|||
126412671|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Physician Decision|3|||
126412672|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Physician Decision|3|||
126412673|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Death|2|||
126412674|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Death|1|||
126412675|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
126412676|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
126412677|NCT00895310|454803912|FG000|Overall Study|Withdrawal by Subject|1|||
126412678|NCT03077919|454805722|FG000|Overall Study|Lost to Follow-up|4|||
126412679|NCT03077919|454805723|FG001|Overall Study|Lost to Follow-up|1|||
126412680|NCT01031979|454805726|FG000|Overall Study|Lost to Follow-up|5|||
126412681|NCT01031979|454805727|FG001|Overall Study|Lost to Follow-up|4|||
126412682|NCT03592368|454805729|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
126412683|NCT03592368|454805730|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
126412684|NCT03592368|454805731|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
126412685|NCT03592368|454805732|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
126412686|NCT03592368|454805729|FG000|Overall Study|Adverse Event|0|||
126412687|NCT03592368|454805730|FG001|Overall Study|Adverse Event|0|||
126412688|NCT03592368|454805731|FG002|Overall Study|Adverse Event|0|||
126412689|NCT03592368|454805732|FG003|Overall Study|Adverse Event|1|||
126412690|NCT03592368|454805729|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
126412691|NCT03592368|454805730|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
126412692|NCT03592368|454805731|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
126412693|NCT03592368|454805732|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
126412694|NCT03831100|454805733|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
126412695|NCT03831100|454805734|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
126412696|NCT01618695|454805741|FG000|Core Phase|Adverse Event|4|||
126412697|NCT01618695|454805742|FG001|Core Phase|Adverse Event|5|||
126412698|NCT01618695|454805743|FG002|Core Phase|Adverse Event|15|||
126412699|NCT01618695|454805744|FG003|Core Phase|Adverse Event|20|||
126412700|NCT01618695|454805741|FG000|Core Phase|Lost to Follow-up|0|||
126412701|NCT01618695|454805742|FG001|Core Phase|Lost to Follow-up|0|||
126412702|NCT01618695|454805743|FG002|Core Phase|Lost to Follow-up|1|||
126412703|NCT01618695|454805744|FG003|Core Phase|Lost to Follow-up|0|||
126412704|NCT01618695|454805741|FG000|Core Phase|Withdrawal by Subject|16|||
126412705|NCT01618695|454805742|FG001|Core Phase|Withdrawal by Subject|11|||
126412706|NCT01618695|454805743|FG002|Core Phase|Withdrawal by Subject|9|||
126412707|NCT01618695|454805744|FG003|Core Phase|Withdrawal by Subject|13|||
126412708|NCT01618695|454805741|FG000|Core Phase|Pregnancy|2|||
126412709|NCT01618695|454805742|FG001|Core Phase|Pregnancy|0|||
126412710|NCT01618695|454805743|FG002|Core Phase|Pregnancy|0|||
126412711|NCT01618695|454805744|FG003|Core Phase|Pregnancy|0|||
126412712|NCT01618695|454805741|FG000|Core Phase|Lack of Efficacy|1|||
126412713|NCT01618695|454805742|FG001|Core Phase|Lack of Efficacy|2|||
126412714|NCT01618695|454805743|FG002|Core Phase|Lack of Efficacy|1|||
126412715|NCT01618695|454805744|FG003|Core Phase|Lack of Efficacy|1|||
126412716|NCT01618695|454805741|FG000|Core Phase|Other than specified|1|||
126412717|NCT01618695|454805742|FG001|Core Phase|Other than specified|2|||
126412718|NCT01618695|454805743|FG002|Core Phase|Other than specified|2|||
126412719|NCT01618695|454805744|FG003|Core Phase|Other than specified|2|||
126412720|NCT01618695|454805741|FG000|Core Phase|Not treated|1|||
126412721|NCT01618695|454805742|FG001|Core Phase|Not treated|0|||
126412722|NCT01618695|454805743|FG002|Core Phase|Not treated|2|||
126412723|NCT01618695|454805744|FG003|Core Phase|Not treated|0|||
126412724|NCT01618695|454805741|FG000|Extension Phase|Lack of Efficacy|17|||
126412725|NCT01618695|454805742|FG001|Extension Phase|Lack of Efficacy|33|||
126412726|NCT01618695|454805743|FG002|Extension Phase|Lack of Efficacy|26|||
126412727|NCT01618695|454805744|FG003|Extension Phase|Lack of Efficacy|24|||
126412728|NCT01618695|454805741|FG000|Extension Phase|Pregnancy|2|||
126412729|NCT01618695|454805742|FG001|Extension Phase|Pregnancy|0|||
126412730|NCT01618695|454805743|FG002|Extension Phase|Pregnancy|1|||
126412731|NCT01618695|454805744|FG003|Extension Phase|Pregnancy|1|||
126412732|NCT01618695|454805741|FG000|Extension Phase|Withdrawal by Subject|43|||
126412733|NCT01618695|454805742|FG001|Extension Phase|Withdrawal by Subject|48|||
126412734|NCT01618695|454805743|FG002|Extension Phase|Withdrawal by Subject|42|||
126412735|NCT01618695|454805744|FG003|Extension Phase|Withdrawal by Subject|33|||
126412736|NCT01618695|454805741|FG000|Extension Phase|Adverse Event|18|||
126412737|NCT01618695|454805742|FG001|Extension Phase|Adverse Event|16|||
126412738|NCT01618695|454805743|FG002|Extension Phase|Adverse Event|9|||
126412739|NCT01618695|454805744|FG003|Extension Phase|Adverse Event|20|||
126412740|NCT01618695|454805741|FG000|Extension Phase|Lost to Follow-up|2|||
126412741|NCT01618695|454805742|FG001|Extension Phase|Lost to Follow-up|1|||
126412742|NCT01618695|454805743|FG002|Extension Phase|Lost to Follow-up|1|||
126412743|NCT01618695|454805744|FG003|Extension Phase|Lost to Follow-up|1|||
126412744|NCT01618695|454805741|FG000|Extension Phase|Other than specified|13|||
126412745|NCT01618695|454805742|FG001|Extension Phase|Other than specified|18|||
126412746|NCT01618695|454805743|FG002|Extension Phase|Other than specified|13|||
126412747|NCT01618695|454805744|FG003|Extension Phase|Other than specified|18|||
126412748|NCT02454478|454805746|FG000|Overall Study|Incomplete DLT Evaluation|1|||
126412749|NCT02950480|454805755|FG000|Overall Study|Withdrawal by Subject|1|||
126412750|NCT02950480|454805756|FG001|Overall Study|Withdrawal by Subject|0|||
126412751|NCT03229109|454805761|FG000|Overall Study|Withdrawal by Subject|0|||
126412752|NCT03229109|454805762|FG001|Overall Study|Withdrawal by Subject|0|||
126412753|NCT03229109|454805763|FG002|Overall Study|Withdrawal by Subject|0|||
126412754|NCT03229109|454805764|FG003|Overall Study|Withdrawal by Subject|1|||
126412755|NCT04207749|454805765|FG000|Overall Study|Lost to Follow-up|0|||
126412756|NCT04207749|454805766|FG001|Overall Study|Lost to Follow-up|2|||
126412757|NCT04207749|454805765|FG000|Overall Study|Protocol Violation|0|||
125890846|NCT01175083|452899618|FG005|Primary Epoch|Lost to Follow-up|1|||
126412758|NCT04207749|454805766|FG001|Overall Study|Protocol Violation|1|||
126412759|NCT04207749|454805765|FG000|Overall Study|Withdrawal by Subject|3|||
126412760|NCT04207749|454805766|FG001|Overall Study|Withdrawal by Subject|0|||
126412761|NCT04207749|454805765|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
126412762|NCT04207749|454805766|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
126054155|NCT00683800|453492225|FG001|Overall Study|Other|2|||
126412763|NCT01835223|454805767|FG000|Overall Study|Adverse Event|1|||
126412764|NCT01835223|454805768|FG001|Overall Study|Adverse Event|0|||
126412765|NCT01835223|454805767|FG000|Overall Study|Withdrawal by Subject|2|||
126412766|NCT01835223|454805768|FG001|Overall Study|Withdrawal by Subject|0|||
125890847|NCT01175083|452899613|FG000|Booster Epoch|Death|0|||
125890848|NCT01175083|452899614|FG001|Booster Epoch|Death|0|||
125890849|NCT01175083|452899615|FG002|Booster Epoch|Death|1|||
125890850|NCT01175083|452899616|FG003|Booster Epoch|Death|0|||
125890851|NCT01175083|452899617|FG004|Booster Epoch|Death|0|||
125890852|NCT01175083|452899618|FG005|Booster Epoch|Death|0|||
125890853|NCT01175083|452899613|FG000|Booster Epoch|Withdrawal by Subject|0|||
125890854|NCT01175083|452899614|FG001|Booster Epoch|Withdrawal by Subject|0|||
125890855|NCT01175083|452899615|FG002|Booster Epoch|Withdrawal by Subject|0|||
125890856|NCT01175083|452899616|FG003|Booster Epoch|Withdrawal by Subject|1|||
125890857|NCT01175083|452899617|FG004|Booster Epoch|Withdrawal by Subject|0|||
126054156|NCT00683800|453492224|FG000|Overall Study|Protocol Violation|13|||
125890858|NCT01175083|452899618|FG005|Booster Epoch|Withdrawal by Subject|0|||
125890859|NCT00475306|452899619|FG000|Overall Study|Protocol Violation|1|||
125890860|NCT00475306|452899620|FG001|Overall Study|Protocol Violation|1|||
125890861|NCT00475306|452899621|FG002|Overall Study|Protocol Violation|0|||
125890862|NCT00475306|452899622|FG003|Overall Study|Protocol Violation|1|||
125890863|NCT01716052|452899623|FG000|Overall Study|Withdrawal of funding|1|||
125890864|NCT01716052|452899624|FG001|Overall Study|Withdrawal of funding|1|||
125890865|NCT02405442|452899625|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
125890866|NCT02405442|452899626|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
125890867|NCT02405442|452899627|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
125890868|NCT02405442|452899628|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
125890869|NCT02405442|452899625|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
125890870|NCT02405442|452899626|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
125890871|NCT02405442|452899627|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
126412767|NCT01835223|454805767|FG000|Overall Study|Disease progression|2|||
126412768|NCT01835223|454805768|FG001|Overall Study|Disease progression|1|||
126412769|NCT01835223|454805767|FG000|Overall Study|Became Inelligible|4|||
126412770|NCT01835223|454805768|FG001|Overall Study|Became Inelligible|0|||
126412771|NCT01504841|454805769|FG000|Overall Study|Withdrawal by Subject|1|||
126412772|NCT01504841|454805770|FG001|Overall Study|Withdrawal by Subject|1|||
126412773|NCT01504841|454805771|FG002|Overall Study|Withdrawal by Subject|0|||
126412774|NCT01610336|454805772|FG000|Overall Study|Progressive Disease|4|||
126412775|NCT01610336|454805773|FG001|Overall Study|Progressive Disease|6|||
126412776|NCT01610336|454805774|FG002|Overall Study|Progressive Disease|6|||
126412777|NCT01610336|454805775|FG003|Overall Study|Progressive Disease|5|||
126412778|NCT01610336|454805776|FG004|Overall Study|Progressive Disease|3|||
126412779|NCT01610336|454805777|FG005|Overall Study|Progressive Disease|10|||
126412780|NCT01610336|454805778|FG006|Overall Study|Progressive Disease|1|||
126412781|NCT01610336|454805779|FG007|Overall Study|Progressive Disease|6|||
126412782|NCT01610336|454805780|FG008|Overall Study|Progressive Disease|6|||
126412783|NCT01610336|454805781|FG009|Overall Study|Progressive Disease|40|||
126412784|NCT01610336|454805782|FG010|Overall Study|Progressive Disease|36|||
126412785|NCT01610336|454805772|FG000|Overall Study|Adverse Event|0|||
126412786|NCT01610336|454805773|FG001|Overall Study|Adverse Event|0|||
126412787|NCT01610336|454805774|FG002|Overall Study|Adverse Event|0|||
126412788|NCT01610336|454805775|FG003|Overall Study|Adverse Event|1|||
126412789|NCT01610336|454805776|FG004|Overall Study|Adverse Event|1|||
126412790|NCT01610336|454805777|FG005|Overall Study|Adverse Event|1|||
126412791|NCT01610336|454805778|FG006|Overall Study|Adverse Event|0|||
126412792|NCT01610336|454805779|FG007|Overall Study|Adverse Event|0|||
126412793|NCT01610336|454805780|FG008|Overall Study|Adverse Event|2|||
126412794|NCT01610336|454805781|FG009|Overall Study|Adverse Event|8|||
126412795|NCT01610336|454805782|FG010|Overall Study|Adverse Event|6|||
126412796|NCT01610336|454805772|FG000|Overall Study|Subject/Guardian decision|1|||
126412797|NCT01610336|454805773|FG001|Overall Study|Subject/Guardian decision|1|||
126412798|NCT01610336|454805774|FG002|Overall Study|Subject/Guardian decision|0|||
126412799|NCT01610336|454805775|FG003|Overall Study|Subject/Guardian decision|1|||
126412800|NCT01610336|454805776|FG004|Overall Study|Subject/Guardian decision|0|||
126412801|NCT01610336|454805777|FG005|Overall Study|Subject/Guardian decision|0|||
126412802|NCT01610336|454805778|FG006|Overall Study|Subject/Guardian decision|0|||
126412803|NCT01610336|454805779|FG007|Overall Study|Subject/Guardian decision|1|||
126412804|NCT01610336|454805780|FG008|Overall Study|Subject/Guardian decision|0|||
126412805|NCT01610336|454805781|FG009|Overall Study|Subject/Guardian decision|2|||
126412806|NCT01610336|454805782|FG010|Overall Study|Subject/Guardian decision|2|||
126412807|NCT01610336|454805772|FG000|Overall Study|Death|0|||
126412808|NCT01610336|454805773|FG001|Overall Study|Death|0|||
126412809|NCT01610336|454805774|FG002|Overall Study|Death|0|||
126412810|NCT01610336|454805775|FG003|Overall Study|Death|0|||
126412811|NCT01610336|454805776|FG004|Overall Study|Death|0|||
126412812|NCT01610336|454805777|FG005|Overall Study|Death|1|||
126412813|NCT01610336|454805778|FG006|Overall Study|Death|3|||
126412814|NCT01610336|454805779|FG007|Overall Study|Death|0|||
126412815|NCT01610336|454805780|FG008|Overall Study|Death|0|||
126412816|NCT01610336|454805781|FG009|Overall Study|Death|1|||
126412817|NCT01610336|454805782|FG010|Overall Study|Death|2|||
126412818|NCT01610336|454805772|FG000|Overall Study|Non-Compliance with study treatment|0|||
126412819|NCT01610336|454805773|FG001|Overall Study|Non-Compliance with study treatment|0|||
126412820|NCT01610336|454805774|FG002|Overall Study|Non-Compliance with study treatment|0|||
126412821|NCT01610336|454805775|FG003|Overall Study|Non-Compliance with study treatment|0|||
126412822|NCT01610336|454805776|FG004|Overall Study|Non-Compliance with study treatment|0|||
126412823|NCT01610336|454805777|FG005|Overall Study|Non-Compliance with study treatment|0|||
126054157|NCT00683800|453492225|FG001|Overall Study|Protocol Violation|16|||
126054158|NCT00683800|453492224|FG000|Overall Study|Withdrawal by Subject|66|||
126054159|NCT00683800|453492225|FG001|Overall Study|Withdrawal by Subject|64|||
126412824|NCT01610336|454805778|FG006|Overall Study|Non-Compliance with study treatment|0|||
126412825|NCT01610336|454805779|FG007|Overall Study|Non-Compliance with study treatment|0|||
126412826|NCT01610336|454805780|FG008|Overall Study|Non-Compliance with study treatment|0|||
126412827|NCT01610336|454805781|FG009|Overall Study|Non-Compliance with study treatment|1|||
126412828|NCT01610336|454805782|FG010|Overall Study|Non-Compliance with study treatment|0|||
126412829|NCT01610336|454805772|FG000|Overall Study|Physician Decision|0|||
126412830|NCT01610336|454805773|FG001|Overall Study|Physician Decision|0|||
126412831|NCT01610336|454805774|FG002|Overall Study|Physician Decision|0|||
126412832|NCT01610336|454805775|FG003|Overall Study|Physician Decision|0|||
126412833|NCT01610336|454805776|FG004|Overall Study|Physician Decision|0|||
126412834|NCT01610336|454805777|FG005|Overall Study|Physician Decision|0|||
126412835|NCT01610336|454805778|FG006|Overall Study|Physician Decision|1|||
125890872|NCT02405442|452899628|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
125890873|NCT02405442|452899625|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
125890874|NCT02405442|452899626|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
126412836|NCT01610336|454805779|FG007|Overall Study|Physician Decision|0|||
126412837|NCT01610336|454805780|FG008|Overall Study|Physician Decision|0|||
126412838|NCT01610336|454805781|FG009|Overall Study|Physician Decision|0|||
126412839|NCT01610336|454805782|FG010|Overall Study|Physician Decision|0|||
126412840|NCT01610336|454805772|FG000|Overall Study|Protocol Deviation|0|||
126412841|NCT01610336|454805773|FG001|Overall Study|Protocol Deviation|0|||
126412842|NCT01610336|454805774|FG002|Overall Study|Protocol Deviation|0|||
126412843|NCT01610336|454805775|FG003|Overall Study|Protocol Deviation|0|||
126412844|NCT01610336|454805776|FG004|Overall Study|Protocol Deviation|0|||
126412845|NCT01610336|454805777|FG005|Overall Study|Protocol Deviation|0|||
126412846|NCT01610336|454805778|FG006|Overall Study|Protocol Deviation|0|||
126412847|NCT01610336|454805779|FG007|Overall Study|Protocol Deviation|0|||
126412848|NCT01610336|454805780|FG008|Overall Study|Protocol Deviation|0|||
126412849|NCT01610336|454805781|FG009|Overall Study|Protocol Deviation|1|||
126412850|NCT01610336|454805782|FG010|Overall Study|Protocol Deviation|0|||
126412851|NCT01610336|454805772|FG000|Overall Study|Transfer to another trial|0|||
126412852|NCT01610336|454805773|FG001|Overall Study|Transfer to another trial|0|||
126412853|NCT01610336|454805774|FG002|Overall Study|Transfer to another trial|0|||
126412854|NCT01610336|454805775|FG003|Overall Study|Transfer to another trial|0|||
126412855|NCT01610336|454805776|FG004|Overall Study|Transfer to another trial|0|||
126412856|NCT01610336|454805777|FG005|Overall Study|Transfer to another trial|0|||
126412857|NCT01610336|454805778|FG006|Overall Study|Transfer to another trial|0|||
126412858|NCT01610336|454805779|FG007|Overall Study|Transfer to another trial|0|||
126412859|NCT01610336|454805780|FG008|Overall Study|Transfer to another trial|0|||
126412860|NCT01610336|454805781|FG009|Overall Study|Transfer to another trial|0|||
126412861|NCT01610336|454805782|FG010|Overall Study|Transfer to another trial|1|||
126412862|NCT03679624|454805783|FG000|Overall Study|Adverse Event|1|||
126412863|NCT03679624|454805784|FG001|Overall Study|Adverse Event|0|||
126412864|NCT01559675|454805787|FG000|Overall Study|Protocol Violation|1|||
126412865|NCT01559675|454805788|FG001|Overall Study|Protocol Violation|2|||
126412866|NCT01559675|454805787|FG000|Overall Study|2nd operation on same patient excluded|14|||
126412867|NCT01559675|454805788|FG001|Overall Study|2nd operation on same patient excluded|12|||
126412868|NCT01496469|454805789|FG000|Overall Study|Adverse Event|1|||
126412869|NCT01496469|454805790|FG001|Overall Study|Adverse Event|0|||
126412870|NCT01496469|454805789|FG000|Overall Study|Protocol Violation|2|||
126412871|NCT01496469|454805790|FG001|Overall Study|Protocol Violation|0|||
126412872|NCT01496469|454805789|FG000|Overall Study|Lost to Follow-up|1|||
126412873|NCT01496469|454805790|FG001|Overall Study|Lost to Follow-up|1|||
126412874|NCT01496469|454805789|FG000|Overall Study|Withdrawal by Subject|4|||
126412875|NCT01496469|454805790|FG001|Overall Study|Withdrawal by Subject|4|||
126412876|NCT01496469|454805789|FG000|Overall Study|BP exceeds protocol limits|1|||
126412877|NCT01496469|454805790|FG001|Overall Study|BP exceeds protocol limits|2|||
126412878|NCT01496469|454805789|FG000|Overall Study|Other|1|||
126412879|NCT01496469|454805790|FG001|Overall Study|Other|1|||
126412880|NCT00291018|454805791|FG000|Overall Study|Not Consented or Declined PAS|12|||
126412881|NCT00291018|454805792|FG001|Overall Study|Not Consented or Declined PAS|15|||
126412882|NCT00291018|454805793|FG002|Overall Study|Not Consented or Declined PAS|15|||
126412883|NCT00291018|454805791|FG000|Overall Study|Death|3|||
126412884|NCT00291018|454805792|FG001|Overall Study|Death|3|||
126412885|NCT00291018|454805793|FG002|Overall Study|Death|4|||
126412886|NCT00291018|454805791|FG000|Overall Study|Withdrawal by Subject|2|||
125890875|NCT02405442|452899627|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
126412887|NCT00291018|454805792|FG001|Overall Study|Withdrawal by Subject|8|||
126412888|NCT00291018|454805793|FG002|Overall Study|Withdrawal by Subject|1|||
126412889|NCT00291018|454805791|FG000|Overall Study|Failures|5|||
126412890|NCT00291018|454805792|FG001|Overall Study|Failures|12|||
126412891|NCT00291018|454805793|FG002|Overall Study|Failures|5|||
126412892|NCT00291018|454805791|FG000|Overall Study|Lost to Follow-up|3|||
126412893|NCT00291018|454805792|FG001|Overall Study|Lost to Follow-up|4|||
126412894|NCT00291018|454805793|FG002|Overall Study|Lost to Follow-up|18|||
126412895|NCT00630344|454805794|FG000|Overall Study|Adverse Event|5|||
126412896|NCT00630344|454805794|FG000|Overall Study|Progressive Disease|19|||
126412897|NCT00630344|454805794|FG000|Overall Study|Physician Decision|9|||
126412898|NCT00630344|454805794|FG000|Overall Study|Withdrawal by Subject|1|||
126412899|NCT00630344|454805794|FG000|Overall Study|Intercurrent Illness|1|||
126412900|NCT00630344|454805794|FG000|Overall Study|Other|1|||
126412901|NCT01357551|454805795|FG000|Overall Study|Withdrawal by Subject|6|||
126412902|NCT01357551|454805796|FG001|Overall Study|Withdrawal by Subject|4|||
126412903|NCT01357551|454805795|FG000|Overall Study|Death|0|||
126412904|NCT01357551|454805796|FG001|Overall Study|Death|1|||
126412905|NCT01357551|454805795|FG000|Overall Study|Lost to Follow-up|16|||
126412906|NCT01357551|454805796|FG001|Overall Study|Lost to Follow-up|6|||
126412907|NCT00413036|454805797|FG000|Overall Study|Adverse Event|44|||
126412908|NCT00413036|454805797|FG000|Overall Study|Lack of Efficacy|129|||
126412909|NCT00413036|454805797|FG000|Overall Study|Withdrawal by Subject|7|||
126412910|NCT00413036|454805797|FG000|Overall Study|Death|9|||
126412911|NCT00413036|454805797|FG000|Overall Study|Other|26|||
126412912|NCT00413036|454805797|FG000|Overall Study|Missing|2|||
126412913|NCT01369641|454805798|FG000|Overall Study|Withdrawal by Subject|1|||
126412914|NCT00842543|454805799|FG000|Overall Study|Withdrawal by Subject|2|||
126412915|NCT00842543|454805800|FG001|Overall Study|Withdrawal by Subject|0|||
126412916|NCT00842543|454805801|FG002|Overall Study|Withdrawal by Subject|3|||
126412917|NCT00842543|454805802|FG003|Overall Study|Withdrawal by Subject|4|||
126412918|NCT01483183|454805807|FG000|Overall Study|Physician Decision|0|||
126412919|NCT01483183|454805808|FG001|Overall Study|Physician Decision|0|||
126412920|NCT01483183|454805809|FG002|Overall Study|Physician Decision|0|||
126412921|NCT01483183|454805810|FG003|Overall Study|Physician Decision|0|||
126412922|NCT01483183|454805811|FG004|Overall Study|Physician Decision|0|||
126412923|NCT01483183|454805812|FG005|Overall Study|Physician Decision|0|||
126412924|NCT01483183|454805813|FG006|Overall Study|Physician Decision|2|||
126412925|NCT01483183|454805814|FG007|Overall Study|Physician Decision|0|||
126412926|NCT01483183|454805815|FG008|Overall Study|Physician Decision|0|||
126412927|NCT01483183|454805816|FG009|Overall Study|Physician Decision|0|||
126412928|NCT01483183|454805807|FG000|Overall Study|Withdrawal by Subject|0|||
126412929|NCT01483183|454805808|FG001|Overall Study|Withdrawal by Subject|0|||
126412930|NCT01483183|454805809|FG002|Overall Study|Withdrawal by Subject|0|||
126412931|NCT01483183|454805810|FG003|Overall Study|Withdrawal by Subject|0|||
126412932|NCT01483183|454805811|FG004|Overall Study|Withdrawal by Subject|0|||
126412933|NCT01483183|454805812|FG005|Overall Study|Withdrawal by Subject|0|||
126412934|NCT01483183|454805813|FG006|Overall Study|Withdrawal by Subject|0|||
126412935|NCT01483183|454805814|FG007|Overall Study|Withdrawal by Subject|0|||
126412936|NCT01483183|454805815|FG008|Overall Study|Withdrawal by Subject|0|||
126412937|NCT01483183|454805816|FG009|Overall Study|Withdrawal by Subject|1|||
126412938|NCT02524158|454805818|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
126412939|NCT02524158|454805819|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
126412940|NCT02524158|454805818|FG000|12-weeks Assessment|Lost to Follow-up|18|||
126412941|NCT02524158|454805819|FG001|12-weeks Assessment|Lost to Follow-up|12|||
126412942|NCT02524158|454805818|FG000|6-month Assessment|Withdrawal by Subject|1|||
126412943|NCT02524158|454805819|FG001|6-month Assessment|Withdrawal by Subject|1|||
126412944|NCT02524158|454805818|FG000|6-month Assessment|Lost to Follow-up|21|||
126412945|NCT02524158|454805819|FG001|6-month Assessment|Lost to Follow-up|20|||
126412946|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412947|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412948|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
126412949|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
126412950|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
126412951|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412952|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
126412953|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
126412954|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
126412955|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412956|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412957|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412958|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412959|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
126412960|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
126412961|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
126412962|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
126412963|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
126412964|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
126412965|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
126412966|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
126412967|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
126412968|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
126412969|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
126412970|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
126412971|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
126412972|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412973|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
126412974|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
126412975|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412976|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412977|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
126412978|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
126412979|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412980|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412981|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412982|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412983|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412984|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412985|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412986|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
126412987|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
126412988|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412989|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125890876|NCT02405442|452899628|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
125890877|NCT02405442|452899625|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125890878|NCT02405442|452899626|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
125890879|NCT02405442|452899627|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125890880|NCT02405442|452899628|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125890881|NCT02405442|452899625|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
125890882|NCT02405442|452899626|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
125890883|NCT02405442|452899627|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
125890884|NCT02405442|452899628|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
125890885|NCT02405442|452899625|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
125890886|NCT02405442|452899626|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
126054160|NCT00683800|453492224|FG000|Overall Study|Lack of Efficacy|61|||
126054161|NCT00683800|453492225|FG001|Overall Study|Lack of Efficacy|104|||
125890887|NCT02405442|452899627|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
125890888|NCT02405442|452899628|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
126054162|NCT00683800|453492224|FG000|Overall Study|Randomized, not treated|35|||
125890889|NCT02405442|452899625|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
125890890|NCT02405442|452899626|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
125890891|NCT02405442|452899627|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
125890892|NCT02405442|452899628|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
126412990|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412991|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
126412992|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412993|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
126412994|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412995|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412996|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412997|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412998|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126412999|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413000|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413001|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
126413002|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413003|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413004|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413005|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
126413006|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413007|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413008|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413009|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413010|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413011|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413012|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413013|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413014|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
126413015|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413016|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413017|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
126413018|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413019|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413020|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413021|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413022|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413023|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413024|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413025|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
126413026|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413027|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413028|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413029|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413030|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413031|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413032|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413033|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413034|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413035|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413036|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413037|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
126413038|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413039|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413040|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413041|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413042|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413043|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413044|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413045|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413046|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413047|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413048|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413049|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413050|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413051|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413052|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413053|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413054|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413055|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125890893|NCT02405442|452899625|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
125890894|NCT02405442|452899626|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
126413056|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
125890895|NCT02405442|452899627|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
125890896|NCT02405442|452899628|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
125890897|NCT02405442|452899625|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125890898|NCT02405442|452899626|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
125890899|NCT02405442|452899627|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125890900|NCT02405442|452899628|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125890901|NCT02405442|452899625|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125890902|NCT02405442|452899626|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
125890903|NCT02405442|452899627|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125890904|NCT02405442|452899628|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125890905|NCT02405442|452899625|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125890906|NCT02405442|452899626|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
125890907|NCT02405442|452899627|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125890908|NCT02405442|452899628|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125890909|NCT02405442|452899625|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125890910|NCT02405442|452899626|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
125890911|NCT02405442|452899627|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125890912|NCT02405442|452899628|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125890913|NCT02405442|452899625|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125890914|NCT02405442|452899626|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
125890915|NCT02405442|452899627|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125890916|NCT02405442|452899628|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125890917|NCT02405442|452899625|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
125890918|NCT02405442|452899626|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125890919|NCT02405442|452899627|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125890920|NCT02405442|452899628|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125890921|NCT03275350|452899630|FG000|Overall Study|Lost to Follow-up|4|||
125890922|NCT03275350|452899631|FG001|Overall Study|Lost to Follow-up|6|||
125890923|NCT03275350|452899630|FG000|Overall Study|Death|2|||
125890924|NCT03275350|452899631|FG001|Overall Study|Death|1|||
125890925|NCT03275350|452899630|FG000|Overall Study|Physician Decision|1|||
125890926|NCT03275350|452899631|FG001|Overall Study|Physician Decision|0|||
125890927|NCT03275350|452899630|FG000|Overall Study|Incarcerated|1|||
125890928|NCT03275350|452899631|FG001|Overall Study|Incarcerated|1|||
125890929|NCT00926029|452899632|FG000|Overall Study|Lost to Follow-up|2|||
125890930|NCT00926029|452899633|FG001|Overall Study|Lost to Follow-up|1|||
125890931|NCT00926029|452899634|FG002|Overall Study|Lost to Follow-up|1|||
125890932|NCT00486291|452899637|FG000|Overall Study|Adverse Event|3|||
125890933|NCT00486291|452899638|FG001|Overall Study|Adverse Event|4|||
125890934|NCT00486291|452899637|FG000|Overall Study|Lost to Follow-up|3|||
125890935|NCT00486291|452899638|FG001|Overall Study|Lost to Follow-up|7|||
125890936|NCT00486291|452899637|FG000|Overall Study|protocol non-compliance|10|||
126054163|NCT00683800|453492225|FG001|Overall Study|Randomized, not treated|33|||
126054164|NCT00205179|453492228|FG000|Overall Study|Death|0|||
126054165|NCT00205179|453492229|FG001|Overall Study|Death|2|||
126054166|NCT00205179|453492228|FG000|Overall Study|Physician Decision|1|||
126054167|NCT00205179|453492229|FG001|Overall Study|Physician Decision|1|||
126054168|NCT00205179|453492228|FG000|Overall Study|Adverse Event|1|||
126413057|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413058|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413059|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413060|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413061|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413062|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413063|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413064|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413065|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413066|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413067|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125890937|NCT00486291|452899638|FG001|Overall Study|protocol non-compliance|15|||
125890938|NCT00486291|452899637|FG000|Overall Study|requirement for restricted medication|0|||
125890939|NCT00486291|452899638|FG001|Overall Study|requirement for restricted medication|3|||
126054169|NCT00205179|453492229|FG001|Overall Study|Adverse Event|1|||
126054170|NCT00586313|453492230|FG000|Overall Study|Lack of Efficacy|2|||
126054171|NCT01700205|453492234|FG000|Overall Study|Withdrawal by Subject|13|||
126054172|NCT01700205|453492235|FG001|Overall Study|Withdrawal by Subject|13|||
126054173|NCT01700205|453492234|FG000|Overall Study|Protocol Violation|2|||
126413068|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413069|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413070|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413071|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413072|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413073|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
126413074|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
126413075|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
126413076|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413077|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413078|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413079|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413080|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413081|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413082|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413083|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413084|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413085|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413086|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
126413087|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
126413088|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413089|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413090|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413091|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413092|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413093|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413094|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413095|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413096|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413097|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413098|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
126413099|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
126413100|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413101|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
126413102|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413103|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413104|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413105|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413106|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413107|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413108|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413109|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413110|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413111|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413112|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
126413113|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413114|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413115|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413116|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413117|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413118|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413119|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413120|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413121|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413122|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413123|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413124|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413125|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413126|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413127|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
126413128|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413129|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413130|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413131|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413132|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413133|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413134|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413135|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413136|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413137|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
126413138|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413139|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413140|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413141|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
126413142|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
126413143|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
126413144|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
126413145|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Death|2|||
126413146|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Death|2|||
126413147|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Death|0|||
126413148|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Death|0|||
126413149|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
126413150|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
126413151|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
126413152|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
126413153|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
126413154|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
126413155|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
126413156|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
126413157|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
126413158|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
126413159|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
126413160|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
126413161|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
126413162|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
126413163|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
126413164|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
126413165|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
126413166|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
126413167|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
126413168|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
126413169|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
126413170|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
126413171|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
126413172|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
126413173|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
126413174|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
126413175|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
126413176|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
126413177|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Death|0|||
126413178|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Death|0|||
126413179|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Death|0|||
126413180|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Death|1|||
126413181|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
126413182|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
126413183|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
126413184|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
126413185|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
126413186|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
125890940|NCT00126490|452899643|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
126413187|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
126413188|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
126413189|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
126413190|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
126413191|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
126413192|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
126413193|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
126413194|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
126413195|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
126413196|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
126413197|NCT02690714|454805844|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
126413198|NCT02690714|454805844|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
126413199|NCT00666965|454805845|FG000|Overall Study|Adverse Event|0|||
126413200|NCT00666965|454805846|FG001|Overall Study|Adverse Event|2|||
126413201|NCT00666965|454805847|FG002|Overall Study|Adverse Event|1|||
126413202|NCT00666965|454805848|FG003|Overall Study|Adverse Event|9|||
126413203|NCT00666965|454805845|FG000|Overall Study|Lack of Efficacy|1|||
126413204|NCT00666965|454805846|FG001|Overall Study|Lack of Efficacy|1|||
126413205|NCT00666965|454805847|FG002|Overall Study|Lack of Efficacy|0|||
126413206|NCT00666965|454805848|FG003|Overall Study|Lack of Efficacy|0|||
126413207|NCT00666965|454805845|FG000|Overall Study|Protocol Violation|0|||
126413208|NCT00666965|454805846|FG001|Overall Study|Protocol Violation|0|||
126413209|NCT00666965|454805847|FG002|Overall Study|Protocol Violation|0|||
126413210|NCT00666965|454805848|FG003|Overall Study|Protocol Violation|2|||
126413211|NCT00666965|454805845|FG000|Overall Study|Discontinuation criteria|2|||
126413212|NCT00666965|454805846|FG001|Overall Study|Discontinuation criteria|1|||
126413213|NCT00666965|454805847|FG002|Overall Study|Discontinuation criteria|1|||
126413214|NCT00666965|454805848|FG003|Overall Study|Discontinuation criteria|2|||
126413215|NCT00666965|454805845|FG000|Overall Study|Withdrawal by Subject|0|||
126413216|NCT00666965|454805846|FG001|Overall Study|Withdrawal by Subject|0|||
126413217|NCT00666965|454805847|FG002|Overall Study|Withdrawal by Subject|0|||
126413218|NCT00666965|454805848|FG003|Overall Study|Withdrawal by Subject|2|||
126413219|NCT02202538|454805852|FG000|Overall Study|Withdrawal by Subject|5|||
126413220|NCT02202538|454805852|FG000|Overall Study|Did not meet all inclusion criteria|2|||
126413221|NCT02202538|454805852|FG000|Overall Study|Investigator Decision|1|||
126413222|NCT01853878|454805853|FG000|Overall Study|Recurrence|2|||
126413223|NCT01853878|454805854|FG001|Overall Study|Recurrence|0|||
126413224|NCT01853878|454805853|FG000|Overall Study|Adverse Event|2|||
126413225|NCT01853878|454805854|FG001|Overall Study|Adverse Event|0|||
126413226|NCT01853878|454805853|FG000|Overall Study|Withdrawal by Subject|3|||
126413227|NCT01853878|454805854|FG001|Overall Study|Withdrawal by Subject|1|||
126413228|NCT01853878|454805853|FG000|Overall Study|Migrated/moved from the study area|1|||
126413229|NCT01853878|454805854|FG001|Overall Study|Migrated/moved from the study area|0|||
126413230|NCT01853878|454805853|FG000|Overall Study|Other|55|||
126413231|NCT01853878|454805854|FG001|Overall Study|Other|43|||
126413232|NCT02161757|454805855|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
125890941|NCT03051178|452899644|FG000|Overall Study|Withdrawal by Subject|5|||
126054174|NCT01700205|453492235|FG001|Overall Study|Protocol Violation|2|||
126413233|NCT02161757|454805856|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
126413234|NCT02161757|454805857|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
126413235|NCT02161757|454805855|FG000|Treatment Through Study Completion|Adverse Event|1|||
126413236|NCT02161757|454805856|FG001|Treatment Through Study Completion|Adverse Event|1|||
126413237|NCT02161757|454805857|FG002|Treatment Through Study Completion|Adverse Event|0|||
126413238|NCT02161757|454805855|FG000|Treatment Through Study Completion|Protocol Violation|0|||
126413239|NCT02161757|454805856|FG001|Treatment Through Study Completion|Protocol Violation|1|||
126413240|NCT02161757|454805857|FG002|Treatment Through Study Completion|Protocol Violation|2|||
126413241|NCT02161757|454805855|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
126413242|NCT02161757|454805856|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
126413243|NCT02161757|454805857|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
126413244|NCT02161757|454805855|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
126413245|NCT02161757|454805856|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
126413246|NCT02161757|454805857|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
126413247|NCT02161757|454805855|FG000|Treatment Through Study Completion|Other|20|||
126413248|NCT02161757|454805856|FG001|Treatment Through Study Completion|Other|19|||
126413249|NCT02161757|454805857|FG002|Treatment Through Study Completion|Other|12|||
126413250|NCT02161757|454805855|FG000|Treatment Through Study Completion|Death|2|||
126413251|NCT02161757|454805856|FG001|Treatment Through Study Completion|Death|1|||
126413252|NCT02161757|454805857|FG002|Treatment Through Study Completion|Death|1|||
126413253|NCT03916081|454805862|FG000|Overall Study|Adverse Event|1|||
126413254|NCT03916081|454805863|FG001|Overall Study|Adverse Event|0|||
126413255|NCT03916081|454805864|FG002|Overall Study|Adverse Event|0|||
126413256|NCT03916081|454805862|FG000|Overall Study|Physician Decision|0|||
126413257|NCT03916081|454805863|FG001|Overall Study|Physician Decision|0|||
126413258|NCT03916081|454805864|FG002|Overall Study|Physician Decision|1|||
126413259|NCT03916081|454805862|FG000|Overall Study|Lost to Follow-up|0|||
126413260|NCT03916081|454805863|FG001|Overall Study|Lost to Follow-up|1|||
126413261|NCT03916081|454805864|FG002|Overall Study|Lost to Follow-up|0|||
126413262|NCT03916081|454805862|FG000|Overall Study|Withdrawal by Subject|3|||
126413263|NCT03916081|454805863|FG001|Overall Study|Withdrawal by Subject|0|||
126413264|NCT03916081|454805864|FG002|Overall Study|Withdrawal by Subject|1|||
126413265|NCT03916081|454805862|FG000|Overall Study|Worsening of AD|0|||
126413266|NCT03916081|454805863|FG001|Overall Study|Worsening of AD|0|||
126413267|NCT03916081|454805864|FG002|Overall Study|Worsening of AD|1|||
126413268|NCT00465647|454805867|FG000|Overall Study|Administrative|2|||
126413269|NCT00465647|454805868|FG001|Overall Study|Administrative|2|||
126413270|NCT00465647|454805869|FG002|Overall Study|Administrative|3|||
126413271|NCT00465647|454805870|FG003|Overall Study|Administrative|2|||
126413272|NCT00465647|454805867|FG000|Overall Study|Adverse Event|2|||
126413273|NCT00465647|454805868|FG001|Overall Study|Adverse Event|0|||
126413274|NCT00465647|454805869|FG002|Overall Study|Adverse Event|3|||
126413275|NCT00465647|454805870|FG003|Overall Study|Adverse Event|2|||
126413276|NCT00465647|454805867|FG000|Overall Study|Withdrawal by Subject|1|||
126413277|NCT00465647|454805868|FG001|Overall Study|Withdrawal by Subject|2|||
126413278|NCT00465647|454805869|FG002|Overall Study|Withdrawal by Subject|2|||
126413279|NCT00465647|454805870|FG003|Overall Study|Withdrawal by Subject|7|||
126413280|NCT00465647|454805867|FG000|Overall Study|"The other reasons included loss of IV"|8|||
126413281|NCT00465647|454805868|FG001|Overall Study|"The other reasons included loss of IV"|4|||
126413282|NCT00465647|454805869|FG002|Overall Study|"The other reasons included loss of IV"|3|||
126413283|NCT00465647|454805870|FG003|Overall Study|"The other reasons included loss of IV"|2|||
126413284|NCT02891382|454805871|FG000|Overall Study|Lost to Follow-up|3|||
126413285|NCT02891382|454805872|FG001|Overall Study|Lost to Follow-up|4|||
126413286|NCT02891382|454805873|FG002|Overall Study|Lost to Follow-up|5|||
126413287|NCT02891382|454805874|FG003|Overall Study|Lost to Follow-up|3|||
126413288|NCT02891382|454805875|FG004|Overall Study|Lost to Follow-up|4|||
126413289|NCT02828020|454805878|FG000|Treatment Period|Adverse Event|3|||
126413290|NCT02828020|454805879|FG001|Treatment Period|Adverse Event|1|||
126413291|NCT02828020|454805880|FG002|Treatment Period|Adverse Event|1|||
126413292|NCT02828020|454805878|FG000|Treatment Period|Withdrawal of Consent|10|||
126413293|NCT02828020|454805879|FG001|Treatment Period|Withdrawal of Consent|14|||
126413294|NCT02828020|454805880|FG002|Treatment Period|Withdrawal of Consent|9|||
126413295|NCT02828020|454805878|FG000|Treatment Period|Lost to Follow-up|21|||
126413296|NCT02828020|454805879|FG001|Treatment Period|Lost to Follow-up|24|||
126413297|NCT02828020|454805880|FG002|Treatment Period|Lost to Follow-up|18|||
126413298|NCT02828020|454805878|FG000|Treatment Period|Lack of Qualifying Event|44|||
126413299|NCT02828020|454805879|FG001|Treatment Period|Lack of Qualifying Event|53|||
126413300|NCT02828020|454805880|FG002|Treatment Period|Lack of Qualifying Event|43|||
126413301|NCT02828020|454805878|FG000|Treatment Period|Pregnancy|0|||
126413302|NCT02828020|454805879|FG001|Treatment Period|Pregnancy|2|||
126413303|NCT02828020|454805880|FG002|Treatment Period|Pregnancy|0|||
126413304|NCT02828020|454805878|FG000|Treatment Period|Protocol Violation|2|||
126413305|NCT02828020|454805879|FG001|Treatment Period|Protocol Violation|4|||
126413306|NCT02828020|454805880|FG002|Treatment Period|Protocol Violation|7|||
126413307|NCT02828020|454805878|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
126413308|NCT02828020|454805879|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
126413309|NCT02828020|454805880|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
126413310|NCT02828020|454805878|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
126413311|NCT02828020|454805879|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
126413312|NCT02828020|454805880|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
126413313|NCT02828020|454805878|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
126413314|NCT02828020|454805879|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
126413315|NCT02828020|454805880|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
126413316|NCT02828020|454805878|FG000|Safety Follow-up Period|Protocol Violation|0|||
126413317|NCT02828020|454805879|FG001|Safety Follow-up Period|Protocol Violation|2|||
126413318|NCT02828020|454805880|FG002|Safety Follow-up Period|Protocol Violation|1|||
126413319|NCT02828020|454805878|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
126413320|NCT02828020|454805879|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
126054175|NCT02251652|453492236|FG000|Overall Study|Withdrawal by Subject|1|||
126054176|NCT00983294|453492240|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
126054177|NCT00983294|453492240|FG000|Colchicine With Azithromycin|Adverse Event|1|||
126413321|NCT02828020|454805880|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
126413322|NCT01339897|454805881|FG000|Overall Study|Adverse Event|1|||
126413323|NCT01339897|454805882|FG001|Overall Study|Adverse Event|0|||
126413324|NCT01339897|454805883|FG002|Overall Study|Adverse Event|0|||
126413325|NCT01339897|454805884|FG003|Overall Study|Adverse Event|1|||
126413326|NCT01138501|454805885|FG000|Overall Study|Protocol Violation|2|||
126413327|NCT01138501|454805885|FG000|Overall Study|Withdrawal by Subject|3|||
126413328|NCT00847197|454805888|FG000|Overall Study|Adverse Event|21|||
126413329|NCT00847197|454805889|FG001|Overall Study|Adverse Event|3|||
126413330|NCT00847197|454805888|FG000|Overall Study|Protocol Violation|0|||
126413331|NCT00847197|454805889|FG001|Overall Study|Protocol Violation|1|||
126413332|NCT00847197|454805888|FG000|Overall Study|Withdrawal by Subject|3|||
126413333|NCT00847197|454805889|FG001|Overall Study|Withdrawal by Subject|1|||
126413334|NCT00622388|454805890|FG000|Overall Study|Disease Progression|47|||
126413335|NCT00622388|454805890|FG000|Overall Study|Adverse Event|6|||
126413336|NCT00622388|454805890|FG000|Overall Study|Protocol Violation|3|||
126413337|NCT00622388|454805890|FG000|Overall Study|Participant Refusal|1|||
126413338|NCT00622388|454805890|FG000|Overall Study|Death|3|||
126413339|NCT00622388|454805890|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
126413340|NCT00622388|454805890|FG000|Overall Study|Took Prohibited Medication|2|||
126413341|NCT00622388|454805890|FG000|Overall Study|Withdrew Consent|1|||
126413342|NCT00622388|454805890|FG000|Overall Study|Insurance Expired|1|||
126413343|NCT00348309|454805891|FG000|Overall Study|Adverse Event|56|||
126413344|NCT00348309|454805892|FG001|Overall Study|Adverse Event|28|||
126413345|NCT00348309|454805893|FG002|Overall Study|Adverse Event|63|||
126413346|NCT00348309|454805891|FG000|Overall Study|Lost to Follow-up|6|||
126413347|NCT00348309|454805892|FG001|Overall Study|Lost to Follow-up|7|||
126413348|NCT00348309|454805893|FG002|Overall Study|Lost to Follow-up|4|||
126413349|NCT00348309|454805891|FG000|Overall Study|Protocol Violation|7|||
126413350|NCT00348309|454805892|FG001|Overall Study|Protocol Violation|12|||
126413351|NCT00348309|454805893|FG002|Overall Study|Protocol Violation|7|||
126413352|NCT00348309|454805891|FG000|Overall Study|Withdrawal by Subject|33|||
126413353|NCT00348309|454805892|FG001|Overall Study|Withdrawal by Subject|37|||
126413354|NCT00348309|454805893|FG002|Overall Study|Withdrawal by Subject|40|||
126413355|NCT00348309|454805891|FG000|Overall Study|Non-compliance|8|||
126413356|NCT00348309|454805892|FG001|Overall Study|Non-compliance|6|||
126413357|NCT00348309|454805893|FG002|Overall Study|Non-compliance|8|||
126413358|NCT00348309|454805891|FG000|Overall Study|Death of caregiver|1|||
126413359|NCT00348309|454805892|FG001|Overall Study|Death of caregiver|0|||
126413360|NCT00348309|454805893|FG002|Overall Study|Death of caregiver|1|||
126413361|NCT00348309|454805891|FG000|Overall Study|Lack of insight, dementia|1|||
126413362|NCT00348309|454805892|FG001|Overall Study|Lack of insight, dementia|0|||
126413363|NCT00348309|454805893|FG002|Overall Study|Lack of insight, dementia|0|||
126413364|NCT00348309|454805891|FG000|Overall Study|Wrong bottle allocated|1|||
126413365|NCT00348309|454805892|FG001|Overall Study|Wrong bottle allocated|0|||
126413366|NCT00348309|454805893|FG002|Overall Study|Wrong bottle allocated|0|||
126413367|NCT00348309|454805891|FG000|Overall Study|Caregiver sick|1|||
126413368|NCT00348309|454805892|FG001|Overall Study|Caregiver sick|0|||
126413369|NCT00348309|454805893|FG002|Overall Study|Caregiver sick|0|||
126413370|NCT00348309|454805891|FG000|Overall Study|Use of prohibited medication|5|||
126413371|NCT00348309|454805892|FG001|Overall Study|Use of prohibited medication|2|||
126413372|NCT00348309|454805893|FG002|Overall Study|Use of prohibited medication|2|||
126054178|NCT04200664|453492244|FG000|Overall Study|Withdrawal by Subject|1|||
126413373|NCT00348309|454805891|FG000|Overall Study|Caregiver withdrawal|3|||
126413374|NCT00348309|454805892|FG001|Overall Study|Caregiver withdrawal|0|||
126413375|NCT00348309|454805893|FG002|Overall Study|Caregiver withdrawal|7|||
126054179|NCT04200664|453492245|FG001|Overall Study|Withdrawal by Subject|0|||
126054180|NCT04200664|453492246|FG002|Overall Study|Withdrawal by Subject|0|||
126413376|NCT00348309|454805891|FG000|Overall Study|Unable to complete ET visit|1|||
126054181|NCT03582475|453492252|FG000|Treatment Period|Withdrawal by Subject|0|||
126054182|NCT03582475|453492253|FG001|Treatment Period|Withdrawal by Subject|1|||
126413377|NCT00348309|454805892|FG001|Overall Study|Unable to complete ET visit|0|||
126413378|NCT00348309|454805893|FG002|Overall Study|Unable to complete ET visit|0|||
126413379|NCT00348309|454805891|FG000|Overall Study|PI closing medical practice|1|||
126413380|NCT00348309|454805892|FG001|Overall Study|PI closing medical practice|0|||
126413381|NCT00348309|454805893|FG002|Overall Study|PI closing medical practice|0|||
126413382|NCT00348309|454805891|FG000|Overall Study|Principal investigator's decision|1|||
126413383|NCT00348309|454805892|FG001|Overall Study|Principal investigator's decision|0|||
126413384|NCT00348309|454805893|FG002|Overall Study|Principal investigator's decision|0|||
126413385|NCT00348309|454805891|FG000|Overall Study|No disponibility of medication|1|||
126413386|NCT00348309|454805892|FG001|Overall Study|No disponibility of medication|0|||
125890942|NCT01598506|452899645|FG000|Overall Study|Withdrawal by Subject|2|||
125890943|NCT01388335|452899648|FG000|Period 1|Progressive Disease|1|||
125890944|NCT01388335|452899648|FG000|Period 2|Progressive Disease|2|||
125890945|NCT01388335|452899648|FG000|Period 2|Sponsor Decision|1|||
125890946|NCT01388335|452899648|FG000|Safety Extension|Progressive Disease|7|||
125890947|NCT04413617|452899652|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
125890948|NCT04413617|452899653|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
125890949|NCT04413617|452899654|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
125890950|NCT04413617|452899655|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
125890951|NCT04413617|452899656|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
125890952|NCT04413617|452899652|FG000|Overall Study|Protocol Violation|0|||
125890953|NCT04413617|452899653|FG001|Overall Study|Protocol Violation|1|||
126413387|NCT00348309|454805893|FG002|Overall Study|No disponibility of medication|0|||
126413388|NCT00348309|454805891|FG000|Overall Study|Worsened neurodegenerative disease|1|||
126413389|NCT00348309|454805892|FG001|Overall Study|Worsened neurodegenerative disease|0|||
126413390|NCT00348309|454805893|FG002|Overall Study|Worsened neurodegenerative disease|0|||
126413391|NCT00348309|454805891|FG000|Overall Study|Cognitive and behaviour worsening|2|||
126413392|NCT00348309|454805892|FG001|Overall Study|Cognitive and behaviour worsening|0|||
126413393|NCT00348309|454805893|FG002|Overall Study|Cognitive and behaviour worsening|0|||
126413394|NCT00348309|454805891|FG000|Overall Study|Worsening of alzheimer|1|||
126413395|NCT00348309|454805892|FG001|Overall Study|Worsening of alzheimer|0|||
126413396|NCT00348309|454805893|FG002|Overall Study|Worsening of alzheimer|1|||
126413397|NCT00348309|454805891|FG000|Overall Study|Did not appear in time for Visit 3|1|||
126413398|NCT00348309|454805892|FG001|Overall Study|Did not appear in time for Visit 3|0|||
126413399|NCT00348309|454805893|FG002|Overall Study|Did not appear in time for Visit 3|0|||
126413400|NCT00348309|454805891|FG000|Overall Study|Participant died|2|||
126413401|NCT00348309|454805892|FG001|Overall Study|Participant died|1|||
126413402|NCT00348309|454805893|FG002|Overall Study|Participant died|1|||
126413403|NCT00348309|454805891|FG000|Overall Study|Decision of sponsor|1|||
126413404|NCT00348309|454805892|FG001|Overall Study|Decision of sponsor|0|||
126413405|NCT00348309|454805893|FG002|Overall Study|Decision of sponsor|0|||
126413406|NCT00348309|454805891|FG000|Overall Study|Ineffectiveness of treatment|0|||
126413407|NCT00348309|454805892|FG001|Overall Study|Ineffectiveness of treatment|1|||
126413408|NCT00348309|454805893|FG002|Overall Study|Ineffectiveness of treatment|0|||
126413409|NCT00348309|454805891|FG000|Overall Study|A foul of exclusion criteria|0|||
126413410|NCT00348309|454805892|FG001|Overall Study|A foul of exclusion criteria|1|||
126413411|NCT00348309|454805893|FG002|Overall Study|A foul of exclusion criteria|0|||
126413412|NCT00348309|454805891|FG000|Overall Study|Participant was hospitalized|0|||
126413413|NCT00348309|454805892|FG001|Overall Study|Participant was hospitalized|1|||
126413414|NCT00348309|454805893|FG002|Overall Study|Participant was hospitalized|0|||
126413415|NCT00348309|454805891|FG000|Overall Study|Sponsor refuseal|0|||
126413416|NCT00348309|454805892|FG001|Overall Study|Sponsor refuseal|1|||
126413417|NCT00348309|454805893|FG002|Overall Study|Sponsor refuseal|1|||
126413418|NCT00348309|454805891|FG000|Overall Study|Forgot often medication|0|||
126413419|NCT00348309|454805892|FG001|Overall Study|Forgot often medication|1|||
126413420|NCT00348309|454805893|FG002|Overall Study|Forgot often medication|0|||
126413421|NCT00348309|454805891|FG000|Overall Study|Medical Monitor decision|0|||
126413422|NCT00348309|454805892|FG001|Overall Study|Medical Monitor decision|0|||
126413423|NCT00348309|454805893|FG002|Overall Study|Medical Monitor decision|1|||
126413424|NCT00348309|454805891|FG000|Overall Study|Increased dose of Aricept|0|||
126413425|NCT00348309|454805892|FG001|Overall Study|Increased dose of Aricept|0|||
126413426|NCT00348309|454805893|FG002|Overall Study|Increased dose of Aricept|1|||
126413427|NCT00348309|454805891|FG000|Overall Study|Site closure|0|||
126413428|NCT00348309|454805892|FG001|Overall Study|Site closure|0|||
125890954|NCT04413617|452899654|FG002|Overall Study|Protocol Violation|0|||
125890955|NCT04413617|452899655|FG003|Overall Study|Protocol Violation|0|||
125890956|NCT04413617|452899656|FG004|Overall Study|Protocol Violation|1|||
126054183|NCT03582475|453492252|FG000|Follow-up Period|Withdrawal by Subject|0|||
126054184|NCT03582475|453492253|FG001|Follow-up Period|Withdrawal by Subject|1|||
126054185|NCT03775486|453492258|FG000|Initial Therapy Phase|Other reason provided|0|||
126413429|NCT00348309|454805893|FG002|Overall Study|Site closure|1|||
126413430|NCT00348309|454805891|FG000|Overall Study|Adverse event not attended|0|||
126054186|NCT03775486|453492259|FG001|Initial Therapy Phase|Other reason provided|15|||
126413431|NCT00348309|454805892|FG001|Overall Study|Adverse event not attended|0|||
126413432|NCT00348309|454805893|FG002|Overall Study|Adverse event not attended|1|||
126413433|NCT00348309|454805891|FG000|Overall Study|ECG abnormal|0|||
126413434|NCT00348309|454805892|FG001|Overall Study|ECG abnormal|0|||
126413435|NCT00348309|454805893|FG002|Overall Study|ECG abnormal|2|||
126413436|NCT00348309|454805891|FG000|Overall Study|Cardiologist recommendations|0|||
126413437|NCT00348309|454805892|FG001|Overall Study|Cardiologist recommendations|0|||
126413438|NCT00348309|454805893|FG002|Overall Study|Cardiologist recommendations|1|||
126413439|NCT00348309|454805891|FG000|Overall Study|HCV career|0|||
126413440|NCT00348309|454805892|FG001|Overall Study|HCV career|0|||
126413441|NCT00348309|454805893|FG002|Overall Study|HCV career|1|||
126413442|NCT01894243|454805894|FG000|Overall Study|Adverse Event|0|||
126413443|NCT01894243|454805895|FG001|Overall Study|Adverse Event|1|||
126413444|NCT01894243|454805896|FG002|Overall Study|Adverse Event|2|||
126413445|NCT01894243|454805894|FG000|Overall Study|Death|0|||
126413446|NCT01894243|454805895|FG001|Overall Study|Death|0|||
126413447|NCT01894243|454805896|FG002|Overall Study|Death|3|||
126413448|NCT01894243|454805894|FG000|Overall Study|Lack of Efficacy|3|||
126413449|NCT01894243|454805895|FG001|Overall Study|Lack of Efficacy|3|||
126413450|NCT01894243|454805896|FG002|Overall Study|Lack of Efficacy|1|||
126413451|NCT01894243|454805894|FG000|Overall Study|Condition under investigation worsened|8|||
126413452|NCT01894243|454805895|FG001|Overall Study|Condition under investigation worsened|6|||
126413453|NCT01894243|454805896|FG002|Overall Study|Condition under investigation worsened|2|||
126413454|NCT01894243|454805894|FG000|Overall Study|Subject decision|1|||
126413455|NCT01894243|454805895|FG001|Overall Study|Subject decision|0|||
126413456|NCT01894243|454805896|FG002|Overall Study|Subject decision|0|||
126413457|NCT01894243|454805894|FG000|Overall Study|Other|1|||
126413458|NCT01894243|454805895|FG001|Overall Study|Other|0|||
126413459|NCT01894243|454805896|FG002|Overall Study|Other|0|||
126413460|NCT01108523|454805900|FG000|Overall Study|Protocol Violation|4|||
126413461|NCT03755661|454805905|FG000|Overall Study|Lost to Follow-up|1|||
126413462|NCT03755661|454805906|FG001|Overall Study|Lost to Follow-up|0|||
126413463|NCT02277119|454805907|FG000|Overall Study|Lack of Efficacy|1|||
126413464|NCT02277119|454805908|FG001|Overall Study|Lack of Efficacy|1|||
126413465|NCT02277119|454805909|FG002|Overall Study|Lack of Efficacy|1|||
126413466|NCT02277119|454805907|FG000|Overall Study|Protocol Violation|2|||
126413467|NCT02277119|454805908|FG001|Overall Study|Protocol Violation|3|||
126413468|NCT02277119|454805909|FG002|Overall Study|Protocol Violation|7|||
126413469|NCT03210961|454808694|FG000|Overall Study|Adverse Event|0|||
126413470|NCT03210961|454808695|FG001|Overall Study|Adverse Event|0|||
126413471|NCT03210961|454808696|FG002|Overall Study|Adverse Event|0|||
126413472|NCT03210961|454808697|FG003|Overall Study|Adverse Event|0|||
126413473|NCT03210961|454808698|FG004|Overall Study|Adverse Event|0|||
126413474|NCT03210961|454808699|FG005|Overall Study|Adverse Event|0|||
126413475|NCT03210961|454808700|FG006|Overall Study|Adverse Event|0|||
126413476|NCT03210961|454808701|FG007|Overall Study|Adverse Event|0|||
126413477|NCT03210961|454808702|FG008|Overall Study|Adverse Event|0|||
126413478|NCT03210961|454808703|FG009|Overall Study|Adverse Event|0|||
126413479|NCT03210961|454808704|FG010|Overall Study|Adverse Event|0|||
126413480|NCT03210961|454808705|FG011|Overall Study|Adverse Event|0|||
126413481|NCT03210961|454808706|FG012|Overall Study|Adverse Event|0|||
126413482|NCT03210961|454808707|FG013|Overall Study|Adverse Event|1|||
126413483|NCT03210961|454808708|FG014|Overall Study|Adverse Event|0|||
126413484|NCT03210961|454808694|FG000|Overall Study|Lost to Follow-up|0|||
126413485|NCT03210961|454808695|FG001|Overall Study|Lost to Follow-up|0|||
126413486|NCT03210961|454808696|FG002|Overall Study|Lost to Follow-up|0|||
126413487|NCT03210961|454808697|FG003|Overall Study|Lost to Follow-up|0|||
126413488|NCT03210961|454808698|FG004|Overall Study|Lost to Follow-up|0|||
126413489|NCT03210961|454808699|FG005|Overall Study|Lost to Follow-up|0|||
126413490|NCT03210961|454808700|FG006|Overall Study|Lost to Follow-up|0|||
126413491|NCT03210961|454808701|FG007|Overall Study|Lost to Follow-up|0|||
126413492|NCT03210961|454808702|FG008|Overall Study|Lost to Follow-up|0|||
126413493|NCT03210961|454808703|FG009|Overall Study|Lost to Follow-up|0|||
126413494|NCT03210961|454808704|FG010|Overall Study|Lost to Follow-up|0|||
126413495|NCT03210961|454808705|FG011|Overall Study|Lost to Follow-up|0|||
126054187|NCT03775486|453492258|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
126054188|NCT03775486|453492259|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
126054189|NCT03775486|453492258|FG000|Initial Therapy Phase|Protocol Violation|0|||
126054190|NCT03775486|453492259|FG001|Initial Therapy Phase|Protocol Violation|2|||
126054191|NCT03775486|453492258|FG000|Initial Therapy Phase|Adverse Event|0|||
126413496|NCT03210961|454808706|FG012|Overall Study|Lost to Follow-up|0|||
126413497|NCT03210961|454808707|FG013|Overall Study|Lost to Follow-up|0|||
126413498|NCT03210961|454808708|FG014|Overall Study|Lost to Follow-up|1|||
126054192|NCT03775486|453492259|FG001|Initial Therapy Phase|Adverse Event|34|||
126413499|NCT03210961|454808694|FG000|Overall Study|Withdrawal by Subject|0|||
125890957|NCT04413617|452899652|FG000|Overall Study|Lack of Efficacy|2|||
126054193|NCT03775486|453492258|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
126054194|NCT03775486|453492259|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
126413500|NCT03210961|454808695|FG001|Overall Study|Withdrawal by Subject|0|||
126413501|NCT03210961|454808696|FG002|Overall Study|Withdrawal by Subject|0|||
126413502|NCT03210961|454808697|FG003|Overall Study|Withdrawal by Subject|0|||
126413503|NCT03210961|454808698|FG004|Overall Study|Withdrawal by Subject|0|||
126413504|NCT03210961|454808699|FG005|Overall Study|Withdrawal by Subject|0|||
126413505|NCT03210961|454808700|FG006|Overall Study|Withdrawal by Subject|0|||
126413506|NCT03210961|454808701|FG007|Overall Study|Withdrawal by Subject|0|||
126413507|NCT03210961|454808702|FG008|Overall Study|Withdrawal by Subject|0|||
126413508|NCT03210961|454808703|FG009|Overall Study|Withdrawal by Subject|0|||
126413509|NCT03210961|454808704|FG010|Overall Study|Withdrawal by Subject|0|||
126413510|NCT03210961|454808705|FG011|Overall Study|Withdrawal by Subject|0|||
126413511|NCT03210961|454808706|FG012|Overall Study|Withdrawal by Subject|0|||
126413512|NCT03210961|454808707|FG013|Overall Study|Withdrawal by Subject|0|||
126413513|NCT03210961|454808708|FG014|Overall Study|Withdrawal by Subject|1|||
126413514|NCT03210961|454808694|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413515|NCT03210961|454808695|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413516|NCT03210961|454808696|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413517|NCT03210961|454808697|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413518|NCT03210961|454808698|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413519|NCT03210961|454808699|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413520|NCT03210961|454808700|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413521|NCT03210961|454808701|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413522|NCT03210961|454808702|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413523|NCT03210961|454808703|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413524|NCT03210961|454808704|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413525|NCT03210961|454808705|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413526|NCT03210961|454808706|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413527|NCT03210961|454808707|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
126413528|NCT03210961|454808708|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413529|NCT03210961|454808694|FG000|Overall Study|Other|0|||
126413530|NCT03210961|454808695|FG001|Overall Study|Other|0|||
126413531|NCT03210961|454808696|FG002|Overall Study|Other|0|||
126413532|NCT03210961|454808697|FG003|Overall Study|Other|1|||
126413533|NCT03210961|454808698|FG004|Overall Study|Other|0|||
126413534|NCT03210961|454808699|FG005|Overall Study|Other|0|||
126413535|NCT03210961|454808700|FG006|Overall Study|Other|1|||
126413536|NCT03210961|454808701|FG007|Overall Study|Other|0|||
126413537|NCT03210961|454808702|FG008|Overall Study|Other|0|||
126413538|NCT03210961|454808703|FG009|Overall Study|Other|0|||
126413539|NCT03210961|454808704|FG010|Overall Study|Other|1|||
126413540|NCT03210961|454808705|FG011|Overall Study|Other|0|||
126413541|NCT03210961|454808706|FG012|Overall Study|Other|2|||
126413542|NCT03210961|454808707|FG013|Overall Study|Other|2|||
126413543|NCT03210961|454808708|FG014|Overall Study|Other|0|||
126413544|NCT01487265|454808709|FG000|Overall Study|Adverse Event|8|||
126413545|NCT01487265|454808709|FG000|Overall Study|Withdrawal by Subject|5|||
126413546|NCT01487265|454808709|FG000|Overall Study|Disease Progression|21|||
126413547|NCT01487265|454808709|FG000|Overall Study|Death|2|||
126413548|NCT01487265|454808709|FG000|Overall Study|Still on Treatment|1|||
126413549|NCT02291419|454808711|FG000|Overall Study|Early study termination|1|||
126413550|NCT02291419|454808712|FG001|Overall Study|Early study termination|5|||
126413551|NCT00965575|454808716|FG000|Overall Study|subject unwillingness to swallow study c|1|||
126413552|NCT00965575|454808717|FG001|Overall Study|subject unwillingness to swallow study c|0|||
126413553|NCT01732770|454808725|FG000|Overall Study|Lost to Follow-up|2|||
126413554|NCT01732770|454808726|FG001|Overall Study|Lost to Follow-up|3|||
126413555|NCT01732770|454808725|FG000|Overall Study|Withdrawal by Subject|5|||
126413556|NCT01732770|454808726|FG001|Overall Study|Withdrawal by Subject|3|||
126413557|NCT01732770|454808725|FG000|Overall Study|Decision by Sponsor|2|||
126413558|NCT01732770|454808726|FG001|Overall Study|Decision by Sponsor|2|||
126413559|NCT01732770|454808725|FG000|Overall Study|Death|1|||
126413560|NCT01732770|454808726|FG001|Overall Study|Death|0|||
126413561|NCT03047031|454808729|FG000|Overall Study|Other than listed|1|||
126413562|NCT03047031|454808730|FG001|Overall Study|Other than listed|0|||
126413563|NCT03047031|454808731|FG002|Overall Study|Other than listed|0|||
126413564|NCT03047031|454808729|FG000|Overall Study|Lost to Follow-up|4|||
126413565|NCT03047031|454808730|FG001|Overall Study|Lost to Follow-up|0|||
126413566|NCT03047031|454808731|FG002|Overall Study|Lost to Follow-up|0|||
126413567|NCT03047031|454808729|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
126413568|NCT03047031|454808730|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
126413569|NCT03047031|454808731|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
126413570|NCT03047031|454808729|FG000|Overall Study|Adverse Event|1|||
126413571|NCT03047031|454808730|FG001|Overall Study|Adverse Event|0|||
126413572|NCT03047031|454808731|FG002|Overall Study|Adverse Event|0|||
126413573|NCT03047031|454808729|FG000|Overall Study|Withdrawal by Subject|2|||
126413574|NCT03047031|454808730|FG001|Overall Study|Withdrawal by Subject|0|||
126413575|NCT03047031|454808731|FG002|Overall Study|Withdrawal by Subject|0|||
126413576|NCT03047031|454808729|FG000|Overall Study|Change to other medication|2|||
126413577|NCT03047031|454808730|FG001|Overall Study|Change to other medication|0|||
126413578|NCT03047031|454808731|FG002|Overall Study|Change to other medication|0|||
126413579|NCT03047031|454808729|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
126413580|NCT03047031|454808730|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
126413581|NCT03047031|454808731|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
126413582|NCT03521141|454808732|FG000|Overall Study|Death|1|||
126413583|NCT03521141|454808733|FG001|Overall Study|Death|0|||
126413584|NCT03521141|454808734|FG002|Overall Study|Death|1|||
126413585|NCT01959139|454808744|FG000|Phase II|Disease progression|0|||
126413586|NCT01959139|454808745|FG001|Phase II|Disease progression|0|||
126413587|NCT01959139|454808746|FG002|Phase II|Disease progression|26|||
126413588|NCT01959139|454808747|FG003|Phase II|Disease progression|34|||
126413589|NCT01959139|454808744|FG000|Phase II|Adverse Event|0|||
126413590|NCT01959139|454808745|FG001|Phase II|Adverse Event|0|||
126413591|NCT01959139|454808746|FG002|Phase II|Adverse Event|10|||
126413592|NCT01959139|454808747|FG003|Phase II|Adverse Event|11|||
126413593|NCT01959139|454808744|FG000|Phase II|Patient Refusal|0|||
126413594|NCT01959139|454808745|FG001|Phase II|Patient Refusal|0|||
126413595|NCT01959139|454808746|FG002|Phase II|Patient Refusal|5|||
126413596|NCT01959139|454808747|FG003|Phase II|Patient Refusal|4|||
126413597|NCT01959139|454808744|FG000|Phase II|Death|0|||
126413598|NCT01959139|454808745|FG001|Phase II|Death|0|||
126413599|NCT01959139|454808746|FG002|Phase II|Death|3|||
126413600|NCT01959139|454808747|FG003|Phase II|Death|1|||
126413601|NCT01959139|454808744|FG000|Phase II|Other/Unknown|0|||
126413602|NCT01959139|454808745|FG001|Phase II|Other/Unknown|0|||
126413603|NCT01959139|454808746|FG002|Phase II|Other/Unknown|8|||
126413604|NCT01959139|454808747|FG003|Phase II|Other/Unknown|5|||
126413605|NCT01959139|454808744|FG000|Phase II|On treatment|0|||
126413606|NCT01959139|454808745|FG001|Phase II|On treatment|0|||
126413607|NCT01959139|454808746|FG002|Phase II|On treatment|4|||
126413608|NCT01959139|454808747|FG003|Phase II|On treatment|0|||
126413609|NCT05362058|454808750|FG000|Treatment Period|Adverse Event|3|||
126413610|NCT05362058|454808751|FG001|Treatment Period|Adverse Event|3|||
126413611|NCT05362058|454808750|FG000|Treatment Period|Assigned treatment by mistake|3|||
126413612|NCT05362058|454808751|FG001|Treatment Period|Assigned treatment by mistake|4|||
126413613|NCT05362058|454808750|FG000|Treatment Period|Death|1|||
126413614|NCT05362058|454808751|FG001|Treatment Period|Death|1|||
126413615|NCT05362058|454808750|FG000|Treatment Period|Lost to Follow-up|6|||
126413616|NCT05362058|454808751|FG001|Treatment Period|Lost to Follow-up|3|||
126413617|NCT05362058|454808750|FG000|Treatment Period|Non-compliance with study drug|0|||
126413618|NCT05362058|454808751|FG001|Treatment Period|Non-compliance with study drug|1|||
126413619|NCT05362058|454808750|FG000|Treatment Period|Physician Decision|1|||
126413620|NCT05362058|454808751|FG001|Treatment Period|Physician Decision|0|||
126413621|NCT05362058|454808750|FG000|Treatment Period|Protocol deviation|1|||
126413622|NCT05362058|454808751|FG001|Treatment Period|Protocol deviation|0|||
126413623|NCT05362058|454808750|FG000|Treatment Period|Withdrawal by Subject|10|||
126413624|NCT05362058|454808751|FG001|Treatment Period|Withdrawal by Subject|11|||
126413625|NCT05362058|454808750|FG000|Follow-Up Period|Death|1|||
126413626|NCT05362058|454808751|FG001|Follow-Up Period|Death|0|||
126413627|NCT05362058|454808750|FG000|Follow-Up Period|Lost to Follow-up|2|||
126413628|NCT05362058|454808751|FG001|Follow-Up Period|Lost to Follow-up|1|||
126413629|NCT05362058|454808750|FG000|Follow-Up Period|Protocol deviation|1|||
126413630|NCT05362058|454808751|FG001|Follow-Up Period|Protocol deviation|1|||
126413631|NCT05362058|454808750|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126413632|NCT05362058|454808751|FG001|Follow-Up Period|Withdrawal by Subject|3|||
126413633|NCT00930553|454808754|FG000|Overall Study|Adverse Event|1|||
126413634|NCT00930553|454808754|FG000|Overall Study|Lack of Efficacy|7|||
126413635|NCT00930553|454808754|FG000|Overall Study|Physician Decision|39|||
126413636|NCT00930553|454808754|FG000|Overall Study|Protocol Violation|1|||
126413637|NCT00930553|454808754|FG000|Overall Study|Pregnancy|1|||
126413638|NCT00930553|454808754|FG000|Overall Study|Withdrawal by Subject|88|||
126413639|NCT00930553|454808754|FG000|Overall Study|Lost to Follow-up|25|||
126413640|NCT00930553|454808754|FG000|Overall Study|Death|9|||
126413641|NCT00930553|454808754|FG000|Overall Study|Study terminated by sponsor|24|||
126413642|NCT00930553|454808754|FG000|Overall Study|Other than specified above|28|||
126413643|NCT01964963|454808755|FG000|Overall Study|Case Report Forms Uncollected|888|||
126413644|NCT01964963|454808755|FG000|Overall Study|Protocol Deviation|50|||
126413645|NCT01964963|454808755|FG000|Overall Study|Data Reliability was not Assured|5|||
126413646|NCT01235234|454808756|FG000|Overall Study|Adverse Event|2|||
126413647|NCT01235234|454808757|FG001|Overall Study|Adverse Event|2|||
126413648|NCT01235234|454808758|FG002|Overall Study|Adverse Event|1|||
126413649|NCT02352753|454808759|FG000|6-Month Dosing Period|Decision by sponsor|2|||
126413650|NCT02352753|454808759|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
126413651|NCT02352753|454808759|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
126413652|NCT02352753|454808759|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
126413653|NCT02352753|454808759|FG000|3-Month Dosing Period|Decision by sponsor|14|||
126413654|NCT02352753|454808759|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
126413655|NCT04042909|454808760|FG000|Overall Study|Withdrawal by Subject|1|||
126413656|NCT04042909|454808761|FG001|Overall Study|Withdrawal by Subject|0|||
126413657|NCT04042909|454808762|FG002|Overall Study|Withdrawal by Subject|0|||
126413658|NCT04042909|454808760|FG000|Overall Study|duplicate cases|2|||
126413659|NCT04042909|454808761|FG001|Overall Study|duplicate cases|0|||
126413660|NCT04042909|454808762|FG002|Overall Study|duplicate cases|0|||
126054195|NCT03775486|453492258|FG000|Maintenance Phase|Withdrawal by Subject|13|||
126054196|NCT03775486|453492259|FG001|Maintenance Phase|Withdrawal by Subject|12|||
126054197|NCT03775486|453492258|FG000|Maintenance Phase|Death|44|||
126054198|NCT03775486|453492259|FG001|Maintenance Phase|Death|45|||
126054199|NCT02744066|453492264|FG000|Overall Study|Withdrawal by parent|0|||
126054200|NCT02744066|453492265|FG001|Overall Study|Withdrawal by parent|1|||
126054201|NCT02744066|453492264|FG000|Overall Study|Discharged from NICU prior to completion|0|||
126413661|NCT04042909|454808760|FG000|Overall Study|technical problem|0|||
126413662|NCT04042909|454808761|FG001|Overall Study|technical problem|1|||
126413663|NCT04042909|454808762|FG002|Overall Study|technical problem|0|||
126413664|NCT00286494|454808763|FG000|Overall Study|Hyperglycemic rescue|12|||
126413665|NCT00286494|454808764|FG001|Overall Study|Hyperglycemic rescue|19|||
126413666|NCT00286494|454808765|FG002|Overall Study|Hyperglycemic rescue|18|||
126413667|NCT00286494|454808763|FG000|Overall Study|Withdrawal by Subject|2|||
126413668|NCT00286494|454808764|FG001|Overall Study|Withdrawal by Subject|10|||
126413669|NCT00286494|454808765|FG002|Overall Study|Withdrawal by Subject|9|||
126413670|NCT00286494|454808763|FG000|Overall Study|Adverse Event|3|||
126054202|NCT02744066|453492265|FG001|Overall Study|Discharged from NICU prior to completion|4|||
126054203|NCT02454959|453492266|FG000|Overall Study|Protocol-Specified Criteria|3|||
126054204|NCT02454959|453492266|FG000|Overall Study|Physician Decision|1|||
126054205|NCT02454959|453492266|FG000|Overall Study|Withdrawal by Subject|3|||
125890958|NCT04413617|452899653|FG001|Overall Study|Lack of Efficacy|0|||
125890959|NCT04413617|452899654|FG002|Overall Study|Lack of Efficacy|2|||
126413671|NCT00286494|454808764|FG001|Overall Study|Adverse Event|8|||
126413672|NCT00286494|454808765|FG002|Overall Study|Adverse Event|6|||
126413673|NCT00286494|454808763|FG000|Overall Study|Physician Decision|5|||
126413674|NCT00286494|454808764|FG001|Overall Study|Physician Decision|5|||
126413675|NCT00286494|454808765|FG002|Overall Study|Physician Decision|1|||
126413676|NCT00286494|454808763|FG000|Overall Study|Lost to Follow-up|3|||
126413677|NCT00286494|454808764|FG001|Overall Study|Lost to Follow-up|1|||
126413678|NCT00286494|454808765|FG002|Overall Study|Lost to Follow-up|3|||
126413679|NCT00286494|454808763|FG000|Overall Study|Protocol Violation|1|||
126413680|NCT00286494|454808764|FG001|Overall Study|Protocol Violation|1|||
126413681|NCT00286494|454808765|FG002|Overall Study|Protocol Violation|2|||
126413682|NCT04776317|454808766|FG000|Overall Study|Physician Decision|0|||
126413683|NCT04776317|454808767|FG001|Overall Study|Physician Decision|1|||
126413684|NCT04776317|454808768|FG002|Overall Study|Physician Decision|0|||
126413685|NCT04776317|454808769|FG003|Overall Study|Physician Decision|0|||
126413686|NCT04776317|454808770|FG004|Overall Study|Physician Decision|0|||
126413687|NCT04776317|454808771|FG005|Overall Study|Physician Decision|0|||
126413688|NCT04776317|454808772|FG006|Overall Study|Physician Decision|0|||
126413689|NCT04776317|454808773|FG007|Overall Study|Physician Decision|0|||
126413690|NCT04776317|454808774|FG008|Overall Study|Physician Decision|0|||
126413691|NCT04776317|454808775|FG009|Overall Study|Physician Decision|0|||
126413692|NCT04776317|454808776|FG010|Overall Study|Physician Decision|0|||
125890960|NCT04413617|452899655|FG003|Overall Study|Lack of Efficacy|1|||
126054206|NCT02454959|453492266|FG000|Overall Study|Adverse Event|2|||
126413693|NCT04776317|454808777|FG011|Overall Study|Physician Decision|0|||
126054207|NCT05810285|453492273|FG000|Overall Study|Death|4|||
126413694|NCT04776317|454808778|FG012|Overall Study|Physician Decision|0|||
126413695|NCT04776317|454808779|FG013|Overall Study|Physician Decision|0|||
126413696|NCT04776317|454808780|FG014|Overall Study|Physician Decision|0|||
126413697|NCT04776317|454808766|FG000|Overall Study|Protocol Violation|0|||
126413698|NCT04776317|454808767|FG001|Overall Study|Protocol Violation|0|||
126054208|NCT05810285|453492274|FG001|Overall Study|Death|21|||
125890961|NCT04413617|452899656|FG004|Overall Study|Lack of Efficacy|0|||
126413699|NCT04776317|454808768|FG002|Overall Study|Protocol Violation|1|||
126413700|NCT04776317|454808769|FG003|Overall Study|Protocol Violation|0|||
126413701|NCT04776317|454808770|FG004|Overall Study|Protocol Violation|0|||
125890962|NCT04413617|452899652|FG000|Overall Study|Withdrawal by Subject|3|||
125890963|NCT04413617|452899653|FG001|Overall Study|Withdrawal by Subject|4|||
125890964|NCT04413617|452899654|FG002|Overall Study|Withdrawal by Subject|2|||
125890965|NCT04413617|452899655|FG003|Overall Study|Withdrawal by Subject|5|||
126413702|NCT04776317|454808771|FG005|Overall Study|Protocol Violation|0|||
126413703|NCT04776317|454808772|FG006|Overall Study|Protocol Violation|0|||
126413704|NCT04776317|454808773|FG007|Overall Study|Protocol Violation|0|||
126413705|NCT04776317|454808774|FG008|Overall Study|Protocol Violation|0|||
126413706|NCT04776317|454808775|FG009|Overall Study|Protocol Violation|0|||
126413707|NCT04776317|454808776|FG010|Overall Study|Protocol Violation|0|||
126413708|NCT04776317|454808777|FG011|Overall Study|Protocol Violation|0|||
126413709|NCT04776317|454808778|FG012|Overall Study|Protocol Violation|0|||
126413710|NCT04776317|454808779|FG013|Overall Study|Protocol Violation|0|||
126413711|NCT04776317|454808780|FG014|Overall Study|Protocol Violation|0|||
126413712|NCT04776317|454808766|FG000|Overall Study|Withdrawal by Subject|0|||
126413713|NCT04776317|454808767|FG001|Overall Study|Withdrawal by Subject|0|||
126413714|NCT04776317|454808768|FG002|Overall Study|Withdrawal by Subject|0|||
126413715|NCT04776317|454808769|FG003|Overall Study|Withdrawal by Subject|0|||
126413716|NCT04776317|454808770|FG004|Overall Study|Withdrawal by Subject|1|||
126413717|NCT04776317|454808771|FG005|Overall Study|Withdrawal by Subject|0|||
126413718|NCT04776317|454808772|FG006|Overall Study|Withdrawal by Subject|0|||
126413719|NCT04776317|454808773|FG007|Overall Study|Withdrawal by Subject|0|||
126413720|NCT04776317|454808774|FG008|Overall Study|Withdrawal by Subject|0|||
126413721|NCT04776317|454808775|FG009|Overall Study|Withdrawal by Subject|0|||
126413722|NCT04776317|454808776|FG010|Overall Study|Withdrawal by Subject|0|||
126413723|NCT04776317|454808777|FG011|Overall Study|Withdrawal by Subject|0|||
126413724|NCT04776317|454808778|FG012|Overall Study|Withdrawal by Subject|0|||
126413725|NCT04776317|454808779|FG013|Overall Study|Withdrawal by Subject|0|||
126413726|NCT04776317|454808780|FG014|Overall Study|Withdrawal by Subject|0|||
126413727|NCT03671304|454808781|FG000|Overall Study|study terminated|7|||
126413728|NCT01856582|454808782|FG000|Overall Study|Died prior to Boost infusion|1|||
126413729|NCT01457846|454808783|FG000|Overall Study|Death before treatment|1|||
126413730|NCT01457846|454808784|FG001|Overall Study|Death before treatment|2|||
126413731|NCT01457846|454808783|FG000|Overall Study|Did not receive treatment|0|||
126413732|NCT01457846|454808784|FG001|Overall Study|Did not receive treatment|1|||
126413733|NCT01457846|454808783|FG000|Overall Study|Death|27|||
126413734|NCT01457846|454808784|FG001|Overall Study|Death|16|||
126413735|NCT01457846|454808783|FG000|Overall Study|Unclassified reason for not completed|11|||
126413736|NCT01457846|454808784|FG001|Overall Study|Unclassified reason for not completed|10|||
126413737|NCT01457846|454808783|FG000|Overall Study|Withdrawal by Subject|1|||
126413738|NCT01457846|454808784|FG001|Overall Study|Withdrawal by Subject|1|||
126413739|NCT01457846|454808783|FG000|Overall Study|Lost to Follow-up|1|||
126413740|NCT01457846|454808784|FG001|Overall Study|Lost to Follow-up|0|||
126413741|NCT01240135|454808785|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
126413742|NCT01240135|454808786|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
126413743|NCT01240135|454808785|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
126413744|NCT01240135|454808786|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
126413745|NCT01371305|454808787|FG000|Overall Study|Adverse Event|0|||
126413746|NCT01371305|454808788|FG001|Overall Study|Adverse Event|0|||
126413747|NCT01371305|454808789|FG002|Overall Study|Adverse Event|0|||
126413748|NCT01371305|454808790|FG003|Overall Study|Adverse Event|2|||
126413749|NCT01371305|454808791|FG004|Overall Study|Adverse Event|1|||
126413750|NCT01371305|454808792|FG005|Overall Study|Adverse Event|0|||
125890966|NCT04413617|452899656|FG004|Overall Study|Withdrawal by Subject|3|||
125890967|NCT04413617|452899652|FG000|Overall Study|Death|1|||
125890968|NCT04413617|452899653|FG001|Overall Study|Death|0|||
126413751|NCT01371305|454808787|FG000|Overall Study|Study terminated by sponsor|0|||
126413752|NCT01371305|454808788|FG001|Overall Study|Study terminated by sponsor|0|||
126413753|NCT01371305|454808789|FG002|Overall Study|Study terminated by sponsor|0|||
126413754|NCT01371305|454808790|FG003|Overall Study|Study terminated by sponsor|0|||
125890969|NCT04413617|452899654|FG002|Overall Study|Death|0|||
125890970|NCT04413617|452899655|FG003|Overall Study|Death|0|||
125890971|NCT04413617|452899656|FG004|Overall Study|Death|0|||
126413755|NCT01371305|454808791|FG004|Overall Study|Study terminated by sponsor|3|||
126413756|NCT01371305|454808792|FG005|Overall Study|Study terminated by sponsor|1|||
126413757|NCT01371305|454808787|FG000|Overall Study|Subject request|0|||
126413758|NCT01371305|454808788|FG001|Overall Study|Subject request|0|||
126413759|NCT01371305|454808789|FG002|Overall Study|Subject request|0|||
126413760|NCT01371305|454808790|FG003|Overall Study|Subject request|0|||
126413761|NCT01371305|454808791|FG004|Overall Study|Subject request|0|||
126413762|NCT01371305|454808792|FG005|Overall Study|Subject request|1|||
126413763|NCT01628965|454808793|FG000|Overall Study|Adverse Event|30|||
126413764|NCT01628965|454808793|FG000|Overall Study|Lack of Efficacy|7|||
126413765|NCT01628965|454808793|FG000|Overall Study|Withdrawal by Subject|3|||
126413766|NCT01628965|454808793|FG000|Overall Study|Lost to Follow-up|1|||
125890972|NCT04413617|452899652|FG000|Overall Study|Adverse Event|1|||
125890973|NCT04413617|452899653|FG001|Overall Study|Adverse Event|0|||
126413767|NCT01628965|454808793|FG000|Overall Study|Discontinuation criteria|8|||
126413768|NCT04356352|454808794|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
126413769|NCT04356352|454808795|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
126413770|NCT04356352|454808796|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
126413771|NCT04356352|454808794|FG000|Overall Study|Protocol Violation|0|||
126413772|NCT04356352|454808795|FG001|Overall Study|Protocol Violation|3|||
126413773|NCT04356352|454808796|FG002|Overall Study|Protocol Violation|1|||
126413774|NCT00379912|454808801|FG000|Overall Study|Lack of Efficacy|1|||
126413775|NCT00379912|454808802|FG001|Overall Study|Lack of Efficacy|0|||
126413776|NCT01128946|454808803|FG000|Period I|Protocol Violation|0|||
126413777|NCT01128946|454808804|FG001|Period I|Protocol Violation|1|||
126413778|NCT01128946|454808805|FG002|Period I|Protocol Violation|0|||
126413779|NCT01128946|454808806|FG003|Period I|Protocol Violation|0|||
126413780|NCT01128946|454808803|FG000|Period I|Withdrawal by Subject|0|||
126413781|NCT01128946|454808804|FG001|Period I|Withdrawal by Subject|0|||
126413782|NCT01128946|454808805|FG002|Period I|Withdrawal by Subject|1|||
126413783|NCT01128946|454808806|FG003|Period I|Withdrawal by Subject|1|||
126413784|NCT01128946|454808803|FG000|Period II|Protocol Violation|0|||
126413785|NCT01128946|454808804|FG001|Period II|Protocol Violation|1|||
126413786|NCT01128946|454808805|FG002|Period II|Protocol Violation|0|||
126413787|NCT01128946|454808806|FG003|Period II|Protocol Violation|0|||
126413788|NCT01128946|454808803|FG000|Period II|Withdrawal by Subject|0|||
126413789|NCT01128946|454808804|FG001|Period II|Withdrawal by Subject|0|||
126413790|NCT01128946|454808805|FG002|Period II|Withdrawal by Subject|0|||
126413791|NCT01128946|454808806|FG003|Period II|Withdrawal by Subject|1|||
126413792|NCT01128946|454808803|FG000|Period III|Protocol Violation|1|||
126413793|NCT01128946|454808804|FG001|Period III|Protocol Violation|0|||
126413794|NCT01128946|454808805|FG002|Period III|Protocol Violation|0|||
126413795|NCT01128946|454808806|FG003|Period III|Protocol Violation|0|||
126413796|NCT01371734|454808807|FG000|Overall Study|Other|2|||
126413797|NCT01371734|454808808|FG001|Overall Study|Other|1|||
126413798|NCT01371734|454808809|FG002|Overall Study|Other|2|||
126413799|NCT01371734|454808807|FG000|Overall Study|Withdrawal by Subject|3|||
126413800|NCT01371734|454808808|FG001|Overall Study|Withdrawal by Subject|4|||
126413801|NCT01371734|454808809|FG002|Overall Study|Withdrawal by Subject|9|||
126413802|NCT01371734|454808807|FG000|Overall Study|Lost to Follow-up|5|||
125890974|NCT04413617|452899654|FG002|Overall Study|Adverse Event|0|||
125890975|NCT04413617|452899655|FG003|Overall Study|Adverse Event|1|||
125890976|NCT04413617|452899656|FG004|Overall Study|Adverse Event|1|||
126413803|NCT01371734|454808808|FG001|Overall Study|Lost to Follow-up|3|||
126413804|NCT01371734|454808809|FG002|Overall Study|Lost to Follow-up|1|||
126413805|NCT01371734|454808807|FG000|Overall Study|Protocol Violation|3|||
126413806|NCT01371734|454808808|FG001|Overall Study|Protocol Violation|1|||
126413807|NCT01371734|454808809|FG002|Overall Study|Protocol Violation|2|||
126413808|NCT01371734|454808807|FG000|Overall Study|Adverse Event|8|||
126413809|NCT01371734|454808808|FG001|Overall Study|Adverse Event|8|||
126413810|NCT01371734|454808809|FG002|Overall Study|Adverse Event|3|||
126413811|NCT01371734|454808807|FG000|Overall Study|Lack of Efficacy|2|||
126413812|NCT01371734|454808808|FG001|Overall Study|Lack of Efficacy|2|||
126413813|NCT01371734|454808809|FG002|Overall Study|Lack of Efficacy|0|||
126413814|NCT00621140|454808810|FG000|Overall Study|Adverse Event|4|||
126413815|NCT00621140|454808811|FG001|Overall Study|Adverse Event|5|||
126413816|NCT00621140|454808810|FG000|Overall Study|Lost to Follow-up|1|||
126413817|NCT00621140|454808811|FG001|Overall Study|Lost to Follow-up|2|||
126413818|NCT00621140|454808810|FG000|Overall Study|Withdrawal by Subject|4|||
126413819|NCT00621140|454808811|FG001|Overall Study|Withdrawal by Subject|6|||
126413820|NCT00621140|454808810|FG000|Overall Study|Other incl. lack of efficacy|6|||
126413821|NCT00621140|454808811|FG001|Overall Study|Other incl. lack of efficacy|5|||
126413822|NCT00360568|454808813|FG000|Overall Study|Adverse Event|1|||
126413823|NCT00360568|454808814|FG001|Overall Study|Adverse Event|2|||
126413824|NCT00360568|454808813|FG000|Overall Study|Lack of Efficacy|1|||
126413825|NCT00360568|454808814|FG001|Overall Study|Lack of Efficacy|0|||
126413826|NCT00360568|454808813|FG000|Overall Study|Withdrawal by Subject|0|||
126413827|NCT00360568|454808814|FG001|Overall Study|Withdrawal by Subject|3|||
126413828|NCT03565237|454808815|FG000|Overall Study|Non-compliance of Investigational Product|1|||
126413829|NCT03565237|454808815|FG000|Overall Study|Physician Decision|1|||
126413830|NCT02873338|454808820|FG000|Overall Study|Adverse Event|0|||
126413831|NCT02873338|454808821|FG001|Overall Study|Adverse Event|2|||
126413832|NCT02873338|454808822|FG002|Overall Study|Adverse Event|1|||
126413833|NCT02873338|454808820|FG000|Overall Study|Death|2|||
126413834|NCT02873338|454808821|FG001|Overall Study|Death|1|||
126413835|NCT02873338|454808822|FG002|Overall Study|Death|1|||
126413836|NCT02873338|454808820|FG000|Overall Study|Withdrawal by Subject|2|||
126413837|NCT02873338|454808821|FG001|Overall Study|Withdrawal by Subject|1|||
126413838|NCT02873338|454808822|FG002|Overall Study|Withdrawal by Subject|3|||
126413839|NCT02873338|454808820|FG000|Overall Study|Lack of Efficacy|0|||
126413840|NCT02873338|454808821|FG001|Overall Study|Lack of Efficacy|2|||
126413841|NCT02873338|454808822|FG002|Overall Study|Lack of Efficacy|0|||
126413842|NCT02873338|454808820|FG000|Overall Study|Other or Missing|14|||
125890977|NCT04413617|452899652|FG000|Overall Study|COVID-19|0|||
126413843|NCT02873338|454808821|FG001|Overall Study|Other or Missing|15|||
126413844|NCT02873338|454808822|FG002|Overall Study|Other or Missing|13|||
126413845|NCT03657095|454808823|FG000|Overall Study|Withdrawal by Subject|1|||
126413846|NCT03657095|454808824|FG001|Overall Study|Withdrawal by Subject|1|||
126413847|NCT03657095|454808823|FG000|Overall Study|Adverse Event|0|||
126413848|NCT03657095|454808824|FG001|Overall Study|Adverse Event|3|||
126413849|NCT03657095|454808823|FG000|Overall Study|Study Terminated by Sponsor|58|||
126413850|NCT03657095|454808824|FG001|Overall Study|Study Terminated by Sponsor|49|||
126413851|NCT01743040|454808825|FG000|Overall Study|Death|1|||
126413852|NCT01743040|454808825|FG000|Overall Study|Lost to Follow-up|66|||
126413853|NCT01743040|454808825|FG000|Overall Study|Physician Decision|40|||
126413854|NCT01743040|454808825|FG000|Overall Study|Protocol Violation|1|||
126413855|NCT01743040|454808825|FG000|Overall Study|Withdrawal by Subject|121|||
126413856|NCT00828750|454808826|FG000|Overall Study|Lack of Efficacy|3|||
126413857|NCT00828750|454808826|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
126413858|NCT00830180|454808827|FG000|Overall Study|Adverse Event|6|||
126413859|NCT00830180|454808827|FG000|Overall Study|Death|11|||
126413860|NCT00830180|454808827|FG000|Overall Study|Insufficient clinical response|1|||
126413861|NCT00830180|454808827|FG000|Overall Study|Withdrawal by Subject|5|||
126413862|NCT00830180|454808827|FG000|Overall Study|Progressive disease|2|||
126413863|NCT00830180|454808827|FG000|Overall Study|Other - Unspecified|1|||
126413864|NCT01832532|454808828|FG000|Overall Study|Withdrawal by Subject|5|||
126413865|NCT01832532|454808829|FG001|Overall Study|Withdrawal by Subject|2|||
126413866|NCT01990612|454808830|FG000|Overall Study|Lost to Follow-up|2|||
126413867|NCT01990612|454808831|FG001|Overall Study|Lost to Follow-up|1|||
126413868|NCT01990612|454808830|FG000|Overall Study|Withdrawal by Subject|5|||
126413869|NCT01990612|454808831|FG001|Overall Study|Withdrawal by Subject|2|||
126413870|NCT02974842|454808832|FG000|Overall Study|Withdrawal by Subject|4|||
126413871|NCT02974842|454808832|FG000|Overall Study|Screen failures|4|||
126413872|NCT01068158|454808840|FG000|Overall Study|Withdrawal by Subject|1|||
126413873|NCT01068158|454808841|FG001|Overall Study|Withdrawal by Subject|2|||
126413874|NCT01068158|454808840|FG000|Overall Study|Lost to Follow-up|7|||
126413875|NCT01068158|454808841|FG001|Overall Study|Lost to Follow-up|0|||
126413876|NCT01068158|454808840|FG000|Overall Study|Protocol Violation|0|||
126413877|NCT01068158|454808841|FG001|Overall Study|Protocol Violation|2|||
126413878|NCT01300572|454808842|FG000|Overall Study|HAMA + post dosimetry|1|||
126413879|NCT00411632|454808844|FG000|Overall Study|Death|1|||
126413880|NCT01748825|454808859|FG000|Dose Escalation|Refused further treatment|2|||
126413881|NCT01748825|454808860|FG001|Dose Escalation|Refused further treatment|2|||
126413882|NCT01748825|454808861|FG002|Dose Escalation|Refused further treatment|0|||
126413883|NCT01748825|454808862|FG003|Dose Escalation|Refused further treatment|0|||
126413884|NCT01748825|454808863|FG004|Dose Escalation|Refused further treatment|1|||
126413885|NCT01748825|454808864|FG005|Dose Escalation|Refused further treatment|2|||
126413886|NCT01748825|454808865|FG006|Dose Escalation|Refused further treatment|0|||
126413887|NCT01748825|454808866|FG007|Dose Escalation|Refused further treatment|0|||
126413888|NCT01748825|454808867|FG008|Dose Escalation|Refused further treatment|0|||
126413889|NCT01748825|454808868|FG009|Dose Escalation|Refused further treatment|0|||
126413890|NCT01748825|454808859|FG000|Dose Escalation|Switched to alternative treatment|0|||
126413891|NCT01748825|454808860|FG001|Dose Escalation|Switched to alternative treatment|0|||
126413892|NCT01748825|454808861|FG002|Dose Escalation|Switched to alternative treatment|0|||
126413893|NCT01748825|454808862|FG003|Dose Escalation|Switched to alternative treatment|1|||
126413894|NCT01748825|454808863|FG004|Dose Escalation|Switched to alternative treatment|0|||
126413895|NCT01748825|454808864|FG005|Dose Escalation|Switched to alternative treatment|0|||
126413896|NCT01748825|454808865|FG006|Dose Escalation|Switched to alternative treatment|0|||
126413897|NCT01748825|454808866|FG007|Dose Escalation|Switched to alternative treatment|0|||
126413898|NCT01748825|454808867|FG008|Dose Escalation|Switched to alternative treatment|0|||
126413899|NCT01748825|454808868|FG009|Dose Escalation|Switched to alternative treatment|0|||
126413900|NCT01748825|454808859|FG000|Dose Escalation|Adverse Event|0|||
126413901|NCT01748825|454808860|FG001|Dose Escalation|Adverse Event|0|||
126413902|NCT01748825|454808861|FG002|Dose Escalation|Adverse Event|0|||
126413903|NCT01748825|454808862|FG003|Dose Escalation|Adverse Event|0|||
126413904|NCT01748825|454808863|FG004|Dose Escalation|Adverse Event|0|||
126413905|NCT01748825|454808864|FG005|Dose Escalation|Adverse Event|0|||
126413906|NCT01748825|454808865|FG006|Dose Escalation|Adverse Event|1|||
126413907|NCT01748825|454808866|FG007|Dose Escalation|Adverse Event|0|||
126413908|NCT01748825|454808867|FG008|Dose Escalation|Adverse Event|0|||
126413909|NCT01748825|454808868|FG009|Dose Escalation|Adverse Event|0|||
126413910|NCT01748825|454808859|FG000|Dose Expansion|Refused further treatment|0|||
126413911|NCT01748825|454808860|FG001|Dose Expansion|Refused further treatment|0|||
126413912|NCT01748825|454808861|FG002|Dose Expansion|Refused further treatment|0|||
126413913|NCT01748825|454808862|FG003|Dose Expansion|Refused further treatment|0|||
126413914|NCT01748825|454808863|FG004|Dose Expansion|Refused further treatment|0|||
126413915|NCT01748825|454808864|FG005|Dose Expansion|Refused further treatment|0|||
126413916|NCT01748825|454808865|FG006|Dose Expansion|Refused further treatment|0|||
126413917|NCT01748825|454808866|FG007|Dose Expansion|Refused further treatment|0|||
126413918|NCT01748825|454808867|FG008|Dose Expansion|Refused further treatment|1|||
126413919|NCT01748825|454808868|FG009|Dose Expansion|Refused further treatment|1|||
126413920|NCT01748825|454808859|FG000|Dose Expansion|Switched to alternative treatment|0|||
126413921|NCT01748825|454808860|FG001|Dose Expansion|Switched to alternative treatment|0|||
126413922|NCT01748825|454808861|FG002|Dose Expansion|Switched to alternative treatment|0|||
126413923|NCT01748825|454808862|FG003|Dose Expansion|Switched to alternative treatment|0|||
126413924|NCT01748825|454808863|FG004|Dose Expansion|Switched to alternative treatment|0|||
126413925|NCT01748825|454808864|FG005|Dose Expansion|Switched to alternative treatment|0|||
126413926|NCT01748825|454808865|FG006|Dose Expansion|Switched to alternative treatment|0|||
126413927|NCT01748825|454808866|FG007|Dose Expansion|Switched to alternative treatment|0|||
126413928|NCT01748825|454808867|FG008|Dose Expansion|Switched to alternative treatment|0|||
126413929|NCT01748825|454808868|FG009|Dose Expansion|Switched to alternative treatment|1|||
126413930|NCT01748825|454808859|FG000|Dose Expansion|Adverse Event|0|||
126413931|NCT01748825|454808860|FG001|Dose Expansion|Adverse Event|0|||
126413932|NCT01748825|454808861|FG002|Dose Expansion|Adverse Event|0|||
126413933|NCT01748825|454808862|FG003|Dose Expansion|Adverse Event|0|||
126413934|NCT01748825|454808863|FG004|Dose Expansion|Adverse Event|0|||
126413935|NCT01748825|454808864|FG005|Dose Expansion|Adverse Event|0|||
126413936|NCT01748825|454808865|FG006|Dose Expansion|Adverse Event|0|||
126413937|NCT01748825|454808866|FG007|Dose Expansion|Adverse Event|0|||
126413938|NCT01748825|454808867|FG008|Dose Expansion|Adverse Event|0|||
126413939|NCT01748825|454808868|FG009|Dose Expansion|Adverse Event|3|||
126413940|NCT01748825|454808859|FG000|Dose Expansion|Physician Decision|0|||
126413941|NCT01748825|454808860|FG001|Dose Expansion|Physician Decision|0|||
126413942|NCT01748825|454808861|FG002|Dose Expansion|Physician Decision|0|||
126413943|NCT01748825|454808862|FG003|Dose Expansion|Physician Decision|0|||
126413944|NCT01748825|454808863|FG004|Dose Expansion|Physician Decision|0|||
126413945|NCT01748825|454808864|FG005|Dose Expansion|Physician Decision|0|||
126413946|NCT01748825|454808865|FG006|Dose Expansion|Physician Decision|0|||
126413947|NCT01748825|454808866|FG007|Dose Expansion|Physician Decision|0|||
126413948|NCT01748825|454808867|FG008|Dose Expansion|Physician Decision|1|||
126413949|NCT01748825|454808868|FG009|Dose Expansion|Physician Decision|0|||
126413950|NCT00852241|454808870|FG000|Overall Study|Physician Decision|18|||
126413951|NCT00659230|454808872|FG000|Overall Study|Lost to Follow-up|2|||
126413952|NCT00659230|454808873|FG001|Overall Study|Lost to Follow-up|5|||
126413953|NCT00659230|454808872|FG000|Overall Study|Lost source documentation|5|||
126413954|NCT00659230|454808873|FG001|Overall Study|Lost source documentation|4|||
126413955|NCT00659230|454808872|FG000|Overall Study|Did not return post-randomization|2|||
126413956|NCT00659230|454808873|FG001|Overall Study|Did not return post-randomization|3|||
126413957|NCT00118430|454808874|FG000|Overall Study|Withdrawal by Subject|6|||
126413958|NCT00118430|454808875|FG001|Overall Study|Withdrawal by Subject|2|||
126413959|NCT00118430|454808876|FG002|Overall Study|Withdrawal by Subject|0|||
126413960|NCT00118430|454808874|FG000|Overall Study|Lost to Follow-up|15|||
126413961|NCT00118430|454808875|FG001|Overall Study|Lost to Follow-up|22|||
126413962|NCT00118430|454808876|FG002|Overall Study|Lost to Follow-up|28|||
126413963|NCT02069392|454808879|FG000|Overall Study|Withdrawal by Subject|4|||
126413964|NCT02069392|454808880|FG001|Overall Study|Withdrawal by Subject|2|||
126413965|NCT00269633|454808881|FG000|Overall Study|Withdrawal by Subject|1|||
126413966|NCT00269633|454808882|FG001|Overall Study|Withdrawal by Subject|0|||
126413967|NCT04412707|454808883|FG000|Cycle 1|Death|0|||
126413968|NCT04412707|454808884|FG001|Cycle 1|Death|3|||
126413969|NCT04412707|454808883|FG000|Cycle 1|Disease progression|1|||
126413970|NCT04412707|454808884|FG001|Cycle 1|Disease progression|2|||
126413971|NCT04412707|454808883|FG000|Cycle 2|Death|0|||
126413972|NCT04412707|454808884|FG001|Cycle 2|Death|1|||
126413973|NCT04412707|454808883|FG000|Cycle 2|Disease progression|3|||
125890978|NCT04413617|452899653|FG001|Overall Study|COVID-19|1|||
125890979|NCT04413617|452899654|FG002|Overall Study|COVID-19|0|||
125890980|NCT04413617|452899655|FG003|Overall Study|COVID-19|0|||
126413974|NCT04412707|454808884|FG001|Cycle 2|Disease progression|0|||
126413975|NCT04412707|454808883|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
126413976|NCT04412707|454808884|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
126413977|NCT04412707|454808883|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
126413978|NCT04412707|454808884|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
126413979|NCT04412707|454808883|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
126413980|NCT04412707|454808884|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
125890981|NCT04413617|452899656|FG004|Overall Study|COVID-19|0|||
126413981|NCT04412707|454808883|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
126413982|NCT04412707|454808884|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
126413983|NCT02476006|454808885|FG000|Overall Study|Death|4|||
126413984|NCT02476006|454808885|FG000|Overall Study|Lack of treatment efficacy|2|||
125890982|NCT02657408|452899657|FG000|Overall Study|Adverse Event|3|||
125890983|NCT02657408|452899658|FG001|Overall Study|Adverse Event|7|||
125890984|NCT00324961|452899660|FG000|Overall Study|Adverse Event|5|||
125890985|NCT00324961|452899660|FG000|Overall Study|Consent Withdrawn|11|||
125890986|NCT00324961|452899660|FG000|Overall Study|Lost to Follow-up|22|||
125890987|NCT00324961|452899660|FG000|Overall Study|Protocol Violation|3|||
125890988|NCT00324961|452899660|FG000|Overall Study|Other|2|||
125890989|NCT03350672|452899664|FG000|Overall Study|Withdrawal by Subject|7|||
125890990|NCT03350672|452899665|FG001|Overall Study|Withdrawal by Subject|0|||
126413985|NCT02476006|454808885|FG000|Overall Study|Pregnancy|1|||
126413986|NCT02476006|454808885|FG000|Overall Study|Participant did not wish to continue|39|||
126413987|NCT02476006|454808885|FG000|Overall Study|Adverse Event|41|||
126413988|NCT02476006|454808885|FG000|Overall Study|Poor compliance to study protocol|3|||
126413989|NCT02476006|454808885|FG000|Overall Study|Sponsor decision|6|||
126413990|NCT02476006|454808885|FG000|Overall Study|Lost to Follow-up|5|||
126413991|NCT02476006|454808885|FG000|Overall Study|Physician Decision|5|||
126413992|NCT02476006|454808885|FG000|Overall Study|Study ended treatment not available|4|||
126413993|NCT02476006|454808885|FG000|Overall Study|Switched to commercial drug|4|||
126413994|NCT02476006|454808885|FG000|Overall Study|Excluded from study|1|||
126413995|NCT02476006|454808885|FG000|Overall Study|Protocol Violation|1|||
126413996|NCT02476006|454808885|FG000|Overall Study|Enrolled but not treated|4|||
126413997|NCT02467582|454811232|FG000|Allocation|Withdrawal by Subject|1|||
126413998|NCT02467582|454811233|FG001|Allocation|Withdrawal by Subject|0|||
126413999|NCT02467582|454811232|FG000|Follow-up|Death|5|||
126414000|NCT02467582|454811233|FG001|Follow-up|Death|4|||
126414001|NCT02467582|454811232|FG000|Follow-up|Lost to Follow-up|6|||
126414002|NCT02467582|454811233|FG001|Follow-up|Lost to Follow-up|5|||
126414003|NCT01370265|454811234|FG000|First Intervention|Adverse Event|1|||
126414004|NCT01370265|454811235|FG001|First Intervention|Adverse Event|1|||
126414005|NCT01959841|454811236|FG000|Overall Study|Adverse Event|1|||
126414006|NCT01959841|454811237|FG001|Overall Study|Adverse Event|3|||
126414007|NCT01959841|454811238|FG002|Overall Study|Adverse Event|2|||
126414008|NCT01959841|454811236|FG000|Overall Study|Lack of Efficacy|5|||
126414009|NCT01959841|454811237|FG001|Overall Study|Lack of Efficacy|0|||
126414010|NCT01959841|454811238|FG002|Overall Study|Lack of Efficacy|0|||
126414011|NCT01959841|454811236|FG000|Overall Study|Lost to Follow-up|1|||
126414012|NCT01959841|454811237|FG001|Overall Study|Lost to Follow-up|1|||
126414013|NCT01959841|454811238|FG002|Overall Study|Lost to Follow-up|0|||
126414014|NCT01959841|454811236|FG000|Overall Study|Physician Decision|0|||
126414015|NCT01959841|454811237|FG001|Overall Study|Physician Decision|2|||
126414016|NCT01959841|454811238|FG002|Overall Study|Physician Decision|3|||
126414017|NCT01959841|454811236|FG000|Overall Study|Protocol Violation|16|||
126414018|NCT01959841|454811237|FG001|Overall Study|Protocol Violation|23|||
126414019|NCT01959841|454811238|FG002|Overall Study|Protocol Violation|16|||
126414020|NCT01959841|454811236|FG000|Overall Study|Withdrawal by Subject|7|||
126414021|NCT01959841|454811237|FG001|Overall Study|Withdrawal by Subject|7|||
126414022|NCT01959841|454811238|FG002|Overall Study|Withdrawal by Subject|5|||
126414023|NCT01959841|454811236|FG000|Overall Study|Clinical laboratory value|2|||
126414024|NCT01959841|454811237|FG001|Overall Study|Clinical laboratory value|6|||
126414025|NCT01959841|454811238|FG002|Overall Study|Clinical laboratory value|6|||
126414026|NCT01959841|454811236|FG000|Overall Study|Platelet count below on day1 or 4|11|||
126414027|NCT01959841|454811237|FG001|Overall Study|Platelet count below on day1 or 4|15|||
126414028|NCT01959841|454811238|FG002|Overall Study|Platelet count below on day1 or 4|11|||
126414029|NCT00780416|454811239|FG000|Overall Study|Physician Decision|3|||
126414030|NCT00780416|454811240|FG001|Overall Study|Physician Decision|3|||
126414031|NCT00780416|454811239|FG000|Overall Study|Protocol Violation|1|||
126414032|NCT00780416|454811240|FG001|Overall Study|Protocol Violation|0|||
126414033|NCT00780416|454811239|FG000|Overall Study|Withdrawal by Subject|8|||
126414034|NCT00780416|454811240|FG001|Overall Study|Withdrawal by Subject|6|||
126414035|NCT00666224|454811243|FG000|Double-Blind|Adverse Event|15|||
126414036|NCT00666224|454811244|FG001|Double-Blind|Adverse Event|5|||
126414037|NCT00666224|454811243|FG000|Double-Blind|Lost to Follow-up|2|||
126414038|NCT00666224|454811244|FG001|Double-Blind|Lost to Follow-up|2|||
126414039|NCT00666224|454811243|FG000|Double-Blind|Withdrawal by Subject|18|||
126414040|NCT00666224|454811244|FG001|Double-Blind|Withdrawal by Subject|14|||
126414041|NCT00666224|454811243|FG000|Double-Blind|Physician Decision|0|||
126414042|NCT00666224|454811244|FG001|Double-Blind|Physician Decision|3|||
126414043|NCT00666224|454811243|FG000|Double-Blind|Sponsor decision|1|||
125890991|NCT03350672|452899666|FG002|Overall Study|Withdrawal by Subject|0|||
126414044|NCT00666224|454811244|FG001|Double-Blind|Sponsor decision|0|||
126414045|NCT00666224|454811243|FG000|Double-Blind|Pregnancy|3|||
126414046|NCT00666224|454811244|FG001|Double-Blind|Pregnancy|2|||
126414047|NCT00666224|454811243|FG000|Double-Blind|Noncompliance|1|||
126414048|NCT00666224|454811244|FG001|Double-Blind|Noncompliance|0|||
126414049|NCT00666224|454811243|FG000|Double-Blind|Death|1|||
125890992|NCT03530124|452899669|FG000|Overall Study|Withdrawal by Subject|0|||
125890993|NCT03530124|452899670|FG001|Overall Study|Withdrawal by Subject|1|||
126414050|NCT00666224|454811244|FG001|Double-Blind|Death|0|||
126414051|NCT00666224|454811243|FG000|Double-Blind|Undefined/Unknown|4|||
126414052|NCT00666224|454811244|FG001|Double-Blind|Undefined/Unknown|1|||
126414053|NCT00666224|454811243|FG000|Open-Label|Adverse Event|8|||
126414054|NCT00666224|454811244|FG001|Open-Label|Adverse Event|43|||
126414055|NCT00666224|454811243|FG000|Open-Label|Lost to Follow-up|4|||
126414056|NCT00666224|454811244|FG001|Open-Label|Lost to Follow-up|5|||
126414057|NCT00666224|454811243|FG000|Open-Label|Withdrawal by Subject|12|||
126414058|NCT00666224|454811244|FG001|Open-Label|Withdrawal by Subject|25|||
126414059|NCT00666224|454811243|FG000|Open-Label|Physician Decision|7|||
126414060|NCT00666224|454811244|FG001|Open-Label|Physician Decision|5|||
126414061|NCT00666224|454811243|FG000|Open-Label|Pregnancy|1|||
126414062|NCT00666224|454811244|FG001|Open-Label|Pregnancy|5|||
126414063|NCT00666224|454811243|FG000|Open-Label|Noncompliance|2|||
126414064|NCT00666224|454811244|FG001|Open-Label|Noncompliance|1|||
126414065|NCT00666224|454811243|FG000|Open-Label|Undefined/Unknown|1|||
126414066|NCT00666224|454811244|FG001|Open-Label|Undefined/Unknown|1|||
126414067|NCT00871338|454811248|FG000|Prior to Booster|Withdrawal by Subject|1|||
126414068|NCT00871338|454811249|FG001|Prior to Booster|Withdrawal by Subject|3|||
126414069|NCT00871338|454811248|FG000|Prior to Booster|Lost to Follow-up|1|||
126414070|NCT00871338|454811249|FG001|Prior to Booster|Lost to Follow-up|0|||
126414071|NCT00265317|454811252|FG000|Lead-In|Objective progression or relapse|6|||
126414072|NCT00265317|454811253|FG001|Lead-In|Objective progression or relapse|11|||
126414073|NCT00265317|454811254|FG002|Lead-In|Objective progression or relapse|0|||
126414074|NCT00265317|454811255|FG003|Lead-In|Objective progression or relapse|0|||
126414075|NCT00265317|454811252|FG000|Lead-In|Adverse Event|2|||
126414076|NCT00265317|454811253|FG001|Lead-In|Adverse Event|1|||
126414077|NCT00265317|454811254|FG002|Lead-In|Adverse Event|0|||
126414078|NCT00265317|454811255|FG003|Lead-In|Adverse Event|0|||
126414079|NCT00265317|454811252|FG000|Lead-In|Death|3|||
126414080|NCT00265317|454811253|FG001|Lead-In|Death|5|||
126414081|NCT00265317|454811254|FG002|Lead-In|Death|0|||
126414082|NCT00265317|454811255|FG003|Lead-In|Death|0|||
126414083|NCT00265317|454811252|FG000|Lead-In|Withdrawal/other than adverse event|1|||
126414084|NCT00265317|454811253|FG001|Lead-In|Withdrawal/other than adverse event|0|||
126414085|NCT00265317|454811254|FG002|Lead-In|Withdrawal/other than adverse event|0|||
126414086|NCT00265317|454811255|FG003|Lead-In|Withdrawal/other than adverse event|0|||
126414087|NCT00265317|454811252|FG000|Phase 2|Objective progression or relapse|0|||
126414088|NCT00265317|454811253|FG001|Phase 2|Objective progression or relapse|0|||
126414089|NCT00265317|454811254|FG002|Phase 2|Objective progression or relapse|37|||
126414090|NCT00265317|454811255|FG003|Phase 2|Objective progression or relapse|38|||
126414091|NCT00265317|454811252|FG000|Phase 2|Global deterioration of health status|0|||
126414092|NCT00265317|454811253|FG001|Phase 2|Global deterioration of health status|0|||
126414093|NCT00265317|454811254|FG002|Phase 2|Global deterioration of health status|3|||
126414094|NCT00265317|454811255|FG003|Phase 2|Global deterioration of health status|0|||
126414095|NCT00265317|454811252|FG000|Phase 2|Adverse Event|0|||
126414096|NCT00265317|454811253|FG001|Phase 2|Adverse Event|0|||
126414097|NCT00265317|454811254|FG002|Phase 2|Adverse Event|7|||
126414098|NCT00265317|454811255|FG003|Phase 2|Adverse Event|5|||
126414099|NCT00265317|454811252|FG000|Phase 2|Death|0|||
126414100|NCT00265317|454811253|FG001|Phase 2|Death|0|||
126054209|NCT05810285|453492273|FG000|Overall Study|Adverse Event|18|||
126054210|NCT05810285|453492274|FG001|Overall Study|Adverse Event|16|||
126414101|NCT00265317|454811254|FG002|Phase 2|Death|12|||
126414102|NCT00265317|454811255|FG003|Phase 2|Death|15|||
126414103|NCT00265317|454811252|FG000|Phase 2|Protocol Violation|0|||
126054211|NCT05325294|453492275|FG000|Overall Study|Adverse Event|3|||
126414104|NCT00265317|454811253|FG001|Phase 2|Protocol Violation|0|||
126414105|NCT00265317|454811254|FG002|Phase 2|Protocol Violation|1|||
126054212|NCT05325294|453492276|FG001|Overall Study|Adverse Event|3|||
126414106|NCT00265317|454811255|FG003|Phase 2|Protocol Violation|4|||
126414107|NCT00265317|454811252|FG000|Phase 2|Lost to Follow-up|0|||
126414108|NCT00265317|454811253|FG001|Phase 2|Lost to Follow-up|0|||
126414109|NCT00265317|454811254|FG002|Phase 2|Lost to Follow-up|0|||
126414110|NCT00265317|454811255|FG003|Phase 2|Lost to Follow-up|1|||
126414111|NCT00265317|454811252|FG000|Phase 2|Withdrawal/other than adverse event|0|||
126414112|NCT00265317|454811253|FG001|Phase 2|Withdrawal/other than adverse event|0|||
126414113|NCT00265317|454811254|FG002|Phase 2|Withdrawal/other than adverse event|2|||
126054213|NCT05325294|453492275|FG000|Overall Study|Physician Decision|0|||
126054214|NCT05325294|453492276|FG001|Overall Study|Physician Decision|1|||
126054215|NCT05325294|453492275|FG000|Overall Study|Withdrawal by Subject|0|||
126054216|NCT05325294|453492276|FG001|Overall Study|Withdrawal by Subject|3|||
126054217|NCT05325294|453492275|FG000|Overall Study|Lost to Follow-up|1|||
126054218|NCT05325294|453492276|FG001|Overall Study|Lost to Follow-up|0|||
126054219|NCT05325294|453492275|FG000|Overall Study|Sponsor Request|0|||
126054220|NCT05325294|453492276|FG001|Overall Study|Sponsor Request|2|||
126054221|NCT04577651|453492277|FG000|Overall Study|Screen Failure|7|||
126054222|NCT04577651|453492277|FG000|Overall Study|Adverse Event|1|||
126054223|NCT04577651|453492277|FG000|Overall Study|Death|1|||
126054224|NCT04577651|453492277|FG000|Overall Study|Physician Decision|1|||
126054225|NCT04577651|453492277|FG000|Overall Study|Withdrawal by Subject|3|||
126414114|NCT00265317|454811255|FG003|Phase 2|Withdrawal/other than adverse event|1|||
126414115|NCT00265317|454811252|FG000|Phase 2|Study terminated by sponsor|0|||
126414116|NCT00265317|454811253|FG001|Phase 2|Study terminated by sponsor|0|||
126414117|NCT00265317|454811254|FG002|Phase 2|Study terminated by sponsor|1|||
126054226|NCT00647387|453492278|FG000|Overall Study|Lost to Follow-up|6|||
126054227|NCT00647387|453492278|FG000|Overall Study|Unsuccessful implant|5|||
126054228|NCT00647387|453492278|FG000|Overall Study|Device explanted|3|||
126054229|NCT00647387|453492278|FG000|Overall Study|Other Reason|3|||
126414118|NCT00265317|454811255|FG003|Phase 2|Study terminated by sponsor|0|||
126414119|NCT00265317|454811252|FG000|Phase 2|Other|0|||
126414120|NCT00265317|454811253|FG001|Phase 2|Other|0|||
126414121|NCT00265317|454811254|FG002|Phase 2|Other|1|||
126414122|NCT00265317|454811255|FG003|Phase 2|Other|1|||
126414123|NCT00711971|454811258|FG000|Overall Study|Lost to Follow-up|3|||
126414124|NCT00711971|454811259|FG001|Overall Study|Lost to Follow-up|4|||
126414125|NCT00711971|454811260|FG002|Overall Study|Lost to Follow-up|1|||
126414126|NCT00536471|454811269|FG000|Overall Study|Lost to Follow-up|48|||
126054230|NCT00647387|453492278|FG000|Overall Study|Death|2|||
126414127|NCT00536471|454811270|FG001|Overall Study|Lost to Follow-up|23|||
126414128|NCT00536471|454811271|FG002|Overall Study|Lost to Follow-up|48|||
126414129|NCT00536471|454811272|FG003|Overall Study|Lost to Follow-up|22|||
126414130|NCT00536471|454811269|FG000|Overall Study|Adverse Event|32|||
126414131|NCT00536471|454811270|FG001|Overall Study|Adverse Event|16|||
126414132|NCT00536471|454811271|FG002|Overall Study|Adverse Event|28|||
126414133|NCT00536471|454811272|FG003|Overall Study|Adverse Event|13|||
126414134|NCT00536471|454811269|FG000|Overall Study|Withdrawal by Subject|40|||
126414135|NCT00536471|454811270|FG001|Overall Study|Withdrawal by Subject|24|||
126414136|NCT00536471|454811271|FG002|Overall Study|Withdrawal by Subject|43|||
126414137|NCT00536471|454811272|FG003|Overall Study|Withdrawal by Subject|21|||
126414138|NCT00536471|454811269|FG000|Overall Study|Lack of Efficacy|17|||
126414139|NCT00536471|454811270|FG001|Overall Study|Lack of Efficacy|18|||
126054231|NCT04172675|453493859|FG000|Overall Study|Withdrawal by Subject|7|||
126054232|NCT04172675|453493860|FG001|Overall Study|Withdrawal by Subject|5|||
126054233|NCT04172675|453493861|FG002|Overall Study|Withdrawal by Subject|1|||
126054234|NCT04172675|453493862|FG003|Overall Study|Withdrawal by Subject|4|||
126054235|NCT03945773|453493863|FG000|Overall Study|Consent Withdrawn|1|||
126414140|NCT00536471|454811271|FG002|Overall Study|Lack of Efficacy|11|||
126054236|NCT03945773|453493864|FG001|Overall Study|Consent Withdrawn|1|||
126414141|NCT00536471|454811272|FG003|Overall Study|Lack of Efficacy|9|||
126414142|NCT00536471|454811269|FG000|Overall Study|Protocol Violation|8|||
126414143|NCT00536471|454811270|FG001|Overall Study|Protocol Violation|1|||
126414144|NCT00536471|454811271|FG002|Overall Study|Protocol Violation|2|||
126414145|NCT00536471|454811272|FG003|Overall Study|Protocol Violation|3|||
126414146|NCT00536471|454811269|FG000|Overall Study|Physician Decision|11|||
126414147|NCT00536471|454811270|FG001|Overall Study|Physician Decision|1|||
126414148|NCT00536471|454811271|FG002|Overall Study|Physician Decision|3|||
126414149|NCT00536471|454811272|FG003|Overall Study|Physician Decision|2|||
126414150|NCT00536471|454811269|FG000|Overall Study|Death|0|||
126414151|NCT00536471|454811270|FG001|Overall Study|Death|0|||
126414152|NCT00536471|454811271|FG002|Overall Study|Death|1|||
126414153|NCT00536471|454811272|FG003|Overall Study|Death|2|||
126414154|NCT00536471|454811269|FG000|Overall Study|Sponsor Decision|0|||
126414155|NCT00536471|454811270|FG001|Overall Study|Sponsor Decision|1|||
126414156|NCT00536471|454811271|FG002|Overall Study|Sponsor Decision|3|||
126414157|NCT00536471|454811272|FG003|Overall Study|Sponsor Decision|2|||
126414158|NCT01440816|454811278|FG000|Overall Study|Disease Progression|0|||
126414159|NCT01440816|454811279|FG001|Overall Study|Disease Progression|9|||
126414160|NCT01440816|454811278|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
126414161|NCT01440816|454811279|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
126414162|NCT00856544|454811280|FG000|Overall Study|Randomized but not treated|3|||
126414163|NCT00856544|454811281|FG001|Overall Study|Randomized but not treated|0|||
126414164|NCT00856544|454811282|FG002|Overall Study|Randomized but not treated|0|||
126414165|NCT00856544|454811283|FG003|Overall Study|Randomized but not treated|0|||
126414166|NCT00856544|454811280|FG000|Overall Study|Death|0|||
126414167|NCT00856544|454811281|FG001|Overall Study|Death|2|||
126414168|NCT00856544|454811282|FG002|Overall Study|Death|0|||
126414169|NCT00856544|454811283|FG003|Overall Study|Death|0|||
126414170|NCT00856544|454811280|FG000|Overall Study|Adverse Event|20|||
126414171|NCT00856544|454811281|FG001|Overall Study|Adverse Event|29|||
126414172|NCT00856544|454811282|FG002|Overall Study|Adverse Event|2|||
126414173|NCT00856544|454811283|FG003|Overall Study|Adverse Event|3|||
126414174|NCT00856544|454811280|FG000|Overall Study|Lack of Efficacy|16|||
126414175|NCT00856544|454811281|FG001|Overall Study|Lack of Efficacy|12|||
126414176|NCT00856544|454811282|FG002|Overall Study|Lack of Efficacy|3|||
126414177|NCT00856544|454811283|FG003|Overall Study|Lack of Efficacy|3|||
126414178|NCT00856544|454811280|FG000|Overall Study|Other|9|||
126414179|NCT00856544|454811281|FG001|Overall Study|Other|16|||
126414180|NCT00856544|454811282|FG002|Overall Study|Other|1|||
126414181|NCT00856544|454811283|FG003|Overall Study|Other|6|||
126414182|NCT00856544|454811280|FG000|Overall Study|Lost to Follow-up|1|||
126414183|NCT00856544|454811281|FG001|Overall Study|Lost to Follow-up|2|||
126414184|NCT00856544|454811282|FG002|Overall Study|Lost to Follow-up|2|||
126414185|NCT00856544|454811283|FG003|Overall Study|Lost to Follow-up|0|||
126414186|NCT00856544|454811280|FG000|Overall Study|Withdrawal by Subject|8|||
126414187|NCT00856544|454811281|FG001|Overall Study|Withdrawal by Subject|5|||
126414188|NCT00856544|454811282|FG002|Overall Study|Withdrawal by Subject|0|||
126414189|NCT00856544|454811283|FG003|Overall Study|Withdrawal by Subject|1|||
126414190|NCT01687101|454811284|FG000|Overall Study|Lost to Follow-up|7|||
126414191|NCT03250182|454811287|FG000|Overall Study|Withdrawal by Subject|1|||
126414192|NCT01858740|454811288|FG000|Overall Study|Death|4|||
126414193|NCT00894361|454811295|FG000|Overall Study|deaths and less than 2 years followup|24|||
126414194|NCT00894361|454811296|FG001|Overall Study|deaths and less than 2 years followup|64|||
126414195|NCT04207060|454811301|FG000|Overall Study|Lost to Follow-up|2|||
126414196|NCT04207060|454811302|FG001|Overall Study|Lost to Follow-up|0|||
126414197|NCT02718716|454811304|FG000|Overall Study|Lack of Efficacy|1|||
126414198|NCT02718716|454811305|FG001|Overall Study|Lack of Efficacy|0|||
126414199|NCT02718716|454811306|FG002|Overall Study|Lack of Efficacy|0|||
126414200|NCT02718716|454811307|FG003|Overall Study|Lack of Efficacy|0|||
126414201|NCT02718716|454811308|FG004|Overall Study|Lack of Efficacy|0|||
126414202|NCT00296140|454811312|FG000|Overall Study|Lost to Follow-up|1|||
126414203|NCT00296140|454811313|FG001|Overall Study|Lost to Follow-up|0|||
126414204|NCT00296140|454811312|FG000|Overall Study|Withdrawal by Subject|1|||
126414205|NCT00296140|454811313|FG001|Overall Study|Withdrawal by Subject|0|||
126414206|NCT00296140|454811312|FG000|Overall Study|Discharge to Nursing Home|1|||
126414207|NCT00296140|454811313|FG001|Overall Study|Discharge to Nursing Home|0|||
126414208|NCT03245398|454811318|FG000|Overall Study|Travelled to another island|1|||
126414209|NCT03245398|454811319|FG001|Overall Study|Travelled to another island|0|||
126414210|NCT00596830|454811322|FG000|Overall Study|Death|258|||
126414211|NCT00596830|454811323|FG001|Overall Study|Death|247|||
126414212|NCT00596830|454811322|FG000|Overall Study|Lost to Follow-up|7|||
126414213|NCT00596830|454811323|FG001|Overall Study|Lost to Follow-up|11|||
126414214|NCT00596830|454811322|FG000|Overall Study|Withdrawal by Subject|22|||
126414215|NCT00596830|454811323|FG001|Overall Study|Withdrawal by Subject|12|||
126054237|NCT03945773|453493863|FG000|Overall Study|Lost to Follow-up|1|||
126414216|NCT00596830|454811322|FG000|Overall Study|Study terminated by sponsor|51|||
126414217|NCT00596830|454811323|FG001|Overall Study|Study terminated by sponsor|62|||
126414218|NCT00596830|454811322|FG000|Overall Study|Follow-up was discontinued|1|||
126414219|NCT00596830|454811323|FG001|Overall Study|Follow-up was discontinued|0|||
126414220|NCT00596830|454811322|FG000|Overall Study|Randomized but not treated|3|||
126414221|NCT00596830|454811323|FG001|Overall Study|Randomized but not treated|7|||
126414222|NCT00887926|454811324|FG000|Overall Study|Withdrawal by Subject|0|||
126414223|NCT00887926|454811325|FG001|Overall Study|Withdrawal by Subject|1|||
126414224|NCT00887926|454811326|FG002|Overall Study|Withdrawal by Subject|0|||
126414225|NCT00887926|454811327|FG003|Overall Study|Withdrawal by Subject|0|||
126414226|NCT00880191|454811328|FG000|Overall Study|Refused further treatment|4|||
126414227|NCT00880191|454811329|FG001|Overall Study|Refused further treatment|1|||
126414228|NCT00880191|454811328|FG000|Overall Study|Adverse Event|8|||
126414229|NCT00880191|454811329|FG001|Overall Study|Adverse Event|6|||
126414230|NCT00880191|454811328|FG000|Overall Study|Hospitalization/efficacy|1|||
126414231|NCT00880191|454811329|FG001|Overall Study|Hospitalization/efficacy|1|||
126414232|NCT02097030|454811330|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
126414233|NCT02097030|454811331|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
126414234|NCT02097030|454811330|FG000|First Intervention (3 Days)|Visual Acuity|0|||
126414235|NCT02097030|454811331|FG001|First Intervention (3 Days)|Visual Acuity|1|||
126414236|NCT01919801|454811332|FG000|Overall Study|Withdrawal by Subject|1|||
126414237|NCT01919801|454811333|FG001|Overall Study|Withdrawal by Subject|0|||
126414238|NCT01919801|454811332|FG000|Overall Study|Physician Decision|0|||
126414239|NCT01919801|454811333|FG001|Overall Study|Physician Decision|1|||
126414240|NCT01919801|454811332|FG000|Overall Study|Lost to Follow-up|0|||
126414241|NCT01919801|454811333|FG001|Overall Study|Lost to Follow-up|1|||
126414242|NCT01919801|454811332|FG000|Overall Study|Other|0|||
126414243|NCT01919801|454811333|FG001|Overall Study|Other|1|||
126105353|NCT01281969|453678602|FG001|Overall Study|not randomized, child consent not given|0|||
126105354|NCT01281969|453678603|FG002|Overall Study|not randomized, child consent not given|2|||
126414244|NCT01843062|454811334|FG000|Overall Study|Protocol Violation|1|||
126414245|NCT01843062|454811335|FG001|Overall Study|Protocol Violation|0|||
126414246|NCT01843062|454811334|FG000|Overall Study|New treatment following progression|2|||
126414247|NCT01843062|454811335|FG001|Overall Study|New treatment following progression|0|||
126054238|NCT03945773|453493864|FG001|Overall Study|Lost to Follow-up|0|||
126054239|NCT03945773|453493863|FG000|Overall Study|Death|46|||
126414248|NCT01843062|454811334|FG000|Overall Study|Pregnancy|1|||
126414249|NCT01843062|454811335|FG001|Overall Study|Pregnancy|0|||
126414250|NCT01843062|454811334|FG000|Overall Study|Adverse Event|2|||
126414251|NCT01843062|454811335|FG001|Overall Study|Adverse Event|0|||
126414252|NCT01843062|454811334|FG000|Overall Study|Incorrect randomisation|1|||
126414253|NCT01843062|454811335|FG001|Overall Study|Incorrect randomisation|0|||
126414254|NCT01843062|454811334|FG000|Overall Study|Withdrawal by Subject|12|||
126054240|NCT03945773|453493864|FG001|Overall Study|Death|22|||
126054241|NCT03945773|453493863|FG000|Overall Study|Physician Decision|1|||
126054242|NCT03945773|453493864|FG001|Overall Study|Physician Decision|0|||
126054243|NCT03945773|453493863|FG000|Overall Study|Other|1|||
126054244|NCT03945773|453493864|FG001|Overall Study|Other|0|||
126054245|NCT03945773|453493863|FG000|Overall Study|Ongoing at the time of DCO|4|||
126054246|NCT03945773|453493864|FG001|Overall Study|Ongoing at the time of DCO|3|||
126054247|NCT05349721|453493865|FG000|Part A (24 Weeks)|Adverse Event|9|||
126054248|NCT05349721|453493866|FG001|Part A (24 Weeks)|Adverse Event|2|||
126054249|NCT05349721|453493865|FG000|Part A (24 Weeks)|Death|8|||
126054250|NCT05349721|453493866|FG001|Part A (24 Weeks)|Death|3|||
126054251|NCT05349721|453493865|FG000|Part A (24 Weeks)|Disease Progression|1|||
126054252|NCT05349721|453493866|FG001|Part A (24 Weeks)|Disease Progression|1|||
126054253|NCT05349721|453493865|FG000|Part A (24 Weeks)|Screen Failure|2|||
126054254|NCT05349721|453493866|FG001|Part A (24 Weeks)|Screen Failure|0|||
126054255|NCT05349721|453493865|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
126054256|NCT05349721|453493866|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
126414255|NCT01843062|454811335|FG001|Overall Study|Withdrawal by Subject|3|||
126414256|NCT01843062|454811334|FG000|Overall Study|Death|1|||
126414257|NCT01843062|454811335|FG001|Overall Study|Death|2|||
126414258|NCT01843062|454811334|FG000|Overall Study|Lost to Follow-up|2|||
126414259|NCT01843062|454811335|FG001|Overall Study|Lost to Follow-up|4|||
126414260|NCT01677858|454811336|FG000|Overall Study|Adverse Event|0|||
126054257|NCT05349721|453493865|FG000|Part A (24 Weeks)|Other Than Specified|5|||
126054258|NCT05349721|453493866|FG001|Part A (24 Weeks)|Other Than Specified|1|||
126054259|NCT05349721|453493865|FG000|Part B (28 Weeks)|Adverse Event|3|||
126414261|NCT01677858|454811337|FG001|Overall Study|Adverse Event|0|||
126414262|NCT01677858|454811338|FG002|Overall Study|Adverse Event|2|||
126414263|NCT01677858|454811339|FG003|Overall Study|Adverse Event|3|||
126414264|NCT01677858|454811340|FG004|Overall Study|Adverse Event|13|||
126414265|NCT01677858|454811336|FG000|Overall Study|Death|0|||
126414266|NCT01677858|454811337|FG001|Overall Study|Death|0|||
126414267|NCT01677858|454811338|FG002|Overall Study|Death|0|||
125890994|NCT03530124|452899669|FG000|Overall Study|Protocol Violation|1|||
125890995|NCT03530124|452899670|FG001|Overall Study|Protocol Violation|0|||
125890996|NCT03530124|452899669|FG000|Overall Study|Discharged prior to study completion|1|||
125890997|NCT03530124|452899670|FG001|Overall Study|Discharged prior to study completion|0|||
125890998|NCT01583296|452899671|FG000|Overall Study|Withdrawal by Subject|11|||
125890999|NCT01583296|452899672|FG001|Overall Study|Withdrawal by Subject|10|||
125891000|NCT01047553|452899673|FG000|Overall Study|Adverse Event|10|||
125891001|NCT01047553|452899674|FG001|Overall Study|Adverse Event|5|||
125891002|NCT01047553|452899673|FG000|Overall Study|Withdrawal by Subject|4|||
125891003|NCT01047553|452899674|FG001|Overall Study|Withdrawal by Subject|2|||
125891004|NCT01047553|452899673|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
125891005|NCT01047553|452899674|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
125891006|NCT01047553|452899673|FG000|Overall Study|Lost to Follow-up|1|||
125891007|NCT01047553|452899674|FG001|Overall Study|Lost to Follow-up|0|||
125891008|NCT01047553|452899673|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
125891009|NCT01047553|452899674|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
125891010|NCT01047553|452899673|FG000|Overall Study|PI's decision|0|||
125891011|NCT01047553|452899674|FG001|Overall Study|PI's decision|1|||
125891012|NCT01063283|452899675|FG000|Cycle 1|Adverse Event|2|||
125891013|NCT01063283|452899676|FG001|Cycle 1|Adverse Event|0|||
125891014|NCT01063283|452899677|FG002|Cycle 1|Adverse Event|0|||
125891015|NCT01063283|452899675|FG000|Cycle 1|Technical failure in data collection|1|||
125891016|NCT01063283|452899676|FG001|Cycle 1|Technical failure in data collection|0|||
125891017|NCT01063283|452899677|FG002|Cycle 1|Technical failure in data collection|0|||
125891018|NCT01120717|452899678|FG000|Overall Study|Withdrawal by Subject|11|||
125891019|NCT01120717|452899679|FG001|Overall Study|Withdrawal by Subject|6|||
125891020|NCT01120717|452899678|FG000|Overall Study|Adverse Event|10|||
125891021|NCT01120717|452899679|FG001|Overall Study|Adverse Event|6|||
125891022|NCT01120717|452899678|FG000|Overall Study|Protocol Deviation|2|||
125891023|NCT01120717|452899679|FG001|Overall Study|Protocol Deviation|5|||
126054260|NCT05349721|453493866|FG001|Part B (28 Weeks)|Adverse Event|0|||
126054261|NCT05349721|453493865|FG000|Part B (28 Weeks)|Death|21|||
126054262|NCT05349721|453493866|FG001|Part B (28 Weeks)|Death|11|||
126054263|NCT05349721|453493865|FG000|Part B (28 Weeks)|Disease Progression|2|||
126054264|NCT05349721|453493866|FG001|Part B (28 Weeks)|Disease Progression|1|||
126054265|NCT05349721|453493865|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
126414268|NCT01677858|454811339|FG003|Overall Study|Death|0|||
126414269|NCT01677858|454811340|FG004|Overall Study|Death|1|||
126414270|NCT01677858|454811336|FG000|Overall Study|Physician Decision|1|||
126414271|NCT01677858|454811337|FG001|Overall Study|Physician Decision|0|||
126414272|NCT01677858|454811338|FG002|Overall Study|Physician Decision|2|||
126414273|NCT01677858|454811339|FG003|Overall Study|Physician Decision|0|||
126414274|NCT01677858|454811340|FG004|Overall Study|Physician Decision|12|||
126414275|NCT01677858|454811336|FG000|Overall Study|Progressive Disease|2|||
126414276|NCT01677858|454811337|FG001|Overall Study|Progressive Disease|1|||
126414277|NCT01677858|454811338|FG002|Overall Study|Progressive Disease|9|||
126414278|NCT01677858|454811339|FG003|Overall Study|Progressive Disease|3|||
126414279|NCT01677858|454811340|FG004|Overall Study|Progressive Disease|43|||
126414280|NCT01677858|454811336|FG000|Overall Study|Withdrawal by Subject|0|||
126414281|NCT01677858|454811337|FG001|Overall Study|Withdrawal by Subject|1|||
125891024|NCT01120717|452899678|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125891025|NCT01120717|452899679|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125891026|NCT01120717|452899678|FG000|Overall Study|Lost to Follow-up|2|||
125891027|NCT01120717|452899679|FG001|Overall Study|Lost to Follow-up|3|||
125891028|NCT01120717|452899678|FG000|Overall Study|Death|3|||
125891029|NCT01120717|452899679|FG001|Overall Study|Death|1|||
125891030|NCT01120717|452899678|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125891031|NCT01120717|452899679|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126414282|NCT01677858|454811338|FG002|Overall Study|Withdrawal by Subject|1|||
126414283|NCT01677858|454811339|FG003|Overall Study|Withdrawal by Subject|0|||
126414284|NCT01677858|454811340|FG004|Overall Study|Withdrawal by Subject|15|||
126414285|NCT01677858|454811336|FG000|Overall Study|Lost to Follow-up|0|||
126414286|NCT01677858|454811337|FG001|Overall Study|Lost to Follow-up|0|||
126414287|NCT01677858|454811338|FG002|Overall Study|Lost to Follow-up|0|||
126414288|NCT01677858|454811339|FG003|Overall Study|Lost to Follow-up|0|||
126414289|NCT01677858|454811340|FG004|Overall Study|Lost to Follow-up|1|||
126414290|NCT00773747|454811341|FG000|Overall Study|Lack of Efficacy|112|||
126414291|NCT00773747|454811342|FG001|Overall Study|Lack of Efficacy|144|||
126414292|NCT00773747|454811341|FG000|Overall Study|Physician Decision|26|||
126414293|NCT00773747|454811342|FG001|Overall Study|Physician Decision|18|||
126414294|NCT00773747|454811341|FG000|Overall Study|Lost to Follow-up|0|||
126414295|NCT00773747|454811342|FG001|Overall Study|Lost to Follow-up|1|||
126414296|NCT00773747|454811341|FG000|Overall Study|Protocol Violation|2|||
126414297|NCT00773747|454811342|FG001|Overall Study|Protocol Violation|2|||
126414298|NCT00773747|454811341|FG000|Overall Study|Withdrawal by Subject|89|||
126414299|NCT00773747|454811342|FG001|Overall Study|Withdrawal by Subject|61|||
126414300|NCT00773747|454811341|FG000|Overall Study|Adverse Event|61|||
126414301|NCT00773747|454811342|FG001|Overall Study|Adverse Event|62|||
126414302|NCT00773747|454811341|FG000|Overall Study|Death|5|||
126414303|NCT00773747|454811342|FG001|Overall Study|Death|8|||
126414304|NCT00773747|454811341|FG000|Overall Study|Not Treated|2|||
126414305|NCT00773747|454811342|FG001|Overall Study|Not Treated|0|||
126414306|NCT02669212|454811345|FG000|Overall Study|Lost to Follow-up|1|||
126414307|NCT02669212|454811346|FG001|Overall Study|Lost to Follow-up|0|||
126414308|NCT02669212|454811345|FG000|Overall Study|Medical Condition|3|||
126414309|NCT02669212|454811346|FG001|Overall Study|Medical Condition|4|||
126414310|NCT02669212|454811345|FG000|Overall Study|Withdrawal by Subject|0|||
125891032|NCT05343624|452899680|FG000|Overall Study|Chart review not completed|1|||
125891033|NCT02504216|452899685|FG000|Overall Study|Lost to Follow-up|3|||
126054266|NCT05349721|453493866|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
126054267|NCT05349721|453493865|FG000|Part B (28 Weeks)|Physician Decision|1|||
126054268|NCT05349721|453493866|FG001|Part B (28 Weeks)|Physician Decision|0|||
126105355|NCT01201265|453678608|FG000|Overall Study|Death|14|||
125891034|NCT02504216|452899686|FG001|Overall Study|Lost to Follow-up|3|||
125891035|NCT02504216|452899685|FG000|Overall Study|Withdrawal by Subject|8|||
126414311|NCT02669212|454811346|FG001|Overall Study|Withdrawal by Subject|2|||
126414312|NCT02669212|454811345|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
126414313|NCT02669212|454811346|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
126414314|NCT03549104|454811347|FG000|Overall Study|Withdrawal by Subject|5|||
126414315|NCT03549104|454811348|FG001|Overall Study|Withdrawal by Subject|2|||
126414316|NCT03549104|454811347|FG000|Overall Study|Covid shelter in place|1|||
126414317|NCT03549104|454811348|FG001|Overall Study|Covid shelter in place|2|||
126414318|NCT04869358|454811349|FG000|Overall Study|Wish to have children.|1|||
126414319|NCT04869358|454811350|FG001|Overall Study|Wish to have children.|0|||
126414320|NCT04869358|454811351|FG002|Overall Study|Wish to have children.|0|||
126414321|NCT04869358|454811352|FG003|Overall Study|Wish to have children.|0|||
126414322|NCT04164732|454811353|FG000|Treatment run-in Period|Adverse Event|4|||
126414323|NCT04164732|454811354|FG001|Treatment run-in Period|Adverse Event|0|||
126414324|NCT04164732|454811355|FG002|Treatment run-in Period|Adverse Event|0|||
126414325|NCT04164732|454811353|FG000|Treatment run-in Period|Physician Decision|1|||
126414326|NCT04164732|454811354|FG001|Treatment run-in Period|Physician Decision|0|||
126414327|NCT04164732|454811355|FG002|Treatment run-in Period|Physician Decision|0|||
126414328|NCT04164732|454811353|FG000|Treatment run-in Period|Screen Failure|1|||
126414329|NCT04164732|454811354|FG001|Treatment run-in Period|Screen Failure|0|||
126414330|NCT04164732|454811355|FG002|Treatment run-in Period|Screen Failure|0|||
126414331|NCT04164732|454811353|FG000|Randomized Treatment Period|Adverse Event|0|||
126414332|NCT04164732|454811354|FG001|Randomized Treatment Period|Adverse Event|1|||
126414333|NCT04164732|454811355|FG002|Randomized Treatment Period|Adverse Event|0|||
126414334|NCT04164732|454811353|FG000|Randomized Treatment Period|Protocol Deviation|0|||
126414335|NCT04164732|454811354|FG001|Randomized Treatment Period|Protocol Deviation|1|||
126414336|NCT04164732|454811355|FG002|Randomized Treatment Period|Protocol Deviation|1|||
126414337|NCT04164732|454811353|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
126414338|NCT04164732|454811354|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
126414339|NCT04164732|454811355|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
126414340|NCT01844778|454811361|FG000|Overall Study|Protocol deviation|0|||
126414341|NCT01844778|454811362|FG001|Overall Study|Protocol deviation|1|||
126414342|NCT01844778|454811363|FG002|Overall Study|Protocol deviation|2|||
126414343|NCT01844778|454811361|FG000|Overall Study|Withdrawal by Subject|2|||
126414344|NCT01844778|454811362|FG001|Overall Study|Withdrawal by Subject|0|||
126414345|NCT01844778|454811363|FG002|Overall Study|Withdrawal by Subject|0|||
126414346|NCT01844778|454811361|FG000|Overall Study|Adverse Event|0|||
126414347|NCT01844778|454811362|FG001|Overall Study|Adverse Event|2|||
126414348|NCT01844778|454811363|FG002|Overall Study|Adverse Event|2|||
126414349|NCT02951429|454811369|FG000|Overall Study|Adverse Event|3|||
126414350|NCT02951429|454811370|FG001|Overall Study|Adverse Event|7|||
126414351|NCT02951429|454811369|FG000|Overall Study|Death|28|||
126414352|NCT02951429|454811370|FG001|Overall Study|Death|36|||
126414353|NCT02951429|454811369|FG000|Overall Study|Lack of Efficacy|0|||
126414354|NCT02951429|454811370|FG001|Overall Study|Lack of Efficacy|1|||
126414355|NCT02951429|454811369|FG000|Overall Study|Lost to Follow-up|0|||
126414356|NCT02951429|454811370|FG001|Overall Study|Lost to Follow-up|1|||
126414357|NCT02951429|454811369|FG000|Overall Study|Lung Transplantation|9|||
126414358|NCT02951429|454811370|FG001|Overall Study|Lung Transplantation|6|||
126414359|NCT02951429|454811369|FG000|Overall Study|Other|1|||
126414360|NCT02951429|454811370|FG001|Overall Study|Other|3|||
126414361|NCT02951429|454811369|FG000|Overall Study|Progressive Disease|1|||
126414362|NCT02951429|454811370|FG001|Overall Study|Progressive Disease|1|||
126414363|NCT02951429|454811369|FG000|Overall Study|Withdrawal by Subject|7|||
126414364|NCT02951429|454811370|FG001|Overall Study|Withdrawal by Subject|11|||
126414365|NCT02951429|454811369|FG000|Overall Study|Participant ongoing in the study|23|||
126414366|NCT02951429|454811370|FG001|Overall Study|Participant ongoing in the study|17|||
126414367|NCT01620528|454811371|FG000|Treatment Period|Did Not Receive Study Drug|0|||
126414368|NCT01620528|454811372|FG001|Treatment Period|Did Not Receive Study Drug|0|||
126414369|NCT01620528|454811373|FG002|Treatment Period|Did Not Receive Study Drug|1|||
126414370|NCT01620528|454811371|FG000|Treatment Period|Withdrawal by Subject|35|||
126414371|NCT01620528|454811372|FG001|Treatment Period|Withdrawal by Subject|21|||
126414372|NCT01620528|454811373|FG002|Treatment Period|Withdrawal by Subject|16|||
126414373|NCT01620528|454811371|FG000|Treatment Period|Adverse Event|17|||
126414374|NCT01620528|454811372|FG001|Treatment Period|Adverse Event|13|||
126414375|NCT01620528|454811373|FG002|Treatment Period|Adverse Event|21|||
126414376|NCT01620528|454811371|FG000|Treatment Period|Lost to Follow-up|16|||
126414377|NCT01620528|454811372|FG001|Treatment Period|Lost to Follow-up|8|||
126414378|NCT01620528|454811373|FG002|Treatment Period|Lost to Follow-up|14|||
126414379|NCT01620528|454811371|FG000|Treatment Period|Other|9|||
126414380|NCT01620528|454811372|FG001|Treatment Period|Other|5|||
126414381|NCT01620528|454811373|FG002|Treatment Period|Other|7|||
126414382|NCT01620528|454811371|FG000|Treatment Period|Subject Noncompliant|11|||
126414383|NCT01620528|454811372|FG001|Treatment Period|Subject Noncompliant|2|||
126414384|NCT01620528|454811373|FG002|Treatment Period|Subject Noncompliant|2|||
126414385|NCT01620528|454811371|FG000|Treatment Period|Pregnancy|7|||
126414386|NCT01620528|454811372|FG001|Treatment Period|Pregnancy|2|||
126414387|NCT01620528|454811373|FG002|Treatment Period|Pregnancy|2|||
126414388|NCT01620528|454811371|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
126414389|NCT01620528|454811372|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
126414390|NCT01620528|454811373|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
126414391|NCT01620528|454811371|FG000|Treatment Period|Exclusionary Medication Received|0|||
126414392|NCT01620528|454811372|FG001|Treatment Period|Exclusionary Medication Received|1|||
126414393|NCT01620528|454811373|FG002|Treatment Period|Exclusionary Medication Received|0|||
126414394|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
126414395|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
126414396|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
126414397|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
126414398|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
126414399|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
126414400|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
126414401|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
126414402|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
126414403|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
126414404|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
126414405|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
126414406|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Other|6|||
126414407|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Other|4|||
126414408|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Other|2|||
126414409|NCT04006392|454811374|FG000|Overall Study|Lost to Follow-up|0|||
126414410|NCT04006392|454811375|FG001|Overall Study|Lost to Follow-up|1|||
126414411|NCT03824587|454811376|FG000|Run-in Period|Screen Failure|0|||
126414412|NCT03824587|454811377|FG001|Run-in Period|Screen Failure|275|||
126414413|NCT03824587|454811376|FG000|Treatment Period|Adverse Event|4|||
126414414|NCT03824587|454811377|FG001|Treatment Period|Adverse Event|1|||
126414415|NCT03824587|454811376|FG000|Treatment Period|Withdrawal by Subject|0|||
126414416|NCT03824587|454811377|FG001|Treatment Period|Withdrawal by Subject|1|||
126414417|NCT03824587|454811376|FG000|Treatment Period|Kidney Transplant|1|||
126414418|NCT03824587|454811377|FG001|Treatment Period|Kidney Transplant|1|||
126414419|NCT00986362|454811378|FG000|Overall Study|Death|2|||
126414420|NCT00986362|454811379|FG001|Overall Study|Death|0|||
126414421|NCT00986362|454811378|FG000|Overall Study|Lost to Follow-up|0|||
126414422|NCT00986362|454811379|FG001|Overall Study|Lost to Follow-up|1|||
126414423|NCT00384332|454811380|FG000|Overall Study|Lost to Follow-up|4|||
126414424|NCT00384332|454811381|FG001|Overall Study|Lost to Follow-up|0|||
126414425|NCT02006979|454811382|FG000|Overall Study|Withdrawal by Subject|1|||
126414426|NCT02006979|454811383|FG001|Overall Study|Withdrawal by Subject|1|||
126414427|NCT02006979|454811382|FG000|Overall Study|Protocol Violation|0|||
126414428|NCT02006979|454811383|FG001|Overall Study|Protocol Violation|1|||
126414429|NCT03170193|454811384|FG000|Overall Study|Withdrawal by Subject|0|||
126414430|NCT03170193|454811385|FG001|Overall Study|Withdrawal by Subject|0|||
126414431|NCT03170193|454811386|FG002|Overall Study|Withdrawal by Subject|0|||
126414432|NCT03170193|454811387|FG003|Overall Study|Withdrawal by Subject|1|||
126414433|NCT03170193|454811388|FG004|Overall Study|Withdrawal by Subject|0|||
126414434|NCT03170193|454811389|FG005|Overall Study|Withdrawal by Subject|0|||
126414435|NCT03170193|454811390|FG006|Overall Study|Withdrawal by Subject|0|||
126414436|NCT03170193|454811384|FG000|Overall Study|Lost to Follow-up|1|||
126414437|NCT03170193|454811385|FG001|Overall Study|Lost to Follow-up|1|||
126414438|NCT03170193|454811386|FG002|Overall Study|Lost to Follow-up|0|||
126414439|NCT03170193|454811387|FG003|Overall Study|Lost to Follow-up|0|||
126414440|NCT03170193|454811388|FG004|Overall Study|Lost to Follow-up|0|||
126414441|NCT03170193|454811389|FG005|Overall Study|Lost to Follow-up|0|||
126414442|NCT03170193|454811390|FG006|Overall Study|Lost to Follow-up|0|||
126414443|NCT01368081|454811391|FG000|Overall Study|Adverse Event|4|||
126414444|NCT01368081|454811392|FG001|Overall Study|Adverse Event|4|||
126414445|NCT01368081|454811393|FG002|Overall Study|Adverse Event|3|||
126414446|NCT01368081|454811394|FG003|Overall Study|Adverse Event|2|||
126414447|NCT01368081|454811395|FG004|Overall Study|Adverse Event|2|||
126414448|NCT01368081|454811396|FG005|Overall Study|Adverse Event|5|||
125891036|NCT02504216|452899686|FG001|Overall Study|Withdrawal by Subject|12|||
125891037|NCT00862082|452899687|FG000|Overall Study|Sponsor decision to terminate the study|5|||
126414449|NCT01368081|454811397|FG006|Overall Study|Adverse Event|6|||
126414450|NCT01368081|454811398|FG007|Overall Study|Adverse Event|2|||
126414451|NCT01368081|454811399|FG008|Overall Study|Adverse Event|3|||
126414452|NCT01368081|454811400|FG009|Overall Study|Adverse Event|5|||
126414453|NCT01368081|454811401|FG010|Overall Study|Adverse Event|6|||
126414454|NCT01368081|454811402|FG011|Overall Study|Adverse Event|1|||
126414455|NCT01368081|454811403|FG012|Overall Study|Adverse Event|3|||
126414456|NCT01368081|454811391|FG000|Overall Study|Lack of Efficacy|0|||
126414457|NCT01368081|454811392|FG001|Overall Study|Lack of Efficacy|1|||
126414458|NCT01368081|454811393|FG002|Overall Study|Lack of Efficacy|0|||
126414459|NCT01368081|454811394|FG003|Overall Study|Lack of Efficacy|1|||
126414460|NCT01368081|454811395|FG004|Overall Study|Lack of Efficacy|0|||
126414461|NCT01368081|454811396|FG005|Overall Study|Lack of Efficacy|0|||
126414462|NCT01368081|454811397|FG006|Overall Study|Lack of Efficacy|0|||
126414463|NCT01368081|454811398|FG007|Overall Study|Lack of Efficacy|2|||
126414464|NCT01368081|454811399|FG008|Overall Study|Lack of Efficacy|0|||
126414465|NCT01368081|454811400|FG009|Overall Study|Lack of Efficacy|0|||
126414466|NCT01368081|454811401|FG010|Overall Study|Lack of Efficacy|0|||
126414467|NCT01368081|454811402|FG011|Overall Study|Lack of Efficacy|0|||
126414468|NCT01368081|454811403|FG012|Overall Study|Lack of Efficacy|0|||
126414469|NCT01368081|454811391|FG000|Overall Study|Protocol Violation|0|||
126414470|NCT01368081|454811392|FG001|Overall Study|Protocol Violation|0|||
126414471|NCT01368081|454811393|FG002|Overall Study|Protocol Violation|0|||
126414472|NCT01368081|454811394|FG003|Overall Study|Protocol Violation|0|||
126414473|NCT01368081|454811395|FG004|Overall Study|Protocol Violation|0|||
126414474|NCT01368081|454811396|FG005|Overall Study|Protocol Violation|1|||
126414475|NCT01368081|454811397|FG006|Overall Study|Protocol Violation|0|||
126414476|NCT01368081|454811398|FG007|Overall Study|Protocol Violation|1|||
126054269|NCT05349721|453493865|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
126054270|NCT05349721|453493866|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
126054271|NCT05349721|453493865|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
126054272|NCT05349721|453493866|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
126054273|NCT05349721|453493865|FG000|Part B (28 Weeks)|Other Than Specified|4|||
126054274|NCT05349721|453493866|FG001|Part B (28 Weeks)|Other Than Specified|2|||
126054275|NCT05349721|453493865|FG000|Part C (108 Weeks)|Death|0|||
126054276|NCT05349721|453493866|FG001|Part C (108 Weeks)|Death|1|||
126414477|NCT01368081|454811399|FG008|Overall Study|Protocol Violation|0|||
126414478|NCT01368081|454811400|FG009|Overall Study|Protocol Violation|0|||
126414479|NCT01368081|454811401|FG010|Overall Study|Protocol Violation|0|||
126414480|NCT01368081|454811402|FG011|Overall Study|Protocol Violation|0|||
126414481|NCT01368081|454811403|FG012|Overall Study|Protocol Violation|0|||
126414482|NCT01368081|454811391|FG000|Overall Study|Lost to Follow-up|0|||
126414483|NCT01368081|454811392|FG001|Overall Study|Lost to Follow-up|0|||
126414484|NCT01368081|454811393|FG002|Overall Study|Lost to Follow-up|0|||
126414485|NCT01368081|454811394|FG003|Overall Study|Lost to Follow-up|0|||
126414486|NCT01368081|454811395|FG004|Overall Study|Lost to Follow-up|0|||
126414487|NCT01368081|454811396|FG005|Overall Study|Lost to Follow-up|0|||
126414488|NCT01368081|454811397|FG006|Overall Study|Lost to Follow-up|0|||
126414489|NCT01368081|454811398|FG007|Overall Study|Lost to Follow-up|0|||
126414490|NCT01368081|454811399|FG008|Overall Study|Lost to Follow-up|0|||
126414491|NCT01368081|454811400|FG009|Overall Study|Lost to Follow-up|0|||
126414492|NCT01368081|454811401|FG010|Overall Study|Lost to Follow-up|0|||
126414493|NCT01368081|454811402|FG011|Overall Study|Lost to Follow-up|0|||
126414494|NCT01368081|454811403|FG012|Overall Study|Lost to Follow-up|1|||
126414495|NCT01368081|454811391|FG000|Overall Study|Withdrawal by Subject|4|||
126414496|NCT01368081|454811392|FG001|Overall Study|Withdrawal by Subject|4|||
126414497|NCT01368081|454811393|FG002|Overall Study|Withdrawal by Subject|1|||
126414498|NCT01368081|454811394|FG003|Overall Study|Withdrawal by Subject|1|||
126414499|NCT01368081|454811395|FG004|Overall Study|Withdrawal by Subject|0|||
126414500|NCT01368081|454811396|FG005|Overall Study|Withdrawal by Subject|3|||
126414501|NCT01368081|454811397|FG006|Overall Study|Withdrawal by Subject|4|||
126414502|NCT01368081|454811398|FG007|Overall Study|Withdrawal by Subject|2|||
126414503|NCT01368081|454811399|FG008|Overall Study|Withdrawal by Subject|5|||
126414504|NCT01368081|454811400|FG009|Overall Study|Withdrawal by Subject|4|||
126414505|NCT01368081|454811401|FG010|Overall Study|Withdrawal by Subject|3|||
126414506|NCT01368081|454811402|FG011|Overall Study|Withdrawal by Subject|2|||
126414507|NCT01368081|454811403|FG012|Overall Study|Withdrawal by Subject|0|||
126414508|NCT01368081|454811391|FG000|Overall Study|Other reason not defined above|2|||
126414509|NCT01368081|454811392|FG001|Overall Study|Other reason not defined above|0|||
126414510|NCT01368081|454811393|FG002|Overall Study|Other reason not defined above|0|||
126414511|NCT01368081|454811394|FG003|Overall Study|Other reason not defined above|1|||
126414512|NCT01368081|454811395|FG004|Overall Study|Other reason not defined above|0|||
126414513|NCT01368081|454811396|FG005|Overall Study|Other reason not defined above|1|||
126414514|NCT01368081|454811397|FG006|Overall Study|Other reason not defined above|2|||
126414515|NCT01368081|454811398|FG007|Overall Study|Other reason not defined above|0|||
126414516|NCT01368081|454811399|FG008|Overall Study|Other reason not defined above|0|||
126414517|NCT01368081|454811400|FG009|Overall Study|Other reason not defined above|1|||
126414518|NCT01368081|454811401|FG010|Overall Study|Other reason not defined above|0|||
126414519|NCT01368081|454811402|FG011|Overall Study|Other reason not defined above|0|||
126414520|NCT01368081|454811403|FG012|Overall Study|Other reason not defined above|3|||
126414521|NCT02560012|454811404|FG000|Overall Study|Study Terminated|2|||
126414522|NCT01007838|454811405|FG000|Overall Study|Withdrawal by Subject|1|||
126414523|NCT01007838|454811406|FG001|Overall Study|Withdrawal by Subject|0|||
126414524|NCT01007838|454811407|FG002|Overall Study|Withdrawal by Subject|0|||
126414525|NCT01007838|454811408|FG003|Overall Study|Withdrawal by Subject|0|||
126414526|NCT01007838|454811405|FG000|Overall Study|Physician Decision|1|||
126414527|NCT01007838|454811406|FG001|Overall Study|Physician Decision|0|||
126414528|NCT01007838|454811407|FG002|Overall Study|Physician Decision|0|||
126414529|NCT01007838|454811408|FG003|Overall Study|Physician Decision|0|||
126414530|NCT01007838|454811405|FG000|Overall Study|Started home haemodialysis|1|||
126414531|NCT01007838|454811406|FG001|Overall Study|Started home haemodialysis|0|||
126414532|NCT01007838|454811407|FG002|Overall Study|Started home haemodialysis|0|||
126414533|NCT01007838|454811408|FG003|Overall Study|Started home haemodialysis|0|||
126414534|NCT04167137|454811409|FG000|Overall Study|Disease progression|1|||
126414535|NCT04167137|454811410|FG001|Overall Study|Disease progression|1|||
126414536|NCT04167137|454811411|FG002|Overall Study|Disease progression|3|||
126414537|NCT04167137|454811412|FG003|Overall Study|Disease progression|3|||
126414538|NCT04167137|454811413|FG004|Overall Study|Disease progression|2|||
126414539|NCT04167137|454811414|FG005|Overall Study|Disease progression|3|||
126054277|NCT05349721|453493865|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
126054278|NCT05349721|453493866|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
126414540|NCT04167137|454811415|FG006|Overall Study|Disease progression|2|||
126414541|NCT04167137|454811416|FG007|Overall Study|Disease progression|2|||
126414542|NCT04167137|454811409|FG000|Overall Study|Withdrawal by Subject|1|||
126414543|NCT04167137|454811410|FG001|Overall Study|Withdrawal by Subject|0|||
126414544|NCT04167137|454811411|FG002|Overall Study|Withdrawal by Subject|0|||
126414545|NCT04167137|454811412|FG003|Overall Study|Withdrawal by Subject|1|||
126414546|NCT04167137|454811413|FG004|Overall Study|Withdrawal by Subject|0|||
126414547|NCT04167137|454811414|FG005|Overall Study|Withdrawal by Subject|2|||
126414548|NCT04167137|454811415|FG006|Overall Study|Withdrawal by Subject|1|||
126414549|NCT04167137|454811416|FG007|Overall Study|Withdrawal by Subject|0|||
126414550|NCT04167137|454811409|FG000|Overall Study|Adverse Event|0|||
126414551|NCT04167137|454811410|FG001|Overall Study|Adverse Event|0|||
126414552|NCT04167137|454811411|FG002|Overall Study|Adverse Event|0|||
126414553|NCT04167137|454811412|FG003|Overall Study|Adverse Event|0|||
126414554|NCT04167137|454811413|FG004|Overall Study|Adverse Event|0|||
125891038|NCT00862082|452899688|FG001|Overall Study|Sponsor decision to terminate the study|0|||
125891039|NCT00862082|452899687|FG000|Overall Study|Withdrawal by Subject|0|||
125891040|NCT00862082|452899688|FG001|Overall Study|Withdrawal by Subject|1|||
125891041|NCT00223080|452899689|FG000|Overall Study|Withdrawal by Subject|253|||
126414555|NCT04167137|454811414|FG005|Overall Study|Adverse Event|1|||
126414556|NCT04167137|454811415|FG006|Overall Study|Adverse Event|0|||
126414557|NCT04167137|454811416|FG007|Overall Study|Adverse Event|1|||
126414558|NCT04167137|454811409|FG000|Overall Study|Physician Decision|0|||
125891042|NCT00223080|452899690|FG001|Overall Study|Withdrawal by Subject|232|||
125891043|NCT00223080|452899689|FG000|Overall Study|Required contraindicated med|0|||
126054279|NCT05349721|453493865|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
126414559|NCT04167137|454811410|FG001|Overall Study|Physician Decision|0|||
126414560|NCT04167137|454811411|FG002|Overall Study|Physician Decision|0|||
126414561|NCT04167137|454811412|FG003|Overall Study|Physician Decision|1|||
126414562|NCT04167137|454811413|FG004|Overall Study|Physician Decision|0|||
126414563|NCT04167137|454811414|FG005|Overall Study|Physician Decision|0|||
126414564|NCT04167137|454811415|FG006|Overall Study|Physician Decision|1|||
126414565|NCT04167137|454811416|FG007|Overall Study|Physician Decision|0|||
126414566|NCT04167137|454811409|FG000|Overall Study|Death|0|||
126414567|NCT04167137|454811410|FG001|Overall Study|Death|1|||
126414568|NCT04167137|454811411|FG002|Overall Study|Death|0|||
126414569|NCT04167137|454811412|FG003|Overall Study|Death|0|||
126414570|NCT04167137|454811413|FG004|Overall Study|Death|0|||
126414571|NCT04167137|454811414|FG005|Overall Study|Death|0|||
126414572|NCT04167137|454811415|FG006|Overall Study|Death|0|||
125891044|NCT00223080|452899690|FG001|Overall Study|Required contraindicated med|1|||
126414573|NCT04167137|454811416|FG007|Overall Study|Death|0|||
125891045|NCT00223080|452899689|FG000|Overall Study|Non-compliant|7|||
126414574|NCT04167137|454811409|FG000|Overall Study|Study terminated by Sponsor|0|||
126414575|NCT04167137|454811410|FG001|Overall Study|Study terminated by Sponsor|0|||
126414576|NCT04167137|454811411|FG002|Overall Study|Study terminated by Sponsor|0|||
126414577|NCT04167137|454811412|FG003|Overall Study|Study terminated by Sponsor|0|||
126414578|NCT04167137|454811413|FG004|Overall Study|Study terminated by Sponsor|0|||
126414579|NCT04167137|454811414|FG005|Overall Study|Study terminated by Sponsor|0|||
126414580|NCT04167137|454811415|FG006|Overall Study|Study terminated by Sponsor|0|||
126414581|NCT04167137|454811416|FG007|Overall Study|Study terminated by Sponsor|1|||
126414582|NCT02147288|454811417|FG000|Overall Study|post-operative hematoma|1|||
126414583|NCT02147288|454811418|FG001|Overall Study|post-operative hematoma|1|||
126414584|NCT02147288|454811419|FG002|Overall Study|post-operative hematoma|0|||
126414585|NCT02147288|454811420|FG003|Overall Study|post-operative hematoma|0|||
126414586|NCT02147288|454811421|FG004|Overall Study|post-operative hematoma|0|||
126414587|NCT02147288|454811422|FG005|Overall Study|post-operative hematoma|0|||
126414588|NCT02147288|454811423|FG006|Overall Study|post-operative hematoma|0|||
126414589|NCT02147288|454811424|FG007|Overall Study|post-operative hematoma|0|||
126414590|NCT02147288|454811425|FG008|Overall Study|post-operative hematoma|0|||
126414591|NCT02147288|454811426|FG009|Overall Study|post-operative hematoma|0|||
126414592|NCT02147288|454811417|FG000|Overall Study|complications from concurrent hernia rep|0|||
126414593|NCT02147288|454811418|FG001|Overall Study|complications from concurrent hernia rep|1|||
126414594|NCT02147288|454811419|FG002|Overall Study|complications from concurrent hernia rep|0|||
126414595|NCT02147288|454811420|FG003|Overall Study|complications from concurrent hernia rep|0|||
126414596|NCT02147288|454811421|FG004|Overall Study|complications from concurrent hernia rep|0|||
126414597|NCT02147288|454811422|FG005|Overall Study|complications from concurrent hernia rep|0|||
126414598|NCT02147288|454811423|FG006|Overall Study|complications from concurrent hernia rep|0|||
126414599|NCT02147288|454811424|FG007|Overall Study|complications from concurrent hernia rep|0|||
126414600|NCT02147288|454811425|FG008|Overall Study|complications from concurrent hernia rep|0|||
126414601|NCT02147288|454811426|FG009|Overall Study|complications from concurrent hernia rep|0|||
126414602|NCT02611817|454812918|FG000|Open-label Induction Phase|Reason not Specified|9|||
126414603|NCT02611817|454812919|FG001|Open-label Induction Phase|Reason not Specified|0|||
126414604|NCT02611817|454812920|FG002|Open-label Induction Phase|Reason not Specified|0|||
126414605|NCT02611817|454812918|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
126414606|NCT02611817|454812919|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
126414607|NCT02611817|454812920|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
126414608|NCT02611817|454812918|FG000|Open-label Induction Phase|Pregnancy|1|||
126414609|NCT02611817|454812919|FG001|Open-label Induction Phase|Pregnancy|0|||
126414610|NCT02611817|454812920|FG002|Open-label Induction Phase|Pregnancy|0|||
126414611|NCT02611817|454812918|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
126414612|NCT02611817|454812919|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
126414613|NCT02611817|454812920|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
126414614|NCT02611817|454812918|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
126414615|NCT02611817|454812919|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
126414616|NCT02611817|454812920|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
126414617|NCT02611817|454812918|FG000|Open-label Induction Phase|Protocol Violation|5|||
126414618|NCT02611817|454812919|FG001|Open-label Induction Phase|Protocol Violation|0|||
126414619|NCT02611817|454812920|FG002|Open-label Induction Phase|Protocol Violation|0|||
126414620|NCT02611817|454812918|FG000|Open-label Induction Phase|Adverse Event|16|||
126414621|NCT02611817|454812919|FG001|Open-label Induction Phase|Adverse Event|0|||
126414622|NCT02611817|454812920|FG002|Open-label Induction Phase|Adverse Event|0|||
126414623|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
126414624|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
126414625|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
126414626|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
126414627|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
126414628|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
126414629|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
126414630|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
126414631|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
126414632|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
126414633|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
126414634|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
126414635|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
126414636|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
126414637|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
126414638|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
126414639|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
126414640|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
126414641|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
126414642|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
126414643|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
126414644|NCT03412812|454812927|FG000|Level 1|Death|3|||
126414645|NCT03412812|454812928|FG001|Level 1|Death|0|||
126414646|NCT03412812|454812927|FG000|Level 1|Adverse Event|0|||
126414647|NCT03412812|454812928|FG001|Level 1|Adverse Event|1|||
126414648|NCT02391363|454812929|FG000|Overall Study|Lost to Follow-up|5|||
126414649|NCT02391363|454812930|FG001|Overall Study|Lost to Follow-up|5|||
126414650|NCT02391363|454812929|FG000|Overall Study|Withdrawal by Subject|6|||
126414651|NCT02391363|454812930|FG001|Overall Study|Withdrawal by Subject|3|||
126414652|NCT03828617|454812931|FG000|Overall Study|Lost to Follow-up|22|||
126414653|NCT03828617|454812932|FG001|Overall Study|Lost to Follow-up|12|||
126414654|NCT03828617|454812933|FG002|Overall Study|Lost to Follow-up|23|||
126414655|NCT03828617|454812934|FG003|Overall Study|Lost to Follow-up|7|||
126414656|NCT03828617|454812931|FG000|Overall Study|No longer met eligibility criteria|0|||
126414657|NCT03828617|454812932|FG001|Overall Study|No longer met eligibility criteria|1|||
126414658|NCT03828617|454812933|FG002|Overall Study|No longer met eligibility criteria|1|||
126414659|NCT03828617|454812934|FG003|Overall Study|No longer met eligibility criteria|3|||
126414660|NCT03828617|454812931|FG000|Overall Study|Protocol Violation|0|||
126414661|NCT03828617|454812932|FG001|Overall Study|Protocol Violation|2|||
126414662|NCT03828617|454812933|FG002|Overall Study|Protocol Violation|0|||
126414663|NCT03828617|454812934|FG003|Overall Study|Protocol Violation|0|||
126414664|NCT03828617|454812931|FG000|Overall Study|Withdrawal by Subject|2|||
126414665|NCT03828617|454812932|FG001|Overall Study|Withdrawal by Subject|0|||
126414666|NCT03828617|454812933|FG002|Overall Study|Withdrawal by Subject|2|||
126414667|NCT03828617|454812934|FG003|Overall Study|Withdrawal by Subject|0|||
126414668|NCT02510001|454812935|FG000|Overall Study|Early disease progression|0|||
126414669|NCT02510001|454812936|FG001|Overall Study|Early disease progression|0|||
126414670|NCT02510001|454812937|FG002|Overall Study|Early disease progression|0|||
126414671|NCT02510001|454812938|FG003|Overall Study|Early disease progression|1|||
126414672|NCT02510001|454812939|FG004|Overall Study|Early disease progression|1|||
126414673|NCT02510001|454812940|FG005|Overall Study|Early disease progression|1|||
126414674|NCT02510001|454812941|FG006|Overall Study|Early disease progression|0|||
126414675|NCT02510001|454812942|FG007|Overall Study|Early disease progression|0|||
126414676|NCT02510001|454812935|FG000|Overall Study|Adverse Event|0|||
126414677|NCT02510001|454812936|FG001|Overall Study|Adverse Event|0|||
126414678|NCT02510001|454812937|FG002|Overall Study|Adverse Event|0|||
126414679|NCT02510001|454812938|FG003|Overall Study|Adverse Event|1|||
126414680|NCT02510001|454812939|FG004|Overall Study|Adverse Event|2|||
126414681|NCT02510001|454812940|FG005|Overall Study|Adverse Event|1|||
126414682|NCT02510001|454812941|FG006|Overall Study|Adverse Event|2|||
126414683|NCT02510001|454812942|FG007|Overall Study|Adverse Event|5|||
126414684|NCT02510001|454812935|FG000|Overall Study|Physician Decision|0|||
126414685|NCT02510001|454812936|FG001|Overall Study|Physician Decision|0|||
126414686|NCT02510001|454812937|FG002|Overall Study|Physician Decision|0|||
126414687|NCT02510001|454812938|FG003|Overall Study|Physician Decision|0|||
126414688|NCT02510001|454812939|FG004|Overall Study|Physician Decision|1|||
126414689|NCT02510001|454812940|FG005|Overall Study|Physician Decision|0|||
126414690|NCT02510001|454812941|FG006|Overall Study|Physician Decision|0|||
126414691|NCT02510001|454812942|FG007|Overall Study|Physician Decision|0|||
126414692|NCT02510001|454812935|FG000|Overall Study|Withdrawal by Subject|0|||
126414693|NCT02510001|454812936|FG001|Overall Study|Withdrawal by Subject|0|||
126414694|NCT02510001|454812937|FG002|Overall Study|Withdrawal by Subject|0|||
126414695|NCT02510001|454812938|FG003|Overall Study|Withdrawal by Subject|0|||
126414696|NCT02510001|454812939|FG004|Overall Study|Withdrawal by Subject|0|||
126414697|NCT02510001|454812940|FG005|Overall Study|Withdrawal by Subject|0|||
126054280|NCT05349721|453493866|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
126054281|NCT05349721|453493865|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
126054282|NCT05349721|453493866|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
126414698|NCT02510001|454812941|FG006|Overall Study|Withdrawal by Subject|0|||
126054283|NCT03070392|453493867|FG000|Overall Study|Not Treated|7|||
126414699|NCT02510001|454812942|FG007|Overall Study|Withdrawal by Subject|2|||
126414700|NCT00303485|454812946|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
126414701|NCT00303485|454812947|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
126414702|NCT00303485|454812946|FG000|Overall Study|Failure to return|0|||
126414703|NCT00303485|454812947|FG001|Overall Study|Failure to return|1|||
126414704|NCT00303485|454812946|FG000|Overall Study|Withdrawal by Subject|1|||
126414705|NCT00303485|454812947|FG001|Overall Study|Withdrawal by Subject|0|||
126414706|NCT01363908|454812956|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
126414707|NCT01363908|454812957|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
126414708|NCT01363908|454812956|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
126414709|NCT01363908|454812957|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
126414710|NCT01363908|454812956|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
126414711|NCT01363908|454812957|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
126414712|NCT01363908|454812956|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
126414713|NCT01363908|454812957|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
126414714|NCT02644343|454812958|FG000|Overall Study|Withdrawal by Subject|1|||
126414715|NCT03437577|454812959|FG000|Pre-Randomization|Withdrawal by Subject|0|||
126414716|NCT03437577|454812960|FG001|Pre-Randomization|Withdrawal by Subject|0|||
126414717|NCT03437577|454812961|FG002|Pre-Randomization|Withdrawal by Subject|10|||
126414718|NCT03437577|454812959|FG000|Post-Randomization|Physician Decision|0|||
126414719|NCT03437577|454812960|FG001|Post-Randomization|Physician Decision|2|||
126414720|NCT03437577|454812961|FG002|Post-Randomization|Physician Decision|0|||
126414721|NCT04878211|454812962|FG000|Overall Study|Lost to Follow-up|0|||
126414722|NCT04878211|454812963|FG001|Overall Study|Lost to Follow-up|0|||
126414723|NCT04878211|454812964|FG002|Overall Study|Lost to Follow-up|0|||
126414724|NCT04878211|454812965|FG003|Overall Study|Lost to Follow-up|1|||
126414725|NCT04878211|454812966|FG004|Overall Study|Lost to Follow-up|0|||
126414726|NCT04878211|454812967|FG005|Overall Study|Lost to Follow-up|1|||
126414727|NCT04878211|454812962|FG000|Overall Study|Protocol deviation|1|||
126414728|NCT04878211|454812963|FG001|Overall Study|Protocol deviation|0|||
126414729|NCT04878211|454812964|FG002|Overall Study|Protocol deviation|0|||
126414730|NCT04878211|454812965|FG003|Overall Study|Protocol deviation|0|||
126414731|NCT04878211|454812966|FG004|Overall Study|Protocol deviation|0|||
126414732|NCT04878211|454812967|FG005|Overall Study|Protocol deviation|0|||
126414733|NCT04878211|454812962|FG000|Overall Study|Study terminated by sponsor|0|||
126414734|NCT04878211|454812963|FG001|Overall Study|Study terminated by sponsor|0|||
126414735|NCT04878211|454812964|FG002|Overall Study|Study terminated by sponsor|0|||
126414736|NCT04878211|454812965|FG003|Overall Study|Study terminated by sponsor|0|||
126414737|NCT04878211|454812966|FG004|Overall Study|Study terminated by sponsor|9|||
126414738|NCT04878211|454812967|FG005|Overall Study|Study terminated by sponsor|4|||
126414739|NCT04878211|454812962|FG000|Overall Study|Subject decision|0|||
126414740|NCT04878211|454812963|FG001|Overall Study|Subject decision|0|||
126414741|NCT04878211|454812964|FG002|Overall Study|Subject decision|0|||
126414742|NCT04878211|454812965|FG003|Overall Study|Subject decision|0|||
126414743|NCT04878211|454812966|FG004|Overall Study|Subject decision|1|||
126414744|NCT04878211|454812967|FG005|Overall Study|Subject decision|0|||
126414745|NCT04774926|454812974|FG000|Overall Study|Adverse Event|15|||
126414746|NCT04774926|454812974|FG000|Overall Study|Lost to Follow-up|3|||
126414747|NCT04774926|454812974|FG000|Overall Study|Physician Decision|6|||
126414748|NCT04774926|454812974|FG000|Overall Study|Withdrawal by Subject|3|||
126414749|NCT04774926|454812974|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
126414750|NCT02783599|454812975|FG000|Overall Study|Progressive disease|23|||
126414751|NCT02783599|454812975|FG000|Overall Study|Surgical Resection|10|||
126414752|NCT02783599|454812975|FG000|Overall Study|Adverse Event|4|||
126414753|NCT02783599|454812975|FG000|Overall Study|Physician Decision|2|||
126414754|NCT02783599|454812975|FG000|Overall Study|Death|1|||
126414755|NCT00787189|454812976|FG000|Overall Study|Lost to Follow-up|2|||
126414756|NCT00787189|454812977|FG001|Overall Study|Lost to Follow-up|2|||
126414757|NCT00847886|454812978|FG000|Overall Study|Adverse Event|0|||
126414758|NCT00847886|454812979|FG001|Overall Study|Adverse Event|1|||
126414759|NCT03920254|454812984|FG000|Overall Study|Adverse Event|1|||
126414760|NCT03920254|454812985|FG001|Overall Study|Adverse Event|0|||
126414761|NCT03920254|454812986|FG002|Overall Study|Adverse Event|0|||
126414762|NCT03920254|454812984|FG000|Overall Study|Physician Decision|0|||
126414763|NCT03920254|454812985|FG001|Overall Study|Physician Decision|1|||
126414764|NCT03920254|454812986|FG002|Overall Study|Physician Decision|2|||
126414765|NCT03920254|454812984|FG000|Overall Study|Study Terminated By Sponsor|12|||
126414766|NCT03920254|454812985|FG001|Overall Study|Study Terminated By Sponsor|17|||
126414767|NCT03920254|454812986|FG002|Overall Study|Study Terminated By Sponsor|12|||
126414768|NCT03920254|454812984|FG000|Overall Study|Withdrawal by Subject|0|||
126414769|NCT03920254|454812985|FG001|Overall Study|Withdrawal by Subject|0|||
126414770|NCT03920254|454812986|FG002|Overall Study|Withdrawal by Subject|1|||
126414771|NCT05274269|454812987|FG000|Overall Study|Adverse Event|0|||
126414772|NCT05274269|454812988|FG001|Overall Study|Adverse Event|3|||
126054284|NCT03070392|453493868|FG001|Overall Study|Not Treated|0|||
126414773|NCT05274269|454812987|FG000|Overall Study|Death|0|||
126414774|NCT05274269|454812988|FG001|Overall Study|Death|1|||
126414775|NCT05274269|454812987|FG000|Overall Study|Other|0|||
126414776|NCT05274269|454812988|FG001|Overall Study|Other|2|||
126414777|NCT05274269|454812987|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
126414778|NCT05274269|454812988|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
126414779|NCT03078855|454812989|FG000|Overall Study|Lack of Efficacy|62|||
126414780|NCT03078855|454812990|FG001|Overall Study|Lack of Efficacy|31|||
126414781|NCT03078855|454812989|FG000|Overall Study|Death|1|||
126414782|NCT03078855|454812990|FG001|Overall Study|Death|0|||
126054285|NCT03070392|453493869|FG002|Overall Study|Not Treated|3|||
126414783|NCT03078855|454812989|FG000|Overall Study|Withdrawal by Subject|12|||
126414784|NCT03078855|454812990|FG001|Overall Study|Withdrawal by Subject|6|||
126414785|NCT03078855|454812989|FG000|Overall Study|Physician Decision|3|||
126414786|NCT03078855|454812990|FG001|Overall Study|Physician Decision|2|||
126414787|NCT03078855|454812989|FG000|Overall Study|Second Malignancy|4|||
126414788|NCT03078855|454812990|FG001|Overall Study|Second Malignancy|0|||
126414789|NCT03078855|454812989|FG000|Overall Study|Ineligible|2|||
126414790|NCT03078855|454812990|FG001|Overall Study|Ineligible|0|||
126414791|NCT03078855|454812989|FG000|Overall Study|Withdrew before day 1 treatment|2|||
126414792|NCT03078855|454812990|FG001|Overall Study|Withdrew before day 1 treatment|1|||
126414793|NCT00391027|454812992|FG000|Overall Study|Adverse Event|8|||
126414794|NCT00391027|454812993|FG001|Overall Study|Adverse Event|8|||
126414795|NCT00391027|454812992|FG000|Overall Study|Lack of Efficacy|3|||
126414796|NCT00391027|454812993|FG001|Overall Study|Lack of Efficacy|0|||
126414797|NCT00391027|454812992|FG000|Overall Study|Withdrawal by Subject|10|||
126414798|NCT00391027|454812993|FG001|Overall Study|Withdrawal by Subject|1|||
126414799|NCT00391027|454812992|FG000|Overall Study|Other|4|||
126414800|NCT00391027|454812993|FG001|Overall Study|Other|3|||
126414801|NCT04124705|454812996|FG000|Titration Period|Adverse Event|9|||
126414802|NCT04124705|454812997|FG001|Titration Period|Adverse Event|5|||
126414803|NCT04124705|454812996|FG000|Titration Period|Withdrawal by Subject|6|||
126414804|NCT04124705|454812997|FG001|Titration Period|Withdrawal by Subject|3|||
126414805|NCT04124705|454812996|FG000|Titration Period|Lost to Follow-up|0|||
126414806|NCT04124705|454812997|FG001|Titration Period|Lost to Follow-up|1|||
126414807|NCT04124705|454812996|FG000|Titration Period|Death|1|||
126414808|NCT04124705|454812997|FG001|Titration Period|Death|1|||
126054286|NCT03070392|453493870|FG003|Overall Study|Not Treated|12|||
126054287|NCT03070392|453493867|FG000|Overall Study|Death|3|||
126054288|NCT03070392|453493868|FG001|Overall Study|Death|0|||
125891046|NCT00223080|452899690|FG001|Overall Study|Non-compliant|7|||
126414809|NCT04124705|454812996|FG000|Titration Period|Lack of Efficacy|2|||
126414810|NCT04124705|454812997|FG001|Titration Period|Lack of Efficacy|0|||
126414811|NCT04124705|454812996|FG000|Titration Period|Physician Decision|2|||
126414812|NCT04124705|454812997|FG001|Titration Period|Physician Decision|0|||
126414813|NCT04124705|454812996|FG000|Titration Period|Non-compliance with Study Drug|2|||
126414814|NCT04124705|454812997|FG001|Titration Period|Non-compliance with Study Drug|0|||
126414815|NCT04124705|454812996|FG000|Titration Period|Other|4|||
126414816|NCT04124705|454812997|FG001|Titration Period|Other|9|||
126414817|NCT04124705|454812996|FG000|Stabilization Period|Adverse Event|4|||
126414818|NCT04124705|454812997|FG001|Stabilization Period|Adverse Event|2|||
126414819|NCT04124705|454812996|FG000|Stabilization Period|Withdrawal by Subject|1|||
126414820|NCT04124705|454812997|FG001|Stabilization Period|Withdrawal by Subject|1|||
126414821|NCT04124705|454812996|FG000|Stabilization Period|Lost to Follow-up|0|||
126414822|NCT04124705|454812997|FG001|Stabilization Period|Lost to Follow-up|1|||
126414823|NCT04124705|454812996|FG000|Stabilization Period|Lack of Efficacy|4|||
126414824|NCT04124705|454812997|FG001|Stabilization Period|Lack of Efficacy|2|||
126414825|NCT04124705|454812996|FG000|Stabilization Period|Protocol Deviation|0|||
126414826|NCT04124705|454812997|FG001|Stabilization Period|Protocol Deviation|2|||
126414827|NCT04124705|454812996|FG000|Stabilization Period|Other|2|||
126414828|NCT04124705|454812997|FG001|Stabilization Period|Other|2|||
126414829|NCT01973998|454812998|FG000|Overall Study|Death|2|||
126414830|NCT01973998|454812999|FG001|Overall Study|Death|2|||
126414831|NCT04302545|454813002|FG000|Overall Study|Lost to Follow-up|3|||
126414832|NCT04302545|454813003|FG001|Overall Study|Lost to Follow-up|4|||
126414833|NCT01636986|454813007|FG000|Overall Study|Withdrawal by Subject|0|||
126414834|NCT01636986|454813008|FG001|Overall Study|Withdrawal by Subject|1|||
126414835|NCT01636986|454813007|FG000|Overall Study|Corneal Staining|0|||
126414836|NCT01636986|454813008|FG001|Overall Study|Corneal Staining|1|||
126414837|NCT02106403|454813013|FG000|Follow-Up Visit 3|Other Reason|0|||
126414838|NCT02106403|454813014|FG001|Follow-Up Visit 3|Other Reason|0|||
126414839|NCT02106403|454813015|FG002|Follow-Up Visit 3|Other Reason|0|||
126414840|NCT02106403|454813016|FG003|Follow-Up Visit 3|Other Reason|0|||
126414841|NCT02106403|454813017|FG004|Follow-Up Visit 3|Other Reason|0|||
126414842|NCT02106403|454813018|FG005|Follow-Up Visit 3|Other Reason|1|||
126414843|NCT04038567|454813020|FG000|Overall Study|Lost to Follow-up|6|||
126414844|NCT04038567|454813021|FG001|Overall Study|Lost to Follow-up|4|||
126414845|NCT04038567|454813022|FG002|Overall Study|Lost to Follow-up|5|||
126414846|NCT04038567|454813023|FG003|Overall Study|Lost to Follow-up|4|||
126414847|NCT04038567|454813024|FG004|Overall Study|Lost to Follow-up|6|||
126414848|NCT04038567|454813025|FG005|Overall Study|Lost to Follow-up|4|||
126414849|NCT04038567|454813026|FG006|Overall Study|Lost to Follow-up|4|||
126414850|NCT04038567|454813027|FG007|Overall Study|Lost to Follow-up|1|||
126414851|NCT04038567|454813020|FG000|Overall Study|Withdrawal by Subject|2|||
126414852|NCT04038567|454813021|FG001|Overall Study|Withdrawal by Subject|1|||
126414853|NCT04038567|454813022|FG002|Overall Study|Withdrawal by Subject|1|||
126414854|NCT04038567|454813023|FG003|Overall Study|Withdrawal by Subject|1|||
126414855|NCT04038567|454813024|FG004|Overall Study|Withdrawal by Subject|4|||
126414856|NCT04038567|454813025|FG005|Overall Study|Withdrawal by Subject|1|||
126414857|NCT04038567|454813026|FG006|Overall Study|Withdrawal by Subject|1|||
126414858|NCT04038567|454813027|FG007|Overall Study|Withdrawal by Subject|1|||
126414859|NCT04038567|454813020|FG000|Overall Study|missed survey window|1|||
126414860|NCT04038567|454813021|FG001|Overall Study|missed survey window|2|||
126414861|NCT04038567|454813022|FG002|Overall Study|missed survey window|0|||
126414862|NCT04038567|454813023|FG003|Overall Study|missed survey window|0|||
126414863|NCT04038567|454813024|FG004|Overall Study|missed survey window|1|||
126414864|NCT04038567|454813025|FG005|Overall Study|missed survey window|1|||
126414865|NCT04038567|454813026|FG006|Overall Study|missed survey window|2|||
126414866|NCT04038567|454813027|FG007|Overall Study|missed survey window|2|||
126414867|NCT04038567|454813020|FG000|Overall Study|technical issues|0|||
126414868|NCT04038567|454813021|FG001|Overall Study|technical issues|0|||
125891047|NCT00223080|452899689|FG000|Overall Study|Moved from study area|37|||
125891048|NCT00223080|452899690|FG001|Overall Study|Moved from study area|47|||
125891049|NCT00223080|452899689|FG000|Overall Study|Lost to Follow-up|259|||
125891050|NCT00223080|452899690|FG001|Overall Study|Lost to Follow-up|284|||
126414869|NCT04038567|454813022|FG002|Overall Study|technical issues|0|||
126414870|NCT04038567|454813023|FG003|Overall Study|technical issues|0|||
126414871|NCT04038567|454813024|FG004|Overall Study|technical issues|0|||
126414872|NCT04038567|454813025|FG005|Overall Study|technical issues|0|||
126414873|NCT04038567|454813026|FG006|Overall Study|technical issues|1|||
126414874|NCT04038567|454813027|FG007|Overall Study|technical issues|0|||
126414875|NCT04038567|454813020|FG000|Overall Study|Medical issues (i.e., illness)|0|||
126414876|NCT04038567|454813021|FG001|Overall Study|Medical issues (i.e., illness)|1|||
126414877|NCT04038567|454813022|FG002|Overall Study|Medical issues (i.e., illness)|2|||
126414878|NCT04038567|454813023|FG003|Overall Study|Medical issues (i.e., illness)|1|||
126414879|NCT04038567|454813024|FG004|Overall Study|Medical issues (i.e., illness)|1|||
126414880|NCT04038567|454813025|FG005|Overall Study|Medical issues (i.e., illness)|1|||
126414881|NCT04038567|454813026|FG006|Overall Study|Medical issues (i.e., illness)|0|||
126414882|NCT04038567|454813027|FG007|Overall Study|Medical issues (i.e., illness)|0|||
126414883|NCT04038567|454813020|FG000|Overall Study|Death|0|||
126414884|NCT04038567|454813021|FG001|Overall Study|Death|0|||
126414885|NCT04038567|454813022|FG002|Overall Study|Death|0|||
126414886|NCT04038567|454813023|FG003|Overall Study|Death|1|||
126414887|NCT04038567|454813024|FG004|Overall Study|Death|1|||
126414888|NCT04038567|454813025|FG005|Overall Study|Death|0|||
126414889|NCT04038567|454813026|FG006|Overall Study|Death|0|||
126414890|NCT04038567|454813027|FG007|Overall Study|Death|1|||
126414891|NCT01496846|454813031|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
126414892|NCT01496846|454813032|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
126414893|NCT01496846|454813033|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
126414894|NCT01496846|454813034|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
126414895|NCT01496846|454813035|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
126414896|NCT01496846|454813036|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
126414897|NCT01772576|454813039|FG000|Overall Study|Death|15|||
126414898|NCT01772576|454813039|FG000|Overall Study|Protocol Violation|1|||
126414899|NCT01772576|454813039|FG000|Overall Study|Lost to Follow-up|3|||
126414900|NCT01772576|454813039|FG000|Overall Study|Study device not used|3|||
126414901|NCT01772576|454813039|FG000|Overall Study|Adverse Event|6|||
126414902|NCT01772576|454813039|FG000|Overall Study|Withdrawal by Subject|6|||
126414903|NCT00923845|454813040|FG000|Induction Therapy|Poor performance status|0|||
126414904|NCT00923845|454813041|FG001|Induction Therapy|Poor performance status|2|||
126414905|NCT01534195|454813048|FG000|Overall Study|Withdrawal by Subject|1|||
126414906|NCT01534195|454813049|FG001|Overall Study|Withdrawal by Subject|1|||
126414907|NCT03052816|454813052|FG000|Overall Study|Withdrawal by Subject|1|||
126414908|NCT03052816|454813053|FG001|Overall Study|Withdrawal by Subject|0|||
126414909|NCT03052816|454813052|FG000|Overall Study|Desired opioids|2|||
126414910|NCT03052816|454813053|FG001|Overall Study|Desired opioids|0|||
126414911|NCT01278797|454813054|FG000|Period 1|Adverse Event|0|||
126414912|NCT01278797|454813055|FG001|Period 1|Adverse Event|1|||
126414913|NCT01278797|454813054|FG000|Period 1|Protocol Violation|1|||
126414914|NCT01278797|454813055|FG001|Period 1|Protocol Violation|0|||
126414915|NCT00895453|454813056|FG000|Overall Study|Lost to Follow-up|25|||
126414916|NCT00895453|454813057|FG001|Overall Study|Lost to Follow-up|25|||
126414917|NCT00895453|454813058|FG002|Overall Study|Lost to Follow-up|23|||
126414918|NCT01736618|454813060|FG000|Overall Study|Death|294|||
126414919|NCT01736618|454813060|FG000|Overall Study|Lost to Follow-up|193|||
126414920|NCT01736618|454813060|FG000|Overall Study|Withdrawal by Subject|54|||
126414921|NCT01736618|454813060|FG000|Overall Study|Subject unable to be followed at study location|223|||
126414922|NCT01736618|454813060|FG000|Overall Study|Physician Decision|33|||
126414923|NCT01736618|454813060|FG000|Overall Study|Transplant or removal of target organ|19|||
126414924|NCT01736618|454813060|FG000|Overall Study|Change in indication or condition|78|||
126414925|NCT01736618|454813060|FG000|Overall Study|Study device explant|103|||
125891051|NCT00223080|452899689|FG000|Overall Study|Death|85|||
126414926|NCT01736618|454813060|FG000|Overall Study|Unable to complete implant|2|||
126414927|NCT00400569|454813065|FG000|Overall Study|Death|1|||
126414928|NCT00620113|454813068|FG000|Overall Study|Adverse Event|3|||
126414929|NCT00620113|454813069|FG001|Overall Study|Adverse Event|2|||
126414930|NCT00620113|454813070|FG002|Overall Study|Adverse Event|2|||
126414931|NCT00620113|454813071|FG003|Overall Study|Adverse Event|1|||
126414932|NCT00620113|454813068|FG000|Overall Study|Lack of Efficacy|2|||
126414933|NCT00620113|454813069|FG001|Overall Study|Lack of Efficacy|3|||
125891052|NCT00223080|452899690|FG001|Overall Study|Death|74|||
125891053|NCT00223080|452899689|FG000|Overall Study|Other|14|||
125891054|NCT00223080|452899690|FG001|Overall Study|Other|11|||
126414934|NCT00620113|454813070|FG002|Overall Study|Lack of Efficacy|0|||
126414935|NCT00620113|454813071|FG003|Overall Study|Lack of Efficacy|2|||
126414936|NCT00620113|454813068|FG000|Overall Study|Physician Decision|1|||
126414937|NCT00620113|454813069|FG001|Overall Study|Physician Decision|0|||
126414938|NCT00620113|454813070|FG002|Overall Study|Physician Decision|0|||
126414939|NCT00620113|454813071|FG003|Overall Study|Physician Decision|2|||
126414940|NCT00620113|454813068|FG000|Overall Study|Protocol Violation|2|||
126414941|NCT00620113|454813069|FG001|Overall Study|Protocol Violation|1|||
126414942|NCT00620113|454813070|FG002|Overall Study|Protocol Violation|0|||
126414943|NCT00620113|454813071|FG003|Overall Study|Protocol Violation|0|||
126414944|NCT00620113|454813068|FG000|Overall Study|Withdrawal by Subject|5|||
126414945|NCT00620113|454813069|FG001|Overall Study|Withdrawal by Subject|1|||
126414946|NCT00620113|454813070|FG002|Overall Study|Withdrawal by Subject|3|||
126414947|NCT00620113|454813071|FG003|Overall Study|Withdrawal by Subject|5|||
126414948|NCT02461745|454813074|FG000|Overall Study|Lack of Efficacy|9|||
126414949|NCT02461745|454813075|FG001|Overall Study|Lack of Efficacy|1|||
126414950|NCT02461745|454813074|FG000|Overall Study|Lost to Follow-up|2|||
126414951|NCT02461745|454813075|FG001|Overall Study|Lost to Follow-up|2|||
126414952|NCT02461745|454813074|FG000|Overall Study|Withdrawal by Subject|3|||
126414953|NCT02461745|454813075|FG001|Overall Study|Withdrawal by Subject|1|||
126414954|NCT00211887|454813078|FG000|Overall Study|Adverse Event|8|||
126414955|NCT00211887|454813079|FG001|Overall Study|Adverse Event|4|||
126414956|NCT00211887|454813080|FG002|Overall Study|Adverse Event|6|||
126414957|NCT00211887|454813078|FG000|Overall Study|Death|1|||
126414958|NCT00211887|454813079|FG001|Overall Study|Death|1|||
126414959|NCT00211887|454813080|FG002|Overall Study|Death|1|||
126414960|NCT00211887|454813078|FG000|Overall Study|Lost to Follow-up|28|||
126414961|NCT00211887|454813079|FG001|Overall Study|Lost to Follow-up|13|||
126414962|NCT00211887|454813080|FG002|Overall Study|Lost to Follow-up|9|||
126414963|NCT00211887|454813078|FG000|Overall Study|Non-medical reason|31|||
126414964|NCT00211887|454813079|FG001|Overall Study|Non-medical reason|14|||
126414965|NCT00211887|454813080|FG002|Overall Study|Non-medical reason|8|||
126414966|NCT00211887|454813078|FG000|Overall Study|Other medical reason|15|||
126414967|NCT00211887|454813079|FG001|Overall Study|Other medical reason|11|||
126414968|NCT00211887|454813080|FG002|Overall Study|Other medical reason|7|||
126414969|NCT00211887|454813078|FG000|Overall Study|Side effects|19|||
126414970|NCT00211887|454813079|FG001|Overall Study|Side effects|13|||
126414971|NCT00211887|454813080|FG002|Overall Study|Side effects|5|||
126414972|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Adverse Event|33|||
126414973|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
126414974|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
126414975|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
126414976|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Physician Decision|6|||
126414977|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
126414978|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
126414979|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
126414980|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
126414981|NCT00965419|454813084|FG000|Follow-up Phase|Adverse Event|9|||
126414982|NCT00965419|454813084|FG000|Follow-up Phase|Protocol Violation|4|||
126414983|NCT00965419|454813084|FG000|Follow-up Phase|Withdrawal by Subject|8|||
126414984|NCT00965419|454813084|FG000|Follow-up Phase|Physician Decision|4|||
126414985|NCT00965419|454813084|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
126414986|NCT00965419|454813084|FG000|Follow-up Phase|Lack of Efficacy|28|||
126414987|NCT02927938|454813085|FG000|Overall Study|Death|0|||
126414988|NCT02927938|454813086|FG001|Overall Study|Death|1|||
126414989|NCT02927938|454813087|FG002|Overall Study|Death|0|||
126414990|NCT02927938|454813088|FG003|Overall Study|Death|4|||
126414991|NCT02927938|454813085|FG000|Overall Study|Early Study Termination|1|||
126414992|NCT02927938|454813086|FG001|Overall Study|Early Study Termination|5|||
126414993|NCT02927938|454813087|FG002|Overall Study|Early Study Termination|4|||
126414994|NCT02927938|454813088|FG003|Overall Study|Early Study Termination|3|||
126414995|NCT00931606|454814957|FG000|Overall Study|Death|1|||
126414996|NCT00931606|454814958|FG001|Overall Study|Death|3|||
126414997|NCT00931606|454814959|FG002|Overall Study|Death|2|||
126414998|NCT00931606|454814960|FG003|Overall Study|Death|0|||
126414999|NCT00931606|454814957|FG000|Overall Study|Lost to Follow-up|0|||
126415000|NCT00931606|454814958|FG001|Overall Study|Lost to Follow-up|1|||
126415001|NCT00931606|454814959|FG002|Overall Study|Lost to Follow-up|0|||
126415002|NCT00931606|454814960|FG003|Overall Study|Lost to Follow-up|0|||
126415003|NCT00931606|454814957|FG000|Overall Study|Physician Decision|0|||
126415004|NCT00931606|454814958|FG001|Overall Study|Physician Decision|0|||
126415005|NCT00931606|454814959|FG002|Overall Study|Physician Decision|3|||
126415006|NCT00931606|454814960|FG003|Overall Study|Physician Decision|0|||
126415007|NCT00931606|454814957|FG000|Overall Study|Sponsor Decision|1|||
126415008|NCT00931606|454814958|FG001|Overall Study|Sponsor Decision|4|||
126415009|NCT00931606|454814959|FG002|Overall Study|Sponsor Decision|0|||
126415010|NCT00931606|454814960|FG003|Overall Study|Sponsor Decision|2|||
126415011|NCT00931606|454814957|FG000|Overall Study|Withdrawal by Subject|3|||
126415012|NCT00931606|454814958|FG001|Overall Study|Withdrawal by Subject|1|||
126054289|NCT03070392|453493869|FG002|Overall Study|Death|0|||
126054290|NCT03070392|453493870|FG003|Overall Study|Death|1|||
126054291|NCT03070392|453493867|FG000|Overall Study|Withdrawal by Subject|7|||
126054292|NCT03070392|453493868|FG001|Overall Study|Withdrawal by Subject|0|||
126054293|NCT03070392|453493869|FG002|Overall Study|Withdrawal by Subject|0|||
126054294|NCT03070392|453493870|FG003|Overall Study|Withdrawal by Subject|3|||
126054295|NCT03070392|453493867|FG000|Overall Study|Physician Decision|1|||
126054296|NCT03070392|453493868|FG001|Overall Study|Physician Decision|0|||
126054297|NCT03070392|453493869|FG002|Overall Study|Physician Decision|0|||
126054298|NCT03070392|453493870|FG003|Overall Study|Physician Decision|2|||
126054299|NCT03070392|453493867|FG000|Overall Study|Progressive Disease|154|||
126054300|NCT03070392|453493868|FG001|Overall Study|Progressive Disease|6|||
126054301|NCT03070392|453493869|FG002|Overall Study|Progressive Disease|2|||
126054302|NCT03070392|453493870|FG003|Overall Study|Progressive Disease|70|||
126054303|NCT03070392|453493867|FG000|Overall Study|Adverse Event|6|||
126054304|NCT03070392|453493868|FG001|Overall Study|Adverse Event|1|||
126054305|NCT03070392|453493869|FG002|Overall Study|Adverse Event|1|||
126054306|NCT03070392|453493870|FG003|Overall Study|Adverse Event|3|||
126415013|NCT00931606|454814959|FG002|Overall Study|Withdrawal by Subject|1|||
126415014|NCT00931606|454814960|FG003|Overall Study|Withdrawal by Subject|1|||
126415015|NCT04794270|454814967|FG000|Period 1|Non Compliance|1|||
126415016|NCT04794270|454814968|FG001|Period 1|Non Compliance|0|||
126415017|NCT04794270|454814967|FG000|Period 1|Adverse Event|1|||
126415018|NCT04794270|454814968|FG001|Period 1|Adverse Event|0|||
126415019|NCT04794270|454814967|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
126415020|NCT04794270|454814968|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
126415021|NCT03826186|454814971|FG000|Overall Study|Protocol Violation|2|||
126415022|NCT03826186|454814972|FG001|Overall Study|Protocol Violation|0|||
126415023|NCT03826186|454814971|FG000|Overall Study|Withdrawal by Subject|1|||
126415024|NCT03826186|454814972|FG001|Overall Study|Withdrawal by Subject|0|||
126415025|NCT03688074|454814974|FG000|Overall Study|Adverse Event|0|||
126415026|NCT03688074|454814975|FG001|Overall Study|Adverse Event|1|||
126415027|NCT03688074|454814974|FG000|Overall Study|Other|1|||
126415028|NCT03688074|454814975|FG001|Overall Study|Other|0|||
126415029|NCT00082407|454814985|FG000|Overall Study|Adverse Event|20|||
126415030|NCT00082407|454814986|FG001|Overall Study|Adverse Event|0|||
126415031|NCT00082407|454814985|FG000|Overall Study|Protocol Violation|14|||
126415032|NCT00082407|454814986|FG001|Overall Study|Protocol Violation|12|||
126415033|NCT00082407|454814985|FG000|Overall Study|Patient Decision|13|||
126415034|NCT00082407|454814986|FG001|Overall Study|Patient Decision|6|||
126415035|NCT00082407|454814985|FG000|Overall Study|Physician Decision|5|||
126415036|NCT00082407|454814986|FG001|Overall Study|Physician Decision|3|||
126415037|NCT00082407|454814985|FG000|Overall Study|Loss of Glucose Control|2|||
126415038|NCT00082407|454814986|FG001|Overall Study|Loss of Glucose Control|2|||
126415039|NCT00082407|454814985|FG000|Overall Study|Death|2|||
126415040|NCT00082407|454814986|FG001|Overall Study|Death|1|||
126415041|NCT00082407|454814985|FG000|Overall Study|Lost to Follow-up|0|||
126415042|NCT00082407|454814986|FG001|Overall Study|Lost to Follow-up|3|||
126415043|NCT00891228|454814988|FG000|Overall Study|Adverse Event|0|||
126415044|NCT00891228|454814989|FG001|Overall Study|Adverse Event|2|||
126415045|NCT00891228|454814990|FG002|Overall Study|Adverse Event|3|||
126415046|NCT00891228|454814988|FG000|Overall Study|Withdrawal by Subject|2|||
126415047|NCT00891228|454814989|FG001|Overall Study|Withdrawal by Subject|4|||
126415048|NCT00891228|454814990|FG002|Overall Study|Withdrawal by Subject|5|||
126415049|NCT00891228|454814988|FG000|Overall Study|Protocol Violation|3|||
126415050|NCT00891228|454814989|FG001|Overall Study|Protocol Violation|1|||
126415051|NCT00891228|454814990|FG002|Overall Study|Protocol Violation|2|||
126415052|NCT00891228|454814988|FG000|Overall Study|Physician Decision|2|||
126415053|NCT00891228|454814989|FG001|Overall Study|Physician Decision|1|||
126415054|NCT00891228|454814990|FG002|Overall Study|Physician Decision|0|||
126415055|NCT00891228|454814988|FG000|Overall Study|Lost to Follow-up|4|||
126415056|NCT00891228|454814989|FG001|Overall Study|Lost to Follow-up|4|||
126415057|NCT00891228|454814990|FG002|Overall Study|Lost to Follow-up|5|||
126415058|NCT00891228|454814988|FG000|Overall Study|Pregnancy|0|||
126415059|NCT00891228|454814989|FG001|Overall Study|Pregnancy|1|||
126415060|NCT00891228|454814990|FG002|Overall Study|Pregnancy|0|||
126415061|NCT02688985|454814993|FG000|Overall Study|Adverse Event|1|||
126415062|NCT02688985|454814994|FG001|Overall Study|Adverse Event|2|||
126415063|NCT02688985|454814995|FG002|Overall Study|Adverse Event|2|||
126415064|NCT02688985|454814996|FG003|Overall Study|Adverse Event|0|||
126415065|NCT02688985|454814997|FG004|Overall Study|Adverse Event|0|||
126415066|NCT02688985|454814993|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
126415067|NCT02688985|454814994|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
126415068|NCT02688985|454814995|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
126415069|NCT02688985|454814996|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
126415070|NCT02688985|454814997|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
126415071|NCT02688985|454814993|FG000|Overall Study|Death|0|||
126415072|NCT02688985|454814994|FG001|Overall Study|Death|0|||
126415073|NCT02688985|454814995|FG002|Overall Study|Death|0|||
126415074|NCT02688985|454814996|FG003|Overall Study|Death|0|||
126415075|NCT02688985|454814997|FG004|Overall Study|Death|1|||
126415076|NCT02688985|454814993|FG000|Overall Study|Lack of Efficacy|0|||
126415077|NCT02688985|454814994|FG001|Overall Study|Lack of Efficacy|0|||
126415078|NCT02688985|454814995|FG002|Overall Study|Lack of Efficacy|0|||
126415079|NCT02688985|454814996|FG003|Overall Study|Lack of Efficacy|0|||
126415080|NCT02688985|454814997|FG004|Overall Study|Lack of Efficacy|1|||
126415081|NCT02688985|454814993|FG000|Overall Study|Lost to Follow-up|2|||
126415082|NCT02688985|454814994|FG001|Overall Study|Lost to Follow-up|0|||
126415083|NCT02688985|454814995|FG002|Overall Study|Lost to Follow-up|1|||
126415084|NCT02688985|454814996|FG003|Overall Study|Lost to Follow-up|1|||
126415085|NCT02688985|454814997|FG004|Overall Study|Lost to Follow-up|1|||
126415086|NCT02688985|454814993|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126415087|NCT02688985|454814994|FG001|Overall Study|Non-Compliance With Study Drug|3|||
126415088|NCT02688985|454814995|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126415089|NCT02688985|454814996|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126415090|NCT02688985|454814997|FG004|Overall Study|Non-Compliance With Study Drug|1|||
126415091|NCT02688985|454814993|FG000|Overall Study|Other|3|||
126415092|NCT02688985|454814994|FG001|Overall Study|Other|4|||
126415093|NCT02688985|454814995|FG002|Overall Study|Other|1|||
126415094|NCT02688985|454814996|FG003|Overall Study|Other|0|||
126415095|NCT02688985|454814997|FG004|Overall Study|Other|0|||
126415096|NCT02688985|454814993|FG000|Overall Study|Physician Decision|2|||
126415097|NCT02688985|454814994|FG001|Overall Study|Physician Decision|2|||
126415098|NCT02688985|454814995|FG002|Overall Study|Physician Decision|0|||
126415099|NCT02688985|454814996|FG003|Overall Study|Physician Decision|0|||
126415100|NCT02688985|454814997|FG004|Overall Study|Physician Decision|1|||
126415101|NCT02688985|454814993|FG000|Overall Study|Pregnancy|0|||
126415102|NCT02688985|454814994|FG001|Overall Study|Pregnancy|0|||
126415103|NCT02688985|454814995|FG002|Overall Study|Pregnancy|2|||
126415104|NCT02688985|454814996|FG003|Overall Study|Pregnancy|1|||
126415105|NCT02688985|454814997|FG004|Overall Study|Pregnancy|0|||
126415106|NCT02688985|454814993|FG000|Overall Study|Study Terminated By Sponsor|0|||
126415107|NCT02688985|454814994|FG001|Overall Study|Study Terminated By Sponsor|0|||
126415108|NCT02688985|454814995|FG002|Overall Study|Study Terminated By Sponsor|0|||
126415109|NCT02688985|454814996|FG003|Overall Study|Study Terminated By Sponsor|1|||
126415110|NCT02688985|454814997|FG004|Overall Study|Study Terminated By Sponsor|0|||
126415111|NCT02688985|454814993|FG000|Overall Study|Withdrawal by Subject|2|||
126415112|NCT02688985|454814994|FG001|Overall Study|Withdrawal by Subject|8|||
126415113|NCT02688985|454814995|FG002|Overall Study|Withdrawal by Subject|7|||
126415114|NCT02688985|454814996|FG003|Overall Study|Withdrawal by Subject|1|||
126415115|NCT02688985|454814997|FG004|Overall Study|Withdrawal by Subject|4|||
126415116|NCT01726582|454814998|FG000|Overall Study|Physician Decision|99|||
126415117|NCT01726582|454814998|FG000|Overall Study|Death|85|||
126415118|NCT03704688|454814999|FG000|Overall Study|Adverse Event|0|||
126415119|NCT03704688|454815000|FG001|Overall Study|Adverse Event|0|||
126415120|NCT03704688|454815001|FG002|Overall Study|Adverse Event|0|||
126415121|NCT03704688|454815002|FG003|Overall Study|Adverse Event|4|||
126415122|NCT03704688|454815003|FG004|Overall Study|Adverse Event|1|||
126415123|NCT03704688|454815004|FG005|Overall Study|Adverse Event|0|||
126415124|NCT03704688|454814999|FG000|Overall Study|Disease Progression|0|||
126415125|NCT03704688|454815000|FG001|Overall Study|Disease Progression|0|||
126415126|NCT03704688|454815001|FG002|Overall Study|Disease Progression|0|||
126415127|NCT03704688|454815002|FG003|Overall Study|Disease Progression|3|||
126415128|NCT03704688|454815003|FG004|Overall Study|Disease Progression|1|||
126415129|NCT03704688|454815004|FG005|Overall Study|Disease Progression|0|||
126415130|NCT03704688|454814999|FG000|Overall Study|Death|0|||
126415131|NCT03704688|454815000|FG001|Overall Study|Death|0|||
126415132|NCT03704688|454815001|FG002|Overall Study|Death|0|||
126415133|NCT03704688|454815002|FG003|Overall Study|Death|0|||
126415134|NCT03704688|454815003|FG004|Overall Study|Death|3|||
126415135|NCT03704688|454815004|FG005|Overall Study|Death|0|||
126415136|NCT02206035|454815005|FG000|Overall Study|Physician Decision|10|||
126415137|NCT02206035|454815006|FG001|Overall Study|Physician Decision|0|||
126415138|NCT02206035|454815007|FG002|Overall Study|Physician Decision|175|||
126415139|NCT05173012|454815009|FG000|Overall Study|Adverse Event|2|||
126415140|NCT05173012|454815010|FG001|Overall Study|Adverse Event|3|||
126415141|NCT05173012|454815011|FG002|Overall Study|Adverse Event|4|||
126415142|NCT05173012|454815012|FG003|Overall Study|Adverse Event|13|||
126415143|NCT05173012|454815013|FG004|Overall Study|Adverse Event|0|||
126415144|NCT05173012|454815014|FG005|Overall Study|Adverse Event|0|||
126415145|NCT05173012|454815015|FG006|Overall Study|Adverse Event|2|||
126415146|NCT05173012|454815016|FG007|Overall Study|Adverse Event|4|||
126415147|NCT05173012|454815009|FG000|Overall Study|Lost to Follow-up|0|||
126415148|NCT05173012|454815010|FG001|Overall Study|Lost to Follow-up|0|||
126415149|NCT05173012|454815011|FG002|Overall Study|Lost to Follow-up|0|||
126415150|NCT05173012|454815012|FG003|Overall Study|Lost to Follow-up|1|||
126415151|NCT05173012|454815013|FG004|Overall Study|Lost to Follow-up|0|||
126415152|NCT05173012|454815014|FG005|Overall Study|Lost to Follow-up|0|||
126415153|NCT05173012|454815015|FG006|Overall Study|Lost to Follow-up|0|||
126415154|NCT05173012|454815016|FG007|Overall Study|Lost to Follow-up|0|||
126415155|NCT05173012|454815009|FG000|Overall Study|Withdrawal by Subject|1|||
126415156|NCT05173012|454815010|FG001|Overall Study|Withdrawal by Subject|0|||
126415157|NCT05173012|454815011|FG002|Overall Study|Withdrawal by Subject|1|||
126415158|NCT05173012|454815012|FG003|Overall Study|Withdrawal by Subject|3|||
126415159|NCT05173012|454815013|FG004|Overall Study|Withdrawal by Subject|1|||
126415160|NCT05173012|454815014|FG005|Overall Study|Withdrawal by Subject|0|||
126415161|NCT05173012|454815015|FG006|Overall Study|Withdrawal by Subject|1|||
126415162|NCT05173012|454815016|FG007|Overall Study|Withdrawal by Subject|0|||
126415163|NCT05173012|454815009|FG000|Overall Study|Protocol Deviation|0|||
126415164|NCT05173012|454815010|FG001|Overall Study|Protocol Deviation|0|||
126415165|NCT05173012|454815011|FG002|Overall Study|Protocol Deviation|0|||
126415166|NCT05173012|454815012|FG003|Overall Study|Protocol Deviation|1|||
126415167|NCT05173012|454815013|FG004|Overall Study|Protocol Deviation|0|||
126415168|NCT05173012|454815014|FG005|Overall Study|Protocol Deviation|0|||
126415169|NCT05173012|454815015|FG006|Overall Study|Protocol Deviation|0|||
126415170|NCT05173012|454815016|FG007|Overall Study|Protocol Deviation|0|||
126415171|NCT05173012|454815009|FG000|Overall Study|Other|0|||
126415172|NCT05173012|454815010|FG001|Overall Study|Other|0|||
126415173|NCT05173012|454815011|FG002|Overall Study|Other|0|||
126415174|NCT05173012|454815012|FG003|Overall Study|Other|2|||
126415175|NCT05173012|454815013|FG004|Overall Study|Other|0|||
126415176|NCT05173012|454815014|FG005|Overall Study|Other|0|||
126415177|NCT05173012|454815015|FG006|Overall Study|Other|0|||
126415178|NCT05173012|454815016|FG007|Overall Study|Other|0|||
125891055|NCT00223080|452899689|FG000|Overall Study|Reason not provided|141|||
125891056|NCT00223080|452899690|FG001|Overall Study|Reason not provided|140|||
125891057|NCT00223080|452899689|FG000|Overall Study|Adverse Event|0|||
125891058|NCT00223080|452899690|FG001|Overall Study|Adverse Event|1|||
125891059|NCT02598583|452899691|FG000|Extension Period|Withdrawal by Subject|1|||
125891060|NCT02598583|452899692|FG001|Extension Period|Withdrawal by Subject|0|||
125891061|NCT03237286|452899693|FG000|Overall Study|Withdrawal by Subject|1|||
125891062|NCT03237286|452899694|FG001|Overall Study|Withdrawal by Subject|0|||
126415179|NCT03668613|454815017|FG000|Overall Study|Adverse Event|1|||
126415180|NCT03668613|454815018|FG001|Overall Study|Adverse Event|2|||
125891063|NCT03237286|452899695|FG002|Overall Study|Withdrawal by Subject|2|||
126415181|NCT03668613|454815017|FG000|Overall Study|Lack of Efficacy|5|||
126415182|NCT03668613|454815018|FG001|Overall Study|Lack of Efficacy|1|||
126415183|NCT03668613|454815017|FG000|Overall Study|Pregnancy|0|||
126105356|NCT01201265|453678608|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126415184|NCT03668613|454815018|FG001|Overall Study|Pregnancy|2|||
126415185|NCT03668613|454815017|FG000|Overall Study|Protocol Violation|1|||
126415186|NCT03668613|454815018|FG001|Overall Study|Protocol Violation|0|||
126415187|NCT03668613|454815017|FG000|Overall Study|Physician Decision|1|||
126415188|NCT03668613|454815018|FG001|Overall Study|Physician Decision|0|||
126415189|NCT03668613|454815017|FG000|Overall Study|Withdrawal by Subject|2|||
126415190|NCT03668613|454815018|FG001|Overall Study|Withdrawal by Subject|1|||
126415191|NCT03668613|454815017|FG000|Overall Study|Guardian decision|1|||
126415192|NCT03668613|454815018|FG001|Overall Study|Guardian decision|0|||
126415193|NCT01068769|454815021|FG000|Overall Study|Ineligible|1|||
126415194|NCT00709618|454815022|FG000|Overall Study|Withdrawal by Subject|4|||
126415195|NCT00709618|454815022|FG000|Overall Study|Lost to Follow-up|1|||
126415196|NCT00709618|454815022|FG000|Overall Study|Study Closed/Terminated|25|||
126415197|NCT01948063|454815025|FG000|Overall Study|Boston MCI halted research protocol|0|||
126415198|NCT01948063|454815026|FG001|Overall Study|Boston MCI halted research protocol|1|||
126415199|NCT01948063|454815025|FG000|Overall Study|Discovered an enrollment in other study|0|||
126415200|NCT01948063|454815026|FG001|Overall Study|Discovered an enrollment in other study|1|||
126415201|NCT01948063|454815025|FG000|Overall Study|Blood samples were accidentally thawed|1|||
126415202|NCT01948063|454815026|FG001|Overall Study|Blood samples were accidentally thawed|0|||
126415203|NCT03781414|454815029|FG000|Overall Study|Study terminated by sponsor|39|||
126415204|NCT03781414|454815030|FG001|Overall Study|Study terminated by sponsor|34|||
126415205|NCT03781414|454815031|FG002|Overall Study|Study terminated by sponsor|25|||
126415206|NCT03781414|454815029|FG000|Overall Study|Adverse Event|3|||
126415207|NCT03781414|454815030|FG001|Overall Study|Adverse Event|6|||
126415208|NCT03781414|454815031|FG002|Overall Study|Adverse Event|3|||
126415209|NCT03781414|454815029|FG000|Overall Study|Physician Decision|2|||
126415210|NCT03781414|454815030|FG001|Overall Study|Physician Decision|0|||
126415211|NCT03781414|454815031|FG002|Overall Study|Physician Decision|1|||
126415212|NCT03781414|454815029|FG000|Overall Study|Withdrawal by Subject|2|||
126415213|NCT03781414|454815030|FG001|Overall Study|Withdrawal by Subject|3|||
126415214|NCT03781414|454815031|FG002|Overall Study|Withdrawal by Subject|3|||
126415215|NCT03781414|454815029|FG000|Overall Study|Death|1|||
126415216|NCT03781414|454815030|FG001|Overall Study|Death|4|||
126415217|NCT03781414|454815031|FG002|Overall Study|Death|0|||
126415218|NCT03781414|454815029|FG000|Overall Study|Lost to Follow-up|1|||
126415219|NCT03781414|454815030|FG001|Overall Study|Lost to Follow-up|1|||
126415220|NCT03781414|454815031|FG002|Overall Study|Lost to Follow-up|0|||
126415221|NCT04752358|454815032|FG000|Overall Study|Death|2|||
126415222|NCT04752358|454815033|FG001|Overall Study|Death|1|||
126415223|NCT00719355|454815034|FG000|Overall Study|Death|0|||
126415224|NCT00719355|454815035|FG001|Overall Study|Death|1|||
126415225|NCT00719355|454815034|FG000|Overall Study|Medical|14|||
126415226|NCT00719355|454815035|FG001|Overall Study|Medical|5|||
126105357|NCT01201265|453678608|FG000|Overall Study|Lost to Follow-up|10|||
126415227|NCT00719355|454815034|FG000|Overall Study|Compliance|4|||
126415228|NCT00719355|454815035|FG001|Overall Study|Compliance|6|||
126415229|NCT00719355|454815034|FG000|Overall Study|Moved|0|||
126415230|NCT00719355|454815035|FG001|Overall Study|Moved|1|||
126415231|NCT03364738|454815036|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
126415232|NCT03364738|454815036|FG000|Overall Study|Withdrawal by Subject|1|||
126415233|NCT03364738|454815036|FG000|Overall Study|Adverse Event|1|||
126415234|NCT00988091|454815044|FG000|Double-blind Period|Withdrawal by Subject|15|||
126415235|NCT00988091|454815045|FG001|Double-blind Period|Withdrawal by Subject|13|||
126415236|NCT00988091|454815044|FG000|Double-blind Period|Lost to Follow-up|12|||
126415237|NCT00988091|454815045|FG001|Double-blind Period|Lost to Follow-up|14|||
126415238|NCT00988091|454815044|FG000|Double-blind Period|Other|8|||
126415239|NCT00988091|454815045|FG001|Double-blind Period|Other|8|||
126415240|NCT00988091|454815044|FG000|Double-blind Period|Adverse Event|6|||
126415241|NCT00988091|454815045|FG001|Double-blind Period|Adverse Event|9|||
126415242|NCT00988091|454815044|FG000|Double-blind Period|Use of exclusionary medication|2|||
126415243|NCT00988091|454815045|FG001|Double-blind Period|Use of exclusionary medication|3|||
126415244|NCT00988091|454815044|FG000|Open-label Period|Adverse Event|4|||
126415245|NCT00988091|454815045|FG001|Open-label Period|Adverse Event|7|||
126415246|NCT00988091|454815044|FG000|Open-label Period|Use of exclusionary medication|1|||
126415247|NCT00988091|454815045|FG001|Open-label Period|Use of exclusionary medication|1|||
126415248|NCT00988091|454815044|FG000|Open-label Period|Protocol Violation|1|||
126415249|NCT00988091|454815045|FG001|Open-label Period|Protocol Violation|1|||
126415250|NCT00988091|454815044|FG000|Open-label Period|Withdrawal by Subject|10|||
126415251|NCT00988091|454815045|FG001|Open-label Period|Withdrawal by Subject|16|||
126415252|NCT00988091|454815044|FG000|Open-label Period|Lost to Follow-up|3|||
126415253|NCT00988091|454815045|FG001|Open-label Period|Lost to Follow-up|5|||
126415254|NCT00988091|454815044|FG000|Open-label Period|Other|2|||
126415255|NCT00988091|454815045|FG001|Open-label Period|Other|3|||
126415256|NCT00994422|454815046|FG000|Overall Study|Lost to Follow-up|7|||
126415257|NCT00994422|454815047|FG001|Overall Study|Lost to Follow-up|1|||
126415258|NCT01846741|454815049|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
126415259|NCT03664765|454815050|FG000|Overall Study|Withdrawal by Subject|4|||
126415260|NCT03664765|454815051|FG001|Overall Study|Withdrawal by Subject|1|||
126415261|NCT03664765|454815050|FG000|Overall Study|Lost to Follow-up|0|||
126415262|NCT03664765|454815051|FG001|Overall Study|Lost to Follow-up|1|||
126415263|NCT01153698|454815052|FG000|Overall Study|Adverse Event|12|||
126415264|NCT01153698|454815052|FG000|Overall Study|Lost to Follow-up|4|||
126415265|NCT01153698|454815052|FG000|Overall Study|Withdrawal by Subject|2|||
126415266|NCT01153698|454815052|FG000|Overall Study|Switch to other anticoagulants|4|||
126415267|NCT01153698|454815052|FG000|Overall Study|Other|2|||
126415268|NCT01153698|454815052|FG000|Overall Study|Not treated with Pradaxa|5|||
126415269|NCT01090063|454815053|FG000|Screen|Screen Failed|4|||
126415270|NCT01090063|454815053|FG000|Treatment|Withdrawal by Subject|4|||
126415271|NCT01817959|454815054|FG000|Overall Study|Graft loss|1|||
126415272|NCT01817959|454815055|FG001|Overall Study|Graft loss|1|||
126415273|NCT01817959|454815054|FG000|Overall Study|forbidden medication|1|||
126415274|NCT01817959|454815055|FG001|Overall Study|forbidden medication|1|||
126415275|NCT01817959|454815054|FG000|Overall Study|Adverse Event|1|||
126415276|NCT01817959|454815055|FG001|Overall Study|Adverse Event|0|||
126415277|NCT01817959|454815054|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
126415278|NCT01817959|454815055|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
126415279|NCT00330681|454815061|FG000|Overall Study|Adverse Event|3|||
126415280|NCT00330681|454815062|FG001|Overall Study|Adverse Event|6|||
126415281|NCT00330681|454815061|FG000|Overall Study|Protocol Violation|0|||
126415282|NCT00330681|454815062|FG001|Overall Study|Protocol Violation|1|||
126415283|NCT00330681|454815061|FG000|Overall Study|Withdrawal by Subject|5|||
126415284|NCT00330681|454815062|FG001|Overall Study|Withdrawal by Subject|5|||
126415285|NCT00330681|454815061|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
126415286|NCT00330681|454815062|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
126415287|NCT02578186|454815063|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
126415288|NCT02578186|454815064|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
126415289|NCT02578186|454815063|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
126415290|NCT02578186|454815064|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
126415291|NCT01140061|454815065|FG000|Part I|Adverse Event|1|||
126415292|NCT01140061|454815066|FG001|Part I|Adverse Event|0|||
126415293|NCT01140061|454815067|FG002|Part I|Adverse Event|0|||
126415294|NCT01140061|454815068|FG003|Part I|Adverse Event|0|||
126415295|NCT01140061|454815069|FG004|Part I|Adverse Event|0|||
126415296|NCT01140061|454815070|FG005|Part I|Adverse Event|0|||
126415297|NCT01140061|454815071|FG006|Part I|Adverse Event|0|||
126415298|NCT01140061|454815072|FG007|Part I|Adverse Event|0|||
126415299|NCT01140061|454815073|FG008|Part I|Adverse Event|0|||
126415300|NCT01140061|454815074|FG009|Part I|Adverse Event|0|||
126415301|NCT01140061|454815065|FG000|Extension|Laboratory Adverse Event|0|||
126415302|NCT01140061|454815066|FG001|Extension|Laboratory Adverse Event|0|||
126415303|NCT01140061|454815067|FG002|Extension|Laboratory Adverse Event|0|||
126415304|NCT01140061|454815068|FG003|Extension|Laboratory Adverse Event|0|||
126415305|NCT01140061|454815069|FG004|Extension|Laboratory Adverse Event|0|||
126415306|NCT01140061|454815070|FG005|Extension|Laboratory Adverse Event|0|||
126415307|NCT01140061|454815071|FG006|Extension|Laboratory Adverse Event|0|||
126415308|NCT01140061|454815072|FG007|Extension|Laboratory Adverse Event|0|||
126415309|NCT01140061|454815073|FG008|Extension|Laboratory Adverse Event|0|||
126415310|NCT01140061|454815074|FG009|Extension|Laboratory Adverse Event|1|||
125891064|NCT03237286|452899693|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
125891065|NCT03237286|452899694|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
125971393|NCT03593655|453182830|FG001|First Product Use Period|Withdrawal by Subject|1|||
126415311|NCT00428389|454815075|FG000|Core Phase|Adverse Event|6|||
126415312|NCT00428389|454815076|FG001|Core Phase|Adverse Event|4|||
126415313|NCT00428389|454815075|FG000|Core Phase|Lack of Efficacy|2|||
126415314|NCT00428389|454815076|FG001|Core Phase|Lack of Efficacy|0|||
126415315|NCT00428389|454815075|FG000|Core Phase|Abnormal test procedure result(s)|0|||
126415316|NCT00428389|454815076|FG001|Core Phase|Abnormal test procedure result(s)|1|||
126415317|NCT00428389|454815075|FG000|Core Phase|Withdrawal by Subject|3|||
126415318|NCT00428389|454815076|FG001|Core Phase|Withdrawal by Subject|4|||
126415319|NCT00428389|454815075|FG000|Core Phase|Protocol deviation|0|||
126415320|NCT00428389|454815076|FG001|Core Phase|Protocol deviation|2|||
126415321|NCT00428389|454815075|FG000|Extension Phase|Adverse Event|17|||
126415322|NCT00428389|454815076|FG001|Extension Phase|Adverse Event|11|||
126415323|NCT00428389|454815075|FG000|Extension Phase|Lack of Efficacy|4|||
126415324|NCT00428389|454815076|FG001|Extension Phase|Lack of Efficacy|3|||
126415325|NCT00428389|454815075|FG000|Extension Phase|Withdrawal by Subject|6|||
126415326|NCT00428389|454815076|FG001|Extension Phase|Withdrawal by Subject|6|||
126415327|NCT00428389|454815075|FG000|Extension Phase|Lost to Follow-up|0|||
126415328|NCT00428389|454815076|FG001|Extension Phase|Lost to Follow-up|3|||
126415329|NCT00428389|454815075|FG000|Extension Phase|Death|1|||
126415330|NCT00428389|454815076|FG001|Extension Phase|Death|0|||
126415331|NCT00428389|454815075|FG000|Extension Phase|Protocol Violation|3|||
126415332|NCT00428389|454815076|FG001|Extension Phase|Protocol Violation|2|||
126415333|NCT00428389|454815075|FG000|Extension Phase|Administrative problems|1|||
126415334|NCT00428389|454815076|FG001|Extension Phase|Administrative problems|1|||
126415335|NCT02669121|454815077|FG000|Overall Study|Adverse Event|4|||
125971394|NCT03593655|453182829|FG000|First Product Use Period|Lost to Follow-up|1|||
125971395|NCT03593655|453182830|FG001|First Product Use Period|Lost to Follow-up|3|||
126415336|NCT02669121|454815078|FG001|Overall Study|Adverse Event|5|||
126415337|NCT02669121|454815077|FG000|Overall Study|Lost to Follow-up|15|||
126415338|NCT02669121|454815078|FG001|Overall Study|Lost to Follow-up|27|||
126415339|NCT02669121|454815077|FG000|Overall Study|Withdrawal by Subject|132|||
126415340|NCT02669121|454815078|FG001|Overall Study|Withdrawal by Subject|140|||
126415341|NCT02669121|454815077|FG000|Overall Study|Pregnancy|0|||
126415342|NCT02669121|454815078|FG001|Overall Study|Pregnancy|1|||
126415343|NCT02669121|454815077|FG000|Overall Study|Discharged from US Military Active Service|117|||
126415344|NCT02669121|454815078|FG001|Overall Study|Discharged from US Military Active Service|91|||
126415345|NCT02669121|454815077|FG000|Overall Study|Reason not Specified|22|||
126415346|NCT02669121|454815078|FG001|Overall Study|Reason not Specified|18|||
126415347|NCT03216746|454815079|FG000|Overall Study|Lost to Follow-up|6|||
126415348|NCT03216746|454815080|FG001|Overall Study|Lost to Follow-up|8|||
126415349|NCT03216746|454815081|FG002|Overall Study|Lost to Follow-up|5|||
126415350|NCT03216746|454815082|FG003|Overall Study|Lost to Follow-up|6|||
126415351|NCT04384523|454815083|FG000|Overall Study|Lost to Follow-up|0|||
126415352|NCT04384523|454815084|FG001|Overall Study|Lost to Follow-up|0|||
126415353|NCT04384523|454815085|FG002|Overall Study|Lost to Follow-up|0|||
126415354|NCT04384523|454815086|FG003|Overall Study|Lost to Follow-up|0|||
126415355|NCT04384523|454815087|FG004|Overall Study|Lost to Follow-up|0|||
126415356|NCT04384523|454815088|FG005|Overall Study|Lost to Follow-up|1|||
126415357|NCT04384523|454815083|FG000|Overall Study|Protocol Violation|0|||
126415358|NCT04384523|454815084|FG001|Overall Study|Protocol Violation|1|||
126415359|NCT04384523|454815085|FG002|Overall Study|Protocol Violation|0|||
126415360|NCT04384523|454815086|FG003|Overall Study|Protocol Violation|0|||
126415361|NCT04384523|454815087|FG004|Overall Study|Protocol Violation|0|||
126415362|NCT04384523|454815088|FG005|Overall Study|Protocol Violation|0|||
126415363|NCT04384523|454815083|FG000|Overall Study|Withdrawal by Subject|1|||
126415364|NCT04384523|454815084|FG001|Overall Study|Withdrawal by Subject|0|||
126415365|NCT04384523|454815085|FG002|Overall Study|Withdrawal by Subject|0|||
126415366|NCT04384523|454815086|FG003|Overall Study|Withdrawal by Subject|0|||
126415367|NCT04384523|454815087|FG004|Overall Study|Withdrawal by Subject|0|||
126415368|NCT04384523|454815088|FG005|Overall Study|Withdrawal by Subject|0|||
126054307|NCT03070392|453493867|FG000|Overall Study|Alternate anticancer treatment|1|||
126054308|NCT03070392|453493868|FG001|Overall Study|Alternate anticancer treatment|0|||
126054309|NCT03070392|453493869|FG002|Overall Study|Alternate anticancer treatment|0|||
126054310|NCT03070392|453493870|FG003|Overall Study|Alternate anticancer treatment|1|||
126415369|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
126415370|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
126415371|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
126415372|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415373|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415374|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415375|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415376|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415377|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415378|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Physician Decision|1|||
125891066|NCT03237286|452899695|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
126054311|NCT03070392|453493867|FG000|Overall Study|Ongoing|73|||
125891067|NCT00948441|452899696|FG000|Overall Study|no longer meet inclusion criteria|1|||
125891068|NCT00948441|452899697|FG001|Overall Study|no longer meet inclusion criteria|4|||
126054312|NCT03070392|453493868|FG001|Overall Study|Ongoing|0|||
126415379|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Physician Decision|2|||
126415380|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Physician Decision|0|||
126415381|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Physician Decision|0|||
126415382|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Physician Decision|0|||
126415383|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Physician Decision|0|||
126415384|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Physician Decision|0|||
126415385|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Physician Decision|0|||
126415386|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Physician Decision|0|||
126054313|NCT03070392|453493869|FG002|Overall Study|Ongoing|0|||
126415387|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
126415388|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
126415389|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
126415390|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
126415391|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
126415392|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
126415393|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
126415394|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
126415395|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
126415396|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
126415397|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415398|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415399|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415400|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415401|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415402|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415403|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415404|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415405|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
126415406|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
126415407|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415408|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415409|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415410|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415411|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415412|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415413|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415414|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Other than Specified|0|||
126415415|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Other than Specified|0|||
126415416|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Other than Specified|3|||
126415417|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Other than Specified|0|||
126415418|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Other than Specified|0|||
126415419|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Other than Specified|0|||
126415420|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Other than Specified|0|||
126415421|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Other than Specified|0|||
126415422|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Other than Specified|0|||
126415423|NCT04405076|454815089|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415424|NCT04405076|454815090|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415425|NCT04405076|454815091|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415426|NCT04405076|454815092|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
126415427|NCT04405076|454815093|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
126415428|NCT04405076|454815094|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
126415429|NCT04405076|454815095|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415430|NCT04405076|454815096|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415431|NCT04405076|454815097|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415432|NCT04405076|454815089|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415433|NCT04405076|454815090|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415434|NCT04405076|454815091|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415435|NCT04405076|454815092|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415436|NCT04405076|454815093|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
126415437|NCT04405076|454815094|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415438|NCT04405076|454815095|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415439|NCT04405076|454815096|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415440|NCT04405076|454815097|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415441|NCT04405076|454815089|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415442|NCT04405076|454815090|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415443|NCT04405076|454815091|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415444|NCT04405076|454815092|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
126415445|NCT04405076|454815093|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
126415446|NCT04405076|454815094|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
126415447|NCT04405076|454815095|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415448|NCT04405076|454815096|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415449|NCT04405076|454815097|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415450|NCT04405076|454815089|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415451|NCT04405076|454815090|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415452|NCT04405076|454815091|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415453|NCT04405076|454815092|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415454|NCT04405076|454815093|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415455|NCT04405076|454815094|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415456|NCT04405076|454815095|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415457|NCT04405076|454815096|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
126415458|NCT04405076|454815097|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
126415459|NCT04405076|454815089|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415460|NCT04405076|454815090|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415461|NCT04405076|454815091|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415462|NCT04405076|454815092|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415463|NCT04405076|454815093|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415464|NCT04405076|454815094|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415465|NCT04405076|454815095|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
126415466|NCT04405076|454815096|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415467|NCT04405076|454815097|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415468|NCT00392990|454815100|FG000|Treatment on Study|Adverse Event|3|||
126415469|NCT00392990|454815101|FG001|Treatment on Study|Adverse Event|1|||
126415470|NCT00392990|454815100|FG000|Follow up for 2 Years|Death|4|||
126415471|NCT00392990|454815101|FG001|Follow up for 2 Years|Death|0|||
126415472|NCT02980133|454815102|FG000|Overall Study|Other than specified|1|||
126415473|NCT02980133|454815103|FG001|Overall Study|Other than specified|1|||
126415474|NCT02980133|454815104|FG002|Overall Study|Other than specified|2|||
126415475|NCT02980133|454815105|FG003|Overall Study|Other than specified|2|||
126415476|NCT02980133|454815102|FG000|Overall Study|Lost to Follow-up|0|||
126415477|NCT02980133|454815103|FG001|Overall Study|Lost to Follow-up|0|||
126415478|NCT02980133|454815104|FG002|Overall Study|Lost to Follow-up|1|||
126415479|NCT02980133|454815105|FG003|Overall Study|Lost to Follow-up|3|||
126415480|NCT02980133|454815102|FG000|Overall Study|Protocol Violation|0|||
126415481|NCT02980133|454815103|FG001|Overall Study|Protocol Violation|1|||
126415482|NCT02980133|454815104|FG002|Overall Study|Protocol Violation|0|||
126415483|NCT02980133|454815105|FG003|Overall Study|Protocol Violation|0|||
126415484|NCT02980133|454815102|FG000|Overall Study|Withdrawal by parent/guardian|6|||
126415485|NCT02980133|454815103|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126415486|NCT02980133|454815104|FG002|Overall Study|Withdrawal by parent/guardian|3|||
126415487|NCT02980133|454815105|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126415488|NCT02980133|454815102|FG000|Overall Study|Withdrawal by Subject|0|||
126415489|NCT02980133|454815103|FG001|Overall Study|Withdrawal by Subject|0|||
126415490|NCT02980133|454815104|FG002|Overall Study|Withdrawal by Subject|1|||
126415491|NCT02980133|454815105|FG003|Overall Study|Withdrawal by Subject|0|||
126415492|NCT00825812|454815106|FG000|Overall Study|Never entered follow up|0|||
126415493|NCT00825812|454815107|FG001|Overall Study|Never entered follow up|0|||
126415494|NCT00825812|454815108|FG002|Overall Study|Never entered follow up|0|||
126415495|NCT00825812|454815109|FG003|Overall Study|Never entered follow up|1|||
126415496|NCT00825812|454815106|FG000|Overall Study|Adverse Event|0|||
126415497|NCT00825812|454815107|FG001|Overall Study|Adverse Event|0|||
126415498|NCT00825812|454815108|FG002|Overall Study|Adverse Event|0|||
126415499|NCT00825812|454815109|FG003|Overall Study|Adverse Event|1|||
126415500|NCT00825812|454815106|FG000|Overall Study|Subject withdrew consent|0|||
126415501|NCT00825812|454815107|FG001|Overall Study|Subject withdrew consent|0|||
126415502|NCT00825812|454815108|FG002|Overall Study|Subject withdrew consent|3|||
126415503|NCT00825812|454815109|FG003|Overall Study|Subject withdrew consent|2|||
126415504|NCT00825812|454815106|FG000|Overall Study|Non-compliance with protocol|0|||
126415505|NCT00825812|454815107|FG001|Overall Study|Non-compliance with protocol|0|||
126415506|NCT00825812|454815108|FG002|Overall Study|Non-compliance with protocol|0|||
126415507|NCT00825812|454815109|FG003|Overall Study|Non-compliance with protocol|1|||
126415508|NCT00825812|454815106|FG000|Overall Study|Administrative|0|||
126415509|NCT00825812|454815107|FG001|Overall Study|Administrative|1|||
126415510|NCT00825812|454815108|FG002|Overall Study|Administrative|3|||
126415511|NCT00825812|454815109|FG003|Overall Study|Administrative|5|||
126415512|NCT00172042|454815110|FG000|Overall Study|Adverse Event|27|||
126415513|NCT00172042|454815111|FG001|Overall Study|Adverse Event|13|||
126415514|NCT00172042|454815110|FG000|Overall Study|Abnormal laboratory value(s)|5|||
126415515|NCT00172042|454815111|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126415516|NCT00172042|454815110|FG000|Overall Study|Abnormal test procedure(s)|0|||
126415517|NCT00172042|454815111|FG001|Overall Study|Abnormal test procedure(s)|3|||
126415518|NCT00172042|454815110|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
126415519|NCT00172042|454815111|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
126415520|NCT00172042|454815110|FG000|Overall Study|Patient no longer requires study drug|10|||
126415521|NCT00172042|454815111|FG001|Overall Study|Patient no longer requires study drug|8|||
126415522|NCT00172042|454815110|FG000|Overall Study|Protocol Violation|8|||
126415523|NCT00172042|454815111|FG001|Overall Study|Protocol Violation|7|||
126415524|NCT00172042|454815110|FG000|Overall Study|Withdrawal by Subject|37|||
126415525|NCT00172042|454815111|FG001|Overall Study|Withdrawal by Subject|25|||
126415526|NCT00172042|454815110|FG000|Overall Study|Lost to Follow-up|3|||
126415527|NCT00172042|454815111|FG001|Overall Study|Lost to Follow-up|5|||
126415528|NCT00172042|454815110|FG000|Overall Study|Administrative problems|13|||
126415529|NCT00172042|454815111|FG001|Overall Study|Administrative problems|10|||
126415530|NCT00172042|454815110|FG000|Overall Study|Death|42|||
126415531|NCT00172042|454815111|FG001|Overall Study|Death|42|||
126415532|NCT00483938|454815112|FG000|Overall Study|Protocol Violation|0|||
126415533|NCT00483938|454815113|FG001|Overall Study|Protocol Violation|0|||
126415534|NCT00483938|454815114|FG002|Overall Study|Protocol Violation|0|||
126415535|NCT00483938|454815115|FG003|Overall Study|Protocol Violation|0|||
126415536|NCT00483938|454815116|FG004|Overall Study|Protocol Violation|0|||
126415537|NCT00483938|454815117|FG005|Overall Study|Protocol Violation|0|||
126415538|NCT00483938|454815118|FG006|Overall Study|Protocol Violation|3|||
126415539|NCT00483938|454815112|FG000|Overall Study|Withdrawal by Subject|1|||
126415540|NCT00483938|454815113|FG001|Overall Study|Withdrawal by Subject|6|||
126415541|NCT00483938|454815114|FG002|Overall Study|Withdrawal by Subject|0|||
126415542|NCT00483938|454815115|FG003|Overall Study|Withdrawal by Subject|0|||
126415543|NCT00483938|454815116|FG004|Overall Study|Withdrawal by Subject|1|||
126415544|NCT00483938|454815117|FG005|Overall Study|Withdrawal by Subject|3|||
126415545|NCT00483938|454815118|FG006|Overall Study|Withdrawal by Subject|2|||
126415546|NCT00483938|454815112|FG000|Overall Study|Lost to Follow-up|1|||
126415547|NCT00483938|454815113|FG001|Overall Study|Lost to Follow-up|2|||
126415548|NCT00483938|454815114|FG002|Overall Study|Lost to Follow-up|0|||
126415549|NCT00483938|454815115|FG003|Overall Study|Lost to Follow-up|2|||
126415550|NCT00483938|454815116|FG004|Overall Study|Lost to Follow-up|1|||
126415551|NCT00483938|454815117|FG005|Overall Study|Lost to Follow-up|1|||
126415552|NCT00483938|454815118|FG006|Overall Study|Lost to Follow-up|3|||
126415553|NCT00483938|454815112|FG000|Overall Study|Death|0|||
126415554|NCT00483938|454815113|FG001|Overall Study|Death|2|||
126415555|NCT00483938|454815114|FG002|Overall Study|Death|0|||
126415556|NCT00483938|454815115|FG003|Overall Study|Death|0|||
126415557|NCT00483938|454815116|FG004|Overall Study|Death|0|||
126415558|NCT00483938|454815117|FG005|Overall Study|Death|0|||
126415559|NCT00483938|454815118|FG006|Overall Study|Death|0|||
126415560|NCT00483938|454815112|FG000|Overall Study|Other|3|||
126415561|NCT00483938|454815113|FG001|Overall Study|Other|9|||
126415562|NCT00483938|454815114|FG002|Overall Study|Other|0|||
126415563|NCT00483938|454815115|FG003|Overall Study|Other|4|||
126415564|NCT00483938|454815116|FG004|Overall Study|Other|0|||
126415565|NCT00483938|454815117|FG005|Overall Study|Other|4|||
126415566|NCT00483938|454815118|FG006|Overall Study|Other|32|||
126415567|NCT02218008|454815119|FG000|Stage 1 (S1)|Adverse Event|6|||
126415568|NCT02218008|454815120|FG001|Stage 1 (S1)|Adverse Event|5|||
126415569|NCT02218008|454815121|FG002|Stage 1 (S1)|Adverse Event|11|||
126415570|NCT02218008|454815122|FG003|Stage 1 (S1)|Adverse Event|0|||
126415571|NCT02218008|454815123|FG004|Stage 1 (S1)|Adverse Event|0|||
126415572|NCT02218008|454815124|FG005|Stage 1 (S1)|Adverse Event|0|||
126415573|NCT02218008|454815119|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
126415574|NCT02218008|454815120|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
126415575|NCT02218008|454815121|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
126415576|NCT02218008|454815122|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
126415577|NCT02218008|454815123|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
126415578|NCT02218008|454815124|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
126415579|NCT02218008|454815119|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
126415580|NCT02218008|454815120|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
126415581|NCT02218008|454815121|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
126415582|NCT02218008|454815122|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
126415583|NCT02218008|454815123|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
126415584|NCT02218008|454815124|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
126415585|NCT02218008|454815119|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
126415586|NCT02218008|454815120|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
126415587|NCT02218008|454815121|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
126415588|NCT02218008|454815122|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
126415589|NCT02218008|454815123|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
126415590|NCT02218008|454815124|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
126415591|NCT02218008|454815119|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
126415592|NCT02218008|454815120|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
126415593|NCT02218008|454815121|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
126415594|NCT02218008|454815122|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
126415595|NCT02218008|454815123|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
126415596|NCT02218008|454815124|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
126415597|NCT02218008|454815119|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
126415598|NCT02218008|454815120|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
126415599|NCT02218008|454815121|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
126415600|NCT02218008|454815122|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
126415601|NCT02218008|454815123|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
126415602|NCT02218008|454815124|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
126415603|NCT02218008|454815119|FG000|Stage 1 (S1)|Pregnancy|0|||
126415604|NCT02218008|454815120|FG001|Stage 1 (S1)|Pregnancy|0|||
126415605|NCT02218008|454815121|FG002|Stage 1 (S1)|Pregnancy|1|||
126415606|NCT02218008|454815122|FG003|Stage 1 (S1)|Pregnancy|0|||
126415607|NCT02218008|454815123|FG004|Stage 1 (S1)|Pregnancy|0|||
126415608|NCT02218008|454815124|FG005|Stage 1 (S1)|Pregnancy|0|||
126415609|NCT02218008|454815119|FG000|Stage 1 (S1)|Protocol Violation|0|||
126415610|NCT02218008|454815120|FG001|Stage 1 (S1)|Protocol Violation|0|||
126415611|NCT02218008|454815121|FG002|Stage 1 (S1)|Protocol Violation|1|||
126054314|NCT03070392|453493870|FG003|Overall Study|Ongoing|11|||
126054315|NCT02972034|453493871|FG000|Overall Study|Death|11|||
126415612|NCT02218008|454815122|FG003|Stage 1 (S1)|Protocol Violation|0|||
126415613|NCT02218008|454815123|FG004|Stage 1 (S1)|Protocol Violation|0|||
126415614|NCT02218008|454815124|FG005|Stage 1 (S1)|Protocol Violation|0|||
126415615|NCT02218008|454815119|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
126415616|NCT02218008|454815120|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415617|NCT02218008|454815121|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415618|NCT02218008|454815122|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415619|NCT02218008|454815123|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415620|NCT02218008|454815124|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415621|NCT02218008|454815119|FG000|Stage 2 (S2)|Adverse Event|0|||
126415622|NCT02218008|454815120|FG001|Stage 2 (S2)|Adverse Event|0|||
126415623|NCT02218008|454815121|FG002|Stage 2 (S2)|Adverse Event|0|||
126415624|NCT02218008|454815122|FG003|Stage 2 (S2)|Adverse Event|2|||
126415625|NCT02218008|454815123|FG004|Stage 2 (S2)|Adverse Event|3|||
126415626|NCT02218008|454815124|FG005|Stage 2 (S2)|Adverse Event|3|||
126415627|NCT02218008|454815119|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
126415628|NCT02218008|454815120|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
126415629|NCT02218008|454815121|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
126415630|NCT02218008|454815122|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
126415631|NCT02218008|454815123|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
126415632|NCT02218008|454815124|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
126415633|NCT02218008|454815119|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
126415634|NCT02218008|454815120|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
126415635|NCT02218008|454815121|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
126415636|NCT02218008|454815122|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
126415637|NCT02218008|454815123|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
126415638|NCT02218008|454815124|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
126415639|NCT02218008|454815119|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415640|NCT02218008|454815120|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415641|NCT02218008|454815121|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415642|NCT02218008|454815122|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
126415643|NCT02218008|454815123|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415644|NCT02218008|454815124|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415645|NCT02218008|454815119|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
126415646|NCT02218008|454815120|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
126415647|NCT02218008|454815121|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
126415648|NCT02218008|454815122|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
126415649|NCT02218008|454815123|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
126415650|NCT02218008|454815124|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
126415651|NCT00106353|454815125|FG000|Part 1|Disease progression|3|||
126415652|NCT00106353|454815126|FG001|Part 1|Disease progression|4|||
126415653|NCT00106353|454815127|FG002|Part 1|Disease progression|1|||
126415654|NCT00106353|454815128|FG003|Part 1|Disease progression|3|||
126415655|NCT00106353|454815129|FG004|Part 1|Disease progression|0|||
126415656|NCT00106353|454815130|FG005|Part 1|Disease progression|0|||
126415657|NCT00106353|454815131|FG006|Part 1|Disease progression|0|||
126415658|NCT00106353|454815125|FG000|Part 1|Withdrawal by Subject|0|||
126415659|NCT00106353|454815126|FG001|Part 1|Withdrawal by Subject|0|||
126415660|NCT00106353|454815127|FG002|Part 1|Withdrawal by Subject|1|||
126415661|NCT00106353|454815128|FG003|Part 1|Withdrawal by Subject|2|||
126415662|NCT00106353|454815129|FG004|Part 1|Withdrawal by Subject|0|||
126415663|NCT00106353|454815130|FG005|Part 1|Withdrawal by Subject|0|||
126415664|NCT00106353|454815131|FG006|Part 1|Withdrawal by Subject|0|||
126415665|NCT00106353|454815125|FG000|Part 1|Symptomatic deterioration|0|||
126415666|NCT00106353|454815126|FG001|Part 1|Symptomatic deterioration|0|||
126415667|NCT00106353|454815127|FG002|Part 1|Symptomatic deterioration|1|||
126415668|NCT00106353|454815128|FG003|Part 1|Symptomatic deterioration|0|||
126415669|NCT00106353|454815129|FG004|Part 1|Symptomatic deterioration|0|||
126415670|NCT00106353|454815130|FG005|Part 1|Symptomatic deterioration|0|||
126415671|NCT00106353|454815131|FG006|Part 1|Symptomatic deterioration|0|||
126415672|NCT00106353|454815125|FG000|Part 1|Entered follow-up phase|1|||
126415673|NCT00106353|454815126|FG001|Part 1|Entered follow-up phase|1|||
126415674|NCT00106353|454815127|FG002|Part 1|Entered follow-up phase|0|||
126415675|NCT00106353|454815128|FG003|Part 1|Entered follow-up phase|1|||
126415676|NCT00106353|454815129|FG004|Part 1|Entered follow-up phase|0|||
126415677|NCT00106353|454815130|FG005|Part 1|Entered follow-up phase|0|||
126415678|NCT00106353|454815131|FG006|Part 1|Entered follow-up phase|0|||
126415679|NCT00106353|454815125|FG000|Part 1|Adverse Event|0|||
126415680|NCT00106353|454815126|FG001|Part 1|Adverse Event|0|||
126415681|NCT00106353|454815127|FG002|Part 1|Adverse Event|0|||
126415682|NCT00106353|454815128|FG003|Part 1|Adverse Event|1|||
126415683|NCT00106353|454815129|FG004|Part 1|Adverse Event|0|||
126415684|NCT00106353|454815130|FG005|Part 1|Adverse Event|0|||
126415685|NCT00106353|454815131|FG006|Part 1|Adverse Event|0|||
126415686|NCT00106353|454815125|FG000|Part 2|Disease progression|0|||
126415687|NCT00106353|454815126|FG001|Part 2|Disease progression|0|||
126415688|NCT00106353|454815127|FG002|Part 2|Disease progression|0|||
126415689|NCT00106353|454815128|FG003|Part 2|Disease progression|0|||
126415690|NCT00106353|454815129|FG004|Part 2|Disease progression|8|||
126415691|NCT00106353|454815130|FG005|Part 2|Disease progression|14|||
126415692|NCT00106353|454815131|FG006|Part 2|Disease progression|13|||
126415693|NCT00106353|454815125|FG000|Part 2|Death|0|||
126415694|NCT00106353|454815126|FG001|Part 2|Death|0|||
126415695|NCT00106353|454815127|FG002|Part 2|Death|0|||
126415696|NCT00106353|454815128|FG003|Part 2|Death|0|||
126415697|NCT00106353|454815129|FG004|Part 2|Death|3|||
126415698|NCT00106353|454815130|FG005|Part 2|Death|0|||
126415699|NCT00106353|454815131|FG006|Part 2|Death|1|||
126415700|NCT00106353|454815125|FG000|Part 2|Symptomatic deterioration|0|||
126415701|NCT00106353|454815126|FG001|Part 2|Symptomatic deterioration|0|||
126415702|NCT00106353|454815127|FG002|Part 2|Symptomatic deterioration|0|||
126415703|NCT00106353|454815128|FG003|Part 2|Symptomatic deterioration|0|||
126415704|NCT00106353|454815129|FG004|Part 2|Symptomatic deterioration|3|||
126415705|NCT00106353|454815130|FG005|Part 2|Symptomatic deterioration|0|||
126415706|NCT00106353|454815131|FG006|Part 2|Symptomatic deterioration|0|||
126415707|NCT00106353|454815125|FG000|Part 2|Adverse Event|0|||
126415708|NCT00106353|454815126|FG001|Part 2|Adverse Event|0|||
126415709|NCT00106353|454815127|FG002|Part 2|Adverse Event|0|||
126415710|NCT00106353|454815128|FG003|Part 2|Adverse Event|0|||
126415711|NCT00106353|454815129|FG004|Part 2|Adverse Event|0|||
126415712|NCT00106353|454815130|FG005|Part 2|Adverse Event|2|||
126415713|NCT00106353|454815131|FG006|Part 2|Adverse Event|1|||
126415714|NCT00106353|454815125|FG000|Part 2|Other|0|||
126415715|NCT00106353|454815126|FG001|Part 2|Other|0|||
126415716|NCT00106353|454815127|FG002|Part 2|Other|0|||
126415717|NCT00106353|454815128|FG003|Part 2|Other|0|||
126415718|NCT00106353|454815129|FG004|Part 2|Other|1|||
126415719|NCT00106353|454815130|FG005|Part 2|Other|1|||
126415720|NCT00106353|454815131|FG006|Part 2|Other|1|||
126415721|NCT00106353|454815125|FG000|Part 2|Withdrawal by Subject|0|||
126415722|NCT00106353|454815126|FG001|Part 2|Withdrawal by Subject|0|||
126415723|NCT00106353|454815127|FG002|Part 2|Withdrawal by Subject|0|||
126415724|NCT00106353|454815128|FG003|Part 2|Withdrawal by Subject|0|||
126415725|NCT00106353|454815129|FG004|Part 2|Withdrawal by Subject|1|||
126415726|NCT00106353|454815130|FG005|Part 2|Withdrawal by Subject|0|||
126415727|NCT00106353|454815131|FG006|Part 2|Withdrawal by Subject|0|||
126415728|NCT00106353|454815125|FG000|Part 2|Physician Decision|0|||
126415729|NCT00106353|454815126|FG001|Part 2|Physician Decision|0|||
126415730|NCT00106353|454815127|FG002|Part 2|Physician Decision|0|||
126415731|NCT00106353|454815128|FG003|Part 2|Physician Decision|0|||
126415732|NCT00106353|454815129|FG004|Part 2|Physician Decision|0|||
126415733|NCT00106353|454815130|FG005|Part 2|Physician Decision|1|||
126415734|NCT00106353|454815131|FG006|Part 2|Physician Decision|0|||
126415735|NCT00408434|454815132|FG000|Overall Study|Adverse Event|0|||
126415736|NCT00408434|454815133|FG001|Overall Study|Adverse Event|0|||
126415737|NCT00408434|454815134|FG002|Overall Study|Adverse Event|1|||
126415738|NCT00408434|454815135|FG003|Overall Study|Adverse Event|0|||
126415739|NCT00408434|454815136|FG004|Overall Study|Adverse Event|0|||
126415740|NCT00408434|454815137|FG005|Overall Study|Adverse Event|0|||
126415741|NCT00408434|454815138|FG006|Overall Study|Adverse Event|0|||
126415742|NCT00408434|454815132|FG000|Overall Study|Progressive disease|6|||
126415743|NCT00408434|454815133|FG001|Overall Study|Progressive disease|3|||
126415744|NCT00408434|454815134|FG002|Overall Study|Progressive disease|4|||
126415745|NCT00408434|454815135|FG003|Overall Study|Progressive disease|3|||
126415746|NCT00408434|454815136|FG004|Overall Study|Progressive disease|3|||
126415747|NCT00408434|454815137|FG005|Overall Study|Progressive disease|1|||
126415748|NCT00408434|454815138|FG006|Overall Study|Progressive disease|4|||
126415749|NCT00408434|454815132|FG000|Overall Study|Other|0|||
126415750|NCT00408434|454815133|FG001|Overall Study|Other|0|||
126415751|NCT00408434|454815134|FG002|Overall Study|Other|1|||
126415752|NCT00408434|454815135|FG003|Overall Study|Other|0|||
126415753|NCT00408434|454815136|FG004|Overall Study|Other|2|||
126415754|NCT00408434|454815137|FG005|Overall Study|Other|1|||
126415755|NCT00408434|454815138|FG006|Overall Study|Other|0|||
126415756|NCT00408434|454815132|FG000|Overall Study|Terminated by Investigator|0|||
126415757|NCT00408434|454815133|FG001|Overall Study|Terminated by Investigator|0|||
126415758|NCT00408434|454815134|FG002|Overall Study|Terminated by Investigator|0|||
126415759|NCT00408434|454815135|FG003|Overall Study|Terminated by Investigator|0|||
126415760|NCT00408434|454815136|FG004|Overall Study|Terminated by Investigator|1|||
126415761|NCT00408434|454815137|FG005|Overall Study|Terminated by Investigator|1|||
126415762|NCT00408434|454815138|FG006|Overall Study|Terminated by Investigator|0|||
126415763|NCT00588354|454815139|FG000|Baseline to 2 Weeks|Adverse Event|1|||
126415764|NCT00588354|454815140|FG001|Baseline to 2 Weeks|Adverse Event|0|||
126415765|NCT00588354|454815139|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
126415766|NCT00588354|454815140|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
126415767|NCT00588354|454815139|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
126415768|NCT00588354|454815140|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
126415769|NCT04000581|454815141|FG000|Overall Study|Withdrawal by Subject|0|||
126415770|NCT04000581|454815142|FG001|Overall Study|Withdrawal by Subject|1|||
126415771|NCT03477838|454815143|FG000|Overall Study|Lost to Follow-up|14|||
126415772|NCT02519595|454815147|FG000|Overall Study|Protocol Violation|8|||
126415773|NCT02519595|454815148|FG001|Overall Study|Protocol Violation|22|||
126415774|NCT02519595|454815149|FG002|Overall Study|Protocol Violation|16|||
126415775|NCT03188510|454815152|FG000|Overall Study|Inappropriate behavior with site staff|0|||
126415776|NCT03188510|454815153|FG001|Overall Study|Inappropriate behavior with site staff|1|||
126415777|NCT03188510|454815154|FG002|Overall Study|Inappropriate behavior with site staff|0|||
126415778|NCT03052049|454815161|FG000|Overall Study|Withdrawal by Subject|2|||
126415779|NCT00999518|454815162|FG000|Overall Study|Adverse Event|1|||
126415780|NCT00999518|454815163|FG001|Overall Study|Adverse Event|6|||
126415781|NCT00999518|454815164|FG002|Overall Study|Adverse Event|3|||
126415782|NCT00999518|454815165|FG003|Overall Study|Adverse Event|1|||
126415783|NCT00999518|454815166|FG004|Overall Study|Adverse Event|2|||
126415784|NCT00999518|454815162|FG000|Overall Study|Lack of Efficacy|2|||
126415785|NCT00999518|454815163|FG001|Overall Study|Lack of Efficacy|0|||
126415786|NCT00999518|454815164|FG002|Overall Study|Lack of Efficacy|0|||
126415787|NCT00999518|454815165|FG003|Overall Study|Lack of Efficacy|2|||
126415788|NCT00999518|454815166|FG004|Overall Study|Lack of Efficacy|2|||
126415789|NCT00999518|454815162|FG000|Overall Study|Lost to Follow-up|0|||
126415790|NCT00999518|454815163|FG001|Overall Study|Lost to Follow-up|0|||
126415791|NCT00999518|454815164|FG002|Overall Study|Lost to Follow-up|0|||
126415792|NCT00999518|454815165|FG003|Overall Study|Lost to Follow-up|4|||
126415793|NCT00999518|454815166|FG004|Overall Study|Lost to Follow-up|1|||
126415794|NCT00999518|454815162|FG000|Overall Study|Did not meet entrance criteria|0|||
126415795|NCT00999518|454815163|FG001|Overall Study|Did not meet entrance criteria|0|||
126415796|NCT00999518|454815164|FG002|Overall Study|Did not meet entrance criteria|0|||
126415797|NCT00999518|454815165|FG003|Overall Study|Did not meet entrance criteria|0|||
126415798|NCT00999518|454815166|FG004|Overall Study|Did not meet entrance criteria|1|||
126415799|NCT00999518|454815162|FG000|Overall Study|Study terminated by sponsor|10|||
126415800|NCT00999518|454815163|FG001|Overall Study|Study terminated by sponsor|6|||
126415801|NCT00999518|454815164|FG002|Overall Study|Study terminated by sponsor|5|||
126415802|NCT00999518|454815165|FG003|Overall Study|Study terminated by sponsor|5|||
126415803|NCT00999518|454815166|FG004|Overall Study|Study terminated by sponsor|9|||
126415804|NCT00999518|454815162|FG000|Overall Study|Pregnancy|0|||
126415805|NCT00999518|454815163|FG001|Overall Study|Pregnancy|0|||
126415806|NCT00999518|454815164|FG002|Overall Study|Pregnancy|1|||
126415807|NCT00999518|454815165|FG003|Overall Study|Pregnancy|0|||
126415808|NCT00999518|454815166|FG004|Overall Study|Pregnancy|0|||
126415809|NCT00999518|454815162|FG000|Overall Study|Protocol Violation|0|||
126415810|NCT00999518|454815163|FG001|Overall Study|Protocol Violation|1|||
126415811|NCT00999518|454815164|FG002|Overall Study|Protocol Violation|0|||
126415812|NCT00999518|454815165|FG003|Overall Study|Protocol Violation|0|||
126415813|NCT00999518|454815166|FG004|Overall Study|Protocol Violation|2|||
126415814|NCT00999518|454815162|FG000|Overall Study|Withdrawal by Subject|5|||
126415815|NCT00999518|454815163|FG001|Overall Study|Withdrawal by Subject|4|||
126415816|NCT00999518|454815164|FG002|Overall Study|Withdrawal by Subject|10|||
126415817|NCT00999518|454815165|FG003|Overall Study|Withdrawal by Subject|6|||
126415818|NCT00999518|454815166|FG004|Overall Study|Withdrawal by Subject|1|||
126415819|NCT00999518|454815162|FG000|Overall Study|Other|5|||
126415820|NCT00999518|454815163|FG001|Overall Study|Other|7|||
126415821|NCT00999518|454815164|FG002|Overall Study|Other|1|||
126415822|NCT00999518|454815165|FG003|Overall Study|Other|4|||
126415823|NCT00999518|454815166|FG004|Overall Study|Other|5|||
126415824|NCT00999518|454815162|FG000|Overall Study|Randomized but not Treated|1|||
126415825|NCT00999518|454815163|FG001|Overall Study|Randomized but not Treated|1|||
126415826|NCT00999518|454815164|FG002|Overall Study|Randomized but not Treated|2|||
126415827|NCT00999518|454815165|FG003|Overall Study|Randomized but not Treated|0|||
126415828|NCT00999518|454815166|FG004|Overall Study|Randomized but not Treated|1|||
126415829|NCT01088399|454815170|FG000|Overall Study|Adverse Event|211|||
126415830|NCT01088399|454815171|FG001|Overall Study|Adverse Event|16|||
126415831|NCT01088399|454815172|FG002|Overall Study|Adverse Event|0|||
126415832|NCT01088399|454815170|FG000|Overall Study|Death|204|||
126415833|NCT01088399|454815171|FG001|Overall Study|Death|45|||
126415834|NCT01088399|454815172|FG002|Overall Study|Death|0|||
126415835|NCT01088399|454815170|FG000|Overall Study|Lack of Efficacy|298|||
126415836|NCT01088399|454815171|FG001|Overall Study|Lack of Efficacy|7|||
126415837|NCT01088399|454815172|FG002|Overall Study|Lack of Efficacy|5|||
126415838|NCT01088399|454815170|FG000|Overall Study|Lost to Follow-up|1070|||
126415839|NCT01088399|454815171|FG001|Overall Study|Lost to Follow-up|278|||
126415840|NCT01088399|454815172|FG002|Overall Study|Lost to Follow-up|58|||
126415841|NCT01088399|454815170|FG000|Overall Study|Physician Decision|531|||
126415842|NCT01088399|454815171|FG001|Overall Study|Physician Decision|88|||
126415843|NCT01088399|454815172|FG002|Overall Study|Physician Decision|16|||
126415844|NCT01088399|454815170|FG000|Overall Study|Withdrawal by Subject|544|||
126415845|NCT01088399|454815171|FG001|Overall Study|Withdrawal by Subject|195|||
126415846|NCT01088399|454815172|FG002|Overall Study|Withdrawal by Subject|33|||
126415847|NCT01088399|454815170|FG000|Overall Study|Change to or start of somatropin therapy|234|||
126415848|NCT01088399|454815171|FG001|Overall Study|Change to or start of somatropin therapy|17|||
126415849|NCT01088399|454815172|FG002|Overall Study|Change to or start of somatropin therapy|12|||
126415850|NCT01088399|454815170|FG000|Overall Study|Sponsor decision|1573|||
126415851|NCT01088399|454815171|FG001|Overall Study|Sponsor decision|298|||
126415852|NCT01088399|454815172|FG002|Overall Study|Sponsor decision|7|||
126054316|NCT02972034|453493872|FG001|Overall Study|Death|1|||
126054317|NCT02972034|453493873|FG002|Overall Study|Death|3|||
126054318|NCT02972034|453493874|FG003|Overall Study|Death|3|||
126054319|NCT02972034|453493875|FG004|Overall Study|Death|2|||
126054320|NCT02972034|453493876|FG005|Overall Study|Death|2|||
126415853|NCT01088399|454815170|FG000|Overall Study|Protocol Violation|10|||
126415854|NCT01088399|454815171|FG001|Overall Study|Protocol Violation|1|||
126415855|NCT01088399|454815172|FG002|Overall Study|Protocol Violation|0|||
126415856|NCT01088399|454815170|FG000|Overall Study|Enrollment criteria not met|48|||
126415857|NCT01088399|454815171|FG001|Overall Study|Enrollment criteria not met|119|||
126415858|NCT01088399|454815172|FG002|Overall Study|Enrollment criteria not met|70|||
126415859|NCT01088399|454815170|FG000|Overall Study|Study summary visit not completed|2398|||
126415860|NCT01088399|454815171|FG001|Overall Study|Study summary visit not completed|283|||
126415861|NCT01088399|454815172|FG002|Overall Study|Study summary visit not completed|80|||
126415862|NCT00782483|454815173|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
126415863|NCT03343626|454816652|FG000|Overall Study|Lost to Follow-up|4|||
126415864|NCT03343626|454816653|FG001|Overall Study|Lost to Follow-up|3|||
126415865|NCT03343626|454816654|FG002|Overall Study|Lost to Follow-up|2|||
126415866|NCT03343626|454816655|FG003|Overall Study|Lost to Follow-up|5|||
126415867|NCT03343626|454816656|FG004|Overall Study|Lost to Follow-up|4|||
126415868|NCT03343626|454816657|FG005|Overall Study|Lost to Follow-up|4|||
126415869|NCT03343626|454816658|FG006|Overall Study|Lost to Follow-up|4|||
126415870|NCT03343626|454816659|FG007|Overall Study|Lost to Follow-up|7|||
126415871|NCT03343626|454816652|FG000|Overall Study|Withdrawal of Consent|2|||
126415872|NCT03343626|454816653|FG001|Overall Study|Withdrawal of Consent|1|||
126415873|NCT03343626|454816654|FG002|Overall Study|Withdrawal of Consent|0|||
126415874|NCT03343626|454816655|FG003|Overall Study|Withdrawal of Consent|3|||
126415875|NCT03343626|454816656|FG004|Overall Study|Withdrawal of Consent|3|||
126415876|NCT03343626|454816657|FG005|Overall Study|Withdrawal of Consent|1|||
126415877|NCT03343626|454816658|FG006|Overall Study|Withdrawal of Consent|1|||
126415878|NCT03343626|454816659|FG007|Overall Study|Withdrawal of Consent|2|||
126415879|NCT03343626|454816652|FG000|Overall Study|Reason not Specified|0|||
126415880|NCT03343626|454816653|FG001|Overall Study|Reason not Specified|1|||
126415881|NCT03343626|454816654|FG002|Overall Study|Reason not Specified|0|||
126415882|NCT03343626|454816655|FG003|Overall Study|Reason not Specified|0|||
126415883|NCT03343626|454816656|FG004|Overall Study|Reason not Specified|0|||
126415884|NCT03343626|454816657|FG005|Overall Study|Reason not Specified|0|||
126415885|NCT03343626|454816658|FG006|Overall Study|Reason not Specified|0|||
126415886|NCT03343626|454816659|FG007|Overall Study|Reason not Specified|1|||
126415887|NCT03343626|454816652|FG000|Overall Study|Data Entry Error|0|||
126415888|NCT03343626|454816653|FG001|Overall Study|Data Entry Error|0|||
126415889|NCT03343626|454816654|FG002|Overall Study|Data Entry Error|0|||
126415890|NCT03343626|454816655|FG003|Overall Study|Data Entry Error|0|||
126415891|NCT03343626|454816656|FG004|Overall Study|Data Entry Error|0|||
126415892|NCT03343626|454816657|FG005|Overall Study|Data Entry Error|0|||
126415893|NCT03343626|454816658|FG006|Overall Study|Data Entry Error|0|||
126415894|NCT03343626|454816659|FG007|Overall Study|Data Entry Error|1|||
126415895|NCT02475278|454816667|FG000|Overall Study|Lost to Follow-up|1|||
126415896|NCT02475278|454816667|FG000|Overall Study|Reason Not Specified|1|||
126415897|NCT00826618|454816668|FG000|Overall Study|Withdrawal by Subject|1|||
126415898|NCT03712787|454816669|FG000|Overall Study|Adverse Event|2|||
126415899|NCT03712787|454816670|FG001|Overall Study|Adverse Event|3|||
126415900|NCT03712787|454816671|FG002|Overall Study|Adverse Event|0|||
126415901|NCT03712787|454816672|FG003|Overall Study|Adverse Event|4|||
126415902|NCT03712787|454816669|FG000|Overall Study|Withdrawal by Subject|4|||
126415903|NCT03712787|454816670|FG001|Overall Study|Withdrawal by Subject|14|||
126415904|NCT03712787|454816671|FG002|Overall Study|Withdrawal by Subject|12|||
126415905|NCT03712787|454816672|FG003|Overall Study|Withdrawal by Subject|8|||
126415906|NCT03712787|454816669|FG000|Overall Study|Lost to Follow-up|1|||
126415907|NCT03712787|454816670|FG001|Overall Study|Lost to Follow-up|1|||
126054321|NCT02972034|453493877|FG006|Overall Study|Death|3|||
126054322|NCT02972034|453493878|FG007|Overall Study|Death|4|||
126054323|NCT02972034|453493879|FG008|Overall Study|Death|8|||
126415908|NCT03712787|454816671|FG002|Overall Study|Lost to Follow-up|2|||
126415909|NCT03712787|454816672|FG003|Overall Study|Lost to Follow-up|1|||
126415910|NCT03712787|454816669|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
126415911|NCT03712787|454816670|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
126415912|NCT03712787|454816671|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
126415913|NCT03712787|454816672|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
126415914|NCT03712787|454816669|FG000|Overall Study|COVID-19 Infection|0|||
126415915|NCT03712787|454816670|FG001|Overall Study|COVID-19 Infection|1|||
126415916|NCT03712787|454816671|FG002|Overall Study|COVID-19 Infection|0|||
126415917|NCT03712787|454816672|FG003|Overall Study|COVID-19 Infection|0|||
126415918|NCT03712787|454816669|FG000|Overall Study|Other, Not Specified|79|||
126415919|NCT03712787|454816670|FG001|Overall Study|Other, Not Specified|77|||
126415920|NCT03712787|454816671|FG002|Overall Study|Other, Not Specified|74|||
126415921|NCT03712787|454816672|FG003|Overall Study|Other, Not Specified|78|||
126415922|NCT00732875|454816676|FG000|Overall Study|Adverse Event|16|||
126415923|NCT00732875|454816676|FG000|Overall Study|Withdrawal by Subject|6|||
126415924|NCT00732875|454816676|FG000|Overall Study|Lack of Efficacy|13|||
126415925|NCT03056339|454816681|FG000|Overall Study|Failed Requirements|0|||
126415926|NCT03056339|454816682|FG001|Overall Study|Failed Requirements|2|||
126415927|NCT03056339|454816683|FG002|Overall Study|Failed Requirements|7|||
126415928|NCT03056339|454816684|FG003|Overall Study|Failed Requirements|1|||
126415929|NCT01128244|454816690|FG000|Overall Study|Adverse Event|1|||
126415930|NCT01128244|454816690|FG000|Overall Study|Scheduling conflict|2|||
126415931|NCT02219334|454816691|FG000|Overall Study|Withdrawal by Subject|1|||
126415932|NCT02219334|454816692|FG001|Overall Study|Withdrawal by Subject|0|||
126415933|NCT02219334|454816691|FG000|Overall Study|Protocol Violation|7|||
126415934|NCT02219334|454816692|FG001|Overall Study|Protocol Violation|3|||
126415935|NCT04171219|454816695|FG000|Overall Study|Adverse Event|1|||
126415936|NCT04171219|454816696|FG001|Overall Study|Adverse Event|0|||
126415937|NCT04171219|454816695|FG000|Overall Study|Death|0|||
126415938|NCT04171219|454816696|FG001|Overall Study|Death|1|||
126415939|NCT04171219|454816695|FG000|Overall Study|Lack of Efficacy|9|||
126415940|NCT04171219|454816696|FG001|Overall Study|Lack of Efficacy|13|||
126415941|NCT04171219|454816695|FG000|Overall Study|Withdrawal by Subject|1|||
126415942|NCT04171219|454816696|FG001|Overall Study|Withdrawal by Subject|2|||
126415943|NCT04171219|454816695|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
126415944|NCT04171219|454816696|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
126415945|NCT04171219|454816695|FG000|Overall Study|Clinical PD/Patient choice|1|||
126415946|NCT04171219|454816696|FG001|Overall Study|Clinical PD/Patient choice|0|||
126415947|NCT04171219|454816695|FG000|Overall Study|Toxicity/ Patient choice|1|||
126415948|NCT04171219|454816696|FG001|Overall Study|Toxicity/ Patient choice|0|||
126415949|NCT04809285|454816699|FG000|Phase 1|Lost to Follow-up|6|||
126415950|NCT04809285|454816699|FG000|Phase 1|Protocol Violation|2|||
126415951|NCT04809285|454816699|FG000|Phase 1|Physician Decision|3|||
126415952|NCT04809285|454816699|FG000|Phase 1|Withdrawal by Subject|29|||
126415953|NCT04809285|454816699|FG000|Phase 2|Protocol Violation|3|||
126415954|NCT04809285|454816699|FG000|Phase 2|Withdrawal by Subject|4|||
126415955|NCT04838626|454816701|FG000|Overall Study|Adverse Event|2|||
126415956|NCT04838626|454816701|FG000|Overall Study|Physician Decision|6|||
126415957|NCT04838626|454816701|FG000|Overall Study|Protocol Violation|3|||
126415958|NCT04838626|454816701|FG000|Overall Study|Withdrawal by Subject|9|||
126415959|NCT04838626|454816701|FG000|Overall Study|Technical Problems|2|||
126415960|NCT02630472|454816706|FG000|Overall Study|Physician Decision|10|||
126415961|NCT02630472|454816707|FG001|Overall Study|Physician Decision|0|||
126415962|NCT01934010|454816708|FG000|Overall Study|Adverse Event|1|||
126415963|NCT01934010|454816709|FG001|Overall Study|Adverse Event|1|||
126415964|NCT01934010|454816710|FG002|Overall Study|Adverse Event|0|||
126415965|NCT01934010|454816708|FG000|Overall Study|Withdrawal by Subject|15|||
126415966|NCT01934010|454816709|FG001|Overall Study|Withdrawal by Subject|6|||
126415967|NCT01934010|454816710|FG002|Overall Study|Withdrawal by Subject|2|||
126415968|NCT01934010|454816708|FG000|Overall Study|Lost to Follow-up|7|||
126415969|NCT01934010|454816709|FG001|Overall Study|Lost to Follow-up|4|||
126415970|NCT01934010|454816710|FG002|Overall Study|Lost to Follow-up|0|||
126415971|NCT01393821|454816711|FG000|Overall Study|Cancel|1|||
126415972|NCT01393821|454816712|FG001|Overall Study|Cancel|1|||
126415973|NCT01393821|454816711|FG000|Overall Study|not evaluable for primary endpoint|4|||
126415974|NCT01393821|454816712|FG001|Overall Study|not evaluable for primary endpoint|2|||
126415975|NCT01858766|454816713|FG000|Overall Study|Randomized but Never Treated|0|||
126415976|NCT01858766|454816714|FG001|Overall Study|Randomized but Never Treated|0|||
126415977|NCT01858766|454816715|FG002|Overall Study|Randomized but Never Treated|0|||
126415978|NCT01858766|454816716|FG003|Overall Study|Randomized but Never Treated|0|||
126415979|NCT01858766|454816717|FG004|Overall Study|Randomized but Never Treated|0|||
126415980|NCT01858766|454816718|FG005|Overall Study|Randomized but Never Treated|1|||
126415981|NCT01858766|454816719|FG006|Overall Study|Randomized but Never Treated|0|||
126415982|NCT01858766|454816720|FG007|Overall Study|Randomized but Never Treated|0|||
126415983|NCT01858766|454816721|FG008|Overall Study|Randomized but Never Treated|0|||
126415984|NCT01858766|454816722|FG009|Overall Study|Randomized but Never Treated|0|||
126415985|NCT01858766|454816723|FG010|Overall Study|Randomized but Never Treated|0|||
126415986|NCT01858766|454816724|FG011|Overall Study|Randomized but Never Treated|0|||
126415987|NCT01858766|454816725|FG012|Overall Study|Randomized but Never Treated|0|||
126415988|NCT01858766|454816726|FG013|Overall Study|Randomized but Never Treated|0|||
126415989|NCT01858766|454816727|FG014|Overall Study|Randomized but Never Treated|0|||
126415990|NCT01858766|454816728|FG015|Overall Study|Randomized but Never Treated|0|||
126415991|NCT01858766|454816729|FG016|Overall Study|Randomized but Never Treated|0|||
126415992|NCT01858766|454816730|FG017|Overall Study|Randomized but Never Treated|1|||
126415993|NCT01858766|454816731|FG018|Overall Study|Randomized but Never Treated|0|||
126415994|NCT01858766|454816713|FG000|Overall Study|Death|0|||
126415995|NCT01858766|454816714|FG001|Overall Study|Death|0|||
126415996|NCT01858766|454816715|FG002|Overall Study|Death|1|||
126415997|NCT01858766|454816716|FG003|Overall Study|Death|0|||
126415998|NCT01858766|454816717|FG004|Overall Study|Death|0|||
126415999|NCT01858766|454816718|FG005|Overall Study|Death|0|||
126416000|NCT01858766|454816719|FG006|Overall Study|Death|0|||
126416001|NCT01858766|454816720|FG007|Overall Study|Death|0|||
126416002|NCT01858766|454816721|FG008|Overall Study|Death|0|||
126416003|NCT01858766|454816722|FG009|Overall Study|Death|0|||
126416004|NCT01858766|454816723|FG010|Overall Study|Death|0|||
126416005|NCT01858766|454816724|FG011|Overall Study|Death|0|||
126416006|NCT01858766|454816725|FG012|Overall Study|Death|0|||
126416007|NCT01858766|454816726|FG013|Overall Study|Death|0|||
126416008|NCT01858766|454816727|FG014|Overall Study|Death|0|||
126416009|NCT01858766|454816728|FG015|Overall Study|Death|0|||
126416010|NCT01858766|454816729|FG016|Overall Study|Death|0|||
126416011|NCT01858766|454816730|FG017|Overall Study|Death|0|||
126416012|NCT01858766|454816731|FG018|Overall Study|Death|0|||
126416013|NCT01858766|454816713|FG000|Overall Study|Lack of Efficacy|1|||
126416014|NCT01858766|454816714|FG001|Overall Study|Lack of Efficacy|0|||
126416015|NCT01858766|454816715|FG002|Overall Study|Lack of Efficacy|0|||
126416016|NCT01858766|454816716|FG003|Overall Study|Lack of Efficacy|0|||
126416017|NCT01858766|454816717|FG004|Overall Study|Lack of Efficacy|1|||
126416018|NCT01858766|454816718|FG005|Overall Study|Lack of Efficacy|2|||
126416019|NCT01858766|454816719|FG006|Overall Study|Lack of Efficacy|0|||
126416020|NCT01858766|454816720|FG007|Overall Study|Lack of Efficacy|0|||
126416021|NCT01858766|454816721|FG008|Overall Study|Lack of Efficacy|0|||
126416022|NCT01858766|454816722|FG009|Overall Study|Lack of Efficacy|0|||
126416023|NCT01858766|454816723|FG010|Overall Study|Lack of Efficacy|0|||
126416024|NCT01858766|454816724|FG011|Overall Study|Lack of Efficacy|3|||
126416025|NCT01858766|454816725|FG012|Overall Study|Lack of Efficacy|5|||
126416026|NCT01858766|454816726|FG013|Overall Study|Lack of Efficacy|3|||
126416027|NCT01858766|454816727|FG014|Overall Study|Lack of Efficacy|5|||
125891069|NCT05334212|452899706|FG000|Overall Study|Study terminated prematurely|7|||
126054324|NCT02972034|453493880|FG009|Overall Study|Death|11|||
126416028|NCT01858766|454816728|FG015|Overall Study|Lack of Efficacy|5|||
126416029|NCT01858766|454816729|FG016|Overall Study|Lack of Efficacy|2|||
126416030|NCT01858766|454816730|FG017|Overall Study|Lack of Efficacy|3|||
126416031|NCT01858766|454816731|FG018|Overall Study|Lack of Efficacy|3|||
126416032|NCT01858766|454816713|FG000|Overall Study|Lost to Follow-up|0|||
126416033|NCT01858766|454816714|FG001|Overall Study|Lost to Follow-up|0|||
126416034|NCT01858766|454816715|FG002|Overall Study|Lost to Follow-up|0|||
126416035|NCT01858766|454816716|FG003|Overall Study|Lost to Follow-up|0|||
126416036|NCT01858766|454816717|FG004|Overall Study|Lost to Follow-up|0|||
126416037|NCT01858766|454816718|FG005|Overall Study|Lost to Follow-up|1|||
126416038|NCT01858766|454816719|FG006|Overall Study|Lost to Follow-up|0|||
126416039|NCT01858766|454816720|FG007|Overall Study|Lost to Follow-up|2|||
125891070|NCT02152956|452899707|FG000|Overall Study|Adverse Event|0|||
126416040|NCT01858766|454816721|FG008|Overall Study|Lost to Follow-up|0|||
126416041|NCT01858766|454816722|FG009|Overall Study|Lost to Follow-up|0|||
126416042|NCT01858766|454816723|FG010|Overall Study|Lost to Follow-up|0|||
126416043|NCT01858766|454816724|FG011|Overall Study|Lost to Follow-up|1|||
126416044|NCT01858766|454816725|FG012|Overall Study|Lost to Follow-up|0|||
126416045|NCT01858766|454816726|FG013|Overall Study|Lost to Follow-up|0|||
126416046|NCT01858766|454816727|FG014|Overall Study|Lost to Follow-up|3|||
126416047|NCT01858766|454816728|FG015|Overall Study|Lost to Follow-up|1|||
126416048|NCT01858766|454816729|FG016|Overall Study|Lost to Follow-up|1|||
126416049|NCT01858766|454816730|FG017|Overall Study|Lost to Follow-up|0|||
126416050|NCT01858766|454816731|FG018|Overall Study|Lost to Follow-up|1|||
126416051|NCT01858766|454816713|FG000|Overall Study|Withdrew Consent|0|||
126416052|NCT01858766|454816714|FG001|Overall Study|Withdrew Consent|0|||
126416053|NCT01858766|454816715|FG002|Overall Study|Withdrew Consent|0|||
126416054|NCT01858766|454816716|FG003|Overall Study|Withdrew Consent|0|||
126416055|NCT01858766|454816717|FG004|Overall Study|Withdrew Consent|0|||
126416056|NCT01858766|454816718|FG005|Overall Study|Withdrew Consent|0|||
126416057|NCT01858766|454816719|FG006|Overall Study|Withdrew Consent|0|||
126416058|NCT01858766|454816720|FG007|Overall Study|Withdrew Consent|0|||
126416059|NCT01858766|454816721|FG008|Overall Study|Withdrew Consent|0|||
126416060|NCT01858766|454816722|FG009|Overall Study|Withdrew Consent|0|||
126416061|NCT01858766|454816723|FG010|Overall Study|Withdrew Consent|0|||
126416062|NCT01858766|454816724|FG011|Overall Study|Withdrew Consent|1|||
126416063|NCT01858766|454816725|FG012|Overall Study|Withdrew Consent|0|||
126416064|NCT01858766|454816726|FG013|Overall Study|Withdrew Consent|0|||
126416065|NCT01858766|454816727|FG014|Overall Study|Withdrew Consent|0|||
126416066|NCT01858766|454816728|FG015|Overall Study|Withdrew Consent|0|||
126416067|NCT01858766|454816729|FG016|Overall Study|Withdrew Consent|0|||
126416068|NCT01858766|454816730|FG017|Overall Study|Withdrew Consent|0|||
126416069|NCT01858766|454816731|FG018|Overall Study|Withdrew Consent|0|||
126416070|NCT03517228|454816734|FG000|Overall Study|Withdrawal by Subject|2|||
126416071|NCT03517228|454816734|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
126416072|NCT03517228|454816734|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
126416073|NCT03517228|454816734|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
126416074|NCT03517228|454816734|FG000|Overall Study|Canceled due to device being updated|1|||
126416075|NCT03517228|454816734|FG000|Overall Study|No V Cares in stock|1|||
126416076|NCT03517228|454816734|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
126416077|NCT01835158|454816740|FG000|Overall Study|Withdrawal by Subject|1|||
126416078|NCT01835158|454816741|FG001|Overall Study|Withdrawal by Subject|6|||
126416079|NCT03422536|454816748|FG000|Randomized|Physician Decision|1|||
126416080|NCT03422536|454816749|FG001|Randomized|Physician Decision|1|||
126416081|NCT03422536|454816748|FG000|Allocation - Received Intervention|Disease progression|19|||
126416082|NCT03422536|454816749|FG001|Allocation - Received Intervention|Disease progression|25|||
126416083|NCT03422536|454816748|FG000|Allocation - Received Intervention|Death|1|||
126416084|NCT03422536|454816749|FG001|Allocation - Received Intervention|Death|3|||
126416085|NCT03422536|454816748|FG000|Allocation - Received Intervention|Adverse Event|1|||
126416086|NCT03422536|454816749|FG001|Allocation - Received Intervention|Adverse Event|0|||
126416087|NCT03422536|454816748|FG000|Allocation - Received Intervention|Physician Decision|1|||
126416088|NCT03422536|454816749|FG001|Allocation - Received Intervention|Physician Decision|1|||
126416089|NCT03422536|454816748|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
126416090|NCT03422536|454816749|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
126416091|NCT03422536|454816748|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
126416092|NCT03422536|454816749|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
126416093|NCT02023996|454816750|FG000|Overall Study|Protocol Violation|6|||
126416094|NCT04929249|454816751|FG000|Overall Study|Adverse Event|2|||
126416095|NCT04929249|454816752|FG001|Overall Study|Adverse Event|1|||
126416096|NCT04929249|454816751|FG000|Overall Study|Death|2|||
126416097|NCT04929249|454816752|FG001|Overall Study|Death|1|||
126416098|NCT04929249|454816751|FG000|Overall Study|Lost to Follow-up|3|||
126416099|NCT04929249|454816752|FG001|Overall Study|Lost to Follow-up|11|||
126416100|NCT04929249|454816751|FG000|Overall Study|Technical problems|0|||
126416101|NCT04929249|454816752|FG001|Overall Study|Technical problems|1|||
126416102|NCT04929249|454816751|FG000|Overall Study|Subject decision|6|||
126416103|NCT04929249|454816752|FG001|Overall Study|Subject decision|8|||
126416104|NCT04929249|454816751|FG000|Overall Study|Withdrew consent|0|||
126416105|NCT04929249|454816752|FG001|Overall Study|Withdrew consent|8|||
126416106|NCT00395850|454816765|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
126416107|NCT00395850|454816766|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
126416108|NCT00395850|454816767|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
126416109|NCT00395850|454816768|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
126416110|NCT00395850|454816765|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
126416111|NCT00395850|454816766|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
126416112|NCT00395850|454816767|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
126416113|NCT00395850|454816768|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
126416114|NCT00395850|454816765|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
126416115|NCT00395850|454816766|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
126416116|NCT00395850|454816767|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
126416117|NCT00395850|454816768|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
126416118|NCT00395850|454816765|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
126416119|NCT00395850|454816766|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
126416120|NCT00395850|454816767|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
126416121|NCT00395850|454816768|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
126416122|NCT00395850|454816765|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
126416123|NCT00395850|454816766|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
126416124|NCT00395850|454816767|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
126416125|NCT00395850|454816768|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
126416126|NCT00395850|454816765|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
126416127|NCT00395850|454816766|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
126416128|NCT00395850|454816767|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
126416129|NCT00395850|454816768|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
126416130|NCT00395850|454816765|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
126416131|NCT00395850|454816766|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
126416132|NCT00395850|454816767|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
126416133|NCT00395850|454816768|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
126416134|NCT01620762|454816771|FG000|Overall Study|Protocol Violation|1|||
126416135|NCT01620762|454816772|FG001|Overall Study|Protocol Violation|1|||
126416136|NCT01620762|454816773|FG002|Overall Study|Protocol Violation|1|||
126416137|NCT01620762|454816771|FG000|Overall Study|Adverse Event|9|||
126416138|NCT01620762|454816772|FG001|Overall Study|Adverse Event|5|||
126416139|NCT01620762|454816773|FG002|Overall Study|Adverse Event|2|||
126416140|NCT01620762|454816771|FG000|Overall Study|Withdrawal by Subject|23|||
126416141|NCT01620762|454816772|FG001|Overall Study|Withdrawal by Subject|26|||
126416142|NCT01620762|454816773|FG002|Overall Study|Withdrawal by Subject|27|||
126416143|NCT01620762|454816771|FG000|Overall Study|Lost to Follow-up|11|||
126416144|NCT01620762|454816772|FG001|Overall Study|Lost to Follow-up|17|||
126416145|NCT01620762|454816773|FG002|Overall Study|Lost to Follow-up|10|||
126416146|NCT01620762|454816771|FG000|Overall Study|Protocol deviation|1|||
126416147|NCT01620762|454816772|FG001|Overall Study|Protocol deviation|1|||
126416148|NCT01620762|454816773|FG002|Overall Study|Protocol deviation|6|||
126416149|NCT01620762|454816771|FG000|Overall Study|Subject deterioration|0|||
126416150|NCT01620762|454816772|FG001|Overall Study|Subject deterioration|1|||
126416151|NCT01620762|454816773|FG002|Overall Study|Subject deterioration|1|||
126416152|NCT01620762|454816771|FG000|Overall Study|Non-specified|3|||
126416153|NCT01620762|454816772|FG001|Overall Study|Non-specified|6|||
126416154|NCT01620762|454816773|FG002|Overall Study|Non-specified|5|||
126416155|NCT01620762|454816771|FG000|Overall Study|Use of prohibted therapies|0|||
126416156|NCT01620762|454816772|FG001|Overall Study|Use of prohibted therapies|1|||
126416157|NCT01620762|454816773|FG002|Overall Study|Use of prohibted therapies|1|||
126416158|NCT00705146|454816778|FG000|Overall Study|Lost to Follow-up|1|||
126416159|NCT00705146|454816779|FG001|Overall Study|Lost to Follow-up|1|||
126416160|NCT00095173|454816782|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
126416161|NCT00095173|454816783|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416162|NCT00095173|454816784|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416163|NCT00095173|454816785|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416164|NCT00095173|454816786|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416165|NCT00095173|454816787|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416166|NCT00095173|454816782|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
126416167|NCT00095173|454816783|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416168|NCT00095173|454816784|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416169|NCT00095173|454816785|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416170|NCT00095173|454816786|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416171|NCT00095173|454816787|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416172|NCT00095173|454816782|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
126416173|NCT00095173|454816783|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416174|NCT00095173|454816784|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416175|NCT00095173|454816785|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416176|NCT00095173|454816786|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416177|NCT00095173|454816787|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416178|NCT00095173|454816782|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
126416179|NCT00095173|454816783|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
126416180|NCT00095173|454816784|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
126054325|NCT02972034|453493881|FG010|Overall Study|Death|3|||
126054326|NCT02972034|453493882|FG011|Overall Study|Death|2|||
126416181|NCT00095173|454816785|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
126416182|NCT00095173|454816786|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
126416183|NCT00095173|454816787|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
126416184|NCT00095173|454816782|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
126416185|NCT00095173|454816783|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
126416186|NCT00095173|454816784|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
126416187|NCT00095173|454816785|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
126416188|NCT00095173|454816786|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
126416189|NCT00095173|454816787|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
126416190|NCT00095173|454816782|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416191|NCT00095173|454816783|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
126416192|NCT00095173|454816784|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416193|NCT00095173|454816785|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416194|NCT00095173|454816786|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416195|NCT00095173|454816787|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416196|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Death|0|||
126416197|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Death|0|||
126416198|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Death|0|||
126416199|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Death|0|||
126416200|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Death|0|||
126416201|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Death|1|||
126416202|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
126416203|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
126416204|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
126416205|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
126416206|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
126416207|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
126416208|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
126416209|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
126416210|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
126416211|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
126416212|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
126416213|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
126416214|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
126416215|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
126416216|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
126416217|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
126416218|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
126416219|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
126416220|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
126416221|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
126416222|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
126416223|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
126416224|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
126416225|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
126416226|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
126416227|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
126416228|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
126416229|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
126416230|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
126054327|NCT02972034|453493883|FG012|Overall Study|Death|11|||
126054328|NCT02972034|453493884|FG013|Overall Study|Death|10|||
126054329|NCT02972034|453493885|FG014|Overall Study|Death|9|||
126054330|NCT02972034|453493871|FG000|Overall Study|Lost to Follow-up|0|||
126054331|NCT02972034|453493872|FG001|Overall Study|Lost to Follow-up|0|||
126054332|NCT02972034|453493873|FG002|Overall Study|Lost to Follow-up|0|||
126416231|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
126416232|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
126054333|NCT02972034|453493874|FG003|Overall Study|Lost to Follow-up|0|||
126416233|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
126416234|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
126054334|NCT02972034|453493875|FG004|Overall Study|Lost to Follow-up|1|||
126416235|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
126416236|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
126416237|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
126416238|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
126416239|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
126416240|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
126416241|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
126416242|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
126416243|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
126416244|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Other|0|||
126416245|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Other|0|||
126416246|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Other|0|||
126416247|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Other|4|||
126416248|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Other|6|||
126416249|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Other|8|||
126416250|NCT01771250|454816794|FG000|Period 1|Met exclusion criteria|1|||
126416251|NCT01771250|454816795|FG001|Period 1|Met exclusion criteria|0|||
126416252|NCT02038075|454816796|FG000|Overall Study|Withdrawal by Subject|3|||
126416253|NCT02038075|454816797|FG001|Overall Study|Withdrawal by Subject|0|||
126416254|NCT00850538|454816798|FG000|Overall Study|unable/unwilling to complete MRI|13|||
126416255|NCT00850538|454816798|FG000|Overall Study|specimen missed due to scheduling error|14|||
126416256|NCT00850538|454816798|FG000|Overall Study|specimen unusable|7|||
126416257|NCT00850538|454816798|FG000|Overall Study|Withdrawal by Subject|3|||
126416258|NCT00850538|454816798|FG000|Overall Study|radiology error|2|||
126416259|NCT00850538|454816798|FG000|Overall Study|Protocol Violation|2|||
126416260|NCT02328027|454816799|FG000|Overall Study|Withdrawal by Subject|0|||
126416261|NCT02328027|454816800|FG001|Overall Study|Withdrawal by Subject|1|||
126416262|NCT03319212|454816801|FG000|Overall Study|Discontinued as moving out of local area|0|||
126416263|NCT03319212|454816802|FG001|Overall Study|Discontinued as moving out of local area|1|||
126416264|NCT03319212|454816801|FG000|Overall Study|Adverse Event|2|||
126054335|NCT02972034|453493876|FG005|Overall Study|Lost to Follow-up|0|||
126054336|NCT02972034|453493877|FG006|Overall Study|Lost to Follow-up|0|||
126054337|NCT02972034|453493878|FG007|Overall Study|Lost to Follow-up|1|||
126416265|NCT03319212|454816802|FG001|Overall Study|Adverse Event|2|||
126416266|NCT03319212|454816801|FG000|Overall Study|Withdrawal by Subject|0|||
126416267|NCT03319212|454816802|FG001|Overall Study|Withdrawal by Subject|1|||
126416268|NCT03319212|454816801|FG000|Overall Study|Lost to Follow-up|0|||
126416269|NCT03319212|454816802|FG001|Overall Study|Lost to Follow-up|1|||
126416270|NCT03319212|454816801|FG000|Overall Study|Physician Decision|1|||
126416271|NCT03319212|454816802|FG001|Overall Study|Physician Decision|0|||
126416272|NCT00250276|454816803|FG000|Overall Study|Serious Adverse Event|0|||
126416273|NCT00250276|454816804|FG001|Overall Study|Serious Adverse Event|0|||
126416274|NCT00250276|454816805|FG002|Overall Study|Serious Adverse Event|1|||
126416275|NCT00250276|454816806|FG003|Overall Study|Serious Adverse Event|0|||
126416276|NCT00250276|454816803|FG000|Overall Study|Non-serious Adverse Event|2|||
126416277|NCT00250276|454816804|FG001|Overall Study|Non-serious Adverse Event|0|||
126416278|NCT00250276|454816805|FG002|Overall Study|Non-serious Adverse Event|0|||
126416279|NCT00250276|454816806|FG003|Overall Study|Non-serious Adverse Event|2|||
126054338|NCT02972034|453493879|FG008|Overall Study|Lost to Follow-up|0|||
126054339|NCT02972034|453493880|FG009|Overall Study|Lost to Follow-up|0|||
126416280|NCT00250276|454816803|FG000|Overall Study|Protocol Violation|0|||
126416281|NCT00250276|454816804|FG001|Overall Study|Protocol Violation|1|||
126416282|NCT00250276|454816805|FG002|Overall Study|Protocol Violation|0|||
126416283|NCT00250276|454816806|FG003|Overall Study|Protocol Violation|0|||
126054340|NCT02972034|453493881|FG010|Overall Study|Lost to Follow-up|0|||
126054341|NCT02972034|453493882|FG011|Overall Study|Lost to Follow-up|0|||
126054342|NCT02972034|453493883|FG012|Overall Study|Lost to Follow-up|0|||
126054343|NCT02972034|453493884|FG013|Overall Study|Lost to Follow-up|0|||
126054344|NCT02972034|453493885|FG014|Overall Study|Lost to Follow-up|1|||
126054345|NCT02972034|453493871|FG000|Overall Study|Physician Decision|0|||
126054346|NCT02972034|453493872|FG001|Overall Study|Physician Decision|0|||
126054347|NCT02972034|453493873|FG002|Overall Study|Physician Decision|0|||
126416284|NCT00250276|454816803|FG000|Overall Study|Withdrawal by Subject|1|||
126416285|NCT00250276|454816804|FG001|Overall Study|Withdrawal by Subject|2|||
126416286|NCT00250276|454816805|FG002|Overall Study|Withdrawal by Subject|3|||
126416287|NCT00250276|454816806|FG003|Overall Study|Withdrawal by Subject|2|||
126416288|NCT00250276|454816803|FG000|Overall Study|Migrated/moved from study area|3|||
126416289|NCT00250276|454816804|FG001|Overall Study|Migrated/moved from study area|0|||
126416290|NCT00250276|454816805|FG002|Overall Study|Migrated/moved from study area|2|||
126416291|NCT00250276|454816806|FG003|Overall Study|Migrated/moved from study area|7|||
126416292|NCT00250276|454816803|FG000|Overall Study|Lost to Follow-up|11|||
126416293|NCT00250276|454816804|FG001|Overall Study|Lost to Follow-up|18|||
126416294|NCT00250276|454816805|FG002|Overall Study|Lost to Follow-up|13|||
126416295|NCT00250276|454816806|FG003|Overall Study|Lost to Follow-up|8|||
126416296|NCT01811186|454816807|FG000|Overall Study|Adverse Event|54|||
126416297|NCT01811186|454816808|FG001|Overall Study|Adverse Event|38|||
126416298|NCT01811186|454816807|FG000|Overall Study|Protocol Violation|5|||
126416299|NCT01811186|454816808|FG001|Overall Study|Protocol Violation|6|||
126416300|NCT01811186|454816807|FG000|Overall Study|Withdrawal by Subject|5|||
126416301|NCT01811186|454816808|FG001|Overall Study|Withdrawal by Subject|10|||
126416302|NCT01811186|454816807|FG000|Overall Study|Lack of Efficacy|3|||
126416303|NCT01811186|454816808|FG001|Overall Study|Lack of Efficacy|6|||
126416304|NCT01811186|454816807|FG000|Overall Study|Lost to Follow-up|4|||
126416305|NCT01811186|454816808|FG001|Overall Study|Lost to Follow-up|2|||
126416306|NCT03369236|454816813|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
126416307|NCT03369236|454816814|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
126416308|NCT03369236|454816813|FG000|Open-label Extension Period|Lack of Efficacy|2|||
126416309|NCT03369236|454816814|FG001|Open-label Extension Period|Lack of Efficacy|1|||
126416310|NCT03369236|454816813|FG000|Open-label Extension Period|Adverse Event|0|||
126416311|NCT03369236|454816814|FG001|Open-label Extension Period|Adverse Event|1|||
126416312|NCT03369236|454816813|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
126416313|NCT03369236|454816814|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
126416314|NCT01865448|454818535|FG000|Overall Study|Adverse Event|1|||
126416315|NCT01865448|454818536|FG001|Overall Study|Adverse Event|1|||
126416316|NCT01865448|454818535|FG000|Overall Study|Pregnancy|0|||
126416317|NCT01865448|454818536|FG001|Overall Study|Pregnancy|1|||
126416318|NCT01865448|454818535|FG000|Overall Study|dropout unrelated to study|1|||
126416319|NCT01865448|454818536|FG001|Overall Study|dropout unrelated to study|1|||
126416320|NCT05111249|454818539|FG000|Overall Study|Lost to Follow-up|0|||
126416321|NCT05111249|454818540|FG001|Overall Study|Lost to Follow-up|2|||
126416322|NCT05111249|454818539|FG000|Overall Study|Physician Decision|0|||
126416323|NCT05111249|454818540|FG001|Overall Study|Physician Decision|1|||
126416324|NCT05111249|454818539|FG000|Overall Study|Participant decision|1|||
126416325|NCT05111249|454818540|FG001|Overall Study|Participant decision|5|||
126416326|NCT05128578|454818541|FG000|Overall Study|Withdrawal by Subject|9|||
126416327|NCT05128578|454818541|FG000|Overall Study|Lost to Follow-up|5|||
126416328|NCT01016600|454818545|FG000|Overall Study|Did not start treatment|1|||
126416329|NCT01016600|454818546|FG001|Overall Study|Did not start treatment|0|||
126416330|NCT01016600|454818547|FG002|Overall Study|Did not start treatment|0|||
126416331|NCT01016600|454818548|FG003|Overall Study|Did not start treatment|0|||
126416332|NCT00872599|454818549|FG000|Second Washout Period|Adverse Event|1|||
126416333|NCT00872599|454818550|FG001|Second Washout Period|Adverse Event|1|||
126416334|NCT02679755|454818551|FG000|Overall Study|Death|0|||
126416335|NCT02679755|454818552|FG001|Overall Study|Death|3|||
126416336|NCT02679755|454818551|FG000|Overall Study|Global deterioration of health status|1|||
126416337|NCT02679755|454818552|FG001|Overall Study|Global deterioration of health status|8|||
126416338|NCT02679755|454818551|FG000|Overall Study|Lost to Follow-up|1|||
126416339|NCT02679755|454818552|FG001|Overall Study|Lost to Follow-up|0|||
126416340|NCT02679755|454818551|FG000|Overall Study|Objective progression or relapse|24|||
126416341|NCT02679755|454818552|FG001|Overall Study|Objective progression or relapse|83|||
126416342|NCT02679755|454818551|FG000|Overall Study|Not defined|0|||
126416343|NCT02679755|454818552|FG001|Overall Study|Not defined|2|||
126416344|NCT02679755|454818551|FG000|Overall Study|Withdrawal by participant|6|||
126416345|NCT02679755|454818552|FG001|Overall Study|Withdrawal by participant|3|||
126416346|NCT02679755|454818551|FG000|Overall Study|Adverse Event|1|||
126416347|NCT02679755|454818552|FG001|Overall Study|Adverse Event|4|||
126416348|NCT02679755|454818551|FG000|Overall Study|Adverse events not related to study drug|1|||
126416349|NCT02679755|454818552|FG001|Overall Study|Adverse events not related to study drug|2|||
126416350|NCT00801229|454818553|FG000|Signed Consent|Withdrawal by Subject|2|||
126416351|NCT00801229|454818554|FG001|Signed Consent|Withdrawal by Subject|2|||
126416352|NCT00801229|454818553|FG000|Signed Consent|Found Ineligible|1|||
126416353|NCT00801229|454818554|FG001|Signed Consent|Found Ineligible|1|||
126416354|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
126416355|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
126416356|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
126416357|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
126416358|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
126416359|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
126054348|NCT02972034|453493874|FG003|Overall Study|Physician Decision|0|||
126054349|NCT02972034|453493875|FG004|Overall Study|Physician Decision|0|||
126054350|NCT02972034|453493876|FG005|Overall Study|Physician Decision|0|||
126054351|NCT02972034|453493877|FG006|Overall Study|Physician Decision|0|||
126416360|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
126416361|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
126416362|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
126416363|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
126416364|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Adverse Event|1|||
126054352|NCT02972034|453493878|FG007|Overall Study|Physician Decision|1|||
126416365|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Adverse Event|1|||
126416366|NCT02451917|454818555|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
126054353|NCT02972034|453493879|FG008|Overall Study|Physician Decision|0|||
126054354|NCT02972034|453493880|FG009|Overall Study|Physician Decision|0|||
126416367|NCT02451917|454818556|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
126416368|NCT02451917|454818555|FG000|First Intervention (24 Weeks)|Death|0|||
126416369|NCT02451917|454818556|FG001|First Intervention (24 Weeks)|Death|1|||
126416370|NCT02451917|454818555|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
126416371|NCT02451917|454818556|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
126416372|NCT02300259|454818559|FG000|Period 1|Adverse Event|0|||
126416373|NCT02300259|454818560|FG001|Period 1|Adverse Event|0|||
126416374|NCT02300259|454818561|FG002|Period 1|Adverse Event|1|||
126416375|NCT02300259|454818559|FG000|Period 1|Withdrawal by Subject|0|||
126416376|NCT02300259|454818560|FG001|Period 1|Withdrawal by Subject|0|||
126416377|NCT02300259|454818561|FG002|Period 1|Withdrawal by Subject|1|||
126416378|NCT02300259|454818559|FG000|Period 2|Adverse Event|1|||
126416379|NCT02300259|454818560|FG001|Period 2|Adverse Event|0|||
126416380|NCT02300259|454818561|FG002|Period 2|Adverse Event|0|||
126416381|NCT02300259|454818559|FG000|Period 2|Withdrawal by Subject|0|||
126416382|NCT02300259|454818560|FG001|Period 2|Withdrawal by Subject|0|||
126416383|NCT02300259|454818561|FG002|Period 2|Withdrawal by Subject|1|||
126416384|NCT04737278|454818562|FG000|Overall Study|Lost to Follow-up|1|||
126416385|NCT04737278|454818563|FG001|Overall Study|Lost to Follow-up|1|||
126416386|NCT04737278|454818562|FG000|Overall Study|Withdrawal by Subject|1|||
126416387|NCT04737278|454818563|FG001|Overall Study|Withdrawal by Subject|0|||
126416388|NCT04737278|454818562|FG000|Overall Study|Protocol Violation|1|||
126416389|NCT04737278|454818563|FG001|Overall Study|Protocol Violation|1|||
126416390|NCT04737278|454818562|FG000|Overall Study|failure to complete questionnaire|1|||
126416391|NCT04737278|454818563|FG001|Overall Study|failure to complete questionnaire|1|||
126416392|NCT00546000|454818564|FG000|Overall Study|Adverse Event|1|||
126416393|NCT00546000|454818564|FG000|Overall Study|Lost to Follow-up|1|||
126416394|NCT00546000|454818564|FG000|Overall Study|Baseline HPA Axis Supression|2|||
126416395|NCT02255461|454818565|FG000|Overall Study|Adverse Event|0|||
126416396|NCT02255461|454818566|FG001|Overall Study|Adverse Event|1|||
126416397|NCT02255461|454818567|FG002|Overall Study|Adverse Event|0|||
126416398|NCT02255461|454818568|FG003|Overall Study|Adverse Event|0|||
126416399|NCT02255461|454818569|FG004|Overall Study|Adverse Event|1|||
126416400|NCT02255461|454818565|FG000|Overall Study|Withdrawal by Subject|0|||
126416401|NCT02255461|454818566|FG001|Overall Study|Withdrawal by Subject|0|||
126416402|NCT02255461|454818567|FG002|Overall Study|Withdrawal by Subject|1|||
126416403|NCT02255461|454818568|FG003|Overall Study|Withdrawal by Subject|0|||
126416404|NCT02255461|454818569|FG004|Overall Study|Withdrawal by Subject|1|||
126416405|NCT02255461|454818565|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
126416406|NCT02255461|454818566|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
126416407|NCT02255461|454818567|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
126416408|NCT02255461|454818568|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
126416409|NCT02255461|454818569|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
126416410|NCT01504412|454818570|FG000|Overall Study|Adverse Event|1|||
126416411|NCT01504412|454818571|FG001|Overall Study|Adverse Event|8|||
126416412|NCT01504412|454818572|FG002|Overall Study|Adverse Event|1|||
126416413|NCT01504412|454818573|FG003|Overall Study|Adverse Event|7|||
126416414|NCT01504412|454818574|FG004|Overall Study|Adverse Event|10|||
126416415|NCT01504412|454818570|FG000|Overall Study|Withdrawal by Subject|2|||
126416416|NCT01504412|454818571|FG001|Overall Study|Withdrawal by Subject|1|||
126416417|NCT01504412|454818572|FG002|Overall Study|Withdrawal by Subject|1|||
126416418|NCT01504412|454818573|FG003|Overall Study|Withdrawal by Subject|5|||
126416419|NCT01504412|454818574|FG004|Overall Study|Withdrawal by Subject|1|||
126416420|NCT01504412|454818570|FG000|Overall Study|Other|2|||
126416421|NCT01504412|454818571|FG001|Overall Study|Other|1|||
126416422|NCT01504412|454818572|FG002|Overall Study|Other|1|||
126416423|NCT01504412|454818573|FG003|Overall Study|Other|6|||
126416424|NCT01504412|454818574|FG004|Overall Study|Other|1|||
126416425|NCT01504412|454818570|FG000|Overall Study|Lost to Follow-up|0|||
126416426|NCT01504412|454818571|FG001|Overall Study|Lost to Follow-up|2|||
126416427|NCT01504412|454818572|FG002|Overall Study|Lost to Follow-up|0|||
126416428|NCT01504412|454818573|FG003|Overall Study|Lost to Follow-up|0|||
126416429|NCT01504412|454818574|FG004|Overall Study|Lost to Follow-up|0|||
126416430|NCT01504412|454818570|FG000|Overall Study|Lack of Efficacy|0|||
126416431|NCT01504412|454818571|FG001|Overall Study|Lack of Efficacy|0|||
126416432|NCT01504412|454818572|FG002|Overall Study|Lack of Efficacy|1|||
126416433|NCT01504412|454818573|FG003|Overall Study|Lack of Efficacy|0|||
126416434|NCT01504412|454818574|FG004|Overall Study|Lack of Efficacy|1|||
126416435|NCT01504412|454818570|FG000|Overall Study|Death|0|||
126416436|NCT01504412|454818571|FG001|Overall Study|Death|0|||
126416437|NCT01504412|454818572|FG002|Overall Study|Death|0|||
126416438|NCT01504412|454818573|FG003|Overall Study|Death|1|||
126416439|NCT01504412|454818574|FG004|Overall Study|Death|0|||
126416440|NCT01449006|454818575|FG000|Overall Study|Lost to Follow-up|1|||
126416441|NCT01449006|454818576|FG001|Overall Study|Lost to Follow-up|0|||
126416442|NCT01449006|454818575|FG000|Overall Study|Withdrawal by Subject|1|||
126416443|NCT01449006|454818576|FG001|Overall Study|Withdrawal by Subject|0|||
126416444|NCT01449006|454818575|FG000|Overall Study|Protocol Violation|1|||
126416445|NCT01449006|454818576|FG001|Overall Study|Protocol Violation|0|||
126416446|NCT03350815|454818577|FG000|Period 1|Adverse Event|10|||
126416447|NCT03350815|454818578|FG001|Period 1|Adverse Event|0|||
126416448|NCT03350815|454818579|FG002|Period 1|Adverse Event|0|||
126416449|NCT03350815|454818580|FG003|Period 1|Adverse Event|0|||
126416450|NCT03350815|454818577|FG000|Period 1|Technical problems|1|||
126416451|NCT03350815|454818578|FG001|Period 1|Technical problems|0|||
126416452|NCT03350815|454818579|FG002|Period 1|Technical problems|0|||
126416453|NCT03350815|454818580|FG003|Period 1|Technical problems|0|||
126416454|NCT03350815|454818577|FG000|Period 1|Lost to Follow-up|3|||
126416455|NCT03350815|454818578|FG001|Period 1|Lost to Follow-up|0|||
126416456|NCT03350815|454818579|FG002|Period 1|Lost to Follow-up|0|||
126416457|NCT03350815|454818580|FG003|Period 1|Lost to Follow-up|0|||
126416458|NCT03350815|454818577|FG000|Period 1|Physician Decision|1|||
126416459|NCT03350815|454818578|FG001|Period 1|Physician Decision|0|||
126416460|NCT03350815|454818579|FG002|Period 1|Physician Decision|0|||
126416461|NCT03350815|454818580|FG003|Period 1|Physician Decision|0|||
126416462|NCT03350815|454818577|FG000|Period 1|Withdrawal by Subject|8|||
126416463|NCT03350815|454818578|FG001|Period 1|Withdrawal by Subject|0|||
126416464|NCT03350815|454818579|FG002|Period 1|Withdrawal by Subject|0|||
126416465|NCT03350815|454818580|FG003|Period 1|Withdrawal by Subject|0|||
126416466|NCT03350815|454818577|FG000|Period 1|Lack of Efficacy|15|||
126416467|NCT03350815|454818578|FG001|Period 1|Lack of Efficacy|0|||
126416468|NCT03350815|454818579|FG002|Period 1|Lack of Efficacy|0|||
126416469|NCT03350815|454818580|FG003|Period 1|Lack of Efficacy|0|||
126416470|NCT03350815|454818577|FG000|Period 1|Non-compliance with study treatment|2|||
126416471|NCT03350815|454818578|FG001|Period 1|Non-compliance with study treatment|0|||
126416472|NCT03350815|454818579|FG002|Period 1|Non-compliance with study treatment|0|||
126416473|NCT03350815|454818580|FG003|Period 1|Non-compliance with study treatment|0|||
126416474|NCT03350815|454818577|FG000|Period 1|Protocol Violation|3|||
126416475|NCT03350815|454818578|FG001|Period 1|Protocol Violation|0|||
126416476|NCT03350815|454818579|FG002|Period 1|Protocol Violation|0|||
126416477|NCT03350815|454818580|FG003|Period 1|Protocol Violation|0|||
126416478|NCT03350815|454818577|FG000|Period 2|Adverse Event|0|||
126416479|NCT03350815|454818578|FG001|Period 2|Adverse Event|3|||
126416480|NCT03350815|454818579|FG002|Period 2|Adverse Event|5|||
126416481|NCT03350815|454818580|FG003|Period 2|Adverse Event|0|||
126416482|NCT03350815|454818577|FG000|Period 2|Technical problem|0|||
126416483|NCT03350815|454818578|FG001|Period 2|Technical problem|1|||
126416484|NCT03350815|454818579|FG002|Period 2|Technical problem|0|||
126416485|NCT03350815|454818580|FG003|Period 2|Technical problem|0|||
125891071|NCT02152956|452899708|FG001|Overall Study|Adverse Event|0|||
125891072|NCT02152956|452899709|FG002|Overall Study|Adverse Event|0|||
125891073|NCT02152956|452899710|FG003|Overall Study|Adverse Event|0|||
125891074|NCT02152956|452899711|FG004|Overall Study|Adverse Event|0|||
125891075|NCT02152956|452899712|FG005|Overall Study|Adverse Event|0|||
125891076|NCT02152956|452899713|FG006|Overall Study|Adverse Event|0|||
125891077|NCT02152956|452899714|FG007|Overall Study|Adverse Event|0|||
125891078|NCT02152956|452899715|FG008|Overall Study|Adverse Event|0|||
125891079|NCT02152956|452899716|FG009|Overall Study|Adverse Event|0|||
125891080|NCT02152956|452899717|FG010|Overall Study|Adverse Event|0|||
125891081|NCT02152956|452899718|FG011|Overall Study|Adverse Event|4|||
125891082|NCT02152956|452899719|FG012|Overall Study|Adverse Event|0|||
125891083|NCT02152956|452899707|FG000|Overall Study|Death|0|||
125891084|NCT02152956|452899708|FG001|Overall Study|Death|3|||
125891085|NCT02152956|452899709|FG002|Overall Study|Death|3|||
125891086|NCT02152956|452899710|FG003|Overall Study|Death|4|||
125891087|NCT02152956|452899711|FG004|Overall Study|Death|1|||
125891088|NCT02152956|452899712|FG005|Overall Study|Death|2|||
125891089|NCT02152956|452899713|FG006|Overall Study|Death|6|||
125891090|NCT02152956|452899714|FG007|Overall Study|Death|6|||
125891091|NCT02152956|452899715|FG008|Overall Study|Death|4|||
125891092|NCT02152956|452899716|FG009|Overall Study|Death|5|||
125891093|NCT02152956|452899717|FG010|Overall Study|Death|3|||
125891094|NCT02152956|452899718|FG011|Overall Study|Death|143|||
125891095|NCT02152956|452899719|FG012|Overall Study|Death|12|||
125891096|NCT02152956|452899707|FG000|Overall Study|Lost to Follow-up|0|||
125891097|NCT02152956|452899708|FG001|Overall Study|Lost to Follow-up|1|||
125891098|NCT02152956|452899709|FG002|Overall Study|Lost to Follow-up|0|||
125891099|NCT02152956|452899710|FG003|Overall Study|Lost to Follow-up|0|||
125891100|NCT02152956|452899711|FG004|Overall Study|Lost to Follow-up|0|||
125891101|NCT02152956|452899712|FG005|Overall Study|Lost to Follow-up|0|||
125891102|NCT02152956|452899713|FG006|Overall Study|Lost to Follow-up|0|||
125891103|NCT02152956|452899714|FG007|Overall Study|Lost to Follow-up|0|||
126054355|NCT02972034|453493881|FG010|Overall Study|Physician Decision|1|||
126054356|NCT02972034|453493882|FG011|Overall Study|Physician Decision|0|||
126054357|NCT02972034|453493883|FG012|Overall Study|Physician Decision|0|||
126054358|NCT02972034|453493884|FG013|Overall Study|Physician Decision|0|||
126054359|NCT02972034|453493885|FG014|Overall Study|Physician Decision|0|||
126054360|NCT02972034|453493871|FG000|Overall Study|Sponsor Decision|0|||
126054361|NCT02972034|453493872|FG001|Overall Study|Sponsor Decision|0|||
126054362|NCT02972034|453493873|FG002|Overall Study|Sponsor Decision|0|||
126416486|NCT03350815|454818577|FG000|Period 2|Lost to Follow-up|0|||
126416487|NCT03350815|454818578|FG001|Period 2|Lost to Follow-up|3|||
126416488|NCT03350815|454818579|FG002|Period 2|Lost to Follow-up|3|||
126416489|NCT03350815|454818580|FG003|Period 2|Lost to Follow-up|0|||
126416490|NCT03350815|454818577|FG000|Period 2|Physician Decision|0|||
126416491|NCT03350815|454818578|FG001|Period 2|Physician Decision|0|||
126416492|NCT03350815|454818579|FG002|Period 2|Physician Decision|1|||
126416493|NCT03350815|454818580|FG003|Period 2|Physician Decision|0|||
126416494|NCT03350815|454818577|FG000|Period 2|Withdrawal by Subject|0|||
126416495|NCT03350815|454818578|FG001|Period 2|Withdrawal by Subject|3|||
126416496|NCT03350815|454818579|FG002|Period 2|Withdrawal by Subject|4|||
126416497|NCT03350815|454818580|FG003|Period 2|Withdrawal by Subject|0|||
126416498|NCT03350815|454818577|FG000|Period 2|Lack of Efficacy|0|||
126416499|NCT03350815|454818578|FG001|Period 2|Lack of Efficacy|6|||
126416500|NCT03350815|454818579|FG002|Period 2|Lack of Efficacy|2|||
126416501|NCT03350815|454818580|FG003|Period 2|Lack of Efficacy|0|||
126416502|NCT03350815|454818577|FG000|Period 2|Protocol Violation|0|||
126416503|NCT03350815|454818578|FG001|Period 2|Protocol Violation|0|||
126416504|NCT03350815|454818579|FG002|Period 2|Protocol Violation|1|||
126416505|NCT03350815|454818580|FG003|Period 2|Protocol Violation|0|||
126416506|NCT03350815|454818577|FG000|Period 2|New therapy for study indication|0|||
126416507|NCT03350815|454818578|FG001|Period 2|New therapy for study indication|0|||
126416508|NCT03350815|454818579|FG002|Period 2|New therapy for study indication|1|||
126416509|NCT03350815|454818580|FG003|Period 2|New therapy for study indication|0|||
126416510|NCT03040674|454818585|FG000|Overall Study|Lost to Follow-up|225|||
126416511|NCT03040674|454818585|FG000|Overall Study|Death|23|||
126416512|NCT02936843|454818586|FG000|Overall Study|Lost to Follow-up|3|||
125891104|NCT02152956|452899715|FG008|Overall Study|Lost to Follow-up|0|||
125891105|NCT02152956|452899716|FG009|Overall Study|Lost to Follow-up|0|||
125891106|NCT02152956|452899717|FG010|Overall Study|Lost to Follow-up|0|||
125891107|NCT02152956|452899718|FG011|Overall Study|Lost to Follow-up|3|||
125891108|NCT02152956|452899719|FG012|Overall Study|Lost to Follow-up|0|||
125891109|NCT02152956|452899707|FG000|Overall Study|Withdrawal by Subject|1|||
125891110|NCT02152956|452899708|FG001|Overall Study|Withdrawal by Subject|0|||
125891111|NCT02152956|452899709|FG002|Overall Study|Withdrawal by Subject|1|||
125891112|NCT02152956|452899710|FG003|Overall Study|Withdrawal by Subject|0|||
125891113|NCT02152956|452899711|FG004|Overall Study|Withdrawal by Subject|2|||
125891114|NCT02152956|452899712|FG005|Overall Study|Withdrawal by Subject|2|||
126054363|NCT02972034|453493874|FG003|Overall Study|Sponsor Decision|1|||
126416513|NCT02936843|454818587|FG001|Overall Study|Lost to Follow-up|1|||
126416514|NCT02936843|454818586|FG000|Overall Study|Withdrawal by Subject|1|||
126416515|NCT02936843|454818587|FG001|Overall Study|Withdrawal by Subject|1|||
126416516|NCT03386487|454818588|FG000|Overall Study|Lost to Follow-up|5|||
126416517|NCT03386487|454818589|FG001|Overall Study|Lost to Follow-up|6|||
126416518|NCT03386487|454818588|FG000|Overall Study|Withdrawal by Subject|11|||
126416519|NCT03386487|454818589|FG001|Overall Study|Withdrawal by Subject|7|||
126416520|NCT03386487|454818588|FG000|Overall Study|Physician Decision|11|||
126416521|NCT03386487|454818589|FG001|Overall Study|Physician Decision|8|||
126416522|NCT02703324|454818590|FG000|Period Two|Withdrawal by Subject|0|||
126416523|NCT02703324|454818591|FG001|Period Two|Withdrawal by Subject|0|||
126416524|NCT02703324|454818592|FG002|Period Two|Withdrawal by Subject|1|||
126416525|NCT02703324|454818593|FG003|Period Two|Withdrawal by Subject|0|||
126416526|NCT02703324|454818594|FG004|Period Two|Withdrawal by Subject|0|||
126054364|NCT02972034|453493875|FG004|Overall Study|Sponsor Decision|0|||
126054365|NCT02972034|453493876|FG005|Overall Study|Sponsor Decision|0|||
126416527|NCT02703324|454818595|FG005|Period Two|Withdrawal by Subject|0|||
126416528|NCT04303572|454818596|FG000|Overall Study|Study closed due to poor enrollment|1|||
126416529|NCT06312592|454818597|FG000|Overall Study|Lost to Follow-up|29|||
126416530|NCT06312592|454818598|FG001|Overall Study|Lost to Follow-up|13|||
126416531|NCT00475709|454818603|FG000|Overall Study|Did not meet eligibility criteria|8|||
126416532|NCT00475709|454818603|FG000|Overall Study|Death|41|||
126416533|NCT00475709|454818603|FG000|Overall Study|Device Explant|6|||
126416534|NCT00475709|454818603|FG000|Overall Study|Lost to Follow-up|21|||
126416535|NCT00555672|454818604|FG000|Overall Study|Death|0|||
126416536|NCT00555672|454818605|FG001|Overall Study|Death|2|||
126416537|NCT00555672|454818604|FG000|Overall Study|Adverse Event|8|||
126416538|NCT00555672|454818605|FG001|Overall Study|Adverse Event|2|||
126416539|NCT00555672|454818604|FG000|Overall Study|Objective progression or relapse|11|||
126416540|NCT00555672|454818605|FG001|Overall Study|Objective progression or relapse|5|||
126416541|NCT00555672|454818604|FG000|Overall Study|Other|3|||
126416542|NCT00555672|454818605|FG001|Overall Study|Other|1|||
126416543|NCT00555672|454818604|FG000|Overall Study|Participant refused|2|||
126416544|NCT00555672|454818605|FG001|Overall Study|Participant refused|0|||
126416545|NCT01415401|454818610|FG000|Overall Study|Adverse Event|5|||
126416546|NCT01415401|454818610|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
126416547|NCT01415401|454818610|FG000|Overall Study|Terminated by Sponsor|1|||
126416548|NCT00836186|454818616|FG000|Overall Study|Blood could not be drawn|1|||
126416549|NCT00532298|454818617|FG000|Overall Study|Adverse Event|1|||
126416550|NCT00532298|454818618|FG001|Overall Study|Adverse Event|0|||
126416551|NCT00532298|454818619|FG002|Overall Study|Adverse Event|0|||
126416552|NCT00532298|454818620|FG003|Overall Study|Adverse Event|0|||
126416553|NCT00532298|454818621|FG004|Overall Study|Adverse Event|1|||
126416554|NCT00532298|454818622|FG005|Overall Study|Adverse Event|1|||
126416555|NCT00532298|454818617|FG000|Overall Study|Lost to Follow-up|1|||
126416556|NCT00532298|454818618|FG001|Overall Study|Lost to Follow-up|1|||
126416557|NCT00532298|454818619|FG002|Overall Study|Lost to Follow-up|1|||
126416558|NCT00532298|454818620|FG003|Overall Study|Lost to Follow-up|0|||
126416559|NCT00532298|454818621|FG004|Overall Study|Lost to Follow-up|0|||
126416560|NCT00532298|454818622|FG005|Overall Study|Lost to Follow-up|1|||
126416561|NCT04531241|454818623|FG000|Period 1|Withdrawal by Subject|2|||
126416562|NCT04531241|454818624|FG001|Period 1|Withdrawal by Subject|0|||
126416563|NCT04531241|454818623|FG000|Period 1|Dispesed incorrect lens power|1|||
126054366|NCT02972034|453493877|FG006|Overall Study|Sponsor Decision|1|||
126054367|NCT02972034|453493878|FG007|Overall Study|Sponsor Decision|1|||
126054368|NCT02972034|453493879|FG008|Overall Study|Sponsor Decision|1|||
126054369|NCT02972034|453493880|FG009|Overall Study|Sponsor Decision|2|||
126416564|NCT04531241|454818624|FG001|Period 1|Dispesed incorrect lens power|0|||
126416565|NCT04531241|454818623|FG000|Period 1|Protocol Violation|1|||
126416566|NCT04531241|454818624|FG001|Period 1|Protocol Violation|0|||
126416567|NCT04531241|454818623|FG000|Period 1|No longer eligible|0|||
126416568|NCT04531241|454818624|FG001|Period 1|No longer eligible|1|||
126416569|NCT04531241|454818623|FG000|Period 1|Lens Discomfort|0|||
126416570|NCT04531241|454818624|FG001|Period 1|Lens Discomfort|1|||
126416571|NCT04531241|454818623|FG000|Period 2|Covid-19 Related|1|||
126054370|NCT02972034|453493881|FG010|Overall Study|Sponsor Decision|2|||
126054371|NCT02972034|453493882|FG011|Overall Study|Sponsor Decision|0|||
126054372|NCT02972034|453493883|FG012|Overall Study|Sponsor Decision|1|||
126054373|NCT02972034|453493884|FG013|Overall Study|Sponsor Decision|0|||
126416572|NCT04531241|454818624|FG001|Period 2|Covid-19 Related|1|||
126416573|NCT04698993|454818629|FG000|Overall Study|PCR results not accessible|2|||
126416574|NCT04698993|454818630|FG001|Overall Study|PCR results not accessible|7|||
126054374|NCT02972034|453493885|FG014|Overall Study|Sponsor Decision|1|||
126416575|NCT04698993|454818629|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
126416576|NCT04698993|454818630|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
126054375|NCT02972034|453493871|FG000|Overall Study|Withdrawal by Subject|3|||
125891115|NCT02152956|452899713|FG006|Overall Study|Withdrawal by Subject|0|||
126054376|NCT02972034|453493872|FG001|Overall Study|Withdrawal by Subject|0|||
126054377|NCT02972034|453493873|FG002|Overall Study|Withdrawal by Subject|0|||
126416577|NCT00527904|454818631|FG000|Overall Study|Adverse Event|45|||
126416578|NCT00527904|454818631|FG000|Overall Study|Withdrawal by Subject|21|||
126416579|NCT00527904|454818631|FG000|Overall Study|Lost to Follow-up|8|||
126416580|NCT00527904|454818631|FG000|Overall Study|misc|22|||
126416581|NCT02708355|454818633|FG000|Overall Study|Adverse Event|1|||
126416582|NCT02708355|454818634|FG001|Overall Study|Adverse Event|0|||
126416583|NCT02708355|454818635|FG002|Overall Study|Adverse Event|0|||
126416584|NCT01320202|454818636|FG000|Overall Study|Adverse Event|5|||
126416585|NCT01320202|454818637|FG001|Overall Study|Adverse Event|5|||
126416586|NCT01320202|454818636|FG000|Overall Study|Death|5|||
126416587|NCT01320202|454818637|FG001|Overall Study|Death|3|||
126416588|NCT01320202|454818636|FG000|Overall Study|Lost to Follow-up|1|||
126416589|NCT01320202|454818637|FG001|Overall Study|Lost to Follow-up|0|||
126416590|NCT01320202|454818636|FG000|Overall Study|Physician Decision|3|||
126416591|NCT01320202|454818637|FG001|Overall Study|Physician Decision|1|||
126416592|NCT01320202|454818636|FG000|Overall Study|Protocol Violation|2|||
126416593|NCT01320202|454818637|FG001|Overall Study|Protocol Violation|1|||
126416594|NCT01320202|454818636|FG000|Overall Study|Withdrawal by Subject|10|||
126416595|NCT01320202|454818637|FG001|Overall Study|Withdrawal by Subject|3|||
126416596|NCT01320202|454818636|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
126416597|NCT01320202|454818637|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
126416598|NCT01320202|454818636|FG000|Overall Study|kidney transplant|1|||
126416599|NCT01320202|454818637|FG001|Overall Study|kidney transplant|2|||
126416600|NCT01320202|454818636|FG000|Overall Study|blood transfusion|1|||
126416601|NCT01320202|454818637|FG001|Overall Study|blood transfusion|7|||
126416602|NCT01320202|454818636|FG000|Overall Study|moved/changed dialysis|5|||
126416603|NCT01320202|454818637|FG001|Overall Study|moved/changed dialysis|2|||
126416604|NCT01320202|454818636|FG000|Overall Study|sponsor request|2|||
126416605|NCT01320202|454818637|FG001|Overall Study|sponsor request|0|||
126416606|NCT01320202|454818636|FG000|Overall Study|ineligible|3|||
126416607|NCT01320202|454818637|FG001|Overall Study|ineligible|0|||
126416608|NCT01320202|454818636|FG000|Overall Study|regained renal function|1|||
126416609|NCT01320202|454818637|FG001|Overall Study|regained renal function|0|||
126416610|NCT00635882|454818638|FG000|Overall Study|Protocol Violation|1|||
126416611|NCT00635882|454818639|FG001|Overall Study|Protocol Violation|0|||
126416612|NCT00635882|454818640|FG002|Overall Study|Protocol Violation|0|||
126416613|NCT00635882|454818641|FG003|Overall Study|Protocol Violation|0|||
126416614|NCT00635882|454818642|FG004|Overall Study|Protocol Violation|0|||
126416615|NCT00635882|454818643|FG005|Overall Study|Protocol Violation|0|||
126416616|NCT00835341|454818644|FG000|Overall Study|Lost to Follow-up|3|||
126416617|NCT00835341|454818645|FG001|Overall Study|Lost to Follow-up|12|||
126416618|NCT01019369|454818647|FG000|Overall Study|Lost to Follow-up|10|||
126416619|NCT01019369|454818648|FG001|Overall Study|Lost to Follow-up|6|||
126416620|NCT01019369|454818647|FG000|Overall Study|Withdrawal by Subject|0|||
126416621|NCT01019369|454818648|FG001|Overall Study|Withdrawal by Subject|1|||
126416622|NCT02513472|454818649|FG000|Overall Study|Radiological Disease Progression|45|||
126416623|NCT02513472|454818650|FG001|Overall Study|Radiological Disease Progression|57|||
126416624|NCT02513472|454818649|FG000|Overall Study|Clinical Disease Progression|5|||
126416625|NCT02513472|454818650|FG001|Overall Study|Clinical Disease Progression|13|||
126416626|NCT02513472|454818649|FG000|Overall Study|Adverse Event|8|||
126416627|NCT02513472|454818650|FG001|Overall Study|Adverse Event|11|||
126416628|NCT02513472|454818649|FG000|Overall Study|Withdrawal by Subject|0|||
126416629|NCT02513472|454818650|FG001|Overall Study|Withdrawal by Subject|4|||
126416630|NCT02513472|454818649|FG000|Overall Study|Subject Choice|2|||
126416631|NCT02513472|454818650|FG001|Overall Study|Subject Choice|7|||
126416632|NCT02513472|454818649|FG000|Overall Study|Treatment Completed as per Protocol|3|||
126416633|NCT02513472|454818650|FG001|Overall Study|Treatment Completed as per Protocol|3|||
126416634|NCT02513472|454818649|FG000|Overall Study|Other|3|||
126416635|NCT02513472|454818650|FG001|Overall Study|Other|6|||
125891116|NCT02152956|452899714|FG007|Overall Study|Withdrawal by Subject|0|||
126416636|NCT01380834|454818651|FG000|Overall Study|Physician Decision|1|||
126054378|NCT02972034|453493874|FG003|Overall Study|Withdrawal by Subject|0|||
126054379|NCT02972034|453493875|FG004|Overall Study|Withdrawal by Subject|1|||
126416637|NCT01380834|454818652|FG001|Overall Study|Physician Decision|0|||
126416638|NCT04310566|454818653|FG000|Period 1|Study Termination due to COVID-19|15|||
126416639|NCT04310566|454818654|FG001|Period 1|Study Termination due to COVID-19|17|||
126416640|NCT04310566|454818653|FG000|Period 1|Protocol Violation|0|||
126416641|NCT04310566|454818654|FG001|Period 1|Protocol Violation|1|||
126416642|NCT04310566|454818653|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
126416643|NCT04310566|454818654|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
126416644|NCT04310566|454818653|FG000|Period 1|Lost to Follow-up|1|||
126416645|NCT04310566|454818654|FG001|Period 1|Lost to Follow-up|0|||
126416646|NCT04310566|454818653|FG000|Period 1|Withdrawal by Subject|0|||
126416647|NCT04310566|454818654|FG001|Period 1|Withdrawal by Subject|1|||
126416648|NCT04310566|454818653|FG000|Period 2|Study Termination|7|||
126054380|NCT02972034|453493876|FG005|Overall Study|Withdrawal by Subject|1|||
126416649|NCT04310566|454818654|FG001|Period 2|Study Termination|5|||
126416650|NCT04565951|454818655|FG000|Overall Study|Lost to Follow-up|66|||
126416651|NCT04565951|454818656|FG001|Overall Study|Lost to Follow-up|38|||
126416652|NCT04565951|454818655|FG000|Overall Study|Withdrawal by Subject|14|||
126416653|NCT04565951|454818656|FG001|Overall Study|Withdrawal by Subject|7|||
126416654|NCT04565951|454818655|FG000|Overall Study|Death|0|||
126416655|NCT04565951|454818656|FG001|Overall Study|Death|1|||
126416656|NCT01711645|454818657|FG000|Overall Study|Withdrawal by Subject|8|||
126416657|NCT01711645|454818657|FG000|Overall Study|Lost to Follow-up|6|||
126416658|NCT01711645|454818657|FG000|Overall Study|Physician Decision|5|||
126416659|NCT01746173|454818663|FG000|Overall Study|Disease Progression|2|||
126416660|NCT01153724|454818666|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126416661|NCT01153724|454818666|FG000|Treatment Period 2|Adverse Event|1|||
126416662|NCT01153724|454818666|FG000|Treatment Period 2|Other reason not defined above|1|||
126416663|NCT04230213|454818672|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
126416664|NCT04230213|454818673|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
126416665|NCT04230213|454818674|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
126416666|NCT04230213|454818672|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
126416667|NCT04230213|454818673|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
126416668|NCT04230213|454818674|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
126416669|NCT04230213|454818672|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
126416670|NCT04230213|454818673|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
126416671|NCT04230213|454818674|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
126416672|NCT04230213|454818672|FG000|TP2: Week 10 to Week 16|Other|0|||
126416673|NCT04230213|454818673|FG001|TP2: Week 10 to Week 16|Other|2|||
126416674|NCT04230213|454818674|FG002|TP2: Week 10 to Week 16|Other|1|||
126416675|NCT04230213|454818672|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
126416676|NCT04230213|454818673|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
126416677|NCT04230213|454818674|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
126416678|NCT04230213|454818672|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
126416679|NCT04230213|454818673|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
126416680|NCT04230213|454818674|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
126416681|NCT04230213|454818672|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
126416682|NCT04230213|454818673|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
126416683|NCT04230213|454818674|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
126416684|NCT04230213|454818672|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
126416685|NCT04230213|454818673|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
126416686|NCT04230213|454818674|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
126416687|NCT04230213|454818672|FG000|TP3: Week 16 to Week 22|Other|0|||
126416688|NCT04230213|454818673|FG001|TP3: Week 16 to Week 22|Other|1|||
126416689|NCT04230213|454818674|FG002|TP3: Week 16 to Week 22|Other|3|||
126416690|NCT04230213|454818672|FG000|TP4: Week 22 to Week 32|Other|0|||
126416691|NCT04230213|454818673|FG001|TP4: Week 22 to Week 32|Other|5|||
126416692|NCT04230213|454818674|FG002|TP4: Week 22 to Week 32|Other|5|||
126416693|NCT04230213|454818672|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
126416694|NCT04230213|454818673|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
126416695|NCT04230213|454818674|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
126416696|NCT04230213|454818672|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
126416697|NCT04230213|454818673|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
126416698|NCT04230213|454818674|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
126416699|NCT04230213|454818672|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
126416700|NCT04230213|454818673|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
126416701|NCT04230213|454818674|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
126416702|NCT04230213|454818672|FG000|Follow up: Week 32 to Week 36|Other|0|||
126416703|NCT04230213|454818673|FG001|Follow up: Week 32 to Week 36|Other|1|||
126416704|NCT04230213|454818674|FG002|Follow up: Week 32 to Week 36|Other|1|||
126416705|NCT02508428|454818677|FG000|Overall Study|Death|32|||
126416706|NCT02508428|454818678|FG001|Overall Study|Death|33|||
126416707|NCT02508428|454818677|FG000|Overall Study|Liner revised|3|||
126416708|NCT02508428|454818678|FG001|Overall Study|Liner revised|19|||
126054381|NCT02972034|453493877|FG006|Overall Study|Withdrawal by Subject|0|||
126054382|NCT02972034|453493878|FG007|Overall Study|Withdrawal by Subject|0|||
126416709|NCT02508428|454818677|FG000|Overall Study|Incomplete follow-up|17|||
126416710|NCT02508428|454818678|FG001|Overall Study|Incomplete follow-up|15|||
126416711|NCT00534976|454818686|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
126054383|NCT02972034|453493879|FG008|Overall Study|Withdrawal by Subject|1|||
126416712|NCT00534976|454818687|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
126416713|NCT00534976|454818686|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
126416714|NCT00534976|454818687|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
126416715|NCT00534976|454818686|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
126416716|NCT00534976|454818687|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
126416717|NCT00861471|454818688|FG000|Overall Study|Withdrawal by Subject|1|||
126416718|NCT00861471|454818688|FG000|Overall Study|Adverse Event|2|||
126416719|NCT00861471|454818688|FG000|Overall Study|Lack of Efficacy|3|||
126416720|NCT00861471|454818688|FG000|Overall Study|treatment for lumbar laminectomy|1|||
126416721|NCT00861471|454818688|FG000|Overall Study|Physician Decision|2|||
126416722|NCT02834247|454818689|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
126416723|NCT02834247|454818690|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
126416724|NCT02834247|454818691|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
126416725|NCT02834247|454818692|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
126416726|NCT02834247|454818689|FG000|Dose Escalation Phase|Death|5|||
126416727|NCT02834247|454818690|FG001|Dose Escalation Phase|Death|6|||
126416728|NCT02834247|454818691|FG002|Dose Escalation Phase|Death|5|||
126416729|NCT02834247|454818692|FG003|Dose Escalation Phase|Death|0|||
126416730|NCT02834247|454818689|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
126416731|NCT02834247|454818690|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
126416732|NCT02834247|454818691|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
126416733|NCT02834247|454818692|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
126416734|NCT02834247|454818689|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
126416735|NCT02834247|454818690|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
126416736|NCT02834247|454818691|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126416737|NCT02834247|454818692|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126416738|NCT02834247|454818689|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
126416739|NCT02834247|454818690|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
126416740|NCT02834247|454818691|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
126416741|NCT02834247|454818692|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
126416742|NCT02834247|454818689|FG000|Dose Expansion Phase|Death|0|||
126416743|NCT02834247|454818690|FG001|Dose Expansion Phase|Death|0|||
126416744|NCT02834247|454818691|FG002|Dose Expansion Phase|Death|0|||
126416745|NCT02834247|454818692|FG003|Dose Expansion Phase|Death|8|||
126416746|NCT02834247|454818689|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
126416747|NCT02834247|454818690|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
126416748|NCT02834247|454818691|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
126416749|NCT02834247|454818692|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
126416750|NCT02834247|454818689|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
126416751|NCT02834247|454818690|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
126416752|NCT02834247|454818691|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
126416753|NCT02834247|454818692|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
126416754|NCT02610777|454821014|FG000|Overall Study|Lost to Follow-up|1|||
126416755|NCT02610777|454821015|FG001|Overall Study|Lost to Follow-up|0|||
126416756|NCT02610777|454821014|FG000|Overall Study|Site Terminated by Sponsor|9|||
126416757|NCT02610777|454821015|FG001|Overall Study|Site Terminated by Sponsor|8|||
126416758|NCT02610777|454821014|FG000|Overall Study|Withdrawal by Subject|2|||
126416759|NCT02610777|454821015|FG001|Overall Study|Withdrawal by Subject|2|||
126416760|NCT02610777|454821014|FG000|Overall Study|Reason not Specified|0|||
126416761|NCT02610777|454821015|FG001|Overall Study|Reason not Specified|1|||
126416762|NCT02610777|454821014|FG000|Overall Study|Death|50|||
126416763|NCT02610777|454821015|FG001|Overall Study|Death|47|||
126416764|NCT02737475|454821018|FG000|Overall Study|Other reasons|0|||
126416765|NCT02737475|454821019|FG001|Overall Study|Other reasons|0|||
126416766|NCT02737475|454821020|FG002|Overall Study|Other reasons|0|||
126416767|NCT02737475|454821021|FG003|Overall Study|Other reasons|0|||
126416768|NCT02737475|454821022|FG004|Overall Study|Other reasons|1|||
126416769|NCT02737475|454821023|FG005|Overall Study|Other reasons|1|||
126416770|NCT02737475|454821024|FG006|Overall Study|Other reasons|0|||
126416771|NCT02737475|454821025|FG007|Overall Study|Other reasons|0|||
126416772|NCT02737475|454821026|FG008|Overall Study|Other reasons|1|||
126416773|NCT02737475|454821027|FG009|Overall Study|Other reasons|0|||
126416774|NCT02737475|454821028|FG010|Overall Study|Other reasons|1|||
126416775|NCT02737475|454821029|FG011|Overall Study|Other reasons|0|||
126416776|NCT02737475|454821030|FG012|Overall Study|Other reasons|0|||
126416777|NCT02737475|454821031|FG013|Overall Study|Other reasons|0|||
126416778|NCT02737475|454821032|FG014|Overall Study|Other reasons|0|||
126416779|NCT02737475|454821033|FG015|Overall Study|Other reasons|0|||
126416780|NCT02737475|454821034|FG016|Overall Study|Other reasons|0|||
126416781|NCT02737475|454821035|FG017|Overall Study|Other reasons|0|||
126416782|NCT02737475|454821036|FG018|Overall Study|Other reasons|0|||
126416783|NCT02737475|454821037|FG019|Overall Study|Other reasons|0|||
126416784|NCT02737475|454821038|FG020|Overall Study|Other reasons|0|||
126416785|NCT02737475|454821039|FG021|Overall Study|Other reasons|1|||
126416786|NCT02737475|454821040|FG022|Overall Study|Other reasons|0|||
126416787|NCT02737475|454821041|FG023|Overall Study|Other reasons|1|||
126416788|NCT02737475|454821042|FG024|Overall Study|Other reasons|1|||
126416789|NCT02737475|454821043|FG025|Overall Study|Other reasons|1|||
126416790|NCT02737475|454821044|FG026|Overall Study|Other reasons|0|||
126416791|NCT02737475|454821018|FG000|Overall Study|Death|1|||
126416792|NCT02737475|454821019|FG001|Overall Study|Death|0|||
126416793|NCT02737475|454821020|FG002|Overall Study|Death|0|||
126416794|NCT02737475|454821021|FG003|Overall Study|Death|1|||
126416795|NCT02737475|454821022|FG004|Overall Study|Death|0|||
126416796|NCT02737475|454821023|FG005|Overall Study|Death|0|||
126416797|NCT02737475|454821024|FG006|Overall Study|Death|0|||
126416798|NCT02737475|454821025|FG007|Overall Study|Death|2|||
126416799|NCT02737475|454821026|FG008|Overall Study|Death|0|||
126416800|NCT02737475|454821027|FG009|Overall Study|Death|0|||
126416801|NCT02737475|454821028|FG010|Overall Study|Death|0|||
126416802|NCT02737475|454821029|FG011|Overall Study|Death|4|||
126416803|NCT02737475|454821030|FG012|Overall Study|Death|2|||
126416804|NCT02737475|454821031|FG013|Overall Study|Death|2|||
126416805|NCT02737475|454821032|FG014|Overall Study|Death|0|||
126416806|NCT02737475|454821033|FG015|Overall Study|Death|2|||
126416807|NCT02737475|454821034|FG016|Overall Study|Death|2|||
126416808|NCT02737475|454821035|FG017|Overall Study|Death|2|||
126416809|NCT02737475|454821036|FG018|Overall Study|Death|1|||
126416810|NCT02737475|454821037|FG019|Overall Study|Death|0|||
126416811|NCT02737475|454821038|FG020|Overall Study|Death|0|||
126416812|NCT02737475|454821039|FG021|Overall Study|Death|0|||
126416813|NCT02737475|454821040|FG022|Overall Study|Death|0|||
126416814|NCT02737475|454821041|FG023|Overall Study|Death|0|||
126416815|NCT02737475|454821042|FG024|Overall Study|Death|0|||
126416816|NCT02737475|454821043|FG025|Overall Study|Death|0|||
126416817|NCT02737475|454821044|FG026|Overall Study|Death|0|||
126416818|NCT02737475|454821018|FG000|Overall Study|Participant withdrew consent|0|||
126416819|NCT02737475|454821019|FG001|Overall Study|Participant withdrew consent|0|||
126416820|NCT02737475|454821020|FG002|Overall Study|Participant withdrew consent|0|||
126416821|NCT02737475|454821021|FG003|Overall Study|Participant withdrew consent|0|||
126416822|NCT02737475|454821022|FG004|Overall Study|Participant withdrew consent|0|||
126416823|NCT02737475|454821023|FG005|Overall Study|Participant withdrew consent|2|||
126416824|NCT02737475|454821024|FG006|Overall Study|Participant withdrew consent|0|||
126416825|NCT02737475|454821025|FG007|Overall Study|Participant withdrew consent|0|||
126416826|NCT02737475|454821026|FG008|Overall Study|Participant withdrew consent|0|||
126416827|NCT02737475|454821027|FG009|Overall Study|Participant withdrew consent|0|||
126416828|NCT02737475|454821028|FG010|Overall Study|Participant withdrew consent|0|||
126416829|NCT02737475|454821029|FG011|Overall Study|Participant withdrew consent|0|||
126416830|NCT02737475|454821030|FG012|Overall Study|Participant withdrew consent|0|||
126416831|NCT02737475|454821031|FG013|Overall Study|Participant withdrew consent|0|||
126416832|NCT02737475|454821032|FG014|Overall Study|Participant withdrew consent|1|||
126416833|NCT02737475|454821033|FG015|Overall Study|Participant withdrew consent|0|||
126416834|NCT02737475|454821034|FG016|Overall Study|Participant withdrew consent|0|||
126416835|NCT02737475|454821035|FG017|Overall Study|Participant withdrew consent|2|||
126416836|NCT02737475|454821036|FG018|Overall Study|Participant withdrew consent|1|||
126416837|NCT02737475|454821037|FG019|Overall Study|Participant withdrew consent|0|||
126416838|NCT02737475|454821038|FG020|Overall Study|Participant withdrew consent|2|||
126416839|NCT02737475|454821039|FG021|Overall Study|Participant withdrew consent|0|||
126416840|NCT02737475|454821040|FG022|Overall Study|Participant withdrew consent|0|||
126416841|NCT02737475|454821041|FG023|Overall Study|Participant withdrew consent|0|||
126416842|NCT02737475|454821042|FG024|Overall Study|Participant withdrew consent|0|||
126416843|NCT02737475|454821043|FG025|Overall Study|Participant withdrew consent|0|||
126416844|NCT02737475|454821044|FG026|Overall Study|Participant withdrew consent|0|||
126416845|NCT02737475|454821018|FG000|Overall Study|Lost to Follow-up|0|||
126416846|NCT02737475|454821019|FG001|Overall Study|Lost to Follow-up|0|||
126416847|NCT02737475|454821020|FG002|Overall Study|Lost to Follow-up|0|||
126416848|NCT02737475|454821021|FG003|Overall Study|Lost to Follow-up|0|||
126416849|NCT02737475|454821022|FG004|Overall Study|Lost to Follow-up|0|||
126416850|NCT02737475|454821023|FG005|Overall Study|Lost to Follow-up|0|||
126416851|NCT02737475|454821024|FG006|Overall Study|Lost to Follow-up|0|||
126416852|NCT02737475|454821025|FG007|Overall Study|Lost to Follow-up|0|||
126416853|NCT02737475|454821026|FG008|Overall Study|Lost to Follow-up|0|||
126416854|NCT02737475|454821027|FG009|Overall Study|Lost to Follow-up|0|||
126416855|NCT02737475|454821028|FG010|Overall Study|Lost to Follow-up|0|||
126054384|NCT02972034|453493880|FG009|Overall Study|Withdrawal by Subject|1|||
126416856|NCT02737475|454821029|FG011|Overall Study|Lost to Follow-up|0|||
126416857|NCT02737475|454821030|FG012|Overall Study|Lost to Follow-up|0|||
126054385|NCT02972034|453493881|FG010|Overall Study|Withdrawal by Subject|2|||
126054386|NCT02972034|453493882|FG011|Overall Study|Withdrawal by Subject|1|||
126416858|NCT02737475|454821031|FG013|Overall Study|Lost to Follow-up|0|||
126416859|NCT02737475|454821032|FG014|Overall Study|Lost to Follow-up|0|||
126416860|NCT02737475|454821033|FG015|Overall Study|Lost to Follow-up|1|||
126416861|NCT02737475|454821034|FG016|Overall Study|Lost to Follow-up|0|||
126416862|NCT02737475|454821035|FG017|Overall Study|Lost to Follow-up|0|||
126416863|NCT02737475|454821036|FG018|Overall Study|Lost to Follow-up|0|||
126416864|NCT02737475|454821037|FG019|Overall Study|Lost to Follow-up|0|||
126416865|NCT02737475|454821038|FG020|Overall Study|Lost to Follow-up|0|||
126416866|NCT02737475|454821039|FG021|Overall Study|Lost to Follow-up|0|||
126416867|NCT02737475|454821040|FG022|Overall Study|Lost to Follow-up|0|||
126416868|NCT02737475|454821041|FG023|Overall Study|Lost to Follow-up|0|||
126416869|NCT02737475|454821042|FG024|Overall Study|Lost to Follow-up|0|||
126054387|NCT02972034|453493883|FG012|Overall Study|Withdrawal by Subject|1|||
126054388|NCT02972034|453493884|FG013|Overall Study|Withdrawal by Subject|1|||
126054389|NCT02972034|453493885|FG014|Overall Study|Withdrawal by Subject|0|||
126054390|NCT02972034|453493871|FG000|Overall Study|Screen Failure|0|||
126054391|NCT02972034|453493872|FG001|Overall Study|Screen Failure|0|||
126054392|NCT02972034|453493873|FG002|Overall Study|Screen Failure|0|||
126054393|NCT02972034|453493874|FG003|Overall Study|Screen Failure|0|||
126054394|NCT02972034|453493875|FG004|Overall Study|Screen Failure|0|||
126416870|NCT02737475|454821043|FG025|Overall Study|Lost to Follow-up|0|||
126416871|NCT02737475|454821044|FG026|Overall Study|Lost to Follow-up|0|||
126416872|NCT02737475|454821018|FG000|Overall Study|Disease Progression|0|||
126416873|NCT02737475|454821019|FG001|Overall Study|Disease Progression|0|||
126416874|NCT02737475|454821020|FG002|Overall Study|Disease Progression|0|||
126416875|NCT02737475|454821021|FG003|Overall Study|Disease Progression|0|||
126416876|NCT02737475|454821022|FG004|Overall Study|Disease Progression|0|||
126416877|NCT02737475|454821023|FG005|Overall Study|Disease Progression|0|||
126416878|NCT02737475|454821024|FG006|Overall Study|Disease Progression|0|||
126416879|NCT02737475|454821025|FG007|Overall Study|Disease Progression|0|||
126416880|NCT02737475|454821026|FG008|Overall Study|Disease Progression|0|||
126416881|NCT02737475|454821027|FG009|Overall Study|Disease Progression|0|||
126416882|NCT02737475|454821028|FG010|Overall Study|Disease Progression|0|||
126416883|NCT02737475|454821029|FG011|Overall Study|Disease Progression|0|||
126416884|NCT02737475|454821030|FG012|Overall Study|Disease Progression|0|||
126416885|NCT02737475|454821031|FG013|Overall Study|Disease Progression|0|||
126416886|NCT02737475|454821032|FG014|Overall Study|Disease Progression|0|||
126416887|NCT02737475|454821033|FG015|Overall Study|Disease Progression|0|||
126416888|NCT02737475|454821034|FG016|Overall Study|Disease Progression|0|||
126416889|NCT02737475|454821035|FG017|Overall Study|Disease Progression|0|||
126416890|NCT02737475|454821036|FG018|Overall Study|Disease Progression|0|||
126416891|NCT02737475|454821037|FG019|Overall Study|Disease Progression|0|||
126416892|NCT02737475|454821038|FG020|Overall Study|Disease Progression|0|||
126416893|NCT02737475|454821039|FG021|Overall Study|Disease Progression|0|||
126416894|NCT02737475|454821040|FG022|Overall Study|Disease Progression|0|||
126416895|NCT02737475|454821041|FG023|Overall Study|Disease Progression|0|||
126416896|NCT02737475|454821042|FG024|Overall Study|Disease Progression|0|||
126416897|NCT02737475|454821043|FG025|Overall Study|Disease Progression|0|||
126416898|NCT02737475|454821044|FG026|Overall Study|Disease Progression|1|||
126416899|NCT00660179|454821046|FG000|Overall Study|Death|44|||
126416900|NCT00660179|454821047|FG001|Overall Study|Death|47|||
126416901|NCT00660179|454821048|FG002|Overall Study|Death|34|||
126416902|NCT00660179|454821046|FG000|Overall Study|Withdrawal of consent|4|||
126416903|NCT00660179|454821047|FG001|Overall Study|Withdrawal of consent|6|||
126416904|NCT00660179|454821048|FG002|Overall Study|Withdrawal of consent|4|||
126416905|NCT00660179|454821046|FG000|Overall Study|Lost to Follow-up|7|||
126416906|NCT00660179|454821047|FG001|Overall Study|Lost to Follow-up|5|||
126416907|NCT00660179|454821048|FG002|Overall Study|Lost to Follow-up|2|||
125891117|NCT02152956|452899715|FG008|Overall Study|Withdrawal by Subject|1|||
126054395|NCT02972034|453493876|FG005|Overall Study|Screen Failure|0|||
126054396|NCT02972034|453493877|FG006|Overall Study|Screen Failure|0|||
126054397|NCT02972034|453493878|FG007|Overall Study|Screen Failure|0|||
126416908|NCT00660179|454821046|FG000|Overall Study|Administrative reason|0|||
126416909|NCT00660179|454821047|FG001|Overall Study|Administrative reason|0|||
126054398|NCT02972034|453493879|FG008|Overall Study|Screen Failure|0|||
126054399|NCT02972034|453493880|FG009|Overall Study|Screen Failure|0|||
126054400|NCT02972034|453493881|FG010|Overall Study|Screen Failure|0|||
126054401|NCT02972034|453493882|FG011|Overall Study|Screen Failure|0|||
126416910|NCT00660179|454821048|FG002|Overall Study|Administrative reason|1|||
126416911|NCT00660179|454821046|FG000|Overall Study|Incorrect randomization|1|||
126416912|NCT00660179|454821047|FG001|Overall Study|Incorrect randomization|0|||
126416913|NCT00660179|454821048|FG002|Overall Study|Incorrect randomization|0|||
126416914|NCT01036321|454821049|FG000|Overall Study|Ineligible after randomization|0|||
126416915|NCT01036321|454821050|FG001|Overall Study|Ineligible after randomization|1|||
126416916|NCT01036321|454821049|FG000|Overall Study|Withdrawal by Subject|3|||
126416917|NCT01036321|454821050|FG001|Overall Study|Withdrawal by Subject|2|||
126416918|NCT01036321|454821049|FG000|Overall Study|Adverse Event|2|||
126416919|NCT01036321|454821050|FG001|Overall Study|Adverse Event|1|||
126416920|NCT00381693|454821053|FG000|Overall Study|Death|1|||
126416921|NCT00381693|454821053|FG000|Overall Study|Adverse Event|4|||
126416922|NCT00381693|454821053|FG000|Overall Study|Patient Choice|1|||
126416923|NCT00381693|454821053|FG000|Overall Study|Progression|2|||
126416924|NCT02506192|454821065|FG000|Overall Study|Withdrawal by Subject|1|||
126416925|NCT02506192|454821066|FG001|Overall Study|Withdrawal by Subject|1|||
126416926|NCT02221674|454821068|FG000|Overall Study|Lost to Follow-up|1|||
126416927|NCT02221674|454821069|FG001|Overall Study|Lost to Follow-up|0|||
126416928|NCT02221674|454821070|FG002|Overall Study|Lost to Follow-up|0|||
126416929|NCT05292131|454821071|FG000|Overall Study|Lost to Follow-up|1|||
126416930|NCT05292131|454821072|FG001|Overall Study|Lost to Follow-up|1|||
126416931|NCT05292131|454821071|FG000|Overall Study|Withdrawal by Subject|0|||
126416932|NCT05292131|454821072|FG001|Overall Study|Withdrawal by Subject|1|||
126416933|NCT04390880|454821074|FG000|Overall Study|Withdrawal by Subject|1|||
126416934|NCT02557542|454821075|FG000|Overall Study|Poor recruitment|3|||
126416935|NCT02557542|454821076|FG001|Overall Study|Poor recruitment|0|||
126416936|NCT06136897|454821077|FG000|Overall Study|Ineligible|3|||
126416937|NCT06136897|454821077|FG000|Overall Study|Mutation status not confirmed|7|||
126416938|NCT06136897|454821077|FG000|Overall Study|Adverse Event|2|||
126416939|NCT06136897|454821077|FG000|Overall Study|Death|1|||
126416940|NCT06136897|454821077|FG000|Overall Study|Disease progression|18|||
126416941|NCT06136897|454821077|FG000|Overall Study|Other complicating disease|1|||
126416942|NCT06136897|454821077|FG000|Overall Study|Withdrawal by Subject|1|||
126416943|NCT06136897|454821077|FG000|Overall Study|Still on treatment|1|||
126416944|NCT06136897|454821077|FG000|Overall Study|Lost to Follow-up|1|||
126416945|NCT03705559|454821078|FG000|Overall Study|COVID Shut down|1|||
126416946|NCT01979952|454821079|FG000|Overall Study|Adverse Event|4|||
126416947|NCT01979952|454821080|FG001|Overall Study|Adverse Event|5|||
126416948|NCT01979952|454821079|FG000|Overall Study|Protocol Violation|1|||
126416949|NCT01979952|454821080|FG001|Overall Study|Protocol Violation|0|||
126416950|NCT01979952|454821079|FG000|Overall Study|Withdrawal by Subject|2|||
126416951|NCT01979952|454821080|FG001|Overall Study|Withdrawal by Subject|1|||
126416952|NCT01979952|454821079|FG000|Overall Study|Other than specified above|1|||
126416953|NCT01979952|454821080|FG001|Overall Study|Other than specified above|0|||
126416954|NCT05438576|454821081|FG000|Overall Study|Death|1|||
126416955|NCT05438576|454821082|FG001|Overall Study|Death|1|||
126416956|NCT05438576|454821081|FG000|Overall Study|Withdrawal by Subject|4|||
126416957|NCT05438576|454821082|FG001|Overall Study|Withdrawal by Subject|2|||
126416958|NCT05438576|454821081|FG000|Overall Study|Not Eligible|2|||
126416959|NCT05438576|454821082|FG001|Overall Study|Not Eligible|1|||
126416960|NCT05438576|454821081|FG000|Overall Study|Did not complete baseline testing|22|||
126416961|NCT05438576|454821082|FG001|Overall Study|Did not complete baseline testing|4|||
126416962|NCT01067144|454821088|FG000|Treatment|Did not receive allocated intervention|4|||
126416963|NCT01067144|454821089|FG001|Treatment|Did not receive allocated intervention|7|||
126416964|NCT01067144|454821088|FG000|Follow-up|Lost to Follow-up|22|||
126416965|NCT01067144|454821089|FG001|Follow-up|Lost to Follow-up|12|||
126416966|NCT01067144|454821088|FG000|Follow-up|Censored owing to second surgery|19|||
126416967|NCT01067144|454821089|FG001|Follow-up|Censored owing to second surgery|28|||
126416968|NCT01067144|454821088|FG000|Follow-up|Withdrawal by Subject|18|||
126416969|NCT01067144|454821089|FG001|Follow-up|Withdrawal by Subject|14|||
126416970|NCT01067144|454821088|FG000|Follow-up|Surgery cancelled|0|||
126416971|NCT01067144|454821089|FG001|Follow-up|Surgery cancelled|1|||
126416972|NCT01067144|454821088|FG000|Follow-up|Death|0|||
126416973|NCT01067144|454821089|FG001|Follow-up|Death|1|||
126416974|NCT00203424|454821091|FG000|Treatment Period|Withdrawal by Subject|4|||
126416975|NCT00203424|454821091|FG000|Treatment Period|Adverse Event|5|||
126416976|NCT00203424|454821091|FG000|Treatment Period|progressive disease|2|||
126416977|NCT00203424|454821091|FG000|Follow-up Period|Withdrawal by Subject|1|||
126416978|NCT00203424|454821091|FG000|Follow-up Period|progressive disease|4|||
126416979|NCT00203424|454821091|FG000|Follow-up Period|Lost to Follow-up|1|||
126416980|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
126416981|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416982|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416983|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416984|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416985|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416986|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
126416987|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416988|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416989|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416990|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416991|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416992|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
126416993|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416994|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416995|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416996|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416997|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416998|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
126416999|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417000|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417001|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417002|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417003|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417004|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
126417005|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417006|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417007|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417008|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417009|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417010|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
126417011|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417012|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417013|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417014|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417015|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417016|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
126417017|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
126417018|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
126417019|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
126417020|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
126417021|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
126417022|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126417023|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
126417024|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
126417025|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
126417026|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
126417027|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126417028|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
126417029|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
126417030|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
126417031|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
126417032|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
126417033|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
126417034|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126417035|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
126417036|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
126417037|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
126417038|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
126417039|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
126417040|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126417041|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
126417042|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
126417043|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
126417044|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
126417045|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
126417046|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126417047|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
126417048|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126417049|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
126417050|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126417051|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
126417052|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
126417053|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
126417054|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
126417055|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
126417056|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
126417057|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
126417058|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126417059|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
126417060|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
126417061|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
126417062|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
126417063|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
126417064|NCT01824355|454821098|FG000|Overall Study|Adverse Event|2|||
126417065|NCT01824355|454821098|FG000|Overall Study|unevaluable reference method results per|1|||
126417066|NCT02576795|454821100|FG000|Overall Study|Lost to Follow-up|0|||
126417067|NCT02576795|454821101|FG001|Overall Study|Lost to Follow-up|0|||
126417068|NCT02576795|454821102|FG002|Overall Study|Lost to Follow-up|1|||
126417069|NCT02576795|454821103|FG003|Overall Study|Lost to Follow-up|0|||
126417070|NCT04427072|454821104|FG000|Randomized Treatment Phase|Progressive disease|9|||
126417071|NCT04427072|454821105|FG001|Randomized Treatment Phase|Progressive disease|4|||
126417072|NCT04427072|454821104|FG000|Randomized Treatment Phase|Adverse Event|3|||
126417073|NCT04427072|454821105|FG001|Randomized Treatment Phase|Adverse Event|1|||
126417074|NCT04427072|454821104|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
126417075|NCT04427072|454821105|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
126417076|NCT04427072|454821104|FG000|Randomized Treatment Phase|Death|0|||
126417077|NCT04427072|454821105|FG001|Randomized Treatment Phase|Death|1|||
126417078|NCT04427072|454821104|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
126417079|NCT04427072|454821105|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
126417080|NCT04427072|454821104|FG000|Extension Treatment Phase|Progressive disease|0|||
126417081|NCT04427072|454821105|FG001|Extension Treatment Phase|Progressive disease|5|||
126417082|NCT05232864|454821106|FG000|Overall Study|Adverse Event|0|||
126417083|NCT05232864|454821107|FG001|Overall Study|Adverse Event|1|||
126417084|NCT05232864|454821106|FG000|Overall Study|Study terminated by sponsor|16|||
126417085|NCT05232864|454821107|FG001|Overall Study|Study terminated by sponsor|14|||
126417086|NCT04765202|454821122|FG000|Overall Study|Lost to Follow-up|1|||
126417087|NCT04765202|454821123|FG001|Overall Study|Lost to Follow-up|1|||
126417088|NCT04765202|454821124|FG002|Overall Study|Lost to Follow-up|2|||
126417089|NCT04765202|454821125|FG003|Overall Study|Lost to Follow-up|2|||
126417090|NCT04765202|454821122|FG000|Overall Study|Physician Decision|0|||
126417091|NCT04765202|454821123|FG001|Overall Study|Physician Decision|0|||
126417092|NCT04765202|454821124|FG002|Overall Study|Physician Decision|1|||
126417093|NCT04765202|454821125|FG003|Overall Study|Physician Decision|1|||
126417094|NCT00465452|454821126|FG000|Overall Study|Adverse Event|1|||
126417095|NCT02104947|454821133|FG000|Overall Study|Withdrawal by Subject|10|||
126417096|NCT02104947|454821134|FG001|Overall Study|Withdrawal by Subject|3|||
126417097|NCT02104947|454821133|FG000|Overall Study|Lost to Follow-up|4|||
126417098|NCT02104947|454821134|FG001|Overall Study|Lost to Follow-up|4|||
126417099|NCT02104947|454821133|FG000|Overall Study|Protocol Violation|6|||
126417100|NCT02104947|454821134|FG001|Overall Study|Protocol Violation|8|||
126417101|NCT02104947|454821133|FG000|Overall Study|Adverse Event|57|||
126417102|NCT02104947|454821134|FG001|Overall Study|Adverse Event|38|||
126417103|NCT02104947|454821133|FG000|Overall Study|Other than stated above|2|||
126417104|NCT02104947|454821134|FG001|Overall Study|Other than stated above|3|||
126417105|NCT00145574|454821135|FG000|Double Blind|Adverse Event|0|||
126417106|NCT00145574|454821136|FG001|Double Blind|Adverse Event|3|||
126417107|NCT00145574|454821137|FG002|Double Blind|Adverse Event|1|||
126417108|NCT00145574|454821135|FG000|Double Blind|Withdrawal by Subject|1|||
126417109|NCT00145574|454821136|FG001|Double Blind|Withdrawal by Subject|1|||
126417110|NCT00145574|454821137|FG002|Double Blind|Withdrawal by Subject|1|||
126417111|NCT00145574|454821135|FG000|Double Blind|required restricted medicine|0|||
126417112|NCT00145574|454821136|FG001|Double Blind|required restricted medicine|1|||
126417113|NCT00145574|454821137|FG002|Double Blind|required restricted medicine|0|||
126417114|NCT00145574|454821135|FG000|Open Label Long-term Extension|Adverse Event|0|||
126417115|NCT00145574|454821136|FG001|Open Label Long-term Extension|Adverse Event|0|||
126417116|NCT00145574|454821137|FG002|Open Label Long-term Extension|Adverse Event|5|||
126417117|NCT00145574|454821135|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
126417118|NCT00145574|454821136|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
126417119|NCT00145574|454821137|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
126417120|NCT00145574|454821135|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
126417121|NCT00145574|454821136|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
126054402|NCT02972034|453493883|FG012|Overall Study|Screen Failure|1|||
126417122|NCT00145574|454821137|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
126417123|NCT00145574|454821135|FG000|Open Label Long-term Extension|required restricted medicine|0|||
126417124|NCT00145574|454821136|FG001|Open Label Long-term Extension|required restricted medicine|0|||
126417125|NCT00145574|454821137|FG002|Open Label Long-term Extension|required restricted medicine|1|||
126417126|NCT00858637|454821141|FG000|Active Comparison Phase|Adverse Event|14|||
126417127|NCT00858637|454821142|FG001|Active Comparison Phase|Adverse Event|0|||
126417128|NCT00858637|454821143|FG002|Active Comparison Phase|Adverse Event|0|||
126417129|NCT00858637|454821144|FG003|Active Comparison Phase|Adverse Event|9|||
126417130|NCT00858637|454821145|FG004|Active Comparison Phase|Adverse Event|0|||
126417131|NCT00858637|454821146|FG005|Active Comparison Phase|Adverse Event|0|||
126417132|NCT00858637|454821141|FG000|Active Comparison Phase|Death|1|||
126417133|NCT00858637|454821142|FG001|Active Comparison Phase|Death|0|||
126417134|NCT00858637|454821143|FG002|Active Comparison Phase|Death|0|||
126417135|NCT00858637|454821144|FG003|Active Comparison Phase|Death|1|||
126417136|NCT00858637|454821145|FG004|Active Comparison Phase|Death|0|||
126417137|NCT00858637|454821146|FG005|Active Comparison Phase|Death|0|||
126417138|NCT00858637|454821141|FG000|Active Comparison Phase|Physician Decision|1|||
126417139|NCT00858637|454821142|FG001|Active Comparison Phase|Physician Decision|0|||
126417140|NCT00858637|454821143|FG002|Active Comparison Phase|Physician Decision|0|||
126417141|NCT00858637|454821144|FG003|Active Comparison Phase|Physician Decision|1|||
126417142|NCT00858637|454821145|FG004|Active Comparison Phase|Physician Decision|0|||
126417143|NCT00858637|454821146|FG005|Active Comparison Phase|Physician Decision|0|||
126417144|NCT00858637|454821141|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
126417145|NCT00858637|454821142|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
126417146|NCT00858637|454821143|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
126417147|NCT00858637|454821144|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
126417148|NCT00858637|454821145|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
126417149|NCT00858637|454821146|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
126417150|NCT00858637|454821141|FG000|Active Comparison Phase|Other Reasons|1|||
126417151|NCT00858637|454821142|FG001|Active Comparison Phase|Other Reasons|0|||
126417152|NCT00858637|454821143|FG002|Active Comparison Phase|Other Reasons|0|||
126417153|NCT00858637|454821144|FG003|Active Comparison Phase|Other Reasons|1|||
126417154|NCT00858637|454821145|FG004|Active Comparison Phase|Other Reasons|0|||
126417155|NCT00858637|454821146|FG005|Active Comparison Phase|Other Reasons|0|||
126417156|NCT00858637|454821141|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
126417157|NCT00858637|454821142|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
126417158|NCT00858637|454821143|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
126417159|NCT00858637|454821144|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
126417160|NCT00858637|454821145|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
126417161|NCT00858637|454821146|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
126417162|NCT00858637|454821141|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417163|NCT00858637|454821142|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417164|NCT00858637|454821143|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417165|NCT00858637|454821144|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417166|NCT00858637|454821145|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417167|NCT00858637|454821146|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
126417168|NCT02305238|454821147|FG000|Overall Study|Death|2|||
126417169|NCT02305238|454821148|FG001|Overall Study|Death|1|||
126417170|NCT02305238|454821149|FG002|Overall Study|Death|0|||
126417171|NCT02305238|454821147|FG000|Overall Study|Progressive disease|4|||
126417172|NCT02305238|454821148|FG001|Overall Study|Progressive disease|4|||
126417173|NCT02305238|454821149|FG002|Overall Study|Progressive disease|0|||
126417174|NCT02305238|454821147|FG000|Overall Study|Logistical difficulties|1|||
126417175|NCT02305238|454821148|FG001|Overall Study|Logistical difficulties|3|||
126417176|NCT02305238|454821149|FG002|Overall Study|Logistical difficulties|0|||
126417177|NCT02305238|454821147|FG000|Overall Study|Protocol Violation|0|||
126417178|NCT02305238|454821148|FG001|Overall Study|Protocol Violation|3|||
126417179|NCT02305238|454821149|FG002|Overall Study|Protocol Violation|0|||
126417180|NCT02305238|454821147|FG000|Overall Study|Physician Decision|2|||
126417181|NCT02305238|454821148|FG001|Overall Study|Physician Decision|1|||
126417182|NCT02305238|454821149|FG002|Overall Study|Physician Decision|0|||
126417183|NCT02305238|454821147|FG000|Overall Study|Adverse Event|4|||
126417184|NCT02305238|454821148|FG001|Overall Study|Adverse Event|2|||
126417185|NCT02305238|454821149|FG002|Overall Study|Adverse Event|0|||
126417186|NCT02305238|454821147|FG000|Overall Study|Withdrawal by Subject|3|||
126417187|NCT02305238|454821148|FG001|Overall Study|Withdrawal by Subject|4|||
126417188|NCT02305238|454821149|FG002|Overall Study|Withdrawal by Subject|0|||
126417189|NCT02305238|454821147|FG000|Overall Study|Randomized failure|0|||
126417190|NCT02305238|454821148|FG001|Overall Study|Randomized failure|0|||
126417191|NCT02305238|454821149|FG002|Overall Study|Randomized failure|8|||
126417192|NCT02305238|454821147|FG000|Overall Study|Required procedure failed|0|||
126417193|NCT02305238|454821148|FG001|Overall Study|Required procedure failed|1|||
126417194|NCT02305238|454821149|FG002|Overall Study|Required procedure failed|0|||
126417195|NCT04677504|454821155|FG000|Overall Study|Death|51|||
126417196|NCT04677504|454821156|FG001|Overall Study|Death|49|||
126417197|NCT04677504|454821155|FG000|Overall Study|Progressive Disease|1|||
126417198|NCT04677504|454821156|FG001|Overall Study|Progressive Disease|0|||
126417199|NCT04677504|454821155|FG000|Overall Study|Symptomatic Deterioration|1|||
126417200|NCT04677504|454821156|FG001|Overall Study|Symptomatic Deterioration|0|||
126417201|NCT04677504|454821155|FG000|Overall Study|Withdrawal by Subject|2|||
126417202|NCT04677504|454821156|FG001|Overall Study|Withdrawal by Subject|5|||
126417203|NCT04677504|454821155|FG000|Overall Study|Study Terminated By Sponsor|28|||
126417204|NCT04677504|454821156|FG001|Overall Study|Study Terminated By Sponsor|24|||
126417205|NCT04677504|454821155|FG000|Overall Study|Adverse Event|0|||
126417206|NCT04677504|454821156|FG001|Overall Study|Adverse Event|1|||
126417207|NCT01371552|454821167|FG000|Part 1, First 3 Days|Inconvenience|0|||
126417208|NCT01371552|454821168|FG001|Part 1, First 3 Days|Inconvenience|0|||
126417209|NCT01371552|454821169|FG002|Part 1, First 3 Days|Inconvenience|1|||
126417210|NCT01371552|454821170|FG003|Part 1, First 3 Days|Inconvenience|0|||
126417211|NCT01371552|454821171|FG004|Part 1, First 3 Days|Inconvenience|0|||
126417212|NCT01371552|454821172|FG005|Part 1, First 3 Days|Inconvenience|0|||
126417213|NCT00167310|454821173|FG000|Overall Study|Protocol Violation|5|||
126417214|NCT00167310|454821174|FG001|Overall Study|Protocol Violation|3|||
126417215|NCT00167310|454821173|FG000|Overall Study|Withdrawal by Subject|3|||
126417216|NCT00167310|454821174|FG001|Overall Study|Withdrawal by Subject|7|||
126417217|NCT03543137|454821175|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
126417218|NCT03543137|454821176|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
126417219|NCT03543137|454821175|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
126417220|NCT03543137|454821176|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
126417221|NCT03543137|454821175|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
126417222|NCT03543137|454821176|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
126417223|NCT04072887|454821177|FG000|Overall Study|Withdrawal by Subject|3|||
126417224|NCT04072887|454821178|FG001|Overall Study|Withdrawal by Subject|8|||
126417225|NCT04072887|454821179|FG002|Overall Study|Withdrawal by Subject|1|||
126417226|NCT04072887|454821180|FG003|Overall Study|Withdrawal by Subject|3|||
126417227|NCT04072887|454821181|FG004|Overall Study|Withdrawal by Subject|3|||
126417228|NCT04072887|454821182|FG005|Overall Study|Withdrawal by Subject|13|||
126417229|NCT04072887|454821177|FG000|Overall Study|Adverse Event|2|||
126417230|NCT04072887|454821178|FG001|Overall Study|Adverse Event|4|||
126417231|NCT04072887|454821179|FG002|Overall Study|Adverse Event|1|||
126417232|NCT04072887|454821180|FG003|Overall Study|Adverse Event|4|||
126417233|NCT04072887|454821181|FG004|Overall Study|Adverse Event|0|||
126417234|NCT04072887|454821182|FG005|Overall Study|Adverse Event|1|||
126417235|NCT04072887|454821177|FG000|Overall Study|Physician Decision|2|||
126417236|NCT04072887|454821178|FG001|Overall Study|Physician Decision|0|||
126417237|NCT04072887|454821179|FG002|Overall Study|Physician Decision|0|||
126417238|NCT04072887|454821180|FG003|Overall Study|Physician Decision|0|||
126417239|NCT04072887|454821181|FG004|Overall Study|Physician Decision|0|||
126417240|NCT04072887|454821182|FG005|Overall Study|Physician Decision|1|||
126417241|NCT04072887|454821177|FG000|Overall Study|Lost to Follow-up|1|||
126417242|NCT04072887|454821178|FG001|Overall Study|Lost to Follow-up|3|||
126417243|NCT04072887|454821179|FG002|Overall Study|Lost to Follow-up|0|||
126417244|NCT04072887|454821180|FG003|Overall Study|Lost to Follow-up|0|||
126417245|NCT04072887|454821181|FG004|Overall Study|Lost to Follow-up|0|||
126417246|NCT04072887|454821182|FG005|Overall Study|Lost to Follow-up|0|||
126417247|NCT04072887|454821177|FG000|Overall Study|Death|0|||
126417248|NCT04072887|454821178|FG001|Overall Study|Death|2|||
126417249|NCT04072887|454821179|FG002|Overall Study|Death|0|||
126417250|NCT04072887|454821180|FG003|Overall Study|Death|2|||
126417251|NCT04072887|454821181|FG004|Overall Study|Death|3|||
126417252|NCT04072887|454821182|FG005|Overall Study|Death|0|||
126417253|NCT03193736|454821183|FG000|Overall Study|Death|2|||
126417254|NCT03193736|454821183|FG000|Overall Study|Withdrawal by Subject|1|||
126417255|NCT03193736|454821183|FG000|Overall Study|Lost to Follow-up|1|||
126417256|NCT03193736|454821183|FG000|Overall Study|implant not received|1|||
126417257|NCT00423449|454821184|FG000|Overall Study|Clinical Adverse Event|1|||
126417258|NCT00423449|454821185|FG001|Overall Study|Clinical Adverse Event|0|||
126417259|NCT00423449|454821186|FG002|Overall Study|Clinical Adverse Event|1|||
126417260|NCT00423449|454821187|FG003|Overall Study|Clinical Adverse Event|8|||
126417261|NCT00423449|454821188|FG004|Overall Study|Clinical Adverse Event|2|||
126417262|NCT00423449|454821184|FG000|Overall Study|Death|1|||
126417263|NCT00423449|454821185|FG001|Overall Study|Death|0|||
126417264|NCT00423449|454821186|FG002|Overall Study|Death|2|||
126417265|NCT00423449|454821187|FG003|Overall Study|Death|1|||
126417266|NCT00423449|454821188|FG004|Overall Study|Death|1|||
126417267|NCT00423449|454821184|FG000|Overall Study|Progressive Disease|1|||
126417268|NCT00423449|454821185|FG001|Overall Study|Progressive Disease|3|||
126417269|NCT00423449|454821186|FG002|Overall Study|Progressive Disease|8|||
126417270|NCT00423449|454821187|FG003|Overall Study|Progressive Disease|11|||
126417271|NCT00423449|454821188|FG004|Overall Study|Progressive Disease|4|||
126417272|NCT00423449|454821184|FG000|Overall Study|Laboratory Adverse Event|0|||
126417273|NCT00423449|454821185|FG001|Overall Study|Laboratory Adverse Event|1|||
126417274|NCT00423449|454821186|FG002|Overall Study|Laboratory Adverse Event|2|||
126417275|NCT00423449|454821187|FG003|Overall Study|Laboratory Adverse Event|0|||
126417276|NCT00423449|454821188|FG004|Overall Study|Laboratory Adverse Event|0|||
126417277|NCT00423449|454821184|FG000|Overall Study|Other|0|||
126417278|NCT00423449|454821185|FG001|Overall Study|Other|0|||
126417279|NCT00423449|454821186|FG002|Overall Study|Other|0|||
126417280|NCT00423449|454821187|FG003|Overall Study|Other|1|||
126417281|NCT00423449|454821188|FG004|Overall Study|Other|0|||
126417282|NCT00423449|454821184|FG000|Overall Study|Protocol Violation|0|||
126417283|NCT00423449|454821185|FG001|Overall Study|Protocol Violation|0|||
126417284|NCT00423449|454821186|FG002|Overall Study|Protocol Violation|2|||
126417285|NCT00423449|454821187|FG003|Overall Study|Protocol Violation|1|||
126417286|NCT00423449|454821188|FG004|Overall Study|Protocol Violation|0|||
126417287|NCT02697435|454821189|FG000|Overall Study|Withdrawal by Subject|1|||
126417288|NCT02697435|454821190|FG001|Overall Study|Withdrawal by Subject|0|||
126417289|NCT02697435|454821189|FG000|Overall Study|Physician Decision|0|||
126417290|NCT02697435|454821190|FG001|Overall Study|Physician Decision|4|||
126417291|NCT04371666|454821197|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
126417292|NCT04371666|454821198|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
126417293|NCT04371666|454821197|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
126417294|NCT04371666|454821198|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
126417295|NCT04371666|454821197|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
126417296|NCT04371666|454821198|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
126417297|NCT04371666|454821197|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
126417298|NCT04371666|454821198|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
126417299|NCT04371666|454821197|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
126417300|NCT04371666|454821198|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
126417301|NCT04371666|454821197|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
126417302|NCT04371666|454821198|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
126417303|NCT01445080|454821199|FG000|Overall Study|Adverse Event|5|||
126417304|NCT01445080|454821200|FG001|Overall Study|Adverse Event|3|||
126417305|NCT01445080|454821201|FG002|Overall Study|Adverse Event|11|||
126417306|NCT01445080|454821202|FG003|Overall Study|Adverse Event|6|||
126417307|NCT01445080|454821203|FG004|Overall Study|Adverse Event|2|||
126417308|NCT01445080|454821204|FG005|Overall Study|Adverse Event|3|||
125891118|NCT02152956|452899716|FG009|Overall Study|Withdrawal by Subject|0|||
125891119|NCT02152956|452899717|FG010|Overall Study|Withdrawal by Subject|0|||
126417309|NCT01445080|454821205|FG006|Overall Study|Adverse Event|0|||
126417310|NCT01445080|454821206|FG007|Overall Study|Adverse Event|3|||
126417311|NCT01445080|454821207|FG008|Overall Study|Adverse Event|10|||
126417312|NCT01445080|454821199|FG000|Overall Study|Physician Decision|0|||
126417313|NCT01445080|454821200|FG001|Overall Study|Physician Decision|0|||
126417314|NCT01445080|454821201|FG002|Overall Study|Physician Decision|1|||
126417315|NCT01445080|454821202|FG003|Overall Study|Physician Decision|0|||
126417316|NCT01445080|454821203|FG004|Overall Study|Physician Decision|0|||
126417317|NCT01445080|454821204|FG005|Overall Study|Physician Decision|3|||
126417318|NCT01445080|454821205|FG006|Overall Study|Physician Decision|2|||
126417319|NCT01445080|454821206|FG007|Overall Study|Physician Decision|2|||
126417320|NCT01445080|454821207|FG008|Overall Study|Physician Decision|0|||
126417321|NCT01445080|454821199|FG000|Overall Study|Withdrawal by Subject|1|||
126417322|NCT01445080|454821200|FG001|Overall Study|Withdrawal by Subject|0|||
126417323|NCT01445080|454821201|FG002|Overall Study|Withdrawal by Subject|0|||
126417324|NCT01445080|454821202|FG003|Overall Study|Withdrawal by Subject|1|||
126417325|NCT01445080|454821203|FG004|Overall Study|Withdrawal by Subject|0|||
126417326|NCT01445080|454821204|FG005|Overall Study|Withdrawal by Subject|0|||
126417327|NCT01445080|454821205|FG006|Overall Study|Withdrawal by Subject|0|||
126417328|NCT01445080|454821206|FG007|Overall Study|Withdrawal by Subject|0|||
126417329|NCT01445080|454821207|FG008|Overall Study|Withdrawal by Subject|2|||
126417330|NCT01445080|454821199|FG000|Overall Study|Ineligible/Inevaluable|1|||
126417331|NCT01445080|454821200|FG001|Overall Study|Ineligible/Inevaluable|2|||
126417332|NCT01445080|454821201|FG002|Overall Study|Ineligible/Inevaluable|0|||
126417333|NCT01445080|454821202|FG003|Overall Study|Ineligible/Inevaluable|1|||
126417334|NCT01445080|454821203|FG004|Overall Study|Ineligible/Inevaluable|2|||
126417335|NCT01445080|454821204|FG005|Overall Study|Ineligible/Inevaluable|3|||
126417336|NCT01445080|454821205|FG006|Overall Study|Ineligible/Inevaluable|0|||
126417337|NCT01445080|454821206|FG007|Overall Study|Ineligible/Inevaluable|0|||
126417338|NCT01445080|454821207|FG008|Overall Study|Ineligible/Inevaluable|6|||
126417339|NCT00445770|454821208|FG000|Overall Study|Adverse Event|9|||
126417340|NCT00445770|454821209|FG001|Overall Study|Adverse Event|15|||
126417341|NCT00445770|454821210|FG002|Overall Study|Adverse Event|19|||
126417342|NCT00445770|454821208|FG000|Overall Study|Lack of Efficacy|38|||
126417343|NCT00445770|454821209|FG001|Overall Study|Lack of Efficacy|13|||
126417344|NCT00445770|454821210|FG002|Overall Study|Lack of Efficacy|6|||
126417345|NCT00445770|454821208|FG000|Overall Study|Lost to Follow-up|0|||
126417346|NCT00445770|454821209|FG001|Overall Study|Lost to Follow-up|2|||
126417347|NCT00445770|454821210|FG002|Overall Study|Lost to Follow-up|0|||
126417348|NCT00445770|454821208|FG000|Overall Study|Other|6|||
126417349|NCT00445770|454821209|FG001|Overall Study|Other|5|||
126417350|NCT00445770|454821210|FG002|Overall Study|Other|6|||
126417351|NCT03857542|454821211|FG000|Overall Study|Adverse Event|1|||
126417352|NCT03857542|454821212|FG001|Overall Study|Adverse Event|3|||
125891120|NCT02152956|452899718|FG011|Overall Study|Withdrawal by Subject|4|||
126417353|NCT03857542|454821211|FG000|Overall Study|Withdrawal by Subject|2|||
126417354|NCT03857542|454821212|FG001|Overall Study|Withdrawal by Subject|1|||
126417355|NCT03857542|454821211|FG000|Overall Study|Lost to Follow-up|2|||
126417356|NCT03857542|454821212|FG001|Overall Study|Lost to Follow-up|1|||
126417357|NCT03857542|454821211|FG000|Overall Study|Reason not Specified|1|||
126417358|NCT03857542|454821212|FG001|Overall Study|Reason not Specified|0|||
126417359|NCT02123576|454821213|FG000|Overall Study|Adverse Event|1|||
126417360|NCT02123576|454821214|FG001|Overall Study|Adverse Event|0|||
126417361|NCT00934128|454821215|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
126417362|NCT00934128|454821216|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
126417363|NCT00934128|454821215|FG000|First Intervention (2 Hours)|Adverse Event|4|||
126417364|NCT00934128|454821216|FG001|First Intervention (2 Hours)|Adverse Event|1|||
126417365|NCT00934128|454821215|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
126417366|NCT00934128|454821216|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
126417367|NCT00934128|454821215|FG000|Washout Period (1 Hour)|Patient preference|1|||
126417368|NCT00934128|454821216|FG001|Washout Period (1 Hour)|Patient preference|3|||
126417369|NCT00934128|454821215|FG000|Washout Period (1 Hour)|Pain|1|||
126417370|NCT00934128|454821216|FG001|Washout Period (1 Hour)|Pain|0|||
126417371|NCT00934128|454821215|FG000|Washout Period (1 Hour)|Too tired|1|||
126417372|NCT00934128|454821216|FG001|Washout Period (1 Hour)|Too tired|0|||
126417373|NCT00934128|454821215|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
126417374|NCT00934128|454821216|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
126417375|NCT00934128|454821215|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
126417376|NCT00934128|454821216|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
126417377|NCT01946152|454822833|FG000|Overall Study|Adverse Event|1|||
126417378|NCT01946152|454822834|FG001|Overall Study|Adverse Event|0|||
126417379|NCT01946152|454822835|FG002|Overall Study|Adverse Event|0|||
126417380|NCT01946152|454822836|FG003|Overall Study|Adverse Event|0|||
126417381|NCT01946152|454822833|FG000|Overall Study|Withdrawal by Subject|0|||
126417382|NCT01946152|454822834|FG001|Overall Study|Withdrawal by Subject|2|||
126417383|NCT01946152|454822835|FG002|Overall Study|Withdrawal by Subject|0|||
126417384|NCT01946152|454822836|FG003|Overall Study|Withdrawal by Subject|0|||
126417385|NCT01946152|454822833|FG000|Overall Study|Progression|0|||
126417386|NCT01946152|454822834|FG001|Overall Study|Progression|1|||
126417387|NCT01946152|454822835|FG002|Overall Study|Progression|4|||
126417388|NCT01946152|454822836|FG003|Overall Study|Progression|7|||
126417389|NCT01946152|454822833|FG000|Overall Study|Physician Decision|0|||
126417390|NCT01946152|454822834|FG001|Overall Study|Physician Decision|0|||
126417391|NCT01946152|454822835|FG002|Overall Study|Physician Decision|1|||
126417392|NCT01946152|454822836|FG003|Overall Study|Physician Decision|0|||
126417393|NCT01946152|454822833|FG000|Overall Study|Second malignancy|0|||
126417394|NCT01946152|454822834|FG001|Overall Study|Second malignancy|0|||
126417395|NCT01946152|454822835|FG002|Overall Study|Second malignancy|1|||
126417396|NCT01946152|454822836|FG003|Overall Study|Second malignancy|0|||
126417397|NCT01946152|454822833|FG000|Overall Study|Adverse Event|0|||
126417398|NCT01946152|454822834|FG001|Overall Study|Adverse Event|0|||
126417399|NCT01946152|454822835|FG002|Overall Study|Adverse Event|0|||
126417400|NCT01946152|454822836|FG003|Overall Study|Adverse Event|1|||
126417401|NCT01698814|454822837|FG000|Overall Study|Adverse Event|0|||
126417402|NCT01698814|454822838|FG001|Overall Study|Adverse Event|2|||
126417403|NCT01698814|454822837|FG000|Overall Study|Lost to Follow-up|0|||
126417404|NCT01698814|454822838|FG001|Overall Study|Lost to Follow-up|1|||
126417405|NCT01698814|454822837|FG000|Overall Study|Pregnancy|1|||
126417406|NCT01698814|454822838|FG001|Overall Study|Pregnancy|0|||
126417407|NCT01698814|454822837|FG000|Overall Study|Randomized in error|1|||
126417408|NCT01698814|454822838|FG001|Overall Study|Randomized in error|0|||
126417409|NCT01061359|454822843|FG000|Overall Study|Death|32|||
126417410|NCT01061359|454822843|FG000|Overall Study|Lost to Follow-up|1072|||
126417411|NCT01061359|454822843|FG000|Overall Study|Relapse|187|||
126417412|NCT01061359|454822843|FG000|Overall Study|Secondary neoplasm|11|||
126417413|NCT04014062|454822844|FG000|Period I: Dosing|Medical Grounds|4|||
126417414|NCT04014062|454822845|FG001|Period I: Dosing|Medical Grounds|5|||
126417415|NCT04014062|454822844|FG000|Period I: Dosing|Withdrawal by Subject|3|||
126417416|NCT04014062|454822845|FG001|Period I: Dosing|Withdrawal by Subject|1|||
126417417|NCT03038126|454822846|FG000|Overall Study|Death|1|||
126417418|NCT03038126|454822847|FG001|Overall Study|Death|1|||
126417419|NCT03038126|454822846|FG000|Overall Study|Withdrawal by Subject|5|||
126417420|NCT03038126|454822847|FG001|Overall Study|Withdrawal by Subject|0|||
126417421|NCT03038126|454822846|FG000|Overall Study|Lost to Follow-up|0|||
126417422|NCT03038126|454822847|FG001|Overall Study|Lost to Follow-up|1|||
126417423|NCT03038126|454822846|FG000|Overall Study|Long Term Hospitalization|2|||
126417424|NCT03038126|454822847|FG001|Overall Study|Long Term Hospitalization|0|||
126417425|NCT03038126|454822846|FG000|Overall Study|Too Ill to Participate|1|||
126417426|NCT03038126|454822847|FG001|Overall Study|Too Ill to Participate|2|||
126417427|NCT01724866|454822848|FG000|Overall Study|Adverse Event|0|||
126417428|NCT01724866|454822849|FG001|Overall Study|Adverse Event|0|||
126417429|NCT01724866|454822850|FG002|Overall Study|Adverse Event|1|||
126417430|NCT01724866|454822851|FG003|Overall Study|Adverse Event|1|||
126417431|NCT01724866|454822848|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
126417432|NCT01724866|454822849|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
126417433|NCT01724866|454822850|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
126417434|NCT01724866|454822851|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
126417435|NCT01724866|454822848|FG000|Overall Study|Investigator's Discretion|0|||
126417436|NCT01724866|454822849|FG001|Overall Study|Investigator's Discretion|1|||
126417437|NCT01724866|454822850|FG002|Overall Study|Investigator's Discretion|1|||
126417438|NCT01724866|454822851|FG003|Overall Study|Investigator's Discretion|0|||
126417439|NCT01724866|454822848|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
126417440|NCT01724866|454822849|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
126417441|NCT01724866|454822850|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
126417442|NCT01724866|454822851|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
126417443|NCT01724866|454822848|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
126417444|NCT01724866|454822849|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
126417445|NCT01724866|454822850|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
126417446|NCT01724866|454822851|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
126417447|NCT01424501|454822852|FG000|Overall Study|Withdrawal by Subject|1|||
126417448|NCT01424501|454822853|FG001|Overall Study|Withdrawal by Subject|0|||
126417449|NCT01424501|454822854|FG002|Overall Study|Withdrawal by Subject|1|||
126417450|NCT01424501|454822855|FG003|Overall Study|Withdrawal by Subject|0|||
126417451|NCT01424501|454822856|FG004|Overall Study|Withdrawal by Subject|0|||
126417452|NCT01424501|454822857|FG005|Overall Study|Withdrawal by Subject|0|||
126417453|NCT01424501|454822852|FG000|Overall Study|Lost to Follow-up|0|||
126417454|NCT01424501|454822853|FG001|Overall Study|Lost to Follow-up|1|||
126417455|NCT01424501|454822854|FG002|Overall Study|Lost to Follow-up|1|||
126417456|NCT01424501|454822855|FG003|Overall Study|Lost to Follow-up|0|||
126417457|NCT01424501|454822856|FG004|Overall Study|Lost to Follow-up|0|||
126417458|NCT01424501|454822857|FG005|Overall Study|Lost to Follow-up|0|||
126417459|NCT01980095|454822858|FG000|Overall Study|Lost to Follow-up|6|||
126417460|NCT01980095|454822859|FG001|Overall Study|Lost to Follow-up|7|||
126417461|NCT01980095|454822858|FG000|Overall Study|Withdrawal by Subject|2|||
126417462|NCT01980095|454822859|FG001|Overall Study|Withdrawal by Subject|3|||
126417463|NCT01980095|454822858|FG000|Overall Study|Poor compliance|5|||
126417464|NCT01980095|454822859|FG001|Overall Study|Poor compliance|0|||
126417465|NCT01980095|454822858|FG000|Overall Study|Safety issue|0|||
126417466|NCT01980095|454822859|FG001|Overall Study|Safety issue|1|||
126417467|NCT01980095|454822858|FG000|Overall Study|Study drug discontinued|1|||
126417468|NCT01980095|454822859|FG001|Overall Study|Study drug discontinued|0|||
126417469|NCT01980095|454822858|FG000|Overall Study|Randomized by mistake|1|||
126417470|NCT01980095|454822859|FG001|Overall Study|Randomized by mistake|0|||
126417471|NCT02974257|454822863|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
126417472|NCT02974257|454822864|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
126417473|NCT02974257|454822863|FG000|Overall Study|Clinical indication for thiamine|1|||
126417474|NCT02974257|454822864|FG001|Overall Study|Clinical indication for thiamine|0|||
126417475|NCT02974257|454822863|FG000|Overall Study|Already on thiamine|1|||
126417476|NCT02974257|454822864|FG001|Overall Study|Already on thiamine|0|||
126417477|NCT02974257|454822863|FG000|Overall Study|Extubated prior to study drug|0|||
126417478|NCT02974257|454822864|FG001|Overall Study|Extubated prior to study drug|1|||
126417479|NCT02974257|454822863|FG000|Overall Study|Death|0|||
126417480|NCT02974257|454822864|FG001|Overall Study|Death|1|||
126417481|NCT02837029|454822865|FG000|Screening|Failed to meet screening requirements.|7|||
126417482|NCT02837029|454822866|FG001|Screening|Failed to meet screening requirements.|3|||
126417483|NCT02837029|454822867|FG002|Screening|Failed to meet screening requirements.|0|||
126417484|NCT02837029|454822865|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
126417485|NCT02837029|454822866|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
126417486|NCT02837029|454822867|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
126417487|NCT02837029|454822865|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
126417488|NCT02837029|454822866|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
126417489|NCT02837029|454822867|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
126417490|NCT02837029|454822865|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
126417491|NCT02837029|454822866|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
126417492|NCT02837029|454822867|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
126417493|NCT02837029|454822865|FG000|Cycle 2 and Beyond|Adverse Event|1|||
126417494|NCT02837029|454822866|FG001|Cycle 2 and Beyond|Adverse Event|0|||
126417495|NCT02837029|454822867|FG002|Cycle 2 and Beyond|Adverse Event|0|||
126417496|NCT02837029|454822865|FG000|2 Year Follow-up|Death|6|||
126417497|NCT02837029|454822866|FG001|2 Year Follow-up|Death|7|||
126417498|NCT02837029|454822867|FG002|2 Year Follow-up|Death|0|||
126417499|NCT00398567|454822868|FG000|Overall Study|Disease Progression|3|||
126417500|NCT00398567|454822869|FG001|Overall Study|Disease Progression|4|||
126417501|NCT00398567|454822870|FG002|Overall Study|Disease Progression|27|||
126417502|NCT00398567|454822868|FG000|Overall Study|Withdrawal by Subject|1|||
126417503|NCT00398567|454822869|FG001|Overall Study|Withdrawal by Subject|0|||
126417504|NCT00398567|454822870|FG002|Overall Study|Withdrawal by Subject|4|||
126417505|NCT00398567|454822868|FG000|Overall Study|Adverse Event|0|||
126417506|NCT00398567|454822869|FG001|Overall Study|Adverse Event|0|||
126417507|NCT00398567|454822870|FG002|Overall Study|Adverse Event|2|||
126417508|NCT00398567|454822868|FG000|Overall Study|Protocol Violation|0|||
126417509|NCT00398567|454822869|FG001|Overall Study|Protocol Violation|0|||
126417510|NCT00398567|454822870|FG002|Overall Study|Protocol Violation|1|||
126417511|NCT02034877|454822871|FG000|Overall Study|Lost to Follow-up|0|||
126417512|NCT02034877|454822872|FG001|Overall Study|Lost to Follow-up|3|||
126417513|NCT02034877|454822871|FG000|Overall Study|No Longer Willing to Participate|0|||
126417514|NCT02034877|454822872|FG001|Overall Study|No Longer Willing to Participate|3|||
126417515|NCT04426318|454822875|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
126417516|NCT04426318|454822876|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
126417517|NCT04273893|454822877|FG000|Overall Study|Withdrawal by Subject|0|||
126417518|NCT04273893|454822878|FG001|Overall Study|Withdrawal by Subject|2|||
126417519|NCT04273893|454822877|FG000|Overall Study|Treatment of Disease Progression|0|||
126417520|NCT04273893|454822878|FG001|Overall Study|Treatment of Disease Progression|2|||
126417521|NCT04273893|454822877|FG000|Overall Study|Death|1|||
126417522|NCT04273893|454822878|FG001|Overall Study|Death|2|||
126417523|NCT04273893|454822877|FG000|Overall Study|Lost to Follow-up|0|||
126417524|NCT04273893|454822878|FG001|Overall Study|Lost to Follow-up|2|||
126417525|NCT04273893|454822877|FG000|Overall Study|Physician Decision|1|||
126417526|NCT04273893|454822878|FG001|Overall Study|Physician Decision|0|||
126417527|NCT03906071|454822879|FG000|Overall Study|Death|180|||
126417528|NCT03906071|454822880|FG001|Overall Study|Death|185|||
126417529|NCT03906071|454822879|FG000|Overall Study|Lost to Follow-up|3|||
126417530|NCT03906071|454822880|FG001|Overall Study|Lost to Follow-up|3|||
126417531|NCT03906071|454822879|FG000|Overall Study|Withdrawal by Subject|15|||
126417532|NCT03906071|454822880|FG001|Overall Study|Withdrawal by Subject|27|||
126417533|NCT03906071|454822879|FG000|Overall Study|Other|2|||
126417534|NCT03906071|454822880|FG001|Overall Study|Other|1|||
126417535|NCT01564732|454822893|FG000|Overall Study|Early termination by the study sponsor|6|||
126417536|NCT01564732|454822894|FG001|Overall Study|Early termination by the study sponsor|5|||
126417537|NCT01957202|454822897|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417538|NCT01957202|454822898|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
126417539|NCT01957202|454822899|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417540|NCT01957202|454822900|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417541|NCT01957202|454822901|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417542|NCT01957202|454822902|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417543|NCT01957202|454822903|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417544|NCT01957202|454822904|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417545|NCT01957202|454822905|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417546|NCT01957202|454822906|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417547|NCT01957202|454822907|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417548|NCT01957202|454822908|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417549|NCT01957202|454822909|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417550|NCT01957202|454822910|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417551|NCT01957202|454822911|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417552|NCT01957202|454822912|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417553|NCT01957202|454822913|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
126417554|NCT01957202|454822914|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417555|NCT01957202|454822897|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417556|NCT01957202|454822898|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417557|NCT01957202|454822899|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417558|NCT01957202|454822900|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417559|NCT01957202|454822901|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417560|NCT01957202|454822902|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417561|NCT01957202|454822903|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417562|NCT01957202|454822904|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417563|NCT01957202|454822905|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417564|NCT01957202|454822906|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417565|NCT01957202|454822907|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417566|NCT01957202|454822908|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417567|NCT01957202|454822909|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417568|NCT01957202|454822910|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417569|NCT01957202|454822911|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417570|NCT01957202|454822912|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417571|NCT01957202|454822913|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
126417572|NCT01957202|454822914|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417573|NCT02598297|454822915|FG000|Overall Study|Study terminated by Sponsor|21|||
126417574|NCT02598297|454822916|FG001|Overall Study|Study terminated by Sponsor|23|||
126417575|NCT02598297|454822915|FG000|Overall Study|Adverse Event|1|||
126417576|NCT02598297|454822916|FG001|Overall Study|Adverse Event|1|||
126417577|NCT02598297|454822915|FG000|Overall Study|Physician Decision|1|||
126417578|NCT02598297|454822916|FG001|Overall Study|Physician Decision|0|||
126417579|NCT02598297|454822915|FG000|Overall Study|Subject/guardian decision|1|||
126417580|NCT02598297|454822916|FG001|Overall Study|Subject/guardian decision|0|||
126417581|NCT02598297|454822915|FG000|Overall Study|Followed for survival|1|||
126417582|NCT02598297|454822916|FG001|Overall Study|Followed for survival|0|||
126417583|NCT00394706|454822918|FG000|Overall Study|Withdrawal by Subject|2|||
126417584|NCT00394706|454822919|FG001|Overall Study|Withdrawal by Subject|0|||
126417585|NCT00394706|454822920|FG002|Overall Study|Withdrawal by Subject|1|||
126417586|NCT00394706|454822921|FG003|Overall Study|Withdrawal by Subject|0|||
126417587|NCT00394706|454822922|FG004|Overall Study|Withdrawal by Subject|0|||
126417588|NCT00394706|454822923|FG005|Overall Study|Withdrawal by Subject|2|||
126417589|NCT00394706|454822924|FG006|Overall Study|Withdrawal by Subject|1|||
126417590|NCT00394706|454822925|FG007|Overall Study|Withdrawal by Subject|0|||
126417591|NCT00394706|454822918|FG000|Overall Study|Lost to Follow-up|2|||
126417592|NCT00394706|454822919|FG001|Overall Study|Lost to Follow-up|2|||
126417593|NCT00394706|454822920|FG002|Overall Study|Lost to Follow-up|8|||
126417594|NCT00394706|454822921|FG003|Overall Study|Lost to Follow-up|1|||
126417595|NCT00394706|454822922|FG004|Overall Study|Lost to Follow-up|2|||
126417596|NCT00394706|454822923|FG005|Overall Study|Lost to Follow-up|5|||
126417597|NCT00394706|454822924|FG006|Overall Study|Lost to Follow-up|2|||
126417598|NCT00394706|454822925|FG007|Overall Study|Lost to Follow-up|0|||
126417599|NCT02003534|454822928|FG000|Overall Study|Lost to Follow-up|47|||
126417600|NCT03534141|454822929|FG000|Overall Study|Enrolled in other clinical trial|1|||
126417601|NCT03534141|454822930|FG001|Overall Study|Enrolled in other clinical trial|0|||
126417602|NCT03534141|454822929|FG000|Overall Study|Liver transplant aborted after randomization|0|||
126417603|NCT03534141|454822930|FG001|Overall Study|Liver transplant aborted after randomization|2|||
126417604|NCT03534141|454822929|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
126417605|NCT03534141|454822930|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
126417606|NCT03785405|454822934|FG000|Overall Study|Adverse Event|16|||
126417607|NCT03785405|454822935|FG001|Overall Study|Adverse Event|1|||
126417608|NCT03785405|454822934|FG000|Overall Study|Death|6|||
126417609|NCT03785405|454822935|FG001|Overall Study|Death|4|||
126417610|NCT03785405|454822934|FG000|Overall Study|Guardian decision|4|||
126417611|NCT03785405|454822935|FG001|Overall Study|Guardian decision|1|||
126417612|NCT03785405|454822934|FG000|Overall Study|Lost to Follow-up|1|||
126417613|NCT03785405|454822935|FG001|Overall Study|Lost to Follow-up|0|||
126417614|NCT03785405|454822934|FG000|Overall Study|Physician Decision|8|||
126417615|NCT03785405|454822935|FG001|Overall Study|Physician Decision|5|||
126417616|NCT03785405|454822934|FG000|Overall Study|Participant decision|2|||
126417617|NCT03785405|454822935|FG001|Overall Study|Participant decision|0|||
126417618|NCT03785405|454822934|FG000|Overall Study|Other|1|||
126417619|NCT03785405|454822935|FG001|Overall Study|Other|0|||
126417620|NCT03785405|454822934|FG000|Overall Study|No treatment was received|0|||
126417621|NCT03785405|454822935|FG001|Overall Study|No treatment was received|1|||
126417622|NCT02881762|454822938|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126417623|NCT02881762|454822939|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126417624|NCT01922271|454822942|FG000|WASHOUT Period|Withdrawal by Subject|1|||
126417625|NCT01922271|454822943|FG001|WASHOUT Period|Withdrawal by Subject|0|||
126417626|NCT01635855|454822950|FG000|Overall Study|Withdrawal by Subject|4|||
126417627|NCT03828019|454822951|FG000|Overall Study|Withdrawal by Subject|3|||
126417628|NCT03828019|454822952|FG001|Overall Study|Withdrawal by Subject|8|||
126417629|NCT03828019|454822951|FG000|Overall Study|Lost to Follow-up|1|||
126417630|NCT03828019|454822952|FG001|Overall Study|Lost to Follow-up|6|||
126417631|NCT03828019|454822951|FG000|Overall Study|Incarcerated|1|||
126417632|NCT03828019|454822952|FG001|Overall Study|Incarcerated|0|||
126417633|NCT03828019|454822951|FG000|Overall Study|Adverse Event|0|||
126417634|NCT03828019|454822952|FG001|Overall Study|Adverse Event|1|||
126417635|NCT03400176|454822953|FG000|Dose Escalation|Progressive disease|1|||
126417636|NCT03400176|454822954|FG001|Dose Escalation|Progressive disease|1|||
126417637|NCT03400176|454822955|FG002|Dose Escalation|Progressive disease|0|||
126417638|NCT03400176|454822956|FG003|Dose Escalation|Progressive disease|0|||
126417639|NCT03400176|454822957|FG004|Dose Escalation|Progressive disease|1|||
126417640|NCT03400176|454822953|FG000|Dose Escalation|Patient decision|0|||
126417641|NCT03400176|454822954|FG001|Dose Escalation|Patient decision|0|||
126417642|NCT03400176|454822955|FG002|Dose Escalation|Patient decision|0|||
126417643|NCT03400176|454822956|FG003|Dose Escalation|Patient decision|0|||
126417644|NCT03400176|454822957|FG004|Dose Escalation|Patient decision|1|||
126417645|NCT03400176|454822953|FG000|Dose Expansion|Patient decision|0|||
126417646|NCT03400176|454822954|FG001|Dose Expansion|Patient decision|0|||
126417647|NCT03400176|454822955|FG002|Dose Expansion|Patient decision|0|||
126417648|NCT03400176|454822956|FG003|Dose Expansion|Patient decision|1|||
126417649|NCT03400176|454822957|FG004|Dose Expansion|Patient decision|0|||
126417650|NCT03400176|454822953|FG000|Dose Expansion|Adverse Event|0|||
126417651|NCT03400176|454822954|FG001|Dose Expansion|Adverse Event|0|||
126417652|NCT03400176|454822955|FG002|Dose Expansion|Adverse Event|0|||
126417653|NCT03400176|454822956|FG003|Dose Expansion|Adverse Event|1|||
126417654|NCT03400176|454822957|FG004|Dose Expansion|Adverse Event|0|||
126417655|NCT03400176|454822953|FG000|Dose Expansion|Physician Decision|0|||
126417656|NCT03400176|454822954|FG001|Dose Expansion|Physician Decision|0|||
126417657|NCT03400176|454822955|FG002|Dose Expansion|Physician Decision|0|||
126417658|NCT03400176|454822956|FG003|Dose Expansion|Physician Decision|1|||
126417659|NCT03400176|454822957|FG004|Dose Expansion|Physician Decision|0|||
126417660|NCT03400176|454822953|FG000|Dose Expansion|Progressive disease|0|||
126417661|NCT03400176|454822954|FG001|Dose Expansion|Progressive disease|0|||
126417662|NCT03400176|454822955|FG002|Dose Expansion|Progressive disease|1|||
126417663|NCT03400176|454822956|FG003|Dose Expansion|Progressive disease|1|||
126417664|NCT03400176|454822957|FG004|Dose Expansion|Progressive disease|0|||
126417665|NCT00206440|454822958|FG000|Overall Study|Protocol Violation|1|||
126417666|NCT00206440|454822959|FG001|Overall Study|Protocol Violation|2|||
126417667|NCT00206440|454822958|FG000|Overall Study|Adverse Event|4|||
126417668|NCT00206440|454822959|FG001|Overall Study|Adverse Event|2|||
126417669|NCT01298765|454822960|FG000|Titration Period|Adverse Event|26|||
126417670|NCT01298765|454822960|FG000|Titration Period|Death|1|||
126417671|NCT01298765|454822960|FG000|Titration Period|Lack of Efficacy|21|||
126417672|NCT01298765|454822960|FG000|Titration Period|Lost to Follow-up|9|||
126417673|NCT01298765|454822960|FG000|Titration Period|Physician Decision|1|||
126417674|NCT01298765|454822960|FG000|Titration Period|Withdrawal by Subject|10|||
126417675|NCT01298765|454822960|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
126417676|NCT01298765|454822960|FG000|Long-Term Treatment Period|Adverse Event|19|||
126417677|NCT01298765|454822960|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
126417678|NCT01298765|454822960|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
126417679|NCT01298765|454822960|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
126417680|NCT01298765|454822960|FG000|Long-Term Treatment Period|Physician Decision|1|||
126417681|NCT01298765|454822960|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
126417682|NCT03302247|454822963|FG000|Overall Study|the study has closed prematurely|2|||
126417683|NCT03302247|454822963|FG000|Overall Study|Death|1|||
126417684|NCT04090242|454822964|FG000|Overall Study|Withdrawal by Subject|1|||
126417685|NCT04090242|454822965|FG001|Overall Study|Withdrawal by Subject|0|||
126417686|NCT03214406|454822966|FG000|Overall Study|did not meet enrollment criteria|9|||
126417687|NCT03214406|454822967|FG001|Overall Study|did not meet enrollment criteria|13|||
126417688|NCT03214406|454822966|FG000|Overall Study|Withdrawal by Subject|1|||
126417689|NCT03214406|454822967|FG001|Overall Study|Withdrawal by Subject|0|||
126417690|NCT03214406|454822966|FG000|Overall Study|Lost to Follow-up|0|||
126417691|NCT03214406|454822967|FG001|Overall Study|Lost to Follow-up|2|||
126417692|NCT01098305|454822970|FG000|Overall Study|Lost to Follow-up|31|||
126417693|NCT01098305|454822971|FG001|Overall Study|Lost to Follow-up|33|||
126417694|NCT03182907|454822973|FG000|Overall Study|Death|3|||
126417695|NCT03182907|454822974|FG001|Overall Study|Death|0|||
126417696|NCT03182907|454822973|FG000|Overall Study|Protocol Violation|4|||
126417697|NCT03182907|454822974|FG001|Overall Study|Protocol Violation|0|||
126417698|NCT03182907|454822973|FG000|Overall Study|Lost to Follow-up|1|||
126417699|NCT03182907|454822974|FG001|Overall Study|Lost to Follow-up|0|||
126417700|NCT03182907|454822973|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126417701|NCT03182907|454822974|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126417702|NCT00429169|454822975|FG000|Overall Study|Lost to Follow-up|0|||
126417703|NCT00429169|454822976|FG001|Overall Study|Lost to Follow-up|1|||
126417704|NCT00429169|454822975|FG000|Overall Study|Ineligibility discovered after entry|2|||
126417705|NCT00429169|454822976|FG001|Overall Study|Ineligibility discovered after entry|1|||
126417706|NCT01180296|454822981|FG000|Overall Study|Protocol Violation|1|||
126417707|NCT01180296|454822982|FG001|Overall Study|Protocol Violation|2|||
126417708|NCT03364309|454822987|FG000|Induction Period|Adverse Event|4|||
126417709|NCT03364309|454822988|FG001|Induction Period|Adverse Event|0|||
126417710|NCT03364309|454822989|FG002|Induction Period|Adverse Event|1|||
126417711|NCT03364309|454822990|FG003|Induction Period|Adverse Event|0|||
126417712|NCT03364309|454822991|FG004|Induction Period|Adverse Event|0|||
126417713|NCT03364309|454822992|FG005|Induction Period|Adverse Event|0|||
126417714|NCT03364309|454822993|FG006|Induction Period|Adverse Event|0|||
126417715|NCT03364309|454822994|FG007|Induction Period|Adverse Event|0|||
126417716|NCT03364309|454822995|FG008|Induction Period|Adverse Event|0|||
126417717|NCT03364309|454822996|FG009|Induction Period|Adverse Event|0|||
126417718|NCT03364309|454822997|FG010|Induction Period|Adverse Event|0|||
126417719|NCT03364309|454822998|FG011|Induction Period|Adverse Event|0|||
126417720|NCT03364309|454822999|FG012|Induction Period|Adverse Event|0|||
126417721|NCT03364309|454823000|FG013|Induction Period|Adverse Event|0|||
126417722|NCT03364309|454823001|FG014|Induction Period|Adverse Event|0|||
126417723|NCT03364309|454823002|FG015|Induction Period|Adverse Event|0|||
126417724|NCT03364309|454823003|FG016|Induction Period|Adverse Event|0|||
126417725|NCT03364309|454823004|FG017|Induction Period|Adverse Event|0|||
126417726|NCT03364309|454823005|FG018|Induction Period|Adverse Event|0|||
126417727|NCT03364309|454822987|FG000|Induction Period|Withdrawal by Subject|1|||
126417728|NCT03364309|454822988|FG001|Induction Period|Withdrawal by Subject|3|||
126417729|NCT03364309|454822989|FG002|Induction Period|Withdrawal by Subject|0|||
126417730|NCT03364309|454822990|FG003|Induction Period|Withdrawal by Subject|0|||
126417731|NCT03364309|454822991|FG004|Induction Period|Withdrawal by Subject|0|||
126417732|NCT03364309|454822992|FG005|Induction Period|Withdrawal by Subject|0|||
126417733|NCT03364309|454822993|FG006|Induction Period|Withdrawal by Subject|0|||
126417734|NCT03364309|454822994|FG007|Induction Period|Withdrawal by Subject|0|||
126417735|NCT03364309|454822995|FG008|Induction Period|Withdrawal by Subject|0|||
126417736|NCT03364309|454822996|FG009|Induction Period|Withdrawal by Subject|0|||
126417737|NCT03364309|454822997|FG010|Induction Period|Withdrawal by Subject|0|||
126417738|NCT03364309|454822998|FG011|Induction Period|Withdrawal by Subject|0|||
126417739|NCT03364309|454822999|FG012|Induction Period|Withdrawal by Subject|0|||
126417740|NCT03364309|454823000|FG013|Induction Period|Withdrawal by Subject|0|||
126417741|NCT03364309|454823001|FG014|Induction Period|Withdrawal by Subject|0|||
126417742|NCT03364309|454823002|FG015|Induction Period|Withdrawal by Subject|0|||
126417743|NCT03364309|454823003|FG016|Induction Period|Withdrawal by Subject|0|||
126417744|NCT03364309|454823004|FG017|Induction Period|Withdrawal by Subject|0|||
126417745|NCT03364309|454823005|FG018|Induction Period|Withdrawal by Subject|0|||
126417746|NCT03364309|454822987|FG000|Induction Period|Lost to Follow-up|1|||
126417747|NCT03364309|454822988|FG001|Induction Period|Lost to Follow-up|0|||
126417748|NCT03364309|454822989|FG002|Induction Period|Lost to Follow-up|0|||
126417749|NCT03364309|454822990|FG003|Induction Period|Lost to Follow-up|0|||
126417750|NCT03364309|454822991|FG004|Induction Period|Lost to Follow-up|0|||
126417751|NCT03364309|454822992|FG005|Induction Period|Lost to Follow-up|0|||
126417752|NCT03364309|454822993|FG006|Induction Period|Lost to Follow-up|0|||
126417753|NCT03364309|454822994|FG007|Induction Period|Lost to Follow-up|0|||
126417754|NCT03364309|454822995|FG008|Induction Period|Lost to Follow-up|0|||
126417755|NCT03364309|454822996|FG009|Induction Period|Lost to Follow-up|0|||
126417756|NCT03364309|454822997|FG010|Induction Period|Lost to Follow-up|0|||
126417757|NCT03364309|454822998|FG011|Induction Period|Lost to Follow-up|0|||
126417758|NCT03364309|454822999|FG012|Induction Period|Lost to Follow-up|0|||
126417759|NCT03364309|454823000|FG013|Induction Period|Lost to Follow-up|0|||
126417760|NCT03364309|454823001|FG014|Induction Period|Lost to Follow-up|0|||
126417761|NCT03364309|454823002|FG015|Induction Period|Lost to Follow-up|0|||
126417762|NCT03364309|454823003|FG016|Induction Period|Lost to Follow-up|0|||
126417763|NCT03364309|454823004|FG017|Induction Period|Lost to Follow-up|0|||
126417764|NCT03364309|454823005|FG018|Induction Period|Lost to Follow-up|0|||
126417765|NCT03364309|454822987|FG000|Induction Period|Physician Decision|0|||
126417766|NCT03364309|454822988|FG001|Induction Period|Physician Decision|1|||
126417767|NCT03364309|454822989|FG002|Induction Period|Physician Decision|0|||
126417768|NCT03364309|454822990|FG003|Induction Period|Physician Decision|0|||
126417769|NCT03364309|454822991|FG004|Induction Period|Physician Decision|0|||
126417770|NCT03364309|454822992|FG005|Induction Period|Physician Decision|0|||
126417771|NCT03364309|454822993|FG006|Induction Period|Physician Decision|0|||
126417772|NCT03364309|454822994|FG007|Induction Period|Physician Decision|0|||
126417773|NCT03364309|454822995|FG008|Induction Period|Physician Decision|0|||
126417774|NCT03364309|454822996|FG009|Induction Period|Physician Decision|0|||
126417775|NCT03364309|454822997|FG010|Induction Period|Physician Decision|0|||
126417776|NCT03364309|454822998|FG011|Induction Period|Physician Decision|0|||
126417777|NCT03364309|454822999|FG012|Induction Period|Physician Decision|0|||
126417778|NCT03364309|454823000|FG013|Induction Period|Physician Decision|0|||
126417779|NCT03364309|454823001|FG014|Induction Period|Physician Decision|0|||
126417780|NCT03364309|454823002|FG015|Induction Period|Physician Decision|0|||
126054403|NCT02972034|453493884|FG013|Overall Study|Screen Failure|0|||
126054404|NCT02972034|453493885|FG014|Overall Study|Screen Failure|0|||
126054405|NCT03861052|453493886|FG000|Overall Study|Adverse Event|1|||
126417781|NCT03364309|454823003|FG016|Induction Period|Physician Decision|0|||
126054406|NCT03861052|453493887|FG001|Overall Study|Adverse Event|1|||
126054407|NCT03861052|453493888|FG002|Overall Study|Adverse Event|2|||
126054408|NCT03861052|453493889|FG003|Overall Study|Adverse Event|4|||
126054409|NCT03861052|453493886|FG000|Overall Study|Lost to Follow-up|0|||
126054410|NCT03861052|453493887|FG001|Overall Study|Lost to Follow-up|0|||
126054411|NCT03861052|453493888|FG002|Overall Study|Lost to Follow-up|0|||
126054412|NCT03861052|453493889|FG003|Overall Study|Lost to Follow-up|1|||
126417782|NCT03364309|454823004|FG017|Induction Period|Physician Decision|0|||
126417783|NCT03364309|454823005|FG018|Induction Period|Physician Decision|0|||
126417784|NCT03364309|454822987|FG000|Maintenance Period|Withdrawal by Subject|0|||
126054413|NCT03861052|453493886|FG000|Overall Study|Physician Decision|0|||
126054414|NCT03861052|453493887|FG001|Overall Study|Physician Decision|1|||
126417785|NCT03364309|454822988|FG001|Maintenance Period|Withdrawal by Subject|0|||
126417786|NCT03364309|454822989|FG002|Maintenance Period|Withdrawal by Subject|0|||
126417787|NCT03364309|454822990|FG003|Maintenance Period|Withdrawal by Subject|1|||
126417788|NCT03364309|454822991|FG004|Maintenance Period|Withdrawal by Subject|3|||
126417789|NCT03364309|454822992|FG005|Maintenance Period|Withdrawal by Subject|1|||
126417790|NCT03364309|454822993|FG006|Maintenance Period|Withdrawal by Subject|3|||
126417791|NCT03364309|454822994|FG007|Maintenance Period|Withdrawal by Subject|0|||
126417792|NCT03364309|454822995|FG008|Maintenance Period|Withdrawal by Subject|1|||
126417793|NCT03364309|454822996|FG009|Maintenance Period|Withdrawal by Subject|1|||
126417794|NCT03364309|454822997|FG010|Maintenance Period|Withdrawal by Subject|2|||
126417795|NCT03364309|454822998|FG011|Maintenance Period|Withdrawal by Subject|0|||
126417796|NCT03364309|454822999|FG012|Maintenance Period|Withdrawal by Subject|0|||
126417797|NCT03364309|454823000|FG013|Maintenance Period|Withdrawal by Subject|0|||
126417798|NCT03364309|454823001|FG014|Maintenance Period|Withdrawal by Subject|0|||
126417799|NCT03364309|454823002|FG015|Maintenance Period|Withdrawal by Subject|0|||
126417800|NCT03364309|454823003|FG016|Maintenance Period|Withdrawal by Subject|0|||
126417801|NCT03364309|454823004|FG017|Maintenance Period|Withdrawal by Subject|0|||
126417802|NCT03364309|454823005|FG018|Maintenance Period|Withdrawal by Subject|0|||
126417803|NCT03364309|454822987|FG000|Maintenance Period|Adverse Event|0|||
126417804|NCT03364309|454822988|FG001|Maintenance Period|Adverse Event|0|||
126417805|NCT03364309|454822989|FG002|Maintenance Period|Adverse Event|0|||
126417806|NCT03364309|454822990|FG003|Maintenance Period|Adverse Event|0|||
126417807|NCT03364309|454822991|FG004|Maintenance Period|Adverse Event|2|||
126417808|NCT03364309|454822992|FG005|Maintenance Period|Adverse Event|0|||
126417809|NCT03364309|454822993|FG006|Maintenance Period|Adverse Event|3|||
126417810|NCT03364309|454822994|FG007|Maintenance Period|Adverse Event|0|||
126417811|NCT03364309|454822995|FG008|Maintenance Period|Adverse Event|1|||
126417812|NCT03364309|454822996|FG009|Maintenance Period|Adverse Event|0|||
126417813|NCT03364309|454822997|FG010|Maintenance Period|Adverse Event|2|||
126417814|NCT03364309|454822998|FG011|Maintenance Period|Adverse Event|0|||
126417815|NCT03364309|454822999|FG012|Maintenance Period|Adverse Event|0|||
126417816|NCT03364309|454823000|FG013|Maintenance Period|Adverse Event|0|||
126417817|NCT03364309|454823001|FG014|Maintenance Period|Adverse Event|0|||
126417818|NCT03364309|454823002|FG015|Maintenance Period|Adverse Event|0|||
126417819|NCT03364309|454823003|FG016|Maintenance Period|Adverse Event|0|||
126417820|NCT03364309|454823004|FG017|Maintenance Period|Adverse Event|0|||
126417821|NCT03364309|454823005|FG018|Maintenance Period|Adverse Event|0|||
126417822|NCT03364309|454822987|FG000|Maintenance Period|Relapsed|0|||
126417823|NCT03364309|454822988|FG001|Maintenance Period|Relapsed|0|||
126417824|NCT03364309|454822989|FG002|Maintenance Period|Relapsed|0|||
126417825|NCT03364309|454822990|FG003|Maintenance Period|Relapsed|43|||
126417826|NCT03364309|454822991|FG004|Maintenance Period|Relapsed|7|||
126417827|NCT03364309|454822992|FG005|Maintenance Period|Relapsed|45|||
126417828|NCT03364309|454822993|FG006|Maintenance Period|Relapsed|10|||
126417829|NCT03364309|454822994|FG007|Maintenance Period|Relapsed|2|||
126417830|NCT03364309|454822995|FG008|Maintenance Period|Relapsed|0|||
126417831|NCT03364309|454822996|FG009|Maintenance Period|Relapsed|0|||
126417832|NCT03364309|454822997|FG010|Maintenance Period|Relapsed|0|||
126417833|NCT03364309|454822998|FG011|Maintenance Period|Relapsed|0|||
126417834|NCT03364309|454822999|FG012|Maintenance Period|Relapsed|0|||
126417835|NCT03364309|454823000|FG013|Maintenance Period|Relapsed|0|||
126417836|NCT03364309|454823001|FG014|Maintenance Period|Relapsed|0|||
126417837|NCT03364309|454823002|FG015|Maintenance Period|Relapsed|0|||
126417838|NCT03364309|454823003|FG016|Maintenance Period|Relapsed|0|||
126417839|NCT03364309|454823004|FG017|Maintenance Period|Relapsed|0|||
126417840|NCT03364309|454823005|FG018|Maintenance Period|Relapsed|0|||
126417841|NCT03364309|454822987|FG000|Maintenance Period|Lack of Efficacy|0|||
126417842|NCT03364309|454822988|FG001|Maintenance Period|Lack of Efficacy|0|||
126417843|NCT03364309|454822989|FG002|Maintenance Period|Lack of Efficacy|0|||
126417844|NCT03364309|454822990|FG003|Maintenance Period|Lack of Efficacy|0|||
126417845|NCT03364309|454822991|FG004|Maintenance Period|Lack of Efficacy|0|||
126417846|NCT03364309|454822992|FG005|Maintenance Period|Lack of Efficacy|0|||
126417847|NCT03364309|454822993|FG006|Maintenance Period|Lack of Efficacy|0|||
126417848|NCT03364309|454822994|FG007|Maintenance Period|Lack of Efficacy|0|||
126417849|NCT03364309|454822995|FG008|Maintenance Period|Lack of Efficacy|1|||
126417850|NCT03364309|454822996|FG009|Maintenance Period|Lack of Efficacy|3|||
126417851|NCT03364309|454822997|FG010|Maintenance Period|Lack of Efficacy|2|||
126417852|NCT03364309|454822998|FG011|Maintenance Period|Lack of Efficacy|0|||
126417853|NCT03364309|454822999|FG012|Maintenance Period|Lack of Efficacy|0|||
126417854|NCT03364309|454823000|FG013|Maintenance Period|Lack of Efficacy|0|||
126417855|NCT03364309|454823001|FG014|Maintenance Period|Lack of Efficacy|0|||
126417856|NCT03364309|454823002|FG015|Maintenance Period|Lack of Efficacy|0|||
126417857|NCT03364309|454823003|FG016|Maintenance Period|Lack of Efficacy|0|||
126417858|NCT03364309|454823004|FG017|Maintenance Period|Lack of Efficacy|0|||
126417859|NCT03364309|454823005|FG018|Maintenance Period|Lack of Efficacy|0|||
126417860|NCT03364309|454822987|FG000|Maintenance Period|Death|0|||
126417861|NCT03364309|454822988|FG001|Maintenance Period|Death|0|||
126417862|NCT03364309|454822989|FG002|Maintenance Period|Death|0|||
126417863|NCT03364309|454822990|FG003|Maintenance Period|Death|0|||
126417864|NCT03364309|454822991|FG004|Maintenance Period|Death|0|||
126417865|NCT03364309|454822992|FG005|Maintenance Period|Death|0|||
126417866|NCT03364309|454822993|FG006|Maintenance Period|Death|0|||
126417867|NCT03364309|454822994|FG007|Maintenance Period|Death|0|||
126417868|NCT03364309|454822995|FG008|Maintenance Period|Death|1|||
126417869|NCT03364309|454822996|FG009|Maintenance Period|Death|0|||
126417870|NCT03364309|454822997|FG010|Maintenance Period|Death|0|||
126417871|NCT03364309|454822998|FG011|Maintenance Period|Death|0|||
126417872|NCT03364309|454822999|FG012|Maintenance Period|Death|0|||
126417873|NCT03364309|454823000|FG013|Maintenance Period|Death|0|||
126417874|NCT03364309|454823001|FG014|Maintenance Period|Death|0|||
126417875|NCT03364309|454823002|FG015|Maintenance Period|Death|0|||
126417876|NCT03364309|454823003|FG016|Maintenance Period|Death|0|||
126417877|NCT03364309|454823004|FG017|Maintenance Period|Death|0|||
126417878|NCT03364309|454823005|FG018|Maintenance Period|Death|0|||
126417879|NCT03364309|454822987|FG000|Maintenance Period|Lost to Follow-up|0|||
126417880|NCT03364309|454822988|FG001|Maintenance Period|Lost to Follow-up|0|||
126417881|NCT03364309|454822989|FG002|Maintenance Period|Lost to Follow-up|0|||
126417882|NCT03364309|454822990|FG003|Maintenance Period|Lost to Follow-up|0|||
126417883|NCT03364309|454822991|FG004|Maintenance Period|Lost to Follow-up|0|||
126417884|NCT03364309|454822992|FG005|Maintenance Period|Lost to Follow-up|0|||
126417885|NCT03364309|454822993|FG006|Maintenance Period|Lost to Follow-up|0|||
126417886|NCT03364309|454822994|FG007|Maintenance Period|Lost to Follow-up|0|||
126417887|NCT03364309|454822995|FG008|Maintenance Period|Lost to Follow-up|1|||
126417888|NCT03364309|454822996|FG009|Maintenance Period|Lost to Follow-up|0|||
126417889|NCT03364309|454822997|FG010|Maintenance Period|Lost to Follow-up|0|||
126417890|NCT03364309|454822998|FG011|Maintenance Period|Lost to Follow-up|0|||
126417891|NCT03364309|454822999|FG012|Maintenance Period|Lost to Follow-up|0|||
126417892|NCT03364309|454823000|FG013|Maintenance Period|Lost to Follow-up|0|||
126417893|NCT03364309|454823001|FG014|Maintenance Period|Lost to Follow-up|0|||
126417894|NCT03364309|454823002|FG015|Maintenance Period|Lost to Follow-up|0|||
126417895|NCT03364309|454823003|FG016|Maintenance Period|Lost to Follow-up|0|||
126417896|NCT03364309|454823004|FG017|Maintenance Period|Lost to Follow-up|0|||
126417897|NCT03364309|454823005|FG018|Maintenance Period|Lost to Follow-up|0|||
126417898|NCT03364309|454822987|FG000|Maintenance Period|Miscellaneous|0|||
126417899|NCT03364309|454822988|FG001|Maintenance Period|Miscellaneous|0|||
126417900|NCT03364309|454822989|FG002|Maintenance Period|Miscellaneous|0|||
126417901|NCT03364309|454822990|FG003|Maintenance Period|Miscellaneous|0|||
126417902|NCT03364309|454822991|FG004|Maintenance Period|Miscellaneous|0|||
126417903|NCT03364309|454822992|FG005|Maintenance Period|Miscellaneous|0|||
126417904|NCT03364309|454822993|FG006|Maintenance Period|Miscellaneous|0|||
126417905|NCT03364309|454822994|FG007|Maintenance Period|Miscellaneous|0|||
126417906|NCT03364309|454822995|FG008|Maintenance Period|Miscellaneous|1|||
126417907|NCT03364309|454822996|FG009|Maintenance Period|Miscellaneous|0|||
126417908|NCT03364309|454822997|FG010|Maintenance Period|Miscellaneous|0|||
126417909|NCT03364309|454822998|FG011|Maintenance Period|Miscellaneous|0|||
126417910|NCT03364309|454822999|FG012|Maintenance Period|Miscellaneous|0|||
126417911|NCT03364309|454823000|FG013|Maintenance Period|Miscellaneous|0|||
126417912|NCT03364309|454823001|FG014|Maintenance Period|Miscellaneous|0|||
126417913|NCT03364309|454823002|FG015|Maintenance Period|Miscellaneous|0|||
126417914|NCT03364309|454823003|FG016|Maintenance Period|Miscellaneous|0|||
126417915|NCT03364309|454823004|FG017|Maintenance Period|Miscellaneous|0|||
126417916|NCT03364309|454823005|FG018|Maintenance Period|Miscellaneous|0|||
126417917|NCT03364309|454822987|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417918|NCT03364309|454822988|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417919|NCT03364309|454822989|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417920|NCT03364309|454822990|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417921|NCT03364309|454822991|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417922|NCT03364309|454822992|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417923|NCT03364309|454822993|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417924|NCT03364309|454822994|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417925|NCT03364309|454822995|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417926|NCT03364309|454822996|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417927|NCT03364309|454822997|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417928|NCT03364309|454822998|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417929|NCT03364309|454822999|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417930|NCT03364309|454823000|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
126417931|NCT03364309|454823001|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
126417932|NCT03364309|454823002|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
126417933|NCT03364309|454823003|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417934|NCT03364309|454823004|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417935|NCT03364309|454823005|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417936|NCT03364309|454822987|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417937|NCT03364309|454822988|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417938|NCT03364309|454822989|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417939|NCT03364309|454822990|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417940|NCT03364309|454822991|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417941|NCT03364309|454822992|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417942|NCT03364309|454822993|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417943|NCT03364309|454822994|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417944|NCT03364309|454822995|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417945|NCT03364309|454822996|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417946|NCT03364309|454822997|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417947|NCT03364309|454822998|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417948|NCT03364309|454822999|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417949|NCT03364309|454823000|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417950|NCT03364309|454823001|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
126417951|NCT03364309|454823002|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417952|NCT03364309|454823003|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417953|NCT03364309|454823004|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417954|NCT03364309|454823005|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417955|NCT03364309|454822987|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
126417956|NCT03364309|454822988|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
126417957|NCT03364309|454822989|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
126417958|NCT03364309|454822990|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
126417959|NCT03364309|454822991|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
126417960|NCT03364309|454822992|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
126417961|NCT03364309|454822993|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
126417962|NCT03364309|454822994|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
126417963|NCT03364309|454822995|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
126417964|NCT03364309|454822996|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
126417965|NCT03364309|454822997|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
126417966|NCT03364309|454822998|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
126417967|NCT03364309|454822999|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
126417968|NCT03364309|454823000|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
126417969|NCT03364309|454823001|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
126417970|NCT03364309|454823002|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
126417971|NCT03364309|454823003|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
126417972|NCT03364309|454823004|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
126417973|NCT03364309|454823005|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
126417974|NCT03364309|454822987|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417975|NCT03364309|454822988|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417976|NCT03364309|454822989|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417977|NCT03364309|454822990|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417978|NCT03364309|454822991|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417979|NCT03364309|454822992|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417980|NCT03364309|454822993|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417981|NCT03364309|454822994|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417982|NCT03364309|454822995|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417983|NCT03364309|454822996|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417984|NCT03364309|454822997|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417985|NCT03364309|454822998|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417986|NCT03364309|454822999|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417987|NCT03364309|454823000|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417988|NCT03364309|454823001|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417989|NCT03364309|454823002|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417990|NCT03364309|454823003|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
126417991|NCT03364309|454823004|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
126417992|NCT03364309|454823005|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
126417993|NCT03364309|454822987|FG000|Post-Treatment Followup Period|Adverse Event|0|||
126417994|NCT03364309|454822988|FG001|Post-Treatment Followup Period|Adverse Event|0|||
126417995|NCT03364309|454822989|FG002|Post-Treatment Followup Period|Adverse Event|0|||
126417996|NCT03364309|454822990|FG003|Post-Treatment Followup Period|Adverse Event|0|||
126417997|NCT03364309|454822991|FG004|Post-Treatment Followup Period|Adverse Event|0|||
126417998|NCT03364309|454822992|FG005|Post-Treatment Followup Period|Adverse Event|0|||
126417999|NCT03364309|454822993|FG006|Post-Treatment Followup Period|Adverse Event|0|||
126418000|NCT03364309|454822994|FG007|Post-Treatment Followup Period|Adverse Event|0|||
126418001|NCT03364309|454822995|FG008|Post-Treatment Followup Period|Adverse Event|0|||
126418002|NCT03364309|454822996|FG009|Post-Treatment Followup Period|Adverse Event|0|||
126418003|NCT03364309|454822997|FG010|Post-Treatment Followup Period|Adverse Event|0|||
126418004|NCT03364309|454822998|FG011|Post-Treatment Followup Period|Adverse Event|0|||
126418005|NCT03364309|454822999|FG012|Post-Treatment Followup Period|Adverse Event|0|||
126418006|NCT03364309|454823000|FG013|Post-Treatment Followup Period|Adverse Event|0|||
126418007|NCT03364309|454823001|FG014|Post-Treatment Followup Period|Adverse Event|0|||
126418008|NCT03364309|454823002|FG015|Post-Treatment Followup Period|Adverse Event|0|||
126418009|NCT03364309|454823003|FG016|Post-Treatment Followup Period|Adverse Event|2|||
126418010|NCT03364309|454823004|FG017|Post-Treatment Followup Period|Adverse Event|6|||
126418011|NCT03364309|454823005|FG018|Post-Treatment Followup Period|Adverse Event|1|||
126418012|NCT03364309|454822987|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418013|NCT03364309|454822988|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418014|NCT03364309|454822989|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418015|NCT03364309|454822990|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418016|NCT03364309|454822991|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418017|NCT03364309|454822992|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418018|NCT03364309|454822993|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418019|NCT03364309|454822994|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418020|NCT03364309|454822995|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418021|NCT03364309|454822996|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418022|NCT03364309|454822997|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418023|NCT03364309|454822998|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418024|NCT03364309|454822999|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418025|NCT03364309|454823000|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418026|NCT03364309|454823001|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418027|NCT03364309|454823002|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418028|NCT03364309|454823003|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418029|NCT03364309|454823004|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
126418030|NCT03364309|454823005|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418031|NCT03364309|454822987|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
126418032|NCT03364309|454822988|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
126418033|NCT03364309|454822989|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
126418034|NCT03364309|454822990|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
126418035|NCT03364309|454822991|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
126418036|NCT03364309|454822992|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
126418037|NCT03364309|454822993|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
126418038|NCT03364309|454822994|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
126418039|NCT03364309|454822995|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
126418040|NCT03364309|454822996|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
126418041|NCT03364309|454822997|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
126418042|NCT03364309|454822998|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
126418043|NCT03364309|454822999|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
126418044|NCT03364309|454823000|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
126418045|NCT03364309|454823001|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
126418046|NCT03364309|454823002|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
126418047|NCT03364309|454823003|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
126418048|NCT03364309|454823004|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
126418049|NCT03364309|454823005|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
126418050|NCT03304873|454823006|FG000|Overall Study|Lost to Follow-up|1|||
126418051|NCT03304873|454823007|FG001|Overall Study|Lost to Follow-up|8|||
126418052|NCT01546688|454823008|FG000|Overall Study|Adverse Event|0|||
126418053|NCT01546688|454823009|FG001|Overall Study|Adverse Event|4|||
126418054|NCT01546688|454823008|FG000|Overall Study|Withdrawal by Subject|2|||
126418055|NCT01546688|454823009|FG001|Overall Study|Withdrawal by Subject|1|||
126418056|NCT01546688|454823008|FG000|Overall Study|Lack of Efficacy|1|||
126418057|NCT01546688|454823009|FG001|Overall Study|Lack of Efficacy|0|||
126418058|NCT01052077|454823013|FG000|Phase A|Lost to Follow-up|22|||
126418059|NCT01052077|454823014|FG001|Phase A|Lost to Follow-up|0|||
126418060|NCT01052077|454823015|FG002|Phase A|Lost to Follow-up|0|||
126418061|NCT01052077|454823016|FG003|Phase A|Lost to Follow-up|0|||
126418062|NCT01052077|454823013|FG000|Phase A|Adverse Event|32|||
126418063|NCT01052077|454823014|FG001|Phase A|Adverse Event|0|||
126418064|NCT01052077|454823015|FG002|Phase A|Adverse Event|0|||
126418065|NCT01052077|454823016|FG003|Phase A|Adverse Event|0|||
126418066|NCT01052077|454823013|FG000|Phase A|Met Withdrawal Criteria|26|||
126418067|NCT01052077|454823014|FG001|Phase A|Met Withdrawal Criteria|0|||
126418068|NCT01052077|454823015|FG002|Phase A|Met Withdrawal Criteria|0|||
126418069|NCT01052077|454823016|FG003|Phase A|Met Withdrawal Criteria|0|||
126418070|NCT01052077|454823013|FG000|Phase A|Physician Decision|10|||
126418071|NCT01052077|454823014|FG001|Phase A|Physician Decision|0|||
126418072|NCT01052077|454823015|FG002|Phase A|Physician Decision|0|||
126418073|NCT01052077|454823016|FG003|Phase A|Physician Decision|0|||
126418074|NCT01052077|454823013|FG000|Phase A|Withdrawal by Subject|29|||
126418075|NCT01052077|454823014|FG001|Phase A|Withdrawal by Subject|0|||
126418076|NCT01052077|454823015|FG002|Phase A|Withdrawal by Subject|0|||
126418077|NCT01052077|454823016|FG003|Phase A|Withdrawal by Subject|0|||
126418078|NCT01052077|454823013|FG000|Phase A|Protocol Deviation|27|||
126418079|NCT01052077|454823014|FG001|Phase A|Protocol Deviation|0|||
126418080|NCT01052077|454823015|FG002|Phase A|Protocol Deviation|0|||
126418081|NCT01052077|454823016|FG003|Phase A|Protocol Deviation|0|||
126418082|NCT01052077|454823013|FG000|Phase B|Lost to Follow-up|0|||
126418083|NCT01052077|454823014|FG001|Phase B|Lost to Follow-up|2|||
126418084|NCT01052077|454823015|FG002|Phase B|Lost to Follow-up|3|||
126418085|NCT01052077|454823016|FG003|Phase B|Lost to Follow-up|0|||
126418086|NCT01052077|454823013|FG000|Phase B|Adverse Event|0|||
126418087|NCT01052077|454823014|FG001|Phase B|Adverse Event|9|||
126418088|NCT01052077|454823015|FG002|Phase B|Adverse Event|2|||
126418089|NCT01052077|454823016|FG003|Phase B|Adverse Event|0|||
126418090|NCT01052077|454823013|FG000|Phase B|Met Withdrawal Criteria|0|||
126418091|NCT01052077|454823014|FG001|Phase B|Met Withdrawal Criteria|2|||
126418092|NCT01052077|454823015|FG002|Phase B|Met Withdrawal Criteria|1|||
126418093|NCT01052077|454823016|FG003|Phase B|Met Withdrawal Criteria|0|||
126418094|NCT01052077|454823013|FG000|Phase B|Physician Decision|0|||
126418095|NCT01052077|454823014|FG001|Phase B|Physician Decision|1|||
126418096|NCT01052077|454823015|FG002|Phase B|Physician Decision|1|||
126418097|NCT01052077|454823016|FG003|Phase B|Physician Decision|0|||
126418098|NCT01052077|454823013|FG000|Phase B|Withdrawal by Subject|0|||
126418099|NCT01052077|454823014|FG001|Phase B|Withdrawal by Subject|0|||
126418100|NCT01052077|454823015|FG002|Phase B|Withdrawal by Subject|5|||
126418101|NCT01052077|454823016|FG003|Phase B|Withdrawal by Subject|0|||
126418102|NCT01052077|454823013|FG000|Phase B|Protocol Deviation|0|||
126418103|NCT01052077|454823014|FG001|Phase B|Protocol Deviation|3|||
126418104|NCT01052077|454823015|FG002|Phase B|Protocol Deviation|4|||
126418105|NCT01052077|454823016|FG003|Phase B|Protocol Deviation|0|||
126418106|NCT01052077|454823013|FG000|Phase B|Lack of Efficacy|0|||
126418107|NCT01052077|454823014|FG001|Phase B|Lack of Efficacy|1|||
126418108|NCT01052077|454823015|FG002|Phase B|Lack of Efficacy|0|||
126418109|NCT01052077|454823016|FG003|Phase B|Lack of Efficacy|0|||
126418110|NCT01052077|454823013|FG000|Phase A+|Lost to Follow-up|0|||
126418111|NCT01052077|454823014|FG001|Phase A+|Lost to Follow-up|0|||
126418112|NCT01052077|454823015|FG002|Phase A+|Lost to Follow-up|0|||
126418113|NCT01052077|454823016|FG003|Phase A+|Lost to Follow-up|8|||
126418114|NCT01052077|454823013|FG000|Phase A+|Adverse Event|0|||
126418115|NCT01052077|454823014|FG001|Phase A+|Adverse Event|0|||
126418116|NCT01052077|454823015|FG002|Phase A+|Adverse Event|0|||
126418117|NCT01052077|454823016|FG003|Phase A+|Adverse Event|4|||
126418118|NCT01052077|454823013|FG000|Phase A+|Met Withdrawal Criteria|0|||
126418119|NCT01052077|454823014|FG001|Phase A+|Met Withdrawal Criteria|0|||
126418120|NCT01052077|454823015|FG002|Phase A+|Met Withdrawal Criteria|0|||
126418121|NCT01052077|454823016|FG003|Phase A+|Met Withdrawal Criteria|2|||
126418122|NCT01052077|454823013|FG000|Phase A+|Withdrawal by Subject|0|||
126418123|NCT01052077|454823014|FG001|Phase A+|Withdrawal by Subject|0|||
126418124|NCT01052077|454823015|FG002|Phase A+|Withdrawal by Subject|0|||
126418125|NCT01052077|454823016|FG003|Phase A+|Withdrawal by Subject|7|||
126418126|NCT02465203|454823017|FG000|Overall Study|Protocol Violation|1|||
126418127|NCT02465203|454823018|FG001|Overall Study|Protocol Violation|1|||
126418128|NCT02465203|454823019|FG002|Overall Study|Protocol Violation|1|||
126418129|NCT02465203|454823017|FG000|Overall Study|Study terminated by sponsor|50|||
126418130|NCT02465203|454823018|FG001|Overall Study|Study terminated by sponsor|34|||
126418131|NCT02465203|454823019|FG002|Overall Study|Study terminated by sponsor|11|||
126418132|NCT02465203|454823017|FG000|Overall Study|New therapy for study indication|4|||
126418133|NCT02465203|454823018|FG001|Overall Study|New therapy for study indication|0|||
126418134|NCT02465203|454823019|FG002|Overall Study|New therapy for study indication|0|||
126418135|NCT02465203|454823017|FG000|Overall Study|Patient/guardian decision|1|||
126418136|NCT02465203|454823018|FG001|Overall Study|Patient/guardian decision|1|||
126418137|NCT02465203|454823019|FG002|Overall Study|Patient/guardian decision|1|||
126418138|NCT00042991|454823020|FG000|Overall Study|Adverse Event|1|||
126418139|NCT00042991|454823021|FG001|Overall Study|Adverse Event|4|||
126418140|NCT00042991|454823022|FG002|Overall Study|Adverse Event|2|||
126418141|NCT00042991|454823023|FG003|Overall Study|Adverse Event|0|||
126418142|NCT00042991|454823024|FG004|Overall Study|Adverse Event|0|||
125891121|NCT02152956|452899719|FG012|Overall Study|Withdrawal by Subject|0|||
126418143|NCT00042991|454823025|FG005|Overall Study|Adverse Event|1|||
126418144|NCT00042991|454823026|FG006|Overall Study|Adverse Event|0|||
126418145|NCT00042991|454823020|FG000|Overall Study|Withdrawal by Subject|0|||
126418146|NCT00042991|454823021|FG001|Overall Study|Withdrawal by Subject|7|||
126418147|NCT00042991|454823022|FG002|Overall Study|Withdrawal by Subject|2|||
126418148|NCT00042991|454823023|FG003|Overall Study|Withdrawal by Subject|0|||
126418149|NCT00042991|454823024|FG004|Overall Study|Withdrawal by Subject|1|||
126418150|NCT00042991|454823025|FG005|Overall Study|Withdrawal by Subject|0|||
126418151|NCT00042991|454823026|FG006|Overall Study|Withdrawal by Subject|0|||
126418152|NCT00042991|454823020|FG000|Overall Study|Disease Progression|5|||
126418153|NCT00042991|454823021|FG001|Overall Study|Disease Progression|29|||
126418154|NCT00042991|454823022|FG002|Overall Study|Disease Progression|2|||
126418155|NCT00042991|454823023|FG003|Overall Study|Disease Progression|2|||
126418156|NCT00042991|454823024|FG004|Overall Study|Disease Progression|1|||
126418157|NCT00042991|454823025|FG005|Overall Study|Disease Progression|4|||
126418158|NCT00042991|454823026|FG006|Overall Study|Disease Progression|2|||
126418159|NCT00042991|454823020|FG000|Overall Study|Alternative Therapy|0|||
126418160|NCT00042991|454823021|FG001|Overall Study|Alternative Therapy|0|||
126418161|NCT00042991|454823022|FG002|Overall Study|Alternative Therapy|0|||
126418162|NCT00042991|454823023|FG003|Overall Study|Alternative Therapy|0|||
126418163|NCT00042991|454823024|FG004|Overall Study|Alternative Therapy|1|||
126418164|NCT00042991|454823025|FG005|Overall Study|Alternative Therapy|0|||
126418165|NCT00042991|454823026|FG006|Overall Study|Alternative Therapy|0|||
126418166|NCT03058692|454825125|FG000|Overall Study|Lost to Follow-up|2|||
126418167|NCT03058692|454825126|FG001|Overall Study|Lost to Follow-up|1|||
126418168|NCT03058692|454825125|FG000|Overall Study|Withdrawal by Subject|1|||
126418169|NCT03058692|454825126|FG001|Overall Study|Withdrawal by Subject|1|||
126418170|NCT01392547|454825127|FG000|Overall Study|Adverse Event|2|||
126418171|NCT01392547|454825127|FG000|Overall Study|Non-compliance|2|||
126418172|NCT01392547|454825127|FG000|Overall Study|Withdrawal criteria|3|||
126418173|NCT01392547|454825127|FG000|Overall Study|Unclassified|1|||
126418174|NCT00799266|454825132|FG000|Overall Study|Adverse Event|0|||
126418175|NCT00799266|454825133|FG001|Overall Study|Adverse Event|1|||
126418176|NCT00799266|454825132|FG000|Overall Study|Subject withdrew consent|3|||
126418177|NCT00799266|454825133|FG001|Overall Study|Subject withdrew consent|0|||
126418178|NCT02828436|454825145|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
126418179|NCT02828436|454825146|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
126418180|NCT02828436|454825145|FG000|Period 1|Lost to Follow-up|0|||
126418181|NCT02828436|454825146|FG001|Period 1|Lost to Follow-up|1|||
126418182|NCT02828436|454825145|FG000|Period 2|Withdrawal by Subject|4|||
126418183|NCT02828436|454825146|FG001|Period 2|Withdrawal by Subject|0|||
126418184|NCT02828436|454825145|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
126418185|NCT02828436|454825146|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
126418186|NCT02828436|454825145|FG000|Period 2|Lost to Follow-up|1|||
126418187|NCT02828436|454825146|FG001|Period 2|Lost to Follow-up|0|||
126418188|NCT01136408|454825147|FG000|Overall Study|Adverse Event|4|||
126418189|NCT01136408|454825148|FG001|Overall Study|Adverse Event|8|||
126418190|NCT01136408|454825149|FG002|Overall Study|Adverse Event|4|||
126418191|NCT01136408|454825147|FG000|Overall Study|Protocol Violation|1|||
126418192|NCT01136408|454825148|FG001|Overall Study|Protocol Violation|1|||
126418193|NCT01136408|454825149|FG002|Overall Study|Protocol Violation|1|||
126418194|NCT04421482|454825153|FG000|Overall Study|Physician Decision|1|||
126418195|NCT02128724|454825156|FG000|Overall Study|Death|1|||
126418196|NCT02128724|454825157|FG001|Overall Study|Death|0|||
126418197|NCT02128724|454825158|FG002|Overall Study|Death|0|||
126418198|NCT02128724|454825159|FG003|Overall Study|Death|0|||
126418199|NCT02128724|454825156|FG000|Overall Study|Adverse Event|0|||
126418200|NCT02128724|454825157|FG001|Overall Study|Adverse Event|1|||
126418201|NCT02128724|454825158|FG002|Overall Study|Adverse Event|0|||
126418202|NCT02128724|454825159|FG003|Overall Study|Adverse Event|0|||
126418203|NCT02128724|454825156|FG000|Overall Study|Physician Decision|0|||
126418204|NCT02128724|454825157|FG001|Overall Study|Physician Decision|0|||
126418205|NCT02128724|454825158|FG002|Overall Study|Physician Decision|0|||
126418206|NCT02128724|454825159|FG003|Overall Study|Physician Decision|2|||
126418207|NCT02128724|454825156|FG000|Overall Study|Withdrawal by Subject|0|||
126418208|NCT02128724|454825157|FG001|Overall Study|Withdrawal by Subject|0|||
126418209|NCT02128724|454825158|FG002|Overall Study|Withdrawal by Subject|0|||
126418210|NCT02128724|454825159|FG003|Overall Study|Withdrawal by Subject|1|||
126418211|NCT03329092|454825160|FG000|Overall Study|Other|2|||
126418212|NCT03329092|454825161|FG001|Overall Study|Other|2|||
126418213|NCT03329092|454825160|FG000|Overall Study|Withdrawal by Subject|16|||
126418214|NCT03329092|454825161|FG001|Overall Study|Withdrawal by Subject|3|||
126418215|NCT03329092|454825160|FG000|Overall Study|Physician Decision|1|||
126418216|NCT03329092|454825161|FG001|Overall Study|Physician Decision|0|||
126418217|NCT03329092|454825160|FG000|Overall Study|Death|17|||
126418218|NCT03329092|454825161|FG001|Overall Study|Death|11|||
126418219|NCT03329092|454825160|FG000|Overall Study|Adverse Event|3|||
126418220|NCT03329092|454825161|FG001|Overall Study|Adverse Event|1|||
126418221|NCT03329092|454825160|FG000|Overall Study|Lost to Follow-up|1|||
126418222|NCT03329092|454825161|FG001|Overall Study|Lost to Follow-up|1|||
126418223|NCT05786508|454825162|FG000|Overall Study|Withdrawal by Subject|2|||
126418224|NCT05786508|454825163|FG001|Overall Study|Withdrawal by Subject|0|||
126418225|NCT01456169|454825165|FG000|Overall Study|Adverse Event|1|||
126418226|NCT01456169|454825166|FG001|Overall Study|Adverse Event|2|||
126418227|NCT01456169|454825167|FG002|Overall Study|Adverse Event|7|||
126418228|NCT01456169|454825165|FG000|Overall Study|Major Protocol Deviation|3|||
126418229|NCT01456169|454825166|FG001|Overall Study|Major Protocol Deviation|2|||
126418230|NCT01456169|454825167|FG002|Overall Study|Major Protocol Deviation|3|||
126418231|NCT01456169|454825165|FG000|Overall Study|Voluntary Withdrawal|3|||
126418232|NCT01456169|454825166|FG001|Overall Study|Voluntary Withdrawal|0|||
126418233|NCT01456169|454825167|FG002|Overall Study|Voluntary Withdrawal|2|||
126418234|NCT01456169|454825165|FG000|Overall Study|Lack of Efficacy|2|||
126418235|NCT01456169|454825166|FG001|Overall Study|Lack of Efficacy|0|||
126418236|NCT01456169|454825167|FG002|Overall Study|Lack of Efficacy|0|||
126418237|NCT01456169|454825165|FG000|Overall Study|Other|1|||
126418238|NCT01456169|454825166|FG001|Overall Study|Other|1|||
126418239|NCT01456169|454825167|FG002|Overall Study|Other|0|||
126418240|NCT02652156|454825173|FG000|Overall Study|Physician Decision|1|||
126418241|NCT02652156|454825174|FG001|Overall Study|Physician Decision|0|||
126418242|NCT02652156|454825175|FG002|Overall Study|Physician Decision|0|||
126418243|NCT02342223|454825177|FG000|Overall Study|Lost to Follow-up|1|||
126418244|NCT00496080|454825180|FG000|Overall Study|Lost to Follow-up|9|||
126418245|NCT00496080|454825180|FG000|Overall Study|Surgical re-intervention|7|||
126418246|NCT00496080|454825180|FG000|Overall Study|Withdrawal by Subject|5|||
126418247|NCT00496080|454825180|FG000|Overall Study|Physician Decision|6|||
126418248|NCT01200368|454825185|FG000|Infant Series|Adverse Event|2|||
126418249|NCT01200368|454825186|FG001|Infant Series|Adverse Event|2|||
126418250|NCT01200368|454825187|FG002|Infant Series|Adverse Event|3|||
126418251|NCT01200368|454825185|FG000|Infant Series|Withdrawal by Subject|0|||
126418252|NCT01200368|454825186|FG001|Infant Series|Withdrawal by Subject|2|||
126418253|NCT01200368|454825187|FG002|Infant Series|Withdrawal by Subject|2|||
126418254|NCT01200368|454825185|FG000|Infant Series|Did not meet entrance criteria|0|||
126418255|NCT01200368|454825186|FG001|Infant Series|Did not meet entrance criteria|1|||
126418256|NCT01200368|454825187|FG002|Infant Series|Did not meet entrance criteria|0|||
126418257|NCT01200368|454825185|FG000|Infant Series|Randomized, not vaccinated|0|||
126418258|NCT01200368|454825186|FG001|Infant Series|Randomized, not vaccinated|1|||
126418259|NCT01200368|454825187|FG002|Infant Series|Randomized, not vaccinated|1|||
126418260|NCT01200368|454825185|FG000|Infant Series|Other|1|||
126418261|NCT01200368|454825186|FG001|Infant Series|Other|0|||
126418262|NCT01200368|454825187|FG002|Infant Series|Other|0|||
126418263|NCT01200368|454825185|FG000|After Infant Series|Adverse Event|6|||
126418264|NCT01200368|454825186|FG001|After Infant Series|Adverse Event|6|||
126418265|NCT01200368|454825187|FG002|After Infant Series|Adverse Event|3|||
126418266|NCT01200368|454825185|FG000|After Infant Series|Withdrawal by Subject|10|||
126418267|NCT01200368|454825186|FG001|After Infant Series|Withdrawal by Subject|8|||
126418268|NCT01200368|454825187|FG002|After Infant Series|Withdrawal by Subject|4|||
126418269|NCT01200368|454825185|FG000|After Infant Series|Lost to Follow-up|1|||
126418270|NCT01200368|454825186|FG001|After Infant Series|Lost to Follow-up|0|||
126418271|NCT01200368|454825187|FG002|After Infant Series|Lost to Follow-up|0|||
126418272|NCT01200368|454825185|FG000|After Infant Series|Other|1|||
126418273|NCT01200368|454825186|FG001|After Infant Series|Other|2|||
126418274|NCT01200368|454825187|FG002|After Infant Series|Other|2|||
126418275|NCT01200368|454825185|FG000|Toddler Dose|Adverse Event|0|||
126418276|NCT01200368|454825186|FG001|Toddler Dose|Adverse Event|3|||
126418277|NCT01200368|454825187|FG002|Toddler Dose|Adverse Event|1|||
126418278|NCT00570310|454825188|FG000|Overall Study|Adverse Event|1|||
126418279|NCT00570310|454825189|FG001|Overall Study|Adverse Event|2|||
126418280|NCT00570310|454825188|FG000|Overall Study|Lack of Efficacy|1|||
126418281|NCT00570310|454825189|FG001|Overall Study|Lack of Efficacy|4|||
126418282|NCT00108862|454825190|FG000|Overall Study|Death|31|||
126418283|NCT00108862|454825191|FG001|Overall Study|Death|37|||
126418284|NCT00108862|454825190|FG000|Overall Study|Withdrawal by Subject|10|||
126418285|NCT00108862|454825191|FG001|Overall Study|Withdrawal by Subject|6|||
126418286|NCT00108862|454825190|FG000|Overall Study|Lost to Follow-up|27|||
126418287|NCT00108862|454825191|FG001|Overall Study|Lost to Follow-up|19|||
126418288|NCT00577824|454825194|FG000|Overall Study|Adverse Event|6|||
126418289|NCT00577824|454825195|FG001|Overall Study|Adverse Event|18|||
126418290|NCT00577824|454825196|FG002|Overall Study|Adverse Event|1|||
126418291|NCT00577824|454825194|FG000|Overall Study|Patient decision|0|||
126418292|NCT00577824|454825195|FG001|Overall Study|Patient decision|1|||
126418293|NCT00577824|454825196|FG002|Overall Study|Patient decision|1|||
126418294|NCT00577824|454825194|FG000|Overall Study|Protocol Violation|1|||
126418295|NCT00577824|454825195|FG001|Overall Study|Protocol Violation|1|||
126418296|NCT00577824|454825196|FG002|Overall Study|Protocol Violation|0|||
126418297|NCT04079816|454825197|FG000|Overall Study|Request of Subject|2|||
126418298|NCT04079816|454825197|FG000|Overall Study|Unable to draw samples|1|||
126418299|NCT04137731|454825198|FG000|Overall Study|Surgery Cancellation|1|||
126418300|NCT04137731|454825199|FG001|Overall Study|Surgery Cancellation|2|||
126418301|NCT04137731|454825198|FG000|Overall Study|Withdrawal by Subject|2|||
126418302|NCT04137731|454825199|FG001|Overall Study|Withdrawal by Subject|0|||
126418303|NCT04137731|454825198|FG000|Overall Study|Protocol Violation|0|||
126418304|NCT04137731|454825199|FG001|Overall Study|Protocol Violation|1|||
126418305|NCT00362648|454825200|FG000|Overall Study|Adverse Event|12|||
126418306|NCT00362648|454825201|FG001|Overall Study|Adverse Event|21|||
126418307|NCT00362648|454825202|FG002|Overall Study|Adverse Event|1|||
126418308|NCT00362648|454825203|FG003|Overall Study|Adverse Event|0|||
126418309|NCT00362648|454825200|FG000|Overall Study|Lost to Follow-up|62|||
126418310|NCT00362648|454825201|FG001|Overall Study|Lost to Follow-up|69|||
126418311|NCT00362648|454825202|FG002|Overall Study|Lost to Follow-up|4|||
126418312|NCT00362648|454825203|FG003|Overall Study|Lost to Follow-up|3|||
126418313|NCT00362648|454825200|FG000|Overall Study|Protocol Violation|4|||
126418314|NCT00362648|454825201|FG001|Overall Study|Protocol Violation|2|||
126418315|NCT00362648|454825202|FG002|Overall Study|Protocol Violation|2|||
126418316|NCT00362648|454825203|FG003|Overall Study|Protocol Violation|2|||
126418317|NCT00362648|454825200|FG000|Overall Study|Withdrawal by Subject|48|||
126418318|NCT00362648|454825201|FG001|Overall Study|Withdrawal by Subject|42|||
126418319|NCT00362648|454825202|FG002|Overall Study|Withdrawal by Subject|2|||
126418320|NCT00362648|454825203|FG003|Overall Study|Withdrawal by Subject|6|||
126418321|NCT03983304|454825204|FG000|Overall Study|Withdrawal by Subject|5|||
126418322|NCT03983304|454825204|FG000|Overall Study|Lost to Follow-up|2|||
126418323|NCT00310817|454825205|FG000|Overall Study|AE or Death|3|||
126418324|NCT00310817|454825206|FG001|Overall Study|AE or Death|1|||
126418325|NCT00310817|454825207|FG002|Overall Study|AE or Death|0|||
126418326|NCT00310817|454825208|FG003|Overall Study|AE or Death|0|||
126418327|NCT00310817|454825205|FG000|Overall Study|Withdrawal by Subject|1|||
126418328|NCT00310817|454825206|FG001|Overall Study|Withdrawal by Subject|4|||
126418329|NCT00310817|454825207|FG002|Overall Study|Withdrawal by Subject|6|||
126418330|NCT00310817|454825208|FG003|Overall Study|Withdrawal by Subject|7|||
126418331|NCT00310817|454825205|FG000|Overall Study|Lost to Follow-up|2|||
126418332|NCT00310817|454825206|FG001|Overall Study|Lost to Follow-up|1|||
126418333|NCT00310817|454825207|FG002|Overall Study|Lost to Follow-up|0|||
126418334|NCT00310817|454825208|FG003|Overall Study|Lost to Follow-up|0|||
126418335|NCT00310817|454825205|FG000|Overall Study|Inappropriate Enrollment|1|||
126418336|NCT00310817|454825206|FG001|Overall Study|Inappropriate Enrollment|0|||
126418337|NCT00310817|454825207|FG002|Overall Study|Inappropriate Enrollment|1|||
126418338|NCT00310817|454825208|FG003|Overall Study|Inappropriate Enrollment|0|||
126418339|NCT00310817|454825205|FG000|Overall Study|Protocol Violation|1|||
126418340|NCT00310817|454825206|FG001|Overall Study|Protocol Violation|1|||
126418341|NCT00310817|454825207|FG002|Overall Study|Protocol Violation|1|||
126418342|NCT00310817|454825208|FG003|Overall Study|Protocol Violation|1|||
126418343|NCT00310817|454825205|FG000|Overall Study|Unable to classify|3|||
126418344|NCT00310817|454825206|FG001|Overall Study|Unable to classify|1|||
126418345|NCT00310817|454825207|FG002|Overall Study|Unable to classify|0|||
126418346|NCT00310817|454825208|FG003|Overall Study|Unable to classify|0|||
126418347|NCT01702246|454825209|FG000|Overall Study|Lost to Follow-up|2|||
126418348|NCT01702246|454825209|FG000|Overall Study|Withdrawal by Subject|2|||
126418349|NCT01702246|454825209|FG000|Overall Study|Physician Decision|1|||
126418350|NCT01587040|454825210|FG000|Overall Study|Protocol Violation|0|||
126418351|NCT01587040|454825211|FG001|Overall Study|Protocol Violation|0|||
126418352|NCT01587040|454825212|FG002|Overall Study|Protocol Violation|1|||
126418353|NCT01587040|454825213|FG003|Overall Study|Protocol Violation|0|||
126418354|NCT01587040|454825210|FG000|Overall Study|Adverse Event|0|||
126418355|NCT01587040|454825211|FG001|Overall Study|Adverse Event|1|||
126418356|NCT01587040|454825212|FG002|Overall Study|Adverse Event|10|||
126418357|NCT01587040|454825213|FG003|Overall Study|Adverse Event|0|||
126418358|NCT01587040|454825210|FG000|Overall Study|Disease progression|12|||
126418359|NCT01587040|454825211|FG001|Overall Study|Disease progression|1|||
126418360|NCT01587040|454825212|FG002|Overall Study|Disease progression|15|||
126418361|NCT01587040|454825213|FG003|Overall Study|Disease progression|3|||
126418362|NCT01587040|454825210|FG000|Overall Study|Other than specified|5|||
126418363|NCT01587040|454825211|FG001|Overall Study|Other than specified|1|||
126418364|NCT01587040|454825212|FG002|Overall Study|Other than specified|11|||
126418365|NCT01587040|454825213|FG003|Overall Study|Other than specified|1|||
126418366|NCT01518374|454825216|FG000|Overall Study|Withdrawal by Subject|2|||
126418367|NCT01518374|454825216|FG000|Overall Study|Protocol Violation|3|||
126418368|NCT01518374|454825216|FG000|Overall Study|Lost to Follow-up|2|||
126418369|NCT04300309|454825217|FG000|Overall Study|Lost to Follow-up|1|||
126418370|NCT04300309|454825218|FG001|Overall Study|Lost to Follow-up|0|||
126418371|NCT03724890|454825221|FG000|Overall Study|Death|2|||
126418372|NCT03724890|454825222|FG001|Overall Study|Death|6|||
126418373|NCT03724890|454825223|FG002|Overall Study|Death|3|||
126418374|NCT03724890|454825224|FG003|Overall Study|Death|5|||
126418375|NCT03724890|454825225|FG004|Overall Study|Death|2|||
126418376|NCT03724890|454825226|FG005|Overall Study|Death|0|||
126418377|NCT03724890|454825227|FG006|Overall Study|Death|2|||
126418378|NCT03724890|454825228|FG007|Overall Study|Death|3|||
126418379|NCT03724890|454825229|FG008|Overall Study|Death|4|||
126418380|NCT03724890|454825230|FG009|Overall Study|Death|2|||
126418381|NCT03724890|454825231|FG010|Overall Study|Death|2|||
126418382|NCT03724890|454825221|FG000|Overall Study|Lost to Follow-up|0|||
126418383|NCT03724890|454825222|FG001|Overall Study|Lost to Follow-up|3|||
126418384|NCT03724890|454825223|FG002|Overall Study|Lost to Follow-up|0|||
126418385|NCT03724890|454825224|FG003|Overall Study|Lost to Follow-up|1|||
126418386|NCT03724890|454825225|FG004|Overall Study|Lost to Follow-up|2|||
126418387|NCT03724890|454825226|FG005|Overall Study|Lost to Follow-up|2|||
126418388|NCT03724890|454825227|FG006|Overall Study|Lost to Follow-up|1|||
126418389|NCT03724890|454825228|FG007|Overall Study|Lost to Follow-up|0|||
126418390|NCT03724890|454825229|FG008|Overall Study|Lost to Follow-up|2|||
126418391|NCT03724890|454825230|FG009|Overall Study|Lost to Follow-up|0|||
126418392|NCT03724890|454825231|FG010|Overall Study|Lost to Follow-up|0|||
126418393|NCT03724890|454825221|FG000|Overall Study|Withdrawal by Subject|1|||
126418394|NCT03724890|454825222|FG001|Overall Study|Withdrawal by Subject|2|||
126418395|NCT03724890|454825223|FG002|Overall Study|Withdrawal by Subject|1|||
125891122|NCT02152956|452899707|FG000|Overall Study|Physician Decision|0|||
125891123|NCT02152956|452899708|FG001|Overall Study|Physician Decision|0|||
125891124|NCT02152956|452899709|FG002|Overall Study|Physician Decision|0|||
125891125|NCT02152956|452899710|FG003|Overall Study|Physician Decision|0|||
126418396|NCT03724890|454825224|FG003|Overall Study|Withdrawal by Subject|0|||
126418397|NCT03724890|454825225|FG004|Overall Study|Withdrawal by Subject|0|||
126418398|NCT03724890|454825226|FG005|Overall Study|Withdrawal by Subject|1|||
126418399|NCT03724890|454825227|FG006|Overall Study|Withdrawal by Subject|0|||
126418400|NCT03724890|454825228|FG007|Overall Study|Withdrawal by Subject|0|||
126418401|NCT03724890|454825229|FG008|Overall Study|Withdrawal by Subject|2|||
126418402|NCT03724890|454825230|FG009|Overall Study|Withdrawal by Subject|2|||
126418403|NCT03724890|454825231|FG010|Overall Study|Withdrawal by Subject|1|||
126418404|NCT03724890|454825221|FG000|Overall Study|Other|1|||
126418405|NCT03724890|454825222|FG001|Overall Study|Other|0|||
126418406|NCT03724890|454825223|FG002|Overall Study|Other|0|||
126418407|NCT03724890|454825224|FG003|Overall Study|Other|0|||
126418408|NCT03724890|454825225|FG004|Overall Study|Other|0|||
126418409|NCT03724890|454825226|FG005|Overall Study|Other|0|||
126418410|NCT03724890|454825227|FG006|Overall Study|Other|0|||
126418411|NCT03724890|454825228|FG007|Overall Study|Other|1|||
126418412|NCT03724890|454825229|FG008|Overall Study|Other|1|||
126418413|NCT03724890|454825230|FG009|Overall Study|Other|0|||
126418414|NCT03724890|454825231|FG010|Overall Study|Other|2|||
126418415|NCT04607837|454825234|FG000|Overall Study|Adverse Event|8|||
126418416|NCT04607837|454825235|FG001|Overall Study|Adverse Event|2|||
126418417|NCT04607837|454825234|FG000|Overall Study|Withdrawal by Subject|8|||
126418418|NCT04607837|454825235|FG001|Overall Study|Withdrawal by Subject|7|||
126418419|NCT04607837|454825234|FG000|Overall Study|Physician Decision|2|||
126418420|NCT04607837|454825235|FG001|Overall Study|Physician Decision|0|||
126418421|NCT04607837|454825234|FG000|Overall Study|Lack of Efficacy|2|||
126418422|NCT04607837|454825235|FG001|Overall Study|Lack of Efficacy|0|||
126418423|NCT04607837|454825234|FG000|Overall Study|Participant terminated by sponsor|1|||
126418424|NCT04607837|454825235|FG001|Overall Study|Participant terminated by sponsor|0|||
126418425|NCT04607837|454825234|FG000|Overall Study|Disease worsening|36|||
126418426|NCT04607837|454825235|FG001|Overall Study|Disease worsening|36|||
126418427|NCT04607837|454825234|FG000|Overall Study|Other|1|||
126418428|NCT04607837|454825235|FG001|Overall Study|Other|0|||
126418429|NCT02362464|454825236|FG000|Overall Study|Switched to alternative therapy|1|||
126418430|NCT02362464|454825236|FG000|Overall Study|Refused further treatment|1|||
126418431|NCT02362464|454825236|FG000|Overall Study|Physician Decision|4|||
126418432|NCT02123823|454825238|FG000|Overall Study|Lack of Efficacy|0|||
126418433|NCT02123823|454825239|FG001|Overall Study|Lack of Efficacy|2|||
126418434|NCT02123823|454825240|FG002|Overall Study|Lack of Efficacy|8|||
125891126|NCT02152956|452899711|FG004|Overall Study|Physician Decision|0|||
125891127|NCT02152956|452899712|FG005|Overall Study|Physician Decision|0|||
125891128|NCT02152956|452899713|FG006|Overall Study|Physician Decision|0|||
125891129|NCT02152956|452899714|FG007|Overall Study|Physician Decision|0|||
125891130|NCT02152956|452899715|FG008|Overall Study|Physician Decision|0|||
126418435|NCT02123823|454825241|FG003|Overall Study|Lack of Efficacy|10|||
125891131|NCT02152956|452899716|FG009|Overall Study|Physician Decision|0|||
126418436|NCT02123823|454825238|FG000|Overall Study|Progressive disease|3|||
126418437|NCT02123823|454825239|FG001|Overall Study|Progressive disease|19|||
126418438|NCT02123823|454825240|FG002|Overall Study|Progressive disease|52|||
125891132|NCT02152956|452899717|FG010|Overall Study|Physician Decision|0|||
126418439|NCT02123823|454825241|FG003|Overall Study|Progressive disease|53|||
125891133|NCT02152956|452899718|FG011|Overall Study|Physician Decision|1|||
125891134|NCT02152956|452899719|FG012|Overall Study|Physician Decision|0|||
126418440|NCT02123823|454825238|FG000|Overall Study|Withdrawal by Subject|0|||
126418441|NCT02123823|454825239|FG001|Overall Study|Withdrawal by Subject|0|||
126418442|NCT02123823|454825240|FG002|Overall Study|Withdrawal by Subject|7|||
126418443|NCT02123823|454825241|FG003|Overall Study|Withdrawal by Subject|2|||
126418444|NCT02123823|454825238|FG000|Overall Study|Adverse Event|0|||
126418445|NCT02123823|454825239|FG001|Overall Study|Adverse Event|0|||
126418446|NCT02123823|454825240|FG002|Overall Study|Adverse Event|3|||
126418447|NCT02123823|454825241|FG003|Overall Study|Adverse Event|5|||
126418448|NCT04346654|454825243|FG000|Overall Study|Adverse Event|2|||
126418449|NCT04346654|454825244|FG001|Overall Study|Adverse Event|0|||
126418450|NCT04346654|454825243|FG000|Overall Study|Non-response|1|||
126418451|NCT04346654|454825244|FG001|Overall Study|Non-response|1|||
126418452|NCT04346654|454825243|FG000|Overall Study|Withdrawal by Subject|2|||
126418453|NCT04346654|454825244|FG001|Overall Study|Withdrawal by Subject|0|||
126418454|NCT04346654|454825243|FG000|Overall Study|Lost to Follow-up|0|||
126418455|NCT04346654|454825244|FG001|Overall Study|Lost to Follow-up|1|||
126418456|NCT04346654|454825243|FG000|Overall Study|Pregnancy|0|||
126418457|NCT04346654|454825244|FG001|Overall Study|Pregnancy|1|||
126418458|NCT05715242|454825245|FG000|Overall Study|Lost to Follow-up|0|||
126418459|NCT05715242|454825246|FG001|Overall Study|Lost to Follow-up|0|||
126418460|NCT05715242|454825247|FG002|Overall Study|Lost to Follow-up|1|||
126418461|NCT05715242|454825248|FG003|Overall Study|Lost to Follow-up|0|||
126418462|NCT05715242|454825249|FG004|Overall Study|Lost to Follow-up|0|||
126418463|NCT05715242|454825250|FG005|Overall Study|Lost to Follow-up|1|||
126418464|NCT05715242|454825251|FG006|Overall Study|Lost to Follow-up|0|||
126418465|NCT05715242|454825252|FG007|Overall Study|Lost to Follow-up|0|||
126418466|NCT05715242|454825253|FG008|Overall Study|Lost to Follow-up|0|||
126418467|NCT05715242|454825254|FG009|Overall Study|Lost to Follow-up|0|||
126418468|NCT05715242|454825255|FG010|Overall Study|Lost to Follow-up|0|||
126418469|NCT05715242|454825256|FG011|Overall Study|Lost to Follow-up|0|||
126418470|NCT05715242|454825257|FG012|Overall Study|Lost to Follow-up|0|||
126418471|NCT05715242|454825258|FG013|Overall Study|Lost to Follow-up|0|||
126418472|NCT05715242|454825259|FG014|Overall Study|Lost to Follow-up|0|||
126418473|NCT05715242|454825260|FG015|Overall Study|Lost to Follow-up|0|||
126418474|NCT02915978|454825261|FG000|Overall Study|Adverse Event|2|||
126418475|NCT02915978|454825262|FG001|Overall Study|Adverse Event|1|||
126418476|NCT02915978|454825263|FG002|Overall Study|Adverse Event|0|||
126418477|NCT02343406|454825269|FG000|Overall Study|Progressive disease|72|||
126418478|NCT02343406|454825270|FG001|Overall Study|Progressive disease|70|||
126418479|NCT02343406|454825271|FG002|Overall Study|Progressive disease|43|||
126418480|NCT02343406|454825272|FG003|Overall Study|Progressive disease|15|||
126418481|NCT02343406|454825273|FG004|Overall Study|Progressive disease|5|||
126418482|NCT02343406|454825269|FG000|Overall Study|Adverse Event|6|||
126418483|NCT02343406|454825270|FG001|Overall Study|Adverse Event|8|||
126418484|NCT02343406|454825271|FG002|Overall Study|Adverse Event|6|||
126418485|NCT02343406|454825272|FG003|Overall Study|Adverse Event|3|||
126418486|NCT02343406|454825273|FG004|Overall Study|Adverse Event|0|||
126418487|NCT02343406|454825269|FG000|Overall Study|Withdrawal by Subject|6|||
126418488|NCT02343406|454825270|FG001|Overall Study|Withdrawal by Subject|4|||
126418489|NCT02343406|454825271|FG002|Overall Study|Withdrawal by Subject|8|||
126418490|NCT02343406|454825272|FG003|Overall Study|Withdrawal by Subject|3|||
126418491|NCT02343406|454825273|FG004|Overall Study|Withdrawal by Subject|0|||
126418492|NCT02343406|454825269|FG000|Overall Study|Death|2|||
126418493|NCT02343406|454825270|FG001|Overall Study|Death|1|||
126418494|NCT02343406|454825271|FG002|Overall Study|Death|0|||
126418495|NCT02343406|454825272|FG003|Overall Study|Death|0|||
126418496|NCT02343406|454825273|FG004|Overall Study|Death|0|||
126418497|NCT02343406|454825269|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
126418498|NCT02343406|454825270|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
126418499|NCT02343406|454825271|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
126418500|NCT02343406|454825272|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
126418501|NCT02343406|454825273|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
126418502|NCT02343406|454825269|FG000|Overall Study|Other primary malignancy|0|||
126418503|NCT02343406|454825270|FG001|Overall Study|Other primary malignancy|1|||
126418504|NCT02343406|454825271|FG002|Overall Study|Other primary malignancy|0|||
126418505|NCT02343406|454825272|FG003|Overall Study|Other primary malignancy|0|||
126418506|NCT02343406|454825273|FG004|Overall Study|Other primary malignancy|0|||
126418507|NCT02343406|454825269|FG000|Overall Study|Other, not specified|2|||
126418508|NCT02343406|454825270|FG001|Overall Study|Other, not specified|1|||
126418509|NCT02343406|454825271|FG002|Overall Study|Other, not specified|1|||
126418510|NCT02343406|454825272|FG003|Overall Study|Other, not specified|4|||
126418511|NCT02343406|454825273|FG004|Overall Study|Other, not specified|0|||
126418512|NCT02451124|454825274|FG000|Overall Study|Withdrawal by Subject|1|||
126418513|NCT00766051|454825275|FG000|Overall Study|Withdrawal by Subject|2|||
126418514|NCT00766051|454825276|FG001|Overall Study|Withdrawal by Subject|0|||
126418515|NCT00856297|454825282|FG000|Overall Study|Unable to classify|2|||
126418516|NCT00856297|454825283|FG001|Overall Study|Unable to classify|0|||
126418517|NCT00856297|454825284|FG002|Overall Study|Unable to classify|0|||
126418518|NCT00856297|454825285|FG003|Overall Study|Unable to classify|0|||
126418519|NCT00856297|454825286|FG004|Overall Study|Unable to classify|0|||
126418520|NCT01362608|454826660|FG000|Overall Study|Protocol Violation|0|||
126418521|NCT01362608|454826661|FG001|Overall Study|Protocol Violation|1|||
126418522|NCT01362608|454826660|FG000|Overall Study|Lost to Follow-up|3|||
126418523|NCT01362608|454826661|FG001|Overall Study|Lost to Follow-up|1|||
126418524|NCT01362608|454826660|FG000|Overall Study|Withdrawal by Subject|1|||
126418525|NCT01362608|454826661|FG001|Overall Study|Withdrawal by Subject|2|||
126418526|NCT01362608|454826660|FG000|Overall Study|Lack of Efficacy|0|||
126418527|NCT01362608|454826661|FG001|Overall Study|Lack of Efficacy|2|||
126418528|NCT01362608|454826660|FG000|Overall Study|Adverse Event|0|||
126418529|NCT01362608|454826661|FG001|Overall Study|Adverse Event|2|||
126418530|NCT04506502|454826664|FG000|Overall Study|Withdrawal by Subject|1|||
126418531|NCT04506502|454826664|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
126418532|NCT03526146|454826665|FG000|Overall Study|Lost to Follow-up|5|||
126418533|NCT03526146|454826665|FG000|Overall Study|Withdrawal by Subject|6|||
126418534|NCT03526146|454826665|FG000|Overall Study|class canceled due to COVID-19|4|||
126418535|NCT02517541|454826668|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
126418536|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
126418537|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
126418538|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
126418539|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
126418540|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
126418541|NCT00699608|454826669|FG000|First Intervention|Withdrawal by Subject|0|||
126418542|NCT00699608|454826670|FG001|First Intervention|Withdrawal by Subject|0|||
126418543|NCT00699608|454826671|FG002|First Intervention|Withdrawal by Subject|1|||
126418544|NCT00699608|454826672|FG003|First Intervention|Withdrawal by Subject|0|||
126418545|NCT00699608|454826673|FG004|First Intervention|Withdrawal by Subject|0|||
126418546|NCT00699608|454826674|FG005|First Intervention|Withdrawal by Subject|0|||
126418547|NCT00699608|454826669|FG000|First Intervention|Protocol Violation|0|||
126418548|NCT00699608|454826670|FG001|First Intervention|Protocol Violation|0|||
126418549|NCT00699608|454826671|FG002|First Intervention|Protocol Violation|0|||
126418550|NCT00699608|454826672|FG003|First Intervention|Protocol Violation|0|||
126418551|NCT00699608|454826673|FG004|First Intervention|Protocol Violation|1|||
126418552|NCT00699608|454826674|FG005|First Intervention|Protocol Violation|0|||
126418553|NCT00699608|454826669|FG000|Second Intervention|Adverse Event|0|||
126418554|NCT00699608|454826670|FG001|Second Intervention|Adverse Event|0|||
126418555|NCT00699608|454826671|FG002|Second Intervention|Adverse Event|1|||
126418556|NCT00699608|454826672|FG003|Second Intervention|Adverse Event|0|||
126418557|NCT00699608|454826673|FG004|Second Intervention|Adverse Event|0|||
126418558|NCT00699608|454826674|FG005|Second Intervention|Adverse Event|0|||
126418559|NCT00699608|454826669|FG000|Second Intervention|Withdrawal by Subject|0|||
126418560|NCT00699608|454826670|FG001|Second Intervention|Withdrawal by Subject|0|||
126418561|NCT00699608|454826671|FG002|Second Intervention|Withdrawal by Subject|0|||
126418562|NCT00699608|454826672|FG003|Second Intervention|Withdrawal by Subject|1|||
126418563|NCT00699608|454826673|FG004|Second Intervention|Withdrawal by Subject|0|||
126418564|NCT00699608|454826674|FG005|Second Intervention|Withdrawal by Subject|0|||
126418565|NCT01510158|454826675|FG000|Overall Study|Adverse Event|7|||
126418566|NCT01510158|454826676|FG001|Overall Study|Adverse Event|8|||
126418567|NCT01510158|454826677|FG002|Overall Study|Adverse Event|5|||
126418568|NCT01510158|454826675|FG000|Overall Study|Gout flare|1|||
126418569|NCT01510158|454826676|FG001|Overall Study|Gout flare|0|||
126418570|NCT01510158|454826677|FG002|Overall Study|Gout flare|0|||
126418571|NCT01510158|454826675|FG000|Overall Study|Protocol Violation|17|||
126418572|NCT01510158|454826676|FG001|Overall Study|Protocol Violation|16|||
126418573|NCT01510158|454826677|FG002|Overall Study|Protocol Violation|24|||
126418574|NCT01510158|454826675|FG000|Overall Study|Sponsor terminated study.|2|||
126418575|NCT01510158|454826676|FG001|Overall Study|Sponsor terminated study.|0|||
126418576|NCT01510158|454826677|FG002|Overall Study|Sponsor terminated study.|2|||
126418577|NCT01510158|454826675|FG000|Overall Study|Lost to Follow-up|13|||
126418578|NCT01510158|454826676|FG001|Overall Study|Lost to Follow-up|16|||
126418579|NCT01510158|454826677|FG002|Overall Study|Lost to Follow-up|9|||
126418580|NCT01510158|454826675|FG000|Overall Study|Withdrawal by Subject|10|||
126418581|NCT01510158|454826676|FG001|Overall Study|Withdrawal by Subject|13|||
126418582|NCT01510158|454826677|FG002|Overall Study|Withdrawal by Subject|10|||
126418583|NCT01510158|454826675|FG000|Overall Study|Death|1|||
126418584|NCT01510158|454826676|FG001|Overall Study|Death|0|||
126418585|NCT01510158|454826677|FG002|Overall Study|Death|0|||
126418586|NCT03010319|454826680|FG000|Overall Study|Adverse Event|15|||
126418587|NCT03010319|454826681|FG001|Overall Study|Adverse Event|9|||
126418588|NCT03010319|454826680|FG000|Overall Study|Withdrawal by Subject|1|||
126418589|NCT03010319|454826681|FG001|Overall Study|Withdrawal by Subject|6|||
126418590|NCT03010319|454826680|FG000|Overall Study|Physician Decision|2|||
126418591|NCT03010319|454826681|FG001|Overall Study|Physician Decision|4|||
126418592|NCT03010319|454826680|FG000|Overall Study|Sponsor requested withdrawal|2|||
126418593|NCT03010319|454826681|FG001|Overall Study|Sponsor requested withdrawal|2|||
126418594|NCT03010319|454826680|FG000|Overall Study|Death|1|||
126418595|NCT03010319|454826681|FG001|Overall Study|Death|0|||
126418596|NCT03010319|454826680|FG000|Overall Study|Lost to Follow-up|0|||
126418597|NCT03010319|454826681|FG001|Overall Study|Lost to Follow-up|1|||
126418598|NCT03010319|454826680|FG000|Overall Study|Other Reason|5|||
126418599|NCT03010319|454826681|FG001|Overall Study|Other Reason|7|||
126418600|NCT04720417|454826682|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
126418601|NCT03574779|454826683|FG000|Overall Study|Screening failure|13|||
126418602|NCT03574779|454826684|FG001|Overall Study|Screening failure|83|||
126418603|NCT02588261|454826687|FG000|Overall Study|Study Terminated by Sponsor|157|||
126418604|NCT02588261|454826688|FG001|Overall Study|Study Terminated by Sponsor|142|||
126418605|NCT02588261|454826687|FG000|Overall Study|Protocol Deviation|1|||
126418606|NCT02588261|454826688|FG001|Overall Study|Protocol Deviation|0|||
126418607|NCT02588261|454826687|FG000|Overall Study|Death|1|||
126418608|NCT02588261|454826688|FG001|Overall Study|Death|2|||
126418609|NCT02588261|454826687|FG000|Overall Study|Withdrawal by Subject|12|||
126418610|NCT02588261|454826688|FG001|Overall Study|Withdrawal by Subject|8|||
126418611|NCT02588261|454826687|FG000|Overall Study|Noncompliance with Study Drug|0|||
126418612|NCT02588261|454826688|FG001|Overall Study|Noncompliance with Study Drug|1|||
126418613|NCT02588261|454826687|FG000|Overall Study|Miscellaneous|5|||
126418614|NCT02588261|454826688|FG001|Overall Study|Miscellaneous|4|||
126418615|NCT02588261|454826687|FG000|Overall Study|Progressive Disease|61|||
126418616|NCT02588261|454826688|FG001|Overall Study|Progressive Disease|82|||
126418617|NCT02588261|454826687|FG000|Overall Study|Adverse Event|29|||
126418618|NCT02588261|454826688|FG001|Overall Study|Adverse Event|24|||
126418619|NCT02588261|454826687|FG000|Overall Study|Lost to Follow-up|1|||
126418620|NCT02588261|454826688|FG001|Overall Study|Lost to Follow-up|0|||
126418621|NCT03781778|454826689|FG000|Overall Study|Withdrawal by Subject|2|||
126418622|NCT03781778|454826690|FG001|Overall Study|Withdrawal by Subject|2|||
126418623|NCT02287467|454826691|FG000|Overall Study|Protocol Violation|12|||
126418624|NCT02287467|454826692|FG001|Overall Study|Protocol Violation|9|||
126418625|NCT03472950|454826695|FG000|Overall Study|Lost to Follow-up|0|||
126418626|NCT03472950|454826696|FG001|Overall Study|Lost to Follow-up|1|||
126418627|NCT03472950|454826695|FG000|Overall Study|Adverse Event|0|||
126418628|NCT03472950|454826696|FG001|Overall Study|Adverse Event|3|||
126418629|NCT00517361|454826701|FG000|Overall Study|Death|6|||
126418630|NCT00517361|454826701|FG000|Overall Study|The study was terminated|5|||
126418631|NCT00195091|454826702|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
126418632|NCT00245037|454826708|FG000|Overall Study|Death|17|||
126418633|NCT06964165|454826713|FG000|Overall Study|Withdrawal by Subject|0|||
126418634|NCT06964165|454826714|FG001|Overall Study|Withdrawal by Subject|1|||
126418635|NCT06964165|454826713|FG000|Overall Study|Ongoing at the time of analysis|15|||
126418636|NCT06964165|454826714|FG001|Overall Study|Ongoing at the time of analysis|14|||
126418637|NCT06964165|454826713|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
126418638|NCT06964165|454826714|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
126418639|NCT06964165|454826713|FG000|Overall Study|Participant removed due to non-compliance|0|||
126418640|NCT06964165|454826714|FG001|Overall Study|Participant removed due to non-compliance|1|||
126418641|NCT01514201|454826728|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
126418642|NCT01514201|454826729|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126054415|NCT03861052|453493888|FG002|Overall Study|Physician Decision|0|||
126418643|NCT01514201|454826730|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126418644|NCT01514201|454826731|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126418645|NCT01514201|454826728|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418646|NCT01514201|454826729|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
126418647|NCT01514201|454826730|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
126418648|NCT01514201|454826731|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418649|NCT01514201|454826728|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
126418650|NCT01514201|454826729|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
126418651|NCT01514201|454826730|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
126418652|NCT01514201|454826731|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
126418653|NCT01514201|454826728|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
126418654|NCT01514201|454826729|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
126418655|NCT01514201|454826730|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126418656|NCT01514201|454826731|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126418657|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
126418658|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
126418659|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
126418660|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
126418661|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
126418662|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
126418663|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
126418664|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
126418665|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
126418666|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
126054416|NCT03861052|453493889|FG003|Overall Study|Physician Decision|0|||
126054417|NCT03861052|453493886|FG000|Overall Study|Withdrawal by Subject|2|||
126054418|NCT03861052|453493887|FG001|Overall Study|Withdrawal by Subject|5|||
126054419|NCT03861052|453493888|FG002|Overall Study|Withdrawal by Subject|3|||
126054420|NCT03861052|453493889|FG003|Overall Study|Withdrawal by Subject|0|||
126054421|NCT03861052|453493886|FG000|Overall Study|Relocation to other city|1|||
126054422|NCT03861052|453493887|FG001|Overall Study|Relocation to other city|0|||
126054423|NCT03861052|453493888|FG002|Overall Study|Relocation to other city|0|||
126054424|NCT03861052|453493889|FG003|Overall Study|Relocation to other city|0|||
126054425|NCT03823703|453493890|FG000|Overall Study|Sponsor request|0|||
126054426|NCT03823703|453493891|FG001|Overall Study|Sponsor request|3|||
126054427|NCT03823703|453493892|FG002|Overall Study|Sponsor request|4|||
126054428|NCT03823703|453493890|FG000|Overall Study|Adverse Event|3|||
126054429|NCT03823703|453493891|FG001|Overall Study|Adverse Event|1|||
126054430|NCT03823703|453493892|FG002|Overall Study|Adverse Event|0|||
126054431|NCT03823703|453493890|FG000|Overall Study|Withdrawal by Subject|0|||
126054432|NCT03823703|453493891|FG001|Overall Study|Withdrawal by Subject|1|||
126054433|NCT03823703|453493892|FG002|Overall Study|Withdrawal by Subject|0|||
126054434|NCT03137459|453493893|FG000|2-month Assessment|Withdrawal by Subject|13|||
126054435|NCT03137459|453493894|FG001|2-month Assessment|Withdrawal by Subject|3|||
126054436|NCT03137459|453493893|FG000|2-month Assessment|Unable to reach|42|||
126054437|NCT03137459|453493894|FG001|2-month Assessment|Unable to reach|32|||
126054438|NCT03137459|453493893|FG000|2-month Assessment|Refused assessment|7|||
126054439|NCT03137459|453493894|FG001|2-month Assessment|Refused assessment|5|||
126054440|NCT03137459|453493893|FG000|2-month Assessment|Acutely ill|6|||
126054441|NCT03137459|453493894|FG001|2-month Assessment|Acutely ill|2|||
126054442|NCT03137459|453493893|FG000|4-month Assessment|Death|4|||
126054443|NCT03137459|453493894|FG001|4-month Assessment|Death|2|||
126054444|NCT03137459|453493893|FG000|4-month Assessment|Withdrawal by Subject|4|||
126054445|NCT03137459|453493894|FG001|4-month Assessment|Withdrawal by Subject|2|||
126054446|NCT03137459|453493893|FG000|4-month Assessment|Unable to reach|44|||
126054447|NCT03137459|453493894|FG001|4-month Assessment|Unable to reach|29|||
126054448|NCT03137459|453493893|FG000|4-month Assessment|Refused assessment|24|||
126054449|NCT03137459|453493894|FG001|4-month Assessment|Refused assessment|10|||
126054450|NCT03137459|453493893|FG000|4-month Assessment|Acutely ill|2|||
126054451|NCT03137459|453493894|FG001|4-month Assessment|Acutely ill|3|||
126054452|NCT03137459|453493893|FG000|6-months|Lost to Follow-up|14|||
126054453|NCT03137459|453493894|FG001|6-months|Lost to Follow-up|11|||
126054454|NCT03137459|453493893|FG000|6-months|Death|0|||
126054455|NCT03137459|453493894|FG001|6-months|Death|2|||
126054456|NCT03137459|453493893|FG000|6-months|Refused assessment|6|||
126054457|NCT03137459|453493894|FG001|6-months|Refused assessment|3|||
126054458|NCT03137459|453493893|FG000|6-months|Acutely ill|1|||
126054459|NCT03137459|453493894|FG001|6-months|Acutely ill|1|||
126054460|NCT01970878|453493896|FG000|Overall Study|Withdrawal by Subject|11|||
126054461|NCT01970878|453493897|FG001|Overall Study|Withdrawal by Subject|10|||
126054462|NCT01970878|453493898|FG002|Overall Study|Withdrawal by Subject|14|||
126054463|NCT01970878|453493899|FG003|Overall Study|Withdrawal by Subject|7|||
126054464|NCT01970878|453493896|FG000|Overall Study|Lost to Follow-up|1|||
126054465|NCT01970878|453493897|FG001|Overall Study|Lost to Follow-up|3|||
126054466|NCT01970878|453493898|FG002|Overall Study|Lost to Follow-up|2|||
126054467|NCT01970878|453493899|FG003|Overall Study|Lost to Follow-up|4|||
126054468|NCT01970878|453493896|FG000|Overall Study|Administrative Reasons|1|||
126054469|NCT01970878|453493897|FG001|Overall Study|Administrative Reasons|0|||
126054470|NCT01970878|453493898|FG002|Overall Study|Administrative Reasons|0|||
126054471|NCT01970878|453493899|FG003|Overall Study|Administrative Reasons|4|||
126054472|NCT01970878|453493896|FG000|Overall Study|Lack of Efficacy|2|||
126054473|NCT01970878|453493897|FG001|Overall Study|Lack of Efficacy|1|||
126054474|NCT01970878|453493898|FG002|Overall Study|Lack of Efficacy|2|||
126054475|NCT01970878|453493899|FG003|Overall Study|Lack of Efficacy|0|||
126054476|NCT01970878|453493896|FG000|Overall Study|Adverse Event|12|||
126054477|NCT01970878|453493897|FG001|Overall Study|Adverse Event|7|||
126054478|NCT01970878|453493898|FG002|Overall Study|Adverse Event|4|||
126054479|NCT01970878|453493899|FG003|Overall Study|Adverse Event|3|||
126054480|NCT01970878|453493896|FG000|Overall Study|Protocol Specified Criteria|10|||
126054481|NCT01970878|453493897|FG001|Overall Study|Protocol Specified Criteria|4|||
126054482|NCT01970878|453493898|FG002|Overall Study|Protocol Specified Criteria|3|||
126054483|NCT01970878|453493899|FG003|Overall Study|Protocol Specified Criteria|6|||
126054484|NCT01970878|453493896|FG000|Overall Study|Physician Decision|0|||
126054485|NCT01970878|453493897|FG001|Overall Study|Physician Decision|1|||
126054486|NCT01970878|453493898|FG002|Overall Study|Physician Decision|1|||
126054487|NCT01970878|453493899|FG003|Overall Study|Physician Decision|0|||
126054488|NCT01970878|453493896|FG000|Overall Study|No Completion Status|0|||
126054489|NCT01970878|453493897|FG001|Overall Study|No Completion Status|1|||
126054490|NCT01970878|453493898|FG002|Overall Study|No Completion Status|0|||
126054491|NCT01970878|453493899|FG003|Overall Study|No Completion Status|0|||
126054492|NCT00925548|453493900|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
126054493|NCT00925548|453493901|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
126054494|NCT04921358|453493902|FG000|Overall Study|Withdrawal by Subject|6|||
126054495|NCT04921358|453493903|FG001|Overall Study|Withdrawal by Subject|13|||
126054496|NCT04921358|453493902|FG000|Overall Study|Lost to Follow-up|3|||
126054497|NCT04921358|453493903|FG001|Overall Study|Lost to Follow-up|6|||
126054498|NCT04921358|453493902|FG000|Overall Study|Study Terminated by Sponsor|86|||
126054499|NCT04921358|453493903|FG001|Overall Study|Study Terminated by Sponsor|89|||
126054500|NCT04921358|453493902|FG000|Overall Study|Death|92|||
126054501|NCT04921358|453493903|FG001|Overall Study|Death|82|||
126054502|NCT02278796|453493904|FG000|Overall Study|Death|2|||
126054503|NCT02278796|453493905|FG001|Overall Study|Death|3|||
126054504|NCT04926857|453493906|FG000|Overall Study|Withdrawal by Subject|40|||
126054505|NCT04926857|453493906|FG000|Overall Study|Death|9|||
126054506|NCT04926857|453493906|FG000|Overall Study|Study product no longer in use|44|||
126054507|NCT04926857|453493906|FG000|Overall Study|Inadequate data to address primary objective|16|||
126054508|NCT02372799|453493907|FG000|Treatment Period|Adverse Event|3|||
126054509|NCT02372799|453493908|FG001|Treatment Period|Adverse Event|10|||
126054510|NCT02372799|453493909|FG002|Treatment Period|Adverse Event|6|||
126054511|NCT02372799|453493907|FG000|Treatment Period|Insufficient therapeutic response|2|||
126054512|NCT02372799|453493908|FG001|Treatment Period|Insufficient therapeutic response|2|||
126054513|NCT02372799|453493909|FG002|Treatment Period|Insufficient therapeutic response|0|||
126054514|NCT02372799|453493907|FG000|Treatment Period|Withdrawal by Subject|10|||
126054515|NCT02372799|453493908|FG001|Treatment Period|Withdrawal by Subject|10|||
125891135|NCT02152956|452899707|FG000|Overall Study|Study terminated by sponsor|0|||
125891136|NCT02152956|452899708|FG001|Overall Study|Study terminated by sponsor|0|||
125891137|NCT02152956|452899709|FG002|Overall Study|Study terminated by sponsor|0|||
125891138|NCT02152956|452899710|FG003|Overall Study|Study terminated by sponsor|0|||
125891139|NCT02152956|452899711|FG004|Overall Study|Study terminated by sponsor|0|||
126418667|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
126418668|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
126418669|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126418670|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125891140|NCT02152956|452899712|FG005|Overall Study|Study terminated by sponsor|0|||
125891141|NCT02152956|452899713|FG006|Overall Study|Study terminated by sponsor|0|||
125891142|NCT02152956|452899714|FG007|Overall Study|Study terminated by sponsor|0|||
125891143|NCT02152956|452899715|FG008|Overall Study|Study terminated by sponsor|0|||
125891144|NCT02152956|452899716|FG009|Overall Study|Study terminated by sponsor|0|||
125891145|NCT02152956|452899717|FG010|Overall Study|Study terminated by sponsor|0|||
125891146|NCT02152956|452899718|FG011|Overall Study|Study terminated by sponsor|29|||
125891147|NCT02152956|452899719|FG012|Overall Study|Study terminated by sponsor|0|||
125891148|NCT02152956|452899707|FG000|Overall Study|progressive disease|0|||
125891149|NCT02152956|452899708|FG001|Overall Study|progressive disease|0|||
125891150|NCT02152956|452899709|FG002|Overall Study|progressive disease|0|||
125891151|NCT02152956|452899710|FG003|Overall Study|progressive disease|0|||
125891152|NCT02152956|452899711|FG004|Overall Study|progressive disease|0|||
125891153|NCT02152956|452899712|FG005|Overall Study|progressive disease|0|||
125891154|NCT02152956|452899713|FG006|Overall Study|progressive disease|0|||
125891155|NCT02152956|452899714|FG007|Overall Study|progressive disease|0|||
125891156|NCT02152956|452899715|FG008|Overall Study|progressive disease|1|||
125891157|NCT02152956|452899716|FG009|Overall Study|progressive disease|0|||
125891158|NCT02152956|452899717|FG010|Overall Study|progressive disease|0|||
125891159|NCT02152956|452899718|FG011|Overall Study|progressive disease|1|||
125891160|NCT02152956|452899719|FG012|Overall Study|progressive disease|0|||
125891161|NCT02445794|452899720|FG000|Overall Study|Adverse Event|0|||
125891162|NCT02445794|452899721|FG001|Overall Study|Adverse Event|0|||
125891163|NCT02445794|452899722|FG002|Overall Study|Adverse Event|2|||
125891164|NCT02445794|452899723|FG003|Overall Study|Adverse Event|0|||
125891165|NCT01668589|452899724|FG000|Overall Study|Lost to Follow-up|29|||
125891166|NCT01668589|452899725|FG001|Overall Study|Lost to Follow-up|37|||
125891167|NCT01668589|452899726|FG002|Overall Study|Lost to Follow-up|15|||
125891168|NCT01668589|452899727|FG003|Overall Study|Lost to Follow-up|5|||
125891169|NCT01668589|452899724|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
126418671|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126418672|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
126418673|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
126418674|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
126418675|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
126418676|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
126418677|NCT01514201|454826728|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418678|NCT01514201|454826729|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418679|NCT01514201|454826730|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418680|NCT01514201|454826731|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
126418681|NCT01514201|454826728|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126105358|NCT01201265|453678608|FG000|Overall Study|Withdrawal by Subject|7|||
125891170|NCT01668589|452899725|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
125891171|NCT01668589|452899726|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
125891172|NCT01668589|452899727|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
125891173|NCT01668589|452899724|FG000|Overall Study|Death|12|||
125891174|NCT01668589|452899725|FG001|Overall Study|Death|3|||
125891175|NCT01668589|452899726|FG002|Overall Study|Death|2|||
125891176|NCT01668589|452899727|FG003|Overall Study|Death|11|||
125891177|NCT01668589|452899724|FG000|Overall Study|Other|44|||
126418682|NCT01514201|454826729|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126418683|NCT01514201|454826730|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126418684|NCT01514201|454826731|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
126418685|NCT01514201|454826728|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
126418686|NCT01514201|454826729|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
126418687|NCT01514201|454826730|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
126418688|NCT01514201|454826731|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
126418689|NCT05888181|454826732|FG000|Overall Study|Lost to Follow-up|1|||
126418690|NCT05888181|454826733|FG001|Overall Study|Lost to Follow-up|1|||
126418691|NCT05888181|454826734|FG002|Overall Study|Lost to Follow-up|0|||
126418692|NCT02735343|454826738|FG000|Overall Study|screen fail|0|||
126418693|NCT02735343|454826739|FG001|Overall Study|screen fail|2|||
126418694|NCT00637416|454826740|FG000|Overall Study|Lost to Follow-up|1|||
126418695|NCT00637416|454826741|FG001|Overall Study|Lost to Follow-up|1|||
126418696|NCT00637416|454826740|FG000|Overall Study|Unable to take study drug|0|||
126418697|NCT00637416|454826741|FG001|Overall Study|Unable to take study drug|1|||
126418698|NCT02534909|454826745|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
126418699|NCT01625000|454826748|FG000|Overall Study|Physician Decision|15|||
126418700|NCT01625000|454826749|FG001|Overall Study|Physician Decision|7|||
126418701|NCT01625000|454826750|FG002|Overall Study|Physician Decision|7|||
126418702|NCT01625000|454826751|FG003|Overall Study|Physician Decision|2|||
126418703|NCT01625000|454826752|FG004|Overall Study|Physician Decision|15|||
126418704|NCT01625000|454826748|FG000|Overall Study|Protocol Violation|3|||
126418705|NCT01625000|454826749|FG001|Overall Study|Protocol Violation|10|||
126418706|NCT01625000|454826750|FG002|Overall Study|Protocol Violation|4|||
126418707|NCT01625000|454826751|FG003|Overall Study|Protocol Violation|1|||
126418708|NCT01625000|454826752|FG004|Overall Study|Protocol Violation|2|||
126418709|NCT01625000|454826748|FG000|Overall Study|Withdrawal by Subject|19|||
126418710|NCT01625000|454826749|FG001|Overall Study|Withdrawal by Subject|16|||
126418711|NCT01625000|454826750|FG002|Overall Study|Withdrawal by Subject|11|||
126418712|NCT01625000|454826751|FG003|Overall Study|Withdrawal by Subject|9|||
126418713|NCT01625000|454826752|FG004|Overall Study|Withdrawal by Subject|17|||
126418714|NCT01625000|454826748|FG000|Overall Study|Adverse Event (including Death)|15|||
126418715|NCT01625000|454826749|FG001|Overall Study|Adverse Event (including Death)|19|||
126418716|NCT01625000|454826750|FG002|Overall Study|Adverse Event (including Death)|11|||
126418717|NCT01625000|454826751|FG003|Overall Study|Adverse Event (including Death)|7|||
126418718|NCT01625000|454826752|FG004|Overall Study|Adverse Event (including Death)|21|||
126418719|NCT00566852|454826753|FG000|Overall Study|Protocol Violation|22|||
126418720|NCT00566852|454826754|FG001|Overall Study|Protocol Violation|24|||
126418721|NCT00566852|454826753|FG000|Overall Study|Death|95|||
126418722|NCT00566852|454826754|FG001|Overall Study|Death|78|||
126418723|NCT00566852|454826753|FG000|Overall Study|Withdrawal by Subject|30|||
126418724|NCT00566852|454826754|FG001|Overall Study|Withdrawal by Subject|25|||
126418725|NCT00566852|454826753|FG000|Overall Study|Patient refusal|37|||
126418726|NCT00566852|454826754|FG001|Overall Study|Patient refusal|37|||
126418727|NCT00566852|454826753|FG000|Overall Study|Not tested due to disability|6|||
126418728|NCT00566852|454826754|FG001|Overall Study|Not tested due to disability|12|||
126418729|NCT00566852|454826753|FG000|Overall Study|Missing reason not specified|1|||
126418730|NCT00566852|454826754|FG001|Overall Study|Missing reason not specified|2|||
126418731|NCT00566852|454826753|FG000|Overall Study|Missing reason not reported|16|||
126418732|NCT00566852|454826754|FG001|Overall Study|Missing reason not reported|20|||
126418733|NCT05870865|454826759|FG000|Randomized|Did not receive study treatment|2|||
126418734|NCT05870865|454826760|FG001|Randomized|Did not receive study treatment|4|||
126418735|NCT05870865|454826761|FG002|Randomized|Did not receive study treatment|4|||
126418736|NCT05870865|454826762|FG003|Randomized|Did not receive study treatment|3|||
126418737|NCT05870865|454826759|FG000|Treatment Period|Adverse Event|1|||
126418738|NCT05870865|454826760|FG001|Treatment Period|Adverse Event|1|||
126054516|NCT02372799|453493909|FG002|Treatment Period|Withdrawal by Subject|2|||
126054517|NCT02372799|453493907|FG000|Treatment Period|Lost to Follow-up|11|||
126054518|NCT02372799|453493908|FG001|Treatment Period|Lost to Follow-up|5|||
126054519|NCT02372799|453493909|FG002|Treatment Period|Lost to Follow-up|3|||
126054520|NCT02372799|453493907|FG000|Treatment Period|Protocol Violation|3|||
126418739|NCT05870865|454826761|FG002|Treatment Period|Adverse Event|1|||
126418740|NCT05870865|454826762|FG003|Treatment Period|Adverse Event|1|||
126418741|NCT05870865|454826759|FG000|Treatment Period|Lost to Follow-up|0|||
126418742|NCT05870865|454826760|FG001|Treatment Period|Lost to Follow-up|1|||
126418743|NCT05870865|454826761|FG002|Treatment Period|Lost to Follow-up|2|||
126054521|NCT02372799|453493908|FG001|Treatment Period|Protocol Violation|0|||
126418744|NCT05870865|454826762|FG003|Treatment Period|Lost to Follow-up|0|||
126418745|NCT05870865|454826759|FG000|Treatment Period|Protocol Violation|0|||
126418746|NCT05870865|454826760|FG001|Treatment Period|Protocol Violation|0|||
126418747|NCT05870865|454826761|FG002|Treatment Period|Protocol Violation|0|||
126418748|NCT05870865|454826762|FG003|Treatment Period|Protocol Violation|1|||
126418749|NCT05870865|454826759|FG000|Treatment Period|Withdrawal by Subject|0|||
126418750|NCT05870865|454826760|FG001|Treatment Period|Withdrawal by Subject|1|||
126418751|NCT05870865|454826761|FG002|Treatment Period|Withdrawal by Subject|1|||
126418752|NCT05870865|454826762|FG003|Treatment Period|Withdrawal by Subject|1|||
126418753|NCT04752332|454826763|FG000|Overall Study|Adverse Event|3|||
126418754|NCT04752332|454826764|FG001|Overall Study|Adverse Event|1|||
126418755|NCT04752332|454826763|FG000|Overall Study|Disease Relapse|1|||
126418756|NCT04752332|454826764|FG001|Overall Study|Disease Relapse|0|||
126418757|NCT04752332|454826763|FG000|Overall Study|Non-compliance With Study Drug|2|||
126418758|NCT04752332|454826764|FG001|Overall Study|Non-compliance With Study Drug|0|||
126054522|NCT02372799|453493909|FG002|Treatment Period|Protocol Violation|0|||
126054523|NCT02372799|453493907|FG000|Treatment Period|Non-compliance with study drug|4|||
126054524|NCT02372799|453493908|FG001|Treatment Period|Non-compliance with study drug|4|||
126054525|NCT02372799|453493909|FG002|Treatment Period|Non-compliance with study drug|4|||
126054526|NCT02372799|453493907|FG000|Treatment Period|Miscellaneous Reasons|1|||
126054527|NCT02372799|453493908|FG001|Treatment Period|Miscellaneous Reasons|1|||
126054528|NCT02372799|453493909|FG002|Treatment Period|Miscellaneous Reasons|0|||
126054529|NCT02372799|453493907|FG000|Down-taper Period|Lost to Follow-up|1|||
126054530|NCT02372799|453493908|FG001|Down-taper Period|Lost to Follow-up|2|||
126054531|NCT02372799|453493909|FG002|Down-taper Period|Lost to Follow-up|2|||
126054532|NCT00747006|453493910|FG000|Overall Study|Adverse Event|1|||
126054533|NCT00747006|453493911|FG001|Overall Study|Adverse Event|0|||
126054534|NCT00747006|453493912|FG002|Overall Study|Adverse Event|0|||
126054535|NCT00747006|453493910|FG000|Overall Study|Lost to Follow-up|0|||
126054536|NCT00747006|453493911|FG001|Overall Study|Lost to Follow-up|1|||
126054537|NCT00747006|453493912|FG002|Overall Study|Lost to Follow-up|0|||
126418759|NCT04752332|454826763|FG000|Overall Study|Physician Decision|2|||
126418760|NCT04752332|454826764|FG001|Overall Study|Physician Decision|1|||
126418761|NCT04752332|454826763|FG000|Overall Study|Protocol Violation|1|||
126418762|NCT04752332|454826764|FG001|Overall Study|Protocol Violation|1|||
126418763|NCT04752332|454826763|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
126418764|NCT04752332|454826764|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
126418765|NCT04752332|454826763|FG000|Overall Study|Study Terminated by Sponsor|10|||
126418766|NCT04752332|454826764|FG001|Overall Study|Study Terminated by Sponsor|48|||
126418767|NCT04752332|454826763|FG000|Overall Study|Withdrawal by Subject|11|||
126418768|NCT04752332|454826764|FG001|Overall Study|Withdrawal by Subject|3|||
126418769|NCT00958165|454826765|FG000|Overall Study|Lost to Follow-up|5|||
126418770|NCT00958165|454826765|FG000|Overall Study|Not eligible|9|||
126418771|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
126418772|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
126418773|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
126418774|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Death|0|||
126418775|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Death|2|||
126418776|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Death|0|||
126418777|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
126418778|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
126418779|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
126418780|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
126418781|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
126418782|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
126418783|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
126418784|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
126418785|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
126418786|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
126418787|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
126418788|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
126418789|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
125891178|NCT01668589|452899725|FG001|Overall Study|Other|10|||
126054538|NCT00747006|453493910|FG000|Overall Study|Physician Decision|2|||
126054539|NCT00747006|453493911|FG001|Overall Study|Physician Decision|0|||
126054540|NCT00747006|453493912|FG002|Overall Study|Physician Decision|1|||
126054541|NCT00345046|453493917|FG000|Overall Study|Protocol Violation|1|||
126054542|NCT00345046|453493918|FG001|Overall Study|Protocol Violation|1|||
126054543|NCT00345046|453493919|FG002|Overall Study|Protocol Violation|2|||
126418790|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
126418791|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
126054544|NCT02824198|453493920|FG000|Overall Study|Non-compliance with the protocol|5|||
126054545|NCT02824198|453493921|FG001|Overall Study|Non-compliance with the protocol|1|||
125891179|NCT01668589|452899726|FG002|Overall Study|Other|7|||
126418792|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Recovery|1|||
126418793|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Recovery|0|||
126418794|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Recovery|1|||
126418795|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
126418796|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
126418797|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
126418798|NCT00195663|454826767|FG000|Open-Label Extension Period|Adverse Event|21|||
126418799|NCT00195663|454826768|FG001|Open-Label Extension Period|Adverse Event|32|||
126418800|NCT00195663|454826769|FG002|Open-Label Extension Period|Adverse Event|36|||
126418801|NCT00195663|454826767|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
126418802|NCT00195663|454826768|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
126418803|NCT00195663|454826769|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
126418804|NCT00195663|454826767|FG000|Open-Label Extension Period|Recovery|0|||
126418805|NCT00195663|454826768|FG001|Open-Label Extension Period|Recovery|2|||
126418806|NCT00195663|454826769|FG002|Open-Label Extension Period|Recovery|2|||
126418807|NCT00195663|454826767|FG000|Open-Label Extension Period|Protocol Violation|3|||
126418808|NCT00195663|454826768|FG001|Open-Label Extension Period|Protocol Violation|4|||
126418809|NCT00195663|454826769|FG002|Open-Label Extension Period|Protocol Violation|4|||
126418810|NCT00195663|454826767|FG000|Open-Label Extension Period|Death|2|||
126418811|NCT00195663|454826768|FG001|Open-Label Extension Period|Death|2|||
126418812|NCT00195663|454826769|FG002|Open-Label Extension Period|Death|2|||
126418813|NCT00195663|454826767|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
126418814|NCT00195663|454826768|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
126418815|NCT00195663|454826769|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
126418816|NCT00195663|454826767|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
126418817|NCT00195663|454826768|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
126418818|NCT00195663|454826769|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
126418819|NCT00195663|454826767|FG000|Open-Label Extension Period|Administrative reasons|11|||
126418820|NCT00195663|454826768|FG001|Open-Label Extension Period|Administrative reasons|11|||
126418821|NCT00195663|454826769|FG002|Open-Label Extension Period|Administrative reasons|13|||
126418822|NCT00604695|454826770|FG000|Overall Study|Did not receive first bolus.|0|||
126418823|NCT00604695|454826771|FG001|Overall Study|Did not receive first bolus.|4|||
126418824|NCT02058563|454826775|FG000|Overall Study|Lost to Follow-up|26|||
126418825|NCT02058563|454826776|FG001|Overall Study|Lost to Follow-up|22|||
126418826|NCT02058563|454826775|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
126418827|NCT02058563|454826776|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
126418828|NCT02058563|454826775|FG000|Overall Study|Consent Withdrawal|1|||
126418829|NCT02058563|454826776|FG001|Overall Study|Consent Withdrawal|1|||
126418830|NCT02058563|454826775|FG000|Overall Study|Other (patient incarcerated)|0|||
126418831|NCT02058563|454826776|FG001|Overall Study|Other (patient incarcerated)|1|||
126418832|NCT00166439|454826777|FG000|Overall Study|Ineligible|5|||
126418833|NCT04039217|454826778|FG000|Overall Study|Lost to Follow-up|1|||
126418834|NCT00615992|454826779|FG000|Overall Study|Protocol Violation|67|||
126418835|NCT04522141|454826780|FG000|Overall Study|Withdrawal by Subject|1|||
126418836|NCT04522141|454826781|FG001|Overall Study|Withdrawal by Subject|0|||
126418837|NCT01868477|454826782|FG000|Overall Study|Adverse Event|2|||
126418838|NCT01868477|454826783|FG001|Overall Study|Adverse Event|4|||
126418839|NCT01868477|454826782|FG000|Overall Study|Disease progression|1|||
126418840|NCT01868477|454826783|FG001|Overall Study|Disease progression|1|||
126418841|NCT01868477|454826782|FG000|Overall Study|Withdrawal by Subject|1|||
126418842|NCT01868477|454826783|FG001|Overall Study|Withdrawal by Subject|0|||
126418843|NCT00811174|454826784|FG000|Overall Study|Protocol Violation|2|||
126418844|NCT00811174|454826784|FG000|Overall Study|Sponsors Decision|1|||
126418845|NCT04864639|454828036|FG000|Overall Study|Death|1|||
126418846|NCT04864639|454828036|FG000|Overall Study|Lost to Follow-up|1|||
126418847|NCT00615017|454828037|FG000|Overall Study|Adverse Event|0|||
126418848|NCT00615017|454828038|FG001|Overall Study|Adverse Event|1|||
126418849|NCT00615017|454828039|FG002|Overall Study|Adverse Event|2|||
126418850|NCT00615017|454828040|FG003|Overall Study|Adverse Event|0|||
126418851|NCT00615017|454828041|FG004|Overall Study|Adverse Event|0|||
126418852|NCT00615017|454828042|FG005|Overall Study|Adverse Event|1|||
126418853|NCT00615017|454828037|FG000|Overall Study|Death|0|||
126418854|NCT00615017|454828038|FG001|Overall Study|Death|0|||
126418855|NCT00615017|454828039|FG002|Overall Study|Death|2|||
126418856|NCT00615017|454828040|FG003|Overall Study|Death|0|||
126418857|NCT00615017|454828041|FG004|Overall Study|Death|1|||
126418858|NCT00615017|454828042|FG005|Overall Study|Death|1|||
126418859|NCT00615017|454828037|FG000|Overall Study|Sepsis resolved|0|||
126418860|NCT00615017|454828038|FG001|Overall Study|Sepsis resolved|0|||
126418861|NCT00615017|454828039|FG002|Overall Study|Sepsis resolved|1|||
126418862|NCT00615017|454828040|FG003|Overall Study|Sepsis resolved|0|||
126418863|NCT00615017|454828041|FG004|Overall Study|Sepsis resolved|0|||
126418864|NCT00615017|454828042|FG005|Overall Study|Sepsis resolved|0|||
126418865|NCT00615017|454828037|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
126418866|NCT00615017|454828038|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
126418867|NCT00615017|454828039|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
126418868|NCT00615017|454828040|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
126418869|NCT00615017|454828041|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
126418870|NCT00615017|454828042|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
126418871|NCT00615017|454828037|FG000|Overall Study|Physician discontinued drug|0|||
126054546|NCT02824198|453493920|FG000|Overall Study|Lost to Follow-up|5|||
126054547|NCT02824198|453493921|FG001|Overall Study|Lost to Follow-up|2|||
126054548|NCT02824198|453493920|FG000|Overall Study|Withdrawal by Subject|5|||
126054549|NCT02824198|453493921|FG001|Overall Study|Withdrawal by Subject|0|||
126054550|NCT00562094|453493922|FG000|Overall Study|Lost to Follow-up|62|||
126054551|NCT03689946|453493925|FG000|Overall Study|Withdrawal by Subject|3|||
126054552|NCT03689946|453493925|FG000|Overall Study|Lost to Follow-up|3|||
126418872|NCT00615017|454828038|FG001|Overall Study|Physician discontinued drug|0|||
126418873|NCT00615017|454828039|FG002|Overall Study|Physician discontinued drug|0|||
126418874|NCT00615017|454828040|FG003|Overall Study|Physician discontinued drug|0|||
126054553|NCT03689946|453493925|FG000|Overall Study|Data corruption|2|||
126418875|NCT00615017|454828041|FG004|Overall Study|Physician discontinued drug|0|||
126418876|NCT00615017|454828042|FG005|Overall Study|Physician discontinued drug|1|||
126418877|NCT00806988|454828043|FG000|Overall Study|Death|15|||
126418878|NCT00806988|454828044|FG001|Overall Study|Death|16|||
126418879|NCT00806988|454828043|FG000|Overall Study|Withdrawal by Subject|8|||
126418880|NCT00806988|454828044|FG001|Overall Study|Withdrawal by Subject|8|||
126418881|NCT00806988|454828043|FG000|Overall Study|Lost to Follow-up|4|||
126418882|NCT00806988|454828044|FG001|Overall Study|Lost to Follow-up|19|||
126418883|NCT03078556|454828047|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
126418884|NCT03078556|454828048|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
126418885|NCT03078556|454828049|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
126418886|NCT03078556|454828050|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
126418887|NCT03078556|454828047|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
126418888|NCT03078556|454828048|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
126418889|NCT03078556|454828049|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
126418890|NCT03078556|454828050|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
126418891|NCT03078556|454828047|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
126418892|NCT03078556|454828048|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
126418893|NCT03078556|454828049|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
126418894|NCT03078556|454828050|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
126418895|NCT03078556|454828047|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
126418896|NCT03078556|454828048|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
126418897|NCT03078556|454828049|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
126418898|NCT03078556|454828050|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
126418899|NCT03314987|454828051|FG000|Overall Study|Lost to Follow-up|13|||
126418900|NCT03314987|454828052|FG001|Overall Study|Lost to Follow-up|13|||
126418901|NCT02751580|454828053|FG000|Overall Study|Lost to Follow-up|4|||
126418902|NCT02751580|454828053|FG000|Overall Study|Death|2|||
126418903|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Technical problems|0|||
126418904|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Technical problems|0|||
126418905|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Technical problems|0|||
126418906|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Technical problems|1|||
126418907|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
126418908|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
126418909|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
126418910|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
126418911|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
126418912|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
126418913|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
126418914|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
126418915|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
126418916|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
126418917|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
126418918|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
126054554|NCT01555138|453493926|FG000|Overall Study|Death|0|||
126054555|NCT01555138|453493927|FG001|Overall Study|Death|1|||
126418919|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Death|0|||
126418920|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Death|3|||
126418921|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Death|1|||
126418922|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Death|0|||
126418923|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
126418924|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
126418925|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
126418926|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
126418927|NCT02152761|454828060|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
126054556|NCT01555138|453493926|FG000|Overall Study|Lost to Follow-up|1|||
126054557|NCT01555138|453493927|FG001|Overall Study|Lost to Follow-up|0|||
126054558|NCT01555138|453493926|FG000|Overall Study|Abnormal Lab reults|1|||
126054559|NCT01555138|453493927|FG001|Overall Study|Abnormal Lab reults|3|||
126418928|NCT02152761|454828061|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
126418929|NCT02152761|454828062|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
126418930|NCT02152761|454828063|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
126418931|NCT02152761|454828060|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
126418932|NCT02152761|454828061|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
126418933|NCT02152761|454828062|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
126418934|NCT02152761|454828063|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
126418935|NCT02152761|454828060|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
126418936|NCT02152761|454828061|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
126418937|NCT02152761|454828062|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
126418938|NCT02152761|454828063|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
126418939|NCT02152761|454828060|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
126418940|NCT02152761|454828061|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
126418941|NCT02152761|454828062|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
126418942|NCT02152761|454828063|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
126418943|NCT03755882|454828064|FG000|Period 1|Protocol Violation|1|||
126418944|NCT03755882|454828065|FG001|Period 1|Protocol Violation|0|||
126418945|NCT03755882|454828064|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
126418946|NCT03755882|454828065|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
126418947|NCT02292446|454828066|FG000|Overall Study|Adverse Event|12|||
126418948|NCT02292446|454828066|FG000|Overall Study|Death|1|||
126418949|NCT02292446|454828066|FG000|Overall Study|Disease progression|2|||
126418950|NCT02292446|454828066|FG000|Overall Study|Subject/guardian decision|2|||
126418951|NCT02292446|454828066|FG000|Overall Study|Withdrawal by Subject|3|||
126418952|NCT00887549|454828069|FG000|Induction Therapy|Adverse Event|8|||
126418953|NCT00887549|454828069|FG000|Induction Therapy|Physician Decision|1|||
126418954|NCT00887549|454828069|FG000|Induction Therapy|Progressive Disease|13|||
126418955|NCT00887549|454828069|FG000|Induction Therapy|Death due to Study Disease|4|||
126418956|NCT00887549|454828069|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
126418957|NCT00887549|454828069|FG000|Maintenance Therapy|Adverse Event|16|||
126418958|NCT00887549|454828069|FG000|Maintenance Therapy|Physician Decision|1|||
126418959|NCT00887549|454828069|FG000|Maintenance Therapy|Progressive Disease|25|||
126418960|NCT00887549|454828069|FG000|Maintenance Therapy|Death due to adverse event|1|||
126418961|NCT03329846|454828072|FG000|Overall Study|Disease progression|4|||
126418962|NCT03329846|454828073|FG001|Overall Study|Disease progression|6|||
126418963|NCT03329846|454828072|FG000|Overall Study|Study drug toxicity|1|||
126418964|NCT03329846|454828073|FG001|Overall Study|Study drug toxicity|0|||
126418965|NCT03329846|454828072|FG000|Overall Study|Participant request to discontinue treatment|0|||
126418966|NCT03329846|454828073|FG001|Overall Study|Participant request to discontinue treatment|1|||
126418967|NCT03329846|454828072|FG000|Overall Study|Participant withdrew consent|1|||
126418968|NCT03329846|454828073|FG001|Overall Study|Participant withdrew consent|0|||
126418969|NCT03329846|454828072|FG000|Overall Study|Other reasons|2|||
126418970|NCT03329846|454828073|FG001|Overall Study|Other reasons|2|||
126418971|NCT00479336|454828074|FG000|Overall Study|Adverse Event|1|||
126418972|NCT00479336|454828075|FG001|Overall Study|Adverse Event|1|||
126418973|NCT00479336|454828076|FG002|Overall Study|Adverse Event|1|||
126418974|NCT00479336|454828077|FG003|Overall Study|Adverse Event|3|||
126418975|NCT00479336|454828074|FG000|Overall Study|Lack of Efficacy|1|||
126418976|NCT00479336|454828075|FG001|Overall Study|Lack of Efficacy|0|||
126418977|NCT00479336|454828076|FG002|Overall Study|Lack of Efficacy|0|||
126418978|NCT00479336|454828077|FG003|Overall Study|Lack of Efficacy|0|||
126418979|NCT00479336|454828074|FG000|Overall Study|Protocol Violation|0|||
126418980|NCT00479336|454828075|FG001|Overall Study|Protocol Violation|1|||
126418981|NCT00479336|454828076|FG002|Overall Study|Protocol Violation|0|||
126418982|NCT00479336|454828077|FG003|Overall Study|Protocol Violation|0|||
126418983|NCT00479336|454828074|FG000|Overall Study|Withdrawal by Subject|1|||
126418984|NCT00479336|454828075|FG001|Overall Study|Withdrawal by Subject|2|||
126418985|NCT00479336|454828076|FG002|Overall Study|Withdrawal by Subject|0|||
126418986|NCT00479336|454828077|FG003|Overall Study|Withdrawal by Subject|0|||
126418987|NCT00479336|454828074|FG000|Overall Study|Physician Decision|0|||
126418988|NCT00479336|454828075|FG001|Overall Study|Physician Decision|1|||
126418989|NCT00479336|454828076|FG002|Overall Study|Physician Decision|0|||
126418990|NCT00479336|454828077|FG003|Overall Study|Physician Decision|2|||
126418991|NCT00479336|454828074|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
126418992|NCT00479336|454828075|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
126418993|NCT00479336|454828076|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
126418994|NCT00479336|454828077|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
126418995|NCT03066193|454828078|FG000|Overall Study|Withdrawal by Subject|1|||
126418996|NCT02021643|454828079|FG000|Overall Study|Enrolled but Never Treated|1|||
126054560|NCT01555138|453493926|FG000|Overall Study|Lack of Efficacy|2|||
126054561|NCT01555138|453493927|FG001|Overall Study|Lack of Efficacy|2|||
126054562|NCT01555138|453493926|FG000|Overall Study|Protocol Violation|5|||
126418997|NCT02021643|454828080|FG001|Overall Study|Enrolled but Never Treated|0|||
126418998|NCT02021643|454828081|FG002|Overall Study|Enrolled but Never Treated|0|||
126418999|NCT02021643|454828082|FG003|Overall Study|Enrolled but Never Treated|0|||
126419000|NCT02021643|454828079|FG000|Overall Study|Adverse Event|0|||
126419001|NCT02021643|454828080|FG001|Overall Study|Adverse Event|1|||
126419002|NCT02021643|454828081|FG002|Overall Study|Adverse Event|0|||
126419003|NCT02021643|454828082|FG003|Overall Study|Adverse Event|0|||
126419004|NCT02021643|454828079|FG000|Overall Study|Death|0|||
126419005|NCT02021643|454828080|FG001|Overall Study|Death|1|||
126419006|NCT02021643|454828081|FG002|Overall Study|Death|0|||
126419007|NCT02021643|454828082|FG003|Overall Study|Death|0|||
126419008|NCT02021643|454828079|FG000|Overall Study|Investigator's Discretion|1|||
126419009|NCT02021643|454828080|FG001|Overall Study|Investigator's Discretion|0|||
126419010|NCT02021643|454828081|FG002|Overall Study|Investigator's Discretion|0|||
126419011|NCT02021643|454828082|FG003|Overall Study|Investigator's Discretion|0|||
126419012|NCT02021643|454828079|FG000|Overall Study|Lack of Efficacy|7|||
126419013|NCT02021643|454828080|FG001|Overall Study|Lack of Efficacy|6|||
126419014|NCT02021643|454828081|FG002|Overall Study|Lack of Efficacy|0|||
126419015|NCT02021643|454828082|FG003|Overall Study|Lack of Efficacy|12|||
126419016|NCT02021643|454828079|FG000|Overall Study|Lost to Follow-up|0|||
126419017|NCT02021643|454828080|FG001|Overall Study|Lost to Follow-up|1|||
126419018|NCT02021643|454828081|FG002|Overall Study|Lost to Follow-up|0|||
126419019|NCT02021643|454828082|FG003|Overall Study|Lost to Follow-up|0|||
126419020|NCT02021643|454828079|FG000|Overall Study|Withdrew Consent|0|||
126419021|NCT02021643|454828080|FG001|Overall Study|Withdrew Consent|1|||
126419022|NCT02021643|454828081|FG002|Overall Study|Withdrew Consent|0|||
126419023|NCT02021643|454828082|FG003|Overall Study|Withdrew Consent|0|||
126419024|NCT04854551|454828083|FG000|Overall Study|Withdrawal by Subject|1|||
126419025|NCT04854551|454828084|FG001|Overall Study|Withdrawal by Subject|1|||
126419026|NCT02631551|454828085|FG000|Overall Study|Adverse Event|1|||
126419027|NCT02631551|454828086|FG001|Overall Study|Adverse Event|2|||
126419028|NCT02631551|454828087|FG002|Overall Study|Adverse Event|4|||
126419029|NCT02631551|454828088|FG003|Overall Study|Adverse Event|0|||
126419030|NCT02631551|454828085|FG000|Overall Study|Lack of Efficacy|0|||
126419031|NCT02631551|454828086|FG001|Overall Study|Lack of Efficacy|0|||
126419032|NCT02631551|454828087|FG002|Overall Study|Lack of Efficacy|1|||
126419033|NCT02631551|454828088|FG003|Overall Study|Lack of Efficacy|0|||
126419034|NCT02631551|454828085|FG000|Overall Study|Lost to Follow-up|1|||
126419035|NCT02631551|454828086|FG001|Overall Study|Lost to Follow-up|2|||
126419036|NCT02631551|454828087|FG002|Overall Study|Lost to Follow-up|0|||
126419037|NCT02631551|454828088|FG003|Overall Study|Lost to Follow-up|3|||
126419038|NCT02631551|454828085|FG000|Overall Study|Withdrawal by Subject|2|||
126419039|NCT02631551|454828086|FG001|Overall Study|Withdrawal by Subject|2|||
126419040|NCT02631551|454828087|FG002|Overall Study|Withdrawal by Subject|0|||
126419041|NCT02631551|454828088|FG003|Overall Study|Withdrawal by Subject|5|||
126419042|NCT02631551|454828085|FG000|Overall Study|Protocol deviation|3|||
126419043|NCT02631551|454828086|FG001|Overall Study|Protocol deviation|6|||
126419044|NCT02631551|454828087|FG002|Overall Study|Protocol deviation|3|||
126419045|NCT02631551|454828088|FG003|Overall Study|Protocol deviation|0|||
126419046|NCT02631551|454828085|FG000|Overall Study|Non-compliance with study procedures|0|||
126419047|NCT02631551|454828086|FG001|Overall Study|Non-compliance with study procedures|0|||
126419048|NCT02631551|454828087|FG002|Overall Study|Non-compliance with study procedures|1|||
126419049|NCT02631551|454828088|FG003|Overall Study|Non-compliance with study procedures|1|||
126419050|NCT02631551|454828085|FG000|Overall Study|Non-compliance with study drug|1|||
126419051|NCT02631551|454828086|FG001|Overall Study|Non-compliance with study drug|0|||
126419052|NCT02631551|454828087|FG002|Overall Study|Non-compliance with study drug|0|||
126419053|NCT02631551|454828088|FG003|Overall Study|Non-compliance with study drug|0|||
126419054|NCT02631551|454828085|FG000|Overall Study|Other, specific reasons not collected|5|||
126054563|NCT01555138|453493927|FG001|Overall Study|Protocol Violation|3|||
126054564|NCT01555138|453493926|FG000|Overall Study|Administrative problems|8|||
126054565|NCT01555138|453493927|FG001|Overall Study|Administrative problems|0|||
126054566|NCT01555138|453493926|FG000|Overall Study|Withdrawal by Subject|16|||
126054567|NCT01555138|453493927|FG001|Overall Study|Withdrawal by Subject|15|||
126054568|NCT01555138|453493926|FG000|Overall Study|Adverse Event|14|||
126419055|NCT02631551|454828086|FG001|Overall Study|Other, specific reasons not collected|7|||
126419056|NCT02631551|454828087|FG002|Overall Study|Other, specific reasons not collected|2|||
126419057|NCT02631551|454828088|FG003|Overall Study|Other, specific reasons not collected|2|||
126419058|NCT04112303|454828089|FG000|Overall Study|Death|1|||
126419059|NCT00377858|454828098|FG000|Overall Study|Withdrawal by Subject|12|||
126419060|NCT00377858|454828099|FG001|Overall Study|Withdrawal by Subject|11|||
126419061|NCT00377858|454828098|FG000|Overall Study|Lost to Follow-up|6|||
126419062|NCT00377858|454828099|FG001|Overall Study|Lost to Follow-up|1|||
126419063|NCT00377858|454828098|FG000|Overall Study|Physician Decision|5|||
126419064|NCT00377858|454828099|FG001|Overall Study|Physician Decision|5|||
126419065|NCT00377858|454828098|FG000|Overall Study|Protocol Violation|3|||
126419066|NCT00377858|454828099|FG001|Overall Study|Protocol Violation|4|||
126419067|NCT00377858|454828098|FG000|Overall Study|Adverse Event|2|||
126419068|NCT00377858|454828099|FG001|Overall Study|Adverse Event|1|||
126419069|NCT00377858|454828098|FG000|Overall Study|Entry Criteria Not Met|2|||
126419070|NCT00377858|454828099|FG001|Overall Study|Entry Criteria Not Met|0|||
126419071|NCT00377858|454828098|FG000|Overall Study|Sponsor Decision|1|||
126419072|NCT00377858|454828099|FG001|Overall Study|Sponsor Decision|2|||
126419073|NCT00377858|454828098|FG000|Overall Study|Death|0|||
126419074|NCT00377858|454828099|FG001|Overall Study|Death|3|||
126419075|NCT05636852|454828100|FG000|Overall Study|Withdrawal by Subject|1|||
126419076|NCT05636852|454828100|FG000|Overall Study|Other than specified|1|||
126419077|NCT01685697|454828101|FG000|Overall Study|Protocol Violation|3|||
126419078|NCT01685697|454828102|FG001|Overall Study|Protocol Violation|3|||
126419079|NCT01076036|454828103|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
126419080|NCT04034004|454828108|FG000|Overall Study|Withdrawal by Subject|1|||
126054569|NCT01555138|453493927|FG001|Overall Study|Adverse Event|14|||
126419081|NCT04034004|454828109|FG001|Overall Study|Withdrawal by Subject|2|||
126419082|NCT04034004|454828110|FG002|Overall Study|Withdrawal by Subject|2|||
126419083|NCT04034004|454828111|FG003|Overall Study|Withdrawal by Subject|3|||
126419084|NCT04034004|454828108|FG000|Overall Study|could not find vein to administer IV|2|||
126419085|NCT04034004|454828109|FG001|Overall Study|could not find vein to administer IV|1|||
126419086|NCT04034004|454828110|FG002|Overall Study|could not find vein to administer IV|0|||
126419087|NCT04034004|454828111|FG003|Overall Study|could not find vein to administer IV|0|||
126419088|NCT04034004|454828108|FG000|Overall Study|nurse accidentally unblinded subject|0|||
126419089|NCT04034004|454828109|FG001|Overall Study|nurse accidentally unblinded subject|0|||
126419090|NCT04034004|454828110|FG002|Overall Study|nurse accidentally unblinded subject|0|||
126419091|NCT04034004|454828111|FG003|Overall Study|nurse accidentally unblinded subject|1|||
126419092|NCT01345188|454828112|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
126419093|NCT01345188|454828112|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
126419094|NCT01397461|454828113|FG000|Overall Study|Withdrawal by Subject|2|||
126419095|NCT01397461|454828114|FG001|Overall Study|Withdrawal by Subject|1|||
126419096|NCT01397461|454828115|FG002|Overall Study|Withdrawal by Subject|0|||
126419097|NCT01397461|454828113|FG000|Overall Study|Lost to Follow-up|0|||
126419098|NCT01397461|454828114|FG001|Overall Study|Lost to Follow-up|2|||
126419099|NCT01397461|454828115|FG002|Overall Study|Lost to Follow-up|1|||
126419100|NCT01397461|454828113|FG000|Overall Study|Lack of Efficacy|0|||
126419101|NCT01397461|454828114|FG001|Overall Study|Lack of Efficacy|3|||
126419102|NCT01397461|454828115|FG002|Overall Study|Lack of Efficacy|0|||
126419103|NCT01397461|454828113|FG000|Overall Study|Not treated|0|||
126419104|NCT01397461|454828114|FG001|Overall Study|Not treated|0|||
126419105|NCT01397461|454828115|FG002|Overall Study|Not treated|1|||
126419106|NCT05729568|454828132|FG000|Overall Study|Still on Study|52|||
126419107|NCT05729568|454828133|FG001|Overall Study|Still on Study|26|||
126419108|NCT05729568|454828132|FG000|Overall Study|Randomized but Never Treated|3|||
126419109|NCT05729568|454828133|FG001|Overall Study|Randomized but Never Treated|0|||
126105359|NCT01201265|453678608|FG000|Overall Study|Disease Progression|4|||
126419110|NCT05729568|454828132|FG000|Overall Study|Adverse Event|0|||
126419111|NCT05729568|454828133|FG001|Overall Study|Adverse Event|1|||
126419112|NCT05729568|454828132|FG000|Overall Study|Investigator's Discretion|1|||
126419113|NCT05729568|454828133|FG001|Overall Study|Investigator's Discretion|0|||
126419114|NCT04181762|454828134|FG000|Overall Study|Adverse Event|1|||
126419115|NCT04181762|454828135|FG001|Overall Study|Adverse Event|3|||
126419116|NCT04181762|454828134|FG000|Overall Study|Lost to Follow-up|1|||
126419117|NCT04181762|454828135|FG001|Overall Study|Lost to Follow-up|1|||
126419118|NCT04181762|454828134|FG000|Overall Study|Physician Decision|1|||
126419119|NCT04181762|454828135|FG001|Overall Study|Physician Decision|3|||
126419120|NCT04181762|454828134|FG000|Overall Study|Pregnancy|0|||
126419121|NCT04181762|454828135|FG001|Overall Study|Pregnancy|1|||
126419122|NCT04181762|454828134|FG000|Overall Study|Lack of Efficacy|2|||
126419123|NCT04181762|454828135|FG001|Overall Study|Lack of Efficacy|2|||
126419124|NCT04181762|454828134|FG000|Overall Study|Study terminated by sponsor|95|||
126419125|NCT04181762|454828135|FG001|Overall Study|Study terminated by sponsor|97|||
126419126|NCT04181762|454828134|FG000|Overall Study|Subject decision|11|||
126419127|NCT04181762|454828135|FG001|Overall Study|Subject decision|4|||
126419128|NCT04181762|454828134|FG000|Overall Study|Death|1|||
126419129|NCT04181762|454828135|FG001|Overall Study|Death|1|||
126419130|NCT04181762|454828134|FG000|Overall Study|Protocol deviation|1|||
126419131|NCT04181762|454828135|FG001|Overall Study|Protocol deviation|0|||
126419132|NCT04181762|454828134|FG000|Overall Study|Withdrawal of informed consent|1|||
126419133|NCT04181762|454828135|FG001|Overall Study|Withdrawal of informed consent|3|||
126419134|NCT04526145|454828136|FG000|Overall Study|Withdrawal by Subject|5|||
126419135|NCT01221350|454828142|FG000|Overall Study|Discontinued intervention (GERD)|1|||
126419136|NCT01221350|454828143|FG001|Overall Study|Discontinued intervention (GERD)|0|||
126419137|NCT01221350|454828142|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
126419138|NCT01221350|454828143|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
126419139|NCT01221350|454828142|FG000|Overall Study|Withdrawal by Subject|4|||
126419140|NCT01221350|454828143|FG001|Overall Study|Withdrawal by Subject|2|||
126419141|NCT00048347|454828159|FG000|Overall Study|Screen failure|2|||
126419142|NCT03508609|454828160|FG000|Overall Study|Withdrawal by Subject|1|||
126419143|NCT00555217|454828161|FG000|Overall Study|Withdrawal by Subject|35|||
126419144|NCT00555217|454828162|FG001|Overall Study|Withdrawal by Subject|31|||
126419145|NCT00555217|454828161|FG000|Overall Study|Lost to Follow-up|19|||
126419146|NCT00555217|454828162|FG001|Overall Study|Lost to Follow-up|20|||
126419147|NCT00555217|454828161|FG000|Overall Study|close out sites|21|||
126419148|NCT00555217|454828162|FG001|Overall Study|close out sites|17|||
126419149|NCT00367835|454828164|FG000|Overall Study|Adverse Event|14|||
126419150|NCT00367835|454828165|FG001|Overall Study|Adverse Event|1|||
126419151|NCT00367835|454828164|FG000|Overall Study|Protocol Violation|1|||
126419152|NCT00367835|454828165|FG001|Overall Study|Protocol Violation|7|||
126419153|NCT00367835|454828164|FG000|Overall Study|Withdrawal by Subject|7|||
126419154|NCT00367835|454828165|FG001|Overall Study|Withdrawal by Subject|6|||
126419155|NCT00367835|454828164|FG000|Overall Study|Lost to Follow-up|1|||
126419156|NCT00367835|454828165|FG001|Overall Study|Lost to Follow-up|4|||
126419157|NCT00367835|454828164|FG000|Overall Study|Lack of Efficacy|3|||
126419158|NCT00367835|454828165|FG001|Overall Study|Lack of Efficacy|12|||
126419159|NCT00367835|454828164|FG000|Overall Study|Subject in juvenile detention center|1|||
126419160|NCT00367835|454828165|FG001|Overall Study|Subject in juvenile detention center|0|||
126419161|NCT00367835|454828164|FG000|Overall Study|refused blood collection|1|||
126419162|NCT00367835|454828165|FG001|Overall Study|refused blood collection|0|||
126419163|NCT00367835|454828164|FG000|Overall Study|Did not respond to calls|1|||
126419164|NCT00367835|454828165|FG001|Overall Study|Did not respond to calls|0|||
126419165|NCT00367835|454828164|FG000|Overall Study|History of lead poisoning|0|||
126419166|NCT00367835|454828165|FG001|Overall Study|History of lead poisoning|1|||
126419167|NCT03761810|454828169|FG000|Overall Study|Adverse Event|12|||
126419168|NCT03761810|454828170|FG001|Overall Study|Adverse Event|0|||
126419169|NCT03761810|454828169|FG000|Overall Study|Lost to Follow-up|15|||
126419170|NCT03761810|454828170|FG001|Overall Study|Lost to Follow-up|7|||
126419171|NCT03761810|454828169|FG000|Overall Study|Pregnancy|1|||
126419172|NCT03761810|454828170|FG001|Overall Study|Pregnancy|0|||
126419173|NCT03761810|454828169|FG000|Overall Study|Withdrawal by Subject|14|||
126419174|NCT03761810|454828170|FG001|Overall Study|Withdrawal by Subject|5|||
126419175|NCT03761810|454828169|FG000|Overall Study|Physician Decision|1|||
126419176|NCT03761810|454828170|FG001|Overall Study|Physician Decision|0|||
126419177|NCT03761810|454828169|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
126419178|NCT03761810|454828170|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126419179|NCT03761810|454828169|FG000|Overall Study|Other Than Specified|1|||
126419180|NCT03761810|454828170|FG001|Overall Study|Other Than Specified|0|||
126419181|NCT01574651|454828171|FG000|Overall Study|Lost to Follow-up|2|||
126419182|NCT01574651|454828172|FG001|Overall Study|Lost to Follow-up|4|||
126419183|NCT01574651|454828171|FG000|Overall Study|Administrative problems|0|||
126419184|NCT01574651|454828172|FG001|Overall Study|Administrative problems|1|||
126419185|NCT01574651|454828171|FG000|Overall Study|Death|3|||
126419186|NCT01574651|454828172|FG001|Overall Study|Death|3|||
126419187|NCT01574651|454828171|FG000|Overall Study|Patient's inability to use the device|0|||
126419188|NCT01574651|454828172|FG001|Overall Study|Patient's inability to use the device|1|||
126419189|NCT01574651|454828171|FG000|Overall Study|Adverse Event|36|||
126419190|NCT01574651|454828172|FG001|Overall Study|Adverse Event|27|||
126419191|NCT01574651|454828171|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126419192|NCT01574651|454828172|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126419193|NCT01574651|454828171|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126419194|NCT01574651|454828172|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126419195|NCT01574651|454828171|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
126419196|NCT01574651|454828172|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126419197|NCT01574651|454828171|FG000|Overall Study|Protocol Violation|3|||
126419198|NCT01574651|454828172|FG001|Overall Study|Protocol Violation|5|||
126419199|NCT01574651|454828171|FG000|Overall Study|Withdrawal by Subject|9|||
126419200|NCT01574651|454828172|FG001|Overall Study|Withdrawal by Subject|10|||
126419201|NCT03887221|454828173|FG000|Overall Study|Protocol Violation|1|||
126419202|NCT03887221|454828174|FG001|Overall Study|Protocol Violation|0|||
126419203|NCT02487030|454828175|FG000|Overall Study|Lack of Efficacy|2|||
126419204|NCT02487030|454828176|FG001|Overall Study|Lack of Efficacy|4|||
126419205|NCT02487030|454828177|FG002|Overall Study|Lack of Efficacy|1|||
126419206|NCT02487030|454828178|FG003|Overall Study|Lack of Efficacy|0|||
126419207|NCT02487030|454828179|FG004|Overall Study|Lack of Efficacy|1|||
126419208|NCT02487030|454828180|FG005|Overall Study|Lack of Efficacy|0|||
126419209|NCT02487030|454828181|FG006|Overall Study|Lack of Efficacy|0|||
126419210|NCT02487030|454828175|FG000|Overall Study|Lost to Follow-up|0|||
126419211|NCT02487030|454828176|FG001|Overall Study|Lost to Follow-up|0|||
126419212|NCT02487030|454828177|FG002|Overall Study|Lost to Follow-up|1|||
126419213|NCT02487030|454828178|FG003|Overall Study|Lost to Follow-up|1|||
126419214|NCT02487030|454828179|FG004|Overall Study|Lost to Follow-up|0|||
126419215|NCT02487030|454828180|FG005|Overall Study|Lost to Follow-up|1|||
126419216|NCT02487030|454828181|FG006|Overall Study|Lost to Follow-up|0|||
126419217|NCT02487030|454828175|FG000|Overall Study|Adverse Event|0|||
126419218|NCT02487030|454828176|FG001|Overall Study|Adverse Event|0|||
126419219|NCT02487030|454828177|FG002|Overall Study|Adverse Event|0|||
126419220|NCT02487030|454828178|FG003|Overall Study|Adverse Event|1|||
126419221|NCT02487030|454828179|FG004|Overall Study|Adverse Event|0|||
126419222|NCT02487030|454828180|FG005|Overall Study|Adverse Event|0|||
126419223|NCT02487030|454828181|FG006|Overall Study|Adverse Event|0|||
126419224|NCT02487030|454828175|FG000|Overall Study|Death|0|||
126419225|NCT02487030|454828176|FG001|Overall Study|Death|0|||
126419226|NCT02487030|454828177|FG002|Overall Study|Death|0|||
126419227|NCT02487030|454828178|FG003|Overall Study|Death|0|||
126419228|NCT02487030|454828179|FG004|Overall Study|Death|1|||
126419229|NCT02487030|454828180|FG005|Overall Study|Death|0|||
126419230|NCT02487030|454828181|FG006|Overall Study|Death|0|||
126419231|NCT02092025|454828182|FG000|Overall Study|Case Report Forms Uncollected|44|||
126419232|NCT02092025|454828182|FG000|Overall Study|Protocol Deviation|24|||
126419233|NCT00264537|454828183|FG000|Overall Study|Death|0|||
126419234|NCT00264537|454828184|FG001|Overall Study|Death|3|||
126419235|NCT00264537|454828185|FG002|Overall Study|Death|3|||
126419236|NCT00264537|454828186|FG003|Overall Study|Death|2|||
126419237|NCT00264537|454828183|FG000|Overall Study|Lost to Follow-up|3|||
126419238|NCT00264537|454828184|FG001|Overall Study|Lost to Follow-up|4|||
126419239|NCT00264537|454828185|FG002|Overall Study|Lost to Follow-up|7|||
126419240|NCT00264537|454828186|FG003|Overall Study|Lost to Follow-up|6|||
126419241|NCT00264537|454828183|FG000|Overall Study|Adverse Event|21|||
126419242|NCT00264537|454828184|FG001|Overall Study|Adverse Event|32|||
126419243|NCT00264537|454828185|FG002|Overall Study|Adverse Event|24|||
126419244|NCT00264537|454828186|FG003|Overall Study|Adverse Event|34|||
126419245|NCT00264537|454828183|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126419246|NCT00264537|454828184|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
126419247|NCT00264537|454828185|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
126419248|NCT00264537|454828186|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
126419249|NCT00264537|454828183|FG000|Overall Study|Other|21|||
126419250|NCT00264537|454828184|FG001|Overall Study|Other|11|||
126419251|NCT00264537|454828185|FG002|Overall Study|Other|10|||
126419252|NCT00264537|454828186|FG003|Overall Study|Other|11|||
126419253|NCT00264537|454828183|FG000|Overall Study|Not treated|0|||
125891180|NCT01668589|452899727|FG003|Overall Study|Other|15|||
126419254|NCT00264537|454828184|FG001|Overall Study|Not treated|2|||
126419255|NCT00264537|454828185|FG002|Overall Study|Not treated|1|||
126419256|NCT00264537|454828186|FG003|Overall Study|Not treated|0|||
126419257|NCT03228212|454828188|FG000|Period 1|Adverse Event|1|||
126419258|NCT03228212|454828189|FG001|Period 1|Adverse Event|0|||
126419259|NCT03228212|454828188|FG000|Period 1|no longer meets eligibility criteria|0|||
126419260|NCT03228212|454828189|FG001|Period 1|no longer meets eligibility criteria|1|||
126419261|NCT03228212|454828188|FG000|Period 2|Lost to Follow-up|1|||
126419262|NCT03228212|454828189|FG001|Period 2|Lost to Follow-up|0|||
126419263|NCT01807299|454828190|FG000|Overall Study|Protocol Violation|3|||
126419264|NCT01807299|454828191|FG001|Overall Study|Protocol Violation|1|||
126419265|NCT01807299|454828192|FG002|Overall Study|Protocol Violation|0|||
126419266|NCT01807299|454828193|FG003|Overall Study|Protocol Violation|2|||
126419267|NCT00999544|454829930|FG000|Overall Study|Withdrawal by Subject|1|||
126419268|NCT02407223|454829932|FG000|Overall Study|Adverse Event|1|||
126419269|NCT02407223|454829933|FG001|Overall Study|Adverse Event|0|||
126419270|NCT02407223|454829934|FG002|Overall Study|Adverse Event|1|||
126419271|NCT02407223|454829932|FG000|Overall Study|Lack of Efficacy|6|||
125891181|NCT00661427|452899730|FG000|Overall Study|Adverse Event|5|||
126419272|NCT02407223|454829933|FG001|Overall Study|Lack of Efficacy|6|||
126419273|NCT02407223|454829934|FG002|Overall Study|Lack of Efficacy|4|||
126419274|NCT02407223|454829932|FG000|Overall Study|Lost to Follow-up|1|||
126419275|NCT02407223|454829933|FG001|Overall Study|Lost to Follow-up|0|||
126419276|NCT02407223|454829934|FG002|Overall Study|Lost to Follow-up|2|||
126419277|NCT02407223|454829932|FG000|Overall Study|Withdrawal by Subject|2|||
126419278|NCT02407223|454829933|FG001|Overall Study|Withdrawal by Subject|4|||
126419279|NCT02407223|454829934|FG002|Overall Study|Withdrawal by Subject|4|||
126419280|NCT02407223|454829932|FG000|Overall Study|Study Terminated by Sponsor|77|||
126419281|NCT02407223|454829933|FG001|Overall Study|Study Terminated by Sponsor|80|||
126419282|NCT02407223|454829934|FG002|Overall Study|Study Terminated by Sponsor|86|||
126419283|NCT02407223|454829932|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
126419284|NCT02407223|454829933|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
126419285|NCT02407223|454829934|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
126419286|NCT02407223|454829932|FG000|Overall Study|Other|29|||
126419287|NCT02407223|454829933|FG001|Overall Study|Other|27|||
126419288|NCT02407223|454829934|FG002|Overall Study|Other|25|||
126419289|NCT01478971|454829943|FG000|Standard of Care Period|Adverse Event|1|||
126419290|NCT01478971|454829943|FG000|Standard of Care Period|Withdrawal by Subject|3|||
126419291|NCT01478971|454829943|FG000|Standard of Care Period|Death|8|||
126419292|NCT01478971|454829943|FG000|Standard of Care Period|Lost to Follow-up|9|||
126419293|NCT01478971|454829943|FG000|Standard of Care Period|Other|4|||
126419294|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Adverse Event|1|||
126419295|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
126419296|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Death|4|||
126419297|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
126419298|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Other|4|||
126419299|NCT00584012|454829944|FG000|Overall Study|Withdrawal by Subject|1|||
126419300|NCT01525615|454829945|FG000|Overall Study|Adverse Event|11|||
126419301|NCT01525615|454829946|FG001|Overall Study|Adverse Event|7|||
126419302|NCT01525615|454829947|FG002|Overall Study|Adverse Event|5|||
126419303|NCT01525615|454829945|FG000|Overall Study|Lost to Follow-up|1|||
126419304|NCT01525615|454829946|FG001|Overall Study|Lost to Follow-up|0|||
126419305|NCT01525615|454829947|FG002|Overall Study|Lost to Follow-up|0|||
126419306|NCT01525615|454829945|FG000|Overall Study|Withdrawal by Subject|1|||
126419307|NCT01525615|454829946|FG001|Overall Study|Withdrawal by Subject|0|||
126419308|NCT01525615|454829947|FG002|Overall Study|Withdrawal by Subject|0|||
126419309|NCT01525615|454829945|FG000|Overall Study|Other reason not described above|1|||
126419310|NCT01525615|454829946|FG001|Overall Study|Other reason not described above|0|||
126419311|NCT01525615|454829947|FG002|Overall Study|Other reason not described above|1|||
126419312|NCT04050618|454829948|FG000|First Intervention|Withdrawal by Subject|2|||
126419313|NCT04050618|454829949|FG001|First Intervention|Withdrawal by Subject|0|||
126419314|NCT04050618|454829948|FG000|Second Intervention|Withdrawal by Subject|1|||
126419315|NCT04050618|454829949|FG001|Second Intervention|Withdrawal by Subject|0|||
126419316|NCT04404556|454829950|FG000|Intervention|Withdrawal by Subject|15|||
126419317|NCT04404556|454829951|FG001|Intervention|Withdrawal by Subject|3|||
126419318|NCT04404556|454829950|FG000|Intervention|Did not complete all intervention sessions|2|||
126419319|NCT04404556|454829951|FG001|Intervention|Did not complete all intervention sessions|1|||
126419320|NCT04404556|454829950|FG000|Post-Intervention|Missing Data|1|||
126419321|NCT04404556|454829951|FG001|Post-Intervention|Missing Data|2|||
126419322|NCT04404556|454829950|FG000|Follow-up 1|Withdrawal by Subject|5|||
126419323|NCT04404556|454829951|FG001|Follow-up 1|Withdrawal by Subject|1|||
126419324|NCT04404556|454829950|FG000|Follow-up 1|Missing Data|4|||
126419325|NCT04404556|454829951|FG001|Follow-up 1|Missing Data|7|||
126419326|NCT04404556|454829950|FG000|Follow-up 2|Withdrawal by Subject|1|||
126419327|NCT04404556|454829951|FG001|Follow-up 2|Withdrawal by Subject|1|||
126419328|NCT04404556|454829950|FG000|Follow-up 2|Missing Data|6|||
126419329|NCT04404556|454829951|FG001|Follow-up 2|Missing Data|5|||
126419330|NCT04775953|454829952|FG000|Overall Study|Lost to Follow-up|6|||
126419331|NCT04775953|454829953|FG001|Overall Study|Lost to Follow-up|11|||
126419332|NCT04775953|454829952|FG000|Overall Study|Death|5|||
126419333|NCT04775953|454829953|FG001|Overall Study|Death|4|||
126419334|NCT04775953|454829952|FG000|Overall Study|Withdrawal by Subject|3|||
126419335|NCT04775953|454829953|FG001|Overall Study|Withdrawal by Subject|3|||
126419336|NCT04775953|454829952|FG000|Overall Study|Protocol Violation|2|||
126419337|NCT04775953|454829953|FG001|Overall Study|Protocol Violation|0|||
126419338|NCT04775953|454829952|FG000|Overall Study|Participant non-compliance|0|||
126419339|NCT04775953|454829953|FG001|Overall Study|Participant non-compliance|1|||
126419340|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
126419341|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
126419342|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
126419343|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
126419344|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
126419345|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
126419346|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
126419347|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
126419348|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
126419349|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
126419350|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
126419351|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
126419352|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
126419353|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
126419354|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
126419355|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
126419356|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
126419357|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
126419358|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
126419359|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
126419360|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
126419361|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
126419362|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
126419363|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
126419364|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
126419365|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
126419366|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
126419367|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
126419368|NCT03777059|454829954|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
126419369|NCT03777059|454829955|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
126419370|NCT03777059|454829956|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
126419371|NCT03777059|454829957|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
126419372|NCT03777059|454829954|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
126419373|NCT03777059|454829955|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
126419374|NCT03777059|454829956|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
126419375|NCT03777059|454829957|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
126419376|NCT03777059|454829954|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
126419377|NCT03777059|454829955|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
126419378|NCT03777059|454829956|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
126419379|NCT03777059|454829957|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
126419380|NCT03777059|454829954|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
126419381|NCT03777059|454829955|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
126419382|NCT03777059|454829956|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
126419383|NCT03777059|454829957|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
126419384|NCT00855959|454829958|FG000|Overall Study|Adverse Event|2|||
126419385|NCT00855959|454829958|FG000|Overall Study|Lost to Follow-up|2|||
126419386|NCT00855959|454829958|FG000|Overall Study|Withdrawal by Subject|3|||
126419387|NCT00855959|454829958|FG000|Overall Study|Pregnancy|1|||
126419388|NCT00855959|454829958|FG000|Overall Study|Incorrect enrolment|1|||
126419389|NCT02813889|454829959|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
126419390|NCT02813889|454829960|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
126419391|NCT02451943|454829967|FG000|Overall Study|Withdrawal by Subject|13|||
126419392|NCT02451943|454829968|FG001|Overall Study|Withdrawal by Subject|16|||
126419393|NCT02451943|454829967|FG000|Overall Study|Lost to Follow-up|3|||
126419394|NCT02451943|454829968|FG001|Overall Study|Lost to Follow-up|4|||
126419395|NCT02451943|454829967|FG000|Overall Study|Sponsor Decision|0|||
126419396|NCT02451943|454829968|FG001|Overall Study|Sponsor Decision|4|||
126419397|NCT00368641|454829969|FG000|Overall Study|Adverse Event|2|||
126419398|NCT00368641|454829970|FG001|Overall Study|Adverse Event|1|||
126419399|NCT00368641|454829969|FG000|Overall Study|Death|1|||
126419400|NCT00368641|454829970|FG001|Overall Study|Death|0|||
126419401|NCT00368641|454829969|FG000|Overall Study|Withdrawal by Subject|1|||
126419402|NCT00368641|454829970|FG001|Overall Study|Withdrawal by Subject|0|||
126419403|NCT00368641|454829969|FG000|Overall Study|Sponsor decision to terminate study|2|||
126419404|NCT00368641|454829970|FG001|Overall Study|Sponsor decision to terminate study|5|||
126419405|NCT01101035|454829972|FG000|Overall Study|Adverse Event|191|||
126419406|NCT01101035|454829973|FG001|Overall Study|Adverse Event|172|||
126419407|NCT01101035|454829972|FG000|Overall Study|Major Protocol Deviation|52|||
126419408|NCT01101035|454829973|FG001|Overall Study|Major Protocol Deviation|46|||
126419409|NCT01101035|454829972|FG000|Overall Study|Lost to Follow-up|226|||
126419410|NCT01101035|454829973|FG001|Overall Study|Lost to Follow-up|223|||
126419411|NCT01101035|454829972|FG000|Overall Study|Voluntary Withdrawal|595|||
126419412|NCT01101035|454829973|FG001|Overall Study|Voluntary Withdrawal|587|||
126419413|NCT01101035|454829972|FG000|Overall Study|Reason not Specified|333|||
126419414|NCT01101035|454829973|FG001|Overall Study|Reason not Specified|363|||
126419415|NCT00763386|454829974|FG000|Overall Study|Adverse Event|43|||
126419416|NCT00763386|454829975|FG001|Overall Study|Adverse Event|33|||
126419417|NCT00763386|454829974|FG000|Overall Study|Death|1|||
126419418|NCT00763386|454829975|FG001|Overall Study|Death|2|||
126419419|NCT00763386|454829974|FG000|Overall Study|Lost to Follow-up|3|||
126419420|NCT00763386|454829975|FG001|Overall Study|Lost to Follow-up|3|||
126419421|NCT00763386|454829974|FG000|Overall Study|Withdrawal by Subject|0|||
126419422|NCT00763386|454829975|FG001|Overall Study|Withdrawal by Subject|1|||
126419423|NCT00763386|454829974|FG000|Overall Study|CRF missing|0|||
126419424|NCT00763386|454829975|FG001|Overall Study|CRF missing|1|||
126419425|NCT00763386|454829974|FG000|Overall Study|Study Prosthesis Removed|1|||
126419426|NCT00763386|454829975|FG001|Overall Study|Study Prosthesis Removed|0|||
126419427|NCT00681629|454829978|FG000|Overall Study|Study termination|4|||
126419428|NCT00681629|454829979|FG001|Overall Study|Study termination|2|||
126419429|NCT00681629|454829978|FG000|Overall Study|Adverse Event|1|||
126419430|NCT00681629|454829979|FG001|Overall Study|Adverse Event|0|||
126419431|NCT00411671|454829980|FG000|Overall Study|Adverse Event|15|||
126419432|NCT00411671|454829980|FG000|Overall Study|Death|2|||
126419433|NCT00411671|454829980|FG000|Overall Study|Lost to Follow-up|3|||
126419434|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
126419435|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126419436|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126419437|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126419438|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126419439|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
126419440|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126419441|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126419442|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126419443|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126419444|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
126419445|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126419446|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126419447|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126419448|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126419449|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
126419450|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126419451|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126419452|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126419453|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126419454|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
126419455|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126419456|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126419457|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126419458|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126419459|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
126419460|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126419461|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126419462|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126419463|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126419464|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
126419465|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126419466|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126419467|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126419468|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126419469|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
126419470|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
126419471|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
126419472|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
126419473|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
126419474|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
126419475|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
126419476|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
126419477|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
126419478|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
126419479|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
126419480|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
126419481|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
126419482|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
126419483|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
126419484|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126419485|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
126419486|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126419487|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
126419488|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
126419489|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
126419490|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
126419491|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126419492|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
126419493|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126419494|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
126419495|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
126419496|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
126419497|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
126419498|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
126419499|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126419500|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126419501|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126419502|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
126419503|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
126419504|NCT03951077|454829989|FG000|Overall Study|Adverse Event|1|||
126419505|NCT03951077|454829990|FG001|Overall Study|Adverse Event|0|||
126419506|NCT03951077|454829991|FG002|Overall Study|Adverse Event|0|||
126419507|NCT03951077|454829992|FG003|Overall Study|Adverse Event|0|||
126419508|NCT03951077|454829993|FG004|Overall Study|Adverse Event|0|||
126419509|NCT03951077|454829994|FG005|Overall Study|Adverse Event|0|||
126419510|NCT03951077|454829989|FG000|Overall Study|Withdrawal by Subject|3|||
126419511|NCT03951077|454829990|FG001|Overall Study|Withdrawal by Subject|3|||
126419512|NCT03951077|454829991|FG002|Overall Study|Withdrawal by Subject|0|||
126419513|NCT03951077|454829992|FG003|Overall Study|Withdrawal by Subject|3|||
126419514|NCT03951077|454829993|FG004|Overall Study|Withdrawal by Subject|3|||
126419515|NCT03951077|454829994|FG005|Overall Study|Withdrawal by Subject|2|||
126419516|NCT03951077|454829989|FG000|Overall Study|Lost to Follow-up|1|||
126419517|NCT03951077|454829990|FG001|Overall Study|Lost to Follow-up|1|||
126419518|NCT03951077|454829991|FG002|Overall Study|Lost to Follow-up|2|||
126419519|NCT03951077|454829992|FG003|Overall Study|Lost to Follow-up|3|||
126419520|NCT03951077|454829993|FG004|Overall Study|Lost to Follow-up|2|||
126419521|NCT03951077|454829994|FG005|Overall Study|Lost to Follow-up|3|||
126419522|NCT03951077|454829989|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
126419523|NCT03951077|454829990|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
126419524|NCT03951077|454829991|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
126419525|NCT03951077|454829992|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
126419526|NCT03951077|454829993|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
126419527|NCT03951077|454829994|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
126419528|NCT03951077|454829989|FG000|Overall Study|Other, Not Specified|12|||
126419529|NCT03951077|454829990|FG001|Overall Study|Other, Not Specified|10|||
126419530|NCT03951077|454829991|FG002|Overall Study|Other, Not Specified|10|||
126419531|NCT03951077|454829992|FG003|Overall Study|Other, Not Specified|5|||
126419532|NCT03951077|454829993|FG004|Overall Study|Other, Not Specified|9|||
126419533|NCT03951077|454829994|FG005|Overall Study|Other, Not Specified|6|||
126419534|NCT03951077|454829989|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
125891182|NCT00661427|452899731|FG001|Overall Study|Adverse Event|5|||
126419535|NCT03951077|454829990|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
126419536|NCT03951077|454829991|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
126419537|NCT03951077|454829992|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
126419538|NCT03951077|454829993|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
126419539|NCT03951077|454829994|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
126419540|NCT01395901|454829997|FG000|Overall Study|Lost to Follow-up|4|||
126419541|NCT01395901|454829998|FG001|Overall Study|Lost to Follow-up|0|||
126419542|NCT01395901|454829997|FG000|Overall Study|Randomized but not received study drug|5|||
126419543|NCT01395901|454829998|FG001|Overall Study|Randomized but not received study drug|4|||
125891183|NCT00661427|452899730|FG000|Overall Study|Patient not treated|0|||
125891184|NCT00661427|452899731|FG001|Overall Study|Patient not treated|2|||
126419544|NCT01395901|454829997|FG000|Overall Study|Adverse Event|0|||
126419545|NCT01395901|454829998|FG001|Overall Study|Adverse Event|1|||
126419546|NCT01395901|454829997|FG000|Overall Study|Withdrawal of consent|1|||
126419547|NCT01395901|454829998|FG001|Overall Study|Withdrawal of consent|0|||
126419548|NCT00713544|454830004|FG000|Overall Study|Adverse Event|5|||
126419549|NCT00713544|454830005|FG001|Overall Study|Adverse Event|3|||
126419550|NCT00713544|454830006|FG002|Overall Study|Adverse Event|7|||
126419551|NCT00713544|454830007|FG003|Overall Study|Adverse Event|7|||
126419552|NCT00713544|454830008|FG004|Overall Study|Adverse Event|3|||
126419553|NCT00713544|454830009|FG005|Overall Study|Adverse Event|5|||
126419554|NCT00713544|454830004|FG000|Overall Study|Withdrawal by Subject|2|||
126419555|NCT00713544|454830005|FG001|Overall Study|Withdrawal by Subject|0|||
126419556|NCT00713544|454830006|FG002|Overall Study|Withdrawal by Subject|3|||
126419557|NCT00713544|454830007|FG003|Overall Study|Withdrawal by Subject|2|||
126419558|NCT00713544|454830008|FG004|Overall Study|Withdrawal by Subject|3|||
126419559|NCT00713544|454830009|FG005|Overall Study|Withdrawal by Subject|1|||
126419560|NCT00713544|454830004|FG000|Overall Study|Protocol Violation|0|||
126419561|NCT00713544|454830005|FG001|Overall Study|Protocol Violation|0|||
126419562|NCT00713544|454830006|FG002|Overall Study|Protocol Violation|0|||
126419563|NCT00713544|454830007|FG003|Overall Study|Protocol Violation|0|||
126419564|NCT00713544|454830008|FG004|Overall Study|Protocol Violation|0|||
126419565|NCT00713544|454830009|FG005|Overall Study|Protocol Violation|1|||
126419566|NCT00713544|454830004|FG000|Overall Study|Physician Decision|0|||
126419567|NCT00713544|454830005|FG001|Overall Study|Physician Decision|0|||
126419568|NCT00713544|454830006|FG002|Overall Study|Physician Decision|0|||
126419569|NCT00713544|454830007|FG003|Overall Study|Physician Decision|0|||
126419570|NCT00713544|454830008|FG004|Overall Study|Physician Decision|0|||
126419571|NCT00713544|454830009|FG005|Overall Study|Physician Decision|2|||
126419572|NCT00713544|454830004|FG000|Overall Study|Lack of Efficacy|0|||
126419573|NCT00713544|454830005|FG001|Overall Study|Lack of Efficacy|1|||
126419574|NCT00713544|454830006|FG002|Overall Study|Lack of Efficacy|0|||
126419575|NCT00713544|454830007|FG003|Overall Study|Lack of Efficacy|1|||
126419576|NCT00713544|454830008|FG004|Overall Study|Lack of Efficacy|1|||
126419577|NCT00713544|454830009|FG005|Overall Study|Lack of Efficacy|0|||
126419578|NCT00713544|454830004|FG000|Overall Study|Lost to Follow-up|0|||
126419579|NCT00713544|454830005|FG001|Overall Study|Lost to Follow-up|0|||
126419580|NCT00713544|454830006|FG002|Overall Study|Lost to Follow-up|1|||
126419581|NCT00713544|454830007|FG003|Overall Study|Lost to Follow-up|0|||
126419582|NCT00713544|454830008|FG004|Overall Study|Lost to Follow-up|0|||
126419583|NCT00713544|454830009|FG005|Overall Study|Lost to Follow-up|0|||
126419584|NCT00713544|454830004|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419585|NCT00713544|454830005|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
126419586|NCT00713544|454830006|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419587|NCT00713544|454830007|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419588|NCT00713544|454830008|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419589|NCT00713544|454830009|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419590|NCT00713544|454830004|FG000|Overall Study|Incorrect enrollment|0|||
126419591|NCT00713544|454830005|FG001|Overall Study|Incorrect enrollment|1|||
126419592|NCT00713544|454830006|FG002|Overall Study|Incorrect enrollment|0|||
126419593|NCT00713544|454830007|FG003|Overall Study|Incorrect enrollment|0|||
126419594|NCT00713544|454830008|FG004|Overall Study|Incorrect enrollment|0|||
126419595|NCT00713544|454830009|FG005|Overall Study|Incorrect enrollment|0|||
126419596|NCT00713544|454830004|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
126419597|NCT00713544|454830005|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
126419598|NCT00713544|454830006|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
126419599|NCT00713544|454830007|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
126419600|NCT00713544|454830008|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
126419601|NCT00713544|454830009|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
126419602|NCT02380287|454830010|FG000|Overall Study|Adverse Event|0|||
126419603|NCT02380287|454830011|FG001|Overall Study|Adverse Event|0|||
126419604|NCT02380287|454830012|FG002|Overall Study|Adverse Event|1|||
126419605|NCT02380287|454830013|FG003|Overall Study|Adverse Event|0|||
126419606|NCT02380287|454830014|FG004|Overall Study|Adverse Event|0|||
126419607|NCT02380287|454830015|FG005|Overall Study|Adverse Event|0|||
126419608|NCT02380287|454830016|FG006|Overall Study|Adverse Event|0|||
126419609|NCT02380287|454830017|FG007|Overall Study|Adverse Event|0|||
126419610|NCT01290757|454830018|FG000|Overall Study|Adverse Event|1|||
126419611|NCT01290757|454830019|FG001|Overall Study|Adverse Event|0|||
126419612|NCT01290757|454830018|FG000|Overall Study|Protocol Violation|1|||
126419613|NCT01290757|454830019|FG001|Overall Study|Protocol Violation|1|||
126419614|NCT01290757|454830018|FG000|Overall Study|Other|0|||
126419615|NCT01290757|454830019|FG001|Overall Study|Other|1|||
126419616|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Death|0|||
126419617|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Death|0|||
126419618|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Death|0|||
126419619|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Death|0|||
126419620|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Death|1|||
126419621|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Death|0|||
126419622|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Death|0|||
126419623|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Death|0|||
126419624|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
126419625|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
126419626|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
126419627|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
126419628|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
126419629|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
126419630|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
126419631|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
126419632|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
126419633|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419634|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419635|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
126419636|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419637|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
126419638|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419639|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419640|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
126419641|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
126419642|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
126419643|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
126419644|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
126419645|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
126419646|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
126419647|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
126419648|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
126419649|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
126419650|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
126419651|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
126419652|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
126419653|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
126419654|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
126419655|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
126419656|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
126419657|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
126419658|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
126419659|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
126419660|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
126419661|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
126419662|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
126419663|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
126419664|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
126419665|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419666|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419667|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419668|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419669|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
126054570|NCT01613417|453493928|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
126419670|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419671|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419672|NCT00726232|454830022|FG000|Expansion Phase|Death|0|||
126419673|NCT00726232|454830023|FG001|Expansion Phase|Death|0|||
126419674|NCT00726232|454830024|FG002|Expansion Phase|Death|0|||
126419675|NCT00726232|454830025|FG003|Expansion Phase|Death|0|||
126419676|NCT00726232|454830026|FG004|Expansion Phase|Death|0|||
126419677|NCT00726232|454830027|FG005|Expansion Phase|Death|0|||
126419678|NCT00726232|454830028|FG006|Expansion Phase|Death|0|||
126419679|NCT00726232|454830029|FG007|Expansion Phase|Death|1|||
126419680|NCT00726232|454830022|FG000|Expansion Phase|Adverse Event|0|||
126419681|NCT00726232|454830023|FG001|Expansion Phase|Adverse Event|0|||
126419682|NCT00726232|454830024|FG002|Expansion Phase|Adverse Event|0|||
126419683|NCT00726232|454830025|FG003|Expansion Phase|Adverse Event|0|||
126419684|NCT00726232|454830026|FG004|Expansion Phase|Adverse Event|0|||
126419685|NCT00726232|454830027|FG005|Expansion Phase|Adverse Event|0|||
126419686|NCT00726232|454830028|FG006|Expansion Phase|Adverse Event|6|||
126419687|NCT00726232|454830029|FG007|Expansion Phase|Adverse Event|11|||
126054571|NCT01613417|453493929|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
126419688|NCT00726232|454830022|FG000|Expansion Phase|Withdrawal by Subject|0|||
126419689|NCT00726232|454830023|FG001|Expansion Phase|Withdrawal by Subject|0|||
126419690|NCT00726232|454830024|FG002|Expansion Phase|Withdrawal by Subject|0|||
126419691|NCT00726232|454830025|FG003|Expansion Phase|Withdrawal by Subject|0|||
126419692|NCT00726232|454830026|FG004|Expansion Phase|Withdrawal by Subject|0|||
126419693|NCT00726232|454830027|FG005|Expansion Phase|Withdrawal by Subject|0|||
126419694|NCT00726232|454830028|FG006|Expansion Phase|Withdrawal by Subject|2|||
126419695|NCT00726232|454830029|FG007|Expansion Phase|Withdrawal by Subject|3|||
126419696|NCT00726232|454830022|FG000|Expansion Phase|Disease progression|0|||
126419697|NCT00726232|454830023|FG001|Expansion Phase|Disease progression|0|||
126419698|NCT00726232|454830024|FG002|Expansion Phase|Disease progression|0|||
126419699|NCT00726232|454830025|FG003|Expansion Phase|Disease progression|0|||
126419700|NCT00726232|454830026|FG004|Expansion Phase|Disease progression|0|||
126419701|NCT00726232|454830027|FG005|Expansion Phase|Disease progression|0|||
126419702|NCT00726232|454830028|FG006|Expansion Phase|Disease progression|4|||
126419703|NCT00726232|454830029|FG007|Expansion Phase|Disease progression|0|||
126419704|NCT00726232|454830022|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
126419705|NCT00726232|454830023|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
126419706|NCT00726232|454830024|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
126419707|NCT00726232|454830025|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
126419708|NCT00726232|454830026|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
126419709|NCT00726232|454830027|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
126419710|NCT00726232|454830028|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
126419711|NCT00726232|454830029|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
126419712|NCT00726232|454830022|FG000|Expansion Phase|Per Investigator: lack of response|0|||
126419713|NCT00726232|454830023|FG001|Expansion Phase|Per Investigator: lack of response|0|||
126419714|NCT00726232|454830024|FG002|Expansion Phase|Per Investigator: lack of response|0|||
126419715|NCT00726232|454830025|FG003|Expansion Phase|Per Investigator: lack of response|0|||
126419716|NCT00726232|454830026|FG004|Expansion Phase|Per Investigator: lack of response|0|||
126419717|NCT00726232|454830027|FG005|Expansion Phase|Per Investigator: lack of response|0|||
126419718|NCT00726232|454830028|FG006|Expansion Phase|Per Investigator: lack of response|1|||
126419719|NCT00726232|454830029|FG007|Expansion Phase|Per Investigator: lack of response|7|||
126419720|NCT00726232|454830022|FG000|Expansion Phase|Unspecified reason|0|||
126419721|NCT00726232|454830023|FG001|Expansion Phase|Unspecified reason|0|||
126419722|NCT00726232|454830024|FG002|Expansion Phase|Unspecified reason|0|||
126419723|NCT00726232|454830025|FG003|Expansion Phase|Unspecified reason|0|||
126419724|NCT00726232|454830026|FG004|Expansion Phase|Unspecified reason|0|||
126419725|NCT00726232|454830027|FG005|Expansion Phase|Unspecified reason|0|||
126419726|NCT00726232|454830028|FG006|Expansion Phase|Unspecified reason|1|||
126419727|NCT00726232|454830029|FG007|Expansion Phase|Unspecified reason|0|||
126419728|NCT03088917|454830030|FG000|Overall Study|In care/cured elsewhere|15|||
126419729|NCT03088917|454830030|FG000|Overall Study|Refuse re-evaluation|13|||
126419730|NCT03088917|454830030|FG000|Overall Study|Contact not established|13|||
126419731|NCT03088917|454830030|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
126419732|NCT03088917|454830030|FG000|Overall Study|Moved outside study region|50|||
126419733|NCT05447663|454830032|FG000|Overall Study|Study terminated by Sponsor|5|||
126419734|NCT05447663|454830032|FG000|Overall Study|Death|2|||
126419735|NCT05447663|454830032|FG000|Overall Study|Withdrawal by Subject|1|||
126419736|NCT06041919|454830033|FG000|Overall Study|Lost to Follow-up|1|||
126419737|NCT06041919|454830034|FG001|Overall Study|Lost to Follow-up|0|||
126419738|NCT06041919|454830035|FG002|Overall Study|Lost to Follow-up|0|||
126419739|NCT06041919|454830036|FG003|Overall Study|Lost to Follow-up|0|||
126419740|NCT06041919|454830037|FG004|Overall Study|Lost to Follow-up|0|||
126419741|NCT06041919|454830033|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
126419742|NCT06041919|454830034|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
126419743|NCT06041919|454830035|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
126419744|NCT06041919|454830036|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
126419745|NCT06041919|454830037|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
126419746|NCT01502228|454830038|FG000|Overall Study|Death|1|||
126419747|NCT02204072|454830041|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
126419748|NCT02204072|454830042|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
126419749|NCT02204072|454830043|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
126419750|NCT02204072|454830044|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
126419751|NCT02204072|454830045|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
126419752|NCT02204072|454830041|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
126419753|NCT02204072|454830042|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
126419754|NCT02204072|454830043|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
126419755|NCT02204072|454830044|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
126419756|NCT02204072|454830045|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
126419757|NCT02204072|454830041|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
126419758|NCT02204072|454830042|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
126054572|NCT00512252|453493930|FG000|Overall Study|Lost to Follow-up|0|||
126054573|NCT00512252|453493931|FG001|Overall Study|Lost to Follow-up|0|||
126054574|NCT00512252|453493932|FG002|Overall Study|Lost to Follow-up|1|||
126054575|NCT00512252|453493930|FG000|Overall Study|Protocol Violation|0|||
126054576|NCT00512252|453493931|FG001|Overall Study|Protocol Violation|0|||
126419759|NCT02204072|454830043|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
126419760|NCT02204072|454830044|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
126419761|NCT02204072|454830045|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
126419762|NCT02204072|454830041|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
126419763|NCT02204072|454830042|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
126419764|NCT02204072|454830043|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
126419765|NCT02204072|454830044|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
126419766|NCT02204072|454830045|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
126419767|NCT04209205|454830046|FG000|Overall Study|Adverse Event|2|||
126419768|NCT04209205|454830047|FG001|Overall Study|Adverse Event|3|||
126419769|NCT04209205|454830046|FG000|Overall Study|Lost to Follow-up|3|||
126419770|NCT04209205|454830047|FG001|Overall Study|Lost to Follow-up|1|||
126419771|NCT04209205|454830046|FG000|Overall Study|Physician Decision|1|||
126419772|NCT04209205|454830047|FG001|Overall Study|Physician Decision|1|||
126419773|NCT04209205|454830046|FG000|Overall Study|Subject decision|10|||
126419774|NCT04209205|454830047|FG001|Overall Study|Subject decision|10|||
126419775|NCT04209205|454830046|FG000|Overall Study|Progressive disease|1|||
126419776|NCT04209205|454830047|FG001|Overall Study|Progressive disease|0|||
126419777|NCT04209205|454830046|FG000|Overall Study|Protocol deviation|0|||
126419778|NCT04209205|454830047|FG001|Overall Study|Protocol deviation|1|||
126419779|NCT04209205|454830046|FG000|Overall Study|New therapy for study indication|1|||
126419780|NCT04209205|454830047|FG001|Overall Study|New therapy for study indication|0|||
126419781|NCT04209205|454830046|FG000|Overall Study|Adverse event - placebo not switched|0|||
126419782|NCT04209205|454830047|FG001|Overall Study|Adverse event - placebo not switched|1|||
126419783|NCT04209205|454830046|FG000|Overall Study|Subject decision - placebo not switched|0|||
126419784|NCT04209205|454830047|FG001|Overall Study|Subject decision - placebo not switched|5|||
126419785|NCT04209205|454830046|FG000|Overall Study|Death - placebo not switched|0|||
126419786|NCT04209205|454830047|FG001|Overall Study|Death - placebo not switched|1|||
126419787|NCT05236257|454830080|FG000|Overall Study|Ongoing with study treatment|29|||
126419788|NCT05236257|454830081|FG001|Overall Study|Ongoing with study treatment|1|||
126419789|NCT05236257|454830080|FG000|Overall Study|Discontinued study treatment|22|||
126419790|NCT05236257|454830081|FG001|Overall Study|Discontinued study treatment|41|||
126419791|NCT00924443|454830085|FG000|Overall Study|Physician Decision|2|||
126419792|NCT00924443|454830085|FG000|Overall Study|Protocol Violation|1|||
126419793|NCT00874848|454830086|FG000|Overall Study|Adverse Event|13|||
126419794|NCT00874848|454830087|FG001|Overall Study|Adverse Event|2|||
126419795|NCT00874848|454830086|FG000|Overall Study|Progressive neoplastic disease|38|||
126419796|NCT00874848|454830087|FG001|Overall Study|Progressive neoplastic disease|18|||
126419797|NCT00874848|454830086|FG000|Overall Study|Withdrawal by Subject|7|||
126419798|NCT00874848|454830087|FG001|Overall Study|Withdrawal by Subject|4|||
126419799|NCT00874848|454830086|FG000|Overall Study|Noncompliance|1|||
126419800|NCT00874848|454830087|FG001|Overall Study|Noncompliance|1|||
126419801|NCT00874848|454830086|FG000|Overall Study|Failure to comply with protocol|0|||
126419802|NCT00874848|454830087|FG001|Overall Study|Failure to comply with protocol|1|||
126419803|NCT00874848|454830086|FG000|Overall Study|Physician Decision|0|||
126419804|NCT00874848|454830087|FG001|Overall Study|Physician Decision|2|||
126419805|NCT01746225|454830092|FG000|Overall Study|Death|1|||
126419806|NCT01746225|454830093|FG001|Overall Study|Death|0|||
126419807|NCT01746225|454830094|FG002|Overall Study|Death|1|||
126419808|NCT01746225|454830092|FG000|Overall Study|Withdrawal by Subject|5|||
126419809|NCT01746225|454830093|FG001|Overall Study|Withdrawal by Subject|15|||
126419810|NCT01746225|454830094|FG002|Overall Study|Withdrawal by Subject|19|||
126419811|NCT01746225|454830092|FG000|Overall Study|Physician Decision|14|||
126419812|NCT01746225|454830093|FG001|Overall Study|Physician Decision|11|||
126419813|NCT01746225|454830094|FG002|Overall Study|Physician Decision|3|||
126419814|NCT01746225|454830092|FG000|Overall Study|Adverse Event|15|||
126419815|NCT01746225|454830093|FG001|Overall Study|Adverse Event|12|||
126419816|NCT01746225|454830094|FG002|Overall Study|Adverse Event|17|||
126054577|NCT00512252|453493932|FG002|Overall Study|Protocol Violation|1|||
126054578|NCT00512252|453493930|FG000|Overall Study|Death|0|||
126054579|NCT00512252|453493931|FG001|Overall Study|Death|0|||
126054580|NCT00512252|453493932|FG002|Overall Study|Death|1|||
126419817|NCT01746225|454830092|FG000|Overall Study|Continuing Treatment|5|||
126419818|NCT01746225|454830093|FG001|Overall Study|Continuing Treatment|8|||
126419819|NCT01746225|454830094|FG002|Overall Study|Continuing Treatment|3|||
126419820|NCT03405818|454830097|FG000|Overall Study|Withdrawal by Subject|4|||
126419821|NCT03405818|454830097|FG000|Overall Study|Lost to Follow-up|4|||
126419822|NCT03197376|454830101|FG000|Primary and Booster Phase|Adverse Event|0|||
126419823|NCT03197376|454830102|FG001|Primary and Booster Phase|Adverse Event|0|||
126054581|NCT01079806|453493935|FG000|Day 1 to Week 96|Adverse Event|0|||
126419824|NCT03197376|454830103|FG002|Primary and Booster Phase|Adverse Event|0|||
126419825|NCT03197376|454830104|FG003|Primary and Booster Phase|Adverse Event|1|||
126419826|NCT03197376|454830101|FG000|Primary and Booster Phase|Death|1|||
126419827|NCT03197376|454830102|FG001|Primary and Booster Phase|Death|0|||
126419828|NCT03197376|454830103|FG002|Primary and Booster Phase|Death|0|||
126419829|NCT03197376|454830104|FG003|Primary and Booster Phase|Death|2|||
126419830|NCT03197376|454830101|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
126419831|NCT03197376|454830102|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
126419832|NCT03197376|454830103|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
126419833|NCT03197376|454830104|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
126419834|NCT03197376|454830101|FG000|Primary and Booster Phase|Physician Decision|1|||
126419835|NCT03197376|454830102|FG001|Primary and Booster Phase|Physician Decision|0|||
126419836|NCT03197376|454830103|FG002|Primary and Booster Phase|Physician Decision|1|||
126419837|NCT03197376|454830104|FG003|Primary and Booster Phase|Physician Decision|3|||
126419838|NCT03197376|454830101|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
126419839|NCT03197376|454830102|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
126419840|NCT03197376|454830103|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
126419841|NCT03197376|454830104|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
126419842|NCT03197376|454830101|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
126419843|NCT03197376|454830102|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
126419844|NCT03197376|454830103|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
126419845|NCT03197376|454830104|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
126419846|NCT03197376|454830101|FG000|Primary and Booster Phase|Not vaccine related|1|||
126419847|NCT03197376|454830102|FG001|Primary and Booster Phase|Not vaccine related|2|||
126419848|NCT03197376|454830103|FG002|Primary and Booster Phase|Not vaccine related|0|||
126419849|NCT03197376|454830104|FG003|Primary and Booster Phase|Not vaccine related|6|||
126419850|NCT03197376|454830101|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
126419851|NCT03197376|454830102|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
126419852|NCT03197376|454830103|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
126419853|NCT03197376|454830104|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
126419854|NCT03197376|454830101|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
126419855|NCT03197376|454830102|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
126419856|NCT03197376|454830103|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
126419857|NCT03197376|454830104|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
126419858|NCT03197376|454830101|FG000|Immune Persistence Phase|Not vaccine related|1|||
126419859|NCT03197376|454830102|FG001|Immune Persistence Phase|Not vaccine related|0|||
126419860|NCT03197376|454830103|FG002|Immune Persistence Phase|Not vaccine related|1|||
126419861|NCT03197376|454830104|FG003|Immune Persistence Phase|Not vaccine related|1|||
126419862|NCT00003199|454830105|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
126419863|NCT00003199|454830105|FG000|Overall Study|Lack of insurance clearance|2|||
126419864|NCT00003199|454830105|FG000|Overall Study|Screen fail|15|||
126419865|NCT01223183|454830107|FG000|Imaging Day 1|Physician Decision|0|||
126419866|NCT01223183|454830108|FG001|Imaging Day 1|Physician Decision|1|||
126419867|NCT01223183|454830107|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
126419868|NCT01223183|454830108|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
126419869|NCT01223183|454830107|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
126419870|NCT01223183|454830108|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
126419871|NCT01641601|454831822|FG000|Overall Study|Study discontinued.|3|||
126419872|NCT01641601|454831823|FG001|Overall Study|Study discontinued.|5|||
126419873|NCT00950846|454831829|FG000|Overall Study|Death|6|||
126419874|NCT00950846|454831829|FG000|Overall Study|Lost to Follow-up|3|||
126419875|NCT00950846|454831829|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
126419876|NCT01799226|454831830|FG000|Overall Study|Withdrawal by Subject|1|||
126419877|NCT01799226|454831831|FG001|Overall Study|Withdrawal by Subject|0|||
126419878|NCT01799226|454831830|FG000|Overall Study|Disqualified at Day 14|1|||
126419879|NCT01799226|454831831|FG001|Overall Study|Disqualified at Day 14|0|||
126419880|NCT02178995|454831832|FG000|Double Blind|Adverse Event|0|||
126419881|NCT02178995|454831833|FG001|Double Blind|Adverse Event|0|||
126419882|NCT02178995|454831834|FG002|Double Blind|Adverse Event|0|||
126419883|NCT02178995|454831835|FG003|Double Blind|Adverse Event|0|||
126419884|NCT02178995|454831836|FG004|Double Blind|Adverse Event|0|||
126419885|NCT02178995|454831837|FG005|Double Blind|Adverse Event|1|||
126419886|NCT02178995|454831838|FG006|Double Blind|Adverse Event|0|||
126419887|NCT02178995|454831839|FG007|Double Blind|Adverse Event|1|||
126419888|NCT02178995|454831840|FG008|Double Blind|Adverse Event|1|||
126419889|NCT02178995|454831832|FG000|Double Blind|Lost to Follow-up|0|||
126419890|NCT02178995|454831833|FG001|Double Blind|Lost to Follow-up|1|||
126419891|NCT02178995|454831834|FG002|Double Blind|Lost to Follow-up|0|||
126419892|NCT02178995|454831835|FG003|Double Blind|Lost to Follow-up|0|||
126419893|NCT02178995|454831836|FG004|Double Blind|Lost to Follow-up|0|||
126419894|NCT02178995|454831837|FG005|Double Blind|Lost to Follow-up|0|||
126419895|NCT02178995|454831838|FG006|Double Blind|Lost to Follow-up|0|||
126419896|NCT02178995|454831839|FG007|Double Blind|Lost to Follow-up|1|||
126419897|NCT02178995|454831840|FG008|Double Blind|Lost to Follow-up|0|||
126419898|NCT02178995|454831832|FG000|Open Label|Adverse Event|2|||
126419899|NCT02178995|454831833|FG001|Open Label|Adverse Event|0|||
126419900|NCT02178995|454831834|FG002|Open Label|Adverse Event|0|||
126419901|NCT02178995|454831835|FG003|Open Label|Adverse Event|0|||
126419902|NCT02178995|454831836|FG004|Open Label|Adverse Event|0|||
126419903|NCT02178995|454831837|FG005|Open Label|Adverse Event|0|||
126419904|NCT02178995|454831838|FG006|Open Label|Adverse Event|0|||
126419905|NCT02178995|454831839|FG007|Open Label|Adverse Event|0|||
126419906|NCT02178995|454831840|FG008|Open Label|Adverse Event|0|||
126419907|NCT00587158|454831841|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
126419908|NCT00587158|454831842|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
126419909|NCT00587158|454831841|FG000|Overall Study|Physician Decision|0|||
126419910|NCT00587158|454831842|FG001|Overall Study|Physician Decision|1|||
126419911|NCT00587158|454831841|FG000|Overall Study|Lost to Follow-up|1|||
126419912|NCT00587158|454831842|FG001|Overall Study|Lost to Follow-up|2|||
126419913|NCT00587158|454831841|FG000|Overall Study|Death|0|||
126419914|NCT00587158|454831842|FG001|Overall Study|Death|1|||
126419915|NCT00587158|454831841|FG000|Overall Study|Subject did not want to take study med|0|||
126419916|NCT00587158|454831842|FG001|Overall Study|Subject did not want to take study med|1|||
126419917|NCT02274792|454831843|FG000|Overall Study|Withdrawal by Subject|13|||
126419918|NCT02274792|454831843|FG000|Overall Study|Lost to Follow-up|8|||
126419919|NCT02274792|454831843|FG000|Overall Study|Protocol Specified Criteria|2|||
126419920|NCT02274792|454831843|FG000|Overall Study|Sponsor Decision|2|||
126419921|NCT05258149|454831850|FG000|Period 1|Protocol Deviation|1|||
126419922|NCT05258149|454831851|FG001|Period 1|Protocol Deviation|0|||
126419923|NCT05258149|454831850|FG000|Period 1|Adverse Event|0|||
126419924|NCT05258149|454831851|FG001|Period 1|Adverse Event|1|||
126419925|NCT05258149|454831850|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
126419926|NCT05258149|454831851|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126419927|NCT05258149|454831850|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
126419928|NCT05258149|454831851|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
126419929|NCT05258149|454831850|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
126419930|NCT05258149|454831851|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
126419931|NCT00832416|454831854|FG000|Overall Study|Lack of Efficacy|17|||
126419932|NCT00832416|454831855|FG001|Overall Study|Lack of Efficacy|15|||
126419933|NCT00832416|454831856|FG002|Overall Study|Lack of Efficacy|13|||
126419934|NCT00832416|454831857|FG003|Overall Study|Lack of Efficacy|52|||
126419935|NCT00832416|454831854|FG000|Overall Study|Withdrawal by Subject|5|||
126419936|NCT00832416|454831855|FG001|Overall Study|Withdrawal by Subject|7|||
126419937|NCT00832416|454831856|FG002|Overall Study|Withdrawal by Subject|2|||
126419938|NCT00832416|454831857|FG003|Overall Study|Withdrawal by Subject|10|||
126419939|NCT00832416|454831854|FG000|Overall Study|Physician Decision|2|||
126419940|NCT00832416|454831855|FG001|Overall Study|Physician Decision|12|||
126419941|NCT00832416|454831856|FG002|Overall Study|Physician Decision|5|||
126419942|NCT00832416|454831857|FG003|Overall Study|Physician Decision|10|||
126419943|NCT00832416|454831854|FG000|Overall Study|Administrative|0|||
126419944|NCT00832416|454831855|FG001|Overall Study|Administrative|0|||
126419945|NCT00832416|454831856|FG002|Overall Study|Administrative|0|||
126419946|NCT00832416|454831857|FG003|Overall Study|Administrative|1|||
126419947|NCT00832416|454831854|FG000|Overall Study|Adverse Event|21|||
126419948|NCT00832416|454831855|FG001|Overall Study|Adverse Event|19|||
126419949|NCT00832416|454831856|FG002|Overall Study|Adverse Event|41|||
126419950|NCT00832416|454831857|FG003|Overall Study|Adverse Event|10|||
126419951|NCT00832416|454831854|FG000|Overall Study|Death|1|||
126419952|NCT00832416|454831855|FG001|Overall Study|Death|0|||
126419953|NCT00832416|454831856|FG002|Overall Study|Death|0|||
126419954|NCT00832416|454831857|FG003|Overall Study|Death|0|||
126419955|NCT02114606|454831858|FG000|Overall Study|Unable to swallow Cytosponge|6|||
126419956|NCT00981461|454831859|FG000|Overall Study|Lost to Follow-up|5|||
126419957|NCT00981461|454831860|FG001|Overall Study|Lost to Follow-up|2|||
126419958|NCT03361293|454831869|FG000|Overall Study|Lost to Follow-up|0|||
126419959|NCT03361293|454831870|FG001|Overall Study|Lost to Follow-up|2|||
126419960|NCT03361293|454831869|FG000|Overall Study|Withdrawal by Subject|1|||
126419961|NCT03361293|454831870|FG001|Overall Study|Withdrawal by Subject|3|||
126419962|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
126419963|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
126419964|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
126419965|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
126419966|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
126419967|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
126419968|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
126419969|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
126419970|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
126419971|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
126419972|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
126419973|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
126419974|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
126419975|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
126419976|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
126419977|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
126419978|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
126419979|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
126419980|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
126419981|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
126419982|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
126419983|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
126419984|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
126419985|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
126419986|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
126419987|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
126419988|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
126419989|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
126419990|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
126419991|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
126419992|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
126419993|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
126419994|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
126419995|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
126419996|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
126419997|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
126419998|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
126419999|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
126420000|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
126420001|NCT00483405|454831876|FG000|Overall Study|Adverse Event|8|||
126420002|NCT00483405|454831876|FG000|Overall Study|Lack of Efficacy|14|||
126420003|NCT00483405|454831876|FG000|Overall Study|Death|3|||
126420004|NCT00483405|454831876|FG000|Overall Study|Withdrawal by Subject|2|||
126420005|NCT00483405|454831876|FG000|Overall Study|Other complicating disease|1|||
126420006|NCT00571038|454831877|FG000|Overall Study|Lost to Follow-up|1|||
126420007|NCT00571038|454831878|FG001|Overall Study|Lost to Follow-up|4|||
126420008|NCT00571038|454831877|FG000|Overall Study|Death|7|||
126420009|NCT00571038|454831878|FG001|Overall Study|Death|5|||
126420010|NCT00571038|454831877|FG000|Overall Study|Withdrawal by Subject|1|||
126420011|NCT00571038|454831878|FG001|Overall Study|Withdrawal by Subject|3|||
126420012|NCT00571038|454831877|FG000|Overall Study|Moved out of state|2|||
126420013|NCT00571038|454831878|FG001|Overall Study|Moved out of state|2|||
126420014|NCT01442714|454831879|FG000|Overall Study|Death|11|||
126420015|NCT01442714|454831879|FG000|Overall Study|Withdrawal by Subject|1|||
126420016|NCT04306510|454831880|FG000|Overall Study|Voluntarily withdrawal|1|||
126420017|NCT04306510|454831880|FG000|Overall Study|Enrolled but Not Treated|1|||
126420018|NCT04829916|454831890|FG000|Overall Study|Withdrawal by Subject|1|||
126420019|NCT04829916|454831891|FG001|Overall Study|Withdrawal by Subject|0|||
126420020|NCT04343755|454831892|FG000|Overall Study|Death|11|||
126420021|NCT04343755|454831892|FG000|Overall Study|Screen Failure|1|||
126420022|NCT00193206|454831893|FG000|Preoperative Therapy|Lack of Efficacy|2|||
126420023|NCT00193206|454831893|FG000|Preoperative Therapy|Adverse Event|2|||
126420024|NCT00193206|454831893|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
126420025|NCT00193206|454831893|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
126420026|NCT00193206|454831893|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
126420027|NCT00193206|454831893|FG000|Postoperative Therapy|Physician Decision|3|||
126420028|NCT00193206|454831893|FG000|Postoperative Therapy|Intercurrent Illness|2|||
126420029|NCT00193206|454831893|FG000|Postoperative Therapy|Lack of Efficacy|1|||
126420030|NCT00193206|454831893|FG000|Postoperative Therapy|Protocol Violation|1|||
126420031|NCT02859246|454831896|FG000|Overall Study|Screen fails|3|||
126420032|NCT02859246|454831896|FG000|Overall Study|Adverse Event|1|||
126420033|NCT02859246|454831896|FG000|Overall Study|Withdrawal by Subject|1|||
126420034|NCT00100789|454831897|FG000|Overall Study|Adverse Event|10|||
126420035|NCT00100789|454831897|FG000|Overall Study|Withdrawal by Subject|1|||
126420036|NCT00100789|454831897|FG000|Overall Study|Progression/relapse|42|||
126420037|NCT00100789|454831897|FG000|Overall Study|Death|2|||
126420038|NCT00100789|454831897|FG000|Overall Study|Not protocol specified|5|||
126420039|NCT00100789|454831897|FG000|Overall Study|Ineligible|3|||
126420040|NCT00100789|454831897|FG000|Overall Study|Never received treatment|1|||
126420041|NCT01746368|454831898|FG000|Overall Study|Lost to Follow-up|2|||
126420042|NCT01746368|454831899|FG001|Overall Study|Lost to Follow-up|0|||
126420043|NCT01746368|454831898|FG000|Overall Study|Withdrawal by Subject|0|||
126420044|NCT01746368|454831899|FG001|Overall Study|Withdrawal by Subject|1|||
126420045|NCT05280717|454831900|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
126420046|NCT05280717|454831901|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
126420047|NCT05280717|454831902|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
126420048|NCT05280717|454831903|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
126420049|NCT05280717|454831904|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
126420050|NCT05280717|454831905|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
126420051|NCT05280717|454831906|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
126420052|NCT05280717|454831900|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
126420053|NCT05280717|454831901|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420054|NCT05280717|454831902|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420055|NCT05280717|454831903|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420056|NCT05280717|454831904|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420057|NCT05280717|454831905|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420058|NCT05280717|454831906|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420059|NCT05280717|454831900|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420060|NCT05280717|454831901|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
126420061|NCT05280717|454831902|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420062|NCT05280717|454831903|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420063|NCT05280717|454831904|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420064|NCT05280717|454831905|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420065|NCT05280717|454831906|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420066|NCT05280717|454831900|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420067|NCT05280717|454831901|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420068|NCT05280717|454831902|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
126420069|NCT05280717|454831903|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420070|NCT05280717|454831904|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420071|NCT05280717|454831905|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420072|NCT05280717|454831906|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420073|NCT05280717|454831900|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420074|NCT05280717|454831901|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420075|NCT05280717|454831902|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420076|NCT05280717|454831903|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420077|NCT05280717|454831904|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420078|NCT05280717|454831905|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
126420079|NCT05280717|454831906|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420080|NCT05280717|454831900|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420081|NCT05280717|454831901|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420082|NCT05280717|454831902|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420083|NCT05280717|454831903|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420084|NCT05280717|454831904|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420085|NCT05280717|454831905|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
126420086|NCT05280717|454831906|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420087|NCT00080301|454831907|FG000|Overall Study|Randomized but Never Treated|5|||
126420088|NCT00080301|454831908|FG001|Overall Study|Randomized but Never Treated|10|||
126420089|NCT00080301|454831907|FG000|Overall Study|Still on Treatment as of CSR date|0|||
126420090|NCT00080301|454831908|FG001|Overall Study|Still on Treatment as of CSR date|1|||
126420091|NCT02940496|454831909|FG000|Overall Study|Adverse Event|1|||
126420092|NCT02940496|454831910|FG001|Overall Study|Adverse Event|0|||
126420093|NCT02940496|454831909|FG000|Overall Study|Death|2|||
126420094|NCT02940496|454831910|FG001|Overall Study|Death|0|||
126420095|NCT02940496|454831909|FG000|Overall Study|Hospice Care|1|||
126420096|NCT02940496|454831910|FG001|Overall Study|Hospice Care|0|||
126420097|NCT02940496|454831909|FG000|Overall Study|No MRE Done|1|||
126420098|NCT02940496|454831910|FG001|Overall Study|No MRE Done|0|||
126420099|NCT02940496|454831909|FG000|Overall Study|MRE Failure|1|||
126420100|NCT02940496|454831910|FG001|Overall Study|MRE Failure|0|||
125891185|NCT03304249|452899734|FG000|Overall Study|Lost to Follow-up|8|||
125891186|NCT03304249|452899735|FG001|Overall Study|Lost to Follow-up|10|||
126420101|NCT01147055|454831918|FG000|First Intervention Period|Lost to Follow-up|1|||
126420102|NCT01147055|454831919|FG001|First Intervention Period|Lost to Follow-up|0|||
126420103|NCT00132808|454831920|FG000|Stratum I|Adverse Event|2|||
126420104|NCT00132808|454831921|FG001|Stratum I|Adverse Event|1|||
126420105|NCT00132808|454831922|FG002|Stratum I|Adverse Event|0|||
126420106|NCT00132808|454831920|FG000|Stratum I|Lost to Follow-up|3|||
126420107|NCT00132808|454831921|FG001|Stratum I|Lost to Follow-up|4|||
126420108|NCT00132808|454831922|FG002|Stratum I|Lost to Follow-up|1|||
126420109|NCT00132808|454831920|FG000|Stratum I|Withdrawal by Subject|4|||
126420110|NCT00132808|454831921|FG001|Stratum I|Withdrawal by Subject|7|||
126420111|NCT00132808|454831922|FG002|Stratum I|Withdrawal by Subject|3|||
126420112|NCT00132808|454831920|FG000|Stratum I|Abnormal test procedure result (s)|0|||
126420113|NCT00132808|454831921|FG001|Stratum I|Abnormal test procedure result (s)|0|||
126420114|NCT00132808|454831922|FG002|Stratum I|Abnormal test procedure result (s)|1|||
126420115|NCT00132808|454831920|FG000|Stratum II|Adverse Event|1|||
126420116|NCT00132808|454831921|FG001|Stratum II|Adverse Event|2|||
126420117|NCT00132808|454831922|FG002|Stratum II|Adverse Event|1|||
126420118|NCT00132808|454831920|FG000|Stratum II|Death|1|||
126420119|NCT00132808|454831921|FG001|Stratum II|Death|0|||
126420120|NCT00132808|454831922|FG002|Stratum II|Death|0|||
126420121|NCT00132808|454831920|FG000|Stratum II|Lost to Follow-up|2|||
126420122|NCT00132808|454831921|FG001|Stratum II|Lost to Follow-up|2|||
126420123|NCT00132808|454831922|FG002|Stratum II|Lost to Follow-up|1|||
126420124|NCT00132808|454831920|FG000|Stratum II|Protocol Violation|0|||
126420125|NCT00132808|454831921|FG001|Stratum II|Protocol Violation|2|||
126420126|NCT00132808|454831922|FG002|Stratum II|Protocol Violation|1|||
126420127|NCT00132808|454831920|FG000|Stratum II|Withdrawal by Subject|4|||
126420128|NCT00132808|454831921|FG001|Stratum II|Withdrawal by Subject|9|||
126420129|NCT00132808|454831922|FG002|Stratum II|Withdrawal by Subject|6|||
126420130|NCT02863328|454831933|FG000|Overall Study|Lost to Follow-up|4|||
126420131|NCT02863328|454831934|FG001|Overall Study|Lost to Follow-up|10|||
126420132|NCT02863328|454831933|FG000|Overall Study|Withdrawal by Subject|7|||
126420133|NCT02863328|454831934|FG001|Overall Study|Withdrawal by Subject|12|||
126420134|NCT02863328|454831933|FG000|Overall Study|Died|0|||
126420135|NCT02863328|454831934|FG001|Overall Study|Died|1|||
126420136|NCT01870726|454831935|FG000|Overall Study|Withdrawal of informed consent|0|||
126420137|NCT01870726|454831936|FG001|Overall Study|Withdrawal of informed consent|0|||
126420138|NCT01870726|454831937|FG002|Overall Study|Withdrawal of informed consent|0|||
126420139|NCT01870726|454831938|FG003|Overall Study|Withdrawal of informed consent|1|||
126420140|NCT01870726|454831939|FG004|Overall Study|Withdrawal of informed consent|0|||
126420141|NCT01870726|454831940|FG005|Overall Study|Withdrawal of informed consent|0|||
126420142|NCT01870726|454831941|FG006|Overall Study|Withdrawal of informed consent|0|||
126420143|NCT01870726|454831935|FG000|Overall Study|Withdrawal by Subject|0|||
126420144|NCT01870726|454831936|FG001|Overall Study|Withdrawal by Subject|1|||
126420145|NCT01870726|454831937|FG002|Overall Study|Withdrawal by Subject|0|||
126420146|NCT01870726|454831938|FG003|Overall Study|Withdrawal by Subject|0|||
126420147|NCT01870726|454831939|FG004|Overall Study|Withdrawal by Subject|0|||
126420148|NCT01870726|454831940|FG005|Overall Study|Withdrawal by Subject|0|||
126420149|NCT01870726|454831941|FG006|Overall Study|Withdrawal by Subject|0|||
126420150|NCT01870726|454831935|FG000|Overall Study|Adverse Event|0|||
125891187|NCT03304249|452899734|FG000|Overall Study|Withdrawal by Subject|12|||
126420151|NCT01870726|454831936|FG001|Overall Study|Adverse Event|0|||
126420152|NCT01870726|454831937|FG002|Overall Study|Adverse Event|0|||
126420153|NCT01870726|454831938|FG003|Overall Study|Adverse Event|0|||
126420154|NCT01870726|454831939|FG004|Overall Study|Adverse Event|1|||
125891188|NCT03304249|452899735|FG001|Overall Study|Withdrawal by Subject|2|||
125891189|NCT03304249|452899734|FG000|Overall Study|Moved Out of District|4|||
125891190|NCT03304249|452899735|FG001|Overall Study|Moved Out of District|2|||
125891191|NCT04189224|452899736|FG000|Period 2|Adverse Event|0|||
126420155|NCT01870726|454831940|FG005|Overall Study|Adverse Event|1|||
126420156|NCT01870726|454831941|FG006|Overall Study|Adverse Event|0|||
126420157|NCT01870726|454831935|FG000|Overall Study|Progressive disease|5|||
126420158|NCT01870726|454831936|FG001|Overall Study|Progressive disease|5|||
126420159|NCT01870726|454831937|FG002|Overall Study|Progressive disease|4|||
126420160|NCT01870726|454831938|FG003|Overall Study|Progressive disease|5|||
126420161|NCT01870726|454831939|FG004|Overall Study|Progressive disease|6|||
126420162|NCT01870726|454831940|FG005|Overall Study|Progressive disease|4|||
126420163|NCT01870726|454831941|FG006|Overall Study|Progressive disease|10|||
126420164|NCT00286429|454831942|FG000|Overall Study|Adverse Event|4|||
126420165|NCT00286429|454831943|FG001|Overall Study|Adverse Event|1|||
126420166|NCT00286429|454831944|FG002|Overall Study|Adverse Event|6|||
126420167|NCT00286429|454831942|FG000|Overall Study|Lack of Efficacy|52|||
126420168|NCT00286429|454831943|FG001|Overall Study|Lack of Efficacy|27|||
126420169|NCT00286429|454831944|FG002|Overall Study|Lack of Efficacy|25|||
125891192|NCT04189224|452899737|FG001|Period 2|Adverse Event|1|||
125891193|NCT01064947|452899738|FG000|Overall Study|negative culture|41|||
126420170|NCT00286429|454831942|FG000|Overall Study|Lost to Follow-up|2|||
126420171|NCT00286429|454831943|FG001|Overall Study|Lost to Follow-up|4|||
126420172|NCT00286429|454831944|FG002|Overall Study|Lost to Follow-up|3|||
126420173|NCT00286429|454831942|FG000|Overall Study|Physician Decision|10|||
126420174|NCT00286429|454831943|FG001|Overall Study|Physician Decision|7|||
126420175|NCT00286429|454831944|FG002|Overall Study|Physician Decision|7|||
126420176|NCT00286429|454831942|FG000|Overall Study|Protocol Violation|3|||
126420177|NCT00286429|454831943|FG001|Overall Study|Protocol Violation|5|||
126420178|NCT00286429|454831944|FG002|Overall Study|Protocol Violation|4|||
126420179|NCT00286429|454831942|FG000|Overall Study|Withdrawal by Subject|3|||
126420180|NCT00286429|454831943|FG001|Overall Study|Withdrawal by Subject|2|||
126420181|NCT00286429|454831944|FG002|Overall Study|Withdrawal by Subject|6|||
126420182|NCT00286429|454831942|FG000|Overall Study|Administrative Error|1|||
126420183|NCT00286429|454831943|FG001|Overall Study|Administrative Error|1|||
126420184|NCT00286429|454831944|FG002|Overall Study|Administrative Error|1|||
126420185|NCT00286429|454831942|FG000|Overall Study|Administrative Decision|0|||
126420186|NCT00286429|454831943|FG001|Overall Study|Administrative Decision|1|||
126420187|NCT00286429|454831944|FG002|Overall Study|Administrative Decision|0|||
126420188|NCT00595478|454831945|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
126420189|NCT00595478|454831946|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
126420190|NCT00595478|454831945|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
126420191|NCT00595478|454831946|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
126420192|NCT01123395|454831948|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
126420193|NCT01123395|454831949|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
126420194|NCT03691571|454831950|FG000|Overall Study|Withdrawal by Subject|9|||
126420195|NCT03691571|454831951|FG001|Overall Study|Withdrawal by Subject|2|||
126420196|NCT00186901|454831954|FG000|Overall Study|Pregnancy|6|||
126420197|NCT00186901|454831955|FG001|Overall Study|Pregnancy|3|||
126420198|NCT00186901|454831956|FG002|Overall Study|Pregnancy|0|||
126420199|NCT00186901|454831954|FG000|Overall Study|Lost to Follow-up|6|||
126420200|NCT00186901|454831955|FG001|Overall Study|Lost to Follow-up|3|||
126420201|NCT00186901|454831956|FG002|Overall Study|Lost to Follow-up|0|||
126420202|NCT00186901|454831954|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
126420203|NCT00186901|454831955|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
126420204|NCT00186901|454831956|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
126420205|NCT00186901|454831954|FG000|Overall Study|ALL relapse or second malignancy|1|||
126420206|NCT00186901|454831955|FG001|Overall Study|ALL relapse or second malignancy|2|||
126420207|NCT00186901|454831956|FG002|Overall Study|ALL relapse or second malignancy|0|||
126420208|NCT00186901|454831954|FG000|Overall Study|Withdrawal by Subject|4|||
126420209|NCT00186901|454831955|FG001|Overall Study|Withdrawal by Subject|5|||
126420210|NCT00186901|454831956|FG002|Overall Study|Withdrawal by Subject|0|||
126420211|NCT00186901|454831954|FG000|Overall Study|Open label|3|||
126420212|NCT00186901|454831955|FG001|Overall Study|Open label|2|||
126420213|NCT00186901|454831956|FG002|Overall Study|Open label|0|||
126420214|NCT00186901|454831954|FG000|Overall Study|Limited adherence to study requirements|20|||
126420215|NCT00186901|454831955|FG001|Overall Study|Limited adherence to study requirements|23|||
126420216|NCT00186901|454831956|FG002|Overall Study|Limited adherence to study requirements|0|||
126420217|NCT00186901|454831954|FG000|Overall Study|Bone Mineral Density > 0|0|||
126420218|NCT00186901|454831955|FG001|Overall Study|Bone Mineral Density > 0|0|||
126420219|NCT00186901|454831956|FG002|Overall Study|Bone Mineral Density > 0|149|||
126420220|NCT00291486|454831962|FG000|Overall Study|Adverse Event|0|||
126420221|NCT00291486|454831963|FG001|Overall Study|Adverse Event|3|||
126420222|NCT00291486|454831964|FG002|Overall Study|Adverse Event|0|||
126420223|NCT00291486|454831965|FG003|Overall Study|Adverse Event|1|||
126420224|NCT00291486|454831966|FG004|Overall Study|Adverse Event|0|||
126420225|NCT00291486|454831962|FG000|Overall Study|Withdrawal by Subject|0|||
126420226|NCT00291486|454831963|FG001|Overall Study|Withdrawal by Subject|0|||
126420227|NCT00291486|454831964|FG002|Overall Study|Withdrawal by Subject|0|||
126420228|NCT00291486|454831965|FG003|Overall Study|Withdrawal by Subject|0|||
126420229|NCT00291486|454831966|FG004|Overall Study|Withdrawal by Subject|1|||
126420230|NCT00291486|454831962|FG000|Overall Study|Disease progression|1|||
126420231|NCT00291486|454831963|FG001|Overall Study|Disease progression|0|||
126420232|NCT00291486|454831964|FG002|Overall Study|Disease progression|1|||
126420233|NCT00291486|454831965|FG003|Overall Study|Disease progression|0|||
126420234|NCT00291486|454831966|FG004|Overall Study|Disease progression|0|||
126420235|NCT01099397|454831969|FG000|Overall Study|Lost to Follow-up|4|||
126420236|NCT01099397|454831969|FG000|Overall Study|Protocol Violation|4|||
126420237|NCT01099397|454831969|FG000|Overall Study|Withdrawal by Subject|5|||
126420238|NCT02363959|454831970|FG000|Overall Study|Medical instability|1|||
126420239|NCT02363959|454831971|FG001|Overall Study|Medical instability|0|||
126420240|NCT00950248|454831974|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
126420241|NCT00950248|454831975|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
126420242|NCT00950248|454831976|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
126420243|NCT00950248|454831974|FG000|Year 1: Baseline|worsening of symptoms|2|||
126420244|NCT00950248|454831975|FG001|Year 1: Baseline|worsening of symptoms|0|||
126420245|NCT00950248|454831976|FG002|Year 1: Baseline|worsening of symptoms|0|||
126420246|NCT00950248|454831974|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
126420247|NCT00950248|454831975|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
126420248|NCT00950248|454831976|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
126420249|NCT00950248|454831974|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
126420250|NCT00950248|454831975|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
126420251|NCT00950248|454831976|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
126420252|NCT00950248|454831974|FG000|Year 2&3 Treatment Randomization|Death|0|||
126420253|NCT00950248|454831975|FG001|Year 2&3 Treatment Randomization|Death|0|||
126420254|NCT00950248|454831976|FG002|Year 2&3 Treatment Randomization|Death|1|||
126420255|NCT00950248|454831974|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
126420256|NCT00950248|454831975|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
126420257|NCT00950248|454831976|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
126420258|NCT01900652|454831978|FG000|Overall Study|Progressive Disease|1|||
126420259|NCT01900652|454831979|FG001|Overall Study|Progressive Disease|0|||
126420260|NCT01900652|454831978|FG000|Overall Study|Consent withdrawn by subject|1|||
126420261|NCT01900652|454831979|FG001|Overall Study|Consent withdrawn by subject|1|||
126420262|NCT01900652|454831978|FG000|Overall Study|Death|3|||
126420263|NCT01900652|454831979|FG001|Overall Study|Death|0|||
126420264|NCT01900652|454831978|FG000|Overall Study|Adverse Event|2|||
126420265|NCT01900652|454831979|FG001|Overall Study|Adverse Event|1|||
126420266|NCT01900652|454831978|FG000|Overall Study|Physician Decision|1|||
126420267|NCT01900652|454831979|FG001|Overall Study|Physician Decision|1|||
126420268|NCT00869518|454831982|FG000|Overall Study|Lost to Follow-up|1|||
126420269|NCT00869518|454831983|FG001|Overall Study|Lost to Follow-up|1|||
126420270|NCT00947115|454831984|FG000|Overall Study|Missed reporting interval|3|||
126420271|NCT00947115|454831985|FG001|Overall Study|Missed reporting interval|4|||
126420272|NCT00947115|454831986|FG002|Overall Study|Missed reporting interval|2|||
126420273|NCT00947115|454831984|FG000|Overall Study|Physician Decision|0|||
126420274|NCT00947115|454831985|FG001|Overall Study|Physician Decision|2|||
126420275|NCT00947115|454831986|FG002|Overall Study|Physician Decision|0|||
126420276|NCT00947115|454831984|FG000|Overall Study|Death|0|||
126420277|NCT00947115|454831985|FG001|Overall Study|Death|1|||
126420278|NCT00947115|454831986|FG002|Overall Study|Death|1|||
126420279|NCT00947115|454831984|FG000|Overall Study|Migrated from study area|2|||
126420280|NCT00947115|454831985|FG001|Overall Study|Migrated from study area|0|||
126420281|NCT00947115|454831986|FG002|Overall Study|Migrated from study area|0|||
126420282|NCT00947115|454831984|FG000|Overall Study|Withdrawal by Subject|1|||
126420283|NCT00947115|454831985|FG001|Overall Study|Withdrawal by Subject|3|||
126420284|NCT00947115|454831986|FG002|Overall Study|Withdrawal by Subject|4|||
126420285|NCT00947115|454831984|FG000|Overall Study|Lost to Follow-up|11|||
126420286|NCT00947115|454831985|FG001|Overall Study|Lost to Follow-up|12|||
126420287|NCT00947115|454831986|FG002|Overall Study|Lost to Follow-up|8|||
126420288|NCT00900029|454831989|FG000|Overall Study|Lost to Follow-up|0|||
126420289|NCT00900029|454831990|FG001|Overall Study|Lost to Follow-up|2|||
126420290|NCT00900029|454831991|FG002|Overall Study|Lost to Follow-up|1|||
126420291|NCT00900029|454831992|FG003|Overall Study|Lost to Follow-up|4|||
126420292|NCT00900029|454831993|FG004|Overall Study|Lost to Follow-up|4|||
126420293|NCT00900029|454831989|FG000|Overall Study|Withdrawal by Subject|2|||
126420294|NCT00900029|454831990|FG001|Overall Study|Withdrawal by Subject|2|||
126420295|NCT00900029|454831991|FG002|Overall Study|Withdrawal by Subject|1|||
126420296|NCT00900029|454831992|FG003|Overall Study|Withdrawal by Subject|1|||
126420297|NCT00900029|454831993|FG004|Overall Study|Withdrawal by Subject|1|||
126420298|NCT00900029|454831989|FG000|Overall Study|Adverse Event|0|||
126420299|NCT00900029|454831990|FG001|Overall Study|Adverse Event|0|||
126420300|NCT00900029|454831991|FG002|Overall Study|Adverse Event|1|||
126420301|NCT00900029|454831992|FG003|Overall Study|Adverse Event|1|||
126420302|NCT00900029|454831993|FG004|Overall Study|Adverse Event|1|||
126420303|NCT00900029|454831989|FG000|Overall Study|Death|1|||
126420304|NCT00900029|454831990|FG001|Overall Study|Death|0|||
126420305|NCT00900029|454831991|FG002|Overall Study|Death|0|||
126420306|NCT00900029|454831992|FG003|Overall Study|Death|1|||
126420307|NCT00900029|454831993|FG004|Overall Study|Death|0|||
126420308|NCT02587819|454831994|FG000|Overall Study|Adverse Event|1|||
126420309|NCT02587819|454831994|FG000|Overall Study|Lost to Follow-up|1|||
126420310|NCT00511238|454831995|FG000|Overall Study|Adverse Event|13|||
126420311|NCT00511238|454831996|FG001|Overall Study|Adverse Event|33|||
126420312|NCT00511238|454831995|FG000|Overall Study|Withdrawal by Subject|2|||
126420313|NCT00511238|454831996|FG001|Overall Study|Withdrawal by Subject|22|||
126420314|NCT00511238|454831995|FG000|Overall Study|Progressive Disease|23|||
126420315|NCT00511238|454831996|FG001|Overall Study|Progressive Disease|157|||
126420316|NCT00511238|454831995|FG000|Overall Study|various reasons|4|||
126420317|NCT00511238|454831996|FG001|Overall Study|various reasons|14|||
126420318|NCT03772665|454831999|FG000|Overall Study|Protocol Violation|1|||
126420319|NCT03772665|454832000|FG001|Overall Study|Protocol Violation|0|||
126420320|NCT00163020|454832001|FG000|Overall Study|Lost to Follow-up|0|||
126420321|NCT00163020|454832002|FG001|Overall Study|Lost to Follow-up|2|||
126420322|NCT02871635|454833611|FG000|Overall Study|Primary lack of efficacy|4|||
126420323|NCT02871635|454833612|FG001|Overall Study|Primary lack of efficacy|4|||
126420324|NCT02871635|454833611|FG000|Overall Study|Protocol Violation|3|||
126420325|NCT02871635|454833612|FG001|Overall Study|Protocol Violation|1|||
126420326|NCT02871635|454833611|FG000|Overall Study|Lost to Follow-up|1|||
126420327|NCT02871635|454833612|FG001|Overall Study|Lost to Follow-up|2|||
126420328|NCT02871635|454833611|FG000|Overall Study|Pregnancy|0|||
126420329|NCT02871635|454833612|FG001|Overall Study|Pregnancy|2|||
126420330|NCT02871635|454833611|FG000|Overall Study|Physician Decision|1|||
126420331|NCT02871635|454833612|FG001|Overall Study|Physician Decision|1|||
126420332|NCT02871635|454833611|FG000|Overall Study|Withdrawal by Subject|3|||
126420333|NCT02871635|454833612|FG001|Overall Study|Withdrawal by Subject|4|||
126420334|NCT02871635|454833611|FG000|Overall Study|Adverse Event|4|||
126054582|NCT01079806|453493936|FG001|Day 1 to Week 96|Adverse Event|3|||
126054583|NCT01079806|453493935|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
126054584|NCT01079806|453493936|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
126420335|NCT02871635|454833612|FG001|Overall Study|Adverse Event|4|||
126420336|NCT02871635|454833611|FG000|Overall Study|Secondary lack of efficacy|2|||
126420337|NCT02871635|454833612|FG001|Overall Study|Secondary lack of efficacy|1|||
126420338|NCT02420379|454833613|FG000|Overall Study|Withdrawal by Subject|0|||
126420339|NCT02420379|454833614|FG001|Overall Study|Withdrawal by Subject|3|||
126420340|NCT02420379|454833613|FG000|Overall Study|Unable to complete due to schooling|0|||
126420341|NCT02420379|454833614|FG001|Overall Study|Unable to complete due to schooling|1|||
126420342|NCT02420379|454833613|FG000|Overall Study|Transitioned to commercial drug|1|||
126420343|NCT02420379|454833614|FG001|Overall Study|Transitioned to commercial drug|0|||
126420344|NCT00502671|454833615|FG000|Overall Study|Disease Progression|13|||
126420345|NCT00502671|454833615|FG000|Overall Study|Personal Reasons|22|||
126420346|NCT00502671|454833615|FG000|Overall Study|Lost to Follow-up|7|||
126420347|NCT00502671|454833615|FG000|Overall Study|Protocol Violation|16|||
126420348|NCT00502671|454833615|FG000|Overall Study|Adverse Event|19|||
126420349|NCT00412893|454833624|FG000|Overall Study|Adverse Event|31|||
126420350|NCT00412893|454833625|FG001|Overall Study|Adverse Event|53|||
126420351|NCT00412893|454833624|FG000|Overall Study|Death|17|||
126420352|NCT00412893|454833625|FG001|Overall Study|Death|21|||
126420353|NCT00412893|454833624|FG000|Overall Study|Insufficient Therapeutic Response|39|||
126420354|NCT00412893|454833625|FG001|Overall Study|Insufficient Therapeutic Response|23|||
126420355|NCT00412893|454833624|FG000|Overall Study|Lost to Follow-up|2|||
126420356|NCT00412893|454833625|FG001|Overall Study|Lost to Follow-up|1|||
126420357|NCT00412893|454833624|FG000|Overall Study|Violation of Selection at Entry|17|||
126420358|NCT00412893|454833625|FG001|Overall Study|Violation of Selection at Entry|10|||
126420359|NCT00412893|454833624|FG000|Overall Study|Other Protocol Violation|10|||
126420360|NCT00412893|454833625|FG001|Overall Study|Other Protocol Violation|6|||
126420361|NCT00412893|454833624|FG000|Overall Study|Did Not Cooperate|12|||
126054585|NCT01079806|453493935|FG000|Day 1 to Week 96|Pregnancy|0|||
126054586|NCT01079806|453493936|FG001|Day 1 to Week 96|Pregnancy|1|||
126420362|NCT00412893|454833625|FG001|Overall Study|Did Not Cooperate|9|||
126420363|NCT00412893|454833624|FG000|Overall Study|Administrative Reason|12|||
126420364|NCT00412893|454833625|FG001|Overall Study|Administrative Reason|15|||
126420365|NCT00412893|454833624|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
126420366|NCT00412893|454833625|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
126420367|NCT00853151|454833626|FG000|Overall Study|Adverse Event|1|||
126420368|NCT00853151|454833627|FG001|Overall Study|Adverse Event|4|||
126420369|NCT00853151|454833628|FG002|Overall Study|Adverse Event|2|||
126420370|NCT00853151|454833629|FG003|Overall Study|Adverse Event|0|||
126420371|NCT00853151|454833626|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126420372|NCT00853151|454833627|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126420373|NCT00853151|454833628|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126420374|NCT00853151|454833629|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126420375|NCT00853151|454833626|FG000|Overall Study|Lost to Follow-up|2|||
126420376|NCT00853151|454833627|FG001|Overall Study|Lost to Follow-up|0|||
126420377|NCT00853151|454833628|FG002|Overall Study|Lost to Follow-up|3|||
126420378|NCT00853151|454833629|FG003|Overall Study|Lost to Follow-up|0|||
126420379|NCT00853151|454833626|FG000|Overall Study|Death|1|||
126420380|NCT00853151|454833627|FG001|Overall Study|Death|0|||
126420381|NCT00853151|454833628|FG002|Overall Study|Death|0|||
126420382|NCT00853151|454833629|FG003|Overall Study|Death|1|||
126420383|NCT00853151|454833626|FG000|Overall Study|Protocol Violation|0|||
126420384|NCT00853151|454833627|FG001|Overall Study|Protocol Violation|0|||
126420385|NCT00853151|454833628|FG002|Overall Study|Protocol Violation|0|||
126420386|NCT00853151|454833629|FG003|Overall Study|Protocol Violation|1|||
126420387|NCT00853151|454833626|FG000|Overall Study|Withdrawal by Subject|5|||
126420388|NCT00853151|454833627|FG001|Overall Study|Withdrawal by Subject|4|||
126420389|NCT00853151|454833628|FG002|Overall Study|Withdrawal by Subject|2|||
126420390|NCT00853151|454833629|FG003|Overall Study|Withdrawal by Subject|1|||
126420391|NCT00853151|454833626|FG000|Overall Study|Physician Decision|0|||
126420392|NCT00853151|454833627|FG001|Overall Study|Physician Decision|2|||
126420393|NCT00853151|454833628|FG002|Overall Study|Physician Decision|1|||
126420394|NCT00853151|454833629|FG003|Overall Study|Physician Decision|0|||
126420395|NCT00853151|454833626|FG000|Overall Study|Sponsor Decision|0|||
126420396|NCT00853151|454833627|FG001|Overall Study|Sponsor Decision|3|||
126420397|NCT00853151|454833628|FG002|Overall Study|Sponsor Decision|0|||
126420398|NCT00853151|454833629|FG003|Overall Study|Sponsor Decision|0|||
126420399|NCT00269919|454833630|FG000|Overall Study|Other|26|||
126420400|NCT00269919|454833630|FG000|Overall Study|Started but not treated|1|||
126420401|NCT04473963|454833631|FG000|Overall Study|Withdrawal by Subject|1|||
126420402|NCT04473963|454833632|FG001|Overall Study|Withdrawal by Subject|1|||
126420403|NCT04473963|454833633|FG002|Overall Study|Withdrawal by Subject|0|||
126420404|NCT04473963|454833631|FG000|Overall Study|Not inducible in AF|0|||
126420405|NCT04473963|454833632|FG001|Overall Study|Not inducible in AF|0|||
126420406|NCT04473963|454833633|FG002|Overall Study|Not inducible in AF|2|||
126420407|NCT01550757|454833634|FG000|Overall Study|Lost to Follow-up|21|||
126420408|NCT01550757|454833635|FG001|Overall Study|Lost to Follow-up|14|||
126420409|NCT01550757|454833636|FG002|Overall Study|Lost to Follow-up|42|||
126420410|NCT01550757|454833637|FG003|Overall Study|Lost to Follow-up|53|||
126420411|NCT01550757|454833634|FG000|Overall Study|Withdrawal by Subject|2|||
126420412|NCT01550757|454833635|FG001|Overall Study|Withdrawal by Subject|0|||
126420413|NCT01550757|454833636|FG002|Overall Study|Withdrawal by Subject|3|||
126420414|NCT01550757|454833637|FG003|Overall Study|Withdrawal by Subject|1|||
126420415|NCT04098809|454833639|FG000|Overall Study|Withdrawal by Subject|1|||
126054587|NCT01079806|453493935|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
126420416|NCT04098809|454833640|FG001|Overall Study|Withdrawal by Subject|3|||
126420417|NCT04098809|454833639|FG000|Overall Study|Physician Decision|2|||
126420418|NCT04098809|454833640|FG001|Overall Study|Physician Decision|1|||
126420419|NCT02741596|454833641|FG000|Overall Study|Adverse Event|1|||
126420420|NCT02741596|454833642|FG001|Overall Study|Adverse Event|5|||
126420421|NCT02741596|454833641|FG000|Overall Study|Lost to Follow-up|1|||
126420422|NCT02741596|454833642|FG001|Overall Study|Lost to Follow-up|1|||
126420423|NCT02741596|454833641|FG000|Overall Study|Physician Decision|2|||
126420424|NCT02741596|454833642|FG001|Overall Study|Physician Decision|1|||
126420425|NCT02741596|454833641|FG000|Overall Study|Pregnancy|3|||
126420426|NCT02741596|454833642|FG001|Overall Study|Pregnancy|1|||
126420427|NCT02741596|454833641|FG000|Overall Study|Other (Unspecified)|0|||
126420428|NCT02741596|454833642|FG001|Overall Study|Other (Unspecified)|3|||
126420429|NCT02741596|454833641|FG000|Overall Study|Subject withdrawn-Other|17|||
126420430|NCT02741596|454833642|FG001|Overall Study|Subject withdrawn-Other|4|||
126420431|NCT02741596|454833641|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
126420432|NCT02741596|454833642|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
126420433|NCT01426958|454833643|FG000|Overall Study|Adverse Event|2|||
126420434|NCT00991939|454833644|FG000|Overall Study|Lost to Follow-up|0|||
126420435|NCT00991939|454833645|FG001|Overall Study|Lost to Follow-up|1|||
126054588|NCT01079806|453493936|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
126420436|NCT00991939|454833644|FG000|Overall Study|Withdrawal by Subject|1|||
126420437|NCT00991939|454833645|FG001|Overall Study|Withdrawal by Subject|0|||
126420438|NCT00991939|454833644|FG000|Overall Study|Entire study terminated|4|||
126420439|NCT00991939|454833645|FG001|Overall Study|Entire study terminated|1|||
126420440|NCT00714415|454833646|FG000|Overall Study|Lack of Efficacy|1|||
126420441|NCT00714415|454833647|FG001|Overall Study|Lack of Efficacy|0|||
126420442|NCT00714415|454833646|FG000|Overall Study|Death|1|||
126420443|NCT00714415|454833647|FG001|Overall Study|Death|0|||
126420444|NCT00740584|454833650|FG000|Overall Study|Withdrawal by Subject|1|||
126420445|NCT02073682|454833660|FG000|Overall Study|Low Creatinine Clearance|1|||
126420446|NCT02073682|454833661|FG001|Overall Study|Low Creatinine Clearance|2|||
126420447|NCT02073682|454833660|FG000|Overall Study|Death|86|||
126420448|NCT02073682|454833661|FG001|Overall Study|Death|100|||
126420449|NCT02073682|454833660|FG000|Overall Study|Cancer Cured|10|||
126420450|NCT02073682|454833661|FG001|Overall Study|Cancer Cured|15|||
126420451|NCT02073682|454833660|FG000|Overall Study|ID: Patient Noncompliance|1|||
126420452|NCT02073682|454833661|FG001|Overall Study|ID: Patient Noncompliance|2|||
126420453|NCT02073682|454833660|FG000|Overall Study|ID: Palliative Treatment Only|10|||
126420454|NCT02073682|454833661|FG001|Overall Study|ID: Palliative Treatment Only|7|||
126420455|NCT02073682|454833660|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
126420456|NCT02073682|454833661|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
126420457|NCT02073682|454833660|FG000|Overall Study|Platelet Count <50,000/mL|1|||
126420458|NCT02073682|454833661|FG001|Overall Study|Platelet Count <50,000/mL|2|||
126420459|NCT02073682|454833660|FG000|Overall Study|Surgery/Medical Procedure|3|||
126420460|NCT02073682|454833661|FG001|Overall Study|Surgery/Medical Procedure|1|||
126420461|NCT02073682|454833660|FG000|Overall Study|Withdrawal by Subject|6|||
126420462|NCT02073682|454833661|FG001|Overall Study|Withdrawal by Subject|8|||
126420463|NCT02073682|454833660|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
126420464|NCT02073682|454833661|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
126420465|NCT02073682|454833660|FG000|Overall Study|Cancer Progression|53|||
126420466|NCT02073682|454833661|FG001|Overall Study|Cancer Progression|33|||
126420467|NCT02073682|454833660|FG000|Overall Study|Protocol Violation|1|||
126420468|NCT02073682|454833661|FG001|Overall Study|Protocol Violation|0|||
126420469|NCT02073682|454833660|FG000|Overall Study|Adverse Event|79|||
125891194|NCT04198714|452899739|FG000|Overall Study|Physician Decision|0|||
126420470|NCT02073682|454833661|FG001|Overall Study|Adverse Event|62|||
126420471|NCT02073682|454833660|FG000|Overall Study|No reason provided|11|||
126420472|NCT02073682|454833661|FG001|Overall Study|No reason provided|9|||
126420473|NCT02073682|454833660|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
126420474|NCT02073682|454833661|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
126420475|NCT02073682|454833660|FG000|Overall Study|Lost to Follow-up|1|||
126420476|NCT02073682|454833661|FG001|Overall Study|Lost to Follow-up|1|||
126420477|NCT02073682|454833660|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
126420478|NCT02073682|454833661|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
126420479|NCT03461146|454833662|FG000|Overall Study|Adverse Event|2|||
126420480|NCT03461146|454833662|FG000|Overall Study|Physician Decision|1|||
126420481|NCT00181766|454833663|FG000|Overall Study|Lost to Follow-up|6|||
126420482|NCT00181766|454833663|FG000|Overall Study|Adverse Event|4|||
126420483|NCT00181766|454833663|FG000|Overall Study|non-compliance|2|||
126420484|NCT00855816|454833664|FG000|Overall Study|Withdrawal by Subject|22|||
126420485|NCT00855816|454833665|FG001|Overall Study|Withdrawal by Subject|15|||
126420486|NCT00855816|454833664|FG000|Overall Study|Lost to Follow-up|3|||
126420487|NCT00855816|454833665|FG001|Overall Study|Lost to Follow-up|5|||
126420488|NCT00855816|454833664|FG000|Overall Study|Death|1|||
126420489|NCT00855816|454833665|FG001|Overall Study|Death|0|||
126420490|NCT00855816|454833664|FG000|Overall Study|Became ineligible|0|||
126420491|NCT00855816|454833665|FG001|Overall Study|Became ineligible|1|||
126420492|NCT01965704|454833669|FG000|Overall Study|Withdrawal by Subject|2|||
126420493|NCT01965704|454833670|FG001|Overall Study|Withdrawal by Subject|2|||
126420494|NCT01965704|454833671|FG002|Overall Study|Withdrawal by Subject|1|||
126420495|NCT01965704|454833672|FG003|Overall Study|Withdrawal by Subject|1|||
126420496|NCT01965704|454833669|FG000|Overall Study|Delivered at home|1|||
126420497|NCT01965704|454833670|FG001|Overall Study|Delivered at home|1|||
126420498|NCT01965704|454833671|FG002|Overall Study|Delivered at home|0|||
126420499|NCT01965704|454833672|FG003|Overall Study|Delivered at home|0|||
126420500|NCT01965704|454833669|FG000|Overall Study|Experienced complications|0|||
125891195|NCT04198714|452899740|FG001|Overall Study|Physician Decision|1|||
125891196|NCT02970942|452899741|FG000|Overall Study|Death|0|||
125891197|NCT02970942|452899742|FG001|Overall Study|Death|1|||
125891198|NCT02970942|452899743|FG002|Overall Study|Death|0|||
125891199|NCT02970942|452899744|FG003|Overall Study|Death|0|||
125891200|NCT02970942|452899741|FG000|Overall Study|Lost to Follow-up|1|||
125891201|NCT02970942|452899742|FG001|Overall Study|Lost to Follow-up|0|||
125891202|NCT02970942|452899743|FG002|Overall Study|Lost to Follow-up|2|||
125891203|NCT02970942|452899744|FG003|Overall Study|Lost to Follow-up|1|||
126054589|NCT01079806|453493935|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
126420501|NCT01965704|454833670|FG001|Overall Study|Experienced complications|0|||
126420502|NCT01965704|454833671|FG002|Overall Study|Experienced complications|2|||
126420503|NCT01965704|454833672|FG003|Overall Study|Experienced complications|2|||
126420504|NCT01965704|454833669|FG000|Overall Study|Adverse Event|0|||
126420505|NCT01965704|454833670|FG001|Overall Study|Adverse Event|0|||
126420506|NCT01965704|454833671|FG002|Overall Study|Adverse Event|1|||
126420507|NCT01965704|454833672|FG003|Overall Study|Adverse Event|1|||
126420508|NCT01965704|454833669|FG000|Overall Study|Did not meet inclusion criteria|0|||
126420509|NCT01965704|454833670|FG001|Overall Study|Did not meet inclusion criteria|0|||
126420510|NCT01965704|454833671|FG002|Overall Study|Did not meet inclusion criteria|1|||
126420511|NCT01965704|454833672|FG003|Overall Study|Did not meet inclusion criteria|1|||
126420512|NCT00687804|454833680|FG000|Core Study|Adverse Event|5|||
126420513|NCT00687804|454833681|FG001|Core Study|Adverse Event|3|||
126420514|NCT00687804|454833682|FG002|Core Study|Adverse Event|3|||
126420515|NCT00687804|454833680|FG000|Core Study|Abnormal laboratory value(s)|1|||
126420516|NCT00687804|454833681|FG001|Core Study|Abnormal laboratory value(s)|0|||
126420517|NCT00687804|454833682|FG002|Core Study|Abnormal laboratory value(s)|0|||
126420518|NCT00687804|454833680|FG000|Core Study|Lack of Efficacy|1|||
126420519|NCT00687804|454833681|FG001|Core Study|Lack of Efficacy|1|||
126420520|NCT00687804|454833682|FG002|Core Study|Lack of Efficacy|1|||
126420521|NCT00687804|454833680|FG000|Core Study|Withdrawal by Subject|4|||
126420522|NCT00687804|454833681|FG001|Core Study|Withdrawal by Subject|7|||
126420523|NCT00687804|454833682|FG002|Core Study|Withdrawal by Subject|7|||
126420524|NCT00687804|454833680|FG000|Core Study|Lost to Follow-up|0|||
126420525|NCT00687804|454833681|FG001|Core Study|Lost to Follow-up|1|||
126420526|NCT00687804|454833682|FG002|Core Study|Lost to Follow-up|0|||
126420527|NCT00687804|454833680|FG000|Core Study|Death|2|||
126420528|NCT00687804|454833681|FG001|Core Study|Death|2|||
126420529|NCT00687804|454833682|FG002|Core Study|Death|2|||
126420530|NCT00687804|454833680|FG000|Core Study|Protocol Violation|1|||
126420531|NCT00687804|454833681|FG001|Core Study|Protocol Violation|1|||
126420532|NCT00687804|454833682|FG002|Core Study|Protocol Violation|0|||
126420533|NCT00687804|454833680|FG000|Open-Label Extension Study|Adverse Event|2|||
126420534|NCT00687804|454833681|FG001|Open-Label Extension Study|Adverse Event|2|||
126420535|NCT00687804|454833682|FG002|Open-Label Extension Study|Adverse Event|2|||
126420536|NCT00687804|454833680|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
126420537|NCT00687804|454833681|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
126420538|NCT00687804|454833682|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
126420539|NCT00687804|454833680|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
126420540|NCT00687804|454833681|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
126420541|NCT00687804|454833682|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
126420542|NCT00687804|454833680|FG000|Open-Label Extension Study|Administrative problems|1|||
126420543|NCT00687804|454833681|FG001|Open-Label Extension Study|Administrative problems|1|||
126420544|NCT00687804|454833682|FG002|Open-Label Extension Study|Administrative problems|0|||
126420545|NCT00687804|454833680|FG000|Open-Label Extension Study|Death|2|||
126420546|NCT00687804|454833681|FG001|Open-Label Extension Study|Death|3|||
126420547|NCT00687804|454833682|FG002|Open-Label Extension Study|Death|3|||
126420548|NCT04390243|454833683|FG000|Overall Study|Death|1|||
126420549|NCT04390243|454833683|FG000|Overall Study|Disease Progression|4|||
126420550|NCT04390243|454833683|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
126420551|NCT00413218|454833687|FG000|Overall Study|Randomized but didn't receive study drug|2|||
126420552|NCT00413218|454833688|FG001|Overall Study|Randomized but didn't receive study drug|8|||
126420553|NCT00413218|454833687|FG000|Overall Study|Death|57|||
126420554|NCT00413218|454833688|FG001|Overall Study|Death|56|||
126420555|NCT00413218|454833687|FG000|Overall Study|Lost to Follow-up|14|||
126420556|NCT00413218|454833688|FG001|Overall Study|Lost to Follow-up|17|||
126420557|NCT00413218|454833687|FG000|Overall Study|Admin|20|||
126420558|NCT00413218|454833688|FG001|Overall Study|Admin|14|||
126420559|NCT00413218|454833687|FG000|Overall Study|Missing|1|||
126420560|NCT00413218|454833688|FG001|Overall Study|Missing|0|||
126420561|NCT00413218|454833687|FG000|Overall Study|Withdrawal by Subject|9|||
126420562|NCT00413218|454833688|FG001|Overall Study|Withdrawal by Subject|1|||
126420563|NCT01196026|454833690|FG000|Overall Study|Withdrawal by Subject|1|||
126420564|NCT01196026|454833691|FG001|Overall Study|Withdrawal by Subject|4|||
126420565|NCT01196026|454833692|FG002|Overall Study|Withdrawal by Subject|0|||
126420566|NCT01196026|454833693|FG003|Overall Study|Withdrawal by Subject|0|||
126420567|NCT01196026|454833694|FG004|Overall Study|Withdrawal by Subject|0|||
126420568|NCT01196026|454833695|FG005|Overall Study|Withdrawal by Subject|0|||
126420569|NCT01196026|454833690|FG000|Overall Study|Lost to Follow-up|0|||
126420570|NCT01196026|454833691|FG001|Overall Study|Lost to Follow-up|3|||
126420571|NCT01196026|454833692|FG002|Overall Study|Lost to Follow-up|0|||
126054590|NCT01079806|453493936|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
126054591|NCT01079806|453493935|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
126420572|NCT01196026|454833693|FG003|Overall Study|Lost to Follow-up|0|||
126420573|NCT01196026|454833694|FG004|Overall Study|Lost to Follow-up|1|||
126420574|NCT01196026|454833695|FG005|Overall Study|Lost to Follow-up|0|||
126420575|NCT01196026|454833690|FG000|Overall Study|Other|0|||
126420576|NCT01196026|454833691|FG001|Overall Study|Other|1|||
126420577|NCT01196026|454833692|FG002|Overall Study|Other|0|||
126420578|NCT01196026|454833693|FG003|Overall Study|Other|0|||
126420579|NCT01196026|454833694|FG004|Overall Study|Other|0|||
126420580|NCT01196026|454833695|FG005|Overall Study|Other|0|||
126420581|NCT01687296|454833696|FG000|Overall Study|Lack of Efficacy|1|||
126420582|NCT01687296|454833697|FG001|Overall Study|Lack of Efficacy|1|||
126420583|NCT01687296|454833696|FG000|Overall Study|Protocol Violation|0|||
126420584|NCT01687296|454833697|FG001|Overall Study|Protocol Violation|1|||
126420585|NCT01687296|454833696|FG000|Overall Study|Withdrawal by Subject|6|||
125891204|NCT02970942|452899741|FG000|Overall Study|Withdrawal by Subject|3|||
125891205|NCT02970942|452899742|FG001|Overall Study|Withdrawal by Subject|5|||
125891206|NCT02970942|452899743|FG002|Overall Study|Withdrawal by Subject|3|||
125891207|NCT02970942|452899744|FG003|Overall Study|Withdrawal by Subject|2|||
125891208|NCT02529553|452899747|FG000|Overall Study|Progressive Disease|1|||
126420586|NCT01687296|454833697|FG001|Overall Study|Withdrawal by Subject|3|||
126420587|NCT03672292|454833701|FG000|Overall Study|Adverse Event|3|||
126420588|NCT03672292|454833702|FG001|Overall Study|Adverse Event|1|||
126420589|NCT03672292|454833701|FG000|Overall Study|Physician Decision|0|||
126420590|NCT03672292|454833702|FG001|Overall Study|Physician Decision|1|||
126420591|NCT03672292|454833701|FG000|Overall Study|Withdrawal by Subject|1|||
126420592|NCT03672292|454833702|FG001|Overall Study|Withdrawal by Subject|2|||
126420593|NCT00799903|454833703|FG000|Overall Study|Investigator Site Closed|25|||
126420594|NCT00799903|454833704|FG001|Overall Study|Investigator Site Closed|23|||
126420595|NCT00799903|454833703|FG000|Overall Study|Withdrawal by Subject|179|||
126420596|NCT00799903|454833704|FG001|Overall Study|Withdrawal by Subject|175|||
126420597|NCT00799903|454833703|FG000|Overall Study|Lost to Follow-up|69|||
126420598|NCT00799903|454833704|FG001|Overall Study|Lost to Follow-up|80|||
126420599|NCT02518971|454833705|FG000|Overall Study|Lost to Follow-up|0|||
126420600|NCT02518971|454833706|FG001|Overall Study|Lost to Follow-up|1|||
126420601|NCT02518971|454833705|FG000|Overall Study|Physician Decision|6|||
126420602|NCT02518971|454833706|FG001|Overall Study|Physician Decision|6|||
126420603|NCT02518971|454833705|FG000|Overall Study|Protocol Violation|6|||
126420604|NCT02518971|454833706|FG001|Overall Study|Protocol Violation|4|||
126420605|NCT02518971|454833705|FG000|Overall Study|Withdrawal by Subject|4|||
126420606|NCT02518971|454833706|FG001|Overall Study|Withdrawal by Subject|5|||
126420607|NCT02518971|454833705|FG000|Overall Study|Side effects|1|||
126420608|NCT02518971|454833706|FG001|Overall Study|Side effects|0|||
126420609|NCT02518971|454833705|FG000|Overall Study|medication lost in mail|0|||
126420610|NCT02518971|454833706|FG001|Overall Study|medication lost in mail|1|||
126420611|NCT02518971|454833705|FG000|Overall Study|eligibility criteria no longer met|6|||
126420612|NCT02518971|454833706|FG001|Overall Study|eligibility criteria no longer met|3|||
126420613|NCT02336230|454833707|FG000|Overall Study|Adverse Event|1|||
126420614|NCT02336230|454833707|FG000|Overall Study|Withdrawal of consent|1|||
126420615|NCT02336230|454833707|FG000|Overall Study|Death|9|||
126420616|NCT02336230|454833707|FG000|Overall Study|Dose not received due to shipping delay|1|||
126420617|NCT02336230|454833707|FG000|Overall Study|Discontinuation of MSC infusion|1|||
126420618|NCT02524171|454833708|FG000|6-month Follow-up|Lost to Follow-up|53|||
126420619|NCT02524171|454833709|FG001|6-month Follow-up|Lost to Follow-up|45|||
126420620|NCT02524171|454833708|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
126420621|NCT02524171|454833709|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
126420622|NCT00757237|454833712|FG000|Overall Study|Lost to Follow-up|0|||
126420623|NCT00757237|454833713|FG001|Overall Study|Lost to Follow-up|1|||
126420624|NCT00757237|454833712|FG000|Overall Study|Protocol Violation|0|||
126420625|NCT00757237|454833713|FG001|Overall Study|Protocol Violation|2|||
126420626|NCT00757237|454833712|FG000|Overall Study|Physician Decision|2|||
126420627|NCT00757237|454833713|FG001|Overall Study|Physician Decision|3|||
126420628|NCT00757237|454833712|FG000|Overall Study|Withdrawal by Subject|8|||
126420629|NCT00757237|454833713|FG001|Overall Study|Withdrawal by Subject|12|||
126420630|NCT00757237|454833712|FG000|Overall Study|Safety or Tolerability|3|||
126420631|NCT00757237|454833713|FG001|Overall Study|Safety or Tolerability|5|||
126420632|NCT00757237|454833712|FG000|Overall Study|Other|0|||
126420633|NCT00757237|454833713|FG001|Overall Study|Other|2|||
126420634|NCT05150990|454833714|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
126420635|NCT05150990|454833715|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
126420636|NCT05150990|454833714|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
126420637|NCT05150990|454833715|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
125891209|NCT02529553|452899748|FG001|Overall Study|Progressive Disease|0|||
125891210|NCT02529553|452899749|FG002|Overall Study|Progressive Disease|1|||
126420638|NCT05150990|454833714|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
126054592|NCT01079806|453493936|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
126054593|NCT01079806|453493935|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
126054594|NCT01079806|453493936|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
126054595|NCT01079806|453493935|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
126420639|NCT05150990|454833715|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
126420640|NCT05150990|454833714|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
126420641|NCT05150990|454833715|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
126420642|NCT05150990|454833714|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
126420643|NCT05150990|454833715|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
126420644|NCT05150990|454833714|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
126420645|NCT05150990|454833715|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
126420646|NCT05150990|454833714|FG000|Overall Study|Death (unrelated to the intervention)|1|||
126420647|NCT05150990|454833715|FG001|Overall Study|Death (unrelated to the intervention)|2|||
126420648|NCT00466921|454833716|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
126420649|NCT00466921|454833716|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
126420650|NCT00466921|454833716|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
126420651|NCT00466921|454833716|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
126420652|NCT00466921|454833716|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
126420653|NCT00466921|454833716|FG000|Follow up for a Minimum of 1 Year|Death|6|||
126420654|NCT01100320|454833717|FG000|Period 1|Withdrawal by Subject|2|||
126420655|NCT01100320|454833718|FG001|Period 1|Withdrawal by Subject|4|||
126420656|NCT01100320|454833717|FG000|Period 1|Positive Drug Screen|1|||
126420657|NCT01100320|454833718|FG001|Period 1|Positive Drug Screen|1|||
126420658|NCT01100320|454833717|FG000|Period 1|Adverse Event|2|||
126420659|NCT01100320|454833718|FG001|Period 1|Adverse Event|2|||
126420660|NCT01100320|454833717|FG000|Period 2|Withdrawal by Subject|1|||
126420661|NCT01100320|454833718|FG001|Period 2|Withdrawal by Subject|1|||
126420662|NCT03797586|454833719|FG000|Overall Study|Lost to Follow-up|3|||
126420663|NCT03797586|454833720|FG001|Overall Study|Lost to Follow-up|6|||
126420664|NCT03797586|454833719|FG000|Overall Study|Death|1|||
126420665|NCT03797586|454833720|FG001|Overall Study|Death|1|||
126420666|NCT03797586|454833719|FG000|Overall Study|Adverse Event|0|||
126420667|NCT03797586|454833720|FG001|Overall Study|Adverse Event|2|||
126420668|NCT02864901|454833721|FG000|Overall Study|Withdrawal by Subject|1|||
126420669|NCT02864901|454833722|FG001|Overall Study|Withdrawal by Subject|0|||
126420670|NCT05730387|454833723|FG000|Overall Study|Stillbirth|0|||
126420671|NCT05730387|454833724|FG001|Overall Study|Stillbirth|262|||
126420672|NCT05730387|454833723|FG000|Overall Study|Died during or after delivery|2|||
126420673|NCT05730387|454833724|FG001|Overall Study|Died during or after delivery|85|||
126420674|NCT05730387|454833723|FG000|Overall Study|Died after being admitted|0|||
126420675|NCT05730387|454833724|FG001|Overall Study|Died after being admitted|44|||
126420676|NCT05730387|454833723|FG000|Overall Study|Lost to Follow-up|69|||
126420677|NCT05730387|454833724|FG001|Overall Study|Lost to Follow-up|77|||
126420678|NCT01219985|454833725|FG000|Overall Study|Physician Decision|20|||
126420679|NCT00596752|454833726|FG000|Overall Study|Other Reason|44|||
126420680|NCT00596752|454833727|FG001|Overall Study|Other Reason|49|||
126420681|NCT00596752|454833726|FG000|Overall Study|Adverse Event|34|||
126420682|NCT00596752|454833727|FG001|Overall Study|Adverse Event|34|||
126420683|NCT00596752|454833726|FG000|Overall Study|Lost to Follow-up|22|||
126420684|NCT00596752|454833727|FG001|Overall Study|Lost to Follow-up|38|||
126420685|NCT00596752|454833726|FG000|Overall Study|Withdrawal by Subject|12|||
126420686|NCT00596752|454833727|FG001|Overall Study|Withdrawal by Subject|9|||
126420687|NCT00596752|454833726|FG000|Overall Study|Unsatisfactory Compliance|9|||
126420688|NCT00596752|454833727|FG001|Overall Study|Unsatisfactory Compliance|6|||
126420689|NCT00596752|454833726|FG000|Overall Study|Lack of Efficacy|4|||
126420690|NCT00596752|454833727|FG001|Overall Study|Lack of Efficacy|7|||
126420691|NCT00596752|454833726|FG000|Overall Study|Protocol Violation|1|||
126420692|NCT00596752|454833727|FG001|Overall Study|Protocol Violation|0|||
126420693|NCT04797780|454833728|FG000|Overall Study|Lost to Follow-up|1|||
126420694|NCT04797780|454833729|FG001|Overall Study|Lost to Follow-up|1|||
126420695|NCT04797780|454833728|FG000|Overall Study|Withdrawal by Subject|14|||
126420696|NCT04797780|454833729|FG001|Overall Study|Withdrawal by Subject|9|||
126420697|NCT04797780|454833728|FG000|Overall Study|Death|49|||
126420698|NCT04797780|454833729|FG001|Overall Study|Death|20|||
126054596|NCT01079806|453493936|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
126420699|NCT04669301|454833730|FG000|Overall Study|Lost to Follow-up|0|||
126420700|NCT04669301|454833731|FG001|Overall Study|Lost to Follow-up|1|||
126420701|NCT04669301|454833732|FG002|Overall Study|Lost to Follow-up|0|||
126420702|NCT04669301|454833730|FG000|Overall Study|Withdrawal by Subject|3|||
126105360|NCT04640077|453678609|FG000|Period 1|Withdrawal by Subject|4|||
126420703|NCT04669301|454833731|FG001|Overall Study|Withdrawal by Subject|2|||
126420704|NCT04669301|454833732|FG002|Overall Study|Withdrawal by Subject|0|||
125891211|NCT02529553|452899750|FG003|Overall Study|Progressive Disease|3|||
126420705|NCT05973006|454833733|FG000|Overall Study|Early termination|3|||
126420706|NCT05973006|454833734|FG001|Overall Study|Early termination|9|||
126420707|NCT00398320|454833735|FG000|Overall Study|Death|1|||
126420708|NCT00398320|454833735|FG000|Overall Study|Adverse Event|4|||
126420709|NCT00398320|454833735|FG000|Overall Study|Physician Decision|1|||
126420710|NCT02663622|454833741|FG000|Overall Study|Death|3|||
126420711|NCT02663622|454833742|FG001|Overall Study|Death|1|||
126420712|NCT02663622|454833743|FG002|Overall Study|Death|1|||
126420713|NCT02663622|454833744|FG003|Overall Study|Death|8|||
126420714|NCT02663622|454833741|FG000|Overall Study|Protocol Violation|0|||
126420715|NCT02663622|454833742|FG001|Overall Study|Protocol Violation|0|||
126420716|NCT02663622|454833743|FG002|Overall Study|Protocol Violation|0|||
126420717|NCT02663622|454833744|FG003|Overall Study|Protocol Violation|1|||
126420718|NCT03553758|454835069|FG000|Overall Study|Lost to Follow-up|1|||
126420719|NCT00447226|454835071|FG000|12-Week Open-label Phase|Adverse Event|0|||
126420720|NCT00447226|454835072|FG001|12-Week Open-label Phase|Adverse Event|3|||
126420721|NCT00447226|454835071|FG000|12-Week Open-label Phase|Protocol Violation|0|||
126420722|NCT00447226|454835072|FG001|12-Week Open-label Phase|Protocol Violation|1|||
126420723|NCT00447226|454835071|FG000|12-Week Open-label Phase|Disease Progression|0|||
126420724|NCT00447226|454835072|FG001|12-Week Open-label Phase|Disease Progression|20|||
126420725|NCT00447226|454835071|FG000|12-Week Open-label Phase|Physician Decision|0|||
126420726|NCT00447226|454835072|FG001|12-Week Open-label Phase|Physician Decision|1|||
126420727|NCT00447226|454835071|FG000|Double-blind Phase|Disease Progression|4|||
126420728|NCT00447226|454835072|FG001|Double-blind Phase|Disease Progression|3|||
126420729|NCT01473732|454835084|FG000|Overall Study|Adverse Event|1|||
126420730|NCT01473732|454835085|FG001|Overall Study|Adverse Event|0|||
126420731|NCT01473732|454835084|FG000|Overall Study|Death|1|||
126420732|NCT01473732|454835085|FG001|Overall Study|Death|0|||
126420733|NCT03579940|454835091|FG000|Period 2|Withdrawal by Subject|0|||
126420734|NCT03579940|454835092|FG001|Period 2|Withdrawal by Subject|0|||
126420735|NCT03579940|454835093|FG002|Period 2|Withdrawal by Subject|1|||
126420736|NCT03579940|454835094|FG003|Period 2|Withdrawal by Subject|0|||
126420737|NCT03579940|454835095|FG004|Period 2|Withdrawal by Subject|0|||
126420738|NCT03579940|454835096|FG005|Period 2|Withdrawal by Subject|0|||
126420739|NCT03579940|454835097|FG006|Period 2|Withdrawal by Subject|0|||
126420740|NCT03579940|454835098|FG007|Period 2|Withdrawal by Subject|0|||
126420741|NCT03579940|454835099|FG008|Period 2|Withdrawal by Subject|0|||
126420742|NCT03579940|454835100|FG009|Period 2|Withdrawal by Subject|0|||
126420743|NCT03579940|454835101|FG010|Period 2|Withdrawal by Subject|0|||
126420744|NCT01217944|454835102|FG000|Overall Study|Protocol Violation|1|||
126420745|NCT01217944|454835103|FG001|Overall Study|Protocol Violation|1|||
126420746|NCT01217944|454835104|FG002|Overall Study|Protocol Violation|0|||
126420747|NCT01217944|454835102|FG000|Overall Study|Lost to Follow-up|3|||
126420748|NCT01217944|454835103|FG001|Overall Study|Lost to Follow-up|1|||
126420749|NCT01217944|454835104|FG002|Overall Study|Lost to Follow-up|0|||
126420750|NCT01217944|454835102|FG000|Overall Study|Withdrawal by Subject|1|||
126420751|NCT01217944|454835103|FG001|Overall Study|Withdrawal by Subject|2|||
126420752|NCT01217944|454835104|FG002|Overall Study|Withdrawal by Subject|0|||
126420753|NCT01217944|454835102|FG000|Overall Study|Lack of Efficacy|1|||
126420754|NCT01217944|454835103|FG001|Overall Study|Lack of Efficacy|0|||
126420755|NCT01217944|454835104|FG002|Overall Study|Lack of Efficacy|0|||
126420756|NCT00671034|454835105|FG000|Overall Study|Adverse Event|5|||
126420757|NCT00671034|454835106|FG001|Overall Study|Adverse Event|7|||
126420758|NCT00671034|454835107|FG002|Overall Study|Adverse Event|1|||
126420759|NCT00671034|454835105|FG000|Overall Study|Death|3|||
126420760|NCT00671034|454835106|FG001|Overall Study|Death|2|||
126420761|NCT00671034|454835107|FG002|Overall Study|Death|1|||
126420762|NCT00671034|454835105|FG000|Overall Study|Physician Decision|12|||
126420763|NCT00671034|454835106|FG001|Overall Study|Physician Decision|4|||
126420764|NCT00671034|454835107|FG002|Overall Study|Physician Decision|5|||
126420765|NCT00671034|454835105|FG000|Overall Study|VHR ALL feature|8|||
126420766|NCT00671034|454835106|FG001|Overall Study|VHR ALL feature|3|||
126420767|NCT00671034|454835107|FG002|Overall Study|VHR ALL feature|5|||
126420768|NCT00671034|454835105|FG000|Overall Study|Refusal|5|||
126420769|NCT00671034|454835106|FG001|Overall Study|Refusal|3|||
126420770|NCT00671034|454835107|FG002|Overall Study|Refusal|5|||
126420771|NCT00671034|454835105|FG000|Overall Study|includes Alternative therapy, etc.|6|||
126420772|NCT00671034|454835106|FG001|Overall Study|includes Alternative therapy, etc.|1|||
126420773|NCT00671034|454835107|FG002|Overall Study|includes Alternative therapy, etc.|7|||
126420774|NCT01751984|454835110|FG000|Overall Study|Adverse Event|5|||
126420775|NCT01751984|454835111|FG001|Overall Study|Adverse Event|3|||
126420776|NCT01751984|454835110|FG000|Overall Study|Withdrawal by Subject|0|||
126420777|NCT01751984|454835111|FG001|Overall Study|Withdrawal by Subject|1|||
126420778|NCT01751984|454835110|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
126420779|NCT01751984|454835111|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
126420780|NCT01388907|454835112|FG000|Overall Study|Adverse Event|2|||
126420781|NCT01388907|454835113|FG001|Overall Study|Adverse Event|0|||
126420782|NCT01797263|454835114|FG000|Overall Study|Withdrawal by Subject|21|||
126420783|NCT01797263|454835115|FG001|Overall Study|Withdrawal by Subject|25|||
126420784|NCT01797263|454835114|FG000|Overall Study|Death|1|||
126420785|NCT01797263|454835115|FG001|Overall Study|Death|0|||
126420786|NCT01797263|454835114|FG000|Overall Study|Lost to Follow-up|15|||
126420787|NCT01797263|454835115|FG001|Overall Study|Lost to Follow-up|15|||
126420788|NCT03187132|454835116|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
126420789|NCT03187132|454835117|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
126420790|NCT03187132|454835116|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
126420791|NCT03187132|454835117|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
126420792|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
126420793|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
126420794|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
126420795|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
126420796|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
126420797|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
126420798|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
126420799|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
126420800|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
126420801|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
126420802|NCT03187132|454835116|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
126420803|NCT03187132|454835117|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
126420804|NCT03187132|454835116|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
126420805|NCT03187132|454835117|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
126420806|NCT03187132|454835116|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
126420807|NCT03187132|454835117|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
126420808|NCT03187132|454835116|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
126420809|NCT03187132|454835117|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
126420810|NCT02045095|454835118|FG000|Overall Study|Other|0|||
126420811|NCT02045095|454835119|FG001|Overall Study|Other|0|||
126420812|NCT02045095|454835120|FG002|Overall Study|Other|1|||
126420813|NCT02045095|454835121|FG003|Overall Study|Other|0|||
126420814|NCT02045095|454835122|FG004|Overall Study|Other|0|||
126420815|NCT02045095|454835123|FG005|Overall Study|Other|2|||
126420816|NCT02045095|454835124|FG006|Overall Study|Other|0|||
126420817|NCT02045095|454835118|FG000|Overall Study|Progressive Disease|3|||
126420818|NCT02045095|454835119|FG001|Overall Study|Progressive Disease|3|||
126420819|NCT02045095|454835120|FG002|Overall Study|Progressive Disease|2|||
126420820|NCT02045095|454835121|FG003|Overall Study|Progressive Disease|4|||
126420821|NCT02045095|454835122|FG004|Overall Study|Progressive Disease|2|||
126420822|NCT02045095|454835123|FG005|Overall Study|Progressive Disease|4|||
126420823|NCT02045095|454835124|FG006|Overall Study|Progressive Disease|1|||
126420824|NCT02045095|454835118|FG000|Overall Study|Withdrawal by Subject|0|||
126420825|NCT02045095|454835119|FG001|Overall Study|Withdrawal by Subject|0|||
126420826|NCT02045095|454835120|FG002|Overall Study|Withdrawal by Subject|0|||
126420827|NCT02045095|454835121|FG003|Overall Study|Withdrawal by Subject|0|||
126420828|NCT02045095|454835122|FG004|Overall Study|Withdrawal by Subject|3|||
126420829|NCT02045095|454835123|FG005|Overall Study|Withdrawal by Subject|0|||
126420830|NCT02045095|454835124|FG006|Overall Study|Withdrawal by Subject|0|||
126420831|NCT02045095|454835118|FG000|Overall Study|Adverse Event|0|||
126420832|NCT02045095|454835119|FG001|Overall Study|Adverse Event|1|||
126420833|NCT02045095|454835120|FG002|Overall Study|Adverse Event|1|||
126420834|NCT02045095|454835121|FG003|Overall Study|Adverse Event|0|||
126420835|NCT02045095|454835122|FG004|Overall Study|Adverse Event|0|||
126420836|NCT02045095|454835123|FG005|Overall Study|Adverse Event|2|||
126420837|NCT02045095|454835124|FG006|Overall Study|Adverse Event|0|||
126420838|NCT03594773|454835125|FG000|Overall Study|Withdrawal by Subject|3|||
126420839|NCT03594773|454835126|FG001|Overall Study|Withdrawal by Subject|2|||
126420840|NCT03594773|454835125|FG000|Overall Study|Lost to Follow-up|3|||
126420841|NCT03594773|454835126|FG001|Overall Study|Lost to Follow-up|4|||
126420842|NCT01461707|454835132|FG000|Overall Study|Withdrawal by Subject|1|||
126420843|NCT01461707|454835133|FG001|Overall Study|Withdrawal by Subject|0|||
126420844|NCT01450761|454835134|FG000|Randomization|Subject no longer meets study criteria|1|||
126420845|NCT01450761|454835135|FG001|Randomization|Subject no longer meets study criteria|2|||
126420846|NCT01450761|454835134|FG000|Randomization|Withdrawal by Subject|2|||
126420847|NCT01450761|454835135|FG001|Randomization|Withdrawal by Subject|0|||
126420848|NCT01450761|454835134|FG000|Randomization|Disease progression|0|||
126420849|NCT01450761|454835135|FG001|Randomization|Disease progression|2|||
126420850|NCT01450761|454835134|FG000|Randomization|Adverse Event unrelated to study drug|1|||
126420851|NCT01450761|454835135|FG001|Randomization|Adverse Event unrelated to study drug|0|||
126420852|NCT01450761|454835134|FG000|Randomization|Other|0|||
126420853|NCT01450761|454835135|FG001|Randomization|Other|1|||
126420854|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Disease progression|33|||
126420855|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Disease progression|32|||
126420856|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
126420857|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
126420858|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
126420859|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
126420860|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
126420861|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
126420862|NCT01450761|454835134|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
126420863|NCT01450761|454835135|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
126420864|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Death|3|||
126420865|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Death|3|||
126420866|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Other|2|||
126420867|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Other|2|||
126420868|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
126420869|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
126420870|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
126420871|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
126420872|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
126420873|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
126420874|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
126420875|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
126420876|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
126420877|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
126420878|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
126420879|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
126420880|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Death|5|||
126420881|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Death|6|||
126420882|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
126420883|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
126420884|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
126420885|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
126420886|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
126420887|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
126420888|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
126420889|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
126420890|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
126420891|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
126420892|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
126420893|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
126420894|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
126420895|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
126420896|NCT00337207|454835148|FG000|Overall Study|Withdrawal by Subject|3|||
126420897|NCT01338818|454835152|FG000|Overall Study|Adverse Event|8|||
126420898|NCT01338818|454835152|FG000|Overall Study|Lack of Efficacy|5|||
126420899|NCT01338818|454835152|FG000|Overall Study|no longer require study drug|1|||
126420900|NCT01338818|454835152|FG000|Overall Study|Withdrawal by Subject|11|||
126420901|NCT01338818|454835152|FG000|Overall Study|Lost to Follow-up|4|||
126420902|NCT01338818|454835152|FG000|Overall Study|Administrative problems|3|||
126420903|NCT01338818|454835152|FG000|Overall Study|Protocol Deviation|4|||
126420904|NCT00556998|454835157|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
126420905|NCT00556998|454835157|FG000|Voriconazole Intravenous (IV)|Other|4|||
126054597|NCT01079806|453493935|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
126420906|NCT00556998|454835157|FG000|Voriconazole Oral|Adverse Event|1|||
126420907|NCT00556998|454835157|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
126420908|NCT00216671|454835160|FG000|Overall Study|Adverse Event|4|||
126420909|NCT00216671|454835161|FG001|Overall Study|Adverse Event|9|||
125891212|NCT02529553|452899751|FG004|Overall Study|Progressive Disease|2|||
126089000|NCT01327846|453620050|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
126420910|NCT00216671|454835160|FG000|Overall Study|Pregnancy|0|||
126420911|NCT00216671|454835161|FG001|Overall Study|Pregnancy|1|||
126420912|NCT00216671|454835160|FG000|Overall Study|Withdrawal by Subject|4|||
126420913|NCT00216671|454835161|FG001|Overall Study|Withdrawal by Subject|2|||
126420914|NCT00216671|454835160|FG000|Overall Study|Refused Injections|3|||
126420915|NCT00216671|454835161|FG001|Overall Study|Refused Injections|13|||
126420916|NCT00216671|454835160|FG000|Overall Study|No Need to Continue Medication|1|||
126420917|NCT00216671|454835161|FG001|Overall Study|No Need to Continue Medication|1|||
126420918|NCT00216671|454835160|FG000|Overall Study|Insufficient Response|9|||
126420919|NCT00216671|454835161|FG001|Overall Study|Insufficient Response|4|||
126420920|NCT00216671|454835160|FG000|Overall Study|Lost to Follow-up|3|||
126420921|NCT00216671|454835161|FG001|Overall Study|Lost to Follow-up|5|||
126420922|NCT00216671|454835160|FG000|Overall Study|Non compliant|2|||
126420923|NCT00216671|454835161|FG001|Overall Study|Non compliant|2|||
126420924|NCT00216671|454835160|FG000|Overall Study|Ineligible|0|||
126420925|NCT00216671|454835161|FG001|Overall Study|Ineligible|2|||
126420926|NCT00216671|454835160|FG000|Overall Study|Physician Decision|1|||
126420927|NCT00216671|454835161|FG001|Overall Study|Physician Decision|1|||
126420928|NCT00216671|454835160|FG000|Overall Study|Protocol Violation|3|||
126420929|NCT00216671|454835161|FG001|Overall Study|Protocol Violation|5|||
126420930|NCT00216671|454835160|FG000|Overall Study|Relapse|1|||
126420931|NCT00216671|454835161|FG001|Overall Study|Relapse|0|||
126420932|NCT00216671|454835160|FG000|Overall Study|Investigator Illness|0|||
126420933|NCT00216671|454835161|FG001|Overall Study|Investigator Illness|1|||
126420934|NCT00216671|454835160|FG000|Overall Study|Patient Moved|0|||
126420935|NCT00216671|454835161|FG001|Overall Study|Patient Moved|1|||
126420936|NCT00216671|454835160|FG000|Overall Study|Ineligible, no efficacy data|2|||
126420937|NCT00216671|454835161|FG001|Overall Study|Ineligible, no efficacy data|2|||
126420938|NCT00216671|454835160|FG000|Overall Study|Insufficient Response Adverse Event|2|||
126420939|NCT00216671|454835161|FG001|Overall Study|Insufficient Response Adverse Event|1|||
126420940|NCT04980612|454835163|FG000|Overall Study|Withdrawal by Subject|7|||
126420941|NCT04980612|454835164|FG001|Overall Study|Withdrawal by Subject|5|||
126420942|NCT01369784|454835167|FG000|Overall Study|Protocol Violation|12|||
126420943|NCT02446717|454835168|FG000|Overall Study|Adverse Event|0|||
126420944|NCT02446717|454835169|FG001|Overall Study|Adverse Event|0|||
126420945|NCT02446717|454835170|FG002|Overall Study|Adverse Event|1|||
126420946|NCT02446717|454835171|FG003|Overall Study|Adverse Event|0|||
126420947|NCT02446717|454835172|FG004|Overall Study|Adverse Event|0|||
126420948|NCT02446717|454835168|FG000|Overall Study|Lost to Follow-up|0|||
126420949|NCT02446717|454835169|FG001|Overall Study|Lost to Follow-up|1|||
126420950|NCT02446717|454835170|FG002|Overall Study|Lost to Follow-up|1|||
126420951|NCT02446717|454835171|FG003|Overall Study|Lost to Follow-up|0|||
126420952|NCT02446717|454835172|FG004|Overall Study|Lost to Follow-up|1|||
126420953|NCT02446717|454835168|FG000|Overall Study|Withdrew consent|0|||
126420954|NCT02446717|454835169|FG001|Overall Study|Withdrew consent|0|||
126420955|NCT02446717|454835170|FG002|Overall Study|Withdrew consent|0|||
126420956|NCT02446717|454835171|FG003|Overall Study|Withdrew consent|1|||
126420957|NCT02446717|454835172|FG004|Overall Study|Withdrew consent|0|||
126420958|NCT02680665|454835173|FG000|Overall Study|No visit after the first prescription|5|||
125891213|NCT02529553|452899752|FG005|Overall Study|Progressive Disease|3|||
126420959|NCT04378270|454835180|FG000|Overall Study|Lack of Efficacy|1|||
126420960|NCT04378270|454835180|FG000|Overall Study|Withdrawal by Subject|1|||
126420961|NCT04378270|454835180|FG000|Overall Study|Screen Failure|1|||
126420962|NCT04378270|454835180|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
126420963|NCT01327599|454835181|FG000|Overall Study|Adverse Event|1|||
126420964|NCT01327599|454835181|FG000|Overall Study|Could Not Attend Visit|1|||
126420965|NCT01327599|454835181|FG000|Overall Study|Withdrawal of Consent|1|||
126420966|NCT04544956|454835184|FG000|Overall Study|Withdrawal by Subject|1|||
126420967|NCT00548145|454835187|FG000|Overall Study|Death|0|||
126420968|NCT00548145|454835188|FG001|Overall Study|Death|1|||
126420969|NCT00548145|454835187|FG000|Overall Study|Withdrawal by Subject|0|||
126420970|NCT00548145|454835188|FG001|Overall Study|Withdrawal by Subject|2|||
126420971|NCT00548145|454835187|FG000|Overall Study|Physician Decision|1|||
126420972|NCT00548145|454835188|FG001|Overall Study|Physician Decision|1|||
126054598|NCT01079806|453493936|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
126054599|NCT01079806|453493935|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
126054600|NCT01079806|453493936|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
126054601|NCT01779700|453493937|FG000|Overall Study|Adverse Event|4|||
126054602|NCT01779700|453493938|FG001|Overall Study|Adverse Event|3|||
126054603|NCT01779700|453493937|FG000|Overall Study|Withdrawal by Subject|0|||
126054604|NCT01779700|453493938|FG001|Overall Study|Withdrawal by Subject|2|||
126054605|NCT00019604|453493939|FG000|Overall Study|Death|1|||
126054606|NCT00019604|453493939|FG000|Overall Study|Progressive disease|23|||
126054607|NCT00019604|453493939|FG000|Overall Study|Refused treatment|1|||
126054608|NCT00019604|453493939|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
126054609|NCT00019604|453493939|FG000|Overall Study|Going to have liver transplant|1|||
126054610|NCT00019604|453493939|FG000|Overall Study|Move to a different study|1|||
126054611|NCT00019604|453493939|FG000|Overall Study|Non compliant on systemic CH|1|||
126054612|NCT00019604|453493939|FG000|Overall Study|Non compliant|1|||
126054613|NCT00019604|453493939|FG000|Overall Study|Resectable disease|1|||
126054614|NCT00019604|453493939|FG000|Overall Study|Started new chemo regimen|1|||
126420973|NCT02119663|454835189|FG000|Overall Study|Disease progression|26|||
126420974|NCT02119663|454835190|FG001|Overall Study|Disease progression|27|||
126420975|NCT02119663|454835189|FG000|Overall Study|Adverse Event|5|||
126420976|NCT02119663|454835190|FG001|Overall Study|Adverse Event|5|||
126420977|NCT02119663|454835189|FG000|Overall Study|Death|3|||
126420978|NCT02119663|454835190|FG001|Overall Study|Death|2|||
126420979|NCT02119663|454835189|FG000|Overall Study|Physician Decision|1|||
126420980|NCT02119663|454835190|FG001|Overall Study|Physician Decision|2|||
126420981|NCT02119663|454835189|FG000|Overall Study|Other unspecified|2|||
126420982|NCT02119663|454835190|FG001|Overall Study|Other unspecified|0|||
126420983|NCT02119663|454835189|FG000|Overall Study|Subject decision|0|||
126420984|NCT02119663|454835190|FG001|Overall Study|Subject decision|1|||
126420985|NCT02119663|454835189|FG000|Overall Study|Study Terminated by the Sponsor|3|||
126420986|NCT02119663|454835190|FG001|Overall Study|Study Terminated by the Sponsor|4|||
126420987|NCT00892775|454835191|FG000|Overall Study|Protocol Violation|1|||
126420988|NCT00892775|454835192|FG001|Overall Study|Protocol Violation|0|||
126420989|NCT00892775|454835191|FG000|Overall Study|Subject difficulties with blood drawing|1|||
126420990|NCT00892775|454835192|FG001|Overall Study|Subject difficulties with blood drawing|0|||
126420991|NCT00892775|454835191|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
126420992|NCT00892775|454835192|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
126420993|NCT00892775|454835191|FG000|Overall Study|Migrated/ moved from study area|1|||
126420994|NCT00892775|454835192|FG001|Overall Study|Migrated/ moved from study area|0|||
126420995|NCT00892775|454835191|FG000|Overall Study|Withdrawal by Subject|0|||
126420996|NCT00892775|454835192|FG001|Overall Study|Withdrawal by Subject|1|||
126420997|NCT00892775|454835191|FG000|Overall Study|Lost to Follow-up|1|||
126420998|NCT00892775|454835192|FG001|Overall Study|Lost to Follow-up|0|||
126420999|NCT00699660|454835193|FG000|Overall Study|Lost to Follow-up|4|||
126421000|NCT00699660|454835194|FG001|Overall Study|Lost to Follow-up|2|||
126421001|NCT00699660|454835193|FG000|Overall Study|missing reports and recording failures|10|||
126421002|NCT00699660|454835194|FG001|Overall Study|missing reports and recording failures|6|||
126421003|NCT00064792|454835195|FG000|Overall Study|Withdrawal by Subject|2|||
126421004|NCT00064792|454835196|FG001|Overall Study|Withdrawal by Subject|0|||
126421005|NCT00064792|454835195|FG000|Overall Study|Adverse Event|3|||
126054615|NCT00019604|453493939|FG000|Overall Study|Pt going to immunotherapy study|1|||
126054616|NCT00019604|453493939|FG000|Overall Study|Too much disease|1|||
126421006|NCT00064792|454835196|FG001|Overall Study|Adverse Event|0|||
126421007|NCT03301350|454835197|FG000|Overall Study|Withdrawal by Subject|4|||
126421008|NCT03301350|454835197|FG000|Overall Study|Adverse Event|1|||
126054617|NCT00019604|453493939|FG000|Overall Study|Unable to evaluate|1|||
126054618|NCT00019604|453493939|FG000|Overall Study|Details for other not available|4|||
126054619|NCT04608409|453493940|FG000|Overall Study|Physician Decision|1|||
126421009|NCT03301350|454835197|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
126421010|NCT03301350|454835197|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
126421011|NCT03301350|454835197|FG000|Overall Study|no detail provided|1|||
126421012|NCT01248949|454835200|FG000|Overall Study|Lost to Follow-up|2|||
126421013|NCT01248949|454835201|FG001|Overall Study|Lost to Follow-up|2|||
126421014|NCT01248949|454835202|FG002|Overall Study|Lost to Follow-up|2|||
126421015|NCT01248949|454835203|FG003|Overall Study|Lost to Follow-up|1|||
126421016|NCT01248949|454835204|FG004|Overall Study|Lost to Follow-up|0|||
126421017|NCT01248949|454835200|FG000|Overall Study|Withdrawal by Subject|5|||
126421018|NCT01248949|454835201|FG001|Overall Study|Withdrawal by Subject|3|||
126421019|NCT01248949|454835202|FG002|Overall Study|Withdrawal by Subject|11|||
126421020|NCT01248949|454835203|FG003|Overall Study|Withdrawal by Subject|3|||
126421021|NCT01248949|454835204|FG004|Overall Study|Withdrawal by Subject|1|||
126421022|NCT01248949|454835200|FG000|Overall Study|Death|22|||
126421023|NCT01248949|454835201|FG001|Overall Study|Death|7|||
126421024|NCT01248949|454835202|FG002|Overall Study|Death|21|||
126421025|NCT01248949|454835203|FG003|Overall Study|Death|6|||
126421026|NCT01248949|454835204|FG004|Overall Study|Death|2|||
126421027|NCT01248949|454835200|FG000|Overall Study|Alternative Therapy|1|||
126421028|NCT01248949|454835201|FG001|Overall Study|Alternative Therapy|0|||
126421029|NCT01248949|454835202|FG002|Overall Study|Alternative Therapy|0|||
126421030|NCT01248949|454835203|FG003|Overall Study|Alternative Therapy|0|||
126421031|NCT01248949|454835204|FG004|Overall Study|Alternative Therapy|0|||
126421032|NCT01248949|454835200|FG000|Overall Study|Alternative Therapy.|1|||
126421033|NCT01248949|454835201|FG001|Overall Study|Alternative Therapy.|0|||
126421034|NCT01248949|454835202|FG002|Overall Study|Alternative Therapy.|0|||
126421035|NCT01248949|454835203|FG003|Overall Study|Alternative Therapy.|0|||
126421036|NCT01248949|454835204|FG004|Overall Study|Alternative Therapy.|0|||
126421037|NCT01248949|454835200|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
126421038|NCT01248949|454835201|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
126421039|NCT01248949|454835202|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
126421040|NCT01248949|454835203|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
126421041|NCT01248949|454835204|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
126421042|NCT01248949|454835200|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
126421043|NCT01248949|454835201|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
126421044|NCT01248949|454835202|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
126421045|NCT01248949|454835203|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
126421046|NCT01248949|454835204|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
126421047|NCT01248949|454835200|FG000|Overall Study|Participant Went To Hospice|0|||
126421048|NCT01248949|454835201|FG001|Overall Study|Participant Went To Hospice|0|||
126421049|NCT01248949|454835202|FG002|Overall Study|Participant Went To Hospice|1|||
126421050|NCT01248949|454835203|FG003|Overall Study|Participant Went To Hospice|0|||
126421051|NCT01248949|454835204|FG004|Overall Study|Participant Went To Hospice|0|||
126421052|NCT01248949|454835200|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
126421053|NCT01248949|454835201|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
126421054|NCT01248949|454835202|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
126421055|NCT01248949|454835203|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
126421056|NCT01248949|454835204|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
126421057|NCT01248949|454835200|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
126421058|NCT01248949|454835201|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
126421059|NCT01248949|454835202|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
126421060|NCT01248949|454835203|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
126421061|NCT01248949|454835204|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
126421062|NCT01248949|454835200|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
126421063|NCT01248949|454835201|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
126421064|NCT01248949|454835202|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
126421065|NCT01248949|454835203|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
126421066|NCT01248949|454835204|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
126421067|NCT01248949|454835200|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
126421068|NCT01248949|454835201|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
126421069|NCT01248949|454835202|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
126421070|NCT01248949|454835203|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
126421071|NCT01248949|454835204|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
126421072|NCT03915470|454835207|FG000|Overall Study|Death|3|||
126421073|NCT03915470|454835208|FG001|Overall Study|Death|1|||
126421074|NCT03915470|454835207|FG000|Overall Study|Adverse Event|1|||
126421075|NCT03915470|454835208|FG001|Overall Study|Adverse Event|0|||
126421076|NCT03915470|454835207|FG000|Overall Study|Physician Decision|1|||
126421077|NCT03915470|454835208|FG001|Overall Study|Physician Decision|0|||
126421078|NCT03915470|454835207|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
126421079|NCT03915470|454835208|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
126421080|NCT03160898|454835209|FG000|Overall Study|Adverse Event|4|||
126421081|NCT03160898|454835210|FG001|Overall Study|Adverse Event|8|||
126421082|NCT03160898|454835211|FG002|Overall Study|Adverse Event|7|||
126421083|NCT03160898|454835212|FG003|Overall Study|Adverse Event|10|||
126421084|NCT03160898|454835209|FG000|Overall Study|Death|1|||
126421085|NCT03160898|454835210|FG001|Overall Study|Death|0|||
126421086|NCT03160898|454835211|FG002|Overall Study|Death|0|||
126421087|NCT03160898|454835212|FG003|Overall Study|Death|1|||
126421088|NCT03160898|454835209|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
126421089|NCT03160898|454835210|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
126421090|NCT03160898|454835211|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
126105361|NCT04640077|453678610|FG001|Period 1|Withdrawal by Subject|5|||
126421091|NCT03160898|454835212|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
126421092|NCT03160898|454835209|FG000|Overall Study|Lost to Follow-up|1|||
126421093|NCT03160898|454835210|FG001|Overall Study|Lost to Follow-up|1|||
126421094|NCT03160898|454835211|FG002|Overall Study|Lost to Follow-up|1|||
126421095|NCT03160898|454835212|FG003|Overall Study|Lost to Follow-up|2|||
126421096|NCT03160898|454835209|FG000|Overall Study|Physician Decision|1|||
126421097|NCT03160898|454835210|FG001|Overall Study|Physician Decision|0|||
126421098|NCT03160898|454835211|FG002|Overall Study|Physician Decision|0|||
126421099|NCT03160898|454835212|FG003|Overall Study|Physician Decision|1|||
126421100|NCT03160898|454835209|FG000|Overall Study|Progressive Disease|4|||
126421101|NCT03160898|454835210|FG001|Overall Study|Progressive Disease|1|||
126421102|NCT03160898|454835211|FG002|Overall Study|Progressive Disease|2|||
126421103|NCT03160898|454835212|FG003|Overall Study|Progressive Disease|1|||
126421104|NCT03160898|454835209|FG000|Overall Study|Protocol Violation|1|||
126421105|NCT03160898|454835210|FG001|Overall Study|Protocol Violation|0|||
126421106|NCT03160898|454835211|FG002|Overall Study|Protocol Violation|2|||
126421107|NCT03160898|454835212|FG003|Overall Study|Protocol Violation|0|||
126421108|NCT03160898|454835209|FG000|Overall Study|Sponsor Discretion|2|||
126421109|NCT03160898|454835210|FG001|Overall Study|Sponsor Discretion|0|||
126421110|NCT03160898|454835211|FG002|Overall Study|Sponsor Discretion|0|||
126421111|NCT03160898|454835212|FG003|Overall Study|Sponsor Discretion|0|||
126421112|NCT03160898|454835209|FG000|Overall Study|Withdrawal by Subject|1|||
126421113|NCT03160898|454835210|FG001|Overall Study|Withdrawal by Subject|3|||
126421114|NCT03160898|454835211|FG002|Overall Study|Withdrawal by Subject|2|||
126421115|NCT03160898|454835212|FG003|Overall Study|Withdrawal by Subject|1|||
126421116|NCT03160898|454835209|FG000|Overall Study|Other|2|||
126421117|NCT03160898|454835210|FG001|Overall Study|Other|0|||
126421118|NCT03160898|454835211|FG002|Overall Study|Other|2|||
126421119|NCT03160898|454835212|FG003|Overall Study|Other|2|||
126421120|NCT03245775|454835215|FG000|Overall Study|Lost to Follow-up|25|||
126421121|NCT03245775|454835216|FG001|Overall Study|Lost to Follow-up|26|||
126421122|NCT03245775|454835217|FG002|Overall Study|Lost to Follow-up|16|||
126421123|NCT03245775|454835218|FG003|Overall Study|Lost to Follow-up|16|||
126421124|NCT02713828|454835219|FG000|Overall Study|Death|2|||
126421125|NCT02713828|454835220|FG001|Overall Study|Death|0|||
126421126|NCT02713828|454835219|FG000|Overall Study|Withdrawal by Subject|1|||
126421127|NCT02713828|454835220|FG001|Overall Study|Withdrawal by Subject|0|||
126421128|NCT02713828|454835219|FG000|Overall Study|study terminated but patient allowed to|2|||
126421129|NCT02713828|454835220|FG001|Overall Study|study terminated but patient allowed to|0|||
126421130|NCT00434109|454835221|FG000|Overall Study|Physician Decision|9|||
126421131|NCT00434109|454835221|FG000|Overall Study|Adverse Event|5|||
126421132|NCT00434109|454835221|FG000|Overall Study|Protocol Violation|1|||
126421133|NCT00434109|454835221|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
126421134|NCT02978833|454835224|FG000|Overall Study|Study terminated|1|||
126421135|NCT02978833|454835225|FG001|Overall Study|Study terminated|1|||
126421136|NCT00103740|454835226|FG000|Period 1 - Core|Adverse Event|1|||
126421137|NCT00103740|454835227|FG001|Period 1 - Core|Adverse Event|0|||
126421138|NCT00103740|454835226|FG000|Period 1 - Core|Protocol Violation|3|||
126421139|NCT00103740|454835227|FG001|Period 1 - Core|Protocol Violation|2|||
126421140|NCT00103740|454835226|FG000|Period 1 - Core|Patient withdrew consent|3|||
126421141|NCT00103740|454835227|FG001|Period 1 - Core|Patient withdrew consent|2|||
126421142|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
126421143|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
126421144|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
126421145|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
126421146|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
126421147|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
126421148|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Death|6|||
126421149|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Death|2|||
126421150|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
126421151|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
126421152|NCT04178720|454835231|FG000|Overall Study|Withdrawal by Subject|2|||
126421153|NCT04178720|454835232|FG001|Overall Study|Withdrawal by Subject|0|||
126421154|NCT04178720|454835231|FG000|Overall Study|Relocation|0|||
125891214|NCT02529553|452899753|FG006|Overall Study|Progressive Disease|3|||
125891215|NCT02529553|452899754|FG007|Overall Study|Progressive Disease|5|||
125891216|NCT02529553|452899755|FG008|Overall Study|Progressive Disease|3|||
125891217|NCT02529553|452899747|FG000|Overall Study|Physician Decision|0|||
125891218|NCT02529553|452899748|FG001|Overall Study|Physician Decision|1|||
125891219|NCT02529553|452899749|FG002|Overall Study|Physician Decision|0|||
125891220|NCT02529553|452899750|FG003|Overall Study|Physician Decision|0|||
126421155|NCT04178720|454835232|FG001|Overall Study|Relocation|1|||
126421156|NCT01792115|454835233|FG000|Overall Study|Lost to Follow-up|0|||
126421157|NCT01792115|454835234|FG001|Overall Study|Lost to Follow-up|1|||
126421158|NCT01792115|454835235|FG002|Overall Study|Lost to Follow-up|0|||
126421159|NCT01594931|454838579|FG000|Overall Study|Adverse Event|3|||
126421160|NCT01594931|454838580|FG001|Overall Study|Adverse Event|1|||
126421161|NCT01594931|454838581|FG002|Overall Study|Adverse Event|1|||
126421162|NCT01594931|454838579|FG000|Overall Study|Withdrawal by Subject|2|||
126421163|NCT01594931|454838580|FG001|Overall Study|Withdrawal by Subject|1|||
126421164|NCT01594931|454838581|FG002|Overall Study|Withdrawal by Subject|1|||
126421165|NCT01594931|454838579|FG000|Overall Study|Lack of Efficacy|7|||
126421166|NCT01594931|454838580|FG001|Overall Study|Lack of Efficacy|2|||
126421167|NCT01594931|454838581|FG002|Overall Study|Lack of Efficacy|2|||
126421168|NCT01594931|454838579|FG000|Overall Study|Lost to Follow-up|4|||
126421169|NCT01594931|454838580|FG001|Overall Study|Lost to Follow-up|3|||
126421170|NCT01594931|454838581|FG002|Overall Study|Lost to Follow-up|3|||
126421171|NCT01594931|454838579|FG000|Overall Study|Protocol Violation|2|||
126421172|NCT01594931|454838580|FG001|Overall Study|Protocol Violation|1|||
126421173|NCT01594931|454838581|FG002|Overall Study|Protocol Violation|0|||
126421174|NCT01594931|454838579|FG000|Overall Study|No defiined|11|||
126421175|NCT01594931|454838580|FG001|Overall Study|No defiined|4|||
126421176|NCT01594931|454838581|FG002|Overall Study|No defiined|7|||
126421177|NCT02936635|454838590|FG000|Overall Study|Adverse Event|43|||
126421178|NCT02936635|454838591|FG001|Overall Study|Adverse Event|25|||
126421179|NCT02936635|454838590|FG000|Overall Study|Progressive Disease|10|||
126421180|NCT02936635|454838591|FG001|Overall Study|Progressive Disease|18|||
126421181|NCT02936635|454838590|FG000|Overall Study|Sponsor Discretion|10|||
126421182|NCT02936635|454838591|FG001|Overall Study|Sponsor Discretion|16|||
126421183|NCT02936635|454838590|FG000|Overall Study|Death|9|||
126421184|NCT02936635|454838591|FG001|Overall Study|Death|15|||
126421185|NCT02936635|454838590|FG000|Overall Study|Withdrawal by Subject|8|||
126421186|NCT02936635|454838591|FG001|Overall Study|Withdrawal by Subject|15|||
126421187|NCT02936635|454838590|FG000|Overall Study|Physician Decision|2|||
126421188|NCT02936635|454838591|FG001|Overall Study|Physician Decision|9|||
126421189|NCT02936635|454838590|FG000|Overall Study|Lost to Follow-up|1|||
126421190|NCT02936635|454838591|FG001|Overall Study|Lost to Follow-up|2|||
126421191|NCT02936635|454838590|FG000|Overall Study|Protocol Violation|1|||
126421192|NCT02936635|454838591|FG001|Overall Study|Protocol Violation|0|||
125891221|NCT02529553|452899751|FG004|Overall Study|Physician Decision|1|||
125891222|NCT02529553|452899752|FG005|Overall Study|Physician Decision|0|||
125891223|NCT02529553|452899753|FG006|Overall Study|Physician Decision|0|||
125891224|NCT02529553|452899754|FG007|Overall Study|Physician Decision|0|||
126421193|NCT02936635|454838590|FG000|Overall Study|Lack of effect/Entry into other study|31|||
125891225|NCT02529553|452899755|FG008|Overall Study|Physician Decision|0|||
125891226|NCT02529553|452899747|FG000|Overall Study|Withdrawal by Subject|0|||
126421194|NCT02936635|454838591|FG001|Overall Study|Lack of effect/Entry into other study|65|||
126421195|NCT01633788|454838592|FG000|Overall Study|Adverse Event|1|||
126421196|NCT01633788|454838593|FG001|Overall Study|Adverse Event|3|||
126421197|NCT01633788|454838594|FG002|Overall Study|Adverse Event|3|||
126421198|NCT01633788|454838595|FG003|Overall Study|Adverse Event|3|||
126421199|NCT01633788|454838592|FG000|Overall Study|Lost to Follow-up|2|||
126421200|NCT01633788|454838593|FG001|Overall Study|Lost to Follow-up|2|||
126421201|NCT01633788|454838594|FG002|Overall Study|Lost to Follow-up|2|||
126421202|NCT01633788|454838595|FG003|Overall Study|Lost to Follow-up|0|||
126421203|NCT01633788|454838592|FG000|Overall Study|Personal Reasons|3|||
126421204|NCT01633788|454838593|FG001|Overall Study|Personal Reasons|1|||
126421205|NCT01633788|454838594|FG002|Overall Study|Personal Reasons|1|||
126421206|NCT01633788|454838595|FG003|Overall Study|Personal Reasons|3|||
126421207|NCT01633788|454838592|FG000|Overall Study|Protocol Violation|1|||
126421208|NCT01633788|454838593|FG001|Overall Study|Protocol Violation|0|||
126421209|NCT01633788|454838594|FG002|Overall Study|Protocol Violation|1|||
126421210|NCT01633788|454838595|FG003|Overall Study|Protocol Violation|0|||
126421211|NCT01633788|454838592|FG000|Overall Study|Other Reasons|0|||
126421212|NCT01633788|454838593|FG001|Overall Study|Other Reasons|2|||
126421213|NCT01633788|454838594|FG002|Overall Study|Other Reasons|3|||
126421214|NCT01633788|454838595|FG003|Overall Study|Other Reasons|7|||
126421215|NCT01929226|454838596|FG000|Overall Study|Lost to Follow-up|4|||
126421216|NCT01929226|454838597|FG001|Overall Study|Lost to Follow-up|0|||
126421217|NCT01929226|454838596|FG000|Overall Study|Withdrawal by Subject|1|||
126421218|NCT01929226|454838597|FG001|Overall Study|Withdrawal by Subject|1|||
126421219|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
126421220|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
126421221|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
126421222|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
126421223|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
126421224|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
126421225|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
126421226|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
126421227|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
126054620|NCT04608409|453493941|FG001|Overall Study|Physician Decision|1|||
126054621|NCT04608409|453493942|FG002|Overall Study|Physician Decision|2|||
126054622|NCT00599196|453493943|FG000|Overall Study|Lack of Efficacy|22|||
126054623|NCT00599196|453493943|FG000|Overall Study|Adverse Event|93|||
126054624|NCT00599196|453493943|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
126054625|NCT00599196|453493943|FG000|Overall Study|Subject withdrew consent|43|||
126054626|NCT00599196|453493943|FG000|Overall Study|Study ended per sponsor|197|||
126054627|NCT00599196|453493943|FG000|Overall Study|Lost to Follow-up|17|||
126421228|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
126421229|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
126421230|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
125891227|NCT02529553|452899748|FG001|Overall Study|Withdrawal by Subject|0|||
126054628|NCT00599196|453493943|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
126421231|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
126421232|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
126421233|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
126421234|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
126421235|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
126421236|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
126421237|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
126421238|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
126421239|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
126421240|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
126421241|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
126421242|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
126421243|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
126421244|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
126421245|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
126421246|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
126421247|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
126421248|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
126421249|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
126421250|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
126421251|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
126421252|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
126421253|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
126421254|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
126421255|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
126421256|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
126421257|NCT00837213|454838605|FG000|Overall Study|Lost to Follow-up|3|||
126421258|NCT00837213|454838606|FG001|Overall Study|Lost to Follow-up|2|||
126421259|NCT00837213|454838605|FG000|Overall Study|Withdrawal by Subject|2|||
126421260|NCT00837213|454838606|FG001|Overall Study|Withdrawal by Subject|2|||
126421261|NCT00837213|454838605|FG000|Overall Study|not stated|1|||
126421262|NCT00837213|454838606|FG001|Overall Study|not stated|1|||
126421263|NCT02698826|454838608|FG000|Overall Study|Death|13|||
126421264|NCT02698826|454838608|FG000|Overall Study|Adverse Event|1|||
126421265|NCT04317040|454838614|FG000|Overall Study|Lost to Follow-up|2|||
126421266|NCT04317040|454838615|FG001|Overall Study|Lost to Follow-up|0|||
126421267|NCT04317040|454838614|FG000|Overall Study|Death|16|||
126421268|NCT04317040|454838615|FG001|Overall Study|Death|18|||
126421269|NCT04317040|454838614|FG000|Overall Study|Withdrawal by Subject|0|||
126421270|NCT04317040|454838615|FG001|Overall Study|Withdrawal by Subject|1|||
126421271|NCT04317040|454838614|FG000|Overall Study|Incomplete assessments|0|||
126421272|NCT04317040|454838615|FG001|Overall Study|Incomplete assessments|1|||
126421273|NCT02366195|454838619|FG000|Overall Study|Protocol-specified criteria|3|||
126421274|NCT02366195|454838619|FG000|Overall Study|Withdrawal by Subject|9|||
126421275|NCT02366195|454838619|FG000|Overall Study|Lost to Follow-up|1|||
126421276|NCT02366195|454838619|FG000|Overall Study|Death|41|||
126421277|NCT04961541|454838626|FG000|Overall Study|Adverse Event|0|||
126421278|NCT04961541|454838627|FG001|Overall Study|Adverse Event|0|||
126421279|NCT04961541|454838628|FG002|Overall Study|Adverse Event|0|||
126421280|NCT04961541|454838629|FG003|Overall Study|Adverse Event|0|||
126421281|NCT04961541|454838630|FG004|Overall Study|Adverse Event|0|||
126421282|NCT04961541|454838631|FG005|Overall Study|Adverse Event|1|||
126421283|NCT04961541|454838632|FG006|Overall Study|Adverse Event|0|||
126421284|NCT04961541|454838633|FG007|Overall Study|Adverse Event|0|||
126421285|NCT04961541|454838634|FG008|Overall Study|Adverse Event|0|||
126421286|NCT04961541|454838635|FG009|Overall Study|Adverse Event|0|||
126421287|NCT04961541|454838636|FG010|Overall Study|Adverse Event|0|||
126421288|NCT04961541|454838637|FG011|Overall Study|Adverse Event|0|||
126421289|NCT04961541|454838638|FG012|Overall Study|Adverse Event|0|||
126421290|NCT04961541|454838639|FG013|Overall Study|Adverse Event|0|||
126421291|NCT04961541|454838626|FG000|Overall Study|Lost to Follow-up|0|||
126421292|NCT04961541|454838627|FG001|Overall Study|Lost to Follow-up|0|||
126421293|NCT04961541|454838628|FG002|Overall Study|Lost to Follow-up|3|||
126421294|NCT04961541|454838629|FG003|Overall Study|Lost to Follow-up|0|||
126421295|NCT04961541|454838630|FG004|Overall Study|Lost to Follow-up|0|||
126421296|NCT04961541|454838631|FG005|Overall Study|Lost to Follow-up|0|||
126421297|NCT04961541|454838632|FG006|Overall Study|Lost to Follow-up|1|||
126421298|NCT04961541|454838633|FG007|Overall Study|Lost to Follow-up|1|||
126421299|NCT04961541|454838634|FG008|Overall Study|Lost to Follow-up|0|||
126421300|NCT04961541|454838635|FG009|Overall Study|Lost to Follow-up|1|||
126421301|NCT04961541|454838636|FG010|Overall Study|Lost to Follow-up|0|||
126421302|NCT04961541|454838637|FG011|Overall Study|Lost to Follow-up|0|||
126421303|NCT04961541|454838638|FG012|Overall Study|Lost to Follow-up|1|||
126421304|NCT04961541|454838639|FG013|Overall Study|Lost to Follow-up|0|||
126421305|NCT04961541|454838626|FG000|Overall Study|Withdrawal by Subject|0|||
126421306|NCT04961541|454838627|FG001|Overall Study|Withdrawal by Subject|0|||
126421307|NCT04961541|454838628|FG002|Overall Study|Withdrawal by Subject|1|||
126421308|NCT04961541|454838629|FG003|Overall Study|Withdrawal by Subject|1|||
126421309|NCT04961541|454838630|FG004|Overall Study|Withdrawal by Subject|0|||
126421310|NCT04961541|454838631|FG005|Overall Study|Withdrawal by Subject|0|||
126421311|NCT04961541|454838632|FG006|Overall Study|Withdrawal by Subject|0|||
126421312|NCT04961541|454838633|FG007|Overall Study|Withdrawal by Subject|0|||
126421313|NCT04961541|454838634|FG008|Overall Study|Withdrawal by Subject|0|||
126421314|NCT04961541|454838635|FG009|Overall Study|Withdrawal by Subject|1|||
126421315|NCT04961541|454838636|FG010|Overall Study|Withdrawal by Subject|0|||
126421316|NCT04961541|454838637|FG011|Overall Study|Withdrawal by Subject|0|||
126421317|NCT04961541|454838638|FG012|Overall Study|Withdrawal by Subject|0|||
126421318|NCT04961541|454838639|FG013|Overall Study|Withdrawal by Subject|0|||
126421319|NCT01843023|454838641|FG000|Overall Study|Death|1|||
126421320|NCT01843023|454838642|FG001|Overall Study|Death|0|||
126421321|NCT01843023|454838641|FG000|Overall Study|Lost to Follow-up|24|||
126421322|NCT01843023|454838642|FG001|Overall Study|Lost to Follow-up|29|||
126421323|NCT01843023|454838641|FG000|Overall Study|Withdrawal by Subject|8|||
126421324|NCT01843023|454838642|FG001|Overall Study|Withdrawal by Subject|6|||
126421325|NCT03305770|454838643|FG000|Overall Study|Physician Decision - prior to dispense|0|||
126421326|NCT03305770|454838644|FG001|Overall Study|Physician Decision - prior to dispense|1|||
126421327|NCT03305770|454838643|FG000|Overall Study|Subject moved|1|||
126421328|NCT03305770|454838644|FG001|Overall Study|Subject moved|0|||
126421329|NCT03539601|454838645|FG000|Overall Study|Withdraw by parent/guardian|1|||
126421330|NCT03539601|454838646|FG001|Overall Study|Withdraw by parent/guardian|0|||
126421331|NCT03539601|454838647|FG002|Overall Study|Withdraw by parent/guardian|1|||
126421332|NCT03539601|454838648|FG003|Overall Study|Withdraw by parent/guardian|0|||
126421333|NCT03539601|454838645|FG000|Overall Study|Adverse Event|0|||
126421334|NCT03539601|454838646|FG001|Overall Study|Adverse Event|2|||
126421335|NCT03539601|454838647|FG002|Overall Study|Adverse Event|0|||
126421336|NCT03539601|454838648|FG003|Overall Study|Adverse Event|0|||
126421337|NCT03539601|454838645|FG000|Overall Study|Lost to Follow-up|2|||
126421338|NCT03539601|454838646|FG001|Overall Study|Lost to Follow-up|4|||
126421339|NCT03539601|454838647|FG002|Overall Study|Lost to Follow-up|5|||
126421340|NCT03539601|454838648|FG003|Overall Study|Lost to Follow-up|0|||
126421341|NCT03539601|454838645|FG000|Overall Study|Withdrawal by Subject|2|||
126421342|NCT03539601|454838646|FG001|Overall Study|Withdrawal by Subject|0|||
126421343|NCT03539601|454838647|FG002|Overall Study|Withdrawal by Subject|0|||
126421344|NCT03539601|454838648|FG003|Overall Study|Withdrawal by Subject|1|||
126421345|NCT03539601|454838645|FG000|Overall Study|Randomized but not treated|1|||
126421346|NCT03539601|454838646|FG001|Overall Study|Randomized but not treated|1|||
126421347|NCT03539601|454838647|FG002|Overall Study|Randomized but not treated|0|||
126421348|NCT03539601|454838648|FG003|Overall Study|Randomized but not treated|0|||
126421349|NCT01970306|454838649|FG000|Overall Study|Not eligible|3|||
126421350|NCT01970306|454838649|FG000|Overall Study|Not able to be treated|9|||
126421351|NCT00226811|454838650|FG000|Overall Study|Death|8|||
126421352|NCT00226811|454838650|FG000|Overall Study|Adverse Event|11|||
126421353|NCT00226811|454838650|FG000|Overall Study|Lack of Efficacy|55|||
126421354|NCT00226811|454838650|FG000|Overall Study|Withdrawal by Subject|2|||
126421355|NCT02741635|454838651|FG000|Overall Study|Withdrawal by Subject|1|||
126421356|NCT01427933|454838652|FG000|Overall Study|Withdrawal by Subject|5|||
126421357|NCT01427933|454838653|FG001|Overall Study|Withdrawal by Subject|8|||
126421358|NCT01427933|454838652|FG000|Overall Study|Lost to Follow-up|1|||
126421359|NCT01427933|454838653|FG001|Overall Study|Lost to Follow-up|5|||
126421360|NCT01427933|454838652|FG000|Overall Study|Other|1|||
126421361|NCT01427933|454838653|FG001|Overall Study|Other|0|||
125891228|NCT02529553|452899749|FG002|Overall Study|Withdrawal by Subject|0|||
126421362|NCT01427933|454838652|FG000|Overall Study|Investigator's Decision|1|||
126421363|NCT01427933|454838653|FG001|Overall Study|Investigator's Decision|0|||
126421364|NCT01633541|454838656|FG000|Overall Study|Death|1|||
126421365|NCT01633541|454838657|FG001|Overall Study|Death|0|||
126421366|NCT01010971|454838658|FG000|Overall Study|Adverse Event|2|||
126421367|NCT01010971|454838659|FG001|Overall Study|Adverse Event|4|||
126421368|NCT01010971|454838660|FG002|Overall Study|Adverse Event|3|||
126421369|NCT01010971|454838658|FG000|Overall Study|Withdrawal by Subject|0|||
126421370|NCT01010971|454838659|FG001|Overall Study|Withdrawal by Subject|2|||
126421371|NCT01010971|454838660|FG002|Overall Study|Withdrawal by Subject|5|||
126421372|NCT01010971|454838658|FG000|Overall Study|Lost to Follow-up|0|||
126421373|NCT01010971|454838659|FG001|Overall Study|Lost to Follow-up|2|||
126421374|NCT01010971|454838660|FG002|Overall Study|Lost to Follow-up|3|||
126421375|NCT01010971|454838658|FG000|Overall Study|Other|1|||
126421376|NCT01010971|454838659|FG001|Overall Study|Other|0|||
125891229|NCT02529553|452899750|FG003|Overall Study|Withdrawal by Subject|0|||
126421377|NCT01010971|454838660|FG002|Overall Study|Other|2|||
126421378|NCT03472326|454838661|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
126421379|NCT03472326|454838662|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
126421380|NCT03472326|454838663|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
126421381|NCT03472326|454838664|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
126421382|NCT03472326|454838661|FG000|Part 2: Combination Therapy|Pregnancy|0|||
126421383|NCT03472326|454838662|FG001|Part 2: Combination Therapy|Pregnancy|0|||
126421384|NCT03472326|454838663|FG002|Part 2: Combination Therapy|Pregnancy|0|||
126421385|NCT03472326|454838664|FG003|Part 2: Combination Therapy|Pregnancy|1|||
126421386|NCT03386721|454838665|FG000|Overall Study|Death|12|||
126421387|NCT03386721|454838666|FG001|Overall Study|Death|21|||
126421388|NCT03386721|454838667|FG002|Overall Study|Death|2|||
126421389|NCT03386721|454838668|FG003|Overall Study|Death|5|||
126421390|NCT03386721|454838669|FG004|Overall Study|Death|1|||
126421391|NCT03386721|454838670|FG005|Overall Study|Death|12|||
126421392|NCT03386721|454838671|FG006|Overall Study|Death|1|||
126421393|NCT03386721|454838672|FG007|Overall Study|Death|1|||
126421394|NCT03386721|454838673|FG008|Overall Study|Death|12|||
126421395|NCT03386721|454838674|FG009|Overall Study|Death|20|||
126421396|NCT03386721|454838675|FG010|Overall Study|Death|21|||
126421397|NCT03386721|454838676|FG011|Overall Study|Death|21|||
126421398|NCT03386721|454838677|FG012|Overall Study|Death|14|||
126421399|NCT03386721|454838678|FG013|Overall Study|Death|2|||
126421400|NCT03386721|454838679|FG014|Overall Study|Death|1|||
126421401|NCT03386721|454838665|FG000|Overall Study|Lost to Follow-up|1|||
126421402|NCT03386721|454838666|FG001|Overall Study|Lost to Follow-up|3|||
126421403|NCT03386721|454838667|FG002|Overall Study|Lost to Follow-up|0|||
126421404|NCT03386721|454838668|FG003|Overall Study|Lost to Follow-up|0|||
126421405|NCT03386721|454838669|FG004|Overall Study|Lost to Follow-up|0|||
126421406|NCT03386721|454838670|FG005|Overall Study|Lost to Follow-up|2|||
126421407|NCT03386721|454838671|FG006|Overall Study|Lost to Follow-up|1|||
126421408|NCT03386721|454838672|FG007|Overall Study|Lost to Follow-up|0|||
126421409|NCT03386721|454838673|FG008|Overall Study|Lost to Follow-up|1|||
126421410|NCT03386721|454838674|FG009|Overall Study|Lost to Follow-up|2|||
126421411|NCT03386721|454838675|FG010|Overall Study|Lost to Follow-up|1|||
126421412|NCT03386721|454838676|FG011|Overall Study|Lost to Follow-up|0|||
126421413|NCT03386721|454838677|FG012|Overall Study|Lost to Follow-up|0|||
126421414|NCT03386721|454838678|FG013|Overall Study|Lost to Follow-up|0|||
126421415|NCT03386721|454838679|FG014|Overall Study|Lost to Follow-up|0|||
126421416|NCT03386721|454838665|FG000|Overall Study|Reason not specified|3|||
126421417|NCT03386721|454838666|FG001|Overall Study|Reason not specified|0|||
126421418|NCT03386721|454838667|FG002|Overall Study|Reason not specified|0|||
126421419|NCT03386721|454838668|FG003|Overall Study|Reason not specified|0|||
126421420|NCT03386721|454838669|FG004|Overall Study|Reason not specified|0|||
126421421|NCT03386721|454838670|FG005|Overall Study|Reason not specified|3|||
126421422|NCT03386721|454838671|FG006|Overall Study|Reason not specified|1|||
126421423|NCT03386721|454838672|FG007|Overall Study|Reason not specified|0|||
126421424|NCT03386721|454838673|FG008|Overall Study|Reason not specified|0|||
126421425|NCT03386721|454838674|FG009|Overall Study|Reason not specified|1|||
126421426|NCT03386721|454838675|FG010|Overall Study|Reason not specified|2|||
126421427|NCT03386721|454838676|FG011|Overall Study|Reason not specified|6|||
126421428|NCT03386721|454838677|FG012|Overall Study|Reason not specified|1|||
126421429|NCT03386721|454838678|FG013|Overall Study|Reason not specified|0|||
126421430|NCT03386721|454838679|FG014|Overall Study|Reason not specified|0|||
126421431|NCT03386721|454838665|FG000|Overall Study|Progressive Disease|0|||
126421432|NCT03386721|454838666|FG001|Overall Study|Progressive Disease|0|||
126421433|NCT03386721|454838667|FG002|Overall Study|Progressive Disease|1|||
126421434|NCT03386721|454838668|FG003|Overall Study|Progressive Disease|0|||
126421435|NCT03386721|454838669|FG004|Overall Study|Progressive Disease|0|||
126421436|NCT03386721|454838670|FG005|Overall Study|Progressive Disease|1|||
126421437|NCT03386721|454838671|FG006|Overall Study|Progressive Disease|0|||
126421438|NCT03386721|454838672|FG007|Overall Study|Progressive Disease|0|||
126421439|NCT03386721|454838673|FG008|Overall Study|Progressive Disease|2|||
126421440|NCT03386721|454838674|FG009|Overall Study|Progressive Disease|1|||
126421441|NCT03386721|454838675|FG010|Overall Study|Progressive Disease|1|||
126421442|NCT03386721|454838676|FG011|Overall Study|Progressive Disease|0|||
126421443|NCT03386721|454838677|FG012|Overall Study|Progressive Disease|1|||
126421444|NCT03386721|454838678|FG013|Overall Study|Progressive Disease|0|||
126421445|NCT03386721|454838679|FG014|Overall Study|Progressive Disease|0|||
126421446|NCT03386721|454838665|FG000|Overall Study|Site Terminated by Sponsor|5|||
126421447|NCT03386721|454838666|FG001|Overall Study|Site Terminated by Sponsor|5|||
126421448|NCT03386721|454838667|FG002|Overall Study|Site Terminated by Sponsor|0|||
126421449|NCT03386721|454838668|FG003|Overall Study|Site Terminated by Sponsor|0|||
126421450|NCT03386721|454838669|FG004|Overall Study|Site Terminated by Sponsor|1|||
126421451|NCT03386721|454838670|FG005|Overall Study|Site Terminated by Sponsor|3|||
126421452|NCT03386721|454838671|FG006|Overall Study|Site Terminated by Sponsor|0|||
126421453|NCT03386721|454838672|FG007|Overall Study|Site Terminated by Sponsor|1|||
126421454|NCT03386721|454838673|FG008|Overall Study|Site Terminated by Sponsor|4|||
126421455|NCT03386721|454838674|FG009|Overall Study|Site Terminated by Sponsor|5|||
126421456|NCT03386721|454838675|FG010|Overall Study|Site Terminated by Sponsor|3|||
126421457|NCT03386721|454838676|FG011|Overall Study|Site Terminated by Sponsor|11|||
126421458|NCT03386721|454838677|FG012|Overall Study|Site Terminated by Sponsor|6|||
126421459|NCT03386721|454838678|FG013|Overall Study|Site Terminated by Sponsor|0|||
126421460|NCT03386721|454838679|FG014|Overall Study|Site Terminated by Sponsor|0|||
126421461|NCT03386721|454838665|FG000|Overall Study|Symptomatic Deterioration|0|||
126421462|NCT03386721|454838666|FG001|Overall Study|Symptomatic Deterioration|0|||
126421463|NCT03386721|454838667|FG002|Overall Study|Symptomatic Deterioration|0|||
126421464|NCT03386721|454838668|FG003|Overall Study|Symptomatic Deterioration|0|||
126421465|NCT03386721|454838669|FG004|Overall Study|Symptomatic Deterioration|0|||
126421466|NCT03386721|454838670|FG005|Overall Study|Symptomatic Deterioration|0|||
126421467|NCT03386721|454838671|FG006|Overall Study|Symptomatic Deterioration|0|||
126421468|NCT03386721|454838672|FG007|Overall Study|Symptomatic Deterioration|0|||
126421469|NCT03386721|454838673|FG008|Overall Study|Symptomatic Deterioration|1|||
126421470|NCT03386721|454838674|FG009|Overall Study|Symptomatic Deterioration|0|||
126421471|NCT03386721|454838675|FG010|Overall Study|Symptomatic Deterioration|0|||
126421472|NCT03386721|454838676|FG011|Overall Study|Symptomatic Deterioration|1|||
126421473|NCT03386721|454838677|FG012|Overall Study|Symptomatic Deterioration|0|||
126421474|NCT03386721|454838678|FG013|Overall Study|Symptomatic Deterioration|0|||
126421475|NCT03386721|454838679|FG014|Overall Study|Symptomatic Deterioration|0|||
126421476|NCT03386721|454838665|FG000|Overall Study|Withdrawal by Subject|1|||
126421477|NCT03386721|454838666|FG001|Overall Study|Withdrawal by Subject|2|||
126421478|NCT03386721|454838667|FG002|Overall Study|Withdrawal by Subject|0|||
126421479|NCT03386721|454838668|FG003|Overall Study|Withdrawal by Subject|0|||
126421480|NCT03386721|454838669|FG004|Overall Study|Withdrawal by Subject|0|||
126421481|NCT03386721|454838670|FG005|Overall Study|Withdrawal by Subject|0|||
126421482|NCT03386721|454838671|FG006|Overall Study|Withdrawal by Subject|0|||
126421483|NCT03386721|454838672|FG007|Overall Study|Withdrawal by Subject|0|||
126421484|NCT03386721|454838673|FG008|Overall Study|Withdrawal by Subject|2|||
126421485|NCT03386721|454838674|FG009|Overall Study|Withdrawal by Subject|1|||
126421486|NCT03386721|454838675|FG010|Overall Study|Withdrawal by Subject|3|||
126421487|NCT03386721|454838676|FG011|Overall Study|Withdrawal by Subject|2|||
126421488|NCT03386721|454838677|FG012|Overall Study|Withdrawal by Subject|3|||
126421489|NCT03386721|454838678|FG013|Overall Study|Withdrawal by Subject|0|||
126421490|NCT03386721|454838679|FG014|Overall Study|Withdrawal by Subject|0|||
126421491|NCT03081884|454838680|FG000|Overall Study|deferred prostate cancer treatment|1|||
126054629|NCT00599196|453493943|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
126054630|NCT00599196|453493943|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
126054631|NCT00599196|453493943|FG000|Overall Study|Other: Pt Moved To Australia|1|||
126054632|NCT00599196|453493943|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
126054633|NCT00599196|453493943|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
126421492|NCT03081884|454838680|FG000|Overall Study|metastasis managed with systemic therapy|3|||
126421493|NCT03948334|454838682|FG000|Overall Study|Adverse Event|1|||
126421494|NCT03948334|454838683|FG001|Overall Study|Adverse Event|4|||
126421495|NCT03948334|454838682|FG000|Overall Study|Lack of Efficacy|2|||
126421496|NCT03948334|454838683|FG001|Overall Study|Lack of Efficacy|0|||
126421497|NCT03948334|454838682|FG000|Overall Study|Lost to Follow-up|1|||
126421498|NCT03948334|454838683|FG001|Overall Study|Lost to Follow-up|0|||
126421499|NCT03948334|454838682|FG000|Overall Study|Physician Decision|1|||
126421500|NCT03948334|454838683|FG001|Overall Study|Physician Decision|0|||
126421501|NCT03948334|454838682|FG000|Overall Study|Pregnancy|0|||
126421502|NCT03948334|454838683|FG001|Overall Study|Pregnancy|1|||
126421503|NCT03948334|454838682|FG000|Overall Study|Protocol Deviation|1|||
126421504|NCT03948334|454838683|FG001|Overall Study|Protocol Deviation|0|||
126421505|NCT03948334|454838682|FG000|Overall Study|Study terminated by Sponsor|50|||
126421506|NCT03948334|454838683|FG001|Overall Study|Study terminated by Sponsor|51|||
126421507|NCT03948334|454838682|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
126421508|NCT03948334|454838683|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
126421509|NCT05114473|454838684|FG000|Overall Study|Lost to Follow-up|2|||
126421510|NCT05114473|454838685|FG001|Overall Study|Lost to Follow-up|2|||
126421511|NCT05114473|454838686|FG002|Overall Study|Lost to Follow-up|0|||
126421512|NCT00700713|454838687|FG000|Overall Study|Protocol Violation|1|||
126421513|NCT00700713|454838688|FG001|Overall Study|Protocol Violation|0|||
126421514|NCT00700713|454838689|FG002|Overall Study|Protocol Violation|1|||
126421515|NCT00700713|454838687|FG000|Overall Study|Withdrawal by Subject|0|||
126421516|NCT00700713|454838688|FG001|Overall Study|Withdrawal by Subject|0|||
126421517|NCT00700713|454838689|FG002|Overall Study|Withdrawal by Subject|1|||
126421518|NCT00550953|454838691|FG000|Overall Study|Adverse Event|4|||
126421519|NCT00550953|454838692|FG001|Overall Study|Adverse Event|3|||
126421520|NCT00550953|454838691|FG000|Overall Study|Not able to visit the site|2|||
126421521|NCT00550953|454838692|FG001|Overall Study|Not able to visit the site|3|||
126421522|NCT02905266|454838693|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
126421523|NCT02905266|454838694|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
126421524|NCT02905266|454838693|FG000|Treatment Phase Part 1|Disease Progression|6|||
126421525|NCT02905266|454838694|FG001|Treatment Phase Part 1|Disease Progression|7|||
126421526|NCT02905266|454838693|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
126421527|NCT02905266|454838694|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
126421528|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
126421529|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
126421530|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
126421531|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
126421532|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
126421533|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
126421534|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Death|0|||
126421535|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Death|1|||
126421536|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
126421537|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
126421538|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
126421539|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
126421540|NCT02905266|454838693|FG000|Maintenance Phase Part 2|Disease Progression|9|||
126421541|NCT02905266|454838694|FG001|Maintenance Phase Part 2|Disease Progression|2|||
126421542|NCT02905266|454838693|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
126421543|NCT02905266|454838694|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
126421544|NCT02905266|454838693|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
126421545|NCT02905266|454838694|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
126421546|NCT01132313|454838695|FG000|Overall Study|Lack of Efficacy|1|||
126421547|NCT01132313|454838696|FG001|Overall Study|Lack of Efficacy|0|||
126421548|NCT01132313|454838697|FG002|Overall Study|Lack of Efficacy|0|||
126421549|NCT01132313|454838698|FG003|Overall Study|Lack of Efficacy|0|||
126421550|NCT01132313|454838699|FG004|Overall Study|Lack of Efficacy|0|||
126421551|NCT01132313|454838700|FG005|Overall Study|Lack of Efficacy|0|||
126421552|NCT01132313|454838701|FG006|Overall Study|Lack of Efficacy|0|||
126421553|NCT01132313|454838702|FG007|Overall Study|Lack of Efficacy|3|||
126421554|NCT01132313|454838703|FG008|Overall Study|Lack of Efficacy|14|||
126421555|NCT01132313|454838704|FG009|Overall Study|Lack of Efficacy|16|||
126421556|NCT01132313|454838705|FG010|Overall Study|Lack of Efficacy|0|||
126421557|NCT01132313|454838706|FG011|Overall Study|Lack of Efficacy|0|||
126421558|NCT01132313|454838695|FG000|Overall Study|Not treated|2|||
126421559|NCT01132313|454838696|FG001|Overall Study|Not treated|0|||
126421560|NCT01132313|454838697|FG002|Overall Study|Not treated|0|||
126421561|NCT01132313|454838698|FG003|Overall Study|Not treated|0|||
126421562|NCT01132313|454838699|FG004|Overall Study|Not treated|2|||
126421563|NCT01132313|454838700|FG005|Overall Study|Not treated|1|||
126421564|NCT01132313|454838701|FG006|Overall Study|Not treated|3|||
126421565|NCT01132313|454838702|FG007|Overall Study|Not treated|0|||
126421566|NCT01132313|454838703|FG008|Overall Study|Not treated|0|||
126421567|NCT01132313|454838704|FG009|Overall Study|Not treated|0|||
126421568|NCT01132313|454838705|FG010|Overall Study|Not treated|0|||
126421569|NCT01132313|454838706|FG011|Overall Study|Not treated|0|||
126421570|NCT01132313|454838695|FG000|Overall Study|Adverse Event|0|||
126421571|NCT01132313|454838696|FG001|Overall Study|Adverse Event|0|||
126421572|NCT01132313|454838697|FG002|Overall Study|Adverse Event|4|||
126421573|NCT01132313|454838698|FG003|Overall Study|Adverse Event|10|||
126421574|NCT01132313|454838699|FG004|Overall Study|Adverse Event|19|||
126421575|NCT01132313|454838700|FG005|Overall Study|Adverse Event|6|||
126421576|NCT01132313|454838701|FG006|Overall Study|Adverse Event|5|||
126421577|NCT01132313|454838702|FG007|Overall Study|Adverse Event|3|||
126421578|NCT01132313|454838703|FG008|Overall Study|Adverse Event|7|||
126421579|NCT01132313|454838704|FG009|Overall Study|Adverse Event|2|||
126421580|NCT01132313|454838705|FG010|Overall Study|Adverse Event|0|||
126421581|NCT01132313|454838706|FG011|Overall Study|Adverse Event|0|||
126421582|NCT01132313|454838695|FG000|Overall Study|Protocol Violation|0|||
126421583|NCT01132313|454838696|FG001|Overall Study|Protocol Violation|0|||
126421584|NCT01132313|454838697|FG002|Overall Study|Protocol Violation|0|||
126421585|NCT01132313|454838698|FG003|Overall Study|Protocol Violation|1|||
126421586|NCT01132313|454838699|FG004|Overall Study|Protocol Violation|0|||
126421587|NCT01132313|454838700|FG005|Overall Study|Protocol Violation|0|||
125891230|NCT02529553|452899751|FG004|Overall Study|Withdrawal by Subject|0|||
125891231|NCT02529553|452899752|FG005|Overall Study|Withdrawal by Subject|1|||
126421588|NCT01132313|454838701|FG006|Overall Study|Protocol Violation|0|||
126421589|NCT01132313|454838702|FG007|Overall Study|Protocol Violation|0|||
126421590|NCT01132313|454838703|FG008|Overall Study|Protocol Violation|0|||
126421591|NCT01132313|454838704|FG009|Overall Study|Protocol Violation|0|||
126421592|NCT01132313|454838705|FG010|Overall Study|Protocol Violation|0|||
126421593|NCT01132313|454838706|FG011|Overall Study|Protocol Violation|0|||
126421594|NCT01132313|454838695|FG000|Overall Study|Lost to Follow-up|0|||
126421595|NCT01132313|454838696|FG001|Overall Study|Lost to Follow-up|0|||
126421596|NCT01132313|454838697|FG002|Overall Study|Lost to Follow-up|1|||
126421597|NCT01132313|454838698|FG003|Overall Study|Lost to Follow-up|0|||
126421598|NCT01132313|454838699|FG004|Overall Study|Lost to Follow-up|0|||
126421599|NCT01132313|454838700|FG005|Overall Study|Lost to Follow-up|0|||
126421600|NCT01132313|454838701|FG006|Overall Study|Lost to Follow-up|0|||
126421601|NCT01132313|454838702|FG007|Overall Study|Lost to Follow-up|1|||
126421602|NCT01132313|454838703|FG008|Overall Study|Lost to Follow-up|0|||
126421603|NCT01132313|454838704|FG009|Overall Study|Lost to Follow-up|0|||
126054634|NCT04497415|453493961|FG000|Overall Study|Lost to Follow-up|43|||
126421604|NCT01132313|454838705|FG010|Overall Study|Lost to Follow-up|0|||
126421605|NCT01132313|454838706|FG011|Overall Study|Lost to Follow-up|0|||
126421606|NCT01132313|454838695|FG000|Overall Study|Withdrawal by Subject|0|||
126054635|NCT04497415|453493962|FG001|Overall Study|Lost to Follow-up|27|||
126421607|NCT01132313|454838696|FG001|Overall Study|Withdrawal by Subject|0|||
126421608|NCT01132313|454838697|FG002|Overall Study|Withdrawal by Subject|3|||
126421609|NCT01132313|454838698|FG003|Overall Study|Withdrawal by Subject|3|||
126421610|NCT01132313|454838699|FG004|Overall Study|Withdrawal by Subject|6|||
126421611|NCT01132313|454838700|FG005|Overall Study|Withdrawal by Subject|0|||
126421612|NCT01132313|454838701|FG006|Overall Study|Withdrawal by Subject|1|||
126421613|NCT01132313|454838702|FG007|Overall Study|Withdrawal by Subject|0|||
126421614|NCT01132313|454838703|FG008|Overall Study|Withdrawal by Subject|0|||
126421615|NCT01132313|454838704|FG009|Overall Study|Withdrawal by Subject|2|||
126421616|NCT01132313|454838705|FG010|Overall Study|Withdrawal by Subject|0|||
126421617|NCT01132313|454838706|FG011|Overall Study|Withdrawal by Subject|0|||
126421618|NCT01132313|454838695|FG000|Overall Study|Lack of antiviral response|0|||
126421619|NCT01132313|454838696|FG001|Overall Study|Lack of antiviral response|0|||
126421620|NCT01132313|454838697|FG002|Overall Study|Lack of antiviral response|12|||
126421621|NCT01132313|454838698|FG003|Overall Study|Lack of antiviral response|18|||
126421622|NCT01132313|454838699|FG004|Overall Study|Lack of antiviral response|18|||
126421623|NCT01132313|454838700|FG005|Overall Study|Lack of antiviral response|18|||
126421624|NCT01132313|454838701|FG006|Overall Study|Lack of antiviral response|21|||
126421625|NCT01132313|454838702|FG007|Overall Study|Lack of antiviral response|0|||
126421626|NCT01132313|454838703|FG008|Overall Study|Lack of antiviral response|0|||
126421627|NCT01132313|454838704|FG009|Overall Study|Lack of antiviral response|0|||
126421628|NCT01132313|454838705|FG010|Overall Study|Lack of antiviral response|1|||
126421629|NCT01132313|454838706|FG011|Overall Study|Lack of antiviral response|0|||
126421630|NCT01132313|454838695|FG000|Overall Study|Other reason not defined above|0|||
126421631|NCT01132313|454838696|FG001|Overall Study|Other reason not defined above|0|||
126421632|NCT01132313|454838697|FG002|Overall Study|Other reason not defined above|0|||
126421633|NCT01132313|454838698|FG003|Overall Study|Other reason not defined above|0|||
126421634|NCT01132313|454838699|FG004|Overall Study|Other reason not defined above|0|||
126421635|NCT01132313|454838700|FG005|Overall Study|Other reason not defined above|0|||
126421636|NCT01132313|454838701|FG006|Overall Study|Other reason not defined above|0|||
126421637|NCT01132313|454838702|FG007|Overall Study|Other reason not defined above|1|||
126421638|NCT01132313|454838703|FG008|Overall Study|Other reason not defined above|0|||
126421639|NCT01132313|454838704|FG009|Overall Study|Other reason not defined above|0|||
126421640|NCT01132313|454838705|FG010|Overall Study|Other reason not defined above|0|||
126421641|NCT01132313|454838706|FG011|Overall Study|Other reason not defined above|0|||
126054636|NCT00734578|453493965|FG000|Overall Study|Adverse Event|4|||
126054637|NCT00734578|453493966|FG001|Overall Study|Adverse Event|6|||
126054638|NCT00734578|453493967|FG002|Overall Study|Adverse Event|1|||
126054639|NCT00734578|453493965|FG000|Overall Study|Protocol Violation|8|||
126054640|NCT00734578|453493966|FG001|Overall Study|Protocol Violation|6|||
126054641|NCT00734578|453493967|FG002|Overall Study|Protocol Violation|3|||
126421642|NCT02715609|454838708|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
125891232|NCT02529553|452899753|FG006|Overall Study|Withdrawal by Subject|0|||
125891233|NCT02529553|452899754|FG007|Overall Study|Withdrawal by Subject|1|||
126054642|NCT00734578|453493965|FG000|Overall Study|Withdrawal by Subject|7|||
126054643|NCT00734578|453493966|FG001|Overall Study|Withdrawal by Subject|8|||
126054644|NCT00734578|453493967|FG002|Overall Study|Withdrawal by Subject|11|||
126421643|NCT02715609|454838709|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
126421644|NCT02715609|454838710|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
126421645|NCT02715609|454838708|FG000|Overall Study|Withdrawal by Subject|0|||
126421646|NCT02715609|454838709|FG001|Overall Study|Withdrawal by Subject|0|||
126421647|NCT02715609|454838710|FG002|Overall Study|Withdrawal by Subject|1|||
126421648|NCT03201419|454838711|FG000|Overall Study|Adverse Event|3|||
126421649|NCT03201419|454838712|FG001|Overall Study|Adverse Event|1|||
126421650|NCT03201419|454838713|FG002|Overall Study|Adverse Event|0|||
126421651|NCT03201419|454838714|FG003|Overall Study|Adverse Event|0|||
126421652|NCT03201419|454838715|FG004|Overall Study|Adverse Event|1|||
126421653|NCT03201419|454838716|FG005|Overall Study|Adverse Event|1|||
126421654|NCT03201419|454838717|FG006|Overall Study|Adverse Event|5|||
126421655|NCT03201419|454838718|FG007|Overall Study|Adverse Event|0|||
126421656|NCT03201419|454838719|FG008|Overall Study|Adverse Event|0|||
126421657|NCT03201419|454838711|FG000|Overall Study|Lost to Follow-up|1|||
126421658|NCT03201419|454838712|FG001|Overall Study|Lost to Follow-up|0|||
126421659|NCT03201419|454838713|FG002|Overall Study|Lost to Follow-up|0|||
126421660|NCT03201419|454838714|FG003|Overall Study|Lost to Follow-up|0|||
126421661|NCT03201419|454838715|FG004|Overall Study|Lost to Follow-up|0|||
126421662|NCT03201419|454838716|FG005|Overall Study|Lost to Follow-up|0|||
126421663|NCT03201419|454838717|FG006|Overall Study|Lost to Follow-up|0|||
126421664|NCT03201419|454838718|FG007|Overall Study|Lost to Follow-up|0|||
126421665|NCT03201419|454838719|FG008|Overall Study|Lost to Follow-up|0|||
126421666|NCT03201419|454838711|FG000|Overall Study|Protocol Deviation|0|||
126421667|NCT03201419|454838712|FG001|Overall Study|Protocol Deviation|0|||
126421668|NCT03201419|454838713|FG002|Overall Study|Protocol Deviation|0|||
126421669|NCT03201419|454838714|FG003|Overall Study|Protocol Deviation|0|||
126421670|NCT03201419|454838715|FG004|Overall Study|Protocol Deviation|0|||
126421671|NCT03201419|454838716|FG005|Overall Study|Protocol Deviation|0|||
126421672|NCT03201419|454838717|FG006|Overall Study|Protocol Deviation|1|||
126421673|NCT03201419|454838718|FG007|Overall Study|Protocol Deviation|0|||
126421674|NCT03201419|454838719|FG008|Overall Study|Protocol Deviation|0|||
126421675|NCT03201419|454838711|FG000|Overall Study|Withdrawal by Subject|4|||
126421676|NCT03201419|454838712|FG001|Overall Study|Withdrawal by Subject|2|||
126421677|NCT03201419|454838713|FG002|Overall Study|Withdrawal by Subject|1|||
126421678|NCT03201419|454838714|FG003|Overall Study|Withdrawal by Subject|0|||
126421679|NCT03201419|454838715|FG004|Overall Study|Withdrawal by Subject|0|||
126421680|NCT03201419|454838716|FG005|Overall Study|Withdrawal by Subject|0|||
126421681|NCT03201419|454838717|FG006|Overall Study|Withdrawal by Subject|0|||
126421682|NCT03201419|454838718|FG007|Overall Study|Withdrawal by Subject|1|||
126421683|NCT03201419|454838719|FG008|Overall Study|Withdrawal by Subject|2|||
126421684|NCT03201419|454838711|FG000|Overall Study|Other|0|||
126421685|NCT03201419|454838712|FG001|Overall Study|Other|0|||
126421686|NCT03201419|454838713|FG002|Overall Study|Other|1|||
126421687|NCT03201419|454838714|FG003|Overall Study|Other|0|||
126421688|NCT03201419|454838715|FG004|Overall Study|Other|0|||
126421689|NCT03201419|454838716|FG005|Overall Study|Other|0|||
126421690|NCT03201419|454838717|FG006|Overall Study|Other|0|||
126421691|NCT03201419|454838718|FG007|Overall Study|Other|0|||
126421692|NCT03201419|454838719|FG008|Overall Study|Other|0|||
126421693|NCT05907395|454838720|FG000|Period 1|No longer met eligibility criteria|0|||
126421694|NCT05907395|454838721|FG001|Period 1|No longer met eligibility criteria|1|||
126421695|NCT05907395|454838722|FG002|Period 1|No longer met eligibility criteria|0|||
126421696|NCT05907395|454838723|FG003|Period 1|No longer met eligibility criteria|0|||
126421697|NCT05907395|454838724|FG004|Period 1|No longer met eligibility criteria|0|||
126421698|NCT05907395|454838725|FG005|Period 1|No longer met eligibility criteria|1|||
126421699|NCT05907395|454838726|FG006|Period 1|No longer met eligibility criteria|1|||
126421700|NCT05907395|454838727|FG007|Period 1|No longer met eligibility criteria|0|||
126421701|NCT05907395|454838728|FG008|Period 1|No longer met eligibility criteria|0|||
126421702|NCT05907395|454838729|FG009|Period 1|No longer met eligibility criteria|0|||
126421703|NCT05907395|454838730|FG010|Period 1|No longer met eligibility criteria|0|||
126421704|NCT05907395|454838731|FG011|Period 1|No longer met eligibility criteria|0|||
126421705|NCT05907395|454838720|FG000|Period 2|Adverse Event|0|||
126421706|NCT05907395|454838721|FG001|Period 2|Adverse Event|0|||
126421707|NCT05907395|454838722|FG002|Period 2|Adverse Event|0|||
126421708|NCT05907395|454838723|FG003|Period 2|Adverse Event|1|||
126421709|NCT05907395|454838724|FG004|Period 2|Adverse Event|0|||
126421710|NCT05907395|454838725|FG005|Period 2|Adverse Event|0|||
126421711|NCT05907395|454838726|FG006|Period 2|Adverse Event|0|||
126421712|NCT05907395|454838727|FG007|Period 2|Adverse Event|1|||
126421713|NCT05907395|454838728|FG008|Period 2|Adverse Event|0|||
126421714|NCT05907395|454838729|FG009|Period 2|Adverse Event|0|||
126421715|NCT05907395|454838730|FG010|Period 2|Adverse Event|0|||
126421716|NCT05907395|454838731|FG011|Period 2|Adverse Event|0|||
126421717|NCT05907395|454838720|FG000|Period 2|Personal reason|0|||
126421718|NCT05907395|454838721|FG001|Period 2|Personal reason|0|||
126421719|NCT05907395|454838722|FG002|Period 2|Personal reason|0|||
126421720|NCT05907395|454838723|FG003|Period 2|Personal reason|0|||
126421721|NCT05907395|454838724|FG004|Period 2|Personal reason|0|||
126421722|NCT05907395|454838725|FG005|Period 2|Personal reason|0|||
126421723|NCT05907395|454838726|FG006|Period 2|Personal reason|0|||
126421724|NCT05907395|454838727|FG007|Period 2|Personal reason|0|||
126421725|NCT05907395|454838728|FG008|Period 2|Personal reason|0|||
126421726|NCT05907395|454838729|FG009|Period 2|Personal reason|1|||
126421727|NCT05907395|454838730|FG010|Period 2|Personal reason|0|||
126421728|NCT05907395|454838731|FG011|Period 2|Personal reason|0|||
126421729|NCT05907395|454838720|FG000|Period 3|Adverse Event|0|||
126421730|NCT05907395|454838721|FG001|Period 3|Adverse Event|0|||
126421731|NCT05907395|454838722|FG002|Period 3|Adverse Event|0|||
126421732|NCT05907395|454838723|FG003|Period 3|Adverse Event|0|||
126421733|NCT05907395|454838724|FG004|Period 3|Adverse Event|1|||
126421734|NCT05907395|454838725|FG005|Period 3|Adverse Event|0|||
126421735|NCT05907395|454838726|FG006|Period 3|Adverse Event|0|||
126421736|NCT05907395|454838727|FG007|Period 3|Adverse Event|0|||
126421737|NCT05907395|454838728|FG008|Period 3|Adverse Event|0|||
126421738|NCT05907395|454838729|FG009|Period 3|Adverse Event|0|||
126421739|NCT05907395|454838730|FG010|Period 3|Adverse Event|0|||
126421740|NCT05907395|454838731|FG011|Period 3|Adverse Event|0|||
126421741|NCT04896593|454838732|FG000|Overall Study|Withdrawal by Subject|2|||
126421742|NCT04896593|454838732|FG000|Overall Study|Lost to Follow-up|1|||
126421743|NCT04896593|454838732|FG000|Overall Study|Did not complete onboarding|2|||
126421744|NCT02777827|454838733|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421745|NCT02777827|454838734|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421746|NCT02777827|454838735|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
126421747|NCT02777827|454838736|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421748|NCT02777827|454838737|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421749|NCT02777827|454838738|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421750|NCT00369577|454838739|FG000|Overall Study|Withdrawal by Subject|0|||
126421751|NCT00369577|454838740|FG001|Overall Study|Withdrawal by Subject|0|||
126421752|NCT00369577|454838741|FG002|Overall Study|Withdrawal by Subject|1|||
126421753|NCT04177212|454838750|FG000|Overall Study|Withdrawal by Subject|9|||
126421754|NCT04177212|454838751|FG001|Overall Study|Withdrawal by Subject|7|||
126421755|NCT04177212|454838750|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
126421756|NCT04177212|454838751|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
126421757|NCT04177212|454838750|FG000|Overall Study|Physician Decision|1|||
126421758|NCT04177212|454838751|FG001|Overall Study|Physician Decision|0|||
126421759|NCT04177212|454838750|FG000|Overall Study|Lost to Follow-up|0|||
126421760|NCT04177212|454838751|FG001|Overall Study|Lost to Follow-up|3|||
126421761|NCT04177212|454838750|FG000|Overall Study|Adverse Event|0|||
126421762|NCT04177212|454838751|FG001|Overall Study|Adverse Event|1|||
126421763|NCT04177212|454838750|FG000|Overall Study|Other|1|||
126421764|NCT04177212|454838751|FG001|Overall Study|Other|2|||
126421765|NCT04725500|454838752|FG000|Screening|Screen Failure|26|||
126421766|NCT04725500|454838752|FG000|Screening|Withdrawal by Subject|1|||
126421767|NCT04725500|454838752|FG000|2 Week Take Home|Screen Fail|5|||
126421768|NCT00930930|454838754|FG000|Overall Study|Death|1|||
126421769|NCT00930930|454838755|FG001|Overall Study|Death|0|||
126421770|NCT00930930|454838754|FG000|Overall Study|Physician Decision|1|||
126421771|NCT00930930|454838755|FG001|Overall Study|Physician Decision|0|||
126421772|NCT00930930|454838754|FG000|Overall Study|Adverse Event|13|||
126421773|NCT00930930|454838755|FG001|Overall Study|Adverse Event|3|||
126421774|NCT00930930|454838754|FG000|Overall Study|Withdrawal by Subject|3|||
126421775|NCT00930930|454838755|FG001|Overall Study|Withdrawal by Subject|1|||
126421776|NCT00930930|454838754|FG000|Overall Study|Disease progression|2|||
126421777|NCT00930930|454838755|FG001|Overall Study|Disease progression|3|||
126421778|NCT00930930|454838754|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
126421779|NCT00930930|454838755|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
126421780|NCT00930930|454838754|FG000|Overall Study|patients not compliant|1|||
126421781|NCT00930930|454838755|FG001|Overall Study|patients not compliant|1|||
126421782|NCT04618744|454838756|FG000|Overall Study|Adverse Event|0|||
126421783|NCT04618744|454838757|FG001|Overall Study|Adverse Event|1|||
126421784|NCT04618744|454838756|FG000|Overall Study|Withdrawal by Subject|0|||
126421785|NCT04618744|454838757|FG001|Overall Study|Withdrawal by Subject|1|||
126421786|NCT02709330|454838758|FG000|Overall Study|Death|5|||
126421787|NCT02709330|454838759|FG001|Overall Study|Death|0|||
126421788|NCT02709330|454838758|FG000|Overall Study|Lost to Follow-up|2|||
126421789|NCT02709330|454838759|FG001|Overall Study|Lost to Follow-up|0|||
126054645|NCT00734578|453493965|FG000|Overall Study|Lost to Follow-up|9|||
126421790|NCT02709330|454838758|FG000|Overall Study|Physician Decision|2|||
126421791|NCT02709330|454838759|FG001|Overall Study|Physician Decision|0|||
126421792|NCT02709330|454838758|FG000|Overall Study|Withdrawal by Subject|4|||
126421793|NCT02709330|454838759|FG001|Overall Study|Withdrawal by Subject|0|||
126421794|NCT01467505|454840567|FG000|Overall Study|Adverse Event|1|||
126421795|NCT01467505|454840568|FG001|Overall Study|Adverse Event|0|||
126421796|NCT01467505|454840567|FG000|Overall Study|Withdrawal by Subject|4|||
126421797|NCT01467505|454840568|FG001|Overall Study|Withdrawal by Subject|0|||
126421798|NCT01467505|454840567|FG000|Overall Study|Study Terminated by Sponsor|28|||
126421799|NCT01467505|454840568|FG001|Overall Study|Study Terminated by Sponsor|3|||
126054646|NCT00734578|453493966|FG001|Overall Study|Lost to Follow-up|3|||
126054647|NCT00734578|453493967|FG002|Overall Study|Lost to Follow-up|5|||
126054648|NCT00734578|453493965|FG000|Overall Study|Lack of Efficacy|3|||
126421800|NCT02807623|454840569|FG000|Overall Study|Lost to Follow-up|23|||
126421801|NCT02807623|454840570|FG001|Overall Study|Lost to Follow-up|18|||
126421802|NCT02807623|454840571|FG002|Overall Study|Lost to Follow-up|22|||
126421803|NCT02807623|454840569|FG000|Overall Study|Drug intolerance|0|||
126421804|NCT02807623|454840570|FG001|Overall Study|Drug intolerance|1|||
126421805|NCT02807623|454840571|FG002|Overall Study|Drug intolerance|0|||
126421806|NCT02807623|454840569|FG000|Overall Study|incomplete blood draw|0|||
126421807|NCT02807623|454840570|FG001|Overall Study|incomplete blood draw|2|||
126421808|NCT02807623|454840571|FG002|Overall Study|incomplete blood draw|1|||
126421809|NCT03449758|454840572|FG000|Overall Study|Major protocol deviation|1|||
126421810|NCT03449758|454840572|FG000|Overall Study|Treatment inefficacy|5|||
126421811|NCT03449758|454840572|FG000|Overall Study|Adverse Event|9|||
126421812|NCT03449758|454840572|FG000|Overall Study|Consent withdrawal|1|||
126421813|NCT03449758|454840572|FG000|Overall Study|Other unspecified reason|3|||
126421814|NCT00922623|454840576|FG000|Overall Study|Other|4|||
126421815|NCT00922623|454840576|FG000|Overall Study|Lost to Follow-up|1|||
126421816|NCT01402817|454840577|FG000|Overall Study|Withdrawal by Subject|3|||
126421817|NCT01402817|454840577|FG000|Overall Study|Study Suspended by FDA|8|||
126421818|NCT00086047|454840578|FG000|Overall Study|Lost to Follow-up|7|||
126421819|NCT00086047|454840579|FG001|Overall Study|Lost to Follow-up|6|||
126421820|NCT00086047|454840578|FG000|Overall Study|Physician Decision|0|||
126421821|NCT00086047|454840579|FG001|Overall Study|Physician Decision|1|||
126421822|NCT02471014|454840580|FG000|Overall Study|Lost to Follow-up|2|||
126421823|NCT02471014|454840581|FG001|Overall Study|Lost to Follow-up|2|||
126421824|NCT01172535|454840582|FG000|Overall Study|Death|3|||
126421825|NCT01172535|454840582|FG000|Overall Study|Withdrawal by Subject|2|||
126421826|NCT01172535|454840582|FG000|Overall Study|Lost to Follow-up|1|||
126421827|NCT01172535|454840582|FG000|Overall Study|Ineligible at study entry|1|||
126421828|NCT01172535|454840582|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
126421829|NCT00988598|454840583|FG000|Overall Study|Withdrawal by Subject|2|||
126421830|NCT00988598|454840584|FG001|Overall Study|Withdrawal by Subject|0|||
126421831|NCT01618669|454840585|FG000|Overall Study|Lost to Follow-up|1|||
126421832|NCT01618669|454840586|FG001|Overall Study|Lost to Follow-up|1|||
126421833|NCT01618669|454840585|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
126421834|NCT01618669|454840586|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
126421835|NCT01618669|454840585|FG000|Overall Study|Adverse Event|16|||
126421836|NCT01618669|454840586|FG001|Overall Study|Adverse Event|7|||
126421837|NCT01618669|454840585|FG000|Overall Study|Protocol Violation|5|||
126421838|NCT01618669|454840586|FG001|Overall Study|Protocol Violation|3|||
126421839|NCT01618669|454840585|FG000|Overall Study|Withdrawal by Subject|9|||
126421840|NCT01618669|454840586|FG001|Overall Study|Withdrawal by Subject|9|||
126421841|NCT01618669|454840585|FG000|Overall Study|Miscellaneous Reason|0|||
126421842|NCT01618669|454840586|FG001|Overall Study|Miscellaneous Reason|1|||
126421843|NCT01177007|454840591|FG000|Overall Study|Lost to Follow-up|2|||
126421844|NCT01177007|454840591|FG000|Overall Study|Death|4|||
126421845|NCT01177007|454840591|FG000|Overall Study|Entered hospice care|5|||
126421846|NCT01177007|454840591|FG000|Overall Study|Required additional Y90 treatment|6|||
126421847|NCT01177007|454840591|FG000|Overall Study|Change in treatment modality|21|||
126421848|NCT01702558|454840593|FG000|Overall Study|Withdrawal by Subject|0|||
126421849|NCT01702558|454840594|FG001|Overall Study|Withdrawal by Subject|0|||
126421850|NCT01702558|454840595|FG002|Overall Study|Withdrawal by Subject|0|||
126421851|NCT01702558|454840596|FG003|Overall Study|Withdrawal by Subject|12|||
126421852|NCT01702558|454840597|FG004|Overall Study|Withdrawal by Subject|4|||
126421853|NCT01702558|454840593|FG000|Overall Study|Lost to Follow-up|0|||
126421854|NCT01702558|454840594|FG001|Overall Study|Lost to Follow-up|0|||
126421855|NCT01702558|454840595|FG002|Overall Study|Lost to Follow-up|0|||
126421856|NCT01702558|454840596|FG003|Overall Study|Lost to Follow-up|3|||
126421857|NCT01702558|454840597|FG004|Overall Study|Lost to Follow-up|0|||
126421858|NCT01702558|454840593|FG000|Overall Study|Death|4|||
126421859|NCT01702558|454840594|FG001|Overall Study|Death|3|||
126421860|NCT01702558|454840595|FG002|Overall Study|Death|3|||
126421861|NCT01702558|454840596|FG003|Overall Study|Death|16|||
126421862|NCT01702558|454840597|FG004|Overall Study|Death|20|||
126421863|NCT01702558|454840593|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
126421864|NCT01702558|454840594|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
126421865|NCT01702558|454840595|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
126421866|NCT01702558|454840596|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
126421867|NCT01702558|454840597|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
126421868|NCT01702558|454840593|FG000|Overall Study|Study Terminated by Sponsor|0|||
126421869|NCT01702558|454840594|FG001|Overall Study|Study Terminated by Sponsor|1|||
126421870|NCT01702558|454840595|FG002|Overall Study|Study Terminated by Sponsor|0|||
126421871|NCT01702558|454840596|FG003|Overall Study|Study Terminated by Sponsor|0|||
126421872|NCT01702558|454840597|FG004|Overall Study|Study Terminated by Sponsor|1|||
126421873|NCT01702558|454840593|FG000|Overall Study|Other|0|||
126421874|NCT01702558|454840594|FG001|Overall Study|Other|0|||
126421875|NCT01702558|454840595|FG002|Overall Study|Other|0|||
126421876|NCT01702558|454840596|FG003|Overall Study|Other|16|||
126421877|NCT01702558|454840597|FG004|Overall Study|Other|17|||
126421878|NCT03259087|454840602|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
126421879|NCT03259087|454840603|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
126421880|NCT03259087|454840604|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
126421881|NCT03259087|454840605|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
126421882|NCT03259087|454840606|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
126054649|NCT00734578|453493966|FG001|Overall Study|Lack of Efficacy|2|||
126054650|NCT00734578|453493967|FG002|Overall Study|Lack of Efficacy|5|||
126054651|NCT00734578|453493965|FG000|Overall Study|Randomized in error|1|||
126054652|NCT00734578|453493966|FG001|Overall Study|Randomized in error|0|||
126054653|NCT00734578|453493967|FG002|Overall Study|Randomized in error|0|||
126054654|NCT00734578|453493965|FG000|Overall Study|Exclusion criteria|1|||
126054655|NCT00734578|453493966|FG001|Overall Study|Exclusion criteria|0|||
126054656|NCT00734578|453493967|FG002|Overall Study|Exclusion criteria|0|||
126421883|NCT03259087|454840602|FG000|Period 2 of Part 2|Adverse Event|0|||
126421884|NCT03259087|454840603|FG001|Period 2 of Part 2|Adverse Event|0|||
126421885|NCT03259087|454840604|FG002|Period 2 of Part 2|Adverse Event|0|||
126421886|NCT03259087|454840605|FG003|Period 2 of Part 2|Adverse Event|0|||
126421887|NCT03259087|454840606|FG004|Period 2 of Part 2|Adverse Event|1|||
126421888|NCT04950465|454840607|FG000|Overall Study|Lost to Follow-up|1|||
126421889|NCT04950465|454840608|FG001|Overall Study|Lost to Follow-up|0|||
126421890|NCT04950465|454840609|FG002|Overall Study|Lost to Follow-up|0|||
126421891|NCT01788566|454840610|FG000|Overall Study|Death|4|||
126421892|NCT01788566|454840610|FG000|Overall Study|Adverse Event|1|||
126421893|NCT01788566|454840610|FG000|Overall Study|Clinical Progressive Disease|3|||
126421894|NCT01620086|454840613|FG000|Overall Study|Withdrawal by Subject|3|||
126421895|NCT01620086|454840614|FG001|Overall Study|Withdrawal by Subject|3|||
126421896|NCT01620086|454840615|FG002|Overall Study|Withdrawal by Subject|0|||
126421897|NCT01620086|454840613|FG000|Overall Study|failed study criteria|1|||
126421898|NCT01620086|454840614|FG001|Overall Study|failed study criteria|4|||
126421899|NCT01620086|454840615|FG002|Overall Study|failed study criteria|0|||
126421900|NCT01620086|454840613|FG000|Overall Study|Physician Decision|1|||
126421901|NCT01620086|454840614|FG001|Overall Study|Physician Decision|0|||
126421902|NCT01620086|454840615|FG002|Overall Study|Physician Decision|0|||
126421903|NCT02562716|454840616|FG000|Overall Study|Adverse Event|7|||
126421904|NCT02562716|454840617|FG001|Overall Study|Adverse Event|14|||
126421905|NCT02562716|454840616|FG000|Overall Study|Withdrawal unrelated to AE|7|||
126421906|NCT02562716|454840617|FG001|Overall Study|Withdrawal unrelated to AE|1|||
126421907|NCT02562716|454840616|FG000|Overall Study|Progression|8|||
126421908|NCT02562716|454840617|FG001|Overall Study|Progression|10|||
126421909|NCT02562716|454840616|FG000|Overall Study|Death|2|||
126421910|NCT02562716|454840617|FG001|Overall Study|Death|1|||
126421911|NCT02562716|454840616|FG000|Overall Study|Not protocol specified|4|||
126421912|NCT02562716|454840617|FG001|Overall Study|Not protocol specified|2|||
126421913|NCT03030417|454840620|FG000|Dose Expansion|Disease progression before treatment|0|||
126421914|NCT03030417|454840621|FG001|Dose Expansion|Disease progression before treatment|0|||
126421915|NCT03030417|454840622|FG002|Dose Expansion|Disease progression before treatment|0|||
126421916|NCT03030417|454840623|FG003|Dose Expansion|Disease progression before treatment|0|||
126421917|NCT03030417|454840624|FG004|Dose Expansion|Disease progression before treatment|0|||
126421918|NCT03030417|454840625|FG005|Dose Expansion|Disease progression before treatment|0|||
126421919|NCT03030417|454840626|FG006|Dose Expansion|Disease progression before treatment|0|||
126421920|NCT03030417|454840627|FG007|Dose Expansion|Disease progression before treatment|0|||
126421921|NCT03030417|454840628|FG008|Dose Expansion|Disease progression before treatment|0|||
126421922|NCT03030417|454840629|FG009|Dose Expansion|Disease progression before treatment|0|||
126421923|NCT03030417|454840630|FG010|Dose Expansion|Disease progression before treatment|0|||
126421924|NCT03030417|454840631|FG011|Dose Expansion|Disease progression before treatment|0|||
126421925|NCT03030417|454840632|FG012|Dose Expansion|Disease progression before treatment|1|||
126421926|NCT01076959|454840633|FG000|Overall Study|Adverse Event|767|||
126421927|NCT01076959|454840633|FG000|Overall Study|Lack of Efficacy|849|||
126421928|NCT01076959|454840633|FG000|Overall Study|Non-compliance|274|||
126421929|NCT01076959|454840633|FG000|Overall Study|Lost to Follow-up|241|||
126421930|NCT01076959|454840633|FG000|Overall Study|Other|119|||
126421931|NCT01078441|454840634|FG000|Overall Study|Withdrawal by Subject|1|||
126421932|NCT01425801|454840635|FG000|Period 1|Withdrawal by Subject|0|||
126421933|NCT01425801|454840636|FG001|Period 1|Withdrawal by Subject|0|||
126421934|NCT01425801|454840637|FG002|Period 1|Withdrawal by Subject|0|||
126421935|NCT01425801|454840638|FG003|Period 1|Withdrawal by Subject|0|||
126054657|NCT02085941|453493971|FG000|Overall Study|Lack of Efficacy|1|||
126054658|NCT02085941|453493972|FG001|Overall Study|Lack of Efficacy|0|||
126054659|NCT02085941|453493971|FG000|Overall Study|Death|6|||
126421936|NCT01425801|454840639|FG004|Period 1|Withdrawal by Subject|1|||
126421937|NCT01425801|454840640|FG005|Period 1|Withdrawal by Subject|0|||
126421938|NCT01425801|454840635|FG000|Period 2|Withdrawal by Subject|0|||
126421939|NCT01425801|454840636|FG001|Period 2|Withdrawal by Subject|0|||
126421940|NCT01425801|454840637|FG002|Period 2|Withdrawal by Subject|0|||
126421941|NCT01425801|454840638|FG003|Period 2|Withdrawal by Subject|0|||
126421942|NCT01425801|454840639|FG004|Period 2|Withdrawal by Subject|1|||
126421943|NCT01425801|454840640|FG005|Period 2|Withdrawal by Subject|0|||
126421944|NCT01425801|454840635|FG000|Period 3|Stability criteria not fullfilled|0|||
126421945|NCT01425801|454840636|FG001|Period 3|Stability criteria not fullfilled|0|||
126054660|NCT02085941|453493972|FG001|Overall Study|Death|1|||
126054661|NCT02085941|453493971|FG000|Overall Study|Lost to Follow-up|1|||
126054662|NCT02085941|453493972|FG001|Overall Study|Lost to Follow-up|0|||
126054663|NCT02085941|453493971|FG000|Overall Study|Physician Decision|0|||
126421946|NCT01425801|454840637|FG002|Period 3|Stability criteria not fullfilled|1|||
126421947|NCT01425801|454840638|FG003|Period 3|Stability criteria not fullfilled|0|||
126421948|NCT01425801|454840639|FG004|Period 3|Stability criteria not fullfilled|0|||
126421949|NCT01425801|454840640|FG005|Period 3|Stability criteria not fullfilled|0|||
126421950|NCT01425801|454840635|FG000|Period 4|Not able to maintain visit schedule|0|||
126421951|NCT01425801|454840636|FG001|Period 4|Not able to maintain visit schedule|0|||
126421952|NCT01425801|454840637|FG002|Period 4|Not able to maintain visit schedule|1|||
126421953|NCT01425801|454840638|FG003|Period 4|Not able to maintain visit schedule|0|||
126421954|NCT01425801|454840639|FG004|Period 4|Not able to maintain visit schedule|0|||
126421955|NCT01425801|454840640|FG005|Period 4|Not able to maintain visit schedule|0|||
126421956|NCT02868554|454840641|FG000|Overall Study|Lost to Follow-up|3|||
126421957|NCT02868554|454840642|FG001|Overall Study|Lost to Follow-up|0|||
126421958|NCT02868554|454840643|FG002|Overall Study|Lost to Follow-up|1|||
126421959|NCT02175017|454840644|FG000|Overall Study|Did not receive the investigational product|1|||
126421960|NCT02175017|454840645|FG001|Overall Study|Did not receive the investigational product|2|||
126421961|NCT02175017|454840644|FG000|Overall Study|Withdrawal by Subject|6|||
126421962|NCT02175017|454840645|FG001|Overall Study|Withdrawal by Subject|3|||
126421963|NCT02175017|454840644|FG000|Overall Study|Met an exclusion criteria|0|||
126421964|NCT02175017|454840645|FG001|Overall Study|Met an exclusion criteria|1|||
126421965|NCT02175017|454840644|FG000|Overall Study|Adverse Event|3|||
126421966|NCT02175017|454840645|FG001|Overall Study|Adverse Event|10|||
126421967|NCT02175017|454840644|FG000|Overall Study|Disease progression|20|||
126421968|NCT02175017|454840645|FG001|Overall Study|Disease progression|27|||
126421969|NCT02175017|454840644|FG000|Overall Study|Other than above reasons|3|||
126421970|NCT02175017|454840645|FG001|Overall Study|Other than above reasons|0|||
126421971|NCT01684202|454840646|FG000|Dose-escalation Period|Adverse Event|0|||
126421972|NCT01684202|454840647|FG001|Dose-escalation Period|Adverse Event|1|||
126421973|NCT01684202|454840648|FG002|Dose-escalation Period|Adverse Event|0|||
126421974|NCT01684202|454840649|FG003|Dose-escalation Period|Adverse Event|0|||
126421975|NCT01684202|454840646|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
126421976|NCT01684202|454840647|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
126421977|NCT01684202|454840648|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
126421978|NCT01684202|454840649|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
126421979|NCT01684202|454840646|FG000|Maintenance Period|Adverse Event|1|||
126421980|NCT01684202|454840647|FG001|Maintenance Period|Adverse Event|1|||
126421981|NCT01684202|454840648|FG002|Maintenance Period|Adverse Event|1|||
126421982|NCT01684202|454840649|FG003|Maintenance Period|Adverse Event|1|||
126421983|NCT01684202|454840646|FG000|Maintenance Period|Physician Decision|0|||
126421984|NCT01684202|454840647|FG001|Maintenance Period|Physician Decision|1|||
126421985|NCT01684202|454840648|FG002|Maintenance Period|Physician Decision|0|||
126421986|NCT01684202|454840649|FG003|Maintenance Period|Physician Decision|0|||
126421987|NCT01684202|454840646|FG000|Maintenance Period|Withdrawal by Subject|0|||
126421988|NCT01684202|454840647|FG001|Maintenance Period|Withdrawal by Subject|1|||
126421989|NCT01684202|454840648|FG002|Maintenance Period|Withdrawal by Subject|0|||
126421990|NCT01684202|454840649|FG003|Maintenance Period|Withdrawal by Subject|0|||
126421991|NCT00191308|454840650|FG000|Overall Study|Adverse Event|1|||
126421992|NCT00779025|454840651|FG000|Overall Study|Withdrawal by Subject|1|||
126421993|NCT03710642|454840652|FG000|Overall Study|Adverse Event|5|||
126421994|NCT03710642|454840653|FG001|Overall Study|Adverse Event|1|||
126421995|NCT03710642|454840652|FG000|Overall Study|non-site physician recommendation|1|||
126421996|NCT03710642|454840653|FG001|Overall Study|non-site physician recommendation|0|||
126421997|NCT03710642|454840652|FG000|Overall Study|Participant unwilling or unable to participate|1|||
126421998|NCT03710642|454840653|FG001|Overall Study|Participant unwilling or unable to participate|1|||
126421999|NCT03710642|454840652|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
126422000|NCT03710642|454840653|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
126422001|NCT03710642|454840652|FG000|Overall Study|NA-no code provided|1|||
126422002|NCT03710642|454840653|FG001|Overall Study|NA-no code provided|0|||
126422003|NCT03710642|454840652|FG000|Overall Study|Withdrawal by Subject|1|||
126054664|NCT02085941|453493972|FG001|Overall Study|Physician Decision|2|||
126422004|NCT03710642|454840653|FG001|Overall Study|Withdrawal by Subject|0|||
126422005|NCT00782717|454840654|FG000|Overall Study|Adverse Event|2|||
126422006|NCT00782717|454840655|FG001|Overall Study|Adverse Event|5|||
126422007|NCT00782717|454840654|FG000|Overall Study|Patient decision unrelated to AE|6|||
126422008|NCT00782717|454840655|FG001|Overall Study|Patient decision unrelated to AE|3|||
126422009|NCT00782717|454840654|FG000|Overall Study|Noncompliance|2|||
126422010|NCT00782717|454840655|FG001|Overall Study|Noncompliance|1|||
126422011|NCT00782717|454840654|FG000|Overall Study|Treatment failure|3|||
126422012|NCT00782717|454840655|FG001|Overall Study|Treatment failure|14|||
126422013|NCT00782717|454840654|FG000|Overall Study|Enrollment close prior to surgery|1|||
126422014|NCT00782717|454840655|FG001|Overall Study|Enrollment close prior to surgery|0|||
126422015|NCT00782717|454840654|FG000|Overall Study|Did not meet entrance criteria|1|||
126422016|NCT00782717|454840655|FG001|Overall Study|Did not meet entrance criteria|3|||
126422017|NCT00782717|454840654|FG000|Overall Study|Exited in error|0|||
126422018|NCT00782717|454840655|FG001|Overall Study|Exited in error|2|||
126422019|NCT02292719|454840656|FG000|Overall Study|Withdrawal by Subject|0|||
126422020|NCT02292719|454840657|FG001|Overall Study|Withdrawal by Subject|0|||
126422021|NCT02292719|454840658|FG002|Overall Study|Withdrawal by Subject|0|||
126422022|NCT02292719|454840659|FG003|Overall Study|Withdrawal by Subject|1|||
126422023|NCT02292719|454840660|FG004|Overall Study|Withdrawal by Subject|1|||
126422024|NCT02292719|454840661|FG005|Overall Study|Withdrawal by Subject|0|||
126422025|NCT02292719|454840656|FG000|Overall Study|Subject enrolled in new study.|0|||
126422026|NCT02292719|454840657|FG001|Overall Study|Subject enrolled in new study.|0|||
126422027|NCT02292719|454840658|FG002|Overall Study|Subject enrolled in new study.|1|||
126422028|NCT02292719|454840659|FG003|Overall Study|Subject enrolled in new study.|0|||
126422029|NCT02292719|454840660|FG004|Overall Study|Subject enrolled in new study.|0|||
126422030|NCT02292719|454840661|FG005|Overall Study|Subject enrolled in new study.|0|||
126422031|NCT02586727|454840667|FG000|Overall Study|Lost to Follow-up|1|||
126422032|NCT02586727|454840668|FG001|Overall Study|Lost to Follow-up|0|||
126422033|NCT04628780|454840673|FG000|Overall Study|Death|0|||
126422034|NCT04628780|454840674|FG001|Overall Study|Death|1|||
126422035|NCT04628780|454840675|FG002|Overall Study|Death|0|||
126422036|NCT04628780|454840676|FG003|Overall Study|Death|0|||
126422037|NCT04628780|454840677|FG004|Overall Study|Death|1|||
126422038|NCT04628780|454840678|FG005|Overall Study|Death|0|||
126422039|NCT04628780|454840673|FG000|Overall Study|Physician Decision|2|||
126422040|NCT04628780|454840674|FG001|Overall Study|Physician Decision|0|||
126422041|NCT04628780|454840675|FG002|Overall Study|Physician Decision|0|||
126422042|NCT04628780|454840676|FG003|Overall Study|Physician Decision|0|||
126422043|NCT04628780|454840677|FG004|Overall Study|Physician Decision|2|||
126422044|NCT04628780|454840678|FG005|Overall Study|Physician Decision|0|||
126422045|NCT04628780|454840673|FG000|Overall Study|Progressive disease|2|||
126422046|NCT04628780|454840674|FG001|Overall Study|Progressive disease|2|||
126422047|NCT04628780|454840675|FG002|Overall Study|Progressive disease|2|||
126422048|NCT04628780|454840676|FG003|Overall Study|Progressive disease|3|||
126422049|NCT04628780|454840677|FG004|Overall Study|Progressive disease|9|||
126422050|NCT04628780|454840678|FG005|Overall Study|Progressive disease|4|||
126422051|NCT04628780|454840673|FG000|Overall Study|Withdrawal by Subject|0|||
126422052|NCT04628780|454840674|FG001|Overall Study|Withdrawal by Subject|1|||
126422053|NCT04628780|454840675|FG002|Overall Study|Withdrawal by Subject|2|||
126422054|NCT04628780|454840676|FG003|Overall Study|Withdrawal by Subject|0|||
126422055|NCT04628780|454840677|FG004|Overall Study|Withdrawal by Subject|3|||
126422056|NCT04628780|454840678|FG005|Overall Study|Withdrawal by Subject|1|||
126422057|NCT04628780|454840673|FG000|Overall Study|Global deterioration of health status|0|||
126054665|NCT04652726|453493977|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
126054666|NCT04652726|453493978|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
126054667|NCT04652726|453493979|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
126054668|NCT04652726|453493977|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
126054669|NCT04652726|453493978|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
126054670|NCT04652726|453493979|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
126054671|NCT02157116|453493980|FG000|Overall Study|Withdrawal by Subject|4|||
126054672|NCT02157116|453493980|FG000|Overall Study|Physician Decision|3|||
126054673|NCT02157116|453493980|FG000|Overall Study|Failed Screening|2|||
126054674|NCT00093496|453493981|FG000|Overall Study|Protocol Violation|1|||
126054675|NCT00093496|453493982|FG001|Overall Study|Protocol Violation|3|||
126422058|NCT04628780|454840674|FG001|Overall Study|Global deterioration of health status|0|||
126422059|NCT04628780|454840675|FG002|Overall Study|Global deterioration of health status|0|||
126422060|NCT04628780|454840676|FG003|Overall Study|Global deterioration of health status|0|||
126422061|NCT04628780|454840677|FG004|Overall Study|Global deterioration of health status|1|||
126422062|NCT04628780|454840678|FG005|Overall Study|Global deterioration of health status|1|||
126422063|NCT03622814|454840680|FG000|Overall Study|Lost to Follow-up|8|||
126054676|NCT03274076|453493984|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
126422064|NCT03622814|454840681|FG001|Overall Study|Lost to Follow-up|14|||
126422065|NCT01288989|454840684|FG000|Overall Study|Death|0|||
126422066|NCT01288989|454840685|FG001|Overall Study|Death|0|||
126422067|NCT01288989|454840686|FG002|Overall Study|Death|0|||
126422068|NCT01288989|454840687|FG003|Overall Study|Death|1|||
126422069|NCT01288989|454840688|FG004|Overall Study|Death|0|||
126422070|NCT01288989|454840684|FG000|Overall Study|Dose limiting toxicity|1|||
126422071|NCT01288989|454840685|FG001|Overall Study|Dose limiting toxicity|0|||
126422072|NCT01288989|454840686|FG002|Overall Study|Dose limiting toxicity|0|||
126422073|NCT01288989|454840687|FG003|Overall Study|Dose limiting toxicity|0|||
126422074|NCT01288989|454840688|FG004|Overall Study|Dose limiting toxicity|0|||
126422075|NCT01288989|454840684|FG000|Overall Study|Adverse Event|0|||
126422076|NCT01288989|454840685|FG001|Overall Study|Adverse Event|0|||
126422077|NCT01288989|454840686|FG002|Overall Study|Adverse Event|0|||
126422078|NCT01288989|454840687|FG003|Overall Study|Adverse Event|0|||
126422079|NCT01288989|454840688|FG004|Overall Study|Adverse Event|2|||
126422080|NCT01288989|454840684|FG000|Overall Study|Physician Decision|0|||
126422081|NCT01288989|454840685|FG001|Overall Study|Physician Decision|0|||
126422082|NCT01288989|454840686|FG002|Overall Study|Physician Decision|0|||
126422083|NCT01288989|454840687|FG003|Overall Study|Physician Decision|0|||
126422084|NCT01288989|454840688|FG004|Overall Study|Physician Decision|1|||
126422085|NCT01288989|454840684|FG000|Overall Study|Withdrawal by Subject|0|||
126422086|NCT01288989|454840685|FG001|Overall Study|Withdrawal by Subject|0|||
126422087|NCT01288989|454840686|FG002|Overall Study|Withdrawal by Subject|0|||
126422088|NCT01288989|454840687|FG003|Overall Study|Withdrawal by Subject|0|||
126422089|NCT01288989|454840688|FG004|Overall Study|Withdrawal by Subject|3|||
126422090|NCT01156714|454840689|FG000|Overall Study|Withdrawal by Subject|9|||
126422091|NCT01156714|454840690|FG001|Overall Study|Withdrawal by Subject|4|||
126422092|NCT01156714|454840691|FG002|Overall Study|Withdrawal by Subject|3|||
126422093|NCT00165672|454840692|FG000|Overall Study|Adverse Event|0|||
126422094|NCT00165672|454840693|FG001|Overall Study|Adverse Event|1|||
126422095|NCT02360228|454840705|FG000|Overall Study|Withdrawal by Subject|1|||
126422096|NCT02360228|454840706|FG001|Overall Study|Withdrawal by Subject|0|||
126422097|NCT02360228|454840707|FG002|Overall Study|Withdrawal by Subject|0|||
126422098|NCT02360228|454840705|FG000|Overall Study|Self-discontinued medication|0|||
126422099|NCT02360228|454840706|FG001|Overall Study|Self-discontinued medication|1|||
126422100|NCT02360228|454840707|FG002|Overall Study|Self-discontinued medication|0|||
126422101|NCT02360228|454840705|FG000|Overall Study|Unstable symptoms during screening|0|||
126422102|NCT02360228|454840706|FG001|Overall Study|Unstable symptoms during screening|0|||
126422103|NCT02360228|454840707|FG002|Overall Study|Unstable symptoms during screening|1|||
126422104|NCT01059318|454840708|FG000|Core Study (26 Week)|Adverse Event|3|||
126422105|NCT01059318|454840708|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
126422106|NCT01059318|454840708|FG000|Extension (36 Week)|Adverse Event|3|||
126422107|NCT04186871|454840711|FG000|Overall Study|Lack of Efficacy|0|||
126422108|NCT04186871|454840712|FG001|Overall Study|Lack of Efficacy|1|||
126422109|NCT04186871|454840713|FG002|Overall Study|Lack of Efficacy|0|||
126422110|NCT04186871|454840714|FG003|Overall Study|Lack of Efficacy|0|||
126422111|NCT04186871|454840715|FG004|Overall Study|Lack of Efficacy|1|||
126422112|NCT04186871|454840716|FG005|Overall Study|Lack of Efficacy|1|||
126422113|NCT04186871|454840711|FG000|Overall Study|Adverse Event|1|||
126422114|NCT04186871|454840712|FG001|Overall Study|Adverse Event|1|||
126422115|NCT04186871|454840713|FG002|Overall Study|Adverse Event|0|||
126422116|NCT04186871|454840714|FG003|Overall Study|Adverse Event|0|||
126422117|NCT04186871|454840715|FG004|Overall Study|Adverse Event|0|||
126422118|NCT04186871|454840716|FG005|Overall Study|Adverse Event|2|||
126422119|NCT04186871|454840711|FG000|Overall Study|Study terminated by sponsor|1|||
126422120|NCT04186871|454840712|FG001|Overall Study|Study terminated by sponsor|2|||
126422121|NCT04186871|454840713|FG002|Overall Study|Study terminated by sponsor|0|||
126422122|NCT04186871|454840714|FG003|Overall Study|Study terminated by sponsor|1|||
126422123|NCT04186871|454840715|FG004|Overall Study|Study terminated by sponsor|0|||
126422124|NCT04186871|454840716|FG005|Overall Study|Study terminated by sponsor|0|||
126422125|NCT04186871|454840711|FG000|Overall Study|Other reasons|0|||
126422126|NCT04186871|454840712|FG001|Overall Study|Other reasons|0|||
126422127|NCT04186871|454840713|FG002|Overall Study|Other reasons|0|||
126422128|NCT04186871|454840714|FG003|Overall Study|Other reasons|0|||
126422129|NCT04186871|454840715|FG004|Overall Study|Other reasons|0|||
126422130|NCT04186871|454840716|FG005|Overall Study|Other reasons|1|||
126422131|NCT04186871|454840711|FG000|Overall Study|Withdrawal by Subject|0|||
126422132|NCT04186871|454840712|FG001|Overall Study|Withdrawal by Subject|0|||
126422133|NCT04186871|454840713|FG002|Overall Study|Withdrawal by Subject|0|||
126422134|NCT04186871|454840714|FG003|Overall Study|Withdrawal by Subject|0|||
126422135|NCT04186871|454840715|FG004|Overall Study|Withdrawal by Subject|0|||
126422136|NCT04186871|454840716|FG005|Overall Study|Withdrawal by Subject|1|||
126422137|NCT04186871|454840711|FG000|Overall Study|Lost to Follow-up|0|||
126422138|NCT04186871|454840712|FG001|Overall Study|Lost to Follow-up|0|||
126422139|NCT04186871|454840713|FG002|Overall Study|Lost to Follow-up|0|||
126422140|NCT04186871|454840714|FG003|Overall Study|Lost to Follow-up|0|||
126422141|NCT04186871|454840715|FG004|Overall Study|Lost to Follow-up|0|||
126422142|NCT04186871|454840716|FG005|Overall Study|Lost to Follow-up|1|||
126422143|NCT03790917|454840717|FG000|Overall Study|Death|1|||
126422144|NCT02464410|454840718|FG000|Overall Study|Death|3|||
126422145|NCT02464410|454840719|FG001|Overall Study|Death|4|||
126422146|NCT02464410|454840718|FG000|Overall Study|Lost to Follow-up|7|||
126422147|NCT02464410|454840719|FG001|Overall Study|Lost to Follow-up|9|||
126422148|NCT02464410|454840718|FG000|Overall Study|Withdrawal by Subject|12|||
126422149|NCT02464410|454840719|FG001|Overall Study|Withdrawal by Subject|3|||
126422150|NCT00176462|454840723|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
126422151|NCT00176462|454840724|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
126422152|NCT00176462|454840723|FG000|Induction (4 Weeks)|Death|1|||
126422153|NCT00176462|454840724|FG001|Induction (4 Weeks)|Death|2|||
126422154|NCT00176462|454840723|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
126422155|NCT00176462|454840724|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
126422156|NCT00176462|454840723|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
126422157|NCT00176462|454840724|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
126422158|NCT00176462|454840723|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
126422159|NCT00176462|454840724|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
126422160|NCT00176462|454840723|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
126422161|NCT00176462|454840724|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
126422162|NCT00176462|454840723|FG000|Consolidation (12 Weeks)|Not documented|0|||
126422163|NCT00176462|454840724|FG001|Consolidation (12 Weeks)|Not documented|1|||
126422164|NCT00176462|454840723|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
126422165|NCT00176462|454840724|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
125891234|NCT02529553|452899755|FG008|Overall Study|Withdrawal by Subject|0|||
125891235|NCT00488683|452899756|FG000|Overall Study|Withdrawal by Subject|1|||
125891236|NCT00488683|452899757|FG001|Overall Study|Withdrawal by Subject|2|||
125891237|NCT00488683|452899758|FG002|Overall Study|Withdrawal by Subject|2|||
125891238|NCT00488683|452899756|FG000|Overall Study|Lost to Follow-up|5|||
125891239|NCT00488683|452899757|FG001|Overall Study|Lost to Follow-up|3|||
125891240|NCT00488683|452899758|FG002|Overall Study|Lost to Follow-up|0|||
125891241|NCT00488683|452899756|FG000|Overall Study|Protocol Violation|5|||
125891242|NCT00488683|452899757|FG001|Overall Study|Protocol Violation|1|||
125891243|NCT00488683|452899758|FG002|Overall Study|Protocol Violation|0|||
125891244|NCT00488683|452899756|FG000|Overall Study|Unable to Classify|1|||
125891245|NCT00488683|452899757|FG001|Overall Study|Unable to Classify|0|||
125891246|NCT00488683|452899758|FG002|Overall Study|Unable to Classify|0|||
125891247|NCT04549545|452901225|FG000|Initial Period|Withdrawal by Subject|4|||
125891248|NCT04549545|452901226|FG001|Initial Period|Withdrawal by Subject|0|||
125891249|NCT04549545|452901225|FG000|Initial Period|Additional ENT Procedure|3|||
125891250|NCT04549545|452901226|FG001|Initial Period|Additional ENT Procedure|0|||
125891251|NCT04549545|452901225|FG000|Initial Period|Lost to Follow-up|3|||
125891252|NCT04549545|452901226|FG001|Initial Period|Lost to Follow-up|1|||
125891253|NCT04549545|452901225|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
125891254|NCT04549545|452901226|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
125891255|NCT04549545|452901225|FG000|Crossover Period|Additional ENT Procedure|0|||
125891256|NCT04549545|452901226|FG001|Crossover Period|Additional ENT Procedure|6|||
125891257|NCT04549545|452901225|FG000|Crossover Period|Lost to Follow-up|0|||
125891258|NCT04549545|452901226|FG001|Crossover Period|Lost to Follow-up|1|||
125891259|NCT04549545|452901225|FG000|Crossover Period|Withdrawal by Subject|0|||
125891260|NCT04549545|452901226|FG001|Crossover Period|Withdrawal by Subject|4|||
125891261|NCT01006291|452901227|FG000|Overall Study|Adverse Event|2|||
125891262|NCT01006291|452901228|FG001|Overall Study|Adverse Event|1|||
125891263|NCT01006291|452901229|FG002|Overall Study|Adverse Event|2|||
125891264|NCT01006291|452901227|FG000|Overall Study|Lack of Efficacy|2|||
125891265|NCT01006291|452901228|FG001|Overall Study|Lack of Efficacy|2|||
125891266|NCT01006291|452901229|FG002|Overall Study|Lack of Efficacy|1|||
125891267|NCT01006291|452901227|FG000|Overall Study|Protocol Violation|3|||
125891268|NCT01006291|452901228|FG001|Overall Study|Protocol Violation|3|||
125891269|NCT01006291|452901229|FG002|Overall Study|Protocol Violation|3|||
125891270|NCT01006291|452901227|FG000|Overall Study|Withdrawal criteria|5|||
125891271|NCT01006291|452901228|FG001|Overall Study|Withdrawal criteria|4|||
125891272|NCT01006291|452901229|FG002|Overall Study|Withdrawal criteria|4|||
125891273|NCT01006291|452901227|FG000|Overall Study|Other|14|||
125891274|NCT01006291|452901228|FG001|Overall Study|Other|14|||
125891275|NCT01006291|452901229|FG002|Overall Study|Other|17|||
125891276|NCT02102204|452901230|FG000|Overall Study|Withdrawal by Subject|137|||
125891277|NCT02102204|452901230|FG000|Overall Study|Death|92|||
125891278|NCT02102204|452901230|FG000|Overall Study|Lost to Follow-up|65|||
125891279|NCT02102204|452901230|FG000|Overall Study|Sponsor Decision|5|||
126422166|NCT00176462|454840723|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
125891280|NCT02102204|452901230|FG000|Overall Study|Ongoing|5|||
125891281|NCT01865552|452901231|FG000|Period 1|Adverse Event|1|||
125891282|NCT01865552|452901232|FG001|Period 1|Adverse Event|0|||
125891283|NCT01865552|452901233|FG002|Period 1|Adverse Event|0|||
125891284|NCT01865552|452901234|FG003|Period 1|Adverse Event|1|||
126422167|NCT00176462|454840724|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
125891285|NCT01865552|452901235|FG004|Period 1|Adverse Event|1|||
125891286|NCT01865552|452901236|FG005|Period 1|Adverse Event|1|||
125891287|NCT01865552|452901231|FG000|Period 1|Pathological lab|0|||
125891288|NCT01865552|452901232|FG001|Period 1|Pathological lab|0|||
125891289|NCT01865552|452901233|FG002|Period 1|Pathological lab|0|||
125891290|NCT01865552|452901234|FG003|Period 1|Pathological lab|0|||
126422168|NCT01408459|454840725|FG000|Overall Study|Withdrawal by Subject|1|||
126422169|NCT01408459|454840726|FG001|Overall Study|Withdrawal by Subject|1|||
126422170|NCT01657292|454840731|FG000|Overall Study|Adverse Event|6|||
126422171|NCT01657292|454840731|FG000|Overall Study|Withdrawal by Subject|2|||
126422172|NCT01657292|454840731|FG000|Overall Study|Violation of eligibility criteria|1|||
126422173|NCT01657292|454840731|FG000|Overall Study|Change of therapy|1|||
126422174|NCT00650845|454840732|FG000|Overall Study|Withdrawal by Subject|5|||
126422175|NCT00650845|454840733|FG001|Overall Study|Withdrawal by Subject|0|||
126422176|NCT00650845|454840732|FG000|Overall Study|Protocol Violation|0|||
126422177|NCT00650845|454840733|FG001|Overall Study|Protocol Violation|13|||
126422178|NCT03932760|454840734|FG000|Overall Study|Became Ineligible|2|||
126422179|NCT03932760|454840735|FG001|Overall Study|Became Ineligible|5|||
126422180|NCT03932760|454840734|FG000|Overall Study|Withdrawal by Subject|6|||
126422181|NCT03932760|454840735|FG001|Overall Study|Withdrawal by Subject|6|||
126422182|NCT01301833|454840736|FG000|Overall Study|Adverse Event|7|||
126422183|NCT01301833|454840737|FG001|Overall Study|Adverse Event|5|||
126422184|NCT01301833|454840738|FG002|Overall Study|Adverse Event|5|||
126422185|NCT01301833|454840739|FG003|Overall Study|Adverse Event|5|||
126422186|NCT01301833|454840736|FG000|Overall Study|Lack of Efficacy|1|||
126422187|NCT01301833|454840737|FG001|Overall Study|Lack of Efficacy|1|||
126422188|NCT01301833|454840738|FG002|Overall Study|Lack of Efficacy|0|||
126422189|NCT01301833|454840739|FG003|Overall Study|Lack of Efficacy|0|||
126422190|NCT01301833|454840736|FG000|Overall Study|Physician Decision|3|||
126422191|NCT01301833|454840737|FG001|Overall Study|Physician Decision|1|||
126422192|NCT01301833|454840738|FG002|Overall Study|Physician Decision|1|||
126422193|NCT01301833|454840739|FG003|Overall Study|Physician Decision|0|||
126422194|NCT01301833|454840736|FG000|Overall Study|Withdrawal by Subject|3|||
126422195|NCT01301833|454840737|FG001|Overall Study|Withdrawal by Subject|1|||
126422196|NCT01301833|454840738|FG002|Overall Study|Withdrawal by Subject|1|||
126422197|NCT01301833|454840739|FG003|Overall Study|Withdrawal by Subject|2|||
126422198|NCT01301833|454840736|FG000|Overall Study|Personal matter|1|||
126422199|NCT01301833|454840737|FG001|Overall Study|Personal matter|0|||
126422200|NCT01301833|454840738|FG002|Overall Study|Personal matter|0|||
126422201|NCT01301833|454840739|FG003|Overall Study|Personal matter|0|||
126422202|NCT03922620|454840740|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
126422203|NCT03922620|454840741|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
126422204|NCT03566082|454840742|FG000|Overall Study|Death|7|||
126422205|NCT03566082|454840742|FG000|Overall Study|Failures (revision required)|2|||
126422206|NCT03566082|454840742|FG000|Overall Study|Lost to Follow-up|8|||
126422207|NCT00983385|454840745|FG000|Observation Period|Not eligible to be dosed|20|||
126422208|NCT00983385|454840745|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
126422209|NCT01279681|454840747|FG000|Overall Study|Disease Progression|9|||
126422210|NCT01279681|454840748|FG001|Overall Study|Disease Progression|6|||
126422211|NCT01279681|454840747|FG000|Overall Study|Withdrawal by Subject|3|||
126422212|NCT01279681|454840748|FG001|Overall Study|Withdrawal by Subject|4|||
126422213|NCT01279681|454840747|FG000|Overall Study|Adverse Event|2|||
126422214|NCT01279681|454840748|FG001|Overall Study|Adverse Event|3|||
126422215|NCT01279681|454840747|FG000|Overall Study|Death|0|||
126422216|NCT01279681|454840748|FG001|Overall Study|Death|1|||
126422217|NCT01279681|454840747|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
126422218|NCT01279681|454840748|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
126422219|NCT01279681|454840747|FG000|Overall Study|Physician Decision|1|||
126422220|NCT01279681|454840748|FG001|Overall Study|Physician Decision|0|||
126422221|NCT01279681|454840747|FG000|Overall Study|Other Reason|0|||
126422222|NCT01279681|454840748|FG001|Overall Study|Other Reason|2|||
126054677|NCT03274076|453493985|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
126054678|NCT03274076|453493986|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
126054679|NCT03274076|453493987|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
126054680|NCT03274076|453493984|FG000|24 Weeks Open Label|Adverse Event|0|||
126054681|NCT03274076|453493985|FG001|24 Weeks Open Label|Adverse Event|0|||
126054682|NCT03274076|453493986|FG002|24 Weeks Open Label|Adverse Event|2|||
126054683|NCT03274076|453493987|FG003|24 Weeks Open Label|Adverse Event|0|||
126054684|NCT03274076|453493984|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
126054685|NCT03274076|453493985|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
126054686|NCT03274076|453493986|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
126054687|NCT03274076|453493987|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
126054688|NCT00795184|453493988|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
126105362|NCT04640077|453678611|FG002|Period 1|Withdrawal by Subject|0|||
126054689|NCT00795184|453493989|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
126054690|NCT02079649|453493990|FG000|Overall Study|Lost to Follow-up|0|||
126054691|NCT02079649|453493991|FG001|Overall Study|Lost to Follow-up|0|||
126054692|NCT02079649|453493992|FG002|Overall Study|Lost to Follow-up|0|||
126054693|NCT02079649|453493993|FG003|Overall Study|Lost to Follow-up|1|||
126054694|NCT02079649|453493990|FG000|Overall Study|Withdrawal by Subject|0|||
126054695|NCT02079649|453493991|FG001|Overall Study|Withdrawal by Subject|0|||
126054696|NCT02079649|453493992|FG002|Overall Study|Withdrawal by Subject|0|||
126054697|NCT02079649|453493993|FG003|Overall Study|Withdrawal by Subject|1|||
126054698|NCT02079649|453493990|FG000|Overall Study|Randomization error (prior to treatment)|1|||
126054699|NCT02079649|453493991|FG001|Overall Study|Randomization error (prior to treatment)|0|||
126054700|NCT02079649|453493992|FG002|Overall Study|Randomization error (prior to treatment)|1|||
126054701|NCT02079649|453493993|FG003|Overall Study|Randomization error (prior to treatment)|0|||
126054702|NCT01170208|453493996|FG000|Overall Study|Withdrawal by Subject|5|||
126054703|NCT01170208|453493997|FG001|Overall Study|Withdrawal by Subject|0|||
126054704|NCT01170208|453493998|FG002|Overall Study|Withdrawal by Subject|1|||
126054705|NCT01170208|453493996|FG000|Overall Study|Protocol Violation|1|||
126054706|NCT01170208|453493997|FG001|Overall Study|Protocol Violation|0|||
126054707|NCT01170208|453493998|FG002|Overall Study|Protocol Violation|1|||
126054708|NCT01160354|453494013|FG000|Overall Study|Death|0|||
126054709|NCT01160354|453494014|FG001|Overall Study|Death|1|||
126054710|NCT01160354|453494015|FG002|Overall Study|Death|1|||
126054711|NCT00853593|453494017|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
126054712|NCT00853593|453494017|FG000|Overall Study|Model 4396 lead not attempted|29|||
126054713|NCT00853593|453494017|FG000|Overall Study|Implant not attempted|4|||
126054714|NCT00600353|453494021|FG000|Overall Study|history of malignancy within 5 years|1|||
126054715|NCT00600353|453494022|FG001|Overall Study|history of malignancy within 5 years|0|||
125891291|NCT01865552|452901235|FG004|Period 1|Pathological lab|1|||
125891292|NCT01865552|452901236|FG005|Period 1|Pathological lab|0|||
125891293|NCT01865552|452901231|FG000|Period 1|Other|0|||
126054716|NCT00600353|453494021|FG000|Overall Study|History of prepartive regimen|0|||
126054717|NCT00600353|453494022|FG001|Overall Study|History of prepartive regimen|1|||
126054718|NCT05966155|453494023|FG000|Overall Study|Death|1|||
125891294|NCT01865552|452901232|FG001|Period 1|Other|0|||
126054719|NCT05966155|453494024|FG001|Overall Study|Death|2|||
126054720|NCT05966155|453494023|FG000|Overall Study|Lost to Follow-up|63|||
126054721|NCT05966155|453494024|FG001|Overall Study|Lost to Follow-up|67|||
126054722|NCT05966155|453494023|FG000|Overall Study|Protocol Violation|1|||
126054723|NCT05966155|453494024|FG001|Overall Study|Protocol Violation|0|||
126054724|NCT05966155|453494023|FG000|Overall Study|Withdrawal by Subject|8|||
126054725|NCT05966155|453494024|FG001|Overall Study|Withdrawal by Subject|9|||
126054726|NCT05966155|453494023|FG000|Overall Study|Enrolled Erroneously|0|||
126054727|NCT05966155|453494024|FG001|Overall Study|Enrolled Erroneously|1|||
126054728|NCT05966155|453494023|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
126054729|NCT05966155|453494024|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
126054730|NCT02743819|453494025|FG000|Overall Study|Lack of Efficacy|5|||
126054731|NCT02743819|453494025|FG000|Overall Study|Death|2|||
126054732|NCT02743819|453494025|FG000|Overall Study|Adverse Event|1|||
126054733|NCT01706159|453494026|FG000|Overall Study|Withdrawal Criteria|2|||
126054734|NCT01706159|453494027|FG001|Overall Study|Withdrawal Criteria|1|||
126054735|NCT01706159|453494026|FG000|Overall Study|Unclassified|6|||
126054736|NCT01706159|453494027|FG001|Overall Study|Unclassified|1|||
126054737|NCT00553332|453494028|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
126054738|NCT02235298|453494030|FG000|Overall Study|Lost to Follow-up|6|||
126054739|NCT02235298|453494031|FG001|Overall Study|Lost to Follow-up|5|||
126054740|NCT02235298|453494030|FG000|Overall Study|Adverse Event|2|||
126054741|NCT02235298|453494031|FG001|Overall Study|Adverse Event|2|||
126054742|NCT02235298|453494030|FG000|Overall Study|Withdrawal by Subject|0|||
126054743|NCT02235298|453494031|FG001|Overall Study|Withdrawal by Subject|1|||
126054744|NCT03683576|453494035|FG000|Overall Study|Withdrawal by Subject|2|||
126054745|NCT03683576|453494036|FG001|Overall Study|Withdrawal by Subject|0|||
126054746|NCT03683576|453494037|FG002|Overall Study|Withdrawal by Subject|8|||
126054747|NCT03683576|453494038|FG003|Overall Study|Withdrawal by Subject|3|||
126054748|NCT03683576|453494035|FG000|Overall Study|Adverse Event|3|||
126054749|NCT03683576|453494036|FG001|Overall Study|Adverse Event|0|||
126054750|NCT03683576|453494037|FG002|Overall Study|Adverse Event|0|||
126054751|NCT03683576|453494038|FG003|Overall Study|Adverse Event|4|||
126054752|NCT03683576|453494035|FG000|Overall Study|Lack of Efficacy|1|||
126054753|NCT03683576|453494036|FG001|Overall Study|Lack of Efficacy|0|||
126054754|NCT03683576|453494037|FG002|Overall Study|Lack of Efficacy|1|||
126054755|NCT03683576|453494038|FG003|Overall Study|Lack of Efficacy|1|||
126054756|NCT03683576|453494035|FG000|Overall Study|Lost to Follow-up|0|||
126054757|NCT03683576|453494036|FG001|Overall Study|Lost to Follow-up|1|||
126054758|NCT03683576|453494037|FG002|Overall Study|Lost to Follow-up|2|||
126054759|NCT03683576|453494038|FG003|Overall Study|Lost to Follow-up|0|||
126054760|NCT03683576|453494035|FG000|Overall Study|Other, Not Specified|0|||
126054761|NCT03683576|453494036|FG001|Overall Study|Other, Not Specified|2|||
126054762|NCT03683576|453494037|FG002|Overall Study|Other, Not Specified|0|||
126054763|NCT03683576|453494038|FG003|Overall Study|Other, Not Specified|0|||
126054764|NCT03683576|453494035|FG000|Overall Study|Protocol Violation|0|||
126054765|NCT03683576|453494036|FG001|Overall Study|Protocol Violation|1|||
126054766|NCT03683576|453494037|FG002|Overall Study|Protocol Violation|1|||
126054767|NCT03683576|453494038|FG003|Overall Study|Protocol Violation|0|||
126054768|NCT01827839|453494039|FG000|Overall Study|Adverse Event|1|||
126054769|NCT01827839|453494039|FG000|Overall Study|Consent Withdrawal|2|||
126054770|NCT00491894|453494043|FG000|Overall Study|Adverse Event|14|||
126054771|NCT00491894|453494043|FG000|Overall Study|Withdrawal by Subject|5|||
126054772|NCT00491894|453494043|FG000|Overall Study|Death|3|||
126054773|NCT00491894|453494043|FG000|Overall Study|Lost to Follow-up|3|||
126054774|NCT00491894|453494043|FG000|Overall Study|Lack of Efficacy|2|||
126054775|NCT00491894|453494043|FG000|Overall Study|Other-Failed to meet any criteria|2|||
126054776|NCT00491894|453494043|FG000|Overall Study|Physician Decision|2|||
126054777|NCT00491894|453494043|FG000|Overall Study|Protocol Violation|2|||
126054778|NCT00491894|453494043|FG000|Overall Study|Other-Intake of prohibited medication|1|||
126054779|NCT02969356|453494047|FG000|Overall Study|Adverse Event|7|||
126054780|NCT02969356|453494047|FG000|Overall Study|Consent withdrawn|2|||
126054781|NCT02969356|453494047|FG000|Overall Study|Lost to Follow-up|3|||
126054782|NCT02969356|453494047|FG000|Overall Study|Did not need to be reinjected|6|||
126054783|NCT02969356|453494047|FG000|Overall Study|Personal reasons|5|||
126054784|NCT02637063|453496095|FG000|Overall Study|Lost to Follow-up|3|||
126054785|NCT02637063|453496096|FG001|Overall Study|Lost to Follow-up|2|||
126054786|NCT02637063|453496097|FG002|Overall Study|Lost to Follow-up|3|||
126054787|NCT02637063|453496095|FG000|Overall Study|Withdrawal by Subject|2|||
126054788|NCT02637063|453496096|FG001|Overall Study|Withdrawal by Subject|2|||
126054789|NCT02637063|453496097|FG002|Overall Study|Withdrawal by Subject|3|||
126054790|NCT00491400|453496098|FG000|Overall Study|Withdrawal by Subject|5|||
126054791|NCT00491400|453496099|FG001|Overall Study|Withdrawal by Subject|4|||
126054792|NCT03499964|453496100|FG000|Overall Study|Lack of Efficacy|6|||
126054793|NCT03499964|453496101|FG001|Overall Study|Lack of Efficacy|26|||
126054794|NCT03499964|453496100|FG000|Overall Study|Adverse Event|1|||
126054795|NCT03499964|453496101|FG001|Overall Study|Adverse Event|0|||
126054796|NCT03499964|453496100|FG000|Overall Study|Death|1|||
126054797|NCT03499964|453496101|FG001|Overall Study|Death|0|||
126054798|NCT03499964|453496100|FG000|Overall Study|Withdrawal by Subject|2|||
126054799|NCT03499964|453496101|FG001|Overall Study|Withdrawal by Subject|1|||
126054800|NCT03499964|453496100|FG000|Overall Study|Lost to Follow-up|1|||
126054801|NCT03499964|453496101|FG001|Overall Study|Lost to Follow-up|0|||
126054802|NCT03739866|453496124|FG000|Overall Study|Lost to Follow-up|0|||
126054803|NCT03739866|453496125|FG001|Overall Study|Lost to Follow-up|0|||
126054804|NCT03739866|453496126|FG002|Overall Study|Lost to Follow-up|0|||
126054805|NCT03739866|453496127|FG003|Overall Study|Lost to Follow-up|1|||
126054806|NCT03739866|453496128|FG004|Overall Study|Lost to Follow-up|0|||
126054807|NCT03739866|453496129|FG005|Overall Study|Lost to Follow-up|0|||
126054808|NCT03739866|453496130|FG006|Overall Study|Lost to Follow-up|0|||
125891295|NCT01865552|452901233|FG002|Period 1|Other|0|||
126054809|NCT03739866|453496131|FG007|Overall Study|Lost to Follow-up|0|||
126054810|NCT03739866|453496124|FG000|Overall Study|Enrolled but not treated|0|||
126054811|NCT03739866|453496125|FG001|Overall Study|Enrolled but not treated|0|||
126054812|NCT03739866|453496126|FG002|Overall Study|Enrolled but not treated|1|||
126054813|NCT03739866|453496127|FG003|Overall Study|Enrolled but not treated|0|||
126054814|NCT03739866|453496128|FG004|Overall Study|Enrolled but not treated|1|||
126054815|NCT03739866|453496129|FG005|Overall Study|Enrolled but not treated|0|||
126054816|NCT03739866|453496130|FG006|Overall Study|Enrolled but not treated|0|||
126054817|NCT03739866|453496131|FG007|Overall Study|Enrolled but not treated|0|||
126054818|NCT00853580|453496132|FG000|Overall Study|Lost to Follow-up|3|||
126054819|NCT00853580|453496133|FG001|Overall Study|Lost to Follow-up|5|||
126054820|NCT00853580|453496132|FG000|Overall Study|Protocol Violation|2|||
126054821|NCT00853580|453496133|FG001|Overall Study|Protocol Violation|1|||
126054822|NCT00853580|453496132|FG000|Overall Study|Withdrawal by Subject|2|||
126054823|NCT00853580|453496133|FG001|Overall Study|Withdrawal by Subject|8|||
126054824|NCT00853580|453496132|FG000|Overall Study|Commenced contraindicated therapy|0|||
126054825|NCT00853580|453496133|FG001|Overall Study|Commenced contraindicated therapy|2|||
126054826|NCT01728324|453496134|FG000|Termination of DBV|Adverse Event|14|||
126054827|NCT01728324|453496135|FG001|Termination of DBV|Adverse Event|13|||
126054828|NCT01728324|453496136|FG002|Termination of DBV|Adverse Event|4|||
126054829|NCT01728324|453496134|FG000|Termination of DBV|Lack of Efficacy|14|||
126054830|NCT01728324|453496135|FG001|Termination of DBV|Lack of Efficacy|12|||
126054831|NCT01728324|453496136|FG002|Termination of DBV|Lack of Efficacy|8|||
126054832|NCT01728324|453496134|FG000|Termination of DBV|Withdrawal by Subject|9|||
126054833|NCT01728324|453496135|FG001|Termination of DBV|Withdrawal by Subject|6|||
126054834|NCT01728324|453496136|FG002|Termination of DBV|Withdrawal by Subject|2|||
126054835|NCT01728324|453496134|FG000|Termination of DBV|Other than stated|1|||
126054836|NCT01728324|453496135|FG001|Termination of DBV|Other than stated|3|||
126054837|NCT01728324|453496136|FG002|Termination of DBV|Other than stated|0|||
126054838|NCT01728324|453496134|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
126054839|NCT01728324|453496135|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
126054840|NCT01728324|453496136|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
126054841|NCT01728324|453496134|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
126054842|NCT01728324|453496135|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
126054843|NCT01728324|453496136|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
126054844|NCT01728324|453496134|FG000|Termination of FDV|Adverse Event|14|||
126054845|NCT01728324|453496135|FG001|Termination of FDV|Adverse Event|13|||
126054846|NCT01728324|453496136|FG002|Termination of FDV|Adverse Event|4|||
126054847|NCT01728324|453496134|FG000|Termination of FDV|Lack of Efficacy|14|||
126054848|NCT01728324|453496135|FG001|Termination of FDV|Lack of Efficacy|12|||
126054849|NCT01728324|453496136|FG002|Termination of FDV|Lack of Efficacy|8|||
126054850|NCT01728324|453496134|FG000|Termination of FDV|Withdrawal by Subject|9|||
126054851|NCT01728324|453496135|FG001|Termination of FDV|Withdrawal by Subject|6|||
126054852|NCT01728324|453496136|FG002|Termination of FDV|Withdrawal by Subject|2|||
126054853|NCT01728324|453496134|FG000|Termination of FDV|Other than stated|1|||
126054854|NCT01728324|453496135|FG001|Termination of FDV|Other than stated|3|||
126054855|NCT01728324|453496136|FG002|Termination of FDV|Other than stated|0|||
126054856|NCT01728324|453496134|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
126054857|NCT01728324|453496135|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
126054858|NCT01728324|453496136|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
126054859|NCT01728324|453496134|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
126054860|NCT01728324|453496135|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
126054861|NCT01728324|453496136|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
126054862|NCT01728324|453496134|FG000|Termination of RBV|Adverse Event|15|||
126054863|NCT01728324|453496135|FG001|Termination of RBV|Adverse Event|16|||
126054864|NCT01728324|453496136|FG002|Termination of RBV|Adverse Event|5|||
126054865|NCT01728324|453496134|FG000|Termination of RBV|Lack of Efficacy|14|||
126054866|NCT01728324|453496135|FG001|Termination of RBV|Lack of Efficacy|11|||
126054867|NCT01728324|453496136|FG002|Termination of RBV|Lack of Efficacy|7|||
126054868|NCT01728324|453496134|FG000|Termination of RBV|Withdrawal by Subject|9|||
126054869|NCT01728324|453496135|FG001|Termination of RBV|Withdrawal by Subject|5|||
126054870|NCT01728324|453496136|FG002|Termination of RBV|Withdrawal by Subject|2|||
126054871|NCT01728324|453496134|FG000|Termination of RBV|Other than stated|1|||
126054872|NCT01728324|453496135|FG001|Termination of RBV|Other than stated|3|||
126054873|NCT01728324|453496136|FG002|Termination of RBV|Other than stated|1|||
126054874|NCT01728324|453496134|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
126054875|NCT01728324|453496135|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
126054876|NCT01728324|453496136|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
126054877|NCT01728324|453496134|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
126054878|NCT01728324|453496135|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
126054879|NCT01728324|453496136|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
126054880|NCT03057600|453496139|FG000|Overall Study|Adverse Event|0|||
126054881|NCT03057600|453496140|FG001|Overall Study|Adverse Event|0|||
126054882|NCT03057600|453496141|FG002|Overall Study|Adverse Event|4|||
126054883|NCT03057600|453496142|FG003|Overall Study|Adverse Event|0|||
126054884|NCT03057600|453496139|FG000|Overall Study|Radiologic Disease Progression|8|||
126054885|NCT03057600|453496140|FG001|Overall Study|Radiologic Disease Progression|7|||
126054886|NCT03057600|453496141|FG002|Overall Study|Radiologic Disease Progression|13|||
126054887|NCT03057600|453496142|FG003|Overall Study|Radiologic Disease Progression|10|||
126054888|NCT03057600|453496139|FG000|Overall Study|Symptomatic Deterioration|0|||
126054889|NCT03057600|453496140|FG001|Overall Study|Symptomatic Deterioration|1|||
126054890|NCT03057600|453496141|FG002|Overall Study|Symptomatic Deterioration|1|||
126054891|NCT03057600|453496142|FG003|Overall Study|Symptomatic Deterioration|0|||
126054892|NCT03057600|453496139|FG000|Overall Study|Investigator Decision|0|||
126054893|NCT03057600|453496140|FG001|Overall Study|Investigator Decision|0|||
126054894|NCT03057600|453496141|FG002|Overall Study|Investigator Decision|1|||
126054895|NCT03057600|453496142|FG003|Overall Study|Investigator Decision|0|||
126054896|NCT03057600|453496139|FG000|Overall Study|Study Termination by Sponsor|0|||
126054897|NCT03057600|453496140|FG001|Overall Study|Study Termination by Sponsor|0|||
126054898|NCT03057600|453496141|FG002|Overall Study|Study Termination by Sponsor|0|||
126054899|NCT03057600|453496142|FG003|Overall Study|Study Termination by Sponsor|2|||
126054900|NCT03057600|453496139|FG000|Overall Study|Withdrawal by Subject|0|||
126054901|NCT03057600|453496140|FG001|Overall Study|Withdrawal by Subject|1|||
126054902|NCT03057600|453496141|FG002|Overall Study|Withdrawal by Subject|0|||
126054903|NCT03057600|453496142|FG003|Overall Study|Withdrawal by Subject|0|||
126054904|NCT03057600|453496139|FG000|Overall Study|Other, Not Specified|1|||
126054905|NCT03057600|453496140|FG001|Overall Study|Other, Not Specified|1|||
126054906|NCT03057600|453496141|FG002|Overall Study|Other, Not Specified|1|||
126054907|NCT03057600|453496142|FG003|Overall Study|Other, Not Specified|1|||
126054908|NCT03489369|453496145|FG000|Overall Study|Documented Progressive Disease|3|||
126054909|NCT03489369|453496146|FG001|Overall Study|Documented Progressive Disease|2|||
126054910|NCT03489369|453496147|FG002|Overall Study|Documented Progressive Disease|3|||
126054911|NCT03489369|453496148|FG003|Overall Study|Documented Progressive Disease|6|||
126054912|NCT03489369|453496145|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
126054913|NCT03489369|453496146|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
126054914|NCT03489369|453496147|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
126054915|NCT03489369|453496148|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
126054916|NCT01968967|453496149|FG000|Treatment Period|Other|22|||
126054917|NCT01968967|453496150|FG001|Treatment Period|Other|22|||
126054918|NCT01968967|453496151|FG002|Treatment Period|Other|0|||
126054919|NCT01968967|453496152|FG003|Treatment Period|Other|0|||
126054920|NCT01968967|453496153|FG004|Treatment Period|Other|0|||
126054921|NCT01968967|453496149|FG000|Treatment Period|Withdrawal by Subject|71|||
126054922|NCT01968967|453496150|FG001|Treatment Period|Withdrawal by Subject|61|||
126054923|NCT01968967|453496151|FG002|Treatment Period|Withdrawal by Subject|0|||
126054924|NCT01968967|453496152|FG003|Treatment Period|Withdrawal by Subject|0|||
126054925|NCT01968967|453496153|FG004|Treatment Period|Withdrawal by Subject|0|||
126054926|NCT01968967|453496149|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
126054927|NCT01968967|453496150|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
126054928|NCT01968967|453496151|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
126054929|NCT01968967|453496152|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
126054930|NCT01968967|453496153|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
126054931|NCT01968967|453496149|FG000|Treatment Period|Lost to Follow-up|26|||
126054932|NCT01968967|453496150|FG001|Treatment Period|Lost to Follow-up|31|||
126054933|NCT01968967|453496151|FG002|Treatment Period|Lost to Follow-up|0|||
126054934|NCT01968967|453496152|FG003|Treatment Period|Lost to Follow-up|0|||
126054935|NCT01968967|453496153|FG004|Treatment Period|Lost to Follow-up|0|||
126054936|NCT01968967|453496149|FG000|Treatment Period|Protocol Violation|1|||
126054937|NCT01968967|453496150|FG001|Treatment Period|Protocol Violation|2|||
126054938|NCT01968967|453496151|FG002|Treatment Period|Protocol Violation|0|||
126054939|NCT01968967|453496152|FG003|Treatment Period|Protocol Violation|0|||
126054940|NCT01968967|453496153|FG004|Treatment Period|Protocol Violation|0|||
125891296|NCT01865552|452901234|FG003|Period 1|Other|0|||
125891297|NCT01865552|452901235|FG004|Period 1|Other|1|||
125891298|NCT01865552|452901236|FG005|Period 1|Other|0|||
125891299|NCT03079102|452901237|FG000|Overall Study|Physician Decision|0|||
125891300|NCT03079102|452901238|FG001|Overall Study|Physician Decision|1|||
126054941|NCT01968967|453496149|FG000|Treatment Period|Adverse Event|9|||
126054942|NCT01968967|453496150|FG001|Treatment Period|Adverse Event|8|||
126054943|NCT01968967|453496151|FG002|Treatment Period|Adverse Event|0|||
126054944|NCT01968967|453496152|FG003|Treatment Period|Adverse Event|0|||
126054945|NCT01968967|453496153|FG004|Treatment Period|Adverse Event|0|||
126054946|NCT01968967|453496149|FG000|Treatment Period|Death|9|||
126054947|NCT01968967|453496150|FG001|Treatment Period|Death|2|||
126054948|NCT01968967|453496151|FG002|Treatment Period|Death|0|||
126054949|NCT01968967|453496152|FG003|Treatment Period|Death|0|||
126054950|NCT01968967|453496153|FG004|Treatment Period|Death|0|||
126054951|NCT01968967|453496149|FG000|Treatment Period|Randomized Not Treated|6|||
126054952|NCT01968967|453496150|FG001|Treatment Period|Randomized Not Treated|5|||
126054953|NCT01968967|453496151|FG002|Treatment Period|Randomized Not Treated|0|||
126054954|NCT01968967|453496152|FG003|Treatment Period|Randomized Not Treated|0|||
126054955|NCT01968967|453496153|FG004|Treatment Period|Randomized Not Treated|0|||
126054956|NCT01968967|453496149|FG000|Extension Period|Withdrew Consent|0|||
126054957|NCT01968967|453496150|FG001|Extension Period|Withdrew Consent|0|||
126054958|NCT01968967|453496151|FG002|Extension Period|Withdrew Consent|2|||
126054959|NCT01968967|453496152|FG003|Extension Period|Withdrew Consent|0|||
126054960|NCT01968967|453496153|FG004|Extension Period|Withdrew Consent|5|||
126054961|NCT03335488|453496154|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
126054962|NCT03335488|453496155|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
126054963|NCT03335488|453496154|FG000|Safety Extension Period|Adverse Event|1|||
126054964|NCT03335488|453496155|FG001|Safety Extension Period|Adverse Event|0|||
126054965|NCT03335488|453496154|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
126054966|NCT03335488|453496155|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
126054967|NCT00388726|453496156|FG000|Overall Study|Adverse Event|50|||
126054968|NCT00388726|453496157|FG001|Overall Study|Adverse Event|24|||
126054969|NCT00388726|453496156|FG000|Overall Study|Progressive Disease|336|||
126054970|NCT00388726|453496157|FG001|Overall Study|Progressive Disease|153|||
126054971|NCT00388726|453496156|FG000|Overall Study|Clinical Progression|61|||
126054972|NCT00388726|453496157|FG001|Overall Study|Clinical Progression|36|||
126054973|NCT00388726|453496156|FG000|Overall Study|Withdrawal by Subject|10|||
126054974|NCT00388726|453496157|FG001|Overall Study|Withdrawal by Subject|7|||
126054975|NCT00388726|453496156|FG000|Overall Study|Administrative|6|||
126054976|NCT00388726|453496157|FG001|Overall Study|Administrative|9|||
126054977|NCT00388726|453496156|FG000|Overall Study|Physician Decision|18|||
126054978|NCT00388726|453496157|FG001|Overall Study|Physician Decision|13|||
126054979|NCT00388726|453496156|FG000|Overall Study|Death|3|||
126054980|NCT00388726|453496157|FG001|Overall Study|Death|2|||
126054981|NCT01953692|453496158|FG000|Overall Study|Adverse Event|5|||
126054982|NCT01953692|453496159|FG001|Overall Study|Adverse Event|2|||
126054983|NCT01953692|453496160|FG002|Overall Study|Adverse Event|4|||
126054984|NCT01953692|453496161|FG003|Overall Study|Adverse Event|2|||
126054985|NCT01953692|453496162|FG004|Overall Study|Adverse Event|1|||
126054986|NCT01953692|453496163|FG005|Overall Study|Adverse Event|2|||
126054987|NCT01953692|453496164|FG006|Overall Study|Adverse Event|0|||
126054988|NCT01953692|453496165|FG007|Overall Study|Adverse Event|0|||
126054989|NCT01953692|453496166|FG008|Overall Study|Adverse Event|0|||
126054990|NCT01953692|453496158|FG000|Overall Study|Clinical Progression|0|||
126054991|NCT01953692|453496159|FG001|Overall Study|Clinical Progression|15|||
126054992|NCT01953692|453496160|FG002|Overall Study|Clinical Progression|7|||
126054993|NCT01953692|453496161|FG003|Overall Study|Clinical Progression|5|||
126054994|NCT01953692|453496162|FG004|Overall Study|Clinical Progression|0|||
126054995|NCT01953692|453496163|FG005|Overall Study|Clinical Progression|7|||
126054996|NCT01953692|453496164|FG006|Overall Study|Clinical Progression|20|||
126054997|NCT01953692|453496165|FG007|Overall Study|Clinical Progression|3|||
126054998|NCT01953692|453496166|FG008|Overall Study|Clinical Progression|3|||
126054999|NCT01953692|453496158|FG000|Overall Study|Death|5|||
126055000|NCT01953692|453496159|FG001|Overall Study|Death|0|||
126055001|NCT01953692|453496160|FG002|Overall Study|Death|2|||
126055002|NCT01953692|453496161|FG003|Overall Study|Death|2|||
126055003|NCT01953692|453496162|FG004|Overall Study|Death|1|||
126055004|NCT01953692|453496163|FG005|Overall Study|Death|3|||
126055005|NCT01953692|453496164|FG006|Overall Study|Death|6|||
126055006|NCT01953692|453496165|FG007|Overall Study|Death|2|||
126055007|NCT01953692|453496166|FG008|Overall Study|Death|1|||
126055008|NCT01953692|453496158|FG000|Overall Study|Excluded Medication|1|||
126055009|NCT01953692|453496159|FG001|Overall Study|Excluded Medication|0|||
126055010|NCT01953692|453496160|FG002|Overall Study|Excluded Medication|0|||
126055011|NCT01953692|453496161|FG003|Overall Study|Excluded Medication|0|||
126055012|NCT01953692|453496162|FG004|Overall Study|Excluded Medication|0|||
126055013|NCT01953692|453496163|FG005|Overall Study|Excluded Medication|0|||
126055014|NCT01953692|453496164|FG006|Overall Study|Excluded Medication|0|||
126055015|NCT01953692|453496165|FG007|Overall Study|Excluded Medication|0|||
126055016|NCT01953692|453496166|FG008|Overall Study|Excluded Medication|0|||
126055017|NCT01953692|453496158|FG000|Overall Study|Lost to Follow-up|1|||
126055018|NCT01953692|453496159|FG001|Overall Study|Lost to Follow-up|0|||
126055019|NCT01953692|453496160|FG002|Overall Study|Lost to Follow-up|3|||
126055020|NCT01953692|453496161|FG003|Overall Study|Lost to Follow-up|1|||
126055021|NCT01953692|453496162|FG004|Overall Study|Lost to Follow-up|0|||
126055022|NCT01953692|453496163|FG005|Overall Study|Lost to Follow-up|1|||
126055023|NCT01953692|453496164|FG006|Overall Study|Lost to Follow-up|0|||
126055024|NCT01953692|453496165|FG007|Overall Study|Lost to Follow-up|0|||
126055025|NCT01953692|453496166|FG008|Overall Study|Lost to Follow-up|0|||
126055026|NCT01953692|453496158|FG000|Overall Study|Physician Decision|11|||
126055027|NCT01953692|453496159|FG001|Overall Study|Physician Decision|4|||
126055028|NCT01953692|453496160|FG002|Overall Study|Physician Decision|2|||
126055029|NCT01953692|453496161|FG003|Overall Study|Physician Decision|2|||
126055030|NCT01953692|453496162|FG004|Overall Study|Physician Decision|1|||
126055031|NCT01953692|453496163|FG005|Overall Study|Physician Decision|2|||
126055032|NCT01953692|453496164|FG006|Overall Study|Physician Decision|4|||
126055033|NCT01953692|453496165|FG007|Overall Study|Physician Decision|1|||
126055034|NCT01953692|453496166|FG008|Overall Study|Physician Decision|0|||
126055035|NCT01953692|453496158|FG000|Overall Study|Protocol Violation|0|||
126055036|NCT01953692|453496159|FG001|Overall Study|Protocol Violation|2|||
126055037|NCT01953692|453496160|FG002|Overall Study|Protocol Violation|1|||
126055038|NCT01953692|453496161|FG003|Overall Study|Protocol Violation|0|||
126055039|NCT01953692|453496162|FG004|Overall Study|Protocol Violation|0|||
126055040|NCT01953692|453496163|FG005|Overall Study|Protocol Violation|0|||
126055041|NCT01953692|453496164|FG006|Overall Study|Protocol Violation|0|||
126055042|NCT01953692|453496165|FG007|Overall Study|Protocol Violation|1|||
126055043|NCT01953692|453496166|FG008|Overall Study|Protocol Violation|0|||
126055044|NCT01953692|453496158|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126055045|NCT01953692|453496159|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126055046|NCT01953692|453496160|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126055047|NCT01953692|453496161|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126055048|NCT01953692|453496162|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126055049|NCT01953692|453496163|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126055050|NCT01953692|453496164|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126055051|NCT01953692|453496165|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
126055052|NCT01953692|453496166|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126055053|NCT01953692|453496158|FG000|Overall Study|Withdrawal by Subject|4|||
126055054|NCT01953692|453496159|FG001|Overall Study|Withdrawal by Subject|2|||
126055055|NCT01953692|453496160|FG002|Overall Study|Withdrawal by Subject|1|||
126055056|NCT01953692|453496161|FG003|Overall Study|Withdrawal by Subject|2|||
126055057|NCT01953692|453496162|FG004|Overall Study|Withdrawal by Subject|0|||
126055058|NCT01953692|453496163|FG005|Overall Study|Withdrawal by Subject|3|||
126055059|NCT01953692|453496164|FG006|Overall Study|Withdrawal by Subject|2|||
126055060|NCT01953692|453496165|FG007|Overall Study|Withdrawal by Subject|1|||
126055061|NCT01953692|453496166|FG008|Overall Study|Withdrawal by Subject|1|||
125891301|NCT02741518|452901241|FG000|Overall Study|Withdrawal by Subject|1|||
126105363|NCT04640077|453678609|FG000|Period 1|Adverse Event|1|||
126055062|NCT04638816|453496167|FG000|Overall Study|Withdrawal by Subject|0|||
126055063|NCT04638816|453496168|FG001|Overall Study|Withdrawal by Subject|1|||
126055064|NCT04638816|453496167|FG000|Overall Study|Lost to Follow-up|0|||
126055065|NCT04638816|453496168|FG001|Overall Study|Lost to Follow-up|1|||
126055066|NCT01822756|453496169|FG000|Overall Study|Adverse Event|0|||
126055067|NCT01822756|453496170|FG001|Overall Study|Adverse Event|0|||
126055068|NCT01822756|453496171|FG002|Overall Study|Adverse Event|0|||
126055069|NCT01822756|453496172|FG003|Overall Study|Adverse Event|2|||
126055070|NCT01822756|453496173|FG004|Overall Study|Adverse Event|0|||
126055071|NCT01822756|453496169|FG000|Overall Study|Disease progression|11|||
126055072|NCT01822756|453496170|FG001|Overall Study|Disease progression|1|||
126055073|NCT01822756|453496171|FG002|Overall Study|Disease progression|7|||
126055074|NCT01822756|453496172|FG003|Overall Study|Disease progression|2|||
126055075|NCT01822756|453496173|FG004|Overall Study|Disease progression|6|||
126055076|NCT01822756|453496169|FG000|Overall Study|Death|2|||
126055077|NCT01822756|453496170|FG001|Overall Study|Death|2|||
126055078|NCT01822756|453496171|FG002|Overall Study|Death|1|||
126055079|NCT01822756|453496172|FG003|Overall Study|Death|0|||
126055080|NCT01822756|453496173|FG004|Overall Study|Death|0|||
126055081|NCT01822756|453496169|FG000|Overall Study|Lost to Follow-up|1|||
126055082|NCT01822756|453496170|FG001|Overall Study|Lost to Follow-up|0|||
126055083|NCT01822756|453496171|FG002|Overall Study|Lost to Follow-up|1|||
126055084|NCT01822756|453496172|FG003|Overall Study|Lost to Follow-up|0|||
126055085|NCT01822756|453496173|FG004|Overall Study|Lost to Follow-up|1|||
126055086|NCT01822756|453496169|FG000|Overall Study|Physician Decision|0|||
126055087|NCT01822756|453496170|FG001|Overall Study|Physician Decision|1|||
126055088|NCT01822756|453496171|FG002|Overall Study|Physician Decision|0|||
126055089|NCT01822756|453496172|FG003|Overall Study|Physician Decision|0|||
126055090|NCT01822756|453496173|FG004|Overall Study|Physician Decision|0|||
126055091|NCT01822756|453496169|FG000|Overall Study|disease progression & patient preference|2|||
126055092|NCT01822756|453496170|FG001|Overall Study|disease progression & patient preference|0|||
126055093|NCT01822756|453496171|FG002|Overall Study|disease progression & patient preference|1|||
126055094|NCT01822756|453496172|FG003|Overall Study|disease progression & patient preference|0|||
126055095|NCT01822756|453496173|FG004|Overall Study|disease progression & patient preference|0|||
126055096|NCT01328496|453496174|FG000|Overall Study|Significant Change in Health Status|1|||
126055097|NCT01328496|453496175|FG001|Overall Study|Significant Change in Health Status|0|||
126055098|NCT03520036|453496188|FG000|Overall Study|Adverse Event|1|||
126055099|NCT03520036|453496189|FG001|Overall Study|Adverse Event|2|||
126055100|NCT03520036|453496190|FG002|Overall Study|Adverse Event|0|||
126055101|NCT03520036|453496188|FG000|Overall Study|Protocol Violation|1|||
126055102|NCT03520036|453496189|FG001|Overall Study|Protocol Violation|0|||
125891302|NCT02741518|452901242|FG001|Overall Study|Withdrawal by Subject|1|||
126055103|NCT03520036|453496190|FG002|Overall Study|Protocol Violation|0|||
126055104|NCT03520036|453496188|FG000|Overall Study|Withdrawal by Subject|0|||
126055105|NCT03520036|453496189|FG001|Overall Study|Withdrawal by Subject|1|||
125891303|NCT01349049|452901243|FG000|Overall Study|Disease progression|3|||
125891304|NCT01349049|452901244|FG001|Overall Study|Disease progression|5|||
125891305|NCT01349049|452901245|FG002|Overall Study|Disease progression|3|||
126055106|NCT03520036|453496190|FG002|Overall Study|Withdrawal by Subject|4|||
126055107|NCT03520036|453496188|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
126055108|NCT03520036|453496189|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
126055109|NCT03520036|453496190|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
126055110|NCT05426109|453496191|FG000|Overall Study|Withdrawal by Subject|0|||
126055111|NCT05426109|453496192|FG001|Overall Study|Withdrawal by Subject|1|||
126055112|NCT03102034|453496193|FG000|Overall Study|Withdrawal by Subject|1|||
126055113|NCT03102034|453496194|FG001|Overall Study|Withdrawal by Subject|0|||
126055114|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
126055115|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
126055116|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
126055117|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
125891306|NCT01349049|452901246|FG003|Overall Study|Disease progression|2|||
126055118|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
125891307|NCT01349049|452901247|FG004|Overall Study|Disease progression|2|||
126055119|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
125891308|NCT01349049|452901248|FG005|Overall Study|Disease progression|2|||
125891309|NCT01349049|452901249|FG006|Overall Study|Disease progression|3|||
126055120|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
126055121|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
126055122|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
126055123|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
125891310|NCT01349049|452901250|FG007|Overall Study|Disease progression|2|||
126105364|NCT04640077|453678610|FG001|Period 1|Adverse Event|1|||
126055124|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
126055125|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
126055126|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
126055127|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
126055128|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
126055129|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
126055130|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
126055131|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
126055132|NCT02222493|453496195|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
126055133|NCT02222493|453496196|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
126055134|NCT02222493|453496195|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
126055135|NCT02222493|453496196|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
126055136|NCT02222493|453496195|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
126055137|NCT02222493|453496196|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
126055138|NCT02222493|453496195|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
126055139|NCT02222493|453496196|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
126055140|NCT02222493|453496195|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
126055141|NCT02222493|453496196|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
126055142|NCT02222493|453496195|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
126055143|NCT02222493|453496196|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
126055144|NCT02222493|453496195|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
126055145|NCT02222493|453496196|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
126055146|NCT02222493|453496195|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
126055147|NCT02222493|453496196|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
126055148|NCT02222493|453496195|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
126055149|NCT02222493|453496196|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
126055150|NCT02222493|453496195|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
126055151|NCT02222493|453496196|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
126055152|NCT02222493|453496195|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
126055153|NCT02222493|453496196|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
126055154|NCT02222493|453496195|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
126105365|NCT04640077|453678611|FG002|Period 1|Adverse Event|0|||
125891311|NCT01349049|452901251|FG008|Overall Study|Disease progression|33|||
126105366|NCT04640077|453678609|FG000|Period 1|Screen Failure|2|||
126105367|NCT04640077|453678610|FG001|Period 1|Screen Failure|0|||
126105368|NCT04640077|453678611|FG002|Period 1|Screen Failure|0|||
126105369|NCT04640077|453678609|FG000|Period 2|Withdrawal by Subject|0|||
126105370|NCT04640077|453678610|FG001|Period 2|Withdrawal by Subject|0|||
126105371|NCT04640077|453678611|FG002|Period 2|Withdrawal by Subject|18|||
126105372|NCT04640077|453678609|FG000|Period 2|Adverse Event|0|||
126105373|NCT04640077|453678610|FG001|Period 2|Adverse Event|0|||
126105374|NCT04640077|453678611|FG002|Period 2|Adverse Event|6|||
126105375|NCT04640077|453678609|FG000|Period 2|Lost to Follow-up|0|||
126105376|NCT04640077|453678610|FG001|Period 2|Lost to Follow-up|0|||
126105377|NCT04640077|453678611|FG002|Period 2|Lost to Follow-up|2|||
126105378|NCT04640077|453678609|FG000|Period 2|Death|0|||
126105379|NCT04640077|453678610|FG001|Period 2|Death|0|||
126105380|NCT04640077|453678611|FG002|Period 2|Death|2|||
126105381|NCT04640077|453678609|FG000|Period 2|Progressive Disease|0|||
126105382|NCT04640077|453678610|FG001|Period 2|Progressive Disease|0|||
126105383|NCT04640077|453678611|FG002|Period 2|Progressive Disease|1|||
126105384|NCT04640077|453678609|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
126105385|NCT04640077|453678610|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
126105386|NCT04640077|453678611|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
126105387|NCT01257425|453678612|FG000|Overall Study|Lack of Efficacy|3|||
126105388|NCT01257425|453678613|FG001|Overall Study|Lack of Efficacy|3|||
126105389|NCT01257425|453678612|FG000|Overall Study|Adverse Event|1|||
126105390|NCT01257425|453678613|FG001|Overall Study|Adverse Event|1|||
126105391|NCT01257425|453678612|FG000|Overall Study|Protocol Violation|1|||
126105392|NCT01257425|453678613|FG001|Overall Study|Protocol Violation|1|||
126105393|NCT01257425|453678612|FG000|Overall Study|Withdrawal by Subject|0|||
126105394|NCT01257425|453678613|FG001|Overall Study|Withdrawal by Subject|1|||
126105395|NCT01257425|453678612|FG000|Overall Study|Death|1|||
126105396|NCT01257425|453678613|FG001|Overall Study|Death|0|||
126105397|NCT01182194|453678615|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
126105398|NCT01182194|453678616|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
126105399|NCT03343301|453678617|FG000|Overall Study|Withdrawal by Subject|1|||
126105400|NCT03343301|453678618|FG001|Overall Study|Withdrawal by Subject|1|||
126105401|NCT03343301|453678617|FG000|Overall Study|Death|0|||
126105402|NCT03343301|453678618|FG001|Overall Study|Death|2|||
126105403|NCT03343301|453678617|FG000|Overall Study|Other|0|||
126105404|NCT03343301|453678618|FG001|Overall Study|Other|6|||
126105405|NCT03343301|453678617|FG000|Overall Study|Missing|2|||
126105406|NCT03343301|453678618|FG001|Overall Study|Missing|0|||
126105407|NCT00368992|453678619|FG000|Overall Study|Ineligible|5|||
126105408|NCT00368992|453678619|FG000|Overall Study|Refused treatment|3|||
126105409|NCT00368992|453678619|FG000|Overall Study|Lack of Efficacy|63|||
126105410|NCT00368992|453678619|FG000|Overall Study|Adverse Event|26|||
126105411|NCT00368992|453678619|FG000|Overall Study|Death|4|||
126105412|NCT00368992|453678619|FG000|Overall Study|Other|9|||
126105413|NCT02668185|453678620|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
126105414|NCT02668185|453678621|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
126105415|NCT02668185|453678620|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
126105416|NCT02668185|453678621|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
126105417|NCT02668185|453678620|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
126105418|NCT02668185|453678621|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
126105419|NCT02668185|453678620|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
126105420|NCT02668185|453678621|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
126105421|NCT01013597|453678622|FG000|Overall Study|Withdrawal by Subject|1|||
126105422|NCT00723021|453678627|FG000|Intervention Period 4|Adverse Event|0|||
126105423|NCT00723021|453678628|FG001|Intervention Period 4|Adverse Event|0|||
126105424|NCT00723021|453678629|FG002|Intervention Period 4|Adverse Event|0|||
126105425|NCT00723021|453678630|FG003|Intervention Period 4|Adverse Event|0|||
126105426|NCT00723021|453678631|FG004|Intervention Period 4|Adverse Event|1|||
125891312|NCT01349049|452901243|FG000|Overall Study|Adverse Event|0|||
125891313|NCT01349049|452901244|FG001|Overall Study|Adverse Event|1|||
125891314|NCT01349049|452901245|FG002|Overall Study|Adverse Event|0|||
125891315|NCT01349049|452901246|FG003|Overall Study|Adverse Event|0|||
126105427|NCT00770341|453678632|FG000|Overall Study|Did not meet eligibility criteria|1|||
125891316|NCT01349049|452901247|FG004|Overall Study|Adverse Event|0|||
126105428|NCT00770341|453678633|FG001|Overall Study|Did not meet eligibility criteria|0|||
126105429|NCT00770341|453678634|FG002|Overall Study|Did not meet eligibility criteria|0|||
126105430|NCT00770341|453678632|FG000|Overall Study|Withdrawal by Subject|0|||
126105431|NCT00770341|453678633|FG001|Overall Study|Withdrawal by Subject|1|||
126105432|NCT00770341|453678634|FG002|Overall Study|Withdrawal by Subject|0|||
126105433|NCT00770341|453678632|FG000|Overall Study|Clinical Adverse Event|3|||
126105434|NCT00770341|453678633|FG001|Overall Study|Clinical Adverse Event|1|||
126105435|NCT00770341|453678634|FG002|Overall Study|Clinical Adverse Event|2|||
126105436|NCT00770341|453678632|FG000|Overall Study|Laboratory adverse event|3|||
126105437|NCT00770341|453678633|FG001|Overall Study|Laboratory adverse event|3|||
126105438|NCT00770341|453678634|FG002|Overall Study|Laboratory adverse event|0|||
126105439|NCT00770341|453678632|FG000|Overall Study|Lack of Efficacy|3|||
126105440|NCT00770341|453678633|FG001|Overall Study|Lack of Efficacy|0|||
126105441|NCT00770341|453678634|FG002|Overall Study|Lack of Efficacy|1|||
126105442|NCT00770341|453678632|FG000|Overall Study|Other|1|||
126105443|NCT00770341|453678633|FG001|Overall Study|Other|0|||
126105444|NCT00770341|453678634|FG002|Overall Study|Other|0|||
126105445|NCT00770341|453678632|FG000|Overall Study|Not treated|1|||
126105446|NCT00770341|453678633|FG001|Overall Study|Not treated|0|||
126105447|NCT00770341|453678634|FG002|Overall Study|Not treated|0|||
126105448|NCT00960531|453678640|FG000|Overall Study|Lack of Efficacy|1|||
126105449|NCT00960531|453678641|FG001|Overall Study|Lack of Efficacy|0|||
126105450|NCT00960531|453678642|FG002|Overall Study|Lack of Efficacy|0|||
126105451|NCT00960531|453678643|FG003|Overall Study|Lack of Efficacy|0|||
126105452|NCT00960531|453678644|FG004|Overall Study|Lack of Efficacy|0|||
126105453|NCT00960531|453678645|FG005|Overall Study|Lack of Efficacy|0|||
126105454|NCT00960531|453678646|FG006|Overall Study|Lack of Efficacy|0|||
126105455|NCT00960531|453678647|FG007|Overall Study|Lack of Efficacy|0|||
126105456|NCT00960531|453678648|FG008|Overall Study|Lack of Efficacy|0|||
126105457|NCT00960531|453678649|FG009|Overall Study|Lack of Efficacy|0|||
126105458|NCT00960531|453678640|FG000|Overall Study|Withdrawal by Subject|1|||
126105459|NCT00960531|453678641|FG001|Overall Study|Withdrawal by Subject|0|||
126105460|NCT00960531|453678642|FG002|Overall Study|Withdrawal by Subject|5|||
126105461|NCT00960531|453678643|FG003|Overall Study|Withdrawal by Subject|2|||
126105462|NCT00960531|453678644|FG004|Overall Study|Withdrawal by Subject|0|||
126105463|NCT00960531|453678645|FG005|Overall Study|Withdrawal by Subject|0|||
126105464|NCT00960531|453678646|FG006|Overall Study|Withdrawal by Subject|2|||
126105465|NCT00960531|453678647|FG007|Overall Study|Withdrawal by Subject|0|||
126105466|NCT00960531|453678648|FG008|Overall Study|Withdrawal by Subject|1|||
126105467|NCT00960531|453678649|FG009|Overall Study|Withdrawal by Subject|0|||
126105468|NCT00960531|453678640|FG000|Overall Study|Caregiver Request|2|||
126105469|NCT00960531|453678641|FG001|Overall Study|Caregiver Request|0|||
125891317|NCT01349049|452901248|FG005|Overall Study|Adverse Event|3|||
125891318|NCT01349049|452901249|FG006|Overall Study|Adverse Event|1|||
126105470|NCT00960531|453678642|FG002|Overall Study|Caregiver Request|6|||
126105471|NCT00960531|453678643|FG003|Overall Study|Caregiver Request|5|||
126105472|NCT00960531|453678644|FG004|Overall Study|Caregiver Request|0|||
126105473|NCT00960531|453678645|FG005|Overall Study|Caregiver Request|2|||
126105474|NCT00960531|453678646|FG006|Overall Study|Caregiver Request|3|||
126105475|NCT00960531|453678647|FG007|Overall Study|Caregiver Request|1|||
126105476|NCT00960531|453678648|FG008|Overall Study|Caregiver Request|3|||
126105477|NCT00960531|453678649|FG009|Overall Study|Caregiver Request|0|||
126105478|NCT00960531|453678640|FG000|Overall Study|Investigator Request|0|||
126105479|NCT00960531|453678641|FG001|Overall Study|Investigator Request|0|||
126055155|NCT02222493|453496196|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
126055156|NCT02222493|453496195|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
126055157|NCT02222493|453496196|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
126055158|NCT03611075|453496199|FG000|Overall Study|Physician Decision|0|||
126055159|NCT03611075|453496200|FG001|Overall Study|Physician Decision|1|||
126055160|NCT03611075|453496201|FG002|Overall Study|Physician Decision|1|||
126055161|NCT03611075|453496202|FG003|Overall Study|Physician Decision|0|||
126055162|NCT03611075|453496203|FG004|Overall Study|Physician Decision|0|||
126055163|NCT03611075|453496204|FG005|Overall Study|Physician Decision|0|||
126055164|NCT03611075|453496205|FG006|Overall Study|Physician Decision|0|||
126055165|NCT03611075|453496206|FG007|Overall Study|Physician Decision|0|||
126055166|NCT03611075|453496207|FG008|Overall Study|Physician Decision|0|||
126055167|NCT03611075|453496199|FG000|Overall Study|Lost to Follow-up|1|||
126055168|NCT03611075|453496200|FG001|Overall Study|Lost to Follow-up|0|||
126055169|NCT03611075|453496201|FG002|Overall Study|Lost to Follow-up|0|||
126055170|NCT03611075|453496202|FG003|Overall Study|Lost to Follow-up|2|||
126055171|NCT03611075|453496203|FG004|Overall Study|Lost to Follow-up|0|||
126055172|NCT03611075|453496204|FG005|Overall Study|Lost to Follow-up|0|||
126055173|NCT03611075|453496205|FG006|Overall Study|Lost to Follow-up|0|||
126055174|NCT03611075|453496206|FG007|Overall Study|Lost to Follow-up|0|||
126055175|NCT03611075|453496207|FG008|Overall Study|Lost to Follow-up|0|||
126055176|NCT03611075|453496199|FG000|Overall Study|Withdrawal by Subject|0|||
126055177|NCT03611075|453496200|FG001|Overall Study|Withdrawal by Subject|1|||
126055178|NCT03611075|453496201|FG002|Overall Study|Withdrawal by Subject|1|||
126055179|NCT03611075|453496202|FG003|Overall Study|Withdrawal by Subject|1|||
126055180|NCT03611075|453496203|FG004|Overall Study|Withdrawal by Subject|0|||
126055181|NCT03611075|453496204|FG005|Overall Study|Withdrawal by Subject|0|||
126055182|NCT03611075|453496205|FG006|Overall Study|Withdrawal by Subject|1|||
126055183|NCT03611075|453496206|FG007|Overall Study|Withdrawal by Subject|0|||
126055184|NCT03611075|453496207|FG008|Overall Study|Withdrawal by Subject|0|||
126055185|NCT03611075|453496199|FG000|Overall Study|Reason unknown|0|||
126055186|NCT03611075|453496200|FG001|Overall Study|Reason unknown|0|||
126055187|NCT03611075|453496201|FG002|Overall Study|Reason unknown|0|||
126055188|NCT03611075|453496202|FG003|Overall Study|Reason unknown|1|||
126055189|NCT03611075|453496203|FG004|Overall Study|Reason unknown|0|||
126055190|NCT03611075|453496204|FG005|Overall Study|Reason unknown|0|||
126055191|NCT03611075|453496205|FG006|Overall Study|Reason unknown|1|||
126055192|NCT03611075|453496206|FG007|Overall Study|Reason unknown|0|||
126055193|NCT03611075|453496207|FG008|Overall Study|Reason unknown|0|||
126055194|NCT00676091|453496208|FG000|Infant Series|Parent or legal guardian request|10|||
126055195|NCT00676091|453496209|FG001|Infant Series|Parent or legal guardian request|8|||
126055196|NCT00676091|453496208|FG000|Infant Series|Protocol Violation|6|||
126055197|NCT00676091|453496209|FG001|Infant Series|Protocol Violation|3|||
126055198|NCT00676091|453496208|FG000|Infant Series|Adverse Event|2|||
126055199|NCT00676091|453496209|FG001|Infant Series|Adverse Event|3|||
126055200|NCT00676091|453496208|FG000|Infant Series|Failed to return|1|||
126055201|NCT00676091|453496209|FG001|Infant Series|Failed to return|3|||
126055202|NCT00676091|453496208|FG000|Infant Series|Lost to Follow-up|1|||
126055203|NCT00676091|453496209|FG001|Infant Series|Lost to Follow-up|0|||
126055204|NCT00676091|453496208|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
126055205|NCT00676091|453496209|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
126055206|NCT00676091|453496208|FG000|After Infant Series|Adverse Event|0|||
126055207|NCT00676091|453496209|FG001|After Infant Series|Adverse Event|1|||
126055208|NCT00676091|453496208|FG000|After Infant Series|Protocol Violation|0|||
126055209|NCT00676091|453496209|FG001|After Infant Series|Protocol Violation|1|||
126055210|NCT00676091|453496208|FG000|After Infant Series|Failed to return|1|||
126055211|NCT00676091|453496209|FG001|After Infant Series|Failed to return|1|||
126055212|NCT00676091|453496208|FG000|Toddler Dose|Failed to return|2|||
126055213|NCT00676091|453496209|FG001|Toddler Dose|Failed to return|0|||
126055214|NCT00676091|453496208|FG000|Toddler Dose|Parent or legal guardian request|1|||
126055215|NCT00676091|453496209|FG001|Toddler Dose|Parent or legal guardian request|0|||
125891319|NCT01349049|452901250|FG007|Overall Study|Adverse Event|0|||
126055216|NCT01701401|453496213|FG000|Overall Study|Randomized But Not Treated|3|||
126055217|NCT01701401|453496214|FG001|Overall Study|Randomized But Not Treated|1|||
126055218|NCT01701401|453496215|FG002|Overall Study|Randomized But Not Treated|0|||
126055219|NCT01701401|453496216|FG003|Overall Study|Randomized But Not Treated|1|||
126055220|NCT01701401|453496213|FG000|Overall Study|Lost to Follow-up|5|||
126055221|NCT01701401|453496214|FG001|Overall Study|Lost to Follow-up|5|||
126055222|NCT01701401|453496215|FG002|Overall Study|Lost to Follow-up|1|||
126055223|NCT01701401|453496216|FG003|Overall Study|Lost to Follow-up|3|||
126055224|NCT01701401|453496213|FG000|Overall Study|Withdrew Consent|0|||
126055225|NCT01701401|453496214|FG001|Overall Study|Withdrew Consent|3|||
126055226|NCT01701401|453496215|FG002|Overall Study|Withdrew Consent|1|||
126055227|NCT01701401|453496216|FG003|Overall Study|Withdrew Consent|2|||
126055228|NCT01701401|453496213|FG000|Overall Study|Lack of Efficacy|1|||
126055229|NCT01701401|453496214|FG001|Overall Study|Lack of Efficacy|0|||
126055230|NCT01701401|453496215|FG002|Overall Study|Lack of Efficacy|2|||
126055231|NCT01701401|453496216|FG003|Overall Study|Lack of Efficacy|0|||
125891320|NCT01349049|452901251|FG008|Overall Study|Adverse Event|4|||
125891321|NCT01349049|452901243|FG000|Overall Study|Physician Decision|0|||
126105480|NCT00960531|453678642|FG002|Overall Study|Investigator Request|1|||
126105481|NCT00960531|453678643|FG003|Overall Study|Investigator Request|0|||
126105482|NCT00960531|453678644|FG004|Overall Study|Investigator Request|0|||
126105483|NCT00960531|453678645|FG005|Overall Study|Investigator Request|0|||
126105484|NCT00960531|453678646|FG006|Overall Study|Investigator Request|0|||
126105485|NCT00960531|453678647|FG007|Overall Study|Investigator Request|0|||
126105486|NCT00960531|453678648|FG008|Overall Study|Investigator Request|0|||
126105487|NCT00960531|453678649|FG009|Overall Study|Investigator Request|0|||
126105488|NCT00960531|453678640|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
126105489|NCT00960531|453678641|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126105490|NCT00960531|453678642|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
126105491|NCT00960531|453678643|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
126105492|NCT00960531|453678644|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
126105493|NCT00960531|453678645|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
126105494|NCT00960531|453678646|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
126105495|NCT00960531|453678647|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
126105496|NCT00960531|453678648|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
126105497|NCT00960531|453678649|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
126105498|NCT00960531|453678640|FG000|Overall Study|Lost to Follow-up|0|||
126105499|NCT00960531|453678641|FG001|Overall Study|Lost to Follow-up|0|||
126105500|NCT00960531|453678642|FG002|Overall Study|Lost to Follow-up|1|||
126105501|NCT00960531|453678643|FG003|Overall Study|Lost to Follow-up|0|||
126105502|NCT00960531|453678644|FG004|Overall Study|Lost to Follow-up|0|||
126105503|NCT00960531|453678645|FG005|Overall Study|Lost to Follow-up|0|||
126105504|NCT00960531|453678646|FG006|Overall Study|Lost to Follow-up|1|||
126105505|NCT00960531|453678647|FG007|Overall Study|Lost to Follow-up|0|||
126105506|NCT00960531|453678648|FG008|Overall Study|Lost to Follow-up|0|||
126105507|NCT00960531|453678649|FG009|Overall Study|Lost to Follow-up|0|||
126105508|NCT00960531|453678640|FG000|Overall Study|Failed to Return|2|||
126105509|NCT00960531|453678641|FG001|Overall Study|Failed to Return|0|||
126105510|NCT00960531|453678642|FG002|Overall Study|Failed to Return|0|||
126105511|NCT00960531|453678643|FG003|Overall Study|Failed to Return|0|||
126105512|NCT00960531|453678644|FG004|Overall Study|Failed to Return|0|||
126105513|NCT00960531|453678645|FG005|Overall Study|Failed to Return|0|||
126105514|NCT00960531|453678646|FG006|Overall Study|Failed to Return|0|||
126105515|NCT00960531|453678647|FG007|Overall Study|Failed to Return|2|||
126105516|NCT00960531|453678648|FG008|Overall Study|Failed to Return|0|||
126105517|NCT00960531|453678649|FG009|Overall Study|Failed to Return|0|||
126105518|NCT00960531|453678640|FG000|Overall Study|Adverse Event (AE)|2|||
126105519|NCT00960531|453678641|FG001|Overall Study|Adverse Event (AE)|0|||
126105520|NCT00960531|453678642|FG002|Overall Study|Adverse Event (AE)|0|||
126105521|NCT00960531|453678643|FG003|Overall Study|Adverse Event (AE)|0|||
126105522|NCT00960531|453678644|FG004|Overall Study|Adverse Event (AE)|0|||
126105523|NCT00960531|453678645|FG005|Overall Study|Adverse Event (AE)|1|||
126105524|NCT00960531|453678646|FG006|Overall Study|Adverse Event (AE)|2|||
126105525|NCT00960531|453678647|FG007|Overall Study|Adverse Event (AE)|0|||
126105526|NCT00960531|453678648|FG008|Overall Study|Adverse Event (AE)|2|||
126105527|NCT00960531|453678649|FG009|Overall Study|Adverse Event (AE)|0|||
126105528|NCT00960531|453678640|FG000|Overall Study|Reason not Specified|2|||
126105529|NCT00960531|453678641|FG001|Overall Study|Reason not Specified|1|||
126105530|NCT00960531|453678642|FG002|Overall Study|Reason not Specified|13|||
126105531|NCT00960531|453678643|FG003|Overall Study|Reason not Specified|1|||
126105532|NCT00960531|453678644|FG004|Overall Study|Reason not Specified|2|||
126105533|NCT00960531|453678645|FG005|Overall Study|Reason not Specified|0|||
126105534|NCT00960531|453678646|FG006|Overall Study|Reason not Specified|16|||
126105535|NCT00960531|453678647|FG007|Overall Study|Reason not Specified|0|||
126105536|NCT00960531|453678648|FG008|Overall Study|Reason not Specified|8|||
126105537|NCT00960531|453678649|FG009|Overall Study|Reason not Specified|1|||
126105538|NCT01163916|453678650|FG000|Overall Study|Withdrawal by Subject|2|||
126105539|NCT01163916|453678651|FG001|Overall Study|Withdrawal by Subject|0|||
126105540|NCT01163916|453678652|FG002|Overall Study|Withdrawal by Subject|2|||
126105541|NCT01163916|453678650|FG000|Overall Study|Adverse Event|2|||
126105542|NCT01163916|453678651|FG001|Overall Study|Adverse Event|0|||
126105543|NCT01163916|453678652|FG002|Overall Study|Adverse Event|1|||
126105544|NCT01163916|453678650|FG000|Overall Study|Lack of Efficacy|2|||
126105545|NCT01163916|453678651|FG001|Overall Study|Lack of Efficacy|0|||
126105546|NCT01163916|453678652|FG002|Overall Study|Lack of Efficacy|1|||
126105547|NCT01163916|453678650|FG000|Overall Study|Other|24|||
126105548|NCT01163916|453678651|FG001|Overall Study|Other|4|||
126105549|NCT01163916|453678652|FG002|Overall Study|Other|16|||
126105550|NCT00883051|453678653|FG000|Overall Study|Lost to Follow-up|0|||
126105551|NCT00883051|453678654|FG001|Overall Study|Lost to Follow-up|0|||
126105552|NCT00883051|453678655|FG002|Overall Study|Lost to Follow-up|0|||
126105553|NCT00883051|453678656|FG003|Overall Study|Lost to Follow-up|0|||
126105554|NCT00883051|453678657|FG004|Overall Study|Lost to Follow-up|1|||
126105555|NCT00883051|453678653|FG000|Overall Study|Did not use study medication|24|||
125891322|NCT01349049|452901244|FG001|Overall Study|Physician Decision|1|||
125891323|NCT01349049|452901245|FG002|Overall Study|Physician Decision|0|||
125891324|NCT01349049|452901246|FG003|Overall Study|Physician Decision|0|||
125891325|NCT01349049|452901247|FG004|Overall Study|Physician Decision|0|||
126055232|NCT01701401|453496213|FG000|Overall Study|Adverse Event|1|||
126055233|NCT01701401|453496214|FG001|Overall Study|Adverse Event|0|||
126055234|NCT01701401|453496215|FG002|Overall Study|Adverse Event|0|||
126055235|NCT01701401|453496216|FG003|Overall Study|Adverse Event|0|||
126055236|NCT01701401|453496213|FG000|Overall Study|Protocol Violation|0|||
126055237|NCT01701401|453496214|FG001|Overall Study|Protocol Violation|0|||
125891326|NCT01349049|452901248|FG005|Overall Study|Physician Decision|0|||
125891327|NCT01349049|452901249|FG006|Overall Study|Physician Decision|0|||
126105556|NCT00883051|453678654|FG001|Overall Study|Did not use study medication|22|||
126105557|NCT00883051|453678655|FG002|Overall Study|Did not use study medication|29|||
126105558|NCT00883051|453678656|FG003|Overall Study|Did not use study medication|29|||
126105559|NCT00883051|453678657|FG004|Overall Study|Did not use study medication|17|||
126105560|NCT02337751|453678658|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
126105561|NCT02337751|453678659|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
126105562|NCT02337751|453678658|FG000|Overall Study|Voluntary Withdrawal|6|||
126105563|NCT02337751|453678659|FG001|Overall Study|Voluntary Withdrawal|8|||
126105564|NCT02337751|453678658|FG000|Overall Study|Lack of Efficacy|2|||
126105565|NCT02337751|453678659|FG001|Overall Study|Lack of Efficacy|5|||
126105566|NCT02337751|453678658|FG000|Overall Study|Investigator's Judgement|1|||
126105567|NCT02337751|453678659|FG001|Overall Study|Investigator's Judgement|0|||
126105568|NCT02656823|453678666|FG000|Overall Study|Adverse Event|3|||
126105569|NCT02656823|453678666|FG000|Overall Study|Lost to Follow-up|2|||
126105570|NCT01910181|453678667|FG000|Overall Study|Death|37|||
126105571|NCT01910181|453678667|FG000|Overall Study|Lost to Follow-up|3|||
126105572|NCT01910181|453678667|FG000|Overall Study|Study Terminated by Sponsor|6|||
126105573|NCT05269355|453678668|FG000|Overall Study|Progressive Disease|104|||
126105574|NCT05269355|453678669|FG001|Overall Study|Progressive Disease|68|||
126105575|NCT05269355|453678668|FG000|Overall Study|Study Terminated by Sponsor|87|||
126105576|NCT05269355|453678669|FG001|Overall Study|Study Terminated by Sponsor|29|||
126105577|NCT05269355|453678668|FG000|Overall Study|Adverse Event|15|||
126105578|NCT05269355|453678669|FG001|Overall Study|Adverse Event|8|||
126105579|NCT05269355|453678668|FG000|Overall Study|Withdrawal by Subject|18|||
126105580|NCT05269355|453678669|FG001|Overall Study|Withdrawal by Subject|5|||
126105581|NCT05269355|453678668|FG000|Overall Study|Physician Decision|6|||
126105582|NCT05269355|453678669|FG001|Overall Study|Physician Decision|4|||
126105583|NCT05269355|453678668|FG000|Overall Study|Death|3|||
126105584|NCT05269355|453678669|FG001|Overall Study|Death|5|||
126105585|NCT05269355|453678668|FG000|Overall Study|Other Than Specified|5|||
126105586|NCT05269355|453678669|FG001|Overall Study|Other Than Specified|1|||
126105587|NCT05269355|453678668|FG000|Overall Study|Randomized But Not Treated|1|||
126105588|NCT05269355|453678669|FG001|Overall Study|Randomized But Not Treated|0|||
126105589|NCT00959647|453678671|FG000|Overall Study|Adverse Event|2|||
126105590|NCT00959647|453678671|FG000|Overall Study|Progressive disease|6|||
126105591|NCT00959647|453678671|FG000|Overall Study|Study terminated by sponsor|4|||
126105592|NCT00959647|453678671|FG000|Overall Study|Withdrawal by Subject|7|||
126105593|NCT01340196|453681094|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
126105594|NCT01620255|453681097|FG000|Overall Study|Withdrawal by Subject|4|||
126105595|NCT01620255|453681098|FG001|Overall Study|Withdrawal by Subject|1|||
126105596|NCT01620255|453681099|FG002|Overall Study|Withdrawal by Subject|1|||
126105597|NCT01620255|453681100|FG003|Overall Study|Withdrawal by Subject|2|||
126105598|NCT01620255|453681101|FG004|Overall Study|Withdrawal by Subject|4|||
126105599|NCT01620255|453681097|FG000|Overall Study|Participant underwent fecal transplant|0|||
126105600|NCT01620255|453681098|FG001|Overall Study|Participant underwent fecal transplant|0|||
126105601|NCT01620255|453681099|FG002|Overall Study|Participant underwent fecal transplant|1|||
125891328|NCT01349049|452901250|FG007|Overall Study|Physician Decision|0|||
125891329|NCT01349049|452901251|FG008|Overall Study|Physician Decision|2|||
125891330|NCT01349049|452901243|FG000|Overall Study|Protocol Violation|0|||
125891331|NCT01349049|452901244|FG001|Overall Study|Protocol Violation|0|||
125891332|NCT01349049|452901245|FG002|Overall Study|Protocol Violation|0|||
125891333|NCT01349049|452901246|FG003|Overall Study|Protocol Violation|0|||
125891334|NCT01349049|452901247|FG004|Overall Study|Protocol Violation|0|||
125891335|NCT01349049|452901248|FG005|Overall Study|Protocol Violation|0|||
125891336|NCT01349049|452901249|FG006|Overall Study|Protocol Violation|0|||
125891337|NCT01349049|452901250|FG007|Overall Study|Protocol Violation|0|||
125891338|NCT01349049|452901251|FG008|Overall Study|Protocol Violation|1|||
125891339|NCT01349049|452901243|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
125891340|NCT01349049|452901244|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
126055238|NCT01701401|453496215|FG002|Overall Study|Protocol Violation|1|||
126055239|NCT01701401|453496216|FG003|Overall Study|Protocol Violation|0|||
126055240|NCT00933270|453496217|FG000|Overall Study|Withdrawal by Subject|26|||
126055241|NCT00933270|453496217|FG000|Overall Study|Insufficient Follow-up|10|||
126055242|NCT00933270|453496217|FG000|Overall Study|Lost to Follow-up|14|||
126055243|NCT00933270|453496217|FG000|Overall Study|Adverse Event|1|||
126055244|NCT00933270|453496217|FG000|Overall Study|Missed Visit|2|||
126055245|NCT00933270|453496217|FG000|Overall Study|Death|24|||
126055246|NCT00933270|453496217|FG000|Overall Study|Moved or would not return|10|||
126055247|NCT00989196|453496218|FG000|Treatment Period|Lost to Follow-up|1|||
126055248|NCT00989196|453496219|FG001|Treatment Period|Lost to Follow-up|0|||
126055249|NCT01000805|453496220|FG000|Overall Study|Adverse Event|21|||
126055250|NCT01000805|453496221|FG001|Overall Study|Adverse Event|9|||
126055251|NCT01000805|453496220|FG000|Overall Study|Lack of Efficacy|5|||
126055252|NCT01000805|453496221|FG001|Overall Study|Lack of Efficacy|16|||
126055253|NCT01000805|453496220|FG000|Overall Study|Lost to Follow-up|16|||
126055254|NCT01000805|453496221|FG001|Overall Study|Lost to Follow-up|21|||
126055255|NCT01000805|453496220|FG000|Overall Study|Physician Decision|0|||
126055256|NCT01000805|453496221|FG001|Overall Study|Physician Decision|1|||
126055257|NCT01000805|453496220|FG000|Overall Study|Protocol Violation|12|||
126055258|NCT01000805|453496221|FG001|Overall Study|Protocol Violation|8|||
126055259|NCT01000805|453496220|FG000|Overall Study|Withdrawal by Subject|16|||
126055260|NCT01000805|453496221|FG001|Overall Study|Withdrawal by Subject|6|||
126055261|NCT01000805|453496220|FG000|Overall Study|Sponsor Decision|0|||
126055262|NCT01000805|453496221|FG001|Overall Study|Sponsor Decision|1|||
126055263|NCT03476798|453496224|FG000|Overall Study|Death|1|||
126055264|NCT03476798|453496224|FG000|Overall Study|Withdrawal by Subject|2|||
126055265|NCT03476798|453496224|FG000|Overall Study|Protocol Violation|2|||
126055266|NCT02409680|453496229|FG000|Overall Study|Lost to Follow-up|15|||
126055267|NCT02409680|453496230|FG001|Overall Study|Lost to Follow-up|30|||
126055268|NCT03343704|453496234|FG000|Overall Study|Refused to complete follow up|0|||
126055269|NCT03343704|453496235|FG001|Overall Study|Refused to complete follow up|1|||
126055270|NCT03343704|453496234|FG000|Overall Study|Death|0|||
126055271|NCT03343704|453496235|FG001|Overall Study|Death|1|||
126055272|NCT03343704|453496234|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
126055273|NCT03343704|453496235|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
126055274|NCT03789656|453496240|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
126055275|NCT03789656|453496241|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
126055276|NCT03789656|453496242|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
126055277|NCT03789656|453496243|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
126055278|NCT03789656|453496244|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
126055279|NCT03789656|453496240|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
126055280|NCT03789656|453496241|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
126055281|NCT03789656|453496242|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
126055282|NCT03789656|453496243|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
126055283|NCT03789656|453496244|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
126055284|NCT03789656|453496240|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
126055285|NCT03789656|453496241|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
126055286|NCT03789656|453496242|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
126055287|NCT03789656|453496243|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
126055288|NCT03789656|453496244|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
126055289|NCT03789656|453496240|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
126055290|NCT03789656|453496241|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
126055291|NCT03789656|453496242|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
126055292|NCT03789656|453496243|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
126055293|NCT03789656|453496244|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
126055294|NCT02434328|453496252|FG000|Overall Study|Adverse Event|9|||
126055295|NCT02434328|453496253|FG001|Overall Study|Adverse Event|4|||
126055296|NCT02434328|453496252|FG000|Overall Study|Lack of Efficacy|0|||
126055297|NCT02434328|453496253|FG001|Overall Study|Lack of Efficacy|2|||
126055298|NCT02434328|453496252|FG000|Overall Study|Physician Decision|0|||
126055299|NCT02434328|453496253|FG001|Overall Study|Physician Decision|1|||
126055300|NCT02434328|453496252|FG000|Overall Study|Withdrawal by Subject|12|||
126055301|NCT02434328|453496253|FG001|Overall Study|Withdrawal by Subject|21|||
126055302|NCT02434328|453496252|FG000|Overall Study|Death|4|||
126055303|NCT02434328|453496253|FG001|Overall Study|Death|7|||
126055304|NCT02434328|453496252|FG000|Overall Study|Lost to Follow-up|1|||
126055305|NCT02434328|453496253|FG001|Overall Study|Lost to Follow-up|6|||
126055306|NCT02434328|453496252|FG000|Overall Study|Other|4|||
126055307|NCT02434328|453496253|FG001|Overall Study|Other|1|||
126055308|NCT00302211|453496260|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
126105602|NCT01620255|453681100|FG003|Overall Study|Participant underwent fecal transplant|0|||
125891341|NCT01349049|452901245|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
125891342|NCT01349049|452901246|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
125891343|NCT01349049|452901247|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
125891344|NCT01349049|452901248|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
125891345|NCT01349049|452901249|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
125891346|NCT01349049|452901250|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
125891347|NCT01349049|452901251|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
125891348|NCT01349049|452901243|FG000|Overall Study|Other|0|||
125891349|NCT01349049|452901244|FG001|Overall Study|Other|0|||
125891350|NCT01349049|452901245|FG002|Overall Study|Other|0|||
125891351|NCT01349049|452901246|FG003|Overall Study|Other|0|||
125891352|NCT01349049|452901247|FG004|Overall Study|Other|0|||
125891353|NCT01349049|452901248|FG005|Overall Study|Other|1|||
125891354|NCT01349049|452901249|FG006|Overall Study|Other|0|||
125891355|NCT01349049|452901250|FG007|Overall Study|Other|0|||
125891356|NCT01349049|452901251|FG008|Overall Study|Other|4|||
125891357|NCT01349049|452901243|FG000|Overall Study|Death|0|||
126055309|NCT00302211|453496261|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
126055310|NCT00302211|453496262|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
125891358|NCT01349049|452901244|FG001|Overall Study|Death|0|||
125891359|NCT01349049|452901245|FG002|Overall Study|Death|0|||
125891360|NCT01349049|452901246|FG003|Overall Study|Death|0|||
125891361|NCT01349049|452901247|FG004|Overall Study|Death|0|||
125891362|NCT01349049|452901248|FG005|Overall Study|Death|0|||
125891363|NCT01349049|452901249|FG006|Overall Study|Death|0|||
126055311|NCT00302211|453496263|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
126055312|NCT00302211|453496264|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
126055313|NCT00302211|453496260|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
126055314|NCT00302211|453496261|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
125891364|NCT01349049|452901250|FG007|Overall Study|Death|1|||
125891365|NCT01349049|452901251|FG008|Overall Study|Death|5|||
125891366|NCT01349049|452901243|FG000|Overall Study|Non-compliance|0|||
125891367|NCT01349049|452901244|FG001|Overall Study|Non-compliance|0|||
125891368|NCT01349049|452901245|FG002|Overall Study|Non-compliance|0|||
125891369|NCT01349049|452901246|FG003|Overall Study|Non-compliance|1|||
125891370|NCT01349049|452901247|FG004|Overall Study|Non-compliance|0|||
125891371|NCT01349049|452901248|FG005|Overall Study|Non-compliance|0|||
126055315|NCT00302211|453496262|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
126055316|NCT00302211|453496263|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
126055317|NCT00302211|453496264|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
126055318|NCT00302211|453496260|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
126055319|NCT00302211|453496261|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
125891372|NCT01349049|452901249|FG006|Overall Study|Non-compliance|0|||
126055320|NCT00302211|453496262|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
126055321|NCT00302211|453496263|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
126055322|NCT00302211|453496264|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
126055323|NCT00302211|453496260|FG000|Double Blind Period (New Patients)|Disease progression|0|||
126055324|NCT00302211|453496261|FG001|Double Blind Period (New Patients)|Disease progression|1|||
126055325|NCT00302211|453496262|FG002|Double Blind Period (New Patients)|Disease progression|1|||
126055326|NCT00302211|453496263|FG003|Double Blind Period (New Patients)|Disease progression|0|||
126055327|NCT00302211|453496264|FG004|Double Blind Period (New Patients)|Disease progression|0|||
126055328|NCT00302211|453496260|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
126055329|NCT00302211|453496261|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
126055330|NCT00302211|453496262|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
126055331|NCT00302211|453496263|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
126055332|NCT00302211|453496264|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
126055333|NCT00302211|453496260|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
126055334|NCT00302211|453496261|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
126055335|NCT00302211|453496262|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
126055336|NCT00302211|453496263|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
126055337|NCT00302211|453496264|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
126055338|NCT00302211|453496260|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
126055339|NCT00302211|453496261|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
126055340|NCT00302211|453496262|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
126055341|NCT00302211|453496263|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
126055342|NCT00302211|453496264|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
126055343|NCT00302211|453496260|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
126055344|NCT00302211|453496261|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
126055345|NCT00302211|453496262|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
126055346|NCT00302211|453496263|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
126055347|NCT00302211|453496264|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
126055348|NCT00302211|453496260|FG000|Open Label-Patients From Double-Blind|Death|0|||
126055349|NCT00302211|453496261|FG001|Open Label-Patients From Double-Blind|Death|0|||
125891373|NCT01349049|452901250|FG007|Overall Study|Non-compliance|0|||
126055350|NCT00302211|453496262|FG002|Open Label-Patients From Double-Blind|Death|0|||
126055351|NCT00302211|453496263|FG003|Open Label-Patients From Double-Blind|Death|1|||
126055352|NCT00302211|453496264|FG004|Open Label-Patients From Double-Blind|Death|1|||
126055353|NCT00302211|453496260|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
126055354|NCT00302211|453496261|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
126055355|NCT00302211|453496262|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
126055356|NCT00302211|453496263|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
126055357|NCT00302211|453496264|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
126055358|NCT00302211|453496260|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
126055359|NCT00302211|453496261|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
126055360|NCT00302211|453496262|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
125891374|NCT01349049|452901251|FG008|Overall Study|Non-compliance|0|||
126055361|NCT00302211|453496263|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
126055362|NCT00302211|453496264|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
126105603|NCT01620255|453681101|FG004|Overall Study|Participant underwent fecal transplant|0|||
126055363|NCT00302211|453496260|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
126055364|NCT00302211|453496261|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
126055365|NCT00302211|453496262|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
126055366|NCT00302211|453496263|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
126055367|NCT00302211|453496264|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
126055368|NCT02294461|453496265|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
126055369|NCT02294461|453496266|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
126055370|NCT02294461|453496267|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
126055371|NCT02294461|453496265|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
126055372|NCT02294461|453496266|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
126055373|NCT02294461|453496267|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
126055374|NCT02294461|453496265|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
126055375|NCT02294461|453496266|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
126055376|NCT02294461|453496267|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
126055377|NCT02294461|453496265|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
126055378|NCT02294461|453496266|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
126055379|NCT02294461|453496267|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
126055380|NCT02294461|453496265|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
126055381|NCT02294461|453496266|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
126055382|NCT02294461|453496267|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
126055383|NCT02294461|453496265|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
126055384|NCT02294461|453496266|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
125891375|NCT01349049|452901243|FG000|Overall Study|Withdrawal by Subject|0|||
125891376|NCT01349049|452901244|FG001|Overall Study|Withdrawal by Subject|0|||
125891377|NCT01349049|452901245|FG002|Overall Study|Withdrawal by Subject|0|||
125891378|NCT01349049|452901246|FG003|Overall Study|Withdrawal by Subject|0|||
125891379|NCT01349049|452901247|FG004|Overall Study|Withdrawal by Subject|0|||
126055385|NCT02294461|453496267|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
126055386|NCT02294461|453496265|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
126105604|NCT01620255|453681097|FG000|Overall Study|Non-compliance|0|||
126055387|NCT02294461|453496266|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
126055388|NCT02294461|453496267|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
126055389|NCT02294461|453496265|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
126055390|NCT02294461|453496266|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
126105605|NCT01620255|453681098|FG001|Overall Study|Non-compliance|1|||
126105606|NCT01620255|453681099|FG002|Overall Study|Non-compliance|0|||
125891380|NCT01349049|452901248|FG005|Overall Study|Withdrawal by Subject|0|||
125891381|NCT01349049|452901249|FG006|Overall Study|Withdrawal by Subject|0|||
125891382|NCT01349049|452901250|FG007|Overall Study|Withdrawal by Subject|0|||
125891383|NCT01349049|452901251|FG008|Overall Study|Withdrawal by Subject|6|||
125891384|NCT02810444|452901256|FG000|Overall Study|Screen Failures|14|||
125891385|NCT02810444|452901256|FG000|Overall Study|Withdrawal by Subject|4|||
125891386|NCT02810444|452901256|FG000|Overall Study|Adverse Event|3|||
125891387|NCT01139008|452901257|FG000|Overall Study|Withdrawal by Subject|5|||
125891388|NCT01139008|452901257|FG000|Overall Study|Non-compliant, lost product|1|||
125891389|NCT01715857|452901258|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
125891390|NCT02785770|452901259|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
125891391|NCT02785770|452901260|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
125891392|NCT02785770|452901261|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
125891393|NCT02785770|452901262|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
125891394|NCT02785770|452901259|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
125891395|NCT02785770|452901260|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
125891396|NCT02785770|452901261|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
125891397|NCT02785770|452901262|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
125891398|NCT02785770|452901259|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
125891399|NCT02785770|452901260|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
125891400|NCT02785770|452901261|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
125891401|NCT02785770|452901262|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
125891402|NCT00505778|452901266|FG000|Overall Study|Adverse Event|2|||
125891403|NCT00505778|452901267|FG001|Overall Study|Adverse Event|7|||
125891404|NCT00505778|452901266|FG000|Overall Study|Physician Decision|8|||
125891405|NCT00505778|452901267|FG001|Overall Study|Physician Decision|14|||
125891406|NCT00505778|452901266|FG000|Overall Study|Lost to Follow-up|17|||
125891407|NCT00505778|452901267|FG001|Overall Study|Lost to Follow-up|23|||
125891408|NCT00505778|452901266|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
125891409|NCT00505778|452901267|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
125891410|NCT00505778|452901266|FG000|Overall Study|Protocol Violation|7|||
125891411|NCT00505778|452901267|FG001|Overall Study|Protocol Violation|9|||
125891412|NCT00505778|452901266|FG000|Overall Study|Withdrawal by Subject|29|||
125891413|NCT00505778|452901267|FG001|Overall Study|Withdrawal by Subject|14|||
125891414|NCT00505778|452901266|FG000|Overall Study|Relapse|65|||
125891415|NCT00505778|452901267|FG001|Overall Study|Relapse|65|||
125891416|NCT00505778|452901266|FG000|Overall Study|Took No Study Drug|2|||
125891417|NCT00505778|452901267|FG001|Overall Study|Took No Study Drug|2|||
125891418|NCT02078960|452901271|FG000|Treatment Period|Other|0|||
125891419|NCT02078960|452901272|FG001|Treatment Period|Other|0|||
125891420|NCT02078960|452901273|FG002|Treatment Period|Other|1|||
125891421|NCT02078960|452901271|FG000|Treatment Period|Lack of Efficacy|0|||
125891422|NCT02078960|452901272|FG001|Treatment Period|Lack of Efficacy|1|||
125891423|NCT02078960|452901273|FG002|Treatment Period|Lack of Efficacy|0|||
125891424|NCT02078960|452901271|FG000|Treatment Period|Disease progression - accelerated phase|0|||
125891425|NCT02078960|452901272|FG001|Treatment Period|Disease progression - accelerated phase|1|||
125891426|NCT02078960|452901273|FG002|Treatment Period|Disease progression - accelerated phase|0|||
126055391|NCT02294461|453496267|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
126105607|NCT01620255|453681100|FG003|Overall Study|Non-compliance|0|||
125891427|NCT02078960|452901271|FG000|Treatment Period|Disease progression - blast phase|1|||
125891428|NCT02078960|452901272|FG001|Treatment Period|Disease progression - blast phase|0|||
125891429|NCT02078960|452901273|FG002|Treatment Period|Disease progression - blast phase|0|||
125891430|NCT02078960|452901271|FG000|Treatment Period|Withdrawal by Subject|0|||
125891431|NCT02078960|452901272|FG001|Treatment Period|Withdrawal by Subject|1|||
125891432|NCT02078960|452901273|FG002|Treatment Period|Withdrawal by Subject|1|||
125891433|NCT02078960|452901271|FG000|Treatment Period|Adverse Event|1|||
125891434|NCT02078960|452901272|FG001|Treatment Period|Adverse Event|0|||
125891435|NCT02078960|452901273|FG002|Treatment Period|Adverse Event|0|||
125891436|NCT02078960|452901271|FG000|Treatment Period|Death|0|||
125891437|NCT02078960|452901272|FG001|Treatment Period|Death|0|||
125891438|NCT02078960|452901273|FG002|Treatment Period|Death|1|||
125891439|NCT02078960|452901271|FG000|Follow-up Period|Death|2|||
125891440|NCT02078960|452901272|FG001|Follow-up Period|Death|0|||
126055392|NCT02294461|453496265|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
126055393|NCT02294461|453496266|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
125891441|NCT02078960|452901273|FG002|Follow-up Period|Death|0|||
126055394|NCT02294461|453496267|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
126055395|NCT02294461|453496265|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
126055396|NCT02294461|453496266|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
126055397|NCT02294461|453496267|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
126055398|NCT02294461|453496265|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
126055399|NCT02294461|453496266|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
126055400|NCT02294461|453496267|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
126055401|NCT02294461|453496265|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
126055402|NCT02294461|453496266|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
126055403|NCT02294461|453496267|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
126055404|NCT02294461|453496265|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
126055405|NCT02294461|453496266|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
126055406|NCT02294461|453496267|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
126055407|NCT02294461|453496265|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
126055408|NCT02294461|453496266|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
126055409|NCT02294461|453496267|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
126055410|NCT05432986|453496268|FG000|Overall Study|Withdrawal by Subject|2|||
126055411|NCT05432986|453496268|FG000|Overall Study|incomplete measurement|7|||
126055412|NCT03009344|453497433|FG000|Overall Study|Lack of Efficacy|5|||
126055413|NCT03009344|453497433|FG000|Overall Study|Withdrawal by Subject|1|||
126055414|NCT03009344|453497433|FG000|Overall Study|Adverse Event|1|||
126055415|NCT00378898|453497434|FG000|Overall Study|Withdrawal by Subject|10|||
126055416|NCT00378898|453497435|FG001|Overall Study|Withdrawal by Subject|5|||
126055417|NCT00378898|453497434|FG000|Overall Study|Protocol Violation|1|||
126055418|NCT00378898|453497435|FG001|Overall Study|Protocol Violation|1|||
126055419|NCT02534233|453497438|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
126055420|NCT00551421|453497439|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
126055421|NCT03136159|453497441|FG000|Overall Study|chorioamnionitis|2|||
126055422|NCT03136159|453497442|FG001|Overall Study|chorioamnionitis|0|||
126055423|NCT03136159|453497441|FG000|Overall Study|vertical skin incision|1|||
126055424|NCT03136159|453497442|FG001|Overall Study|vertical skin incision|0|||
126055425|NCT03136159|453497441|FG000|Overall Study|additional dressing|1|||
126055426|NCT03136159|453497442|FG001|Overall Study|additional dressing|0|||
126055427|NCT03136159|453497441|FG000|Overall Study|never got dressing placed|1|||
126055428|NCT03136159|453497442|FG001|Overall Study|never got dressing placed|0|||
126055429|NCT01732757|453497444|FG000|Overall Study|Lost to Follow-up|1|||
126055430|NCT01732757|453497445|FG001|Overall Study|Lost to Follow-up|0|||
126055431|NCT01732757|453497446|FG002|Overall Study|Lost to Follow-up|0|||
126055432|NCT00089609|453497452|FG000|Overall Study|Withdrawal by Subject|3|||
125891442|NCT02078960|452901271|FG000|Follow-up Period|Lost to Follow-up|0|||
126055433|NCT00089609|453497453|FG001|Overall Study|Withdrawal by Subject|1|||
126055434|NCT03116464|453497454|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
126055435|NCT00597376|453497455|FG000|Overall Study|Withdrawal by Subject|4|||
126055436|NCT00597376|453497456|FG001|Overall Study|Withdrawal by Subject|3|||
126055437|NCT00597376|453497455|FG000|Overall Study|Adverse Event|4|||
126055438|NCT00597376|453497456|FG001|Overall Study|Adverse Event|1|||
126055439|NCT04237792|453497461|FG000|Treatment (Day 1)|Adverse Event|1|||
126055440|NCT04237792|453497462|FG001|Treatment (Day 1)|Adverse Event|0|||
126055441|NCT04237792|453497463|FG002|Treatment (Day 1)|Adverse Event|0|||
126055442|NCT04237792|453497464|FG003|Treatment (Day 1)|Adverse Event|0|||
126055443|NCT04237792|453497465|FG004|Treatment (Day 1)|Adverse Event|1|||
126055444|NCT04237792|453497466|FG005|Treatment (Day 1)|Adverse Event|1|||
125891443|NCT02078960|452901272|FG001|Follow-up Period|Lost to Follow-up|1|||
125891444|NCT02078960|452901273|FG002|Follow-up Period|Lost to Follow-up|0|||
126055445|NCT04237792|453497461|FG000|Treatment (Day 1)|Other|0|||
126055446|NCT04237792|453497462|FG001|Treatment (Day 1)|Other|0|||
126055447|NCT04237792|453497463|FG002|Treatment (Day 1)|Other|1|||
126055448|NCT04237792|453497464|FG003|Treatment (Day 1)|Other|0|||
126055449|NCT04237792|453497465|FG004|Treatment (Day 1)|Other|0|||
126055450|NCT04237792|453497466|FG005|Treatment (Day 1)|Other|1|||
126055451|NCT04237792|453497461|FG000|Treatment (Day 1)|Not treated|1|||
126055452|NCT04237792|453497462|FG001|Treatment (Day 1)|Not treated|1|||
126055453|NCT04237792|453497463|FG002|Treatment (Day 1)|Not treated|2|||
126055454|NCT04237792|453497464|FG003|Treatment (Day 1)|Not treated|1|||
126055455|NCT04237792|453497465|FG004|Treatment (Day 1)|Not treated|0|||
126055456|NCT04237792|453497466|FG005|Treatment (Day 1)|Not treated|1|||
126055457|NCT04693637|453497467|FG000|Overall Study|Death|4|||
126055458|NCT04693637|453497467|FG000|Overall Study|Withdrawal by Subject|3|||
126055459|NCT04693637|453497467|FG000|Overall Study|Physician Decision|2|||
126055460|NCT04693637|453497467|FG000|Overall Study|Lost to Follow-up|1|||
126055461|NCT03205566|453497470|FG000|Phase 1|Protocol Violation|1|||
126055462|NCT03205566|453497471|FG001|Phase 1|Protocol Violation|1|||
126055463|NCT02022670|453497472|FG000|Overall Study|Adverse Event|1|||
126055464|NCT02022670|453497473|FG001|Overall Study|Adverse Event|0|||
126055465|NCT02022670|453497474|FG002|Overall Study|Adverse Event|1|||
126055466|NCT02113449|453497475|FG000|Overall Study|Adverse Event|4|||
126055467|NCT01074242|453497480|FG000|Overall Study|Case report before date of contract|40|||
126055468|NCT01074242|453497480|FG000|Overall Study|Lost to Follow-up|1|||
126055469|NCT01074242|453497480|FG000|Overall Study|Case report unclear|6|||
126055470|NCT01074242|453497480|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
126055471|NCT01074242|453497480|FG000|Overall Study|Duplicate Case Report Form|5|||
126055472|NCT00109031|453497481|FG000|Overall Study|Adverse Event|0|||
126055473|NCT00109031|453497482|FG001|Overall Study|Adverse Event|0|||
126055474|NCT00109031|453497483|FG002|Overall Study|Adverse Event|1|||
126055475|NCT00109031|453497484|FG003|Overall Study|Adverse Event|0|||
126055476|NCT00109031|453497481|FG000|Overall Study|Withdrawal by Subject|0|||
126105608|NCT01620255|453681101|FG004|Overall Study|Non-compliance|0|||
126055477|NCT00109031|453497482|FG001|Overall Study|Withdrawal by Subject|1|||
126055478|NCT00109031|453497483|FG002|Overall Study|Withdrawal by Subject|0|||
126055479|NCT00109031|453497484|FG003|Overall Study|Withdrawal by Subject|0|||
126055480|NCT00109031|453497481|FG000|Overall Study|Physician Decision|0|||
126055481|NCT00109031|453497482|FG001|Overall Study|Physician Decision|1|||
126055482|NCT00109031|453497483|FG002|Overall Study|Physician Decision|0|||
126055483|NCT00109031|453497484|FG003|Overall Study|Physician Decision|0|||
126055484|NCT00109031|453497481|FG000|Overall Study|Protocol Violation|0|||
126055485|NCT00109031|453497482|FG001|Overall Study|Protocol Violation|0|||
126055486|NCT00109031|453497483|FG002|Overall Study|Protocol Violation|1|||
126055487|NCT00109031|453497484|FG003|Overall Study|Protocol Violation|0|||
126055488|NCT01957163|453497490|FG000|Overall Study|Adverse Event|5|||
126055489|NCT01957163|453497491|FG001|Overall Study|Adverse Event|2|||
126055490|NCT01957163|453497492|FG002|Overall Study|Adverse Event|4|||
126055491|NCT01957163|453497490|FG000|Overall Study|Lack of Efficacy|5|||
126055492|NCT01957163|453497491|FG001|Overall Study|Lack of Efficacy|4|||
126055493|NCT01957163|453497492|FG002|Overall Study|Lack of Efficacy|9|||
126055494|NCT01957163|453497490|FG000|Overall Study|Protocol Violation|1|||
126055495|NCT01957163|453497491|FG001|Overall Study|Protocol Violation|2|||
126055496|NCT01957163|453497492|FG002|Overall Study|Protocol Violation|0|||
126055497|NCT01957163|453497490|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
126055498|NCT01957163|453497491|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
126055499|NCT01957163|453497492|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
126055500|NCT01957163|453497490|FG000|Overall Study|Lost to Follow-up|0|||
126055501|NCT01957163|453497491|FG001|Overall Study|Lost to Follow-up|1|||
126055502|NCT01957163|453497492|FG002|Overall Study|Lost to Follow-up|0|||
126055503|NCT01957163|453497490|FG000|Overall Study|Withdrawal by Subject|4|||
126055504|NCT01957163|453497491|FG001|Overall Study|Withdrawal by Subject|2|||
126055505|NCT01957163|453497492|FG002|Overall Study|Withdrawal by Subject|4|||
126055506|NCT03697603|453497493|FG000|Overall Study|Adverse Event|3|||
126055507|NCT03697603|453497494|FG001|Overall Study|Adverse Event|18|||
126055508|NCT03697603|453497495|FG002|Overall Study|Adverse Event|3|||
126055509|NCT03697603|453497493|FG000|Overall Study|Physician Decision|1|||
126055510|NCT03697603|453497494|FG001|Overall Study|Physician Decision|0|||
126055511|NCT03697603|453497495|FG002|Overall Study|Physician Decision|2|||
126055512|NCT03697603|453497493|FG000|Overall Study|Protocol Violation|3|||
126055513|NCT03697603|453497494|FG001|Overall Study|Protocol Violation|8|||
126055514|NCT03697603|453497495|FG002|Overall Study|Protocol Violation|5|||
126055515|NCT03697603|453497493|FG000|Overall Study|Withdrawal by Subject|5|||
126055516|NCT03697603|453497494|FG001|Overall Study|Withdrawal by Subject|1|||
126055517|NCT03697603|453497495|FG002|Overall Study|Withdrawal by Subject|1|||
126055518|NCT03697603|453497493|FG000|Overall Study|Protocol Violation|0|||
126055519|NCT03697603|453497494|FG001|Overall Study|Protocol Violation|0|||
126055520|NCT03697603|453497495|FG002|Overall Study|Protocol Violation|1|||
126055521|NCT02686658|453497496|FG000|Overall Study|Adverse Event|0|||
126055522|NCT02686658|453497497|FG001|Overall Study|Adverse Event|0|||
126055523|NCT02686658|453497498|FG002|Overall Study|Adverse Event|1|||
126055524|NCT02686658|453497499|FG003|Overall Study|Adverse Event|1|||
126055525|NCT02686658|453497500|FG004|Overall Study|Adverse Event|2|||
126105609|NCT01620255|453681097|FG000|Overall Study|Adverse Event|0|||
126105610|NCT01620255|453681098|FG001|Overall Study|Adverse Event|4|||
126105611|NCT01620255|453681099|FG002|Overall Study|Adverse Event|0|||
126105612|NCT01620255|453681100|FG003|Overall Study|Adverse Event|1|||
126105613|NCT01620255|453681101|FG004|Overall Study|Adverse Event|1|||
126105614|NCT01620255|453681097|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
126105615|NCT01620255|453681098|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
126055526|NCT02686658|453497501|FG005|Overall Study|Adverse Event|1|||
126055527|NCT02686658|453497496|FG000|Overall Study|Investigator decision|0|||
126055528|NCT02686658|453497497|FG001|Overall Study|Investigator decision|0|||
126055529|NCT02686658|453497498|FG002|Overall Study|Investigator decision|0|||
126055530|NCT02686658|453497499|FG003|Overall Study|Investigator decision|1|||
126055531|NCT02686658|453497500|FG004|Overall Study|Investigator decision|2|||
126055532|NCT02686658|453497501|FG005|Overall Study|Investigator decision|1|||
126055533|NCT02686658|453497496|FG000|Overall Study|Sponsor decision|1|||
126055534|NCT02686658|453497497|FG001|Overall Study|Sponsor decision|2|||
126055535|NCT02686658|453497498|FG002|Overall Study|Sponsor decision|1|||
126055536|NCT02686658|453497499|FG003|Overall Study|Sponsor decision|5|||
126055537|NCT02686658|453497500|FG004|Overall Study|Sponsor decision|13|||
126055538|NCT02686658|453497501|FG005|Overall Study|Sponsor decision|2|||
126055539|NCT02686658|453497496|FG000|Overall Study|Lost to Follow-up|0|||
126055540|NCT02686658|453497497|FG001|Overall Study|Lost to Follow-up|0|||
126055541|NCT02686658|453497498|FG002|Overall Study|Lost to Follow-up|2|||
126055542|NCT02686658|453497499|FG003|Overall Study|Lost to Follow-up|0|||
126055543|NCT02686658|453497500|FG004|Overall Study|Lost to Follow-up|0|||
126055544|NCT02686658|453497501|FG005|Overall Study|Lost to Follow-up|1|||
126055545|NCT02686658|453497496|FG000|Overall Study|Death|1|||
126055546|NCT02686658|453497497|FG001|Overall Study|Death|0|||
126055547|NCT02686658|453497498|FG002|Overall Study|Death|0|||
126055548|NCT02686658|453497499|FG003|Overall Study|Death|1|||
126055549|NCT02686658|453497500|FG004|Overall Study|Death|1|||
126055550|NCT02686658|453497501|FG005|Overall Study|Death|1|||
126055551|NCT02686658|453497496|FG000|Overall Study|Withdrawal by Subject|2|||
126055552|NCT02686658|453497497|FG001|Overall Study|Withdrawal by Subject|5|||
126055553|NCT02686658|453497498|FG002|Overall Study|Withdrawal by Subject|4|||
126055554|NCT02686658|453497499|FG003|Overall Study|Withdrawal by Subject|4|||
126055555|NCT02686658|453497500|FG004|Overall Study|Withdrawal by Subject|17|||
126055556|NCT02686658|453497501|FG005|Overall Study|Withdrawal by Subject|8|||
126055557|NCT02686658|453497496|FG000|Overall Study|Placed in hospice care|0|||
126055558|NCT02686658|453497497|FG001|Overall Study|Placed in hospice care|0|||
126055559|NCT02686658|453497498|FG002|Overall Study|Placed in hospice care|1|||
126055560|NCT02686658|453497499|FG003|Overall Study|Placed in hospice care|0|||
126055561|NCT02686658|453497500|FG004|Overall Study|Placed in hospice care|0|||
126055562|NCT02686658|453497501|FG005|Overall Study|Placed in hospice care|0|||
126055563|NCT02686658|453497496|FG000|Overall Study|Participant non-compliance|0|||
126055564|NCT02686658|453497497|FG001|Overall Study|Participant non-compliance|0|||
126055565|NCT02686658|453497498|FG002|Overall Study|Participant non-compliance|0|||
126055566|NCT02686658|453497499|FG003|Overall Study|Participant non-compliance|0|||
126055567|NCT02686658|453497500|FG004|Overall Study|Participant non-compliance|0|||
126055568|NCT02686658|453497501|FG005|Overall Study|Participant non-compliance|1|||
126055569|NCT02686658|453497496|FG000|Overall Study|Concern over coronavirus disease care|0|||
126055570|NCT02686658|453497497|FG001|Overall Study|Concern over coronavirus disease care|0|||
126055571|NCT02686658|453497498|FG002|Overall Study|Concern over coronavirus disease care|0|||
126055572|NCT02686658|453497499|FG003|Overall Study|Concern over coronavirus disease care|0|||
126055573|NCT02686658|453497500|FG004|Overall Study|Concern over coronavirus disease care|2|||
125891445|NCT00796978|452901277|FG000|Overall Study|Cardiac adverse event|5|||
125891446|NCT00796978|452901277|FG000|Overall Study|Adverse Event|4|||
126055574|NCT02686658|453497501|FG005|Overall Study|Concern over coronavirus disease care|1|||
126055575|NCT02309294|453497504|FG000|Overall Study|Withdrawal by Subject|2|||
126055576|NCT00467272|453497507|FG000|Overall Study|Pneumonia|2|||
126055577|NCT00467272|453497507|FG000|Overall Study|Thrombophlebitis|1|||
126055578|NCT00570505|453497510|FG000|Overall Study|Adverse Event|7|||
126055579|NCT00570505|453497510|FG000|Overall Study|Withdrawal by Subject|7|||
126055580|NCT00570505|453497510|FG000|Overall Study|Lost to Follow-up|23|||
126055581|NCT00570505|453497510|FG000|Overall Study|Other loss to follow-up|4|||
126055582|NCT00614614|453497513|FG000|Primary Vaccination Phase|Adverse Event|6|||
126055583|NCT00614614|453497514|FG001|Primary Vaccination Phase|Adverse Event|0|||
126055584|NCT00614614|453497515|FG002|Primary Vaccination Phase|Adverse Event|0|||
126055585|NCT00614614|453497516|FG003|Primary Vaccination Phase|Adverse Event|0|||
126055586|NCT00614614|453497517|FG004|Primary Vaccination Phase|Adverse Event|0|||
126055587|NCT00614614|453497513|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
126055588|NCT00614614|453497514|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
126055589|NCT00614614|453497515|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
126105616|NCT01620255|453681099|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
126105617|NCT01620255|453681100|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
126105618|NCT01620255|453681101|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
126105619|NCT00288509|453681106|FG000|Treatment Cycle 1|Adverse Event|1|||
126105620|NCT00288509|453681106|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
126105621|NCT00288509|453681106|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
126055590|NCT00614614|453497516|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
126055591|NCT00614614|453497517|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
126055592|NCT00614614|453497513|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
126055593|NCT00614614|453497514|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
126055594|NCT00614614|453497515|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
126055595|NCT00614614|453497516|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
126055596|NCT00614614|453497517|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
126055597|NCT00614614|453497513|FG000|Primary Vaccination Phase|Protocol Violation|9|||
126055598|NCT00614614|453497514|FG001|Primary Vaccination Phase|Protocol Violation|3|||
126055599|NCT00614614|453497515|FG002|Primary Vaccination Phase|Protocol Violation|0|||
126055600|NCT00614614|453497516|FG003|Primary Vaccination Phase|Protocol Violation|0|||
126055601|NCT00614614|453497517|FG004|Primary Vaccination Phase|Protocol Violation|0|||
126055602|NCT00614614|453497513|FG000|Primary Vaccination Phase|Other|4|||
126055603|NCT00614614|453497514|FG001|Primary Vaccination Phase|Other|0|||
126055604|NCT00614614|453497515|FG002|Primary Vaccination Phase|Other|0|||
126055605|NCT00614614|453497516|FG003|Primary Vaccination Phase|Other|0|||
126055606|NCT00614614|453497517|FG004|Primary Vaccination Phase|Other|0|||
126055607|NCT00614614|453497513|FG000|Booster Vaccination Phase|Adverse Event|0|||
126055608|NCT00614614|453497514|FG001|Booster Vaccination Phase|Adverse Event|0|||
126055609|NCT00614614|453497515|FG002|Booster Vaccination Phase|Adverse Event|1|||
126055610|NCT00614614|453497516|FG003|Booster Vaccination Phase|Adverse Event|1|||
125891447|NCT00796978|452901277|FG000|Overall Study|Withdrawal by Subject|3|||
126055611|NCT00614614|453497517|FG004|Booster Vaccination Phase|Adverse Event|0|||
125891448|NCT02364336|452901278|FG000|Overall Study|Adverse Event|0|||
126055612|NCT00614614|453497513|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
126055613|NCT00614614|453497514|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
126055614|NCT00614614|453497515|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
126055615|NCT00614614|453497516|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
126055616|NCT00614614|453497517|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
126055617|NCT00614614|453497513|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
126055618|NCT00614614|453497514|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
126055619|NCT00614614|453497515|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
126055620|NCT00614614|453497516|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
126055621|NCT00614614|453497517|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
126055622|NCT00614614|453497513|FG000|Booster Vaccination Phase|Protocol Violation|0|||
126055623|NCT00614614|453497514|FG001|Booster Vaccination Phase|Protocol Violation|0|||
126055624|NCT00614614|453497515|FG002|Booster Vaccination Phase|Protocol Violation|2|||
126055625|NCT00614614|453497516|FG003|Booster Vaccination Phase|Protocol Violation|3|||
126055626|NCT00614614|453497517|FG004|Booster Vaccination Phase|Protocol Violation|0|||
126055627|NCT00614614|453497513|FG000|Booster Vaccination Phase|Other|0|||
126055628|NCT00614614|453497514|FG001|Booster Vaccination Phase|Other|1|||
126055629|NCT00614614|453497515|FG002|Booster Vaccination Phase|Other|3|||
126055630|NCT00614614|453497516|FG003|Booster Vaccination Phase|Other|2|||
126055631|NCT00614614|453497517|FG004|Booster Vaccination Phase|Other|1|||
126055632|NCT05212285|453497518|FG000|Overall Study|Lack of Efficacy|12|||
126055633|NCT05212285|453497519|FG001|Overall Study|Lack of Efficacy|8|||
126055634|NCT05212285|453497518|FG000|Overall Study|Withdrawal by Subject|8|||
126055635|NCT05212285|453497519|FG001|Overall Study|Withdrawal by Subject|1|||
126055636|NCT05212285|453497518|FG000|Overall Study|Lost to Follow-up|13|||
126055637|NCT05212285|453497519|FG001|Overall Study|Lost to Follow-up|1|||
126055638|NCT05212285|453497518|FG000|Overall Study|miss data|21|||
126055639|NCT05212285|453497519|FG001|Overall Study|miss data|2|||
126055640|NCT03924869|453497523|FG000|Overall Study|Death|66|||
126055641|NCT03924869|453497524|FG001|Overall Study|Death|53|||
126055642|NCT03924869|453497523|FG000|Overall Study|Lost to Follow-up|2|||
126055643|NCT03924869|453497524|FG001|Overall Study|Lost to Follow-up|0|||
126055644|NCT03924869|453497523|FG000|Overall Study|Physician Decision|0|||
126105622|NCT00288509|453681106|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
126055645|NCT03924869|453497524|FG001|Overall Study|Physician Decision|3|||
126055646|NCT03924869|453497523|FG000|Overall Study|Withdrawal by Subject|5|||
126055647|NCT03924869|453497524|FG001|Overall Study|Withdrawal by Subject|1|||
126055648|NCT03924869|453497523|FG000|Overall Study|Participants Ongoing|154|||
126055649|NCT03924869|453497524|FG001|Overall Study|Participants Ongoing|164|||
126055650|NCT02542943|453497525|FG000|Overall Study|Lost to Follow-up|1|||
125891449|NCT02364336|452901279|FG001|Overall Study|Adverse Event|1|||
126055651|NCT02542943|453497526|FG001|Overall Study|Lost to Follow-up|0|||
126055652|NCT02542943|453497527|FG002|Overall Study|Lost to Follow-up|0|||
126055653|NCT02542943|453497525|FG000|Overall Study|Withdrawal by Subject|0|||
126055654|NCT02542943|453497526|FG001|Overall Study|Withdrawal by Subject|1|||
126055655|NCT02542943|453497527|FG002|Overall Study|Withdrawal by Subject|0|||
126055656|NCT05824559|453497531|FG000|Overall Study|Adverse Event|2|||
125891450|NCT02136069|452901281|FG000|Overall Study|UC flare-up|1|||
125891451|NCT02136069|452901282|FG001|Overall Study|UC flare-up|0|||
125891452|NCT02136069|452901281|FG000|Overall Study|Adverse Event|6|||
125891453|NCT02136069|452901282|FG001|Overall Study|Adverse Event|8|||
125891454|NCT02136069|452901281|FG000|Overall Study|Death|0|||
125891455|NCT02136069|452901282|FG001|Overall Study|Death|1|||
126055657|NCT05824559|453497531|FG000|Overall Study|Physician Decision|2|||
126055658|NCT05824559|453497531|FG000|Overall Study|Progressive Disease|16|||
126055659|NCT05824559|453497531|FG000|Overall Study|Study Terminated by Sponsor|1|||
126055660|NCT05824559|453497531|FG000|Overall Study|Withdrawal by Subject|2|||
126055661|NCT04602728|453497537|FG000|Overall Study|Lost to Follow-up|4|||
126055662|NCT04602728|453497538|FG001|Overall Study|Lost to Follow-up|4|||
126055663|NCT05865392|453497539|FG000|Overall Study|Withdrawal by Subject|4|||
126055664|NCT05865392|453497540|FG001|Overall Study|Withdrawal by Subject|0|||
126055665|NCT05865392|453497539|FG000|Overall Study|Didn't meet inclusion criteria|4|||
126055666|NCT05865392|453497540|FG001|Overall Study|Didn't meet inclusion criteria|0|||
126055667|NCT05366751|453497543|FG000|Overall Study|Adverse Event|25|||
126055668|NCT05366751|453497543|FG000|Overall Study|Physician Decision|3|||
126055669|NCT05366751|453497543|FG000|Overall Study|Lost to Follow-up|2|||
126055670|NCT05366751|453497543|FG000|Overall Study|Withdrawal by Subject|14|||
126055671|NCT05366751|453497543|FG000|Overall Study|Study Terminated by Sponsor|50|||
126055672|NCT05366751|453497543|FG000|Overall Study|Site Terminated by Sponsor|3|||
126055673|NCT02634307|453498818|FG000|Overall Study|Adverse Event|50|||
126055674|NCT02634307|453498819|FG001|Overall Study|Adverse Event|24|||
126055675|NCT02634307|453498820|FG002|Overall Study|Adverse Event|14|||
126055676|NCT02634307|453498818|FG000|Overall Study|Lost to Follow-up|21|||
126055677|NCT02634307|453498819|FG001|Overall Study|Lost to Follow-up|5|||
126055678|NCT02634307|453498820|FG002|Overall Study|Lost to Follow-up|6|||
126055679|NCT02634307|453498818|FG000|Overall Study|Pregnancy|5|||
126055680|NCT02634307|453498819|FG001|Overall Study|Pregnancy|1|||
126055681|NCT02634307|453498820|FG002|Overall Study|Pregnancy|3|||
126055682|NCT02634307|453498818|FG000|Overall Study|Withdrawal by Subject|38|||
126055683|NCT02634307|453498819|FG001|Overall Study|Withdrawal by Subject|24|||
126055684|NCT02634307|453498820|FG002|Overall Study|Withdrawal by Subject|18|||
126055685|NCT02634307|453498818|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126055686|NCT02634307|453498819|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126055687|NCT02634307|453498820|FG002|Overall Study|Non-Compliance with Study Drug|2|||
126055688|NCT02634307|453498818|FG000|Overall Study|Lack of Efficacy|1|||
126055689|NCT02634307|453498819|FG001|Overall Study|Lack of Efficacy|5|||
126055690|NCT02634307|453498820|FG002|Overall Study|Lack of Efficacy|3|||
126055691|NCT02634307|453498818|FG000|Overall Study|Physician Decision|7|||
126055692|NCT02634307|453498819|FG001|Overall Study|Physician Decision|5|||
126055693|NCT02634307|453498820|FG002|Overall Study|Physician Decision|5|||
126055694|NCT02634307|453498818|FG000|Overall Study|Reason not Specified|3|||
126055695|NCT02634307|453498819|FG001|Overall Study|Reason not Specified|5|||
126055696|NCT02634307|453498820|FG002|Overall Study|Reason not Specified|10|||
126055697|NCT02698475|453498821|FG000|Main Study Period|Lack of Efficacy|1|||
126055698|NCT02698475|453498821|FG000|Main Study Period|Protocol Violation|2|||
126055699|NCT02698475|453498821|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
126055700|NCT02698475|453498821|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
126055701|NCT02698475|453498821|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
126055702|NCT02698475|453498821|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
126055703|NCT02698475|453498821|FG000|Long-Term Extension Period|Other|1|||
126055704|NCT02132949|453498822|FG000|Overall Study|Death|7|||
126055705|NCT02132949|453498823|FG001|Overall Study|Death|13|||
126055706|NCT02132949|453498822|FG000|Overall Study|Lost to Follow-up|14|||
126055707|NCT02132949|453498823|FG001|Overall Study|Lost to Follow-up|4|||
126055708|NCT02132949|453498822|FG000|Overall Study|Withdrawal by Subject|6|||
126055709|NCT02132949|453498823|FG001|Overall Study|Withdrawal by Subject|5|||
126055710|NCT02132949|453498822|FG000|Overall Study|Noncompliance|5|||
126055711|NCT02132949|453498823|FG001|Overall Study|Noncompliance|1|||
126055712|NCT02132949|453498822|FG000|Overall Study|Physician Decision|3|||
126055713|NCT02132949|453498823|FG001|Overall Study|Physician Decision|1|||
126055714|NCT02132949|453498822|FG000|Overall Study|Disease Progression|3|||
125891456|NCT02136069|452901281|FG000|Overall Study|Lack of Efficacy|10|||
125891457|NCT02136069|452901282|FG001|Overall Study|Lack of Efficacy|4|||
125891458|NCT02136069|452901281|FG000|Overall Study|Lost to Follow-up|1|||
125891459|NCT02136069|452901282|FG001|Overall Study|Lost to Follow-up|0|||
125891460|NCT02136069|452901281|FG000|Overall Study|Non-Compliance|1|||
125891461|NCT02136069|452901282|FG001|Overall Study|Non-Compliance|0|||
125891462|NCT02136069|452901281|FG000|Overall Study|Physician Decision|5|||
125891463|NCT02136069|452901282|FG001|Overall Study|Physician Decision|4|||
125891464|NCT02136069|452901281|FG000|Overall Study|Withdrawal by Subject|10|||
125891465|NCT02136069|452901282|FG001|Overall Study|Withdrawal by Subject|11|||
125891466|NCT01092546|452901283|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
125891467|NCT01667419|452901284|FG000|Overall Study|Reason Not Specified|1|||
125891468|NCT01667419|452901285|FG001|Overall Study|Reason Not Specified|0|||
125891469|NCT01667419|452901286|FG002|Overall Study|Reason Not Specified|0|||
125891470|NCT01667419|452901287|FG003|Overall Study|Reason Not Specified|0|||
125891471|NCT01667419|452901284|FG000|Overall Study|Withdrawal by Subject|16|||
125891472|NCT01667419|452901285|FG001|Overall Study|Withdrawal by Subject|8|||
125891473|NCT01667419|452901286|FG002|Overall Study|Withdrawal by Subject|9|||
125891474|NCT01667419|452901287|FG003|Overall Study|Withdrawal by Subject|8|||
125891475|NCT01667419|452901284|FG000|Overall Study|Non-compliance|0|||
125891476|NCT01667419|452901285|FG001|Overall Study|Non-compliance|0|||
125891477|NCT01667419|452901286|FG002|Overall Study|Non-compliance|0|||
125891478|NCT01667419|452901287|FG003|Overall Study|Non-compliance|1|||
125891479|NCT01667419|452901284|FG000|Overall Study|Protocol Violation|1|||
125891480|NCT01667419|452901285|FG001|Overall Study|Protocol Violation|0|||
125891481|NCT01667419|452901286|FG002|Overall Study|Protocol Violation|0|||
125891482|NCT01667419|452901287|FG003|Overall Study|Protocol Violation|0|||
125891483|NCT01667419|452901284|FG000|Overall Study|Lost to Follow-up|7|||
125891484|NCT01667419|452901285|FG001|Overall Study|Lost to Follow-up|6|||
125891485|NCT01667419|452901286|FG002|Overall Study|Lost to Follow-up|2|||
125891486|NCT01667419|452901287|FG003|Overall Study|Lost to Follow-up|4|||
125891487|NCT01667419|452901284|FG000|Overall Study|Death|18|||
125891488|NCT01667419|452901285|FG001|Overall Study|Death|33|||
125891489|NCT01667419|452901286|FG002|Overall Study|Death|25|||
125891490|NCT01667419|452901287|FG003|Overall Study|Death|26|||
125891491|NCT04364984|452901289|FG000|Overall Study|Death|2|||
126055715|NCT02132949|453498823|FG001|Overall Study|Disease Progression|0|||
126055716|NCT02132949|453498822|FG000|Overall Study|Adverse Event|2|||
126055717|NCT02132949|453498823|FG001|Overall Study|Adverse Event|1|||
125891492|NCT04364984|452901290|FG001|Overall Study|Death|2|||
125891493|NCT04364984|452901291|FG002|Overall Study|Death|0|||
125891494|NCT02910986|452901292|FG000|Overall Study|non-Latina|14|||
125891495|NCT02910986|452901293|FG001|Overall Study|non-Latina|13|||
125891496|NCT02910986|452901294|FG002|Overall Study|non-Latina|12|||
126055718|NCT02132949|453498822|FG000|Overall Study|Withdrew Prior to Treatment|1|||
126055719|NCT02132949|453498823|FG001|Overall Study|Withdrew Prior to Treatment|2|||
126055720|NCT02132949|453498822|FG000|Overall Study|Reason Unspecified|0|||
126055721|NCT02132949|453498823|FG001|Overall Study|Reason Unspecified|1|||
126055722|NCT00745875|453498826|FG000|Overall Study|Continuing study treatment|4|||
126055723|NCT00745875|453498827|FG001|Overall Study|Continuing study treatment|4|||
126055724|NCT01532648|453498828|FG000|Overall Study|Lost to Follow-up|3|||
126055725|NCT01532648|453498829|FG001|Overall Study|Lost to Follow-up|4|||
126055726|NCT01532648|453498828|FG000|Overall Study|Lack of Efficacy|4|||
126055727|NCT01532648|453498829|FG001|Overall Study|Lack of Efficacy|1|||
126055728|NCT01532648|453498828|FG000|Overall Study|Protocol Violation|1|||
126055729|NCT01532648|453498829|FG001|Overall Study|Protocol Violation|1|||
126055730|NCT01532648|453498828|FG000|Overall Study|Adverse Event|12|||
126055731|NCT01532648|453498829|FG001|Overall Study|Adverse Event|9|||
126055732|NCT01532648|453498828|FG000|Overall Study|Withdrawal by Subject|16|||
126055733|NCT01532648|453498829|FG001|Overall Study|Withdrawal by Subject|2|||
126055734|NCT02148705|453498830|FG000|Overall Study|Death|2|||
126055735|NCT02148705|453498831|FG001|Overall Study|Death|0|||
126055736|NCT02148705|453498832|FG002|Overall Study|Death|0|||
126055737|NCT02148705|453498830|FG000|Overall Study|Lost to Follow-up|13|||
126055738|NCT02148705|453498831|FG001|Overall Study|Lost to Follow-up|4|||
126055739|NCT02148705|453498832|FG002|Overall Study|Lost to Follow-up|10|||
126105623|NCT00288509|453681106|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
126055740|NCT02148705|453498830|FG000|Overall Study|Withdrawal by Subject|3|||
126055741|NCT02148705|453498831|FG001|Overall Study|Withdrawal by Subject|0|||
126055742|NCT02148705|453498832|FG002|Overall Study|Withdrawal by Subject|2|||
126055743|NCT02148705|453498830|FG000|Overall Study|Not Treated|0|||
126055744|NCT02148705|453498831|FG001|Overall Study|Not Treated|1|||
126055745|NCT02148705|453498832|FG002|Overall Study|Not Treated|5|||
126055746|NCT01583166|453498833|FG000|Overall Study|Withdrawal by Subject|4|||
126055747|NCT01583166|453498834|FG001|Overall Study|Withdrawal by Subject|6|||
126055748|NCT01737021|453498835|FG000|Overall Study|Lost to Follow-up|5|||
126055749|NCT01737021|453498836|FG001|Overall Study|Lost to Follow-up|3|||
126055750|NCT02310581|453498837|FG000|Overall Study|Adverse Event|1|||
126055751|NCT02310581|453498838|FG001|Overall Study|Adverse Event|1|||
125891497|NCT02910986|452901292|FG000|Overall Study|Failure to return T! survey|72|||
125891498|NCT02910986|452901293|FG001|Overall Study|Failure to return T! survey|84|||
125891499|NCT02910986|452901294|FG002|Overall Study|Failure to return T! survey|72|||
125891500|NCT02910986|452901292|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
125891501|NCT02910986|452901293|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
125891502|NCT02910986|452901294|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
126055752|NCT02310581|453498839|FG002|Overall Study|Adverse Event|1|||
125891503|NCT02910986|452901292|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
126055753|NCT02310581|453498840|FG003|Overall Study|Adverse Event|0|||
126055754|NCT02310581|453498837|FG000|Overall Study|Withdrawal by Subject|2|||
125891504|NCT02910986|452901293|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
125891505|NCT02910986|452901294|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
125891506|NCT01941186|452901295|FG000|Follow-up|Lost to Follow-up|1|||
125891507|NCT01941186|452901296|FG001|Follow-up|Lost to Follow-up|0|||
125891508|NCT04380519|452901297|FG000|Overall Study|Withdrawal by Subject|4|||
125891509|NCT04380519|452901298|FG001|Overall Study|Withdrawal by Subject|0|||
125891510|NCT04380519|452901299|FG002|Overall Study|Withdrawal by Subject|1|||
125891511|NCT04380519|452901297|FG000|Overall Study|Death|14|||
125891512|NCT04380519|452901298|FG001|Overall Study|Death|9|||
125891513|NCT04380519|452901299|FG002|Overall Study|Death|6|||
125891514|NCT04380519|452901297|FG000|Overall Study|Adverse Event|0|||
125891515|NCT04380519|452901298|FG001|Overall Study|Adverse Event|1|||
125891516|NCT04380519|452901299|FG002|Overall Study|Adverse Event|0|||
125891517|NCT04380519|452901297|FG000|Overall Study|relatives' decision|0|||
125891518|NCT04380519|452901298|FG001|Overall Study|relatives' decision|1|||
125891519|NCT04380519|452901299|FG002|Overall Study|relatives' decision|0|||
125891520|NCT01068600|452901300|FG000|Overall Study|Withdrawal by Subject|5|||
125891521|NCT01068600|452901301|FG001|Overall Study|Withdrawal by Subject|6|||
125891522|NCT01068600|452901300|FG000|Overall Study|Adverse Event|3|||
125891523|NCT01068600|452901301|FG001|Overall Study|Adverse Event|3|||
125891524|NCT01068600|452901300|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125891525|NCT01068600|452901301|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125891526|NCT01068600|452901300|FG000|Overall Study|Lost to Follow-up|1|||
125891527|NCT01068600|452901301|FG001|Overall Study|Lost to Follow-up|2|||
125891528|NCT01068600|452901300|FG000|Overall Study|Protocol deviation|1|||
125891529|NCT01068600|452901301|FG001|Overall Study|Protocol deviation|1|||
125891530|NCT01068600|452901300|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125891531|NCT01068600|452901301|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125891532|NCT01068600|452901300|FG000|Overall Study|Administrative problems|0|||
125891533|NCT01068600|452901301|FG001|Overall Study|Administrative problems|1|||
125891534|NCT04173494|452901302|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
125891535|NCT04173494|452901303|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
125891536|NCT04173494|452901302|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
125891537|NCT04173494|452901303|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
125891538|NCT04173494|452901302|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
125891539|NCT04173494|452901303|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
125891540|NCT04173494|452901302|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
125891541|NCT04173494|452901303|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
125891542|NCT04173494|452901302|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
125891543|NCT04173494|452901303|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
125891544|NCT04173494|452901302|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
125891545|NCT04173494|452901303|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
125891546|NCT04173494|452901302|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
125891547|NCT04173494|452901303|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
125891548|NCT04173494|452901302|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
125891549|NCT04173494|452901303|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
125891550|NCT04173494|452901302|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
125891551|NCT04173494|452901303|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
125891552|NCT04173494|452901302|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
125891553|NCT04173494|452901303|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
126055755|NCT02310581|453498838|FG001|Overall Study|Withdrawal by Subject|1|||
125891554|NCT04173494|452901302|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
125891555|NCT04173494|452901303|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
125891556|NCT04173494|452901302|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
125891557|NCT04173494|452901303|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
125891558|NCT04173494|452901302|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
125891559|NCT04173494|452901303|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
125891560|NCT04173494|452901302|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
125891561|NCT04173494|452901303|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
125891562|NCT04173494|452901302|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
125891563|NCT04173494|452901303|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
125891564|NCT04173494|452901302|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
125891565|NCT04173494|452901303|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
125891566|NCT02474069|452901304|FG000|Selection Phase (SP)|Adverse Event|8|||
125891567|NCT02474069|452901305|FG001|Selection Phase (SP)|Adverse Event|0|||
125891568|NCT02474069|452901306|FG002|Selection Phase (SP)|Adverse Event|0|||
125891569|NCT02474069|452901304|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
125891570|NCT02474069|452901305|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
125891571|NCT02474069|452901306|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
125891572|NCT02474069|452901304|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
125891573|NCT02474069|452901305|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
125891574|NCT02474069|452901306|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
125891575|NCT02474069|452901304|FG000|Selection Phase (SP)|Physician Decision|1|||
125891576|NCT02474069|452901305|FG001|Selection Phase (SP)|Physician Decision|0|||
125891577|NCT02474069|452901306|FG002|Selection Phase (SP)|Physician Decision|0|||
125891578|NCT02474069|452901304|FG000|Selection Phase (SP)|Protocol Violation|1|||
125891579|NCT02474069|452901305|FG001|Selection Phase (SP)|Protocol Violation|0|||
125891580|NCT02474069|452901306|FG002|Selection Phase (SP)|Protocol Violation|0|||
125891581|NCT02474069|452901304|FG000|Selection Phase (SP)|No longer requires treatment|1|||
125891582|NCT02474069|452901305|FG001|Selection Phase (SP)|No longer requires treatment|0|||
125891583|NCT02474069|452901306|FG002|Selection Phase (SP)|No longer requires treatment|0|||
125891584|NCT02474069|452901304|FG000|Selection Phase (SP)|Technical Problem|1|||
125891585|NCT02474069|452901305|FG001|Selection Phase (SP)|Technical Problem|0|||
125891586|NCT02474069|452901306|FG002|Selection Phase (SP)|Technical Problem|0|||
125891587|NCT02474069|452901304|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
125891588|NCT02474069|452901305|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
125891589|NCT02474069|452901306|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
125891590|NCT02474069|452901304|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
125891591|NCT02474069|452901305|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
125891592|NCT02474069|452901306|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
125891593|NCT02474069|452901304|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
125891594|NCT02474069|452901305|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
125891595|NCT02474069|452901306|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
125891596|NCT02474069|452901304|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
125891597|NCT02474069|452901305|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
125891598|NCT02474069|452901306|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
125891599|NCT02474069|452901304|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
125891600|NCT02474069|452901305|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
125891601|NCT02474069|452901306|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
125891602|NCT02474069|452901304|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
125891603|NCT02474069|452901305|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
125891604|NCT02474069|452901306|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
125891605|NCT01623050|452901309|FG000|Overall Study|Lost to Follow-up|9|||
125891606|NCT00393861|452901310|FG000|Overall Study|Adverse Event|2|||
125891607|NCT00393861|452901310|FG000|Overall Study|Disease Progression|24|||
125891608|NCT01727024|452901311|FG000|Period 1|Lost to Follow-up|1|||
125891609|NCT01727024|452901312|FG001|Period 1|Lost to Follow-up|1|||
125891610|NCT01727024|452901311|FG000|Period 1|Withdrawal by Subject|2|||
125891611|NCT01727024|452901312|FG001|Period 1|Withdrawal by Subject|3|||
125891612|NCT02167139|452901313|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
126055756|NCT02310581|453498839|FG002|Overall Study|Withdrawal by Subject|0|||
126055757|NCT02310581|453498840|FG003|Overall Study|Withdrawal by Subject|1|||
126055758|NCT04652869|453498841|FG000|Overall Study|Withdrawal by Subject|0|||
126055759|NCT04652869|453498842|FG001|Overall Study|Withdrawal by Subject|2|||
126055760|NCT04652869|453498843|FG002|Overall Study|Withdrawal by Subject|0|||
126055761|NCT01833455|453498844|FG000|Overall Study|Withdrawal by Subject|1|||
126055762|NCT01833455|453498845|FG001|Overall Study|Withdrawal by Subject|0|||
126055763|NCT00887224|453498846|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
126055764|NCT00887224|453498847|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
126055765|NCT00887224|453498848|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
126055766|NCT00887224|453498846|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
126055767|NCT00887224|453498847|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
126055768|NCT00887224|453498848|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
126055769|NCT00887224|453498846|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
126055770|NCT00887224|453498847|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
126055771|NCT00887224|453498848|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
126055772|NCT00887224|453498846|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
126055773|NCT00887224|453498847|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
126055774|NCT00887224|453498848|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
126055775|NCT00887224|453498846|FG000|Open-label Response (OLR) Phase|Other|1|||
126055776|NCT00887224|453498847|FG001|Open-label Response (OLR) Phase|Other|0|||
126055777|NCT00887224|453498848|FG002|Open-label Response (OLR) Phase|Other|0|||
126055778|NCT00887224|453498846|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
126055779|NCT00887224|453498847|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
126055780|NCT00887224|453498848|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
126055781|NCT00887224|453498846|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
126055782|NCT00887224|453498847|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
126055783|NCT00887224|453498848|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
126055784|NCT00887224|453498846|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
126055785|NCT00887224|453498847|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
126055786|NCT00887224|453498848|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
126055787|NCT00887224|453498846|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
126055788|NCT00887224|453498847|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
126055789|NCT00887224|453498848|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
126055790|NCT00887224|453498846|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
126055791|NCT00887224|453498847|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
126055792|NCT00887224|453498848|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
126055793|NCT00887224|453498846|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
126055794|NCT00887224|453498847|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
126055795|NCT00887224|453498848|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
126055796|NCT00887224|453498846|FG000|Open-label Stability (OLS) Phase|Other|1|||
126055797|NCT00887224|453498847|FG001|Open-label Stability (OLS) Phase|Other|0|||
126055798|NCT00887224|453498848|FG002|Open-label Stability (OLS) Phase|Other|0|||
126055799|NCT00887224|453498846|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
126055800|NCT00887224|453498847|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
126055801|NCT00887224|453498848|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
126055802|NCT00887224|453498846|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
126055803|NCT00887224|453498847|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
126055804|NCT00887224|453498848|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
126055805|NCT00887224|453498846|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
126055806|NCT00887224|453498847|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
126055807|NCT00887224|453498848|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
126055808|NCT00887224|453498846|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
126055809|NCT00887224|453498847|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
126055810|NCT00887224|453498848|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
126055811|NCT00887224|453498846|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
126055812|NCT00887224|453498847|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
126055813|NCT00887224|453498848|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
126055814|NCT00887224|453498846|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
126055815|NCT00887224|453498847|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
126055816|NCT00887224|453498848|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
126105624|NCT00288509|453681106|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
126055817|NCT00887224|453498846|FG000|OL Taper Phase / OL Follow Up|Other|30|||
126055818|NCT00887224|453498847|FG001|OL Taper Phase / OL Follow Up|Other|0|||
126055819|NCT00887224|453498848|FG002|OL Taper Phase / OL Follow Up|Other|0|||
126055820|NCT00887224|453498846|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
126055821|NCT00887224|453498847|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
126055822|NCT00887224|453498848|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
126055823|NCT00887224|453498846|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
126055824|NCT00887224|453498847|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
126055825|NCT00887224|453498848|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
126055826|NCT00887224|453498846|FG000|Double-blind (DB) Phase|Adverse Event|0|||
126055827|NCT00887224|453498847|FG001|Double-blind (DB) Phase|Adverse Event|7|||
126055828|NCT00887224|453498848|FG002|Double-blind (DB) Phase|Adverse Event|2|||
126055829|NCT00887224|453498846|FG000|Double-blind (DB) Phase|Failed to return|0|||
126055830|NCT00887224|453498847|FG001|Double-blind (DB) Phase|Failed to return|2|||
126055831|NCT00887224|453498848|FG002|Double-blind (DB) Phase|Failed to return|2|||
126055832|NCT00887224|453498846|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
126055833|NCT00887224|453498847|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
126055834|NCT00887224|453498848|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
126055835|NCT00887224|453498846|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
126055836|NCT00887224|453498847|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
126105625|NCT00288509|453681106|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
126055837|NCT00887224|453498848|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
126055838|NCT00887224|453498846|FG000|Double-blind (DB) Phase|Other|0|||
126055839|NCT00887224|453498847|FG001|Double-blind (DB) Phase|Other|2|||
126105626|NCT00288509|453681106|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
125891613|NCT02167139|452901314|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
125891614|NCT02167139|452901315|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
125891615|NCT02167139|452901316|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
126105627|NCT00288509|453681106|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
125891616|NCT02167139|452901313|FG000|Randomised, Double-blind|Adverse Event|2|||
125891617|NCT02167139|452901314|FG001|Randomised, Double-blind|Adverse Event|9|||
126105628|NCT00288509|453681106|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
125891618|NCT02167139|452901315|FG002|Randomised, Double-blind|Adverse Event|0|||
125891619|NCT02167139|452901316|FG003|Randomised, Double-blind|Adverse Event|0|||
125891620|NCT02167139|452901313|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
125891621|NCT02167139|452901314|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
126055840|NCT00887224|453498848|FG002|Double-blind (DB) Phase|Other|0|||
126055841|NCT00887224|453498846|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
126055842|NCT00887224|453498847|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
126055843|NCT00887224|453498848|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
126055844|NCT00887224|453498846|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
126055845|NCT00887224|453498847|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
126055846|NCT00887224|453498848|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
126055847|NCT00887224|453498846|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
126055848|NCT00887224|453498847|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
126055849|NCT00887224|453498848|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
126055850|NCT00887224|453498846|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
126055851|NCT00887224|453498847|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
126055852|NCT00887224|453498848|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
126055853|NCT00887224|453498846|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
126055854|NCT00887224|453498847|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
126055855|NCT00887224|453498848|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
126055856|NCT00887224|453498846|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
126055857|NCT00887224|453498847|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
126055858|NCT00887224|453498848|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
126055859|NCT00887224|453498846|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
126055860|NCT00887224|453498847|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
126055861|NCT00887224|453498848|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
126055862|NCT00887224|453498846|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
126055863|NCT00887224|453498847|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
126055864|NCT00887224|453498848|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
126055865|NCT00887224|453498846|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
126055866|NCT00887224|453498847|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
126055867|NCT00887224|453498848|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
126055868|NCT01256359|453498851|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
126055869|NCT01256359|453498852|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
126055870|NCT01256359|453498851|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
126055871|NCT01256359|453498852|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
126055872|NCT02000752|453498853|FG000|Overall Study|Dystocic delivery|19|||
126055873|NCT02000752|453498854|FG001|Overall Study|Dystocic delivery|8|||
126055874|NCT02000752|453498853|FG000|Overall Study|Shift Changes|12|||
126055875|NCT02000752|453498854|FG001|Overall Study|Shift Changes|5|||
126055876|NCT04658784|453498860|FG000|6-month Follow-up|Lost to Follow-up|2|||
126055877|NCT04658784|453498861|FG001|6-month Follow-up|Lost to Follow-up|5|||
126055878|NCT02095145|453498863|FG000|Overall Study|Withdrawal by Subject|1|||
126055879|NCT02095145|453498864|FG001|Overall Study|Withdrawal by Subject|0|||
126055880|NCT02630186|453498865|FG000|Overall Study|Withdrawal by Subject|1|||
126055881|NCT00670488|453498867|FG000|Overall Study|Adverse Event|0|||
126055882|NCT00670488|453498868|FG001|Overall Study|Adverse Event|7|||
126055883|NCT00670488|453498869|FG002|Overall Study|Adverse Event|0|||
126055884|NCT00670488|453498870|FG003|Overall Study|Adverse Event|3|||
126055885|NCT00670488|453498871|FG004|Overall Study|Adverse Event|1|||
126055886|NCT00670488|453498872|FG005|Overall Study|Adverse Event|1|||
126055887|NCT00670488|453498873|FG006|Overall Study|Adverse Event|5|||
126055888|NCT00670488|453498874|FG007|Overall Study|Adverse Event|1|||
126055889|NCT00670488|453498875|FG008|Overall Study|Adverse Event|0|||
126055890|NCT00670488|453498876|FG009|Overall Study|Adverse Event|1|||
126055891|NCT00670488|453498867|FG000|Overall Study|Physician Decision|1|||
126055892|NCT00670488|453498868|FG001|Overall Study|Physician Decision|9|||
126055893|NCT00670488|453498869|FG002|Overall Study|Physician Decision|0|||
126055894|NCT00670488|453498870|FG003|Overall Study|Physician Decision|1|||
126055895|NCT00670488|453498871|FG004|Overall Study|Physician Decision|0|||
126055896|NCT00670488|453498872|FG005|Overall Study|Physician Decision|0|||
126055897|NCT00670488|453498873|FG006|Overall Study|Physician Decision|0|||
126055898|NCT00670488|453498874|FG007|Overall Study|Physician Decision|0|||
126055899|NCT00670488|453498875|FG008|Overall Study|Physician Decision|0|||
126055900|NCT00670488|453498876|FG009|Overall Study|Physician Decision|0|||
126055901|NCT00670488|453498867|FG000|Overall Study|Progressive Disease|2|||
126055902|NCT00670488|453498868|FG001|Overall Study|Progressive Disease|41|||
126055903|NCT00670488|453498869|FG002|Overall Study|Progressive Disease|3|||
126055904|NCT00670488|453498870|FG003|Overall Study|Progressive Disease|2|||
126055905|NCT00670488|453498871|FG004|Overall Study|Progressive Disease|2|||
126055906|NCT00670488|453498872|FG005|Overall Study|Progressive Disease|4|||
126055907|NCT00670488|453498873|FG006|Overall Study|Progressive Disease|11|||
126055908|NCT00670488|453498874|FG007|Overall Study|Progressive Disease|2|||
126055909|NCT00670488|453498875|FG008|Overall Study|Progressive Disease|2|||
126055910|NCT00670488|453498876|FG009|Overall Study|Progressive Disease|1|||
126055911|NCT00670488|453498867|FG000|Overall Study|Withdrawal by Subject|0|||
126055912|NCT00670488|453498868|FG001|Overall Study|Withdrawal by Subject|1|||
126055913|NCT00670488|453498869|FG002|Overall Study|Withdrawal by Subject|0|||
126055914|NCT00670488|453498870|FG003|Overall Study|Withdrawal by Subject|1|||
126055915|NCT00670488|453498871|FG004|Overall Study|Withdrawal by Subject|0|||
126055916|NCT00670488|453498872|FG005|Overall Study|Withdrawal by Subject|0|||
126055917|NCT00670488|453498873|FG006|Overall Study|Withdrawal by Subject|1|||
126055918|NCT00670488|453498874|FG007|Overall Study|Withdrawal by Subject|0|||
126055919|NCT00670488|453498875|FG008|Overall Study|Withdrawal by Subject|1|||
126055920|NCT00670488|453498876|FG009|Overall Study|Withdrawal by Subject|0|||
126055921|NCT01034306|453498884|FG000|Overall Study|Adverse Event|1|||
126055922|NCT01034306|453498885|FG001|Overall Study|Adverse Event|0|||
126055923|NCT01034306|453498884|FG000|Overall Study|Lost to Follow-up|0|||
126055924|NCT01034306|453498885|FG001|Overall Study|Lost to Follow-up|1|||
126055925|NCT01034306|453498884|FG000|Overall Study|Withdrawal by Subject|2|||
126055926|NCT01034306|453498885|FG001|Overall Study|Withdrawal by Subject|2|||
126055927|NCT01034306|453498884|FG000|Overall Study|hospitalized and decided to stop|1|||
126055928|NCT01034306|453498885|FG001|Overall Study|hospitalized and decided to stop|0|||
126055929|NCT01034306|453498884|FG000|Overall Study|Noncomplience|1|||
126055930|NCT01034306|453498885|FG001|Overall Study|Noncomplience|0|||
126055931|NCT00836498|453498886|FG000|Overall Study|Adverse Event|1|||
126055932|NCT00836498|453498887|FG001|Overall Study|Adverse Event|0|||
126055933|NCT00836498|453498886|FG000|Overall Study|Lost to Follow-up|1|||
126055934|NCT00836498|453498887|FG001|Overall Study|Lost to Follow-up|0|||
126055935|NCT00836498|453498886|FG000|Overall Study|Withdrawal by Subject|2|||
126055936|NCT00836498|453498887|FG001|Overall Study|Withdrawal by Subject|1|||
126055937|NCT01619059|453498888|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
126055938|NCT01619059|453498889|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
126055939|NCT01619059|453498888|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
126055940|NCT01619059|453498889|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
126055941|NCT01619059|453498888|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
126055942|NCT01619059|453498889|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
126055943|NCT01619059|453498888|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
126055944|NCT01619059|453498889|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
126055945|NCT01619059|453498888|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
126055946|NCT01619059|453498889|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
126055947|NCT01619059|453498888|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
126055948|NCT01619059|453498889|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
126055949|NCT01619059|453498888|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
126055950|NCT01619059|453498889|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
126055951|NCT01619059|453498888|FG000|Long-Term (LT) Treatment Period|Death|1|||
126055952|NCT01619059|453498889|FG001|Long-Term (LT) Treatment Period|Death|0|||
126055953|NCT01619059|453498888|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
126055954|NCT01619059|453498889|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
126055955|NCT01619059|453498888|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
126055956|NCT01619059|453498889|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
126055957|NCT03418545|453498890|FG000|Overall Study|Withdrawal by Participant|2|||
126055958|NCT03418545|453498891|FG001|Overall Study|Withdrawal by Participant|4|||
126055959|NCT03418545|453498890|FG000|Overall Study|Lost to Follow-up|3|||
126055960|NCT03418545|453498891|FG001|Overall Study|Lost to Follow-up|5|||
126055961|NCT03418545|453498890|FG000|Overall Study|Reason Not Specified|0|||
126055962|NCT03418545|453498891|FG001|Overall Study|Reason Not Specified|1|||
126055963|NCT03418545|453498890|FG000|Overall Study|Missing Completion Status|0|||
126055964|NCT03418545|453498891|FG001|Overall Study|Missing Completion Status|1|||
126055965|NCT02384382|453498899|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
126055966|NCT02384382|453498899|FG000|Overall Study|Death|1|||
126055967|NCT02384382|453498899|FG000|Overall Study|Adverse Event|1|||
126055968|NCT02384382|453498899|FG000|Overall Study|Disease progression|16|||
126055969|NCT03567616|453498908|FG000|Overall Study|Disease progression|4|||
126055970|NCT03567616|453498908|FG000|Overall Study|Withdrawal by Subject|1|||
126055971|NCT03567616|453498908|FG000|Overall Study|Physician Decision|1|||
126055972|NCT03567616|453498908|FG000|Overall Study|Death|1|||
126055973|NCT03567616|453498908|FG000|Overall Study|Adverse Event|1|||
126055974|NCT02831049|453498923|FG000|Overall Study|Lost to Follow-up|0|||
126055975|NCT02831049|453498924|FG001|Overall Study|Lost to Follow-up|0|||
126055976|NCT02831049|453498925|FG002|Overall Study|Lost to Follow-up|1|||
126055977|NCT02831049|453498923|FG000|Overall Study|Withdrawal by Subject|0|||
126055978|NCT02831049|453498924|FG001|Overall Study|Withdrawal by Subject|1|||
126055979|NCT02831049|453498925|FG002|Overall Study|Withdrawal by Subject|1|||
126055980|NCT02831049|453498923|FG000|Overall Study|Pandemic shutdown|1|||
126055981|NCT02831049|453498924|FG001|Overall Study|Pandemic shutdown|0|||
126055982|NCT02831049|453498925|FG002|Overall Study|Pandemic shutdown|0|||
126055983|NCT04224272|453498926|FG000|Part 1 - Dose Finding|Death|4|||
126055984|NCT04224272|453498926|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
125891622|NCT02167139|452901315|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
125891623|NCT02167139|452901316|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
126055985|NCT04224272|453498926|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
126055986|NCT04224272|453498926|FG000|Part 2 - Dose Expansion|Death|10|||
126055987|NCT04224272|453498926|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
126055988|NCT02609048|453498927|FG000|Overall Study|Adverse Event|3|||
126055989|NCT02609048|453498928|FG001|Overall Study|Adverse Event|0|||
126055990|NCT02609048|453498929|FG002|Overall Study|Adverse Event|0|||
126055991|NCT02609048|453498927|FG000|Overall Study|Randomized but never treated|1|||
126055992|NCT02609048|453498928|FG001|Overall Study|Randomized but never treated|1|||
126055993|NCT02609048|453498929|FG002|Overall Study|Randomized but never treated|1|||
126055994|NCT02609048|453498927|FG000|Overall Study|Withdrawal of informed consent|1|||
126055995|NCT02609048|453498928|FG001|Overall Study|Withdrawal of informed consent|0|||
125891624|NCT02167139|452901313|FG000|Randomised, Double-blind|Other|3|||
126055996|NCT02609048|453498929|FG002|Overall Study|Withdrawal of informed consent|0|||
126055997|NCT02609048|453498927|FG000|Overall Study|Reason not specified|6|||
126055998|NCT02609048|453498928|FG001|Overall Study|Reason not specified|9|||
126055999|NCT02609048|453498929|FG002|Overall Study|Reason not specified|9|||
126056000|NCT02485925|453498930|FG000|Overall Study|Withdrawal by Subject|3|||
126056001|NCT02485925|453498930|FG000|Overall Study|Death|1|||
126056002|NCT02485925|453498930|FG000|Overall Study|Lost to Follow-up|11|||
126105629|NCT00288509|453681106|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
126056003|NCT05995977|453498931|FG000|Overall Study|Withdrawal by Subject|1|||
126056004|NCT05995977|453498932|FG001|Overall Study|Withdrawal by Subject|4|||
126056005|NCT05995977|453498931|FG000|Overall Study|Lost to Follow-up|2|||
126056006|NCT05995977|453498932|FG001|Overall Study|Lost to Follow-up|0|||
126056007|NCT04181788|453498933|FG000|TREATMENT|Adverse Event|0|||
126056008|NCT04181788|453498934|FG001|TREATMENT|Adverse Event|2|||
126056009|NCT04181788|453498935|FG002|TREATMENT|Adverse Event|1|||
126056010|NCT04181788|453498936|FG003|TREATMENT|Adverse Event|0|||
126056011|NCT04181788|453498937|FG004|TREATMENT|Adverse Event|1|||
126056012|NCT04181788|453498938|FG005|TREATMENT|Adverse Event|3|||
126056013|NCT04181788|453498933|FG000|TREATMENT|Death|0|||
126056014|NCT04181788|453498934|FG001|TREATMENT|Death|0|||
126056015|NCT04181788|453498935|FG002|TREATMENT|Death|0|||
126056016|NCT04181788|453498936|FG003|TREATMENT|Death|0|||
126056017|NCT04181788|453498937|FG004|TREATMENT|Death|8|||
126056018|NCT04181788|453498938|FG005|TREATMENT|Death|8|||
126056019|NCT04181788|453498933|FG000|TREATMENT|Physician Decision|0|||
126056020|NCT04181788|453498934|FG001|TREATMENT|Physician Decision|0|||
126056021|NCT04181788|453498935|FG002|TREATMENT|Physician Decision|0|||
126056022|NCT04181788|453498936|FG003|TREATMENT|Physician Decision|0|||
126056023|NCT04181788|453498937|FG004|TREATMENT|Physician Decision|0|||
126056024|NCT04181788|453498938|FG005|TREATMENT|Physician Decision|1|||
126056025|NCT04181788|453498933|FG000|TREATMENT|Progressive disease|3|||
126056026|NCT04181788|453498934|FG001|TREATMENT|Progressive disease|3|||
126056027|NCT04181788|453498935|FG002|TREATMENT|Progressive disease|5|||
126056028|NCT04181788|453498936|FG003|TREATMENT|Progressive disease|7|||
126056029|NCT04181788|453498937|FG004|TREATMENT|Progressive disease|20|||
126056030|NCT04181788|453498938|FG005|TREATMENT|Progressive disease|38|||
126056031|NCT04181788|453498933|FG000|TREATMENT|Global deterioration of health status|0|||
126056032|NCT04181788|453498934|FG001|TREATMENT|Global deterioration of health status|2|||
126056033|NCT04181788|453498935|FG002|TREATMENT|Global deterioration of health status|0|||
126056034|NCT04181788|453498936|FG003|TREATMENT|Global deterioration of health status|0|||
126056035|NCT04181788|453498937|FG004|TREATMENT|Global deterioration of health status|2|||
126056036|NCT04181788|453498938|FG005|TREATMENT|Global deterioration of health status|8|||
126056037|NCT04181788|453498933|FG000|TREATMENT|Withdrawal by Subject|1|||
126056038|NCT04181788|453498934|FG001|TREATMENT|Withdrawal by Subject|2|||
126056039|NCT04181788|453498935|FG002|TREATMENT|Withdrawal by Subject|0|||
126056040|NCT04181788|453498936|FG003|TREATMENT|Withdrawal by Subject|0|||
126056041|NCT04181788|453498937|FG004|TREATMENT|Withdrawal by Subject|3|||
126056042|NCT04181788|453498938|FG005|TREATMENT|Withdrawal by Subject|5|||
126056043|NCT04181788|453498933|FG000|TREATMENT|Other unspecified|0|||
126056044|NCT04181788|453498934|FG001|TREATMENT|Other unspecified|0|||
126056045|NCT04181788|453498935|FG002|TREATMENT|Other unspecified|0|||
126056046|NCT04181788|453498936|FG003|TREATMENT|Other unspecified|0|||
125891625|NCT02167139|452901314|FG001|Randomised, Double-blind|Other|0|||
126056047|NCT04181788|453498937|FG004|TREATMENT|Other unspecified|0|||
126056048|NCT04181788|453498938|FG005|TREATMENT|Other unspecified|2|||
126056049|NCT04181788|453498933|FG000|TREATMENT|Ongoing|0|||
126056050|NCT04181788|453498934|FG001|TREATMENT|Ongoing|3|||
126056051|NCT04181788|453498935|FG002|TREATMENT|Ongoing|0|||
126056052|NCT04181788|453498936|FG003|TREATMENT|Ongoing|5|||
126056053|NCT04181788|453498937|FG004|TREATMENT|Ongoing|7|||
126056054|NCT04181788|453498938|FG005|TREATMENT|Ongoing|15|||
126056055|NCT04181788|453498933|FG000|FOLLOW-UP|Death|0|||
126056056|NCT04181788|453498934|FG001|FOLLOW-UP|Death|0|||
126056057|NCT04181788|453498935|FG002|FOLLOW-UP|Death|1|||
126056058|NCT04181788|453498936|FG003|FOLLOW-UP|Death|2|||
126056059|NCT04181788|453498937|FG004|FOLLOW-UP|Death|8|||
126056060|NCT04181788|453498938|FG005|FOLLOW-UP|Death|20|||
126056061|NCT04181788|453498933|FG000|FOLLOW-UP|Lost to Follow-up|0|||
126056062|NCT04181788|453498934|FG001|FOLLOW-UP|Lost to Follow-up|0|||
126056063|NCT04181788|453498935|FG002|FOLLOW-UP|Lost to Follow-up|0|||
126056064|NCT04181788|453498936|FG003|FOLLOW-UP|Lost to Follow-up|0|||
126056065|NCT04181788|453498937|FG004|FOLLOW-UP|Lost to Follow-up|0|||
126056066|NCT04181788|453498938|FG005|FOLLOW-UP|Lost to Follow-up|2|||
126056067|NCT04181788|453498933|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
126056068|NCT04181788|453498934|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
126056069|NCT04181788|453498935|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
126056070|NCT04181788|453498936|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
126056071|NCT04181788|453498937|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
126056072|NCT04181788|453498938|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
126056073|NCT04181788|453498933|FG000|FOLLOW-UP|Other unspecified|0|||
126056074|NCT04181788|453498934|FG001|FOLLOW-UP|Other unspecified|1|||
126056075|NCT04181788|453498935|FG002|FOLLOW-UP|Other unspecified|0|||
126056076|NCT04181788|453498936|FG003|FOLLOW-UP|Other unspecified|0|||
126056077|NCT04181788|453498937|FG004|FOLLOW-UP|Other unspecified|0|||
126056078|NCT04181788|453498938|FG005|FOLLOW-UP|Other unspecified|3|||
126056079|NCT04181788|453498933|FG000|FOLLOW-UP|Ongoing|0|||
126056080|NCT04181788|453498934|FG001|FOLLOW-UP|Ongoing|0|||
126056081|NCT04181788|453498935|FG002|FOLLOW-UP|Ongoing|1|||
126056082|NCT04181788|453498936|FG003|FOLLOW-UP|Ongoing|3|||
126056083|NCT04181788|453498937|FG004|FOLLOW-UP|Ongoing|2|||
126056084|NCT04181788|453498938|FG005|FOLLOW-UP|Ongoing|2|||
126056085|NCT04937504|453498939|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
126056086|NCT04937504|453498940|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
126056087|NCT04937504|453498939|FG000|9 Months Assessment|Lost to Follow-up|3|||
126056088|NCT04937504|453498940|FG001|9 Months Assessment|Lost to Follow-up|2|||
126056089|NCT04535414|453498941|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
126056090|NCT04535414|453498942|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
126056091|NCT04535414|453498941|FG000|Overall Study|Cancelled appointment|1|||
126056092|NCT04535414|453498942|FG001|Overall Study|Cancelled appointment|0|||
126056093|NCT04535414|453498941|FG000|Overall Study|cancelled - food in stomach|2|||
126056094|NCT04535414|453498942|FG001|Overall Study|cancelled - food in stomach|0|||
126056095|NCT04535414|453498941|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
126056096|NCT04535414|453498942|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
126056097|NCT04535414|453498941|FG000|Overall Study|Withdrawal by Subject|0|||
126056098|NCT04535414|453498942|FG001|Overall Study|Withdrawal by Subject|1|||
126056099|NCT03662659|453498943|FG000|Pre-treatment|Participant no longer met study criteria|1|||
126056100|NCT03662659|453498944|FG001|Pre-treatment|Participant no longer met study criteria|1|||
126056101|NCT03662659|453498943|FG000|Pre-treatment|Other reasons|1|||
126056102|NCT03662659|453498944|FG001|Pre-treatment|Other reasons|0|||
126056103|NCT03662659|453498943|FG000|Treatment|Completed Treatment|0|||
126056104|NCT03662659|453498944|FG001|Treatment|Completed Treatment|2|||
126056105|NCT03662659|453498943|FG000|Treatment|Disease Progression|85|||
126056106|NCT03662659|453498944|FG001|Treatment|Disease Progression|97|||
126056107|NCT03662659|453498943|FG000|Treatment|Study Drug Toxicity|19|||
126056108|NCT03662659|453498944|FG001|Treatment|Study Drug Toxicity|9|||
126056109|NCT03662659|453498943|FG000|Treatment|Death|11|||
126056110|NCT03662659|453498944|FG001|Treatment|Death|9|||
126056111|NCT03662659|453498943|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
126056112|NCT03662659|453498944|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
126056113|NCT03662659|453498943|FG000|Treatment|Withdrawal by Subject|1|||
126105630|NCT00288509|453681106|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
126056114|NCT03662659|453498944|FG001|Treatment|Withdrawal by Subject|1|||
126056115|NCT03662659|453498943|FG000|Treatment|Poor/Non-compliance|1|||
126105631|NCT00288509|453681106|FG000|Treatment Cycle 4|Physician Decision|4|||
126105632|NCT00288509|453681106|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
126056116|NCT03662659|453498944|FG001|Treatment|Poor/Non-compliance|0|||
126056117|NCT03662659|453498943|FG000|Treatment|Participant no longer meets study criteria|1|||
126105633|NCT01155375|453681114|FG000|Overall Study|Adverse Event|1|||
126105634|NCT01155375|453681115|FG001|Overall Study|Adverse Event|0|||
126105635|NCT01480674|453681119|FG000|Overall Study|Death|23|||
126105636|NCT01480674|453681119|FG000|Overall Study|Lost to Follow-up|2|||
126105637|NCT01480674|453681119|FG000|Overall Study|visit not done|10|||
126105638|NCT03818204|453681120|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105639|NCT03818204|453681121|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105640|NCT03818204|453681122|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105641|NCT03818204|453681123|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105642|NCT03818204|453681124|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
126105643|NCT03818204|453681125|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105644|NCT03818204|453681126|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105645|NCT03818204|453681127|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105646|NCT03818204|453681128|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105647|NCT03818204|453681129|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125891626|NCT02167139|452901315|FG002|Randomised, Double-blind|Other|0|||
126105648|NCT03818204|453681130|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105649|NCT03818204|453681131|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105650|NCT03818204|453681132|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125891627|NCT02167139|452901316|FG003|Randomised, Double-blind|Other|0|||
126105651|NCT03818204|453681133|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
126056118|NCT03662659|453498944|FG001|Treatment|Participant no longer meets study criteria|0|||
126056119|NCT03662659|453498943|FG000|Treatment|Other reasons|10|||
126056120|NCT03662659|453498944|FG001|Treatment|Other reasons|8|||
126056121|NCT03662659|453498943|FG000|Treatment|Administrative reasons by sponsor|1|||
126056122|NCT03662659|453498944|FG001|Treatment|Administrative reasons by sponsor|0|||
126056123|NCT03662659|453498943|FG000|Treatment|maximum clinical benefit|0|||
126056124|NCT03662659|453498944|FG001|Treatment|maximum clinical benefit|2|||
126056125|NCT04118894|453498946|FG000|Overall Study|Lost to Follow-up|21|||
126056126|NCT04118894|453498946|FG000|Overall Study|Withdrawal by Subject|10|||
126056127|NCT04118894|453498946|FG000|Overall Study|Adverse Event|4|||
126056128|NCT02556918|453500805|FG000|Overall Study|Protocol Violation|5|||
126056129|NCT02556918|453500806|FG001|Overall Study|Protocol Violation|6|||
126056130|NCT02556918|453500805|FG000|Overall Study|Withdrawal by Subject|4|||
126056131|NCT02556918|453500806|FG001|Overall Study|Withdrawal by Subject|4|||
126056132|NCT01823224|453500817|FG000|Overall Study|Lost to Follow-up|5|||
125891628|NCT02167139|452901313|FG000|Transition-extension|Adverse Event|2|||
126056133|NCT01823224|453500818|FG001|Overall Study|Lost to Follow-up|6|||
126056134|NCT01823224|453500817|FG000|Overall Study|didn't qualify|1|||
126056135|NCT01823224|453500818|FG001|Overall Study|didn't qualify|2|||
126056136|NCT01823224|453500817|FG000|Overall Study|pharmacy error|0|||
126056137|NCT01823224|453500818|FG001|Overall Study|pharmacy error|1|||
126056138|NCT01823224|453500817|FG000|Overall Study|missed med dose|0|||
126056139|NCT01823224|453500818|FG001|Overall Study|missed med dose|1|||
126105652|NCT03818204|453681134|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126056140|NCT01823224|453500817|FG000|Overall Study|Withdrawal by Subject|0|||
126056141|NCT01823224|453500818|FG001|Overall Study|Withdrawal by Subject|1|||
126056142|NCT01673594|453500828|FG000|Overall Study|Adverse Event|3|||
125891629|NCT02167139|452901314|FG001|Transition-extension|Adverse Event|0|||
126056143|NCT01673594|453500829|FG001|Overall Study|Adverse Event|1|||
126105653|NCT03818204|453681135|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126056144|NCT01673594|453500828|FG000|Overall Study|Lost to Follow-up|1|||
125891630|NCT02167139|452901315|FG002|Transition-extension|Adverse Event|2|||
125891631|NCT02167139|452901316|FG003|Transition-extension|Adverse Event|3|||
125891632|NCT02167139|452901313|FG000|Transition-extension|Withdrawal by Subject|2|||
126105654|NCT03818204|453681136|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126105655|NCT03818204|453681137|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126056145|NCT01673594|453500829|FG001|Overall Study|Lost to Follow-up|0|||
126056146|NCT01673594|453500828|FG000|Overall Study|Physician Decision|2|||
126056147|NCT01673594|453500829|FG001|Overall Study|Physician Decision|4|||
126056148|NCT01673594|453500828|FG000|Overall Study|Withdrawal by Subject|0|||
126056149|NCT01673594|453500829|FG001|Overall Study|Withdrawal by Subject|1|||
126056150|NCT03883828|453500832|FG000|Overall Study|Did not start radiotherapy|1|||
126056151|NCT03883828|453500833|FG001|Overall Study|Did not start radiotherapy|2|||
126056152|NCT04938453|453500836|FG000|Washout Period 1|Adverse Event|1|||
126056153|NCT04938453|453500837|FG001|Washout Period 1|Adverse Event|0|||
126056154|NCT04938453|453500836|FG000|Washout Period 1|Physician Decision|0|||
126056155|NCT04938453|453500837|FG001|Washout Period 1|Physician Decision|1|||
126056156|NCT00273052|453500841|FG000|Overall Study|Withdrawal by Subject|16|||
126056157|NCT00273052|453500842|FG001|Overall Study|Withdrawal by Subject|19|||
126056158|NCT00273052|453500841|FG000|Overall Study|Adverse Event|21|||
126056159|NCT00273052|453500842|FG001|Overall Study|Adverse Event|19|||
126056160|NCT00273052|453500841|FG000|Overall Study|Protocol Violation|14|||
126056161|NCT00273052|453500842|FG001|Overall Study|Protocol Violation|18|||
126056162|NCT00273052|453500841|FG000|Overall Study|Lost to Follow-up|7|||
126056163|NCT00273052|453500842|FG001|Overall Study|Lost to Follow-up|25|||
126056164|NCT00273052|453500841|FG000|Overall Study|Lack of Efficacy|6|||
126056165|NCT00273052|453500842|FG001|Overall Study|Lack of Efficacy|4|||
126105656|NCT03818204|453681138|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126056166|NCT00273052|453500841|FG000|Overall Study|Non-Compliance|3|||
126056167|NCT00273052|453500842|FG001|Overall Study|Non-Compliance|1|||
126056168|NCT00273052|453500841|FG000|Overall Study|Other|2|||
126105657|NCT03818204|453681120|FG000|Overall Study|Physician Decision|0|||
126056169|NCT00273052|453500842|FG001|Overall Study|Other|0|||
126056170|NCT00273052|453500841|FG000|Overall Study|Worsening serum lipid levels|0|||
126056171|NCT00273052|453500842|FG001|Overall Study|Worsening serum lipid levels|2|||
126056172|NCT00454194|453500844|FG000|Overall Study|Adverse Event|7|||
126056173|NCT00454194|453500845|FG001|Overall Study|Adverse Event|2|||
126056174|NCT00454194|453500844|FG000|Overall Study|Withdrawal by Subject|12|||
126105658|NCT03818204|453681121|FG001|Overall Study|Physician Decision|0|||
126105659|NCT03818204|453681122|FG002|Overall Study|Physician Decision|0|||
126105660|NCT03818204|453681123|FG003|Overall Study|Physician Decision|0|||
126105661|NCT03818204|453681124|FG004|Overall Study|Physician Decision|0|||
126105662|NCT03818204|453681125|FG005|Overall Study|Physician Decision|0|||
126105663|NCT03818204|453681126|FG006|Overall Study|Physician Decision|0|||
126105664|NCT03818204|453681127|FG007|Overall Study|Physician Decision|0|||
126105665|NCT03818204|453681128|FG008|Overall Study|Physician Decision|0|||
126105666|NCT03818204|453681129|FG009|Overall Study|Physician Decision|0|||
126056175|NCT00454194|453500845|FG001|Overall Study|Withdrawal by Subject|8|||
126056176|NCT00454194|453500844|FG000|Overall Study|Other Medical Problems|1|||
126056177|NCT00454194|453500845|FG001|Overall Study|Other Medical Problems|2|||
126056178|NCT00454194|453500844|FG000|Overall Study|Other Unspecified Reason|2|||
126056179|NCT00454194|453500845|FG001|Overall Study|Other Unspecified Reason|2|||
126056180|NCT02827201|453500846|FG000|Overall Study|Death|1|||
126056181|NCT02827201|453500847|FG001|Overall Study|Death|2|||
126056182|NCT02827201|453500846|FG000|Overall Study|Patients not treated|1|||
126056183|NCT02827201|453500847|FG001|Overall Study|Patients not treated|1|||
126056184|NCT03345979|453500848|FG000|Overall Study|Withdrawal by Subject|20|||
126056185|NCT03345979|453500849|FG001|Overall Study|Withdrawal by Subject|31|||
126056186|NCT03345979|453500848|FG000|Overall Study|Adverse Event|10|||
126056187|NCT03345979|453500849|FG001|Overall Study|Adverse Event|11|||
126056188|NCT03345979|453500848|FG000|Overall Study|Lost to Follow-up|8|||
126056189|NCT03345979|453500849|FG001|Overall Study|Lost to Follow-up|9|||
126056190|NCT03345979|453500848|FG000|Overall Study|Lack of Efficacy|4|||
126056191|NCT03345979|453500849|FG001|Overall Study|Lack of Efficacy|2|||
126056192|NCT03345979|453500848|FG000|Overall Study|Protocol Violation|1|||
126056193|NCT03345979|453500849|FG001|Overall Study|Protocol Violation|3|||
126056194|NCT03345979|453500848|FG000|Overall Study|Physician Decision|0|||
126056195|NCT03345979|453500849|FG001|Overall Study|Physician Decision|2|||
126056196|NCT00620854|453500850|FG000|Washout 1|Withdrawal by Subject|0|||
126056197|NCT00620854|453500851|FG001|Washout 1|Withdrawal by Subject|0|||
126056198|NCT00620854|453500852|FG002|Washout 1|Withdrawal by Subject|1|||
126056199|NCT00620854|453500853|FG003|Washout 1|Withdrawal by Subject|1|||
126056200|NCT00620854|453500854|FG004|Washout 1|Withdrawal by Subject|0|||
126056201|NCT00620854|453500855|FG005|Washout 1|Withdrawal by Subject|0|||
126056202|NCT00999596|453500856|FG000|Overall Study|Statistical population not required|101|||
126056203|NCT00439218|453500859|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
126056204|NCT03176407|453500860|FG000|Overall Study|Protocol Violation|1|||
126056205|NCT03176407|453500860|FG000|Overall Study|human failure|1|||
126056206|NCT03176407|453500860|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
126056207|NCT01428583|453500862|FG000|Overall Study|Adverse Event|75|||
126056208|NCT01428583|453500862|FG000|Overall Study|Withdrawal by Subject|51|||
126056209|NCT01428583|453500862|FG000|Overall Study|Lack of Efficacy|37|||
126056210|NCT01428583|453500862|FG000|Overall Study|Lost to Follow-up|17|||
126056211|NCT01428583|453500862|FG000|Overall Study|Death|1|||
126056212|NCT01428583|453500862|FG000|Overall Study|Pregnancy|1|||
126056213|NCT01428583|453500862|FG000|Overall Study|Protocol Violation|1|||
126056214|NCT01428583|453500862|FG000|Overall Study|Physician Decision|12|||
126056215|NCT01428583|453500862|FG000|Overall Study|Non-compliant|25|||
126056216|NCT01428583|453500862|FG000|Overall Study|Confirmed positive urine drug test|8|||
126105667|NCT03818204|453681130|FG010|Overall Study|Physician Decision|0|||
126105668|NCT03818204|453681131|FG011|Overall Study|Physician Decision|0|||
125891633|NCT02167139|452901314|FG001|Transition-extension|Withdrawal by Subject|0|||
126056217|NCT01428583|453500862|FG000|Overall Study|Sponsor's request|3|||
126056218|NCT01428583|453500862|FG000|Overall Study|Other|6|||
126056219|NCT01124045|453500864|FG000|Overall Study|Lost to Follow-up|0|||
126056220|NCT01124045|453500865|FG001|Overall Study|Lost to Follow-up|1|||
126056221|NCT01124045|453500864|FG000|Overall Study|Physician Decision|0|||
126056222|NCT01124045|453500865|FG001|Overall Study|Physician Decision|2|||
126056223|NCT05553366|453500866|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
126056224|NCT05553366|453500867|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
126056225|NCT05553366|453500868|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
126056226|NCT05553366|453500866|FG000|Overall Study|Lost to Follow-up|3|||
126056227|NCT05553366|453500867|FG001|Overall Study|Lost to Follow-up|3|||
126056228|NCT05553366|453500868|FG002|Overall Study|Lost to Follow-up|3|||
126056229|NCT05553366|453500866|FG000|Overall Study|Other non-compliance|1|||
126056230|NCT05553366|453500867|FG001|Overall Study|Other non-compliance|1|||
126056231|NCT05553366|453500868|FG002|Overall Study|Other non-compliance|0|||
126056232|NCT05553366|453500866|FG000|Overall Study|Randomized but not dosed|0|||
126056233|NCT05553366|453500867|FG001|Overall Study|Randomized but not dosed|0|||
126056234|NCT05553366|453500868|FG002|Overall Study|Randomized but not dosed|2|||
126056235|NCT02022657|453500869|FG000|Overall Study|Withdrawal by Subject|2|||
126056236|NCT02022657|453500870|FG001|Overall Study|Withdrawal by Subject|0|||
126056237|NCT02022657|453500871|FG002|Overall Study|Withdrawal by Subject|1|||
126056238|NCT02022657|453500872|FG003|Overall Study|Withdrawal by Subject|0|||
126056239|NCT02022657|453500873|FG004|Overall Study|Withdrawal by Subject|0|||
126056240|NCT02022657|453500874|FG005|Overall Study|Withdrawal by Subject|0|||
126056241|NCT02022657|453500869|FG000|Overall Study|Physician Decision|0|||
126056242|NCT02022657|453500870|FG001|Overall Study|Physician Decision|0|||
126056243|NCT02022657|453500871|FG002|Overall Study|Physician Decision|0|||
126056244|NCT02022657|453500872|FG003|Overall Study|Physician Decision|0|||
126056245|NCT02022657|453500873|FG004|Overall Study|Physician Decision|0|||
126056246|NCT02022657|453500874|FG005|Overall Study|Physician Decision|1|||
126056247|NCT00659373|453500879|FG000|Overall Study|Withdrawal by Subject|3|||
126056248|NCT00659373|453500880|FG001|Overall Study|Withdrawal by Subject|5|||
126056249|NCT00659373|453500879|FG000|Overall Study|Assessment Missed|2|||
126056250|NCT00659373|453500880|FG001|Overall Study|Assessment Missed|2|||
126056251|NCT02382640|453500881|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
126056252|NCT02382640|453500882|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
126056253|NCT02382640|453500883|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
126056254|NCT02382640|453500884|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
126056255|NCT03162614|453500887|FG000|Overall Study|Lost to Follow-up|2|||
126056256|NCT03162614|453500888|FG001|Overall Study|Lost to Follow-up|1|||
126056257|NCT03162614|453500889|FG002|Overall Study|Lost to Follow-up|1|||
126056258|NCT03162614|453500890|FG003|Overall Study|Lost to Follow-up|1|||
126056259|NCT03162614|453500891|FG004|Overall Study|Lost to Follow-up|2|||
126056260|NCT03162614|453500892|FG005|Overall Study|Lost to Follow-up|0|||
126056261|NCT03162614|453500887|FG000|Overall Study|Protocol Violation|0|||
126056262|NCT03162614|453500888|FG001|Overall Study|Protocol Violation|1|||
126056263|NCT03162614|453500889|FG002|Overall Study|Protocol Violation|0|||
126056264|NCT03162614|453500890|FG003|Overall Study|Protocol Violation|1|||
126056265|NCT03162614|453500891|FG004|Overall Study|Protocol Violation|0|||
125891634|NCT02167139|452901315|FG002|Transition-extension|Withdrawal by Subject|4|||
125891635|NCT02167139|452901316|FG003|Transition-extension|Withdrawal by Subject|1|||
126056266|NCT03162614|453500892|FG005|Overall Study|Protocol Violation|0|||
126056267|NCT03162614|453500887|FG000|Overall Study|Withdrawal by Subject|2|||
126056268|NCT03162614|453500888|FG001|Overall Study|Withdrawal by Subject|1|||
126056269|NCT03162614|453500889|FG002|Overall Study|Withdrawal by Subject|1|||
126056270|NCT03162614|453500890|FG003|Overall Study|Withdrawal by Subject|1|||
126056271|NCT03162614|453500891|FG004|Overall Study|Withdrawal by Subject|0|||
125891636|NCT02167139|452901313|FG000|Transition-extension|Lack of Efficacy|0|||
126056272|NCT03162614|453500892|FG005|Overall Study|Withdrawal by Subject|0|||
126056273|NCT03162614|453500887|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
126056274|NCT03162614|453500888|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
126056275|NCT03162614|453500889|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
125891637|NCT02167139|452901314|FG001|Transition-extension|Lack of Efficacy|0|||
125891638|NCT02167139|452901315|FG002|Transition-extension|Lack of Efficacy|1|||
125891639|NCT02167139|452901316|FG003|Transition-extension|Lack of Efficacy|1|||
125891640|NCT02167139|452901313|FG000|Transition-extension|Other|1|||
125891641|NCT02167139|452901314|FG001|Transition-extension|Other|0|||
125891642|NCT02167139|452901315|FG002|Transition-extension|Other|1|||
125891643|NCT02167139|452901316|FG003|Transition-extension|Other|0|||
125891644|NCT02167139|452901313|FG000|Transition-extension|Lost to Follow-up|1|||
125891645|NCT02167139|452901314|FG001|Transition-extension|Lost to Follow-up|0|||
125891646|NCT02167139|452901315|FG002|Transition-extension|Lost to Follow-up|0|||
125891647|NCT02167139|452901316|FG003|Transition-extension|Lost to Follow-up|0|||
125891648|NCT00947882|452901330|FG000|Overall Study|Adverse Event|0|||
125891649|NCT00947882|452901331|FG001|Overall Study|Adverse Event|1|||
126056276|NCT03162614|453500890|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
126056277|NCT03162614|453500891|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
126056278|NCT03162614|453500892|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
126056279|NCT00380250|453500893|FG000|Overall Study|Withdrawal by Subject|39|||
126056280|NCT00380250|453500894|FG001|Overall Study|Withdrawal by Subject|28|||
126056281|NCT00380250|453500893|FG000|Overall Study|Adverse Event|20|||
126056282|NCT00380250|453500894|FG001|Overall Study|Adverse Event|9|||
126056283|NCT00380250|453500893|FG000|Overall Study|Lack of Efficacy|10|||
126056284|NCT00380250|453500894|FG001|Overall Study|Lack of Efficacy|8|||
126056285|NCT00380250|453500893|FG000|Overall Study|Protocol Violation|15|||
126056286|NCT00380250|453500894|FG001|Overall Study|Protocol Violation|5|||
126056287|NCT00380250|453500893|FG000|Overall Study|Lost to Follow-up|14|||
126056288|NCT00380250|453500894|FG001|Overall Study|Lost to Follow-up|5|||
126056289|NCT00380250|453500893|FG000|Overall Study|Physician Decision|1|||
126056290|NCT00380250|453500894|FG001|Overall Study|Physician Decision|0|||
126056291|NCT02630966|453500895|FG000|Overall Study|Adverse Event|1|||
126056292|NCT02630966|453500896|FG001|Overall Study|Adverse Event|3|||
126056293|NCT02630966|453500895|FG000|Overall Study|Significant Protocol Deviation|0|||
126056294|NCT02630966|453500896|FG001|Overall Study|Significant Protocol Deviation|2|||
126056295|NCT02630966|453500895|FG000|Overall Study|Voluntary Withdrawal|1|||
126056296|NCT02630966|453500896|FG001|Overall Study|Voluntary Withdrawal|1|||
126056297|NCT02630966|453500895|FG000|Overall Study|Lack of Efficacy|0|||
126056298|NCT02630966|453500896|FG001|Overall Study|Lack of Efficacy|2|||
126056299|NCT00641537|453500897|FG000|96-week Period|Adverse Event|0|||
126056300|NCT00641537|453500898|FG001|96-week Period|Adverse Event|1|||
126056301|NCT00641537|453500899|FG002|96-week Period|Adverse Event|3|||
126056302|NCT00641537|453500900|FG003|96-week Period|Adverse Event|0|||
126056303|NCT00641537|453500901|FG004|96-week Period|Adverse Event|2|||
126056304|NCT00641537|453500902|FG005|96-week Period|Adverse Event|0|||
126056305|NCT00641537|453500903|FG006|96-week Period|Adverse Event|0|||
126056306|NCT00641537|453500904|FG007|96-week Period|Adverse Event|0|||
126056307|NCT00641537|453500897|FG000|96-week Period|Lost to Follow-up|3|||
126056308|NCT00641537|453500898|FG001|96-week Period|Lost to Follow-up|1|||
126056309|NCT00641537|453500899|FG002|96-week Period|Lost to Follow-up|2|||
126056310|NCT00641537|453500900|FG003|96-week Period|Lost to Follow-up|2|||
126056311|NCT00641537|453500901|FG004|96-week Period|Lost to Follow-up|4|||
126056312|NCT00641537|453500902|FG005|96-week Period|Lost to Follow-up|0|||
126056313|NCT00641537|453500903|FG006|96-week Period|Lost to Follow-up|1|||
126056314|NCT00641537|453500904|FG007|96-week Period|Lost to Follow-up|0|||
126056315|NCT00641537|453500897|FG000|96-week Period|Protocol Violation|0|||
126056316|NCT00641537|453500898|FG001|96-week Period|Protocol Violation|1|||
126056317|NCT00641537|453500899|FG002|96-week Period|Protocol Violation|0|||
126056318|NCT00641537|453500900|FG003|96-week Period|Protocol Violation|1|||
126056319|NCT00641537|453500901|FG004|96-week Period|Protocol Violation|0|||
126056320|NCT00641537|453500902|FG005|96-week Period|Protocol Violation|1|||
126056321|NCT00641537|453500903|FG006|96-week Period|Protocol Violation|0|||
126056322|NCT00641537|453500904|FG007|96-week Period|Protocol Violation|0|||
126056323|NCT00641537|453500897|FG000|96-week Period|Death|2|||
126056324|NCT00641537|453500898|FG001|96-week Period|Death|0|||
126056325|NCT00641537|453500899|FG002|96-week Period|Death|1|||
126056326|NCT00641537|453500900|FG003|96-week Period|Death|0|||
126056327|NCT00641537|453500901|FG004|96-week Period|Death|0|||
126056328|NCT00641537|453500902|FG005|96-week Period|Death|0|||
126056329|NCT00641537|453500903|FG006|96-week Period|Death|0|||
126056330|NCT00641537|453500904|FG007|96-week Period|Death|0|||
126056331|NCT00641537|453500897|FG000|96-week Period|Other|4|||
126056332|NCT00641537|453500898|FG001|96-week Period|Other|7|||
126056333|NCT00641537|453500899|FG002|96-week Period|Other|14|||
126056334|NCT00641537|453500900|FG003|96-week Period|Other|9|||
126056335|NCT00641537|453500901|FG004|96-week Period|Other|11|||
126056336|NCT00641537|453500902|FG005|96-week Period|Other|6|||
126056337|NCT00641537|453500903|FG006|96-week Period|Other|4|||
126056338|NCT00641537|453500904|FG007|96-week Period|Other|6|||
126056339|NCT00641537|453500897|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
126056340|NCT00641537|453500898|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
126056341|NCT00641537|453500899|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
126056342|NCT00641537|453500900|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
126056343|NCT00641537|453500901|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
126056344|NCT00641537|453500902|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
126056345|NCT00641537|453500903|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
126056346|NCT00641537|453500904|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
126056347|NCT00641537|453500897|FG000|24-Week Supplemental Follow-up Period|Other|0|||
126056348|NCT00641537|453500898|FG001|24-Week Supplemental Follow-up Period|Other|2|||
126056349|NCT00641537|453500899|FG002|24-Week Supplemental Follow-up Period|Other|2|||
126056350|NCT00641537|453500900|FG003|24-Week Supplemental Follow-up Period|Other|1|||
126056351|NCT00641537|453500901|FG004|24-Week Supplemental Follow-up Period|Other|3|||
126056352|NCT00641537|453500902|FG005|24-Week Supplemental Follow-up Period|Other|0|||
126056353|NCT00641537|453500903|FG006|24-Week Supplemental Follow-up Period|Other|1|||
126105669|NCT03818204|453681132|FG012|Overall Study|Physician Decision|0|||
126105670|NCT03818204|453681133|FG013|Overall Study|Physician Decision|0|||
126105671|NCT03818204|453681134|FG014|Overall Study|Physician Decision|1|||
126105672|NCT03818204|453681135|FG015|Overall Study|Physician Decision|0|||
126105673|NCT03818204|453681136|FG016|Overall Study|Physician Decision|0|||
126105674|NCT03818204|453681137|FG017|Overall Study|Physician Decision|0|||
126105675|NCT03818204|453681138|FG018|Overall Study|Physician Decision|0|||
126105676|NCT00887250|453681139|FG000|Overall Study|Adverse Event|3|||
126105677|NCT00887250|453681140|FG001|Overall Study|Adverse Event|0|||
126105678|NCT00887250|453681141|FG002|Overall Study|Adverse Event|7|||
126105679|NCT00887250|453681139|FG000|Overall Study|Lack of Efficacy|9|||
126105680|NCT00887250|453681140|FG001|Overall Study|Lack of Efficacy|6|||
126105681|NCT00887250|453681141|FG002|Overall Study|Lack of Efficacy|1|||
126105682|NCT00887250|453681139|FG000|Overall Study|Lost to Follow-up|2|||
126105683|NCT00887250|453681140|FG001|Overall Study|Lost to Follow-up|3|||
126105684|NCT00887250|453681141|FG002|Overall Study|Lost to Follow-up|1|||
126105685|NCT00887250|453681139|FG000|Overall Study|Protocol Violation|2|||
126105686|NCT00887250|453681140|FG001|Overall Study|Protocol Violation|2|||
126105687|NCT00887250|453681141|FG002|Overall Study|Protocol Violation|1|||
125891650|NCT00947882|452901332|FG002|Overall Study|Adverse Event|4|||
125891651|NCT00947882|452901333|FG003|Overall Study|Adverse Event|4|||
125891652|NCT00947882|452901330|FG000|Overall Study|Withdrawal by Subject|2|||
125891653|NCT00947882|452901331|FG001|Overall Study|Withdrawal by Subject|0|||
126105688|NCT00887250|453681139|FG000|Overall Study|Withdrawal by Subject|2|||
126105689|NCT00887250|453681140|FG001|Overall Study|Withdrawal by Subject|1|||
126105690|NCT00887250|453681141|FG002|Overall Study|Withdrawal by Subject|2|||
126105691|NCT00887250|453681139|FG000|Overall Study|Patient uncooperative|0|||
126105692|NCT00887250|453681140|FG001|Overall Study|Patient uncooperative|0|||
126105693|NCT00887250|453681141|FG002|Overall Study|Patient uncooperative|1|||
126105694|NCT01933113|453681142|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
126105695|NCT00879762|453681143|FG000|Overall Study|Lost to Follow-up|3|||
126056354|NCT00641537|453500904|FG007|24-Week Supplemental Follow-up Period|Other|1|||
126056355|NCT01801007|453500905|FG000|Overall Study|Adverse Event|2|||
126056356|NCT01801007|453500905|FG000|Overall Study|Lost to Follow-up|4|||
126056357|NCT01801007|453500905|FG000|Overall Study|Withdrawal by Subject|5|||
126056358|NCT00665392|453500906|FG000|Overall Study|not treated|1|||
126056359|NCT00243867|453500907|FG000|Overall Study|Adverse Event|24|||
126056360|NCT00243867|453500908|FG001|Overall Study|Adverse Event|34|||
126056361|NCT00243867|453500907|FG000|Overall Study|Lack of Efficacy|115|||
126056362|NCT00243867|453500908|FG001|Overall Study|Lack of Efficacy|78|||
126056363|NCT00243867|453500907|FG000|Overall Study|Withdrawal by Subject|11|||
126056364|NCT00243867|453500908|FG001|Overall Study|Withdrawal by Subject|23|||
126056365|NCT00243867|453500907|FG000|Overall Study|Lost to Follow-up|2|||
126056366|NCT00243867|453500908|FG001|Overall Study|Lost to Follow-up|1|||
126056367|NCT00243867|453500907|FG000|Overall Study|Physician Decision|2|||
126056368|NCT00243867|453500908|FG001|Overall Study|Physician Decision|7|||
126056369|NCT00243867|453500907|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
126056370|NCT00243867|453500908|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
126056371|NCT01321073|453500913|FG000|Overall Study|Did not attempt implant|4|||
126056372|NCT01321073|453500913|FG000|Overall Study|Death|3|||
126056373|NCT01638000|453500920|FG000|Overall Study|Randomized but Never Received Drug|7|||
126056374|NCT01638000|453500921|FG001|Overall Study|Randomized but Never Received Drug|10|||
126056375|NCT01638000|453500920|FG000|Overall Study|Adverse Event|14|||
126056376|NCT01638000|453500921|FG001|Overall Study|Adverse Event|16|||
126056377|NCT01638000|453500920|FG000|Overall Study|Lack of Efficacy|5|||
126056378|NCT01638000|453500921|FG001|Overall Study|Lack of Efficacy|6|||
126056379|NCT01638000|453500920|FG000|Overall Study|Protocol Violation|11|||
126056380|NCT01638000|453500921|FG001|Overall Study|Protocol Violation|13|||
126056381|NCT01638000|453500920|FG000|Overall Study|Withdrawal by Subject|21|||
126056382|NCT01638000|453500921|FG001|Overall Study|Withdrawal by Subject|24|||
126056383|NCT01638000|453500920|FG000|Overall Study|Miscellaneous|2|||
126056384|NCT01638000|453500921|FG001|Overall Study|Miscellaneous|2|||
126056385|NCT05352230|453500922|FG000|First Intervention (3 Months)|study terminated|2|||
126056386|NCT05352230|453500923|FG001|First Intervention (3 Months)|study terminated|2|||
126056387|NCT01683409|453500924|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
126056388|NCT01683409|453500925|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
126056389|NCT01683409|453500926|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
126056390|NCT01683409|453500927|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
126105696|NCT00879762|453681144|FG001|Overall Study|Lost to Follow-up|1|||
126056391|NCT01683409|453500928|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
126056392|NCT01683409|453500924|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
126056393|NCT01683409|453500925|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
126105697|NCT04981366|453681145|FG000|Overall Study|Withdrawal by Subject|5|||
126105698|NCT04981366|453681146|FG001|Overall Study|Withdrawal by Subject|4|||
126105699|NCT04981366|453681147|FG002|Overall Study|Withdrawal by Subject|8|||
126105700|NCT04981366|453681145|FG000|Overall Study|Health issues unrelated to the trial|1|||
126105701|NCT04981366|453681146|FG001|Overall Study|Health issues unrelated to the trial|2|||
126105702|NCT04981366|453681147|FG002|Overall Study|Health issues unrelated to the trial|0|||
126105703|NCT00881608|453681148|FG000|Overall Study|Study prematurely terminated|11|||
126105704|NCT03214094|453681149|FG000|Overall Study|Case Report Forms Uncollected|14|||
126105705|NCT03214094|453681149|FG000|Overall Study|Protocol Deviation|46|||
126105706|NCT00795951|453681152|FG000|Overall Study|Lost to Follow-up|1|||
126105707|NCT00795951|453681152|FG000|Overall Study|Withdrawal by Subject|1|||
126105708|NCT01122862|453681164|FG000|Period 1|Protocol Violation|0|||
126105709|NCT01122862|453681165|FG001|Period 1|Protocol Violation|1|||
126105710|NCT01122862|453681166|FG002|Period 1|Protocol Violation|0|||
126105711|NCT01122862|453681164|FG000|Period 2|Adverse Event|0|||
126105712|NCT01122862|453681165|FG001|Period 2|Adverse Event|0|||
126105713|NCT01122862|453681166|FG002|Period 2|Adverse Event|1|||
126105714|NCT02699983|453681169|FG000|Overall Study|Withdrawal by Subject|1|||
126105715|NCT02699983|453681170|FG001|Overall Study|Withdrawal by Subject|0|||
126105716|NCT03421431|453681171|FG000|Overall Study|Adverse Event|2|||
126105717|NCT03421431|453681172|FG001|Overall Study|Adverse Event|1|||
125891654|NCT00947882|452901332|FG002|Overall Study|Withdrawal by Subject|8|||
125891655|NCT00947882|452901333|FG003|Overall Study|Withdrawal by Subject|2|||
125891656|NCT00947882|452901330|FG000|Overall Study|Protocol Violation|0|||
125891657|NCT00947882|452901331|FG001|Overall Study|Protocol Violation|0|||
125891658|NCT00947882|452901332|FG002|Overall Study|Protocol Violation|1|||
125891659|NCT00947882|452901333|FG003|Overall Study|Protocol Violation|0|||
125891660|NCT00947882|452901330|FG000|Overall Study|Lost to Follow-up|0|||
125891661|NCT00947882|452901331|FG001|Overall Study|Lost to Follow-up|2|||
125891662|NCT00947882|452901332|FG002|Overall Study|Lost to Follow-up|1|||
125891663|NCT00947882|452901333|FG003|Overall Study|Lost to Follow-up|0|||
125891664|NCT00947882|452901330|FG000|Overall Study|Other/Unknown|10|||
125891665|NCT00947882|452901331|FG001|Overall Study|Other/Unknown|13|||
125891666|NCT00947882|452901332|FG002|Overall Study|Other/Unknown|3|||
125891667|NCT00947882|452901333|FG003|Overall Study|Other/Unknown|6|||
125891668|NCT00947882|452901330|FG000|Overall Study|Trial Terminated by Sponsor|62|||
125891669|NCT00947882|452901331|FG001|Overall Study|Trial Terminated by Sponsor|61|||
125891670|NCT00947882|452901332|FG002|Overall Study|Trial Terminated by Sponsor|62|||
125891671|NCT00947882|452901333|FG003|Overall Study|Trial Terminated by Sponsor|70|||
125891672|NCT00329797|452901334|FG000|Overall Study|Protocol Violation|1|||
125891673|NCT00329797|452901335|FG001|Overall Study|Protocol Violation|0|||
125891674|NCT00329797|452901334|FG000|Overall Study|Withdrawal by Subject|6|||
125891675|NCT00329797|452901335|FG001|Overall Study|Withdrawal by Subject|6|||
125891676|NCT01396057|452901336|FG000|Overall Study|Adverse Event|2|||
125891677|NCT01396057|452901337|FG001|Overall Study|Adverse Event|6|||
125891678|NCT01396057|452901336|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125891679|NCT01396057|452901337|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125891680|NCT01396057|452901336|FG000|Overall Study|Protocol deviation|4|||
125891681|NCT01396057|452901337|FG001|Overall Study|Protocol deviation|4|||
125891682|NCT01396057|452901336|FG000|Overall Study|Consent withdrawn|3|||
125891683|NCT01396057|452901337|FG001|Overall Study|Consent withdrawn|2|||
125891684|NCT03037580|452901340|FG000|Overall Study|Withdrawal by Subject|3|||
125891685|NCT03037580|452901341|FG001|Overall Study|Withdrawal by Subject|0|||
125891686|NCT03037580|452901340|FG000|Overall Study|Adverse Event|1|||
125891687|NCT03037580|452901341|FG001|Overall Study|Adverse Event|0|||
125891688|NCT03037580|452901340|FG000|Overall Study|Study Terminated by Sponsor|12|||
125891689|NCT03037580|452901341|FG001|Overall Study|Study Terminated by Sponsor|15|||
125891690|NCT03037580|452901340|FG000|Overall Study|Death|0|||
125891691|NCT03037580|452901341|FG001|Overall Study|Death|1|||
125891692|NCT02087423|452901342|FG000|Overall Study|Withdrawal by Subject|20|||
125891693|NCT02087423|452901343|FG001|Overall Study|Withdrawal by Subject|20|||
125891694|NCT02087423|452901344|FG002|Overall Study|Withdrawal by Subject|3|||
125891695|NCT02087423|452901342|FG000|Overall Study|Death|68|||
125891696|NCT02087423|452901343|FG001|Overall Study|Death|207|||
125891697|NCT02087423|452901344|FG002|Overall Study|Death|40|||
125891698|NCT02087423|452901342|FG000|Overall Study|Lost to Follow-up|0|||
125891699|NCT02087423|452901343|FG001|Overall Study|Lost to Follow-up|2|||
125891700|NCT02087423|452901344|FG002|Overall Study|Lost to Follow-up|0|||
125891701|NCT02087423|452901342|FG000|Overall Study|Terminated from study at final DCO|23|||
126056394|NCT01683409|453500926|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
126056395|NCT01683409|453500927|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
126056396|NCT01683409|453500928|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
126056397|NCT01683409|453500924|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
125891702|NCT02087423|452901343|FG001|Overall Study|Terminated from study at final DCO|36|||
125891703|NCT02087423|452901344|FG002|Overall Study|Terminated from study at final DCO|25|||
125891704|NCT03500224|452901345|FG000|Overall Study|Withdrawal by Subject|2|||
126056398|NCT01683409|453500925|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
126056399|NCT01683409|453500926|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
126056400|NCT01683409|453500927|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
126056401|NCT01683409|453500928|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
126056402|NCT01683409|453500924|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
126056403|NCT01683409|453500925|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
126056404|NCT01683409|453500926|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
126056405|NCT01683409|453500927|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
126056406|NCT01683409|453500928|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
126056407|NCT01683409|453500924|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
126056408|NCT01683409|453500925|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
126056409|NCT01683409|453500926|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
126056410|NCT01683409|453500927|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
126056411|NCT01683409|453500928|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
126056412|NCT01683409|453500924|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
126056413|NCT01683409|453500925|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
126056414|NCT01683409|453500926|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
126056415|NCT01683409|453500927|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
126056416|NCT01683409|453500928|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
126056417|NCT01683409|453500924|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
126056418|NCT01683409|453500925|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
126056419|NCT01683409|453500926|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
126056420|NCT01683409|453500927|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
126056421|NCT01683409|453500928|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
126056422|NCT01683409|453500924|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
126056423|NCT01683409|453500925|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
126056424|NCT01683409|453500926|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
126056425|NCT01683409|453500927|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
126056426|NCT01683409|453500928|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
126056427|NCT01683409|453500924|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
126056428|NCT01683409|453500925|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
126056429|NCT01683409|453500926|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
126056430|NCT01683409|453500927|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
126056431|NCT01683409|453500928|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
126056432|NCT01683409|453500924|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
126056433|NCT01683409|453500925|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
126056434|NCT01683409|453500926|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
126056435|NCT01683409|453500927|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
126056436|NCT01683409|453500928|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
126056437|NCT01683409|453500924|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
126056438|NCT01683409|453500925|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
126056439|NCT01683409|453500926|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
126056440|NCT01683409|453500927|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
126056441|NCT01683409|453500928|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
126056442|NCT04218864|453500929|FG000|Overall Study|Lost to Follow-up|8|||
126056443|NCT04218864|453500930|FG001|Overall Study|Lost to Follow-up|4|||
126056444|NCT04218864|453500929|FG000|Overall Study|Withdrawal by Subject|1|||
126056445|NCT04218864|453500930|FG001|Overall Study|Withdrawal by Subject|3|||
126056446|NCT01227421|453500931|FG000|Overall Study|Lost to Follow-up|6|||
126056447|NCT01227421|453500932|FG001|Overall Study|Lost to Follow-up|7|||
126056448|NCT01227421|453500933|FG002|Overall Study|Lost to Follow-up|5|||
126056449|NCT01227421|453500931|FG000|Overall Study|Adverse Event|2|||
126056450|NCT01227421|453500932|FG001|Overall Study|Adverse Event|7|||
126056451|NCT01227421|453500933|FG002|Overall Study|Adverse Event|2|||
126056452|NCT01227421|453500931|FG000|Overall Study|Withdrawal by Subject|1|||
126056453|NCT01227421|453500932|FG001|Overall Study|Withdrawal by Subject|2|||
126056454|NCT01227421|453500933|FG002|Overall Study|Withdrawal by Subject|1|||
126056455|NCT01227421|453500931|FG000|Overall Study|Protocol Violation|1|||
126056456|NCT01227421|453500932|FG001|Overall Study|Protocol Violation|1|||
126056457|NCT01227421|453500933|FG002|Overall Study|Protocol Violation|2|||
126105718|NCT03421431|453681173|FG002|Overall Study|Adverse Event|12|||
126105719|NCT03421431|453681171|FG000|Overall Study|Lost to Follow-up|1|||
126056458|NCT01227421|453500931|FG000|Overall Study|Randomized in error|1|||
126056459|NCT01227421|453500932|FG001|Overall Study|Randomized in error|1|||
126056460|NCT01227421|453500933|FG002|Overall Study|Randomized in error|0|||
126056461|NCT02499328|453500934|FG000|Overall Study|Withdrawal by Subject|1|||
126056462|NCT02499328|453500935|FG001|Overall Study|Withdrawal by Subject|1|||
126056463|NCT02499328|453500936|FG002|Overall Study|Withdrawal by Subject|5|||
126056464|NCT02499328|453500937|FG003|Overall Study|Withdrawal by Subject|3|||
126056465|NCT02499328|453500938|FG004|Overall Study|Withdrawal by Subject|5|||
126056466|NCT02499328|453500939|FG005|Overall Study|Withdrawal by Subject|0|||
126105720|NCT03421431|453681172|FG001|Overall Study|Lost to Follow-up|1|||
126105721|NCT03421431|453681173|FG002|Overall Study|Lost to Follow-up|1|||
126105722|NCT03421431|453681171|FG000|Overall Study|Withdrawal by Subject|3|||
126105723|NCT03421431|453681172|FG001|Overall Study|Withdrawal by Subject|2|||
126056467|NCT02499328|453500940|FG006|Overall Study|Withdrawal by Subject|0|||
126056468|NCT02499328|453500941|FG007|Overall Study|Withdrawal by Subject|0|||
126056469|NCT02499328|453500942|FG008|Overall Study|Withdrawal by Subject|2|||
126056470|NCT02499328|453500943|FG009|Overall Study|Withdrawal by Subject|2|||
126056471|NCT02499328|453500944|FG010|Overall Study|Withdrawal by Subject|0|||
126056472|NCT02499328|453500945|FG011|Overall Study|Withdrawal by Subject|3|||
126056473|NCT02499328|453500946|FG012|Overall Study|Withdrawal by Subject|7|||
126056474|NCT02499328|453500947|FG013|Overall Study|Withdrawal by Subject|3|||
126105724|NCT03421431|453681173|FG002|Overall Study|Withdrawal by Subject|1|||
126105725|NCT03421431|453681171|FG000|Overall Study|Protocol Violation|0|||
126105726|NCT03421431|453681172|FG001|Overall Study|Protocol Violation|1|||
126105727|NCT03421431|453681173|FG002|Overall Study|Protocol Violation|0|||
126105728|NCT03421431|453681171|FG000|Overall Study|Participant met Stopping Rules|0|||
126105729|NCT03421431|453681172|FG001|Overall Study|Participant met Stopping Rules|1|||
126105730|NCT03421431|453681173|FG002|Overall Study|Participant met Stopping Rules|0|||
126105731|NCT00141726|453681174|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
126105732|NCT00235326|453681182|FG000|Overall Study|Lost to Follow-up|746|||
126056475|NCT02499328|453500948|FG014|Overall Study|Withdrawal by Subject|1|||
126056476|NCT02499328|453500949|FG015|Overall Study|Withdrawal by Subject|0|||
126056477|NCT02499328|453500950|FG016|Overall Study|Withdrawal by Subject|0|||
126056478|NCT02499328|453500951|FG017|Overall Study|Withdrawal by Subject|3|||
126056479|NCT02499328|453500952|FG018|Overall Study|Withdrawal by Subject|0|||
126056480|NCT02499328|453500934|FG000|Overall Study|Lost to Follow-up|0|||
126056481|NCT02499328|453500935|FG001|Overall Study|Lost to Follow-up|1|||
126056482|NCT02499328|453500936|FG002|Overall Study|Lost to Follow-up|1|||
126056483|NCT02499328|453500937|FG003|Overall Study|Lost to Follow-up|2|||
126056484|NCT02499328|453500938|FG004|Overall Study|Lost to Follow-up|0|||
126056485|NCT02499328|453500939|FG005|Overall Study|Lost to Follow-up|0|||
126056486|NCT02499328|453500940|FG006|Overall Study|Lost to Follow-up|0|||
126056487|NCT02499328|453500941|FG007|Overall Study|Lost to Follow-up|2|||
126056488|NCT02499328|453500942|FG008|Overall Study|Lost to Follow-up|3|||
126056489|NCT02499328|453500943|FG009|Overall Study|Lost to Follow-up|0|||
126056490|NCT02499328|453500944|FG010|Overall Study|Lost to Follow-up|0|||
126056491|NCT02499328|453500945|FG011|Overall Study|Lost to Follow-up|0|||
126056492|NCT02499328|453500946|FG012|Overall Study|Lost to Follow-up|0|||
126105733|NCT00235326|453681183|FG001|Overall Study|Lost to Follow-up|1400|||
126105734|NCT01790126|453681184|FG000|Overall Study|PSA Progression|12|||
126105735|NCT01790126|453681185|FG001|Overall Study|PSA Progression|16|||
126105736|NCT01790126|453681186|FG002|Overall Study|PSA Progression|16|||
126105737|NCT01790126|453681184|FG000|Overall Study|Other|5|||
126105738|NCT01790126|453681185|FG001|Overall Study|Other|4|||
126105739|NCT01790126|453681186|FG002|Overall Study|Other|8|||
126105740|NCT01790126|453681184|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
126105741|NCT01790126|453681185|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
126105742|NCT01790126|453681186|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
126105743|NCT01790126|453681184|FG000|Overall Study|Withdrawal by Physician|1|||
126105744|NCT01790126|453681185|FG001|Overall Study|Withdrawal by Physician|1|||
126105745|NCT01790126|453681186|FG002|Overall Study|Withdrawal by Physician|2|||
126105746|NCT01790126|453681184|FG000|Overall Study|Withdrawal by Subject|3|||
126105747|NCT01790126|453681185|FG001|Overall Study|Withdrawal by Subject|1|||
126105748|NCT01790126|453681186|FG002|Overall Study|Withdrawal by Subject|2|||
126105749|NCT01790126|453681184|FG000|Overall Study|Lost to Follow-up|1|||
126105750|NCT01790126|453681185|FG001|Overall Study|Lost to Follow-up|0|||
126105751|NCT01790126|453681186|FG002|Overall Study|Lost to Follow-up|1|||
126105752|NCT01790126|453681184|FG000|Overall Study|Adverse Event|0|||
126105753|NCT01790126|453681185|FG001|Overall Study|Adverse Event|2|||
126105754|NCT01790126|453681186|FG002|Overall Study|Adverse Event|0|||
126105755|NCT01790126|453681184|FG000|Overall Study|Death|2|||
126105756|NCT01790126|453681185|FG001|Overall Study|Death|0|||
126056493|NCT02499328|453500947|FG013|Overall Study|Lost to Follow-up|0|||
126056494|NCT02499328|453500948|FG014|Overall Study|Lost to Follow-up|0|||
126056495|NCT02499328|453500949|FG015|Overall Study|Lost to Follow-up|0|||
126105757|NCT01790126|453681186|FG002|Overall Study|Death|0|||
126105758|NCT01790126|453681184|FG000|Overall Study|Radiographic Progression|3|||
126105759|NCT01790126|453681185|FG001|Overall Study|Radiographic Progression|1|||
126105760|NCT01790126|453681186|FG002|Overall Study|Radiographic Progression|0|||
126105761|NCT01128738|453681187|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
126105762|NCT01128738|453681188|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
126105763|NCT01128738|453681187|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
126105764|NCT01128738|453681188|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
126105765|NCT01128738|453681187|FG000|Second TP|Lost to Follow-up|0|||
126105766|NCT01128738|453681188|FG001|Second TP|Lost to Follow-up|1|||
126105767|NCT01128738|453681187|FG000|Second TP|Withdrawal by Subject|0|||
126056496|NCT02499328|453500950|FG016|Overall Study|Lost to Follow-up|0|||
126056497|NCT02499328|453500951|FG017|Overall Study|Lost to Follow-up|0|||
126056498|NCT02499328|453500952|FG018|Overall Study|Lost to Follow-up|1|||
126056499|NCT02499328|453500934|FG000|Overall Study|Death|0|||
126056500|NCT02499328|453500935|FG001|Overall Study|Death|3|||
126056501|NCT02499328|453500936|FG002|Overall Study|Death|3|||
126056502|NCT02499328|453500937|FG003|Overall Study|Death|2|||
126056503|NCT02499328|453500938|FG004|Overall Study|Death|4|||
126056504|NCT02499328|453500939|FG005|Overall Study|Death|7|||
126056505|NCT02499328|453500940|FG006|Overall Study|Death|3|||
126056506|NCT02499328|453500941|FG007|Overall Study|Death|0|||
126056507|NCT02499328|453500942|FG008|Overall Study|Death|2|||
126056508|NCT02499328|453500943|FG009|Overall Study|Death|6|||
126056509|NCT02499328|453500944|FG010|Overall Study|Death|6|||
126056510|NCT02499328|453500945|FG011|Overall Study|Death|20|||
126056511|NCT02499328|453500946|FG012|Overall Study|Death|9|||
126056512|NCT02499328|453500947|FG013|Overall Study|Death|7|||
126056513|NCT02499328|453500948|FG014|Overall Study|Death|3|||
126056514|NCT02499328|453500949|FG015|Overall Study|Death|1|||
126056515|NCT02499328|453500950|FG016|Overall Study|Death|1|||
126056516|NCT02499328|453500951|FG017|Overall Study|Death|16|||
126056517|NCT02499328|453500952|FG018|Overall Study|Death|5|||
126056518|NCT02499328|453500934|FG000|Overall Study|"Other"|2|||
126056519|NCT02499328|453500935|FG001|Overall Study|"Other"|2|||
126056520|NCT02499328|453500936|FG002|Overall Study|"Other"|1|||
126056521|NCT02499328|453500937|FG003|Overall Study|"Other"|3|||
126056522|NCT02499328|453500938|FG004|Overall Study|"Other"|6|||
126056523|NCT02499328|453500939|FG005|Overall Study|"Other"|2|||
126056524|NCT02499328|453500940|FG006|Overall Study|"Other"|3|||
126056525|NCT02499328|453500941|FG007|Overall Study|"Other"|4|||
126056526|NCT02499328|453500942|FG008|Overall Study|"Other"|6|||
126056527|NCT02499328|453500943|FG009|Overall Study|"Other"|16|||
126056528|NCT02499328|453500944|FG010|Overall Study|"Other"|13|||
126056529|NCT02499328|453500945|FG011|Overall Study|"Other"|31|||
126056530|NCT02499328|453500946|FG012|Overall Study|"Other"|8|||
126056531|NCT02499328|453500947|FG013|Overall Study|"Other"|7|||
126056532|NCT02499328|453500948|FG014|Overall Study|"Other"|6|||
126056533|NCT02499328|453500949|FG015|Overall Study|"Other"|0|||
126056534|NCT02499328|453500950|FG016|Overall Study|"Other"|0|||
126056535|NCT02499328|453500951|FG017|Overall Study|"Other"|34|||
126056536|NCT02499328|453500952|FG018|Overall Study|"Other"|43|||
126056537|NCT02499328|453500934|FG000|Overall Study|Disease Progression|0|||
126056538|NCT02499328|453500935|FG001|Overall Study|Disease Progression|0|||
126056539|NCT02499328|453500936|FG002|Overall Study|Disease Progression|0|||
126056540|NCT02499328|453500937|FG003|Overall Study|Disease Progression|0|||
126056541|NCT02499328|453500938|FG004|Overall Study|Disease Progression|0|||
126056542|NCT02499328|453500939|FG005|Overall Study|Disease Progression|0|||
126056543|NCT02499328|453500940|FG006|Overall Study|Disease Progression|1|||
126056544|NCT02499328|453500941|FG007|Overall Study|Disease Progression|0|||
126105768|NCT01128738|453681188|FG001|Second TP|Withdrawal by Subject|2|||
126056545|NCT02499328|453500942|FG008|Overall Study|Disease Progression|1|||
126056546|NCT02499328|453500943|FG009|Overall Study|Disease Progression|0|||
126056547|NCT02499328|453500944|FG010|Overall Study|Disease Progression|1|||
126056548|NCT02499328|453500945|FG011|Overall Study|Disease Progression|0|||
126056549|NCT02499328|453500946|FG012|Overall Study|Disease Progression|0|||
126056550|NCT02499328|453500947|FG013|Overall Study|Disease Progression|0|||
126056551|NCT02499328|453500948|FG014|Overall Study|Disease Progression|0|||
126056552|NCT02499328|453500949|FG015|Overall Study|Disease Progression|0|||
126056553|NCT02499328|453500950|FG016|Overall Study|Disease Progression|0|||
126056554|NCT02499328|453500951|FG017|Overall Study|Disease Progression|2|||
126056555|NCT02499328|453500952|FG018|Overall Study|Disease Progression|0|||
126056556|NCT02499328|453500934|FG000|Overall Study|Adverse Event|1|||
126056557|NCT02499328|453500935|FG001|Overall Study|Adverse Event|0|||
126056558|NCT02499328|453500936|FG002|Overall Study|Adverse Event|0|||
126056559|NCT02499328|453500937|FG003|Overall Study|Adverse Event|1|||
126056560|NCT02499328|453500938|FG004|Overall Study|Adverse Event|0|||
126056561|NCT02499328|453500939|FG005|Overall Study|Adverse Event|0|||
126105769|NCT01178671|453681189|FG000|Overall Study|Adverse Event|4|||
126105770|NCT01178671|453681190|FG001|Overall Study|Adverse Event|6|||
126105771|NCT01178671|453681189|FG000|Overall Study|Protocol Violation|1|||
126105772|NCT01178671|453681190|FG001|Overall Study|Protocol Violation|1|||
126105773|NCT01178671|453681189|FG000|Overall Study|Lack of Efficacy|0|||
126105774|NCT01178671|453681190|FG001|Overall Study|Lack of Efficacy|1|||
126105775|NCT01178671|453681189|FG000|Overall Study|Lost to Follow-up|3|||
126105776|NCT01178671|453681190|FG001|Overall Study|Lost to Follow-up|1|||
126105777|NCT01178671|453681189|FG000|Overall Study|Physician Decision|4|||
126105778|NCT01178671|453681190|FG001|Overall Study|Physician Decision|6|||
126105779|NCT01211197|453681194|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126105780|NCT01211197|453681195|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126105781|NCT01211197|453681196|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126105782|NCT01211197|453681197|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126105783|NCT01211197|453681198|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126105784|NCT01211197|453681199|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126105785|NCT01211197|453681194|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
126105786|NCT01211197|453681195|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
126105787|NCT01211197|453681196|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
126105788|NCT01211197|453681197|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
126105789|NCT01211197|453681198|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
126105790|NCT01211197|453681199|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
126105791|NCT02349451|453681200|FG000|Overall Study|Withdrawal by Subject|0|||
126105792|NCT02349451|453681201|FG001|Overall Study|Withdrawal by Subject|1|||
126105793|NCT02349451|453681202|FG002|Overall Study|Withdrawal by Subject|2|||
126105794|NCT02349451|453681203|FG003|Overall Study|Withdrawal by Subject|1|||
126105795|NCT02683941|453681204|FG000|Double-blind Phase|Adverse Event|0|||
126105796|NCT02683941|453681205|FG001|Double-blind Phase|Adverse Event|1|||
126105797|NCT02683941|453681204|FG000|Double-blind Phase|Withdrawal by Subject|4|||
126105798|NCT02683941|453681205|FG001|Double-blind Phase|Withdrawal by Subject|2|||
126105799|NCT02683941|453681204|FG000|Double-blind Phase|Lost to Follow-up|1|||
126105800|NCT02683941|453681205|FG001|Double-blind Phase|Lost to Follow-up|0|||
126105801|NCT02683941|453681204|FG000|Double-blind Phase|Disease Progression|5|||
126105802|NCT02683941|453681205|FG001|Double-blind Phase|Disease Progression|2|||
126105803|NCT02683941|453681204|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
126105804|NCT02683941|453681205|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
126105805|NCT02683941|453681204|FG000|Open-label Treatment Phase|Disease Progression|1|||
126105806|NCT02683941|453681205|FG001|Open-label Treatment Phase|Disease Progression|2|||
126105807|NCT02683941|453681204|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
126105808|NCT02683941|453681205|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
126105809|NCT02683941|453681204|FG000|Open-label Treatment Phase|Other|1|||
126105810|NCT02683941|453681205|FG001|Open-label Treatment Phase|Other|0|||
126105811|NCT02683941|453681204|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
126105812|NCT02683941|453681205|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
126056562|NCT02499328|453500940|FG006|Overall Study|Adverse Event|0|||
126056563|NCT02499328|453500941|FG007|Overall Study|Adverse Event|0|||
126056564|NCT02499328|453500942|FG008|Overall Study|Adverse Event|0|||
126056565|NCT02499328|453500943|FG009|Overall Study|Adverse Event|0|||
126056566|NCT02499328|453500944|FG010|Overall Study|Adverse Event|0|||
126056567|NCT02499328|453500945|FG011|Overall Study|Adverse Event|0|||
126056568|NCT02499328|453500946|FG012|Overall Study|Adverse Event|1|||
126056569|NCT02499328|453500947|FG013|Overall Study|Adverse Event|0|||
126056570|NCT02499328|453500948|FG014|Overall Study|Adverse Event|0|||
125891705|NCT01324401|452901348|FG000|Overall Study|Withdrawn before any treatment|0|||
125891706|NCT01324401|452901349|FG001|Overall Study|Withdrawn before any treatment|3|||
125891707|NCT01324401|452901348|FG000|Overall Study|Adverse Event|1|||
125891708|NCT01324401|452901349|FG001|Overall Study|Adverse Event|3|||
125891709|NCT01708902|452901351|FG000|Overall Study|Adverse Event|3|||
125891710|NCT01708902|452901352|FG001|Overall Study|Adverse Event|4|||
125891711|NCT01708902|452901353|FG002|Overall Study|Adverse Event|9|||
125891712|NCT01708902|452901354|FG003|Overall Study|Adverse Event|2|||
125891713|NCT01708902|452901355|FG004|Overall Study|Adverse Event|7|||
125891714|NCT01708902|452901356|FG005|Overall Study|Adverse Event|3|||
125891715|NCT01708902|452901357|FG006|Overall Study|Adverse Event|5|||
125891716|NCT01708902|452901351|FG000|Overall Study|Lack of Efficacy|3|||
126056571|NCT02499328|453500949|FG015|Overall Study|Adverse Event|0|||
126056572|NCT02499328|453500950|FG016|Overall Study|Adverse Event|0|||
126056573|NCT02499328|453500951|FG017|Overall Study|Adverse Event|0|||
126056574|NCT02499328|453500952|FG018|Overall Study|Adverse Event|0|||
126056575|NCT00145470|453500953|FG000|Overall Study|Adverse Event|19|||
126056576|NCT00145470|453500954|FG001|Overall Study|Adverse Event|25|||
126056577|NCT00145470|453500953|FG000|Overall Study|Lack of Efficacy|27|||
126056578|NCT00145470|453500954|FG001|Overall Study|Lack of Efficacy|13|||
126056579|NCT00145470|453500953|FG000|Overall Study|Withdrawal by Subject|36|||
126056580|NCT00145470|453500954|FG001|Overall Study|Withdrawal by Subject|34|||
126056581|NCT00145470|453500953|FG000|Overall Study|Lost to Follow-up|21|||
126056582|NCT00145470|453500954|FG001|Overall Study|Lost to Follow-up|17|||
126056583|NCT00145470|453500953|FG000|Overall Study|Reason Not Reported|9|||
126056584|NCT00145470|453500954|FG001|Overall Study|Reason Not Reported|9|||
125891717|NCT01708902|452901352|FG001|Overall Study|Lack of Efficacy|1|||
125891718|NCT01708902|452901353|FG002|Overall Study|Lack of Efficacy|0|||
125891719|NCT01708902|452901354|FG003|Overall Study|Lack of Efficacy|0|||
125891720|NCT01708902|452901355|FG004|Overall Study|Lack of Efficacy|0|||
125891721|NCT01708902|452901356|FG005|Overall Study|Lack of Efficacy|1|||
125891722|NCT01708902|452901357|FG006|Overall Study|Lack of Efficacy|0|||
125891723|NCT01708902|452901351|FG000|Overall Study|Non compliance with protocol|0|||
125891724|NCT01708902|452901352|FG001|Overall Study|Non compliance with protocol|2|||
125891725|NCT01708902|452901353|FG002|Overall Study|Non compliance with protocol|1|||
125891726|NCT01708902|452901354|FG003|Overall Study|Non compliance with protocol|3|||
125891727|NCT01708902|452901355|FG004|Overall Study|Non compliance with protocol|0|||
125891728|NCT01708902|452901356|FG005|Overall Study|Non compliance with protocol|0|||
125891729|NCT01708902|452901357|FG006|Overall Study|Non compliance with protocol|0|||
125891730|NCT01708902|452901351|FG000|Overall Study|Lost to Follow-up|2|||
125891731|NCT01708902|452901352|FG001|Overall Study|Lost to Follow-up|1|||
125891732|NCT01708902|452901353|FG002|Overall Study|Lost to Follow-up|2|||
125891733|NCT01708902|452901354|FG003|Overall Study|Lost to Follow-up|2|||
125891734|NCT01708902|452901355|FG004|Overall Study|Lost to Follow-up|0|||
125891735|NCT01708902|452901356|FG005|Overall Study|Lost to Follow-up|0|||
125891736|NCT01708902|452901357|FG006|Overall Study|Lost to Follow-up|1|||
125891737|NCT01708902|452901351|FG000|Overall Study|Refused to continue trial medication|8|||
125891738|NCT01708902|452901352|FG001|Overall Study|Refused to continue trial medication|0|||
125891739|NCT01708902|452901353|FG002|Overall Study|Refused to continue trial medication|4|||
125891740|NCT01708902|452901354|FG003|Overall Study|Refused to continue trial medication|2|||
125891741|NCT01708902|452901355|FG004|Overall Study|Refused to continue trial medication|8|||
125891742|NCT01708902|452901356|FG005|Overall Study|Refused to continue trial medication|1|||
125891743|NCT01708902|452901357|FG006|Overall Study|Refused to continue trial medication|1|||
125891744|NCT01708902|452901351|FG000|Overall Study|Other Reason|1|||
126056585|NCT06269003|453500956|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
126056586|NCT06269003|453500957|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
126056587|NCT06269003|453500958|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
125891745|NCT01708902|452901352|FG001|Overall Study|Other Reason|0|||
126105813|NCT02683941|453681204|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
126105814|NCT02683941|453681205|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
125891746|NCT01708902|452901353|FG002|Overall Study|Other Reason|1|||
125891747|NCT01708902|452901354|FG003|Overall Study|Other Reason|1|||
125891748|NCT01708902|452901355|FG004|Overall Study|Other Reason|1|||
125891749|NCT01708902|452901356|FG005|Overall Study|Other Reason|2|||
125891750|NCT01708902|452901357|FG006|Overall Study|Other Reason|0|||
125891751|NCT00530816|452901359|FG000|Overall Study|Progressive Disease|16|||
126056588|NCT06269003|453500959|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
126056589|NCT04447027|453500960|FG000|Dose Escalation|Withdrawal by Subject|1|||
125891752|NCT00530816|452901360|FG001|Overall Study|Progressive Disease|24|||
125891753|NCT00530816|452901361|FG002|Overall Study|Progressive Disease|24|||
126056590|NCT04447027|453500961|FG001|Dose Escalation|Withdrawal by Subject|4|||
125891754|NCT00530816|452901359|FG000|Overall Study|Adverse Event|6|||
125891755|NCT00530816|452901360|FG001|Overall Study|Adverse Event|13|||
125891756|NCT00530816|452901361|FG002|Overall Study|Adverse Event|7|||
125891757|NCT00530816|452901359|FG000|Overall Study|Other|3|||
125891758|NCT00530816|452901360|FG001|Overall Study|Other|3|||
125891759|NCT00530816|452901361|FG002|Overall Study|Other|4|||
125891760|NCT00530816|452901359|FG000|Overall Study|Withdrawal by Subject|1|||
125891761|NCT00530816|452901360|FG001|Overall Study|Withdrawal by Subject|2|||
125891762|NCT00530816|452901361|FG002|Overall Study|Withdrawal by Subject|6|||
125891763|NCT01388985|452901364|FG000|Overall Study|Death|0|||
125891764|NCT01388985|452901365|FG001|Overall Study|Death|1|||
126105815|NCT02683941|453681204|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
126105816|NCT02683941|453681205|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
126105817|NCT02683941|453681204|FG000|Open-label Follow-up Phase|Other|8|||
125891765|NCT01388985|452901364|FG000|Overall Study|Lost to Follow-up|30|||
125891766|NCT01388985|452901365|FG001|Overall Study|Lost to Follow-up|30|||
125891767|NCT01388985|452901364|FG000|Overall Study|Withdrawal by Subject|13|||
125891768|NCT01388985|452901365|FG001|Overall Study|Withdrawal by Subject|4|||
125891769|NCT01388985|452901364|FG000|Overall Study|Subject unavailable|1|||
125891770|NCT01388985|452901365|FG001|Overall Study|Subject unavailable|1|||
125891771|NCT01388985|452901364|FG000|Overall Study|Other (no reason)|0|||
126105818|NCT02683941|453681205|FG001|Open-label Follow-up Phase|Other|1|||
126105819|NCT00261846|453681206|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
126105820|NCT00261846|453681207|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
126105821|NCT00261846|453681208|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
126105822|NCT00261846|453681209|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105823|NCT00261846|453681210|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105824|NCT00261846|453681211|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105825|NCT00261846|453681212|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105826|NCT00261846|453681213|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105827|NCT00261846|453681214|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105828|NCT00261846|453681215|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105829|NCT00261846|453681216|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105830|NCT00261846|453681217|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126105831|NCT00261846|453681206|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105832|NCT00261846|453681207|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105833|NCT00261846|453681208|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105834|NCT00261846|453681209|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
126105835|NCT00261846|453681210|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105836|NCT00261846|453681211|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105837|NCT00261846|453681212|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105838|NCT00261846|453681213|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105839|NCT00261846|453681214|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
126105840|NCT00261846|453681215|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105841|NCT00261846|453681216|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105842|NCT00261846|453681217|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126105843|NCT00261846|453681206|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126105844|NCT00261846|453681207|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126105845|NCT00261846|453681208|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126105846|NCT00261846|453681209|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
126105847|NCT00261846|453681210|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
126105848|NCT00261846|453681211|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
126105849|NCT00261846|453681212|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
126105850|NCT00261846|453681213|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
126105851|NCT00261846|453681214|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126105852|NCT00261846|453681215|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
126105853|NCT00261846|453681216|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126105854|NCT00261846|453681217|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126105855|NCT00261846|453681206|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126105856|NCT00261846|453681207|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126105857|NCT00261846|453681208|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126105858|NCT00261846|453681209|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
126105859|NCT00261846|453681210|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
126105860|NCT00261846|453681211|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126105861|NCT00261846|453681212|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
126105862|NCT00261846|453681213|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126105863|NCT00261846|453681214|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
126105864|NCT00261846|453681215|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
125891772|NCT01388985|452901365|FG001|Overall Study|Other (no reason)|1|||
126105865|NCT00261846|453681216|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
125891773|NCT01388985|452901364|FG000|Overall Study|Error of nurse|5|||
125891774|NCT01388985|452901365|FG001|Overall Study|Error of nurse|1|||
125891775|NCT01057589|452901366|FG000|Overall Study|Disease Progression|35|||
125891776|NCT01057589|452901366|FG000|Overall Study|Adverse Event|10|||
125891777|NCT01057589|452901366|FG000|Overall Study|Physician Decision|8|||
125891778|NCT01057589|452901366|FG000|Overall Study|Withdrawal by Subject|3|||
125891779|NCT01057589|452901366|FG000|Overall Study|Sponsor Decision|1|||
125891780|NCT01057589|452901366|FG000|Overall Study|Death|8|||
125891781|NCT01057589|452901366|FG000|Overall Study|Lost to Follow-up|1|||
125891782|NCT00899431|452901369|FG000|Overall Study|Physician Decision|1|||
125891783|NCT00899431|452901370|FG001|Overall Study|Physician Decision|0|||
126105866|NCT00261846|453681217|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126105867|NCT00261846|453681206|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
126105868|NCT00261846|453681207|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
126105869|NCT00261846|453681208|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
126105870|NCT00261846|453681209|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
126105871|NCT00261846|453681210|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
126105872|NCT00261846|453681211|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
126105873|NCT00261846|453681212|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
126105874|NCT00261846|453681213|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
126105875|NCT00261846|453681214|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
126105876|NCT00261846|453681215|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
126105877|NCT00261846|453681216|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
126105878|NCT00261846|453681217|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
126105879|NCT00261846|453681206|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
126105880|NCT00261846|453681207|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
126105881|NCT00261846|453681208|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
126105882|NCT00261846|453681209|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
126105883|NCT00261846|453681210|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
126105884|NCT00261846|453681211|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
126105885|NCT00261846|453681212|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
126105886|NCT00261846|453681213|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
126105887|NCT00261846|453681214|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
126105888|NCT00261846|453681215|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
126105889|NCT00261846|453681216|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
126105890|NCT00261846|453681217|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
126105891|NCT00261846|453681206|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
126105892|NCT00261846|453681207|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
126105893|NCT00261846|453681208|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
126105894|NCT00261846|453681209|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
126105895|NCT00261846|453681210|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
126105896|NCT00261846|453681211|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
126105897|NCT00261846|453681212|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
126105898|NCT00261846|453681213|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
126105899|NCT00261846|453681214|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
126105900|NCT00261846|453681215|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
126105901|NCT00261846|453681216|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
126105902|NCT00261846|453681217|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
126105903|NCT00150969|453681218|FG000|24 Month Main Study|Adverse Event|3|||
126105904|NCT00150969|453681219|FG001|24 Month Main Study|Adverse Event|4|||
126105905|NCT00150969|453681218|FG000|24 Month Main Study|Death|1|||
126105906|NCT00150969|453681219|FG001|24 Month Main Study|Death|1|||
126105907|NCT00150969|453681218|FG000|24 Month Main Study|Lack of Efficacy|1|||
126105908|NCT00150969|453681219|FG001|24 Month Main Study|Lack of Efficacy|8|||
126105909|NCT00150969|453681218|FG000|24 Month Main Study|Lost to Follow-up|3|||
126105910|NCT00150969|453681219|FG001|24 Month Main Study|Lost to Follow-up|2|||
126105911|NCT00150969|453681218|FG000|24 Month Main Study|Protocol Violation|4|||
126105912|NCT00150969|453681219|FG001|24 Month Main Study|Protocol Violation|2|||
125891784|NCT00899431|452901371|FG002|Overall Study|Physician Decision|0|||
125891785|NCT01253577|452901373|FG000|Overall Study|Lost to Follow-up|3|||
125891786|NCT00334113|452901374|FG000|Overall Study|Lost to Follow-up|2|||
125891787|NCT00334113|452901375|FG001|Overall Study|Lost to Follow-up|2|||
125891788|NCT00334113|452901374|FG000|Overall Study|Withdrawal by Subject|0|||
125891789|NCT00334113|452901375|FG001|Overall Study|Withdrawal by Subject|1|||
125891790|NCT02509026|452901376|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
125891791|NCT02509026|452901376|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
125891792|NCT02509026|452901376|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
125891793|NCT02509026|452901376|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
125891794|NCT02509026|452901376|FG000|Induction Period (24 Weeks)|Other|2|||
125891795|NCT02509026|452901376|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
125891796|NCT02509026|452901376|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
125891797|NCT02509026|452901376|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
125891798|NCT02509026|452901376|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
125891799|NCT02509026|452901376|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
125891800|NCT02509026|452901376|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
126105913|NCT00150969|453681218|FG000|24 Month Main Study|Withdrawal by Subject|7|||
126105914|NCT00150969|453681219|FG001|24 Month Main Study|Withdrawal by Subject|4|||
126105915|NCT00150969|453681218|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
126105916|NCT00150969|453681219|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
126105917|NCT00150969|453681218|FG000|24-48 Month Extension|Lack of Efficacy|0|||
126105918|NCT00150969|453681219|FG001|24-48 Month Extension|Lack of Efficacy|1|||
126105919|NCT00150969|453681218|FG000|24-48 Month Extension|Adverse Event|1|||
126105920|NCT00150969|453681219|FG001|24-48 Month Extension|Adverse Event|3|||
125891801|NCT02509026|452901376|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
126056591|NCT04447027|453500962|FG002|Dose Escalation|Withdrawal by Subject|3|||
126056592|NCT04447027|453500963|FG003|Dose Escalation|Withdrawal by Subject|3|||
126056593|NCT04447027|453500964|FG004|Dose Escalation|Withdrawal by Subject|1|||
126056594|NCT04447027|453500965|FG005|Dose Escalation|Withdrawal by Subject|0|||
126056595|NCT04447027|453500966|FG006|Dose Escalation|Withdrawal by Subject|0|||
126056596|NCT04447027|453500967|FG007|Dose Escalation|Withdrawal by Subject|0|||
126056597|NCT04447027|453500968|FG008|Dose Escalation|Withdrawal by Subject|0|||
126056598|NCT04447027|453500960|FG000|Dose Escalation|Refused further treatment|0|||
126056599|NCT04447027|453500961|FG001|Dose Escalation|Refused further treatment|1|||
126056600|NCT04447027|453500962|FG002|Dose Escalation|Refused further treatment|1|||
125891802|NCT02509026|452901376|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
125891803|NCT00721968|452901377|FG000|Overall Study|Lost to Follow-up|2|||
125891804|NCT00721968|452901378|FG001|Overall Study|Lost to Follow-up|0|||
125891805|NCT02923921|452902986|FG000|Overall Study|Sponsor Decision|39|||
125891806|NCT02923921|452902987|FG001|Overall Study|Sponsor Decision|38|||
125891807|NCT02923921|452902986|FG000|Overall Study|Lost to Follow-up|1|||
125891808|NCT02923921|452902987|FG001|Overall Study|Lost to Follow-up|0|||
125891809|NCT02923921|452902986|FG000|Overall Study|Withdrawal by Subject|6|||
125891810|NCT02923921|452902987|FG001|Overall Study|Withdrawal by Subject|13|||
125891811|NCT02923921|452902986|FG000|Overall Study|Unknown, Not Collected|7|||
125891812|NCT02923921|452902987|FG001|Overall Study|Unknown, Not Collected|6|||
125891813|NCT00479687|452902988|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
125891814|NCT00479687|452902989|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
125891815|NCT00479687|452902990|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
126056601|NCT04447027|453500963|FG003|Dose Escalation|Refused further treatment|0|||
125891816|NCT00479687|452902988|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
125891817|NCT00479687|452902989|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
125891818|NCT00479687|452902990|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
125891819|NCT00479687|452902988|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
126056602|NCT04447027|453500964|FG004|Dose Escalation|Refused further treatment|0|||
126056603|NCT04447027|453500965|FG005|Dose Escalation|Refused further treatment|0|||
126056604|NCT04447027|453500966|FG006|Dose Escalation|Refused further treatment|0|||
126056605|NCT04447027|453500967|FG007|Dose Escalation|Refused further treatment|0|||
126056606|NCT04447027|453500968|FG008|Dose Escalation|Refused further treatment|0|||
126056607|NCT04447027|453500960|FG000|Dose Expansion|Withdrawal by Subject|0|||
126056608|NCT04447027|453500961|FG001|Dose Expansion|Withdrawal by Subject|0|||
126056609|NCT04447027|453500962|FG002|Dose Expansion|Withdrawal by Subject|0|||
126056610|NCT04447027|453500963|FG003|Dose Expansion|Withdrawal by Subject|0|||
126056611|NCT04447027|453500964|FG004|Dose Expansion|Withdrawal by Subject|0|||
126056612|NCT04447027|453500965|FG005|Dose Expansion|Withdrawal by Subject|2|||
126056613|NCT04447027|453500966|FG006|Dose Expansion|Withdrawal by Subject|0|||
126056614|NCT04447027|453500967|FG007|Dose Expansion|Withdrawal by Subject|2|||
126056615|NCT04447027|453500968|FG008|Dose Expansion|Withdrawal by Subject|0|||
126056616|NCT04186247|453500969|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
126056617|NCT04186247|453500970|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
126056618|NCT04186247|453500971|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
126056619|NCT04186247|453500972|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
126056620|NCT04186247|453500973|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
126056621|NCT04323800|453502628|FG000|Overall Study|Withdrawal by Subject|4|||
126056622|NCT04323800|453502629|FG001|Overall Study|Withdrawal by Subject|4|||
126056623|NCT04323800|453502628|FG000|Overall Study|Incomplete transfusion|1|||
126056624|NCT04323800|453502629|FG001|Overall Study|Incomplete transfusion|0|||
126056625|NCT04323800|453502628|FG000|Overall Study|Other|0|||
126056626|NCT04323800|453502629|FG001|Overall Study|Other|1|||
126056627|NCT04323800|453502628|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
126056628|NCT04323800|453502629|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
126056629|NCT00489554|453502630|FG000|Overall Study|Adverse Event|2|||
126056630|NCT00489554|453502630|FG000|Overall Study|Withdrawal by Subject|1|||
126056631|NCT00489554|453502630|FG000|Overall Study|Lost to Follow-up|1|||
126056632|NCT06571695|453502631|FG000|Overall Study|Lost to Follow-up|1|||
126056633|NCT06571695|453502632|FG001|Overall Study|Lost to Follow-up|6|||
126056634|NCT01380145|453502633|FG000|Overall Study|Progressive disease|4|||
126056635|NCT02038049|453502638|FG000|Overall Study|Lost to Follow-up|1|||
126056636|NCT02038049|453502639|FG001|Overall Study|Lost to Follow-up|0|||
126056637|NCT01808534|453502640|FG000|Overall Study|Disease progression|3|||
126056638|NCT01808534|453502640|FG000|Overall Study|Physician Decision|1|||
126056639|NCT02660086|453502641|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
126056640|NCT02660086|453502642|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
126056641|NCT02660086|453502641|FG000|Overall Study- 12-month|Left full-time employment|12|||
126056642|NCT02660086|453502642|FG001|Overall Study- 12-month|Left full-time employment|20|||
126056643|NCT02660086|453502641|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
126056644|NCT02660086|453502642|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
126056645|NCT02660086|453502641|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
125891820|NCT00479687|452902989|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
125891821|NCT00479687|452902990|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
125891822|NCT00479687|452902988|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
125891823|NCT00479687|452902989|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
125891824|NCT00479687|452902990|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
125891825|NCT00479687|452902988|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
125891826|NCT00479687|452902989|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
126056646|NCT02660086|453502642|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
126056647|NCT02660086|453502641|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
126105921|NCT00150969|453681218|FG000|24-48 Month Extension|Other Reason|81|||
126105922|NCT00150969|453681219|FG001|24-48 Month Extension|Other Reason|91|||
126105923|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
126105924|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
126105925|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
126105926|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
126105927|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
126105928|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
126105929|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
126105930|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
126105931|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
126105932|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
126105933|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
126105934|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
126105935|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
126105936|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
126105937|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
126105938|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
126105939|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
126105940|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
126105941|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
126105942|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
126105943|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
126105944|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
126105945|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
126105946|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
126105947|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
126105948|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
126105949|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
126105950|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
126105951|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
126105952|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
126105953|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Other|10|||
126105954|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Other|7|||
126105955|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Other|8|||
126105956|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Other|8|||
126105957|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Other|0|||
126105958|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
126105959|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
126105960|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
126105961|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
126105962|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
126105963|NCT00615836|453681220|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
126105964|NCT00615836|453681221|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
126105965|NCT00615836|453681222|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
125891827|NCT00479687|452902990|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
126105966|NCT00615836|453681223|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
126105967|NCT00615836|453681224|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
126105968|NCT01313689|453681225|FG000|24-Week Randomization 1|Adverse Event|10|||
126105969|NCT01313689|453681226|FG001|24-Week Randomization 1|Adverse Event|5|||
126105970|NCT01313689|453681227|FG002|24-Week Randomization 1|Adverse Event|0|||
126105971|NCT01313689|453681228|FG003|24-Week Randomization 1|Adverse Event|0|||
126105972|NCT01313689|453681229|FG004|24-Week Randomization 1|Adverse Event|0|||
126105973|NCT01313689|453681225|FG000|24-Week Randomization 1|Physician Decision|4|||
126105974|NCT01313689|453681226|FG001|24-Week Randomization 1|Physician Decision|5|||
126105975|NCT01313689|453681227|FG002|24-Week Randomization 1|Physician Decision|0|||
126105976|NCT01313689|453681228|FG003|24-Week Randomization 1|Physician Decision|0|||
126105977|NCT01313689|453681229|FG004|24-Week Randomization 1|Physician Decision|0|||
126105978|NCT01313689|453681225|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
126105979|NCT01313689|453681226|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
126105980|NCT01313689|453681227|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
126105981|NCT01313689|453681228|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
126105982|NCT01313689|453681229|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
126105983|NCT01313689|453681225|FG000|24-Week Randomization 2|Adverse Event|0|||
126105984|NCT01313689|453681226|FG001|24-Week Randomization 2|Adverse Event|0|||
126105985|NCT01313689|453681227|FG002|24-Week Randomization 2|Adverse Event|2|||
126105986|NCT01313689|453681228|FG003|24-Week Randomization 2|Adverse Event|0|||
126105987|NCT01313689|453681229|FG004|24-Week Randomization 2|Adverse Event|8|||
126105988|NCT01313689|453681225|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
126105989|NCT01313689|453681226|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
126105990|NCT01313689|453681227|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
126105991|NCT01313689|453681228|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
126105992|NCT01313689|453681229|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
126105993|NCT01313689|453681225|FG000|24-Week Randomization 2|Physician Decision|0|||
126105994|NCT01313689|453681226|FG001|24-Week Randomization 2|Physician Decision|0|||
126105995|NCT01313689|453681227|FG002|24-Week Randomization 2|Physician Decision|0|||
126105996|NCT01313689|453681228|FG003|24-Week Randomization 2|Physician Decision|0|||
126105997|NCT01313689|453681229|FG004|24-Week Randomization 2|Physician Decision|4|||
126105998|NCT02121834|453681231|FG000|Overall Study|Protocol Violation|0|||
126105999|NCT02121834|453681232|FG001|Overall Study|Protocol Violation|1|||
126106000|NCT02121834|453681233|FG002|Overall Study|Protocol Violation|0|||
126106001|NCT02121834|453681234|FG003|Overall Study|Protocol Violation|0|||
126106002|NCT02121834|453681235|FG004|Overall Study|Protocol Violation|0|||
126106003|NCT02121834|453681236|FG005|Overall Study|Protocol Violation|0|||
126106004|NCT02121834|453681237|FG006|Overall Study|Protocol Violation|0|||
126106005|NCT02121834|453681231|FG000|Overall Study|Withdrawal by Subject|0|||
126106006|NCT02121834|453681232|FG001|Overall Study|Withdrawal by Subject|1|||
126106007|NCT02121834|453681233|FG002|Overall Study|Withdrawal by Subject|1|||
126106008|NCT02121834|453681234|FG003|Overall Study|Withdrawal by Subject|0|||
126106009|NCT02121834|453681235|FG004|Overall Study|Withdrawal by Subject|0|||
126106010|NCT02121834|453681236|FG005|Overall Study|Withdrawal by Subject|0|||
126106011|NCT02121834|453681237|FG006|Overall Study|Withdrawal by Subject|0|||
126106012|NCT02121834|453681231|FG000|Overall Study|Lost to Follow-up|0|||
126106013|NCT02121834|453681232|FG001|Overall Study|Lost to Follow-up|0|||
126106014|NCT02121834|453681233|FG002|Overall Study|Lost to Follow-up|1|||
126106015|NCT02121834|453681234|FG003|Overall Study|Lost to Follow-up|0|||
126106016|NCT02121834|453681235|FG004|Overall Study|Lost to Follow-up|0|||
126106017|NCT02121834|453681236|FG005|Overall Study|Lost to Follow-up|0|||
126106018|NCT02121834|453681237|FG006|Overall Study|Lost to Follow-up|0|||
125891828|NCT00479687|452902988|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
125891829|NCT00479687|452902989|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
125891830|NCT00479687|452902990|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
125891831|NCT00479687|452902988|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
125891832|NCT00479687|452902989|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
125891833|NCT00479687|452902990|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
125891834|NCT00479687|452902988|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
125891835|NCT00479687|452902989|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
125891836|NCT00479687|452902990|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
125891837|NCT00479687|452902988|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
125891838|NCT00479687|452902989|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
125891839|NCT00479687|452902990|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
125891840|NCT01474239|452902991|FG000|Overall Study|Disease Progression|37|||
125891841|NCT01474239|452902992|FG001|Overall Study|Disease Progression|25|||
125891842|NCT01474239|452902991|FG000|Overall Study|Adverse Event|12|||
125891843|NCT01474239|452902992|FG001|Overall Study|Adverse Event|3|||
125891844|NCT01474239|452902991|FG000|Overall Study|Withdrawal by Subject|1|||
125891845|NCT01474239|452902992|FG001|Overall Study|Withdrawal by Subject|2|||
125891846|NCT01474239|452902991|FG000|Overall Study|Death|1|||
125891847|NCT01474239|452902992|FG001|Overall Study|Death|1|||
125891848|NCT01474239|452902991|FG000|Overall Study|Clinical Disease Progression|7|||
125891849|NCT01474239|452902992|FG001|Overall Study|Clinical Disease Progression|1|||
125891850|NCT01474239|452902991|FG000|Overall Study|Withdrawal for Economic Reason|1|||
125891851|NCT01474239|452902992|FG001|Overall Study|Withdrawal for Economic Reason|0|||
125891852|NCT02175199|452902995|FG000|Overall Study|Withdrawal by Subject|1|||
125891853|NCT02175199|452902996|FG001|Overall Study|Withdrawal by Subject|5|||
125891854|NCT02175199|452902995|FG000|Overall Study|Randomized in Error|1|||
125891855|NCT02175199|452902996|FG001|Overall Study|Randomized in Error|0|||
125891856|NCT02175199|452902995|FG000|Overall Study|Sponsor Decision|1|||
125891857|NCT02175199|452902996|FG001|Overall Study|Sponsor Decision|0|||
125891858|NCT03983317|452903001|FG000|Overall Study|Physician Decision|5|||
125891859|NCT00798759|452903003|FG000|Overall Study|Adverse Event|3|||
125891860|NCT00798759|452903004|FG001|Overall Study|Adverse Event|3|||
125891861|NCT00798759|452903003|FG000|Overall Study|Lost to Follow-up|1|||
125891862|NCT00798759|452903004|FG001|Overall Study|Lost to Follow-up|1|||
125891863|NCT00798759|452903003|FG000|Overall Study|Protocol Violation|4|||
125891864|NCT00798759|452903004|FG001|Overall Study|Protocol Violation|8|||
125891865|NCT00798759|452903003|FG000|Overall Study|Other|0|||
126056648|NCT02660086|453502642|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
126056649|NCT02660086|453502641|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
126056650|NCT02660086|453502642|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
126056651|NCT00667017|453502645|FG000|Overall Study|Withdrawal by Subject|1|||
126056652|NCT02605174|453502652|FG000|Overall Study|Adverse Event|0|||
126056653|NCT02605174|453502653|FG001|Overall Study|Adverse Event|0|||
126056654|NCT02605174|453502654|FG002|Overall Study|Adverse Event|1|||
126056655|NCT02605174|453502655|FG003|Overall Study|Adverse Event|0|||
126056656|NCT02605174|453502656|FG004|Overall Study|Adverse Event|4|||
126056657|NCT02605174|453502657|FG005|Overall Study|Adverse Event|0|||
126056658|NCT02605174|453502658|FG006|Overall Study|Adverse Event|0|||
126056659|NCT02605174|453502652|FG000|Overall Study|Lost to Follow-up|20|||
125891866|NCT00798759|452903004|FG001|Overall Study|Other|1|||
125891867|NCT01754727|452903005|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
126056660|NCT02605174|453502653|FG001|Overall Study|Lost to Follow-up|7|||
126056661|NCT02605174|453502654|FG002|Overall Study|Lost to Follow-up|27|||
125891868|NCT04518995|452903006|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
125891869|NCT04518995|452903007|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
126056662|NCT02605174|453502655|FG003|Overall Study|Lost to Follow-up|10|||
126056663|NCT02605174|453502656|FG004|Overall Study|Lost to Follow-up|20|||
126056664|NCT02605174|453502657|FG005|Overall Study|Lost to Follow-up|10|||
126056665|NCT02605174|453502658|FG006|Overall Study|Lost to Follow-up|29|||
126056666|NCT02605174|453502652|FG000|Overall Study|Protocol Violation|10|||
126056667|NCT02605174|453502653|FG001|Overall Study|Protocol Violation|4|||
126056668|NCT02605174|453502654|FG002|Overall Study|Protocol Violation|14|||
126056669|NCT02605174|453502655|FG003|Overall Study|Protocol Violation|6|||
126056670|NCT02605174|453502656|FG004|Overall Study|Protocol Violation|7|||
126056671|NCT02605174|453502657|FG005|Overall Study|Protocol Violation|7|||
126056672|NCT02605174|453502658|FG006|Overall Study|Protocol Violation|12|||
126056673|NCT02605174|453502652|FG000|Overall Study|Pregnancy|1|||
126056674|NCT02605174|453502653|FG001|Overall Study|Pregnancy|0|||
126056675|NCT02605174|453502654|FG002|Overall Study|Pregnancy|0|||
126056676|NCT02605174|453502655|FG003|Overall Study|Pregnancy|2|||
126056677|NCT02605174|453502656|FG004|Overall Study|Pregnancy|0|||
126056678|NCT02605174|453502657|FG005|Overall Study|Pregnancy|0|||
126056679|NCT02605174|453502658|FG006|Overall Study|Pregnancy|0|||
126056680|NCT02605174|453502652|FG000|Overall Study|Withdrawal by Subject|9|||
126056681|NCT02605174|453502653|FG001|Overall Study|Withdrawal by Subject|6|||
126056682|NCT02605174|453502654|FG002|Overall Study|Withdrawal by Subject|14|||
126056683|NCT02605174|453502655|FG003|Overall Study|Withdrawal by Subject|11|||
126056684|NCT02605174|453502656|FG004|Overall Study|Withdrawal by Subject|6|||
126056685|NCT02605174|453502657|FG005|Overall Study|Withdrawal by Subject|4|||
126056686|NCT02605174|453502658|FG006|Overall Study|Withdrawal by Subject|15|||
126056687|NCT02605174|453502652|FG000|Overall Study|Physician Decision|2|||
126056688|NCT02605174|453502653|FG001|Overall Study|Physician Decision|0|||
126056689|NCT02605174|453502654|FG002|Overall Study|Physician Decision|0|||
126056690|NCT02605174|453502655|FG003|Overall Study|Physician Decision|0|||
126056691|NCT02605174|453502656|FG004|Overall Study|Physician Decision|0|||
126056692|NCT02605174|453502657|FG005|Overall Study|Physician Decision|0|||
126056693|NCT02605174|453502658|FG006|Overall Study|Physician Decision|3|||
126056694|NCT02605174|453502652|FG000|Overall Study|Randomization Failure|22|||
126056695|NCT02605174|453502653|FG001|Overall Study|Randomization Failure|6|||
126056696|NCT02605174|453502654|FG002|Overall Study|Randomization Failure|20|||
126056697|NCT02605174|453502655|FG003|Overall Study|Randomization Failure|7|||
126056698|NCT02605174|453502656|FG004|Overall Study|Randomization Failure|16|||
126056699|NCT02605174|453502657|FG005|Overall Study|Randomization Failure|11|||
126056700|NCT02605174|453502658|FG006|Overall Study|Randomization Failure|30|||
126056701|NCT03737110|453502659|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
126056702|NCT03737110|453502660|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
126056703|NCT03737110|453502661|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
126056704|NCT03737110|453502662|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
126056705|NCT03737110|453502663|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
126056706|NCT03737110|453502664|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
126056707|NCT03737110|453502659|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
126056708|NCT03737110|453502660|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126056709|NCT03737110|453502661|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126056710|NCT03737110|453502662|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126056711|NCT03737110|453502663|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126056712|NCT03737110|453502664|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126056713|NCT03737110|453502659|FG000|Run-in (RI) Period|Adverse Event|4|||
126056714|NCT03737110|453502660|FG001|Run-in (RI) Period|Adverse Event|0|||
126056715|NCT03737110|453502661|FG002|Run-in (RI) Period|Adverse Event|0|||
126056716|NCT03737110|453502662|FG003|Run-in (RI) Period|Adverse Event|0|||
126056717|NCT03737110|453502663|FG004|Run-in (RI) Period|Adverse Event|0|||
126056718|NCT03737110|453502664|FG005|Run-in (RI) Period|Adverse Event|0|||
126056719|NCT03737110|453502659|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126056720|NCT03737110|453502660|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
126056721|NCT03737110|453502661|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126056722|NCT03737110|453502662|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126056723|NCT03737110|453502663|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126056724|NCT03737110|453502664|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126056725|NCT03737110|453502659|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126056726|NCT03737110|453502660|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126056727|NCT03737110|453502661|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
126056728|NCT03737110|453502662|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126056729|NCT03737110|453502663|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126056730|NCT03737110|453502664|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126056731|NCT03737110|453502659|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126056732|NCT03737110|453502660|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126056733|NCT03737110|453502661|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126056734|NCT03737110|453502662|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
126106019|NCT00551460|453681238|FG000|Overall Study|Adverse Event|1|||
126106020|NCT00551460|453681238|FG000|Overall Study|Withdrawal by Subject|1|||
126106021|NCT00551460|453681238|FG000|Overall Study|Physician Decision|1|||
126106022|NCT00551460|453681238|FG000|Overall Study|Death|7|||
126106023|NCT00551460|453681238|FG000|Overall Study|Ineligible|4|||
126106024|NCT00551460|453681238|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
126106025|NCT01971203|453681239|FG000|Overall Study|Protocol Violation|3|||
126106026|NCT01971203|453681240|FG001|Overall Study|Protocol Violation|2|||
126106027|NCT01971203|453681239|FG000|Overall Study|Withdrawal by Subject|5|||
126106028|NCT01971203|453681240|FG001|Overall Study|Withdrawal by Subject|6|||
126106029|NCT01971203|453681239|FG000|Overall Study|Adverse Event|1|||
126106030|NCT01971203|453681240|FG001|Overall Study|Adverse Event|0|||
126106031|NCT03353350|453681241|FG000|30-week Core Treatment Period|Protocol Violation|1|||
126106032|NCT03353350|453681242|FG001|30-week Core Treatment Period|Protocol Violation|1|||
126106033|NCT03353350|453681243|FG002|30-week Core Treatment Period|Protocol Violation|1|||
126106034|NCT03353350|453681244|FG003|30-week Core Treatment Period|Protocol Violation|0|||
126106035|NCT03353350|453681241|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
126106036|NCT03353350|453681242|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
126106037|NCT03353350|453681243|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
126106038|NCT03353350|453681244|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
126106039|NCT03353350|453681241|FG000|30-week Core Treatment Period|Adverse Event|0|||
126106040|NCT03353350|453681242|FG001|30-week Core Treatment Period|Adverse Event|4|||
126106041|NCT03353350|453681243|FG002|30-week Core Treatment Period|Adverse Event|2|||
126106042|NCT03353350|453681244|FG003|30-week Core Treatment Period|Adverse Event|3|||
126056735|NCT03737110|453502663|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126056736|NCT03737110|453502664|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126056737|NCT03737110|453502659|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
126056738|NCT03737110|453502660|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
126056739|NCT03737110|453502661|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
126056740|NCT03737110|453502662|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
126056741|NCT03737110|453502663|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
126056742|NCT03737110|453502664|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
126056743|NCT03737110|453502659|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126056744|NCT03737110|453502660|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126056745|NCT03737110|453502661|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126056746|NCT03737110|453502662|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126056747|NCT03737110|453502663|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
126056748|NCT03737110|453502664|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126056749|NCT02575365|453502669|FG000|Overall Study|Lost to Follow-up|4|||
126056750|NCT03865732|453502670|FG000|Overall Study|Adverse Event|0|||
126056751|NCT03865732|453502671|FG001|Overall Study|Adverse Event|1|||
126056752|NCT03392194|453502672|FG000|Overall Study|Withdrawal by Subject|1|||
126056753|NCT03392194|453502673|FG001|Overall Study|Withdrawal by Subject|2|||
126056754|NCT03392194|453502672|FG000|Overall Study|Conflicts with personal schedule|1|||
126056755|NCT03392194|453502673|FG001|Overall Study|Conflicts with personal schedule|0|||
126056756|NCT01951703|453502684|FG000|First Intervention|Withdrawal by Subject|1|||
126056757|NCT01951703|453502685|FG001|First Intervention|Withdrawal by Subject|0|||
126056758|NCT01951703|453502684|FG000|First Intervention|Subject was not compliant|1|||
126056759|NCT01951703|453502685|FG001|First Intervention|Subject was not compliant|1|||
126056760|NCT01951703|453502684|FG000|First Intervention|Physician Decision|1|||
126056761|NCT01951703|453502685|FG001|First Intervention|Physician Decision|0|||
126056762|NCT01951703|453502684|FG000|Second Intervention|Protocol Violation|0|||
126056763|NCT01951703|453502685|FG001|Second Intervention|Protocol Violation|1|||
126056764|NCT01951703|453502684|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
126106043|NCT03353350|453681241|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
126106044|NCT03353350|453681242|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
126056765|NCT01951703|453502685|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
126106045|NCT03353350|453681243|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
126106046|NCT03353350|453681244|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
126106047|NCT03353350|453681241|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
126106048|NCT03353350|453681242|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
126106049|NCT03353350|453681243|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
126106050|NCT03353350|453681244|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
126106051|NCT03353350|453681241|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
126106052|NCT03353350|453681242|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
126106053|NCT03353350|453681243|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
126106054|NCT03353350|453681244|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
126106055|NCT03353350|453681241|FG000|26-week Treatment Extension Period|Adverse Event|1|||
126106056|NCT03353350|453681242|FG001|26-week Treatment Extension Period|Adverse Event|0|||
126106057|NCT03353350|453681243|FG002|26-week Treatment Extension Period|Adverse Event|0|||
126106058|NCT03353350|453681244|FG003|26-week Treatment Extension Period|Adverse Event|1|||
126106059|NCT03353350|453681241|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
126106060|NCT03353350|453681242|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
126106061|NCT03353350|453681243|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
126106062|NCT03353350|453681244|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
126106063|NCT00147823|453681250|FG000|Overall Study|Lost to Follow-up|6|||
126106064|NCT00147823|453681251|FG001|Overall Study|Lost to Follow-up|12|||
126106065|NCT00147823|453681250|FG000|Overall Study|Physician Decision|1|||
126106066|NCT00147823|453681251|FG001|Overall Study|Physician Decision|0|||
126106067|NCT00147823|453681250|FG000|Overall Study|Withdrawal by Subject|0|||
126106068|NCT00147823|453681251|FG001|Overall Study|Withdrawal by Subject|1|||
126106069|NCT00147823|453681250|FG000|Overall Study|Did not receive vitoss due to infection|6|||
126106070|NCT00147823|453681251|FG001|Overall Study|Did not receive vitoss due to infection|2|||
126106071|NCT01012713|453681252|FG000|Overall Study|Lack of Efficacy|3|||
126106072|NCT02571049|453681253|FG000|Screening|Did not meet entry criteria|2|||
126106073|NCT02571049|453681254|FG001|Screening|Did not meet entry criteria|2|||
126106074|NCT02571049|453681253|FG000|Randomization|No migraine attack|0|||
126106075|NCT02571049|453681254|FG001|Randomization|No migraine attack|1|||
126106076|NCT02571049|453681253|FG000|Randomization|Adverse Event|0|||
126106077|NCT02571049|453681254|FG001|Randomization|Adverse Event|1|||
126106078|NCT01055262|453681255|FG000|Overall Study|Adverse Event|5|||
126106079|NCT01055262|453681255|FG000|Overall Study|Protocol Violation|3|||
126106080|NCT01055262|453681255|FG000|Overall Study|Uncooperativeness|1|||
126106081|NCT03370471|453681256|FG000|Overall Study|Withdrawal by Subject|6|||
126106082|NCT03370471|453681257|FG001|Overall Study|Withdrawal by Subject|1|||
126106083|NCT03370471|453681256|FG000|Overall Study|Unable to access veins for blood draw|0|||
126106084|NCT03370471|453681257|FG001|Overall Study|Unable to access veins for blood draw|1|||
126106085|NCT03370471|453681256|FG000|Overall Study|Screen fail|1|||
126106086|NCT03370471|453681257|FG001|Overall Study|Screen fail|0|||
126106087|NCT00561951|453681258|FG000|Overall Study|Adverse Event|11|||
126106088|NCT00561951|453681259|FG001|Overall Study|Adverse Event|14|||
126106089|NCT00561951|453681260|FG002|Overall Study|Adverse Event|14|||
126106090|NCT00561951|453681258|FG000|Overall Study|Lack of Efficacy|5|||
126106091|NCT00561951|453681259|FG001|Overall Study|Lack of Efficacy|3|||
126106092|NCT00561951|453681260|FG002|Overall Study|Lack of Efficacy|2|||
126106093|NCT00561951|453681258|FG000|Overall Study|Lost to Follow-up|1|||
126106094|NCT00561951|453681259|FG001|Overall Study|Lost to Follow-up|1|||
126106095|NCT00561951|453681260|FG002|Overall Study|Lost to Follow-up|0|||
126106096|NCT00561951|453681258|FG000|Overall Study|Withdrawal by Subject|10|||
126106097|NCT00561951|453681259|FG001|Overall Study|Withdrawal by Subject|9|||
126106098|NCT00561951|453681260|FG002|Overall Study|Withdrawal by Subject|10|||
126106099|NCT00561951|453681258|FG000|Overall Study|Protocol Violation|4|||
126106100|NCT00561951|453681259|FG001|Overall Study|Protocol Violation|3|||
126106101|NCT00561951|453681260|FG002|Overall Study|Protocol Violation|4|||
126106102|NCT00561951|453681258|FG000|Overall Study|Physician Decision|1|||
126106103|NCT00561951|453681259|FG001|Overall Study|Physician Decision|0|||
126106104|NCT00561951|453681260|FG002|Overall Study|Physician Decision|0|||
126106105|NCT00561951|453681258|FG000|Overall Study|Pregnancy|0|||
126106106|NCT00561951|453681259|FG001|Overall Study|Pregnancy|1|||
126106107|NCT00561951|453681260|FG002|Overall Study|Pregnancy|0|||
126106108|NCT00561951|453681258|FG000|Overall Study|Meet Withdrawal Criterion|0|||
126106109|NCT00561951|453681259|FG001|Overall Study|Meet Withdrawal Criterion|1|||
126106110|NCT00561951|453681260|FG002|Overall Study|Meet Withdrawal Criterion|1|||
126106111|NCT00561951|453681258|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
126106112|NCT00561951|453681259|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
126106113|NCT00561951|453681260|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
126106114|NCT00392327|453681272|FG000|Overall Study|Death|1|||
126106115|NCT00392327|453681273|FG001|Overall Study|Death|0|||
126106116|NCT00392327|453681274|FG002|Overall Study|Death|1|||
125891870|NCT04518995|452903008|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
125891871|NCT04518995|452903006|FG000|Overall Study|Lack of Efficacy|2|||
125891872|NCT04518995|452903007|FG001|Overall Study|Lack of Efficacy|1|||
125891873|NCT04518995|452903008|FG002|Overall Study|Lack of Efficacy|0|||
125891874|NCT04518995|452903006|FG000|Overall Study|Non-compliance With Study Drug|0|||
125891875|NCT04518995|452903007|FG001|Overall Study|Non-compliance With Study Drug|3|||
125891876|NCT04518995|452903008|FG002|Overall Study|Non-compliance With Study Drug|2|||
125891877|NCT04518995|452903006|FG000|Overall Study|Pregnancy|0|||
125891878|NCT04518995|452903007|FG001|Overall Study|Pregnancy|0|||
125891879|NCT04518995|452903008|FG002|Overall Study|Pregnancy|1|||
125891880|NCT04518995|452903006|FG000|Overall Study|Protocol Violation|2|||
125891881|NCT04518995|452903007|FG001|Overall Study|Protocol Violation|0|||
125891882|NCT04518995|452903008|FG002|Overall Study|Protocol Violation|1|||
125891883|NCT04518995|452903006|FG000|Overall Study|Reason not Specified|4|||
125891884|NCT04518995|452903007|FG001|Overall Study|Reason not Specified|11|||
125891885|NCT04518995|452903008|FG002|Overall Study|Reason not Specified|2|||
125891886|NCT04518995|452903006|FG000|Overall Study|Lost to Follow-up|1|||
125891887|NCT04518995|452903007|FG001|Overall Study|Lost to Follow-up|10|||
125891888|NCT04518995|452903008|FG002|Overall Study|Lost to Follow-up|6|||
125891889|NCT02891070|452903011|FG000|Overall Study|Adverse Event|1|||
125891890|NCT02891070|452903012|FG001|Overall Study|Adverse Event|0|||
125891891|NCT02891070|452903011|FG000|Overall Study|Physician Decision|0|||
125891892|NCT02891070|452903012|FG001|Overall Study|Physician Decision|1|||
125891893|NCT02891070|452903011|FG000|Overall Study|Lost to Follow-up|4|||
125891894|NCT02891070|452903012|FG001|Overall Study|Lost to Follow-up|4|||
125891895|NCT02891070|452903011|FG000|Overall Study|Other|1|||
125891896|NCT02891070|452903012|FG001|Overall Study|Other|0|||
125891897|NCT02891070|452903011|FG000|Overall Study|Protocol Violation|0|||
125891898|NCT02891070|452903012|FG001|Overall Study|Protocol Violation|1|||
125891899|NCT02891070|452903011|FG000|Overall Study|Withdrawal by Subject|1|||
125891900|NCT02891070|452903012|FG001|Overall Study|Withdrawal by Subject|2|||
125891901|NCT02891070|452903011|FG000|Overall Study|Death|3|||
125891902|NCT02891070|452903012|FG001|Overall Study|Death|0|||
125891903|NCT04491604|452903013|FG000|Overall Study|Withdrawal by Subject|3|||
125891904|NCT02934503|452903014|FG000|Overall Study|progression of disease|3|||
125891905|NCT02934503|452903014|FG000|Overall Study|Withdrawal by Subject|1|||
125891906|NCT02881567|452903015|FG000|Overall Study|Adverse Event|1|||
125891907|NCT02881567|452903015|FG000|Overall Study|Lost to Follow-up|3|||
125891908|NCT02881567|452903015|FG000|Overall Study|Consent withdrawn|1|||
125891909|NCT02881567|452903015|FG000|Overall Study|Investigator decision|1|||
125891910|NCT02881567|452903015|FG000|Overall Study|Study terminated by sponsor|9|||
125891911|NCT02881567|452903015|FG000|Overall Study|Reason not Specified|3|||
125891912|NCT04248491|452903019|FG000|Overall Study|Lost to Follow-up|1|||
125891913|NCT04248491|452903020|FG001|Overall Study|Lost to Follow-up|0|||
125891914|NCT00975689|452903026|FG000|Overall Study|Adverse Event|0|||
125891915|NCT00975689|452903027|FG001|Overall Study|Adverse Event|3|||
125891916|NCT00975689|452903026|FG000|Overall Study|Withdrawal by Subject|1|||
125891917|NCT00975689|452903027|FG001|Overall Study|Withdrawal by Subject|0|||
125891918|NCT00975689|452903026|FG000|Overall Study|Physician Decision|1|||
125891919|NCT00975689|452903027|FG001|Overall Study|Physician Decision|0|||
125891920|NCT04335136|452903028|FG000|Overall Study|Death|8|||
125891921|NCT04335136|452903029|FG001|Overall Study|Death|4|||
125891922|NCT04335136|452903028|FG000|Overall Study|Lost to Follow-up|2|||
126056766|NCT01009645|453502686|FG000|Overall Study|Lost to Follow-up|2|||
125891923|NCT04335136|452903029|FG001|Overall Study|Lost to Follow-up|0|||
125891924|NCT04335136|452903028|FG000|Overall Study|Protocol Violation|1|||
126056767|NCT01009645|453502687|FG001|Overall Study|Lost to Follow-up|8|||
126056768|NCT01009645|453502688|FG002|Overall Study|Lost to Follow-up|4|||
126056769|NCT01009645|453502689|FG003|Overall Study|Lost to Follow-up|5|||
126056770|NCT00487240|453502692|FG000|Overall Study|Withdrawal by Subject|12|||
126056771|NCT00487240|453502693|FG001|Overall Study|Withdrawal by Subject|6|||
126056772|NCT00487240|453502692|FG000|Overall Study|Lost to Follow-up|7|||
126056773|NCT00487240|453502693|FG001|Overall Study|Lost to Follow-up|6|||
126056774|NCT00487240|453502692|FG000|Overall Study|Adverse Event|0|||
126056775|NCT00487240|453502693|FG001|Overall Study|Adverse Event|4|||
126056776|NCT00487240|453502692|FG000|Overall Study|Protocol Violation|5|||
125891925|NCT04335136|452903029|FG001|Overall Study|Protocol Violation|0|||
125891926|NCT04335136|452903028|FG000|Overall Study|Withdrawal by Subject|1|||
125891927|NCT04335136|452903029|FG001|Overall Study|Withdrawal by Subject|1|||
125891928|NCT04335136|452903028|FG000|Overall Study|Health-threatening condition|0|||
125891929|NCT04335136|452903029|FG001|Overall Study|Health-threatening condition|1|||
125891930|NCT04335136|452903028|FG000|Overall Study|Adverse Event|0|||
125891931|NCT04335136|452903029|FG001|Overall Study|Adverse Event|1|||
125891932|NCT04335136|452903028|FG000|Overall Study|Erroneously randomized|2|||
125891933|NCT04335136|452903029|FG001|Overall Study|Erroneously randomized|0|||
125891934|NCT02597478|452903030|FG000|Overall Study|Withdrawal by Subject|2|||
125891935|NCT02597478|452903031|FG001|Overall Study|Withdrawal by Subject|0|||
125891936|NCT02597478|452903030|FG000|Overall Study|Change of opioid dose|1|||
125891937|NCT02597478|452903031|FG001|Overall Study|Change of opioid dose|0|||
125891938|NCT02597478|452903030|FG000|Overall Study|Insufficient exertional dyspnea|0|||
125891939|NCT02597478|452903031|FG001|Overall Study|Insufficient exertional dyspnea|1|||
125891940|NCT01652469|452903032|FG000|Overall Study|Withdrawal by Subject|1|||
125891941|NCT01652469|452903033|FG001|Overall Study|Withdrawal by Subject|4|||
125891942|NCT01652469|452903032|FG000|Overall Study|Lost to Follow-up|0|||
125891943|NCT01652469|452903033|FG001|Overall Study|Lost to Follow-up|2|||
125891944|NCT01402102|452903034|FG000|Overall Study|Protocol Violation|1|||
125891945|NCT01402102|452903035|FG001|Overall Study|Protocol Violation|0|||
125891946|NCT01402102|452903034|FG000|Overall Study|Insufficiency of compliance|1|||
125891947|NCT01402102|452903035|FG001|Overall Study|Insufficiency of compliance|1|||
125891948|NCT01402102|452903034|FG000|Overall Study|Withdrawal by Subject|0|||
125891949|NCT01402102|452903035|FG001|Overall Study|Withdrawal by Subject|2|||
125891950|NCT01305577|452903037|FG000|Overall Study|Adverse Event|2|||
125891951|NCT01305577|452903038|FG001|Overall Study|Adverse Event|2|||
125891952|NCT01305577|452903039|FG002|Overall Study|Adverse Event|1|||
125891953|NCT01305577|452903037|FG000|Overall Study|Withdrawal by Subject|7|||
125891954|NCT01305577|452903038|FG001|Overall Study|Withdrawal by Subject|5|||
125891955|NCT01305577|452903039|FG002|Overall Study|Withdrawal by Subject|6|||
125891956|NCT01305577|452903037|FG000|Overall Study|Lost to Follow-up|4|||
126056777|NCT00487240|453502693|FG001|Overall Study|Protocol Violation|5|||
126056778|NCT00487240|453502692|FG000|Overall Study|Entry Criteria Not Met|3|||
126056779|NCT00487240|453502693|FG001|Overall Study|Entry Criteria Not Met|4|||
125891957|NCT01305577|452903038|FG001|Overall Study|Lost to Follow-up|3|||
125891958|NCT01305577|452903039|FG002|Overall Study|Lost to Follow-up|2|||
125891959|NCT01305577|452903037|FG000|Overall Study|Protocol Deviation|0|||
126056780|NCT00487240|453502692|FG000|Overall Study|Sponsor Decision|2|||
125891960|NCT01305577|452903038|FG001|Overall Study|Protocol Deviation|1|||
125891961|NCT01305577|452903039|FG002|Overall Study|Protocol Deviation|1|||
126106117|NCT00392327|453681275|FG003|Overall Study|Death|0|||
126106118|NCT00392327|453681276|FG004|Overall Study|Death|0|||
126106119|NCT00392327|453681277|FG005|Overall Study|Death|0|||
126106120|NCT00392327|453681278|FG006|Overall Study|Death|0|||
126106121|NCT00392327|453681279|FG007|Overall Study|Death|0|||
126106122|NCT00392327|453681272|FG000|Overall Study|Lack of Efficacy|8|||
126106123|NCT00392327|453681273|FG001|Overall Study|Lack of Efficacy|8|||
126106124|NCT00392327|453681274|FG002|Overall Study|Lack of Efficacy|9|||
126106125|NCT00392327|453681275|FG003|Overall Study|Lack of Efficacy|6|||
126106126|NCT00392327|453681276|FG004|Overall Study|Lack of Efficacy|3|||
126106127|NCT00392327|453681277|FG005|Overall Study|Lack of Efficacy|3|||
126106128|NCT00392327|453681278|FG006|Overall Study|Lack of Efficacy|3|||
126106129|NCT00392327|453681279|FG007|Overall Study|Lack of Efficacy|3|||
126106130|NCT00392327|453681272|FG000|Overall Study|Physician Decision|3|||
126106131|NCT00392327|453681273|FG001|Overall Study|Physician Decision|5|||
126106132|NCT00392327|453681274|FG002|Overall Study|Physician Decision|2|||
126106133|NCT00392327|453681275|FG003|Overall Study|Physician Decision|2|||
126106134|NCT00392327|453681276|FG004|Overall Study|Physician Decision|0|||
126106135|NCT00392327|453681277|FG005|Overall Study|Physician Decision|1|||
126106136|NCT00392327|453681278|FG006|Overall Study|Physician Decision|5|||
126106137|NCT00392327|453681279|FG007|Overall Study|Physician Decision|3|||
126106138|NCT00392327|453681272|FG000|Overall Study|Protocol Violation|0|||
126106139|NCT00392327|453681273|FG001|Overall Study|Protocol Violation|0|||
126106140|NCT00392327|453681274|FG002|Overall Study|Protocol Violation|1|||
126106141|NCT00392327|453681275|FG003|Overall Study|Protocol Violation|0|||
126106142|NCT00392327|453681276|FG004|Overall Study|Protocol Violation|0|||
126106143|NCT00392327|453681277|FG005|Overall Study|Protocol Violation|0|||
126106144|NCT00392327|453681278|FG006|Overall Study|Protocol Violation|0|||
126106145|NCT00392327|453681279|FG007|Overall Study|Protocol Violation|0|||
126106146|NCT00392327|453681272|FG000|Overall Study|Withdrawal by Subject|3|||
126106147|NCT00392327|453681273|FG001|Overall Study|Withdrawal by Subject|2|||
126106148|NCT00392327|453681274|FG002|Overall Study|Withdrawal by Subject|4|||
126106149|NCT00392327|453681275|FG003|Overall Study|Withdrawal by Subject|6|||
126106150|NCT00392327|453681276|FG004|Overall Study|Withdrawal by Subject|0|||
126106151|NCT00392327|453681277|FG005|Overall Study|Withdrawal by Subject|1|||
126106152|NCT00392327|453681278|FG006|Overall Study|Withdrawal by Subject|1|||
126106153|NCT00392327|453681279|FG007|Overall Study|Withdrawal by Subject|5|||
126106154|NCT00392327|453681272|FG000|Overall Study|Ineligible|0|||
126106155|NCT00392327|453681273|FG001|Overall Study|Ineligible|4|||
126106156|NCT00392327|453681274|FG002|Overall Study|Ineligible|3|||
126106157|NCT00392327|453681275|FG003|Overall Study|Ineligible|2|||
126106158|NCT00392327|453681276|FG004|Overall Study|Ineligible|0|||
126106159|NCT00392327|453681277|FG005|Overall Study|Ineligible|0|||
126106160|NCT00392327|453681278|FG006|Overall Study|Ineligible|0|||
126106161|NCT00392327|453681279|FG007|Overall Study|Ineligible|0|||
126106162|NCT04508023|453681280|FG000|Overall Study|Withdrawal by Subject|1|||
126106163|NCT04508023|453681281|FG001|Overall Study|Withdrawal by Subject|2|||
126106164|NCT00421707|453681288|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
126106165|NCT00421707|453681289|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
126106166|NCT00421707|453681288|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
126106167|NCT00421707|453681289|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
126106168|NCT00421707|453681288|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
126106169|NCT00421707|453681289|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
126106170|NCT00421707|453681288|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
126106171|NCT00421707|453681289|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
126106172|NCT00421707|453681288|FG000|Period 2: Washout|Adverse Event|1|||
126106173|NCT00421707|453681289|FG001|Period 2: Washout|Adverse Event|1|||
126106174|NCT00421707|453681288|FG000|Period 2: Washout|Withdrawal by Subject|0|||
126106175|NCT00421707|453681289|FG001|Period 2: Washout|Withdrawal by Subject|1|||
126106176|NCT00421707|453681288|FG000|Period 2: Washout|Lost to Follow-up|0|||
126106177|NCT00421707|453681289|FG001|Period 2: Washout|Lost to Follow-up|1|||
126106178|NCT00421707|453681288|FG000|Period 2: Washout|Other: Pregnancy|0|||
126106179|NCT00421707|453681289|FG001|Period 2: Washout|Other: Pregnancy|1|||
126106180|NCT00421707|453681288|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
126106181|NCT00421707|453681289|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
126106182|NCT00421707|453681288|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
126106183|NCT00421707|453681289|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
126106184|NCT00421707|453681288|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
126106185|NCT00421707|453681289|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
126056781|NCT00487240|453502693|FG001|Overall Study|Sponsor Decision|1|||
126056782|NCT00487240|453502692|FG000|Overall Study|Physician Decision|2|||
126056783|NCT00487240|453502693|FG001|Overall Study|Physician Decision|0|||
126056784|NCT01019135|453502694|FG000|Overall Study|Did not receive allocated intervention|12|||
126056785|NCT01019135|453502695|FG001|Overall Study|Did not receive allocated intervention|6|||
126056786|NCT01019135|453502696|FG002|Overall Study|Did not receive allocated intervention|25|||
126056787|NCT01019135|453502694|FG000|Overall Study|Did not attend CR|8|||
126056788|NCT01019135|453502695|FG001|Overall Study|Did not attend CR|13|||
125891962|NCT00905645|452903040|FG000|Overall Study|Death (not device related)|10|||
126056789|NCT01019135|453502696|FG002|Overall Study|Did not attend CR|6|||
126056790|NCT05124210|453502697|FG000|Overall Study|Lost to Follow-up|1|||
126056791|NCT05124210|453502698|FG001|Overall Study|Lost to Follow-up|0|||
126056792|NCT05124210|453502697|FG000|Overall Study|Withdrawal by Subject|1|||
126056793|NCT05124210|453502698|FG001|Overall Study|Withdrawal by Subject|0|||
126056794|NCT00768755|453502701|FG000|Phase 1|Death|6|||
126056795|NCT00768755|453502702|FG001|Phase 1|Death|0|||
126056796|NCT00768755|453502703|FG002|Phase 1|Death|0|||
126056797|NCT00768755|453502704|FG003|Phase 1|Death|0|||
126056798|NCT00768755|453502701|FG000|Phase 1|Other|4|||
126056799|NCT00768755|453502702|FG001|Phase 1|Other|0|||
126056800|NCT00768755|453502703|FG002|Phase 1|Other|0|||
126056801|NCT00768755|453502704|FG003|Phase 1|Other|0|||
126056802|NCT00768755|453502701|FG000|Phase 2|Death|0|||
126056803|NCT00768755|453502702|FG001|Phase 2|Death|37|||
126056804|NCT00768755|453502703|FG002|Phase 2|Death|48|||
126056805|NCT00768755|453502704|FG003|Phase 2|Death|31|||
126056806|NCT00768755|453502701|FG000|Phase 2|Protocol Violation|0|||
126056807|NCT00768755|453502702|FG001|Phase 2|Protocol Violation|2|||
126056808|NCT00768755|453502703|FG002|Phase 2|Protocol Violation|0|||
126056809|NCT00768755|453502704|FG003|Phase 2|Protocol Violation|1|||
126056810|NCT00768755|453502701|FG000|Phase 2|Lost to Follow-up|0|||
126056811|NCT00768755|453502702|FG001|Phase 2|Lost to Follow-up|1|||
126056812|NCT00768755|453502703|FG002|Phase 2|Lost to Follow-up|1|||
126056813|NCT00768755|453502704|FG003|Phase 2|Lost to Follow-up|4|||
126056814|NCT00768755|453502701|FG000|Phase 2|Withdrawal by Subject|0|||
126056815|NCT00768755|453502702|FG001|Phase 2|Withdrawal by Subject|1|||
126056816|NCT00768755|453502703|FG002|Phase 2|Withdrawal by Subject|0|||
126056817|NCT00768755|453502704|FG003|Phase 2|Withdrawal by Subject|1|||
126056818|NCT00768755|453502701|FG000|Phase 2|Other|0|||
126056819|NCT00768755|453502702|FG001|Phase 2|Other|1|||
126056820|NCT00768755|453502703|FG002|Phase 2|Other|2|||
126056821|NCT00768755|453502704|FG003|Phase 2|Other|4|||
126056822|NCT00768755|453502701|FG000|Phase 2|Study Terminated by Sponsor|0|||
126056823|NCT00768755|453502702|FG001|Phase 2|Study Terminated by Sponsor|13|||
126056824|NCT00768755|453502703|FG002|Phase 2|Study Terminated by Sponsor|7|||
126056825|NCT00768755|453502704|FG003|Phase 2|Study Terminated by Sponsor|14|||
126056826|NCT00768755|453502701|FG000|Phase 2|Randomized but not treated|0|||
126056827|NCT00768755|453502702|FG001|Phase 2|Randomized but not treated|0|||
126056828|NCT00768755|453502703|FG002|Phase 2|Randomized but not treated|0|||
126056829|NCT00768755|453502704|FG003|Phase 2|Randomized but not treated|2|||
126056830|NCT03298087|453502707|FG000|Overall Study|Withdrawal by Subject|4|||
125891963|NCT00905645|452903041|FG001|Overall Study|Death (not device related)|4|||
126106186|NCT03261700|453681290|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
126106187|NCT03261700|453681291|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
126106188|NCT01723254|453681292|FG000|Overall Study|Conflict with work schedule|0|||
126106189|NCT01723254|453681293|FG001|Overall Study|Conflict with work schedule|0|||
126106190|NCT01723254|453681294|FG002|Overall Study|Conflict with work schedule|0|||
126106191|NCT01723254|453681295|FG003|Overall Study|Conflict with work schedule|0|||
126106192|NCT01723254|453681296|FG004|Overall Study|Conflict with work schedule|0|||
126106193|NCT01723254|453681297|FG005|Overall Study|Conflict with work schedule|0|||
126106194|NCT01723254|453681298|FG006|Overall Study|Conflict with work schedule|0|||
126106195|NCT01723254|453681299|FG007|Overall Study|Conflict with work schedule|1|||
126106196|NCT01723254|453681292|FG000|Overall Study|Personal issues|0|||
126106197|NCT01723254|453681293|FG001|Overall Study|Personal issues|0|||
126106198|NCT01723254|453681294|FG002|Overall Study|Personal issues|0|||
126106199|NCT01723254|453681295|FG003|Overall Study|Personal issues|0|||
126106200|NCT01723254|453681296|FG004|Overall Study|Personal issues|0|||
126106201|NCT01723254|453681297|FG005|Overall Study|Personal issues|1|||
126106202|NCT01723254|453681298|FG006|Overall Study|Personal issues|0|||
126106203|NCT01723254|453681299|FG007|Overall Study|Personal issues|0|||
126106204|NCT01723254|453681292|FG000|Overall Study|No longer have time to participate|0|||
126106205|NCT01723254|453681293|FG001|Overall Study|No longer have time to participate|0|||
126106206|NCT01723254|453681294|FG002|Overall Study|No longer have time to participate|0|||
126106207|NCT01723254|453681295|FG003|Overall Study|No longer have time to participate|1|||
126106208|NCT01723254|453681296|FG004|Overall Study|No longer have time to participate|0|||
126106209|NCT01723254|453681297|FG005|Overall Study|No longer have time to participate|0|||
126106210|NCT01723254|453681298|FG006|Overall Study|No longer have time to participate|0|||
126106211|NCT01723254|453681299|FG007|Overall Study|No longer have time to participate|0|||
126106212|NCT01723254|453681292|FG000|Overall Study|Move/Left to another country/city|0|||
126106213|NCT01723254|453681293|FG001|Overall Study|Move/Left to another country/city|0|||
126106214|NCT01723254|453681294|FG002|Overall Study|Move/Left to another country/city|2|||
126106215|NCT01723254|453681295|FG003|Overall Study|Move/Left to another country/city|1|||
126106216|NCT01723254|453681296|FG004|Overall Study|Move/Left to another country/city|1|||
126106217|NCT01723254|453681297|FG005|Overall Study|Move/Left to another country/city|0|||
126106218|NCT01723254|453681298|FG006|Overall Study|Move/Left to another country/city|0|||
126106219|NCT01723254|453681299|FG007|Overall Study|Move/Left to another country/city|0|||
126106220|NCT01723254|453681292|FG000|Overall Study|Protocol Violation|0|||
126106221|NCT01723254|453681293|FG001|Overall Study|Protocol Violation|1|||
126106222|NCT01723254|453681294|FG002|Overall Study|Protocol Violation|0|||
126106223|NCT01723254|453681295|FG003|Overall Study|Protocol Violation|0|||
126106224|NCT01723254|453681296|FG004|Overall Study|Protocol Violation|0|||
126106225|NCT01723254|453681297|FG005|Overall Study|Protocol Violation|0|||
126106226|NCT01723254|453681298|FG006|Overall Study|Protocol Violation|0|||
126106227|NCT01723254|453681299|FG007|Overall Study|Protocol Violation|0|||
126106228|NCT01723254|453681292|FG000|Overall Study|Withdrawal by Subject|1|||
126106229|NCT01723254|453681293|FG001|Overall Study|Withdrawal by Subject|2|||
126106230|NCT01723254|453681294|FG002|Overall Study|Withdrawal by Subject|1|||
126106231|NCT01723254|453681295|FG003|Overall Study|Withdrawal by Subject|0|||
126106232|NCT01723254|453681296|FG004|Overall Study|Withdrawal by Subject|1|||
126106233|NCT01723254|453681297|FG005|Overall Study|Withdrawal by Subject|1|||
126106234|NCT01723254|453681298|FG006|Overall Study|Withdrawal by Subject|1|||
126106235|NCT01723254|453681299|FG007|Overall Study|Withdrawal by Subject|2|||
126106236|NCT00655486|453682816|FG000|Overall Study|Adverse Event|10|||
126106237|NCT00655486|453682816|FG000|Overall Study|Lack of Efficacy|8|||
126106238|NCT00655486|453682816|FG000|Overall Study|Withdrawal by Subject|4|||
126106239|NCT00655486|453682816|FG000|Overall Study|Protocol Violation|1|||
126106240|NCT00655486|453682816|FG000|Overall Study|Unsatisfactory compliance|2|||
126106241|NCT00655486|453682816|FG000|Overall Study|Other: Pregnancy|1|||
126106242|NCT00655486|453682816|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
126106243|NCT00655486|453682816|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
126106244|NCT03840486|453682817|FG000|Overall Study|Withdrawal by Subject|0|||
126106245|NCT03840486|453682818|FG001|Overall Study|Withdrawal by Subject|1|||
126106246|NCT03840486|453682819|FG002|Overall Study|Withdrawal by Subject|0|||
126106247|NCT03840486|453682820|FG003|Overall Study|Withdrawal by Subject|0|||
126106248|NCT03840486|453682821|FG004|Overall Study|Withdrawal by Subject|0|||
126106249|NCT03840486|453682822|FG005|Overall Study|Withdrawal by Subject|0|||
126106250|NCT03840486|453682823|FG006|Overall Study|Withdrawal by Subject|0|||
126106251|NCT03840486|453682824|FG007|Overall Study|Withdrawal by Subject|0|||
126106252|NCT03840486|453682825|FG008|Overall Study|Withdrawal by Subject|0|||
126106253|NCT03840486|453682826|FG009|Overall Study|Withdrawal by Subject|0|||
126106254|NCT03840486|453682827|FG010|Overall Study|Withdrawal by Subject|0|||
126106255|NCT03840486|453682828|FG011|Overall Study|Withdrawal by Subject|0|||
126106256|NCT02768870|453682829|FG000|Overall Study|Death|1|||
126106257|NCT02768870|453682829|FG000|Overall Study|Reoperation|6|||
126106258|NCT02768870|453682829|FG000|Overall Study|Lost to Follow-up|1|||
126106259|NCT02768870|453682829|FG000|Overall Study|Exit|4|||
126106260|NCT03401229|453682830|FG000|Overall Study|Lost to Follow-up|2|||
126106261|NCT03401229|453682831|FG001|Overall Study|Lost to Follow-up|1|||
126106262|NCT03401229|453682830|FG000|Overall Study|Other|1|||
126106263|NCT03401229|453682831|FG001|Overall Study|Other|3|||
126106264|NCT03401229|453682830|FG000|Overall Study|Adverse Event|8|||
126106265|NCT03401229|453682831|FG001|Overall Study|Adverse Event|6|||
126106266|NCT03401229|453682830|FG000|Overall Study|Withdrawal by Subject|29|||
126106267|NCT03401229|453682831|FG001|Overall Study|Withdrawal by Subject|26|||
126106268|NCT03401229|453682830|FG000|Overall Study|COVID-19|0|||
126106269|NCT03401229|453682831|FG001|Overall Study|COVID-19|1|||
126106270|NCT01774110|453682832|FG000|Overall Study|Lost to Follow-up|7|||
126106271|NCT00640016|453682833|FG000|Overall Study|Withdrawal by Subject|0|||
126106272|NCT00640016|453682834|FG001|Overall Study|Withdrawal by Subject|1|||
126106273|NCT00640016|453682835|FG002|Overall Study|Withdrawal by Subject|0|||
126106274|NCT00640016|453682836|FG003|Overall Study|Withdrawal by Subject|0|||
126106275|NCT00640016|453682833|FG000|Overall Study|Study termination|2|||
126106276|NCT00640016|453682834|FG001|Overall Study|Study termination|1|||
126106277|NCT00640016|453682835|FG002|Overall Study|Study termination|3|||
126106278|NCT00640016|453682836|FG003|Overall Study|Study termination|2|||
126106279|NCT00640016|453682833|FG000|Overall Study|Adverse Event|0|||
126106280|NCT00640016|453682834|FG001|Overall Study|Adverse Event|0|||
126106281|NCT00640016|453682835|FG002|Overall Study|Adverse Event|0|||
126106282|NCT00640016|453682836|FG003|Overall Study|Adverse Event|1|||
126106283|NCT03575143|453682837|FG000|Overall Study|Lost to Follow-up|0|||
126106284|NCT03575143|453682838|FG001|Overall Study|Lost to Follow-up|0|||
126106285|NCT03575143|453682839|FG002|Overall Study|Lost to Follow-up|4|||
126106286|NCT03575143|453682837|FG000|Overall Study|Withdrawal by Subject|0|||
126106287|NCT03575143|453682838|FG001|Overall Study|Withdrawal by Subject|0|||
126106288|NCT03575143|453682839|FG002|Overall Study|Withdrawal by Subject|5|||
126106289|NCT03575143|453682837|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
126106290|NCT03575143|453682838|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
126106291|NCT03575143|453682839|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
126106292|NCT01287065|453682840|FG000|Treatment Period 1|Adverse Event|0|||
126106293|NCT01287065|453682841|FG001|Treatment Period 1|Adverse Event|0|||
126106294|NCT01287065|453682842|FG002|Treatment Period 1|Adverse Event|0|||
126106295|NCT01287065|453682843|FG003|Treatment Period 1|Adverse Event|0|||
126106296|NCT01287065|453682844|FG004|Treatment Period 1|Adverse Event|1|||
126106297|NCT01287065|453682845|FG005|Treatment Period 1|Adverse Event|0|||
126106298|NCT01287065|453682840|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126106299|NCT01287065|453682841|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126106300|NCT01287065|453682842|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126106301|NCT01287065|453682843|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126106302|NCT01287065|453682844|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126106303|NCT01287065|453682845|FG005|Treatment Period 1|Withdrawal by Subject|1|||
126106304|NCT02875977|453682846|FG000|Overall Study|Lost to Follow-up|42|||
126106305|NCT02875977|453682847|FG001|Overall Study|Lost to Follow-up|29|||
126106306|NCT01259726|453682848|FG000|Overall Study|Death|1|||
126106307|NCT01259726|453682849|FG001|Overall Study|Death|0|||
126106308|NCT01259726|453682850|FG002|Overall Study|Death|0|||
126106309|NCT01259726|453682851|FG003|Overall Study|Death|0|||
126106310|NCT01259726|453682848|FG000|Overall Study|Physician Decision|2|||
126106311|NCT01259726|453682849|FG001|Overall Study|Physician Decision|0|||
126106312|NCT01259726|453682850|FG002|Overall Study|Physician Decision|1|||
126106313|NCT01259726|453682851|FG003|Overall Study|Physician Decision|1|||
126106314|NCT01259726|453682848|FG000|Overall Study|Withdrawal by Subject|1|||
126106315|NCT01259726|453682849|FG001|Overall Study|Withdrawal by Subject|3|||
126106316|NCT01259726|453682850|FG002|Overall Study|Withdrawal by Subject|2|||
126106317|NCT01259726|453682851|FG003|Overall Study|Withdrawal by Subject|1|||
126106318|NCT01259726|453682848|FG000|Overall Study|Lost to Follow-up|1|||
126106319|NCT01259726|453682849|FG001|Overall Study|Lost to Follow-up|1|||
126106320|NCT01259726|453682850|FG002|Overall Study|Lost to Follow-up|1|||
126106321|NCT01259726|453682851|FG003|Overall Study|Lost to Follow-up|3|||
126106322|NCT01978262|453682852|FG000|Overall Study|Withdrawal by Subject|9|||
126106323|NCT01978262|453682852|FG000|Overall Study|Lost to Follow-up|2|||
126106324|NCT02435966|453682860|FG000|Overall Study|Withdrawal by Subject|0|||
126106325|NCT02435966|453682861|FG001|Overall Study|Withdrawal by Subject|1|||
126106326|NCT02435966|453682862|FG002|Overall Study|Withdrawal by Subject|0|||
126106327|NCT02168842|453682864|FG000|Overall Study|Withdrawal by Subject|5|||
126106328|NCT02168842|453682865|FG001|Overall Study|Withdrawal by Subject|3|||
126106329|NCT02168842|453682864|FG000|Overall Study|Lost to Follow-up|0|||
126106330|NCT02168842|453682865|FG001|Overall Study|Lost to Follow-up|2|||
126106331|NCT02168842|453682864|FG000|Overall Study|Death|2|||
126106332|NCT02168842|453682865|FG001|Overall Study|Death|1|||
126106333|NCT02168842|453682864|FG000|Overall Study|Physician Decision|1|||
126106334|NCT02168842|453682865|FG001|Overall Study|Physician Decision|2|||
126106335|NCT00325039|453682866|FG000|Overall Study|Lost to Follow-up|18|||
126106336|NCT00325039|453682867|FG001|Overall Study|Lost to Follow-up|14|||
126106337|NCT02974088|453682868|FG000|Overall Study|Lost to Follow-up|0|||
126106338|NCT02974088|453682869|FG001|Overall Study|Lost to Follow-up|2|||
126106339|NCT02974088|453682868|FG000|Overall Study|Adverse Event|0|||
126106340|NCT02974088|453682869|FG001|Overall Study|Adverse Event|1|||
126106341|NCT00687973|453682875|FG000|Overall Study|Adverse Event|18|||
126106342|NCT00687973|453682876|FG001|Overall Study|Adverse Event|28|||
126106343|NCT00687973|453682875|FG000|Overall Study|Lack of Efficacy|2|||
125891964|NCT00905645|452903042|FG002|Overall Study|Death (not device related)|15|||
125891965|NCT00905645|452903043|FG003|Overall Study|Death (not device related)|8|||
125891966|NCT00905645|452903040|FG000|Overall Study|Explantation of study device(s)|78|||
125891967|NCT00905645|452903041|FG001|Overall Study|Explantation of study device(s)|47|||
125891968|NCT00905645|452903042|FG002|Overall Study|Explantation of study device(s)|28|||
125891969|NCT00905645|452903043|FG003|Overall Study|Explantation of study device(s)|21|||
125891970|NCT00905645|452903040|FG000|Overall Study|Subject Request|41|||
125891971|NCT00905645|452903041|FG001|Overall Study|Subject Request|17|||
125891972|NCT00905645|452903042|FG002|Overall Study|Subject Request|13|||
125891973|NCT00905645|452903043|FG003|Overall Study|Subject Request|11|||
125891974|NCT00905645|452903040|FG000|Overall Study|Lost to Follow-up|299|||
125891975|NCT00905645|452903041|FG001|Overall Study|Lost to Follow-up|103|||
125891976|NCT00905645|452903042|FG002|Overall Study|Lost to Follow-up|51|||
125891977|NCT00905645|452903043|FG003|Overall Study|Lost to Follow-up|12|||
125891978|NCT01731938|452903044|FG000|Preliminary Part I|Withdrawal by Subject|2|||
125891979|NCT01731938|452903045|FG001|Preliminary Part I|Withdrawal by Subject|2|||
125891980|NCT01731938|452903044|FG000|Preliminary Part I|Physician Decision|1|||
125891981|NCT01731938|452903045|FG001|Preliminary Part I|Physician Decision|0|||
125891982|NCT01731938|452903044|FG000|Preliminary Part I|Lost to Follow-up|0|||
126106344|NCT00687973|453682876|FG001|Overall Study|Lack of Efficacy|3|||
126106345|NCT00687973|453682875|FG000|Overall Study|Protocol Violation|1|||
126056831|NCT01530334|453502711|FG000|Overall Study|Adverse Event|3|||
126056832|NCT01530334|453502711|FG000|Overall Study|unknown reason|1|||
126056833|NCT01530334|453502711|FG000|Overall Study|Progressive disease|47|||
126056834|NCT01485887|453502712|FG000|Overall Study|Withdrawal by Subject|2|||
126056835|NCT01485887|453502712|FG000|Overall Study|Adverse Event|8|||
126056836|NCT01485887|453502712|FG000|Overall Study|Deterioration of primary disease|1|||
126056837|NCT01485887|453502712|FG000|Overall Study|Primary disease markedly improved|1|||
126056838|NCT03184987|453502716|FG000|Overall Study|Withdrawal by Subject|0|||
126056839|NCT03184987|453502717|FG001|Overall Study|Withdrawal by Subject|1|||
126056840|NCT03184987|453502718|FG002|Overall Study|Withdrawal by Subject|2|||
126056841|NCT03184987|453502716|FG000|Overall Study|Physician Decision|0|||
126056842|NCT03184987|453502717|FG001|Overall Study|Physician Decision|0|||
126056843|NCT03184987|453502718|FG002|Overall Study|Physician Decision|1|||
126056844|NCT03184987|453502716|FG000|Overall Study|Adverse Event|1|||
126056845|NCT03184987|453502717|FG001|Overall Study|Adverse Event|0|||
126056846|NCT03184987|453502718|FG002|Overall Study|Adverse Event|1|||
126056847|NCT02203799|453502719|FG000|Overall Study|Withdrawal by Subject|3|||
126056848|NCT00681109|453502720|FG000|Overall Study|Lost to Follow-up|2|||
126056849|NCT00681109|453502721|FG001|Overall Study|Lost to Follow-up|6|||
126056850|NCT00681109|453502722|FG002|Overall Study|Lost to Follow-up|0|||
126056851|NCT04660799|453502723|FG000|Overall Study|Progressive Disease|1|||
126056852|NCT04660799|453502724|FG001|Overall Study|Progressive Disease|1|||
126056853|NCT04660799|453502723|FG000|Overall Study|Death|2|||
126056854|NCT04660799|453502724|FG001|Overall Study|Death|1|||
126056855|NCT04660799|453502723|FG000|Overall Study|Adverse Event|2|||
126056856|NCT04660799|453502724|FG001|Overall Study|Adverse Event|1|||
126056857|NCT04660799|453502723|FG000|Overall Study|Withdrawal by Subject|2|||
126056858|NCT04660799|453502724|FG001|Overall Study|Withdrawal by Subject|5|||
126056859|NCT01220999|453502729|FG000|Overall Study|Progressive disease|0|||
126056860|NCT01220999|453502730|FG001|Overall Study|Progressive disease|0|||
126056861|NCT01220999|453502731|FG002|Overall Study|Progressive disease|1|||
126056862|NCT01220999|453502732|FG003|Overall Study|Progressive disease|0|||
126056863|NCT01220999|453502733|FG004|Overall Study|Progressive disease|0|||
126056864|NCT01560429|453502734|FG000|Overall Study|Protocol Violation|3|||
126056865|NCT01560429|453502735|FG001|Overall Study|Protocol Violation|6|||
126056866|NCT00391170|453502746|FG000|Overall Study|Withdrawal by Subject|1|||
126056867|NCT00391170|453502747|FG001|Overall Study|Withdrawal by Subject|0|||
126056868|NCT00391170|453502746|FG000|Overall Study|Adverse Event|3|||
126056869|NCT00391170|453502747|FG001|Overall Study|Adverse Event|2|||
126056870|NCT00391170|453502746|FG000|Overall Study|Physician Decision|2|||
126056871|NCT00391170|453502747|FG001|Overall Study|Physician Decision|2|||
126056872|NCT03035942|453502750|FG000|Overall Study|Adverse Event|8|||
126056873|NCT03035942|453502751|FG001|Overall Study|Adverse Event|4|||
126056874|NCT03035942|453502752|FG002|Overall Study|Adverse Event|5|||
126056875|NCT05270460|453502753|FG000|Overall Study|Adverse Event|0|||
126056876|NCT05270460|453502754|FG001|Overall Study|Adverse Event|1|||
126056877|NCT05270460|453502755|FG002|Overall Study|Adverse Event|0|||
126056878|NCT05270460|453502753|FG000|Overall Study|Early Termination|0|||
126056879|NCT05270460|453502754|FG001|Overall Study|Early Termination|1|||
126056880|NCT05270460|453502755|FG002|Overall Study|Early Termination|0|||
126056881|NCT01989104|453502756|FG000|Overall Study|Withdrawal by Subject|3|||
126056882|NCT01989104|453502757|FG001|Overall Study|Withdrawal by Subject|0|||
126056883|NCT01989104|453502758|FG002|Overall Study|Withdrawal by Subject|0|||
126056884|NCT01989104|453502759|FG003|Overall Study|Withdrawal by Subject|0|||
126056885|NCT01989104|453502760|FG004|Overall Study|Withdrawal by Subject|0|||
126056886|NCT04029090|453502762|FG000|Overall Study|Protocol Violation|1|||
126056887|NCT04029090|453502763|FG001|Overall Study|Protocol Violation|0|||
126056888|NCT04029090|453502764|FG002|Overall Study|Protocol Violation|0|||
126106346|NCT00687973|453682876|FG001|Overall Study|Protocol Violation|2|||
126106347|NCT00687973|453682875|FG000|Overall Study|Administrative Reasons|0|||
126056889|NCT04029090|453502762|FG000|Overall Study|Withdrawal by Subject|0|||
126056890|NCT04029090|453502763|FG001|Overall Study|Withdrawal by Subject|1|||
126056891|NCT04029090|453502764|FG002|Overall Study|Withdrawal by Subject|0|||
126056892|NCT01065779|453502765|FG000|Overall Study|Duplicate Investigation|1|||
126056893|NCT01065779|453502765|FG000|Overall Study|Investigation Before Contract Date|37|||
126056894|NCT01065779|453502765|FG000|Overall Study|Non-enrollment Period Administration|10|||
126056895|NCT01065779|453502765|FG000|Overall Study|Not Administered With Study Drug|17|||
126056896|NCT01065779|453502765|FG000|Overall Study|Failed to Follow-up|10|||
126056897|NCT01065779|453502765|FG000|Overall Study|Inclusion Criteria Violation|7|||
126056898|NCT02157948|453502769|FG000|Overall Study|Withdrawal by Subject|4|||
126056899|NCT02157948|453502770|FG001|Overall Study|Withdrawal by Subject|5|||
126056900|NCT02157948|453502769|FG000|Overall Study|Lost to Follow-up|3|||
126056901|NCT02157948|453502770|FG001|Overall Study|Lost to Follow-up|2|||
126056902|NCT02157948|453502769|FG000|Overall Study|Protocol Specified Criteria|2|||
126056903|NCT02157948|453502770|FG001|Overall Study|Protocol Specified Criteria|1|||
126056904|NCT02157948|453502769|FG000|Overall Study|Decision by Sponsor|0|||
126056905|NCT02157948|453502770|FG001|Overall Study|Decision by Sponsor|1|||
126056906|NCT03775213|453502777|FG000|Overall Study|Withdrawal by Subject|51|||
126056907|NCT03775213|453502778|FG001|Overall Study|Withdrawal by Subject|53|||
126056908|NCT03775213|453502777|FG000|Overall Study|Incomplete Survey|7|||
126056909|NCT03775213|453502778|FG001|Overall Study|Incomplete Survey|7|||
126056910|NCT04821271|453502779|FG000|Period 1|Withdrawal by Subject|2|||
126056911|NCT04821271|453502780|FG001|Period 1|Withdrawal by Subject|0|||
126056912|NCT01567852|453503451|FG000|Overall Study|Withdrawal by Subject|3|||
126056913|NCT01567852|453503452|FG001|Overall Study|Withdrawal by Subject|6|||
126056914|NCT01567852|453503451|FG000|Overall Study|ECT discontinued|1|||
126056915|NCT01567852|453503452|FG001|Overall Study|ECT discontinued|1|||
126056916|NCT04809623|453503453|FG000|Overall Study|Study Terminated by Sponsor|1|||
126056917|NCT04809623|453503454|FG001|Overall Study|Study Terminated by Sponsor|0|||
126056918|NCT02202317|453503456|FG000|Overall Study|Lost to Follow-up|1|||
126056919|NCT00822900|453503468|FG000|Overall Study|Withdrawal by Subject|14|||
126056920|NCT00822900|453503469|FG001|Overall Study|Withdrawal by Subject|14|||
126056921|NCT00822900|453503468|FG000|Overall Study|Lost to Follow-up|9|||
126056922|NCT00822900|453503469|FG001|Overall Study|Lost to Follow-up|9|||
126056923|NCT00822900|453503468|FG000|Overall Study|Death|83|||
126056924|NCT00822900|453503469|FG001|Overall Study|Death|69|||
126056925|NCT00822900|453503468|FG000|Overall Study|Became a ward of the state|2|||
126056926|NCT00822900|453503469|FG001|Overall Study|Became a ward of the state|1|||
126056927|NCT02095678|453503470|FG000|Overall Study|Withdrawal by Subject|0|||
126056928|NCT02095678|453503471|FG001|Overall Study|Withdrawal by Subject|1|||
126056929|NCT02095678|453503470|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
126056930|NCT02095678|453503471|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
126056931|NCT02095678|453503470|FG000|Overall Study|lesion impacted by previous treatment|1|||
126056932|NCT02095678|453503471|FG001|Overall Study|lesion impacted by previous treatment|1|||
126056933|NCT02095678|453503470|FG000|Overall Study|No Confirmed Diagnosis|0|||
126056934|NCT02095678|453503471|FG001|Overall Study|No Confirmed Diagnosis|3|||
126056935|NCT02095678|453503470|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
126056936|NCT02095678|453503471|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
126106348|NCT00687973|453682876|FG001|Overall Study|Administrative Reasons|2|||
126106349|NCT00687973|453682875|FG000|Overall Study|Withdrawal by Subject|3|||
126106350|NCT00687973|453682876|FG001|Overall Study|Withdrawal by Subject|3|||
126106351|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
126106352|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
126106353|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Death|0|||
126106354|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Death|2|||
126106355|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
126106356|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
126106357|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
126106358|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
126106359|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
126106360|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
126106361|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
126106362|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
126106363|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
126106364|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
126056937|NCT02095678|453503470|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
126056938|NCT02095678|453503471|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
126056939|NCT00701415|453503472|FG000|Overall Study|Adverse Event|0|||
126056940|NCT00701415|453503473|FG001|Overall Study|Adverse Event|1|||
126056941|NCT00701415|453503472|FG000|Overall Study|Social/family issues and needle phobia|1|||
126056942|NCT00701415|453503473|FG001|Overall Study|Social/family issues and needle phobia|0|||
126106365|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
126056943|NCT02106884|453503476|FG000|Overall Study|Change of diagnosis/exclusion|0|||
126056944|NCT02106884|453503477|FG001|Overall Study|Change of diagnosis/exclusion|1|||
126056945|NCT02161458|453503478|FG000|Overall Study|Withdrawal by Subject|0|||
126056946|NCT02161458|453503479|FG001|Overall Study|Withdrawal by Subject|4|||
126056947|NCT02161458|453503480|FG002|Overall Study|Withdrawal by Subject|4|||
126056948|NCT02161458|453503481|FG003|Overall Study|Withdrawal by Subject|0|||
126056949|NCT02161458|453503478|FG000|Overall Study|Lost to Follow-up|0|||
126056950|NCT02161458|453503479|FG001|Overall Study|Lost to Follow-up|2|||
126056951|NCT02161458|453503480|FG002|Overall Study|Lost to Follow-up|1|||
126056952|NCT02161458|453503481|FG003|Overall Study|Lost to Follow-up|0|||
126056953|NCT00705159|453503487|FG000|Overall Study|Withdrawal by Subject|0|||
126056954|NCT00705159|453503488|FG001|Overall Study|Withdrawal by Subject|1|||
126056955|NCT00705159|453503489|FG002|Overall Study|Withdrawal by Subject|1|||
126056956|NCT00705159|453503490|FG003|Overall Study|Withdrawal by Subject|1|||
126056957|NCT00705159|453503487|FG000|Overall Study|Protocol Violation|0|||
126056958|NCT00705159|453503488|FG001|Overall Study|Protocol Violation|1|||
126056959|NCT00705159|453503489|FG002|Overall Study|Protocol Violation|0|||
126056960|NCT00705159|453503490|FG003|Overall Study|Protocol Violation|0|||
126056961|NCT00705159|453503487|FG000|Overall Study|Adverse Event|0|||
126056962|NCT00705159|453503488|FG001|Overall Study|Adverse Event|0|||
126056963|NCT00705159|453503489|FG002|Overall Study|Adverse Event|1|||
126056964|NCT00705159|453503490|FG003|Overall Study|Adverse Event|0|||
126056965|NCT00705159|453503487|FG000|Overall Study|Lost to Follow-up|0|||
126056966|NCT00705159|453503488|FG001|Overall Study|Lost to Follow-up|0|||
126056967|NCT00705159|453503489|FG002|Overall Study|Lost to Follow-up|3|||
126056968|NCT00705159|453503490|FG003|Overall Study|Lost to Follow-up|2|||
126056969|NCT00705159|453503487|FG000|Overall Study|Screen Failure|0|||
126056970|NCT00705159|453503488|FG001|Overall Study|Screen Failure|0|||
126056971|NCT00705159|453503489|FG002|Overall Study|Screen Failure|0|||
126056972|NCT00705159|453503490|FG003|Overall Study|Screen Failure|1|||
126056973|NCT03026166|453503491|FG000|Overall Study|Death|22|||
126056974|NCT03026166|453503492|FG001|Overall Study|Death|7|||
126056975|NCT03026166|453503491|FG000|Overall Study|Physician Decision|2|||
126056976|NCT03026166|453503492|FG001|Overall Study|Physician Decision|0|||
126056977|NCT03026166|453503491|FG000|Overall Study|Withdrawal by Subject|1|||
126056978|NCT03026166|453503492|FG001|Overall Study|Withdrawal by Subject|2|||
126056979|NCT03026166|453503491|FG000|Overall Study|Lost to Follow-up|1|||
126056980|NCT03026166|453503492|FG001|Overall Study|Lost to Follow-up|0|||
126056981|NCT03026166|453503491|FG000|Overall Study|Study Terminated by Sponsor|3|||
126056982|NCT03026166|453503492|FG001|Overall Study|Study Terminated by Sponsor|3|||
126056983|NCT03026166|453503491|FG000|Overall Study|Other|1|||
126056984|NCT03026166|453503492|FG001|Overall Study|Other|0|||
126056985|NCT02091752|453503495|FG000|Overall Study|Study terminated by Sponsor|2|||
126056986|NCT02091752|453503495|FG000|Overall Study|Adverse Event|1|||
126056987|NCT01604824|453503496|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126056988|NCT01604824|453503497|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126056989|NCT01604824|453503498|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126056990|NCT01604824|453503499|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126056991|NCT01604824|453503500|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
126056992|NCT01604824|453503501|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126056993|NCT01604824|453503496|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
126056994|NCT01604824|453503497|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
126106366|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
126106367|NCT00343252|453682877|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
126106368|NCT00343252|453682878|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
126106369|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
126106370|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
126106371|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Death|3|||
126106372|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Death|3|||
126056995|NCT01604824|453503498|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
126056996|NCT01604824|453503499|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
126056997|NCT01604824|453503500|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
126056998|NCT01604824|453503501|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
126056999|NCT04076059|453503504|FG000|Double Blind Phase|Progressive disease|22|||
126057000|NCT04076059|453503505|FG001|Double Blind Phase|Progressive disease|26|||
126057001|NCT04076059|453503506|FG002|Double Blind Phase|Progressive disease|0|||
126057002|NCT04076059|453503504|FG000|Double Blind Phase|Withdrawal by Subject|4|||
126057003|NCT04076059|453503505|FG001|Double Blind Phase|Withdrawal by Subject|11|||
126057004|NCT04076059|453503506|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126057005|NCT04076059|453503504|FG000|Double Blind Phase|Death|1|||
126057006|NCT04076059|453503505|FG001|Double Blind Phase|Death|1|||
126057007|NCT04076059|453503506|FG002|Double Blind Phase|Death|0|||
126057008|NCT04076059|453503504|FG000|Double Blind Phase|Lost to Follow-up|1|||
126057009|NCT04076059|453503505|FG001|Double Blind Phase|Lost to Follow-up|0|||
126057010|NCT04076059|453503506|FG002|Double Blind Phase|Lost to Follow-up|0|||
126057011|NCT04076059|453503504|FG000|Double Blind Phase|Adverse Event|5|||
126057012|NCT04076059|453503505|FG001|Double Blind Phase|Adverse Event|1|||
126057013|NCT04076059|453503506|FG002|Double Blind Phase|Adverse Event|0|||
126106373|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
126106374|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
126106375|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
126106376|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
126106377|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
126106378|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
126106379|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
126106380|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
126106381|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
126106382|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
126106383|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
126106384|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
126106385|NCT00343252|453682877|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
126106386|NCT00343252|453682878|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
126106387|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
126106388|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
126106389|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Death|4|||
126106390|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Death|5|||
126106391|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
126106392|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
126106393|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
126106394|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
126106395|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
126106396|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
126106397|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
126106398|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
126106399|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
126106400|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
126106401|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
126106402|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
126106403|NCT00343252|453682877|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
126106404|NCT00343252|453682878|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
126106405|NCT01740323|453682879|FG000|Overall Study|Adverse Event|1|||
126106406|NCT01740323|453682880|FG001|Overall Study|Adverse Event|0|||
126106407|NCT01740323|453682879|FG000|Overall Study|Randomized but did not take study drug|1|||
126106408|NCT01740323|453682880|FG001|Overall Study|Randomized but did not take study drug|0|||
126106409|NCT02019927|453682883|FG000|Overall Study|Lost to Follow-up|2|||
126106410|NCT02019927|453682884|FG001|Overall Study|Lost to Follow-up|4|||
126106411|NCT02019927|453682885|FG002|Overall Study|Lost to Follow-up|1|||
126106412|NCT02019927|453682886|FG003|Overall Study|Lost to Follow-up|2|||
126106413|NCT02019927|453682887|FG004|Overall Study|Lost to Follow-up|3|||
126106414|NCT02019927|453682888|FG005|Overall Study|Lost to Follow-up|1|||
125891983|NCT01731938|452903045|FG001|Preliminary Part I|Lost to Follow-up|3|||
125891984|NCT01731938|452903044|FG000|Preliminary Part I|Missed Week 6 visit|0|||
126057014|NCT04076059|453503504|FG000|Double Blind Phase|Ongoing Participants|82|||
126057015|NCT04076059|453503505|FG001|Double Blind Phase|Ongoing Participants|18|||
126057016|NCT04076059|453503506|FG002|Double Blind Phase|Ongoing Participants|0|||
126057017|NCT04076059|453503504|FG000|Double Blind Phase|Miscellaneous|3|||
126057018|NCT04076059|453503505|FG001|Double Blind Phase|Miscellaneous|1|||
126057019|NCT04076059|453503506|FG002|Double Blind Phase|Miscellaneous|0|||
126057020|NCT04076059|453503504|FG000|Double Blind Phase|Protocol Deviation|1|||
126057021|NCT04076059|453503505|FG001|Double Blind Phase|Protocol Deviation|1|||
126057022|NCT04076059|453503506|FG002|Double Blind Phase|Protocol Deviation|0|||
126057023|NCT04076059|453503504|FG000|Double Blind Phase|Did not take study drug|1|||
126057024|NCT04076059|453503505|FG001|Double Blind Phase|Did not take study drug|1|||
126057025|NCT04076059|453503506|FG002|Double Blind Phase|Did not take study drug|0|||
126057026|NCT04076059|453503504|FG000|Open Label Phase|Progressive disease|0|||
126057027|NCT04076059|453503505|FG001|Open Label Phase|Progressive disease|0|||
126057028|NCT04076059|453503506|FG002|Open Label Phase|Progressive disease|7|||
126057029|NCT04076059|453503504|FG000|Open Label Phase|Withdrawal by Subject|0|||
126057030|NCT04076059|453503505|FG001|Open Label Phase|Withdrawal by Subject|0|||
126057031|NCT04076059|453503506|FG002|Open Label Phase|Withdrawal by Subject|3|||
126057032|NCT04076059|453503504|FG000|Open Label Phase|Death|0|||
126057033|NCT04076059|453503505|FG001|Open Label Phase|Death|0|||
126057034|NCT04076059|453503506|FG002|Open Label Phase|Death|2|||
126057035|NCT04076059|453503504|FG000|Open Label Phase|Ongoing Participants|0|||
126057036|NCT04076059|453503505|FG001|Open Label Phase|Ongoing Participants|0|||
126057037|NCT04076059|453503506|FG002|Open Label Phase|Ongoing Participants|11|||
126057038|NCT01218594|453503508|FG000|Overall Study|Death|1|||
126057039|NCT01218594|453503508|FG000|Overall Study|Withdrawal by Subject|3|||
126057040|NCT01218594|453503508|FG000|Overall Study|Adverse Event|2|||
126057041|NCT01218594|453503508|FG000|Overall Study|Physician Decision|6|||
126057042|NCT00452114|453503509|FG000|Overall Study|Physician Decision|3|||
126057043|NCT00452114|453503510|FG001|Overall Study|Physician Decision|3|||
126057044|NCT00949117|453505244|FG000|Overall Study|Lack of Efficacy|2|||
126057045|NCT00949117|453505245|FG001|Overall Study|Lack of Efficacy|3|||
126057046|NCT00949117|453505244|FG000|Overall Study|Protocol Violation|1|||
126057047|NCT00949117|453505245|FG001|Overall Study|Protocol Violation|1|||
126057048|NCT00949117|453505244|FG000|Overall Study|Adverse Event|0|||
126057049|NCT00949117|453505245|FG001|Overall Study|Adverse Event|1|||
126057050|NCT03964974|453505246|FG000|Overall Study|Lost to Follow-up|3|||
126057051|NCT03964974|453505247|FG001|Overall Study|Lost to Follow-up|2|||
126057052|NCT03964974|453505246|FG000|Overall Study|Withdrawal by Subject|0|||
126057053|NCT03964974|453505247|FG001|Overall Study|Withdrawal by Subject|3|||
126057054|NCT01214200|453505248|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
126057055|NCT01214200|453505248|FG000|Overall Study|Withdrawal by Subject|2|||
126057056|NCT01719172|453505249|FG000|Overall Study|Lost to Follow-up|1|||
126057057|NCT01719172|453505249|FG000|Overall Study|Death|1|||
126057058|NCT04250636|453505252|FG000|Overall Study|Lost to Follow-up|2|||
126057059|NCT03041090|453505253|FG000|Overall Study|technical error|0|||
126057060|NCT03041090|453505254|FG001|Overall Study|technical error|3|||
126057061|NCT01353274|453505255|FG000|Overall Study|No case report form (CRF) collected|28|||
126057062|NCT01409837|453505256|FG000|Overall Study|Withdrawal by Subject|2|||
126057063|NCT01409837|453505257|FG001|Overall Study|Withdrawal by Subject|1|||
126057064|NCT01409837|453505256|FG000|Overall Study|Lost to Follow-up|1|||
126057065|NCT01409837|453505257|FG001|Overall Study|Lost to Follow-up|0|||
126057066|NCT01409837|453505256|FG000|Overall Study|Physician Decision|0|||
126057067|NCT01409837|453505257|FG001|Overall Study|Physician Decision|1|||
126057068|NCT03960645|453505258|FG000|Overall Study|Protocol Violation|1|||
126057069|NCT03960645|453505259|FG001|Overall Study|Protocol Violation|0|||
126057070|NCT03292406|453505261|FG000|Overall Study|Progressive Disease|6|||
126057071|NCT03292406|453505262|FG001|Overall Study|Progressive Disease|3|||
126057072|NCT03292406|453505263|FG002|Overall Study|Progressive Disease|4|||
126057073|NCT03292406|453505261|FG000|Overall Study|Adverse Event|7|||
126057074|NCT03292406|453505262|FG001|Overall Study|Adverse Event|1|||
126057075|NCT03292406|453505263|FG002|Overall Study|Adverse Event|4|||
126057076|NCT03292406|453505261|FG000|Overall Study|Withdrawal by Subject|0|||
126057077|NCT03292406|453505262|FG001|Overall Study|Withdrawal by Subject|7|||
126057078|NCT03292406|453505263|FG002|Overall Study|Withdrawal by Subject|2|||
126057079|NCT03292406|453505261|FG000|Overall Study|Protocol Violation|0|||
126057080|NCT03292406|453505262|FG001|Overall Study|Protocol Violation|1|||
126057081|NCT03292406|453505263|FG002|Overall Study|Protocol Violation|1|||
126057082|NCT03292406|453505261|FG000|Overall Study|Other|0|||
126057083|NCT03292406|453505262|FG001|Overall Study|Other|1|||
126057084|NCT03292406|453505263|FG002|Overall Study|Other|2|||
126057085|NCT00022672|453505265|FG000|Main Phase: 24 Months|Adverse Event|6|||
126057086|NCT00022672|453505266|FG001|Main Phase: 24 Months|Adverse Event|0|||
126057087|NCT00022672|453505265|FG000|Main Phase: 24 Months|Death|0|||
126057088|NCT00022672|453505266|FG001|Main Phase: 24 Months|Death|3|||
126057089|NCT00022672|453505265|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
125891985|NCT01731938|452903045|FG001|Preliminary Part I|Missed Week 6 visit|3|||
125891986|NCT01731938|452903044|FG000|Primary Part II|Withdrawal by Subject|5|||
125891987|NCT01731938|452903045|FG001|Primary Part II|Withdrawal by Subject|4|||
126106415|NCT03945825|453682891|FG000|Overall Study|Enrolled but treatment not administered|0|||
126106416|NCT03945825|453682892|FG001|Overall Study|Enrolled but treatment not administered|0|||
126106417|NCT03945825|453682893|FG002|Overall Study|Enrolled but treatment not administered|0|||
126106418|NCT03945825|453682894|FG003|Overall Study|Enrolled but treatment not administered|0|||
126106419|NCT03945825|453682895|FG004|Overall Study|Enrolled but treatment not administered|1|||
126106420|NCT03945825|453682896|FG005|Overall Study|Enrolled but treatment not administered|0|||
126106421|NCT03945825|453682891|FG000|Overall Study|Lost to Follow-up|1|||
126106422|NCT03945825|453682892|FG001|Overall Study|Lost to Follow-up|5|||
126106423|NCT03945825|453682893|FG002|Overall Study|Lost to Follow-up|0|||
126106424|NCT03945825|453682894|FG003|Overall Study|Lost to Follow-up|1|||
126106425|NCT03945825|453682895|FG004|Overall Study|Lost to Follow-up|2|||
126106426|NCT03945825|453682896|FG005|Overall Study|Lost to Follow-up|2|||
126106427|NCT03945825|453682891|FG000|Overall Study|Withdrawal by Subject|1|||
126106428|NCT03945825|453682892|FG001|Overall Study|Withdrawal by Subject|0|||
126106429|NCT03945825|453682893|FG002|Overall Study|Withdrawal by Subject|1|||
126106430|NCT03945825|453682894|FG003|Overall Study|Withdrawal by Subject|1|||
126106431|NCT03945825|453682895|FG004|Overall Study|Withdrawal by Subject|0|||
126106432|NCT03945825|453682896|FG005|Overall Study|Withdrawal by Subject|1|||
126106433|NCT01423253|453682904|FG000|Overall Study|Adverse Event|2|||
126106434|NCT01423253|453682904|FG000|Overall Study|Lack of Efficacy|2|||
126106435|NCT01423253|453682904|FG000|Overall Study|Lost to Follow-up|1|||
126106436|NCT01423253|453682904|FG000|Overall Study|Protocol Violation|2|||
126106437|NCT01423253|453682904|FG000|Overall Study|Withdrawal by Subject|2|||
126106438|NCT00307125|453682905|FG000|Screening Phase|Adverse Event|1|||
126106439|NCT00307125|453682906|FG001|Screening Phase|Adverse Event|0|||
126106440|NCT00307125|453682907|FG002|Screening Phase|Adverse Event|0|||
126106441|NCT00307125|453682905|FG000|Screening Phase|Protocol Violation|27|||
126106442|NCT00307125|453682906|FG001|Screening Phase|Protocol Violation|0|||
126106443|NCT00307125|453682907|FG002|Screening Phase|Protocol Violation|0|||
126106444|NCT00307125|453682905|FG000|Screening Phase|Lost to Follow-up|87|||
126106445|NCT00307125|453682906|FG001|Screening Phase|Lost to Follow-up|0|||
126106446|NCT00307125|453682907|FG002|Screening Phase|Lost to Follow-up|0|||
126106447|NCT00307125|453682905|FG000|Screening Phase|Death|10|||
126106448|NCT00307125|453682906|FG001|Screening Phase|Death|0|||
126106449|NCT00307125|453682907|FG002|Screening Phase|Death|0|||
126057090|NCT00022672|453505266|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
126057091|NCT00022672|453505265|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
126057092|NCT00022672|453505266|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
126057093|NCT00022672|453505265|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
126057094|NCT00022672|453505266|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
126057095|NCT00022672|453505265|FG000|Main Phase: 24 Months|Refused Treatment|3|||
126057096|NCT00022672|453505266|FG001|Main Phase: 24 Months|Refused Treatment|4|||
126057097|NCT00022672|453505265|FG000|Main Phase: 24 Months|Failure to Return|1|||
126057098|NCT00022672|453505266|FG001|Main Phase: 24 Months|Failure to Return|1|||
126057099|NCT00022672|453505265|FG000|Main Phase: 24 Months|Other|1|||
126057100|NCT00022672|453505266|FG001|Main Phase: 24 Months|Other|0|||
126057101|NCT00022672|453505265|FG000|Extension Phase|Adverse Event|1|||
126057102|NCT00022672|453505266|FG001|Extension Phase|Adverse Event|3|||
125891988|NCT01731938|452903044|FG000|Primary Part II|Lost to Follow-up|4|||
125891989|NCT01731938|452903045|FG001|Primary Part II|Lost to Follow-up|5|||
126057103|NCT00022672|453505265|FG000|Extension Phase|Death|0|||
126057104|NCT00022672|453505266|FG001|Extension Phase|Death|1|||
126057105|NCT00022672|453505265|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
126057106|NCT00022672|453505266|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
126057107|NCT00022672|453505265|FG000|Extension Phase|Refused Treatment|0|||
125891990|NCT01731938|452903044|FG000|Primary Part II|Death|2|||
126106450|NCT00307125|453682905|FG000|Screening Phase|Withdrawal by Subject|77|||
126106451|NCT00307125|453682906|FG001|Screening Phase|Withdrawal by Subject|0|||
126106452|NCT00307125|453682907|FG002|Screening Phase|Withdrawal by Subject|0|||
126106453|NCT00307125|453682905|FG000|Screening Phase|Physician Decision|26|||
126106454|NCT00307125|453682906|FG001|Screening Phase|Physician Decision|0|||
126106455|NCT00307125|453682907|FG002|Screening Phase|Physician Decision|0|||
126106456|NCT00307125|453682905|FG000|Screening Phase|Sponsor Decision|4|||
126106457|NCT00307125|453682906|FG001|Screening Phase|Sponsor Decision|0|||
126106458|NCT00307125|453682907|FG002|Screening Phase|Sponsor Decision|0|||
126106459|NCT00307125|453682905|FG000|Screening Phase|Study Terminated|17|||
126106460|NCT00307125|453682906|FG001|Screening Phase|Study Terminated|0|||
126106461|NCT00307125|453682907|FG002|Screening Phase|Study Terminated|0|||
126106462|NCT00307125|453682905|FG000|Screening Phase|Graft Loss|3|||
126106463|NCT00307125|453682906|FG001|Screening Phase|Graft Loss|0|||
126106464|NCT00307125|453682907|FG002|Screening Phase|Graft Loss|0|||
126106465|NCT00307125|453682905|FG000|Screening Phase|Graft Failure|8|||
126106466|NCT00307125|453682906|FG001|Screening Phase|Graft Failure|0|||
126106467|NCT00307125|453682907|FG002|Screening Phase|Graft Failure|0|||
126106468|NCT00307125|453682905|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
126106469|NCT00307125|453682906|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
126106470|NCT00307125|453682907|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
126106471|NCT00307125|453682905|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
126106472|NCT00307125|453682906|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
126106473|NCT00307125|453682907|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
126106474|NCT00307125|453682905|FG000|Screening Phase|Moved or transferred facilities|34|||
126106475|NCT00307125|453682906|FG001|Screening Phase|Moved or transferred facilities|0|||
126106476|NCT00307125|453682907|FG002|Screening Phase|Moved or transferred facilities|0|||
126106477|NCT00307125|453682905|FG000|Screening Phase|Received Pancreas Transplant|8|||
126106478|NCT00307125|453682906|FG001|Screening Phase|Received Pancreas Transplant|0|||
126106479|NCT00307125|453682907|FG002|Screening Phase|Received Pancreas Transplant|0|||
126106480|NCT00307125|453682905|FG000|Screening Phase|Ineligible for pilot|4|||
126106481|NCT00307125|453682906|FG001|Screening Phase|Ineligible for pilot|0|||
126106482|NCT00307125|453682907|FG002|Screening Phase|Ineligible for pilot|0|||
126106483|NCT00307125|453682905|FG000|Screening Phase|Try to get pregnant|1|||
126106484|NCT00307125|453682906|FG001|Screening Phase|Try to get pregnant|0|||
126106485|NCT00307125|453682907|FG002|Screening Phase|Try to get pregnant|0|||
126106486|NCT00307125|453682905|FG000|Screening Phase|Developed acute leukemia|1|||
126106487|NCT00307125|453682906|FG001|Screening Phase|Developed acute leukemia|0|||
126106488|NCT00307125|453682907|FG002|Screening Phase|Developed acute leukemia|0|||
126106489|NCT00307125|453682905|FG000|Screening Phase|Metastatic colon cancer|1|||
126106490|NCT00307125|453682906|FG001|Screening Phase|Metastatic colon cancer|0|||
126106491|NCT00307125|453682907|FG002|Screening Phase|Metastatic colon cancer|0|||
126106492|NCT00307125|453682905|FG000|Screening Phase|Malignancy|1|||
126106493|NCT00307125|453682906|FG001|Screening Phase|Malignancy|0|||
126106494|NCT00307125|453682907|FG002|Screening Phase|Malignancy|0|||
126106495|NCT00307125|453682905|FG000|Screening Phase|PAK|1|||
126106496|NCT00307125|453682906|FG001|Screening Phase|PAK|0|||
126106497|NCT00307125|453682907|FG002|Screening Phase|PAK|0|||
126106498|NCT00307125|453682905|FG000|Screening Phase|Ineligible|1|||
126106499|NCT00307125|453682906|FG001|Screening Phase|Ineligible|0|||
126106500|NCT00307125|453682907|FG002|Screening Phase|Ineligible|0|||
126106501|NCT00307125|453682905|FG000|Screening Phase|Screen Error|1|||
126106502|NCT00307125|453682906|FG001|Screening Phase|Screen Error|0|||
126106503|NCT00307125|453682907|FG002|Screening Phase|Screen Error|0|||
126106504|NCT00307125|453682905|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
126106505|NCT00307125|453682906|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
126106506|NCT00307125|453682907|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
126106507|NCT00307125|453682905|FG000|Screening Phase|AMR and treated with rituximab|1|||
126106508|NCT00307125|453682906|FG001|Screening Phase|AMR and treated with rituximab|0|||
126106509|NCT00307125|453682907|FG002|Screening Phase|AMR and treated with rituximab|0|||
126106510|NCT00307125|453682905|FG000|Screening Phase|Coronary artery bypass|1|||
126106511|NCT00307125|453682906|FG001|Screening Phase|Coronary artery bypass|0|||
126106512|NCT00307125|453682907|FG002|Screening Phase|Coronary artery bypass|0|||
126106513|NCT00307125|453682905|FG000|Pilot Phase|Lost to Follow-up|0|||
126106514|NCT00307125|453682906|FG001|Pilot Phase|Lost to Follow-up|1|||
126106515|NCT00307125|453682907|FG002|Pilot Phase|Lost to Follow-up|0|||
126106516|NCT00307125|453682905|FG000|Pilot Phase|Withdrawal by Subject|0|||
126106517|NCT00307125|453682906|FG001|Pilot Phase|Withdrawal by Subject|1|||
126106518|NCT00307125|453682907|FG002|Pilot Phase|Withdrawal by Subject|1|||
126106519|NCT00051363|453682908|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
126106520|NCT00051363|453682909|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
126106521|NCT00051363|453682908|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
126106522|NCT00051363|453682909|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
126106523|NCT00051363|453682908|FG000|Overall Study|Death|2|||
126106524|NCT00051363|453682909|FG001|Overall Study|Death|2|||
126106525|NCT00051363|453682908|FG000|Overall Study|Excluded Pre-Randomization|2|||
126106526|NCT00051363|453682909|FG001|Overall Study|Excluded Pre-Randomization|5|||
126106527|NCT00985153|453682910|FG000|Overall Study|Lost to Follow-up|16|||
126106528|NCT00985153|453682911|FG001|Overall Study|Lost to Follow-up|19|||
126106529|NCT00985153|453682912|FG002|Overall Study|Lost to Follow-up|17|||
126106530|NCT00985153|453682913|FG003|Overall Study|Lost to Follow-up|20|||
126106531|NCT00985153|453682910|FG000|Overall Study|Protocol Violation|3|||
126106532|NCT00985153|453682911|FG001|Overall Study|Protocol Violation|2|||
126106533|NCT00985153|453682912|FG002|Overall Study|Protocol Violation|4|||
126106534|NCT00985153|453682913|FG003|Overall Study|Protocol Violation|3|||
126106535|NCT00985153|453682910|FG000|Overall Study|Withdrawal by Subject|6|||
126106536|NCT00985153|453682911|FG001|Overall Study|Withdrawal by Subject|11|||
126106537|NCT00985153|453682912|FG002|Overall Study|Withdrawal by Subject|11|||
126106538|NCT00985153|453682913|FG003|Overall Study|Withdrawal by Subject|10|||
126106539|NCT00985153|453682910|FG000|Overall Study|Missed One or More Bleeds|7|||
126106540|NCT00985153|453682911|FG001|Overall Study|Missed One or More Bleeds|7|||
126106541|NCT00985153|453682912|FG002|Overall Study|Missed One or More Bleeds|8|||
126106542|NCT00985153|453682913|FG003|Overall Study|Missed One or More Bleeds|10|||
126106543|NCT00985153|453682910|FG000|Overall Study|Incomplete Safety Follow-up|3|||
126106544|NCT00985153|453682911|FG001|Overall Study|Incomplete Safety Follow-up|5|||
126106545|NCT00985153|453682912|FG002|Overall Study|Incomplete Safety Follow-up|4|||
126106546|NCT00985153|453682913|FG003|Overall Study|Incomplete Safety Follow-up|4|||
126106547|NCT01596621|453682915|FG000|Overall Study|Death|4|||
126106548|NCT01596621|453682915|FG000|Overall Study|Withdrawal by Subject|9|||
126106549|NCT01596621|453682915|FG000|Overall Study|Disease Progression|49|||
126106550|NCT01596621|453682915|FG000|Overall Study|Lost to Follow-up|3|||
126106551|NCT01596621|453682915|FG000|Overall Study|Other than specified|13|||
126106552|NCT01074216|453682918|FG000|Overall Study|Physician Decision|1|||
126106553|NCT01074216|453682918|FG000|Overall Study|Not Treated|12|||
126106554|NCT01323634|453682919|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
126106555|NCT01323634|453682920|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
126106556|NCT01323634|453682921|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
126106557|NCT01323634|453682919|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
126106558|NCT01323634|453682920|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
126106559|NCT01323634|453682921|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
126106560|NCT01323634|453682919|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
126106561|NCT01323634|453682920|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126106562|NCT01323634|453682921|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126106563|NCT01323634|453682919|FG000|2-week Run-in Period|Physician Decision|5|||
126106564|NCT01323634|453682920|FG001|2-week Run-in Period|Physician Decision|0|||
126106565|NCT01323634|453682921|FG002|2-week Run-in Period|Physician Decision|0|||
126106566|NCT01323634|453682919|FG000|2-week Run-in Period|Protocol Violation|1|||
126106567|NCT01323634|453682920|FG001|2-week Run-in Period|Protocol Violation|0|||
126106568|NCT01323634|453682921|FG002|2-week Run-in Period|Protocol Violation|0|||
126106569|NCT01323634|453682919|FG000|2-week Run-in Period|Adverse Event|1|||
126106570|NCT01323634|453682920|FG001|2-week Run-in Period|Adverse Event|0|||
126106571|NCT01323634|453682921|FG002|2-week Run-in Period|Adverse Event|0|||
126106572|NCT01323634|453682919|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126106573|NCT01323634|453682920|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
126106574|NCT01323634|453682921|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
126106575|NCT01323634|453682919|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126106576|NCT01323634|453682920|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126057108|NCT00022672|453505266|FG001|Extension Phase|Refused Treatment|2|||
126057109|NCT00022672|453505265|FG000|Extension Phase|Other|1|||
126057110|NCT00022672|453505266|FG001|Extension Phase|Other|1|||
126057111|NCT00403494|453505267|FG000|Overall Study|Adverse Event|10|||
126057112|NCT00403494|453505268|FG001|Overall Study|Adverse Event|8|||
126057113|NCT00403494|453505267|FG000|Overall Study|Withdrew Consent|3|||
126057114|NCT00403494|453505268|FG001|Overall Study|Withdrew Consent|2|||
126057115|NCT00403494|453505267|FG000|Overall Study|Inappropriately enrolled|0|||
126057116|NCT00403494|453505268|FG001|Overall Study|Inappropriately enrolled|1|||
126057117|NCT00403494|453505267|FG000|Overall Study|Lost to Follow-up|0|||
126057118|NCT00403494|453505268|FG001|Overall Study|Lost to Follow-up|2|||
126057119|NCT00403494|453505267|FG000|Overall Study|Protocol noncompliance|0|||
126057120|NCT00403494|453505268|FG001|Overall Study|Protocol noncompliance|1|||
126057121|NCT00403494|453505267|FG000|Overall Study|Death|1|||
126057122|NCT00403494|453505268|FG001|Overall Study|Death|0|||
126057123|NCT00403494|453505267|FG000|Overall Study|Sponsor Request|1|||
126057124|NCT00403494|453505268|FG001|Overall Study|Sponsor Request|0|||
126057125|NCT01450007|453505269|FG000|Overall Study|Late exclusion before treatment|2|||
126057126|NCT01450007|453505270|FG001|Overall Study|Late exclusion before treatment|3|||
126057127|NCT01450007|453505271|FG002|Overall Study|Late exclusion before treatment|2|||
126057128|NCT01450007|453505269|FG000|Overall Study|Protocol Violation|0|||
126057129|NCT01450007|453505270|FG001|Overall Study|Protocol Violation|1|||
126057130|NCT01450007|453505271|FG002|Overall Study|Protocol Violation|1|||
126057131|NCT01450007|453505269|FG000|Overall Study|Adverse Event|0|||
126057132|NCT01450007|453505270|FG001|Overall Study|Adverse Event|1|||
126057133|NCT01450007|453505271|FG002|Overall Study|Adverse Event|0|||
126057134|NCT03851094|453505273|FG000|Overall Study|Withdrawal by Subject|0|||
125891991|NCT01731938|452903045|FG001|Primary Part II|Death|1|||
125891992|NCT01731938|452903044|FG000|Primary Part II|Missed Week 6 visit|2|||
125891993|NCT01731938|452903045|FG001|Primary Part II|Missed Week 6 visit|3|||
125891994|NCT04931888|452903046|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
125891995|NCT04931888|452903047|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
126057135|NCT03851094|453505274|FG001|Overall Study|Withdrawal by Subject|1|||
126057136|NCT03851094|453505273|FG000|Overall Study|Participant lost device|0|||
126057137|NCT03851094|453505274|FG001|Overall Study|Participant lost device|1|||
126057138|NCT03851094|453505273|FG000|Overall Study|Participant returned device|0|||
126057139|NCT03851094|453505274|FG001|Overall Study|Participant returned device|2|||
126057140|NCT01332266|453505275|FG000|Phase 1b|Death|3|||
126057141|NCT01332266|453505276|FG001|Phase 1b|Death|3|||
126057142|NCT01332266|453505277|FG002|Phase 1b|Death|2|||
126057143|NCT01332266|453505278|FG003|Phase 1b|Death|0|||
126057144|NCT01332266|453505279|FG004|Phase 1b|Death|0|||
126057145|NCT01332266|453505275|FG000|Phase 1b|Lost to Follow-up|0|||
126057146|NCT01332266|453505276|FG001|Phase 1b|Lost to Follow-up|1|||
126057147|NCT01332266|453505277|FG002|Phase 1b|Lost to Follow-up|0|||
126057148|NCT01332266|453505278|FG003|Phase 1b|Lost to Follow-up|0|||
126057149|NCT01332266|453505279|FG004|Phase 1b|Lost to Follow-up|0|||
126057150|NCT01332266|453505275|FG000|Phase 1b|Withdrawal by Subject|1|||
126057151|NCT01332266|453505276|FG001|Phase 1b|Withdrawal by Subject|1|||
126057152|NCT01332266|453505277|FG002|Phase 1b|Withdrawal by Subject|1|||
126057153|NCT01332266|453505278|FG003|Phase 1b|Withdrawal by Subject|0|||
126057154|NCT01332266|453505279|FG004|Phase 1b|Withdrawal by Subject|0|||
126057155|NCT01332266|453505275|FG000|Phase 2|Death|0|||
126057156|NCT01332266|453505276|FG001|Phase 2|Death|0|||
126057157|NCT01332266|453505277|FG002|Phase 2|Death|0|||
126057158|NCT01332266|453505278|FG003|Phase 2|Death|33|||
126057159|NCT01332266|453505279|FG004|Phase 2|Death|36|||
126057160|NCT01332266|453505275|FG000|Phase 2|Lost to Follow-up|0|||
126057161|NCT01332266|453505276|FG001|Phase 2|Lost to Follow-up|0|||
126057162|NCT01332266|453505277|FG002|Phase 2|Lost to Follow-up|0|||
126057163|NCT01332266|453505278|FG003|Phase 2|Lost to Follow-up|2|||
126057164|NCT01332266|453505279|FG004|Phase 2|Lost to Follow-up|0|||
126057165|NCT01332266|453505275|FG000|Phase 2|Physician Decision|0|||
126057166|NCT01332266|453505276|FG001|Phase 2|Physician Decision|0|||
126057167|NCT01332266|453505277|FG002|Phase 2|Physician Decision|0|||
126057168|NCT01332266|453505278|FG003|Phase 2|Physician Decision|3|||
126057169|NCT01332266|453505279|FG004|Phase 2|Physician Decision|1|||
126057170|NCT01332266|453505275|FG000|Phase 2|Symptomatic deterioration|0|||
126057171|NCT01332266|453505276|FG001|Phase 2|Symptomatic deterioration|0|||
126057172|NCT01332266|453505277|FG002|Phase 2|Symptomatic deterioration|0|||
126057173|NCT01332266|453505278|FG003|Phase 2|Symptomatic deterioration|0|||
126057174|NCT01332266|453505279|FG004|Phase 2|Symptomatic deterioration|1|||
126057175|NCT01332266|453505275|FG000|Phase 2|Progression Disease|0|||
126057176|NCT01332266|453505276|FG001|Phase 2|Progression Disease|0|||
126057177|NCT01332266|453505277|FG002|Phase 2|Progression Disease|0|||
126057178|NCT01332266|453505278|FG003|Phase 2|Progression Disease|2|||
126057179|NCT01332266|453505279|FG004|Phase 2|Progression Disease|1|||
126057180|NCT01332266|453505275|FG000|Phase 2|Withdrawal by Subject|0|||
126057181|NCT01332266|453505276|FG001|Phase 2|Withdrawal by Subject|0|||
126057182|NCT01332266|453505277|FG002|Phase 2|Withdrawal by Subject|0|||
126057183|NCT01332266|453505278|FG003|Phase 2|Withdrawal by Subject|2|||
126057184|NCT01332266|453505279|FG004|Phase 2|Withdrawal by Subject|2|||
126057185|NCT01536704|453505282|FG000|Washout Period 1|Withdrawal by Subject|1|||
126057186|NCT01536704|453505283|FG001|Washout Period 1|Withdrawal by Subject|2|||
126106577|NCT01323634|453682921|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
126106578|NCT01323634|453682919|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126106579|NCT01323634|453682920|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
126106580|NCT01323634|453682921|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
126106581|NCT01323634|453682919|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126106582|NCT01323634|453682920|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
126106583|NCT01323634|453682921|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
126106584|NCT01323634|453682919|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
126106585|NCT01323634|453682920|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
126106586|NCT01323634|453682921|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
126106587|NCT01323634|453682919|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126106588|NCT01323634|453682920|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
126106589|NCT01323634|453682921|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
126106590|NCT01323634|453682919|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
126106591|NCT01323634|453682920|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
126057187|NCT01536704|453505284|FG002|Washout Period 1|Withdrawal by Subject|0|||
126057188|NCT01536704|453505285|FG003|Washout Period 1|Withdrawal by Subject|0|||
126057189|NCT01536704|453505282|FG000|Washout Period 2|Adverse Event|1|||
126057190|NCT01536704|453505283|FG001|Washout Period 2|Adverse Event|0|||
126057191|NCT01536704|453505284|FG002|Washout Period 2|Adverse Event|0|||
126057192|NCT01536704|453505285|FG003|Washout Period 2|Adverse Event|0|||
126106592|NCT01323634|453682921|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
126106593|NCT05056987|453682922|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
126106594|NCT05056987|453682923|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
126106595|NCT05056987|453682922|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
126106596|NCT05056987|453682923|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
126106597|NCT02678247|453682926|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
126106598|NCT02678247|453682927|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
126106599|NCT02678247|453682926|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
126106600|NCT02678247|453682927|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
126106601|NCT02678247|453682926|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
126106602|NCT02678247|453682927|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
126106603|NCT02678247|453682926|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
126106604|NCT02678247|453682927|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
126106605|NCT02678247|453682926|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
126106606|NCT02678247|453682927|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
126106607|NCT02678247|453682926|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
126106608|NCT02678247|453682927|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
126106609|NCT00753272|453682931|FG000|Overall Study|Adverse Event|878|||
126106610|NCT00753272|453682932|FG001|Overall Study|Adverse Event|869|||
126106611|NCT00753272|453682931|FG000|Overall Study|Protocol Violation|28|||
126106612|NCT00753272|453682932|FG001|Overall Study|Protocol Violation|46|||
126106613|NCT00753272|453682931|FG000|Overall Study|Withdrawal by Subject|2481|||
126106614|NCT00753272|453682932|FG001|Overall Study|Withdrawal by Subject|2407|||
126106615|NCT00753272|453682931|FG000|Overall Study|Lost to Follow-up|491|||
126106616|NCT00753272|453682932|FG001|Overall Study|Lost to Follow-up|497|||
126106617|NCT00753272|453682931|FG000|Overall Study|Other|1104|||
126106618|NCT00753272|453682932|FG001|Overall Study|Other|1088|||
126106619|NCT00971243|453682933|FG000|Double Blind Period|Adverse Event|2|||
126106620|NCT00971243|453682934|FG001|Double Blind Period|Adverse Event|3|||
126106621|NCT00971243|453682935|FG002|Double Blind Period|Adverse Event|2|||
126106622|NCT00971243|453682936|FG003|Double Blind Period|Adverse Event|2|||
126106623|NCT00971243|453682937|FG004|Double Blind Period|Adverse Event|3|||
126106624|NCT00971243|453682933|FG000|Double Blind Period|Lost to Follow-up|0|||
126106625|NCT00971243|453682934|FG001|Double Blind Period|Lost to Follow-up|1|||
126106626|NCT00971243|453682935|FG002|Double Blind Period|Lost to Follow-up|1|||
126106627|NCT00971243|453682936|FG003|Double Blind Period|Lost to Follow-up|0|||
126106628|NCT00971243|453682937|FG004|Double Blind Period|Lost to Follow-up|1|||
126106629|NCT00971243|453682933|FG000|Double Blind Period|Physician Decision|10|||
126106630|NCT00971243|453682934|FG001|Double Blind Period|Physician Decision|6|||
126106631|NCT00971243|453682935|FG002|Double Blind Period|Physician Decision|7|||
126106632|NCT00971243|453682936|FG003|Double Blind Period|Physician Decision|6|||
126106633|NCT00971243|453682937|FG004|Double Blind Period|Physician Decision|7|||
126106634|NCT00971243|453682933|FG000|Double Blind Period|Protocol Violation|2|||
126106635|NCT00971243|453682934|FG001|Double Blind Period|Protocol Violation|0|||
126106636|NCT00971243|453682935|FG002|Double Blind Period|Protocol Violation|3|||
126106637|NCT00971243|453682936|FG003|Double Blind Period|Protocol Violation|2|||
126106638|NCT00971243|453682937|FG004|Double Blind Period|Protocol Violation|2|||
126106639|NCT00971243|453682933|FG000|Double Blind Period|Withdrawal by Subject|4|||
126106640|NCT00971243|453682934|FG001|Double Blind Period|Withdrawal by Subject|1|||
126106641|NCT00971243|453682935|FG002|Double Blind Period|Withdrawal by Subject|4|||
126106642|NCT00971243|453682936|FG003|Double Blind Period|Withdrawal by Subject|4|||
126106643|NCT00971243|453682937|FG004|Double Blind Period|Withdrawal by Subject|4|||
126106644|NCT00971243|453682933|FG000|Double Blind Period|Other reasons|1|||
126106645|NCT00971243|453682934|FG001|Double Blind Period|Other reasons|0|||
126106646|NCT00971243|453682935|FG002|Double Blind Period|Other reasons|2|||
126106647|NCT00971243|453682936|FG003|Double Blind Period|Other reasons|0|||
126106648|NCT00971243|453682937|FG004|Double Blind Period|Other reasons|1|||
126106649|NCT00971243|453682933|FG000|Open-label Period|Adverse Event|1|||
126106650|NCT00971243|453682934|FG001|Open-label Period|Adverse Event|0|||
126106651|NCT00971243|453682935|FG002|Open-label Period|Adverse Event|1|||
126106652|NCT00971243|453682936|FG003|Open-label Period|Adverse Event|1|||
126106653|NCT00971243|453682937|FG004|Open-label Period|Adverse Event|0|||
126106654|NCT00971243|453682933|FG000|Open-label Period|Physician Decision|5|||
126106655|NCT00971243|453682934|FG001|Open-label Period|Physician Decision|9|||
126106656|NCT00971243|453682935|FG002|Open-label Period|Physician Decision|3|||
126106657|NCT00971243|453682936|FG003|Open-label Period|Physician Decision|7|||
126106658|NCT00971243|453682937|FG004|Open-label Period|Physician Decision|2|||
126106659|NCT00971243|453682933|FG000|Open-label Period|Protocol Violation|1|||
126106660|NCT00971243|453682934|FG001|Open-label Period|Protocol Violation|1|||
126106661|NCT00971243|453682935|FG002|Open-label Period|Protocol Violation|1|||
126106662|NCT00971243|453682936|FG003|Open-label Period|Protocol Violation|0|||
126106663|NCT00971243|453682937|FG004|Open-label Period|Protocol Violation|1|||
126106664|NCT00971243|453682933|FG000|Open-label Period|Withdrawal by Subject|1|||
125891996|NCT04931888|452903048|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
125891997|NCT04931888|452903049|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
125891998|NCT04538144|452903050|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
125891999|NCT04538144|452903051|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
125892000|NCT04538144|452903052|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
125892001|NCT04538144|452903053|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
125892002|NCT00771953|452903054|FG000|Overall Study|Adverse Event|5|||
125892003|NCT00771953|452903055|FG001|Overall Study|Adverse Event|3|||
125892004|NCT00771953|452903054|FG000|Overall Study|Death|2|||
125892005|NCT00771953|452903055|FG001|Overall Study|Death|2|||
125892006|NCT00771953|452903054|FG000|Overall Study|Progression before active Tx|1|||
125892007|NCT00771953|452903055|FG001|Overall Study|Progression before active Tx|2|||
125892008|NCT00771953|452903054|FG000|Overall Study|Sponsor decision|1|||
125892009|NCT00771953|452903055|FG001|Overall Study|Sponsor decision|0|||
125892010|NCT00771953|452903054|FG000|Overall Study|Other complicating disease|1|||
125892011|NCT00771953|452903055|FG001|Overall Study|Other complicating disease|0|||
125892012|NCT00771953|452903054|FG000|Overall Study|Withdrawal by Subject|0|||
125892013|NCT00771953|452903055|FG001|Overall Study|Withdrawal by Subject|3|||
125892014|NCT05246514|452903060|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
125892015|NCT05246514|452903060|FG000|Overall Study|Withdrawal by Subject|1|||
125892016|NCT05246514|452903060|FG000|Overall Study|Death|13|||
125892017|NCT02722304|452903061|FG000|Overall Study|Study Terminated by Sponsor|1|||
125892018|NCT02722304|452903062|FG001|Overall Study|Study Terminated by Sponsor|0|||
125892019|NCT02722304|452903063|FG002|Overall Study|Study Terminated by Sponsor|2|||
125892020|NCT02722304|452903064|FG003|Overall Study|Study Terminated by Sponsor|1|||
125892021|NCT02722304|452903065|FG004|Overall Study|Study Terminated by Sponsor|1|||
125892022|NCT02722304|452903061|FG000|Overall Study|Other|0|||
125892023|NCT02722304|452903062|FG001|Overall Study|Other|0|||
125892024|NCT02722304|452903063|FG002|Overall Study|Other|0|||
125892025|NCT02722304|452903064|FG003|Overall Study|Other|1|||
125892026|NCT02722304|452903065|FG004|Overall Study|Other|1|||
125892027|NCT02644109|452903066|FG000|Overall Study|Adverse Event|0|||
125892028|NCT02644109|452903067|FG001|Overall Study|Adverse Event|4|||
125892029|NCT00104520|452903070|FG000|Overall Study|Unrelated adverse event|34|||
125892030|NCT00104520|452903071|FG001|Overall Study|Unrelated adverse event|47|||
125892031|NCT00104520|452903070|FG000|Overall Study|Study drug intolerance|0|||
125892032|NCT00104520|452903071|FG001|Overall Study|Study drug intolerance|1|||
125892033|NCT00104520|452903070|FG000|Overall Study|Related adverse event|13|||
125892034|NCT00104520|452903071|FG001|Overall Study|Related adverse event|15|||
125892035|NCT00104520|452903070|FG000|Overall Study|Lost to Follow-up|1|||
125892036|NCT00104520|452903071|FG001|Overall Study|Lost to Follow-up|0|||
125892037|NCT00104520|452903070|FG000|Overall Study|Noncompliance|0|||
125892038|NCT00104520|452903071|FG001|Overall Study|Noncompliance|2|||
125892039|NCT00104520|452903070|FG000|Overall Study|Personal/administrative|1|||
125892040|NCT00104520|452903071|FG001|Overall Study|Personal/administrative|1|||
125892041|NCT00104520|452903070|FG000|Overall Study|Other|1|||
125892042|NCT00104520|452903071|FG001|Overall Study|Other|5|||
125892043|NCT01026324|452903073|FG000|Follow up/Survival|Withdrawal by Subject|1|||
125892044|NCT01026324|452903074|FG001|Follow up/Survival|Withdrawal by Subject|0|||
125892045|NCT01026324|452903075|FG002|Follow up/Survival|Withdrawal by Subject|0|||
125892046|NCT05188053|452903076|FG000|Overall Study|Lost to Follow-up|23|||
125892047|NCT05188053|452903077|FG001|Overall Study|Lost to Follow-up|30|||
125892048|NCT05188053|452903076|FG000|Overall Study|Protocol Violation|16|||
126057193|NCT01536704|453505282|FG000|Washout Period 2|Withdrawal by Subject|0|||
126057194|NCT01536704|453505283|FG001|Washout Period 2|Withdrawal by Subject|0|||
126057195|NCT01536704|453505284|FG002|Washout Period 2|Withdrawal by Subject|0|||
126057196|NCT01536704|453505285|FG003|Washout Period 2|Withdrawal by Subject|1|||
126057197|NCT01536704|453505282|FG000|Period 3|Adverse Event|0|||
126057198|NCT01536704|453505283|FG001|Period 3|Adverse Event|0|||
126057199|NCT01536704|453505284|FG002|Period 3|Adverse Event|0|||
126057200|NCT01536704|453505285|FG003|Period 3|Adverse Event|1|||
126057201|NCT01536704|453505282|FG000|Washout Period 3|Adverse Event|0|||
126057202|NCT01536704|453505283|FG001|Washout Period 3|Adverse Event|0|||
126057203|NCT01536704|453505284|FG002|Washout Period 3|Adverse Event|1|||
126057204|NCT01536704|453505285|FG003|Washout Period 3|Adverse Event|0|||
126057205|NCT00047385|453505286|FG000|Overall Study|Death before any screening|2|||
126057206|NCT00047385|453505287|FG001|Overall Study|Death before any screening|5|||
125892049|NCT05188053|452903077|FG001|Overall Study|Protocol Violation|16|||
125892050|NCT05188053|452903076|FG000|Overall Study|Physician Decision|3|||
125892051|NCT05188053|452903077|FG001|Overall Study|Physician Decision|0|||
125892052|NCT05188053|452903076|FG000|Overall Study|Withdrawal by Subject|0|||
125892053|NCT05188053|452903077|FG001|Overall Study|Withdrawal by Subject|1|||
125892054|NCT02447302|452903081|FG000|Overall Study|Physician Decision|1|||
125892055|NCT02447302|452903082|FG001|Overall Study|Physician Decision|0|||
125892056|NCT02447302|452903083|FG002|Overall Study|Physician Decision|0|||
125892057|NCT02447302|452903081|FG000|Overall Study|Adverse Event|4|||
125892058|NCT02447302|452903082|FG001|Overall Study|Adverse Event|3|||
125892059|NCT02447302|452903083|FG002|Overall Study|Adverse Event|0|||
126057207|NCT00047385|453505286|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
126057208|NCT00047385|453505287|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
126057209|NCT00047385|453505286|FG000|Overall Study|Eligible for screening but had no screen|260|||
126057210|NCT00047385|453505287|FG001|Overall Study|Eligible for screening but had no screen|492|||
126057211|NCT03490032|453505288|FG000|Overall Study|family issue (child custody)|1|||
126057212|NCT03490032|453505289|FG001|Overall Study|family issue (child custody)|0|||
126057213|NCT03490032|453505290|FG002|Overall Study|family issue (child custody)|0|||
126057214|NCT01852045|453505291|FG000|Overall Study|Adverse Event|1|||
126057215|NCT01852045|453505292|FG001|Overall Study|Adverse Event|0|||
126057216|NCT01852045|453505293|FG002|Overall Study|Adverse Event|0|||
126057217|NCT01852045|453505291|FG000|Overall Study|Lack of Efficacy|3|||
126057218|NCT01852045|453505292|FG001|Overall Study|Lack of Efficacy|0|||
126057219|NCT01852045|453505293|FG002|Overall Study|Lack of Efficacy|0|||
126057220|NCT01852045|453505291|FG000|Overall Study|Lost to Follow-up|0|||
126057221|NCT01852045|453505292|FG001|Overall Study|Lost to Follow-up|1|||
126057222|NCT01852045|453505293|FG002|Overall Study|Lost to Follow-up|1|||
126057223|NCT01852045|453505291|FG000|Overall Study|Withdrawal by Subject|1|||
126057224|NCT01852045|453505292|FG001|Overall Study|Withdrawal by Subject|0|||
126057225|NCT01852045|453505293|FG002|Overall Study|Withdrawal by Subject|1|||
126057226|NCT01852045|453505291|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126057227|NCT01852045|453505292|FG001|Overall Study|Other Miscellaneous Reasons|3|||
126057228|NCT01852045|453505293|FG002|Overall Study|Other Miscellaneous Reasons|2|||
126057229|NCT01698918|453505295|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
126057230|NCT01698918|453505295|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
126057231|NCT01698918|453505295|FG000|First Line Treatment (Core+Extension)|Death|2|||
126057232|NCT01698918|453505295|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
126057233|NCT01698918|453505295|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
126057234|NCT01698918|453505295|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
126057235|NCT01698918|453505295|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
126057236|NCT01698918|453505295|FG000|Second Line Treatment (Core+Extension)|Death|1|||
126057237|NCT01698918|453505295|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
126057238|NCT01698918|453505295|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
126057239|NCT00310037|453505297|FG000|Overall Study|Adverse Event|7|||
126057240|NCT00310037|453505298|FG001|Overall Study|Adverse Event|14|||
126057241|NCT00310037|453505297|FG000|Overall Study|Withdrawal by Subject|4|||
126057242|NCT00310037|453505298|FG001|Overall Study|Withdrawal by Subject|3|||
126057243|NCT00310037|453505297|FG000|Overall Study|Progression|6|||
126057244|NCT00310037|453505298|FG001|Overall Study|Progression|0|||
126057245|NCT00310037|453505297|FG000|Overall Study|Non-protocol treatment|1|||
126057246|NCT00310037|453505298|FG001|Overall Study|Non-protocol treatment|0|||
126057247|NCT02128269|453505303|FG000|Treatment Period|Adverse Event|1|||
126057248|NCT02128269|453505303|FG000|Treatment Period|Physician Decision|1|||
126057249|NCT00878189|453505304|FG000|Overall Study|Death|0|||
126057250|NCT00878189|453505305|FG001|Overall Study|Death|1|||
126057251|NCT00878189|453505306|FG002|Overall Study|Death|0|||
126057252|NCT00878189|453505307|FG003|Overall Study|Death|1|||
126057253|NCT00878189|453505308|FG004|Overall Study|Death|0|||
126057254|NCT00878189|453505309|FG005|Overall Study|Death|0|||
126057255|NCT00878189|453505310|FG006|Overall Study|Death|0|||
126057256|NCT00878189|453505311|FG007|Overall Study|Death|0|||
126057257|NCT00878189|453505312|FG008|Overall Study|Death|1|||
126057258|NCT00878189|453505304|FG000|Overall Study|Participant Refused to Follow-up|0|||
126057259|NCT00878189|453505305|FG001|Overall Study|Participant Refused to Follow-up|0|||
126057260|NCT00878189|453505306|FG002|Overall Study|Participant Refused to Follow-up|0|||
126057261|NCT00878189|453505307|FG003|Overall Study|Participant Refused to Follow-up|0|||
126057262|NCT00878189|453505308|FG004|Overall Study|Participant Refused to Follow-up|0|||
126057263|NCT00878189|453505309|FG005|Overall Study|Participant Refused to Follow-up|4|||
126057264|NCT00878189|453505310|FG006|Overall Study|Participant Refused to Follow-up|0|||
126057265|NCT00878189|453505311|FG007|Overall Study|Participant Refused to Follow-up|0|||
126057266|NCT00878189|453505312|FG008|Overall Study|Participant Refused to Follow-up|0|||
126057267|NCT00878189|453505304|FG000|Overall Study|Other|3|||
126057268|NCT00878189|453505305|FG001|Overall Study|Other|2|||
126057269|NCT00878189|453505306|FG002|Overall Study|Other|4|||
126057270|NCT00878189|453505307|FG003|Overall Study|Other|7|||
126057271|NCT00878189|453505308|FG004|Overall Study|Other|4|||
126057272|NCT00878189|453505309|FG005|Overall Study|Other|18|||
126057273|NCT00878189|453505310|FG006|Overall Study|Other|15|||
126057274|NCT00878189|453505311|FG007|Overall Study|Other|3|||
126057275|NCT00878189|453505312|FG008|Overall Study|Other|4|||
126057276|NCT00878189|453505304|FG000|Overall Study|Lost to Follow-up|0|||
126057277|NCT00878189|453505305|FG001|Overall Study|Lost to Follow-up|0|||
126057278|NCT00878189|453505306|FG002|Overall Study|Lost to Follow-up|0|||
126057279|NCT00878189|453505307|FG003|Overall Study|Lost to Follow-up|0|||
126057280|NCT00878189|453505308|FG004|Overall Study|Lost to Follow-up|0|||
126057281|NCT00878189|453505309|FG005|Overall Study|Lost to Follow-up|1|||
126057282|NCT00878189|453505310|FG006|Overall Study|Lost to Follow-up|1|||
126057283|NCT00878189|453505311|FG007|Overall Study|Lost to Follow-up|0|||
126057284|NCT00878189|453505312|FG008|Overall Study|Lost to Follow-up|0|||
126057285|NCT00878189|453505304|FG000|Overall Study|Objection Progression or Relapse|0|||
126057286|NCT00878189|453505305|FG001|Overall Study|Objection Progression or Relapse|0|||
126057287|NCT00878189|453505306|FG002|Overall Study|Objection Progression or Relapse|0|||
126057288|NCT00878189|453505307|FG003|Overall Study|Objection Progression or Relapse|0|||
126057289|NCT00878189|453505308|FG004|Overall Study|Objection Progression or Relapse|0|||
126057290|NCT00878189|453505309|FG005|Overall Study|Objection Progression or Relapse|0|||
126057291|NCT00878189|453505310|FG006|Overall Study|Objection Progression or Relapse|0|||
126057292|NCT00878189|453505311|FG007|Overall Study|Objection Progression or Relapse|0|||
126057293|NCT00878189|453505312|FG008|Overall Study|Objection Progression or Relapse|3|||
126057294|NCT02007070|453505313|FG000|Overall Study|Adverse Event|4|||
126057295|NCT02007070|453505313|FG000|Overall Study|Clinical Progression|4|||
126057296|NCT02007070|453505313|FG000|Overall Study|Death|1|||
126057297|NCT02007070|453505313|FG000|Overall Study|Protocol Violation|2|||
126057298|NCT02007070|453505313|FG000|Overall Study|Physician Decision|1|||
126057299|NCT02007070|453505313|FG000|Overall Study|Progressive Disease|21|||
126057300|NCT00703092|453505314|FG000|Overall Study|Withdrawal by Subject|2|||
126057301|NCT02708498|453505315|FG000|Overall Study|Death|20|||
126057302|NCT02708498|453505316|FG001|Overall Study|Death|19|||
126057303|NCT02708498|453505317|FG002|Overall Study|Death|0|||
126057304|NCT02708498|453505318|FG003|Overall Study|Death|0|||
126057305|NCT02708498|453505319|FG004|Overall Study|Death|1|||
126057306|NCT02708498|453505320|FG005|Overall Study|Death|0|||
126057307|NCT02708498|453505321|FG006|Overall Study|Death|0|||
126057308|NCT02708498|453505322|FG007|Overall Study|Death|0|||
126057309|NCT02708498|453505315|FG000|Overall Study|Unknown reason, missing data|0|||
126057310|NCT02708498|453505316|FG001|Overall Study|Unknown reason, missing data|0|||
126057311|NCT02708498|453505317|FG002|Overall Study|Unknown reason, missing data|62|||
126057312|NCT02708498|453505318|FG003|Overall Study|Unknown reason, missing data|51|||
126057313|NCT02708498|453505319|FG004|Overall Study|Unknown reason, missing data|195|||
126057314|NCT02708498|453505320|FG005|Overall Study|Unknown reason, missing data|132|||
126057315|NCT02708498|453505321|FG006|Overall Study|Unknown reason, missing data|0|||
126057316|NCT02708498|453505322|FG007|Overall Study|Unknown reason, missing data|0|||
126057317|NCT01021748|453505324|FG000|Overall Study|Adverse Event|2|||
126057318|NCT01021748|453505325|FG001|Overall Study|Adverse Event|1|||
126057319|NCT01021748|453505326|FG002|Overall Study|Adverse Event|2|||
126057320|NCT01021748|453505327|FG003|Overall Study|Adverse Event|0|||
126057321|NCT01021748|453505328|FG004|Overall Study|Adverse Event|2|||
126057322|NCT01021748|453505329|FG005|Overall Study|Adverse Event|0|||
126057323|NCT01021748|453505330|FG006|Overall Study|Adverse Event|1|||
126057324|NCT01021748|453505331|FG007|Overall Study|Adverse Event|0|||
126057325|NCT01021748|453505332|FG008|Overall Study|Adverse Event|7|||
126057326|NCT01021748|453505324|FG000|Overall Study|Physician Decision|1|||
126057327|NCT01021748|453505325|FG001|Overall Study|Physician Decision|0|||
126057328|NCT01021748|453505326|FG002|Overall Study|Physician Decision|1|||
126057329|NCT01021748|453505327|FG003|Overall Study|Physician Decision|1|||
126057330|NCT01021748|453505328|FG004|Overall Study|Physician Decision|0|||
126057331|NCT01021748|453505329|FG005|Overall Study|Physician Decision|0|||
126057332|NCT01021748|453505330|FG006|Overall Study|Physician Decision|1|||
126057333|NCT01021748|453505331|FG007|Overall Study|Physician Decision|1|||
126057334|NCT01021748|453505332|FG008|Overall Study|Physician Decision|2|||
126057335|NCT01021748|453505324|FG000|Overall Study|Progressive Disease|3|||
126057336|NCT01021748|453505325|FG001|Overall Study|Progressive Disease|3|||
126106665|NCT00971243|453682934|FG001|Open-label Period|Withdrawal by Subject|0|||
126106666|NCT00971243|453682935|FG002|Open-label Period|Withdrawal by Subject|0|||
126106667|NCT00971243|453682936|FG003|Open-label Period|Withdrawal by Subject|2|||
126106668|NCT00971243|453682937|FG004|Open-label Period|Withdrawal by Subject|1|||
126106669|NCT00971243|453682933|FG000|Open-label Period|Other reason|0|||
126106670|NCT00971243|453682934|FG001|Open-label Period|Other reason|0|||
126106671|NCT00971243|453682935|FG002|Open-label Period|Other reason|0|||
126106672|NCT00971243|453682936|FG003|Open-label Period|Other reason|0|||
126106673|NCT00971243|453682937|FG004|Open-label Period|Other reason|2|||
126106674|NCT03604523|453682940|FG000|Overall Study|Physician Decision|1|||
126106675|NCT03604523|453682941|FG001|Overall Study|Physician Decision|0|||
126106676|NCT01675479|453682945|FG000|Overall Study|Lost to Follow-up|11|||
126106677|NCT01696942|453682949|FG000|Overall Study|Withdrawal by Subject|1|||
126106678|NCT01696942|453682950|FG001|Overall Study|Withdrawal by Subject|0|||
126106679|NCT01696942|453682949|FG000|Overall Study|Protocol Violation|1|||
126106680|NCT01696942|453682950|FG001|Overall Study|Protocol Violation|2|||
126106681|NCT01696942|453682949|FG000|Overall Study|screen failure|0|||
126106682|NCT01696942|453682950|FG001|Overall Study|screen failure|1|||
126106683|NCT01313117|453682951|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
126106684|NCT01313117|453682951|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
126106685|NCT04223856|453682954|FG000|Overall Study|Progressive disease|153|||
126106686|NCT04223856|453682955|FG001|Overall Study|Progressive disease|73|||
126106687|NCT04223856|453682954|FG000|Overall Study|Adverse Event|97|||
126106688|NCT04223856|453682955|FG001|Overall Study|Adverse Event|62|||
126106689|NCT04223856|453682954|FG000|Overall Study|Physician Decision|9|||
126106690|NCT04223856|453682955|FG001|Overall Study|Physician Decision|28|||
126106691|NCT04223856|453682954|FG000|Overall Study|Withdrawal by Subject|22|||
126106692|NCT04223856|453682955|FG001|Overall Study|Withdrawal by Subject|24|||
126106693|NCT04223856|453682954|FG000|Overall Study|Other|7|||
126106694|NCT04223856|453682955|FG001|Overall Study|Other|2|||
126106695|NCT04223856|453682954|FG000|Overall Study|Randomized but not treated|2|||
126106696|NCT04223856|453682955|FG001|Overall Study|Randomized but not treated|11|||
126106697|NCT04223856|453682954|FG000|Overall Study|On-treatment|144|||
126106698|NCT04223856|453682955|FG001|Overall Study|On-treatment|0|||
126106699|NCT03226275|453682956|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
126106700|NCT03226275|453682957|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
126106701|NCT03226275|453682958|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
126106702|NCT03226275|453682959|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
126106703|NCT03226275|453682956|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
126106704|NCT03226275|453682957|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
125892060|NCT02447302|452903081|FG000|Overall Study|Withdrawal by Subject|0|||
125892061|NCT02447302|452903082|FG001|Overall Study|Withdrawal by Subject|1|||
125892062|NCT02447302|452903083|FG002|Overall Study|Withdrawal by Subject|5|||
125892063|NCT02447302|452903081|FG000|Overall Study|Sponsor Decision|0|||
125892064|NCT02447302|452903082|FG001|Overall Study|Sponsor Decision|0|||
125892065|NCT02447302|452903083|FG002|Overall Study|Sponsor Decision|1|||
125892066|NCT01456897|452903088|FG000|Overall Study|Adverse Event|19|||
125892067|NCT01456897|452903089|FG001|Overall Study|Adverse Event|22|||
125892068|NCT01456897|452903088|FG000|Overall Study|Protocol Violation|3|||
125892069|NCT01456897|452903089|FG001|Overall Study|Protocol Violation|4|||
125892070|NCT01456897|452903088|FG000|Overall Study|Physician Decision|5|||
125892071|NCT01456897|452903089|FG001|Overall Study|Physician Decision|3|||
125892072|NCT01456897|452903088|FG000|Overall Study|Withdrawal by Subject|44|||
125892073|NCT01456897|452903089|FG001|Overall Study|Withdrawal by Subject|17|||
125892074|NCT01456897|452903088|FG000|Overall Study|Lack of Efficacy|4|||
125892075|NCT01456897|452903089|FG001|Overall Study|Lack of Efficacy|11|||
125892076|NCT01396070|452903095|FG000|Overall Study|Withdrawal by Subject|2|||
126106705|NCT03226275|453682958|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
126106706|NCT03226275|453682959|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
126106707|NCT03442114|453682960|FG000|Overall Study|Lost to Follow-up|13|||
126106708|NCT03442114|453682961|FG001|Overall Study|Lost to Follow-up|13|||
126106709|NCT03442114|453682960|FG000|Overall Study|Physician Decision|2|||
126106710|NCT03442114|453682961|FG001|Overall Study|Physician Decision|2|||
125892077|NCT01396070|452903095|FG000|Overall Study|Death|2|||
125892078|NCT01396070|452903095|FG000|Overall Study|Adverse Event|8|||
126106711|NCT03442114|453682960|FG000|Overall Study|Protocol Violation|0|||
125892079|NCT01396070|452903095|FG000|Overall Study|Physician Decision|3|||
126106712|NCT03442114|453682961|FG001|Overall Study|Protocol Violation|2|||
126106713|NCT03442114|453682960|FG000|Overall Study|Withdrawal by Subject|1|||
126106714|NCT03442114|453682961|FG001|Overall Study|Withdrawal by Subject|3|||
126106715|NCT03442114|453682960|FG000|Overall Study|Guardianship Change|0|||
125892080|NCT01396070|452903095|FG000|Overall Study|Lack of Efficacy|4|||
125892081|NCT01561313|452903097|FG000|Overall Study|Withdrawal by Subject|1|||
125892082|NCT01561313|452903098|FG001|Overall Study|Withdrawal by Subject|0|||
125892083|NCT01561313|452903097|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
125892084|NCT01561313|452903098|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
126057337|NCT01021748|453505326|FG002|Overall Study|Progressive Disease|4|||
126057338|NCT01021748|453505327|FG003|Overall Study|Progressive Disease|6|||
126057339|NCT01021748|453505328|FG004|Overall Study|Progressive Disease|7|||
126057340|NCT01021748|453505329|FG005|Overall Study|Progressive Disease|3|||
126057341|NCT01021748|453505330|FG006|Overall Study|Progressive Disease|0|||
126057342|NCT01021748|453505331|FG007|Overall Study|Progressive Disease|5|||
126057343|NCT01021748|453505332|FG008|Overall Study|Progressive Disease|6|||
126057344|NCT01021748|453505324|FG000|Overall Study|Withdrawal by Subject|0|||
126057345|NCT01021748|453505325|FG001|Overall Study|Withdrawal by Subject|0|||
126057346|NCT01021748|453505326|FG002|Overall Study|Withdrawal by Subject|0|||
126057347|NCT01021748|453505327|FG003|Overall Study|Withdrawal by Subject|0|||
126057348|NCT01021748|453505328|FG004|Overall Study|Withdrawal by Subject|0|||
126057349|NCT01021748|453505329|FG005|Overall Study|Withdrawal by Subject|0|||
126057350|NCT01021748|453505330|FG006|Overall Study|Withdrawal by Subject|1|||
126057351|NCT01021748|453505331|FG007|Overall Study|Withdrawal by Subject|0|||
126057352|NCT01021748|453505332|FG008|Overall Study|Withdrawal by Subject|1|||
126057353|NCT01021748|453505324|FG000|Overall Study|Not Treated|0|||
126057354|NCT01021748|453505325|FG001|Overall Study|Not Treated|1|||
126057355|NCT01021748|453505326|FG002|Overall Study|Not Treated|0|||
126057356|NCT01021748|453505327|FG003|Overall Study|Not Treated|0|||
126057357|NCT01021748|453505328|FG004|Overall Study|Not Treated|0|||
126057358|NCT01021748|453505329|FG005|Overall Study|Not Treated|0|||
126057359|NCT01021748|453505330|FG006|Overall Study|Not Treated|0|||
126057360|NCT01021748|453505331|FG007|Overall Study|Not Treated|0|||
126057361|NCT01021748|453505332|FG008|Overall Study|Not Treated|0|||
126057362|NCT03316170|453505339|FG000|Overall Study|Death|1|||
126057363|NCT03316170|453505340|FG001|Overall Study|Death|0|||
126057364|NCT03316170|453505339|FG000|Overall Study|Lost to Follow-up|6|||
126057365|NCT03316170|453505340|FG001|Overall Study|Lost to Follow-up|7|||
126057366|NCT03052517|453505341|FG000|Overall Study|Study Terminated By Sponsor|928|||
126057367|NCT03052517|453505342|FG001|Overall Study|Study Terminated By Sponsor|938|||
126057368|NCT03052517|453505343|FG002|Overall Study|Study Terminated By Sponsor|296|||
126057369|NCT03052517|453505341|FG000|Overall Study|Subject/Guardian Decision|50|||
126057370|NCT03052517|453505342|FG001|Overall Study|Subject/Guardian Decision|45|||
126057371|NCT03052517|453505343|FG002|Overall Study|Subject/Guardian Decision|22|||
126057372|NCT03052517|453505341|FG000|Overall Study|Lack of Efficacy|23|||
126057373|NCT03052517|453505342|FG001|Overall Study|Lack of Efficacy|14|||
126057374|NCT03052517|453505343|FG002|Overall Study|Lack of Efficacy|7|||
126057375|NCT03052517|453505341|FG000|Overall Study|Adverse Event|6|||
126057376|NCT03052517|453505342|FG001|Overall Study|Adverse Event|5|||
126057377|NCT03052517|453505343|FG002|Overall Study|Adverse Event|0|||
126057378|NCT03052517|453505341|FG000|Overall Study|Physician Decision|4|||
126057379|NCT03052517|453505342|FG001|Overall Study|Physician Decision|5|||
126057380|NCT03052517|453505343|FG002|Overall Study|Physician Decision|1|||
126057381|NCT03052517|453505341|FG000|Overall Study|Death|3|||
126057382|NCT03052517|453505342|FG001|Overall Study|Death|0|||
126057383|NCT03052517|453505343|FG002|Overall Study|Death|1|||
126057384|NCT03052517|453505341|FG000|Overall Study|Lost to Follow-up|2|||
126057385|NCT03052517|453505342|FG001|Overall Study|Lost to Follow-up|4|||
126057386|NCT03052517|453505343|FG002|Overall Study|Lost to Follow-up|0|||
126057387|NCT03052517|453505341|FG000|Overall Study|Pregnancy|1|||
126057388|NCT03052517|453505342|FG001|Overall Study|Pregnancy|0|||
126057389|NCT03052517|453505343|FG002|Overall Study|Pregnancy|1|||
126057390|NCT03052517|453505341|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
126057391|NCT03052517|453505342|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
126057392|NCT03052517|453505343|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
126057393|NCT03052517|453505341|FG000|Overall Study|Technical Problems|0|||
126057394|NCT03052517|453505342|FG001|Overall Study|Technical Problems|1|||
126057395|NCT03052517|453505343|FG002|Overall Study|Technical Problems|0|||
126057396|NCT01640288|453505344|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
126057397|NCT01640288|453505345|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
126106716|NCT03442114|453682961|FG001|Overall Study|Guardianship Change|1|||
126106717|NCT02903368|453682962|FG000|Part 1|Adverse Event|3|||
126057398|NCT01640288|453505344|FG000|Overall Study|Screen Failure|20|||
126057399|NCT01640288|453505345|FG001|Overall Study|Screen Failure|18|||
126057400|NCT01640288|453505344|FG000|Overall Study|Withdrawn by PI|5|||
126057401|NCT01640288|453505345|FG001|Overall Study|Withdrawn by PI|0|||
126057402|NCT01640288|453505344|FG000|Overall Study|Withdrawal by Subject|1|||
126057403|NCT01640288|453505345|FG001|Overall Study|Withdrawal by Subject|0|||
126057404|NCT04803734|453505346|FG000|Overall Study|Withdrawal by Subject|0|||
126057405|NCT04803734|453505347|FG001|Overall Study|Withdrawal by Subject|1|||
126057406|NCT04803734|453505346|FG000|Overall Study|Protocol Violation|0|||
126057407|NCT04803734|453505347|FG001|Overall Study|Protocol Violation|1|||
126057408|NCT02309515|453505348|FG000|Overall Study|Withdrawal by Subject|0|||
126057409|NCT02309515|453505349|FG001|Overall Study|Withdrawal by Subject|1|||
126057410|NCT00195819|453505357|FG000|Double-Blind|Withdrawal by Subject|1|||
126057411|NCT00195819|453505358|FG001|Double-Blind|Withdrawal by Subject|0|||
126057412|NCT00195819|453505357|FG000|Double-Blind|Moved|1|||
126057413|NCT00195819|453505358|FG001|Double-Blind|Moved|0|||
126057414|NCT00195819|453505357|FG000|Open-label|Adverse Event|0|||
125892085|NCT04254913|452903099|FG000|Overall Study|Adverse Event|1|||
125892086|NCT02695420|452903100|FG000|Overall Study|Death|0|||
125892087|NCT02695420|452903101|FG001|Overall Study|Death|1|||
125892088|NCT02695420|452903102|FG002|Overall Study|Death|0|||
125892089|NCT02695420|452903103|FG003|Overall Study|Death|0|||
125892090|NCT04535453|452903104|FG000|Overall Study|Death|0|||
125892091|NCT04535453|452903105|FG001|Overall Study|Death|1|||
125892092|NCT04535453|452903106|FG002|Overall Study|Death|0|||
125892093|NCT04535453|452903107|FG003|Overall Study|Death|0|||
125892094|NCT04535453|452903108|FG004|Overall Study|Death|0|||
125892095|NCT04535453|452903109|FG005|Overall Study|Death|0|||
125892096|NCT04535453|452903110|FG006|Overall Study|Death|0|||
125892097|NCT04535453|452903111|FG007|Overall Study|Death|0|||
125892098|NCT04535453|452903112|FG008|Overall Study|Death|0|||
125892099|NCT04535453|452903113|FG009|Overall Study|Death|0|||
125892100|NCT04535453|452903114|FG010|Overall Study|Death|0|||
125892101|NCT04535453|452903115|FG011|Overall Study|Death|0|||
125892102|NCT04535453|452903104|FG000|Overall Study|Lost to Follow-up|1|||
125892103|NCT04535453|452903105|FG001|Overall Study|Lost to Follow-up|1|||
125892104|NCT04535453|452903106|FG002|Overall Study|Lost to Follow-up|1|||
125892105|NCT04535453|452903107|FG003|Overall Study|Lost to Follow-up|0|||
125892106|NCT04535453|452903108|FG004|Overall Study|Lost to Follow-up|3|||
125892107|NCT04535453|452903109|FG005|Overall Study|Lost to Follow-up|1|||
125892108|NCT04535453|452903110|FG006|Overall Study|Lost to Follow-up|0|||
125892109|NCT04535453|452903111|FG007|Overall Study|Lost to Follow-up|0|||
125892110|NCT04535453|452903112|FG008|Overall Study|Lost to Follow-up|1|||
125892111|NCT04535453|452903113|FG009|Overall Study|Lost to Follow-up|1|||
125892112|NCT04535453|452903114|FG010|Overall Study|Lost to Follow-up|0|||
125892113|NCT04535453|452903115|FG011|Overall Study|Lost to Follow-up|0|||
126057415|NCT00195819|453505358|FG001|Open-label|Adverse Event|9|||
126057416|NCT00195819|453505357|FG000|Open-label|Lack of Efficacy|0|||
126057417|NCT00195819|453505358|FG001|Open-label|Lack of Efficacy|2|||
126057418|NCT00195819|453505357|FG000|Open-label|Pregnancy|0|||
126057419|NCT00195819|453505358|FG001|Open-label|Pregnancy|1|||
126057420|NCT00195819|453505357|FG000|Open-label|Protocol Violation|0|||
126057421|NCT00195819|453505358|FG001|Open-label|Protocol Violation|2|||
126057422|NCT00195819|453505357|FG000|Open-label|Moved|0|||
126057423|NCT00195819|453505358|FG001|Open-label|Moved|1|||
126057424|NCT00195819|453505357|FG000|Open-label|Withdrawal by Subject|0|||
126057425|NCT00195819|453505358|FG001|Open-label|Withdrawal by Subject|5|||
126057426|NCT01629589|453505361|FG000|Overall Study|Protocol Violation|4|||
126057427|NCT01629589|453505362|FG001|Overall Study|Protocol Violation|2|||
126057428|NCT01629589|453505361|FG000|Overall Study|Lost to Follow-up|2|||
126057429|NCT01629589|453505362|FG001|Overall Study|Lost to Follow-up|1|||
126057430|NCT01629589|453505361|FG000|Overall Study|Withdrawal by Subject|2|||
126057431|NCT01629589|453505362|FG001|Overall Study|Withdrawal by Subject|3|||
126057432|NCT01629589|453505361|FG000|Overall Study|Did not receive study vaccine|0|||
126057433|NCT01629589|453505362|FG001|Overall Study|Did not receive study vaccine|1|||
126057434|NCT03781375|453505363|FG000|Double-blind Phase|Adverse Event|0|||
126057435|NCT03781375|453505364|FG001|Double-blind Phase|Adverse Event|1|||
126057436|NCT03781375|453505363|FG000|Double-blind Phase|Lack of Response|6|||
126057437|NCT03781375|453505364|FG001|Double-blind Phase|Lack of Response|2|||
126057438|NCT03781375|453505363|FG000|Double-blind Phase|Other|1|||
126057439|NCT03781375|453505364|FG001|Double-blind Phase|Other|3|||
126057440|NCT03781375|453505363|FG000|Open-label Phase|Protocol Issues|0|||
126057441|NCT03781375|453505364|FG001|Open-label Phase|Protocol Issues|1|||
126057442|NCT03781375|453505363|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
126057443|NCT03781375|453505364|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
126057444|NCT03781375|453505363|FG000|Open-label Phase|Other|2|||
126057445|NCT03781375|453505364|FG001|Open-label Phase|Other|2|||
126057446|NCT01303510|453505367|FG000|Overall Study|Lost to Follow-up|1|||
126057447|NCT01303510|453505368|FG001|Overall Study|Lost to Follow-up|0|||
126057448|NCT02404441|453505369|FG000|Phase 1 Part|Adverse Event|1|||
126057449|NCT02404441|453505370|FG001|Phase 1 Part|Adverse Event|0|||
126106718|NCT02903368|453682963|FG001|Part 1|Adverse Event|0|||
125892114|NCT04535453|452903104|FG000|Overall Study|Physician Decision|0|||
125892115|NCT04535453|452903105|FG001|Overall Study|Physician Decision|0|||
125892116|NCT04535453|452903106|FG002|Overall Study|Physician Decision|0|||
126057450|NCT02404441|453505371|FG002|Phase 1 Part|Adverse Event|0|||
126057451|NCT02404441|453505372|FG003|Phase 1 Part|Adverse Event|0|||
126057452|NCT02404441|453505373|FG004|Phase 1 Part|Adverse Event|0|||
126057453|NCT02404441|453505374|FG005|Phase 1 Part|Adverse Event|0|||
126057454|NCT02404441|453505375|FG006|Phase 1 Part|Adverse Event|0|||
125892117|NCT04535453|452903107|FG003|Overall Study|Physician Decision|1|||
126057455|NCT02404441|453505376|FG007|Phase 1 Part|Adverse Event|0|||
126106719|NCT02903368|453682964|FG002|Part 1|Adverse Event|0|||
125892118|NCT04535453|452903108|FG004|Overall Study|Physician Decision|0|||
125892119|NCT04535453|452903109|FG005|Overall Study|Physician Decision|0|||
125892120|NCT04535453|452903110|FG006|Overall Study|Physician Decision|0|||
125892121|NCT04535453|452903111|FG007|Overall Study|Physician Decision|0|||
126057456|NCT02404441|453505377|FG008|Phase 1 Part|Adverse Event|0|||
126057457|NCT02404441|453505378|FG009|Phase 1 Part|Adverse Event|0|||
126057458|NCT02404441|453505369|FG000|Phase 1 Part|Physician Decision|0|||
126106720|NCT02903368|453682965|FG003|Part 1|Adverse Event|0|||
126106721|NCT02903368|453682962|FG000|Part 1|Withdrawal by Subject|1|||
126106722|NCT02903368|453682963|FG001|Part 1|Withdrawal by Subject|0|||
126106723|NCT02903368|453682964|FG002|Part 1|Withdrawal by Subject|0|||
126057459|NCT02404441|453505370|FG001|Phase 1 Part|Physician Decision|1|||
126057460|NCT02404441|453505371|FG002|Phase 1 Part|Physician Decision|0|||
126057461|NCT02404441|453505372|FG003|Phase 1 Part|Physician Decision|0|||
126057462|NCT02404441|453505373|FG004|Phase 1 Part|Physician Decision|0|||
126057463|NCT02404441|453505374|FG005|Phase 1 Part|Physician Decision|0|||
126057464|NCT02404441|453505375|FG006|Phase 1 Part|Physician Decision|0|||
126057465|NCT02404441|453505376|FG007|Phase 1 Part|Physician Decision|0|||
126057466|NCT02404441|453505377|FG008|Phase 1 Part|Physician Decision|0|||
126057467|NCT02404441|453505378|FG009|Phase 1 Part|Physician Decision|0|||
126057468|NCT02404441|453505369|FG000|Phase 1 Part|Progressive Disease|14|||
126057469|NCT02404441|453505370|FG001|Phase 1 Part|Progressive Disease|11|||
126057470|NCT02404441|453505371|FG002|Phase 1 Part|Progressive Disease|7|||
126057471|NCT02404441|453505372|FG003|Phase 1 Part|Progressive Disease|6|||
126057472|NCT02404441|453505373|FG004|Phase 1 Part|Progressive Disease|9|||
126057473|NCT02404441|453505374|FG005|Phase 1 Part|Progressive Disease|0|||
126057474|NCT02404441|453505375|FG006|Phase 1 Part|Progressive Disease|0|||
126057475|NCT02404441|453505376|FG007|Phase 1 Part|Progressive Disease|0|||
126057476|NCT02404441|453505377|FG008|Phase 1 Part|Progressive Disease|0|||
126057477|NCT02404441|453505378|FG009|Phase 1 Part|Progressive Disease|0|||
126057478|NCT02404441|453505369|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
126057479|NCT02404441|453505370|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
126057480|NCT02404441|453505371|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
126057481|NCT02404441|453505372|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
126057482|NCT02404441|453505373|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
126057483|NCT02404441|453505374|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
126057484|NCT02404441|453505375|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
126057485|NCT02404441|453505376|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
126057486|NCT02404441|453505377|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
126057487|NCT02404441|453505378|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
126057488|NCT02404441|453505369|FG000|Phase 1 Part|Death|1|||
126057489|NCT02404441|453505370|FG001|Phase 1 Part|Death|1|||
126057490|NCT02404441|453505371|FG002|Phase 1 Part|Death|1|||
126057491|NCT02404441|453505372|FG003|Phase 1 Part|Death|0|||
126057492|NCT02404441|453505373|FG004|Phase 1 Part|Death|1|||
126057493|NCT02404441|453505374|FG005|Phase 1 Part|Death|0|||
126057494|NCT02404441|453505375|FG006|Phase 1 Part|Death|0|||
126057495|NCT02404441|453505376|FG007|Phase 1 Part|Death|0|||
126057496|NCT02404441|453505377|FG008|Phase 1 Part|Death|0|||
126057497|NCT02404441|453505378|FG009|Phase 1 Part|Death|0|||
126057498|NCT02404441|453505369|FG000|Phase 2 Part|Adverse Event|0|||
126057499|NCT02404441|453505370|FG001|Phase 2 Part|Adverse Event|0|||
126057500|NCT02404441|453505371|FG002|Phase 2 Part|Adverse Event|0|||
126057501|NCT02404441|453505372|FG003|Phase 2 Part|Adverse Event|0|||
126057502|NCT02404441|453505373|FG004|Phase 2 Part|Adverse Event|0|||
126057503|NCT02404441|453505374|FG005|Phase 2 Part|Adverse Event|2|||
126057504|NCT02404441|453505375|FG006|Phase 2 Part|Adverse Event|3|||
126057505|NCT02404441|453505376|FG007|Phase 2 Part|Adverse Event|3|||
126057506|NCT02404441|453505377|FG008|Phase 2 Part|Adverse Event|6|||
126057507|NCT02404441|453505378|FG009|Phase 2 Part|Adverse Event|1|||
126057508|NCT02404441|453505369|FG000|Phase 2 Part|Physician Decision|0|||
126057509|NCT02404441|453505370|FG001|Phase 2 Part|Physician Decision|0|||
126057510|NCT02404441|453505371|FG002|Phase 2 Part|Physician Decision|0|||
126057511|NCT02404441|453505372|FG003|Phase 2 Part|Physician Decision|0|||
126057512|NCT02404441|453505373|FG004|Phase 2 Part|Physician Decision|0|||
126057513|NCT02404441|453505374|FG005|Phase 2 Part|Physician Decision|7|||
126057514|NCT02404441|453505375|FG006|Phase 2 Part|Physician Decision|9|||
126106724|NCT02903368|453682965|FG003|Part 1|Withdrawal by Subject|0|||
126057515|NCT02404441|453505376|FG007|Phase 2 Part|Physician Decision|2|||
126057516|NCT02404441|453505377|FG008|Phase 2 Part|Physician Decision|1|||
126057517|NCT02404441|453505378|FG009|Phase 2 Part|Physician Decision|3|||
126057518|NCT02404441|453505369|FG000|Phase 2 Part|Progressive disease|0|||
126057519|NCT02404441|453505370|FG001|Phase 2 Part|Progressive disease|0|||
126057520|NCT02404441|453505371|FG002|Phase 2 Part|Progressive disease|0|||
126057521|NCT02404441|453505372|FG003|Phase 2 Part|Progressive disease|0|||
126057522|NCT02404441|453505373|FG004|Phase 2 Part|Progressive disease|0|||
126057523|NCT02404441|453505374|FG005|Phase 2 Part|Progressive disease|43|||
126106725|NCT02903368|453682962|FG000|Part 2|Adverse Event|0|||
125892122|NCT04535453|452903112|FG008|Overall Study|Physician Decision|0|||
126057524|NCT02404441|453505375|FG006|Phase 2 Part|Progressive disease|32|||
126057525|NCT02404441|453505376|FG007|Phase 2 Part|Progressive disease|31|||
126057526|NCT02404441|453505377|FG008|Phase 2 Part|Progressive disease|39|||
126057527|NCT02404441|453505378|FG009|Phase 2 Part|Progressive disease|27|||
126057528|NCT02404441|453505369|FG000|Phase 2 Part|Subject/guardian decision|0|||
126057529|NCT02404441|453505370|FG001|Phase 2 Part|Subject/guardian decision|0|||
126057530|NCT02404441|453505371|FG002|Phase 2 Part|Subject/guardian decision|0|||
126057531|NCT02404441|453505372|FG003|Phase 2 Part|Subject/guardian decision|0|||
126057532|NCT02404441|453505373|FG004|Phase 2 Part|Subject/guardian decision|0|||
126057533|NCT02404441|453505374|FG005|Phase 2 Part|Subject/guardian decision|3|||
126057534|NCT02404441|453505375|FG006|Phase 2 Part|Subject/guardian decision|9|||
126057535|NCT02404441|453505376|FG007|Phase 2 Part|Subject/guardian decision|0|||
126057536|NCT02404441|453505377|FG008|Phase 2 Part|Subject/guardian decision|3|||
126057537|NCT02404441|453505378|FG009|Phase 2 Part|Subject/guardian decision|2|||
126057538|NCT02404441|453505369|FG000|Phase 2 Part|Death|0|||
126057539|NCT02404441|453505370|FG001|Phase 2 Part|Death|0|||
126057540|NCT02404441|453505371|FG002|Phase 2 Part|Death|0|||
126057541|NCT02404441|453505372|FG003|Phase 2 Part|Death|0|||
126057542|NCT02404441|453505373|FG004|Phase 2 Part|Death|0|||
126057543|NCT02404441|453505374|FG005|Phase 2 Part|Death|4|||
126057544|NCT02404441|453505375|FG006|Phase 2 Part|Death|8|||
126057545|NCT02404441|453505376|FG007|Phase 2 Part|Death|4|||
126057546|NCT02404441|453505377|FG008|Phase 2 Part|Death|10|||
126057547|NCT02404441|453505378|FG009|Phase 2 Part|Death|9|||
126057548|NCT02234141|453505379|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
126057549|NCT02234141|453505380|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
126057550|NCT02234141|453505381|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
126057551|NCT02234141|453505382|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
126057552|NCT02234141|453505383|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
126057553|NCT02234141|453505384|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
126057554|NCT02234141|453505385|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
126057555|NCT02234141|453505379|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126057556|NCT02234141|453505380|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
126057557|NCT02234141|453505381|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126057558|NCT02234141|453505382|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126057559|NCT02234141|453505383|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126057560|NCT02234141|453505384|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126057561|NCT02234141|453505385|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126057562|NCT02234141|453505379|FG000|Treatment Period (24 Weeks)|Death|1|||
126057563|NCT02234141|453505380|FG001|Treatment Period (24 Weeks)|Death|2|||
126057564|NCT02234141|453505381|FG002|Treatment Period (24 Weeks)|Death|0|||
126057565|NCT02234141|453505382|FG003|Treatment Period (24 Weeks)|Death|1|||
126057566|NCT02234141|453505383|FG004|Treatment Period (24 Weeks)|Death|0|||
126057567|NCT02234141|453505384|FG005|Treatment Period (24 Weeks)|Death|0|||
126057568|NCT02234141|453505385|FG006|Treatment Period (24 Weeks)|Death|0|||
126057569|NCT02234141|453505379|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
126057570|NCT02234141|453505380|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
126057571|NCT02234141|453505381|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
126057572|NCT02234141|453505382|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
126057573|NCT02234141|453505383|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
126057574|NCT02234141|453505384|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
126057575|NCT02234141|453505385|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
126057576|NCT02234141|453505379|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126057577|NCT02234141|453505380|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
126057578|NCT02234141|453505381|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126057579|NCT02234141|453505382|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126057580|NCT02234141|453505383|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126057581|NCT02234141|453505384|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126057582|NCT02234141|453505385|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126057583|NCT02234141|453505379|FG000|Long-Term Treatment Period|Death|0|||
126057584|NCT02234141|453505380|FG001|Long-Term Treatment Period|Death|0|||
126057585|NCT02234141|453505381|FG002|Long-Term Treatment Period|Death|0|||
126057586|NCT02234141|453505382|FG003|Long-Term Treatment Period|Death|0|||
126057587|NCT02234141|453505383|FG004|Long-Term Treatment Period|Death|0|||
126057588|NCT02234141|453505384|FG005|Long-Term Treatment Period|Death|1|||
126057589|NCT02234141|453505385|FG006|Long-Term Treatment Period|Death|0|||
126057590|NCT02234141|453505379|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
126057591|NCT02234141|453505380|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
126057592|NCT02234141|453505381|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
126057593|NCT02234141|453505382|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
126057594|NCT02234141|453505383|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
126057595|NCT02234141|453505384|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
126057596|NCT02234141|453505385|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
126057597|NCT02234141|453505379|FG000|Long-Term Treatment Period|Adverse Event|4|||
126057598|NCT02234141|453505380|FG001|Long-Term Treatment Period|Adverse Event|0|||
126057599|NCT02234141|453505381|FG002|Long-Term Treatment Period|Adverse Event|5|||
126057600|NCT02234141|453505382|FG003|Long-Term Treatment Period|Adverse Event|0|||
126057601|NCT02234141|453505383|FG004|Long-Term Treatment Period|Adverse Event|1|||
126057602|NCT02234141|453505384|FG005|Long-Term Treatment Period|Adverse Event|1|||
126057603|NCT02234141|453505385|FG006|Long-Term Treatment Period|Adverse Event|1|||
126057604|NCT02234141|453505379|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
126057605|NCT02234141|453505380|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
126057606|NCT02234141|453505381|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
126057607|NCT02234141|453505382|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
126057608|NCT02234141|453505383|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
126057609|NCT02234141|453505384|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
126057610|NCT02234141|453505385|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
126057611|NCT02234141|453505379|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
126057612|NCT02234141|453505380|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
126057613|NCT02234141|453505381|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
126057614|NCT02234141|453505382|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
126057615|NCT02234141|453505383|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
126057616|NCT02234141|453505384|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
126057617|NCT02234141|453505385|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
126057618|NCT03042767|453505386|FG000|Overall Study|Lost to Follow-up|1|||
126057619|NCT03042767|453505387|FG001|Overall Study|Lost to Follow-up|2|||
126057620|NCT02037568|453505388|FG000|Overall Study|Withdrawal by Subject|17|||
126057621|NCT02037568|453505389|FG001|Overall Study|Withdrawal by Subject|24|||
126057622|NCT02037568|453505388|FG000|Overall Study|Lost to Follow-up|16|||
126057623|NCT02037568|453505389|FG001|Overall Study|Lost to Follow-up|13|||
126057624|NCT02037568|453505388|FG000|Overall Study|Screen Failure|3|||
126057625|NCT02037568|453505389|FG001|Overall Study|Screen Failure|1|||
126057626|NCT02037568|453505388|FG000|Overall Study|Patient did not receive transplant|0|||
126057627|NCT02037568|453505389|FG001|Overall Study|Patient did not receive transplant|1|||
126057628|NCT03861234|453505390|FG000|Overall Study|Not treated|0|||
126057629|NCT03861234|453505391|FG001|Overall Study|Not treated|0|||
126057630|NCT03861234|453505392|FG002|Overall Study|Not treated|0|||
126057631|NCT03861234|453505393|FG003|Overall Study|Not treated|0|||
126057632|NCT03861234|453505394|FG004|Overall Study|Not treated|0|||
126057633|NCT03861234|453505395|FG005|Overall Study|Not treated|1|||
126057634|NCT03861234|453505396|FG006|Overall Study|Not treated|0|||
126057635|NCT03861234|453505397|FG007|Overall Study|Not treated|0|||
126057636|NCT03861234|453505390|FG000|Overall Study|Adverse Event|0|||
126057637|NCT03861234|453505391|FG001|Overall Study|Adverse Event|0|||
126057638|NCT03861234|453505392|FG002|Overall Study|Adverse Event|0|||
126057639|NCT03861234|453505393|FG003|Overall Study|Adverse Event|0|||
126057640|NCT03861234|453505394|FG004|Overall Study|Adverse Event|0|||
126057641|NCT03861234|453505395|FG005|Overall Study|Adverse Event|1|||
126057642|NCT03861234|453505396|FG006|Overall Study|Adverse Event|0|||
126057643|NCT03861234|453505397|FG007|Overall Study|Adverse Event|0|||
126057644|NCT03861234|453505390|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
126057645|NCT03861234|453505391|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
126057646|NCT03861234|453505392|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
126057647|NCT03861234|453505393|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
126057648|NCT03861234|453505394|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
126057649|NCT03861234|453505395|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
126057650|NCT03861234|453505396|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
126057651|NCT03861234|453505397|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
126057652|NCT03861234|453505390|FG000|Overall Study|As per sponsor decision|0|||
126057653|NCT03861234|453505391|FG001|Overall Study|As per sponsor decision|0|||
126057654|NCT03861234|453505392|FG002|Overall Study|As per sponsor decision|0|||
126057655|NCT03861234|453505393|FG003|Overall Study|As per sponsor decision|0|||
126057656|NCT03861234|453505394|FG004|Overall Study|As per sponsor decision|0|||
126057657|NCT03861234|453505395|FG005|Overall Study|As per sponsor decision|0|||
126057658|NCT03861234|453505396|FG006|Overall Study|As per sponsor decision|1|||
126057659|NCT03861234|453505397|FG007|Overall Study|As per sponsor decision|0|||
126057660|NCT03861234|453505390|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
126057661|NCT03861234|453505391|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
126057662|NCT03861234|453505392|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
126057663|NCT03861234|453505393|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
126057664|NCT03861234|453505394|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
126057665|NCT03861234|453505395|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
126057666|NCT03861234|453505396|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
126057667|NCT03861234|453505397|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
126057668|NCT00621842|453505398|FG000|Overall Study|Adverse Event|6|||
126057669|NCT00621842|453505398|FG000|Overall Study|Withdrawal by Subject|7|||
126057670|NCT00621842|453505398|FG000|Overall Study|Protocol Violation|4|||
126057671|NCT00621842|453505398|FG000|Overall Study|Lack of Efficacy|2|||
126106726|NCT02903368|453682963|FG001|Part 2|Adverse Event|0|||
125892123|NCT04535453|452903113|FG009|Overall Study|Physician Decision|0|||
125892124|NCT04535453|452903114|FG010|Overall Study|Physician Decision|0|||
125892125|NCT04535453|452903115|FG011|Overall Study|Physician Decision|0|||
125892126|NCT04535453|452903104|FG000|Overall Study|Withdrawal by Subject|3|||
125892127|NCT04535453|452903105|FG001|Overall Study|Withdrawal by Subject|6|||
125892128|NCT04535453|452903106|FG002|Overall Study|Withdrawal by Subject|3|||
125892129|NCT04535453|452903107|FG003|Overall Study|Withdrawal by Subject|3|||
125892130|NCT04535453|452903108|FG004|Overall Study|Withdrawal by Subject|2|||
125892131|NCT04535453|452903109|FG005|Overall Study|Withdrawal by Subject|1|||
125892132|NCT04535453|452903110|FG006|Overall Study|Withdrawal by Subject|1|||
125892133|NCT04535453|452903111|FG007|Overall Study|Withdrawal by Subject|1|||
125892134|NCT04535453|452903112|FG008|Overall Study|Withdrawal by Subject|1|||
125892135|NCT04535453|452903113|FG009|Overall Study|Withdrawal by Subject|1|||
125892136|NCT04535453|452903114|FG010|Overall Study|Withdrawal by Subject|0|||
125892137|NCT04535453|452903115|FG011|Overall Study|Withdrawal by Subject|1|||
125892138|NCT04535453|452903104|FG000|Overall Study|Other|0|||
125892139|NCT04535453|452903105|FG001|Overall Study|Other|0|||
125892140|NCT04535453|452903106|FG002|Overall Study|Other|1|||
125892141|NCT04535453|452903107|FG003|Overall Study|Other|0|||
125892142|NCT04535453|452903108|FG004|Overall Study|Other|1|||
125892143|NCT04535453|452903109|FG005|Overall Study|Other|0|||
125892144|NCT04535453|452903110|FG006|Overall Study|Other|1|||
125892145|NCT04535453|452903111|FG007|Overall Study|Other|1|||
125892146|NCT04535453|452903112|FG008|Overall Study|Other|1|||
125892147|NCT04535453|452903113|FG009|Overall Study|Other|0|||
125892148|NCT04535453|452903114|FG010|Overall Study|Other|0|||
125892149|NCT04535453|452903115|FG011|Overall Study|Other|0|||
125892150|NCT00916929|452903116|FG000|Overall Study|Lost to Follow-up|1|||
125892151|NCT00916929|452903117|FG001|Overall Study|Lost to Follow-up|3|||
125892152|NCT00916929|452903116|FG000|Overall Study|Death|5|||
125892153|NCT00916929|452903117|FG001|Overall Study|Death|10|||
125892154|NCT00916929|452903116|FG000|Overall Study|Withdrawal by Subject|1|||
125892155|NCT00916929|452903117|FG001|Overall Study|Withdrawal by Subject|5|||
125892156|NCT00916929|452903116|FG000|Overall Study|Left ventricular epicardial lead|1|||
125892157|NCT00916929|452903117|FG001|Overall Study|Left ventricular epicardial lead|2|||
125892158|NCT00916929|452903116|FG000|Overall Study|Transferred to hospice care|1|||
125892159|NCT00916929|452903117|FG001|Overall Study|Transferred to hospice care|1|||
125892160|NCT00916929|452903116|FG000|Overall Study|System explant|1|||
125892161|NCT00916929|452903117|FG001|Overall Study|System explant|0|||
125892162|NCT00916929|452903116|FG000|Overall Study|Moved to another state|0|||
125892163|NCT00916929|452903117|FG001|Overall Study|Moved to another state|1|||
125892164|NCT00916929|452903116|FG000|Overall Study|Device unable to process impedance data|0|||
125892165|NCT00916929|452903117|FG001|Overall Study|Device unable to process impedance data|7|||
125892166|NCT02929407|452903118|FG000|Overall Study|Adverse Event|1|||
125892167|NCT02442804|452903122|FG000|Overall Study|Withdrawal by Subject|0|||
125892168|NCT02442804|452903123|FG001|Overall Study|Withdrawal by Subject|1|||
125892169|NCT02442804|452903122|FG000|Overall Study|Adverse Event|1|||
125892170|NCT02442804|452903123|FG001|Overall Study|Adverse Event|0|||
125892171|NCT02036853|452903124|FG000|Overall Study|Adverse Event|0|||
125892172|NCT02036853|452903125|FG001|Overall Study|Adverse Event|2|||
125892173|NCT02036853|452903124|FG000|Overall Study|Lack of Efficacy|0|||
126057672|NCT02066636|453505399|FG000|Overall Study|Disease progression|51|||
126057673|NCT02066636|453505400|FG001|Overall Study|Disease progression|60|||
126057674|NCT02066636|453505401|FG002|Overall Study|Disease progression|700|||
126057675|NCT02066636|453505399|FG000|Overall Study|Study drug toxicity|13|||
126057676|NCT02066636|453505400|FG001|Overall Study|Study drug toxicity|2|||
126057677|NCT02066636|453505401|FG002|Overall Study|Study drug toxicity|58|||
126057678|NCT02066636|453505399|FG000|Overall Study|Death|4|||
126057679|NCT02066636|453505400|FG001|Overall Study|Death|2|||
126057680|NCT02066636|453505401|FG002|Overall Study|Death|158|||
126057681|NCT02066636|453505399|FG000|Overall Study|Adverse event unrelated to study drug|6|||
126057682|NCT02066636|453505400|FG001|Overall Study|Adverse event unrelated to study drug|4|||
126057683|NCT02066636|453505401|FG002|Overall Study|Adverse event unrelated to study drug|45|||
126057684|NCT02066636|453505399|FG000|Overall Study|Participant request to discontinue treatment|12|||
125892174|NCT02036853|452903125|FG001|Overall Study|Lack of Efficacy|2|||
125892175|NCT02036853|452903124|FG000|Overall Study|Physician Decision|0|||
125892176|NCT02036853|452903125|FG001|Overall Study|Physician Decision|1|||
125892177|NCT02036853|452903124|FG000|Overall Study|Withdrawal by Subject|0|||
125892178|NCT02036853|452903125|FG001|Overall Study|Withdrawal by Subject|1|||
125892179|NCT01742286|452903126|FG000|Escalation Phase|Administrative problems|1|||
126057685|NCT02066636|453505400|FG001|Overall Study|Participant request to discontinue treatment|12|||
126057686|NCT02066636|453505401|FG002|Overall Study|Participant request to discontinue treatment|70|||
125892180|NCT01742286|452903127|FG001|Escalation Phase|Administrative problems|1|||
125892181|NCT01742286|452903128|FG002|Escalation Phase|Administrative problems|0|||
125892182|NCT01742286|452903129|FG003|Escalation Phase|Administrative problems|0|||
125892183|NCT01742286|452903130|FG004|Escalation Phase|Administrative problems|0|||
125892184|NCT01742286|452903131|FG005|Escalation Phase|Administrative problems|0|||
125892185|NCT01742286|452903132|FG006|Escalation Phase|Administrative problems|2|||
125892186|NCT01742286|452903126|FG000|Escalation Phase|Adverse Event|0|||
125892187|NCT01742286|452903127|FG001|Escalation Phase|Adverse Event|1|||
125892188|NCT01742286|452903128|FG002|Escalation Phase|Adverse Event|2|||
125892189|NCT01742286|452903129|FG003|Escalation Phase|Adverse Event|0|||
125892190|NCT01742286|452903130|FG004|Escalation Phase|Adverse Event|0|||
125892191|NCT01742286|452903131|FG005|Escalation Phase|Adverse Event|1|||
125892192|NCT01742286|452903132|FG006|Escalation Phase|Adverse Event|0|||
125892193|NCT01742286|452903126|FG000|Escalation Phase|Disease progression|3|||
125892194|NCT01742286|452903127|FG001|Escalation Phase|Disease progression|7|||
125892195|NCT01742286|452903128|FG002|Escalation Phase|Disease progression|4|||
125892196|NCT01742286|452903129|FG003|Escalation Phase|Disease progression|1|||
125892197|NCT01742286|452903130|FG004|Escalation Phase|Disease progression|4|||
125892198|NCT01742286|452903131|FG005|Escalation Phase|Disease progression|3|||
125892199|NCT01742286|452903132|FG006|Escalation Phase|Disease progression|2|||
125892200|NCT01742286|452903126|FG000|Escalation Phase|Death|0|||
125892201|NCT01742286|452903127|FG001|Escalation Phase|Death|0|||
125892202|NCT01742286|452903128|FG002|Escalation Phase|Death|0|||
125892203|NCT01742286|452903129|FG003|Escalation Phase|Death|0|||
125892204|NCT01742286|452903130|FG004|Escalation Phase|Death|0|||
125892205|NCT01742286|452903131|FG005|Escalation Phase|Death|1|||
126106727|NCT02903368|453682964|FG002|Part 2|Adverse Event|5|||
126106728|NCT02903368|453682965|FG003|Part 2|Adverse Event|0|||
125892206|NCT01742286|452903132|FG006|Escalation Phase|Death|0|||
125892207|NCT01742286|452903126|FG000|Escalation Phase|Physician Decision|0|||
125892208|NCT01742286|452903127|FG001|Escalation Phase|Physician Decision|3|||
125892209|NCT01742286|452903128|FG002|Escalation Phase|Physician Decision|0|||
125892210|NCT01742286|452903129|FG003|Escalation Phase|Physician Decision|1|||
125892211|NCT01742286|452903130|FG004|Escalation Phase|Physician Decision|0|||
125892212|NCT01742286|452903131|FG005|Escalation Phase|Physician Decision|0|||
125892213|NCT01742286|452903132|FG006|Escalation Phase|Physician Decision|2|||
125892214|NCT01742286|452903126|FG000|Escalation Phase|Subject/guardian decision|1|||
125892215|NCT01742286|452903127|FG001|Escalation Phase|Subject/guardian decision|0|||
125892216|NCT01742286|452903128|FG002|Escalation Phase|Subject/guardian decision|0|||
125892217|NCT01742286|452903129|FG003|Escalation Phase|Subject/guardian decision|0|||
125892218|NCT01742286|452903130|FG004|Escalation Phase|Subject/guardian decision|0|||
125892219|NCT01742286|452903131|FG005|Escalation Phase|Subject/guardian decision|0|||
125892220|NCT01742286|452903132|FG006|Escalation Phase|Subject/guardian decision|0|||
125892221|NCT01742286|452903126|FG000|Expansion Phase|Administrative problems|0|||
125892222|NCT01742286|452903127|FG001|Expansion Phase|Administrative problems|0|||
125892223|NCT01742286|452903128|FG002|Expansion Phase|Administrative problems|0|||
126106729|NCT02903368|453682962|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
126106730|NCT02903368|453682963|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
126106731|NCT02903368|453682964|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
126106732|NCT02903368|453682965|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
125892224|NCT01742286|452903129|FG003|Expansion Phase|Administrative problems|0|||
125892225|NCT01742286|452903130|FG004|Expansion Phase|Administrative problems|0|||
125892226|NCT01742286|452903131|FG005|Expansion Phase|Administrative problems|0|||
125892227|NCT01742286|452903132|FG006|Expansion Phase|Administrative problems|5|||
125892228|NCT01742286|452903126|FG000|Expansion Phase|Physician Decision|0|||
125892229|NCT01742286|452903127|FG001|Expansion Phase|Physician Decision|0|||
126106733|NCT02903368|453682962|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
126106734|NCT02903368|453682963|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
126106735|NCT02903368|453682964|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
126106736|NCT02903368|453682965|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
126106737|NCT02903368|453682962|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
126106738|NCT02903368|453682963|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
126106739|NCT02903368|453682964|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
126106740|NCT02903368|453682965|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
126106741|NCT00171704|453684685|FG000|Overall Study|Adverse Event|24|||
126106742|NCT00171704|453684686|FG001|Overall Study|Adverse Event|33|||
126106743|NCT00171704|453684685|FG000|Overall Study|Disease Progression|14|||
126106744|NCT00171704|453684686|FG001|Overall Study|Disease Progression|9|||
126106745|NCT00171704|453684685|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
126106746|NCT00171704|453684686|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
126106747|NCT00171704|453684685|FG000|Overall Study|Administrative Problems|2|||
126106748|NCT00171704|453684686|FG001|Overall Study|Administrative Problems|1|||
126106749|NCT00171704|453684685|FG000|Overall Study|Death|2|||
126106750|NCT00171704|453684686|FG001|Overall Study|Death|2|||
126106751|NCT00171704|453684685|FG000|Overall Study|Withdrawal by Subject|1|||
126106752|NCT00171704|453684686|FG001|Overall Study|Withdrawal by Subject|3|||
126106753|NCT00171704|453684685|FG000|Overall Study|Protocol Violation|0|||
126106754|NCT00171704|453684686|FG001|Overall Study|Protocol Violation|1|||
126106755|NCT02141984|453684687|FG000|Overall Study|Lack of Efficacy|2|||
126106756|NCT00816400|453684691|FG000|Overall Study|Death|2|||
126106757|NCT00816400|453684692|FG001|Overall Study|Death|3|||
126106758|NCT00816400|453684693|FG002|Overall Study|Death|3|||
126106759|NCT00816400|453684694|FG003|Overall Study|Death|3|||
126106760|NCT00816400|453684695|FG004|Overall Study|Death|2|||
126106761|NCT00816400|453684696|FG005|Overall Study|Death|3|||
126106762|NCT00816400|453684697|FG006|Overall Study|Death|2|||
126106763|NCT00816400|453684698|FG007|Overall Study|Death|5|||
126106764|NCT00816400|453684699|FG008|Overall Study|Death|6|||
126106765|NCT00816400|453684691|FG000|Overall Study|In hospice care at the end of the study|0|||
126106766|NCT00816400|453684692|FG001|Overall Study|In hospice care at the end of the study|0|||
126106767|NCT00816400|453684693|FG002|Overall Study|In hospice care at the end of the study|2|||
126106768|NCT00816400|453684694|FG003|Overall Study|In hospice care at the end of the study|0|||
126106769|NCT00816400|453684695|FG004|Overall Study|In hospice care at the end of the study|0|||
126106770|NCT00816400|453684696|FG005|Overall Study|In hospice care at the end of the study|0|||
126106771|NCT00816400|453684697|FG006|Overall Study|In hospice care at the end of the study|0|||
126106772|NCT00816400|453684698|FG007|Overall Study|In hospice care at the end of the study|0|||
126106773|NCT00816400|453684699|FG008|Overall Study|In hospice care at the end of the study|0|||
126106774|NCT00081770|453684700|FG000|Overall Study|Adverse Event|130|||
126106775|NCT00081770|453684701|FG001|Overall Study|Adverse Event|98|||
126106776|NCT00081770|453684702|FG002|Overall Study|Adverse Event|136|||
126106777|NCT00081770|453684700|FG000|Overall Study|Lack of Efficacy|262|||
126106778|NCT00081770|453684701|FG001|Overall Study|Lack of Efficacy|357|||
126106779|NCT00081770|453684702|FG002|Overall Study|Lack of Efficacy|211|||
126106780|NCT00081770|453684700|FG000|Overall Study|Lost to Follow-up|45|||
126106781|NCT00081770|453684701|FG001|Overall Study|Lost to Follow-up|34|||
126106782|NCT00081770|453684702|FG002|Overall Study|Lost to Follow-up|45|||
126106783|NCT00081770|453684700|FG000|Overall Study|Protocol Violation|15|||
126106784|NCT00081770|453684701|FG001|Overall Study|Protocol Violation|10|||
126106785|NCT00081770|453684702|FG002|Overall Study|Protocol Violation|10|||
126106786|NCT00081770|453684700|FG000|Overall Study|Withdrawal by Subject|45|||
126106787|NCT00081770|453684701|FG001|Overall Study|Withdrawal by Subject|40|||
126106788|NCT00081770|453684702|FG002|Overall Study|Withdrawal by Subject|42|||
126106789|NCT00081770|453684700|FG000|Overall Study|Did not meet protocol eligibility|2|||
126106790|NCT00081770|453684701|FG001|Overall Study|Did not meet protocol eligibility|0|||
126106791|NCT00081770|453684702|FG002|Overall Study|Did not meet protocol eligibility|3|||
126106792|NCT00081770|453684700|FG000|Overall Study|Administrative|1|||
126106793|NCT00081770|453684701|FG001|Overall Study|Administrative|0|||
126106794|NCT00081770|453684702|FG002|Overall Study|Administrative|1|||
126106795|NCT00081770|453684700|FG000|Overall Study|Other|2|||
126106796|NCT00081770|453684701|FG001|Overall Study|Other|7|||
126106797|NCT00081770|453684702|FG002|Overall Study|Other|8|||
126106798|NCT00601419|453684703|FG000|Overall Study|Lost to Follow-up|3|||
126106799|NCT00601419|453684703|FG000|Overall Study|Missed Visits|1|||
126106800|NCT01614197|453684704|FG000|Overall Study|Withdrawal by Subject|0|||
126057687|NCT02066636|453505399|FG000|Overall Study|Participant withdrew consent|10|||
126057688|NCT02066636|453505400|FG001|Overall Study|Participant withdrew consent|18|||
126057689|NCT02066636|453505401|FG002|Overall Study|Participant withdrew consent|61|||
126057690|NCT02066636|453505399|FG000|Overall Study|Lost to Follow-up|0|||
126057691|NCT02066636|453505400|FG001|Overall Study|Lost to Follow-up|2|||
126057692|NCT02066636|453505401|FG002|Overall Study|Lost to Follow-up|2|||
126057693|NCT02066636|453505399|FG000|Overall Study|Maximum clinical benefit|2|||
126057694|NCT02066636|453505400|FG001|Overall Study|Maximum clinical benefit|2|||
126057695|NCT02066636|453505401|FG002|Overall Study|Maximum clinical benefit|3|||
126057696|NCT02066636|453505399|FG000|Overall Study|Poor/non-compliance|2|||
126057697|NCT02066636|453505400|FG001|Overall Study|Poor/non-compliance|1|||
126057698|NCT02066636|453505401|FG002|Overall Study|Poor/non-compliance|1|||
126057699|NCT02066636|453505399|FG000|Overall Study|Participant no loner meets study criteria|3|||
126057700|NCT02066636|453505400|FG001|Overall Study|Participant no loner meets study criteria|2|||
126057701|NCT02066636|453505401|FG002|Overall Study|Participant no loner meets study criteria|28|||
126057702|NCT02066636|453505399|FG000|Overall Study|Administrative reasons by sponsor|8|||
126057703|NCT02066636|453505400|FG001|Overall Study|Administrative reasons by sponsor|5|||
126057704|NCT02066636|453505401|FG002|Overall Study|Administrative reasons by sponsor|0|||
126057705|NCT02066636|453505399|FG000|Overall Study|Other reasons|16|||
126057706|NCT02066636|453505400|FG001|Overall Study|Other reasons|15|||
126057707|NCT02066636|453505401|FG002|Overall Study|Other reasons|50|||
126057708|NCT02833948|453505403|FG000|Overall Study|Death|2|||
126057709|NCT02833948|453505404|FG001|Overall Study|Death|3|||
126057710|NCT02833948|453505403|FG000|Overall Study|were not scanned|8|||
126057711|NCT02833948|453505404|FG001|Overall Study|were not scanned|13|||
126057712|NCT02833948|453505403|FG000|Overall Study|scans could not be evaluated|5|||
126057713|NCT02833948|453505404|FG001|Overall Study|scans could not be evaluated|2|||
126057714|NCT02852824|453505407|FG000|Overall Study|Withdrawal by Subject|1|||
126057715|NCT02852824|453505408|FG001|Overall Study|Withdrawal by Subject|0|||
126057716|NCT02852824|453505409|FG002|Overall Study|Withdrawal by Subject|0|||
126057717|NCT02852824|453505410|FG003|Overall Study|Withdrawal by Subject|0|||
126057718|NCT02852824|453505411|FG004|Overall Study|Withdrawal by Subject|0|||
126057719|NCT02852824|453505412|FG005|Overall Study|Withdrawal by Subject|0|||
126057720|NCT02852824|453505413|FG006|Overall Study|Withdrawal by Subject|0|||
126057721|NCT02852824|453505407|FG000|Overall Study|Adverse Event|0|||
126057722|NCT02852824|453505408|FG001|Overall Study|Adverse Event|0|||
126057723|NCT02852824|453505409|FG002|Overall Study|Adverse Event|0|||
126057724|NCT02852824|453505410|FG003|Overall Study|Adverse Event|0|||
126057725|NCT02852824|453505411|FG004|Overall Study|Adverse Event|2|||
126057726|NCT02852824|453505412|FG005|Overall Study|Adverse Event|0|||
126057727|NCT02852824|453505413|FG006|Overall Study|Adverse Event|0|||
126057728|NCT00680771|453505414|FG000|Overall Study|Withdrawal by Subject|1|||
126057729|NCT00680771|453505415|FG001|Overall Study|Withdrawal by Subject|0|||
126057730|NCT00680771|453505414|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
126057731|NCT00680771|453505415|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
126057732|NCT00680771|453505414|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
126057733|NCT00680771|453505415|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
126057734|NCT02521493|453505419|FG000|Overall Study|Death|3|||
126057735|NCT02521493|453505420|FG001|Overall Study|Death|4|||
126057736|NCT02521493|453505421|FG002|Overall Study|Death|1|||
126057737|NCT02521493|453505419|FG000|Overall Study|Physician Decision|19|||
126057738|NCT02521493|453505420|FG001|Overall Study|Physician Decision|1|||
126057739|NCT02521493|453505421|FG002|Overall Study|Physician Decision|2|||
126057740|NCT02521493|453505419|FG000|Overall Study|Withdrawal by Subject|3|||
126057741|NCT02521493|453505420|FG001|Overall Study|Withdrawal by Subject|0|||
126057742|NCT02521493|453505421|FG002|Overall Study|Withdrawal by Subject|0|||
126057743|NCT02521493|453505419|FG000|Overall Study|Ineligible|0|||
126057744|NCT02521493|453505420|FG001|Overall Study|Ineligible|1|||
126057745|NCT02521493|453505421|FG002|Overall Study|Ineligible|0|||
126057746|NCT02521493|453505419|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
126057747|NCT02521493|453505420|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
126057748|NCT02521493|453505421|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
126057749|NCT02521493|453505419|FG000|Overall Study|No MRD result|0|||
126057750|NCT02521493|453505420|FG001|Overall Study|No MRD result|0|||
126057751|NCT02521493|453505421|FG002|Overall Study|No MRD result|4|||
126057752|NCT04748341|453505422|FG000|Overall Study|Lost to Follow-up|1|||
126057753|NCT04748341|453505423|FG001|Overall Study|Lost to Follow-up|1|||
126057754|NCT03769090|453506852|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
126057755|NCT03769090|453506853|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
126057756|NCT03769090|453506854|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
126057757|NCT03769090|453506852|FG000|Overall Study|Withdrawal by Subject|52|||
126057758|NCT03769090|453506853|FG001|Overall Study|Withdrawal by Subject|62|||
126057759|NCT03769090|453506854|FG002|Overall Study|Withdrawal by Subject|74|||
126057760|NCT03769090|453506852|FG000|Overall Study|Death|4|||
126057761|NCT03769090|453506853|FG001|Overall Study|Death|2|||
126057762|NCT03769090|453506854|FG002|Overall Study|Death|2|||
126057763|NCT03769090|453506852|FG000|Overall Study|Adverse Event|7|||
126057764|NCT03769090|453506853|FG001|Overall Study|Adverse Event|7|||
126057765|NCT03769090|453506854|FG002|Overall Study|Adverse Event|8|||
126057766|NCT03769090|453506852|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
126057767|NCT03769090|453506853|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
126057768|NCT03769090|453506854|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
126057769|NCT03769090|453506852|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
126057770|NCT03769090|453506853|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
126057771|NCT03769090|453506854|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
126057772|NCT03769090|453506852|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
126057773|NCT03769090|453506853|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
126057774|NCT03769090|453506854|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
126057775|NCT03769090|453506852|FG000|Overall Study|Protocol Violation|5|||
126057776|NCT03769090|453506853|FG001|Overall Study|Protocol Violation|6|||
126057777|NCT03769090|453506854|FG002|Overall Study|Protocol Violation|8|||
126057778|NCT03769090|453506852|FG000|Overall Study|Pregnancy|1|||
126057779|NCT03769090|453506853|FG001|Overall Study|Pregnancy|0|||
126057780|NCT03769090|453506854|FG002|Overall Study|Pregnancy|3|||
126057781|NCT03769090|453506852|FG000|Overall Study|Lost to Follow-up|19|||
126057782|NCT03769090|453506853|FG001|Overall Study|Lost to Follow-up|25|||
126057783|NCT03769090|453506854|FG002|Overall Study|Lost to Follow-up|21|||
126057784|NCT03769090|453506852|FG000|Overall Study|Condition under investigation worsened|2|||
126057785|NCT03769090|453506853|FG001|Overall Study|Condition under investigation worsened|0|||
126057786|NCT03769090|453506854|FG002|Overall Study|Condition under investigation worsened|1|||
126057787|NCT03769090|453506852|FG000|Overall Study|Lack of Efficacy|1|||
126057788|NCT03769090|453506853|FG001|Overall Study|Lack of Efficacy|2|||
126057789|NCT03769090|453506854|FG002|Overall Study|Lack of Efficacy|2|||
126057790|NCT03769090|453506852|FG000|Overall Study|Other reasons|8|||
126057791|NCT03769090|453506853|FG001|Overall Study|Other reasons|12|||
126057792|NCT03769090|453506854|FG002|Overall Study|Other reasons|15|||
126057793|NCT00799409|453506855|FG000|Overall Study|Withdrawal by Subject|1|||
126057794|NCT00799409|453506856|FG001|Overall Study|Withdrawal by Subject|0|||
126057795|NCT00799409|453506857|FG002|Overall Study|Withdrawal by Subject|0|||
126057796|NCT00799409|453506855|FG000|Overall Study|Lost to Follow-up|1|||
126057797|NCT00799409|453506856|FG001|Overall Study|Lost to Follow-up|0|||
126057798|NCT00799409|453506857|FG002|Overall Study|Lost to Follow-up|0|||
126057799|NCT00799409|453506855|FG000|Overall Study|Optimal Dose Not Achieved|2|||
126057800|NCT00799409|453506856|FG001|Overall Study|Optimal Dose Not Achieved|0|||
126057801|NCT00799409|453506857|FG002|Overall Study|Optimal Dose Not Achieved|0|||
126057802|NCT00799409|453506855|FG000|Overall Study|Failure to follow study protocol)|1|||
126057803|NCT00799409|453506856|FG001|Overall Study|Failure to follow study protocol)|0|||
126057804|NCT00799409|453506857|FG002|Overall Study|Failure to follow study protocol)|0|||
126057805|NCT00799409|453506855|FG000|Overall Study|Did not attend lab school day 1|1|||
126057806|NCT00799409|453506856|FG001|Overall Study|Did not attend lab school day 1|0|||
126057807|NCT00799409|453506857|FG002|Overall Study|Did not attend lab school day 1|0|||
126057808|NCT00799409|453506855|FG000|Overall Study|medication compliance|1|||
126057809|NCT00799409|453506856|FG001|Overall Study|medication compliance|0|||
126057810|NCT00799409|453506857|FG002|Overall Study|medication compliance|0|||
126057811|NCT00443820|453506858|FG000|Overall Study|Adverse Event|1|||
126057812|NCT00443820|453506859|FG001|Overall Study|Adverse Event|1|||
126057813|NCT00443820|453506860|FG002|Overall Study|Adverse Event|0|||
126057814|NCT00443820|453506861|FG003|Overall Study|Adverse Event|0|||
126057815|NCT00443820|453506858|FG000|Overall Study|Lack of Efficacy|3|||
126057816|NCT00443820|453506859|FG001|Overall Study|Lack of Efficacy|2|||
126057817|NCT00443820|453506860|FG002|Overall Study|Lack of Efficacy|1|||
126057818|NCT00443820|453506861|FG003|Overall Study|Lack of Efficacy|1|||
126057819|NCT00443820|453506858|FG000|Overall Study|Protocol Violation|2|||
126057820|NCT00443820|453506859|FG001|Overall Study|Protocol Violation|1|||
126057821|NCT00443820|453506860|FG002|Overall Study|Protocol Violation|2|||
126057822|NCT00443820|453506861|FG003|Overall Study|Protocol Violation|1|||
126057823|NCT00443820|453506858|FG000|Overall Study|Withdrawal by Subject|6|||
126057824|NCT00443820|453506859|FG001|Overall Study|Withdrawal by Subject|7|||
126057825|NCT00443820|453506860|FG002|Overall Study|Withdrawal by Subject|8|||
126057826|NCT00443820|453506861|FG003|Overall Study|Withdrawal by Subject|9|||
126057827|NCT00443820|453506858|FG000|Overall Study|Lost to Follow-up|9|||
126057828|NCT00443820|453506859|FG001|Overall Study|Lost to Follow-up|8|||
126057829|NCT00443820|453506860|FG002|Overall Study|Lost to Follow-up|6|||
126057830|NCT00443820|453506861|FG003|Overall Study|Lost to Follow-up|5|||
126057831|NCT00443820|453506858|FG000|Overall Study|Administrative problems|0|||
126057832|NCT00443820|453506859|FG001|Overall Study|Administrative problems|0|||
126057833|NCT00443820|453506860|FG002|Overall Study|Administrative problems|0|||
126057834|NCT00443820|453506861|FG003|Overall Study|Administrative problems|1|||
126057835|NCT00443820|453506858|FG000|Overall Study|Death|0|||
126057836|NCT00443820|453506859|FG001|Overall Study|Death|0|||
126057837|NCT00443820|453506860|FG002|Overall Study|Death|1|||
126057838|NCT00443820|453506861|FG003|Overall Study|Death|0|||
126057839|NCT04633200|453506862|FG000|Overall Study|Lost to Follow-up|3|||
126057840|NCT04633200|453506863|FG001|Overall Study|Lost to Follow-up|5|||
126057841|NCT02713594|453506864|FG000|Overall Study|Withdrawal by Subject|32|||
126057842|NCT02713594|453506865|FG001|Overall Study|Withdrawal by Subject|22|||
126057843|NCT02713594|453506864|FG000|Overall Study|Lost to Follow-up|358|||
126106801|NCT01614197|453684705|FG001|Overall Study|Withdrawal by Subject|1|||
126057844|NCT02713594|453506865|FG001|Overall Study|Lost to Follow-up|374|||
126057845|NCT00670449|453506866|FG000|Overall Study|Adverse Event|6|||
126106802|NCT01614197|453684706|FG002|Overall Study|Withdrawal by Subject|0|||
126057846|NCT00670449|453506867|FG001|Overall Study|Adverse Event|2|||
126057847|NCT00670449|453506868|FG002|Overall Study|Adverse Event|8|||
126057848|NCT00670449|453506869|FG003|Overall Study|Adverse Event|5|||
126057849|NCT00670449|453506866|FG000|Overall Study|Protocol Deviation|1|||
126057850|NCT00670449|453506867|FG001|Overall Study|Protocol Deviation|2|||
126057851|NCT00670449|453506868|FG002|Overall Study|Protocol Deviation|0|||
126057852|NCT00670449|453506869|FG003|Overall Study|Protocol Deviation|1|||
126057853|NCT00670449|453506866|FG000|Overall Study|Administrative Problems|0|||
126057854|NCT00670449|453506867|FG001|Overall Study|Administrative Problems|2|||
126057855|NCT00670449|453506868|FG002|Overall Study|Administrative Problems|0|||
126057856|NCT00670449|453506869|FG003|Overall Study|Administrative Problems|1|||
126057857|NCT00670449|453506866|FG000|Overall Study|Subject Withdrew Consent|0|||
126057858|NCT00670449|453506867|FG001|Overall Study|Subject Withdrew Consent|2|||
126057859|NCT00670449|453506868|FG002|Overall Study|Subject Withdrew Consent|0|||
126057860|NCT00670449|453506869|FG003|Overall Study|Subject Withdrew Consent|1|||
126057861|NCT00670449|453506866|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
126057862|NCT00670449|453506867|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126057863|NCT00670449|453506868|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126057864|NCT00670449|453506869|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126057865|NCT00670449|453506866|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
126057866|NCT00670449|453506867|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
126057867|NCT00670449|453506868|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
126057868|NCT00670449|453506869|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
126057869|NCT02771366|453506870|FG000|Period 1|Withdrawal by Subject|0|||
126057870|NCT02771366|453506871|FG001|Period 1|Withdrawal by Subject|2|||
126057871|NCT02771366|453506870|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
126057872|NCT02771366|453506871|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
126057873|NCT00671853|453506874|FG000|Overall Study|Lack of Efficacy|3|||
126057874|NCT00671853|453506875|FG001|Overall Study|Lack of Efficacy|7|||
126057875|NCT00671853|453506874|FG000|Overall Study|Adverse Event|7|||
126057876|NCT00671853|453506875|FG001|Overall Study|Adverse Event|1|||
126057877|NCT00671853|453506874|FG000|Overall Study|Withdrawal by Subject|1|||
126057878|NCT00671853|453506875|FG001|Overall Study|Withdrawal by Subject|5|||
126057879|NCT00671853|453506874|FG000|Overall Study|Lost to Follow-up|8|||
126057880|NCT00671853|453506875|FG001|Overall Study|Lost to Follow-up|8|||
126057881|NCT00671853|453506874|FG000|Overall Study|Physician Decision|0|||
126057882|NCT00671853|453506875|FG001|Overall Study|Physician Decision|2|||
126057883|NCT00671853|453506874|FG000|Overall Study|Non-adherence with study procedures|1|||
126057884|NCT00671853|453506875|FG001|Overall Study|Non-adherence with study procedures|4|||
126057885|NCT00587171|453506877|FG000|Overall Study|Lost to Follow-up|1|||
126057886|NCT00587171|453506878|FG001|Overall Study|Lost to Follow-up|1|||
126057887|NCT01848483|453506879|FG000|Overall Study|Death|2|||
126057888|NCT01848483|453506880|FG001|Overall Study|Death|1|||
126057889|NCT01848483|453506879|FG000|Overall Study|Lost to Follow-up|6|||
126057890|NCT01848483|453506880|FG001|Overall Study|Lost to Follow-up|8|||
126057891|NCT01848483|453506879|FG000|Overall Study|Withdrawal by Subject|1|||
126057892|NCT01848483|453506880|FG001|Overall Study|Withdrawal by Subject|0|||
126057893|NCT01848483|453506879|FG000|Overall Study|Incarceration|2|||
126057894|NCT01848483|453506880|FG001|Overall Study|Incarceration|2|||
126057895|NCT01148017|453506881|FG000|Overall Study|Withdrawal by Subject|31|||
126057896|NCT01148017|453506882|FG001|Overall Study|Withdrawal by Subject|14|||
126057897|NCT01148017|453506883|FG002|Overall Study|Withdrawal by Subject|0|||
126057898|NCT01148017|453506884|FG003|Overall Study|Withdrawal by Subject|0|||
126057899|NCT01148017|453506881|FG000|Overall Study|Lost to Follow-up|23|||
126057900|NCT01148017|453506882|FG001|Overall Study|Lost to Follow-up|10|||
126057901|NCT01148017|453506883|FG002|Overall Study|Lost to Follow-up|0|||
126057902|NCT01148017|453506884|FG003|Overall Study|Lost to Follow-up|0|||
126057903|NCT01148017|453506881|FG000|Overall Study|Inappropriate enrollment|1|||
126057904|NCT01148017|453506882|FG001|Overall Study|Inappropriate enrollment|0|||
126057905|NCT01148017|453506883|FG002|Overall Study|Inappropriate enrollment|0|||
126057906|NCT01148017|453506884|FG003|Overall Study|Inappropriate enrollment|0|||
126057907|NCT01148017|453506881|FG000|Overall Study|Administrative reason|22|||
126057908|NCT01148017|453506882|FG001|Overall Study|Administrative reason|9|||
126057909|NCT01148017|453506883|FG002|Overall Study|Administrative reason|0|||
126057910|NCT01148017|453506884|FG003|Overall Study|Administrative reason|0|||
126057911|NCT01148017|453506881|FG000|Overall Study|Unable to classify|3|||
126057912|NCT01148017|453506882|FG001|Overall Study|Unable to classify|1|||
126057913|NCT01148017|453506883|FG002|Overall Study|Unable to classify|0|||
126057914|NCT01148017|453506884|FG003|Overall Study|Unable to classify|0|||
126057915|NCT03928743|453506885|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
126057916|NCT03928743|453506886|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
126057917|NCT03928743|453506887|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
126057918|NCT03928743|453506885|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
126057919|NCT03928743|453506886|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
126057920|NCT03928743|453506887|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
126057921|NCT03928743|453506885|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
126057922|NCT03928743|453506886|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
126057923|NCT03928743|453506887|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
126106803|NCT01614197|453684707|FG003|Overall Study|Withdrawal by Subject|0|||
126106804|NCT02245672|453684708|FG000|Overall Study|Adverse Event|4|||
126106805|NCT02245672|453684709|FG001|Overall Study|Adverse Event|4|||
126106806|NCT02245672|453684710|FG002|Overall Study|Adverse Event|4|||
126106807|NCT02245672|453684708|FG000|Overall Study|Lost to Follow-up|3|||
126106808|NCT02245672|453684709|FG001|Overall Study|Lost to Follow-up|5|||
126106809|NCT02245672|453684710|FG002|Overall Study|Lost to Follow-up|1|||
126106810|NCT02245672|453684708|FG000|Overall Study|Withdrawal by Subject|6|||
126106811|NCT02245672|453684709|FG001|Overall Study|Withdrawal by Subject|3|||
126106812|NCT02245672|453684710|FG002|Overall Study|Withdrawal by Subject|0|||
126106813|NCT02245672|453684708|FG000|Overall Study|Randomized in error (not treated)|0|||
126106814|NCT02245672|453684709|FG001|Overall Study|Randomized in error (not treated)|1|||
126106815|NCT02245672|453684710|FG002|Overall Study|Randomized in error (not treated)|0|||
126106816|NCT00971932|453684711|FG000|Overall Study|Withdrawal by Subject|1|||
126106817|NCT00971932|453684711|FG000|Overall Study|Investigator's decision|2|||
126106818|NCT00971932|453684711|FG000|Overall Study|Ongoing|4|||
126106819|NCT01765192|453684714|FG000|Treatment Period 1|Adverse Event|0|||
126106820|NCT01765192|453684715|FG001|Treatment Period 1|Adverse Event|1|||
126106821|NCT01765192|453684714|FG000|Washout Period|Voluntary Withdrawal|1|||
126106822|NCT01765192|453684715|FG001|Washout Period|Voluntary Withdrawal|1|||
126106823|NCT01765192|453684714|FG000|Washout Period|Reason not specified|1|||
126106824|NCT01765192|453684715|FG001|Washout Period|Reason not specified|0|||
126106825|NCT01765192|453684714|FG000|Treatment Period 2|Reason not specified|0|||
126106826|NCT01765192|453684715|FG001|Treatment Period 2|Reason not specified|2|||
126106827|NCT01765192|453684714|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
126106828|NCT01765192|453684715|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
126106829|NCT00876694|453684720|FG000|Overall Study|Adverse Event|10|||
126106830|NCT00876694|453684721|FG001|Overall Study|Adverse Event|7|||
126106831|NCT00876694|453684720|FG000|Overall Study|Subject withdrew consent|6|||
126106832|NCT00876694|453684721|FG001|Overall Study|Subject withdrew consent|4|||
126106833|NCT00876694|453684720|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126106834|NCT00876694|453684721|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126106835|NCT00876694|453684720|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126106836|NCT00876694|453684721|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126106837|NCT00876694|453684720|FG000|Overall Study|Administrative problems|1|||
126106838|NCT00876694|453684721|FG001|Overall Study|Administrative problems|1|||
126106839|NCT00876694|453684720|FG000|Overall Study|Death|1|||
126106840|NCT00876694|453684721|FG001|Overall Study|Death|0|||
126106841|NCT01215422|453684726|FG000|Overall Study|Relocation|1|||
125892230|NCT01742286|452903128|FG002|Expansion Phase|Physician Decision|4|||
125892231|NCT01742286|452903129|FG003|Expansion Phase|Physician Decision|0|||
125892232|NCT01742286|452903130|FG004|Expansion Phase|Physician Decision|0|||
125892233|NCT01742286|452903131|FG005|Expansion Phase|Physician Decision|0|||
125892234|NCT01742286|452903132|FG006|Expansion Phase|Physician Decision|9|||
125892235|NCT01742286|452903126|FG000|Expansion Phase|Adverse Event|0|||
125892236|NCT01742286|452903127|FG001|Expansion Phase|Adverse Event|0|||
125892237|NCT01742286|452903128|FG002|Expansion Phase|Adverse Event|0|||
125892238|NCT01742286|452903129|FG003|Expansion Phase|Adverse Event|0|||
125892239|NCT01742286|452903130|FG004|Expansion Phase|Adverse Event|0|||
125892240|NCT01742286|452903131|FG005|Expansion Phase|Adverse Event|0|||
125892241|NCT01742286|452903132|FG006|Expansion Phase|Adverse Event|6|||
125892242|NCT01742286|452903126|FG000|Expansion Phase|Disease progression|0|||
125892243|NCT01742286|452903127|FG001|Expansion Phase|Disease progression|0|||
125892244|NCT01742286|452903128|FG002|Expansion Phase|Disease progression|3|||
125892245|NCT01742286|452903129|FG003|Expansion Phase|Disease progression|0|||
125892246|NCT01742286|452903130|FG004|Expansion Phase|Disease progression|0|||
125892247|NCT01742286|452903131|FG005|Expansion Phase|Disease progression|0|||
125892248|NCT01742286|452903132|FG006|Expansion Phase|Disease progression|15|||
125892249|NCT01742286|452903126|FG000|Expansion Phase|Withdrawal by Subject|0|||
125892250|NCT01742286|452903127|FG001|Expansion Phase|Withdrawal by Subject|0|||
125892251|NCT01742286|452903128|FG002|Expansion Phase|Withdrawal by Subject|0|||
125892252|NCT01742286|452903129|FG003|Expansion Phase|Withdrawal by Subject|0|||
125892253|NCT01742286|452903130|FG004|Expansion Phase|Withdrawal by Subject|0|||
125892254|NCT01742286|452903131|FG005|Expansion Phase|Withdrawal by Subject|0|||
125892255|NCT01742286|452903132|FG006|Expansion Phase|Withdrawal by Subject|1|||
125892256|NCT02633020|452903133|FG000|Overall Study|Adverse Event|1|||
125892257|NCT02633020|452903134|FG001|Overall Study|Adverse Event|0|||
125892258|NCT01136785|452903135|FG000|Overall Study|Protocol Violation|2|||
125892259|NCT01136785|452903136|FG001|Overall Study|Protocol Violation|1|||
125892260|NCT02954172|452903137|FG000|Overall Study|Protocol Violation|3|||
125892261|NCT02954172|452903138|FG001|Overall Study|Protocol Violation|0|||
125892262|NCT02954172|452903137|FG000|Overall Study|allergic reaction|2|||
125892263|NCT02954172|452903138|FG001|Overall Study|allergic reaction|1|||
125892264|NCT02954172|452903137|FG000|Overall Study|non-measurable lesions at baseline|1|||
125892265|NCT02954172|452903138|FG001|Overall Study|non-measurable lesions at baseline|2|||
125892266|NCT00853567|452903141|FG000|Overall Study|Study prematurely terminated|71|||
125892267|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
125892268|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
125892269|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
125892270|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
125892271|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
125892272|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
125892273|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
125892274|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
125892275|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
125892276|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
125892277|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
125892278|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
125892279|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
125892280|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
125892281|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
126106842|NCT01215422|453684727|FG001|Overall Study|Relocation|0|||
126106843|NCT01215422|453684728|FG002|Overall Study|Relocation|0|||
126106844|NCT01215422|453684729|FG003|Overall Study|Relocation|0|||
126106845|NCT01215422|453684726|FG000|Overall Study|Failed intubations|0|||
126106846|NCT01215422|453684727|FG001|Overall Study|Failed intubations|0|||
125892282|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
125892283|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
125892284|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
125892285|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
125892286|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
125892287|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
125892288|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
126106847|NCT01215422|453684728|FG002|Overall Study|Failed intubations|3|||
125892289|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
125892290|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
125892291|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
125892292|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
126106848|NCT01215422|453684729|FG003|Overall Study|Failed intubations|8|||
126106849|NCT01215422|453684726|FG000|Overall Study|Did not complete all intubations|7|||
126057924|NCT03928743|453506885|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
126057925|NCT03928743|453506886|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
126057926|NCT03928743|453506887|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
126057927|NCT03928743|453506885|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
126057928|NCT03928743|453506886|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
126057929|NCT03928743|453506887|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
126057930|NCT03928743|453506885|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
126057931|NCT03928743|453506886|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
126057932|NCT03928743|453506887|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
126057933|NCT03928743|453506885|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
126057934|NCT03928743|453506886|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
126057935|NCT03928743|453506887|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
126057936|NCT03928743|453506885|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
125892293|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
125892294|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
125892295|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
125892296|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
125892297|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
125892298|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
125892299|NCT03818035|452903142|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
125892300|NCT03818035|452903143|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
126057937|NCT03928743|453506886|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
125892301|NCT03818035|452903144|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
125892302|NCT03818035|452903145|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
125892303|NCT03818035|452903142|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
125892304|NCT03818035|452903143|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
126057938|NCT03928743|453506887|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
126057939|NCT03928743|453506885|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
126057940|NCT03928743|453506886|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
126057941|NCT03928743|453506887|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
126057942|NCT03928743|453506885|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
126057943|NCT03928743|453506886|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
126057944|NCT03928743|453506887|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
126057945|NCT03928743|453506885|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
126057946|NCT03928743|453506886|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
126057947|NCT03928743|453506887|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
126057948|NCT01779050|453506888|FG000|Overall Study|Withdrawal by Subject|1|||
126057949|NCT01779050|453506889|FG001|Overall Study|Withdrawal by Subject|0|||
126057950|NCT02392507|453506890|FG000|Induction Regimen|Death|3|||
126057951|NCT02392507|453506890|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
126057952|NCT02392507|453506890|FG000|Induction Regimen|Physician Decision|1|||
126057953|NCT02392507|453506890|FG000|Induction Regimen|Withdrawal by Subject|2|||
126057954|NCT02392507|453506890|FG000|Maintenance Regimen|Death|1|||
126057955|NCT02392507|453506890|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
126057956|NCT02224755|453506891|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
126057957|NCT02224755|453506892|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
126057958|NCT02224755|453506891|FG000|Two Year Follow up Post-implant|Death|103|||
126057959|NCT02224755|453506892|FG001|Two Year Follow up Post-implant|Death|98|||
126057960|NCT02224755|453506891|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
126057961|NCT02224755|453506892|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
126057962|NCT02224755|453506891|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
126057963|NCT02224755|453506892|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
126057964|NCT02224755|453506891|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
126057965|NCT02224755|453506892|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
126057966|NCT01829711|453506893|FG000|Overall Study|Lost to Follow-up|2|||
126106850|NCT01215422|453684727|FG001|Overall Study|Did not complete all intubations|0|||
126106851|NCT01215422|453684728|FG002|Overall Study|Did not complete all intubations|0|||
126106852|NCT01215422|453684729|FG003|Overall Study|Did not complete all intubations|0|||
126106853|NCT00294554|453684732|FG000|Overall Study|Lack of Efficacy|0|||
126106854|NCT00294554|453684733|FG001|Overall Study|Lack of Efficacy|1|||
126106855|NCT00294554|453684732|FG000|Overall Study|Physician Decision|0|||
126106856|NCT00294554|453684733|FG001|Overall Study|Physician Decision|1|||
126106857|NCT00462865|453684734|FG000|Overall Study|Adverse Event|1|||
126106858|NCT02864381|453684735|FG000|Overall Study|Death|58|||
126106859|NCT02864381|453684736|FG001|Overall Study|Death|61|||
126106860|NCT02864381|453684735|FG000|Overall Study|Withdrew Consent|5|||
126106861|NCT02864381|453684736|FG001|Overall Study|Withdrew Consent|6|||
126106862|NCT02864381|453684735|FG000|Overall Study|Reason Unknown|7|||
126106863|NCT02864381|453684736|FG001|Overall Study|Reason Unknown|3|||
126106864|NCT02864381|453684735|FG000|Overall Study|Lost to Follow-up|1|||
126106865|NCT02864381|453684736|FG001|Overall Study|Lost to Follow-up|1|||
126106866|NCT02864381|453684735|FG000|Overall Study|Investigator's Discretion|1|||
126106867|NCT02864381|453684736|FG001|Overall Study|Investigator's Discretion|0|||
126106868|NCT02864381|453684735|FG000|Overall Study|Protocol Violation|0|||
125892305|NCT03818035|452903144|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
125892306|NCT03818035|452903145|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
125892307|NCT03818035|452903142|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
125892308|NCT03818035|452903143|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
125892309|NCT03818035|452903144|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
125892310|NCT03818035|452903145|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
125892311|NCT03818035|452903142|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
125892312|NCT03818035|452903143|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
125892313|NCT03818035|452903144|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
125892314|NCT03818035|452903145|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
125892315|NCT03818035|452903142|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
125892316|NCT03818035|452903143|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
125892317|NCT03818035|452903144|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
125892318|NCT03818035|452903145|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
125892319|NCT03818035|452903142|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
125892320|NCT03818035|452903143|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
125892321|NCT03818035|452903144|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
125892322|NCT03818035|452903145|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
125892323|NCT03818035|452903142|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
125892324|NCT03818035|452903143|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
125892325|NCT03818035|452903144|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
125892326|NCT03818035|452903145|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
125892327|NCT03374202|452903148|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
125892328|NCT03374202|452903149|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
125892329|NCT03374202|452903150|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
125892330|NCT03374202|452903148|FG000|Five Year Long Term Follow Up|Death|0|||
125892331|NCT03374202|452903149|FG001|Five Year Long Term Follow Up|Death|1|||
125892332|NCT03374202|452903150|FG002|Five Year Long Term Follow Up|Death|0|||
125892333|NCT01395524|452904647|FG000|Overall Study|Non-compliance with study schedule|1|||
125892334|NCT01395524|452904648|FG001|Overall Study|Non-compliance with study schedule|0|||
125892335|NCT01395524|452904649|FG002|Overall Study|Non-compliance with study schedule|1|||
125892336|NCT01395524|452904647|FG000|Overall Study|Lost to Follow-up|3|||
125892337|NCT01395524|452904648|FG001|Overall Study|Lost to Follow-up|1|||
125892338|NCT01395524|452904649|FG002|Overall Study|Lost to Follow-up|1|||
125892339|NCT01395524|452904647|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
125892340|NCT01395524|452904648|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
125892341|NCT01395524|452904649|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
125892342|NCT01395524|452904647|FG000|Overall Study|Severe noncompliance with protocol|1|||
125892343|NCT01395524|452904648|FG001|Overall Study|Severe noncompliance with protocol|0|||
125892344|NCT01395524|452904649|FG002|Overall Study|Severe noncompliance with protocol|0|||
125892345|NCT01395524|452904647|FG000|Overall Study|Adverse Event|4|||
125892346|NCT01395524|452904648|FG001|Overall Study|Adverse Event|4|||
125892347|NCT01395524|452904649|FG002|Overall Study|Adverse Event|3|||
125892348|NCT01395524|452904647|FG000|Overall Study|Death|1|||
126106869|NCT02864381|453684736|FG001|Overall Study|Protocol Violation|1|||
126106870|NCT04142450|453684737|FG000|Overall Study|Screen Failure|1|||
126106871|NCT04142450|453684737|FG000|Overall Study|Lost to Follow-up|1|||
125892349|NCT01395524|452904648|FG001|Overall Study|Death|0|||
125892350|NCT01395524|452904649|FG002|Overall Study|Death|0|||
125892351|NCT01395524|452904647|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
125892352|NCT01395524|452904648|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125892353|NCT01395524|452904649|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125892354|NCT01395524|452904647|FG000|Overall Study|Withdrawal by Subject|4|||
126106872|NCT01146054|453684738|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
126106873|NCT01146054|453684738|FG000|Overall Study|Rapid tumor progression|2|||
126106874|NCT01146054|453684738|FG000|Overall Study|Other illness precluded treatment|2|||
126106875|NCT01146054|453684738|FG000|Overall Study|Lost to Follow-up|1|||
126106876|NCT04335812|453684739|FG000|Overall Study|Withdrawal by Subject|1|||
126106877|NCT04335812|453684740|FG001|Overall Study|Withdrawal by Subject|3|||
126106878|NCT04335812|453684739|FG000|Overall Study|Lost to Follow-up|12|||
126106879|NCT04335812|453684740|FG001|Overall Study|Lost to Follow-up|12|||
126106880|NCT04335812|453684739|FG000|Overall Study|Did not engage in the intervention|22|||
126106881|NCT04335812|453684740|FG001|Overall Study|Did not engage in the intervention|18|||
126106882|NCT03249714|453684751|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
126106883|NCT03249714|453684752|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
126106884|NCT03249714|453684751|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
126106885|NCT03249714|453684752|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
126106886|NCT03249714|453684751|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
126106887|NCT03249714|453684752|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
126106888|NCT03249714|453684751|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
126106889|NCT03249714|453684752|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
126106890|NCT01607554|453684760|FG000|Overall Study|Disease progression|2|||
126106891|NCT01139021|453684761|FG000|Overall Study|Adverse Event|0|||
126106892|NCT01139021|453684762|FG001|Overall Study|Adverse Event|0|||
126106893|NCT01139021|453684763|FG002|Overall Study|Adverse Event|0|||
126106894|NCT01139021|453684764|FG003|Overall Study|Adverse Event|0|||
126106895|NCT01139021|453684765|FG004|Overall Study|Adverse Event|1|||
126106896|NCT01139021|453684766|FG005|Overall Study|Adverse Event|0|||
126106897|NCT01139021|453684761|FG000|Overall Study|Lost to Follow-up|0|||
126106898|NCT01139021|453684762|FG001|Overall Study|Lost to Follow-up|0|||
126106899|NCT01139021|453684763|FG002|Overall Study|Lost to Follow-up|0|||
126106900|NCT01139021|453684764|FG003|Overall Study|Lost to Follow-up|0|||
126106901|NCT01139021|453684765|FG004|Overall Study|Lost to Follow-up|2|||
126106902|NCT01139021|453684766|FG005|Overall Study|Lost to Follow-up|0|||
126106903|NCT01139021|453684761|FG000|Overall Study|Protocol Violation|1|||
126106904|NCT01139021|453684762|FG001|Overall Study|Protocol Violation|0|||
126106905|NCT01139021|453684763|FG002|Overall Study|Protocol Violation|0|||
126106906|NCT01139021|453684764|FG003|Overall Study|Protocol Violation|0|||
126106907|NCT01139021|453684765|FG004|Overall Study|Protocol Violation|2|||
126106908|NCT01139021|453684766|FG005|Overall Study|Protocol Violation|0|||
126106909|NCT01139021|453684761|FG000|Overall Study|Withdrawal by Subject|0|||
126106910|NCT01139021|453684762|FG001|Overall Study|Withdrawal by Subject|0|||
126106911|NCT01139021|453684763|FG002|Overall Study|Withdrawal by Subject|0|||
126106912|NCT01139021|453684764|FG003|Overall Study|Withdrawal by Subject|1|||
126106913|NCT01139021|453684765|FG004|Overall Study|Withdrawal by Subject|4|||
126106914|NCT01139021|453684766|FG005|Overall Study|Withdrawal by Subject|0|||
126106915|NCT02963610|453684767|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
126106916|NCT01294683|453684774|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
126106917|NCT01294683|453684775|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
126106918|NCT01294683|453684774|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
126106919|NCT01294683|453684775|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
126106920|NCT01294683|453684774|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
126106921|NCT01294683|453684775|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
126106922|NCT01294683|453684774|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
126106923|NCT01294683|453684775|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
126106924|NCT01294683|453684774|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
126106925|NCT01294683|453684775|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
126106926|NCT01294683|453684774|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
126106927|NCT01294683|453684775|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
126106928|NCT01294683|453684774|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
126106929|NCT01294683|453684775|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
126106930|NCT01294683|453684774|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
126106931|NCT01294683|453684775|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
126106932|NCT01294683|453684774|FG000|Post Crossover (Period III)|Adverse Event|6|||
126106933|NCT01294683|453684775|FG001|Post Crossover (Period III)|Adverse Event|6|||
126106934|NCT01294683|453684774|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
126106935|NCT01294683|453684775|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
126106936|NCT01294683|453684774|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
126106937|NCT01294683|453684775|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
126106938|NCT01294683|453684774|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
126106939|NCT01294683|453684775|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
126106940|NCT01032382|453684776|FG000|Overall Study|Disease dissemination|1|||
126106941|NCT01032382|453684777|FG001|Overall Study|Disease dissemination|1|||
125892355|NCT01395524|452904648|FG001|Overall Study|Withdrawal by Subject|8|||
125892356|NCT01395524|452904649|FG002|Overall Study|Withdrawal by Subject|8|||
125892357|NCT01395524|452904647|FG000|Overall Study|Did not receive treatment|1|||
125892358|NCT01395524|452904648|FG001|Overall Study|Did not receive treatment|1|||
125892359|NCT01395524|452904649|FG002|Overall Study|Did not receive treatment|3|||
125892360|NCT01395524|452904647|FG000|Overall Study|Subject had spinal surgery|0|||
125892361|NCT01395524|452904648|FG001|Overall Study|Subject had spinal surgery|0|||
125892362|NCT01395524|452904649|FG002|Overall Study|Subject had spinal surgery|1|||
125892363|NCT01657461|452904650|FG000|Overall Study|Death|9|||
125892364|NCT01657461|452904651|FG001|Overall Study|Death|12|||
125892365|NCT01657461|452904650|FG000|Overall Study|Lost to Follow-up|0|||
125892366|NCT01657461|452904651|FG001|Overall Study|Lost to Follow-up|3|||
125892367|NCT01657461|452904650|FG000|Overall Study|Physician Decision|0|||
125892368|NCT01657461|452904651|FG001|Overall Study|Physician Decision|2|||
125892369|NCT01657461|452904650|FG000|Overall Study|Withdrawal by Subject|1|||
125892370|NCT01657461|452904651|FG001|Overall Study|Withdrawal by Subject|3|||
125892371|NCT00295880|452904660|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
125892372|NCT00295880|452904660|FG000|Overall Study|Unit randomization did not occur|1|||
125892373|NCT00843284|452904661|FG000|Overall Study|Adverse Event|39|||
125892374|NCT00843284|452904661|FG000|Overall Study|Lack of Efficacy|5|||
125892375|NCT00843284|452904661|FG000|Overall Study|Lost to Follow-up|11|||
125892376|NCT00843284|452904661|FG000|Overall Study|Other|10|||
125892377|NCT00843284|452904661|FG000|Overall Study|Withdrawal by Subject|4|||
125892378|NCT00843284|452904661|FG000|Overall Study|Death|3|||
125892379|NCT01761162|452904666|FG000|Overall Study|Withdrawal by Subject|3|||
125892380|NCT02160899|452904676|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
125892381|NCT02160899|452904677|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
125892382|NCT02160899|452904678|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
125892383|NCT02160899|452904679|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
125892384|NCT02160899|452904680|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
125892385|NCT02160899|452904681|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
125892386|NCT01256294|452904682|FG000|Overall Study|Adverse Event|1|||
125892387|NCT01256294|452904683|FG001|Overall Study|Adverse Event|0|||
125892388|NCT01256294|452904682|FG000|Overall Study|Withdrawal by Subject|1|||
125892389|NCT01256294|452904683|FG001|Overall Study|Withdrawal by Subject|1|||
125892390|NCT01256294|452904682|FG000|Overall Study|Protocol deviation|2|||
125892391|NCT01256294|452904683|FG001|Overall Study|Protocol deviation|1|||
125892392|NCT04681352|452904684|FG000|Overall Study|Lost to Follow-up|2|||
125892393|NCT04681352|452904684|FG000|Overall Study|Withdrawal by Subject|22|||
125892394|NCT01643772|452904685|FG000|Overall Study|Protocol Violation|0|||
125892395|NCT01643772|452904686|FG001|Overall Study|Protocol Violation|0|||
125892396|NCT01643772|452904687|FG002|Overall Study|Protocol Violation|0|||
125892397|NCT01643772|452904688|FG003|Overall Study|Protocol Violation|1|||
125892398|NCT01643772|452904685|FG000|Overall Study|Adverse Event|0|||
125892399|NCT01643772|452904686|FG001|Overall Study|Adverse Event|0|||
125892400|NCT01643772|452904687|FG002|Overall Study|Adverse Event|0|||
125892401|NCT01643772|452904688|FG003|Overall Study|Adverse Event|1|||
125892402|NCT02338882|452904692|FG000|Overall Study|Death|1|||
125892403|NCT02338882|452904693|FG001|Overall Study|Death|0|||
125892404|NCT02338882|452904692|FG000|Overall Study|Lost to Follow-up|6|||
125892405|NCT02338882|452904693|FG001|Overall Study|Lost to Follow-up|3|||
125892406|NCT04838977|452904696|FG000|Overall Study|Lost to Follow-up|2|||
125892407|NCT04838977|452904697|FG001|Overall Study|Lost to Follow-up|3|||
125892408|NCT04838977|452904696|FG000|Overall Study|Withdrawal by Subject|1|||
125892409|NCT04838977|452904697|FG001|Overall Study|Withdrawal by Subject|1|||
125892410|NCT02314637|452904705|FG000|Overall Study|Adverse Event|4|||
125892411|NCT02314637|452904706|FG001|Overall Study|Adverse Event|8|||
125892412|NCT02314637|452904705|FG000|Overall Study|Lack of Efficacy|1|||
125892413|NCT02314637|452904706|FG001|Overall Study|Lack of Efficacy|0|||
125892414|NCT02314637|452904705|FG000|Overall Study|Physician Decision|5|||
125892415|NCT02314637|452904706|FG001|Overall Study|Physician Decision|2|||
125892416|NCT02314637|452904705|FG000|Overall Study|Withdrawal by Subject|5|||
125892417|NCT02314637|452904706|FG001|Overall Study|Withdrawal by Subject|4|||
125892418|NCT02314637|452904705|FG000|Overall Study|Other Reason|1|||
125892419|NCT02314637|452904706|FG001|Overall Study|Other Reason|0|||
125892420|NCT00724867|452904709|FG000|Overall Study|Adverse Event|25|||
125892421|NCT00724867|452904709|FG000|Overall Study|Lack of Efficacy|14|||
125892422|NCT00724867|452904709|FG000|Overall Study|Lost to Follow-up|12|||
125892423|NCT00724867|452904709|FG000|Overall Study|Non-compliance with study drug|6|||
125892424|NCT00724867|452904709|FG000|Overall Study|Physician Decision|17|||
125892425|NCT00724867|452904709|FG000|Overall Study|Protocol Violation|1|||
125892426|NCT00724867|452904709|FG000|Overall Study|Withdrawal by Subject|31|||
125892427|NCT00724867|452904709|FG000|Overall Study|Sponsor decision to end study|14|||
125892428|NCT00724867|452904709|FG000|Overall Study|Subject incarcerated|1|||
125892429|NCT00724867|452904709|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
125892430|NCT00724867|452904709|FG000|Overall Study|Subject moved out of state|1|||
125892431|NCT00724867|452904709|FG000|Overall Study|Elected to exit due to site closure|2|||
126106942|NCT01032382|453684776|FG000|Overall Study|Treatment failure|3|||
126106943|NCT01032382|453684777|FG001|Overall Study|Treatment failure|1|||
126106944|NCT01032382|453684776|FG000|Overall Study|Index lesion relapse|1|||
126106945|NCT01032382|453684777|FG001|Overall Study|Index lesion relapse|3|||
126106946|NCT00412971|453684778|FG000|Overall Study|Lost to Follow-up|17|||
126106947|NCT00412971|453684779|FG001|Overall Study|Lost to Follow-up|9|||
126106948|NCT00412971|453684778|FG000|Overall Study|Protocol Violation|13|||
126106949|NCT00412971|453684779|FG001|Overall Study|Protocol Violation|1|||
126106950|NCT02409368|453684780|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
126106951|NCT02409368|453684781|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
126106952|NCT02409368|453684782|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
126106953|NCT02409368|453684783|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
126106954|NCT02409368|453684780|FG000|ECOG Reclassification|Death|1|||
126106955|NCT02409368|453684781|FG001|ECOG Reclassification|Death|5|||
126106956|NCT02409368|453684782|FG002|ECOG Reclassification|Death|0|||
126106957|NCT02409368|453684783|FG003|ECOG Reclassification|Death|0|||
126106958|NCT02409368|453684780|FG000|ECOG Reclassification|Disease Progression|113|||
126106959|NCT02409368|453684781|FG001|ECOG Reclassification|Disease Progression|382|||
126106960|NCT02409368|453684782|FG002|ECOG Reclassification|Disease Progression|70|||
126106961|NCT02409368|453684783|FG003|ECOG Reclassification|Disease Progression|1|||
126106962|NCT02409368|453684780|FG000|ECOG Reclassification|Lost to Follow-up|1|||
126106963|NCT02409368|453684781|FG001|ECOG Reclassification|Lost to Follow-up|5|||
126106964|NCT02409368|453684782|FG002|ECOG Reclassification|Lost to Follow-up|0|||
126106965|NCT02409368|453684783|FG003|ECOG Reclassification|Lost to Follow-up|0|||
126106966|NCT02409368|453684780|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
126106967|NCT02409368|453684781|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
126106968|NCT02409368|453684782|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
126106969|NCT02409368|453684783|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
126106970|NCT02409368|453684780|FG000|ECOG Reclassification|Poor/non-compliance|0|||
126106971|NCT02409368|453684781|FG001|ECOG Reclassification|Poor/non-compliance|3|||
126106972|NCT02409368|453684782|FG002|ECOG Reclassification|Poor/non-compliance|2|||
126106973|NCT02409368|453684783|FG003|ECOG Reclassification|Poor/non-compliance|0|||
126106974|NCT02409368|453684780|FG000|ECOG Reclassification|Study drug toxicity|17|||
126106975|NCT02409368|453684781|FG001|ECOG Reclassification|Study drug toxicity|42|||
126106976|NCT02409368|453684782|FG002|ECOG Reclassification|Study drug toxicity|7|||
126106977|NCT02409368|453684783|FG003|ECOG Reclassification|Study drug toxicity|0|||
126106978|NCT02409368|453684780|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
126106979|NCT02409368|453684781|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
126106980|NCT02409368|453684782|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
126106981|NCT02409368|453684783|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
126106982|NCT02409368|453684780|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
126106983|NCT02409368|453684781|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
126106984|NCT02409368|453684782|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
126106985|NCT02409368|453684783|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
126106986|NCT02409368|453684780|FG000|ECOG Reclassification|Participant withdrew consent|2|||
126106987|NCT02409368|453684781|FG001|ECOG Reclassification|Participant withdrew consent|3|||
126106988|NCT02409368|453684782|FG002|ECOG Reclassification|Participant withdrew consent|4|||
126106989|NCT02409368|453684783|FG003|ECOG Reclassification|Participant withdrew consent|0|||
126106990|NCT02409368|453684780|FG000|ECOG Reclassification|Other Reasons|5|||
126106991|NCT02409368|453684781|FG001|ECOG Reclassification|Other Reasons|26|||
126106992|NCT02409368|453684782|FG002|ECOG Reclassification|Other Reasons|2|||
126106993|NCT02409368|453684783|FG003|ECOG Reclassification|Other Reasons|0|||
126106994|NCT02409368|453684780|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
126106995|NCT02409368|453684781|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
126106996|NCT02409368|453684782|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
126106997|NCT02409368|453684783|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
126106998|NCT01296347|453684784|FG000|Allocation|Withdrawal by Subject|1|||
126106999|NCT01296347|453684785|FG001|Allocation|Withdrawal by Subject|2|||
126107000|NCT01296347|453684784|FG000|Allocation|Lack of Efficacy|1|||
126107001|NCT01296347|453684785|FG001|Allocation|Lack of Efficacy|2|||
126107002|NCT01296347|453684784|FG000|Allocation|not received infusion|1|||
126107003|NCT01296347|453684785|FG001|Allocation|not received infusion|0|||
126107004|NCT01296347|453684784|FG000|6 Week Follow up|Death|0|||
126107005|NCT01296347|453684785|FG001|6 Week Follow up|Death|1|||
126107006|NCT01296347|453684784|FG000|3 Month Follow up|Death|1|||
126107007|NCT01296347|453684785|FG001|3 Month Follow up|Death|0|||
126107008|NCT01296347|453684784|FG000|3 Month Follow up|Lost to Follow-up|0|||
126107009|NCT01296347|453684785|FG001|3 Month Follow up|Lost to Follow-up|1|||
126107010|NCT01296347|453684784|FG000|6 Month Follow up|Death|2|||
126107011|NCT01296347|453684785|FG001|6 Month Follow up|Death|1|||
126107012|NCT01296347|453684784|FG000|6 Month Follow up|Lost to Follow-up|0|||
126107013|NCT01296347|453684785|FG001|6 Month Follow up|Lost to Follow-up|1|||
126107014|NCT01296347|453684784|FG000|12 Month Follow up|Lost to Follow-up|3|||
126057967|NCT01829711|453506893|FG000|Overall Study|Withdrawal by Subject|3|||
126057968|NCT01829711|453506893|FG000|Overall Study|Death|4|||
126057969|NCT01829711|453506893|FG000|Overall Study|Started new therapies|17|||
126057970|NCT01829711|453506893|FG000|Overall Study|Adverse Event|3|||
126057971|NCT01829711|453506893|FG000|Overall Study|Due to progression of disease|13|||
126057972|NCT01829711|453506893|FG000|Overall Study|Due to lack of response|1|||
126057973|NCT01480258|453506896|FG000|Infant Series|Protocol Violation|2|||
126057974|NCT01480258|453506897|FG001|Infant Series|Protocol Violation|0|||
126057975|NCT01480258|453506896|FG000|Infant Series|Physician Decision|0|||
126057976|NCT01480258|453506897|FG001|Infant Series|Physician Decision|1|||
126057977|NCT01480258|453506896|FG000|Infant Series|Not Vaccinated|3|||
126057978|NCT01480258|453506897|FG001|Infant Series|Not Vaccinated|0|||
126057979|NCT01480258|453506896|FG000|Infant Series|Adverse Event|1|||
126057980|NCT01480258|453506897|FG001|Infant Series|Adverse Event|1|||
126057981|NCT01480258|453506896|FG000|Infant Series|Withdrawal by Subject|1|||
126057982|NCT01480258|453506897|FG001|Infant Series|Withdrawal by Subject|6|||
126057983|NCT01480258|453506896|FG000|Interim Period|Lost to Follow-up|0|||
126057984|NCT01480258|453506897|FG001|Interim Period|Lost to Follow-up|2|||
126057985|NCT01480258|453506896|FG000|Interim Period|Physician Decision|1|||
126057986|NCT01480258|453506897|FG001|Interim Period|Physician Decision|0|||
126057987|NCT01480258|453506896|FG000|Interim Period|Protocol Violation|0|||
126057988|NCT01480258|453506897|FG001|Interim Period|Protocol Violation|1|||
126057989|NCT01480258|453506896|FG000|Interim Period|Withdrawal by Subject|9|||
126057990|NCT01480258|453506897|FG001|Interim Period|Withdrawal by Subject|6|||
126057991|NCT02169414|453506898|FG000|Overall Study|Withdrawal by Subject|1|||
126057992|NCT02169414|453506899|FG001|Overall Study|Withdrawal by Subject|0|||
126057993|NCT02169414|453506900|FG002|Overall Study|Withdrawal by Subject|0|||
126057994|NCT02169414|453506901|FG003|Overall Study|Withdrawal by Subject|0|||
126057995|NCT02169414|453506898|FG000|Overall Study|Adverse Event|0|||
126057996|NCT02169414|453506899|FG001|Overall Study|Adverse Event|1|||
126057997|NCT02169414|453506900|FG002|Overall Study|Adverse Event|0|||
126057998|NCT02169414|453506901|FG003|Overall Study|Adverse Event|0|||
126057999|NCT03374254|453506902|FG000|Overall Study|Death|5|||
126058000|NCT03374254|453506903|FG001|Overall Study|Death|16|||
126058001|NCT03374254|453506904|FG002|Overall Study|Death|13|||
126058002|NCT03374254|453506905|FG003|Overall Study|Death|11|||
126058003|NCT03374254|453506906|FG004|Overall Study|Death|9|||
126058004|NCT03374254|453506907|FG005|Overall Study|Death|12|||
126058005|NCT03374254|453506908|FG006|Overall Study|Death|11|||
126058006|NCT03374254|453506909|FG007|Overall Study|Death|6|||
126058007|NCT03374254|453506910|FG008|Overall Study|Death|7|||
126058008|NCT03374254|453506902|FG000|Overall Study|Lost to Follow-up|0|||
126058009|NCT03374254|453506903|FG001|Overall Study|Lost to Follow-up|0|||
126058010|NCT03374254|453506904|FG002|Overall Study|Lost to Follow-up|0|||
126058011|NCT03374254|453506905|FG003|Overall Study|Lost to Follow-up|0|||
126058012|NCT03374254|453506906|FG004|Overall Study|Lost to Follow-up|0|||
126058013|NCT03374254|453506907|FG005|Overall Study|Lost to Follow-up|0|||
126058014|NCT03374254|453506908|FG006|Overall Study|Lost to Follow-up|2|||
126058015|NCT03374254|453506909|FG007|Overall Study|Lost to Follow-up|0|||
126058016|NCT03374254|453506910|FG008|Overall Study|Lost to Follow-up|0|||
126058017|NCT03374254|453506902|FG000|Overall Study|Sponsor Decision|1|||
126058018|NCT03374254|453506903|FG001|Overall Study|Sponsor Decision|0|||
126058019|NCT03374254|453506904|FG002|Overall Study|Sponsor Decision|2|||
126058020|NCT03374254|453506905|FG003|Overall Study|Sponsor Decision|3|||
126058021|NCT03374254|453506906|FG004|Overall Study|Sponsor Decision|2|||
126058022|NCT03374254|453506907|FG005|Overall Study|Sponsor Decision|3|||
126058023|NCT03374254|453506908|FG006|Overall Study|Sponsor Decision|3|||
126058024|NCT03374254|453506909|FG007|Overall Study|Sponsor Decision|3|||
125892432|NCT00373113|452904710|FG000|Overall Study|Death|1|||
126058025|NCT03374254|453506910|FG008|Overall Study|Sponsor Decision|4|||
126058026|NCT03374254|453506902|FG000|Overall Study|Withdrawal by Subject|0|||
126107015|NCT01296347|453684785|FG001|12 Month Follow up|Lost to Follow-up|1|||
126107016|NCT01296347|453684784|FG000|12 Month Follow up|Death|1|||
126107017|NCT01296347|453684785|FG001|12 Month Follow up|Death|1|||
126107018|NCT01296347|453684784|FG000|12 Month Follow up|Withdrawal by Subject|0|||
126107019|NCT01296347|453684785|FG001|12 Month Follow up|Withdrawal by Subject|1|||
126107020|NCT01585987|453684786|FG000|Randomized|Withdrawal by Subject|0|||
126107021|NCT01585987|453684787|FG001|Randomized|Withdrawal by Subject|4|||
126107022|NCT01585987|453684786|FG000|Randomized|No longer met criteria|0|||
126107023|NCT01585987|453684787|FG001|Randomized|No longer met criteria|2|||
126107024|NCT01585987|453684786|FG000|Treated|Disease Progression|39|||
126107025|NCT01585987|453684787|FG001|Treated|Disease Progression|36|||
126107026|NCT01585987|453684786|FG000|Treated|Study Drug Toxicity|9|||
126107027|NCT01585987|453684787|FG001|Treated|Study Drug Toxicity|5|||
126107028|NCT01585987|453684786|FG000|Treated|Adverse Event|3|||
126107029|NCT01585987|453684787|FG001|Treated|Adverse Event|0|||
126107030|NCT01585987|453684786|FG000|Treated|Withdrawal by Subject|1|||
126107031|NCT01585987|453684787|FG001|Treated|Withdrawal by Subject|2|||
126107032|NCT01585987|453684786|FG000|Treated|Death|1|||
126107033|NCT01585987|453684787|FG001|Treated|Death|0|||
126058027|NCT03374254|453506903|FG001|Overall Study|Withdrawal by Subject|0|||
126058028|NCT03374254|453506904|FG002|Overall Study|Withdrawal by Subject|0|||
126058029|NCT03374254|453506905|FG003|Overall Study|Withdrawal by Subject|2|||
126058030|NCT03374254|453506906|FG004|Overall Study|Withdrawal by Subject|0|||
126058031|NCT03374254|453506907|FG005|Overall Study|Withdrawal by Subject|1|||
126058032|NCT03374254|453506908|FG006|Overall Study|Withdrawal by Subject|0|||
126058033|NCT03374254|453506909|FG007|Overall Study|Withdrawal by Subject|0|||
126058034|NCT03374254|453506910|FG008|Overall Study|Withdrawal by Subject|0|||
126058035|NCT00624377|453506914|FG000|Overall Study|Lost to Follow-up|355|||
126058036|NCT00624377|453506914|FG000|Overall Study|Withdrawal by Subject|100|||
126058037|NCT00624377|453506914|FG000|Overall Study|Adverse Event|14|||
126058038|NCT00624377|453506914|FG000|Overall Study|Other|91|||
126058039|NCT00624377|453506914|FG000|Overall Study|Non-evaluable population|84|||
126058040|NCT05260437|453506915|FG000|Overall Study|Lost to Follow-up|5|||
125892433|NCT00373113|452904711|FG001|Overall Study|Death|7|||
126058041|NCT05260437|453506916|FG001|Overall Study|Lost to Follow-up|2|||
126058042|NCT05260437|453506917|FG002|Overall Study|Lost to Follow-up|1|||
126058043|NCT05260437|453506918|FG003|Overall Study|Lost to Follow-up|2|||
126058044|NCT05260437|453506919|FG004|Overall Study|Lost to Follow-up|2|||
126058045|NCT05260437|453506915|FG000|Overall Study|Withdrawal by Subject|3|||
126058046|NCT05260437|453506916|FG001|Overall Study|Withdrawal by Subject|0|||
126058047|NCT05260437|453506917|FG002|Overall Study|Withdrawal by Subject|4|||
126058048|NCT05260437|453506918|FG003|Overall Study|Withdrawal by Subject|5|||
126058049|NCT05260437|453506919|FG004|Overall Study|Withdrawal by Subject|0|||
126058050|NCT05260437|453506915|FG000|Overall Study|Vaccine Not Administered|0|||
126058051|NCT05260437|453506916|FG001|Overall Study|Vaccine Not Administered|1|||
126058052|NCT05260437|453506917|FG002|Overall Study|Vaccine Not Administered|0|||
126058053|NCT05260437|453506918|FG003|Overall Study|Vaccine Not Administered|0|||
126058054|NCT05260437|453506919|FG004|Overall Study|Vaccine Not Administered|0|||
126058055|NCT00910962|453506920|FG000|Overall Study|Adverse Event|5|||
126058056|NCT00910962|453506921|FG001|Overall Study|Adverse Event|20|||
126058057|NCT00910962|453506922|FG002|Overall Study|Adverse Event|17|||
126058058|NCT00910962|453506920|FG000|Overall Study|Protocol Violation|1|||
126058059|NCT00910962|453506921|FG001|Overall Study|Protocol Violation|3|||
126058060|NCT00910962|453506922|FG002|Overall Study|Protocol Violation|3|||
126058061|NCT00910962|453506920|FG000|Overall Study|Lost to Follow-up|0|||
126058062|NCT00910962|453506921|FG001|Overall Study|Lost to Follow-up|3|||
126058063|NCT00910962|453506922|FG002|Overall Study|Lost to Follow-up|1|||
126058064|NCT00910962|453506920|FG000|Overall Study|Physician Decision|0|||
126058065|NCT00910962|453506921|FG001|Overall Study|Physician Decision|6|||
126058066|NCT00910962|453506922|FG002|Overall Study|Physician Decision|6|||
126058067|NCT00910962|453506920|FG000|Overall Study|Withdrawal by Subject|25|||
126058068|NCT00910962|453506921|FG001|Overall Study|Withdrawal by Subject|32|||
126058069|NCT00910962|453506922|FG002|Overall Study|Withdrawal by Subject|32|||
126058070|NCT00910962|453506920|FG000|Overall Study|Reached defined stopping criteria|12|||
126058071|NCT00910962|453506921|FG001|Overall Study|Reached defined stopping criteria|14|||
126058072|NCT00910962|453506922|FG002|Overall Study|Reached defined stopping criteria|17|||
126058073|NCT00923078|453506923|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
126058074|NCT00923078|453506924|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
126058075|NCT00923078|453506925|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
126058076|NCT00923078|453506923|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
126058077|NCT00923078|453506924|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
126058078|NCT00923078|453506925|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
126058079|NCT01858688|453506926|FG000|Overall Study|Withdrawal by Subject|8|||
126058080|NCT01858688|453506926|FG000|Overall Study|Participant began another therapy|3|||
126058081|NCT01858688|453506926|FG000|Overall Study|Physician Decision|2|||
126058082|NCT01858688|453506926|FG000|Overall Study|Progressive Disease|2|||
126058083|NCT01858688|453506926|FG000|Overall Study|Reason not reproted|5|||
126058084|NCT01999335|453506927|FG000|Overall Study|Discontinued before receiving treatment|0|||
126058085|NCT01999335|453506928|FG001|Overall Study|Discontinued before receiving treatment|0|||
126058086|NCT01999335|453506929|FG002|Overall Study|Discontinued before receiving treatment|0|||
126058087|NCT01999335|453506930|FG003|Overall Study|Discontinued before receiving treatment|0|||
126058088|NCT01999335|453506931|FG004|Overall Study|Discontinued before receiving treatment|2|||
126058089|NCT00787176|453506932|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
126058090|NCT00787176|453506933|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
126058091|NCT00787176|453506934|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
126058092|NCT00787176|453506935|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
126058093|NCT04679675|453506940|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
126058094|NCT04679675|453506941|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
126058095|NCT04679675|453506942|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
126058096|NCT04679675|453506943|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
126107034|NCT01585987|453684786|FG000|Treated|Lost to Follow-up|0|||
126107035|NCT01585987|453684787|FG001|Treated|Lost to Follow-up|1|||
126107036|NCT01585987|453684786|FG000|Treated|Maximum Clinical Benefit|0|||
126107037|NCT01585987|453684787|FG001|Treated|Maximum Clinical Benefit|1|||
126107038|NCT01585987|453684786|FG000|Treated|Non-Specified|1|||
126107039|NCT01585987|453684787|FG001|Treated|Non-Specified|2|||
126107040|NCT01585987|453684786|FG000|Treated|Subject Request|0|||
126107041|NCT01585987|453684787|FG001|Treated|Subject Request|1|||
126107042|NCT01585987|453684786|FG000|Treated|Poor/Non-Compliance|0|||
126107043|NCT01585987|453684787|FG001|Treated|Poor/Non-Compliance|1|||
126107044|NCT02041520|453684788|FG000|Overall Study|Adverse Event|2|||
126107045|NCT02041520|453684789|FG001|Overall Study|Adverse Event|1|||
126107046|NCT02041520|453684788|FG000|Overall Study|Withdrawal by Subject|3|||
126107047|NCT02041520|453684789|FG001|Overall Study|Withdrawal by Subject|4|||
126107048|NCT02041520|453684788|FG000|Overall Study|Protocol Violation|1|||
126107049|NCT02041520|453684789|FG001|Overall Study|Protocol Violation|0|||
126107050|NCT02041520|453684788|FG000|Overall Study|Lost to Follow-up|0|||
126107051|NCT02041520|453684789|FG001|Overall Study|Lost to Follow-up|1|||
126107052|NCT02041520|453684788|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
125892434|NCT00373113|452904710|FG000|Overall Study|Adverse Event|38|||
126107053|NCT02041520|453684789|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
126107054|NCT01759407|453684790|FG000|Overall Study|Protocol Violation|0|||
126107055|NCT01759407|453684791|FG001|Overall Study|Protocol Violation|2|||
126107056|NCT03737474|453684792|FG000|Overall Study|Adverse Event|18|||
126107057|NCT03737474|453684793|FG001|Overall Study|Adverse Event|48|||
126107058|NCT03737474|453684792|FG000|Overall Study|Lack of Efficacy|1|||
126107059|NCT03737474|453684793|FG001|Overall Study|Lack of Efficacy|3|||
126107060|NCT03737474|453684792|FG000|Overall Study|Protocol Violation|0|||
126107061|NCT03737474|453684793|FG001|Overall Study|Protocol Violation|8|||
126107062|NCT03737474|453684792|FG000|Overall Study|Withdrawal by Subject|5|||
126107063|NCT03737474|453684793|FG001|Overall Study|Withdrawal by Subject|20|||
126107064|NCT03737474|453684792|FG000|Overall Study|Non-compliance With Study Drug|0|||
126107065|NCT03737474|453684793|FG001|Overall Study|Non-compliance With Study Drug|1|||
126107066|NCT03737474|453684792|FG000|Overall Study|Physician Decision|1|||
126107067|NCT03737474|453684793|FG001|Overall Study|Physician Decision|4|||
126107068|NCT02513745|453684794|FG000|Overall Study|Criteria at time of surgery not met.|3|||
126107069|NCT02513745|453684795|FG001|Overall Study|Criteria at time of surgery not met.|3|||
126107070|NCT01209143|453684796|FG000|Overall Study|Adverse Event|2|||
125892435|NCT00373113|452904711|FG001|Overall Study|Adverse Event|24|||
125892436|NCT00373113|452904710|FG000|Overall Study|Study terminated by sponsor|9|||
125892437|NCT00373113|452904711|FG001|Overall Study|Study terminated by sponsor|1|||
125892438|NCT00373113|452904710|FG000|Overall Study|Global deterioration of health status|10|||
125892439|NCT00373113|452904711|FG001|Overall Study|Global deterioration of health status|7|||
125892440|NCT00373113|452904710|FG000|Overall Study|Lost to Follow-up|1|||
125892441|NCT00373113|452904711|FG001|Overall Study|Lost to Follow-up|3|||
125892442|NCT00373113|452904710|FG000|Overall Study|Objective progression or relapse|150|||
125892443|NCT00373113|452904711|FG001|Overall Study|Objective progression or relapse|169|||
125892444|NCT00373113|452904710|FG000|Overall Study|Other|14|||
125892445|NCT00373113|452904711|FG001|Overall Study|Other|17|||
125892446|NCT00373113|452904710|FG000|Overall Study|Protocol Violation|5|||
125892447|NCT00373113|452904711|FG001|Overall Study|Protocol Violation|1|||
125892448|NCT00373113|452904710|FG000|Overall Study|Withdrawal by Subject|10|||
125892449|NCT00373113|452904711|FG001|Overall Study|Withdrawal by Subject|15|||
125892450|NCT01536067|452904720|FG000|Overall Study|Disease Progression|1|||
125892451|NCT03120351|452904721|FG000|Overall Study|Physician Decision|1|||
125892452|NCT03120351|452904722|FG001|Overall Study|Physician Decision|1|||
125892453|NCT01256190|452904723|FG000|Overall Study|Lost to Follow-up|2|||
125892454|NCT01256190|452904724|FG001|Overall Study|Lost to Follow-up|0|||
125892455|NCT02834793|452904725|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
125892456|NCT02834793|452904726|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
125892457|NCT02834793|452904727|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
125892458|NCT02834793|452904728|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
125892459|NCT02834793|452904725|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
126058097|NCT04679675|453506940|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
126058098|NCT04679675|453506941|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
126107071|NCT01209143|453684797|FG001|Overall Study|Adverse Event|1|||
125892460|NCT02834793|452904726|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
125892461|NCT02834793|452904727|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
125892462|NCT02834793|452904728|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
126058099|NCT04679675|453506942|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
126058100|NCT04679675|453506943|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
126058101|NCT03326856|453506944|FG000|Overall Study|Lost to Follow-up|1|||
126058102|NCT03326856|453506945|FG001|Overall Study|Lost to Follow-up|1|||
125892463|NCT02834793|452904725|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
125892464|NCT02834793|452904726|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
125892465|NCT02834793|452904727|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
125892466|NCT02834793|452904728|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
125892467|NCT02834793|452904725|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
125892468|NCT02834793|452904726|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
125892469|NCT02834793|452904727|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
125892470|NCT02834793|452904728|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
125892471|NCT02834793|452904725|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
125892472|NCT02834793|452904726|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
126058103|NCT03326856|453506946|FG002|Overall Study|Lost to Follow-up|0|||
126058104|NCT03326856|453506947|FG003|Overall Study|Lost to Follow-up|0|||
126058105|NCT03326856|453506948|FG004|Overall Study|Lost to Follow-up|0|||
125892473|NCT02834793|452904727|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
126058106|NCT00526994|453506949|FG000|Overall Study|Lost to Follow-up|98|||
126058107|NCT00526994|453506950|FG001|Overall Study|Lost to Follow-up|108|||
125892474|NCT02834793|452904728|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
125892475|NCT02834793|452904725|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
125892476|NCT02834793|452904726|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
125892477|NCT02834793|452904727|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
125892478|NCT02834793|452904728|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
125892479|NCT02834793|452904725|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
125892480|NCT02834793|452904726|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
125892481|NCT02834793|452904727|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
125892482|NCT02834793|452904728|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
125892483|NCT02834793|452904725|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
125892484|NCT02834793|452904726|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
125892485|NCT02834793|452904727|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
125892486|NCT02834793|452904728|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
125892487|NCT02834793|452904725|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
126058108|NCT00526994|453506951|FG002|Overall Study|Lost to Follow-up|96|||
126058109|NCT00526994|453506949|FG000|Overall Study|Death|4|||
126058110|NCT00526994|453506950|FG001|Overall Study|Death|3|||
126058111|NCT00526994|453506951|FG002|Overall Study|Death|3|||
126058112|NCT00526994|453506949|FG000|Overall Study|Withdrawal by Subject|2|||
126058113|NCT00526994|453506950|FG001|Overall Study|Withdrawal by Subject|7|||
126058114|NCT00526994|453506951|FG002|Overall Study|Withdrawal by Subject|5|||
126058115|NCT00526994|453506949|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
126058116|NCT00526994|453506950|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
126058117|NCT00526994|453506951|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
126058118|NCT03692871|453506955|FG000|Overall Study|Death|1|||
126058119|NCT03692871|453506956|FG001|Overall Study|Death|1|||
126058120|NCT03692871|453506955|FG000|Overall Study|Lost to Follow-up|24|||
126058121|NCT03692871|453506956|FG001|Overall Study|Lost to Follow-up|9|||
126058122|NCT03692871|453506955|FG000|Overall Study|Physician Decision|22|||
126058123|NCT03692871|453506956|FG001|Overall Study|Physician Decision|7|||
126058124|NCT03692871|453506955|FG000|Overall Study|Protocol Deviation|1|||
126058125|NCT03692871|453506956|FG001|Overall Study|Protocol Deviation|0|||
126058126|NCT03692871|453506955|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
126058127|NCT03692871|453506956|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
126058128|NCT02644122|453506960|FG000|Overall Study|Withdrawal by Subject|1|||
126058129|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
126058130|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
126058131|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
126058132|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
126058133|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
126058134|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
126058135|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
126058136|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
126058137|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
126058138|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
126058139|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
126058140|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
126058141|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
126058142|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
126058143|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
126058144|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
126058145|NCT03182244|453506961|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
126058146|NCT03182244|453506962|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
126058147|NCT03182244|453506961|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
126058148|NCT03182244|453506962|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
126058149|NCT03182244|453506961|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
126058150|NCT03182244|453506962|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
126058151|NCT03182244|453506961|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
126058152|NCT03182244|453506962|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
126058153|NCT03182244|453506961|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
126058154|NCT03182244|453506962|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
126058155|NCT01316913|453506963|FG000|Overall Study|Adverse Event|17|||
126058156|NCT01316913|453506964|FG001|Overall Study|Adverse Event|20|||
126058157|NCT01316913|453506965|FG002|Overall Study|Adverse Event|15|||
126058158|NCT01316913|453506966|FG003|Overall Study|Adverse Event|11|||
126058159|NCT01316913|453506963|FG000|Overall Study|Lack of Efficacy|22|||
126058160|NCT01316913|453506964|FG001|Overall Study|Lack of Efficacy|12|||
126058161|NCT01316913|453506965|FG002|Overall Study|Lack of Efficacy|9|||
126058162|NCT01316913|453506966|FG003|Overall Study|Lack of Efficacy|13|||
126058163|NCT01316913|453506963|FG000|Overall Study|Protocol Violation|1|||
125892488|NCT02834793|452904726|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
125892489|NCT02834793|452904727|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
126058164|NCT01316913|453506964|FG001|Overall Study|Protocol Violation|4|||
125892490|NCT02834793|452904728|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
125892491|NCT02834793|452904725|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
125892492|NCT02834793|452904726|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
125892493|NCT02834793|452904727|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
125892494|NCT02834793|452904728|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
125892495|NCT02834793|452904725|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
125892496|NCT02834793|452904726|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
125892497|NCT02834793|452904727|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
125892498|NCT02834793|452904728|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
125892499|NCT02834793|452904725|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
125892500|NCT02834793|452904726|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
125892501|NCT02834793|452904727|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
125892502|NCT02834793|452904728|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
125892503|NCT02834793|452904725|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
125892504|NCT02834793|452904726|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
125892505|NCT02834793|452904727|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
125892506|NCT02834793|452904728|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
126058165|NCT01316913|453506965|FG002|Overall Study|Protocol Violation|4|||
126058166|NCT01316913|453506966|FG003|Overall Study|Protocol Violation|1|||
126058167|NCT01316913|453506963|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
126058168|NCT01316913|453506964|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
126058169|NCT01316913|453506965|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
126058170|NCT01316913|453506966|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
126058171|NCT01316913|453506963|FG000|Overall Study|Lost to Follow-up|0|||
126058172|NCT01316913|453506964|FG001|Overall Study|Lost to Follow-up|1|||
126058173|NCT01316913|453506965|FG002|Overall Study|Lost to Follow-up|0|||
126058174|NCT01316913|453506966|FG003|Overall Study|Lost to Follow-up|2|||
126058175|NCT01316913|453506963|FG000|Overall Study|Withdrawal by Subject|10|||
126058176|NCT01316913|453506964|FG001|Overall Study|Withdrawal by Subject|9|||
126058177|NCT01316913|453506965|FG002|Overall Study|Withdrawal by Subject|10|||
126058178|NCT01316913|453506966|FG003|Overall Study|Withdrawal by Subject|6|||
126058179|NCT05169684|453506967|FG000|Overall Study|Adverse Event|1|||
126058180|NCT05169684|453506968|FG001|Overall Study|Adverse Event|3|||
126058181|NCT05169684|453506967|FG000|Overall Study|Physician Decision|0|||
126058182|NCT05169684|453506968|FG001|Overall Study|Physician Decision|1|||
126058183|NCT05169684|453506967|FG000|Overall Study|Progressive Disease|1|||
126058184|NCT05169684|453506968|FG001|Overall Study|Progressive Disease|1|||
126058185|NCT05169684|453506967|FG000|Overall Study|Participant request to discontinue treatment|0|||
126058186|NCT05169684|453506968|FG001|Overall Study|Participant request to discontinue treatment|1|||
126058187|NCT05169684|453506967|FG000|Overall Study|Other Reason|0|||
126058188|NCT05169684|453506968|FG001|Overall Study|Other Reason|1|||
126058189|NCT03539055|453506969|FG000|Overall Study|Death|4|||
126058190|NCT03539055|453506969|FG000|Overall Study|Lost to Follow-up|1|||
126058191|NCT03539055|453506969|FG000|Overall Study|Withdrawal by Subject|2|||
126058192|NCT03539055|453506969|FG000|Overall Study|Screen Fail|7|||
126058193|NCT03539055|453506969|FG000|Overall Study|Drug Intolerance|2|||
126058194|NCT02060487|453506970|FG000|Overall Study|Other|1|||
126058195|NCT02060487|453506971|FG001|Overall Study|Other|2|||
126058196|NCT02060487|453506972|FG002|Overall Study|Other|1|||
125892507|NCT02834793|452904725|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
126058197|NCT02060487|453506970|FG000|Overall Study|Lack of Efficacy|0|||
126058198|NCT02060487|453506971|FG001|Overall Study|Lack of Efficacy|1|||
126058199|NCT02060487|453506972|FG002|Overall Study|Lack of Efficacy|0|||
125892508|NCT02834793|452904726|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
126107072|NCT01209143|453684796|FG000|Overall Study|Death|0|||
126107073|NCT01209143|453684797|FG001|Overall Study|Death|1|||
126107074|NCT01209143|453684796|FG000|Overall Study|Physician Decision|3|||
126107075|NCT01209143|453684797|FG001|Overall Study|Physician Decision|1|||
126107076|NCT01209143|453684796|FG000|Overall Study|Lost to Follow-up|1|||
126107077|NCT01209143|453684797|FG001|Overall Study|Lost to Follow-up|0|||
126107078|NCT01209143|453684796|FG000|Overall Study|Withdrawal by Subject|2|||
126107079|NCT01209143|453684797|FG001|Overall Study|Withdrawal by Subject|1|||
126107080|NCT01209143|453684796|FG000|Overall Study|Disease progression|11|||
126107081|NCT01209143|453684797|FG001|Overall Study|Disease progression|16|||
126107082|NCT01145755|453684798|FG000|Overall Study|Adverse Event|2|||
126107083|NCT01145755|453684799|FG001|Overall Study|Adverse Event|4|||
126107084|NCT01145755|453684800|FG002|Overall Study|Adverse Event|2|||
126107085|NCT01145755|453684798|FG000|Overall Study|Withdrawal by Subject|2|||
126107086|NCT01145755|453684799|FG001|Overall Study|Withdrawal by Subject|2|||
126107087|NCT01145755|453684800|FG002|Overall Study|Withdrawal by Subject|2|||
126107088|NCT01145755|453684798|FG000|Overall Study|Lost to Follow-up|2|||
126107089|NCT01145755|453684799|FG001|Overall Study|Lost to Follow-up|3|||
126107090|NCT01145755|453684800|FG002|Overall Study|Lost to Follow-up|1|||
126107091|NCT01145755|453684798|FG000|Overall Study|Protocol Violation|0|||
126107092|NCT01145755|453684799|FG001|Overall Study|Protocol Violation|3|||
126107093|NCT01145755|453684800|FG002|Overall Study|Protocol Violation|1|||
126107094|NCT01145755|453684798|FG000|Overall Study|Study Closure|14|||
126107095|NCT01145755|453684799|FG001|Overall Study|Study Closure|14|||
126107096|NCT01145755|453684800|FG002|Overall Study|Study Closure|17|||
126107097|NCT01145755|453684798|FG000|Overall Study|Lack of Efficacy|0|||
126107098|NCT01145755|453684799|FG001|Overall Study|Lack of Efficacy|1|||
126107099|NCT01145755|453684800|FG002|Overall Study|Lack of Efficacy|0|||
126107100|NCT01145755|453684798|FG000|Overall Study|Patient could not swollow medication|0|||
126107101|NCT01145755|453684799|FG001|Overall Study|Patient could not swollow medication|0|||
126107102|NCT01145755|453684800|FG002|Overall Study|Patient could not swollow medication|1|||
126107103|NCT01145755|453684798|FG000|Overall Study|Withdrawal by Subject|0|||
126107104|NCT01145755|453684799|FG001|Overall Study|Withdrawal by Subject|0|||
126107105|NCT01145755|453684800|FG002|Overall Study|Withdrawal by Subject|1|||
126107106|NCT01145755|453684798|FG000|Overall Study|Positive urine ethanol|0|||
126107107|NCT01145755|453684799|FG001|Overall Study|Positive urine ethanol|1|||
126107108|NCT01145755|453684800|FG002|Overall Study|Positive urine ethanol|0|||
126107109|NCT02092220|453684806|FG000|Period 1|Unrelated Illness|0|||
126107110|NCT02092220|453684807|FG001|Period 1|Unrelated Illness|2|||
126107111|NCT02092220|453684806|FG000|Period 2|Severe Hypoglycaemia|1|||
126107112|NCT02092220|453684807|FG001|Period 2|Severe Hypoglycaemia|0|||
126107113|NCT02092220|453684806|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
126107114|NCT02092220|453684807|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
126107115|NCT02739360|453684808|FG000|Overall Study|Adverse Event|1|||
126107116|NCT02739360|453684808|FG000|Overall Study|Study terminated by Sponsor|2|||
126107117|NCT01193920|453684809|FG000|Overall Study|Withdrawal by Subject|1|||
126107118|NCT01193920|453684810|FG001|Overall Study|Withdrawal by Subject|0|||
126107119|NCT01193920|453684811|FG002|Overall Study|Withdrawal by Subject|5|||
126107120|NCT01193920|453684812|FG003|Overall Study|Withdrawal by Subject|1|||
126107121|NCT01193920|453684813|FG004|Overall Study|Withdrawal by Subject|3|||
126107122|NCT01193920|453684814|FG005|Overall Study|Withdrawal by Subject|1|||
126107123|NCT01193920|453684815|FG006|Overall Study|Withdrawal by Subject|3|||
126107124|NCT01193920|453684816|FG007|Overall Study|Withdrawal by Subject|0|||
126107125|NCT01193920|453684817|FG008|Overall Study|Withdrawal by Subject|1|||
126107126|NCT01193920|453684818|FG009|Overall Study|Withdrawal by Subject|0|||
126107127|NCT01193920|453684809|FG000|Overall Study|Lost to Follow-up|1|||
126107128|NCT01193920|453684810|FG001|Overall Study|Lost to Follow-up|0|||
126107129|NCT01193920|453684811|FG002|Overall Study|Lost to Follow-up|1|||
126107130|NCT01193920|453684812|FG003|Overall Study|Lost to Follow-up|1|||
126107131|NCT01193920|453684813|FG004|Overall Study|Lost to Follow-up|3|||
126107132|NCT01193920|453684814|FG005|Overall Study|Lost to Follow-up|3|||
126107133|NCT01193920|453684815|FG006|Overall Study|Lost to Follow-up|1|||
126107134|NCT01193920|453684816|FG007|Overall Study|Lost to Follow-up|0|||
126107135|NCT01193920|453684817|FG008|Overall Study|Lost to Follow-up|2|||
126107136|NCT01193920|453684818|FG009|Overall Study|Lost to Follow-up|3|||
126107137|NCT01193920|453684809|FG000|Overall Study|Protocol Violation|1|||
126107138|NCT01193920|453684810|FG001|Overall Study|Protocol Violation|0|||
126107139|NCT01193920|453684811|FG002|Overall Study|Protocol Violation|0|||
126107140|NCT01193920|453684812|FG003|Overall Study|Protocol Violation|0|||
126107141|NCT01193920|453684813|FG004|Overall Study|Protocol Violation|0|||
126107142|NCT01193920|453684814|FG005|Overall Study|Protocol Violation|0|||
126107143|NCT01193920|453684815|FG006|Overall Study|Protocol Violation|0|||
126107144|NCT01193920|453684816|FG007|Overall Study|Protocol Violation|0|||
126107145|NCT01193920|453684817|FG008|Overall Study|Protocol Violation|0|||
126107146|NCT01193920|453684818|FG009|Overall Study|Protocol Violation|0|||
126107147|NCT01193920|453684809|FG000|Overall Study|Death|0|||
125892509|NCT02834793|452904727|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
126107148|NCT01193920|453684810|FG001|Overall Study|Death|0|||
126107149|NCT01193920|453684811|FG002|Overall Study|Death|0|||
126107150|NCT01193920|453684812|FG003|Overall Study|Death|1|||
126107151|NCT01193920|453684813|FG004|Overall Study|Death|0|||
126107152|NCT01193920|453684814|FG005|Overall Study|Death|0|||
126107153|NCT01193920|453684815|FG006|Overall Study|Death|2|||
126107154|NCT01193920|453684816|FG007|Overall Study|Death|3|||
126107155|NCT01193920|453684817|FG008|Overall Study|Death|2|||
126107156|NCT01193920|453684818|FG009|Overall Study|Death|4|||
126107157|NCT01193920|453684809|FG000|Overall Study|Unable to classify|0|||
126107158|NCT01193920|453684810|FG001|Overall Study|Unable to classify|0|||
126107159|NCT01193920|453684811|FG002|Overall Study|Unable to classify|0|||
126107160|NCT01193920|453684812|FG003|Overall Study|Unable to classify|1|||
126107161|NCT01193920|453684813|FG004|Overall Study|Unable to classify|0|||
126107162|NCT01193920|453684814|FG005|Overall Study|Unable to classify|0|||
126107163|NCT01193920|453684815|FG006|Overall Study|Unable to classify|0|||
126107164|NCT01193920|453684816|FG007|Overall Study|Unable to classify|1|||
126107165|NCT01193920|453684817|FG008|Overall Study|Unable to classify|0|||
126107166|NCT01193920|453684818|FG009|Overall Study|Unable to classify|0|||
126107167|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
126107168|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
126107169|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
126107170|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
126058200|NCT02060487|453506970|FG000|Overall Study|Withdrawal by Subject|3|||
126058201|NCT02060487|453506971|FG001|Overall Study|Withdrawal by Subject|10|||
126058202|NCT02060487|453506972|FG002|Overall Study|Withdrawal by Subject|4|||
126058203|NCT02060487|453506970|FG000|Overall Study|Study Terminated By Sponsor|87|||
126058204|NCT02060487|453506971|FG001|Overall Study|Study Terminated By Sponsor|89|||
126058205|NCT02060487|453506972|FG002|Overall Study|Study Terminated By Sponsor|100|||
126058206|NCT02060487|453506970|FG000|Overall Study|Randomized in error|1|||
126058207|NCT02060487|453506971|FG001|Overall Study|Randomized in error|0|||
126058208|NCT02060487|453506972|FG002|Overall Study|Randomized in error|0|||
126058209|NCT02060487|453506970|FG000|Overall Study|Protocol Violation|0|||
126058210|NCT02060487|453506971|FG001|Overall Study|Protocol Violation|1|||
126058211|NCT02060487|453506972|FG002|Overall Study|Protocol Violation|1|||
126058212|NCT02060487|453506970|FG000|Overall Study|Lost to Follow-up|3|||
126058213|NCT02060487|453506971|FG001|Overall Study|Lost to Follow-up|0|||
126058214|NCT02060487|453506972|FG002|Overall Study|Lost to Follow-up|2|||
126058215|NCT02060487|453506970|FG000|Overall Study|Death|34|||
126058216|NCT02060487|453506971|FG001|Overall Study|Death|25|||
126058217|NCT02060487|453506972|FG002|Overall Study|Death|19|||
126058218|NCT02060487|453506970|FG000|Overall Study|Adverse Event|0|||
126058219|NCT02060487|453506971|FG001|Overall Study|Adverse Event|0|||
126058220|NCT02060487|453506972|FG002|Overall Study|Adverse Event|1|||
126058221|NCT05484661|453506973|FG000|Overall Study|Withdrawal by Subject|1|||
126058222|NCT05484661|453506974|FG001|Overall Study|Withdrawal by Subject|0|||
126058223|NCT01856569|453506975|FG000|Overall Study|Other|1|||
126058224|NCT01856569|453506975|FG000|Overall Study|Changed Site/Structure|1|||
126058225|NCT01856569|453506975|FG000|Overall Study|Lost to Follow-up|3|||
126058226|NCT01856569|453506975|FG000|Overall Study|Did not met inclusion criteria|8|||
126058227|NCT01860079|453506976|FG000|Overall Study|Physician Decision|14|||
126058228|NCT01860079|453506977|FG001|Overall Study|Physician Decision|22|||
126058229|NCT02950961|453506985|FG000|Overall Study|Study had to stop due to COVID.|7|||
126058230|NCT02241785|453506986|FG000|Overall Study|Sponsor Termination|43|||
126058231|NCT02241785|453506986|FG000|Overall Study|Withdrawal by Subject|1|||
126058232|NCT02241785|453506986|FG000|Overall Study|Lost to Follow-up|2|||
126058233|NCT02241785|453506986|FG000|Overall Study|Adverse Event|1|||
126058234|NCT03055988|453506989|FG000|Period 1|Adverse Event|0|||
126058235|NCT03055988|453506990|FG001|Period 1|Adverse Event|1|||
126058236|NCT03055988|453506989|FG000|Period 1|Lost to Follow-up|1|||
126058237|NCT03055988|453506990|FG001|Period 1|Lost to Follow-up|0|||
126058238|NCT03055988|453506989|FG000|Period 1|Withdrawal by Subject|0|||
126058239|NCT03055988|453506990|FG001|Period 1|Withdrawal by Subject|4|||
126058240|NCT03055988|453506989|FG000|Period 2|Adverse Event|0|||
126058241|NCT03055988|453506990|FG001|Period 2|Adverse Event|1|||
126058242|NCT03055988|453506989|FG000|Period 2|Other than listed|1|||
126058243|NCT03055988|453506990|FG001|Period 2|Other than listed|1|||
126058244|NCT00845520|453506991|FG000|Overall Study|Death|1|||
126058245|NCT00845520|453506992|FG001|Overall Study|Death|2|||
126058246|NCT00845520|453506993|FG002|Overall Study|Death|0|||
126058247|NCT00845520|453506991|FG000|Overall Study|Lost to Follow-up|1|||
126058248|NCT00845520|453506992|FG001|Overall Study|Lost to Follow-up|0|||
126058249|NCT00845520|453506993|FG002|Overall Study|Lost to Follow-up|0|||
126058250|NCT00845520|453506991|FG000|Overall Study|Adverse Event|0|||
126058251|NCT00845520|453506992|FG001|Overall Study|Adverse Event|0|||
126058252|NCT00845520|453506993|FG002|Overall Study|Adverse Event|1|||
126058253|NCT01736475|453506994|FG000|Overall Study|Adverse Event|4|||
126058254|NCT01736475|453506995|FG001|Overall Study|Adverse Event|0|||
126058255|NCT01736475|453506994|FG000|Overall Study|Withdrawal by Subject|2|||
126058256|NCT01736475|453506995|FG001|Overall Study|Withdrawal by Subject|0|||
126058257|NCT01736475|453506994|FG000|Overall Study|Protocol Violation|4|||
126058258|NCT01736475|453506995|FG001|Overall Study|Protocol Violation|0|||
126058259|NCT01736475|453506994|FG000|Overall Study|Other - Screen failure|1|||
126058260|NCT01736475|453506995|FG001|Overall Study|Other - Screen failure|0|||
126058261|NCT01736475|453506994|FG000|Overall Study|Other - Surgical procedure|1|||
126058262|NCT01736475|453506995|FG001|Overall Study|Other - Surgical procedure|0|||
126058263|NCT02807857|453506996|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
126058264|NCT02807857|453506996|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
126058265|NCT02807857|453506996|FG000|Follow-Up Set|Withdrawal by Subject|8|||
126058266|NCT02807857|453506996|FG000|Follow-Up Set|Lost to Follow-up|7|||
126058267|NCT02807857|453506996|FG000|Follow-Up Set|Physician Decision|6|||
126058268|NCT02807857|453506996|FG000|Follow-Up Set|Adverse Event|3|||
126058269|NCT02807857|453506996|FG000|Follow-Up Set|Death|27|||
126107171|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
126107172|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
126107173|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
126107174|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
126107175|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
126107176|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
126107177|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
126107178|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
126107179|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
125892510|NCT02834793|452904728|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
125892511|NCT02834793|452904725|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
125892512|NCT02834793|452904726|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
125892513|NCT02834793|452904727|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
125892514|NCT02834793|452904728|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
125892515|NCT01049009|452904729|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
125892516|NCT01049009|452904730|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
125892517|NCT01049009|452904729|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125892518|NCT01049009|452904730|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125892519|NCT01049009|452904729|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
125892520|NCT01049009|452904730|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
125892521|NCT01049009|452904729|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
125892522|NCT01049009|452904730|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
125892523|NCT02423902|452904731|FG000|Overall Study|Disease progression|1|||
125892524|NCT02423902|452904732|FG001|Overall Study|Disease progression|4|||
125892525|NCT02350478|452904733|FG000|Overall Study|Lost to Follow-up|5|||
125892526|NCT02350478|452904734|FG001|Overall Study|Lost to Follow-up|1|||
125892527|NCT00622440|452904747|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
125892528|NCT00622440|452904748|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
125892529|NCT00622440|452904747|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
125892530|NCT00622440|452904748|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
125892531|NCT00622440|452904747|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
125892532|NCT00622440|452904748|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
125892533|NCT00622440|452904747|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
125892534|NCT00622440|452904748|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
125892535|NCT01519869|452904749|FG000|Overall Study|Lost to Follow-up|1|||
125892536|NCT03023813|452904750|FG000|Overall Study|Lost to Follow-up|1|||
125892537|NCT03023813|452904751|FG001|Overall Study|Lost to Follow-up|2|||
125892538|NCT03023813|452904752|FG002|Overall Study|Lost to Follow-up|0|||
125892539|NCT02433080|452904754|FG000|Overall Study|Lost to Follow-up|1|||
125892540|NCT02433080|452904755|FG001|Overall Study|Lost to Follow-up|2|||
125892541|NCT02433080|452904754|FG000|Overall Study|Withdrawal by Subject|0|||
125892542|NCT02433080|452904755|FG001|Overall Study|Withdrawal by Subject|2|||
125892543|NCT04530136|452904756|FG000|Overall Study|Lost to Follow-up|2|||
125892544|NCT04530136|452904757|FG001|Overall Study|Lost to Follow-up|3|||
125892545|NCT04530136|452904756|FG000|Overall Study|Withdrawal by Subject|1|||
125892546|NCT04530136|452904757|FG001|Overall Study|Withdrawal by Subject|0|||
125892547|NCT04530136|452904756|FG000|Overall Study|Death|0|||
125892548|NCT04530136|452904757|FG001|Overall Study|Death|1|||
125892549|NCT01309282|452904758|FG000|Overall Study|Lost to Follow-up|1|||
125892550|NCT01387542|452904759|FG000|Overall Study|Adverse Event|3|||
125892551|NCT01387542|452904759|FG000|Overall Study|Withdrawal by Subject|1|||
125892552|NCT01387542|452904759|FG000|Overall Study|Changed diagnosis|1|||
125892553|NCT01387542|452904759|FG000|Overall Study|Insufficient response|1|||
125892554|NCT01387542|452904759|FG000|Overall Study|Non-compliant|1|||
125892555|NCT01387542|452904759|FG000|Overall Study|Lost to Follow-up|1|||
126058270|NCT02807857|453506996|FG000|Follow-Up Set|Relocation|2|||
126058271|NCT03905642|453506998|FG000|Overall Study|Withdrawal by Subject|3|||
126058272|NCT03905642|453506998|FG000|Overall Study|Pregnancy|1|||
125892556|NCT01010867|452904760|FG000|Overall Study|< 50% adherence to probiotic|1|||
125892557|NCT00884741|452904763|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
125892558|NCT00884741|452904764|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
126107180|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
126107181|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
126107182|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
126107183|NCT01231516|453684821|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
126107184|NCT01231516|453684822|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
126107185|NCT01231516|453684821|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
126107186|NCT01231516|453684822|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
126107187|NCT01231516|453684821|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
126107188|NCT01231516|453684822|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
126107189|NCT01231516|453684821|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
126107190|NCT01231516|453684822|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
126107191|NCT01231516|453684821|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
126107192|NCT01231516|453684822|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
126107193|NCT01231516|453684821|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
126107194|NCT01231516|453684822|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
126107195|NCT01231516|453684821|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
126107196|NCT01231516|453684822|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
126107197|NCT01231516|453684821|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
126107198|NCT01231516|453684822|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
126107199|NCT03170154|453684823|FG000|Overall Study|Lost to Follow-up|4|||
126107200|NCT03170154|453684823|FG000|Overall Study|Death|2|||
126107201|NCT03170154|453684823|FG000|Overall Study|Withdrawal by Subject|2|||
126107202|NCT00026208|453684824|FG000|Overall Study|Complications of auto accident|1|||
126107203|NCT00026208|453684825|FG001|Overall Study|Complications of auto accident|0|||
126107204|NCT05266586|453684826|FG000|Overall Study|Adverse Event|2|||
126107205|NCT05266586|453684827|FG001|Overall Study|Adverse Event|2|||
126107206|NCT05266586|453684828|FG002|Overall Study|Adverse Event|1|||
126107207|NCT05266586|453684826|FG000|Overall Study|Withdrawal by Subject|1|||
126107208|NCT05266586|453684827|FG001|Overall Study|Withdrawal by Subject|0|||
126107209|NCT05266586|453684828|FG002|Overall Study|Withdrawal by Subject|1|||
126107210|NCT05266586|453684826|FG000|Overall Study|Non-compliance with study drug|0|||
126107211|NCT05266586|453684827|FG001|Overall Study|Non-compliance with study drug|1|||
126107212|NCT05266586|453684828|FG002|Overall Study|Non-compliance with study drug|0|||
126107213|NCT05266586|453684826|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
126107214|NCT05266586|453684827|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
126107215|NCT05266586|453684828|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
126107216|NCT02225353|453684829|FG000|Overall Study|Lost to Follow-up|0|||
126107217|NCT02225353|453684830|FG001|Overall Study|Lost to Follow-up|1|||
126107218|NCT02225353|453684831|FG002|Overall Study|Lost to Follow-up|3|||
126107219|NCT02225353|453684829|FG000|Overall Study|Protocol Violation|4|||
126107220|NCT02225353|453684830|FG001|Overall Study|Protocol Violation|5|||
126107221|NCT02225353|453684831|FG002|Overall Study|Protocol Violation|12|||
126107222|NCT01117857|453684832|FG000|Overall Study|Lost to Follow-up|4|||
126107223|NCT01117857|453684832|FG000|Overall Study|Withdrawal by Subject|4|||
126107224|NCT01117857|453684832|FG000|Overall Study|Physician Decision|1|||
126107225|NCT02730598|453684835|FG000|Overall Study|Withdrawal by Subject|3|||
125892559|NCT00884741|452904765|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
126058273|NCT03905642|453506998|FG000|Overall Study|Adverse Event|1|||
126058274|NCT03905642|453506998|FG000|Overall Study|Lack of Efficacy|1|||
126058275|NCT03905642|453506998|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
126058276|NCT02014402|453508793|FG000|Overall Study|Adverse Event|1|||
126058277|NCT02014402|453508794|FG001|Overall Study|Adverse Event|0|||
126058278|NCT02014402|453508795|FG002|Overall Study|Adverse Event|0|||
126058279|NCT02014402|453508796|FG003|Overall Study|Adverse Event|0|||
126058280|NCT02014402|453508793|FG000|Overall Study|Withdrawal by Subject|1|||
126058281|NCT02014402|453508794|FG001|Overall Study|Withdrawal by Subject|2|||
126058282|NCT02014402|453508795|FG002|Overall Study|Withdrawal by Subject|2|||
126058283|NCT02014402|453508796|FG003|Overall Study|Withdrawal by Subject|1|||
126058284|NCT02014402|453508793|FG000|Overall Study|Subject did not have transportation|0|||
126058285|NCT02014402|453508794|FG001|Overall Study|Subject did not have transportation|1|||
126058286|NCT02014402|453508795|FG002|Overall Study|Subject did not have transportation|0|||
126058287|NCT02014402|453508796|FG003|Overall Study|Subject did not have transportation|0|||
126058288|NCT02014402|453508793|FG000|Overall Study|Lost to Follow-up|0|||
126058289|NCT02014402|453508794|FG001|Overall Study|Lost to Follow-up|0|||
126058290|NCT02014402|453508795|FG002|Overall Study|Lost to Follow-up|1|||
126058291|NCT02014402|453508796|FG003|Overall Study|Lost to Follow-up|2|||
126058292|NCT01190124|453508797|FG000|Overall Study|Death|3|||
126058293|NCT01190124|453508798|FG001|Overall Study|Death|0|||
126058294|NCT01190124|453508799|FG002|Overall Study|Death|0|||
126058295|NCT01190124|453508797|FG000|Overall Study|Therapeutic Failure|12|||
126058296|NCT01190124|453508798|FG001|Overall Study|Therapeutic Failure|0|||
126058297|NCT01190124|453508799|FG002|Overall Study|Therapeutic Failure|1|||
126058298|NCT01190124|453508797|FG000|Overall Study|Lost to Follow-up|2|||
126058299|NCT01190124|453508798|FG001|Overall Study|Lost to Follow-up|0|||
126058300|NCT01190124|453508799|FG002|Overall Study|Lost to Follow-up|0|||
126058301|NCT03493282|453508800|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
126058302|NCT03493282|453508801|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
126058303|NCT03493282|453508802|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
126058304|NCT03493282|453508800|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
126058305|NCT03493282|453508801|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
126058306|NCT03493282|453508802|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
126058307|NCT00070707|453508803|FG000|Overall Study|Adverse Event|1|||
126058308|NCT00070707|453508804|FG001|Overall Study|Adverse Event|2|||
126058309|NCT00070707|453508803|FG000|Overall Study|Lack of Efficacy|4|||
126058310|NCT00070707|453508804|FG001|Overall Study|Lack of Efficacy|1|||
126107226|NCT02730598|453684836|FG001|Overall Study|Withdrawal by Subject|3|||
126107227|NCT02730598|453684835|FG000|Overall Study|Protocol Violation|0|||
126107228|NCT02730598|453684836|FG001|Overall Study|Protocol Violation|1|||
126107229|NCT02730598|453684835|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
126107230|NCT02730598|453684836|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
126107231|NCT03282240|453684837|FG000|Overall Study|Adverse Event|2|||
126107232|NCT03282240|453684838|FG001|Overall Study|Adverse Event|2|||
126107233|NCT03282240|453684839|FG002|Overall Study|Adverse Event|0|||
125892560|NCT00884741|452904766|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
126058311|NCT00070707|453508803|FG000|Overall Study|Protocol Violation|8|||
126058312|NCT00070707|453508804|FG001|Overall Study|Protocol Violation|4|||
126058313|NCT00070707|453508803|FG000|Overall Study|Unrelated to Study Medication|1|||
126107234|NCT03282240|453684837|FG000|Overall Study|Lost to Follow-up|3|||
126058314|NCT00070707|453508804|FG001|Overall Study|Unrelated to Study Medication|0|||
125892561|NCT00884741|452904763|FG000|Step 1 Registration: Tissue Screening|Death|3|||
125892562|NCT00884741|452904764|FG001|Step 1 Registration: Tissue Screening|Death|0|||
125892563|NCT00884741|452904765|FG002|Step 1 Registration: Tissue Screening|Death|0|||
125892564|NCT00884741|452904766|FG003|Step 1 Registration: Tissue Screening|Death|0|||
125892565|NCT00884741|452904763|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
125892566|NCT00884741|452904764|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
125892567|NCT00884741|452904765|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
125892568|NCT00884741|452904766|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
125892569|NCT00884741|452904763|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
125892570|NCT00884741|452904764|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
125892571|NCT00884741|452904765|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
125892572|NCT00884741|452904766|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
125892573|NCT00884741|452904763|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
125892574|NCT00884741|452904764|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
125892575|NCT00884741|452904765|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
125892576|NCT00884741|452904766|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
125892577|NCT00884741|452904763|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
125892578|NCT00884741|452904764|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
125892579|NCT00884741|452904765|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
125892580|NCT00884741|452904766|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
125892581|NCT00884741|452904763|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
125892582|NCT00884741|452904764|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
125892583|NCT00884741|452904765|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
125892584|NCT00884741|452904766|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
125892585|NCT00884741|452904763|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
125892586|NCT00884741|452904764|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
125892587|NCT00884741|452904765|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
125892588|NCT00884741|452904766|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
125892589|NCT00884741|452904763|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
125892590|NCT00884741|452904764|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
125892591|NCT00884741|452904765|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
125892592|NCT00884741|452904766|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
125892593|NCT00884741|452904763|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
125892594|NCT00884741|452904764|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
125892595|NCT00884741|452904765|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
125892596|NCT00884741|452904766|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
125892597|NCT00884741|452904763|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
125892598|NCT00884741|452904764|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
125892599|NCT00884741|452904765|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
125892600|NCT00884741|452904766|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
125892601|NCT00884741|452904763|FG000|Randomization|Protocol Violation|0|||
125892602|NCT00884741|452904764|FG001|Randomization|Protocol Violation|0|||
125892603|NCT00884741|452904765|FG002|Randomization|Protocol Violation|8|||
125892604|NCT00884741|452904766|FG003|Randomization|Protocol Violation|8|||
125892605|NCT01233232|452904767|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
125892606|NCT01233232|452904768|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
125892607|NCT01233232|452904769|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
125892608|NCT02762370|452904770|FG000|Overall Study|Protocol Violation|1|||
125892609|NCT02762370|452904771|FG001|Overall Study|Protocol Violation|0|||
125892610|NCT00101452|452904776|FG000|Overall Study|Adverse Event|2|||
125892611|NCT00101452|452904777|FG001|Overall Study|Adverse Event|0|||
125892612|NCT00101452|452904778|FG002|Overall Study|Adverse Event|1|||
125892613|NCT00101452|452904776|FG000|Overall Study|Lost to Follow-up|13|||
125892614|NCT00101452|452904777|FG001|Overall Study|Lost to Follow-up|8|||
125892615|NCT00101452|452904778|FG002|Overall Study|Lost to Follow-up|14|||
126058315|NCT01128959|453508805|FG000|Lead in Period|Adverse Event|3|||
126058316|NCT01128959|453508805|FG000|Treatment Period|Adverse Event|3|||
126058317|NCT01128959|453508805|FG000|Treatment Period|Withdrawal by Subject|1|||
126058318|NCT02338999|453508806|FG000|First Intervention|Withdrawal by Subject|3|||
126058319|NCT02338999|453508807|FG001|First Intervention|Withdrawal by Subject|1|||
126058320|NCT02338999|453508806|FG000|Washout Period|Withdrawal by Subject|0|||
126058321|NCT02338999|453508807|FG001|Washout Period|Withdrawal by Subject|2|||
126058322|NCT02338999|453508806|FG000|Second Intervention|Withdrawal by Subject|0|||
126058323|NCT02338999|453508807|FG001|Second Intervention|Withdrawal by Subject|2|||
126058324|NCT02958553|453508808|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
126058325|NCT02958553|453508808|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
126058326|NCT00308308|453508809|FG000|Overall Study|Adverse Event|17|||
126058327|NCT00308308|453508810|FG001|Overall Study|Adverse Event|2|||
126058328|NCT00308308|453508809|FG000|Overall Study|Lost to Follow-up|5|||
126058329|NCT00308308|453508810|FG001|Overall Study|Lost to Follow-up|5|||
126058330|NCT00308308|453508809|FG000|Overall Study|Physician Decision|15|||
126058331|NCT00308308|453508810|FG001|Overall Study|Physician Decision|7|||
126058332|NCT00308308|453508809|FG000|Overall Study|Protocol Violation|3|||
126058333|NCT00308308|453508810|FG001|Overall Study|Protocol Violation|14|||
126058334|NCT00308308|453508809|FG000|Overall Study|Withdrawal by Subject|47|||
126058335|NCT00308308|453508810|FG001|Overall Study|Withdrawal by Subject|19|||
126058336|NCT00308308|453508809|FG000|Overall Study|Various|7|||
126058337|NCT00308308|453508810|FG001|Overall Study|Various|5|||
126058338|NCT00308308|453508809|FG000|Overall Study|Randomized but not dosed|8|||
126058339|NCT00308308|453508810|FG001|Overall Study|Randomized but not dosed|16|||
126058340|NCT00308308|453508809|FG000|Overall Study|Other|1|||
126058341|NCT00308308|453508810|FG001|Overall Study|Other|0|||
126058342|NCT01686152|453508811|FG000|Overall Study|Withdrawal by Subject|11|||
126058343|NCT01686152|453508812|FG001|Overall Study|Withdrawal by Subject|11|||
126058344|NCT01686152|453508813|FG002|Overall Study|Withdrawal by Subject|3|||
126058345|NCT01686152|453508811|FG000|Overall Study|Drug Code Unblinded|0|||
126058346|NCT01686152|453508812|FG001|Overall Study|Drug Code Unblinded|1|||
126058347|NCT01686152|453508813|FG002|Overall Study|Drug Code Unblinded|0|||
126058348|NCT01686152|453508811|FG000|Overall Study|Protocol Violation|6|||
126058349|NCT01686152|453508812|FG001|Overall Study|Protocol Violation|1|||
126107235|NCT03282240|453684838|FG001|Overall Study|Lost to Follow-up|0|||
126107236|NCT03282240|453684839|FG002|Overall Study|Lost to Follow-up|0|||
126107237|NCT03282240|453684837|FG000|Overall Study|Protocol Deviation|4|||
126107238|NCT03282240|453684838|FG001|Overall Study|Protocol Deviation|1|||
126107239|NCT03282240|453684839|FG002|Overall Study|Protocol Deviation|2|||
126107240|NCT03282240|453684837|FG000|Overall Study|Withdrawal by Subject|1|||
126107241|NCT03282240|453684838|FG001|Overall Study|Withdrawal by Subject|0|||
126107242|NCT03282240|453684839|FG002|Overall Study|Withdrawal by Subject|1|||
126107243|NCT02910739|453684840|FG000|Overall Study|Adverse Event|1|||
126107244|NCT02910739|453684841|FG001|Overall Study|Adverse Event|0|||
126107245|NCT02910739|453684842|FG002|Overall Study|Adverse Event|0|||
126107246|NCT02910739|453684843|FG003|Overall Study|Adverse Event|0|||
126107247|NCT02146326|453684844|FG000|Overall Study|Lost to Follow-up|3|||
126107248|NCT02146326|453684845|FG001|Overall Study|Lost to Follow-up|3|||
126107249|NCT02146326|453684846|FG002|Overall Study|Lost to Follow-up|11|||
126107250|NCT02146326|453684847|FG003|Overall Study|Lost to Follow-up|19|||
126107251|NCT02146326|453684844|FG000|Overall Study|Withdrawal by Subject|2|||
126107252|NCT02146326|453684845|FG001|Overall Study|Withdrawal by Subject|1|||
126107253|NCT02146326|453684846|FG002|Overall Study|Withdrawal by Subject|15|||
126107254|NCT02146326|453684847|FG003|Overall Study|Withdrawal by Subject|11|||
126107255|NCT02146326|453684844|FG000|Overall Study|Separated from mental health center|23|||
126107256|NCT02146326|453684845|FG001|Overall Study|Separated from mental health center|33|||
126107257|NCT02146326|453684846|FG002|Overall Study|Separated from mental health center|0|||
126107258|NCT02146326|453684847|FG003|Overall Study|Separated from mental health center|0|||
126107259|NCT02146326|453684844|FG000|Overall Study|Incarcerated|0|||
126107260|NCT02146326|453684845|FG001|Overall Study|Incarcerated|0|||
126107261|NCT02146326|453684846|FG002|Overall Study|Incarcerated|3|||
126107262|NCT02146326|453684847|FG003|Overall Study|Incarcerated|8|||
126107263|NCT02146326|453684844|FG000|Overall Study|Death|0|||
126107264|NCT02146326|453684845|FG001|Overall Study|Death|0|||
126107265|NCT02146326|453684846|FG002|Overall Study|Death|4|||
126107266|NCT02146326|453684847|FG003|Overall Study|Death|4|||
126107267|NCT02146326|453684844|FG000|Overall Study|Unable to complete interview|0|||
126107268|NCT02146326|453684845|FG001|Overall Study|Unable to complete interview|0|||
126107269|NCT02146326|453684846|FG002|Overall Study|Unable to complete interview|10|||
126107270|NCT02146326|453684847|FG003|Overall Study|Unable to complete interview|6|||
126107271|NCT01340651|453684848|FG000|Overall Study|Adverse Event|3|||
126107272|NCT01340651|453684848|FG000|Overall Study|Consent Withdrawn|2|||
126107273|NCT01340651|453684848|FG000|Overall Study|Commercial Supply per Sponsor|12|||
126107274|NCT00688103|453684856|FG000|Overall Study|Adverse Event|4|||
126107275|NCT00688103|453684857|FG001|Overall Study|Adverse Event|1|||
126107276|NCT00688103|453684856|FG000|Overall Study|Lack of Efficacy|11|||
126058350|NCT01686152|453508813|FG002|Overall Study|Protocol Violation|0|||
126058351|NCT01686152|453508811|FG000|Overall Study|Adverse Event|12|||
126058352|NCT01686152|453508812|FG001|Overall Study|Adverse Event|11|||
126058353|NCT01686152|453508813|FG002|Overall Study|Adverse Event|0|||
126058354|NCT01686152|453508811|FG000|Overall Study|Lack of Efficacy|0|||
126058355|NCT01686152|453508812|FG001|Overall Study|Lack of Efficacy|0|||
126058356|NCT01686152|453508813|FG002|Overall Study|Lack of Efficacy|1|||
126058357|NCT01686152|453508811|FG000|Overall Study|IP Non-compliance|5|||
126058358|NCT01686152|453508812|FG001|Overall Study|IP Non-compliance|5|||
126058359|NCT01686152|453508813|FG002|Overall Study|IP Non-compliance|0|||
126058360|NCT01686152|453508811|FG000|Overall Study|Lost to Follow-up|7|||
126058361|NCT01686152|453508812|FG001|Overall Study|Lost to Follow-up|6|||
126058362|NCT01686152|453508813|FG002|Overall Study|Lost to Follow-up|5|||
126058363|NCT01802333|453508814|FG000|Overall Study|Ineligible|2|||
126058364|NCT01802333|453508815|FG001|Overall Study|Ineligible|6|||
126058365|NCT01802333|453508816|FG002|Overall Study|Ineligible|8|||
126058366|NCT01802333|453508814|FG000|Overall Study|Adverse Event|1|||
126058367|NCT01802333|453508815|FG001|Overall Study|Adverse Event|8|||
126058368|NCT01802333|453508816|FG002|Overall Study|Adverse Event|8|||
126058369|NCT01802333|453508814|FG000|Overall Study|Withdrawal by Subject|6|||
126058370|NCT01802333|453508815|FG001|Overall Study|Withdrawal by Subject|6|||
126058371|NCT01802333|453508816|FG002|Overall Study|Withdrawal by Subject|5|||
126058372|NCT01802333|453508814|FG000|Overall Study|Progression/relapse|1|||
126058373|NCT01802333|453508815|FG001|Overall Study|Progression/relapse|3|||
126058374|NCT01802333|453508816|FG002|Overall Study|Progression/relapse|0|||
126058375|NCT01802333|453508814|FG000|Overall Study|Death|7|||
126058376|NCT01802333|453508815|FG001|Overall Study|Death|14|||
126058377|NCT01802333|453508816|FG002|Overall Study|Death|13|||
126058378|NCT01802333|453508814|FG000|Overall Study|Other - not protocol specified|32|||
126058379|NCT01802333|453508815|FG001|Overall Study|Other - not protocol specified|22|||
126058380|NCT01802333|453508816|FG002|Overall Study|Other - not protocol specified|24|||
126058381|NCT01802333|453508814|FG000|Overall Study|Did not start treatment|0|||
126058382|NCT01802333|453508815|FG001|Overall Study|Did not start treatment|2|||
126058383|NCT01802333|453508816|FG002|Overall Study|Did not start treatment|5|||
126058384|NCT01947491|453508818|FG000|Overall Study|Lost to Follow-up|5|||
126058385|NCT01947491|453508819|FG001|Overall Study|Lost to Follow-up|3|||
126058386|NCT01947491|453508820|FG002|Overall Study|Lost to Follow-up|1|||
126058387|NCT01947491|453508821|FG003|Overall Study|Lost to Follow-up|2|||
126058388|NCT01947491|453508818|FG000|Overall Study|Lack of Efficacy|1|||
126058389|NCT01947491|453508819|FG001|Overall Study|Lack of Efficacy|0|||
126107277|NCT00688103|453684857|FG001|Overall Study|Lack of Efficacy|1|||
126107278|NCT00688103|453684856|FG000|Overall Study|Withdrawal by Subject|4|||
126107279|NCT00688103|453684857|FG001|Overall Study|Withdrawal by Subject|2|||
126107280|NCT00688103|453684856|FG000|Overall Study|complex reasons|11|||
126107281|NCT00688103|453684857|FG001|Overall Study|complex reasons|9|||
126107282|NCT03602261|453684858|FG000|Overall Study|Adverse Event|5|||
126107283|NCT03602261|453684859|FG001|Overall Study|Adverse Event|1|||
126107284|NCT03602261|453684858|FG000|Overall Study|Physician Decision|1|||
126107285|NCT03602261|453684859|FG001|Overall Study|Physician Decision|0|||
126107286|NCT03602261|453684858|FG000|Overall Study|Withdrawal by Subject|1|||
126107287|NCT03602261|453684859|FG001|Overall Study|Withdrawal by Subject|1|||
126107288|NCT03602261|453684858|FG000|Overall Study|Lack of Efficacy|0|||
126107289|NCT03602261|453684859|FG001|Overall Study|Lack of Efficacy|1|||
126107290|NCT03602261|453684858|FG000|Overall Study|Subject moving out of state|1|||
126107291|NCT03602261|453684859|FG001|Overall Study|Subject moving out of state|0|||
126107292|NCT01101477|453687598|FG000|Overall Study|Protocol Violation|5|||
126107293|NCT01101477|453687599|FG001|Overall Study|Protocol Violation|3|||
126107294|NCT01101477|453687600|FG002|Overall Study|Protocol Violation|1|||
126107295|NCT02382016|453687601|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
126107296|NCT02382016|453687602|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
126107297|NCT02382016|453687601|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
126107298|NCT02382016|453687602|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
126107299|NCT02382016|453687601|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
126107300|NCT02382016|453687602|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
126107301|NCT02382016|453687601|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
126107302|NCT02382016|453687602|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
126107303|NCT02382016|453687601|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
126107304|NCT02382016|453687602|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
126107305|NCT02382016|453687601|FG000|Open-label (OL) Treatment Period|Death|4|||
126107306|NCT02382016|453687602|FG001|Open-label (OL) Treatment Period|Death|0|||
126107307|NCT02382016|453687601|FG000|OL Extension Period|Physician Decision|3|||
126107308|NCT02382016|453687602|FG001|OL Extension Period|Physician Decision|0|||
126107309|NCT02382016|453687601|FG000|OL Extension Period|Death|2|||
126107310|NCT02382016|453687602|FG001|OL Extension Period|Death|0|||
126107311|NCT02382016|453687601|FG000|OL Extension Period|Withdrawal by Subject|1|||
126107312|NCT02382016|453687602|FG001|OL Extension Period|Withdrawal by Subject|0|||
126107313|NCT00084266|453687603|FG000|Overall Study|Death|42|||
126107314|NCT00084266|453687604|FG001|Overall Study|Death|39|||
126107315|NCT00084266|453687603|FG000|Overall Study|Adverse Event|8|||
126107316|NCT00084266|453687604|FG001|Overall Study|Adverse Event|5|||
126107317|NCT00084266|453687603|FG000|Overall Study|Lack of Efficacy|2|||
126107318|NCT00084266|453687604|FG001|Overall Study|Lack of Efficacy|4|||
126107319|NCT00084266|453687603|FG000|Overall Study|Lost to Follow-up|5|||
126107320|NCT00084266|453687604|FG001|Overall Study|Lost to Follow-up|3|||
126107321|NCT00084266|453687603|FG000|Overall Study|Participant not willing to participate|3|||
126107322|NCT00084266|453687604|FG001|Overall Study|Participant not willing to participate|8|||
126107323|NCT00084266|453687603|FG000|Overall Study|Other|360|||
126107324|NCT00084266|453687604|FG001|Overall Study|Other|344|||
126107325|NCT00084266|453687603|FG000|Overall Study|Randomized not treated|21|||
126107326|NCT00084266|453687604|FG001|Overall Study|Randomized not treated|20|||
126107327|NCT00730171|453687605|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
126107328|NCT00730171|453687605|FG000|Overall Study|Adverse Event|193|||
126107329|NCT00730171|453687605|FG000|Overall Study|Protocol Violation|48|||
126107330|NCT00730171|453687605|FG000|Overall Study|Withdrawal by Subject|202|||
126107331|NCT00730171|453687605|FG000|Overall Study|Lost to Follow-up|121|||
126107332|NCT00730171|453687605|FG000|Overall Study|Insufficient Therapeutic Response|141|||
126107333|NCT00730171|453687605|FG000|Overall Study|Other|61|||
126107334|NCT01729156|453687606|FG000|Overall Study|Withdrawal by Subject|1|||
126107335|NCT01729156|453687607|FG001|Overall Study|Withdrawal by Subject|0|||
126107336|NCT01729156|453687608|FG002|Overall Study|Withdrawal by Subject|0|||
126107337|NCT02544217|453687609|FG000|Overall Study|Withdrawal by Subject|1|||
126107338|NCT02544217|453687610|FG001|Overall Study|Withdrawal by Subject|1|||
126107339|NCT02544217|453687611|FG002|Overall Study|Withdrawal by Subject|0|||
126107340|NCT02544217|453687612|FG003|Overall Study|Withdrawal by Subject|0|||
126107341|NCT02544217|453687613|FG004|Overall Study|Withdrawal by Subject|0|||
126107342|NCT02544217|453687614|FG005|Overall Study|Withdrawal by Subject|0|||
126107343|NCT02901041|453687617|FG000|Overall Study|Withdrawal by PI|4|||
126107344|NCT02901041|453687618|FG001|Overall Study|Withdrawal by PI|8|||
126107345|NCT02901041|453687617|FG000|Overall Study|Withdrawal by Subject|7|||
126107346|NCT02901041|453687618|FG001|Overall Study|Withdrawal by Subject|3|||
126107347|NCT00975507|453687622|FG000|Overall Study|Adverse Event|1|||
126107348|NCT00975507|453687623|FG001|Overall Study|Adverse Event|0|||
126107349|NCT00975507|453687622|FG000|Overall Study|Lost to Follow-up|7|||
126107350|NCT00975507|453687623|FG001|Overall Study|Lost to Follow-up|1|||
126107351|NCT00975507|453687622|FG000|Overall Study|Protocol Violation|2|||
125892616|NCT00101452|452904776|FG000|Overall Study|Withdrawal by Subject|10|||
126058390|NCT01947491|453508820|FG002|Overall Study|Lack of Efficacy|0|||
126058391|NCT01947491|453508821|FG003|Overall Study|Lack of Efficacy|1|||
126058392|NCT01947491|453508818|FG000|Overall Study|Protocol Violation|1|||
126058393|NCT01947491|453508819|FG001|Overall Study|Protocol Violation|0|||
126058394|NCT01947491|453508820|FG002|Overall Study|Protocol Violation|0|||
126058395|NCT01947491|453508821|FG003|Overall Study|Protocol Violation|0|||
126058396|NCT01947491|453508818|FG000|Overall Study|Withdrawal by Subject|1|||
126058397|NCT01947491|453508819|FG001|Overall Study|Withdrawal by Subject|1|||
126058398|NCT01947491|453508820|FG002|Overall Study|Withdrawal by Subject|1|||
126058399|NCT01947491|453508821|FG003|Overall Study|Withdrawal by Subject|0|||
126058400|NCT01947491|453508818|FG000|Overall Study|Worsening of condition|0|||
126058401|NCT01947491|453508819|FG001|Overall Study|Worsening of condition|1|||
126058402|NCT01947491|453508820|FG002|Overall Study|Worsening of condition|0|||
126058403|NCT01947491|453508821|FG003|Overall Study|Worsening of condition|0|||
126058404|NCT01947491|453508818|FG000|Overall Study|Adverse Event|0|||
126058405|NCT01947491|453508819|FG001|Overall Study|Adverse Event|1|||
126058406|NCT01947491|453508820|FG002|Overall Study|Adverse Event|0|||
126058407|NCT01947491|453508821|FG003|Overall Study|Adverse Event|2|||
126058408|NCT02067663|453508822|FG000|Overall Study|Lost to Follow-up|13|||
126058409|NCT02067663|453508823|FG001|Overall Study|Lost to Follow-up|14|||
126058410|NCT03137784|453508824|FG000|Overall Study|Adverse Event|1|||
126058411|NCT03137784|453508825|FG001|Overall Study|Adverse Event|1|||
126058412|NCT03137784|453508826|FG002|Overall Study|Adverse Event|0|||
126058413|NCT03137784|453508827|FG003|Overall Study|Adverse Event|0|||
126058414|NCT03137784|453508828|FG004|Overall Study|Adverse Event|0|||
126058415|NCT03137784|453508829|FG005|Overall Study|Adverse Event|0|||
126058416|NCT03137784|453508824|FG000|Overall Study|Subject/guardian decision|1|||
126058417|NCT03137784|453508825|FG001|Overall Study|Subject/guardian decision|0|||
126058418|NCT03137784|453508826|FG002|Overall Study|Subject/guardian decision|0|||
126058419|NCT03137784|453508827|FG003|Overall Study|Subject/guardian decision|0|||
126058420|NCT03137784|453508828|FG004|Overall Study|Subject/guardian decision|0|||
126058421|NCT03137784|453508829|FG005|Overall Study|Subject/guardian decision|0|||
126058422|NCT03137784|453508824|FG000|Overall Study|Non-compliance with study treatment|0|||
126058423|NCT03137784|453508825|FG001|Overall Study|Non-compliance with study treatment|0|||
126058424|NCT03137784|453508826|FG002|Overall Study|Non-compliance with study treatment|0|||
126058425|NCT03137784|453508827|FG003|Overall Study|Non-compliance with study treatment|0|||
126058426|NCT03137784|453508828|FG004|Overall Study|Non-compliance with study treatment|1|||
126058427|NCT03137784|453508829|FG005|Overall Study|Non-compliance with study treatment|0|||
126058428|NCT02736188|453508830|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
126058429|NCT02736188|453508830|FG000|Overall Study|Adverse Event|1|||
126107352|NCT00975507|453687623|FG001|Overall Study|Protocol Violation|0|||
126107353|NCT00975507|453687622|FG000|Overall Study|Withdrawal by Subject|10|||
126107354|NCT00975507|453687623|FG001|Overall Study|Withdrawal by Subject|3|||
126107355|NCT01112306|453687626|FG000|Overall Study|Death|175|||
126107356|NCT01112306|453687626|FG000|Overall Study|Lost to Follow-up|9|||
126107357|NCT01112306|453687626|FG000|Overall Study|Withdrawal by Subject|31|||
126107358|NCT01112306|453687626|FG000|Overall Study|Other|70|||
126107359|NCT03952806|453687628|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
125892617|NCT00101452|452904777|FG001|Overall Study|Withdrawal by Subject|14|||
125892618|NCT00101452|452904778|FG002|Overall Study|Withdrawal by Subject|9|||
125892619|NCT00101452|452904776|FG000|Overall Study|Baseline Fail|2|||
125892620|NCT00101452|452904777|FG001|Overall Study|Baseline Fail|1|||
125892621|NCT00101452|452904778|FG002|Overall Study|Baseline Fail|2|||
125892622|NCT00101452|452904776|FG000|Overall Study|Physician Decision|0|||
125892623|NCT00101452|452904777|FG001|Overall Study|Physician Decision|3|||
125892624|NCT00101452|452904778|FG002|Overall Study|Physician Decision|2|||
125892625|NCT00101452|452904776|FG000|Overall Study|Protocol Violation|2|||
125892626|NCT00101452|452904777|FG001|Overall Study|Protocol Violation|1|||
125892627|NCT00101452|452904778|FG002|Overall Study|Protocol Violation|3|||
125892628|NCT00101452|452904776|FG000|Overall Study|Other|15|||
125892629|NCT00101452|452904777|FG001|Overall Study|Other|16|||
125892630|NCT00101452|452904778|FG002|Overall Study|Other|12|||
125892631|NCT00499590|452904779|FG000|Overall Study|Study Terminated|112|||
125892632|NCT00499590|452904780|FG001|Overall Study|Study Terminated|112|||
125892633|NCT00499590|452904781|FG002|Overall Study|Study Terminated|112|||
125892634|NCT00499590|452904779|FG000|Overall Study|Not treated|1|||
125892635|NCT00499590|452904780|FG001|Overall Study|Not treated|0|||
125892636|NCT00499590|452904781|FG002|Overall Study|Not treated|1|||
125892637|NCT05661851|452904782|FG000|Overall Study|Protocol Violation|1|||
125892638|NCT05661851|452904783|FG001|Overall Study|Protocol Violation|1|||
125892639|NCT05661851|452904782|FG000|Overall Study|Covid-19 Related|3|||
125892640|NCT05661851|452904783|FG001|Overall Study|Covid-19 Related|4|||
125892641|NCT05661851|452904782|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
125892642|NCT05661851|452904783|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
125892643|NCT05661851|452904782|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
125892644|NCT05661851|452904783|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
125892645|NCT01014910|452904784|FG000|Overall Study|Withdrawal by Subject|0|||
125892646|NCT01014910|452904785|FG001|Overall Study|Withdrawal by Subject|2|||
125892647|NCT00612807|452904786|FG000|Overall Study|Withdrawal by Subject|2|||
125892648|NCT00612807|452904787|FG001|Overall Study|Withdrawal by Subject|0|||
125892649|NCT01215097|452904788|FG000|Overall Study|Adverse Event|1|||
125892650|NCT01215097|452904789|FG001|Overall Study|Adverse Event|3|||
125892651|NCT01215097|452904788|FG000|Overall Study|Protocol Violation|0|||
125892652|NCT01215097|452904789|FG001|Overall Study|Protocol Violation|2|||
125892653|NCT01215097|452904788|FG000|Overall Study|Lost to Follow-up|2|||
125892654|NCT01215097|452904789|FG001|Overall Study|Lost to Follow-up|0|||
125892655|NCT01215097|452904788|FG000|Overall Study|Withdrawal by Subject|6|||
125892656|NCT01215097|452904789|FG001|Overall Study|Withdrawal by Subject|3|||
125892657|NCT01215097|452904788|FG000|Overall Study|Lack of Efficacy|0|||
125892658|NCT01215097|452904789|FG001|Overall Study|Lack of Efficacy|3|||
125892659|NCT01215097|452904788|FG000|Overall Study|patient's refusal to come|2|||
126107360|NCT03952806|453687629|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
125892660|NCT01215097|452904789|FG001|Overall Study|patient's refusal to come|2|||
125892661|NCT01215097|452904788|FG000|Overall Study|patient's private reason|1|||
125892662|NCT01215097|452904789|FG001|Overall Study|patient's private reason|1|||
125892663|NCT02252939|452904790|FG000|Overall Study|Lost to Follow-up|3|||
125892664|NCT00870584|452904794|FG000|Overall Study|Adverse Event|3|||
126058430|NCT02736188|453508830|FG000|Overall Study|Withdrawal by Subject|1|||
126058431|NCT02736188|453508830|FG000|Overall Study|Other|6|||
126058432|NCT00240994|453508831|FG000|Overall Study|Lost to Follow-up|1|||
126058433|NCT00240994|453508831|FG000|Overall Study|Protocol Violation|1|||
126058434|NCT00240994|453508831|FG000|Overall Study|Graft failure|1|||
126058435|NCT03142932|453508832|FG000|Overall Study|Lost to Follow-up|2|||
126058436|NCT03142932|453508833|FG001|Overall Study|Lost to Follow-up|11|||
126058437|NCT04070105|453508834|FG000|Overall Study|Lost to Follow-up|0|||
126058438|NCT04070105|453508835|FG001|Overall Study|Lost to Follow-up|0|||
126058439|NCT04070105|453508836|FG002|Overall Study|Lost to Follow-up|0|||
126058440|NCT04070105|453508837|FG003|Overall Study|Lost to Follow-up|0|||
126058441|NCT04070105|453508838|FG004|Overall Study|Lost to Follow-up|0|||
126058442|NCT04070105|453508839|FG005|Overall Study|Lost to Follow-up|1|||
126058443|NCT00749944|453508844|FG000|Overall Study|Lost to Follow-up|2|||
126058444|NCT00749944|453508845|FG001|Overall Study|Lost to Follow-up|1|||
126058445|NCT00749944|453508844|FG000|Overall Study|Other|1|||
126058446|NCT00749944|453508845|FG001|Overall Study|Other|0|||
126058447|NCT00749944|453508844|FG000|Overall Study|Withdrawal by Subject|2|||
126058448|NCT00749944|453508845|FG001|Overall Study|Withdrawal by Subject|0|||
126058449|NCT03547154|453508859|FG000|Overall Study|Disease Progression/Recurrence|6|||
126058450|NCT03547154|453508860|FG001|Overall Study|Disease Progression/Recurrence|14|||
126058451|NCT03547154|453508859|FG000|Overall Study|Adverse Event|26|||
126058452|NCT03547154|453508860|FG001|Overall Study|Adverse Event|31|||
126058453|NCT03547154|453508859|FG000|Overall Study|Protocol Violation|6|||
126058454|NCT03547154|453508860|FG001|Overall Study|Protocol Violation|1|||
126058455|NCT03547154|453508859|FG000|Overall Study|Physician Decision|4|||
126058456|NCT03547154|453508860|FG001|Overall Study|Physician Decision|3|||
126058457|NCT03547154|453508859|FG000|Overall Study|Insufficient Therapeutic Response|13|||
126058458|NCT03547154|453508860|FG001|Overall Study|Insufficient Therapeutic Response|10|||
126058459|NCT03547154|453508859|FG000|Overall Study|Withdrawal by Subject|10|||
126058460|NCT03547154|453508860|FG001|Overall Study|Withdrawal by Subject|6|||
126058461|NCT03547154|453508859|FG000|Overall Study|Not Selected|0|||
126058462|NCT03547154|453508860|FG001|Overall Study|Not Selected|1|||
126058463|NCT03547154|453508859|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
126058464|NCT03547154|453508860|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
126058465|NCT00895245|453508861|FG000|Overall Study|Lack of Efficacy|6|||
126058466|NCT02706483|453508862|FG000|Overall Study|Adverse Event|97|||
126058467|NCT02706483|453508862|FG000|Overall Study|Death|1|||
126058468|NCT02706483|453508862|FG000|Overall Study|Lack of Efficacy|39|||
126058469|NCT02706483|453508862|FG000|Overall Study|Lost to Follow-up|101|||
126058470|NCT02706483|453508862|FG000|Overall Study|Non-compliance with study drug|15|||
126058471|NCT02706483|453508862|FG000|Overall Study|Physician Decision|6|||
126058472|NCT02706483|453508862|FG000|Overall Study|Pregnancy|6|||
126058473|NCT02706483|453508862|FG000|Overall Study|Protocol Violation|18|||
126058474|NCT02706483|453508862|FG000|Overall Study|Withdrawal by Subject|136|||
126058475|NCT02706483|453508862|FG000|Overall Study|Non-compliance with visits|6|||
126058476|NCT02706483|453508862|FG000|Overall Study|Site closure|4|||
126058477|NCT02706483|453508862|FG000|Overall Study|Subject moved|1|||
126058478|NCT01972776|453508863|FG000|Part 1|Withdrawal by Subject|0|||
126058479|NCT01972776|453508864|FG001|Part 1|Withdrawal by Subject|0|||
126058480|NCT01972776|453508865|FG002|Part 1|Withdrawal by Subject|1|||
126058481|NCT01972776|453508866|FG003|Part 1|Withdrawal by Subject|0|||
126058482|NCT01972776|453508867|FG004|Part 1|Withdrawal by Subject|0|||
126058483|NCT01972776|453508868|FG005|Part 1|Withdrawal by Subject|0|||
126058484|NCT01972776|453508863|FG000|Part 1|Adverse Event|0|||
126058485|NCT01972776|453508864|FG001|Part 1|Adverse Event|0|||
126058486|NCT01972776|453508865|FG002|Part 1|Adverse Event|1|||
126058487|NCT01972776|453508866|FG003|Part 1|Adverse Event|1|||
126058488|NCT01972776|453508867|FG004|Part 1|Adverse Event|0|||
126058489|NCT01972776|453508868|FG005|Part 1|Adverse Event|0|||
126058490|NCT01972776|453508863|FG000|Part 2|Adverse Event|0|||
126058491|NCT01972776|453508864|FG001|Part 2|Adverse Event|0|||
126058492|NCT01972776|453508865|FG002|Part 2|Adverse Event|0|||
126058493|NCT01972776|453508866|FG003|Part 2|Adverse Event|0|||
126058494|NCT01972776|453508867|FG004|Part 2|Adverse Event|3|||
126058495|NCT01972776|453508868|FG005|Part 2|Adverse Event|0|||
126058496|NCT01972776|453508863|FG000|Part 2|Administrative problems|0|||
126058497|NCT01972776|453508864|FG001|Part 2|Administrative problems|0|||
126058498|NCT01972776|453508865|FG002|Part 2|Administrative problems|0|||
126058499|NCT01972776|453508866|FG003|Part 2|Administrative problems|0|||
126058500|NCT01972776|453508867|FG004|Part 2|Administrative problems|10|||
126058501|NCT01972776|453508868|FG005|Part 2|Administrative problems|7|||
126058502|NCT01543204|453508869|FG000|Overall Study|Non-compliance|1|||
126058503|NCT01543204|453508869|FG000|Overall Study|Adverse Event|1|||
126058504|NCT01543204|453508869|FG000|Overall Study|Withdrawal by Subject|4|||
126058505|NCT01543204|453508869|FG000|Overall Study|Requirement for Alternative Therapy|1|||
126058506|NCT01543204|453508869|FG000|Overall Study|Lost to Follow-up|1|||
126058507|NCT02449902|453508873|FG000|Overall Study|Adverse Event|0|||
126058508|NCT02449902|453508874|FG001|Overall Study|Adverse Event|1|||
126058509|NCT02449902|453508873|FG000|Overall Study|Withdrawal by Subject|0|||
126058510|NCT02449902|453508874|FG001|Overall Study|Withdrawal by Subject|1|||
126058511|NCT02362789|453508875|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
126058512|NCT02362789|453508876|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
126058513|NCT02362789|453508877|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
126058514|NCT02362789|453508875|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
126058515|NCT02362789|453508876|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
126058516|NCT02362789|453508877|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
126058517|NCT02362789|453508875|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
126058518|NCT02362789|453508876|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
126058519|NCT02362789|453508877|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
126058520|NCT02362789|453508875|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
126058521|NCT02362789|453508876|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
126058522|NCT02362789|453508877|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
126058523|NCT02362789|453508875|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
126058524|NCT02362789|453508876|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
126058525|NCT02362789|453508877|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
126058526|NCT00068107|453508884|FG000|Overall Study|end-stage renal disease|6|||
126058527|NCT00068107|453508884|FG000|Overall Study|Death|2|||
126058528|NCT00068107|453508884|FG000|Overall Study|Withdrawal by Subject|1|||
126058529|NCT03288506|453508885|FG000|Overall Study|Withdrawal by Subject|52|||
126058530|NCT01419184|453508888|FG000|Overall Study|Site data not available|3|||
126058531|NCT01419184|453508889|FG001|Overall Study|Site data not available|2|||
126058532|NCT01419184|453508888|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
126058533|NCT01419184|453508889|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
126058534|NCT01419184|453508888|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
126058535|NCT01419184|453508889|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
126058536|NCT01419184|453508888|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
126107361|NCT03952806|453687628|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
126107362|NCT03952806|453687629|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
126107363|NCT03952806|453687628|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
126107364|NCT03952806|453687629|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
126107365|NCT03952806|453687628|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
126107366|NCT03952806|453687629|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
126107367|NCT03952806|453687628|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
126107368|NCT03952806|453687629|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
126107369|NCT03952806|453687628|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
126107370|NCT03952806|453687629|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
126107371|NCT03952806|453687628|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
126107372|NCT03952806|453687629|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
126107373|NCT03952806|453687628|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
126107374|NCT03952806|453687629|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
126107375|NCT03952806|453687628|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
126107376|NCT03952806|453687629|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
126107377|NCT03952806|453687628|FG000|OLE Phase (48 Weeks)|Other|16|||
126107378|NCT03952806|453687629|FG001|OLE Phase (48 Weeks)|Other|13|||
126107379|NCT00655863|453687630|FG000|Overall Study|Lost to Follow-up|0|||
126107380|NCT00655863|453687631|FG001|Overall Study|Lost to Follow-up|0|||
126107381|NCT00655863|453687632|FG002|Overall Study|Lost to Follow-up|1|||
126107382|NCT01138007|453687633|FG000|Overall Study|Adverse Event|4|||
126107383|NCT01138007|453687634|FG001|Overall Study|Adverse Event|12|||
126107384|NCT01138007|453687635|FG002|Overall Study|Adverse Event|9|||
126107385|NCT01138007|453687633|FG000|Overall Study|Lack of Efficacy|2|||
126107386|NCT01138007|453687634|FG001|Overall Study|Lack of Efficacy|0|||
126107387|NCT01138007|453687635|FG002|Overall Study|Lack of Efficacy|6|||
126107388|NCT01138007|453687633|FG000|Overall Study|Protocol Violation|2|||
126107389|NCT01138007|453687634|FG001|Overall Study|Protocol Violation|3|||
126107390|NCT01138007|453687635|FG002|Overall Study|Protocol Violation|2|||
126107391|NCT01138007|453687633|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
126107392|NCT01138007|453687634|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
126107393|NCT01138007|453687635|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
126107394|NCT01138007|453687633|FG000|Overall Study|Lost to Follow-up|3|||
126107395|NCT01138007|453687634|FG001|Overall Study|Lost to Follow-up|3|||
126107396|NCT01138007|453687635|FG002|Overall Study|Lost to Follow-up|5|||
126107397|NCT01138007|453687633|FG000|Overall Study|Physician Decision|0|||
126107398|NCT01138007|453687634|FG001|Overall Study|Physician Decision|5|||
126107399|NCT01138007|453687635|FG002|Overall Study|Physician Decision|3|||
126107400|NCT01138007|453687633|FG000|Overall Study|Withdrawal by Subject|5|||
126107401|NCT01138007|453687634|FG001|Overall Study|Withdrawal by Subject|6|||
126107402|NCT01138007|453687635|FG002|Overall Study|Withdrawal by Subject|15|||
126107403|NCT04661878|453687636|FG000|Overall Study|Lost to Follow-up|6|||
126107404|NCT04661878|453687637|FG001|Overall Study|Lost to Follow-up|5|||
126107405|NCT04442737|453687642|FG000|Overall Study|Lost to Follow-up|1|||
126107406|NCT04442737|453687643|FG001|Overall Study|Lost to Follow-up|3|||
126107407|NCT04442737|453687642|FG000|Overall Study|Withdrawal by Subject|3|||
126107408|NCT04442737|453687643|FG001|Overall Study|Withdrawal by Subject|2|||
126058537|NCT01419184|453508889|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
126058538|NCT01419184|453508888|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
126058539|NCT01419184|453508889|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
126058540|NCT01419184|453508888|FG000|Overall Study|Participant randomized, not treated|1|||
126058541|NCT01419184|453508889|FG001|Overall Study|Participant randomized, not treated|0|||
126058542|NCT02691702|453508890|FG000|Overall Study|Adverse Event|1|||
126058543|NCT02691702|453508891|FG001|Overall Study|Adverse Event|0|||
126058544|NCT02691702|453508892|FG002|Overall Study|Adverse Event|0|||
126058545|NCT02691702|453508893|FG003|Overall Study|Adverse Event|0|||
126058546|NCT02691702|453508894|FG004|Overall Study|Adverse Event|0|||
126058547|NCT02691702|453508895|FG005|Overall Study|Adverse Event|0|||
126058548|NCT02691702|453508896|FG006|Overall Study|Adverse Event|0|||
126058549|NCT02691702|453508897|FG007|Overall Study|Adverse Event|0|||
126058550|NCT02691702|453508898|FG008|Overall Study|Adverse Event|1|||
126058551|NCT02691702|453508899|FG009|Overall Study|Adverse Event|0|||
126058552|NCT02691702|453508900|FG010|Overall Study|Adverse Event|1|||
126058553|NCT02691702|453508890|FG000|Overall Study|Lost to Follow-up|0|||
126107409|NCT04442737|453687642|FG000|Overall Study|Adverse Event|3|||
125892665|NCT00870584|452904795|FG001|Overall Study|Adverse Event|3|||
125892666|NCT00870584|452904794|FG000|Overall Study|Withdrawal by Subject|6|||
125892667|NCT00870584|452904795|FG001|Overall Study|Withdrawal by Subject|7|||
125892668|NCT00870584|452904794|FG000|Overall Study|Lost to Follow-up|5|||
125892669|NCT00870584|452904795|FG001|Overall Study|Lost to Follow-up|1|||
125892670|NCT00870584|452904794|FG000|Overall Study|Protocol Deviation|2|||
125892671|NCT00870584|452904795|FG001|Overall Study|Protocol Deviation|2|||
125892672|NCT01497366|452904796|FG000|Overall Study|Virologic failure|2|||
125892673|NCT01497366|452904797|FG001|Overall Study|Virologic failure|50|||
125892674|NCT01497366|452904796|FG000|Overall Study|Lost to Follow-up|11|||
125892675|NCT01497366|452904797|FG001|Overall Study|Lost to Follow-up|10|||
125892676|NCT01497366|452904796|FG000|Overall Study|Withdrawal by Subject|6|||
125892677|NCT01497366|452904797|FG001|Overall Study|Withdrawal by Subject|6|||
125892678|NCT01497366|452904796|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
125892679|NCT01497366|452904797|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
125892680|NCT01497366|452904796|FG000|Overall Study|Other|5|||
125892681|NCT01497366|452904797|FG001|Overall Study|Other|0|||
125892682|NCT01497366|452904796|FG000|Overall Study|Death|1|||
125892683|NCT01497366|452904797|FG001|Overall Study|Death|1|||
125892684|NCT01497366|452904796|FG000|Overall Study|Randomized but not treated|7|||
125892685|NCT01497366|452904797|FG001|Overall Study|Randomized but not treated|21|||
125892686|NCT02745080|452904811|FG000|Overall Study|Adverse Event|13|||
125892687|NCT02745080|452904812|FG001|Overall Study|Adverse Event|21|||
125892688|NCT02745080|452904811|FG000|Overall Study|Lack of Efficacy|11|||
125892689|NCT02745080|452904812|FG001|Overall Study|Lack of Efficacy|23|||
125892690|NCT02745080|452904811|FG000|Overall Study|Lost to Follow-up|3|||
126107410|NCT04442737|453687643|FG001|Overall Study|Adverse Event|2|||
126107411|NCT04442737|453687642|FG000|Overall Study|Death|0|||
126107412|NCT04442737|453687643|FG001|Overall Study|Death|1|||
126107413|NCT04442737|453687642|FG000|Overall Study|Protocol Violation|0|||
126107414|NCT04442737|453687643|FG001|Overall Study|Protocol Violation|2|||
126107415|NCT04442737|453687642|FG000|Overall Study|Other|1|||
126107416|NCT04442737|453687643|FG001|Overall Study|Other|1|||
126107417|NCT00744523|453687644|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
126107418|NCT00744523|453687645|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
126107419|NCT05333224|453687649|FG000|Overall Study - Infants|Lost to Follow-up|1|||
126107420|NCT05333224|453687650|FG001|Overall Study - Infants|Lost to Follow-up|1|||
126107421|NCT00063154|453687651|FG000|Overall Study|Disease progression|27|||
126107422|NCT00063154|453687651|FG000|Overall Study|Adverse Event|2|||
126107423|NCT00063154|453687651|FG000|Overall Study|Physician Decision|10|||
126107424|NCT00063154|453687651|FG000|Overall Study|Death|3|||
126107425|NCT00063154|453687651|FG000|Overall Study|Reason unspecified|1|||
126107426|NCT00063154|453687651|FG000|Overall Study|Did not receive treatment|8|||
126107427|NCT03588728|453687652|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
126107428|NCT03588728|453687653|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
126107429|NCT03588728|453687654|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
126107430|NCT03588728|453687655|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
126107431|NCT03588728|453687652|FG000|Overall Study|Lab shut down due to COVID-19|0|||
126107432|NCT03588728|453687653|FG001|Overall Study|Lab shut down due to COVID-19|0|||
126107433|NCT03588728|453687654|FG002|Overall Study|Lab shut down due to COVID-19|0|||
126107434|NCT03588728|453687655|FG003|Overall Study|Lab shut down due to COVID-19|1|||
126107435|NCT03588728|453687652|FG000|Overall Study|multiple technical issues|1|||
126107436|NCT03588728|453687653|FG001|Overall Study|multiple technical issues|0|||
126107437|NCT03588728|453687654|FG002|Overall Study|multiple technical issues|0|||
126107438|NCT03588728|453687655|FG003|Overall Study|multiple technical issues|0|||
126107439|NCT03588728|453687652|FG000|Overall Study|Hospitalized for COVID|1|||
126107440|NCT03588728|453687653|FG001|Overall Study|Hospitalized for COVID|0|||
126107441|NCT03588728|453687654|FG002|Overall Study|Hospitalized for COVID|0|||
126107442|NCT03588728|453687655|FG003|Overall Study|Hospitalized for COVID|0|||
126107443|NCT03588728|453687652|FG000|Overall Study|Schedule change unable to attend sessions|1|||
126107444|NCT03588728|453687653|FG001|Overall Study|Schedule change unable to attend sessions|0|||
126107445|NCT03588728|453687654|FG002|Overall Study|Schedule change unable to attend sessions|0|||
126107446|NCT03588728|453687655|FG003|Overall Study|Schedule change unable to attend sessions|0|||
126107447|NCT02027701|453687656|FG000|Overall Study|Adverse Event|3|||
126107448|NCT02027701|453687656|FG000|Overall Study|Lack of Efficacy|8|||
126107449|NCT02027701|453687656|FG000|Overall Study|Physician Decision|2|||
126107450|NCT02027701|453687656|FG000|Overall Study|Withdrawal by Subject|3|||
126107451|NCT03285178|453687657|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
126107452|NCT03285178|453687658|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126107453|NCT03285178|453687659|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126107454|NCT03285178|453687660|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126107455|NCT03285178|453687661|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126107456|NCT03285178|453687662|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126107457|NCT03285178|453687663|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126107458|NCT03285178|453687657|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
126107459|NCT03285178|453687658|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126107460|NCT03285178|453687659|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126107461|NCT03285178|453687660|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126107462|NCT03285178|453687661|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126107463|NCT03285178|453687662|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
125892691|NCT02745080|452904812|FG001|Overall Study|Lost to Follow-up|3|||
125892692|NCT02745080|452904811|FG000|Overall Study|Physician Decision|3|||
126107464|NCT03285178|453687663|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126107465|NCT03285178|453687657|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
126107466|NCT03285178|453687658|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
126107467|NCT03285178|453687659|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
126107468|NCT03285178|453687660|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
126107469|NCT03285178|453687661|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
126107470|NCT03285178|453687662|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
126107471|NCT03285178|453687663|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
126107472|NCT03285178|453687657|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
126107473|NCT03285178|453687658|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126107474|NCT03285178|453687659|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126107475|NCT03285178|453687660|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126107476|NCT03285178|453687661|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126107477|NCT03285178|453687662|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126107478|NCT03285178|453687663|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126107479|NCT03285178|453687657|FG000|Single-Blind Run-In Period|Physician Decision|2|||
126107480|NCT03285178|453687658|FG001|Single-Blind Run-In Period|Physician Decision|0|||
126107481|NCT03285178|453687659|FG002|Single-Blind Run-In Period|Physician Decision|0|||
126107482|NCT03285178|453687660|FG003|Single-Blind Run-In Period|Physician Decision|0|||
126107483|NCT03285178|453687661|FG004|Single-Blind Run-In Period|Physician Decision|0|||
126107484|NCT03285178|453687662|FG005|Single-Blind Run-In Period|Physician Decision|0|||
126107485|NCT03285178|453687663|FG006|Single-Blind Run-In Period|Physician Decision|0|||
126107486|NCT03285178|453687657|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126107487|NCT03285178|453687658|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
126107488|NCT03285178|453687659|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
126107489|NCT03285178|453687660|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126107490|NCT03285178|453687661|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126107491|NCT03285178|453687662|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126107492|NCT03285178|453687663|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126107493|NCT03285178|453687657|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126107494|NCT03285178|453687658|FG001|Double-Blind Treatment Period|Adverse Event|0|||
126107495|NCT03285178|453687659|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126107496|NCT03285178|453687660|FG003|Double-Blind Treatment Period|Adverse Event|0|||
126107497|NCT03285178|453687661|FG004|Double-Blind Treatment Period|Adverse Event|0|||
126107498|NCT03285178|453687662|FG005|Double-Blind Treatment Period|Adverse Event|0|||
126107499|NCT03285178|453687663|FG006|Double-Blind Treatment Period|Adverse Event|2|||
126107500|NCT03285178|453687657|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126107501|NCT03285178|453687658|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126107502|NCT03285178|453687659|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
126107503|NCT03285178|453687660|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
126107504|NCT03285178|453687661|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
126107505|NCT03285178|453687662|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
126107506|NCT03285178|453687663|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
126107507|NCT03285178|453687657|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126107508|NCT03285178|453687658|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126107509|NCT03285178|453687659|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126107510|NCT03285178|453687660|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126107511|NCT03285178|453687661|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126107512|NCT03285178|453687662|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126107513|NCT03285178|453687663|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126107514|NCT03285178|453687657|FG000|Double-Blind Treatment Period|COVID-19|0|||
126107515|NCT03285178|453687658|FG001|Double-Blind Treatment Period|COVID-19|0|||
126107516|NCT03285178|453687659|FG002|Double-Blind Treatment Period|COVID-19|1|||
126107517|NCT03285178|453687660|FG003|Double-Blind Treatment Period|COVID-19|0|||
126107518|NCT03285178|453687661|FG004|Double-Blind Treatment Period|COVID-19|0|||
126107519|NCT03285178|453687662|FG005|Double-Blind Treatment Period|COVID-19|0|||
126107520|NCT03285178|453687663|FG006|Double-Blind Treatment Period|COVID-19|0|||
126107521|NCT01388790|453687664|FG000|Overall Study|Ongoing at data cut-off date|8|||
126107522|NCT01128894|453687665|FG000|Overall Study|Adverse Event|31|||
126107523|NCT01128894|453687666|FG001|Overall Study|Adverse Event|41|||
126107524|NCT01128894|453687665|FG000|Overall Study|Protocol Violation|2|||
126107525|NCT01128894|453687666|FG001|Overall Study|Protocol Violation|1|||
126107526|NCT01128894|453687665|FG000|Overall Study|Noncompliance|4|||
125892693|NCT02745080|452904812|FG001|Overall Study|Physician Decision|0|||
125892694|NCT02745080|452904811|FG000|Overall Study|Protocol Violation|3|||
125892695|NCT02745080|452904812|FG001|Overall Study|Protocol Violation|1|||
125892696|NCT02745080|452904811|FG000|Overall Study|Withdrawal by Subject|22|||
125892697|NCT02745080|452904812|FG001|Overall Study|Withdrawal by Subject|41|||
125892698|NCT01821560|452904815|FG000|Overall Study|Lost to Follow-up|5|||
125892699|NCT01821560|452904816|FG001|Overall Study|Lost to Follow-up|5|||
125892700|NCT01821560|452904815|FG000|Overall Study|Withdrawal by Subject|1|||
125892701|NCT01821560|452904816|FG001|Overall Study|Withdrawal by Subject|1|||
125892702|NCT01821560|452904815|FG000|Overall Study|Protocol Violation|0|||
125892703|NCT01821560|452904816|FG001|Overall Study|Protocol Violation|1|||
125892704|NCT01338298|452904819|FG000|Overall Study|Withdrawal by Subject|1|||
125892705|NCT01338298|452904820|FG001|Overall Study|Withdrawal by Subject|1|||
125892706|NCT01338298|452904819|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
125892707|NCT01338298|452904820|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
125892708|NCT01338298|452904819|FG000|Overall Study|Administrative error|0|||
125892709|NCT01338298|452904820|FG001|Overall Study|Administrative error|1|||
125892710|NCT01338298|452904819|FG000|Overall Study|Positive symptom worsening|1|||
125892711|NCT01338298|452904820|FG001|Overall Study|Positive symptom worsening|0|||
125892712|NCT01338298|452904819|FG000|Overall Study|Depressive symptoms and nausea|1|||
125892713|NCT01338298|452904820|FG001|Overall Study|Depressive symptoms and nausea|0|||
125892714|NCT01338298|452904819|FG000|Overall Study|Non-adherence|1|||
125892715|NCT01338298|452904820|FG001|Overall Study|Non-adherence|0|||
125892716|NCT05601544|452904821|FG000|Phase 2 Period 1|Adverse Event|0|||
125892717|NCT05601544|452904822|FG001|Phase 2 Period 1|Adverse Event|1|||
125892718|NCT05601544|452904823|FG002|Phase 2 Period 1|Adverse Event|0|||
125892719|NCT05601544|452904824|FG003|Phase 2 Period 1|Adverse Event|0|||
125892720|NCT05601544|452904825|FG004|Phase 2 Period 1|Adverse Event|0|||
125892721|NCT05601544|452904826|FG005|Phase 2 Period 1|Adverse Event|0|||
125892722|NCT00122980|452906708|FG000|Overall Study|Death|0|||
125892723|NCT00122980|452906709|FG001|Overall Study|Death|1|||
125892724|NCT00122980|452906708|FG000|Overall Study|Physician Decision|2|||
125892725|NCT00122980|452906709|FG001|Overall Study|Physician Decision|0|||
125892726|NCT00122980|452906708|FG000|Overall Study|Protocol Violation|5|||
125892727|NCT00122980|452906709|FG001|Overall Study|Protocol Violation|1|||
125892728|NCT00122980|452906708|FG000|Overall Study|Withdrawal by Subject|2|||
125892729|NCT00122980|452906709|FG001|Overall Study|Withdrawal by Subject|3|||
125892730|NCT00122980|452906708|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
125892731|NCT00122980|452906709|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
125892732|NCT00122980|452906708|FG000|Overall Study|Study termination|27|||
125892733|NCT00122980|452906709|FG001|Overall Study|Study termination|35|||
125892734|NCT01124864|452906710|FG000|Overall Study|Follow up phase competed as per protocol|18|||
125892735|NCT01124864|452906711|FG001|Overall Study|Follow up phase competed as per protocol|22|||
126107527|NCT01128894|453687666|FG001|Overall Study|Noncompliance|5|||
125892736|NCT01124864|452906712|FG002|Overall Study|Follow up phase competed as per protocol|24|||
125892737|NCT01124864|452906713|FG003|Overall Study|Follow up phase competed as per protocol|18|||
125892738|NCT01124864|452906714|FG004|Overall Study|Follow up phase competed as per protocol|26|||
125892739|NCT01124864|452906715|FG005|Overall Study|Follow up phase competed as per protocol|2|||
125892740|NCT01124864|452906710|FG000|Overall Study|Death|6|||
125892741|NCT01124864|452906711|FG001|Overall Study|Death|9|||
125892742|NCT01124864|452906712|FG002|Overall Study|Death|6|||
125892743|NCT01124864|452906713|FG003|Overall Study|Death|2|||
125892744|NCT01124864|452906714|FG004|Overall Study|Death|1|||
125892745|NCT01124864|452906715|FG005|Overall Study|Death|0|||
125892746|NCT01124864|452906710|FG000|Overall Study|Withdrawal by Subject|2|||
125892747|NCT01124864|452906711|FG001|Overall Study|Withdrawal by Subject|3|||
126107528|NCT01128894|453687665|FG000|Overall Study|Lost to Follow-up|8|||
126107529|NCT01128894|453687666|FG001|Overall Study|Lost to Follow-up|8|||
126107530|NCT01128894|453687665|FG000|Overall Study|Withdrawal by Subject|10|||
126107531|NCT01128894|453687666|FG001|Overall Study|Withdrawal by Subject|12|||
126107532|NCT01128894|453687665|FG000|Overall Study|Physician Decision|2|||
126107533|NCT01128894|453687666|FG001|Overall Study|Physician Decision|1|||
126107534|NCT01128894|453687665|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
126107535|NCT01128894|453687666|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
126107536|NCT00195507|453687667|FG000|Overall Study|Adverse Event|24|||
125892748|NCT01124864|452906712|FG002|Overall Study|Withdrawal by Subject|4|||
125892749|NCT01124864|452906713|FG003|Overall Study|Withdrawal by Subject|0|||
125892750|NCT01124864|452906714|FG004|Overall Study|Withdrawal by Subject|2|||
126107537|NCT00195507|453687668|FG001|Overall Study|Adverse Event|13|||
126107538|NCT00195507|453687667|FG000|Overall Study|Death|0|||
125892751|NCT01124864|452906715|FG005|Overall Study|Withdrawal by Subject|1|||
126107539|NCT00195507|453687668|FG001|Overall Study|Death|1|||
126107540|NCT00195507|453687667|FG000|Overall Study|Failed to Return|4|||
125892752|NCT01124864|452906710|FG000|Overall Study|Lost to Follow-up|1|||
126107541|NCT00195507|453687668|FG001|Overall Study|Failed to Return|3|||
125892753|NCT01124864|452906711|FG001|Overall Study|Lost to Follow-up|1|||
125892754|NCT01124864|452906712|FG002|Overall Study|Lost to Follow-up|0|||
125892755|NCT01124864|452906713|FG003|Overall Study|Lost to Follow-up|1|||
125892756|NCT01124864|452906714|FG004|Overall Study|Lost to Follow-up|0|||
125892757|NCT01124864|452906715|FG005|Overall Study|Lost to Follow-up|0|||
125892758|NCT01124864|452906710|FG000|Overall Study|Protocol Violation|1|||
125892759|NCT01124864|452906711|FG001|Overall Study|Protocol Violation|0|||
125892760|NCT01124864|452906712|FG002|Overall Study|Protocol Violation|0|||
125892761|NCT01124864|452906713|FG003|Overall Study|Protocol Violation|0|||
125892762|NCT01124864|452906714|FG004|Overall Study|Protocol Violation|1|||
125892763|NCT01124864|452906715|FG005|Overall Study|Protocol Violation|0|||
125892764|NCT01243242|452906716|FG000|Overall Study|Adverse Event|1|||
125892765|NCT01243242|452906717|FG001|Overall Study|Adverse Event|1|||
125892766|NCT01243242|452906716|FG000|Overall Study|Withdrawal by Subject|1|||
125892767|NCT01243242|452906717|FG001|Overall Study|Withdrawal by Subject|1|||
125892768|NCT01243242|452906716|FG000|Overall Study|Physician Decision|0|||
125892769|NCT01243242|452906717|FG001|Overall Study|Physician Decision|1|||
125892770|NCT01243242|452906716|FG000|Overall Study|sponsor decision|0|||
125892771|NCT01243242|452906717|FG001|Overall Study|sponsor decision|1|||
125892772|NCT01243242|452906716|FG000|Overall Study|non compliance|1|||
125892773|NCT01243242|452906717|FG001|Overall Study|non compliance|0|||
125892774|NCT00724711|452906718|FG000|Overall Study|Adverse Event|7|||
125892775|NCT00724711|452906719|FG001|Overall Study|Adverse Event|3|||
125892776|NCT00724711|452906718|FG000|Overall Study|Pregnancy|0|||
125892777|NCT00724711|452906719|FG001|Overall Study|Pregnancy|1|||
125892778|NCT00724711|452906718|FG000|Overall Study|Lack of Efficacy|0|||
125892779|NCT00724711|452906719|FG001|Overall Study|Lack of Efficacy|1|||
125892780|NCT00724711|452906718|FG000|Overall Study|Physician Decision|0|||
125892781|NCT00724711|452906719|FG001|Overall Study|Physician Decision|3|||
125892782|NCT00724711|452906718|FG000|Overall Study|Withdrawal by Subject|5|||
125892783|NCT00724711|452906719|FG001|Overall Study|Withdrawal by Subject|4|||
125892784|NCT00724711|452906718|FG000|Overall Study|Lost to Follow-up|4|||
125892785|NCT00724711|452906719|FG001|Overall Study|Lost to Follow-up|5|||
125892786|NCT00724711|452906718|FG000|Overall Study|Protocol Violation|1|||
125892787|NCT00724711|452906719|FG001|Overall Study|Protocol Violation|0|||
125892788|NCT01945710|452906720|FG000|Overall Study|Progressive Disease|5|||
125892789|NCT01945710|452906721|FG001|Overall Study|Progressive Disease|4|||
125892790|NCT01945710|452906722|FG002|Overall Study|Progressive Disease|3|||
125892791|NCT01945710|452906723|FG003|Overall Study|Progressive Disease|2|||
125892792|NCT01945710|452906724|FG004|Overall Study|Progressive Disease|7|||
126058554|NCT02691702|453508891|FG001|Overall Study|Lost to Follow-up|0|||
126058555|NCT02691702|453508892|FG002|Overall Study|Lost to Follow-up|1|||
126058556|NCT02691702|453508893|FG003|Overall Study|Lost to Follow-up|0|||
126058557|NCT02691702|453508894|FG004|Overall Study|Lost to Follow-up|0|||
126058558|NCT02691702|453508895|FG005|Overall Study|Lost to Follow-up|2|||
125892793|NCT01945710|452906725|FG005|Overall Study|Progressive Disease|3|||
125892794|NCT01945710|452906726|FG006|Overall Study|Progressive Disease|19|||
125892795|NCT01945710|452906720|FG000|Overall Study|Adverse Event|0|||
125892796|NCT01945710|452906721|FG001|Overall Study|Adverse Event|1|||
126058559|NCT02691702|453508896|FG006|Overall Study|Lost to Follow-up|0|||
126107542|NCT00195507|453687667|FG000|Overall Study|Physician Decision|1|||
126107543|NCT00195507|453687668|FG001|Overall Study|Physician Decision|2|||
126107544|NCT00195507|453687667|FG000|Overall Study|Lost to Follow-up|3|||
126107545|NCT00195507|453687668|FG001|Overall Study|Lost to Follow-up|2|||
126107546|NCT00195507|453687667|FG000|Overall Study|Protocol Violation|5|||
126107547|NCT00195507|453687668|FG001|Overall Study|Protocol Violation|4|||
126107548|NCT00195507|453687667|FG000|Overall Study|Lack of Efficacy|40|||
126107549|NCT00195507|453687668|FG001|Overall Study|Lack of Efficacy|67|||
126107550|NCT00195507|453687667|FG000|Overall Study|Withdrawal by Subject|16|||
126107551|NCT00195507|453687668|FG001|Overall Study|Withdrawal by Subject|23|||
126107552|NCT00195507|453687667|FG000|Overall Study|Protocol Deviation|6|||
126107553|NCT00195507|453687668|FG001|Overall Study|Protocol Deviation|3|||
126107554|NCT00973362|453687669|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
126107555|NCT00973362|453687670|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
126107556|NCT00973362|453687669|FG000|Baseline Evaluation|No colposcopy visit|62|||
126107557|NCT00973362|453687670|FG001|Baseline Evaluation|No colposcopy visit|0|||
126107558|NCT00973362|453687669|FG000|Baseline Evaluation|Inevaluable|686|||
126107559|NCT00973362|453687670|FG001|Baseline Evaluation|Inevaluable|223|||
126107560|NCT00973362|453687669|FG000|3-Year Follow-up|Lost to Follow-up|17|||
126107561|NCT00973362|453687670|FG001|3-Year Follow-up|Lost to Follow-up|0|||
126107562|NCT00887679|453687671|FG000|Overall Study|Withdrawal by Subject|1|||
125892797|NCT01945710|452906722|FG002|Overall Study|Adverse Event|0|||
126107563|NCT00887679|453687671|FG000|Overall Study|Lost to Follow-up|4|||
126107564|NCT00887679|453687671|FG000|Overall Study|Physician Decision|5|||
126107565|NCT01630434|453687678|FG000|Overall Study|Donor lungs turned down|1|||
126107566|NCT01630434|453687679|FG001|Overall Study|Donor lungs turned down|0|||
126107567|NCT01630434|453687678|FG000|Overall Study|Protocol Violation|9|||
126107568|NCT01630434|453687679|FG001|Overall Study|Protocol Violation|4|||
126058560|NCT02691702|453508897|FG007|Overall Study|Lost to Follow-up|0|||
126058561|NCT02691702|453508898|FG008|Overall Study|Lost to Follow-up|0|||
126058562|NCT02691702|453508899|FG009|Overall Study|Lost to Follow-up|0|||
126058563|NCT02691702|453508900|FG010|Overall Study|Lost to Follow-up|1|||
126058564|NCT02691702|453508890|FG000|Overall Study|Withdrawal by Subject|1|||
126058565|NCT02691702|453508891|FG001|Overall Study|Withdrawal by Subject|1|||
126058566|NCT02691702|453508892|FG002|Overall Study|Withdrawal by Subject|0|||
126058567|NCT02691702|453508893|FG003|Overall Study|Withdrawal by Subject|0|||
126058568|NCT02691702|453508894|FG004|Overall Study|Withdrawal by Subject|0|||
126058569|NCT02691702|453508895|FG005|Overall Study|Withdrawal by Subject|1|||
126058570|NCT02691702|453508896|FG006|Overall Study|Withdrawal by Subject|2|||
126058571|NCT02691702|453508897|FG007|Overall Study|Withdrawal by Subject|0|||
126058572|NCT02691702|453508898|FG008|Overall Study|Withdrawal by Subject|0|||
126058573|NCT02691702|453508899|FG009|Overall Study|Withdrawal by Subject|0|||
126058574|NCT02691702|453508900|FG010|Overall Study|Withdrawal by Subject|0|||
126058575|NCT02691702|453508890|FG000|Overall Study|Other|0|||
126058576|NCT02691702|453508891|FG001|Overall Study|Other|0|||
126107569|NCT01630434|453687678|FG000|Overall Study|Death|20|||
126107570|NCT01630434|453687679|FG001|Overall Study|Death|26|||
126107571|NCT02578862|453687680|FG000|Overall Study|Withdrawal by Subject|0|||
125892798|NCT01945710|452906723|FG003|Overall Study|Adverse Event|0|||
126058577|NCT02691702|453508892|FG002|Overall Study|Other|0|||
125892799|NCT01945710|452906724|FG004|Overall Study|Adverse Event|0|||
126058578|NCT02691702|453508893|FG003|Overall Study|Other|0|||
126058579|NCT02691702|453508894|FG004|Overall Study|Other|0|||
126058580|NCT02691702|453508895|FG005|Overall Study|Other|0|||
126058581|NCT02691702|453508896|FG006|Overall Study|Other|1|||
126058582|NCT02691702|453508897|FG007|Overall Study|Other|0|||
126058583|NCT02691702|453508898|FG008|Overall Study|Other|1|||
126058584|NCT02691702|453508899|FG009|Overall Study|Other|0|||
126058585|NCT02691702|453508900|FG010|Overall Study|Other|0|||
126058586|NCT02691702|453508890|FG000|Overall Study|Protocol Violation|0|||
126058587|NCT02691702|453508891|FG001|Overall Study|Protocol Violation|0|||
126058588|NCT02691702|453508892|FG002|Overall Study|Protocol Violation|0|||
126058589|NCT02691702|453508893|FG003|Overall Study|Protocol Violation|0|||
126058590|NCT02691702|453508894|FG004|Overall Study|Protocol Violation|0|||
126058591|NCT02691702|453508895|FG005|Overall Study|Protocol Violation|0|||
126058592|NCT02691702|453508896|FG006|Overall Study|Protocol Violation|0|||
126058593|NCT02691702|453508897|FG007|Overall Study|Protocol Violation|0|||
126058594|NCT02691702|453508898|FG008|Overall Study|Protocol Violation|0|||
126058595|NCT02691702|453508899|FG009|Overall Study|Protocol Violation|2|||
126058596|NCT02691702|453508900|FG010|Overall Study|Protocol Violation|0|||
126058597|NCT01668719|453508901|FG000|Phase I|On treatment|1|||
126058598|NCT01668719|453508902|FG001|Phase I|On treatment|0|||
126058599|NCT01668719|453508903|FG002|Phase I|On treatment|0|||
126058600|NCT01668719|453508901|FG000|Phase I|Adverse Event|2|||
126058601|NCT01668719|453508902|FG001|Phase I|Adverse Event|0|||
126058602|NCT01668719|453508903|FG002|Phase I|Adverse Event|0|||
126058603|NCT01668719|453508901|FG000|Phase I|Progression/relapse|1|||
126058604|NCT01668719|453508902|FG001|Phase I|Progression/relapse|0|||
126058605|NCT01668719|453508903|FG002|Phase I|Progression/relapse|0|||
126058606|NCT01668719|453508901|FG000|Phase I|not protocol specified|2|||
126058607|NCT01668719|453508902|FG001|Phase I|not protocol specified|0|||
126058608|NCT01668719|453508903|FG002|Phase I|not protocol specified|0|||
126058609|NCT01668719|453508901|FG000|Phase II|On treatment|0|||
126058610|NCT01668719|453508902|FG001|Phase II|On treatment|4|||
126058611|NCT01668719|453508903|FG002|Phase II|On treatment|3|||
126058612|NCT01668719|453508901|FG000|Phase II|Adverse Event|0|||
126058613|NCT01668719|453508902|FG001|Phase II|Adverse Event|18|||
126058614|NCT01668719|453508903|FG002|Phase II|Adverse Event|18|||
126058615|NCT01668719|453508901|FG000|Phase II|Refusal unrelated to adverse event|0|||
126058616|NCT01668719|453508902|FG001|Phase II|Refusal unrelated to adverse event|4|||
126058617|NCT01668719|453508903|FG002|Phase II|Refusal unrelated to adverse event|1|||
126058618|NCT01668719|453508901|FG000|Phase II|Progression/relapse|0|||
126058619|NCT01668719|453508902|FG001|Phase II|Progression/relapse|13|||
126058620|NCT01668719|453508903|FG002|Phase II|Progression/relapse|17|||
126058621|NCT01668719|453508901|FG000|Phase II|Death|0|||
126058622|NCT01668719|453508902|FG001|Phase II|Death|0|||
125892800|NCT01945710|452906725|FG005|Overall Study|Adverse Event|0|||
126058623|NCT01668719|453508903|FG002|Phase II|Death|2|||
126058624|NCT01668719|453508901|FG000|Phase II|not protocol specified|0|||
126058625|NCT01668719|453508902|FG001|Phase II|not protocol specified|13|||
126058626|NCT01668719|453508903|FG002|Phase II|not protocol specified|7|||
126058627|NCT00875706|453508904|FG000|Overall Study|Withdrawal by Subject|1|||
126058628|NCT00875706|453508905|FG001|Overall Study|Withdrawal by Subject|0|||
126058629|NCT00875706|453508906|FG002|Overall Study|Withdrawal by Subject|0|||
126058630|NCT00786188|453508907|FG000|Overall Study|Adverse Event|3|||
125892801|NCT01945710|452906726|FG006|Overall Study|Adverse Event|0|||
126058631|NCT00786188|453508908|FG001|Overall Study|Adverse Event|1|||
126058632|NCT00786188|453508907|FG000|Overall Study|Withdrawal by Subject|2|||
126058633|NCT00786188|453508908|FG001|Overall Study|Withdrawal by Subject|0|||
126058634|NCT02279732|453508910|FG000|Overall Study|Death|23|||
126058635|NCT02279732|453508911|FG001|Overall Study|Death|20|||
125892802|NCT01945710|452906720|FG000|Overall Study|Other|2|||
125892803|NCT01945710|452906721|FG001|Overall Study|Other|0|||
125892804|NCT01945710|452906722|FG002|Overall Study|Other|3|||
125892805|NCT01945710|452906723|FG003|Overall Study|Other|1|||
125892806|NCT01945710|452906724|FG004|Overall Study|Other|1|||
125892807|NCT01945710|452906725|FG005|Overall Study|Other|0|||
125892808|NCT01945710|452906726|FG006|Overall Study|Other|4|||
125892809|NCT01945710|452906720|FG000|Overall Study|Withdrawal by Subject|0|||
125892810|NCT01945710|452906721|FG001|Overall Study|Withdrawal by Subject|1|||
125892811|NCT01945710|452906722|FG002|Overall Study|Withdrawal by Subject|1|||
125892812|NCT01945710|452906723|FG003|Overall Study|Withdrawal by Subject|0|||
126058636|NCT02279732|453508910|FG000|Overall Study|Disease Progression|13|||
126058637|NCT02279732|453508911|FG001|Overall Study|Disease Progression|3|||
126058638|NCT02279732|453508910|FG000|Overall Study|Withdrawal by Subject|2|||
126058639|NCT02279732|453508911|FG001|Overall Study|Withdrawal by Subject|7|||
126058640|NCT02279732|453508910|FG000|Overall Study|Adverse Event|1|||
126058641|NCT02279732|453508911|FG001|Overall Study|Adverse Event|2|||
126058642|NCT02279732|453508910|FG000|Overall Study|Administrative Reason By Sponsor|0|||
126058643|NCT02279732|453508911|FG001|Overall Study|Administrative Reason By Sponsor|2|||
126058644|NCT02279732|453508910|FG000|Overall Study|Study Drug Toxicity|2|||
126058645|NCT02279732|453508911|FG001|Overall Study|Study Drug Toxicity|0|||
126058646|NCT02279732|453508910|FG000|Overall Study|Lost to Follow-up|0|||
126058647|NCT02279732|453508911|FG001|Overall Study|Lost to Follow-up|1|||
126058648|NCT02279732|453508910|FG000|Overall Study|Maximum Clinical Benefit|1|||
126058649|NCT02279732|453508911|FG001|Overall Study|Maximum Clinical Benefit|0|||
126058650|NCT02279732|453508910|FG000|Overall Study|Subject Requested to Discontinue|0|||
126058651|NCT02279732|453508911|FG001|Overall Study|Subject Requested to Discontinue|1|||
126058652|NCT02279732|453508910|FG000|Overall Study|Other|53|||
126058653|NCT02279732|453508911|FG001|Overall Study|Other|67|||
126058654|NCT02279732|453508910|FG000|Overall Study|Other|3|||
126058655|NCT02279732|453508911|FG001|Overall Study|Other|3|||
126058656|NCT02970318|453508912|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
126058657|NCT02970318|453508913|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
126058658|NCT02970318|453508914|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
126058659|NCT02970318|453508915|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
126058660|NCT02970318|453508912|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
126058661|NCT02970318|453508913|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
126058662|NCT02970318|453508914|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
126058663|NCT02970318|453508915|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
126058664|NCT02970318|453508912|FG000|Overall for Arm A & Main for Arm B|Death|41|||
126058665|NCT02970318|453508913|FG001|Overall for Arm A & Main for Arm B|Death|33|||
126058666|NCT02970318|453508914|FG002|Overall for Arm A & Main for Arm B|Death|0|||
126058667|NCT02970318|453508915|FG003|Overall for Arm A & Main for Arm B|Death|0|||
126058668|NCT02970318|453508912|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
126058669|NCT02970318|453508913|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
126058670|NCT02970318|453508914|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
126058671|NCT02970318|453508915|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
126058672|NCT02970318|453508912|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
126058673|NCT02970318|453508913|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
126058674|NCT02970318|453508914|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
126058675|NCT02970318|453508915|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
126058676|NCT02970318|453508912|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
126058677|NCT02970318|453508913|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
126058678|NCT02970318|453508914|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
126058679|NCT02970318|453508915|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
126058680|NCT02970318|453508912|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
126058681|NCT02970318|453508913|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
126058682|NCT02970318|453508914|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
126058683|NCT02970318|453508915|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
126058684|NCT00824408|453508916|FG000|Run-in Phase|Progressive disease|4|||
126058685|NCT00824408|453508917|FG001|Run-in Phase|Progressive disease|4|||
126058686|NCT00824408|453508918|FG002|Run-in Phase|Progressive disease|0|||
126058687|NCT00824408|453508919|FG003|Run-in Phase|Progressive disease|0|||
126058688|NCT00824408|453508920|FG004|Run-in Phase|Progressive disease|0|||
126058689|NCT00824408|453508916|FG000|Run-in Phase|Adverse Event|1|||
126058690|NCT00824408|453508917|FG001|Run-in Phase|Adverse Event|1|||
126058691|NCT00824408|453508918|FG002|Run-in Phase|Adverse Event|0|||
126058692|NCT00824408|453508919|FG003|Run-in Phase|Adverse Event|0|||
126058693|NCT00824408|453508920|FG004|Run-in Phase|Adverse Event|0|||
126058694|NCT00824408|453508916|FG000|Run-in Phase|Refused to continue medication|1|||
126058695|NCT00824408|453508917|FG001|Run-in Phase|Refused to continue medication|0|||
126058696|NCT00824408|453508918|FG002|Run-in Phase|Refused to continue medication|0|||
126058697|NCT00824408|453508919|FG003|Run-in Phase|Refused to continue medication|0|||
126058698|NCT00824408|453508920|FG004|Run-in Phase|Refused to continue medication|0|||
126058699|NCT00824408|453508916|FG000|Run-in Phase|Other reason not defined above|0|||
126058700|NCT00824408|453508917|FG001|Run-in Phase|Other reason not defined above|1|||
126058701|NCT00824408|453508918|FG002|Run-in Phase|Other reason not defined above|0|||
126058702|NCT00824408|453508919|FG003|Run-in Phase|Other reason not defined above|0|||
126058703|NCT00824408|453508920|FG004|Run-in Phase|Other reason not defined above|0|||
126058704|NCT00824408|453508916|FG000|Randomized Phase|Not treated|0|||
126058705|NCT00824408|453508917|FG001|Randomized Phase|Not treated|0|||
126058706|NCT00824408|453508918|FG002|Randomized Phase|Not treated|1|||
126058707|NCT00824408|453508919|FG003|Randomized Phase|Not treated|1|||
126058708|NCT00824408|453508920|FG004|Randomized Phase|Not treated|1|||
126058709|NCT00824408|453508916|FG000|Randomized Phase|Progressive disease|0|||
126058710|NCT00824408|453508917|FG001|Randomized Phase|Progressive disease|0|||
125892813|NCT01945710|452906724|FG004|Overall Study|Withdrawal by Subject|1|||
125892814|NCT01945710|452906725|FG005|Overall Study|Withdrawal by Subject|0|||
125892815|NCT01945710|452906726|FG006|Overall Study|Withdrawal by Subject|0|||
125892816|NCT00375609|452906727|FG000|Overall Study|Did not receive treatment|1|||
125892817|NCT00375609|452906728|FG001|Overall Study|Did not receive treatment|0|||
125892818|NCT00375609|452906729|FG002|Overall Study|Did not receive treatment|0|||
125892819|NCT00375609|452906727|FG000|Overall Study|Adverse Event|0|||
125892820|NCT00375609|452906728|FG001|Overall Study|Adverse Event|3|||
125892821|NCT00375609|452906729|FG002|Overall Study|Adverse Event|0|||
125892822|NCT00375609|452906727|FG000|Overall Study|Lost to Follow-up|1|||
125892823|NCT00375609|452906728|FG001|Overall Study|Lost to Follow-up|0|||
125892824|NCT00375609|452906729|FG002|Overall Study|Lost to Follow-up|0|||
125892825|NCT00375609|452906727|FG000|Overall Study|Physician Decision|0|||
125892826|NCT00375609|452906728|FG001|Overall Study|Physician Decision|0|||
125892827|NCT00375609|452906729|FG002|Overall Study|Physician Decision|1|||
125892828|NCT00375609|452906727|FG000|Overall Study|Withdrawal by Subject|1|||
125892829|NCT00375609|452906728|FG001|Overall Study|Withdrawal by Subject|4|||
125892830|NCT00375609|452906729|FG002|Overall Study|Withdrawal by Subject|0|||
125892831|NCT00375609|452906727|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
125892832|NCT00375609|452906728|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
125892833|NCT00375609|452906729|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
125892834|NCT01368562|452906730|FG000|Overall Study|Adverse Event|1|||
125892835|NCT01368562|452906730|FG000|Overall Study|Disease progression|1|||
125892836|NCT01368562|452906730|FG000|Overall Study|Lost to Follow-up|1|||
125892837|NCT01368562|452906730|FG000|Overall Study|Death|6|||
125892838|NCT01368562|452906730|FG000|Overall Study|Unresponsive to treatment|5|||
125892839|NCT01368562|452906730|FG000|Overall Study|Other|3|||
125892840|NCT01368562|452906730|FG000|Overall Study|Other than specified|2|||
125892841|NCT00669409|452906733|FG000|Part 2|Withdrawal by Subject|0|||
125892842|NCT00669409|452906734|FG001|Part 2|Withdrawal by Subject|0|||
125892843|NCT00669409|452906735|FG002|Part 2|Withdrawal by Subject|0|||
125892844|NCT00669409|452906736|FG003|Part 2|Withdrawal by Subject|0|||
125892845|NCT00669409|452906737|FG004|Part 2|Withdrawal by Subject|0|||
125892846|NCT00669409|452906738|FG005|Part 2|Withdrawal by Subject|0|||
125892847|NCT00669409|452906739|FG006|Part 2|Withdrawal by Subject|0|||
125892848|NCT00669409|452906740|FG007|Part 2|Withdrawal by Subject|0|||
125892849|NCT00669409|452906741|FG008|Part 2|Withdrawal by Subject|0|||
125892850|NCT00669409|452906742|FG009|Part 2|Withdrawal by Subject|1|||
125892851|NCT00669409|452906743|FG010|Part 2|Withdrawal by Subject|0|||
125892852|NCT03583385|452906744|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125892853|NCT03583385|452906745|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125892854|NCT03583385|452906744|FG000|Treatment Period 2|Adverse Event|1|||
126107572|NCT02578862|453687681|FG001|Overall Study|Withdrawal by Subject|1|||
126107573|NCT02578862|453687680|FG000|Overall Study|Unplanned unilateral procedure|0|||
125892855|NCT03583385|452906745|FG001|Treatment Period 2|Adverse Event|0|||
125892856|NCT02864862|452906747|FG000|Overall Study|Lost to Follow-up|1|||
125892857|NCT02864862|452906748|FG001|Overall Study|Lost to Follow-up|0|||
125892858|NCT02864862|452906749|FG002|Overall Study|Lost to Follow-up|1|||
125892859|NCT02864862|452906747|FG000|Overall Study|Protocol Violation|0|||
125892860|NCT02864862|452906748|FG001|Overall Study|Protocol Violation|0|||
125892861|NCT02864862|452906749|FG002|Overall Study|Protocol Violation|1|||
125892862|NCT05573386|452906750|FG000|Overall Study|Withdrawal by Subject|3|||
125892863|NCT05573386|452906751|FG001|Overall Study|Withdrawal by Subject|2|||
125892864|NCT04195893|452906760|FG000|Second Intervention|Withdrawal by Subject|1|||
126107574|NCT02578862|453687681|FG001|Overall Study|Unplanned unilateral procedure|1|||
126107575|NCT01026454|453687682|FG000|Second Intervention|Pregnancy|1|||
126107576|NCT01026454|453687683|FG001|Second Intervention|Pregnancy|1|||
126107577|NCT02893930|453687684|FG000|Overall Study|Adverse Event|3|||
126107578|NCT02893930|453687684|FG000|Overall Study|Death|1|||
126107579|NCT02893930|453687684|FG000|Overall Study|Disease progression|5|||
126107580|NCT02893930|453687684|FG000|Overall Study|Withdrawal by Subject|2|||
126107581|NCT02893930|453687684|FG000|Overall Study|Physician Decision|1|||
126107582|NCT02893930|453687684|FG000|Overall Study|Ineligible|1|||
126107583|NCT02349360|453687685|FG000|Overall Study|Withdrawal by Subject|0|||
126107584|NCT02349360|453687686|FG001|Overall Study|Withdrawal by Subject|1|||
126107585|NCT00394953|453687687|FG000|First Treatment Period|Adverse Event|1|||
126107586|NCT00394953|453687688|FG001|First Treatment Period|Adverse Event|2|||
126107587|NCT00394953|453687687|FG000|First Treatment Period|Death|6|||
126107588|NCT00394953|453687688|FG001|First Treatment Period|Death|7|||
126107589|NCT00394953|453687687|FG000|First Treatment Period|Lack of Efficacy|1|||
126107590|NCT00394953|453687688|FG001|First Treatment Period|Lack of Efficacy|1|||
126107591|NCT00394953|453687687|FG000|First Treatment Period|Withdrawal by Subject|6|||
126107592|NCT00394953|453687688|FG001|First Treatment Period|Withdrawal by Subject|3|||
126107593|NCT00394953|453687687|FG000|First Treatment Period|Lost to Follow-up|0|||
126107594|NCT00394953|453687688|FG001|First Treatment Period|Lost to Follow-up|1|||
126107595|NCT00394953|453687687|FG000|First Treatment Period|Renal transplant|11|||
126107596|NCT00394953|453687688|FG001|First Treatment Period|Renal transplant|7|||
126107597|NCT00394953|453687687|FG000|First Treatment Period|Not defined|4|||
126107598|NCT00394953|453687688|FG001|First Treatment Period|Not defined|1|||
126107599|NCT00394953|453687687|FG000|Second Treatment Period|Adverse Event|2|||
126107600|NCT00394953|453687688|FG001|Second Treatment Period|Adverse Event|5|||
126107601|NCT00394953|453687687|FG000|Second Treatment Period|Death|8|||
126107602|NCT00394953|453687688|FG001|Second Treatment Period|Death|4|||
126107603|NCT00394953|453687687|FG000|Second Treatment Period|Lack of Efficacy|9|||
126107604|NCT00394953|453687688|FG001|Second Treatment Period|Lack of Efficacy|47|||
126107605|NCT00394953|453687687|FG000|Second Treatment Period|Withdrawal by Subject|3|||
126107606|NCT00394953|453687688|FG001|Second Treatment Period|Withdrawal by Subject|3|||
126107607|NCT00394953|453687687|FG000|Second Treatment Period|Lost to Follow-up|0|||
126107608|NCT00394953|453687688|FG001|Second Treatment Period|Lost to Follow-up|1|||
126107609|NCT00394953|453687687|FG000|Second Treatment Period|Renal transplant|4|||
126107610|NCT00394953|453687688|FG001|Second Treatment Period|Renal transplant|6|||
126107611|NCT00394953|453687687|FG000|Second Treatment Period|Not defined|3|||
126107612|NCT00394953|453687688|FG001|Second Treatment Period|Not defined|8|||
126107613|NCT01176773|453687689|FG000|Overall Study|Screen Failure|2|||
126107614|NCT01176773|453687689|FG000|Overall Study|Withdrew consent|1|||
126107615|NCT02196714|453687699|FG000|Overall Study|Protocol Violation|0|||
126107616|NCT02196714|453687700|FG001|Overall Study|Protocol Violation|0|||
126107617|NCT02196714|453687701|FG002|Overall Study|Protocol Violation|1|||
126107618|NCT02196714|453687702|FG003|Overall Study|Protocol Violation|0|||
126107619|NCT01592864|453687704|FG000|Overall Study|Withdrawal by Subject|0|||
126107620|NCT01592864|453687705|FG001|Overall Study|Withdrawal by Subject|1|||
126107621|NCT04079803|453687710|FG000|Overall Study|Withdrawal by Subject|0|||
126058711|NCT00824408|453508918|FG002|Randomized Phase|Progressive disease|25|||
126058712|NCT00824408|453508919|FG003|Randomized Phase|Progressive disease|36|||
126058713|NCT00824408|453508920|FG004|Randomized Phase|Progressive disease|34|||
126058714|NCT00824408|453508916|FG000|Randomized Phase|Adverse Event|0|||
126058715|NCT00824408|453508917|FG001|Randomized Phase|Adverse Event|0|||
126058716|NCT00824408|453508918|FG002|Randomized Phase|Adverse Event|4|||
126058717|NCT00824408|453508919|FG003|Randomized Phase|Adverse Event|5|||
126058718|NCT00824408|453508920|FG004|Randomized Phase|Adverse Event|5|||
126058719|NCT00824408|453508916|FG000|Randomized Phase|Refused to continue medication|0|||
126058720|NCT00824408|453508917|FG001|Randomized Phase|Refused to continue medication|0|||
126058721|NCT00824408|453508918|FG002|Randomized Phase|Refused to continue medication|2|||
126058722|NCT00824408|453508919|FG003|Randomized Phase|Refused to continue medication|2|||
126058723|NCT00824408|453508920|FG004|Randomized Phase|Refused to continue medication|2|||
126058724|NCT00824408|453508916|FG000|Randomized Phase|Other reason not defined above|0|||
126058725|NCT00824408|453508917|FG001|Randomized Phase|Other reason not defined above|0|||
126058726|NCT00824408|453508918|FG002|Randomized Phase|Other reason not defined above|4|||
126058727|NCT00824408|453508919|FG003|Randomized Phase|Other reason not defined above|2|||
126058728|NCT00824408|453508920|FG004|Randomized Phase|Other reason not defined above|4|||
126107622|NCT04079803|453687711|FG001|Overall Study|Withdrawal by Subject|0|||
126107623|NCT04079803|453687712|FG002|Overall Study|Withdrawal by Subject|1|||
126058729|NCT01880736|453508921|FG000|Overall Study|Adverse Event|0|||
126058730|NCT01880736|453508922|FG001|Overall Study|Adverse Event|0|||
126107624|NCT01881750|453687713|FG000|Overall Study|Changes in concomitant therapies|2|||
126107625|NCT01881750|453687714|FG001|Overall Study|Changes in concomitant therapies|3|||
126107626|NCT01881750|453687713|FG000|Overall Study|Lost to Follow-up|0|||
126107627|NCT01881750|453687714|FG001|Overall Study|Lost to Follow-up|1|||
126107628|NCT02804178|453687720|FG000|Overall Study|Adverse Event|1|||
126107629|NCT01290601|453687721|FG000|Overall Study|Adverse Event|0|||
125892865|NCT04195893|452906761|FG001|Second Intervention|Withdrawal by Subject|0|||
125892866|NCT01802073|452906764|FG000|Overall Study|Lost to Follow-up|0|||
125892867|NCT01802073|452906765|FG001|Overall Study|Lost to Follow-up|1|||
125892868|NCT01802073|452906764|FG000|Overall Study|Non-compliant|4|||
125892869|NCT01802073|452906765|FG001|Overall Study|Non-compliant|2|||
125892870|NCT01802073|452906764|FG000|Overall Study|Withdrawal by Subject|1|||
125892871|NCT01802073|452906765|FG001|Overall Study|Withdrawal by Subject|1|||
125892872|NCT01802073|452906764|FG000|Overall Study|Physician Decision|0|||
125892873|NCT01802073|452906765|FG001|Overall Study|Physician Decision|7|||
125892874|NCT02123472|452906769|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
125892875|NCT02123472|452906770|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
125892876|NCT00918736|452906771|FG000|Overall Study|Withdrawal by Subject|4|||
125892877|NCT01474018|452906772|FG000|Overall Study|Lost to Follow-up|0|||
125892878|NCT01474018|452906773|FG001|Overall Study|Lost to Follow-up|1|||
125892879|NCT01474018|452906772|FG000|Overall Study|Withdrawal by Subject|0|||
125892880|NCT01474018|452906773|FG001|Overall Study|Withdrawal by Subject|2|||
125892881|NCT01137604|452906774|FG000|Overall Study|Adverse Event|3|||
125892882|NCT01137604|452906775|FG001|Overall Study|Adverse Event|6|||
125892883|NCT01137604|452906776|FG002|Overall Study|Adverse Event|9|||
125892884|NCT01137604|452906777|FG003|Overall Study|Adverse Event|9|||
125892885|NCT01137604|452906774|FG000|Overall Study|Participant Choice|0|||
125892886|NCT01137604|452906775|FG001|Overall Study|Participant Choice|2|||
125892887|NCT01137604|452906776|FG002|Overall Study|Participant Choice|2|||
125892888|NCT01137604|452906777|FG003|Overall Study|Participant Choice|0|||
125892889|NCT01137604|452906774|FG000|Overall Study|Withdrawal of consent|0|||
125892890|NCT01137604|452906775|FG001|Overall Study|Withdrawal of consent|0|||
125892891|NCT01137604|452906776|FG002|Overall Study|Withdrawal of consent|0|||
125892892|NCT01137604|452906777|FG003|Overall Study|Withdrawal of consent|2|||
125892893|NCT01137604|452906774|FG000|Overall Study|Clinical progression/deterioration|1|||
125892894|NCT01137604|452906775|FG001|Overall Study|Clinical progression/deterioration|2|||
125892895|NCT01137604|452906776|FG002|Overall Study|Clinical progression/deterioration|2|||
125892896|NCT01137604|452906777|FG003|Overall Study|Clinical progression/deterioration|0|||
125892897|NCT03462511|452906778|FG000|Overall Study|Withdrawal by Subject|2|||
125892898|NCT03462511|452906779|FG001|Overall Study|Withdrawal by Subject|3|||
125892899|NCT00435045|452906781|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
125892900|NCT00435045|452906782|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
125892901|NCT00435045|452906781|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
125892902|NCT00435045|452906782|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
125892903|NCT00435045|452906781|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
125892904|NCT00435045|452906782|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
125892905|NCT00435045|452906781|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
125892906|NCT00435045|452906782|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
125892907|NCT00435045|452906781|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
125892908|NCT00435045|452906782|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
125892909|NCT00435045|452906781|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
125892910|NCT00435045|452906782|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
125892911|NCT00435045|452906781|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
125892912|NCT00435045|452906782|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
125892913|NCT00435045|452906781|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
125892914|NCT00435045|452906782|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
125892915|NCT00435045|452906781|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
125892916|NCT00435045|452906782|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
125892917|NCT00435045|452906781|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
125892918|NCT00435045|452906782|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
125892919|NCT00435045|452906781|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
126058731|NCT01880736|453508923|FG002|Overall Study|Adverse Event|0|||
126058732|NCT01880736|453508924|FG003|Overall Study|Adverse Event|1|||
125892920|NCT00435045|452906782|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
125892921|NCT01297491|452906783|FG000|Overall Study|Adverse Event|11|||
125892922|NCT01297491|452906784|FG001|Overall Study|Adverse Event|6|||
125892923|NCT01297491|452906783|FG000|Overall Study|Physician Decision|3|||
126058733|NCT01880736|453508921|FG000|Overall Study|Withdrawal Criteria|1|||
126058734|NCT01880736|453508922|FG001|Overall Study|Withdrawal Criteria|2|||
126058735|NCT01880736|453508923|FG002|Overall Study|Withdrawal Criteria|1|||
125892924|NCT01297491|452906784|FG001|Overall Study|Physician Decision|2|||
125892925|NCT01297491|452906783|FG000|Overall Study|Progressive disease|11|||
125892926|NCT01297491|452906784|FG001|Overall Study|Progressive disease|20|||
125892927|NCT01297491|452906783|FG000|Overall Study|Patient/Guardian decision|3|||
125892928|NCT01297491|452906784|FG001|Overall Study|Patient/Guardian decision|4|||
125892929|NCT01297491|452906783|FG000|Overall Study|Death|2|||
125892930|NCT01297491|452906784|FG001|Overall Study|Death|1|||
125892931|NCT00312195|452906785|FG000|Overall Study|Adverse Event|4|||
126107630|NCT01290601|453687722|FG001|Overall Study|Adverse Event|2|||
126107631|NCT01290601|453687723|FG002|Overall Study|Adverse Event|0|||
125892932|NCT00312195|452906786|FG001|Overall Study|Adverse Event|6|||
125892933|NCT00312195|452906785|FG000|Overall Study|Lost to Follow-up|1|||
126107632|NCT01290601|453687724|FG003|Overall Study|Adverse Event|0|||
126107633|NCT01290601|453687721|FG000|Overall Study|Lack of Efficacy|2|||
126107634|NCT01290601|453687722|FG001|Overall Study|Lack of Efficacy|1|||
126107635|NCT01290601|453687723|FG002|Overall Study|Lack of Efficacy|0|||
126107636|NCT01290601|453687724|FG003|Overall Study|Lack of Efficacy|0|||
126107637|NCT01290601|453687721|FG000|Overall Study|Lost to Follow-up|7|||
126107638|NCT01290601|453687722|FG001|Overall Study|Lost to Follow-up|2|||
126107639|NCT01290601|453687723|FG002|Overall Study|Lost to Follow-up|0|||
126107640|NCT01290601|453687724|FG003|Overall Study|Lost to Follow-up|0|||
126107641|NCT01290601|453687721|FG000|Overall Study|Other|1|||
126107642|NCT01290601|453687722|FG001|Overall Study|Other|0|||
126107643|NCT01290601|453687723|FG002|Overall Study|Other|0|||
126107644|NCT01290601|453687724|FG003|Overall Study|Other|0|||
126107645|NCT01290601|453687721|FG000|Overall Study|Protocol Violation|1|||
126107646|NCT01290601|453687722|FG001|Overall Study|Protocol Violation|0|||
126107647|NCT01290601|453687723|FG002|Overall Study|Protocol Violation|0|||
126107648|NCT01290601|453687724|FG003|Overall Study|Protocol Violation|0|||
126107649|NCT01749540|453687725|FG000|Overall Study|Protocol Violation|0|||
126107650|NCT01749540|453687726|FG001|Overall Study|Protocol Violation|0|||
126107651|NCT01749540|453687727|FG002|Overall Study|Protocol Violation|0|||
126107652|NCT01749540|453687728|FG003|Overall Study|Protocol Violation|0|||
126107653|NCT01749540|453687729|FG004|Overall Study|Protocol Violation|0|||
126107654|NCT01749540|453687730|FG005|Overall Study|Protocol Violation|1|||
126107655|NCT01749540|453687731|FG006|Overall Study|Protocol Violation|1|||
126107656|NCT01749540|453687725|FG000|Overall Study|Withdrawal by Subject|0|||
126107657|NCT01749540|453687726|FG001|Overall Study|Withdrawal by Subject|0|||
126107658|NCT01749540|453687727|FG002|Overall Study|Withdrawal by Subject|0|||
126107659|NCT01749540|453687728|FG003|Overall Study|Withdrawal by Subject|1|||
126107660|NCT01749540|453687729|FG004|Overall Study|Withdrawal by Subject|0|||
126107661|NCT01749540|453687730|FG005|Overall Study|Withdrawal by Subject|0|||
126107662|NCT01749540|453687731|FG006|Overall Study|Withdrawal by Subject|0|||
126107663|NCT01749540|453687725|FG000|Overall Study|Initiated into extension study A536-06|0|||
126107664|NCT01749540|453687726|FG001|Overall Study|Initiated into extension study A536-06|0|||
125892934|NCT00312195|452906786|FG001|Overall Study|Lost to Follow-up|0|||
125892935|NCT00312195|452906785|FG000|Overall Study|Protocol Violation|1|||
125892936|NCT00312195|452906786|FG001|Overall Study|Protocol Violation|0|||
125892937|NCT02511106|452906787|FG000|Overall Study|Lost to Follow-up|6|||
125892938|NCT02511106|452906788|FG001|Overall Study|Lost to Follow-up|4|||
126107665|NCT01749540|453687727|FG002|Overall Study|Initiated into extension study A536-06|0|||
125892939|NCT02511106|452906787|FG000|Overall Study|Withdrawal by Subject|24|||
125892940|NCT02511106|452906788|FG001|Overall Study|Withdrawal by Subject|21|||
126107666|NCT01749540|453687728|FG003|Overall Study|Initiated into extension study A536-06|0|||
126107667|NCT01749540|453687729|FG004|Overall Study|Initiated into extension study A536-06|0|||
126107668|NCT01749540|453687730|FG005|Overall Study|Initiated into extension study A536-06|2|||
126107669|NCT01749540|453687731|FG006|Overall Study|Initiated into extension study A536-06|24|||
126107670|NCT02240693|453687732|FG000|Overall Study|Adverse Event|0|||
126107671|NCT02240693|453687733|FG001|Overall Study|Adverse Event|0|||
126107672|NCT02240693|453687734|FG002|Overall Study|Adverse Event|0|||
126107673|NCT02240693|453687735|FG003|Overall Study|Adverse Event|0|||
126107674|NCT02240693|453687736|FG004|Overall Study|Adverse Event|1|||
126107675|NCT02240693|453687732|FG000|Overall Study|Withdrawal by Subject|0|||
126107676|NCT02240693|453687733|FG001|Overall Study|Withdrawal by Subject|0|||
126107677|NCT02240693|453687734|FG002|Overall Study|Withdrawal by Subject|2|||
126107678|NCT02240693|453687735|FG003|Overall Study|Withdrawal by Subject|1|||
126107679|NCT02240693|453687736|FG004|Overall Study|Withdrawal by Subject|0|||
126107680|NCT02240693|453687732|FG000|Overall Study|Other than specified|0|||
126107681|NCT02240693|453687733|FG001|Overall Study|Other than specified|0|||
126107682|NCT02240693|453687734|FG002|Overall Study|Other than specified|2|||
126107683|NCT02240693|453687735|FG003|Overall Study|Other than specified|0|||
126107684|NCT02240693|453687736|FG004|Overall Study|Other than specified|0|||
126107685|NCT01948908|453687737|FG000|Overall Study|Protocol Violation|1|||
126107686|NCT01948908|453687738|FG001|Overall Study|Protocol Violation|0|||
126107687|NCT01948908|453687739|FG002|Overall Study|Protocol Violation|2|||
126107688|NCT00777946|453687742|FG000|Overall Study|Adverse Event|11|||
126107689|NCT00777946|453687743|FG001|Overall Study|Adverse Event|1|||
126107690|NCT00777946|453687744|FG002|Overall Study|Adverse Event|3|||
126107691|NCT00777946|453687742|FG000|Overall Study|Lack of Efficacy|0|||
126107692|NCT00777946|453687743|FG001|Overall Study|Lack of Efficacy|0|||
126107693|NCT00777946|453687744|FG002|Overall Study|Lack of Efficacy|9|||
126107694|NCT00777946|453687742|FG000|Overall Study|Condition no longer required study drug|1|||
126107695|NCT00777946|453687743|FG001|Overall Study|Condition no longer required study drug|0|||
126107696|NCT00777946|453687744|FG002|Overall Study|Condition no longer required study drug|0|||
126107697|NCT00777946|453687742|FG000|Overall Study|Patient withdrew consent|3|||
126107698|NCT00777946|453687743|FG001|Overall Study|Patient withdrew consent|2|||
126107699|NCT00777946|453687744|FG002|Overall Study|Patient withdrew consent|3|||
126107700|NCT00777946|453687742|FG000|Overall Study|Lost to Follow-up|3|||
126107701|NCT00777946|453687743|FG001|Overall Study|Lost to Follow-up|1|||
126107702|NCT00777946|453687744|FG002|Overall Study|Lost to Follow-up|0|||
126107703|NCT00777946|453687742|FG000|Overall Study|Protocol deviation|2|||
126107704|NCT00777946|453687743|FG001|Overall Study|Protocol deviation|1|||
126107705|NCT00777946|453687744|FG002|Overall Study|Protocol deviation|1|||
126107706|NCT00777946|453687742|FG000|Overall Study|Randomized in error|1|||
126107707|NCT00777946|453687743|FG001|Overall Study|Randomized in error|1|||
126107708|NCT00777946|453687744|FG002|Overall Study|Randomized in error|0|||
126107709|NCT04675151|453687745|FG000|Overall Study|Protocol Violation|1|||
126107710|NCT04675151|453687746|FG001|Overall Study|Protocol Violation|0|||
126107711|NCT04675151|453687747|FG002|Overall Study|Protocol Violation|0|||
126107712|NCT04675151|453687748|FG003|Overall Study|Protocol Violation|1|||
126107713|NCT01598311|453687750|FG000|Overall Study|Physician Decision|4|||
126107714|NCT01598311|453687751|FG001|Overall Study|Physician Decision|5|||
126107715|NCT01598311|453687750|FG000|Overall Study|Adverse Event|9|||
126107716|NCT01598311|453687751|FG001|Overall Study|Adverse Event|13|||
126107717|NCT01598311|453687750|FG000|Overall Study|Lost to Follow-up|7|||
126107718|NCT01598311|453687751|FG001|Overall Study|Lost to Follow-up|12|||
126107719|NCT01598311|453687750|FG000|Overall Study|Withdrawal by Subject|9|||
126107720|NCT01598311|453687751|FG001|Overall Study|Withdrawal by Subject|13|||
126107721|NCT01598311|453687750|FG000|Overall Study|No reason provided.|0|||
126107722|NCT01598311|453687751|FG001|Overall Study|No reason provided.|5|||
126107723|NCT01598311|453687750|FG000|Overall Study|Randomized but never treated|8|||
126107724|NCT01598311|453687751|FG001|Overall Study|Randomized but never treated|5|||
126107725|NCT01598311|453687750|FG000|Overall Study|Treated but no confirmed CDAD|9|||
126107726|NCT01598311|453687751|FG001|Overall Study|Treated but no confirmed CDAD|8|||
126107727|NCT01598311|453687750|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
125892941|NCT02511106|452906787|FG000|Overall Study|Death|42|||
126107728|NCT01598311|453687751|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
126107729|NCT01485354|453689440|FG000|Overall Study|Withdrawal by Subject|5|||
126107730|NCT02101034|453689441|FG000|Overall Study|Enrolled but did not start treatment|0|||
126107731|NCT02101034|453689442|FG001|Overall Study|Enrolled but did not start treatment|0|||
126107732|NCT02101034|453689443|FG002|Overall Study|Enrolled but did not start treatment|1|||
126107733|NCT02101034|453689444|FG003|Overall Study|Enrolled but did not start treatment|0|||
126107734|NCT02101034|453689445|FG004|Overall Study|Enrolled but did not start treatment|0|||
126107735|NCT01103245|453689450|FG000|Overall Study|Withdrawal by Subject|1|||
126107736|NCT01103245|453689451|FG001|Overall Study|Withdrawal by Subject|0|||
126107737|NCT01103245|453689452|FG002|Overall Study|Withdrawal by Subject|3|||
126107738|NCT01103245|453689453|FG003|Overall Study|Withdrawal by Subject|0|||
126107739|NCT01103245|453689450|FG000|Overall Study|Inadequate IV access|1|||
125892942|NCT02511106|452906788|FG001|Overall Study|Death|82|||
126107740|NCT01103245|453689451|FG001|Overall Study|Inadequate IV access|0|||
126107741|NCT01103245|453689452|FG002|Overall Study|Inadequate IV access|0|||
126107742|NCT01103245|453689453|FG003|Overall Study|Inadequate IV access|0|||
126107743|NCT01103245|453689450|FG000|Overall Study|Adverse Event|0|||
126107744|NCT01103245|453689451|FG001|Overall Study|Adverse Event|2|||
126107745|NCT01103245|453689452|FG002|Overall Study|Adverse Event|1|||
126107746|NCT01103245|453689453|FG003|Overall Study|Adverse Event|0|||
126107747|NCT01103245|453689450|FG000|Overall Study|Physician Decision|1|||
126107748|NCT01103245|453689451|FG001|Overall Study|Physician Decision|0|||
126107749|NCT01103245|453689452|FG002|Overall Study|Physician Decision|0|||
126107750|NCT01103245|453689453|FG003|Overall Study|Physician Decision|0|||
126107751|NCT00995020|453689460|FG000|Overall Study|margin analysis not performed|2|||
126107752|NCT00995020|453689461|FG001|Overall Study|margin analysis not performed|5|||
126107753|NCT00995020|453689460|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
126107754|NCT00995020|453689461|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
126107755|NCT00719563|453689469|FG000|Overall Study|Adverse Event|16|||
126107756|NCT00719563|453689470|FG001|Overall Study|Adverse Event|13|||
126107757|NCT00719563|453689469|FG000|Overall Study|Medical condition changed|3|||
126107758|NCT00719563|453689470|FG001|Overall Study|Medical condition changed|5|||
126107759|NCT00719563|453689469|FG000|Overall Study|Lack of Efficacy|3|||
126107760|NCT00719563|453689470|FG001|Overall Study|Lack of Efficacy|7|||
126107761|NCT00719563|453689469|FG000|Overall Study|Personal reasons|6|||
126107762|NCT00719563|453689470|FG001|Overall Study|Personal reasons|7|||
126107763|NCT00719563|453689469|FG000|Overall Study|Unknown reasons|4|||
126107764|NCT00719563|453689470|FG001|Overall Study|Unknown reasons|6|||
126107765|NCT00719563|453689469|FG000|Overall Study|Noncompliant|1|||
126107766|NCT00719563|453689470|FG001|Overall Study|Noncompliant|1|||
126107767|NCT00719563|453689469|FG000|Overall Study|Lost to Follow-up|5|||
126107768|NCT00719563|453689470|FG001|Overall Study|Lost to Follow-up|3|||
126107769|NCT00567268|453689471|FG000|Overall Study|Protocol Violation|7|||
126107770|NCT00567268|453689471|FG000|Overall Study|Lost to Follow-up|36|||
126107771|NCT00567268|453689471|FG000|Overall Study|No Visit After First Day of Treatment|2|||
126107772|NCT00567268|453689471|FG000|Overall Study|No Drug Administration|4|||
126107773|NCT00567268|453689471|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
126107774|NCT00792805|453689472|FG000|Overall Study|Adverse Event|12|||
126107775|NCT00792805|453689473|FG001|Overall Study|Adverse Event|10|||
126107776|NCT00792805|453689474|FG002|Overall Study|Adverse Event|10|||
126107777|NCT00792805|453689472|FG000|Overall Study|Subject withdrew consent|5|||
126107778|NCT00792805|453689473|FG001|Overall Study|Subject withdrew consent|6|||
126107779|NCT00792805|453689474|FG002|Overall Study|Subject withdrew consent|5|||
126107780|NCT00792805|453689472|FG000|Overall Study|Administrative problems|2|||
126107781|NCT00792805|453689473|FG001|Overall Study|Administrative problems|0|||
126107782|NCT00792805|453689474|FG002|Overall Study|Administrative problems|4|||
126107783|NCT00792805|453689472|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126107784|NCT00792805|453689473|FG001|Overall Study|Abnormal test procedure result(s)|2|||
126107785|NCT00792805|453689474|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126107786|NCT00792805|453689472|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126107787|NCT00792805|453689473|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
126107788|NCT00792805|453689474|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
126107789|NCT00792805|453689472|FG000|Overall Study|Lost to Follow-up|1|||
126107790|NCT00792805|453689473|FG001|Overall Study|Lost to Follow-up|1|||
126107791|NCT00792805|453689474|FG002|Overall Study|Lost to Follow-up|6|||
126107792|NCT00792805|453689472|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126107793|NCT00792805|453689473|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126107794|NCT00792805|453689474|FG002|Overall Study|Abnormal laboratory value(s)|1|||
126107795|NCT00792805|453689472|FG000|Overall Study|Protocol deviation|0|||
126107796|NCT00792805|453689473|FG001|Overall Study|Protocol deviation|1|||
126107797|NCT00792805|453689474|FG002|Overall Study|Protocol deviation|1|||
126107798|NCT02120625|453689475|FG000|Overall Study|Physician Decision|2|||
126107799|NCT02952001|453689478|FG000|Overall Study|Adverse Event|3|||
126107800|NCT02952001|453689479|FG001|Overall Study|Adverse Event|0|||
126107801|NCT02952001|453689478|FG000|Overall Study|Prohibited therapy|10|||
126107802|NCT02952001|453689479|FG001|Overall Study|Prohibited therapy|3|||
126107803|NCT02952001|453689478|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
126107804|NCT02952001|453689479|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
126107805|NCT03278106|453689482|FG000|Overall Study|No protocol treatment|1|||
126107806|NCT00820027|453689483|FG000|Overall Study|Adverse Event|15|||
126107807|NCT00820027|453689484|FG001|Overall Study|Adverse Event|8|||
126107808|NCT00820027|453689485|FG002|Overall Study|Adverse Event|10|||
126107809|NCT00820027|453689486|FG003|Overall Study|Adverse Event|5|||
126107810|NCT00820027|453689483|FG000|Overall Study|Lack of Efficacy|2|||
126107811|NCT00820027|453689484|FG001|Overall Study|Lack of Efficacy|1|||
126107812|NCT00820027|453689485|FG002|Overall Study|Lack of Efficacy|2|||
126107813|NCT00820027|453689486|FG003|Overall Study|Lack of Efficacy|2|||
126107814|NCT00820027|453689483|FG000|Overall Study|Physician Decision|0|||
126107815|NCT00820027|453689484|FG001|Overall Study|Physician Decision|1|||
126107816|NCT00820027|453689485|FG002|Overall Study|Physician Decision|1|||
126107817|NCT00820027|453689486|FG003|Overall Study|Physician Decision|0|||
126107818|NCT00820027|453689483|FG000|Overall Study|Protocol Violation|3|||
126107819|NCT00820027|453689484|FG001|Overall Study|Protocol Violation|0|||
126107820|NCT00820027|453689485|FG002|Overall Study|Protocol Violation|4|||
126107821|NCT00820027|453689486|FG003|Overall Study|Protocol Violation|0|||
126107822|NCT00820027|453689483|FG000|Overall Study|Withdrawal by Subject|6|||
126107823|NCT00820027|453689484|FG001|Overall Study|Withdrawal by Subject|4|||
126107824|NCT00820027|453689485|FG002|Overall Study|Withdrawal by Subject|4|||
126107825|NCT00820027|453689486|FG003|Overall Study|Withdrawal by Subject|6|||
126107826|NCT02982187|453689487|FG000|Overall Study|Withdrawal by Subject|0|||
126107827|NCT02982187|453689488|FG001|Overall Study|Withdrawal by Subject|0|||
126107828|NCT02982187|453689489|FG002|Overall Study|Withdrawal by Subject|0|||
126107829|NCT02982187|453689490|FG003|Overall Study|Withdrawal by Subject|0|||
126107830|NCT02982187|453689491|FG004|Overall Study|Withdrawal by Subject|0|||
126107831|NCT02982187|453689492|FG005|Overall Study|Withdrawal by Subject|0|||
126107832|NCT02982187|453689493|FG006|Overall Study|Withdrawal by Subject|1|||
126058736|NCT01880736|453508924|FG003|Overall Study|Withdrawal Criteria|5|||
126058737|NCT00266656|453508928|FG000|Overall Study|Death|1|||
126058738|NCT00266656|453508929|FG001|Overall Study|Death|0|||
126058739|NCT00266656|453508928|FG000|Overall Study|Lost to Follow-up|4|||
126058740|NCT00266656|453508929|FG001|Overall Study|Lost to Follow-up|1|||
126058741|NCT00266656|453508928|FG000|Overall Study|Withdrawal by Subject|4|||
126058742|NCT00266656|453508929|FG001|Overall Study|Withdrawal by Subject|2|||
126058743|NCT00266656|453508928|FG000|Overall Study|Did Not Reach Final Height|4|||
126058744|NCT00266656|453508929|FG001|Overall Study|Did Not Reach Final Height|8|||
126058745|NCT00266656|453508928|FG000|Overall Study|Parent/Caregiver Decision|1|||
126058746|NCT00266656|453508929|FG001|Overall Study|Parent/Caregiver Decision|2|||
126058747|NCT02915783|453508930|FG000|Overall Study|Death|21|||
126058748|NCT02915783|453508930|FG000|Overall Study|Lost to Follow-up|1|||
126058749|NCT02915783|453508930|FG000|Overall Study|Withdrawal by Subject|2|||
126058750|NCT01915914|453508931|FG000|Acute Phase|Withdrawal by Subject|4|||
126058751|NCT01915914|453508932|FG001|Acute Phase|Withdrawal by Subject|0|||
126058752|NCT01915914|453508933|FG002|Acute Phase|Withdrawal by Subject|0|||
126058753|NCT01915914|453508934|FG003|Acute Phase|Withdrawal by Subject|0|||
126058754|NCT01915914|453508931|FG000|Acute Phase|Lost to Follow-up|4|||
126058755|NCT01915914|453508932|FG001|Acute Phase|Lost to Follow-up|0|||
126058756|NCT01915914|453508933|FG002|Acute Phase|Lost to Follow-up|0|||
126058757|NCT01915914|453508934|FG003|Acute Phase|Lost to Follow-up|0|||
126058758|NCT01915914|453508931|FG000|Acute Phase|Physician Decision|1|||
126058759|NCT01915914|453508932|FG001|Acute Phase|Physician Decision|0|||
126058760|NCT01915914|453508933|FG002|Acute Phase|Physician Decision|0|||
126058761|NCT01915914|453508934|FG003|Acute Phase|Physician Decision|0|||
126058762|NCT01915914|453508931|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
126058763|NCT01915914|453508932|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
126058764|NCT01915914|453508933|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
126058765|NCT01915914|453508934|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
126058766|NCT01915914|453508931|FG000|Acute Phase|"Not Achieved treatment success"|1|||
126058767|NCT01915914|453508932|FG001|Acute Phase|"Not Achieved treatment success"|0|||
126058768|NCT01915914|453508933|FG002|Acute Phase|"Not Achieved treatment success"|0|||
126058769|NCT01915914|453508934|FG003|Acute Phase|"Not Achieved treatment success"|0|||
126058770|NCT01915914|453508931|FG000|Acute Phase|Missing|1|||
126058771|NCT01915914|453508932|FG001|Acute Phase|Missing|0|||
126058772|NCT01915914|453508933|FG002|Acute Phase|Missing|0|||
126058773|NCT01915914|453508934|FG003|Acute Phase|Missing|0|||
126058774|NCT01915914|453508931|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126058775|NCT01915914|453508932|FG001|Maintenance Phase|Withdrawal by Subject|1|||
126058776|NCT01915914|453508933|FG002|Maintenance Phase|Withdrawal by Subject|1|||
126058777|NCT01915914|453508934|FG003|Maintenance Phase|Withdrawal by Subject|0|||
126058778|NCT01915914|453508931|FG000|Maintenance Phase|Lost to Follow-up|0|||
126058779|NCT01915914|453508932|FG001|Maintenance Phase|Lost to Follow-up|4|||
126058780|NCT01915914|453508933|FG002|Maintenance Phase|Lost to Follow-up|1|||
126058781|NCT01915914|453508934|FG003|Maintenance Phase|Lost to Follow-up|0|||
126058782|NCT01915914|453508931|FG000|Maintenance Phase|Missing|0|||
126058783|NCT01915914|453508932|FG001|Maintenance Phase|Missing|1|||
126058784|NCT01915914|453508933|FG002|Maintenance Phase|Missing|0|||
126058785|NCT01915914|453508934|FG003|Maintenance Phase|Missing|0|||
126058786|NCT01915914|453508931|FG000|Follow-up Phase|Withdrawal by Subject|0|||
126058787|NCT01915914|453508932|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126058788|NCT01915914|453508933|FG002|Follow-up Phase|Withdrawal by Subject|0|||
126058789|NCT01915914|453508934|FG003|Follow-up Phase|Withdrawal by Subject|1|||
126058790|NCT01915914|453508931|FG000|Follow-up Phase|Physician Decision|0|||
126058791|NCT01915914|453508932|FG001|Follow-up Phase|Physician Decision|0|||
126107833|NCT02982187|453689494|FG007|Overall Study|Withdrawal by Subject|0|||
126058792|NCT01915914|453508933|FG002|Follow-up Phase|Physician Decision|0|||
126058793|NCT01915914|453508934|FG003|Follow-up Phase|Physician Decision|1|||
126058794|NCT00116649|453508935|FG000|Overall Study|Adverse Event|20|||
126058795|NCT00116649|453508935|FG000|Overall Study|Lack of Efficacy|1|||
126058796|NCT00116649|453508935|FG000|Overall Study|Lost to Follow-up|32|||
126058797|NCT00116649|453508935|FG000|Overall Study|Withdrawal by Subject|68|||
126058798|NCT00116649|453508935|FG000|Overall Study|Local Skin Reaction|9|||
126058799|NCT00116649|453508935|FG000|Overall Study|Various Reasons|18|||
126058800|NCT00116649|453508935|FG000|Overall Study|Protocol Specified|7|||
126058801|NCT02114515|453508938|FG000|Overall Study|Lost to Follow-up|52|||
126058802|NCT02114515|453508939|FG001|Overall Study|Lost to Follow-up|55|||
126107834|NCT02604433|453689495|FG000|Overall Study|Withdrawal by Subject|37|||
126107835|NCT02604433|453689496|FG001|Overall Study|Withdrawal by Subject|16|||
126107836|NCT02604433|453689495|FG000|Overall Study|Adverse Event|4|||
126107837|NCT02604433|453689496|FG001|Overall Study|Adverse Event|0|||
126107838|NCT02604433|453689495|FG000|Overall Study|Other reasons|3|||
126107839|NCT02604433|453689496|FG001|Overall Study|Other reasons|5|||
126107840|NCT02604433|453689495|FG000|Overall Study|Death|4|||
126107841|NCT02604433|453689496|FG001|Overall Study|Death|1|||
126107842|NCT02604433|453689495|FG000|Overall Study|Transition to Rollover Protocol|169|||
126107843|NCT02604433|453689496|FG001|Overall Study|Transition to Rollover Protocol|82|||
126107844|NCT02604433|453689495|FG000|Overall Study|Physician Decision|1|||
126107845|NCT02604433|453689496|FG001|Overall Study|Physician Decision|1|||
126107846|NCT02604433|453689495|FG000|Overall Study|Lack of Efficacy|0|||
126107847|NCT02604433|453689496|FG001|Overall Study|Lack of Efficacy|1|||
126107848|NCT03437278|453689497|FG000|Overall Study|Adverse Event|0|||
126107849|NCT03437278|453689498|FG001|Overall Study|Adverse Event|0|||
126107850|NCT03437278|453689499|FG002|Overall Study|Adverse Event|1|||
126107851|NCT03437278|453689497|FG000|Overall Study|Progressive disease|1|||
126107852|NCT03437278|453689498|FG001|Overall Study|Progressive disease|0|||
126107853|NCT03437278|453689499|FG002|Overall Study|Progressive disease|0|||
126107854|NCT03437278|453689497|FG000|Overall Study|Physician Decision|1|||
126107855|NCT03437278|453689498|FG001|Overall Study|Physician Decision|0|||
126107856|NCT03437278|453689499|FG002|Overall Study|Physician Decision|1|||
126107857|NCT02202551|453689500|FG000|Overall Study|Adverse Event|8|||
126107858|NCT02202551|453689501|FG001|Overall Study|Adverse Event|19|||
126107859|NCT02202551|453689502|FG002|Overall Study|Adverse Event|5|||
126107860|NCT02202551|453689503|FG003|Overall Study|Adverse Event|9|||
126107861|NCT02202551|453689500|FG000|Overall Study|Death|3|||
126107862|NCT02202551|453689501|FG001|Overall Study|Death|2|||
126107863|NCT02202551|453689502|FG002|Overall Study|Death|1|||
126107864|NCT02202551|453689503|FG003|Overall Study|Death|1|||
126107865|NCT02202551|453689500|FG000|Overall Study|Lost to Follow-up|0|||
126107866|NCT02202551|453689501|FG001|Overall Study|Lost to Follow-up|1|||
126107867|NCT02202551|453689502|FG002|Overall Study|Lost to Follow-up|0|||
126107868|NCT02202551|453689503|FG003|Overall Study|Lost to Follow-up|1|||
126107869|NCT02202551|453689500|FG000|Overall Study|Needed to take excluded medication|0|||
126107870|NCT02202551|453689501|FG001|Overall Study|Needed to take excluded medication|2|||
126107871|NCT02202551|453689502|FG002|Overall Study|Needed to take excluded medication|0|||
126107872|NCT02202551|453689503|FG003|Overall Study|Needed to take excluded medication|1|||
126107873|NCT02202551|453689500|FG000|Overall Study|Subject moved away|0|||
126107874|NCT02202551|453689501|FG001|Overall Study|Subject moved away|1|||
126107875|NCT02202551|453689502|FG002|Overall Study|Subject moved away|0|||
126107876|NCT02202551|453689503|FG003|Overall Study|Subject moved away|0|||
126107877|NCT02202551|453689500|FG000|Overall Study|DBS surgery|3|||
126107878|NCT02202551|453689501|FG001|Overall Study|DBS surgery|0|||
126107879|NCT02202551|453689502|FG002|Overall Study|DBS surgery|0|||
126107880|NCT02202551|453689503|FG003|Overall Study|DBS surgery|0|||
126107881|NCT02202551|453689500|FG000|Overall Study|Dyskinesia upon taper|1|||
126107882|NCT02202551|453689501|FG001|Overall Study|Dyskinesia upon taper|0|||
126107883|NCT02202551|453689502|FG002|Overall Study|Dyskinesia upon taper|0|||
126107884|NCT02202551|453689503|FG003|Overall Study|Dyskinesia upon taper|0|||
126107885|NCT02202551|453689500|FG000|Overall Study|Lack of Efficacy|0|||
126107886|NCT02202551|453689501|FG001|Overall Study|Lack of Efficacy|1|||
126107887|NCT02202551|453689502|FG002|Overall Study|Lack of Efficacy|0|||
126107888|NCT02202551|453689503|FG003|Overall Study|Lack of Efficacy|0|||
126107889|NCT02202551|453689500|FG000|Overall Study|Physician Decision|1|||
126107890|NCT02202551|453689501|FG001|Overall Study|Physician Decision|0|||
126107891|NCT02202551|453689502|FG002|Overall Study|Physician Decision|0|||
126107892|NCT02202551|453689503|FG003|Overall Study|Physician Decision|0|||
126107893|NCT02202551|453689500|FG000|Overall Study|Site closure|3|||
126107894|NCT02202551|453689501|FG001|Overall Study|Site closure|0|||
126107895|NCT02202551|453689502|FG002|Overall Study|Site closure|0|||
126107896|NCT02202551|453689503|FG003|Overall Study|Site closure|1|||
126107897|NCT02202551|453689500|FG000|Overall Study|Unable to complete visits per protocol|1|||
126107898|NCT02202551|453689501|FG001|Overall Study|Unable to complete visits per protocol|0|||
126107899|NCT02202551|453689502|FG002|Overall Study|Unable to complete visits per protocol|0|||
126107900|NCT02202551|453689503|FG003|Overall Study|Unable to complete visits per protocol|0|||
126107901|NCT02202551|453689500|FG000|Overall Study|Worsening Dyskinesia|0|||
126107902|NCT02202551|453689501|FG001|Overall Study|Worsening Dyskinesia|0|||
126107903|NCT02202551|453689502|FG002|Overall Study|Worsening Dyskinesia|0|||
126107904|NCT02202551|453689503|FG003|Overall Study|Worsening Dyskinesia|1|||
126107905|NCT02202551|453689500|FG000|Overall Study|Protocol Violation|0|||
126107906|NCT02202551|453689501|FG001|Overall Study|Protocol Violation|1|||
126107907|NCT02202551|453689502|FG002|Overall Study|Protocol Violation|0|||
126107908|NCT02202551|453689503|FG003|Overall Study|Protocol Violation|0|||
126107909|NCT02202551|453689500|FG000|Overall Study|Sponsor's decision|2|||
126107910|NCT02202551|453689501|FG001|Overall Study|Sponsor's decision|0|||
126107911|NCT02202551|453689502|FG002|Overall Study|Sponsor's decision|0|||
126107912|NCT02202551|453689503|FG003|Overall Study|Sponsor's decision|0|||
126107913|NCT02202551|453689500|FG000|Overall Study|Subject unwilling to proceed|1|||
126107914|NCT02202551|453689501|FG001|Overall Study|Subject unwilling to proceed|5|||
126107915|NCT02202551|453689502|FG002|Overall Study|Subject unwilling to proceed|3|||
126107916|NCT02202551|453689503|FG003|Overall Study|Subject unwilling to proceed|5|||
125892943|NCT02511106|452906787|FG000|Overall Study|Ongoing study at data cut-off|3|||
125892944|NCT02511106|452906788|FG001|Overall Study|Ongoing study at data cut-off|2|||
125892945|NCT02511106|452906787|FG000|Overall Study|Without specified reason|3|||
125892946|NCT02511106|452906788|FG001|Overall Study|Without specified reason|0|||
125892947|NCT00344487|452906792|FG000|Overall Study|immunologic failure|1|||
125892948|NCT03679754|452906795|FG000|Overall Study|Investigator request|1|||
125892949|NCT00964171|452906798|FG000|Overall Study|Death|5|||
125892950|NCT01262820|452906802|FG000|Overall Study|Adverse Event|5|||
125892951|NCT01262820|452906802|FG000|Overall Study|Lack of Efficacy|9|||
125892952|NCT01262820|452906802|FG000|Overall Study|Drug held for 21+ days|1|||
125892953|NCT00910299|452906803|FG000|Overall Study|Withdrawal by Subject|16|||
125892954|NCT00910299|452906804|FG001|Overall Study|Withdrawal by Subject|13|||
126107917|NCT02202551|453689500|FG000|Overall Study|Subject consent withdrawn|0|||
126107918|NCT02202551|453689501|FG001|Overall Study|Subject consent withdrawn|3|||
126107919|NCT02202551|453689502|FG002|Overall Study|Subject consent withdrawn|1|||
126107920|NCT02202551|453689503|FG003|Overall Study|Subject consent withdrawn|2|||
126107921|NCT02202551|453689500|FG000|Overall Study|eGFR<50mL/min/m2|2|||
126107922|NCT02202551|453689501|FG001|Overall Study|eGFR<50mL/min/m2|2|||
126107923|NCT02202551|453689502|FG002|Overall Study|eGFR<50mL/min/m2|0|||
125892955|NCT00910299|452906803|FG000|Overall Study|Sponsor Decision|58|||
125892956|NCT00910299|452906804|FG001|Overall Study|Sponsor Decision|60|||
125892957|NCT00910299|452906803|FG000|Overall Study|Didn't receive any study drug|2|||
125892958|NCT00910299|452906804|FG001|Overall Study|Didn't receive any study drug|1|||
126107924|NCT02202551|453689503|FG003|Overall Study|eGFR<50mL/min/m2|1|||
126107925|NCT02147353|453689504|FG000|Overall Study|Lost to Follow-up|2|||
126107926|NCT02147353|453689505|FG001|Overall Study|Lost to Follow-up|0|||
126058803|NCT02114515|453508938|FG000|Overall Study|Death|12|||
126058804|NCT02114515|453508939|FG001|Overall Study|Death|12|||
126058805|NCT02114515|453508938|FG000|Overall Study|Withdrawal by Subject|4|||
126058806|NCT02114515|453508939|FG001|Overall Study|Withdrawal by Subject|22|||
126058807|NCT02114515|453508938|FG000|Overall Study|Other|65|||
126058808|NCT02114515|453508939|FG001|Overall Study|Other|61|||
126058809|NCT01075152|453508940|FG000|Overall Study|Withdrawal by Subject|1|||
126058810|NCT01075152|453508941|FG001|Overall Study|Withdrawal by Subject|0|||
126058811|NCT02334215|453508942|FG000|Overall Study|Death|1|||
126058812|NCT02334215|453508943|FG001|Overall Study|Death|1|||
126058813|NCT02334215|453508944|FG002|Overall Study|Death|0|||
126058814|NCT02334215|453508942|FG000|Overall Study|Lost to Follow-up|1|||
126058815|NCT02334215|453508943|FG001|Overall Study|Lost to Follow-up|0|||
126058816|NCT02334215|453508944|FG002|Overall Study|Lost to Follow-up|4|||
126058817|NCT02334215|453508942|FG000|Overall Study|Withdrawal by Subject|2|||
126058818|NCT02334215|453508943|FG001|Overall Study|Withdrawal by Subject|2|||
126058819|NCT02334215|453508944|FG002|Overall Study|Withdrawal by Subject|1|||
126058820|NCT02334215|453508942|FG000|Overall Study|Not released from incarceration on time|3|||
126058821|NCT02334215|453508943|FG001|Overall Study|Not released from incarceration on time|3|||
126058822|NCT02334215|453508944|FG002|Overall Study|Not released from incarceration on time|3|||
126058823|NCT02334215|453508942|FG000|Overall Study|Incarcerated|0|||
126058824|NCT02334215|453508943|FG001|Overall Study|Incarcerated|0|||
126058825|NCT02334215|453508944|FG002|Overall Study|Incarcerated|7|||
126058826|NCT03976323|453508947|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
126058827|NCT03976323|453508948|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
126058828|NCT03976323|453508949|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
126058829|NCT03976323|453508947|FG000|Induction Phase|Death|80|||
126058830|NCT03976323|453508948|FG001|Induction Phase|Death|0|||
126058831|NCT03976323|453508949|FG002|Induction Phase|Death|0|||
126058832|NCT03976323|453508947|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
126058833|NCT03976323|453508948|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
126058834|NCT03976323|453508949|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
126058835|NCT03976323|453508947|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126058836|NCT03976323|453508948|FG001|Maintenance Phase|Withdrawal by Subject|9|||
126058837|NCT03976323|453508949|FG002|Maintenance Phase|Withdrawal by Subject|3|||
126058838|NCT03976323|453508947|FG000|Maintenance Phase|Physician Decision|0|||
126058839|NCT03976323|453508948|FG001|Maintenance Phase|Physician Decision|0|||
126058840|NCT03976323|453508949|FG002|Maintenance Phase|Physician Decision|1|||
126058841|NCT03976323|453508947|FG000|Maintenance Phase|Death|0|||
126058842|NCT03976323|453508948|FG001|Maintenance Phase|Death|228|||
126058843|NCT03976323|453508949|FG002|Maintenance Phase|Death|234|||
126058844|NCT01523392|453510793|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126058845|NCT01523392|453510794|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126058846|NCT01523392|453510793|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
126058847|NCT01523392|453510794|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
126058848|NCT01523392|453510793|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
126058849|NCT01523392|453510794|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
126058850|NCT01377844|453510796|FG000|Overall Study|Withdrawal by Subject|25|||
126058851|NCT01377844|453510797|FG001|Overall Study|Withdrawal by Subject|28|||
126058852|NCT01377844|453510796|FG000|Overall Study|Protocol Violation|2|||
126058853|NCT01377844|453510797|FG001|Overall Study|Protocol Violation|3|||
126058854|NCT01377844|453510796|FG000|Overall Study|Adverse Event|3|||
126058855|NCT01377844|453510797|FG001|Overall Study|Adverse Event|0|||
126058856|NCT01377844|453510796|FG000|Overall Study|Physician Decision|6|||
126058857|NCT01377844|453510797|FG001|Overall Study|Physician Decision|3|||
126058858|NCT01377844|453510796|FG000|Overall Study|Study terminated by Sponsor|0|||
126058859|NCT01377844|453510797|FG001|Overall Study|Study terminated by Sponsor|1|||
126058860|NCT02236611|453510799|FG000|Overall Study|Adverse Event|10|||
126058861|NCT02236611|453510800|FG001|Overall Study|Adverse Event|16|||
126058862|NCT02236611|453510799|FG000|Overall Study|Lack of Efficacy|4|||
126058863|NCT02236611|453510800|FG001|Overall Study|Lack of Efficacy|7|||
126058864|NCT02236611|453510799|FG000|Overall Study|Lost to Follow-up|0|||
126058865|NCT02236611|453510800|FG001|Overall Study|Lost to Follow-up|2|||
126058866|NCT02236611|453510799|FG000|Overall Study|Protocol deviation|3|||
126058867|NCT02236611|453510800|FG001|Overall Study|Protocol deviation|5|||
126058868|NCT02236611|453510799|FG000|Overall Study|Withdrew consent|9|||
126058869|NCT02236611|453510800|FG001|Overall Study|Withdrew consent|4|||
126058870|NCT03403036|453510804|FG000|Overall Study|Lack of Efficacy|5|||
126058871|NCT02701296|453510807|FG000|Overall Study|Incomplete Data|0|||
126058872|NCT02701296|453510808|FG001|Overall Study|Incomplete Data|2|||
126058873|NCT00704340|453510809|FG000|Overall Study|Lost to Follow-up|2|||
126058874|NCT00704340|453510810|FG001|Overall Study|Lost to Follow-up|1|||
126058875|NCT00704340|453510809|FG000|Overall Study|Death|0|||
126058876|NCT00704340|453510810|FG001|Overall Study|Death|1|||
126058877|NCT01437540|453510811|FG000|Overall Study|Not listed below|7|||
126058878|NCT01437540|453510812|FG001|Overall Study|Not listed below|6|||
126058879|NCT01437540|453510811|FG000|Overall Study|COPD exacerbation|13|||
126058880|NCT01437540|453510812|FG001|Overall Study|COPD exacerbation|3|||
126058881|NCT01437540|453510811|FG000|Overall Study|Lost to Follow-up|3|||
126058882|NCT01437540|453510812|FG001|Overall Study|Lost to Follow-up|5|||
126058883|NCT01437540|453510811|FG000|Overall Study|Lack of Efficacy|23|||
126058884|NCT01437540|453510812|FG001|Overall Study|Lack of Efficacy|11|||
126058885|NCT01437540|453510811|FG000|Overall Study|Protocol Violation|24|||
126058886|NCT01437540|453510812|FG001|Overall Study|Protocol Violation|12|||
126058887|NCT01437540|453510811|FG000|Overall Study|Adverse Event|26|||
126058888|NCT01437540|453510812|FG001|Overall Study|Adverse Event|13|||
126058889|NCT01437540|453510811|FG000|Overall Study|Withdrawal by Subject|31|||
126058890|NCT01437540|453510812|FG001|Overall Study|Withdrawal by Subject|15|||
126058891|NCT02547974|453510813|FG000|Overall Study|Withdrawal by Subject|1|||
126058892|NCT02547974|453510814|FG001|Overall Study|Withdrawal by Subject|0|||
126058893|NCT02547974|453510815|FG002|Overall Study|Withdrawal by Subject|0|||
126058894|NCT02547974|453510816|FG003|Overall Study|Withdrawal by Subject|0|||
126058895|NCT01393600|453510820|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
126058896|NCT01393600|453510821|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
126058897|NCT01393600|453510822|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
126058898|NCT01393600|453510823|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
126058899|NCT01393600|453510820|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
126058900|NCT01393600|453510821|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
126058901|NCT01393600|453510822|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
126058902|NCT01393600|453510823|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
126058903|NCT01393600|453510820|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
126058904|NCT01393600|453510821|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
126058905|NCT01393600|453510822|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
126058906|NCT01393600|453510823|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
126058907|NCT01393600|453510820|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
126058908|NCT01393600|453510821|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
126058909|NCT01393600|453510822|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
126058910|NCT01393600|453510823|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
126058911|NCT01393600|453510820|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
126058912|NCT01393600|453510821|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
126058913|NCT01393600|453510822|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
126058914|NCT01393600|453510823|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
126058915|NCT01393600|453510820|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
126058916|NCT01393600|453510821|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
126058917|NCT01393600|453510822|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
126058918|NCT01393600|453510823|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
126058919|NCT01393600|453510820|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
126058920|NCT01393600|453510821|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
126058921|NCT01393600|453510822|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
126058922|NCT01393600|453510823|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
126058923|NCT00603798|453510824|FG000|Overall Study|Adverse Event|4|||
126058924|NCT00603798|453510825|FG001|Overall Study|Adverse Event|2|||
125892959|NCT00711477|452906805|FG000|Overall Study|Adverse Event|3|||
125892960|NCT00711477|452906806|FG001|Overall Study|Adverse Event|1|||
125892961|NCT00711477|452906805|FG000|Overall Study|Lost to Follow-up|0|||
125892962|NCT00711477|452906806|FG001|Overall Study|Lost to Follow-up|1|||
125892963|NCT00711477|452906805|FG000|Overall Study|Noncompliance|0|||
125892964|NCT00711477|452906806|FG001|Overall Study|Noncompliance|1|||
125892965|NCT00145977|452906813|FG000|Overall Study|Lack of Efficacy|0|||
125892966|NCT00145977|452906814|FG001|Overall Study|Lack of Efficacy|4|||
125892967|NCT00145977|452906813|FG000|Overall Study|Lost to Follow-up|1|||
125892968|NCT00145977|452906814|FG001|Overall Study|Lost to Follow-up|0|||
125892969|NCT00145977|452906813|FG000|Overall Study|Withdrawal by Subject|1|||
125892970|NCT00145977|452906814|FG001|Overall Study|Withdrawal by Subject|0|||
125892971|NCT00782834|452906821|FG000|Treatment Phase|fibrous tumor not GIST|1|||
125892972|NCT02055118|452906822|FG000|Overall Study|Withdrawal by Subject|0|||
125892973|NCT02055118|452906823|FG001|Overall Study|Withdrawal by Subject|2|||
125892974|NCT02055118|452906824|FG002|Overall Study|Withdrawal by Subject|0|||
125892975|NCT02281383|452906825|FG000|Overall Study|Progressive Disease|1|||
125892976|NCT02281383|452906825|FG000|Overall Study|Withdrawal by Subject|6|||
125892977|NCT02281383|452906825|FG000|Overall Study|Protocol Violation|2|||
125892978|NCT02281383|452906825|FG000|Overall Study|Death|1|||
125892979|NCT02281383|452906825|FG000|Overall Study|Adverse Event|2|||
125892980|NCT02560025|452906828|FG000|Overall Study|Ineligible after consent/ registration|3|||
125892981|NCT02703337|452906829|FG000|Period One (Part A)|Withdrawal by Subject|0|||
125892982|NCT02703337|452906830|FG001|Period One (Part A)|Withdrawal by Subject|0|||
125892983|NCT02703337|452906831|FG002|Period One (Part A)|Withdrawal by Subject|0|||
125892984|NCT02703337|452906832|FG003|Period One (Part A)|Withdrawal by Subject|0|||
125892985|NCT02703337|452906833|FG004|Period One (Part A)|Withdrawal by Subject|1|||
125892986|NCT02703337|452906834|FG005|Period One (Part A)|Withdrawal by Subject|0|||
125892987|NCT02703337|452906835|FG006|Period One (Part A)|Withdrawal by Subject|0|||
125892988|NCT02703337|452906836|FG007|Period One (Part A)|Withdrawal by Subject|0|||
125892989|NCT00282308|452906837|FG000|Treatment Period|Lost to Follow-up|1|||
125892990|NCT00282308|452906838|FG001|Treatment Period|Lost to Follow-up|0|||
125892991|NCT00282308|452906839|FG002|Treatment Period|Lost to Follow-up|0|||
125892992|NCT00282308|452906837|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
125892993|NCT00282308|452906838|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
125892994|NCT00282308|452906839|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
125892995|NCT00282308|452906837|FG000|Treatment Period|Adverse Event|0|||
125892996|NCT00282308|452906838|FG001|Treatment Period|Adverse Event|2|||
125892997|NCT00282308|452906839|FG002|Treatment Period|Adverse Event|0|||
125892998|NCT00282308|452906837|FG000|Treatment Period|Not Treated with Study Drug|1|||
126058925|NCT00603798|453510826|FG002|Overall Study|Adverse Event|1|||
125892999|NCT00282308|452906838|FG001|Treatment Period|Not Treated with Study Drug|0|||
125893000|NCT00282308|452906839|FG002|Treatment Period|Not Treated with Study Drug|0|||
125893001|NCT00282308|452906837|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
125893002|NCT00282308|452906838|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
126058926|NCT00603798|453510824|FG000|Overall Study|Withdrawal by Subject|4|||
126058927|NCT00603798|453510825|FG001|Overall Study|Withdrawal by Subject|3|||
126058928|NCT00603798|453510826|FG002|Overall Study|Withdrawal by Subject|4|||
126058929|NCT00603798|453510824|FG000|Overall Study|Lost to Follow-up|1|||
126058930|NCT00603798|453510825|FG001|Overall Study|Lost to Follow-up|0|||
126058931|NCT00603798|453510826|FG002|Overall Study|Lost to Follow-up|1|||
126058932|NCT00603798|453510824|FG000|Overall Study|Non-compliance with study procedures|0|||
126058933|NCT00603798|453510825|FG001|Overall Study|Non-compliance with study procedures|1|||
126058934|NCT00603798|453510826|FG002|Overall Study|Non-compliance with study procedures|0|||
126058935|NCT00603798|453510824|FG000|Overall Study|Not due to AE|1|||
126058936|NCT00603798|453510825|FG001|Overall Study|Not due to AE|1|||
126058937|NCT00603798|453510826|FG002|Overall Study|Not due to AE|4|||
125893003|NCT00282308|452906839|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
125893004|NCT00282308|452906837|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
126058938|NCT04766996|453510827|FG000|Overall Study|Withdrawal by Subject|1|||
126058939|NCT04766996|453510828|FG001|Overall Study|Withdrawal by Subject|0|||
126058940|NCT04766996|453510829|FG002|Overall Study|Withdrawal by Subject|13|||
126058941|NCT02988713|453510832|FG000|Overall Study|Withdrawal by Subject|1|||
126058942|NCT02988713|453510832|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
126058943|NCT04248868|453510838|FG000|Overall Study|Death|1|||
125893005|NCT00282308|452906838|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
125893006|NCT00282308|452906839|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
125893007|NCT00282308|452906837|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
125893008|NCT00282308|452906838|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
125893009|NCT00282308|452906839|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
125893010|NCT00282308|452906837|FG000|Safety Follow-up Period|Adverse Event|0|||
125893011|NCT00282308|452906838|FG001|Safety Follow-up Period|Adverse Event|0|||
125893012|NCT00282308|452906839|FG002|Safety Follow-up Period|Adverse Event|1|||
125893013|NCT00282308|452906837|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
125893014|NCT00282308|452906838|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
125893015|NCT00282308|452906839|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
125893016|NCT00282308|452906837|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
125893017|NCT00282308|452906838|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
125893018|NCT00282308|452906839|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
125893019|NCT00282308|452906837|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
125893020|NCT00282308|452906838|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
125893021|NCT00282308|452906839|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
125893022|NCT01001325|452906840|FG000|Overall Study|Lost to Follow-up|16|||
125893023|NCT01001325|452906841|FG001|Overall Study|Lost to Follow-up|10|||
125893024|NCT01001325|452906840|FG000|Overall Study|Protocol Violation|2|||
125893025|NCT01001325|452906841|FG001|Overall Study|Protocol Violation|0|||
126107927|NCT02147353|453689504|FG000|Overall Study|unable to make visits|4|||
126107928|NCT02147353|453689505|FG001|Overall Study|unable to make visits|0|||
126107929|NCT02147353|453689504|FG000|Overall Study|medication noncompliance|3|||
126107930|NCT02147353|453689505|FG001|Overall Study|medication noncompliance|0|||
126107931|NCT01326533|453689518|FG000|Overall Study|Lost to Follow-up|2|||
126107932|NCT01326533|453689519|FG001|Overall Study|Lost to Follow-up|0|||
126107933|NCT01326533|453689518|FG000|Overall Study|Withdrawal by Subject|1|||
126107934|NCT01326533|453689519|FG001|Overall Study|Withdrawal by Subject|0|||
126107935|NCT01326533|453689518|FG000|Overall Study|Adverse Event|1|||
126107936|NCT01326533|453689519|FG001|Overall Study|Adverse Event|0|||
126107937|NCT00926211|453689520|FG000|Overall Study|Lost to Follow-up|1|||
126107938|NCT01106404|453689524|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
126107939|NCT01106404|453689525|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
126107940|NCT01106404|453689524|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
126107941|NCT01106404|453689525|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
126107942|NCT01106404|453689524|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
126107943|NCT01106404|453689525|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
126107944|NCT01106404|453689524|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
126107945|NCT01106404|453689525|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
126107946|NCT00775450|453689526|FG000|Overall Study|Serious Adverse Event|2|||
125893026|NCT01584440|452906842|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
126058944|NCT04248868|453510838|FG000|Overall Study|Lost to Follow-up|3|||
126058945|NCT04248868|453510838|FG000|Overall Study|Protocol Violation|2|||
126058946|NCT03131713|453510839|FG000|Overall Study|Lost to Follow-up|5|||
126058947|NCT03131713|453510840|FG001|Overall Study|Lost to Follow-up|0|||
126058948|NCT02208843|453510841|FG000|Overall Study|Clinical symptoms of progression|2|||
126058949|NCT02208843|453510841|FG000|Overall Study|Progression disease according to RECIST|24|||
126058950|NCT02208843|453510841|FG000|Overall Study|Adverse Event|12|||
126058951|NCT02208843|453510841|FG000|Overall Study|Protocol Violation|1|||
126058952|NCT02208843|453510841|FG000|Overall Study|Withdrawal by Subject|1|||
126058953|NCT02208843|453510841|FG000|Overall Study|Switched to commercial afatinib|20|||
126058954|NCT01976507|453510842|FG000|Overall Study|Adverse Event|6|||
126058955|NCT01976507|453510842|FG000|Overall Study|ablation not done, drug not given|1|||
126058956|NCT01794299|453510852|FG000|Overall Study|ATIR manufacturing not possible|1|||
126058957|NCT01794299|453510852|FG000|Overall Study|Death|14|||
126058958|NCT01794299|453510852|FG000|Overall Study|Graft failure|1|||
126058959|NCT01794299|453510852|FG000|Overall Study|ATIR batch rejected|2|||
126058960|NCT01794299|453510852|FG000|Overall Study|Relapse|2|||
126058961|NCT01794299|453510852|FG000|Overall Study|Discontinued from active follow-up|1|||
126058962|NCT01794299|453510852|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
126058963|NCT01029704|453510856|FG000|Overall Study|Adverse Event|0|||
126058964|NCT01029704|453510857|FG001|Overall Study|Adverse Event|0|||
126107947|NCT00775450|453689527|FG001|Overall Study|Serious Adverse Event|0|||
126107948|NCT00775450|453689528|FG002|Overall Study|Serious Adverse Event|0|||
126107949|NCT00775450|453689529|FG003|Overall Study|Serious Adverse Event|0|||
126107950|NCT00775450|453689530|FG004|Overall Study|Serious Adverse Event|0|||
126107951|NCT00775450|453689526|FG000|Overall Study|Protocol Violation|0|||
126107952|NCT00775450|453689527|FG001|Overall Study|Protocol Violation|0|||
126107953|NCT00775450|453689528|FG002|Overall Study|Protocol Violation|0|||
126107954|NCT00775450|453689529|FG003|Overall Study|Protocol Violation|0|||
126107955|NCT00775450|453689530|FG004|Overall Study|Protocol Violation|1|||
126107956|NCT00775450|453689526|FG000|Overall Study|Withdrawal by Subject|1|||
126107957|NCT00775450|453689527|FG001|Overall Study|Withdrawal by Subject|0|||
126107958|NCT00775450|453689528|FG002|Overall Study|Withdrawal by Subject|0|||
126107959|NCT00775450|453689529|FG003|Overall Study|Withdrawal by Subject|0|||
126107960|NCT00775450|453689530|FG004|Overall Study|Withdrawal by Subject|1|||
126107961|NCT00894686|453689537|FG000|Overall Study|Withdrawal by Subject|50|||
126107962|NCT00894686|453689537|FG000|Overall Study|Physician Decision|1|||
126107963|NCT00894686|453689537|FG000|Overall Study|Other|5|||
126107964|NCT00564018|453689540|FG000|Overall Study|Withdrawal by Subject|2|||
126107965|NCT00564018|453689541|FG001|Overall Study|Withdrawal by Subject|3|||
126107966|NCT00564018|453689542|FG002|Overall Study|Withdrawal by Subject|1|||
126107967|NCT03267940|453689543|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
126107968|NCT03267940|453689544|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
126107969|NCT03267940|453689545|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
126107970|NCT03267940|453689546|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
126107971|NCT03267940|453689547|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
126107972|NCT03267940|453689548|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
126107973|NCT03267940|453689543|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126107974|NCT03267940|453689544|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
126107975|NCT03267940|453689545|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126107976|NCT03267940|453689546|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126107977|NCT03267940|453689547|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126107978|NCT03267940|453689548|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126058965|NCT01029704|453510858|FG002|Overall Study|Adverse Event|0|||
126058966|NCT01029704|453510859|FG003|Overall Study|Adverse Event|0|||
126058967|NCT01029704|453510860|FG004|Overall Study|Adverse Event|0|||
126058968|NCT01029704|453510861|FG005|Overall Study|Adverse Event|0|||
126058969|NCT01029704|453510862|FG006|Overall Study|Adverse Event|1|||
126058970|NCT01029704|453510863|FG007|Overall Study|Adverse Event|1|||
126058971|NCT01029704|453510864|FG008|Overall Study|Adverse Event|0|||
126058972|NCT01029704|453510856|FG000|Overall Study|Withdrawal by Subject|0|||
126058973|NCT01029704|453510857|FG001|Overall Study|Withdrawal by Subject|0|||
126058974|NCT01029704|453510858|FG002|Overall Study|Withdrawal by Subject|0|||
126058975|NCT01029704|453510859|FG003|Overall Study|Withdrawal by Subject|0|||
126058976|NCT01029704|453510860|FG004|Overall Study|Withdrawal by Subject|2|||
126058977|NCT01029704|453510861|FG005|Overall Study|Withdrawal by Subject|1|||
126058978|NCT01029704|453510862|FG006|Overall Study|Withdrawal by Subject|1|||
126058979|NCT01029704|453510863|FG007|Overall Study|Withdrawal by Subject|1|||
126058980|NCT01029704|453510864|FG008|Overall Study|Withdrawal by Subject|0|||
126058981|NCT01029704|453510856|FG000|Overall Study|Lost to Follow-up|0|||
126058982|NCT01029704|453510857|FG001|Overall Study|Lost to Follow-up|0|||
126058983|NCT01029704|453510858|FG002|Overall Study|Lost to Follow-up|0|||
126058984|NCT01029704|453510859|FG003|Overall Study|Lost to Follow-up|0|||
126058985|NCT01029704|453510860|FG004|Overall Study|Lost to Follow-up|0|||
126058986|NCT01029704|453510861|FG005|Overall Study|Lost to Follow-up|0|||
126058987|NCT01029704|453510862|FG006|Overall Study|Lost to Follow-up|1|||
126058988|NCT01029704|453510863|FG007|Overall Study|Lost to Follow-up|1|||
126058989|NCT01029704|453510864|FG008|Overall Study|Lost to Follow-up|1|||
126058990|NCT01029704|453510856|FG000|Overall Study|Lack of Efficacy|0|||
126058991|NCT01029704|453510857|FG001|Overall Study|Lack of Efficacy|0|||
126058992|NCT01029704|453510858|FG002|Overall Study|Lack of Efficacy|0|||
126058993|NCT01029704|453510859|FG003|Overall Study|Lack of Efficacy|0|||
126058994|NCT01029704|453510860|FG004|Overall Study|Lack of Efficacy|2|||
126058995|NCT01029704|453510861|FG005|Overall Study|Lack of Efficacy|3|||
126107979|NCT03267940|453689543|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126107980|NCT03267940|453689544|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
126058996|NCT01029704|453510862|FG006|Overall Study|Lack of Efficacy|1|||
126058997|NCT01029704|453510863|FG007|Overall Study|Lack of Efficacy|2|||
126058998|NCT01029704|453510864|FG008|Overall Study|Lack of Efficacy|0|||
126058999|NCT01029704|453510856|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
126107981|NCT03267940|453689545|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126107982|NCT03267940|453689546|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126107983|NCT03267940|453689547|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126107984|NCT03267940|453689548|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126107985|NCT03267940|453689543|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
126107986|NCT03267940|453689544|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
126107987|NCT03267940|453689545|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
126107988|NCT03267940|453689546|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
126107989|NCT03267940|453689547|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
126107990|NCT03267940|453689548|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
126107991|NCT03267940|453689543|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
126107992|NCT03267940|453689544|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
126107993|NCT03267940|453689545|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
126107994|NCT03267940|453689546|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
126107995|NCT03267940|453689547|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
126107996|NCT03267940|453689548|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
126107997|NCT03267940|453689543|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
126107998|NCT03267940|453689544|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
126107999|NCT03267940|453689545|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
126108000|NCT03267940|453689546|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
126108001|NCT03267940|453689547|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
126108002|NCT03267940|453689548|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
126108003|NCT03267940|453689543|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
126108004|NCT03267940|453689544|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
125893027|NCT01584440|452906843|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
125893028|NCT01584440|452906844|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
125893029|NCT01584440|452906845|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
125893030|NCT01584440|452906846|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
125893031|NCT01584440|452906842|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
125893032|NCT01584440|452906843|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
125893033|NCT01584440|452906844|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
125893034|NCT01584440|452906845|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
125893035|NCT01584440|452906846|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
125893036|NCT01584440|452906842|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
125893037|NCT01584440|452906843|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
125893038|NCT01584440|452906844|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
126059000|NCT01029704|453510857|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
126059001|NCT01029704|453510858|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
126059002|NCT01029704|453510859|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
126059003|NCT01029704|453510860|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
126059004|NCT01029704|453510861|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
126059005|NCT01029704|453510862|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
126059006|NCT01029704|453510863|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
126059007|NCT01029704|453510864|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
126059008|NCT00089791|453510865|FG000|Overall Study|Physician Decision|6|||
126059009|NCT00089791|453510866|FG001|Overall Study|Physician Decision|3|||
126059010|NCT00089791|453510865|FG000|Overall Study|Adverse Event|81|||
126059011|NCT00089791|453510866|FG001|Overall Study|Adverse Event|93|||
126059012|NCT00089791|453510865|FG000|Overall Study|Withdrawal by Subject|403|||
126059013|NCT00089791|453510866|FG001|Overall Study|Withdrawal by Subject|344|||
126059014|NCT00089791|453510865|FG000|Overall Study|Death|78|||
126059015|NCT00089791|453510866|FG001|Overall Study|Death|62|||
126059016|NCT00089791|453510865|FG000|Overall Study|Disease progression|7|||
126059017|NCT00089791|453510866|FG001|Overall Study|Disease progression|3|||
126059018|NCT00089791|453510865|FG000|Overall Study|Ineligibility determined|12|||
126059019|NCT00089791|453510866|FG001|Overall Study|Ineligibility determined|9|||
126059020|NCT00089791|453510865|FG000|Overall Study|Lost to Follow-up|57|||
126059021|NCT00089791|453510866|FG001|Overall Study|Lost to Follow-up|57|||
126059022|NCT00089791|453510865|FG000|Overall Study|Noncompliance|17|||
126059023|NCT00089791|453510866|FG001|Overall Study|Noncompliance|13|||
126059024|NCT00089791|453510865|FG000|Overall Study|Other|20|||
126059025|NCT00089791|453510866|FG001|Overall Study|Other|32|||
126059026|NCT00089791|453510865|FG000|Overall Study|Protocol deviation|12|||
126059027|NCT00089791|453510866|FG001|Overall Study|Protocol deviation|10|||
126108005|NCT03267940|453689545|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
126108006|NCT03267940|453689546|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
126108007|NCT03267940|453689547|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
126108008|NCT03267940|453689548|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
126108009|NCT03267940|453689543|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
126108010|NCT03267940|453689544|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
126108011|NCT03267940|453689545|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
126108012|NCT03267940|453689546|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
125893039|NCT01584440|452906845|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
125893040|NCT01584440|452906846|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
126108013|NCT03267940|453689547|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
126108014|NCT03267940|453689548|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
126108015|NCT03267940|453689543|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
126108016|NCT03267940|453689544|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
126108017|NCT03267940|453689545|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
126108018|NCT03267940|453689546|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
126108019|NCT03267940|453689547|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
126108020|NCT03267940|453689548|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
126108021|NCT00388154|453689549|FG000|Overall Study|Withdrawal by Subject|1|||
126108022|NCT03291587|453689558|FG000|Overall Study|Lost to Follow-up|62|||
126108023|NCT03291587|453689559|FG001|Overall Study|Lost to Follow-up|43|||
126108024|NCT03291587|453689558|FG000|Overall Study|Refused to Answer|5|||
126108025|NCT03291587|453689559|FG001|Overall Study|Refused to Answer|2|||
126108026|NCT03291587|453689558|FG000|Overall Study|Death|2|||
126108027|NCT03291587|453689559|FG001|Overall Study|Death|4|||
126108028|NCT03291587|453689558|FG000|Overall Study|Not interested in participating|8|||
126108029|NCT03291587|453689559|FG001|Overall Study|Not interested in participating|6|||
126108030|NCT03291587|453689558|FG000|Overall Study|Too busy to participate|4|||
126108031|NCT03291587|453689559|FG001|Overall Study|Too busy to participate|2|||
126108032|NCT00796120|453689561|FG000|Overall Study|Death|3|||
126108033|NCT00796120|453689562|FG001|Overall Study|Death|0|||
126108034|NCT00796120|453689561|FG000|Overall Study|Adverse Event|11|||
126108035|NCT00796120|453689562|FG001|Overall Study|Adverse Event|6|||
126108036|NCT00796120|453689561|FG000|Overall Study|Progressive disease|22|||
126108037|NCT00796120|453689562|FG001|Overall Study|Progressive disease|13|||
126108038|NCT00796120|453689561|FG000|Overall Study|Participant refusal|3|||
126108039|NCT00796120|453689562|FG001|Overall Study|Participant refusal|4|||
126108040|NCT00796120|453689561|FG000|Overall Study|Other|6|||
126108041|NCT00796120|453689562|FG001|Overall Study|Other|17|||
126108042|NCT00796120|453689561|FG000|Overall Study|Physician Decision|16|||
126108043|NCT00796120|453689562|FG001|Overall Study|Physician Decision|17|||
126108044|NCT00796120|453689561|FG000|Overall Study|Randomized but not treated|0|||
125893041|NCT01584440|452906842|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
125893042|NCT01584440|452906843|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
126108045|NCT00796120|453689562|FG001|Overall Study|Randomized but not treated|3|||
126108046|NCT00413972|453689566|FG000|Overall Study|Adverse Event|2|||
126108047|NCT00413972|453689567|FG001|Overall Study|Adverse Event|1|||
126108048|NCT00413972|453689568|FG002|Overall Study|Adverse Event|0|||
126108049|NCT00413972|453689569|FG003|Overall Study|Adverse Event|0|||
126108050|NCT00413972|453689566|FG000|Overall Study|Lost to Follow-up|1|||
126108051|NCT00413972|453689567|FG001|Overall Study|Lost to Follow-up|2|||
125893043|NCT01584440|452906844|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
125893044|NCT01584440|452906845|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
125893045|NCT01584440|452906846|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
125893046|NCT01584440|452906842|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
125893047|NCT01584440|452906843|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125893048|NCT01584440|452906844|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125893049|NCT01584440|452906845|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125893050|NCT01584440|452906846|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125893051|NCT01584440|452906842|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
125893052|NCT01584440|452906843|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
125893053|NCT01584440|452906844|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
125893054|NCT01584440|452906845|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
125893055|NCT01584440|452906846|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
125893056|NCT01584440|452906842|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
125893057|NCT01584440|452906843|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
125893058|NCT01584440|452906844|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
125893059|NCT01584440|452906845|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
125893060|NCT01584440|452906846|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
125893061|NCT01584440|452906842|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
125893062|NCT01584440|452906843|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
125893063|NCT01584440|452906844|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
125893064|NCT01584440|452906845|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
125893065|NCT01584440|452906846|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
125893066|NCT01584440|452906842|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
125893067|NCT01584440|452906843|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
125893068|NCT01584440|452906844|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
125893069|NCT01584440|452906845|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
125893070|NCT01584440|452906846|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
125893071|NCT00531427|452906847|FG000|Overall Study|Withdrawal by Subject|7|||
125893072|NCT00531427|452906848|FG001|Overall Study|Withdrawal by Subject|13|||
125893073|NCT00531427|452906847|FG000|Overall Study|Adverse Event|44|||
125893074|NCT00531427|452906848|FG001|Overall Study|Adverse Event|30|||
125893075|NCT00531427|452906847|FG000|Overall Study|Lost to Follow-up|4|||
125893076|NCT00531427|452906848|FG001|Overall Study|Lost to Follow-up|3|||
125893077|NCT00531427|452906847|FG000|Overall Study|Lack of Efficacy|14|||
125893078|NCT00531427|452906848|FG001|Overall Study|Lack of Efficacy|39|||
125893079|NCT00531427|452906847|FG000|Overall Study|Administrative|4|||
126108052|NCT00413972|453689568|FG002|Overall Study|Lost to Follow-up|1|||
125893080|NCT00531427|452906848|FG001|Overall Study|Administrative|9|||
125893081|NCT02626624|452906863|FG000|Overall Study|Adverse Event|1|||
125893082|NCT02626624|452906863|FG000|Overall Study|Lost to Follow-up|3|||
126108053|NCT00413972|453689569|FG003|Overall Study|Lost to Follow-up|0|||
125893083|NCT02626624|452906863|FG000|Overall Study|Protocol Violation|4|||
125893084|NCT02626624|452906863|FG000|Overall Study|Death|2|||
125893085|NCT00095940|452908209|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
125893086|NCT00095940|452908210|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
125893087|NCT00095940|452908211|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
125893088|NCT00095940|452908212|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
126108054|NCT00413972|453689566|FG000|Overall Study|Withdrawal by Subject|4|||
126108055|NCT00413972|453689567|FG001|Overall Study|Withdrawal by Subject|5|||
126108056|NCT00413972|453689568|FG002|Overall Study|Withdrawal by Subject|7|||
126108057|NCT00413972|453689569|FG003|Overall Study|Withdrawal by Subject|2|||
126108058|NCT00413972|453689566|FG000|Overall Study|Protocol Violation|0|||
126108059|NCT00413972|453689567|FG001|Overall Study|Protocol Violation|0|||
126108060|NCT00413972|453689568|FG002|Overall Study|Protocol Violation|2|||
126108061|NCT00413972|453689569|FG003|Overall Study|Protocol Violation|0|||
126108062|NCT00413972|453689566|FG000|Overall Study|Other|0|||
126108063|NCT00413972|453689567|FG001|Overall Study|Other|0|||
126108064|NCT00413972|453689568|FG002|Overall Study|Other|0|||
126108065|NCT00413972|453689569|FG003|Overall Study|Other|1|||
126108066|NCT01898923|453689570|FG000|Overall Study|Lack of Efficacy|5|||
126108067|NCT01898923|453689571|FG001|Overall Study|Lack of Efficacy|6|||
126108068|NCT01898923|453689570|FG000|Overall Study|Adverse Event|3|||
126108069|NCT01898923|453689571|FG001|Overall Study|Adverse Event|1|||
126108070|NCT01898923|453689570|FG000|Overall Study|Lost to Follow-up|0|||
126108071|NCT01898923|453689571|FG001|Overall Study|Lost to Follow-up|1|||
126108072|NCT01898923|453689570|FG000|Overall Study|Withdrawal by Subject|4|||
126108073|NCT01898923|453689571|FG001|Overall Study|Withdrawal by Subject|7|||
126108074|NCT01898923|453689570|FG000|Overall Study|Physician Decision|3|||
126108075|NCT01898923|453689571|FG001|Overall Study|Physician Decision|4|||
126108076|NCT01898923|453689570|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
126108077|NCT01898923|453689571|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
126108078|NCT00381303|453689574|FG000|Overall Study|Lost to Follow-up|25|||
126108079|NCT00381303|453689575|FG001|Overall Study|Lost to Follow-up|9|||
126108080|NCT00381303|453689574|FG000|Overall Study|AE/HIV-related event|22|||
126108081|NCT00381303|453689575|FG001|Overall Study|AE/HIV-related event|6|||
126108082|NCT00381303|453689574|FG000|Overall Study|Non-Adherence|13|||
126108083|NCT00381303|453689575|FG001|Overall Study|Non-Adherence|6|||
126108084|NCT00381303|453689574|FG000|Overall Study|Withdrawal by Subject|13|||
126108085|NCT00381303|453689575|FG001|Overall Study|Withdrawal by Subject|6|||
126108086|NCT00381303|453689574|FG000|Overall Study|Virologic failure|6|||
125893089|NCT00095940|452908213|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
125893090|NCT00095940|452908214|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
125893091|NCT00095940|452908215|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
125893092|NCT00095940|452908216|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
125893093|NCT00095940|452908217|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
125893094|NCT00095940|452908209|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
125893095|NCT00095940|452908210|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
125893096|NCT00095940|452908211|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
125893097|NCT00095940|452908212|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125893098|NCT00095940|452908213|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125893099|NCT00095940|452908214|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125893100|NCT00095940|452908215|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
126108087|NCT00381303|453689575|FG001|Overall Study|Virologic failure|4|||
126108088|NCT00381303|453689574|FG000|Overall Study|Ineligible to continue the trial|2|||
126108089|NCT00381303|453689575|FG001|Overall Study|Ineligible to continue the trial|1|||
126108090|NCT00381303|453689574|FG000|Overall Study|Pregnancy|2|||
126108091|NCT00381303|453689575|FG001|Overall Study|Pregnancy|0|||
126108092|NCT00381303|453689574|FG000|Overall Study|Physician Decision|1|||
126108093|NCT00381303|453689575|FG001|Overall Study|Physician Decision|0|||
126108094|NCT00381303|453689574|FG000|Overall Study|Physician's decision to close the site|3|||
126108095|NCT00381303|453689575|FG001|Overall Study|Physician's decision to close the site|1|||
126108096|NCT00381303|453689574|FG000|Overall Study|Subject moved out of state|2|||
126108097|NCT00381303|453689575|FG001|Overall Study|Subject moved out of state|0|||
126108098|NCT00381303|453689574|FG000|Overall Study|Subject taking too many different meds|1|||
126108099|NCT00381303|453689575|FG001|Overall Study|Subject taking too many different meds|0|||
126108100|NCT00381303|453689574|FG000|Overall Study|No virologic response by week 12|1|||
126108101|NCT00381303|453689575|FG001|Overall Study|No virologic response by week 12|0|||
126108102|NCT00381303|453689574|FG000|Overall Study|Subject was too busy for appointments|1|||
126108103|NCT00381303|453689575|FG001|Overall Study|Subject was too busy for appointments|0|||
126108104|NCT00381303|453689574|FG000|Overall Study|Subject did not continue visits|1|||
126108105|NCT00381303|453689575|FG001|Overall Study|Subject did not continue visits|0|||
126108106|NCT00381303|453689574|FG000|Overall Study|Subject primary physician's decision|1|||
126108107|NCT00381303|453689575|FG001|Overall Study|Subject primary physician's decision|0|||
126108108|NCT01966471|453689578|FG000|Overall Study|Death|44|||
126108109|NCT01966471|453689579|FG001|Overall Study|Death|56|||
126108110|NCT01966471|453689578|FG000|Overall Study|Lost to Follow-up|46|||
126108111|NCT01966471|453689579|FG001|Overall Study|Lost to Follow-up|39|||
125893101|NCT00095940|452908216|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125893102|NCT00095940|452908217|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
125893103|NCT00095940|452908209|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
125893104|NCT00095940|452908210|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
125893105|NCT00095940|452908211|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
125893106|NCT00095940|452908212|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
125893107|NCT00095940|452908213|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
125893108|NCT00095940|452908214|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
125893109|NCT00095940|452908215|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
125893110|NCT00095940|452908216|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
125893111|NCT00095940|452908217|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
125893112|NCT03539549|452908218|FG000|Overall Study|Adverse Event|12|||
125893113|NCT03539549|452908218|FG000|Overall Study|Lost to Follow-up|1|||
125893114|NCT03539549|452908218|FG000|Overall Study|Death|2|||
125893115|NCT03539549|452908218|FG000|Overall Study|Progressive Disease|1|||
125893116|NCT03539549|452908218|FG000|Overall Study|Reason not Specified|1|||
125893117|NCT04693234|452908222|FG000|Overall Study|Death|79|||
126108112|NCT01966471|453689578|FG000|Overall Study|Various reasons|4|||
126108113|NCT01966471|453689579|FG001|Overall Study|Various reasons|4|||
126108114|NCT01966471|453689578|FG000|Overall Study|Physician Decision|7|||
126108115|NCT01966471|453689579|FG001|Overall Study|Physician Decision|5|||
126108116|NCT01966471|453689578|FG000|Overall Study|Study Terminated By Sponsor|758|||
126108117|NCT01966471|453689579|FG001|Overall Study|Study Terminated By Sponsor|773|||
126108118|NCT01966471|453689578|FG000|Overall Study|Withdrawal by Subject|59|||
125893118|NCT04693234|452908223|FG001|Overall Study|Death|19|||
126108119|NCT01966471|453689579|FG001|Overall Study|Withdrawal by Subject|51|||
126108120|NCT01030198|453689580|FG000|Overall Study|Could not measure efficacy accurately|0|||
126108121|NCT01030198|453689581|FG001|Overall Study|Could not measure efficacy accurately|7|||
126108122|NCT02370043|453689582|FG000|Overall Study|Withdrawal by Subject|0|||
126108123|NCT02370043|453689583|FG001|Overall Study|Withdrawal by Subject|0|||
126108124|NCT02370043|453689584|FG002|Overall Study|Withdrawal by Subject|0|||
126108125|NCT02370043|453689585|FG003|Overall Study|Withdrawal by Subject|0|||
126108126|NCT02370043|453689586|FG004|Overall Study|Withdrawal by Subject|1|||
126108127|NCT02370043|453689587|FG005|Overall Study|Withdrawal by Subject|1|||
126108128|NCT00688181|453689588|FG000|Overall Study|Lost to Follow-up|17|||
126108129|NCT00688181|453689588|FG000|Overall Study|Unknown Reason|4|||
126108130|NCT00688181|453689588|FG000|Overall Study|Non-clinical Reason|2|||
126108131|NCT01050205|453689589|FG000|Overall Study|Lost to Follow-up|7|||
126108132|NCT01050205|453689590|FG001|Overall Study|Lost to Follow-up|1|||
126108133|NCT01050205|453689589|FG000|Overall Study|Withdrawal by Subject|1|||
126108134|NCT01050205|453689590|FG001|Overall Study|Withdrawal by Subject|1|||
126108135|NCT01050205|453689589|FG000|Overall Study|Relocated from area|1|||
126108136|NCT01050205|453689590|FG001|Overall Study|Relocated from area|2|||
126108137|NCT01050205|453689589|FG000|Overall Study|Discontinued Intervention|2|||
126108138|NCT01050205|453689590|FG001|Overall Study|Discontinued Intervention|0|||
126108139|NCT01119001|453689591|FG000|Overall Study|Withdrawal by Subject|2|||
126108140|NCT00954421|453689592|FG000|Screening|screen failures|3|||
126108141|NCT00954421|453689592|FG000|6 Months of DBS|Withdrawal by Subject|1|||
126108142|NCT00954421|453689592|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
126108143|NCT00633061|453689593|FG000|Overall Study|Study closed|86|||
126108144|NCT00633061|453689594|FG001|Overall Study|Study closed|0|||
126108145|NCT05245097|453689595|FG000|Overall Study|Adverse Event|13|||
126108146|NCT05245097|453689596|FG001|Overall Study|Adverse Event|2|||
126108147|NCT05245097|453689595|FG000|Overall Study|Protocol Violation|8|||
126108148|NCT05245097|453689596|FG001|Overall Study|Protocol Violation|6|||
126108149|NCT05245097|453689595|FG000|Overall Study|Withdrawal by Subject|18|||
126108150|NCT05245097|453689596|FG001|Overall Study|Withdrawal by Subject|0|||
126108151|NCT05245097|453689595|FG000|Overall Study|Death|6|||
126108152|NCT05245097|453689596|FG001|Overall Study|Death|7|||
125893119|NCT04693234|452908222|FG000|Overall Study|Sponsor Ended Study|47|||
125893120|NCT04693234|452908223|FG001|Overall Study|Sponsor Ended Study|18|||
126108153|NCT05245097|453689595|FG000|Overall Study|Physician Decision|6|||
126108154|NCT05245097|453689596|FG001|Overall Study|Physician Decision|0|||
126108155|NCT05245097|453689595|FG000|Overall Study|Relocation|4|||
126108156|NCT05245097|453689596|FG001|Overall Study|Relocation|3|||
126108157|NCT00607022|453689602|FG000|Overall Study|Withdrawal by Subject|1|||
126108158|NCT00607022|453689603|FG001|Overall Study|Withdrawal by Subject|0|||
126108159|NCT00607022|453689604|FG002|Overall Study|Withdrawal by Subject|0|||
126108160|NCT00810394|453689605|FG000|Overall Study|Withdrawal by Subject|3|||
126108161|NCT03254485|453689606|FG000|Overall Study|Adverse Event|3|||
126108162|NCT03254485|453689607|FG001|Overall Study|Adverse Event|0|||
126108163|NCT03254485|453689608|FG002|Overall Study|Adverse Event|0|||
126108164|NCT03254485|453689609|FG003|Overall Study|Adverse Event|6|||
126108165|NCT03254485|453689606|FG000|Overall Study|Protocol Violation|6|||
126108166|NCT03254485|453689607|FG001|Overall Study|Protocol Violation|0|||
126108167|NCT03254485|453689608|FG002|Overall Study|Protocol Violation|0|||
126108168|NCT03254485|453689609|FG003|Overall Study|Protocol Violation|2|||
126108169|NCT03254485|453689606|FG000|Overall Study|Withdrawal by Subject|1|||
126108170|NCT03254485|453689607|FG001|Overall Study|Withdrawal by Subject|0|||
126108171|NCT03254485|453689608|FG002|Overall Study|Withdrawal by Subject|0|||
126108172|NCT03254485|453689609|FG003|Overall Study|Withdrawal by Subject|4|||
126108173|NCT03254485|453689606|FG000|Overall Study|Death|0|||
126108174|NCT03254485|453689607|FG001|Overall Study|Death|0|||
126108175|NCT03254485|453689608|FG002|Overall Study|Death|0|||
126108176|NCT03254485|453689609|FG003|Overall Study|Death|1|||
126108177|NCT03254485|453689606|FG000|Overall Study|Lost to Follow-up|1|||
126108178|NCT03254485|453689607|FG001|Overall Study|Lost to Follow-up|0|||
126108179|NCT03254485|453689608|FG002|Overall Study|Lost to Follow-up|0|||
126108180|NCT03254485|453689609|FG003|Overall Study|Lost to Follow-up|0|||
126108181|NCT03254485|453689606|FG000|Overall Study|Other|1|||
126108182|NCT03254485|453689607|FG001|Overall Study|Other|0|||
126108183|NCT03254485|453689608|FG002|Overall Study|Other|0|||
126108184|NCT03254485|453689609|FG003|Overall Study|Other|2|||
126108185|NCT00467285|453689610|FG000|Overall Study|Lost to Follow-up|4|||
126108186|NCT00467285|453689611|FG001|Overall Study|Lost to Follow-up|4|||
126108187|NCT01658826|453689625|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
126108188|NCT01658826|453689626|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
126108189|NCT01658826|453689625|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
126108190|NCT01658826|453689626|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
126108191|NCT01658826|453689625|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
126108192|NCT01658826|453689626|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
126108193|NCT01658826|453689625|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
126108194|NCT01658826|453689626|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
126108195|NCT01658826|453689625|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
126108196|NCT01658826|453689626|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
126108197|NCT01658826|453689625|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
126108198|NCT01658826|453689626|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
126108199|NCT01658826|453689625|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
126108200|NCT01658826|453689626|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
126108201|NCT01658826|453689625|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
126108202|NCT01658826|453689626|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
126108203|NCT01658826|453689625|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
126108204|NCT01658826|453689626|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
126108205|NCT00658684|453689627|FG000|Overall Study|Adverse Event|10|||
126108206|NCT00658684|453689628|FG001|Overall Study|Adverse Event|8|||
126108207|NCT00658684|453689629|FG002|Overall Study|Adverse Event|2|||
126108208|NCT00658684|453689630|FG003|Overall Study|Adverse Event|0|||
126108209|NCT00658684|453689627|FG000|Overall Study|Withdrawal by Subject|6|||
126108210|NCT00658684|453689628|FG001|Overall Study|Withdrawal by Subject|4|||
126108211|NCT00658684|453689629|FG002|Overall Study|Withdrawal by Subject|1|||
126108212|NCT00658684|453689630|FG003|Overall Study|Withdrawal by Subject|1|||
126108213|NCT00658684|453689627|FG000|Overall Study|Lack of Efficacy|1|||
126108214|NCT00658684|453689628|FG001|Overall Study|Lack of Efficacy|1|||
126108215|NCT00658684|453689629|FG002|Overall Study|Lack of Efficacy|0|||
126108216|NCT00658684|453689630|FG003|Overall Study|Lack of Efficacy|0|||
126108217|NCT00658684|453689627|FG000|Overall Study|Protocol Violation|1|||
126108218|NCT00658684|453689628|FG001|Overall Study|Protocol Violation|1|||
126108219|NCT00658684|453689629|FG002|Overall Study|Protocol Violation|0|||
126108220|NCT00658684|453689630|FG003|Overall Study|Protocol Violation|0|||
126108221|NCT00658684|453689627|FG000|Overall Study|Pregnancy|1|||
126108222|NCT00658684|453689628|FG001|Overall Study|Pregnancy|1|||
126108223|NCT00658684|453689629|FG002|Overall Study|Pregnancy|0|||
126108224|NCT00658684|453689630|FG003|Overall Study|Pregnancy|0|||
126108225|NCT06515483|453689633|FG000|Overall Study|Subject withdraw due to family issues|1|||
126108226|NCT06515483|453689634|FG001|Overall Study|Subject withdraw due to family issues|0|||
125893121|NCT04693234|452908222|FG000|Overall Study|Withdrawal by Subject|10|||
125893122|NCT04693234|452908223|FG001|Overall Study|Withdrawal by Subject|2|||
126108227|NCT05677893|453691079|FG000|Overall Study|Withdrawal by Subject|0|||
126108228|NCT05677893|453691080|FG001|Overall Study|Withdrawal by Subject|0|||
126108229|NCT05677893|453691081|FG002|Overall Study|Withdrawal by Subject|0|||
126108230|NCT05677893|453691082|FG003|Overall Study|Withdrawal by Subject|0|||
125893123|NCT04693234|452908222|FG000|Overall Study|Lost to Follow-up|2|||
125893124|NCT04693234|452908223|FG001|Overall Study|Lost to Follow-up|1|||
125893125|NCT04643158|452908224|FG000|Overall Study|Study terminated by sponsor|0|||
125893126|NCT04643158|452908225|FG001|Overall Study|Study terminated by sponsor|0|||
125893127|NCT04643158|452908226|FG002|Overall Study|Study terminated by sponsor|1|||
125893128|NCT04643158|452908227|FG003|Overall Study|Study terminated by sponsor|0|||
125893129|NCT04643158|452908228|FG004|Overall Study|Study terminated by sponsor|0|||
125893130|NCT04643158|452908229|FG005|Overall Study|Study terminated by sponsor|1|||
125893131|NCT04643158|452908230|FG006|Overall Study|Study terminated by sponsor|0|||
125893132|NCT04643158|452908224|FG000|Overall Study|Global/country situation|0|||
125893133|NCT04643158|452908225|FG001|Overall Study|Global/country situation|0|||
125893134|NCT04643158|452908226|FG002|Overall Study|Global/country situation|1|||
125893135|NCT04643158|452908227|FG003|Overall Study|Global/country situation|0|||
125893136|NCT04643158|452908228|FG004|Overall Study|Global/country situation|0|||
125893137|NCT04643158|452908229|FG005|Overall Study|Global/country situation|0|||
125893138|NCT04643158|452908230|FG006|Overall Study|Global/country situation|0|||
125893139|NCT04643158|452908224|FG000|Overall Study|Withdrawal by Subject|0|||
125893140|NCT04643158|452908225|FG001|Overall Study|Withdrawal by Subject|0|||
125893141|NCT04643158|452908226|FG002|Overall Study|Withdrawal by Subject|0|||
125893142|NCT04643158|452908227|FG003|Overall Study|Withdrawal by Subject|0|||
125893143|NCT04643158|452908228|FG004|Overall Study|Withdrawal by Subject|0|||
125893144|NCT04643158|452908229|FG005|Overall Study|Withdrawal by Subject|1|||
125893145|NCT04643158|452908230|FG006|Overall Study|Withdrawal by Subject|0|||
125893146|NCT04540198|452908231|FG000|Overall Study|Lost to Follow-up|25|||
125893147|NCT04540198|452908232|FG001|Overall Study|Lost to Follow-up|23|||
125893148|NCT04540198|452908231|FG000|Overall Study|Withdrawal by Subject|15|||
125893149|NCT04540198|452908232|FG001|Overall Study|Withdrawal by Subject|9|||
125893150|NCT04540198|452908231|FG000|Overall Study|Discontinued|1|||
125893151|NCT04540198|452908232|FG001|Overall Study|Discontinued|0|||
125893152|NCT02888119|452908233|FG000|Overall Study|Lost to Follow-up|5|||
125893153|NCT02888119|452908234|FG001|Overall Study|Lost to Follow-up|4|||
125893154|NCT02888119|452908235|FG002|Overall Study|Lost to Follow-up|0|||
125893155|NCT03646123|452908236|FG000|Overall Study|Withdrawal by Subject|2|||
125893156|NCT03646123|452908237|FG001|Overall Study|Withdrawal by Subject|2|||
125893157|NCT03646123|452908238|FG002|Overall Study|Withdrawal by Subject|3|||
125893158|NCT03646123|452908236|FG000|Overall Study|Study termination by sponsor|0|||
125893159|NCT03646123|452908237|FG001|Overall Study|Study termination by sponsor|45|||
125893160|NCT03646123|452908238|FG002|Overall Study|Study termination by sponsor|139|||
125893161|NCT03646123|452908236|FG000|Overall Study|Lost to Follow-up|4|||
125893162|NCT03646123|452908237|FG001|Overall Study|Lost to Follow-up|10|||
125893163|NCT03646123|452908238|FG002|Overall Study|Lost to Follow-up|10|||
125893164|NCT03646123|452908236|FG000|Overall Study|Death|2|||
125893165|NCT03646123|452908237|FG001|Overall Study|Death|1|||
125893166|NCT03646123|452908238|FG002|Overall Study|Death|1|||
125893167|NCT03646123|452908236|FG000|Overall Study|Other|2|||
125893168|NCT03646123|452908237|FG001|Overall Study|Other|0|||
125893169|NCT03646123|452908238|FG002|Overall Study|Other|2|||
125893170|NCT02925416|452908244|FG000|Overall Study|Adverse Event|2|||
125893171|NCT02925416|452908245|FG001|Overall Study|Adverse Event|0|||
125893172|NCT03595228|452908246|FG000|Overall Study|Death|2|||
125893173|NCT03595228|452908246|FG000|Overall Study|Lack of Efficacy|13|||
125893174|NCT03595228|452908246|FG000|Overall Study|Withdrawal by Subject|3|||
125893175|NCT03595228|452908246|FG000|Overall Study|Withdrawal by Sponsor|1|||
125893176|NCT00200356|452908247|FG000|Overall Study|Lack of Efficacy|3|||
125893177|NCT00200356|452908248|FG001|Overall Study|Lack of Efficacy|3|||
125893178|NCT00200356|452908247|FG000|Overall Study|Protocol Violation|4|||
125893179|NCT00200356|452908248|FG001|Overall Study|Protocol Violation|4|||
125893180|NCT00200356|452908247|FG000|Overall Study|Nontreatment|1|||
125893181|NCT00200356|452908248|FG001|Overall Study|Nontreatment|0|||
125893182|NCT01015638|452908251|FG000|Overall Study|Withdrawal by Subject|1|||
125893183|NCT01015638|452908252|FG001|Overall Study|Withdrawal by Subject|0|||
125893184|NCT01703754|452908256|FG000|Overall Study|Clinically significant disease progression|2|||
125893185|NCT01703754|452908257|FG001|Overall Study|Clinically significant disease progression|2|||
125893186|NCT01703754|452908258|FG002|Overall Study|Clinically significant disease progression|1|||
125893187|NCT01703754|452908256|FG000|Overall Study|Adverse Event|1|||
125893188|NCT01703754|452908257|FG001|Overall Study|Adverse Event|1|||
125893189|NCT01703754|452908258|FG002|Overall Study|Adverse Event|0|||
125893190|NCT01703754|452908256|FG000|Overall Study|Withdrawal by Subject|2|||
125893191|NCT01703754|452908257|FG001|Overall Study|Withdrawal by Subject|0|||
125893192|NCT01703754|452908258|FG002|Overall Study|Withdrawal by Subject|0|||
125893193|NCT02872935|452908261|FG000|Overall Study|Other|0|||
125893194|NCT02872935|452908262|FG001|Overall Study|Other|1|||
125893195|NCT01276054|452908264|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
125893196|NCT01276054|452908265|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
125893197|NCT02792829|452908266|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125893198|NCT02792829|452908267|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
125893199|NCT02792829|452908268|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125893200|NCT02792829|452908269|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125893201|NCT02792829|452908270|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125893202|NCT02792829|452908271|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125893203|NCT02792829|452908272|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125893204|NCT02792829|452908273|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125893205|NCT02792829|452908266|FG000|Treatment Period 2|Adverse Event|0|||
125893206|NCT02792829|452908267|FG001|Treatment Period 2|Adverse Event|0|||
125893207|NCT02792829|452908268|FG002|Treatment Period 2|Adverse Event|0|||
125893208|NCT02792829|452908269|FG003|Treatment Period 2|Adverse Event|0|||
125893209|NCT02792829|452908270|FG004|Treatment Period 2|Adverse Event|1|||
125893210|NCT02792829|452908271|FG005|Treatment Period 2|Adverse Event|0|||
125893211|NCT02792829|452908272|FG006|Treatment Period 2|Adverse Event|1|||
125893212|NCT02792829|452908273|FG007|Treatment Period 2|Adverse Event|1|||
125893213|NCT02792829|452908266|FG000|Treatment Period 2|Use of proscribed medications|0|||
125893214|NCT02792829|452908267|FG001|Treatment Period 2|Use of proscribed medications|0|||
125893215|NCT02792829|452908268|FG002|Treatment Period 2|Use of proscribed medications|0|||
125893216|NCT02792829|452908269|FG003|Treatment Period 2|Use of proscribed medications|0|||
125893217|NCT02792829|452908270|FG004|Treatment Period 2|Use of proscribed medications|0|||
125893218|NCT02792829|452908271|FG005|Treatment Period 2|Use of proscribed medications|0|||
125893219|NCT02792829|452908272|FG006|Treatment Period 2|Use of proscribed medications|0|||
125893220|NCT02792829|452908273|FG007|Treatment Period 2|Use of proscribed medications|1|||
125893221|NCT00452361|452908274|FG000|Overall Study|Adverse Event|8|||
125893222|NCT00452361|452908275|FG001|Overall Study|Adverse Event|0|||
125893223|NCT00452361|452908274|FG000|Overall Study|Withdrawal by Subject|0|||
125893224|NCT00452361|452908275|FG001|Overall Study|Withdrawal by Subject|1|||
125893225|NCT00452361|452908274|FG000|Overall Study|Premature termination|13|||
125893226|NCT00452361|452908275|FG001|Overall Study|Premature termination|9|||
125893227|NCT03116152|452908276|FG000|Overall Study|Disease Progression|49|||
125893228|NCT03116152|452908277|FG001|Overall Study|Disease Progression|47|||
125893229|NCT03116152|452908276|FG000|Overall Study|Death|5|||
125893230|NCT03116152|452908277|FG001|Overall Study|Death|2|||
125893231|NCT03116152|452908276|FG000|Overall Study|Adverse Event|21|||
125893232|NCT03116152|452908277|FG001|Overall Study|Adverse Event|7|||
125893233|NCT03116152|452908276|FG000|Overall Study|Protocol Violation|2|||
125893234|NCT03116152|452908277|FG001|Overall Study|Protocol Violation|2|||
125893235|NCT03116152|452908276|FG000|Overall Study|Withdrawal by Subject|0|||
125893236|NCT03116152|452908277|FG001|Overall Study|Withdrawal by Subject|1|||
125893237|NCT03116152|452908276|FG000|Overall Study|Physician Decision|3|||
125893238|NCT03116152|452908277|FG001|Overall Study|Physician Decision|2|||
125893239|NCT03116152|452908276|FG000|Overall Study|other|11|||
125893240|NCT03116152|452908277|FG001|Overall Study|other|34|||
125893241|NCT03179605|452908278|FG000|Overall Study|Withdrawal by Subject|1|||
125893242|NCT00228553|452908282|FG000|Overall Study|Adverse Event|112|||
125893243|NCT00228553|452908282|FG000|Overall Study|Lack of Efficacy|34|||
125893244|NCT00228553|452908282|FG000|Overall Study|Lost to Follow-up|67|||
125893245|NCT00228553|452908282|FG000|Overall Study|Physician Decision|48|||
125893246|NCT00228553|452908282|FG000|Overall Study|Protocol Violation|6|||
125893247|NCT00228553|452908282|FG000|Overall Study|Withdrawal by Subject|115|||
126059028|NCT00089791|453510865|FG000|Overall Study|Requirement for alternative therapy|7|||
125893248|NCT00228553|452908282|FG000|Overall Study|Pregnancy|2|||
125893249|NCT00228553|452908282|FG000|Overall Study|Miscellaneous|46|||
125893250|NCT02878798|452908283|FG000|Overall Study|Withdrawal by Subject|5|||
125893251|NCT02878798|452908284|FG001|Overall Study|Withdrawal by Subject|4|||
125893252|NCT02878798|452908283|FG000|Overall Study|Lost to Follow-up|2|||
126059029|NCT00089791|453510866|FG001|Overall Study|Requirement for alternative therapy|4|||
125893253|NCT02878798|452908284|FG001|Overall Study|Lost to Follow-up|2|||
125893254|NCT02878798|452908283|FG000|Overall Study|Protocol Violation|0|||
125893255|NCT02878798|452908284|FG001|Overall Study|Protocol Violation|1|||
125893256|NCT01536392|452908285|FG000|Overall Study|Adverse Event|2|||
125893257|NCT01536392|452908286|FG001|Overall Study|Adverse Event|2|||
126108231|NCT05677893|453691083|FG004|Overall Study|Withdrawal by Subject|1|||
126108232|NCT05677893|453691084|FG005|Overall Study|Withdrawal by Subject|1|||
126108233|NCT05677893|453691085|FG006|Overall Study|Withdrawal by Subject|0|||
126108234|NCT05677893|453691079|FG000|Overall Study|Others|1|||
126108235|NCT05677893|453691080|FG001|Overall Study|Others|0|||
126108236|NCT05677893|453691081|FG002|Overall Study|Others|0|||
126108237|NCT05677893|453691082|FG003|Overall Study|Others|0|||
126108238|NCT05677893|453691083|FG004|Overall Study|Others|0|||
126108239|NCT05677893|453691084|FG005|Overall Study|Others|0|||
126108240|NCT05677893|453691085|FG006|Overall Study|Others|0|||
126108241|NCT00720941|453691086|FG000|Overall Study|Protocol Violation|1|||
126108242|NCT00720941|453691087|FG001|Overall Study|Protocol Violation|2|||
126108243|NCT00720941|453691086|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
126108244|NCT00720941|453691087|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
126108245|NCT00720941|453691086|FG000|Overall Study|Lost to Follow-up|20|||
126108246|NCT00720941|453691087|FG001|Overall Study|Lost to Follow-up|15|||
126108247|NCT00720941|453691086|FG000|Overall Study|Physician Decision|14|||
126108248|NCT00720941|453691087|FG001|Overall Study|Physician Decision|12|||
126108249|NCT00720941|453691086|FG000|Overall Study|Withdrawal by Subject|29|||
126108250|NCT00720941|453691087|FG001|Overall Study|Withdrawal by Subject|36|||
126108251|NCT00604279|453691088|FG000|Overall Study|Lack of Efficacy|22|||
126108252|NCT00604279|453691089|FG001|Overall Study|Lack of Efficacy|9|||
126108253|NCT00604279|453691088|FG000|Overall Study|Lost to Follow-up|9|||
126108254|NCT00604279|453691089|FG001|Overall Study|Lost to Follow-up|14|||
126108255|NCT00604279|453691088|FG000|Overall Study|Pregnancy|2|||
126108256|NCT00604279|453691089|FG001|Overall Study|Pregnancy|0|||
126108257|NCT00604279|453691088|FG000|Overall Study|Protocol Violation|3|||
126108258|NCT00604279|453691089|FG001|Overall Study|Protocol Violation|1|||
126108259|NCT00604279|453691088|FG000|Overall Study|Withdrawal by Subject|16|||
126108260|NCT00604279|453691089|FG001|Overall Study|Withdrawal by Subject|5|||
126108261|NCT00604279|453691088|FG000|Overall Study|Adverse Event|4|||
126108262|NCT00604279|453691089|FG001|Overall Study|Adverse Event|5|||
126108263|NCT00604279|453691088|FG000|Overall Study|Other|8|||
126108264|NCT00604279|453691089|FG001|Overall Study|Other|4|||
126108265|NCT00355056|453691090|FG000|Randomization Period|Early Termination|4|||
126108266|NCT00355056|453691091|FG001|Randomization Period|Early Termination|6|||
126108267|NCT01072877|453691092|FG000|Overall Study|Lost to Follow-up|1|||
126059030|NCT00148122|453510867|FG000|Overall Study|Withdrawal by Subject|2|||
126059031|NCT01137682|453510870|FG000|Overall Study|Adverse Event-CORE|2|||
126059032|NCT01137682|453510871|FG001|Overall Study|Adverse Event-CORE|4|||
126059033|NCT01137682|453510872|FG002|Overall Study|Adverse Event-CORE|0|||
126108268|NCT01072877|453691093|FG001|Overall Study|Lost to Follow-up|1|||
126108269|NCT01072877|453691094|FG002|Overall Study|Lost to Follow-up|0|||
126108270|NCT01072877|453691095|FG003|Overall Study|Lost to Follow-up|2|||
126108271|NCT01072877|453691096|FG004|Overall Study|Lost to Follow-up|0|||
126108272|NCT02720536|453691097|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
126108273|NCT02720536|453691097|FG000|Overall Study|PR - pregnancy|2|||
126108274|NCT02720536|453691097|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
126108275|NCT02720536|453691097|FG000|Overall Study|PR - death|1|||
126108276|NCT02720536|453691097|FG000|Overall Study|PR - adverse event|1|||
126108277|NCT02720536|453691097|FG000|Overall Study|PR - abnormal lab value(s)|1|||
126108278|NCT02720536|453691097|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
126108279|NCT01717989|453691100|FG000|Overall Study|Ineligibility determined|6|||
126108280|NCT01717989|453691100|FG000|Overall Study|Protocol deviation|6|||
126108281|NCT01717989|453691100|FG000|Overall Study|Withdrawal by Subject|11|||
126108282|NCT01717989|453691100|FG000|Overall Study|Physician Decision|2|||
126108283|NCT01717989|453691100|FG000|Overall Study|Lost to Follow-up|11|||
126108284|NCT01717989|453691100|FG000|Overall Study|Death|439|||
126108285|NCT01717989|453691100|FG000|Overall Study|Protocol-specified criteria|551|||
126059034|NCT01137682|453510870|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
126059035|NCT01137682|453510871|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
126059036|NCT01137682|453510872|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
126059037|NCT01137682|453510870|FG000|Overall Study|Administrative problems-CORE|2|||
126059038|NCT01137682|453510871|FG001|Overall Study|Administrative problems-CORE|1|||
126059039|NCT01137682|453510872|FG002|Overall Study|Administrative problems-CORE|0|||
126059040|NCT01137682|453510870|FG000|Overall Study|Protocol Violation-CORE|0|||
126059041|NCT01137682|453510871|FG001|Overall Study|Protocol Violation-CORE|1|||
126059042|NCT01137682|453510872|FG002|Overall Study|Protocol Violation-CORE|1|||
126059043|NCT01137682|453510870|FG000|Overall Study|Adverse Event-Extension|4|||
126059044|NCT01137682|453510871|FG001|Overall Study|Adverse Event-Extension|8|||
126059045|NCT01137682|453510872|FG002|Overall Study|Adverse Event-Extension|7|||
126059046|NCT01137682|453510870|FG000|Overall Study|Lack of Efficacy-Extension|15|||
126059047|NCT01137682|453510871|FG001|Overall Study|Lack of Efficacy-Extension|9|||
126059048|NCT01137682|453510872|FG002|Overall Study|Lack of Efficacy-Extension|13|||
126059049|NCT01137682|453510870|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
126059050|NCT01137682|453510871|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
126059051|NCT01137682|453510872|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
126059052|NCT01137682|453510870|FG000|Overall Study|Lost to Follow Up-Extension|0|||
126059053|NCT01137682|453510871|FG001|Overall Study|Lost to Follow Up-Extension|1|||
126059054|NCT01137682|453510872|FG002|Overall Study|Lost to Follow Up-Extension|0|||
126059055|NCT01137682|453510870|FG000|Overall Study|Administrative problems-Extension|0|||
126059056|NCT01137682|453510871|FG001|Overall Study|Administrative problems-Extension|2|||
126059057|NCT01137682|453510872|FG002|Overall Study|Administrative problems-Extension|0|||
126059058|NCT01137682|453510870|FG000|Overall Study|Death-Extension|2|||
126059059|NCT01137682|453510871|FG001|Overall Study|Death-Extension|0|||
126059060|NCT01137682|453510872|FG002|Overall Study|Death-Extension|0|||
126059061|NCT01137682|453510870|FG000|Overall Study|Protocol Violation-Extension|2|||
126059062|NCT01137682|453510871|FG001|Overall Study|Protocol Violation-Extension|1|||
126059063|NCT01137682|453510872|FG002|Overall Study|Protocol Violation-Extension|0|||
126059064|NCT01137682|453510870|FG000|Overall Study|Did not enter extension|2|||
126059065|NCT01137682|453510871|FG001|Overall Study|Did not enter extension|3|||
126059066|NCT01137682|453510872|FG002|Overall Study|Did not enter extension|2|||
126059067|NCT01137682|453510870|FG000|Overall Study|Did not receive treatment in extension|0|||
126059068|NCT01137682|453510871|FG001|Overall Study|Did not receive treatment in extension|0|||
126059069|NCT01137682|453510872|FG002|Overall Study|Did not receive treatment in extension|1|||
126059070|NCT01365546|453510873|FG000|Overall Study|Withdrawal by Subject|1|||
126059071|NCT01365546|453510873|FG000|Overall Study|Screen failure|9|||
126059072|NCT01365546|453510873|FG000|Overall Study|Study termination|1|||
126059073|NCT00721734|453510874|FG000|Overall Study|Progressive Disease|3|||
126059074|NCT00721734|453510875|FG001|Overall Study|Progressive Disease|10|||
126059075|NCT00721734|453510876|FG002|Overall Study|Progressive Disease|4|||
126059076|NCT00721734|453510877|FG003|Overall Study|Progressive Disease|5|||
126108286|NCT01717989|453691100|FG000|Overall Study|Other|40|||
126108287|NCT03224325|453691101|FG000|Overall Study|Adverse Event|1|||
126059077|NCT00721734|453510878|FG004|Overall Study|Progressive Disease|2|||
126059078|NCT00721734|453510874|FG000|Overall Study|Adverse Event|3|||
126059079|NCT00721734|453510875|FG001|Overall Study|Adverse Event|1|||
126059080|NCT00721734|453510876|FG002|Overall Study|Adverse Event|4|||
126059081|NCT00721734|453510877|FG003|Overall Study|Adverse Event|0|||
126108288|NCT03224325|453691102|FG001|Overall Study|Adverse Event|0|||
125893258|NCT01536392|452908285|FG000|Overall Study|Physician Decision|2|||
125893259|NCT01536392|452908286|FG001|Overall Study|Physician Decision|3|||
125893260|NCT01536392|452908285|FG000|Overall Study|Withdrawal by Subject|3|||
125893261|NCT01536392|452908286|FG001|Overall Study|Withdrawal by Subject|6|||
125893262|NCT01536392|452908285|FG000|Overall Study|Non Compliance|3|||
125893263|NCT01536392|452908286|FG001|Overall Study|Non Compliance|4|||
125893264|NCT01536392|452908285|FG000|Overall Study|Completed therapy early|3|||
125893265|NCT01536392|452908286|FG001|Overall Study|Completed therapy early|0|||
125893266|NCT02873429|452908288|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
125893267|NCT02873429|452908289|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
125893268|NCT02873429|452908288|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
125893269|NCT02873429|452908289|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
125893270|NCT02873429|452908288|FG000|16 Weeks|Lost to Follow-up|3|||
125893271|NCT02873429|452908289|FG001|16 Weeks|Lost to Follow-up|0|||
125893272|NCT02259088|452908290|FG000|Overall Study|Adverse Event|6|||
125893273|NCT02259088|452908291|FG001|Overall Study|Adverse Event|4|||
125893274|NCT02259088|452908290|FG000|Overall Study|Lost to Follow-up|2|||
125893275|NCT02259088|452908291|FG001|Overall Study|Lost to Follow-up|0|||
125893276|NCT02259088|452908290|FG000|Overall Study|Death|2|||
125893277|NCT02259088|452908291|FG001|Overall Study|Death|0|||
125893278|NCT02259088|452908290|FG000|Overall Study|Physician Decision|5|||
125893279|NCT02259088|452908291|FG001|Overall Study|Physician Decision|2|||
125893280|NCT02259088|452908290|FG000|Overall Study|Protocol deviation|5|||
125893281|NCT02259088|452908291|FG001|Overall Study|Protocol deviation|0|||
125893282|NCT02259088|452908290|FG000|Overall Study|Subject/guardian decision|8|||
125893283|NCT02259088|452908291|FG001|Overall Study|Subject/guardian decision|8|||
125893284|NCT01033448|452908293|FG000|Overall Study|Withdrawal by Subject|4|||
125893285|NCT01033448|452908293|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
125893286|NCT01033448|452908293|FG000|Overall Study|Lost to Follow-up|3|||
125893287|NCT01033448|452908293|FG000|Overall Study|Withdrew due to other reasons|3|||
125893288|NCT01033448|452908293|FG000|Overall Study|Unknown disposition|1|||
125893289|NCT01818752|452908294|FG000|Overall Study|Adverse Event|64|||
125893290|NCT01818752|452908295|FG001|Overall Study|Adverse Event|74|||
126108289|NCT03224325|453691103|FG002|Overall Study|Adverse Event|0|||
126108290|NCT03224325|453691104|FG003|Overall Study|Adverse Event|0|||
126108291|NCT03224325|453691105|FG004|Overall Study|Adverse Event|0|||
126108292|NCT03224325|453691106|FG005|Overall Study|Adverse Event|0|||
126108293|NCT03224325|453691107|FG006|Overall Study|Adverse Event|1|||
126108294|NCT03224325|453691101|FG000|Overall Study|Withdrawal by Subject|0|||
126108295|NCT03224325|453691102|FG001|Overall Study|Withdrawal by Subject|0|||
126108296|NCT03224325|453691103|FG002|Overall Study|Withdrawal by Subject|0|||
126108297|NCT03224325|453691104|FG003|Overall Study|Withdrawal by Subject|1|||
126108298|NCT03224325|453691105|FG004|Overall Study|Withdrawal by Subject|0|||
126108299|NCT03224325|453691106|FG005|Overall Study|Withdrawal by Subject|0|||
126108300|NCT03224325|453691107|FG006|Overall Study|Withdrawal by Subject|0|||
126108301|NCT00937833|453691109|FG000|Overall Study|Protocol Violation|1|||
126108302|NCT00937833|453691110|FG001|Overall Study|Protocol Violation|2|||
126108303|NCT00937833|453691109|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
126108304|NCT00937833|453691110|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
126108305|NCT00937833|453691109|FG000|Overall Study|Lost to Follow-up|10|||
126108306|NCT00937833|453691110|FG001|Overall Study|Lost to Follow-up|8|||
126108307|NCT00937833|453691109|FG000|Overall Study|Withdrawal by Subject|4|||
126108308|NCT00937833|453691110|FG001|Overall Study|Withdrawal by Subject|6|||
126108309|NCT00818389|453691112|FG000|Overall Study|Death|1|||
126108310|NCT00818389|453691113|FG001|Overall Study|Death|3|||
126108311|NCT00818389|453691112|FG000|Overall Study|ALS Disease Progression|1|||
126108312|NCT00818389|453691113|FG001|Overall Study|ALS Disease Progression|0|||
126108313|NCT00818389|453691112|FG000|Overall Study|Withdrawal by Subject|2|||
126108314|NCT00818389|453691113|FG001|Overall Study|Withdrawal by Subject|2|||
126108315|NCT00818389|453691112|FG000|Overall Study|Adverse Event|0|||
126108316|NCT00818389|453691113|FG001|Overall Study|Adverse Event|1|||
126108317|NCT03548987|453691114|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
126108318|NCT03548987|453691115|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
126108319|NCT03548987|453691114|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
126108320|NCT03548987|453691115|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
126108321|NCT03548987|453691114|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
126108322|NCT03548987|453691115|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
126108323|NCT03548987|453691114|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
126108324|NCT03548987|453691115|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
126108325|NCT03548987|453691114|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
126108326|NCT03548987|453691115|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
126108327|NCT03548987|453691114|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
126108328|NCT03548987|453691115|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
126108329|NCT03548987|453691114|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
126108330|NCT03548987|453691115|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
126108331|NCT03548987|453691114|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
126108332|NCT03548987|453691115|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
126108333|NCT03548987|453691114|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
126108334|NCT03548987|453691115|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
126108335|NCT03548987|453691114|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
126108336|NCT03548987|453691115|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
126108337|NCT03548987|453691114|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
126108338|NCT03548987|453691115|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
126108339|NCT03548987|453691114|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
126108340|NCT03548987|453691115|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
126108341|NCT03548987|453691114|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
126108342|NCT03548987|453691115|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
126108343|NCT03548987|453691114|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
126108344|NCT03548987|453691115|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
126108345|NCT00756470|453691120|FG000|Overall Study|Withdrawal by Subject|1|||
126108346|NCT00756470|453691120|FG000|Overall Study|Adverse Event|4|||
126108347|NCT03181451|453691121|FG000|Overall Study|Adverse Event|0|||
126108348|NCT03181451|453691122|FG001|Overall Study|Adverse Event|1|||
126108349|NCT03181451|453691123|FG002|Overall Study|Adverse Event|0|||
126108350|NCT03181451|453691121|FG000|Overall Study|Withdrawal by Subject|0|||
126108351|NCT03181451|453691122|FG001|Overall Study|Withdrawal by Subject|1|||
126108352|NCT03181451|453691123|FG002|Overall Study|Withdrawal by Subject|0|||
126108353|NCT00752622|453691136|FG000|Induction Phase|Adverse Event|3|||
126108354|NCT00752622|453691136|FG000|Induction Phase|Other|3|||
126108355|NCT00752622|453691136|FG000|Induction Phase|Non-responder|14|||
126108356|NCT00752622|453691136|FG000|Induction Phase|Withdrawal by Subject|1|||
126108357|NCT00752622|453691136|FG000|Induction Phase|Premature study termination|14|||
126108358|NCT00752622|453691136|FG000|Observational Phase|Premature Study Termination|36|||
126108359|NCT00752622|453691136|FG000|Observational Phase|Non-responder|2|||
126108360|NCT00752622|453691136|FG000|Observational Phase|Withdrawal by Subject|2|||
126108361|NCT00752622|453691136|FG000|Observational Phase|Adverse Event|1|||
126059082|NCT00721734|453510878|FG004|Overall Study|Adverse Event|3|||
126059083|NCT00721734|453510874|FG000|Overall Study|Withdrawal by Subject|2|||
126059084|NCT00721734|453510875|FG001|Overall Study|Withdrawal by Subject|1|||
126059085|NCT00721734|453510876|FG002|Overall Study|Withdrawal by Subject|0|||
126059086|NCT00721734|453510877|FG003|Overall Study|Withdrawal by Subject|0|||
126059087|NCT00721734|453510878|FG004|Overall Study|Withdrawal by Subject|1|||
126059088|NCT00721734|453510874|FG000|Overall Study|Other|0|||
126059089|NCT00721734|453510875|FG001|Overall Study|Other|0|||
126059090|NCT00721734|453510876|FG002|Overall Study|Other|0|||
126059091|NCT00721734|453510877|FG003|Overall Study|Other|1|||
126059092|NCT00721734|453510878|FG004|Overall Study|Other|0|||
126059093|NCT00472082|453510879|FG000|Overall Study|Study prematurely terminated|5|||
126059094|NCT04617847|453510880|FG000|Overall Study|Withdrawal by Subject|1|||
126059095|NCT04617847|453510881|FG001|Overall Study|Withdrawal by Subject|0|||
126059096|NCT04617847|453510880|FG000|Overall Study|Adverse Event|0|||
126059097|NCT04617847|453510881|FG001|Overall Study|Adverse Event|2|||
126059098|NCT04617847|453510880|FG000|Overall Study|Death|0|||
126059099|NCT04617847|453510881|FG001|Overall Study|Death|1|||
126059100|NCT04617847|453510880|FG000|Overall Study|Termination of Study by Sponsor|2|||
126059101|NCT04617847|453510881|FG001|Overall Study|Termination of Study by Sponsor|21|||
126059102|NCT01989689|453510882|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
126059103|NCT01989689|453510883|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
126059104|NCT01989689|453510882|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
126059105|NCT01989689|453510883|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
126059106|NCT00761267|453510884|FG000|Overall Study|Death|1|||
126059107|NCT00761267|453510885|FG001|Overall Study|Death|2|||
126059108|NCT00761267|453510886|FG002|Overall Study|Death|5|||
126059109|NCT00761267|453510884|FG000|Overall Study|Lost to Follow-up|0|||
126059110|NCT00761267|453510885|FG001|Overall Study|Lost to Follow-up|0|||
126059111|NCT00761267|453510886|FG002|Overall Study|Lost to Follow-up|1|||
126059112|NCT00761267|453510884|FG000|Overall Study|Randomized but not treated|1|||
126059113|NCT00761267|453510885|FG001|Overall Study|Randomized but not treated|1|||
126059114|NCT00761267|453510886|FG002|Overall Study|Randomized but not treated|0|||
126059115|NCT00761267|453510884|FG000|Overall Study|Withdrawal by Subject|0|||
126059116|NCT00761267|453510885|FG001|Overall Study|Withdrawal by Subject|1|||
126059117|NCT00761267|453510886|FG002|Overall Study|Withdrawal by Subject|0|||
126059118|NCT04492475|453510887|FG000|Overall Study|Enrolled but not treated|8|||
126059119|NCT04492475|453510888|FG001|Overall Study|Enrolled but not treated|8|||
126059120|NCT04492475|453510887|FG000|Overall Study|Withdrawal by Subject|4|||
126059121|NCT04492475|453510888|FG001|Overall Study|Withdrawal by Subject|0|||
126059122|NCT04492475|453510887|FG000|Overall Study|Became ineligible after enrollment|2|||
126059123|NCT04492475|453510888|FG001|Overall Study|Became ineligible after enrollment|0|||
126059124|NCT03938272|453510889|FG000|Overall Study|Withdrawal by Subject|1|||
126059125|NCT03938272|453510890|FG001|Overall Study|Withdrawal by Subject|0|||
126059126|NCT03938272|453510889|FG000|Overall Study|Physician Decision|0|||
126059127|NCT03938272|453510890|FG001|Overall Study|Physician Decision|2|||
126059128|NCT03938272|453510889|FG000|Overall Study|Study termination by sponsor|10|||
126108362|NCT00752622|453691136|FG000|Observational Phase|Other|2|||
126108363|NCT00752622|453691136|FG000|Interventional Phase|Non-responder|2|||
126108364|NCT00752622|453691136|FG000|Interventional Phase|Physician Decision|1|||
126108365|NCT00752622|453691136|FG000|Interventional Phase|Premature Study Termination|5|||
126108366|NCT00576836|453691137|FG000|Overall Study|Death|0|||
126108367|NCT00576836|453691138|FG001|Overall Study|Death|1|||
126108368|NCT00576836|453691137|FG000|Overall Study|Physician Decision|0|||
126108369|NCT00576836|453691138|FG001|Overall Study|Physician Decision|1|||
126108370|NCT02520284|453691139|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
126108371|NCT02520284|453691140|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
126059129|NCT03938272|453510890|FG001|Overall Study|Study termination by sponsor|8|||
125893291|NCT01818752|452908294|FG000|Overall Study|Death|14|||
125893292|NCT01818752|452908295|FG001|Overall Study|Death|18|||
125893293|NCT01818752|452908294|FG000|Overall Study|Non-compliance|16|||
125893294|NCT01818752|452908295|FG001|Overall Study|Non-compliance|20|||
125893295|NCT01818752|452908294|FG000|Overall Study|Withdrawal by Subject|15|||
125893296|NCT01818752|452908295|FG001|Overall Study|Withdrawal by Subject|14|||
125893297|NCT01818752|452908294|FG000|Overall Study|Physician Decision|9|||
125893298|NCT01818752|452908295|FG001|Overall Study|Physician Decision|8|||
125893299|NCT01818752|452908294|FG000|Overall Study|Disease Progression|54|||
125893300|NCT01818752|452908295|FG001|Overall Study|Disease Progression|48|||
125893301|NCT01818752|452908294|FG000|Overall Study|Other|7|||
125893302|NCT01818752|452908295|FG001|Overall Study|Other|8|||
125893303|NCT01818752|452908294|FG000|Overall Study|Continuing Treatment|1|||
125893304|NCT01818752|452908295|FG001|Overall Study|Continuing Treatment|4|||
125893305|NCT01818752|452908294|FG000|Overall Study|Randomized but not Dosed|7|||
125893306|NCT01818752|452908295|FG001|Overall Study|Randomized but not Dosed|4|||
125893307|NCT04270370|452908296|FG000|Overall Study|Lost to Follow-up|1|||
125893308|NCT04270370|452908297|FG001|Overall Study|Lost to Follow-up|0|||
125893309|NCT04270370|452908298|FG002|Overall Study|Lost to Follow-up|0|||
125893310|NCT04270370|452908299|FG003|Overall Study|Lost to Follow-up|0|||
125893311|NCT04270370|452908300|FG004|Overall Study|Lost to Follow-up|0|||
125893312|NCT04270370|452908301|FG005|Overall Study|Lost to Follow-up|0|||
125893313|NCT04270370|452908302|FG006|Overall Study|Lost to Follow-up|0|||
125893314|NCT04270370|452908303|FG007|Overall Study|Lost to Follow-up|0|||
125893315|NCT04270370|452908304|FG008|Overall Study|Lost to Follow-up|1|||
125893316|NCT04270370|452908305|FG009|Overall Study|Lost to Follow-up|0|||
125893317|NCT04270370|452908306|FG010|Overall Study|Lost to Follow-up|0|||
125893318|NCT04270370|452908307|FG011|Overall Study|Lost to Follow-up|0|||
125893319|NCT01324141|452908308|FG000|Overall Study|Declined to participate before treatment started|1|||
125893320|NCT01324141|452908308|FG000|Overall Study|Disease progression on study|1|||
125893321|NCT04629066|452908309|FG000|Overall Study|Lost to Follow-up|3|||
125893322|NCT04629066|452908310|FG001|Overall Study|Lost to Follow-up|2|||
125893323|NCT00530504|452908313|FG000|Overall Study|Death|54|||
125893324|NCT00530504|452908313|FG000|Overall Study|Lost to Follow-up|26|||
125893325|NCT00530504|452908313|FG000|Overall Study|Withdrawal by Subject|39|||
125893326|NCT00530504|452908313|FG000|Overall Study|Exited study due to other reasons|33|||
125893327|NCT02872285|452908316|FG000|Overall Study|Withdrawal by Subject|2|||
125893328|NCT02872285|452908317|FG001|Overall Study|Withdrawal by Subject|0|||
125893329|NCT02872285|452908316|FG000|Overall Study|Lost to Follow-up|2|||
125893330|NCT02872285|452908317|FG001|Overall Study|Lost to Follow-up|2|||
125893331|NCT02872285|452908316|FG000|Overall Study|Discontinued due to back surgery|1|||
125893332|NCT02872285|452908317|FG001|Overall Study|Discontinued due to back surgery|0|||
125893333|NCT05477108|452908318|FG000|Overall Study|Participants randomized, not treated|1|||
125893334|NCT05477108|452908319|FG001|Overall Study|Participants randomized, not treated|1|||
125893335|NCT05477108|452908320|FG002|Overall Study|Participants randomized, not treated|1|||
125893336|NCT05477108|452908318|FG000|Overall Study|Physician Decision|0|||
125893337|NCT05477108|452908319|FG001|Overall Study|Physician Decision|0|||
125893338|NCT05477108|452908320|FG002|Overall Study|Physician Decision|1|||
125893339|NCT05477108|452908318|FG000|Overall Study|withdrawn from study|0|||
125893340|NCT05477108|452908319|FG001|Overall Study|withdrawn from study|0|||
125893341|NCT05477108|452908320|FG002|Overall Study|withdrawn from study|1|||
125893342|NCT02660983|452908321|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
125893343|NCT02660983|452908322|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
125893344|NCT02660983|452908321|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
125893345|NCT02660983|452908322|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
125893346|NCT02660983|452908321|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
125893347|NCT02660983|452908322|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
125893348|NCT02660983|452908321|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
126108372|NCT02520284|453691141|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
126108373|NCT02520284|453691139|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
126108374|NCT02520284|453691140|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
125893349|NCT02660983|452908322|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
125893350|NCT02660983|452908321|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
125893351|NCT02660983|452908322|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
125893352|NCT02660983|452908321|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
125893353|NCT02660983|452908322|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
125893354|NCT02660983|452908321|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
125893355|NCT02660983|452908322|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
125893356|NCT01165216|452908330|FG000|Overall Study|Adverse Event|6|||
125893357|NCT01165216|452908331|FG001|Overall Study|Adverse Event|3|||
125893358|NCT01165216|452908330|FG000|Overall Study|Withdrawal by Subject|1|||
125893359|NCT01165216|452908331|FG001|Overall Study|Withdrawal by Subject|1|||
125893360|NCT01165216|452908330|FG000|Overall Study|Disease progression|1|||
126108375|NCT02520284|453691141|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
125893361|NCT01165216|452908331|FG001|Overall Study|Disease progression|3|||
126108376|NCT02520284|453691139|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
126108377|NCT02520284|453691140|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
126108378|NCT02520284|453691141|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
126108379|NCT02520284|453691139|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
126108380|NCT02520284|453691140|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
126108381|NCT02520284|453691141|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
126108382|NCT02520284|453691139|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
126108383|NCT02520284|453691140|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
126108384|NCT02520284|453691141|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
126108385|NCT02520284|453691139|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
126108386|NCT02520284|453691140|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
126108387|NCT02520284|453691141|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
126108388|NCT02520284|453691139|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
126108389|NCT02520284|453691140|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
126108390|NCT02520284|453691141|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
126108391|NCT02520284|453691139|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
126108392|NCT02520284|453691140|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
126108393|NCT02520284|453691141|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
126108394|NCT02520284|453691139|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
126108395|NCT02520284|453691140|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
126108396|NCT02520284|453691141|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
125893362|NCT04303195|452908333|FG000|Overall Study|Adverse Event|1|||
125893363|NCT04303195|452908334|FG001|Overall Study|Adverse Event|3|||
125893364|NCT04303195|452908335|FG002|Overall Study|Adverse Event|7|||
125893365|NCT04303195|452908336|FG003|Overall Study|Adverse Event|0|||
125893366|NCT04303195|452908333|FG000|Overall Study|Lost to Follow-up|1|||
125893367|NCT04303195|452908334|FG001|Overall Study|Lost to Follow-up|0|||
125893368|NCT04303195|452908335|FG002|Overall Study|Lost to Follow-up|1|||
125893369|NCT04303195|452908336|FG003|Overall Study|Lost to Follow-up|4|||
125893370|NCT04303195|452908333|FG000|Overall Study|Withdrawal by Subject|3|||
125893371|NCT04303195|452908334|FG001|Overall Study|Withdrawal by Subject|1|||
125893372|NCT04303195|452908335|FG002|Overall Study|Withdrawal by Subject|1|||
125893373|NCT04303195|452908336|FG003|Overall Study|Withdrawal by Subject|1|||
125893374|NCT04303195|452908333|FG000|Overall Study|No study drug administered or protocol deviation|0|||
125893375|NCT04303195|452908334|FG001|Overall Study|No study drug administered or protocol deviation|2|||
125893376|NCT04303195|452908335|FG002|Overall Study|No study drug administered or protocol deviation|0|||
125893377|NCT04303195|452908336|FG003|Overall Study|No study drug administered or protocol deviation|2|||
125893378|NCT06457204|452908337|FG000|Washout|Adverse Event|0|||
125893379|NCT06457204|452908338|FG001|Washout|Adverse Event|2|||
125893380|NCT01065454|452908339|FG000|Treatment|Adverse Event|7|||
125893381|NCT01065454|452908340|FG001|Treatment|Adverse Event|4|||
125893382|NCT01065454|452908341|FG002|Treatment|Adverse Event|3|||
125893383|NCT01065454|452908342|FG003|Treatment|Adverse Event|6|||
125893384|NCT01065454|452908339|FG000|Treatment|Death|1|||
125893385|NCT01065454|452908340|FG001|Treatment|Death|0|||
125893386|NCT01065454|452908341|FG002|Treatment|Death|0|||
125893387|NCT01065454|452908342|FG003|Treatment|Death|0|||
125893388|NCT01065454|452908339|FG000|Treatment|Non-compliance|1|||
125893389|NCT01065454|452908340|FG001|Treatment|Non-compliance|0|||
125893390|NCT01065454|452908341|FG002|Treatment|Non-compliance|0|||
125893391|NCT01065454|452908342|FG003|Treatment|Non-compliance|1|||
125893392|NCT01065454|452908339|FG000|Treatment|Protocol Decision|0|||
125893393|NCT01065454|452908340|FG001|Treatment|Protocol Decision|0|||
125893394|NCT01065454|452908341|FG002|Treatment|Protocol Decision|3|||
125893395|NCT01065454|452908342|FG003|Treatment|Protocol Decision|2|||
125893396|NCT01065454|452908339|FG000|Treatment|Protocol Violation|1|||
125893397|NCT01065454|452908340|FG001|Treatment|Protocol Violation|0|||
126108397|NCT02520284|453691139|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
126108398|NCT02520284|453691140|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
125893398|NCT01065454|452908341|FG002|Treatment|Protocol Violation|1|||
125893399|NCT01065454|452908342|FG003|Treatment|Protocol Violation|0|||
125893400|NCT01065454|452908339|FG000|Treatment|Withdrawal by Subject|3|||
125893401|NCT01065454|452908340|FG001|Treatment|Withdrawal by Subject|1|||
125893402|NCT01065454|452908341|FG002|Treatment|Withdrawal by Subject|2|||
125893403|NCT01065454|452908342|FG003|Treatment|Withdrawal by Subject|3|||
125893404|NCT01065454|452908339|FG000|Follow up|Adverse Event|1|||
125893405|NCT01065454|452908340|FG001|Follow up|Adverse Event|0|||
125893406|NCT01065454|452908341|FG002|Follow up|Adverse Event|0|||
125893407|NCT01065454|452908342|FG003|Follow up|Adverse Event|1|||
125893408|NCT01065454|452908339|FG000|Follow up|Death|0|||
125893409|NCT01065454|452908340|FG001|Follow up|Death|1|||
125893410|NCT01065454|452908341|FG002|Follow up|Death|1|||
125893411|NCT01065454|452908342|FG003|Follow up|Death|0|||
125893412|NCT01065454|452908339|FG000|Follow up|Lost to Follow-up|0|||
126059130|NCT03989232|453510891|FG000|Overall Study|Lost to Follow-up|3|||
125893413|NCT01065454|452908340|FG001|Follow up|Lost to Follow-up|0|||
125893414|NCT01065454|452908341|FG002|Follow up|Lost to Follow-up|0|||
125893415|NCT01065454|452908342|FG003|Follow up|Lost to Follow-up|1|||
125893416|NCT01065454|452908339|FG000|Follow up|Progressive disease|0|||
126059131|NCT03989232|453510892|FG001|Overall Study|Lost to Follow-up|10|||
126108399|NCT02520284|453691141|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
126108400|NCT02520284|453691139|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
126108401|NCT02520284|453691140|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
126108402|NCT02520284|453691141|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
126108403|NCT01211522|453691145|FG000|Overall Study|Withdrawal by Subject|3|||
126108404|NCT01211522|453691146|FG001|Overall Study|Withdrawal by Subject|7|||
126108405|NCT01211522|453691147|FG002|Overall Study|Withdrawal by Subject|5|||
126108406|NCT01116882|453691153|FG000|30-day|Lost to Follow-up|50|||
126108407|NCT01116882|453691154|FG001|30-day|Lost to Follow-up|21|||
126108408|NCT01116882|453691153|FG000|30-day|Withdrawal by Subject|2|||
126108409|NCT01116882|453691154|FG001|30-day|Withdrawal by Subject|4|||
126108410|NCT01116882|453691153|FG000|30-day|Other Reasons|16|||
126108411|NCT01116882|453691154|FG001|30-day|Other Reasons|6|||
126108412|NCT01116882|453691153|FG000|12-month|Lost to Follow-up|111|||
126108413|NCT01116882|453691154|FG001|12-month|Lost to Follow-up|42|||
126108414|NCT01116882|453691153|FG000|12-month|Other Reasons|151|||
126108415|NCT01116882|453691154|FG001|12-month|Other Reasons|49|||
126108416|NCT01116882|453691153|FG000|12-month|Withdrawal by Subject|5|||
126108417|NCT01116882|453691154|FG001|12-month|Withdrawal by Subject|8|||
126108418|NCT00547365|453691155|FG000|Overall Study|Physician Decision|1|||
126108419|NCT00547365|453691155|FG000|Overall Study|Lost to Follow-up|1|||
126108420|NCT00547365|453691155|FG000|Overall Study|Protocol Violation|2|||
126108421|NCT00547365|453691155|FG000|Overall Study|death (not related to study)|4|||
126108422|NCT01139658|453691156|FG000|Overall Study|Adverse Event|10|||
126108423|NCT01139658|453691157|FG001|Overall Study|Adverse Event|27|||
126108424|NCT01139658|453691156|FG000|Overall Study|Lack of Efficacy|15|||
126108425|NCT01139658|453691157|FG001|Overall Study|Lack of Efficacy|7|||
126108426|NCT01139658|453691156|FG000|Overall Study|Withdrawal by Subject|2|||
126108427|NCT01139658|453691157|FG001|Overall Study|Withdrawal by Subject|4|||
126108428|NCT01139658|453691156|FG000|Overall Study|No documentation of treatment|1|||
126108429|NCT01139658|453691157|FG001|Overall Study|No documentation of treatment|0|||
126108430|NCT01139658|453691156|FG000|Overall Study|Other|28|||
126108431|NCT01139658|453691157|FG001|Overall Study|Other|75|||
126108432|NCT01777269|453691158|FG000|Overall Study|Adverse Event|24|||
126108433|NCT01777269|453691159|FG001|Overall Study|Adverse Event|33|||
126108434|NCT01777269|453691158|FG000|Overall Study|Lack of Efficacy|8|||
126108435|NCT01777269|453691159|FG001|Overall Study|Lack of Efficacy|10|||
126108436|NCT01777269|453691158|FG000|Overall Study|Protocol Violation|4|||
126108437|NCT01777269|453691159|FG001|Overall Study|Protocol Violation|4|||
126108438|NCT01777269|453691158|FG000|Overall Study|Participants reached stopping criteria|1|||
126108439|NCT01777269|453691159|FG001|Overall Study|Participants reached stopping criteria|1|||
126108440|NCT01777269|453691158|FG000|Overall Study|Lost to Follow-up|4|||
126108441|NCT01777269|453691159|FG001|Overall Study|Lost to Follow-up|0|||
126108442|NCT01777269|453691158|FG000|Overall Study|Physician Decision|5|||
126059132|NCT03989232|453510891|FG000|Overall Study|Withdrawal by Subject|6|||
126059133|NCT03989232|453510892|FG001|Overall Study|Withdrawal by Subject|6|||
126059134|NCT03989232|453510891|FG000|Overall Study|Death|1|||
126059135|NCT03989232|453510892|FG001|Overall Study|Death|2|||
126059136|NCT03652610|453510900|FG000|Overall Study|Lost to Follow-up|1|||
126059137|NCT03652610|453510901|FG001|Overall Study|Lost to Follow-up|0|||
126059138|NCT03652610|453510900|FG000|Overall Study|Withdrawal by Subject|3|||
126059139|NCT03652610|453510901|FG001|Overall Study|Withdrawal by Subject|5|||
126059140|NCT00326183|453510902|FG000|Overall Study|Lost to Follow-up|104|||
126059141|NCT00326183|453510903|FG001|Overall Study|Lost to Follow-up|56|||
126059142|NCT00326183|453510902|FG000|Overall Study|Protocol Violation|6|||
126059143|NCT00326183|453510903|FG001|Overall Study|Protocol Violation|3|||
126108443|NCT01777269|453691159|FG001|Overall Study|Physician Decision|2|||
126108444|NCT01777269|453691158|FG000|Overall Study|Withdrawal by Subject|9|||
126108445|NCT01777269|453691159|FG001|Overall Study|Withdrawal by Subject|9|||
126108446|NCT00504881|453691160|FG000|Overall Study|Lack of Efficacy|1|||
126108447|NCT00504881|453691161|FG001|Overall Study|Lack of Efficacy|5|||
126108448|NCT00504881|453691160|FG000|Overall Study|Lost to Follow-up|0|||
126108449|NCT00504881|453691161|FG001|Overall Study|Lost to Follow-up|2|||
126059144|NCT00326183|453510902|FG000|Overall Study|Withdrawal by Subject|35|||
126059145|NCT00326183|453510903|FG001|Overall Study|Withdrawal by Subject|7|||
126108450|NCT00504881|453691160|FG000|Overall Study|Withdrawal by Subject|1|||
126108451|NCT00504881|453691161|FG001|Overall Study|Withdrawal by Subject|4|||
126059146|NCT00326183|453510902|FG000|Overall Study|Subject Moved|7|||
126108452|NCT00504881|453691160|FG000|Overall Study|Non-Compliance|1|||
126108453|NCT00504881|453691161|FG001|Overall Study|Non-Compliance|0|||
126108454|NCT00504881|453691160|FG000|Overall Study|No Birth Control|0|||
126108455|NCT00504881|453691161|FG001|Overall Study|No Birth Control|1|||
126108456|NCT00504881|453691160|FG000|Overall Study|Safety Visit not performed|0|||
126108457|NCT00504881|453691161|FG001|Overall Study|Safety Visit not performed|1|||
126108458|NCT00504881|453691160|FG000|Overall Study|AE, serious fatal|0|||
126108459|NCT00504881|453691161|FG001|Overall Study|AE, serious fatal|1|||
126108460|NCT00504881|453691160|FG000|Overall Study|SAE, non-fatal|2|||
126108461|NCT00504881|453691161|FG001|Overall Study|SAE, non-fatal|6|||
126108462|NCT00504881|453691160|FG000|Overall Study|AE, non-serious non-fatal|4|||
126108463|NCT00504881|453691161|FG001|Overall Study|AE, non-serious non-fatal|14|||
126108464|NCT00504881|453691160|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
126108465|NCT00504881|453691161|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
126108466|NCT00504881|453691160|FG000|Overall Study|AE of unknown type|1|||
126108467|NCT00504881|453691161|FG001|Overall Study|AE of unknown type|0|||
126108468|NCT00593957|453691166|FG000|Overall Study|Physician Decision|0|||
126108469|NCT00593957|453691167|FG001|Overall Study|Physician Decision|1|||
126108470|NCT00593957|453691168|FG002|Overall Study|Physician Decision|2|||
126108471|NCT00494481|453691171|FG000|Overall Study|Condition under investigation worsened|11|||
126108472|NCT00494481|453691172|FG001|Overall Study|Condition under investigation worsened|13|||
126108473|NCT00494481|453691171|FG000|Overall Study|Adverse Event|15|||
126108474|NCT00494481|453691172|FG001|Overall Study|Adverse Event|11|||
126108475|NCT00494481|453691171|FG000|Overall Study|Other|1|||
126108476|NCT00494481|453691172|FG001|Overall Study|Other|0|||
126108477|NCT00494481|453691171|FG000|Overall Study|Never received IP|2|||
126108478|NCT00494481|453691172|FG001|Overall Study|Never received IP|0|||
126108479|NCT00332189|453691173|FG000|Overall Study|Adverse Event|3|||
126108480|NCT00332189|453691173|FG000|Overall Study|Uncooperative/Noncompliant|3|||
126108481|NCT00332189|453691173|FG000|Overall Study|Withdrawal by Subject|9|||
126108482|NCT00332189|453691173|FG000|Overall Study|Lack of Efficacy|4|||
126108483|NCT00332189|453691173|FG000|Overall Study|Moved out of country|2|||
126108484|NCT02279862|453691174|FG000|Overall Study|Study drug toxicity|3|||
126108485|NCT02279862|453691175|FG001|Overall Study|Study drug toxicity|6|||
126108486|NCT02279862|453691174|FG000|Overall Study|No longer meets criteria|0|||
126108487|NCT02279862|453691175|FG001|Overall Study|No longer meets criteria|1|||
125893417|NCT01065454|452908340|FG001|Follow up|Progressive disease|0|||
125893418|NCT01065454|452908341|FG002|Follow up|Progressive disease|0|||
125893419|NCT01065454|452908342|FG003|Follow up|Progressive disease|1|||
125893420|NCT01065454|452908339|FG000|Follow up|Withdrawal by Subject|1|||
125893421|NCT01065454|452908340|FG001|Follow up|Withdrawal by Subject|1|||
125893422|NCT01065454|452908341|FG002|Follow up|Withdrawal by Subject|1|||
125893423|NCT01065454|452908342|FG003|Follow up|Withdrawal by Subject|0|||
125893424|NCT01065454|452908339|FG000|Follow up|study ongoing|37|||
125893425|NCT01065454|452908340|FG001|Follow up|study ongoing|22|||
125893426|NCT01065454|452908341|FG002|Follow up|study ongoing|15|||
125893427|NCT01065454|452908342|FG003|Follow up|study ongoing|41|||
125893428|NCT01601652|452908343|FG000|Overall Study|Death|1|||
125893429|NCT05688670|452908344|FG000|Overall Study|Change in surgery plan|1|||
125893430|NCT05688670|452908345|FG001|Overall Study|Change in surgery plan|4|||
125893431|NCT05688670|452908344|FG000|Overall Study|Inability to extubate|1|||
125893432|NCT05688670|452908345|FG001|Overall Study|Inability to extubate|2|||
125893433|NCT05688670|452908344|FG000|Overall Study|Day of surgery cancellation|0|||
125893434|NCT05688670|452908345|FG001|Overall Study|Day of surgery cancellation|1|||
125893435|NCT05688670|452908344|FG000|Overall Study|Reintubated on PCICU arrival|0|||
125893436|NCT05688670|452908345|FG001|Overall Study|Reintubated on PCICU arrival|1|||
125893437|NCT01097005|452908346|FG000|Overall Study|Case Report Form not collected|18|||
125893438|NCT01097005|452908346|FG000|Overall Study|Subjects cannot visit the hospital|1|||
125893439|NCT01097005|452908346|FG000|Overall Study|Poor medication compliance|1|||
125893440|NCT01097005|452908346|FG000|Overall Study|No examination data available|244|||
125893441|NCT01097005|452908346|FG000|Overall Study|Deviation from exclusion criteria|37|||
125893442|NCT01097005|452908346|FG000|Overall Study|Adverse Event|14|||
125893443|NCT01097005|452908346|FG000|Overall Study|Discontinuance by complication|50|||
125893444|NCT03425253|452908347|FG000|Overall Study|Adverse Event|2|||
125893445|NCT03425253|452908347|FG000|Overall Study|Lost to Follow-up|3|||
125893446|NCT03425253|452908347|FG000|Overall Study|Withdrew Consent|6|||
125893447|NCT03425253|452908347|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
125893448|NCT05009979|452908348|FG000|Overall Study|Withdrawal by Subject|1|||
125893449|NCT01868542|452909934|FG000|Overall Study|Protocol Violation|0|||
125893450|NCT01868542|452909935|FG001|Overall Study|Protocol Violation|1|||
125893451|NCT01868542|452909934|FG000|Overall Study|Unclassified|0|||
125893452|NCT01868542|452909935|FG001|Overall Study|Unclassified|1|||
125893453|NCT03844945|452909938|FG000|Overall Study|Adverse Event|1|||
125893454|NCT03844945|452909939|FG001|Overall Study|Adverse Event|1|||
125893455|NCT03844945|452909940|FG002|Overall Study|Adverse Event|4|||
125893456|NCT03844945|452909941|FG003|Overall Study|Adverse Event|0|||
125893457|NCT03844945|452909938|FG000|Overall Study|Withdrawal by Subject|0|||
125893458|NCT03844945|452909939|FG001|Overall Study|Withdrawal by Subject|0|||
125893459|NCT03844945|452909940|FG002|Overall Study|Withdrawal by Subject|1|||
125893460|NCT03844945|452909941|FG003|Overall Study|Withdrawal by Subject|0|||
125893461|NCT03844945|452909938|FG000|Overall Study|Lack of Efficacy|0|||
125893462|NCT03844945|452909939|FG001|Overall Study|Lack of Efficacy|0|||
125893463|NCT03844945|452909940|FG002|Overall Study|Lack of Efficacy|0|||
125893464|NCT03844945|452909941|FG003|Overall Study|Lack of Efficacy|1|||
125893465|NCT04129151|452909948|FG000|Overall Study|Adverse Event|1|||
125893466|NCT04129151|452909948|FG000|Overall Study|Disease Progression|7|||
125893467|NCT04129151|452909948|FG000|Overall Study|Study closure|1|||
125893468|NCT02051933|452909949|FG000|Overall Study|Physician Decision|0|||
125893469|NCT02051933|452909950|FG001|Overall Study|Physician Decision|1|||
125893470|NCT00588861|452909954|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
125893471|NCT00588861|452909955|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
125893472|NCT00588861|452909954|FG000|6 Months|Patients did not return for follow-up|98|||
125893473|NCT00588861|452909955|FG001|6 Months|Patients did not return for follow-up|73|||
125893474|NCT00588861|452909954|FG000|1 Year|Patients did not return for follow-up|89|||
125893475|NCT00588861|452909955|FG001|1 Year|Patients did not return for follow-up|82|||
125893476|NCT00588861|452909954|FG000|2 Years|Patients did not return for follow-up|92|||
125893477|NCT00588861|452909955|FG001|2 Years|Patients did not return for follow-up|87|||
125893478|NCT00588861|452909954|FG000|4 Years|Patients did not return for follow-up|91|||
125893479|NCT00588861|452909955|FG001|4 Years|Patients did not return for follow-up|103|||
125893480|NCT00588861|452909954|FG000|6 Years|Patients did not return for follow-up|104|||
125893481|NCT00588861|452909955|FG001|6 Years|Patients did not return for follow-up|109|||
125893482|NCT00588861|452909954|FG000|8 Years|Patients did not return for follow-up|105|||
125893483|NCT00588861|452909955|FG001|8 Years|Patients did not return for follow-up|114|||
125893484|NCT00588861|452909954|FG000|10 Years|Incomplete due to study termination|107|||
125893485|NCT00588861|452909955|FG001|10 Years|Incomplete due to study termination|114|||
125893486|NCT02730195|452909956|FG000|Overall Study|Withdrawal by Subject|1|||
125893487|NCT00265148|452909958|FG000|Overall Study|Adverse Event|2|||
125893488|NCT00265148|452909959|FG001|Overall Study|Adverse Event|2|||
125893489|NCT00265148|452909958|FG000|Overall Study|Lack of Efficacy|0|||
125893490|NCT00265148|452909959|FG001|Overall Study|Lack of Efficacy|2|||
125893491|NCT00265148|452909958|FG000|Overall Study|Protocol Violation|3|||
125893492|NCT00265148|452909959|FG001|Overall Study|Protocol Violation|2|||
125893493|NCT00265148|452909958|FG000|Overall Study|Lost to Follow-up|0|||
126108488|NCT02279862|453691174|FG000|Overall Study|Administrative reason by sponsor|0|||
126108489|NCT02279862|453691175|FG001|Overall Study|Administrative reason by sponsor|1|||
126108490|NCT02279862|453691174|FG000|Overall Study|Disease progression|5|||
126108491|NCT02279862|453691175|FG001|Overall Study|Disease progression|2|||
126108492|NCT02279862|453691174|FG000|Overall Study|Study closed by sponsor|16|||
126108493|NCT02279862|453691175|FG001|Overall Study|Study closed by sponsor|13|||
126108494|NCT02279862|453691174|FG000|Overall Study|Other|1|||
126108495|NCT02279862|453691175|FG001|Overall Study|Other|2|||
126108496|NCT02279862|453691174|FG000|Overall Study|Withdrawal by Subject|1|||
126108497|NCT02279862|453691175|FG001|Overall Study|Withdrawal by Subject|0|||
126108498|NCT01163721|453691176|FG000|Overall Study|Adverse Event|5|||
126108499|NCT01163721|453691177|FG001|Overall Study|Adverse Event|6|||
126108500|NCT01163721|453691176|FG000|Overall Study|Withdrawal by Subject|3|||
126108501|NCT01163721|453691177|FG001|Overall Study|Withdrawal by Subject|4|||
126108502|NCT01163721|453691176|FG000|Overall Study|Lost to Follow-up|0|||
126108503|NCT01163721|453691177|FG001|Overall Study|Lost to Follow-up|1|||
126108504|NCT01163721|453691176|FG000|Overall Study|Physician Decision|0|||
126108505|NCT01163721|453691177|FG001|Overall Study|Physician Decision|1|||
126108506|NCT02511678|453691178|FG000|Overall Study|Withdrawal by Subject|2|||
126108507|NCT02511678|453691178|FG000|Overall Study|Lost to Follow-up|4|||
126108508|NCT02511678|453691178|FG000|Overall Study|Death|19|||
126108509|NCT02511678|453691178|FG000|Overall Study|Adverse Event|1|||
126108510|NCT02511678|453691178|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
126108511|NCT02511678|453691178|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
126108512|NCT02511678|453691178|FG000|Overall Study|Required Radiofrequency Ablation|1|||
126108513|NCT02511678|453691178|FG000|Overall Study|Biopsy was Negative|1|||
126108514|NCT02511678|453691178|FG000|Overall Study|Protocol Violation|1|||
126108515|NCT02511678|453691178|FG000|Overall Study|Received Radiation Treatment|1|||
126108516|NCT01295281|453691179|FG000|First Intervention (7 Days)|Death|0|||
126108517|NCT01295281|453691180|FG001|First Intervention (7 Days)|Death|1|||
126108518|NCT01411839|453691182|FG000|Overall Study|Lost to Follow-up|4|||
126108519|NCT01411839|453691183|FG001|Overall Study|Lost to Follow-up|3|||
126108520|NCT05461794|453691186|FG000|Overall Study|Withdrawal by Subject|1|||
126108521|NCT05461794|453691187|FG001|Overall Study|Withdrawal by Subject|1|||
126108522|NCT05461794|453691188|FG002|Overall Study|Withdrawal by Subject|3|||
126108523|NCT05461794|453691186|FG000|Overall Study|Study Terminated By Sponsor|18|||
126108524|NCT05461794|453691187|FG001|Overall Study|Study Terminated By Sponsor|13|||
126108525|NCT05461794|453691188|FG002|Overall Study|Study Terminated By Sponsor|16|||
126108526|NCT05461794|453691186|FG000|Overall Study|Death|20|||
126108527|NCT05461794|453691187|FG001|Overall Study|Death|5|||
126108528|NCT05461794|453691188|FG002|Overall Study|Death|19|||
126108529|NCT02684357|453691189|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
126108530|NCT02684357|453691190|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
126108531|NCT02684357|453691191|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
126108532|NCT02684357|453691192|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
126108533|NCT02684357|453691193|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
126108534|NCT02684357|453691194|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
126108535|NCT02684357|453691189|FG000|Part A|Lost to Follow-up|0|||
126108536|NCT02684357|453691190|FG001|Part A|Lost to Follow-up|2|||
126108537|NCT02684357|453691191|FG002|Part A|Lost to Follow-up|2|||
126108538|NCT02684357|453691192|FG003|Part A|Lost to Follow-up|0|||
125893494|NCT00265148|452909959|FG001|Overall Study|Lost to Follow-up|1|||
126108539|NCT02684357|453691193|FG004|Part A|Lost to Follow-up|0|||
126108540|NCT02684357|453691194|FG005|Part A|Lost to Follow-up|0|||
126108541|NCT02684357|453691189|FG000|Part A|Withdrawal by Subject|3|||
126108542|NCT02684357|453691190|FG001|Part A|Withdrawal by Subject|0|||
126108543|NCT02684357|453691191|FG002|Part A|Withdrawal by Subject|0|||
126108544|NCT02684357|453691192|FG003|Part A|Withdrawal by Subject|0|||
126108545|NCT02684357|453691193|FG004|Part A|Withdrawal by Subject|0|||
126108546|NCT02684357|453691194|FG005|Part A|Withdrawal by Subject|0|||
126108547|NCT02684357|453691189|FG000|Part A|Other|0|||
126108548|NCT02684357|453691190|FG001|Part A|Other|1|||
126108549|NCT02684357|453691191|FG002|Part A|Other|0|||
126108550|NCT02684357|453691192|FG003|Part A|Other|0|||
126108551|NCT02684357|453691193|FG004|Part A|Other|0|||
126108552|NCT02684357|453691194|FG005|Part A|Other|0|||
126108553|NCT02684357|453691189|FG000|Part B|Adverse Event (Other)|0|||
126108554|NCT02684357|453691190|FG001|Part B|Adverse Event (Other)|0|||
126108555|NCT02684357|453691191|FG002|Part B|Adverse Event (Other)|0|||
126108556|NCT02684357|453691192|FG003|Part B|Adverse Event (Other)|1|||
126108557|NCT02684357|453691193|FG004|Part B|Adverse Event (Other)|1|||
126108558|NCT02684357|453691194|FG005|Part B|Adverse Event (Other)|1|||
126108559|NCT02684357|453691189|FG000|Part B|Lost to Follow-up|0|||
126108560|NCT02684357|453691190|FG001|Part B|Lost to Follow-up|0|||
126108561|NCT02684357|453691191|FG002|Part B|Lost to Follow-up|0|||
126108562|NCT02684357|453691192|FG003|Part B|Lost to Follow-up|1|||
126108563|NCT02684357|453691193|FG004|Part B|Lost to Follow-up|1|||
126108564|NCT02684357|453691194|FG005|Part B|Lost to Follow-up|7|||
126108565|NCT02684357|453691189|FG000|Part B|Withdrawal by Subject|0|||
126108566|NCT02684357|453691190|FG001|Part B|Withdrawal by Subject|0|||
126108567|NCT02684357|453691191|FG002|Part B|Withdrawal by Subject|0|||
126108568|NCT02684357|453691192|FG003|Part B|Withdrawal by Subject|0|||
126108569|NCT02684357|453691193|FG004|Part B|Withdrawal by Subject|2|||
126108570|NCT02684357|453691194|FG005|Part B|Withdrawal by Subject|4|||
126108571|NCT02684357|453691189|FG000|Part B|Other|0|||
126108572|NCT02684357|453691190|FG001|Part B|Other|0|||
126108573|NCT02684357|453691191|FG002|Part B|Other|0|||
126108574|NCT02684357|453691192|FG003|Part B|Other|1|||
126108575|NCT02684357|453691193|FG004|Part B|Other|0|||
126108576|NCT02684357|453691194|FG005|Part B|Other|1|||
126108577|NCT01079130|453691195|FG000|Overall Study|Adverse Event|1|||
126108578|NCT01079130|453691196|FG001|Overall Study|Adverse Event|1|||
126108579|NCT01079130|453691197|FG002|Overall Study|Adverse Event|0|||
126108580|NCT01079130|453691198|FG003|Overall Study|Adverse Event|1|||
126108581|NCT01079130|453691199|FG004|Overall Study|Adverse Event|5|||
126108582|NCT01079130|453691200|FG005|Overall Study|Adverse Event|1|||
126108583|NCT01079130|453691195|FG000|Overall Study|Administrative problems|1|||
126108584|NCT01079130|453691196|FG001|Overall Study|Administrative problems|3|||
126108585|NCT01079130|453691197|FG002|Overall Study|Administrative problems|0|||
126108586|NCT01079130|453691198|FG003|Overall Study|Administrative problems|0|||
126108587|NCT01079130|453691199|FG004|Overall Study|Administrative problems|0|||
126108588|NCT01079130|453691200|FG005|Overall Study|Administrative problems|1|||
126108589|NCT01079130|453691195|FG000|Overall Study|Withdrawal by Subject|0|||
126108590|NCT01079130|453691196|FG001|Overall Study|Withdrawal by Subject|1|||
126108591|NCT01079130|453691197|FG002|Overall Study|Withdrawal by Subject|0|||
126108592|NCT01079130|453691198|FG003|Overall Study|Withdrawal by Subject|0|||
126108593|NCT01079130|453691199|FG004|Overall Study|Withdrawal by Subject|1|||
126108594|NCT01079130|453691200|FG005|Overall Study|Withdrawal by Subject|3|||
126108595|NCT01079130|453691195|FG000|Overall Study|Protocol deviation|0|||
126108596|NCT01079130|453691196|FG001|Overall Study|Protocol deviation|2|||
126108597|NCT01079130|453691197|FG002|Overall Study|Protocol deviation|1|||
126108598|NCT01079130|453691198|FG003|Overall Study|Protocol deviation|2|||
126108599|NCT01079130|453691199|FG004|Overall Study|Protocol deviation|0|||
126108600|NCT01079130|453691200|FG005|Overall Study|Protocol deviation|0|||
126108601|NCT01079130|453691195|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126108602|NCT01079130|453691196|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126108603|NCT01079130|453691197|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126108604|NCT01079130|453691198|FG003|Overall Study|Abnormal test procedure result(s)|0|||
126108605|NCT01079130|453691199|FG004|Overall Study|Abnormal test procedure result(s)|1|||
126108606|NCT01079130|453691200|FG005|Overall Study|Abnormal test procedure result(s)|0|||
126108607|NCT01079130|453691195|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126108608|NCT01079130|453691196|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126108609|NCT01079130|453691197|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126108610|NCT01079130|453691198|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
126108611|NCT01079130|453691199|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
125893495|NCT00265148|452909958|FG000|Overall Study|Withdrawal by Subject|2|||
126108612|NCT01079130|453691200|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
126108613|NCT01079130|453691195|FG000|Overall Study|Lost to Follow-up|0|||
126108614|NCT01079130|453691196|FG001|Overall Study|Lost to Follow-up|0|||
126108615|NCT01079130|453691197|FG002|Overall Study|Lost to Follow-up|0|||
126108616|NCT01079130|453691198|FG003|Overall Study|Lost to Follow-up|0|||
126108617|NCT01079130|453691199|FG004|Overall Study|Lost to Follow-up|1|||
126108618|NCT01079130|453691200|FG005|Overall Study|Lost to Follow-up|0|||
126108619|NCT04821869|453691206|FG000|Overall Study|Adverse Event|4|||
126108620|NCT04821869|453691206|FG000|Overall Study|Withdrawal by Subject|2|||
126108621|NCT04821869|453691206|FG000|Overall Study|Did not meet FEV1 criteria|1|||
126108622|NCT03444324|453691207|FG000|Overall Study|Withdrawal by Subject|0|||
126108623|NCT03444324|453691208|FG001|Overall Study|Withdrawal by Subject|1|||
126108624|NCT03444324|453691207|FG000|Overall Study|Lost to Follow-up|4|||
126108625|NCT03444324|453691208|FG001|Overall Study|Lost to Follow-up|2|||
126108626|NCT03444324|453691207|FG000|Overall Study|Protocol Violation|0|||
126108627|NCT03444324|453691208|FG001|Overall Study|Protocol Violation|1|||
126108628|NCT03444324|453691207|FG000|Overall Study|Lack of Trial Compliance|1|||
126108629|NCT03444324|453691208|FG001|Overall Study|Lack of Trial Compliance|1|||
126108630|NCT03444324|453691207|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
126108631|NCT03444324|453691208|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
126108632|NCT01390181|453692526|FG000|Overall Study|Lost to Follow-up|1|||
126108633|NCT01390181|453692526|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
126108634|NCT02805725|453692527|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
126108635|NCT02805725|453692528|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
126108636|NCT02805725|453692529|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
126108637|NCT02805725|453692530|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
126108638|NCT02805725|453692531|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
126108639|NCT02805725|453692527|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
126108640|NCT02805725|453692528|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
126108641|NCT02805725|453692529|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
126108642|NCT02805725|453692530|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
126108643|NCT02805725|453692531|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
126108644|NCT02805725|453692527|FG000|Phase II|Protocol Violation|0|||
126108645|NCT02805725|453692528|FG001|Phase II|Protocol Violation|0|||
126108646|NCT02805725|453692529|FG002|Phase II|Protocol Violation|0|||
126108647|NCT02805725|453692530|FG003|Phase II|Protocol Violation|0|||
126108648|NCT02805725|453692531|FG004|Phase II|Protocol Violation|6|||
126108649|NCT01195545|453692532|FG000|Overall Study|Protocol Violation|4|||
126108650|NCT02425644|453692533|FG000|Overall Study|Lost to Follow-up|2|||
126108651|NCT02425644|453692534|FG001|Overall Study|Lost to Follow-up|3|||
126108652|NCT02425644|453692533|FG000|Overall Study|Withdrawal by Subject|41|||
126108653|NCT02425644|453692534|FG001|Overall Study|Withdrawal by Subject|36|||
126108654|NCT02425644|453692533|FG000|Overall Study|Lack of Efficacy|3|||
126108655|NCT02425644|453692534|FG001|Overall Study|Lack of Efficacy|10|||
126108656|NCT02425644|453692533|FG000|Overall Study|Adverse Event|13|||
126108657|NCT02425644|453692534|FG001|Overall Study|Adverse Event|3|||
126108658|NCT02425644|453692533|FG000|Overall Study|Death|0|||
126108659|NCT02425644|453692534|FG001|Overall Study|Death|2|||
126108660|NCT02425644|453692533|FG000|Overall Study|Other|18|||
126108661|NCT02425644|453692534|FG001|Overall Study|Other|17|||
126108662|NCT00909792|453692535|FG000|Period 1|Did not meet inclusion criteria|0|||
126108663|NCT00909792|453692536|FG001|Period 1|Did not meet inclusion criteria|1|||
126108664|NCT00909792|453692535|FG000|Period 2|Biomicroscopy|1|||
126108665|NCT00909792|453692536|FG001|Period 2|Biomicroscopy|0|||
126108666|NCT00909792|453692535|FG000|Period 2|Lost to Follow-up|0|||
126108667|NCT00909792|453692536|FG001|Period 2|Lost to Follow-up|1|||
126108668|NCT00293722|453692539|FG000|Overall Study|Other|427|||
126108669|NCT02824263|453692541|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
126108670|NCT02824263|453692542|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
126108671|NCT02824263|453692541|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
126108672|NCT02824263|453692542|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
126108673|NCT00568321|453692543|FG000|Overall Study|Adverse Event|1|||
126108674|NCT00568321|453692544|FG001|Overall Study|Adverse Event|0|||
126108675|NCT00568321|453692545|FG002|Overall Study|Adverse Event|0|||
126108676|NCT00568321|453692543|FG000|Overall Study|Lack of Efficacy|8|||
126108677|NCT00568321|453692544|FG001|Overall Study|Lack of Efficacy|5|||
126108678|NCT00568321|453692545|FG002|Overall Study|Lack of Efficacy|6|||
126108679|NCT00568321|453692543|FG000|Overall Study|Lost to Follow-up|0|||
126108680|NCT00568321|453692544|FG001|Overall Study|Lost to Follow-up|0|||
126108681|NCT00568321|453692545|FG002|Overall Study|Lost to Follow-up|1|||
126108682|NCT00568321|453692543|FG000|Overall Study|Withdrawal by Subject|2|||
126108683|NCT00568321|453692544|FG001|Overall Study|Withdrawal by Subject|0|||
126108684|NCT00568321|453692545|FG002|Overall Study|Withdrawal by Subject|0|||
126108685|NCT00568321|453692543|FG000|Overall Study|Protocol Violation|0|||
126108686|NCT00568321|453692544|FG001|Overall Study|Protocol Violation|0|||
126108687|NCT00568321|453692545|FG002|Overall Study|Protocol Violation|1|||
126108688|NCT00568321|453692543|FG000|Overall Study|Randomized, not treated|2|||
126108689|NCT00568321|453692544|FG001|Overall Study|Randomized, not treated|0|||
126108690|NCT00568321|453692545|FG002|Overall Study|Randomized, not treated|1|||
126108691|NCT00221195|453692546|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
126108692|NCT00221195|453692547|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
126108693|NCT00221195|453692546|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
126108694|NCT00221195|453692547|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
126108695|NCT00221195|453692546|FG000|Washout Period (Months 7-9)|Death|0|||
126108696|NCT00221195|453692547|FG001|Washout Period (Months 7-9)|Death|1|||
126108697|NCT00221195|453692546|FG000|Therapy 2 (Months 10-15)|Death|1|||
126108698|NCT00221195|453692547|FG001|Therapy 2 (Months 10-15)|Death|0|||
126108699|NCT00221195|453692546|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
126108700|NCT00221195|453692547|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
126108701|NCT01106014|453692551|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
126108702|NCT01106014|453692552|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
126108703|NCT01106014|453692551|FG000|Overall Study|Adverse Event|78|||
126108704|NCT01106014|453692552|FG001|Overall Study|Adverse Event|42|||
126108705|NCT01106014|453692551|FG000|Overall Study|Withdrawal by Subject|43|||
126108706|NCT01106014|453692552|FG001|Overall Study|Withdrawal by Subject|37|||
126108707|NCT01106014|453692551|FG000|Overall Study|Administrative reason|7|||
126108708|NCT01106014|453692552|FG001|Overall Study|Administrative reason|6|||
126108709|NCT01106014|453692551|FG000|Overall Study|Lost to Follow-up|2|||
126108710|NCT01106014|453692552|FG001|Overall Study|Lost to Follow-up|3|||
126108711|NCT00908232|453692553|FG000|Cycle 1 to 4|Death|5|||
126108712|NCT00908232|453692554|FG001|Cycle 1 to 4|Death|0|||
126108713|NCT00908232|453692555|FG002|Cycle 1 to 4|Death|0|||
126108714|NCT00908232|453692556|FG003|Cycle 1 to 4|Death|0|||
126108715|NCT00908232|453692553|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
126108716|NCT00908232|453692554|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
126108717|NCT00908232|453692555|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
126108718|NCT00908232|453692556|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
126108719|NCT00908232|453692553|FG000|Cycle 1 to 4|Progressive Disease|6|||
126108720|NCT00908232|453692554|FG001|Cycle 1 to 4|Progressive Disease|0|||
126108721|NCT00908232|453692555|FG002|Cycle 1 to 4|Progressive Disease|0|||
126108722|NCT00908232|453692556|FG003|Cycle 1 to 4|Progressive Disease|0|||
126108723|NCT00908232|453692553|FG000|Cycle 1 to 4|Adverse Event|12|||
126108724|NCT00908232|453692554|FG001|Cycle 1 to 4|Adverse Event|0|||
126108725|NCT00908232|453692555|FG002|Cycle 1 to 4|Adverse Event|0|||
126108726|NCT00908232|453692556|FG003|Cycle 1 to 4|Adverse Event|0|||
126108727|NCT00908232|453692553|FG000|Cycle 1 to 4|Other|1|||
126108728|NCT00908232|453692554|FG001|Cycle 1 to 4|Other|0|||
126108729|NCT00908232|453692555|FG002|Cycle 1 to 4|Other|0|||
126108730|NCT00908232|453692556|FG003|Cycle 1 to 4|Other|0|||
126108731|NCT00908232|453692553|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
126108732|NCT00908232|453692554|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
126108733|NCT00908232|453692555|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
126108734|NCT00908232|453692556|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
126108735|NCT00908232|453692553|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
126108736|NCT00908232|453692554|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
126108737|NCT00908232|453692555|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
126108738|NCT00908232|453692556|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
126108739|NCT00908232|453692553|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
126108740|NCT00908232|453692554|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
126108741|NCT00908232|453692555|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
126108742|NCT00908232|453692556|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
126108743|NCT00908232|453692553|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
126108744|NCT00908232|453692554|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
126108745|NCT00908232|453692555|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
126108746|NCT00908232|453692556|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
126108747|NCT00908232|453692553|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
126108748|NCT00908232|453692554|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
126108749|NCT00908232|453692555|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
126108750|NCT00908232|453692556|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
126108751|NCT00908232|453692553|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
126108752|NCT00908232|453692554|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
126108753|NCT00908232|453692555|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
126108754|NCT00908232|453692556|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
126108755|NCT00908232|453692553|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
126108756|NCT00908232|453692554|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
126108757|NCT00908232|453692555|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
126108758|NCT00908232|453692556|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
126108759|NCT00908232|453692553|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
126108760|NCT00908232|453692554|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
126108761|NCT00908232|453692555|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
126108762|NCT00908232|453692556|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
126108763|NCT02260882|453692557|FG000|Overall Study|Protocol Violation|0|||
126108764|NCT02260882|453692558|FG001|Overall Study|Protocol Violation|1|||
126108765|NCT00954174|453692559|FG000|Overall Study|Adverse Event|28|||
126108766|NCT00954174|453692560|FG001|Overall Study|Adverse Event|23|||
126108767|NCT00954174|453692561|FG002|Overall Study|Adverse Event|4|||
126108768|NCT00954174|453692562|FG003|Overall Study|Adverse Event|9|||
126108769|NCT00954174|453692559|FG000|Overall Study|Death|4|||
126108770|NCT00954174|453692560|FG001|Overall Study|Death|2|||
126108771|NCT00954174|453692561|FG002|Overall Study|Death|0|||
126108772|NCT00954174|453692562|FG003|Overall Study|Death|0|||
126108773|NCT00954174|453692559|FG000|Overall Study|Lack of Efficacy|32|||
126108774|NCT00954174|453692560|FG001|Overall Study|Lack of Efficacy|22|||
126108775|NCT00954174|453692561|FG002|Overall Study|Lack of Efficacy|8|||
126108776|NCT00954174|453692562|FG003|Overall Study|Lack of Efficacy|6|||
126108777|NCT00954174|453692559|FG000|Overall Study|Withdrawal by Subject|14|||
126108778|NCT00954174|453692560|FG001|Overall Study|Withdrawal by Subject|10|||
126108779|NCT00954174|453692561|FG002|Overall Study|Withdrawal by Subject|4|||
126108780|NCT00954174|453692562|FG003|Overall Study|Withdrawal by Subject|3|||
126108781|NCT00954174|453692559|FG000|Overall Study|Medical Reason|4|||
126108782|NCT00954174|453692560|FG001|Overall Study|Medical Reason|2|||
126108783|NCT00954174|453692561|FG002|Overall Study|Medical Reason|1|||
126108784|NCT00954174|453692562|FG003|Overall Study|Medical Reason|0|||
126108785|NCT00954174|453692559|FG000|Overall Study|Ineligible|40|||
126108786|NCT00954174|453692560|FG001|Overall Study|Ineligible|47|||
126108787|NCT00954174|453692561|FG002|Overall Study|Ineligible|7|||
126108788|NCT00954174|453692562|FG003|Overall Study|Ineligible|4|||
126108789|NCT00954174|453692559|FG000|Overall Study|Never Treated|4|||
126108790|NCT00954174|453692560|FG001|Overall Study|Never Treated|17|||
126108791|NCT00954174|453692561|FG002|Overall Study|Never Treated|0|||
126108792|NCT00954174|453692562|FG003|Overall Study|Never Treated|3|||
126108793|NCT01776424|453692567|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
126108794|NCT01776424|453692568|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
126108795|NCT01776424|453692569|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
126108796|NCT01776424|453692567|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
126108797|NCT01776424|453692568|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
126108798|NCT01776424|453692569|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
126108799|NCT01776424|453692567|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
126108800|NCT01776424|453692568|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
126108801|NCT01776424|453692569|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
126108802|NCT01776424|453692567|FG000|LTOLE Part (Open Label)|Refused|5|||
126108803|NCT01776424|453692568|FG001|LTOLE Part (Open Label)|Refused|2|||
126108804|NCT01776424|453692569|FG002|LTOLE Part (Open Label)|Refused|11|||
126108805|NCT01776424|453692567|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
126108806|NCT01776424|453692568|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
126108807|NCT01776424|453692569|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
126108808|NCT00146757|453692570|FG000|Overall Study|Death|1|||
126108809|NCT00146757|453692571|FG001|Overall Study|Death|0|||
126108810|NCT00146757|453692570|FG000|Overall Study|Adverse Event|1|||
126108811|NCT00146757|453692571|FG001|Overall Study|Adverse Event|0|||
126108812|NCT03037619|453692583|FG000|Overall Study|Lost to Follow-up|0|||
126059147|NCT00326183|453510903|FG001|Overall Study|Subject Moved|4|||
126059148|NCT00326183|453510902|FG000|Overall Study|Other|47|||
126059149|NCT00326183|453510903|FG001|Overall Study|Other|13|||
126059150|NCT00326183|453510902|FG000|Overall Study|Adverse Event|1|||
126059151|NCT00326183|453510903|FG001|Overall Study|Adverse Event|0|||
126059152|NCT01323790|453510906|FG000|Overall Study|Other|3|||
126059153|NCT01323790|453510907|FG001|Overall Study|Other|2|||
126059154|NCT01323790|453510908|FG002|Overall Study|Other|1|||
126059155|NCT01323790|453510906|FG000|Overall Study|Lost to Follow-up|11|||
126059156|NCT01323790|453510907|FG001|Overall Study|Lost to Follow-up|9|||
126059157|NCT01323790|453510908|FG002|Overall Study|Lost to Follow-up|9|||
126059158|NCT01323790|453510906|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
126059159|NCT01323790|453510907|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
126059160|NCT01323790|453510908|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
126059161|NCT01323790|453510906|FG000|Overall Study|Lack of Efficacy|3|||
126059162|NCT01323790|453510907|FG001|Overall Study|Lack of Efficacy|0|||
126059163|NCT01323790|453510908|FG002|Overall Study|Lack of Efficacy|3|||
126059164|NCT01323790|453510906|FG000|Overall Study|Adverse Event|11|||
126059165|NCT01323790|453510907|FG001|Overall Study|Adverse Event|24|||
126059166|NCT01323790|453510908|FG002|Overall Study|Adverse Event|12|||
126059167|NCT01323790|453510906|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126059168|NCT01323790|453510907|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126059169|NCT01323790|453510908|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
126059170|NCT01323790|453510906|FG000|Overall Study|Withdrawal by Subject|23|||
126108813|NCT03037619|453692584|FG001|Overall Study|Lost to Follow-up|1|||
126108814|NCT01498289|453692585|FG000|Overall Study|Adverse Event|16|||
126108815|NCT01498289|453692586|FG001|Overall Study|Adverse Event|18|||
126108816|NCT01498289|453692585|FG000|Overall Study|Death|6|||
126108817|NCT01498289|453692586|FG001|Overall Study|Death|8|||
126108818|NCT01498289|453692585|FG000|Overall Study|Withdrawal unrelated to AE|16|||
126108819|NCT01498289|453692586|FG001|Overall Study|Withdrawal unrelated to AE|16|||
126108820|NCT01498289|453692585|FG000|Overall Study|Progression/relapse|53|||
126108821|NCT01498289|453692586|FG001|Overall Study|Progression/relapse|59|||
126108822|NCT01498289|453692585|FG000|Overall Study|Not protocol specified|7|||
126108823|NCT01498289|453692586|FG001|Overall Study|Not protocol specified|2|||
126108824|NCT01498289|453692585|FG000|Overall Study|Reason under review|0|||
126108825|NCT01498289|453692586|FG001|Overall Study|Reason under review|1|||
126108826|NCT03294109|453692587|FG000|Overall Study|Withdrawal by Subject|6|||
126108827|NCT03294109|453692588|FG001|Overall Study|Withdrawal by Subject|5|||
126108828|NCT01794923|453692593|FG000|Overall Study|Adverse Event|0|||
126108829|NCT01794923|453692594|FG001|Overall Study|Adverse Event|0|||
126108830|NCT01794923|453692595|FG002|Overall Study|Adverse Event|1|||
126059171|NCT01323790|453510907|FG001|Overall Study|Withdrawal by Subject|20|||
126059172|NCT01323790|453510908|FG002|Overall Study|Withdrawal by Subject|13|||
126059173|NCT01323790|453510906|FG000|Overall Study|Did Not Receive Treatment|2|||
126059174|NCT01323790|453510907|FG001|Overall Study|Did Not Receive Treatment|0|||
126059175|NCT01323790|453510908|FG002|Overall Study|Did Not Receive Treatment|1|||
126059176|NCT01323790|453510906|FG000|Overall Study|Severe non-compliance with protocol|2|||
126059177|NCT01323790|453510907|FG001|Overall Study|Severe non-compliance with protocol|2|||
126059178|NCT01323790|453510908|FG002|Overall Study|Severe non-compliance with protocol|2|||
126059179|NCT01263496|453510909|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
126059180|NCT01263496|453510910|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126059181|NCT01263496|453510911|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126059182|NCT01263496|453510912|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126059183|NCT01263496|453510913|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126059184|NCT01263496|453510914|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126059185|NCT01263496|453510915|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126059186|NCT01263496|453510916|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126059187|NCT01263496|453510917|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126059188|NCT01263496|453510909|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126059189|NCT01263496|453510910|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126059190|NCT01263496|453510911|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126059191|NCT01263496|453510912|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
126059192|NCT01263496|453510913|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
126059193|NCT01263496|453510914|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126059194|NCT01263496|453510915|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126059195|NCT01263496|453510916|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126059196|NCT01263496|453510917|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126059197|NCT01263496|453510909|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
126059198|NCT01263496|453510910|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
126059199|NCT01263496|453510911|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
126059200|NCT01263496|453510912|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
126108831|NCT04744285|453692598|FG000|Overall Study|Withdrawal by Subject|1|||
126108832|NCT04744285|453692599|FG001|Overall Study|Withdrawal by Subject|1|||
126108833|NCT04744285|453692600|FG002|Overall Study|Withdrawal by Subject|2|||
126108834|NCT04744285|453692601|FG003|Overall Study|Withdrawal by Subject|1|||
126108835|NCT01774084|453692602|FG000|Overall Study|Personal reasons|1|||
126108836|NCT01774084|453692603|FG001|Overall Study|Personal reasons|0|||
126108837|NCT00821431|453692604|FG000|Overall Study|Adverse Event|6|||
126108838|NCT00821431|453692605|FG001|Overall Study|Adverse Event|3|||
126108839|NCT00821431|453692604|FG000|Overall Study|Withdrawal by Subject|5|||
126108840|NCT00821431|453692605|FG001|Overall Study|Withdrawal by Subject|0|||
126108841|NCT00821431|453692604|FG000|Overall Study|Lost to Follow-up|1|||
126108842|NCT00821431|453692605|FG001|Overall Study|Lost to Follow-up|0|||
126108843|NCT00821431|453692604|FG000|Overall Study|Protocol Violation|3|||
126108844|NCT00821431|453692605|FG001|Overall Study|Protocol Violation|1|||
126108845|NCT00821431|453692604|FG000|Overall Study|Physician Decision|0|||
126108846|NCT00821431|453692605|FG001|Overall Study|Physician Decision|1|||
125893496|NCT00265148|452909959|FG001|Overall Study|Withdrawal by Subject|1|||
125893497|NCT00265148|452909958|FG000|Overall Study|Physician Decision|1|||
125893498|NCT00265148|452909959|FG001|Overall Study|Physician Decision|0|||
125893499|NCT00265148|452909958|FG000|Overall Study|Increasing frailty|0|||
126108847|NCT02030405|453692613|FG000|Overall Study|Withdrawal by Subject|1|||
126108848|NCT02030405|453692613|FG000|Overall Study|Lost to Follow-up|1|||
126108849|NCT00986440|453692614|FG000|Overall Study|Progressive disease|27|||
126108850|NCT00986440|453692615|FG001|Overall Study|Progressive disease|37|||
126108851|NCT00986440|453692614|FG000|Overall Study|Serious adverse event or adverse event|9|||
126108852|NCT00986440|453692615|FG001|Overall Study|Serious adverse event or adverse event|2|||
126108853|NCT00986440|453692614|FG000|Overall Study|Withdrawal by Subject|1|||
126108854|NCT00986440|453692615|FG001|Overall Study|Withdrawal by Subject|2|||
126108855|NCT00986440|453692614|FG000|Overall Study|Screen failure (not dosed)|4|||
126108856|NCT00986440|453692615|FG001|Overall Study|Screen failure (not dosed)|2|||
126108857|NCT00803270|453692616|FG000|Overall Study|Lost to Follow-up|1|||
126108858|NCT00803270|453692617|FG001|Overall Study|Lost to Follow-up|2|||
126108859|NCT02973048|453692618|FG000|Overall Study|Epidural catheter insertion failure|1|||
126108860|NCT02973048|453692619|FG001|Overall Study|Epidural catheter insertion failure|0|||
126108861|NCT02973048|453692618|FG000|Overall Study|Withdrawal by Subject|0|||
126108862|NCT02973048|453692619|FG001|Overall Study|Withdrawal by Subject|3|||
126108863|NCT03707925|453692624|FG000|Overall Study|Inevaluable|1|||
126108864|NCT03431857|453692626|FG000|Overall Study|Death|6|||
126108865|NCT03431857|453692626|FG000|Overall Study|Lost to Follow-up|41|||
126108866|NCT03431857|453692626|FG000|Overall Study|Adverse Event|6|||
126108867|NCT03431857|453692626|FG000|Overall Study|Withdrawal by Subject|1|||
126108868|NCT01323621|453692627|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
126108869|NCT01323621|453692628|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
126108870|NCT01323621|453692629|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
126108871|NCT01323621|453692627|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
126108872|NCT01323621|453692628|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
126108873|NCT01323621|453692629|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
126108874|NCT01323621|453692627|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
126108875|NCT01323621|453692628|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
126108876|NCT01323621|453692629|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
126108877|NCT01323621|453692627|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
126108878|NCT01323621|453692628|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
126108879|NCT01323621|453692629|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
126108880|NCT01323621|453692627|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
126108881|NCT01323621|453692628|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
126108882|NCT01323621|453692629|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
126108883|NCT01323621|453692627|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
126108884|NCT01323621|453692628|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
126108885|NCT01323621|453692629|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
126108886|NCT01323621|453692627|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
126108887|NCT01323621|453692628|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
126108888|NCT01323621|453692629|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
126108889|NCT01323621|453692627|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
126108890|NCT01323621|453692628|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
126108891|NCT01323621|453692629|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
126108892|NCT01323621|453692627|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
126108893|NCT01323621|453692628|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
126108894|NCT01323621|453692629|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
126108895|NCT01323621|453692627|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126108896|NCT01323621|453692628|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126108897|NCT01323621|453692629|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126108898|NCT01323621|453692627|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
126108899|NCT01323621|453692628|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
126108900|NCT01323621|453692629|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
126108901|NCT01323621|453692627|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126108902|NCT01323621|453692628|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
126108903|NCT01323621|453692629|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
126108904|NCT00651157|453692631|FG000|Overall Study|Death|1|||
126108905|NCT00651157|453692631|FG000|Overall Study|Protocol Violation|1|||
126108906|NCT00364156|453692635|FG000|Overall Study|Withdrawal by Subject|73|||
126108907|NCT00364156|453692636|FG001|Overall Study|Withdrawal by Subject|80|||
126108908|NCT00364156|453692635|FG000|Overall Study|Protocol Violation|6|||
126108909|NCT00364156|453692636|FG001|Overall Study|Protocol Violation|1|||
126108910|NCT01472380|453692637|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
126108911|NCT01472380|453692637|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
126108912|NCT00292461|453692638|FG000|Overall Study|Adverse Event|4|||
126108913|NCT00292461|453692639|FG001|Overall Study|Adverse Event|2|||
126108914|NCT00292461|453692638|FG000|Overall Study|Lack of Efficacy|1|||
126108915|NCT00292461|453692639|FG001|Overall Study|Lack of Efficacy|0|||
126108916|NCT00292461|453692638|FG000|Overall Study|Withdrawal by Subject|0|||
126108917|NCT00292461|453692639|FG001|Overall Study|Withdrawal by Subject|1|||
126108918|NCT00292461|453692638|FG000|Overall Study|Protocol Violation|4|||
126059201|NCT01263496|453510913|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
126059202|NCT01263496|453510914|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
126059203|NCT01263496|453510915|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
126059204|NCT01263496|453510916|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
126059205|NCT01263496|453510917|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
126059206|NCT01263496|453510909|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126059207|NCT01263496|453510910|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
126059208|NCT01263496|453510911|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126059209|NCT01263496|453510912|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126059210|NCT01263496|453510913|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126059211|NCT01263496|453510914|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126059212|NCT01263496|453510915|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126059213|NCT01263496|453510916|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126059214|NCT01263496|453510917|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126059215|NCT01263496|453510909|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126059216|NCT01263496|453510910|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126059217|NCT01263496|453510911|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126059218|NCT01263496|453510912|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126059219|NCT01263496|453510913|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
126059220|NCT01263496|453510914|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126059221|NCT01263496|453510915|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126059222|NCT01263496|453510916|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126059223|NCT01263496|453510917|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126059224|NCT01263496|453510909|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
126059225|NCT01263496|453510910|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
126059226|NCT01263496|453510911|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
126059227|NCT01263496|453510912|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126059228|NCT01263496|453510913|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
126059229|NCT01263496|453510914|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126059230|NCT01263496|453510915|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126059231|NCT01263496|453510916|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126059232|NCT01263496|453510917|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126059233|NCT01263496|453510909|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126059234|NCT01263496|453510910|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126059235|NCT01263496|453510911|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126059236|NCT01263496|453510912|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126059237|NCT01263496|453510913|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126059238|NCT01263496|453510914|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126059239|NCT01263496|453510915|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126059240|NCT01263496|453510916|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
126059241|NCT01263496|453510917|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126059242|NCT02203032|453510918|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
126059243|NCT02203032|453510919|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
126059244|NCT02203032|453510920|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
126059245|NCT02203032|453510921|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
126059246|NCT02203032|453510918|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
126059247|NCT02203032|453510919|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
126059248|NCT02203032|453510920|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
126059249|NCT02203032|453510921|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
126059250|NCT02203032|453510918|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
126059251|NCT02203032|453510919|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
126059252|NCT02203032|453510920|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
126059253|NCT02203032|453510921|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
126059254|NCT02203032|453510918|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
126059255|NCT02203032|453510919|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
126059256|NCT02203032|453510920|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
126059257|NCT02203032|453510921|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
126059258|NCT02203032|453510918|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
126059259|NCT02203032|453510919|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
126059260|NCT02203032|453510920|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
126059261|NCT02203032|453510921|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
126059262|NCT02203032|453510918|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
126059263|NCT02203032|453510919|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
126059264|NCT02203032|453510920|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
125893500|NCT00265148|452909959|FG001|Overall Study|Increasing frailty|1|||
125893501|NCT00265148|452909958|FG000|Overall Study|Subject chose to change of the dose|1|||
125893502|NCT00265148|452909959|FG001|Overall Study|Subject chose to change of the dose|0|||
125893503|NCT00942994|452909964|FG000|Overall Study|Adverse Event|7|||
125893504|NCT00942994|452909965|FG001|Overall Study|Adverse Event|4|||
125893505|NCT00942994|452909964|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125893506|NCT00942994|452909965|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125893507|NCT00942994|452909964|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125893508|NCT00942994|452909965|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125893509|NCT00942994|452909964|FG000|Overall Study|Patient withdrew consent|5|||
125893510|NCT00942994|452909965|FG001|Overall Study|Patient withdrew consent|8|||
125893511|NCT00942994|452909964|FG000|Overall Study|Lost to Follow-up|1|||
125893512|NCT00942994|452909965|FG001|Overall Study|Lost to Follow-up|4|||
125893513|NCT00942994|452909964|FG000|Overall Study|Protocol deviation|1|||
125893514|NCT00942994|452909965|FG001|Overall Study|Protocol deviation|2|||
125893515|NCT01874340|452909968|FG000|Overall Study|Study terminated by Sponsor|6|||
125893516|NCT01874340|452909969|FG001|Overall Study|Study terminated by Sponsor|8|||
125893517|NCT01874340|452909970|FG002|Overall Study|Study terminated by Sponsor|8|||
125893518|NCT01874340|452909971|FG003|Overall Study|Study terminated by Sponsor|4|||
125893519|NCT01874340|452909968|FG000|Overall Study|Withdrawal by Subject|0|||
125893520|NCT01874340|452909969|FG001|Overall Study|Withdrawal by Subject|0|||
125893521|NCT01874340|452909970|FG002|Overall Study|Withdrawal by Subject|0|||
125893522|NCT01874340|452909971|FG003|Overall Study|Withdrawal by Subject|1|||
125893523|NCT01311024|452909979|FG000|Overall Study|Protocol Violation|35|||
125893524|NCT01311024|452909980|FG001|Overall Study|Protocol Violation|22|||
125893525|NCT01523275|452909981|FG000|Overall Study|Lost to Follow-up|1|||
125893526|NCT01523275|452909982|FG001|Overall Study|Lost to Follow-up|2|||
125893527|NCT01523275|452909981|FG000|Overall Study|Withdrawal by Subject|1|||
125893528|NCT01523275|452909982|FG001|Overall Study|Withdrawal by Subject|0|||
125893529|NCT00689117|452909985|FG000|Overall Study|Adverse Event|6|||
126108919|NCT00292461|453692639|FG001|Overall Study|Protocol Violation|3|||
126108920|NCT00292461|453692638|FG000|Overall Study|Lost to Follow-up|1|||
125893530|NCT00689117|452909986|FG001|Overall Study|Adverse Event|0|||
126059265|NCT02203032|453510921|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
126059266|NCT02203032|453510918|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
126059267|NCT02203032|453510919|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
126059268|NCT02203032|453510920|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
126059269|NCT02203032|453510921|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
126059270|NCT02203032|453510918|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
126059271|NCT02203032|453510919|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
126059272|NCT02203032|453510920|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
126059273|NCT02203032|453510921|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
126059274|NCT02203032|453510918|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
126059275|NCT02203032|453510919|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
126059276|NCT02203032|453510920|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
126059277|NCT02203032|453510921|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
126059278|NCT02203032|453510918|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
126059279|NCT02203032|453510919|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
126059280|NCT02203032|453510920|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
126059281|NCT02203032|453510921|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
126059282|NCT02203032|453510918|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
126059283|NCT02203032|453510919|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
126059284|NCT02203032|453510920|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
126059285|NCT02203032|453510921|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
126059286|NCT02203032|453510918|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
126059287|NCT02203032|453510919|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
126059288|NCT02203032|453510920|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
126059289|NCT02203032|453510921|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
126059290|NCT02432274|453510922|FG000|Overall Study|Death|2|||
126059291|NCT02432274|453510923|FG001|Overall Study|Death|6|||
126059292|NCT02432274|453510924|FG002|Overall Study|Death|7|||
126059293|NCT02432274|453510925|FG003|Overall Study|Death|0|||
126059294|NCT02432274|453510926|FG004|Overall Study|Death|27|||
126059295|NCT02432274|453510927|FG005|Overall Study|Death|7|||
126059296|NCT02432274|453510928|FG006|Overall Study|Death|9|||
126059297|NCT02432274|453510929|FG007|Overall Study|Death|14|||
126059298|NCT02432274|453510922|FG000|Overall Study|Withdrawal of Consent|0|||
126059299|NCT02432274|453510923|FG001|Overall Study|Withdrawal of Consent|0|||
126059300|NCT02432274|453510924|FG002|Overall Study|Withdrawal of Consent|0|||
126059301|NCT02432274|453510925|FG003|Overall Study|Withdrawal of Consent|0|||
126059302|NCT02432274|453510926|FG004|Overall Study|Withdrawal of Consent|2|||
126059303|NCT02432274|453510927|FG005|Overall Study|Withdrawal of Consent|0|||
126059304|NCT02432274|453510928|FG006|Overall Study|Withdrawal of Consent|1|||
126059305|NCT02432274|453510929|FG007|Overall Study|Withdrawal of Consent|2|||
126059306|NCT00513071|453510932|FG000|Overall Study|Adverse Event|1|||
126059307|NCT00513071|453510932|FG000|Overall Study|Withdrawal by Subject|1|||
126059308|NCT00513071|453510932|FG000|Overall Study|Physician Decision|3|||
126059309|NCT00667732|453510935|FG000|Run -In (8 Weeks)|Adverse Event|4|||
126059310|NCT00667732|453510936|FG001|Run -In (8 Weeks)|Adverse Event|0|||
126059311|NCT00667732|453510937|FG002|Run -In (8 Weeks)|Adverse Event|0|||
126059312|NCT00667732|453510935|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
126059313|NCT00667732|453510936|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
126059314|NCT00667732|453510937|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
126059315|NCT00667732|453510935|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
126059316|NCT00667732|453510936|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
126059317|NCT00667732|453510937|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
126059318|NCT02659540|453510938|FG000|Overall Study|Adverse Event|3|||
126059319|NCT02659540|453510939|FG001|Overall Study|Adverse Event|2|||
126059320|NCT02659540|453510938|FG000|Overall Study|Death|1|||
126059321|NCT02659540|453510939|FG001|Overall Study|Death|0|||
126059322|NCT02659540|453510938|FG000|Overall Study|Progressive disease|2|||
126059323|NCT02659540|453510939|FG001|Overall Study|Progressive disease|6|||
126059324|NCT01240590|453510940|FG000|Phase I|Refused further treatment|0|||
126059325|NCT01240590|453510941|FG001|Phase I|Refused further treatment|0|||
126059326|NCT01240590|453510942|FG002|Phase I|Refused further treatment|3|||
126059327|NCT01240590|453510943|FG003|Phase I|Refused further treatment|0|||
126059328|NCT01240590|453510944|FG004|Phase I|Refused further treatment|0|||
126059329|NCT01240590|453510940|FG000|Phase II|Refused further treatment|0|||
126059330|NCT01240590|453510941|FG001|Phase II|Refused further treatment|0|||
126059331|NCT01240590|453510942|FG002|Phase II|Refused further treatment|0|||
126059332|NCT01240590|453510943|FG003|Phase II|Refused further treatment|2|||
126059333|NCT01240590|453510944|FG004|Phase II|Refused further treatment|1|||
126059334|NCT03890484|453510949|FG000|Overall Study|Lost to Follow-up|1|||
126059335|NCT03890484|453510950|FG001|Overall Study|Lost to Follow-up|1|||
126059336|NCT02106325|453510951|FG000|Phase 1|Lost to Follow-up|2|||
126059337|NCT02106325|453510952|FG001|Phase 1|Lost to Follow-up|2|||
126059338|NCT02106325|453510951|FG000|Phase 2|Lost to Follow-up|2|||
126059339|NCT02106325|453510952|FG001|Phase 2|Lost to Follow-up|3|||
126059340|NCT02106325|453510951|FG000|Phase 3|Lost to Follow-up|2|||
125893531|NCT00689117|452909987|FG002|Overall Study|Adverse Event|5|||
125893532|NCT00689117|452909988|FG003|Overall Study|Adverse Event|0|||
126059341|NCT02106325|453510952|FG001|Phase 3|Lost to Follow-up|1|||
126059342|NCT00824850|453510954|FG000|Overall Study|Withdrawal by Subject|0|||
126059343|NCT00824850|453510955|FG001|Overall Study|Withdrawal by Subject|1|||
126059344|NCT04820491|453510956|FG000|Overall Study|Withdrawal by Subject|1|||
126059345|NCT04820491|453510957|FG001|Overall Study|Withdrawal by Subject|0|||
126059346|NCT05184062|453510958|FG000|Overall Study|Lost to Follow-up|5|||
126059347|NCT05184062|453510959|FG001|Overall Study|Lost to Follow-up|1|||
126059348|NCT05184062|453510958|FG000|Overall Study|Withdrawal by Subject|1|||
126059349|NCT05184062|453510959|FG001|Overall Study|Withdrawal by Subject|0|||
126059350|NCT00535626|453512437|FG000|Overall Study|Death|15|||
126059351|NCT00535626|453512437|FG000|Overall Study|Lost to Follow-up|29|||
126059352|NCT00535626|453512437|FG000|Overall Study|Withdrawal by Subject|20|||
126059353|NCT00535626|453512437|FG000|Overall Study|Removal/revision of study component|8|||
126059354|NCT00535626|453512437|FG000|Overall Study|Subject terminated|31|||
126059355|NCT00535626|453512437|FG000|Overall Study|Unable to return|2|||
126059356|NCT02830893|453512438|FG000|Overall Study|Relocation to out of the country|1|||
126059357|NCT02830893|453512439|FG001|Overall Study|Relocation to out of the country|0|||
126059358|NCT02830893|453512438|FG000|Overall Study|Lost to Follow-up|0|||
126059359|NCT02830893|453512439|FG001|Overall Study|Lost to Follow-up|2|||
126059360|NCT02830893|453512438|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
126059361|NCT02830893|453512439|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
126059362|NCT01277302|453512440|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
126059363|NCT01277302|453512441|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
126059364|NCT01277302|453512442|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
126059365|NCT01277302|453512440|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
126059366|NCT01277302|453512441|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
126059367|NCT01277302|453512442|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
126059368|NCT01277302|453512440|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
126059369|NCT01277302|453512441|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
126059370|NCT01277302|453512442|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
126059371|NCT01277302|453512440|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
126059372|NCT01277302|453512441|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
126059373|NCT01277302|453512442|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
125893533|NCT00689117|452909985|FG000|Overall Study|Lost to Follow-up|26|||
126059374|NCT01277302|453512440|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
126059375|NCT01277302|453512441|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
126059376|NCT01277302|453512442|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
126059377|NCT01277302|453512440|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
126059378|NCT01277302|453512441|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
126059379|NCT01277302|453512442|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
126059380|NCT01277302|453512440|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
126059381|NCT01277302|453512441|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
126059382|NCT01277302|453512442|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
126059383|NCT01277302|453512440|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
126059384|NCT01277302|453512441|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
126059385|NCT01277302|453512442|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
126059386|NCT01277302|453512440|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
126059387|NCT01277302|453512441|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
126059388|NCT01277302|453512442|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
126059389|NCT02710669|453512443|FG000|Overall Study|Physician Decision|2|||
126108921|NCT00292461|453692639|FG001|Overall Study|Lost to Follow-up|0|||
126108922|NCT01891721|453692643|FG000|Overall Study|Lost to Follow-up|10|||
126108923|NCT01891721|453692644|FG001|Overall Study|Lost to Follow-up|5|||
126108924|NCT01891721|453692645|FG002|Overall Study|Lost to Follow-up|1|||
126108925|NCT04908189|453692668|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
126108926|NCT04908189|453692669|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
126108927|NCT04908189|453692670|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
126108928|NCT04908189|453692668|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
126108929|NCT04908189|453692669|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
126108930|NCT04908189|453692670|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
126108931|NCT04908189|453692668|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
126108932|NCT04908189|453692669|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
126108933|NCT04908189|453692670|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
126108934|NCT04908189|453692668|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
126108935|NCT04908189|453692669|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
126108936|NCT04908189|453692670|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
126108937|NCT04908189|453692668|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
126108938|NCT04908189|453692669|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
126108939|NCT04908189|453692670|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
126108940|NCT04908189|453692668|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
126108941|NCT04908189|453692669|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
126108942|NCT04908189|453692670|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
126108943|NCT04908189|453692668|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
126108944|NCT04908189|453692669|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
126108945|NCT04908189|453692670|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
126108946|NCT04908189|453692668|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
126108947|NCT04908189|453692669|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
126108948|NCT04908189|453692670|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
126108949|NCT04908189|453692668|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
126108950|NCT04908189|453692669|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
126108951|NCT04908189|453692670|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
126108952|NCT04908189|453692668|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
126108953|NCT04908189|453692669|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
126108954|NCT04908189|453692670|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
126108955|NCT04908189|453692668|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
126108956|NCT04908189|453692669|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
126108957|NCT04908189|453692670|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
126108958|NCT04908189|453692668|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
126108959|NCT04908189|453692669|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
126108960|NCT04908189|453692670|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
126108961|NCT04683731|453692671|FG000|Overall Study|Withdrawal by Subject|1|||
126108962|NCT04683731|453692672|FG001|Overall Study|Withdrawal by Subject|0|||
126108963|NCT04683731|453692673|FG002|Overall Study|Withdrawal by Subject|3|||
126108964|NCT04683731|453692674|FG003|Overall Study|Withdrawal by Subject|2|||
126108965|NCT04683731|453692671|FG000|Overall Study|Determined patient was not eligible|3|||
126108966|NCT04683731|453692672|FG001|Overall Study|Determined patient was not eligible|3|||
126108967|NCT04683731|453692673|FG002|Overall Study|Determined patient was not eligible|12|||
126108968|NCT04683731|453692674|FG003|Overall Study|Determined patient was not eligible|3|||
126108969|NCT01210118|453692677|FG000|Overall Study|Lost to Follow-up|1|||
126108970|NCT01210118|453692678|FG001|Overall Study|Lost to Follow-up|1|||
126108971|NCT01210118|453692677|FG000|Overall Study|Protocol Violation|1|||
126108972|NCT01210118|453692678|FG001|Overall Study|Protocol Violation|1|||
126108973|NCT01210118|453692677|FG000|Overall Study|Spontaneous abortion|1|||
126108974|NCT01210118|453692678|FG001|Overall Study|Spontaneous abortion|3|||
126108975|NCT02958267|453692679|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
125893534|NCT00689117|452909986|FG001|Overall Study|Lost to Follow-up|19|||
125893535|NCT00689117|452909987|FG002|Overall Study|Lost to Follow-up|17|||
125893536|NCT00689117|452909988|FG003|Overall Study|Lost to Follow-up|11|||
125893537|NCT00689117|452909985|FG000|Overall Study|Lack of Efficacy|1|||
125893538|NCT00689117|452909986|FG001|Overall Study|Lack of Efficacy|2|||
125893539|NCT00689117|452909987|FG002|Overall Study|Lack of Efficacy|2|||
125893540|NCT00689117|452909988|FG003|Overall Study|Lack of Efficacy|2|||
125893541|NCT00689117|452909985|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
125893542|NCT00689117|452909986|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
126108976|NCT02958267|453692680|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
126108977|NCT02958267|453692679|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
125893543|NCT00689117|452909987|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
125893544|NCT00689117|452909988|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
125893545|NCT00689117|452909985|FG000|Overall Study|Withdrawal by Subject|19|||
125893546|NCT00689117|452909986|FG001|Overall Study|Withdrawal by Subject|18|||
125893547|NCT00689117|452909987|FG002|Overall Study|Withdrawal by Subject|26|||
125893548|NCT00689117|452909988|FG003|Overall Study|Withdrawal by Subject|13|||
125893549|NCT00689117|452909985|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
125893550|NCT00689117|452909986|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
125893551|NCT00689117|452909987|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
125893552|NCT00689117|452909988|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
125893553|NCT00689117|452909985|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125893554|NCT00689117|452909986|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
125893555|NCT00689117|452909987|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125893556|NCT00689117|452909988|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125893557|NCT00689117|452909985|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
125893558|NCT00689117|452909986|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
125893559|NCT00689117|452909987|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
125893560|NCT00689117|452909988|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
125893561|NCT00689117|452909985|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
125893562|NCT00689117|452909986|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
125893563|NCT00689117|452909987|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
125893564|NCT00689117|452909988|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
125893565|NCT00689117|452909985|FG000|Overall Study|Use of Prohibitive Medication|2|||
125893566|NCT00689117|452909986|FG001|Overall Study|Use of Prohibitive Medication|1|||
125893567|NCT00689117|452909987|FG002|Overall Study|Use of Prohibitive Medication|3|||
125893568|NCT00689117|452909988|FG003|Overall Study|Use of Prohibitive Medication|0|||
125893569|NCT00689117|452909985|FG000|Overall Study|Pregnancy|0|||
125893570|NCT00689117|452909986|FG001|Overall Study|Pregnancy|2|||
125893571|NCT00689117|452909987|FG002|Overall Study|Pregnancy|0|||
125893572|NCT00689117|452909988|FG003|Overall Study|Pregnancy|2|||
125893573|NCT00689117|452909985|FG000|Overall Study|Incarceration|2|||
125893574|NCT00689117|452909986|FG001|Overall Study|Incarceration|0|||
125893575|NCT00689117|452909987|FG002|Overall Study|Incarceration|0|||
125893576|NCT00689117|452909988|FG003|Overall Study|Incarceration|0|||
125893577|NCT00689117|452909985|FG000|Overall Study|Fear of Birth Defects|0|||
125893578|NCT00689117|452909986|FG001|Overall Study|Fear of Birth Defects|0|||
125893579|NCT00689117|452909987|FG002|Overall Study|Fear of Birth Defects|1|||
125893580|NCT00689117|452909988|FG003|Overall Study|Fear of Birth Defects|0|||
125893581|NCT00689117|452909985|FG000|Overall Study|Transportation|1|||
125893582|NCT00689117|452909986|FG001|Overall Study|Transportation|0|||
125893583|NCT00689117|452909987|FG002|Overall Study|Transportation|0|||
125893584|NCT00689117|452909988|FG003|Overall Study|Transportation|0|||
125893585|NCT00689117|452909985|FG000|Overall Study|Patient Withdrew from Study|0|||
125893586|NCT00689117|452909986|FG001|Overall Study|Patient Withdrew from Study|0|||
125893587|NCT00689117|452909987|FG002|Overall Study|Patient Withdrew from Study|0|||
125893588|NCT00689117|452909988|FG003|Overall Study|Patient Withdrew from Study|1|||
125893589|NCT00689117|452909985|FG000|Overall Study|Personal Reason|0|||
125893590|NCT00689117|452909986|FG001|Overall Study|Personal Reason|1|||
125893591|NCT00689117|452909987|FG002|Overall Study|Personal Reason|0|||
125893592|NCT00689117|452909988|FG003|Overall Study|Personal Reason|0|||
125893593|NCT00689117|452909985|FG000|Overall Study|Dispensing Error|0|||
125893594|NCT00689117|452909986|FG001|Overall Study|Dispensing Error|1|||
125893595|NCT00689117|452909987|FG002|Overall Study|Dispensing Error|0|||
125893596|NCT00689117|452909988|FG003|Overall Study|Dispensing Error|0|||
125893597|NCT01206322|452909989|FG000|Overall Study|Adverse Event|0|||
125893598|NCT01206322|452909990|FG001|Overall Study|Adverse Event|0|||
125893599|NCT01206322|452909991|FG002|Overall Study|Adverse Event|0|||
125893600|NCT01206322|452909992|FG003|Overall Study|Adverse Event|1|||
125893601|NCT01086358|452909995|FG000|First Intervention|Lost to Follow-up|9|||
125893602|NCT01086358|452909996|FG001|First Intervention|Lost to Follow-up|4|||
125893603|NCT01086358|452909995|FG000|First Intervention|Withdrawal by Subject|0|||
125893604|NCT01086358|452909996|FG001|First Intervention|Withdrawal by Subject|1|||
125893605|NCT01086358|452909995|FG000|Second Intervention|Lost to Follow-up|4|||
125893606|NCT01086358|452909996|FG001|Second Intervention|Lost to Follow-up|4|||
125893607|NCT02471612|452909999|FG000|Overall Study|Lost to Follow-up|2|||
125893608|NCT03206788|452910000|FG000|Overall Study|Withdrawal by Subject|0|||
125893609|NCT03206788|452910001|FG001|Overall Study|Withdrawal by Subject|1|||
125893610|NCT03206788|452910000|FG000|Overall Study|Adverse Event|0|||
125893611|NCT03206788|452910001|FG001|Overall Study|Adverse Event|1|||
125893612|NCT03206788|452910000|FG000|Overall Study|Physician Decision|0|||
125893613|NCT03206788|452910001|FG001|Overall Study|Physician Decision|1|||
125893614|NCT03899805|452910002|FG000|Overall Study|Physician Decision|3|||
126059390|NCT02710669|453512444|FG001|Overall Study|Physician Decision|1|||
125893615|NCT03899805|452910003|FG001|Overall Study|Physician Decision|0|||
125893616|NCT03899805|452910004|FG002|Overall Study|Physician Decision|2|||
126059391|NCT02710669|453512445|FG002|Overall Study|Physician Decision|0|||
125893617|NCT03899805|452910002|FG000|Overall Study|Withdrawal by Subject|1|||
125893618|NCT03899805|452910003|FG001|Overall Study|Withdrawal by Subject|0|||
125893619|NCT03899805|452910004|FG002|Overall Study|Withdrawal by Subject|2|||
125893620|NCT03899805|452910002|FG000|Overall Study|Progressive Disease|10|||
125893621|NCT03899805|452910003|FG001|Overall Study|Progressive Disease|18|||
125893622|NCT03899805|452910004|FG002|Overall Study|Progressive Disease|12|||
125893623|NCT03899805|452910002|FG000|Overall Study|Adverse Event|3|||
125893624|NCT03899805|452910003|FG001|Overall Study|Adverse Event|1|||
125893625|NCT03899805|452910004|FG002|Overall Study|Adverse Event|0|||
125893626|NCT03899805|452910002|FG000|Overall Study|Death|2|||
125893627|NCT03899805|452910003|FG001|Overall Study|Death|0|||
125893628|NCT03899805|452910004|FG002|Overall Study|Death|0|||
125893629|NCT03899805|452910002|FG000|Overall Study|Came off for surgery|0|||
125893630|NCT03899805|452910003|FG001|Overall Study|Came off for surgery|0|||
125893631|NCT03899805|452910004|FG002|Overall Study|Came off for surgery|1|||
125893632|NCT03317405|452910005|FG000|Overall Study|Withdrawal by Subject|1|||
125893633|NCT03317405|452910006|FG001|Overall Study|Withdrawal by Subject|0|||
125893634|NCT03317405|452910007|FG002|Overall Study|Withdrawal by Subject|0|||
125893635|NCT03317405|452910005|FG000|Overall Study|Physician Decision|0|||
125893636|NCT03317405|452910006|FG001|Overall Study|Physician Decision|0|||
125893637|NCT03317405|452910007|FG002|Overall Study|Physician Decision|1|||
125893638|NCT03317405|452910005|FG000|Overall Study|Surgery Rescheduled|0|||
125893639|NCT03317405|452910006|FG001|Overall Study|Surgery Rescheduled|1|||
125893640|NCT03317405|452910007|FG002|Overall Study|Surgery Rescheduled|0|||
125893641|NCT01018810|452910010|FG000|Overall Study|Withdrawal by Subject|0|||
125893642|NCT01018810|452910011|FG001|Overall Study|Withdrawal by Subject|1|||
125893643|NCT01018810|452910012|FG002|Overall Study|Withdrawal by Subject|0|||
125893644|NCT01018810|452910013|FG003|Overall Study|Withdrawal by Subject|0|||
125893645|NCT01018810|452910014|FG004|Overall Study|Withdrawal by Subject|0|||
125893646|NCT01018810|452910010|FG000|Overall Study|Sponsor Decision|2|||
125893647|NCT01018810|452910011|FG001|Overall Study|Sponsor Decision|0|||
125893648|NCT01018810|452910012|FG002|Overall Study|Sponsor Decision|1|||
125893649|NCT01018810|452910013|FG003|Overall Study|Sponsor Decision|1|||
125893650|NCT01018810|452910014|FG004|Overall Study|Sponsor Decision|1|||
125893651|NCT01640314|452910015|FG000|Overall Study|Protocol Violation|0|||
125893652|NCT01640314|452910016|FG001|Overall Study|Protocol Violation|1|||
125893653|NCT04450381|452910017|FG000|Overall Study|Protocol Violation|4|||
125893654|NCT04450381|452910017|FG000|Overall Study|Wrong device setting|2|||
125893655|NCT02424578|452910018|FG000|Overall Study|Withdrawal by Subject|0|||
125893656|NCT02424578|452910019|FG001|Overall Study|Withdrawal by Subject|1|||
125893657|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
125893658|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
125893659|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Adverse Event|7|||
125893660|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Adverse Event|6|||
125893661|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
125893662|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
125893663|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Physician Decision|4|||
125893664|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Physician Decision|4|||
125893665|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
125893666|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
125893667|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
125893668|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
125893669|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
125893670|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
125893671|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Non-compliance|1|||
125893672|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Non-compliance|0|||
125893673|NCT00470834|452910022|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
125893674|NCT00470834|452910023|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
125893675|NCT00470834|452910022|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
125893676|NCT00470834|452910023|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
125893677|NCT00470834|452910022|FG000|Extension Period (24 Months)|Adverse Event|3|||
125893678|NCT00470834|452910023|FG001|Extension Period (24 Months)|Adverse Event|4|||
125893679|NCT00470834|452910022|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
125893680|NCT00470834|452910023|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
125893681|NCT00470834|452910022|FG000|Extension Period (24 Months)|Physician Decision|4|||
125893682|NCT00470834|452910023|FG001|Extension Period (24 Months)|Physician Decision|3|||
125893683|NCT00470834|452910022|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
125893684|NCT00470834|452910023|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
125893685|NCT00470834|452910022|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
125893686|NCT00470834|452910023|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
125893687|NCT00470834|452910022|FG000|Extension Period (24 Months)|Non-compliance|0|||
125893688|NCT00470834|452910023|FG001|Extension Period (24 Months)|Non-compliance|1|||
125893689|NCT00470834|452910022|FG000|Extension Period (24 Months)|Disease Progression|0|||
125893690|NCT00470834|452910023|FG001|Extension Period (24 Months)|Disease Progression|1|||
125893691|NCT01989208|452910026|FG000|200 mg (7 Days)|Protocol Violation|0|||
125893692|NCT01989208|452910027|FG001|200 mg (7 Days)|Protocol Violation|1|||
125893693|NCT04973436|452910028|FG000|Overall Study|Lost to Follow-up|3|||
125893694|NCT04973436|452910028|FG000|Overall Study|Withdrawal by Subject|1|||
125893695|NCT04973436|452910028|FG000|Overall Study|Death|2|||
125893696|NCT00566696|452910029|FG000|Overall Study|Met Exclusion Criteria|2|||
125893697|NCT00566696|452910029|FG000|Overall Study|Muromonab not available|1|||
125893698|NCT00566696|452910029|FG000|Overall Study|Health Status Change|1|||
125893699|NCT00566696|452910029|FG000|Overall Study|Physician Decision|1|||
125893700|NCT00566696|452910029|FG000|Overall Study|Non-Patient Donors|37|||
125893701|NCT06338462|452910030|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
125893702|NCT00776919|452910032|FG000|Overall Study|Withdrawal by Subject|16|||
125893703|NCT00776919|452910033|FG001|Overall Study|Withdrawal by Subject|14|||
125893704|NCT00776919|452910034|FG002|Overall Study|Withdrawal by Subject|15|||
125893705|NCT00776919|452910035|FG003|Overall Study|Withdrawal by Subject|26|||
125893706|NCT00776919|452910032|FG000|Overall Study|Lost to Follow-up|8|||
125893707|NCT00776919|452910033|FG001|Overall Study|Lost to Follow-up|12|||
125893708|NCT00776919|452910034|FG002|Overall Study|Lost to Follow-up|11|||
125893709|NCT00776919|452910035|FG003|Overall Study|Lost to Follow-up|8|||
125893710|NCT00776919|452910032|FG000|Overall Study|Adverse Event|1|||
125893711|NCT00776919|452910033|FG001|Overall Study|Adverse Event|0|||
125893712|NCT00776919|452910034|FG002|Overall Study|Adverse Event|2|||
125893713|NCT00776919|452910035|FG003|Overall Study|Adverse Event|2|||
125893714|NCT00776919|452910032|FG000|Overall Study|Protocol Violation|1|||
125893715|NCT00776919|452910033|FG001|Overall Study|Protocol Violation|2|||
125893716|NCT00776919|452910034|FG002|Overall Study|Protocol Violation|0|||
125893717|NCT00776919|452910035|FG003|Overall Study|Protocol Violation|1|||
125893718|NCT00776919|452910032|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
125893719|NCT00776919|452910033|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
125893720|NCT00776919|452910034|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
125893721|NCT00776919|452910035|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
125893722|NCT00635999|452910038|FG000|Overall Study|Withdrawal by Subject|4|||
125893723|NCT00635999|452910039|FG001|Overall Study|Withdrawal by Subject|2|||
125893724|NCT00635999|452910040|FG002|Overall Study|Withdrawal by Subject|1|||
125893725|NCT01808092|452910043|FG000|Overall Study|Death|39|||
125893726|NCT01808092|452910044|FG001|Overall Study|Death|29|||
125893727|NCT01808092|452910043|FG000|Overall Study|Lost to Follow-up|3|||
125893728|NCT01808092|452910044|FG001|Overall Study|Lost to Follow-up|7|||
125893729|NCT01808092|452910043|FG000|Overall Study|Withdrawal by Subject|9|||
125893730|NCT01808092|452910044|FG001|Overall Study|Withdrawal by Subject|4|||
125893731|NCT01808092|452910043|FG000|Overall Study|Other Eligibility criteria|3|||
125893732|NCT01808092|452910044|FG001|Overall Study|Other Eligibility criteria|5|||
125893733|NCT03952039|452910045|FG000|Overall Study|Adverse Event|22|||
125893734|NCT03952039|452910046|FG001|Overall Study|Adverse Event|8|||
125893735|NCT03952039|452910045|FG000|Overall Study|Withdrawal by Participant|17|||
125893736|NCT03952039|452910046|FG001|Overall Study|Withdrawal by Participant|12|||
125893737|NCT03952039|452910045|FG000|Overall Study|Death|13|||
125893738|NCT03952039|452910046|FG001|Overall Study|Death|6|||
125893739|NCT03952039|452910045|FG000|Overall Study|Lack of Efficacy|12|||
125893740|NCT03952039|452910046|FG001|Overall Study|Lack of Efficacy|2|||
125893741|NCT03952039|452910045|FG000|Overall Study|Physician Decision|9|||
125893742|NCT03952039|452910046|FG001|Overall Study|Physician Decision|3|||
125893743|NCT03952039|452910045|FG000|Overall Study|Progressive Disease|6|||
125893744|NCT03952039|452910046|FG001|Overall Study|Progressive Disease|4|||
125893745|NCT03952039|452910045|FG000|Overall Study|Other Reasons|12|||
125893746|NCT03952039|452910046|FG001|Overall Study|Other Reasons|4|||
125893747|NCT04614324|452910056|FG000|Overall Study|Lost to Follow-up|3|||
125893748|NCT04614324|452910056|FG000|Overall Study|Physician Decision|1|||
125893749|NCT04614324|452910056|FG000|Overall Study|Withdrawal by Subject|2|||
125893750|NCT04614324|452910056|FG000|Overall Study|Remaining in Follow up|123|||
125893751|NCT05289037|452910057|FG000|Overall Study|Withdrawal by Subject|7|||
125893752|NCT05289037|452910058|FG001|Overall Study|Withdrawal by Subject|0|||
125893753|NCT05289037|452910059|FG002|Overall Study|Withdrawal by Subject|3|||
125893754|NCT05289037|452910060|FG003|Overall Study|Withdrawal by Subject|3|||
125893755|NCT05289037|452910061|FG004|Overall Study|Withdrawal by Subject|1|||
125893756|NCT05289037|452910062|FG005|Overall Study|Withdrawal by Subject|5|||
126059392|NCT02710669|453512443|FG000|Overall Study|Institutional delays (including COVID)|2|||
125893757|NCT05289037|452910063|FG006|Overall Study|Withdrawal by Subject|2|||
125893758|NCT05289037|452910064|FG007|Overall Study|Withdrawal by Subject|1|||
125893759|NCT05289037|452910065|FG008|Overall Study|Withdrawal by Subject|2|||
125893760|NCT05289037|452910066|FG009|Overall Study|Withdrawal by Subject|2|||
125893761|NCT05289037|452910067|FG010|Overall Study|Withdrawal by Subject|1|||
125893762|NCT05289037|452910068|FG011|Overall Study|Withdrawal by Subject|0|||
125893763|NCT05289037|452910069|FG012|Overall Study|Withdrawal by Subject|1|||
125893764|NCT05289037|452910070|FG013|Overall Study|Withdrawal by Subject|2|||
125893765|NCT05289037|452910071|FG014|Overall Study|Withdrawal by Subject|0|||
125893766|NCT05289037|452910072|FG015|Overall Study|Withdrawal by Subject|3|||
125893767|NCT05289037|452910073|FG016|Overall Study|Withdrawal by Subject|3|||
125893768|NCT05289037|452910057|FG000|Overall Study|Lost to Follow-up|1|||
125893769|NCT05289037|452910058|FG001|Overall Study|Lost to Follow-up|4|||
125893770|NCT05289037|452910059|FG002|Overall Study|Lost to Follow-up|3|||
125893771|NCT05289037|452910060|FG003|Overall Study|Lost to Follow-up|3|||
125893772|NCT05289037|452910061|FG004|Overall Study|Lost to Follow-up|3|||
125893773|NCT05289037|452910062|FG005|Overall Study|Lost to Follow-up|2|||
125893774|NCT05289037|452910063|FG006|Overall Study|Lost to Follow-up|3|||
125893775|NCT05289037|452910064|FG007|Overall Study|Lost to Follow-up|2|||
125893776|NCT05289037|452910065|FG008|Overall Study|Lost to Follow-up|2|||
125893777|NCT05289037|452910066|FG009|Overall Study|Lost to Follow-up|1|||
125893778|NCT05289037|452910067|FG010|Overall Study|Lost to Follow-up|3|||
125893779|NCT05289037|452910068|FG011|Overall Study|Lost to Follow-up|4|||
125893780|NCT05289037|452910069|FG012|Overall Study|Lost to Follow-up|2|||
125893781|NCT05289037|452910070|FG013|Overall Study|Lost to Follow-up|7|||
125893782|NCT05289037|452910071|FG014|Overall Study|Lost to Follow-up|4|||
125893783|NCT05289037|452910072|FG015|Overall Study|Lost to Follow-up|6|||
125893784|NCT05289037|452910073|FG016|Overall Study|Lost to Follow-up|4|||
125893785|NCT05289037|452910057|FG000|Overall Study|Death|0|||
125893786|NCT05289037|452910058|FG001|Overall Study|Death|0|||
125893787|NCT05289037|452910059|FG002|Overall Study|Death|0|||
125893788|NCT05289037|452910060|FG003|Overall Study|Death|0|||
125893789|NCT05289037|452910061|FG004|Overall Study|Death|0|||
125893790|NCT05289037|452910062|FG005|Overall Study|Death|1|||
125893791|NCT05289037|452910063|FG006|Overall Study|Death|0|||
125893792|NCT05289037|452910064|FG007|Overall Study|Death|0|||
125893793|NCT05289037|452910065|FG008|Overall Study|Death|0|||
125893794|NCT05289037|452910066|FG009|Overall Study|Death|0|||
125893795|NCT05289037|452910067|FG010|Overall Study|Death|0|||
125893796|NCT05289037|452910068|FG011|Overall Study|Death|0|||
125893797|NCT05289037|452910069|FG012|Overall Study|Death|0|||
125893798|NCT05289037|452910070|FG013|Overall Study|Death|0|||
125893799|NCT05289037|452910071|FG014|Overall Study|Death|1|||
125893800|NCT05289037|452910072|FG015|Overall Study|Death|0|||
125893801|NCT05289037|452910073|FG016|Overall Study|Death|0|||
125893802|NCT05289037|452910057|FG000|Overall Study|Did not receive vaccine|0|||
125893803|NCT05289037|452910058|FG001|Overall Study|Did not receive vaccine|3|||
125893804|NCT05289037|452910059|FG002|Overall Study|Did not receive vaccine|0|||
125893805|NCT05289037|452910060|FG003|Overall Study|Did not receive vaccine|0|||
125893806|NCT05289037|452910061|FG004|Overall Study|Did not receive vaccine|1|||
125893807|NCT05289037|452910062|FG005|Overall Study|Did not receive vaccine|1|||
125893808|NCT05289037|452910063|FG006|Overall Study|Did not receive vaccine|1|||
125893809|NCT05289037|452910064|FG007|Overall Study|Did not receive vaccine|0|||
125893810|NCT05289037|452910065|FG008|Overall Study|Did not receive vaccine|0|||
125893811|NCT05289037|452910066|FG009|Overall Study|Did not receive vaccine|0|||
125893812|NCT05289037|452910067|FG010|Overall Study|Did not receive vaccine|0|||
125893813|NCT05289037|452910068|FG011|Overall Study|Did not receive vaccine|0|||
125893814|NCT05289037|452910069|FG012|Overall Study|Did not receive vaccine|0|||
125893815|NCT05289037|452910070|FG013|Overall Study|Did not receive vaccine|0|||
125893816|NCT05289037|452910071|FG014|Overall Study|Did not receive vaccine|1|||
125893817|NCT05289037|452910072|FG015|Overall Study|Did not receive vaccine|0|||
125893818|NCT05289037|452910073|FG016|Overall Study|Did not receive vaccine|0|||
125893819|NCT05289037|452910057|FG000|Overall Study|Unable to make last visit|0|||
125893820|NCT05289037|452910058|FG001|Overall Study|Unable to make last visit|0|||
125893821|NCT05289037|452910059|FG002|Overall Study|Unable to make last visit|1|||
125893822|NCT05289037|452910060|FG003|Overall Study|Unable to make last visit|0|||
125893823|NCT05289037|452910061|FG004|Overall Study|Unable to make last visit|0|||
125893824|NCT05289037|452910062|FG005|Overall Study|Unable to make last visit|0|||
125893825|NCT05289037|452910063|FG006|Overall Study|Unable to make last visit|0|||
126059393|NCT02710669|453512444|FG001|Overall Study|Institutional delays (including COVID)|2|||
126059394|NCT02710669|453512445|FG002|Overall Study|Institutional delays (including COVID)|0|||
126059395|NCT02710669|453512443|FG000|Overall Study|arrived in afib/aflutter|10|||
126059396|NCT02710669|453512444|FG001|Overall Study|arrived in afib/aflutter|8|||
126059397|NCT02710669|453512445|FG002|Overall Study|arrived in afib/aflutter|2|||
126059398|NCT00731692|453512446|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
126059399|NCT00731692|453512447|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
125893826|NCT05289037|452910064|FG007|Overall Study|Unable to make last visit|0|||
125893827|NCT05289037|452910065|FG008|Overall Study|Unable to make last visit|0|||
126059400|NCT00731692|453512448|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
125893828|NCT05289037|452910066|FG009|Overall Study|Unable to make last visit|0|||
125893829|NCT05289037|452910067|FG010|Overall Study|Unable to make last visit|0|||
125893830|NCT05289037|452910068|FG011|Overall Study|Unable to make last visit|0|||
125893831|NCT05289037|452910069|FG012|Overall Study|Unable to make last visit|0|||
125893832|NCT05289037|452910070|FG013|Overall Study|Unable to make last visit|0|||
125893833|NCT05289037|452910071|FG014|Overall Study|Unable to make last visit|0|||
125893834|NCT05289037|452910072|FG015|Overall Study|Unable to make last visit|0|||
125893835|NCT05289037|452910073|FG016|Overall Study|Unable to make last visit|0|||
125893836|NCT05289037|452910057|FG000|Overall Study|Protocol deviation|0|||
125893837|NCT05289037|452910058|FG001|Overall Study|Protocol deviation|0|||
125893838|NCT05289037|452910059|FG002|Overall Study|Protocol deviation|0|||
125893839|NCT05289037|452910060|FG003|Overall Study|Protocol deviation|0|||
125893840|NCT05289037|452910061|FG004|Overall Study|Protocol deviation|0|||
125893841|NCT05289037|452910062|FG005|Overall Study|Protocol deviation|0|||
125893842|NCT05289037|452910063|FG006|Overall Study|Protocol deviation|0|||
125893843|NCT05289037|452910064|FG007|Overall Study|Protocol deviation|0|||
125893844|NCT05289037|452910065|FG008|Overall Study|Protocol deviation|0|||
125893845|NCT05289037|452910066|FG009|Overall Study|Protocol deviation|0|||
125893846|NCT05289037|452910067|FG010|Overall Study|Protocol deviation|0|||
125893847|NCT05289037|452910068|FG011|Overall Study|Protocol deviation|0|||
125893848|NCT05289037|452910069|FG012|Overall Study|Protocol deviation|0|||
125893849|NCT05289037|452910070|FG013|Overall Study|Protocol deviation|0|||
125893850|NCT05289037|452910071|FG014|Overall Study|Protocol deviation|0|||
125893851|NCT05289037|452910072|FG015|Overall Study|Protocol deviation|1|||
125893852|NCT05289037|452910073|FG016|Overall Study|Protocol deviation|0|||
125893853|NCT05141448|452910074|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125893854|NCT05141448|452910075|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
125893855|NCT05141448|452910076|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125893856|NCT05141448|452910077|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125893857|NCT05141448|452910078|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125893858|NCT05141448|452910079|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125893859|NCT05141448|452910074|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125893860|NCT05141448|452910075|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125893861|NCT05141448|452910076|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125893862|NCT05141448|452910077|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125893863|NCT05141448|452910078|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
125893864|NCT05141448|452910079|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125893865|NCT05141448|452910074|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125893866|NCT05141448|452910075|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
125893867|NCT05141448|452910076|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125893868|NCT05141448|452910077|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125893869|NCT05141448|452910078|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125893870|NCT05141448|452910079|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125893871|NCT05141448|452910074|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125893872|NCT05141448|452910075|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125893873|NCT05141448|452910076|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125893874|NCT05141448|452910077|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125893875|NCT05141448|452910078|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125893876|NCT05141448|452910079|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
125893877|NCT05141448|452910074|FG000|Period 2|COVID-19 Related|0|||
125893878|NCT05141448|452910075|FG001|Period 2|COVID-19 Related|0|||
125893879|NCT05141448|452910076|FG002|Period 2|COVID-19 Related|0|||
125893880|NCT05141448|452910077|FG003|Period 2|COVID-19 Related|1|||
125893881|NCT05141448|452910078|FG004|Period 2|COVID-19 Related|0|||
125893882|NCT05141448|452910079|FG005|Period 2|COVID-19 Related|1|||
125893883|NCT05141448|452910074|FG000|3|Covid-19 related|2|||
125893884|NCT05141448|452910075|FG001|3|Covid-19 related|0|||
125893885|NCT05141448|452910076|FG002|3|Covid-19 related|0|||
125893886|NCT05141448|452910077|FG003|3|Covid-19 related|0|||
125893887|NCT05141448|452910078|FG004|3|Covid-19 related|0|||
125893888|NCT05141448|452910079|FG005|3|Covid-19 related|1|||
125893889|NCT05141448|452910074|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
125893890|NCT05141448|452910075|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
125893891|NCT05141448|452910076|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
125893892|NCT05141448|452910077|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
125893893|NCT05141448|452910078|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
126108978|NCT02958267|453692680|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
126108979|NCT02958267|453692679|FG000|Follow-up Visits|Additional treatment pursued|2|||
126108980|NCT02958267|453692680|FG001|Follow-up Visits|Additional treatment pursued|1|||
125893894|NCT05141448|452910079|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
125893895|NCT04627285|452910080|FG000|Overall Study|Adverse Event|0|||
125893896|NCT04627285|452910081|FG001|Overall Study|Adverse Event|2|||
125893897|NCT04627285|452910080|FG000|Overall Study|Lost to Follow-up|1|||
125893898|NCT04627285|452910081|FG001|Overall Study|Lost to Follow-up|0|||
125893899|NCT04627285|452910080|FG000|Overall Study|Withdrawal by Subject|1|||
125893900|NCT04627285|452910081|FG001|Overall Study|Withdrawal by Subject|1|||
125893901|NCT04627285|452910080|FG000|Overall Study|Sponsor decision|5|||
125893902|NCT04627285|452910081|FG001|Overall Study|Sponsor decision|0|||
125893903|NCT04627285|452910080|FG000|Overall Study|Participant left country; aunt informed the site|0|||
126108981|NCT01853982|453692681|FG000|Overall Study|Withdrawal by Subject|1|||
126108982|NCT01853982|453692682|FG001|Overall Study|Withdrawal by Subject|0|||
126108983|NCT01853982|453692681|FG000|Overall Study|Death|1|||
126108984|NCT01853982|453692682|FG001|Overall Study|Death|0|||
126108985|NCT01853982|453692681|FG000|Overall Study|Lost to Follow-up|0|||
126108986|NCT01853982|453692682|FG001|Overall Study|Lost to Follow-up|1|||
126108987|NCT01839487|453692683|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
126108988|NCT01839487|453692684|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126108989|NCT01839487|453692685|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126108990|NCT01839487|453692686|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126108991|NCT01839487|453692687|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126108992|NCT01839487|453692688|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126108993|NCT01839487|453692683|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
126108994|NCT01839487|453692684|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
126108995|NCT01839487|453692685|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
126108996|NCT01839487|453692686|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
126108997|NCT01839487|453692687|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
126108998|NCT01839487|453692688|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
126108999|NCT01839487|453692683|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126109000|NCT01839487|453692684|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
126109001|NCT01839487|453692685|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126109002|NCT01839487|453692686|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126109003|NCT01839487|453692687|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126109004|NCT01839487|453692688|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126109005|NCT01839487|453692683|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
126109006|NCT01839487|453692684|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126109007|NCT01839487|453692685|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126109008|NCT01839487|453692686|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126109009|NCT01839487|453692687|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126109010|NCT01839487|453692688|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126109011|NCT01839487|453692683|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
126109012|NCT01839487|453692684|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
126109013|NCT01839487|453692685|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
126109014|NCT01839487|453692686|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
126109015|NCT01839487|453692687|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
126109016|NCT01839487|453692688|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
126109017|NCT01839487|453692683|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
126109018|NCT01839487|453692684|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
126109019|NCT01839487|453692685|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
126109020|NCT01839487|453692686|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
126109021|NCT01839487|453692687|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
126109022|NCT01839487|453692688|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
126109023|NCT01839487|453692683|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
126109024|NCT01839487|453692684|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
126109025|NCT01839487|453692685|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
126109026|NCT01839487|453692686|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
126109027|NCT01839487|453692687|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
126109028|NCT01839487|453692688|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
126109029|NCT01839487|453692683|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
126109030|NCT01839487|453692684|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
126109031|NCT01839487|453692685|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
126109032|NCT01839487|453692686|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
126109033|NCT01839487|453692687|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
126109034|NCT01839487|453692688|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
126109035|NCT01839487|453692683|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
126109036|NCT01839487|453692684|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
126109037|NCT01839487|453692685|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
126109038|NCT01839487|453692686|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
126109039|NCT01839487|453692687|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
126109040|NCT01839487|453692688|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
126109041|NCT05066724|453692689|FG000|Overall Study|Adverse Event|1|||
126109042|NCT05066724|453692689|FG000|Overall Study|Non-Compliance With Study Drug|5|||
126109043|NCT05066724|453692689|FG000|Overall Study|Withdrawal by Subject|6|||
126109044|NCT05066724|453692689|FG000|Overall Study|Physician Decision|2|||
125893904|NCT04627285|452910081|FG001|Overall Study|Participant left country; aunt informed the site|1|||
125893905|NCT03703297|452910082|FG000|Overall Study|Death|115|||
125893906|NCT03703297|452910083|FG001|Overall Study|Death|0|||
125893907|NCT03703297|452910084|FG002|Overall Study|Death|144|||
125893908|NCT03703297|452910082|FG000|Overall Study|Withdrawal by Subject|9|||
125893909|NCT03703297|452910083|FG001|Overall Study|Withdrawal by Subject|0|||
125893910|NCT03703297|452910084|FG002|Overall Study|Withdrawal by Subject|11|||
125893911|NCT03703297|452910082|FG000|Overall Study|Ongoing at the time of DCO|140|||
125893912|NCT03703297|452910083|FG001|Overall Study|Ongoing at the time of DCO|200|||
125893913|NCT03703297|452910084|FG002|Overall Study|Ongoing at the time of DCO|111|||
125893914|NCT01217307|452912309|FG000|Overall Study|Withdrawal by Subject|0|||
125893915|NCT01217307|452912310|FG001|Overall Study|Withdrawal by Subject|1|||
125893916|NCT04473235|452912311|FG000|Overall Study|Lost to Follow-up|6|||
125893917|NCT04473235|452912312|FG001|Overall Study|Lost to Follow-up|5|||
125893918|NCT04473235|452912311|FG000|Overall Study|Declined continuation|2|||
125893919|NCT04473235|452912312|FG001|Overall Study|Declined continuation|0|||
125893920|NCT04473235|452912311|FG000|Overall Study|Physician Decision|1|||
125893921|NCT04473235|452912312|FG001|Overall Study|Physician Decision|1|||
125893922|NCT04473235|452912311|FG000|Overall Study|Protocol Violation|10|||
125893923|NCT04473235|452912312|FG001|Overall Study|Protocol Violation|6|||
125893924|NCT01754402|452912313|FG000|Overall Study|Death|0|||
125893925|NCT01754402|452912314|FG001|Overall Study|Death|0|||
125893926|NCT01754402|452912315|FG002|Overall Study|Death|1|||
125893927|NCT01754402|452912313|FG000|Overall Study|Adverse Event|2|||
125893928|NCT01754402|452912314|FG001|Overall Study|Adverse Event|2|||
125893929|NCT01754402|452912315|FG002|Overall Study|Adverse Event|1|||
125893930|NCT01754402|452912313|FG000|Overall Study|Withdrawal by Subject|0|||
125893931|NCT01754402|452912314|FG001|Overall Study|Withdrawal by Subject|0|||
125893932|NCT01754402|452912315|FG002|Overall Study|Withdrawal by Subject|1|||
125893933|NCT01754402|452912313|FG000|Overall Study|Lack of Efficacy|0|||
125893934|NCT01754402|452912314|FG001|Overall Study|Lack of Efficacy|0|||
125893935|NCT01754402|452912315|FG002|Overall Study|Lack of Efficacy|1|||
125893936|NCT01282463|452912316|FG000|Overall Study|Lost to Follow-up|1|||
125893937|NCT01282463|452912317|FG001|Overall Study|Lost to Follow-up|0|||
125893938|NCT01282463|452912318|FG002|Overall Study|Lost to Follow-up|0|||
125893939|NCT01282463|452912316|FG000|Overall Study|Withdrawal by Subject|6|||
125893940|NCT01282463|452912317|FG001|Overall Study|Withdrawal by Subject|2|||
125893941|NCT01282463|452912318|FG002|Overall Study|Withdrawal by Subject|3|||
125893942|NCT01282463|452912316|FG000|Overall Study|"Never Treated Death"|0|||
125893943|NCT01282463|452912317|FG001|Overall Study|"Never Treated Death"|1|||
125893944|NCT01282463|452912318|FG002|Overall Study|"Never Treated Death"|0|||
125893945|NCT01282463|452912316|FG000|Overall Study|"Never Treated PD"|0|||
125893946|NCT01282463|452912317|FG001|Overall Study|"Never Treated PD"|1|||
125893947|NCT01282463|452912318|FG002|Overall Study|"Never Treated PD"|0|||
125893948|NCT01282463|452912316|FG000|Overall Study|Protocol Violation|0|||
125893949|NCT01282463|452912317|FG001|Overall Study|Protocol Violation|0|||
125893950|NCT01282463|452912318|FG002|Overall Study|Protocol Violation|1|||
125893951|NCT01282463|452912316|FG000|Overall Study|Physician Decision|1|||
125893952|NCT01282463|452912317|FG001|Overall Study|Physician Decision|0|||
125893953|NCT01282463|452912318|FG002|Overall Study|Physician Decision|0|||
125893954|NCT01221285|452912321|FG000|Overall Study|Withdrawal by Subject|1|||
125893955|NCT01239992|452912323|FG000|Overall Study|Withdrawal by Subject|2|||
125893956|NCT02248675|452912326|FG000|Overall Study|Lost to Follow-up|3|||
125893957|NCT02248675|452912327|FG001|Overall Study|Lost to Follow-up|1|||
125893958|NCT00813943|452912334|FG000|Overall Study|Ongoing at cut-off date|5|||
125893959|NCT00813943|452912335|FG001|Overall Study|Ongoing at cut-off date|5|||
125893960|NCT00813943|452912336|FG002|Overall Study|Ongoing at cut-off date|3|||
125893961|NCT02551991|452912337|FG000|Overall Study|Death|5|||
125893962|NCT02551991|452912338|FG001|Overall Study|Death|7|||
125893963|NCT02551991|452912339|FG002|Overall Study|Death|8|||
125893964|NCT02551991|452912340|FG003|Overall Study|Death|7|||
125893965|NCT02551991|452912341|FG004|Overall Study|Death|17|||
125893966|NCT02551991|452912337|FG000|Overall Study|Withdrawal by Subject|1|||
125893967|NCT02551991|452912338|FG001|Overall Study|Withdrawal by Subject|0|||
125893968|NCT02551991|452912339|FG002|Overall Study|Withdrawal by Subject|0|||
125893969|NCT02551991|452912340|FG003|Overall Study|Withdrawal by Subject|0|||
125893970|NCT02551991|452912341|FG004|Overall Study|Withdrawal by Subject|2|||
125893971|NCT02551991|452912337|FG000|Overall Study|Lost to Follow-up|0|||
125893972|NCT02551991|452912338|FG001|Overall Study|Lost to Follow-up|0|||
125893973|NCT02551991|452912339|FG002|Overall Study|Lost to Follow-up|1|||
125893974|NCT02551991|452912340|FG003|Overall Study|Lost to Follow-up|0|||
125893975|NCT02551991|452912341|FG004|Overall Study|Lost to Follow-up|0|||
125893976|NCT02551991|452912337|FG000|Overall Study|Sponsor Decision|1|||
125893977|NCT02551991|452912338|FG001|Overall Study|Sponsor Decision|0|||
125893978|NCT02551991|452912339|FG002|Overall Study|Sponsor Decision|1|||
125893979|NCT02551991|452912340|FG003|Overall Study|Sponsor Decision|0|||
125893980|NCT02551991|452912341|FG004|Overall Study|Sponsor Decision|5|||
125893981|NCT02551991|452912337|FG000|Overall Study|Other|0|||
125893982|NCT02551991|452912338|FG001|Overall Study|Other|0|||
125893983|NCT02551991|452912339|FG002|Overall Study|Other|0|||
125893984|NCT02551991|452912340|FG003|Overall Study|Other|0|||
125893985|NCT02551991|452912341|FG004|Overall Study|Other|1|||
125893986|NCT00984620|452912342|FG000|Overall Study|Adverse Event|5|||
125893987|NCT00984620|452912343|FG001|Overall Study|Adverse Event|5|||
125893988|NCT00984620|452912342|FG000|Overall Study|Lost to Follow-up|1|||
125893989|NCT00984620|452912343|FG001|Overall Study|Lost to Follow-up|1|||
125893990|NCT00984620|452912342|FG000|Overall Study|Withdrawal by Subject|0|||
125893991|NCT00984620|452912343|FG001|Overall Study|Withdrawal by Subject|2|||
125893992|NCT00984620|452912342|FG000|Overall Study|reason other than listed above|0|||
125893993|NCT00984620|452912343|FG001|Overall Study|reason other than listed above|4|||
125893994|NCT04975438|452912346|FG000|Overall Study|Lost to Follow-up|1|||
125893995|NCT04975438|452912347|FG001|Overall Study|Lost to Follow-up|0|||
125893996|NCT04975438|452912348|FG002|Overall Study|Lost to Follow-up|1|||
125893997|NCT04975438|452912349|FG003|Overall Study|Lost to Follow-up|0|||
125893998|NCT04975438|452912346|FG000|Overall Study|Withdrawal by Subject|1|||
125893999|NCT04975438|452912347|FG001|Overall Study|Withdrawal by Subject|0|||
125894000|NCT04975438|452912348|FG002|Overall Study|Withdrawal by Subject|0|||
125894001|NCT04975438|452912349|FG003|Overall Study|Withdrawal by Subject|0|||
125894002|NCT02640508|452912354|FG000|Overall Study|Death|19|||
125894003|NCT02640508|452912354|FG000|Overall Study|Withdrawal by Subject|8|||
125894004|NCT02640508|452912354|FG000|Overall Study|Physician Decision|1|||
125894005|NCT02640508|452912354|FG000|Overall Study|Lost to Follow-up|1|||
125894006|NCT05405257|452912358|FG000|Overall Study|Withdrawal by Subject|1|||
125894007|NCT00275340|452912359|FG000|Overall Study|Lost to Follow-up|2|||
125894008|NCT00275340|452912360|FG001|Overall Study|Lost to Follow-up|4|||
125894009|NCT02379637|452912364|FG000|Overall Study|Protocol Violation|0|||
125894010|NCT02379637|452912365|FG001|Overall Study|Protocol Violation|1|||
125894011|NCT02379637|452912364|FG000|Overall Study|Adverse Event|1|||
125894012|NCT02379637|452912365|FG001|Overall Study|Adverse Event|0|||
125894013|NCT02379637|452912364|FG000|Overall Study|Withdrawal by Subject|1|||
125894014|NCT02379637|452912365|FG001|Overall Study|Withdrawal by Subject|0|||
125894015|NCT00862641|452912366|FG000|Overall Study|Randomized, but drug not received|1|||
125894016|NCT00862641|452912367|FG001|Overall Study|Randomized, but drug not received|4|||
125894017|NCT00862641|452912368|FG002|Overall Study|Randomized, but drug not received|1|||
125894018|NCT00862641|452912369|FG003|Overall Study|Randomized, but drug not received|4|||
125894019|NCT02365480|452912370|FG000|Overall Study|Withdrawal by Subject|2|||
125894020|NCT02365480|452912371|FG001|Overall Study|Withdrawal by Subject|0|||
125894021|NCT03091348|452912372|FG000|Overall Study|Lost to Follow-up|2|||
125894022|NCT03091348|452912373|FG001|Overall Study|Lost to Follow-up|1|||
125894023|NCT02791763|452912374|FG000|Overall Study|Protocol Violation|0|||
125894024|NCT02791763|452912375|FG001|Overall Study|Protocol Violation|0|||
125894025|NCT02791763|452912376|FG002|Overall Study|Protocol Violation|1|||
125894026|NCT02791763|452912374|FG000|Overall Study|Withdrawal by Subject|5|||
125894027|NCT02791763|452912375|FG001|Overall Study|Withdrawal by Subject|1|||
125894028|NCT02791763|452912376|FG002|Overall Study|Withdrawal by Subject|0|||
125894029|NCT02791763|452912374|FG000|Overall Study|Physician Decision|0|||
125894030|NCT02791763|452912375|FG001|Overall Study|Physician Decision|1|||
125894031|NCT02791763|452912376|FG002|Overall Study|Physician Decision|0|||
125894032|NCT02791763|452912374|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
125894033|NCT02791763|452912375|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
125894034|NCT02791763|452912376|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
125894035|NCT02791763|452912374|FG000|Overall Study|Cancer event|1|||
125894036|NCT02791763|452912375|FG001|Overall Study|Cancer event|3|||
125894037|NCT02791763|452912376|FG002|Overall Study|Cancer event|0|||
125894038|NCT02791763|452912374|FG000|Overall Study|Participant had renal transplant|3|||
125894039|NCT02791763|452912375|FG001|Overall Study|Participant had renal transplant|0|||
125894040|NCT02791763|452912376|FG002|Overall Study|Participant had renal transplant|0|||
125894041|NCT02791763|452912374|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
125894042|NCT02791763|452912375|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
125894043|NCT02791763|452912376|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
125894044|NCT02791763|452912374|FG000|Overall Study|Adverse Event|12|||
125894045|NCT02791763|452912375|FG001|Overall Study|Adverse Event|13|||
125894046|NCT02791763|452912376|FG002|Overall Study|Adverse Event|7|||
126059401|NCT00731692|453512446|FG000|Core Study (36 Months)|Physician Decision|1|||
126059402|NCT00731692|453512447|FG001|Core Study (36 Months)|Physician Decision|0|||
125894047|NCT00706342|452912377|FG000|Overall Study|Adverse Event|3|||
126059403|NCT00731692|453512448|FG002|Core Study (36 Months)|Physician Decision|2|||
126059404|NCT00731692|453512446|FG000|Core Study (36 Months)|Death|2|||
126059405|NCT00731692|453512447|FG001|Core Study (36 Months)|Death|1|||
126059406|NCT00731692|453512448|FG002|Core Study (36 Months)|Death|2|||
125894048|NCT00706342|452912377|FG000|Overall Study|Not responding to treatment|2|||
125894049|NCT00706342|452912377|FG000|Overall Study|Withdrawn due to failure to respond|1|||
125894050|NCT00706342|452912377|FG000|Overall Study|Death|1|||
125894051|NCT00706342|452912377|FG000|Overall Study|Withdrew from the study on his own.|1|||
125894052|NCT00706342|452912377|FG000|Overall Study|Investigator discretion|2|||
125894053|NCT00706342|452912377|FG000|Overall Study|Non-responder Week 12|1|||
125894054|NCT00706342|452912377|FG000|Overall Study|Ongoing|6|||
125894055|NCT00706342|452912377|FG000|Overall Study|WIthdrawal of consent|1|||
125894056|NCT04534686|452912378|FG000|Baseline Measurement|Lost to Follow-up|4|||
125894057|NCT04534686|452912379|FG001|Baseline Measurement|Lost to Follow-up|6|||
125894058|NCT04534686|452912378|FG000|Baseline Measurement|Withdrawal by Subject|3|||
125894059|NCT04534686|452912379|FG001|Baseline Measurement|Withdrawal by Subject|1|||
125894060|NCT04534686|452912378|FG000|Intervention|Withdrawal by Subject|2|||
125894061|NCT04534686|452912379|FG001|Intervention|Withdrawal by Subject|2|||
125894062|NCT01419197|452912384|FG000|Overall Study|Death|247|||
125894063|NCT01419197|452912385|FG001|Overall Study|Death|122|||
125894064|NCT01419197|452912384|FG000|Overall Study|Physician Decision|4|||
125894065|NCT01419197|452912385|FG001|Overall Study|Physician Decision|4|||
125894066|NCT01419197|452912384|FG000|Overall Study|Non-compliance|3|||
125894067|NCT01419197|452912385|FG001|Overall Study|Non-compliance|1|||
125894068|NCT01419197|452912384|FG000|Overall Study|Withdrawal by Subject|33|||
125894069|NCT01419197|452912385|FG001|Overall Study|Withdrawal by Subject|32|||
125894070|NCT01419197|452912384|FG000|Overall Study|Study Completed by Sponsor|103|||
125894071|NCT01419197|452912385|FG001|Overall Study|Study Completed by Sponsor|34|||
125894072|NCT01419197|452912384|FG000|Overall Study|Reason Not Specified|0|||
125894073|NCT01419197|452912385|FG001|Overall Study|Reason Not Specified|1|||
125894074|NCT01419197|452912384|FG000|Overall Study|Lost to Follow-up|14|||
125894075|NCT01419197|452912385|FG001|Overall Study|Lost to Follow-up|4|||
125894076|NCT01781299|452912386|FG000|Overall Study|Withdrawal by Subject|0|||
125894077|NCT01781299|452912387|FG001|Overall Study|Withdrawal by Subject|1|||
125894078|NCT00146848|452912388|FG000|Pre-randomization|Death|19|||
125894079|NCT00146848|452912389|FG001|Pre-randomization|Death|0|||
125894080|NCT00146848|452912390|FG002|Pre-randomization|Death|0|||
125894081|NCT00146848|452912388|FG000|Pre-randomization|Lost to Follow-up|70|||
125894082|NCT00146848|452912389|FG001|Pre-randomization|Lost to Follow-up|0|||
125894083|NCT00146848|452912390|FG002|Pre-randomization|Lost to Follow-up|0|||
125894084|NCT00146848|452912388|FG000|Pre-randomization|Physician Decision|8|||
125894085|NCT00146848|452912389|FG001|Pre-randomization|Physician Decision|0|||
125894086|NCT00146848|452912390|FG002|Pre-randomization|Physician Decision|0|||
125894087|NCT00146848|452912388|FG000|Pre-randomization|Protocol Violation|172|||
125894088|NCT00146848|452912389|FG001|Pre-randomization|Protocol Violation|0|||
125894089|NCT00146848|452912390|FG002|Pre-randomization|Protocol Violation|0|||
125894090|NCT00146848|452912388|FG000|Pre-randomization|Withdrawal by Subject|40|||
125894091|NCT00146848|452912389|FG001|Pre-randomization|Withdrawal by Subject|0|||
125894092|NCT00146848|452912390|FG002|Pre-randomization|Withdrawal by Subject|0|||
125894093|NCT00146848|452912388|FG000|Post-randomization|Lost to Follow-up|12|||
125894094|NCT00146848|452912389|FG001|Post-randomization|Lost to Follow-up|15|||
125894095|NCT00146848|452912390|FG002|Post-randomization|Lost to Follow-up|12|||
125894096|NCT00146848|452912388|FG000|Post-randomization|Withdrawn|26|||
125894097|NCT00146848|452912389|FG001|Post-randomization|Withdrawn|32|||
125894098|NCT00146848|452912390|FG002|Post-randomization|Withdrawn|27|||
125894099|NCT01798849|452912391|FG000|Overall Study|Physician Decision|0|||
125894100|NCT01798849|452912392|FG001|Overall Study|Physician Decision|0|||
125894101|NCT01798849|452912393|FG002|Overall Study|Physician Decision|1|||
125894102|NCT02636361|452912394|FG000|Period 4|Physician Decision|0|||
125894103|NCT02636361|452912395|FG001|Period 4|Physician Decision|0|||
125894104|NCT02636361|452912396|FG002|Period 4|Physician Decision|0|||
125894105|NCT02636361|452912397|FG003|Period 4|Physician Decision|1|||
125894106|NCT02636361|452912398|FG004|Period 4|Physician Decision|0|||
125894107|NCT02032238|452912399|FG000|Overall Study|Lost to Follow-up|2|||
125894108|NCT02032238|452912400|FG001|Overall Study|Lost to Follow-up|0|||
125894109|NCT02410343|452912401|FG000|Core Period (24 Weeks)|Adverse Event|1|||
125894110|NCT02410343|452912402|FG001|Core Period (24 Weeks)|Adverse Event|0|||
125894111|NCT02410343|452912401|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
125894112|NCT02410343|452912402|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
125894113|NCT02410343|452912401|FG000|Extension Period (12 Months)|Adverse Event|1|||
125894114|NCT02410343|452912402|FG001|Extension Period (12 Months)|Adverse Event|0|||
125894115|NCT02410343|452912401|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
125894116|NCT02410343|452912402|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
125894117|NCT02720042|452912409|FG000|Overall Study|Death|3|||
125894118|NCT02720042|452912409|FG000|Overall Study|Lost to Follow-up|4|||
125894119|NCT02720042|452912409|FG000|Overall Study|Withdrawal by Subject|1|||
125894120|NCT02720042|452912409|FG000|Overall Study|Physician Decision|3|||
125894121|NCT02720042|452912409|FG000|Overall Study|Phasix Mesh explanted|1|||
125894122|NCT02720042|452912409|FG000|Overall Study|unable due to non-study-related illness|3|||
125894123|NCT00246740|452912410|FG000|Initial Enrollment|Death|1|||
125894124|NCT00246740|452912411|FG001|Initial Enrollment|Death|0|||
125894125|NCT00246740|452912410|FG000|Initial Enrollment|Additional surgery scheduled|0|||
125894126|NCT00246740|452912411|FG001|Initial Enrollment|Additional surgery scheduled|2|||
125894127|NCT00246740|452912410|FG000|Initial Enrollment|Surgery schedule change|4|||
125894128|NCT00246740|452912411|FG001|Initial Enrollment|Surgery schedule change|4|||
125894129|NCT00246740|452912410|FG000|Initial Enrollment|Other|1|||
125894130|NCT00246740|452912411|FG001|Initial Enrollment|Other|2|||
125894131|NCT01510769|452912412|FG000|Overall Study|Adverse Event|7|||
125894132|NCT01510769|452912413|FG001|Overall Study|Adverse Event|6|||
125894133|NCT01510769|452912414|FG002|Overall Study|Adverse Event|4|||
125894134|NCT01510769|452912412|FG000|Overall Study|Gout Flare|0|||
125894135|NCT01510769|452912413|FG001|Overall Study|Gout Flare|3|||
125894136|NCT01510769|452912414|FG002|Overall Study|Gout Flare|1|||
125894137|NCT01510769|452912412|FG000|Overall Study|Protocol Violation|11|||
125894138|NCT01510769|452912413|FG001|Overall Study|Protocol Violation|10|||
125894139|NCT01510769|452912414|FG002|Overall Study|Protocol Violation|9|||
125894140|NCT01510769|452912412|FG000|Overall Study|Lost to Follow-up|5|||
125894141|NCT01510769|452912413|FG001|Overall Study|Lost to Follow-up|1|||
125894142|NCT01510769|452912414|FG002|Overall Study|Lost to Follow-up|5|||
125894143|NCT01510769|452912412|FG000|Overall Study|Withdrawal by Subject|3|||
125894144|NCT01510769|452912413|FG001|Overall Study|Withdrawal by Subject|4|||
125894145|NCT01510769|452912414|FG002|Overall Study|Withdrawal by Subject|3|||
125894146|NCT01510769|452912412|FG000|Overall Study|Death|1|||
125894147|NCT01510769|452912413|FG001|Overall Study|Death|1|||
125894148|NCT01510769|452912414|FG002|Overall Study|Death|0|||
125894149|NCT00335764|452912415|FG000|Overall Study|wrong histology|1|||
125894150|NCT00335764|452912416|FG001|Overall Study|wrong histology|0|||
125894151|NCT00335764|452912417|FG002|Overall Study|wrong histology|0|||
125894152|NCT00335764|452912418|FG003|Overall Study|wrong histology|0|||
125894153|NCT00335764|452912419|FG004|Overall Study|wrong histology|1|||
125894154|NCT02466659|452912422|FG000|Overall Study|Lost to Follow-up|5|||
125894155|NCT02466659|452912423|FG001|Overall Study|Lost to Follow-up|2|||
125894156|NCT00929643|452912424|FG000|Overall Study|Protocol Violation|2|||
125894157|NCT00934440|452912427|FG000|Overall Study|Lost to Follow-up|1|||
125894158|NCT00744042|452912428|FG000|Overall Study|Withdrawal by Subject|1|||
125894159|NCT03158285|452912433|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
125894160|NCT03158285|452912434|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
125894161|NCT03158285|452912435|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
125894162|NCT03158285|452912433|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
125894163|NCT03158285|452912434|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
125894164|NCT03158285|452912435|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
125894165|NCT03158285|452912433|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
125894166|NCT03158285|452912434|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
125894167|NCT03158285|452912435|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
125894168|NCT03158285|452912433|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
125894169|NCT03158285|452912434|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
125894170|NCT03158285|452912435|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
125894171|NCT03158285|452912433|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
125894172|NCT03158285|452912434|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
125894173|NCT03158285|452912435|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
125894174|NCT03158285|452912433|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
125894175|NCT03158285|452912434|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
125894176|NCT03158285|452912435|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
125894177|NCT03158285|452912433|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
125894178|NCT03158285|452912434|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
125894179|NCT03158285|452912435|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
125894180|NCT03158285|452912433|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
125894181|NCT03158285|452912434|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
125894182|NCT03158285|452912435|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
125894183|NCT03158285|452912433|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
125894184|NCT03158285|452912434|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
125894185|NCT03158285|452912435|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
125894186|NCT03158285|452912433|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
125894187|NCT03158285|452912434|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
125894188|NCT03158285|452912435|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
125894189|NCT03158285|452912433|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
125894190|NCT03158285|452912434|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
125894191|NCT03158285|452912435|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
125894192|NCT03158285|452912433|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
125894193|NCT03158285|452912434|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
125894194|NCT03158285|452912435|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
125894195|NCT03158285|452912433|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
125894196|NCT03158285|452912434|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
125894197|NCT03158285|452912435|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
125894198|NCT03158285|452912433|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
126059407|NCT00731692|453512446|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
125894199|NCT03158285|452912434|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
125894200|NCT03158285|452912435|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
125894201|NCT03158285|452912433|FG000|Active Treatment Period: Week 52-100|Death|1|||
125894202|NCT03158285|452912434|FG001|Active Treatment Period: Week 52-100|Death|0|||
126109045|NCT00475033|453692690|FG000|Infant Series|Failed to return|3|||
126109046|NCT00475033|453692691|FG001|Infant Series|Failed to return|4|||
126109047|NCT00475033|453692690|FG000|Infant Series|Parent or legal guardian request|1|||
126109048|NCT00475033|453692691|FG001|Infant Series|Parent or legal guardian request|5|||
126109049|NCT00475033|453692690|FG000|Infant Series|Protocol Violation|1|||
126109050|NCT00475033|453692691|FG001|Infant Series|Protocol Violation|2|||
126109051|NCT00475033|453692690|FG000|Infant Series|Lost to Follow-up|2|||
126109052|NCT00475033|453692691|FG001|Infant Series|Lost to Follow-up|0|||
126109053|NCT00475033|453692690|FG000|Infant Series|Adverse Event|0|||
126109054|NCT00475033|453692691|FG001|Infant Series|Adverse Event|2|||
126109055|NCT00475033|453692690|FG000|After the Infant Series|Adverse Event|0|||
126109056|NCT00475033|453692691|FG001|After the Infant Series|Adverse Event|4|||
126109057|NCT00475033|453692690|FG000|After the Infant Series|Parent or legal guardian request|2|||
126109058|NCT00475033|453692691|FG001|After the Infant Series|Parent or legal guardian request|2|||
126109059|NCT00475033|453692690|FG000|After the Infant Series|Failed to return|2|||
126109060|NCT00475033|453692691|FG001|After the Infant Series|Failed to return|1|||
126109061|NCT00475033|453692690|FG000|After the Infant Series|Protocol Violation|1|||
126109062|NCT00475033|453692691|FG001|After the Infant Series|Protocol Violation|0|||
126109063|NCT00475033|453692690|FG000|After the Infant Series|Lost to Follow-up|1|||
126109064|NCT00475033|453692691|FG001|After the Infant Series|Lost to Follow-up|0|||
126109065|NCT00475033|453692690|FG000|After the Infant Series|Other|0|||
126109066|NCT00475033|453692691|FG001|After the Infant Series|Other|1|||
126109067|NCT00475033|453692690|FG000|Toddler Dose|Parent or legal guardian request|2|||
126109068|NCT00475033|453692691|FG001|Toddler Dose|Parent or legal guardian request|0|||
126109069|NCT00475033|453692690|FG000|Toddler Dose|Failed to return|1|||
126109070|NCT00475033|453692691|FG001|Toddler Dose|Failed to return|0|||
126109071|NCT00475033|453692690|FG000|Toddler Dose|Lost to Follow-up|1|||
126109072|NCT00475033|453692691|FG001|Toddler Dose|Lost to Follow-up|0|||
126109073|NCT02525861|453694215|FG000|Overall Study|Adverse Event|1|||
126109074|NCT02525861|453694216|FG001|Overall Study|Adverse Event|0|||
126109075|NCT02525861|453694215|FG000|Overall Study|Withdrawal by Subject|0|||
126109076|NCT02525861|453694216|FG001|Overall Study|Withdrawal by Subject|1|||
126109077|NCT02525861|453694215|FG000|Overall Study|Physician Decision|0|||
126109078|NCT02525861|453694216|FG001|Overall Study|Physician Decision|1|||
126109079|NCT01794520|453694217|FG000|Overall Study|Adverse events- related to progression|0|||
126109080|NCT01794520|453694218|FG001|Overall Study|Adverse events- related to progression|0|||
126109081|NCT01794520|453694219|FG002|Overall Study|Adverse events- related to progression|1|||
126109082|NCT01794520|453694220|FG003|Overall Study|Adverse events- related to progression|2|||
126109083|NCT01794520|453694221|FG004|Overall Study|Adverse events- related to progression|0|||
126109084|NCT01794520|453694222|FG005|Overall Study|Adverse events- related to progression|1|||
126109085|NCT01794520|453694223|FG006|Overall Study|Adverse events- related to progression|0|||
126109086|NCT01794520|453694217|FG000|Overall Study|Adverse event- not related to progression|1|||
126109087|NCT01794520|453694218|FG001|Overall Study|Adverse event- not related to progression|1|||
126109088|NCT01794520|453694219|FG002|Overall Study|Adverse event- not related to progression|0|||
126109089|NCT01794520|453694220|FG003|Overall Study|Adverse event- not related to progression|0|||
126109090|NCT01794520|453694221|FG004|Overall Study|Adverse event- not related to progression|2|||
126109091|NCT01794520|453694222|FG005|Overall Study|Adverse event- not related to progression|0|||
126109092|NCT01794520|453694223|FG006|Overall Study|Adverse event- not related to progression|0|||
126109093|NCT01794520|453694217|FG000|Overall Study|Progressive disease|5|||
126109094|NCT01794520|453694218|FG001|Overall Study|Progressive disease|6|||
126109095|NCT01794520|453694219|FG002|Overall Study|Progressive disease|2|||
126109096|NCT01794520|453694220|FG003|Overall Study|Progressive disease|5|||
126109097|NCT01794520|453694221|FG004|Overall Study|Progressive disease|27|||
126109098|NCT01794520|453694222|FG005|Overall Study|Progressive disease|18|||
126109099|NCT01794520|453694223|FG006|Overall Study|Progressive disease|0|||
126109100|NCT01794520|453694217|FG000|Overall Study|Withdrew consent|0|||
126109101|NCT01794520|453694218|FG001|Overall Study|Withdrew consent|0|||
126109102|NCT01794520|453694219|FG002|Overall Study|Withdrew consent|1|||
126109103|NCT01794520|453694220|FG003|Overall Study|Withdrew consent|1|||
126109104|NCT01794520|453694221|FG004|Overall Study|Withdrew consent|0|||
126109105|NCT01794520|453694222|FG005|Overall Study|Withdrew consent|0|||
126109106|NCT01794520|453694223|FG006|Overall Study|Withdrew consent|0|||
126109107|NCT01794520|453694217|FG000|Overall Study|Lost to Follow-up|0|||
126109108|NCT01794520|453694218|FG001|Overall Study|Lost to Follow-up|0|||
126109109|NCT01794520|453694219|FG002|Overall Study|Lost to Follow-up|0|||
126109110|NCT01794520|453694220|FG003|Overall Study|Lost to Follow-up|0|||
126109111|NCT01794520|453694221|FG004|Overall Study|Lost to Follow-up|1|||
126109112|NCT01794520|453694222|FG005|Overall Study|Lost to Follow-up|0|||
126109113|NCT01794520|453694223|FG006|Overall Study|Lost to Follow-up|0|||
126109114|NCT01794520|453694217|FG000|Overall Study|Toxicity|0|||
126109115|NCT01794520|453694218|FG001|Overall Study|Toxicity|2|||
126109116|NCT01794520|453694219|FG002|Overall Study|Toxicity|0|||
126109117|NCT01794520|453694220|FG003|Overall Study|Toxicity|0|||
126109118|NCT01794520|453694221|FG004|Overall Study|Toxicity|0|||
126109119|NCT01794520|453694222|FG005|Overall Study|Toxicity|0|||
126109120|NCT01794520|453694223|FG006|Overall Study|Toxicity|0|||
126059408|NCT00731692|453512447|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
126059409|NCT00731692|453512448|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
126059410|NCT00731692|453512446|FG000|Core Study (36 Months)|Administrative|2|||
126059411|NCT00731692|453512447|FG001|Core Study (36 Months)|Administrative|2|||
126059412|NCT00731692|453512448|FG002|Core Study (36 Months)|Administrative|6|||
126059413|NCT00731692|453512446|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
126059414|NCT00731692|453512447|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
126059415|NCT00731692|453512448|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
126059416|NCT00731692|453512446|FG000|Core Study (36 Months)|Protocol Violation|4|||
126059417|NCT00731692|453512447|FG001|Core Study (36 Months)|Protocol Violation|5|||
126059418|NCT00731692|453512448|FG002|Core Study (36 Months)|Protocol Violation|8|||
126059419|NCT00731692|453512446|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
126059420|NCT00731692|453512447|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
126059421|NCT00731692|453512448|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
126059422|NCT00731692|453512446|FG000|Core Study (36 Months)|Adverse Event|25|||
126059423|NCT00731692|453512447|FG001|Core Study (36 Months)|Adverse Event|28|||
126059424|NCT00731692|453512448|FG002|Core Study (36 Months)|Adverse Event|29|||
126059425|NCT00731692|453512446|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
126059426|NCT00731692|453512447|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
126059427|NCT00731692|453512448|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
126059428|NCT00731692|453512446|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
126059429|NCT00731692|453512447|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
126059430|NCT00731692|453512448|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
126059431|NCT00731692|453512446|FG000|Extension Phase|Abnormal test procedure|0|||
126059432|NCT00731692|453512447|FG001|Extension Phase|Abnormal test procedure|0|||
126059433|NCT00731692|453512448|FG002|Extension Phase|Abnormal test procedure|1|||
126059434|NCT00731692|453512446|FG000|Extension Phase|Abnormal lab values|0|||
126059435|NCT00731692|453512447|FG001|Extension Phase|Abnormal lab values|0|||
126059436|NCT00731692|453512448|FG002|Extension Phase|Abnormal lab values|1|||
126059437|NCT00731692|453512446|FG000|Extension Phase|Lost to Follow-up|0|||
126059438|NCT00731692|453512447|FG001|Extension Phase|Lost to Follow-up|1|||
126059439|NCT00731692|453512448|FG002|Extension Phase|Lost to Follow-up|4|||
126059440|NCT00731692|453512446|FG000|Extension Phase|Withdrawal by Subject|4|||
126059441|NCT00731692|453512447|FG001|Extension Phase|Withdrawal by Subject|5|||
126059442|NCT00731692|453512448|FG002|Extension Phase|Withdrawal by Subject|3|||
126059443|NCT00731692|453512446|FG000|Extension Phase|Adverse Event|1|||
126059444|NCT00731692|453512447|FG001|Extension Phase|Adverse Event|1|||
126059445|NCT00731692|453512448|FG002|Extension Phase|Adverse Event|15|||
126059446|NCT03332589|453512449|FG000|Overall Study|Lack of Efficacy|2|||
126059447|NCT03332589|453512450|FG001|Overall Study|Lack of Efficacy|0|||
126059448|NCT03332589|453512451|FG002|Overall Study|Lack of Efficacy|0|||
126059449|NCT03332589|453512449|FG000|Overall Study|Adverse Event|1|||
126059450|NCT03332589|453512450|FG001|Overall Study|Adverse Event|0|||
126059451|NCT03332589|453512451|FG002|Overall Study|Adverse Event|0|||
126059452|NCT03332589|453512449|FG000|Overall Study|Death|1|||
126059453|NCT03332589|453512450|FG001|Overall Study|Death|0|||
126059454|NCT03332589|453512451|FG002|Overall Study|Death|0|||
126059455|NCT00108355|453512455|FG000|Overall Study|Peritonitis at index paracentesis|1|||
126059456|NCT00108355|453512456|FG001|Overall Study|Peritonitis at index paracentesis|1|||
126059457|NCT00108355|453512455|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
126059458|NCT00108355|453512456|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
126059459|NCT02002689|453512461|FG000|Overall Study|Disease Progression|7|||
126059460|NCT02002689|453512461|FG000|Overall Study|Adverse Event|3|||
126059461|NCT01185340|453512464|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
126059462|NCT01185340|453512465|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126059463|NCT01185340|453512466|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126059464|NCT01185340|453512467|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126059465|NCT01185340|453512464|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
126059466|NCT01185340|453512465|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125894203|NCT03158285|452912435|FG002|Active Treatment Period: Week 52-100|Death|0|||
125894204|NCT03158285|452912433|FG000|Active Treatment Period: Week 52-100|Other|4|||
125894205|NCT03158285|452912434|FG001|Active Treatment Period: Week 52-100|Other|1|||
125894206|NCT03158285|452912435|FG002|Active Treatment Period: Week 52-100|Other|0|||
125894207|NCT01516034|452912438|FG000|Overall Study|Physician Decision|1|||
125894208|NCT01516034|452912438|FG000|Overall Study|Lack of Efficacy|7|||
125894209|NCT02228980|452912439|FG000|Overall Study|Adverse Event|14|||
125894210|NCT02228980|452912440|FG001|Overall Study|Adverse Event|0|||
125894211|NCT02228980|452912441|FG002|Overall Study|Adverse Event|0|||
125894212|NCT02228980|452912442|FG003|Overall Study|Adverse Event|0|||
125894213|NCT02228980|452912439|FG000|Overall Study|Protocol Violation|7|||
125894214|NCT02228980|452912440|FG001|Overall Study|Protocol Violation|0|||
125894215|NCT02228980|452912441|FG002|Overall Study|Protocol Violation|0|||
125894216|NCT02228980|452912442|FG003|Overall Study|Protocol Violation|0|||
125894217|NCT02228980|452912439|FG000|Overall Study|Withdrawal by Subject|3|||
125894218|NCT02228980|452912440|FG001|Overall Study|Withdrawal by Subject|3|||
125894219|NCT02228980|452912441|FG002|Overall Study|Withdrawal by Subject|2|||
125894220|NCT02228980|452912442|FG003|Overall Study|Withdrawal by Subject|3|||
125894221|NCT03060551|452912443|FG000|Overall Study|Withdrawal by Subject|1|||
125894222|NCT03060551|452912443|FG000|Overall Study|Adverse Event|1|||
125894223|NCT00750152|452912446|FG000|Overall Study|Adverse Event|2|||
125894224|NCT00750152|452912447|FG001|Overall Study|Adverse Event|1|||
125894225|NCT00750152|452912446|FG000|Overall Study|Lost to Follow-up|8|||
125894226|NCT00750152|452912447|FG001|Overall Study|Lost to Follow-up|13|||
125894227|NCT00750152|452912446|FG000|Overall Study|Withdrawal by Subject|3|||
125894228|NCT00750152|452912447|FG001|Overall Study|Withdrawal by Subject|3|||
125894229|NCT00750152|452912446|FG000|Overall Study|Physician Decision|1|||
125894230|NCT00750152|452912447|FG001|Overall Study|Physician Decision|1|||
125894231|NCT00750152|452912446|FG000|Overall Study|Non-compliance|0|||
125894232|NCT00750152|452912447|FG001|Overall Study|Non-compliance|1|||
125894233|NCT00750152|452912446|FG000|Overall Study|Termination by sponsor|1|||
125894234|NCT00750152|452912447|FG001|Overall Study|Termination by sponsor|0|||
125894235|NCT00750152|452912446|FG000|Overall Study|Other|7|||
125894236|NCT00750152|452912447|FG001|Overall Study|Other|8|||
125894237|NCT01642615|452912448|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
125894238|NCT01642615|452912449|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125894239|NCT01642615|452912450|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125894240|NCT01642615|452912448|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
125894241|NCT01642615|452912449|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
125894242|NCT01642615|452912450|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
125894243|NCT01642615|452912448|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
125894244|NCT01642615|452912449|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
125894245|NCT01642615|452912450|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
125894246|NCT01642615|452912448|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
125894247|NCT01642615|452912449|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
125894248|NCT01642615|452912450|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
125894249|NCT01642615|452912448|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
125894250|NCT01642615|452912449|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
125894251|NCT01642615|452912450|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
125894252|NCT01642615|452912448|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
125894253|NCT01642615|452912449|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
125894254|NCT01642615|452912450|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
125894255|NCT01642615|452912448|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
125894256|NCT01642615|452912449|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
125894257|NCT01642615|452912450|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
125894258|NCT01642615|452912448|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125894259|NCT01642615|452912449|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
125894260|NCT01642615|452912450|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125894261|NCT01642615|452912448|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
125894262|NCT01642615|452912449|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
125894263|NCT01642615|452912450|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
125894264|NCT01028300|452912453|FG000|Overall Study|Study Terminated|4|||
125894265|NCT01214395|452912456|FG000|Overall Study|All patients had infection|5|||
125894266|NCT00715910|452912457|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
125894267|NCT00715910|452912458|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
125894268|NCT00715910|452912459|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
125894269|NCT00715910|452912460|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
125894270|NCT00715910|452912461|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
125894271|NCT00715910|452912462|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
125894272|NCT00715910|452912457|FG000|Booster and ESFU Phase|Other|0|||
125894273|NCT00715910|452912458|FG001|Booster and ESFU Phase|Other|0|||
125894274|NCT00715910|452912459|FG002|Booster and ESFU Phase|Other|0|||
125894275|NCT00715910|452912460|FG003|Booster and ESFU Phase|Other|5|||
126059467|NCT01185340|453512466|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126059468|NCT01185340|453512467|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126059469|NCT01185340|453512464|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
126059470|NCT01185340|453512465|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126059471|NCT01185340|453512466|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126059472|NCT01185340|453512467|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126059473|NCT01185340|453512464|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
126059474|NCT01185340|453512465|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126059475|NCT01185340|453512466|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126059476|NCT01185340|453512467|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126059477|NCT01185340|453512464|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
126059478|NCT01185340|453512465|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126059479|NCT01185340|453512466|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126059480|NCT01185340|453512467|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126059481|NCT01185340|453512464|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
126059482|NCT01185340|453512465|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126059483|NCT01185340|453512466|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126059484|NCT01185340|453512467|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126059485|NCT01185340|453512464|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
126059486|NCT01185340|453512465|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126059487|NCT01185340|453512466|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126059488|NCT01185340|453512467|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126059489|NCT01185340|453512464|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
126059490|NCT01185340|453512465|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
126059491|NCT01185340|453512466|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
126059492|NCT01185340|453512467|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
126059493|NCT01185340|453512464|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
126059494|NCT01185340|453512465|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
126059495|NCT01185340|453512466|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
126059496|NCT01185340|453512467|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
126059497|NCT01185340|453512464|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
126059498|NCT01185340|453512465|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
126059499|NCT01185340|453512466|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
126059500|NCT01185340|453512467|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
126059501|NCT01185340|453512464|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126059502|NCT01185340|453512465|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
126059503|NCT01185340|453512466|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126059504|NCT01185340|453512467|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
126059505|NCT01185340|453512464|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
126059506|NCT01185340|453512465|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126059507|NCT01185340|453512466|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
126059508|NCT01185340|453512467|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126059509|NCT01185340|453512464|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
126059510|NCT01185340|453512465|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
126059511|NCT01185340|453512466|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
126059512|NCT01185340|453512467|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
126059513|NCT01185340|453512464|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126059514|NCT01185340|453512465|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126059515|NCT01185340|453512466|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
126059516|NCT01185340|453512467|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
126059517|NCT00087516|453512468|FG000|Overall Study|Adverse Event|10|||
126109121|NCT01794520|453694217|FG000|Overall Study|Study terminated by sponsor|0|||
125894276|NCT00715910|452912461|FG004|Booster and ESFU Phase|Other|1|||
125894277|NCT00715910|452912462|FG005|Booster and ESFU Phase|Other|0|||
125894278|NCT02034409|452912466|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
125894279|NCT02034409|452912467|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
125894280|NCT02034409|452912466|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
125894281|NCT02034409|452912467|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
125894282|NCT02034409|452912466|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
125894283|NCT02034409|452912467|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
125894284|NCT02034409|452912466|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
125894285|NCT02034409|452912467|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
125894286|NCT02034409|452912466|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
125894287|NCT02034409|452912467|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
125894288|NCT02034409|452912466|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
125894289|NCT02034409|452912467|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
125894290|NCT01699867|452912468|FG000|Overall Study|Screening Failure|3|||
125894291|NCT05092360|452912470|FG000|Overall Study|Withdrawal by Subject|21|||
125894292|NCT05092360|452912471|FG001|Overall Study|Withdrawal by Subject|4|||
125894293|NCT05092360|452912472|FG002|Overall Study|Withdrawal by Subject|9|||
125894294|NCT05092360|452912473|FG003|Overall Study|Withdrawal by Subject|26|||
125894295|NCT05092360|452912470|FG000|Overall Study|Death|97|||
125894296|NCT05092360|452912471|FG001|Overall Study|Death|14|||
125894297|NCT05092360|452912472|FG002|Overall Study|Death|31|||
125894298|NCT05092360|452912473|FG003|Overall Study|Death|101|||
125894299|NCT05092360|452912470|FG000|Overall Study|Lost to Follow-up|1|||
125894300|NCT05092360|452912471|FG001|Overall Study|Lost to Follow-up|2|||
125894301|NCT05092360|452912472|FG002|Overall Study|Lost to Follow-up|2|||
125894302|NCT05092360|452912473|FG003|Overall Study|Lost to Follow-up|2|||
125894303|NCT05092360|452912470|FG000|Overall Study|Study terminated by sponsor|65|||
125894304|NCT05092360|452912471|FG001|Overall Study|Study terminated by sponsor|7|||
125894305|NCT05092360|452912472|FG002|Overall Study|Study terminated by sponsor|13|||
125894306|NCT05092360|452912473|FG003|Overall Study|Study terminated by sponsor|61|||
125894307|NCT02848729|452914055|FG000|Overall Study|Withdrawal by Subject|1|||
125894308|NCT02848729|452914056|FG001|Overall Study|Withdrawal by Subject|0|||
125894309|NCT02848729|452914055|FG000|Overall Study|Emesis|15|||
125894310|NCT02848729|452914056|FG001|Overall Study|Emesis|11|||
125894311|NCT01904773|452914057|FG000|Screen|Screen failure|3|||
125894312|NCT01904773|452914058|FG001|Screen|Screen failure|0|||
125894313|NCT01904773|452914059|FG002|Screen|Screen failure|0|||
125894314|NCT01904773|452914060|FG003|Screen|Screen failure|0|||
125894315|NCT01904773|452914061|FG004|Screen|Screen failure|0|||
125894316|NCT01904773|452914062|FG005|Screen|Screen failure|0|||
125894317|NCT01904773|452914063|FG006|Screen|Screen failure|0|||
125894318|NCT01904773|452914064|FG007|Screen|Screen failure|0|||
125894319|NCT01904773|452914065|FG008|Screen|Screen failure|0|||
125894320|NCT01904773|452914057|FG000|Screen|Withdrawal by Subject|1|||
125894321|NCT01904773|452914058|FG001|Screen|Withdrawal by Subject|0|||
125894322|NCT01904773|452914059|FG002|Screen|Withdrawal by Subject|0|||
125894323|NCT01904773|452914060|FG003|Screen|Withdrawal by Subject|0|||
125894324|NCT01904773|452914061|FG004|Screen|Withdrawal by Subject|0|||
125894325|NCT01904773|452914062|FG005|Screen|Withdrawal by Subject|0|||
125894326|NCT01904773|452914063|FG006|Screen|Withdrawal by Subject|0|||
125894327|NCT01904773|452914064|FG007|Screen|Withdrawal by Subject|0|||
126059518|NCT00087516|453512469|FG001|Overall Study|Adverse Event|10|||
126059519|NCT00087516|453512470|FG002|Overall Study|Adverse Event|3|||
126059520|NCT00087516|453512471|FG003|Overall Study|Adverse Event|6|||
126059521|NCT00087516|453512468|FG000|Overall Study|Lack of Efficacy|82|||
126059522|NCT00087516|453512469|FG001|Overall Study|Lack of Efficacy|80|||
126059523|NCT00087516|453512470|FG002|Overall Study|Lack of Efficacy|39|||
126059524|NCT00087516|453512471|FG003|Overall Study|Lack of Efficacy|29|||
125894328|NCT01904773|452914065|FG008|Screen|Withdrawal by Subject|0|||
125894329|NCT01904773|452914057|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
125894330|NCT01904773|452914058|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126059525|NCT00087516|453512468|FG000|Overall Study|Lost to Follow-up|8|||
126059526|NCT00087516|453512469|FG001|Overall Study|Lost to Follow-up|6|||
126109122|NCT01794520|453694218|FG001|Overall Study|Study terminated by sponsor|0|||
126109123|NCT01794520|453694219|FG002|Overall Study|Study terminated by sponsor|1|||
126109124|NCT01794520|453694220|FG003|Overall Study|Study terminated by sponsor|0|||
126109125|NCT01794520|453694221|FG004|Overall Study|Study terminated by sponsor|1|||
126109126|NCT01794520|453694222|FG005|Overall Study|Study terminated by sponsor|0|||
126109127|NCT01794520|453694223|FG006|Overall Study|Study terminated by sponsor|7|||
125894331|NCT01904773|452914059|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125894332|NCT01904773|452914060|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125894333|NCT01904773|452914061|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125894334|NCT01904773|452914062|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125894335|NCT01904773|452914063|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125894336|NCT01904773|452914064|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125894337|NCT01904773|452914065|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125894338|NCT01904773|452914057|FG000|First Intervention|Adverse Event|0|||
125894339|NCT01904773|452914058|FG001|First Intervention|Adverse Event|0|||
125894340|NCT01904773|452914059|FG002|First Intervention|Adverse Event|0|||
125894341|NCT01904773|452914060|FG003|First Intervention|Adverse Event|0|||
125894342|NCT01904773|452914061|FG004|First Intervention|Adverse Event|0|||
125894343|NCT01904773|452914062|FG005|First Intervention|Adverse Event|0|||
125894344|NCT01904773|452914063|FG006|First Intervention|Adverse Event|1|||
125894345|NCT01904773|452914064|FG007|First Intervention|Adverse Event|0|||
125894346|NCT01904773|452914065|FG008|First Intervention|Adverse Event|0|||
125894347|NCT01904773|452914057|FG000|Placebo Washout First Intervention|Condition worsened|0|||
125894348|NCT01904773|452914058|FG001|Placebo Washout First Intervention|Condition worsened|1|||
125894349|NCT01904773|452914059|FG002|Placebo Washout First Intervention|Condition worsened|0|||
125894350|NCT01904773|452914060|FG003|Placebo Washout First Intervention|Condition worsened|0|||
125894351|NCT01904773|452914061|FG004|Placebo Washout First Intervention|Condition worsened|0|||
125894352|NCT01904773|452914062|FG005|Placebo Washout First Intervention|Condition worsened|0|||
125894353|NCT01904773|452914063|FG006|Placebo Washout First Intervention|Condition worsened|0|||
125894354|NCT01904773|452914064|FG007|Placebo Washout First Intervention|Condition worsened|0|||
125894355|NCT01904773|452914065|FG008|Placebo Washout First Intervention|Condition worsened|0|||
125894356|NCT01904773|452914057|FG000|Fifth Intervention|Adverse Event|0|||
125894357|NCT01904773|452914058|FG001|Fifth Intervention|Adverse Event|0|||
125894358|NCT01904773|452914059|FG002|Fifth Intervention|Adverse Event|0|||
125894359|NCT01904773|452914060|FG003|Fifth Intervention|Adverse Event|0|||
125894360|NCT01904773|452914061|FG004|Fifth Intervention|Adverse Event|0|||
125894361|NCT01904773|452914062|FG005|Fifth Intervention|Adverse Event|0|||
125894362|NCT01904773|452914063|FG006|Fifth Intervention|Adverse Event|0|||
125894363|NCT01904773|452914064|FG007|Fifth Intervention|Adverse Event|1|||
125894364|NCT01904773|452914065|FG008|Fifth Intervention|Adverse Event|0|||
125894365|NCT01904773|452914057|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125894366|NCT01904773|452914058|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
125894367|NCT01904773|452914059|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125894368|NCT01904773|452914060|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125894369|NCT01904773|452914061|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125894370|NCT01904773|452914062|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125894371|NCT01904773|452914063|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125894372|NCT01904773|452914064|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125894373|NCT01904773|452914065|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125894374|NCT00220779|452914069|FG000|Overall Study|Adverse Event|1|||
125894375|NCT00220779|452914070|FG001|Overall Study|Adverse Event|0|||
125894376|NCT00220779|452914071|FG002|Overall Study|Adverse Event|0|||
125894377|NCT00220779|452914069|FG000|Overall Study|Withdrawal by Subject|1|||
125894378|NCT00220779|452914070|FG001|Overall Study|Withdrawal by Subject|4|||
125894379|NCT00220779|452914071|FG002|Overall Study|Withdrawal by Subject|1|||
125894380|NCT00220779|452914069|FG000|Overall Study|Non-compliance|1|||
125894381|NCT00220779|452914070|FG001|Overall Study|Non-compliance|0|||
125894382|NCT00220779|452914071|FG002|Overall Study|Non-compliance|0|||
125894383|NCT00220779|452914069|FG000|Overall Study|Too time consuming|1|||
125894384|NCT00220779|452914070|FG001|Overall Study|Too time consuming|0|||
126109128|NCT01794520|453694217|FG000|Overall Study|Death|0|||
126109129|NCT01794520|453694218|FG001|Overall Study|Death|0|||
126109130|NCT01794520|453694219|FG002|Overall Study|Death|0|||
125894385|NCT00220779|452914071|FG002|Overall Study|Too time consuming|0|||
125894386|NCT00220779|452914069|FG000|Overall Study|Pregnancy|0|||
125894387|NCT00220779|452914070|FG001|Overall Study|Pregnancy|0|||
125894388|NCT00220779|452914071|FG002|Overall Study|Pregnancy|2|||
125894389|NCT00220779|452914069|FG000|Overall Study|Lack of Efficacy|3|||
125894390|NCT00220779|452914070|FG001|Overall Study|Lack of Efficacy|0|||
125894391|NCT00220779|452914071|FG002|Overall Study|Lack of Efficacy|1|||
125894392|NCT00791076|452914072|FG000|Overall Study|Study was terminated,PI left institution|8|||
125894393|NCT03390101|452914075|FG000|Weeks 0-12|Withdrawal by Subject|0|||
126109131|NCT01794520|453694220|FG003|Overall Study|Death|0|||
126109132|NCT01794520|453694221|FG004|Overall Study|Death|1|||
126109133|NCT01794520|453694222|FG005|Overall Study|Death|0|||
126109134|NCT01794520|453694223|FG006|Overall Study|Death|22|||
126109135|NCT01794520|453694217|FG000|Overall Study|Other, not specified|0|||
126109136|NCT01794520|453694218|FG001|Overall Study|Other, not specified|0|||
126109137|NCT01794520|453694219|FG002|Overall Study|Other, not specified|1|||
126109138|NCT01794520|453694220|FG003|Overall Study|Other, not specified|1|||
126109139|NCT01794520|453694221|FG004|Overall Study|Other, not specified|4|||
126109140|NCT01794520|453694222|FG005|Overall Study|Other, not specified|1|||
126109141|NCT01794520|453694223|FG006|Overall Study|Other, not specified|2|||
126109142|NCT04796896|453694224|FG000|Overall Study|Adverse Event|1|||
126109143|NCT04796896|453694225|FG001|Overall Study|Adverse Event|0|||
126109144|NCT04796896|453694226|FG002|Overall Study|Adverse Event|0|||
126109145|NCT04796896|453694227|FG003|Overall Study|Adverse Event|0|||
126109146|NCT04796896|453694228|FG004|Overall Study|Adverse Event|0|||
126109147|NCT04796896|453694229|FG005|Overall Study|Adverse Event|1|||
126109148|NCT04796896|453694230|FG006|Overall Study|Adverse Event|1|||
126109149|NCT04796896|453694231|FG007|Overall Study|Adverse Event|0|||
126109150|NCT04796896|453694232|FG008|Overall Study|Adverse Event|1|||
126109151|NCT04796896|453694233|FG009|Overall Study|Adverse Event|1|||
126109152|NCT04796896|453694234|FG010|Overall Study|Adverse Event|1|||
126109153|NCT04796896|453694235|FG011|Overall Study|Adverse Event|0|||
126109154|NCT04796896|453694224|FG000|Overall Study|Lost to Follow-up|24|||
126109155|NCT04796896|453694225|FG001|Overall Study|Lost to Follow-up|15|||
126109156|NCT04796896|453694226|FG002|Overall Study|Lost to Follow-up|6|||
126109157|NCT04796896|453694227|FG003|Overall Study|Lost to Follow-up|4|||
126109158|NCT04796896|453694228|FG004|Overall Study|Lost to Follow-up|21|||
126109159|NCT04796896|453694229|FG005|Overall Study|Lost to Follow-up|55|||
126109160|NCT04796896|453694230|FG006|Overall Study|Lost to Follow-up|237|||
126109161|NCT04796896|453694231|FG007|Overall Study|Lost to Follow-up|52|||
126109162|NCT04796896|453694232|FG008|Overall Study|Lost to Follow-up|221|||
126109163|NCT04796896|453694233|FG009|Overall Study|Lost to Follow-up|43|||
126109164|NCT04796896|453694234|FG010|Overall Study|Lost to Follow-up|142|||
126109165|NCT04796896|453694235|FG011|Overall Study|Lost to Follow-up|18|||
126109166|NCT04796896|453694224|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
126109167|NCT04796896|453694225|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
126109168|NCT04796896|453694226|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
126109169|NCT04796896|453694227|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
126109170|NCT04796896|453694228|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
126109171|NCT04796896|453694229|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
126109172|NCT04796896|453694230|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
126109173|NCT04796896|453694231|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
126109174|NCT04796896|453694232|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
126109175|NCT04796896|453694233|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
126109176|NCT04796896|453694234|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
126109177|NCT04796896|453694235|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
125894394|NCT03390101|452914076|FG001|Weeks 0-12|Withdrawal by Subject|1|||
125894395|NCT03390101|452914077|FG002|Weeks 0-12|Withdrawal by Subject|1|||
125894396|NCT03390101|452914075|FG000|Weeks 0-12|Lost to Follow-up|0|||
125894397|NCT03390101|452914076|FG001|Weeks 0-12|Lost to Follow-up|1|||
125894398|NCT03390101|452914077|FG002|Weeks 0-12|Lost to Follow-up|0|||
125894399|NCT03390101|452914075|FG000|Weeks 12-54|Withdrawal by Subject|0|||
125894400|NCT03390101|452914076|FG001|Weeks 12-54|Withdrawal by Subject|3|||
125894401|NCT03390101|452914077|FG002|Weeks 12-54|Withdrawal by Subject|1|||
125894402|NCT03390101|452914075|FG000|Weeks 12-54|Pregnancy|1|||
125894403|NCT03390101|452914076|FG001|Weeks 12-54|Pregnancy|0|||
125894404|NCT03390101|452914077|FG002|Weeks 12-54|Pregnancy|0|||
125894405|NCT03390101|452914075|FG000|Weeks 12-54|Adverse Event|2|||
125894406|NCT03390101|452914076|FG001|Weeks 12-54|Adverse Event|1|||
125894407|NCT03390101|452914077|FG002|Weeks 12-54|Adverse Event|1|||
125894408|NCT00281658|452914078|FG000|Randomized Phase|Adverse Event|0|||
125894409|NCT00281658|452914079|FG001|Randomized Phase|Adverse Event|2|||
125894410|NCT00281658|452914080|FG002|Randomized Phase|Adverse Event|0|||
125894411|NCT00281658|452914081|FG003|Randomized Phase|Adverse Event|0|||
125894412|NCT00281658|452914078|FG000|Randomized Phase|Lost to Follow-up|34|||
125894413|NCT00281658|452914079|FG001|Randomized Phase|Lost to Follow-up|27|||
125894414|NCT00281658|452914080|FG002|Randomized Phase|Lost to Follow-up|0|||
125894415|NCT00281658|452914081|FG003|Randomized Phase|Lost to Follow-up|0|||
125894416|NCT00281658|452914078|FG000|Randomized Phase|Withdrawal by Subject|8|||
126059527|NCT00087516|453512470|FG002|Overall Study|Lost to Follow-up|5|||
126059528|NCT00087516|453512471|FG003|Overall Study|Lost to Follow-up|5|||
126059529|NCT00087516|453512468|FG000|Overall Study|Protocol Violation|4|||
126059530|NCT00087516|453512469|FG001|Overall Study|Protocol Violation|8|||
126059531|NCT00087516|453512470|FG002|Overall Study|Protocol Violation|3|||
126059532|NCT00087516|453512471|FG003|Overall Study|Protocol Violation|6|||
126059533|NCT00087516|453512468|FG000|Overall Study|Withdrawal by Subject|16|||
126059534|NCT00087516|453512469|FG001|Overall Study|Withdrawal by Subject|27|||
126059535|NCT00087516|453512470|FG002|Overall Study|Withdrawal by Subject|11|||
126059536|NCT00087516|453512471|FG003|Overall Study|Withdrawal by Subject|12|||
126059537|NCT00087516|453512468|FG000|Overall Study|Site terminated|0|||
126059538|NCT00087516|453512469|FG001|Overall Study|Site terminated|2|||
126059539|NCT00087516|453512470|FG002|Overall Study|Site terminated|1|||
126059540|NCT00087516|453512471|FG003|Overall Study|Site terminated|0|||
126059541|NCT00087516|453512468|FG000|Overall Study|Protocol specified discontinuation|35|||
126059542|NCT00087516|453512469|FG001|Overall Study|Protocol specified discontinuation|33|||
126059543|NCT00087516|453512470|FG002|Overall Study|Protocol specified discontinuation|33|||
126059544|NCT00087516|453512471|FG003|Overall Study|Protocol specified discontinuation|26|||
126059545|NCT00087516|453512468|FG000|Overall Study|Patient moved|3|||
126059546|NCT00087516|453512469|FG001|Overall Study|Patient moved|2|||
126059547|NCT00087516|453512470|FG002|Overall Study|Patient moved|1|||
126059548|NCT00087516|453512471|FG003|Overall Study|Patient moved|0|||
126059549|NCT00087516|453512468|FG000|Overall Study|Patient was non-compliant|3|||
126059550|NCT00087516|453512469|FG001|Overall Study|Patient was non-compliant|1|||
126059551|NCT00087516|453512470|FG002|Overall Study|Patient was non-compliant|0|||
126059552|NCT00087516|453512471|FG003|Overall Study|Patient was non-compliant|0|||
126059553|NCT00087516|453512468|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
126059554|NCT00087516|453512469|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
126059555|NCT00087516|453512470|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
126059556|NCT00087516|453512471|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
126059557|NCT00087516|453512468|FG000|Overall Study|Other|0|||
126059558|NCT00087516|453512469|FG001|Overall Study|Other|0|||
126059559|NCT00087516|453512470|FG002|Overall Study|Other|1|||
126059560|NCT00087516|453512471|FG003|Overall Study|Other|0|||
126059561|NCT02065895|453512472|FG000|Overall Study|Protocol Violation|1|||
126059562|NCT02065895|453512473|FG001|Overall Study|Protocol Violation|0|||
126059563|NCT02065895|453512474|FG002|Overall Study|Protocol Violation|0|||
126059564|NCT02065895|453512475|FG003|Overall Study|Protocol Violation|1|||
126059565|NCT02065895|453512476|FG004|Overall Study|Protocol Violation|0|||
126059566|NCT02065895|453512477|FG005|Overall Study|Protocol Violation|0|||
126059567|NCT02065895|453512472|FG000|Overall Study|Scheduling conflicts|0|||
126059568|NCT02065895|453512473|FG001|Overall Study|Scheduling conflicts|1|||
126059569|NCT02065895|453512474|FG002|Overall Study|Scheduling conflicts|0|||
126059570|NCT02065895|453512475|FG003|Overall Study|Scheduling conflicts|0|||
126059571|NCT02065895|453512476|FG004|Overall Study|Scheduling conflicts|0|||
126059572|NCT02065895|453512477|FG005|Overall Study|Scheduling conflicts|0|||
126059573|NCT00569166|453512482|FG000|Overall Study|Withdrawal by Subject|7|||
126059574|NCT00569166|453512483|FG001|Overall Study|Withdrawal by Subject|5|||
126059575|NCT00569166|453512484|FG002|Overall Study|Withdrawal by Subject|3|||
126059576|NCT00569166|453512482|FG000|Overall Study|Lost to Follow-up|2|||
126059577|NCT00569166|453512483|FG001|Overall Study|Lost to Follow-up|1|||
126059578|NCT00569166|453512484|FG002|Overall Study|Lost to Follow-up|1|||
126059579|NCT05005247|453512485|FG000|Overall Study|Withdrawal by Subject|0|||
126059580|NCT05005247|453512486|FG001|Overall Study|Withdrawal by Subject|1|||
126059581|NCT05005247|453512487|FG002|Overall Study|Withdrawal by Subject|0|||
126109178|NCT04796896|453694224|FG000|Overall Study|Physician Decision|1|||
126109179|NCT04796896|453694225|FG001|Overall Study|Physician Decision|0|||
126109180|NCT04796896|453694226|FG002|Overall Study|Physician Decision|0|||
126109181|NCT04796896|453694227|FG003|Overall Study|Physician Decision|0|||
126109182|NCT04796896|453694228|FG004|Overall Study|Physician Decision|0|||
126109183|NCT04796896|453694229|FG005|Overall Study|Physician Decision|3|||
126109184|NCT04796896|453694230|FG006|Overall Study|Physician Decision|18|||
126109185|NCT04796896|453694231|FG007|Overall Study|Physician Decision|1|||
126109186|NCT04796896|453694232|FG008|Overall Study|Physician Decision|7|||
126109187|NCT04796896|453694233|FG009|Overall Study|Physician Decision|0|||
126109188|NCT04796896|453694234|FG010|Overall Study|Physician Decision|5|||
126109189|NCT04796896|453694235|FG011|Overall Study|Physician Decision|0|||
126109190|NCT04796896|453694224|FG000|Overall Study|Withdrawal by Subject|36|||
126109191|NCT04796896|453694225|FG001|Overall Study|Withdrawal by Subject|31|||
126109192|NCT04796896|453694226|FG002|Overall Study|Withdrawal by Subject|11|||
126109193|NCT04796896|453694227|FG003|Overall Study|Withdrawal by Subject|8|||
126109194|NCT04796896|453694228|FG004|Overall Study|Withdrawal by Subject|16|||
126109195|NCT04796896|453694229|FG005|Overall Study|Withdrawal by Subject|162|||
126109196|NCT04796896|453694230|FG006|Overall Study|Withdrawal by Subject|299|||
126109197|NCT04796896|453694231|FG007|Overall Study|Withdrawal by Subject|149|||
126109198|NCT04796896|453694232|FG008|Overall Study|Withdrawal by Subject|303|||
126109199|NCT04796896|453694233|FG009|Overall Study|Withdrawal by Subject|94|||
126109200|NCT04796896|453694234|FG010|Overall Study|Withdrawal by Subject|192|||
126109201|NCT04796896|453694235|FG011|Overall Study|Withdrawal by Subject|16|||
126109202|NCT04796896|453694224|FG000|Overall Study|Other Than Specified|6|||
126109203|NCT04796896|453694225|FG001|Overall Study|Other Than Specified|5|||
126109204|NCT04796896|453694226|FG002|Overall Study|Other Than Specified|3|||
126109205|NCT04796896|453694227|FG003|Overall Study|Other Than Specified|2|||
126109206|NCT04796896|453694228|FG004|Overall Study|Other Than Specified|6|||
126109207|NCT04796896|453694229|FG005|Overall Study|Other Than Specified|31|||
126109208|NCT04796896|453694230|FG006|Overall Study|Other Than Specified|86|||
126109209|NCT04796896|453694231|FG007|Overall Study|Other Than Specified|66|||
126109210|NCT04796896|453694232|FG008|Overall Study|Other Than Specified|388|||
126109211|NCT04796896|453694233|FG009|Overall Study|Other Than Specified|48|||
126109212|NCT04796896|453694234|FG010|Overall Study|Other Than Specified|258|||
126109213|NCT04796896|453694235|FG011|Overall Study|Other Than Specified|4|||
126109214|NCT04796896|453694224|FG000|Overall Study|Protocol Deviation|0|||
126109215|NCT04796896|453694225|FG001|Overall Study|Protocol Deviation|0|||
126109216|NCT04796896|453694226|FG002|Overall Study|Protocol Deviation|0|||
125894417|NCT00281658|452914079|FG001|Randomized Phase|Withdrawal by Subject|7|||
125894418|NCT00281658|452914080|FG002|Randomized Phase|Withdrawal by Subject|0|||
125894419|NCT00281658|452914081|FG003|Randomized Phase|Withdrawal by Subject|0|||
125894420|NCT00281658|452914078|FG000|Randomized Phase|Study closed/terminated|1|||
125894421|NCT00281658|452914079|FG001|Randomized Phase|Study closed/terminated|1|||
125894422|NCT00281658|452914080|FG002|Randomized Phase|Study closed/terminated|0|||
125894423|NCT00281658|452914081|FG003|Randomized Phase|Study closed/terminated|0|||
126109217|NCT04796896|453694227|FG003|Overall Study|Protocol Deviation|1|||
126109218|NCT04796896|453694228|FG004|Overall Study|Protocol Deviation|1|||
126109219|NCT04796896|453694229|FG005|Overall Study|Protocol Deviation|2|||
126109220|NCT04796896|453694230|FG006|Overall Study|Protocol Deviation|2|||
126109221|NCT04796896|453694231|FG007|Overall Study|Protocol Deviation|2|||
126109222|NCT04796896|453694232|FG008|Overall Study|Protocol Deviation|2|||
126109223|NCT04796896|453694233|FG009|Overall Study|Protocol Deviation|1|||
126109224|NCT04796896|453694234|FG010|Overall Study|Protocol Deviation|0|||
126109225|NCT04796896|453694235|FG011|Overall Study|Protocol Deviation|0|||
126109226|NCT04796896|453694224|FG000|Overall Study|Missing|0|||
126109227|NCT04796896|453694225|FG001|Overall Study|Missing|0|||
126109228|NCT04796896|453694226|FG002|Overall Study|Missing|0|||
126109229|NCT04796896|453694227|FG003|Overall Study|Missing|0|||
126109230|NCT04796896|453694228|FG004|Overall Study|Missing|0|||
126109231|NCT04796896|453694229|FG005|Overall Study|Missing|0|||
126109232|NCT04796896|453694230|FG006|Overall Study|Missing|2|||
126109233|NCT04796896|453694231|FG007|Overall Study|Missing|1|||
126109234|NCT04796896|453694232|FG008|Overall Study|Missing|2|||
125894424|NCT00281658|452914078|FG000|Randomized Phase|Disease progression|36|||
125894425|NCT00281658|452914079|FG001|Randomized Phase|Disease progression|27|||
125894426|NCT00281658|452914080|FG002|Randomized Phase|Disease progression|0|||
125894427|NCT00281658|452914081|FG003|Randomized Phase|Disease progression|0|||
125894428|NCT00281658|452914078|FG000|Randomized Phase|Physician Decision|1|||
125894429|NCT00281658|452914079|FG001|Randomized Phase|Physician Decision|1|||
125894430|NCT00281658|452914080|FG002|Randomized Phase|Physician Decision|0|||
125894431|NCT00281658|452914081|FG003|Randomized Phase|Physician Decision|0|||
125894432|NCT00281658|452914078|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
125894433|NCT00281658|452914079|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
125894434|NCT00281658|452914080|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
125894435|NCT00281658|452914081|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
125894436|NCT00281658|452914078|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
125894437|NCT00281658|452914079|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
125894438|NCT00281658|452914080|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
125894439|NCT00281658|452914081|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
125894440|NCT00281658|452914078|FG000|Randomized Phase|Treatment ongoing|1|||
125894441|NCT00281658|452914079|FG001|Randomized Phase|Treatment ongoing|0|||
125894442|NCT00281658|452914080|FG002|Randomized Phase|Treatment ongoing|0|||
125894443|NCT00281658|452914081|FG003|Randomized Phase|Treatment ongoing|0|||
125894444|NCT00281658|452914078|FG000|Open Label Phase|Adverse Event|0|||
125894445|NCT00281658|452914079|FG001|Open Label Phase|Adverse Event|0|||
125894446|NCT00281658|452914080|FG002|Open Label Phase|Adverse Event|1|||
125894447|NCT00281658|452914081|FG003|Open Label Phase|Adverse Event|0|||
125894448|NCT00281658|452914078|FG000|Open Label Phase|Lost to Follow-up|0|||
125894449|NCT00281658|452914079|FG001|Open Label Phase|Lost to Follow-up|0|||
125894450|NCT00281658|452914080|FG002|Open Label Phase|Lost to Follow-up|16|||
125894451|NCT00281658|452914081|FG003|Open Label Phase|Lost to Follow-up|2|||
125894452|NCT00281658|452914078|FG000|Open Label Phase|Withdrawal by Subject|0|||
125894453|NCT00281658|452914079|FG001|Open Label Phase|Withdrawal by Subject|0|||
125894454|NCT00281658|452914080|FG002|Open Label Phase|Withdrawal by Subject|3|||
125894455|NCT00281658|452914081|FG003|Open Label Phase|Withdrawal by Subject|2|||
125894456|NCT00281658|452914078|FG000|Open Label Phase|Disease progression|0|||
125894457|NCT00281658|452914079|FG001|Open Label Phase|Disease progression|0|||
125894458|NCT00281658|452914080|FG002|Open Label Phase|Disease progression|18|||
125894459|NCT00281658|452914081|FG003|Open Label Phase|Disease progression|0|||
125894460|NCT00281658|452914078|FG000|Open Label Phase|Physician Decision|0|||
125894461|NCT00281658|452914079|FG001|Open Label Phase|Physician Decision|0|||
125894462|NCT00281658|452914080|FG002|Open Label Phase|Physician Decision|1|||
125894463|NCT00281658|452914081|FG003|Open Label Phase|Physician Decision|0|||
125894464|NCT00281658|452914078|FG000|Open Label Phase|Relocation of patient|0|||
125894465|NCT00281658|452914079|FG001|Open Label Phase|Relocation of patient|0|||
125894466|NCT00281658|452914080|FG002|Open Label Phase|Relocation of patient|1|||
125894467|NCT00281658|452914081|FG003|Open Label Phase|Relocation of patient|0|||
125894468|NCT00281658|452914078|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
125894469|NCT00281658|452914079|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
125894470|NCT00281658|452914080|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
125894471|NCT00281658|452914081|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
125894472|NCT01343693|452914082|FG000|Overall Study|Lost to Follow-up|9|||
125894473|NCT02704143|452914083|FG000|Overall Study|disease progression|10|||
126109235|NCT04796896|453694233|FG009|Overall Study|Missing|1|||
125894474|NCT01235598|452914084|FG000|Overall Study|Adverse Event|0|||
125894475|NCT01235598|452914085|FG001|Overall Study|Adverse Event|3|||
125894476|NCT01235598|452914084|FG000|Overall Study|Lack of Efficacy|0|||
125894477|NCT01235598|452914085|FG001|Overall Study|Lack of Efficacy|1|||
125894478|NCT01235598|452914084|FG000|Overall Study|Withdrawal by Subject|1|||
125894479|NCT01235598|452914085|FG001|Overall Study|Withdrawal by Subject|0|||
126109236|NCT04796896|453694234|FG010|Overall Study|Missing|1|||
126109237|NCT04796896|453694235|FG011|Overall Study|Missing|0|||
126109238|NCT04796896|453694224|FG000|Overall Study|Death|0|||
126109239|NCT04796896|453694225|FG001|Overall Study|Death|0|||
126109240|NCT04796896|453694226|FG002|Overall Study|Death|0|||
125894480|NCT02151773|452914086|FG000|Overall Study|Protocol Deviation|64|||
125894481|NCT00395343|452914087|FG000|Overall Study|Adverse Event|13|||
125894482|NCT00395343|452914088|FG001|Overall Study|Adverse Event|5|||
125894483|NCT00395343|452914087|FG000|Overall Study|Lack of Efficacy|0|||
125894484|NCT00395343|452914088|FG001|Overall Study|Lack of Efficacy|1|||
125894485|NCT00395343|452914087|FG000|Overall Study|Lost to Follow-up|4|||
125894486|NCT00395343|452914088|FG001|Overall Study|Lost to Follow-up|4|||
125894487|NCT00395343|452914087|FG000|Overall Study|Physician Decision|2|||
125894488|NCT00395343|452914088|FG001|Overall Study|Physician Decision|4|||
125894489|NCT00395343|452914087|FG000|Overall Study|Protocol Violation|6|||
125894490|NCT00395343|452914088|FG001|Overall Study|Protocol Violation|8|||
125894491|NCT00395343|452914087|FG000|Overall Study|Withdrawal by Subject|11|||
125894492|NCT00395343|452914088|FG001|Overall Study|Withdrawal by Subject|12|||
125894493|NCT00395343|452914087|FG000|Overall Study|Other|5|||
125894494|NCT00395343|452914088|FG001|Overall Study|Other|2|||
125894495|NCT01463007|452914089|FG000|Overall Study|Physician Decision|1|||
125894496|NCT00387790|452914091|FG000|Overall Study|Adverse Event|5|||
125894497|NCT00387790|452914091|FG000|Overall Study|Lack of Efficacy|2|||
125894498|NCT00387790|452914091|FG000|Overall Study|Physician Decision|2|||
125894499|NCT00387790|452914091|FG000|Overall Study|Withdrawal by Subject|3|||
125894500|NCT00387790|452914091|FG000|Overall Study|Ineligible for study|2|||
125894501|NCT00444678|452914092|FG000|Overall Study|Toxicity|11|||
125894502|NCT00444678|452914092|FG000|Overall Study|Disease Progression|12|||
125894503|NCT00444678|452914092|FG000|Overall Study|Death|3|||
125894504|NCT00444678|452914092|FG000|Overall Study|Physician Decision|3|||
125894505|NCT00444678|452914092|FG000|Overall Study|Withdrawal by Subject|2|||
125894506|NCT00606905|452914093|FG000|Overall Study|No Pregnancy|9|||
125894507|NCT00606905|452914094|FG001|Overall Study|No Pregnancy|6|||
125894508|NCT00606905|452914093|FG000|Overall Study|Non-Index Pregnancy|1|||
125894509|NCT00606905|452914094|FG001|Overall Study|Non-Index Pregnancy|4|||
125894510|NCT00606905|452914093|FG000|Overall Study|Withdrew|5|||
125894511|NCT00606905|452914094|FG001|Overall Study|Withdrew|5|||
125894512|NCT03700684|452914103|FG000|Overall Study|COVID-19|0|||
125894513|NCT03700684|452914104|FG001|Overall Study|COVID-19|0|||
125894514|NCT03700684|452914105|FG002|Overall Study|COVID-19|2|||
125894515|NCT03319745|452914107|FG000|Overall Study|Death|1|||
125894516|NCT03319745|452914107|FG000|Overall Study|Toxicity Precluding Surgery|1|||
125894517|NCT00870103|452914108|FG000|Overall Study|Physician Decision|2|||
125894518|NCT00870103|452914108|FG000|Overall Study|Lost to Follow-up|2|||
125894519|NCT01317550|452914109|FG000|Overall Study|Withdrawal by Subject|1|||
125894520|NCT01317550|452914110|FG001|Overall Study|Withdrawal by Subject|0|||
125894521|NCT01317550|452914111|FG002|Overall Study|Withdrawal by Subject|0|||
125894522|NCT01317550|452914112|FG003|Overall Study|Withdrawal by Subject|0|||
125894523|NCT01317550|452914109|FG000|Overall Study|Lack of compliance study med|1|||
125894524|NCT01317550|452914110|FG001|Overall Study|Lack of compliance study med|0|||
125894525|NCT01317550|452914111|FG002|Overall Study|Lack of compliance study med|0|||
125894526|NCT01317550|452914112|FG003|Overall Study|Lack of compliance study med|0|||
125894527|NCT03179202|452914113|FG000|Overall Study|Screen Failure|67|||
125894528|NCT03179202|452914113|FG000|Overall Study|Subject Lost to Follow Up|12|||
125894529|NCT03179202|452914113|FG000|Overall Study|Withdrawal by Subject|7|||
125894530|NCT03179202|452914113|FG000|Overall Study|Adverse Event|3|||
125894531|NCT03179202|452914113|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
125894532|NCT03179202|452914113|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
125894533|NCT03255629|452914114|FG000|Overall Study|Adverse Event|1|||
125894534|NCT03255629|452914115|FG001|Overall Study|Adverse Event|0|||
125894535|NCT03255629|452914114|FG000|Overall Study|did not experience hypoglycemia|2|||
125894536|NCT03255629|452914115|FG001|Overall Study|did not experience hypoglycemia|1|||
125894537|NCT01120782|452914116|FG000|Overall Study|Test article shipping error|11|||
125894538|NCT00859638|452914117|FG000|Overall Study|Lost to Follow-up|6|||
125894539|NCT00859638|452914118|FG001|Overall Study|Lost to Follow-up|1|||
125894540|NCT00859638|452914117|FG000|Overall Study|Withdrawal by Subject|3|||
125894541|NCT00859638|452914118|FG001|Overall Study|Withdrawal by Subject|2|||
125894542|NCT00859638|452914117|FG000|Overall Study|Ill health|1|||
125894543|NCT00859638|452914118|FG001|Overall Study|Ill health|1|||
125894544|NCT02969408|452914120|FG000|Overall Study|Adverse Event|2|||
125894545|NCT02969408|452914120|FG000|Overall Study|Withdrawal by Subject|8|||
125894546|NCT02969408|452914120|FG000|Overall Study|Lost to Follow-up|4|||
125894547|NCT02969408|452914120|FG000|Overall Study|Protocol Violation|1|||
125894548|NCT02969408|452914120|FG000|Overall Study|Other than specified|1|||
125894549|NCT02779556|452914124|FG000|Baseline|Partial baseline interview completed|1|||
125894550|NCT02779556|452914125|FG001|Baseline|Partial baseline interview completed|0|||
125894551|NCT02779556|452914124|FG000|3 Months|Lost to Follow-up|40|||
125894552|NCT02779556|452914125|FG001|3 Months|Lost to Follow-up|29|||
125894553|NCT02779556|452914124|FG000|3 Months|Missed 3 month clinic visit|27|||
125894554|NCT02779556|452914125|FG001|3 Months|Missed 3 month clinic visit|19|||
125894555|NCT02779556|452914124|FG000|6 Month|Lost to Follow-up|33|||
125894556|NCT02779556|452914125|FG001|6 Month|Lost to Follow-up|39|||
125894557|NCT02779556|452914124|FG000|6 Month HbA1c|No value collected during window|69|||
125894558|NCT02779556|452914125|FG001|6 Month HbA1c|No value collected during window|50|||
125894559|NCT02779556|452914124|FG000|12 Month HbA1c|No value collected during window|138|||
125894560|NCT02779556|452914125|FG001|12 Month HbA1c|No value collected during window|102|||
125894561|NCT03110770|452914129|FG000|Overall Study|Death|1|||
125894562|NCT03110770|452914130|FG001|Overall Study|Death|0|||
125894563|NCT03110770|452914131|FG002|Overall Study|Death|0|||
125894564|NCT03110770|452914132|FG003|Overall Study|Death|1|||
125894565|NCT03110770|452914133|FG004|Overall Study|Death|0|||
125894566|NCT03110770|452914129|FG000|Overall Study|Enrolled but did not receive product|0|||
125894567|NCT03110770|452914130|FG001|Overall Study|Enrolled but did not receive product|0|||
125894568|NCT03110770|452914131|FG002|Overall Study|Enrolled but did not receive product|0|||
125894569|NCT03110770|452914132|FG003|Overall Study|Enrolled but did not receive product|8|||
125894570|NCT03110770|452914133|FG004|Overall Study|Enrolled but did not receive product|7|||
125894571|NCT03110770|452914129|FG000|Overall Study|Lost to Follow-up|0|||
125894572|NCT03110770|452914130|FG001|Overall Study|Lost to Follow-up|0|||
125894573|NCT03110770|452914131|FG002|Overall Study|Lost to Follow-up|0|||
125894574|NCT03110770|452914132|FG003|Overall Study|Lost to Follow-up|53|||
125894575|NCT03110770|452914133|FG004|Overall Study|Lost to Follow-up|45|||
125894576|NCT03110770|452914129|FG000|Overall Study|Investigator Decision|0|||
125894577|NCT03110770|452914130|FG001|Overall Study|Investigator Decision|0|||
125894578|NCT03110770|452914131|FG002|Overall Study|Investigator Decision|0|||
125894579|NCT03110770|452914132|FG003|Overall Study|Investigator Decision|5|||
125894580|NCT03110770|452914133|FG004|Overall Study|Investigator Decision|3|||
125894581|NCT03110770|452914129|FG000|Overall Study|Withdrawal by Subject|0|||
125894582|NCT03110770|452914130|FG001|Overall Study|Withdrawal by Subject|0|||
125894583|NCT03110770|452914131|FG002|Overall Study|Withdrawal by Subject|0|||
125894584|NCT03110770|452914132|FG003|Overall Study|Withdrawal by Subject|24|||
125894585|NCT03110770|452914133|FG004|Overall Study|Withdrawal by Subject|24|||
125894586|NCT03110770|452914129|FG000|Overall Study|Moved from area|5|||
125894587|NCT03110770|452914130|FG001|Overall Study|Moved from area|0|||
125894588|NCT03110770|452914131|FG002|Overall Study|Moved from area|2|||
125894589|NCT03110770|452914132|FG003|Overall Study|Moved from area|42|||
125894590|NCT03110770|452914133|FG004|Overall Study|Moved from area|43|||
125894591|NCT03110770|452914129|FG000|Overall Study|Illness/Injury unrelated to product|0|||
125894592|NCT03110770|452914130|FG001|Overall Study|Illness/Injury unrelated to product|0|||
125894593|NCT03110770|452914131|FG002|Overall Study|Illness/Injury unrelated to product|0|||
125894594|NCT03110770|452914132|FG003|Overall Study|Illness/Injury unrelated to product|0|||
125894595|NCT03110770|452914133|FG004|Overall Study|Illness/Injury unrelated to product|1|||
125894596|NCT01767142|452914136|FG000|Overall Study|Lost to Follow-up|3|||
125894597|NCT02082340|452914142|FG000|Overall Study|Lost to Follow-up|1|||
125894598|NCT02082340|452914143|FG001|Overall Study|Lost to Follow-up|1|||
125894599|NCT01625260|452914144|FG000|Overall Study|Adverse Event|3|||
125894600|NCT01625260|452914145|FG001|Overall Study|Adverse Event|0|||
125894601|NCT01625260|452914144|FG000|Overall Study|Study Terminated by Investigator|2|||
125894602|NCT01625260|452914145|FG001|Overall Study|Study Terminated by Investigator|0|||
125894603|NCT01625260|452914144|FG000|Overall Study|Disease Progression|2|||
125894604|NCT01625260|452914145|FG001|Overall Study|Disease Progression|0|||
125894605|NCT01625260|452914144|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
125894606|NCT01625260|452914145|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
125894607|NCT02937584|452914146|FG000|Period 1|Adverse Event|1|||
125894608|NCT02937584|452914147|FG001|Period 1|Adverse Event|2|||
125894609|NCT02937584|452914146|FG000|Washout|Adverse Event|0|||
125894610|NCT02937584|452914147|FG001|Washout|Adverse Event|1|||
125894611|NCT00635219|452914148|FG000|Overall Study|Adverse Event|12|||
125894612|NCT00635219|452914149|FG001|Overall Study|Adverse Event|10|||
125894613|NCT00635219|452914150|FG002|Overall Study|Adverse Event|18|||
125894614|NCT00635219|452914151|FG003|Overall Study|Adverse Event|15|||
126059582|NCT00484198|453512488|FG000|Overall Study|Participant Withdrew Consent|12|||
126059583|NCT00484198|453512489|FG001|Overall Study|Participant Withdrew Consent|21|||
126059584|NCT00484198|453512490|FG002|Overall Study|Participant Withdrew Consent|47|||
126059585|NCT00484198|453512491|FG003|Overall Study|Participant Withdrew Consent|59|||
126059586|NCT00484198|453512488|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
126059587|NCT00484198|453512489|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
126059588|NCT00484198|453512490|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
126059589|NCT00484198|453512491|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
125894615|NCT00635219|452914152|FG004|Overall Study|Adverse Event|19|||
125894616|NCT00635219|452914148|FG000|Overall Study|Lack of Efficacy|5|||
125894617|NCT00635219|452914149|FG001|Overall Study|Lack of Efficacy|6|||
125894618|NCT00635219|452914150|FG002|Overall Study|Lack of Efficacy|3|||
125894619|NCT00635219|452914151|FG003|Overall Study|Lack of Efficacy|4|||
125894620|NCT00635219|452914152|FG004|Overall Study|Lack of Efficacy|6|||
125894621|NCT00635219|452914148|FG000|Overall Study|Non-compliance With Study Product|0|||
125894622|NCT00635219|452914149|FG001|Overall Study|Non-compliance With Study Product|0|||
125894623|NCT00635219|452914150|FG002|Overall Study|Non-compliance With Study Product|0|||
125894624|NCT00635219|452914151|FG003|Overall Study|Non-compliance With Study Product|2|||
125894625|NCT00635219|452914152|FG004|Overall Study|Non-compliance With Study Product|1|||
125894626|NCT00635219|452914148|FG000|Overall Study|Protocol Violation|0|||
125894627|NCT00635219|452914149|FG001|Overall Study|Protocol Violation|2|||
125894628|NCT00635219|452914150|FG002|Overall Study|Protocol Violation|3|||
125894629|NCT00635219|452914151|FG003|Overall Study|Protocol Violation|2|||
125894630|NCT00635219|452914152|FG004|Overall Study|Protocol Violation|4|||
125894631|NCT00635219|452914148|FG000|Overall Study|Withdrawal of Consent|8|||
125894632|NCT00635219|452914149|FG001|Overall Study|Withdrawal of Consent|6|||
125894633|NCT00635219|452914150|FG002|Overall Study|Withdrawal of Consent|8|||
125894634|NCT00635219|452914151|FG003|Overall Study|Withdrawal of Consent|11|||
125894635|NCT00635219|452914152|FG004|Overall Study|Withdrawal of Consent|8|||
125894636|NCT00635219|452914148|FG000|Overall Study|Lost to Follow-up|0|||
125894637|NCT00635219|452914149|FG001|Overall Study|Lost to Follow-up|0|||
125894638|NCT00635219|452914150|FG002|Overall Study|Lost to Follow-up|2|||
125894639|NCT00635219|452914151|FG003|Overall Study|Lost to Follow-up|0|||
125894640|NCT00635219|452914152|FG004|Overall Study|Lost to Follow-up|3|||
125894641|NCT00635219|452914148|FG000|Overall Study|Administrative or Other Reasons|0|||
125894642|NCT00635219|452914149|FG001|Overall Study|Administrative or Other Reasons|1|||
125894643|NCT00635219|452914150|FG002|Overall Study|Administrative or Other Reasons|1|||
125894644|NCT00635219|452914151|FG003|Overall Study|Administrative or Other Reasons|0|||
125894645|NCT00635219|452914152|FG004|Overall Study|Administrative or Other Reasons|1|||
125894646|NCT04075734|452914161|FG000|Overall Study|Lost to Follow-up|1|||
125894647|NCT04075734|452914162|FG001|Overall Study|Lost to Follow-up|1|||
125894648|NCT04075734|452914163|FG002|Overall Study|Lost to Follow-up|0|||
125894649|NCT04075734|452914161|FG000|Overall Study|Withdrawal by Subject|3|||
125894650|NCT04075734|452914162|FG001|Overall Study|Withdrawal by Subject|0|||
125894651|NCT04075734|452914163|FG002|Overall Study|Withdrawal by Subject|0|||
125894652|NCT01598129|452914164|FG000|Overall Study|Disease progression|6|||
125894653|NCT01598129|452914164|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
125894654|NCT01598129|452914164|FG000|Overall Study|Withdrawal by Subject|1|||
125894655|NCT00591318|452914165|FG000|Overall Study|Lack of Efficacy|2|||
125894656|NCT00591318|452914166|FG001|Overall Study|Lack of Efficacy|0|||
125894657|NCT00591318|452914165|FG000|Overall Study|Adverse Event|2|||
125894658|NCT00591318|452914166|FG001|Overall Study|Adverse Event|0|||
125894659|NCT01776307|452914167|FG000|Overall Study|Not dosed|0|||
125894660|NCT01776307|452914168|FG001|Overall Study|Not dosed|0|||
125894661|NCT01776307|452914169|FG002|Overall Study|Not dosed|1|||
126109241|NCT04796896|453694227|FG003|Overall Study|Death|0|||
126109242|NCT04796896|453694228|FG004|Overall Study|Death|0|||
125894662|NCT03615040|452914170|FG000|Overall Study|Withdrawal by Subject|2|||
126109243|NCT04796896|453694229|FG005|Overall Study|Death|0|||
126109244|NCT04796896|453694230|FG006|Overall Study|Death|0|||
126109245|NCT04796896|453694231|FG007|Overall Study|Death|0|||
126109246|NCT04796896|453694232|FG008|Overall Study|Death|1|||
126109247|NCT04796896|453694233|FG009|Overall Study|Death|0|||
125894663|NCT03615040|452914171|FG001|Overall Study|Withdrawal by Subject|1|||
125894664|NCT03615040|452914170|FG000|Overall Study|Physician Decision|2|||
125894665|NCT03615040|452914171|FG001|Overall Study|Physician Decision|2|||
125894666|NCT03615040|452914170|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
125894667|NCT03615040|452914171|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
126059590|NCT00484198|453512488|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
126059591|NCT00484198|453512489|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
126059592|NCT00484198|453512490|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
126059593|NCT00484198|453512491|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
126059594|NCT00484198|453512488|FG000|Overall Study|Adverse Event|3|||
126059595|NCT00484198|453512489|FG001|Overall Study|Adverse Event|11|||
126059596|NCT00484198|453512490|FG002|Overall Study|Adverse Event|32|||
126059597|NCT00484198|453512491|FG003|Overall Study|Adverse Event|31|||
126059598|NCT00484198|453512488|FG000|Overall Study|Protocol Violation|0|||
126059599|NCT00484198|453512489|FG001|Overall Study|Protocol Violation|5|||
126059600|NCT00484198|453512490|FG002|Overall Study|Protocol Violation|6|||
126059601|NCT00484198|453512491|FG003|Overall Study|Protocol Violation|8|||
126059602|NCT00484198|453512488|FG000|Overall Study|Other|7|||
126059603|NCT00484198|453512489|FG001|Overall Study|Other|10|||
126059604|NCT00484198|453512490|FG002|Overall Study|Other|31|||
126059605|NCT00484198|453512491|FG003|Overall Study|Other|28|||
126059606|NCT00486954|453512493|FG000|Pilot Part|Adverse Event|4|||
126059607|NCT00486954|453512494|FG001|Pilot Part|Adverse Event|0|||
126059608|NCT00486954|453512495|FG002|Pilot Part|Adverse Event|5|||
126059609|NCT00486954|453512496|FG003|Pilot Part|Adverse Event|0|||
126059610|NCT00486954|453512497|FG004|Pilot Part|Adverse Event|0|||
126059611|NCT00486954|453512493|FG000|Pilot Part|Disease Progression|2|||
126059612|NCT00486954|453512494|FG001|Pilot Part|Disease Progression|0|||
126109248|NCT04796896|453694234|FG010|Overall Study|Death|0|||
126059613|NCT00486954|453512495|FG002|Pilot Part|Disease Progression|1|||
126059614|NCT00486954|453512496|FG003|Pilot Part|Disease Progression|0|||
126059615|NCT00486954|453512497|FG004|Pilot Part|Disease Progression|0|||
126109249|NCT04796896|453694235|FG011|Overall Study|Death|0|||
126109250|NCT01177787|453694236|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
126109251|NCT01177787|453694236|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
126109252|NCT01177787|453694236|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
126109253|NCT00402363|453694237|FG000|Overall Study|Adverse Event|9|||
126109254|NCT00402363|453694238|FG001|Overall Study|Adverse Event|14|||
126109255|NCT00402363|453694239|FG002|Overall Study|Adverse Event|2|||
126109256|NCT00402363|453694240|FG003|Overall Study|Adverse Event|2|||
126109257|NCT00402363|453694237|FG000|Overall Study|Withdrew Consent|10|||
126109258|NCT00402363|453694238|FG001|Overall Study|Withdrew Consent|5|||
126109259|NCT00402363|453694239|FG002|Overall Study|Withdrew Consent|2|||
126109260|NCT00402363|453694240|FG003|Overall Study|Withdrew Consent|1|||
126109261|NCT00402363|453694237|FG000|Overall Study|Protocol Violation|3|||
126109262|NCT00402363|453694238|FG001|Overall Study|Protocol Violation|5|||
126109263|NCT00402363|453694239|FG002|Overall Study|Protocol Violation|0|||
126109264|NCT00402363|453694240|FG003|Overall Study|Protocol Violation|3|||
126109265|NCT00402363|453694237|FG000|Overall Study|Lost to Follow-up|5|||
126109266|NCT00402363|453694238|FG001|Overall Study|Lost to Follow-up|4|||
126109267|NCT00402363|453694239|FG002|Overall Study|Lost to Follow-up|0|||
126109268|NCT00402363|453694240|FG003|Overall Study|Lost to Follow-up|2|||
126109269|NCT00402363|453694237|FG000|Overall Study|"Captured as Other"|6|||
126109270|NCT00402363|453694238|FG001|Overall Study|"Captured as Other"|2|||
126109271|NCT00402363|453694239|FG002|Overall Study|"Captured as Other"|2|||
126109272|NCT00402363|453694240|FG003|Overall Study|"Captured as Other"|2|||
126109273|NCT02634346|453694241|FG000|Overall Study|Withdrawal by Subject|8|||
126109274|NCT02634346|453694242|FG001|Overall Study|Withdrawal by Subject|9|||
126109275|NCT02634346|453694243|FG002|Overall Study|Withdrawal by Subject|8|||
126109276|NCT02634346|453694241|FG000|Overall Study|Adverse Event|2|||
126109277|NCT02634346|453694242|FG001|Overall Study|Adverse Event|2|||
126109278|NCT02634346|453694243|FG002|Overall Study|Adverse Event|7|||
126109279|NCT02634346|453694241|FG000|Overall Study|Lack of Efficacy|1|||
126109280|NCT02634346|453694242|FG001|Overall Study|Lack of Efficacy|2|||
126109281|NCT02634346|453694243|FG002|Overall Study|Lack of Efficacy|8|||
126109282|NCT02634346|453694241|FG000|Overall Study|Lost to Follow-up|1|||
126109283|NCT02634346|453694242|FG001|Overall Study|Lost to Follow-up|0|||
126109284|NCT02634346|453694243|FG002|Overall Study|Lost to Follow-up|0|||
126109285|NCT02634346|453694241|FG000|Overall Study|Protocol Violation|0|||
126109286|NCT02634346|453694242|FG001|Overall Study|Protocol Violation|1|||
126109287|NCT02634346|453694243|FG002|Overall Study|Protocol Violation|0|||
126109288|NCT01008696|453694245|FG000|Overall Study|Participant's evasion of hospital visit|5|||
126109289|NCT01008696|453694246|FG001|Overall Study|Participant's evasion of hospital visit|4|||
126109290|NCT01008696|453694245|FG000|Overall Study|Withdrawal by Subject|2|||
126109291|NCT01008696|453694246|FG001|Overall Study|Withdrawal by Subject|4|||
126109292|NCT01008696|453694245|FG000|Overall Study|Physician Decision|5|||
126109293|NCT01008696|453694246|FG001|Overall Study|Physician Decision|1|||
126109294|NCT01008696|453694245|FG000|Overall Study|Adverse Event|1|||
126109295|NCT01008696|453694246|FG001|Overall Study|Adverse Event|0|||
126109296|NCT01008696|453694245|FG000|Overall Study|Participants' non-cooperation|2|||
126109297|NCT01008696|453694246|FG001|Overall Study|Participants' non-cooperation|3|||
126109298|NCT01008696|453694245|FG000|Overall Study|Other|2|||
126109299|NCT01008696|453694246|FG001|Overall Study|Other|3|||
126109300|NCT01008696|453694245|FG000|Overall Study|Other|0|||
126109301|NCT01008696|453694246|FG001|Overall Study|Other|2|||
125894668|NCT03615040|452914170|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
125894669|NCT03615040|452914171|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
125894670|NCT03615040|452914170|FG000|Overall Study|Death|0|||
125894671|NCT03615040|452914171|FG001|Overall Study|Death|2|||
125894672|NCT04074161|452914176|FG000|Overall Study|Withdrawal by Subject|2|||
125894673|NCT04074161|452914177|FG001|Overall Study|Withdrawal by Subject|4|||
125894674|NCT04074161|452914178|FG002|Overall Study|Withdrawal by Subject|1|||
125894675|NCT04074161|452914176|FG000|Overall Study|Lost to Follow-up|4|||
125894676|NCT04074161|452914177|FG001|Overall Study|Lost to Follow-up|5|||
125894677|NCT04074161|452914178|FG002|Overall Study|Lost to Follow-up|3|||
125894678|NCT03890666|452914183|FG000|Overall Study|Withdrawal by Subject|0|||
126109302|NCT01676909|453694247|FG000|Overall Study|Withdrawal by Subject|3|||
126109303|NCT01676909|453694248|FG001|Overall Study|Withdrawal by Subject|5|||
126109304|NCT01676909|453694247|FG000|Overall Study|Lost to Follow-up|15|||
126109305|NCT01676909|453694248|FG001|Overall Study|Lost to Follow-up|9|||
126109306|NCT00823901|453694252|FG000|Overall Study|Adverse Event|1|||
126109307|NCT00823901|453694253|FG001|Overall Study|Adverse Event|1|||
126109308|NCT00823901|453694252|FG000|Overall Study|Lack of Efficacy|1|||
126109309|NCT00823901|453694253|FG001|Overall Study|Lack of Efficacy|0|||
126109310|NCT00823901|453694252|FG000|Overall Study|Lost to Follow-up|2|||
126109311|NCT00823901|453694253|FG001|Overall Study|Lost to Follow-up|1|||
126109312|NCT01369511|453694255|FG000|Overall Study|Adverse Event|1|||
126109313|NCT01369511|453694256|FG001|Overall Study|Adverse Event|1|||
126109314|NCT01369511|453694257|FG002|Overall Study|Adverse Event|5|||
126109315|NCT01369511|453694258|FG003|Overall Study|Adverse Event|0|||
126109316|NCT01369511|453694255|FG000|Overall Study|Entry criteria not met|2|||
126109317|NCT01369511|453694256|FG001|Overall Study|Entry criteria not met|0|||
126109318|NCT01369511|453694257|FG002|Overall Study|Entry criteria not met|0|||
126109319|NCT01369511|453694258|FG003|Overall Study|Entry criteria not met|1|||
126109320|NCT01369511|453694255|FG000|Overall Study|Lost to Follow-up|0|||
126109321|NCT01369511|453694256|FG001|Overall Study|Lost to Follow-up|1|||
126109322|NCT01369511|453694257|FG002|Overall Study|Lost to Follow-up|1|||
126109323|NCT01369511|453694258|FG003|Overall Study|Lost to Follow-up|2|||
126109324|NCT01369511|453694255|FG000|Overall Study|Protocol Violation|0|||
126109325|NCT01369511|453694256|FG001|Overall Study|Protocol Violation|1|||
126109326|NCT01369511|453694257|FG002|Overall Study|Protocol Violation|0|||
126109327|NCT01369511|453694258|FG003|Overall Study|Protocol Violation|2|||
126109328|NCT01369511|453694255|FG000|Overall Study|Physician Decision|3|||
126109329|NCT01369511|453694256|FG001|Overall Study|Physician Decision|4|||
126109330|NCT01369511|453694257|FG002|Overall Study|Physician Decision|0|||
126109331|NCT01369511|453694258|FG003|Overall Study|Physician Decision|0|||
126109332|NCT01369511|453694255|FG000|Overall Study|Sponsor decision|2|||
126109333|NCT01369511|453694256|FG001|Overall Study|Sponsor decision|0|||
126109334|NCT01369511|453694257|FG002|Overall Study|Sponsor decision|1|||
126109335|NCT01369511|453694258|FG003|Overall Study|Sponsor decision|0|||
126109336|NCT01369511|453694255|FG000|Overall Study|Withdrawal by Subject|5|||
126109337|NCT01369511|453694256|FG001|Overall Study|Withdrawal by Subject|6|||
126109338|NCT01369511|453694257|FG002|Overall Study|Withdrawal by Subject|4|||
126109339|NCT01369511|453694258|FG003|Overall Study|Withdrawal by Subject|6|||
126109340|NCT01376349|453694259|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
126109341|NCT01376349|453694260|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
126109342|NCT01376349|453694261|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
126109343|NCT01376349|453694259|FG000|Raondomized Treatment|Adverse Event|13|||
126109344|NCT01376349|453694260|FG001|Raondomized Treatment|Adverse Event|17|||
126109345|NCT01376349|453694261|FG002|Raondomized Treatment|Adverse Event|14|||
126109346|NCT01376349|453694259|FG000|Raondomized Treatment|Unkown|1|||
126109347|NCT01376349|453694260|FG001|Raondomized Treatment|Unkown|2|||
126109348|NCT01376349|453694261|FG002|Raondomized Treatment|Unkown|1|||
126109349|NCT01376349|453694259|FG000|Raondomized Treatment|Alternative Treatment|0|||
126109350|NCT01376349|453694260|FG001|Raondomized Treatment|Alternative Treatment|0|||
126109351|NCT01376349|453694261|FG002|Raondomized Treatment|Alternative Treatment|1|||
126109352|NCT01180998|453694262|FG000|Overall Study|Poor Vision|0|||
126109353|NCT01180998|453694263|FG001|Overall Study|Poor Vision|2|||
126109354|NCT01180998|453694264|FG002|Overall Study|Poor Vision|2|||
126109355|NCT01180998|453694262|FG000|Overall Study|Lost to Follow-up|0|||
126109356|NCT01180998|453694263|FG001|Overall Study|Lost to Follow-up|0|||
126109357|NCT01180998|453694264|FG002|Overall Study|Lost to Follow-up|1|||
126109358|NCT01180998|453694262|FG000|Overall Study|Protocol Violation|1|||
126109359|NCT01180998|453694263|FG001|Overall Study|Protocol Violation|2|||
126109360|NCT01180998|453694264|FG002|Overall Study|Protocol Violation|0|||
126109361|NCT01180998|453694262|FG000|Overall Study|Withdrawal by Subject|0|||
126109362|NCT01180998|453694263|FG001|Overall Study|Withdrawal by Subject|0|||
126109363|NCT01180998|453694264|FG002|Overall Study|Withdrawal by Subject|1|||
126109364|NCT01180998|453694262|FG000|Overall Study|Poor comfort|3|||
126109365|NCT01180998|453694263|FG001|Overall Study|Poor comfort|0|||
126109366|NCT01180998|453694264|FG002|Overall Study|Poor comfort|4|||
125894679|NCT03890666|452914184|FG001|Overall Study|Withdrawal by Subject|1|||
125894680|NCT03890666|452914183|FG000|Overall Study|Protocol deviation|1|||
125894681|NCT03890666|452914184|FG001|Overall Study|Protocol deviation|4|||
125894682|NCT03890666|452914183|FG000|Overall Study|Lost to Follow-up|2|||
125894683|NCT03890666|452914184|FG001|Overall Study|Lost to Follow-up|5|||
125894684|NCT03890666|452914183|FG000|Overall Study|Other than specified|1|||
125894685|NCT03890666|452914184|FG001|Overall Study|Other than specified|8|||
125894686|NCT01639729|452914185|FG000|Overall Study|Withdrawal by Subject|1|||
125894687|NCT01639729|452914186|FG001|Overall Study|Withdrawal by Subject|0|||
125894688|NCT01639729|452914187|FG002|Overall Study|Withdrawal by Subject|1|||
125894689|NCT01639729|452914188|FG003|Overall Study|Withdrawal by Subject|1|||
125894690|NCT01639729|452914189|FG004|Overall Study|Withdrawal by Subject|0|||
125894691|NCT01639729|452914190|FG005|Overall Study|Withdrawal by Subject|0|||
125894692|NCT03052426|452914191|FG000|Overall Study|Withdrawal by Subject|0|||
126109367|NCT01180998|453694262|FG000|Overall Study|Poor lens handling|0|||
126109368|NCT01180998|453694263|FG001|Overall Study|Poor lens handling|0|||
126109369|NCT01180998|453694264|FG002|Overall Study|Poor lens handling|2|||
126109370|NCT00162032|453694265|FG000|Overall Study|Lost to Follow-up|4|||
126109371|NCT00162032|453694266|FG001|Overall Study|Lost to Follow-up|2|||
125894693|NCT03052426|452914192|FG001|Overall Study|Withdrawal by Subject|1|||
125894694|NCT03052426|452914193|FG002|Overall Study|Withdrawal by Subject|0|||
125894695|NCT03052426|452914191|FG000|Overall Study|Lost to Follow-up|2|||
126109372|NCT00162032|453694265|FG000|Overall Study|Reason not specified|1|||
126109373|NCT00162032|453694266|FG001|Overall Study|Reason not specified|0|||
126109374|NCT01176968|453694267|FG000|Overall Study|Adverse Event|10|||
126109375|NCT01176968|453694268|FG001|Overall Study|Adverse Event|11|||
126109376|NCT01176968|453694267|FG000|Overall Study|Death|2|||
126109377|NCT01176968|453694268|FG001|Overall Study|Death|3|||
126109378|NCT01176968|453694267|FG000|Overall Study|Lack of Efficacy|0|||
126109379|NCT01176968|453694268|FG001|Overall Study|Lack of Efficacy|1|||
126109380|NCT01176968|453694267|FG000|Overall Study|Lost to Follow-up|16|||
126109381|NCT01176968|453694268|FG001|Overall Study|Lost to Follow-up|14|||
126109382|NCT01176968|453694267|FG000|Overall Study|Withdrawal by Subject|48|||
126109383|NCT01176968|453694268|FG001|Overall Study|Withdrawal by Subject|48|||
126109384|NCT01176968|453694267|FG000|Overall Study|Protocol Violation|2|||
126109385|NCT01176968|453694268|FG001|Overall Study|Protocol Violation|1|||
126109386|NCT01176968|453694267|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126109387|NCT01176968|453694268|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
126109388|NCT01176968|453694267|FG000|Overall Study|Study terminated by sponsor|0|||
126109389|NCT01176968|453694268|FG001|Overall Study|Study terminated by sponsor|1|||
126109390|NCT01176968|453694267|FG000|Overall Study|Reason not defined|5|||
126109391|NCT01176968|453694268|FG001|Overall Study|Reason not defined|3|||
126109392|NCT00833911|453694269|FG000|Titration|Adverse Event|18|||
126109393|NCT00833911|453694269|FG000|Titration|Withdrawal by Subject|3|||
126109394|NCT00833911|453694269|FG000|Maintenance Phase I|Adverse Event|73|||
126109395|NCT00833911|453694269|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
126109396|NCT00833911|453694269|FG000|Maintenance Phase I|Physician Decision|10|||
126109397|NCT00833911|453694269|FG000|Maintenance Phase I|Lack of Efficacy|4|||
126109398|NCT00833911|453694269|FG000|Maintenance Phase II|Adverse Event|6|||
126109399|NCT00833911|453694269|FG000|Maintenance Phase II|Physician Decision|2|||
126109400|NCT00833911|453694269|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
126109401|NCT00833911|453694269|FG000|Maintenance Phase II|Lack of Efficacy|1|||
126109402|NCT00718640|453694270|FG000|Overall Study|Adverse Event|4|||
126109403|NCT00718640|453694270|FG000|Overall Study|Death|1|||
126109404|NCT00718640|453694270|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
126109405|NCT01137955|453694271|FG000|Overall Study|Withdrawal by Subject|5|||
126109406|NCT01137955|453694272|FG001|Overall Study|Withdrawal by Subject|4|||
126109407|NCT01207596|453694273|FG000|Overall Study|Physician Decision|4|||
126109408|NCT01207596|453694273|FG000|Overall Study|Lack of Efficacy|1|||
126109409|NCT01207596|453694273|FG000|Overall Study|Adverse Event|3|||
126109410|NCT01207596|453694273|FG000|Overall Study|Withdrawal by Subject|1|||
126109411|NCT00068588|453694274|FG000|Overall Study|Adverse Event|0|||
126109412|NCT00068588|453694275|FG001|Overall Study|Adverse Event|0|||
126109413|NCT00068588|453694276|FG002|Overall Study|Adverse Event|2|||
126109414|NCT00068588|453694274|FG000|Overall Study|Withdrawal by Subject|0|||
126109415|NCT00068588|453694275|FG001|Overall Study|Withdrawal by Subject|0|||
126109416|NCT00068588|453694276|FG002|Overall Study|Withdrawal by Subject|1|||
126109417|NCT00068588|453694274|FG000|Overall Study|Poor KPS|0|||
126109418|NCT00068588|453694275|FG001|Overall Study|Poor KPS|0|||
126109419|NCT00068588|453694276|FG002|Overall Study|Poor KPS|1|||
126109420|NCT05193500|453694277|FG000|Overall Study|Withdrawal by Subject|7|||
126109421|NCT05193500|453694278|FG001|Overall Study|Withdrawal by Subject|4|||
126109422|NCT05193500|453694279|FG002|Overall Study|Withdrawal by Subject|3|||
126109423|NCT05193500|453694280|FG003|Overall Study|Withdrawal by Subject|5|||
126109424|NCT04098068|453694281|FG000|Overall Study|Disease Progression|7|||
126109425|NCT04098068|453694281|FG000|Overall Study|Withdrawal by Subject|2|||
126109426|NCT04098068|453694281|FG000|Overall Study|New Cancer Diagnosis|1|||
126109427|NCT03871829|453694282|FG000|Overall Study|Lost to Follow-up|0|||
126109428|NCT03871829|453694283|FG001|Overall Study|Lost to Follow-up|1|||
126109429|NCT03871829|453694282|FG000|Overall Study|Withdrawal by Subject|1|||
126109430|NCT03871829|453694283|FG001|Overall Study|Withdrawal by Subject|1|||
126109431|NCT03871829|453694282|FG000|Overall Study|Death|12|||
126059616|NCT00486954|453512493|FG000|Randomized Part|Lost to Follow-up|0|||
126059617|NCT00486954|453512494|FG001|Randomized Part|Lost to Follow-up|0|||
126059618|NCT00486954|453512495|FG002|Randomized Part|Lost to Follow-up|0|||
126059619|NCT00486954|453512496|FG003|Randomized Part|Lost to Follow-up|0|||
126059620|NCT00486954|453512497|FG004|Randomized Part|Lost to Follow-up|1|||
126059621|NCT00486954|453512493|FG000|Randomized Part|Withdrawal by Subject|0|||
126059622|NCT00486954|453512494|FG001|Randomized Part|Withdrawal by Subject|0|||
126059623|NCT00486954|453512495|FG002|Randomized Part|Withdrawal by Subject|0|||
126059624|NCT00486954|453512496|FG003|Randomized Part|Withdrawal by Subject|1|||
126059625|NCT00486954|453512497|FG004|Randomized Part|Withdrawal by Subject|0|||
126059626|NCT00486954|453512493|FG000|Randomized Part|Sponsor Terminated Study|0|||
126059627|NCT00486954|453512494|FG001|Randomized Part|Sponsor Terminated Study|0|||
126059628|NCT00486954|453512495|FG002|Randomized Part|Sponsor Terminated Study|0|||
126059629|NCT00486954|453512496|FG003|Randomized Part|Sponsor Terminated Study|19|||
126059630|NCT00486954|453512497|FG004|Randomized Part|Sponsor Terminated Study|13|||
126059631|NCT00929526|453512498|FG000|Overall Study|Withdrawal by Subject|1|||
126059632|NCT00929526|453512499|FG001|Overall Study|Withdrawal by Subject|11|||
126059633|NCT00929526|453512498|FG000|Overall Study|Lost to Follow-up|8|||
126059634|NCT00929526|453512499|FG001|Overall Study|Lost to Follow-up|12|||
126059635|NCT00929526|453512498|FG000|Overall Study|Other|8|||
126059636|NCT00929526|453512499|FG001|Overall Study|Other|6|||
126059637|NCT02245620|453512502|FG000|Overall Study|Physician Decision|1|||
126109432|NCT03871829|453694283|FG001|Overall Study|Death|8|||
125894696|NCT03052426|452914192|FG001|Overall Study|Lost to Follow-up|0|||
126109433|NCT03871829|453694282|FG000|Overall Study|Study terminated by sponsor|31|||
125894697|NCT03052426|452914193|FG002|Overall Study|Lost to Follow-up|1|||
125894698|NCT03083990|452914196|FG000|Overall Study|Adverse Event|1|||
125894699|NCT03083990|452914197|FG001|Overall Study|Adverse Event|0|||
125894700|NCT04145219|452914198|FG000|Overall Study|Adverse Event|18|||
125894701|NCT04145219|452914199|FG001|Overall Study|Adverse Event|6|||
125894702|NCT04145219|452914198|FG000|Overall Study|Lost to Follow-up|2|||
125894703|NCT04145219|452914199|FG001|Overall Study|Lost to Follow-up|3|||
125894704|NCT04145219|452914198|FG000|Overall Study|Physician Decision|0|||
125894705|NCT04145219|452914199|FG001|Overall Study|Physician Decision|2|||
125894706|NCT04145219|452914198|FG000|Overall Study|Withdrawal by Subject|12|||
125894707|NCT04145219|452914199|FG001|Overall Study|Withdrawal by Subject|8|||
125894708|NCT04145219|452914198|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
125894709|NCT04145219|452914199|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
125894710|NCT03672097|452914200|FG000|Period 1|Withdrawal by Subject|2|||
125894711|NCT03672097|452914200|FG000|Period 1|Adverse Event|1|||
125894712|NCT03672097|452914200|FG000|Period 1|Did not receive treatment|1|||
125894713|NCT03672097|452914200|FG000|Period 2|Withdrawal by Subject|3|||
125894714|NCT03672097|452914200|FG000|Period 2|Other|1|||
125894715|NCT00119678|452914204|FG000|Double-blind Treatment Period|Death|1|||
125894716|NCT00119678|452914205|FG001|Double-blind Treatment Period|Death|0|||
125894717|NCT00119678|452914204|FG000|Double-blind Treatment Period|Adverse Event|7|||
125894718|NCT00119678|452914205|FG001|Double-blind Treatment Period|Adverse Event|1|||
125894719|NCT00119678|452914204|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
125894720|NCT00119678|452914205|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
125894721|NCT00119678|452914204|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
125894722|NCT00119678|452914205|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
125894723|NCT00119678|452914204|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
125894724|NCT00119678|452914205|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
125894725|NCT00119678|452914204|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
125894726|NCT00119678|452914205|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
125894727|NCT00119678|452914204|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
125894728|NCT00119678|452914205|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
125894729|NCT00119678|452914204|FG000|Double-blind Treatment Period|Pregnancy|0|||
125894730|NCT00119678|452914205|FG001|Double-blind Treatment Period|Pregnancy|2|||
125894731|NCT00119678|452914204|FG000|Double-blind Treatment Period|Not treated|1|||
125894732|NCT00119678|452914205|FG001|Double-blind Treatment Period|Not treated|2|||
125894733|NCT00119678|452914204|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
125894734|NCT00119678|452914205|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
125894735|NCT00119678|452914204|FG000|Open-label Treatment Period|Death|1|||
125894736|NCT00119678|452914205|FG001|Open-label Treatment Period|Death|0|||
125894737|NCT00119678|452914204|FG000|Open-label Treatment Period|Adverse Event|3|||
125894738|NCT00119678|452914205|FG001|Open-label Treatment Period|Adverse Event|0|||
125894739|NCT00119678|452914204|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
125894740|NCT00119678|452914205|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
125894741|NCT00119678|452914204|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
125894742|NCT00119678|452914205|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
125894743|NCT00119678|452914204|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
125894744|NCT00119678|452914205|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
125894745|NCT00119678|452914204|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
125894746|NCT00119678|452914205|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
125894747|NCT00119678|452914204|FG000|Open-label Treatment Period|Pregnancy|1|||
125894748|NCT00119678|452914205|FG001|Open-label Treatment Period|Pregnancy|0|||
125894749|NCT00119678|452914204|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
125894750|NCT00119678|452914205|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
125894751|NCT01761240|452914211|FG000|Overall Study|Progressive disease:radiology assessment|3|||
125894752|NCT01761240|452914212|FG001|Overall Study|Progressive disease:radiology assessment|3|||
125894753|NCT01761240|452914213|FG002|Overall Study|Progressive disease:radiology assessment|0|||
125894754|NCT01761240|452914214|FG003|Overall Study|Progressive disease:radiology assessment|0|||
125894755|NCT01761240|452914215|FG004|Overall Study|Progressive disease:radiology assessment|0|||
125894756|NCT01761240|452914211|FG000|Overall Study|Progressive disease:clinical assessment|0|||
125894757|NCT01761240|452914212|FG001|Overall Study|Progressive disease:clinical assessment|0|||
125894758|NCT01761240|452914213|FG002|Overall Study|Progressive disease:clinical assessment|3|||
125894759|NCT01761240|452914214|FG003|Overall Study|Progressive disease:clinical assessment|1|||
125894760|NCT01761240|452914215|FG004|Overall Study|Progressive disease:clinical assessment|0|||
125894761|NCT01761240|452914211|FG000|Overall Study|Withdrawal by Subject|0|||
125894762|NCT01761240|452914212|FG001|Overall Study|Withdrawal by Subject|0|||
125894763|NCT01761240|452914213|FG002|Overall Study|Withdrawal by Subject|0|||
125894764|NCT01761240|452914214|FG003|Overall Study|Withdrawal by Subject|3|||
125894765|NCT01761240|452914215|FG004|Overall Study|Withdrawal by Subject|1|||
125894766|NCT01761240|452914211|FG000|Overall Study|Adverse Event|0|||
125894767|NCT01761240|452914212|FG001|Overall Study|Adverse Event|0|||
126109434|NCT03871829|453694283|FG001|Overall Study|Study terminated by sponsor|34|||
126109435|NCT05458479|453694289|FG000|Overall Study|Lost to Follow-up|1|||
126109436|NCT00784693|453694290|FG000|Overall Study|Lost to Follow-up|0|||
126109437|NCT00784693|453694291|FG001|Overall Study|Lost to Follow-up|1|||
126109438|NCT00784693|453694290|FG000|Overall Study|Lack of Efficacy|1|||
126109439|NCT00784693|453694291|FG001|Overall Study|Lack of Efficacy|1|||
126109440|NCT00784693|453694290|FG000|Overall Study|Withdrawal by Subject|0|||
126109441|NCT00784693|453694291|FG001|Overall Study|Withdrawal by Subject|4|||
126109442|NCT00784693|453694290|FG000|Overall Study|Randomized but not Treated|1|||
126109443|NCT00784693|453694291|FG001|Overall Study|Randomized but not Treated|0|||
126109444|NCT00784693|453694290|FG000|Overall Study|Other|1|||
126109445|NCT00784693|453694291|FG001|Overall Study|Other|0|||
126109446|NCT01324323|453694292|FG000|Overall Study|Withdrawal by Subject|1|||
126109447|NCT00993915|453694299|FG000|Overall Study|Insufficient clinical response|3|||
126109448|NCT00993915|453694299|FG000|Overall Study|Withdrawal by Subject|2|||
126109449|NCT00993915|453694299|FG000|Overall Study|Other|1|||
126109450|NCT00993915|453694299|FG000|Overall Study|Ongoing|3|||
126109451|NCT02119325|453694300|FG000|Washout Period 1|Adverse Event|0|||
126109452|NCT02119325|453694301|FG001|Washout Period 1|Adverse Event|1|||
126109453|NCT01386658|453694302|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
125894768|NCT01761240|452914213|FG002|Overall Study|Adverse Event|0|||
126109454|NCT01386658|453694303|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
126109455|NCT01386658|453694302|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
126109456|NCT01386658|453694303|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
126109457|NCT02249767|453694311|FG000|Overall Study|Did not use medication|8|||
126059638|NCT02245620|453512503|FG001|Overall Study|Physician Decision|1|||
126059639|NCT01102426|453512504|FG000|Overall Study|Randomized but not treated|4|||
126059640|NCT01102426|453512505|FG001|Overall Study|Randomized but not treated|1|||
126059641|NCT01102426|453512504|FG000|Overall Study|Adverse Events (treatment-related)|15|||
126059642|NCT01102426|453512505|FG001|Overall Study|Adverse Events (treatment-related)|8|||
125894769|NCT01761240|452914214|FG003|Overall Study|Adverse Event|1|||
125894770|NCT01761240|452914215|FG004|Overall Study|Adverse Event|6|||
126109458|NCT02249767|453694312|FG001|Overall Study|Did not use medication|9|||
126109459|NCT02249767|453694313|FG002|Overall Study|Did not use medication|8|||
126109460|NCT02465463|453694315|FG000|Overall Study|Lost to Follow-up|2|||
126109461|NCT02465463|453694316|FG001|Overall Study|Lost to Follow-up|1|||
126109462|NCT02465463|453694315|FG000|Overall Study|Death|1|||
126109463|NCT02465463|453694316|FG001|Overall Study|Death|0|||
126109464|NCT02465463|453694315|FG000|Overall Study|Protocol Violation|1|||
126109465|NCT02465463|453694316|FG001|Overall Study|Protocol Violation|0|||
126109466|NCT04526197|453694319|FG000|Period 1|Adverse Event|0|||
126109467|NCT04526197|453694320|FG001|Period 1|Adverse Event|1|||
126109468|NCT04526197|453694319|FG000|Period 1|Withdrawal by Subject|1|||
126109469|NCT04526197|453694320|FG001|Period 1|Withdrawal by Subject|0|||
126109470|NCT04526197|453694319|FG000|Period 2|Adverse Event|0|||
126109471|NCT04526197|453694320|FG001|Period 2|Adverse Event|1|||
126109472|NCT04526197|453694319|FG000|Period 2|Withdrawal by Subject|0|||
126109473|NCT04526197|453694320|FG001|Period 2|Withdrawal by Subject|1|||
126109474|NCT00372385|453694321|FG000|Overall Study|Adverse Event|6|||
126109475|NCT00372385|453694322|FG001|Overall Study|Adverse Event|11|||
126109476|NCT00372385|453694323|FG002|Overall Study|Adverse Event|9|||
126109477|NCT00372385|453694324|FG003|Overall Study|Adverse Event|7|||
126109478|NCT00372385|453694321|FG000|Overall Study|Noncompliance|0|||
126109479|NCT00372385|453694322|FG001|Overall Study|Noncompliance|1|||
126109480|NCT00372385|453694323|FG002|Overall Study|Noncompliance|1|||
126109481|NCT00372385|453694324|FG003|Overall Study|Noncompliance|1|||
126109482|NCT00372385|453694321|FG000|Overall Study|Physician Decision|1|||
126109483|NCT00372385|453694322|FG001|Overall Study|Physician Decision|0|||
126109484|NCT00372385|453694323|FG002|Overall Study|Physician Decision|0|||
126109485|NCT00372385|453694324|FG003|Overall Study|Physician Decision|0|||
126109486|NCT00372385|453694321|FG000|Overall Study|Lost to Follow-up|2|||
126109487|NCT00372385|453694322|FG001|Overall Study|Lost to Follow-up|0|||
126109488|NCT00372385|453694323|FG002|Overall Study|Lost to Follow-up|0|||
126109489|NCT00372385|453694324|FG003|Overall Study|Lost to Follow-up|0|||
126109490|NCT00372385|453694321|FG000|Overall Study|Withdrawal by Subject|2|||
126109491|NCT00372385|453694322|FG001|Overall Study|Withdrawal by Subject|1|||
126109492|NCT00372385|453694323|FG002|Overall Study|Withdrawal by Subject|0|||
126109493|NCT00372385|453694324|FG003|Overall Study|Withdrawal by Subject|0|||
126109494|NCT00372385|453694321|FG000|Overall Study|Refusal of Treatment|3|||
126109495|NCT00372385|453694322|FG001|Overall Study|Refusal of Treatment|6|||
126109496|NCT00372385|453694323|FG002|Overall Study|Refusal of Treatment|0|||
126109497|NCT00372385|453694324|FG003|Overall Study|Refusal of Treatment|0|||
126109498|NCT00372385|453694321|FG000|Overall Study|No Response|1|||
126109499|NCT00372385|453694322|FG001|Overall Study|No Response|1|||
126109500|NCT00372385|453694323|FG002|Overall Study|No Response|0|||
126109501|NCT00372385|453694324|FG003|Overall Study|No Response|0|||
126109502|NCT00372385|453694321|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
126109503|NCT00372385|453694322|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
126109504|NCT00372385|453694323|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
126109505|NCT00372385|453694324|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
126109506|NCT00372385|453694321|FG000|Overall Study|Virologic Stopping Rule|17|||
126109507|NCT00372385|453694322|FG001|Overall Study|Virologic Stopping Rule|0|||
126109508|NCT00372385|453694323|FG002|Overall Study|Virologic Stopping Rule|0|||
126109509|NCT00372385|453694324|FG003|Overall Study|Virologic Stopping Rule|0|||
126109510|NCT01699789|453694325|FG000|Overall Study|Withdrawal by Subject|18|||
126109511|NCT01699789|453694326|FG001|Overall Study|Withdrawal by Subject|23|||
126109512|NCT01699789|453694325|FG000|Overall Study|Death|1|||
126109513|NCT01699789|453694326|FG001|Overall Study|Death|2|||
126109514|NCT01699789|453694325|FG000|Overall Study|Lost to Follow-up|83|||
126109515|NCT01699789|453694326|FG001|Overall Study|Lost to Follow-up|101|||
126109516|NCT02411578|453694329|FG000|Crossover Trial Phase|Pregnancy|0|||
126109517|NCT02411578|453694330|FG001|Crossover Trial Phase|Pregnancy|1|||
126109518|NCT01557348|453694331|FG000|Overall Study|Adverse Event|6|||
126109519|NCT01557348|453694332|FG001|Overall Study|Adverse Event|16|||
126109520|NCT01557348|453694331|FG000|Overall Study|Infusion reaction event|5|||
126109521|NCT01557348|453694332|FG001|Overall Study|Infusion reaction event|5|||
126109522|NCT01557348|453694331|FG000|Overall Study|Death|7|||
126109523|NCT01557348|453694332|FG001|Overall Study|Death|4|||
126109524|NCT01557348|453694331|FG000|Overall Study|Insufficient Therapeutic Response|13|||
126109525|NCT01557348|453694332|FG001|Overall Study|Insufficient Therapeutic Response|28|||
125894771|NCT01761240|452914211|FG000|Overall Study|Death|0|||
126109526|NCT01557348|453694331|FG000|Overall Study|Withdrawal by Subject|5|||
126109527|NCT01557348|453694332|FG001|Overall Study|Withdrawal by Subject|4|||
126109528|NCT01557348|453694331|FG000|Overall Study|Lost to Follow-up|26|||
126109529|NCT01557348|453694332|FG001|Overall Study|Lost to Follow-up|22|||
125894772|NCT01761240|452914212|FG001|Overall Study|Death|1|||
125894773|NCT01761240|452914213|FG002|Overall Study|Death|1|||
125894774|NCT01761240|452914214|FG003|Overall Study|Death|2|||
125894775|NCT01761240|452914215|FG004|Overall Study|Death|1|||
125894776|NCT01761240|452914211|FG000|Overall Study|Non-compliance|0|||
125894777|NCT01761240|452914212|FG001|Overall Study|Non-compliance|0|||
125894778|NCT01761240|452914213|FG002|Overall Study|Non-compliance|1|||
125894779|NCT01761240|452914214|FG003|Overall Study|Non-compliance|0|||
125894780|NCT01761240|452914215|FG004|Overall Study|Non-compliance|0|||
125894781|NCT04002908|452914220|FG000|Overall Study|Death|41|||
125894782|NCT04002908|452914221|FG001|Overall Study|Death|0|||
125894783|NCT04002908|452914222|FG002|Overall Study|Death|0|||
125894784|NCT04002908|452914223|FG003|Overall Study|Death|0|||
125894785|NCT04002908|452914220|FG000|Overall Study|Withdrawal by Subject|112|||
125894786|NCT04002908|452914221|FG001|Overall Study|Withdrawal by Subject|0|||
125894787|NCT04002908|452914222|FG002|Overall Study|Withdrawal by Subject|0|||
125894788|NCT04002908|452914223|FG003|Overall Study|Withdrawal by Subject|0|||
125894789|NCT04002908|452914220|FG000|Overall Study|Lost to Follow-up|72|||
125894790|NCT04002908|452914221|FG001|Overall Study|Lost to Follow-up|0|||
125894791|NCT04002908|452914222|FG002|Overall Study|Lost to Follow-up|0|||
125894792|NCT04002908|452914223|FG003|Overall Study|Lost to Follow-up|0|||
125894793|NCT04002908|452914220|FG000|Overall Study|Infant died, so mother withdrawn|34|||
125894794|NCT04002908|452914221|FG001|Overall Study|Infant died, so mother withdrawn|0|||
125894795|NCT04002908|452914222|FG002|Overall Study|Infant died, so mother withdrawn|0|||
126109530|NCT01557348|453694331|FG000|Overall Study|Administrative|18|||
126109531|NCT01557348|453694332|FG001|Overall Study|Administrative|11|||
126059643|NCT01102426|453512504|FG000|Overall Study|Physician Decision|9|||
126059644|NCT01102426|453512505|FG001|Overall Study|Physician Decision|6|||
126059645|NCT01102426|453512504|FG000|Overall Study|Progressive Disease|85|||
126059646|NCT01102426|453512505|FG001|Overall Study|Progressive Disease|44|||
126059647|NCT01102426|453512504|FG000|Overall Study|Adverse Events (unrelated to|9|||
126059648|NCT01102426|453512505|FG001|Overall Study|Adverse Events (unrelated to|1|||
126059649|NCT01102426|453512504|FG000|Overall Study|Patient Refusal|24|||
126059650|NCT01102426|453512505|FG001|Overall Study|Patient Refusal|12|||
126059651|NCT01102426|453512504|FG000|Overall Study|Death (due to adverse events|0|||
126059652|NCT01102426|453512505|FG001|Overall Study|Death (due to adverse events|1|||
126059653|NCT01102426|453512504|FG000|Overall Study|Death (non-related to the study|19|||
126059654|NCT01102426|453512505|FG001|Overall Study|Death (non-related to the study|8|||
126059655|NCT00889863|453512506|FG000|Part I: Open Label|Death|1|||
126059656|NCT00889863|453512507|FG001|Part I: Open Label|Death|0|||
126059657|NCT00889863|453512506|FG000|Part I: Open Label|Adverse Event|4|||
126059658|NCT00889863|453512507|FG001|Part I: Open Label|Adverse Event|0|||
126059659|NCT00889863|453512506|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
126059660|NCT00889863|453512507|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
126059661|NCT00889863|453512506|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
126059662|NCT00889863|453512507|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
126059663|NCT00889863|453512506|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
126059664|NCT00889863|453512507|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
126059665|NCT00889863|453512506|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
126059666|NCT00889863|453512507|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
126059667|NCT00889863|453512506|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
126059668|NCT00889863|453512507|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
126059669|NCT04361617|453512508|FG000|Overall Study|Withdrawal by Subject|0|||
126059670|NCT04361617|453512509|FG001|Overall Study|Withdrawal by Subject|1|||
126059671|NCT00930644|453512510|FG000|Overall Study|Withdrawal by Subject|4|||
126059672|NCT00930644|453512510|FG000|Overall Study|Physician Decision|2|||
126059673|NCT00930644|453512510|FG000|Overall Study|Death|1|||
126059674|NCT00930644|453512510|FG000|Overall Study|Adverse Event|16|||
126059675|NCT01918033|453512512|FG000|Overall Study|Adverse Event|1|||
126059676|NCT01918033|453512513|FG001|Overall Study|Adverse Event|0|||
126059677|NCT01918033|453512514|FG002|Overall Study|Adverse Event|2|||
126059678|NCT01918033|453512512|FG000|Overall Study|Lost to Follow-up|0|||
126059679|NCT01918033|453512513|FG001|Overall Study|Lost to Follow-up|1|||
126059680|NCT01918033|453512514|FG002|Overall Study|Lost to Follow-up|0|||
126059681|NCT01918033|453512512|FG000|Overall Study|Protocol Violation|2|||
126059682|NCT01918033|453512513|FG001|Overall Study|Protocol Violation|0|||
126059683|NCT01918033|453512514|FG002|Overall Study|Protocol Violation|1|||
126059684|NCT01918033|453512512|FG000|Overall Study|Withdrawal by Subject|2|||
126059685|NCT01918033|453512513|FG001|Overall Study|Withdrawal by Subject|1|||
126059686|NCT01918033|453512514|FG002|Overall Study|Withdrawal by Subject|0|||
126059687|NCT03259568|453512522|FG000|Overall Study|Participant performance was low|3|||
126059688|NCT03006393|453512523|FG000|Overall Study|Withdrawal by Subject|1|||
126059689|NCT03006393|453512524|FG001|Overall Study|Withdrawal by Subject|1|||
126059690|NCT03006393|453512523|FG000|Overall Study|Pregnancy|0|||
126059691|NCT03006393|453512524|FG001|Overall Study|Pregnancy|1|||
126059692|NCT03006393|453512523|FG000|Overall Study|Lost to Follow-up|0|||
126059693|NCT03006393|453512524|FG001|Overall Study|Lost to Follow-up|1|||
126059694|NCT03136861|453512525|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
126059695|NCT03136861|453512526|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
126059696|NCT03136861|453512527|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126059697|NCT03136861|453512528|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126059698|NCT03136861|453512529|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126059699|NCT03136861|453512530|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126059700|NCT03136861|453512531|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126059701|NCT03136861|453512525|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
126059702|NCT03136861|453512526|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
126059703|NCT03136861|453512527|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126059704|NCT03136861|453512528|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126059705|NCT03136861|453512529|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126059706|NCT03136861|453512530|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126059707|NCT03136861|453512531|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126059708|NCT03136861|453512525|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
126059709|NCT03136861|453512526|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
126059710|NCT03136861|453512527|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126109532|NCT05125679|453694333|FG000|Overall Study|Study Terminated by Sponsor|2|||
126109533|NCT05125679|453694334|FG001|Overall Study|Study Terminated by Sponsor|5|||
126109534|NCT04484259|453694335|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
126109535|NCT04484259|453694336|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
126109536|NCT04484259|453694337|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
126109537|NCT04484259|453694338|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
126109538|NCT04484259|453694339|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
126109539|NCT04484259|453694335|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
126109540|NCT04484259|453694336|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
126109541|NCT04484259|453694337|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
126109542|NCT04484259|453694338|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
126109543|NCT04484259|453694339|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
126109544|NCT04484259|453694335|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
126109545|NCT04484259|453694336|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
125894796|NCT04002908|452914223|FG003|Overall Study|Infant died, so mother withdrawn|0|||
125894797|NCT00006289|452914226|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
125894798|NCT00006289|452914227|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
125894799|NCT00006289|452914226|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
125894800|NCT00006289|452914227|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
125894801|NCT04359901|452914237|FG000|Overall Study|Withdrawal by Subject|0|||
125894802|NCT04359901|452914238|FG001|Overall Study|Withdrawal by Subject|1|||
125894803|NCT04359901|452914237|FG000|Overall Study|Death|6|||
125894804|NCT04359901|452914238|FG001|Overall Study|Death|2|||
125971396|NCT03593655|453182829|FG000|Second Product Use Period|Withdrawal by Subject|1|||
125971397|NCT03593655|453182830|FG001|Second Product Use Period|Withdrawal by Subject|1|||
125971398|NCT03593655|453182829|FG000|Second Product Use Period|Lost to Follow-up|1|||
125971399|NCT03593655|453182830|FG001|Second Product Use Period|Lost to Follow-up|0|||
125971400|NCT03593655|453182829|FG000|Third Product Use Period|Lost to Follow-up|1|||
125971401|NCT03593655|453182830|FG001|Third Product Use Period|Lost to Follow-up|2|||
125971402|NCT03593655|453182829|FG000|Third Product Use Period|Physician Decision|0|||
125971403|NCT03593655|453182830|FG001|Third Product Use Period|Physician Decision|1|||
125971404|NCT03593655|453182829|FG000|Third Product Use Period|Withdrawal by Subject|0|||
125971405|NCT03593655|453182830|FG001|Third Product Use Period|Withdrawal by Subject|1|||
125971406|NCT03732209|453182831|FG000|Overall Study|Lost to Follow-up|4|||
125971407|NCT03732209|453182832|FG001|Overall Study|Lost to Follow-up|4|||
125971408|NCT03732209|453182831|FG000|Overall Study|Withdrawal by Subject|8|||
125971409|NCT03732209|453182832|FG001|Overall Study|Withdrawal by Subject|9|||
125971410|NCT05046795|453182833|FG000|Overall Study|Adverse Event|13|||
125971411|NCT05046795|453182834|FG001|Overall Study|Adverse Event|15|||
125971412|NCT05046795|453182833|FG000|Overall Study|Withdrawal by Subject|4|||
125971413|NCT05046795|453182834|FG001|Overall Study|Withdrawal by Subject|7|||
125971414|NCT05046795|453182833|FG000|Overall Study|Physician Decision|1|||
125971415|NCT05046795|453182834|FG001|Overall Study|Physician Decision|2|||
125971416|NCT05046795|453182833|FG000|Overall Study|Protocol Violation|1|||
125971417|NCT05046795|453182834|FG001|Overall Study|Protocol Violation|2|||
125971418|NCT05046795|453182833|FG000|Overall Study|Death|1|||
126109546|NCT04484259|453694337|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
125971419|NCT05046795|453182834|FG001|Overall Study|Death|0|||
125971420|NCT05046795|453182833|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
125971421|NCT05046795|453182834|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
125971422|NCT01358526|453182850|FG000|Open-label Titration Period|Adverse Event|95|||
125971423|NCT01358526|453182851|FG001|Open-label Titration Period|Adverse Event|0|||
125894805|NCT01888432|452915786|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
125894806|NCT01888432|452915787|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
125894807|NCT01888432|452915786|FG000|12-month Analysis (FAS)|Physician Decision|1|||
125894808|NCT01888432|452915787|FG001|12-month Analysis (FAS)|Physician Decision|1|||
125894809|NCT01888432|452915786|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
125894810|NCT01888432|452915787|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
125894811|NCT01888432|452915786|FG000|12-month Analysis (FAS)|Death|4|||
125894812|NCT01888432|452915787|FG001|12-month Analysis (FAS)|Death|3|||
125894813|NCT01888432|452915786|FG000|24-month Analysis (FAS)|Graft loss|0|||
125894814|NCT01888432|452915787|FG001|24-month Analysis (FAS)|Graft loss|1|||
125894815|NCT01888432|452915786|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
125894816|NCT01888432|452915787|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
125894817|NCT01888432|452915786|FG000|24-month Analysis (FAS)|Physician Decision|2|||
125894818|NCT01888432|452915787|FG001|24-month Analysis (FAS)|Physician Decision|4|||
125894819|NCT01888432|452915786|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
125894820|NCT01888432|452915787|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
125894821|NCT01888432|452915786|FG000|24-month Analysis (FAS)|Death|8|||
125894822|NCT01888432|452915787|FG001|24-month Analysis (FAS)|Death|4|||
125894823|NCT01888432|452915786|FG000|36-month Analysis (Extension)|Death|1|||
125894824|NCT01888432|452915787|FG001|36-month Analysis (Extension)|Death|0|||
125894825|NCT00130247|452915790|FG000|Overall Study|Pregnancy|1|||
125894826|NCT00130247|452915791|FG001|Overall Study|Pregnancy|0|||
125894827|NCT00130247|452915790|FG000|Overall Study|Post-randomization exclusion|1|||
125894828|NCT00130247|452915791|FG001|Overall Study|Post-randomization exclusion|2|||
125894829|NCT00130247|452915790|FG000|Overall Study|Not compliant with DOT|0|||
125894830|NCT00130247|452915791|FG001|Overall Study|Not compliant with DOT|2|||
125894831|NCT00640224|452915792|FG000|Overall Study|Lost to Follow-up|5|||
125894832|NCT00640224|452915793|FG001|Overall Study|Lost to Follow-up|2|||
125894833|NCT00640224|452915794|FG002|Overall Study|Lost to Follow-up|0|||
125894834|NCT00640224|452915795|FG003|Overall Study|Lost to Follow-up|0|||
125894835|NCT00640224|452915792|FG000|Overall Study|Withdrawal by Subject|1|||
125894836|NCT00640224|452915793|FG001|Overall Study|Withdrawal by Subject|0|||
125894837|NCT00640224|452915794|FG002|Overall Study|Withdrawal by Subject|0|||
125894838|NCT00640224|452915795|FG003|Overall Study|Withdrawal by Subject|0|||
125894839|NCT00640224|452915792|FG000|Overall Study|Headaches|0|||
125894840|NCT00640224|452915793|FG001|Overall Study|Headaches|1|||
125894841|NCT00640224|452915794|FG002|Overall Study|Headaches|0|||
125894842|NCT00640224|452915795|FG003|Overall Study|Headaches|0|||
125894843|NCT04224688|452915803|FG000|Overall Study|Withdrawal by Subject|1|||
125894844|NCT04224688|452915804|FG001|Overall Study|Withdrawal by Subject|3|||
125894845|NCT04224688|452915803|FG000|Overall Study|Lack of Efficacy|1|||
125894846|NCT04224688|452915804|FG001|Overall Study|Lack of Efficacy|1|||
125894847|NCT04224688|452915803|FG000|Overall Study|Adverse event, not fatal|0|||
125894848|NCT04224688|452915804|FG001|Overall Study|Adverse event, not fatal|2|||
125894849|NCT04224688|452915803|FG000|Overall Study|COVID-19|0|||
125894850|NCT04224688|452915804|FG001|Overall Study|COVID-19|1|||
125894851|NCT01024309|452915810|FG000|Overall Study|Physician Decision|4|||
125894852|NCT01024309|452915811|FG001|Overall Study|Physician Decision|0|||
125894853|NCT01024309|452915810|FG000|Overall Study|Withdrawal by Subject|4|||
125894854|NCT01024309|452915811|FG001|Overall Study|Withdrawal by Subject|4|||
125894855|NCT05194579|452915814|FG000|Overall Study|Lost to Follow-up|2|||
125894856|NCT05194579|452915815|FG001|Overall Study|Lost to Follow-up|3|||
125894857|NCT05194579|452915814|FG000|Overall Study|Withdrawal by Subject|3|||
125894858|NCT05194579|452915815|FG001|Overall Study|Withdrawal by Subject|4|||
125894859|NCT05194579|452915814|FG000|Overall Study|Refused further study procedures|0|||
125894860|NCT05194579|452915815|FG001|Overall Study|Refused further study procedures|1|||
125894861|NCT05194579|452915814|FG000|Overall Study|Protocol deviation|1|||
125894862|NCT05194579|452915815|FG001|Overall Study|Protocol deviation|0|||
125894863|NCT03232333|452915821|FG000|Overall Study|Infection or Osteomyelitis|9|||
125894864|NCT03232333|452915821|FG000|Overall Study|Lost to Follow-up|4|||
125894865|NCT03232333|452915821|FG000|Overall Study|Withdrawal by Subject|2|||
125894866|NCT00653432|452915825|FG000|Overall Study|Adverse Event|4|||
125894867|NCT00653432|452915826|FG001|Overall Study|Adverse Event|1|||
125894868|NCT00653432|452915825|FG000|Overall Study|Withdrawal by Subject|4|||
125894869|NCT00653432|452915826|FG001|Overall Study|Withdrawal by Subject|5|||
125894870|NCT00653432|452915825|FG000|Overall Study|Lost to Follow-up|7|||
125894871|NCT00653432|452915826|FG001|Overall Study|Lost to Follow-up|6|||
125894872|NCT00653432|452915825|FG000|Overall Study|Use/Need of Con Therapy|2|||
125894873|NCT00653432|452915826|FG001|Overall Study|Use/Need of Con Therapy|1|||
125894874|NCT00653432|452915825|FG000|Overall Study|Other - Reason Not Provided|5|||
125894875|NCT00653432|452915826|FG001|Overall Study|Other - Reason Not Provided|3|||
125894876|NCT00567255|452915827|FG000|Overall Study|Adverse Event|241|||
125894877|NCT00567255|452915828|FG001|Overall Study|Adverse Event|68|||
125894878|NCT00567255|452915827|FG000|Overall Study|Lost to Follow-up|77|||
125894879|NCT00567255|452915828|FG001|Overall Study|Lost to Follow-up|48|||
125894880|NCT00567255|452915827|FG000|Overall Study|Withdrawal by Subject|75|||
125894881|NCT00567255|452915828|FG001|Overall Study|Withdrawal by Subject|56|||
126109547|NCT04484259|453694338|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
126109548|NCT04484259|453694339|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
126109549|NCT04484259|453694335|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
126109550|NCT04484259|453694336|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
126109551|NCT04484259|453694337|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
126109552|NCT04484259|453694338|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
126109553|NCT04484259|453694339|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
126109554|NCT04484259|453694335|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
126109555|NCT04484259|453694336|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
126109556|NCT04484259|453694337|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
126109557|NCT04484259|453694338|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
126109558|NCT04484259|453694339|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
126109559|NCT04484259|453694335|FG000|Randomized Treatment|Withdrawal by Subject|1|||
126109560|NCT04484259|453694336|FG001|Randomized Treatment|Withdrawal by Subject|0|||
126109561|NCT04484259|453694337|FG002|Randomized Treatment|Withdrawal by Subject|0|||
126109562|NCT04484259|453694338|FG003|Randomized Treatment|Withdrawal by Subject|0|||
126109563|NCT04484259|453694339|FG004|Randomized Treatment|Withdrawal by Subject|0|||
126109564|NCT01422850|453694348|FG000|Overall Study|Physician Decision|3|||
126109565|NCT04484831|453694349|FG000|Overall Study|Withdrawal by Subject|1|||
126109566|NCT04484831|453694350|FG001|Overall Study|Withdrawal by Subject|0|||
126109567|NCT02244996|453694351|FG000|Overall Study|Lack of Efficacy|2|||
126109568|NCT02244996|453694352|FG001|Overall Study|Lack of Efficacy|6|||
126109569|NCT01335009|453694353|FG000|Overall Study|Too ill to travel to study sites|1|||
126109570|NCT01335009|453694354|FG001|Overall Study|Too ill to travel to study sites|0|||
126109571|NCT01335009|453694353|FG000|Overall Study|Death|28|||
126109572|NCT01335009|453694354|FG001|Overall Study|Death|32|||
126109573|NCT01335009|453694353|FG000|Overall Study|Withdrawal by Subject|1|||
126109574|NCT01335009|453694354|FG001|Overall Study|Withdrawal by Subject|1|||
126109575|NCT01335009|453694353|FG000|Overall Study|Lost to Follow-up|1|||
126109576|NCT01335009|453694354|FG001|Overall Study|Lost to Follow-up|0|||
126109577|NCT04751656|453695629|FG000|Overall Study|Lost to Follow-up|1|||
126109578|NCT01128361|453695641|FG000|Overall Study|Lost to Follow-up|0|||
126109579|NCT01128361|453695642|FG001|Overall Study|Lost to Follow-up|1|||
126109580|NCT01128361|453695641|FG000|Overall Study|Withdrawal by Subject|5|||
126109581|NCT01128361|453695642|FG001|Overall Study|Withdrawal by Subject|2|||
126109582|NCT00146328|453695643|FG000|Overall Study|Adverse Event|39|||
126109583|NCT00146328|453695644|FG001|Overall Study|Adverse Event|48|||
126109584|NCT00146328|453695645|FG002|Overall Study|Adverse Event|79|||
126109585|NCT00146328|453695643|FG000|Overall Study|Protocol Violation|11|||
126109586|NCT00146328|453695644|FG001|Overall Study|Protocol Violation|6|||
126109587|NCT00146328|453695645|FG002|Overall Study|Protocol Violation|12|||
126109588|NCT00146328|453695643|FG000|Overall Study|Lost to Follow-up|7|||
126109589|NCT00146328|453695644|FG001|Overall Study|Lost to Follow-up|4|||
126109590|NCT00146328|453695645|FG002|Overall Study|Lost to Follow-up|7|||
126109591|NCT00146328|453695643|FG000|Overall Study|Withdrawal by Subject|16|||
126109592|NCT00146328|453695644|FG001|Overall Study|Withdrawal by Subject|16|||
126109593|NCT00146328|453695645|FG002|Overall Study|Withdrawal by Subject|22|||
126109594|NCT00146328|453695643|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
125894882|NCT00567255|452915827|FG000|Overall Study|Lack of Efficacy|19|||
125894883|NCT00567255|452915828|FG001|Overall Study|Lack of Efficacy|33|||
125894884|NCT00567255|452915827|FG000|Overall Study|Protocol Violation|20|||
125894885|NCT00567255|452915828|FG001|Overall Study|Protocol Violation|8|||
125894886|NCT00567255|452915827|FG000|Overall Study|Pregnancy|6|||
125894887|NCT00567255|452915828|FG001|Overall Study|Pregnancy|0|||
125894888|NCT00567255|452915827|FG000|Overall Study|Drug noncompliance,moved,other|25|||
125894889|NCT00567255|452915828|FG001|Overall Study|Drug noncompliance,moved,other|15|||
125894890|NCT01290796|452915833|FG000|Overall Study|Lost to Follow-up|21|||
126109595|NCT00146328|453695644|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
126109596|NCT00146328|453695645|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
126109597|NCT00146328|453695643|FG000|Overall Study|Trial ended/site closed|8|||
126109598|NCT00146328|453695644|FG001|Overall Study|Trial ended/site closed|2|||
126109599|NCT00146328|453695645|FG002|Overall Study|Trial ended/site closed|19|||
126109600|NCT00146328|453695643|FG000|Overall Study|Patient decision to end|0|||
126109601|NCT00146328|453695644|FG001|Overall Study|Patient decision to end|1|||
126109602|NCT00146328|453695645|FG002|Overall Study|Patient decision to end|6|||
125894891|NCT01290796|452915833|FG000|Overall Study|Withdrawal by Subject|4|||
126109603|NCT00146328|453695643|FG000|Overall Study|Enroll into other trial|2|||
126109604|NCT00146328|453695644|FG001|Overall Study|Enroll into other trial|4|||
126109605|NCT00146328|453695645|FG002|Overall Study|Enroll into other trial|2|||
125894892|NCT01290796|452915833|FG000|Overall Study|Physician Decision|2|||
125894893|NCT01290796|452915833|FG000|Overall Study|Secondary Surgical Intervention|2|||
125894894|NCT01290796|452915833|FG000|Overall Study|Withdrawal by Sponsor|1|||
126109606|NCT00146328|453695643|FG000|Overall Study|Death|0|||
126109607|NCT00146328|453695644|FG001|Overall Study|Death|1|||
126109608|NCT00146328|453695645|FG002|Overall Study|Death|1|||
126059711|NCT03136861|453512528|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126059712|NCT03136861|453512529|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126059713|NCT03136861|453512530|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126059714|NCT03136861|453512531|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
125894895|NCT02343549|452915834|FG000|Overall Study|Death|11|||
125894896|NCT02343549|452915834|FG000|Overall Study|Withdrawal by Subject|2|||
125894897|NCT03087617|452915835|FG000|Overall Study|Lost to Follow-up|32|||
125894898|NCT03087617|452915836|FG001|Overall Study|Lost to Follow-up|30|||
125894899|NCT03087617|452915837|FG002|Overall Study|Lost to Follow-up|30|||
125894900|NCT03087617|452915838|FG003|Overall Study|Lost to Follow-up|39|||
125894901|NCT00787267|452915842|FG000|Overall Study|Screen failure/Ineligible|10|||
125894902|NCT00787267|452915842|FG000|Overall Study|No Reason Provided|1|||
125894903|NCT00787267|452915842|FG000|Overall Study|Withdrawal by Subject|1|||
125894904|NCT04343235|452915843|FG000|Overall Study|Lost to Follow-up|3|||
125894905|NCT04343235|452915844|FG001|Overall Study|Lost to Follow-up|2|||
125894906|NCT00865280|452915845|FG000|Overall Study|Withdrawal by Subject|4|||
125894907|NCT00865280|452915846|FG001|Overall Study|Withdrawal by Subject|1|||
125894908|NCT00865280|452915845|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
125894909|NCT00865280|452915846|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
125894910|NCT00865280|452915845|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
125894911|NCT00865280|452915846|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
125894912|NCT00865280|452915845|FG000|Overall Study|Exclusion Condition|1|||
125894913|NCT00865280|452915846|FG001|Overall Study|Exclusion Condition|0|||
125894914|NCT00865280|452915845|FG000|Overall Study|Adverse Event|0|||
125894915|NCT00865280|452915846|FG001|Overall Study|Adverse Event|1|||
125894916|NCT01788215|452915847|FG000|Overall Study|Withdrawal by Subject|0|||
125894917|NCT01788215|452915848|FG001|Overall Study|Withdrawal by Subject|1|||
125894918|NCT01788215|452915847|FG000|Overall Study|Lost to Follow-up|2|||
125894919|NCT01788215|452915848|FG001|Overall Study|Lost to Follow-up|0|||
125894920|NCT01950013|452915851|FG000|Overall Study|Withdrawal by Subject|0|||
125894921|NCT01950013|452915852|FG001|Overall Study|Withdrawal by Subject|2|||
125894922|NCT01950013|452915853|FG002|Overall Study|Withdrawal by Subject|0|||
125894923|NCT00612105|452915862|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
125894924|NCT00612105|452915863|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
125894925|NCT00612105|452915862|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
125894926|NCT00612105|452915863|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
125894927|NCT00612105|452915862|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
125894928|NCT00612105|452915863|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
125894929|NCT00612105|452915862|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
125894930|NCT00612105|452915863|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
125894931|NCT00612105|452915862|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
125894932|NCT00612105|452915863|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
125894933|NCT00612105|452915862|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
125894934|NCT00612105|452915863|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
125894935|NCT00612105|452915862|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
125894936|NCT00612105|452915863|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
125894937|NCT00612105|452915862|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
125894938|NCT00612105|452915863|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
125894939|NCT00612105|452915862|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
125894940|NCT00612105|452915863|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
125894941|NCT00612105|452915862|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
125894942|NCT00612105|452915863|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
125894943|NCT00612105|452915862|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
125894944|NCT00612105|452915863|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
125894945|NCT00612105|452915862|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
125894946|NCT00612105|452915863|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
125894947|NCT00271505|452915865|FG000|Overall Study|Screen Failure|3|||
125894948|NCT00271505|452915865|FG000|Overall Study|Adverse Event|1|||
125894949|NCT00271505|452915865|FG000|Overall Study|Death|1|||
125894950|NCT04556383|452915866|FG000|PCP|Lack of Efficacy|28|||
125894951|NCT04556383|452915867|FG001|PCP|Lack of Efficacy|23|||
125894952|NCT04556383|452915868|FG002|PCP|Lack of Efficacy|23|||
125894953|NCT04556383|452915869|FG003|PCP|Lack of Efficacy|0|||
125894954|NCT04556383|452915866|FG000|PCP|Study terminated by sponsor|15|||
126109609|NCT00146328|453695643|FG000|Overall Study|Moved|2|||
126109610|NCT00146328|453695644|FG001|Overall Study|Moved|0|||
126109611|NCT00146328|453695645|FG002|Overall Study|Moved|0|||
126109612|NCT00146328|453695643|FG000|Overall Study|Interaction with other medication|2|||
126109613|NCT00146328|453695644|FG001|Overall Study|Interaction with other medication|0|||
126109614|NCT00146328|453695645|FG002|Overall Study|Interaction with other medication|1|||
126109615|NCT01256658|453695646|FG000|Period 1|Lost to Follow-up|837|||
126109616|NCT01256658|453695647|FG001|Period 1|Lost to Follow-up|661|||
125894955|NCT04556383|452915867|FG001|PCP|Study terminated by sponsor|13|||
125894956|NCT04556383|452915868|FG002|PCP|Study terminated by sponsor|16|||
125894957|NCT04556383|452915869|FG003|PCP|Study terminated by sponsor|0|||
125894958|NCT04556383|452915866|FG000|PCP|Withdrawal by Subject|8|||
125894959|NCT04556383|452915867|FG001|PCP|Withdrawal by Subject|6|||
125894960|NCT04556383|452915868|FG002|PCP|Withdrawal by Subject|6|||
125894961|NCT04556383|452915869|FG003|PCP|Withdrawal by Subject|0|||
125894962|NCT04556383|452915866|FG000|PCP|Adverse Event|1|||
125894963|NCT04556383|452915867|FG001|PCP|Adverse Event|7|||
125894964|NCT04556383|452915868|FG002|PCP|Adverse Event|7|||
125894965|NCT04556383|452915869|FG003|PCP|Adverse Event|0|||
125894966|NCT04556383|452915866|FG000|PCP|Other, Not Specified|1|||
125894967|NCT04556383|452915867|FG001|PCP|Other, Not Specified|2|||
125894968|NCT04556383|452915868|FG002|PCP|Other, Not Specified|1|||
125894969|NCT04556383|452915869|FG003|PCP|Other, Not Specified|0|||
125894970|NCT04556383|452915866|FG000|PCP|Protocol Violation|1|||
125894971|NCT04556383|452915867|FG001|PCP|Protocol Violation|0|||
125894972|NCT04556383|452915868|FG002|PCP|Protocol Violation|1|||
125894973|NCT04556383|452915869|FG003|PCP|Protocol Violation|0|||
125894974|NCT04556383|452915866|FG000|PCP|Lost to Follow-up|1|||
125894975|NCT04556383|452915867|FG001|PCP|Lost to Follow-up|0|||
125894976|NCT04556383|452915868|FG002|PCP|Lost to Follow-up|0|||
125894977|NCT04556383|452915869|FG003|PCP|Lost to Follow-up|0|||
125894978|NCT04556383|452915866|FG000|PCP|Physician Decision|0|||
125894979|NCT04556383|452915867|FG001|PCP|Physician Decision|1|||
125894980|NCT04556383|452915868|FG002|PCP|Physician Decision|0|||
125894981|NCT04556383|452915869|FG003|PCP|Physician Decision|0|||
126109617|NCT01256658|453695646|FG000|Period 1|Withdrawal by Subject|35|||
126109618|NCT01256658|453695647|FG001|Period 1|Withdrawal by Subject|43|||
125894982|NCT04556383|452915866|FG000|PCP|Site terminated by sponsor|0|||
125894983|NCT04556383|452915867|FG001|PCP|Site terminated by sponsor|1|||
125894984|NCT04556383|452915868|FG002|PCP|Site terminated by sponsor|0|||
125894985|NCT04556383|452915869|FG003|PCP|Site terminated by sponsor|0|||
125894986|NCT04556383|452915866|FG000|OLE|Study terminated by sponsor|0|||
125894987|NCT04556383|452915867|FG001|OLE|Study terminated by sponsor|0|||
126109619|NCT01256658|453695646|FG000|Period 1|Death|48|||
126109620|NCT01256658|453695647|FG001|Period 1|Death|44|||
125894988|NCT04556383|452915868|FG002|OLE|Study terminated by sponsor|0|||
125894989|NCT04556383|452915869|FG003|OLE|Study terminated by sponsor|68|||
125894990|NCT04556383|452915866|FG000|OLE|Withdrawal by Subject|0|||
125894991|NCT04556383|452915867|FG001|OLE|Withdrawal by Subject|0|||
125894992|NCT04556383|452915868|FG002|OLE|Withdrawal by Subject|0|||
125894993|NCT04556383|452915869|FG003|OLE|Withdrawal by Subject|10|||
125894994|NCT04556383|452915866|FG000|OLE|Lack of Efficacy|0|||
125894995|NCT04556383|452915867|FG001|OLE|Lack of Efficacy|0|||
126109621|NCT00300781|453695648|FG000|Overall Study|Disease Progression|55|||
126109622|NCT00300781|453695649|FG001|Overall Study|Disease Progression|52|||
126109623|NCT00300781|453695648|FG000|Overall Study|Adverse Event|5|||
126109624|NCT00300781|453695649|FG001|Overall Study|Adverse Event|6|||
126109625|NCT00300781|453695648|FG000|Overall Study|Withdrawal by Subject|1|||
126109626|NCT00300781|453695649|FG001|Overall Study|Withdrawal by Subject|2|||
126109627|NCT00300781|453695648|FG000|Overall Study|Physician Decision|1|||
126109628|NCT00300781|453695649|FG001|Overall Study|Physician Decision|0|||
126109629|NCT00300781|453695648|FG000|Overall Study|Not Recorded|0|||
126109630|NCT00300781|453695649|FG001|Overall Study|Not Recorded|1|||
126109631|NCT00300781|453695648|FG000|Overall Study|Symptomatic Deterioration|1|||
126109632|NCT00300781|453695649|FG001|Overall Study|Symptomatic Deterioration|0|||
126109633|NCT00300781|453695648|FG000|Overall Study|Lost to Follow-up|0|||
126109634|NCT00300781|453695649|FG001|Overall Study|Lost to Follow-up|1|||
126109635|NCT02072434|453695653|FG000|Overall Study|Protocol Violation|10|||
126109636|NCT02072434|453695654|FG001|Overall Study|Protocol Violation|9|||
126109637|NCT02072434|453695653|FG000|Overall Study|Physician Decision|5|||
126109638|NCT02072434|453695654|FG001|Overall Study|Physician Decision|10|||
126109639|NCT02072434|453695653|FG000|Overall Study|Adverse event, serious fatal|1|||
126109640|NCT02072434|453695654|FG001|Overall Study|Adverse event, serious fatal|6|||
126109641|NCT02072434|453695653|FG000|Overall Study|Adverse Event|7|||
126109642|NCT02072434|453695654|FG001|Overall Study|Adverse Event|6|||
126109643|NCT02072434|453695653|FG000|Overall Study|Withdrawal by Subject|17|||
126109644|NCT02072434|453695654|FG001|Overall Study|Withdrawal by Subject|29|||
126109645|NCT02072434|453695653|FG000|Overall Study|Other|14|||
126109646|NCT02072434|453695654|FG001|Overall Study|Other|29|||
126109647|NCT02072434|453695653|FG000|Overall Study|Lost to Follow-up|0|||
126109648|NCT02072434|453695654|FG001|Overall Study|Lost to Follow-up|1|||
126109649|NCT01117454|453695655|FG000|Overall Study|Pregnancy|0|||
126109650|NCT01117454|453695656|FG001|Overall Study|Pregnancy|1|||
126109651|NCT00888433|453695659|FG000|Overall Study|Withdrawal by Subject|1|||
126109652|NCT00888433|453695660|FG001|Overall Study|Withdrawal by Subject|2|||
126109653|NCT00888433|453695659|FG000|Overall Study|Missed Visit|2|||
126109654|NCT00888433|453695660|FG001|Overall Study|Missed Visit|1|||
126109655|NCT01681628|453695661|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
126109656|NCT01681628|453695662|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
126109657|NCT01681628|453695661|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
126109658|NCT01681628|453695662|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
126109659|NCT01681628|453695661|FG000|19 Months Follow-up|Death|1|||
126109660|NCT01681628|453695662|FG001|19 Months Follow-up|Death|0|||
126109661|NCT01681628|453695661|FG000|19 Months Follow-up|Lost to Follow-up|61|||
126109662|NCT01681628|453695662|FG001|19 Months Follow-up|Lost to Follow-up|43|||
126109663|NCT04356183|453695670|FG000|Overall Study|Lost to Follow-up|1|||
126109664|NCT04356183|453695671|FG001|Overall Study|Lost to Follow-up|0|||
126109665|NCT04356183|453695670|FG000|Overall Study|Withdrawal by Subject|1|||
126109666|NCT04356183|453695671|FG001|Overall Study|Withdrawal by Subject|1|||
126109667|NCT02170389|453695678|FG000|Overall Study|Study terminated prior to start of treat|1|||
125894996|NCT04556383|452915868|FG002|OLE|Lack of Efficacy|0|||
125894997|NCT04556383|452915869|FG003|OLE|Lack of Efficacy|7|||
125894998|NCT04556383|452915866|FG000|OLE|Adverse Event|0|||
125894999|NCT04556383|452915867|FG001|OLE|Adverse Event|0|||
125895000|NCT04556383|452915868|FG002|OLE|Adverse Event|0|||
125895001|NCT04556383|452915869|FG003|OLE|Adverse Event|2|||
125895002|NCT04556383|452915866|FG000|OLE|Other, Not Specified|0|||
125895003|NCT04556383|452915867|FG001|OLE|Other, Not Specified|0|||
125895004|NCT04556383|452915868|FG002|OLE|Other, Not Specified|0|||
125895005|NCT04556383|452915869|FG003|OLE|Other, Not Specified|2|||
125895006|NCT04556383|452915866|FG000|OLE|Death|0|||
125895007|NCT04556383|452915867|FG001|OLE|Death|0|||
125895008|NCT04556383|452915868|FG002|OLE|Death|0|||
125895009|NCT04556383|452915869|FG003|OLE|Death|1|||
125895010|NCT04556383|452915866|FG000|OLE|Lost to Follow-up|0|||
125895011|NCT04556383|452915867|FG001|OLE|Lost to Follow-up|0|||
125895012|NCT04556383|452915868|FG002|OLE|Lost to Follow-up|0|||
125895013|NCT04556383|452915869|FG003|OLE|Lost to Follow-up|1|||
125895014|NCT00509145|452915870|FG000|Overall Study|Death|0|||
125895015|NCT00509145|452915871|FG001|Overall Study|Death|2|||
125895016|NCT00509145|452915870|FG000|Overall Study|Adverse Event|42|||
125895017|NCT00509145|452915871|FG001|Overall Study|Adverse Event|28|||
125895018|NCT00509145|452915870|FG000|Overall Study|Withdrawal by Subject|32|||
125895019|NCT00509145|452915871|FG001|Overall Study|Withdrawal by Subject|38|||
125895020|NCT00509145|452915870|FG000|Overall Study|Physician Decision|11|||
125895021|NCT00509145|452915871|FG001|Overall Study|Physician Decision|14|||
125895022|NCT00509145|452915870|FG000|Overall Study|Protocol Violation|1|||
125895023|NCT00509145|452915871|FG001|Overall Study|Protocol Violation|6|||
125895024|NCT00509145|452915870|FG000|Overall Study|Pregnancy|3|||
125895025|NCT00509145|452915871|FG001|Overall Study|Pregnancy|8|||
125895026|NCT00509145|452915870|FG000|Overall Study|Lost to Follow-up|6|||
125895027|NCT00509145|452915871|FG001|Overall Study|Lost to Follow-up|5|||
126109668|NCT00667355|453695679|FG000|Overall Study|Adverse Event|5|||
125895028|NCT00509145|452915870|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
125895029|NCT00509145|452915871|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
125895030|NCT00509145|452915870|FG000|Overall Study|Other|6|||
125895031|NCT00509145|452915871|FG001|Overall Study|Other|6|||
125895032|NCT01994889|452915873|FG000|Overall Study|Adverse Event|5|||
125895033|NCT01994889|452915874|FG001|Overall Study|Adverse Event|12|||
125895034|NCT01994889|452915875|FG002|Overall Study|Adverse Event|11|||
125895035|NCT01994889|452915873|FG000|Overall Study|Cardiac Device Implantation|0|||
125895036|NCT01994889|452915874|FG001|Overall Study|Cardiac Device Implantation|2|||
125895037|NCT01994889|452915875|FG002|Overall Study|Cardiac Device Implantation|0|||
125895038|NCT01994889|452915873|FG000|Overall Study|Organ Transplantation|1|||
125895039|NCT01994889|452915874|FG001|Overall Study|Organ Transplantation|5|||
125895040|NCT01994889|452915875|FG002|Overall Study|Organ Transplantation|5|||
125895041|NCT01994889|452915873|FG000|Overall Study|No longer willing to participate|8|||
125895042|NCT01994889|452915874|FG001|Overall Study|No longer willing to participate|17|||
125895043|NCT01994889|452915875|FG002|Overall Study|No longer willing to participate|37|||
125895044|NCT01994889|452915873|FG000|Overall Study|Lost to Follow-up|0|||
125895045|NCT01994889|452915874|FG001|Overall Study|Lost to Follow-up|1|||
125895046|NCT01994889|452915875|FG002|Overall Study|Lost to Follow-up|0|||
125895047|NCT01994889|452915873|FG000|Overall Study|Protocol Violation|0|||
125895048|NCT01994889|452915874|FG001|Overall Study|Protocol Violation|1|||
125895049|NCT01994889|452915875|FG002|Overall Study|Protocol Violation|1|||
125895050|NCT01994889|452915873|FG000|Overall Study|Death|14|||
125895051|NCT01994889|452915874|FG001|Overall Study|Death|25|||
125895052|NCT01994889|452915875|FG002|Overall Study|Death|38|||
126059715|NCT03136861|453512525|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126059716|NCT03136861|453512526|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
126059717|NCT03136861|453512527|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126059718|NCT03136861|453512528|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126059719|NCT03136861|453512529|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126059720|NCT03136861|453512530|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126059721|NCT03136861|453512531|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126059722|NCT03136861|453512525|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
126059723|NCT03136861|453512526|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
125895053|NCT02969655|452915876|FG000|Overall Study|Withdrawal by Subject|3|||
126059724|NCT03136861|453512527|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126059725|NCT03136861|453512528|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
125895054|NCT02969655|452915877|FG001|Overall Study|Withdrawal by Subject|2|||
125895055|NCT02969655|452915876|FG000|Overall Study|Physician Decision|4|||
125895056|NCT02969655|452915877|FG001|Overall Study|Physician Decision|3|||
125895057|NCT02969655|452915876|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
125895058|NCT02969655|452915877|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
125895059|NCT02969655|452915876|FG000|Overall Study|Adverse Event|10|||
125895060|NCT02969655|452915877|FG001|Overall Study|Adverse Event|8|||
125895061|NCT02674204|452915878|FG000|Overall Study|Adverse Event|1|||
125895062|NCT02674204|452915879|FG001|Overall Study|Adverse Event|0|||
126109669|NCT00667355|453695679|FG000|Overall Study|Lost to Follow-up|1|||
126109670|NCT00667355|453695679|FG000|Overall Study|Other reason was not specified|5|||
126109671|NCT02175004|453695681|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
126109672|NCT02175004|453695682|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
126109673|NCT02175004|453695681|FG000|Overall Study|Investigator Judgment|1|||
126109674|NCT02175004|453695682|FG001|Overall Study|Investigator Judgment|4|||
126109675|NCT02175004|453695681|FG000|Overall Study|Voluntary Withdrawal|6|||
126109676|NCT02175004|453695682|FG001|Overall Study|Voluntary Withdrawal|19|||
126109677|NCT02175004|453695681|FG000|Overall Study|Liver Transplant|1|||
126109678|NCT02175004|453695682|FG001|Overall Study|Liver Transplant|0|||
125895063|NCT00557856|452915883|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
125895064|NCT00557856|452915884|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
125895065|NCT00557856|452915885|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
125895066|NCT00557856|452915886|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
125895067|NCT00557856|452915887|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
126109679|NCT02175004|453695681|FG000|Overall Study|Disease Progression|1|||
126109680|NCT02175004|453695682|FG001|Overall Study|Disease Progression|0|||
126109681|NCT02175004|453695681|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
126109682|NCT02175004|453695682|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
126109683|NCT02960854|453695683|FG000|Overall Study|Not Disclosed|2|||
126109684|NCT02960854|453695684|FG001|Overall Study|Not Disclosed|2|||
126109685|NCT02960854|453695683|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
126109686|NCT02960854|453695684|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
126109687|NCT02960854|453695683|FG000|Overall Study|Subject Withdrew Consent|0|||
126109688|NCT02960854|453695684|FG001|Overall Study|Subject Withdrew Consent|1|||
126109689|NCT02960854|453695683|FG000|Overall Study|Death|4|||
126109690|NCT02960854|453695684|FG001|Overall Study|Death|6|||
126109691|NCT01383161|453695685|FG000|Overall Study|Adverse Event|5|||
126109692|NCT01383161|453695686|FG001|Overall Study|Adverse Event|1|||
126109693|NCT01383161|453695685|FG000|Overall Study|Withdrawal by Subject|0|||
126109694|NCT01383161|453695686|FG001|Overall Study|Withdrawal by Subject|2|||
126109695|NCT01383161|453695685|FG000|Overall Study|Lack of Efficacy|0|||
126109696|NCT01383161|453695686|FG001|Overall Study|Lack of Efficacy|1|||
126109697|NCT03942406|453695693|FG000|Overall Study|Lost to Follow-up|4|||
126109698|NCT03942406|453695694|FG001|Overall Study|Lost to Follow-up|5|||
126109699|NCT03942406|453695695|FG002|Overall Study|Lost to Follow-up|3|||
126109700|NCT03942406|453695696|FG003|Overall Study|Lost to Follow-up|7|||
126109701|NCT03942406|453695697|FG004|Overall Study|Lost to Follow-up|1|||
126109702|NCT03942406|453695698|FG005|Overall Study|Lost to Follow-up|0|||
126109703|NCT03942406|453695699|FG006|Overall Study|Lost to Follow-up|0|||
126109704|NCT03942406|453695693|FG000|Overall Study|Withdrawal by Subject|3|||
126109705|NCT03942406|453695694|FG001|Overall Study|Withdrawal by Subject|1|||
126109706|NCT03942406|453695695|FG002|Overall Study|Withdrawal by Subject|1|||
126109707|NCT03942406|453695696|FG003|Overall Study|Withdrawal by Subject|3|||
126109708|NCT03942406|453695697|FG004|Overall Study|Withdrawal by Subject|0|||
126109709|NCT03942406|453695698|FG005|Overall Study|Withdrawal by Subject|0|||
126109710|NCT03942406|453695699|FG006|Overall Study|Withdrawal by Subject|0|||
126109711|NCT03942406|453695693|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
126109712|NCT03942406|453695694|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
126109713|NCT03942406|453695695|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
126109714|NCT03942406|453695696|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
126109715|NCT03942406|453695697|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
126109716|NCT03942406|453695698|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
126109717|NCT03942406|453695699|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
126109718|NCT00216203|453695702|FG000|Overall Study|Withdrawal by Subject|2|||
126109719|NCT04263909|453695703|FG000|Overall Study|Physician Decision|1|||
126109720|NCT04263909|453695704|FG001|Overall Study|Physician Decision|0|||
126109721|NCT04263909|453695705|FG002|Overall Study|Physician Decision|0|||
125895068|NCT00557856|452915888|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
125895069|NCT00557856|452915889|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
125895070|NCT00557856|452915890|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
125895071|NCT00557856|452915891|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
125895072|NCT00557856|452915883|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
126109722|NCT04263909|453695703|FG000|Overall Study|Adverse Event|3|||
126109723|NCT04263909|453695704|FG001|Overall Study|Adverse Event|0|||
126109724|NCT04263909|453695705|FG002|Overall Study|Adverse Event|0|||
126109725|NCT04263909|453695703|FG000|Overall Study|Protocol Violation|5|||
126109726|NCT04263909|453695704|FG001|Overall Study|Protocol Violation|0|||
126109727|NCT04263909|453695705|FG002|Overall Study|Protocol Violation|0|||
126109728|NCT02310672|453695706|FG000|Overall Study|Death|1|||
126109729|NCT02310672|453695706|FG000|Overall Study|Lost to Follow-up|1|||
126109730|NCT02310672|453695706|FG000|Overall Study|Withdrawal by Subject|1|||
126109731|NCT02310672|453695706|FG000|Overall Study|Sponsor's decision|12|||
126109732|NCT04288778|453695707|FG000|Overall Study|Withdrawal by Subject|2|||
126109733|NCT04288778|453695707|FG000|Overall Study|Adverse Event|5|||
125895073|NCT00557856|452915884|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125895074|NCT00557856|452915885|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
125895075|NCT00557856|452915886|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125895076|NCT00557856|452915887|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125895077|NCT00557856|452915888|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125895078|NCT00557856|452915889|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125895079|NCT00557856|452915890|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125895080|NCT00557856|452915891|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125895081|NCT00557856|452915883|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
125895082|NCT00557856|452915884|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
125895083|NCT00557856|452915885|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
125895084|NCT00557856|452915886|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
125895085|NCT00557856|452915887|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
125895086|NCT00557856|452915888|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
125895087|NCT00557856|452915889|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
125895088|NCT00557856|452915890|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
125895089|NCT00557856|452915891|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
125895090|NCT00557856|452915883|FG000|Part 1: Dose Escalation Phase|Other|0|||
125895091|NCT00557856|452915884|FG001|Part 1: Dose Escalation Phase|Other|0|||
125895092|NCT00557856|452915885|FG002|Part 1: Dose Escalation Phase|Other|1|||
125895093|NCT00557856|452915886|FG003|Part 1: Dose Escalation Phase|Other|1|||
125895094|NCT00557856|452915887|FG004|Part 1: Dose Escalation Phase|Other|0|||
125895095|NCT00557856|452915888|FG005|Part 1: Dose Escalation Phase|Other|0|||
125895096|NCT00557856|452915889|FG006|Part 1: Dose Escalation Phase|Other|0|||
125895097|NCT00557856|452915890|FG007|Part 1: Dose Escalation Phase|Other|1|||
125895098|NCT00557856|452915891|FG008|Part 1: Dose Escalation Phase|Other|0|||
125895099|NCT00557856|452915883|FG000|Part 1: Dose Escalation Phase|Death|0|||
125895100|NCT00557856|452915884|FG001|Part 1: Dose Escalation Phase|Death|0|||
125895101|NCT00557856|452915885|FG002|Part 1: Dose Escalation Phase|Death|0|||
125895102|NCT00557856|452915886|FG003|Part 1: Dose Escalation Phase|Death|0|||
125895103|NCT00557856|452915887|FG004|Part 1: Dose Escalation Phase|Death|0|||
125895104|NCT00557856|452915888|FG005|Part 1: Dose Escalation Phase|Death|1|||
125895105|NCT00557856|452915889|FG006|Part 1: Dose Escalation Phase|Death|0|||
125895106|NCT00557856|452915890|FG007|Part 1: Dose Escalation Phase|Death|0|||
125895107|NCT00557856|452915891|FG008|Part 1: Dose Escalation Phase|Death|0|||
125895108|NCT00557856|452915883|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125895109|NCT00557856|452915884|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125895110|NCT00557856|452915885|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125895111|NCT00557856|452915886|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125895112|NCT00557856|452915887|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125895113|NCT00557856|452915888|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
125895114|NCT00557856|452915889|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
125895115|NCT00557856|452915890|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125895116|NCT00557856|452915891|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125895117|NCT00557856|452915883|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
125895118|NCT00557856|452915884|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125895119|NCT00557856|452915885|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125895120|NCT00557856|452915886|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125895121|NCT00557856|452915887|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125895122|NCT00557856|452915888|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125895123|NCT00557856|452915889|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125895124|NCT00557856|452915890|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125895125|NCT00557856|452915891|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125895126|NCT00557856|452915883|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
125895127|NCT00557856|452915884|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
125895128|NCT00557856|452915885|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
125895129|NCT00557856|452915886|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
125895130|NCT00557856|452915887|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
125895131|NCT00557856|452915888|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
125895132|NCT00557856|452915889|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
125895133|NCT00557856|452915890|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
126109734|NCT04288778|453695707|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126109735|NCT04288778|453695707|FG000|Overall Study|Other|1|||
126109736|NCT04288778|453695707|FG000|Overall Study|Started but not treated|2|||
126109737|NCT03118674|453695712|FG000|Overall Study|Lost to Follow-up|2|||
126109738|NCT03118674|453695712|FG000|Overall Study|Screen Faliure|8|||
126109739|NCT03118674|453695712|FG000|Overall Study|Withdrawal by Subject|5|||
126109740|NCT03153137|453695713|FG000|Overall Study|Lost to Follow-up|1|||
125895134|NCT00557856|452915891|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
125895135|NCT00557856|452915883|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125895136|NCT00557856|452915884|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125895137|NCT00557856|452915885|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125895138|NCT00557856|452915886|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125895139|NCT00557856|452915887|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125895140|NCT00557856|452915888|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125895141|NCT00557856|452915889|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125895142|NCT00557856|452915890|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125895143|NCT00557856|452915891|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
125895144|NCT00557856|452915883|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
125895145|NCT00557856|452915884|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
125895146|NCT00557856|452915885|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
125895147|NCT00557856|452915886|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
125895148|NCT00557856|452915887|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
125895149|NCT00557856|452915888|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
125895150|NCT00557856|452915889|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
125895151|NCT00557856|452915890|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
125895152|NCT00557856|452915891|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
125895153|NCT00557856|452915883|FG000|Part 2: Exploratory Phase|Other|0|||
125895154|NCT00557856|452915884|FG001|Part 2: Exploratory Phase|Other|0|||
125895155|NCT00557856|452915885|FG002|Part 2: Exploratory Phase|Other|0|||
125895156|NCT00557856|452915886|FG003|Part 2: Exploratory Phase|Other|0|||
125895157|NCT00557856|452915887|FG004|Part 2: Exploratory Phase|Other|0|||
125895158|NCT00557856|452915888|FG005|Part 2: Exploratory Phase|Other|0|||
125895159|NCT00557856|452915889|FG006|Part 2: Exploratory Phase|Other|0|||
125895160|NCT00557856|452915890|FG007|Part 2: Exploratory Phase|Other|0|||
125895161|NCT00557856|452915891|FG008|Part 2: Exploratory Phase|Other|1|||
125895162|NCT00557856|452915883|FG000|Part 2: Exploratory Phase|Death|0|||
125895163|NCT00557856|452915884|FG001|Part 2: Exploratory Phase|Death|0|||
125895164|NCT00557856|452915885|FG002|Part 2: Exploratory Phase|Death|0|||
125895165|NCT00557856|452915886|FG003|Part 2: Exploratory Phase|Death|0|||
125895166|NCT00557856|452915887|FG004|Part 2: Exploratory Phase|Death|0|||
125895167|NCT00557856|452915888|FG005|Part 2: Exploratory Phase|Death|0|||
125895168|NCT00557856|452915889|FG006|Part 2: Exploratory Phase|Death|0|||
125895169|NCT00557856|452915890|FG007|Part 2: Exploratory Phase|Death|0|||
125895170|NCT00557856|452915891|FG008|Part 2: Exploratory Phase|Death|2|||
125895171|NCT00557856|452915883|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
125895172|NCT00557856|452915884|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
125895173|NCT00557856|452915885|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
125895174|NCT00557856|452915886|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
125895175|NCT00557856|452915887|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
125895176|NCT00557856|452915888|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
125895177|NCT00557856|452915889|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
125895178|NCT00557856|452915890|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
125895179|NCT00557856|452915891|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
125895180|NCT01675167|452915892|FG000|Open-label Titration Phase|Adverse Event|81|||
125895181|NCT01675167|452915893|FG001|Open-label Titration Phase|Adverse Event|0|||
125895182|NCT01675167|452915894|FG002|Open-label Titration Phase|Adverse Event|0|||
125895183|NCT01675167|452915892|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
125895184|NCT01675167|452915893|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
125895185|NCT01675167|452915894|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
125895186|NCT01675167|452915892|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
125895187|NCT01675167|452915893|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
125895188|NCT01675167|452915894|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
125895189|NCT01675167|452915892|FG000|Open-label Titration Phase|Protocol Violation|43|||
125895190|NCT01675167|452915893|FG001|Open-label Titration Phase|Protocol Violation|0|||
125895191|NCT01675167|452915894|FG002|Open-label Titration Phase|Protocol Violation|0|||
125895192|NCT01675167|452915892|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
125895193|NCT01675167|452915893|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
125895194|NCT01675167|452915894|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
125895195|NCT01675167|452915892|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
125895196|NCT01675167|452915893|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
125895197|NCT01675167|452915894|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
125895198|NCT01675167|452915892|FG000|Open-label Titration Phase|Other|55|||
125895199|NCT01675167|452915893|FG001|Open-label Titration Phase|Other|0|||
125895200|NCT01675167|452915894|FG002|Open-label Titration Phase|Other|0|||
125895201|NCT01675167|452915892|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
125895202|NCT01675167|452915893|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
125895203|NCT01675167|452915894|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
125895204|NCT01675167|452915892|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125895205|NCT01675167|452915893|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
125895206|NCT01675167|452915894|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
125895207|NCT01675167|452915892|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125895208|NCT01675167|452915893|FG001|Double-blind Treatment Phase|Adverse Event|5|||
125895209|NCT01675167|452915894|FG002|Double-blind Treatment Phase|Adverse Event|13|||
125895210|NCT01675167|452915892|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
125895211|NCT01675167|452915893|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
125895212|NCT01675167|452915894|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
125895213|NCT01675167|452915892|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125895214|NCT01675167|452915893|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
125895215|NCT01675167|452915894|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
125895216|NCT01675167|452915892|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
125895217|NCT01675167|452915893|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
125895218|NCT01675167|452915894|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
125895219|NCT01675167|452915892|FG000|Double-blind Treatment Phase|Other|0|||
125895220|NCT01675167|452915893|FG001|Double-blind Treatment Phase|Other|7|||
125895221|NCT01675167|452915894|FG002|Double-blind Treatment Phase|Other|5|||
125895222|NCT01525225|452915895|FG000|Enrollment|No longer met study criteria|1|||
125895223|NCT01525225|452915895|FG000|Enrollment|Other|1|||
125895224|NCT00243841|452915898|FG000|Overall Study|Physician Decision|0|||
125895225|NCT00243841|452915899|FG001|Overall Study|Physician Decision|0|||
125895226|NCT00243841|452915900|FG002|Overall Study|Physician Decision|1|||
125895227|NCT00243841|452915901|FG003|Overall Study|Physician Decision|0|||
125895228|NCT00243841|452915902|FG004|Overall Study|Physician Decision|0|||
125895229|NCT00243841|452915903|FG005|Overall Study|Physician Decision|2|||
125895230|NCT00363545|452915904|FG000|Overall Study|Serious Adverse Event|0|||
125895231|NCT00363545|452915905|FG001|Overall Study|Serious Adverse Event|1|||
125895232|NCT00363545|452915904|FG000|Overall Study|Withdrawal by Subject|12|||
125895233|NCT00363545|452915905|FG001|Overall Study|Withdrawal by Subject|15|||
125895234|NCT00363545|452915904|FG000|Overall Study|Migrated/moved from study area|3|||
125895235|NCT00363545|452915905|FG001|Overall Study|Migrated/moved from study area|6|||
125895236|NCT00363545|452915904|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
125895237|NCT00363545|452915905|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
125895238|NCT00363545|452915904|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
125895239|NCT00363545|452915905|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
125895240|NCT00363545|452915904|FG000|Overall Study|Others|1|||
125895241|NCT00363545|452915905|FG001|Overall Study|Others|0|||
125895242|NCT01182844|452915906|FG000|Overall Study|Withdrawal by Subject|0|||
125895243|NCT01182844|452915907|FG001|Overall Study|Withdrawal by Subject|2|||
125895244|NCT01379508|452915908|FG000|Treatment to Week 104|Adverse Event|2|||
125895245|NCT01379508|452915909|FG001|Treatment to Week 104|Adverse Event|0|||
125895246|NCT01379508|452915910|FG002|Treatment to Week 104|Adverse Event|5|||
125895247|NCT01379508|452915911|FG003|Treatment to Week 104|Adverse Event|0|||
125895248|NCT01379508|452915908|FG000|Treatment to Week 104|Abnormal lab value|1|||
125895249|NCT01379508|452915909|FG001|Treatment to Week 104|Abnormal lab value|0|||
125895250|NCT01379508|452915910|FG002|Treatment to Week 104|Abnormal lab value|0|||
125895251|NCT01379508|452915911|FG003|Treatment to Week 104|Abnormal lab value|0|||
125895252|NCT01379508|452915908|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
125895253|NCT01379508|452915909|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
125895254|NCT01379508|452915910|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
125895255|NCT01379508|452915911|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
125895256|NCT01379508|452915908|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
125895257|NCT01379508|452915909|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
125895258|NCT01379508|452915910|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
125895259|NCT01379508|452915911|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
125895260|NCT01379508|452915908|FG000|Treatment to Week 104|Lost to Follow-up|5|||
125895261|NCT01379508|452915909|FG001|Treatment to Week 104|Lost to Follow-up|0|||
125895262|NCT01379508|452915910|FG002|Treatment to Week 104|Lost to Follow-up|3|||
125895263|NCT01379508|452915911|FG003|Treatment to Week 104|Lost to Follow-up|0|||
125895264|NCT01379508|452915908|FG000|Treatment to Week 104|Administrative problems|3|||
125895265|NCT01379508|452915909|FG001|Treatment to Week 104|Administrative problems|1|||
125895266|NCT01379508|452915910|FG002|Treatment to Week 104|Administrative problems|0|||
126109741|NCT03153137|453695714|FG001|Overall Study|Lost to Follow-up|0|||
125895267|NCT01379508|452915911|FG003|Treatment to Week 104|Administrative problems|0|||
125895268|NCT01379508|452915908|FG000|Treatment to Week 104|Protocol Violation|1|||
126059726|NCT03136861|453512529|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126109742|NCT03153137|453695713|FG000|Overall Study|Withdrawal by Subject|2|||
126109743|NCT03153137|453695714|FG001|Overall Study|Withdrawal by Subject|1|||
126109744|NCT03153137|453695713|FG000|Overall Study|Physician Decision|0|||
126109745|NCT03153137|453695714|FG001|Overall Study|Physician Decision|3|||
126109746|NCT04209621|453695715|FG000|Overall Study|Death|1|||
126109747|NCT04209621|453695715|FG000|Overall Study|Study Terminated Early|2|||
126109748|NCT01372410|453695716|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
126109749|NCT01372410|453695717|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
126109750|NCT01372410|453695718|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126109751|NCT01372410|453695719|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126109752|NCT01372410|453695720|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
126109753|NCT01372410|453695721|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126109754|NCT01372410|453695722|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126109755|NCT01372410|453695723|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126109756|NCT01372410|453695716|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
126109757|NCT01372410|453695717|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
126109758|NCT01372410|453695718|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
126109759|NCT01372410|453695719|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
126109760|NCT01372410|453695720|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
126109761|NCT01372410|453695721|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
126109762|NCT01372410|453695722|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
126109763|NCT01372410|453695723|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
126109764|NCT01372410|453695716|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126109765|NCT01372410|453695717|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126109766|NCT01372410|453695718|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126109767|NCT01372410|453695719|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126109768|NCT01372410|453695720|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
126109769|NCT01372410|453695721|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126109770|NCT01372410|453695722|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126109771|NCT01372410|453695723|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126109772|NCT01372410|453695716|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126109773|NCT01372410|453695717|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126109774|NCT01372410|453695718|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126109775|NCT01372410|453695719|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126109776|NCT01372410|453695720|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126109777|NCT01372410|453695721|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126109778|NCT01372410|453695722|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
126109779|NCT01372410|453695723|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126109780|NCT01372410|453695716|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
126109781|NCT01372410|453695717|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126109782|NCT01372410|453695718|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126109783|NCT01372410|453695719|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126109784|NCT01372410|453695720|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126109785|NCT01372410|453695721|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126109786|NCT01372410|453695722|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126109787|NCT01372410|453695723|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
126109788|NCT01372410|453695716|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126109789|NCT01372410|453695717|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126109790|NCT01372410|453695718|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126109791|NCT01372410|453695719|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126109792|NCT01372410|453695720|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
126109793|NCT01372410|453695721|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126109794|NCT01372410|453695722|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126109795|NCT01372410|453695723|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126109796|NCT01372410|453695716|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126109797|NCT01372410|453695717|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126109798|NCT01372410|453695718|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126109799|NCT01372410|453695719|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126109800|NCT01372410|453695720|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
126109801|NCT01372410|453695721|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126109802|NCT01372410|453695722|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
126109803|NCT01372410|453695723|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
126109804|NCT01372410|453695716|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126109805|NCT01372410|453695717|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126109806|NCT01372410|453695718|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126109807|NCT01372410|453695719|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126109808|NCT01372410|453695720|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126109809|NCT01372410|453695721|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125895269|NCT01379508|452915909|FG001|Treatment to Week 104|Protocol Violation|1|||
126109810|NCT01372410|453695722|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126109811|NCT01372410|453695723|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
126109812|NCT01372410|453695716|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
126109813|NCT01372410|453695717|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
126109814|NCT01372410|453695718|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
126109815|NCT01372410|453695719|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
126109816|NCT01372410|453695720|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
126109817|NCT01372410|453695721|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
126109818|NCT01372410|453695722|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
126109819|NCT01372410|453695723|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
126109820|NCT01372410|453695716|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126109821|NCT01372410|453695717|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126109822|NCT01372410|453695718|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126109823|NCT01372410|453695719|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126109824|NCT01372410|453695720|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126109825|NCT01372410|453695721|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
126109826|NCT01372410|453695722|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126109827|NCT01372410|453695723|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126109828|NCT04585646|453695724|FG000|First Intervention|Physician Decision|1|||
126109829|NCT04585646|453695725|FG001|First Intervention|Physician Decision|0|||
126109830|NCT04585646|453695724|FG000|First Intervention|Lost to Follow-up|0|||
126109831|NCT04585646|453695725|FG001|First Intervention|Lost to Follow-up|3|||
126109832|NCT04585646|453695724|FG000|First Intervention|Withdrawal by Subject|0|||
126109833|NCT04585646|453695725|FG001|First Intervention|Withdrawal by Subject|1|||
126109834|NCT01067326|453695732|FG000|Overall Study|Adverse Event|0|||
126109835|NCT01067326|453695733|FG001|Overall Study|Adverse Event|2|||
126109836|NCT01067326|453695732|FG000|Overall Study|Withdrawal by Subject|1|||
126109837|NCT01067326|453695733|FG001|Overall Study|Withdrawal by Subject|0|||
126109838|NCT01067326|453695732|FG000|Overall Study|Early Study Termination|1|||
126109839|NCT01067326|453695733|FG001|Overall Study|Early Study Termination|1|||
125895270|NCT01379508|452915910|FG002|Treatment to Week 104|Protocol Violation|1|||
125895271|NCT01379508|452915911|FG003|Treatment to Week 104|Protocol Violation|0|||
126109840|NCT01230788|453695740|FG000|Overall Study|Prescribed exclusion drug|1|||
126109841|NCT00769860|453695741|FG000|Overall Study|Withdrawal by Subject|2|||
126109842|NCT00769860|453695742|FG001|Overall Study|Withdrawal by Subject|0|||
126109843|NCT01603082|453695743|FG000|Overall Study|Adverse Event|0|||
126109844|NCT01603082|453695744|FG001|Overall Study|Adverse Event|1|||
126109845|NCT01603082|453695743|FG000|Overall Study|Withdrawal by Subject|1|||
126059727|NCT03136861|453512530|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126059728|NCT03136861|453512531|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126059729|NCT03136861|453512525|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
126059730|NCT03136861|453512526|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
126059731|NCT03136861|453512527|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
126059732|NCT03136861|453512528|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
126059733|NCT03136861|453512529|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
126059734|NCT03136861|453512530|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
126059735|NCT03136861|453512531|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
126059736|NCT03136861|453512525|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126059737|NCT03136861|453512526|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126059738|NCT03136861|453512527|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
126059739|NCT03136861|453512528|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126059740|NCT03136861|453512529|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126059741|NCT03136861|453512530|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126059742|NCT03136861|453512531|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126089001|NCT01327846|453620051|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
125895272|NCT01379508|452915908|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
125895273|NCT01379508|452915909|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
125895274|NCT01379508|452915910|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
125895275|NCT01379508|452915911|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
125895276|NCT01379508|452915908|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
125895277|NCT01379508|452915909|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
125895278|NCT01379508|452915910|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
126109846|NCT01603082|453695744|FG001|Overall Study|Withdrawal by Subject|0|||
126109847|NCT01603082|453695743|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
126109848|NCT01603082|453695744|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
126109849|NCT01019317|453695747|FG000|Overall Study|Not Eligible|4|||
126109850|NCT02000427|453695750|FG000|Overall Study|Death|22|||
126109851|NCT04343248|453695751|FG000|Overall Study|Withdrawal by Subject|5|||
126109852|NCT04343248|453695752|FG001|Overall Study|Withdrawal by Subject|6|||
126109853|NCT04343248|453695751|FG000|Overall Study|Death|1|||
126109854|NCT04343248|453695752|FG001|Overall Study|Death|2|||
126109855|NCT04343248|453695751|FG000|Overall Study|Lost to Follow-up|9|||
126109856|NCT04343248|453695752|FG001|Overall Study|Lost to Follow-up|6|||
126109857|NCT04343248|453695751|FG000|Overall Study|Physician Decision|0|||
126109858|NCT04343248|453695752|FG001|Overall Study|Physician Decision|1|||
126109859|NCT04343248|453695751|FG000|Overall Study|Adverse Event|1|||
126109860|NCT04343248|453695752|FG001|Overall Study|Adverse Event|0|||
126109861|NCT02708095|453695753|FG000|Overall Study|Adverse Event|4|||
126109862|NCT02708095|453695754|FG001|Overall Study|Adverse Event|10|||
126109863|NCT02708095|453695755|FG002|Overall Study|Adverse Event|11|||
126109864|NCT02708095|453695753|FG000|Overall Study|Lack of Efficacy|9|||
126109865|NCT02708095|453695754|FG001|Overall Study|Lack of Efficacy|3|||
126109866|NCT02708095|453695755|FG002|Overall Study|Lack of Efficacy|0|||
126109867|NCT02708095|453695753|FG000|Overall Study|Lost to Follow-up|2|||
126109868|NCT02708095|453695754|FG001|Overall Study|Lost to Follow-up|0|||
126109869|NCT02708095|453695755|FG002|Overall Study|Lost to Follow-up|0|||
126109870|NCT02708095|453695753|FG000|Overall Study|Physician Decision|2|||
126109871|NCT02708095|453695754|FG001|Overall Study|Physician Decision|3|||
126109872|NCT02708095|453695755|FG002|Overall Study|Physician Decision|2|||
126109873|NCT02708095|453695753|FG000|Overall Study|Protocol Violation|0|||
126109874|NCT02708095|453695754|FG001|Overall Study|Protocol Violation|0|||
126109875|NCT02708095|453695755|FG002|Overall Study|Protocol Violation|1|||
126109876|NCT02708095|453695753|FG000|Overall Study|Withdrawal by Subject|5|||
126109877|NCT02708095|453695754|FG001|Overall Study|Withdrawal by Subject|3|||
126109878|NCT02708095|453695755|FG002|Overall Study|Withdrawal by Subject|4|||
125895279|NCT01379508|452915911|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
126109879|NCT01313650|453695756|FG000|Overall Study|Adverse Event|9|||
126109880|NCT01313650|453695757|FG001|Overall Study|Adverse Event|34|||
126109881|NCT01313650|453695758|FG002|Overall Study|Adverse Event|24|||
126109882|NCT01313650|453695759|FG003|Overall Study|Adverse Event|23|||
126109883|NCT01313650|453695756|FG000|Overall Study|Lack of Efficacy|37|||
126109884|NCT01313650|453695757|FG001|Overall Study|Lack of Efficacy|20|||
126109885|NCT01313650|453695758|FG002|Overall Study|Lack of Efficacy|32|||
126109886|NCT01313650|453695759|FG003|Overall Study|Lack of Efficacy|20|||
126109887|NCT01313650|453695756|FG000|Overall Study|Lost to Follow-up|1|||
126109888|NCT01313650|453695757|FG001|Overall Study|Lost to Follow-up|0|||
125895280|NCT01379508|452915908|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
125895281|NCT01379508|452915909|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
125895282|NCT01379508|452915910|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
125895283|NCT01379508|452915911|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
125895284|NCT01379508|452915908|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
125895285|NCT01379508|452915909|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
125895286|NCT01379508|452915910|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
125895287|NCT01379508|452915911|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
125895288|NCT01457352|452915912|FG000|Period 1|Adverse Event|2|||
125895289|NCT01457352|452915913|FG001|Period 1|Adverse Event|0|||
125895290|NCT01457352|452915912|FG000|Period 1|Withdrawal by Subject|2|||
125895291|NCT01457352|452915913|FG001|Period 1|Withdrawal by Subject|0|||
125895292|NCT01457352|452915912|FG000|Period 1|Physician Decision|2|||
125895293|NCT01457352|452915913|FG001|Period 1|Physician Decision|0|||
125895294|NCT01457352|452915912|FG000|Period 1|MS related disease progression|1|||
125895295|NCT01457352|452915913|FG001|Period 1|MS related disease progression|0|||
125895296|NCT01457352|452915912|FG000|Period 1|Withdrawn|1|||
125895297|NCT01457352|452915913|FG001|Period 1|Withdrawn|0|||
125895298|NCT01457352|452915912|FG000|Period 1|withdrew per sponsor|1|||
125895299|NCT01457352|452915913|FG001|Period 1|withdrew per sponsor|0|||
125895300|NCT01457352|452915912|FG000|Period 1|Protocol Violation|4|||
125895301|NCT01457352|452915913|FG001|Period 1|Protocol Violation|0|||
125895302|NCT01457352|452915912|FG000|Period 1|Did not meet eligibility criteria|3|||
125895303|NCT01457352|452915913|FG001|Period 1|Did not meet eligibility criteria|0|||
125895304|NCT01457352|452915912|FG000|Period 2|Withdrawal by Subject|23|||
125895305|NCT01457352|452915913|FG001|Period 2|Withdrawal by Subject|0|||
125895306|NCT01457352|452915912|FG000|Period 2|Adverse Event|22|||
125895307|NCT01457352|452915913|FG001|Period 2|Adverse Event|0|||
125895308|NCT01457352|452915912|FG000|Period 2|no analysis|10|||
125895309|NCT01457352|452915913|FG001|Period 2|no analysis|0|||
125895310|NCT01457352|452915912|FG000|Period 2|Lack of Efficacy|8|||
125895311|NCT01457352|452915913|FG001|Period 2|Lack of Efficacy|0|||
125895312|NCT01457352|452915912|FG000|Period 2|Protocol Violation|4|||
125895313|NCT01457352|452915913|FG001|Period 2|Protocol Violation|0|||
125895314|NCT01457352|452915912|FG000|Period 2|Sponsor's withdrawal|7|||
125895315|NCT01457352|452915913|FG001|Period 2|Sponsor's withdrawal|0|||
125895316|NCT01457352|452915912|FG000|Period 2|Lost to Follow-up|1|||
125895317|NCT01457352|452915913|FG001|Period 2|Lost to Follow-up|0|||
125895318|NCT01457352|452915912|FG000|Period 2|dose change|1|||
125895319|NCT01457352|452915913|FG001|Period 2|dose change|0|||
125895320|NCT01457352|452915912|FG000|Period 2|Physician Decision|1|||
125895321|NCT01457352|452915913|FG001|Period 2|Physician Decision|0|||
125895322|NCT01457352|452915912|FG000|Period 2|Did not meet eligibility criteria|3|||
125895323|NCT01457352|452915913|FG001|Period 2|Did not meet eligibility criteria|0|||
125895324|NCT01457352|452915912|FG000|Period 3|Adverse Event|1|||
125895325|NCT01457352|452915913|FG001|Period 3|Adverse Event|1|||
125895326|NCT01457352|452915912|FG000|Period 3|Withdrawal by Subject|0|||
125895327|NCT01457352|452915913|FG001|Period 3|Withdrawal by Subject|2|||
125895328|NCT01457352|452915912|FG000|Period 3|incorrect treatment|0|||
125895329|NCT01457352|452915913|FG001|Period 3|incorrect treatment|1|||
125895330|NCT01457352|452915912|FG000|Period 3|Sponsor's withdrawal|0|||
125895331|NCT01457352|452915913|FG001|Period 3|Sponsor's withdrawal|1|||
125895332|NCT02537015|452915914|FG000|Overall Study|Adverse Event|3|||
125895333|NCT02537015|452915914|FG000|Overall Study|Withdrawal by Subject|2|||
125895334|NCT02537015|452915914|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125895335|NCT04174365|452915915|FG000|Overall Study|Lost to Follow-up|1|||
125895336|NCT04174365|452915916|FG001|Overall Study|Lost to Follow-up|2|||
125895337|NCT04174365|452915915|FG000|Overall Study|Adverse Event|2|||
125895338|NCT04174365|452915916|FG001|Overall Study|Adverse Event|1|||
125895339|NCT04174365|452915915|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
125895340|NCT04174365|452915916|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
125895341|NCT04174365|452915915|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
125895342|NCT04174365|452915916|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
125895343|NCT04174365|452915915|FG000|Overall Study|Protocol Deviation|1|||
125895344|NCT04174365|452915916|FG001|Overall Study|Protocol Deviation|0|||
125895345|NCT04174365|452915915|FG000|Overall Study|Lack of Efficacy|0|||
125895346|NCT04174365|452915916|FG001|Overall Study|Lack of Efficacy|2|||
125895347|NCT04174365|452915915|FG000|Overall Study|Disease Relapse|1|||
125895348|NCT04174365|452915916|FG001|Overall Study|Disease Relapse|0|||
125895349|NCT04174365|452915915|FG000|Overall Study|Reason Not Specified|0|||
125895350|NCT04174365|452915916|FG001|Overall Study|Reason Not Specified|1|||
125895351|NCT01925131|452918845|FG000|Overall Study|Death|0|||
125895352|NCT01925131|452918846|FG001|Overall Study|Death|0|||
125895353|NCT01925131|452918847|FG002|Overall Study|Death|1|||
125895354|NCT01925131|452918848|FG003|Overall Study|Death|0|||
125895355|NCT01925131|452918849|FG004|Overall Study|Death|0|||
125895356|NCT01925131|452918850|FG005|Overall Study|Death|0|||
125895357|NCT01925131|452918845|FG000|Overall Study|Progression/Relapse|1|||
125895358|NCT01925131|452918846|FG001|Overall Study|Progression/Relapse|1|||
126109889|NCT01313650|453695758|FG002|Overall Study|Lost to Follow-up|3|||
126109890|NCT01313650|453695759|FG003|Overall Study|Lost to Follow-up|2|||
126109891|NCT01313650|453695756|FG000|Overall Study|Withdrawal by Subject|16|||
126109892|NCT01313650|453695757|FG001|Overall Study|Withdrawal by Subject|20|||
126109893|NCT01313650|453695758|FG002|Overall Study|Withdrawal by Subject|15|||
126109894|NCT01313650|453695759|FG003|Overall Study|Withdrawal by Subject|15|||
126109895|NCT01313650|453695756|FG000|Overall Study|Protocol Violation|4|||
126109896|NCT01313650|453695757|FG001|Overall Study|Protocol Violation|7|||
126109897|NCT01313650|453695758|FG002|Overall Study|Protocol Violation|5|||
126109898|NCT01313650|453695759|FG003|Overall Study|Protocol Violation|6|||
126109899|NCT01313650|453695756|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
125895359|NCT01925131|452918847|FG002|Overall Study|Progression/Relapse|4|||
125895360|NCT01925131|452918848|FG003|Overall Study|Progression/Relapse|0|||
125895361|NCT01925131|452918849|FG004|Overall Study|Progression/Relapse|0|||
125895362|NCT01925131|452918850|FG005|Overall Study|Progression/Relapse|1|||
125895363|NCT01925131|452918845|FG000|Overall Study|Patient Refusal|1|||
125895364|NCT01925131|452918846|FG001|Overall Study|Patient Refusal|0|||
125895365|NCT01925131|452918847|FG002|Overall Study|Patient Refusal|0|||
125895366|NCT01925131|452918848|FG003|Overall Study|Patient Refusal|0|||
125895367|NCT01925131|452918849|FG004|Overall Study|Patient Refusal|0|||
125895368|NCT01925131|452918850|FG005|Overall Study|Patient Refusal|0|||
125895369|NCT01925131|452918845|FG000|Overall Study|Adverse Event|0|||
125895370|NCT01925131|452918846|FG001|Overall Study|Adverse Event|0|||
125895371|NCT01925131|452918847|FG002|Overall Study|Adverse Event|2|||
125895372|NCT01925131|452918848|FG003|Overall Study|Adverse Event|0|||
125895373|NCT01925131|452918849|FG004|Overall Study|Adverse Event|1|||
125895374|NCT01925131|452918850|FG005|Overall Study|Adverse Event|3|||
125895375|NCT01925131|452918845|FG000|Overall Study|Other - Not Protocol Specified|3|||
125895376|NCT01925131|452918846|FG001|Overall Study|Other - Not Protocol Specified|1|||
125895377|NCT01925131|452918847|FG002|Overall Study|Other - Not Protocol Specified|2|||
125895378|NCT01925131|452918848|FG003|Overall Study|Other - Not Protocol Specified|5|||
125895379|NCT01925131|452918849|FG004|Overall Study|Other - Not Protocol Specified|10|||
125895380|NCT01925131|452918850|FG005|Overall Study|Other - Not Protocol Specified|6|||
125895381|NCT01696929|452918854|FG000|Overall Study|Physician Decision|1|||
125895382|NCT02522624|452918855|FG000|Overall Study|Technical failure|1|||
125895383|NCT02522624|452918856|FG001|Overall Study|Technical failure|0|||
125895384|NCT02156271|452918857|FG000|Overall Study|Physician Decision|4|||
125895385|NCT02156271|452918858|FG001|Overall Study|Physician Decision|3|||
126109900|NCT01313650|453695757|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
126109901|NCT01313650|453695758|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
126109902|NCT01313650|453695759|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
125895386|NCT00109590|452918859|FG000|Overall Study|Lost to Follow-up|1|||
125895387|NCT00109590|452918860|FG001|Overall Study|Lost to Follow-up|0|||
125895388|NCT00109590|452918861|FG002|Overall Study|Lost to Follow-up|1|||
125895389|NCT00109590|452918859|FG000|Overall Study|Never Started Treatment|1|||
125895390|NCT00109590|452918860|FG001|Overall Study|Never Started Treatment|2|||
126109903|NCT05393037|453695760|FG000|Part A|Death|1|||
125895391|NCT00109590|452918861|FG002|Overall Study|Never Started Treatment|3|||
126109904|NCT05393037|453695761|FG001|Part A|Death|0|||
126109905|NCT05393037|453695760|FG000|Part A|Lost to Follow-up|1|||
125895392|NCT02123251|452918862|FG000|Overall Study|Death|1|||
125895393|NCT02123251|452918863|FG001|Overall Study|Death|1|||
126109906|NCT05393037|453695761|FG001|Part A|Lost to Follow-up|1|||
126109907|NCT05393037|453695760|FG000|Part A|Withdrawal by Subject|2|||
126109908|NCT05393037|453695761|FG001|Part A|Withdrawal by Subject|4|||
126109909|NCT05393037|453695760|FG000|Part B|Lost to Follow-up|1|||
126109910|NCT05393037|453695761|FG001|Part B|Lost to Follow-up|0|||
126109911|NCT01012739|453695762|FG000|Treatment Period 1|Adverse Event|0|||
126109912|NCT01012739|453695763|FG001|Treatment Period 1|Adverse Event|0|||
126109913|NCT01012739|453695764|FG002|Treatment Period 1|Adverse Event|0|||
126109914|NCT01012739|453695765|FG003|Treatment Period 1|Adverse Event|1|||
126109915|NCT01012739|453695762|FG000|Treatment Period 2|Abnormal test procedure results|0|||
126109916|NCT01012739|453695763|FG001|Treatment Period 2|Abnormal test procedure results|0|||
126109917|NCT01012739|453695764|FG002|Treatment Period 2|Abnormal test procedure results|0|||
126109918|NCT01012739|453695765|FG003|Treatment Period 2|Abnormal test procedure results|1|||
126109919|NCT04540133|453695766|FG000|Overall Study|Lost to Follow-up|1|||
126109920|NCT04540133|453695767|FG001|Overall Study|Lost to Follow-up|0|||
126109921|NCT00458341|453695768|FG000|Cycle 1|Adverse Event|1|||
126109922|NCT00458341|453695769|FG001|Cycle 1|Adverse Event|0|||
126109923|NCT03471871|453695771|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
126109924|NCT03471871|453695772|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
126109925|NCT03471871|453695773|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
126109926|NCT03471871|453695774|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
126109927|NCT03471871|453695775|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
126109928|NCT03471871|453695771|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
126109929|NCT03471871|453695772|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
126109930|NCT03471871|453695773|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
126109931|NCT03471871|453695774|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
126109932|NCT03471871|453695775|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
126109933|NCT03471871|453695771|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
126109934|NCT03471871|453695772|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
126109935|NCT03471871|453695773|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
126109936|NCT03471871|453695774|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
126109937|NCT03471871|453695775|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
126109938|NCT03471871|453695771|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
126109939|NCT03471871|453695772|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
126109940|NCT03471871|453695773|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
126109941|NCT03471871|453695774|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
126109942|NCT03471871|453695775|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
126109943|NCT03471871|453695771|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
126109944|NCT03471871|453695772|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
126109945|NCT03471871|453695773|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
126109946|NCT03471871|453695774|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
126109947|NCT03471871|453695775|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
126109948|NCT03040622|453695776|FG000|Overall Study|unable to implant device|3|||
125895394|NCT02123251|452918862|FG000|Overall Study|Withdrawal by Subject|0|||
125895395|NCT02123251|452918863|FG001|Overall Study|Withdrawal by Subject|3|||
126109949|NCT03769181|453697589|FG000|Overall Study|Adverse Event|1|||
126109950|NCT03769181|453697590|FG001|Overall Study|Adverse Event|0|||
126109951|NCT03769181|453697591|FG002|Overall Study|Adverse Event|2|||
125895396|NCT02123251|452918862|FG000|Overall Study|Lost Medicaid eligibility|29|||
125895397|NCT02123251|452918863|FG001|Overall Study|Lost Medicaid eligibility|22|||
125895398|NCT02123251|452918862|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
126109952|NCT03769181|453697592|FG003|Overall Study|Adverse Event|4|||
126109953|NCT03769181|453697589|FG000|Overall Study|Withdrawal by Subject|1|||
126109954|NCT03769181|453697590|FG001|Overall Study|Withdrawal by Subject|0|||
126109955|NCT03769181|453697591|FG002|Overall Study|Withdrawal by Subject|2|||
126109956|NCT03769181|453697592|FG003|Overall Study|Withdrawal by Subject|1|||
126109957|NCT03769181|453697589|FG000|Overall Study|Progressive disease|9|||
126059743|NCT03136861|453512525|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126059744|NCT03136861|453512526|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126059745|NCT03136861|453512527|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
126059746|NCT03136861|453512528|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126109958|NCT03769181|453697590|FG001|Overall Study|Progressive disease|7|||
126109959|NCT03769181|453697591|FG002|Overall Study|Progressive disease|13|||
126109960|NCT03769181|453697592|FG003|Overall Study|Progressive disease|6|||
126109961|NCT03769181|453697589|FG000|Overall Study|Other - Unspecified|2|||
126109962|NCT03769181|453697590|FG001|Overall Study|Other - Unspecified|1|||
126109963|NCT03769181|453697591|FG002|Overall Study|Other - Unspecified|0|||
126109964|NCT03769181|453697592|FG003|Overall Study|Other - Unspecified|0|||
126109965|NCT03971422|453697593|FG000|Overall Study|Lost to Follow-up|0|||
126109966|NCT03971422|453697594|FG001|Overall Study|Lost to Follow-up|1|||
126109967|NCT03971422|453697595|FG002|Overall Study|Lost to Follow-up|0|||
126109968|NCT03971422|453697593|FG000|Overall Study|Lack of Efficacy|5|||
126109969|NCT03971422|453697594|FG001|Overall Study|Lack of Efficacy|1|||
126109970|NCT03971422|453697595|FG002|Overall Study|Lack of Efficacy|1|||
126109971|NCT03971422|453697593|FG000|Overall Study|Adverse event, not fatal|2|||
126109972|NCT03971422|453697594|FG001|Overall Study|Adverse event, not fatal|2|||
126109973|NCT03971422|453697595|FG002|Overall Study|Adverse event, not fatal|5|||
126109974|NCT03971422|453697593|FG000|Overall Study|Worsening of MG Symptoms|1|||
126109975|NCT03971422|453697594|FG001|Overall Study|Worsening of MG Symptoms|4|||
126109976|NCT03971422|453697595|FG002|Overall Study|Worsening of MG Symptoms|2|||
126109977|NCT03971422|453697593|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
126109978|NCT03971422|453697594|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
126109979|NCT03971422|453697595|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
126109980|NCT03971422|453697593|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
126109981|NCT03971422|453697594|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
126109982|NCT03971422|453697595|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
126109983|NCT03971422|453697593|FG000|Overall Study|Due to COVID-19 pandemic|0|||
126109984|NCT03971422|453697594|FG001|Overall Study|Due to COVID-19 pandemic|1|||
126109985|NCT03971422|453697595|FG002|Overall Study|Due to COVID-19 pandemic|1|||
126109986|NCT03566810|453697596|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
126109987|NCT03566810|453697597|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
126109988|NCT03566810|453697598|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
126109989|NCT03566810|453697599|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
126109990|NCT03217266|453697600|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
126109991|NCT03217266|453697601|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
126109992|NCT03217266|453697602|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
126109993|NCT03217266|453697603|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
126109994|NCT03217266|453697600|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
126109995|NCT03217266|453697601|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
126109996|NCT03217266|453697602|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
126109997|NCT03217266|453697603|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
126109998|NCT03217266|453697600|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
126109999|NCT03217266|453697601|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
126110000|NCT03217266|453697602|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
126110001|NCT03217266|453697603|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
126110002|NCT03078907|453697607|FG000|Overall Study|Adverse Event|2|||
126110003|NCT03078907|453697608|FG001|Overall Study|Adverse Event|0|||
126110004|NCT03078907|453697607|FG000|Overall Study|Other|1|||
126110005|NCT03078907|453697608|FG001|Overall Study|Other|0|||
126110006|NCT03078907|453697607|FG000|Overall Study|Protocol Violation|0|||
126110007|NCT03078907|453697608|FG001|Overall Study|Protocol Violation|1|||
126110008|NCT01955122|453697609|FG000|Overall Study|Physician Decision|5|||
126110009|NCT01955122|453697610|FG001|Overall Study|Physician Decision|5|||
126110010|NCT00826111|453697611|FG000|Overall Study|Lost to Follow-up|0|||
126110011|NCT00826111|453697612|FG001|Overall Study|Lost to Follow-up|1|||
126110012|NCT00826111|453697611|FG000|Overall Study|Protocol Violation|1|||
126110013|NCT00826111|453697612|FG001|Overall Study|Protocol Violation|0|||
126110014|NCT00826111|453697611|FG000|Overall Study|Withdrawal by Subject|5|||
126110015|NCT00826111|453697612|FG001|Overall Study|Withdrawal by Subject|0|||
126110016|NCT00826111|453697611|FG000|Overall Study|Physician Decision|1|||
126110017|NCT00826111|453697612|FG001|Overall Study|Physician Decision|1|||
126110018|NCT01672788|453697613|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
126110019|NCT01672788|453697614|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
126110020|NCT01672788|453697615|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
126110021|NCT01672788|453697616|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
125895399|NCT02123251|452918863|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
125895400|NCT02617485|452918881|FG000|Treatment and Observation Period|Adverse Event|9|||
125895401|NCT02617485|452918882|FG001|Treatment and Observation Period|Adverse Event|1|||
125895402|NCT02617485|452918881|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
126110022|NCT03511053|453697619|FG000|Overall Study|Withdrawal by Subject|1|||
126110023|NCT01929980|453697620|FG000|Overall Study|Physician Decision|1|||
126110024|NCT00985166|453697621|FG000|Overall Study|Lost to Follow-up|3|||
126110025|NCT00985166|453697622|FG001|Overall Study|Lost to Follow-up|2|||
126110026|NCT00985166|453697623|FG002|Overall Study|Lost to Follow-up|2|||
126110027|NCT00985166|453697621|FG000|Overall Study|Withdrawal by Subject|3|||
125895403|NCT02617485|452918882|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
126110028|NCT00985166|453697622|FG001|Overall Study|Withdrawal by Subject|2|||
126110029|NCT00985166|453697623|FG002|Overall Study|Withdrawal by Subject|0|||
125895404|NCT02617485|452918881|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
125895405|NCT02617485|452918882|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
125895406|NCT02617485|452918881|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
125895407|NCT02617485|452918882|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
125895408|NCT02617485|452918881|FG000|Treatment and Observation Period|Physician Decision|0|||
125895409|NCT02617485|452918882|FG001|Treatment and Observation Period|Physician Decision|1|||
125895410|NCT02617485|452918881|FG000|Follow-up Period|Adverse Event|1|||
125895411|NCT02617485|452918882|FG001|Follow-up Period|Adverse Event|0|||
125895412|NCT02617485|452918881|FG000|Follow-up Period|Withdrawal by Subject|1|||
125895413|NCT02617485|452918882|FG001|Follow-up Period|Withdrawal by Subject|0|||
125895414|NCT02617485|452918881|FG000|Follow-up Period|Disease progression|2|||
125895415|NCT02617485|452918882|FG001|Follow-up Period|Disease progression|1|||
125895416|NCT02617485|452918881|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
125895417|NCT02617485|452918882|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
125895418|NCT02617485|452918881|FG000|Follow-up Period|Patient needed radiotherapy|9|||
125895419|NCT02617485|452918882|FG001|Follow-up Period|Patient needed radiotherapy|5|||
125895420|NCT02617485|452918881|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
125895421|NCT02617485|452918882|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
125895422|NCT00409331|452918883|FG000|Overall Study|Physician Decision|1|||
125895423|NCT01511055|452918888|FG000|Overall Study|Withdrawal by Subject|6|||
125895424|NCT04590248|452918890|FG000|Overall Study|Lost to Follow-up|1|||
125895425|NCT04590248|452918890|FG000|Overall Study|Withdrawal by Subject|16|||
125895426|NCT04590248|452918890|FG000|Overall Study|Other|2|||
125895427|NCT02052414|452918893|FG000|Overall Study|Adverse Event|12|||
125895428|NCT02052414|452918893|FG000|Overall Study|Lack of Efficacy|2|||
125895429|NCT02052414|452918893|FG000|Overall Study|Withdrawal by Subject|3|||
125895430|NCT04605991|452918897|FG000|Overall Study|Adverse Event|5|||
125895431|NCT04605991|452918897|FG000|Overall Study|Lack of Efficacy|1|||
125895432|NCT04605991|452918897|FG000|Overall Study|Lost to Follow-up|8|||
125895433|NCT04605991|452918897|FG000|Overall Study|Physician Decision|4|||
125895434|NCT04605991|452918897|FG000|Overall Study|Withdrawal by Subject|14|||
125895435|NCT04605991|452918897|FG000|Overall Study|Non-compliance with study|1|||
125895436|NCT03263702|452918898|FG000|Overall Study|Lost to Follow-up|2|||
125895437|NCT03263702|452918899|FG001|Overall Study|Lost to Follow-up|2|||
125895438|NCT03263702|452918898|FG000|Overall Study|Withdrawal by Subject|1|||
125895439|NCT03263702|452918899|FG001|Overall Study|Withdrawal by Subject|2|||
125895440|NCT02527200|452918900|FG000|Overall Study|Withdrawal by Subject|3|||
125895441|NCT02527200|452918901|FG001|Overall Study|Withdrawal by Subject|2|||
125895442|NCT02527200|452918902|FG002|Overall Study|Withdrawal by Subject|1|||
125895443|NCT02527200|452918903|FG003|Overall Study|Withdrawal by Subject|0|||
125895444|NCT02527200|452918900|FG000|Overall Study|Unclassified|0|||
125895445|NCT02527200|452918901|FG001|Overall Study|Unclassified|1|||
125895446|NCT02527200|452918902|FG002|Overall Study|Unclassified|0|||
125895447|NCT02527200|452918903|FG003|Overall Study|Unclassified|0|||
125895448|NCT02527200|452918900|FG000|Overall Study|Lost to Follow-up|0|||
125895449|NCT02527200|452918901|FG001|Overall Study|Lost to Follow-up|0|||
125895450|NCT02527200|452918902|FG002|Overall Study|Lost to Follow-up|1|||
125895451|NCT02527200|452918903|FG003|Overall Study|Lost to Follow-up|0|||
125895452|NCT00966875|452918905|FG000|Part A|Adverse Event|2|||
125895453|NCT00966875|452918906|FG001|Part A|Adverse Event|1|||
125895454|NCT00966875|452918907|FG002|Part A|Adverse Event|0|||
125895455|NCT00966875|452918908|FG003|Part A|Adverse Event|1|||
125895456|NCT00966875|452918909|FG004|Part A|Adverse Event|0|||
125895457|NCT00966875|452918910|FG005|Part A|Adverse Event|1|||
125895458|NCT00966875|452918911|FG006|Part A|Adverse Event|0|||
125895459|NCT00966875|452918912|FG007|Part A|Adverse Event|3|||
125895460|NCT00966875|452918913|FG008|Part A|Adverse Event|3|||
125895461|NCT00966875|452918905|FG000|Part A|Entry Criteria|0|||
125895462|NCT00966875|452918906|FG001|Part A|Entry Criteria|0|||
125895463|NCT00966875|452918907|FG002|Part A|Entry Criteria|0|||
125895464|NCT00966875|452918908|FG003|Part A|Entry Criteria|0|||
125895465|NCT00966875|452918909|FG004|Part A|Entry Criteria|0|||
125895466|NCT00966875|452918910|FG005|Part A|Entry Criteria|2|||
125895467|NCT00966875|452918911|FG006|Part A|Entry Criteria|0|||
125895468|NCT00966875|452918912|FG007|Part A|Entry Criteria|0|||
125895469|NCT00966875|452918913|FG008|Part A|Entry Criteria|0|||
125895470|NCT00966875|452918905|FG000|Part A|Lack of Efficacy|0|||
125895471|NCT00966875|452918906|FG001|Part A|Lack of Efficacy|1|||
125895472|NCT00966875|452918907|FG002|Part A|Lack of Efficacy|0|||
125895473|NCT00966875|452918908|FG003|Part A|Lack of Efficacy|0|||
125895474|NCT00966875|452918909|FG004|Part A|Lack of Efficacy|0|||
125895475|NCT00966875|452918910|FG005|Part A|Lack of Efficacy|0|||
125895476|NCT00966875|452918911|FG006|Part A|Lack of Efficacy|4|||
125895477|NCT00966875|452918912|FG007|Part A|Lack of Efficacy|0|||
125895478|NCT00966875|452918913|FG008|Part A|Lack of Efficacy|0|||
125895479|NCT00966875|452918905|FG000|Part A|Lost to Follow-up|2|||
125895480|NCT00966875|452918906|FG001|Part A|Lost to Follow-up|0|||
125895481|NCT00966875|452918907|FG002|Part A|Lost to Follow-up|0|||
125895482|NCT00966875|452918908|FG003|Part A|Lost to Follow-up|0|||
125895483|NCT00966875|452918909|FG004|Part A|Lost to Follow-up|0|||
125895484|NCT00966875|452918910|FG005|Part A|Lost to Follow-up|1|||
125895485|NCT00966875|452918911|FG006|Part A|Lost to Follow-up|0|||
125895486|NCT00966875|452918912|FG007|Part A|Lost to Follow-up|0|||
125895487|NCT00966875|452918913|FG008|Part A|Lost to Follow-up|0|||
125895488|NCT00966875|452918905|FG000|Part A|Parent/Caregiver Decision|0|||
125895489|NCT00966875|452918906|FG001|Part A|Parent/Caregiver Decision|0|||
125895490|NCT00966875|452918907|FG002|Part A|Parent/Caregiver Decision|0|||
125895491|NCT00966875|452918908|FG003|Part A|Parent/Caregiver Decision|1|||
125895492|NCT00966875|452918909|FG004|Part A|Parent/Caregiver Decision|0|||
125895493|NCT00966875|452918910|FG005|Part A|Parent/Caregiver Decision|0|||
125895494|NCT00966875|452918911|FG006|Part A|Parent/Caregiver Decision|0|||
125895495|NCT00966875|452918912|FG007|Part A|Parent/Caregiver Decision|0|||
125895496|NCT00966875|452918913|FG008|Part A|Parent/Caregiver Decision|0|||
125895497|NCT00966875|452918905|FG000|Part A|Physician Decision|0|||
125895498|NCT00966875|452918906|FG001|Part A|Physician Decision|0|||
125895499|NCT00966875|452918907|FG002|Part A|Physician Decision|0|||
125895500|NCT00966875|452918908|FG003|Part A|Physician Decision|0|||
125895501|NCT00966875|452918909|FG004|Part A|Physician Decision|1|||
125895502|NCT00966875|452918910|FG005|Part A|Physician Decision|0|||
125895503|NCT00966875|452918911|FG006|Part A|Physician Decision|1|||
125895504|NCT00966875|452918912|FG007|Part A|Physician Decision|0|||
125895505|NCT00966875|452918913|FG008|Part A|Physician Decision|2|||
125895506|NCT00966875|452918905|FG000|Part A|Sponsor Decision|0|||
125895507|NCT00966875|452918906|FG001|Part A|Sponsor Decision|0|||
125895508|NCT00966875|452918907|FG002|Part A|Sponsor Decision|1|||
125895509|NCT00966875|452918908|FG003|Part A|Sponsor Decision|0|||
125895510|NCT00966875|452918909|FG004|Part A|Sponsor Decision|1|||
125895511|NCT00966875|452918910|FG005|Part A|Sponsor Decision|0|||
125895512|NCT00966875|452918911|FG006|Part A|Sponsor Decision|0|||
125895513|NCT00966875|452918912|FG007|Part A|Sponsor Decision|2|||
125895514|NCT00966875|452918913|FG008|Part A|Sponsor Decision|1|||
125895515|NCT00966875|452918905|FG000|Part A|Withdrawal by Subject|2|||
125895516|NCT00966875|452918906|FG001|Part A|Withdrawal by Subject|2|||
125895517|NCT00966875|452918907|FG002|Part A|Withdrawal by Subject|1|||
125895518|NCT00966875|452918908|FG003|Part A|Withdrawal by Subject|1|||
125895519|NCT00966875|452918909|FG004|Part A|Withdrawal by Subject|3|||
125895520|NCT00966875|452918910|FG005|Part A|Withdrawal by Subject|0|||
125895521|NCT00966875|452918911|FG006|Part A|Withdrawal by Subject|5|||
125895522|NCT00966875|452918912|FG007|Part A|Withdrawal by Subject|1|||
125895523|NCT00966875|452918913|FG008|Part A|Withdrawal by Subject|1|||
125895524|NCT00966875|452918905|FG000|Part A|Protocol Violation|0|||
125895525|NCT00966875|452918906|FG001|Part A|Protocol Violation|0|||
125895526|NCT00966875|452918907|FG002|Part A|Protocol Violation|0|||
125895527|NCT00966875|452918908|FG003|Part A|Protocol Violation|0|||
125895528|NCT00966875|452918909|FG004|Part A|Protocol Violation|0|||
125895529|NCT00966875|452918910|FG005|Part A|Protocol Violation|0|||
125895530|NCT00966875|452918911|FG006|Part A|Protocol Violation|2|||
125895531|NCT00966875|452918912|FG007|Part A|Protocol Violation|1|||
125895532|NCT00966875|452918913|FG008|Part A|Protocol Violation|1|||
125895533|NCT00966875|452918905|FG000|Part B|Adverse Event|0|||
125895534|NCT00966875|452918906|FG001|Part B|Adverse Event|1|||
125895535|NCT00966875|452918907|FG002|Part B|Adverse Event|1|||
125895536|NCT00966875|452918908|FG003|Part B|Adverse Event|0|||
125895537|NCT00966875|452918909|FG004|Part B|Adverse Event|1|||
125895538|NCT00966875|452918910|FG005|Part B|Adverse Event|0|||
125895539|NCT00966875|452918911|FG006|Part B|Adverse Event|5|||
125895540|NCT00966875|452918912|FG007|Part B|Adverse Event|2|||
125895541|NCT00966875|452918913|FG008|Part B|Adverse Event|2|||
125895542|NCT00966875|452918905|FG000|Part B|Death|0|||
125895543|NCT00966875|452918906|FG001|Part B|Death|0|||
125895544|NCT00966875|452918907|FG002|Part B|Death|1|||
125895545|NCT00966875|452918908|FG003|Part B|Death|0|||
125895546|NCT00966875|452918909|FG004|Part B|Death|0|||
125895547|NCT00966875|452918910|FG005|Part B|Death|0|||
125895548|NCT00966875|452918911|FG006|Part B|Death|0|||
126110030|NCT00985166|453697621|FG000|Overall Study|Test not done|2|||
126110031|NCT00985166|453697622|FG001|Overall Study|Test not done|0|||
126110032|NCT00985166|453697623|FG002|Overall Study|Test not done|4|||
125895549|NCT00966875|452918912|FG007|Part B|Death|1|||
125895550|NCT00966875|452918913|FG008|Part B|Death|0|||
125895551|NCT00966875|452918905|FG000|Part B|Lack of Efficacy|2|||
125895552|NCT00966875|452918906|FG001|Part B|Lack of Efficacy|1|||
125895553|NCT00966875|452918907|FG002|Part B|Lack of Efficacy|1|||
125895554|NCT00966875|452918908|FG003|Part B|Lack of Efficacy|1|||
125895555|NCT00966875|452918909|FG004|Part B|Lack of Efficacy|2|||
125895556|NCT00966875|452918910|FG005|Part B|Lack of Efficacy|3|||
125895557|NCT00966875|452918911|FG006|Part B|Lack of Efficacy|12|||
125895558|NCT00966875|452918912|FG007|Part B|Lack of Efficacy|9|||
125895559|NCT00966875|452918913|FG008|Part B|Lack of Efficacy|6|||
125895560|NCT00966875|452918905|FG000|Part B|Lost to Follow-up|0|||
125895561|NCT00966875|452918906|FG001|Part B|Lost to Follow-up|0|||
125895562|NCT00966875|452918907|FG002|Part B|Lost to Follow-up|0|||
125895563|NCT00966875|452918908|FG003|Part B|Lost to Follow-up|1|||
125895564|NCT00966875|452918909|FG004|Part B|Lost to Follow-up|0|||
125895565|NCT00966875|452918910|FG005|Part B|Lost to Follow-up|0|||
125895566|NCT00966875|452918911|FG006|Part B|Lost to Follow-up|0|||
125895567|NCT00966875|452918912|FG007|Part B|Lost to Follow-up|0|||
125895568|NCT00966875|452918913|FG008|Part B|Lost to Follow-up|1|||
125895569|NCT00966875|452918905|FG000|Part B|Physician Decision|0|||
125895570|NCT00966875|452918906|FG001|Part B|Physician Decision|0|||
125895571|NCT00966875|452918907|FG002|Part B|Physician Decision|1|||
125895572|NCT00966875|452918908|FG003|Part B|Physician Decision|0|||
125895573|NCT00966875|452918909|FG004|Part B|Physician Decision|2|||
125895574|NCT00966875|452918910|FG005|Part B|Physician Decision|1|||
125895575|NCT00966875|452918911|FG006|Part B|Physician Decision|0|||
125895576|NCT00966875|452918912|FG007|Part B|Physician Decision|0|||
125895577|NCT00966875|452918913|FG008|Part B|Physician Decision|2|||
125895578|NCT00966875|452918905|FG000|Part B|Sponsor Decision|1|||
125895579|NCT00966875|452918906|FG001|Part B|Sponsor Decision|0|||
125895580|NCT00966875|452918907|FG002|Part B|Sponsor Decision|0|||
125895581|NCT00966875|452918908|FG003|Part B|Sponsor Decision|0|||
125895582|NCT00966875|452918909|FG004|Part B|Sponsor Decision|0|||
125895583|NCT00966875|452918910|FG005|Part B|Sponsor Decision|1|||
125895584|NCT00966875|452918911|FG006|Part B|Sponsor Decision|0|||
125895585|NCT00966875|452918912|FG007|Part B|Sponsor Decision|2|||
125895586|NCT00966875|452918913|FG008|Part B|Sponsor Decision|1|||
125895587|NCT00966875|452918905|FG000|Part B|Withdrawal by Subject|2|||
125895588|NCT00966875|452918906|FG001|Part B|Withdrawal by Subject|1|||
125895589|NCT00966875|452918907|FG002|Part B|Withdrawal by Subject|2|||
125895590|NCT00966875|452918908|FG003|Part B|Withdrawal by Subject|1|||
125895591|NCT00966875|452918909|FG004|Part B|Withdrawal by Subject|2|||
125895592|NCT00966875|452918910|FG005|Part B|Withdrawal by Subject|1|||
125895593|NCT00966875|452918911|FG006|Part B|Withdrawal by Subject|4|||
125895594|NCT00966875|452918912|FG007|Part B|Withdrawal by Subject|5|||
125895595|NCT00966875|452918913|FG008|Part B|Withdrawal by Subject|5|||
125895596|NCT00966875|452918905|FG000|Part B|Entry Criteria|0|||
125895597|NCT00966875|452918906|FG001|Part B|Entry Criteria|0|||
125895598|NCT00966875|452918907|FG002|Part B|Entry Criteria|0|||
125895599|NCT00966875|452918908|FG003|Part B|Entry Criteria|0|||
125895600|NCT00966875|452918909|FG004|Part B|Entry Criteria|0|||
125895601|NCT00966875|452918910|FG005|Part B|Entry Criteria|0|||
125895602|NCT00966875|452918911|FG006|Part B|Entry Criteria|1|||
125895603|NCT00966875|452918912|FG007|Part B|Entry Criteria|0|||
125895604|NCT00966875|452918913|FG008|Part B|Entry Criteria|1|||
125895605|NCT02386189|452918916|FG000|Overall Study|Lost to Follow-up|2|||
125895606|NCT02386189|452918917|FG001|Overall Study|Lost to Follow-up|3|||
125895607|NCT02386189|452918916|FG000|Overall Study|Withdrawal by Subject|1|||
125895608|NCT02386189|452918917|FG001|Overall Study|Withdrawal by Subject|0|||
125895609|NCT02386189|452918916|FG000|Overall Study|Death|1|||
125895610|NCT02386189|452918917|FG001|Overall Study|Death|0|||
125895611|NCT04657666|452918918|FG000|Period 1|Withdrawal of participant consent|2|||
125895612|NCT04657666|452918919|FG001|Period 1|Withdrawal of participant consent|1|||
125895613|NCT04657666|452918918|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
125895614|NCT04657666|452918919|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
125895615|NCT04657666|452918918|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
125895616|NCT04657666|452918919|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
125895617|NCT04657666|452918918|FG000|Period 2|Other|2|||
125895618|NCT04657666|452918919|FG001|Period 2|Other|0|||
125895619|NCT04657666|452918918|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
125895620|NCT04657666|452918919|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
125895621|NCT01659554|452918920|FG000|Overall Study|Study Termination|4|||
125895622|NCT01022398|452918921|FG000|Overall Study|Study terminated|2|||
125895623|NCT01022398|452918922|FG001|Overall Study|Study terminated|2|||
125895624|NCT00361634|452918924|FG000|Overall Study|Lost to Follow-up|1|||
125895625|NCT00361634|452918924|FG000|Overall Study|Withdrawal by Subject|1|||
125895626|NCT00833417|452918925|FG000|Overall Study|Adverse Event|5|||
125895627|NCT00833417|452918926|FG001|Overall Study|Adverse Event|16|||
125895628|NCT00833417|452918925|FG000|Overall Study|Death|1|||
125895629|NCT00833417|452918926|FG001|Overall Study|Death|3|||
125895630|NCT00833417|452918925|FG000|Overall Study|Lost to Follow-up|1|||
125895631|NCT00833417|452918926|FG001|Overall Study|Lost to Follow-up|2|||
125895632|NCT00833417|452918925|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
125895633|NCT00833417|452918926|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
125895634|NCT00833417|452918925|FG000|Overall Study|Patient Decision to Withdraw|4|||
125895635|NCT00833417|452918926|FG001|Overall Study|Patient Decision to Withdraw|23|||
125895636|NCT00833417|452918925|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
125895637|NCT00833417|452918926|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
125895638|NCT00833417|452918925|FG000|Overall Study|Disease Progression|18|||
125895639|NCT00833417|452918926|FG001|Overall Study|Disease Progression|17|||
125895640|NCT00833417|452918925|FG000|Overall Study|Reason Not Specified|0|||
125895641|NCT00833417|452918926|FG001|Overall Study|Reason Not Specified|1|||
125895642|NCT03330002|452918927|FG000|Overall Study|Lost to Follow-up|15|||
125895643|NCT03330002|452918927|FG000|Overall Study|Death|7|||
125895644|NCT00505076|452918928|FG000|Overall Study|Adverse Event|1|||
125895645|NCT00505076|452918929|FG001|Overall Study|Adverse Event|0|||
125895646|NCT00505076|452918930|FG002|Overall Study|Adverse Event|1|||
125895647|NCT00505076|452918928|FG000|Overall Study|Protocol Violation|2|||
125895648|NCT00505076|452918929|FG001|Overall Study|Protocol Violation|1|||
125895649|NCT00505076|452918930|FG002|Overall Study|Protocol Violation|2|||
125895650|NCT00505076|452918928|FG000|Overall Study|Withdrawal by Subject|0|||
125895651|NCT00505076|452918929|FG001|Overall Study|Withdrawal by Subject|1|||
125895652|NCT00505076|452918930|FG002|Overall Study|Withdrawal by Subject|2|||
125895653|NCT02745145|452918931|FG000|Overall Study|Adverse Event|1|||
125895654|NCT02745145|452918932|FG001|Overall Study|Adverse Event|0|||
125895655|NCT02745145|452918933|FG002|Overall Study|Adverse Event|0|||
125895656|NCT02745145|452918931|FG000|Overall Study|Death|0|||
125895657|NCT02745145|452918932|FG001|Overall Study|Death|1|||
125895658|NCT02745145|452918933|FG002|Overall Study|Death|0|||
125895659|NCT02745145|452918931|FG000|Overall Study|Progressive disease|0|||
125895660|NCT02745145|452918932|FG001|Overall Study|Progressive disease|0|||
125895661|NCT02745145|452918933|FG002|Overall Study|Progressive disease|1|||
125895662|NCT02745145|452918931|FG000|Overall Study|Withdrew consent|1|||
125895663|NCT02745145|452918932|FG001|Overall Study|Withdrew consent|1|||
125895664|NCT02745145|452918933|FG002|Overall Study|Withdrew consent|1|||
125895665|NCT02745145|452918931|FG000|Overall Study|Study Termination|8|||
125895666|NCT02745145|452918932|FG001|Overall Study|Study Termination|3|||
125895667|NCT02745145|452918933|FG002|Overall Study|Study Termination|7|||
125895668|NCT00388583|452918934|FG000|Overall Study|Protocol Violation|1|||
125895669|NCT00388583|452918935|FG001|Overall Study|Protocol Violation|0|||
125895670|NCT00388583|452918934|FG000|Overall Study|Withdrawal by Subject|3|||
125895671|NCT00388583|452918935|FG001|Overall Study|Withdrawal by Subject|3|||
125895672|NCT00388583|452918934|FG000|Overall Study|Serious Adverse Event|2|||
125895673|NCT00388583|452918935|FG001|Overall Study|Serious Adverse Event|0|||
125895674|NCT00388583|452918934|FG000|Overall Study|Did not receive vaccine|0|||
125895675|NCT00388583|452918935|FG001|Overall Study|Did not receive vaccine|1|||
125895676|NCT00322621|452918936|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
125895677|NCT00322621|452918937|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
125895678|NCT00322621|452918938|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
125895679|NCT00322621|452918936|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
125895680|NCT00322621|452918937|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
125895681|NCT00322621|452918938|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
125895682|NCT00322621|452918936|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
125895683|NCT00322621|452918937|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
125895684|NCT00322621|452918938|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
125895685|NCT00322621|452918936|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
125895686|NCT00322621|452918937|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
125895687|NCT00322621|452918938|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
125895688|NCT00322621|452918936|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
125895689|NCT00322621|452918937|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
125895690|NCT00322621|452918938|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
125895691|NCT00322621|452918936|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
125895692|NCT00322621|452918937|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
125895693|NCT00322621|452918938|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
125895694|NCT00322621|452918936|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
125895695|NCT00322621|452918937|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
125895696|NCT00322621|452918938|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
125895697|NCT00322621|452918936|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
125895698|NCT00322621|452918937|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
125895699|NCT00322621|452918938|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
125895700|NCT00322621|452918936|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
125895701|NCT00322621|452918937|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
125895702|NCT00322621|452918938|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
125895703|NCT00322621|452918936|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
125895704|NCT00322621|452918937|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
125895705|NCT00322621|452918938|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
125895706|NCT00322621|452918936|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
125895707|NCT00322621|452918937|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
125895708|NCT00322621|452918938|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
125895709|NCT01090323|452918939|FG000|Overall Study|Adverse Event|12|||
125895710|NCT01090323|452918940|FG001|Overall Study|Adverse Event|2|||
125895711|NCT01090323|452918939|FG000|Overall Study|Abnormal Lab Values|3|||
125895712|NCT01090323|452918940|FG001|Overall Study|Abnormal Lab Values|1|||
125895713|NCT01090323|452918939|FG000|Overall Study|Abnormal Test Procedure Results|2|||
125895714|NCT01090323|452918940|FG001|Overall Study|Abnormal Test Procedure Results|0|||
125895715|NCT01090323|452918939|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125895716|NCT01090323|452918940|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125895717|NCT01090323|452918939|FG000|Overall Study|Condition no longer requires drug|5|||
125895718|NCT01090323|452918940|FG001|Overall Study|Condition no longer requires drug|4|||
125895719|NCT01090323|452918939|FG000|Overall Study|Protocol Violation|2|||
125895720|NCT01090323|452918940|FG001|Overall Study|Protocol Violation|1|||
125895721|NCT01090323|452918939|FG000|Overall Study|Withdrew consent|33|||
125895722|NCT01090323|452918940|FG001|Overall Study|Withdrew consent|11|||
125895723|NCT01090323|452918939|FG000|Overall Study|Lost to Follow-up|11|||
125895724|NCT01090323|452918940|FG001|Overall Study|Lost to Follow-up|6|||
125895725|NCT01090323|452918939|FG000|Overall Study|Administrative problems|6|||
125895726|NCT01090323|452918940|FG001|Overall Study|Administrative problems|4|||
125895727|NCT01090323|452918939|FG000|Overall Study|Death|1|||
125895728|NCT01090323|452918940|FG001|Overall Study|Death|2|||
125895729|NCT01090323|452918939|FG000|Overall Study|Stopped end of core|7|||
125895730|NCT01090323|452918940|FG001|Overall Study|Stopped end of core|0|||
125895731|NCT01090323|452918939|FG000|Overall Study|Stopped end of extension 1#|3|||
125895732|NCT01090323|452918940|FG001|Overall Study|Stopped end of extension 1#|1|||
125895733|NCT01864005|452918941|FG000|Overall Study|Protocol Violation|0|||
125895734|NCT01864005|452918942|FG001|Overall Study|Protocol Violation|1|||
125895735|NCT01864005|452918941|FG000|Overall Study|Withdrawal by Subject|0|||
125895736|NCT01864005|452918942|FG001|Overall Study|Withdrawal by Subject|1|||
125895737|NCT01864005|452918941|FG000|Overall Study|Incorrect enrolment|1|||
125895738|NCT01864005|452918942|FG001|Overall Study|Incorrect enrolment|0|||
125895739|NCT01864005|452918941|FG000|Overall Study|Disease need|1|||
125895740|NCT01864005|452918942|FG001|Overall Study|Disease need|1|||
125895741|NCT01864005|452918941|FG000|Overall Study|Need GP IIb/IIIa|1|||
125895742|NCT01864005|452918942|FG001|Overall Study|Need GP IIb/IIIa|3|||
125895743|NCT00763698|452918943|FG000|Overall Study|Unsuccessful Implant|5|||
125895744|NCT00763698|452918943|FG000|Overall Study|Death|4|||
125895745|NCT00763698|452918943|FG000|Overall Study|Withdrawal by Subject|1|||
125895746|NCT02059291|452918944|FG000|Epoch 2|Lack of Efficacy|0|||
125895747|NCT02059291|452918945|FG001|Epoch 2|Lack of Efficacy|0|||
125895748|NCT02059291|452918946|FG002|Epoch 2|Lack of Efficacy|0|||
125895749|NCT02059291|452918947|FG003|Epoch 2|Lack of Efficacy|1|||
125895750|NCT02059291|452918948|FG004|Epoch 2|Lack of Efficacy|0|||
125895751|NCT02059291|452918949|FG005|Epoch 2|Lack of Efficacy|1|||
125895752|NCT02059291|452918950|FG006|Epoch 2|Lack of Efficacy|0|||
125895753|NCT02059291|452918951|FG007|Epoch 2|Lack of Efficacy|0|||
125895754|NCT02059291|452918952|FG008|Epoch 2|Lack of Efficacy|0|||
125895755|NCT02059291|452918953|FG009|Epoch 2|Lack of Efficacy|0|||
125895756|NCT02059291|452918954|FG010|Epoch 2|Lack of Efficacy|0|||
125895757|NCT02059291|452918955|FG011|Epoch 2|Lack of Efficacy|0|||
125895758|NCT02059291|452918956|FG012|Epoch 2|Lack of Efficacy|0|||
125895759|NCT02059291|452918957|FG013|Epoch 2|Lack of Efficacy|0|||
125895760|NCT02059291|452918958|FG014|Epoch 2|Lack of Efficacy|0|||
125895761|NCT02059291|452918959|FG015|Epoch 2|Lack of Efficacy|0|||
125895762|NCT02059291|452918960|FG016|Epoch 2|Lack of Efficacy|0|||
125895763|NCT02059291|452918961|FG017|Epoch 2|Lack of Efficacy|0|||
125895764|NCT02059291|452918962|FG018|Epoch 2|Lack of Efficacy|0|||
125895765|NCT02059291|452918963|FG019|Epoch 2|Lack of Efficacy|0|||
125895766|NCT02059291|452918964|FG020|Epoch 2|Lack of Efficacy|0|||
125895767|NCT02059291|452918965|FG021|Epoch 2|Lack of Efficacy|0|||
125895768|NCT02059291|452918966|FG022|Epoch 2|Lack of Efficacy|0|||
125895769|NCT02059291|452918967|FG023|Epoch 2|Lack of Efficacy|0|||
125895770|NCT02059291|452918968|FG024|Epoch 2|Lack of Efficacy|0|||
125895771|NCT02059291|452918944|FG000|Epoch 2|Adverse Event|0|||
125895772|NCT02059291|452918945|FG001|Epoch 2|Adverse Event|0|||
125895773|NCT02059291|452918946|FG002|Epoch 2|Adverse Event|1|||
125895774|NCT02059291|452918947|FG003|Epoch 2|Adverse Event|1|||
125895775|NCT02059291|452918948|FG004|Epoch 2|Adverse Event|0|||
125895776|NCT02059291|452918949|FG005|Epoch 2|Adverse Event|0|||
125895777|NCT02059291|452918950|FG006|Epoch 2|Adverse Event|0|||
125895778|NCT02059291|452918951|FG007|Epoch 2|Adverse Event|1|||
125895779|NCT02059291|452918952|FG008|Epoch 2|Adverse Event|1|||
125895780|NCT02059291|452918953|FG009|Epoch 2|Adverse Event|0|||
125895781|NCT02059291|452918954|FG010|Epoch 2|Adverse Event|0|||
125895782|NCT02059291|452918955|FG011|Epoch 2|Adverse Event|0|||
125895783|NCT02059291|452918956|FG012|Epoch 2|Adverse Event|0|||
125895784|NCT02059291|452918957|FG013|Epoch 2|Adverse Event|0|||
125895785|NCT02059291|452918958|FG014|Epoch 2|Adverse Event|0|||
125895786|NCT02059291|452918959|FG015|Epoch 2|Adverse Event|0|||
125895787|NCT02059291|452918960|FG016|Epoch 2|Adverse Event|0|||
125895788|NCT02059291|452918961|FG017|Epoch 2|Adverse Event|0|||
125895789|NCT02059291|452918962|FG018|Epoch 2|Adverse Event|0|||
125895790|NCT02059291|452918963|FG019|Epoch 2|Adverse Event|0|||
125895791|NCT02059291|452918964|FG020|Epoch 2|Adverse Event|0|||
125895792|NCT02059291|452918965|FG021|Epoch 2|Adverse Event|0|||
125895793|NCT02059291|452918966|FG022|Epoch 2|Adverse Event|0|||
125895794|NCT02059291|452918967|FG023|Epoch 2|Adverse Event|0|||
125895795|NCT02059291|452918968|FG024|Epoch 2|Adverse Event|0|||
126059747|NCT03136861|453512529|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
125895796|NCT02059291|452918944|FG000|Epoch 2|Withdrawal by Subject|0|||
125895797|NCT02059291|452918945|FG001|Epoch 2|Withdrawal by Subject|1|||
125895798|NCT02059291|452918946|FG002|Epoch 2|Withdrawal by Subject|0|||
125895799|NCT02059291|452918947|FG003|Epoch 2|Withdrawal by Subject|0|||
125895800|NCT02059291|452918948|FG004|Epoch 2|Withdrawal by Subject|0|||
125895801|NCT02059291|452918949|FG005|Epoch 2|Withdrawal by Subject|1|||
125895802|NCT02059291|452918950|FG006|Epoch 2|Withdrawal by Subject|0|||
125895803|NCT02059291|452918951|FG007|Epoch 2|Withdrawal by Subject|0|||
125895804|NCT02059291|452918952|FG008|Epoch 2|Withdrawal by Subject|1|||
125895805|NCT02059291|452918953|FG009|Epoch 2|Withdrawal by Subject|0|||
125895806|NCT02059291|452918954|FG010|Epoch 2|Withdrawal by Subject|0|||
125895807|NCT02059291|452918955|FG011|Epoch 2|Withdrawal by Subject|0|||
125895808|NCT02059291|452918956|FG012|Epoch 2|Withdrawal by Subject|0|||
125895809|NCT02059291|452918957|FG013|Epoch 2|Withdrawal by Subject|0|||
125895810|NCT02059291|452918958|FG014|Epoch 2|Withdrawal by Subject|0|||
125895811|NCT02059291|452918959|FG015|Epoch 2|Withdrawal by Subject|0|||
125895812|NCT02059291|452918960|FG016|Epoch 2|Withdrawal by Subject|0|||
125895813|NCT02059291|452918961|FG017|Epoch 2|Withdrawal by Subject|0|||
125895814|NCT02059291|452918962|FG018|Epoch 2|Withdrawal by Subject|0|||
125895815|NCT02059291|452918963|FG019|Epoch 2|Withdrawal by Subject|0|||
125895816|NCT02059291|452918964|FG020|Epoch 2|Withdrawal by Subject|0|||
126110033|NCT00985166|453697621|FG000|Overall Study|Other|1|||
125895817|NCT02059291|452918965|FG021|Epoch 2|Withdrawal by Subject|0|||
125895818|NCT02059291|452918966|FG022|Epoch 2|Withdrawal by Subject|0|||
125895819|NCT02059291|452918967|FG023|Epoch 2|Withdrawal by Subject|0|||
125895820|NCT02059291|452918968|FG024|Epoch 2|Withdrawal by Subject|0|||
125895821|NCT02059291|452918944|FG000|Epoch 3|Physician Decision|0|||
125895822|NCT02059291|452918945|FG001|Epoch 3|Physician Decision|0|||
125895823|NCT02059291|452918946|FG002|Epoch 3|Physician Decision|0|||
125895824|NCT02059291|452918947|FG003|Epoch 3|Physician Decision|0|||
125895825|NCT02059291|452918948|FG004|Epoch 3|Physician Decision|0|||
125895826|NCT02059291|452918949|FG005|Epoch 3|Physician Decision|0|||
125895827|NCT02059291|452918950|FG006|Epoch 3|Physician Decision|0|||
125895828|NCT02059291|452918951|FG007|Epoch 3|Physician Decision|0|||
125895829|NCT02059291|452918952|FG008|Epoch 3|Physician Decision|0|||
125895830|NCT02059291|452918953|FG009|Epoch 3|Physician Decision|0|||
125895831|NCT02059291|452918954|FG010|Epoch 3|Physician Decision|0|||
125895832|NCT02059291|452918955|FG011|Epoch 3|Physician Decision|0|||
125895833|NCT02059291|452918956|FG012|Epoch 3|Physician Decision|0|||
125895834|NCT02059291|452918957|FG013|Epoch 3|Physician Decision|1|||
125895835|NCT02059291|452918958|FG014|Epoch 3|Physician Decision|0|||
125895836|NCT02059291|452918959|FG015|Epoch 3|Physician Decision|1|||
125895837|NCT02059291|452918960|FG016|Epoch 3|Physician Decision|0|||
125895838|NCT02059291|452918961|FG017|Epoch 3|Physician Decision|0|||
125895839|NCT02059291|452918962|FG018|Epoch 3|Physician Decision|0|||
125895840|NCT02059291|452918963|FG019|Epoch 3|Physician Decision|0|||
125895841|NCT02059291|452918964|FG020|Epoch 3|Physician Decision|0|||
125895842|NCT02059291|452918965|FG021|Epoch 3|Physician Decision|0|||
125895843|NCT02059291|452918966|FG022|Epoch 3|Physician Decision|0|||
125895844|NCT02059291|452918967|FG023|Epoch 3|Physician Decision|0|||
125895845|NCT02059291|452918968|FG024|Epoch 3|Physician Decision|0|||
125895846|NCT02059291|452918944|FG000|Epoch 3|Adverse Event|0|||
125895847|NCT02059291|452918945|FG001|Epoch 3|Adverse Event|0|||
125895848|NCT02059291|452918946|FG002|Epoch 3|Adverse Event|0|||
125895849|NCT02059291|452918947|FG003|Epoch 3|Adverse Event|0|||
125895850|NCT02059291|452918948|FG004|Epoch 3|Adverse Event|0|||
125895851|NCT02059291|452918949|FG005|Epoch 3|Adverse Event|0|||
125895852|NCT02059291|452918950|FG006|Epoch 3|Adverse Event|0|||
125895853|NCT02059291|452918951|FG007|Epoch 3|Adverse Event|0|||
125895854|NCT02059291|452918952|FG008|Epoch 3|Adverse Event|0|||
125895855|NCT02059291|452918953|FG009|Epoch 3|Adverse Event|0|||
125895856|NCT02059291|452918954|FG010|Epoch 3|Adverse Event|0|||
125895857|NCT02059291|452918955|FG011|Epoch 3|Adverse Event|0|||
125895858|NCT02059291|452918956|FG012|Epoch 3|Adverse Event|0|||
125895859|NCT02059291|452918957|FG013|Epoch 3|Adverse Event|0|||
125895860|NCT02059291|452918958|FG014|Epoch 3|Adverse Event|0|||
125895861|NCT02059291|452918959|FG015|Epoch 3|Adverse Event|1|||
125895862|NCT02059291|452918960|FG016|Epoch 3|Adverse Event|0|||
125895863|NCT02059291|452918961|FG017|Epoch 3|Adverse Event|0|||
125895864|NCT02059291|452918962|FG018|Epoch 3|Adverse Event|0|||
125895865|NCT02059291|452918963|FG019|Epoch 3|Adverse Event|0|||
125895866|NCT02059291|452918964|FG020|Epoch 3|Adverse Event|0|||
125895867|NCT02059291|452918965|FG021|Epoch 3|Adverse Event|0|||
125895868|NCT02059291|452918966|FG022|Epoch 3|Adverse Event|0|||
125895869|NCT02059291|452918967|FG023|Epoch 3|Adverse Event|0|||
125895870|NCT02059291|452918968|FG024|Epoch 3|Adverse Event|0|||
125895871|NCT02059291|452918944|FG000|Epoch 3|Lack of Efficacy|0|||
125895872|NCT02059291|452918945|FG001|Epoch 3|Lack of Efficacy|0|||
125895873|NCT02059291|452918946|FG002|Epoch 3|Lack of Efficacy|0|||
125895874|NCT02059291|452918947|FG003|Epoch 3|Lack of Efficacy|0|||
125895875|NCT02059291|452918948|FG004|Epoch 3|Lack of Efficacy|0|||
125895876|NCT02059291|452918949|FG005|Epoch 3|Lack of Efficacy|0|||
125895877|NCT02059291|452918950|FG006|Epoch 3|Lack of Efficacy|0|||
125895878|NCT02059291|452918951|FG007|Epoch 3|Lack of Efficacy|0|||
125895879|NCT02059291|452918952|FG008|Epoch 3|Lack of Efficacy|0|||
125895880|NCT02059291|452918953|FG009|Epoch 3|Lack of Efficacy|0|||
125895881|NCT02059291|452918954|FG010|Epoch 3|Lack of Efficacy|0|||
125895882|NCT02059291|452918955|FG011|Epoch 3|Lack of Efficacy|0|||
125895883|NCT02059291|452918956|FG012|Epoch 3|Lack of Efficacy|0|||
125895884|NCT02059291|452918957|FG013|Epoch 3|Lack of Efficacy|0|||
125895885|NCT02059291|452918958|FG014|Epoch 3|Lack of Efficacy|0|||
125895886|NCT02059291|452918959|FG015|Epoch 3|Lack of Efficacy|3|||
125895887|NCT02059291|452918960|FG016|Epoch 3|Lack of Efficacy|0|||
125895888|NCT02059291|452918961|FG017|Epoch 3|Lack of Efficacy|0|||
125895889|NCT02059291|452918962|FG018|Epoch 3|Lack of Efficacy|0|||
125895890|NCT02059291|452918963|FG019|Epoch 3|Lack of Efficacy|0|||
125895891|NCT02059291|452918964|FG020|Epoch 3|Lack of Efficacy|0|||
125895892|NCT02059291|452918965|FG021|Epoch 3|Lack of Efficacy|0|||
125895893|NCT02059291|452918966|FG022|Epoch 3|Lack of Efficacy|0|||
125895894|NCT02059291|452918967|FG023|Epoch 3|Lack of Efficacy|0|||
125895895|NCT02059291|452918968|FG024|Epoch 3|Lack of Efficacy|0|||
125895896|NCT02059291|452918944|FG000|Epoch 3|Withdrawal by Subject|0|||
125895897|NCT02059291|452918945|FG001|Epoch 3|Withdrawal by Subject|0|||
125895898|NCT02059291|452918946|FG002|Epoch 3|Withdrawal by Subject|0|||
125895899|NCT02059291|452918947|FG003|Epoch 3|Withdrawal by Subject|0|||
125895900|NCT02059291|452918948|FG004|Epoch 3|Withdrawal by Subject|0|||
125895901|NCT02059291|452918949|FG005|Epoch 3|Withdrawal by Subject|0|||
125895902|NCT02059291|452918950|FG006|Epoch 3|Withdrawal by Subject|0|||
125895903|NCT02059291|452918951|FG007|Epoch 3|Withdrawal by Subject|0|||
125895904|NCT02059291|452918952|FG008|Epoch 3|Withdrawal by Subject|0|||
125895905|NCT02059291|452918953|FG009|Epoch 3|Withdrawal by Subject|0|||
125895906|NCT02059291|452918954|FG010|Epoch 3|Withdrawal by Subject|0|||
125895907|NCT02059291|452918955|FG011|Epoch 3|Withdrawal by Subject|0|||
125895908|NCT02059291|452918956|FG012|Epoch 3|Withdrawal by Subject|0|||
125895909|NCT02059291|452918957|FG013|Epoch 3|Withdrawal by Subject|0|||
125895910|NCT02059291|452918958|FG014|Epoch 3|Withdrawal by Subject|0|||
125895911|NCT02059291|452918959|FG015|Epoch 3|Withdrawal by Subject|1|||
125895912|NCT02059291|452918960|FG016|Epoch 3|Withdrawal by Subject|0|||
125895913|NCT02059291|452918961|FG017|Epoch 3|Withdrawal by Subject|0|||
125895914|NCT02059291|452918962|FG018|Epoch 3|Withdrawal by Subject|0|||
125895915|NCT02059291|452918963|FG019|Epoch 3|Withdrawal by Subject|0|||
125895916|NCT02059291|452918964|FG020|Epoch 3|Withdrawal by Subject|0|||
125895917|NCT02059291|452918965|FG021|Epoch 3|Withdrawal by Subject|0|||
125895918|NCT02059291|452918966|FG022|Epoch 3|Withdrawal by Subject|0|||
125895919|NCT02059291|452918967|FG023|Epoch 3|Withdrawal by Subject|0|||
125895920|NCT02059291|452918968|FG024|Epoch 3|Withdrawal by Subject|0|||
125895921|NCT02059291|452918944|FG000|Epoch 4|Adverse Event|0|||
125895922|NCT02059291|452918945|FG001|Epoch 4|Adverse Event|0|||
125895923|NCT02059291|452918946|FG002|Epoch 4|Adverse Event|0|||
125895924|NCT02059291|452918947|FG003|Epoch 4|Adverse Event|0|||
125895925|NCT02059291|452918948|FG004|Epoch 4|Adverse Event|0|||
125895926|NCT02059291|452918949|FG005|Epoch 4|Adverse Event|0|||
125895927|NCT02059291|452918950|FG006|Epoch 4|Adverse Event|0|||
125895928|NCT02059291|452918951|FG007|Epoch 4|Adverse Event|0|||
125895929|NCT02059291|452918952|FG008|Epoch 4|Adverse Event|0|||
125895930|NCT02059291|452918953|FG009|Epoch 4|Adverse Event|0|||
125895931|NCT02059291|452918954|FG010|Epoch 4|Adverse Event|0|||
125895932|NCT02059291|452918955|FG011|Epoch 4|Adverse Event|0|||
125895933|NCT02059291|452918956|FG012|Epoch 4|Adverse Event|0|||
125895934|NCT02059291|452918957|FG013|Epoch 4|Adverse Event|0|||
125895935|NCT02059291|452918958|FG014|Epoch 4|Adverse Event|0|||
125895936|NCT02059291|452918959|FG015|Epoch 4|Adverse Event|0|||
125895937|NCT02059291|452918960|FG016|Epoch 4|Adverse Event|1|||
125895938|NCT02059291|452918961|FG017|Epoch 4|Adverse Event|0|||
125895939|NCT02059291|452918962|FG018|Epoch 4|Adverse Event|0|||
125895940|NCT02059291|452918963|FG019|Epoch 4|Adverse Event|0|||
125895941|NCT02059291|452918964|FG020|Epoch 4|Adverse Event|0|||
125895942|NCT02059291|452918965|FG021|Epoch 4|Adverse Event|0|||
125895943|NCT02059291|452918966|FG022|Epoch 4|Adverse Event|1|||
125895944|NCT02059291|452918967|FG023|Epoch 4|Adverse Event|0|||
125895945|NCT02059291|452918968|FG024|Epoch 4|Adverse Event|0|||
125895946|NCT02059291|452918944|FG000|Epoch 4|Pregnancy|0|||
125895947|NCT02059291|452918945|FG001|Epoch 4|Pregnancy|0|||
125895948|NCT02059291|452918946|FG002|Epoch 4|Pregnancy|0|||
125895949|NCT02059291|452918947|FG003|Epoch 4|Pregnancy|0|||
125895950|NCT02059291|452918948|FG004|Epoch 4|Pregnancy|0|||
125895951|NCT02059291|452918949|FG005|Epoch 4|Pregnancy|0|||
125895952|NCT02059291|452918950|FG006|Epoch 4|Pregnancy|0|||
125895953|NCT02059291|452918951|FG007|Epoch 4|Pregnancy|0|||
125895954|NCT02059291|452918952|FG008|Epoch 4|Pregnancy|0|||
125895955|NCT02059291|452918953|FG009|Epoch 4|Pregnancy|0|||
125895956|NCT02059291|452918954|FG010|Epoch 4|Pregnancy|0|||
125895957|NCT02059291|452918955|FG011|Epoch 4|Pregnancy|0|||
125895958|NCT02059291|452918956|FG012|Epoch 4|Pregnancy|0|||
125895959|NCT02059291|452918957|FG013|Epoch 4|Pregnancy|0|||
125895960|NCT02059291|452918958|FG014|Epoch 4|Pregnancy|0|||
125895961|NCT02059291|452918959|FG015|Epoch 4|Pregnancy|0|||
125895962|NCT02059291|452918960|FG016|Epoch 4|Pregnancy|1|||
125895963|NCT02059291|452918961|FG017|Epoch 4|Pregnancy|0|||
125895964|NCT02059291|452918962|FG018|Epoch 4|Pregnancy|0|||
125895965|NCT02059291|452918963|FG019|Epoch 4|Pregnancy|0|||
125895966|NCT02059291|452918964|FG020|Epoch 4|Pregnancy|0|||
125895967|NCT02059291|452918965|FG021|Epoch 4|Pregnancy|0|||
125895968|NCT02059291|452918966|FG022|Epoch 4|Pregnancy|0|||
125895969|NCT02059291|452918967|FG023|Epoch 4|Pregnancy|0|||
125895970|NCT02059291|452918968|FG024|Epoch 4|Pregnancy|0|||
125895971|NCT02059291|452918944|FG000|Epoch 4|Withdrawal by Subject|0|||
125895972|NCT02059291|452918945|FG001|Epoch 4|Withdrawal by Subject|0|||
125895973|NCT02059291|452918946|FG002|Epoch 4|Withdrawal by Subject|0|||
125895974|NCT02059291|452918947|FG003|Epoch 4|Withdrawal by Subject|0|||
125895975|NCT02059291|452918948|FG004|Epoch 4|Withdrawal by Subject|0|||
125895976|NCT02059291|452918949|FG005|Epoch 4|Withdrawal by Subject|0|||
125895977|NCT02059291|452918950|FG006|Epoch 4|Withdrawal by Subject|0|||
125895978|NCT02059291|452918951|FG007|Epoch 4|Withdrawal by Subject|0|||
125895979|NCT02059291|452918952|FG008|Epoch 4|Withdrawal by Subject|0|||
125895980|NCT02059291|452918953|FG009|Epoch 4|Withdrawal by Subject|0|||
125895981|NCT02059291|452918954|FG010|Epoch 4|Withdrawal by Subject|0|||
125895982|NCT02059291|452918955|FG011|Epoch 4|Withdrawal by Subject|0|||
125895983|NCT02059291|452918956|FG012|Epoch 4|Withdrawal by Subject|0|||
125895984|NCT02059291|452918957|FG013|Epoch 4|Withdrawal by Subject|0|||
125895985|NCT02059291|452918958|FG014|Epoch 4|Withdrawal by Subject|0|||
125895986|NCT02059291|452918959|FG015|Epoch 4|Withdrawal by Subject|0|||
125895987|NCT02059291|452918960|FG016|Epoch 4|Withdrawal by Subject|0|||
125895988|NCT02059291|452918961|FG017|Epoch 4|Withdrawal by Subject|0|||
125895989|NCT02059291|452918962|FG018|Epoch 4|Withdrawal by Subject|0|||
125895990|NCT02059291|452918963|FG019|Epoch 4|Withdrawal by Subject|0|||
125895991|NCT02059291|452918964|FG020|Epoch 4|Withdrawal by Subject|1|||
125895992|NCT02059291|452918965|FG021|Epoch 4|Withdrawal by Subject|0|||
125895993|NCT02059291|452918966|FG022|Epoch 4|Withdrawal by Subject|0|||
125895994|NCT02059291|452918967|FG023|Epoch 4|Withdrawal by Subject|0|||
125895995|NCT02059291|452918968|FG024|Epoch 4|Withdrawal by Subject|0|||
125895996|NCT02059291|452918944|FG000|Epoch 4|Lack of Efficacy|0|||
125895997|NCT02059291|452918945|FG001|Epoch 4|Lack of Efficacy|0|||
125895998|NCT02059291|452918946|FG002|Epoch 4|Lack of Efficacy|0|||
125895999|NCT02059291|452918947|FG003|Epoch 4|Lack of Efficacy|0|||
125896000|NCT02059291|452918948|FG004|Epoch 4|Lack of Efficacy|0|||
125896001|NCT02059291|452918949|FG005|Epoch 4|Lack of Efficacy|0|||
125896002|NCT02059291|452918950|FG006|Epoch 4|Lack of Efficacy|0|||
125896003|NCT02059291|452918951|FG007|Epoch 4|Lack of Efficacy|0|||
125896004|NCT02059291|452918952|FG008|Epoch 4|Lack of Efficacy|0|||
125896005|NCT02059291|452918953|FG009|Epoch 4|Lack of Efficacy|0|||
125896006|NCT02059291|452918954|FG010|Epoch 4|Lack of Efficacy|0|||
125896007|NCT02059291|452918955|FG011|Epoch 4|Lack of Efficacy|0|||
125896008|NCT02059291|452918956|FG012|Epoch 4|Lack of Efficacy|0|||
125896009|NCT02059291|452918957|FG013|Epoch 4|Lack of Efficacy|0|||
125896010|NCT02059291|452918958|FG014|Epoch 4|Lack of Efficacy|0|||
125896011|NCT02059291|452918959|FG015|Epoch 4|Lack of Efficacy|0|||
125896012|NCT02059291|452918960|FG016|Epoch 4|Lack of Efficacy|0|||
125896013|NCT02059291|452918961|FG017|Epoch 4|Lack of Efficacy|0|||
125896014|NCT02059291|452918962|FG018|Epoch 4|Lack of Efficacy|0|||
125896015|NCT02059291|452918963|FG019|Epoch 4|Lack of Efficacy|0|||
125896016|NCT02059291|452918964|FG020|Epoch 4|Lack of Efficacy|0|||
125896017|NCT02059291|452918965|FG021|Epoch 4|Lack of Efficacy|0|||
125896018|NCT02059291|452918966|FG022|Epoch 4|Lack of Efficacy|0|||
125896019|NCT02059291|452918967|FG023|Epoch 4|Lack of Efficacy|1|||
125896020|NCT02059291|452918968|FG024|Epoch 4|Lack of Efficacy|0|||
125896021|NCT01433289|452918969|FG000|Overall Study|Pregnancy|0|||
125896022|NCT01433289|452918970|FG001|Overall Study|Pregnancy|1|||
125896023|NCT01433289|452918971|FG002|Overall Study|Pregnancy|0|||
125896024|NCT01433289|452918972|FG003|Overall Study|Pregnancy|0|||
125896025|NCT03241368|452918973|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
125896026|NCT03241368|452918973|FG000|Overall Study|Lost to Follow-up|1|||
125896027|NCT03241368|452918973|FG000|Overall Study|Physician Decision|6|||
125896028|NCT03241368|452918973|FG000|Overall Study|Withdrawal by Subject|6|||
125896029|NCT03241368|452918973|FG000|Overall Study|Protocol Violation|1|||
125896030|NCT00080899|452918976|FG000|Overall Study|Adverse Event|1|||
125896031|NCT01616693|452918978|FG000|Evaluated for Safety|Physician Decision|1|||
125896032|NCT01616693|452918979|FG001|Evaluated for Safety|Physician Decision|0|||
125896033|NCT01616693|452918980|FG002|Evaluated for Safety|Physician Decision|1|||
125896034|NCT01616693|452918981|FG003|Evaluated for Safety|Physician Decision|0|||
125896035|NCT01616693|452918978|FG000|Received Both Vaccines|Adverse Event|2|||
125896036|NCT01616693|452918979|FG001|Received Both Vaccines|Adverse Event|0|||
125896037|NCT01616693|452918980|FG002|Received Both Vaccines|Adverse Event|0|||
125896038|NCT01616693|452918981|FG003|Received Both Vaccines|Adverse Event|0|||
125896039|NCT01616693|452918978|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
125896040|NCT01616693|452918979|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
125896041|NCT01616693|452918980|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
125896042|NCT01616693|452918981|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
125896043|NCT01616693|452918978|FG000|Received Both Vaccines|Lost to Follow-up|4|||
125896044|NCT01616693|452918979|FG001|Received Both Vaccines|Lost to Follow-up|3|||
125896045|NCT01616693|452918980|FG002|Received Both Vaccines|Lost to Follow-up|4|||
125896046|NCT01616693|452918981|FG003|Received Both Vaccines|Lost to Follow-up|4|||
125896047|NCT01616693|452918978|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
125896048|NCT01616693|452918979|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
125896049|NCT01616693|452918980|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
125896050|NCT01616693|452918981|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
125896051|NCT00653939|452918982|FG000|Overall Study|Adverse Event|1|||
125896052|NCT00653939|452918983|FG001|Overall Study|Adverse Event|3|||
125896053|NCT00653939|452918982|FG000|Overall Study|Withdrawal by Subject|3|||
125896054|NCT00653939|452918983|FG001|Overall Study|Withdrawal by Subject|3|||
125896055|NCT00653939|452918982|FG000|Overall Study|Physician Decision|4|||
125896056|NCT00653939|452918983|FG001|Overall Study|Physician Decision|0|||
125896057|NCT00653939|452918982|FG000|Overall Study|Disease Progression|2|||
125896058|NCT00653939|452918983|FG001|Overall Study|Disease Progression|3|||
125896059|NCT00653939|452918982|FG000|Overall Study|Other|2|||
125896060|NCT00653939|452918983|FG001|Overall Study|Other|6|||
125896061|NCT01105767|452918984|FG000|Overall Study|Lost to Follow-up|1160|||
125896062|NCT01105767|452918985|FG001|Overall Study|Lost to Follow-up|1614|||
125896063|NCT01105767|452918986|FG002|Overall Study|Lost to Follow-up|1184|||
125896064|NCT00743106|452918987|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
125896065|NCT00743106|452918988|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
125896066|NCT03704636|452918990|FG000|Overall Study|Inadequate Venous Flow|3|||
125896067|NCT00539188|452918993|FG000|Overall Study|Withdrawal by Subject|1|||
125896068|NCT00539188|452918994|FG001|Overall Study|Withdrawal by Subject|0|||
125896069|NCT00539188|452918993|FG000|Overall Study|Lost to Follow-up|2|||
125896070|NCT00539188|452918994|FG001|Overall Study|Lost to Follow-up|1|||
125896071|NCT02874144|452918997|FG000|Overall Study|Lost to Follow-up|3|||
125896072|NCT02874144|452918998|FG001|Overall Study|Lost to Follow-up|5|||
125896073|NCT00486811|452919000|FG000|Overall Study|Adverse Event|28|||
125896074|NCT00486811|452919001|FG001|Overall Study|Adverse Event|60|||
125896075|NCT00486811|452919002|FG002|Overall Study|Adverse Event|135|||
125896076|NCT00486811|452919000|FG000|Overall Study|Lack of Efficacy|34|||
125896077|NCT00486811|452919001|FG001|Overall Study|Lack of Efficacy|14|||
125896078|NCT00486811|452919002|FG002|Overall Study|Lack of Efficacy|7|||
125896079|NCT00486811|452919000|FG000|Overall Study|Lost to Follow-up|4|||
125896080|NCT00486811|452919001|FG001|Overall Study|Lost to Follow-up|6|||
125896081|NCT00486811|452919002|FG002|Overall Study|Lost to Follow-up|4|||
125896082|NCT00486811|452919000|FG000|Overall Study|Withdrawal by Subject|33|||
125896083|NCT00486811|452919001|FG001|Overall Study|Withdrawal by Subject|44|||
125896084|NCT00486811|452919002|FG002|Overall Study|Withdrawal by Subject|58|||
125896085|NCT00486811|452919000|FG000|Overall Study|Study drug non-compliant|5|||
125896086|NCT00486811|452919001|FG001|Overall Study|Study drug non-compliant|6|||
125896087|NCT00486811|452919002|FG002|Overall Study|Study drug non-compliant|3|||
125896088|NCT00486811|452919000|FG000|Overall Study|All other|18|||
125896089|NCT00486811|452919001|FG001|Overall Study|All other|11|||
125896090|NCT00486811|452919002|FG002|Overall Study|All other|7|||
125896091|NCT03753789|452919005|FG000|Overall Study|Withdrawal by Subject|2|||
125896092|NCT01578850|452919010|FG000|Period 1|Insufficient Clinical Response|1|||
125896093|NCT01578850|452919011|FG001|Period 1|Insufficient Clinical Response|0|||
125896094|NCT01578850|452919012|FG002|Period 1|Insufficient Clinical Response|0|||
125896095|NCT01578850|452919010|FG000|Period 1|Adverse Event|11|||
125896096|NCT01578850|452919011|FG001|Period 1|Adverse Event|0|||
125896097|NCT01578850|452919012|FG002|Period 1|Adverse Event|0|||
125896098|NCT01578850|452919010|FG000|Period 1|Death|1|||
125896099|NCT01578850|452919011|FG001|Period 1|Death|0|||
125896100|NCT01578850|452919012|FG002|Period 1|Death|0|||
125896101|NCT01578850|452919010|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
125896102|NCT01578850|452919011|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
125896103|NCT01578850|452919012|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
125896104|NCT01578850|452919010|FG000|Period 1|Withdrawal by Subject|9|||
125896105|NCT01578850|452919011|FG001|Period 1|Withdrawal by Subject|0|||
125896106|NCT01578850|452919012|FG002|Period 1|Withdrawal by Subject|0|||
125896107|NCT01578850|452919010|FG000|Period 1|Study Terminated by Sponsor|3|||
125896108|NCT01578850|452919011|FG001|Period 1|Study Terminated by Sponsor|0|||
125896109|NCT01578850|452919012|FG002|Period 1|Study Terminated by Sponsor|0|||
125896110|NCT01578850|452919010|FG000|Period 2|Insufficient Clinical Response|0|||
125896111|NCT01578850|452919011|FG001|Period 2|Insufficient Clinical Response|1|||
125896112|NCT01578850|452919012|FG002|Period 2|Insufficient Clinical Response|0|||
125896113|NCT01578850|452919010|FG000|Period 2|Adverse Event|0|||
125896114|NCT01578850|452919011|FG001|Period 2|Adverse Event|3|||
125896115|NCT01578850|452919012|FG002|Period 2|Adverse Event|6|||
125896116|NCT01578850|452919010|FG000|Period 2|Lost to Follow-up|0|||
125896117|NCT01578850|452919011|FG001|Period 2|Lost to Follow-up|1|||
125896118|NCT01578850|452919012|FG002|Period 2|Lost to Follow-up|2|||
125896119|NCT01578850|452919010|FG000|Period 2|Withdrawal by Subject|0|||
125896120|NCT01578850|452919011|FG001|Period 2|Withdrawal by Subject|2|||
125896121|NCT01578850|452919012|FG002|Period 2|Withdrawal by Subject|2|||
125896122|NCT01578850|452919010|FG000|Period 2|Study Terminated by Sponsor|0|||
125896123|NCT01578850|452919011|FG001|Period 2|Study Terminated by Sponsor|5|||
125896124|NCT01578850|452919012|FG002|Period 2|Study Terminated by Sponsor|4|||
125896125|NCT01578850|452919010|FG000|Period 2|Unspecified Reasons|0|||
125896126|NCT01578850|452919011|FG001|Period 2|Unspecified Reasons|1|||
125896127|NCT01578850|452919012|FG002|Period 2|Unspecified Reasons|0|||
125896128|NCT01711216|452919015|FG000|Overall Study|Adverse Event|4|||
125896129|NCT01711216|452919015|FG000|Overall Study|Pregnancy|56|||
125896130|NCT01711216|452919015|FG000|Overall Study|Withdrawal by Subject|6|||
125896131|NCT01711216|452919015|FG000|Overall Study|Lost to Follow-up|46|||
125896132|NCT01711216|452919015|FG000|Overall Study|variety of other minor reasons|83|||
125896133|NCT01711216|452919015|FG000|Overall Study|no reason specified|22|||
125896134|NCT02929498|452919016|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
125896135|NCT02929498|452919017|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
125896136|NCT02929498|452919018|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
125896137|NCT02929498|452919016|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
125896138|NCT02929498|452919017|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
125896139|NCT02929498|452919018|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
125896140|NCT02744040|452919019|FG000|Overall Study|Withdrawal by Subject|3|||
125896141|NCT02744040|452919020|FG001|Overall Study|Withdrawal by Subject|2|||
125896142|NCT02744040|452919021|FG002|Overall Study|Withdrawal by Subject|2|||
125896143|NCT02744040|452919019|FG000|Overall Study|Physician Decision|0|||
125896144|NCT02744040|452919020|FG001|Overall Study|Physician Decision|8|||
125896145|NCT02744040|452919021|FG002|Overall Study|Physician Decision|13|||
125896146|NCT02744040|452919019|FG000|Overall Study|Lost to Follow-up|3|||
125896147|NCT02744040|452919020|FG001|Overall Study|Lost to Follow-up|1|||
125896148|NCT02744040|452919021|FG002|Overall Study|Lost to Follow-up|7|||
125896149|NCT00096356|452919022|FG000|Overall Study|Adverse Event|11|||
125896150|NCT00096356|452919023|FG001|Overall Study|Adverse Event|9|||
125896151|NCT00096356|452919022|FG000|Overall Study|Physician Decision|5|||
125896152|NCT00096356|452919023|FG001|Overall Study|Physician Decision|3|||
125896153|NCT00096356|452919022|FG000|Overall Study|Withdrawal by Subject|17|||
125896154|NCT00096356|452919023|FG001|Overall Study|Withdrawal by Subject|23|||
125896155|NCT00096356|452919022|FG000|Overall Study|Lack of Efficacy|1|||
125896156|NCT00096356|452919023|FG001|Overall Study|Lack of Efficacy|0|||
125896157|NCT00096356|452919022|FG000|Overall Study|multiple reasons|10|||
125896158|NCT00096356|452919023|FG001|Overall Study|multiple reasons|18|||
125896159|NCT00946153|452919025|FG000|Phase 2|Adverse Event|0|||
125896160|NCT00946153|452919026|FG001|Phase 2|Adverse Event|0|||
125896161|NCT00946153|452919027|FG002|Phase 2|Adverse Event|0|||
125896162|NCT00946153|452919028|FG003|Phase 2|Adverse Event|0|||
125896163|NCT00946153|452919029|FG004|Phase 2|Adverse Event|6|||
125896164|NCT00946153|452919025|FG000|Phase 2|Need more reduction of dose|0|||
125896165|NCT00946153|452919026|FG001|Phase 2|Need more reduction of dose|0|||
125896166|NCT00946153|452919027|FG002|Phase 2|Need more reduction of dose|0|||
125896167|NCT00946153|452919028|FG003|Phase 2|Need more reduction of dose|0|||
125896168|NCT00946153|452919029|FG004|Phase 2|Need more reduction of dose|2|||
125896169|NCT00946153|452919025|FG000|Phase 2|Physician Decision|0|||
125896170|NCT00946153|452919026|FG001|Phase 2|Physician Decision|0|||
125896171|NCT00946153|452919027|FG002|Phase 2|Physician Decision|0|||
125896172|NCT00946153|452919028|FG003|Phase 2|Physician Decision|0|||
125896173|NCT00946153|452919029|FG004|Phase 2|Physician Decision|1|||
125896174|NCT00946153|452919025|FG000|Phase 2|14 days washout for recovery due to AE|0|||
125896175|NCT00946153|452919026|FG001|Phase 2|14 days washout for recovery due to AE|0|||
125896176|NCT00946153|452919027|FG002|Phase 2|14 days washout for recovery due to AE|0|||
125896177|NCT00946153|452919028|FG003|Phase 2|14 days washout for recovery due to AE|0|||
125896178|NCT00946153|452919029|FG004|Phase 2|14 days washout for recovery due to AE|4|||
125896179|NCT01030666|452919030|FG000|Overall Study|Lost to Follow-up|3|||
125896180|NCT01030666|452919031|FG001|Overall Study|Lost to Follow-up|2|||
125896181|NCT00934843|452919032|FG000|Overall Study|Protocol Violation|0|||
125896182|NCT00934843|452919033|FG001|Overall Study|Protocol Violation|1|||
125896183|NCT01144299|452919036|FG000|Overall Study|Lost to Follow-up|1|||
125896184|NCT01144299|452919037|FG001|Overall Study|Lost to Follow-up|0|||
125896185|NCT01144299|452919036|FG000|Overall Study|Withdrawal by Subject|1|||
125896186|NCT01144299|452919037|FG001|Overall Study|Withdrawal by Subject|0|||
125896187|NCT03698591|452919043|FG000|Overall Study|Withdrawal by Subject|2|||
125896188|NCT03698591|452919044|FG001|Overall Study|Withdrawal by Subject|2|||
125896189|NCT03698591|452919043|FG000|Overall Study|Failed drug screen|1|||
125896190|NCT03698591|452919044|FG001|Overall Study|Failed drug screen|1|||
125896191|NCT03698591|452919043|FG000|Overall Study|Failed health screen|0|||
125896192|NCT03698591|452919044|FG001|Overall Study|Failed health screen|1|||
125896193|NCT03698591|452919043|FG000|Overall Study|Ineligible for financial compensation|1|||
125896194|NCT03698591|452919044|FG001|Overall Study|Ineligible for financial compensation|0|||
125896195|NCT03698591|452919043|FG000|Overall Study|Equipment Error|1|||
125896196|NCT03698591|452919044|FG001|Overall Study|Equipment Error|0|||
125896197|NCT03698591|452919043|FG000|Overall Study|Could not establish TMS dosage|0|||
125896198|NCT03698591|452919044|FG001|Overall Study|Could not establish TMS dosage|1|||
125896199|NCT00831493|452919048|FG000|Overall Study|Intractable nausea and vomiting|1|||
125896200|NCT03976648|452919055|FG000|Overall Study|Adverse Event|0|||
125896201|NCT03976648|452919056|FG001|Overall Study|Adverse Event|2|||
125896202|NCT03976648|452919055|FG000|Overall Study|Study terminated by sponsor|21|||
125896203|NCT03976648|452919056|FG001|Overall Study|Study terminated by sponsor|8|||
125896204|NCT00881868|452919057|FG000|Overall Study|Adverse Event|0|||
125896205|NCT00881868|452919058|FG001|Overall Study|Adverse Event|1|||
125896206|NCT00881868|452919057|FG000|Overall Study|Lost to Follow-up|2|||
125896207|NCT00881868|452919058|FG001|Overall Study|Lost to Follow-up|1|||
125896208|NCT00881868|452919057|FG000|Overall Study|Physician Decision|4|||
125896209|NCT00881868|452919058|FG001|Overall Study|Physician Decision|0|||
125896210|NCT00881868|452919057|FG000|Overall Study|Protocol Violation|2|||
125896211|NCT00881868|452919058|FG001|Overall Study|Protocol Violation|0|||
125896212|NCT03255083|452919059|FG000|Overall Study|Clinical progression|1|||
125896213|NCT03255083|452919060|FG001|Overall Study|Clinical progression|0|||
125896214|NCT03255083|452919061|FG002|Overall Study|Clinical progression|0|||
125896215|NCT03255083|452919062|FG003|Overall Study|Clinical progression|0|||
125896216|NCT03255083|452919059|FG000|Overall Study|Adverse Event|0|||
125896217|NCT03255083|452919060|FG001|Overall Study|Adverse Event|1|||
125896218|NCT03255083|452919061|FG002|Overall Study|Adverse Event|0|||
125896219|NCT03255083|452919062|FG003|Overall Study|Adverse Event|0|||
125896220|NCT03255083|452919059|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
125896221|NCT03255083|452919060|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
125896222|NCT03255083|452919061|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
125896223|NCT03255083|452919062|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
125896224|NCT03255083|452919059|FG000|Overall Study|Withdrawal by Subject|1|||
125896225|NCT03255083|452919060|FG001|Overall Study|Withdrawal by Subject|1|||
125896226|NCT03255083|452919061|FG002|Overall Study|Withdrawal by Subject|1|||
125896227|NCT03255083|452919062|FG003|Overall Study|Withdrawal by Subject|0|||
125896228|NCT01981551|452919063|FG000|Overall Study|Refused further treatment|8|||
125896229|NCT01981551|452919063|FG000|Overall Study|Adverse Event|1|||
125896230|NCT01794338|452920606|FG000|Overall Study|Death|2|||
125896231|NCT01794338|452920607|FG001|Overall Study|Death|0|||
125896232|NCT01794338|452920606|FG000|Overall Study|Lost to Follow-up|6|||
125896233|NCT01794338|452920607|FG001|Overall Study|Lost to Follow-up|9|||
125896234|NCT00535288|452920608|FG000|Overall Study|Adverse Event|20|||
125896235|NCT00535288|452920609|FG001|Overall Study|Adverse Event|19|||
125896236|NCT00535288|452920610|FG002|Overall Study|Adverse Event|25|||
125896237|NCT00535288|452920611|FG003|Overall Study|Adverse Event|20|||
125896238|NCT00535288|452920612|FG004|Overall Study|Adverse Event|30|||
125896239|NCT00535288|452920608|FG000|Overall Study|Lost to Follow-up|0|||
125896240|NCT00535288|452920609|FG001|Overall Study|Lost to Follow-up|3|||
125896241|NCT00535288|452920610|FG002|Overall Study|Lost to Follow-up|0|||
125896242|NCT00535288|452920611|FG003|Overall Study|Lost to Follow-up|0|||
125896243|NCT00535288|452920612|FG004|Overall Study|Lost to Follow-up|0|||
125896244|NCT00535288|452920608|FG000|Overall Study|Lack of Efficacy|26|||
125896245|NCT00535288|452920609|FG001|Overall Study|Lack of Efficacy|3|||
125896246|NCT00535288|452920610|FG002|Overall Study|Lack of Efficacy|4|||
125896247|NCT00535288|452920611|FG003|Overall Study|Lack of Efficacy|4|||
125896248|NCT00535288|452920612|FG004|Overall Study|Lack of Efficacy|7|||
125896249|NCT00535288|452920608|FG000|Overall Study|Unwilling to cooperate|6|||
125896250|NCT00535288|452920609|FG001|Overall Study|Unwilling to cooperate|6|||
125896251|NCT00535288|452920610|FG002|Overall Study|Unwilling to cooperate|3|||
125896252|NCT00535288|452920611|FG003|Overall Study|Unwilling to cooperate|3|||
125896253|NCT00535288|452920612|FG004|Overall Study|Unwilling to cooperate|4|||
125896254|NCT00535288|452920608|FG000|Overall Study|Other|2|||
125896255|NCT00535288|452920609|FG001|Overall Study|Other|1|||
125896256|NCT00535288|452920610|FG002|Overall Study|Other|1|||
125896257|NCT00535288|452920611|FG003|Overall Study|Other|2|||
125896258|NCT00535288|452920612|FG004|Overall Study|Other|1|||
125896259|NCT00830869|452920614|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
125896260|NCT00830869|452920615|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
125896261|NCT00830869|452920616|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
125896262|NCT00830869|452920617|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
125896263|NCT00830869|452920618|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
125896264|NCT00830869|452920619|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
125896265|NCT00830869|452920620|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
125896266|NCT00830869|452920621|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
125896267|NCT00830869|452920622|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
125896268|NCT00830869|452920623|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
125896269|NCT00830869|452920624|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
125896270|NCT00830869|452920625|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
125896271|NCT00830869|452920614|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
125896272|NCT00830869|452920615|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
125896273|NCT00830869|452920616|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
125896274|NCT00830869|452920617|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
125896275|NCT00830869|452920618|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
125896276|NCT00830869|452920619|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
125896277|NCT00830869|452920620|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
125896278|NCT00830869|452920621|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
125896279|NCT00830869|452920622|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
125896280|NCT00830869|452920623|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
125896281|NCT00830869|452920624|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
125896282|NCT00830869|452920625|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
125896283|NCT00830869|452920614|FG000|Period 1: Part 1|Adverse Event|0|||
125896284|NCT00830869|452920615|FG001|Period 1: Part 1|Adverse Event|0|||
125896285|NCT00830869|452920616|FG002|Period 1: Part 1|Adverse Event|0|||
125896286|NCT00830869|452920617|FG003|Period 1: Part 1|Adverse Event|0|||
125896287|NCT00830869|452920618|FG004|Period 1: Part 1|Adverse Event|0|||
125896288|NCT00830869|452920619|FG005|Period 1: Part 1|Adverse Event|1|||
125896289|NCT00830869|452920620|FG006|Period 1: Part 1|Adverse Event|1|||
125896290|NCT00830869|452920621|FG007|Period 1: Part 1|Adverse Event|0|||
125896291|NCT00830869|452920622|FG008|Period 1: Part 1|Adverse Event|0|||
125896292|NCT00830869|452920623|FG009|Period 1: Part 1|Adverse Event|0|||
125896293|NCT00830869|452920624|FG010|Period 1: Part 1|Adverse Event|0|||
125896294|NCT00830869|452920625|FG011|Period 1: Part 1|Adverse Event|0|||
125896295|NCT00830869|452920614|FG000|Period 1: Part 1|Progressive disease|1|||
125896296|NCT00830869|452920615|FG001|Period 1: Part 1|Progressive disease|0|||
125896297|NCT00830869|452920616|FG002|Period 1: Part 1|Progressive disease|1|||
125896298|NCT00830869|452920617|FG003|Period 1: Part 1|Progressive disease|6|||
125896299|NCT00830869|452920618|FG004|Period 1: Part 1|Progressive disease|4|||
125896300|NCT00830869|452920619|FG005|Period 1: Part 1|Progressive disease|4|||
125896301|NCT00830869|452920620|FG006|Period 1: Part 1|Progressive disease|1|||
125896302|NCT00830869|452920621|FG007|Period 1: Part 1|Progressive disease|0|||
125896303|NCT00830869|452920622|FG008|Period 1: Part 1|Progressive disease|0|||
125896304|NCT00830869|452920623|FG009|Period 1: Part 1|Progressive disease|0|||
125896305|NCT00830869|452920624|FG010|Period 1: Part 1|Progressive disease|0|||
125896306|NCT00830869|452920625|FG011|Period 1: Part 1|Progressive disease|0|||
125896307|NCT00830869|452920614|FG000|Period 2: Part 2|Protocol Violation|0|||
125896308|NCT00830869|452920615|FG001|Period 2: Part 2|Protocol Violation|0|||
125896309|NCT00830869|452920616|FG002|Period 2: Part 2|Protocol Violation|0|||
125896310|NCT00830869|452920617|FG003|Period 2: Part 2|Protocol Violation|0|||
125896311|NCT00830869|452920618|FG004|Period 2: Part 2|Protocol Violation|0|||
125896312|NCT00830869|452920619|FG005|Period 2: Part 2|Protocol Violation|0|||
125896313|NCT00830869|452920620|FG006|Period 2: Part 2|Protocol Violation|0|||
125896314|NCT00830869|452920621|FG007|Period 2: Part 2|Protocol Violation|1|||
125896315|NCT00830869|452920622|FG008|Period 2: Part 2|Protocol Violation|0|||
125896316|NCT00830869|452920623|FG009|Period 2: Part 2|Protocol Violation|1|||
125896317|NCT00830869|452920624|FG010|Period 2: Part 2|Protocol Violation|0|||
125896318|NCT00830869|452920625|FG011|Period 2: Part 2|Protocol Violation|0|||
125896319|NCT00830869|452920614|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
125896320|NCT00830869|452920615|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
125896321|NCT00830869|452920616|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
125896322|NCT00830869|452920617|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
125896323|NCT00830869|452920618|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
125896324|NCT00830869|452920619|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
125896325|NCT00830869|452920620|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
125896326|NCT00830869|452920621|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
125896327|NCT00830869|452920622|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
125896328|NCT00830869|452920623|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
125896329|NCT00830869|452920624|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
125896330|NCT00830869|452920625|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
125896331|NCT00830869|452920614|FG000|Period 2: Part 2|Adverse Event|0|||
125896332|NCT00830869|452920615|FG001|Period 2: Part 2|Adverse Event|0|||
125896333|NCT00830869|452920616|FG002|Period 2: Part 2|Adverse Event|0|||
125896334|NCT00830869|452920617|FG003|Period 2: Part 2|Adverse Event|0|||
125896335|NCT00830869|452920618|FG004|Period 2: Part 2|Adverse Event|0|||
125896336|NCT00830869|452920619|FG005|Period 2: Part 2|Adverse Event|0|||
125896337|NCT00830869|452920620|FG006|Period 2: Part 2|Adverse Event|0|||
125896338|NCT00830869|452920621|FG007|Period 2: Part 2|Adverse Event|4|||
125896339|NCT00830869|452920622|FG008|Period 2: Part 2|Adverse Event|3|||
125896340|NCT00830869|452920623|FG009|Period 2: Part 2|Adverse Event|2|||
125896341|NCT00830869|452920624|FG010|Period 2: Part 2|Adverse Event|2|||
125896342|NCT00830869|452920625|FG011|Period 2: Part 2|Adverse Event|0|||
125896343|NCT00830869|452920614|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
125896344|NCT00830869|452920615|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
125896345|NCT00830869|452920616|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
125896346|NCT00830869|452920617|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
125896347|NCT00830869|452920618|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
125896348|NCT00830869|452920619|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
125896349|NCT00830869|452920620|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
125896350|NCT00830869|452920621|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
125896351|NCT00830869|452920622|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
125896352|NCT00830869|452920623|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
125896353|NCT00830869|452920624|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
125896354|NCT00830869|452920625|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
125896355|NCT00830869|452920614|FG000|Period 2: Part 2|Progressive disease|0|||
125896356|NCT00830869|452920615|FG001|Period 2: Part 2|Progressive disease|0|||
125896357|NCT00830869|452920616|FG002|Period 2: Part 2|Progressive disease|0|||
125896358|NCT00830869|452920617|FG003|Period 2: Part 2|Progressive disease|0|||
125896359|NCT00830869|452920618|FG004|Period 2: Part 2|Progressive disease|0|||
125896360|NCT00830869|452920619|FG005|Period 2: Part 2|Progressive disease|0|||
125896361|NCT00830869|452920620|FG006|Period 2: Part 2|Progressive disease|0|||
125896362|NCT00830869|452920621|FG007|Period 2: Part 2|Progressive disease|14|||
125896363|NCT00830869|452920622|FG008|Period 2: Part 2|Progressive disease|11|||
125896364|NCT00830869|452920623|FG009|Period 2: Part 2|Progressive disease|12|||
125896365|NCT00830869|452920624|FG010|Period 2: Part 2|Progressive disease|8|||
125896366|NCT00830869|452920625|FG011|Period 2: Part 2|Progressive disease|15|||
125896367|NCT00830869|452920614|FG000|Period 2: Part 2|Other|0|||
125896368|NCT00830869|452920615|FG001|Period 2: Part 2|Other|0|||
125896369|NCT00830869|452920616|FG002|Period 2: Part 2|Other|0|||
125896370|NCT00830869|452920617|FG003|Period 2: Part 2|Other|0|||
125896371|NCT00830869|452920618|FG004|Period 2: Part 2|Other|0|||
125896372|NCT00830869|452920619|FG005|Period 2: Part 2|Other|0|||
125896373|NCT00830869|452920620|FG006|Period 2: Part 2|Other|0|||
125896374|NCT00830869|452920621|FG007|Period 2: Part 2|Other|0|||
125896375|NCT00830869|452920622|FG008|Period 2: Part 2|Other|0|||
125896376|NCT00830869|452920623|FG009|Period 2: Part 2|Other|1|||
125896377|NCT00830869|452920624|FG010|Period 2: Part 2|Other|0|||
125896378|NCT00830869|452920625|FG011|Period 2: Part 2|Other|0|||
125896379|NCT00617669|452920626|FG000|Overall Study|Withdrawal by Subject|71|||
125896380|NCT00617669|452920627|FG001|Overall Study|Withdrawal by Subject|77|||
125896381|NCT00617669|452920626|FG000|Overall Study|Lost to Follow-up|3|||
125896382|NCT00617669|452920627|FG001|Overall Study|Lost to Follow-up|2|||
125896383|NCT00617669|452920626|FG000|Overall Study|Adverse Event|87|||
125896384|NCT00617669|452920627|FG001|Overall Study|Adverse Event|76|||
125896385|NCT00617669|452920626|FG000|Overall Study|Protocol Violation|2|||
125896386|NCT00617669|452920627|FG001|Overall Study|Protocol Violation|3|||
125896387|NCT00617669|452920626|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
125896388|NCT00617669|452920627|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
125896389|NCT00617669|452920626|FG000|Overall Study|Patients randomized but not treated|2|||
125896390|NCT00617669|452920627|FG001|Overall Study|Patients randomized but not treated|3|||
125896391|NCT03745820|452920628|FG000|Overall Study|Adverse Event|0|||
125896392|NCT03745820|452920629|FG001|Overall Study|Adverse Event|3|||
125896393|NCT03745820|452920630|FG002|Overall Study|Adverse Event|2|||
125896394|NCT03745820|452920628|FG000|Overall Study|Non-Compliance with Study Drug|4|||
125896395|NCT03745820|452920629|FG001|Overall Study|Non-Compliance with Study Drug|3|||
125896396|NCT03745820|452920630|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125896397|NCT03745820|452920628|FG000|Overall Study|Withdrawal by Subject|4|||
125896398|NCT03745820|452920629|FG001|Overall Study|Withdrawal by Subject|4|||
125896399|NCT03745820|452920630|FG002|Overall Study|Withdrawal by Subject|4|||
125896400|NCT03745820|452920628|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
125896401|NCT03745820|452920629|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
125896402|NCT03745820|452920630|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
125896403|NCT03745820|452920628|FG000|Overall Study|Lost to Follow-up|2|||
125896404|NCT03745820|452920629|FG001|Overall Study|Lost to Follow-up|0|||
125896405|NCT03745820|452920630|FG002|Overall Study|Lost to Follow-up|3|||
125896406|NCT03745820|452920628|FG000|Overall Study|Reason not Specified|2|||
125896407|NCT03745820|452920629|FG001|Overall Study|Reason not Specified|4|||
125896408|NCT03745820|452920630|FG002|Overall Study|Reason not Specified|1|||
125896409|NCT03680742|452920631|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
125896410|NCT02894502|452920634|FG000|Baseline|Withdrawal by Subject|24|||
125896411|NCT02894502|452920635|FG001|Baseline|Withdrawal by Subject|31|||
125896412|NCT02894502|452920636|FG002|Baseline|Withdrawal by Subject|36|||
125896413|NCT02894502|452920634|FG000|Baseline|Death|3|||
125896414|NCT02894502|452920635|FG001|Baseline|Death|1|||
125896415|NCT02894502|452920636|FG002|Baseline|Death|9|||
125896416|NCT02894502|452920634|FG000|First Follow up|Withdrawal by Subject|32|||
125896417|NCT02894502|452920635|FG001|First Follow up|Withdrawal by Subject|29|||
125896418|NCT02894502|452920636|FG002|First Follow up|Withdrawal by Subject|37|||
126110034|NCT00985166|453697622|FG001|Overall Study|Other|0|||
126110035|NCT00985166|453697623|FG002|Overall Study|Other|1|||
126110036|NCT01028222|453697624|FG000|Overall Study|Protocol deviation|1|||
126110037|NCT01028222|453697625|FG001|Overall Study|Protocol deviation|0|||
126110038|NCT01028222|453697624|FG000|Overall Study|Disease progression|33|||
126110039|NCT01028222|453697625|FG001|Overall Study|Disease progression|9|||
125896419|NCT02894502|452920634|FG000|First Follow up|Death|2|||
125896420|NCT02894502|452920635|FG001|First Follow up|Death|2|||
125896421|NCT02894502|452920636|FG002|First Follow up|Death|3|||
125896422|NCT02894502|452920634|FG000|Second Follow up|Withdrawal by Subject|13|||
125896423|NCT02894502|452920635|FG001|Second Follow up|Withdrawal by Subject|15|||
125896424|NCT02894502|452920636|FG002|Second Follow up|Withdrawal by Subject|13|||
125896425|NCT02894502|452920634|FG000|Second Follow up|Death|2|||
125896426|NCT02894502|452920635|FG001|Second Follow up|Death|3|||
125896427|NCT02894502|452920636|FG002|Second Follow up|Death|1|||
125896428|NCT02894502|452920634|FG000|Third Follow up|Withdrawal by Subject|5|||
125896429|NCT02894502|452920635|FG001|Third Follow up|Withdrawal by Subject|6|||
125896430|NCT02894502|452920636|FG002|Third Follow up|Withdrawal by Subject|3|||
125896431|NCT02894502|452920634|FG000|Third Follow up|Death|1|||
125896432|NCT02894502|452920635|FG001|Third Follow up|Death|1|||
125896433|NCT02894502|452920636|FG002|Third Follow up|Death|0|||
125896434|NCT01410357|452920637|FG000|Overall Study|Death|2|||
125896435|NCT01410357|452920638|FG001|Overall Study|Death|1|||
125896436|NCT01410357|452920637|FG000|Overall Study|Withdrawal by Subject|1|||
125896437|NCT01410357|452920638|FG001|Overall Study|Withdrawal by Subject|2|||
125896438|NCT01410357|452920637|FG000|Overall Study|Lost to Follow-up|23|||
125896439|NCT01410357|452920638|FG001|Overall Study|Lost to Follow-up|21|||
125896440|NCT00615901|452920639|FG000|Overall Study|Withdrawal by Subject|2|||
125896441|NCT00615901|452920639|FG000|Overall Study|Adverse Event|7|||
126110040|NCT01028222|453697624|FG000|Overall Study|Administrative problems|1|||
125896442|NCT03598114|452920640|FG000|Overall Study|Staff turnover/left the program|3|||
125896443|NCT03598114|452920641|FG001|Overall Study|Staff turnover/left the program|39|||
125896444|NCT01589653|452920645|FG000|Overall Study|Protocol Violation|3|||
125896445|NCT01589653|452920646|FG001|Overall Study|Protocol Violation|1|||
125896446|NCT01589653|452920645|FG000|Overall Study|Withdrawal criteria|4|||
125896447|NCT01589653|452920646|FG001|Overall Study|Withdrawal criteria|7|||
125896448|NCT01589653|452920645|FG000|Overall Study|Unclassified|0|||
125896449|NCT01589653|452920646|FG001|Overall Study|Unclassified|3|||
125896450|NCT00668733|452920647|FG000|Overall Study|Lost to Follow-up|2|||
125896451|NCT00668733|452920648|FG001|Overall Study|Lost to Follow-up|3|||
125896452|NCT00668733|452920647|FG000|Overall Study|Withdrawal by Subject|0|||
125896453|NCT00668733|452920648|FG001|Overall Study|Withdrawal by Subject|4|||
125896454|NCT00945906|452920651|FG000|Overall Study|Withdrawal by Subject|1|||
125896455|NCT00945906|452920651|FG000|Overall Study|Did not want to return for last visit|2|||
125896456|NCT00945906|452920651|FG000|Overall Study|Unable to return for last visit|2|||
125896457|NCT00945906|452920651|FG000|Overall Study|Moved to another country|2|||
125896458|NCT04250077|452920653|FG000|Overall Study|Withdrawal by Subject|0|||
125896459|NCT04250077|452920654|FG001|Overall Study|Withdrawal by Subject|1|||
125896460|NCT04250077|452920655|FG002|Overall Study|Withdrawal by Subject|0|||
125896461|NCT04250077|452920653|FG000|Overall Study|Lost to Follow-up|2|||
125896462|NCT04250077|452920654|FG001|Overall Study|Lost to Follow-up|3|||
125896463|NCT04250077|452920655|FG002|Overall Study|Lost to Follow-up|0|||
125896464|NCT01883453|452920656|FG000|Overall Study|No episode of common cold|25|||
125896465|NCT01883453|452920657|FG001|Overall Study|No episode of common cold|23|||
125896466|NCT00647270|452920658|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
125896467|NCT00647270|452920659|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
125896468|NCT00647270|452920660|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
125896469|NCT00647270|452920658|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
125896470|NCT00647270|452920659|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
125896471|NCT00647270|452920660|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
125896472|NCT00647270|452920658|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
125896473|NCT00647270|452920659|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
125896474|NCT00647270|452920660|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
125896475|NCT00647270|452920658|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
125896476|NCT00647270|452920659|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
125896477|NCT00647270|452920660|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
125896478|NCT00647270|452920658|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
125896479|NCT00647270|452920659|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
125896480|NCT00647270|452920660|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
125896481|NCT00647270|452920658|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
125896482|NCT00647270|452920659|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
125896483|NCT00647270|452920660|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
125896484|NCT00647270|452920658|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
125896485|NCT00647270|452920659|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
125896486|NCT00647270|452920660|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
125896487|NCT03337490|452920661|FG000|Overall Study|Withdrawal by Subject|1|||
125896488|NCT03337490|452920662|FG001|Overall Study|Withdrawal by Subject|0|||
125896489|NCT03337490|452920663|FG002|Overall Study|Withdrawal by Subject|0|||
125896490|NCT03337490|452920661|FG000|Overall Study|Lack of Efficacy|10|||
125896491|NCT03337490|452920662|FG001|Overall Study|Lack of Efficacy|12|||
125896492|NCT03337490|452920663|FG002|Overall Study|Lack of Efficacy|35|||
125896493|NCT03337490|452920661|FG000|Overall Study|Physician Decision|0|||
125896494|NCT03337490|452920662|FG001|Overall Study|Physician Decision|1|||
125896495|NCT03337490|452920663|FG002|Overall Study|Physician Decision|0|||
125896496|NCT03337490|452920661|FG000|Overall Study|Lost to Follow-up|0|||
125896497|NCT03337490|452920662|FG001|Overall Study|Lost to Follow-up|1|||
125896498|NCT03337490|452920663|FG002|Overall Study|Lost to Follow-up|0|||
125896499|NCT00233454|452920664|FG000|Overall Study|Death|6|||
125896500|NCT02366091|452920665|FG000|Overall Study|Withdrawal by Subject|3|||
125896501|NCT02366091|452920666|FG001|Overall Study|Withdrawal by Subject|7|||
125896502|NCT02366091|452920667|FG002|Overall Study|Withdrawal by Subject|3|||
125896503|NCT02366091|452920668|FG003|Overall Study|Withdrawal by Subject|1|||
125896504|NCT01155011|452920669|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
125896505|NCT01155011|452920670|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
125896506|NCT01155011|452920669|FG000|Baseline to 6 Months|investigator decision, moved|4|||
125896507|NCT01155011|452920670|FG001|Baseline to 6 Months|investigator decision, moved|5|||
125896508|NCT01155011|452920669|FG000|Baseline to 6 Months|Death|0|||
125896509|NCT01155011|452920670|FG001|Baseline to 6 Months|Death|1|||
125896510|NCT01155011|452920669|FG000|6 to 12 Months|Withdrawal by Subject|8|||
125896511|NCT01155011|452920670|FG001|6 to 12 Months|Withdrawal by Subject|5|||
125896512|NCT01155011|452920669|FG000|6 to 12 Months|Death|1|||
125896513|NCT01155011|452920670|FG001|6 to 12 Months|Death|5|||
125896514|NCT01743001|452920671|FG000|Overall Study|Physician Decision|1|||
125896515|NCT01743001|452920672|FG001|Overall Study|Physician Decision|0|||
125896516|NCT01743001|452920671|FG000|Overall Study|Pregnancy|1|||
125896517|NCT01743001|452920672|FG001|Overall Study|Pregnancy|0|||
125896518|NCT01743001|452920671|FG000|Overall Study|Death|1|||
125896519|NCT01743001|452920672|FG001|Overall Study|Death|0|||
125896520|NCT01565343|452920673|FG000|Overall Study|Administrative decision/technical issues|1|||
125896521|NCT01565343|452920674|FG001|Overall Study|Administrative decision/technical issues|0|||
125896522|NCT01565343|452920675|FG002|Overall Study|Administrative decision/technical issues|0|||
125896523|NCT01853839|452920681|FG000|Overall Study|Violated inclusion criteria|2|||
125896524|NCT01853839|452920681|FG000|Overall Study|Not meet ITT population definition|58|||
125896525|NCT01853839|452920681|FG000|Overall Study|End of treatment visit too early|33|||
125896526|NCT01853839|452920681|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
125896527|NCT02709538|452920682|FG000|Overall Study|Adverse Event|13|||
125896528|NCT02709538|452920683|FG001|Overall Study|Adverse Event|2|||
125896529|NCT02709538|452920684|FG002|Overall Study|Adverse Event|3|||
125896530|NCT02709538|452920682|FG000|Overall Study|Lack of Efficacy|1|||
125896531|NCT02709538|452920683|FG001|Overall Study|Lack of Efficacy|0|||
125896532|NCT02709538|452920684|FG002|Overall Study|Lack of Efficacy|0|||
125896533|NCT02709538|452920682|FG000|Overall Study|Lost to Follow-up|24|||
125896534|NCT02709538|452920683|FG001|Overall Study|Lost to Follow-up|8|||
125896535|NCT02709538|452920684|FG002|Overall Study|Lost to Follow-up|4|||
125896536|NCT02709538|452920682|FG000|Overall Study|Physician Decision|1|||
125896537|NCT02709538|452920683|FG001|Overall Study|Physician Decision|0|||
125896538|NCT02709538|452920684|FG002|Overall Study|Physician Decision|0|||
125896539|NCT02709538|452920682|FG000|Overall Study|Withdrawal by Subject|40|||
125896540|NCT02709538|452920683|FG001|Overall Study|Withdrawal by Subject|7|||
125896541|NCT02709538|452920684|FG002|Overall Study|Withdrawal by Subject|4|||
125896542|NCT02709538|452920682|FG000|Overall Study|Non-compliance with study procedures|5|||
125896543|NCT02709538|452920683|FG001|Overall Study|Non-compliance with study procedures|0|||
125896544|NCT02709538|452920684|FG002|Overall Study|Non-compliance with study procedures|0|||
125896545|NCT02709538|452920682|FG000|Overall Study|Non-compliance with study drug|2|||
125896546|NCT02709538|452920683|FG001|Overall Study|Non-compliance with study drug|0|||
125896547|NCT02709538|452920684|FG002|Overall Study|Non-compliance with study drug|0|||
125896548|NCT02709538|452920682|FG000|Overall Study|Protocol deviation|10|||
125896549|NCT02709538|452920683|FG001|Overall Study|Protocol deviation|4|||
125896550|NCT02709538|452920684|FG002|Overall Study|Protocol deviation|4|||
125896551|NCT02709538|452920682|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
125896552|NCT02709538|452920683|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
125896553|NCT02709538|452920684|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
125896554|NCT02709538|452920682|FG000|Overall Study|Other|16|||
125896555|NCT02709538|452920683|FG001|Overall Study|Other|7|||
125896556|NCT02709538|452920684|FG002|Overall Study|Other|5|||
125896557|NCT00835211|452920685|FG000|First Intervention|Withdrawal by Subject|0|||
125896558|NCT00835211|452920686|FG001|First Intervention|Withdrawal by Subject|1|||
125896559|NCT00835211|452920685|FG000|Washout: 7 Days|Adverse Event|2|||
125896560|NCT00835211|452920686|FG001|Washout: 7 Days|Adverse Event|1|||
125896561|NCT00835211|452920685|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125896562|NCT00835211|452920686|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125896563|NCT02160041|452920687|FG000|Overall Study|Adverse Event|11|||
125896564|NCT02160041|452920687|FG000|Overall Study|Death|2|||
125896565|NCT02160041|452920687|FG000|Overall Study|disease progression|57|||
125896566|NCT02160041|452920687|FG000|Overall Study|Protocol Violation|1|||
125896567|NCT02160041|452920687|FG000|Overall Study|non-compliance with study|1|||
125896568|NCT02160041|452920687|FG000|Overall Study|Physician Decision|3|||
125896569|NCT02160041|452920687|FG000|Overall Study|Withdrawal by Subject|8|||
125896570|NCT02160041|452920687|FG000|Overall Study|study terminated by by sponsor|1|||
125896571|NCT01403948|452920688|FG000|Overall Study|Progressive disease|0|||
125896572|NCT01403948|452920689|FG001|Overall Study|Progressive disease|2|||
125896573|NCT01403948|452920690|FG002|Overall Study|Progressive disease|2|||
125896574|NCT01403948|452920691|FG003|Overall Study|Progressive disease|4|||
125896575|NCT01403948|452920692|FG004|Overall Study|Progressive disease|2|||
125896576|NCT01403948|452920693|FG005|Overall Study|Progressive disease|6|||
125896577|NCT01403948|452920694|FG006|Overall Study|Progressive disease|2|||
125896578|NCT01403948|452920695|FG007|Overall Study|Progressive disease|4|||
125896579|NCT01403948|452920696|FG008|Overall Study|Progressive disease|5|||
125896580|NCT01403948|452920697|FG009|Overall Study|Progressive disease|5|||
125896581|NCT01403948|452920688|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
125896582|NCT01403948|452920689|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
125896583|NCT01403948|452920690|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
125896584|NCT01403948|452920691|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
125896585|NCT01403948|452920692|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
125896586|NCT01403948|452920693|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
125896587|NCT01403948|452920694|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
125896588|NCT01403948|452920695|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
125896589|NCT01403948|452920696|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
125896590|NCT01403948|452920697|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
125896591|NCT01403948|452920688|FG000|Overall Study|Lost to Follow-up|0|||
125896592|NCT01403948|452920689|FG001|Overall Study|Lost to Follow-up|0|||
125896593|NCT01403948|452920690|FG002|Overall Study|Lost to Follow-up|0|||
125896594|NCT01403948|452920691|FG003|Overall Study|Lost to Follow-up|0|||
125896595|NCT01403948|452920692|FG004|Overall Study|Lost to Follow-up|0|||
125896596|NCT01403948|452920693|FG005|Overall Study|Lost to Follow-up|0|||
125896597|NCT01403948|452920694|FG006|Overall Study|Lost to Follow-up|0|||
125896598|NCT01403948|452920695|FG007|Overall Study|Lost to Follow-up|0|||
125896599|NCT01403948|452920696|FG008|Overall Study|Lost to Follow-up|0|||
125896600|NCT01403948|452920697|FG009|Overall Study|Lost to Follow-up|1|||
125896601|NCT01403948|452920688|FG000|Overall Study|Refused cont. medication|0|||
125896602|NCT01403948|452920689|FG001|Overall Study|Refused cont. medication|0|||
125896603|NCT01403948|452920690|FG002|Overall Study|Refused cont. medication|0|||
125896604|NCT01403948|452920691|FG003|Overall Study|Refused cont. medication|0|||
125896605|NCT01403948|452920692|FG004|Overall Study|Refused cont. medication|1|||
125896606|NCT01403948|452920693|FG005|Overall Study|Refused cont. medication|0|||
125896607|NCT01403948|452920694|FG006|Overall Study|Refused cont. medication|0|||
125896608|NCT01403948|452920695|FG007|Overall Study|Refused cont. medication|0|||
125896609|NCT01403948|452920696|FG008|Overall Study|Refused cont. medication|0|||
125896610|NCT01403948|452920697|FG009|Overall Study|Refused cont. medication|1|||
125896611|NCT01403948|452920688|FG000|Overall Study|other than above|1|||
125896612|NCT01403948|452920689|FG001|Overall Study|other than above|2|||
125896613|NCT01403948|452920690|FG002|Overall Study|other than above|1|||
125896614|NCT01403948|452920691|FG003|Overall Study|other than above|0|||
125896615|NCT01403948|452920692|FG004|Overall Study|other than above|1|||
125896616|NCT01403948|452920693|FG005|Overall Study|other than above|1|||
125896617|NCT01403948|452920694|FG006|Overall Study|other than above|2|||
125896618|NCT01403948|452920695|FG007|Overall Study|other than above|0|||
125896619|NCT01403948|452920696|FG008|Overall Study|other than above|0|||
125896620|NCT01403948|452920697|FG009|Overall Study|other than above|0|||
125896621|NCT05498701|452920698|FG000|Period 3|Adverse Event|1|||
125896622|NCT05498701|452920699|FG001|Period 3|Adverse Event|0|||
125896623|NCT00006409|452920703|FG000|Baseline|Protocol Violation|48|||
125896624|NCT00006409|452920704|FG001|Baseline|Protocol Violation|70|||
125896625|NCT00006409|452920705|FG002|Baseline|Protocol Violation|0|||
125896626|NCT00006409|452920706|FG003|Baseline|Protocol Violation|0|||
125896627|NCT00006409|452920707|FG004|Baseline|Protocol Violation|0|||
125896628|NCT00006409|452920708|FG005|Baseline|Protocol Violation|0|||
125896629|NCT00006409|452920703|FG000|Post-2 Year Intervention|Protocol Violation|0|||
125896630|NCT00006409|452920704|FG001|Post-2 Year Intervention|Protocol Violation|0|||
125896631|NCT00006409|452920705|FG002|Post-2 Year Intervention|Protocol Violation|251|||
125896632|NCT00006409|452920706|FG003|Post-2 Year Intervention|Protocol Violation|168|||
125896633|NCT00006409|452920707|FG004|Post-2 Year Intervention|Protocol Violation|0|||
125896634|NCT00006409|452920708|FG005|Post-2 Year Intervention|Protocol Violation|0|||
125896635|NCT00006409|452920703|FG000|Post-3 Year Intervention|Protocol Violation|0|||
125896636|NCT00006409|452920704|FG001|Post-3 Year Intervention|Protocol Violation|0|||
125896637|NCT00006409|452920705|FG002|Post-3 Year Intervention|Protocol Violation|0|||
125896638|NCT00006409|452920706|FG003|Post-3 Year Intervention|Protocol Violation|0|||
125896639|NCT00006409|452920707|FG004|Post-3 Year Intervention|Protocol Violation|62|||
125896640|NCT00006409|452920708|FG005|Post-3 Year Intervention|Protocol Violation|62|||
125896641|NCT00638183|452920709|FG000|Overall Study|Adverse Event|23|||
125896642|NCT00638183|452920709|FG000|Overall Study|Lack of Efficacy|14|||
125896643|NCT00638183|452920709|FG000|Overall Study|Physician Decision|9|||
125896644|NCT00638183|452920709|FG000|Overall Study|Lost to Follow-up|46|||
125896645|NCT00638183|452920709|FG000|Overall Study|Other reason not defined above|27|||
125896646|NCT02350764|452920710|FG000|Overall Study|Adverse Event|4|||
125896647|NCT02350764|452920710|FG000|Overall Study|Death|3|||
125896648|NCT02350764|452920710|FG000|Overall Study|Physician Decision|2|||
125896649|NCT02350764|452920710|FG000|Overall Study|Withdrawal by Subject|2|||
125896650|NCT03531632|452920711|FG000|Overall Study|Adverse Event|0|||
125896651|NCT03531632|452920712|FG001|Overall Study|Adverse Event|0|||
125896652|NCT03531632|452920713|FG002|Overall Study|Adverse Event|1|||
125896653|NCT03531632|452920711|FG000|Overall Study|Death|4|||
125896654|NCT03531632|452920712|FG001|Overall Study|Death|0|||
125896655|NCT03531632|452920713|FG002|Overall Study|Death|14|||
125896656|NCT03531632|452920711|FG000|Overall Study|Study Terminated|1|||
125896657|NCT03531632|452920712|FG001|Overall Study|Study Terminated|3|||
125896658|NCT03531632|452920713|FG002|Overall Study|Study Terminated|11|||
125896659|NCT00600119|452920714|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
125896660|NCT00600119|452920715|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
125896661|NCT00600119|452920716|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
125896662|NCT00600119|452920717|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
125896663|NCT00600119|452920718|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
125896664|NCT00600119|452920719|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
125896665|NCT00600119|452920714|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125896666|NCT00600119|452920715|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
125896667|NCT00600119|452920716|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
125896668|NCT00600119|452920717|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125896669|NCT00600119|452920718|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125896670|NCT00600119|452920719|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125896671|NCT00600119|452920714|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
125896672|NCT00600119|452920715|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
125896673|NCT00600119|452920716|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
125896674|NCT00600119|452920717|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
125896675|NCT00600119|452920718|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
125896676|NCT00600119|452920719|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
125896677|NCT00600119|452920714|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
125896678|NCT00600119|452920715|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125896679|NCT00600119|452920716|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125896680|NCT00600119|452920717|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125896681|NCT00600119|452920718|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125896682|NCT00600119|452920719|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125896683|NCT00600119|452920714|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
125896684|NCT00600119|452920715|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
125896685|NCT00600119|452920716|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
125896686|NCT00600119|452920717|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
125896687|NCT00600119|452920718|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
125896688|NCT00600119|452920719|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
125896689|NCT00600119|452920714|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
125896690|NCT00600119|452920715|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
125896691|NCT00600119|452920716|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125896692|NCT00600119|452920717|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125896693|NCT00600119|452920718|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125896694|NCT00600119|452920719|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125896695|NCT00600119|452920714|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
125896696|NCT00600119|452920715|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125896697|NCT00600119|452920716|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125896698|NCT00600119|452920717|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
125896699|NCT00600119|452920718|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
125896700|NCT00600119|452920719|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
125896701|NCT00600119|452920714|FG000|Double-blind Treatment Period|Other|0|||
125896702|NCT00600119|452920715|FG001|Double-blind Treatment Period|Other|0|||
125896703|NCT00600119|452920716|FG002|Double-blind Treatment Period|Other|0|||
125896704|NCT00600119|452920717|FG003|Double-blind Treatment Period|Other|0|||
125896705|NCT00600119|452920718|FG004|Double-blind Treatment Period|Other|2|||
125896706|NCT00600119|452920719|FG005|Double-blind Treatment Period|Other|1|||
125896707|NCT00600119|452920714|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
125896708|NCT00600119|452920715|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
125896709|NCT00600119|452920716|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
125896710|NCT00600119|452920717|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
125896711|NCT00600119|452920718|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
125896712|NCT00600119|452920719|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
125896713|NCT00600119|452920714|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125896714|NCT00600119|452920715|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
125896715|NCT00600119|452920716|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125896716|NCT00600119|452920717|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125896717|NCT00600119|452920718|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125896718|NCT00600119|452920719|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125896719|NCT00600119|452920714|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
125896720|NCT00600119|452920715|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
125896721|NCT00600119|452920716|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
125896722|NCT00600119|452920717|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
125896723|NCT00600119|452920718|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
125896724|NCT00600119|452920719|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
125896725|NCT00600119|452920714|FG000|Double-blind Treatment Period|Physician Decision|2|||
125896726|NCT00600119|452920715|FG001|Double-blind Treatment Period|Physician Decision|0|||
125896727|NCT00600119|452920716|FG002|Double-blind Treatment Period|Physician Decision|0|||
125896728|NCT00600119|452920717|FG003|Double-blind Treatment Period|Physician Decision|0|||
125896729|NCT00600119|452920718|FG004|Double-blind Treatment Period|Physician Decision|0|||
125896730|NCT00600119|452920719|FG005|Double-blind Treatment Period|Physician Decision|0|||
125896731|NCT00600119|452920714|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125896732|NCT00600119|452920715|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
125896733|NCT00600119|452920716|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125896734|NCT00600119|452920717|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
125896735|NCT00600119|452920718|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
125896736|NCT00600119|452920719|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
125896737|NCT00600119|452920714|FG000|Double-blind Treatment Period|Adverse Event|1|||
125896738|NCT00600119|452920715|FG001|Double-blind Treatment Period|Adverse Event|1|||
125896739|NCT00600119|452920716|FG002|Double-blind Treatment Period|Adverse Event|0|||
125896740|NCT00600119|452920717|FG003|Double-blind Treatment Period|Adverse Event|1|||
125896741|NCT00600119|452920718|FG004|Double-blind Treatment Period|Adverse Event|2|||
125896742|NCT00600119|452920719|FG005|Double-blind Treatment Period|Adverse Event|10|||
125896743|NCT00600119|452920714|FG000|Follow-up Period|Adverse Event|0|||
125896744|NCT00600119|452920715|FG001|Follow-up Period|Adverse Event|0|||
125896745|NCT00600119|452920716|FG002|Follow-up Period|Adverse Event|0|||
125896746|NCT00600119|452920717|FG003|Follow-up Period|Adverse Event|0|||
125896747|NCT00600119|452920718|FG004|Follow-up Period|Adverse Event|0|||
125896748|NCT00600119|452920719|FG005|Follow-up Period|Adverse Event|1|||
125896749|NCT00600119|452920714|FG000|Follow-up Period|Other|1|||
125896750|NCT00600119|452920715|FG001|Follow-up Period|Other|0|||
125896751|NCT00600119|452920716|FG002|Follow-up Period|Other|0|||
125896752|NCT00600119|452920717|FG003|Follow-up Period|Other|0|||
125896753|NCT00600119|452920718|FG004|Follow-up Period|Other|0|||
125896754|NCT00600119|452920719|FG005|Follow-up Period|Other|0|||
125896755|NCT00729469|452920720|FG000|Overall Study|Adverse Event|14|||
125896756|NCT00729469|452920721|FG001|Overall Study|Adverse Event|25|||
125896757|NCT00729469|452920720|FG000|Overall Study|Lost to Follow-up|9|||
125896758|NCT00729469|452920721|FG001|Overall Study|Lost to Follow-up|9|||
125896759|NCT00729469|452920720|FG000|Overall Study|Protocol Violation|2|||
125896760|NCT00729469|452920721|FG001|Overall Study|Protocol Violation|1|||
125896761|NCT00729469|452920720|FG000|Overall Study|Withdrawal by Subject|19|||
125896762|NCT00729469|452920721|FG001|Overall Study|Withdrawal by Subject|8|||
125896763|NCT00729469|452920720|FG000|Overall Study|Other-Not mentioned|9|||
125896764|NCT00729469|452920721|FG001|Overall Study|Other-Not mentioned|4|||
125896765|NCT01270802|452920724|FG000|Overall Study|Withdrawal by Subject|1|||
125896766|NCT01270802|452920725|FG001|Overall Study|Withdrawal by Subject|0|||
125896767|NCT01270802|452920724|FG000|Overall Study|Adverse Event|1|||
125896768|NCT01270802|452920725|FG001|Overall Study|Adverse Event|0|||
125896769|NCT01270802|452920724|FG000|Overall Study|Lost to Follow-up|0|||
125896770|NCT01270802|452920725|FG001|Overall Study|Lost to Follow-up|1|||
125896771|NCT01763996|452920726|FG000|Treatment Period 2|Adverse Event|0|||
125896772|NCT01763996|452920727|FG001|Treatment Period 2|Adverse Event|1|||
125896773|NCT01546623|452920731|FG000|Overall Study|Adverse Event|2|||
125896774|NCT01546623|452920732|FG001|Overall Study|Adverse Event|3|||
125896775|NCT01546623|452920731|FG000|Overall Study|Major Protocol Deviation|1|||
125896776|NCT01546623|452920732|FG001|Overall Study|Major Protocol Deviation|1|||
125896777|NCT01546623|452920731|FG000|Overall Study|High Prostate specific antigen|2|||
125896778|NCT01546623|452920732|FG001|Overall Study|High Prostate specific antigen|1|||
125896779|NCT01546623|452920731|FG000|Overall Study|Did Not Receive Study Drug|1|||
125896780|NCT01546623|452920732|FG001|Overall Study|Did Not Receive Study Drug|1|||
125896781|NCT01134705|452920733|FG000|Overall Study|Adverse Event|1|||
125896782|NCT01134705|452920734|FG001|Overall Study|Adverse Event|7|||
125896783|NCT01134705|452920733|FG000|Overall Study|Withdrawal by Subject|6|||
125896784|NCT01134705|452920734|FG001|Overall Study|Withdrawal by Subject|6|||
125896785|NCT01134705|452920733|FG000|Overall Study|Pregnancy|1|||
125896786|NCT01134705|452920734|FG001|Overall Study|Pregnancy|0|||
125896787|NCT01134705|452920733|FG000|Overall Study|Lost to Follow-up|5|||
125896788|NCT01134705|452920734|FG001|Overall Study|Lost to Follow-up|2|||
125896789|NCT01134705|452920733|FG000|Overall Study|Protocol Violation|1|||
125896790|NCT01134705|452920734|FG001|Overall Study|Protocol Violation|1|||
125896791|NCT01134705|452920733|FG000|Overall Study|Other|1|||
125896792|NCT01134705|452920734|FG001|Overall Study|Other|6|||
125896793|NCT04784442|452920735|FG000|Overall Study|Adverse Event|1|||
125896794|NCT04784442|452920736|FG001|Overall Study|Adverse Event|0|||
125896795|NCT04784442|452920737|FG002|Overall Study|Adverse Event|2|||
125896796|NCT04784442|452920738|FG003|Overall Study|Adverse Event|1|||
125896797|NCT04784442|452920735|FG000|Overall Study|Protocol Violation|1|||
125896798|NCT04784442|452920736|FG001|Overall Study|Protocol Violation|0|||
125896799|NCT04784442|452920737|FG002|Overall Study|Protocol Violation|0|||
125896800|NCT04784442|452920738|FG003|Overall Study|Protocol Violation|0|||
125896801|NCT04784442|452920735|FG000|Overall Study|Non-compliance with study drug|1|||
125896802|NCT04784442|452920736|FG001|Overall Study|Non-compliance with study drug|0|||
125896803|NCT04784442|452920737|FG002|Overall Study|Non-compliance with study drug|0|||
125896804|NCT04784442|452920738|FG003|Overall Study|Non-compliance with study drug|0|||
125896805|NCT01590758|452920741|FG000|Overall Study|Withdrawal by Subject|0|||
125896806|NCT01590758|452920742|FG001|Overall Study|Withdrawal by Subject|3|||
125896807|NCT01590758|452920741|FG000|Overall Study|Physician Decision|1|||
125896808|NCT01590758|452920742|FG001|Overall Study|Physician Decision|2|||
125896809|NCT01590758|452920741|FG000|Overall Study|Lost to Follow-up|4|||
125896810|NCT01590758|452920742|FG001|Overall Study|Lost to Follow-up|2|||
125896811|NCT02756806|452920743|FG000|Overall Study|Study terminated early|5|||
125896812|NCT02717832|452920744|FG000|Overall Study|Inability to place IV|3|||
125896813|NCT01008423|452920745|FG000|Overall Study|Adverse Event|13|||
125896814|NCT01008423|452920746|FG001|Overall Study|Adverse Event|6|||
125896815|NCT01008423|452920745|FG000|Overall Study|Withdrawal by Subject|4|||
125896816|NCT01008423|452920746|FG001|Overall Study|Withdrawal by Subject|7|||
125896817|NCT01008423|452920745|FG000|Overall Study|Lost to Follow-up|0|||
125896818|NCT01008423|452920746|FG001|Overall Study|Lost to Follow-up|2|||
125896819|NCT01008423|452920745|FG000|Overall Study|Low Cortisol|0|||
125896820|NCT01008423|452920746|FG001|Overall Study|Low Cortisol|1|||
125896821|NCT01008423|452920745|FG000|Overall Study|Lack of Efficacy|0|||
125896822|NCT01008423|452920746|FG001|Overall Study|Lack of Efficacy|5|||
125896823|NCT01008423|452920745|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
125896824|NCT01008423|452920746|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
125896825|NCT01008423|452920745|FG000|Overall Study|Personal Conflict|1|||
125896826|NCT01008423|452920746|FG001|Overall Study|Personal Conflict|0|||
125896827|NCT01008423|452920745|FG000|Overall Study|Other|0|||
125896828|NCT01008423|452920746|FG001|Overall Study|Other|1|||
125896829|NCT03288142|452920748|FG000|Overall Study|Lost to Follow-up|22|||
125896830|NCT03288142|452920749|FG001|Overall Study|Lost to Follow-up|15|||
125896831|NCT00960570|452920752|FG000|21 Day Washout Period|Adverse Event|1|||
125896832|NCT00960570|452920752|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
125896833|NCT00960570|452920752|FG000|1 Day Period Between Dosing|Adverse Event|2|||
125896834|NCT00960570|452920752|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
125896835|NCT01451437|452920753|FG000|Overall Study|Adverse Event|0|||
125896836|NCT01451437|452920754|FG001|Overall Study|Adverse Event|0|||
125896837|NCT01451437|452920755|FG002|Overall Study|Adverse Event|0|||
125896838|NCT01451437|452920756|FG003|Overall Study|Adverse Event|0|||
125896839|NCT01451437|452920757|FG004|Overall Study|Adverse Event|0|||
125896840|NCT01451437|452920758|FG005|Overall Study|Adverse Event|1|||
125896841|NCT01451437|452920759|FG006|Overall Study|Adverse Event|1|||
125896842|NCT01451437|452920760|FG007|Overall Study|Adverse Event|2|||
125896843|NCT01451437|452920761|FG008|Overall Study|Adverse Event|1|||
125896844|NCT01451437|452920753|FG000|Overall Study|Physician Decision|1|||
125896845|NCT01451437|452920754|FG001|Overall Study|Physician Decision|1|||
125896846|NCT01451437|452920755|FG002|Overall Study|Physician Decision|2|||
125896847|NCT01451437|452920756|FG003|Overall Study|Physician Decision|0|||
125896848|NCT01451437|452920757|FG004|Overall Study|Physician Decision|0|||
125896849|NCT01451437|452920758|FG005|Overall Study|Physician Decision|0|||
125896850|NCT01451437|452920759|FG006|Overall Study|Physician Decision|0|||
125896851|NCT01451437|452920760|FG007|Overall Study|Physician Decision|0|||
125896852|NCT01451437|452920761|FG008|Overall Study|Physician Decision|0|||
125896853|NCT01451437|452920753|FG000|Overall Study|Disease Progression|0|||
125896854|NCT01451437|452920754|FG001|Overall Study|Disease Progression|0|||
125896855|NCT01451437|452920755|FG002|Overall Study|Disease Progression|1|||
125896856|NCT01451437|452920756|FG003|Overall Study|Disease Progression|1|||
125896857|NCT01451437|452920757|FG004|Overall Study|Disease Progression|3|||
125896858|NCT01451437|452920758|FG005|Overall Study|Disease Progression|2|||
125896859|NCT01451437|452920759|FG006|Overall Study|Disease Progression|3|||
125896860|NCT01451437|452920760|FG007|Overall Study|Disease Progression|1|||
125896861|NCT01451437|452920761|FG008|Overall Study|Disease Progression|3|||
125896862|NCT01451437|452920753|FG000|Overall Study|Protocol Violation|0|||
125896863|NCT01451437|452920754|FG001|Overall Study|Protocol Violation|0|||
125896864|NCT01451437|452920755|FG002|Overall Study|Protocol Violation|0|||
125896865|NCT01451437|452920756|FG003|Overall Study|Protocol Violation|0|||
125896866|NCT01451437|452920757|FG004|Overall Study|Protocol Violation|0|||
125896867|NCT01451437|452920758|FG005|Overall Study|Protocol Violation|0|||
125896868|NCT01451437|452920759|FG006|Overall Study|Protocol Violation|1|||
125896869|NCT01451437|452920760|FG007|Overall Study|Protocol Violation|0|||
125896870|NCT01451437|452920761|FG008|Overall Study|Protocol Violation|0|||
125896871|NCT01451437|452920753|FG000|Overall Study|Withdrawal by Subject|0|||
125896872|NCT01451437|452920754|FG001|Overall Study|Withdrawal by Subject|0|||
125896873|NCT01451437|452920755|FG002|Overall Study|Withdrawal by Subject|0|||
125896874|NCT01451437|452920756|FG003|Overall Study|Withdrawal by Subject|0|||
125896875|NCT01451437|452920757|FG004|Overall Study|Withdrawal by Subject|1|||
125896876|NCT01451437|452920758|FG005|Overall Study|Withdrawal by Subject|0|||
125896877|NCT01451437|452920759|FG006|Overall Study|Withdrawal by Subject|1|||
125896878|NCT01451437|452920760|FG007|Overall Study|Withdrawal by Subject|0|||
125896879|NCT01451437|452920761|FG008|Overall Study|Withdrawal by Subject|0|||
125896880|NCT03254108|452922987|FG000|Overall Study|Adverse Event|0|||
125896881|NCT03254108|452922988|FG001|Overall Study|Adverse Event|2|||
125896882|NCT03254108|452922989|FG002|Overall Study|Adverse Event|0|||
125896883|NCT03254108|452922990|FG003|Overall Study|Adverse Event|1|||
125896884|NCT03254108|452922991|FG004|Overall Study|Adverse Event|1|||
125896885|NCT03254108|452922987|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
125896886|NCT03254108|452922988|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
125896887|NCT03254108|452922989|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
125896888|NCT03254108|452922990|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
125896889|NCT03254108|452922991|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
125896890|NCT00490529|452922993|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
125896891|NCT00490529|452922993|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
125896892|NCT00490529|452922993|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
125896893|NCT00490529|452922993|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
125896894|NCT00490529|452922993|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
125896895|NCT00490529|452922993|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
125896896|NCT03254459|452922994|FG000|Overall Study|Adverse Event|7|||
125896897|NCT03254459|452922995|FG001|Overall Study|Adverse Event|20|||
125896898|NCT03254459|452922994|FG000|Overall Study|Withdrawal by Subject Consent|3|||
125896899|NCT03254459|452922995|FG001|Overall Study|Withdrawal by Subject Consent|1|||
125896900|NCT03254459|452922994|FG000|Overall Study|Lost to Follow-up|0|||
125896901|NCT03254459|452922995|FG001|Overall Study|Lost to Follow-up|1|||
125896902|NCT03254459|452922994|FG000|Overall Study|Miscellaneous|0|||
125896903|NCT03254459|452922995|FG001|Overall Study|Miscellaneous|1|||
125896904|NCT00727441|452922996|FG000|Overall Study|Disease Progression|11|||
126110041|NCT01028222|453697625|FG001|Overall Study|Administrative problems|1|||
126110042|NCT01028222|453697624|FG000|Overall Study|Lost to Follow-up|0|||
126110043|NCT01028222|453697625|FG001|Overall Study|Lost to Follow-up|1|||
126110044|NCT01028222|453697624|FG000|Overall Study|Withdrawal by Subject|1|||
125896905|NCT00727441|452922997|FG001|Overall Study|Disease Progression|14|||
125896906|NCT00727441|452922998|FG002|Overall Study|Disease Progression|17|||
125896907|NCT00727441|452922996|FG000|Overall Study|Eligibility|7|||
125896908|NCT00727441|452922997|FG001|Overall Study|Eligibility|5|||
125896909|NCT00727441|452922998|FG002|Overall Study|Eligibility|7|||
125896910|NCT00727441|452922996|FG000|Overall Study|Death|0|||
125896911|NCT00727441|452922997|FG001|Overall Study|Death|1|||
125896912|NCT00727441|452922998|FG002|Overall Study|Death|1|||
125896913|NCT00727441|452922996|FG000|Overall Study|Physician Decision|0|||
125896914|NCT00727441|452922997|FG001|Overall Study|Physician Decision|1|||
125896915|NCT00727441|452922998|FG002|Overall Study|Physician Decision|0|||
125896916|NCT00727441|452922996|FG000|Overall Study|Withdrawal by Subject|0|||
125896917|NCT00727441|452922997|FG001|Overall Study|Withdrawal by Subject|1|||
125896918|NCT00727441|452922998|FG002|Overall Study|Withdrawal by Subject|0|||
125896919|NCT00745849|452922999|FG000|First Intervention|Withdrawal by Subject|0|||
125896920|NCT00745849|452923000|FG001|First Intervention|Withdrawal by Subject|1|||
125896921|NCT00745849|452922999|FG000|First Intervention|Lost to Follow-up|1|||
125896922|NCT00745849|452923000|FG001|First Intervention|Lost to Follow-up|1|||
125896923|NCT00745849|452922999|FG000|Second Intervention|Lost to Follow-up|2|||
125896924|NCT00745849|452923000|FG001|Second Intervention|Lost to Follow-up|1|||
125896925|NCT01129583|452923001|FG000|Overall Study|Death|1|||
125896926|NCT01129583|452923002|FG001|Overall Study|Death|0|||
125896927|NCT01129583|452923001|FG000|Overall Study|Lost to Follow-up|1|||
125896928|NCT01129583|452923002|FG001|Overall Study|Lost to Follow-up|1|||
125896929|NCT01129583|452923001|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
125896930|NCT01129583|452923002|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
125896931|NCT02600871|452923003|FG000|Overall Study|Lost to Follow-up|13|||
125896932|NCT02600871|452923004|FG001|Overall Study|Lost to Follow-up|10|||
125896933|NCT01909791|452923009|FG000|Overall Study|Death|9|||
125896934|NCT01909791|452923010|FG001|Overall Study|Death|8|||
125896935|NCT01909791|452923011|FG002|Overall Study|Death|4|||
125896936|NCT01909791|452923009|FG000|Overall Study|Withdrawal by Subject|5|||
125896937|NCT01909791|452923010|FG001|Overall Study|Withdrawal by Subject|9|||
125896938|NCT01909791|452923011|FG002|Overall Study|Withdrawal by Subject|13|||
125896939|NCT01909791|452923009|FG000|Overall Study|Lost to Follow-up|5|||
125896940|NCT01909791|452923010|FG001|Overall Study|Lost to Follow-up|11|||
125896941|NCT01909791|452923011|FG002|Overall Study|Lost to Follow-up|10|||
125896942|NCT01909791|452923009|FG000|Overall Study|Missed Visit|2|||
125896943|NCT01909791|452923010|FG001|Overall Study|Missed Visit|0|||
125896944|NCT01909791|452923011|FG002|Overall Study|Missed Visit|1|||
125896945|NCT02168387|452923012|FG000|Overall Study|Planned exubation|6|||
125896946|NCT02168387|452923013|FG001|Overall Study|Planned exubation|3|||
125896947|NCT02168387|452923012|FG000|Overall Study|Death|1|||
125896948|NCT02168387|452923013|FG001|Overall Study|Death|0|||
125896949|NCT03467152|452923014|FG000|Overall Study|Adverse Event|4|||
125896950|NCT03467152|452923015|FG001|Overall Study|Adverse Event|5|||
125896951|NCT03467152|452923016|FG002|Overall Study|Adverse Event|0|||
125896952|NCT03467152|452923014|FG000|Overall Study|Subject Choice|1|||
125896953|NCT03467152|452923015|FG001|Overall Study|Subject Choice|3|||
125896954|NCT03467152|452923016|FG002|Overall Study|Subject Choice|0|||
125896955|NCT03467152|452923014|FG000|Overall Study|Lost to Follow-up|1|||
125896956|NCT03467152|452923015|FG001|Overall Study|Lost to Follow-up|0|||
125896957|NCT03467152|452923016|FG002|Overall Study|Lost to Follow-up|0|||
125896958|NCT03467152|452923014|FG000|Overall Study|Withdrawal by Subject|4|||
125896959|NCT03467152|452923015|FG001|Overall Study|Withdrawal by Subject|2|||
125896960|NCT03467152|452923016|FG002|Overall Study|Withdrawal by Subject|0|||
125896961|NCT03467152|452923014|FG000|Overall Study|Others|3|||
125896962|NCT03467152|452923015|FG001|Overall Study|Others|0|||
125896963|NCT03467152|452923016|FG002|Overall Study|Others|0|||
125896964|NCT03467152|452923014|FG000|Overall Study|Not treated|3|||
125896965|NCT03467152|452923015|FG001|Overall Study|Not treated|1|||
125896966|NCT03467152|452923016|FG002|Overall Study|Not treated|6|||
125896967|NCT01236547|452923017|FG000|Overall Study|Protocol Violation|0|||
125896968|NCT01236547|452923018|FG001|Overall Study|Protocol Violation|1|||
125896969|NCT01236547|452923019|FG002|Overall Study|Protocol Violation|1|||
125896970|NCT01236547|452923020|FG003|Overall Study|Protocol Violation|6|||
125896971|NCT01236547|452923021|FG004|Overall Study|Protocol Violation|12|||
125896972|NCT00910624|452923022|FG000|Treatment Phase|Adverse Event|2|||
125896973|NCT00910624|452923023|FG001|Treatment Phase|Adverse Event|6|||
125896974|NCT00910624|452923024|FG002|Treatment Phase|Adverse Event|6|||
125896975|NCT00910624|452923025|FG003|Treatment Phase|Adverse Event|0|||
125896976|NCT00910624|452923022|FG000|Treatment Phase|Treatment Failure|23|||
125896977|NCT00910624|452923023|FG001|Treatment Phase|Treatment Failure|10|||
125896978|NCT00910624|452923024|FG002|Treatment Phase|Treatment Failure|0|||
125896979|NCT00910624|452923025|FG003|Treatment Phase|Treatment Failure|0|||
125896980|NCT00910624|452923022|FG000|Treatment Phase|Lost to Follow-up|0|||
125896981|NCT00910624|452923023|FG001|Treatment Phase|Lost to Follow-up|0|||
125896982|NCT00910624|452923024|FG002|Treatment Phase|Lost to Follow-up|1|||
125896983|NCT00910624|452923025|FG003|Treatment Phase|Lost to Follow-up|0|||
125896984|NCT00910624|452923022|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
125896985|NCT00910624|452923023|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
125896986|NCT00910624|452923024|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
125896987|NCT00910624|452923025|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
125896988|NCT00910624|452923022|FG000|Treatment Phase|Withdrawal by Subject|2|||
125896989|NCT00910624|452923023|FG001|Treatment Phase|Withdrawal by Subject|1|||
125896990|NCT00910624|452923024|FG002|Treatment Phase|Withdrawal by Subject|0|||
125896991|NCT00910624|452923025|FG003|Treatment Phase|Withdrawal by Subject|0|||
125896992|NCT00910624|452923022|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
125896993|NCT00910624|452923023|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
125896994|NCT00910624|452923024|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
125896995|NCT00910624|452923025|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
125896996|NCT00910624|452923022|FG000|Follow-Up Phase|Adverse Event|0|||
125896997|NCT00910624|452923023|FG001|Follow-Up Phase|Adverse Event|0|||
125896998|NCT00910624|452923024|FG002|Follow-Up Phase|Adverse Event|1|||
125896999|NCT00910624|452923025|FG003|Follow-Up Phase|Adverse Event|0|||
125897000|NCT00910624|452923022|FG000|Follow-Up Phase|Lost to Follow-up|3|||
125897001|NCT00910624|452923023|FG001|Follow-Up Phase|Lost to Follow-up|1|||
125897002|NCT00910624|452923024|FG002|Follow-Up Phase|Lost to Follow-up|2|||
125897003|NCT00910624|452923025|FG003|Follow-Up Phase|Lost to Follow-up|0|||
125897004|NCT00910624|452923022|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
125897005|NCT00910624|452923023|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
125897006|NCT00910624|452923024|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
125897007|NCT00910624|452923025|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
125897008|NCT00910624|452923022|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
125897009|NCT00910624|452923023|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
125897010|NCT00910624|452923024|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
125897011|NCT00910624|452923025|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
125897012|NCT00910624|452923022|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
125897013|NCT00910624|452923023|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
125897014|NCT00910624|452923024|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
125897015|NCT00910624|452923025|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
125897016|NCT00910624|452923022|FG000|Follow-Up Phase|Administrative|0|||
125897017|NCT00910624|452923023|FG001|Follow-Up Phase|Administrative|1|||
125897018|NCT00910624|452923024|FG002|Follow-Up Phase|Administrative|1|||
125897019|NCT00910624|452923025|FG003|Follow-Up Phase|Administrative|0|||
125897020|NCT01713933|452923026|FG000|Overall Study|Lost to Follow-up|2|||
125897021|NCT01713933|452923026|FG000|Overall Study|Withdrawal by Subject|3|||
125897022|NCT01713933|452923026|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
125897023|NCT00412373|452923027|FG000|Overall Study|Adverse Event|8|||
125897024|NCT00412373|452923028|FG001|Overall Study|Adverse Event|13|||
125897025|NCT00412373|452923027|FG000|Overall Study|Lack of Efficacy|16|||
126110045|NCT01028222|453697625|FG001|Overall Study|Withdrawal by Subject|0|||
125897026|NCT00412373|452923028|FG001|Overall Study|Lack of Efficacy|22|||
125897027|NCT00412373|452923027|FG000|Overall Study|Lost to Follow-up|7|||
125897028|NCT00412373|452923028|FG001|Overall Study|Lost to Follow-up|13|||
125897029|NCT00412373|452923027|FG000|Overall Study|Withdrawal by Subject|8|||
125897030|NCT00412373|452923028|FG001|Overall Study|Withdrawal by Subject|27|||
125897031|NCT00412373|452923027|FG000|Overall Study|Other|2|||
125897032|NCT00412373|452923028|FG001|Overall Study|Other|2|||
125897033|NCT04022733|452923032|FG000|Overall Study|conversion to open surgery|3|||
125897034|NCT04022733|452923033|FG001|Overall Study|conversion to open surgery|2|||
125897035|NCT04022733|452923032|FG000|Overall Study|bradycardia|0|||
125897036|NCT04022733|452923033|FG001|Overall Study|bradycardia|1|||
125897037|NCT00797966|452923034|FG000|Phase A|Lost to Follow-up|0|||
125897038|NCT00797966|452923035|FG001|Phase A|Lost to Follow-up|0|||
125897039|NCT00797966|452923036|FG002|Phase A|Lost to Follow-up|0|||
125897040|NCT00797966|452923037|FG003|Phase A|Lost to Follow-up|0|||
125897041|NCT00797966|452923038|FG004|Phase A|Lost to Follow-up|33|||
125897042|NCT00797966|452923039|FG005|Phase A|Lost to Follow-up|0|||
125897043|NCT00797966|452923034|FG000|Phase A|Adverse Event|0|||
125897044|NCT00797966|452923035|FG001|Phase A|Adverse Event|0|||
125897045|NCT00797966|452923036|FG002|Phase A|Adverse Event|0|||
125897046|NCT00797966|452923037|FG003|Phase A|Adverse Event|0|||
125897047|NCT00797966|452923038|FG004|Phase A|Adverse Event|46|||
125897048|NCT00797966|452923039|FG005|Phase A|Adverse Event|0|||
125897049|NCT00797966|452923034|FG000|Phase A|Met withdrawal criteria|0|||
125897050|NCT00797966|452923035|FG001|Phase A|Met withdrawal criteria|0|||
125897051|NCT00797966|452923036|FG002|Phase A|Met withdrawal criteria|0|||
125897052|NCT00797966|452923037|FG003|Phase A|Met withdrawal criteria|0|||
125897053|NCT00797966|452923038|FG004|Phase A|Met withdrawal criteria|4|||
125897054|NCT00797966|452923039|FG005|Phase A|Met withdrawal criteria|0|||
125897055|NCT00797966|452923034|FG000|Phase A|Physician Decision|0|||
125897056|NCT00797966|452923035|FG001|Phase A|Physician Decision|0|||
125897057|NCT00797966|452923036|FG002|Phase A|Physician Decision|0|||
125897058|NCT00797966|452923037|FG003|Phase A|Physician Decision|0|||
125897059|NCT00797966|452923038|FG004|Phase A|Physician Decision|13|||
125897060|NCT00797966|452923039|FG005|Phase A|Physician Decision|0|||
125897061|NCT00797966|452923034|FG000|Phase A|Withdrawal by Subject|0|||
125897062|NCT00797966|452923035|FG001|Phase A|Withdrawal by Subject|0|||
125897063|NCT00797966|452923036|FG002|Phase A|Withdrawal by Subject|0|||
125897064|NCT00797966|452923037|FG003|Phase A|Withdrawal by Subject|0|||
125897065|NCT00797966|452923038|FG004|Phase A|Withdrawal by Subject|33|||
125897066|NCT00797966|452923039|FG005|Phase A|Withdrawal by Subject|0|||
125897067|NCT00797966|452923034|FG000|Phase A|Protocol deviation|0|||
125897068|NCT00797966|452923035|FG001|Phase A|Protocol deviation|0|||
125897069|NCT00797966|452923036|FG002|Phase A|Protocol deviation|0|||
125897070|NCT00797966|452923037|FG003|Phase A|Protocol deviation|0|||
125897071|NCT00797966|452923038|FG004|Phase A|Protocol deviation|56|||
125897072|NCT00797966|452923039|FG005|Phase A|Protocol deviation|0|||
125897073|NCT00797966|452923034|FG000|Phase B|Lost to Follow-up|0|||
125897074|NCT00797966|452923035|FG001|Phase B|Lost to Follow-up|1|||
125897075|NCT00797966|452923036|FG002|Phase B|Lost to Follow-up|3|||
125897076|NCT00797966|452923037|FG003|Phase B|Lost to Follow-up|0|||
125897077|NCT00797966|452923038|FG004|Phase B|Lost to Follow-up|0|||
125897078|NCT00797966|452923039|FG005|Phase B|Lost to Follow-up|0|||
125897079|NCT00797966|452923034|FG000|Phase B|Adverse Event|2|||
125897080|NCT00797966|452923035|FG001|Phase B|Adverse Event|1|||
125897081|NCT00797966|452923036|FG002|Phase B|Adverse Event|3|||
125897082|NCT00797966|452923037|FG003|Phase B|Adverse Event|1|||
125897083|NCT00797966|452923038|FG004|Phase B|Adverse Event|0|||
125897084|NCT00797966|452923039|FG005|Phase B|Adverse Event|0|||
125897085|NCT00797966|452923034|FG000|Phase B|Met Withdrawal Criteria|3|||
125897086|NCT00797966|452923035|FG001|Phase B|Met Withdrawal Criteria|3|||
125897087|NCT00797966|452923036|FG002|Phase B|Met Withdrawal Criteria|6|||
125897088|NCT00797966|452923037|FG003|Phase B|Met Withdrawal Criteria|1|||
125897089|NCT00797966|452923038|FG004|Phase B|Met Withdrawal Criteria|0|||
125897090|NCT00797966|452923039|FG005|Phase B|Met Withdrawal Criteria|0|||
125897091|NCT00797966|452923034|FG000|Phase B|Physician Decision|1|||
125897092|NCT00797966|452923035|FG001|Phase B|Physician Decision|0|||
125897093|NCT00797966|452923036|FG002|Phase B|Physician Decision|3|||
125897094|NCT00797966|452923037|FG003|Phase B|Physician Decision|1|||
125897095|NCT00797966|452923038|FG004|Phase B|Physician Decision|0|||
125897096|NCT00797966|452923039|FG005|Phase B|Physician Decision|0|||
125897097|NCT00797966|452923034|FG000|Phase B|Withdrawal by Subject|1|||
125897098|NCT00797966|452923035|FG001|Phase B|Withdrawal by Subject|4|||
125897099|NCT00797966|452923036|FG002|Phase B|Withdrawal by Subject|3|||
125897100|NCT00797966|452923037|FG003|Phase B|Withdrawal by Subject|3|||
125897101|NCT00797966|452923038|FG004|Phase B|Withdrawal by Subject|0|||
125897102|NCT00797966|452923039|FG005|Phase B|Withdrawal by Subject|0|||
125897103|NCT00797966|452923034|FG000|Phase B|Protocol Deviation|4|||
125897104|NCT00797966|452923035|FG001|Phase B|Protocol Deviation|8|||
125897105|NCT00797966|452923036|FG002|Phase B|Protocol Deviation|2|||
125897106|NCT00797966|452923037|FG003|Phase B|Protocol Deviation|6|||
125897107|NCT00797966|452923038|FG004|Phase B|Protocol Deviation|0|||
125897108|NCT00797966|452923039|FG005|Phase B|Protocol Deviation|0|||
125897109|NCT00797966|452923034|FG000|Phase B|Lack of Efficacy|0|||
125897110|NCT00797966|452923035|FG001|Phase B|Lack of Efficacy|1|||
125897111|NCT00797966|452923036|FG002|Phase B|Lack of Efficacy|1|||
125897112|NCT00797966|452923037|FG003|Phase B|Lack of Efficacy|4|||
125897113|NCT00797966|452923038|FG004|Phase B|Lack of Efficacy|0|||
125897114|NCT00797966|452923039|FG005|Phase B|Lack of Efficacy|0|||
125897115|NCT00797966|452923034|FG000|Phase A+|Lost to Follow-up|0|||
125897116|NCT00797966|452923035|FG001|Phase A+|Lost to Follow-up|0|||
125897117|NCT00797966|452923036|FG002|Phase A+|Lost to Follow-up|0|||
125897118|NCT00797966|452923037|FG003|Phase A+|Lost to Follow-up|0|||
125897119|NCT00797966|452923038|FG004|Phase A+|Lost to Follow-up|0|||
125897120|NCT00797966|452923039|FG005|Phase A+|Lost to Follow-up|9|||
125897121|NCT00797966|452923034|FG000|Phase A+|Met withdrawal criteria|0|||
125897122|NCT00797966|452923035|FG001|Phase A+|Met withdrawal criteria|0|||
125897123|NCT00797966|452923036|FG002|Phase A+|Met withdrawal criteria|0|||
125897124|NCT00797966|452923037|FG003|Phase A+|Met withdrawal criteria|0|||
125897125|NCT00797966|452923038|FG004|Phase A+|Met withdrawal criteria|0|||
125897126|NCT00797966|452923039|FG005|Phase A+|Met withdrawal criteria|5|||
125897127|NCT00797966|452923034|FG000|Phase A+|Withdrawal by Subject|0|||
125897128|NCT00797966|452923035|FG001|Phase A+|Withdrawal by Subject|0|||
125897129|NCT00797966|452923036|FG002|Phase A+|Withdrawal by Subject|0|||
125897130|NCT00797966|452923037|FG003|Phase A+|Withdrawal by Subject|0|||
125897131|NCT00797966|452923038|FG004|Phase A+|Withdrawal by Subject|0|||
125897132|NCT00797966|452923039|FG005|Phase A+|Withdrawal by Subject|6|||
125897133|NCT00797966|452923034|FG000|Phase A+|Adverse Event|0|||
125897134|NCT00797966|452923035|FG001|Phase A+|Adverse Event|0|||
125897135|NCT00797966|452923036|FG002|Phase A+|Adverse Event|0|||
125897136|NCT00797966|452923037|FG003|Phase A+|Adverse Event|0|||
125897137|NCT00797966|452923038|FG004|Phase A+|Adverse Event|0|||
125897138|NCT00797966|452923039|FG005|Phase A+|Adverse Event|4|||
125897139|NCT00797966|452923034|FG000|Phase A+|Protocol deviation|0|||
125897140|NCT00797966|452923035|FG001|Phase A+|Protocol deviation|0|||
125897141|NCT00797966|452923036|FG002|Phase A+|Protocol deviation|0|||
125897142|NCT00797966|452923037|FG003|Phase A+|Protocol deviation|0|||
125897143|NCT00797966|452923038|FG004|Phase A+|Protocol deviation|0|||
125897144|NCT00797966|452923039|FG005|Phase A+|Protocol deviation|4|||
125897145|NCT03859973|452923041|FG000|Overall Study|Other reason than listed|3|||
125897146|NCT03859973|452923042|FG001|Overall Study|Other reason than listed|2|||
125897147|NCT03859973|452923041|FG000|Overall Study|COVID-19 related, not due to AE|3|||
125897148|NCT03859973|452923042|FG001|Overall Study|COVID-19 related, not due to AE|4|||
125897149|NCT03859973|452923041|FG000|Overall Study|Withdrawal by Subject|8|||
125897150|NCT03859973|452923042|FG001|Overall Study|Withdrawal by Subject|9|||
125897151|NCT03859973|452923041|FG000|Overall Study|Lost to Follow-up|2|||
125897152|NCT03859973|452923042|FG001|Overall Study|Lost to Follow-up|3|||
125897153|NCT03859973|452923041|FG000|Overall Study|Protocol Violation|1|||
125897154|NCT03859973|452923042|FG001|Overall Study|Protocol Violation|3|||
125897155|NCT03859973|452923041|FG000|Overall Study|Adverse Event|3|||
125897156|NCT03859973|452923042|FG001|Overall Study|Adverse Event|5|||
125897157|NCT02855541|452923043|FG000|Overall Study|Change in health status|2|||
125897158|NCT02855541|452923043|FG000|Overall Study|Withdrawal by Subject|2|||
125897159|NCT00422513|452923044|FG000|Overall Study|Lack of Efficacy|4|||
125897160|NCT00422513|452923045|FG001|Overall Study|Lack of Efficacy|5|||
125897161|NCT00422513|452923044|FG000|Overall Study|Protocol Violation|23|||
125897162|NCT00422513|452923045|FG001|Overall Study|Protocol Violation|7|||
125897163|NCT00422513|452923044|FG000|Overall Study|Refused Treatment|4|||
125897164|NCT00422513|452923045|FG001|Overall Study|Refused Treatment|2|||
125897165|NCT00422513|452923044|FG000|Overall Study|Withdrawal by Subject|2|||
125897166|NCT00422513|452923045|FG001|Overall Study|Withdrawal by Subject|1|||
125897167|NCT00422513|452923044|FG000|Overall Study|early termination of the study|67|||
125897168|NCT00422513|452923045|FG001|Overall Study|early termination of the study|80|||
125897169|NCT00422513|452923044|FG000|Overall Study|Adverse Event|4|||
125897170|NCT00422513|452923045|FG001|Overall Study|Adverse Event|4|||
125897171|NCT00422513|452923044|FG000|Overall Study|Death|3|||
125897172|NCT00422513|452923045|FG001|Overall Study|Death|7|||
125897173|NCT03135119|452923046|FG000|Overall Study|Lost to Follow-up|2|||
125897174|NCT03135119|452923047|FG001|Overall Study|Lost to Follow-up|0|||
125897175|NCT03135119|452923046|FG000|Overall Study|Physician Decision|1|||
125897176|NCT03135119|452923047|FG001|Overall Study|Physician Decision|1|||
125897177|NCT03135119|452923046|FG000|Overall Study|COVID-19 Shutdown|2|||
125897178|NCT03135119|452923047|FG001|Overall Study|COVID-19 Shutdown|2|||
125897179|NCT01478048|452923048|FG000|Overall Study|Disease Progression|52|||
125897180|NCT01478048|452923049|FG001|Overall Study|Disease Progression|35|||
125897181|NCT01478048|452923048|FG000|Overall Study|study drug toxicity|11|||
125897182|NCT01478048|452923049|FG001|Overall Study|study drug toxicity|14|||
125897183|NCT01478048|452923048|FG000|Overall Study|Adverse Event|2|||
125897184|NCT01478048|452923049|FG001|Overall Study|Adverse Event|11|||
125897185|NCT01478048|452923048|FG000|Overall Study|subject request to discontinue treatment|3|||
125897186|NCT01478048|452923049|FG001|Overall Study|subject request to discontinue treatment|5|||
125897187|NCT01478048|452923048|FG000|Overall Study|Withdrawal by Subject|2|||
125897188|NCT01478048|452923049|FG001|Overall Study|Withdrawal by Subject|5|||
125897189|NCT01478048|452923048|FG000|Overall Study|non-specified|6|||
125897190|NCT01478048|452923049|FG001|Overall Study|non-specified|4|||
125897191|NCT01478048|452923048|FG000|Overall Study|poor/non-compliance|0|||
125897192|NCT01478048|452923049|FG001|Overall Study|poor/non-compliance|1|||
125897193|NCT01478048|452923048|FG000|Overall Study|no longer meets study criteria|1|||
125897194|NCT01478048|452923049|FG001|Overall Study|no longer meets study criteria|0|||
125897195|NCT03032380|452923058|FG000|Overall Study|Adverse Event|0|||
125897196|NCT03032380|452923059|FG001|Overall Study|Adverse Event|1|||
125897197|NCT03032380|452923058|FG000|Overall Study|Lack of Efficacy|1|||
125897198|NCT03032380|452923059|FG001|Overall Study|Lack of Efficacy|0|||
125897199|NCT03032380|452923058|FG000|Overall Study|Withdrawal by Subject|2|||
125897200|NCT03032380|452923059|FG001|Overall Study|Withdrawal by Subject|3|||
125897201|NCT03032380|452923058|FG000|Overall Study|Recovery|0|||
125897202|NCT03032380|452923059|FG001|Overall Study|Recovery|1|||
125897203|NCT03032380|452923058|FG000|Overall Study|Death|39|||
125897204|NCT03032380|452923059|FG001|Overall Study|Death|34|||
125897205|NCT03032380|452923058|FG000|Overall Study|Other - Miscellaneous|0|||
125897206|NCT03032380|452923059|FG001|Overall Study|Other - Miscellaneous|1|||
125897207|NCT01561898|452923060|FG000|Overall Study|Withdrawal by Subject|0|||
125897208|NCT01561898|452923061|FG001|Overall Study|Withdrawal by Subject|8|||
125897209|NCT01561898|452923062|FG002|Overall Study|Withdrawal by Subject|12|||
125897210|NCT01561898|452923063|FG003|Overall Study|Withdrawal by Subject|5|||
125897211|NCT01561898|452923060|FG000|Overall Study|Lack of Efficacy|0|||
125897212|NCT01561898|452923061|FG001|Overall Study|Lack of Efficacy|8|||
125897213|NCT01561898|452923062|FG002|Overall Study|Lack of Efficacy|10|||
125897214|NCT01561898|452923063|FG003|Overall Study|Lack of Efficacy|5|||
125897215|NCT01561898|452923060|FG000|Overall Study|Worsening of complications|0|||
125897216|NCT01561898|452923061|FG001|Overall Study|Worsening of complications|1|||
125897217|NCT01561898|452923062|FG002|Overall Study|Worsening of complications|0|||
125897218|NCT01561898|452923063|FG003|Overall Study|Worsening of complications|0|||
125897219|NCT01561898|452923060|FG000|Overall Study|Lost to Follow-up|0|||
125897220|NCT01561898|452923061|FG001|Overall Study|Lost to Follow-up|0|||
125897221|NCT01561898|452923062|FG002|Overall Study|Lost to Follow-up|1|||
125897222|NCT01561898|452923063|FG003|Overall Study|Lost to Follow-up|0|||
125897223|NCT01561898|452923060|FG000|Overall Study|Adverse Event|1|||
125897224|NCT01561898|452923061|FG001|Overall Study|Adverse Event|19|||
125897225|NCT01561898|452923062|FG002|Overall Study|Adverse Event|14|||
125897226|NCT01561898|452923063|FG003|Overall Study|Adverse Event|9|||
125897227|NCT01561898|452923060|FG000|Overall Study|Physician Decision|1|||
125897228|NCT01561898|452923061|FG001|Overall Study|Physician Decision|5|||
125897229|NCT01561898|452923062|FG002|Overall Study|Physician Decision|7|||
125897230|NCT01561898|452923063|FG003|Overall Study|Physician Decision|1|||
125897231|NCT00294762|452923064|FG000|Overall Study|Did not receive study treatment|3|||
125897232|NCT00294762|452923065|FG001|Overall Study|Did not receive study treatment|3|||
125897233|NCT02238080|452923066|FG000|Overall Study|Death|13|||
125897234|NCT02238080|452923066|FG000|Overall Study|Treatment interrupted|6|||
125897235|NCT02238080|452923066|FG000|Overall Study|Withdrawal by Subject|2|||
125897236|NCT02238080|452923066|FG000|Overall Study|Other|4|||
125897237|NCT01738646|452923067|FG000|Overall Study|Still Receiving Treatment|2|||
125897238|NCT04093024|452923070|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
125897239|NCT04093024|452923071|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
125897240|NCT04093024|452923070|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
125897241|NCT04093024|452923071|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
125897242|NCT04093024|452923070|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
125897243|NCT04093024|452923071|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
125897244|NCT04093024|452923070|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
125897245|NCT04093024|452923071|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
125897246|NCT02267317|452923076|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
125897247|NCT02267317|452923077|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125897248|NCT02267317|452923078|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125897249|NCT02267317|452923079|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125897250|NCT02267317|452923080|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125897251|NCT02267317|452923081|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125897252|NCT02267317|452923076|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
125897253|NCT02267317|452923077|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125897254|NCT02267317|452923078|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125897255|NCT02267317|452923079|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125897256|NCT02267317|452923080|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125897257|NCT02267317|452923081|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125897258|NCT00796445|452923082|FG000|Overall Study|Protocol Violation|5|||
125897259|NCT00796445|452923083|FG001|Overall Study|Protocol Violation|3|||
125897260|NCT00796445|452923082|FG000|Overall Study|Adverse event, serious fatal|10|||
125897261|NCT00796445|452923083|FG001|Overall Study|Adverse event, serious fatal|5|||
125897262|NCT00796445|452923082|FG000|Overall Study|Adverse event, non-fatal|4|||
125897263|NCT00796445|452923083|FG001|Overall Study|Adverse event, non-fatal|0|||
125897264|NCT00796445|452923082|FG000|Overall Study|Disease progression/recurrence|537|||
125897265|NCT00796445|452923083|FG001|Overall Study|Disease progression/recurrence|268|||
125897266|NCT00796445|452923082|FG000|Overall Study|Other|10|||
125897267|NCT00796445|452923083|FG001|Overall Study|Other|7|||
125897268|NCT00796445|452923082|FG000|Overall Study|Withdrawal by Subject|18|||
125897269|NCT00796445|452923083|FG001|Overall Study|Withdrawal by Subject|9|||
125897270|NCT00796445|452923082|FG000|Overall Study|Invalid Informed Consent Form|1|||
125897271|NCT00796445|452923083|FG001|Overall Study|Invalid Informed Consent Form|0|||
125897272|NCT03774823|452923086|FG000|Overall Study|Withdrawal by Subject|1|||
125897273|NCT03774823|452923087|FG001|Overall Study|Withdrawal by Subject|1|||
125897274|NCT00958438|452923088|FG000|Overall Study|Protocol Violation|3|||
125897275|NCT00958438|452923089|FG001|Overall Study|Protocol Violation|2|||
125897276|NCT00958438|452923090|FG002|Overall Study|Protocol Violation|2|||
125897277|NCT00958438|452923088|FG000|Overall Study|Withdrawal by Subject|4|||
125897278|NCT00958438|452923089|FG001|Overall Study|Withdrawal by Subject|2|||
125897279|NCT00958438|452923090|FG002|Overall Study|Withdrawal by Subject|1|||
125897280|NCT00958438|452923088|FG000|Overall Study|Adverse Event|0|||
125897281|NCT00958438|452923089|FG001|Overall Study|Adverse Event|3|||
125897282|NCT00958438|452923090|FG002|Overall Study|Adverse Event|0|||
125897283|NCT00958438|452923088|FG000|Overall Study|Physician Decision|1|||
125897284|NCT00958438|452923089|FG001|Overall Study|Physician Decision|0|||
125897285|NCT00958438|452923090|FG002|Overall Study|Physician Decision|1|||
125897286|NCT00958438|452923088|FG000|Overall Study|Other than specified above|2|||
125897287|NCT00958438|452923089|FG001|Overall Study|Other than specified above|3|||
125897288|NCT00958438|452923090|FG002|Overall Study|Other than specified above|2|||
125897289|NCT00759564|452923091|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
125897290|NCT00759564|452923092|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
125897291|NCT00759564|452923093|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
125897292|NCT00759564|452923094|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
125897293|NCT00759564|452923095|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
125897294|NCT02238067|452923097|FG000|Overall Study|Not completed survey at Month 6|45|||
125897295|NCT01566214|452923099|FG000|Overall Study|Lost to Follow-up|3|||
125897296|NCT01566214|452923100|FG001|Overall Study|Lost to Follow-up|0|||
125897297|NCT04620798|452923103|FG000|Overall Study|Lost to Follow-up|126|||
125897298|NCT04620798|452923104|FG001|Overall Study|Lost to Follow-up|138|||
125897299|NCT01960907|452923110|FG000|Overall Study|Death|4|||
125897300|NCT01960907|452923111|FG001|Overall Study|Death|3|||
125897301|NCT01960907|452923110|FG000|Overall Study|Withdrawal by Subject|32|||
125897302|NCT01960907|452923111|FG001|Overall Study|Withdrawal by Subject|42|||
125897303|NCT00832624|452923115|FG000|Overall Study|Study Terminated|10|||
125897304|NCT02395172|452923116|FG000|Overall Study|Participants randomized but not treated|3|||
125897305|NCT02395172|452923117|FG001|Overall Study|Participants randomized but not treated|31|||
125897306|NCT00717236|452923118|FG000|Double-Blind Period|Adverse Event|33|||
125897307|NCT00717236|452923119|FG001|Double-Blind Period|Adverse Event|6|||
125897308|NCT00717236|452923118|FG000|Double-Blind Period|Lack of Efficacy|6|||
125897309|NCT00717236|452923119|FG001|Double-Blind Period|Lack of Efficacy|6|||
125897310|NCT00717236|452923118|FG000|Double-Blind Period|Lost to Follow-up|3|||
125897311|NCT00717236|452923119|FG001|Double-Blind Period|Lost to Follow-up|5|||
125897312|NCT00717236|452923118|FG000|Double-Blind Period|Withdrawal by Subject|10|||
125897313|NCT00717236|452923119|FG001|Double-Blind Period|Withdrawal by Subject|2|||
125897314|NCT00717236|452923118|FG000|Double-Blind Period|Loss of efficacy|3|||
125897315|NCT00717236|452923119|FG001|Double-Blind Period|Loss of efficacy|0|||
125897316|NCT00717236|452923118|FG000|Double-Blind Period|Other: Death|1|||
125897317|NCT00717236|452923119|FG001|Double-Blind Period|Other: Death|0|||
125897318|NCT00717236|452923118|FG000|Double-Blind Period|Other: Pregnancy|1|||
125897319|NCT00717236|452923119|FG001|Double-Blind Period|Other: Pregnancy|0|||
125897320|NCT00717236|452923118|FG000|Double-Blind Period|Other: Protocol Violation|2|||
125897321|NCT00717236|452923119|FG001|Double-Blind Period|Other: Protocol Violation|0|||
125897322|NCT00717236|452923118|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
125897323|NCT00717236|452923119|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
125897324|NCT00717236|452923118|FG000|Double-Blind Period|Other: Site withdrew|2|||
125897325|NCT00717236|452923119|FG001|Double-Blind Period|Other: Site withdrew|0|||
125897326|NCT00717236|452923118|FG000|Double-Blind Period|Other: Screening failure|1|||
125897327|NCT00717236|452923119|FG001|Double-Blind Period|Other: Screening failure|0|||
125897328|NCT00717236|452923118|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
125897329|NCT00717236|452923119|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
125897330|NCT00717236|452923118|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
125897331|NCT00717236|452923119|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
125897332|NCT00717236|452923118|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
125897333|NCT00717236|452923119|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
125897334|NCT00717236|452923118|FG000|Double-Blind Period|Other: History of cancer|1|||
125897335|NCT00717236|452923119|FG001|Double-Blind Period|Other: History of cancer|0|||
125897336|NCT00717236|452923118|FG000|Double-Blind Period|Other: Sponsor request|1|||
125897337|NCT00717236|452923119|FG001|Double-Blind Period|Other: Sponsor request|0|||
125897338|NCT00717236|452923118|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
125897339|NCT00717236|452923119|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
125897340|NCT00717236|452923118|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
125897341|NCT00717236|452923119|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
125897342|NCT00717236|452923118|FG000|Double-Blind Period|Other: Subject moved|1|||
125897343|NCT00717236|452923119|FG001|Double-Blind Period|Other: Subject moved|1|||
125897344|NCT00717236|452923118|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
125897345|NCT00717236|452923119|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
125897346|NCT00717236|452923118|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
125897347|NCT00717236|452923119|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
125897348|NCT00717236|452923118|FG000|Double-Blind Period|Other: Transportation problems|0|||
125897349|NCT00717236|452923119|FG001|Double-Blind Period|Other: Transportation problems|1|||
125897350|NCT00717236|452923118|FG000|Double-Blind Period|Other: Investigator Decision|0|||
125897351|NCT00717236|452923119|FG001|Double-Blind Period|Other: Investigator Decision|1|||
125897352|NCT00717236|452923118|FG000|Open-Label Period|Adverse Event|29|||
125897353|NCT00717236|452923119|FG001|Open-Label Period|Adverse Event|4|||
125897354|NCT00717236|452923118|FG000|Open-Label Period|Lack of Efficacy|30|||
125897355|NCT00717236|452923119|FG001|Open-Label Period|Lack of Efficacy|8|||
125897356|NCT00717236|452923118|FG000|Open-Label Period|Lost to Follow-up|28|||
125897357|NCT00717236|452923119|FG001|Open-Label Period|Lost to Follow-up|4|||
125897358|NCT00717236|452923118|FG000|Open-Label Period|Withdrawal by Subject|20|||
125897359|NCT00717236|452923119|FG001|Open-Label Period|Withdrawal by Subject|2|||
125897360|NCT00717236|452923118|FG000|Open-Label Period|Loss of Efficacy|6|||
125897361|NCT00717236|452923119|FG001|Open-Label Period|Loss of Efficacy|1|||
125897362|NCT00717236|452923118|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
125897363|NCT00717236|452923119|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
125897364|NCT00717236|452923118|FG000|Open-Label Period|Other: Lack of Compliance|1|||
125897365|NCT00717236|452923119|FG001|Open-Label Period|Other: Lack of Compliance|1|||
125897366|NCT00717236|452923118|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
125897367|NCT00717236|452923119|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
125897368|NCT00717236|452923118|FG000|Open-Label Period|Other: Moved|1|||
125897369|NCT00717236|452923119|FG001|Open-Label Period|Other: Moved|0|||
125897370|NCT00717236|452923118|FG000|Open-Label Period|Other: Investigator Decision|1|||
125897371|NCT00717236|452923119|FG001|Open-Label Period|Other: Investigator Decision|0|||
125897372|NCT00717236|452923118|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
125897373|NCT00717236|452923119|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
125897374|NCT00717236|452923118|FG000|Open-Label Period|Other: Sponsor Request|3|||
125897375|NCT00717236|452923119|FG001|Open-Label Period|Other: Sponsor Request|0|||
125897376|NCT00717236|452923118|FG000|Open-Label Period|Other: Cataract Surgery|1|||
125897377|NCT00717236|452923119|FG001|Open-Label Period|Other: Cataract Surgery|0|||
125897378|NCT00717236|452923118|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
125897379|NCT00717236|452923119|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
125897380|NCT00717236|452923118|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
125897381|NCT00717236|452923119|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
125897382|NCT00717236|452923118|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
125897383|NCT00717236|452923119|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
125897384|NCT00475982|452923120|FG000|Overall Study|surgery rescheduled|7|||
125897385|NCT00475982|452923121|FG001|Overall Study|surgery rescheduled|3|||
125897386|NCT00783198|452923126|FG000|Overall Study|Adverse Event|15|||
125897387|NCT00783198|452923127|FG001|Overall Study|Adverse Event|19|||
125897388|NCT00783198|452923128|FG002|Overall Study|Adverse Event|3|||
125897389|NCT00783198|452923126|FG000|Overall Study|Lost to Follow-up|11|||
125897390|NCT00783198|452923127|FG001|Overall Study|Lost to Follow-up|1|||
125897391|NCT00783198|452923128|FG002|Overall Study|Lost to Follow-up|7|||
125897392|NCT00783198|452923126|FG000|Overall Study|Withdrawal by Subject|22|||
125897393|NCT00783198|452923127|FG001|Overall Study|Withdrawal by Subject|14|||
125897394|NCT00783198|452923128|FG002|Overall Study|Withdrawal by Subject|20|||
125897395|NCT00783198|452923126|FG000|Overall Study|Noncompliance with protocol|7|||
125897396|NCT00783198|452923127|FG001|Overall Study|Noncompliance with protocol|7|||
125897397|NCT00783198|452923128|FG002|Overall Study|Noncompliance with protocol|10|||
125897398|NCT00783198|452923126|FG000|Overall Study|Did not meet protocol eligibility|0|||
125897399|NCT00783198|452923127|FG001|Overall Study|Did not meet protocol eligibility|1|||
125897400|NCT00783198|452923128|FG002|Overall Study|Did not meet protocol eligibility|0|||
125897401|NCT00783198|452923126|FG000|Overall Study|Administrative|2|||
125897402|NCT00783198|452923127|FG001|Overall Study|Administrative|1|||
125897403|NCT00783198|452923128|FG002|Overall Study|Administrative|2|||
125897404|NCT00439738|452923131|FG000|Overall Study|Withdrawal by Subject|16|||
125897405|NCT00439738|452923132|FG001|Overall Study|Withdrawal by Subject|13|||
125897406|NCT00439738|452923131|FG000|Overall Study|Adverse Event|6|||
125897407|NCT00439738|452923132|FG001|Overall Study|Adverse Event|4|||
125897408|NCT00439738|452923131|FG000|Overall Study|Lost to Follow-up|5|||
125897409|NCT00439738|452923132|FG001|Overall Study|Lost to Follow-up|6|||
125897410|NCT00439738|452923131|FG000|Overall Study|Protocol Violation|6|||
125897411|NCT00439738|452923132|FG001|Overall Study|Protocol Violation|3|||
125897412|NCT00439738|452923131|FG000|Overall Study|Lack of Efficacy|2|||
125897413|NCT00439738|452923132|FG001|Overall Study|Lack of Efficacy|2|||
125897414|NCT00439738|452923131|FG000|Overall Study|Abnormal Lab Values|1|||
125897415|NCT00439738|452923132|FG001|Overall Study|Abnormal Lab Values|0|||
125897416|NCT00978757|452923133|FG000|Overall Study|Physician Decision|1|||
125897417|NCT00978757|452923134|FG001|Overall Study|Physician Decision|3|||
125897418|NCT00402740|452923138|FG000|Overall Study|Withdrawal by Subject|18|||
125897419|NCT00402740|452923138|FG000|Overall Study|Death|50|||
126110046|NCT01028222|453697624|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
126110047|NCT01028222|453697625|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
126110048|NCT01028222|453697624|FG000|Overall Study|Adverse Event|2|||
126110049|NCT01028222|453697625|FG001|Overall Study|Adverse Event|0|||
125897420|NCT00402740|452923138|FG000|Overall Study|Lost to Follow-up|6|||
125897421|NCT00402740|452923138|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
125897422|NCT00402740|452923138|FG000|Overall Study|Subject disposition unknown.|1|||
125897423|NCT01700387|452923139|FG000|Overall Study|Withdrawal by Subject|1|||
125897424|NCT01700387|452923140|FG001|Overall Study|Withdrawal by Subject|2|||
125897425|NCT01700387|452923139|FG000|Overall Study|Adverse Event|1|||
125897426|NCT01700387|452923140|FG001|Overall Study|Adverse Event|1|||
125897427|NCT01700387|452923139|FG000|Overall Study|Lost to Follow-up|2|||
125897428|NCT01700387|452923140|FG001|Overall Study|Lost to Follow-up|1|||
125897429|NCT01185353|452923142|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
125897430|NCT01185353|452923143|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
125897431|NCT01185353|452923144|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
125897432|NCT01185353|452923145|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
125897433|NCT01185353|452923146|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
125897434|NCT01185353|452923147|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125897435|NCT01185353|452923148|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125897436|NCT01185353|452923149|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
126110050|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
125897437|NCT01185353|452923150|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125897438|NCT01185353|452923151|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125897439|NCT01185353|452923142|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125897440|NCT01185353|452923143|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125897441|NCT01185353|452923144|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125897442|NCT01185353|452923145|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125897443|NCT01185353|452923146|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
125897444|NCT01185353|452923147|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126110051|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
125897445|NCT01185353|452923148|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125897446|NCT01185353|452923149|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125897447|NCT01185353|452923150|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125897448|NCT01185353|452923151|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125897449|NCT01185353|452923142|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
125897450|NCT01185353|452923143|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125897451|NCT01185353|452923144|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125897452|NCT01185353|452923145|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125897453|NCT01185353|452923146|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
125897454|NCT01185353|452923147|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125897455|NCT01185353|452923148|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125897456|NCT01185353|452923149|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125897457|NCT01185353|452923150|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125897458|NCT01185353|452923151|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125897459|NCT01185353|452923142|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125897460|NCT01185353|452923143|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125897461|NCT01185353|452923144|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
125897462|NCT01185353|452923145|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125897463|NCT01185353|452923146|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
125897464|NCT01185353|452923147|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125897465|NCT01185353|452923148|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125897466|NCT01185353|452923149|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125897467|NCT01185353|452923150|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125897468|NCT01185353|452923151|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125897469|NCT01185353|452923142|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125897470|NCT01185353|452923143|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125897471|NCT01185353|452923144|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125897472|NCT01185353|452923145|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125897473|NCT01185353|452923146|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
125897474|NCT01185353|452923147|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126110052|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
126110053|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
125897475|NCT01185353|452923148|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125897476|NCT01185353|452923149|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125897477|NCT01185353|452923150|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125897478|NCT01185353|452923151|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125897479|NCT01185353|452923142|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
125897480|NCT01185353|452923143|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125897481|NCT01185353|452923144|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125897482|NCT01185353|452923145|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125897483|NCT01185353|452923146|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
125897484|NCT01185353|452923147|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125897485|NCT01185353|452923148|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125897486|NCT01185353|452923149|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125897487|NCT01185353|452923150|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125897488|NCT01185353|452923151|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125897489|NCT01185353|452923142|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125897490|NCT01185353|452923143|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125897491|NCT01185353|452923144|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
125897492|NCT01185353|452923145|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125897493|NCT01185353|452923146|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125897494|NCT01185353|452923147|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
125897495|NCT01185353|452923148|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125897496|NCT01185353|452923149|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125897497|NCT01185353|452923150|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125897498|NCT01185353|452923151|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125897499|NCT01185353|452923142|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125897500|NCT01185353|452923143|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
125897501|NCT01185353|452923144|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125897502|NCT01185353|452923145|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
125897503|NCT01185353|452923146|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125897504|NCT01185353|452923147|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125897505|NCT01185353|452923148|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125897506|NCT01185353|452923149|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125897507|NCT01185353|452923150|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125897508|NCT01185353|452923151|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125897509|NCT01185353|452923142|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125897510|NCT01185353|452923143|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125897511|NCT01185353|452923144|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125897512|NCT01185353|452923145|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
125897513|NCT01185353|452923146|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125897514|NCT01185353|452923147|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125897515|NCT01185353|452923148|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
125897516|NCT01185353|452923149|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125897517|NCT01185353|452923150|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125897518|NCT01185353|452923151|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125897519|NCT01185353|452923142|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125897520|NCT01185353|452923143|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125897521|NCT01185353|452923144|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
125897522|NCT01185353|452923145|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
125897523|NCT01185353|452923146|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125897524|NCT01185353|452923147|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
125897525|NCT01185353|452923148|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
125897526|NCT01185353|452923149|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125897527|NCT01185353|452923150|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125897528|NCT01185353|452923151|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125897529|NCT01185353|452923142|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897530|NCT01185353|452923143|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897531|NCT01185353|452923144|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897532|NCT01185353|452923145|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897533|NCT01185353|452923146|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897534|NCT01185353|452923147|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897535|NCT01185353|452923148|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
125897536|NCT01185353|452923149|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897537|NCT01185353|452923150|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897538|NCT01185353|452923151|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125897539|NCT01185353|452923142|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125897540|NCT01185353|452923143|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125897541|NCT01185353|452923144|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125897542|NCT01185353|452923145|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125897543|NCT01185353|452923146|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125897544|NCT01185353|452923147|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125897545|NCT01185353|452923148|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125897546|NCT01185353|452923149|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
125897547|NCT01185353|452923150|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
125897548|NCT01185353|452923151|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
125897549|NCT01185353|452923142|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125897550|NCT01185353|452923143|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125897551|NCT01185353|452923144|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125897552|NCT01185353|452923145|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125897553|NCT01185353|452923146|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125897554|NCT01185353|452923147|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125897555|NCT01185353|452923148|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125897556|NCT01185353|452923149|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
125897557|NCT01185353|452923150|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
125897558|NCT01185353|452923151|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
125897559|NCT01185353|452923142|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125897560|NCT01185353|452923143|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125897561|NCT01185353|452923144|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125897562|NCT01185353|452923145|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125897563|NCT01185353|452923146|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125897564|NCT01185353|452923147|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125897565|NCT01185353|452923148|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125897566|NCT01185353|452923149|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
125897567|NCT01185353|452923150|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
125897568|NCT01185353|452923151|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
125897569|NCT01185353|452923142|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897570|NCT01185353|452923143|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897571|NCT01185353|452923144|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897572|NCT01185353|452923145|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897573|NCT01185353|452923146|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897574|NCT01185353|452923147|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897575|NCT01185353|452923148|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897576|NCT01185353|452923149|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897577|NCT01185353|452923150|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
125897578|NCT01185353|452923151|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125897579|NCT01185353|452923142|FG000|Part C (Weeks 24 Through 76)|Death|0|||
125897580|NCT01185353|452923143|FG001|Part C (Weeks 24 Through 76)|Death|0|||
125897581|NCT01185353|452923144|FG002|Part C (Weeks 24 Through 76)|Death|0|||
125897582|NCT01185353|452923145|FG003|Part C (Weeks 24 Through 76)|Death|0|||
125897583|NCT01185353|452923146|FG004|Part C (Weeks 24 Through 76)|Death|0|||
125897584|NCT01185353|452923147|FG005|Part C (Weeks 24 Through 76)|Death|0|||
125897585|NCT01185353|452923148|FG006|Part C (Weeks 24 Through 76)|Death|0|||
125897586|NCT01185353|452923149|FG007|Part C (Weeks 24 Through 76)|Death|0|||
125897587|NCT01185353|452923150|FG008|Part C (Weeks 24 Through 76)|Death|0|||
125897588|NCT01185353|452923151|FG009|Part C (Weeks 24 Through 76)|Death|1|||
126110054|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
125897589|NCT01185353|452923142|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125897590|NCT01185353|452923143|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126110055|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
125897591|NCT01185353|452923144|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125897592|NCT01185353|452923145|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125897593|NCT01185353|452923146|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125897594|NCT01185353|452923147|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125897595|NCT01185353|452923148|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125897596|NCT01185353|452923149|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125897597|NCT01185353|452923150|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125897598|NCT01185353|452923151|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
125897599|NCT01185353|452923142|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897600|NCT01185353|452923143|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897601|NCT01185353|452923144|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897602|NCT01185353|452923145|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897603|NCT01185353|452923146|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897604|NCT01185353|452923147|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897605|NCT01185353|452923148|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897606|NCT01185353|452923149|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897607|NCT01185353|452923150|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125897608|NCT01185353|452923151|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
125897609|NCT01185353|452923142|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897610|NCT01185353|452923143|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897611|NCT01185353|452923144|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897612|NCT01185353|452923145|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897613|NCT01185353|452923146|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897614|NCT01185353|452923147|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897615|NCT01185353|452923148|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897616|NCT01185353|452923149|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897617|NCT01185353|452923150|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
125897618|NCT01185353|452923151|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
125897619|NCT01185353|452923142|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125897620|NCT01185353|452923143|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125897621|NCT01185353|452923144|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125897622|NCT01185353|452923145|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125897623|NCT01185353|452923146|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125897624|NCT01185353|452923147|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125897625|NCT01185353|452923148|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125897626|NCT01185353|452923149|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
125897627|NCT01185353|452923150|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
125897628|NCT01185353|452923151|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125897629|NCT01185353|452923142|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125897630|NCT01185353|452923143|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125897631|NCT01185353|452923144|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125897632|NCT01185353|452923145|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125897633|NCT01185353|452923146|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125897634|NCT01185353|452923147|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125897635|NCT01185353|452923148|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125897636|NCT01185353|452923149|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
125897637|NCT01185353|452923150|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
125897638|NCT01185353|452923151|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
125897639|NCT01185353|452923142|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125897640|NCT01185353|452923143|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125897641|NCT01185353|452923144|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125897642|NCT01185353|452923145|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125897643|NCT01185353|452923146|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125897644|NCT01185353|452923147|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125897645|NCT01185353|452923148|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125897646|NCT01185353|452923149|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
125897647|NCT01185353|452923150|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
125897648|NCT01185353|452923151|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125897649|NCT02270944|452923152|FG000|Overall Study|Lost to Follow-up|9|||
125897650|NCT02270944|452923153|FG001|Overall Study|Lost to Follow-up|4|||
125897651|NCT02270944|452923152|FG000|Overall Study|Withdrawal by Subject|2|||
125897652|NCT02270944|452923153|FG001|Overall Study|Withdrawal by Subject|1|||
125897653|NCT00095147|452923154|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
125897654|NCT00095147|452923155|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
125897655|NCT00095147|452923156|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
125897656|NCT00095147|452923157|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
125897657|NCT00095147|452923158|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
125897658|NCT00095147|452923154|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
126110056|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
126110057|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
126110058|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
126110059|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
126110060|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
126110061|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
126110062|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Death|3|||
126110063|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Death|1|||
125897659|NCT00095147|452923155|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
125897660|NCT00095147|452923156|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
125897661|NCT00095147|452923157|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
125897662|NCT00095147|452923158|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
125897663|NCT00095147|452923154|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
125897664|NCT00095147|452923155|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
125897665|NCT00095147|452923156|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
125897666|NCT00095147|452923157|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
126110064|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
125897667|NCT00095147|452923158|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
125897668|NCT00095147|452923154|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
125897669|NCT00095147|452923155|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
125897670|NCT00095147|452923156|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
125897671|NCT00095147|452923157|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
125897672|NCT00095147|452923158|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
125897673|NCT00095147|452923154|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
125897674|NCT00095147|452923155|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
125897675|NCT00095147|452923156|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
125897676|NCT00095147|452923157|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
125897677|NCT00095147|452923158|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
125897678|NCT00095147|452923154|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
125897679|NCT00095147|452923155|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
125897680|NCT00095147|452923156|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
125897681|NCT00095147|452923157|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
125897682|NCT00095147|452923158|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
125897683|NCT00095147|452923154|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
125897684|NCT00095147|452923155|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
125897685|NCT00095147|452923156|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
125897686|NCT00095147|452923157|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
125897687|NCT00095147|452923158|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
125897688|NCT00095147|452923154|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
125897689|NCT00095147|452923155|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
125897690|NCT00095147|452923156|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
125897691|NCT00095147|452923157|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
125897692|NCT00095147|452923158|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
125897693|NCT00095147|452923154|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
125897694|NCT00095147|452923155|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
125897695|NCT00095147|452923156|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
125897696|NCT00095147|452923157|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
125897697|NCT00095147|452923158|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
125897698|NCT00095147|452923154|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
125897699|NCT00095147|452923155|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
125897700|NCT00095147|452923156|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
125897701|NCT00095147|452923157|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
125897702|NCT00095147|452923158|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
125897703|NCT00095147|452923154|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
125897704|NCT00095147|452923155|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
125897705|NCT00095147|452923156|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
125897706|NCT00095147|452923157|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
125897707|NCT00095147|452923158|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
125897708|NCT00095147|452923154|FG000|Long-term Extension Period|Death|0|||
125897709|NCT00095147|452923155|FG001|Long-term Extension Period|Death|0|||
125897710|NCT00095147|452923156|FG002|Long-term Extension Period|Death|0|||
125897711|NCT00095147|452923157|FG003|Long-term Extension Period|Death|0|||
125897712|NCT00095147|452923158|FG004|Long-term Extension Period|Death|3|||
125897713|NCT00095147|452923154|FG000|Long-term Extension Period|Adverse Event|0|||
125897714|NCT00095147|452923155|FG001|Long-term Extension Period|Adverse Event|0|||
125897715|NCT00095147|452923156|FG002|Long-term Extension Period|Adverse Event|0|||
125897716|NCT00095147|452923157|FG003|Long-term Extension Period|Adverse Event|0|||
125897717|NCT00095147|452923158|FG004|Long-term Extension Period|Adverse Event|11|||
125897718|NCT00095147|452923154|FG000|Long-term Extension Period|Lack of Efficacy|0|||
125897719|NCT00095147|452923155|FG001|Long-term Extension Period|Lack of Efficacy|0|||
125897720|NCT00095147|452923156|FG002|Long-term Extension Period|Lack of Efficacy|0|||
125897721|NCT00095147|452923157|FG003|Long-term Extension Period|Lack of Efficacy|0|||
125897722|NCT00095147|452923158|FG004|Long-term Extension Period|Lack of Efficacy|9|||
125897723|NCT00095147|452923154|FG000|Long-term Extension Period|Lost to Follow-up|0|||
125897724|NCT00095147|452923155|FG001|Long-term Extension Period|Lost to Follow-up|0|||
125897725|NCT00095147|452923156|FG002|Long-term Extension Period|Lost to Follow-up|0|||
125897726|NCT00095147|452923157|FG003|Long-term Extension Period|Lost to Follow-up|0|||
125897727|NCT00095147|452923158|FG004|Long-term Extension Period|Lost to Follow-up|6|||
125897728|NCT00095147|452923154|FG000|Long-term Extension Period|Withdrawal of consent|0|||
125897729|NCT00095147|452923155|FG001|Long-term Extension Period|Withdrawal of consent|0|||
125897730|NCT00095147|452923156|FG002|Long-term Extension Period|Withdrawal of consent|0|||
125897731|NCT00095147|452923157|FG003|Long-term Extension Period|Withdrawal of consent|0|||
125897732|NCT00095147|452923158|FG004|Long-term Extension Period|Withdrawal of consent|12|||
125897733|NCT00095147|452923154|FG000|Long-term Extension Period|Pregnancy|0|||
125897734|NCT00095147|452923155|FG001|Long-term Extension Period|Pregnancy|0|||
125897735|NCT00095147|452923156|FG002|Long-term Extension Period|Pregnancy|0|||
125897736|NCT00095147|452923157|FG003|Long-term Extension Period|Pregnancy|0|||
125897737|NCT00095147|452923158|FG004|Long-term Extension Period|Pregnancy|1|||
125897738|NCT00095147|452923154|FG000|Long-term Extension Period|No longer meets study criteria|0|||
125897739|NCT00095147|452923155|FG001|Long-term Extension Period|No longer meets study criteria|0|||
125897740|NCT00095147|452923156|FG002|Long-term Extension Period|No longer meets study criteria|0|||
125897741|NCT00095147|452923157|FG003|Long-term Extension Period|No longer meets study criteria|0|||
125897742|NCT00095147|452923158|FG004|Long-term Extension Period|No longer meets study criteria|1|||
125897743|NCT00095147|452923154|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
125897744|NCT00095147|452923155|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
125897745|NCT00095147|452923156|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
125897746|NCT00095147|452923157|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
125897747|NCT00095147|452923158|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
125897748|NCT00095147|452923154|FG000|Long-term Extension Period|Leaving country|0|||
125897749|NCT00095147|452923155|FG001|Long-term Extension Period|Leaving country|0|||
125897750|NCT00095147|452923156|FG002|Long-term Extension Period|Leaving country|0|||
125897751|NCT00095147|452923157|FG003|Long-term Extension Period|Leaving country|0|||
125897752|NCT00095147|452923158|FG004|Long-term Extension Period|Leaving country|1|||
125897753|NCT01375075|452923161|FG000|Overall Study|Adverse Event|0|||
125897754|NCT01375075|452923162|FG001|Overall Study|Adverse Event|0|||
125897755|NCT01375075|452923163|FG002|Overall Study|Adverse Event|3|||
125897756|NCT01375075|452923164|FG003|Overall Study|Adverse Event|1|||
125897757|NCT01375075|452923165|FG004|Overall Study|Adverse Event|0|||
125897758|NCT01375075|452923166|FG005|Overall Study|Adverse Event|1|||
125897759|NCT01375075|452923161|FG000|Overall Study|Entry Criterion Not Met|1|||
125897760|NCT01375075|452923162|FG001|Overall Study|Entry Criterion Not Met|0|||
125897761|NCT01375075|452923163|FG002|Overall Study|Entry Criterion Not Met|0|||
125897762|NCT01375075|452923164|FG003|Overall Study|Entry Criterion Not Met|0|||
125897763|NCT01375075|452923165|FG004|Overall Study|Entry Criterion Not Met|0|||
125897764|NCT01375075|452923166|FG005|Overall Study|Entry Criterion Not Met|1|||
125897765|NCT01375075|452923161|FG000|Overall Study|Withdrawal by Subject|0|||
125897766|NCT01375075|452923162|FG001|Overall Study|Withdrawal by Subject|1|||
125897767|NCT01375075|452923163|FG002|Overall Study|Withdrawal by Subject|0|||
125897768|NCT01375075|452923164|FG003|Overall Study|Withdrawal by Subject|0|||
125897769|NCT01375075|452923165|FG004|Overall Study|Withdrawal by Subject|0|||
125897770|NCT01375075|452923166|FG005|Overall Study|Withdrawal by Subject|1|||
125897771|NCT01011309|452923167|FG000|Overall Study|Adverse Event|2|||
125897772|NCT01011309|452923168|FG001|Overall Study|Adverse Event|1|||
125897773|NCT01011309|452923169|FG002|Overall Study|Adverse Event|2|||
125897774|NCT01011309|452923167|FG000|Overall Study|Lack of Efficacy|0|||
125897775|NCT01011309|452923168|FG001|Overall Study|Lack of Efficacy|1|||
125897776|NCT01011309|452923169|FG002|Overall Study|Lack of Efficacy|0|||
125897777|NCT01011309|452923167|FG000|Overall Study|Protocol Violation|0|||
125897778|NCT01011309|452923168|FG001|Overall Study|Protocol Violation|1|||
125897779|NCT01011309|452923169|FG002|Overall Study|Protocol Violation|3|||
125897780|NCT03472547|452923176|FG000|Overall Study|Withdrawal by Subject|30|||
125897781|NCT04236141|452924499|FG000|Overall Study|Death|18|||
125897782|NCT04236141|452924500|FG001|Overall Study|Death|10|||
125897783|NCT04236141|452924499|FG000|Overall Study|Withdrawal by Participant|1|||
125897784|NCT04236141|452924500|FG001|Overall Study|Withdrawal by Participant|0|||
125897785|NCT04236141|452924499|FG000|Overall Study|Reason not Specified|1|||
125897786|NCT04236141|452924500|FG001|Overall Study|Reason not Specified|0|||
125897787|NCT04236141|452924499|FG000|Overall Study|Study terminated by Sponsor|8|||
125897788|NCT04236141|452924500|FG001|Overall Study|Study terminated by Sponsor|4|||
125897789|NCT01031836|452924501|FG000|Stage I|Adverse Event|1|||
125897790|NCT01031836|452924502|FG001|Stage I|Adverse Event|1|||
125897791|NCT01031836|452924503|FG002|Stage I|Adverse Event|0|||
125897792|NCT01031836|452924504|FG003|Stage I|Adverse Event|0|||
125897793|NCT01031836|452924505|FG004|Stage I|Adverse Event|0|||
125897794|NCT01031836|452924506|FG005|Stage I|Adverse Event|0|||
125897795|NCT01031836|452924501|FG000|Stage I|Other|0|||
125897796|NCT01031836|452924502|FG001|Stage I|Other|1|||
125897797|NCT01031836|452924503|FG002|Stage I|Other|0|||
125897798|NCT01031836|452924504|FG003|Stage I|Other|0|||
125897799|NCT01031836|452924505|FG004|Stage I|Other|0|||
125897800|NCT01031836|452924506|FG005|Stage I|Other|1|||
125897801|NCT01031836|452924501|FG000|Stage II|Adverse Event|0|||
125897802|NCT01031836|452924502|FG001|Stage II|Adverse Event|0|||
125897803|NCT01031836|452924503|FG002|Stage II|Adverse Event|2|||
125897804|NCT01031836|452924504|FG003|Stage II|Adverse Event|2|||
125897805|NCT01031836|452924505|FG004|Stage II|Adverse Event|1|||
125897806|NCT01031836|452924506|FG005|Stage II|Adverse Event|1|||
125897807|NCT01031836|452924501|FG000|Stage II|Other|2|||
125897808|NCT01031836|452924502|FG001|Stage II|Other|0|||
125897809|NCT01031836|452924503|FG002|Stage II|Other|0|||
125897810|NCT01031836|452924504|FG003|Stage II|Other|1|||
125897811|NCT01031836|452924505|FG004|Stage II|Other|1|||
125897812|NCT01031836|452924506|FG005|Stage II|Other|0|||
125897813|NCT01948193|452924507|FG000|Overall Study|Serious event|2|||
125897814|NCT01948193|452924507|FG000|Overall Study|Lost to Follow-up|7|||
125897815|NCT03137069|452924509|FG000|Overall Study|Withdrawal by Subject|1|||
125897816|NCT03137069|452924510|FG001|Overall Study|Withdrawal by Subject|2|||
125897817|NCT03137069|452924511|FG002|Overall Study|Withdrawal by Subject|2|||
125897818|NCT03137069|452924512|FG003|Overall Study|Withdrawal by Subject|2|||
125897819|NCT03137069|452924513|FG004|Overall Study|Withdrawal by Subject|0|||
125897820|NCT03137069|452924514|FG005|Overall Study|Withdrawal by Subject|0|||
125897821|NCT03137069|452924509|FG000|Overall Study|Adverse Event|0|||
125897822|NCT03137069|452924510|FG001|Overall Study|Adverse Event|3|||
125897823|NCT03137069|452924511|FG002|Overall Study|Adverse Event|1|||
125897824|NCT03137069|452924512|FG003|Overall Study|Adverse Event|1|||
125897825|NCT03137069|452924513|FG004|Overall Study|Adverse Event|0|||
125897826|NCT03137069|452924514|FG005|Overall Study|Adverse Event|1|||
125897827|NCT03137069|452924509|FG000|Overall Study|Protocol Violation|0|||
125897828|NCT03137069|452924510|FG001|Overall Study|Protocol Violation|1|||
125897829|NCT03137069|452924511|FG002|Overall Study|Protocol Violation|0|||
125897830|NCT03137069|452924512|FG003|Overall Study|Protocol Violation|1|||
125897831|NCT03137069|452924513|FG004|Overall Study|Protocol Violation|1|||
125897832|NCT03137069|452924514|FG005|Overall Study|Protocol Violation|1|||
125897833|NCT03137069|452924509|FG000|Overall Study|Physician Decision|0|||
125897834|NCT03137069|452924510|FG001|Overall Study|Physician Decision|0|||
125897835|NCT03137069|452924511|FG002|Overall Study|Physician Decision|0|||
125897836|NCT03137069|452924512|FG003|Overall Study|Physician Decision|1|||
125897837|NCT03137069|452924513|FG004|Overall Study|Physician Decision|0|||
125897838|NCT03137069|452924514|FG005|Overall Study|Physician Decision|0|||
125897839|NCT03137069|452924509|FG000|Overall Study|Study Terminated by Sponsor|0|||
125897840|NCT03137069|452924510|FG001|Overall Study|Study Terminated by Sponsor|0|||
125897841|NCT03137069|452924511|FG002|Overall Study|Study Terminated by Sponsor|0|||
125897842|NCT03137069|452924512|FG003|Overall Study|Study Terminated by Sponsor|0|||
125897843|NCT03137069|452924513|FG004|Overall Study|Study Terminated by Sponsor|1|||
125897844|NCT03137069|452924514|FG005|Overall Study|Study Terminated by Sponsor|0|||
125897845|NCT03137069|452924509|FG000|Overall Study|Data Entry Error|0|||
125897846|NCT03137069|452924510|FG001|Overall Study|Data Entry Error|0|||
125897847|NCT03137069|452924511|FG002|Overall Study|Data Entry Error|0|||
125897848|NCT03137069|452924512|FG003|Overall Study|Data Entry Error|1|||
125897849|NCT03137069|452924513|FG004|Overall Study|Data Entry Error|0|||
125897850|NCT03137069|452924514|FG005|Overall Study|Data Entry Error|0|||
125897851|NCT02043899|452924516|FG000|Overall Study|Adverse Event|3|||
125897852|NCT02043899|452924516|FG000|Overall Study|Physician Decision|1|||
125897853|NCT02043899|452924516|FG000|Overall Study|Withdrawal by Subject|2|||
125897854|NCT02043899|452924516|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
125897855|NCT02043899|452924516|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
125897856|NCT02043899|452924516|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
125897857|NCT02043899|452924516|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
125897858|NCT02043899|452924516|FG000|Overall Study|Treatment delayed|1|||
125897859|NCT01954927|452924518|FG000|Overall Study|Withdrawal by Subject|3|||
125897860|NCT01954927|452924519|FG001|Overall Study|Withdrawal by Subject|1|||
125897861|NCT03320824|452924520|FG000|Overall Study|Withdrawal by Subject|8|||
125897862|NCT03320824|452924521|FG001|Overall Study|Withdrawal by Subject|1|||
125897863|NCT03320824|452924520|FG000|Overall Study|Lost to Follow-up|10|||
125897864|NCT03320824|452924521|FG001|Overall Study|Lost to Follow-up|1|||
125897865|NCT03320824|452924520|FG000|Overall Study|moved out of state|0|||
125897866|NCT03320824|452924521|FG001|Overall Study|moved out of state|1|||
125897867|NCT03320824|452924520|FG000|Overall Study|could not complete final visit|0|||
125897868|NCT03320824|452924521|FG001|Overall Study|could not complete final visit|1|||
125897869|NCT00955305|452924522|FG000|Overall Study|Disease progression|39|||
125897870|NCT00955305|452924523|FG001|Overall Study|Disease progression|41|||
125897871|NCT00955305|452924522|FG000|Overall Study|Adverse Event|22|||
125897872|NCT00955305|452924523|FG001|Overall Study|Adverse Event|22|||
125897873|NCT00955305|452924522|FG000|Overall Study|Death|2|||
125897874|NCT00955305|452924523|FG001|Overall Study|Death|1|||
125897875|NCT00955305|452924522|FG000|Overall Study|Withdrawal by Subject|5|||
125897876|NCT00955305|452924523|FG001|Overall Study|Withdrawal by Subject|4|||
125897877|NCT00955305|452924522|FG000|Overall Study|Alternative therapy|4|||
125897878|NCT00955305|452924523|FG001|Overall Study|Alternative therapy|0|||
125897879|NCT00955305|452924522|FG000|Overall Study|Other complicating disease|2|||
125897880|NCT00955305|452924523|FG001|Overall Study|Other complicating disease|4|||
125897881|NCT00955305|452924522|FG000|Overall Study|Physician Decision|1|||
125897882|NCT00955305|452924523|FG001|Overall Study|Physician Decision|0|||
125897883|NCT00955305|452924522|FG000|Overall Study|Continued presence of residual disease|0|||
125897884|NCT00955305|452924523|FG001|Overall Study|Continued presence of residual disease|1|||
125897885|NCT00955305|452924522|FG000|Overall Study|Functional decline|2|||
125897886|NCT00955305|452924523|FG001|Overall Study|Functional decline|0|||
125897887|NCT00955305|452924522|FG000|Overall Study|Maximum response achieved|0|||
125897888|NCT00955305|452924523|FG001|Overall Study|Maximum response achieved|1|||
125897889|NCT00955305|452924522|FG000|Overall Study|Lost to Follow-up|0|||
125897890|NCT00955305|452924523|FG001|Overall Study|Lost to Follow-up|1|||
125897891|NCT00955305|452924522|FG000|Overall Study|No off-treatment reason submitted|1|||
125897892|NCT00955305|452924523|FG001|Overall Study|No off-treatment reason submitted|0|||
125897893|NCT00955305|452924522|FG000|Overall Study|Never started protocol treatment|5|||
125897894|NCT00955305|452924523|FG001|Overall Study|Never started protocol treatment|5|||
125897895|NCT00955305|452924522|FG000|Overall Study|Ineligible|5|||
125897896|NCT00955305|452924523|FG001|Overall Study|Ineligible|7|||
125897897|NCT03387111|452924524|FG000|Overall Study|Progressive Disease|3|||
125897898|NCT03387111|452924524|FG000|Overall Study|Other|1|||
125897899|NCT00507728|452924540|FG000|Randomization to Month 3|Lost to Follow-up|15|||
125897900|NCT00507728|452924541|FG001|Randomization to Month 3|Lost to Follow-up|14|||
125897901|NCT00507728|452924542|FG002|Randomization to Month 3|Lost to Follow-up|20|||
125897902|NCT00507728|452924540|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
125897903|NCT00507728|452924541|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
125897904|NCT00507728|452924542|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
125897905|NCT01964755|452924543|FG000|Overall Study|Death|2|||
125897906|NCT01332799|452924545|FG000|Overall Study|Insufficient funding|10|||
125897907|NCT01332799|452924546|FG001|Overall Study|Insufficient funding|10|||
125897908|NCT04140227|452924549|FG000|Overall Study|Withdrawal by Subject|26|||
125897909|NCT04140227|452924549|FG000|Overall Study|Lost to Follow-up|8|||
125897910|NCT04140227|452924549|FG000|Overall Study|Adverse Event|8|||
125897911|NCT04140227|452924549|FG000|Overall Study|Death|1|||
125897912|NCT04140227|452924549|FG000|Overall Study|Other|3|||
125897913|NCT04140227|452924549|FG000|Overall Study|Protocol Violation|2|||
125897914|NCT05315908|452924554|FG000|Overall Study|Lost to Follow-up|4477|||
125897915|NCT05315908|452924555|FG001|Overall Study|Lost to Follow-up|4606|||
125897916|NCT01541397|452924560|FG000|Overall Study|Study ended prior to data collection|4|||
125897917|NCT01541397|452924561|FG001|Overall Study|Study ended prior to data collection|2|||
125897918|NCT01689532|452924562|FG000|Overall Study|Adverse Event|9|||
125897919|NCT01689532|452924563|FG001|Overall Study|Adverse Event|5|||
125897920|NCT01689532|452924562|FG000|Overall Study|Lack of Efficacy|2|||
125897921|NCT01689532|452924563|FG001|Overall Study|Lack of Efficacy|2|||
125897922|NCT01689532|452924562|FG000|Overall Study|Withdrawal by Subject|1|||
125897923|NCT01689532|452924563|FG001|Overall Study|Withdrawal by Subject|2|||
125897924|NCT01689532|452924562|FG000|Overall Study|Physician Decision|2|||
125897925|NCT01689532|452924563|FG001|Overall Study|Physician Decision|0|||
125897926|NCT01363349|452924564|FG000|Overall Study|Adverse Event|6|||
125897927|NCT01363349|452924565|FG001|Overall Study|Adverse Event|7|||
125897928|NCT01363349|452924564|FG000|Overall Study|Lack of Efficacy|3|||
125897929|NCT01363349|452924565|FG001|Overall Study|Lack of Efficacy|10|||
125897930|NCT01363349|452924564|FG000|Overall Study|Non compliance/Protocol deviations|2|||
125897931|NCT01363349|452924565|FG001|Overall Study|Non compliance/Protocol deviations|2|||
125897932|NCT01363349|452924564|FG000|Overall Study|Withdrawal by Subject|14|||
125897933|NCT01363349|452924565|FG001|Overall Study|Withdrawal by Subject|6|||
125897934|NCT01363349|452924564|FG000|Overall Study|Lost to Follow-up|5|||
125897935|NCT01363349|452924565|FG001|Overall Study|Lost to Follow-up|6|||
125897936|NCT01363349|452924564|FG000|Overall Study|Not reported|36|||
125897937|NCT01363349|452924565|FG001|Overall Study|Not reported|37|||
125897938|NCT01363349|452924564|FG000|Overall Study|missing|1|||
125897939|NCT01363349|452924565|FG001|Overall Study|missing|2|||
125897940|NCT02208063|452924566|FG000|Overall Study|Death|3|||
125897941|NCT02208063|452924567|FG001|Overall Study|Death|5|||
125897942|NCT02208063|452924566|FG000|Overall Study|Not Specified in report|3|||
125897943|NCT02208063|452924567|FG001|Overall Study|Not Specified in report|4|||
125897944|NCT02208063|452924566|FG000|Overall Study|Withdrawal by Subject|5|||
125897945|NCT02208063|452924567|FG001|Overall Study|Withdrawal by Subject|2|||
125897946|NCT02208063|452924566|FG000|Overall Study|Lost to Follow-up|1|||
125897947|NCT02208063|452924567|FG001|Overall Study|Lost to Follow-up|0|||
125897948|NCT00913458|452924568|FG000|Phase 1|Non-Responder|54|||
125897949|NCT00913458|452924569|FG001|Phase 1|Non-Responder|0|||
125897950|NCT00913458|452924570|FG002|Phase 1|Non-Responder|0|||
125897951|NCT00913458|452924571|FG003|Phase 1|Non-Responder|0|||
125897952|NCT00913458|452924572|FG004|Phase 1|Non-Responder|0|||
125897953|NCT00913458|452924573|FG005|Phase 1|Non-Responder|0|||
125897954|NCT00913458|452924574|FG006|Phase 1|Non-Responder|0|||
125897955|NCT00913458|452924568|FG000|Phase 1|Subject Request|17|||
125897956|NCT00913458|452924569|FG001|Phase 1|Subject Request|0|||
125897957|NCT00913458|452924570|FG002|Phase 1|Subject Request|0|||
125897958|NCT00913458|452924571|FG003|Phase 1|Subject Request|0|||
125897959|NCT00913458|452924572|FG004|Phase 1|Subject Request|0|||
125897960|NCT00913458|452924573|FG005|Phase 1|Subject Request|0|||
125897961|NCT00913458|452924574|FG006|Phase 1|Subject Request|0|||
125897962|NCT00913458|452924568|FG000|Phase 1|Adverse Event|20|||
125897963|NCT00913458|452924569|FG001|Phase 1|Adverse Event|0|||
125897964|NCT00913458|452924570|FG002|Phase 1|Adverse Event|0|||
125897965|NCT00913458|452924571|FG003|Phase 1|Adverse Event|0|||
125897966|NCT00913458|452924572|FG004|Phase 1|Adverse Event|0|||
125897967|NCT00913458|452924573|FG005|Phase 1|Adverse Event|0|||
125897968|NCT00913458|452924574|FG006|Phase 1|Adverse Event|0|||
125897969|NCT00913458|452924568|FG000|Phase 1|Lost to Follow-up|2|||
125897970|NCT00913458|452924569|FG001|Phase 1|Lost to Follow-up|0|||
125897971|NCT00913458|452924570|FG002|Phase 1|Lost to Follow-up|0|||
125897972|NCT00913458|452924571|FG003|Phase 1|Lost to Follow-up|0|||
125897973|NCT00913458|452924572|FG004|Phase 1|Lost to Follow-up|0|||
125897974|NCT00913458|452924573|FG005|Phase 1|Lost to Follow-up|0|||
125897975|NCT00913458|452924574|FG006|Phase 1|Lost to Follow-up|0|||
125897976|NCT00913458|452924568|FG000|Phase 1|Protocol Violation|10|||
125897977|NCT00913458|452924569|FG001|Phase 1|Protocol Violation|0|||
125897978|NCT00913458|452924570|FG002|Phase 1|Protocol Violation|0|||
125897979|NCT00913458|452924571|FG003|Phase 1|Protocol Violation|0|||
125897980|NCT00913458|452924572|FG004|Phase 1|Protocol Violation|0|||
125897981|NCT00913458|452924573|FG005|Phase 1|Protocol Violation|0|||
125897982|NCT00913458|452924574|FG006|Phase 1|Protocol Violation|0|||
125897983|NCT00913458|452924568|FG000|Phase 1|Sponsor|2|||
125897984|NCT00913458|452924569|FG001|Phase 1|Sponsor|0|||
125897985|NCT00913458|452924570|FG002|Phase 1|Sponsor|0|||
125897986|NCT00913458|452924571|FG003|Phase 1|Sponsor|0|||
125897987|NCT00913458|452924572|FG004|Phase 1|Sponsor|0|||
125897988|NCT00913458|452924573|FG005|Phase 1|Sponsor|0|||
125897989|NCT00913458|452924574|FG006|Phase 1|Sponsor|0|||
125897990|NCT00913458|452924568|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
125897991|NCT00913458|452924569|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
125897992|NCT00913458|452924570|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
125897993|NCT00913458|452924571|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
125897994|NCT00913458|452924572|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
125897995|NCT00913458|452924573|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
125897996|NCT00913458|452924574|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
125897997|NCT00913458|452924568|FG000|Phase 2|Non-Responder|0|||
125897998|NCT00913458|452924569|FG001|Phase 2|Non-Responder|5|||
125897999|NCT00913458|452924570|FG002|Phase 2|Non-Responder|7|||
125898000|NCT00913458|452924571|FG003|Phase 2|Non-Responder|12|||
125898001|NCT00913458|452924572|FG004|Phase 2|Non-Responder|0|||
125898002|NCT00913458|452924573|FG005|Phase 2|Non-Responder|0|||
125898003|NCT00913458|452924574|FG006|Phase 2|Non-Responder|0|||
125898004|NCT00913458|452924568|FG000|Phase 2|Subject Request|0|||
125898005|NCT00913458|452924569|FG001|Phase 2|Subject Request|0|||
125898006|NCT00913458|452924570|FG002|Phase 2|Subject Request|1|||
125898007|NCT00913458|452924571|FG003|Phase 2|Subject Request|2|||
125898008|NCT00913458|452924572|FG004|Phase 2|Subject Request|0|||
125898009|NCT00913458|452924573|FG005|Phase 2|Subject Request|0|||
125898010|NCT00913458|452924574|FG006|Phase 2|Subject Request|0|||
125898011|NCT00913458|452924568|FG000|Phase 2|Adverse Event|0|||
125898012|NCT00913458|452924569|FG001|Phase 2|Adverse Event|3|||
125898013|NCT00913458|452924570|FG002|Phase 2|Adverse Event|0|||
125898014|NCT00913458|452924571|FG003|Phase 2|Adverse Event|1|||
125898015|NCT00913458|452924572|FG004|Phase 2|Adverse Event|0|||
125898016|NCT00913458|452924573|FG005|Phase 2|Adverse Event|0|||
125898017|NCT00913458|452924574|FG006|Phase 2|Adverse Event|0|||
125898018|NCT00913458|452924568|FG000|Phase 2|Lost to Follow-up|0|||
125898019|NCT00913458|452924569|FG001|Phase 2|Lost to Follow-up|0|||
125898020|NCT00913458|452924570|FG002|Phase 2|Lost to Follow-up|0|||
125898021|NCT00913458|452924571|FG003|Phase 2|Lost to Follow-up|1|||
125898022|NCT00913458|452924572|FG004|Phase 2|Lost to Follow-up|0|||
125898023|NCT00913458|452924573|FG005|Phase 2|Lost to Follow-up|0|||
125898024|NCT00913458|452924574|FG006|Phase 2|Lost to Follow-up|0|||
125898025|NCT00913458|452924568|FG000|Phase 2|Protocol Violation|0|||
125898026|NCT00913458|452924569|FG001|Phase 2|Protocol Violation|2|||
125898027|NCT00913458|452924570|FG002|Phase 2|Protocol Violation|0|||
125898028|NCT00913458|452924571|FG003|Phase 2|Protocol Violation|0|||
125898029|NCT00913458|452924572|FG004|Phase 2|Protocol Violation|0|||
125898030|NCT00913458|452924573|FG005|Phase 2|Protocol Violation|0|||
125898031|NCT00913458|452924574|FG006|Phase 2|Protocol Violation|0|||
125898032|NCT00913458|452924568|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
125898033|NCT00913458|452924569|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
125898034|NCT00913458|452924570|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
125898035|NCT00913458|452924571|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
125898036|NCT00913458|452924572|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
125898037|NCT00913458|452924573|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
125898038|NCT00913458|452924574|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
125898039|NCT00913458|452924568|FG000|Phase 3|Adverse Event|0|||
125898040|NCT00913458|452924569|FG001|Phase 3|Adverse Event|0|||
125898041|NCT00913458|452924570|FG002|Phase 3|Adverse Event|0|||
125898042|NCT00913458|452924571|FG003|Phase 3|Adverse Event|0|||
125898043|NCT00913458|452924572|FG004|Phase 3|Adverse Event|5|||
125898044|NCT00913458|452924573|FG005|Phase 3|Adverse Event|4|||
125898045|NCT00913458|452924574|FG006|Phase 3|Adverse Event|1|||
125898046|NCT00913458|452924568|FG000|Phase 3|Lost to Follow-up|0|||
125898047|NCT00913458|452924569|FG001|Phase 3|Lost to Follow-up|0|||
125898048|NCT00913458|452924570|FG002|Phase 3|Lost to Follow-up|0|||
125898049|NCT00913458|452924571|FG003|Phase 3|Lost to Follow-up|0|||
125898050|NCT00913458|452924572|FG004|Phase 3|Lost to Follow-up|2|||
125898051|NCT00913458|452924573|FG005|Phase 3|Lost to Follow-up|0|||
125898052|NCT00913458|452924574|FG006|Phase 3|Lost to Follow-up|0|||
125898053|NCT00913458|452924568|FG000|Phase 3|Non-Responder|0|||
125898054|NCT00913458|452924569|FG001|Phase 3|Non-Responder|0|||
125898055|NCT00913458|452924570|FG002|Phase 3|Non-Responder|0|||
125898056|NCT00913458|452924571|FG003|Phase 3|Non-Responder|0|||
125898057|NCT00913458|452924572|FG004|Phase 3|Non-Responder|0|||
125898058|NCT00913458|452924573|FG005|Phase 3|Non-Responder|1|||
125898059|NCT00913458|452924574|FG006|Phase 3|Non-Responder|3|||
125898060|NCT00913458|452924568|FG000|Phase 3|Withdrawal by Subject|0|||
125898061|NCT00913458|452924569|FG001|Phase 3|Withdrawal by Subject|0|||
125898062|NCT00913458|452924570|FG002|Phase 3|Withdrawal by Subject|0|||
125898063|NCT00913458|452924571|FG003|Phase 3|Withdrawal by Subject|0|||
125898064|NCT00913458|452924572|FG004|Phase 3|Withdrawal by Subject|1|||
125898065|NCT00913458|452924573|FG005|Phase 3|Withdrawal by Subject|2|||
125898066|NCT00913458|452924574|FG006|Phase 3|Withdrawal by Subject|0|||
125898067|NCT00913458|452924568|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
125898068|NCT00913458|452924569|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
125898069|NCT00913458|452924570|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
125898070|NCT00913458|452924571|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
125898071|NCT00913458|452924572|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
125898072|NCT00913458|452924573|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
125898073|NCT00913458|452924574|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
125898074|NCT02279407|452924575|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
125898075|NCT02279407|452924576|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
125898076|NCT02279407|452924577|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
125898077|NCT02279407|452924578|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
125898078|NCT02279407|452924575|FG000|Overall Study|Withdrawal by Subject|1|||
125898079|NCT02279407|452924576|FG001|Overall Study|Withdrawal by Subject|0|||
125898080|NCT02279407|452924577|FG002|Overall Study|Withdrawal by Subject|1|||
125898081|NCT02279407|452924578|FG003|Overall Study|Withdrawal by Subject|1|||
125898082|NCT02279407|452924575|FG000|Overall Study|Adverse Event|1|||
125898083|NCT02279407|452924576|FG001|Overall Study|Adverse Event|1|||
125898084|NCT02279407|452924577|FG002|Overall Study|Adverse Event|2|||
125898085|NCT02279407|452924578|FG003|Overall Study|Adverse Event|0|||
125898086|NCT00422084|452924583|FG000|Overall Study|Adverse Event|21|||
125898087|NCT00422084|452924584|FG001|Overall Study|Adverse Event|7|||
125898088|NCT00422084|452924583|FG000|Overall Study|Withdrawal by Subject|12|||
125898089|NCT00422084|452924584|FG001|Overall Study|Withdrawal by Subject|9|||
125898090|NCT00422084|452924583|FG000|Overall Study|Lost to Follow-up|14|||
125898091|NCT00422084|452924584|FG001|Overall Study|Lost to Follow-up|9|||
125898092|NCT00422084|452924583|FG000|Overall Study|Protocol Violation|4|||
125898093|NCT00422084|452924584|FG001|Overall Study|Protocol Violation|1|||
125898094|NCT00422084|452924583|FG000|Overall Study|Lack of Efficacy|40|||
125898095|NCT00422084|452924584|FG001|Overall Study|Lack of Efficacy|42|||
125898096|NCT00422084|452924583|FG000|Overall Study|P. vivax infection|3|||
125898097|NCT00422084|452924584|FG001|Overall Study|P. vivax infection|6|||
125898098|NCT00422084|452924583|FG000|Overall Study|Cyesis|1|||
125898099|NCT00422084|452924584|FG001|Overall Study|Cyesis|0|||
125898100|NCT00422084|452924583|FG000|Overall Study|Withdrawn from study accidentally|1|||
125898101|NCT00422084|452924584|FG001|Overall Study|Withdrawn from study accidentally|0|||
125898102|NCT00422084|452924583|FG000|Overall Study|Non-compliance|1|||
125898103|NCT00422084|452924584|FG001|Overall Study|Non-compliance|0|||
125898104|NCT00422084|452924583|FG000|Overall Study|Re-location|0|||
125898105|NCT00422084|452924584|FG001|Overall Study|Re-location|1|||
125898106|NCT00422084|452924583|FG000|Overall Study|Not defined|1|||
125898107|NCT00422084|452924584|FG001|Overall Study|Not defined|1|||
125898108|NCT02788279|452924585|FG000|Overall Study|Death|62|||
125898109|NCT02788279|452924586|FG001|Overall Study|Death|136|||
125898110|NCT02788279|452924587|FG002|Overall Study|Death|72|||
125898111|NCT02788279|452924585|FG000|Overall Study|Withdrawal by Subject|10|||
125898112|NCT02788279|452924586|FG001|Overall Study|Withdrawal by Subject|15|||
125898113|NCT02788279|452924587|FG002|Overall Study|Withdrawal by Subject|5|||
125898114|NCT02788279|452924585|FG000|Overall Study|Lost to Follow-up|0|||
125898115|NCT02788279|452924586|FG001|Overall Study|Lost to Follow-up|3|||
125898116|NCT02788279|452924587|FG002|Overall Study|Lost to Follow-up|2|||
125898117|NCT02788279|452924585|FG000|Overall Study|Sponsor decision|18|||
125898118|NCT02788279|452924586|FG001|Overall Study|Sponsor decision|29|||
125898119|NCT02788279|452924587|FG002|Overall Study|Sponsor decision|11|||
125898120|NCT00329849|452924588|FG000|Overall Study|Withdrawal by Subject|6|||
125898121|NCT00329849|452924589|FG001|Overall Study|Withdrawal by Subject|4|||
125898122|NCT03996369|452924590|FG000|Overall Study|Protocol deviation|1|||
125898123|NCT03996369|452924591|FG001|Overall Study|Protocol deviation|1|||
125898124|NCT03996369|452924590|FG000|Overall Study|Physician Decision|4|||
125898125|NCT03996369|452924591|FG001|Overall Study|Physician Decision|2|||
125898126|NCT03996369|452924590|FG000|Overall Study|Participant decision|0|||
125898127|NCT03996369|452924591|FG001|Overall Study|Participant decision|1|||
125898128|NCT03996369|452924590|FG000|Overall Study|Lack of Efficacy|4|||
125898129|NCT03996369|452924591|FG001|Overall Study|Lack of Efficacy|0|||
125898130|NCT03996369|452924590|FG000|Overall Study|Adverse Event|9|||
125898131|NCT03996369|452924591|FG001|Overall Study|Adverse Event|0|||
125898132|NCT03996369|452924590|FG000|Overall Study|Withdrawal by Subject|6|||
125898133|NCT03996369|452924591|FG001|Overall Study|Withdrawal by Subject|8|||
125898134|NCT03996369|452924590|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
125898135|NCT03996369|452924591|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
125898136|NCT03996369|452924590|FG000|Overall Study|Lost to Follow-up|0|||
125898137|NCT03996369|452924591|FG001|Overall Study|Lost to Follow-up|1|||
125898138|NCT01782469|452924592|FG000|Overall Study|Lost to Follow-up|1|||
125898139|NCT00357760|452924599|FG000|Overall Study|Disease progression|44|||
125898140|NCT00357760|452924600|FG001|Overall Study|Disease progression|17|||
125898141|NCT00357760|452924599|FG000|Overall Study|Adverse Event|10|||
125898142|NCT00357760|452924600|FG001|Overall Study|Adverse Event|7|||
125898143|NCT00357760|452924599|FG000|Overall Study|Death|0|||
125898144|NCT00357760|452924600|FG001|Overall Study|Death|3|||
125898145|NCT00357760|452924599|FG000|Overall Study|Alternative therapy|1|||
125898146|NCT00357760|452924600|FG001|Overall Study|Alternative therapy|0|||
125898147|NCT00357760|452924599|FG000|Overall Study|Withdrawal by Subject|0|||
125898148|NCT00357760|452924600|FG001|Overall Study|Withdrawal by Subject|2|||
125898149|NCT00357760|452924599|FG000|Overall Study|Never started treatment|2|||
125898150|NCT00357760|452924600|FG001|Overall Study|Never started treatment|1|||
125898151|NCT00357760|452924599|FG000|Overall Study|Ineligible|0|||
125898152|NCT00357760|452924600|FG001|Overall Study|Ineligible|2|||
125898153|NCT00357760|452924599|FG000|Overall Study|Physician Decision|2|||
125898154|NCT00357760|452924600|FG001|Overall Study|Physician Decision|1|||
125898155|NCT00357760|452924599|FG000|Overall Study|Protocol Violation|0|||
125898156|NCT00357760|452924600|FG001|Overall Study|Protocol Violation|1|||
125898157|NCT00357760|452924599|FG000|Overall Study|To receive hospice care|0|||
125898158|NCT00357760|452924600|FG001|Overall Study|To receive hospice care|1|||
125898159|NCT04136444|452924601|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
125898160|NCT04136444|452924602|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
125898161|NCT02184572|452924608|FG000|Overall Study|Lost to Follow-up|29|||
125898162|NCT02184572|452924609|FG001|Overall Study|Lost to Follow-up|21|||
125898163|NCT02184572|452924608|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
125898164|NCT02184572|452924609|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
125898165|NCT02184572|452924608|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
125898166|NCT02184572|452924609|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
125898167|NCT02184572|452924608|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
125898168|NCT02184572|452924609|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
125898169|NCT02184572|452924608|FG000|Overall Study|Traveling Outside The Country|1|||
125898170|NCT02184572|452924609|FG001|Overall Study|Traveling Outside The Country|0|||
125898171|NCT02184572|452924608|FG000|Overall Study|Withdrawal by Subject|14|||
125898172|NCT02184572|452924609|FG001|Overall Study|Withdrawal by Subject|9|||
125898173|NCT03726996|452924610|FG000|Overall Study|Parent's decision|2|||
125898174|NCT03726996|452924610|FG000|Overall Study|Study early termination|2|||
125898175|NCT01328444|452924611|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
125898176|NCT01328444|452924612|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
125898177|NCT01328444|452924613|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
125898178|NCT01328444|452924614|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
125898179|NCT01328444|452924615|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
125898180|NCT01328444|452924616|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
125898181|NCT01328444|452924611|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
125898182|NCT01328444|452924612|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
125898183|NCT01328444|452924613|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
125898184|NCT01328444|452924614|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
125898185|NCT01328444|452924615|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
125898186|NCT01328444|452924616|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
125898187|NCT01328444|452924611|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125898188|NCT01328444|452924612|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125898189|NCT01328444|452924613|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125898190|NCT01328444|452924614|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
125898191|NCT01328444|452924615|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125898192|NCT01328444|452924616|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
125898193|NCT01328444|452924611|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
125898194|NCT01328444|452924612|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
125898195|NCT01328444|452924613|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
125898196|NCT01328444|452924614|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
125898197|NCT01328444|452924615|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
125898198|NCT01328444|452924616|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
125898199|NCT01328444|452924611|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
125898200|NCT01328444|452924612|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125898201|NCT01328444|452924613|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125898202|NCT01328444|452924614|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125898203|NCT01328444|452924615|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125898204|NCT01328444|452924616|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125898205|NCT01328444|452924611|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125898206|NCT01328444|452924612|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
125898207|NCT01328444|452924613|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
125898208|NCT01328444|452924614|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
125898209|NCT01328444|452924615|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
125898210|NCT01328444|452924616|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125898211|NCT01328444|452924611|FG000|Washout Period (14 Days)|Adverse Event|1|||
125898212|NCT01328444|452924612|FG001|Washout Period (14 Days)|Adverse Event|1|||
125898213|NCT01328444|452924613|FG002|Washout Period (14 Days)|Adverse Event|0|||
125898214|NCT01328444|452924614|FG003|Washout Period (14 Days)|Adverse Event|1|||
125898215|NCT01328444|452924615|FG004|Washout Period (14 Days)|Adverse Event|1|||
125898216|NCT01328444|452924616|FG005|Washout Period (14 Days)|Adverse Event|2|||
125898217|NCT01328444|452924611|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
125898218|NCT01328444|452924612|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
125898219|NCT01328444|452924613|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
125898220|NCT01328444|452924614|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
125898221|NCT01328444|452924615|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
125898222|NCT01328444|452924616|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
125898223|NCT01328444|452924611|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
125898224|NCT01328444|452924612|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
125898225|NCT01328444|452924613|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
125898226|NCT01328444|452924614|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
125898227|NCT01328444|452924615|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
125898228|NCT01328444|452924616|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
125898229|NCT01328444|452924611|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
125898230|NCT01328444|452924612|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125898231|NCT01328444|452924613|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125898232|NCT01328444|452924614|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125898233|NCT01328444|452924615|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125898234|NCT01328444|452924616|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125898235|NCT01328444|452924611|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
125898236|NCT01328444|452924612|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125898237|NCT01328444|452924613|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125898238|NCT01328444|452924614|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
125898239|NCT01328444|452924615|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
125898240|NCT01328444|452924616|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
125898241|NCT01328444|452924611|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
125898242|NCT01328444|452924612|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
125898243|NCT01328444|452924613|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
125898244|NCT01328444|452924614|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
125898245|NCT01328444|452924615|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
125898246|NCT01328444|452924616|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
125898247|NCT01328444|452924611|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125898248|NCT01328444|452924612|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125898249|NCT01328444|452924613|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125898250|NCT01328444|452924614|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
125898251|NCT01328444|452924615|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
125898252|NCT01328444|452924616|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125898253|NCT01328444|452924611|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
125898254|NCT01328444|452924612|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
125898255|NCT01328444|452924613|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
125898256|NCT01328444|452924614|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
125898257|NCT01328444|452924615|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
125898258|NCT01328444|452924616|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
125898259|NCT01328444|452924611|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125898260|NCT01328444|452924612|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125898261|NCT01328444|452924613|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125898262|NCT01328444|452924614|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125898263|NCT01328444|452924615|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125898264|NCT01328444|452924616|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125898265|NCT02743611|452924617|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
125898266|NCT02743611|452924618|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
125898267|NCT02743611|452924619|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
125898268|NCT02743611|452924620|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
125898269|NCT00561977|452924621|FG000|Overall Study|Withdrawal by Subject|0|||
125898270|NCT00561977|452924622|FG001|Overall Study|Withdrawal by Subject|2|||
125898271|NCT00561977|452924623|FG002|Overall Study|Withdrawal by Subject|1|||
125898272|NCT00561977|452924621|FG000|Overall Study|Pregnancy|0|||
125898273|NCT00561977|452924622|FG001|Overall Study|Pregnancy|1|||
125898274|NCT00561977|452924623|FG002|Overall Study|Pregnancy|1|||
125898275|NCT00946985|452924624|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
125898276|NCT00946985|452924624|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
125898277|NCT00946985|452924624|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
125898278|NCT00946985|452924624|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
125898279|NCT00946985|452924624|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
125898280|NCT00946985|452924624|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
125898281|NCT00946985|452924624|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
125898282|NCT00946985|452924624|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
125898283|NCT00946985|452924624|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
125898284|NCT04345367|452924625|FG000|Overall Study|Other|3|||
125898285|NCT04345367|452924626|FG001|Overall Study|Other|4|||
125898286|NCT04345367|452924625|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
125898287|NCT04345367|452924626|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
125898288|NCT04345367|452924625|FG000|Overall Study|Withdrawal by Subject|11|||
125898289|NCT04345367|452924626|FG001|Overall Study|Withdrawal by Subject|11|||
125898290|NCT04345367|452924625|FG000|Overall Study|Protocol Violation|4|||
125898291|NCT04345367|452924626|FG001|Overall Study|Protocol Violation|3|||
125898292|NCT04345367|452924625|FG000|Overall Study|Lost to Follow-up|2|||
125898293|NCT04345367|452924626|FG001|Overall Study|Lost to Follow-up|4|||
125898294|NCT04345367|452924625|FG000|Overall Study|Lack of Efficacy|2|||
125898295|NCT04345367|452924626|FG001|Overall Study|Lack of Efficacy|0|||
125898296|NCT04345367|452924625|FG000|Overall Study|Death|2|||
125898297|NCT04345367|452924626|FG001|Overall Study|Death|0|||
125898298|NCT04345367|452924625|FG000|Overall Study|Adverse Event|10|||
125898299|NCT04345367|452924626|FG001|Overall Study|Adverse Event|9|||
125898300|NCT00852371|452924627|FG000|Overall Study|Lost to Follow-up|2|||
125898301|NCT00852371|452924628|FG001|Overall Study|Lost to Follow-up|3|||
125898302|NCT00852371|452924629|FG002|Overall Study|Lost to Follow-up|4|||
125898303|NCT00852371|452924630|FG003|Overall Study|Lost to Follow-up|2|||
125898304|NCT00796523|452924631|FG000|Overall Study|Lost to Follow-up|9|||
125898305|NCT00796523|452924632|FG001|Overall Study|Lost to Follow-up|7|||
125898306|NCT04525885|452924634|FG000|Overall Study|Screen Failure|1|||
125898307|NCT04525885|452924635|FG001|Overall Study|Screen Failure|0|||
125898308|NCT04525885|452924636|FG002|Overall Study|Screen Failure|0|||
125898309|NCT04525885|452924634|FG000|Overall Study|Withdrawal by Subject|14|||
125898310|NCT04525885|452924635|FG001|Overall Study|Withdrawal by Subject|6|||
125898311|NCT04525885|452924636|FG002|Overall Study|Withdrawal by Subject|20|||
125898312|NCT04525885|452924634|FG000|Overall Study|Physician Decision|1|||
125898313|NCT04525885|452924635|FG001|Overall Study|Physician Decision|0|||
125898314|NCT04525885|452924636|FG002|Overall Study|Physician Decision|1|||
125898315|NCT00781885|452924644|FG000|Overall Study|Physician Decision|1|||
125898316|NCT01755026|452924645|FG000|Overall Study|Adverse Event|1|||
125898317|NCT01755026|452924646|FG001|Overall Study|Adverse Event|0|||
125898318|NCT01755026|452924645|FG000|Overall Study|Withdrawal by Subject|1|||
125898319|NCT01755026|452924646|FG001|Overall Study|Withdrawal by Subject|1|||
125898320|NCT01325337|452926286|FG000|Overall Study|Adverse Event|0|||
125898321|NCT01325337|452926287|FG001|Overall Study|Adverse Event|2|||
125898322|NCT01325337|452926288|FG002|Overall Study|Adverse Event|2|||
125898323|NCT01325337|452926289|FG003|Overall Study|Adverse Event|1|||
125898324|NCT01325337|452926290|FG004|Overall Study|Adverse Event|2|||
125898325|NCT01325337|452926286|FG000|Overall Study|Lost to Follow-up|2|||
125898326|NCT01325337|452926287|FG001|Overall Study|Lost to Follow-up|2|||
125898327|NCT01325337|452926288|FG002|Overall Study|Lost to Follow-up|2|||
125898328|NCT01325337|452926289|FG003|Overall Study|Lost to Follow-up|1|||
125898329|NCT01325337|452926290|FG004|Overall Study|Lost to Follow-up|2|||
125898330|NCT01325337|452926286|FG000|Overall Study|Personal Reasons|2|||
125898331|NCT01325337|452926287|FG001|Overall Study|Personal Reasons|5|||
125898332|NCT01325337|452926288|FG002|Overall Study|Personal Reasons|4|||
125898333|NCT01325337|452926289|FG003|Overall Study|Personal Reasons|8|||
125898334|NCT01325337|452926290|FG004|Overall Study|Personal Reasons|3|||
125898335|NCT01325337|452926286|FG000|Overall Study|Withdrawal by Subject|1|||
125898336|NCT01325337|452926287|FG001|Overall Study|Withdrawal by Subject|0|||
125898337|NCT01325337|452926288|FG002|Overall Study|Withdrawal by Subject|1|||
125898338|NCT01325337|452926289|FG003|Overall Study|Withdrawal by Subject|0|||
125898339|NCT01325337|452926290|FG004|Overall Study|Withdrawal by Subject|1|||
125898340|NCT00362180|452926291|FG000|Treated Period|Withdrawal by Subject|1|||
125898341|NCT00362180|452926292|FG001|Treated Period|Withdrawal by Subject|0|||
125898342|NCT00362180|452926293|FG002|Treated Period|Withdrawal by Subject|0|||
125898343|NCT00362180|452926294|FG003|Treated Period|Withdrawal by Subject|0|||
125898344|NCT00362180|452926295|FG004|Treated Period|Withdrawal by Subject|0|||
125898345|NCT00362180|452926296|FG005|Treated Period|Withdrawal by Subject|0|||
125898346|NCT00362180|452926297|FG006|Treated Period|Withdrawal by Subject|0|||
125898347|NCT00362180|452926298|FG007|Treated Period|Withdrawal by Subject|0|||
125898348|NCT00362180|452926299|FG008|Treated Period|Withdrawal by Subject|0|||
125898349|NCT00362180|452926291|FG000|Treated Period|Adverse Event|0|||
125898350|NCT00362180|452926292|FG001|Treated Period|Adverse Event|0|||
125898351|NCT00362180|452926293|FG002|Treated Period|Adverse Event|0|||
125898352|NCT00362180|452926294|FG003|Treated Period|Adverse Event|0|||
125898353|NCT00362180|452926295|FG004|Treated Period|Adverse Event|0|||
125898354|NCT00362180|452926296|FG005|Treated Period|Adverse Event|1|||
125898355|NCT00362180|452926297|FG006|Treated Period|Adverse Event|0|||
125898356|NCT00362180|452926298|FG007|Treated Period|Adverse Event|1|||
125898357|NCT00362180|452926299|FG008|Treated Period|Adverse Event|0|||
125898358|NCT02434471|452926309|FG000|Overall Study|Physician Decision|9|||
125898359|NCT00369629|452926310|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
125898360|NCT00369629|452926311|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
125898361|NCT00369629|452926312|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
125898362|NCT00369629|452926313|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
125898363|NCT00369629|452926310|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
125898364|NCT00369629|452926311|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
125898365|NCT00369629|452926312|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
125898366|NCT00369629|452926313|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
125898367|NCT00369629|452926310|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
125898368|NCT00369629|452926311|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
125898369|NCT00369629|452926312|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
125898370|NCT00369629|452926313|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
125898371|NCT00369629|452926310|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
125898372|NCT00369629|452926311|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
125898373|NCT00369629|452926312|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
125898374|NCT00369629|452926313|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
125898375|NCT00369629|452926310|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
125898376|NCT00369629|452926311|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
125898377|NCT00369629|452926312|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
125898378|NCT00369629|452926313|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
125898379|NCT00369629|452926310|FG000|Completed 4 More Cycles|Progressive disease|2|||
125898380|NCT00369629|452926311|FG001|Completed 4 More Cycles|Progressive disease|1|||
125898381|NCT00369629|452926312|FG002|Completed 4 More Cycles|Progressive disease|2|||
125898382|NCT00369629|452926313|FG003|Completed 4 More Cycles|Progressive disease|0|||
125898383|NCT00369629|452926310|FG000|Follow up for 1 Year|Death|2|||
125898384|NCT00369629|452926311|FG001|Follow up for 1 Year|Death|1|||
125898385|NCT00369629|452926312|FG002|Follow up for 1 Year|Death|1|||
125898386|NCT00369629|452926313|FG003|Follow up for 1 Year|Death|0|||
125898387|NCT00369629|452926310|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
125898388|NCT00369629|452926311|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
125898389|NCT00369629|452926312|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
125898390|NCT00369629|452926313|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
125898391|NCT00369629|452926310|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
125898392|NCT00369629|452926311|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
125898393|NCT00369629|452926312|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
125898394|NCT00369629|452926313|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
125898395|NCT02184455|452926314|FG000|Overall Study|Lost to Follow-up|1|||
125898396|NCT01347580|452926318|FG000|Overall Study|Withdrawal by Subject|13|||
125898397|NCT01347580|452926319|FG001|Overall Study|Withdrawal by Subject|23|||
125898398|NCT01347580|452926318|FG000|Overall Study|Death|30|||
125898399|NCT01347580|452926319|FG001|Overall Study|Death|19|||
125898400|NCT01347580|452926318|FG000|Overall Study|Protocol Violation|10|||
125898401|NCT01347580|452926319|FG001|Overall Study|Protocol Violation|7|||
125898402|NCT01347580|452926318|FG000|Overall Study|Lost to Follow-up|3|||
125898403|NCT01347580|452926319|FG001|Overall Study|Lost to Follow-up|1|||
125898404|NCT01347580|452926318|FG000|Overall Study|Had other reason|9|||
125898405|NCT01347580|452926319|FG001|Overall Study|Had other reason|6|||
125898406|NCT00874939|452926320|FG000|Overall Study|Study terminated|4|||
125898407|NCT02870933|452926321|FG000|Overall Study|Death|2|||
125898408|NCT02870933|452926322|FG001|Overall Study|Death|1|||
125898409|NCT02870933|452926321|FG000|Overall Study|Withdrawal by Subject|0|||
125898410|NCT02870933|452926322|FG001|Overall Study|Withdrawal by Subject|1|||
125898411|NCT01250496|452926325|FG000|Overall Study|Study terminated|124|||
125898412|NCT01250496|452926326|FG001|Overall Study|Study terminated|124|||
125898413|NCT00003590|452926327|FG000|Overall Study|Ineligible Patient|1|||
125898414|NCT00003590|452926327|FG000|Overall Study|Adverse Event|7|||
125898415|NCT00003590|452926327|FG000|Overall Study|Withdrawal by Subject|1|||
125898416|NCT00003590|452926327|FG000|Overall Study|Lack of Efficacy|11|||
125898417|NCT00003590|452926327|FG000|Overall Study|Death|1|||
125898418|NCT00003590|452926327|FG000|Overall Study|Physician Decision|1|||
125898419|NCT01425463|452926328|FG000|Overall Study|Adverse Event|5|||
125898420|NCT01425463|452926329|FG001|Overall Study|Adverse Event|7|||
125898421|NCT01425463|452926328|FG000|Overall Study|Lack of Efficacy|1|||
125898422|NCT01425463|452926329|FG001|Overall Study|Lack of Efficacy|1|||
125898423|NCT01425463|452926328|FG000|Overall Study|Protocol Violation|2|||
125898424|NCT01425463|452926329|FG001|Overall Study|Protocol Violation|2|||
125898425|NCT01425463|452926328|FG000|Overall Study|Lost to Follow-up|5|||
125898426|NCT01425463|452926329|FG001|Overall Study|Lost to Follow-up|2|||
125898427|NCT01425463|452926328|FG000|Overall Study|Withdrawal by Subject|7|||
125898428|NCT01425463|452926329|FG001|Overall Study|Withdrawal by Subject|5|||
125898429|NCT01425463|452926328|FG000|Overall Study|Unknown Reason|4|||
125898430|NCT01425463|452926329|FG001|Overall Study|Unknown Reason|7|||
125898431|NCT00883688|452926332|FG000|Overall Study|Ineligible|2|||
125898432|NCT01009840|452926336|FG000|Overall Study|Lost to Follow-up|1|||
125898433|NCT01009840|452926336|FG000|Overall Study|Adverse Event|4|||
125898434|NCT01009840|452926336|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
125898435|NCT01009840|452926336|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
125898436|NCT01009840|452926336|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
125898437|NCT01104376|452926339|FG000|Overall Study|Withdrawal by Subject|15|||
125898438|NCT01104376|452926339|FG000|Overall Study|Consented but excluded after labs|13|||
125898439|NCT03085914|452926351|FG000|Overall Study|Death|6|||
125898440|NCT03085914|452926352|FG001|Overall Study|Death|6|||
125898441|NCT03085914|452926353|FG002|Overall Study|Death|4|||
125898442|NCT03085914|452926354|FG003|Overall Study|Death|1|||
125898443|NCT03085914|452926355|FG004|Overall Study|Death|5|||
125898444|NCT03085914|452926356|FG005|Overall Study|Death|2|||
125898445|NCT03085914|452926357|FG006|Overall Study|Death|2|||
125898446|NCT03085914|452926351|FG000|Overall Study|Withdrawal by Subject|1|||
125898447|NCT03085914|452926352|FG001|Overall Study|Withdrawal by Subject|1|||
125898448|NCT03085914|452926353|FG002|Overall Study|Withdrawal by Subject|2|||
125898449|NCT03085914|452926354|FG003|Overall Study|Withdrawal by Subject|2|||
126110065|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
125898450|NCT03085914|452926355|FG004|Overall Study|Withdrawal by Subject|2|||
125898451|NCT03085914|452926356|FG005|Overall Study|Withdrawal by Subject|0|||
125898452|NCT03085914|452926357|FG006|Overall Study|Withdrawal by Subject|1|||
125898453|NCT03085914|452926351|FG000|Overall Study|Lost to Follow-up|0|||
125898454|NCT03085914|452926352|FG001|Overall Study|Lost to Follow-up|0|||
125898455|NCT03085914|452926353|FG002|Overall Study|Lost to Follow-up|1|||
125898456|NCT03085914|452926354|FG003|Overall Study|Lost to Follow-up|0|||
125898457|NCT03085914|452926355|FG004|Overall Study|Lost to Follow-up|0|||
125898458|NCT03085914|452926356|FG005|Overall Study|Lost to Follow-up|1|||
125898459|NCT03085914|452926357|FG006|Overall Study|Lost to Follow-up|1|||
125898460|NCT03085914|452926351|FG000|Overall Study|Reason was not specified,|2|||
125898461|NCT03085914|452926352|FG001|Overall Study|Reason was not specified,|2|||
125898462|NCT03085914|452926353|FG002|Overall Study|Reason was not specified,|2|||
125898463|NCT03085914|452926354|FG003|Overall Study|Reason was not specified,|3|||
125898464|NCT03085914|452926355|FG004|Overall Study|Reason was not specified,|3|||
125898465|NCT03085914|452926356|FG005|Overall Study|Reason was not specified,|3|||
125898466|NCT03085914|452926357|FG006|Overall Study|Reason was not specified,|6|||
125898467|NCT03085914|452926351|FG000|Overall Study|Progressive Disease|0|||
125898468|NCT03085914|452926352|FG001|Overall Study|Progressive Disease|0|||
125898469|NCT03085914|452926353|FG002|Overall Study|Progressive Disease|2|||
125898470|NCT03085914|452926354|FG003|Overall Study|Progressive Disease|2|||
125898471|NCT03085914|452926355|FG004|Overall Study|Progressive Disease|1|||
125898472|NCT03085914|452926356|FG005|Overall Study|Progressive Disease|1|||
125898473|NCT03085914|452926357|FG006|Overall Study|Progressive Disease|1|||
125898474|NCT03085914|452926351|FG000|Overall Study|Study Terminated by the Sponsor|0|||
125898475|NCT03085914|452926352|FG001|Overall Study|Study Terminated by the Sponsor|0|||
125898476|NCT03085914|452926353|FG002|Overall Study|Study Terminated by the Sponsor|0|||
125898477|NCT03085914|452926354|FG003|Overall Study|Study Terminated by the Sponsor|1|||
125898478|NCT03085914|452926355|FG004|Overall Study|Study Terminated by the Sponsor|2|||
125898479|NCT03085914|452926356|FG005|Overall Study|Study Terminated by the Sponsor|1|||
125898480|NCT03085914|452926357|FG006|Overall Study|Study Terminated by the Sponsor|0|||
125898481|NCT04644315|452926358|FG000|Overall Study|Subject withdrawal of consent|1|||
125898482|NCT01445548|452926359|FG000|Overall Study|Adverse Event|1|||
125898483|NCT03642132|452926361|FG000|Chemotherapy Period|Adverse Event|1|||
125898484|NCT03642132|452926362|FG001|Chemotherapy Period|Adverse Event|1|||
125898485|NCT03642132|452926363|FG002|Chemotherapy Period|Adverse Event|0|||
125898486|NCT03642132|452926361|FG000|Chemotherapy Period|Physician's decision|4|||
125898487|NCT03642132|452926362|FG001|Chemotherapy Period|Physician's decision|1|||
125898488|NCT03642132|452926363|FG002|Chemotherapy Period|Physician's decision|0|||
125898489|NCT03642132|452926361|FG000|Chemotherapy Period|Progressive disease|0|||
125898490|NCT03642132|452926362|FG001|Chemotherapy Period|Progressive disease|0|||
125898491|NCT03642132|452926363|FG002|Chemotherapy Period|Progressive disease|1|||
125898492|NCT03642132|452926361|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
125898493|NCT03642132|452926362|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
125898494|NCT03642132|452926363|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
125898495|NCT03642132|452926361|FG000|Chemotherapy Period|Other|1|||
125898496|NCT03642132|452926362|FG001|Chemotherapy Period|Other|0|||
125898497|NCT03642132|452926363|FG002|Chemotherapy Period|Other|2|||
125898498|NCT03642132|452926361|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
125898499|NCT03642132|452926362|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
125898500|NCT03642132|452926363|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
125898501|NCT03642132|452926361|FG000|Maintenance Period|Adverse Event|1|||
125898502|NCT03642132|452926362|FG001|Maintenance Period|Adverse Event|2|||
125898503|NCT03642132|452926363|FG002|Maintenance Period|Adverse Event|0|||
125898504|NCT03642132|452926361|FG000|Maintenance Period|Non-compliance with study drug|0|||
125898505|NCT03642132|452926362|FG001|Maintenance Period|Non-compliance with study drug|0|||
125898506|NCT03642132|452926363|FG002|Maintenance Period|Non-compliance with study drug|1|||
125898507|NCT03642132|452926361|FG000|Maintenance Period|Physician's decision|2|||
125898508|NCT03642132|452926362|FG001|Maintenance Period|Physician's decision|2|||
125898509|NCT03642132|452926363|FG002|Maintenance Period|Physician's decision|2|||
125898510|NCT03642132|452926361|FG000|Maintenance Period|Progressive disease|9|||
125898511|NCT03642132|452926362|FG001|Maintenance Period|Progressive disease|3|||
125898512|NCT03642132|452926363|FG002|Maintenance Period|Progressive disease|6|||
125898513|NCT03642132|452926361|FG000|Maintenance Period|Other|0|||
125898514|NCT03642132|452926362|FG001|Maintenance Period|Other|0|||
125898515|NCT03642132|452926363|FG002|Maintenance Period|Other|3|||
125898516|NCT03642132|452926361|FG000|Maintenance Period|Withdrawal by Subject|1|||
125898517|NCT03642132|452926362|FG001|Maintenance Period|Withdrawal by Subject|1|||
125898518|NCT03642132|452926363|FG002|Maintenance Period|Withdrawal by Subject|2|||
125898519|NCT03642132|452926361|FG000|Follow-up Period|Other|0|||
125898520|NCT03642132|452926362|FG001|Follow-up Period|Other|0|||
125898521|NCT03642132|452926363|FG002|Follow-up Period|Other|1|||
125898522|NCT03642132|452926361|FG000|Follow-up Period|Withdrawal by Subject|1|||
125898523|NCT03642132|452926362|FG001|Follow-up Period|Withdrawal by Subject|2|||
125898524|NCT03642132|452926363|FG002|Follow-up Period|Withdrawal by Subject|0|||
125898525|NCT03642132|452926361|FG000|Follow-up Period|Study terminated by sponsor|1|||
125898526|NCT03642132|452926362|FG001|Follow-up Period|Study terminated by sponsor|0|||
125898527|NCT03642132|452926363|FG002|Follow-up Period|Study terminated by sponsor|1|||
125898528|NCT03642132|452926361|FG000|Follow-up Period|Lack of Efficacy|1|||
125898529|NCT03642132|452926362|FG001|Follow-up Period|Lack of Efficacy|0|||
125898530|NCT03642132|452926363|FG002|Follow-up Period|Lack of Efficacy|0|||
125898531|NCT03642132|452926361|FG000|Follow-up Period|Death|1|||
125898532|NCT03642132|452926362|FG001|Follow-up Period|Death|0|||
125898533|NCT03642132|452926363|FG002|Follow-up Period|Death|2|||
125898534|NCT03642132|452926361|FG000|Follow-up Period|Adverse Event|1|||
125898535|NCT03642132|452926362|FG001|Follow-up Period|Adverse Event|0|||
125898536|NCT03642132|452926363|FG002|Follow-up Period|Adverse Event|0|||
125898537|NCT04493892|452926370|FG000|Overall Study|Withdrawal by Subject|15|||
125898538|NCT01128621|452926371|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
125898539|NCT01128621|452926372|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
125898540|NCT01958489|452926375|FG000|Period 2|Adverse Event|0|||
125898541|NCT01958489|452926376|FG001|Period 2|Adverse Event|1|||
125898542|NCT03595618|452926377|FG000|Overall Study|Adverse Event|16|||
125898543|NCT03595618|452926378|FG001|Overall Study|Adverse Event|17|||
125898544|NCT03595618|452926379|FG002|Overall Study|Adverse Event|20|||
125898545|NCT03595618|452926380|FG003|Overall Study|Adverse Event|8|||
125898546|NCT03595618|452926377|FG000|Overall Study|Withdrawal by Subject|12|||
125898547|NCT03595618|452926378|FG001|Overall Study|Withdrawal by Subject|14|||
125898548|NCT03595618|452926379|FG002|Overall Study|Withdrawal by Subject|14|||
125898549|NCT03595618|452926380|FG003|Overall Study|Withdrawal by Subject|10|||
125898550|NCT03595618|452926377|FG000|Overall Study|Lost to Follow-up|6|||
125898551|NCT03595618|452926378|FG001|Overall Study|Lost to Follow-up|4|||
125898552|NCT03595618|452926379|FG002|Overall Study|Lost to Follow-up|5|||
125898553|NCT03595618|452926380|FG003|Overall Study|Lost to Follow-up|6|||
125898554|NCT03595618|452926377|FG000|Overall Study|Protocol Violation|2|||
125898555|NCT03595618|452926378|FG001|Overall Study|Protocol Violation|0|||
125898556|NCT03595618|452926379|FG002|Overall Study|Protocol Violation|6|||
125898557|NCT03595618|452926380|FG003|Overall Study|Protocol Violation|2|||
125898558|NCT03595618|452926377|FG000|Overall Study|Physician Decision|0|||
125898559|NCT03595618|452926378|FG001|Overall Study|Physician Decision|0|||
125898560|NCT03595618|452926379|FG002|Overall Study|Physician Decision|1|||
125898561|NCT03595618|452926380|FG003|Overall Study|Physician Decision|2|||
125898562|NCT03595618|452926377|FG000|Overall Study|Miscellaneous|7|||
125898563|NCT03595618|452926378|FG001|Overall Study|Miscellaneous|5|||
125898564|NCT03595618|452926379|FG002|Overall Study|Miscellaneous|10|||
125898565|NCT03595618|452926380|FG003|Overall Study|Miscellaneous|6|||
125898566|NCT00917644|452926381|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
125898567|NCT00917644|452926382|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
125898568|NCT00917644|452926381|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
125898569|NCT00917644|452926382|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
125898570|NCT00917644|452926381|FG000|Period 2: Second Intervention|family emergency|1|||
125898571|NCT00917644|452926382|FG001|Period 2: Second Intervention|family emergency|0|||
125898572|NCT02338232|452926383|FG000|Overall Study|Screen Failure|3|||
125898573|NCT02338232|452926383|FG000|Overall Study|Withdrawal by Subject|6|||
125898574|NCT02338232|452926383|FG000|Overall Study|Adverse Event|2|||
125898575|NCT02500056|452926384|FG000|Overall Study|Lost to Follow-up|3|||
125898576|NCT02500056|452926385|FG001|Overall Study|Lost to Follow-up|7|||
125898577|NCT02500056|452926384|FG000|Overall Study|Recurrence|1|||
125898578|NCT02500056|452926385|FG001|Overall Study|Recurrence|0|||
125898579|NCT02500056|452926384|FG000|Overall Study|Death|3|||
125898580|NCT02500056|452926385|FG001|Overall Study|Death|1|||
125898581|NCT00864916|452926386|FG000|Overall Study|Lost to Follow-up|4|||
125898582|NCT00864916|452926387|FG001|Overall Study|Lost to Follow-up|4|||
125898583|NCT00864916|452926386|FG000|Overall Study|Protocol Violation|1|||
125898584|NCT00864916|452926387|FG001|Overall Study|Protocol Violation|0|||
125898585|NCT00864916|452926386|FG000|Overall Study|Withdrawal by Subject|1|||
125898586|NCT00864916|452926387|FG001|Overall Study|Withdrawal by Subject|0|||
125898587|NCT01253811|452926390|FG000|Overall Study|Withdrawal criteria|1|||
125898588|NCT01087736|452926391|FG000|Overall Study|Lost to Follow-up|1|||
125898589|NCT01087736|452926392|FG001|Overall Study|Lost to Follow-up|0|||
125898590|NCT01087736|452926391|FG000|Overall Study|Death|0|||
125898591|NCT01087736|452926392|FG001|Overall Study|Death|1|||
125898592|NCT01087736|452926391|FG000|Overall Study|Withdrawal by Subject|0|||
125898593|NCT01087736|452926392|FG001|Overall Study|Withdrawal by Subject|1|||
125898594|NCT01101308|452926399|FG000|Period 1|Adverse Event|2|||
125898595|NCT01101308|452926400|FG001|Period 1|Adverse Event|1|||
125898596|NCT01101308|452926399|FG000|Period 1|Positive for cotinine|1|||
125898597|NCT01101308|452926400|FG001|Period 1|Positive for cotinine|0|||
125898598|NCT03180619|452926402|FG000|Overall Study|Withdrew Consent|5|||
125898599|NCT03180619|452926403|FG001|Overall Study|Withdrew Consent|0|||
125898600|NCT03180619|452926404|FG002|Overall Study|Withdrew Consent|2|||
125898601|NCT03180619|452926402|FG000|Overall Study|Death|2|||
125898602|NCT03180619|452926403|FG001|Overall Study|Death|1|||
125898603|NCT03180619|452926404|FG002|Overall Study|Death|2|||
125898604|NCT03180619|452926402|FG000|Overall Study|Adverse Event|2|||
125898605|NCT03180619|452926403|FG001|Overall Study|Adverse Event|0|||
125898606|NCT03180619|452926404|FG002|Overall Study|Adverse Event|1|||
125898607|NCT03180619|452926402|FG000|Overall Study|Investigator's discretion|2|||
125898608|NCT03180619|452926403|FG001|Overall Study|Investigator's discretion|0|||
125898609|NCT03180619|452926404|FG002|Overall Study|Investigator's discretion|1|||
125898610|NCT00392379|452926405|FG000|Overall Study|Withdrawal by Subject|17|||
125898611|NCT00392379|452926406|FG001|Overall Study|Withdrawal by Subject|28|||
125898612|NCT00392379|452926405|FG000|Overall Study|Lost to Follow-up|4|||
125898613|NCT00392379|452926406|FG001|Overall Study|Lost to Follow-up|9|||
125898614|NCT00392379|452926405|FG000|Overall Study|Adverse Event|1|||
125898615|NCT00392379|452926406|FG001|Overall Study|Adverse Event|1|||
125898616|NCT04255394|452926407|FG000|Overall Study|Death|35|||
125898617|NCT04255394|452926408|FG001|Overall Study|Death|25|||
125898618|NCT04255394|452926407|FG000|Overall Study|Device removed|2|||
125898619|NCT04255394|452926408|FG001|Overall Study|Device removed|10|||
125898620|NCT04255394|452926407|FG000|Overall Study|Withdrawal by Subject|9|||
125898621|NCT04255394|452926408|FG001|Overall Study|Withdrawal by Subject|8|||
125898622|NCT04255394|452926407|FG000|Overall Study|Screen Failure/Not treated|12|||
125898623|NCT04255394|452926408|FG001|Overall Study|Screen Failure/Not treated|8|||
125898624|NCT04255394|452926407|FG000|Overall Study|Lost to Follow-up|123|||
125898625|NCT04255394|452926408|FG001|Overall Study|Lost to Follow-up|265|||
125898626|NCT04255394|452926407|FG000|Overall Study|Adverse Event|1|||
125898627|NCT04255394|452926408|FG001|Overall Study|Adverse Event|3|||
125898628|NCT02285062|452926411|FG000|Pre-Treatment Period|Protocol Violation|0|||
125898629|NCT02285062|452926412|FG001|Pre-Treatment Period|Protocol Violation|2|||
125898630|NCT02285062|452926411|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
125898631|NCT02285062|452926412|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125898632|NCT03041129|452926413|FG000|Overall Study|Withdrawal by Subject|2|||
125898633|NCT03041129|452926414|FG001|Overall Study|Withdrawal by Subject|0|||
125898634|NCT03041129|452926415|FG002|Overall Study|Withdrawal by Subject|0|||
125898635|NCT03041129|452926416|FG003|Overall Study|Withdrawal by Subject|0|||
125898636|NCT00821509|452926417|FG000|Overall Study|Withdrawal by Subject|12|||
125898637|NCT00821509|452926418|FG001|Overall Study|Withdrawal by Subject|11|||
125898638|NCT00821509|452926419|FG002|Overall Study|Withdrawal by Subject|34|||
125898639|NCT03678870|452926420|FG000|Overall Study|prescribed non- protocol medications|10|||
125898640|NCT03678870|452926421|FG001|Overall Study|prescribed non- protocol medications|6|||
125898641|NCT03678870|452926420|FG000|Overall Study|Lost to Follow-up|3|||
125898642|NCT03678870|452926421|FG001|Overall Study|Lost to Follow-up|2|||
125898643|NCT03104816|452926423|FG000|Overall Study|Lack of Efficacy|0|||
125898644|NCT03104816|452926424|FG001|Overall Study|Lack of Efficacy|2|||
125898645|NCT03104816|452926425|FG002|Overall Study|Lack of Efficacy|0|||
125898646|NCT03104816|452926423|FG000|Overall Study|Protocol Violation|2|||
125898647|NCT03104816|452926424|FG001|Overall Study|Protocol Violation|0|||
125898648|NCT03104816|452926425|FG002|Overall Study|Protocol Violation|2|||
125898649|NCT01159431|452926427|FG000|Overall Study|Adverse Event|1|||
125898650|NCT01159431|452926428|FG001|Overall Study|Adverse Event|2|||
125898651|NCT01159431|452926427|FG000|Overall Study|non-compliance|1|||
125898652|NCT01159431|452926428|FG001|Overall Study|non-compliance|1|||
125898653|NCT01159431|452926427|FG000|Overall Study|Lack of Efficacy|0|||
125898654|NCT01159431|452926428|FG001|Overall Study|Lack of Efficacy|3|||
125898655|NCT01227629|452926429|FG000|Overall Study|Adverse Event|2|||
125898656|NCT01227629|452926430|FG001|Overall Study|Adverse Event|2|||
125898657|NCT01227629|452926431|FG002|Overall Study|Adverse Event|1|||
125898658|NCT01227629|452926432|FG003|Overall Study|Adverse Event|6|||
125898659|NCT01227629|452926433|FG004|Overall Study|Adverse Event|1|||
125898660|NCT01227629|452926434|FG005|Overall Study|Adverse Event|1|||
125898661|NCT01227629|452926435|FG006|Overall Study|Adverse Event|6|||
125898662|NCT01227629|452926436|FG007|Overall Study|Adverse Event|6|||
125898663|NCT01227629|452926437|FG008|Overall Study|Adverse Event|4|||
125898664|NCT01227629|452926438|FG009|Overall Study|Adverse Event|0|||
125898665|NCT01227629|452926429|FG000|Overall Study|Protocol Violation|0|||
125898666|NCT01227629|452926430|FG001|Overall Study|Protocol Violation|0|||
125898667|NCT01227629|452926431|FG002|Overall Study|Protocol Violation|0|||
125898668|NCT01227629|452926432|FG003|Overall Study|Protocol Violation|1|||
125898669|NCT01227629|452926433|FG004|Overall Study|Protocol Violation|0|||
125898670|NCT01227629|452926434|FG005|Overall Study|Protocol Violation|0|||
125898671|NCT01227629|452926435|FG006|Overall Study|Protocol Violation|0|||
125898672|NCT01227629|452926436|FG007|Overall Study|Protocol Violation|0|||
125898673|NCT01227629|452926437|FG008|Overall Study|Protocol Violation|0|||
125898674|NCT01227629|452926438|FG009|Overall Study|Protocol Violation|0|||
125898675|NCT01227629|452926429|FG000|Overall Study|Lost to Follow-up|0|||
125898676|NCT01227629|452926430|FG001|Overall Study|Lost to Follow-up|0|||
125898677|NCT01227629|452926431|FG002|Overall Study|Lost to Follow-up|0|||
125898678|NCT01227629|452926432|FG003|Overall Study|Lost to Follow-up|0|||
125898679|NCT01227629|452926433|FG004|Overall Study|Lost to Follow-up|1|||
125898680|NCT01227629|452926434|FG005|Overall Study|Lost to Follow-up|0|||
125898681|NCT01227629|452926435|FG006|Overall Study|Lost to Follow-up|0|||
125898682|NCT01227629|452926436|FG007|Overall Study|Lost to Follow-up|0|||
125898683|NCT01227629|452926437|FG008|Overall Study|Lost to Follow-up|0|||
125898684|NCT01227629|452926438|FG009|Overall Study|Lost to Follow-up|0|||
125898685|NCT01227629|452926429|FG000|Overall Study|Withdrawal by Subject|0|||
125898686|NCT01227629|452926430|FG001|Overall Study|Withdrawal by Subject|0|||
125898687|NCT01227629|452926431|FG002|Overall Study|Withdrawal by Subject|0|||
125898688|NCT01227629|452926432|FG003|Overall Study|Withdrawal by Subject|0|||
125898689|NCT01227629|452926433|FG004|Overall Study|Withdrawal by Subject|0|||
125898690|NCT01227629|452926434|FG005|Overall Study|Withdrawal by Subject|0|||
125898691|NCT01227629|452926435|FG006|Overall Study|Withdrawal by Subject|2|||
125898692|NCT01227629|452926436|FG007|Overall Study|Withdrawal by Subject|0|||
125898693|NCT01227629|452926437|FG008|Overall Study|Withdrawal by Subject|0|||
125898694|NCT01227629|452926438|FG009|Overall Study|Withdrawal by Subject|1|||
125898695|NCT01227629|452926429|FG000|Overall Study|Other|0|||
125898696|NCT01227629|452926430|FG001|Overall Study|Other|0|||
125898697|NCT01227629|452926431|FG002|Overall Study|Other|0|||
125898698|NCT01227629|452926432|FG003|Overall Study|Other|1|||
125898699|NCT01227629|452926433|FG004|Overall Study|Other|0|||
125898700|NCT01227629|452926434|FG005|Overall Study|Other|0|||
125898701|NCT01227629|452926435|FG006|Overall Study|Other|0|||
125898702|NCT01227629|452926436|FG007|Overall Study|Other|0|||
125898703|NCT01227629|452926437|FG008|Overall Study|Other|2|||
125898704|NCT01227629|452926438|FG009|Overall Study|Other|1|||
125898705|NCT00534599|452926444|FG000|Overall Study|Adverse Event|25|||
125898706|NCT00534599|452926445|FG001|Overall Study|Adverse Event|4|||
125898707|NCT00534599|452926444|FG000|Overall Study|Incorrect enrollment|2|||
125898708|NCT00534599|452926445|FG001|Overall Study|Incorrect enrollment|1|||
125898709|NCT00534599|452926444|FG000|Overall Study|Mis-randomization|2|||
125898710|NCT00534599|452926445|FG001|Overall Study|Mis-randomization|2|||
125898711|NCT00534599|452926444|FG000|Overall Study|Developed study-specific d/c criteria|5|||
125898712|NCT00534599|452926445|FG001|Overall Study|Developed study-specific d/c criteria|0|||
125898713|NCT00534599|452926444|FG000|Overall Study|Lack of Efficacy|0|||
125898714|NCT00534599|452926445|FG001|Overall Study|Lack of Efficacy|1|||
125898715|NCT00534599|452926444|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
125898716|NCT00534599|452926445|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
125898717|NCT00534599|452926444|FG000|Overall Study|Protocol Violation|1|||
125898718|NCT00534599|452926445|FG001|Overall Study|Protocol Violation|3|||
125898719|NCT00534599|452926444|FG000|Overall Study|Lost to Follow-up|11|||
125898720|NCT00534599|452926445|FG001|Overall Study|Lost to Follow-up|14|||
125898721|NCT00534599|452926444|FG000|Overall Study|Withdrawal by Subject|4|||
125898722|NCT00534599|452926445|FG001|Overall Study|Withdrawal by Subject|6|||
125898723|NCT00534599|452926444|FG000|Overall Study|Other|7|||
125898724|NCT00534599|452926445|FG001|Overall Study|Other|0|||
125898725|NCT03645434|452926449|FG000|Period 1|Adverse Event|0|||
125898726|NCT03645434|452926450|FG001|Period 1|Adverse Event|0|||
125898727|NCT03645434|452926451|FG002|Period 1|Adverse Event|0|||
125898728|NCT03645434|452926452|FG003|Period 1|Adverse Event|1|||
125898729|NCT03645434|452926453|FG004|Period 1|Adverse Event|0|||
125898730|NCT03645434|452926454|FG005|Period 1|Adverse Event|0|||
125898731|NCT03645434|452926449|FG000|Period 1|COPD exacerbation|0|||
125898732|NCT03645434|452926450|FG001|Period 1|COPD exacerbation|0|||
125898733|NCT03645434|452926451|FG002|Period 1|COPD exacerbation|0|||
125898734|NCT03645434|452926452|FG003|Period 1|COPD exacerbation|0|||
125898735|NCT03645434|452926453|FG004|Period 1|COPD exacerbation|1|||
125898736|NCT03645434|452926454|FG005|Period 1|COPD exacerbation|0|||
125898737|NCT03865316|452928146|FG000|Overall Study|Procedure Cancelled|4|||
125898738|NCT03865316|452928146|FG000|Overall Study|Equipment failure|4|||
125898739|NCT03658876|452928148|FG000|Overall Study|Protocol Violation|3|||
125898740|NCT03658876|452928149|FG001|Overall Study|Protocol Violation|2|||
125898741|NCT03658876|452928148|FG000|Overall Study|Withdrawal by Subject|2|||
125898742|NCT03658876|452928149|FG001|Overall Study|Withdrawal by Subject|0|||
125898743|NCT03658876|452928148|FG000|Overall Study|Death|0|||
125898744|NCT03658876|452928149|FG001|Overall Study|Death|1|||
125898745|NCT03658876|452928148|FG000|Overall Study|Intercurrent illness|6|||
125898746|NCT03658876|452928149|FG001|Overall Study|Intercurrent illness|4|||
125898747|NCT03658876|452928148|FG000|Overall Study|Transplantation/other operation|1|||
125898748|NCT03658876|452928149|FG001|Overall Study|Transplantation/other operation|5|||
125898749|NCT01330017|452928150|FG000|Overall Study|Adverse Event|0|||
125898750|NCT01330017|452928151|FG001|Overall Study|Adverse Event|1|||
125898751|NCT01330017|452928152|FG002|Overall Study|Adverse Event|1|||
125898752|NCT01330017|452928153|FG003|Overall Study|Adverse Event|4|||
125898753|NCT01330017|452928154|FG004|Overall Study|Adverse Event|0|||
125898754|NCT01330017|452928150|FG000|Overall Study|Withdrawal by Subject|0|||
125898755|NCT01330017|452928151|FG001|Overall Study|Withdrawal by Subject|0|||
125898756|NCT01330017|452928152|FG002|Overall Study|Withdrawal by Subject|1|||
125898757|NCT01330017|452928153|FG003|Overall Study|Withdrawal by Subject|0|||
125898758|NCT01330017|452928154|FG004|Overall Study|Withdrawal by Subject|1|||
125898759|NCT01330017|452928150|FG000|Overall Study|Lost to Follow-up|0|||
125898760|NCT01330017|452928151|FG001|Overall Study|Lost to Follow-up|0|||
125898761|NCT01330017|452928152|FG002|Overall Study|Lost to Follow-up|1|||
125898762|NCT01330017|452928153|FG003|Overall Study|Lost to Follow-up|0|||
125898763|NCT01330017|452928154|FG004|Overall Study|Lost to Follow-up|0|||
125898764|NCT01330017|452928150|FG000|Overall Study|Protocol Violation|0|||
125898765|NCT01330017|452928151|FG001|Overall Study|Protocol Violation|0|||
125898766|NCT01330017|452928152|FG002|Overall Study|Protocol Violation|0|||
125898767|NCT01330017|452928153|FG003|Overall Study|Protocol Violation|1|||
125898768|NCT01330017|452928154|FG004|Overall Study|Protocol Violation|0|||
125898769|NCT01330017|452928150|FG000|Overall Study|Unknown Reason|5|||
125898770|NCT01330017|452928151|FG001|Overall Study|Unknown Reason|3|||
125898771|NCT01330017|452928152|FG002|Overall Study|Unknown Reason|5|||
125898772|NCT01330017|452928153|FG003|Overall Study|Unknown Reason|7|||
125898773|NCT01330017|452928154|FG004|Overall Study|Unknown Reason|2|||
125898774|NCT02616146|452928155|FG000|Overall Study|Adverse Event|64|||
125898775|NCT02616146|452928156|FG001|Overall Study|Adverse Event|24|||
125898776|NCT02616146|452928155|FG000|Overall Study|Lost to Follow-up|23|||
125898777|NCT02616146|452928156|FG001|Overall Study|Lost to Follow-up|13|||
125898778|NCT02616146|452928155|FG000|Overall Study|Non-compliance with study protocol|2|||
125898779|NCT02616146|452928156|FG001|Overall Study|Non-compliance with study protocol|0|||
125898780|NCT02616146|452928155|FG000|Overall Study|Non-compliance with study drug|4|||
125898781|NCT02616146|452928156|FG001|Overall Study|Non-compliance with study drug|2|||
125898782|NCT02616146|452928155|FG000|Overall Study|Pregnancy|2|||
125898783|NCT02616146|452928156|FG001|Overall Study|Pregnancy|2|||
125898784|NCT02616146|452928155|FG000|Overall Study|Pregnancy wish|3|||
125898785|NCT02616146|452928156|FG001|Overall Study|Pregnancy wish|0|||
125898786|NCT02616146|452928155|FG000|Overall Study|Protocol Violation|6|||
125898787|NCT02616146|452928156|FG001|Overall Study|Protocol Violation|3|||
125898788|NCT02616146|452928155|FG000|Overall Study|Study terminated by sponsor|1372|||
125898789|NCT02616146|452928156|FG001|Overall Study|Study terminated by sponsor|432|||
125898790|NCT02616146|452928155|FG000|Overall Study|Participant moved|4|||
125898791|NCT02616146|452928156|FG001|Overall Study|Participant moved|3|||
125898792|NCT02616146|452928155|FG000|Overall Study|Withdrawal by Subject|30|||
125898793|NCT02616146|452928156|FG001|Overall Study|Withdrawal by Subject|24|||
125898794|NCT02616146|452928155|FG000|Overall Study|Physician Decision|2|||
125898795|NCT02616146|452928156|FG001|Overall Study|Physician Decision|1|||
125898796|NCT00336856|452928157|FG000|Overall Study|Withdrawal by Subject|3|||
125898797|NCT00336856|452928157|FG000|Overall Study|Found ineligible at time of analysis|1|||
125898798|NCT01106092|452928158|FG000|Overall Study|Withdrawal by Subject|0|||
125898799|NCT01106092|452928159|FG001|Overall Study|Withdrawal by Subject|0|||
125898800|NCT01106092|452928160|FG002|Overall Study|Withdrawal by Subject|0|||
125898801|NCT01106092|452928161|FG003|Overall Study|Withdrawal by Subject|1|||
125898802|NCT00843778|452928162|FG000|Overall Study|Adverse Event|15|||
125898803|NCT00843778|452928162|FG000|Overall Study|Lack of Efficacy|14|||
125898804|NCT00843778|452928162|FG000|Overall Study|Loss of efficacy|2|||
125898805|NCT00843778|452928162|FG000|Overall Study|Withdrawal by Subject|4|||
125898806|NCT03338959|452928167|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
125898807|NCT03338959|452928167|FG000|Overall Study|Physician Decision|1|||
125898808|NCT01604278|452928168|FG000|Overall Study|Lack of Efficacy|0|||
125898809|NCT01604278|452928169|FG001|Overall Study|Lack of Efficacy|1|||
125898810|NCT01604278|452928168|FG000|Overall Study|Lost to Follow-up|1|||
125898811|NCT01604278|452928169|FG001|Overall Study|Lost to Follow-up|0|||
125898812|NCT01604278|452928168|FG000|Overall Study|Administrative problems|2|||
125898813|NCT01604278|452928169|FG001|Overall Study|Administrative problems|1|||
125898814|NCT01604278|452928168|FG000|Overall Study|Withdrawal by Subject|3|||
125898815|NCT01604278|452928169|FG001|Overall Study|Withdrawal by Subject|3|||
125898816|NCT01604278|452928168|FG000|Overall Study|Adverse Event|3|||
125898817|NCT01604278|452928169|FG001|Overall Study|Adverse Event|5|||
125898818|NCT01604278|452928168|FG000|Overall Study|Protocol Deviation|5|||
125898819|NCT01604278|452928169|FG001|Overall Study|Protocol Deviation|3|||
125898820|NCT03328182|452928172|FG000|Overall Study|Withdrawal by Subject|1|||
125898821|NCT03328182|452928172|FG000|Overall Study|Protocol Violation|2|||
125898822|NCT03328182|452928172|FG000|Overall Study|No Product Evaluated|1|||
125898823|NCT01444092|452928175|FG000|Overall Study|Adverse Event|8|||
125898824|NCT01444092|452928175|FG000|Overall Study|Protocol Violation|1|||
125898825|NCT01444092|452928175|FG000|Overall Study|Withdrawal by Subject|1|||
125898826|NCT01444092|452928175|FG000|Overall Study|Other Eligibility criteria|7|||
125898827|NCT04585009|452928176|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
125898828|NCT04585009|452928177|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898829|NCT04585009|452928178|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898830|NCT04585009|452928179|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898831|NCT04585009|452928180|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898832|NCT04585009|452928181|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898833|NCT04585009|452928182|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898834|NCT04585009|452928183|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898835|NCT04585009|452928184|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898836|NCT04585009|452928185|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898837|NCT04585009|452928186|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898838|NCT04585009|452928187|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125898839|NCT04585009|452928176|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
125898840|NCT04585009|452928177|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898841|NCT04585009|452928178|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898842|NCT04585009|452928179|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898843|NCT04585009|452928180|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898844|NCT04585009|452928181|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898845|NCT04585009|452928182|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898846|NCT04585009|452928183|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898847|NCT04585009|452928184|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898848|NCT04585009|452928185|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898849|NCT04585009|452928186|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898850|NCT04585009|452928187|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125898851|NCT04585009|452928176|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898852|NCT04585009|452928177|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898853|NCT04585009|452928178|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898854|NCT04585009|452928179|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898855|NCT04585009|452928180|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898856|NCT04585009|452928181|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898857|NCT04585009|452928182|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898858|NCT04585009|452928183|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
125898859|NCT04585009|452928184|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898860|NCT04585009|452928185|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898861|NCT04585009|452928186|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126059748|NCT03136861|453512530|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
125898862|NCT04585009|452928187|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125898863|NCT04585009|452928176|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898864|NCT04585009|452928177|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898865|NCT04585009|452928178|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898866|NCT04585009|452928179|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898867|NCT04585009|452928180|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
125898868|NCT04585009|452928181|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898869|NCT04585009|452928182|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898870|NCT04585009|452928183|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898871|NCT04585009|452928184|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898872|NCT04585009|452928185|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898873|NCT04585009|452928186|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898874|NCT04585009|452928187|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125898875|NCT04585009|452928176|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898876|NCT04585009|452928177|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898877|NCT04585009|452928178|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898878|NCT04585009|452928179|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898879|NCT04585009|452928180|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898880|NCT04585009|452928181|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898881|NCT04585009|452928182|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898882|NCT04585009|452928183|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898883|NCT04585009|452928184|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898884|NCT04585009|452928185|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
125898885|NCT04585009|452928186|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898886|NCT04585009|452928187|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125898887|NCT04585009|452928176|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898888|NCT04585009|452928177|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898889|NCT04585009|452928178|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898890|NCT04585009|452928179|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898891|NCT04585009|452928180|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898892|NCT04585009|452928181|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898893|NCT04585009|452928182|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898894|NCT04585009|452928183|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898895|NCT04585009|452928184|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898896|NCT04585009|452928185|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898897|NCT04585009|452928186|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125898898|NCT04585009|452928187|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
125898899|NCT02577887|452928190|FG000|Overall Study|Death|93|||
125898900|NCT02577887|452928190|FG000|Overall Study|Protocol Violation|125|||
125898901|NCT02577887|452928190|FG000|Overall Study|Withdrawal by Subject|80|||
125898902|NCT03560518|452928191|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
125898903|NCT03560518|452928192|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
125898904|NCT03560518|452928193|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
125898905|NCT03560518|452928191|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
125898906|NCT03560518|452928192|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
125898907|NCT03560518|452928193|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
125898908|NCT03560518|452928191|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125898909|NCT03560518|452928192|FG001|Double Blind Treatment Period|Protocol Violation|2|||
125898910|NCT03560518|452928193|FG002|Double Blind Treatment Period|Protocol Violation|0|||
125898911|NCT03560518|452928191|FG000|Double Blind Treatment Period|Pregnancy|0|||
125898912|NCT03560518|452928192|FG001|Double Blind Treatment Period|Pregnancy|2|||
125898913|NCT03560518|452928193|FG002|Double Blind Treatment Period|Pregnancy|0|||
125898914|NCT03560518|452928191|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
125898915|NCT03560518|452928192|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
125898916|NCT03560518|452928193|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
125898917|NCT03560518|452928191|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
125898918|NCT03560518|452928192|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
125898919|NCT03560518|452928193|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
125898920|NCT03560518|452928191|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
125898921|NCT03560518|452928192|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
125898922|NCT03560518|452928193|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
125898923|NCT03560518|452928191|FG000|Double Blind Treatment Period|Adverse Event|0|||
125898924|NCT03560518|452928192|FG001|Double Blind Treatment Period|Adverse Event|3|||
125898925|NCT03560518|452928193|FG002|Double Blind Treatment Period|Adverse Event|1|||
125898926|NCT02122783|452928199|FG000|Overall Study|Adverse Event|0|||
125898927|NCT02122783|452928200|FG001|Overall Study|Adverse Event|1|||
125898928|NCT01579812|452928202|FG000|Overall Study|Ineligible after treatment start|40|||
125898929|NCT01579812|452928202|FG000|Overall Study|Patient choice|3|||
125898930|NCT01579812|452928202|FG000|Overall Study|Noncompliance|3|||
125898931|NCT01579812|452928202|FG000|Overall Study|Withdrawal by Subject|6|||
125898932|NCT05277337|452928204|FG000|Overall Study|Lost to Follow-up|2|||
125898933|NCT05277337|452928205|FG001|Overall Study|Lost to Follow-up|0|||
125898934|NCT05277337|452928204|FG000|Overall Study|Withdrawal by Subject|1|||
125898935|NCT05277337|452928205|FG001|Overall Study|Withdrawal by Subject|0|||
125898936|NCT02282345|452928206|FG000|Overall Study|Progression|0|||
125898937|NCT02282345|452928207|FG001|Overall Study|Progression|1|||
125898938|NCT01185301|452928208|FG000|Overall Study|Adverse Event|3|||
125898939|NCT01185301|452928209|FG001|Overall Study|Adverse Event|0|||
125898940|NCT01185301|452928210|FG002|Overall Study|Adverse Event|2|||
125898941|NCT01185301|452928211|FG003|Overall Study|Adverse Event|3|||
125898942|NCT01185301|452928208|FG000|Overall Study|Withdrawal by Subject|7|||
125898943|NCT01185301|452928209|FG001|Overall Study|Withdrawal by Subject|5|||
125898944|NCT01185301|452928210|FG002|Overall Study|Withdrawal by Subject|2|||
125898945|NCT01185301|452928211|FG003|Overall Study|Withdrawal by Subject|3|||
125898946|NCT01185301|452928208|FG000|Overall Study|Lost to Follow-up|2|||
125898947|NCT01185301|452928209|FG001|Overall Study|Lost to Follow-up|0|||
125898948|NCT01185301|452928210|FG002|Overall Study|Lost to Follow-up|0|||
125898949|NCT01185301|452928211|FG003|Overall Study|Lost to Follow-up|1|||
125898950|NCT01185301|452928208|FG000|Overall Study|Other Reason|3|||
125898951|NCT01185301|452928209|FG001|Overall Study|Other Reason|2|||
125898952|NCT01185301|452928210|FG002|Overall Study|Other Reason|2|||
125898953|NCT01185301|452928211|FG003|Overall Study|Other Reason|2|||
125898954|NCT02683746|452928212|FG000|Overall Study|Adverse Event|3|||
125898955|NCT02683746|452928213|FG001|Overall Study|Adverse Event|2|||
125898956|NCT02683746|452928212|FG000|Overall Study|Lost to Follow-up|5|||
125898957|NCT02683746|452928213|FG001|Overall Study|Lost to Follow-up|6|||
125898958|NCT02683746|452928212|FG000|Overall Study|Withdrawal by Subject|6|||
125898959|NCT02683746|452928213|FG001|Overall Study|Withdrawal by Subject|5|||
125898960|NCT02683746|452928212|FG000|Overall Study|Physician Decision|2|||
125898961|NCT02683746|452928213|FG001|Overall Study|Physician Decision|1|||
125898962|NCT04987944|452928214|FG000|Overall Study|Adverse Event|0|||
125898963|NCT04987944|452928215|FG001|Overall Study|Adverse Event|1|||
125898964|NCT04987944|452928214|FG000|Overall Study|Withdrawal by Subject|0|||
125898965|NCT04987944|452928215|FG001|Overall Study|Withdrawal by Subject|1|||
125898966|NCT02353143|452928220|FG000|Overall Study|Withdrawal by Subject|1|||
125898967|NCT02353143|452928221|FG001|Overall Study|Withdrawal by Subject|0|||
125898968|NCT02353143|452928222|FG002|Overall Study|Withdrawal by Subject|0|||
125898969|NCT02353143|452928223|FG003|Overall Study|Withdrawal by Subject|0|||
125898970|NCT02353143|452928224|FG004|Overall Study|Withdrawal by Subject|1|||
125898971|NCT02353143|452928225|FG005|Overall Study|Withdrawal by Subject|0|||
125898972|NCT02353143|452928226|FG006|Overall Study|Withdrawal by Subject|0|||
125898973|NCT02353143|452928227|FG007|Overall Study|Withdrawal by Subject|1|||
125898974|NCT02353143|452928228|FG008|Overall Study|Withdrawal by Subject|1|||
125898975|NCT02353143|452928220|FG000|Overall Study|Lack of Efficacy|2|||
125898976|NCT02353143|452928221|FG001|Overall Study|Lack of Efficacy|1|||
125898977|NCT02353143|452928222|FG002|Overall Study|Lack of Efficacy|2|||
125898978|NCT02353143|452928223|FG003|Overall Study|Lack of Efficacy|4|||
125898979|NCT02353143|452928224|FG004|Overall Study|Lack of Efficacy|13|||
126059749|NCT03136861|453512531|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126059750|NCT01584648|453512532|FG000|Overall Study|Death|136|||
126059751|NCT01584648|453512533|FG001|Overall Study|Death|146|||
126059752|NCT01584648|453512532|FG000|Overall Study|Lost to Follow-up|9|||
126059753|NCT01584648|453512533|FG001|Overall Study|Lost to Follow-up|9|||
126059754|NCT01584648|453512532|FG000|Overall Study|Investigator discretion|3|||
126059755|NCT01584648|453512533|FG001|Overall Study|Investigator discretion|2|||
125898980|NCT02353143|452928225|FG005|Overall Study|Lack of Efficacy|2|||
125898981|NCT02353143|452928226|FG006|Overall Study|Lack of Efficacy|2|||
125898982|NCT02353143|452928227|FG007|Overall Study|Lack of Efficacy|2|||
125898983|NCT02353143|452928228|FG008|Overall Study|Lack of Efficacy|1|||
125898984|NCT02353143|452928220|FG000|Overall Study|reason not specified|1|||
125898985|NCT02353143|452928221|FG001|Overall Study|reason not specified|2|||
125898986|NCT02353143|452928222|FG002|Overall Study|reason not specified|0|||
125898987|NCT02353143|452928223|FG003|Overall Study|reason not specified|0|||
125898988|NCT02353143|452928224|FG004|Overall Study|reason not specified|6|||
125898989|NCT02353143|452928225|FG005|Overall Study|reason not specified|1|||
125898990|NCT02353143|452928226|FG006|Overall Study|reason not specified|0|||
125898991|NCT02353143|452928227|FG007|Overall Study|reason not specified|3|||
125898992|NCT02353143|452928228|FG008|Overall Study|reason not specified|1|||
125898993|NCT02353143|452928220|FG000|Overall Study|Physician Decision|0|||
125898994|NCT02353143|452928221|FG001|Overall Study|Physician Decision|4|||
125898995|NCT02353143|452928222|FG002|Overall Study|Physician Decision|2|||
125898996|NCT02353143|452928223|FG003|Overall Study|Physician Decision|3|||
125898997|NCT02353143|452928224|FG004|Overall Study|Physician Decision|4|||
125898998|NCT02353143|452928225|FG005|Overall Study|Physician Decision|0|||
125898999|NCT02353143|452928226|FG006|Overall Study|Physician Decision|1|||
125899000|NCT02353143|452928227|FG007|Overall Study|Physician Decision|2|||
125899001|NCT02353143|452928228|FG008|Overall Study|Physician Decision|0|||
125899002|NCT02353143|452928220|FG000|Overall Study|Adverse Event|0|||
125899003|NCT02353143|452928221|FG001|Overall Study|Adverse Event|0|||
125899004|NCT02353143|452928222|FG002|Overall Study|Adverse Event|1|||
125899005|NCT02353143|452928223|FG003|Overall Study|Adverse Event|0|||
125899006|NCT02353143|452928224|FG004|Overall Study|Adverse Event|1|||
125899007|NCT02353143|452928225|FG005|Overall Study|Adverse Event|1|||
125899008|NCT02353143|452928226|FG006|Overall Study|Adverse Event|0|||
125899009|NCT02353143|452928227|FG007|Overall Study|Adverse Event|0|||
125899010|NCT02353143|452928228|FG008|Overall Study|Adverse Event|0|||
125899011|NCT02353143|452928220|FG000|Overall Study|patient receiving other treatment for AML|0|||
125899012|NCT02353143|452928221|FG001|Overall Study|patient receiving other treatment for AML|0|||
125899013|NCT02353143|452928222|FG002|Overall Study|patient receiving other treatment for AML|1|||
125899014|NCT02353143|452928223|FG003|Overall Study|patient receiving other treatment for AML|0|||
125899015|NCT02353143|452928224|FG004|Overall Study|patient receiving other treatment for AML|0|||
125899016|NCT02353143|452928225|FG005|Overall Study|patient receiving other treatment for AML|0|||
125899017|NCT02353143|452928226|FG006|Overall Study|patient receiving other treatment for AML|0|||
125899018|NCT02353143|452928227|FG007|Overall Study|patient receiving other treatment for AML|0|||
125899019|NCT02353143|452928228|FG008|Overall Study|patient receiving other treatment for AML|0|||
125899020|NCT02353143|452928220|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
125899021|NCT02353143|452928221|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
125899022|NCT02353143|452928222|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
125899023|NCT02353143|452928223|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
125899024|NCT02353143|452928224|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
125899025|NCT02353143|452928225|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
125899026|NCT02353143|452928226|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
125899027|NCT02353143|452928227|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
125899028|NCT02353143|452928228|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
125899029|NCT04905498|452928234|FG000|Overall Study|Lost to Follow-up|0|||
125899030|NCT04905498|452928235|FG001|Overall Study|Lost to Follow-up|2|||
125899031|NCT04905498|452928234|FG000|Overall Study|COVID lockdown|1|||
125899032|NCT04905498|452928235|FG001|Overall Study|COVID lockdown|0|||
125899033|NCT02946931|452928238|FG000|Overall Study|Did not require collection of CRFs|588|||
125899034|NCT02946931|452928238|FG000|Overall Study|Other than listed|37|||
125899035|NCT02946931|452928238|FG000|Overall Study|Discharge from hospital|118|||
125899036|NCT02946931|452928238|FG000|Overall Study|Adverse Event|81|||
125899037|NCT02946931|452928238|FG000|Overall Study|CRFs not valid|1|||
125899038|NCT02946931|452928238|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
125899039|NCT00869778|452928239|FG000|Overall Study|Adverse Event|2|||
125899040|NCT00869778|452928240|FG001|Overall Study|Adverse Event|0|||
125899041|NCT00869778|452928241|FG002|Overall Study|Adverse Event|0|||
125899042|NCT00869778|452928239|FG000|Overall Study|Withdrawal by Subject|3|||
125899043|NCT00869778|452928240|FG001|Overall Study|Withdrawal by Subject|4|||
125899044|NCT00869778|452928241|FG002|Overall Study|Withdrawal by Subject|5|||
125899045|NCT00869778|452928239|FG000|Overall Study|Pregnancy|1|||
125899046|NCT00869778|452928240|FG001|Overall Study|Pregnancy|0|||
125899047|NCT00869778|452928241|FG002|Overall Study|Pregnancy|0|||
125899048|NCT00869778|452928239|FG000|Overall Study|Protocol Violation|5|||
125899049|NCT00869778|452928240|FG001|Overall Study|Protocol Violation|3|||
125899050|NCT00869778|452928241|FG002|Overall Study|Protocol Violation|5|||
125899051|NCT00869778|452928239|FG000|Overall Study|Unblinding|1|||
125899052|NCT00869778|452928240|FG001|Overall Study|Unblinding|0|||
126059756|NCT01584648|453512532|FG000|Overall Study|Withdrew consent|13|||
126059757|NCT01584648|453512533|FG001|Overall Study|Withdrew consent|4|||
125899053|NCT00869778|452928241|FG002|Overall Study|Unblinding|0|||
125899054|NCT03339297|452928242|FG000|Overall Study|Relapse of Hematologic Disease|1|||
125899055|NCT03339297|452928243|FG001|Overall Study|Relapse of Hematologic Disease|0|||
125899056|NCT03339297|452928242|FG000|Overall Study|Death|10|||
125899057|NCT03339297|452928243|FG001|Overall Study|Death|7|||
125899058|NCT03339297|452928242|FG000|Overall Study|Hepatic Candidosis|1|||
125899059|NCT03339297|452928243|FG001|Overall Study|Hepatic Candidosis|0|||
125899060|NCT03339297|452928242|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
125899061|NCT03339297|452928243|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
125899062|NCT03339297|452928242|FG000|Overall Study|Consent Withdrawn by Participant|3|||
125899063|NCT03339297|452928243|FG001|Overall Study|Consent Withdrawn by Participant|3|||
125899064|NCT03339297|452928242|FG000|Overall Study|Disease Relapse|2|||
125899065|NCT03339297|452928243|FG001|Overall Study|Disease Relapse|0|||
125899066|NCT03339297|452928242|FG000|Overall Study|Physician Decision|1|||
125899067|NCT03339297|452928243|FG001|Overall Study|Physician Decision|1|||
125899068|NCT03339297|452928242|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
125899069|NCT03339297|452928243|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
125899070|NCT03339297|452928242|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
125899071|NCT03339297|452928243|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
125899072|NCT03339297|452928242|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
125899073|NCT03339297|452928243|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
125899074|NCT03339297|452928242|FG000|Overall Study|Adverse Event, Non-fatal|1|||
125899075|NCT03339297|452928243|FG001|Overall Study|Adverse Event, Non-fatal|0|||
125899076|NCT03339297|452928242|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
125899077|NCT03339297|452928243|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
125899078|NCT03339297|452928242|FG000|Overall Study|Patient Was Not Eligible|1|||
125899079|NCT03339297|452928243|FG001|Overall Study|Patient Was Not Eligible|0|||
125899080|NCT03051620|452928246|FG000|Overall Study|Lost to Follow-up|6|||
125899081|NCT03051620|452928246|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
125899082|NCT00393510|452928247|FG000|Overall Study|Physician Decision|3|||
125899083|NCT00393510|452928248|FG001|Overall Study|Physician Decision|9|||
125899084|NCT03077087|452928251|FG000|Overall Study|Physician Decision|2|||
125899085|NCT02112045|452928257|FG000|Overall Study|Withdrawal by Subject|1|||
125899086|NCT02112045|452928258|FG001|Overall Study|Withdrawal by Subject|0|||
125899087|NCT00977080|452928260|FG000|Overall Study|Adverse Event|2|||
125899088|NCT00977080|452928261|FG001|Overall Study|Adverse Event|7|||
125899089|NCT00977080|452928262|FG002|Overall Study|Adverse Event|7|||
125899090|NCT00977080|452928263|FG003|Overall Study|Adverse Event|7|||
125899091|NCT00977080|452928260|FG000|Overall Study|Withdrawal by Subject|1|||
125899092|NCT00977080|452928261|FG001|Overall Study|Withdrawal by Subject|5|||
125899093|NCT00977080|452928262|FG002|Overall Study|Withdrawal by Subject|1|||
125899094|NCT00977080|452928263|FG003|Overall Study|Withdrawal by Subject|5|||
125899095|NCT00977080|452928260|FG000|Overall Study|Protocol Violation|7|||
125899096|NCT00977080|452928261|FG001|Overall Study|Protocol Violation|3|||
125899097|NCT00977080|452928262|FG002|Overall Study|Protocol Violation|4|||
125899098|NCT00977080|452928263|FG003|Overall Study|Protocol Violation|3|||
125899099|NCT00977080|452928260|FG000|Overall Study|Noncompliance|0|||
125899100|NCT00977080|452928261|FG001|Overall Study|Noncompliance|2|||
125899101|NCT00977080|452928262|FG002|Overall Study|Noncompliance|1|||
125899102|NCT00977080|452928263|FG003|Overall Study|Noncompliance|0|||
125899103|NCT00977080|452928260|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
125899104|NCT00977080|452928261|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
125899105|NCT00977080|452928262|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
125899106|NCT00977080|452928263|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
125899107|NCT00977080|452928260|FG000|Overall Study|Required kidney transplantation|1|||
125899108|NCT00977080|452928261|FG001|Overall Study|Required kidney transplantation|3|||
125899109|NCT00977080|452928262|FG002|Overall Study|Required kidney transplantation|3|||
125899110|NCT00977080|452928263|FG003|Overall Study|Required kidney transplantation|1|||
125899111|NCT00977080|452928260|FG000|Overall Study|Travel for family reasons|1|||
125899112|NCT00977080|452928261|FG001|Overall Study|Travel for family reasons|0|||
125899113|NCT00977080|452928262|FG002|Overall Study|Travel for family reasons|0|||
125899114|NCT00977080|452928263|FG003|Overall Study|Travel for family reasons|0|||
125899115|NCT00441116|452928266|FG000|Overall Study|Adverse Event|1|||
125899116|NCT00441116|452928267|FG001|Overall Study|Adverse Event|1|||
125899117|NCT00441116|452928266|FG000|Overall Study|Withdrawal by Subject|1|||
125899118|NCT00441116|452928267|FG001|Overall Study|Withdrawal by Subject|0|||
125899119|NCT00441116|452928266|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
125899120|NCT00441116|452928267|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
125899121|NCT00796991|452928279|FG000|Overall Study|Adverse Event|0|||
125899122|NCT00796991|452928280|FG001|Overall Study|Adverse Event|0|||
125899123|NCT00796991|452928281|FG002|Overall Study|Adverse Event|1|||
125899124|NCT00796991|452928279|FG000|Overall Study|Death|2|||
125899125|NCT00796991|452928280|FG001|Overall Study|Death|0|||
125899126|NCT00796991|452928281|FG002|Overall Study|Death|0|||
125899127|NCT00796991|452928279|FG000|Overall Study|Disease Progression|10|||
125899128|NCT00796991|452928280|FG001|Overall Study|Disease Progression|9|||
125899129|NCT00796991|452928281|FG002|Overall Study|Disease Progression|7|||
125899130|NCT00796991|452928279|FG000|Overall Study|Study Drug Toxicity|3|||
125899131|NCT00796991|452928280|FG001|Overall Study|Study Drug Toxicity|3|||
125899132|NCT00796991|452928281|FG002|Overall Study|Study Drug Toxicity|5|||
125899133|NCT00796991|452928279|FG000|Overall Study|Withdrawal by Subject|0|||
125899134|NCT00796991|452928280|FG001|Overall Study|Withdrawal by Subject|0|||
125899135|NCT00796991|452928281|FG002|Overall Study|Withdrawal by Subject|1|||
125899136|NCT01765218|452928282|FG000|Overall Study|Protocol Violation|1|||
125899137|NCT01765218|452928283|FG001|Overall Study|Protocol Violation|2|||
125899138|NCT03148691|452928284|FG000|Overall Study|Protocol Violation|1|||
125899139|NCT03148691|452928285|FG001|Overall Study|Protocol Violation|2|||
125899140|NCT03148691|452928286|FG002|Overall Study|Protocol Violation|7|||
125899141|NCT03148691|452928284|FG000|Overall Study|Lost to Follow-up|0|||
125899142|NCT03148691|452928285|FG001|Overall Study|Lost to Follow-up|0|||
125899143|NCT03148691|452928286|FG002|Overall Study|Lost to Follow-up|1|||
125899144|NCT03148691|452928284|FG000|Overall Study|Other|1|||
125899145|NCT03148691|452928285|FG001|Overall Study|Other|0|||
125899146|NCT03148691|452928286|FG002|Overall Study|Other|0|||
125899147|NCT03148691|452928284|FG000|Overall Study|Withdrawal by Subject|1|||
125899148|NCT03148691|452928285|FG001|Overall Study|Withdrawal by Subject|0|||
125899149|NCT03148691|452928286|FG002|Overall Study|Withdrawal by Subject|0|||
125899150|NCT00171834|452928287|FG000|Overall Study|Adverse Event|2|||
125899151|NCT00171834|452928288|FG001|Overall Study|Adverse Event|1|||
125899152|NCT00171834|452928289|FG002|Overall Study|Adverse Event|3|||
125899153|NCT00171834|452928290|FG003|Overall Study|Adverse Event|2|||
125899154|NCT00171834|452928291|FG004|Overall Study|Adverse Event|2|||
125899155|NCT00171834|452928292|FG005|Overall Study|Adverse Event|15|||
125899156|NCT00171834|452928293|FG006|Overall Study|Adverse Event|1|||
125899157|NCT00171834|452928287|FG000|Overall Study|Withdrawal by Subject|0|||
125899158|NCT00171834|452928288|FG001|Overall Study|Withdrawal by Subject|2|||
125899159|NCT00171834|452928289|FG002|Overall Study|Withdrawal by Subject|0|||
125899160|NCT00171834|452928290|FG003|Overall Study|Withdrawal by Subject|1|||
125899161|NCT00171834|452928291|FG004|Overall Study|Withdrawal by Subject|1|||
125899162|NCT00171834|452928292|FG005|Overall Study|Withdrawal by Subject|1|||
125899163|NCT00171834|452928293|FG006|Overall Study|Withdrawal by Subject|0|||
125899164|NCT00171834|452928287|FG000|Overall Study|Death from study indication|0|||
125899165|NCT00171834|452928288|FG001|Overall Study|Death from study indication|1|||
125899166|NCT00171834|452928289|FG002|Overall Study|Death from study indication|0|||
125899167|NCT00171834|452928290|FG003|Overall Study|Death from study indication|0|||
125899168|NCT00171834|452928291|FG004|Overall Study|Death from study indication|1|||
125899169|NCT00171834|452928292|FG005|Overall Study|Death from study indication|0|||
125899170|NCT00171834|452928293|FG006|Overall Study|Death from study indication|0|||
125899171|NCT00171834|452928287|FG000|Overall Study|Disease Progression|4|||
125899172|NCT00171834|452928288|FG001|Overall Study|Disease Progression|8|||
125899173|NCT00171834|452928289|FG002|Overall Study|Disease Progression|8|||
125899174|NCT00171834|452928290|FG003|Overall Study|Disease Progression|9|||
125899175|NCT00171834|452928291|FG004|Overall Study|Disease Progression|2|||
125899176|NCT00171834|452928292|FG005|Overall Study|Disease Progression|18|||
125899177|NCT00171834|452928293|FG006|Overall Study|Disease Progression|3|||
125899178|NCT00171834|452928287|FG000|Overall Study|Treatment Duration Completed|0|||
125899179|NCT00171834|452928288|FG001|Overall Study|Treatment Duration Completed|0|||
125899180|NCT00171834|452928289|FG002|Overall Study|Treatment Duration Completed|1|||
125899181|NCT00171834|452928290|FG003|Overall Study|Treatment Duration Completed|0|||
125899182|NCT00171834|452928291|FG004|Overall Study|Treatment Duration Completed|2|||
125899183|NCT00171834|452928292|FG005|Overall Study|Treatment Duration Completed|1|||
125899184|NCT00171834|452928293|FG006|Overall Study|Treatment Duration Completed|0|||
125899185|NCT02365233|452928303|FG000|Overall Study|IRB withheld the data|1|||
125899186|NCT02365233|452928304|FG001|Overall Study|IRB withheld the data|2|||
125899187|NCT02365233|452928305|FG002|Overall Study|IRB withheld the data|2|||
125899188|NCT01978938|452928306|FG000|Overall Study|Lost to Follow-up|12|||
125899189|NCT01978938|452928307|FG001|Overall Study|Lost to Follow-up|6|||
125899190|NCT01978938|452928306|FG000|Overall Study|Withdrawal by Subject|8|||
125899191|NCT01978938|452928307|FG001|Overall Study|Withdrawal by Subject|4|||
125899192|NCT01978938|452928306|FG000|Overall Study|Adverse Event, non-fatal|2|||
125899193|NCT01978938|452928307|FG001|Overall Study|Adverse Event, non-fatal|1|||
125899194|NCT01978938|452928306|FG000|Overall Study|Participant noncompliance|1|||
125899195|NCT01978938|452928307|FG001|Overall Study|Participant noncompliance|1|||
125899196|NCT01978938|452928306|FG000|Overall Study|Did not meet inclusion criteria|0|||
125899197|NCT01978938|452928307|FG001|Overall Study|Did not meet inclusion criteria|1|||
125899198|NCT01978938|452928306|FG000|Overall Study|Previously scheduled procedure|0|||
125899199|NCT01978938|452928307|FG001|Overall Study|Previously scheduled procedure|1|||
125899200|NCT02342418|452928308|FG000|Overall Study|Adverse Event|0|||
125899201|NCT02342418|452928309|FG001|Overall Study|Adverse Event|1|||
125899202|NCT01246466|452930376|FG000|Overall Study|Death|1|||
125899203|NCT01246466|452930376|FG000|Overall Study|Withdrawal by Subject|1|||
125899204|NCT01012219|452930379|FG000|Period 1|Withdrawal by Subject|1|||
125899205|NCT01012219|452930379|FG000|Period 2|Withdrawal by Subject|1|||
125899206|NCT01350544|452930388|FG000|Overall Study|Administrative Withdrawal|0|||
125899207|NCT01350544|452930389|FG001|Overall Study|Administrative Withdrawal|1|||
125899208|NCT01350544|452930388|FG000|Overall Study|Death|1|||
125899209|NCT01350544|452930389|FG001|Overall Study|Death|2|||
125899210|NCT01350544|452930388|FG000|Overall Study|Moved out of LA County|2|||
125899211|NCT01350544|452930389|FG001|Overall Study|Moved out of LA County|2|||
125899212|NCT01350544|452930388|FG000|Overall Study|Medical Issues|1|||
125899213|NCT01350544|452930389|FG001|Overall Study|Medical Issues|1|||
125899214|NCT01350544|452930388|FG000|Overall Study|Withdrawal by Subject|0|||
125899215|NCT01350544|452930389|FG001|Overall Study|Withdrawal by Subject|1|||
125899216|NCT01350544|452930388|FG000|Overall Study|Incarceration|1|||
125899217|NCT01350544|452930389|FG001|Overall Study|Incarceration|0|||
125899218|NCT01350544|452930388|FG000|Overall Study|Lost to Follow-up|18|||
125899219|NCT01350544|452930389|FG001|Overall Study|Lost to Follow-up|15|||
125899220|NCT01328366|452930390|FG000|Overall Study|Death|1|||
125899221|NCT01328366|452930390|FG000|Overall Study|Withdrawal by Subject|2|||
125899222|NCT01328366|452930390|FG000|Overall Study|Lost to Follow-up|7|||
125899223|NCT01122264|452930394|FG000|Overall Study|Adverse Event|6|||
125899224|NCT01122264|452930395|FG001|Overall Study|Adverse Event|5|||
125899225|NCT01122264|452930396|FG002|Overall Study|Adverse Event|7|||
125899226|NCT01122264|452930394|FG000|Overall Study|Death|1|||
125899227|NCT01122264|452930395|FG001|Overall Study|Death|0|||
125899228|NCT01122264|452930396|FG002|Overall Study|Death|0|||
125899229|NCT01122264|452930394|FG000|Overall Study|Lost to Follow-up|5|||
125899230|NCT01122264|452930395|FG001|Overall Study|Lost to Follow-up|9|||
125899231|NCT01122264|452930396|FG002|Overall Study|Lost to Follow-up|13|||
125899232|NCT01122264|452930394|FG000|Overall Study|Entry Criteria Not Met|1|||
125899233|NCT01122264|452930395|FG001|Overall Study|Entry Criteria Not Met|0|||
125899234|NCT01122264|452930396|FG002|Overall Study|Entry Criteria Not Met|0|||
125899235|NCT01122264|452930394|FG000|Overall Study|Protocol Violation|7|||
125899236|NCT01122264|452930395|FG001|Overall Study|Protocol Violation|7|||
125899237|NCT01122264|452930396|FG002|Overall Study|Protocol Violation|9|||
126059758|NCT01584648|453512532|FG000|Overall Study|Study closed/terminated|50|||
125899238|NCT01122264|452930394|FG000|Overall Study|Withdrawal by Subject|6|||
125899239|NCT01122264|452930395|FG001|Overall Study|Withdrawal by Subject|6|||
125899240|NCT01122264|452930396|FG002|Overall Study|Withdrawal by Subject|16|||
125899241|NCT01122264|452930394|FG000|Overall Study|Physician Decision|3|||
125899242|NCT01122264|452930395|FG001|Overall Study|Physician Decision|1|||
125899243|NCT01122264|452930396|FG002|Overall Study|Physician Decision|1|||
125899244|NCT01122264|452930394|FG000|Overall Study|Lack of Efficacy|3|||
125899245|NCT01122264|452930395|FG001|Overall Study|Lack of Efficacy|1|||
125899246|NCT01122264|452930396|FG002|Overall Study|Lack of Efficacy|1|||
125899247|NCT03005873|452930397|FG000|Overall Study|Prohibited medication use post radnomization|1|||
125899248|NCT03005873|452930398|FG001|Overall Study|Prohibited medication use post radnomization|1|||
125899249|NCT03005873|452930399|FG002|Overall Study|Prohibited medication use post radnomization|1|||
125899250|NCT03005873|452930397|FG000|Overall Study|Withdrew consent|0|||
125899251|NCT03005873|452930398|FG001|Overall Study|Withdrew consent|1|||
125899252|NCT03005873|452930399|FG002|Overall Study|Withdrew consent|2|||
125899253|NCT03005873|452930397|FG000|Overall Study|Lost to Follow-up|0|||
125899254|NCT03005873|452930398|FG001|Overall Study|Lost to Follow-up|1|||
125899255|NCT03005873|452930399|FG002|Overall Study|Lost to Follow-up|0|||
125899256|NCT03005873|452930397|FG000|Overall Study|Ineligible post randomization|0|||
125899257|NCT03005873|452930398|FG001|Overall Study|Ineligible post randomization|0|||
125899258|NCT03005873|452930399|FG002|Overall Study|Ineligible post randomization|1|||
125899259|NCT00097981|452930408|FG000|Overall Study|Adverse Event|31|||
125899260|NCT00097981|452930409|FG001|Overall Study|Adverse Event|44|||
125899261|NCT00097981|452930408|FG000|Overall Study|Withdrawal by Subject|10|||
125899262|NCT00097981|452930409|FG001|Overall Study|Withdrawal by Subject|8|||
125899263|NCT00097981|452930408|FG000|Overall Study|Protocol Violation|1|||
125899264|NCT00097981|452930409|FG001|Overall Study|Protocol Violation|1|||
125899265|NCT00097981|452930408|FG000|Overall Study|Death|2|||
125899266|NCT00097981|452930409|FG001|Overall Study|Death|4|||
125899267|NCT00097981|452930408|FG000|Overall Study|Physician Decision|7|||
125899268|NCT00097981|452930409|FG001|Overall Study|Physician Decision|1|||
125899269|NCT00097981|452930408|FG000|Overall Study|Disease Progression|8|||
125899270|NCT00097981|452930409|FG001|Overall Study|Disease Progression|2|||
125899271|NCT00097981|452930408|FG000|Overall Study|Transplant planned|28|||
125899272|NCT00097981|452930409|FG001|Overall Study|Transplant planned|27|||
125899273|NCT00097981|452930408|FG000|Overall Study|Other|19|||
125899274|NCT00097981|452930409|FG001|Overall Study|Other|13|||
125899275|NCT00538785|452930410|FG000|Overall Study|Death|9|||
125899276|NCT00538785|452930411|FG001|Overall Study|Death|10|||
125899277|NCT00538785|452930410|FG000|Overall Study|Withdrawal of consent|9|||
125899278|NCT00538785|452930411|FG001|Overall Study|Withdrawal of consent|7|||
125899279|NCT00538785|452930410|FG000|Overall Study|Lost to Follow-up|1|||
125899280|NCT00538785|452930411|FG001|Overall Study|Lost to Follow-up|0|||
125899281|NCT01002820|452930412|FG000|Overall Study|Adverse Event|1|||
125899282|NCT01002820|452930412|FG000|Overall Study|Withdrawal by Subject|2|||
125899283|NCT01002820|452930412|FG000|Overall Study|Lack of Efficacy|1|||
125899284|NCT00895011|452930414|FG000|Overall Study|Withdrawal by Subject|14|||
125899285|NCT00895011|452930415|FG001|Overall Study|Withdrawal by Subject|7|||
125899286|NCT00895011|452930416|FG002|Overall Study|Withdrawal by Subject|2|||
125899287|NCT00895011|452930414|FG000|Overall Study|Lost to Follow-up|5|||
125899288|NCT00895011|452930415|FG001|Overall Study|Lost to Follow-up|4|||
125899289|NCT00895011|452930416|FG002|Overall Study|Lost to Follow-up|1|||
125899290|NCT00895011|452930414|FG000|Overall Study|Protocol Violation|3|||
125899291|NCT00895011|452930415|FG001|Overall Study|Protocol Violation|1|||
125899292|NCT00895011|452930416|FG002|Overall Study|Protocol Violation|3|||
125899293|NCT00895011|452930414|FG000|Overall Study|Adverse Event|1|||
125899294|NCT00895011|452930415|FG001|Overall Study|Adverse Event|2|||
125899295|NCT00895011|452930416|FG002|Overall Study|Adverse Event|2|||
125899296|NCT00895011|452930414|FG000|Overall Study|schedule conflict|1|||
125899297|NCT00895011|452930415|FG001|Overall Study|schedule conflict|0|||
125899298|NCT00895011|452930416|FG002|Overall Study|schedule conflict|0|||
125899299|NCT02230527|452930418|FG000|Overall Study|Withdrawal by Subject|1|||
125899300|NCT02230527|452930419|FG001|Overall Study|Withdrawal by Subject|1|||
125899301|NCT02230527|452930418|FG000|Overall Study|Death|1|||
125899302|NCT02230527|452930419|FG001|Overall Study|Death|0|||
125899303|NCT02230527|452930418|FG000|Overall Study|Lost to Follow-up|2|||
125899304|NCT02230527|452930419|FG001|Overall Study|Lost to Follow-up|1|||
125899305|NCT02230527|452930418|FG000|Overall Study|Other|1|||
125899306|NCT02230527|452930419|FG001|Overall Study|Other|0|||
125899307|NCT02661178|452930420|FG000|Part 1|Protocol Violation|1|||
125899308|NCT02661178|452930421|FG001|Part 1|Protocol Violation|0|||
125899309|NCT02661178|452930422|FG002|Part 1|Protocol Violation|0|||
125899310|NCT02661178|452930423|FG003|Part 1|Protocol Violation|0|||
125899311|NCT02661178|452930424|FG004|Part 1|Protocol Violation|0|||
125899312|NCT02661178|452930425|FG005|Part 1|Protocol Violation|0|||
125899313|NCT02661178|452930426|FG006|Part 1|Protocol Violation|0|||
125899314|NCT02661178|452930427|FG007|Part 1|Protocol Violation|0|||
125899315|NCT02661178|452930428|FG008|Part 1|Protocol Violation|0|||
125899316|NCT02661178|452930429|FG009|Part 1|Protocol Violation|0|||
125899317|NCT02661178|452930430|FG010|Part 1|Protocol Violation|0|||
125899318|NCT02661178|452930431|FG011|Part 1|Protocol Violation|0|||
125899319|NCT02661178|452930432|FG012|Part 1|Protocol Violation|0|||
125899320|NCT02661178|452930433|FG013|Part 1|Protocol Violation|0|||
125899321|NCT02661178|452930434|FG014|Part 1|Protocol Violation|0|||
125899322|NCT04461600|452930436|FG000|Overall Study|Death|6|||
125899323|NCT04461600|452930437|FG001|Overall Study|Death|5|||
125899324|NCT04461600|452930436|FG000|Overall Study|Withdrawal by Subject|0|||
125899325|NCT04461600|452930437|FG001|Overall Study|Withdrawal by Subject|1|||
125899326|NCT01242813|452930438|FG000|Overall Study|Lost to Follow-up|2|||
125899327|NCT01369329|452930441|FG000|Overall Study|Withdrawal by Subject|8|||
125899328|NCT01369329|452930442|FG001|Overall Study|Withdrawal by Subject|6|||
125899329|NCT01369329|452930443|FG002|Overall Study|Withdrawal by Subject|10|||
125899330|NCT01369329|452930441|FG000|Overall Study|Lost to Follow-up|2|||
125899331|NCT01369329|452930442|FG001|Overall Study|Lost to Follow-up|2|||
125899332|NCT01369329|452930443|FG002|Overall Study|Lost to Follow-up|2|||
125899333|NCT01369329|452930441|FG000|Overall Study|Other|2|||
125899334|NCT01369329|452930442|FG001|Overall Study|Other|3|||
125899335|NCT01369329|452930443|FG002|Overall Study|Other|2|||
125899336|NCT01252667|452930444|FG000|Overall Study|Transplant aborted post-conditioning|0|||
125899337|NCT01252667|452930445|FG001|Overall Study|Transplant aborted post-conditioning|0|||
125899338|NCT01252667|452930446|FG002|Overall Study|Transplant aborted post-conditioning|0|||
125899339|NCT01252667|452930447|FG003|Overall Study|Transplant aborted post-conditioning|0|||
125899340|NCT01252667|452930448|FG004|Overall Study|Transplant aborted post-conditioning|0|||
125899341|NCT01252667|452930449|FG005|Overall Study|Transplant aborted post-conditioning|1|||
125899342|NCT01836276|452930450|FG000|Overall Study|Lost to Follow-up|28|||
125899343|NCT01836276|452930451|FG001|Overall Study|Lost to Follow-up|51|||
125899344|NCT00331552|452930454|FG000|Period 3: Phase II|Neurological Symptoms|1|||
125899345|NCT00331552|452930455|FG001|Period 3: Phase II|Neurological Symptoms|0|||
125899346|NCT00331552|452930454|FG000|Period 3: Phase II|Severe Nausea|1|||
125899347|NCT00331552|452930455|FG001|Period 3: Phase II|Severe Nausea|0|||
125899348|NCT02984943|452930456|FG000|Overall Study|Withdrawal by Subject|3|||
125899349|NCT02984943|452930456|FG000|Overall Study|Physician Decision|1|||
125899350|NCT01133990|452930457|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
125899351|NCT01133990|452930458|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125899352|NCT01133990|452930459|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125899353|NCT01133990|452930460|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125899354|NCT01133990|452930461|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125899355|NCT01133990|452930462|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125899356|NCT01133990|452930457|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
125899357|NCT01133990|452930458|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125899358|NCT01133990|452930459|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125899359|NCT01133990|452930460|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125899360|NCT01133990|452930461|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125899361|NCT01133990|452930462|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125899362|NCT01133990|452930457|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
125899363|NCT01133990|452930458|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125899364|NCT01133990|452930459|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125899365|NCT01133990|452930460|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125899366|NCT01133990|452930461|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125899367|NCT01133990|452930462|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125899368|NCT01133990|452930457|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
125899369|NCT01133990|452930458|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125899370|NCT01133990|452930459|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125899371|NCT01133990|452930460|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125899372|NCT01133990|452930461|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125899373|NCT01133990|452930462|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125899374|NCT02213133|452930465|FG000|Overall Study|Participant discontinued study therapy|2|||
125899375|NCT02213133|452930466|FG001|Overall Study|Participant discontinued study therapy|0|||
125899376|NCT02213133|452930467|FG002|Overall Study|Participant discontinued study therapy|0|||
125899377|NCT02213133|452930465|FG000|Overall Study|Participant withdrew informed consent|2|||
125899378|NCT02213133|452930466|FG001|Overall Study|Participant withdrew informed consent|1|||
125899379|NCT02213133|452930467|FG002|Overall Study|Participant withdrew informed consent|2|||
125899380|NCT02213133|452930465|FG000|Overall Study|Disease progression|11|||
125899381|NCT02213133|452930466|FG001|Overall Study|Disease progression|2|||
125899382|NCT02213133|452930467|FG002|Overall Study|Disease progression|0|||
125899383|NCT02213133|452930465|FG000|Overall Study|Adverse Event (AE)|1|||
125899384|NCT02213133|452930466|FG001|Overall Study|Adverse Event (AE)|0|||
125899385|NCT02213133|452930467|FG002|Overall Study|Adverse Event (AE)|0|||
125899386|NCT02213133|452930465|FG000|Overall Study|Death|16|||
125899387|NCT02213133|452930466|FG001|Overall Study|Death|2|||
125899388|NCT02213133|452930467|FG002|Overall Study|Death|1|||
125899389|NCT02213133|452930465|FG000|Overall Study|Other|5|||
125899390|NCT02213133|452930466|FG001|Overall Study|Other|0|||
125899391|NCT02213133|452930467|FG002|Overall Study|Other|0|||
125899392|NCT04740905|452930474|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
125899393|NCT04740905|452930475|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
125899394|NCT04740905|452930474|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
125899395|NCT04740905|452930475|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
125899396|NCT04740905|452930474|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
125899397|NCT04740905|452930475|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
125899398|NCT04740905|452930474|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
125899399|NCT04740905|452930475|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
125899400|NCT04740905|452930474|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
125899401|NCT04740905|452930475|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
125899402|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
125899403|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
125899404|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
125899405|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
125899406|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
125899407|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
125899408|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
125899409|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
125899410|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
125899411|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
125899412|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
125899413|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
125899414|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
125899415|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
125899416|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
125899417|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
125899418|NCT04740905|452930474|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
125899419|NCT04740905|452930475|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
125899420|NCT02412488|452930478|FG000|Overall Study|Lost to Follow-up|10|||
125899421|NCT02412488|452930478|FG000|Overall Study|Withdrawal by Subject|5|||
125899422|NCT02412488|452930478|FG000|Overall Study|Physician Decision|1|||
125899423|NCT02412488|452930478|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
125899424|NCT02412488|452930478|FG000|Overall Study|Reveal LINQ explant|1|||
125899425|NCT01989468|452930479|FG000|Overall Study|Adverse Event|10|||
125899426|NCT01989468|452930480|FG001|Overall Study|Adverse Event|15|||
125899427|NCT01989468|452930481|FG002|Overall Study|Adverse Event|4|||
125899428|NCT01989468|452930482|FG003|Overall Study|Adverse Event|5|||
125899429|NCT01989468|452930483|FG004|Overall Study|Adverse Event|4|||
125899430|NCT01989468|452930479|FG000|Overall Study|Lack of Efficacy|11|||
125899431|NCT01989468|452930480|FG001|Overall Study|Lack of Efficacy|11|||
125899432|NCT01989468|452930481|FG002|Overall Study|Lack of Efficacy|7|||
125899433|NCT01989468|452930482|FG003|Overall Study|Lack of Efficacy|4|||
125899434|NCT01989468|452930483|FG004|Overall Study|Lack of Efficacy|2|||
125899435|NCT01989468|452930479|FG000|Overall Study|Lost to Follow-up|5|||
125899436|NCT01989468|452930480|FG001|Overall Study|Lost to Follow-up|2|||
125899437|NCT01989468|452930481|FG002|Overall Study|Lost to Follow-up|0|||
125899438|NCT01989468|452930482|FG003|Overall Study|Lost to Follow-up|1|||
125899439|NCT01989468|452930483|FG004|Overall Study|Lost to Follow-up|1|||
125899440|NCT01989468|452930479|FG000|Overall Study|Physician Decision|4|||
125899441|NCT01989468|452930480|FG001|Overall Study|Physician Decision|1|||
125899442|NCT01989468|452930481|FG002|Overall Study|Physician Decision|0|||
125899443|NCT01989468|452930482|FG003|Overall Study|Physician Decision|1|||
125899444|NCT01989468|452930483|FG004|Overall Study|Physician Decision|0|||
125899445|NCT01989468|452930479|FG000|Overall Study|Pregnancy|0|||
125899446|NCT01989468|452930480|FG001|Overall Study|Pregnancy|1|||
125899447|NCT01989468|452930481|FG002|Overall Study|Pregnancy|0|||
125899448|NCT01989468|452930482|FG003|Overall Study|Pregnancy|0|||
125899449|NCT01989468|452930483|FG004|Overall Study|Pregnancy|0|||
125899450|NCT01989468|452930479|FG000|Overall Study|Technical Problems|3|||
125899451|NCT01989468|452930480|FG001|Overall Study|Technical Problems|1|||
125899452|NCT01989468|452930481|FG002|Overall Study|Technical Problems|3|||
125899453|NCT01989468|452930482|FG003|Overall Study|Technical Problems|1|||
125899454|NCT01989468|452930483|FG004|Overall Study|Technical Problems|0|||
125899455|NCT01989468|452930479|FG000|Overall Study|Subject Guardian Decision|11|||
125899456|NCT01989468|452930480|FG001|Overall Study|Subject Guardian Decision|6|||
125899457|NCT01989468|452930481|FG002|Overall Study|Subject Guardian Decision|4|||
125899458|NCT01989468|452930482|FG003|Overall Study|Subject Guardian Decision|4|||
125899459|NCT01989468|452930483|FG004|Overall Study|Subject Guardian Decision|1|||
125899460|NCT01989468|452930479|FG000|Overall Study|Death|3|||
125899461|NCT01989468|452930480|FG001|Overall Study|Death|0|||
125899462|NCT01989468|452930481|FG002|Overall Study|Death|1|||
125899463|NCT01989468|452930482|FG003|Overall Study|Death|0|||
125899464|NCT01989468|452930483|FG004|Overall Study|Death|0|||
125899465|NCT03222492|452930486|FG000|Overall Study|Withdrawal by Subject|0|||
125899466|NCT03222492|452930487|FG001|Overall Study|Withdrawal by Subject|0|||
125899467|NCT03222492|452930488|FG002|Overall Study|Withdrawal by Subject|1|||
125899468|NCT03222492|452930489|FG003|Overall Study|Withdrawal by Subject|0|||
125899469|NCT03222492|452930486|FG000|Overall Study|COVID-19 related|0|||
125899470|NCT03222492|452930487|FG001|Overall Study|COVID-19 related|0|||
125899471|NCT03222492|452930488|FG002|Overall Study|COVID-19 related|1|||
125899472|NCT03222492|452930489|FG003|Overall Study|COVID-19 related|0|||
125899473|NCT01224782|452930492|FG000|Overall Study|Lost to Follow-up|177|||
125899474|NCT01224782|452930492|FG000|Overall Study|Withdrawal by Subject|16|||
125899475|NCT01224782|452930492|FG000|Overall Study|Death|14|||
125899476|NCT01224782|452930492|FG000|Overall Study|Improvement|13|||
125899477|NCT01224782|452930492|FG000|Overall Study|Adverse Event|12|||
125899478|NCT01224782|452930492|FG000|Overall Study|Adverse Reaction|11|||
125899479|NCT01224782|452930492|FG000|Overall Study|Noncompliance|10|||
125899480|NCT01224782|452930492|FG000|Overall Study|Other|4|||
125899481|NCT01224782|452930492|FG000|Overall Study|Start of Dialysis|3|||
125899482|NCT01224782|452930492|FG000|Overall Study|Change of Treatment|1|||
125899483|NCT01224782|452930492|FG000|Overall Study|Financial Reasons|1|||
125899484|NCT01224782|452930492|FG000|Overall Study|Deterioration|1|||
125899485|NCT01224782|452930492|FG000|Overall Study|Transplantation|1|||
125899486|NCT00065429|452930495|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125899487|NCT00065429|452930496|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125899488|NCT00065429|452930497|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125899489|NCT00065429|452930498|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125899490|NCT00065429|452930499|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125899491|NCT00065429|452930500|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
125899492|NCT00065429|452930501|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125899493|NCT00065429|452930495|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125899494|NCT00065429|452930496|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125899495|NCT00065429|452930497|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
125899496|NCT00065429|452930498|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125899497|NCT00065429|452930499|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125899498|NCT00065429|452930500|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125899499|NCT00065429|452930501|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125899500|NCT00065429|452930495|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
125899501|NCT00065429|452930496|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125899502|NCT00065429|452930497|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125899503|NCT00065429|452930498|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125899504|NCT00065429|452930499|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125899505|NCT00065429|452930500|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125899506|NCT00065429|452930501|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125899507|NCT00065429|452930495|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
125899508|NCT00065429|452930496|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
125899509|NCT00065429|452930497|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
125899510|NCT00065429|452930498|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
125899511|NCT00065429|452930499|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
125899512|NCT00065429|452930500|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
125899513|NCT00065429|452930501|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
125899514|NCT00065429|452930495|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
125899515|NCT00065429|452930496|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
125899516|NCT00065429|452930497|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
125899517|NCT00065429|452930498|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
125899518|NCT00065429|452930499|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
125899519|NCT00065429|452930500|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
125899520|NCT00065429|452930501|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
125899521|NCT00065429|452930495|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125899522|NCT00065429|452930496|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125899523|NCT00065429|452930497|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125899524|NCT00065429|452930498|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125899525|NCT00065429|452930499|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
125899526|NCT00065429|452930500|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125899527|NCT00065429|452930501|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125899528|NCT00065429|452930495|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125899529|NCT00065429|452930496|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125899530|NCT00065429|452930497|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125899531|NCT00065429|452930498|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125899532|NCT00065429|452930499|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
125899533|NCT00065429|452930500|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125899534|NCT00065429|452930501|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125899535|NCT02015221|452930504|FG000|Overall Study|Withdrawal by Subject|8|||
125899536|NCT02015221|452930505|FG001|Overall Study|Withdrawal by Subject|6|||
125899537|NCT02015221|452930504|FG000|Overall Study|Lost to Follow-up|1|||
125899538|NCT02015221|452930505|FG001|Overall Study|Lost to Follow-up|0|||
125899539|NCT00995566|452930506|FG000|Overall Study|Adverse Event|2|||
125899540|NCT00995566|452930506|FG000|Overall Study|Early study termination|52|||
125899541|NCT00510653|452930507|FG000|Overall Study|Withdrawal by Subject|8|||
125899542|NCT00510653|452930507|FG000|Overall Study|Monetary|3|||
125899543|NCT01947855|452930508|FG000|Overall Study|Withdrawal by Subject|1|||
125899544|NCT01947855|452930509|FG001|Overall Study|Withdrawal by Subject|0|||
125899545|NCT01947855|452930510|FG002|Overall Study|Withdrawal by Subject|0|||
125899546|NCT00436501|452930511|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
125899547|NCT00436501|452930512|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
125899548|NCT00436501|452930511|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
125899549|NCT00436501|452930512|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
125899550|NCT03011892|452930514|FG000|Double Blind (DB) Period|Adverse Event|0|||
125899551|NCT03011892|452930515|FG001|Double Blind (DB) Period|Adverse Event|1|||
125899552|NCT03011892|452930516|FG002|Double Blind (DB) Period|Adverse Event|1|||
125899553|NCT03011892|452930517|FG003|Double Blind (DB) Period|Adverse Event|0|||
125899554|NCT03011892|452930518|FG004|Double Blind (DB) Period|Adverse Event|0|||
125899555|NCT03011892|452930519|FG005|Double Blind (DB) Period|Adverse Event|0|||
125899556|NCT03011892|452930520|FG006|Double Blind (DB) Period|Adverse Event|0|||
125899557|NCT03011892|452930521|FG007|Double Blind (DB) Period|Adverse Event|0|||
125899558|NCT03011892|452930522|FG008|Double Blind (DB) Period|Adverse Event|0|||
125899559|NCT03011892|452930523|FG009|Double Blind (DB) Period|Adverse Event|0|||
125899560|NCT03011892|452930524|FG010|Double Blind (DB) Period|Adverse Event|0|||
125899561|NCT03011892|452930525|FG011|Double Blind (DB) Period|Adverse Event|0|||
125899562|NCT03011892|452930514|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
125899563|NCT03011892|452930515|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
125899564|NCT03011892|452930516|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
125899565|NCT03011892|452930517|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
125899566|NCT03011892|452930518|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
125899567|NCT03011892|452930519|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
125899568|NCT03011892|452930520|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
125899569|NCT03011892|452930521|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
125899570|NCT03011892|452930522|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
125899571|NCT03011892|452930523|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
125899572|NCT03011892|452930524|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
125899573|NCT03011892|452930525|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
125899574|NCT03011892|452930514|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
125899575|NCT03011892|452930515|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
125899576|NCT03011892|452930516|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
125899577|NCT03011892|452930517|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
125899578|NCT03011892|452930518|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
125899579|NCT03011892|452930519|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
125899580|NCT03011892|452930520|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
125899581|NCT03011892|452930521|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
125899582|NCT03011892|452930522|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
125899583|NCT03011892|452930523|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
125899584|NCT03011892|452930524|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
125899585|NCT03011892|452930525|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
125899586|NCT03011892|452930514|FG000|Double Blind (DB) Period|Other|1|||
125899587|NCT03011892|452930515|FG001|Double Blind (DB) Period|Other|1|||
125899588|NCT03011892|452930516|FG002|Double Blind (DB) Period|Other|1|||
125899589|NCT03011892|452930517|FG003|Double Blind (DB) Period|Other|0|||
125899590|NCT03011892|452930518|FG004|Double Blind (DB) Period|Other|1|||
125899591|NCT03011892|452930519|FG005|Double Blind (DB) Period|Other|0|||
125899592|NCT03011892|452930520|FG006|Double Blind (DB) Period|Other|0|||
125899593|NCT03011892|452930521|FG007|Double Blind (DB) Period|Other|0|||
125899594|NCT03011892|452930522|FG008|Double Blind (DB) Period|Other|0|||
125899595|NCT03011892|452930523|FG009|Double Blind (DB) Period|Other|0|||
125899596|NCT03011892|452930524|FG010|Double Blind (DB) Period|Other|0|||
125899597|NCT03011892|452930525|FG011|Double Blind (DB) Period|Other|0|||
125899598|NCT03011892|452930514|FG000|Double Blind (DB) Period|Physician Decision|1|||
125899599|NCT03011892|452930515|FG001|Double Blind (DB) Period|Physician Decision|0|||
125899600|NCT03011892|452930516|FG002|Double Blind (DB) Period|Physician Decision|1|||
125899601|NCT03011892|452930517|FG003|Double Blind (DB) Period|Physician Decision|0|||
125899602|NCT03011892|452930518|FG004|Double Blind (DB) Period|Physician Decision|0|||
125899603|NCT03011892|452930519|FG005|Double Blind (DB) Period|Physician Decision|0|||
125899604|NCT03011892|452930520|FG006|Double Blind (DB) Period|Physician Decision|0|||
125899605|NCT03011892|452930521|FG007|Double Blind (DB) Period|Physician Decision|0|||
125899606|NCT03011892|452930522|FG008|Double Blind (DB) Period|Physician Decision|0|||
125899607|NCT03011892|452930523|FG009|Double Blind (DB) Period|Physician Decision|0|||
125899608|NCT03011892|452930524|FG010|Double Blind (DB) Period|Physician Decision|0|||
125899609|NCT03011892|452930525|FG011|Double Blind (DB) Period|Physician Decision|0|||
125899610|NCT03011892|452930514|FG000|Double Blind (DB) Period|Pregnancy|0|||
125899611|NCT03011892|452930515|FG001|Double Blind (DB) Period|Pregnancy|0|||
125899612|NCT03011892|452930516|FG002|Double Blind (DB) Period|Pregnancy|0|||
125899613|NCT03011892|452930517|FG003|Double Blind (DB) Period|Pregnancy|0|||
125899614|NCT03011892|452930518|FG004|Double Blind (DB) Period|Pregnancy|1|||
125899615|NCT03011892|452930519|FG005|Double Blind (DB) Period|Pregnancy|0|||
125899616|NCT03011892|452930520|FG006|Double Blind (DB) Period|Pregnancy|0|||
125899617|NCT03011892|452930521|FG007|Double Blind (DB) Period|Pregnancy|0|||
125899618|NCT03011892|452930522|FG008|Double Blind (DB) Period|Pregnancy|0|||
125899619|NCT03011892|452930523|FG009|Double Blind (DB) Period|Pregnancy|0|||
125899620|NCT03011892|452930524|FG010|Double Blind (DB) Period|Pregnancy|0|||
125899621|NCT03011892|452930525|FG011|Double Blind (DB) Period|Pregnancy|0|||
125899622|NCT03011892|452930514|FG000|Double Blind (DB) Period|Protocol Violation|1|||
125899623|NCT03011892|452930515|FG001|Double Blind (DB) Period|Protocol Violation|0|||
125899624|NCT03011892|452930516|FG002|Double Blind (DB) Period|Protocol Violation|0|||
125899625|NCT03011892|452930517|FG003|Double Blind (DB) Period|Protocol Violation|0|||
125899626|NCT03011892|452930518|FG004|Double Blind (DB) Period|Protocol Violation|0|||
125899627|NCT03011892|452930519|FG005|Double Blind (DB) Period|Protocol Violation|0|||
125899628|NCT03011892|452930520|FG006|Double Blind (DB) Period|Protocol Violation|0|||
125899629|NCT03011892|452930521|FG007|Double Blind (DB) Period|Protocol Violation|0|||
125899630|NCT03011892|452930522|FG008|Double Blind (DB) Period|Protocol Violation|0|||
125899631|NCT03011892|452930523|FG009|Double Blind (DB) Period|Protocol Violation|0|||
125899632|NCT03011892|452930524|FG010|Double Blind (DB) Period|Protocol Violation|0|||
125899633|NCT03011892|452930525|FG011|Double Blind (DB) Period|Protocol Violation|0|||
125899634|NCT03011892|452930514|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
125899635|NCT03011892|452930515|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
125899636|NCT03011892|452930516|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
125899637|NCT03011892|452930517|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
125899638|NCT03011892|452930518|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
125899639|NCT03011892|452930519|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
125899640|NCT03011892|452930520|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
125899641|NCT03011892|452930521|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
125899642|NCT03011892|452930522|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
125899643|NCT03011892|452930523|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
125899644|NCT03011892|452930524|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
125899645|NCT03011892|452930525|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
125899646|NCT03011892|452930514|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
125899647|NCT03011892|452930515|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
125899648|NCT03011892|452930516|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
125899649|NCT03011892|452930517|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
125899650|NCT03011892|452930518|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
125899651|NCT03011892|452930519|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
125899652|NCT03011892|452930520|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
125899653|NCT03011892|452930521|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
125899654|NCT03011892|452930522|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
125899655|NCT03011892|452930523|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
125899656|NCT03011892|452930524|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
125899657|NCT03011892|452930525|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
125899658|NCT03011892|452930514|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
125899659|NCT03011892|452930515|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
125899660|NCT03011892|452930516|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
125899661|NCT03011892|452930517|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
125899662|NCT03011892|452930518|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
125899663|NCT03011892|452930519|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
125899664|NCT03011892|452930520|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
125899665|NCT03011892|452930521|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
125899666|NCT03011892|452930522|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
125899667|NCT03011892|452930523|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
125899668|NCT03011892|452930524|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
125899669|NCT03011892|452930525|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
125899670|NCT03011892|452930514|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
125899671|NCT03011892|452930515|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
125899672|NCT03011892|452930516|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
125899673|NCT03011892|452930517|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
125899674|NCT03011892|452930518|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
125899675|NCT03011892|452930519|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
125899676|NCT03011892|452930520|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
125899677|NCT03011892|452930521|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
125899678|NCT03011892|452930522|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
125899679|NCT03011892|452930523|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
125899680|NCT03011892|452930524|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
125899681|NCT03011892|452930525|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
125899682|NCT03011892|452930514|FG000|Open Label (OL) Period|Reason not specified|0|||
125899683|NCT03011892|452930515|FG001|Open Label (OL) Period|Reason not specified|0|||
125899684|NCT03011892|452930516|FG002|Open Label (OL) Period|Reason not specified|0|||
125899685|NCT03011892|452930517|FG003|Open Label (OL) Period|Reason not specified|0|||
125899686|NCT03011892|452930518|FG004|Open Label (OL) Period|Reason not specified|0|||
125899687|NCT03011892|452930519|FG005|Open Label (OL) Period|Reason not specified|0|||
125899688|NCT03011892|452930520|FG006|Open Label (OL) Period|Reason not specified|0|||
125899689|NCT03011892|452930521|FG007|Open Label (OL) Period|Reason not specified|1|||
125899690|NCT03011892|452930522|FG008|Open Label (OL) Period|Reason not specified|0|||
125899691|NCT03011892|452930523|FG009|Open Label (OL) Period|Reason not specified|0|||
125899692|NCT03011892|452930524|FG010|Open Label (OL) Period|Reason not specified|0|||
125899693|NCT03011892|452930525|FG011|Open Label (OL) Period|Reason not specified|0|||
125899694|NCT02312687|452930526|FG000|Overall Study|Other, Not Specified|1|||
125899695|NCT00217464|452930529|FG000|Overall Study|Progression|15|||
125899696|NCT00217464|452930529|FG000|Overall Study|Other|2|||
125899697|NCT01576159|452930530|FG000|Overall Study|Withdrawal by Subject|0|||
125899698|NCT01576159|452930531|FG001|Overall Study|Withdrawal by Subject|1|||
125899699|NCT01576159|452930532|FG002|Overall Study|Withdrawal by Subject|0|||
125899700|NCT01576159|452930533|FG003|Overall Study|Withdrawal by Subject|0|||
125899701|NCT01576159|452930530|FG000|Overall Study|Physician Decision|0|||
125899702|NCT01576159|452930531|FG001|Overall Study|Physician Decision|0|||
125899703|NCT01576159|452930532|FG002|Overall Study|Physician Decision|1|||
126059759|NCT01584648|453512533|FG001|Overall Study|Study closed/terminated|23|||
126059760|NCT01584648|453512532|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
125899704|NCT01576159|452930533|FG003|Overall Study|Physician Decision|0|||
125899705|NCT01576159|452930530|FG000|Overall Study|Lost to Follow-up|0|||
125899706|NCT01576159|452930531|FG001|Overall Study|Lost to Follow-up|0|||
125899707|NCT01576159|452930532|FG002|Overall Study|Lost to Follow-up|0|||
125899708|NCT01576159|452930533|FG003|Overall Study|Lost to Follow-up|1|||
125899709|NCT01576159|452930530|FG000|Overall Study|Protocol Violation|1|||
125899710|NCT01576159|452930531|FG001|Overall Study|Protocol Violation|0|||
125899711|NCT01576159|452930532|FG002|Overall Study|Protocol Violation|0|||
125899712|NCT01576159|452930533|FG003|Overall Study|Protocol Violation|0|||
125899713|NCT00169442|452930534|FG000|Overall Study|Withdrawal by Subject|0|||
125899714|NCT00169442|452930535|FG001|Overall Study|Withdrawal by Subject|0|||
125899715|NCT00169442|452930536|FG002|Overall Study|Withdrawal by Subject|1|||
125899716|NCT00169442|452930537|FG003|Overall Study|Withdrawal by Subject|0|||
125899717|NCT00169442|452930538|FG004|Overall Study|Withdrawal by Subject|0|||
125899718|NCT00169442|452930539|FG005|Overall Study|Withdrawal by Subject|0|||
125899719|NCT00169442|452930534|FG000|Overall Study|Migrated/moved from study area|0|||
125899720|NCT00169442|452930535|FG001|Overall Study|Migrated/moved from study area|0|||
125899721|NCT00169442|452930536|FG002|Overall Study|Migrated/moved from study area|0|||
125899722|NCT00169442|452930537|FG003|Overall Study|Migrated/moved from study area|0|||
125899723|NCT00169442|452930538|FG004|Overall Study|Migrated/moved from study area|0|||
125899724|NCT00169442|452930539|FG005|Overall Study|Migrated/moved from study area|2|||
125899725|NCT00169442|452930534|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125899726|NCT00169442|452930535|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125899727|NCT00169442|452930536|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125899728|NCT00169442|452930537|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
126059761|NCT01584648|453512533|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
126059762|NCT05376397|453512534|FG000|Overall Study|Lost to Follow-up|1|||
126059763|NCT01328756|453512535|FG000|Overall Study|Protocol Violation|4|||
125899729|NCT00169442|452930538|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
125899730|NCT00169442|452930539|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125899731|NCT00169442|452930534|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125899732|NCT00169442|452930535|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
126059764|NCT01328756|453512535|FG000|Overall Study|Adverse Event|39|||
125899733|NCT00169442|452930536|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125899734|NCT00169442|452930537|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
126059765|NCT01328756|453512535|FG000|Overall Study|Lack of Efficacy|5|||
126059766|NCT01328756|453512535|FG000|Overall Study|Withdrawal by Subject|41|||
125899735|NCT00169442|452930538|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125899736|NCT00169442|452930539|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125899737|NCT01426789|452930540|FG000|Part 1|Protocol deviation|0|||
125899738|NCT01426789|452930541|FG001|Part 1|Protocol deviation|1|||
125899739|NCT01426789|452930542|FG002|Part 1|Protocol deviation|0|||
125899740|NCT01426789|452930543|FG003|Part 1|Protocol deviation|0|||
125899741|NCT01426789|452930544|FG004|Part 1|Protocol deviation|0|||
125899742|NCT01426789|452930545|FG005|Part 1|Protocol deviation|0|||
125899743|NCT01426789|452930540|FG000|Part 1|Lost to Follow-up|1|||
125899744|NCT01426789|452930541|FG001|Part 1|Lost to Follow-up|2|||
125899745|NCT01426789|452930542|FG002|Part 1|Lost to Follow-up|0|||
125899746|NCT01426789|452930543|FG003|Part 1|Lost to Follow-up|0|||
125899747|NCT01426789|452930544|FG004|Part 1|Lost to Follow-up|0|||
125899748|NCT01426789|452930545|FG005|Part 1|Lost to Follow-up|0|||
125899749|NCT01426789|452930540|FG000|Part 1|Lack of Efficacy|2|||
125899750|NCT01426789|452930541|FG001|Part 1|Lack of Efficacy|1|||
125899751|NCT01426789|452930542|FG002|Part 1|Lack of Efficacy|0|||
125899752|NCT01426789|452930543|FG003|Part 1|Lack of Efficacy|0|||
125899753|NCT01426789|452930544|FG004|Part 1|Lack of Efficacy|0|||
125899754|NCT01426789|452930545|FG005|Part 1|Lack of Efficacy|0|||
125899755|NCT01426789|452930540|FG000|Part 1|Adverse Event|3|||
125899756|NCT01426789|452930541|FG001|Part 1|Adverse Event|0|||
125899757|NCT01426789|452930542|FG002|Part 1|Adverse Event|0|||
125899758|NCT01426789|452930543|FG003|Part 1|Adverse Event|0|||
125899759|NCT01426789|452930544|FG004|Part 1|Adverse Event|0|||
125899760|NCT01426789|452930545|FG005|Part 1|Adverse Event|0|||
125899761|NCT01426789|452930540|FG000|Part 2|Protocol deviation|0|||
125899762|NCT01426789|452930541|FG001|Part 2|Protocol deviation|0|||
125899763|NCT01426789|452930542|FG002|Part 2|Protocol deviation|1|||
125899764|NCT01426789|452930543|FG003|Part 2|Protocol deviation|0|||
125899765|NCT01426789|452930544|FG004|Part 2|Protocol deviation|0|||
125899766|NCT01426789|452930545|FG005|Part 2|Protocol deviation|0|||
125899767|NCT01426789|452930540|FG000|Part 2|Death|0|||
125899768|NCT01426789|452930541|FG001|Part 2|Death|0|||
125899769|NCT01426789|452930542|FG002|Part 2|Death|1|||
125899770|NCT01426789|452930543|FG003|Part 2|Death|0|||
125899771|NCT01426789|452930544|FG004|Part 2|Death|1|||
125899772|NCT01426789|452930545|FG005|Part 2|Death|0|||
125899773|NCT01426789|452930540|FG000|Part 2|Administrative problems|0|||
125899774|NCT01426789|452930541|FG001|Part 2|Administrative problems|0|||
125899775|NCT01426789|452930542|FG002|Part 2|Administrative problems|2|||
125899776|NCT01426789|452930543|FG003|Part 2|Administrative problems|0|||
125899777|NCT01426789|452930544|FG004|Part 2|Administrative problems|1|||
125899778|NCT01426789|452930545|FG005|Part 2|Administrative problems|0|||
125899779|NCT01426789|452930540|FG000|Part 2|Lost to Follow-up|0|||
125899780|NCT01426789|452930541|FG001|Part 2|Lost to Follow-up|0|||
125899781|NCT01426789|452930542|FG002|Part 2|Lost to Follow-up|4|||
125899782|NCT01426789|452930543|FG003|Part 2|Lost to Follow-up|0|||
125899783|NCT01426789|452930544|FG004|Part 2|Lost to Follow-up|1|||
125899784|NCT01426789|452930545|FG005|Part 2|Lost to Follow-up|0|||
125899785|NCT01426789|452930540|FG000|Part 2|Withdrawal by Subject|0|||
125899786|NCT01426789|452930541|FG001|Part 2|Withdrawal by Subject|0|||
125899787|NCT01426789|452930542|FG002|Part 2|Withdrawal by Subject|0|||
125899788|NCT01426789|452930543|FG003|Part 2|Withdrawal by Subject|1|||
125899789|NCT01426789|452930544|FG004|Part 2|Withdrawal by Subject|2|||
125899790|NCT01426789|452930545|FG005|Part 2|Withdrawal by Subject|0|||
125899791|NCT01426789|452930540|FG000|Part 2|Lack of Efficacy|0|||
125899792|NCT01426789|452930541|FG001|Part 2|Lack of Efficacy|0|||
125899793|NCT01426789|452930542|FG002|Part 2|Lack of Efficacy|5|||
125899794|NCT01426789|452930543|FG003|Part 2|Lack of Efficacy|0|||
125899795|NCT01426789|452930544|FG004|Part 2|Lack of Efficacy|2|||
125899796|NCT01426789|452930545|FG005|Part 2|Lack of Efficacy|0|||
125899797|NCT01426789|452930540|FG000|Part 2|Adverse Event|0|||
125899798|NCT01426789|452930541|FG001|Part 2|Adverse Event|0|||
125899799|NCT01426789|452930542|FG002|Part 2|Adverse Event|2|||
125899800|NCT01426789|452930543|FG003|Part 2|Adverse Event|0|||
125899801|NCT01426789|452930544|FG004|Part 2|Adverse Event|1|||
125899802|NCT01426789|452930545|FG005|Part 2|Adverse Event|0|||
125899803|NCT01181986|452930548|FG000|Phase 1|Lost to Follow-up|0|||
125899804|NCT01181986|452930549|FG001|Phase 1|Lost to Follow-up|1|||
125899805|NCT01181986|452930550|FG002|Phase 1|Lost to Follow-up|1|||
125899806|NCT01181986|452930548|FG000|Phase 1|Adverse Event|0|||
125899807|NCT01181986|452930549|FG001|Phase 1|Adverse Event|0|||
125899808|NCT01181986|452930550|FG002|Phase 1|Adverse Event|1|||
125899809|NCT01181986|452930548|FG000|Phase 1|Protocol Violation|1|||
125899810|NCT01181986|452930549|FG001|Phase 1|Protocol Violation|0|||
125899811|NCT01181986|452930550|FG002|Phase 1|Protocol Violation|0|||
125899812|NCT01181986|452930548|FG000|Phase 2|Adverse Event|0|||
125899813|NCT01181986|452930549|FG001|Phase 2|Adverse Event|3|||
125899814|NCT01181986|452930550|FG002|Phase 2|Adverse Event|0|||
125899815|NCT01181986|452930548|FG000|Phase 2|Medical condition|0|||
125899816|NCT01181986|452930549|FG001|Phase 2|Medical condition|1|||
125899817|NCT01181986|452930550|FG002|Phase 2|Medical condition|0|||
125899818|NCT00311584|452930553|FG000|Overall Study|Death|1|||
125899819|NCT00311584|452930554|FG001|Overall Study|Death|0|||
125899820|NCT00311584|452930553|FG000|Overall Study|Lack of Efficacy|12|||
125899821|NCT00311584|452930554|FG001|Overall Study|Lack of Efficacy|15|||
125899822|NCT00311584|452930553|FG000|Overall Study|Physician Decision|4|||
125899823|NCT00311584|452930554|FG001|Overall Study|Physician Decision|5|||
125899824|NCT00311584|452930553|FG000|Overall Study|Withdrawal by Subject|1|||
125899825|NCT00311584|452930554|FG001|Overall Study|Withdrawal by Subject|1|||
125899826|NCT00311584|452930553|FG000|Overall Study|ineligible|2|||
125899827|NCT00311584|452930554|FG001|Overall Study|ineligible|2|||
125899828|NCT03720652|452930555|FG000|Overall Study|Withdrawal by Subject|2|||
125899829|NCT03720652|452930556|FG001|Overall Study|Withdrawal by Subject|7|||
125899830|NCT03720652|452930555|FG000|Overall Study|Lost to Follow-up|0|||
125899831|NCT03720652|452930556|FG001|Overall Study|Lost to Follow-up|4|||
125899832|NCT03073733|452930557|FG000|Overall Study|Lost to Follow-up|1|||
125899833|NCT03073733|452930558|FG001|Overall Study|Lost to Follow-up|0|||
125899834|NCT03073733|452930559|FG002|Overall Study|Lost to Follow-up|0|||
125899835|NCT03073733|452930557|FG000|Overall Study|Physician Decision|0|||
125899836|NCT03073733|452930558|FG001|Overall Study|Physician Decision|1|||
125899837|NCT03073733|452930559|FG002|Overall Study|Physician Decision|0|||
125899838|NCT03073733|452930557|FG000|Overall Study|Withdrawal by Subject|0|||
125899839|NCT03073733|452930558|FG001|Overall Study|Withdrawal by Subject|0|||
125899840|NCT03073733|452930559|FG002|Overall Study|Withdrawal by Subject|1|||
125899841|NCT01454778|452930564|FG000|Overall Study|Lost to Follow-up|2|||
125899842|NCT01454778|452930564|FG000|Overall Study|Death|1|||
125899843|NCT00835731|452930565|FG000|Overall Study|Withdrawal by Subject|1|||
125899844|NCT00835731|452930566|FG001|Overall Study|Withdrawal by Subject|0|||
125899845|NCT00835731|452930565|FG000|Overall Study|Physician Decision|1|||
125899846|NCT00835731|452930566|FG001|Overall Study|Physician Decision|1|||
125899847|NCT00348881|452930567|FG000|Overall Study|Lost to Follow-up|12|||
125899848|NCT00348881|452930568|FG001|Overall Study|Lost to Follow-up|6|||
125899849|NCT00348881|452930567|FG000|Overall Study|Withdrawal by Subject|3|||
125899850|NCT00348881|452930568|FG001|Overall Study|Withdrawal by Subject|4|||
125899851|NCT00348881|452930567|FG000|Overall Study|Adverse Event|2|||
125899852|NCT00348881|452930568|FG001|Overall Study|Adverse Event|0|||
125899853|NCT00348881|452930567|FG000|Overall Study|Serious Adverse Event|0|||
125899854|NCT00348881|452930568|FG001|Overall Study|Serious Adverse Event|2|||
125899855|NCT02654717|452930569|FG000|Overall Study|Adverse Event|2|||
125899856|NCT02654717|452930570|FG001|Overall Study|Adverse Event|2|||
125899857|NCT02654717|452930569|FG000|Overall Study|Protocol Violation|1|||
125899858|NCT02654717|452930570|FG001|Overall Study|Protocol Violation|2|||
125899859|NCT02654717|452930569|FG000|Overall Study|Withdrawal by Subject|0|||
125899860|NCT02654717|452930570|FG001|Overall Study|Withdrawal by Subject|1|||
125899861|NCT02654717|452930569|FG000|Overall Study|Non-permitted medication|3|||
125899862|NCT02654717|452930570|FG001|Overall Study|Non-permitted medication|0|||
125899863|NCT01221272|452932233|FG000|Period 1|Adverse Event|2|||
125899864|NCT01221272|452932234|FG001|Period 1|Adverse Event|0|||
125899865|NCT01221272|452932233|FG000|Period 1|Consent Withdrawal|0|||
125899866|NCT01221272|452932234|FG001|Period 1|Consent Withdrawal|1|||
125899867|NCT01221272|452932233|FG000|Period 1|Significant Dosing Noncompliance|0|||
125899868|NCT01221272|452932234|FG001|Period 1|Significant Dosing Noncompliance|1|||
125899869|NCT01221272|452932233|FG000|Period 2|Adverse Event|0|||
125899870|NCT01221272|452932234|FG001|Period 2|Adverse Event|2|||
125899871|NCT04839562|452932239|FG000|Overall Study|Withdrawal by Subject|0|||
125899872|NCT04839562|452932240|FG001|Overall Study|Withdrawal by Subject|1|||
125899873|NCT04839562|452932239|FG000|Overall Study|Physician Decision|0|||
125899874|NCT04839562|452932240|FG001|Overall Study|Physician Decision|1|||
125899875|NCT00877773|452932241|FG000|Overall Study|Disease Progression|44|||
125899876|NCT00003472|452932244|FG000|Overall Study|Not evaluable|3|||
125899877|NCT00528970|452932245|FG000|Overall Study|Adverse Event|6|||
125899878|NCT00528970|452932246|FG001|Overall Study|Adverse Event|8|||
125899879|NCT00528970|452932247|FG002|Overall Study|Adverse Event|5|||
125899880|NCT00528970|452932245|FG000|Overall Study|Lost to Follow-up|0|||
125899881|NCT00528970|452932246|FG001|Overall Study|Lost to Follow-up|0|||
125899882|NCT00528970|452932247|FG002|Overall Study|Lost to Follow-up|1|||
125899883|NCT00528970|452932245|FG000|Overall Study|Other than specified|2|||
125899884|NCT00528970|452932246|FG001|Overall Study|Other than specified|3|||
125899885|NCT00528970|452932247|FG002|Overall Study|Other than specified|3|||
125899886|NCT00528970|452932245|FG000|Overall Study|Protocol Violation|2|||
125899887|NCT00528970|452932246|FG001|Overall Study|Protocol Violation|1|||
125899888|NCT00528970|452932247|FG002|Overall Study|Protocol Violation|4|||
125899889|NCT00528970|452932245|FG000|Overall Study|Lack of Efficacy|0|||
125899890|NCT00528970|452932246|FG001|Overall Study|Lack of Efficacy|0|||
125899891|NCT00528970|452932247|FG002|Overall Study|Lack of Efficacy|1|||
125899892|NCT00528970|452932245|FG000|Overall Study|Withdrawal by Subject|4|||
125899893|NCT00528970|452932246|FG001|Overall Study|Withdrawal by Subject|3|||
125899894|NCT00528970|452932247|FG002|Overall Study|Withdrawal by Subject|5|||
125899895|NCT00528970|452932245|FG000|Overall Study|Randomized but not treated|0|||
125899896|NCT00528970|452932246|FG001|Overall Study|Randomized but not treated|0|||
125899897|NCT00528970|452932247|FG002|Overall Study|Randomized but not treated|1|||
125899898|NCT01673347|452932248|FG000|Overall Study|failure of allograft|7|||
125899899|NCT03086967|452932249|FG000|Overall Study|Screen Failure|2|||
125899900|NCT03086967|452932250|FG001|Overall Study|Screen Failure|2|||
125899901|NCT00704522|452932256|FG000|Overall Study|Lack of Efficacy|65|||
125899902|NCT00704522|452932257|FG001|Overall Study|Lack of Efficacy|17|||
125899903|NCT00704522|452932256|FG000|Overall Study|Failure to appear again at hospital|56|||
125899904|NCT00704522|452932257|FG001|Overall Study|Failure to appear again at hospital|10|||
125899905|NCT00704522|452932256|FG000|Overall Study|Withdrawal by Subject|17|||
125899906|NCT00704522|452932257|FG001|Overall Study|Withdrawal by Subject|8|||
125899907|NCT00704522|452932256|FG000|Overall Study|Adverse Event|9|||
125899908|NCT00704522|452932257|FG001|Overall Study|Adverse Event|1|||
125899909|NCT00704522|452932256|FG000|Overall Study|Undefined causes|9|||
125899910|NCT00704522|452932257|FG001|Overall Study|Undefined causes|7|||
125899911|NCT00704522|452932256|FG000|Overall Study|No information on therapy end|27|||
125899912|NCT00704522|452932257|FG001|Overall Study|No information on therapy end|2|||
125899913|NCT00775203|452932258|FG000|Overall Study|Adverse Event|25|||
125899914|NCT00775203|452932259|FG001|Overall Study|Adverse Event|6|||
125899915|NCT00775203|452932258|FG000|Overall Study|Lack of Efficacy|8|||
125899916|NCT00775203|452932259|FG001|Overall Study|Lack of Efficacy|9|||
125899917|NCT00775203|452932258|FG000|Overall Study|Withdrawal by Subject|11|||
125899918|NCT00775203|452932259|FG001|Overall Study|Withdrawal by Subject|9|||
125899919|NCT00775203|452932258|FG000|Overall Study|Lost to Follow-up|11|||
125899920|NCT00775203|452932259|FG001|Overall Study|Lost to Follow-up|15|||
125899921|NCT00775203|452932258|FG000|Overall Study|Administrative reason|2|||
125899922|NCT00775203|452932259|FG001|Overall Study|Administrative reason|0|||
125899923|NCT00775203|452932258|FG000|Overall Study|Noncompliance|4|||
125899924|NCT00775203|452932259|FG001|Overall Study|Noncompliance|2|||
125899925|NCT00775203|452932258|FG000|Overall Study|Protocol Violation|0|||
125899926|NCT00775203|452932259|FG001|Overall Study|Protocol Violation|1|||
125899927|NCT00775203|452932258|FG000|Overall Study|Entered other study|1|||
125899928|NCT00775203|452932259|FG001|Overall Study|Entered other study|0|||
125899929|NCT00775203|452932258|FG000|Overall Study|Physician Decision|0|||
125899930|NCT00775203|452932259|FG001|Overall Study|Physician Decision|1|||
125899931|NCT00770146|452932274|FG000|Treatment Period|Withdrawal by Subject|6|||
125899932|NCT00770146|452932275|FG001|Treatment Period|Withdrawal by Subject|13|||
125899933|NCT00770146|452932274|FG000|Treatment Period|Adverse Event|2|||
125899934|NCT00770146|452932275|FG001|Treatment Period|Adverse Event|26|||
125899935|NCT00770146|452932274|FG000|Treatment Period|Other|1|||
125899936|NCT00770146|452932275|FG001|Treatment Period|Other|5|||
125899937|NCT00770146|452932274|FG000|Treatment Period|Protocol non-compliance|0|||
125899938|NCT00770146|452932275|FG001|Treatment Period|Protocol non-compliance|1|||
125899939|NCT00770146|452932274|FG000|Follow-up Period|Withdrawal by Subject|7|||
125899940|NCT00770146|452932275|FG001|Follow-up Period|Withdrawal by Subject|13|||
125899941|NCT00770146|452932274|FG000|Follow-up Period|Adverse Event|0|||
125899942|NCT00770146|452932275|FG001|Follow-up Period|Adverse Event|2|||
125899943|NCT00770146|452932274|FG000|Follow-up Period|Other|4|||
125899944|NCT00770146|452932275|FG001|Follow-up Period|Other|5|||
125899945|NCT00816023|452932277|FG000|Overall Study|Lost to Follow-up|1|||
125899946|NCT00816023|452932278|FG001|Overall Study|Lost to Follow-up|1|||
125899947|NCT00816023|452932279|FG002|Overall Study|Lost to Follow-up|0|||
125899948|NCT00816023|452932280|FG003|Overall Study|Lost to Follow-up|0|||
125899949|NCT00816023|452932277|FG000|Overall Study|Withdrawal by Subject|1|||
125899950|NCT00816023|452932278|FG001|Overall Study|Withdrawal by Subject|0|||
125899951|NCT00816023|452932279|FG002|Overall Study|Withdrawal by Subject|0|||
125899952|NCT00816023|452932280|FG003|Overall Study|Withdrawal by Subject|0|||
125899953|NCT00816023|452932277|FG000|Overall Study|Physician Decision|0|||
125899954|NCT00816023|452932278|FG001|Overall Study|Physician Decision|0|||
125899955|NCT00816023|452932279|FG002|Overall Study|Physician Decision|1|||
125899956|NCT00816023|452932280|FG003|Overall Study|Physician Decision|0|||
125899957|NCT00816023|452932277|FG000|Overall Study|assessments complete prior to window|1|||
125899958|NCT00816023|452932278|FG001|Overall Study|assessments complete prior to window|1|||
125899959|NCT00816023|452932279|FG002|Overall Study|assessments complete prior to window|2|||
125899960|NCT00816023|452932280|FG003|Overall Study|assessments complete prior to window|1|||
125899961|NCT00816023|452932277|FG000|Overall Study|Randomized Not Treated|6|||
125899962|NCT00816023|452932278|FG001|Overall Study|Randomized Not Treated|4|||
125899963|NCT00816023|452932279|FG002|Overall Study|Randomized Not Treated|6|||
125899964|NCT00816023|452932280|FG003|Overall Study|Randomized Not Treated|11|||
125899965|NCT01525901|452932281|FG000|Period 2: 12 Weeks|Adverse Event|0|||
125899966|NCT01525901|452932282|FG001|Period 2: 12 Weeks|Adverse Event|1|||
125899967|NCT01525901|452932283|FG002|Period 2: 12 Weeks|Adverse Event|0|||
125899968|NCT01525901|452932284|FG003|Period 2: 12 Weeks|Adverse Event|0|||
125899969|NCT05027971|452932289|FG000|Overall Study|Physician Decision|7|||
125899970|NCT05027971|452932290|FG001|Overall Study|Physician Decision|3|||
125899971|NCT05027971|452932289|FG000|Overall Study|Lost to Follow-up|1|||
125899972|NCT05027971|452932290|FG001|Overall Study|Lost to Follow-up|1|||
125899973|NCT05027971|452932289|FG000|Overall Study|Withdrawal by Subject|0|||
125899974|NCT05027971|452932290|FG001|Overall Study|Withdrawal by Subject|2|||
125899975|NCT05027971|452932289|FG000|Overall Study|Non-study fiber used.|0|||
125899976|NCT05027971|452932290|FG001|Overall Study|Non-study fiber used.|1|||
125899977|NCT05027971|452932289|FG000|Overall Study|Protocol Violation|0|||
125899978|NCT05027971|452932290|FG001|Overall Study|Protocol Violation|2|||
126059767|NCT01328756|453512535|FG000|Overall Study|Lost to Follow-up|5|||
126059768|NCT01328756|453512535|FG000|Overall Study|Other|29|||
125899979|NCT02486627|452932291|FG000|Overall Study|Death|1|||
126059769|NCT03200574|453512551|FG000|Overall Study|Death|4|||
126059770|NCT03200574|453512551|FG000|Overall Study|Withdrawal by Subject|8|||
126059771|NCT03200574|453512551|FG000|Overall Study|Long-Term need for anticoagulation|1|||
126059772|NCT03200574|453512551|FG000|Overall Study|Relocation|2|||
125899980|NCT02486627|452932292|FG001|Overall Study|Death|0|||
125899981|NCT02486627|452932291|FG000|Overall Study|Other Unspecified|0|||
125899982|NCT02486627|452932292|FG001|Overall Study|Other Unspecified|2|||
125899983|NCT02486627|452932291|FG000|Overall Study|Consent Withdrawn by Participant|4|||
125899984|NCT02486627|452932292|FG001|Overall Study|Consent Withdrawn by Participant|3|||
125899985|NCT02486627|452932291|FG000|Overall Study|Significant Participant Noncompliance|1|||
125899986|NCT02486627|452932292|FG001|Overall Study|Significant Participant Noncompliance|1|||
125899987|NCT02486627|452932291|FG000|Overall Study|Lost to Follow-up|1|||
125899988|NCT02486627|452932292|FG001|Overall Study|Lost to Follow-up|3|||
125899989|NCT01073462|452932293|FG000|Overall Study|Death|14|||
125899990|NCT01073462|452932293|FG000|Overall Study|Kidney transplant|10|||
125899991|NCT01073462|452932293|FG000|Overall Study|Low parathyroid hormone levels|8|||
125899992|NCT01073462|452932293|FG000|Overall Study|Serious adverse event|2|||
125899993|NCT01073462|452932293|FG000|Overall Study|Lost to Follow-up|7|||
125899994|NCT05395091|452932296|FG000|Baseline to Month 12|Adverse Event|7|||
125899995|NCT05395091|452932297|FG001|Baseline to Month 12|Adverse Event|2|||
125899996|NCT05395091|452932298|FG002|Baseline to Month 12|Adverse Event|0|||
125899997|NCT05395091|452932296|FG000|Baseline to Month 12|Death|3|||
125899998|NCT05395091|452932297|FG001|Baseline to Month 12|Death|1|||
125899999|NCT05395091|452932298|FG002|Baseline to Month 12|Death|0|||
125900000|NCT05395091|452932296|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
125900001|NCT05395091|452932297|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
125900002|NCT05395091|452932298|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
125900003|NCT05395091|452932296|FG000|Baseline to Month 12|Protocol Violation|2|||
125900004|NCT05395091|452932297|FG001|Baseline to Month 12|Protocol Violation|3|||
125900005|NCT05395091|452932298|FG002|Baseline to Month 12|Protocol Violation|0|||
125900006|NCT05395091|452932296|FG000|Baseline to Month 12|Physician Decision|1|||
125900007|NCT05395091|452932297|FG001|Baseline to Month 12|Physician Decision|0|||
125900008|NCT05395091|452932298|FG002|Baseline to Month 12|Physician Decision|0|||
125900009|NCT05395091|452932296|FG000|Month 12 to Month 18|Death|1|||
125900010|NCT05395091|452932297|FG001|Month 12 to Month 18|Death|0|||
125900011|NCT05395091|452932298|FG002|Month 12 to Month 18|Death|0|||
125900012|NCT05395091|452932296|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
125900013|NCT05395091|452932297|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
125900014|NCT05395091|452932298|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
125900015|NCT05395091|452932296|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
125900016|NCT05395091|452932297|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
125900017|NCT05395091|452932298|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
125900018|NCT05395091|452932296|FG000|Month 12 to Month 18|Other reasons|0|||
125900019|NCT05395091|452932297|FG001|Month 12 to Month 18|Other reasons|0|||
125900020|NCT05395091|452932298|FG002|Month 12 to Month 18|Other reasons|1|||
125900021|NCT03554486|452932300|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
125900022|NCT03554486|452932301|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
125900023|NCT03554486|452932302|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
125900024|NCT03554486|452932300|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
125900025|NCT03554486|452932301|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
126110066|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Adverse Event|7|||
126110067|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Adverse Event|8|||
125900026|NCT03554486|452932302|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
125900027|NCT03554486|452932300|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125900028|NCT03554486|452932301|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
125900029|NCT03554486|452932302|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
125900030|NCT01509053|452932303|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
125900031|NCT01509053|452932303|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
125900032|NCT01509053|452932303|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
125900033|NCT01509053|452932303|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
125900034|NCT01509053|452932303|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
125900035|NCT01509053|452932303|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
125900036|NCT01738477|452932305|FG000|Overall Study|Lost to Follow-up|1|||
125900037|NCT01738477|452932306|FG001|Overall Study|Lost to Follow-up|4|||
125900038|NCT01915303|452932307|FG000|Core Phase|Adverse Event|7|||
125900039|NCT01915303|452932307|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
125900040|NCT01915303|452932307|FG000|Core Phase|Death|2|||
125900041|NCT01915303|452932307|FG000|Core Phase|Protocol Violation|2|||
125900042|NCT01915303|452932307|FG000|Core Phase|Abnormal lab value|1|||
125900043|NCT01915303|452932307|FG000|Core Phase|Withdrawal by Subject|1|||
125900044|NCT01915303|452932307|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
125900045|NCT01915303|452932307|FG000|Extension Phase|Withdrawal by Subject|4|||
125900046|NCT01915303|452932307|FG000|Extension Phase|Adverse Event|3|||
125900047|NCT01915303|452932307|FG000|Extension Phase|Death|1|||
125900048|NCT01915303|452932307|FG000|Extension Phase|Protocol Violation|1|||
125900049|NCT02925338|452932308|FG000|Overall Study|Death|0|||
125900050|NCT02925338|452932309|FG001|Overall Study|Death|2|||
125900051|NCT02925338|452932310|FG002|Overall Study|Death|1|||
125900052|NCT02925338|452932311|FG003|Overall Study|Death|0|||
125900053|NCT02925338|452932312|FG004|Overall Study|Death|0|||
125900054|NCT02925338|452932308|FG000|Overall Study|Lost to Follow-up|30|||
125900055|NCT02925338|452932309|FG001|Overall Study|Lost to Follow-up|10|||
125900056|NCT02925338|452932310|FG002|Overall Study|Lost to Follow-up|1|||
125900057|NCT02925338|452932311|FG003|Overall Study|Lost to Follow-up|16|||
125900058|NCT02925338|452932312|FG004|Overall Study|Lost to Follow-up|3|||
125900059|NCT02925338|452932308|FG000|Overall Study|Withdrawal by Subject|3|||
125900060|NCT02925338|452932309|FG001|Overall Study|Withdrawal by Subject|0|||
125900061|NCT02925338|452932310|FG002|Overall Study|Withdrawal by Subject|3|||
125900062|NCT02925338|452932311|FG003|Overall Study|Withdrawal by Subject|2|||
125900063|NCT02925338|452932312|FG004|Overall Study|Withdrawal by Subject|2|||
125900064|NCT02925338|452932308|FG000|Overall Study|Missing|38|||
125900065|NCT02925338|452932309|FG001|Overall Study|Missing|27|||
125900066|NCT02925338|452932310|FG002|Overall Study|Missing|0|||
125900067|NCT02925338|452932311|FG003|Overall Study|Missing|3|||
125900068|NCT02925338|452932312|FG004|Overall Study|Missing|2|||
125900069|NCT02925338|452932308|FG000|Overall Study|Participant's Decision|11|||
125900070|NCT02925338|452932309|FG001|Overall Study|Participant's Decision|7|||
125900071|NCT02925338|452932310|FG002|Overall Study|Participant's Decision|3|||
125900072|NCT02925338|452932311|FG003|Overall Study|Participant's Decision|8|||
125900073|NCT02925338|452932312|FG004|Overall Study|Participant's Decision|1|||
125900074|NCT02925338|452932308|FG000|Overall Study|Treatment Discontinuation|144|||
125900075|NCT02925338|452932309|FG001|Overall Study|Treatment Discontinuation|65|||
125900076|NCT02925338|452932310|FG002|Overall Study|Treatment Discontinuation|56|||
125900077|NCT02925338|452932311|FG003|Overall Study|Treatment Discontinuation|131|||
125900078|NCT02925338|452932312|FG004|Overall Study|Treatment Discontinuation|22|||
125900079|NCT02509117|452932313|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900080|NCT02509117|452932314|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
125900081|NCT02509117|452932315|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900082|NCT02509117|452932316|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900083|NCT02509117|452932317|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900084|NCT02509117|452932318|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900085|NCT02509117|452932319|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900086|NCT02509117|452932320|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900087|NCT02509117|452932321|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900088|NCT02509117|452932322|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125900089|NCT02509117|452932313|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900090|NCT02509117|452932314|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900091|NCT02509117|452932315|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900092|NCT02509117|452932316|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900093|NCT02509117|452932317|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900094|NCT02509117|452932318|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900095|NCT02509117|452932319|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900096|NCT02509117|452932320|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900097|NCT02509117|452932321|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125900098|NCT02509117|452932322|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
125900099|NCT02509117|452932313|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900100|NCT02509117|452932314|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900101|NCT02509117|452932315|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900102|NCT02509117|452932316|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900103|NCT02509117|452932317|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900104|NCT02509117|452932318|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900105|NCT02509117|452932319|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900106|NCT02509117|452932320|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900107|NCT02509117|452932321|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125900108|NCT02509117|452932322|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
125900109|NCT00548184|452932327|FG000|Overall Study|Adverse Event|3|||
125900110|NCT00548184|452932327|FG000|Overall Study|took other drug|1|||
125900111|NCT00548184|452932327|FG000|Overall Study|Found Her2 negative|1|||
125900112|NCT00636363|452932328|FG000|Overall Study|Conjunctivitis|0|||
125900113|NCT00636363|452932329|FG001|Overall Study|Conjunctivitis|0|||
125900114|NCT00636363|452932330|FG002|Overall Study|Conjunctivitis|1|||
125900115|NCT00636363|452932328|FG000|Overall Study|Adverse Event|0|||
125900116|NCT00636363|452932329|FG001|Overall Study|Adverse Event|0|||
125900117|NCT00636363|452932330|FG002|Overall Study|Adverse Event|1|||
125900118|NCT00636363|452932328|FG000|Overall Study|Positive slit lamp finding|0|||
125900119|NCT00636363|452932329|FG001|Overall Study|Positive slit lamp finding|2|||
125900120|NCT00636363|452932330|FG002|Overall Study|Positive slit lamp finding|1|||
125900121|NCT00636363|452932328|FG000|Overall Study|Study related symptoms/complaints|8|||
125900122|NCT00636363|452932329|FG001|Overall Study|Study related symptoms/complaints|7|||
125900123|NCT00636363|452932330|FG002|Overall Study|Study related symptoms/complaints|4|||
125900124|NCT00636363|452932328|FG000|Overall Study|Met ineligibility criteria|0|||
125900125|NCT00636363|452932329|FG001|Overall Study|Met ineligibility criteria|0|||
125900126|NCT00636363|452932330|FG002|Overall Study|Met ineligibility criteria|3|||
125900127|NCT00636363|452932328|FG000|Overall Study|Missed > 1 visit|0|||
125900128|NCT00636363|452932329|FG001|Overall Study|Missed > 1 visit|1|||
125900129|NCT00636363|452932330|FG002|Overall Study|Missed > 1 visit|3|||
125900130|NCT00636363|452932328|FG000|Overall Study|Lack of motivation|1|||
125900131|NCT00636363|452932329|FG001|Overall Study|Lack of motivation|0|||
125900132|NCT00636363|452932330|FG002|Overall Study|Lack of motivation|1|||
125900133|NCT00636363|452932328|FG000|Overall Study|Protocol Violation|0|||
125900134|NCT00636363|452932329|FG001|Overall Study|Protocol Violation|3|||
125900135|NCT00636363|452932330|FG002|Overall Study|Protocol Violation|0|||
125900136|NCT00636363|452932328|FG000|Overall Study|Lost to Follow-up|3|||
125900137|NCT00636363|452932329|FG001|Overall Study|Lost to Follow-up|4|||
125900138|NCT00636363|452932330|FG002|Overall Study|Lost to Follow-up|2|||
125900139|NCT00636363|452932328|FG000|Overall Study|Withdrawal by Subject|1|||
125900140|NCT00636363|452932329|FG001|Overall Study|Withdrawal by Subject|3|||
125900141|NCT00636363|452932330|FG002|Overall Study|Withdrawal by Subject|2|||
125900142|NCT00280748|452932332|FG000|Overall Study|Decline in performance|3|||
125900143|NCT00280748|452932332|FG000|Overall Study|Extra-cranial disease progression|1|||
125900144|NCT00029146|452932333|FG000|Overall Study|Lost to Follow-up|2|||
125900145|NCT00029146|452932334|FG001|Overall Study|Lost to Follow-up|1|||
125900146|NCT00313781|452932335|FG000|Before Crossover|Death|22|||
125900147|NCT00313781|452932336|FG001|Before Crossover|Death|8|||
126059773|NCT03200574|453512551|FG000|Overall Study|Lost to Follow-up|2|||
125900148|NCT00313781|452932337|FG002|Before Crossover|Death|0|||
125900149|NCT00313781|452932335|FG000|Before Crossover|Lost to Follow-up|0|||
125900150|NCT00313781|452932336|FG001|Before Crossover|Lost to Follow-up|3|||
125900151|NCT00313781|452932337|FG002|Before Crossover|Lost to Follow-up|0|||
125900152|NCT00313781|452932335|FG000|Before Crossover|Withdrawal by Subject|3|||
125900153|NCT00313781|452932336|FG001|Before Crossover|Withdrawal by Subject|1|||
125900154|NCT00313781|452932337|FG002|Before Crossover|Withdrawal by Subject|0|||
125900155|NCT00313781|452932335|FG000|Before Crossover|Other|45|||
125900156|NCT00313781|452932336|FG001|Before Crossover|Other|30|||
125900157|NCT00313781|452932337|FG002|Before Crossover|Other|0|||
125900158|NCT00313781|452932335|FG000|Before Crossover|Crossover|0|||
125900159|NCT00313781|452932336|FG001|Before Crossover|Crossover|37|||
125900160|NCT00313781|452932337|FG002|Before Crossover|Crossover|0|||
125900161|NCT00313781|452932335|FG000|Before Crossover|Randomized, not treated|5|||
125900162|NCT00313781|452932336|FG001|Before Crossover|Randomized, not treated|0|||
125900163|NCT00313781|452932337|FG002|Before Crossover|Randomized, not treated|0|||
125900164|NCT00313781|452932335|FG000|After Crossover|Death|0|||
125900165|NCT00313781|452932336|FG001|After Crossover|Death|0|||
125900166|NCT00313781|452932337|FG002|After Crossover|Death|6|||
125900167|NCT00313781|452932335|FG000|After Crossover|Withdrawal by Subject|0|||
125900168|NCT00313781|452932336|FG001|After Crossover|Withdrawal by Subject|0|||
125900169|NCT00313781|452932337|FG002|After Crossover|Withdrawal by Subject|3|||
125900170|NCT00313781|452932335|FG000|After Crossover|Other|0|||
125900171|NCT00313781|452932336|FG001|After Crossover|Other|0|||
125900172|NCT00313781|452932337|FG002|After Crossover|Other|18|||
125900173|NCT03567343|452932339|FG000|Overall Study|Lost to Follow-up|2|||
125900174|NCT03567343|452932340|FG001|Overall Study|Lost to Follow-up|1|||
125900175|NCT03567343|452932339|FG000|Overall Study|No longer eligible|2|||
125900176|NCT03567343|452932340|FG001|Overall Study|No longer eligible|1|||
125900177|NCT03567343|452932339|FG000|Overall Study|Adverse Event|1|||
125900178|NCT03567343|452932340|FG001|Overall Study|Adverse Event|0|||
125900179|NCT03567343|452932339|FG000|Overall Study|Protocol Violation|1|||
125900180|NCT03567343|452932340|FG001|Overall Study|Protocol Violation|1|||
125900181|NCT01433250|452932341|FG000|Overall Study|Protocol Violation|0|||
125900182|NCT01433250|452932342|FG001|Overall Study|Protocol Violation|1|||
125900183|NCT01433250|452932341|FG000|Overall Study|Withdrawal by Subject|3|||
125900184|NCT01433250|452932342|FG001|Overall Study|Withdrawal by Subject|2|||
125900185|NCT00834080|452932343|FG000|Overall Study|Adverse Event|7|||
125900186|NCT00834080|452932343|FG000|Overall Study|Lost to Follow-up|7|||
125900187|NCT00834080|452932343|FG000|Overall Study|Withdrawal by Subject|5|||
125900188|NCT00834080|452932343|FG000|Overall Study|Other - Pregnancy|1|||
125900189|NCT00834080|452932343|FG000|Overall Study|Other - False positive tests of the UDS|1|||
125900190|NCT00834080|452932343|FG000|Overall Study|Physician Decision|1|||
126110068|NCT03236246|453697628|FG000|24-Week Dose Titration Period|Captured as Other|1|||
126110069|NCT03236246|453697629|FG001|24-Week Dose Titration Period|Captured as Other|2|||
126110070|NCT03236246|453697628|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
126110071|NCT03236246|453697629|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
126110072|NCT03236246|453697628|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
125900191|NCT00834080|452932343|FG000|Overall Study|Subject Relocated|1|||
125900192|NCT02431260|452932344|FG000|Overall Study|Subject Decision|0|||
125900193|NCT02431260|452932345|FG001|Overall Study|Subject Decision|1|||
125900194|NCT02431260|452932346|FG002|Overall Study|Subject Decision|1|||
125900195|NCT02431260|452932347|FG003|Overall Study|Subject Decision|0|||
125900196|NCT02431260|452932348|FG004|Overall Study|Subject Decision|0|||
125900197|NCT02431260|452932349|FG005|Overall Study|Subject Decision|0|||
125900198|NCT02431260|452932350|FG006|Overall Study|Subject Decision|0|||
125900199|NCT02431260|452932351|FG007|Overall Study|Subject Decision|0|||
125900200|NCT02431260|452932352|FG008|Overall Study|Subject Decision|1|||
125900201|NCT02431260|452932353|FG009|Overall Study|Subject Decision|1|||
125900202|NCT02431260|452932354|FG010|Overall Study|Subject Decision|0|||
125900203|NCT02431260|452932355|FG011|Overall Study|Subject Decision|1|||
125900204|NCT02431260|452932356|FG012|Overall Study|Subject Decision|0|||
125900205|NCT02431260|452932357|FG013|Overall Study|Subject Decision|0|||
125900206|NCT02431260|452932344|FG000|Overall Study|Death|4|||
125900207|NCT02431260|452932345|FG001|Overall Study|Death|4|||
125900208|NCT02431260|452932346|FG002|Overall Study|Death|3|||
125900209|NCT02431260|452932347|FG003|Overall Study|Death|4|||
125900210|NCT02431260|452932348|FG004|Overall Study|Death|2|||
125900211|NCT02431260|452932349|FG005|Overall Study|Death|2|||
125900212|NCT02431260|452932350|FG006|Overall Study|Death|3|||
125900213|NCT02431260|452932351|FG007|Overall Study|Death|1|||
125900214|NCT02431260|452932352|FG008|Overall Study|Death|6|||
125900215|NCT02431260|452932353|FG009|Overall Study|Death|6|||
125900216|NCT02431260|452932354|FG010|Overall Study|Death|3|||
125900217|NCT02431260|452932355|FG011|Overall Study|Death|2|||
125900218|NCT02431260|452932356|FG012|Overall Study|Death|5|||
125900219|NCT02431260|452932357|FG013|Overall Study|Death|1|||
125900220|NCT02431260|452932344|FG000|Overall Study|Lost to Follow-up|0|||
125900221|NCT02431260|452932345|FG001|Overall Study|Lost to Follow-up|0|||
125900222|NCT02431260|452932346|FG002|Overall Study|Lost to Follow-up|0|||
125900223|NCT02431260|452932347|FG003|Overall Study|Lost to Follow-up|0|||
125900224|NCT02431260|452932348|FG004|Overall Study|Lost to Follow-up|0|||
125900225|NCT02431260|452932349|FG005|Overall Study|Lost to Follow-up|1|||
125900226|NCT02431260|452932350|FG006|Overall Study|Lost to Follow-up|0|||
125900227|NCT02431260|452932351|FG007|Overall Study|Lost to Follow-up|0|||
125900228|NCT02431260|452932352|FG008|Overall Study|Lost to Follow-up|0|||
125900229|NCT02431260|452932353|FG009|Overall Study|Lost to Follow-up|0|||
125900230|NCT02431260|452932354|FG010|Overall Study|Lost to Follow-up|0|||
125900231|NCT02431260|452932355|FG011|Overall Study|Lost to Follow-up|0|||
125900232|NCT02431260|452932356|FG012|Overall Study|Lost to Follow-up|0|||
125900233|NCT02431260|452932357|FG013|Overall Study|Lost to Follow-up|0|||
126059774|NCT04183491|453512552|FG000|Overall Study|Withdrawal by Subject|0|||
126059775|NCT04183491|453512553|FG001|Overall Study|Withdrawal by Subject|0|||
126059776|NCT04183491|453512554|FG002|Overall Study|Withdrawal by Subject|1|||
126059777|NCT04183491|453512555|FG003|Overall Study|Withdrawal by Subject|0|||
125900234|NCT02431260|452932344|FG000|Overall Study|Study Terminated by the Sponsor|0|||
125900235|NCT02431260|452932345|FG001|Overall Study|Study Terminated by the Sponsor|0|||
125900236|NCT02431260|452932346|FG002|Overall Study|Study Terminated by the Sponsor|2|||
125900237|NCT02431260|452932347|FG003|Overall Study|Study Terminated by the Sponsor|1|||
125900238|NCT02431260|452932348|FG004|Overall Study|Study Terminated by the Sponsor|1|||
125900239|NCT02431260|452932349|FG005|Overall Study|Study Terminated by the Sponsor|0|||
125900240|NCT02431260|452932350|FG006|Overall Study|Study Terminated by the Sponsor|1|||
125900241|NCT02431260|452932351|FG007|Overall Study|Study Terminated by the Sponsor|2|||
125900242|NCT02431260|452932352|FG008|Overall Study|Study Terminated by the Sponsor|1|||
125900243|NCT02431260|452932353|FG009|Overall Study|Study Terminated by the Sponsor|1|||
126059778|NCT04183491|453512556|FG004|Overall Study|Withdrawal by Subject|0|||
126059779|NCT04183491|453512557|FG005|Overall Study|Withdrawal by Subject|1|||
126059780|NCT04183491|453512558|FG006|Overall Study|Withdrawal by Subject|0|||
125900244|NCT02431260|452932354|FG010|Overall Study|Study Terminated by the Sponsor|1|||
125900245|NCT02431260|452932355|FG011|Overall Study|Study Terminated by the Sponsor|0|||
125900246|NCT02431260|452932356|FG012|Overall Study|Study Terminated by the Sponsor|4|||
125900247|NCT02431260|452932357|FG013|Overall Study|Study Terminated by the Sponsor|0|||
125900248|NCT02431260|452932344|FG000|Overall Study|Physician Decision|0|||
125900249|NCT02431260|452932345|FG001|Overall Study|Physician Decision|0|||
125900250|NCT02431260|452932346|FG002|Overall Study|Physician Decision|0|||
125900251|NCT02431260|452932347|FG003|Overall Study|Physician Decision|0|||
125900252|NCT02431260|452932348|FG004|Overall Study|Physician Decision|0|||
125900253|NCT02431260|452932349|FG005|Overall Study|Physician Decision|1|||
125900254|NCT02431260|452932350|FG006|Overall Study|Physician Decision|0|||
125900255|NCT02431260|452932351|FG007|Overall Study|Physician Decision|0|||
125900256|NCT02431260|452932352|FG008|Overall Study|Physician Decision|0|||
125900257|NCT02431260|452932353|FG009|Overall Study|Physician Decision|0|||
125900258|NCT02431260|452932354|FG010|Overall Study|Physician Decision|0|||
125900259|NCT02431260|452932355|FG011|Overall Study|Physician Decision|0|||
125900260|NCT02431260|452932356|FG012|Overall Study|Physician Decision|0|||
125900261|NCT02431260|452932357|FG013|Overall Study|Physician Decision|0|||
125900262|NCT02431260|452932344|FG000|Overall Study|Other Unspecified|0|||
125900263|NCT02431260|452932345|FG001|Overall Study|Other Unspecified|0|||
125900264|NCT02431260|452932346|FG002|Overall Study|Other Unspecified|0|||
125900265|NCT02431260|452932347|FG003|Overall Study|Other Unspecified|0|||
125900266|NCT02431260|452932348|FG004|Overall Study|Other Unspecified|0|||
125900267|NCT02431260|452932349|FG005|Overall Study|Other Unspecified|0|||
125900268|NCT02431260|452932350|FG006|Overall Study|Other Unspecified|0|||
125900269|NCT02431260|452932351|FG007|Overall Study|Other Unspecified|0|||
125900270|NCT02431260|452932352|FG008|Overall Study|Other Unspecified|0|||
125900271|NCT02431260|452932353|FG009|Overall Study|Other Unspecified|0|||
125900272|NCT02431260|452932354|FG010|Overall Study|Other Unspecified|0|||
125900273|NCT02431260|452932355|FG011|Overall Study|Other Unspecified|1|||
125900274|NCT02431260|452932356|FG012|Overall Study|Other Unspecified|1|||
125900275|NCT02431260|452932357|FG013|Overall Study|Other Unspecified|0|||
125900276|NCT03007888|452932361|FG000|First Intervention (14 Days)|Adverse Event|1|||
125900277|NCT03007888|452932362|FG001|First Intervention (14 Days)|Adverse Event|0|||
125900278|NCT01806662|452932363|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
125900279|NCT01806662|452932364|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
125900280|NCT01806662|452932363|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
125900281|NCT01806662|452932364|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
125900282|NCT01806662|452932363|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
125900283|NCT01806662|452932364|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
125900284|NCT01806662|452932363|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
125900285|NCT01806662|452932364|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
125900286|NCT00043550|452932368|FG000|Overall Study|Withdrawal by Subject|22|||
125900287|NCT00043550|452932369|FG001|Overall Study|Withdrawal by Subject|12|||
125900288|NCT00043550|452932370|FG002|Overall Study|Withdrawal by Subject|20|||
125900289|NCT00827931|452932373|FG000|Overall Study|Death|3|||
125900290|NCT00827931|452932374|FG001|Overall Study|Death|5|||
125900291|NCT00827931|452932373|FG000|Overall Study|Adverse Event|1|||
125900292|NCT00827931|452932374|FG001|Overall Study|Adverse Event|0|||
125900293|NCT00827931|452932373|FG000|Overall Study|Lost to Follow-up|1|||
125900294|NCT00827931|452932374|FG001|Overall Study|Lost to Follow-up|0|||
125900295|NCT00827931|452932373|FG000|Overall Study|Withdrawal by Subject|0|||
125900296|NCT00827931|452932374|FG001|Overall Study|Withdrawal by Subject|1|||
125900297|NCT00827931|452932373|FG000|Overall Study|Other|1|||
125900298|NCT00827931|452932374|FG001|Overall Study|Other|0|||
125900299|NCT01917656|452932378|FG000|Overall Study|Adverse Event|11|||
125900300|NCT01917656|452932379|FG001|Overall Study|Adverse Event|0|||
125900301|NCT01917656|452932378|FG000|Overall Study|Withdrawal criteria|8|||
125900302|NCT01917656|452932379|FG001|Overall Study|Withdrawal criteria|14|||
125900303|NCT01917656|452932378|FG000|Overall Study|Unclassified|0|||
125900304|NCT01917656|452932379|FG001|Overall Study|Unclassified|3|||
125900305|NCT01917656|452932378|FG000|Overall Study|Withdrawal by Subject|4|||
125900306|NCT01917656|452932379|FG001|Overall Study|Withdrawal by Subject|3|||
125900307|NCT01917656|452932378|FG000|Overall Study|Lost to Follow-up|3|||
125900308|NCT01917656|452932379|FG001|Overall Study|Lost to Follow-up|4|||
125900309|NCT02081859|452932380|FG000|Overall Study|No fertilization|2|||
125900310|NCT02081859|452932381|FG001|Overall Study|No fertilization|2|||
125900311|NCT02081859|452932380|FG000|Overall Study|No sperm|1|||
125900312|NCT02081859|452932381|FG001|Overall Study|No sperm|0|||
125900313|NCT02081859|452932380|FG000|Overall Study|Unanticipated freeze all cycle|2|||
125900314|NCT02081859|452932381|FG001|Overall Study|Unanticipated freeze all cycle|6|||
125900315|NCT02081859|452932380|FG000|Overall Study|< 4 embryos|27|||
125900316|NCT02081859|452932381|FG001|Overall Study|< 4 embryos|23|||
125900317|NCT02081859|452932380|FG000|Overall Study|Other reasons|2|||
125900318|NCT02081859|452932381|FG001|Overall Study|Other reasons|0|||
125900319|NCT00492063|452932388|FG000|Overall Study|Death|0|||
125900320|NCT00492063|452932389|FG001|Overall Study|Death|0|||
125900321|NCT00492063|452932390|FG002|Overall Study|Death|1|||
125900322|NCT00492063|452932391|FG003|Overall Study|Death|2|||
125900323|NCT00492063|452932388|FG000|Overall Study|Withdrawal by Subject|4|||
125900324|NCT00492063|452932389|FG001|Overall Study|Withdrawal by Subject|3|||
125900325|NCT00492063|452932390|FG002|Overall Study|Withdrawal by Subject|5|||
125900326|NCT00492063|452932391|FG003|Overall Study|Withdrawal by Subject|4|||
125900327|NCT00492063|452932388|FG000|Overall Study|Lost to Follow-up|6|||
125900328|NCT00492063|452932389|FG001|Overall Study|Lost to Follow-up|11|||
125900329|NCT00492063|452932390|FG002|Overall Study|Lost to Follow-up|5|||
125900330|NCT00492063|452932391|FG003|Overall Study|Lost to Follow-up|3|||
125900331|NCT00492063|452932388|FG000|Overall Study|Protocol Violation|0|||
125900332|NCT00492063|452932389|FG001|Overall Study|Protocol Violation|0|||
125900333|NCT00492063|452932390|FG002|Overall Study|Protocol Violation|0|||
125900334|NCT00492063|452932391|FG003|Overall Study|Protocol Violation|1|||
125900335|NCT01870076|452932392|FG000|Overall Study|Withdrawal by Subject|1|||
125900336|NCT01870076|452932393|FG001|Overall Study|Withdrawal by Subject|0|||
125900337|NCT01870076|452932394|FG002|Overall Study|Withdrawal by Subject|1|||
125900338|NCT01870076|452932395|FG003|Overall Study|Withdrawal by Subject|0|||
125900339|NCT00167778|452932400|FG000|Overall Study|Withdrawal by Subject|1|||
125900340|NCT00576420|452934247|FG000|Overall Study|Death|0|||
125900341|NCT00576420|452934248|FG001|Overall Study|Death|0|||
125900342|NCT00576420|452934249|FG002|Overall Study|Death|1|||
125900343|NCT01771809|452934254|FG000|Overall Study|Adverse Event|4|||
125900344|NCT01771809|452934255|FG001|Overall Study|Adverse Event|12|||
125900345|NCT01771809|452934254|FG000|Overall Study|Protocol Violation|0|||
125900346|NCT01771809|452934255|FG001|Overall Study|Protocol Violation|1|||
125900347|NCT01771809|452934254|FG000|Overall Study|Withdrawal by Subject|34|||
125900348|NCT01771809|452934255|FG001|Overall Study|Withdrawal by Subject|42|||
125900349|NCT01771809|452934254|FG000|Overall Study|Lost to Follow-up|1|||
125900350|NCT01771809|452934255|FG001|Overall Study|Lost to Follow-up|3|||
125900351|NCT01771809|452934254|FG000|Overall Study|Other (Insufficient clinical response)|22|||
125900352|NCT01771809|452934255|FG001|Overall Study|Other (Insufficient clinical response)|20|||
125900353|NCT01771809|452934254|FG000|Overall Study|Death|1|||
125900354|NCT01771809|452934255|FG001|Overall Study|Death|0|||
125900355|NCT01771809|452934254|FG000|Overall Study|Other (other)|9|||
125900356|NCT01771809|452934255|FG001|Overall Study|Other (other)|5|||
125900357|NCT02656680|452934256|FG000|Overall Study|Lost to Follow-up|0|||
125900358|NCT02656680|452934257|FG001|Overall Study|Lost to Follow-up|1|||
125900359|NCT02656680|452934258|FG002|Overall Study|Lost to Follow-up|7|||
125900360|NCT01142089|452934264|FG000|Overall Study|Physician Decision|1|||
125900361|NCT01142089|452934265|FG001|Overall Study|Physician Decision|0|||
125900362|NCT01142089|452934264|FG000|Overall Study|Withdrawal by Subject|1|||
125900363|NCT01142089|452934265|FG001|Overall Study|Withdrawal by Subject|2|||
125900364|NCT01142089|452934264|FG000|Overall Study|Use of prohibited medications|0|||
125900365|NCT01142089|452934265|FG001|Overall Study|Use of prohibited medications|1|||
125900366|NCT01142089|452934264|FG000|Overall Study|Noncompliance with study procedures|2|||
125900367|NCT01142089|452934265|FG001|Overall Study|Noncompliance with study procedures|1|||
125900368|NCT01142089|452934264|FG000|Overall Study|Patient required rescue medication|8|||
125900369|NCT01142089|452934265|FG001|Overall Study|Patient required rescue medication|17|||
125900370|NCT02907892|452934268|FG000|Overall Study|Lost to Follow-up|27|||
125900371|NCT02907892|452934269|FG001|Overall Study|Lost to Follow-up|40|||
125900372|NCT01974765|452934270|FG000|Overall Study|Withdrawal by Subject|1|||
125900373|NCT01974765|452934270|FG000|Overall Study|Death|1|||
125900374|NCT01974765|452934270|FG000|Overall Study|Adverse Event|2|||
125900375|NCT03860935|452934271|FG000|Overall Study|Withdrawal of Consent|15|||
125900376|NCT03860935|452934272|FG001|Overall Study|Withdrawal of Consent|6|||
125900377|NCT03860935|452934271|FG000|Overall Study|Death|75|||
125900378|NCT03860935|452934272|FG001|Overall Study|Death|51|||
125900379|NCT01430754|452934273|FG000|Run-In Phase|Circadian Period Ineligible|24|||
125900380|NCT01430754|452934274|FG001|Run-In Phase|Circadian Period Ineligible|0|||
125900381|NCT01430754|452934273|FG000|Run-In Phase|Protocol Violation|6|||
125900382|NCT01430754|452934274|FG001|Run-In Phase|Protocol Violation|0|||
125900383|NCT01430754|452934273|FG000|Run-In Phase|Adverse Event|2|||
125900384|NCT01430754|452934274|FG001|Run-In Phase|Adverse Event|0|||
125900385|NCT01430754|452934273|FG000|Run-In Phase|Other|2|||
125900386|NCT01430754|452934274|FG001|Run-In Phase|Other|0|||
125900387|NCT01430754|452934273|FG000|Run-In Phase|Withdrawal by Subject|2|||
125900388|NCT01430754|452934274|FG001|Run-In Phase|Withdrawal by Subject|0|||
125900389|NCT01430754|452934273|FG000|Run-In Phase|Lost to Follow-up|1|||
125900390|NCT01430754|452934274|FG001|Run-In Phase|Lost to Follow-up|0|||
125900391|NCT00701662|452934278|FG000|Overall Study|Lack of Efficacy|1|||
125900392|NCT00635024|452934279|FG000|Overall Study|Adverse Event|1|||
125900393|NCT01105065|452934280|FG000|Overall Study|Adverse Event|5|||
125900394|NCT01105065|452934280|FG000|Overall Study|Technical Problems|1|||
125900395|NCT01038869|452934282|FG000|Overall Study|Withdrawal by Subject|1|||
125900396|NCT01038869|452934282|FG000|Overall Study|Lost to Follow-up|6|||
125900397|NCT04575597|452934283|FG000|Overall Study|Death|0|||
125900398|NCT04575597|452934284|FG001|Overall Study|Death|0|||
125900399|NCT04575597|452934285|FG002|Overall Study|Death|0|||
125900400|NCT04575597|452934286|FG003|Overall Study|Death|1|||
125900401|NCT04575597|452934287|FG004|Overall Study|Death|3|||
125900402|NCT04575597|452934288|FG005|Overall Study|Death|14|||
125900403|NCT04575597|452934283|FG000|Overall Study|Lost to Follow-up|2|||
125900404|NCT04575597|452934284|FG001|Overall Study|Lost to Follow-up|1|||
125900405|NCT04575597|452934285|FG002|Overall Study|Lost to Follow-up|1|||
125900406|NCT04575597|452934286|FG003|Overall Study|Lost to Follow-up|2|||
125900407|NCT04575597|452934287|FG004|Overall Study|Lost to Follow-up|10|||
125900408|NCT04575597|452934288|FG005|Overall Study|Lost to Follow-up|8|||
125900409|NCT04575597|452934283|FG000|Overall Study|Withdrawal by Subject|2|||
125900410|NCT04575597|452934284|FG001|Overall Study|Withdrawal by Subject|2|||
125900411|NCT04575597|452934285|FG002|Overall Study|Withdrawal by Subject|4|||
125900412|NCT04575597|452934286|FG003|Overall Study|Withdrawal by Subject|2|||
125900413|NCT04575597|452934287|FG004|Overall Study|Withdrawal by Subject|25|||
125900414|NCT04575597|452934288|FG005|Overall Study|Withdrawal by Subject|28|||
125900415|NCT04575597|452934283|FG000|Overall Study|Not Recorded|0|||
125900416|NCT04575597|452934284|FG001|Overall Study|Not Recorded|0|||
125900417|NCT04575597|452934285|FG002|Overall Study|Not Recorded|0|||
125900418|NCT04575597|452934286|FG003|Overall Study|Not Recorded|0|||
125900419|NCT04575597|452934287|FG004|Overall Study|Not Recorded|0|||
125900420|NCT04575597|452934288|FG005|Overall Study|Not Recorded|2|||
125900421|NCT04575597|452934283|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125900422|NCT04575597|452934284|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125900423|NCT04575597|452934285|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125900424|NCT04575597|452934286|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125900425|NCT04575597|452934287|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
125900426|NCT04575597|452934288|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
125900427|NCT03316911|452934293|FG000|Overall Study|Lost to Follow-up|33|||
125900428|NCT03316911|452934294|FG001|Overall Study|Lost to Follow-up|29|||
125900429|NCT01119937|452934295|FG000|Overall Study|Adverse Event|11|||
125900430|NCT01119937|452934296|FG001|Overall Study|Adverse Event|5|||
125900431|NCT01119937|452934295|FG000|Overall Study|Protocol deviation|3|||
125900432|NCT01119937|452934296|FG001|Overall Study|Protocol deviation|1|||
125900433|NCT01119937|452934295|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125900434|NCT01119937|452934296|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125900435|NCT01119937|452934295|FG000|Overall Study|Withdrawal by Subject|2|||
125900436|NCT01119937|452934296|FG001|Overall Study|Withdrawal by Subject|1|||
125900437|NCT02536404|452934301|FG000|Overall Study|Adverse Event|5|||
125900438|NCT02536404|452934302|FG001|Overall Study|Adverse Event|0|||
125900439|NCT02536404|452934301|FG000|Overall Study|Withdrawal by Subject|4|||
125900440|NCT02536404|452934302|FG001|Overall Study|Withdrawal by Subject|1|||
125900441|NCT02536404|452934301|FG000|Overall Study|Physician Decision|10|||
125900442|NCT02536404|452934302|FG001|Overall Study|Physician Decision|0|||
125900443|NCT02536404|452934301|FG000|Overall Study|Sponsor decision|1|||
125900444|NCT02536404|452934302|FG001|Overall Study|Sponsor decision|0|||
125900445|NCT00321646|452934304|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
125900446|NCT00321646|452934304|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
125900447|NCT00321646|452934304|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
125900448|NCT02576145|452934307|FG000|Overall Study|Adverse Event|1|||
125900449|NCT02576145|452934308|FG001|Overall Study|Adverse Event|0|||
125900450|NCT02576145|452934307|FG000|Overall Study|Withdrawal by Subject|1|||
125900451|NCT02576145|452934308|FG001|Overall Study|Withdrawal by Subject|0|||
125900452|NCT02576145|452934307|FG000|Overall Study|Acute rejection|1|||
125900453|NCT02576145|452934308|FG001|Overall Study|Acute rejection|0|||
125900454|NCT02576145|452934307|FG000|Overall Study|Tetanus Titers Decreased|0|||
125900455|NCT02576145|452934308|FG001|Overall Study|Tetanus Titers Decreased|1|||
125900456|NCT02660138|452934309|FG000|Overall Study|Adverse Event|0|||
125900457|NCT02660138|452934310|FG001|Overall Study|Adverse Event|3|||
125900458|NCT02660138|452934311|FG002|Overall Study|Adverse Event|2|||
125900459|NCT02660138|452934309|FG000|Overall Study|Lack of Efficacy|1|||
125900460|NCT02660138|452934310|FG001|Overall Study|Lack of Efficacy|2|||
125900461|NCT02660138|452934311|FG002|Overall Study|Lack of Efficacy|1|||
125900462|NCT02660138|452934309|FG000|Overall Study|Withdrawal by Subject|7|||
125900463|NCT02660138|452934310|FG001|Overall Study|Withdrawal by Subject|6|||
125900464|NCT02660138|452934311|FG002|Overall Study|Withdrawal by Subject|6|||
125900465|NCT02660138|452934309|FG000|Overall Study|Lost to Follow-up|4|||
125900466|NCT02660138|452934310|FG001|Overall Study|Lost to Follow-up|4|||
125900467|NCT02660138|452934311|FG002|Overall Study|Lost to Follow-up|1|||
125900468|NCT02660138|452934309|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
125900469|NCT02660138|452934310|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
125900470|NCT02660138|452934311|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
125900471|NCT02660138|452934309|FG000|Overall Study|Other|1|||
125900472|NCT02660138|452934310|FG001|Overall Study|Other|1|||
125900473|NCT02660138|452934311|FG002|Overall Study|Other|0|||
125900474|NCT02660138|452934309|FG000|Overall Study|Not treated|0|||
125900475|NCT02660138|452934310|FG001|Overall Study|Not treated|1|||
125900476|NCT02660138|452934311|FG002|Overall Study|Not treated|0|||
125900477|NCT00308581|452934312|FG000|Induction Phase|Adverse Event|0|||
125900478|NCT00308581|452934313|FG001|Induction Phase|Adverse Event|0|||
125900479|NCT00308581|452934314|FG002|Induction Phase|Adverse Event|37|||
125900480|NCT00308581|452934312|FG000|Induction Phase|Lack of Efficacy|0|||
125900481|NCT00308581|452934313|FG001|Induction Phase|Lack of Efficacy|0|||
125900482|NCT00308581|452934314|FG002|Induction Phase|Lack of Efficacy|121|||
125900483|NCT00308581|452934312|FG000|Induction Phase|Withdrawal by Subject|0|||
125900484|NCT00308581|452934313|FG001|Induction Phase|Withdrawal by Subject|0|||
125900485|NCT00308581|452934314|FG002|Induction Phase|Withdrawal by Subject|5|||
125900486|NCT00308581|452934312|FG000|Induction Phase|Unknown reason|0|||
125900487|NCT00308581|452934313|FG001|Induction Phase|Unknown reason|0|||
125900488|NCT00308581|452934314|FG002|Induction Phase|Unknown reason|3|||
125900489|NCT00308581|452934312|FG000|Randomized Maintenance Phase|Adverse Event|10|||
125900490|NCT00308581|452934313|FG001|Randomized Maintenance Phase|Adverse Event|17|||
125900491|NCT00308581|452934314|FG002|Randomized Maintenance Phase|Adverse Event|0|||
125900492|NCT00308581|452934312|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
125900493|NCT00308581|452934313|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
125900494|NCT00308581|452934314|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
125900495|NCT00308581|452934312|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
125900496|NCT00308581|452934313|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
125900497|NCT00308581|452934314|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
125900498|NCT00308581|452934312|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
125900499|NCT00308581|452934313|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
125900500|NCT00308581|452934314|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
125900501|NCT00308581|452934312|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
125900502|NCT00308581|452934313|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
125900503|NCT00308581|452934314|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
125900504|NCT00308581|452934312|FG000|Randomized Maintenance Phase|Unknown reason|3|||
125900505|NCT00308581|452934313|FG001|Randomized Maintenance Phase|Unknown reason|0|||
125900506|NCT00308581|452934314|FG002|Randomized Maintenance Phase|Unknown reason|0|||
125900507|NCT01087788|452934316|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
125900508|NCT01087788|452934317|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
125900509|NCT01087788|452934318|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
125900510|NCT01087788|452934316|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
125900511|NCT01087788|452934317|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
125900512|NCT01087788|452934318|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
125900513|NCT01087788|452934316|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
125900514|NCT01087788|452934317|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
125900515|NCT01087788|452934318|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
125900516|NCT01087788|452934316|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
125900517|NCT01087788|452934317|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
125900518|NCT01087788|452934318|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
125900519|NCT01087788|452934316|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
125900520|NCT01087788|452934317|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
125900521|NCT01087788|452934318|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
125900522|NCT01087788|452934316|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
125900523|NCT01087788|452934317|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
125900524|NCT01087788|452934318|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
125900525|NCT01087788|452934316|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
125900526|NCT01087788|452934317|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
125900527|NCT01087788|452934318|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
125900528|NCT01087788|452934316|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
125900529|NCT01087788|452934317|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
125900530|NCT01087788|452934318|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
125900531|NCT01087788|452934316|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
125900532|NCT01087788|452934317|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
125900533|NCT01087788|452934318|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
125900534|NCT01087788|452934316|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
125900535|NCT01087788|452934317|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
125900536|NCT01087788|452934318|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
125900537|NCT01087788|452934316|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
125900538|NCT01087788|452934317|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
125900539|NCT01087788|452934318|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
125900540|NCT01087788|452934316|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
125900541|NCT01087788|452934317|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
125900542|NCT01087788|452934318|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
125900543|NCT01087788|452934316|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
125900544|NCT01087788|452934317|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
125900545|NCT01087788|452934318|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
125900546|NCT01087788|452934316|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
125900547|NCT01087788|452934317|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
125900548|NCT01087788|452934318|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
125900549|NCT01087788|452934316|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
125900550|NCT01087788|452934317|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
125900551|NCT01087788|452934318|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
125900552|NCT01087788|452934316|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
125900553|NCT01087788|452934317|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
125900554|NCT01087788|452934318|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
125900555|NCT01087788|452934316|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
125900556|NCT01087788|452934317|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
125900557|NCT01087788|452934318|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
125900558|NCT01087788|452934316|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
125900559|NCT01087788|452934317|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
125900560|NCT01087788|452934318|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
125900561|NCT01087788|452934316|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
125900562|NCT01087788|452934317|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
125900563|NCT01087788|452934318|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
125900564|NCT01087788|452934316|FG000|24-weeks Dose-blind Period|Patient moved|0|||
125900565|NCT01087788|452934317|FG001|24-weeks Dose-blind Period|Patient moved|0|||
125900566|NCT01087788|452934318|FG002|24-weeks Dose-blind Period|Patient moved|1|||
125900567|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
125900568|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
125900569|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
125900570|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
125900571|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
125900572|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
125900573|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
125900574|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
125900575|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
125900576|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
125900577|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
125900578|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
125900579|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
125900580|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
125900581|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
125900582|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
125900583|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
125900584|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
125900585|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
125900586|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
125900587|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
125900588|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
125900589|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
125900590|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
125900591|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
125900592|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
125900593|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
125900594|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
125900595|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
125900596|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
125900597|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
125900598|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
125900599|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
125900600|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
125900601|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
125900602|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
125900603|NCT01087788|452934316|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
125900604|NCT01087788|452934317|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
125900605|NCT01087788|452934318|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
125900606|NCT00534313|452934322|FG000|Short-term Period|Adverse Event|1|||
125900607|NCT00534313|452934323|FG001|Short-term Period|Adverse Event|2|||
125900608|NCT00534313|452934324|FG002|Short-term Period|Adverse Event|1|||
125900609|NCT00534313|452934325|FG003|Short-term Period|Adverse Event|3|||
125900610|NCT00534313|452934322|FG000|Short-term Period|Lack of Efficacy|3|||
125900611|NCT00534313|452934323|FG001|Short-term Period|Lack of Efficacy|4|||
125900612|NCT00534313|452934324|FG002|Short-term Period|Lack of Efficacy|0|||
125900613|NCT00534313|452934325|FG003|Short-term Period|Lack of Efficacy|3|||
125900614|NCT00534313|452934322|FG000|Short-term Period|Participant not meeting study criteria|0|||
125900615|NCT00534313|452934323|FG001|Short-term Period|Participant not meeting study criteria|0|||
125900616|NCT00534313|452934324|FG002|Short-term Period|Participant not meeting study criteria|0|||
125900617|NCT00534313|452934325|FG003|Short-term Period|Participant not meeting study criteria|1|||
125900618|NCT00534313|452934322|FG000|Short-term Period|Participant withdrew consent|2|||
125900619|NCT00534313|452934323|FG001|Short-term Period|Participant withdrew consent|0|||
125900620|NCT00534313|452934324|FG002|Short-term Period|Participant withdrew consent|0|||
125900621|NCT00534313|452934325|FG003|Short-term Period|Participant withdrew consent|2|||
125900622|NCT00534313|452934322|FG000|Short-term Period|Pregnancy|0|||
125900623|NCT00534313|452934323|FG001|Short-term Period|Pregnancy|0|||
125900624|NCT00534313|452934324|FG002|Short-term Period|Pregnancy|1|||
125900625|NCT00534313|452934325|FG003|Short-term Period|Pregnancy|0|||
125900626|NCT00534313|452934322|FG000|Long-term Period|Adverse Event|2|||
125900627|NCT00534313|452934323|FG001|Long-term Period|Adverse Event|1|||
125900628|NCT00534313|452934324|FG002|Long-term Period|Adverse Event|0|||
125900629|NCT00534313|452934325|FG003|Long-term Period|Adverse Event|1|||
125900630|NCT00534313|452934322|FG000|Long-term Period|Lack of Efficacy|14|||
125900631|NCT00534313|452934323|FG001|Long-term Period|Lack of Efficacy|10|||
125900632|NCT00534313|452934324|FG002|Long-term Period|Lack of Efficacy|14|||
125900633|NCT00534313|452934325|FG003|Long-term Period|Lack of Efficacy|12|||
125900634|NCT00534313|452934322|FG000|Long-term Period|Lost to Follow-up|1|||
125900635|NCT00534313|452934323|FG001|Long-term Period|Lost to Follow-up|2|||
125900636|NCT00534313|452934324|FG002|Long-term Period|Lost to Follow-up|0|||
125900637|NCT00534313|452934325|FG003|Long-term Period|Lost to Follow-up|0|||
125900638|NCT00534313|452934322|FG000|Long-term Period|Withdrawal by Subject|2|||
125900639|NCT00534313|452934323|FG001|Long-term Period|Withdrawal by Subject|2|||
125900640|NCT00534313|452934324|FG002|Long-term Period|Withdrawal by Subject|0|||
125900641|NCT00534313|452934325|FG003|Long-term Period|Withdrawal by Subject|0|||
125900642|NCT00534313|452934322|FG000|Long-term Period|No longer meets study criteria|0|||
125900643|NCT00534313|452934323|FG001|Long-term Period|No longer meets study criteria|1|||
125900644|NCT00534313|452934324|FG002|Long-term Period|No longer meets study criteria|0|||
125900645|NCT00534313|452934325|FG003|Long-term Period|No longer meets study criteria|0|||
125900646|NCT00534313|452934322|FG000|Long-term Period|Poor compliance/noncompliance|0|||
125900647|NCT00534313|452934323|FG001|Long-term Period|Poor compliance/noncompliance|1|||
125900648|NCT00534313|452934324|FG002|Long-term Period|Poor compliance/noncompliance|1|||
125900649|NCT00534313|452934325|FG003|Long-term Period|Poor compliance/noncompliance|0|||
125900650|NCT00534313|452934322|FG000|Long-term Period|Administrative reason by sponsor|17|||
125900651|NCT00534313|452934323|FG001|Long-term Period|Administrative reason by sponsor|15|||
125900652|NCT00534313|452934324|FG002|Long-term Period|Administrative reason by sponsor|26|||
125900653|NCT00534313|452934325|FG003|Long-term Period|Administrative reason by sponsor|18|||
125900654|NCT00534313|452934322|FG000|Long-term Period|Other|1|||
125900655|NCT00534313|452934323|FG001|Long-term Period|Other|2|||
125900656|NCT00534313|452934324|FG002|Long-term Period|Other|2|||
125900657|NCT00534313|452934325|FG003|Long-term Period|Other|2|||
125900658|NCT03709576|452934331|FG000|Overall Study|progression prior to enrollment|1|||
125900659|NCT02282293|452934339|FG000|Overall Study|Lost to Follow-up|2|||
125900660|NCT02282293|452934340|FG001|Overall Study|Lost to Follow-up|2|||
125900661|NCT02282293|452934339|FG000|Overall Study|Unable to comply with study procedures|1|||
125900662|NCT02282293|452934340|FG001|Overall Study|Unable to comply with study procedures|0|||
125900663|NCT02282293|452934339|FG000|Overall Study|Moved out of study area|0|||
125900664|NCT02282293|452934340|FG001|Overall Study|Moved out of study area|1|||
125900665|NCT01924429|452934352|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
125900666|NCT01924429|452934353|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
125900667|NCT00384111|452934354|FG000|Overall Study|Disease Progression|3|||
125900668|NCT00384111|452934354|FG000|Overall Study|Adverse Event|1|||
125900669|NCT00384111|452934354|FG000|Overall Study|Investigator Decision|3|||
125900670|NCT00384111|452934354|FG000|Overall Study|Study Terminated by the Sponsor|19|||
125900671|NCT00807573|452934355|FG000|Overall Study|Withdrawal by Subject|1|||
125900672|NCT00807573|452934355|FG000|Overall Study|Adverse Event|1|||
125900673|NCT01089361|452934356|FG000|Overall Study|Death|1|||
125900674|NCT01089361|452934357|FG001|Overall Study|Death|0|||
125900675|NCT03612856|452934358|FG000|Pre-dose Period|Physician Decision|0|||
125900676|NCT03612856|452934359|FG001|Pre-dose Period|Physician Decision|1|||
125900677|NCT03612856|452934360|FG002|Pre-dose Period|Physician Decision|1|||
125900678|NCT03612856|452934358|FG000|Pre-dose Period|Withdrawal by Subject|0|||
125900679|NCT03612856|452934359|FG001|Pre-dose Period|Withdrawal by Subject|1|||
125900680|NCT03612856|452934360|FG002|Pre-dose Period|Withdrawal by Subject|0|||
126110073|NCT03236246|453697629|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
126110074|NCT03236246|453697628|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
126110075|NCT03236246|453697629|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
126110076|NCT03236246|453697628|FG000|24-Week Dose Maintenance Period|Death|0|||
126110077|NCT03236246|453697629|FG001|24-Week Dose Maintenance Period|Death|1|||
126110078|NCT03236246|453697628|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
126110079|NCT03236246|453697629|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
126110080|NCT02598557|453697630|FG000|Overall Study|Withdrawal by Subject|1|||
126110081|NCT02598557|453697631|FG001|Overall Study|Withdrawal by Subject|0|||
126110082|NCT02598557|453697632|FG002|Overall Study|Withdrawal by Subject|1|||
126110083|NCT02598557|453697630|FG000|Overall Study|Participant did not start treatment|2|||
126110084|NCT02598557|453697631|FG001|Overall Study|Participant did not start treatment|1|||
126110085|NCT02598557|453697632|FG002|Overall Study|Participant did not start treatment|1|||
125900681|NCT04463069|452934361|FG000|Overall Study|Withdrawal by Subject|2|||
125900682|NCT04463069|452934362|FG001|Overall Study|Withdrawal by Subject|10|||
125900683|NCT04463069|452934361|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
125900684|NCT04463069|452934362|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
125900685|NCT01155167|452934365|FG000|Overall Study|Insufficient ultrasound data|2|||
125900686|NCT01155167|452934366|FG001|Overall Study|Insufficient ultrasound data|0|||
125900687|NCT01155167|452934365|FG000|Overall Study|Access site changed to femoral artery|1|||
125900688|NCT01155167|452934366|FG001|Overall Study|Access site changed to femoral artery|0|||
125900689|NCT02880956|452934372|FG000|Overall Study|Adverse Event|3|||
125900690|NCT02880956|452934373|FG001|Overall Study|Adverse Event|6|||
125900691|NCT02880956|452934374|FG002|Overall Study|Adverse Event|5|||
125900692|NCT02880956|452934375|FG003|Overall Study|Adverse Event|4|||
125900693|NCT02880956|452934372|FG000|Overall Study|Withdrawal by Subject|9|||
125900694|NCT02880956|452934373|FG001|Overall Study|Withdrawal by Subject|4|||
125900695|NCT02880956|452934374|FG002|Overall Study|Withdrawal by Subject|6|||
125900696|NCT02880956|452934375|FG003|Overall Study|Withdrawal by Subject|11|||
125900697|NCT02880956|452934372|FG000|Overall Study|Lost to Follow-up|0|||
125900698|NCT02880956|452934373|FG001|Overall Study|Lost to Follow-up|1|||
125900699|NCT02880956|452934374|FG002|Overall Study|Lost to Follow-up|0|||
125900700|NCT02880956|452934375|FG003|Overall Study|Lost to Follow-up|0|||
125900701|NCT02880956|452934372|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
125900702|NCT02880956|452934373|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
125900703|NCT02880956|452934374|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
125900704|NCT02880956|452934375|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
125900705|NCT02880956|452934372|FG000|Overall Study|Other, Not Specified|4|||
125900706|NCT02880956|452934373|FG001|Overall Study|Other, Not Specified|2|||
125900707|NCT02880956|452934374|FG002|Overall Study|Other, Not Specified|0|||
125900708|NCT02880956|452934375|FG003|Overall Study|Other, Not Specified|3|||
125900709|NCT00853970|452934376|FG000|Overall Study|Withdrawal by Subject|2|||
125900710|NCT00853970|452934377|FG001|Overall Study|Withdrawal by Subject|1|||
125900711|NCT00853970|452934376|FG000|Overall Study|Cancelled surgery|4|||
125900712|NCT00853970|452934377|FG001|Overall Study|Cancelled surgery|2|||
125900713|NCT01340872|452936364|FG000|Double-blind Phase|Adverse Event|6|||
125900714|NCT01340872|452936365|FG001|Double-blind Phase|Adverse Event|4|||
125900715|NCT01340872|452936366|FG002|Double-blind Phase|Adverse Event|0|||
125900716|NCT01340872|452936367|FG003|Double-blind Phase|Adverse Event|0|||
125900717|NCT01340872|452936364|FG000|Double-blind Phase|Withdrawal by Subject|3|||
125900718|NCT01340872|452936365|FG001|Double-blind Phase|Withdrawal by Subject|5|||
125900719|NCT01340872|452936366|FG002|Double-blind Phase|Withdrawal by Subject|0|||
125900720|NCT01340872|452936367|FG003|Double-blind Phase|Withdrawal by Subject|0|||
125900721|NCT01340872|452936364|FG000|Double-blind Phase|Lost to Follow-up|0|||
125900722|NCT01340872|452936365|FG001|Double-blind Phase|Lost to Follow-up|1|||
125900723|NCT01340872|452936366|FG002|Double-blind Phase|Lost to Follow-up|0|||
125900724|NCT01340872|452936367|FG003|Double-blind Phase|Lost to Follow-up|0|||
125900725|NCT01340872|452936364|FG000|Double-blind Phase|Protocol Violation|0|||
125900726|NCT01340872|452936365|FG001|Double-blind Phase|Protocol Violation|1|||
125900727|NCT01340872|452936366|FG002|Double-blind Phase|Protocol Violation|0|||
125900728|NCT01340872|452936367|FG003|Double-blind Phase|Protocol Violation|0|||
125900729|NCT01340872|452936364|FG000|Open-label Phase|Physician Decision|0|||
125900730|NCT01340872|452936365|FG001|Open-label Phase|Physician Decision|0|||
125900731|NCT01340872|452936366|FG002|Open-label Phase|Physician Decision|2|||
125900732|NCT01340872|452936367|FG003|Open-label Phase|Physician Decision|1|||
125900733|NCT01340872|452936364|FG000|Open-label Phase|Pregnancy|0|||
125900734|NCT01340872|452936365|FG001|Open-label Phase|Pregnancy|0|||
125900735|NCT01340872|452936366|FG002|Open-label Phase|Pregnancy|1|||
125900736|NCT01340872|452936367|FG003|Open-label Phase|Pregnancy|0|||
125900737|NCT01340872|452936364|FG000|Open-label Phase|Adverse Event|0|||
125900738|NCT01340872|452936365|FG001|Open-label Phase|Adverse Event|0|||
125900739|NCT01340872|452936366|FG002|Open-label Phase|Adverse Event|8|||
125900740|NCT01340872|452936367|FG003|Open-label Phase|Adverse Event|4|||
125900741|NCT01340872|452936364|FG000|Open-label Phase|Withdrawal by Subject|0|||
125900742|NCT01340872|452936365|FG001|Open-label Phase|Withdrawal by Subject|0|||
125900743|NCT01340872|452936366|FG002|Open-label Phase|Withdrawal by Subject|1|||
125900744|NCT01340872|452936367|FG003|Open-label Phase|Withdrawal by Subject|6|||
125900745|NCT01340872|452936364|FG000|Open-label Phase|Worsening of IBD|0|||
125900746|NCT01340872|452936365|FG001|Open-label Phase|Worsening of IBD|0|||
125900747|NCT01340872|452936366|FG002|Open-label Phase|Worsening of IBD|1|||
125900748|NCT01340872|452936367|FG003|Open-label Phase|Worsening of IBD|0|||
125900749|NCT03603509|452936368|FG000|Overall Study|Lost to Follow-up|3|||
125900750|NCT03603509|452936369|FG001|Overall Study|Lost to Follow-up|4|||
125900751|NCT01258998|452936372|FG000|Overall Study|Ineligible|1|||
125900752|NCT01143389|452936373|FG000|Overall Study|Lost to Follow-up|26|||
125900753|NCT01143389|452936374|FG001|Overall Study|Lost to Follow-up|25|||
125900754|NCT04966910|452936377|FG000|Baseline|Participant did not complete measure|0|||
125900755|NCT04966910|452936378|FG001|Baseline|Participant did not complete measure|0|||
125900756|NCT04966910|452936379|FG002|Baseline|Participant did not complete measure|1|||
125900757|NCT04966910|452936380|FG003|Baseline|Participant did not complete measure|0|||
125900758|NCT04966910|452936377|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
125900759|NCT04966910|452936378|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
125900760|NCT04966910|452936379|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
125900761|NCT04966910|452936380|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
125900762|NCT04966910|452936377|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
125900763|NCT04966910|452936378|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
125900764|NCT04966910|452936379|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
125900765|NCT04966910|452936380|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
125900766|NCT04966910|452936377|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
125900767|NCT04966910|452936378|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
125900768|NCT04966910|452936379|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
125900769|NCT04966910|452936380|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
125900770|NCT02276027|452936382|FG000|Overall Study|Death|1|||
125900771|NCT02276027|452936383|FG001|Overall Study|Death|0|||
125900772|NCT02276027|452936384|FG002|Overall Study|Death|0|||
125900773|NCT02276027|452936385|FG003|Overall Study|Death|2|||
125900774|NCT02276027|452936382|FG000|Overall Study|Physician Decision|0|||
125900775|NCT02276027|452936383|FG001|Overall Study|Physician Decision|0|||
125900776|NCT02276027|452936384|FG002|Overall Study|Physician Decision|0|||
125900777|NCT02276027|452936385|FG003|Overall Study|Physician Decision|1|||
125900778|NCT02276027|452936382|FG000|Overall Study|Progressive disease|1|||
125900779|NCT02276027|452936383|FG001|Overall Study|Progressive disease|13|||
125900780|NCT02276027|452936384|FG002|Overall Study|Progressive disease|12|||
125900781|NCT02276027|452936385|FG003|Overall Study|Progressive disease|14|||
125900782|NCT02276027|452936382|FG000|Overall Study|Subject/guardian decision|0|||
125900783|NCT02276027|452936383|FG001|Overall Study|Subject/guardian decision|1|||
125900784|NCT02276027|452936384|FG002|Overall Study|Subject/guardian decision|0|||
125900785|NCT02276027|452936385|FG003|Overall Study|Subject/guardian decision|3|||
125900786|NCT02276027|452936382|FG000|Overall Study|Adverse Event|0|||
125900787|NCT02276027|452936383|FG001|Overall Study|Adverse Event|2|||
125900788|NCT02276027|452936384|FG002|Overall Study|Adverse Event|8|||
125900789|NCT02276027|452936385|FG003|Overall Study|Adverse Event|2|||
125900790|NCT03224598|452936386|FG000|Overall Study|Lost to Follow-up|0|||
125900791|NCT03224598|452936387|FG001|Overall Study|Lost to Follow-up|2|||
125900792|NCT03224598|452936388|FG002|Overall Study|Lost to Follow-up|0|||
125900793|NCT03224598|452936386|FG000|Overall Study|Other|0|||
125900794|NCT03224598|452936387|FG001|Overall Study|Other|1|||
125900795|NCT03224598|452936388|FG002|Overall Study|Other|0|||
125900796|NCT01527357|452936398|FG000|Overall Study|Death|8|||
125900797|NCT01527357|452936399|FG001|Overall Study|Death|2|||
125900798|NCT01527357|452936398|FG000|Overall Study|Lost to Follow-up|6|||
125900799|NCT01527357|452936399|FG001|Overall Study|Lost to Follow-up|4|||
125900800|NCT01527357|452936398|FG000|Overall Study|Withdrew Consent|1|||
125900801|NCT01527357|452936399|FG001|Overall Study|Withdrew Consent|1|||
125900802|NCT01527357|452936398|FG000|Overall Study|Non-compliance|0|||
125900803|NCT01527357|452936399|FG001|Overall Study|Non-compliance|1|||
125900804|NCT01527357|452936398|FG000|Overall Study|No Day 29 Visit|0|||
125900805|NCT01527357|452936399|FG001|Overall Study|No Day 29 Visit|1|||
125900806|NCT01527357|452936398|FG000|Overall Study|Did Not Receive Treatment|2|||
125900807|NCT01527357|452936399|FG001|Overall Study|Did Not Receive Treatment|0|||
125900808|NCT02446171|452936400|FG000|Overall Study|Withdrawal by Subject|0|||
125900809|NCT02446171|452936401|FG001|Overall Study|Withdrawal by Subject|0|||
125900810|NCT02446171|452936402|FG002|Overall Study|Withdrawal by Subject|2|||
125900811|NCT02446171|452936403|FG003|Overall Study|Withdrawal by Subject|0|||
125900812|NCT04531462|452936404|FG000|Overall Study|Withdrawal by Subject|3|||
125900813|NCT04531462|452936405|FG001|Overall Study|Withdrawal by Subject|1|||
125900814|NCT04531462|452936404|FG000|Overall Study|Adverse Event|3|||
125900815|NCT04531462|452936405|FG001|Overall Study|Adverse Event|3|||
125900816|NCT00504582|452936406|FG000|Overall Study|Lost to Follow-up|1|||
125900817|NCT00504582|452936407|FG001|Overall Study|Lost to Follow-up|0|||
125900818|NCT00504582|452936408|FG002|Overall Study|Lost to Follow-up|0|||
125900819|NCT02292784|452936411|FG000|Overall Study|Lost to Follow-up|1|||
125900820|NCT02292784|452936412|FG001|Overall Study|Lost to Follow-up|17|||
125900821|NCT02292784|452936413|FG002|Overall Study|Lost to Follow-up|18|||
125900822|NCT02292784|452936411|FG000|Overall Study|Withdrawal by Subject|0|||
125900823|NCT02292784|452936412|FG001|Overall Study|Withdrawal by Subject|3|||
125900824|NCT02292784|452936413|FG002|Overall Study|Withdrawal by Subject|3|||
125900825|NCT00348933|452936414|FG000|Overall Study|Withdrawal by Subject|10|||
125900826|NCT00348933|452936414|FG000|Overall Study|Lost to Follow-up|6|||
125900827|NCT00348933|452936414|FG000|Overall Study|Protocol Violation|2|||
125900828|NCT00348933|452936414|FG000|Overall Study|Adverse Event|7|||
125900829|NCT01264081|452936415|FG000|Participants Screened|Screening failures|30|||
125900830|NCT01264081|452936415|FG000|Started Treatment|Withdrawal by Subject|1|||
125900831|NCT01264081|452936415|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
125900832|NCT01489111|452936416|FG000|Overall Study|Withdrawal criterion|1|||
125900833|NCT00134784|452936417|FG000|Overall Study|Withdrawal by Subject|2|||
125900834|NCT00134784|452936418|FG001|Overall Study|Withdrawal by Subject|2|||
125900835|NCT00134784|452936419|FG002|Overall Study|Withdrawal by Subject|2|||
125900836|NCT00134784|452936420|FG003|Overall Study|Withdrawal by Subject|1|||
125900837|NCT00730028|452936425|FG000|Overall Study|Adverse Event|23|||
125900838|NCT00730028|452936426|FG001|Overall Study|Adverse Event|26|||
125900839|NCT00730028|452936427|FG002|Overall Study|Adverse Event|16|||
125900840|NCT00730028|452936428|FG003|Overall Study|Adverse Event|20|||
125900841|NCT00730028|452936429|FG004|Overall Study|Adverse Event|43|||
125900842|NCT00730028|452936425|FG000|Overall Study|Lost to Follow-up|13|||
125900843|NCT00730028|452936426|FG001|Overall Study|Lost to Follow-up|26|||
125900844|NCT00730028|452936427|FG002|Overall Study|Lost to Follow-up|22|||
125900845|NCT00730028|452936428|FG003|Overall Study|Lost to Follow-up|26|||
125900846|NCT00730028|452936429|FG004|Overall Study|Lost to Follow-up|25|||
125900847|NCT00730028|452936425|FG000|Overall Study|Protocol Violation|6|||
125900848|NCT00730028|452936426|FG001|Overall Study|Protocol Violation|1|||
125900849|NCT00730028|452936427|FG002|Overall Study|Protocol Violation|1|||
125900850|NCT00730028|452936428|FG003|Overall Study|Protocol Violation|2|||
125900851|NCT00730028|452936429|FG004|Overall Study|Protocol Violation|0|||
125900852|NCT00730028|452936425|FG000|Overall Study|Withdrawal by Subject|9|||
125900853|NCT00730028|452936426|FG001|Overall Study|Withdrawal by Subject|5|||
125900854|NCT00730028|452936427|FG002|Overall Study|Withdrawal by Subject|4|||
125900855|NCT00730028|452936428|FG003|Overall Study|Withdrawal by Subject|5|||
125900856|NCT00730028|452936429|FG004|Overall Study|Withdrawal by Subject|9|||
125900857|NCT00730028|452936425|FG000|Overall Study|Physician Decision|3|||
125900858|NCT00730028|452936426|FG001|Overall Study|Physician Decision|3|||
125900859|NCT00730028|452936427|FG002|Overall Study|Physician Decision|2|||
125900860|NCT00730028|452936428|FG003|Overall Study|Physician Decision|3|||
125900861|NCT00730028|452936429|FG004|Overall Study|Physician Decision|2|||
125900862|NCT00730028|452936425|FG000|Overall Study|Treatment Failure|5|||
125900863|NCT00730028|452936426|FG001|Overall Study|Treatment Failure|5|||
125900864|NCT00730028|452936427|FG002|Overall Study|Treatment Failure|0|||
125900865|NCT00730028|452936428|FG003|Overall Study|Treatment Failure|0|||
125900866|NCT00730028|452936429|FG004|Overall Study|Treatment Failure|1|||
125900867|NCT00730028|452936425|FG000|Overall Study|Randomization Error|1|||
125900868|NCT00730028|452936426|FG001|Overall Study|Randomization Error|0|||
125900869|NCT00730028|452936427|FG002|Overall Study|Randomization Error|0|||
125900870|NCT00730028|452936428|FG003|Overall Study|Randomization Error|0|||
125900871|NCT00730028|452936429|FG004|Overall Study|Randomization Error|2|||
125900872|NCT03811093|452936430|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
125900873|NCT03811093|452936431|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
125900874|NCT03811093|452936430|FG000|Overall Study|Unable to measure body fat percentage|2|||
125900875|NCT03811093|452936431|FG001|Overall Study|Unable to measure body fat percentage|0|||
125900876|NCT00464490|452936432|FG000|Overall Study|Physician Decision|11|||
125900877|NCT00464490|452936433|FG001|Overall Study|Physician Decision|11|||
125900878|NCT03188042|452936434|FG000|Overall Study|Withdrawal by Subject|1|||
125900879|NCT03188042|452936435|FG001|Overall Study|Withdrawal by Subject|1|||
125900880|NCT01238588|452936442|FG000|Overall Study|Withdrawal by Subject|1|||
125900881|NCT01238588|452936442|FG000|Overall Study|Physician Decision|2|||
125900882|NCT01903252|452936447|FG000|Double-Blind Induction|Adverse Event|20|||
125900883|NCT01903252|452936448|FG001|Double-Blind Induction|Adverse Event|18|||
125900884|NCT01903252|452936449|FG002|Double-Blind Induction|Adverse Event|0|||
125900885|NCT01903252|452936450|FG003|Double-Blind Induction|Adverse Event|0|||
125900886|NCT01903252|452936451|FG004|Double-Blind Induction|Adverse Event|0|||
125900887|NCT01903252|452936452|FG005|Double-Blind Induction|Adverse Event|0|||
125900888|NCT01903252|452936447|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
125900889|NCT01903252|452936448|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
125900890|NCT01903252|452936449|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
125900891|NCT01903252|452936450|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
125900892|NCT01903252|452936451|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
125900893|NCT01903252|452936452|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
125900894|NCT01903252|452936447|FG000|Double-Blind Induction|Physician Decision|2|||
125900895|NCT01903252|452936448|FG001|Double-Blind Induction|Physician Decision|3|||
125900896|NCT01903252|452936449|FG002|Double-Blind Induction|Physician Decision|0|||
125900897|NCT01903252|452936450|FG003|Double-Blind Induction|Physician Decision|0|||
125900898|NCT01903252|452936451|FG004|Double-Blind Induction|Physician Decision|0|||
125900899|NCT01903252|452936452|FG005|Double-Blind Induction|Physician Decision|0|||
125900900|NCT01903252|452936447|FG000|Double-Blind Induction|non-compliance,|7|||
125900901|NCT01903252|452936448|FG001|Double-Blind Induction|non-compliance,|7|||
125900902|NCT01903252|452936449|FG002|Double-Blind Induction|non-compliance,|0|||
125900903|NCT01903252|452936450|FG003|Double-Blind Induction|non-compliance,|0|||
125900904|NCT01903252|452936451|FG004|Double-Blind Induction|non-compliance,|0|||
125900905|NCT01903252|452936452|FG005|Double-Blind Induction|non-compliance,|0|||
125900906|NCT01903252|452936447|FG000|Extended Induction, Open-Label|Adverse Event|0|||
125900907|NCT01903252|452936448|FG001|Extended Induction, Open-Label|Adverse Event|0|||
125900908|NCT01903252|452936449|FG002|Extended Induction, Open-Label|Adverse Event|17|||
125900909|NCT01903252|452936450|FG003|Extended Induction, Open-Label|Adverse Event|0|||
125900910|NCT01903252|452936451|FG004|Extended Induction, Open-Label|Adverse Event|0|||
125900911|NCT01903252|452936452|FG005|Extended Induction, Open-Label|Adverse Event|0|||
125900912|NCT01903252|452936447|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125900913|NCT01903252|452936448|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125900914|NCT01903252|452936449|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
125900915|NCT01903252|452936450|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125900916|NCT01903252|452936451|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125900917|NCT01903252|452936452|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125900918|NCT01903252|452936447|FG000|Extended Induction, Open-Label|Physician Decision|0|||
125900919|NCT01903252|452936448|FG001|Extended Induction, Open-Label|Physician Decision|0|||
125900920|NCT01903252|452936449|FG002|Extended Induction, Open-Label|Physician Decision|1|||
125900921|NCT01903252|452936450|FG003|Extended Induction, Open-Label|Physician Decision|0|||
125900922|NCT01903252|452936451|FG004|Extended Induction, Open-Label|Physician Decision|0|||
125900923|NCT01903252|452936452|FG005|Extended Induction, Open-Label|Physician Decision|0|||
125900924|NCT01903252|452936447|FG000|Maintenance, Open-Label|Adverse Event|0|||
125900925|NCT01903252|452936448|FG001|Maintenance, Open-Label|Adverse Event|0|||
125900926|NCT01903252|452936449|FG002|Maintenance, Open-Label|Adverse Event|0|||
125900927|NCT01903252|452936450|FG003|Maintenance, Open-Label|Adverse Event|3|||
125900928|NCT01903252|452936451|FG004|Maintenance, Open-Label|Adverse Event|9|||
125900929|NCT01903252|452936452|FG005|Maintenance, Open-Label|Adverse Event|14|||
125900930|NCT01903252|452936447|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
125900931|NCT01903252|452936448|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
125900932|NCT01903252|452936449|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
125900933|NCT01903252|452936450|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
125900934|NCT01903252|452936451|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
125900935|NCT01903252|452936452|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
125900936|NCT01903252|452936447|FG000|Maintenance, Open-Label|Other|0|||
125900937|NCT01903252|452936448|FG001|Maintenance, Open-Label|Other|0|||
125900938|NCT01903252|452936449|FG002|Maintenance, Open-Label|Other|0|||
125900939|NCT01903252|452936450|FG003|Maintenance, Open-Label|Other|2|||
125900940|NCT01903252|452936451|FG004|Maintenance, Open-Label|Other|6|||
125900941|NCT01903252|452936452|FG005|Maintenance, Open-Label|Other|2|||
125900942|NCT02437110|452936453|FG000|Screening|Lost to Follow-up|3|||
125900943|NCT02437110|452936453|FG000|Screening|Physician Decision|1|||
125900944|NCT02437110|452936453|FG000|ART|Adverse Event|3|||
125900945|NCT02437110|452936453|FG000|ART|Protocol Violation|3|||
125900946|NCT02437110|452936453|FG000|ART|Withdrawal by Subject|4|||
125900947|NCT02437110|452936453|FG000|ART|Lost to follow-up prior to start of intervention|1|||
125900948|NCT02437110|452936453|FG000|ART|Physician decision prior to start of intervention|2|||
125900949|NCT02437110|452936453|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
125900950|NCT02437110|452936453|FG000|Post-ART|Lost to Follow-up|3|||
125900951|NCT02437110|452936453|FG000|Post-ART|Protocol Violation|4|||
125900952|NCT02437110|452936453|FG000|Post-ART|Withdrawal by Subject|3|||
125900953|NCT03836001|452936456|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
125900954|NCT03836001|452936457|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
125900955|NCT03836001|452936458|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
125900956|NCT03836001|452936456|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
125900957|NCT03836001|452936457|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
125900958|NCT03836001|452936458|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
125900959|NCT03836001|452936456|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
125900960|NCT03836001|452936457|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
125900961|NCT03836001|452936458|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
125900962|NCT03836001|452936456|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
125900963|NCT03836001|452936457|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
125900964|NCT03836001|452936458|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
125900965|NCT01381562|452936459|FG000|Overall Study|Adverse Event|0|||
125900966|NCT01381562|452936460|FG001|Overall Study|Adverse Event|1|||
125900967|NCT01381562|452936461|FG002|Overall Study|Adverse Event|0|||
125900968|NCT01642732|452936466|FG000|Overall Study|Withdrawal by Subject|1|||
125900969|NCT00899353|452936469|FG000|Overall Study|Adverse Event|2|||
125900970|NCT00899353|452936469|FG000|Overall Study|Lost to Follow-up|1|||
125900971|NCT00899353|452936469|FG000|Overall Study|Withdrawal by Subject|2|||
125900972|NCT02730793|452936475|FG000|Overall Study|Physician Decision|0|||
125900973|NCT02730793|452936476|FG001|Overall Study|Physician Decision|1|||
125900974|NCT02730793|452936475|FG000|Overall Study|Withdrawal by Subject|0|||
125900975|NCT02730793|452936476|FG001|Overall Study|Withdrawal by Subject|1|||
125900976|NCT01284491|452936477|FG000|Overall Study|Study termination|13|||
125900977|NCT02694757|452936480|FG000|Overall Study|Lack of Efficacy|3|||
125900978|NCT02650921|452936481|FG000|Overall Study|Withdrawal by Subject|4|||
125900979|NCT02650921|452936481|FG000|Overall Study|Lost to Follow-up|2|||
125900980|NCT02650921|452936481|FG000|Overall Study|Adverse Event|1|||
125900981|NCT02650921|452936481|FG000|Overall Study|Due to Medical Condition|1|||
125900982|NCT00783302|452936482|FG000|Overall Study|Lost to Follow-up|17|||
125900983|NCT00783302|452936482|FG000|Overall Study|Technical Problems|11|||
125900984|NCT00783302|452936482|FG000|Overall Study|Protocol Violation|3|||
125900985|NCT00783302|452936482|FG000|Overall Study|Physician Decision|1|||
125900986|NCT00783302|452936482|FG000|Overall Study|Withdrawal by Subject|3|||
125900987|NCT04604132|452936483|FG000|Overall Study|Adverse Event|2|||
125900988|NCT04604132|452936484|FG001|Overall Study|Adverse Event|0|||
125900989|NCT04604132|452936485|FG002|Overall Study|Adverse Event|0|||
125900990|NCT04604132|452936486|FG003|Overall Study|Adverse Event|1|||
125900991|NCT04604132|452936487|FG004|Overall Study|Adverse Event|2|||
125900992|NCT04604132|452936483|FG000|Overall Study|Study terminated by sponsor|0|||
125900993|NCT04604132|452936484|FG001|Overall Study|Study terminated by sponsor|0|||
125900994|NCT04604132|452936485|FG002|Overall Study|Study terminated by sponsor|0|||
125900995|NCT04604132|452936486|FG003|Overall Study|Study terminated by sponsor|0|||
125900996|NCT04604132|452936487|FG004|Overall Study|Study terminated by sponsor|1|||
125900997|NCT04604132|452936483|FG000|Overall Study|Progressive disease: Clinical progression|0|||
125900998|NCT04604132|452936484|FG001|Overall Study|Progressive disease: Clinical progression|0|||
125900999|NCT04604132|452936485|FG002|Overall Study|Progressive disease: Clinical progression|1|||
125901000|NCT04604132|452936486|FG003|Overall Study|Progressive disease: Clinical progression|0|||
125901001|NCT04604132|452936487|FG004|Overall Study|Progressive disease: Clinical progression|0|||
125901002|NCT04604132|452936483|FG000|Overall Study|Progressive disease: Radiological progression|8|||
125901003|NCT04604132|452936484|FG001|Overall Study|Progressive disease: Radiological progression|7|||
125901004|NCT04604132|452936485|FG002|Overall Study|Progressive disease: Radiological progression|10|||
125901005|NCT04604132|452936486|FG003|Overall Study|Progressive disease: Radiological progression|4|||
125901006|NCT04604132|452936487|FG004|Overall Study|Progressive disease: Radiological progression|3|||
125901007|NCT04604132|452936483|FG000|Overall Study|Death|3|||
125901008|NCT04604132|452936484|FG001|Overall Study|Death|1|||
125901009|NCT04604132|452936485|FG002|Overall Study|Death|2|||
125901010|NCT04604132|452936486|FG003|Overall Study|Death|1|||
125901011|NCT04604132|452936487|FG004|Overall Study|Death|0|||
125901012|NCT00952380|452936488|FG000|Overall Study|Other|0|||
125901013|NCT00952380|452936489|FG001|Overall Study|Other|0|||
125901014|NCT00952380|452936490|FG002|Overall Study|Other|0|||
125901015|NCT00952380|452936491|FG003|Overall Study|Other|0|||
125901016|NCT00952380|452936492|FG004|Overall Study|Other|1|||
125901017|NCT00952380|452936488|FG000|Overall Study|Withdrawal by Subject|0|||
125901018|NCT00952380|452936489|FG001|Overall Study|Withdrawal by Subject|0|||
125901019|NCT00952380|452936490|FG002|Overall Study|Withdrawal by Subject|1|||
125901020|NCT00952380|452936491|FG003|Overall Study|Withdrawal by Subject|0|||
125901021|NCT00952380|452936492|FG004|Overall Study|Withdrawal by Subject|2|||
125901022|NCT00952380|452936488|FG000|Overall Study|Adverse Event|0|||
125901023|NCT00952380|452936489|FG001|Overall Study|Adverse Event|1|||
125901024|NCT00952380|452936490|FG002|Overall Study|Adverse Event|0|||
125901025|NCT00952380|452936491|FG003|Overall Study|Adverse Event|0|||
125901026|NCT00952380|452936492|FG004|Overall Study|Adverse Event|3|||
125901027|NCT00952380|452936488|FG000|Overall Study|Physician Decision|0|||
125901028|NCT00952380|452936489|FG001|Overall Study|Physician Decision|0|||
125901029|NCT00952380|452936490|FG002|Overall Study|Physician Decision|1|||
125901030|NCT00952380|452936491|FG003|Overall Study|Physician Decision|2|||
125901031|NCT00952380|452936492|FG004|Overall Study|Physician Decision|0|||
125901032|NCT00952380|452936488|FG000|Overall Study|Non-compliant to protocol|0|||
125901033|NCT00952380|452936489|FG001|Overall Study|Non-compliant to protocol|0|||
125901034|NCT00952380|452936490|FG002|Overall Study|Non-compliant to protocol|0|||
125901035|NCT00952380|452936491|FG003|Overall Study|Non-compliant to protocol|1|||
125901036|NCT00952380|452936492|FG004|Overall Study|Non-compliant to protocol|0|||
125901037|NCT03400956|452936493|FG000|Treatment Period 1|Adverse Event|0|||
125901038|NCT03400956|452936494|FG001|Treatment Period 1|Adverse Event|1|||
125901039|NCT03400956|452936495|FG002|Treatment Period 1|Adverse Event|0|||
125901040|NCT03400956|452936493|FG000|Treatment Period 1|Lost to Follow-up|0|||
125901041|NCT03400956|452936494|FG001|Treatment Period 1|Lost to Follow-up|0|||
125901042|NCT03400956|452936495|FG002|Treatment Period 1|Lost to Follow-up|1|||
125901043|NCT03400956|452936493|FG000|Treatment Period 1|Protocol Violation|0|||
125901044|NCT03400956|452936494|FG001|Treatment Period 1|Protocol Violation|2|||
125901045|NCT03400956|452936495|FG002|Treatment Period 1|Protocol Violation|0|||
125901046|NCT03400956|452936493|FG000|Treatment Period 1|Study terminated by sponsor|3|||
125901047|NCT03400956|452936494|FG001|Treatment Period 1|Study terminated by sponsor|1|||
125901048|NCT03400956|452936495|FG002|Treatment Period 1|Study terminated by sponsor|1|||
125901049|NCT03400956|452936493|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125901050|NCT03400956|452936494|FG001|Treatment Period 1|Withdrawal by Subject|2|||
125901051|NCT03400956|452936495|FG002|Treatment Period 1|Withdrawal by Subject|4|||
125901052|NCT03400956|452936493|FG000|Treatment Period 1|Other|1|||
125901053|NCT03400956|452936494|FG001|Treatment Period 1|Other|2|||
125901054|NCT03400956|452936495|FG002|Treatment Period 1|Other|3|||
125901055|NCT03400956|452936493|FG000|Post-treatment Period 1|Adverse Event|0|||
125901056|NCT03400956|452936494|FG001|Post-treatment Period 1|Adverse Event|0|||
125901057|NCT03400956|452936495|FG002|Post-treatment Period 1|Adverse Event|1|||
125901058|NCT03400956|452936493|FG000|Post-treatment Period 1|Physician Decision|2|||
125901059|NCT03400956|452936494|FG001|Post-treatment Period 1|Physician Decision|3|||
125901060|NCT03400956|452936495|FG002|Post-treatment Period 1|Physician Decision|0|||
125901061|NCT03400956|452936493|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
125901062|NCT03400956|452936494|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
125901063|NCT03400956|452936495|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
125901064|NCT03400956|452936493|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
125901065|NCT03400956|452936494|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
125901066|NCT03400956|452936495|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
125901067|NCT03400956|452936493|FG000|Post-treatment Period 1|Other|4|||
125901068|NCT03400956|452936494|FG001|Post-treatment Period 1|Other|3|||
125901069|NCT03400956|452936495|FG002|Post-treatment Period 1|Other|4|||
125901070|NCT03400956|452936493|FG000|Treatment Period 2|Adverse Event|2|||
125901071|NCT03400956|452936494|FG001|Treatment Period 2|Adverse Event|1|||
125901072|NCT03400956|452936495|FG002|Treatment Period 2|Adverse Event|1|||
125901073|NCT03400956|452936493|FG000|Treatment Period 2|Lost to Follow-up|1|||
125901074|NCT03400956|452936494|FG001|Treatment Period 2|Lost to Follow-up|1|||
125901075|NCT03400956|452936495|FG002|Treatment Period 2|Lost to Follow-up|0|||
125901076|NCT03400956|452936493|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125901077|NCT03400956|452936494|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125901078|NCT03400956|452936495|FG002|Treatment Period 2|Withdrawal by Subject|3|||
125901079|NCT03400956|452936493|FG000|Treatment Period 2|Other|1|||
125901080|NCT03400956|452936494|FG001|Treatment Period 2|Other|1|||
125901081|NCT03400956|452936495|FG002|Treatment Period 2|Other|0|||
125901082|NCT03400956|452936493|FG000|Follow-up Period|Withdrawal by Subject|0|||
125901083|NCT03400956|452936494|FG001|Follow-up Period|Withdrawal by Subject|0|||
125901084|NCT03400956|452936495|FG002|Follow-up Period|Withdrawal by Subject|1|||
125901085|NCT03400956|452936493|FG000|Follow-up Period|Other|0|||
125901086|NCT03400956|452936494|FG001|Follow-up Period|Other|0|||
125901087|NCT03400956|452936495|FG002|Follow-up Period|Other|1|||
125901088|NCT00160667|452936496|FG000|Overall Study|Adverse Event|3|||
125901089|NCT00160667|452936497|FG001|Overall Study|Adverse Event|1|||
125901090|NCT00160667|452936498|FG002|Overall Study|Adverse Event|4|||
125901091|NCT00160667|452936496|FG000|Overall Study|Withdrawal by Subject|2|||
125901092|NCT00160667|452936497|FG001|Overall Study|Withdrawal by Subject|0|||
125901093|NCT00160667|452936498|FG002|Overall Study|Withdrawal by Subject|1|||
125901094|NCT00160667|452936496|FG000|Overall Study|Lack of Efficacy|0|||
125901095|NCT00160667|452936497|FG001|Overall Study|Lack of Efficacy|1|||
125901096|NCT00160667|452936498|FG002|Overall Study|Lack of Efficacy|0|||
125901097|NCT00160667|452936496|FG000|Overall Study|Protocol Violation|0|||
125901098|NCT00160667|452936497|FG001|Overall Study|Protocol Violation|1|||
125901099|NCT00160667|452936498|FG002|Overall Study|Protocol Violation|0|||
125901100|NCT00160667|452936496|FG000|Overall Study|Patient decision|0|||
125901101|NCT00160667|452936497|FG001|Overall Study|Patient decision|0|||
125901102|NCT00160667|452936498|FG002|Overall Study|Patient decision|1|||
125901103|NCT00927940|452936499|FG000|Overall Study|Death|1|||
125901104|NCT03044574|452936503|FG000|Overall Study|Lost to Follow-up|37|||
125901105|NCT03044574|452936504|FG001|Overall Study|Lost to Follow-up|45|||
125901106|NCT00890045|452936505|FG000|Overall Study|Death|0|||
125901107|NCT00890045|452936506|FG001|Overall Study|Death|1|||
125901108|NCT00890045|452936505|FG000|Overall Study|Did not receive HeRO Graft|0|||
125901109|NCT00890045|452936506|FG001|Overall Study|Did not receive HeRO Graft|2|||
125901110|NCT00890045|452936505|FG000|Overall Study|Lost to Follow-up|5|||
125901111|NCT00890045|452936506|FG001|Overall Study|Lost to Follow-up|7|||
125901112|NCT00483756|452936511|FG000|Overall Study|Death|2|||
125901113|NCT00483756|452936512|FG001|Overall Study|Death|0|||
125901114|NCT00483756|452936513|FG002|Overall Study|Death|1|||
125901115|NCT00483756|452936511|FG000|Overall Study|Adverse Event|19|||
125901116|NCT00483756|452936512|FG001|Overall Study|Adverse Event|38|||
125901117|NCT00483756|452936513|FG002|Overall Study|Adverse Event|40|||
125901118|NCT00483756|452936511|FG000|Overall Study|Lack of Efficacy|1|||
125901119|NCT00483756|452936512|FG001|Overall Study|Lack of Efficacy|0|||
125901120|NCT00483756|452936513|FG002|Overall Study|Lack of Efficacy|0|||
125901121|NCT00483756|452936511|FG000|Overall Study|Lost to Follow-up|3|||
125901122|NCT00483756|452936512|FG001|Overall Study|Lost to Follow-up|1|||
125901123|NCT00483756|452936513|FG002|Overall Study|Lost to Follow-up|0|||
125901124|NCT00483756|452936511|FG000|Overall Study|Withdrawal by Subject|5|||
125901125|NCT00483756|452936512|FG001|Overall Study|Withdrawal by Subject|3|||
125901126|NCT00483756|452936513|FG002|Overall Study|Withdrawal by Subject|4|||
125901127|NCT00483756|452936511|FG000|Overall Study|Other|2|||
125901128|NCT00483756|452936512|FG001|Overall Study|Other|4|||
125901129|NCT00483756|452936513|FG002|Overall Study|Other|3|||
125901130|NCT00483756|452936511|FG000|Overall Study|Randomized, Not Treated|1|||
125901131|NCT00483756|452936512|FG001|Overall Study|Randomized, Not Treated|4|||
125901132|NCT00483756|452936513|FG002|Overall Study|Randomized, Not Treated|4|||
125901133|NCT00495040|452936514|FG000|Overall Study|Withdrawal by Subject|3|||
125901134|NCT01892384|452936515|FG000|Overall Study|Withdrawal by Subject|1|||
125901135|NCT01892384|452936516|FG001|Overall Study|Withdrawal by Subject|1|||
125901136|NCT01892384|452936517|FG002|Overall Study|Withdrawal by Subject|0|||
125901137|NCT01892384|452936518|FG003|Overall Study|Withdrawal by Subject|0|||
125901138|NCT00592774|452936519|FG000|Overall Study|Adverse Event|5|||
125901139|NCT00592774|452936520|FG001|Overall Study|Adverse Event|19|||
125901140|NCT00592774|452936521|FG002|Overall Study|Adverse Event|2|||
125901141|NCT00592774|452936522|FG003|Overall Study|Adverse Event|14|||
125901142|NCT00592774|452936523|FG004|Overall Study|Adverse Event|8|||
125901143|NCT00592774|452936519|FG000|Overall Study|Protocol Violation|0|||
125901144|NCT00592774|452936520|FG001|Overall Study|Protocol Violation|1|||
125901145|NCT00592774|452936521|FG002|Overall Study|Protocol Violation|0|||
125901146|NCT00592774|452936522|FG003|Overall Study|Protocol Violation|0|||
125901147|NCT00592774|452936523|FG004|Overall Study|Protocol Violation|1|||
125901148|NCT00592774|452936519|FG000|Overall Study|Withdrawal by Subject|3|||
125901149|NCT00592774|452936520|FG001|Overall Study|Withdrawal by Subject|7|||
125901150|NCT00592774|452936521|FG002|Overall Study|Withdrawal by Subject|0|||
125901151|NCT00592774|452936522|FG003|Overall Study|Withdrawal by Subject|0|||
125901152|NCT00592774|452936523|FG004|Overall Study|Withdrawal by Subject|0|||
125901153|NCT00592774|452936519|FG000|Overall Study|Lack of Efficacy|3|||
125901154|NCT00592774|452936520|FG001|Overall Study|Lack of Efficacy|3|||
125901155|NCT00592774|452936521|FG002|Overall Study|Lack of Efficacy|0|||
125901156|NCT00592774|452936522|FG003|Overall Study|Lack of Efficacy|0|||
125901157|NCT00592774|452936523|FG004|Overall Study|Lack of Efficacy|2|||
125901158|NCT00592774|452936519|FG000|Overall Study|Physician Decision|0|||
125901159|NCT00592774|452936520|FG001|Overall Study|Physician Decision|1|||
125901160|NCT00592774|452936521|FG002|Overall Study|Physician Decision|1|||
125901161|NCT00592774|452936522|FG003|Overall Study|Physician Decision|0|||
125901162|NCT00592774|452936523|FG004|Overall Study|Physician Decision|1|||
125901163|NCT00592774|452936519|FG000|Overall Study|Other|0|||
125901164|NCT00592774|452936520|FG001|Overall Study|Other|1|||
125901165|NCT00592774|452936521|FG002|Overall Study|Other|1|||
125901166|NCT00592774|452936522|FG003|Overall Study|Other|0|||
125901167|NCT00592774|452936523|FG004|Overall Study|Other|2|||
125901168|NCT01700439|452936524|FG000|Overall Study|Lost to Follow-up|47|||
125901169|NCT01700439|452936524|FG000|Overall Study|Withdrawal by Subject|183|||
125901170|NCT01700439|452936524|FG000|Overall Study|Death|186|||
125901171|NCT00621621|452936525|FG000|Overall Study|Subjects were exited at EP study|30|||
125901172|NCT00621621|452936526|FG001|Overall Study|Subjects were exited at EP study|0|||
125901173|NCT00906971|452936533|FG000|Overall Study|Withdrawal by Subject|8|||
125901174|NCT00906971|452936534|FG001|Overall Study|Withdrawal by Subject|2|||
125901175|NCT00906971|452936533|FG000|Overall Study|Lost to Follow-up|0|||
125901176|NCT00906971|452936534|FG001|Overall Study|Lost to Follow-up|1|||
125901177|NCT04054947|452936535|FG000|Overall Study|Withdrawal by Subject|1|||
125901178|NCT04054947|452936536|FG001|Overall Study|Withdrawal by Subject|0|||
125901179|NCT04054947|452936535|FG000|Overall Study|Lost to Follow-up|2|||
125901180|NCT04054947|452936536|FG001|Overall Study|Lost to Follow-up|5|||
125901181|NCT01606878|452936537|FG000|Overall Study|Adverse Event|1|||
125901182|NCT01606878|452936538|FG001|Overall Study|Adverse Event|1|||
125901183|NCT01606878|452936539|FG002|Overall Study|Adverse Event|0|||
125901184|NCT01606878|452936540|FG003|Overall Study|Adverse Event|0|||
125901185|NCT01606878|452936541|FG004|Overall Study|Adverse Event|0|||
125901186|NCT01606878|452936542|FG005|Overall Study|Adverse Event|0|||
125901187|NCT01606878|452936543|FG006|Overall Study|Adverse Event|1|||
125901188|NCT01606878|452936544|FG007|Overall Study|Adverse Event|0|||
125901189|NCT01606878|452936545|FG008|Overall Study|Adverse Event|1|||
125901190|NCT01606878|452936546|FG009|Overall Study|Adverse Event|3|||
125901191|NCT01606878|452936547|FG010|Overall Study|Adverse Event|0|||
125901192|NCT01606878|452936537|FG000|Overall Study|Lack of Efficacy|1|||
125901193|NCT01606878|452936538|FG001|Overall Study|Lack of Efficacy|1|||
125901194|NCT01606878|452936539|FG002|Overall Study|Lack of Efficacy|1|||
125901195|NCT01606878|452936540|FG003|Overall Study|Lack of Efficacy|2|||
125901196|NCT01606878|452936541|FG004|Overall Study|Lack of Efficacy|1|||
125901197|NCT01606878|452936542|FG005|Overall Study|Lack of Efficacy|2|||
125901198|NCT01606878|452936543|FG006|Overall Study|Lack of Efficacy|1|||
125901199|NCT01606878|452936544|FG007|Overall Study|Lack of Efficacy|2|||
125901200|NCT01606878|452936545|FG008|Overall Study|Lack of Efficacy|2|||
125901201|NCT01606878|452936546|FG009|Overall Study|Lack of Efficacy|0|||
125901202|NCT01606878|452936547|FG010|Overall Study|Lack of Efficacy|1|||
125901203|NCT01606878|452936537|FG000|Overall Study|Physician Decision|1|||
125901204|NCT01606878|452936538|FG001|Overall Study|Physician Decision|0|||
125901205|NCT01606878|452936539|FG002|Overall Study|Physician Decision|2|||
125901206|NCT01606878|452936540|FG003|Overall Study|Physician Decision|1|||
125901207|NCT01606878|452936541|FG004|Overall Study|Physician Decision|1|||
125901208|NCT01606878|452936542|FG005|Overall Study|Physician Decision|1|||
125901209|NCT01606878|452936543|FG006|Overall Study|Physician Decision|2|||
125901210|NCT01606878|452936544|FG007|Overall Study|Physician Decision|0|||
125901211|NCT01606878|452936545|FG008|Overall Study|Physician Decision|1|||
125901212|NCT01606878|452936546|FG009|Overall Study|Physician Decision|0|||
125901213|NCT01606878|452936547|FG010|Overall Study|Physician Decision|0|||
125901214|NCT01606878|452936537|FG000|Overall Study|Withdrawal by Subject|3|||
125901215|NCT01606878|452936538|FG001|Overall Study|Withdrawal by Subject|2|||
125901216|NCT01606878|452936539|FG002|Overall Study|Withdrawal by Subject|2|||
125901217|NCT01606878|452936540|FG003|Overall Study|Withdrawal by Subject|0|||
125901218|NCT01606878|452936541|FG004|Overall Study|Withdrawal by Subject|1|||
125901219|NCT01606878|452936542|FG005|Overall Study|Withdrawal by Subject|1|||
125901220|NCT01606878|452936543|FG006|Overall Study|Withdrawal by Subject|2|||
125901221|NCT01606878|452936544|FG007|Overall Study|Withdrawal by Subject|1|||
125901222|NCT01606878|452936545|FG008|Overall Study|Withdrawal by Subject|2|||
125901223|NCT01606878|452936546|FG009|Overall Study|Withdrawal by Subject|0|||
125901224|NCT01606878|452936547|FG010|Overall Study|Withdrawal by Subject|2|||
125901225|NCT03473548|452936548|FG000|Overall Study|Did not attempt HST testing|3|||
125901226|NCT03473548|452936549|FG001|Overall Study|Did not attempt HST testing|0|||
125901227|NCT00129311|452936550|FG000|Overall Study|Withdrawal by Subject|12|||
125901228|NCT00129311|452936551|FG001|Overall Study|Withdrawal by Subject|19|||
125901229|NCT03565367|452938131|FG000|Overall Study|No scan due to technical issues|4|||
125901230|NCT03565367|452938132|FG001|Overall Study|No scan due to technical issues|0|||
125901231|NCT04352127|452938133|FG000|Overall Study|Unable to obtain readings|4|||
125901232|NCT04352127|452938134|FG001|Overall Study|Unable to obtain readings|1|||
125901233|NCT05338671|452938135|FG000|Overall Study|Lost to Follow-up|2|||
125901234|NCT05338671|452938136|FG001|Overall Study|Lost to Follow-up|2|||
125901235|NCT05338671|452938135|FG000|Overall Study|Root canal completed in a single visit|1|||
125901236|NCT05338671|452938136|FG001|Overall Study|Root canal completed in a single visit|0|||
125901237|NCT03874429|452938137|FG000|Overall Study|Adverse Event|2|||
125901238|NCT03874429|452938138|FG001|Overall Study|Adverse Event|2|||
125901239|NCT03874429|452938137|FG000|Overall Study|Lack of Efficacy|0|||
125901240|NCT03874429|452938138|FG001|Overall Study|Lack of Efficacy|1|||
125901241|NCT03874429|452938137|FG000|Overall Study|Covid-19 pandemic|4|||
125901242|NCT03874429|452938138|FG001|Overall Study|Covid-19 pandemic|2|||
125901243|NCT00868517|452938141|FG000|Overall Study|Withdrawal by Subject|3|||
125901244|NCT00868517|452938142|FG001|Overall Study|Withdrawal by Subject|3|||
125901245|NCT00868517|452938143|FG002|Overall Study|Withdrawal by Subject|2|||
125901246|NCT00868517|452938141|FG000|Overall Study|Protocol Violation|1|||
125901247|NCT00868517|452938142|FG001|Overall Study|Protocol Violation|1|||
125901248|NCT00868517|452938143|FG002|Overall Study|Protocol Violation|0|||
125901249|NCT00420641|452938146|FG000|Overall Study|Adverse Event|3|||
125901250|NCT00420641|452938147|FG001|Overall Study|Adverse Event|25|||
125901251|NCT00420641|452938148|FG002|Overall Study|Adverse Event|10|||
125901252|NCT00420641|452938146|FG000|Overall Study|Lost to Follow-up|2|||
125901253|NCT00420641|452938147|FG001|Overall Study|Lost to Follow-up|4|||
125901254|NCT00420641|452938148|FG002|Overall Study|Lost to Follow-up|2|||
125901255|NCT00420641|452938146|FG000|Overall Study|Protocol Violation|8|||
125901256|NCT00420641|452938147|FG001|Overall Study|Protocol Violation|8|||
125901257|NCT00420641|452938148|FG002|Overall Study|Protocol Violation|7|||
125901258|NCT00420641|452938146|FG000|Overall Study|Withdrawal by Subject|15|||
125901259|NCT00420641|452938147|FG001|Overall Study|Withdrawal by Subject|21|||
125901260|NCT00420641|452938148|FG002|Overall Study|Withdrawal by Subject|14|||
125901261|NCT00420641|452938146|FG000|Overall Study|Lack of Efficacy|6|||
125901262|NCT00420641|452938147|FG001|Overall Study|Lack of Efficacy|5|||
125901263|NCT00420641|452938148|FG002|Overall Study|Lack of Efficacy|4|||
125901264|NCT00420641|452938146|FG000|Overall Study|Non-compliance|7|||
125901265|NCT00420641|452938147|FG001|Overall Study|Non-compliance|5|||
125901266|NCT00420641|452938148|FG002|Overall Study|Non-compliance|4|||
125901267|NCT00420641|452938146|FG000|Overall Study|Other|4|||
125901268|NCT00420641|452938147|FG001|Overall Study|Other|4|||
125901269|NCT00420641|452938148|FG002|Overall Study|Other|3|||
125901270|NCT02815280|452938151|FG000|Double-Blind Phase|Adverse Event|1|||
125901271|NCT02815280|452938152|FG001|Double-Blind Phase|Adverse Event|1|||
125901272|NCT02815280|452938151|FG000|Double-Blind Phase|Lost to Follow-up|10|||
125901273|NCT02815280|452938152|FG001|Double-Blind Phase|Lost to Follow-up|9|||
125901274|NCT02815280|452938151|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
125901275|NCT02815280|452938152|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
125901276|NCT02815280|452938151|FG000|Double-Blind Phase|Protocol Violation|2|||
125901277|NCT02815280|452938152|FG001|Double-Blind Phase|Protocol Violation|2|||
125901278|NCT02815280|452938151|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
125901279|NCT02815280|452938152|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
125901280|NCT02815280|452938151|FG000|Open-Label Phase|Adverse Event|2|||
125901281|NCT02815280|452938152|FG001|Open-Label Phase|Adverse Event|3|||
125901282|NCT02815280|452938151|FG000|Open-Label Phase|Lost to Follow-up|18|||
125901283|NCT02815280|452938152|FG001|Open-Label Phase|Lost to Follow-up|9|||
125901284|NCT02815280|452938151|FG000|Open-Label Phase|Withdrawal by Subject|33|||
125901285|NCT02815280|452938152|FG001|Open-Label Phase|Withdrawal by Subject|18|||
125901286|NCT02815280|452938151|FG000|Open-Label Phase|Protocol Violation|3|||
125901287|NCT02815280|452938152|FG001|Open-Label Phase|Protocol Violation|0|||
125901288|NCT02815280|452938151|FG000|Open-Label Phase|Administrative|26|||
125901289|NCT02815280|452938152|FG001|Open-Label Phase|Administrative|12|||
125901290|NCT02815280|452938151|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
125901291|NCT02815280|452938152|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
125901292|NCT01534182|452938166|FG000|Overall Study|Administrative problems|1|||
125901293|NCT01534182|452938167|FG001|Overall Study|Administrative problems|0|||
125901294|NCT01534182|452938166|FG000|Overall Study|Withdrawal by Subject|4|||
125901295|NCT01534182|452938167|FG001|Overall Study|Withdrawal by Subject|7|||
125901296|NCT01534182|452938166|FG000|Overall Study|Adverse Event|7|||
125901297|NCT01534182|452938167|FG001|Overall Study|Adverse Event|3|||
125901298|NCT01944839|452938168|FG000|Overall Study|Physician Decision|2|||
125901299|NCT01944839|452938169|FG001|Overall Study|Physician Decision|2|||
125901300|NCT01944839|452938168|FG000|Overall Study|Protocol Violation|0|||
125901301|NCT01944839|452938169|FG001|Overall Study|Protocol Violation|1|||
125901302|NCT01944839|452938168|FG000|Overall Study|Adverse Event|10|||
125901303|NCT01944839|452938169|FG001|Overall Study|Adverse Event|5|||
125901304|NCT01944839|452938168|FG000|Overall Study|Withdrawal by Subject|9|||
125901305|NCT01944839|452938169|FG001|Overall Study|Withdrawal by Subject|17|||
125901306|NCT01944839|452938168|FG000|Overall Study|Lost to Follow-up|1|||
125901307|NCT01944839|452938169|FG001|Overall Study|Lost to Follow-up|0|||
125901308|NCT01944839|452938168|FG000|Overall Study|Subject non-compliance|0|||
125901309|NCT01944839|452938169|FG001|Overall Study|Subject non-compliance|3|||
125901310|NCT05093790|452938173|FG000|Overall Study|Failure to meet continuation criteria|0|||
125901311|NCT05093790|452938174|FG001|Overall Study|Failure to meet continuation criteria|0|||
125901312|NCT05093790|452938175|FG002|Overall Study|Failure to meet continuation criteria|1|||
125901313|NCT05093790|452938176|FG003|Overall Study|Failure to meet continuation criteria|0|||
125901314|NCT05093790|452938173|FG000|Overall Study|Adverse Event|1|||
125901315|NCT05093790|452938174|FG001|Overall Study|Adverse Event|0|||
125901316|NCT05093790|452938175|FG002|Overall Study|Adverse Event|0|||
125901317|NCT05093790|452938176|FG003|Overall Study|Adverse Event|0|||
125901318|NCT04449029|452938179|FG000|Overall Study|Adverse Event|0|||
125901319|NCT04449029|452938180|FG001|Overall Study|Adverse Event|1|||
125901320|NCT04449029|452938181|FG002|Overall Study|Adverse Event|1|||
125901321|NCT04449029|452938182|FG003|Overall Study|Adverse Event|0|||
125901322|NCT04449029|452938183|FG004|Overall Study|Adverse Event|1|||
125901323|NCT04449029|452938184|FG005|Overall Study|Adverse Event|0|||
125901324|NCT04449029|452938185|FG006|Overall Study|Adverse Event|1|||
125901325|NCT04449029|452938186|FG007|Overall Study|Adverse Event|0|||
125901326|NCT04449029|452938179|FG000|Overall Study|Lost to Follow-up|0|||
125901327|NCT04449029|452938180|FG001|Overall Study|Lost to Follow-up|1|||
125901328|NCT04449029|452938181|FG002|Overall Study|Lost to Follow-up|0|||
125901329|NCT04449029|452938182|FG003|Overall Study|Lost to Follow-up|0|||
125901330|NCT04449029|452938183|FG004|Overall Study|Lost to Follow-up|0|||
125901331|NCT04449029|452938184|FG005|Overall Study|Lost to Follow-up|0|||
125901332|NCT04449029|452938185|FG006|Overall Study|Lost to Follow-up|0|||
125901333|NCT04449029|452938186|FG007|Overall Study|Lost to Follow-up|0|||
125901334|NCT04449029|452938179|FG000|Overall Study|Protocol Violation|0|||
125901335|NCT04449029|452938180|FG001|Overall Study|Protocol Violation|1|||
125901336|NCT04449029|452938181|FG002|Overall Study|Protocol Violation|0|||
125901337|NCT04449029|452938182|FG003|Overall Study|Protocol Violation|0|||
125901338|NCT04449029|452938183|FG004|Overall Study|Protocol Violation|0|||
125901339|NCT04449029|452938184|FG005|Overall Study|Protocol Violation|0|||
125901340|NCT04449029|452938185|FG006|Overall Study|Protocol Violation|0|||
125901341|NCT04449029|452938186|FG007|Overall Study|Protocol Violation|0|||
125901342|NCT04449029|452938179|FG000|Overall Study|Physician Decision|0|||
125901343|NCT04449029|452938180|FG001|Overall Study|Physician Decision|0|||
125901344|NCT04449029|452938181|FG002|Overall Study|Physician Decision|0|||
125901345|NCT04449029|452938182|FG003|Overall Study|Physician Decision|0|||
125901346|NCT04449029|452938183|FG004|Overall Study|Physician Decision|0|||
125901347|NCT04449029|452938184|FG005|Overall Study|Physician Decision|1|||
125901348|NCT04449029|452938185|FG006|Overall Study|Physician Decision|0|||
125901349|NCT04449029|452938186|FG007|Overall Study|Physician Decision|0|||
125901350|NCT04449029|452938179|FG000|Overall Study|Withdrawal by Subject|3|||
125901351|NCT04449029|452938180|FG001|Overall Study|Withdrawal by Subject|0|||
125901352|NCT04449029|452938181|FG002|Overall Study|Withdrawal by Subject|1|||
125901353|NCT04449029|452938182|FG003|Overall Study|Withdrawal by Subject|1|||
125901354|NCT04449029|452938183|FG004|Overall Study|Withdrawal by Subject|5|||
125901355|NCT04449029|452938184|FG005|Overall Study|Withdrawal by Subject|1|||
125901356|NCT04449029|452938185|FG006|Overall Study|Withdrawal by Subject|4|||
125901357|NCT04449029|452938186|FG007|Overall Study|Withdrawal by Subject|0|||
125901358|NCT02025556|452938188|FG000|Overall Study|Adverse Event|0|||
125901359|NCT02025556|452938189|FG001|Overall Study|Adverse Event|4|||
125901360|NCT02025556|452938190|FG002|Overall Study|Adverse Event|2|||
125901361|NCT02025556|452938188|FG000|Overall Study|Lack of Efficacy|2|||
125901362|NCT02025556|452938189|FG001|Overall Study|Lack of Efficacy|1|||
125901363|NCT02025556|452938190|FG002|Overall Study|Lack of Efficacy|0|||
125901364|NCT02025556|452938188|FG000|Overall Study|Protocol Violation|2|||
125901365|NCT02025556|452938189|FG001|Overall Study|Protocol Violation|1|||
125901366|NCT02025556|452938190|FG002|Overall Study|Protocol Violation|0|||
125901367|NCT02025556|452938188|FG000|Overall Study|Withdrawal by Subject|0|||
125901368|NCT02025556|452938189|FG001|Overall Study|Withdrawal by Subject|3|||
125901369|NCT02025556|452938190|FG002|Overall Study|Withdrawal by Subject|6|||
125901370|NCT02025556|452938188|FG000|Overall Study|Lost to Follow-up|2|||
125901371|NCT02025556|452938189|FG001|Overall Study|Lost to Follow-up|4|||
125901372|NCT02025556|452938190|FG002|Overall Study|Lost to Follow-up|0|||
125901373|NCT02025556|452938188|FG000|Overall Study|Reason not reported|0|||
125901374|NCT02025556|452938189|FG001|Overall Study|Reason not reported|0|||
125901375|NCT02025556|452938190|FG002|Overall Study|Reason not reported|1|||
125901376|NCT00627445|452938192|FG000|Overall Study|Adverse Event|3|||
125901377|NCT00627445|452938193|FG001|Overall Study|Adverse Event|3|||
125901378|NCT00627445|452938192|FG000|Overall Study|Lack of Efficacy|0|||
125901379|NCT00627445|452938193|FG001|Overall Study|Lack of Efficacy|1|||
125901380|NCT00627445|452938192|FG000|Overall Study|Other|6|||
125901381|NCT00627445|452938193|FG001|Overall Study|Other|8|||
125901382|NCT04098224|452938194|FG000|Overall Study|Adverse Event|1|||
125901383|NCT04098224|452938195|FG001|Overall Study|Adverse Event|0|||
125901384|NCT04098224|452938194|FG000|Overall Study|Physician Decision|1|||
125901385|NCT04098224|452938195|FG001|Overall Study|Physician Decision|0|||
125901386|NCT04098224|452938194|FG000|Overall Study|Patient not required enteral feeding|1|||
125901387|NCT04098224|452938195|FG001|Overall Study|Patient not required enteral feeding|0|||
125901388|NCT04098224|452938194|FG000|Overall Study|Patient failure nasogastric tube|1|||
125901389|NCT04098224|452938195|FG001|Overall Study|Patient failure nasogastric tube|0|||
125901390|NCT04098224|452938194|FG000|Overall Study|Patient early extubation|1|||
125901391|NCT04098224|452938195|FG001|Overall Study|Patient early extubation|3|||
125901392|NCT02217527|452938196|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
125901393|NCT02217527|452938197|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
125901394|NCT02217527|452938196|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
125901395|NCT02217527|452938197|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
125901396|NCT01203852|452938198|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
125901397|NCT01203852|452938198|FG000|Washout 2 Weeks|Physician Decision|46|||
125901398|NCT00247611|452938201|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
125901399|NCT00247611|452938202|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
125901400|NCT00247611|452938201|FG000|Baselined|Completed baseline only|9|||
125901401|NCT00247611|452938202|FG001|Baselined|Completed baseline only|8|||
125901402|NCT01587898|452938203|FG000|Overall Study|Adverse Event|1|||
125901403|NCT01587898|452938204|FG001|Overall Study|Adverse Event|1|||
125901404|NCT01587898|452938205|FG002|Overall Study|Adverse Event|0|||
125901405|NCT01587898|452938206|FG003|Overall Study|Adverse Event|0|||
125901406|NCT01587898|452938203|FG000|Overall Study|Protocol Violation|0|||
125901407|NCT01587898|452938204|FG001|Overall Study|Protocol Violation|2|||
125901408|NCT01587898|452938205|FG002|Overall Study|Protocol Violation|1|||
125901409|NCT01587898|452938206|FG003|Overall Study|Protocol Violation|1|||
125901410|NCT01587898|452938203|FG000|Overall Study|Lost to Follow-up|0|||
125901411|NCT01587898|452938204|FG001|Overall Study|Lost to Follow-up|0|||
125901412|NCT01587898|452938205|FG002|Overall Study|Lost to Follow-up|0|||
125901413|NCT01587898|452938206|FG003|Overall Study|Lost to Follow-up|1|||
125901414|NCT01587898|452938203|FG000|Overall Study|Withdrawal by Subject|2|||
125901415|NCT01587898|452938204|FG001|Overall Study|Withdrawal by Subject|1|||
125901416|NCT01587898|452938205|FG002|Overall Study|Withdrawal by Subject|0|||
125901417|NCT01587898|452938206|FG003|Overall Study|Withdrawal by Subject|0|||
125901418|NCT01587898|452938203|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
125901419|NCT01587898|452938204|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
125901420|NCT01587898|452938205|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
125901421|NCT01587898|452938206|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
125901422|NCT00502203|452938207|FG000|Overall Study|Inevaluable|1|||
125901423|NCT01227824|452938210|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
125901424|NCT01227824|452938211|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
125901425|NCT01227824|452938212|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
125901426|NCT01227824|452938210|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
125901427|NCT01227824|452938211|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
125901428|NCT01227824|452938212|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
125901429|NCT01227824|452938210|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
125901430|NCT01227824|452938211|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
125901431|NCT01227824|452938212|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
125901432|NCT01227824|452938210|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
125901433|NCT01227824|452938211|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
125901434|NCT01227824|452938212|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
125901435|NCT01227824|452938210|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
125901436|NCT01227824|452938211|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
125901437|NCT01227824|452938212|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
125901438|NCT01227824|452938210|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
125901439|NCT01227824|452938211|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
125901440|NCT01227824|452938212|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
125901441|NCT01227824|452938210|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
125901442|NCT01227824|452938211|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
125901443|NCT01227824|452938212|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
125901444|NCT01227824|452938210|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
125901445|NCT01227824|452938211|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
125901446|NCT01227824|452938212|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
125901447|NCT01227824|452938210|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
125901448|NCT01227824|452938211|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
125901449|NCT01227824|452938212|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
125901450|NCT01227824|452938210|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
125901451|NCT01227824|452938211|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
125901452|NCT01227824|452938212|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
125901453|NCT01227824|452938210|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
125901454|NCT01227824|452938211|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
125901455|NCT01227824|452938212|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
125901456|NCT01227824|452938210|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
125901457|NCT01227824|452938211|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
125901458|NCT01227824|452938212|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
125901459|NCT01227824|452938210|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
125901460|NCT01227824|452938211|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
125901461|NCT01227824|452938212|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
125901462|NCT01227824|452938210|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
125901463|NCT01227824|452938211|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
125901464|NCT01227824|452938212|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
125901465|NCT01227824|452938210|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
125901466|NCT01227824|452938211|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
125901467|NCT01227824|452938212|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
125901468|NCT02395302|452938215|FG000|Overall Study|Screen Failure|3|||
125901469|NCT02395302|452938215|FG000|Overall Study|Run In Failure|7|||
125901470|NCT02395302|452938215|FG000|Overall Study|Withdrawal by Subject|2|||
125901471|NCT02395302|452938215|FG000|Overall Study|Physician Decision|2|||
125901472|NCT01306929|452938218|FG000|Overall Study|Withdrawal by Subject|23|||
125901473|NCT01306929|452938218|FG000|Overall Study|Adverse Event|21|||
125901474|NCT01306929|452938218|FG000|Overall Study|Physician Decision|13|||
125901475|NCT01306929|452938218|FG000|Overall Study|Death|8|||
125901476|NCT01306929|452938218|FG000|Overall Study|Withdrawal by parent/guardian|5|||
125901477|NCT01306929|452938218|FG000|Overall Study|Protocol Violation|3|||
125901478|NCT01306929|452938218|FG000|Overall Study|Non-compliance with study drug|2|||
125901479|NCT01306929|452938218|FG000|Overall Study|Lost to Follow-up|2|||
125901480|NCT01306929|452938218|FG000|Overall Study|Various|17|||
125901481|NCT00710762|452938223|FG000|Overall Study|Progressive disease|27|||
125901482|NCT00710762|452938224|FG001|Overall Study|Progressive disease|30|||
125901483|NCT00710762|452938223|FG000|Overall Study|Adverse Event other disease worsening|2|||
125901484|NCT00710762|452938224|FG001|Overall Study|Adverse Event other disease worsening|1|||
125901485|NCT00710762|452938223|FG000|Overall Study|Other Adverse Event|7|||
125901486|NCT00710762|452938224|FG001|Overall Study|Other Adverse Event|7|||
125901487|NCT00710762|452938223|FG000|Overall Study|Lost to Follow-up|1|||
125901488|NCT00710762|452938224|FG001|Overall Study|Lost to Follow-up|0|||
125901489|NCT00710762|452938223|FG000|Overall Study|Reason other than listed above|2|||
125901490|NCT00710762|452938224|FG001|Overall Study|Reason other than listed above|2|||
125901491|NCT01829243|452938234|FG000|First Intervention|Screen Failure|4|||
125901492|NCT01829243|452938235|FG001|First Intervention|Screen Failure|2|||
125901493|NCT00608569|452938239|FG000|Overall Study|Death|4|||
125901494|NCT00608569|452938240|FG001|Overall Study|Death|3|||
125901495|NCT00608569|452938239|FG000|Overall Study|Lost to Follow-up|4|||
125901496|NCT00608569|452938240|FG001|Overall Study|Lost to Follow-up|5|||
125901497|NCT00608569|452938239|FG000|Overall Study|Withdrawal by Subject|1|||
125901498|NCT00608569|452938240|FG001|Overall Study|Withdrawal by Subject|0|||
125901499|NCT00608569|452938239|FG000|Overall Study|Adverse Event|1|||
125901500|NCT00608569|452938240|FG001|Overall Study|Adverse Event|0|||
125901501|NCT00608569|452938239|FG000|Overall Study|Unable to adhere with study requirements|0|||
125901502|NCT00608569|452938240|FG001|Overall Study|Unable to adhere with study requirements|1|||
125901503|NCT00053898|452938241|FG000|Overall Study|No follow-up data from any source|9|||
125901504|NCT00053898|452938242|FG001|Overall Study|No follow-up data from any source|12|||
125901505|NCT00053898|452938241|FG000|Overall Study|Follow-up from telephone contact only|5|||
125901506|NCT00053898|452938242|FG001|Overall Study|Follow-up from telephone contact only|1|||
125901507|NCT01077375|452938247|FG000|Overall Study|Adverse Event|2|||
125901508|NCT01077375|452938248|FG001|Overall Study|Adverse Event|15|||
125901509|NCT01077375|452938247|FG000|Overall Study|Lack of Efficacy|6|||
125901510|NCT01077375|452938248|FG001|Overall Study|Lack of Efficacy|8|||
125901511|NCT01077375|452938247|FG000|Overall Study|Withdrawal by Subject|0|||
125901512|NCT01077375|452938248|FG001|Overall Study|Withdrawal by Subject|6|||
125901513|NCT01077375|452938247|FG000|Overall Study|Lost to Follow-up|2|||
125901514|NCT01077375|452938248|FG001|Overall Study|Lost to Follow-up|5|||
125901515|NCT01077375|452938247|FG000|Overall Study|Other Reason|0|||
125901516|NCT01077375|452938248|FG001|Overall Study|Other Reason|1|||
125901517|NCT00545129|452938249|FG000|Overall Study|Lack of Efficacy|2|||
125901518|NCT00545129|452938250|FG001|Overall Study|Lack of Efficacy|5|||
125901519|NCT00545129|452938249|FG000|Overall Study|Death|2|||
125901520|NCT00545129|452938250|FG001|Overall Study|Death|1|||
125901521|NCT00545129|452938249|FG000|Overall Study|Adverse Event|1|||
125901522|NCT00545129|452938250|FG001|Overall Study|Adverse Event|1|||
125901523|NCT00545129|452938249|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
125901524|NCT00545129|452938250|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
125901525|NCT00545129|452938249|FG000|Overall Study|Other|3|||
125901526|NCT00545129|452938250|FG001|Overall Study|Other|3|||
125901527|NCT01894568|452938251|FG000|Overall Study|Adverse Event|2|||
125901528|NCT01894568|452938252|FG001|Overall Study|Adverse Event|3|||
125901529|NCT01894568|452938251|FG000|Overall Study|Protocol required discontinuation|2|||
125901530|NCT01894568|452938252|FG001|Overall Study|Protocol required discontinuation|1|||
125901531|NCT01894568|452938251|FG000|Overall Study|Withdrawal by Subject|5|||
125901532|NCT01894568|452938252|FG001|Overall Study|Withdrawal by Subject|5|||
125901533|NCT01894568|452938251|FG000|Overall Study|Physician Decision|1|||
125901534|NCT01894568|452938252|FG001|Overall Study|Physician Decision|0|||
125901535|NCT01894568|452938251|FG000|Overall Study|Lost to Follow-up|0|||
125901536|NCT01894568|452938252|FG001|Overall Study|Lost to Follow-up|1|||
125901537|NCT01514370|452938254|FG000|Overall Study|Protocol Violation|2|||
125901538|NCT01514370|452938255|FG001|Overall Study|Protocol Violation|3|||
125901539|NCT01514370|452938254|FG000|Overall Study|Lost to Follow-up|0|||
125901540|NCT01514370|452938255|FG001|Overall Study|Lost to Follow-up|2|||
125901541|NCT01514370|452938254|FG000|Overall Study|Withdrawal by Subject|2|||
125901542|NCT01514370|452938255|FG001|Overall Study|Withdrawal by Subject|1|||
125901543|NCT01514370|452938254|FG000|Overall Study|Adverse Event|1|||
125901544|NCT01514370|452938255|FG001|Overall Study|Adverse Event|3|||
125901545|NCT01514370|452938254|FG000|Overall Study|Other|6|||
125901546|NCT01514370|452938255|FG001|Overall Study|Other|7|||
125901547|NCT01551420|452938256|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
125901548|NCT01551420|452938257|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
125901549|NCT01551420|452938256|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
125901550|NCT01551420|452938257|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
125901551|NCT01551420|452938256|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
125901552|NCT01551420|452938257|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
125901553|NCT01551420|452938256|FG000|Screened for Part B Eligibility|Declined participation|8|||
125901554|NCT01551420|452938257|FG001|Screened for Part B Eligibility|Declined participation|1|||
125901555|NCT01551420|452938256|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
125901556|NCT01551420|452938257|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
125901557|NCT01551420|452938256|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
125901558|NCT01551420|452938257|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
125901559|NCT01551420|452938256|FG000|Home Use (Part B)|Withdrawal by staff|0|||
125901560|NCT01551420|452938257|FG001|Home Use (Part B)|Withdrawal by staff|1|||
125901561|NCT03353740|452938261|FG000|Overall Study|Images for these participants not viable|52|||
125901562|NCT02232880|452938263|FG000|Overall Study|study stopped prior to randomization|1|||
125901563|NCT02545543|452938264|FG000|Overall Study|Lost to Follow-up|67|||
125901564|NCT02545543|452938265|FG001|Overall Study|Lost to Follow-up|25|||
125901565|NCT02545543|452938264|FG000|Overall Study|Physician Decision|3|||
125901566|NCT02545543|452938265|FG001|Overall Study|Physician Decision|0|||
125901567|NCT02545543|452938264|FG000|Overall Study|Withdrawal by Subject|9|||
125901568|NCT02545543|452938265|FG001|Overall Study|Withdrawal by Subject|8|||
125901569|NCT02545543|452938264|FG000|Overall Study|Noncomplaince|1|||
125901570|NCT02545543|452938265|FG001|Overall Study|Noncomplaince|0|||
125901571|NCT02545543|452938264|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
125901572|NCT02545543|452938265|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
125901573|NCT02829944|452938266|FG000|Overall Study|Physician Decision|0|||
125901574|NCT02829944|452938267|FG001|Overall Study|Physician Decision|1|||
125901575|NCT02829944|452938266|FG000|Overall Study|Screen Failure|2|||
125901576|NCT02829944|452938267|FG001|Overall Study|Screen Failure|2|||
125901577|NCT02829944|452938266|FG000|Overall Study|Inadequate Neuraxial Block|1|||
125901578|NCT02829944|452938267|FG001|Overall Study|Inadequate Neuraxial Block|1|||
125901579|NCT02829944|452938266|FG000|Overall Study|Withdrawal by Subject|2|||
125901580|NCT02829944|452938267|FG001|Overall Study|Withdrawal by Subject|1|||
125901581|NCT02829944|452938266|FG000|Overall Study|Catheter Displacement|1|||
125901582|NCT02829944|452938267|FG001|Overall Study|Catheter Displacement|0|||
125901583|NCT02829944|452938266|FG000|Overall Study|Catheter broke|0|||
125901584|NCT02829944|452938267|FG001|Overall Study|Catheter broke|1|||
125901585|NCT02829944|452938266|FG000|Overall Study|Staff unavailable|0|||
125901586|NCT02829944|452938267|FG001|Overall Study|Staff unavailable|1|||
125901587|NCT01395784|452938268|FG000|Overall Study|Lost to Follow-up|7|||
125901588|NCT01395784|452938268|FG000|Overall Study|Withdrawal by Subject|3|||
125901589|NCT01395784|452938268|FG000|Overall Study|Physician Decision|5|||
125901590|NCT04268823|452938269|FG000|Overall Study|Adverse Event|1|||
126110086|NCT02598557|453697630|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
126110087|NCT02598557|453697631|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
125901591|NCT04268823|452938270|FG001|Overall Study|Adverse Event|0|||
125901592|NCT04268823|452938269|FG000|Overall Study|Participant Decision|1|||
125901593|NCT04268823|452938270|FG001|Overall Study|Participant Decision|0|||
126110088|NCT02598557|453697632|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
125901594|NCT02055365|452939727|FG000|Overall Study|Prematurely Withdrawn|1|||
125901595|NCT00603590|452939728|FG000|Overall Study|Did not attend study clinic|39|||
125901596|NCT00603590|452939729|FG001|Overall Study|Did not attend study clinic|30|||
125901597|NCT00603590|452939728|FG000|Overall Study|Refused blood test|5|||
125901598|NCT00603590|452939729|FG001|Overall Study|Refused blood test|1|||
125901599|NCT00603590|452939728|FG000|Overall Study|Patient discontinued study drug|22|||
125901600|NCT00603590|452939729|FG001|Overall Study|Patient discontinued study drug|15|||
125901601|NCT00603590|452939728|FG000|Overall Study|Adverse Event|2|||
125901602|NCT00603590|452939729|FG001|Overall Study|Adverse Event|0|||
125901603|NCT00603590|452939728|FG000|Overall Study|Lost to Follow-up|8|||
125901604|NCT00603590|452939729|FG001|Overall Study|Lost to Follow-up|4|||
125901605|NCT00603590|452939728|FG000|Overall Study|Cardiovascular event|0|||
125901606|NCT00603590|452939729|FG001|Overall Study|Cardiovascular event|1|||
125901607|NCT03699475|452939735|FG000|Overall Study|Death|1|||
125901608|NCT00137839|452939736|FG000|Overall Study|Adverse Event|7|||
125901609|NCT00137839|452939736|FG000|Overall Study|Physician Decision|7|||
125901610|NCT00137839|452939736|FG000|Overall Study|Death|8|||
125901611|NCT00137839|452939736|FG000|Overall Study|Disease Progression|60|||
125901612|NCT00137839|452939736|FG000|Overall Study|Not Start Treatment|1|||
125901613|NCT00137839|452939736|FG000|Overall Study|Prolonged Treatment Delay|1|||
125901614|NCT02882152|452939741|FG000|Overall Study|Lost to Follow-up|1|||
125901615|NCT02882152|452939742|FG001|Overall Study|Lost to Follow-up|0|||
125901616|NCT03739242|452939745|FG000|Overall Study|Withdrawal by Subject|1|||
125901617|NCT03739242|452939746|FG001|Overall Study|Withdrawal by Subject|1|||
125901618|NCT03739242|452939745|FG000|Overall Study|Protocol Violation|0|||
125901619|NCT03739242|452939746|FG001|Overall Study|Protocol Violation|1|||
125901620|NCT01475071|452939753|FG000|Overall Study|Physician Decision|1|||
125901621|NCT01475071|452939753|FG000|Overall Study|Withdrawal by Subject|6|||
125901622|NCT01475071|452939753|FG000|Overall Study|Lost to Follow-up|1|||
125901623|NCT01343823|452939754|FG000|Overall Study|Study Terminated|1|||
125901624|NCT01343823|452939755|FG001|Overall Study|Study Terminated|0|||
125901625|NCT01343823|452939756|FG002|Overall Study|Study Terminated|0|||
125901626|NCT01343823|452939757|FG003|Overall Study|Study Terminated|1|||
125901627|NCT01343823|452939754|FG000|Overall Study|Withdrawal by Subject|1|||
125901628|NCT01343823|452939755|FG001|Overall Study|Withdrawal by Subject|0|||
125901629|NCT01343823|452939756|FG002|Overall Study|Withdrawal by Subject|0|||
125901630|NCT01343823|452939757|FG003|Overall Study|Withdrawal by Subject|0|||
125901631|NCT00923364|452939758|FG000|Overall Study|Death|3|||
125901632|NCT00923364|452939759|FG001|Overall Study|Death|0|||
125901633|NCT00923364|452939758|FG000|Overall Study|Did not go to transplant|1|||
125901634|NCT00923364|452939759|FG001|Overall Study|Did not go to transplant|0|||
125901635|NCT01752036|452939760|FG000|Overall Study|Death|2|||
125901636|NCT01011478|452939761|FG000|Overall Study|No follow up data|12|||
125901637|NCT01011478|452939762|FG001|Overall Study|No follow up data|7|||
125901638|NCT01437995|452939763|FG000|Overall Study|Lost to Follow-up|11|||
125901639|NCT01437995|452939764|FG001|Overall Study|Lost to Follow-up|18|||
125901640|NCT01437995|452939765|FG002|Overall Study|Lost to Follow-up|20|||
125901641|NCT00978432|452939766|FG000|Overall Study|Withdrawal by Subject|0|||
125901642|NCT00978432|452939767|FG001|Overall Study|Withdrawal by Subject|0|||
125901643|NCT00978432|452939768|FG002|Overall Study|Withdrawal by Subject|1|||
125901644|NCT00978432|452939766|FG000|Overall Study|Lack of Efficacy|1|||
125901645|NCT00978432|452939767|FG001|Overall Study|Lack of Efficacy|1|||
125901646|NCT00978432|452939768|FG002|Overall Study|Lack of Efficacy|3|||
125901647|NCT00978432|452939766|FG000|Overall Study|Adverse Event|2|||
125901648|NCT00978432|452939767|FG001|Overall Study|Adverse Event|0|||
125901649|NCT00978432|452939768|FG002|Overall Study|Adverse Event|1|||
125901650|NCT04456673|452939769|FG000|Overall Study|Adverse Event|7|||
125901651|NCT04456673|452939770|FG001|Overall Study|Adverse Event|14|||
125901652|NCT04456673|452939769|FG000|Overall Study|Poor compliance to protocol|1|||
125901653|NCT04456673|452939770|FG001|Overall Study|Poor compliance to protocol|0|||
125901654|NCT04456673|452939769|FG000|Overall Study|Withdrawal by Subject|31|||
125901655|NCT04456673|452939770|FG001|Overall Study|Withdrawal by Subject|23|||
125901656|NCT04456673|452939769|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
125901657|NCT04456673|452939770|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
125901658|NCT04391049|452939771|FG000|Overall Study|Protocol Violation|1|||
125901659|NCT00246571|452939774|FG000|Overall Study|Adverse Event|7|||
125901660|NCT00246571|452939775|FG001|Overall Study|Adverse Event|0|||
125901661|NCT00246571|452939774|FG000|Overall Study|Protocol Violation|0|||
125901662|NCT00246571|452939775|FG001|Overall Study|Protocol Violation|1|||
125901663|NCT00246571|452939774|FG000|Overall Study|Withdrawal by Subject|2|||
125901664|NCT00246571|452939775|FG001|Overall Study|Withdrawal by Subject|3|||
125901665|NCT00246571|452939774|FG000|Overall Study|Lack of Efficacy|84|||
125901666|NCT00246571|452939775|FG001|Overall Study|Lack of Efficacy|21|||
125901667|NCT00246571|452939774|FG000|Overall Study|Death|17|||
125901668|NCT00246571|452939775|FG001|Overall Study|Death|3|||
125901669|NCT00246571|452939774|FG000|Overall Study|Sponsor|0|||
125901670|NCT00246571|452939775|FG001|Overall Study|Sponsor|1|||
125901671|NCT00246571|452939774|FG000|Overall Study|Did not meet entrance criteria|2|||
125901672|NCT00246571|452939775|FG001|Overall Study|Did not meet entrance criteria|1|||
125901673|NCT00246571|452939774|FG000|Overall Study|Laboratory abnormalities|1|||
125901674|NCT00246571|452939775|FG001|Overall Study|Laboratory abnormalities|0|||
125901675|NCT00246571|452939774|FG000|Overall Study|Crossover participants|0|||
125901676|NCT00246571|452939775|FG001|Overall Study|Crossover participants|74|||
125901677|NCT02160002|452939776|FG000|Overall Study|Withdrawal by Subject|2|||
125901678|NCT02160002|452939777|FG001|Overall Study|Withdrawal by Subject|1|||
125901679|NCT04896229|452939779|FG000|Overall Study|Lost to Follow-up|113|||
125901680|NCT04896229|452939780|FG001|Overall Study|Lost to Follow-up|113|||
125901681|NCT04418661|452939781|FG000|Overall Study|Adverse Event|0|||
125901682|NCT04418661|452939782|FG001|Overall Study|Adverse Event|1|||
125901683|NCT04418661|452939783|FG002|Overall Study|Adverse Event|5|||
125901684|NCT04418661|452939784|FG003|Overall Study|Adverse Event|3|||
125901685|NCT04418661|452939785|FG004|Overall Study|Adverse Event|0|||
125901686|NCT04418661|452939786|FG005|Overall Study|Adverse Event|2|||
125901687|NCT04418661|452939781|FG000|Overall Study|Progressive disease|4|||
125901688|NCT04418661|452939782|FG001|Overall Study|Progressive disease|11|||
125901689|NCT04418661|452939783|FG002|Overall Study|Progressive disease|6|||
125901690|NCT04418661|452939784|FG003|Overall Study|Progressive disease|11|||
125901691|NCT04418661|452939785|FG004|Overall Study|Progressive disease|1|||
125901692|NCT04418661|452939786|FG005|Overall Study|Progressive disease|12|||
125901693|NCT04418661|452939781|FG000|Overall Study|Withdrawal by Subject|0|||
125901694|NCT04418661|452939782|FG001|Overall Study|Withdrawal by Subject|1|||
125901695|NCT04418661|452939783|FG002|Overall Study|Withdrawal by Subject|0|||
125901696|NCT04418661|452939784|FG003|Overall Study|Withdrawal by Subject|1|||
125901697|NCT04418661|452939785|FG004|Overall Study|Withdrawal by Subject|0|||
125901698|NCT04418661|452939786|FG005|Overall Study|Withdrawal by Subject|0|||
125901699|NCT04418661|452939781|FG000|Overall Study|Other|0|||
125901700|NCT04418661|452939782|FG001|Overall Study|Other|0|||
125901701|NCT04418661|452939783|FG002|Overall Study|Other|1|||
125901702|NCT04418661|452939784|FG003|Overall Study|Other|3|||
125901703|NCT04418661|452939785|FG004|Overall Study|Other|0|||
125901704|NCT04418661|452939786|FG005|Overall Study|Other|1|||
125901705|NCT00159822|452939789|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
125901706|NCT00159822|452939789|FG000|Voriconazole Treatment Period|Adverse Event|9|||
125901707|NCT00159822|452939789|FG000|Voriconazole Treatment Period|Death|4|||
125901708|NCT00159822|452939789|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
125901709|NCT00159822|452939789|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
125901710|NCT00159822|452939789|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
125901711|NCT00159822|452939789|FG000|Post-treatment Follow-up Period|Death|1|||
125901712|NCT00159822|452939789|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
125901713|NCT00159822|452939789|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
125901714|NCT00713310|452939790|FG000|Overall Study|Adverse Event|5|||
125901715|NCT00713310|452939791|FG001|Overall Study|Adverse Event|2|||
125901716|NCT00713310|452939790|FG000|Overall Study|Lack of Efficacy|0|||
125901717|NCT00713310|452939791|FG001|Overall Study|Lack of Efficacy|2|||
125901718|NCT00713310|452939790|FG000|Overall Study|Withdrawal by Subject|0|||
125901719|NCT00713310|452939791|FG001|Overall Study|Withdrawal by Subject|2|||
125901720|NCT00275821|452939793|FG000|Overall Study|Adverse Event|4|||
125901721|NCT00275821|452939794|FG001|Overall Study|Adverse Event|12|||
125901722|NCT00275821|452939795|FG002|Overall Study|Adverse Event|5|||
125901723|NCT00275821|452939793|FG000|Overall Study|Administrative problems|3|||
125901724|NCT00275821|452939794|FG001|Overall Study|Administrative problems|4|||
125901725|NCT00275821|452939795|FG002|Overall Study|Administrative problems|4|||
125901726|NCT00275821|452939793|FG000|Overall Study|Withdrawal by Subject|0|||
125901727|NCT00275821|452939794|FG001|Overall Study|Withdrawal by Subject|2|||
125901728|NCT00275821|452939795|FG002|Overall Study|Withdrawal by Subject|1|||
125901729|NCT00275821|452939793|FG000|Overall Study|Lost to Follow-up|0|||
125901730|NCT00275821|452939794|FG001|Overall Study|Lost to Follow-up|1|||
125901731|NCT00275821|452939795|FG002|Overall Study|Lost to Follow-up|1|||
125901732|NCT00275821|452939793|FG000|Overall Study|Death|0|||
125901733|NCT00275821|452939794|FG001|Overall Study|Death|2|||
125901734|NCT00275821|452939795|FG002|Overall Study|Death|1|||
125901735|NCT00275821|452939793|FG000|Overall Study|Lack of Efficacy|2|||
125901736|NCT00275821|452939794|FG001|Overall Study|Lack of Efficacy|1|||
125901737|NCT00275821|452939795|FG002|Overall Study|Lack of Efficacy|0|||
125901738|NCT00275821|452939793|FG000|Overall Study|Protocol Violation|5|||
125901739|NCT00275821|452939794|FG001|Overall Study|Protocol Violation|1|||
125901740|NCT00275821|452939795|FG002|Overall Study|Protocol Violation|0|||
125901741|NCT00329901|452939796|FG000|Overall Study|Withdrawal by Subject|4|||
125901742|NCT00329901|452939797|FG001|Overall Study|Withdrawal by Subject|3|||
125901743|NCT00329901|452939798|FG002|Overall Study|Withdrawal by Subject|2|||
125901744|NCT00329901|452939796|FG000|Overall Study|Lost to Follow-up|2|||
125901745|NCT00329901|452939797|FG001|Overall Study|Lost to Follow-up|0|||
125901746|NCT00329901|452939798|FG002|Overall Study|Lost to Follow-up|1|||
125901747|NCT00329901|452939796|FG000|Overall Study|Protocol Violation|1|||
125901748|NCT00329901|452939797|FG001|Overall Study|Protocol Violation|0|||
125901749|NCT00329901|452939798|FG002|Overall Study|Protocol Violation|1|||
125901750|NCT00329901|452939796|FG000|Overall Study|Unable to classify|2|||
125901751|NCT00329901|452939797|FG001|Overall Study|Unable to classify|2|||
125901752|NCT00329901|452939798|FG002|Overall Study|Unable to classify|0|||
125901753|NCT00992589|452939799|FG000|Open-Label Phase|Adverse Event|4|||
125901754|NCT00992589|452939800|FG001|Open-Label Phase|Adverse Event|0|||
125901755|NCT00992589|452939801|FG002|Open-Label Phase|Adverse Event|0|||
125901756|NCT00992589|452939802|FG003|Open-Label Phase|Adverse Event|0|||
125901757|NCT00992589|452939799|FG000|Open-Label Phase|Withdrawal by Subject|20|||
125901758|NCT00992589|452939800|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125901759|NCT00992589|452939801|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125901760|NCT00992589|452939802|FG003|Open-Label Phase|Withdrawal by Subject|0|||
125901761|NCT00992589|452939799|FG000|Open-Label Phase|Lost to Follow-up|1|||
125901762|NCT00992589|452939800|FG001|Open-Label Phase|Lost to Follow-up|0|||
125901763|NCT00992589|452939801|FG002|Open-Label Phase|Lost to Follow-up|0|||
125901764|NCT00992589|452939802|FG003|Open-Label Phase|Lost to Follow-up|0|||
125901765|NCT00992589|452939799|FG000|Open-Label Phase|Protocol Violation|3|||
125901766|NCT00992589|452939800|FG001|Open-Label Phase|Protocol Violation|0|||
125901767|NCT00992589|452939801|FG002|Open-Label Phase|Protocol Violation|0|||
125901768|NCT00992589|452939802|FG003|Open-Label Phase|Protocol Violation|0|||
125901769|NCT00992589|452939799|FG000|Open-Label Phase|Physician Decision|4|||
125901770|NCT00992589|452939800|FG001|Open-Label Phase|Physician Decision|0|||
125901771|NCT00992589|452939801|FG002|Open-Label Phase|Physician Decision|0|||
125901772|NCT00992589|452939802|FG003|Open-Label Phase|Physician Decision|0|||
125901773|NCT00992589|452939799|FG000|Open-Label Phase|Other|45|||
125901774|NCT00992589|452939800|FG001|Open-Label Phase|Other|0|||
125901775|NCT00992589|452939801|FG002|Open-Label Phase|Other|0|||
125901776|NCT00992589|452939802|FG003|Open-Label Phase|Other|0|||
125901777|NCT00992589|452939799|FG000|Double-Blind Phase|Adverse Event|0|||
125901778|NCT00992589|452939800|FG001|Double-Blind Phase|Adverse Event|6|||
125901779|NCT00992589|452939801|FG002|Double-Blind Phase|Adverse Event|2|||
125901780|NCT00992589|452939802|FG003|Double-Blind Phase|Adverse Event|3|||
125901781|NCT00992589|452939799|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125901782|NCT00992589|452939800|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
125901783|NCT00992589|452939801|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
125901784|NCT00992589|452939802|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
125901785|NCT00992589|452939799|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125901786|NCT00992589|452939800|FG001|Double-Blind Phase|Lost to Follow-up|0|||
125901787|NCT00992589|452939801|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125901788|NCT00992589|452939802|FG003|Double-Blind Phase|Lost to Follow-up|2|||
125901789|NCT00992589|452939799|FG000|Double-Blind Phase|Other|0|||
125901790|NCT00992589|452939800|FG001|Double-Blind Phase|Other|1|||
125901791|NCT00992589|452939801|FG002|Double-Blind Phase|Other|6|||
125901792|NCT00992589|452939802|FG003|Double-Blind Phase|Other|3|||
125901793|NCT01215916|452939803|FG000|Overall Study|Progressive Disease|0|||
125901794|NCT01215916|452939804|FG001|Overall Study|Progressive Disease|2|||
125901795|NCT01215916|452939805|FG002|Overall Study|Progressive Disease|1|||
125901796|NCT01215916|452939806|FG003|Overall Study|Progressive Disease|2|||
125901797|NCT01215916|452939807|FG004|Overall Study|Progressive Disease|5|||
125901798|NCT01215916|452939808|FG005|Overall Study|Progressive Disease|4|||
125901799|NCT01215916|452939809|FG006|Overall Study|Progressive Disease|5|||
125901800|NCT01215916|452939810|FG007|Overall Study|Progressive Disease|3|||
125901801|NCT01215916|452939811|FG008|Overall Study|Progressive Disease|1|||
125901802|NCT01215916|452939803|FG000|Overall Study|Adverse Event|1|||
125901803|NCT01215916|452939804|FG001|Overall Study|Adverse Event|1|||
125901804|NCT01215916|452939805|FG002|Overall Study|Adverse Event|0|||
125901805|NCT01215916|452939806|FG003|Overall Study|Adverse Event|1|||
125901806|NCT01215916|452939807|FG004|Overall Study|Adverse Event|0|||
125901807|NCT01215916|452939808|FG005|Overall Study|Adverse Event|0|||
125901808|NCT01215916|452939809|FG006|Overall Study|Adverse Event|3|||
125901809|NCT01215916|452939810|FG007|Overall Study|Adverse Event|0|||
125901810|NCT01215916|452939811|FG008|Overall Study|Adverse Event|0|||
125901811|NCT01215916|452939803|FG000|Overall Study|Withdrawal by Subject|0|||
125901812|NCT01215916|452939804|FG001|Overall Study|Withdrawal by Subject|1|||
125901813|NCT01215916|452939805|FG002|Overall Study|Withdrawal by Subject|1|||
125901814|NCT01215916|452939806|FG003|Overall Study|Withdrawal by Subject|2|||
125901815|NCT01215916|452939807|FG004|Overall Study|Withdrawal by Subject|0|||
125901816|NCT01215916|452939808|FG005|Overall Study|Withdrawal by Subject|0|||
125901817|NCT01215916|452939809|FG006|Overall Study|Withdrawal by Subject|1|||
125901818|NCT01215916|452939810|FG007|Overall Study|Withdrawal by Subject|0|||
125901819|NCT01215916|452939811|FG008|Overall Study|Withdrawal by Subject|0|||
125901820|NCT01215916|452939803|FG000|Overall Study|Death|0|||
125901821|NCT01215916|452939804|FG001|Overall Study|Death|1|||
125901822|NCT01215916|452939805|FG002|Overall Study|Death|0|||
125901823|NCT01215916|452939806|FG003|Overall Study|Death|0|||
125901824|NCT01215916|452939807|FG004|Overall Study|Death|1|||
125901825|NCT01215916|452939808|FG005|Overall Study|Death|0|||
125901826|NCT01215916|452939809|FG006|Overall Study|Death|0|||
125901827|NCT01215916|452939810|FG007|Overall Study|Death|0|||
125901828|NCT01215916|452939811|FG008|Overall Study|Death|1|||
125901829|NCT01215916|452939803|FG000|Overall Study|Physician Decision|0|||
125901830|NCT01215916|452939804|FG001|Overall Study|Physician Decision|0|||
125901831|NCT01215916|452939805|FG002|Overall Study|Physician Decision|1|||
125901832|NCT01215916|452939806|FG003|Overall Study|Physician Decision|1|||
125901833|NCT01215916|452939807|FG004|Overall Study|Physician Decision|0|||
125901834|NCT01215916|452939808|FG005|Overall Study|Physician Decision|0|||
125901835|NCT01215916|452939809|FG006|Overall Study|Physician Decision|0|||
125901836|NCT01215916|452939810|FG007|Overall Study|Physician Decision|0|||
125901837|NCT01215916|452939811|FG008|Overall Study|Physician Decision|0|||
125901838|NCT02142387|452939812|FG000|Overall Study|<19 years old|49|||
125901839|NCT02142387|452939813|FG001|Overall Study|<19 years old|326|||
125901840|NCT02142387|452939812|FG000|Overall Study|non-cardiac etiology|504|||
125901841|NCT02142387|452939813|FG001|Overall Study|non-cardiac etiology|3431|||
125901842|NCT02142387|452939812|FG000|Overall Study|CPR not performed|74|||
125901843|NCT02142387|452939813|FG001|Overall Study|CPR not performed|473|||
125901844|NCT02142387|452939812|FG000|Overall Study|witnessed by paramedic|139|||
125901845|NCT02142387|452939813|FG001|Overall Study|witnessed by paramedic|917|||
125901846|NCT02142387|452939812|FG000|Overall Study|incomplete data|1|||
125901847|NCT02142387|452939813|FG001|Overall Study|incomplete data|9|||
125901848|NCT02142387|452939812|FG000|Overall Study|occurred not at home|298|||
125901849|NCT02142387|452939813|FG001|Overall Study|occurred not at home|2474|||
125901850|NCT05028361|452939814|FG000|Overall Study|Withdrawal by Subject|1|||
125901851|NCT05028361|452939815|FG001|Overall Study|Withdrawal by Subject|0|||
125901852|NCT00779259|452939820|FG000|Quinine Alone|Adverse Event|2|||
125901853|NCT02047318|452939824|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
125901854|NCT02047318|452939824|FG000|Core Study Period|Adverse Event|1|||
125901855|NCT02047318|452939824|FG000|Core Study Period|Withdrawal by caregiver|3|||
125901856|NCT02047318|452939824|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
125901857|NCT02296138|452939825|FG000|Overall Study|Adverse Event|348|||
125901858|NCT02296138|452939826|FG001|Overall Study|Adverse Event|259|||
125901859|NCT02296138|452939825|FG000|Overall Study|Lack of Efficacy|59|||
125901860|NCT02296138|452939826|FG001|Overall Study|Lack of Efficacy|37|||
125901861|NCT02296138|452939825|FG000|Overall Study|Protocol Violation|35|||
125901862|NCT02296138|452939826|FG001|Overall Study|Protocol Violation|36|||
125901863|NCT02296138|452939825|FG000|Overall Study|Lost to Follow-up|9|||
125901864|NCT02296138|452939826|FG001|Overall Study|Lost to Follow-up|12|||
125901865|NCT02296138|452939825|FG000|Overall Study|Withdrawal by Subject|184|||
125901866|NCT02296138|452939826|FG001|Overall Study|Withdrawal by Subject|131|||
125901867|NCT02296138|452939825|FG000|Overall Study|Not Treated|1|||
125901868|NCT02296138|452939826|FG001|Overall Study|Not Treated|1|||
125901869|NCT02296138|452939825|FG000|Overall Study|Patients with data irregularities|10|||
125901870|NCT02296138|452939826|FG001|Overall Study|Patients with data irregularities|11|||
125901871|NCT02296138|452939825|FG000|Overall Study|Other than specified|15|||
125901872|NCT02296138|452939826|FG001|Overall Study|Other than specified|13|||
125901873|NCT00711516|452939827|FG000|Overall Study|Adverse Event|1|||
125901874|NCT00711516|452939828|FG001|Overall Study|Adverse Event|1|||
125901875|NCT00711516|452939827|FG000|Overall Study|Withdrawal by Subject|0|||
125901876|NCT00711516|452939828|FG001|Overall Study|Withdrawal by Subject|1|||
125901877|NCT00711516|452939827|FG000|Overall Study|Protocol Violation|0|||
125901878|NCT00711516|452939828|FG001|Overall Study|Protocol Violation|1|||
125901879|NCT01029405|452939832|FG000|Overall Study|Withdrawal by Subject|0|||
125901880|NCT01029405|452939833|FG001|Overall Study|Withdrawal by Subject|1|||
125901881|NCT01029405|452939834|FG002|Overall Study|Withdrawal by Subject|2|||
125901882|NCT01029405|452939835|FG003|Overall Study|Withdrawal by Subject|0|||
125901883|NCT01029405|452939832|FG000|Overall Study|Protocol Violation|0|||
125901884|NCT01029405|452939833|FG001|Overall Study|Protocol Violation|0|||
125901885|NCT01029405|452939834|FG002|Overall Study|Protocol Violation|0|||
125901886|NCT01029405|452939835|FG003|Overall Study|Protocol Violation|1|||
125901887|NCT01029405|452939832|FG000|Overall Study|Adverse Event|0|||
125901888|NCT01029405|452939833|FG001|Overall Study|Adverse Event|0|||
125901889|NCT01029405|452939834|FG002|Overall Study|Adverse Event|1|||
125901890|NCT01029405|452939835|FG003|Overall Study|Adverse Event|1|||
125901891|NCT01029405|452939832|FG000|Overall Study|Lost to Follow-up|2|||
125901892|NCT01029405|452939833|FG001|Overall Study|Lost to Follow-up|1|||
125901893|NCT01029405|452939834|FG002|Overall Study|Lost to Follow-up|1|||
125901894|NCT01029405|452939835|FG003|Overall Study|Lost to Follow-up|2|||
125901895|NCT01029405|452939832|FG000|Overall Study|Other|0|||
125901896|NCT01029405|452939833|FG001|Overall Study|Other|1|||
125901897|NCT01029405|452939834|FG002|Overall Study|Other|0|||
125901898|NCT01029405|452939835|FG003|Overall Study|Other|1|||
125901899|NCT00409175|452939836|FG000|Overall Study|Adverse Event|4|||
125901900|NCT00409175|452939837|FG001|Overall Study|Adverse Event|3|||
125901901|NCT00409175|452939836|FG000|Overall Study|Withdrawal by Subject|1|||
125901902|NCT00409175|452939837|FG001|Overall Study|Withdrawal by Subject|2|||
125901903|NCT00409175|452939836|FG000|Overall Study|Negative genotype|0|||
125901904|NCT00409175|452939837|FG001|Overall Study|Negative genotype|1|||
125901905|NCT00409175|452939836|FG000|Overall Study|Liver transplantation|13|||
125901906|NCT00409175|452939837|FG001|Overall Study|Liver transplantation|13|||
125901907|NCT02108262|452939840|FG000|Overall Study|Non-compliance|0|||
125901908|NCT02108262|452939841|FG001|Overall Study|Non-compliance|2|||
125901909|NCT02108262|452939842|FG002|Overall Study|Non-compliance|1|||
125901910|NCT02108262|452939843|FG003|Overall Study|Non-compliance|1|||
125901911|NCT02108262|452939840|FG000|Overall Study|Randomized by error/screen failure|0|||
125901912|NCT02108262|452939841|FG001|Overall Study|Randomized by error/screen failure|0|||
125901913|NCT02108262|452939842|FG002|Overall Study|Randomized by error/screen failure|1|||
125901914|NCT02108262|452939843|FG003|Overall Study|Randomized by error/screen failure|0|||
125901915|NCT02108262|452939840|FG000|Overall Study|Distance to center|0|||
125901916|NCT02108262|452939841|FG001|Overall Study|Distance to center|1|||
125901917|NCT02108262|452939842|FG002|Overall Study|Distance to center|1|||
125901918|NCT02108262|452939843|FG003|Overall Study|Distance to center|0|||
125901919|NCT02108262|452939840|FG000|Overall Study|Adverse Event|0|||
125901920|NCT02108262|452939841|FG001|Overall Study|Adverse Event|11|||
125901921|NCT02108262|452939842|FG002|Overall Study|Adverse Event|6|||
125901922|NCT02108262|452939843|FG003|Overall Study|Adverse Event|12|||
125901923|NCT02108262|452939840|FG000|Overall Study|Death|0|||
125901924|NCT02108262|452939841|FG001|Overall Study|Death|2|||
125901925|NCT02108262|452939842|FG002|Overall Study|Death|2|||
125901926|NCT02108262|452939843|FG003|Overall Study|Death|1|||
125901927|NCT02108262|452939840|FG000|Overall Study|Lost to Follow-up|0|||
126059781|NCT02538094|453512559|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
126059782|NCT02538094|453512560|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
125901928|NCT02108262|452939841|FG001|Overall Study|Lost to Follow-up|0|||
125901929|NCT02108262|452939842|FG002|Overall Study|Lost to Follow-up|1|||
125901930|NCT02108262|452939843|FG003|Overall Study|Lost to Follow-up|0|||
125901931|NCT02108262|452939840|FG000|Overall Study|Physician Decision|0|||
125901932|NCT02108262|452939841|FG001|Overall Study|Physician Decision|0|||
125901933|NCT02108262|452939842|FG002|Overall Study|Physician Decision|2|||
125901934|NCT02108262|452939843|FG003|Overall Study|Physician Decision|0|||
125901935|NCT02108262|452939840|FG000|Overall Study|Withdrawal by Subject|0|||
125901936|NCT02108262|452939841|FG001|Overall Study|Withdrawal by Subject|7|||
125901937|NCT02108262|452939842|FG002|Overall Study|Withdrawal by Subject|3|||
125901938|NCT02108262|452939843|FG003|Overall Study|Withdrawal by Subject|4|||
125901939|NCT02108262|452939840|FG000|Overall Study|Due to key hepatic values|0|||
125901940|NCT02108262|452939841|FG001|Overall Study|Due to key hepatic values|1|||
125901941|NCT02108262|452939842|FG002|Overall Study|Due to key hepatic values|0|||
125901942|NCT02108262|452939843|FG003|Overall Study|Due to key hepatic values|0|||
125901943|NCT02108262|452939840|FG000|Overall Study|Unable to contact patient|0|||
125901944|NCT02108262|452939841|FG001|Overall Study|Unable to contact patient|3|||
125901945|NCT02108262|452939842|FG002|Overall Study|Unable to contact patient|1|||
125901946|NCT02108262|452939843|FG003|Overall Study|Unable to contact patient|2|||
125901947|NCT02108262|452939840|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
125901948|NCT02108262|452939841|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
125901949|NCT02108262|452939842|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
125901950|NCT02108262|452939843|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
125901951|NCT02108262|452939840|FG000|Overall Study|Patient did not want another infusion|0|||
125901952|NCT02108262|452939841|FG001|Overall Study|Patient did not want another infusion|3|||
125901953|NCT02108262|452939842|FG002|Overall Study|Patient did not want another infusion|3|||
125901954|NCT02108262|452939843|FG003|Overall Study|Patient did not want another infusion|2|||
125901955|NCT02108262|452939840|FG000|Overall Study|Vacation|0|||
125901956|NCT02108262|452939841|FG001|Overall Study|Vacation|1|||
125901957|NCT02108262|452939842|FG002|Overall Study|Vacation|0|||
125901958|NCT02108262|452939843|FG003|Overall Study|Vacation|0|||
125901959|NCT02108262|452939840|FG000|Overall Study|Patient decision|0|||
125901960|NCT02108262|452939841|FG001|Overall Study|Patient decision|7|||
125901961|NCT02108262|452939842|FG002|Overall Study|Patient decision|9|||
125901962|NCT02108262|452939843|FG003|Overall Study|Patient decision|14|||
125901963|NCT02108262|452939840|FG000|Overall Study|Missed IV due to pharmacy error|0|||
125901964|NCT02108262|452939841|FG001|Overall Study|Missed IV due to pharmacy error|0|||
125901965|NCT02108262|452939842|FG002|Overall Study|Missed IV due to pharmacy error|1|||
125901966|NCT02108262|452939843|FG003|Overall Study|Missed IV due to pharmacy error|0|||
125901967|NCT00761150|452939844|FG000|Open-label Period|Adverse Event|36|||
125901968|NCT00761150|452939845|FG001|Open-label Period|Adverse Event|0|||
125901969|NCT00761150|452939846|FG002|Open-label Period|Adverse Event|0|||
125901970|NCT00761150|452939844|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
125901971|NCT00761150|452939845|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
125901972|NCT00761150|452939846|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
125901973|NCT00761150|452939844|FG000|Open-label Period|Lost to Follow-up|7|||
125901974|NCT00761150|452939845|FG001|Open-label Period|Lost to Follow-up|0|||
125901975|NCT00761150|452939846|FG002|Open-label Period|Lost to Follow-up|0|||
125901976|NCT00761150|452939844|FG000|Open-label Period|Lack of Efficacy|4|||
125901977|NCT00761150|452939845|FG001|Open-label Period|Lack of Efficacy|0|||
125901978|NCT00761150|452939846|FG002|Open-label Period|Lack of Efficacy|0|||
125901979|NCT00761150|452939844|FG000|Open-label Period|Withdrawal by Subject|5|||
125901980|NCT00761150|452939845|FG001|Open-label Period|Withdrawal by Subject|0|||
125901981|NCT00761150|452939846|FG002|Open-label Period|Withdrawal by Subject|0|||
125901982|NCT00761150|452939844|FG000|Open-label Period|Noncompliance|2|||
125901983|NCT00761150|452939845|FG001|Open-label Period|Noncompliance|0|||
125901984|NCT00761150|452939846|FG002|Open-label Period|Noncompliance|0|||
125901985|NCT00761150|452939844|FG000|Open-label Period|Other|5|||
125901986|NCT00761150|452939845|FG001|Open-label Period|Other|0|||
125901987|NCT00761150|452939846|FG002|Open-label Period|Other|0|||
125901988|NCT00761150|452939844|FG000|Double-blind Period|Lack of Efficacy|0|||
126110089|NCT02598557|453697630|FG000|Overall Study|Adverse Event|1|||
125901989|NCT00761150|452939845|FG001|Double-blind Period|Lack of Efficacy|2|||
125901990|NCT00761150|452939846|FG002|Double-blind Period|Lack of Efficacy|19|||
125901991|NCT00761150|452939844|FG000|Double-blind Period|Adverse Event|0|||
125901992|NCT00761150|452939845|FG001|Double-blind Period|Adverse Event|3|||
125901993|NCT00761150|452939846|FG002|Double-blind Period|Adverse Event|3|||
125901994|NCT00761150|452939844|FG000|Double-blind Period|Withdrawal by Subject|0|||
125901995|NCT00761150|452939845|FG001|Double-blind Period|Withdrawal by Subject|3|||
125901996|NCT00761150|452939846|FG002|Double-blind Period|Withdrawal by Subject|2|||
125901997|NCT00761150|452939844|FG000|Double-blind Period|Lost to Follow-up|0|||
125901998|NCT00761150|452939845|FG001|Double-blind Period|Lost to Follow-up|2|||
125901999|NCT00761150|452939846|FG002|Double-blind Period|Lost to Follow-up|1|||
125902000|NCT00761150|452939844|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
125902001|NCT00761150|452939845|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
125902002|NCT00761150|452939846|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
125902003|NCT00761150|452939844|FG000|Double-blind Period|Noncompliance|0|||
125902004|NCT00761150|452939845|FG001|Double-blind Period|Noncompliance|1|||
125902005|NCT00761150|452939846|FG002|Double-blind Period|Noncompliance|0|||
125902006|NCT00761150|452939844|FG000|Double-blind Period|Other|0|||
125902007|NCT00761150|452939845|FG001|Double-blind Period|Other|3|||
125902008|NCT00761150|452939846|FG002|Double-blind Period|Other|3|||
125902009|NCT05463198|452939847|FG000|Overall Study|Withdrawal by Subject|19|||
125902010|NCT05463198|452939847|FG000|Overall Study|Procedure Notes Missing|18|||
125902011|NCT01860846|452939848|FG000|Overall Study|Lost to Follow-up|33|||
125902012|NCT00466687|452939851|FG000|Overall Study|Adverse Event|1|||
125902013|NCT00466687|452939851|FG000|Overall Study|Other complicating illness|3|||
125902014|NCT00466687|452939851|FG000|Overall Study|Withdrawal by Subject|1|||
125902015|NCT00466687|452939851|FG000|Overall Study|Disease progression|29|||
125902016|NCT01925989|452939852|FG000|Period 1|Sponsor Decision|1|||
125902017|NCT01925989|452939853|FG001|Period 1|Sponsor Decision|1|||
125902018|NCT01925989|452939854|FG002|Period 1|Sponsor Decision|0|||
125902019|NCT01925989|452939852|FG000|Period 1|Withdrawal by Subject|0|||
125902020|NCT01925989|452939853|FG001|Period 1|Withdrawal by Subject|1|||
125902021|NCT01925989|452939854|FG002|Period 1|Withdrawal by Subject|0|||
125902022|NCT03459690|452939859|FG000|Overall Study|Lost to Follow-up|0|||
125902023|NCT03459690|452939860|FG001|Overall Study|Lost to Follow-up|1|||
125902024|NCT03459690|452939859|FG000|Overall Study|Withdrawal by Subject|1|||
125902025|NCT03459690|452939860|FG001|Overall Study|Withdrawal by Subject|1|||
125902026|NCT02586506|452939861|FG000|Overall Study|Protocol Violation|6|||
125902027|NCT02586506|452939861|FG000|Overall Study|Lost to Follow-up|1|||
125902028|NCT02586506|452939861|FG000|Overall Study|Other Reason|2|||
125902029|NCT02514473|452939866|FG000|Overall Study|Adverse Event|0|||
125902030|NCT02514473|452939867|FG001|Overall Study|Adverse Event|2|||
125902031|NCT02514473|452939866|FG000|Overall Study|Withdrawal by Subject|2|||
125902032|NCT02514473|452939867|FG001|Overall Study|Withdrawal by Subject|1|||
125902033|NCT02514473|452939866|FG000|Overall Study|Lost to Follow-up|0|||
125902034|NCT02514473|452939867|FG001|Overall Study|Lost to Follow-up|1|||
125902035|NCT02514473|452939866|FG000|Overall Study|Other|1|||
125902036|NCT02514473|452939867|FG001|Overall Study|Other|1|||
125902037|NCT02158364|452939868|FG000|Overall Study|Case report forms uncollected|10|||
125902038|NCT02158364|452939868|FG000|Overall Study|Protocol Deviation|50|||
125902039|NCT00674154|452939871|FG000|Overall Study|Withdrawal by Subject|3|||
125902040|NCT00674154|452939872|FG001|Overall Study|Withdrawal by Subject|1|||
125902041|NCT00674154|452939871|FG000|Overall Study|Did not want parathyroidectomy|0|||
125902042|NCT00674154|452939872|FG001|Overall Study|Did not want parathyroidectomy|2|||
125902043|NCT00924170|452939873|FG000|Overall Study|Refused further treatment|0|||
125902044|NCT00924170|452939874|FG001|Overall Study|Refused further treatment|1|||
125902045|NCT00924170|452939873|FG000|Overall Study|Physician Decision|0|||
125902046|NCT00924170|452939874|FG001|Overall Study|Physician Decision|1|||
125902047|NCT00924170|452939873|FG000|Overall Study|Progressive disease|3|||
125902048|NCT00924170|452939874|FG001|Overall Study|Progressive disease|6|||
125902049|NCT00924170|452939873|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
125902050|NCT00924170|452939874|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
125902051|NCT00924170|452939873|FG000|Overall Study|Death|1|||
125902052|NCT00924170|452939874|FG001|Overall Study|Death|0|||
125902053|NCT00278915|452939877|FG000|Overall Study|Disease progression|1|||
125902054|NCT02520089|452939878|FG000|Overall Study|Lost to Follow-up|3|||
125902055|NCT02520089|452939879|FG001|Overall Study|Lost to Follow-up|4|||
125902056|NCT00336583|452941668|FG000|Overall Study|Lost to Follow-up|1|||
125902057|NCT00336583|452941668|FG000|Overall Study|Death|1|||
125902058|NCT03039621|452941669|FG000|Overall Study|Violation of inclusion criteria|3|||
125902059|NCT03039621|452941670|FG001|Overall Study|Violation of inclusion criteria|2|||
125902060|NCT03039621|452941669|FG000|Overall Study|Non-compliance with protocol requirement|4|||
125902061|NCT03039621|452941670|FG001|Overall Study|Non-compliance with protocol requirement|5|||
125902062|NCT03039621|452941669|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
125902063|NCT03039621|452941670|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
125902064|NCT03039621|452941669|FG000|Overall Study|Violation of non-inclusion criteria|1|||
125902065|NCT03039621|452941670|FG001|Overall Study|Violation of non-inclusion criteria|2|||
125902066|NCT00814333|452941673|FG000|Enrollment|Lost to Follow-up|1|||
125902067|NCT00814333|452941674|FG001|Enrollment|Lost to Follow-up|0|||
125902068|NCT02927067|452941675|FG000|Overall Study|Withdrawn Consent|20|||
125902069|NCT02927067|452941676|FG001|Overall Study|Withdrawn Consent|12|||
125902070|NCT02927067|452941675|FG000|Overall Study|Death|18|||
125902071|NCT02927067|452941676|FG001|Overall Study|Death|31|||
125902072|NCT02927067|452941675|FG000|Overall Study|Adverse Event|13|||
125902073|NCT02927067|452941676|FG001|Overall Study|Adverse Event|10|||
125902074|NCT02927067|452941675|FG000|Overall Study|Noncompliance|5|||
125902075|NCT02927067|452941676|FG001|Overall Study|Noncompliance|2|||
125902076|NCT02927067|452941675|FG000|Overall Study|Reason not Specified|4|||
125902077|NCT02927067|452941676|FG001|Overall Study|Reason not Specified|6|||
125902078|NCT02716896|452941677|FG000|Overall Study|Physician Decision|0|||
125902079|NCT02716896|452941678|FG001|Overall Study|Physician Decision|1|||
126110090|NCT02598557|453697631|FG001|Overall Study|Adverse Event|1|||
125902080|NCT01727700|452941679|FG000|Overall Study|Adverse Event|0|||
125902081|NCT01727700|452941680|FG001|Overall Study|Adverse Event|7|||
125902082|NCT01727700|452941681|FG002|Overall Study|Adverse Event|1|||
125902083|NCT01727700|452941679|FG000|Overall Study|Particpant withdrew consent|0|||
125902084|NCT01727700|452941680|FG001|Overall Study|Particpant withdrew consent|3|||
125902085|NCT01727700|452941681|FG002|Overall Study|Particpant withdrew consent|1|||
125902086|NCT01727700|452941679|FG000|Overall Study|Protocol Violation|2|||
125902087|NCT01727700|452941680|FG001|Overall Study|Protocol Violation|0|||
125902088|NCT01727700|452941681|FG002|Overall Study|Protocol Violation|0|||
125902089|NCT02519855|452941682|FG000|Overall Study|Adverse Event|0|||
125902090|NCT02519855|452941683|FG001|Overall Study|Adverse Event|1|||
125902091|NCT02519855|452941682|FG000|Overall Study|Lost to Follow-up|3|||
125902092|NCT02519855|452941683|FG001|Overall Study|Lost to Follow-up|3|||
125902093|NCT00003830|452941697|FG000|Overall Study|No follow up data|3|||
125902094|NCT00003830|452941698|FG001|Overall Study|No follow up data|0|||
125902095|NCT00003830|452941697|FG000|Overall Study|Sentinel node positive patients|829|||
125902096|NCT00003830|452941698|FG001|Overall Study|Sentinel node positive patients|793|||
125902097|NCT05347147|452941702|FG000|Overall Study|Lost to Follow-up|0|||
125902098|NCT05347147|452941703|FG001|Overall Study|Lost to Follow-up|1|||
125902099|NCT05347147|452941702|FG000|Overall Study|Sponsor request|3|||
125902100|NCT05347147|452941703|FG001|Overall Study|Sponsor request|3|||
125902101|NCT05347147|452941702|FG000|Overall Study|Study termination|2|||
125902102|NCT05347147|452941703|FG001|Overall Study|Study termination|1|||
125902103|NCT02446743|452941704|FG000|Overall Study|Withdrawal by Subject|1|||
125902104|NCT02446743|452941705|FG001|Overall Study|Withdrawal by Subject|1|||
125902105|NCT02446743|452941704|FG000|Overall Study|Lost to Follow-up|1|||
125902106|NCT02446743|452941705|FG001|Overall Study|Lost to Follow-up|0|||
125902107|NCT02446743|452941704|FG000|Overall Study|Adverse Event|1|||
125902108|NCT02446743|452941705|FG001|Overall Study|Adverse Event|1|||
125902109|NCT02446743|452941704|FG000|Overall Study|Other|2|||
125902110|NCT02446743|452941705|FG001|Overall Study|Other|3|||
125902111|NCT03718299|452941706|FG000|Overall Study|Adverse Event|1|||
125902112|NCT03718299|452941706|FG000|Overall Study|Withdrawal by Subject|6|||
125902113|NCT03718299|452941706|FG000|Overall Study|Physician Decision|2|||
125902114|NCT03718299|452941706|FG000|Overall Study|Lost to Follow-up|1|||
125902115|NCT00976508|452941708|FG000|Overall Study|Death|7|||
125902116|NCT00976508|452941709|FG001|Overall Study|Death|1|||
125902117|NCT00976508|452941708|FG000|Overall Study|Lost to Follow-up|1|||
125902118|NCT00976508|452941709|FG001|Overall Study|Lost to Follow-up|0|||
125902119|NCT00976508|452941708|FG000|Overall Study|Withdrawal by Subject|1|||
125902120|NCT00976508|452941709|FG001|Overall Study|Withdrawal by Subject|0|||
125902121|NCT00976508|452941708|FG000|Overall Study|Disease Progression|4|||
125902122|NCT00976508|452941709|FG001|Overall Study|Disease Progression|4|||
125902123|NCT00976508|452941708|FG000|Overall Study|Subject Enrolled in Hospice|1|||
125902124|NCT00976508|452941709|FG001|Overall Study|Subject Enrolled in Hospice|0|||
125902125|NCT00976508|452941708|FG000|Overall Study|Terminated by the Sponsor|0|||
125902126|NCT00976508|452941709|FG001|Overall Study|Terminated by the Sponsor|1|||
125902127|NCT01205581|452941713|FG000|Overall Study|Withdrawal by Subject|1|||
125902128|NCT01205581|452941714|FG001|Overall Study|Withdrawal by Subject|0|||
125902129|NCT01205581|452941715|FG002|Overall Study|Withdrawal by Subject|0|||
125902130|NCT01205581|452941716|FG003|Overall Study|Withdrawal by Subject|0|||
125902131|NCT01205581|452941717|FG004|Overall Study|Withdrawal by Subject|0|||
125902132|NCT01205581|452941718|FG005|Overall Study|Withdrawal by Subject|0|||
125902133|NCT02278471|452941719|FG000|Overall Study|Lost to Follow-up|6|||
125902134|NCT02278471|452941720|FG001|Overall Study|Lost to Follow-up|15|||
125902135|NCT02278471|452941719|FG000|Overall Study|Death|2|||
125902136|NCT02278471|452941720|FG001|Overall Study|Death|2|||
125902137|NCT02278471|452941719|FG000|Overall Study|Withdrawal by Subject|0|||
125902138|NCT02278471|452941720|FG001|Overall Study|Withdrawal by Subject|3|||
125902139|NCT00640835|452941721|FG000|Overall Study|Adverse Event|5|||
125902140|NCT00640835|452941722|FG001|Overall Study|Adverse Event|3|||
125902141|NCT00640835|452941721|FG000|Overall Study|Withdrawal by Subject|12|||
125902142|NCT00640835|452941722|FG001|Overall Study|Withdrawal by Subject|14|||
125902143|NCT00640835|452941721|FG000|Overall Study|Physician Decision|10|||
125902144|NCT00640835|452941722|FG001|Overall Study|Physician Decision|14|||
125902145|NCT00640835|452941721|FG000|Overall Study|Sponsor's Decision|11|||
125902146|NCT00640835|452941722|FG001|Overall Study|Sponsor's Decision|7|||
125902147|NCT00640835|452941721|FG000|Overall Study|Protocol Violation|2|||
125902148|NCT00640835|452941722|FG001|Overall Study|Protocol Violation|2|||
125902149|NCT00640835|452941721|FG000|Overall Study|Lost to Follow-up|17|||
125902150|NCT00640835|452941722|FG001|Overall Study|Lost to Follow-up|13|||
125902151|NCT00640835|452941721|FG000|Overall Study|Other Reason|19|||
125902152|NCT00640835|452941722|FG001|Overall Study|Other Reason|4|||
125902153|NCT03468543|452941723|FG000|Overall Study|Protocol stopping rules met|3|||
125902154|NCT04618770|452941725|FG000|Overall Study|Censored from Analysis|12|||
125902155|NCT04618770|452941725|FG000|Overall Study|Early Termination|25|||
125902156|NCT00045942|452941730|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
125902157|NCT00045942|452941731|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125902158|NCT00045942|452941732|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125902159|NCT00045942|452941733|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125902160|NCT00045942|452941734|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125902161|NCT00045942|452941735|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125902162|NCT00045942|452941736|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125902163|NCT00045942|452941737|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125902164|NCT00045942|452941738|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125902165|NCT00045942|452941730|FG000|PKC412A2104 (Core)|Adverse Event|5|||
125902166|NCT00045942|452941731|FG001|PKC412A2104 (Core)|Adverse Event|0|||
125902167|NCT00045942|452941732|FG002|PKC412A2104 (Core)|Adverse Event|0|||
125902168|NCT00045942|452941733|FG003|PKC412A2104 (Core)|Adverse Event|0|||
125902169|NCT00045942|452941734|FG004|PKC412A2104 (Core)|Adverse Event|0|||
125902170|NCT00045942|452941735|FG005|PKC412A2104 (Core)|Adverse Event|0|||
125902171|NCT00045942|452941736|FG006|PKC412A2104 (Core)|Adverse Event|0|||
125902172|NCT00045942|452941737|FG007|PKC412A2104 (Core)|Adverse Event|0|||
125902173|NCT00045942|452941738|FG008|PKC412A2104 (Core)|Adverse Event|0|||
125902174|NCT00045942|452941730|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
125902175|NCT00045942|452941731|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
125902176|NCT00045942|452941732|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
125902177|NCT00045942|452941733|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
125902178|NCT00045942|452941734|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
125902179|NCT00045942|452941735|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
125902180|NCT00045942|452941736|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
125902181|NCT00045942|452941737|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
125902182|NCT00045942|452941738|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
125902183|NCT00045942|452941730|FG000|PKC412A2104 (Core)|Death|1|||
125902184|NCT00045942|452941731|FG001|PKC412A2104 (Core)|Death|0|||
125902185|NCT00045942|452941732|FG002|PKC412A2104 (Core)|Death|0|||
125902186|NCT00045942|452941733|FG003|PKC412A2104 (Core)|Death|0|||
125902187|NCT00045942|452941734|FG004|PKC412A2104 (Core)|Death|0|||
125902188|NCT00045942|452941735|FG005|PKC412A2104 (Core)|Death|0|||
125902189|NCT00045942|452941736|FG006|PKC412A2104 (Core)|Death|0|||
125902190|NCT00045942|452941737|FG007|PKC412A2104 (Core)|Death|0|||
125902191|NCT00045942|452941738|FG008|PKC412A2104 (Core)|Death|0|||
125902192|NCT00045942|452941730|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
125902193|NCT00045942|452941731|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
125902194|NCT00045942|452941732|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
125902195|NCT00045942|452941733|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
125902196|NCT00045942|452941734|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
125902197|NCT00045942|452941735|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
125902198|NCT00045942|452941736|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
125902199|NCT00045942|452941737|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
125902200|NCT00045942|452941738|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
125902201|NCT00045942|452941730|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
125902202|NCT00045942|452941731|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
125902203|NCT00045942|452941732|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
125902204|NCT00045942|452941733|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
125902205|NCT00045942|452941734|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
125902206|NCT00045942|452941735|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
125902207|NCT00045942|452941736|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
125902208|NCT00045942|452941737|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
125902209|NCT00045942|452941738|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
125902210|NCT00045942|452941730|FG000|PKC412A2104E1|Lack of Efficacy|0|||
125902211|NCT00045942|452941731|FG001|PKC412A2104E1|Lack of Efficacy|11|||
125902212|NCT00045942|452941732|FG002|PKC412A2104E1|Lack of Efficacy|11|||
125902213|NCT00045942|452941733|FG003|PKC412A2104E1|Lack of Efficacy|23|||
125902214|NCT00045942|452941734|FG004|PKC412A2104E1|Lack of Efficacy|17|||
125902215|NCT00045942|452941735|FG005|PKC412A2104E1|Lack of Efficacy|0|||
125902216|NCT00045942|452941736|FG006|PKC412A2104E1|Lack of Efficacy|0|||
125902217|NCT00045942|452941737|FG007|PKC412A2104E1|Lack of Efficacy|0|||
125902218|NCT00045942|452941738|FG008|PKC412A2104E1|Lack of Efficacy|0|||
125902219|NCT00045942|452941730|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
125902220|NCT00045942|452941731|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
125902221|NCT00045942|452941732|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
125902222|NCT00045942|452941733|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
125902223|NCT00045942|452941734|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
125902224|NCT00045942|452941735|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
125902225|NCT00045942|452941736|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
125902226|NCT00045942|452941737|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
125902227|NCT00045942|452941738|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
125902228|NCT00045942|452941730|FG000|PKC412A2104E1|Adverse Event|0|||
125902229|NCT00045942|452941731|FG001|PKC412A2104E1|Adverse Event|1|||
125902230|NCT00045942|452941732|FG002|PKC412A2104E1|Adverse Event|1|||
125902231|NCT00045942|452941733|FG003|PKC412A2104E1|Adverse Event|3|||
125902232|NCT00045942|452941734|FG004|PKC412A2104E1|Adverse Event|6|||
125902233|NCT00045942|452941735|FG005|PKC412A2104E1|Adverse Event|0|||
125902234|NCT00045942|452941736|FG006|PKC412A2104E1|Adverse Event|0|||
125902235|NCT00045942|452941737|FG007|PKC412A2104E1|Adverse Event|0|||
125902236|NCT00045942|452941738|FG008|PKC412A2104E1|Adverse Event|0|||
125902237|NCT00045942|452941730|FG000|PKC412A2104E1|Death|0|||
125902238|NCT00045942|452941731|FG001|PKC412A2104E1|Death|4|||
125902239|NCT00045942|452941732|FG002|PKC412A2104E1|Death|1|||
125902240|NCT00045942|452941733|FG003|PKC412A2104E1|Death|1|||
125902241|NCT00045942|452941734|FG004|PKC412A2104E1|Death|1|||
125902242|NCT00045942|452941735|FG005|PKC412A2104E1|Death|0|||
125902243|NCT00045942|452941736|FG006|PKC412A2104E1|Death|0|||
125902244|NCT00045942|452941737|FG007|PKC412A2104E1|Death|0|||
125902245|NCT00045942|452941738|FG008|PKC412A2104E1|Death|0|||
125902246|NCT00045942|452941730|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125902247|NCT00045942|452941731|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125902248|NCT00045942|452941732|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
125902249|NCT00045942|452941733|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
125902250|NCT00045942|452941734|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125902251|NCT00045942|452941735|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125902252|NCT00045942|452941736|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125902253|NCT00045942|452941737|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125902254|NCT00045942|452941738|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125902255|NCT00045942|452941730|FG000|PKC412A2104E2|Lost to Follow-up|0|||
125902256|NCT00045942|452941731|FG001|PKC412A2104E2|Lost to Follow-up|0|||
125902257|NCT00045942|452941732|FG002|PKC412A2104E2|Lost to Follow-up|0|||
125902258|NCT00045942|452941733|FG003|PKC412A2104E2|Lost to Follow-up|0|||
125902259|NCT00045942|452941734|FG004|PKC412A2104E2|Lost to Follow-up|0|||
125902260|NCT00045942|452941735|FG005|PKC412A2104E2|Lost to Follow-up|0|||
125902261|NCT00045942|452941736|FG006|PKC412A2104E2|Lost to Follow-up|0|||
125902262|NCT00045942|452941737|FG007|PKC412A2104E2|Lost to Follow-up|3|||
125902263|NCT00045942|452941738|FG008|PKC412A2104E2|Lost to Follow-up|0|||
125902264|NCT00045942|452941730|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
125902265|NCT00045942|452941731|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
125902266|NCT00045942|452941732|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
125902267|NCT00045942|452941733|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
125902268|NCT00045942|452941734|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
125902269|NCT00045942|452941735|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
125902270|NCT00045942|452941736|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
125902271|NCT00045942|452941737|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
125902272|NCT00045942|452941738|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
125902273|NCT00045942|452941730|FG000|PKC412A2104E2|Lack of Efficacy|0|||
125902274|NCT00045942|452941731|FG001|PKC412A2104E2|Lack of Efficacy|0|||
125902275|NCT00045942|452941732|FG002|PKC412A2104E2|Lack of Efficacy|0|||
125902276|NCT00045942|452941733|FG003|PKC412A2104E2|Lack of Efficacy|0|||
125902277|NCT00045942|452941734|FG004|PKC412A2104E2|Lack of Efficacy|0|||
125902278|NCT00045942|452941735|FG005|PKC412A2104E2|Lack of Efficacy|3|||
125902279|NCT00045942|452941736|FG006|PKC412A2104E2|Lack of Efficacy|2|||
125902280|NCT00045942|452941737|FG007|PKC412A2104E2|Lack of Efficacy|2|||
125902281|NCT00045942|452941738|FG008|PKC412A2104E2|Lack of Efficacy|6|||
125902282|NCT00045942|452941730|FG000|PKC412A2104E2|Adverse Event|0|||
125902283|NCT00045942|452941731|FG001|PKC412A2104E2|Adverse Event|0|||
125902284|NCT00045942|452941732|FG002|PKC412A2104E2|Adverse Event|0|||
125902285|NCT00045942|452941733|FG003|PKC412A2104E2|Adverse Event|0|||
125902286|NCT00045942|452941734|FG004|PKC412A2104E2|Adverse Event|0|||
125902287|NCT00045942|452941735|FG005|PKC412A2104E2|Adverse Event|4|||
125902288|NCT00045942|452941736|FG006|PKC412A2104E2|Adverse Event|3|||
125902289|NCT00045942|452941737|FG007|PKC412A2104E2|Adverse Event|1|||
125902290|NCT00045942|452941738|FG008|PKC412A2104E2|Adverse Event|0|||
125902291|NCT00045942|452941730|FG000|PKC412A2104E2|Death|0|||
125902292|NCT00045942|452941731|FG001|PKC412A2104E2|Death|0|||
125902293|NCT00045942|452941732|FG002|PKC412A2104E2|Death|0|||
125902294|NCT00045942|452941733|FG003|PKC412A2104E2|Death|0|||
125902295|NCT00045942|452941734|FG004|PKC412A2104E2|Death|0|||
125902296|NCT00045942|452941735|FG005|PKC412A2104E2|Death|1|||
125902297|NCT00045942|452941736|FG006|PKC412A2104E2|Death|2|||
125902298|NCT00045942|452941737|FG007|PKC412A2104E2|Death|0|||
125902299|NCT00045942|452941738|FG008|PKC412A2104E2|Death|0|||
125902300|NCT02095132|452941739|FG000|Overall Study|Adverse Event|0|||
125902301|NCT02095132|452941740|FG001|Overall Study|Adverse Event|0|||
125902302|NCT02095132|452941741|FG002|Overall Study|Adverse Event|0|||
125902303|NCT02095132|452941742|FG003|Overall Study|Adverse Event|0|||
125902304|NCT02095132|452941743|FG004|Overall Study|Adverse Event|1|||
125902305|NCT02095132|452941744|FG005|Overall Study|Adverse Event|0|||
125902306|NCT02095132|452941745|FG006|Overall Study|Adverse Event|1|||
125902307|NCT02095132|452941746|FG007|Overall Study|Adverse Event|0|||
125902308|NCT02095132|452941747|FG008|Overall Study|Adverse Event|0|||
125902309|NCT02095132|452941739|FG000|Overall Study|Death|0|||
125902310|NCT02095132|452941740|FG001|Overall Study|Death|0|||
125902311|NCT02095132|452941741|FG002|Overall Study|Death|0|||
125902312|NCT02095132|452941742|FG003|Overall Study|Death|0|||
125902313|NCT02095132|452941743|FG004|Overall Study|Death|0|||
125902314|NCT02095132|452941744|FG005|Overall Study|Death|0|||
125902315|NCT02095132|452941745|FG006|Overall Study|Death|1|||
125902316|NCT02095132|452941746|FG007|Overall Study|Death|0|||
125902317|NCT02095132|452941747|FG008|Overall Study|Death|0|||
125902318|NCT02095132|452941739|FG000|Overall Study|Lack of Efficacy|3|||
125902319|NCT02095132|452941740|FG001|Overall Study|Lack of Efficacy|5|||
125902320|NCT02095132|452941741|FG002|Overall Study|Lack of Efficacy|2|||
125902321|NCT02095132|452941742|FG003|Overall Study|Lack of Efficacy|8|||
125902322|NCT02095132|452941743|FG004|Overall Study|Lack of Efficacy|3|||
125902323|NCT02095132|452941744|FG005|Overall Study|Lack of Efficacy|6|||
125902324|NCT02095132|452941745|FG006|Overall Study|Lack of Efficacy|10|||
125902325|NCT02095132|452941746|FG007|Overall Study|Lack of Efficacy|9|||
125902326|NCT02095132|452941747|FG008|Overall Study|Lack of Efficacy|8|||
125902327|NCT02095132|452941739|FG000|Overall Study|Physician Decision|1|||
125902328|NCT02095132|452941740|FG001|Overall Study|Physician Decision|0|||
125902329|NCT02095132|452941741|FG002|Overall Study|Physician Decision|0|||
125902330|NCT02095132|452941742|FG003|Overall Study|Physician Decision|0|||
125902331|NCT02095132|452941743|FG004|Overall Study|Physician Decision|0|||
125902332|NCT02095132|452941744|FG005|Overall Study|Physician Decision|0|||
125902333|NCT02095132|452941745|FG006|Overall Study|Physician Decision|1|||
125902334|NCT02095132|452941746|FG007|Overall Study|Physician Decision|0|||
125902335|NCT02095132|452941747|FG008|Overall Study|Physician Decision|2|||
125902336|NCT02095132|452941739|FG000|Overall Study|Withdrawal by Subject|0|||
125902337|NCT02095132|452941740|FG001|Overall Study|Withdrawal by Subject|0|||
125902338|NCT02095132|452941741|FG002|Overall Study|Withdrawal by Subject|2|||
125902339|NCT02095132|452941742|FG003|Overall Study|Withdrawal by Subject|2|||
125902340|NCT02095132|452941743|FG004|Overall Study|Withdrawal by Subject|3|||
125902341|NCT02095132|452941744|FG005|Overall Study|Withdrawal by Subject|0|||
125902342|NCT02095132|452941745|FG006|Overall Study|Withdrawal by Subject|5|||
125902343|NCT02095132|452941746|FG007|Overall Study|Withdrawal by Subject|0|||
125902344|NCT02095132|452941747|FG008|Overall Study|Withdrawal by Subject|0|||
125902345|NCT01895361|452941751|FG000|Overall Study|Adverse Event|1|||
125902346|NCT01895361|452941752|FG001|Overall Study|Adverse Event|1|||
125902347|NCT01895361|452941753|FG002|Overall Study|Adverse Event|3|||
125902348|NCT01895361|452941751|FG000|Overall Study|Death|2|||
125902349|NCT01895361|452941752|FG001|Overall Study|Death|1|||
125902350|NCT01895361|452941753|FG002|Overall Study|Death|2|||
125902351|NCT01895361|452941751|FG000|Overall Study|Lost to Follow-up|4|||
125902352|NCT01895361|452941752|FG001|Overall Study|Lost to Follow-up|4|||
125902353|NCT01895361|452941753|FG002|Overall Study|Lost to Follow-up|6|||
125902354|NCT01895361|452941751|FG000|Overall Study|Non-compliance with study|1|||
125902355|NCT01895361|452941752|FG001|Overall Study|Non-compliance with study|3|||
125902356|NCT01895361|452941753|FG002|Overall Study|Non-compliance with study|1|||
125902357|NCT01895361|452941751|FG000|Overall Study|Physician Decision|2|||
125902358|NCT01895361|452941752|FG001|Overall Study|Physician Decision|2|||
125902359|NCT01895361|452941753|FG002|Overall Study|Physician Decision|2|||
125902360|NCT01895361|452941751|FG000|Overall Study|Withdrawal by Subject|7|||
125902361|NCT01895361|452941752|FG001|Overall Study|Withdrawal by Subject|6|||
125902362|NCT01895361|452941753|FG002|Overall Study|Withdrawal by Subject|6|||
125902363|NCT01895361|452941751|FG000|Overall Study|Lack of Efficacy|0|||
125902364|NCT01895361|452941752|FG001|Overall Study|Lack of Efficacy|1|||
125902365|NCT01895361|452941753|FG002|Overall Study|Lack of Efficacy|0|||
125902366|NCT01895361|452941751|FG000|Overall Study|Reasons different from categories above|7|||
125902367|NCT01895361|452941752|FG001|Overall Study|Reasons different from categories above|3|||
125902368|NCT01895361|452941753|FG002|Overall Study|Reasons different from categories above|4|||
125902369|NCT00761748|452941757|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
125902370|NCT00761748|452941758|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
125902371|NCT00761748|452941757|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
125902372|NCT00761748|452941758|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
125902373|NCT01209832|452941759|FG000|Period 1|Sponsor Decision and was not dosed|1|||
125902374|NCT01209832|452941759|FG000|Period 2|Sponsor Decision|1|||
125902375|NCT01268579|452941760|FG000|Overall Study|Adverse Event|1|||
125902376|NCT01268579|452941760|FG000|Overall Study|Withdrawal by Subject|2|||
125902377|NCT02692651|452941761|FG000|Study Treatment|Death|7|||
125902378|NCT02692651|452941762|FG001|Study Treatment|Death|3|||
125902379|NCT02692651|452941761|FG000|Study Treatment|comfort care|1|||
125902380|NCT02692651|452941762|FG001|Study Treatment|comfort care|1|||
125902381|NCT02692651|452941761|FG000|Study Treatment|Protocol violation per treating team preference|8|||
125902382|NCT02692651|452941762|FG001|Study Treatment|Protocol violation per treating team preference|6|||
125902383|NCT02692651|452941761|FG000|Post Study Treatment Follow-up|Death|4|||
125902384|NCT02692651|452941762|FG001|Post Study Treatment Follow-up|Death|4|||
125902385|NCT02480712|452941763|FG000|Overall Study|Enrolled but Never Treated|1|||
125902386|NCT02480712|452941763|FG000|Overall Study|Lost to Follow-up|5|||
125902387|NCT02480712|452941763|FG000|Overall Study|Withdrew Consent|3|||
125902388|NCT02480712|452941763|FG000|Overall Study|Death|1|||
125902389|NCT02480712|452941763|FG000|Overall Study|Lack of Efficacy|1|||
125902390|NCT02239120|452941764|FG000|Overall Study|Death|56|||
125902391|NCT02239120|452941765|FG001|Overall Study|Death|58|||
125902392|NCT02239120|452941764|FG000|Overall Study|Lost to Follow-up|19|||
125902393|NCT02239120|452941765|FG001|Overall Study|Lost to Follow-up|14|||
125902394|NCT01107379|452941766|FG000|Overall Study|Withdrawal by Subject|18|||
125902395|NCT01107379|452941766|FG000|Overall Study|Lost to Follow-up|3|||
125902396|NCT00609362|452941767|FG000|Overall Study|Withdrawal by Subject|2|||
125902397|NCT00609362|452941768|FG001|Overall Study|Withdrawal by Subject|1|||
126059783|NCT02538094|453512559|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
126059784|NCT02538094|453512560|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
126059785|NCT01528605|453512574|FG000|Overall Study|Lost to Follow-up|1|||
126059786|NCT01528605|453512575|FG001|Overall Study|Lost to Follow-up|0|||
126059787|NCT01528605|453512576|FG002|Overall Study|Lost to Follow-up|1|||
125902398|NCT00609362|452941767|FG000|Overall Study|Adverse Event|1|||
125902399|NCT00609362|452941768|FG001|Overall Study|Adverse Event|0|||
125902400|NCT04559529|452941769|FG000|First Intervention (1 Day)|Adverse Event|0|||
125902401|NCT04559529|452941770|FG001|First Intervention (1 Day)|Adverse Event|0|||
125902402|NCT04559529|452941771|FG002|First Intervention (1 Day)|Adverse Event|0|||
125902403|NCT04559529|452941772|FG003|First Intervention (1 Day)|Adverse Event|1|||
125902404|NCT04559529|452941769|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
125902405|NCT04559529|452941770|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
125902406|NCT04559529|452941771|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
125902407|NCT04559529|452941772|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
125902408|NCT04559529|452941769|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
125902409|NCT04559529|452941770|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
125902410|NCT04559529|452941771|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
125902411|NCT04559529|452941772|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
125902412|NCT01009281|452941773|FG000|Overall Study|Administrative problems|7|||
125902413|NCT00548405|452941774|FG000|Overall Study|Adverse Event|6|||
125902414|NCT00548405|452941775|FG001|Overall Study|Adverse Event|2|||
125902415|NCT00548405|452941776|FG002|Overall Study|Adverse Event|0|||
125902416|NCT00548405|452941774|FG000|Overall Study|Lack of Efficacy|6|||
125902417|NCT00548405|452941775|FG001|Overall Study|Lack of Efficacy|0|||
125902418|NCT00548405|452941776|FG002|Overall Study|Lack of Efficacy|0|||
125902419|NCT00548405|452941774|FG000|Overall Study|Physician Decision|3|||
125902420|NCT00548405|452941775|FG001|Overall Study|Physician Decision|4|||
125902421|NCT00548405|452941776|FG002|Overall Study|Physician Decision|1|||
125902422|NCT00548405|452941774|FG000|Overall Study|Pregnancy|1|||
125902423|NCT00548405|452941775|FG001|Overall Study|Pregnancy|0|||
125902424|NCT00548405|452941776|FG002|Overall Study|Pregnancy|0|||
125902425|NCT00548405|452941774|FG000|Overall Study|Protocol Violation|1|||
125902426|NCT00548405|452941775|FG001|Overall Study|Protocol Violation|0|||
125902427|NCT00548405|452941776|FG002|Overall Study|Protocol Violation|0|||
125902428|NCT00548405|452941774|FG000|Overall Study|Withdrawal by Subject|36|||
125902429|NCT00548405|452941775|FG001|Overall Study|Withdrawal by Subject|12|||
125902430|NCT00548405|452941776|FG002|Overall Study|Withdrawal by Subject|5|||
125902431|NCT00548405|452941774|FG000|Overall Study|Lost to Follow-up|1|||
125902432|NCT00548405|452941775|FG001|Overall Study|Lost to Follow-up|1|||
125902433|NCT00548405|452941776|FG002|Overall Study|Lost to Follow-up|2|||
125902434|NCT00548405|452941774|FG000|Overall Study|Death|0|||
125902435|NCT00548405|452941775|FG001|Overall Study|Death|1|||
125902436|NCT00548405|452941776|FG002|Overall Study|Death|1|||
125902437|NCT00548405|452941774|FG000|Overall Study|Sponsor decision|1|||
125902438|NCT00548405|452941775|FG001|Overall Study|Sponsor decision|0|||
125902439|NCT00548405|452941776|FG002|Overall Study|Sponsor decision|0|||
125902440|NCT00548405|452941774|FG000|Overall Study|Randomized but not treated|1|||
125902441|NCT00548405|452941775|FG001|Overall Study|Randomized but not treated|0|||
125902442|NCT00548405|452941776|FG002|Overall Study|Randomized but not treated|0|||
125902443|NCT02582684|452941777|FG000|Overall Study|Unable to contact subject/parent|4|||
125902444|NCT02582684|452941777|FG000|Overall Study|Subject not able to get to clinic|10|||
125902445|NCT02582684|452941777|FG000|Overall Study|Subject withdrew consent|1|||
125902446|NCT02582684|452941777|FG000|Overall Study|Found to be ineligible after enrollment|2|||
125902447|NCT01878149|452941778|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
125902448|NCT01878149|452941779|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
125902449|NCT00899392|452941789|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
125902450|NCT00899392|452941790|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
125902451|NCT01261780|452941797|FG000|Overall Study|Withdrawal by Subject|1|||
125902452|NCT01261780|452941798|FG001|Overall Study|Withdrawal by Subject|0|||
125902453|NCT01261780|452941797|FG000|Overall Study|Event not related to subject|1|||
125902454|NCT01261780|452941798|FG001|Overall Study|Event not related to subject|2|||
125902455|NCT01239732|452941799|FG000|Overall Study|Termination of study per protocol|667|||
125902456|NCT01239732|452941799|FG000|Overall Study|Death|226|||
125902457|NCT01239732|452941799|FG000|Overall Study|Withdrawal by Subject|87|||
125902458|NCT01239732|452941799|FG000|Overall Study|Adverse Event|6|||
125902459|NCT01239732|452941799|FG000|Overall Study|Protocol Violation|3|||
125902460|NCT01239732|452941799|FG000|Overall Study|Participant non compliance|5|||
125902461|NCT01239732|452941799|FG000|Overall Study|Study termination by sponsor|2|||
125902462|NCT01239732|452941799|FG000|Overall Study|Investigator's decision|4|||
125902463|NCT01239732|452941799|FG000|Overall Study|Treatment failure|2|||
125902464|NCT01239732|452941799|FG000|Overall Study|Other|19|||
125902465|NCT00732940|452941800|FG000|Overall Study|Withdrawal by Subject|1|||
125902466|NCT00732940|452941801|FG001|Overall Study|Withdrawal by Subject|2|||
125902467|NCT00732940|452941800|FG000|Overall Study|Adverse Event|0|||
125902468|NCT00732940|452941801|FG001|Overall Study|Adverse Event|1|||
125902469|NCT00732940|452941800|FG000|Overall Study|Lost to Follow-up|1|||
125902470|NCT00732940|452941801|FG001|Overall Study|Lost to Follow-up|0|||
125902471|NCT02241889|452941802|FG000|Overall Study|device issues|0|||
125902472|NCT02241889|452941803|FG001|Overall Study|device issues|0|||
125902473|NCT02241889|452941804|FG002|Overall Study|device issues|1|||
125902474|NCT02241889|452941805|FG003|Overall Study|device issues|0|||
125902475|NCT02241889|452941806|FG004|Overall Study|device issues|0|||
125902476|NCT02241889|452941807|FG005|Overall Study|device issues|0|||
125902477|NCT02241889|452941802|FG000|Overall Study|Withdrawal by Subject|0|||
125902478|NCT02241889|452941803|FG001|Overall Study|Withdrawal by Subject|0|||
125902479|NCT02241889|452941804|FG002|Overall Study|Withdrawal by Subject|0|||
125902480|NCT02241889|452941805|FG003|Overall Study|Withdrawal by Subject|0|||
125902481|NCT02241889|452941806|FG004|Overall Study|Withdrawal by Subject|0|||
125902482|NCT02241889|452941807|FG005|Overall Study|Withdrawal by Subject|1|||
125902483|NCT01120067|452941813|FG000|Overall Study|Lost to Follow-up|3|||
125902484|NCT01120067|452941814|FG001|Overall Study|Lost to Follow-up|1|||
125902485|NCT01120067|452941813|FG000|Overall Study|fail to engage >3 sessions|2|||
125902486|NCT01120067|452941814|FG001|Overall Study|fail to engage >3 sessions|0|||
125902487|NCT00266877|452941816|FG000|Overall Study|Death|1|||
125902488|NCT00266877|452941817|FG001|Overall Study|Death|1|||
125902489|NCT00266877|452941818|FG002|Overall Study|Death|1|||
125902490|NCT00266877|452941816|FG000|Overall Study|Adverse Event|6|||
125902491|NCT00266877|452941817|FG001|Overall Study|Adverse Event|4|||
125902492|NCT00266877|452941818|FG002|Overall Study|Adverse Event|1|||
125902493|NCT00266877|452941816|FG000|Overall Study|Physician Decision|2|||
125902494|NCT00266877|452941817|FG001|Overall Study|Physician Decision|1|||
125902495|NCT00266877|452941818|FG002|Overall Study|Physician Decision|1|||
125902496|NCT00266877|452941816|FG000|Overall Study|Withdrawal by Subject|3|||
125902497|NCT00266877|452941817|FG001|Overall Study|Withdrawal by Subject|1|||
125902498|NCT00266877|452941818|FG002|Overall Study|Withdrawal by Subject|1|||
125902499|NCT00266877|452941816|FG000|Overall Study|Disease Progression|72|||
125902500|NCT00266877|452941817|FG001|Overall Study|Disease Progression|37|||
125902501|NCT00266877|452941818|FG002|Overall Study|Disease Progression|23|||
125902502|NCT00266877|452941816|FG000|Overall Study|Symptomatic Deterioration|6|||
125902503|NCT00266877|452941817|FG001|Overall Study|Symptomatic Deterioration|3|||
125902504|NCT00266877|452941818|FG002|Overall Study|Symptomatic Deterioration|1|||
125902505|NCT00266877|452941816|FG000|Overall Study|Hospitalization|1|||
125902506|NCT00266877|452941817|FG001|Overall Study|Hospitalization|0|||
125902507|NCT00266877|452941818|FG002|Overall Study|Hospitalization|0|||
125902508|NCT00266877|452941816|FG000|Overall Study|Concomitant Radiotherapy|0|||
125902509|NCT00266877|452941817|FG001|Overall Study|Concomitant Radiotherapy|1|||
125902510|NCT00266877|452941818|FG002|Overall Study|Concomitant Radiotherapy|0|||
125902511|NCT03985878|452941827|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
125902512|NCT03985878|452941827|FG000|Overall Study|Study Terminated by Sponsor|12|||
125902513|NCT03985878|452941827|FG000|Overall Study|Withdrawal by Subject|1|||
125902514|NCT00002931|452943055|FG000|Overall Study|rapidly progressing disease during|2|||
125902515|NCT00910247|452943057|FG000|Overall Study|Adverse Event|15|||
125902516|NCT00910247|452943057|FG000|Overall Study|Death|2|||
125902517|NCT00910247|452943057|FG000|Overall Study|Lost to Follow-up|10|||
125902518|NCT00910247|452943057|FG000|Overall Study|Physician Decision|3|||
125902519|NCT00910247|452943057|FG000|Overall Study|Protocol Violation|10|||
125902520|NCT00910247|452943057|FG000|Overall Study|Withdrawal by Subject|25|||
125902521|NCT00910247|452943057|FG000|Overall Study|Not collected|4|||
125902522|NCT01879579|452943058|FG000|Overall Study|Phone incompatible with texting platform|3|||
125902523|NCT01879579|452943059|FG001|Overall Study|Phone incompatible with texting platform|0|||
125902524|NCT01879579|452943058|FG000|Overall Study|Did not enroll in texting platform|1|||
125902525|NCT01879579|452943059|FG001|Overall Study|Did not enroll in texting platform|0|||
125902526|NCT01879579|452943058|FG000|Overall Study|Did not initiate insulin treatment|1|||
125902527|NCT01879579|452943059|FG001|Overall Study|Did not initiate insulin treatment|0|||
125902528|NCT01879579|452943058|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
125902529|NCT01879579|452943059|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
125902530|NCT01879579|452943058|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
125902531|NCT01879579|452943059|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
125902532|NCT01757691|452943063|FG000|Overall Study|Administrative problems|2|||
125902533|NCT01757691|452943064|FG001|Overall Study|Administrative problems|0|||
125902534|NCT02919969|452943071|FG000|Overall Study|Lack of Efficacy|22|||
125902535|NCT02919969|452943071|FG000|Overall Study|Death|4|||
125902536|NCT02919969|452943071|FG000|Overall Study|Physician Decision|3|||
125902537|NCT02919969|452943071|FG000|Overall Study|Withdrawal by Subject|2|||
125902538|NCT01842633|452943072|FG000|Overall Study|Screen Failure|1|||
125902539|NCT01842633|452943073|FG001|Overall Study|Screen Failure|0|||
125902540|NCT01842633|452943074|FG002|Overall Study|Screen Failure|0|||
125902541|NCT01842633|452943072|FG000|Overall Study|Adverse Event|1|||
125902542|NCT01842633|452943073|FG001|Overall Study|Adverse Event|1|||
125902543|NCT01842633|452943074|FG002|Overall Study|Adverse Event|0|||
125902544|NCT01842633|452943072|FG000|Overall Study|Withdrawal by Subject|0|||
125902545|NCT01842633|452943073|FG001|Overall Study|Withdrawal by Subject|1|||
125902546|NCT01842633|452943074|FG002|Overall Study|Withdrawal by Subject|0|||
125902547|NCT01842633|452943072|FG000|Overall Study|Technical issues|1|||
125902548|NCT01842633|452943073|FG001|Overall Study|Technical issues|0|||
125902549|NCT01842633|452943074|FG002|Overall Study|Technical issues|0|||
125902550|NCT01122394|452943079|FG000|Overall Study|Withdrawal by Subject|1|||
125902551|NCT01122394|452943080|FG001|Overall Study|Withdrawal by Subject|1|||
125902552|NCT01122394|452943079|FG000|Overall Study|Lost to Follow-up|2|||
125902553|NCT01122394|452943080|FG001|Overall Study|Lost to Follow-up|2|||
125902554|NCT01122394|452943079|FG000|Overall Study|Adverse Event|0|||
125902555|NCT01122394|452943080|FG001|Overall Study|Adverse Event|1|||
125902556|NCT00718081|452943083|FG000|Overall Study|Adverse Event|0|||
125902557|NCT00718081|452943084|FG001|Overall Study|Adverse Event|1|||
125902558|NCT00718081|452943085|FG002|Overall Study|Adverse Event|0|||
125902559|NCT00718081|452943083|FG000|Overall Study|Lack of Efficacy|7|||
125902560|NCT00718081|452943084|FG001|Overall Study|Lack of Efficacy|3|||
125902561|NCT00718081|452943085|FG002|Overall Study|Lack of Efficacy|21|||
125902562|NCT01397825|452943087|FG000|Overall Study|Progressive Disease|10|||
125902563|NCT01397825|452943088|FG001|Overall Study|Progressive Disease|3|||
125902564|NCT01397825|452943089|FG002|Overall Study|Progressive Disease|11|||
125902565|NCT01397825|452943090|FG003|Overall Study|Progressive Disease|1|||
125902566|NCT01397825|452943091|FG004|Overall Study|Progressive Disease|0|||
125902567|NCT01397825|452943087|FG000|Overall Study|Symptomatic Deterioration|2|||
125902568|NCT01397825|452943088|FG001|Overall Study|Symptomatic Deterioration|0|||
125902569|NCT01397825|452943089|FG002|Overall Study|Symptomatic Deterioration|4|||
125902570|NCT01397825|452943090|FG003|Overall Study|Symptomatic Deterioration|0|||
125902571|NCT01397825|452943091|FG004|Overall Study|Symptomatic Deterioration|0|||
125902572|NCT01397825|452943087|FG000|Overall Study|Adverse Event|0|||
125902573|NCT01397825|452943088|FG001|Overall Study|Adverse Event|1|||
125902574|NCT01397825|452943089|FG002|Overall Study|Adverse Event|5|||
125902575|NCT01397825|452943090|FG003|Overall Study|Adverse Event|1|||
125902576|NCT01397825|452943091|FG004|Overall Study|Adverse Event|0|||
125902577|NCT01397825|452943087|FG000|Overall Study|Withdrawal by Subject|1|||
125902578|NCT01397825|452943088|FG001|Overall Study|Withdrawal by Subject|0|||
125902579|NCT01397825|452943089|FG002|Overall Study|Withdrawal by Subject|5|||
125902580|NCT01397825|452943090|FG003|Overall Study|Withdrawal by Subject|1|||
125902581|NCT01397825|452943091|FG004|Overall Study|Withdrawal by Subject|0|||
125902582|NCT01931670|452943092|FG000|Treatment Period|Exclusionary Medication Received|1|||
125902583|NCT01931670|452943093|FG001|Treatment Period|Exclusionary Medication Received|1|||
125902584|NCT01931670|452943094|FG002|Treatment Period|Exclusionary Medication Received|1|||
125902585|NCT01931670|452943092|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
125902586|NCT01931670|452943093|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
125902587|NCT01931670|452943094|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
125902588|NCT01931670|452943092|FG000|Treatment Period|Subject Noncompliant|4|||
125902589|NCT01931670|452943093|FG001|Treatment Period|Subject Noncompliant|9|||
125902590|NCT01931670|452943094|FG002|Treatment Period|Subject Noncompliant|5|||
125902591|NCT01931670|452943092|FG000|Treatment Period|Adverse Event|19|||
125902592|NCT01931670|452943093|FG001|Treatment Period|Adverse Event|8|||
125902593|NCT01931670|452943094|FG002|Treatment Period|Adverse Event|21|||
125902594|NCT01931670|452943092|FG000|Treatment Period|Lack of Efficacy|11|||
125902595|NCT01931670|452943093|FG001|Treatment Period|Lack of Efficacy|2|||
125902596|NCT01931670|452943094|FG002|Treatment Period|Lack of Efficacy|2|||
125902597|NCT01931670|452943092|FG000|Treatment Period|Pregnancy|7|||
125902598|NCT01931670|452943093|FG001|Treatment Period|Pregnancy|2|||
125902599|NCT01931670|452943094|FG002|Treatment Period|Pregnancy|0|||
125902600|NCT01931670|452943092|FG000|Treatment Period|Other|8|||
125902601|NCT01931670|452943093|FG001|Treatment Period|Other|7|||
125902602|NCT01931670|452943094|FG002|Treatment Period|Other|2|||
125902603|NCT01931670|452943092|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
125902604|NCT01931670|452943093|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
125902605|NCT01931670|452943094|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
125902606|NCT01931670|452943092|FG000|Treatment Period|Lost to Follow-up|19|||
125902607|NCT01931670|452943093|FG001|Treatment Period|Lost to Follow-up|5|||
125902608|NCT01931670|452943094|FG002|Treatment Period|Lost to Follow-up|7|||
125902609|NCT01931670|452943092|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
125902610|NCT01931670|452943093|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
125902611|NCT01931670|452943094|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
125902612|NCT01931670|452943092|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
125902613|NCT01931670|452943093|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
125902614|NCT01931670|452943094|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
125902615|NCT01931670|452943092|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
125902616|NCT01931670|452943093|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
125902617|NCT01931670|452943094|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
125902618|NCT01931670|452943092|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
125902619|NCT01931670|452943093|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
125902620|NCT01931670|452943094|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
125902621|NCT01931670|452943092|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
125902622|NCT01931670|452943093|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
125902623|NCT01931670|452943094|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
125902624|NCT01931670|452943092|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
125902625|NCT01931670|452943093|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
125902626|NCT01931670|452943094|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
125902627|NCT00815516|452943095|FG000|Overall Study|Death|3|||
125902628|NCT00815516|452943096|FG001|Overall Study|Death|1|||
125902629|NCT00815516|452943095|FG000|Overall Study|Physician Decision|1|||
125902630|NCT00815516|452943096|FG001|Overall Study|Physician Decision|0|||
125902631|NCT01992159|452943103|FG000|Overall Study|Withdrawal by Subject|4|||
125902632|NCT01992159|452943104|FG001|Overall Study|Withdrawal by Subject|7|||
125902633|NCT01992159|452943105|FG002|Overall Study|Withdrawal by Subject|0|||
125902634|NCT01992159|452943106|FG003|Overall Study|Withdrawal by Subject|3|||
125902635|NCT01992159|452943103|FG000|Overall Study|Adverse Event|0|||
125902636|NCT01992159|452943104|FG001|Overall Study|Adverse Event|1|||
125902637|NCT01992159|452943105|FG002|Overall Study|Adverse Event|0|||
125902638|NCT01992159|452943106|FG003|Overall Study|Adverse Event|1|||
125902639|NCT01992159|452943103|FG000|Overall Study|Death|0|||
125902640|NCT01992159|452943104|FG001|Overall Study|Death|0|||
125902641|NCT01992159|452943105|FG002|Overall Study|Death|1|||
125902642|NCT01992159|452943106|FG003|Overall Study|Death|0|||
125902643|NCT03023046|452943107|FG000|Overall Study|Withdrawal by Subject|1|||
125902644|NCT01741012|452943108|FG000|Overall Study|Lost to Follow-up|1|||
125902645|NCT01741012|452943108|FG000|Overall Study|Withdrawal by Subject|2|||
125902646|NCT04393298|452943111|FG000|Overall Study|Adverse Event|0|||
125902647|NCT04393298|452943112|FG001|Overall Study|Adverse Event|0|||
125902648|NCT04393298|452943113|FG002|Overall Study|Adverse Event|0|||
125902649|NCT04393298|452943114|FG003|Overall Study|Adverse Event|0|||
125902650|NCT04393298|452943115|FG004|Overall Study|Adverse Event|1|||
125902651|NCT04393298|452943116|FG005|Overall Study|Adverse Event|0|||
125902652|NCT04393298|452943117|FG006|Overall Study|Adverse Event|0|||
125902653|NCT04393298|452943118|FG007|Overall Study|Adverse Event|0|||
125902654|NCT04393298|452943119|FG008|Overall Study|Adverse Event|2|||
125902655|NCT04393298|452943120|FG009|Overall Study|Adverse Event|0|||
125902656|NCT04393298|452943121|FG010|Overall Study|Adverse Event|0|||
125902657|NCT04393298|452943122|FG011|Overall Study|Adverse Event|0|||
125902658|NCT04393298|452943123|FG012|Overall Study|Adverse Event|1|||
125902659|NCT04393298|452943124|FG013|Overall Study|Adverse Event|1|||
125902660|NCT04393298|452943125|FG014|Overall Study|Adverse Event|0|||
125902661|NCT04393298|452943111|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126059788|NCT01528605|453512577|FG003|Overall Study|Lost to Follow-up|1|||
126059789|NCT01528605|453512578|FG004|Overall Study|Lost to Follow-up|0|||
126059790|NCT01528605|453512579|FG005|Overall Study|Lost to Follow-up|0|||
126059791|NCT01528605|453512574|FG000|Overall Study|Death|1|||
126059792|NCT01528605|453512575|FG001|Overall Study|Death|0|||
125902662|NCT04393298|452943112|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902663|NCT04393298|452943113|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
125902664|NCT04393298|452943114|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902665|NCT04393298|452943115|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902666|NCT04393298|452943116|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902667|NCT04393298|452943117|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902668|NCT04393298|452943118|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902669|NCT04393298|452943119|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902670|NCT04393298|452943120|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126059793|NCT01528605|453512576|FG002|Overall Study|Death|0|||
125902671|NCT04393298|452943121|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902672|NCT04393298|452943122|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902673|NCT04393298|452943123|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902674|NCT04393298|452943124|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125902675|NCT04393298|452943125|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
125902676|NCT04393298|452943111|FG000|Overall Study|Lack of Efficacy|0|||
125902677|NCT04393298|452943112|FG001|Overall Study|Lack of Efficacy|0|||
125902678|NCT04393298|452943113|FG002|Overall Study|Lack of Efficacy|0|||
125902679|NCT04393298|452943114|FG003|Overall Study|Lack of Efficacy|0|||
125902680|NCT04393298|452943115|FG004|Overall Study|Lack of Efficacy|0|||
125902681|NCT04393298|452943116|FG005|Overall Study|Lack of Efficacy|0|||
125902682|NCT04393298|452943117|FG006|Overall Study|Lack of Efficacy|0|||
125902683|NCT04393298|452943118|FG007|Overall Study|Lack of Efficacy|0|||
125902684|NCT04393298|452943119|FG008|Overall Study|Lack of Efficacy|0|||
125902685|NCT04393298|452943120|FG009|Overall Study|Lack of Efficacy|0|||
125902686|NCT04393298|452943121|FG010|Overall Study|Lack of Efficacy|0|||
125902687|NCT04393298|452943122|FG011|Overall Study|Lack of Efficacy|0|||
125902688|NCT04393298|452943123|FG012|Overall Study|Lack of Efficacy|0|||
125902689|NCT04393298|452943124|FG013|Overall Study|Lack of Efficacy|0|||
125902690|NCT04393298|452943125|FG014|Overall Study|Lack of Efficacy|1|||
125902691|NCT04393298|452943111|FG000|Overall Study|Progression|1|||
125902692|NCT04393298|452943112|FG001|Overall Study|Progression|0|||
125902693|NCT04393298|452943113|FG002|Overall Study|Progression|0|||
125902694|NCT04393298|452943114|FG003|Overall Study|Progression|0|||
125902695|NCT04393298|452943115|FG004|Overall Study|Progression|0|||
125902696|NCT04393298|452943116|FG005|Overall Study|Progression|0|||
125902697|NCT04393298|452943117|FG006|Overall Study|Progression|0|||
125902698|NCT04393298|452943118|FG007|Overall Study|Progression|0|||
125902699|NCT04393298|452943119|FG008|Overall Study|Progression|0|||
125902700|NCT04393298|452943120|FG009|Overall Study|Progression|0|||
125902701|NCT04393298|452943121|FG010|Overall Study|Progression|1|||
125902702|NCT04393298|452943122|FG011|Overall Study|Progression|1|||
125902703|NCT04393298|452943123|FG012|Overall Study|Progression|0|||
125902704|NCT04393298|452943124|FG013|Overall Study|Progression|0|||
125902705|NCT04393298|452943125|FG014|Overall Study|Progression|0|||
125902706|NCT04393298|452943111|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
125902707|NCT04393298|452943112|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902708|NCT04393298|452943113|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902709|NCT04393298|452943114|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902710|NCT04393298|452943115|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902711|NCT04393298|452943116|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902712|NCT04393298|452943117|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902713|NCT04393298|452943118|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902714|NCT04393298|452943119|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902715|NCT04393298|452943120|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902716|NCT04393298|452943121|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902717|NCT04393298|452943122|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902718|NCT04393298|452943123|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902719|NCT04393298|452943124|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902720|NCT04393298|452943125|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
125902721|NCT04393298|452943111|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902722|NCT04393298|452943112|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
125902723|NCT04393298|452943113|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902724|NCT04393298|452943114|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902725|NCT04393298|452943115|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902726|NCT04393298|452943116|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902727|NCT04393298|452943117|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902728|NCT04393298|452943118|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902729|NCT04393298|452943119|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902730|NCT04393298|452943120|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902731|NCT04393298|452943121|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902732|NCT04393298|452943122|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902733|NCT04393298|452943123|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902734|NCT04393298|452943124|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902735|NCT04393298|452943125|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125902736|NCT04393298|452943111|FG000|Overall Study|Clinical Progression|0|||
125902737|NCT04393298|452943112|FG001|Overall Study|Clinical Progression|2|||
125902738|NCT04393298|452943113|FG002|Overall Study|Clinical Progression|0|||
125902739|NCT04393298|452943114|FG003|Overall Study|Clinical Progression|0|||
125902740|NCT04393298|452943115|FG004|Overall Study|Clinical Progression|0|||
125902741|NCT04393298|452943116|FG005|Overall Study|Clinical Progression|0|||
125902742|NCT04393298|452943117|FG006|Overall Study|Clinical Progression|0|||
125902743|NCT04393298|452943118|FG007|Overall Study|Clinical Progression|0|||
125902744|NCT04393298|452943119|FG008|Overall Study|Clinical Progression|0|||
125902745|NCT04393298|452943120|FG009|Overall Study|Clinical Progression|0|||
125902746|NCT04393298|452943121|FG010|Overall Study|Clinical Progression|0|||
125902747|NCT04393298|452943122|FG011|Overall Study|Clinical Progression|0|||
125902748|NCT04393298|452943123|FG012|Overall Study|Clinical Progression|0|||
125902749|NCT04393298|452943124|FG013|Overall Study|Clinical Progression|0|||
125902750|NCT04393298|452943125|FG014|Overall Study|Clinical Progression|0|||
125902751|NCT04393298|452943111|FG000|Overall Study|Disease Progression|0|||
125902752|NCT04393298|452943112|FG001|Overall Study|Disease Progression|1|||
125902753|NCT04393298|452943113|FG002|Overall Study|Disease Progression|0|||
125902754|NCT04393298|452943114|FG003|Overall Study|Disease Progression|0|||
125902755|NCT04393298|452943115|FG004|Overall Study|Disease Progression|0|||
125902756|NCT04393298|452943116|FG005|Overall Study|Disease Progression|3|||
125902757|NCT04393298|452943117|FG006|Overall Study|Disease Progression|2|||
125902758|NCT04393298|452943118|FG007|Overall Study|Disease Progression|1|||
125902759|NCT04393298|452943119|FG008|Overall Study|Disease Progression|2|||
125902760|NCT04393298|452943120|FG009|Overall Study|Disease Progression|1|||
125902761|NCT04393298|452943121|FG010|Overall Study|Disease Progression|0|||
125902762|NCT04393298|452943122|FG011|Overall Study|Disease Progression|3|||
125902763|NCT04393298|452943123|FG012|Overall Study|Disease Progression|0|||
125902764|NCT04393298|452943124|FG013|Overall Study|Disease Progression|0|||
125902765|NCT04393298|452943125|FG014|Overall Study|Disease Progression|1|||
125902766|NCT04393298|452943111|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902767|NCT04393298|452943112|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902768|NCT04393298|452943113|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
125902769|NCT04393298|452943114|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902770|NCT04393298|452943115|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902771|NCT04393298|452943116|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902772|NCT04393298|452943117|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902773|NCT04393298|452943118|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902774|NCT04393298|452943119|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902775|NCT04393298|452943120|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902776|NCT04393298|452943121|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902777|NCT04393298|452943122|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902778|NCT04393298|452943123|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902779|NCT04393298|452943124|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902780|NCT04393298|452943125|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125902781|NCT04393298|452943111|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902782|NCT04393298|452943112|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902783|NCT04393298|452943113|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
125902784|NCT04393298|452943114|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902785|NCT04393298|452943115|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902786|NCT04393298|452943116|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902787|NCT04393298|452943117|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902788|NCT04393298|452943118|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902789|NCT04393298|452943119|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902790|NCT04393298|452943120|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902791|NCT04393298|452943121|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902792|NCT04393298|452943122|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902793|NCT04393298|452943123|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902794|NCT04393298|452943124|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902795|NCT04393298|452943125|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
125902796|NCT04393298|452943111|FG000|Overall Study|Progressive Disease (PD)|0|||
125902797|NCT04393298|452943112|FG001|Overall Study|Progressive Disease (PD)|0|||
125902798|NCT04393298|452943113|FG002|Overall Study|Progressive Disease (PD)|0|||
125902799|NCT04393298|452943114|FG003|Overall Study|Progressive Disease (PD)|3|||
125902800|NCT04393298|452943115|FG004|Overall Study|Progressive Disease (PD)|0|||
125902801|NCT04393298|452943116|FG005|Overall Study|Progressive Disease (PD)|0|||
125902802|NCT04393298|452943117|FG006|Overall Study|Progressive Disease (PD)|0|||
125902803|NCT04393298|452943118|FG007|Overall Study|Progressive Disease (PD)|0|||
125902804|NCT04393298|452943119|FG008|Overall Study|Progressive Disease (PD)|0|||
125902805|NCT04393298|452943120|FG009|Overall Study|Progressive Disease (PD)|0|||
125902806|NCT04393298|452943121|FG010|Overall Study|Progressive Disease (PD)|0|||
125902807|NCT04393298|452943122|FG011|Overall Study|Progressive Disease (PD)|0|||
125902808|NCT04393298|452943123|FG012|Overall Study|Progressive Disease (PD)|0|||
125902809|NCT04393298|452943124|FG013|Overall Study|Progressive Disease (PD)|0|||
125902810|NCT04393298|452943125|FG014|Overall Study|Progressive Disease (PD)|0|||
125902811|NCT04393298|452943111|FG000|Overall Study|Started a New Cancer Treatment|0|||
125902812|NCT04393298|452943112|FG001|Overall Study|Started a New Cancer Treatment|0|||
126059794|NCT01528605|453512577|FG003|Overall Study|Death|0|||
125902813|NCT04393298|452943113|FG002|Overall Study|Started a New Cancer Treatment|0|||
125902814|NCT04393298|452943114|FG003|Overall Study|Started a New Cancer Treatment|0|||
125902815|NCT04393298|452943115|FG004|Overall Study|Started a New Cancer Treatment|1|||
125902816|NCT04393298|452943116|FG005|Overall Study|Started a New Cancer Treatment|0|||
125902817|NCT04393298|452943117|FG006|Overall Study|Started a New Cancer Treatment|0|||
125902818|NCT04393298|452943118|FG007|Overall Study|Started a New Cancer Treatment|0|||
125902819|NCT04393298|452943119|FG008|Overall Study|Started a New Cancer Treatment|0|||
125902820|NCT04393298|452943120|FG009|Overall Study|Started a New Cancer Treatment|0|||
125902821|NCT04393298|452943121|FG010|Overall Study|Started a New Cancer Treatment|0|||
125902822|NCT04393298|452943122|FG011|Overall Study|Started a New Cancer Treatment|0|||
125902823|NCT04393298|452943123|FG012|Overall Study|Started a New Cancer Treatment|0|||
125902824|NCT04393298|452943124|FG013|Overall Study|Started a New Cancer Treatment|0|||
125902825|NCT04393298|452943125|FG014|Overall Study|Started a New Cancer Treatment|0|||
125902826|NCT04393298|452943111|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902827|NCT04393298|452943112|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902828|NCT04393298|452943113|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902829|NCT04393298|452943114|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902830|NCT04393298|452943115|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
125902831|NCT04393298|452943116|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902832|NCT04393298|452943117|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902833|NCT04393298|452943118|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902834|NCT04393298|452943119|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902835|NCT04393298|452943120|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902836|NCT04393298|452943121|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902837|NCT04393298|452943122|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902838|NCT04393298|452943123|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902839|NCT04393298|452943124|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902840|NCT04393298|452943125|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125902841|NCT04393298|452943111|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902842|NCT04393298|452943112|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902843|NCT04393298|452943113|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902844|NCT04393298|452943114|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902845|NCT04393298|452943115|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902846|NCT04393298|452943116|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
125902847|NCT04393298|452943117|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902848|NCT04393298|452943118|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902849|NCT04393298|452943119|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902850|NCT04393298|452943120|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902851|NCT04393298|452943121|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902852|NCT04393298|452943122|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126059795|NCT01528605|453512578|FG004|Overall Study|Death|0|||
126059796|NCT01528605|453512579|FG005|Overall Study|Death|0|||
126059797|NCT01156675|453512580|FG000|Overall Study|Death|5|||
126059798|NCT01156675|453512581|FG001|Overall Study|Death|3|||
125902853|NCT04393298|452943123|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902854|NCT04393298|452943124|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902855|NCT04393298|452943125|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125902856|NCT04393298|452943111|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902857|NCT04393298|452943112|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902858|NCT04393298|452943113|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902859|NCT04393298|452943114|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902860|NCT04393298|452943115|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902861|NCT04393298|452943116|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
125902862|NCT04393298|452943117|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902863|NCT04393298|452943118|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902864|NCT04393298|452943119|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902865|NCT04393298|452943120|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902866|NCT04393298|452943121|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902867|NCT04393298|452943122|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902868|NCT04393298|452943123|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902869|NCT04393298|452943124|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125902870|NCT04393298|452943125|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
125902871|NCT04393298|452943111|FG000|Overall Study|Death|0|||
125902872|NCT04393298|452943112|FG001|Overall Study|Death|0|||
125902873|NCT04393298|452943113|FG002|Overall Study|Death|0|||
125902874|NCT04393298|452943114|FG003|Overall Study|Death|0|||
125902875|NCT04393298|452943115|FG004|Overall Study|Death|0|||
125902876|NCT04393298|452943116|FG005|Overall Study|Death|1|||
125902877|NCT04393298|452943117|FG006|Overall Study|Death|1|||
125902878|NCT04393298|452943118|FG007|Overall Study|Death|0|||
125902879|NCT04393298|452943119|FG008|Overall Study|Death|1|||
125902880|NCT04393298|452943120|FG009|Overall Study|Death|1|||
125902881|NCT04393298|452943121|FG010|Overall Study|Death|0|||
125902882|NCT04393298|452943122|FG011|Overall Study|Death|1|||
125902883|NCT04393298|452943123|FG012|Overall Study|Death|1|||
125902884|NCT04393298|452943124|FG013|Overall Study|Death|0|||
125902885|NCT04393298|452943125|FG014|Overall Study|Death|1|||
125902886|NCT04393298|452943111|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902887|NCT04393298|452943112|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902888|NCT04393298|452943113|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902889|NCT04393298|452943114|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902890|NCT04393298|452943115|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902891|NCT04393298|452943116|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
125902892|NCT04393298|452943117|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902893|NCT04393298|452943118|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902894|NCT04393298|452943119|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902895|NCT04393298|452943120|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126059799|NCT01156675|453512582|FG002|Overall Study|Death|0|||
126059800|NCT01156675|453512580|FG000|Overall Study|No data|29|||
126059801|NCT01156675|453512581|FG001|Overall Study|No data|22|||
126059802|NCT01156675|453512582|FG002|Overall Study|No data|2|||
125902896|NCT04393298|452943121|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902897|NCT04393298|452943122|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902898|NCT04393298|452943123|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902899|NCT04393298|452943124|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902900|NCT04393298|452943125|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125902901|NCT04393298|452943111|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
125902902|NCT04393298|452943112|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
125902903|NCT04393298|452943113|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
125902904|NCT04393298|452943114|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
125902905|NCT04393298|452943115|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
125902906|NCT04393298|452943116|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
125902907|NCT04393298|452943117|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
125902908|NCT04393298|452943118|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
125902909|NCT04393298|452943119|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
125902910|NCT04393298|452943120|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
125902911|NCT04393298|452943121|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
125902912|NCT04393298|452943122|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
125902913|NCT04393298|452943123|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
125902914|NCT04393298|452943124|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
125902915|NCT04393298|452943125|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
125902916|NCT04393298|452943111|FG000|Overall Study|Patient Passed Away|0|||
125902917|NCT04393298|452943112|FG001|Overall Study|Patient Passed Away|0|||
125902918|NCT04393298|452943113|FG002|Overall Study|Patient Passed Away|0|||
125902919|NCT04393298|452943114|FG003|Overall Study|Patient Passed Away|0|||
125902920|NCT04393298|452943115|FG004|Overall Study|Patient Passed Away|0|||
125902921|NCT04393298|452943116|FG005|Overall Study|Patient Passed Away|0|||
125902922|NCT04393298|452943117|FG006|Overall Study|Patient Passed Away|0|||
125902923|NCT04393298|452943118|FG007|Overall Study|Patient Passed Away|1|||
125902924|NCT04393298|452943119|FG008|Overall Study|Patient Passed Away|0|||
125902925|NCT04393298|452943120|FG009|Overall Study|Patient Passed Away|0|||
125902926|NCT04393298|452943121|FG010|Overall Study|Patient Passed Away|0|||
125902927|NCT04393298|452943122|FG011|Overall Study|Patient Passed Away|0|||
125902928|NCT04393298|452943123|FG012|Overall Study|Patient Passed Away|0|||
125902929|NCT04393298|452943124|FG013|Overall Study|Patient Passed Away|0|||
125902930|NCT04393298|452943125|FG014|Overall Study|Patient Passed Away|0|||
125902931|NCT04393298|452943111|FG000|Overall Study|Patient Deceased|0|||
125902932|NCT04393298|452943112|FG001|Overall Study|Patient Deceased|0|||
125902933|NCT04393298|452943113|FG002|Overall Study|Patient Deceased|0|||
125902934|NCT04393298|452943114|FG003|Overall Study|Patient Deceased|0|||
125902935|NCT04393298|452943115|FG004|Overall Study|Patient Deceased|0|||
125902936|NCT04393298|452943116|FG005|Overall Study|Patient Deceased|0|||
125902937|NCT04393298|452943117|FG006|Overall Study|Patient Deceased|0|||
125902938|NCT04393298|452943118|FG007|Overall Study|Patient Deceased|1|||
125902939|NCT04393298|452943119|FG008|Overall Study|Patient Deceased|0|||
125902940|NCT04393298|452943120|FG009|Overall Study|Patient Deceased|0|||
125902941|NCT04393298|452943121|FG010|Overall Study|Patient Deceased|0|||
125902942|NCT04393298|452943122|FG011|Overall Study|Patient Deceased|0|||
125902943|NCT04393298|452943123|FG012|Overall Study|Patient Deceased|0|||
125902944|NCT04393298|452943124|FG013|Overall Study|Patient Deceased|0|||
125902945|NCT04393298|452943125|FG014|Overall Study|Patient Deceased|0|||
125902946|NCT04393298|452943111|FG000|Overall Study|Patient Discharged to Hospice|0|||
125902947|NCT04393298|452943112|FG001|Overall Study|Patient Discharged to Hospice|0|||
125902948|NCT04393298|452943113|FG002|Overall Study|Patient Discharged to Hospice|0|||
125902949|NCT04393298|452943114|FG003|Overall Study|Patient Discharged to Hospice|0|||
125902950|NCT04393298|452943115|FG004|Overall Study|Patient Discharged to Hospice|0|||
125902951|NCT04393298|452943116|FG005|Overall Study|Patient Discharged to Hospice|0|||
125902952|NCT04393298|452943117|FG006|Overall Study|Patient Discharged to Hospice|0|||
125902953|NCT04393298|452943118|FG007|Overall Study|Patient Discharged to Hospice|0|||
125902954|NCT04393298|452943119|FG008|Overall Study|Patient Discharged to Hospice|1|||
125902955|NCT04393298|452943120|FG009|Overall Study|Patient Discharged to Hospice|0|||
125902956|NCT04393298|452943121|FG010|Overall Study|Patient Discharged to Hospice|0|||
125902957|NCT04393298|452943122|FG011|Overall Study|Patient Discharged to Hospice|0|||
125902958|NCT04393298|452943123|FG012|Overall Study|Patient Discharged to Hospice|0|||
125902959|NCT04393298|452943124|FG013|Overall Study|Patient Discharged to Hospice|0|||
125902960|NCT04393298|452943125|FG014|Overall Study|Patient Discharged to Hospice|0|||
125902961|NCT04393298|452943111|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902962|NCT04393298|452943112|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902963|NCT04393298|452943113|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902964|NCT04393298|452943114|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902965|NCT04393298|452943115|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902966|NCT04393298|452943116|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902967|NCT04393298|452943117|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902968|NCT04393298|452943118|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902969|NCT04393298|452943119|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902970|NCT04393298|452943120|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
125902971|NCT04393298|452943121|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902972|NCT04393298|452943122|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902973|NCT04393298|452943123|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902974|NCT04393298|452943124|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902975|NCT04393298|452943125|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125902976|NCT04393298|452943111|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
125902977|NCT04393298|452943112|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
125902978|NCT04393298|452943113|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
125902979|NCT04393298|452943114|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
125902980|NCT04393298|452943115|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
125902981|NCT04393298|452943116|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
125902982|NCT04393298|452943117|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
125902983|NCT04393298|452943118|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
125902984|NCT04393298|452943119|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
125902985|NCT04393298|452943120|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
125902986|NCT04393298|452943121|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
125902987|NCT04393298|452943122|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
125902988|NCT04393298|452943123|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
125902989|NCT04393298|452943124|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
125902990|NCT04393298|452943125|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
125902991|NCT02311582|452943126|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
125902992|NCT02311582|452943127|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
125902993|NCT02311582|452943128|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
125902994|NCT02311582|452943129|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
125902995|NCT02311582|452943130|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
125902996|NCT04972630|452943132|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
125902997|NCT04972630|452943133|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
125902998|NCT04972630|452943134|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
125902999|NCT01129024|452943142|FG000|Overall Study|Physician Decision|5|||
125903000|NCT01129024|452943142|FG000|Overall Study|Study Terminated by Sponsor|8|||
125903001|NCT01129024|452943142|FG000|Overall Study|Withdrawal by Subject|2|||
125903002|NCT01129024|452943142|FG000|Overall Study|Lack of Efficacy|3|||
125903003|NCT01129024|452943142|FG000|Overall Study|Needed a Platelet Transfusion|1|||
125903004|NCT00924781|452943145|FG000|Overall Study|Study terminated by sponsor|12|||
125903005|NCT00924781|452943146|FG001|Overall Study|Study terminated by sponsor|10|||
125903006|NCT02048241|452943151|FG000|Overall Study|Withdrawal by Subject|0|||
125903007|NCT02048241|452943152|FG001|Overall Study|Withdrawal by Subject|1|||
125903008|NCT00402233|452943153|FG000|Overall Study|Adverse Event|1|||
125903009|NCT00402233|452943154|FG001|Overall Study|Adverse Event|7|||
125903010|NCT00402233|452943155|FG002|Overall Study|Adverse Event|9|||
125903011|NCT00402233|452943156|FG003|Overall Study|Adverse Event|9|||
125903012|NCT00402233|452943153|FG000|Overall Study|Protocol Violation|0|||
125903013|NCT00402233|452943154|FG001|Overall Study|Protocol Violation|1|||
125903014|NCT00402233|452943155|FG002|Overall Study|Protocol Violation|0|||
125903015|NCT00402233|452943156|FG003|Overall Study|Protocol Violation|0|||
125903016|NCT00402233|452943153|FG000|Overall Study|Withdrawal by Subject|2|||
125903017|NCT00402233|452943154|FG001|Overall Study|Withdrawal by Subject|1|||
125903018|NCT00402233|452943155|FG002|Overall Study|Withdrawal by Subject|2|||
125903019|NCT00402233|452943156|FG003|Overall Study|Withdrawal by Subject|2|||
125903020|NCT00402233|452943153|FG000|Overall Study|Worsening of disease under study|2|||
125903021|NCT00402233|452943154|FG001|Overall Study|Worsening of disease under study|0|||
125903022|NCT00402233|452943155|FG002|Overall Study|Worsening of disease under study|0|||
125903023|NCT00402233|452943156|FG003|Overall Study|Worsening of disease under study|0|||
125903024|NCT00402233|452943153|FG000|Overall Study|Worsening of other pre-existing disease|0|||
125903025|NCT00402233|452943154|FG001|Overall Study|Worsening of other pre-existing disease|1|||
125903026|NCT00402233|452943155|FG002|Overall Study|Worsening of other pre-existing disease|0|||
125903027|NCT00402233|452943156|FG003|Overall Study|Worsening of other pre-existing disease|0|||
125903028|NCT04658940|452943157|FG000|Overall Study|Withdrawal by Subject|1|||
125903029|NCT03579602|452943158|FG000|Overall Study|Subject unable to receive study drug|0|||
125903030|NCT03579602|452943159|FG001|Overall Study|Subject unable to receive study drug|2|||
125903031|NCT03579602|452943158|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
125903032|NCT03579602|452943159|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
125903033|NCT02518464|452943160|FG000|Overall Study|Adverse Event|2|||
125903034|NCT00604214|452943183|FG000|Baseline to Day 28|Death|223|||
125903035|NCT00604214|452943184|FG001|Baseline to Day 28|Death|202|||
125903036|NCT00604214|452943183|FG000|Baseline to Day 28|Lost to Follow-up|2|||
125903037|NCT00604214|452943184|FG001|Baseline to Day 28|Lost to Follow-up|4|||
125903038|NCT00604214|452943183|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
125903039|NCT00604214|452943184|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
125903040|NCT00604214|452943183|FG000|Day 29 to Day 90|Death|64|||
125903041|NCT00604214|452943184|FG001|Day 29 to Day 90|Death|67|||
125903042|NCT00604214|452943183|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
125903043|NCT00604214|452943184|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
126059803|NCT02326220|453512583|FG000|Double-blind Treatment Period|Adverse Event|1|||
126059804|NCT02326220|453512584|FG001|Double-blind Treatment Period|Adverse Event|2|||
126059805|NCT02326220|453512585|FG002|Double-blind Treatment Period|Adverse Event|0|||
126059806|NCT02326220|453512583|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126059807|NCT02326220|453512584|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126059808|NCT02326220|453512585|FG002|Double-blind Treatment Period|Protocol Violation|0|||
126059809|NCT02326220|453512583|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126059810|NCT02326220|453512584|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126059811|NCT02326220|453512585|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126059812|NCT02326220|453512583|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
126059813|NCT02326220|453512584|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126059814|NCT02326220|453512585|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
126110091|NCT02598557|453697632|FG002|Overall Study|Adverse Event|0|||
126059815|NCT02326220|453512583|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126059816|NCT02326220|453512584|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
126059817|NCT02326220|453512585|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
126059818|NCT02699099|453512586|FG000|Overall Study|Adverse Event|1|||
125903044|NCT00604214|452943183|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
125903045|NCT00604214|452943184|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
125903046|NCT00604214|452943183|FG000|Day 91 to Day 180|Death|19|||
126059819|NCT02699099|453512587|FG001|Overall Study|Adverse Event|0|||
126059820|NCT02699099|453512588|FG002|Overall Study|Adverse Event|2|||
126110092|NCT01637623|453697635|FG000|Overall Study|Lost to Follow-up|0|||
125903047|NCT00604214|452943184|FG001|Day 91 to Day 180|Death|23|||
125903048|NCT00604214|452943183|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
125903049|NCT00604214|452943184|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
125903050|NCT00604214|452943183|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
125903051|NCT00604214|452943184|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
125903052|NCT00686998|452943185|FG000|Overall Study|Adverse Event|3|||
125903053|NCT00686998|452943186|FG001|Overall Study|Adverse Event|2|||
125903054|NCT00686998|452943187|FG002|Overall Study|Adverse Event|1|||
125903055|NCT00686998|452943185|FG000|Overall Study|Withdrawal by Subject|2|||
125903056|NCT00686998|452943186|FG001|Overall Study|Withdrawal by Subject|1|||
125903057|NCT00686998|452943187|FG002|Overall Study|Withdrawal by Subject|2|||
125903058|NCT00686998|452943185|FG000|Overall Study|Lack of Efficacy|7|||
125903059|NCT00686998|452943186|FG001|Overall Study|Lack of Efficacy|5|||
125903060|NCT00686998|452943187|FG002|Overall Study|Lack of Efficacy|0|||
125903061|NCT00686998|452943185|FG000|Overall Study|Other|0|||
125903062|NCT00686998|452943186|FG001|Overall Study|Other|0|||
125903063|NCT00686998|452943187|FG002|Overall Study|Other|1|||
125903064|NCT00686998|452943185|FG000|Overall Study|Safety Reasons|1|||
125903065|NCT00686998|452943186|FG001|Overall Study|Safety Reasons|0|||
125903066|NCT00686998|452943187|FG002|Overall Study|Safety Reasons|0|||
125903067|NCT00130442|452944315|FG000|Overall Study|Withdrawal by Subject|0|||
125903068|NCT00130442|452944316|FG001|Overall Study|Withdrawal by Subject|1|||
125903069|NCT00130442|452944315|FG000|Overall Study|did not meet criteria|1|||
125903070|NCT00130442|452944316|FG001|Overall Study|did not meet criteria|1|||
125903071|NCT02233946|452944317|FG000|Baseline|Withdrawal by Subject|2|||
125903072|NCT02233946|452944318|FG001|Baseline|Withdrawal by Subject|0|||
125903073|NCT02233946|452944317|FG000|3-months Follow-up|Lost to Follow-up|53|||
125903074|NCT02233946|452944318|FG001|3-months Follow-up|Lost to Follow-up|29|||
125903075|NCT02233946|452944317|FG000|6-months Follow-up|Lost to Follow-up|21|||
125903076|NCT02233946|452944318|FG001|6-months Follow-up|Lost to Follow-up|2|||
125903077|NCT02233946|452944317|FG000|9-month Follow-up|Lost to Follow-up|20|||
125903078|NCT02233946|452944318|FG001|9-month Follow-up|Lost to Follow-up|11|||
125903079|NCT02233946|452944317|FG000|12-month Follow-up|Lost to Follow-up|28|||
125903080|NCT02233946|452944318|FG001|12-month Follow-up|Lost to Follow-up|11|||
125903081|NCT02054481|452944321|FG000|Overall Study|Adverse Event|1|||
125903082|NCT02054481|452944322|FG001|Overall Study|Adverse Event|1|||
125903083|NCT02054481|452944323|FG002|Overall Study|Adverse Event|0|||
125903084|NCT02054481|452944324|FG003|Overall Study|Adverse Event|1|||
125903085|NCT02054481|452944321|FG000|Overall Study|Lost to Follow-up|1|||
125903086|NCT02054481|452944322|FG001|Overall Study|Lost to Follow-up|0|||
125903087|NCT02054481|452944323|FG002|Overall Study|Lost to Follow-up|0|||
125903088|NCT02054481|452944324|FG003|Overall Study|Lost to Follow-up|0|||
125903089|NCT02054481|452944321|FG000|Overall Study|Other reason|2|||
125903090|NCT02054481|452944322|FG001|Overall Study|Other reason|1|||
125903091|NCT02054481|452944323|FG002|Overall Study|Other reason|2|||
125903092|NCT02054481|452944324|FG003|Overall Study|Other reason|0|||
125903093|NCT02320903|452944325|FG000|Overall Study|Withdrawal by Subject|0|||
125903094|NCT02320903|452944326|FG001|Overall Study|Withdrawal by Subject|9|||
125903095|NCT02320903|452944327|FG002|Overall Study|Withdrawal by Subject|9|||
125903096|NCT02320903|452944325|FG000|Overall Study|Exited therapy; no longer eligible|8|||
125903097|NCT02320903|452944326|FG001|Overall Study|Exited therapy; no longer eligible|2|||
125903098|NCT02320903|452944327|FG002|Overall Study|Exited therapy; no longer eligible|2|||
125903099|NCT02320903|452944325|FG000|Overall Study|Lost to Follow-up|0|||
125903100|NCT02320903|452944326|FG001|Overall Study|Lost to Follow-up|5|||
125903101|NCT02320903|452944327|FG002|Overall Study|Lost to Follow-up|5|||
125903102|NCT00773383|452944328|FG000|Overall Study|Adverse Event|4|||
125903103|NCT00773383|452944328|FG000|Overall Study|Death|1|||
125903104|NCT00773383|452944328|FG000|Overall Study|Progression of Disease|23|||
125903105|NCT00773383|452944328|FG000|Overall Study|Other|2|||
125903106|NCT00773383|452944328|FG000|Overall Study|No study dose received|1|||
125903107|NCT03384693|452944329|FG000|Overall Study|Adverse Event|3|||
125903108|NCT03621475|452944332|FG000|Overall Study|No longer required restraints at initiation|0|||
125903109|NCT03621475|452944333|FG001|Overall Study|No longer required restraints at initiation|1|||
125903110|NCT01095094|452944335|FG000|Overall Study|Withdrawal by Subject|1|||
125903111|NCT01095094|452944335|FG000|Overall Study|Death|1|||
125903112|NCT01095094|452944335|FG000|Overall Study|Physician Decision|1|||
125903113|NCT02093351|452944336|FG000|Part A|Adverse Event|0|||
126059821|NCT02699099|453512586|FG000|Overall Study|Lost to Follow-up|0|||
126059822|NCT02699099|453512587|FG001|Overall Study|Lost to Follow-up|1|||
125903114|NCT02093351|452944337|FG001|Part A|Adverse Event|1|||
125903115|NCT02093351|452944338|FG002|Part A|Adverse Event|1|||
125903116|NCT02093351|452944339|FG003|Part A|Adverse Event|0|||
125903117|NCT02093351|452944336|FG000|Part A|Condition under investigation worsened|2|||
125903118|NCT02093351|452944337|FG001|Part A|Condition under investigation worsened|0|||
125903119|NCT02093351|452944338|FG002|Part A|Condition under investigation worsened|2|||
126059823|NCT02699099|453512588|FG002|Overall Study|Lost to Follow-up|0|||
126110093|NCT01637623|453697636|FG001|Overall Study|Lost to Follow-up|0|||
125903120|NCT02093351|452944339|FG003|Part A|Condition under investigation worsened|0|||
125903121|NCT02093351|452944336|FG000|Part A|Death|0|||
125903122|NCT02093351|452944337|FG001|Part A|Death|1|||
125903123|NCT02093351|452944338|FG002|Part A|Death|0|||
125903124|NCT02093351|452944339|FG003|Part A|Death|0|||
126110094|NCT01637623|453697637|FG002|Overall Study|Lost to Follow-up|2|||
126110095|NCT01637623|453697635|FG000|Overall Study|Physician Decision|1|||
126110096|NCT01637623|453697636|FG001|Overall Study|Physician Decision|0|||
126110097|NCT01637623|453697637|FG002|Overall Study|Physician Decision|1|||
125903125|NCT02093351|452944336|FG000|Part B|Patient decision|0|||
125903126|NCT02093351|452944337|FG001|Part B|Patient decision|0|||
125903127|NCT02093351|452944338|FG002|Part B|Patient decision|0|||
125903128|NCT02093351|452944339|FG003|Part B|Patient decision|3|||
125903129|NCT02093351|452944336|FG000|Part B|Disease progression|0|||
125903130|NCT02093351|452944337|FG001|Part B|Disease progression|0|||
125903131|NCT02093351|452944338|FG002|Part B|Disease progression|0|||
125903132|NCT02093351|452944339|FG003|Part B|Disease progression|4|||
125903133|NCT02093351|452944336|FG000|Part B|Complete response|0|||
125903134|NCT02093351|452944337|FG001|Part B|Complete response|0|||
125903135|NCT02093351|452944338|FG002|Part B|Complete response|0|||
125903136|NCT02093351|452944339|FG003|Part B|Complete response|1|||
125903137|NCT02093351|452944336|FG000|Part B|Adverse event + disease progression|0|||
125903138|NCT02093351|452944337|FG001|Part B|Adverse event + disease progression|0|||
125903139|NCT02093351|452944338|FG002|Part B|Adverse event + disease progression|0|||
125903140|NCT02093351|452944339|FG003|Part B|Adverse event + disease progression|1|||
125903141|NCT02093351|452944336|FG000|Part B|Lack of therapeutic response|0|||
125903142|NCT02093351|452944337|FG001|Part B|Lack of therapeutic response|0|||
125903143|NCT02093351|452944338|FG002|Part B|Lack of therapeutic response|0|||
125903144|NCT02093351|452944339|FG003|Part B|Lack of therapeutic response|12|||
125903145|NCT02093351|452944336|FG000|Part B|Condition under investigation worsened|0|||
125903146|NCT02093351|452944337|FG001|Part B|Condition under investigation worsened|0|||
125903147|NCT02093351|452944338|FG002|Part B|Condition under investigation worsened|0|||
125903148|NCT02093351|452944339|FG003|Part B|Condition under investigation worsened|39|||
125903149|NCT02093351|452944336|FG000|Part B|Adverse Event|0|||
125903150|NCT02093351|452944337|FG001|Part B|Adverse Event|0|||
125903151|NCT02093351|452944338|FG002|Part B|Adverse Event|0|||
125903152|NCT02093351|452944339|FG003|Part B|Adverse Event|2|||
125903153|NCT02093351|452944336|FG000|Part B|Death|0|||
125903154|NCT02093351|452944337|FG001|Part B|Death|0|||
125903155|NCT02093351|452944338|FG002|Part B|Death|0|||
125903156|NCT02093351|452944339|FG003|Part B|Death|1|||
125903157|NCT01099709|452944340|FG000|Period 1|Withdrawal by Subject|0|||
125903158|NCT01099709|452944341|FG001|Period 1|Withdrawal by Subject|1|||
125903159|NCT01099709|452944340|FG000|Period 1|Positive cotinine test|0|||
125903160|NCT01099709|452944341|FG001|Period 1|Positive cotinine test|1|||
125903161|NCT01099709|452944340|FG000|Period 1|Adverse Event|1|||
125903162|NCT01099709|452944341|FG001|Period 1|Adverse Event|0|||
125903163|NCT00039871|452944345|FG000|Overall Study|Adverse Event|165|||
125903164|NCT00039871|452944345|FG000|Overall Study|Lost to Follow-up|18|||
125903165|NCT00039871|452944345|FG000|Overall Study|Protocol Violation|24|||
125903166|NCT00039871|452944345|FG000|Overall Study|Withdrawal by Subject|97|||
125903167|NCT00039871|452944345|FG000|Overall Study|Did not meet eligibility criteria|11|||
125903168|NCT00039871|452944345|FG000|Overall Study|Administrative|1|||
125903169|NCT00039871|452944345|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
125903170|NCT00039871|452944345|FG000|Overall Study|Never entered follow-up|7|||
125903171|NCT01736657|452944350|FG000|Overall Study|insufficient vascular access|1|||
125903172|NCT00997438|452944360|FG000|Overall Study|Blood draw difficulty|2|||
125903173|NCT00997438|452944361|FG001|Overall Study|Blood draw difficulty|0|||
125903174|NCT00997438|452944362|FG002|Overall Study|Blood draw difficulty|1|||
125903175|NCT00997438|452944360|FG000|Overall Study|Withdrawal by Subject|1|||
125903176|NCT00997438|452944361|FG001|Overall Study|Withdrawal by Subject|1|||
125903177|NCT00997438|452944362|FG002|Overall Study|Withdrawal by Subject|0|||
125903178|NCT00997438|452944360|FG000|Overall Study|Exclusion criteria at visit 1|2|||
125903179|NCT00997438|452944361|FG001|Overall Study|Exclusion criteria at visit 1|2|||
125903180|NCT00997438|452944362|FG002|Overall Study|Exclusion criteria at visit 1|3|||
125903181|NCT01236118|452944363|FG000|Overall Study|Adverse Event|2|||
125903182|NCT01236118|452944364|FG001|Overall Study|Adverse Event|0|||
125903183|NCT01236118|452944365|FG002|Overall Study|Adverse Event|2|||
125903184|NCT01236118|452944363|FG000|Overall Study|Physician Decision|0|||
125903185|NCT01236118|452944364|FG001|Overall Study|Physician Decision|1|||
125903186|NCT01236118|452944365|FG002|Overall Study|Physician Decision|0|||
125903187|NCT01236118|452944363|FG000|Overall Study|Withdrawal by Subject|0|||
125903188|NCT01236118|452944364|FG001|Overall Study|Withdrawal by Subject|0|||
125903189|NCT01236118|452944365|FG002|Overall Study|Withdrawal by Subject|1|||
125903190|NCT04656275|452944368|FG000|Overall Study|Study terminated by sponsor|2|||
125903191|NCT04656275|452944369|FG001|Overall Study|Study terminated by sponsor|4|||
125903192|NCT00686634|452944373|FG000|Overall Study|Protocol Violation|6|||
125903193|NCT02361580|452944376|FG000|Overall Study|Lost to Follow-up|6|||
125903194|NCT02361580|452944377|FG001|Overall Study|Lost to Follow-up|3|||
125903195|NCT01653132|452944378|FG000|First Intervention|Protocol Violation|1|||
125903196|NCT01653132|452944379|FG001|First Intervention|Protocol Violation|0|||
125903197|NCT03828370|452944380|FG000|3 Month Follow-up|Lost to Follow-up|4|||
125903198|NCT03828370|452944381|FG001|3 Month Follow-up|Lost to Follow-up|12|||
125903199|NCT03828370|452944380|FG000|9 Month Follow up|Lost to Follow-up|12|||
125903200|NCT03828370|452944381|FG001|9 Month Follow up|Lost to Follow-up|20|||
125903201|NCT02677324|452944382|FG000|Overall Study|Disease Progression|6|||
125903202|NCT02677324|452944382|FG000|Overall Study|Inability to Swallow pills|1|||
125903203|NCT02677324|452944382|FG000|Overall Study|Non-compliance|1|||
126059824|NCT02699099|453512586|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
126059825|NCT02699099|453512587|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
126059826|NCT02699099|453512588|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
126059827|NCT03659136|453512594|FG000|Overall Study|Not treated|2|||
126059828|NCT03659136|453512595|FG001|Overall Study|Not treated|0|||
126059829|NCT03659136|453512594|FG000|Overall Study|Covid-19 related|1|||
126059830|NCT03659136|453512595|FG001|Overall Study|Covid-19 related|1|||
126110098|NCT05628285|453697642|FG000|Overall Study|Lost to Follow-up|1|||
125903204|NCT02677324|452944382|FG000|Overall Study|Lack of Efficacy|1|||
125903205|NCT02677324|452944382|FG000|Overall Study|Medical insurance coverage|1|||
125903206|NCT02677324|452944382|FG000|Overall Study|Adverse Event|1|||
125903207|NCT02677324|452944382|FG000|Overall Study|IgM Myeloma diagnosis|1|||
125903208|NCT03312751|452944385|FG000|Overall Study|Death|7|||
125903209|NCT03312751|452944386|FG001|Overall Study|Death|9|||
125903210|NCT03312751|452944385|FG000|Overall Study|Study discontinuation due to other reason|0|||
125903211|NCT03312751|452944386|FG001|Overall Study|Study discontinuation due to other reason|1|||
125903212|NCT03490981|452944387|FG000|Overall Study|Lost to Follow-up|1|||
125903213|NCT03490981|452944388|FG001|Overall Study|Lost to Follow-up|2|||
125903214|NCT00475423|452944395|FG000|Overall Study|Protocol Violation|5|||
125903215|NCT00475423|452944395|FG000|Overall Study|Adverse Event|4|||
125903216|NCT00475423|452944395|FG000|Overall Study|Withdrawal by Subject|6|||
125903217|NCT00475423|452944395|FG000|Overall Study|Lack of Efficacy|8|||
125903218|NCT00475423|452944395|FG000|Overall Study|Death|1|||
125903219|NCT00475423|452944395|FG000|Overall Study|Reason not specified|1|||
125903220|NCT00475423|452944395|FG000|Overall Study|Lost to Follow-up|7|||
125903221|NCT00046891|452944396|FG000|Overall Study|Cancels|5|||
125903222|NCT00046891|452944397|FG001|Overall Study|Cancels|9|||
125903223|NCT00046891|452944396|FG000|Overall Study|Ineligible|1|||
125903224|NCT00046891|452944397|FG001|Overall Study|Ineligible|1|||
125903225|NCT00046891|452944396|FG000|Overall Study|Withdrawal by Subject|18|||
125903226|NCT00046891|452944397|FG001|Overall Study|Withdrawal by Subject|15|||
125903227|NCT00046891|452944396|FG000|Overall Study|Adverse Event|5|||
125903228|NCT00046891|452944397|FG001|Overall Study|Adverse Event|5|||
125903229|NCT02496676|452944398|FG000|Phase 1 - Period 1|Adverse Event|0|||
125903230|NCT02496676|452944399|FG001|Phase 1 - Period 1|Adverse Event|1|||
125903231|NCT02496676|452944398|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
125903232|NCT02496676|452944399|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
125903233|NCT04381988|452944400|FG000|Overall Study|The study was terminated|4|||
125903234|NCT04381988|452944401|FG001|Overall Study|The study was terminated|0|||
125903235|NCT01624870|452944402|FG000|Overall Study|Death|19|||
125903236|NCT01624870|452944402|FG000|Overall Study|Withdrawal by Subject|1|||
125903237|NCT01624870|452944402|FG000|Overall Study|CoreValve not implanted|6|||
125903238|NCT01624870|452944402|FG000|Overall Study|Lost to follow up|1|||
125903239|NCT04672252|452944406|FG000|Overall Study|Protocol Violation|1|||
125903240|NCT04672252|452944407|FG001|Overall Study|Protocol Violation|0|||
125903241|NCT04391569|452944408|FG000|Overall Study|Death|15|||
125903242|NCT04391569|452944409|FG001|Overall Study|Death|10|||
125903243|NCT04391569|452944408|FG000|Overall Study|Withdrawal by Subject|1|||
125903244|NCT04391569|452944409|FG001|Overall Study|Withdrawal by Subject|0|||
125903245|NCT04391569|452944408|FG000|Overall Study|Lost to Follow-up|3|||
125903246|NCT04391569|452944409|FG001|Overall Study|Lost to Follow-up|2|||
125903247|NCT04391569|452944408|FG000|Overall Study|Lack of Efficacy|0|||
125903248|NCT04391569|452944409|FG001|Overall Study|Lack of Efficacy|1|||
125903249|NCT04391569|452944408|FG000|Overall Study|Participant discharged to hospice facility|0|||
125903250|NCT04391569|452944409|FG001|Overall Study|Participant discharged to hospice facility|1|||
125903251|NCT04391569|452944408|FG000|Overall Study|Participant family decision|1|||
125903252|NCT04391569|452944409|FG001|Overall Study|Participant family decision|0|||
125903253|NCT04391569|452944408|FG000|Overall Study|Participant discharged prematurely|1|||
125903254|NCT04391569|452944409|FG001|Overall Study|Participant discharged prematurely|0|||
125903255|NCT03025035|452944410|FG000|Overall Study|Death|2|||
125903256|NCT03025035|452944410|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
126059831|NCT03659136|453512594|FG000|Overall Study|Withdrawal by Subject|1|||
126059832|NCT03659136|453512595|FG001|Overall Study|Withdrawal by Subject|6|||
126059833|NCT03659136|453512594|FG000|Overall Study|Adverse Event|4|||
126059834|NCT03659136|453512595|FG001|Overall Study|Adverse Event|6|||
126059835|NCT03659136|453512594|FG000|Overall Study|Progressive disease|37|||
126059836|NCT03659136|453512595|FG001|Overall Study|Progressive disease|31|||
126059837|NCT03659136|453512594|FG000|Overall Study|Study closure|2|||
126059838|NCT03659136|453512595|FG001|Overall Study|Study closure|2|||
126059839|NCT03659136|453512594|FG000|Overall Study|Sponsor decision/recommendation|3|||
125903257|NCT01431638|452944411|FG000|Overall Study|Adverse Event|1|||
125903258|NCT01431638|452944412|FG001|Overall Study|Adverse Event|3|||
125903259|NCT01431638|452944413|FG002|Overall Study|Adverse Event|1|||
125903260|NCT01431638|452944411|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125903261|NCT01431638|452944412|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125903262|NCT01431638|452944413|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
125903263|NCT01431638|452944411|FG000|Overall Study|Participants condition no longer requires study drug|0|||
125903264|NCT01431638|452944412|FG001|Overall Study|Participants condition no longer requires study drug|1|||
125903265|NCT01431638|452944413|FG002|Overall Study|Participants condition no longer requires study drug|0|||
125903266|NCT01431638|452944411|FG000|Overall Study|Participant withdrew consent|14|||
126059840|NCT03659136|453512595|FG001|Overall Study|Sponsor decision/recommendation|2|||
126059841|NCT03659136|453512594|FG000|Overall Study|Switched to other drug/therapy|2|||
125903267|NCT01431638|452944412|FG001|Overall Study|Participant withdrew consent|5|||
125903268|NCT01431638|452944413|FG002|Overall Study|Participant withdrew consent|8|||
125903269|NCT01431638|452944411|FG000|Overall Study|Lost to Follow-up|7|||
125903270|NCT01431638|452944412|FG001|Overall Study|Lost to Follow-up|9|||
125903271|NCT01431638|452944413|FG002|Overall Study|Lost to Follow-up|7|||
125903272|NCT01431638|452944411|FG000|Overall Study|Administrative problems|1|||
125903273|NCT01431638|452944412|FG001|Overall Study|Administrative problems|4|||
125903274|NCT01431638|452944413|FG002|Overall Study|Administrative problems|6|||
125903275|NCT01431638|452944411|FG000|Overall Study|Death|1|||
125903276|NCT01431638|452944412|FG001|Overall Study|Death|0|||
125903277|NCT01431638|452944413|FG002|Overall Study|Death|0|||
125903278|NCT01431638|452944411|FG000|Overall Study|Protocol deviation|1|||
125903279|NCT01431638|452944412|FG001|Overall Study|Protocol deviation|1|||
125903280|NCT01431638|452944413|FG002|Overall Study|Protocol deviation|4|||
125903281|NCT01431638|452944411|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
125903282|NCT01431638|452944412|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
125903283|NCT01431638|452944413|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
125903284|NCT00773838|452944414|FG000|Overall Study|Adverse Event|29|||
125903285|NCT00773838|452944414|FG000|Overall Study|Lost to Follow-up|1|||
125903286|NCT00773838|452944414|FG000|Overall Study|Physician Decision|8|||
125903287|NCT00773838|452944414|FG000|Overall Study|Progressive Disease|82|||
125903288|NCT00773838|452944414|FG000|Overall Study|Protocol Violation|2|||
125903289|NCT00773838|452944414|FG000|Overall Study|Withdrawal by Subject|21|||
125903290|NCT03562767|452944417|FG000|Overall Study|Physician Decision|2|||
125903291|NCT03562767|452944418|FG001|Overall Study|Physician Decision|0|||
125903292|NCT03562767|452944419|FG002|Overall Study|Physician Decision|0|||
125903293|NCT03562767|452944417|FG000|Overall Study|Logistic Reason|1|||
125903294|NCT03562767|452944418|FG001|Overall Study|Logistic Reason|3|||
125903295|NCT03562767|452944419|FG002|Overall Study|Logistic Reason|0|||
125903296|NCT01658813|452944420|FG000|Overall Study|Disease progression|3|||
125903297|NCT00938886|452944421|FG000|Overall Study|Death|0|||
125903298|NCT00938886|452944422|FG001|Overall Study|Death|1|||
125903299|NCT00938886|452944421|FG000|Overall Study|Withdrawal by Subject|4|||
126059842|NCT03659136|453512595|FG001|Overall Study|Switched to other drug/therapy|2|||
126059843|NCT03659136|453512594|FG000|Overall Study|Lack of clinical benefit|0|||
126059844|NCT03659136|453512595|FG001|Overall Study|Lack of clinical benefit|1|||
126059845|NCT00647699|453514194|FG000|Overall Study|Lost to Follow-up|5|||
126059846|NCT00647699|453514195|FG001|Overall Study|Lost to Follow-up|4|||
126059847|NCT00647699|453514194|FG000|Overall Study|Withdrawal by Subject|3|||
126059848|NCT00647699|453514195|FG001|Overall Study|Withdrawal by Subject|8|||
126059849|NCT00413283|453514196|FG000|Overall Study|Withdrawal by Subject|1|||
125903300|NCT00938886|452944422|FG001|Overall Study|Withdrawal by Subject|7|||
125903301|NCT00938886|452944421|FG000|Overall Study|Lost to Follow-up|3|||
125903302|NCT00938886|452944422|FG001|Overall Study|Lost to Follow-up|2|||
125903303|NCT02674854|452944423|FG000|Overall Study|Adverse Event|17|||
125903304|NCT02674854|452944424|FG001|Overall Study|Adverse Event|15|||
125903305|NCT02674854|452944425|FG002|Overall Study|Adverse Event|5|||
125903306|NCT02674854|452944423|FG000|Overall Study|Withdrawal by Subject|1|||
125903307|NCT02674854|452944424|FG001|Overall Study|Withdrawal by Subject|5|||
125903308|NCT02674854|452944425|FG002|Overall Study|Withdrawal by Subject|4|||
125903309|NCT02674854|452944423|FG000|Overall Study|No-compliant subject|1|||
126059850|NCT00413283|453514197|FG001|Overall Study|Withdrawal by Subject|0|||
126059851|NCT00413283|453514198|FG002|Overall Study|Withdrawal by Subject|0|||
126059852|NCT00413283|453514199|FG003|Overall Study|Withdrawal by Subject|1|||
125903310|NCT02674854|452944424|FG001|Overall Study|No-compliant subject|0|||
125903311|NCT02674854|452944425|FG002|Overall Study|No-compliant subject|1|||
125903312|NCT02674854|452944423|FG000|Overall Study|Lost to Follow-up|1|||
125903313|NCT02674854|452944424|FG001|Overall Study|Lost to Follow-up|0|||
125903314|NCT02674854|452944425|FG002|Overall Study|Lost to Follow-up|2|||
125903315|NCT02674854|452944423|FG000|Overall Study|Lack of Efficacy|0|||
125903316|NCT02674854|452944424|FG001|Overall Study|Lack of Efficacy|3|||
125903317|NCT02674854|452944425|FG002|Overall Study|Lack of Efficacy|0|||
125903318|NCT02674854|452944423|FG000|Overall Study|Disallowed Concurrent Medication|2|||
125903319|NCT02674854|452944424|FG001|Overall Study|Disallowed Concurrent Medication|2|||
125903320|NCT02674854|452944425|FG002|Overall Study|Disallowed Concurrent Medication|0|||
125903321|NCT02674854|452944423|FG000|Overall Study|Protocol Violation|1|||
125903322|NCT02674854|452944424|FG001|Overall Study|Protocol Violation|1|||
125903323|NCT02674854|452944425|FG002|Overall Study|Protocol Violation|2|||
125903324|NCT02674854|452944423|FG000|Overall Study|Death|0|||
125903325|NCT02674854|452944424|FG001|Overall Study|Death|1|||
125903326|NCT02674854|452944425|FG002|Overall Study|Death|0|||
125903327|NCT02674854|452944423|FG000|Overall Study|Subject missed V6.2|1|||
125903328|NCT02674854|452944424|FG001|Overall Study|Subject missed V6.2|0|||
125903329|NCT02674854|452944425|FG002|Overall Study|Subject missed V6.2|0|||
125903330|NCT00913692|452944426|FG000|Screening (4 Months)|Physician Decision|3|||
125903331|NCT00913692|452944426|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
125903332|NCT00913692|452944426|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
125903333|NCT04231981|452944427|FG000|Overall Study|Adverse Event|1|||
125903334|NCT04231981|452944427|FG000|Overall Study|Death|16|||
125903335|NCT04231981|452944427|FG000|Overall Study|Lost to Follow-up|1|||
125903336|NCT02889562|452944428|FG000|Overall Study|Physician Decision|0|||
125903337|NCT02889562|452944429|FG001|Overall Study|Physician Decision|1|||
125903338|NCT02889562|452944428|FG000|Overall Study|Withdrawal by Subject|0|||
125903339|NCT02889562|452944429|FG001|Overall Study|Withdrawal by Subject|1|||
125903340|NCT01470989|452944432|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
125903341|NCT01470989|452944433|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
125903342|NCT01470989|452944432|FG000|Overall Study|Adverse Event|2|||
125903343|NCT01470989|452944433|FG001|Overall Study|Adverse Event|5|||
125903344|NCT01470989|452944432|FG000|Overall Study|Abnormal laboratory value|1|||
125903345|NCT01470989|452944433|FG001|Overall Study|Abnormal laboratory value|1|||
125903346|NCT01470989|452944432|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125903347|NCT01470989|452944433|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125903348|NCT01470989|452944432|FG000|Overall Study|Withdrawal by Subject|19|||
125903349|NCT01470989|452944433|FG001|Overall Study|Withdrawal by Subject|17|||
125903350|NCT01470989|452944432|FG000|Overall Study|Lost to Follow-up|18|||
125903351|NCT01470989|452944433|FG001|Overall Study|Lost to Follow-up|13|||
125903352|NCT01470989|452944432|FG000|Overall Study|Administrative problems|2|||
125903353|NCT01470989|452944433|FG001|Overall Study|Administrative problems|4|||
125903354|NCT01470989|452944432|FG000|Overall Study|Death|2|||
125903355|NCT01470989|452944433|FG001|Overall Study|Death|2|||
125903356|NCT01470989|452944432|FG000|Overall Study|Protocol deviation|1|||
125903357|NCT01470989|452944433|FG001|Overall Study|Protocol deviation|2|||
125903358|NCT00969280|452944434|FG000|Overall Study|Protocol Violation|2|||
125903359|NCT00969280|452944435|FG001|Overall Study|Protocol Violation|1|||
125903360|NCT00969280|452944434|FG000|Overall Study|Withdrawal by Subject|0|||
125903361|NCT00969280|452944435|FG001|Overall Study|Withdrawal by Subject|1|||
125903362|NCT00969280|452944434|FG000|Overall Study|infection of influenza A(H1N1)|0|||
125903363|NCT00969280|452944435|FG001|Overall Study|infection of influenza A(H1N1)|1|||
125903364|NCT02119676|452944436|FG000|Overall Study|Adverse Event|9|||
125903365|NCT02119676|452944437|FG001|Overall Study|Adverse Event|17|||
125903366|NCT02119676|452944438|FG002|Overall Study|Adverse Event|10|||
125903367|NCT02119676|452944439|FG003|Overall Study|Adverse Event|10|||
125903368|NCT02119676|452944436|FG000|Overall Study|Disease progression|53|||
125903369|NCT02119676|452944437|FG001|Overall Study|Disease progression|55|||
125903370|NCT02119676|452944438|FG002|Overall Study|Disease progression|68|||
125903371|NCT02119676|452944439|FG003|Overall Study|Disease progression|73|||
125903372|NCT02119676|452944436|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
125903373|NCT02119676|452944437|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
125903374|NCT02119676|452944438|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
125903375|NCT02119676|452944439|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
125903376|NCT02119676|452944436|FG000|Overall Study|Physician Decision|4|||
125903377|NCT02119676|452944437|FG001|Overall Study|Physician Decision|2|||
125903378|NCT02119676|452944438|FG002|Overall Study|Physician Decision|3|||
125903379|NCT02119676|452944439|FG003|Overall Study|Physician Decision|2|||
125903380|NCT02119676|452944436|FG000|Overall Study|Death|9|||
125903381|NCT02119676|452944437|FG001|Overall Study|Death|3|||
125903382|NCT02119676|452944438|FG002|Overall Study|Death|2|||
125903383|NCT02119676|452944439|FG003|Overall Study|Death|1|||
125903384|NCT02119676|452944436|FG000|Overall Study|Noncompliance|0|||
125903385|NCT02119676|452944437|FG001|Overall Study|Noncompliance|1|||
125903386|NCT02119676|452944438|FG002|Overall Study|Noncompliance|0|||
125903387|NCT02119676|452944439|FG003|Overall Study|Noncompliance|0|||
125903388|NCT02119676|452944436|FG000|Overall Study|Lost to Follow-up|0|||
125903389|NCT02119676|452944437|FG001|Overall Study|Lost to Follow-up|0|||
125903390|NCT02119676|452944438|FG002|Overall Study|Lost to Follow-up|1|||
125903391|NCT02119676|452944439|FG003|Overall Study|Lost to Follow-up|0|||
125903392|NCT02119676|452944436|FG000|Overall Study|Protocol deviation|0|||
125903393|NCT02119676|452944437|FG001|Overall Study|Protocol deviation|0|||
125903394|NCT02119676|452944438|FG002|Overall Study|Protocol deviation|1|||
125903395|NCT02119676|452944439|FG003|Overall Study|Protocol deviation|0|||
125903396|NCT02119676|452944436|FG000|Overall Study|Other, unspecified|2|||
125903397|NCT02119676|452944437|FG001|Overall Study|Other, unspecified|1|||
126110099|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
126110100|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
126110101|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
126110102|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
126110103|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
126110104|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
126110105|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
126110106|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
126110107|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Death|1|||
126110108|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Death|1|||
126110109|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
126110110|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
126110111|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
125903398|NCT02119676|452944438|FG002|Overall Study|Other, unspecified|3|||
125903399|NCT02119676|452944439|FG003|Overall Study|Other, unspecified|4|||
125903400|NCT02119676|452944436|FG000|Overall Study|Did not receive study med|2|||
125903401|NCT02119676|452944437|FG001|Overall Study|Did not receive study med|2|||
125903402|NCT02119676|452944438|FG002|Overall Study|Did not receive study med|4|||
125903403|NCT02119676|452944439|FG003|Overall Study|Did not receive study med|5|||
125903404|NCT00570232|452944440|FG000|Overall Study|Adverse Event|10|||
125903405|NCT00570232|452944440|FG000|Overall Study|discontinued due to medical condition|3|||
125903406|NCT00570232|452944440|FG000|Overall Study|discontinued due to recurrence|8|||
125903407|NCT00570232|452944440|FG000|Overall Study|discontinued due to noncompliance|2|||
126059853|NCT00413283|453514196|FG000|Overall Study|Death|0|||
126059854|NCT00413283|453514197|FG001|Overall Study|Death|0|||
126059855|NCT00413283|453514198|FG002|Overall Study|Death|1|||
125903408|NCT02216812|452944441|FG000|Overall Study|Lost to Follow-up|10|||
125903409|NCT02216812|452944442|FG001|Overall Study|Lost to Follow-up|5|||
125903410|NCT01585584|452944443|FG000|Overall Study|Lack of Efficacy|1|||
125903411|NCT01585584|452944443|FG000|Overall Study|Withdrawal by Subject|1|||
125903412|NCT01585584|452944443|FG000|Overall Study|Physician Decision|2|||
125903413|NCT00266864|452944444|FG000|Overall Study|Lost to Follow-up|4|||
125903414|NCT00266864|452944445|FG001|Overall Study|Lost to Follow-up|1|||
125903415|NCT00266864|452944444|FG000|Overall Study|Withdrawal by Subject|1|||
125903416|NCT00266864|452944445|FG001|Overall Study|Withdrawal by Subject|1|||
126059856|NCT00413283|453514199|FG003|Overall Study|Death|1|||
125903417|NCT01163318|452944446|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
126059857|NCT00413283|453514196|FG000|Overall Study|Adverse Event|0|||
125903418|NCT01163318|452944446|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
125903419|NCT01163318|452944446|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
125903420|NCT01163318|452944446|FG000|Overall Study|Participants Without Case Report Form|7|||
125903421|NCT01163318|452944446|FG000|Overall Study|Multiple Reasons Per Participant|224|||
125903422|NCT01006603|452944448|FG000|Overall Study|Withdrawal by Subject|17|||
125903423|NCT01006603|452944449|FG001|Overall Study|Withdrawal by Subject|19|||
125903424|NCT01006603|452944448|FG000|Overall Study|Lost to Follow-up|0|||
125903425|NCT01006603|452944449|FG001|Overall Study|Lost to Follow-up|1|||
125903426|NCT01006603|452944448|FG000|Overall Study|Safety reason|1|||
125903427|NCT01006603|452944449|FG001|Overall Study|Safety reason|1|||
125903428|NCT01006603|452944448|FG000|Overall Study|Protocol Violation|1|||
125903429|NCT01006603|452944449|FG001|Overall Study|Protocol Violation|3|||
125903430|NCT01006603|452944448|FG000|Overall Study|Incorrect enrolment|0|||
125903431|NCT01006603|452944449|FG001|Overall Study|Incorrect enrolment|2|||
125903432|NCT01006603|452944448|FG000|Overall Study|Adverse Event|15|||
125903433|NCT01006603|452944449|FG001|Overall Study|Adverse Event|7|||
125903434|NCT01006603|452944448|FG000|Overall Study|Death|1|||
125903435|NCT01006603|452944449|FG001|Overall Study|Death|1|||
125903436|NCT01006603|452944448|FG000|Overall Study|Study specific discontinuation criteria|33|||
125903437|NCT01006603|452944449|FG001|Overall Study|Study specific discontinuation criteria|34|||
125903438|NCT01006603|452944448|FG000|Overall Study|Other|3|||
125903439|NCT01006603|452944449|FG001|Overall Study|Other|7|||
125903440|NCT04085367|452945900|FG000|Overall Study|Adverse Event|1|||
125903441|NCT04085367|452945901|FG001|Overall Study|Adverse Event|1|||
125903442|NCT04085367|452945900|FG000|Overall Study|Withdrawal by Subject|13|||
125903443|NCT04085367|452945901|FG001|Overall Study|Withdrawal by Subject|4|||
125903444|NCT04085367|452945900|FG000|Overall Study|Lost to Follow-up|3|||
125903445|NCT04085367|452945901|FG001|Overall Study|Lost to Follow-up|1|||
125903446|NCT04085367|452945900|FG000|Overall Study|Other unspecified|2|||
125903447|NCT04085367|452945901|FG001|Overall Study|Other unspecified|1|||
125903448|NCT04085367|452945900|FG000|Overall Study|Status Unknown|1|||
125903449|NCT04085367|452945901|FG001|Overall Study|Status Unknown|1|||
125903450|NCT01611454|452945913|FG000|Overall Study|Lack of Efficacy|18|||
125903451|NCT01611454|452945914|FG001|Overall Study|Lack of Efficacy|10|||
125903452|NCT03269552|452945915|FG000|Overall Study|Adverse Event|2|||
125903453|NCT04389970|452945916|FG000|Overall Study|Lost to Follow-up|1|||
125903454|NCT00470158|452945920|FG000|Overall Study|Death|0|||
125903455|NCT00470158|452945921|FG001|Overall Study|Death|0|||
125903456|NCT00470158|452945922|FG002|Overall Study|Death|0|||
125903457|NCT00470158|452945923|FG003|Overall Study|Death|0|||
125903458|NCT00470158|452945924|FG004|Overall Study|Death|2|||
125903459|NCT00470158|452945920|FG000|Overall Study|Lost to Follow-up|7|||
125903460|NCT00470158|452945921|FG001|Overall Study|Lost to Follow-up|8|||
125903461|NCT00470158|452945922|FG002|Overall Study|Lost to Follow-up|8|||
125903462|NCT00470158|452945923|FG003|Overall Study|Lost to Follow-up|5|||
125903463|NCT00470158|452945924|FG004|Overall Study|Lost to Follow-up|4|||
125903464|NCT00470158|452945920|FG000|Overall Study|Protocol Violation|1|||
125903465|NCT00470158|452945921|FG001|Overall Study|Protocol Violation|0|||
125903466|NCT00470158|452945922|FG002|Overall Study|Protocol Violation|0|||
125903467|NCT00470158|452945923|FG003|Overall Study|Protocol Violation|0|||
125903468|NCT00470158|452945924|FG004|Overall Study|Protocol Violation|0|||
125903469|NCT01249118|452945925|FG000|First Washout Period|Physician Decision|0|||
125903470|NCT01249118|452945926|FG001|First Washout Period|Physician Decision|1|||
125903471|NCT01249118|452945927|FG002|First Washout Period|Physician Decision|0|||
125903472|NCT00880685|452945928|FG000|Memantine 10mg|Lost to Follow-up|2|||
125903473|NCT00880685|452945928|FG000|Memantine 20mg|Withdrawal by Subject|1|||
125903474|NCT00095238|452945929|FG000|Overall Study|Lack of Efficacy|9|||
125903475|NCT00095238|452945930|FG001|Overall Study|Lack of Efficacy|9|||
125903476|NCT00095238|452945929|FG000|Overall Study|Adverse Event|331|||
125903477|NCT00095238|452945930|FG001|Overall Study|Adverse Event|287|||
125903478|NCT00095238|452945929|FG000|Overall Study|Subject Withdrew Consent|208|||
125903479|NCT00095238|452945930|FG001|Overall Study|Subject Withdrew Consent|223|||
125903480|NCT00095238|452945929|FG000|Overall Study|Death|154|||
125903481|NCT00095238|452945930|FG001|Overall Study|Death|170|||
125903482|NCT00095238|452945929|FG000|Overall Study|Lost to Follow-up|19|||
125903483|NCT00095238|452945930|FG001|Overall Study|Lost to Follow-up|24|||
125903484|NCT00095238|452945929|FG000|Overall Study|Noncompliance|44|||
125903485|NCT00095238|452945930|FG001|Overall Study|Noncompliance|45|||
125903486|NCT00095238|452945929|FG000|Overall Study|No longer met study criteria|4|||
125903487|NCT00095238|452945930|FG001|Overall Study|No longer met study criteria|5|||
125903488|NCT00095238|452945929|FG000|Overall Study|Study terminated by sponsor|0|||
125903489|NCT00095238|452945930|FG001|Overall Study|Study terminated by sponsor|1|||
125903490|NCT00095238|452945929|FG000|Overall Study|Missing|1|||
125903491|NCT00095238|452945930|FG001|Overall Study|Missing|0|||
125903492|NCT00095238|452945929|FG000|Overall Study|Other Reasons|87|||
125903493|NCT00095238|452945930|FG001|Overall Study|Other Reasons|88|||
125903494|NCT03505671|452945931|FG000|Overall Study|Withdrawal by Subject|2|||
125903495|NCT03505671|452945932|FG001|Overall Study|Withdrawal by Subject|1|||
125903496|NCT03505671|452945931|FG000|Overall Study|Lost to Follow-up|1|||
125903497|NCT03505671|452945932|FG001|Overall Study|Lost to Follow-up|0|||
125903498|NCT04535167|452945933|FG000|Treatment|Adverse Event|0|||
125903499|NCT04535167|452945934|FG001|Treatment|Adverse Event|0|||
125903500|NCT04535167|452945935|FG002|Treatment|Adverse Event|0|||
125903501|NCT04535167|452945936|FG003|Treatment|Adverse Event|0|||
125903502|NCT04535167|452945937|FG004|Treatment|Adverse Event|0|||
125903503|NCT04535167|452945938|FG005|Treatment|Adverse Event|0|||
125903504|NCT04535167|452945939|FG006|Treatment|Adverse Event|1|||
125903505|NCT04535167|452945933|FG000|Follow-Up|Death|0|||
125903506|NCT04535167|452945934|FG001|Follow-Up|Death|0|||
125903507|NCT04535167|452945935|FG002|Follow-Up|Death|0|||
125903508|NCT04535167|452945936|FG003|Follow-Up|Death|0|||
125903509|NCT04535167|452945937|FG004|Follow-Up|Death|0|||
125903510|NCT04535167|452945938|FG005|Follow-Up|Death|0|||
125903511|NCT04535167|452945939|FG006|Follow-Up|Death|1|||
125903512|NCT04535167|452945933|FG000|Follow-Up|Lost to Follow-up|0|||
125903513|NCT04535167|452945934|FG001|Follow-Up|Lost to Follow-up|0|||
125903514|NCT04535167|452945935|FG002|Follow-Up|Lost to Follow-up|0|||
125903515|NCT04535167|452945936|FG003|Follow-Up|Lost to Follow-up|1|||
125903516|NCT04535167|452945937|FG004|Follow-Up|Lost to Follow-up|0|||
125903517|NCT04535167|452945938|FG005|Follow-Up|Lost to Follow-up|0|||
125903518|NCT04535167|452945939|FG006|Follow-Up|Lost to Follow-up|0|||
125903519|NCT02038829|452945940|FG000|Washout Period 1|Death|0|||
125903520|NCT02038829|452945941|FG001|Washout Period 1|Death|0|||
125903521|NCT02038829|452945942|FG002|Washout Period 1|Death|0|||
125903522|NCT02038829|452945943|FG003|Washout Period 1|Death|0|||
125903523|NCT02038829|452945944|FG004|Washout Period 1|Death|1|||
125903524|NCT02038829|452945945|FG005|Washout Period 1|Death|0|||
125903525|NCT02038829|452945946|FG006|Washout Period 1|Death|0|||
125903526|NCT02038829|452945947|FG007|Washout Period 1|Death|0|||
125903527|NCT02038829|452945948|FG008|Washout Period 1|Death|0|||
125903528|NCT02038829|452945949|FG009|Washout Period 1|Death|0|||
125903529|NCT02038829|452945950|FG010|Washout Period 1|Death|0|||
125903530|NCT02038829|452945951|FG011|Washout Period 1|Death|0|||
125903531|NCT02038829|452945940|FG000|Treatment Period 2|Adverse Event|0|||
125903532|NCT02038829|452945941|FG001|Treatment Period 2|Adverse Event|0|||
125903533|NCT02038829|452945942|FG002|Treatment Period 2|Adverse Event|0|||
125903534|NCT02038829|452945943|FG003|Treatment Period 2|Adverse Event|0|||
125903535|NCT02038829|452945944|FG004|Treatment Period 2|Adverse Event|0|||
125903536|NCT02038829|452945945|FG005|Treatment Period 2|Adverse Event|0|||
125903537|NCT02038829|452945946|FG006|Treatment Period 2|Adverse Event|0|||
125903538|NCT02038829|452945947|FG007|Treatment Period 2|Adverse Event|0|||
125903539|NCT02038829|452945948|FG008|Treatment Period 2|Adverse Event|0|||
125903540|NCT02038829|452945949|FG009|Treatment Period 2|Adverse Event|0|||
125903541|NCT02038829|452945950|FG010|Treatment Period 2|Adverse Event|1|||
125903542|NCT02038829|452945951|FG011|Treatment Period 2|Adverse Event|0|||
125903543|NCT02038829|452945940|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125903544|NCT02038829|452945941|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125903545|NCT02038829|452945942|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125903546|NCT02038829|452945943|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125903547|NCT02038829|452945944|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125903548|NCT02038829|452945945|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125903549|NCT02038829|452945946|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125903550|NCT02038829|452945947|FG007|Treatment Period 2|Withdrawal by Subject|0|||
125903551|NCT02038829|452945948|FG008|Treatment Period 2|Withdrawal by Subject|0|||
125903552|NCT02038829|452945949|FG009|Treatment Period 2|Withdrawal by Subject|0|||
125903553|NCT02038829|452945950|FG010|Treatment Period 2|Withdrawal by Subject|0|||
125903554|NCT02038829|452945951|FG011|Treatment Period 2|Withdrawal by Subject|0|||
125903555|NCT02038829|452945940|FG000|Washout Period 2|Adverse Event|0|||
125903556|NCT02038829|452945941|FG001|Washout Period 2|Adverse Event|0|||
125903557|NCT02038829|452945942|FG002|Washout Period 2|Adverse Event|0|||
125903558|NCT02038829|452945943|FG003|Washout Period 2|Adverse Event|0|||
125903559|NCT02038829|452945944|FG004|Washout Period 2|Adverse Event|0|||
125903560|NCT02038829|452945945|FG005|Washout Period 2|Adverse Event|0|||
125903561|NCT02038829|452945946|FG006|Washout Period 2|Adverse Event|0|||
125903562|NCT02038829|452945947|FG007|Washout Period 2|Adverse Event|0|||
125903563|NCT02038829|452945948|FG008|Washout Period 2|Adverse Event|1|||
125903564|NCT02038829|452945949|FG009|Washout Period 2|Adverse Event|0|||
125903565|NCT02038829|452945950|FG010|Washout Period 2|Adverse Event|0|||
125903566|NCT02038829|452945951|FG011|Washout Period 2|Adverse Event|0|||
125903567|NCT02038829|452945940|FG000|Washout Period 2|Withdrawal by Subject|0|||
125903568|NCT02038829|452945941|FG001|Washout Period 2|Withdrawal by Subject|0|||
125903569|NCT02038829|452945942|FG002|Washout Period 2|Withdrawal by Subject|0|||
125903570|NCT02038829|452945943|FG003|Washout Period 2|Withdrawal by Subject|0|||
125903571|NCT02038829|452945944|FG004|Washout Period 2|Withdrawal by Subject|0|||
125903572|NCT02038829|452945945|FG005|Washout Period 2|Withdrawal by Subject|1|||
125903573|NCT02038829|452945946|FG006|Washout Period 2|Withdrawal by Subject|0|||
125903574|NCT02038829|452945947|FG007|Washout Period 2|Withdrawal by Subject|0|||
125903575|NCT02038829|452945948|FG008|Washout Period 2|Withdrawal by Subject|0|||
125903576|NCT02038829|452945949|FG009|Washout Period 2|Withdrawal by Subject|0|||
125903577|NCT02038829|452945950|FG010|Washout Period 2|Withdrawal by Subject|0|||
125903578|NCT02038829|452945951|FG011|Washout Period 2|Withdrawal by Subject|0|||
125903579|NCT02038829|452945940|FG000|Treatment Period 4|Adverse Event|0|||
125903580|NCT02038829|452945941|FG001|Treatment Period 4|Adverse Event|1|||
125903581|NCT02038829|452945942|FG002|Treatment Period 4|Adverse Event|0|||
125903582|NCT02038829|452945943|FG003|Treatment Period 4|Adverse Event|0|||
125903583|NCT02038829|452945944|FG004|Treatment Period 4|Adverse Event|0|||
125903584|NCT02038829|452945945|FG005|Treatment Period 4|Adverse Event|0|||
125903585|NCT02038829|452945946|FG006|Treatment Period 4|Adverse Event|0|||
125903586|NCT02038829|452945947|FG007|Treatment Period 4|Adverse Event|0|||
125903587|NCT02038829|452945948|FG008|Treatment Period 4|Adverse Event|0|||
125903588|NCT02038829|452945949|FG009|Treatment Period 4|Adverse Event|0|||
125903589|NCT02038829|452945950|FG010|Treatment Period 4|Adverse Event|0|||
125903590|NCT02038829|452945951|FG011|Treatment Period 4|Adverse Event|0|||
125903591|NCT02038829|452945940|FG000|Washout Period 4|Adverse Event|0|||
125903592|NCT02038829|452945941|FG001|Washout Period 4|Adverse Event|0|||
125903593|NCT02038829|452945942|FG002|Washout Period 4|Adverse Event|0|||
125903594|NCT02038829|452945943|FG003|Washout Period 4|Adverse Event|0|||
125903595|NCT02038829|452945944|FG004|Washout Period 4|Adverse Event|0|||
125903596|NCT02038829|452945945|FG005|Washout Period 4|Adverse Event|0|||
125903597|NCT02038829|452945946|FG006|Washout Period 4|Adverse Event|1|||
125903598|NCT02038829|452945947|FG007|Washout Period 4|Adverse Event|0|||
125903599|NCT02038829|452945948|FG008|Washout Period 4|Adverse Event|0|||
125903600|NCT02038829|452945949|FG009|Washout Period 4|Adverse Event|0|||
125903601|NCT02038829|452945950|FG010|Washout Period 4|Adverse Event|0|||
125903602|NCT02038829|452945951|FG011|Washout Period 4|Adverse Event|0|||
125903603|NCT02038829|452945940|FG000|Treatment Period 6|Adverse Event|0|||
125903604|NCT02038829|452945941|FG001|Treatment Period 6|Adverse Event|0|||
125903605|NCT02038829|452945942|FG002|Treatment Period 6|Adverse Event|1|||
125903606|NCT02038829|452945943|FG003|Treatment Period 6|Adverse Event|0|||
125903607|NCT02038829|452945944|FG004|Treatment Period 6|Adverse Event|0|||
125903608|NCT02038829|452945945|FG005|Treatment Period 6|Adverse Event|0|||
125903609|NCT02038829|452945946|FG006|Treatment Period 6|Adverse Event|0|||
125903610|NCT02038829|452945947|FG007|Treatment Period 6|Adverse Event|0|||
125903611|NCT02038829|452945948|FG008|Treatment Period 6|Adverse Event|0|||
125903612|NCT02038829|452945949|FG009|Treatment Period 6|Adverse Event|0|||
125903613|NCT02038829|452945950|FG010|Treatment Period 6|Adverse Event|0|||
125903614|NCT02038829|452945951|FG011|Treatment Period 6|Adverse Event|0|||
125903615|NCT00075270|452945952|FG000|Overall Study|Withdrawal by Subject|28|||
125903616|NCT00075270|452945953|FG001|Overall Study|Withdrawal by Subject|21|||
125903617|NCT00075270|452945952|FG000|Overall Study|Lost to Follow-up|25|||
125903618|NCT00075270|452945953|FG001|Overall Study|Lost to Follow-up|28|||
125903619|NCT00075270|452945952|FG000|Overall Study|Protocol Violation|0|||
125903620|NCT00075270|452945953|FG001|Overall Study|Protocol Violation|2|||
125903621|NCT00075270|452945952|FG000|Overall Study|Death|198|||
125903622|NCT00075270|452945953|FG001|Overall Study|Death|215|||
125903623|NCT00075270|452945952|FG000|Overall Study|Other/Unknown|9|||
125903624|NCT00075270|452945953|FG001|Overall Study|Other/Unknown|5|||
125903625|NCT00075270|452945952|FG000|Overall Study|Missing|26|||
125903626|NCT00075270|452945953|FG001|Overall Study|Missing|13|||
125903627|NCT00708201|452945956|FG000|Overall Study|Adverse Event|4|||
125903628|NCT00708201|452945957|FG001|Overall Study|Adverse Event|4|||
125903629|NCT00708201|452945956|FG000|Overall Study|Withdrawal by Subject|1|||
125903630|NCT00708201|452945957|FG001|Overall Study|Withdrawal by Subject|1|||
125903631|NCT00708201|452945956|FG000|Overall Study|Lost to Follow-up|2|||
125903632|NCT00708201|452945957|FG001|Overall Study|Lost to Follow-up|0|||
125903633|NCT00708201|452945956|FG000|Overall Study|Protocol Violation|0|||
125903634|NCT00708201|452945957|FG001|Overall Study|Protocol Violation|1|||
125903635|NCT00282464|452945958|FG000|Overall Study|Adverse Event|26|||
125903636|NCT00282464|452945959|FG001|Overall Study|Adverse Event|20|||
125903637|NCT00282464|452945958|FG000|Overall Study|Lack of Efficacy|8|||
125903638|NCT00282464|452945959|FG001|Overall Study|Lack of Efficacy|8|||
125903639|NCT00282464|452945958|FG000|Overall Study|Lost to Follow-up|10|||
125903640|NCT00282464|452945959|FG001|Overall Study|Lost to Follow-up|10|||
125903641|NCT00282464|452945958|FG000|Overall Study|Withdrawal by Subject|24|||
125903642|NCT00282464|452945959|FG001|Overall Study|Withdrawal by Subject|10|||
125903643|NCT00282464|452945958|FG000|Overall Study|laboratory abnormality|1|||
125903644|NCT00282464|452945959|FG001|Overall Study|laboratory abnormality|2|||
125903645|NCT00282464|452945958|FG000|Overall Study|Protocol Violation|0|||
125903646|NCT00282464|452945959|FG001|Overall Study|Protocol Violation|7|||
125903647|NCT00282464|452945958|FG000|Overall Study|Patient moved|1|||
125903648|NCT00282464|452945959|FG001|Overall Study|Patient moved|0|||
125903649|NCT00282464|452945958|FG000|Overall Study|patient non-compliant|3|||
125903650|NCT00282464|452945959|FG001|Overall Study|patient non-compliant|0|||
125903651|NCT00282464|452945958|FG000|Overall Study|patient no show|0|||
125903652|NCT00282464|452945959|FG001|Overall Study|patient no show|1|||
125903653|NCT00282464|452945958|FG000|Overall Study|patient incarcerated|0|||
125903654|NCT00282464|452945959|FG001|Overall Study|patient incarcerated|1|||
125903655|NCT00282464|452945958|FG000|Overall Study|family crisis|0|||
125903656|NCT00282464|452945959|FG001|Overall Study|family crisis|1|||
125903657|NCT00282464|452945958|FG000|Overall Study|dispensed wrong kit|0|||
125903658|NCT00282464|452945959|FG001|Overall Study|dispensed wrong kit|1|||
125903659|NCT00282464|452945958|FG000|Overall Study|dropped due to missed visits|0|||
125903660|NCT00282464|452945959|FG001|Overall Study|dropped due to missed visits|1|||
125903661|NCT00812487|452945960|FG000|Overall Study|Lost to Follow-up|2|||
125903662|NCT00812487|452945961|FG001|Overall Study|Lost to Follow-up|0|||
125903663|NCT00812487|452945960|FG000|Overall Study|Withdrawal by Subject|3|||
125903664|NCT00812487|452945961|FG001|Overall Study|Withdrawal by Subject|2|||
125903665|NCT00812487|452945960|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
125903666|NCT00812487|452945961|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
125903667|NCT00812487|452945960|FG000|Overall Study|Protocol Violation|0|||
125903668|NCT00812487|452945961|FG001|Overall Study|Protocol Violation|1|||
125903669|NCT02360605|452945962|FG000|Overall Study|Withdrawal by Subject|4|||
125903670|NCT02360605|452945963|FG001|Overall Study|Withdrawal by Subject|9|||
125903671|NCT02360605|452945962|FG000|Overall Study|Lost to Follow-up|7|||
125903672|NCT02360605|452945963|FG001|Overall Study|Lost to Follow-up|8|||
125903673|NCT02360605|452945962|FG000|Overall Study|Death|0|||
125903674|NCT02360605|452945963|FG001|Overall Study|Death|1|||
125903675|NCT00290407|452945966|FG000|Overall Study|Physician Decision|2|||
125903676|NCT01117792|452945968|FG000|Overall Study|Death|1|||
125903677|NCT01117792|452945968|FG000|Overall Study|Adverse Event|3|||
125903678|NCT00723203|452945969|FG000|Overall Study|Withdrawal by Subject|3|||
125903679|NCT01721577|452945970|FG000|Overall Study|Lack of Efficacy|1|||
125903680|NCT01721577|452945971|FG001|Overall Study|Lack of Efficacy|0|||
125903681|NCT01721577|452945970|FG000|Overall Study|Death|1|||
125903682|NCT01721577|452945971|FG001|Overall Study|Death|0|||
125903683|NCT01721577|452945970|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
125903684|NCT01721577|452945971|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
125903685|NCT01721577|452945970|FG000|Overall Study|Adverse Event|0|||
125903686|NCT01721577|452945971|FG001|Overall Study|Adverse Event|2|||
125903687|NCT00740051|452945979|FG000|Overall Study|Lack of Efficacy|2|||
125903688|NCT00740051|452945980|FG001|Overall Study|Lack of Efficacy|5|||
125903689|NCT00740051|452945979|FG000|Overall Study|Adverse Event|1|||
125903690|NCT00740051|452945980|FG001|Overall Study|Adverse Event|4|||
125903691|NCT00740051|452945979|FG000|Overall Study|Protocol Violation|2|||
125903692|NCT00740051|452945980|FG001|Overall Study|Protocol Violation|6|||
125903693|NCT00740051|452945979|FG000|Overall Study|Lost to Follow-up|3|||
125903694|NCT00740051|452945980|FG001|Overall Study|Lost to Follow-up|8|||
125903695|NCT00740051|452945979|FG000|Overall Study|Withdrawal by Subject|6|||
125903696|NCT00740051|452945980|FG001|Overall Study|Withdrawal by Subject|8|||
125903697|NCT00740051|452945979|FG000|Overall Study|Other reason (not specified)|4|||
125903698|NCT00740051|452945980|FG001|Overall Study|Other reason (not specified)|1|||
125903699|NCT00274924|452945981|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
125903700|NCT00274924|452945982|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
125903701|NCT00274924|452945983|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
125903702|NCT00274924|452945981|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
125903703|NCT00274924|452945982|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
125903704|NCT00274924|452945983|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
125903705|NCT00274924|452945981|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
125903706|NCT00274924|452945982|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
125903707|NCT00274924|452945983|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
125903708|NCT00274924|452945981|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
125903709|NCT00274924|452945982|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
125903710|NCT00274924|452945983|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
125903711|NCT00274924|452945981|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
125903712|NCT00274924|452945982|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
125903713|NCT00274924|452945983|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
125903714|NCT00274924|452945981|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
125903715|NCT00274924|452945982|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
125903716|NCT00274924|452945983|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
125903717|NCT00274924|452945981|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
125903718|NCT00274924|452945982|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
125903719|NCT00274924|452945983|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
125903720|NCT00274924|452945981|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
125903721|NCT00274924|452945982|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
125903722|NCT00274924|452945983|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
125903723|NCT00274924|452945981|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
125903724|NCT00274924|452945982|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
125903725|NCT00274924|452945983|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
125903726|NCT00274924|452945981|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
125903727|NCT00274924|452945982|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
125903728|NCT00274924|452945983|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
125903729|NCT00274924|452945981|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
125903730|NCT00274924|452945982|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
125903731|NCT00274924|452945983|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
125903732|NCT00274924|452945981|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
126059858|NCT00413283|453514197|FG001|Overall Study|Adverse Event|0|||
126059859|NCT00413283|453514198|FG002|Overall Study|Adverse Event|0|||
125903733|NCT00274924|452945982|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
125903734|NCT00274924|452945983|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
125903735|NCT00274924|452945981|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
125903736|NCT00274924|452945982|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
125903737|NCT00274924|452945983|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
125903738|NCT01903525|452945987|FG000|Overall Study|Lost to Follow-up|5|||
125903739|NCT01903525|452945988|FG001|Overall Study|Lost to Follow-up|9|||
125903740|NCT01903525|452945987|FG000|Overall Study|Adverse Event|0|||
125903741|NCT01903525|452945988|FG001|Overall Study|Adverse Event|1|||
125903742|NCT02106923|452945994|FG000|Overall Study|Protocol Violation|0|||
125903743|NCT02106923|452945995|FG001|Overall Study|Protocol Violation|0|||
125903744|NCT02106923|452945996|FG002|Overall Study|Protocol Violation|0|||
125903745|NCT02106923|452945997|FG003|Overall Study|Protocol Violation|0|||
125903746|NCT02106923|452945998|FG004|Overall Study|Protocol Violation|0|||
125903747|NCT02106923|452945999|FG005|Overall Study|Protocol Violation|1|||
125903748|NCT03485495|452946000|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
125903749|NCT03485495|452946001|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
125903750|NCT02915874|452946003|FG000|Overall Study|Lost to Follow-up|5|||
125903751|NCT02915874|452946004|FG001|Overall Study|Lost to Follow-up|4|||
125903752|NCT02915874|452946003|FG000|Overall Study|Withdrawal by Subject|1|||
125903753|NCT02915874|452946004|FG001|Overall Study|Withdrawal by Subject|1|||
125903754|NCT02915874|452946003|FG000|Overall Study|Started New Anxiety Medication|0|||
125903755|NCT02915874|452946004|FG001|Overall Study|Started New Anxiety Medication|1|||
125903756|NCT01056380|452946005|FG000|Overall Study|Lost to Follow-up|2|||
125903757|NCT01056380|452946006|FG001|Overall Study|Lost to Follow-up|3|||
125903758|NCT03901456|452946007|FG000|Overall Study|Withdrawal by Subject|0|||
125903759|NCT03901456|452946008|FG001|Overall Study|Withdrawal by Subject|0|||
125903760|NCT03901456|452946009|FG002|Overall Study|Withdrawal by Subject|1|||
125903761|NCT03901456|452946007|FG000|Overall Study|Lost to Follow-up|0|||
125903762|NCT03901456|452946008|FG001|Overall Study|Lost to Follow-up|1|||
125903763|NCT03901456|452946009|FG002|Overall Study|Lost to Follow-up|0|||
125903764|NCT01589770|452946015|FG000|Overall Study|EGFR <60ml/min|6|||
125903765|NCT01589770|452946016|FG001|Overall Study|EGFR <60ml/min|4|||
125903766|NCT01589770|452946015|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
125903767|NCT01589770|452946016|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
125903768|NCT00725842|452946017|FG000|Overall Study|Lost to Follow-up|19|||
125903769|NCT00725842|452946017|FG000|Overall Study|Death|1|||
125903770|NCT00725842|452946017|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
125903771|NCT00725842|452946017|FG000|Overall Study|Consent date prior to study start date|5|||
125903772|NCT00725842|452946017|FG000|Overall Study|Inclusion criterion not met|1|||
125903773|NCT00725842|452946017|FG000|Overall Study|No Visit 1 data|1|||
125903774|NCT01853618|452946018|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
125903775|NCT01853618|452946019|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
125903776|NCT01853618|452946020|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
125903777|NCT01853618|452946021|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
125903778|NCT01853618|452946022|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
125903779|NCT01853618|452946018|FG000|Overall Study|Progressive disease|1|||
125903780|NCT01853618|452946019|FG001|Overall Study|Progressive disease|1|||
125903781|NCT01853618|452946020|FG002|Overall Study|Progressive disease|1|||
125903782|NCT01853618|452946021|FG003|Overall Study|Progressive disease|1|||
126110112|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
126110113|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
125903783|NCT01853618|452946022|FG004|Overall Study|Progressive disease|2|||
125903784|NCT01853618|452946018|FG000|Overall Study|Physician Decision|0|||
125903785|NCT01853618|452946019|FG001|Overall Study|Physician Decision|1|||
125903786|NCT01853618|452946020|FG002|Overall Study|Physician Decision|1|||
125903787|NCT01853618|452946021|FG003|Overall Study|Physician Decision|0|||
125903788|NCT01853618|452946022|FG004|Overall Study|Physician Decision|0|||
125903789|NCT01853618|452946018|FG000|Overall Study|Refused further treatment|0|||
125903790|NCT01853618|452946019|FG001|Overall Study|Refused further treatment|0|||
125903791|NCT01853618|452946020|FG002|Overall Study|Refused further treatment|0|||
125903792|NCT01853618|452946021|FG003|Overall Study|Refused further treatment|0|||
125903793|NCT01853618|452946022|FG004|Overall Study|Refused further treatment|1|||
125903794|NCT01075191|452946025|FG000|Overall Study|Death|1|||
125903795|NCT01075191|452946025|FG000|Overall Study|Intensification|3|||
125903796|NCT01075191|452946025|FG000|Overall Study|Co-morbidities|1|||
125903797|NCT01075191|452946025|FG000|Overall Study|Adverse Event|4|||
125903798|NCT01075191|452946025|FG000|Overall Study|Noncompliance|3|||
125903799|NCT01075191|452946025|FG000|Overall Study|Therapy Break|3|||
125903800|NCT01075191|452946025|FG000|Overall Study|Patient's Wish|2|||
125903801|NCT01075191|452946025|FG000|Overall Study|Unknown Reasons|1|||
125903802|NCT02068768|452946026|FG000|Overall Study|Lost to Follow-up|5|||
125903803|NCT02068768|452946026|FG000|Overall Study|Early Termination by Sponsor|2|||
125903804|NCT04738318|452946027|FG000|Overall Study|Protocol Violation|1|||
125903805|NCT04738318|452946028|FG001|Overall Study|Protocol Violation|0|||
125903806|NCT01226121|452946029|FG000|Overall Study|Lost to Follow-up|2|||
125903807|NCT01226121|452946030|FG001|Overall Study|Lost to Follow-up|0|||
125903808|NCT01226121|452946031|FG002|Overall Study|Lost to Follow-up|1|||
125903809|NCT01037088|452946032|FG000|Overall Study|Withdrawal by Subject|3|||
125903810|NCT00527488|452946033|FG000|Overall Study|Withdrawn prior to dosing|0|||
125903811|NCT00527488|452946034|FG001|Overall Study|Withdrawn prior to dosing|1|||
125903812|NCT00527488|452946035|FG002|Overall Study|Withdrawn prior to dosing|1|||
125903813|NCT00527488|452946036|FG003|Overall Study|Withdrawn prior to dosing|0|||
125903814|NCT01958827|452946037|FG000|Overall Study|Adverse Event|3|||
125903815|NCT01958827|452946037|FG000|Overall Study|Lack of Efficacy|6|||
125903816|NCT01958827|452946037|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
125903817|NCT03036800|452946038|FG000|Overall Study|Protocol Violation|1|||
125903818|NCT03036800|452946039|FG001|Overall Study|Protocol Violation|0|||
125903819|NCT03036800|452946038|FG000|Overall Study|Non-compliance|1|||
125903820|NCT03036800|452946039|FG001|Overall Study|Non-compliance|0|||
125903821|NCT03036800|452946038|FG000|Overall Study|Lost to Follow-up|1|||
125903822|NCT03036800|452946039|FG001|Overall Study|Lost to Follow-up|0|||
125903823|NCT03036800|452946038|FG000|Overall Study|Death|1|||
125903824|NCT03036800|452946039|FG001|Overall Study|Death|0|||
125903825|NCT03036800|452946038|FG000|Overall Study|Tolerance|5|||
125903826|NCT03036800|452946039|FG001|Overall Study|Tolerance|0|||
125903827|NCT03036800|452946038|FG000|Overall Study|Unknown/no reason given|50|||
125903828|NCT03036800|452946039|FG001|Overall Study|Unknown/no reason given|39|||
125903829|NCT01077154|452946040|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
125903830|NCT01077154|452946041|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
125903831|NCT01077154|452946040|FG000|Overall Study|Withdrawal by Subject|369|||
125903832|NCT01077154|452946041|FG001|Overall Study|Withdrawal by Subject|385|||
125903833|NCT01077154|452946040|FG000|Overall Study|Death|215|||
125903834|NCT01077154|452946041|FG001|Overall Study|Death|214|||
125903835|NCT01077154|452946040|FG000|Overall Study|Lost to Follow-up|43|||
125903836|NCT01077154|452946041|FG001|Overall Study|Lost to Follow-up|35|||
125903837|NCT01077154|452946040|FG000|Overall Study|Noncompliance|22|||
125903838|NCT01077154|452946041|FG001|Overall Study|Noncompliance|20|||
125903839|NCT01077154|452946040|FG000|Overall Study|Disease Progression|18|||
125903840|NCT01077154|452946041|FG001|Overall Study|Disease Progression|20|||
125903841|NCT01077154|452946040|FG000|Overall Study|Ineligibility Determined|10|||
125903842|NCT01077154|452946041|FG001|Overall Study|Ineligibility Determined|14|||
125903843|NCT01077154|452946040|FG000|Overall Study|Other|14|||
125903844|NCT01077154|452946041|FG001|Overall Study|Other|11|||
125903845|NCT01077154|452946040|FG000|Overall Study|Adverse Event|9|||
125903846|NCT01077154|452946041|FG001|Overall Study|Adverse Event|9|||
125903847|NCT01077154|452946040|FG000|Overall Study|Administrative Decision|1|||
126059860|NCT00413283|453514199|FG003|Overall Study|Adverse Event|1|||
125903848|NCT01077154|452946041|FG001|Overall Study|Administrative Decision|6|||
125903849|NCT01077154|452946040|FG000|Overall Study|Protocol Deviation|1|||
125903850|NCT01077154|452946041|FG001|Overall Study|Protocol Deviation|0|||
125903851|NCT05985980|452946042|FG000|Overall Study|Withdrawal by Subject|1|||
125903852|NCT05985980|452946042|FG000|Overall Study|Withdrawal by Subject|1|||
125903853|NCT05985980|452946042|FG000|Overall Study|Withdrawal by Subject|1|||
125903854|NCT05985980|452946042|FG000|Overall Study|Withdrawal by Subject|1|||
125903855|NCT02207946|452946043|FG000|Overall Study|Lost to Follow-up|1|||
125903856|NCT02207946|452946044|FG001|Overall Study|Lost to Follow-up|0|||
125903857|NCT02207946|452946043|FG000|Overall Study|Adverse Event|0|||
125903858|NCT02207946|452946044|FG001|Overall Study|Adverse Event|1|||
125903859|NCT00811642|452946045|FG000|Overall Study|Adverse Event|3|||
125903860|NCT00811642|452946045|FG000|Overall Study|Protocol Violation|1|||
125903861|NCT00811642|452946045|FG000|Overall Study|Death|2|||
125903862|NCT00811642|452946045|FG000|Overall Study|Withdrawal by Subject|7|||
125903863|NCT00811642|452946045|FG000|Overall Study|Cumulative use of antifungal agent|2|||
125903864|NCT00706849|452947914|FG000|Treatment Period|Adverse Event|0|||
125903865|NCT00706849|452947915|FG001|Treatment Period|Adverse Event|9|||
125903866|NCT00706849|452947914|FG000|Treatment Period|Other|0|||
125903867|NCT00706849|452947915|FG001|Treatment Period|Other|1|||
125903868|NCT00706849|452947914|FG000|Follow-up Period|Withdrawal by Subject|0|||
125903869|NCT00706849|452947915|FG001|Follow-up Period|Withdrawal by Subject|2|||
125903870|NCT00706849|452947914|FG000|Follow-up Period|Protocol non-compliance|0|||
125903871|NCT00706849|452947915|FG001|Follow-up Period|Protocol non-compliance|1|||
125903872|NCT00920907|452947916|FG000|Induction Period|Adverse Event|0|||
125903873|NCT00920907|452947917|FG001|Induction Period|Adverse Event|2|||
125903874|NCT00920907|452947916|FG000|Induction Period|Death|1|||
125903875|NCT00920907|452947917|FG001|Induction Period|Death|1|||
125903876|NCT00920907|452947916|FG000|Induction Period|Disease Progression|12|||
125903877|NCT00920907|452947917|FG001|Induction Period|Disease Progression|11|||
125903878|NCT00920907|452947916|FG000|Induction Period|Study Drug Toxicity|8|||
125903879|NCT00920907|452947917|FG001|Induction Period|Study Drug Toxicity|6|||
125903880|NCT00920907|452947916|FG000|Induction Period|No longer meets study criteria|0|||
125903881|NCT00920907|452947917|FG001|Induction Period|No longer meets study criteria|1|||
125903882|NCT00920907|452947916|FG000|Induction Period|Withdrawal by Subject|1|||
125903883|NCT00920907|452947917|FG001|Induction Period|Withdrawal by Subject|1|||
125903884|NCT00920907|452947916|FG000|Maintenance Period|Disease Progression|3|||
125903885|NCT00920907|452947917|FG001|Maintenance Period|Disease Progression|7|||
125903886|NCT00920907|452947916|FG000|Maintenance Period|Administrative (study closure)|7|||
125903887|NCT00920907|452947917|FG001|Maintenance Period|Administrative (study closure)|2|||
125903888|NCT00920907|452947916|FG000|Maintenance Period|Study Drug Toxicity|0|||
125903889|NCT00920907|452947917|FG001|Maintenance Period|Study Drug Toxicity|2|||
125903890|NCT00920907|452947916|FG000|Maintenance Period|Death|1|||
125903891|NCT00920907|452947917|FG001|Maintenance Period|Death|1|||
125903892|NCT00920907|452947916|FG000|Maintenance Period|Withdrawal by Subject|1|||
125903893|NCT00920907|452947917|FG001|Maintenance Period|Withdrawal by Subject|0|||
125903894|NCT00920907|452947916|FG000|Maintenance Period|Adverse Event|0|||
125903895|NCT00920907|452947917|FG001|Maintenance Period|Adverse Event|1|||
125903896|NCT02616601|452947918|FG000|Overall Study|Withdrawal by Subject|4|||
125903897|NCT02616601|452947919|FG001|Overall Study|Withdrawal by Subject|4|||
125903898|NCT02616601|452947920|FG002|Overall Study|Withdrawal by Subject|3|||
125903899|NCT02616601|452947918|FG000|Overall Study|Adverse Event|2|||
125903900|NCT02616601|452947919|FG001|Overall Study|Adverse Event|0|||
125903901|NCT02616601|452947920|FG002|Overall Study|Adverse Event|2|||
125903902|NCT02616601|452947918|FG000|Overall Study|Death|1|||
125903903|NCT02616601|452947919|FG001|Overall Study|Death|0|||
125903904|NCT02616601|452947920|FG002|Overall Study|Death|0|||
125903905|NCT02616601|452947918|FG000|Overall Study|Lost to Follow-up|1|||
125903906|NCT02616601|452947919|FG001|Overall Study|Lost to Follow-up|0|||
125903907|NCT02616601|452947920|FG002|Overall Study|Lost to Follow-up|1|||
125903908|NCT02616601|452947918|FG000|Overall Study|Non-Compliance with Test Article|1|||
125903909|NCT02616601|452947919|FG001|Overall Study|Non-Compliance with Test Article|0|||
125903910|NCT02616601|452947920|FG002|Overall Study|Non-Compliance with Test Article|1|||
125903911|NCT02186301|452947921|FG000|Overall Study|Progressive Disease|7|||
125903912|NCT02186301|452947922|FG001|Overall Study|Progressive Disease|22|||
125903913|NCT02186301|452947923|FG002|Overall Study|Progressive Disease|27|||
125903914|NCT02186301|452947921|FG000|Overall Study|Adverse Event|5|||
125903915|NCT02186301|452947922|FG001|Overall Study|Adverse Event|5|||
126059861|NCT00413283|453514196|FG000|Overall Study|Ineligibility determined|0|||
125903916|NCT02186301|452947923|FG002|Overall Study|Adverse Event|5|||
126059862|NCT00413283|453514197|FG001|Overall Study|Ineligibility determined|0|||
125903917|NCT02186301|452947921|FG000|Overall Study|Death|1|||
125903918|NCT02186301|452947922|FG001|Overall Study|Death|0|||
125903919|NCT02186301|452947923|FG002|Overall Study|Death|0|||
125903920|NCT02186301|452947921|FG000|Overall Study|Withdrawal by Subject|5|||
125903921|NCT02186301|452947922|FG001|Overall Study|Withdrawal by Subject|1|||
125903922|NCT02186301|452947923|FG002|Overall Study|Withdrawal by Subject|3|||
125903923|NCT02186301|452947921|FG000|Overall Study|Physician Decision|1|||
125903924|NCT02186301|452947922|FG001|Overall Study|Physician Decision|0|||
125903925|NCT02186301|452947923|FG002|Overall Study|Physician Decision|1|||
125903926|NCT02186301|452947921|FG000|Overall Study|Study Terminated by Sponsor|1|||
125903927|NCT02186301|452947922|FG001|Overall Study|Study Terminated by Sponsor|0|||
125903928|NCT02186301|452947923|FG002|Overall Study|Study Terminated by Sponsor|11|||
125903929|NCT02186301|452947921|FG000|Overall Study|Protocol Deviation|0|||
125903930|NCT02186301|452947922|FG001|Overall Study|Protocol Deviation|2|||
125903931|NCT02186301|452947923|FG002|Overall Study|Protocol Deviation|0|||
125903932|NCT02186301|452947921|FG000|Overall Study|Missing|0|||
125903933|NCT02186301|452947922|FG001|Overall Study|Missing|0|||
125903934|NCT02186301|452947923|FG002|Overall Study|Missing|2|||
125903935|NCT02186301|452947921|FG000|Overall Study|Other|0|||
125903936|NCT02186301|452947922|FG001|Overall Study|Other|0|||
125903937|NCT02186301|452947923|FG002|Overall Study|Other|1|||
125903938|NCT00371761|452947924|FG000|Overall Study|Adverse Event|1|||
125903939|NCT00371761|452947925|FG001|Overall Study|Adverse Event|1|||
125903940|NCT00371761|452947924|FG000|Overall Study|Withdrawal by Subject|1|||
125903941|NCT00371761|452947925|FG001|Overall Study|Withdrawal by Subject|3|||
125903942|NCT00371761|452947924|FG000|Overall Study|Investigator Judgment|2|||
125903943|NCT00371761|452947925|FG001|Overall Study|Investigator Judgment|3|||
125903944|NCT00371761|452947924|FG000|Overall Study|Study termination|4|||
125903945|NCT00371761|452947925|FG001|Overall Study|Study termination|3|||
125903946|NCT03560739|452947927|FG000|Overall Study|Adverse Event|0|||
125903947|NCT03560739|452947928|FG001|Overall Study|Adverse Event|1|||
125903948|NCT03560739|452947929|FG002|Overall Study|Adverse Event|0|||
125903949|NCT03560739|452947930|FG003|Overall Study|Adverse Event|0|||
125903950|NCT03361176|452947931|FG000|Overall Study|Lost to Follow-up|1|||
125903951|NCT03361176|452947932|FG001|Overall Study|Lost to Follow-up|2|||
125903952|NCT03361176|452947931|FG000|Overall Study|Adverse Event|0|||
125903953|NCT03361176|452947932|FG001|Overall Study|Adverse Event|2|||
125903954|NCT03361176|452947931|FG000|Overall Study|Withdrawal by Subject|0|||
125903955|NCT03361176|452947932|FG001|Overall Study|Withdrawal by Subject|1|||
125903956|NCT03123185|452947933|FG000|Overall Study|Withdrawal by Subject|0|||
125903957|NCT03123185|452947934|FG001|Overall Study|Withdrawal by Subject|0|||
125903958|NCT03123185|452947935|FG002|Overall Study|Withdrawal by Subject|0|||
125903959|NCT03123185|452947936|FG003|Overall Study|Withdrawal by Subject|0|||
125903960|NCT03123185|452947937|FG004|Overall Study|Withdrawal by Subject|0|||
125903961|NCT03123185|452947938|FG005|Overall Study|Withdrawal by Subject|0|||
125903962|NCT03123185|452947939|FG006|Overall Study|Withdrawal by Subject|0|||
125903963|NCT03123185|452947940|FG007|Overall Study|Withdrawal by Subject|0|||
125903964|NCT03123185|452947941|FG008|Overall Study|Withdrawal by Subject|0|||
125903965|NCT03123185|452947942|FG009|Overall Study|Withdrawal by Subject|0|||
125903966|NCT03123185|452947943|FG010|Overall Study|Withdrawal by Subject|0|||
125903967|NCT03123185|452947944|FG011|Overall Study|Withdrawal by Subject|0|||
125903968|NCT03123185|452947945|FG012|Overall Study|Withdrawal by Subject|1|||
125903969|NCT03123185|452947946|FG013|Overall Study|Withdrawal by Subject|0|||
125903970|NCT04179890|452947947|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
125903971|NCT04179890|452947948|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
125903972|NCT04179890|452947947|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
125903973|NCT04179890|452947948|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
125903974|NCT04179890|452947947|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
126059863|NCT00413283|453514198|FG002|Overall Study|Ineligibility determined|0|||
126059864|NCT00413283|453514199|FG003|Overall Study|Ineligibility determined|1|||
126059865|NCT00413283|453514196|FG000|Overall Study|Protocol deviation|0|||
126059866|NCT00413283|453514197|FG001|Overall Study|Protocol deviation|1|||
126059867|NCT00413283|453514198|FG002|Overall Study|Protocol deviation|0|||
126059868|NCT00413283|453514199|FG003|Overall Study|Protocol deviation|0|||
126059869|NCT00413283|453514196|FG000|Overall Study|Requirement for alternative therapy|0|||
126059870|NCT00413283|453514197|FG001|Overall Study|Requirement for alternative therapy|2|||
125903975|NCT04179890|452947948|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
125903976|NCT04179890|452947947|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
125903977|NCT04179890|452947948|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
125903978|NCT04179890|452947947|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
126059871|NCT00413283|453514198|FG002|Overall Study|Requirement for alternative therapy|0|||
126059872|NCT00413283|453514199|FG003|Overall Study|Requirement for alternative therapy|0|||
125903979|NCT04179890|452947948|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
125903980|NCT04179890|452947947|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
125903981|NCT04179890|452947948|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
125903982|NCT04179890|452947947|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
125903983|NCT04179890|452947948|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
125903984|NCT04179890|452947947|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
125903985|NCT04179890|452947948|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
125903986|NCT04179890|452947947|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
125903987|NCT04179890|452947948|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
125903988|NCT02579928|452947949|FG000|Overall Study|Withdrawal by Subject|1|||
125903989|NCT02579928|452947950|FG001|Overall Study|Withdrawal by Subject|0|||
125903990|NCT03754972|452947953|FG000|Overall Study|Protocol Violation|25|||
125903991|NCT03422627|452947954|FG000|Overall Study|Protocol-specified Criteria|1|||
125903992|NCT03422627|452947955|FG001|Overall Study|Protocol-specified Criteria|1|||
125903993|NCT03422627|452947956|FG002|Overall Study|Protocol-specified Criteria|0|||
125903994|NCT03422627|452947957|FG003|Overall Study|Protocol-specified Criteria|0|||
125903995|NCT03422627|452947958|FG004|Overall Study|Protocol-specified Criteria|2|||
125903996|NCT03422627|452947954|FG000|Overall Study|Requirement for Alternative Therapy|1|||
125903997|NCT03422627|452947955|FG001|Overall Study|Requirement for Alternative Therapy|1|||
125903998|NCT03422627|452947956|FG002|Overall Study|Requirement for Alternative Therapy|2|||
125903999|NCT03422627|452947957|FG003|Overall Study|Requirement for Alternative Therapy|0|||
125904000|NCT03422627|452947958|FG004|Overall Study|Requirement for Alternative Therapy|0|||
125904001|NCT03422627|452947954|FG000|Overall Study|Disease Progression|1|||
125904002|NCT03422627|452947955|FG001|Overall Study|Disease Progression|0|||
125904003|NCT03422627|452947956|FG002|Overall Study|Disease Progression|1|||
125904004|NCT03422627|452947957|FG003|Overall Study|Disease Progression|2|||
125904005|NCT03422627|452947958|FG004|Overall Study|Disease Progression|0|||
125904006|NCT03422627|452947954|FG000|Overall Study|Adverse Event|2|||
125904007|NCT03422627|452947955|FG001|Overall Study|Adverse Event|1|||
125904008|NCT03422627|452947956|FG002|Overall Study|Adverse Event|0|||
125904009|NCT03422627|452947957|FG003|Overall Study|Adverse Event|0|||
125904010|NCT03422627|452947958|FG004|Overall Study|Adverse Event|2|||
125904011|NCT03422627|452947954|FG000|Overall Study|Ineligibility Determined|0|||
125904012|NCT03422627|452947955|FG001|Overall Study|Ineligibility Determined|1|||
125904013|NCT03422627|452947956|FG002|Overall Study|Ineligibility Determined|0|||
125904014|NCT03422627|452947957|FG003|Overall Study|Ineligibility Determined|0|||
125904015|NCT03422627|452947958|FG004|Overall Study|Ineligibility Determined|0|||
125904016|NCT03422627|452947954|FG000|Overall Study|Death|0|||
125904017|NCT03422627|452947955|FG001|Overall Study|Death|1|||
125904018|NCT03422627|452947956|FG002|Overall Study|Death|1|||
125904019|NCT03422627|452947957|FG003|Overall Study|Death|0|||
125904020|NCT03422627|452947958|FG004|Overall Study|Death|0|||
125904021|NCT03422627|452947954|FG000|Overall Study|Withdrawal by Subject|0|||
125904022|NCT03422627|452947955|FG001|Overall Study|Withdrawal by Subject|0|||
125904023|NCT03422627|452947956|FG002|Overall Study|Withdrawal by Subject|0|||
125904024|NCT03422627|452947957|FG003|Overall Study|Withdrawal by Subject|1|||
125904025|NCT03422627|452947958|FG004|Overall Study|Withdrawal by Subject|0|||
125904026|NCT00934648|452947961|FG000|Overall Study|Failure to return|8|||
125904027|NCT00934648|452947961|FG000|Overall Study|Withdrawal by Subject|1|||
125904028|NCT01993836|452947962|FG000|Overall Study|Surgery Cancelled|3|||
125904029|NCT01993836|452947963|FG001|Overall Study|Surgery Cancelled|0|||
125904030|NCT01993836|452947964|FG002|Overall Study|Surgery Cancelled|0|||
125904031|NCT01993836|452947962|FG000|Overall Study|Physician Decision|2|||
125904032|NCT01993836|452947963|FG001|Overall Study|Physician Decision|1|||
125904033|NCT01993836|452947964|FG002|Overall Study|Physician Decision|0|||
125904034|NCT01993836|452947962|FG000|Overall Study|Death|0|||
125904035|NCT01993836|452947963|FG001|Overall Study|Death|2|||
125904036|NCT01993836|452947964|FG002|Overall Study|Death|0|||
125904037|NCT01993836|452947962|FG000|Overall Study|Withdrawal by Subject|12|||
125904038|NCT01993836|452947963|FG001|Overall Study|Withdrawal by Subject|10|||
125904039|NCT01993836|452947964|FG002|Overall Study|Withdrawal by Subject|5|||
125904040|NCT02195687|452947966|FG000|Overall Study|Personal Reasons|1|||
125904041|NCT02195687|452947967|FG001|Overall Study|Personal Reasons|1|||
125904042|NCT02195687|452947966|FG000|Overall Study|Lost to Follow-up|4|||
125904043|NCT02195687|452947967|FG001|Overall Study|Lost to Follow-up|1|||
125904044|NCT04369924|452947970|FG000|Overall Study|Lost to Follow-up|302|||
125904045|NCT04369924|452947971|FG001|Overall Study|Lost to Follow-up|339|||
125904046|NCT02554279|452947972|FG000|Overall Study|Adverse Event|2|||
125904047|NCT02554279|452947973|FG001|Overall Study|Adverse Event|5|||
125904048|NCT02554279|452947972|FG000|Overall Study|Lost to Follow-up|3|||
125904049|NCT02554279|452947973|FG001|Overall Study|Lost to Follow-up|2|||
125904050|NCT02554279|452947972|FG000|Overall Study|Withdrawal by Subject|6|||
125904051|NCT02554279|452947973|FG001|Overall Study|Withdrawal by Subject|4|||
125904052|NCT02554279|452947972|FG000|Overall Study|Protocol Violation|2|||
125904053|NCT02554279|452947973|FG001|Overall Study|Protocol Violation|1|||
125904054|NCT02554279|452947972|FG000|Overall Study|Other reason|19|||
125904055|NCT02554279|452947973|FG001|Overall Study|Other reason|6|||
125904056|NCT01933789|452947974|FG000|Overall Study|Death|0|||
125904057|NCT01933789|452947975|FG001|Overall Study|Death|0|||
125904058|NCT01933789|452947976|FG002|Overall Study|Death|0|||
125904059|NCT01933789|452947977|FG003|Overall Study|Death|0|||
125904060|NCT01933789|452947978|FG004|Overall Study|Death|21|||
125904061|NCT01933789|452947979|FG005|Overall Study|Death|32|||
125904062|NCT01933789|452947980|FG006|Overall Study|Death|0|||
125904063|NCT01933789|452947981|FG007|Overall Study|Death|0|||
125904064|NCT01933789|452947982|FG008|Overall Study|Death|0|||
125904065|NCT01933789|452947974|FG000|Overall Study|Lost to Follow-up|0|||
125904066|NCT01933789|452947975|FG001|Overall Study|Lost to Follow-up|0|||
125904067|NCT01933789|452947976|FG002|Overall Study|Lost to Follow-up|0|||
125904068|NCT01933789|452947977|FG003|Overall Study|Lost to Follow-up|1|||
125904069|NCT01933789|452947978|FG004|Overall Study|Lost to Follow-up|8|||
125904070|NCT01933789|452947979|FG005|Overall Study|Lost to Follow-up|9|||
125904071|NCT01933789|452947980|FG006|Overall Study|Lost to Follow-up|1|||
125904072|NCT01933789|452947981|FG007|Overall Study|Lost to Follow-up|4|||
125904073|NCT01933789|452947982|FG008|Overall Study|Lost to Follow-up|0|||
125904074|NCT01933789|452947974|FG000|Overall Study|Withdrawal by Subject|2|||
125904075|NCT01933789|452947975|FG001|Overall Study|Withdrawal by Subject|1|||
125904076|NCT01933789|452947976|FG002|Overall Study|Withdrawal by Subject|0|||
125904077|NCT01933789|452947977|FG003|Overall Study|Withdrawal by Subject|0|||
125904078|NCT01933789|452947978|FG004|Overall Study|Withdrawal by Subject|17|||
125904079|NCT01933789|452947979|FG005|Overall Study|Withdrawal by Subject|16|||
125904080|NCT01933789|452947980|FG006|Overall Study|Withdrawal by Subject|1|||
125904081|NCT01933789|452947981|FG007|Overall Study|Withdrawal by Subject|4|||
125904082|NCT01933789|452947982|FG008|Overall Study|Withdrawal by Subject|0|||
125904083|NCT01933789|452947974|FG000|Overall Study|Became Ineligible|4|||
125904084|NCT01933789|452947975|FG001|Overall Study|Became Ineligible|0|||
125904085|NCT01933789|452947976|FG002|Overall Study|Became Ineligible|0|||
125904086|NCT01933789|452947977|FG003|Overall Study|Became Ineligible|0|||
125904087|NCT01933789|452947978|FG004|Overall Study|Became Ineligible|13|||
125904088|NCT01933789|452947979|FG005|Overall Study|Became Ineligible|10|||
125904089|NCT01933789|452947980|FG006|Overall Study|Became Ineligible|13|||
125904090|NCT01933789|452947981|FG007|Overall Study|Became Ineligible|6|||
125904091|NCT01933789|452947982|FG008|Overall Study|Became Ineligible|0|||
125904092|NCT01055496|452947983|FG000|Overall Study|Withdrawal by Subject|2|||
125904093|NCT01055496|452947984|FG001|Overall Study|Withdrawal by Subject|4|||
125904094|NCT01055496|452947983|FG000|Overall Study|Death|13|||
125904095|NCT01055496|452947984|FG001|Overall Study|Death|23|||
125904096|NCT01055496|452947983|FG000|Overall Study|Lost to Follow-up|0|||
125904097|NCT01055496|452947984|FG001|Overall Study|Lost to Follow-up|2|||
125904098|NCT01055496|452947983|FG000|Overall Study|Other - Unspecified|0|||
125904099|NCT01055496|452947984|FG001|Overall Study|Other - Unspecified|1|||
125904100|NCT01966432|452947985|FG000|Overall Study|Lost to Follow-up|3|||
125904101|NCT01966432|452947986|FG001|Overall Study|Lost to Follow-up|2|||
125904102|NCT01966432|452947987|FG002|Overall Study|Lost to Follow-up|5|||
125904103|NCT01966432|452947985|FG000|Overall Study|Withdrawal by Subject|1|||
125904104|NCT01966432|452947986|FG001|Overall Study|Withdrawal by Subject|3|||
125904105|NCT01966432|452947987|FG002|Overall Study|Withdrawal by Subject|0|||
125904106|NCT01966432|452947985|FG000|Overall Study|Subject Incarcerated|0|||
125904107|NCT01966432|452947986|FG001|Overall Study|Subject Incarcerated|0|||
125904108|NCT01966432|452947987|FG002|Overall Study|Subject Incarcerated|1|||
125904109|NCT01966432|452947985|FG000|Overall Study|SBIRT program ended|1|||
125904110|NCT01966432|452947986|FG001|Overall Study|SBIRT program ended|8|||
125904111|NCT01966432|452947987|FG002|Overall Study|SBIRT program ended|20|||
125904112|NCT01673282|452947988|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
125904113|NCT01673282|452947989|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
125904114|NCT01673282|452947988|FG000|Overall Study|Lack of Efficacy|9|||
125904115|NCT01673282|452947989|FG001|Overall Study|Lack of Efficacy|2|||
125904116|NCT01673282|452947988|FG000|Overall Study|Lost to Follow-up|11|||
125904117|NCT01673282|452947989|FG001|Overall Study|Lost to Follow-up|10|||
125904118|NCT01673282|452947988|FG000|Overall Study|Withdrawal by Subject|3|||
125904119|NCT01673282|452947989|FG001|Overall Study|Withdrawal by Subject|3|||
125904120|NCT01673282|452947988|FG000|Overall Study|Other|1|||
125904121|NCT01673282|452947989|FG001|Overall Study|Other|6|||
125904122|NCT01323920|452947995|FG000|Overall Study|Death|5|||
125904123|NCT01323920|452947995|FG000|Overall Study|Withdrawal by Subject|1|||
125904124|NCT00509262|452947999|FG000|Overall Study|Adverse Event|16|||
125904125|NCT00509262|452948000|FG001|Overall Study|Adverse Event|18|||
125904126|NCT00509262|452947999|FG000|Overall Study|Other|2|||
125904127|NCT00509262|452948000|FG001|Overall Study|Other|2|||
125904128|NCT00509262|452947999|FG000|Overall Study|Lack of Efficacy|1|||
125904129|NCT00509262|452948000|FG001|Overall Study|Lack of Efficacy|0|||
125904130|NCT00509262|452947999|FG000|Overall Study|Lost to Follow-up|1|||
125904131|NCT00509262|452948000|FG001|Overall Study|Lost to Follow-up|6|||
125904132|NCT00509262|452947999|FG000|Overall Study|Physician Decision|1|||
126110114|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
125904133|NCT00509262|452948000|FG001|Overall Study|Physician Decision|3|||
125904134|NCT00509262|452947999|FG000|Overall Study|Protocol Violation|2|||
125904135|NCT00509262|452948000|FG001|Overall Study|Protocol Violation|2|||
125904136|NCT00509262|452947999|FG000|Overall Study|Withdrawal by Subject|24|||
125904137|NCT00509262|452948000|FG001|Overall Study|Withdrawal by Subject|11|||
125904138|NCT01715129|452948007|FG000|Overall Study|Adverse Event, fatal|1|||
125904139|NCT01715129|452948007|FG000|Overall Study|Lack of Efficacy|3|||
125904140|NCT01715129|452948007|FG000|Overall Study|Protocol Violation|1|||
125904141|NCT01715129|452948007|FG000|Overall Study|Consent Withdrawn|2|||
125904142|NCT01715129|452948007|FG000|Overall Study|Lost to Follow-up|1|||
125904143|NCT01715129|452948007|FG000|Overall Study|Other|1|||
125904144|NCT02793622|452948008|FG000|Overall Study|Lost to Follow-up|31|||
125904145|NCT02793622|452948009|FG001|Overall Study|Lost to Follow-up|19|||
125904146|NCT02793622|452948008|FG000|Overall Study|Withdrawal by Subject|21|||
126059873|NCT00413283|453514196|FG000|Overall Study|Other|0|||
125904147|NCT02793622|452948009|FG001|Overall Study|Withdrawal by Subject|17|||
125904148|NCT02793622|452948008|FG000|Overall Study|Adverse Event|0|||
125904149|NCT02793622|452948009|FG001|Overall Study|Adverse Event|1|||
125904150|NCT02793622|452948008|FG000|Overall Study|Protocol Violation|1|||
125904151|NCT02793622|452948009|FG001|Overall Study|Protocol Violation|5|||
125904152|NCT01146860|452948010|FG000|Overall Study|Withdrawal by Subject|0|||
125904153|NCT01146860|452948011|FG001|Overall Study|Withdrawal by Subject|1|||
125904154|NCT00722371|452948012|FG000|Overall Study|Adverse Event|6|||
125904155|NCT00722371|452948013|FG001|Overall Study|Adverse Event|13|||
125904156|NCT00722371|452948014|FG002|Overall Study|Adverse Event|9|||
125904157|NCT00722371|452948015|FG003|Overall Study|Adverse Event|10|||
125904158|NCT00722371|452948016|FG004|Overall Study|Adverse Event|6|||
125904159|NCT00722371|452948017|FG005|Overall Study|Adverse Event|8|||
125904160|NCT00722371|452948018|FG006|Overall Study|Adverse Event|4|||
125904161|NCT00722371|452948012|FG000|Overall Study|Contraindication|0|||
125904162|NCT00722371|452948013|FG001|Overall Study|Contraindication|0|||
125904163|NCT00722371|452948014|FG002|Overall Study|Contraindication|1|||
125904164|NCT00722371|452948015|FG003|Overall Study|Contraindication|0|||
125904165|NCT00722371|452948016|FG004|Overall Study|Contraindication|0|||
125904166|NCT00722371|452948017|FG005|Overall Study|Contraindication|0|||
125904167|NCT00722371|452948018|FG006|Overall Study|Contraindication|0|||
125904168|NCT00722371|452948012|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
125904169|NCT00722371|452948013|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
125904170|NCT00722371|452948014|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
125904171|NCT00722371|452948015|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
125904172|NCT00722371|452948016|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
125904173|NCT00722371|452948017|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
125904174|NCT00722371|452948018|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
125904175|NCT00722371|452948012|FG000|Overall Study|Excluded medication|0|||
125904176|NCT00722371|452948013|FG001|Overall Study|Excluded medication|1|||
125904177|NCT00722371|452948014|FG002|Overall Study|Excluded medication|1|||
125904178|NCT00722371|452948015|FG003|Overall Study|Excluded medication|0|||
125904179|NCT00722371|452948016|FG004|Overall Study|Excluded medication|0|||
125904180|NCT00722371|452948017|FG005|Overall Study|Excluded medication|0|||
125904181|NCT00722371|452948018|FG006|Overall Study|Excluded medication|1|||
125904182|NCT00722371|452948012|FG000|Overall Study|Hyperglycemia|2|||
125904183|NCT00722371|452948013|FG001|Overall Study|Hyperglycemia|6|||
125904184|NCT00722371|452948014|FG002|Overall Study|Hyperglycemia|4|||
125904185|NCT00722371|452948015|FG003|Overall Study|Hyperglycemia|2|||
125904186|NCT00722371|452948016|FG004|Overall Study|Hyperglycemia|5|||
125904187|NCT00722371|452948017|FG005|Overall Study|Hyperglycemia|1|||
125904188|NCT00722371|452948018|FG006|Overall Study|Hyperglycemia|1|||
125904189|NCT00722371|452948012|FG000|Overall Study|Hypoglycemia|1|||
125904190|NCT00722371|452948013|FG001|Overall Study|Hypoglycemia|0|||
125904191|NCT00722371|452948014|FG002|Overall Study|Hypoglycemia|0|||
125904192|NCT00722371|452948015|FG003|Overall Study|Hypoglycemia|0|||
125904193|NCT00722371|452948016|FG004|Overall Study|Hypoglycemia|0|||
125904194|NCT00722371|452948017|FG005|Overall Study|Hypoglycemia|0|||
125904195|NCT00722371|452948018|FG006|Overall Study|Hypoglycemia|0|||
125904196|NCT00722371|452948012|FG000|Overall Study|Lack of Efficacy|4|||
125904197|NCT00722371|452948013|FG001|Overall Study|Lack of Efficacy|6|||
125904198|NCT00722371|452948014|FG002|Overall Study|Lack of Efficacy|6|||
125904199|NCT00722371|452948015|FG003|Overall Study|Lack of Efficacy|6|||
125904200|NCT00722371|452948016|FG004|Overall Study|Lack of Efficacy|2|||
125904201|NCT00722371|452948017|FG005|Overall Study|Lack of Efficacy|3|||
125904202|NCT00722371|452948018|FG006|Overall Study|Lack of Efficacy|0|||
125904203|NCT00722371|452948012|FG000|Overall Study|Lost to Follow-up|11|||
125904204|NCT00722371|452948013|FG001|Overall Study|Lost to Follow-up|14|||
125904205|NCT00722371|452948014|FG002|Overall Study|Lost to Follow-up|21|||
125904206|NCT00722371|452948015|FG003|Overall Study|Lost to Follow-up|13|||
125904207|NCT00722371|452948016|FG004|Overall Study|Lost to Follow-up|8|||
125904208|NCT00722371|452948017|FG005|Overall Study|Lost to Follow-up|16|||
125904209|NCT00722371|452948018|FG006|Overall Study|Lost to Follow-up|13|||
126110115|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
125904210|NCT00722371|452948012|FG000|Overall Study|Physician Decision|5|||
125904211|NCT00722371|452948013|FG001|Overall Study|Physician Decision|2|||
125904212|NCT00722371|452948014|FG002|Overall Study|Physician Decision|2|||
125904213|NCT00722371|452948015|FG003|Overall Study|Physician Decision|5|||
125904214|NCT00722371|452948016|FG004|Overall Study|Physician Decision|2|||
125904215|NCT00722371|452948017|FG005|Overall Study|Physician Decision|3|||
125904216|NCT00722371|452948018|FG006|Overall Study|Physician Decision|4|||
125904217|NCT00722371|452948012|FG000|Overall Study|Pregnancy|1|||
125904218|NCT00722371|452948013|FG001|Overall Study|Pregnancy|1|||
125904219|NCT00722371|452948014|FG002|Overall Study|Pregnancy|0|||
125904220|NCT00722371|452948015|FG003|Overall Study|Pregnancy|0|||
125904221|NCT00722371|452948016|FG004|Overall Study|Pregnancy|0|||
125904222|NCT00722371|452948017|FG005|Overall Study|Pregnancy|1|||
125904223|NCT00722371|452948018|FG006|Overall Study|Pregnancy|0|||
125904224|NCT00722371|452948012|FG000|Overall Study|Protocol Violation|6|||
125904225|NCT00722371|452948013|FG001|Overall Study|Protocol Violation|1|||
125904226|NCT00722371|452948014|FG002|Overall Study|Protocol Violation|0|||
125904227|NCT00722371|452948015|FG003|Overall Study|Protocol Violation|1|||
125904228|NCT00722371|452948016|FG004|Overall Study|Protocol Violation|4|||
125904229|NCT00722371|452948017|FG005|Overall Study|Protocol Violation|2|||
125904230|NCT00722371|452948018|FG006|Overall Study|Protocol Violation|1|||
125904231|NCT00722371|452948012|FG000|Overall Study|Withdrawal by Subject|18|||
125904232|NCT00722371|452948013|FG001|Overall Study|Withdrawal by Subject|27|||
125904233|NCT00722371|452948014|FG002|Overall Study|Withdrawal by Subject|19|||
125904234|NCT00722371|452948015|FG003|Overall Study|Withdrawal by Subject|23|||
125904235|NCT00722371|452948016|FG004|Overall Study|Withdrawal by Subject|19|||
125904236|NCT00722371|452948017|FG005|Overall Study|Withdrawal by Subject|18|||
125904237|NCT00722371|452948018|FG006|Overall Study|Withdrawal by Subject|26|||
125904238|NCT01092832|452948019|FG000|Overall Study|Other|1|||
125904239|NCT01092832|452948020|FG001|Overall Study|Other|0|||
125904240|NCT00555425|452948025|FG000|Overall Study|Missed Medication > 1 wk|34|||
125904241|NCT00555425|452948026|FG001|Overall Study|Missed Medication > 1 wk|15|||
125904242|NCT00555425|452948025|FG000|Overall Study|Missed 3 physician management visits|1|||
125904243|NCT00555425|452948026|FG001|Overall Study|Missed 3 physician management visits|0|||
125904244|NCT00555425|452948025|FG000|Overall Study|Met criteria for protective transfer|16|||
125904245|NCT00555425|452948026|FG001|Overall Study|Met criteria for protective transfer|3|||
125904246|NCT00555425|452948025|FG000|Overall Study|Became pregnant and transferred care|0|||
125904247|NCT00555425|452948026|FG001|Overall Study|Became pregnant and transferred care|1|||
125904248|NCT02635646|452948028|FG000|Overall Study|Lost to Follow-up|24|||
125904249|NCT02635646|452948029|FG001|Overall Study|Lost to Follow-up|25|||
125904250|NCT02635646|452948028|FG000|Overall Study|Pregnancy|1|||
125904251|NCT02635646|452948029|FG001|Overall Study|Pregnancy|1|||
125904252|NCT00400153|452948036|FG000|Overall Study|AE due to study disease worsening|14|||
125904253|NCT00400153|452948037|FG001|Overall Study|AE due to study disease worsening|19|||
125904254|NCT00400153|452948038|FG002|Overall Study|AE due to study disease worsening|20|||
126059874|NCT00413283|453514197|FG001|Overall Study|Other|0|||
125904255|NCT00400153|452948036|FG000|Overall Study|AE due to other disease worsening|2|||
126059875|NCT00413283|453514198|FG002|Overall Study|Other|1|||
125904256|NCT00400153|452948037|FG001|Overall Study|AE due to other disease worsening|1|||
125904257|NCT00400153|452948038|FG002|Overall Study|AE due to other disease worsening|0|||
125904258|NCT00400153|452948036|FG000|Overall Study|AE due to other condition|3|||
125904259|NCT00400153|452948037|FG001|Overall Study|AE due to other condition|14|||
125904260|NCT00400153|452948038|FG002|Overall Study|AE due to other condition|15|||
125904261|NCT00400153|452948036|FG000|Overall Study|Protocol Violation|7|||
125904262|NCT00400153|452948037|FG001|Overall Study|Protocol Violation|4|||
125904263|NCT00400153|452948038|FG002|Overall Study|Protocol Violation|9|||
125904264|NCT00400153|452948036|FG000|Overall Study|Lost to Follow-up|2|||
125904265|NCT00400153|452948037|FG001|Overall Study|Lost to Follow-up|1|||
125904266|NCT00400153|452948038|FG002|Overall Study|Lost to Follow-up|4|||
125904267|NCT00400153|452948036|FG000|Overall Study|Withdrawal by Subject|12|||
125904268|NCT00400153|452948037|FG001|Overall Study|Withdrawal by Subject|11|||
125904269|NCT00400153|452948038|FG002|Overall Study|Withdrawal by Subject|10|||
125904270|NCT00400153|452948036|FG000|Overall Study|Other reasons - not mentioned above|8|||
125904271|NCT00400153|452948037|FG001|Overall Study|Other reasons - not mentioned above|5|||
125904272|NCT00400153|452948038|FG002|Overall Study|Other reasons - not mentioned above|3|||
125904273|NCT00393042|452948039|FG000|First Intervention|Withdrawal by Subject|1|||
125904274|NCT00393042|452948040|FG001|First Intervention|Withdrawal by Subject|2|||
125904275|NCT00393042|452948039|FG000|First Intervention|Lost to Follow-up|3|||
125904276|NCT00393042|452948040|FG001|First Intervention|Lost to Follow-up|3|||
125904277|NCT00393042|452948039|FG000|First Intervention|Protocol Violation|1|||
125904278|NCT00393042|452948040|FG001|First Intervention|Protocol Violation|0|||
125904279|NCT00393042|452948039|FG000|First Intervention|Adverse Event|0|||
125904280|NCT00393042|452948040|FG001|First Intervention|Adverse Event|1|||
125904281|NCT00393042|452948039|FG000|Second Intervetion|Adverse Event|0|||
125904282|NCT00393042|452948040|FG001|Second Intervetion|Adverse Event|3|||
125904283|NCT00393042|452948039|FG000|Second Intervetion|Withdrawal by Subject|0|||
125904284|NCT00393042|452948040|FG001|Second Intervetion|Withdrawal by Subject|2|||
125904285|NCT00393042|452948039|FG000|Second Intervetion|Lack of Efficacy|1|||
125904286|NCT00393042|452948040|FG001|Second Intervetion|Lack of Efficacy|0|||
125904287|NCT00393042|452948039|FG000|Second Intervetion|Lost to Follow-up|0|||
125904288|NCT00393042|452948040|FG001|Second Intervetion|Lost to Follow-up|2|||
125904289|NCT00393042|452948039|FG000|Second Intervetion|Protocol Violation|1|||
125904290|NCT00393042|452948040|FG001|Second Intervetion|Protocol Violation|1|||
125904291|NCT01150474|452948042|FG000|Overall Study|Withdrawal by Subject|5|||
125904292|NCT01150474|452948043|FG001|Overall Study|Withdrawal by Subject|2|||
125904293|NCT01150474|452948042|FG000|Overall Study|Cancer found|1|||
125904294|NCT01150474|452948043|FG001|Overall Study|Cancer found|0|||
125904295|NCT01150474|452948042|FG000|Overall Study|Multiple Studies|0|||
125904296|NCT01150474|452948043|FG001|Overall Study|Multiple Studies|1|||
125904297|NCT01150474|452948042|FG000|Overall Study|Rectotomy|1|||
125904298|NCT01150474|452948043|FG001|Overall Study|Rectotomy|0|||
125904299|NCT01150474|452948042|FG000|Overall Study|Drug did not arrive in time|1|||
125904300|NCT01150474|452948043|FG001|Overall Study|Drug did not arrive in time|0|||
125904301|NCT01150474|452948042|FG000|Overall Study|Drug not administered|1|||
125904302|NCT01150474|452948043|FG001|Overall Study|Drug not administered|0|||
125904303|NCT01150474|452948042|FG000|Overall Study|Surgery Changed|1|||
125904304|NCT01150474|452948043|FG001|Overall Study|Surgery Changed|0|||
125904305|NCT01423604|452948044|FG000|Safety Run-In|Adverse Event|3|||
125904306|NCT01423604|452948045|FG001|Safety Run-In|Adverse Event|0|||
125904307|NCT01423604|452948044|FG000|Safety Run-In|Death|1|||
125904308|NCT01423604|452948045|FG001|Safety Run-In|Death|0|||
125904309|NCT01423604|452948044|FG000|Safety Run-In|Physician Decision|1|||
125904310|NCT01423604|452948045|FG001|Safety Run-In|Physician Decision|0|||
125904311|NCT01423604|452948044|FG000|Safety Run-In|Disease progression|3|||
125904312|NCT01423604|452948045|FG001|Safety Run-In|Disease progression|0|||
125904313|NCT01423604|452948044|FG000|Safety Run-In|Patient decision|1|||
125904314|NCT01423604|452948045|FG001|Safety Run-In|Patient decision|0|||
125904315|NCT01423604|452948044|FG000|Randomized|Adverse Event|4|||
125904316|NCT01423604|452948045|FG001|Randomized|Adverse Event|10|||
125904317|NCT01423604|452948044|FG000|Randomized|Death|1|||
125904318|NCT01423604|452948045|FG001|Randomized|Death|0|||
125904319|NCT01423604|452948044|FG000|Randomized|Physician Decision|16|||
125904320|NCT01423604|452948045|FG001|Randomized|Physician Decision|13|||
125904321|NCT01423604|452948044|FG000|Randomized|Other - unspecified|37|||
125904322|NCT01423604|452948045|FG001|Randomized|Other - unspecified|31|||
125904323|NCT01423604|452948044|FG000|Randomized|Patient decision|5|||
125904324|NCT01423604|452948045|FG001|Randomized|Patient decision|9|||
125904325|NCT00424255|452948046|FG000|Overall Study|Death|115|||
125904326|NCT00424255|452948047|FG001|Overall Study|Death|111|||
125904327|NCT00424255|452948046|FG000|Overall Study|Lost to Follow-up|26|||
125904328|NCT00424255|452948047|FG001|Overall Study|Lost to Follow-up|20|||
125904329|NCT00424255|452948046|FG000|Overall Study|Protocol Violation|0|||
125904330|NCT00424255|452948047|FG001|Overall Study|Protocol Violation|1|||
125904331|NCT00424255|452948046|FG000|Overall Study|Withdrawal by Subject|34|||
125904332|NCT00424255|452948047|FG001|Overall Study|Withdrawal by Subject|38|||
125904333|NCT00424255|452948046|FG000|Overall Study|Physician Decision|3|||
125904334|NCT00424255|452948047|FG001|Overall Study|Physician Decision|7|||
125904335|NCT00424255|452948046|FG000|Overall Study|Cognitive Disturbance|1|||
125904336|NCT00424255|452948047|FG001|Overall Study|Cognitive Disturbance|0|||
125904337|NCT00424255|452948046|FG000|Overall Study|Non-compliance by Participants|1|||
125904338|NCT00424255|452948047|FG001|Overall Study|Non-compliance by Participants|0|||
125904339|NCT00424255|452948046|FG000|Overall Study|Fatigue|1|||
125904340|NCT00424255|452948047|FG001|Overall Study|Fatigue|0|||
125904341|NCT00424255|452948046|FG000|Overall Study|Disease Progression|0|||
125904342|NCT00424255|452948047|FG001|Overall Study|Disease Progression|2|||
125904343|NCT00424255|452948046|FG000|Overall Study|Sponsor Terminated Study|161|||
125904344|NCT00424255|452948047|FG001|Overall Study|Sponsor Terminated Study|167|||
125904345|NCT02290431|452948048|FG000|Overall Study|Adverse Event|20|||
125904346|NCT02290431|452948048|FG000|Overall Study|Progressive disease|4|||
125904347|NCT02290431|452948048|FG000|Overall Study|Study terminated by Sponsor|1|||
125904348|NCT02290431|452948048|FG000|Overall Study|Physician Decision|2|||
125904349|NCT00821327|452948051|FG000|Overall Study|Adverse Event|13|||
125904350|NCT00821327|452948051|FG000|Overall Study|Patient Request|1|||
125904351|NCT00821327|452948051|FG000|Overall Study|Investigator Request|2|||
125904352|NCT00821327|452948051|FG000|Overall Study|Sponsor Request|1|||
125904353|NCT00821327|452948051|FG000|Overall Study|Disease Progression|13|||
125904354|NCT00821327|452948051|FG000|Overall Study|Other/Unknown|5|||
125904355|NCT00459979|452948054|FG000|Overall Study|Withdrawal by Subject|1|||
125904356|NCT00459979|452948054|FG000|Overall Study|Protocol Violation|1|||
125904357|NCT01007253|452948057|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
125904358|NCT01007253|452948058|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
125904359|NCT01007253|452948059|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
125904360|NCT01007253|452948060|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
125904361|NCT00814801|452948061|FG000|Overall Study|Adverse Event|15|||
125904362|NCT00814801|452948062|FG001|Overall Study|Adverse Event|16|||
125904363|NCT00814801|452948063|FG002|Overall Study|Adverse Event|19|||
125904364|NCT00814801|452948061|FG000|Overall Study|Withdrawal by Subject|9|||
125904365|NCT00814801|452948062|FG001|Overall Study|Withdrawal by Subject|11|||
125904366|NCT00814801|452948063|FG002|Overall Study|Withdrawal by Subject|14|||
125904367|NCT00814801|452948061|FG000|Overall Study|Inappropriate as a subject|1|||
125904368|NCT00814801|452948062|FG001|Overall Study|Inappropriate as a subject|1|||
125904369|NCT00814801|452948063|FG002|Overall Study|Inappropriate as a subject|1|||
125904370|NCT00814801|452948061|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
125904371|NCT00814801|452948062|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
125904372|NCT00814801|452948063|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
125904373|NCT00814801|452948061|FG000|Overall Study|Missing or change of caregiver|6|||
125904374|NCT00814801|452948062|FG001|Overall Study|Missing or change of caregiver|2|||
125904375|NCT00814801|452948063|FG002|Overall Study|Missing or change of caregiver|4|||
125904376|NCT00814801|452948061|FG000|Overall Study|Non-compliance|0|||
125904377|NCT00814801|452948062|FG001|Overall Study|Non-compliance|1|||
125904378|NCT00814801|452948063|FG002|Overall Study|Non-compliance|1|||
125904379|NCT00814801|452948061|FG000|Overall Study|Other|2|||
125904380|NCT00814801|452948062|FG001|Overall Study|Other|6|||
125904381|NCT00814801|452948063|FG002|Overall Study|Other|4|||
125904382|NCT01163032|452948064|FG000|Randomization Phase|Withdrawal by Subject|2|||
125904383|NCT01163032|452948065|FG001|Randomization Phase|Withdrawal by Subject|3|||
125904384|NCT01163032|452948066|FG002|Randomization Phase|Withdrawal by Subject|0|||
125904385|NCT01163032|452948064|FG000|Randomization Phase|Adverse Event|3|||
125904386|NCT01163032|452948065|FG001|Randomization Phase|Adverse Event|3|||
125904387|NCT01163032|452948066|FG002|Randomization Phase|Adverse Event|0|||
125904388|NCT01163032|452948064|FG000|Randomization Phase|Protocol Violation|0|||
125904389|NCT01163032|452948065|FG001|Randomization Phase|Protocol Violation|1|||
125904390|NCT01163032|452948066|FG002|Randomization Phase|Protocol Violation|0|||
125904391|NCT01163032|452948064|FG000|Randomization Phase|Various*|5|||
125904392|NCT01163032|452948065|FG001|Randomization Phase|Various*|4|||
125904393|NCT01163032|452948066|FG002|Randomization Phase|Various*|0|||
125904394|NCT01163032|452948064|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
125904395|NCT01163032|452948065|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
125904396|NCT01163032|452948066|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
125904397|NCT01163032|452948064|FG000|Open Label Extension Phase|Adverse Event|0|||
125904398|NCT01163032|452948065|FG001|Open Label Extension Phase|Adverse Event|0|||
125904399|NCT01163032|452948066|FG002|Open Label Extension Phase|Adverse Event|3|||
125904400|NCT01163032|452948064|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
125904401|NCT01163032|452948065|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
125904402|NCT01163032|452948066|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
125904403|NCT01163032|452948064|FG000|Open Label Extension Phase|Protocol Violation|0|||
125904404|NCT01163032|452948065|FG001|Open Label Extension Phase|Protocol Violation|0|||
125904405|NCT01163032|452948066|FG002|Open Label Extension Phase|Protocol Violation|1|||
125904406|NCT01163032|452948064|FG000|Open Label Extension Phase|Study Termination|0|||
125904407|NCT01163032|452948065|FG001|Open Label Extension Phase|Study Termination|0|||
125904408|NCT01163032|452948066|FG002|Open Label Extension Phase|Study Termination|7|||
125904409|NCT01163032|452948064|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
125904410|NCT01163032|452948065|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
125904411|NCT01163032|452948066|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
125904412|NCT04030026|452948068|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
125904413|NCT04030026|452948069|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
125904414|NCT04030026|452948068|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
125904415|NCT04030026|452948069|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
125904416|NCT04030026|452948068|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
125904417|NCT04030026|452948069|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
125904418|NCT04030026|452948068|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
125904419|NCT04030026|452948069|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
125904420|NCT04030026|452948068|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
125904421|NCT04030026|452948069|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
125904422|NCT04030026|452948068|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
125904423|NCT04030026|452948069|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
125904424|NCT04030026|452948068|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
125904425|NCT04030026|452948069|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
125904426|NCT00523367|452948070|FG000|Overall Study|19 screen failures|19|||
125904427|NCT00523367|452948070|FG000|Overall Study|4 Withdrawn by PI|4|||
125904428|NCT01275339|452949622|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
125904429|NCT01275339|452949623|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
125904430|NCT01275339|452949624|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
125904431|NCT01275339|452949625|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
125904432|NCT01275339|452949622|FG000|Overall Study|Withdrawal by Subject|0|||
125904433|NCT01275339|452949623|FG001|Overall Study|Withdrawal by Subject|0|||
125904434|NCT01275339|452949624|FG002|Overall Study|Withdrawal by Subject|1|||
125904435|NCT01275339|452949625|FG003|Overall Study|Withdrawal by Subject|0|||
125904436|NCT02469038|452949626|FG000|Overall Study|Physician Decision|4|||
125904437|NCT02469038|452949627|FG001|Overall Study|Physician Decision|5|||
125904438|NCT01083173|452949633|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
125904439|NCT01083173|452949634|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
125904440|NCT01083173|452949633|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
125904441|NCT01083173|452949634|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
125904442|NCT01083173|452949633|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
125904443|NCT01083173|452949634|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
125904444|NCT01083173|452949633|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
125904445|NCT01083173|452949634|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
125904446|NCT01083173|452949633|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
125904447|NCT01083173|452949634|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
125904448|NCT01083173|452949633|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
125904449|NCT01083173|452949634|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
125904450|NCT01083173|452949633|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
125904451|NCT01083173|452949634|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
125904452|NCT01083173|452949633|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
125904453|NCT01083173|452949634|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
125904454|NCT01083173|452949633|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
126059876|NCT00413283|453514199|FG003|Overall Study|Other|0|||
126059877|NCT02354417|453514200|FG000|Overall Study|Physician Decision|1|||
126059878|NCT00246129|453514201|FG000|Overall Study|Lost to Follow-up|1|||
126059879|NCT00246129|453514202|FG001|Overall Study|Lost to Follow-up|0|||
126059880|NCT00246129|453514201|FG000|Overall Study|Death|2|||
126059881|NCT00246129|453514202|FG001|Overall Study|Death|1|||
125904455|NCT01083173|452949634|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
125904456|NCT01083173|452949633|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
125904457|NCT01083173|452949634|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
125904458|NCT01083173|452949633|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
125904459|NCT01083173|452949634|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
125904460|NCT01850602|452949639|FG000|Overall Study|Adverse Event|7|||
125904461|NCT01850602|452949640|FG001|Overall Study|Adverse Event|10|||
125904462|NCT01850602|452949639|FG000|Overall Study|Physician Decision|2|||
125904463|NCT01850602|452949640|FG001|Overall Study|Physician Decision|1|||
125904464|NCT01850602|452949639|FG000|Overall Study|Withdrawal by Subject|2|||
125904465|NCT01850602|452949640|FG001|Overall Study|Withdrawal by Subject|4|||
125904466|NCT01850602|452949639|FG000|Overall Study|Decrease in serum calcium|2|||
125904467|NCT01850602|452949640|FG001|Overall Study|Decrease in serum calcium|3|||
125904468|NCT01850602|452949639|FG000|Overall Study|Increase in serum ferritin|1|||
125904469|NCT01850602|452949640|FG001|Overall Study|Increase in serum ferritin|0|||
125904470|NCT00930982|452949641|FG000|Overall Study|Adverse Event|19|||
125904471|NCT00930982|452949642|FG001|Overall Study|Adverse Event|23|||
125904472|NCT00930982|452949641|FG000|Overall Study|Protocol Violation|1|||
125904473|NCT00930982|452949642|FG001|Overall Study|Protocol Violation|5|||
125904474|NCT00930982|452949641|FG000|Overall Study|Withdrawal by Subject|1|||
125904475|NCT00930982|452949642|FG001|Overall Study|Withdrawal by Subject|1|||
125904476|NCT01609478|452949643|FG000|Overall Study|Adverse Event|3|||
125904477|NCT01609478|452949644|FG001|Overall Study|Adverse Event|1|||
125904478|NCT01609478|452949645|FG002|Overall Study|Adverse Event|5|||
125904479|NCT01609478|452949643|FG000|Overall Study|Protocol Deviation|0|||
125904480|NCT01609478|452949644|FG001|Overall Study|Protocol Deviation|1|||
125904481|NCT01609478|452949645|FG002|Overall Study|Protocol Deviation|1|||
125904482|NCT01609478|452949643|FG000|Overall Study|Non-Compliance with study treatment|1|||
125904483|NCT01609478|452949644|FG001|Overall Study|Non-Compliance with study treatment|0|||
125904484|NCT01609478|452949645|FG002|Overall Study|Non-Compliance with study treatment|0|||
125904485|NCT01609478|452949643|FG000|Overall Study|Physician Decision|1|||
125904486|NCT01609478|452949644|FG001|Overall Study|Physician Decision|0|||
125904487|NCT01609478|452949645|FG002|Overall Study|Physician Decision|1|||
125904488|NCT01609478|452949643|FG000|Overall Study|Withdrawal by Subject|2|||
125904489|NCT01609478|452949644|FG001|Overall Study|Withdrawal by Subject|0|||
125904490|NCT01609478|452949645|FG002|Overall Study|Withdrawal by Subject|2|||
125904491|NCT00768469|452949647|FG000|Overall Study|Adverse Event|0|||
125904492|NCT00768469|452949648|FG001|Overall Study|Adverse Event|2|||
125904493|NCT00768469|452949647|FG000|Overall Study|Disease Progression|3|||
125904494|NCT00768469|452949648|FG001|Overall Study|Disease Progression|4|||
125904495|NCT00768469|452949647|FG000|Overall Study|Withdrawal by Subject|0|||
125904496|NCT00768469|452949648|FG001|Overall Study|Withdrawal by Subject|1|||
125904497|NCT04966741|452949649|FG000|Overall Study|Lost to Follow-up|1|||
125904498|NCT04966741|452949650|FG001|Overall Study|Lost to Follow-up|0|||
125904499|NCT02953509|452949658|FG000|Overall Study|Death|1|||
125904500|NCT02953509|452949659|FG001|Overall Study|Death|3|||
125904501|NCT02953509|452949660|FG002|Overall Study|Death|3|||
125904502|NCT02953509|452949661|FG003|Overall Study|Death|4|||
125904503|NCT02953509|452949662|FG004|Overall Study|Death|12|||
125904504|NCT02953509|452949663|FG005|Overall Study|Death|3|||
125904505|NCT02953509|452949664|FG006|Overall Study|Death|25|||
125904506|NCT02953509|452949665|FG007|Overall Study|Death|10|||
125904507|NCT02953509|452949666|FG008|Overall Study|Death|21|||
125904508|NCT02953509|452949667|FG009|Overall Study|Death|20|||
125904509|NCT02953509|452949658|FG000|Overall Study|Reason Not Specified|0|||
125904510|NCT02953509|452949659|FG001|Overall Study|Reason Not Specified|2|||
125904511|NCT02953509|452949660|FG002|Overall Study|Reason Not Specified|8|||
125904512|NCT02953509|452949661|FG003|Overall Study|Reason Not Specified|2|||
125904513|NCT02953509|452949662|FG004|Overall Study|Reason Not Specified|11|||
125904514|NCT02953509|452949663|FG005|Overall Study|Reason Not Specified|4|||
125904515|NCT02953509|452949664|FG006|Overall Study|Reason Not Specified|12|||
125904516|NCT02953509|452949665|FG007|Overall Study|Reason Not Specified|2|||
125904517|NCT02953509|452949666|FG008|Overall Study|Reason Not Specified|7|||
125904518|NCT02953509|452949667|FG009|Overall Study|Reason Not Specified|2|||
125904519|NCT02953509|452949658|FG000|Overall Study|Consent Withdrawn|1|||
125904520|NCT02953509|452949659|FG001|Overall Study|Consent Withdrawn|1|||
125904521|NCT02953509|452949660|FG002|Overall Study|Consent Withdrawn|2|||
125904522|NCT02953509|452949661|FG003|Overall Study|Consent Withdrawn|1|||
125904523|NCT02953509|452949662|FG004|Overall Study|Consent Withdrawn|3|||
125904524|NCT02953509|452949663|FG005|Overall Study|Consent Withdrawn|0|||
125904525|NCT02953509|452949664|FG006|Overall Study|Consent Withdrawn|4|||
125904526|NCT02953509|452949665|FG007|Overall Study|Consent Withdrawn|1|||
125904527|NCT02953509|452949666|FG008|Overall Study|Consent Withdrawn|1|||
125904528|NCT02953509|452949667|FG009|Overall Study|Consent Withdrawn|4|||
125904529|NCT02953509|452949658|FG000|Overall Study|Lost to Follow-up|0|||
125904530|NCT02953509|452949659|FG001|Overall Study|Lost to Follow-up|0|||
125904531|NCT02953509|452949660|FG002|Overall Study|Lost to Follow-up|0|||
125904532|NCT02953509|452949661|FG003|Overall Study|Lost to Follow-up|0|||
125904533|NCT02953509|452949662|FG004|Overall Study|Lost to Follow-up|0|||
125904534|NCT02953509|452949663|FG005|Overall Study|Lost to Follow-up|0|||
125904535|NCT02953509|452949664|FG006|Overall Study|Lost to Follow-up|1|||
125904536|NCT02953509|452949665|FG007|Overall Study|Lost to Follow-up|1|||
125904537|NCT02953509|452949666|FG008|Overall Study|Lost to Follow-up|1|||
125904538|NCT02953509|452949667|FG009|Overall Study|Lost to Follow-up|1|||
125904539|NCT02953509|452949658|FG000|Overall Study|Study terminated by sponsor|1|||
125904540|NCT02953509|452949659|FG001|Overall Study|Study terminated by sponsor|0|||
125904541|NCT02953509|452949660|FG002|Overall Study|Study terminated by sponsor|0|||
125904542|NCT02953509|452949661|FG003|Overall Study|Study terminated by sponsor|0|||
125904543|NCT02953509|452949662|FG004|Overall Study|Study terminated by sponsor|0|||
125904544|NCT02953509|452949663|FG005|Overall Study|Study terminated by sponsor|0|||
125904545|NCT02953509|452949664|FG006|Overall Study|Study terminated by sponsor|1|||
125904546|NCT02953509|452949665|FG007|Overall Study|Study terminated by sponsor|0|||
125904547|NCT02953509|452949666|FG008|Overall Study|Study terminated by sponsor|1|||
125904548|NCT02953509|452949667|FG009|Overall Study|Study terminated by sponsor|1|||
125904549|NCT00484185|452949668|FG000|Overall Study|Lost to Follow-up|44|||
125904550|NCT00484185|452949668|FG000|Overall Study|Other|20|||
125904551|NCT00484185|452949668|FG000|Overall Study|Randomized but not treated|5|||
125904552|NCT00484185|452949668|FG000|Overall Study|Death|2|||
125904553|NCT00459056|452949669|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
125904554|NCT00459056|452949670|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
125904555|NCT02522871|452949671|FG000|Overall Study|Protocol Violation|1|||
125904556|NCT02522871|452949672|FG001|Overall Study|Protocol Violation|4|||
125904557|NCT02522871|452949671|FG000|Overall Study|Treated without randomization|1|||
125904558|NCT02522871|452949672|FG001|Overall Study|Treated without randomization|0|||
125904559|NCT02522871|452949671|FG000|Overall Study|Death|9|||
125904560|NCT02522871|452949672|FG001|Overall Study|Death|9|||
125904561|NCT02522871|452949671|FG000|Overall Study|Died in operating room prior to transplant|0|||
125904562|NCT02522871|452949672|FG001|Overall Study|Died in operating room prior to transplant|1|||
125904563|NCT03021564|452949674|FG000|Overall Study|Death|84|||
125904564|NCT03021564|452949675|FG001|Overall Study|Death|466|||
125904565|NCT03021564|452949674|FG000|Overall Study|Lost to Follow-up|0|||
125904566|NCT03021564|452949675|FG001|Overall Study|Lost to Follow-up|2|||
125904567|NCT00219544|452949676|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
125904568|NCT00219544|452949677|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
125904569|NCT00219544|452949676|FG000|Single Blind Treatment Period|Adverse Event|9|||
125904570|NCT00219544|452949677|FG001|Single Blind Treatment Period|Adverse Event|0|||
125904571|NCT00219544|452949676|FG000|Single Blind Treatment Period|Protocol Violation|4|||
125904572|NCT00219544|452949677|FG001|Single Blind Treatment Period|Protocol Violation|0|||
125904573|NCT00219544|452949676|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
125904574|NCT00219544|452949677|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
125904575|NCT00219544|452949676|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
125904576|NCT00219544|452949677|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
125904577|NCT00219544|452949676|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
125904578|NCT00219544|452949677|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
125904579|NCT00745615|452949682|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
125904580|NCT00745615|452949683|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
125904581|NCT00745615|452949684|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
125904582|NCT00745615|452949685|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
125904583|NCT00745615|452949686|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
125904584|NCT00745615|452949687|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
125904585|NCT00745615|452949682|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125904586|NCT00745615|452949683|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
125904587|NCT00745615|452949684|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125904588|NCT00745615|452949685|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125904589|NCT00745615|452949686|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125904590|NCT00745615|452949687|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125904591|NCT00745615|452949682|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
125904592|NCT00745615|452949683|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
125904593|NCT00745615|452949684|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
126110116|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
126110117|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
125904594|NCT00745615|452949685|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
125904595|NCT00745615|452949686|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
125904596|NCT00745615|452949687|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
125904597|NCT00745615|452949682|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125904598|NCT00745615|452949683|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
125904599|NCT00745615|452949684|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125904600|NCT00745615|452949685|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125904601|NCT00745615|452949686|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125904602|NCT00745615|452949687|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125904603|NCT00745615|452949682|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125904604|NCT00745615|452949683|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
125904605|NCT00745615|452949684|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125904606|NCT00745615|452949685|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125904607|NCT00745615|452949686|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125904608|NCT00745615|452949687|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125904609|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
125904610|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
125904611|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
125904612|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
125904613|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
125904614|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
125904615|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
125904616|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
125904617|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
125904618|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
125904619|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
125904620|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
125904621|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
125904622|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
125904623|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
125904624|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
125904625|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
125904626|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
125904627|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
125904628|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
125904629|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
125904630|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
125904631|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
125904632|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
125904633|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
125904634|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
125904635|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
125904636|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
125904637|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
125904638|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
125904639|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
125904640|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
125904641|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
125904642|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
125904643|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
125904644|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
125904645|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125904646|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125904647|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125904648|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125904649|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125904650|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
125904651|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
125904652|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
125904653|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
125904654|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
125904655|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
125904656|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
125904657|NCT00745615|452949682|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
125904658|NCT00745615|452949683|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
125904659|NCT00745615|452949684|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
125904660|NCT00745615|452949685|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
125904661|NCT00745615|452949686|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
125904662|NCT00745615|452949687|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
125904663|NCT00586664|452949690|FG000|Overall Study|Withdrawal by Subject|3|||
125904664|NCT00586664|452949691|FG001|Overall Study|Withdrawal by Subject|7|||
125904665|NCT00586664|452949692|FG002|Overall Study|Withdrawal by Subject|1|||
125904666|NCT00586664|452949690|FG000|Overall Study|Exclusion criteria met|2|||
125904667|NCT00586664|452949691|FG001|Overall Study|Exclusion criteria met|0|||
125904668|NCT00586664|452949692|FG002|Overall Study|Exclusion criteria met|0|||
125904669|NCT02751931|452949696|FG000|Overall Study|Adverse Event|3|||
125904670|NCT02751931|452949697|FG001|Overall Study|Adverse Event|0|||
125904671|NCT02751931|452949696|FG000|Overall Study|Other: Miscelleneous|10|||
125904672|NCT02751931|452949697|FG001|Overall Study|Other: Miscelleneous|8|||
125904673|NCT02380690|452949699|FG000|Overall Study|Lost to Follow-up|14|||
125904674|NCT02380690|452949700|FG001|Overall Study|Lost to Follow-up|4|||
125904675|NCT02380690|452949699|FG000|Overall Study|Withdrawal by Subject|20|||
126110118|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
126110119|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
125904676|NCT02380690|452949700|FG001|Overall Study|Withdrawal by Subject|8|||
125904677|NCT00727532|452949701|FG000|Overall Study|Adverse Event|1|||
125904678|NCT00727532|452949701|FG000|Overall Study|Withdrawal by Subject|1|||
125904679|NCT00829933|452949702|FG000|Overall Study|Adverse Event|2|||
125904680|NCT00829933|452949703|FG001|Overall Study|Adverse Event|3|||
125904681|NCT00829933|452949704|FG002|Overall Study|Adverse Event|2|||
125904682|NCT00829933|452949705|FG003|Overall Study|Adverse Event|1|||
125904683|NCT00829933|452949702|FG000|Overall Study|Death|0|||
125904684|NCT00829933|452949703|FG001|Overall Study|Death|0|||
125904685|NCT00829933|452949704|FG002|Overall Study|Death|1|||
125904686|NCT00829933|452949705|FG003|Overall Study|Death|1|||
125904687|NCT00829933|452949702|FG000|Overall Study|Lack of Efficacy|0|||
125904688|NCT00829933|452949703|FG001|Overall Study|Lack of Efficacy|1|||
125904689|NCT00829933|452949704|FG002|Overall Study|Lack of Efficacy|0|||
125904690|NCT00829933|452949705|FG003|Overall Study|Lack of Efficacy|0|||
125904691|NCT00829933|452949702|FG000|Overall Study|Physician Decision|5|||
125904692|NCT00829933|452949703|FG001|Overall Study|Physician Decision|7|||
125904693|NCT00829933|452949704|FG002|Overall Study|Physician Decision|8|||
125904694|NCT00829933|452949705|FG003|Overall Study|Physician Decision|1|||
125904695|NCT00829933|452949702|FG000|Overall Study|Pregnancy|0|||
125904696|NCT00829933|452949703|FG001|Overall Study|Pregnancy|0|||
125904697|NCT00829933|452949704|FG002|Overall Study|Pregnancy|0|||
125904698|NCT00829933|452949705|FG003|Overall Study|Pregnancy|2|||
125904699|NCT00829933|452949702|FG000|Overall Study|Protocol Violation|2|||
125904700|NCT00829933|452949703|FG001|Overall Study|Protocol Violation|1|||
125904701|NCT00829933|452949704|FG002|Overall Study|Protocol Violation|0|||
125904702|NCT00829933|452949705|FG003|Overall Study|Protocol Violation|0|||
125904703|NCT00829933|452949702|FG000|Overall Study|withdrew before treatment started|5|||
125904704|NCT00829933|452949703|FG001|Overall Study|withdrew before treatment started|1|||
125904705|NCT00829933|452949704|FG002|Overall Study|withdrew before treatment started|2|||
125904706|NCT00829933|452949705|FG003|Overall Study|withdrew before treatment started|9|||
125904707|NCT01986933|452949713|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
125904708|NCT01986933|452949714|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
125904709|NCT01986933|452949715|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
125904710|NCT01986933|452949716|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
125904711|NCT01986933|452949717|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
125904712|NCT01986933|452949713|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
125904713|NCT01986933|452949714|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
125904714|NCT01986933|452949715|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
125904715|NCT01986933|452949716|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
125904716|NCT01986933|452949717|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
125904717|NCT01986933|452949713|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
125904718|NCT01986933|452949714|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
125904719|NCT01986933|452949715|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
125904720|NCT01986933|452949716|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
125904721|NCT01986933|452949717|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
125904722|NCT01986933|452949713|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
125904723|NCT01986933|452949714|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
125904724|NCT01986933|452949715|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
125904725|NCT01986933|452949716|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
125904726|NCT01986933|452949717|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
125904727|NCT01986933|452949713|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
125904728|NCT01986933|452949714|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
125904729|NCT01986933|452949715|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
125904730|NCT01986933|452949716|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
125904731|NCT01986933|452949717|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
125904732|NCT01986933|452949713|FG000|Active-to-active (Part B)|Adverse Event|0|||
125904733|NCT01986933|452949714|FG001|Active-to-active (Part B)|Adverse Event|2|||
125904734|NCT01986933|452949715|FG002|Active-to-active (Part B)|Adverse Event|0|||
125904735|NCT01986933|452949716|FG003|Active-to-active (Part B)|Adverse Event|1|||
125904736|NCT01986933|452949717|FG004|Active-to-active (Part B)|Adverse Event|3|||
125904737|NCT01986933|452949713|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
125904738|NCT01986933|452949714|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
125904739|NCT01986933|452949715|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
125904740|NCT01986933|452949716|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
125904741|NCT01986933|452949717|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
125904742|NCT01986933|452949713|FG000|Active-to-active (Part B)|Pregnancy|0|||
125904743|NCT01986933|452949714|FG001|Active-to-active (Part B)|Pregnancy|0|||
125904744|NCT01986933|452949715|FG002|Active-to-active (Part B)|Pregnancy|0|||
125904745|NCT01986933|452949716|FG003|Active-to-active (Part B)|Pregnancy|0|||
125904746|NCT01986933|452949717|FG004|Active-to-active (Part B)|Pregnancy|1|||
125904747|NCT01986933|452949713|FG000|Active-to-active (Part B)|Physician Decision|0|||
125904748|NCT01986933|452949714|FG001|Active-to-active (Part B)|Physician Decision|0|||
125904749|NCT01986933|452949715|FG002|Active-to-active (Part B)|Physician Decision|1|||
125904750|NCT01986933|452949716|FG003|Active-to-active (Part B)|Physician Decision|1|||
125904751|NCT01986933|452949717|FG004|Active-to-active (Part B)|Physician Decision|0|||
125904752|NCT01986933|452949713|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
125904753|NCT01986933|452949714|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
125904754|NCT01986933|452949715|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
125904755|NCT01986933|452949716|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
125904756|NCT01986933|452949717|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
125904757|NCT01986933|452949713|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
125904758|NCT01986933|452949714|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
125904759|NCT01986933|452949715|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
125904760|NCT01986933|452949716|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
125904761|NCT01986933|452949717|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
125904762|NCT01986933|452949713|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
125904763|NCT01986933|452949714|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
125904764|NCT01986933|452949715|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
125904765|NCT01986933|452949716|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
125904766|NCT01986933|452949717|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
125904767|NCT01986933|452949713|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
125904768|NCT01986933|452949714|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
125904769|NCT01986933|452949715|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
125904770|NCT01986933|452949716|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
125904771|NCT01986933|452949717|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
125904772|NCT01986933|452949713|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
125904773|NCT01986933|452949714|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
125904774|NCT01986933|452949715|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
125904775|NCT01986933|452949716|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
125904776|NCT01986933|452949717|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
125904777|NCT01986933|452949713|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
125904778|NCT01986933|452949714|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
125904779|NCT01986933|452949715|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
125904780|NCT01986933|452949716|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
125904781|NCT01986933|452949717|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
125904782|NCT01986933|452949713|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
125904783|NCT01986933|452949714|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
125904784|NCT01986933|452949715|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
125904785|NCT01986933|452949716|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
125904786|NCT01986933|452949717|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
125904787|NCT01986933|452949713|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
125904788|NCT01986933|452949714|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
125904789|NCT01986933|452949715|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
125904790|NCT01986933|452949716|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
125904791|NCT01986933|452949717|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
125904792|NCT03119701|452949718|FG000|6-day Dosing|Death|4|||
125904793|NCT03119701|452949719|FG001|6-day Dosing|Death|1|||
125904794|NCT03119701|452949718|FG000|6-day Dosing|Adverse Event|3|||
125904795|NCT03119701|452949719|FG001|6-day Dosing|Adverse Event|0|||
125904796|NCT03119701|452949718|FG000|6-day Dosing|Physician Decision|0|||
125904797|NCT03119701|452949719|FG001|6-day Dosing|Physician Decision|1|||
125904798|NCT03119701|452949718|FG000|6-day Dosing|Withdrawal by Subject|0|||
125904799|NCT03119701|452949719|FG001|6-day Dosing|Withdrawal by Subject|1|||
125904800|NCT03119701|452949718|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
125904801|NCT03119701|452949719|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
125904802|NCT00817479|452949720|FG000|Overall Study|Physician Decision|1|||
125904803|NCT00817479|452949721|FG001|Overall Study|Physician Decision|1|||
125904804|NCT00282347|452949722|FG000|Treatment Period|Death|2|||
125904805|NCT00282347|452949723|FG001|Treatment Period|Death|0|||
125904806|NCT00282347|452949722|FG000|Treatment Period|Lost to Follow-up|2|||
125904807|NCT00282347|452949723|FG001|Treatment Period|Lost to Follow-up|5|||
125904808|NCT00282347|452949722|FG000|Treatment Period|Withdrawal by Subject|1|||
125904809|NCT00282347|452949723|FG001|Treatment Period|Withdrawal by Subject|3|||
125904810|NCT00282347|452949722|FG000|Treatment Period|Physician Decision|0|||
125904811|NCT00282347|452949723|FG001|Treatment Period|Physician Decision|1|||
125904812|NCT00282347|452949722|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
125904813|NCT00282347|452949723|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
125904814|NCT00282347|452949722|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
125904815|NCT00282347|452949723|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
125904816|NCT00282347|452949722|FG000|Safety Follow-up Period|Physician Decision|1|||
125904817|NCT00282347|452949723|FG001|Safety Follow-up Period|Physician Decision|1|||
125904818|NCT00282347|452949722|FG000|Safety Follow-up Period|Protocol Deviation|0|||
125904819|NCT00282347|452949723|FG001|Safety Follow-up Period|Protocol Deviation|2|||
125904820|NCT00282347|452949722|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
125904821|NCT00282347|452949723|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
125904822|NCT00282347|452949722|FG000|B Cell Follow-up Period|Physician Decision|1|||
125904823|NCT00282347|452949723|FG001|B Cell Follow-up Period|Physician Decision|0|||
125904824|NCT00282347|452949722|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
125904825|NCT00282347|452949723|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
125904826|NCT02361346|452949724|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
125904827|NCT02361346|452949725|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
125904828|NCT02361346|452949726|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
125904829|NCT02361346|452949727|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
125904830|NCT02361346|452949728|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
125904831|NCT02361346|452949729|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
125904832|NCT02361346|452949730|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
125904833|NCT02361346|452949731|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
125904834|NCT02361346|452949732|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
125904835|NCT02361346|452949724|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125904836|NCT02361346|452949725|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125904837|NCT02361346|452949726|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125904838|NCT02361346|452949727|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125904839|NCT02361346|452949728|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
125904840|NCT02361346|452949729|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125904841|NCT02361346|452949730|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125904842|NCT02361346|452949731|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125904843|NCT02361346|452949732|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125904844|NCT02361346|452949724|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
125904845|NCT02361346|452949725|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
125904846|NCT02361346|452949726|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
125904847|NCT02361346|452949727|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
125904848|NCT02361346|452949728|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
125904849|NCT02361346|452949729|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
125904850|NCT02361346|452949730|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
125904851|NCT02361346|452949731|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
125904852|NCT02361346|452949732|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
125904853|NCT02361346|452949724|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125904854|NCT02361346|452949725|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125904855|NCT02361346|452949726|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125904856|NCT02361346|452949727|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125904857|NCT02361346|452949728|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125904858|NCT02361346|452949729|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125904859|NCT02361346|452949730|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125904860|NCT02361346|452949731|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
125904861|NCT02361346|452949732|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125904862|NCT02361346|452949724|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125904863|NCT02361346|452949725|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125904864|NCT02361346|452949726|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125904865|NCT02361346|452949727|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125904866|NCT02361346|452949728|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125904867|NCT02361346|452949729|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125904868|NCT02361346|452949730|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125904869|NCT02361346|452949731|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
125904870|NCT02361346|452949732|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125904871|NCT02361346|452949724|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125904872|NCT02361346|452949725|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125904873|NCT02361346|452949726|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125904874|NCT02361346|452949727|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125904875|NCT02361346|452949728|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125904876|NCT02361346|452949729|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125904877|NCT02361346|452949730|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125904878|NCT02361346|452949731|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
125904879|NCT02361346|452949732|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125904880|NCT00782795|452949733|FG000|Overall Study|Withdrawal by Subject|1|||
125904881|NCT00782795|452949734|FG001|Overall Study|Withdrawal by Subject|2|||
125904882|NCT04480424|452949735|FG000|Overall Study|Withdrawal by Subject|0|||
125904883|NCT04480424|452949736|FG001|Overall Study|Withdrawal by Subject|2|||
125904884|NCT04480424|452949735|FG000|Overall Study|Lost to Follow-up|3|||
125904885|NCT04480424|452949736|FG001|Overall Study|Lost to Follow-up|3|||
125904886|NCT04480424|452949735|FG000|Overall Study|Death|14|||
125904887|NCT04480424|452949736|FG001|Overall Study|Death|16|||
125904888|NCT04480424|452949735|FG000|Overall Study|Reason not Specified|5|||
125904889|NCT04480424|452949736|FG001|Overall Study|Reason not Specified|5|||
125904890|NCT02782923|452949737|FG000|Overall Study|Lost to Follow-up|15|||
125904891|NCT00993044|452949739|FG000|Irinotecan 50 mg|Physician Decision|1|||
125904892|NCT00734747|452949740|FG000|SRS Procedure|No staples placed|3|||
125904893|NCT00734747|452949740|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
125904894|NCT05772702|452949751|FG000|Overall Study|Adverse Event|1|||
125904895|NCT01909453|452949752|FG000|Overall Study|Ongoing|118|||
125904896|NCT01909453|452949753|FG001|Overall Study|Ongoing|103|||
125904897|NCT01909453|452949754|FG002|Overall Study|Ongoing|83|||
125904898|NCT01909453|452949755|FG003|Overall Study|Ongoing|164|||
125904899|NCT01909453|452949756|FG004|Overall Study|Ongoing|50|||
125904900|NCT01909453|452949752|FG000|Overall Study|Death|69|||
125904901|NCT01909453|452949753|FG001|Overall Study|Death|74|||
125904902|NCT01909453|452949754|FG002|Overall Study|Death|88|||
125904903|NCT01909453|452949755|FG003|Overall Study|Death|86|||
125904904|NCT01909453|452949756|FG004|Overall Study|Death|29|||
125904905|NCT01909453|452949752|FG000|Overall Study|Lost to Follow-up|3|||
125904906|NCT01909453|452949753|FG001|Overall Study|Lost to Follow-up|4|||
125904907|NCT01909453|452949754|FG002|Overall Study|Lost to Follow-up|4|||
125904908|NCT01909453|452949755|FG003|Overall Study|Lost to Follow-up|3|||
125904909|NCT01909453|452949756|FG004|Overall Study|Lost to Follow-up|3|||
125904910|NCT01909453|452949752|FG000|Overall Study|Withdrawal by Subject|2|||
125904911|NCT01909453|452949753|FG001|Overall Study|Withdrawal by Subject|13|||
125904912|NCT01909453|452949754|FG002|Overall Study|Withdrawal by Subject|16|||
125904913|NCT01909453|452949755|FG003|Overall Study|Withdrawal by Subject|5|||
125904914|NCT01909453|452949756|FG004|Overall Study|Withdrawal by Subject|4|||
125904915|NCT00884377|452951101|FG000|Overall Study|Withdrawal by Subject|1|||
125904916|NCT00884377|452951102|FG001|Overall Study|Withdrawal by Subject|0|||
125904917|NCT00884377|452951101|FG000|Overall Study|Could not confirm diagnosis|1|||
125904918|NCT00884377|452951102|FG001|Overall Study|Could not confirm diagnosis|0|||
125904919|NCT00884377|452951101|FG000|Overall Study|Physician Decision|0|||
125904920|NCT00884377|452951102|FG001|Overall Study|Physician Decision|1|||
125904921|NCT02003365|452951103|FG000|Overall Study|Lost to Follow-up|0|||
125904922|NCT02003365|452951104|FG001|Overall Study|Lost to Follow-up|0|||
125904923|NCT02003365|452951105|FG002|Overall Study|Lost to Follow-up|1|||
125904924|NCT00622739|452951106|FG000|Overall Study|Physician Decision|1|||
125904925|NCT00622739|452951107|FG001|Overall Study|Physician Decision|0|||
125904926|NCT00622739|452951106|FG000|Overall Study|Adverse Event|1|||
125904927|NCT00622739|452951107|FG001|Overall Study|Adverse Event|2|||
125904928|NCT00622739|452951106|FG000|Overall Study|Lack of Efficacy|0|||
125904929|NCT00622739|452951107|FG001|Overall Study|Lack of Efficacy|2|||
125904930|NCT00622739|452951106|FG000|Overall Study|Withdrawal by Subject|0|||
125904931|NCT00622739|452951107|FG001|Overall Study|Withdrawal by Subject|1|||
125904932|NCT00622739|452951106|FG000|Overall Study|Lost to Follow-up|0|||
125904933|NCT00622739|452951107|FG001|Overall Study|Lost to Follow-up|1|||
125904934|NCT03150485|452951115|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125904935|NCT03150485|452951116|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125904936|NCT03150485|452951117|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
125904937|NCT03150485|452951118|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
125904938|NCT03150485|452951119|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
125904939|NCT03150485|452951120|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
125904940|NCT01394718|452951122|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
125904941|NCT01394718|452951123|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
125904942|NCT03387150|452951124|FG000|Overall Study|Withdrawal by Subject|3|||
125904943|NCT03387150|452951125|FG001|Overall Study|Withdrawal by Subject|0|||
125904944|NCT03387150|452951126|FG002|Overall Study|Withdrawal by Subject|3|||
125904945|NCT03387150|452951127|FG003|Overall Study|Withdrawal by Subject|4|||
125904946|NCT03387150|452951128|FG004|Overall Study|Withdrawal by Subject|1|||
125904947|NCT03387150|452951129|FG005|Overall Study|Withdrawal by Subject|2|||
125904948|NCT03387150|452951130|FG006|Overall Study|Withdrawal by Subject|0|||
125904949|NCT03387150|452951124|FG000|Overall Study|Lost to Follow-up|3|||
125904950|NCT03387150|452951125|FG001|Overall Study|Lost to Follow-up|2|||
125904951|NCT03387150|452951126|FG002|Overall Study|Lost to Follow-up|2|||
125904952|NCT03387150|452951127|FG003|Overall Study|Lost to Follow-up|3|||
125904953|NCT03387150|452951128|FG004|Overall Study|Lost to Follow-up|3|||
125904954|NCT03387150|452951129|FG005|Overall Study|Lost to Follow-up|3|||
125904955|NCT03387150|452951130|FG006|Overall Study|Lost to Follow-up|0|||
125904956|NCT03387150|452951124|FG000|Overall Study|Participant unable to adhere to visit|0|||
125904957|NCT03387150|452951125|FG001|Overall Study|Participant unable to adhere to visit|1|||
125904958|NCT03387150|452951126|FG002|Overall Study|Participant unable to adhere to visit|0|||
125904959|NCT03387150|452951127|FG003|Overall Study|Participant unable to adhere to visit|0|||
125904960|NCT03387150|452951128|FG004|Overall Study|Participant unable to adhere to visit|2|||
125904961|NCT03387150|452951129|FG005|Overall Study|Participant unable to adhere to visit|2|||
125904962|NCT03387150|452951130|FG006|Overall Study|Participant unable to adhere to visit|0|||
125904963|NCT04617795|452951131|FG000|Main Study|Lost to Follow-up|1|||
125904964|NCT04617795|452951132|FG001|Main Study|Lost to Follow-up|0|||
125904965|NCT02395016|452951133|FG000|Overall Study|Adverse Event|4|||
125904966|NCT02395016|452951134|FG001|Overall Study|Adverse Event|3|||
125904967|NCT02395016|452951133|FG000|Overall Study|Withdrawal by Subject|9|||
125904968|NCT02395016|452951134|FG001|Overall Study|Withdrawal by Subject|6|||
125904969|NCT02395016|452951133|FG000|Overall Study|Protocol Violation|2|||
125904970|NCT02395016|452951134|FG001|Overall Study|Protocol Violation|3|||
125904971|NCT01547780|452951135|FG000|Baseline PET Scan|Physician Decision|1|||
125904972|NCT01547780|452951136|FG001|Baseline PET Scan|Physician Decision|0|||
125904973|NCT01547780|452951137|FG002|Baseline PET Scan|Physician Decision|1|||
125904974|NCT01547780|452951138|FG003|Baseline PET Scan|Physician Decision|0|||
125904975|NCT01547780|452951135|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
125904976|NCT01547780|452951136|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
125904977|NCT01547780|452951137|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
126110120|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
125904978|NCT01547780|452951138|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
125904979|NCT02478398|452951146|FG000|Overall Study|Adverse Event|20|||
125904980|NCT02478398|452951147|FG001|Overall Study|Adverse Event|5|||
125904981|NCT02478398|452951146|FG000|Overall Study|Lost to Follow-up|5|||
125904982|NCT02478398|452951147|FG001|Overall Study|Lost to Follow-up|4|||
125904983|NCT02478398|452951146|FG000|Overall Study|Non-Compliance With Study Drug|5|||
125904984|NCT02478398|452951147|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125904985|NCT02478398|452951146|FG000|Overall Study|Protocol Violation|3|||
125904986|NCT02478398|452951147|FG001|Overall Study|Protocol Violation|1|||
125904987|NCT02478398|452951146|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
125904988|NCT02478398|452951147|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
125904989|NCT02478398|452951146|FG000|Overall Study|Withdrawal By Participant|10|||
125904990|NCT02478398|452951147|FG001|Overall Study|Withdrawal By Participant|4|||
125904991|NCT01362595|452951149|FG000|Overall Study|Screen failure|10|||
125904992|NCT01362595|452951149|FG000|Overall Study|Withdrawal by Subject|2|||
125904993|NCT00959374|452951150|FG000|Overall Study|Withdrawal by Subject|2|||
125904994|NCT00959374|452951150|FG000|Overall Study|Lost to Follow-up|14|||
125904995|NCT00959374|452951150|FG000|Overall Study|Death|1|||
125904996|NCT00959374|452951150|FG000|Overall Study|Protocol Violation|1|||
125904997|NCT00959374|452951150|FG000|Overall Study|Implant Removed/Not Replaced|4|||
125904998|NCT00959374|452951150|FG000|Overall Study|Physician Decision|1|||
125904999|NCT02448680|452951151|FG000|Overall Study|Physician Decision|1|||
125905000|NCT02448680|452951152|FG001|Overall Study|Physician Decision|1|||
125905001|NCT02448680|452951151|FG000|Overall Study|Withdrawal by Subject|0|||
125905002|NCT02448680|452951152|FG001|Overall Study|Withdrawal by Subject|2|||
125905003|NCT00636987|452951153|FG000|Overall Study|Death|44|||
125905004|NCT00636987|452951153|FG000|Overall Study|Explanted|13|||
125905005|NCT00636987|452951153|FG000|Overall Study|Lost to Follow-up|63|||
125905006|NCT00636987|452951153|FG000|Overall Study|5 year visit window not complete|69|||
125905007|NCT01251146|452951154|FG000|Overall Study|Lost to Follow-up|3|||
125905008|NCT01251146|452951155|FG001|Overall Study|Lost to Follow-up|10|||
125905009|NCT01739400|452951158|FG000|Overall Study|Physician Decision|3|||
125905010|NCT01739400|452951159|FG001|Overall Study|Physician Decision|0|||
125905011|NCT01739400|452951158|FG000|Overall Study|Lost to Follow-up|2|||
125905012|NCT01739400|452951159|FG001|Overall Study|Lost to Follow-up|0|||
125905013|NCT01739400|452951158|FG000|Overall Study|Death|5|||
125905014|NCT01739400|452951159|FG001|Overall Study|Death|2|||
125905015|NCT01739400|452951158|FG000|Overall Study|Withdrawal by Subject|7|||
125905016|NCT01739400|452951159|FG001|Overall Study|Withdrawal by Subject|7|||
125905017|NCT01857310|452951161|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
125905018|NCT01857310|452951162|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
125905019|NCT02497976|452951165|FG000|Overall Study|Withdrawal by Subject|2|||
125905020|NCT02497976|452951166|FG001|Overall Study|Withdrawal by Subject|0|||
125905021|NCT02497976|452951165|FG000|Overall Study|Moved out of area|0|||
125905022|NCT02497976|452951166|FG001|Overall Study|Moved out of area|1|||
125905023|NCT00584740|452951167|FG000|Overall Study|Adverse Event|1|||
125905024|NCT00584740|452951168|FG001|Overall Study|Adverse Event|1|||
125905025|NCT00584740|452951167|FG000|Overall Study|Lack of Efficacy|8|||
125905026|NCT00584740|452951168|FG001|Overall Study|Lack of Efficacy|2|||
125905027|NCT00584740|452951167|FG000|Overall Study|Withdrawal by Subject|3|||
125905028|NCT00584740|452951168|FG001|Overall Study|Withdrawal by Subject|2|||
125905029|NCT00584740|452951167|FG000|Overall Study|Lost to Follow-up|0|||
125905030|NCT00584740|452951168|FG001|Overall Study|Lost to Follow-up|1|||
125905031|NCT03915860|452951173|FG000|Overall Study|Adverse Event|3|||
125905032|NCT03915860|452951173|FG000|Overall Study|Withdrawal by Subject|6|||
125905033|NCT03915860|452951173|FG000|Overall Study|Lost to Follow-up|2|||
125905034|NCT03915860|452951173|FG000|Overall Study|Other than specified|3|||
125905035|NCT02195011|452951174|FG000|Overall Study|Adverse Event|4|||
125905036|NCT02195011|452951175|FG001|Overall Study|Adverse Event|0|||
125905037|NCT02195011|452951174|FG000|Overall Study|Progressive Disease|18|||
125905038|NCT02195011|452951175|FG001|Overall Study|Progressive Disease|1|||
125905039|NCT02195011|452951174|FG000|Overall Study|Withdrawal by Subject|3|||
125905040|NCT02195011|452951175|FG001|Overall Study|Withdrawal by Subject|0|||
125905041|NCT03189381|452951176|FG000|Overall Study|Death|1|||
125905042|NCT03189381|452951177|FG001|Overall Study|Death|0|||
125905043|NCT03761797|452951178|FG000|Overall Study|Changing hospital|11|||
125905044|NCT03761797|452951178|FG000|Overall Study|Improvement/remission|6|||
125905045|NCT03761797|452951178|FG000|Overall Study|Withdrawal by Subject|19|||
125905046|NCT03761797|452951178|FG000|Overall Study|Lost to Follow-up|33|||
125905047|NCT03761797|452951178|FG000|Overall Study|Adverse Event|37|||
125905048|NCT03761797|452951178|FG000|Overall Study|Case report form (CRF) not collected|5|||
125905049|NCT03761797|452951178|FG000|Overall Study|No patient visit after entry|13|||
125905050|NCT03761797|452951178|FG000|Overall Study|Switch to other diabetes medication|10|||
125905051|NCT03761797|452951178|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
125905052|NCT03761797|452951178|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
125905053|NCT03761797|452951178|FG000|Overall Study|Insufficient effectives|2|||
125905054|NCT03761797|452951178|FG000|Overall Study|Excessive alcohol intake|1|||
125905055|NCT00251004|452951179|FG000|Overall Study|Withdrawal by Subject|23|||
125905056|NCT00251004|452951180|FG001|Overall Study|Withdrawal by Subject|16|||
125905057|NCT00251004|452951181|FG002|Overall Study|Withdrawal by Subject|14|||
125905058|NCT00251004|452951179|FG000|Overall Study|Death|9|||
125905059|NCT00251004|452951180|FG001|Overall Study|Death|10|||
125905060|NCT00251004|452951181|FG002|Overall Study|Death|8|||
125905061|NCT00251004|452951179|FG000|Overall Study|Lost to Follow-up|1|||
125905062|NCT00251004|452951180|FG001|Overall Study|Lost to Follow-up|2|||
125905063|NCT00251004|452951181|FG002|Overall Study|Lost to Follow-up|1|||
125905064|NCT00251004|452951179|FG000|Overall Study|Graft Loss|12|||
125905065|NCT00251004|452951180|FG001|Overall Study|Graft Loss|13|||
125905066|NCT00251004|452951181|FG002|Overall Study|Graft Loss|8|||
125905067|NCT00645788|452951182|FG000|Overall Study|Did not receive study drug|1|||
125905068|NCT00645788|452951183|FG001|Overall Study|Did not receive study drug|1|||
125905069|NCT00645788|452951184|FG002|Overall Study|Did not receive study drug|0|||
125905070|NCT00645788|452951185|FG003|Overall Study|Did not receive study drug|0|||
125905071|NCT00645788|452951182|FG000|Overall Study|Adverse Event|4|||
125905072|NCT00645788|452951183|FG001|Overall Study|Adverse Event|9|||
125905073|NCT00645788|452951184|FG002|Overall Study|Adverse Event|5|||
125905074|NCT00645788|452951185|FG003|Overall Study|Adverse Event|3|||
125905075|NCT00645788|452951182|FG000|Overall Study|Lost to Follow-up|1|||
125905076|NCT00645788|452951183|FG001|Overall Study|Lost to Follow-up|0|||
125905077|NCT00645788|452951184|FG002|Overall Study|Lost to Follow-up|0|||
125905078|NCT00645788|452951185|FG003|Overall Study|Lost to Follow-up|0|||
125905079|NCT00645788|452951182|FG000|Overall Study|Protocol Violation|1|||
125905080|NCT00645788|452951183|FG001|Overall Study|Protocol Violation|0|||
125905081|NCT00645788|452951184|FG002|Overall Study|Protocol Violation|2|||
125905082|NCT00645788|452951185|FG003|Overall Study|Protocol Violation|0|||
125905083|NCT00645788|452951182|FG000|Overall Study|Withdrawal by Subject|0|||
125905084|NCT00645788|452951183|FG001|Overall Study|Withdrawal by Subject|1|||
125905085|NCT00645788|452951184|FG002|Overall Study|Withdrawal by Subject|0|||
125905086|NCT00645788|452951185|FG003|Overall Study|Withdrawal by Subject|2|||
125905087|NCT00645788|452951182|FG000|Overall Study|Pulmonary exacerbation|13|||
125905088|NCT00645788|452951183|FG001|Overall Study|Pulmonary exacerbation|16|||
125905089|NCT00645788|452951184|FG002|Overall Study|Pulmonary exacerbation|11|||
125905090|NCT00645788|452951185|FG003|Overall Study|Pulmonary exacerbation|9|||
125905091|NCT03149848|452951186|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
125905092|NCT03149848|452951186|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
125905093|NCT01244490|452951187|FG000|Overall Study|Lack of Efficacy|14|||
125905094|NCT01244490|452951188|FG001|Overall Study|Lack of Efficacy|5|||
125905095|NCT01244490|452951189|FG002|Overall Study|Lack of Efficacy|5|||
125905096|NCT01244490|452951187|FG000|Overall Study|Withdrawal by Subject|4|||
125905097|NCT01244490|452951188|FG001|Overall Study|Withdrawal by Subject|4|||
125905098|NCT01244490|452951189|FG002|Overall Study|Withdrawal by Subject|9|||
125905099|NCT01244490|452951187|FG000|Overall Study|Adverse Event|1|||
125905100|NCT01244490|452951188|FG001|Overall Study|Adverse Event|9|||
125905101|NCT01244490|452951189|FG002|Overall Study|Adverse Event|5|||
125905102|NCT01244490|452951187|FG000|Overall Study|Lost to Follow-up|0|||
125905103|NCT01244490|452951188|FG001|Overall Study|Lost to Follow-up|6|||
126110121|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
125905104|NCT01244490|452951189|FG002|Overall Study|Lost to Follow-up|3|||
125905105|NCT01244490|452951187|FG000|Overall Study|Other|0|||
125905106|NCT01244490|452951188|FG001|Overall Study|Other|0|||
125905107|NCT01244490|452951189|FG002|Overall Study|Other|1|||
125905108|NCT00256282|452951197|FG000|Overall Study|Disease progression, relapse during acti|12|||
125905109|NCT00256282|452951197|FG000|Overall Study|Adverse Event|3|||
125905110|NCT00256282|452951197|FG000|Overall Study|Physician Decision|1|||
125905111|NCT00327470|452951200|FG000|Overall Study|Randomized, but not treated|0|||
125905112|NCT00327470|452951201|FG001|Overall Study|Randomized, but not treated|2|||
125905113|NCT00327470|452951200|FG000|Overall Study|Adverse Event|9|||
125905114|NCT00327470|452951201|FG001|Overall Study|Adverse Event|14|||
125905115|NCT00327470|452951200|FG000|Overall Study|Lack of Efficacy|7|||
125905116|NCT00327470|452951201|FG001|Overall Study|Lack of Efficacy|19|||
125905117|NCT00327470|452951200|FG000|Overall Study|Other|5|||
125905118|NCT00327470|452951201|FG001|Overall Study|Other|9|||
125905119|NCT00327470|452951200|FG000|Overall Study|Lost to Follow-up|1|||
125905120|NCT00327470|452951201|FG001|Overall Study|Lost to Follow-up|3|||
125905121|NCT00327470|452951200|FG000|Overall Study|Withdrawal by Subject|6|||
125905122|NCT00327470|452951201|FG001|Overall Study|Withdrawal by Subject|12|||
125905123|NCT00327470|452951200|FG000|Overall Study|Death|1|||
125905124|NCT00327470|452951201|FG001|Overall Study|Death|4|||
125905125|NCT02581943|452951204|FG000|Overall Study|Death|5|||
125905126|NCT02581943|452951205|FG001|Overall Study|Death|2|||
125905127|NCT02581943|452951204|FG000|Overall Study|Disease Progression|12|||
125905128|NCT02581943|452951205|FG001|Overall Study|Disease Progression|15|||
125905129|NCT02581943|452951204|FG000|Overall Study|Withdrawal by Subject|1|||
125905130|NCT02581943|452951205|FG001|Overall Study|Withdrawal by Subject|2|||
125905131|NCT01307020|452951207|FG000|Overall Study|Lost to Follow-up|0|||
125905132|NCT01307020|452951208|FG001|Overall Study|Lost to Follow-up|0|||
125905133|NCT01307020|452951209|FG002|Overall Study|Lost to Follow-up|1|||
125905134|NCT01307020|452951210|FG003|Overall Study|Lost to Follow-up|1|||
125905135|NCT01307020|452951211|FG004|Overall Study|Lost to Follow-up|0|||
125905136|NCT01307020|452951212|FG005|Overall Study|Lost to Follow-up|0|||
125905137|NCT01307020|452951213|FG006|Overall Study|Lost to Follow-up|1|||
125905138|NCT01307020|452951214|FG007|Overall Study|Lost to Follow-up|0|||
125905139|NCT01307020|452951215|FG008|Overall Study|Lost to Follow-up|0|||
125905140|NCT01307020|452951216|FG009|Overall Study|Lost to Follow-up|0|||
125905141|NCT01307020|452951207|FG000|Overall Study|Electronic data capture failure|0|||
125905142|NCT01307020|452951208|FG001|Overall Study|Electronic data capture failure|1|||
125905143|NCT01307020|452951209|FG002|Overall Study|Electronic data capture failure|0|||
125905144|NCT01307020|452951210|FG003|Overall Study|Electronic data capture failure|0|||
125905145|NCT01307020|452951211|FG004|Overall Study|Electronic data capture failure|0|||
125905146|NCT01307020|452951212|FG005|Overall Study|Electronic data capture failure|0|||
125905147|NCT01307020|452951213|FG006|Overall Study|Electronic data capture failure|0|||
125905148|NCT01307020|452951214|FG007|Overall Study|Electronic data capture failure|0|||
125905149|NCT01307020|452951215|FG008|Overall Study|Electronic data capture failure|0|||
125905150|NCT01307020|452951216|FG009|Overall Study|Electronic data capture failure|0|||
125905151|NCT02021656|452951217|FG000|Overall Study|Adverse Event|1|||
125905152|NCT02021656|452951217|FG000|Overall Study|Lack of Efficacy|2|||
125905153|NCT02021656|452951217|FG000|Overall Study|Lost to Follow-up|1|||
125905154|NCT02021656|452951217|FG000|Overall Study|Withdrew Consent|2|||
125905155|NCT00596362|452951226|FG000|Overall Study|Progressive Disease|1|||
125905156|NCT00356122|452951229|FG000|TREATMENT|Lack of Efficacy|26|||
125905157|NCT00356122|452951229|FG000|TREATMENT|Adverse Event|10|||
125905158|NCT00356122|452951229|FG000|TREATMENT|Subject's request|4|||
125905159|NCT00356122|452951229|FG000|TREATMENT|Other|4|||
125905160|NCT00356122|452951229|FG000|TREATMENT|Did not receive study medication|1|||
125905161|NCT00356122|452951229|FG000|FOLLOW-UP|Death|37|||
125905162|NCT00356122|452951229|FG000|FOLLOW-UP|Lost to Follow-up|2|||
125905163|NCT00356122|452951229|FG000|FOLLOW-UP|Other|2|||
125905164|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
125905165|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
125905166|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
125905167|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
125905168|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
125905169|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
125905170|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
125905171|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
125905172|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
125905173|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
125905174|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
125905175|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
125905176|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
125905177|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
125905178|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
125905179|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
125905180|NCT00491556|452951230|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
125905181|NCT00491556|452951231|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
125905182|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
125905183|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
125905184|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
125905185|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
125905186|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
125905187|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
125905188|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
125905189|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
125905190|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
125905191|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
125905192|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
125905193|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
125905194|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
125905195|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
125905196|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
125905197|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
125905198|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
125905199|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
125905200|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
125905201|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
125905202|NCT00491556|452951230|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
125905203|NCT00491556|452951231|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
125905204|NCT02418156|452951232|FG000|Overall Study|Lost to Follow-up|12|||
125905205|NCT02418156|452951232|FG000|Overall Study|Death|2|||
125905206|NCT02418156|452951232|FG000|Overall Study|Physician Decision|1|||
125905207|NCT02418156|452951232|FG000|Overall Study|Withdrawal by Subject|1|||
125905208|NCT02418156|452951232|FG000|Overall Study|Subject refused to return|1|||
125905209|NCT00562627|452952795|FG000|Overall Study|Protocol Violation|1|||
125905210|NCT00562627|452952796|FG001|Overall Study|Protocol Violation|1|||
125905211|NCT00562627|452952797|FG002|Overall Study|Protocol Violation|1|||
125905212|NCT00625742|452952798|FG000|Overall Study|Disease Progression|2|||
125905213|NCT00625742|452952798|FG000|Overall Study|Withdrawal by Subject|1|||
125905214|NCT00625742|452952798|FG000|Overall Study|Adverse Event|4|||
125905215|NCT00625742|452952798|FG000|Overall Study|Lost to Follow-up|4|||
125905216|NCT00625742|452952798|FG000|Overall Study|Ineligible|1|||
125905217|NCT01709578|452952799|FG000|Overall Study|Rescued and entered in long term safety|63|||
125905218|NCT01709578|452952800|FG001|Overall Study|Rescued and entered in long term safety|25|||
125905219|NCT01709578|452952801|FG002|Overall Study|Rescued and entered in long term safety|26|||
125905220|NCT01709578|452952799|FG000|Overall Study|Adverse Event|9|||
125905221|NCT01709578|452952800|FG001|Overall Study|Adverse Event|18|||
125905222|NCT01709578|452952801|FG002|Overall Study|Adverse Event|17|||
125905223|NCT01709578|452952799|FG000|Overall Study|Lack of Efficacy|5|||
125905224|NCT01709578|452952800|FG001|Overall Study|Lack of Efficacy|4|||
125905225|NCT01709578|452952801|FG002|Overall Study|Lack of Efficacy|2|||
125905226|NCT01709578|452952799|FG000|Overall Study|Poor compliance to protocol|1|||
125905227|NCT01709578|452952800|FG001|Overall Study|Poor compliance to protocol|2|||
125905228|NCT01709578|452952801|FG002|Overall Study|Poor compliance to protocol|1|||
125905229|NCT01709578|452952799|FG000|Overall Study|Other, not related to safety or efficacy|2|||
125905230|NCT01709578|452952800|FG001|Overall Study|Other, not related to safety or efficacy|7|||
125905231|NCT01709578|452952801|FG002|Overall Study|Other, not related to safety or efficacy|5|||
125905232|NCT04050371|452952802|FG000|Overall Study|Withdrawal by Subject|1|||
125905233|NCT04050371|452952803|FG001|Overall Study|Withdrawal by Subject|0|||
125905234|NCT01314911|452952805|FG000|Overall Study|Lost to Follow-up|3|||
125905235|NCT01314911|452952806|FG001|Overall Study|Lost to Follow-up|2|||
125905236|NCT01314911|452952805|FG000|Overall Study|Withdrawal by Subject|1|||
125905237|NCT01314911|452952806|FG001|Overall Study|Withdrawal by Subject|3|||
125905238|NCT01314911|452952805|FG000|Overall Study|Received Non-randomized Study Drug|0|||
125905239|NCT01314911|452952806|FG001|Overall Study|Received Non-randomized Study Drug|1|||
125905240|NCT01314911|452952805|FG000|Overall Study|Never Started Treatment|1|||
125905241|NCT01314911|452952806|FG001|Overall Study|Never Started Treatment|0|||
125905242|NCT03442764|452952808|FG000|Overall Study|Adverse Event|1|||
125905243|NCT03442764|452952809|FG001|Overall Study|Adverse Event|0|||
125905244|NCT03442764|452952810|FG002|Overall Study|Adverse Event|0|||
125905245|NCT04850313|452952811|FG000|Overall Study|Withdrawal by Subject|0|||
125905246|NCT04850313|452952812|FG001|Overall Study|Withdrawal by Subject|1|||
125905247|NCT00814879|452952813|FG000|By Week 24|Cancer Diagnosis|1|||
125905248|NCT00814879|452952814|FG001|By Week 24|Cancer Diagnosis|0|||
125905249|NCT00814879|452952813|FG000|By Week 24|Incarceration|0|||
125905250|NCT00814879|452952814|FG001|By Week 24|Incarceration|1|||
125905251|NCT00814879|452952813|FG000|By Week 48|Lost to Follow-up|2|||
125905252|NCT00814879|452952814|FG001|By Week 48|Lost to Follow-up|2|||
125905253|NCT00814879|452952813|FG000|By Week 48|Death|0|||
125905254|NCT00814879|452952814|FG001|By Week 48|Death|1|||
125905255|NCT01461057|452952815|FG000|Overall Study|Death|10|||
125905256|NCT01461057|452952816|FG001|Overall Study|Death|9|||
125905257|NCT01461057|452952815|FG000|Overall Study|Withdrawal by Subject|2|||
125905258|NCT01461057|452952816|FG001|Overall Study|Withdrawal by Subject|3|||
125905259|NCT01461057|452952815|FG000|Overall Study|Physician Decision|0|||
125905260|NCT01461057|452952816|FG001|Overall Study|Physician Decision|2|||
125905261|NCT01461057|452952815|FG000|Overall Study|Adverse Event|0|||
125905262|NCT01461057|452952816|FG001|Overall Study|Adverse Event|1|||
125905263|NCT01461057|452952815|FG000|Overall Study|Progression of Disease|1|||
125905264|NCT01461057|452952816|FG001|Overall Study|Progression of Disease|0|||
125905265|NCT01461057|452952815|FG000|Overall Study|Study Terminated by Sponsor|2|||
125905266|NCT01461057|452952816|FG001|Overall Study|Study Terminated by Sponsor|0|||
125905267|NCT01288976|452952817|FG000|Overall Study|Withdrawal by Subject|58|||
125905268|NCT01288976|452952818|FG001|Overall Study|Withdrawal by Subject|12|||
125905269|NCT01288976|452952819|FG002|Overall Study|Withdrawal by Subject|9|||
125905270|NCT01288976|452952817|FG000|Overall Study|Death|98|||
125905271|NCT01288976|452952818|FG001|Overall Study|Death|6|||
125905272|NCT01288976|452952819|FG002|Overall Study|Death|4|||
125905273|NCT01288976|452952817|FG000|Overall Study|Data unavailable|22|||
125905274|NCT01288976|452952818|FG001|Overall Study|Data unavailable|9|||
125905275|NCT01288976|452952819|FG002|Overall Study|Data unavailable|7|||
125905276|NCT03350984|452952822|FG000|Overall Study|Death|1|||
125905277|NCT03350984|452952823|FG001|Overall Study|Death|0|||
125905278|NCT03350984|452952822|FG000|Overall Study|Lost to Follow-up|5|||
125905279|NCT03350984|452952823|FG001|Overall Study|Lost to Follow-up|6|||
125905280|NCT03350984|452952822|FG000|Overall Study|Protocol Violation|1|||
125905281|NCT03350984|452952823|FG001|Overall Study|Protocol Violation|2|||
125905282|NCT03350984|452952822|FG000|Overall Study|Physician Decision|1|||
125905283|NCT03350984|452952823|FG001|Overall Study|Physician Decision|0|||
125905284|NCT00642473|452952824|FG000|Overall Study|Withdrawal by Subject|0|||
125905285|NCT00642473|452952825|FG001|Overall Study|Withdrawal by Subject|5|||
125905286|NCT00642473|452952824|FG000|Overall Study|Progression or death|2|||
125905287|NCT00642473|452952825|FG001|Overall Study|Progression or death|4|||
125905288|NCT00642473|452952824|FG000|Overall Study|Other|2|||
125905289|NCT00642473|452952825|FG001|Overall Study|Other|2|||
125905290|NCT00737464|452952831|FG000|Overall Study|Adverse Event|1|||
125905291|NCT00737464|452952831|FG000|Overall Study|Death|6|||
125905292|NCT00737464|452952831|FG000|Overall Study|Other - Failure to Return|1|||
125905293|NCT00737464|452952831|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
125905294|NCT00737464|452952831|FG000|Overall Study|Other reasons|4|||
125905295|NCT02742246|452952834|FG000|Overall Study|Never initiated treatment|5|||
125905296|NCT02742246|452952835|FG001|Overall Study|Never initiated treatment|3|||
125905297|NCT02742246|452952836|FG002|Overall Study|Never initiated treatment|1|||
125905298|NCT02742246|452952834|FG000|Overall Study|dropped out during treatment|7|||
125905299|NCT02742246|452952835|FG001|Overall Study|dropped out during treatment|13|||
125905300|NCT02742246|452952836|FG002|Overall Study|dropped out during treatment|10|||
125905301|NCT02742246|452952834|FG000|Overall Study|Death|1|||
125905302|NCT02742246|452952835|FG001|Overall Study|Death|0|||
125905303|NCT02742246|452952836|FG002|Overall Study|Death|0|||
125905304|NCT03220438|452952837|FG000|Overall Study|Lost to Follow-up|0|||
125905305|NCT03220438|452952838|FG001|Overall Study|Lost to Follow-up|0|||
125905306|NCT03220438|452952839|FG002|Overall Study|Lost to Follow-up|1|||
125905307|NCT03220438|452952840|FG003|Overall Study|Lost to Follow-up|0|||
125905308|NCT03584373|452952842|FG000|Overall Study|Lost to Follow-up|7|||
125905309|NCT03584373|452952843|FG001|Overall Study|Lost to Follow-up|8|||
125905310|NCT01487577|452952844|FG000|Overall Study|Became ineligible after signing consent|1|||
125905311|NCT00662532|452952849|FG000|Overall Study|Adverse Event|0|||
125905312|NCT00662532|452952850|FG001|Overall Study|Adverse Event|1|||
125905313|NCT00662532|452952849|FG000|Overall Study|Lost to Follow-up|0|||
125905314|NCT00662532|452952850|FG001|Overall Study|Lost to Follow-up|1|||
125905315|NCT00367770|452952851|FG000|Overall Study|Adverse Event|1|||
125905316|NCT00367770|452952851|FG000|Overall Study|Withdrawal by Subject|1|||
125905317|NCT01155479|452952852|FG000|Part I|Adverse Event|13|||
125905318|NCT01155479|452952853|FG001|Part I|Adverse Event|8|||
125905319|NCT01155479|452952854|FG002|Part I|Adverse Event|18|||
125905320|NCT01155479|452952855|FG003|Part I|Adverse Event|7|||
125905321|NCT01155479|452952856|FG004|Part I|Adverse Event|6|||
125905322|NCT01155479|452952852|FG000|Part I|Administrative|2|||
125905323|NCT01155479|452952853|FG001|Part I|Administrative|2|||
125905324|NCT01155479|452952854|FG002|Part I|Administrative|2|||
125905325|NCT01155479|452952855|FG003|Part I|Administrative|0|||
125905326|NCT01155479|452952856|FG004|Part I|Administrative|0|||
125905327|NCT01155479|452952852|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
125905328|NCT01155479|452952853|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
125905329|NCT01155479|452952854|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
125905330|NCT01155479|452952855|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
125905331|NCT01155479|452952856|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
125905332|NCT01155479|452952852|FG000|Part I|Withdrawal by Subject|11|||
125905333|NCT01155479|452952853|FG001|Part I|Withdrawal by Subject|13|||
125905334|NCT01155479|452952854|FG002|Part I|Withdrawal by Subject|8|||
125905335|NCT01155479|452952855|FG003|Part I|Withdrawal by Subject|8|||
125905336|NCT01155479|452952856|FG004|Part I|Withdrawal by Subject|9|||
125905337|NCT01155479|452952852|FG000|Part I|Lost to Follow-up|0|||
125905338|NCT01155479|452952853|FG001|Part I|Lost to Follow-up|0|||
125905339|NCT01155479|452952854|FG002|Part I|Lost to Follow-up|1|||
125905340|NCT01155479|452952855|FG003|Part I|Lost to Follow-up|1|||
125905341|NCT01155479|452952856|FG004|Part I|Lost to Follow-up|0|||
125905342|NCT01155479|452952852|FG000|Part I|Treatment Failure|3|||
125905343|NCT01155479|452952853|FG001|Part I|Treatment Failure|0|||
125905344|NCT01155479|452952854|FG002|Part I|Treatment Failure|3|||
125905345|NCT01155479|452952855|FG003|Part I|Treatment Failure|1|||
125905346|NCT01155479|452952856|FG004|Part I|Treatment Failure|2|||
125905347|NCT01155479|452952852|FG000|Part I|Did Not Receive Treatment|4|||
125905348|NCT01155479|452952853|FG001|Part I|Did Not Receive Treatment|2|||
125905349|NCT01155479|452952854|FG002|Part I|Did Not Receive Treatment|2|||
125905350|NCT01155479|452952855|FG003|Part I|Did Not Receive Treatment|6|||
125905351|NCT01155479|452952856|FG004|Part I|Did Not Receive Treatment|1|||
125905352|NCT01155479|452952852|FG000|Part I|Non-Compliance with Protocol|2|||
125905353|NCT01155479|452952853|FG001|Part I|Non-Compliance with Protocol|1|||
125905354|NCT01155479|452952854|FG002|Part I|Non-Compliance with Protocol|3|||
125905355|NCT01155479|452952855|FG003|Part I|Non-Compliance with Protocol|3|||
125905356|NCT01155479|452952856|FG004|Part I|Non-Compliance with Protocol|2|||
125905357|NCT01155479|452952852|FG000|Part II|Adverse Event|7|||
125905358|NCT01155479|452952853|FG001|Part II|Adverse Event|6|||
125905359|NCT01155479|452952854|FG002|Part II|Adverse Event|8|||
125905360|NCT01155479|452952855|FG003|Part II|Adverse Event|3|||
125905361|NCT01155479|452952856|FG004|Part II|Adverse Event|4|||
125905362|NCT01155479|452952852|FG000|Part II|Administrative|43|||
126059882|NCT00246129|453514201|FG000|Overall Study|suffered primary non-function|1|||
126059883|NCT00246129|453514202|FG001|Overall Study|suffered primary non-function|0|||
126059884|NCT00246129|453514201|FG000|Overall Study|grafts failed|3|||
126059885|NCT00246129|453514202|FG001|Overall Study|grafts failed|1|||
126059886|NCT03469258|453514203|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
126059887|NCT03340961|453514207|FG000|Overall Study|Adverse Event|1|||
126059888|NCT03340961|453514208|FG001|Overall Study|Adverse Event|3|||
126059889|NCT03340961|453514209|FG002|Overall Study|Adverse Event|2|||
126059890|NCT03340961|453514210|FG003|Overall Study|Adverse Event|4|||
126059891|NCT03340961|453514207|FG000|Overall Study|Lost to Follow-up|0|||
126059892|NCT03340961|453514208|FG001|Overall Study|Lost to Follow-up|1|||
126059893|NCT03340961|453514209|FG002|Overall Study|Lost to Follow-up|0|||
126059894|NCT03340961|453514210|FG003|Overall Study|Lost to Follow-up|1|||
125905363|NCT01155479|452952853|FG001|Part II|Administrative|49|||
125905364|NCT01155479|452952854|FG002|Part II|Administrative|36|||
125905365|NCT01155479|452952855|FG003|Part II|Administrative|38|||
126059895|NCT03340961|453514207|FG000|Overall Study|Withdrawal by Subject|3|||
126059896|NCT03340961|453514208|FG001|Overall Study|Withdrawal by Subject|2|||
126059897|NCT03340961|453514209|FG002|Overall Study|Withdrawal by Subject|4|||
126059898|NCT03340961|453514210|FG003|Overall Study|Withdrawal by Subject|7|||
126059899|NCT03340961|453514207|FG000|Overall Study|Use of prohibited treatment|0|||
126059900|NCT03340961|453514208|FG001|Overall Study|Use of prohibited treatment|3|||
126059901|NCT03340961|453514209|FG002|Overall Study|Use of prohibited treatment|2|||
126059902|NCT03340961|453514210|FG003|Overall Study|Use of prohibited treatment|4|||
126059903|NCT03340961|453514207|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
126059904|NCT03340961|453514208|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
126059905|NCT03340961|453514209|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
125905366|NCT01155479|452952856|FG004|Part II|Administrative|46|||
126059906|NCT03340961|453514210|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
126059907|NCT03340961|453514207|FG000|Overall Study|Subject developed an exclusion criterion|0|||
126059908|NCT03340961|453514208|FG001|Overall Study|Subject developed an exclusion criterion|1|||
126059909|NCT03340961|453514209|FG002|Overall Study|Subject developed an exclusion criterion|0|||
125905367|NCT01155479|452952852|FG000|Part II|Withdrawal by Subject|8|||
125905368|NCT01155479|452952853|FG001|Part II|Withdrawal by Subject|4|||
125905369|NCT01155479|452952854|FG002|Part II|Withdrawal by Subject|12|||
125905370|NCT01155479|452952855|FG003|Part II|Withdrawal by Subject|7|||
126059910|NCT03340961|453514210|FG003|Overall Study|Subject developed an exclusion criterion|0|||
126059911|NCT03340961|453514207|FG000|Overall Study|Protocol Violation|1|||
126059912|NCT03340961|453514208|FG001|Overall Study|Protocol Violation|0|||
126059913|NCT03340961|453514209|FG002|Overall Study|Protocol Violation|1|||
126059914|NCT03340961|453514210|FG003|Overall Study|Protocol Violation|0|||
126059915|NCT03340961|453514207|FG000|Overall Study|Adverse Event|1|||
126059916|NCT03340961|453514208|FG001|Overall Study|Adverse Event|1|||
126059917|NCT03340961|453514209|FG002|Overall Study|Adverse Event|0|||
125905371|NCT01155479|452952856|FG004|Part II|Withdrawal by Subject|3|||
125905372|NCT01155479|452952852|FG000|Part II|Lost to Follow-up|1|||
126059918|NCT03340961|453514210|FG003|Overall Study|Adverse Event|0|||
126059919|NCT03340961|453514207|FG000|Overall Study|Lack of Efficacy|0|||
126059920|NCT03340961|453514208|FG001|Overall Study|Lack of Efficacy|0|||
125905373|NCT01155479|452952853|FG001|Part II|Lost to Follow-up|0|||
126059921|NCT03340961|453514209|FG002|Overall Study|Lack of Efficacy|0|||
126059922|NCT03340961|453514210|FG003|Overall Study|Lack of Efficacy|1|||
126059923|NCT01853384|453514211|FG000|Randomized|Adverse Event|5|||
126059924|NCT01853384|453514212|FG001|Randomized|Adverse Event|3|||
126059925|NCT01853384|453514211|FG000|Randomized|Death|1|||
126059926|NCT01853384|453514212|FG001|Randomized|Death|2|||
126059927|NCT01853384|453514211|FG000|Randomized|Lost to Follow-up|1|||
126059928|NCT01853384|453514212|FG001|Randomized|Lost to Follow-up|1|||
126059929|NCT01853384|453514211|FG000|Randomized|Withdrawal by Subject|5|||
126059930|NCT01853384|453514212|FG001|Randomized|Withdrawal by Subject|3|||
126059931|NCT01853384|453514211|FG000|Randomized|Sponsor Decision|47|||
126059932|NCT01853384|453514212|FG001|Randomized|Sponsor Decision|34|||
126059933|NCT01853384|453514211|FG000|Randomized|Other|3|||
126059934|NCT01853384|453514212|FG001|Randomized|Other|3|||
125905374|NCT01155479|452952854|FG002|Part II|Lost to Follow-up|0|||
125905375|NCT01155479|452952855|FG003|Part II|Lost to Follow-up|0|||
125905376|NCT01155479|452952856|FG004|Part II|Lost to Follow-up|1|||
125905377|NCT01155479|452952852|FG000|Part II|Treatment Failure|0|||
125905378|NCT01155479|452952853|FG001|Part II|Treatment Failure|1|||
125905379|NCT01155479|452952854|FG002|Part II|Treatment Failure|2|||
125905380|NCT01155479|452952855|FG003|Part II|Treatment Failure|0|||
125905381|NCT01155479|452952856|FG004|Part II|Treatment Failure|1|||
125905382|NCT01155479|452952852|FG000|Part II|Non-Compliance with Protocol|0|||
126059935|NCT01853384|453514211|FG000|Completed Follow up Visit 1|Early Termination|13|||
125905383|NCT01155479|452952853|FG001|Part II|Non-Compliance with Protocol|1|||
125905384|NCT01155479|452952854|FG002|Part II|Non-Compliance with Protocol|0|||
125905385|NCT01155479|452952855|FG003|Part II|Non-Compliance with Protocol|2|||
125905386|NCT01155479|452952856|FG004|Part II|Non-Compliance with Protocol|0|||
125905387|NCT00998764|452952857|FG000|Overall Study|Lack of Efficacy|3|||
125905388|NCT00998764|452952858|FG001|Overall Study|Lack of Efficacy|6|||
125905389|NCT00998764|452952857|FG000|Overall Study|Adverse Event|17|||
125905390|NCT00998764|452952858|FG001|Overall Study|Adverse Event|12|||
125905391|NCT00998764|452952857|FG000|Overall Study|Withdrawal by Subject|19|||
125905392|NCT00998764|452952858|FG001|Overall Study|Withdrawal by Subject|25|||
125905393|NCT00998764|452952857|FG000|Overall Study|Physician Decision|3|||
125905394|NCT00998764|452952858|FG001|Overall Study|Physician Decision|3|||
125905395|NCT00998764|452952857|FG000|Overall Study|Death|3|||
125905396|NCT00998764|452952858|FG001|Overall Study|Death|1|||
125905397|NCT00998764|452952857|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
125905398|NCT00998764|452952858|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
125905399|NCT00998764|452952857|FG000|Overall Study|Protocol Violation|0|||
125905400|NCT00998764|452952858|FG001|Overall Study|Protocol Violation|1|||
125905401|NCT00998764|452952857|FG000|Overall Study|Failed to Return|1|||
125905402|NCT00998764|452952858|FG001|Overall Study|Failed to Return|1|||
125905403|NCT00998764|452952857|FG000|Overall Study|Lost to Follow-up|1|||
125905404|NCT00998764|452952858|FG001|Overall Study|Lost to Follow-up|1|||
125905405|NCT00998764|452952857|FG000|Overall Study|Loss of Caregiver|0|||
125905406|NCT00998764|452952858|FG001|Overall Study|Loss of Caregiver|3|||
125905407|NCT00998764|452952857|FG000|Overall Study|Other|4|||
125905408|NCT00998764|452952858|FG001|Overall Study|Other|4|||
125905409|NCT00998764|452952857|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
125905410|NCT00998764|452952858|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
125905411|NCT04761627|452952859|FG000|Run-in Period|Death|1|||
125905412|NCT04761627|452952860|FG001|Run-in Period|Death|0|||
125905413|NCT04761627|452952861|FG002|Run-in Period|Death|0|||
125905414|NCT04761627|452952859|FG000|Run-in Period|Required alternative therapy|2|||
125905415|NCT04761627|452952860|FG001|Run-in Period|Required alternative therapy|0|||
125905416|NCT04761627|452952861|FG002|Run-in Period|Required alternative therapy|0|||
125905417|NCT04761627|452952859|FG000|Run-in Period|Lost to Follow-up|2|||
125905418|NCT04761627|452952860|FG001|Run-in Period|Lost to Follow-up|0|||
125905419|NCT04761627|452952861|FG002|Run-in Period|Lost to Follow-up|0|||
125905420|NCT04761627|452952859|FG000|Run-in Period|Protocol Violation|3|||
125905421|NCT04761627|452952860|FG001|Run-in Period|Protocol Violation|0|||
125905422|NCT04761627|452952861|FG002|Run-in Period|Protocol Violation|0|||
125905423|NCT04761627|452952859|FG000|Run-in Period|Abnormal liver function|1|||
125905424|NCT04761627|452952860|FG001|Run-in Period|Abnormal liver function|0|||
125905425|NCT04761627|452952861|FG002|Run-in Period|Abnormal liver function|0|||
125905426|NCT04761627|452952859|FG000|Run-in Period|Adverse Event|6|||
125905427|NCT04761627|452952860|FG001|Run-in Period|Adverse Event|0|||
125905428|NCT04761627|452952861|FG002|Run-in Period|Adverse Event|0|||
125905429|NCT04761627|452952859|FG000|Run-in Period|Withdrawal by Subject|7|||
125905430|NCT04761627|452952860|FG001|Run-in Period|Withdrawal by Subject|0|||
125905431|NCT04761627|452952861|FG002|Run-in Period|Withdrawal by Subject|0|||
125905432|NCT04761627|452952859|FG000|Run-in Period|Did not meet PASI 50|15|||
125905433|NCT04761627|452952860|FG001|Run-in Period|Did not meet PASI 50|0|||
125905434|NCT04761627|452952861|FG002|Run-in Period|Did not meet PASI 50|0|||
125905435|NCT04761627|452952859|FG000|Run-in Period|Study site closure|2|||
125905436|NCT04761627|452952860|FG001|Run-in Period|Study site closure|0|||
125905437|NCT04761627|452952861|FG002|Run-in Period|Study site closure|0|||
125905438|NCT04761627|452952859|FG000|Run-in Period|Pregnancy|2|||
125905439|NCT04761627|452952860|FG001|Run-in Period|Pregnancy|0|||
125905440|NCT04761627|452952861|FG002|Run-in Period|Pregnancy|0|||
125905441|NCT04761627|452952859|FG000|Post-randomization Period|Military service|0|||
125905442|NCT04761627|452952860|FG001|Post-randomization Period|Military service|1|||
125905443|NCT04761627|452952861|FG002|Post-randomization Period|Military service|0|||
125905444|NCT04761627|452952859|FG000|Post-randomization Period|Adverse Event|0|||
125905445|NCT04761627|452952860|FG001|Post-randomization Period|Adverse Event|4|||
125905446|NCT04761627|452952861|FG002|Post-randomization Period|Adverse Event|2|||
125905447|NCT04761627|452952859|FG000|Post-randomization Period|Lost to Follow-up|0|||
125905448|NCT04761627|452952860|FG001|Post-randomization Period|Lost to Follow-up|6|||
125905449|NCT04761627|452952861|FG002|Post-randomization Period|Lost to Follow-up|6|||
125905450|NCT04761627|452952859|FG000|Post-randomization Period|Withdrawal by Subject|0|||
125905451|NCT04761627|452952860|FG001|Post-randomization Period|Withdrawal by Subject|7|||
125905452|NCT04761627|452952861|FG002|Post-randomization Period|Withdrawal by Subject|6|||
125905453|NCT04761627|452952859|FG000|Post-randomization Period|Pregnancy|0|||
125905454|NCT04761627|452952860|FG001|Post-randomization Period|Pregnancy|0|||
125905455|NCT04761627|452952861|FG002|Post-randomization Period|Pregnancy|1|||
126059936|NCT01853384|453514212|FG001|Completed Follow up Visit 1|Early Termination|9|||
125905456|NCT04761627|452952859|FG000|Post-randomization Period|Study site closure|0|||
125905457|NCT04761627|452952860|FG001|Post-randomization Period|Study site closure|0|||
125905458|NCT04761627|452952861|FG002|Post-randomization Period|Study site closure|1|||
125905459|NCT04761627|452952859|FG000|Post-randomization Period|Family planning|0|||
125905460|NCT04761627|452952860|FG001|Post-randomization Period|Family planning|1|||
125905461|NCT04761627|452952861|FG002|Post-randomization Period|Family planning|0|||
125905462|NCT01214174|452952862|FG000|Overall Study|Withdrawal by Subject|0|||
125905463|NCT01214174|452952863|FG001|Overall Study|Withdrawal by Subject|0|||
125905464|NCT01214174|452952864|FG002|Overall Study|Withdrawal by Subject|1|||
125905465|NCT01634178|452952867|FG000|Treatment Period 1|Adverse Event|0|||
125905466|NCT01634178|452952868|FG001|Treatment Period 1|Adverse Event|1|||
125905467|NCT01634178|452952867|FG000|Treatment Period 2|Adverse Event|1|||
125905468|NCT01634178|452952868|FG001|Treatment Period 2|Adverse Event|0|||
125905469|NCT00991952|452952881|FG000|Overall Study|Adverse Event|0|||
125905470|NCT00991952|452952882|FG001|Overall Study|Adverse Event|1|||
125905471|NCT02483533|452952883|FG000|Overall Study|Lack of Efficacy|50|||
125905472|NCT02483533|452952884|FG001|Overall Study|Lack of Efficacy|50|||
125905473|NCT03452527|452952885|FG000|Overall Study|Withdrawal by Subject|1|||
125905474|NCT03452527|452952886|FG001|Overall Study|Withdrawal by Subject|1|||
125905475|NCT03452527|452952885|FG000|Overall Study|Study Terminated|2|||
125905476|NCT03452527|452952886|FG001|Overall Study|Study Terminated|3|||
125905477|NCT00582816|452952887|FG000|Overall Study|Engraftment Failure|3|||
125905478|NCT00174291|452952898|FG000|Overall Study|Lost to Follow-up|1|||
125905479|NCT00174291|452952899|FG001|Overall Study|Lost to Follow-up|1|||
125905480|NCT00174291|452952898|FG000|Overall Study|Protocol Violation|0|||
125905481|NCT00174291|452952899|FG001|Overall Study|Protocol Violation|2|||
125905482|NCT00174291|452952898|FG000|Overall Study|Study terminated by sponsor|1|||
125905483|NCT00174291|452952899|FG001|Overall Study|Study terminated by sponsor|0|||
125905484|NCT00174291|452952898|FG000|Overall Study|Withdrawal by Subject|3|||
125905485|NCT00174291|452952899|FG001|Overall Study|Withdrawal by Subject|3|||
125905486|NCT03116347|452952902|FG000|Overall Study|Withdrawal by Subject|1|||
125905487|NCT03116347|452952903|FG001|Overall Study|Withdrawal by Subject|2|||
125905488|NCT03170232|452952904|FG000|Overall Study|Adverse Event|0|||
125905489|NCT03170232|452952905|FG001|Overall Study|Adverse Event|1|||
125905490|NCT03170232|452952904|FG000|Overall Study|Protocol Violation|0|||
125905491|NCT03170232|452952905|FG001|Overall Study|Protocol Violation|1|||
125905492|NCT03170232|452952904|FG000|Overall Study|Lack of Efficacy|0|||
125905493|NCT03170232|452952905|FG001|Overall Study|Lack of Efficacy|1|||
125905494|NCT03170232|452952904|FG000|Overall Study|Study closed/terminated|26|||
125905495|NCT03170232|452952905|FG001|Overall Study|Study closed/terminated|23|||
125905496|NCT03170232|452952904|FG000|Overall Study|Lost to Follow-up|1|||
125905497|NCT03170232|452952905|FG001|Overall Study|Lost to Follow-up|0|||
125905498|NCT03170232|452952904|FG000|Overall Study|Withdrawal by Subject|0|||
125905499|NCT03170232|452952905|FG001|Overall Study|Withdrawal by Subject|1|||
125905500|NCT00586326|452952906|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
125905501|NCT00586326|452952906|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
125905502|NCT00586326|452952906|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
125905503|NCT00586326|452952906|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
125905504|NCT00586326|452952906|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
125905505|NCT00586326|452952906|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
125905506|NCT00586326|452952906|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
125905507|NCT00586326|452952906|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
125905508|NCT00586326|452952906|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
125905509|NCT00586326|452952906|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
125905510|NCT00586326|452952906|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
125905511|NCT00586326|452952906|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
125905512|NCT00586326|452952906|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
125905513|NCT00586326|452952906|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
125905514|NCT00586326|452952906|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
125905515|NCT00586326|452952906|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
125905516|NCT00586326|452952906|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
125905517|NCT01439347|452952907|FG000|Overall Study|Death|10|||
125905518|NCT01439347|452952908|FG001|Overall Study|Death|9|||
125905519|NCT01439347|452952907|FG000|Overall Study|Withdrawal by Subject|0|||
125905520|NCT01439347|452952908|FG001|Overall Study|Withdrawal by Subject|1|||
125905521|NCT01439347|452952907|FG000|Overall Study|Physician Decision|1|||
125905522|NCT01439347|452952908|FG001|Overall Study|Physician Decision|0|||
125905523|NCT01439347|452952907|FG000|Overall Study|Sponsor Terminated Study|2|||
125905524|NCT01439347|452952908|FG001|Overall Study|Sponsor Terminated Study|3|||
125905525|NCT04068896|452952910|FG000|Overall Study|Adverse Event|2|||
125905526|NCT04068896|452952911|FG001|Overall Study|Adverse Event|0|||
125905527|NCT04068896|452952912|FG002|Overall Study|Adverse Event|1|||
125905528|NCT04068896|452952913|FG003|Overall Study|Adverse Event|0|||
125905529|NCT04068896|452952914|FG004|Overall Study|Adverse Event|0|||
125905530|NCT04068896|452952915|FG005|Overall Study|Adverse Event|0|||
125905531|NCT04068896|452952910|FG000|Overall Study|Death|3|||
125905532|NCT04068896|452952911|FG001|Overall Study|Death|1|||
125905533|NCT04068896|452952912|FG002|Overall Study|Death|3|||
125905534|NCT04068896|452952913|FG003|Overall Study|Death|19|||
126059937|NCT01853384|453514211|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
125905535|NCT04068896|452952914|FG004|Overall Study|Death|17|||
125905536|NCT04068896|452952915|FG005|Overall Study|Death|0|||
125905537|NCT04068896|452952910|FG000|Overall Study|Physician Decision|0|||
125905538|NCT04068896|452952911|FG001|Overall Study|Physician Decision|0|||
125905539|NCT04068896|452952912|FG002|Overall Study|Physician Decision|0|||
125905540|NCT04068896|452952913|FG003|Overall Study|Physician Decision|1|||
125905541|NCT04068896|452952914|FG004|Overall Study|Physician Decision|0|||
125905542|NCT04068896|452952915|FG005|Overall Study|Physician Decision|0|||
125905543|NCT04068896|452952910|FG000|Overall Study|progressive disease|3|||
125905544|NCT04068896|452952911|FG001|Overall Study|progressive disease|5|||
125905545|NCT04068896|452952912|FG002|Overall Study|progressive disease|3|||
125905546|NCT04068896|452952913|FG003|Overall Study|progressive disease|2|||
125905547|NCT04068896|452952914|FG004|Overall Study|progressive disease|1|||
125905548|NCT04068896|452952915|FG005|Overall Study|progressive disease|2|||
125905549|NCT04068896|452952910|FG000|Overall Study|Study terminated by sponsor|0|||
125905550|NCT04068896|452952911|FG001|Overall Study|Study terminated by sponsor|0|||
125905551|NCT04068896|452952912|FG002|Overall Study|Study terminated by sponsor|1|||
125905552|NCT04068896|452952913|FG003|Overall Study|Study terminated by sponsor|2|||
125905553|NCT04068896|452952914|FG004|Overall Study|Study terminated by sponsor|1|||
125905554|NCT04068896|452952915|FG005|Overall Study|Study terminated by sponsor|4|||
125905555|NCT04068896|452952910|FG000|Overall Study|Protocol Violation|0|||
125905556|NCT04068896|452952911|FG001|Overall Study|Protocol Violation|0|||
125905557|NCT04068896|452952912|FG002|Overall Study|Protocol Violation|0|||
125905558|NCT04068896|452952913|FG003|Overall Study|Protocol Violation|1|||
125905559|NCT04068896|452952914|FG004|Overall Study|Protocol Violation|0|||
125905560|NCT04068896|452952915|FG005|Overall Study|Protocol Violation|0|||
125905561|NCT04068896|452952910|FG000|Overall Study|Withdrawal by Subject|0|||
125905562|NCT04068896|452952911|FG001|Overall Study|Withdrawal by Subject|3|||
125905563|NCT04068896|452952912|FG002|Overall Study|Withdrawal by Subject|0|||
125905564|NCT04068896|452952913|FG003|Overall Study|Withdrawal by Subject|2|||
125905565|NCT04068896|452952914|FG004|Overall Study|Withdrawal by Subject|1|||
125905566|NCT04068896|452952915|FG005|Overall Study|Withdrawal by Subject|0|||
125905567|NCT04068896|452952910|FG000|Overall Study|Symptomatic deterioration|2|||
125905568|NCT04068896|452952911|FG001|Overall Study|Symptomatic deterioration|0|||
125905569|NCT04068896|452952912|FG002|Overall Study|Symptomatic deterioration|0|||
125905570|NCT04068896|452952913|FG003|Overall Study|Symptomatic deterioration|0|||
125905571|NCT04068896|452952914|FG004|Overall Study|Symptomatic deterioration|0|||
125905572|NCT04068896|452952915|FG005|Overall Study|Symptomatic deterioration|0|||
125905573|NCT01101191|452952916|FG000|Period 1|Withdrawal by Subject|1|||
125905574|NCT01101191|452952917|FG001|Period 1|Withdrawal by Subject|0|||
125905575|NCT01101191|452952916|FG000|Period 1|Adverse Event|1|||
125905576|NCT01101191|452952917|FG001|Period 1|Adverse Event|2|||
125905577|NCT02009384|452952918|FG000|Overall Study|Death|2|||
125905578|NCT00718237|452952920|FG000|Overall Study|Adverse Event|1|||
125905579|NCT00718237|452952921|FG001|Overall Study|Adverse Event|3|||
125905580|NCT00718237|452952920|FG000|Overall Study|Lost to Follow-up|2|||
125905581|NCT00718237|452952921|FG001|Overall Study|Lost to Follow-up|2|||
125905582|NCT00718237|452952920|FG000|Overall Study|Physician Decision|1|||
125905583|NCT00718237|452952921|FG001|Overall Study|Physician Decision|0|||
125905584|NCT00718237|452952920|FG000|Overall Study|Withdrawal by Subject|9|||
125905585|NCT00718237|452952921|FG001|Overall Study|Withdrawal by Subject|10|||
125905586|NCT02694718|452952922|FG000|Overall Study|Death|1|||
125905587|NCT02694718|452952922|FG000|Overall Study|Withdrawal by Subject|1|||
125905588|NCT02925793|452952923|FG000|Overall Study|Adverse Event|3|||
125905589|NCT02925793|452952924|FG001|Overall Study|Adverse Event|3|||
125905590|NCT02925793|452952925|FG002|Overall Study|Adverse Event|6|||
125905591|NCT02925793|452952923|FG000|Overall Study|Withdrawal by Subject|16|||
125905592|NCT02925793|452952924|FG001|Overall Study|Withdrawal by Subject|15|||
126059938|NCT01853384|453514212|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
126059939|NCT01853384|453514211|FG000|Completed Follow up Visit 2|Adverse Event|1|||
126059940|NCT01853384|453514212|FG001|Completed Follow up Visit 2|Adverse Event|0|||
125905593|NCT02925793|452952925|FG002|Overall Study|Withdrawal by Subject|13|||
125905594|NCT02925793|452952923|FG000|Overall Study|Investigator Discretion|0|||
125905595|NCT02925793|452952924|FG001|Overall Study|Investigator Discretion|1|||
125905596|NCT02925793|452952925|FG002|Overall Study|Investigator Discretion|1|||
125905597|NCT02925793|452952923|FG000|Overall Study|Lost to Follow-up|2|||
125905598|NCT02925793|452952924|FG001|Overall Study|Lost to Follow-up|3|||
125905599|NCT02925793|452952925|FG002|Overall Study|Lost to Follow-up|1|||
125905600|NCT02925793|452952923|FG000|Overall Study|Lack of Efficacy|2|||
125905601|NCT02925793|452952924|FG001|Overall Study|Lack of Efficacy|6|||
125905602|NCT02925793|452952925|FG002|Overall Study|Lack of Efficacy|4|||
125905603|NCT02925793|452952923|FG000|Overall Study|Other:|2|||
126059941|NCT01853384|453514211|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
126059942|NCT01853384|453514212|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
125905604|NCT02925793|452952924|FG001|Overall Study|Other:|1|||
125905605|NCT02925793|452952925|FG002|Overall Study|Other:|3|||
125905606|NCT00879879|452952926|FG000|Overall Study|Death|1|||
125905607|NCT00879879|452952926|FG000|Overall Study|Withdrawal by Subject|1|||
125905608|NCT00879879|452952926|FG000|Overall Study|Physician Decision|1|||
125905609|NCT00667446|452952928|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
125905610|NCT00667446|452952929|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
125905611|NCT00667446|452952928|FG000|Treatment Period (36 Months)|Other|2|||
125905612|NCT00667446|452952929|FG001|Treatment Period (36 Months)|Other|2|||
125905613|NCT00667446|452952928|FG000|Treatment Period (36 Months)|Personal reasons|2|||
125905614|NCT00667446|452952929|FG001|Treatment Period (36 Months)|Personal reasons|2|||
125905615|NCT00667446|452952928|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
125905616|NCT00667446|452952929|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
125905617|NCT00667446|452952928|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
125905618|NCT00667446|452952929|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
125905619|NCT00667446|452952928|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
125905620|NCT00667446|452952929|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
125905621|NCT00667446|452952928|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
125905622|NCT00667446|452952929|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
125905623|NCT00667446|452952928|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
125905624|NCT00667446|452952929|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
125905625|NCT00667446|452952928|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
126059943|NCT01853384|453514211|FG000|Completed Follow up Visit 2|Death|1|||
126059944|NCT01853384|453514212|FG001|Completed Follow up Visit 2|Death|0|||
126059945|NCT01853384|453514211|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
126059946|NCT01853384|453514212|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
125905626|NCT00667446|452952929|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
125905627|NCT01343901|452952930|FG000|Overall Study|Death|85|||
125905628|NCT01343901|452952930|FG000|Overall Study|Physician Decision|4|||
125905629|NCT01343901|452952930|FG000|Overall Study|Lost to Follow-up|12|||
125905630|NCT01343901|452952930|FG000|Overall Study|Management by another medical team|11|||
125905631|NCT01343901|452952930|FG000|Overall Study|Participant decision|1|||
125905632|NCT03324581|452952936|FG000|Overall Study|Adverse Event|18|||
125905633|NCT03324581|452952937|FG001|Overall Study|Adverse Event|11|||
125905634|NCT03324581|452952938|FG002|Overall Study|Adverse Event|7|||
125905635|NCT03324581|452952936|FG000|Overall Study|Lack of Efficacy|0|||
125905636|NCT03324581|452952937|FG001|Overall Study|Lack of Efficacy|1|||
125905637|NCT03324581|452952938|FG002|Overall Study|Lack of Efficacy|0|||
125905638|NCT03324581|452952936|FG000|Overall Study|Lost to Follow-up|5|||
125905639|NCT03324581|452952937|FG001|Overall Study|Lost to Follow-up|3|||
125905640|NCT03324581|452952938|FG002|Overall Study|Lost to Follow-up|6|||
125905641|NCT03324581|452952936|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
125905642|NCT03324581|452952937|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
125905643|NCT03324581|452952938|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
125905644|NCT03324581|452952936|FG000|Overall Study|Physician Decision|0|||
125905645|NCT03324581|452952937|FG001|Overall Study|Physician Decision|1|||
125905646|NCT03324581|452952938|FG002|Overall Study|Physician Decision|2|||
126059947|NCT01205126|453514213|FG000|Titration Phase|Adverse Event|5|||
125905647|NCT03324581|452952936|FG000|Overall Study|Protocol Deviation|8|||
125905648|NCT03324581|452952937|FG001|Overall Study|Protocol Deviation|9|||
125905649|NCT03324581|452952938|FG002|Overall Study|Protocol Deviation|4|||
125905650|NCT03324581|452952936|FG000|Overall Study|Withdrawal by Subject|6|||
126059948|NCT01205126|453514214|FG001|Titration Phase|Adverse Event|3|||
126059949|NCT01205126|453514213|FG000|Titration Phase|Withdrawal by Subject|5|||
126059950|NCT01205126|453514214|FG001|Titration Phase|Withdrawal by Subject|5|||
125905651|NCT03324581|452952937|FG001|Overall Study|Withdrawal by Subject|8|||
125905652|NCT03324581|452952938|FG002|Overall Study|Withdrawal by Subject|6|||
125905653|NCT03324581|452952936|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
125905654|NCT03324581|452952937|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
125905655|NCT03324581|452952938|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
125905656|NCT02274038|452952939|FG000|Overall Study|Death|1|||
125905657|NCT03783702|452952940|FG000|Overall Study|Lost to Follow-up|6|||
125905658|NCT03783702|452952941|FG001|Overall Study|Lost to Follow-up|8|||
125905659|NCT03783702|452952940|FG000|Overall Study|Protocol Violation|1|||
125905660|NCT03783702|452952941|FG001|Overall Study|Protocol Violation|3|||
125905661|NCT00769483|452952942|FG000|Overall Study|Withdrawal by Subject|0|||
125905662|NCT00769483|452952943|FG001|Overall Study|Withdrawal by Subject|1|||
125905663|NCT00769483|452952944|FG002|Overall Study|Withdrawal by Subject|0|||
125905664|NCT00769483|452952945|FG003|Overall Study|Withdrawal by Subject|0|||
125905665|NCT00769483|452952946|FG004|Overall Study|Withdrawal by Subject|1|||
125905666|NCT00769483|452952947|FG005|Overall Study|Withdrawal by Subject|0|||
125905667|NCT03455764|452952948|FG000|Overall Study|Adverse Event|1|||
125905668|NCT03455764|452952949|FG001|Overall Study|Adverse Event|0|||
125905669|NCT03455764|452952950|FG002|Overall Study|Adverse Event|0|||
125905670|NCT03455764|452952951|FG003|Overall Study|Adverse Event|0|||
125905671|NCT03455764|452952952|FG004|Overall Study|Adverse Event|0|||
125905672|NCT03455764|452952948|FG000|Overall Study|Disease Progression|4|||
125905673|NCT03455764|452952949|FG001|Overall Study|Disease Progression|0|||
125905674|NCT03455764|452952950|FG002|Overall Study|Disease Progression|0|||
125905675|NCT03455764|452952951|FG003|Overall Study|Disease Progression|0|||
125905676|NCT03455764|452952952|FG004|Overall Study|Disease Progression|0|||
125905677|NCT03455764|452952948|FG000|Overall Study|On Treatment|1|||
125905678|NCT03455764|452952949|FG001|Overall Study|On Treatment|0|||
125905679|NCT03455764|452952950|FG002|Overall Study|On Treatment|0|||
125905680|NCT03455764|452952951|FG003|Overall Study|On Treatment|0|||
125905681|NCT03455764|452952952|FG004|Overall Study|On Treatment|0|||
125905682|NCT00995865|452952953|FG000|Overall Study|Protocol Violation|2|||
125905683|NCT00995865|452952954|FG001|Overall Study|Protocol Violation|0|||
125905684|NCT00995865|452952955|FG002|Overall Study|Protocol Violation|0|||
125905685|NCT00995865|452952953|FG000|Overall Study|Lost to Follow-up|0|||
125905686|NCT00995865|452952954|FG001|Overall Study|Lost to Follow-up|0|||
125905687|NCT00995865|452952955|FG002|Overall Study|Lost to Follow-up|1|||
125905688|NCT05080660|452952957|FG000|Overall Study|Adverse Event|4|||
125905689|NCT05080660|452952958|FG001|Overall Study|Adverse Event|0|||
125905690|NCT05080660|452952957|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
125905691|NCT05080660|452952958|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
125905692|NCT05080660|452952957|FG000|Overall Study|Physician Decision|1|||
125905693|NCT05080660|452952958|FG001|Overall Study|Physician Decision|0|||
125905694|NCT05080660|452952957|FG000|Overall Study|Protocol Deviation|2|||
125905695|NCT05080660|452952958|FG001|Overall Study|Protocol Deviation|0|||
125905696|NCT05080660|452952957|FG000|Overall Study|Withdrawal by Subject|5|||
125905697|NCT05080660|452952958|FG001|Overall Study|Withdrawal by Subject|2|||
125905698|NCT04221230|452952968|FG000|Overall Study|Lost to Follow-up|12|||
125905699|NCT04221230|452952969|FG001|Overall Study|Lost to Follow-up|12|||
125905700|NCT04221230|452952968|FG000|Overall Study|Protocol Violation|2|||
125905701|NCT04221230|452952969|FG001|Overall Study|Protocol Violation|2|||
125905702|NCT04221230|452952968|FG000|Overall Study|Adverse Event|0|||
125905703|NCT04221230|452952969|FG001|Overall Study|Adverse Event|8|||
125905704|NCT04221230|452952968|FG000|Overall Study|Physician Decision|1|||
125905705|NCT04221230|452952969|FG001|Overall Study|Physician Decision|0|||
125905706|NCT04221230|452952968|FG000|Overall Study|Withdrawal by Subject|13|||
125905707|NCT04221230|452952969|FG001|Overall Study|Withdrawal by Subject|11|||
125905708|NCT04221230|452952968|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125905709|NCT04221230|452952969|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126059951|NCT01205126|453514213|FG000|Titration Phase|Lost to Follow-up|2|||
126059952|NCT01205126|453514214|FG001|Titration Phase|Lost to Follow-up|2|||
126059953|NCT01205126|453514213|FG000|Titration Phase|No stable titration dose|1|||
125905710|NCT04221230|452952968|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125905711|NCT04221230|452952969|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
125905712|NCT04221230|452952968|FG000|Overall Study|Pregnancy|0|||
125905713|NCT04221230|452952969|FG001|Overall Study|Pregnancy|1|||
125905714|NCT04221230|452952968|FG000|Overall Study|Other|1|||
125905715|NCT04221230|452952969|FG001|Overall Study|Other|2|||
125905716|NCT03687970|452952971|FG000|Overall Study|visit scheduling conflicts|2|||
125905717|NCT03687970|452952972|FG001|Overall Study|visit scheduling conflicts|0|||
126059954|NCT01205126|453514214|FG001|Titration Phase|No stable titration dose|0|||
125905718|NCT04854642|452954492|FG000|Overall Study|Adverse Event|1|||
125905719|NCT04854642|452954493|FG001|Overall Study|Adverse Event|2|||
125905720|NCT04854642|452954492|FG000|Overall Study|Withdrawal by Subject|0|||
125905721|NCT04854642|452954493|FG001|Overall Study|Withdrawal by Subject|1|||
125905722|NCT00597701|452954494|FG000|Overall Study|Withdrawal by Subject|5|||
125905723|NCT00597701|452954495|FG001|Overall Study|Withdrawal by Subject|5|||
126059955|NCT01205126|453514213|FG000|Titration Phase|More than maximum dosage required|2|||
125905724|NCT00597701|452954494|FG000|Overall Study|Death|0|||
125905725|NCT00597701|452954495|FG001|Overall Study|Death|1|||
125905726|NCT00597701|452954494|FG000|Overall Study|Physician Decision|2|||
126110122|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
125905727|NCT00597701|452954495|FG001|Overall Study|Physician Decision|0|||
125905728|NCT00597701|452954494|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
125905729|NCT00597701|452954495|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
125905730|NCT01107418|452954496|FG000|Overall Study|Disease Progression|45|||
125905731|NCT01107418|452954496|FG000|Overall Study|Adverse Event|3|||
125905732|NCT01107418|452954496|FG000|Overall Study|Withdrawal by Subject|1|||
125905733|NCT01107418|452954496|FG000|Overall Study|Study Closing|1|||
125905734|NCT01107418|452954496|FG000|Overall Study|Started Other Therapy|1|||
125905735|NCT01107418|452954496|FG000|Overall Study|Entered Extension Study|1|||
125905736|NCT00301821|452954500|FG000|Overall Study|Ineligible|25|||
125905737|NCT00301821|452954500|FG000|Overall Study|Cancel|1|||
125905738|NCT04078178|452954505|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
125905739|NCT04078178|452954506|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
125905740|NCT04078178|452954505|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
125905741|NCT04078178|452954506|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
125905742|NCT04078178|452954505|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
125905743|NCT04078178|452954506|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
125905744|NCT04078178|452954505|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
125905745|NCT04078178|452954506|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
125905746|NCT04078178|452954505|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
125905747|NCT04078178|452954506|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
125905748|NCT04006119|452954507|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
125905749|NCT04006119|452954507|FG000|End of Treatment Veledimex|Adverse Event|2|||
125905750|NCT04006119|452954507|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
125905751|NCT04006119|452954507|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
125905752|NCT04006119|452954507|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
125905753|NCT04006119|452954507|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
125905754|NCT00472459|452954508|FG000|Overall Study|Adverse Event|13|||
125905755|NCT00472459|452954509|FG001|Overall Study|Adverse Event|13|||
125905756|NCT00472459|452954508|FG000|Overall Study|Withdrawal by Subject|5|||
125905757|NCT00472459|452954509|FG001|Overall Study|Withdrawal by Subject|5|||
125905758|NCT00472459|452954508|FG000|Overall Study|Protocol Violation|3|||
125905759|NCT00472459|452954509|FG001|Overall Study|Protocol Violation|3|||
125905760|NCT00472459|452954508|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
125905761|NCT00472459|452954509|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
125905762|NCT00472459|452954508|FG000|Overall Study|Lost to Follow-up|1|||
125905763|NCT00472459|452954509|FG001|Overall Study|Lost to Follow-up|1|||
125905764|NCT00588952|452954510|FG000|Overall Study|Adverse Event|0|||
125905765|NCT00588952|452954511|FG001|Overall Study|Adverse Event|2|||
125905766|NCT00588952|452954510|FG000|Overall Study|Withdrawal by Subject|3|||
125905767|NCT00588952|452954511|FG001|Overall Study|Withdrawal by Subject|5|||
125905768|NCT01277042|452954512|FG000|Overall Study|Adverse Event|4|||
125905769|NCT01277042|452954513|FG001|Overall Study|Adverse Event|3|||
125905770|NCT01277042|452954512|FG000|Overall Study|Lost to Follow-up|2|||
125905771|NCT01277042|452954513|FG001|Overall Study|Lost to Follow-up|2|||
125905772|NCT01277042|452954512|FG000|Overall Study|Withdrawal by Subject|2|||
125905773|NCT01277042|452954513|FG001|Overall Study|Withdrawal by Subject|0|||
125905774|NCT02284178|452954514|FG000|Overall Study|Met exclusion criteria|49|||
125905775|NCT02284178|452954515|FG001|Overall Study|Met exclusion criteria|54|||
125905776|NCT01483690|452954520|FG000|Overall Study|Adverse Event|1|||
125905777|NCT01483690|452954521|FG001|Overall Study|Adverse Event|2|||
125905778|NCT01483690|452954520|FG000|Overall Study|clinical deterioration|1|||
125905779|NCT01483690|452954521|FG001|Overall Study|clinical deterioration|0|||
125905780|NCT01483690|452954520|FG000|Overall Study|Physician Decision|0|||
125905781|NCT01483690|452954521|FG001|Overall Study|Physician Decision|2|||
125905782|NCT01483690|452954520|FG000|Overall Study|exclusionary procedure|0|||
125905783|NCT01483690|452954521|FG001|Overall Study|exclusionary procedure|1|||
125905784|NCT00478881|452954522|FG000|Overall Study|Adverse Event|31|||
125905785|NCT00478881|452954523|FG001|Overall Study|Adverse Event|12|||
125905786|NCT00478881|452954522|FG000|Overall Study|Lack of Efficacy|0|||
125905787|NCT00478881|452954523|FG001|Overall Study|Lack of Efficacy|3|||
125905788|NCT00478881|452954522|FG000|Overall Study|Lost to Follow-up|0|||
125905789|NCT00478881|452954523|FG001|Overall Study|Lost to Follow-up|1|||
125905790|NCT00478881|452954522|FG000|Overall Study|Protocol Violation|2|||
125905791|NCT00478881|452954523|FG001|Overall Study|Protocol Violation|2|||
125905792|NCT00478881|452954522|FG000|Overall Study|Withdrawal by Subject|6|||
125905793|NCT00478881|452954523|FG001|Overall Study|Withdrawal by Subject|2|||
126059956|NCT01205126|453514214|FG001|Titration Phase|More than maximum dosage required|3|||
126059957|NCT01205126|453514213|FG000|Titration Phase|Other|8|||
125905794|NCT00478881|452954522|FG000|Overall Study|Non-Compliance with Study Medication|0|||
125905795|NCT00478881|452954523|FG001|Overall Study|Non-Compliance with Study Medication|2|||
125905796|NCT03410823|452954526|FG000|Overall Study|Death|1|||
125905797|NCT03410823|452954526|FG000|Overall Study|Withdrawal by Subject|2|||
125905798|NCT03410823|452954526|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
125905799|NCT03569293|452954527|FG000|Overall Study|Adverse Event|4|||
125905800|NCT03569293|452954528|FG001|Overall Study|Adverse Event|1|||
125905801|NCT03569293|452954529|FG002|Overall Study|Adverse Event|5|||
125905802|NCT03569293|452954530|FG003|Overall Study|Adverse Event|1|||
125905803|NCT03569293|452954531|FG004|Overall Study|Adverse Event|0|||
125905804|NCT03569293|452954532|FG005|Overall Study|Adverse Event|0|||
125905805|NCT03569293|452954527|FG000|Overall Study|Withdrawal by Subject|16|||
125905806|NCT03569293|452954528|FG001|Overall Study|Withdrawal by Subject|2|||
125905807|NCT03569293|452954529|FG002|Overall Study|Withdrawal by Subject|4|||
125905808|NCT03569293|452954530|FG003|Overall Study|Withdrawal by Subject|1|||
125905809|NCT03569293|452954531|FG004|Overall Study|Withdrawal by Subject|0|||
125905810|NCT03569293|452954532|FG005|Overall Study|Withdrawal by Subject|0|||
125905811|NCT03569293|452954527|FG000|Overall Study|Lost to Follow-up|1|||
125905812|NCT03569293|452954528|FG001|Overall Study|Lost to Follow-up|3|||
125905813|NCT03569293|452954529|FG002|Overall Study|Lost to Follow-up|1|||
125905814|NCT03569293|452954530|FG003|Overall Study|Lost to Follow-up|1|||
125905815|NCT03569293|452954531|FG004|Overall Study|Lost to Follow-up|0|||
125905816|NCT03569293|452954532|FG005|Overall Study|Lost to Follow-up|0|||
125905817|NCT03569293|452954527|FG000|Overall Study|Other|8|||
125905818|NCT03569293|452954528|FG001|Overall Study|Other|2|||
125905819|NCT03569293|452954529|FG002|Overall Study|Other|1|||
125905820|NCT03569293|452954530|FG003|Overall Study|Other|1|||
125905821|NCT03569293|452954531|FG004|Overall Study|Other|0|||
125905822|NCT03569293|452954532|FG005|Overall Study|Other|0|||
125905823|NCT03569293|452954527|FG000|Overall Study|Ongoing at Time of Analysis|8|||
125905824|NCT03569293|452954528|FG001|Overall Study|Ongoing at Time of Analysis|1|||
125905825|NCT03569293|452954529|FG002|Overall Study|Ongoing at Time of Analysis|3|||
125905826|NCT03569293|452954530|FG003|Overall Study|Ongoing at Time of Analysis|0|||
125905827|NCT03569293|452954531|FG004|Overall Study|Ongoing at Time of Analysis|0|||
125905828|NCT03569293|452954532|FG005|Overall Study|Ongoing at Time of Analysis|0|||
125905829|NCT05128929|452954535|FG000|Overall Study|Adverse Event|0|||
125905830|NCT05128929|452954536|FG001|Overall Study|Adverse Event|1|||
125905831|NCT03553836|452954537|FG000|Overall Study|Ongoing in Study|460|||
125905832|NCT03553836|452954538|FG001|Overall Study|Ongoing in Study|459|||
125905833|NCT03553836|452954537|FG000|Overall Study|Withdrawal by Subject|9|||
125905834|NCT03553836|452954538|FG001|Overall Study|Withdrawal by Subject|10|||
125905835|NCT03553836|452954537|FG000|Overall Study|Lost to Follow-up|1|||
125905836|NCT03553836|452954538|FG001|Overall Study|Lost to Follow-up|3|||
125905837|NCT03553836|452954537|FG000|Overall Study|Death|17|||
125905838|NCT03553836|452954538|FG001|Overall Study|Death|17|||
125905839|NCT04062123|452954539|FG000|Overall Study|Withdrawal by Subject|0|||
125905840|NCT04062123|452954540|FG001|Overall Study|Withdrawal by Subject|1|||
125905841|NCT04062123|452954541|FG002|Overall Study|Withdrawal by Subject|0|||
125905842|NCT01041495|452954542|FG000|Overall Study|Withdrawal by Subject|2|||
125905843|NCT01041495|452954543|FG001|Overall Study|Withdrawal by Subject|5|||
125905844|NCT01041495|452954542|FG000|Overall Study|Adverse Event|2|||
125905845|NCT01041495|452954543|FG001|Overall Study|Adverse Event|1|||
125905846|NCT01041495|452954542|FG000|Overall Study|Lost to Follow-up|0|||
125905847|NCT01041495|452954543|FG001|Overall Study|Lost to Follow-up|1|||
125905848|NCT03780400|452954547|FG000|Overall Study|Lost to Follow-up|5|||
125905849|NCT03780400|452954547|FG000|Overall Study|Withdrawal by Subject|2|||
125905850|NCT01479985|452954548|FG000|Overall Study|Tablet malfunction, no data saved|1|||
125905851|NCT01479985|452954549|FG001|Overall Study|Tablet malfunction, no data saved|1|||
125905852|NCT01479985|452954548|FG000|Overall Study|No decisional conflict scale responses|0|||
125905853|NCT01479985|452954549|FG001|Overall Study|No decisional conflict scale responses|2|||
125905854|NCT01479985|452954548|FG000|Overall Study|No post-visit survey|5|||
125905855|NCT01479985|452954549|FG001|Overall Study|No post-visit survey|3|||
125905856|NCT01653782|452954550|FG000|Overall Study|Withdrawal by Subject|9|||
125905857|NCT01653782|452954551|FG001|Overall Study|Withdrawal by Subject|15|||
125905858|NCT01653782|452954552|FG002|Overall Study|Withdrawal by Subject|4|||
125905859|NCT01653782|452954550|FG000|Overall Study|Lost to Follow-up|7|||
125905860|NCT01653782|452954551|FG001|Overall Study|Lost to Follow-up|3|||
125905861|NCT01653782|452954552|FG002|Overall Study|Lost to Follow-up|2|||
125905862|NCT01142128|452954553|FG000|Overall Study|Physician Decision|1|||
125905863|NCT01142128|452954553|FG000|Overall Study|Lost to Follow-up|1|||
125905864|NCT01142128|452954553|FG000|Overall Study|Withdrawal by Subject|2|||
125905865|NCT00442468|452954554|FG000|Overall Study|Adverse Event|4|||
125905866|NCT00442468|452954554|FG000|Overall Study|Withdrawal by Subject|91|||
125905867|NCT00442468|452954554|FG000|Overall Study|Did not complete all study procedures|88|||
125905868|NCT05867342|452954557|FG000|Overall Study|Investigator Decision|3|||
125905869|NCT05867342|452954558|FG001|Overall Study|Investigator Decision|3|||
125905870|NCT00470184|452954559|FG000|Overall Study|Not Treated(became ineligible)|4|||
125905871|NCT00470184|452954559|FG000|Overall Study|Not treated (other)|1|||
125905872|NCT00470184|452954559|FG000|Overall Study|disease Progression|4|||
125905873|NCT00470184|452954559|FG000|Overall Study|Adverse Event|3|||
125905874|NCT00470184|452954559|FG000|Overall Study|Withdrawal by Subject|4|||
125905875|NCT00470184|452954559|FG000|Overall Study|other|5|||
125905876|NCT00470184|452954559|FG000|Overall Study|recurrence|1|||
125905877|NCT03823378|452954560|FG000|Overall Study|Adverse Event|2|||
125905878|NCT03823378|452954561|FG001|Overall Study|Adverse Event|2|||
125905879|NCT03823378|452954562|FG002|Overall Study|Adverse Event|0|||
125905880|NCT03823378|452954563|FG003|Overall Study|Adverse Event|0|||
125905881|NCT03823378|452954564|FG004|Overall Study|Adverse Event|0|||
125905882|NCT03823378|452954565|FG005|Overall Study|Adverse Event|0|||
125905883|NCT03823378|452954560|FG000|Overall Study|Lost to Follow-up|0|||
125905884|NCT03823378|452954561|FG001|Overall Study|Lost to Follow-up|1|||
125905885|NCT03823378|452954562|FG002|Overall Study|Lost to Follow-up|0|||
125905886|NCT03823378|452954563|FG003|Overall Study|Lost to Follow-up|0|||
125905887|NCT03823378|452954564|FG004|Overall Study|Lost to Follow-up|1|||
125905888|NCT03823378|452954565|FG005|Overall Study|Lost to Follow-up|0|||
125905889|NCT03823378|452954560|FG000|Overall Study|Withdrawal by Subject|0|||
125905890|NCT03823378|452954561|FG001|Overall Study|Withdrawal by Subject|1|||
125905891|NCT03823378|452954562|FG002|Overall Study|Withdrawal by Subject|4|||
125905892|NCT03823378|452954563|FG003|Overall Study|Withdrawal by Subject|2|||
125905893|NCT03823378|452954564|FG004|Overall Study|Withdrawal by Subject|0|||
125905894|NCT03823378|452954565|FG005|Overall Study|Withdrawal by Subject|1|||
125905895|NCT03823378|452954560|FG000|Overall Study|Other, not specified|19|||
125905896|NCT03823378|452954561|FG001|Overall Study|Other, not specified|12|||
125905897|NCT03823378|452954562|FG002|Overall Study|Other, not specified|6|||
125905898|NCT03823378|452954563|FG003|Overall Study|Other, not specified|8|||
125905899|NCT03823378|452954564|FG004|Overall Study|Other, not specified|17|||
125905900|NCT03823378|452954565|FG005|Overall Study|Other, not specified|7|||
125905901|NCT05442775|452954566|FG000|Overall Study|Trial terminated|61|||
125905902|NCT05442775|452954566|FG000|Overall Study|Lack of Efficacy|4|||
125905903|NCT05442775|452954566|FG000|Overall Study|Withdrawal by Subject|4|||
125905904|NCT05442775|452954566|FG000|Overall Study|Death|1|||
125905905|NCT05442775|452954566|FG000|Overall Study|Participant removed at Sponsor request|1|||
125905906|NCT00058539|452954568|FG000|Overall Study|Disease progression|24|||
125905907|NCT00058539|452954568|FG000|Overall Study|Adverse Event|3|||
125905908|NCT00058539|452954568|FG000|Overall Study|Withdrawal by Subject|5|||
125905909|NCT00058539|452954568|FG000|Overall Study|Physician Decision|9|||
125905910|NCT00058539|452954568|FG000|Overall Study|Death|1|||
125905911|NCT03190369|452954569|FG000|Overall Study|Poor compliance to protocol|0|||
125905912|NCT03190369|452954570|FG001|Overall Study|Poor compliance to protocol|1|||
125905913|NCT03190369|452954569|FG000|Overall Study|Withdraw before treatment|1|||
125905914|NCT03190369|452954570|FG001|Overall Study|Withdraw before treatment|5|||
125905915|NCT03190369|452954569|FG000|Overall Study|Randomized but not treated|0|||
125905916|NCT03190369|452954570|FG001|Overall Study|Randomized but not treated|2|||
125905917|NCT02093026|452954571|FG000|Overall Study|Adverse Event|26|||
125905918|NCT02093026|452954571|FG000|Overall Study|Death|10|||
125905919|NCT02093026|452954571|FG000|Overall Study|Other|157|||
125905920|NCT02376829|452954572|FG000|Overall Study|Withdrawal by Subject|27|||
125905921|NCT02376829|452954573|FG001|Overall Study|Withdrawal by Subject|44|||
125905922|NCT01255787|452954574|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
125905923|NCT01255787|452954575|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
125905924|NCT01255787|452954576|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
125905925|NCT01255787|452954577|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
125905926|NCT01255787|452954574|FG000|Overall Study|Major Protocol Deviation|1|||
125905927|NCT01255787|452954575|FG001|Overall Study|Major Protocol Deviation|1|||
125905928|NCT01255787|452954576|FG002|Overall Study|Major Protocol Deviation|0|||
125905929|NCT01255787|452954577|FG003|Overall Study|Major Protocol Deviation|4|||
125905930|NCT01255787|452954574|FG000|Overall Study|Lost to Follow-up|1|||
125905931|NCT01255787|452954575|FG001|Overall Study|Lost to Follow-up|2|||
125905932|NCT01255787|452954576|FG002|Overall Study|Lost to Follow-up|4|||
125905933|NCT01255787|452954577|FG003|Overall Study|Lost to Follow-up|2|||
125905934|NCT01255787|452954574|FG000|Overall Study|Withdrawal of Consent|3|||
125905935|NCT01255787|452954575|FG001|Overall Study|Withdrawal of Consent|9|||
125905936|NCT01255787|452954576|FG002|Overall Study|Withdrawal of Consent|3|||
125905937|NCT01255787|452954577|FG003|Overall Study|Withdrawal of Consent|4|||
125905938|NCT01255787|452954574|FG000|Overall Study|Pregnancy|0|||
125905939|NCT01255787|452954575|FG001|Overall Study|Pregnancy|0|||
125905940|NCT01255787|452954576|FG002|Overall Study|Pregnancy|0|||
125905941|NCT01255787|452954577|FG003|Overall Study|Pregnancy|1|||
125905942|NCT01255787|452954574|FG000|Overall Study|Lack of Efficacy|2|||
125905943|NCT01255787|452954575|FG001|Overall Study|Lack of Efficacy|2|||
126059958|NCT01205126|453514214|FG001|Titration Phase|Other|6|||
126059959|NCT01205126|453514213|FG000|Between Titration & Maintenance Phase|Other|0|||
125905944|NCT01255787|452954576|FG002|Overall Study|Lack of Efficacy|2|||
125905945|NCT01255787|452954577|FG003|Overall Study|Lack of Efficacy|2|||
125905946|NCT01255787|452954574|FG000|Overall Study|Noncompliance with Study Drug|3|||
125905947|NCT01255787|452954575|FG001|Overall Study|Noncompliance with Study Drug|1|||
125905948|NCT01255787|452954576|FG002|Overall Study|Noncompliance with Study Drug|0|||
125905949|NCT01255787|452954577|FG003|Overall Study|Noncompliance with Study Drug|0|||
125905950|NCT00476047|452954578|FG000|Overall Study|Lost to Follow-up|1|||
125905951|NCT05153473|452954579|FG000|Overall Study|Death|46|||
125905952|NCT05153473|452954579|FG000|Overall Study|Lost to Follow-up|3|||
125905953|NCT02283177|452954580|FG000|Overall Study|Withdrawal by Subject|1|||
125905954|NCT02283177|452954581|FG001|Overall Study|Withdrawal by Subject|1|||
125905955|NCT02398227|452954582|FG000|Overall Study|Lost to Follow-up|21|||
125905956|NCT02398227|452954583|FG001|Overall Study|Lost to Follow-up|12|||
125905957|NCT02398227|452954582|FG000|Overall Study|Withdrawal by Subject|5|||
125905958|NCT02398227|452954583|FG001|Overall Study|Withdrawal by Subject|6|||
125905959|NCT02398227|452954582|FG000|Overall Study|Removed from treatment and dropped out|1|||
125905960|NCT02398227|452954583|FG001|Overall Study|Removed from treatment and dropped out|0|||
125905961|NCT01185834|452954584|FG000|Overall Study|Lost to Follow-up|2|||
125905962|NCT01185834|452954584|FG000|Overall Study|Discomfort|4|||
125905963|NCT01185834|452954584|FG000|Overall Study|Biomicroscopy|4|||
125905964|NCT01185834|452954584|FG000|Overall Study|Time/Job Conflict|2|||
125905965|NCT01185834|452954584|FG000|Overall Study|Early exit - Site error|2|||
125905966|NCT01975831|452954585|FG000|Overall Study|Adverse Event|1|||
125905967|NCT01975831|452954586|FG001|Overall Study|Adverse Event|2|||
125905968|NCT01975831|452954587|FG002|Overall Study|Adverse Event|2|||
125905969|NCT01975831|452954588|FG003|Overall Study|Adverse Event|0|||
125905970|NCT01975831|452954589|FG004|Overall Study|Adverse Event|1|||
125905971|NCT01975831|452954590|FG005|Overall Study|Adverse Event|1|||
125905972|NCT01975831|452954591|FG006|Overall Study|Adverse Event|3|||
125905973|NCT01975831|452954592|FG007|Overall Study|Adverse Event|4|||
125905974|NCT01975831|452954593|FG008|Overall Study|Adverse Event|1|||
125905975|NCT01975831|452954585|FG000|Overall Study|Death|1|||
125905976|NCT01975831|452954586|FG001|Overall Study|Death|1|||
125905977|NCT01975831|452954587|FG002|Overall Study|Death|0|||
125905978|NCT01975831|452954588|FG003|Overall Study|Death|0|||
125905979|NCT01975831|452954589|FG004|Overall Study|Death|1|||
125905980|NCT01975831|452954590|FG005|Overall Study|Death|0|||
125905981|NCT01975831|452954591|FG006|Overall Study|Death|1|||
125905982|NCT01975831|452954592|FG007|Overall Study|Death|0|||
125905983|NCT01975831|452954593|FG008|Overall Study|Death|0|||
125905984|NCT01975831|452954585|FG000|Overall Study|Progressive Disease|1|||
125905985|NCT01975831|452954586|FG001|Overall Study|Progressive Disease|3|||
125905986|NCT01975831|452954587|FG002|Overall Study|Progressive Disease|2|||
125905987|NCT01975831|452954588|FG003|Overall Study|Progressive Disease|4|||
125905988|NCT01975831|452954589|FG004|Overall Study|Progressive Disease|13|||
125905989|NCT01975831|452954590|FG005|Overall Study|Progressive Disease|9|||
125905990|NCT01975831|452954591|FG006|Overall Study|Progressive Disease|10|||
125905991|NCT01975831|452954592|FG007|Overall Study|Progressive Disease|8|||
125905992|NCT01975831|452954593|FG008|Overall Study|Progressive Disease|10|||
125905993|NCT01975831|452954585|FG000|Overall Study|Withdrawal by Subject|0|||
125905994|NCT01975831|452954586|FG001|Overall Study|Withdrawal by Subject|3|||
125905995|NCT01975831|452954587|FG002|Overall Study|Withdrawal by Subject|0|||
125905996|NCT01975831|452954588|FG003|Overall Study|Withdrawal by Subject|0|||
125905997|NCT01975831|452954589|FG004|Overall Study|Withdrawal by Subject|3|||
125905998|NCT01975831|452954590|FG005|Overall Study|Withdrawal by Subject|1|||
125905999|NCT01975831|452954591|FG006|Overall Study|Withdrawal by Subject|1|||
125906000|NCT01975831|452954592|FG007|Overall Study|Withdrawal by Subject|0|||
125906001|NCT01975831|452954593|FG008|Overall Study|Withdrawal by Subject|0|||
125906002|NCT01975831|452954585|FG000|Overall Study|Physician Decision|0|||
125906003|NCT01975831|452954586|FG001|Overall Study|Physician Decision|0|||
125906004|NCT01975831|452954587|FG002|Overall Study|Physician Decision|0|||
125906005|NCT01975831|452954588|FG003|Overall Study|Physician Decision|0|||
125906006|NCT01975831|452954589|FG004|Overall Study|Physician Decision|0|||
125906007|NCT01975831|452954590|FG005|Overall Study|Physician Decision|1|||
125906008|NCT01975831|452954591|FG006|Overall Study|Physician Decision|0|||
125906009|NCT01975831|452954592|FG007|Overall Study|Physician Decision|1|||
125906010|NCT01975831|452954593|FG008|Overall Study|Physician Decision|0|||
125906011|NCT01975831|452954585|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
125906012|NCT01975831|452954586|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
125906013|NCT01975831|452954587|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
125906014|NCT01975831|452954588|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
125906015|NCT01975831|452954589|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
125906016|NCT01975831|452954590|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
125906017|NCT01975831|452954591|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
125906018|NCT01975831|452954592|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
125906019|NCT01975831|452954593|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
125906020|NCT01975831|452954585|FG000|Overall Study|Entered Hospice|0|||
125906021|NCT01975831|452954586|FG001|Overall Study|Entered Hospice|0|||
125906022|NCT01975831|452954587|FG002|Overall Study|Entered Hospice|0|||
125906023|NCT01975831|452954588|FG003|Overall Study|Entered Hospice|0|||
125906024|NCT01975831|452954589|FG004|Overall Study|Entered Hospice|0|||
125906025|NCT01975831|452954590|FG005|Overall Study|Entered Hospice|1|||
125906026|NCT01975831|452954591|FG006|Overall Study|Entered Hospice|0|||
125906027|NCT01975831|452954592|FG007|Overall Study|Entered Hospice|0|||
125906028|NCT01975831|452954593|FG008|Overall Study|Entered Hospice|0|||
125906029|NCT01975831|452954585|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
125906030|NCT01975831|452954586|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
125906031|NCT01975831|452954587|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
125906032|NCT01975831|452954588|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
125906033|NCT01975831|452954589|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
125906034|NCT01975831|452954590|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
125906035|NCT01975831|452954591|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
125906036|NCT01975831|452954592|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
125906037|NCT01975831|452954593|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
125906038|NCT00887744|452954594|FG000|Overall Study|Adverse Event|3|||
125906039|NCT00887744|452954594|FG000|Overall Study|Death|1|||
125906040|NCT00887744|452954594|FG000|Overall Study|Lost to Follow-up|3|||
125906041|NCT00887744|452954594|FG000|Overall Study|Withdrawal by Subject|18|||
125906042|NCT00887744|452954594|FG000|Overall Study|Various reasons|9|||
125906043|NCT04473482|452954595|FG000|Overall Study|Death|0|||
125906044|NCT04473482|452954596|FG001|Overall Study|Death|3|||
125906045|NCT04473482|452954595|FG000|Overall Study|Lost to Follow-up|9|||
125906046|NCT04473482|452954596|FG001|Overall Study|Lost to Follow-up|7|||
125906047|NCT04473482|452954595|FG000|Overall Study|Withdrawal by Subject|2|||
125906048|NCT04473482|452954596|FG001|Overall Study|Withdrawal by Subject|1|||
125906049|NCT00321893|452954598|FG000|Overall Study|Non-Compliance/Refusal|16|||
125906050|NCT00321893|452954599|FG001|Overall Study|Non-Compliance/Refusal|10|||
125906051|NCT00321893|452954598|FG000|Overall Study|Lost to Follow-up|2|||
125906052|NCT00321893|452954599|FG001|Overall Study|Lost to Follow-up|1|||
125906053|NCT00321893|452954598|FG000|Overall Study|Adverse Event|6|||
125906054|NCT00321893|452954599|FG001|Overall Study|Adverse Event|3|||
125906055|NCT01306877|452954600|FG000|Overall Study|Lost to Follow-up|3|||
125906056|NCT01306877|452954601|FG001|Overall Study|Lost to Follow-up|3|||
125906057|NCT01306877|452954600|FG000|Overall Study|Physician Decision|0|||
125906058|NCT01306877|452954601|FG001|Overall Study|Physician Decision|1|||
126059960|NCT01205126|453514214|FG001|Between Titration & Maintenance Phase|Other|4|||
125906059|NCT00999921|452954606|FG000|Overall Study|Lost to Follow-up|10|||
126059961|NCT01205126|453514213|FG000|Maintenance Phase|Adverse Event|3|||
126059962|NCT01205126|453514214|FG001|Maintenance Phase|Adverse Event|7|||
126059963|NCT01205126|453514213|FG000|Maintenance Phase|Death|4|||
126059964|NCT01205126|453514214|FG001|Maintenance Phase|Death|4|||
126059965|NCT01205126|453514213|FG000|Maintenance Phase|More than the maximum dosage required|5|||
126059966|NCT01205126|453514214|FG001|Maintenance Phase|More than the maximum dosage required|5|||
125906060|NCT00999921|452954607|FG001|Overall Study|Lost to Follow-up|19|||
125906061|NCT00989573|452954608|FG000|Overall Study|Adverse Event|8|||
125906062|NCT00989573|452954609|FG001|Overall Study|Adverse Event|12|||
125906063|NCT00989573|452954610|FG002|Overall Study|Adverse Event|4|||
126059967|NCT01205126|453514213|FG000|Maintenance Phase|Prohibited drugs used|1|||
125906064|NCT00989573|452954608|FG000|Overall Study|Physician Decision|0|||
125906065|NCT00989573|452954609|FG001|Overall Study|Physician Decision|2|||
126059968|NCT01205126|453514214|FG001|Maintenance Phase|Prohibited drugs used|0|||
125906066|NCT00989573|452954610|FG002|Overall Study|Physician Decision|0|||
125906067|NCT00989573|452954608|FG000|Overall Study|Protocol Violation|1|||
125906068|NCT00989573|452954609|FG001|Overall Study|Protocol Violation|1|||
125906069|NCT00989573|452954610|FG002|Overall Study|Protocol Violation|1|||
125906070|NCT00989573|452954608|FG000|Overall Study|Withdrawal by Subject|4|||
125906071|NCT00989573|452954609|FG001|Overall Study|Withdrawal by Subject|7|||
125906072|NCT00989573|452954610|FG002|Overall Study|Withdrawal by Subject|3|||
125906073|NCT01076075|452954615|FG000|Overall Study|Adverse Event|3|||
125906074|NCT01076075|452954616|FG001|Overall Study|Adverse Event|9|||
125906075|NCT01076075|452954615|FG000|Overall Study|Lack of Efficacy|5|||
125906076|NCT01076075|452954616|FG001|Overall Study|Lack of Efficacy|4|||
125906077|NCT01076075|452954615|FG000|Overall Study|Lost to Follow-up|6|||
125906078|NCT01076075|452954616|FG001|Overall Study|Lost to Follow-up|5|||
125906079|NCT01076075|452954615|FG000|Overall Study|other|19|||
125906080|NCT01076075|452954616|FG001|Overall Study|other|9|||
125906081|NCT01076075|452954615|FG000|Overall Study|Protocol Violation|0|||
125906082|NCT01076075|452954616|FG001|Overall Study|Protocol Violation|1|||
125906083|NCT01076075|452954615|FG000|Overall Study|Withdrawal by Subject|8|||
125906084|NCT01076075|452954616|FG001|Overall Study|Withdrawal by Subject|19|||
125906085|NCT01888003|452954621|FG000|Overall Study|Study Terminated|5|||
125906086|NCT01888003|452954622|FG001|Overall Study|Study Terminated|6|||
125906087|NCT01888003|452954623|FG002|Overall Study|Study Terminated|40|||
125906088|NCT02359851|452954624|FG000|Overall Study|Death|1|||
125906089|NCT02359851|452954624|FG000|Overall Study|Disease progression|1|||
125906090|NCT00055471|452954625|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
125906091|NCT00055471|452954626|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
125906092|NCT00055471|452954627|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
125906093|NCT00055471|452954625|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
125906094|NCT00055471|452954626|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
125906095|NCT00055471|452954627|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
125906096|NCT00055471|452954625|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
125906097|NCT00055471|452954626|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
125906098|NCT00055471|452954627|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
125906099|NCT01854944|452954628|FG000|Overall Study|Withdrawal by Subject|0|||
125906100|NCT01854944|452954629|FG001|Overall Study|Withdrawal by Subject|0|||
125906101|NCT01854944|452954630|FG002|Overall Study|Withdrawal by Subject|1|||
125906102|NCT02101112|452954631|FG000|Overall Study|Adverse Event|0|||
125906103|NCT02101112|452954632|FG001|Overall Study|Adverse Event|0|||
125906104|NCT02101112|452954633|FG002|Overall Study|Adverse Event|1|||
125906105|NCT02101112|452954634|FG003|Overall Study|Adverse Event|0|||
125906106|NCT02101112|452954635|FG004|Overall Study|Adverse Event|0|||
125906107|NCT02101112|452954636|FG005|Overall Study|Adverse Event|0|||
125906108|NCT02101112|452954631|FG000|Overall Study|Withdrawal by Subject|0|||
125906109|NCT02101112|452954632|FG001|Overall Study|Withdrawal by Subject|0|||
125906110|NCT02101112|452954633|FG002|Overall Study|Withdrawal by Subject|0|||
125906111|NCT02101112|452954634|FG003|Overall Study|Withdrawal by Subject|0|||
125906112|NCT02101112|452954635|FG004|Overall Study|Withdrawal by Subject|1|||
125906113|NCT02101112|452954636|FG005|Overall Study|Withdrawal by Subject|0|||
125906114|NCT04340063|452954637|FG000|Overall Study|Withdrawal by Subject|1|||
125906115|NCT04340063|452954638|FG001|Overall Study|Withdrawal by Subject|2|||
125906116|NCT04340063|452954637|FG000|Overall Study|Lost to Follow-up|3|||
125906117|NCT04340063|452954638|FG001|Overall Study|Lost to Follow-up|1|||
125906118|NCT04340063|452954637|FG000|Overall Study|Protocol Violation|0|||
125906119|NCT04340063|452954638|FG001|Overall Study|Protocol Violation|1|||
125906120|NCT01857583|452954639|FG000|Overall Study|Adverse Event|0|||
125906121|NCT01857583|452954640|FG001|Overall Study|Adverse Event|0|||
125906122|NCT01857583|452954641|FG002|Overall Study|Adverse Event|1|||
125906123|NCT01857583|452954642|FG003|Overall Study|Adverse Event|1|||
125906124|NCT01857583|452954639|FG000|Overall Study|Death|0|||
125906125|NCT01857583|452954640|FG001|Overall Study|Death|1|||
125906126|NCT01857583|452954641|FG002|Overall Study|Death|1|||
125906127|NCT01857583|452954642|FG003|Overall Study|Death|0|||
125906128|NCT01857583|452954639|FG000|Overall Study|Physician Decision|0|||
125906129|NCT01857583|452954640|FG001|Overall Study|Physician Decision|0|||
125906130|NCT01857583|452954641|FG002|Overall Study|Physician Decision|0|||
125906131|NCT01857583|452954642|FG003|Overall Study|Physician Decision|1|||
125906132|NCT01857583|452954639|FG000|Overall Study|Withdrawal by Subject|1|||
125906133|NCT01857583|452954640|FG001|Overall Study|Withdrawal by Subject|0|||
125906134|NCT01857583|452954641|FG002|Overall Study|Withdrawal by Subject|1|||
125906135|NCT01857583|452954642|FG003|Overall Study|Withdrawal by Subject|2|||
125906136|NCT00458536|452954645|FG000|Overall Study|Disease progression prior to treatment|7|||
125906137|NCT00458536|452954645|FG000|Overall Study|Unable to make vaccine|3|||
125906138|NCT00458536|452954645|FG000|Overall Study|No measurable disease after surgery|2|||
125906139|NCT00458536|452954645|FG000|Overall Study|Did not have renal cell carcinoma|2|||
125906140|NCT00458536|452954645|FG000|Overall Study|Patient did not have surgery|1|||
125906141|NCT00458536|452954645|FG000|Overall Study|Ineligible due to toxicity|1|||
125906142|NCT00458536|452954645|FG000|Overall Study|Withdrawal by Subject|1|||
125906143|NCT00458536|452954645|FG000|Overall Study|Progressive disease during treatment|2|||
125906144|NCT00076024|452956326|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
125906145|NCT00076024|452956327|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
125906146|NCT00076024|452956328|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
125906147|NCT00076024|452956329|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
125906148|NCT00076024|452956326|FG000|Phase 1, Lead-in|Adverse Event|1|||
125906149|NCT00076024|452956327|FG001|Phase 1, Lead-in|Adverse Event|0|||
125906150|NCT00076024|452956328|FG002|Phase 1, Lead-in|Adverse Event|0|||
126110123|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
126110124|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
125906151|NCT00076024|452956329|FG003|Phase 1, Lead-in|Adverse Event|0|||
125906152|NCT00076024|452956326|FG000|Phase 1, Lead-in|Clinical progression|1|||
125906153|NCT00076024|452956327|FG001|Phase 1, Lead-in|Clinical progression|0|||
125906154|NCT00076024|452956328|FG002|Phase 1, Lead-in|Clinical progression|0|||
125906155|NCT00076024|452956329|FG003|Phase 1, Lead-in|Clinical progression|0|||
125906156|NCT00076024|452956326|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
125906157|NCT00076024|452956327|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
125906158|NCT00076024|452956328|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
125906159|NCT00076024|452956329|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
125906160|NCT00076024|452956326|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
125906161|NCT00076024|452956327|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
125906162|NCT00076024|452956328|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
125906163|NCT00076024|452956329|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
125906164|NCT00076024|452956326|FG000|Phase 2, Double-blind|Adverse Event|0|||
125906165|NCT00076024|452956327|FG001|Phase 2, Double-blind|Adverse Event|25|||
125906166|NCT00076024|452956328|FG002|Phase 2, Double-blind|Adverse Event|6|||
125906167|NCT00076024|452956329|FG003|Phase 2, Double-blind|Adverse Event|0|||
125906168|NCT00076024|452956326|FG000|Phase 2, Double-blind|Un-specified|0|||
125906169|NCT00076024|452956327|FG001|Phase 2, Double-blind|Un-specified|14|||
125906170|NCT00076024|452956328|FG002|Phase 2, Double-blind|Un-specified|6|||
125906171|NCT00076024|452956329|FG003|Phase 2, Double-blind|Un-specified|0|||
125906172|NCT00076024|452956326|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
125906173|NCT00076024|452956327|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
125906174|NCT00076024|452956328|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
125906175|NCT00076024|452956329|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
125906176|NCT00076024|452956326|FG000|Phase 2, Open-label|Adverse Event|0|||
125906177|NCT00076024|452956327|FG001|Phase 2, Open-label|Adverse Event|0|||
125906178|NCT00076024|452956328|FG002|Phase 2, Open-label|Adverse Event|0|||
125906179|NCT00076024|452956329|FG003|Phase 2, Open-label|Adverse Event|2|||
125906180|NCT00076024|452956326|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
125906181|NCT00076024|452956327|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
125906182|NCT00076024|452956328|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
125906183|NCT00076024|452956329|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
125906184|NCT00076024|452956326|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
125906185|NCT00076024|452956327|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
125906186|NCT00076024|452956328|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
125906187|NCT00076024|452956329|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
125906188|NCT00076024|452956326|FG000|Phase 2, Open-label|Other|0|||
125906189|NCT00076024|452956327|FG001|Phase 2, Open-label|Other|0|||
125906190|NCT00076024|452956328|FG002|Phase 2, Open-label|Other|0|||
125906191|NCT00076024|452956329|FG003|Phase 2, Open-label|Other|2|||
125906192|NCT03981822|452956334|FG000|Overall Study|Lost to Follow-up|0|||
125906193|NCT03981822|452956335|FG001|Overall Study|Lost to Follow-up|1|||
125906194|NCT03981822|452956336|FG002|Overall Study|Lost to Follow-up|1|||
125906195|NCT03981822|452956337|FG003|Overall Study|Lost to Follow-up|0|||
125906196|NCT03981822|452956338|FG004|Overall Study|Lost to Follow-up|6|||
125906197|NCT03981822|452956339|FG005|Overall Study|Lost to Follow-up|4|||
125906198|NCT03981822|452956340|FG006|Overall Study|Lost to Follow-up|4|||
125906199|NCT03981822|452956341|FG007|Overall Study|Lost to Follow-up|2|||
125906200|NCT03981822|452956334|FG000|Overall Study|Withdrawal by Subject|0|||
125906201|NCT03981822|452956335|FG001|Overall Study|Withdrawal by Subject|1|||
125906202|NCT03981822|452956336|FG002|Overall Study|Withdrawal by Subject|0|||
125906203|NCT03981822|452956337|FG003|Overall Study|Withdrawal by Subject|0|||
125906204|NCT03981822|452956338|FG004|Overall Study|Withdrawal by Subject|0|||
125906205|NCT03981822|452956339|FG005|Overall Study|Withdrawal by Subject|1|||
125906206|NCT03981822|452956340|FG006|Overall Study|Withdrawal by Subject|0|||
125906207|NCT03981822|452956341|FG007|Overall Study|Withdrawal by Subject|2|||
125906208|NCT03981822|452956334|FG000|Overall Study|COVID-19 Related|0|||
125906209|NCT03981822|452956335|FG001|Overall Study|COVID-19 Related|0|||
125906210|NCT03981822|452956336|FG002|Overall Study|COVID-19 Related|0|||
125906211|NCT03981822|452956337|FG003|Overall Study|COVID-19 Related|0|||
125906212|NCT03981822|452956338|FG004|Overall Study|COVID-19 Related|2|||
125906213|NCT03981822|452956339|FG005|Overall Study|COVID-19 Related|1|||
125906214|NCT03981822|452956340|FG006|Overall Study|COVID-19 Related|2|||
125906215|NCT03981822|452956341|FG007|Overall Study|COVID-19 Related|1|||
125906216|NCT06460493|452956342|FG000|Overall Study|Withdrawal by Subject|2|||
125906217|NCT04704154|452956347|FG000|Overall Study|Adverse Event|3|||
125906218|NCT04704154|452956348|FG001|Overall Study|Adverse Event|2|||
125906219|NCT04704154|452956349|FG002|Overall Study|Adverse Event|4|||
125906220|NCT04704154|452956350|FG003|Overall Study|Adverse Event|2|||
125906221|NCT04704154|452956351|FG004|Overall Study|Adverse Event|3|||
125906222|NCT04704154|452956352|FG005|Overall Study|Adverse Event|0|||
125906223|NCT04704154|452956347|FG000|Overall Study|Death|3|||
125906224|NCT04704154|452956348|FG001|Overall Study|Death|0|||
125906225|NCT04704154|452956349|FG002|Overall Study|Death|0|||
125906226|NCT04704154|452956350|FG003|Overall Study|Death|0|||
125906227|NCT04704154|452956351|FG004|Overall Study|Death|3|||
125906228|NCT04704154|452956352|FG005|Overall Study|Death|0|||
125906229|NCT04704154|452956347|FG000|Overall Study|Physician Decision|1|||
125906230|NCT04704154|452956348|FG001|Overall Study|Physician Decision|0|||
125906231|NCT04704154|452956349|FG002|Overall Study|Physician Decision|1|||
125906232|NCT04704154|452956350|FG003|Overall Study|Physician Decision|0|||
125906233|NCT04704154|452956351|FG004|Overall Study|Physician Decision|2|||
125906234|NCT04704154|452956352|FG005|Overall Study|Physician Decision|0|||
125906235|NCT04704154|452956347|FG000|Overall Study|Participant Decision|1|||
125906236|NCT04704154|452956348|FG001|Overall Study|Participant Decision|1|||
125906237|NCT04704154|452956349|FG002|Overall Study|Participant Decision|0|||
125906238|NCT04704154|452956350|FG003|Overall Study|Participant Decision|0|||
125906239|NCT04704154|452956351|FG004|Overall Study|Participant Decision|0|||
125906240|NCT04704154|452956352|FG005|Overall Study|Participant Decision|0|||
125906241|NCT04704154|452956347|FG000|Overall Study|Progressive Disease|19|||
125906242|NCT04704154|452956348|FG001|Overall Study|Progressive Disease|17|||
125906243|NCT04704154|452956349|FG002|Overall Study|Progressive Disease|20|||
125906244|NCT04704154|452956350|FG003|Overall Study|Progressive Disease|18|||
125906245|NCT04704154|452956351|FG004|Overall Study|Progressive Disease|36|||
125906246|NCT04704154|452956352|FG005|Overall Study|Progressive Disease|30|||
125906247|NCT04704154|452956347|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
125906248|NCT04704154|452956348|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
125906249|NCT04704154|452956349|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
125906250|NCT04704154|452956350|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
125906251|NCT04704154|452956351|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
125906252|NCT04704154|452956352|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
125906253|NCT04704154|452956347|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
125906254|NCT04704154|452956348|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
125906255|NCT04704154|452956349|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
125906256|NCT04704154|452956350|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
125906257|NCT04704154|452956351|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
125906258|NCT04704154|452956352|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
125906259|NCT04251156|452956353|FG000|Overall Study|Lost to Follow-up|1|||
125906260|NCT04251156|452956354|FG001|Overall Study|Lost to Follow-up|1|||
125906261|NCT04251156|452956353|FG000|Overall Study|Withdrawal by Subject|4|||
125906262|NCT04251156|452956354|FG001|Overall Study|Withdrawal by Subject|4|||
125906263|NCT02963831|452956355|FG000|Overall Study|Progressive Disease|3|||
125906264|NCT02963831|452956356|FG001|Overall Study|Progressive Disease|3|||
125906265|NCT02963831|452956357|FG002|Overall Study|Progressive Disease|16|||
125906266|NCT02963831|452956358|FG003|Overall Study|Progressive Disease|27|||
125906267|NCT02963831|452956355|FG000|Overall Study|Withdrawal by Subject|1|||
125906268|NCT02963831|452956356|FG001|Overall Study|Withdrawal by Subject|0|||
125906269|NCT02963831|452956357|FG002|Overall Study|Withdrawal by Subject|2|||
125906270|NCT02963831|452956358|FG003|Overall Study|Withdrawal by Subject|4|||
125906271|NCT02963831|452956355|FG000|Overall Study|Adverse Event|0|||
125906272|NCT02963831|452956356|FG001|Overall Study|Adverse Event|1|||
125906273|NCT02963831|452956357|FG002|Overall Study|Adverse Event|1|||
125906274|NCT02963831|452956358|FG003|Overall Study|Adverse Event|2|||
125906275|NCT02963831|452956355|FG000|Overall Study|Death|0|||
125906276|NCT02963831|452956356|FG001|Overall Study|Death|0|||
125906277|NCT02963831|452956357|FG002|Overall Study|Death|0|||
125906278|NCT02963831|452956358|FG003|Overall Study|Death|2|||
125906279|NCT04543409|452956359|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125906280|NCT04543409|452956360|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125906281|NCT04543409|452956359|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
125906282|NCT04543409|452956360|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
125906283|NCT04543409|452956359|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
125906284|NCT04543409|452956360|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
125906285|NCT04543409|452956359|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
125906286|NCT04543409|452956360|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
125906287|NCT04543409|452956359|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
125906288|NCT04543409|452956360|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
125906289|NCT04543409|452956359|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
125906290|NCT04543409|452956360|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
125906291|NCT04543409|452956359|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
125906292|NCT04543409|452956360|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
125906293|NCT04543409|452956359|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
125906294|NCT04543409|452956360|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
125906295|NCT04543409|452956359|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
125906296|NCT04543409|452956360|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
125906297|NCT04543409|452956359|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
126059969|NCT01205126|453514213|FG000|Maintenance Phase|Other|11|||
125906298|NCT04543409|452956360|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
125906299|NCT04543409|452956359|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
125906300|NCT04543409|452956360|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
125906301|NCT01923168|452956361|FG000|Overall Study|Protocol Violation|1|||
125906302|NCT01923168|452956362|FG001|Overall Study|Protocol Violation|1|||
125906303|NCT01923168|452956363|FG002|Overall Study|Protocol Violation|0|||
125906304|NCT01923168|452956361|FG000|Overall Study|Subject/guardian decision|14|||
125906305|NCT01923168|452956362|FG001|Overall Study|Subject/guardian decision|14|||
125906306|NCT01923168|452956363|FG002|Overall Study|Subject/guardian decision|4|||
125906307|NCT01923168|452956361|FG000|Overall Study|Adverse Event|12|||
125906308|NCT01923168|452956362|FG001|Overall Study|Adverse Event|12|||
125906309|NCT01923168|452956363|FG002|Overall Study|Adverse Event|0|||
125906310|NCT01923168|452956361|FG000|Overall Study|Physician Decision|6|||
125906311|NCT01923168|452956362|FG001|Overall Study|Physician Decision|9|||
125906312|NCT01923168|452956363|FG002|Overall Study|Physician Decision|5|||
125906313|NCT01923168|452956361|FG000|Overall Study|Progressive disease|4|||
125906314|NCT01923168|452956362|FG001|Overall Study|Progressive disease|3|||
125906315|NCT01923168|452956363|FG002|Overall Study|Progressive disease|7|||
125906316|NCT01923168|452956361|FG000|Overall Study|Death|0|||
125906317|NCT01923168|452956362|FG001|Overall Study|Death|0|||
125906318|NCT01923168|452956363|FG002|Overall Study|Death|1|||
125906319|NCT03418571|452956364|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
125906320|NCT03418571|452956365|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
125906321|NCT03882008|452956366|FG000|Overall Study|Withdrawal by Subject|1|||
125906322|NCT03882008|452956366|FG000|Overall Study|Lost to Follow-up|1|||
125906323|NCT03519386|452956367|FG000|Overall Study|Withdrawal by Subject|4|||
125906324|NCT03519386|452956368|FG001|Overall Study|Withdrawal by Subject|1|||
125906325|NCT03519386|452956369|FG002|Overall Study|Withdrawal by Subject|2|||
125906326|NCT03519386|452956367|FG000|Overall Study|Physician Decision|1|||
125906327|NCT03519386|452956368|FG001|Overall Study|Physician Decision|1|||
125906328|NCT03519386|452956369|FG002|Overall Study|Physician Decision|1|||
125906329|NCT03519386|452956367|FG000|Overall Study|Lost to Follow-up|0|||
125906330|NCT03519386|452956368|FG001|Overall Study|Lost to Follow-up|1|||
125906331|NCT03519386|452956369|FG002|Overall Study|Lost to Follow-up|1|||
125906332|NCT03519386|452956367|FG000|Overall Study|Death|1|||
125906333|NCT03519386|452956368|FG001|Overall Study|Death|0|||
125906334|NCT03519386|452956369|FG002|Overall Study|Death|4|||
125906335|NCT03519386|452956367|FG000|Overall Study|Adverse Event|2|||
125906336|NCT03519386|452956368|FG001|Overall Study|Adverse Event|1|||
125906337|NCT03519386|452956369|FG002|Overall Study|Adverse Event|2|||
125906338|NCT03519386|452956367|FG000|Overall Study|Explanted|2|||
125906339|NCT03519386|452956368|FG001|Overall Study|Explanted|1|||
125906340|NCT03519386|452956369|FG002|Overall Study|Explanted|0|||
125906341|NCT03519386|452956367|FG000|Overall Study|Ongoing in study|190|||
125906342|NCT03519386|452956368|FG001|Overall Study|Ongoing in study|192|||
125906343|NCT03519386|452956369|FG002|Overall Study|Ongoing in study|183|||
125906344|NCT04341662|452956371|FG000|Overall Study|Did not have source-verified blood loss data|423|||
125906345|NCT04341662|452956372|FG001|Overall Study|Did not have source-verified blood loss data|514|||
125906346|NCT03101267|452956373|FG000|Primary Study Period|Withdrawal by Subject|1|||
125906347|NCT03101267|452956374|FG001|Primary Study Period|Withdrawal by Subject|2|||
125906348|NCT03101267|452956375|FG002|Primary Study Period|Withdrawal by Subject|3|||
125906349|NCT03101267|452956373|FG000|Primary Study Period|Miscellaneous|2|||
125906350|NCT03101267|452956374|FG001|Primary Study Period|Miscellaneous|0|||
125906351|NCT03101267|452956375|FG002|Primary Study Period|Miscellaneous|0|||
125906352|NCT01222403|452956376|FG000|Overall Study|Inappropriate enrollment|0|||
125906353|NCT01222403|452956377|FG001|Overall Study|Inappropriate enrollment|2|||
125906354|NCT01028378|452956379|FG000|Overall Study|Lost to Follow-up|12|||
125906355|NCT01028378|452956379|FG000|Overall Study|Withdrawal by Subject|1|||
125906356|NCT01028378|452956379|FG000|Overall Study|Adminstrative Reasons|4|||
125906357|NCT01262352|452956380|FG000|Period 1|Illness after randomization|1|||
125906358|NCT01262352|452956381|FG001|Period 1|Illness after randomization|0|||
125906359|NCT01262352|452956380|FG000|Washout|Adverse Event|1|||
125906360|NCT01262352|452956381|FG001|Washout|Adverse Event|1|||
125906361|NCT01262352|452956380|FG000|Washout|Extended Washout|0|||
125906362|NCT01262352|452956381|FG001|Washout|Extended Washout|1|||
125906363|NCT00107952|452956385|FG000|Overall Study|Death|75|||
125906364|NCT00107952|452956386|FG001|Overall Study|Death|61|||
125906365|NCT00107952|452956385|FG000|Overall Study|Lost to Follow-up|0|||
125906366|NCT00107952|452956386|FG001|Overall Study|Lost to Follow-up|3|||
125906367|NCT00107952|452956385|FG000|Overall Study|Withdrawal by Subject|9|||
125906368|NCT00107952|452956386|FG001|Overall Study|Withdrawal by Subject|6|||
125906369|NCT00107952|452956385|FG000|Overall Study|Other|2|||
125906370|NCT00107952|452956386|FG001|Overall Study|Other|5|||
125906371|NCT00107952|452956385|FG000|Overall Study|Never received study treatment|9|||
125906372|NCT00107952|452956386|FG001|Overall Study|Never received study treatment|6|||
125906373|NCT01401959|452956387|FG000|Enrolled|Withdrawal by Subject|1|||
125906374|NCT01401959|452956388|FG001|Enrolled|Withdrawal by Subject|0|||
125906375|NCT01401959|452956389|FG002|Enrolled|Withdrawal by Subject|0|||
125906376|NCT01401959|452956387|FG000|Treated|Disease Progression|2|||
125906377|NCT01401959|452956388|FG001|Treated|Disease Progression|2|||
125906378|NCT01401959|452956389|FG002|Treated|Disease Progression|1|||
125906379|NCT01401959|452956387|FG000|Treated|Adverse Event|4|||
125906380|NCT01401959|452956388|FG001|Treated|Adverse Event|3|||
125906381|NCT01401959|452956389|FG002|Treated|Adverse Event|2|||
125906382|NCT01401959|452956387|FG000|Treated|Withdrawal by Subject|1|||
125906383|NCT01401959|452956388|FG001|Treated|Withdrawal by Subject|2|||
125906384|NCT01401959|452956389|FG002|Treated|Withdrawal by Subject|2|||
125906385|NCT01401959|452956387|FG000|Treated|Protocol Violation|0|||
125906386|NCT01401959|452956388|FG001|Treated|Protocol Violation|1|||
125906387|NCT01401959|452956389|FG002|Treated|Protocol Violation|0|||
125906388|NCT03614975|452956392|FG000|Overall Study|Physician Decision|7|||
125906389|NCT03614975|452956393|FG001|Overall Study|Physician Decision|5|||
125906390|NCT03614975|452956392|FG000|Overall Study|Withdrawal by Subject|2|||
125906391|NCT03614975|452956393|FG001|Overall Study|Withdrawal by Subject|2|||
125906392|NCT03614975|452956392|FG000|Overall Study|Specimens not in lab batch shipment|1|||
125906393|NCT03614975|452956393|FG001|Overall Study|Specimens not in lab batch shipment|1|||
125906394|NCT00450385|452956394|FG000|Overall Study|Death|3|||
125906395|NCT00450385|452956394|FG000|Overall Study|Protocol Violation|1|||
125906396|NCT00450385|452956394|FG000|Overall Study|Withdrawal by Subject|2|||
125906397|NCT00450385|452956394|FG000|Overall Study|Lack of Efficacy|2|||
125906398|NCT00450385|452956394|FG000|Overall Study|Adverse Event|1|||
125906399|NCT00450385|452956394|FG000|Overall Study|Physician Decision|1|||
125906400|NCT00450385|452956394|FG000|Overall Study|Other|3|||
125906401|NCT01569464|452956395|FG000|Overall Study|Adverse Event|4|||
125906402|NCT01569464|452956396|FG001|Overall Study|Adverse Event|0|||
125906403|NCT01569464|452956395|FG000|Overall Study|Lack of Efficacy|1|||
125906404|NCT01569464|452956396|FG001|Overall Study|Lack of Efficacy|0|||
125906405|NCT01569464|452956395|FG000|Overall Study|Protocol Violation|1|||
125906406|NCT01569464|452956396|FG001|Overall Study|Protocol Violation|0|||
125906407|NCT01569464|452956395|FG000|Overall Study|Lost to Follow-up|2|||
125906408|NCT01569464|452956396|FG001|Overall Study|Lost to Follow-up|3|||
125906409|NCT01569464|452956395|FG000|Overall Study|Withdrawal by Subject|1|||
125906410|NCT01569464|452956396|FG001|Overall Study|Withdrawal by Subject|1|||
125906411|NCT01569464|452956395|FG000|Overall Study|Other|1|||
125906412|NCT01569464|452956396|FG001|Overall Study|Other|1|||
125906413|NCT01390220|452956402|FG000|Test Dose Phase|Adverse Event|17|||
125906414|NCT01390220|452956403|FG001|Test Dose Phase|Adverse Event|0|||
125906415|NCT01390220|452956404|FG002|Test Dose Phase|Adverse Event|0|||
125906416|NCT01390220|452956402|FG000|Test Dose Phase|Withdrawal by Subject|8|||
125906417|NCT01390220|452956403|FG001|Test Dose Phase|Withdrawal by Subject|0|||
125906418|NCT01390220|452956404|FG002|Test Dose Phase|Withdrawal by Subject|0|||
125906419|NCT01390220|452956402|FG000|Test Dose Phase|Lost to Follow-up|2|||
125906420|NCT01390220|452956403|FG001|Test Dose Phase|Lost to Follow-up|0|||
125906421|NCT01390220|452956404|FG002|Test Dose Phase|Lost to Follow-up|0|||
125906422|NCT01390220|452956402|FG000|Test Dose Phase|Protocol Violation|8|||
125906423|NCT01390220|452956403|FG001|Test Dose Phase|Protocol Violation|0|||
125906424|NCT01390220|452956404|FG002|Test Dose Phase|Protocol Violation|0|||
125906425|NCT01390220|452956402|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
125906426|NCT01390220|452956403|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
125906427|NCT01390220|452956404|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
125906428|NCT01390220|452956402|FG000|Test Dose Phase|Study/Site closure|6|||
125906429|NCT01390220|452956403|FG001|Test Dose Phase|Study/Site closure|0|||
125906430|NCT01390220|452956404|FG002|Test Dose Phase|Study/Site closure|0|||
125906431|NCT01390220|452956402|FG000|Test Dose Phase|Caregiver no longer available|5|||
125906432|NCT01390220|452956403|FG001|Test Dose Phase|Caregiver no longer available|0|||
125906433|NCT01390220|452956404|FG002|Test Dose Phase|Caregiver no longer available|0|||
125906434|NCT01390220|452956402|FG000|Test Dose Phase|Noncompliance|2|||
125906435|NCT01390220|452956403|FG001|Test Dose Phase|Noncompliance|0|||
125906436|NCT01390220|452956404|FG002|Test Dose Phase|Noncompliance|0|||
125906437|NCT01390220|452956402|FG000|Test Dose Phase|Logistical|6|||
125906438|NCT01390220|452956403|FG001|Test Dose Phase|Logistical|0|||
125906439|NCT01390220|452956404|FG002|Test Dose Phase|Logistical|0|||
125906440|NCT01390220|452956402|FG000|Comparative Phase|Withdrawal by Subject|0|||
125906441|NCT01390220|452956403|FG001|Comparative Phase|Withdrawal by Subject|1|||
125906442|NCT01390220|452956404|FG002|Comparative Phase|Withdrawal by Subject|0|||
125906443|NCT03063203|452956405|FG000|Overall Study|Chose alternative therapy|3|||
125906444|NCT03063203|452956405|FG000|Overall Study|Death|2|||
125906445|NCT03063203|452956405|FG000|Overall Study|Disease progression|4|||
125906446|NCT03063203|452956405|FG000|Overall Study|Physician Decision|5|||
125906447|NCT02045303|452956406|FG000|Overall Study|Protocol Violation|2|||
125906448|NCT02045303|452956407|FG001|Overall Study|Protocol Violation|1|||
125906449|NCT02045303|452956408|FG002|Overall Study|Protocol Violation|0|||
125906450|NCT02045303|452956406|FG000|Overall Study|Withdrawal by Subject|0|||
125906451|NCT02045303|452956407|FG001|Overall Study|Withdrawal by Subject|2|||
125906452|NCT02045303|452956408|FG002|Overall Study|Withdrawal by Subject|0|||
125906453|NCT01642407|452956409|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
125906454|NCT01642407|452956409|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
125906455|NCT01642407|452956409|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
125906456|NCT03533686|452956412|FG000|Overall Study|Withdrawal by Subject|1|||
125906457|NCT03533686|452956413|FG001|Overall Study|Withdrawal by Subject|0|||
125906458|NCT03533686|452956414|FG002|Overall Study|Withdrawal by Subject|0|||
125906459|NCT03533686|452956415|FG003|Overall Study|Withdrawal by Subject|3|||
125906460|NCT03533686|452956416|FG004|Overall Study|Withdrawal by Subject|5|||
125906461|NCT03533686|452956417|FG005|Overall Study|Withdrawal by Subject|1|||
125906462|NCT03533686|452956412|FG000|Overall Study|Lost to Follow-up|0|||
125906463|NCT03533686|452956413|FG001|Overall Study|Lost to Follow-up|1|||
125906464|NCT03533686|452956414|FG002|Overall Study|Lost to Follow-up|0|||
125906465|NCT03533686|452956415|FG003|Overall Study|Lost to Follow-up|0|||
125906466|NCT03533686|452956416|FG004|Overall Study|Lost to Follow-up|2|||
125906467|NCT03533686|452956417|FG005|Overall Study|Lost to Follow-up|0|||
125906468|NCT03533686|452956412|FG000|Overall Study|Screen Failure|0|||
125906469|NCT03533686|452956413|FG001|Overall Study|Screen Failure|0|||
125906470|NCT03533686|452956414|FG002|Overall Study|Screen Failure|0|||
125906471|NCT03533686|452956415|FG003|Overall Study|Screen Failure|2|||
125906472|NCT03533686|452956416|FG004|Overall Study|Screen Failure|0|||
125906473|NCT03533686|452956417|FG005|Overall Study|Screen Failure|0|||
125906474|NCT01856023|452956418|FG000|Overall Study|Death|1|||
125906475|NCT01856023|452956419|FG001|Overall Study|Death|2|||
125906476|NCT01856023|452956418|FG000|Overall Study|Adverse Event|2|||
125906477|NCT01856023|452956419|FG001|Overall Study|Adverse Event|1|||
125906478|NCT01856023|452956418|FG000|Overall Study|Lack of Efficacy|5|||
125906479|NCT01856023|452956419|FG001|Overall Study|Lack of Efficacy|5|||
125906480|NCT01856023|452956418|FG000|Overall Study|non compliance, study closure|1|||
125906481|NCT01856023|452956419|FG001|Overall Study|non compliance, study closure|3|||
125906482|NCT01856023|452956418|FG000|Overall Study|Withdrawal by Subject|1|||
125906483|NCT01856023|452956419|FG001|Overall Study|Withdrawal by Subject|1|||
125906484|NCT00245583|452956420|FG000|Overall Study|Lost to Follow-up|1|||
125906485|NCT00245583|452956421|FG001|Overall Study|Lost to Follow-up|5|||
125906486|NCT00245583|452956420|FG000|Overall Study|Adverse Event|2|||
125906487|NCT00245583|452956421|FG001|Overall Study|Adverse Event|1|||
125906488|NCT00245583|452956420|FG000|Overall Study|Lack of Efficacy|1|||
125906489|NCT00245583|452956421|FG001|Overall Study|Lack of Efficacy|0|||
125906490|NCT00245583|452956420|FG000|Overall Study|Withdrawal by Subject|2|||
125906491|NCT00245583|452956421|FG001|Overall Study|Withdrawal by Subject|3|||
125906492|NCT00829283|452956422|FG000|Overall Study|Lost to Follow-up|7|||
125906493|NCT00829283|452956423|FG001|Overall Study|Lost to Follow-up|25|||
125906494|NCT00591578|452956426|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
125906495|NCT00591578|452956427|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
125906496|NCT00591578|452956428|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
125906497|NCT00591578|452956426|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
125906498|NCT00591578|452956427|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
125906499|NCT00591578|452956428|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
125906500|NCT00591578|452956426|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
125906501|NCT00591578|452956427|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
125906502|NCT00591578|452956428|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
125906503|NCT00591578|452956426|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
125906504|NCT00591578|452956427|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
125906505|NCT00591578|452956428|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
125906506|NCT00591578|452956426|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
125906507|NCT00591578|452956427|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
125906508|NCT00591578|452956428|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
125906509|NCT00591578|452956426|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
125906510|NCT00591578|452956427|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
125906511|NCT00591578|452956428|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
125906512|NCT00591578|452956426|FG000|Double-Blind Treatment Phase|Other|4|||
125906513|NCT00591578|452956427|FG001|Double-Blind Treatment Phase|Other|9|||
125906514|NCT00591578|452956428|FG002|Double-Blind Treatment Phase|Other|4|||
125906515|NCT00591578|452956426|FG000|Open-Label Extension Phase|Adverse Event|3|||
125906516|NCT00591578|452956427|FG001|Open-Label Extension Phase|Adverse Event|5|||
125906517|NCT00591578|452956428|FG002|Open-Label Extension Phase|Adverse Event|0|||
125906518|NCT00591578|452956426|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
125906519|NCT00591578|452956427|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
125906520|NCT00591578|452956428|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125906521|NCT00591578|452956426|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
125906522|NCT00591578|452956427|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
125906523|NCT00591578|452956428|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
125906524|NCT00591578|452956426|FG000|Open-Label Extension Phase|Other|1|||
125906525|NCT00591578|452956427|FG001|Open-Label Extension Phase|Other|0|||
125906526|NCT00591578|452956428|FG002|Open-Label Extension Phase|Other|0|||
125906527|NCT03945175|452956429|FG000|Overall Study|Did not meet inclusion criteria|31|||
126110125|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
125906528|NCT03945175|452956429|FG000|Overall Study|Withdrew consent|2|||
125906529|NCT03945175|452956429|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
125906530|NCT03945175|452956429|FG000|Overall Study|Early termination during Mydayis treatment|1|||
125906531|NCT00870233|452956430|FG000|Overall Study|Withdrawal by Subject|18|||
125906532|NCT00870233|452956430|FG000|Overall Study|Did not undergo laparotomy|3|||
125906533|NCT00870233|452956430|FG000|Overall Study|Incompatible internet browser|2|||
125906534|NCT00870233|452956430|FG000|Overall Study|Death|1|||
125906535|NCT00378079|452956431|FG000|Overall Study|Lost to Follow-up|6|||
125906536|NCT00378079|452956432|FG001|Overall Study|Lost to Follow-up|1|||
125906537|NCT00378079|452956433|FG002|Overall Study|Lost to Follow-up|0|||
125906538|NCT00006389|452956434|FG000|Overall Study|Adverse Event|1|||
125906539|NCT01445886|452956443|FG000|Overall Study|Lost to Follow-up|2|||
125906540|NCT01445886|452956443|FG000|Overall Study|Protocol Violation|3|||
125906541|NCT03500679|452956444|FG000|Overall Study|Lost to Follow-up|6|||
125906542|NCT03500679|452956445|FG001|Overall Study|Lost to Follow-up|3|||
125906543|NCT03500679|452956444|FG000|Overall Study|Withdrawal by Subject|3|||
125906544|NCT03500679|452956445|FG001|Overall Study|Withdrawal by Subject|0|||
125906545|NCT01962922|452956446|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
125906546|NCT01962922|452956447|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
125906547|NCT01962922|452956446|FG000|PK Portion Day 7|non-compliance|1|||
125906548|NCT01962922|452956447|FG001|PK Portion Day 7|non-compliance|0|||
125906549|NCT01962922|452956446|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
125906550|NCT01962922|452956447|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
125906551|NCT01962922|452956446|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
125906552|NCT01962922|452956447|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
125906553|NCT03224546|452956448|FG000|Overall Study|Lost to Follow-up|9|||
125906554|NCT03224546|452956449|FG001|Overall Study|Lost to Follow-up|8|||
125906555|NCT03224546|452956450|FG002|Overall Study|Lost to Follow-up|3|||
125906556|NCT03224546|452956448|FG000|Overall Study|Withdrawal by Subject|7|||
125906557|NCT03224546|452956449|FG001|Overall Study|Withdrawal by Subject|14|||
125906558|NCT03224546|452956450|FG002|Overall Study|Withdrawal by Subject|12|||
125906559|NCT02730208|452956451|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125906560|NCT02730208|452956452|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
125906561|NCT00510952|452956458|FG000|Overall Study|Adverse Event|1|||
125906562|NCT00510952|452956459|FG001|Overall Study|Adverse Event|0|||
125906563|NCT00510952|452956458|FG000|Overall Study|Entry Criteria Not Met|3|||
125906564|NCT00510952|452956459|FG001|Overall Study|Entry Criteria Not Met|1|||
125906565|NCT00510952|452956458|FG000|Overall Study|Lost to Follow-up|5|||
125906566|NCT00510952|452956459|FG001|Overall Study|Lost to Follow-up|3|||
125906567|NCT00510952|452956458|FG000|Overall Study|Physician Decision|1|||
125906568|NCT00510952|452956459|FG001|Overall Study|Physician Decision|1|||
125906569|NCT00510952|452956458|FG000|Overall Study|Protocol Violation|7|||
125906570|NCT00510952|452956459|FG001|Overall Study|Protocol Violation|4|||
125906571|NCT00510952|452956458|FG000|Overall Study|Sponsor Decision|1|||
125906572|NCT00510952|452956459|FG001|Overall Study|Sponsor Decision|0|||
125906573|NCT00510952|452956458|FG000|Overall Study|Withdrawal by Subject|6|||
126110126|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
125906574|NCT00510952|452956459|FG001|Overall Study|Withdrawal by Subject|7|||
125906575|NCT00510952|452956458|FG000|Overall Study|Did Not Receive Study Drug|2|||
125906576|NCT00510952|452956459|FG001|Overall Study|Did Not Receive Study Drug|0|||
125906577|NCT02793128|452956464|FG000|Overall Study|Death|4|||
125906578|NCT02793128|452956464|FG000|Overall Study|Withdrawal by Subject|2|||
125906579|NCT02793128|452956464|FG000|Overall Study|Physician Decision|1|||
125906580|NCT02793128|452956464|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
125906581|NCT02793128|452956464|FG000|Overall Study|Patient elected nephroureterectomy|1|||
125906582|NCT03670836|452956468|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
125906583|NCT03670836|452956469|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
125906584|NCT03670836|452956468|FG000|Per Protocol Population (PP)|Physician Decision|9|||
125906585|NCT03670836|452956469|FG001|Per Protocol Population (PP)|Physician Decision|10|||
125906586|NCT03670836|452956468|FG000|Per Protocol Population (PP)|Physician Decision|4|||
125906587|NCT03670836|452956469|FG001|Per Protocol Population (PP)|Physician Decision|6|||
125906588|NCT03670836|452956468|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
125906589|NCT03670836|452956469|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
125906590|NCT03287635|452956470|FG000|Overall Study|Lost to Follow-up|5|||
125906591|NCT03287635|452956470|FG000|Overall Study|Withdrawal by Subject|1|||
125906592|NCT03287635|452956470|FG000|Overall Study|Physician Decision|1|||
125906593|NCT04285580|452958236|FG000|Overall Study|Protocol Violation|0|||
125906594|NCT04285580|452958237|FG001|Overall Study|Protocol Violation|1|||
125906595|NCT02582255|452958238|FG000|Overall Study|Protocol Violation|0|||
125906596|NCT02582255|452958239|FG001|Overall Study|Protocol Violation|3|||
125906597|NCT01155219|452958244|FG000|Overall Study|Adverse Event|3|||
125906598|NCT01155219|452958245|FG001|Overall Study|Adverse Event|1|||
125906599|NCT01155219|452958244|FG000|Overall Study|non-medical reason|1|||
125906600|NCT01155219|452958245|FG001|Overall Study|non-medical reason|2|||
125906601|NCT00719264|452958246|FG000|Overall Study|Adverse Event|41|||
125906602|NCT00719264|452958247|FG001|Overall Study|Adverse Event|49|||
125906603|NCT00719264|452958246|FG000|Overall Study|Death|13|||
125906604|NCT00719264|452958247|FG001|Overall Study|Death|10|||
125906605|NCT00719264|452958246|FG000|Overall Study|Administrative Problems|6|||
125906606|NCT00719264|452958247|FG001|Overall Study|Administrative Problems|4|||
125906607|NCT00719264|452958246|FG000|Overall Study|Lost to Follow-up|1|||
125906608|NCT00719264|452958247|FG001|Overall Study|Lost to Follow-up|1|||
125906609|NCT00719264|452958246|FG000|Overall Study|Withdrawal by Subject|12|||
125906610|NCT00719264|452958247|FG001|Overall Study|Withdrawal by Subject|7|||
125906611|NCT00719264|452958246|FG000|Overall Study|Protocol Deviation|1|||
125906612|NCT00719264|452958247|FG001|Overall Study|Protocol Deviation|3|||
125906613|NCT00719264|452958246|FG000|Overall Study|New Cancer Therapy|4|||
125906614|NCT00719264|452958247|FG001|Overall Study|New Cancer Therapy|2|||
125906615|NCT00719264|452958246|FG000|Overall Study|Disease Progression|104|||
125906616|NCT00719264|452958247|FG001|Overall Study|Disease Progression|107|||
125906617|NCT00920829|452958255|FG000|Allocation|No post randomization data|3|||
125906618|NCT00920829|452958256|FG001|Allocation|No post randomization data|1|||
125906619|NCT00920829|452958257|FG002|Allocation|No post randomization data|0|||
125906620|NCT00920829|452958258|FG003|Allocation|No post randomization data|2|||
125906621|NCT00920829|452958255|FG000|Available for Analysis|Withdrawal by Subject|6|||
125906622|NCT00920829|452958256|FG001|Available for Analysis|Withdrawal by Subject|6|||
125906623|NCT00920829|452958257|FG002|Available for Analysis|Withdrawal by Subject|6|||
125906624|NCT00920829|452958258|FG003|Available for Analysis|Withdrawal by Subject|10|||
125906625|NCT00920829|452958255|FG000|Available for Analysis|Required Medical Treatment|0|||
125906626|NCT00920829|452958256|FG001|Available for Analysis|Required Medical Treatment|1|||
125906627|NCT00920829|452958257|FG002|Available for Analysis|Required Medical Treatment|2|||
125906628|NCT00920829|452958258|FG003|Available for Analysis|Required Medical Treatment|0|||
125906629|NCT00920829|452958255|FG000|Available for Analysis|Adverse Event|1|||
125906630|NCT00920829|452958256|FG001|Available for Analysis|Adverse Event|2|||
125906631|NCT00920829|452958257|FG002|Available for Analysis|Adverse Event|1|||
125906632|NCT00920829|452958258|FG003|Available for Analysis|Adverse Event|0|||
125906633|NCT00920829|452958255|FG000|Available for Analysis|Death|1|||
125906634|NCT00920829|452958256|FG001|Available for Analysis|Death|0|||
125906635|NCT00920829|452958257|FG002|Available for Analysis|Death|0|||
125906636|NCT00920829|452958258|FG003|Available for Analysis|Death|0|||
125906637|NCT00920829|452958255|FG000|Available for Analysis|Protocol Violation|0|||
126110127|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
125906638|NCT00920829|452958256|FG001|Available for Analysis|Protocol Violation|0|||
125906639|NCT00920829|452958257|FG002|Available for Analysis|Protocol Violation|1|||
125906640|NCT00920829|452958258|FG003|Available for Analysis|Protocol Violation|0|||
125906641|NCT00920829|452958255|FG000|Available for Analysis|Required more treatment|0|||
125906642|NCT00920829|452958256|FG001|Available for Analysis|Required more treatment|2|||
125906643|NCT00920829|452958257|FG002|Available for Analysis|Required more treatment|0|||
125906644|NCT00920829|452958258|FG003|Available for Analysis|Required more treatment|1|||
125906645|NCT04533880|452958259|FG000|Overall Study|Lost to Follow-up|0|||
125906646|NCT04533880|452958260|FG001|Overall Study|Lost to Follow-up|1|||
125906647|NCT04533880|452958261|FG002|Overall Study|Lost to Follow-up|1|||
125906648|NCT03489551|452958266|FG000|Overall Study|Withdrawal by Subject|2|||
125906649|NCT02987660|452958267|FG000|Overall Study|Study terminated by sponsor|10|||
125906650|NCT02987660|452958268|FG001|Overall Study|Study terminated by sponsor|10|||
125906651|NCT00054717|452958269|FG000|Overall Study|Randomized but not treated|2|||
125906652|NCT00054717|452958270|FG001|Overall Study|Randomized but not treated|8|||
125906653|NCT00054717|452958269|FG000|Overall Study|Adverse Event|70|||
125906654|NCT00054717|452958270|FG001|Overall Study|Adverse Event|22|||
125906655|NCT00054717|452958269|FG000|Overall Study|Protocol Violation|18|||
125906656|NCT00054717|452958270|FG001|Overall Study|Protocol Violation|19|||
125906657|NCT00054717|452958269|FG000|Overall Study|Lost to Follow-up|23|||
125906658|NCT00054717|452958270|FG001|Overall Study|Lost to Follow-up|13|||
125906659|NCT00054717|452958269|FG000|Overall Study|Withdrawal by Subject|32|||
125906660|NCT00054717|452958270|FG001|Overall Study|Withdrawal by Subject|20|||
125906661|NCT00054717|452958269|FG000|Overall Study|Other reason not defined above|117|||
125906662|NCT00054717|452958270|FG001|Overall Study|Other reason not defined above|217|||
125906663|NCT03707184|452958271|FG000|Overall Study|Withdrawal by Subject|2|||
125906664|NCT04209426|452958272|FG000|Overall Study|Lost to Follow-up|3|||
125906665|NCT04209426|452958273|FG001|Overall Study|Lost to Follow-up|2|||
125906666|NCT04423939|452958274|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
125906667|NCT04423939|452958275|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
125906668|NCT04423939|452958274|FG000|Overall Study|Death|3|||
125906669|NCT04423939|452958275|FG001|Overall Study|Death|0|||
125906670|NCT04423939|452958274|FG000|Overall Study|Withdrawal by Subject|3|||
125906671|NCT04423939|452958275|FG001|Overall Study|Withdrawal by Subject|0|||
125906672|NCT04423939|452958274|FG000|Overall Study|Caregiver to patient who died|0|||
125906673|NCT04423939|452958275|FG001|Overall Study|Caregiver to patient who died|3|||
125906674|NCT04423939|452958274|FG000|Overall Study|Caregiver to patient who withdrew|0|||
125906675|NCT04423939|452958275|FG001|Overall Study|Caregiver to patient who withdrew|3|||
125906676|NCT04626310|452958278|FG000|Overall Study|4-miss from treatment|6|||
125906677|NCT04626310|452958279|FG001|Overall Study|4-miss from treatment|5|||
125906678|NCT04626310|452958280|FG002|Overall Study|4-miss from treatment|5|||
125906679|NCT04626310|452958278|FG000|Overall Study|Withdrawal by Subject|1|||
125906680|NCT04626310|452958279|FG001|Overall Study|Withdrawal by Subject|0|||
125906681|NCT04626310|452958280|FG002|Overall Study|Withdrawal by Subject|3|||
125906682|NCT02278341|452958281|FG000|Overall Study|Randomized but never received study drug|1|||
125906683|NCT02278341|452958282|FG001|Overall Study|Randomized but never received study drug|1|||
125906684|NCT02278341|452958281|FG000|Overall Study|Adverse Event|3|||
125906685|NCT02278341|452958282|FG001|Overall Study|Adverse Event|0|||
125906686|NCT02278341|452958281|FG000|Overall Study|Death|68|||
125906687|NCT02278341|452958282|FG001|Overall Study|Death|56|||
125906688|NCT02278341|452958281|FG000|Overall Study|Withdrawal by Subject|30|||
125906689|NCT02278341|452958282|FG001|Overall Study|Withdrawal by Subject|19|||
125906690|NCT02278341|452958281|FG000|Overall Study|Lost to Follow-up|0|||
125906691|NCT02278341|452958282|FG001|Overall Study|Lost to Follow-up|1|||
125906692|NCT02278341|452958281|FG000|Overall Study|Physician Decision|1|||
125906693|NCT02278341|452958282|FG001|Overall Study|Physician Decision|1|||
125906694|NCT02278341|452958281|FG000|Overall Study|Miscellaneous|15|||
125906695|NCT02278341|452958282|FG001|Overall Study|Miscellaneous|14|||
125906696|NCT02604017|452958283|FG000|Overall Study|Withdrew Consent|0|||
125906697|NCT02604017|452958284|FG001|Overall Study|Withdrew Consent|2|||
125906698|NCT02604017|452958283|FG000|Overall Study|Lost to Follow-up|5|||
125906699|NCT02604017|452958284|FG001|Overall Study|Lost to Follow-up|6|||
125906700|NCT02604017|452958283|FG000|Overall Study|Other|1|||
125906701|NCT02604017|452958284|FG001|Overall Study|Other|0|||
125906702|NCT00740246|452958285|FG000|Overall Study|Received Blood Transfusion|0|||
125906703|NCT00740246|452958286|FG001|Overall Study|Received Blood Transfusion|1|||
125906704|NCT00740246|452958285|FG000|Overall Study|Adverse Event|1|||
125906705|NCT00740246|452958286|FG001|Overall Study|Adverse Event|2|||
125906706|NCT00740246|452958285|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
125906707|NCT00740246|452958286|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
125906708|NCT00740246|452958285|FG000|Overall Study|Lost to Follow-up|2|||
125906709|NCT00740246|452958286|FG001|Overall Study|Lost to Follow-up|2|||
125906710|NCT00740246|452958285|FG000|Overall Study|Withdrawal by Subject|4|||
125906711|NCT00740246|452958286|FG001|Overall Study|Withdrawal by Subject|3|||
125906712|NCT00740246|452958285|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
125906713|NCT00740246|452958286|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
125906714|NCT00740246|452958285|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
125906715|NCT00740246|452958286|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
125906716|NCT00740246|452958285|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
125906717|NCT00740246|452958286|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
125906718|NCT00740246|452958285|FG000|Overall Study|Unable To Comply With Study Visits|2|||
125906719|NCT00740246|452958286|FG001|Overall Study|Unable To Comply With Study Visits|0|||
125906720|NCT00740246|452958285|FG000|Overall Study|Unable to Access Vein|0|||
125906721|NCT00740246|452958286|FG001|Overall Study|Unable to Access Vein|2|||
125906722|NCT00740246|452958285|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
125906723|NCT00740246|452958286|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
125906724|NCT02821910|452958289|FG000|Overall Study|Withdrawal by Subject|0|||
125906725|NCT02821910|452958290|FG001|Overall Study|Withdrawal by Subject|0|||
125906726|NCT02821910|452958291|FG002|Overall Study|Withdrawal by Subject|1|||
125906727|NCT02821910|452958292|FG003|Overall Study|Withdrawal by Subject|0|||
125906728|NCT02821910|452958293|FG004|Overall Study|Withdrawal by Subject|0|||
125906729|NCT02821910|452958294|FG005|Overall Study|Withdrawal by Subject|1|||
125906730|NCT02821910|452958289|FG000|Overall Study|Other than specified|1|||
125906731|NCT02821910|452958290|FG001|Overall Study|Other than specified|0|||
125906732|NCT02821910|452958291|FG002|Overall Study|Other than specified|1|||
125906733|NCT02821910|452958292|FG003|Overall Study|Other than specified|0|||
125906734|NCT02821910|452958293|FG004|Overall Study|Other than specified|0|||
125906735|NCT02821910|452958294|FG005|Overall Study|Other than specified|0|||
125906736|NCT00287079|452958295|FG000|Overall Study|Qualifying relapse|12|||
125906737|NCT00287079|452958296|FG001|Overall Study|Qualifying relapse|1|||
125906738|NCT00287079|452958295|FG000|Overall Study|Non-qualifying relapse|1|||
125906739|NCT00287079|452958296|FG001|Overall Study|Non-qualifying relapse|0|||
125906740|NCT00287079|452958295|FG000|Overall Study|Adverse Event|5|||
125906741|NCT00287079|452958296|FG001|Overall Study|Adverse Event|0|||
125906742|NCT00287079|452958295|FG000|Overall Study|Protocol Violation|1|||
125906743|NCT00287079|452958296|FG001|Overall Study|Protocol Violation|0|||
125906744|NCT00287079|452958295|FG000|Overall Study|Other|3|||
125906745|NCT00287079|452958296|FG001|Overall Study|Other|0|||
125906746|NCT01082640|452958297|FG000|Overall Study|Adverse Event|9|||
125906747|NCT01082640|452958298|FG001|Overall Study|Adverse Event|5|||
125906748|NCT01082640|452958299|FG002|Overall Study|Adverse Event|3|||
125906749|NCT01082640|452958297|FG000|Overall Study|Withdrawal by Subject|3|||
125906750|NCT01082640|452958298|FG001|Overall Study|Withdrawal by Subject|3|||
125906751|NCT01082640|452958299|FG002|Overall Study|Withdrawal by Subject|2|||
125906752|NCT01082640|452958297|FG000|Overall Study|Major protocol deviation|3|||
125906753|NCT01082640|452958298|FG001|Overall Study|Major protocol deviation|3|||
125906754|NCT01082640|452958299|FG002|Overall Study|Major protocol deviation|0|||
125906755|NCT01082640|452958297|FG000|Overall Study|Lost to Follow-up|0|||
125906756|NCT01082640|452958298|FG001|Overall Study|Lost to Follow-up|3|||
125906757|NCT01082640|452958299|FG002|Overall Study|Lost to Follow-up|0|||
125906758|NCT01082640|452958297|FG000|Overall Study|Other|2|||
125906759|NCT01082640|452958298|FG001|Overall Study|Other|1|||
125906760|NCT01082640|452958299|FG002|Overall Study|Other|3|||
125906761|NCT01282203|452958304|FG000|Overall Study|Adverse Event|1|||
125906762|NCT01606254|452958307|FG000|Overall Study|Withdrawal by Subject|1|||
125906763|NCT01606254|452958308|FG001|Overall Study|Withdrawal by Subject|3|||
125906764|NCT01606254|452958309|FG002|Overall Study|Withdrawal by Subject|0|||
125906765|NCT01606254|452958310|FG003|Overall Study|Withdrawal by Subject|2|||
125906766|NCT01606254|452958307|FG000|Overall Study|Adverse Event|1|||
125906767|NCT01606254|452958308|FG001|Overall Study|Adverse Event|1|||
125906768|NCT01606254|452958309|FG002|Overall Study|Adverse Event|0|||
125906769|NCT01606254|452958310|FG003|Overall Study|Adverse Event|1|||
125906770|NCT02011893|452958312|FG000|Enrollment to Randomization|Adverse Event|2|||
125906771|NCT02011893|452958313|FG001|Enrollment to Randomization|Adverse Event|0|||
125906772|NCT02011893|452958314|FG002|Enrollment to Randomization|Adverse Event|0|||
125906773|NCT02011893|452958312|FG000|Enrollment to Randomization|Physician Decision|10|||
125906774|NCT02011893|452958313|FG001|Enrollment to Randomization|Physician Decision|0|||
125906775|NCT02011893|452958314|FG002|Enrollment to Randomization|Physician Decision|0|||
125906776|NCT02011893|452958312|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
125906777|NCT02011893|452958313|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
125906778|NCT02011893|452958314|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
125906779|NCT02011893|452958312|FG000|Enrollment to Randomization|Screening Failure|29|||
125906780|NCT02011893|452958313|FG001|Enrollment to Randomization|Screening Failure|0|||
125906781|NCT02011893|452958314|FG002|Enrollment to Randomization|Screening Failure|0|||
125906782|NCT02011893|452958312|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
125906783|NCT02011893|452958313|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
125906784|NCT02011893|452958314|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
125906785|NCT02011893|452958312|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
125906786|NCT02011893|452958313|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
125906787|NCT02011893|452958314|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
125906788|NCT02011893|452958312|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
125906789|NCT02011893|452958313|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
125906790|NCT02011893|452958314|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
125906791|NCT02011893|452958312|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
125906792|NCT02011893|452958313|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
125906793|NCT02011893|452958314|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
125906794|NCT02011893|452958312|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
125906795|NCT02011893|452958313|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
125906796|NCT02011893|452958314|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
125906797|NCT03977454|452958315|FG000|Overall Study|immediate postoperative revision|2|||
125906798|NCT03977454|452958316|FG001|Overall Study|immediate postoperative revision|2|||
125906799|NCT01289782|452958317|FG000|Overall Study|Lost to Follow-up|14|||
125906800|NCT01289782|452958318|FG001|Overall Study|Lost to Follow-up|7|||
125906801|NCT01289782|452958317|FG000|Overall Study|Protocol Violation|1|||
125906802|NCT01289782|452958318|FG001|Overall Study|Protocol Violation|1|||
125906803|NCT01289782|452958317|FG000|Overall Study|Withdrawal by Subject|8|||
125906804|NCT01289782|452958318|FG001|Overall Study|Withdrawal by Subject|2|||
125906805|NCT01289782|452958317|FG000|Overall Study|Sponsor's Decision|1|||
125906806|NCT01289782|452958318|FG001|Overall Study|Sponsor's Decision|0|||
125906807|NCT01289782|452958317|FG000|Overall Study|Reason not specified|1|||
125906808|NCT01289782|452958318|FG001|Overall Study|Reason not specified|2|||
125906809|NCT01241240|452958319|FG000|Overall Study|Adverse Event|5|||
125906810|NCT01241240|452958320|FG001|Overall Study|Adverse Event|4|||
125906811|NCT01241240|452958319|FG000|Overall Study|Lost to Follow-up|2|||
125906812|NCT01241240|452958320|FG001|Overall Study|Lost to Follow-up|4|||
125906813|NCT01241240|452958319|FG000|Overall Study|Personal Reasons|1|||
125906814|NCT01241240|452958320|FG001|Overall Study|Personal Reasons|1|||
125906815|NCT04365257|452958324|FG000|Overall Study|Physician Decision|1|||
125906816|NCT04365257|452958325|FG001|Overall Study|Physician Decision|0|||
126059970|NCT01205126|453514214|FG001|Maintenance Phase|Other|8|||
126059971|NCT01205126|453514213|FG000|Maintenance Phase|Lost to Follow-up|5|||
126059972|NCT01205126|453514214|FG001|Maintenance Phase|Lost to Follow-up|5|||
126059973|NCT01205126|453514213|FG000|Maintenance Phase|Withdrawal by Subject|8|||
126059974|NCT01205126|453514214|FG001|Maintenance Phase|Withdrawal by Subject|11|||
126059975|NCT00638456|453514217|FG000|Overall Study|Withdrawal by Subject|6|||
125906817|NCT04365257|452958324|FG000|Overall Study|Patient Noncompliance|1|||
125906818|NCT04365257|452958325|FG001|Overall Study|Patient Noncompliance|0|||
126059976|NCT00638456|453514218|FG001|Overall Study|Withdrawal by Subject|2|||
126059977|NCT03236779|453514219|FG000|Overall Study|Lost to Follow-up|13|||
125906819|NCT04365257|452958324|FG000|Overall Study|Withdrawal by Subject|0|||
125906820|NCT04365257|452958325|FG001|Overall Study|Withdrawal by Subject|1|||
125906821|NCT00518973|452958326|FG000|Overall Study|Withdrawal by Subject|3|||
125906822|NCT00518973|452958327|FG001|Overall Study|Withdrawal by Subject|2|||
125906823|NCT02129777|452958330|FG000|Double-Blind Period|Adverse Event|0|||
125906824|NCT02129777|452958331|FG001|Double-Blind Period|Adverse Event|0|||
125906825|NCT02129777|452958332|FG002|Double-Blind Period|Adverse Event|0|||
125906826|NCT02129777|452958333|FG003|Double-Blind Period|Adverse Event|0|||
125906827|NCT02129777|452958334|FG004|Double-Blind Period|Adverse Event|1|||
125906828|NCT02129777|452958335|FG005|Double-Blind Period|Adverse Event|0|||
125906829|NCT02129777|452958336|FG006|Double-Blind Period|Adverse Event|0|||
125906830|NCT02129777|452958330|FG000|Double-Blind Period|Lost to Follow-up|1|||
125906831|NCT02129777|452958331|FG001|Double-Blind Period|Lost to Follow-up|1|||
125906832|NCT02129777|452958332|FG002|Double-Blind Period|Lost to Follow-up|1|||
125906833|NCT02129777|452958333|FG003|Double-Blind Period|Lost to Follow-up|2|||
125906834|NCT02129777|452958334|FG004|Double-Blind Period|Lost to Follow-up|0|||
125906835|NCT02129777|452958335|FG005|Double-Blind Period|Lost to Follow-up|0|||
125906836|NCT02129777|452958336|FG006|Double-Blind Period|Lost to Follow-up|0|||
125906837|NCT02129777|452958330|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125906838|NCT02129777|452958331|FG001|Double-Blind Period|Withdrawal by Subject|4|||
125906839|NCT02129777|452958332|FG002|Double-Blind Period|Withdrawal by Subject|3|||
125906840|NCT02129777|452958333|FG003|Double-Blind Period|Withdrawal by Subject|2|||
125906841|NCT02129777|452958334|FG004|Double-Blind Period|Withdrawal by Subject|3|||
125906842|NCT02129777|452958335|FG005|Double-Blind Period|Withdrawal by Subject|0|||
125906843|NCT02129777|452958336|FG006|Double-Blind Period|Withdrawal by Subject|0|||
125906844|NCT02129777|452958330|FG000|Double-Blind Period|Pregnancy|0|||
125906845|NCT02129777|452958331|FG001|Double-Blind Period|Pregnancy|0|||
125906846|NCT02129777|452958332|FG002|Double-Blind Period|Pregnancy|0|||
125906847|NCT02129777|452958333|FG003|Double-Blind Period|Pregnancy|0|||
125906848|NCT02129777|452958334|FG004|Double-Blind Period|Pregnancy|1|||
125906849|NCT02129777|452958335|FG005|Double-Blind Period|Pregnancy|0|||
125906850|NCT02129777|452958336|FG006|Double-Blind Period|Pregnancy|0|||
125906851|NCT02129777|452958330|FG000|Double-Blind Period|Lack of Efficacy|3|||
125906852|NCT02129777|452958331|FG001|Double-Blind Period|Lack of Efficacy|1|||
125906853|NCT02129777|452958332|FG002|Double-Blind Period|Lack of Efficacy|0|||
125906854|NCT02129777|452958333|FG003|Double-Blind Period|Lack of Efficacy|3|||
125906855|NCT02129777|452958334|FG004|Double-Blind Period|Lack of Efficacy|2|||
125906856|NCT02129777|452958335|FG005|Double-Blind Period|Lack of Efficacy|0|||
125906857|NCT02129777|452958336|FG006|Double-Blind Period|Lack of Efficacy|0|||
125906858|NCT02129777|452958330|FG000|Double-Blind Period|Other|1|||
125906859|NCT02129777|452958331|FG001|Double-Blind Period|Other|2|||
125906860|NCT02129777|452958332|FG002|Double-Blind Period|Other|0|||
125906861|NCT02129777|452958333|FG003|Double-Blind Period|Other|0|||
125906862|NCT02129777|452958334|FG004|Double-Blind Period|Other|0|||
125906863|NCT02129777|452958335|FG005|Double-Blind Period|Other|0|||
125906864|NCT02129777|452958336|FG006|Double-Blind Period|Other|0|||
125906865|NCT02129777|452958330|FG000|Open-Label Period|Lack of Efficacy|0|||
125906866|NCT02129777|452958331|FG001|Open-Label Period|Lack of Efficacy|0|||
125906867|NCT02129777|452958332|FG002|Open-Label Period|Lack of Efficacy|0|||
125906868|NCT02129777|452958333|FG003|Open-Label Period|Lack of Efficacy|0|||
125906869|NCT02129777|452958334|FG004|Open-Label Period|Lack of Efficacy|0|||
125906870|NCT02129777|452958335|FG005|Open-Label Period|Lack of Efficacy|0|||
125906871|NCT02129777|452958336|FG006|Open-Label Period|Lack of Efficacy|5|||
125906872|NCT02129777|452958330|FG000|Open-Label Period|Lost to Follow-up|0|||
125906873|NCT02129777|452958331|FG001|Open-Label Period|Lost to Follow-up|0|||
125906874|NCT02129777|452958332|FG002|Open-Label Period|Lost to Follow-up|0|||
125906875|NCT02129777|452958333|FG003|Open-Label Period|Lost to Follow-up|0|||
125906876|NCT02129777|452958334|FG004|Open-Label Period|Lost to Follow-up|0|||
125906877|NCT02129777|452958335|FG005|Open-Label Period|Lost to Follow-up|1|||
125906878|NCT02129777|452958336|FG006|Open-Label Period|Lost to Follow-up|1|||
125906879|NCT02129777|452958330|FG000|Open-Label Period|Withdrawal by Subject|0|||
125906880|NCT02129777|452958331|FG001|Open-Label Period|Withdrawal by Subject|0|||
125906881|NCT02129777|452958332|FG002|Open-Label Period|Withdrawal by Subject|0|||
125906882|NCT02129777|452958333|FG003|Open-Label Period|Withdrawal by Subject|0|||
125906883|NCT02129777|452958334|FG004|Open-Label Period|Withdrawal by Subject|0|||
125906884|NCT02129777|452958335|FG005|Open-Label Period|Withdrawal by Subject|1|||
125906885|NCT02129777|452958336|FG006|Open-Label Period|Withdrawal by Subject|3|||
125906886|NCT02129777|452958330|FG000|Open-Label Period|Study Termination|0|||
125906887|NCT02129777|452958331|FG001|Open-Label Period|Study Termination|0|||
125906888|NCT02129777|452958332|FG002|Open-Label Period|Study Termination|0|||
125906889|NCT02129777|452958333|FG003|Open-Label Period|Study Termination|0|||
125906890|NCT02129777|452958334|FG004|Open-Label Period|Study Termination|0|||
125906891|NCT02129777|452958335|FG005|Open-Label Period|Study Termination|10|||
125906892|NCT02129777|452958336|FG006|Open-Label Period|Study Termination|39|||
125906893|NCT01001299|452958337|FG000|Overall Study|Insufficient Therapeutic Response|20|||
125906894|NCT01001299|452958337|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
125906895|NCT01001299|452958337|FG000|Overall Study|Death|1|||
125906896|NCT01001299|452958337|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
125906897|NCT01001299|452958337|FG000|Overall Study|Withdrew Consent|1|||
125906898|NCT01565499|452958344|FG000|Overall Study|Physician Decision|1|||
125906899|NCT01565499|452958344|FG000|Overall Study|Adverse Event|5|||
125906900|NCT01565499|452958344|FG000|Overall Study|Withdrawal by Subject|2|||
125906901|NCT00542451|452958348|FG000|Overall Study|Adverse Event|31|||
125906902|NCT00542451|452958348|FG000|Overall Study|Withdrawal by Subject|30|||
125906903|NCT00542451|452958348|FG000|Overall Study|Physician Decision|4|||
125906904|NCT00542451|452958348|FG000|Overall Study|Recurrent disease|1|||
125906905|NCT00542451|452958348|FG000|Overall Study|unknown reason|1|||
125906906|NCT00542451|452958348|FG000|Overall Study|Death|2|||
125906907|NCT00542451|452958348|FG000|Overall Study|Lost to Follow-up|10|||
125906908|NCT01582854|452958349|FG000|Overall Study|Death|8|||
125906909|NCT01582854|452958350|FG001|Overall Study|Death|5|||
125906910|NCT01582854|452958349|FG000|Overall Study|Adverse Event|2|||
125906911|NCT01582854|452958350|FG001|Overall Study|Adverse Event|3|||
125906912|NCT01582854|452958349|FG000|Overall Study|Withdrawal by Participant|8|||
125906913|NCT01582854|452958350|FG001|Overall Study|Withdrawal by Participant|11|||
125906914|NCT01582854|452958349|FG000|Overall Study|Lost to Follow-up|1|||
125906915|NCT01582854|452958350|FG001|Overall Study|Lost to Follow-up|2|||
125906916|NCT01582854|452958349|FG000|Overall Study|Physician Decision|0|||
125906917|NCT01582854|452958350|FG001|Overall Study|Physician Decision|1|||
125906918|NCT01582854|452958349|FG000|Overall Study|Recurrent Stroke|13|||
125906919|NCT01582854|452958350|FG001|Overall Study|Recurrent Stroke|8|||
125906920|NCT01582854|452958349|FG000|Overall Study|Disallowed Concomitant Medication|3|||
125906921|NCT01582854|452958350|FG001|Overall Study|Disallowed Concomitant Medication|2|||
125906922|NCT01582854|452958349|FG000|Overall Study|Carotid or Neurosurgery|0|||
125906923|NCT01582854|452958350|FG001|Overall Study|Carotid or Neurosurgery|1|||
125906924|NCT01582854|452958349|FG000|Overall Study|General Anaesthesia|0|||
125906925|NCT01582854|452958350|FG001|Overall Study|General Anaesthesia|1|||
125906926|NCT01582854|452958349|FG000|Overall Study|Other Miscellaneous Reason|1|||
125906927|NCT01582854|452958350|FG001|Overall Study|Other Miscellaneous Reason|0|||
125906928|NCT02652767|452958355|FG000|Overall Study|Death|2|||
125906929|NCT02652767|452958355|FG000|Overall Study|Lost to Follow-up|1|||
125906930|NCT02652767|452958355|FG000|Overall Study|Withdrawal by Subject|1|||
125906931|NCT00064298|452958368|FG000|Overall Study|Withdrawal by Subject|2|||
125906932|NCT00064298|452958369|FG001|Overall Study|Withdrawal by Subject|1|||
125906933|NCT00064298|452958368|FG000|Overall Study|Lost to Follow-up|2|||
125906934|NCT00064298|452958369|FG001|Overall Study|Lost to Follow-up|2|||
125906935|NCT00064298|452958368|FG000|Overall Study|Death|0|||
125906936|NCT00064298|452958369|FG001|Overall Study|Death|1|||
125906937|NCT00064298|452958368|FG000|Overall Study|Disease Progression|2|||
125906938|NCT00064298|452958369|FG001|Overall Study|Disease Progression|1|||
125906939|NCT04718103|452958370|FG000|Overall Study|Adverse Event|1|||
125906940|NCT04718103|452958371|FG001|Overall Study|Adverse Event|1|||
125906941|NCT04718103|452958370|FG000|Overall Study|Lack of Efficacy|4|||
125906942|NCT04718103|452958371|FG001|Overall Study|Lack of Efficacy|1|||
125906943|NCT04718103|452958370|FG000|Overall Study|Lost to Follow-up|2|||
125906944|NCT04718103|452958371|FG001|Overall Study|Lost to Follow-up|2|||
125906945|NCT04718103|452958370|FG000|Overall Study|Physician Decision|2|||
125906946|NCT04718103|452958371|FG001|Overall Study|Physician Decision|0|||
125906947|NCT04718103|452958370|FG000|Overall Study|Pregnancy|0|||
125906948|NCT04718103|452958371|FG001|Overall Study|Pregnancy|1|||
125906949|NCT04718103|452958370|FG000|Overall Study|Withdrawal by Subject|10|||
125906950|NCT04718103|452958371|FG001|Overall Study|Withdrawal by Subject|6|||
125906951|NCT04718103|452958370|FG000|Overall Study|Randomized, not treated|4|||
125906952|NCT04718103|452958371|FG001|Overall Study|Randomized, not treated|1|||
125906953|NCT04718103|452958370|FG000|Overall Study|GCP violations|7|||
125906954|NCT04718103|452958371|FG001|Overall Study|GCP violations|5|||
125906955|NCT00136604|452958372|FG000|Overall Study|Lost to Follow-up|1|||
125906956|NCT00136604|452958373|FG001|Overall Study|Lost to Follow-up|0|||
125906957|NCT00136604|452958374|FG002|Overall Study|Lost to Follow-up|0|||
125906958|NCT00136604|452958375|FG003|Overall Study|Lost to Follow-up|0|||
125906959|NCT00136604|452958376|FG004|Overall Study|Lost to Follow-up|1|||
125906960|NCT00136604|452958372|FG000|Overall Study|Migrated/moved from study area|0|||
125906961|NCT00136604|452958373|FG001|Overall Study|Migrated/moved from study area|1|||
125906962|NCT00136604|452958374|FG002|Overall Study|Migrated/moved from study area|0|||
125906963|NCT00136604|452958375|FG003|Overall Study|Migrated/moved from study area|0|||
125906964|NCT00136604|452958376|FG004|Overall Study|Migrated/moved from study area|0|||
125906965|NCT03631355|452958379|FG000|Overall Study|Lost to Follow-up|1|||
125906966|NCT03631355|452958380|FG001|Overall Study|Lost to Follow-up|2|||
125906967|NCT01233687|452958381|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
126059978|NCT03236779|453514220|FG001|Overall Study|Lost to Follow-up|21|||
125906968|NCT01233687|452958381|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
125906969|NCT01233687|452958381|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
125906970|NCT03640559|452958384|FG000|Overall Study|Physician Decision|1|||
125906971|NCT03640559|452958385|FG001|Overall Study|Physician Decision|1|||
125906972|NCT03640559|452958384|FG000|Overall Study|Withdrawal by Subject|1|||
125906973|NCT03640559|452958385|FG001|Overall Study|Withdrawal by Subject|0|||
126059979|NCT00805792|453514221|FG000|Overall Study|Death|3|||
126059980|NCT00805792|453514221|FG000|Overall Study|Lost to Follow-up|2|||
126059981|NCT01836523|453514222|FG000|Overall Study|Adverse Event|15|||
126059982|NCT01836523|453514223|FG001|Overall Study|Adverse Event|41|||
126059983|NCT01836523|453514224|FG002|Overall Study|Adverse Event|49|||
126059984|NCT01836523|453514225|FG003|Overall Study|Adverse Event|14|||
126059985|NCT01836523|453514222|FG000|Overall Study|Protocol Violation|6|||
126059986|NCT01836523|453514223|FG001|Overall Study|Protocol Violation|3|||
126059987|NCT01836523|453514224|FG002|Overall Study|Protocol Violation|2|||
126059988|NCT01836523|453514225|FG003|Overall Study|Protocol Violation|4|||
125906974|NCT02125604|452958386|FG000|Overall Study|Other|4|||
125906975|NCT02125604|452958386|FG000|Overall Study|Investigator Decision|1|||
125906976|NCT02125604|452958386|FG000|Overall Study|Lost to Follow-up|2|||
125906977|NCT02125604|452958386|FG000|Overall Study|Consent Withdrawn|4|||
125906978|NCT02125604|452958386|FG000|Overall Study|Adverse Event|20|||
125906979|NCT01876810|452958389|FG000|Overall Study|Physician Decision|0|||
125906980|NCT01876810|452958390|FG001|Overall Study|Physician Decision|1|||
125906981|NCT00323869|452958394|FG000|Overall Study|Death|1|||
125906982|NCT03034200|452960419|FG000|Overall Study|Disease progression|8|||
125906983|NCT03034200|452960420|FG001|Overall Study|Disease progression|10|||
125906984|NCT03034200|452960421|FG002|Overall Study|Disease progression|4|||
125906985|NCT03034200|452960419|FG000|Overall Study|Physician Decision|2|||
125906986|NCT03034200|452960420|FG001|Overall Study|Physician Decision|0|||
125906987|NCT03034200|452960421|FG002|Overall Study|Physician Decision|3|||
125906988|NCT03034200|452960419|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
125906989|NCT03034200|452960420|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
125906990|NCT03034200|452960421|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
125906991|NCT03034200|452960419|FG000|Overall Study|Adjuvant Therapy|0|||
125906992|NCT03034200|452960420|FG001|Overall Study|Adjuvant Therapy|0|||
125906993|NCT03034200|452960421|FG002|Overall Study|Adjuvant Therapy|1|||
125906994|NCT05523323|452960422|FG000|Overall Study|Death|26|||
125906995|NCT05523323|452960423|FG001|Overall Study|Death|21|||
125906996|NCT05523323|452960422|FG000|Overall Study|Ongoing participants|35|||
125906997|NCT05523323|452960423|FG001|Overall Study|Ongoing participants|30|||
125906998|NCT03435640|452960424|FG000|Overall Study|Withdrawal by Subject|0|||
125906999|NCT03435640|452960425|FG001|Overall Study|Withdrawal by Subject|1|||
125907000|NCT03435640|452960426|FG002|Overall Study|Withdrawal by Subject|0|||
125907001|NCT03435640|452960427|FG003|Overall Study|Withdrawal by Subject|2|||
125907002|NCT03435640|452960428|FG004|Overall Study|Withdrawal by Subject|0|||
125907003|NCT03435640|452960429|FG005|Overall Study|Withdrawal by Subject|0|||
125907004|NCT03435640|452960430|FG006|Overall Study|Withdrawal by Subject|3|||
125907005|NCT03435640|452960431|FG007|Overall Study|Withdrawal by Subject|0|||
125907006|NCT03435640|452960432|FG008|Overall Study|Withdrawal by Subject|0|||
125907007|NCT03435640|452960433|FG009|Overall Study|Withdrawal by Subject|2|||
125907008|NCT03435640|452960434|FG010|Overall Study|Withdrawal by Subject|3|||
125907009|NCT03435640|452960424|FG000|Overall Study|Lost to Follow-up|0|||
125907010|NCT03435640|452960425|FG001|Overall Study|Lost to Follow-up|0|||
125907011|NCT03435640|452960426|FG002|Overall Study|Lost to Follow-up|1|||
125907012|NCT03435640|452960427|FG003|Overall Study|Lost to Follow-up|0|||
125907013|NCT03435640|452960428|FG004|Overall Study|Lost to Follow-up|0|||
125907014|NCT03435640|452960429|FG005|Overall Study|Lost to Follow-up|0|||
125907015|NCT03435640|452960430|FG006|Overall Study|Lost to Follow-up|0|||
125907016|NCT03435640|452960431|FG007|Overall Study|Lost to Follow-up|0|||
125907017|NCT03435640|452960432|FG008|Overall Study|Lost to Follow-up|0|||
125907018|NCT03435640|452960433|FG009|Overall Study|Lost to Follow-up|0|||
125907019|NCT03435640|452960434|FG010|Overall Study|Lost to Follow-up|0|||
125907020|NCT01711879|452960435|FG000|Overall Study|Death|1|||
125907021|NCT01711879|452960436|FG001|Overall Study|Death|0|||
125907022|NCT02239224|452960439|FG000|Overall Study|Administrative|0|||
125907023|NCT02239224|452960440|FG001|Overall Study|Administrative|0|||
125907024|NCT02239224|452960441|FG002|Overall Study|Administrative|3|||
125907025|NCT02239224|452960442|FG003|Overall Study|Administrative|1|||
125907026|NCT03183778|452960446|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
125907027|NCT01466179|452960447|FG000|Overall Study|Ongoing in core study|2|||
125907028|NCT01466179|452960447|FG000|Overall Study|Physician Decision|46|||
125907029|NCT01466179|452960447|FG000|Overall Study|Progressive disease|43|||
125907030|NCT01466179|452960447|FG000|Overall Study|Adverse Event|32|||
125907031|NCT01466179|452960447|FG000|Overall Study|Disease relapse|23|||
125907032|NCT01466179|452960447|FG000|Overall Study|Lack of Efficacy|14|||
125907033|NCT01466179|452960447|FG000|Overall Study|Death|7|||
125907034|NCT01466179|452960447|FG000|Overall Study|Withdrawal by Subject|7|||
125907035|NCT01466179|452960447|FG000|Overall Study|Protocol Violation|2|||
125907036|NCT01466179|452960447|FG000|Overall Study|Other|3|||
125907037|NCT00749580|452960448|FG000|Overall Study|Lost to Follow-up|4|||
125907038|NCT00749580|452960449|FG001|Overall Study|Lost to Follow-up|8|||
125907039|NCT00749580|452960448|FG000|Overall Study|Adverse Event|0|||
125907040|NCT00749580|452960449|FG001|Overall Study|Adverse Event|1|||
125907041|NCT03868124|452960458|FG000|Overall Study|Withdrawal by Subject|4|||
125907042|NCT03868124|452960459|FG001|Overall Study|Withdrawal by Subject|0|||
125907043|NCT03868124|452960460|FG002|Overall Study|Withdrawal by Subject|1|||
125907044|NCT03868124|452960458|FG000|Overall Study|Physician Decision|1|||
125907045|NCT03868124|452960459|FG001|Overall Study|Physician Decision|0|||
125907046|NCT03868124|452960460|FG002|Overall Study|Physician Decision|1|||
125907047|NCT03868124|452960458|FG000|Overall Study|Lost to Follow-up|1|||
125907048|NCT03868124|452960459|FG001|Overall Study|Lost to Follow-up|1|||
125907049|NCT03868124|452960460|FG002|Overall Study|Lost to Follow-up|2|||
125907050|NCT03868124|452960458|FG000|Overall Study|Death|1|||
125907051|NCT03868124|452960459|FG001|Overall Study|Death|1|||
125907052|NCT03868124|452960460|FG002|Overall Study|Death|2|||
125907053|NCT03868124|452960458|FG000|Overall Study|Adverse Event|0|||
125907054|NCT03868124|452960459|FG001|Overall Study|Adverse Event|0|||
125907055|NCT03868124|452960460|FG002|Overall Study|Adverse Event|3|||
125907056|NCT03868124|452960458|FG000|Overall Study|Explanted|2|||
125907057|NCT03868124|452960459|FG001|Overall Study|Explanted|1|||
125907058|NCT03868124|452960460|FG002|Overall Study|Explanted|0|||
125907059|NCT03868124|452960458|FG000|Overall Study|Ongoing in study|176|||
125907060|NCT03868124|452960459|FG001|Overall Study|Ongoing in study|180|||
125907061|NCT03868124|452960460|FG002|Overall Study|Ongoing in study|183|||
125907062|NCT04565236|452960461|FG000|Overall Study|Patient/Guardian Decision|0|||
125907063|NCT04565236|452960462|FG001|Overall Study|Patient/Guardian Decision|0|||
125907064|NCT04565236|452960463|FG002|Overall Study|Patient/Guardian Decision|1|||
125907065|NCT04565236|452960464|FG003|Overall Study|Patient/Guardian Decision|0|||
125907066|NCT04902326|452960465|FG000|Overall Study|Withdrawal by Subject|1|||
125907067|NCT04902326|452960466|FG001|Overall Study|Withdrawal by Subject|3|||
125907068|NCT04902326|452960467|FG002|Overall Study|Withdrawal by Subject|0|||
125907069|NCT04902326|452960468|FG003|Overall Study|Withdrawal by Subject|1|||
125907070|NCT04902326|452960465|FG000|Overall Study|Lost to Follow-up|14|||
125907071|NCT04902326|452960466|FG001|Overall Study|Lost to Follow-up|14|||
125907072|NCT04902326|452960467|FG002|Overall Study|Lost to Follow-up|14|||
125907073|NCT04902326|452960468|FG003|Overall Study|Lost to Follow-up|6|||
125907074|NCT01117051|452960469|FG000|Overall Study|Withdrawal by Subject|5|||
125907075|NCT01117051|452960470|FG001|Overall Study|Withdrawal by Subject|3|||
125907076|NCT01117051|452960469|FG000|Overall Study|Adverse Event|4|||
125907077|NCT01117051|452960470|FG001|Overall Study|Adverse Event|3|||
125907078|NCT01117051|452960469|FG000|Overall Study|Lost to Follow-up|0|||
125907079|NCT01117051|452960470|FG001|Overall Study|Lost to Follow-up|1|||
125907080|NCT01117051|452960469|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
125907081|NCT01117051|452960470|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
125907082|NCT01117051|452960469|FG000|Overall Study|Sponsor's decision|3|||
125907083|NCT01117051|452960470|FG001|Overall Study|Sponsor's decision|1|||
125907084|NCT01117051|452960469|FG000|Overall Study|Surgical procedure|0|||
125907085|NCT01117051|452960470|FG001|Overall Study|Surgical procedure|1|||
125907086|NCT01117051|452960469|FG000|Overall Study|Randomized by mistake|0|||
125907087|NCT01117051|452960470|FG001|Overall Study|Randomized by mistake|1|||
125907088|NCT01117051|452960469|FG000|Overall Study|Convenience issue|1|||
125907089|NCT01117051|452960470|FG001|Overall Study|Convenience issue|0|||
125907090|NCT00206076|452960472|FG000|Overall Study|Physician Decision|2|||
125907091|NCT00206076|452960473|FG001|Overall Study|Physician Decision|0|||
125907092|NCT00206076|452960472|FG000|Overall Study|Withdrawal by Subject|1|||
125907093|NCT00206076|452960473|FG001|Overall Study|Withdrawal by Subject|1|||
125907094|NCT00366340|452960476|FG000|Infant Series|Protocol Violation|3|||
125907095|NCT00366340|452960477|FG001|Infant Series|Protocol Violation|4|||
125907096|NCT00366340|452960476|FG000|Infant Series|Withdrawal by Subject|3|||
125907097|NCT00366340|452960477|FG001|Infant Series|Withdrawal by Subject|3|||
125907098|NCT00366340|452960476|FG000|Infant Series|Adverse Event|0|||
125907099|NCT00366340|452960477|FG001|Infant Series|Adverse Event|2|||
125907100|NCT00366340|452960476|FG000|Infant Series|Lost to Follow-up|1|||
125907101|NCT00366340|452960477|FG001|Infant Series|Lost to Follow-up|1|||
125907102|NCT00366340|452960476|FG000|Infant Series|Failure to return|1|||
125907103|NCT00366340|452960477|FG001|Infant Series|Failure to return|0|||
125907104|NCT00366340|452960476|FG000|After the Infant Series|Parent/legal guardian request|1|||
125907105|NCT00366340|452960477|FG001|After the Infant Series|Parent/legal guardian request|1|||
125907106|NCT00366340|452960476|FG000|After the Infant Series|Failed to return|0|||
125907107|NCT00366340|452960477|FG001|After the Infant Series|Failed to return|1|||
125907108|NCT00366340|452960476|FG000|After the Infant Series|Protocol Violation|2|||
125907109|NCT00366340|452960477|FG001|After the Infant Series|Protocol Violation|2|||
125907110|NCT00366340|452960476|FG000|After the Infant Series|Adverse Event|0|||
125907111|NCT00366340|452960477|FG001|After the Infant Series|Adverse Event|1|||
125907112|NCT00366340|452960476|FG000|After the Infant Series|Lost to Follow-up|0|||
125907113|NCT00366340|452960477|FG001|After the Infant Series|Lost to Follow-up|1|||
125907114|NCT00366340|452960476|FG000|Toddler Dose|Failed to return|1|||
125907115|NCT00366340|452960477|FG001|Toddler Dose|Failed to return|0|||
125907116|NCT00366340|452960476|FG000|Toddler Dose|Parent/legal guardian request|0|||
125907117|NCT00366340|452960477|FG001|Toddler Dose|Parent/legal guardian request|1|||
125907118|NCT03355664|452960478|FG000|Overall Study|Adverse Event|1|||
125907119|NCT03355664|452960479|FG001|Overall Study|Adverse Event|2|||
125907120|NCT03355664|452960478|FG000|Overall Study|Lost to Follow-up|11|||
125907121|NCT03355664|452960479|FG001|Overall Study|Lost to Follow-up|7|||
125907122|NCT03355664|452960478|FG000|Overall Study|Protocol Violation|1|||
125907123|NCT03355664|452960479|FG001|Overall Study|Protocol Violation|2|||
125907124|NCT03355664|452960478|FG000|Overall Study|Withdrawal by Subject|2|||
125907125|NCT03355664|452960479|FG001|Overall Study|Withdrawal by Subject|1|||
125907126|NCT01315236|452960485|FG000|Double-blind Phase|Death|1|||
125907127|NCT01315236|452960486|FG001|Double-blind Phase|Death|0|||
125907128|NCT01315236|452960485|FG000|Double-blind Phase|Adverse Event|1|||
125907129|NCT01315236|452960486|FG001|Double-blind Phase|Adverse Event|0|||
125907130|NCT01315236|452960485|FG000|Double-blind Phase|Withdrawal of Consent|1|||
125907131|NCT01315236|452960486|FG001|Double-blind Phase|Withdrawal of Consent|0|||
125907132|NCT01315236|452960485|FG000|Double-blind Phase|Lost to Follow-up|1|||
125907133|NCT01315236|452960486|FG001|Double-blind Phase|Lost to Follow-up|0|||
125907134|NCT01315236|452960485|FG000|Open-label Phase|Death|1|||
125907135|NCT01315236|452960486|FG001|Open-label Phase|Death|0|||
125907136|NCT01315236|452960485|FG000|Open-label Phase|Adverse Event|0|||
125907137|NCT01315236|452960486|FG001|Open-label Phase|Adverse Event|1|||
125907138|NCT01315236|452960485|FG000|Open-label Phase|Other|0|||
125907139|NCT01315236|452960486|FG001|Open-label Phase|Other|1|||
125907140|NCT01315236|452960485|FG000|12-Month Follow-up Period|Death|0|||
125907141|NCT01315236|452960486|FG001|12-Month Follow-up Period|Death|1|||
125907142|NCT01315236|452960485|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
125907143|NCT01315236|452960486|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
125907144|NCT01751802|452960487|FG000|Overall Study|Adverse Event|4|||
125907145|NCT01751802|452960488|FG001|Overall Study|Adverse Event|2|||
126059989|NCT01836523|453514222|FG000|Overall Study|Met Withdrawal Criteria|13|||
125907146|NCT00589784|452960492|FG000|Overall Study|Withdrawal by Subject|0|||
125907147|NCT00589784|452960493|FG001|Overall Study|Withdrawal by Subject|6|||
125907148|NCT00589784|452960492|FG000|Overall Study|Patient inevaluable|1|||
125907149|NCT00589784|452960493|FG001|Overall Study|Patient inevaluable|0|||
125907150|NCT00589784|452960492|FG000|Overall Study|Adverse Event|0|||
125907151|NCT00589784|452960493|FG001|Overall Study|Adverse Event|4|||
125907152|NCT00521001|452960496|FG000|Overall Study|Ineligible|1|||
125907153|NCT01025154|452960499|FG000|Overall Study|Lost to Follow-up|1|||
125907154|NCT01025154|452960499|FG000|Overall Study|Withdrawal by Subject|1|||
125907155|NCT00322153|452960500|FG000|Overall Study|Adverse Event|21|||
125907156|NCT00322153|452960501|FG001|Overall Study|Adverse Event|34|||
125907157|NCT00322153|452960500|FG000|Overall Study|Protocol Violation|6|||
125907158|NCT00322153|452960501|FG001|Overall Study|Protocol Violation|14|||
125907159|NCT00322153|452960500|FG000|Overall Study|Withdrawal by Subject|18|||
125907160|NCT00322153|452960501|FG001|Overall Study|Withdrawal by Subject|10|||
125907161|NCT00322153|452960500|FG000|Overall Study|Lack of Efficacy|8|||
125907162|NCT00322153|452960501|FG001|Overall Study|Lack of Efficacy|3|||
125907163|NCT00322153|452960500|FG000|Overall Study|Lost to Follow-up|5|||
125907164|NCT00322153|452960501|FG001|Overall Study|Lost to Follow-up|4|||
125907165|NCT00322153|452960500|FG000|Overall Study|Withdrawn for other reasons|5|||
125907166|NCT00322153|452960501|FG001|Overall Study|Withdrawn for other reasons|4|||
125907167|NCT01309893|452960502|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
125907168|NCT01309893|452960503|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
125907169|NCT01309893|452960502|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
125907170|NCT01309893|452960503|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
125907171|NCT02414139|452960504|FG000|Treatment Period|Adverse Event|11|||
125907172|NCT02414139|452960505|FG001|Treatment Period|Adverse Event|6|||
125907173|NCT02414139|452960506|FG002|Treatment Period|Adverse Event|8|||
125907174|NCT02414139|452960507|FG003|Treatment Period|Adverse Event|5|||
125907175|NCT02414139|452960508|FG004|Treatment Period|Adverse Event|14|||
125907176|NCT02414139|452960509|FG005|Treatment Period|Adverse Event|3|||
125907177|NCT02414139|452960510|FG006|Treatment Period|Adverse Event|6|||
125907178|NCT02414139|452960511|FG007|Treatment Period|Adverse Event|1|||
125907179|NCT02414139|452960512|FG008|Treatment Period|Adverse Event|6|||
125907180|NCT02414139|452960513|FG009|Treatment Period|Adverse Event|8|||
125907181|NCT02414139|452960504|FG000|Treatment Period|Death|0|||
125907182|NCT02414139|452960505|FG001|Treatment Period|Death|0|||
125907183|NCT02414139|452960506|FG002|Treatment Period|Death|1|||
125907184|NCT02414139|452960507|FG003|Treatment Period|Death|1|||
125907185|NCT02414139|452960508|FG004|Treatment Period|Death|0|||
125907186|NCT02414139|452960509|FG005|Treatment Period|Death|0|||
125907187|NCT02414139|452960510|FG006|Treatment Period|Death|0|||
125907188|NCT02414139|452960511|FG007|Treatment Period|Death|0|||
125907189|NCT02414139|452960512|FG008|Treatment Period|Death|0|||
125907190|NCT02414139|452960513|FG009|Treatment Period|Death|1|||
125907191|NCT02414139|452960504|FG000|Treatment Period|Physician Decision|5|||
125907192|NCT02414139|452960505|FG001|Treatment Period|Physician Decision|4|||
125907193|NCT02414139|452960506|FG002|Treatment Period|Physician Decision|6|||
125907194|NCT02414139|452960507|FG003|Treatment Period|Physician Decision|1|||
125907195|NCT02414139|452960508|FG004|Treatment Period|Physician Decision|4|||
125907196|NCT02414139|452960509|FG005|Treatment Period|Physician Decision|0|||
125907197|NCT02414139|452960510|FG006|Treatment Period|Physician Decision|2|||
125907198|NCT02414139|452960511|FG007|Treatment Period|Physician Decision|0|||
125907199|NCT02414139|452960512|FG008|Treatment Period|Physician Decision|1|||
125907200|NCT02414139|452960513|FG009|Treatment Period|Physician Decision|4|||
125907201|NCT02414139|452960504|FG000|Treatment Period|Progressive disease|48|||
125907202|NCT02414139|452960505|FG001|Treatment Period|Progressive disease|31|||
125907203|NCT02414139|452960506|FG002|Treatment Period|Progressive disease|37|||
125907204|NCT02414139|452960507|FG003|Treatment Period|Progressive disease|21|||
125907205|NCT02414139|452960508|FG004|Treatment Period|Progressive disease|43|||
125907206|NCT02414139|452960509|FG005|Treatment Period|Progressive disease|12|||
125907207|NCT02414139|452960510|FG006|Treatment Period|Progressive disease|16|||
125907208|NCT02414139|452960511|FG007|Treatment Period|Progressive disease|2|||
125907209|NCT02414139|452960512|FG008|Treatment Period|Progressive disease|20|||
125907210|NCT02414139|452960513|FG009|Treatment Period|Progressive disease|14|||
125907211|NCT02414139|452960504|FG000|Treatment Period|Protocol deviation|0|||
125907212|NCT02414139|452960505|FG001|Treatment Period|Protocol deviation|0|||
125907213|NCT02414139|452960506|FG002|Treatment Period|Protocol deviation|1|||
125907214|NCT02414139|452960507|FG003|Treatment Period|Protocol deviation|0|||
125907215|NCT02414139|452960508|FG004|Treatment Period|Protocol deviation|0|||
125907216|NCT02414139|452960509|FG005|Treatment Period|Protocol deviation|0|||
125907217|NCT02414139|452960510|FG006|Treatment Period|Protocol deviation|0|||
125907218|NCT02414139|452960511|FG007|Treatment Period|Protocol deviation|0|||
125907219|NCT02414139|452960512|FG008|Treatment Period|Protocol deviation|0|||
125907220|NCT02414139|452960513|FG009|Treatment Period|Protocol deviation|0|||
125907221|NCT02414139|452960504|FG000|Treatment Period|Subject/Guardian decision|5|||
125907222|NCT02414139|452960505|FG001|Treatment Period|Subject/Guardian decision|1|||
126059990|NCT01836523|453514223|FG001|Overall Study|Met Withdrawal Criteria|13|||
126059991|NCT01836523|453514224|FG002|Overall Study|Met Withdrawal Criteria|21|||
126059992|NCT01836523|453514225|FG003|Overall Study|Met Withdrawal Criteria|27|||
125907223|NCT02414139|452960506|FG002|Treatment Period|Subject/Guardian decision|1|||
125907224|NCT02414139|452960507|FG003|Treatment Period|Subject/Guardian decision|2|||
125907225|NCT02414139|452960508|FG004|Treatment Period|Subject/Guardian decision|5|||
125907226|NCT02414139|452960509|FG005|Treatment Period|Subject/Guardian decision|0|||
125907227|NCT02414139|452960510|FG006|Treatment Period|Subject/Guardian decision|2|||
125907228|NCT02414139|452960511|FG007|Treatment Period|Subject/Guardian decision|0|||
125907229|NCT02414139|452960512|FG008|Treatment Period|Subject/Guardian decision|1|||
125907230|NCT02414139|452960513|FG009|Treatment Period|Subject/Guardian decision|1|||
125907231|NCT02414139|452960504|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125907232|NCT02414139|452960505|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125907233|NCT02414139|452960506|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
126059993|NCT01836523|453514222|FG000|Overall Study|Unclassified|17|||
125907234|NCT02414139|452960507|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125907235|NCT02414139|452960508|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
125907236|NCT02414139|452960509|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125907237|NCT02414139|452960510|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
125907238|NCT02414139|452960511|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125907239|NCT02414139|452960512|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
125907240|NCT02414139|452960513|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
125907241|NCT02414139|452960504|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
125907242|NCT02414139|452960505|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125907243|NCT02414139|452960506|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125907244|NCT02414139|452960507|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125907245|NCT02414139|452960508|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
125907246|NCT02414139|452960509|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125907247|NCT02414139|452960510|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125907248|NCT02414139|452960511|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125907249|NCT02414139|452960512|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125907250|NCT02414139|452960513|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125907251|NCT02414139|452960504|FG000|Post-treatment Efficacy Follow-up|Death|0|||
125907252|NCT02414139|452960505|FG001|Post-treatment Efficacy Follow-up|Death|1|||
125907253|NCT02414139|452960506|FG002|Post-treatment Efficacy Follow-up|Death|0|||
125907254|NCT02414139|452960507|FG003|Post-treatment Efficacy Follow-up|Death|0|||
125907255|NCT02414139|452960508|FG004|Post-treatment Efficacy Follow-up|Death|1|||
125907256|NCT02414139|452960509|FG005|Post-treatment Efficacy Follow-up|Death|0|||
125907257|NCT02414139|452960510|FG006|Post-treatment Efficacy Follow-up|Death|0|||
125907258|NCT02414139|452960511|FG007|Post-treatment Efficacy Follow-up|Death|0|||
125907259|NCT02414139|452960512|FG008|Post-treatment Efficacy Follow-up|Death|0|||
125907260|NCT02414139|452960513|FG009|Post-treatment Efficacy Follow-up|Death|1|||
125907261|NCT02414139|452960504|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
125907262|NCT02414139|452960505|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907263|NCT02414139|452960506|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907264|NCT02414139|452960507|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907265|NCT02414139|452960508|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907266|NCT02414139|452960509|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907267|NCT02414139|452960510|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907268|NCT02414139|452960511|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907269|NCT02414139|452960512|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907270|NCT02414139|452960513|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125907271|NCT02414139|452960504|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
125907272|NCT02414139|452960505|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125907273|NCT02414139|452960506|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
125907274|NCT02414139|452960507|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125907275|NCT02414139|452960508|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
125907276|NCT02414139|452960509|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125907277|NCT02414139|452960510|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125907278|NCT02414139|452960511|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125907279|NCT02414139|452960512|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125907280|NCT02414139|452960513|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125907281|NCT02414139|452960504|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
125907282|NCT02414139|452960505|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
125907283|NCT02414139|452960506|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
125907284|NCT02414139|452960507|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
125907285|NCT02414139|452960508|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
125907286|NCT02414139|452960509|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
125907287|NCT02414139|452960510|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
125907288|NCT02414139|452960511|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
125907289|NCT02414139|452960512|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
125907290|NCT02414139|452960513|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
125907291|NCT02414139|452960504|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125907292|NCT02414139|452960505|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
126059994|NCT01836523|453514223|FG001|Overall Study|Unclassified|28|||
126059995|NCT01836523|453514224|FG002|Overall Study|Unclassified|19|||
126059996|NCT01836523|453514225|FG003|Overall Study|Unclassified|29|||
126059997|NCT00813709|453514227|FG000|Double Blind Period|Adverse Event|4|||
126059998|NCT00813709|453514228|FG001|Double Blind Period|Adverse Event|1|||
126059999|NCT00813709|453514229|FG002|Double Blind Period|Adverse Event|4|||
126060000|NCT00813709|453514230|FG003|Double Blind Period|Adverse Event|0|||
125907293|NCT02414139|452960506|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126060001|NCT00813709|453514231|FG004|Double Blind Period|Adverse Event|0|||
125907294|NCT02414139|452960507|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125907295|NCT02414139|452960508|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125907296|NCT02414139|452960509|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125907297|NCT02414139|452960510|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125907298|NCT02414139|452960511|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125907299|NCT02414139|452960512|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125907300|NCT02414139|452960513|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
125907301|NCT02414139|452960504|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
125907302|NCT02414139|452960505|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125907303|NCT02414139|452960506|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
125907304|NCT02414139|452960507|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125907305|NCT02414139|452960508|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125907306|NCT02414139|452960509|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125907307|NCT02414139|452960510|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
125907308|NCT02414139|452960511|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
125907309|NCT02414139|452960512|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
125907310|NCT02414139|452960513|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125907311|NCT02632838|452960514|FG000|Overall Study|Withdrawal by Subject|3|||
125907312|NCT02632838|452960515|FG001|Overall Study|Withdrawal by Subject|0|||
125907313|NCT02632838|452960514|FG000|Overall Study|Lost to Follow-up|0|||
125907314|NCT02632838|452960515|FG001|Overall Study|Lost to Follow-up|2|||
125907315|NCT02810340|452960516|FG000|Overall Study|Withdrawal by Subject|1|||
125907316|NCT02810340|452960517|FG001|Overall Study|Withdrawal by Subject|0|||
125907317|NCT02810340|452960518|FG002|Overall Study|Withdrawal by Subject|0|||
125907318|NCT02810340|452960516|FG000|Overall Study|Incarceration|0|||
125907319|NCT02810340|452960517|FG001|Overall Study|Incarceration|1|||
125907320|NCT02810340|452960518|FG002|Overall Study|Incarceration|0|||
125907321|NCT02810340|452960516|FG000|Overall Study|Lost to Follow-up|0|||
125907322|NCT02810340|452960517|FG001|Overall Study|Lost to Follow-up|0|||
125907323|NCT02810340|452960518|FG002|Overall Study|Lost to Follow-up|1|||
125907324|NCT01484938|452960524|FG000|Overall Study|Adverse Event|2|||
125907325|NCT01484938|452960524|FG000|Overall Study|Lost to Follow-up|1|||
125907326|NCT01484938|452960524|FG000|Overall Study|Noncompliance|1|||
125907327|NCT02942576|452960525|FG000|Overall Study|Adverse Event|28|||
125907328|NCT02942576|452960526|FG001|Overall Study|Adverse Event|6|||
125907329|NCT02942576|452960525|FG000|Overall Study|Withdrawal by Subject|7|||
125907330|NCT02942576|452960526|FG001|Overall Study|Withdrawal by Subject|5|||
125907331|NCT02942576|452960525|FG000|Overall Study|Physician Decision|1|||
125907332|NCT02942576|452960526|FG001|Overall Study|Physician Decision|4|||
125907333|NCT02942576|452960525|FG000|Overall Study|Other|10|||
125907334|NCT02942576|452960526|FG001|Overall Study|Other|8|||
125907335|NCT00938964|452960527|FG000|Overall Study|Death|3|||
125907336|NCT00938964|452960528|FG001|Overall Study|Death|3|||
125907337|NCT00938964|452960527|FG000|Overall Study|Lost to Follow-up|2|||
125907338|NCT00938964|452960528|FG001|Overall Study|Lost to Follow-up|3|||
125907339|NCT00938964|452960527|FG000|Overall Study|Withdrawal by Subject|22|||
126060002|NCT00813709|453514232|FG005|Double Blind Period|Adverse Event|0|||
126060003|NCT00813709|453514227|FG000|Double Blind Period|Lost to Follow-up|3|||
126060004|NCT00813709|453514228|FG001|Double Blind Period|Lost to Follow-up|2|||
126060005|NCT00813709|453514229|FG002|Double Blind Period|Lost to Follow-up|2|||
125907340|NCT00938964|452960528|FG001|Overall Study|Withdrawal by Subject|18|||
125907341|NCT00938964|452960527|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
125907342|NCT00938964|452960528|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
125907343|NCT01227564|452960534|FG000|Overall Study|No Longer Willing to Participate|4|||
125907344|NCT01227564|452960535|FG001|Overall Study|No Longer Willing to Participate|2|||
125907345|NCT01227564|452960536|FG002|Overall Study|No Longer Willing to Participate|5|||
125907346|NCT01227564|452960534|FG000|Overall Study|Participant moved to another town|0|||
125907347|NCT01227564|452960535|FG001|Overall Study|Participant moved to another town|0|||
125907348|NCT01227564|452960536|FG002|Overall Study|Participant moved to another town|1|||
125907349|NCT00772070|452960547|FG000|Overall Study|Lost to Follow-up|0|||
126060006|NCT00813709|453514230|FG003|Double Blind Period|Lost to Follow-up|0|||
126060007|NCT00813709|453514231|FG004|Double Blind Period|Lost to Follow-up|0|||
126060008|NCT00813709|453514232|FG005|Double Blind Period|Lost to Follow-up|0|||
125907350|NCT00772070|452960548|FG001|Overall Study|Lost to Follow-up|8|||
125907351|NCT00772070|452960547|FG000|Overall Study|Withdrawal by Subject|0|||
125907352|NCT00772070|452960548|FG001|Overall Study|Withdrawal by Subject|2|||
125907353|NCT00772070|452960547|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
125907354|NCT00772070|452960548|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
126060009|NCT00813709|453514227|FG000|Double Blind Period|Switched to open label phase|9|||
125907355|NCT01309308|452960549|FG000|Overall Study|Lost to Follow-up|6|||
125907356|NCT01309308|452960550|FG001|Overall Study|Lost to Follow-up|4|||
125907357|NCT01017575|452960551|FG000|Overall Study|Lack of Efficacy|0|||
126060010|NCT00813709|453514228|FG001|Double Blind Period|Switched to open label phase|26|||
125907358|NCT01017575|452960552|FG001|Overall Study|Lack of Efficacy|1|||
125907359|NCT01017575|452960553|FG002|Overall Study|Lack of Efficacy|0|||
125907360|NCT01017575|452960554|FG003|Overall Study|Lack of Efficacy|1|||
125907361|NCT01017575|452960555|FG004|Overall Study|Lack of Efficacy|1|||
125907362|NCT01017575|452960551|FG000|Overall Study|Adverse Event|0|||
125907363|NCT01017575|452960552|FG001|Overall Study|Adverse Event|1|||
125907364|NCT01017575|452960553|FG002|Overall Study|Adverse Event|0|||
125907365|NCT01017575|452960554|FG003|Overall Study|Adverse Event|0|||
125907366|NCT01017575|452960555|FG004|Overall Study|Adverse Event|2|||
125907367|NCT01017575|452960551|FG000|Overall Study|Withdrawal by Subject|1|||
125907368|NCT01017575|452960552|FG001|Overall Study|Withdrawal by Subject|0|||
125907369|NCT01017575|452960553|FG002|Overall Study|Withdrawal by Subject|0|||
125907370|NCT01017575|452960554|FG003|Overall Study|Withdrawal by Subject|0|||
125907371|NCT01017575|452960555|FG004|Overall Study|Withdrawal by Subject|0|||
125907372|NCT00495131|452960556|FG000|Overall Study|Adverse Event|6|||
125907373|NCT00495131|452960557|FG001|Overall Study|Adverse Event|2|||
125907374|NCT00495131|452960556|FG000|Overall Study|Lack of Efficacy|0|||
125907375|NCT00495131|452960557|FG001|Overall Study|Lack of Efficacy|2|||
125907376|NCT00495131|452960556|FG000|Overall Study|Lost to Follow-up|0|||
125907377|NCT00495131|452960557|FG001|Overall Study|Lost to Follow-up|2|||
125907378|NCT00495131|452960556|FG000|Overall Study|Withdrawal by Subject|1|||
125907379|NCT00495131|452960557|FG001|Overall Study|Withdrawal by Subject|0|||
125907380|NCT00744471|452960558|FG000|Overall Study|Randomized but not treated|1|||
125907381|NCT00744471|452960559|FG001|Overall Study|Randomized but not treated|1|||
125907382|NCT00744471|452960560|FG002|Overall Study|Randomized but not treated|4|||
125907383|NCT00744471|452960561|FG003|Overall Study|Randomized but not treated|0|||
125907384|NCT00744471|452960558|FG000|Overall Study|Death|0|||
125907385|NCT00744471|452960559|FG001|Overall Study|Death|0|||
125907386|NCT00744471|452960560|FG002|Overall Study|Death|0|||
125907387|NCT00744471|452960561|FG003|Overall Study|Death|1|||
125907388|NCT00744471|452960558|FG000|Overall Study|Adverse Event|6|||
125907389|NCT00744471|452960559|FG001|Overall Study|Adverse Event|7|||
125907390|NCT00744471|452960560|FG002|Overall Study|Adverse Event|5|||
125907391|NCT00744471|452960561|FG003|Overall Study|Adverse Event|9|||
125907392|NCT00744471|452960558|FG000|Overall Study|Withdrawal by Subject|9|||
125907393|NCT00744471|452960559|FG001|Overall Study|Withdrawal by Subject|9|||
125907394|NCT00744471|452960560|FG002|Overall Study|Withdrawal by Subject|15|||
125907395|NCT00744471|452960561|FG003|Overall Study|Withdrawal by Subject|12|||
125907396|NCT00744471|452960558|FG000|Overall Study|Protocol Violation|1|||
125907397|NCT00744471|452960559|FG001|Overall Study|Protocol Violation|4|||
125907398|NCT00744471|452960560|FG002|Overall Study|Protocol Violation|1|||
125907399|NCT00744471|452960561|FG003|Overall Study|Protocol Violation|2|||
125907400|NCT00744471|452960558|FG000|Overall Study|Entered extension study|41|||
125907401|NCT00744471|452960559|FG001|Overall Study|Entered extension study|84|||
125907402|NCT00744471|452960560|FG002|Overall Study|Entered extension study|100|||
125907403|NCT00744471|452960561|FG003|Overall Study|Entered extension study|91|||
125907404|NCT00744471|452960558|FG000|Overall Study|Other|2|||
125907405|NCT00744471|452960559|FG001|Overall Study|Other|3|||
125907406|NCT00744471|452960560|FG002|Overall Study|Other|6|||
125907407|NCT00744471|452960561|FG003|Overall Study|Other|2|||
125907408|NCT00744471|452960558|FG000|Overall Study|Lack of Efficacy|83|||
125907409|NCT00744471|452960559|FG001|Overall Study|Lack of Efficacy|37|||
126060011|NCT00813709|453514229|FG002|Double Blind Period|Switched to open label phase|18|||
125907410|NCT00744471|452960560|FG002|Overall Study|Lack of Efficacy|19|||
125907411|NCT00744471|452960561|FG003|Overall Study|Lack of Efficacy|31|||
125907412|NCT00744471|452960558|FG000|Overall Study|Lost to Follow-up|0|||
125907413|NCT00744471|452960559|FG001|Overall Study|Lost to Follow-up|0|||
125907414|NCT00744471|452960560|FG002|Overall Study|Lost to Follow-up|2|||
125907415|NCT00744471|452960561|FG003|Overall Study|Lost to Follow-up|0|||
125907416|NCT04706416|452960566|FG000|Overall Study|Lost to Follow-up|2|||
125907417|NCT04706416|452960567|FG001|Overall Study|Lost to Follow-up|0|||
125907418|NCT01539317|452960571|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
125907419|NCT01539317|452960572|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
125907420|NCT00976573|452960579|FG000|Overall Study|Ineligible|0|||
125907421|NCT00976573|452960580|FG001|Overall Study|Ineligible|1|||
125907422|NCT00976573|452960579|FG000|Overall Study|Cancel prior to receiving treatment|4|||
125907423|NCT00976573|452960580|FG001|Overall Study|Cancel prior to receiving treatment|2|||
125907424|NCT02117427|452960581|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
125907425|NCT02117427|452960582|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
125907426|NCT02117427|452960583|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
125907427|NCT02117427|452960581|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
125907428|NCT02117427|452960582|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
125907429|NCT02117427|452960583|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
125907430|NCT02117427|452960581|FG000|Overall Study|Physician Decision|0|||
125907431|NCT02117427|452960582|FG001|Overall Study|Physician Decision|2|||
125907432|NCT02117427|452960583|FG002|Overall Study|Physician Decision|0|||
125907433|NCT02117427|452960581|FG000|Overall Study|No longer meets inclusion criteria|0|||
126060012|NCT00813709|453514230|FG003|Double Blind Period|Switched to open label phase|0|||
126060013|NCT00813709|453514231|FG004|Double Blind Period|Switched to open label phase|0|||
126060014|NCT00813709|453514232|FG005|Double Blind Period|Switched to open label phase|0|||
126060015|NCT00813709|453514227|FG000|Double Blind Period|Randomized but not treated|1|||
125907434|NCT02117427|452960582|FG001|Overall Study|No longer meets inclusion criteria|1|||
125907435|NCT02117427|452960583|FG002|Overall Study|No longer meets inclusion criteria|0|||
125907436|NCT02117427|452960581|FG000|Overall Study|Death|0|||
125907437|NCT02117427|452960582|FG001|Overall Study|Death|1|||
125907438|NCT02117427|452960583|FG002|Overall Study|Death|0|||
125907439|NCT00937391|452960592|FG000|Stage 2|Withdrawal by Subject|1|||
125907440|NCT02211638|452960593|FG000|Overall Study|Case Report Forms Uncollected|291|||
125907441|NCT02211638|452960593|FG000|Overall Study|Protocol Violation|692|||
125907442|NCT04041700|452960596|FG000|Overall Study|Pregnancy|1|||
125907443|NCT04041700|452960596|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
125907444|NCT02775903|452960597|FG000|Overall Study|Death|7|||
125907445|NCT02775903|452960598|FG001|Overall Study|Death|11|||
125907446|NCT02775903|452960599|FG002|Overall Study|Death|12|||
125907447|NCT02775903|452960600|FG003|Overall Study|Death|11|||
125907448|NCT02775903|452960597|FG000|Overall Study|Adverse Event|0|||
125907449|NCT02775903|452960598|FG001|Overall Study|Adverse Event|1|||
125907450|NCT02775903|452960599|FG002|Overall Study|Adverse Event|12|||
125907451|NCT02775903|452960600|FG003|Overall Study|Adverse Event|3|||
125907452|NCT02775903|452960597|FG000|Overall Study|Progressive disease|15|||
125907453|NCT02775903|452960598|FG001|Overall Study|Progressive disease|14|||
125907454|NCT02775903|452960599|FG002|Overall Study|Progressive disease|30|||
125907455|NCT02775903|452960600|FG003|Overall Study|Progressive disease|20|||
125907456|NCT02775903|452960597|FG000|Overall Study|Lack of Efficacy|2|||
125907457|NCT02775903|452960598|FG001|Overall Study|Lack of Efficacy|2|||
125907458|NCT02775903|452960599|FG002|Overall Study|Lack of Efficacy|2|||
125907459|NCT02775903|452960600|FG003|Overall Study|Lack of Efficacy|6|||
125907460|NCT02775903|452960597|FG000|Overall Study|Withdrawal by Subject|7|||
125907461|NCT02775903|452960598|FG001|Overall Study|Withdrawal by Subject|5|||
125907462|NCT02775903|452960599|FG002|Overall Study|Withdrawal by Subject|5|||
125907463|NCT02775903|452960600|FG003|Overall Study|Withdrawal by Subject|8|||
125907464|NCT02775903|452960597|FG000|Overall Study|Other reasons|7|||
125907465|NCT02775903|452960598|FG001|Overall Study|Other reasons|8|||
125907466|NCT02775903|452960599|FG002|Overall Study|Other reasons|2|||
125907467|NCT02775903|452960600|FG003|Overall Study|Other reasons|12|||
125907468|NCT04571515|452960603|FG000|Overall Study|Physician Decision|0|||
125907469|NCT04571515|452960604|FG001|Overall Study|Physician Decision|0|||
125907470|NCT04571515|452960605|FG002|Overall Study|Physician Decision|0|||
125907471|NCT04571515|452960606|FG003|Overall Study|Physician Decision|0|||
125907472|NCT04571515|452960607|FG004|Overall Study|Physician Decision|1|||
126060016|NCT00813709|453514228|FG001|Double Blind Period|Randomized but not treated|3|||
126060017|NCT00813709|453514229|FG002|Double Blind Period|Randomized but not treated|1|||
126060018|NCT00813709|453514230|FG003|Double Blind Period|Randomized but not treated|0|||
126060019|NCT00813709|453514231|FG004|Double Blind Period|Randomized but not treated|0|||
126060020|NCT00813709|453514232|FG005|Double Blind Period|Randomized but not treated|0|||
126060021|NCT00813709|453514227|FG000|Double Blind Period|Other|14|||
125907473|NCT04571515|452960603|FG000|Overall Study|Withdrawal by Subject|0|||
125907474|NCT04571515|452960604|FG001|Overall Study|Withdrawal by Subject|0|||
125907475|NCT04571515|452960605|FG002|Overall Study|Withdrawal by Subject|0|||
125907476|NCT04571515|452960606|FG003|Overall Study|Withdrawal by Subject|0|||
125907477|NCT04571515|452960607|FG004|Overall Study|Withdrawal by Subject|1|||
125907478|NCT04571515|452960603|FG000|Overall Study|insufficient pain|1|||
125907479|NCT04571515|452960604|FG001|Overall Study|insufficient pain|0|||
126060022|NCT00813709|453514228|FG001|Double Blind Period|Other|9|||
126060023|NCT00813709|453514229|FG002|Double Blind Period|Other|6|||
126060024|NCT00813709|453514230|FG003|Double Blind Period|Other|0|||
126060025|NCT00813709|453514231|FG004|Double Blind Period|Other|0|||
126060026|NCT00813709|453514232|FG005|Double Blind Period|Other|0|||
126060027|NCT00813709|453514227|FG000|Open Label Period|Adverse Event|0|||
126060028|NCT00813709|453514228|FG001|Open Label Period|Adverse Event|0|||
126060029|NCT00813709|453514229|FG002|Open Label Period|Adverse Event|0|||
126060030|NCT00813709|453514230|FG003|Open Label Period|Adverse Event|5|||
125907480|NCT04571515|452960605|FG002|Overall Study|insufficient pain|0|||
125907481|NCT04571515|452960606|FG003|Overall Study|insufficient pain|0|||
125907482|NCT04571515|452960607|FG004|Overall Study|insufficient pain|1|||
125907483|NCT05140382|452960608|FG000|Overall Study|Death|3|||
125907484|NCT05140382|452960609|FG001|Overall Study|Death|0|||
125907485|NCT05140382|452960610|FG002|Overall Study|Death|0|||
125907486|NCT05140382|452960608|FG000|Overall Study|Investigator decision|1|||
125907487|NCT05140382|452960609|FG001|Overall Study|Investigator decision|0|||
125907488|NCT05140382|452960610|FG002|Overall Study|Investigator decision|0|||
125907489|NCT05140382|452960608|FG000|Overall Study|Other|4|||
125907490|NCT05140382|452960609|FG001|Overall Study|Other|0|||
125907491|NCT05140382|452960610|FG002|Overall Study|Other|1|||
125907492|NCT05140382|452960608|FG000|Overall Study|Progressive disease|20|||
125907493|NCT05140382|452960609|FG001|Overall Study|Progressive disease|1|||
125907494|NCT05140382|452960610|FG002|Overall Study|Progressive disease|12|||
125907495|NCT05140382|452960608|FG000|Overall Study|Subjective disease progression|2|||
125907496|NCT05140382|452960609|FG001|Overall Study|Subjective disease progression|1|||
125907497|NCT05140382|452960610|FG002|Overall Study|Subjective disease progression|0|||
125907498|NCT05140382|452960608|FG000|Overall Study|Unknown at data cut-off|0|||
125907499|NCT05140382|452960609|FG001|Overall Study|Unknown at data cut-off|0|||
125907500|NCT05140382|452960610|FG002|Overall Study|Unknown at data cut-off|1|||
126060031|NCT00813709|453514231|FG004|Open Label Period|Adverse Event|4|||
126060032|NCT00813709|453514232|FG005|Open Label Period|Adverse Event|3|||
125907501|NCT05140382|452960608|FG000|Overall Study|Withdrawal by Subject|1|||
125907502|NCT05140382|452960609|FG001|Overall Study|Withdrawal by Subject|0|||
125907503|NCT05140382|452960610|FG002|Overall Study|Withdrawal by Subject|4|||
125907504|NCT05140382|452960608|FG000|Overall Study|Withdrawal of consent|0|||
125907505|NCT05140382|452960609|FG001|Overall Study|Withdrawal of consent|0|||
125907506|NCT05140382|452960610|FG002|Overall Study|Withdrawal of consent|1|||
125907507|NCT01683019|452961905|FG000|Overall Study|Withdrawal by Subject|2|||
125907508|NCT01683019|452961906|FG001|Overall Study|Withdrawal by Subject|1|||
125907509|NCT01683019|452961907|FG002|Overall Study|Withdrawal by Subject|4|||
125907510|NCT00543855|452961908|FG000|Overall Study|Adverse Event|3|||
125907511|NCT00543855|452961909|FG001|Overall Study|Adverse Event|1|||
125907512|NCT00543855|452961910|FG002|Overall Study|Adverse Event|3|||
125907513|NCT00543855|452961911|FG003|Overall Study|Adverse Event|4|||
125907514|NCT00543855|452961908|FG000|Overall Study|Lost to Follow-up|0|||
125907515|NCT00543855|452961909|FG001|Overall Study|Lost to Follow-up|0|||
125907516|NCT00543855|452961910|FG002|Overall Study|Lost to Follow-up|1|||
125907517|NCT00543855|452961911|FG003|Overall Study|Lost to Follow-up|0|||
125907518|NCT00543855|452961908|FG000|Overall Study|Withdrawal by Subject|0|||
125907519|NCT00543855|452961909|FG001|Overall Study|Withdrawal by Subject|1|||
125907520|NCT00543855|452961910|FG002|Overall Study|Withdrawal by Subject|2|||
125907521|NCT00543855|452961911|FG003|Overall Study|Withdrawal by Subject|0|||
125907522|NCT00543855|452961908|FG000|Overall Study|Protocol Violation|1|||
125907523|NCT00543855|452961909|FG001|Overall Study|Protocol Violation|0|||
125907524|NCT00543855|452961910|FG002|Overall Study|Protocol Violation|0|||
125907525|NCT00543855|452961911|FG003|Overall Study|Protocol Violation|0|||
125907526|NCT04444895|452961913|FG000|Overall Study|Adverse Event|2|||
125907527|NCT04444895|452961913|FG000|Overall Study|Lost to Follow-up|2|||
125907528|NCT04444895|452961913|FG000|Overall Study|Withdrawal by Subject|5|||
125907529|NCT03954041|452961917|FG000|Overall Study|Lost to Follow-up|3|||
125907530|NCT03954041|452961918|FG001|Overall Study|Lost to Follow-up|3|||
125907531|NCT03954041|452961919|FG002|Overall Study|Lost to Follow-up|6|||
125907532|NCT03954041|452961917|FG000|Overall Study|Death|4|||
125907533|NCT03954041|452961918|FG001|Overall Study|Death|0|||
125907534|NCT03954041|452961919|FG002|Overall Study|Death|1|||
125907535|NCT03954041|452961917|FG000|Overall Study|Death by neurologic criteria|0|||
125907536|NCT03954041|452961918|FG001|Overall Study|Death by neurologic criteria|0|||
125907537|NCT03954041|452961919|FG002|Overall Study|Death by neurologic criteria|1|||
125907538|NCT03954041|452961917|FG000|Overall Study|Reason not specified|7|||
125907539|NCT03954041|452961918|FG001|Overall Study|Reason not specified|4|||
125907540|NCT03954041|452961919|FG002|Overall Study|Reason not specified|2|||
125907541|NCT03954041|452961917|FG000|Overall Study|Withdrew prior to dosing|4|||
125907542|NCT03954041|452961918|FG001|Overall Study|Withdrew prior to dosing|2|||
125907543|NCT03954041|452961919|FG002|Overall Study|Withdrew prior to dosing|0|||
125907544|NCT00427960|452961921|FG000|Overall Study|Adverse Event|2|||
125907545|NCT00427960|452961922|FG001|Overall Study|Adverse Event|0|||
125907546|NCT00427960|452961921|FG000|Overall Study|Withdrawal by Subject|0|||
125907547|NCT00427960|452961922|FG001|Overall Study|Withdrawal by Subject|3|||
125907548|NCT00427960|452961921|FG000|Overall Study|Other|0|||
125907549|NCT00427960|452961922|FG001|Overall Study|Other|1|||
125907550|NCT00423670|452961923|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
125907551|NCT00423670|452961924|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
125907552|NCT00423670|452961925|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
125907553|NCT00423670|452961926|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
125907554|NCT00423670|452961927|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
125907555|NCT00423670|452961928|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
125907556|NCT00423670|452961929|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
125907557|NCT00423670|452961930|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
125907558|NCT00423670|452961923|FG000|Treatment Period|Adverse Event|8|||
125907559|NCT00423670|452961924|FG001|Treatment Period|Adverse Event|12|||
125907560|NCT00423670|452961925|FG002|Treatment Period|Adverse Event|15|||
125907561|NCT00423670|452961926|FG003|Treatment Period|Adverse Event|20|||
125907562|NCT00423670|452961927|FG004|Treatment Period|Adverse Event|9|||
125907563|NCT00423670|452961928|FG005|Treatment Period|Adverse Event|4|||
125907564|NCT00423670|452961929|FG006|Treatment Period|Adverse Event|7|||
125907565|NCT00423670|452961930|FG007|Treatment Period|Adverse Event|2|||
125907566|NCT00423670|452961923|FG000|Treatment Period|Protocol-defined clinical event|0|||
125907567|NCT00423670|452961924|FG001|Treatment Period|Protocol-defined clinical event|7|||
125907568|NCT00423670|452961925|FG002|Treatment Period|Protocol-defined clinical event|4|||
125907569|NCT00423670|452961926|FG003|Treatment Period|Protocol-defined clinical event|12|||
125907570|NCT00423670|452961927|FG004|Treatment Period|Protocol-defined clinical event|5|||
125907571|NCT00423670|452961928|FG005|Treatment Period|Protocol-defined clinical event|4|||
125907572|NCT00423670|452961929|FG006|Treatment Period|Protocol-defined clinical event|16|||
125907573|NCT00423670|452961930|FG007|Treatment Period|Protocol-defined clinical event|15|||
126060033|NCT00813709|453514227|FG000|Open Label Period|Lack of Efficacy|0|||
126060034|NCT00813709|453514228|FG001|Open Label Period|Lack of Efficacy|0|||
126060035|NCT00813709|453514229|FG002|Open Label Period|Lack of Efficacy|0|||
126060036|NCT00813709|453514230|FG003|Open Label Period|Lack of Efficacy|3|||
126060037|NCT00813709|453514231|FG004|Open Label Period|Lack of Efficacy|1|||
126060038|NCT00813709|453514232|FG005|Open Label Period|Lack of Efficacy|1|||
126060039|NCT00813709|453514227|FG000|Open Label Period|Randomized but not treated|0|||
126060040|NCT00813709|453514228|FG001|Open Label Period|Randomized but not treated|0|||
126060041|NCT00813709|453514229|FG002|Open Label Period|Randomized but not treated|0|||
126060042|NCT00813709|453514230|FG003|Open Label Period|Randomized but not treated|1|||
126060043|NCT00813709|453514231|FG004|Open Label Period|Randomized but not treated|0|||
126060044|NCT00813709|453514232|FG005|Open Label Period|Randomized but not treated|1|||
126060045|NCT00813709|453514227|FG000|Open Label Period|Other|0|||
125907574|NCT00423670|452961923|FG000|Treatment Period|Lost to Follow-up|2|||
125907575|NCT00423670|452961924|FG001|Treatment Period|Lost to Follow-up|1|||
125907576|NCT00423670|452961925|FG002|Treatment Period|Lost to Follow-up|3|||
125907577|NCT00423670|452961926|FG003|Treatment Period|Lost to Follow-up|1|||
125907578|NCT00423670|452961927|FG004|Treatment Period|Lost to Follow-up|6|||
125907579|NCT00423670|452961928|FG005|Treatment Period|Lost to Follow-up|0|||
125907580|NCT00423670|452961929|FG006|Treatment Period|Lost to Follow-up|3|||
125907581|NCT00423670|452961930|FG007|Treatment Period|Lost to Follow-up|1|||
125907582|NCT00423670|452961923|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
125907583|NCT00423670|452961924|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
125907584|NCT00423670|452961925|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
125907585|NCT00423670|452961926|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
125907586|NCT00423670|452961927|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
125907587|NCT00423670|452961928|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
125907588|NCT00423670|452961929|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
125907589|NCT00423670|452961930|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
125907590|NCT00423670|452961923|FG000|Treatment Period|Investigator decision|0|||
125907591|NCT00423670|452961924|FG001|Treatment Period|Investigator decision|0|||
125907592|NCT00423670|452961925|FG002|Treatment Period|Investigator decision|0|||
125907593|NCT00423670|452961926|FG003|Treatment Period|Investigator decision|0|||
125907594|NCT00423670|452961927|FG004|Treatment Period|Investigator decision|0|||
125907595|NCT00423670|452961928|FG005|Treatment Period|Investigator decision|0|||
125907596|NCT00423670|452961929|FG006|Treatment Period|Investigator decision|0|||
125907597|NCT00423670|452961930|FG007|Treatment Period|Investigator decision|1|||
125907598|NCT00423670|452961923|FG000|Treatment Period|Non-compliance with protocol|3|||
125907599|NCT00423670|452961924|FG001|Treatment Period|Non-compliance with protocol|1|||
125907600|NCT00423670|452961925|FG002|Treatment Period|Non-compliance with protocol|1|||
125907601|NCT00423670|452961926|FG003|Treatment Period|Non-compliance with protocol|3|||
125907602|NCT00423670|452961927|FG004|Treatment Period|Non-compliance with protocol|2|||
125907603|NCT00423670|452961928|FG005|Treatment Period|Non-compliance with protocol|0|||
125907604|NCT00423670|452961929|FG006|Treatment Period|Non-compliance with protocol|2|||
125907605|NCT00423670|452961930|FG007|Treatment Period|Non-compliance with protocol|2|||
125907606|NCT00423670|452961923|FG000|Follow-up Period|Lost to Follow-up|0|||
125907607|NCT00423670|452961924|FG001|Follow-up Period|Lost to Follow-up|12|||
125907608|NCT00423670|452961925|FG002|Follow-up Period|Lost to Follow-up|8|||
125907609|NCT00423670|452961926|FG003|Follow-up Period|Lost to Follow-up|3|||
125907610|NCT00423670|452961927|FG004|Follow-up Period|Lost to Follow-up|1|||
126060046|NCT00813709|453514228|FG001|Open Label Period|Other|0|||
125907611|NCT00423670|452961928|FG005|Follow-up Period|Lost to Follow-up|0|||
125907612|NCT00423670|452961929|FG006|Follow-up Period|Lost to Follow-up|5|||
125907613|NCT00423670|452961930|FG007|Follow-up Period|Lost to Follow-up|0|||
126060047|NCT00813709|453514229|FG002|Open Label Period|Other|0|||
126060048|NCT00813709|453514230|FG003|Open Label Period|Other|11|||
126060049|NCT00813709|453514231|FG004|Open Label Period|Other|5|||
125907614|NCT00423670|452961923|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
125907615|NCT00423670|452961924|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
125907616|NCT00423670|452961925|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
126060050|NCT00813709|453514232|FG005|Open Label Period|Other|6|||
126060051|NCT02753075|453514233|FG000|Overall Study|Adverse Event|2|||
125907617|NCT00423670|452961926|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
125907618|NCT00423670|452961927|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
125907619|NCT00423670|452961928|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
125907620|NCT00423670|452961929|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
125907621|NCT00423670|452961930|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
125907622|NCT00423670|452961923|FG000|Follow-up Period|Non-compliance with protocol|2|||
125907623|NCT00423670|452961924|FG001|Follow-up Period|Non-compliance with protocol|0|||
125907624|NCT00423670|452961925|FG002|Follow-up Period|Non-compliance with protocol|1|||
125907625|NCT00423670|452961926|FG003|Follow-up Period|Non-compliance with protocol|1|||
125907626|NCT00423670|452961927|FG004|Follow-up Period|Non-compliance with protocol|0|||
125907627|NCT00423670|452961928|FG005|Follow-up Period|Non-compliance with protocol|0|||
125907628|NCT00423670|452961929|FG006|Follow-up Period|Non-compliance with protocol|3|||
125907629|NCT00423670|452961930|FG007|Follow-up Period|Non-compliance with protocol|2|||
125907630|NCT04163718|452961931|FG000|Overall Study|Study terminated|12|||
125907631|NCT01058265|452961932|FG000|Overall Study|Lost to Follow-up|11|||
125907632|NCT01058265|452961933|FG001|Overall Study|Lost to Follow-up|12|||
125907633|NCT02962765|452961934|FG000|Overall Study|Protocol Violation|9|||
125907634|NCT02962765|452961934|FG000|Overall Study|Withdrawal by Subject|3|||
125907635|NCT02962765|452961934|FG000|Overall Study|Lost to Follow-up|1|||
125907636|NCT02962765|452961934|FG000|Overall Study|Death|1|||
125907637|NCT02962765|452961934|FG000|Overall Study|Limited access to study medication|3|||
125907638|NCT00750880|452961937|FG000|Overall Study|Adverse Event|76|||
125907639|NCT00750880|452961937|FG000|Overall Study|Death|4|||
125907640|NCT00750880|452961937|FG000|Overall Study|Lack of Efficacy|46|||
125907641|NCT00750880|452961937|FG000|Overall Study|Lost to Follow-up|10|||
125907642|NCT00750880|452961937|FG000|Overall Study|Protocol Violation|15|||
125907643|NCT00750880|452961937|FG000|Overall Study|Withdrawal by Subject|33|||
125907644|NCT00750880|452961937|FG000|Overall Study|Physician Decision|20|||
125907645|NCT00750880|452961937|FG000|Overall Study|Administrative|11|||
125907646|NCT00984568|452961941|FG000|Overall Study|Withdrawal by Subject|1|||
125907647|NCT00984568|452961942|FG001|Overall Study|Withdrawal by Subject|2|||
125907648|NCT00984568|452961941|FG000|Overall Study|Lack of Efficacy|2|||
125907649|NCT00984568|452961942|FG001|Overall Study|Lack of Efficacy|0|||
125907650|NCT00984568|452961941|FG000|Overall Study|Adverse Event|2|||
125907651|NCT00984568|452961942|FG001|Overall Study|Adverse Event|0|||
125907652|NCT00984568|452961941|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
125907653|NCT00984568|452961942|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
125907654|NCT00984568|452961941|FG000|Overall Study|Lost to Follow-up|0|||
125907655|NCT00984568|452961942|FG001|Overall Study|Lost to Follow-up|1|||
125907656|NCT00984568|452961941|FG000|Overall Study|Opportunistic Infection|1|||
125907657|NCT00984568|452961942|FG001|Overall Study|Opportunistic Infection|0|||
125907658|NCT00984568|452961941|FG000|Overall Study|Unknown Reason|1|||
125907659|NCT00984568|452961942|FG001|Overall Study|Unknown Reason|3|||
125907660|NCT02964507|452961943|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
125907661|NCT02964507|452961944|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
125907662|NCT02964507|452961945|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
125907663|NCT02964507|452961946|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
125907664|NCT02964507|452961947|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
125907665|NCT02964507|452961948|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
125907666|NCT02964507|452961949|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
125907667|NCT02964507|452961950|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
125907668|NCT02964507|452961943|FG000|Overall Study|Study terminated by Sponsor|9|||
125907669|NCT02964507|452961944|FG001|Overall Study|Study terminated by Sponsor|1|||
125907670|NCT02964507|452961945|FG002|Overall Study|Study terminated by Sponsor|9|||
125907671|NCT02964507|452961946|FG003|Overall Study|Study terminated by Sponsor|3|||
125907672|NCT02964507|452961947|FG004|Overall Study|Study terminated by Sponsor|3|||
125907673|NCT02964507|452961948|FG005|Overall Study|Study terminated by Sponsor|2|||
125907674|NCT02964507|452961949|FG006|Overall Study|Study terminated by Sponsor|0|||
125907675|NCT02964507|452961950|FG007|Overall Study|Study terminated by Sponsor|0|||
125907676|NCT02964507|452961943|FG000|Overall Study|Other|3|||
125907677|NCT02964507|452961944|FG001|Overall Study|Other|0|||
125907678|NCT02964507|452961945|FG002|Overall Study|Other|0|||
125907679|NCT02964507|452961946|FG003|Overall Study|Other|0|||
125907680|NCT02964507|452961947|FG004|Overall Study|Other|1|||
125907681|NCT02964507|452961948|FG005|Overall Study|Other|0|||
125907682|NCT02964507|452961949|FG006|Overall Study|Other|0|||
125907683|NCT02964507|452961950|FG007|Overall Study|Other|0|||
125907684|NCT02964507|452961943|FG000|Overall Study|Death|11|||
125907685|NCT02964507|452961944|FG001|Overall Study|Death|9|||
125907686|NCT02964507|452961945|FG002|Overall Study|Death|12|||
125907687|NCT02964507|452961946|FG003|Overall Study|Death|2|||
125907688|NCT02964507|452961947|FG004|Overall Study|Death|10|||
125907689|NCT02964507|452961948|FG005|Overall Study|Death|5|||
125907690|NCT02964507|452961949|FG006|Overall Study|Death|0|||
125907691|NCT02964507|452961950|FG007|Overall Study|Death|0|||
125907692|NCT02964507|452961943|FG000|Overall Study|Withdrawal by Subject|1|||
126060052|NCT02753075|453514234|FG001|Overall Study|Adverse Event|1|||
125907693|NCT02964507|452961944|FG001|Overall Study|Withdrawal by Subject|0|||
125907694|NCT02964507|452961945|FG002|Overall Study|Withdrawal by Subject|1|||
125907695|NCT02964507|452961946|FG003|Overall Study|Withdrawal by Subject|1|||
125907696|NCT02964507|452961947|FG004|Overall Study|Withdrawal by Subject|0|||
125907697|NCT02964507|452961948|FG005|Overall Study|Withdrawal by Subject|1|||
125907698|NCT02964507|452961949|FG006|Overall Study|Withdrawal by Subject|0|||
125907699|NCT02964507|452961950|FG007|Overall Study|Withdrawal by Subject|0|||
125907700|NCT02964507|452961943|FG000|Overall Study|Physician Decision|2|||
125907701|NCT02964507|452961944|FG001|Overall Study|Physician Decision|0|||
125907702|NCT02964507|452961945|FG002|Overall Study|Physician Decision|3|||
125907703|NCT02964507|452961946|FG003|Overall Study|Physician Decision|0|||
125907704|NCT02964507|452961947|FG004|Overall Study|Physician Decision|1|||
125907705|NCT02964507|452961948|FG005|Overall Study|Physician Decision|0|||
125907706|NCT02964507|452961949|FG006|Overall Study|Physician Decision|0|||
125907707|NCT02964507|452961950|FG007|Overall Study|Physician Decision|0|||
125907708|NCT02675231|452961951|FG000|Overall Study|Withdrawal by Subject|2|||
125907709|NCT02675231|452961952|FG001|Overall Study|Withdrawal by Subject|4|||
125907710|NCT02675231|452961953|FG002|Overall Study|Withdrawal by Subject|2|||
125907711|NCT02675231|452961951|FG000|Overall Study|Lost to Follow-up|3|||
125907712|NCT02675231|452961952|FG001|Overall Study|Lost to Follow-up|4|||
125907713|NCT02675231|452961953|FG002|Overall Study|Lost to Follow-up|3|||
125907714|NCT02495233|452961956|FG000|Overall Study|Miscellaneous|0|||
125907715|NCT02495233|452961957|FG001|Overall Study|Miscellaneous|1|||
125907716|NCT03880461|452961959|FG000|Overall Study|Determined ineligible after enrollment|45|||
125907717|NCT03880461|452961960|FG001|Overall Study|Determined ineligible after enrollment|44|||
125907718|NCT03880461|452961959|FG000|Overall Study|No weight measurement after enrollment|24|||
125907719|NCT03880461|452961960|FG001|Overall Study|No weight measurement after enrollment|17|||
125907720|NCT01858636|452961964|FG000|Overall Study|No Device Deployment Attempted|24|||
125907721|NCT01858636|452961964|FG000|Overall Study|Physician Decision|1|||
125907722|NCT01858636|452961964|FG000|Overall Study|Death|1|||
125907723|NCT01858636|452961964|FG000|Overall Study|Lost to Follow-up|1|||
125907724|NCT01858636|452961964|FG000|Overall Study|Withdrawal by Subject|1|||
125907725|NCT03523000|452961966|FG000|Overall Study|Withdrawal by Subject|3|||
125907726|NCT03523000|452961967|FG001|Overall Study|Withdrawal by Subject|0|||
125907727|NCT03523000|452961966|FG000|Overall Study|Unsuccessful trial|2|||
125907728|NCT03523000|452961967|FG001|Overall Study|Unsuccessful trial|0|||
125907729|NCT02862600|452961978|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
125907730|NCT02862600|452961978|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
125907731|NCT02862600|452961978|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
125907732|NCT02862600|452961978|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
125907733|NCT01476644|452961985|FG000|Overall Study|Death|5|||
125907734|NCT01476644|452961985|FG000|Overall Study|moved to another state|2|||
125907735|NCT01476644|452961985|FG000|Overall Study|Lost to Follow-up|19|||
126060053|NCT02753075|453514235|FG002|Overall Study|Adverse Event|0|||
126060054|NCT02753075|453514233|FG000|Overall Study|Lost to Follow-up|2|||
126060055|NCT02753075|453514234|FG001|Overall Study|Lost to Follow-up|0|||
126060056|NCT02753075|453514235|FG002|Overall Study|Lost to Follow-up|0|||
125907736|NCT01476644|452961985|FG000|Overall Study|Withdrawal by Subject|13|||
125907737|NCT00095628|452961986|FG000|Overall Study|Disease progression prior to treatment|1|||
125907738|NCT04271280|452961987|FG000|Overall Study|Lost to Follow-up|300|||
125907739|NCT04271280|452961987|FG000|Overall Study|Death|153|||
125907740|NCT04271280|452961987|FG000|Overall Study|Withdrawal of consent by patient|59|||
125907741|NCT04271280|452961987|FG000|Overall Study|Other|51|||
125907742|NCT04271280|452961987|FG000|Overall Study|No end of study information|42|||
125907743|NCT03194490|452962008|FG000|Overall Study|Lost to Follow-up|1|||
125907744|NCT03194490|452962009|FG001|Overall Study|Lost to Follow-up|3|||
125907745|NCT03194490|452962008|FG000|Overall Study|participant developed specific neck pain|1|||
125907746|NCT03194490|452962009|FG001|Overall Study|participant developed specific neck pain|0|||
125907747|NCT01758289|452962010|FG000|Overall Study|Premature Study Termination|44|||
125907748|NCT01758289|452962010|FG000|Overall Study|Adverse Event|9|||
125907749|NCT01574079|452962011|FG000|Overall Study|Physician Decision|0|||
125907750|NCT01574079|452962012|FG001|Overall Study|Physician Decision|2|||
125907751|NCT01574079|452962011|FG000|Overall Study|Lost to Follow-up|1|||
126060057|NCT02753075|453514233|FG000|Overall Study|Withdrawal of Consent|1|||
126060058|NCT02753075|453514234|FG001|Overall Study|Withdrawal of Consent|1|||
125907752|NCT01574079|452962012|FG001|Overall Study|Lost to Follow-up|0|||
126060059|NCT02753075|453514235|FG002|Overall Study|Withdrawal of Consent|3|||
126060060|NCT02753075|453514233|FG000|Overall Study|Physician Decision|3|||
125907753|NCT01436162|452962016|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
125907754|NCT01436162|452962017|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
125907755|NCT01436162|452962018|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
125907756|NCT01436162|452962016|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
125907757|NCT01436162|452962017|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
125907758|NCT01436162|452962018|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
125907759|NCT01436162|452962016|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
125907760|NCT01436162|452962017|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
125907761|NCT01436162|452962018|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
125907762|NCT01436162|452962016|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
125907763|NCT01436162|452962017|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
125907764|NCT01436162|452962018|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
125907765|NCT01436162|452962016|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
125907766|NCT01436162|452962017|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125907767|NCT01436162|452962018|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125907768|NCT01436162|452962016|FG000|Single-blind Lead-in Phase|Other|107|||
125907769|NCT01436162|452962017|FG001|Single-blind Lead-in Phase|Other|0|||
125907770|NCT01436162|452962018|FG002|Single-blind Lead-in Phase|Other|0|||
125907771|NCT01436162|452962016|FG000|Randomized Phase|Adverse Event|1|||
125907772|NCT01436162|452962017|FG001|Randomized Phase|Adverse Event|5|||
125907773|NCT01436162|452962018|FG002|Randomized Phase|Adverse Event|6|||
125907774|NCT01436162|452962016|FG000|Randomized Phase|Protocol Violation|4|||
125907775|NCT01436162|452962017|FG001|Randomized Phase|Protocol Violation|4|||
125907776|NCT01436162|452962018|FG002|Randomized Phase|Protocol Violation|2|||
125907777|NCT01436162|452962016|FG000|Randomized Phase|Withdrawal by Subject|16|||
125907778|NCT01436162|452962017|FG001|Randomized Phase|Withdrawal by Subject|9|||
125907779|NCT01436162|452962018|FG002|Randomized Phase|Withdrawal by Subject|8|||
125907780|NCT01436162|452962016|FG000|Randomized Phase|Lost to Follow-up|17|||
125907781|NCT01436162|452962017|FG001|Randomized Phase|Lost to Follow-up|5|||
125907782|NCT01436162|452962018|FG002|Randomized Phase|Lost to Follow-up|4|||
125907783|NCT01436162|452962016|FG000|Randomized Phase|Lack of Efficacy|0|||
125907784|NCT01436162|452962017|FG001|Randomized Phase|Lack of Efficacy|1|||
125907785|NCT01436162|452962018|FG002|Randomized Phase|Lack of Efficacy|1|||
125907786|NCT01436162|452962016|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
125907787|NCT01436162|452962017|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
125907788|NCT01436162|452962018|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
125907789|NCT01436162|452962016|FG000|Randomized Phase|Other|2|||
125907790|NCT01436162|452962017|FG001|Randomized Phase|Other|5|||
125907791|NCT01436162|452962018|FG002|Randomized Phase|Other|4|||
125907792|NCT01931202|452962022|FG000|Overall Study|Withdrawal by Subject|0|||
125907793|NCT01931202|452962023|FG001|Overall Study|Withdrawal by Subject|0|||
125907794|NCT01931202|452962024|FG002|Overall Study|Withdrawal by Subject|2|||
125907795|NCT01931202|452962022|FG000|Overall Study|Lost to Follow-up|0|||
125907796|NCT01931202|452962023|FG001|Overall Study|Lost to Follow-up|5|||
125907797|NCT01931202|452962024|FG002|Overall Study|Lost to Follow-up|2|||
125907798|NCT04597918|452962027|FG000|Overall Study|Withdrawal by Subject|6|||
125907799|NCT04597918|452962027|FG000|Overall Study|Lost to Follow-up|3|||
125907800|NCT04597918|452962027|FG000|Overall Study|Death|1|||
125907801|NCT00395538|452962028|FG000|Overall Study|Did not re-consent to revised protocol|1|||
125907802|NCT00395538|452962029|FG001|Overall Study|Did not re-consent to revised protocol|10|||
125907803|NCT00395538|452962030|FG002|Overall Study|Did not re-consent to revised protocol|0|||
125907804|NCT00395538|452962028|FG000|Overall Study|FDA partial hold on PTH|0|||
125907805|NCT00395538|452962029|FG001|Overall Study|FDA partial hold on PTH|0|||
125907806|NCT00395538|452962030|FG002|Overall Study|FDA partial hold on PTH|11|||
125907807|NCT00395538|452962028|FG000|Overall Study|Failed screening|0|||
125907808|NCT00395538|452962029|FG001|Overall Study|Failed screening|0|||
125907809|NCT00395538|452962030|FG002|Overall Study|Failed screening|4|||
125907810|NCT00395538|452962028|FG000|Overall Study|Switch to Natpara|0|||
125907811|NCT00395538|452962029|FG001|Overall Study|Switch to Natpara|0|||
125907812|NCT00395538|452962030|FG002|Overall Study|Switch to Natpara|3|||
125907813|NCT00395538|452962028|FG000|Overall Study|Adverse Event|1|||
125907814|NCT00395538|452962029|FG001|Overall Study|Adverse Event|0|||
126060061|NCT02753075|453514234|FG001|Overall Study|Physician Decision|1|||
126060062|NCT02753075|453514235|FG002|Overall Study|Physician Decision|0|||
126060063|NCT01393964|453514239|FG000|Overall Study|Disease Progression|4|||
126060064|NCT01393964|453514240|FG001|Overall Study|Disease Progression|3|||
126060065|NCT01393964|453514241|FG002|Overall Study|Disease Progression|5|||
126060066|NCT01393964|453514239|FG000|Overall Study|Study drug toxicity|1|||
126060067|NCT01393964|453514240|FG001|Overall Study|Study drug toxicity|0|||
126060068|NCT01393964|453514241|FG002|Overall Study|Study drug toxicity|0|||
125907815|NCT00395538|452962030|FG002|Overall Study|Adverse Event|2|||
126060069|NCT01393964|453514239|FG000|Overall Study|Withdrawal by Subject|0|||
125907816|NCT00395538|452962028|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
125907817|NCT00395538|452962029|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
125907818|NCT00395538|452962030|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
125907819|NCT00395538|452962028|FG000|Overall Study|Non-compliance with study protocol|0|||
125907820|NCT00395538|452962029|FG001|Overall Study|Non-compliance with study protocol|1|||
125907821|NCT00395538|452962030|FG002|Overall Study|Non-compliance with study protocol|0|||
125907822|NCT00395538|452962028|FG000|Overall Study|PTH resistance|0|||
125907823|NCT00395538|452962029|FG001|Overall Study|PTH resistance|0|||
125907824|NCT00395538|452962030|FG002|Overall Study|PTH resistance|1|||
125907825|NCT00395538|452962028|FG000|Overall Study|Pregnancy|1|||
125907826|NCT00395538|452962029|FG001|Overall Study|Pregnancy|0|||
125907827|NCT00395538|452962030|FG002|Overall Study|Pregnancy|0|||
125907828|NCT00395538|452962028|FG000|Overall Study|Partial recovery of parathyroid function|0|||
125907829|NCT00395538|452962029|FG001|Overall Study|Partial recovery of parathyroid function|0|||
125907830|NCT00395538|452962030|FG002|Overall Study|Partial recovery of parathyroid function|1|||
125907831|NCT00395538|452962028|FG000|Overall Study|Participant elected to discontinue|0|||
125907832|NCT00395538|452962029|FG001|Overall Study|Participant elected to discontinue|0|||
125907833|NCT00395538|452962030|FG002|Overall Study|Participant elected to discontinue|1|||
125907834|NCT01074047|452962031|FG000|Treatment Phase|Adverse Event|89|||
125907835|NCT01074047|452962032|FG001|Treatment Phase|Adverse Event|66|||
125907836|NCT01074047|452962031|FG000|Treatment Phase|Disease Progression|16|||
125907837|NCT01074047|452962032|FG001|Treatment Phase|Disease Progression|21|||
125907838|NCT01074047|452962031|FG000|Treatment Phase|Withdrawal by Subject|27|||
125907839|NCT01074047|452962032|FG001|Treatment Phase|Withdrawal by Subject|48|||
125907840|NCT01074047|452962031|FG000|Treatment Phase|Death|53|||
125907841|NCT01074047|452962032|FG001|Treatment Phase|Death|58|||
125907842|NCT01074047|452962031|FG000|Treatment Phase|Lost to Follow-up|0|||
125907843|NCT01074047|452962032|FG001|Treatment Phase|Lost to Follow-up|1|||
125907844|NCT01074047|452962031|FG000|Treatment Phase|Protocol Violation|0|||
125907845|NCT01074047|452962032|FG001|Treatment Phase|Protocol Violation|1|||
125907846|NCT01074047|452962031|FG000|Treatment Phase|Miscellaneous|32|||
125907847|NCT01074047|452962032|FG001|Treatment Phase|Miscellaneous|39|||
125907848|NCT01074047|452962031|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
125907849|NCT01074047|452962032|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
125907850|NCT01074047|452962031|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
125907851|NCT01074047|452962032|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
125907852|NCT01074047|452962031|FG000|Survival Follow-Up Phase|Death|116|||
125907853|NCT01074047|452962032|FG001|Survival Follow-Up Phase|Death|124|||
125907854|NCT01074047|452962031|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
125907855|NCT01074047|452962032|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
125907856|NCT01074047|452962031|FG000|Extension Phase|Physician Decision|1|||
125907857|NCT01074047|452962032|FG001|Extension Phase|Physician Decision|0|||
125907858|NCT01074047|452962031|FG000|Extension Phase|Adverse Event|5|||
125907859|NCT01074047|452962032|FG001|Extension Phase|Adverse Event|0|||
125907860|NCT01074047|452962031|FG000|Extension Phase|Disease Progression|9|||
125907861|NCT01074047|452962032|FG001|Extension Phase|Disease Progression|0|||
125907862|NCT01074047|452962031|FG000|Extension Phase|Withdrawal by Subject|2|||
125907863|NCT01074047|452962032|FG001|Extension Phase|Withdrawal by Subject|0|||
125907864|NCT01074047|452962031|FG000|Extension Phase|Death|5|||
125907865|NCT01074047|452962032|FG001|Extension Phase|Death|0|||
125907866|NCT02294773|452963775|FG000|Overall Study|Withdrawal by Subject|0|||
125907867|NCT02294773|452963776|FG001|Overall Study|Withdrawal by Subject|2|||
125907868|NCT03052764|452963777|FG000|Double-Blind Treatment Period|Adverse Event|2|||
125907869|NCT03052764|452963778|FG001|Double-Blind Treatment Period|Adverse Event|0|||
125907870|NCT03052764|452963777|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
125907871|NCT03052764|452963778|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
125907872|NCT03052764|452963777|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
125907873|NCT03052764|452963778|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
125907874|NCT03052764|452963777|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
125907875|NCT03052764|452963778|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125907876|NCT03052764|452963777|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
125907877|NCT03052764|452963778|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
125907878|NCT05828095|452963779|FG000|Overall Study|Lost to Follow-up|1|||
126110128|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
126110129|NCT00559585|453697646|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
125907879|NCT05828095|452963780|FG001|Overall Study|Lost to Follow-up|0|||
125907880|NCT05828095|452963779|FG000|Overall Study|Reactogenicity symptom|0|||
125907881|NCT05828095|452963780|FG001|Overall Study|Reactogenicity symptom|1|||
125907882|NCT03206073|452963781|FG000|Overall Study|Participant Noncompliance|0|||
125907883|NCT03206073|452963782|FG001|Overall Study|Participant Noncompliance|1|||
125907884|NCT03206073|452963783|FG002|Overall Study|Participant Noncompliance|0|||
125907885|NCT03206073|452963784|FG003|Overall Study|Participant Noncompliance|0|||
125907886|NCT03206073|452963781|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
125907887|NCT03206073|452963782|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
125907888|NCT03206073|452963783|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
125907889|NCT03206073|452963784|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
125907890|NCT03206073|452963781|FG000|Overall Study|Death|0|||
125907891|NCT03206073|452963782|FG001|Overall Study|Death|0|||
125907892|NCT03206073|452963783|FG002|Overall Study|Death|1|||
125907893|NCT03206073|452963784|FG003|Overall Study|Death|0|||
125907894|NCT03206073|452963781|FG000|Overall Study|Taken off active treatment|0|||
125907895|NCT03206073|452963782|FG001|Overall Study|Taken off active treatment|0|||
125907896|NCT03206073|452963783|FG002|Overall Study|Taken off active treatment|3|||
125907897|NCT03206073|452963784|FG003|Overall Study|Taken off active treatment|0|||
125907898|NCT03332771|452963785|FG000|Overall Study|Adverse Event|6|||
125907899|NCT03332771|452963786|FG001|Overall Study|Adverse Event|4|||
125907900|NCT03332771|452963787|FG002|Overall Study|Adverse Event|1|||
125907901|NCT03332771|452963788|FG003|Overall Study|Adverse Event|3|||
125907902|NCT03332771|452963785|FG000|Overall Study|Poor Compliance to Protocol|0|||
125907903|NCT03332771|452963786|FG001|Overall Study|Poor Compliance to Protocol|1|||
125907904|NCT03332771|452963787|FG002|Overall Study|Poor Compliance to Protocol|0|||
125907905|NCT03332771|452963788|FG003|Overall Study|Poor Compliance to Protocol|1|||
125907906|NCT03332771|452963785|FG000|Overall Study|Lost to Follow-up|2|||
125907907|NCT03332771|452963786|FG001|Overall Study|Lost to Follow-up|2|||
125907908|NCT03332771|452963787|FG002|Overall Study|Lost to Follow-up|1|||
125907909|NCT03332771|452963788|FG003|Overall Study|Lost to Follow-up|2|||
125907910|NCT03332771|452963785|FG000|Overall Study|At the Participant's own request|20|||
125907911|NCT03332771|452963786|FG001|Overall Study|At the Participant's own request|26|||
125907912|NCT03332771|452963787|FG002|Overall Study|At the Participant's own request|14|||
125907913|NCT03332771|452963788|FG003|Overall Study|At the Participant's own request|23|||
125907914|NCT03332771|452963785|FG000|Overall Study|Reason Not Specified|6|||
125907915|NCT03332771|452963786|FG001|Overall Study|Reason Not Specified|18|||
125907916|NCT03332771|452963787|FG002|Overall Study|Reason Not Specified|16|||
125907917|NCT03332771|452963788|FG003|Overall Study|Reason Not Specified|19|||
125907918|NCT00096954|452963789|FG000|Overall Study|Adverse Event|3|||
125907919|NCT00096954|452963790|FG001|Overall Study|Adverse Event|1|||
125907920|NCT00096954|452963789|FG000|Overall Study|Withdrawal by Subject|9|||
125907921|NCT00096954|452963790|FG001|Overall Study|Withdrawal by Subject|8|||
125907922|NCT00096954|452963789|FG000|Overall Study|Physician Decision|1|||
125907923|NCT00096954|452963790|FG001|Overall Study|Physician Decision|1|||
125907924|NCT00096954|452963789|FG000|Overall Study|Sponsors Decision|1|||
125907925|NCT00096954|452963790|FG001|Overall Study|Sponsors Decision|1|||
125907926|NCT00096954|452963789|FG000|Overall Study|Pregnancy|1|||
125907927|NCT00096954|452963790|FG001|Overall Study|Pregnancy|1|||
125907928|NCT00096954|452963789|FG000|Overall Study|Initiation of immunotherapy|1|||
125907929|NCT00096954|452963790|FG001|Overall Study|Initiation of immunotherapy|0|||
125907930|NCT00096954|452963789|FG000|Overall Study|Non-compliance|0|||
125907931|NCT00096954|452963790|FG001|Overall Study|Non-compliance|3|||
125907932|NCT00096954|452963789|FG000|Overall Study|Lost to Follow-up|8|||
125907933|NCT00096954|452963790|FG001|Overall Study|Lost to Follow-up|5|||
125907934|NCT04478123|452963792|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
125907935|NCT04478123|452963792|FG000|Overall Study|NE|1|||
125907936|NCT03581786|452963795|FG000|Overall Study|Death|67|||
125907937|NCT03581786|452963796|FG001|Overall Study|Death|47|||
125907938|NCT03581786|452963795|FG000|Overall Study|Withdrawal by Subject|2|||
125907939|NCT03581786|452963796|FG001|Overall Study|Withdrawal by Subject|5|||
125907940|NCT03581786|452963795|FG000|Overall Study|Lost to Follow-up|7|||
125907941|NCT03581786|452963796|FG001|Overall Study|Lost to Follow-up|4|||
125907942|NCT03581786|452963795|FG000|Overall Study|reason other than specified above|0|||
125907943|NCT03581786|452963796|FG001|Overall Study|reason other than specified above|1|||
125907944|NCT01347307|452963799|FG000|Overall Study|Death|0|||
125907945|NCT01347307|452963800|FG001|Overall Study|Death|4|||
125907946|NCT01347307|452963799|FG000|Overall Study|Physician Decision|0|||
125907947|NCT01347307|452963800|FG001|Overall Study|Physician Decision|1|||
125907948|NCT04123665|452963805|FG000|Overall Study|Withdrawal by Subject|7|||
125907949|NCT04123665|452963806|FG001|Overall Study|Withdrawal by Subject|0|||
125907950|NCT04123665|452963805|FG000|Overall Study|Lost to Follow-up|1|||
125907951|NCT04123665|452963806|FG001|Overall Study|Lost to Follow-up|0|||
125907952|NCT02237911|452963807|FG000|Overall Study|Withdrawal by Subject|4|||
125907953|NCT02237911|452963808|FG001|Overall Study|Withdrawal by Subject|7|||
125907954|NCT02237911|452963809|FG002|Overall Study|Withdrawal by Subject|2|||
125907955|NCT02237911|452963807|FG000|Overall Study|Lost to Follow-up|3|||
125907956|NCT02237911|452963808|FG001|Overall Study|Lost to Follow-up|1|||
125907957|NCT02237911|452963809|FG002|Overall Study|Lost to Follow-up|1|||
125907958|NCT00053365|452963810|FG000|Overall Study|Incorrect cell type|1|||
125907959|NCT00053365|452963810|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
125907960|NCT00053365|452963810|FG000|Overall Study|Never treated|4|||
125907961|NCT00958789|452963815|FG000|Overall Study|Death|5|||
125907962|NCT00958789|452963815|FG000|Overall Study|Lost to Follow-up|14|||
125907963|NCT00958789|452963815|FG000|Overall Study|Withdrawal by Subject|17|||
125907964|NCT00958789|452963815|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
125907965|NCT00958789|452963815|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
125907966|NCT00958789|452963815|FG000|Overall Study|Subject terminated|2|||
125907967|NCT00958789|452963815|FG000|Overall Study|Revision|7|||
125907968|NCT00721123|452963817|FG000|Overall Study|Adverse Event|96|||
125907969|NCT00721123|452963817|FG000|Overall Study|Death|10|||
125907970|NCT00721123|452963817|FG000|Overall Study|Insufficient Therapeutic Response|21|||
125907971|NCT00721123|452963817|FG000|Overall Study|Protocol Violation|1|||
125907972|NCT00721123|452963817|FG000|Overall Study|Refused Treatment|41|||
125907973|NCT00721123|452963817|FG000|Overall Study|Failure to Return|9|||
125907974|NCT00721123|452963817|FG000|Overall Study|Withdrawal by Subject|5|||
125907975|NCT04177355|452963821|FG000|Overall Study|Lost to Follow-up|0|||
125907976|NCT04177355|452963822|FG001|Overall Study|Lost to Follow-up|2|||
125907977|NCT04177355|452963823|FG002|Overall Study|Lost to Follow-up|0|||
125907978|NCT04177355|452963824|FG003|Overall Study|Lost to Follow-up|1|||
125907979|NCT04177355|452963825|FG004|Overall Study|Lost to Follow-up|2|||
125907980|NCT04177355|452963826|FG005|Overall Study|Lost to Follow-up|0|||
125907981|NCT04177355|452963827|FG006|Overall Study|Lost to Follow-up|1|||
125907982|NCT04177355|452963828|FG007|Overall Study|Lost to Follow-up|0|||
125907983|NCT04177355|452963829|FG008|Overall Study|Lost to Follow-up|0|||
125907984|NCT04177355|452963830|FG009|Overall Study|Lost to Follow-up|0|||
125907985|NCT04177355|452963831|FG010|Overall Study|Lost to Follow-up|0|||
125907986|NCT04177355|452963821|FG000|Overall Study|Withdrawal by Subject|0|||
126060070|NCT01393964|453514240|FG001|Overall Study|Withdrawal by Subject|0|||
126060071|NCT01393964|453514241|FG002|Overall Study|Withdrawal by Subject|1|||
126060072|NCT01393964|453514239|FG000|Overall Study|Adverse event unrelated to study drug|0|||
126060073|NCT01393964|453514240|FG001|Overall Study|Adverse event unrelated to study drug|3|||
126060074|NCT01393964|453514241|FG002|Overall Study|Adverse event unrelated to study drug|0|||
126060075|NCT01393964|453514239|FG000|Overall Study|Subject request stop study treatment|0|||
126060076|NCT01393964|453514240|FG001|Overall Study|Subject request stop study treatment|1|||
126060077|NCT01393964|453514241|FG002|Overall Study|Subject request stop study treatment|0|||
125907987|NCT04177355|452963822|FG001|Overall Study|Withdrawal by Subject|0|||
125907988|NCT04177355|452963823|FG002|Overall Study|Withdrawal by Subject|0|||
125907989|NCT04177355|452963824|FG003|Overall Study|Withdrawal by Subject|1|||
125907990|NCT04177355|452963825|FG004|Overall Study|Withdrawal by Subject|1|||
125907991|NCT04177355|452963826|FG005|Overall Study|Withdrawal by Subject|0|||
125907992|NCT04177355|452963827|FG006|Overall Study|Withdrawal by Subject|0|||
125907993|NCT04177355|452963828|FG007|Overall Study|Withdrawal by Subject|0|||
125907994|NCT04177355|452963829|FG008|Overall Study|Withdrawal by Subject|1|||
125907995|NCT04177355|452963830|FG009|Overall Study|Withdrawal by Subject|0|||
125907996|NCT04177355|452963831|FG010|Overall Study|Withdrawal by Subject|0|||
125907997|NCT00397943|452963832|FG000|Overall Study|Unspecified reasons|12|||
125907998|NCT00397943|452963833|FG001|Overall Study|Unspecified reasons|9|||
125907999|NCT00397943|452963834|FG002|Overall Study|Unspecified reasons|0|||
125908000|NCT00397943|452963835|FG003|Overall Study|Unspecified reasons|0|||
125908001|NCT00397943|452963836|FG004|Overall Study|Unspecified reasons|0|||
125908002|NCT00433511|452963839|FG000|Step 1|Adverse Event|50|||
125908003|NCT00433511|452963840|FG001|Step 1|Adverse Event|157|||
125908004|NCT00433511|452963841|FG002|Step 1|Adverse Event|153|||
125908005|NCT00433511|452963839|FG000|Step 1|Withdrawal by Subject|45|||
125908006|NCT00433511|452963840|FG001|Step 1|Withdrawal by Subject|143|||
125908007|NCT00433511|452963841|FG002|Step 1|Withdrawal by Subject|154|||
125908008|NCT00433511|452963839|FG000|Step 1|Death|3|||
125908009|NCT00433511|452963840|FG001|Step 1|Death|1|||
125908010|NCT00433511|452963841|FG002|Step 1|Death|1|||
125908011|NCT00433511|452963839|FG000|Step 1|Physician Decision|1|||
125908012|NCT00433511|452963840|FG001|Step 1|Physician Decision|4|||
125908013|NCT00433511|452963841|FG002|Step 1|Physician Decision|3|||
125908014|NCT00433511|452963839|FG000|Step 1|Never started protocol therapy|28|||
125908015|NCT00433511|452963840|FG001|Step 1|Never started protocol therapy|64|||
125908016|NCT00433511|452963841|FG002|Step 1|Never started protocol therapy|66|||
125908017|NCT00433511|452963839|FG000|Step 1|Alternative therapy|2|||
125908018|NCT00433511|452963840|FG001|Step 1|Alternative therapy|1|||
125908019|NCT00433511|452963841|FG002|Step 1|Alternative therapy|3|||
125908020|NCT00433511|452963839|FG000|Step 1|Disease progression, relapse|5|||
125908021|NCT00433511|452963840|FG001|Step 1|Disease progression, relapse|3|||
125908022|NCT00433511|452963841|FG002|Step 1|Disease progression, relapse|3|||
125908023|NCT00433511|452963839|FG000|Step 1|Other complicating disease|2|||
125908024|NCT00433511|452963840|FG001|Step 1|Other complicating disease|6|||
125908025|NCT00433511|452963841|FG002|Step 1|Other complicating disease|3|||
125908026|NCT00433511|452963839|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
125908027|NCT00433511|452963840|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
125908028|NCT00433511|452963841|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
125908029|NCT00433511|452963839|FG000|Step 1|Suspected recurrence|0|||
125908030|NCT00433511|452963840|FG001|Step 1|Suspected recurrence|1|||
125908031|NCT00433511|452963841|FG002|Step 1|Suspected recurrence|0|||
125908032|NCT00433511|452963839|FG000|Step 1|Insurance/drug distribution issues|0|||
125908033|NCT00433511|452963840|FG001|Step 1|Insurance/drug distribution issues|1|||
125908034|NCT00433511|452963841|FG002|Step 1|Insurance/drug distribution issues|2|||
125908035|NCT00433511|452963839|FG000|Step 1|Patient moved|0|||
125908036|NCT00433511|452963840|FG001|Step 1|Patient moved|0|||
125908037|NCT00433511|452963841|FG002|Step 1|Patient moved|1|||
125908038|NCT00433511|452963839|FG000|Step 2 (Arm D)|Adverse Event|0|||
125908039|NCT00433511|452963840|FG001|Step 2 (Arm D)|Adverse Event|0|||
125908040|NCT00433511|452963841|FG002|Step 2 (Arm D)|Adverse Event|135|||
126060078|NCT01393964|453514239|FG000|Overall Study|Subject decided to move to transplant|1|||
125908041|NCT00433511|452963839|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
125908042|NCT00433511|452963840|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
125908043|NCT00433511|452963841|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
125908044|NCT00433511|452963839|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
125908045|NCT00433511|452963840|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
125908046|NCT00433511|452963841|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
125908047|NCT00433511|452963839|FG000|Step 2 (Arm D)|Physician Decision|0|||
125908048|NCT00433511|452963840|FG001|Step 2 (Arm D)|Physician Decision|0|||
125908049|NCT00433511|452963841|FG002|Step 2 (Arm D)|Physician Decision|9|||
125908050|NCT00433511|452963839|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
125908051|NCT00433511|452963840|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
126060079|NCT01393964|453514240|FG001|Overall Study|Subject decided to move to transplant|0|||
126060080|NCT01393964|453514241|FG002|Overall Study|Subject decided to move to transplant|0|||
126060081|NCT01393964|453514239|FG000|Overall Study|Subject switched to commercial supply|1|||
126060082|NCT01393964|453514240|FG001|Overall Study|Subject switched to commercial supply|0|||
126060083|NCT01393964|453514241|FG002|Overall Study|Subject switched to commercial supply|2|||
126060084|NCT01393964|453514239|FG000|Overall Study|Subject plateaued in terms of effect|1|||
126060085|NCT01393964|453514240|FG001|Overall Study|Subject plateaued in terms of effect|0|||
126060086|NCT01393964|453514241|FG002|Overall Study|Subject plateaued in terms of effect|0|||
126060087|NCT01393964|453514239|FG000|Overall Study|Investigator removed subject from study|0|||
126060088|NCT01393964|453514240|FG001|Overall Study|Investigator removed subject from study|1|||
126060089|NCT01393964|453514241|FG002|Overall Study|Investigator removed subject from study|0|||
126060090|NCT01393964|453514239|FG000|Overall Study|Subject converted to roll-over study|0|||
126060091|NCT01393964|453514240|FG001|Overall Study|Subject converted to roll-over study|1|||
125908052|NCT00433511|452963841|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
125908053|NCT00433511|452963839|FG000|Step 2 (Arm D)|Other complicating disease|0|||
126060092|NCT01393964|453514241|FG002|Overall Study|Subject converted to roll-over study|0|||
125908054|NCT00433511|452963840|FG001|Step 2 (Arm D)|Other complicating disease|0|||
125908055|NCT00433511|452963841|FG002|Step 2 (Arm D)|Other complicating disease|3|||
125908056|NCT00433511|452963839|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
125908057|NCT00433511|452963840|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
125908058|NCT00433511|452963841|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
125908059|NCT00433511|452963839|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
125908060|NCT00433511|452963840|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
125908061|NCT00433511|452963841|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
125908062|NCT00433511|452963839|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
125908063|NCT00433511|452963840|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
125908064|NCT00433511|452963841|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
125908065|NCT00433511|452963839|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
125908066|NCT00433511|452963840|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
125908067|NCT00433511|452963841|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
125908068|NCT03139604|452963842|FG000|Overall Study|Other|7|||
125908069|NCT03139604|452963843|FG001|Overall Study|Other|3|||
125908070|NCT03139604|452963842|FG000|Overall Study|Withdrawal by Subject|16|||
125908071|NCT03139604|452963843|FG001|Overall Study|Withdrawal by Subject|17|||
125908072|NCT03139604|452963842|FG000|Overall Study|Physician Decision|1|||
125908073|NCT03139604|452963843|FG001|Overall Study|Physician Decision|2|||
125908074|NCT03139604|452963842|FG000|Overall Study|Lost to Follow-up|3|||
125908075|NCT03139604|452963843|FG001|Overall Study|Lost to Follow-up|1|||
125908076|NCT03139604|452963842|FG000|Overall Study|Death|65|||
125908077|NCT03139604|452963843|FG001|Overall Study|Death|67|||
125908078|NCT03139604|452963842|FG000|Overall Study|Study Terminated by Sponsor|122|||
125908079|NCT03139604|452963843|FG001|Overall Study|Study Terminated by Sponsor|127|||
125908080|NCT03139604|452963842|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
125908081|NCT03139604|452963843|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
125908082|NCT04950608|452963844|FG000|Overall Study|Withdrawal by Subject|2|||
125908083|NCT04950608|452963844|FG000|Overall Study|Physician Decision|3|||
125908084|NCT05007717|452963845|FG000|Overall Study|Death|3|||
126060093|NCT01393964|453514239|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
126060094|NCT01393964|453514240|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
125908085|NCT05007717|452963846|FG001|Overall Study|Death|2|||
125908086|NCT02806973|452963848|FG000|Period 1|Withdrawal by Subject|0|||
125908087|NCT02806973|452963849|FG001|Period 1|Withdrawal by Subject|2|||
125908088|NCT02806973|452963850|FG002|Period 1|Withdrawal by Subject|1|||
125908089|NCT02806973|452963851|FG003|Period 1|Withdrawal by Subject|1|||
125908090|NCT02806973|452963848|FG000|Period 1|Adverse Event|0|||
125908091|NCT02806973|452963849|FG001|Period 1|Adverse Event|0|||
125908092|NCT02806973|452963850|FG002|Period 1|Adverse Event|0|||
125908093|NCT02806973|452963851|FG003|Period 1|Adverse Event|1|||
125908094|NCT02806973|452963848|FG000|Period 3|Withdrawal by Subject|0|||
125908095|NCT02806973|452963849|FG001|Period 3|Withdrawal by Subject|0|||
125908096|NCT02806973|452963850|FG002|Period 3|Withdrawal by Subject|0|||
125908097|NCT02806973|452963851|FG003|Period 3|Withdrawal by Subject|3|||
125908098|NCT02806973|452963848|FG000|Period 3|Adverse Event|0|||
125908099|NCT02806973|452963849|FG001|Period 3|Adverse Event|0|||
125908100|NCT02806973|452963850|FG002|Period 3|Adverse Event|1|||
125908101|NCT02806973|452963851|FG003|Period 3|Adverse Event|0|||
125908102|NCT02007512|452963857|FG000|Double Blind Treatment Period|Adverse Event|4|||
125908103|NCT02007512|452963858|FG001|Double Blind Treatment Period|Adverse Event|6|||
125908104|NCT02007512|452963859|FG002|Double Blind Treatment Period|Adverse Event|2|||
125908105|NCT02007512|452963860|FG003|Double Blind Treatment Period|Adverse Event|2|||
125908106|NCT02007512|452963857|FG000|Double Blind Treatment Period|Death|1|||
125908107|NCT02007512|452963858|FG001|Double Blind Treatment Period|Death|0|||
125908108|NCT02007512|452963859|FG002|Double Blind Treatment Period|Death|0|||
125908109|NCT02007512|452963860|FG003|Double Blind Treatment Period|Death|0|||
125908110|NCT02007512|452963857|FG000|Double Blind Treatment Period|Disease progression|51|||
125908111|NCT02007512|452963858|FG001|Double Blind Treatment Period|Disease progression|50|||
125908112|NCT02007512|452963859|FG002|Double Blind Treatment Period|Disease progression|57|||
125908113|NCT02007512|452963860|FG003|Double Blind Treatment Period|Disease progression|52|||
125908114|NCT02007512|452963857|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
125908115|NCT02007512|452963858|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
125908116|NCT02007512|452963859|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
125908117|NCT02007512|452963860|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
125908118|NCT02007512|452963857|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125908119|NCT02007512|452963858|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125908120|NCT02007512|452963859|FG002|Double Blind Treatment Period|Protocol Violation|0|||
125908121|NCT02007512|452963860|FG003|Double Blind Treatment Period|Protocol Violation|1|||
125908122|NCT02007512|452963857|FG000|Double Blind Treatment Period|Other|2|||
125908123|NCT02007512|452963858|FG001|Double Blind Treatment Period|Other|1|||
125908124|NCT02007512|452963859|FG002|Double Blind Treatment Period|Other|1|||
125908125|NCT02007512|452963860|FG003|Double Blind Treatment Period|Other|2|||
125908126|NCT02007512|452963857|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
125908127|NCT02007512|452963858|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
125908128|NCT02007512|452963859|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
125908129|NCT02007512|452963860|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
125908130|NCT02007512|452963857|FG000|Open Label Treatment Period|Adverse Event|1|||
125908131|NCT02007512|452963858|FG001|Open Label Treatment Period|Adverse Event|0|||
125908132|NCT02007512|452963859|FG002|Open Label Treatment Period|Adverse Event|0|||
125908133|NCT02007512|452963860|FG003|Open Label Treatment Period|Adverse Event|0|||
125908134|NCT02007512|452963857|FG000|Open Label Treatment Period|Other|1|||
125908135|NCT02007512|452963858|FG001|Open Label Treatment Period|Other|1|||
125908136|NCT02007512|452963859|FG002|Open Label Treatment Period|Other|0|||
125908137|NCT02007512|452963860|FG003|Open Label Treatment Period|Other|0|||
125908138|NCT02007512|452963857|FG000|Open Label Treatment Period|Disease progression|23|||
125908139|NCT02007512|452963858|FG001|Open Label Treatment Period|Disease progression|11|||
125908140|NCT02007512|452963859|FG002|Open Label Treatment Period|Disease progression|0|||
125908141|NCT02007512|452963860|FG003|Open Label Treatment Period|Disease progression|0|||
125908142|NCT00608543|452963865|FG000|Overall Study|Adverse Event|4|||
125908143|NCT03282565|452963868|FG000|Overall Study|COVID-19 Research Shutdown|0|||
125908144|NCT03282565|452963869|FG001|Overall Study|COVID-19 Research Shutdown|2|||
125908145|NCT03282565|452963870|FG002|Overall Study|COVID-19 Research Shutdown|2|||
125908146|NCT02131532|452963871|FG000|Overall Study|Withdrawal by Subject|1|||
125908147|NCT02131532|452963871|FG000|Overall Study|Physician Decision|1|||
125908148|NCT02131532|452963871|FG000|Overall Study|Other health conditions|2|||
125908149|NCT01466595|452963872|FG000|Overall Study|Withdrawal by Subject|0|||
125908150|NCT01466595|452963873|FG001|Overall Study|Withdrawal by Subject|1|||
125908151|NCT00450112|452963874|FG000|Overall Study|Other Treatment Required|5|||
125908152|NCT00450112|452963875|FG001|Overall Study|Other Treatment Required|1|||
125908153|NCT00450112|452963874|FG000|Overall Study|Withdrawal by Subject|4|||
125908154|NCT00450112|452963875|FG001|Overall Study|Withdrawal by Subject|1|||
125908155|NCT00450112|452963874|FG000|Overall Study|Lost to Follow-up|2|||
125908156|NCT00450112|452963875|FG001|Overall Study|Lost to Follow-up|1|||
125908157|NCT00450112|452963874|FG000|Overall Study|Others|2|||
125908158|NCT00450112|452963875|FG001|Overall Study|Others|3|||
125908159|NCT01264016|452963876|FG000|Overall Study|Withdrawal by Subject|1|||
125908160|NCT01264016|452963876|FG000|Overall Study|Felt faint at sight of blood|1|||
125908161|NCT02147184|452963877|FG000|Overall Study|Lost to Follow-up|28|||
125908162|NCT02147184|452963878|FG001|Overall Study|Lost to Follow-up|15|||
125908163|NCT02147184|452963877|FG000|Overall Study|Study Burden|11|||
125908164|NCT02147184|452963878|FG001|Overall Study|Study Burden|7|||
125908165|NCT02147184|452963877|FG000|Overall Study|Pregnancy|6|||
125908166|NCT02147184|452963878|FG001|Overall Study|Pregnancy|0|||
125908167|NCT02147184|452963877|FG000|Overall Study|Moved out of state|3|||
125908168|NCT02147184|452963878|FG001|Overall Study|Moved out of state|3|||
125908169|NCT02147184|452963877|FG000|Overall Study|Physician Decision|0|||
125908170|NCT02147184|452963878|FG001|Overall Study|Physician Decision|2|||
125908171|NCT02147184|452963877|FG000|Overall Study|Other|1|||
125908172|NCT02147184|452963878|FG001|Overall Study|Other|0|||
125908173|NCT02117414|452963879|FG000|Overall Study|Death|5|||
125908174|NCT02117414|452963880|FG001|Overall Study|Death|2|||
125908175|NCT02117414|452963879|FG000|Overall Study|Withdrawal by Subject|10|||
125908176|NCT02117414|452963880|FG001|Overall Study|Withdrawal by Subject|4|||
125908177|NCT00417482|452963881|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
125908178|NCT00417482|452963882|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
125908179|NCT00417482|452963883|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
125908180|NCT00417482|452963881|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
125908181|NCT00417482|452963882|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
125908182|NCT00417482|452963883|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
125908183|NCT00417482|452963881|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
125908184|NCT00417482|452963882|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
125908185|NCT00417482|452963883|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
125908186|NCT00417482|452963881|FG000|Phase B 1st 16 Weeks|Death|1|||
125908187|NCT00417482|452963882|FG001|Phase B 1st 16 Weeks|Death|0|||
125908188|NCT00417482|452963883|FG002|Phase B 1st 16 Weeks|Death|0|||
125908189|NCT00417482|452963881|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
125908190|NCT00417482|452963882|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
125908191|NCT00417482|452963883|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
125908192|NCT00417482|452963881|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
125908193|NCT00417482|452963882|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
125908194|NCT00417482|452963883|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
125908195|NCT00417482|452963881|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
125908196|NCT00417482|452963882|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
125908197|NCT00417482|452963883|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
125908198|NCT00417482|452963881|FG000|Phase B 2nd 16 Weeks|Death|1|||
125908199|NCT00417482|452963882|FG001|Phase B 2nd 16 Weeks|Death|1|||
125908200|NCT00417482|452963883|FG002|Phase B 2nd 16 Weeks|Death|0|||
125908201|NCT06400979|452963886|FG000|Overall Study|Lost to Follow-up|29|||
125908202|NCT06400979|452963886|FG000|Overall Study|Withdrawal by Subject|1|||
125908203|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
125908204|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
125908205|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
125908206|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
125908207|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125908208|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
125908209|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125908210|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
125908211|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
125908212|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
125908213|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
125908214|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
125908215|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
125908216|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
125908217|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
125908218|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
125908219|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Program Termination|3|||
125908220|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Program Termination|0|||
125908221|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Program Termination|1|||
125908222|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Program Termination|1|||
125908223|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
125908224|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
125908225|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
125908226|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
125908227|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
125908228|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
125908229|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
125908230|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
125908231|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
125908232|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
125908233|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
125908234|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
125908235|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
125908236|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
125908237|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
125908238|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
125908239|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
125908240|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
125908241|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
125908242|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
125908243|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
125908244|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
125908245|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
125908246|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
125908247|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
125908248|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
125908249|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
125908250|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
125908251|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
125908252|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
125908253|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
125908254|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
125908255|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
125908256|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
125908257|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
125908258|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
125908259|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
125908260|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
125908261|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
125908262|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
125908263|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
125908264|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
125908265|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
125908266|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
125908267|NCT03739840|452963887|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
125908268|NCT03739840|452963888|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
125908269|NCT03739840|452963889|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
125908270|NCT03739840|452963890|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
125908271|NCT03739840|452963887|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
125908272|NCT03739840|452963888|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
125908273|NCT03739840|452963889|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
125908274|NCT03739840|452963890|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
125908275|NCT03739840|452963887|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
125908276|NCT03739840|452963888|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
125908277|NCT03739840|452963889|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
125908278|NCT03739840|452963890|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
125908279|NCT03739840|452963887|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
125908280|NCT03739840|452963888|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
125908281|NCT03739840|452963889|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
125908282|NCT03739840|452963890|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
125908283|NCT03739840|452963887|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
125908284|NCT03739840|452963888|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
125908285|NCT03739840|452963889|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
125908286|NCT03739840|452963890|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
125908287|NCT03739840|452963887|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
125908288|NCT03739840|452963888|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
125908289|NCT03739840|452963889|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
125908290|NCT03739840|452963890|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
125908291|NCT03739840|452963887|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
125908292|NCT03739840|452963888|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
125908293|NCT03739840|452963889|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
125908294|NCT03739840|452963890|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
125908295|NCT03739840|452963887|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
125908296|NCT03739840|452963888|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
125908297|NCT03739840|452963889|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
125908298|NCT03739840|452963890|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
125908299|NCT03739840|452963887|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
125908300|NCT03739840|452963888|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
125908301|NCT03739840|452963889|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
125908302|NCT03739840|452963890|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
125908303|NCT04025710|452963894|FG000|Overall Study|Death|3|||
125908304|NCT04025710|452963894|FG000|Overall Study|Lost to Follow-up|5|||
125908305|NCT04025710|452963894|FG000|Overall Study|Withdrawal by Subject|1|||
125908306|NCT04025710|452963894|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
125908307|NCT04025710|452963894|FG000|Overall Study|Drop-out according to protocol|34|||
125908308|NCT02431247|452963895|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
125908309|NCT02431247|452963896|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
125908310|NCT02431247|452963897|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
125908311|NCT02431247|452963895|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
125908312|NCT02431247|452963896|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
125908313|NCT02431247|452963897|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
125908314|NCT02431247|452963895|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
125908315|NCT02431247|452963896|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
125908316|NCT02431247|452963897|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
125908317|NCT02431247|452963895|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
125908318|NCT02431247|452963896|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
125908319|NCT02431247|452963897|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
125908320|NCT02431247|452963895|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
125908321|NCT02431247|452963896|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
125908322|NCT02431247|452963897|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
125908323|NCT02431247|452963895|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
125908324|NCT02431247|452963896|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
125908325|NCT02431247|452963897|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
125908326|NCT02431247|452963895|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
125908327|NCT02431247|452963896|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
125908328|NCT02431247|452963897|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
125908329|NCT02431247|452963895|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
125908330|NCT02431247|452963896|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
125908331|NCT02431247|452963897|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
125908332|NCT02431247|452963895|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
125908333|NCT02431247|452963896|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
125908334|NCT02431247|452963897|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
126060095|NCT01393964|453514241|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
126060096|NCT03265132|453514248|FG000|Overall Study|Adverse Event|0|||
126060097|NCT03265132|453514249|FG001|Overall Study|Adverse Event|1|||
126060098|NCT03265132|453514248|FG000|Overall Study|Lack of Efficacy|0|||
126060099|NCT03265132|453514249|FG001|Overall Study|Lack of Efficacy|2|||
126060100|NCT03265132|453514248|FG000|Overall Study|Progressive disease|0|||
126060101|NCT03265132|453514249|FG001|Overall Study|Progressive disease|2|||
126060102|NCT03265132|453514248|FG000|Overall Study|Withdrawal by Subject|0|||
126060103|NCT03265132|453514249|FG001|Overall Study|Withdrawal by Subject|1|||
126060104|NCT00687297|453514250|FG000|Randomization|Withdrawal by Subject|2|||
126060105|NCT00687297|453514251|FG001|Randomization|Withdrawal by Subject|0|||
126060106|NCT00687297|453514250|FG000|Randomization|Withdrew before treatment, ineligible|1|||
126060107|NCT00687297|453514251|FG001|Randomization|Withdrew before treatment, ineligible|1|||
126060108|NCT00687297|453514250|FG000|Induction|Withdrawal by Subject|4|||
126060109|NCT00687297|453514251|FG001|Induction|Withdrawal by Subject|4|||
126060110|NCT00687297|453514250|FG000|Induction|Adverse Event|16|||
126060111|NCT00687297|453514251|FG001|Induction|Adverse Event|15|||
126060112|NCT00687297|453514250|FG000|Induction|Death|7|||
126060113|NCT00687297|453514251|FG001|Induction|Death|11|||
125908335|NCT02431247|452963895|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
125908336|NCT02431247|452963896|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
125908337|NCT02431247|452963897|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
125908338|NCT02431247|452963895|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
125908339|NCT02431247|452963896|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
125908340|NCT02431247|452963897|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
125908341|NCT02431247|452963895|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
125908342|NCT02431247|452963896|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
125908343|NCT02431247|452963897|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
125908344|NCT02431247|452963895|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
125908345|NCT02431247|452963896|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
125908346|NCT02431247|452963897|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
125908347|NCT02431247|452963895|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
125908348|NCT02431247|452963896|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
125908349|NCT02431247|452963897|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
125908350|NCT01562873|452963898|FG000|Overall Study|Disease Progression per RECIST|10|||
125908351|NCT01562873|452963899|FG001|Overall Study|Disease Progression per RECIST|0|||
125908352|NCT01562873|452963898|FG000|Overall Study|Adverse Event|1|||
125908353|NCT01562873|452963899|FG001|Overall Study|Adverse Event|0|||
125908354|NCT01562873|452963898|FG000|Overall Study|Clinical Disease Progression|9|||
125908355|NCT01562873|452963899|FG001|Overall Study|Clinical Disease Progression|0|||
125908356|NCT01562873|452963898|FG000|Overall Study|Clinical PD and adverse event|1|||
125908357|NCT01562873|452963899|FG001|Overall Study|Clinical PD and adverse event|0|||
125908358|NCT01369485|452963900|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
125908359|NCT01369485|452963901|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
125908360|NCT01369485|452963900|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
125908361|NCT01369485|452963901|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
125908362|NCT01369485|452963900|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
125908363|NCT01369485|452963901|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
125908364|NCT01369485|452963900|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
125908365|NCT01369485|452963901|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
125908366|NCT01369485|452963900|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
125908367|NCT01369485|452963901|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
125908368|NCT01369485|452963900|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
125908369|NCT01369485|452963901|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
125908370|NCT01369485|452963900|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
125908371|NCT01369485|452963901|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
125908372|NCT01369485|452963900|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
125908373|NCT01369485|452963901|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
125908374|NCT01369485|452963900|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
125908375|NCT01369485|452963901|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
125908376|NCT01369485|452963900|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
125908377|NCT01369485|452963901|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
125908378|NCT00194675|452963912|FG000|Overall Study|Lost to Follow-up|1|||
125908379|NCT00194675|452963913|FG001|Overall Study|Lost to Follow-up|1|||
125908380|NCT00194675|452963912|FG000|Overall Study|lack of interest|1|||
125908381|NCT00194675|452963913|FG001|Overall Study|lack of interest|1|||
125908382|NCT00194675|452963912|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
125908383|NCT00194675|452963913|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
126060114|NCT00687297|453514250|FG000|Induction|Lack of Efficacy|17|||
125908384|NCT00194675|452963912|FG000|Overall Study|Protocol Violation|1|||
125908385|NCT00194675|452963913|FG001|Overall Study|Protocol Violation|0|||
125908386|NCT00194675|452963912|FG000|Overall Study|Death|1|||
125908387|NCT00194675|452963913|FG001|Overall Study|Death|0|||
125908388|NCT01285960|452963914|FG000|Overall Study|Withdrawal by Subject|2|||
125908389|NCT01285960|452963914|FG000|Overall Study|Lost to Follow-up|2|||
125908390|NCT01285960|452963914|FG000|Overall Study|2 subjects received less 10 sonications|2|||
125908391|NCT02280473|452963917|FG000|Overall Study|Adverse Event|1|||
125908392|NCT02280473|452963918|FG001|Overall Study|Adverse Event|1|||
125908393|NCT02280473|452963917|FG000|Overall Study|Lack of Efficacy|0|||
125908394|NCT02280473|452963918|FG001|Overall Study|Lack of Efficacy|1|||
126060115|NCT00687297|453514251|FG001|Induction|Lack of Efficacy|21|||
126060116|NCT00687297|453514250|FG000|Induction|Ineligible|0|||
126060117|NCT00687297|453514251|FG001|Induction|Ineligible|1|||
126060118|NCT00687297|453514250|FG000|Induction|Patient Noncompliance|1|||
126060119|NCT00687297|453514251|FG001|Induction|Patient Noncompliance|0|||
126060120|NCT00687297|453514250|FG000|Induction|Physician Decision|0|||
126060121|NCT00687297|453514251|FG001|Induction|Physician Decision|2|||
126060122|NCT00687297|453514250|FG000|Induction|Other|0|||
126060123|NCT00687297|453514251|FG001|Induction|Other|1|||
126060124|NCT00244751|453514256|FG000|Overall Study|Adverse Event|7|||
126060125|NCT00244751|453514257|FG001|Overall Study|Adverse Event|7|||
126060126|NCT00244751|453514258|FG002|Overall Study|Adverse Event|5|||
126060127|NCT00244751|453514256|FG000|Overall Study|Lost to Follow-up|0|||
126060128|NCT00244751|453514257|FG001|Overall Study|Lost to Follow-up|1|||
126060129|NCT00244751|453514258|FG002|Overall Study|Lost to Follow-up|0|||
126060130|NCT00244751|453514256|FG000|Overall Study|Protocol Violation|1|||
126060131|NCT00244751|453514257|FG001|Overall Study|Protocol Violation|0|||
126060132|NCT00244751|453514258|FG002|Overall Study|Protocol Violation|1|||
126060133|NCT00244751|453514256|FG000|Overall Study|Withdrawal by Subject|7|||
126060134|NCT00244751|453514257|FG001|Overall Study|Withdrawal by Subject|5|||
126060135|NCT00244751|453514258|FG002|Overall Study|Withdrawal by Subject|3|||
126060136|NCT00244751|453514256|FG000|Overall Study|Elevated liver enzymes|1|||
126060137|NCT00244751|453514257|FG001|Overall Study|Elevated liver enzymes|0|||
126060138|NCT00244751|453514258|FG002|Overall Study|Elevated liver enzymes|0|||
126060139|NCT00244751|453514256|FG000|Overall Study|Lack of compliance with protocol|0|||
126060140|NCT00244751|453514257|FG001|Overall Study|Lack of compliance with protocol|1|||
126060141|NCT00244751|453514258|FG002|Overall Study|Lack of compliance with protocol|0|||
126060142|NCT00244751|453514256|FG000|Overall Study|Safety reasons|0|||
126060143|NCT00244751|453514257|FG001|Overall Study|Safety reasons|1|||
126060144|NCT00244751|453514258|FG002|Overall Study|Safety reasons|0|||
126060145|NCT00244751|453514256|FG000|Overall Study|Participant randomized by mistake|0|||
126060146|NCT00244751|453514257|FG001|Overall Study|Participant randomized by mistake|0|||
126060147|NCT00244751|453514258|FG002|Overall Study|Participant randomized by mistake|1|||
126060148|NCT02206607|453514259|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
126060149|NCT02206607|453514260|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
126060150|NCT02206607|453514261|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
126060151|NCT02206607|453514262|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
126060152|NCT02206607|453514263|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
126060153|NCT02206607|453514259|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
126060154|NCT02206607|453514260|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
126060155|NCT02206607|453514261|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
126060156|NCT02206607|453514262|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
126060157|NCT02206607|453514263|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
126060158|NCT00879710|453514264|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
126060159|NCT00879710|453514265|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
126060160|NCT00879710|453514266|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
125908395|NCT02280473|452963917|FG000|Overall Study|Lost to Follow-up|0|||
125908396|NCT02280473|452963918|FG001|Overall Study|Lost to Follow-up|1|||
125908397|NCT01484054|452963919|FG000|Period 1|Withdrawal by Subject|0|||
125908398|NCT01484054|452963920|FG001|Period 1|Withdrawal by Subject|1|||
125908399|NCT01610271|452963921|FG000|Overall Study|Surgery not complete|0|||
125908400|NCT01610271|452963922|FG001|Overall Study|Surgery not complete|1|||
125908401|NCT01610271|452963921|FG000|Overall Study|Prosthesis not implanted|2|||
125908402|NCT01610271|452963922|FG001|Overall Study|Prosthesis not implanted|3|||
125908403|NCT00364130|452963923|FG000|Intervention Period|Lost to Follow-up|4|||
125908404|NCT00364130|452963924|FG001|Intervention Period|Lost to Follow-up|3|||
125908405|NCT00364130|452963923|FG000|Intervention Period|Pregnancy|1|||
126060161|NCT00879710|453514267|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
126060162|NCT00879710|453514264|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
126060163|NCT00879710|453514265|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
126060164|NCT00879710|453514266|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
126060165|NCT00879710|453514267|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
126060166|NCT01262456|453514268|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
126060167|NCT01262456|453514269|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
126060168|NCT01262456|453514270|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
126060169|NCT01262456|453514268|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
126060170|NCT01262456|453514269|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
126060171|NCT01262456|453514270|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
126060172|NCT01262456|453514268|FG000|3-Month Double-Blind Period|Adverse Event|6|||
126060173|NCT01262456|453514269|FG001|3-Month Double-Blind Period|Adverse Event|4|||
126060174|NCT01262456|453514270|FG002|3-Month Double-Blind Period|Adverse Event|8|||
126060175|NCT01262456|453514268|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
126060176|NCT01262456|453514269|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
126060177|NCT01262456|453514270|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
126060178|NCT01262456|453514268|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
126060179|NCT01262456|453514269|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
126060180|NCT01262456|453514270|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
126060181|NCT01262456|453514268|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
126060182|NCT01262456|453514269|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
125908406|NCT00364130|452963924|FG001|Intervention Period|Pregnancy|0|||
125908407|NCT00364130|452963923|FG000|Intervention Period|Withdrawal by Subject|4|||
125908408|NCT00364130|452963924|FG001|Intervention Period|Withdrawal by Subject|5|||
125908409|NCT00364130|452963923|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
125908410|NCT00364130|452963924|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
125908411|NCT00410202|452963925|FG000|On-Treatment|Continuing treatment|69|||
125908412|NCT00410202|452963926|FG001|On-Treatment|Continuing treatment|71|||
125908413|NCT00410202|452963927|FG002|On-Treatment|Continuing treatment|66|||
125908414|NCT00410202|452963925|FG000|On-Treatment|Adverse Event|1|||
125908415|NCT00410202|452963926|FG001|On-Treatment|Adverse Event|3|||
125908416|NCT00410202|452963927|FG002|On-Treatment|Adverse Event|2|||
125908417|NCT00410202|452963925|FG000|On-Treatment|Death|1|||
125908418|NCT00410202|452963926|FG001|On-Treatment|Death|0|||
125908419|NCT00410202|452963927|FG002|On-Treatment|Death|0|||
125908420|NCT00410202|452963925|FG000|On-Treatment|Lost to Follow-up|1|||
125908421|NCT00410202|452963926|FG001|On-Treatment|Lost to Follow-up|0|||
125908422|NCT00410202|452963927|FG002|On-Treatment|Lost to Follow-up|1|||
125908423|NCT00410202|452963925|FG000|On-Treatment|Lack of Efficacy|1|||
125908424|NCT00410202|452963926|FG001|On-Treatment|Lack of Efficacy|4|||
125908425|NCT00410202|452963927|FG002|On-Treatment|Lack of Efficacy|0|||
125908426|NCT00410202|452963925|FG000|On-Treatment|Withdrawal by Subject|2|||
125908427|NCT00410202|452963926|FG001|On-Treatment|Withdrawal by Subject|1|||
125908428|NCT00410202|452963927|FG002|On-Treatment|Withdrawal by Subject|1|||
125908429|NCT00410202|452963925|FG000|On-Treatment|Other Reason|0|||
125908430|NCT00410202|452963926|FG001|On-Treatment|Other Reason|0|||
125908431|NCT00410202|452963927|FG002|On-Treatment|Other Reason|1|||
125908432|NCT00410202|452963925|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
125908433|NCT00410202|452963926|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
125908434|NCT00410202|452963927|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
125908435|NCT00410202|452963925|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
125908436|NCT00410202|452963926|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
125908437|NCT00410202|452963927|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
125908438|NCT00410202|452963925|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
125908439|NCT00410202|452963926|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
125908440|NCT00410202|452963927|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
125908441|NCT00144027|452963929|FG000|Overall Study|Lost to Follow-up|1|||
125908442|NCT00144027|452963930|FG001|Overall Study|Lost to Follow-up|3|||
125908443|NCT00144027|452963929|FG000|Overall Study|Withdrawal by Subject|2|||
125908444|NCT00144027|452963930|FG001|Overall Study|Withdrawal by Subject|2|||
125908445|NCT00144027|452963929|FG000|Overall Study|did not complete baseline assessment|0|||
125908446|NCT00144027|452963930|FG001|Overall Study|did not complete baseline assessment|6|||
125908447|NCT00285207|452963931|FG000|Overall Study|Lost to Follow-up|3|||
125908448|NCT00285207|452963932|FG001|Overall Study|Lost to Follow-up|2|||
125908449|NCT00285207|452963931|FG000|Overall Study|Withdrawal by Subject|5|||
125908450|NCT00285207|452963932|FG001|Overall Study|Withdrawal by Subject|2|||
125908451|NCT00285207|452963931|FG000|Overall Study|Pregnancy|1|||
125908452|NCT00285207|452963932|FG001|Overall Study|Pregnancy|1|||
125908453|NCT00285207|452963931|FG000|Overall Study|non-compliance|0|||
125908454|NCT00285207|452963932|FG001|Overall Study|non-compliance|1|||
125908455|NCT03026088|452965504|FG000|Overall Study|Study termination|20|||
125908456|NCT01869725|452965506|FG000|Overall Study|ineligible after registration|1|||
125908457|NCT01869725|452965506|FG000|Overall Study|Death|1|||
125908458|NCT01869725|452965506|FG000|Overall Study|Lost to Follow-up|2|||
125908459|NCT01143207|452965507|FG000|Overall Study|Lost to Follow-up|2|||
125908460|NCT03416374|452965520|FG000|Between Treatment Period I and II|Other|0|||
126060183|NCT01262456|453514270|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
126060184|NCT01262456|453514268|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
126060185|NCT01262456|453514269|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
126060186|NCT01262456|453514270|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
126060187|NCT01262456|453514268|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
125908461|NCT03416374|452965521|FG001|Between Treatment Period I and II|Other|9|||
125908462|NCT03416374|452965520|FG000|Treatment Period II|Lack of Efficacy|3|||
125908463|NCT03416374|452965521|FG001|Treatment Period II|Lack of Efficacy|11|||
125908464|NCT03416374|452965520|FG000|Treatment Period II|Adverse Event|1|||
125908465|NCT03416374|452965521|FG001|Treatment Period II|Adverse Event|4|||
125908466|NCT03416374|452965520|FG000|Treatment Period II|Death|0|||
125908467|NCT03416374|452965521|FG001|Treatment Period II|Death|1|||
125908468|NCT03416374|452965520|FG000|Treatment Period II|Other|0|||
125908469|NCT03416374|452965521|FG001|Treatment Period II|Other|2|||
125908470|NCT01052844|452965522|FG000|Overall Study|Adverse Event|0|||
125908471|NCT01052844|452965523|FG001|Overall Study|Adverse Event|1|||
125908472|NCT03463031|452965524|FG000|Overall Study|Withdrawal by Subject|4|||
125908473|NCT03463031|452965525|FG001|Overall Study|Withdrawal by Subject|2|||
125908474|NCT03463031|452965524|FG000|Overall Study|Investigator/Sponsor Decision|0|||
125908475|NCT03463031|452965525|FG001|Overall Study|Investigator/Sponsor Decision|1|||
126060188|NCT01262456|453514269|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
125908476|NCT03463031|452965524|FG000|Overall Study|Lost to Follow-up|1|||
125908477|NCT03463031|452965525|FG001|Overall Study|Lost to Follow-up|1|||
125908478|NCT03463031|452965524|FG000|Overall Study|Adverse Event|4|||
125908479|NCT03463031|452965525|FG001|Overall Study|Adverse Event|1|||
125908480|NCT03463031|452965524|FG000|Overall Study|Use of prohibited medication by subject|1|||
125908481|NCT03463031|452965525|FG001|Overall Study|Use of prohibited medication by subject|0|||
125908482|NCT00214500|452965531|FG000|Treatment Period|Adverse Event|1|||
125908483|NCT00214500|452965531|FG000|Extension Period|Withdrawal by Subject|2|||
125908484|NCT00147251|452965532|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
125908485|NCT00147251|452965533|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
125908486|NCT01629706|452965534|FG000|Phase 1 PureVision|Screen Failure|4|||
125908487|NCT01629706|452965534|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
125908488|NCT01629706|452965534|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
125908489|NCT01629706|452965534|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
125908490|NCT01629706|452965534|FG000|Phase 2 Habitual|Screen Failure|6|||
125908491|NCT01629706|452965534|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
125908492|NCT01629706|452965534|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
125908493|NCT01629706|452965534|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
125908494|NCT01629706|452965534|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
125908495|NCT02537574|452965536|FG000|Overall Study|Adverse Event|1|||
125908496|NCT02537574|452965537|FG001|Overall Study|Adverse Event|3|||
125908497|NCT02537574|452965538|FG002|Overall Study|Adverse Event|2|||
125908498|NCT02537574|452965536|FG000|Overall Study|Lost to Follow-up|40|||
125908499|NCT02537574|452965537|FG001|Overall Study|Lost to Follow-up|51|||
125908500|NCT02537574|452965538|FG002|Overall Study|Lost to Follow-up|55|||
125908501|NCT02537574|452965536|FG000|Overall Study|Noncompliance with study drug|0|||
125908502|NCT02537574|452965537|FG001|Overall Study|Noncompliance with study drug|1|||
125908503|NCT02537574|452965538|FG002|Overall Study|Noncompliance with study drug|1|||
125908504|NCT02537574|452965536|FG000|Overall Study|Physician Decision|2|||
125908505|NCT02537574|452965537|FG001|Overall Study|Physician Decision|0|||
125908506|NCT02537574|452965538|FG002|Overall Study|Physician Decision|0|||
125908507|NCT02537574|452965536|FG000|Overall Study|Protocol Violation|4|||
125908508|NCT02537574|452965537|FG001|Overall Study|Protocol Violation|2|||
125908509|NCT02537574|452965538|FG002|Overall Study|Protocol Violation|3|||
125908510|NCT02537574|452965536|FG000|Overall Study|Withdrawal by Subject|37|||
125908511|NCT02537574|452965537|FG001|Overall Study|Withdrawal by Subject|27|||
125908512|NCT02537574|452965538|FG002|Overall Study|Withdrawal by Subject|29|||
125908513|NCT02537574|452965536|FG000|Overall Study|Lack of Efficacy|14|||
125908514|NCT02537574|452965537|FG001|Overall Study|Lack of Efficacy|16|||
125908515|NCT02537574|452965538|FG002|Overall Study|Lack of Efficacy|15|||
125908516|NCT02537574|452965536|FG000|Overall Study|Duplicate Patient|1|||
125908517|NCT02537574|452965537|FG001|Overall Study|Duplicate Patient|0|||
125908518|NCT02537574|452965538|FG002|Overall Study|Duplicate Patient|0|||
125908519|NCT02537574|452965536|FG000|Overall Study|Patient not Stable|0|||
125908520|NCT02537574|452965537|FG001|Overall Study|Patient not Stable|1|||
125908521|NCT02537574|452965538|FG002|Overall Study|Patient not Stable|0|||
125908522|NCT02537574|452965536|FG000|Overall Study|Incarceration|0|||
125908523|NCT02537574|452965537|FG001|Overall Study|Incarceration|1|||
125908524|NCT02537574|452965538|FG002|Overall Study|Incarceration|0|||
125908525|NCT02537574|452965536|FG000|Overall Study|Failed Naloxone Challenge|0|||
125908526|NCT02537574|452965537|FG001|Overall Study|Failed Naloxone Challenge|1|||
125908527|NCT02537574|452965538|FG002|Overall Study|Failed Naloxone Challenge|0|||
125908528|NCT02537574|452965536|FG000|Overall Study|Transportation Issues|0|||
125908529|NCT02537574|452965537|FG001|Overall Study|Transportation Issues|0|||
125908530|NCT02537574|452965538|FG002|Overall Study|Transportation Issues|1|||
125908531|NCT02537574|452965536|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
125908532|NCT02537574|452965537|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
125908533|NCT02537574|452965538|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
125908534|NCT02537574|452965536|FG000|Overall Study|Noncompliance with Protocol|0|||
125908535|NCT02537574|452965537|FG001|Overall Study|Noncompliance with Protocol|0|||
126060189|NCT01262456|453514270|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
126060190|NCT01262456|453514268|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
126060191|NCT01262456|453514269|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
126060192|NCT01262456|453514270|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
126060193|NCT04085614|453514271|FG000|Overall Study|Protocol Violation|9|||
125908536|NCT02537574|452965538|FG002|Overall Study|Noncompliance with Protocol|1|||
125908537|NCT02663687|452965539|FG000|Overall Study|Adverse Event|1|||
125908538|NCT02663687|452965540|FG001|Overall Study|Adverse Event|0|||
125908539|NCT02663687|452965541|FG002|Overall Study|Adverse Event|0|||
125908540|NCT02663687|452965542|FG003|Overall Study|Adverse Event|0|||
125908541|NCT02663687|452965543|FG004|Overall Study|Adverse Event|0|||
125908542|NCT02663687|452965539|FG000|Overall Study|Other|1|||
126060194|NCT04085614|453514272|FG001|Overall Study|Protocol Violation|6|||
125908543|NCT02663687|452965540|FG001|Overall Study|Other|0|||
125908544|NCT02663687|452965541|FG002|Overall Study|Other|1|||
125908545|NCT02663687|452965542|FG003|Overall Study|Other|0|||
126060195|NCT02399449|453514273|FG000|Overall Study|Withdrawal by Subject|3|||
125908546|NCT02663687|452965543|FG004|Overall Study|Other|0|||
125908547|NCT03595774|452965544|FG000|Overall Study|Adverse Event|1|||
125908548|NCT03595774|452965545|FG001|Overall Study|Adverse Event|0|||
125908549|NCT03595774|452965546|FG002|Overall Study|Adverse Event|1|||
125908550|NCT03595774|452965547|FG003|Overall Study|Adverse Event|0|||
125908551|NCT03595774|452965544|FG000|Overall Study|screen failure|0|||
125908552|NCT03595774|452965545|FG001|Overall Study|screen failure|1|||
125908553|NCT03595774|452965546|FG002|Overall Study|screen failure|0|||
125908554|NCT03595774|452965547|FG003|Overall Study|screen failure|1|||
125908555|NCT01151098|452965548|FG000|Overall Study|Adverse Event|82|||
125908556|NCT01151098|452965548|FG000|Overall Study|Lost to Follow-up|6|||
125908557|NCT01151098|452965548|FG000|Overall Study|Lack of Efficacy|15|||
125908558|NCT01151098|452965548|FG000|Overall Study|Protocol Violation|1|||
125908559|NCT01151098|452965548|FG000|Overall Study|Miscellaneous|13|||
125908560|NCT00116168|452965555|FG000|Overall Study|Lost to Follow-up|6|||
125908561|NCT00116168|452965556|FG001|Overall Study|Lost to Follow-up|5|||
125908562|NCT00116168|452965557|FG002|Overall Study|Lost to Follow-up|0|||
125908563|NCT00116168|452965558|FG003|Overall Study|Lost to Follow-up|0|||
125908564|NCT02788474|452965559|FG000|Double Blind Treatment Period|Not treated|1|||
125908565|NCT02788474|452965560|FG001|Double Blind Treatment Period|Not treated|0|||
125908566|NCT02788474|452965559|FG000|Double Blind Treatment Period|Patient's refusal|3|||
125908567|NCT02788474|452965560|FG001|Double Blind Treatment Period|Patient's refusal|0|||
125908568|NCT02788474|452965559|FG000|Double Blind Treatment Period|Adverse Event|6|||
125908569|NCT02788474|452965560|FG001|Double Blind Treatment Period|Adverse Event|4|||
125908570|NCT02788474|452965559|FG000|Open Label Treatment Period|Adverse Event|29|||
125908571|NCT02788474|452965560|FG001|Open Label Treatment Period|Adverse Event|9|||
125908572|NCT02788474|452965559|FG000|Open Label Treatment Period|Other than reason specified|1|||
125908573|NCT02788474|452965560|FG001|Open Label Treatment Period|Other than reason specified|0|||
125908574|NCT02788474|452965559|FG000|Open Label Treatment Period|Patient's refusal|1|||
125908575|NCT02788474|452965560|FG001|Open Label Treatment Period|Patient's refusal|3|||
125908576|NCT02788474|452965559|FG000|Open Label Treatment Period|Non-compliance|1|||
125908577|NCT02788474|452965560|FG001|Open Label Treatment Period|Non-compliance|0|||
125908578|NCT00117286|452965561|FG000|Overall Study|Adverse Event|12|||
125908579|NCT00117286|452965562|FG001|Overall Study|Adverse Event|6|||
125908580|NCT00117286|452965561|FG000|Overall Study|Lost to Follow-up|2|||
125908581|NCT00117286|452965562|FG001|Overall Study|Lost to Follow-up|0|||
125908582|NCT00117286|452965561|FG000|Overall Study|Protocol Violation|3|||
125908583|NCT00117286|452965562|FG001|Overall Study|Protocol Violation|3|||
125908584|NCT00117286|452965561|FG000|Overall Study|Withdrawal by Subject|6|||
125908585|NCT00117286|452965562|FG001|Overall Study|Withdrawal by Subject|2|||
125908586|NCT00117286|452965561|FG000|Overall Study|Physician Decision|3|||
125908587|NCT00117286|452965562|FG001|Overall Study|Physician Decision|7|||
125908588|NCT00117286|452965561|FG000|Overall Study|Lack of Efficacy|2|||
125908589|NCT00117286|452965562|FG001|Overall Study|Lack of Efficacy|1|||
125908590|NCT00117286|452965561|FG000|Overall Study|Research site closing|0|||
125908591|NCT00117286|452965562|FG001|Overall Study|Research site closing|2|||
125908592|NCT00048061|452965564|FG000|Overall Study|Adverse Event|41|||
125908593|NCT00048061|452965565|FG001|Overall Study|Adverse Event|32|||
125908594|NCT00048061|452965566|FG002|Overall Study|Adverse Event|44|||
125908595|NCT00048061|452965567|FG003|Overall Study|Adverse Event|37|||
125908596|NCT00048061|452965564|FG000|Overall Study|Lost to Follow-up|3|||
125908597|NCT00048061|452965565|FG001|Overall Study|Lost to Follow-up|2|||
125908598|NCT00048061|452965566|FG002|Overall Study|Lost to Follow-up|4|||
125908599|NCT00048061|452965567|FG003|Overall Study|Lost to Follow-up|5|||
125908600|NCT00048061|452965564|FG000|Overall Study|Withdrawal by Subject|20|||
125908601|NCT00048061|452965565|FG001|Overall Study|Withdrawal by Subject|29|||
125908602|NCT00048061|452965566|FG002|Overall Study|Withdrawal by Subject|29|||
125908603|NCT00048061|452965567|FG003|Overall Study|Withdrawal by Subject|32|||
125908604|NCT00048061|452965564|FG000|Overall Study|Did not follow-up|5|||
125908605|NCT00048061|452965565|FG001|Overall Study|Did not follow-up|5|||
125908606|NCT00048061|452965566|FG002|Overall Study|Did not follow-up|4|||
125908607|NCT00048061|452965567|FG003|Overall Study|Did not follow-up|5|||
125908608|NCT00048061|452965564|FG000|Overall Study|Early improvement|6|||
125908609|NCT00048061|452965565|FG001|Overall Study|Early improvement|5|||
125908610|NCT00048061|452965566|FG002|Overall Study|Early improvement|3|||
125908611|NCT00048061|452965567|FG003|Overall Study|Early improvement|0|||
125908612|NCT03555435|452965568|FG000|Overall Study|Lost to Follow-up|17|||
125908613|NCT03555435|452965569|FG001|Overall Study|Lost to Follow-up|19|||
125908614|NCT03555435|452965570|FG002|Overall Study|Lost to Follow-up|8|||
125908615|NCT01272661|452965574|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
125908616|NCT01272661|452965575|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
125908617|NCT01272661|452965576|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
125908618|NCT02869438|452965577|FG000|Overall Study|Lost to Follow-up|1|||
125908619|NCT02869438|452965578|FG001|Overall Study|Lost to Follow-up|0|||
125908620|NCT02869438|452965577|FG000|Overall Study|Adverse Event|1|||
125908621|NCT02869438|452965578|FG001|Overall Study|Adverse Event|0|||
125908622|NCT02869438|452965577|FG000|Overall Study|Withdrawal by Subject|1|||
125908623|NCT02869438|452965578|FG001|Overall Study|Withdrawal by Subject|2|||
125908624|NCT02169284|452965584|FG000|Overall Study|Physician Decision|0|||
125908625|NCT02169284|452965585|FG001|Overall Study|Physician Decision|1|||
125908626|NCT03583073|452965586|FG000|Overall Study|Lost to Follow-up|8|||
125908627|NCT03583073|452965587|FG001|Overall Study|Lost to Follow-up|12|||
125908628|NCT01013649|452965588|FG000|First Step|Withdrawal by Subject|36|||
125908629|NCT01013649|452965589|FG001|First Step|Withdrawal by Subject|19|||
125908630|NCT01013649|452965590|FG002|First Step|Withdrawal by Subject|0|||
125908631|NCT01013649|452965591|FG003|First Step|Withdrawal by Subject|0|||
125908632|NCT01013649|452965588|FG000|First Step|Progression|58|||
125908633|NCT01013649|452965589|FG001|First Step|Progression|23|||
125908634|NCT01013649|452965590|FG002|First Step|Progression|0|||
125908635|NCT01013649|452965591|FG003|First Step|Progression|0|||
125908636|NCT01013649|452965588|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
125908637|NCT01013649|452965589|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
125908638|NCT01013649|452965590|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
125908639|NCT01013649|452965591|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
125908640|NCT01013649|452965588|FG000|First Step|Death|3|||
125908641|NCT01013649|452965589|FG001|First Step|Death|4|||
125908642|NCT01013649|452965590|FG002|First Step|Death|0|||
125908643|NCT01013649|452965591|FG003|First Step|Death|0|||
125908644|NCT01013649|452965588|FG000|First Step|Adverse Event|9|||
125908645|NCT01013649|452965589|FG001|First Step|Adverse Event|5|||
125908646|NCT01013649|452965590|FG002|First Step|Adverse Event|0|||
125908647|NCT01013649|452965591|FG003|First Step|Adverse Event|0|||
125908648|NCT01013649|452965588|FG000|First Step|Other|4|||
125908649|NCT01013649|452965589|FG001|First Step|Other|6|||
125908650|NCT01013649|452965590|FG002|First Step|Other|0|||
125908651|NCT01013649|452965591|FG003|First Step|Other|0|||
125908652|NCT01367119|452965592|FG000|Overall Study|Adverse Event|1|||
125908653|NCT01367119|452965593|FG001|Overall Study|Adverse Event|0|||
125908654|NCT01367119|452965592|FG000|Overall Study|Withdrawal by Subject|1|||
125908655|NCT01367119|452965593|FG001|Overall Study|Withdrawal by Subject|1|||
125908656|NCT03180684|452965596|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
125908657|NCT03180684|452965597|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
125908658|NCT03180684|452965596|FG000|Overall Study|Physician Decision|1|||
125908659|NCT03180684|452965597|FG001|Overall Study|Physician Decision|0|||
125908660|NCT03180684|452965596|FG000|Overall Study|Lost to Follow-up|1|||
125908661|NCT03180684|452965597|FG001|Overall Study|Lost to Follow-up|0|||
125908662|NCT03180684|452965596|FG000|Overall Study|Progressive Disease|1|||
125908663|NCT03180684|452965597|FG001|Overall Study|Progressive Disease|0|||
125908664|NCT01115803|452965598|FG000|Overall Study|Withdrawal by Subject|0|||
125908665|NCT01115803|452965599|FG001|Overall Study|Withdrawal by Subject|0|||
125908666|NCT01115803|452965600|FG002|Overall Study|Withdrawal by Subject|0|||
125908667|NCT01115803|452965601|FG003|Overall Study|Withdrawal by Subject|0|||
125908668|NCT01115803|452965602|FG004|Overall Study|Withdrawal by Subject|0|||
125908669|NCT01115803|452965603|FG005|Overall Study|Withdrawal by Subject|0|||
125908670|NCT01115803|452965604|FG006|Overall Study|Withdrawal by Subject|1|||
125908671|NCT01115803|452965598|FG000|Overall Study|Lost to Follow-up|0|||
125908672|NCT01115803|452965599|FG001|Overall Study|Lost to Follow-up|0|||
125908673|NCT01115803|452965600|FG002|Overall Study|Lost to Follow-up|1|||
125908674|NCT01115803|452965601|FG003|Overall Study|Lost to Follow-up|0|||
125908675|NCT01115803|452965602|FG004|Overall Study|Lost to Follow-up|0|||
125908676|NCT01115803|452965603|FG005|Overall Study|Lost to Follow-up|0|||
125908677|NCT01115803|452965604|FG006|Overall Study|Lost to Follow-up|0|||
125908678|NCT01115803|452965598|FG000|Overall Study|Progressive Disease during Cycle1|0|||
125908679|NCT01115803|452965599|FG001|Overall Study|Progressive Disease during Cycle1|0|||
125908680|NCT01115803|452965600|FG002|Overall Study|Progressive Disease during Cycle1|0|||
125908681|NCT01115803|452965601|FG003|Overall Study|Progressive Disease during Cycle1|0|||
125908682|NCT01115803|452965602|FG004|Overall Study|Progressive Disease during Cycle1|0|||
125908683|NCT01115803|452965603|FG005|Overall Study|Progressive Disease during Cycle1|0|||
125908684|NCT01115803|452965604|FG006|Overall Study|Progressive Disease during Cycle1|1|||
125908685|NCT03475875|452965605|FG000|Period 1|Lost to Follow-up|1|||
125908686|NCT03475875|452965606|FG001|Period 1|Lost to Follow-up|0|||
125908687|NCT03475875|452965605|FG000|Period 1|Adverse Event|2|||
125908688|NCT03475875|452965606|FG001|Period 1|Adverse Event|1|||
125908689|NCT03475875|452965605|FG000|Period 2|Adverse Event|3|||
125908690|NCT03475875|452965606|FG001|Period 2|Adverse Event|0|||
125908691|NCT03475875|452965605|FG000|Period 2|Protocol Violation|0|||
125908692|NCT03475875|452965606|FG001|Period 2|Protocol Violation|1|||
125908693|NCT02017171|452965607|FG000|Overall Study|Death|10|||
125908694|NCT02017171|452965608|FG001|Overall Study|Death|4|||
125908695|NCT02017171|452965607|FG000|Overall Study|Withdrawal by Subject|23|||
125908696|NCT02017171|452965608|FG001|Overall Study|Withdrawal by Subject|17|||
125908697|NCT02017171|452965607|FG000|Overall Study|Lost to Follow-up|21|||
125908698|NCT02017171|452965608|FG001|Overall Study|Lost to Follow-up|20|||
125908699|NCT02017171|452965607|FG000|Overall Study|ESKD|6|||
125908700|NCT02017171|452965608|FG001|Overall Study|ESKD|2|||
125908701|NCT02017171|452965607|FG000|Overall Study|Miscellaneous|2|||
125908702|NCT02017171|452965608|FG001|Overall Study|Miscellaneous|3|||
125908703|NCT03091777|452965610|FG000|Overall Study|Pregnancy|2|||
125908704|NCT03091777|452965611|FG001|Overall Study|Pregnancy|1|||
125908705|NCT03091777|452965612|FG002|Overall Study|Pregnancy|0|||
125908706|NCT03091777|452965610|FG000|Overall Study|Adverse Event|2|||
125908707|NCT03091777|452965611|FG001|Overall Study|Adverse Event|1|||
125908708|NCT03091777|452965612|FG002|Overall Study|Adverse Event|4|||
125908709|NCT03091777|452965610|FG000|Overall Study|Withdrawal by Subject|4|||
125908710|NCT03091777|452965611|FG001|Overall Study|Withdrawal by Subject|2|||
125908711|NCT03091777|452965612|FG002|Overall Study|Withdrawal by Subject|6|||
125908712|NCT03091777|452965610|FG000|Overall Study|Protocol Violation|2|||
125908713|NCT03091777|452965611|FG001|Overall Study|Protocol Violation|1|||
125908714|NCT03091777|452965612|FG002|Overall Study|Protocol Violation|1|||
125908715|NCT03091777|452965610|FG000|Overall Study|Lost to Follow-up|12|||
125908716|NCT03091777|452965611|FG001|Overall Study|Lost to Follow-up|14|||
125908717|NCT03091777|452965612|FG002|Overall Study|Lost to Follow-up|7|||
125908718|NCT03091777|452965610|FG000|Overall Study|Lack of Efficacy|0|||
125908719|NCT03091777|452965611|FG001|Overall Study|Lack of Efficacy|0|||
125908720|NCT03091777|452965612|FG002|Overall Study|Lack of Efficacy|5|||
125908721|NCT03091777|452965610|FG000|Overall Study|Noncompliance with study drug|2|||
125908722|NCT03091777|452965611|FG001|Overall Study|Noncompliance with study drug|3|||
125908723|NCT03091777|452965612|FG002|Overall Study|Noncompliance with study drug|1|||
125908724|NCT03091777|452965610|FG000|Overall Study|Physician Decision|1|||
125908725|NCT03091777|452965611|FG001|Overall Study|Physician Decision|0|||
125908726|NCT03091777|452965612|FG002|Overall Study|Physician Decision|1|||
125908727|NCT03091777|452965610|FG000|Overall Study|Abnormal Laboratory Value|7|||
125908728|NCT03091777|452965611|FG001|Overall Study|Abnormal Laboratory Value|11|||
125908729|NCT03091777|452965612|FG002|Overall Study|Abnormal Laboratory Value|12|||
125908730|NCT03370289|452965613|FG000|Overall Study|Screen Failure|1|||
125908731|NCT03370289|452965613|FG000|Overall Study|Sample Size Sufficient|4|||
125908732|NCT02220998|452965614|FG000|Overall Study|Randomized but Never Treated|1|||
125908733|NCT02220998|452965615|FG001|Overall Study|Randomized but Never Treated|2|||
125908734|NCT02220998|452965614|FG000|Overall Study|Death|2|||
125908735|NCT02220998|452965615|FG001|Overall Study|Death|0|||
125908736|NCT02220998|452965614|FG000|Overall Study|Lack of Efficacy|0|||
126110130|NCT00559585|453697647|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
125908737|NCT02220998|452965615|FG001|Overall Study|Lack of Efficacy|5|||
125908738|NCT02220998|452965614|FG000|Overall Study|Lost to Follow-up|4|||
125908739|NCT02220998|452965615|FG001|Overall Study|Lost to Follow-up|4|||
125908740|NCT02314143|452965616|FG000|Overall Study|Adverse Event|0|||
125908741|NCT02314143|452965617|FG001|Overall Study|Adverse Event|6|||
125908742|NCT02314143|452965618|FG002|Overall Study|Adverse Event|4|||
125908743|NCT02314143|452965616|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
125908744|NCT02314143|452965617|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
125908745|NCT02314143|452965618|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
125908746|NCT02314143|452965616|FG000|Overall Study|Physician Decision|2|||
125908747|NCT02314143|452965617|FG001|Overall Study|Physician Decision|1|||
125908748|NCT02314143|452965618|FG002|Overall Study|Physician Decision|0|||
125908749|NCT02314143|452965616|FG000|Overall Study|Withdrawal by Subject|1|||
125908750|NCT02314143|452965617|FG001|Overall Study|Withdrawal by Subject|0|||
125908751|NCT02314143|452965618|FG002|Overall Study|Withdrawal by Subject|1|||
126060196|NCT02399449|453514274|FG001|Overall Study|Withdrawal by Subject|9|||
126060197|NCT02399449|453514273|FG000|Overall Study|Physician Decision|0|||
126060198|NCT02399449|453514274|FG001|Overall Study|Physician Decision|1|||
126060199|NCT02516202|453514275|FG000|Overall Study|Withdrawal by Subject|1|||
126060200|NCT02516202|453514276|FG001|Overall Study|Withdrawal by Subject|0|||
126060201|NCT02516202|453514277|FG002|Overall Study|Withdrawal by Subject|1|||
126060202|NCT02516202|453514275|FG000|Overall Study|Lost to Follow-up|1|||
126060203|NCT02516202|453514276|FG001|Overall Study|Lost to Follow-up|1|||
126060204|NCT02516202|453514277|FG002|Overall Study|Lost to Follow-up|1|||
126060205|NCT02516202|453514275|FG000|Overall Study|Stopped Follow-up|0|||
126060206|NCT02516202|453514276|FG001|Overall Study|Stopped Follow-up|0|||
126060207|NCT02516202|453514277|FG002|Overall Study|Stopped Follow-up|1|||
126060208|NCT00337610|453514278|FG000|Overall Study|Adverse Event|2|||
126060209|NCT00337610|453514279|FG001|Overall Study|Adverse Event|2|||
126060210|NCT00337610|453514278|FG000|Overall Study|Death|0|||
126060211|NCT00337610|453514279|FG001|Overall Study|Death|1|||
126060212|NCT00337610|453514278|FG000|Overall Study|Lack of Efficacy|6|||
126060213|NCT00337610|453514279|FG001|Overall Study|Lack of Efficacy|3|||
126060214|NCT00337610|453514278|FG000|Overall Study|Lost to Follow-up|3|||
126060215|NCT00337610|453514279|FG001|Overall Study|Lost to Follow-up|3|||
126060216|NCT00337610|453514278|FG000|Overall Study|Withdrawal by Subject|6|||
126060217|NCT00337610|453514279|FG001|Overall Study|Withdrawal by Subject|5|||
126060218|NCT03205488|453514282|FG000|Overall Study|Adverse Event|1|||
126060219|NCT03205488|453514283|FG001|Overall Study|Adverse Event|2|||
126060220|NCT03205488|453514284|FG002|Overall Study|Adverse Event|4|||
126060221|NCT03205488|453514282|FG000|Overall Study|Protocol Violation|0|||
126060222|NCT03205488|453514283|FG001|Overall Study|Protocol Violation|0|||
126060223|NCT03205488|453514284|FG002|Overall Study|Protocol Violation|1|||
126060224|NCT04867382|453514285|FG000|Overall Study|Did not complete the survey|2|||
126060225|NCT04867382|453514286|FG001|Overall Study|Did not complete the survey|1|||
126060226|NCT05445557|453514290|FG000|Double Blind Part|Lost to Follow-up|1|||
126060227|NCT02008916|453514291|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
126060228|NCT02008916|453514292|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
126060229|NCT02008916|453514293|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
126060230|NCT02008916|453514291|FG000|Week 16 - 156|Adverse Event|4|||
126060231|NCT02008916|453514292|FG001|Week 16 - 156|Adverse Event|2|||
126060232|NCT02008916|453514293|FG002|Week 16 - 156|Adverse Event|3|||
126060233|NCT02008916|453514291|FG000|Week 16 - 156|Withdrawal by Subject|7|||
126060234|NCT02008916|453514292|FG001|Week 16 - 156|Withdrawal by Subject|3|||
126060235|NCT02008916|453514293|FG002|Week 16 - 156|Withdrawal by Subject|5|||
126060236|NCT02008916|453514291|FG000|Week 16 - 156|No longer requires treatment|0|||
126060237|NCT02008916|453514292|FG001|Week 16 - 156|No longer requires treatment|1|||
126060238|NCT02008916|453514293|FG002|Week 16 - 156|No longer requires treatment|0|||
126060239|NCT02008916|453514291|FG000|Week 16 - 156|Lost to Follow-up|5|||
126060240|NCT02008916|453514292|FG001|Week 16 - 156|Lost to Follow-up|0|||
126060241|NCT02008916|453514293|FG002|Week 16 - 156|Lost to Follow-up|0|||
126060242|NCT02008916|453514291|FG000|Week 16 - 156|Lack of Efficacy|3|||
126060243|NCT02008916|453514292|FG001|Week 16 - 156|Lack of Efficacy|5|||
126060244|NCT02008916|453514293|FG002|Week 16 - 156|Lack of Efficacy|2|||
126060245|NCT02008916|453514291|FG000|Week 16 - 156|Pregnancy|0|||
126060246|NCT02008916|453514292|FG001|Week 16 - 156|Pregnancy|1|||
126060247|NCT02008916|453514293|FG002|Week 16 - 156|Pregnancy|0|||
126060248|NCT02008916|453514291|FG000|Week 16 - 156|Physician Decision|0|||
126060249|NCT02008916|453514292|FG001|Week 16 - 156|Physician Decision|1|||
126060250|NCT02008916|453514293|FG002|Week 16 - 156|Physician Decision|0|||
126060251|NCT03803475|453514294|FG000|Overall Study|Physician Decision|1|||
126060252|NCT00392197|453514297|FG000|Overall Study|Adverse Event|4|||
126060253|NCT00392197|453514298|FG001|Overall Study|Adverse Event|12|||
126060254|NCT00392197|453514297|FG000|Overall Study|Lack of Efficacy|3|||
126060255|NCT00392197|453514298|FG001|Overall Study|Lack of Efficacy|4|||
126060256|NCT00392197|453514297|FG000|Overall Study|Lost to Follow-up|0|||
126060257|NCT00392197|453514298|FG001|Overall Study|Lost to Follow-up|1|||
126060258|NCT00392197|453514297|FG000|Overall Study|Physician Decision|3|||
126060259|NCT00392197|453514298|FG001|Overall Study|Physician Decision|2|||
126060260|NCT00392197|453514297|FG000|Overall Study|Protocol Violation|7|||
126060261|NCT00392197|453514298|FG001|Overall Study|Protocol Violation|5|||
126060262|NCT00392197|453514297|FG000|Overall Study|Withdrawal by Subject|4|||
126060263|NCT00392197|453514298|FG001|Overall Study|Withdrawal by Subject|6|||
126060264|NCT00428714|453514300|FG000|Overall Study|Progressive Disease|28|||
126060265|NCT00428714|453514301|FG001|Overall Study|Progressive Disease|36|||
126060266|NCT00428714|453514300|FG000|Overall Study|Withdrawal by Subject|0|||
126060267|NCT00428714|453514301|FG001|Overall Study|Withdrawal by Subject|3|||
126060268|NCT00428714|453514300|FG000|Overall Study|Adverse Event|0|||
126060269|NCT00428714|453514301|FG001|Overall Study|Adverse Event|2|||
126060270|NCT00428714|453514300|FG000|Overall Study|Physician Decision|1|||
126060271|NCT00428714|453514301|FG001|Overall Study|Physician Decision|1|||
126060272|NCT00428714|453514300|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
126060273|NCT00428714|453514301|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
126060274|NCT00428714|453514300|FG000|Overall Study|Death due to other then PD|1|||
126060275|NCT00428714|453514301|FG001|Overall Study|Death due to other then PD|0|||
126060276|NCT01681511|453514302|FG000|Overall Study|No Treatment Received|1|||
126060277|NCT01681511|453514303|FG001|Overall Study|No Treatment Received|3|||
126060278|NCT01681511|453514302|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
126060279|NCT01681511|453514303|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
126060280|NCT01681511|453514302|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
126060281|NCT01681511|453514303|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
126060282|NCT01681511|453514302|FG000|Overall Study|No Daily Urine Sample Collected|0|||
126060283|NCT01681511|453514303|FG001|Overall Study|No Daily Urine Sample Collected|1|||
126060284|NCT01681511|453514302|FG000|Overall Study|No post-catheter sample collected|11|||
126060285|NCT01681511|453514303|FG001|Overall Study|No post-catheter sample collected|4|||
126060286|NCT00090519|453514317|FG000|Overall Study|Adverse Event|5|||
126060287|NCT00090519|453514318|FG001|Overall Study|Adverse Event|4|||
126060288|NCT00090519|453514317|FG000|Overall Study|Death|9|||
126060289|NCT00090519|453514318|FG001|Overall Study|Death|9|||
126060290|NCT00090519|453514317|FG000|Overall Study|Lost to Follow-up|26|||
126060291|NCT00090519|453514318|FG001|Overall Study|Lost to Follow-up|29|||
126060292|NCT00090519|453514317|FG000|Overall Study|Withdrawal by Subject|28|||
126060293|NCT00090519|453514318|FG001|Overall Study|Withdrawal by Subject|29|||
126060294|NCT00090519|453514317|FG000|Overall Study|Physician Decision|2|||
126060295|NCT00090519|453514318|FG001|Overall Study|Physician Decision|3|||
125908752|NCT00873860|452965619|FG000|Overall Study|Lost to Follow-up|1|||
126060296|NCT00090519|453514317|FG000|Overall Study|Sponsor Decision|3|||
126060297|NCT00090519|453514318|FG001|Overall Study|Sponsor Decision|1|||
126110131|NCT00559585|453697646|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
126060298|NCT02161146|453514319|FG000|Overall Study|Adverse Event|1|||
126060299|NCT02161146|453514320|FG001|Overall Study|Adverse Event|1|||
126060300|NCT02161146|453514321|FG002|Overall Study|Adverse Event|0|||
126060301|NCT02161146|453514322|FG003|Overall Study|Adverse Event|1|||
126060302|NCT02161146|453514323|FG004|Overall Study|Adverse Event|0|||
126060303|NCT02161146|453514319|FG000|Overall Study|Lost to Follow-up|0|||
126060304|NCT02161146|453514320|FG001|Overall Study|Lost to Follow-up|1|||
126060305|NCT02161146|453514321|FG002|Overall Study|Lost to Follow-up|0|||
126060306|NCT02161146|453514322|FG003|Overall Study|Lost to Follow-up|0|||
126060307|NCT02161146|453514323|FG004|Overall Study|Lost to Follow-up|0|||
125908753|NCT00873860|452965620|FG001|Overall Study|Lost to Follow-up|0|||
125908754|NCT00873860|452965621|FG002|Overall Study|Lost to Follow-up|0|||
125908755|NCT00873860|452965622|FG003|Overall Study|Lost to Follow-up|1|||
125908756|NCT00873860|452965619|FG000|Overall Study|Withdrawal by Subject|1|||
125908757|NCT00873860|452965620|FG001|Overall Study|Withdrawal by Subject|0|||
125908758|NCT00873860|452965621|FG002|Overall Study|Withdrawal by Subject|2|||
125908759|NCT00873860|452965622|FG003|Overall Study|Withdrawal by Subject|0|||
125908760|NCT00873860|452965619|FG000|Overall Study|Death|1|||
125908761|NCT00873860|452965620|FG001|Overall Study|Death|0|||
126060308|NCT02161146|453514319|FG000|Overall Study|Personal Reasons|0|||
126060309|NCT02161146|453514320|FG001|Overall Study|Personal Reasons|1|||
125908762|NCT00873860|452965621|FG002|Overall Study|Death|0|||
125908763|NCT00873860|452965622|FG003|Overall Study|Death|0|||
126060310|NCT02161146|453514321|FG002|Overall Study|Personal Reasons|0|||
126060311|NCT02161146|453514322|FG003|Overall Study|Personal Reasons|2|||
126060312|NCT02161146|453514323|FG004|Overall Study|Personal Reasons|1|||
126060313|NCT02161146|453514319|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126060314|NCT02161146|453514320|FG001|Overall Study|Other Miscellaneous Reasons|1|||
126060315|NCT02161146|453514321|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126060316|NCT02161146|453514322|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126060317|NCT02161146|453514323|FG004|Overall Study|Other Miscellaneous Reasons|0|||
126060318|NCT02613403|453514326|FG000|Overall Study|Lost to Follow-up|0|||
126060319|NCT02613403|453514327|FG001|Overall Study|Lost to Follow-up|1|||
125908764|NCT00873860|452965619|FG000|Overall Study|Other|1|||
125908765|NCT00873860|452965620|FG001|Overall Study|Other|0|||
126060320|NCT02613403|453514328|FG002|Overall Study|Lost to Follow-up|0|||
126060321|NCT02613403|453514329|FG003|Overall Study|Lost to Follow-up|0|||
125908766|NCT00873860|452965621|FG002|Overall Study|Other|1|||
125908767|NCT00873860|452965622|FG003|Overall Study|Other|0|||
125908768|NCT02140775|452965625|FG000|Overall Study|Withdrawal by Subject|30|||
125908769|NCT02140775|452965626|FG001|Overall Study|Withdrawal by Subject|7|||
125908770|NCT04650854|452965629|FG000|Overall Study|Adverse Event|1|||
125908771|NCT04650854|452965630|FG001|Overall Study|Adverse Event|12|||
125908772|NCT04650854|452965631|FG002|Overall Study|Adverse Event|14|||
125908773|NCT04650854|452965629|FG000|Overall Study|Lack of Efficacy|1|||
125908774|NCT04650854|452965630|FG001|Overall Study|Lack of Efficacy|3|||
125908775|NCT04650854|452965631|FG002|Overall Study|Lack of Efficacy|6|||
125908776|NCT04650854|452965629|FG000|Overall Study|Lost to Follow-up|1|||
125908777|NCT04650854|452965630|FG001|Overall Study|Lost to Follow-up|1|||
125908778|NCT04650854|452965631|FG002|Overall Study|Lost to Follow-up|0|||
125908779|NCT04650854|452965629|FG000|Overall Study|Withdrawal by Subject|2|||
125908780|NCT04650854|452965630|FG001|Overall Study|Withdrawal by Subject|17|||
125908781|NCT04650854|452965631|FG002|Overall Study|Withdrawal by Subject|9|||
125908782|NCT04650854|452965629|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
125908783|NCT04650854|452965630|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
125908784|NCT04650854|452965631|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
125908785|NCT04650854|452965629|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
125908786|NCT04650854|452965630|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
125908787|NCT04650854|452965631|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
125908788|NCT04650854|452965629|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
125908789|NCT04650854|452965630|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
125908790|NCT04650854|452965631|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
125908791|NCT04650854|452965629|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
125908792|NCT04650854|452965630|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
125908793|NCT04650854|452965631|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
125908794|NCT04650854|452965629|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
125908795|NCT04650854|452965630|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
125908796|NCT04650854|452965631|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
125908797|NCT04650854|452965629|FG000|Overall Study|Use of Rescue Medication|0|||
125908798|NCT04650854|452965630|FG001|Overall Study|Use of Rescue Medication|0|||
125908799|NCT04650854|452965631|FG002|Overall Study|Use of Rescue Medication|1|||
125908800|NCT04650854|452965629|FG000|Overall Study|Last Treatment Per Sponsor|0|||
125908801|NCT04650854|452965630|FG001|Overall Study|Last Treatment Per Sponsor|0|||
125908802|NCT04650854|452965631|FG002|Overall Study|Last Treatment Per Sponsor|2|||
125908803|NCT04650854|452965629|FG000|Overall Study|Rescue Medication|0|||
125908804|NCT04650854|452965630|FG001|Overall Study|Rescue Medication|0|||
125908805|NCT04650854|452965631|FG002|Overall Study|Rescue Medication|1|||
125908806|NCT04650854|452965629|FG000|Overall Study|Participant Want to Start a Family|0|||
125908807|NCT04650854|452965630|FG001|Overall Study|Participant Want to Start a Family|0|||
125908808|NCT04650854|452965631|FG002|Overall Study|Participant Want to Start a Family|1|||
125908809|NCT04650854|452965629|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
125908810|NCT04650854|452965630|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
125908811|NCT04650854|452965631|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
125908812|NCT04650854|452965629|FG000|Overall Study|Participant Screened For MG0020|0|||
125908813|NCT04650854|452965630|FG001|Overall Study|Participant Screened For MG0020|2|||
125908814|NCT04650854|452965631|FG002|Overall Study|Participant Screened For MG0020|3|||
125908815|NCT04650854|452965629|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
125908816|NCT04650854|452965630|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
125908817|NCT04650854|452965631|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
125908818|NCT04650854|452965629|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
125908819|NCT04650854|452965630|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
125908820|NCT04650854|452965631|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
125908821|NCT04650854|452965629|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
125908822|NCT04650854|452965630|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
125908823|NCT04650854|452965631|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
125908824|NCT04650854|452965629|FG000|Overall Study|End Of Study|0|||
125908825|NCT04650854|452965630|FG001|Overall Study|End Of Study|2|||
125908826|NCT04650854|452965631|FG002|Overall Study|End Of Study|1|||
125908827|NCT04650854|452965629|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
125908828|NCT04650854|452965630|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
125908829|NCT04650854|452965631|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
125908830|NCT04650854|452965629|FG000|Overall Study|Participant Received Rescue Medication|0|||
125908831|NCT04650854|452965630|FG001|Overall Study|Participant Received Rescue Medication|1|||
125908832|NCT04650854|452965631|FG002|Overall Study|Participant Received Rescue Medication|0|||
125908833|NCT04650854|452965629|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
125908834|NCT04650854|452965630|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
125908835|NCT04650854|452965631|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
125908836|NCT04650854|452965629|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
125908837|NCT04650854|452965630|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
125908838|NCT04650854|452965631|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
125908839|NCT04650854|452965629|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
125908840|NCT04650854|452965630|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
126060322|NCT02613403|453514330|FG004|Overall Study|Lost to Follow-up|0|||
126060323|NCT02613403|453514326|FG000|Overall Study|Withdrawal by Subject|2|||
126060324|NCT02613403|453514327|FG001|Overall Study|Withdrawal by Subject|0|||
126060325|NCT02613403|453514328|FG002|Overall Study|Withdrawal by Subject|0|||
126060326|NCT02613403|453514329|FG003|Overall Study|Withdrawal by Subject|0|||
126060327|NCT02613403|453514330|FG004|Overall Study|Withdrawal by Subject|0|||
126060328|NCT02189759|453514331|FG000|Overall Study|Lost to Follow-up|0|||
126060329|NCT02189759|453514332|FG001|Overall Study|Lost to Follow-up|0|||
126060330|NCT02189759|453514333|FG002|Overall Study|Lost to Follow-up|2|||
126060331|NCT02189759|453514334|FG003|Overall Study|Lost to Follow-up|5|||
126060332|NCT00800176|453514337|FG000|Overall Study|Adverse Event|2|||
126060333|NCT00800176|453514338|FG001|Overall Study|Adverse Event|1|||
126060334|NCT00800176|453514339|FG002|Overall Study|Adverse Event|0|||
126060335|NCT00800176|453514340|FG003|Overall Study|Adverse Event|2|||
126060336|NCT00800176|453514341|FG004|Overall Study|Adverse Event|1|||
126060337|NCT00800176|453514342|FG005|Overall Study|Adverse Event|1|||
126060338|NCT00800176|453514337|FG000|Overall Study|Refused treatment|3|||
126060339|NCT00800176|453514338|FG001|Overall Study|Refused treatment|2|||
126060340|NCT00800176|453514339|FG002|Overall Study|Refused treatment|0|||
126060341|NCT00800176|453514340|FG003|Overall Study|Refused treatment|0|||
126060342|NCT00800176|453514341|FG004|Overall Study|Refused treatment|1|||
126060343|NCT00800176|453514342|FG005|Overall Study|Refused treatment|4|||
126060344|NCT00800176|453514337|FG000|Overall Study|Failure to return|3|||
126060345|NCT00800176|453514338|FG001|Overall Study|Failure to return|3|||
126060346|NCT00800176|453514339|FG002|Overall Study|Failure to return|0|||
126060347|NCT00800176|453514340|FG003|Overall Study|Failure to return|2|||
126060348|NCT00800176|453514341|FG004|Overall Study|Failure to return|0|||
126060349|NCT00800176|453514342|FG005|Overall Study|Failure to return|0|||
126060350|NCT00800176|453514337|FG000|Overall Study|Other|1|||
126060351|NCT00800176|453514338|FG001|Overall Study|Other|0|||
126060352|NCT00800176|453514339|FG002|Overall Study|Other|0|||
126060353|NCT00800176|453514340|FG003|Overall Study|Other|0|||
126060354|NCT00800176|453514341|FG004|Overall Study|Other|2|||
126060355|NCT00800176|453514342|FG005|Overall Study|Other|0|||
126060356|NCT02548585|453514345|FG000|Overall Study|Withdrawal by Subject|0|||
126060357|NCT02548585|453514346|FG001|Overall Study|Withdrawal by Subject|0|||
126060358|NCT02548585|453514347|FG002|Overall Study|Withdrawal by Subject|0|||
126060359|NCT02548585|453514348|FG003|Overall Study|Withdrawal by Subject|0|||
126060360|NCT02548585|453514349|FG004|Overall Study|Withdrawal by Subject|0|||
126060361|NCT02548585|453514350|FG005|Overall Study|Withdrawal by Subject|1|||
126060362|NCT02548585|453514351|FG006|Overall Study|Withdrawal by Subject|0|||
126060363|NCT02548585|453514345|FG000|Overall Study|Lost to Follow-up|1|||
126060364|NCT02548585|453514346|FG001|Overall Study|Lost to Follow-up|0|||
126060365|NCT02548585|453514347|FG002|Overall Study|Lost to Follow-up|0|||
126060366|NCT02548585|453514348|FG003|Overall Study|Lost to Follow-up|0|||
126060367|NCT02548585|453514349|FG004|Overall Study|Lost to Follow-up|0|||
126060368|NCT02548585|453514350|FG005|Overall Study|Lost to Follow-up|0|||
126060369|NCT02548585|453514351|FG006|Overall Study|Lost to Follow-up|0|||
126060370|NCT02548585|453514345|FG000|Overall Study|Other|1|||
126060371|NCT02548585|453514346|FG001|Overall Study|Other|0|||
126060372|NCT02548585|453514347|FG002|Overall Study|Other|0|||
126060373|NCT02548585|453514348|FG003|Overall Study|Other|2|||
126060374|NCT02548585|453514349|FG004|Overall Study|Other|3|||
126060375|NCT02548585|453514350|FG005|Overall Study|Other|0|||
126060376|NCT02548585|453514351|FG006|Overall Study|Other|1|||
126060377|NCT02548585|453514345|FG000|Overall Study|Randomized but not treated|0|||
126060378|NCT02548585|453514346|FG001|Overall Study|Randomized but not treated|0|||
126060379|NCT02548585|453514347|FG002|Overall Study|Randomized but not treated|0|||
126060380|NCT02548585|453514348|FG003|Overall Study|Randomized but not treated|0|||
126060381|NCT02548585|453514349|FG004|Overall Study|Randomized but not treated|0|||
126060382|NCT02548585|453514350|FG005|Overall Study|Randomized but not treated|1|||
126060383|NCT02548585|453514351|FG006|Overall Study|Randomized but not treated|0|||
126060384|NCT03242863|453514355|FG000|Study Week 1|Withdrawal by Subject|0|||
126060385|NCT03242863|453514356|FG001|Study Week 1|Withdrawal by Subject|1|||
126060386|NCT03242863|453514357|FG002|Study Week 1|Withdrawal by Subject|0|||
126060387|NCT03242863|453514358|FG003|Study Week 1|Withdrawal by Subject|0|||
126060388|NCT03242863|453514359|FG004|Study Week 1|Withdrawal by Subject|3|||
126060389|NCT03242863|453514360|FG005|Study Week 1|Withdrawal by Subject|0|||
126060390|NCT01276509|453516197|FG000|Overall Study|Adverse Event|9|||
126060391|NCT01276509|453516198|FG001|Overall Study|Adverse Event|8|||
126060392|NCT01276509|453516199|FG002|Overall Study|Adverse Event|4|||
126060393|NCT01276509|453516200|FG003|Overall Study|Adverse Event|3|||
126060394|NCT01276509|453516197|FG000|Overall Study|Lack of Efficacy|2|||
126060395|NCT01276509|453516198|FG001|Overall Study|Lack of Efficacy|1|||
126060396|NCT01276509|453516199|FG002|Overall Study|Lack of Efficacy|1|||
126060397|NCT01276509|453516200|FG003|Overall Study|Lack of Efficacy|2|||
125908841|NCT04650854|452965631|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
125908842|NCT04650854|452965629|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
125908843|NCT04650854|452965630|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
125908844|NCT04650854|452965631|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
125908845|NCT04650854|452965629|FG000|Overall Study|Enrollment Cup|0|||
125908846|NCT04650854|452965630|FG001|Overall Study|Enrollment Cup|0|||
125908847|NCT04650854|452965631|FG002|Overall Study|Enrollment Cup|1|||
125908848|NCT00704808|452965632|FG000|Overall Study|Discontinued prior to starting treatment|14|||
125908849|NCT00704808|452965632|FG000|Overall Study|Death|7|||
125908850|NCT00704808|452965632|FG000|Overall Study|Tumor progression|80|||
125908851|NCT00704808|452965632|FG000|Overall Study|Patient's decision|11|||
125908852|NCT00704808|452965632|FG000|Overall Study|Early therapy discontinuation|16|||
125908853|NCT00704808|452965632|FG000|Overall Study|Adverse Event|1|||
125908854|NCT00704808|452965632|FG000|Overall Study|Lost to Follow-up|1|||
125908855|NCT00704808|452965632|FG000|Overall Study|Treatment change|1|||
125908856|NCT01280955|452965636|FG000|Overall Study|Death|2|||
125908857|NCT01280955|452965636|FG000|Overall Study|Withdrawal by Subject|1|||
125908858|NCT04223232|452965637|FG000|Overall Study|Withdrawal by Subject|1|||
125908859|NCT05281601|452965638|FG000|Overall Study|Physician Decision|2|||
125908860|NCT05281601|452965639|FG001|Overall Study|Physician Decision|0|||
125908861|NCT05281601|452965638|FG000|Overall Study|Lost to Follow-up|2|||
125908862|NCT05281601|452965639|FG001|Overall Study|Lost to Follow-up|0|||
125908863|NCT05281601|452965638|FG000|Overall Study|Death|1|||
125908864|NCT05281601|452965639|FG001|Overall Study|Death|0|||
125908865|NCT05281601|452965638|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125908866|NCT05281601|452965639|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125908867|NCT05063318|452965640|FG000|Overall Study|Progressive disease|2|||
125908868|NCT05063318|452965641|FG001|Overall Study|Progressive disease|0|||
125908869|NCT05063318|452965642|FG002|Overall Study|Progressive disease|3|||
125908870|NCT05063318|452965640|FG000|Overall Study|Compassionate use|1|||
125908871|NCT05063318|452965641|FG001|Overall Study|Compassionate use|3|||
125908872|NCT05063318|452965642|FG002|Overall Study|Compassionate use|3|||
125908873|NCT05063318|452965640|FG000|Overall Study|Adverse Event|0|||
125908874|NCT05063318|452965641|FG001|Overall Study|Adverse Event|1|||
125908875|NCT05063318|452965642|FG002|Overall Study|Adverse Event|0|||
125908876|NCT05063318|452965640|FG000|Overall Study|Withdrawal by Subject|0|||
125908877|NCT05063318|452965641|FG001|Overall Study|Withdrawal by Subject|1|||
125908878|NCT05063318|452965642|FG002|Overall Study|Withdrawal by Subject|0|||
125908879|NCT03172910|452967326|FG000|Overall Study|Adverse Event|0|||
125908880|NCT03172910|452967327|FG001|Overall Study|Adverse Event|0|||
125908881|NCT03172910|452967328|FG002|Overall Study|Adverse Event|0|||
125908882|NCT03172910|452967329|FG003|Overall Study|Adverse Event|0|||
125908883|NCT03172910|452967330|FG004|Overall Study|Adverse Event|1|||
125908884|NCT01659658|452967333|FG000|Overall Study|Withdrawal by Patient|18|||
125908885|NCT01659658|452967334|FG001|Overall Study|Withdrawal by Patient|4|||
125908886|NCT01659658|452967335|FG002|Overall Study|Withdrawal by Patient|2|||
125908887|NCT01659658|452967336|FG003|Overall Study|Withdrawal by Patient|0|||
125908888|NCT01659658|452967337|FG004|Overall Study|Withdrawal by Patient|11|||
125908889|NCT01659658|452967333|FG000|Overall Study|Study Terminated by Sponsor|9|||
125908890|NCT01659658|452967334|FG001|Overall Study|Study Terminated by Sponsor|7|||
125908891|NCT01659658|452967335|FG002|Overall Study|Study Terminated by Sponsor|0|||
125908892|NCT01659658|452967336|FG003|Overall Study|Study Terminated by Sponsor|1|||
125908893|NCT01659658|452967337|FG004|Overall Study|Study Terminated by Sponsor|4|||
125908894|NCT01659658|452967333|FG000|Overall Study|Reason not Specified|61|||
125908895|NCT01659658|452967334|FG001|Overall Study|Reason not Specified|15|||
125908896|NCT01659658|452967335|FG002|Overall Study|Reason not Specified|8|||
125908897|NCT01659658|452967336|FG003|Overall Study|Reason not Specified|1|||
125908898|NCT01659658|452967337|FG004|Overall Study|Reason not Specified|34|||
125908899|NCT01659658|452967333|FG000|Overall Study|Lost to Follow-up|2|||
125908900|NCT01659658|452967334|FG001|Overall Study|Lost to Follow-up|0|||
125908901|NCT01659658|452967335|FG002|Overall Study|Lost to Follow-up|0|||
125908902|NCT01659658|452967336|FG003|Overall Study|Lost to Follow-up|0|||
125908903|NCT01659658|452967337|FG004|Overall Study|Lost to Follow-up|0|||
125908904|NCT01397201|452967339|FG000|Overall Study|Not treated|0|||
125908905|NCT01397201|452967340|FG001|Overall Study|Not treated|0|||
125908906|NCT01397201|452967341|FG002|Overall Study|Not treated|1|||
125908907|NCT01397201|452967342|FG003|Overall Study|Not treated|0|||
125908908|NCT01397201|452967343|FG004|Overall Study|Not treated|0|||
125908909|NCT01397201|452967339|FG000|Overall Study|Not yet defined|3|||
125908910|NCT01397201|452967340|FG001|Overall Study|Not yet defined|6|||
125908911|NCT01397201|452967341|FG002|Overall Study|Not yet defined|5|||
125908912|NCT01397201|452967342|FG003|Overall Study|Not yet defined|5|||
125908913|NCT01397201|452967343|FG004|Overall Study|Not yet defined|4|||
125908914|NCT01397201|452967339|FG000|Overall Study|Adverse Event|2|||
125908915|NCT01397201|452967340|FG001|Overall Study|Adverse Event|0|||
125908916|NCT01397201|452967341|FG002|Overall Study|Adverse Event|0|||
125908917|NCT01397201|452967342|FG003|Overall Study|Adverse Event|0|||
125908918|NCT01397201|452967343|FG004|Overall Study|Adverse Event|0|||
126060398|NCT01276509|453516197|FG000|Overall Study|Pregnancy|1|||
126060399|NCT01276509|453516198|FG001|Overall Study|Pregnancy|0|||
126060400|NCT01276509|453516199|FG002|Overall Study|Pregnancy|0|||
126060401|NCT01276509|453516200|FG003|Overall Study|Pregnancy|0|||
126060402|NCT01276509|453516197|FG000|Overall Study|Withdrawal by Subject|1|||
126060403|NCT01276509|453516198|FG001|Overall Study|Withdrawal by Subject|2|||
126060404|NCT01276509|453516199|FG002|Overall Study|Withdrawal by Subject|0|||
126060405|NCT01276509|453516200|FG003|Overall Study|Withdrawal by Subject|0|||
126060406|NCT01276509|453516197|FG000|Overall Study|Other|0|||
126060407|NCT01276509|453516198|FG001|Overall Study|Other|1|||
126060408|NCT01276509|453516199|FG002|Overall Study|Other|0|||
126060409|NCT01276509|453516200|FG003|Overall Study|Other|0|||
126060410|NCT02196259|453516206|FG000|Overall Study|Researcher choice|0|||
126060411|NCT02196259|453516207|FG001|Overall Study|Researcher choice|0|||
126060412|NCT02196259|453516208|FG002|Overall Study|Researcher choice|1|||
125908919|NCT00215683|452967344|FG000|Overall Study|Adverse Event|15|||
125908920|NCT00215683|452967345|FG001|Overall Study|Adverse Event|16|||
125908921|NCT00215683|452967346|FG002|Overall Study|Adverse Event|15|||
125908922|NCT00215683|452967344|FG000|Overall Study|Lack of Efficacy|5|||
125908923|NCT00215683|452967345|FG001|Overall Study|Lack of Efficacy|1|||
125908924|NCT00215683|452967346|FG002|Overall Study|Lack of Efficacy|2|||
125908925|NCT00215683|452967344|FG000|Overall Study|Lost to Follow-up|0|||
125908926|NCT00215683|452967345|FG001|Overall Study|Lost to Follow-up|2|||
125908927|NCT00215683|452967346|FG002|Overall Study|Lost to Follow-up|1|||
125908928|NCT00215683|452967344|FG000|Overall Study|Withdrawal by Subject|9|||
125908929|NCT00215683|452967345|FG001|Overall Study|Withdrawal by Subject|4|||
125908930|NCT00215683|452967346|FG002|Overall Study|Withdrawal by Subject|13|||
125908931|NCT00215683|452967344|FG000|Overall Study|Physician Decision|0|||
125908932|NCT00215683|452967345|FG001|Overall Study|Physician Decision|0|||
125908933|NCT00215683|452967346|FG002|Overall Study|Physician Decision|1|||
125908934|NCT00215683|452967344|FG000|Overall Study|Difficult to attend visits|0|||
125908935|NCT00215683|452967345|FG001|Overall Study|Difficult to attend visits|1|||
125908936|NCT00215683|452967346|FG002|Overall Study|Difficult to attend visits|0|||
125908937|NCT00215683|452967344|FG000|Overall Study|No study drug available|0|||
125908938|NCT00215683|452967345|FG001|Overall Study|No study drug available|1|||
125908939|NCT00215683|452967346|FG002|Overall Study|No study drug available|0|||
125908940|NCT00215683|452967344|FG000|Overall Study|Intermittent therapy required|0|||
125908941|NCT00215683|452967345|FG001|Overall Study|Intermittent therapy required|1|||
125908942|NCT00215683|452967346|FG002|Overall Study|Intermittent therapy required|0|||
125908943|NCT01083485|452967347|FG000|Overall Study|Adverse Event|0|||
125908944|NCT01083485|452967348|FG001|Overall Study|Adverse Event|1|||
125908945|NCT01083485|452967347|FG000|Overall Study|Protocol Violation|1|||
125908946|NCT01083485|452967348|FG001|Overall Study|Protocol Violation|0|||
125908947|NCT01083485|452967347|FG000|Overall Study|Withdrawal by Subject|5|||
125908948|NCT01083485|452967348|FG001|Overall Study|Withdrawal by Subject|2|||
125908949|NCT01083485|452967347|FG000|Overall Study|Other|1|||
125908950|NCT01083485|452967348|FG001|Overall Study|Other|0|||
125908951|NCT04493333|452967355|FG000|Overall Study|Withdrawal by Subject|1|||
125908952|NCT04493333|452967356|FG001|Overall Study|Withdrawal by Subject|1|||
125908953|NCT04493333|452967355|FG000|Overall Study|Ineligible|0|||
125908954|NCT04493333|452967356|FG001|Overall Study|Ineligible|1|||
125908955|NCT04493333|452967355|FG000|Overall Study|Noncompliance|2|||
125908956|NCT04493333|452967356|FG001|Overall Study|Noncompliance|1|||
125908957|NCT00451451|452967359|FG000|Overall Study|Adverse Event|11|||
125908958|NCT00451451|452967360|FG001|Overall Study|Adverse Event|21|||
125908959|NCT00451451|452967361|FG002|Overall Study|Adverse Event|26|||
125908960|NCT00451451|452967362|FG003|Overall Study|Adverse Event|10|||
125908961|NCT00451451|452967359|FG000|Overall Study|Lost to Follow-up|11|||
125908962|NCT00451451|452967360|FG001|Overall Study|Lost to Follow-up|9|||
125908963|NCT00451451|452967361|FG002|Overall Study|Lost to Follow-up|8|||
125908964|NCT00451451|452967362|FG003|Overall Study|Lost to Follow-up|11|||
125908965|NCT00451451|452967359|FG000|Overall Study|Consent Withdrawn|14|||
125908966|NCT00451451|452967360|FG001|Overall Study|Consent Withdrawn|9|||
125908967|NCT00451451|452967361|FG002|Overall Study|Consent Withdrawn|17|||
125908968|NCT00451451|452967362|FG003|Overall Study|Consent Withdrawn|17|||
125908969|NCT00451451|452967359|FG000|Overall Study|Investigator Decision|6|||
125908970|NCT00451451|452967360|FG001|Overall Study|Investigator Decision|2|||
125908971|NCT00451451|452967361|FG002|Overall Study|Investigator Decision|1|||
125908972|NCT00451451|452967362|FG003|Overall Study|Investigator Decision|2|||
125908973|NCT00451451|452967359|FG000|Overall Study|Subject Non-Compliance|8|||
125908974|NCT00451451|452967360|FG001|Overall Study|Subject Non-Compliance|4|||
125908975|NCT00451451|452967361|FG002|Overall Study|Subject Non-Compliance|3|||
125908976|NCT00451451|452967362|FG003|Overall Study|Subject Non-Compliance|3|||
125908977|NCT00451451|452967359|FG000|Overall Study|Death|1|||
125908978|NCT00451451|452967360|FG001|Overall Study|Death|0|||
125908979|NCT00451451|452967361|FG002|Overall Study|Death|0|||
125908980|NCT00451451|452967362|FG003|Overall Study|Death|1|||
125908981|NCT00451451|452967359|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
125908982|NCT00451451|452967360|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
125908983|NCT00451451|452967361|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
125908984|NCT00451451|452967362|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
125908985|NCT00084838|452967363|FG000|Overall Study|Death|1|||
125908986|NCT00084838|452967363|FG000|Overall Study|Adverse Event|2|||
126060413|NCT02196259|453516206|FG000|Overall Study|Partial data analysis|0|||
125908987|NCT00084838|452967363|FG000|Overall Study|Withdrawal by Subject|1|||
125908988|NCT00084838|452967363|FG000|Overall Study|Progressive Disease|4|||
125908989|NCT00084838|452967363|FG000|Overall Study|Pt Non-Compliance|1|||
125908990|NCT00084838|452967363|FG000|Overall Study|Ineligible|4|||
126060414|NCT02196259|453516207|FG001|Overall Study|Partial data analysis|3|||
125908991|NCT00122278|452967364|FG000|Overall Study|Lost to Follow-up|2|||
125908992|NCT00122278|452967365|FG001|Overall Study|Lost to Follow-up|0|||
125908993|NCT01865084|452967366|FG000|Double Blind Period (DB)|Adverse Event|2|||
125908994|NCT01865084|452967367|FG001|Double Blind Period (DB)|Adverse Event|2|||
126060415|NCT02196259|453516208|FG002|Overall Study|Partial data analysis|0|||
126060416|NCT01668355|453516209|FG000|Overall Study|Death|3|||
126060417|NCT01668355|453516210|FG001|Overall Study|Death|1|||
126060418|NCT01668355|453516209|FG000|Overall Study|Withdrawal by Subject|6|||
126060419|NCT01668355|453516210|FG001|Overall Study|Withdrawal by Subject|1|||
126060420|NCT00215943|453516211|FG000|Overall Study|Disease Progression|3|||
126060421|NCT00215943|453516212|FG001|Overall Study|Disease Progression|5|||
126060422|NCT00215943|453516211|FG000|Overall Study|Alternate therapy|0|||
126060423|NCT00215943|453516212|FG001|Overall Study|Alternate therapy|1|||
126060424|NCT00215943|453516211|FG000|Overall Study|Adverse Event|3|||
126060425|NCT00215943|453516212|FG001|Overall Study|Adverse Event|6|||
126060426|NCT00215943|453516211|FG000|Overall Study|Other disease|0|||
126060427|NCT00215943|453516212|FG001|Overall Study|Other disease|1|||
126060428|NCT00215943|453516211|FG000|Overall Study|Other complications|3|||
126060429|NCT00215943|453516212|FG001|Overall Study|Other complications|1|||
126060430|NCT04311983|453516213|FG000|Overall Study|Lost to Follow-up|421|||
126060431|NCT04311983|453516214|FG001|Overall Study|Lost to Follow-up|456|||
126060432|NCT04311983|453516213|FG000|Overall Study|Incomplete survey|7|||
126060433|NCT04311983|453516214|FG001|Overall Study|Incomplete survey|9|||
126060434|NCT04311983|453516213|FG000|Overall Study|Death|1|||
126060435|NCT04311983|453516214|FG001|Overall Study|Death|0|||
126060436|NCT00403845|453516224|FG000|Treatment Period 1|Subject withdrew consent|1|||
126060437|NCT00403845|453516225|FG001|Treatment Period 1|Subject withdrew consent|0|||
126060438|NCT00403845|453516226|FG002|Treatment Period 1|Subject withdrew consent|0|||
126060439|NCT00403845|453516227|FG003|Treatment Period 1|Subject withdrew consent|0|||
126060440|NCT00403845|453516224|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
126060441|NCT00403845|453516225|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
126060442|NCT00403845|453516226|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
126060443|NCT00403845|453516227|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
126060444|NCT00403845|453516224|FG000|Treatment Period 2|Subject withdrew consent|1|||
126060445|NCT00403845|453516225|FG001|Treatment Period 2|Subject withdrew consent|0|||
126060446|NCT00403845|453516226|FG002|Treatment Period 2|Subject withdrew consent|0|||
126060447|NCT00403845|453516227|FG003|Treatment Period 2|Subject withdrew consent|0|||
126060448|NCT00403845|453516224|FG000|Treatment Period 3|Subject withdrew consent|0|||
126060449|NCT00403845|453516225|FG001|Treatment Period 3|Subject withdrew consent|0|||
126060450|NCT00403845|453516226|FG002|Treatment Period 3|Subject withdrew consent|0|||
126060451|NCT00403845|453516227|FG003|Treatment Period 3|Subject withdrew consent|1|||
126060452|NCT00403845|453516224|FG000|Treatment Period 3|Adverse Event|0|||
126060453|NCT00403845|453516225|FG001|Treatment Period 3|Adverse Event|0|||
126060454|NCT00403845|453516226|FG002|Treatment Period 3|Adverse Event|0|||
126060455|NCT00403845|453516227|FG003|Treatment Period 3|Adverse Event|1|||
126060456|NCT02152384|453516228|FG000|Period 1|Withdrawal by Subject|0|||
126060457|NCT02152384|453516229|FG001|Period 1|Withdrawal by Subject|1|||
126060458|NCT02152384|453516228|FG000|Period 1|Adverse Event|1|||
126060459|NCT02152384|453516229|FG001|Period 1|Adverse Event|1|||
126060460|NCT00088166|453516231|FG000|Overall Study|Adverse Event|11|||
126060461|NCT00088166|453516232|FG001|Overall Study|Adverse Event|9|||
126060462|NCT00088166|453516231|FG000|Overall Study|Death|3|||
126060463|NCT00088166|453516232|FG001|Overall Study|Death|1|||
126060464|NCT00088166|453516231|FG000|Overall Study|Lost to Follow-up|0|||
126060465|NCT00088166|453516232|FG001|Overall Study|Lost to Follow-up|1|||
126060466|NCT00088166|453516231|FG000|Overall Study|Physician Decision|4|||
126060467|NCT00088166|453516232|FG001|Overall Study|Physician Decision|1|||
126060468|NCT00088166|453516231|FG000|Overall Study|Protocol Violation|1|||
126060469|NCT00088166|453516232|FG001|Overall Study|Protocol Violation|5|||
126060470|NCT00088166|453516231|FG000|Overall Study|Patient deterioration|29|||
126060471|NCT00088166|453516232|FG001|Overall Study|Patient deterioration|39|||
126060472|NCT00088166|453516231|FG000|Overall Study|Withdrawal by Subject|5|||
126060473|NCT00088166|453516232|FG001|Overall Study|Withdrawal by Subject|5|||
126060474|NCT02671266|453516233|FG000|Overall Study|Withdrawal by Subject|1|||
126060475|NCT02671266|453516234|FG001|Overall Study|Withdrawal by Subject|1|||
126060476|NCT00666705|453516235|FG000|Overall Study|Withdrawal by Subject|1|||
126060477|NCT01109979|453516236|FG000|Overall Study|Physician Decision|2|||
126060478|NCT01109979|453516237|FG001|Overall Study|Physician Decision|0|||
126060479|NCT01109979|453516236|FG000|Overall Study|Withdrawal by Subject|0|||
126060480|NCT01109979|453516237|FG001|Overall Study|Withdrawal by Subject|1|||
126060481|NCT01228734|453516238|FG000|Overall Study|Randomized, but not treated|0|||
126060482|NCT01228734|453516239|FG001|Overall Study|Randomized, but not treated|4|||
126060483|NCT03128099|453516241|FG000|Overall Study|High dose task was too long|0|||
126060484|NCT03128099|453516242|FG001|Overall Study|High dose task was too long|4|||
126060485|NCT03128099|453516243|FG002|Overall Study|High dose task was too long|0|||
126060486|NCT03128099|453516241|FG000|Overall Study|Participant got a full time job.|1|||
126060487|NCT03128099|453516242|FG001|Overall Study|Participant got a full time job.|0|||
126060488|NCT03128099|453516243|FG002|Overall Study|Participant got a full time job.|0|||
125908995|NCT01865084|452967368|FG002|Double Blind Period (DB)|Adverse Event|1|||
125908996|NCT01865084|452967366|FG000|Double Blind Period (DB)|Protocol Violation|0|||
125908997|NCT01865084|452967367|FG001|Double Blind Period (DB)|Protocol Violation|0|||
125908998|NCT01865084|452967368|FG002|Double Blind Period (DB)|Protocol Violation|1|||
125908999|NCT01865084|452967366|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
125909000|NCT01865084|452967367|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
125909001|NCT01865084|452967368|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
125909002|NCT01865084|452967366|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
125909003|NCT01865084|452967367|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
125909004|NCT01865084|452967368|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
125909005|NCT01865084|452967366|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
125909006|NCT01865084|452967367|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
125909007|NCT01865084|452967368|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
125909008|NCT01865084|452967366|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
125909009|NCT01865084|452967367|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
125909010|NCT01865084|452967368|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
125909011|NCT01865084|452967366|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
125909012|NCT01865084|452967367|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
125909013|NCT01865084|452967368|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
125909014|NCT01865084|452967366|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
125909015|NCT01865084|452967367|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
125909016|NCT01865084|452967368|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
125909017|NCT01865084|452967366|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
125909018|NCT01865084|452967367|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
125909019|NCT01865084|452967368|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
125909020|NCT03607422|452967369|FG000|Overall Study|Adverse Event|7|||
125909021|NCT03607422|452967370|FG001|Overall Study|Adverse Event|3|||
125909022|NCT03607422|452967371|FG002|Overall Study|Adverse Event|2|||
125909023|NCT03607422|452967372|FG003|Overall Study|Adverse Event|0|||
125909024|NCT03607422|452967373|FG004|Overall Study|Adverse Event|2|||
125909025|NCT03607422|452967374|FG005|Overall Study|Adverse Event|0|||
125909026|NCT03607422|452967369|FG000|Overall Study|Withdrawal by Subject|11|||
125909027|NCT03607422|452967370|FG001|Overall Study|Withdrawal by Subject|3|||
125909028|NCT03607422|452967371|FG002|Overall Study|Withdrawal by Subject|6|||
125909029|NCT03607422|452967372|FG003|Overall Study|Withdrawal by Subject|2|||
125909030|NCT03607422|452967373|FG004|Overall Study|Withdrawal by Subject|0|||
125909031|NCT03607422|452967374|FG005|Overall Study|Withdrawal by Subject|0|||
125909032|NCT03607422|452967369|FG000|Overall Study|Lost to Follow-up|0|||
125909033|NCT03607422|452967370|FG001|Overall Study|Lost to Follow-up|0|||
125909034|NCT03607422|452967371|FG002|Overall Study|Lost to Follow-up|1|||
125909035|NCT03607422|452967372|FG003|Overall Study|Lost to Follow-up|0|||
125909036|NCT03607422|452967373|FG004|Overall Study|Lost to Follow-up|0|||
125909037|NCT03607422|452967374|FG005|Overall Study|Lost to Follow-up|0|||
125909038|NCT03607422|452967369|FG000|Overall Study|Other|12|||
125909039|NCT03607422|452967370|FG001|Overall Study|Other|4|||
125909040|NCT03607422|452967371|FG002|Overall Study|Other|1|||
125909041|NCT03607422|452967372|FG003|Overall Study|Other|2|||
125909042|NCT03607422|452967373|FG004|Overall Study|Other|0|||
125909043|NCT03607422|452967374|FG005|Overall Study|Other|2|||
125909044|NCT03607422|452967369|FG000|Overall Study|Ongoing at Time of Analysis|8|||
125909045|NCT03607422|452967370|FG001|Overall Study|Ongoing at Time of Analysis|0|||
125909046|NCT03607422|452967371|FG002|Overall Study|Ongoing at Time of Analysis|2|||
125909047|NCT03607422|452967372|FG003|Overall Study|Ongoing at Time of Analysis|1|||
125909048|NCT03607422|452967373|FG004|Overall Study|Ongoing at Time of Analysis|1|||
125909049|NCT03607422|452967374|FG005|Overall Study|Ongoing at Time of Analysis|1|||
125909050|NCT03693170|452967375|FG000|Overall Study|Disease Progression|48|||
125909051|NCT03693170|452967375|FG000|Overall Study|Adverse Event|16|||
125909052|NCT03693170|452967375|FG000|Overall Study|Physician Decision|6|||
125909053|NCT03693170|452967375|FG000|Overall Study|Protocol Violation|2|||
125909054|NCT03693170|452967375|FG000|Overall Study|Death|1|||
125909055|NCT03693170|452967375|FG000|Overall Study|Non compliance with study drug|1|||
125909056|NCT03693170|452967375|FG000|Overall Study|Withdrawal by Subject|1|||
125909057|NCT01442038|452967378|FG000|Overall Study|Death|35|||
125909058|NCT01442038|452967379|FG001|Overall Study|Death|29|||
125909059|NCT01442038|452967378|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
125909060|NCT01442038|452967379|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
125909061|NCT01442038|452967378|FG000|Overall Study|Participant Withdrew Consent|137|||
125909062|NCT01442038|452967379|FG001|Overall Study|Participant Withdrew Consent|102|||
125909063|NCT01442038|452967378|FG000|Overall Study|Lost to Follow-up|37|||
125909064|NCT01442038|452967379|FG001|Overall Study|Lost to Follow-up|51|||
125909065|NCT01442038|452967378|FG000|Overall Study|Adverse Event|26|||
125909066|NCT01442038|452967379|FG001|Overall Study|Adverse Event|15|||
125909067|NCT01442038|452967378|FG000|Overall Study|Protocol Deviation|9|||
125909068|NCT01442038|452967379|FG001|Overall Study|Protocol Deviation|20|||
125909069|NCT01442038|452967378|FG000|Overall Study|Investigator's Discretion|13|||
125909070|NCT01442038|452967379|FG001|Overall Study|Investigator's Discretion|16|||
125909071|NCT01442038|452967378|FG000|Overall Study|Study Terminated By Sponsor|2|||
125909072|NCT01442038|452967379|FG001|Overall Study|Study Terminated By Sponsor|3|||
125909073|NCT00089284|452967380|FG000|Overall Study|Adverse event before starting treatment|0|||
125909074|NCT00089284|452967381|FG001|Overall Study|Adverse event before starting treatment|0|||
125909075|NCT00089284|452967382|FG002|Overall Study|Adverse event before starting treatment|0|||
125909076|NCT00089284|452967383|FG003|Overall Study|Adverse event before starting treatment|0|||
125909077|NCT00089284|452967384|FG004|Overall Study|Adverse event before starting treatment|0|||
125909078|NCT00089284|452967385|FG005|Overall Study|Adverse event before starting treatment|0|||
125909079|NCT00089284|452967386|FG006|Overall Study|Adverse event before starting treatment|1|||
125909080|NCT02428608|452967387|FG000|Overall Study|Pregnancy|2|||
125909081|NCT02428608|452967387|FG000|Overall Study|Lost to Follow-up|37|||
125909082|NCT02428608|452967387|FG000|Overall Study|Withdrawal by Subject|2|||
125909083|NCT02428608|452967387|FG000|Overall Study|scheduling conflicts|15|||
125909084|NCT02428608|452967387|FG000|Overall Study|moved away|10|||
125909085|NCT02428608|452967387|FG000|Overall Study|Death|1|||
125909086|NCT02428608|452967387|FG000|Overall Study|various|16|||
125909087|NCT03646643|452967390|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
125909088|NCT03646643|452967391|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
125909089|NCT03646643|452967390|FG000|Overall Study|Lost to Follow-up|0|||
125909090|NCT03646643|452967391|FG001|Overall Study|Lost to Follow-up|1|||
125909091|NCT04131556|452967392|FG000|Overall Study|Adverse Event|1|||
125909092|NCT04131556|452967392|FG000|Overall Study|Withdrawal by Subject|1|||
125909093|NCT04521777|452967393|FG000|Overall Study|Death|2|||
125909094|NCT04521777|452967393|FG000|Overall Study|Withdrawal by Subject|2|||
125909095|NCT00900601|452967394|FG000|Overall Study|Physician Decision|1|||
125909096|NCT01933217|452967395|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
125909097|NCT01933217|452967396|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
125909098|NCT01933217|452967395|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
125909099|NCT01933217|452967396|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
125909100|NCT03923738|452967399|FG000|Period 1|Adverse Event|1|||
125909101|NCT03923738|452967399|FG000|Period 1|Withdrawal by Subject|1|||
125909102|NCT00057954|452967404|FG000|Overall Study|Death|1|||
125909103|NCT00057954|452967404|FG000|Overall Study|Disease progression|1|||
125909104|NCT01068652|452967409|FG000|Overall Study|Adverse Event|4|||
125909105|NCT01068652|452967410|FG001|Overall Study|Adverse Event|0|||
125909106|NCT01068652|452967409|FG000|Overall Study|Lack of Efficacy|0|||
125909107|NCT01068652|452967410|FG001|Overall Study|Lack of Efficacy|2|||
125909108|NCT01068652|452967409|FG000|Overall Study|Lost to Follow-up|2|||
125909109|NCT01068652|452967410|FG001|Overall Study|Lost to Follow-up|1|||
125909110|NCT01068652|452967409|FG000|Overall Study|Protocol Violation|3|||
125909111|NCT01068652|452967410|FG001|Overall Study|Protocol Violation|6|||
125909112|NCT01068652|452967409|FG000|Overall Study|Withdrawal criteria|1|||
125909113|NCT01068652|452967410|FG001|Overall Study|Withdrawal criteria|2|||
125909114|NCT01068652|452967409|FG000|Overall Study|Patient was not eligible|1|||
125909115|NCT01068652|452967410|FG001|Overall Study|Patient was not eligible|0|||
125909116|NCT01068652|452967409|FG000|Overall Study|Unclassified|7|||
125909117|NCT01068652|452967410|FG001|Overall Study|Unclassified|4|||
125909118|NCT03343067|452967411|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
125909119|NCT03343067|452967412|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
125909120|NCT03343067|452967413|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
125909121|NCT01323946|452967414|FG000|Overall Study|Lost to Follow-up|0|||
125909122|NCT01323946|452967415|FG001|Overall Study|Lost to Follow-up|1|||
125909123|NCT01323946|452967416|FG002|Overall Study|Lost to Follow-up|0|||
125909124|NCT01323946|452967414|FG000|Overall Study|Parents refused the last blood draw|1|||
125909125|NCT01323946|452967415|FG001|Overall Study|Parents refused the last blood draw|0|||
125909126|NCT01323946|452967416|FG002|Overall Study|Parents refused the last blood draw|0|||
125909127|NCT01323946|452967414|FG000|Overall Study|Withdrawal by Subject|2|||
125909128|NCT01323946|452967415|FG001|Overall Study|Withdrawal by Subject|2|||
125909129|NCT01323946|452967416|FG002|Overall Study|Withdrawal by Subject|0|||
125909130|NCT01243671|452967417|FG000|Overall Study|Adverse Event|3|||
125909131|NCT01243671|452967417|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
125909132|NCT01243671|452967417|FG000|Overall Study|Other|1|||
125909133|NCT04505540|452967418|FG000|Baseline|Protocol Violation|10|||
125909134|NCT04505540|452967418|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
125909135|NCT04505540|452967418|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
125909136|NCT04505540|452967418|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
125909137|NCT04505540|452967418|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
125909138|NCT04505540|452967418|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
125909139|NCT04505540|452967418|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
125909140|NCT04505540|452967418|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
125909141|NCT04505540|452967418|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
125909142|NCT04505540|452967418|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
125909143|NCT04505540|452967418|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
125909144|NCT04505540|452967418|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
125909145|NCT04505540|452967418|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
125909146|NCT05342532|452967419|FG000|Overall Study|Adverse Event|5|||
125909147|NCT05342532|452967420|FG001|Overall Study|Adverse Event|20|||
125909148|NCT05342532|452967419|FG000|Overall Study|Lost to Follow-up|10|||
125909149|NCT05342532|452967420|FG001|Overall Study|Lost to Follow-up|15|||
125909150|NCT02057393|452967421|FG000|Overall Study|Withdrawal by Subject|1|||
125909151|NCT02057393|452967421|FG000|Overall Study|Patient did not meet criteria|1|||
125909152|NCT02536833|452967422|FG000|Overall Study|Discontinued Before Treatment|0|||
125909153|NCT02536833|452967423|FG001|Overall Study|Discontinued Before Treatment|0|||
125909154|NCT02536833|452967424|FG002|Overall Study|Discontinued Before Treatment|1|||
125909155|NCT02536833|452967425|FG003|Overall Study|Discontinued Before Treatment|2|||
125909156|NCT02536833|452967422|FG000|Overall Study|Adverse Event|1|||
125909157|NCT02536833|452967423|FG001|Overall Study|Adverse Event|3|||
125909158|NCT02536833|452967424|FG002|Overall Study|Adverse Event|4|||
125909159|NCT02536833|452967425|FG003|Overall Study|Adverse Event|1|||
125909160|NCT02536833|452967422|FG000|Overall Study|Lost to Follow-up|2|||
125909161|NCT02536833|452967423|FG001|Overall Study|Lost to Follow-up|1|||
125909162|NCT02536833|452967424|FG002|Overall Study|Lost to Follow-up|2|||
125909163|NCT02536833|452967425|FG003|Overall Study|Lost to Follow-up|2|||
125909164|NCT02536833|452967422|FG000|Overall Study|Physician Decision|0|||
125909165|NCT02536833|452967423|FG001|Overall Study|Physician Decision|0|||
125909166|NCT02536833|452967424|FG002|Overall Study|Physician Decision|0|||
125909167|NCT02536833|452967425|FG003|Overall Study|Physician Decision|1|||
125909168|NCT02536833|452967422|FG000|Overall Study|Site Terminated by Sponsor|2|||
125909169|NCT02536833|452967423|FG001|Overall Study|Site Terminated by Sponsor|2|||
125909170|NCT02536833|452967424|FG002|Overall Study|Site Terminated by Sponsor|2|||
125909171|NCT02536833|452967425|FG003|Overall Study|Site Terminated by Sponsor|2|||
125909172|NCT02536833|452967422|FG000|Overall Study|Subject Non-Compliance|0|||
125909173|NCT02536833|452967423|FG001|Overall Study|Subject Non-Compliance|1|||
125909174|NCT02536833|452967424|FG002|Overall Study|Subject Non-Compliance|1|||
125909175|NCT02536833|452967425|FG003|Overall Study|Subject Non-Compliance|0|||
125909176|NCT02536833|452967422|FG000|Overall Study|Withdrawal by Subject|4|||
125909177|NCT02536833|452967423|FG001|Overall Study|Withdrawal by Subject|3|||
125909178|NCT02536833|452967424|FG002|Overall Study|Withdrawal by Subject|5|||
125909179|NCT02536833|452967425|FG003|Overall Study|Withdrawal by Subject|11|||
125909180|NCT02764190|452967427|FG000|Overall Study|Lost to Follow-up|17|||
125909181|NCT02764190|452967428|FG001|Overall Study|Lost to Follow-up|13|||
125909182|NCT01172275|452967433|FG000|Overall Study|Lost to Follow-up|1|||
125909183|NCT01172275|452967434|FG001|Overall Study|Lost to Follow-up|0|||
125909184|NCT01172275|452967433|FG000|Overall Study|Protocol Violation|1|||
125909185|NCT01172275|452967434|FG001|Overall Study|Protocol Violation|0|||
125909186|NCT05308290|452967439|FG000|Overall Study|Death|1|||
125909187|NCT05308290|452967440|FG001|Overall Study|Death|0|||
125909188|NCT05308290|452967439|FG000|Overall Study|Lost to Follow-up|2|||
125909189|NCT05308290|452967440|FG001|Overall Study|Lost to Follow-up|1|||
125909190|NCT05308290|452967439|FG000|Overall Study|still in study followup|0|||
125909191|NCT05308290|452967440|FG001|Overall Study|still in study followup|1|||
125909192|NCT04437368|452967441|FG000|Overall Study|Death|3|||
125909193|NCT04437368|452967442|FG001|Overall Study|Death|0|||
125909194|NCT04437368|452967443|FG002|Overall Study|Death|2|||
125909195|NCT04437368|452967441|FG000|Overall Study|Study terminated by sponsor|16|||
125909196|NCT04437368|452967442|FG001|Overall Study|Study terminated by sponsor|1|||
125909197|NCT04437368|452967443|FG002|Overall Study|Study terminated by sponsor|25|||
125909198|NCT04437368|452967441|FG000|Overall Study|Withdrawal by Subject|4|||
125909199|NCT04437368|452967442|FG001|Overall Study|Withdrawal by Subject|0|||
125909200|NCT04437368|452967443|FG002|Overall Study|Withdrawal by Subject|3|||
125909201|NCT04437368|452967441|FG000|Overall Study|Sponsor instructions|23|||
125909202|NCT04437368|452967442|FG001|Overall Study|Sponsor instructions|0|||
125909203|NCT04437368|452967443|FG002|Overall Study|Sponsor instructions|0|||
125909204|NCT01982331|452967444|FG000|Received Vaccination 2|Adverse Event|1|||
125909205|NCT01982331|452967445|FG001|Received Vaccination 2|Adverse Event|2|||
125909206|NCT01982331|452967444|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
125909207|NCT01982331|452967445|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
125909208|NCT01982331|452967444|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
125909209|NCT01982331|452967445|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
125909210|NCT02393690|452967455|FG000|Overall Study|Ineligible|0|||
125909211|NCT02393690|452967456|FG001|Overall Study|Ineligible|1|||
125909212|NCT00586846|452967457|FG000|Overall Study|Physician Decision|1|||
125909213|NCT00586846|452967457|FG000|Overall Study|Death|1|||
125909214|NCT00586846|452967457|FG000|Overall Study|Evaluable for Toxicity Only|4|||
125909215|NCT01674634|452967458|FG000|Overall Study|Withdrawal by Subject|3|||
125909216|NCT01674634|452967458|FG000|Overall Study|Lost to Follow-up|3|||
125909217|NCT01721070|452967459|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
125909218|NCT02204007|452967460|FG000|Overall Study|Surgery Canceled|1|||
125909219|NCT02204007|452967461|FG001|Overall Study|Surgery Canceled|1|||
125909220|NCT02059005|452967462|FG000|Overall Study|Death|1|||
125909221|NCT02059005|452967463|FG001|Overall Study|Death|3|||
125909222|NCT02059005|452967462|FG000|Overall Study|Lost to Follow-up|19|||
125909223|NCT02059005|452967463|FG001|Overall Study|Lost to Follow-up|19|||
125909224|NCT02059005|452967462|FG000|Overall Study|Incarceration|0|||
125909225|NCT02059005|452967463|FG001|Overall Study|Incarceration|1|||
125909226|NCT02059005|452967462|FG000|Overall Study|Inpatient|0|||
125909227|NCT02059005|452967463|FG001|Overall Study|Inpatient|1|||
125909228|NCT02142803|452967464|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
125909229|NCT02142803|452967465|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
125909230|NCT02142803|452967466|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
125909231|NCT02142803|452967467|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
125909232|NCT02718300|452967473|FG000|Overall Study|Death|4|||
125909233|NCT02718300|452967474|FG001|Overall Study|Death|5|||
125909234|NCT02718300|452967475|FG002|Overall Study|Death|17|||
125909235|NCT02718300|452967473|FG000|Overall Study|Lost to Follow-up|1|||
125909236|NCT02718300|452967474|FG001|Overall Study|Lost to Follow-up|0|||
125909237|NCT02718300|452967475|FG002|Overall Study|Lost to Follow-up|2|||
125909238|NCT02718300|452967473|FG000|Overall Study|Physician Decision|1|||
125909239|NCT02718300|452967474|FG001|Overall Study|Physician Decision|0|||
125909240|NCT02718300|452967475|FG002|Overall Study|Physician Decision|2|||
125909241|NCT02718300|452967473|FG000|Overall Study|Study Terminated by Sponsor|6|||
125909242|NCT02718300|452967474|FG001|Overall Study|Study Terminated by Sponsor|3|||
125909243|NCT02718300|452967475|FG002|Overall Study|Study Terminated by Sponsor|4|||
125909244|NCT02718300|452967473|FG000|Overall Study|Withdrawal by Subject|0|||
125909245|NCT02718300|452967474|FG001|Overall Study|Withdrawal by Subject|4|||
125909246|NCT02718300|452967475|FG002|Overall Study|Withdrawal by Subject|3|||
125909247|NCT02718300|452967473|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
125909248|NCT02718300|452967474|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
125909249|NCT02718300|452967475|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
126060489|NCT03128099|453516241|FG000|Overall Study|Became homeless and lost contact|1|||
126060490|NCT03128099|453516242|FG001|Overall Study|Became homeless and lost contact|0|||
126060491|NCT03128099|453516243|FG002|Overall Study|Became homeless and lost contact|0|||
126060492|NCT03128099|453516241|FG000|Overall Study|Did not complete all the assessments|0|||
126060493|NCT03128099|453516242|FG001|Overall Study|Did not complete all the assessments|0|||
126060494|NCT03128099|453516243|FG002|Overall Study|Did not complete all the assessments|1|||
126060495|NCT03456856|453516246|FG000|Overall Study|Lost to Follow-up|2|||
126060496|NCT03456856|453516246|FG000|Overall Study|Withdrawal by Subject|1|||
126060497|NCT02542696|453516249|FG000|Overall Study|Adverse Event|167|||
126060498|NCT02542696|453516249|FG000|Overall Study|Lack of Efficacy|26|||
126060499|NCT02542696|453516249|FG000|Overall Study|Lost to Follow-up|6|||
126060500|NCT02542696|453516249|FG000|Overall Study|Withdrawal by Subject|104|||
126060501|NCT02542696|453516249|FG000|Overall Study|Protocol Violation|5|||
126060502|NCT02542696|453516249|FG000|Overall Study|Death|8|||
125909250|NCT03120624|452967476|FG000|Overall Study|Withdrawal by Subject|0|||
125909251|NCT03120624|452967477|FG001|Overall Study|Withdrawal by Subject|1|||
125909252|NCT03120624|452967478|FG002|Overall Study|Withdrawal by Subject|0|||
126060503|NCT02542696|453516249|FG000|Overall Study|DECREASED OFF TIME|1|||
126060504|NCT02542696|453516249|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
126060505|NCT02542696|453516249|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
126060506|NCT02542696|453516249|FG000|Overall Study|MEDICAL HISTORY|1|||
126060507|NCT02542696|453516249|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
126060508|NCT02542696|453516249|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
126060509|NCT02542696|453516249|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
126060510|NCT02542696|453516249|FG000|Overall Study|SPONSOR DECISION|3|||
126060511|NCT02542696|453516249|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
126060512|NCT02542696|453516249|FG000|Overall Study|SUBJECT DECISION|2|||
126060513|NCT02410278|453516250|FG000|Run-in Period|Adverse Event|5|||
126060514|NCT02410278|453516251|FG001|Run-in Period|Adverse Event|0|||
126060515|NCT02410278|453516252|FG002|Run-in Period|Adverse Event|0|||
126060516|NCT02410278|453516250|FG000|Run-in Period|GSRS Threshold Not Met|30|||
126060517|NCT02410278|453516251|FG001|Run-in Period|GSRS Threshold Not Met|0|||
126060518|NCT02410278|453516252|FG002|Run-in Period|GSRS Threshold Not Met|0|||
126060519|NCT02410278|453516250|FG000|Run-in Period|Lost to Follow-up|1|||
126060520|NCT02410278|453516251|FG001|Run-in Period|Lost to Follow-up|0|||
126060521|NCT02410278|453516252|FG002|Run-in Period|Lost to Follow-up|0|||
126060522|NCT02410278|453516250|FG000|Run-in Period|Withdrawal by Subject|1|||
126060523|NCT02410278|453516251|FG001|Run-in Period|Withdrawal by Subject|0|||
126060524|NCT02410278|453516252|FG002|Run-in Period|Withdrawal by Subject|0|||
126060525|NCT02410278|453516250|FG000|Run-in Period|Pregnancy|1|||
126060526|NCT02410278|453516251|FG001|Run-in Period|Pregnancy|0|||
126060527|NCT02410278|453516252|FG002|Run-in Period|Pregnancy|0|||
126060528|NCT02410278|453516250|FG000|Study Treatment Period|Adverse Event|0|||
126060529|NCT02410278|453516251|FG001|Study Treatment Period|Adverse Event|6|||
126060530|NCT02410278|453516252|FG002|Study Treatment Period|Adverse Event|3|||
126060531|NCT02410278|453516250|FG000|Study Treatment Period|Physician Decision|0|||
126060532|NCT02410278|453516251|FG001|Study Treatment Period|Physician Decision|0|||
126060533|NCT02410278|453516252|FG002|Study Treatment Period|Physician Decision|1|||
125909253|NCT03120624|452967479|FG003|Overall Study|Withdrawal by Subject|0|||
125909254|NCT03120624|452967480|FG004|Overall Study|Withdrawal by Subject|0|||
125909255|NCT03120624|452967481|FG005|Overall Study|Withdrawal by Subject|0|||
125909256|NCT03120624|452967482|FG006|Overall Study|Withdrawal by Subject|0|||
125909257|NCT03120624|452967483|FG007|Overall Study|Withdrawal by Subject|0|||
125909258|NCT01927341|452969156|FG000|Phase 1b|Lost to Follow-up|1|||
125909259|NCT01927341|452969157|FG001|Phase 1b|Lost to Follow-up|0|||
125909260|NCT01927341|452969158|FG002|Phase 1b|Lost to Follow-up|0|||
125909261|NCT01927341|452969159|FG003|Phase 1b|Lost to Follow-up|0|||
125909262|NCT01927341|452969160|FG004|Phase 1b|Lost to Follow-up|0|||
125909263|NCT01927341|452969156|FG000|Phase 1b|Death|2|||
125909264|NCT01927341|452969157|FG001|Phase 1b|Death|0|||
125909265|NCT01927341|452969158|FG002|Phase 1b|Death|0|||
125909266|NCT01927341|452969159|FG003|Phase 1b|Death|0|||
125909267|NCT01927341|452969160|FG004|Phase 1b|Death|0|||
125909268|NCT01927341|452969156|FG000|Phase 1b|Follow-up completed|7|||
125909269|NCT01927341|452969157|FG001|Phase 1b|Follow-up completed|0|||
125909270|NCT01927341|452969158|FG002|Phase 1b|Follow-up completed|0|||
125909271|NCT01927341|452969159|FG003|Phase 1b|Follow-up completed|0|||
125909272|NCT01927341|452969160|FG004|Phase 1b|Follow-up completed|0|||
125909273|NCT01927341|452969156|FG000|Phase 2|Lost to Follow-up|0|||
125909274|NCT01927341|452969157|FG001|Phase 2|Lost to Follow-up|1|||
125909275|NCT01927341|452969158|FG002|Phase 2|Lost to Follow-up|0|||
125909276|NCT01927341|452969159|FG003|Phase 2|Lost to Follow-up|0|||
125909277|NCT01927341|452969160|FG004|Phase 2|Lost to Follow-up|0|||
125909278|NCT01927341|452969156|FG000|Phase 2|Participant withdrew consent|0|||
125909279|NCT01927341|452969157|FG001|Phase 2|Participant withdrew consent|2|||
125909280|NCT01927341|452969158|FG002|Phase 2|Participant withdrew consent|1|||
126060534|NCT02410278|453516250|FG000|Study Treatment Period|Withdrawal by Subject|0|||
126060535|NCT02410278|453516251|FG001|Study Treatment Period|Withdrawal by Subject|1|||
126060536|NCT02410278|453516252|FG002|Study Treatment Period|Withdrawal by Subject|0|||
126060537|NCT02410278|453516250|FG000|Study Treatment Period|Other|0|||
126060538|NCT02410278|453516251|FG001|Study Treatment Period|Other|3|||
126060539|NCT02410278|453516252|FG002|Study Treatment Period|Other|0|||
125909281|NCT01927341|452969159|FG003|Phase 2|Participant withdrew consent|2|||
125909282|NCT01927341|452969160|FG004|Phase 2|Participant withdrew consent|3|||
125909283|NCT01927341|452969156|FG000|Phase 2|Death|0|||
125909284|NCT01927341|452969157|FG001|Phase 2|Death|4|||
125909285|NCT01927341|452969158|FG002|Phase 2|Death|0|||
125909286|NCT01927341|452969159|FG003|Phase 2|Death|3|||
125909287|NCT01927341|452969160|FG004|Phase 2|Death|2|||
125909288|NCT01927341|452969156|FG000|Phase 2|New cancer therapy|0|||
126060540|NCT02410278|453516250|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
126060541|NCT02410278|453516251|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
125909289|NCT01927341|452969157|FG001|Phase 2|New cancer therapy|1|||
125909290|NCT01927341|452969158|FG002|Phase 2|New cancer therapy|0|||
125909291|NCT01927341|452969159|FG003|Phase 2|New cancer therapy|4|||
125909292|NCT01927341|452969160|FG004|Phase 2|New cancer therapy|1|||
125909293|NCT01927341|452969156|FG000|Phase 2|Disease progression|0|||
125909294|NCT01927341|452969157|FG001|Phase 2|Disease progression|1|||
125909295|NCT01927341|452969158|FG002|Phase 2|Disease progression|1|||
126060542|NCT02410278|453516252|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
126060543|NCT03695185|453516254|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
126060544|NCT03695185|453516254|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
126060545|NCT03695185|453516254|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
126060546|NCT03695185|453516254|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
126060547|NCT03695185|453516254|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
126060548|NCT03695185|453516254|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
126060549|NCT02137785|453516257|FG000|Overall Study|Lost to Follow-up|1|||
126060550|NCT02137785|453516258|FG001|Overall Study|Lost to Follow-up|0|||
126060551|NCT02137785|453516257|FG000|Overall Study|Withdrawal by Subject|1|||
126060552|NCT02137785|453516258|FG001|Overall Study|Withdrawal by Subject|4|||
126060553|NCT02137785|453516257|FG000|Overall Study|subject moved out of state|1|||
126060554|NCT02137785|453516258|FG001|Overall Study|subject moved out of state|0|||
126060555|NCT02584257|453516259|FG000|Period 1|Withdrawal by Subject|0|||
126060556|NCT02584257|453516260|FG001|Period 1|Withdrawal by Subject|0|||
126060557|NCT02584257|453516261|FG002|Period 1|Withdrawal by Subject|0|||
126060558|NCT02584257|453516262|FG003|Period 1|Withdrawal by Subject|0|||
126060559|NCT02584257|453516263|FG004|Period 1|Withdrawal by Subject|0|||
126060560|NCT02584257|453516264|FG005|Period 1|Withdrawal by Subject|0|||
126060561|NCT02584257|453516265|FG006|Period 1|Withdrawal by Subject|1|||
126060562|NCT02584257|453516266|FG007|Period 1|Withdrawal by Subject|0|||
126060563|NCT02584257|453516267|FG008|Period 1|Withdrawal by Subject|0|||
126060564|NCT02584257|453516259|FG000|Period 2|Physician Decision|1|||
126060565|NCT02584257|453516260|FG001|Period 2|Physician Decision|0|||
126060566|NCT02584257|453516261|FG002|Period 2|Physician Decision|0|||
126060567|NCT02584257|453516262|FG003|Period 2|Physician Decision|0|||
126060568|NCT02584257|453516263|FG004|Period 2|Physician Decision|0|||
126060569|NCT02584257|453516264|FG005|Period 2|Physician Decision|0|||
126060570|NCT02584257|453516265|FG006|Period 2|Physician Decision|0|||
126060571|NCT02584257|453516266|FG007|Period 2|Physician Decision|0|||
126060572|NCT02584257|453516267|FG008|Period 2|Physician Decision|0|||
126060573|NCT02584257|453516259|FG000|Period 2|Adverse Event|0|||
126060574|NCT02584257|453516260|FG001|Period 2|Adverse Event|1|||
126060575|NCT02584257|453516261|FG002|Period 2|Adverse Event|0|||
126060576|NCT02584257|453516262|FG003|Period 2|Adverse Event|0|||
126060577|NCT02584257|453516263|FG004|Period 2|Adverse Event|0|||
126060578|NCT02584257|453516264|FG005|Period 2|Adverse Event|0|||
126060579|NCT02584257|453516265|FG006|Period 2|Adverse Event|0|||
126060580|NCT02584257|453516266|FG007|Period 2|Adverse Event|0|||
126060581|NCT02584257|453516267|FG008|Period 2|Adverse Event|0|||
126060582|NCT01670877|453516268|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126060583|NCT01670877|453516269|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
126060584|NCT01670877|453516270|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126060585|NCT01670877|453516271|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126060586|NCT01670877|453516272|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126060587|NCT01670877|453516273|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126060588|NCT01670877|453516268|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126060589|NCT01670877|453516269|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126060590|NCT01670877|453516270|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
126060591|NCT01670877|453516271|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126060592|NCT01670877|453516272|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126060593|NCT01670877|453516273|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126060594|NCT01670877|453516268|FG000|Part I and Part 2|Grade 2 vomiting|0|||
126060595|NCT01670877|453516269|FG001|Part I and Part 2|Grade 2 vomiting|0|||
126060596|NCT01670877|453516270|FG002|Part I and Part 2|Grade 2 vomiting|0|||
126060597|NCT01670877|453516271|FG003|Part I and Part 2|Grade 2 vomiting|1|||
126060598|NCT01670877|453516272|FG004|Part I and Part 2|Grade 2 vomiting|0|||
126060599|NCT01670877|453516273|FG005|Part I and Part 2|Grade 2 vomiting|0|||
126060600|NCT01670877|453516268|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126060601|NCT01670877|453516269|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126060602|NCT01670877|453516270|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126060603|NCT01670877|453516271|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
126060604|NCT01670877|453516272|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126060605|NCT01670877|453516273|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126060606|NCT01670877|453516268|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126060607|NCT01670877|453516269|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126060608|NCT01670877|453516270|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126060609|NCT01670877|453516271|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
126060610|NCT01670877|453516272|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126060611|NCT01670877|453516273|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126060612|NCT03390166|453516274|FG000|Overall Study|Death|0|||
126060613|NCT03390166|453516275|FG001|Overall Study|Death|1|||
126060614|NCT03390166|453516274|FG000|Overall Study|Lost to Follow-up|6|||
126060615|NCT03390166|453516275|FG001|Overall Study|Lost to Follow-up|4|||
126060616|NCT03390166|453516274|FG000|Overall Study|Physician Decision|2|||
125909296|NCT01927341|452969159|FG003|Phase 2|Disease progression|1|||
126060617|NCT03390166|453516275|FG001|Overall Study|Physician Decision|1|||
126060618|NCT03390166|453516274|FG000|Overall Study|Move from study area|3|||
126060619|NCT03390166|453516275|FG001|Overall Study|Move from study area|2|||
126060620|NCT03390166|453516274|FG000|Overall Study|To militarycamp for conscript|1|||
126060621|NCT03390166|453516275|FG001|Overall Study|To militarycamp for conscript|0|||
126060622|NCT03390166|453516274|FG000|Overall Study|To drug therapy course|0|||
126060623|NCT03390166|453516275|FG001|Overall Study|To drug therapy course|1|||
126060624|NCT03390166|453516274|FG000|Overall Study|Move to work oversea|0|||
126060625|NCT03390166|453516275|FG001|Overall Study|Move to work oversea|1|||
125909297|NCT01927341|452969160|FG004|Phase 2|Disease progression|0|||
125909298|NCT01927341|452969156|FG000|Phase 2|Follow-up completed|0|||
125909299|NCT01927341|452969157|FG001|Phase 2|Follow-up completed|6|||
125909300|NCT01927341|452969158|FG002|Phase 2|Follow-up completed|3|||
125909301|NCT01927341|452969159|FG003|Phase 2|Follow-up completed|5|||
125909302|NCT01927341|452969160|FG004|Phase 2|Follow-up completed|2|||
125909303|NCT01994590|452969161|FG000|Overall Study|Adverse Event|1|||
125909304|NCT01994590|452969161|FG000|Overall Study|Trial Terminated|1|||
125909305|NCT02247531|452969162|FG000|Overall Study|Adverse Event|3|||
125909306|NCT02247531|452969163|FG001|Overall Study|Adverse Event|4|||
125909307|NCT02247531|452969164|FG002|Overall Study|Adverse Event|9|||
125909308|NCT02247531|452969162|FG000|Overall Study|Death|8|||
125909309|NCT02247531|452969163|FG001|Overall Study|Death|9|||
125909310|NCT02247531|452969164|FG002|Overall Study|Death|5|||
125909311|NCT02247531|452969162|FG000|Overall Study|Lost to Follow-up|1|||
125909312|NCT02247531|452969163|FG001|Overall Study|Lost to Follow-up|8|||
125909313|NCT02247531|452969164|FG002|Overall Study|Lost to Follow-up|3|||
125909314|NCT02247531|452969162|FG000|Overall Study|Non-compliance|2|||
125909315|NCT02247531|452969163|FG001|Overall Study|Non-compliance|2|||
125909316|NCT02247531|452969164|FG002|Overall Study|Non-compliance|0|||
125909317|NCT02247531|452969162|FG000|Overall Study|Withdrawal by Subject|26|||
125909318|NCT02247531|452969163|FG001|Overall Study|Withdrawal by Subject|31|||
125909319|NCT02247531|452969164|FG002|Overall Study|Withdrawal by Subject|25|||
125909320|NCT02247531|452969162|FG000|Overall Study|Study Terminated by Sponsor|64|||
125909321|NCT02247531|452969163|FG001|Overall Study|Study Terminated by Sponsor|66|||
125909322|NCT02247531|452969164|FG002|Overall Study|Study Terminated by Sponsor|62|||
125909323|NCT02247531|452969162|FG000|Overall Study|Physician Decision|0|||
125909324|NCT02247531|452969163|FG001|Overall Study|Physician Decision|2|||
125909325|NCT02247531|452969164|FG002|Overall Study|Physician Decision|2|||
125909326|NCT02247531|452969162|FG000|Overall Study|Unspecified Reason|2|||
125909327|NCT02247531|452969163|FG001|Overall Study|Unspecified Reason|3|||
125909328|NCT02247531|452969164|FG002|Overall Study|Unspecified Reason|4|||
125909329|NCT03875118|452969165|FG000|Overall Study|Withdrawal by Subject|4|||
125909330|NCT03875118|452969166|FG001|Overall Study|Withdrawal by Subject|4|||
125909331|NCT03228420|452969176|FG000|Overall Study|Lost to Follow-up|5|||
125909332|NCT03228420|452969177|FG001|Overall Study|Lost to Follow-up|3|||
125909333|NCT03228420|452969176|FG000|Overall Study|Withdrawal by Subject|10|||
125909334|NCT03228420|452969177|FG001|Overall Study|Withdrawal by Subject|0|||
125909335|NCT03228420|452969176|FG000|Overall Study|Adverse Event|5|||
125909336|NCT03228420|452969177|FG001|Overall Study|Adverse Event|2|||
125909337|NCT01298531|452969178|FG000|Overall Study|Lack of Efficacy|0|||
125909338|NCT01298531|452969179|FG001|Overall Study|Lack of Efficacy|1|||
125909339|NCT01298531|452969178|FG000|Overall Study|Lost to Follow-up|2|||
125909340|NCT01298531|452969179|FG001|Overall Study|Lost to Follow-up|0|||
125909341|NCT01298531|452969178|FG000|Overall Study|Protocol Violation|1|||
125909342|NCT01298531|452969179|FG001|Overall Study|Protocol Violation|1|||
125909343|NCT01298531|452969178|FG000|Overall Study|Adverse Event|4|||
125909344|NCT01298531|452969179|FG001|Overall Study|Adverse Event|3|||
125909345|NCT01298531|452969178|FG000|Overall Study|Does not meet entrance criteria|0|||
125909346|NCT01298531|452969179|FG001|Overall Study|Does not meet entrance criteria|1|||
125909347|NCT01298531|452969178|FG000|Overall Study|Other|2|||
125909348|NCT01298531|452969179|FG001|Overall Study|Other|1|||
125909349|NCT03468985|452969180|FG000|Overall Study|Adverse Event|0|||
125909350|NCT03468985|452969181|FG001|Overall Study|Adverse Event|2|||
125909351|NCT03468985|452969182|FG002|Overall Study|Adverse Event|0|||
125909352|NCT03468985|452969183|FG003|Overall Study|Adverse Event|0|||
125909353|NCT03468985|452969180|FG000|Overall Study|Withdrawal by Subject|0|||
125909354|NCT03468985|452969181|FG001|Overall Study|Withdrawal by Subject|0|||
125909355|NCT03468985|452969182|FG002|Overall Study|Withdrawal by Subject|0|||
125909356|NCT03468985|452969183|FG003|Overall Study|Withdrawal by Subject|1|||
125909357|NCT04060862|452969186|FG000|Overall Study|Symptomatic Deterioration|1|||
125909358|NCT04060862|452969186|FG000|Overall Study|Un-specified|6|||
125909359|NCT04060862|452969186|FG000|Overall Study|Progressive disease|12|||
125909360|NCT04060862|452969186|FG000|Overall Study|Physician Decision|1|||
125909361|NCT02545075|452969189|FG000|Randomization|Lost to Follow-up|0|||
125909362|NCT02545075|452969190|FG001|Randomization|Lost to Follow-up|1|||
125909363|NCT02545075|452969189|FG000|Randomization|Withdrawal by Subject|0|||
125909364|NCT02545075|452969190|FG001|Randomization|Withdrawal by Subject|6|||
125909365|NCT02545075|452969189|FG000|Treatment|Disease progression|71|||
125909366|NCT02545075|452969190|FG001|Treatment|Disease progression|32|||
125909367|NCT02545075|452969189|FG000|Treatment|Participant dicontinued study treatment|7|||
125909368|NCT02545075|452969190|FG001|Treatment|Participant dicontinued study treatment|9|||
125909369|NCT02545075|452969189|FG000|Treatment|Withdrawal by Subject|1|||
125909370|NCT02545075|452969190|FG001|Treatment|Withdrawal by Subject|0|||
125909371|NCT02545075|452969189|FG000|Treatment|Adverse event not related to study drug|1|||
125909372|NCT02545075|452969190|FG001|Treatment|Adverse event not related to study drug|0|||
125909373|NCT02545075|452969189|FG000|Treatment|Death|1|||
125909374|NCT02545075|452969190|FG001|Treatment|Death|0|||
125909375|NCT02545075|452969189|FG000|Treatment|Participant drug toxicity|1|||
125909376|NCT02545075|452969190|FG001|Treatment|Participant drug toxicity|0|||
125909377|NCT02545075|452969189|FG000|Treatment|Completed treatment|40|||
125909378|NCT02545075|452969190|FG001|Treatment|Completed treatment|12|||
125909379|NCT03583164|452969191|FG000|Overall Study|Death in Main Phase|35|||
125909380|NCT03583164|452969191|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
125909381|NCT03583164|452969191|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
125909382|NCT03583164|452969191|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
125909383|NCT03583164|452969191|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
125909384|NCT03583164|452969191|FG000|Overall Study|Physician decision in Main Phase|1|||
125909385|NCT03583164|452969191|FG000|Overall Study|Physician decision in Extended Phase|2|||
125909386|NCT03583164|452969191|FG000|Overall Study|Death in Extended Phase|13|||
125909387|NCT03583164|452969191|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
125909388|NCT03583164|452969191|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
125909389|NCT03583164|452969191|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
125909390|NCT03583164|452969191|FG000|Overall Study|Treatment failure in Main Phase|2|||
125909391|NCT03583164|452969191|FG000|Overall Study|Treatment failure in Extended Phase|4|||
125909392|NCT03583164|452969191|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
125909393|NCT03583164|452969191|FG000|Overall Study|Other not specified reason in Main Phase|2|||
125909394|NCT00735254|452969192|FG000|Overall Study|Protocol Violation|1|||
125909395|NCT00735254|452969193|FG001|Overall Study|Protocol Violation|1|||
125909396|NCT00735254|452969194|FG002|Overall Study|Protocol Violation|1|||
125909397|NCT00735254|452969195|FG003|Overall Study|Protocol Violation|0|||
125909398|NCT00559754|452969196|FG000|Overall Study|Disease progression|1|||
125909399|NCT00559754|452969196|FG000|Overall Study|Adverse Event|5|||
125909400|NCT00559754|452969196|FG000|Overall Study|Protocol Violation|1|||
125909401|NCT00559754|452969196|FG000|Overall Study|Investigator criteria|2|||
125909402|NCT00559754|452969196|FG000|Overall Study|Withdrawal by Subject|2|||
125909403|NCT01251744|452969197|FG000|Overall Study|Lost to Follow-up|1|||
125909404|NCT01251744|452969198|FG001|Overall Study|Lost to Follow-up|0|||
125909405|NCT00751621|452969199|FG000|Overall Study|Adverse Event|1|||
125909406|NCT00751621|452969199|FG000|Overall Study|Withdrawal by Subject|1|||
125909407|NCT00751621|452969199|FG000|Overall Study|Subject moved to another country|1|||
125909408|NCT00751621|452969199|FG000|Overall Study|Poor adherence to asthma treatment|1|||
125909409|NCT00573248|452969200|FG000|Overall Study|scheduling conflicts|15|||
125909410|NCT00573248|452969201|FG001|Overall Study|scheduling conflicts|11|||
125909411|NCT05323656|452969206|FG000|Overall Study|Still On-Treatment|6|||
125909412|NCT05323656|452969207|FG001|Overall Study|Still On-Treatment|6|||
125909413|NCT05323656|452969206|FG000|Overall Study|Progressive Disease|15|||
125909414|NCT05323656|452969207|FG001|Overall Study|Progressive Disease|14|||
125909415|NCT05323656|452969206|FG000|Overall Study|Adverse Event|2|||
125909416|NCT05323656|452969207|FG001|Overall Study|Adverse Event|3|||
125909417|NCT05323656|452969206|FG000|Overall Study|Death|1|||
125909418|NCT05323656|452969207|FG001|Overall Study|Death|2|||
125909419|NCT05323656|452969206|FG000|Overall Study|Withdrawal by Subject|1|||
125909420|NCT05323656|452969207|FG001|Overall Study|Withdrawal by Subject|0|||
125909421|NCT05323656|452969206|FG000|Overall Study|Clinical disease progression|0|||
125909422|NCT05323656|452969207|FG001|Overall Study|Clinical disease progression|1|||
125909423|NCT05323656|452969206|FG000|Overall Study|Patient and Investigator decision|1|||
125909424|NCT05323656|452969207|FG001|Overall Study|Patient and Investigator decision|0|||
125909425|NCT05323656|452969206|FG000|Overall Study|Physician Decision|0|||
125909426|NCT05323656|452969207|FG001|Overall Study|Physician Decision|1|||
125909427|NCT03309046|452969210|FG000|Overall Study|Withdrawal by Subject|4|||
125909428|NCT03309046|452969211|FG001|Overall Study|Withdrawal by Subject|17|||
125909429|NCT03963401|452969212|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
125909430|NCT03963401|452969213|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
125909431|NCT03963401|452969214|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
125909432|NCT03963401|452969215|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
125909433|NCT03963401|452969216|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
125909434|NCT03963401|452969217|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
125909435|NCT03963401|452969212|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
125909436|NCT03963401|452969213|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
125909437|NCT03963401|452969214|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
125909438|NCT03963401|452969215|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
125909439|NCT03963401|452969216|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
125909440|NCT03963401|452969217|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
125909441|NCT03963401|452969212|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
125909442|NCT03963401|452969213|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
125909443|NCT03963401|452969214|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
125909444|NCT03963401|452969215|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
125909445|NCT03963401|452969216|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
125909446|NCT03963401|452969217|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
125909447|NCT03963401|452969212|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125909448|NCT03963401|452969213|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
126060626|NCT03693989|453516278|FG000|Overall Study|Protocol Violation|3|||
126060627|NCT03693989|453516279|FG001|Overall Study|Protocol Violation|4|||
126060628|NCT00113529|453516280|FG000|Overall Study|Adverse Event|4|||
126060629|NCT00113529|453516280|FG000|Overall Study|Lack of Efficacy|20|||
126060630|NCT00113529|453516280|FG000|Overall Study|Decision of sponsor|6|||
126060631|NCT00113529|453516280|FG000|Overall Study|Withdrawal by Subject|4|||
125909449|NCT03963401|452969214|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125909450|NCT03963401|452969215|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125909451|NCT03963401|452969216|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125909452|NCT03963401|452969217|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125909453|NCT03963401|452969212|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
125909454|NCT03963401|452969213|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
125909455|NCT03963401|452969214|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
125909456|NCT03963401|452969215|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
125909457|NCT03963401|452969216|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
125909458|NCT03963401|452969217|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
125909459|NCT03963401|452969212|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
125909460|NCT03963401|452969213|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
125909461|NCT03963401|452969214|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
125909462|NCT03963401|452969215|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
125909463|NCT03963401|452969216|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
125909464|NCT03963401|452969217|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
125909465|NCT03963401|452969212|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125909466|NCT03963401|452969213|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125909467|NCT03963401|452969214|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
125909468|NCT03963401|452969215|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125909469|NCT03963401|452969216|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125909470|NCT03963401|452969217|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125909471|NCT03963401|452969212|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
125909472|NCT03963401|452969213|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125909473|NCT03963401|452969214|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125909474|NCT03963401|452969215|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125909475|NCT03963401|452969216|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125909476|NCT03963401|452969217|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125909477|NCT03963401|452969212|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
125909478|NCT03963401|452969213|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
125909479|NCT03963401|452969214|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
125909480|NCT03963401|452969215|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
125909481|NCT03963401|452969216|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
125909482|NCT03963401|452969217|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
125909483|NCT03963401|452969212|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
125909484|NCT03963401|452969213|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125909485|NCT03963401|452969214|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125909486|NCT03963401|452969215|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125909487|NCT03963401|452969216|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125909488|NCT03963401|452969217|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125909489|NCT03963401|452969212|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
125909490|NCT03963401|452969213|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
125909491|NCT03963401|452969214|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
125909492|NCT03963401|452969215|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
125909493|NCT03963401|452969216|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
125909494|NCT03963401|452969217|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
125909495|NCT02676466|452969221|FG000|Overall Study|Death|0|||
125909496|NCT02676466|452969222|FG001|Overall Study|Death|2|||
125909497|NCT02676466|452969223|FG002|Overall Study|Death|1|||
125909498|NCT02676466|452969224|FG003|Overall Study|Death|0|||
125909499|NCT02676466|452969225|FG004|Overall Study|Death|0|||
125909500|NCT02676466|452969226|FG005|Overall Study|Death|0|||
125909501|NCT02676466|452969227|FG006|Overall Study|Death|0|||
125909502|NCT02676466|452969228|FG007|Overall Study|Death|0|||
126060632|NCT02825550|453516282|FG000|Overall Study|Physician Decision|1|||
126060633|NCT00042939|453516283|FG000|Overall Study|Adverse Event|6|||
126060634|NCT00042939|453516284|FG001|Overall Study|Adverse Event|7|||
125909503|NCT02676466|452969221|FG000|Overall Study|Withdrawal by Subject|4|||
125909504|NCT02676466|452969222|FG001|Overall Study|Withdrawal by Subject|3|||
126060635|NCT00042939|453516283|FG000|Overall Study|Death|3|||
126060636|NCT00042939|453516284|FG001|Overall Study|Death|2|||
126060637|NCT00042939|453516283|FG000|Overall Study|Withdrawal by Subject|3|||
126060638|NCT00042939|453516284|FG001|Overall Study|Withdrawal by Subject|4|||
125909505|NCT02676466|452969223|FG002|Overall Study|Withdrawal by Subject|1|||
125909506|NCT02676466|452969224|FG003|Overall Study|Withdrawal by Subject|0|||
125909507|NCT02676466|452969225|FG004|Overall Study|Withdrawal by Subject|3|||
125909508|NCT02676466|452969226|FG005|Overall Study|Withdrawal by Subject|1|||
125909509|NCT02676466|452969227|FG006|Overall Study|Withdrawal by Subject|1|||
125909510|NCT02676466|452969228|FG007|Overall Study|Withdrawal by Subject|1|||
125909511|NCT01178073|452969231|FG000|Overall Study|Adverse Event|34|||
125909512|NCT01178073|452969232|FG001|Overall Study|Adverse Event|27|||
125909513|NCT01178073|452969233|FG002|Overall Study|Adverse Event|24|||
125909514|NCT01178073|452969231|FG000|Overall Study|Protocol Violation|1|||
125909515|NCT01178073|452969232|FG001|Overall Study|Protocol Violation|1|||
125909516|NCT01178073|452969233|FG002|Overall Study|Protocol Violation|1|||
125909517|NCT01178073|452969231|FG000|Overall Study|Lost to Follow-up|2|||
125909518|NCT01178073|452969232|FG001|Overall Study|Lost to Follow-up|0|||
125909519|NCT01178073|452969233|FG002|Overall Study|Lost to Follow-up|3|||
125909520|NCT01178073|452969231|FG000|Overall Study|Physician Decision|14|||
125909521|NCT01178073|452969232|FG001|Overall Study|Physician Decision|10|||
125909522|NCT01178073|452969233|FG002|Overall Study|Physician Decision|10|||
125909523|NCT01178073|452969231|FG000|Overall Study|Withdrawal by Subject|10|||
125909524|NCT01178073|452969232|FG001|Overall Study|Withdrawal by Subject|6|||
125909525|NCT01178073|452969233|FG002|Overall Study|Withdrawal by Subject|8|||
125909526|NCT01178073|452969231|FG000|Overall Study|Missing Completion Status|1|||
125909527|NCT01178073|452969232|FG001|Overall Study|Missing Completion Status|0|||
125909528|NCT01178073|452969233|FG002|Overall Study|Missing Completion Status|0|||
125909529|NCT03497676|452969234|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
125909530|NCT03497676|452969235|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
125909531|NCT03497676|452969236|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
125909532|NCT03497676|452969237|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
125909533|NCT03497676|452969234|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
125909534|NCT03497676|452969235|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
125909535|NCT03497676|452969236|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
125909536|NCT03497676|452969237|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
125909537|NCT03497676|452969234|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
125909538|NCT03497676|452969235|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
125909539|NCT03497676|452969236|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
125909540|NCT03497676|452969237|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
125909541|NCT03497676|452969234|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
125909542|NCT03497676|452969235|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
125909543|NCT03497676|452969236|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
125909544|NCT03497676|452969237|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
125909545|NCT03497676|452969234|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
125909546|NCT03497676|452969235|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
125909547|NCT03497676|452969236|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
125909548|NCT03497676|452969237|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
125909549|NCT03497676|452969234|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
125909550|NCT03497676|452969235|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
125909551|NCT03497676|452969236|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
125909552|NCT03497676|452969237|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
125909553|NCT03497676|452969234|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
125909554|NCT03497676|452969235|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
125909555|NCT03497676|452969236|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
125909556|NCT03497676|452969237|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
125909557|NCT03497676|452969234|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
125909558|NCT03497676|452969235|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
125909559|NCT03497676|452969236|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
125909560|NCT03497676|452969237|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
125909561|NCT01226043|452969247|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
125909562|NCT01226043|452969248|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
125909563|NCT01226043|452969249|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
125909564|NCT01226043|452969250|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
125909565|NCT01226043|452969247|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
125909566|NCT01226043|452969248|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
125909567|NCT01226043|452969249|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
125909568|NCT01226043|452969250|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
125909569|NCT01226043|452969247|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
125909570|NCT01226043|452969248|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
126060639|NCT00042939|453516283|FG000|Overall Study|Other disease|1|||
126060640|NCT00042939|453516284|FG001|Overall Study|Other disease|0|||
125909571|NCT01226043|452969249|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
126060641|NCT00042939|453516283|FG000|Overall Study|Ineligible|2|||
125909572|NCT01226043|452969250|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
125909573|NCT01226043|452969247|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
125909574|NCT01226043|452969248|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
125909575|NCT01226043|452969249|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
125909576|NCT01226043|452969250|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
125909577|NCT01226043|452969247|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
125909578|NCT01226043|452969248|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
125909579|NCT01226043|452969249|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
125909580|NCT01226043|452969250|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
125909581|NCT01226043|452969247|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
125909582|NCT01226043|452969248|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
125909583|NCT01226043|452969249|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
125909584|NCT01226043|452969250|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
125909585|NCT01226043|452969247|FG000|6-week Re-randomization Phase|Adverse Event|0|||
125909586|NCT01226043|452969248|FG001|6-week Re-randomization Phase|Adverse Event|0|||
125909587|NCT01226043|452969249|FG002|6-week Re-randomization Phase|Adverse Event|1|||
125909588|NCT01226043|452969250|FG003|6-week Re-randomization Phase|Adverse Event|1|||
125909589|NCT01226043|452969247|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
125909590|NCT01226043|452969248|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
125909591|NCT01226043|452969249|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
125909592|NCT01226043|452969250|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
125909593|NCT01226043|452969247|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
125909594|NCT01226043|452969248|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
125909595|NCT01226043|452969249|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
125909596|NCT01226043|452969250|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
125909597|NCT01226043|452969247|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
125909598|NCT01226043|452969248|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
125909599|NCT01226043|452969249|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
125909600|NCT01226043|452969250|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
125909601|NCT01226043|452969247|FG000|6-week Re-randomization Phase|Physician Decision|0|||
125909602|NCT01226043|452969248|FG001|6-week Re-randomization Phase|Physician Decision|0|||
125909603|NCT01226043|452969249|FG002|6-week Re-randomization Phase|Physician Decision|3|||
125909604|NCT01226043|452969250|FG003|6-week Re-randomization Phase|Physician Decision|2|||
125909605|NCT01226043|452969247|FG000|6-week Re-randomization Phase|completed in error|0|||
125909606|NCT01226043|452969248|FG001|6-week Re-randomization Phase|completed in error|0|||
125909607|NCT01226043|452969249|FG002|6-week Re-randomization Phase|completed in error|0|||
125909608|NCT01226043|452969250|FG003|6-week Re-randomization Phase|completed in error|1|||
125909609|NCT01226043|452969247|FG000|30-week Observational Phase|Adverse Event|0|||
125909610|NCT01226043|452969248|FG001|30-week Observational Phase|Adverse Event|0|||
125909611|NCT01226043|452969249|FG002|30-week Observational Phase|Adverse Event|1|||
125909612|NCT01226043|452969250|FG003|30-week Observational Phase|Adverse Event|1|||
125909613|NCT01226043|452969247|FG000|30-week Observational Phase|Protocol Violation|0|||
125909614|NCT01226043|452969248|FG001|30-week Observational Phase|Protocol Violation|0|||
125909615|NCT01226043|452969249|FG002|30-week Observational Phase|Protocol Violation|0|||
125909616|NCT01226043|452969250|FG003|30-week Observational Phase|Protocol Violation|1|||
125909617|NCT01226043|452969247|FG000|30-week Observational Phase|Lost to Follow-up|0|||
125909618|NCT01226043|452969248|FG001|30-week Observational Phase|Lost to Follow-up|0|||
125909619|NCT01226043|452969249|FG002|30-week Observational Phase|Lost to Follow-up|2|||
125909620|NCT01226043|452969250|FG003|30-week Observational Phase|Lost to Follow-up|2|||
125909621|NCT01226043|452969247|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
125909622|NCT01226043|452969248|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
125909623|NCT01226043|452969249|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
125909624|NCT01226043|452969250|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
125909625|NCT01226043|452969247|FG000|30-week Observational Phase|Physician Decision|0|||
125909626|NCT01226043|452969248|FG001|30-week Observational Phase|Physician Decision|0|||
125909627|NCT01226043|452969249|FG002|30-week Observational Phase|Physician Decision|2|||
125909628|NCT01226043|452969250|FG003|30-week Observational Phase|Physician Decision|2|||
125909629|NCT00910988|452969251|FG000|Overall Study|Lost to Follow-up|2|||
125909630|NCT00910988|452969252|FG001|Overall Study|Lost to Follow-up|4|||
125909631|NCT00910988|452969253|FG002|Overall Study|Lost to Follow-up|3|||
125909632|NCT00910988|452969254|FG003|Overall Study|Lost to Follow-up|0|||
125909633|NCT03004443|452969255|FG000|Overall Study|Pregnancy|0|||
125909634|NCT03004443|452969256|FG001|Overall Study|Pregnancy|1|||
125909635|NCT00828854|452969257|FG000|Overall Study|Disease Progression|17|||
125909636|NCT00828854|452969257|FG000|Overall Study|Adverse Event|9|||
125909637|NCT00828854|452969257|FG000|Overall Study|Reason not Specified|1|||
125909638|NCT00191646|452969259|FG000|Overall Study|Toxicity|26|||
125909639|NCT00191646|452969260|FG001|Overall Study|Toxicity|37|||
125909640|NCT00191646|452969259|FG000|Overall Study|Disease Progression|5|||
125909641|NCT00191646|452969260|FG001|Overall Study|Disease Progression|6|||
125909642|NCT00191646|452969259|FG000|Overall Study|Physician Decision|20|||
126060642|NCT00042939|453516284|FG001|Overall Study|Ineligible|2|||
126060643|NCT00042939|453516283|FG000|Overall Study|Deterioration of health|3|||
126060644|NCT00042939|453516284|FG001|Overall Study|Deterioration of health|4|||
126060645|NCT00042939|453516283|FG000|Overall Study|QOL diminished|1|||
126060646|NCT00042939|453516284|FG001|Overall Study|QOL diminished|0|||
126060647|NCT00042939|453516283|FG000|Overall Study|Rising ca 19-9|1|||
126060648|NCT00042939|453516284|FG001|Overall Study|Rising ca 19-9|0|||
126060649|NCT00042939|453516283|FG000|Overall Study|Patient non-compliance|1|||
126110132|NCT00559585|453697647|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
126060650|NCT00042939|453516284|FG001|Overall Study|Patient non-compliance|0|||
126060651|NCT00042939|453516283|FG000|Overall Study|Still on treatment|1|||
126060652|NCT00042939|453516284|FG001|Overall Study|Still on treatment|0|||
126060653|NCT00042939|453516283|FG000|Overall Study|Treatment break > 4 weeks|0|||
126060654|NCT00042939|453516284|FG001|Overall Study|Treatment break > 4 weeks|1|||
126060655|NCT00042939|453516283|FG000|Overall Study|Did not start treatment|2|||
126060656|NCT00042939|453516284|FG001|Overall Study|Did not start treatment|1|||
125909643|NCT00191646|452969260|FG001|Overall Study|Physician Decision|11|||
126060657|NCT03150589|453516287|FG000|Overall Study|Withdrawal by Subject|16|||
126060658|NCT03150589|453516288|FG001|Overall Study|Withdrawal by Subject|9|||
125909644|NCT00191646|452969259|FG000|Overall Study|Withdrawal by Subject|58|||
125909645|NCT00191646|452969260|FG001|Overall Study|Withdrawal by Subject|39|||
125909646|NCT00191646|452969259|FG000|Overall Study|Protocol Violation|5|||
125909647|NCT00191646|452969260|FG001|Overall Study|Protocol Violation|7|||
125909648|NCT00191646|452969259|FG000|Overall Study|Death|6|||
125909649|NCT00191646|452969260|FG001|Overall Study|Death|8|||
125909650|NCT00191646|452969259|FG000|Overall Study|Other|33|||
125909651|NCT00191646|452969260|FG001|Overall Study|Other|34|||
125909652|NCT00191646|452969259|FG000|Overall Study|Missing Data|18|||
125909653|NCT00191646|452969260|FG001|Overall Study|Missing Data|11|||
125909654|NCT05211284|452969265|FG000|Overall Study|Study Terminated|3|||
125909655|NCT05211284|452969266|FG001|Overall Study|Study Terminated|1|||
125909656|NCT03911843|452969267|FG000|Overall Study|Adverse Event|2|||
125909657|NCT03911843|452969268|FG001|Overall Study|Adverse Event|0|||
125909658|NCT03911843|452969267|FG000|Overall Study|Protocol Violation|2|||
125909659|NCT03911843|452969268|FG001|Overall Study|Protocol Violation|0|||
125909660|NCT03911843|452969267|FG000|Overall Study|Lost to Follow-up|0|||
125909661|NCT03911843|452969268|FG001|Overall Study|Lost to Follow-up|1|||
125909662|NCT01907100|452969269|FG000|Overall Study|PD based on modified RECIST criteria|31|||
125909663|NCT01907100|452969270|FG001|Overall Study|PD based on modified RECIST criteria|32|||
125909664|NCT01907100|452969271|FG002|Overall Study|PD based on modified RECIST criteria|95|||
125909665|NCT01907100|452969272|FG003|Overall Study|PD based on modified RECIST criteria|92|||
125909666|NCT01907100|452969269|FG000|Overall Study|Withdrawal by Subject|2|||
125909667|NCT01907100|452969270|FG001|Overall Study|Withdrawal by Subject|5|||
125909668|NCT01907100|452969271|FG002|Overall Study|Withdrawal by Subject|10|||
125909669|NCT01907100|452969272|FG003|Overall Study|Withdrawal by Subject|13|||
125909670|NCT01907100|452969269|FG000|Overall Study|Protocol Violation|0|||
125909671|NCT01907100|452969270|FG001|Overall Study|Protocol Violation|0|||
125909672|NCT01907100|452969271|FG002|Overall Study|Protocol Violation|1|||
125909673|NCT01907100|452969272|FG003|Overall Study|Protocol Violation|1|||
125909674|NCT01907100|452969269|FG000|Overall Study|Lost to Follow-up|0|||
125909675|NCT01907100|452969270|FG001|Overall Study|Lost to Follow-up|0|||
125909676|NCT01907100|452969271|FG002|Overall Study|Lost to Follow-up|0|||
125909677|NCT01907100|452969272|FG003|Overall Study|Lost to Follow-up|1|||
125909678|NCT01907100|452969269|FG000|Overall Study|Not treated|2|||
125909679|NCT01907100|452969270|FG001|Overall Study|Not treated|0|||
125909680|NCT01907100|452969271|FG002|Overall Study|Not treated|1|||
125909681|NCT01907100|452969272|FG003|Overall Study|Not treated|2|||
125909682|NCT01907100|452969269|FG000|Overall Study|Other than reasons specified|1|||
125909683|NCT01907100|452969270|FG001|Overall Study|Other than reasons specified|0|||
125909684|NCT01907100|452969271|FG002|Overall Study|Other than reasons specified|10|||
125909685|NCT01907100|452969272|FG003|Overall Study|Other than reasons specified|6|||
125909686|NCT01907100|452969269|FG000|Overall Study|Adverse event (AE)|6|||
125909687|NCT01907100|452969270|FG001|Overall Study|Adverse event (AE)|3|||
125909688|NCT01907100|452969271|FG002|Overall Study|Adverse event (AE)|22|||
125909689|NCT01907100|452969272|FG003|Overall Study|Adverse event (AE)|23|||
125909690|NCT01907100|452969269|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
125909691|NCT01907100|452969270|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
125909692|NCT01907100|452969271|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
125909693|NCT01907100|452969272|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
125909694|NCT00739596|452969277|FG000|Overall Study|Adverse Event|12|||
125909695|NCT00739596|452969278|FG001|Overall Study|Adverse Event|6|||
125909696|NCT00739596|452969277|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
125909697|NCT00739596|452969278|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125909698|NCT00739596|452969277|FG000|Overall Study|Patient Withdrew Consent|8|||
125909699|NCT00739596|452969278|FG001|Overall Study|Patient Withdrew Consent|8|||
125909700|NCT00739596|452969277|FG000|Overall Study|Lost to Follow-up|0|||
125909701|NCT00739596|452969278|FG001|Overall Study|Lost to Follow-up|2|||
125909702|NCT00739596|452969277|FG000|Overall Study|Protocol Deviation|1|||
125909703|NCT00739596|452969278|FG001|Overall Study|Protocol Deviation|1|||
125909704|NCT00908011|452969279|FG000|Overall Study|Withdrawal by Subject|2|||
125909705|NCT00908011|452969280|FG001|Overall Study|Withdrawal by Subject|2|||
125909706|NCT00644228|452969281|FG000|Randomization & Eligibility|Ineligible|31|||
125909707|NCT00644228|452969282|FG001|Randomization & Eligibility|Ineligible|21|||
125909708|NCT00644228|452969281|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
125909709|NCT00644228|452969282|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
125909710|NCT00644228|452969281|FG000|Randomization & Eligibility|Invalid Consent|0|||
125909711|NCT00644228|452969282|FG001|Randomization & Eligibility|Invalid Consent|1|||
125909712|NCT00644228|452969281|FG000|Induction Therapy|Adverse Event|22|||
125909713|NCT00644228|452969282|FG001|Induction Therapy|Adverse Event|55|||
125909714|NCT00644228|452969281|FG000|Induction Therapy|Withdrawal by Subject|10|||
125909715|NCT00644228|452969282|FG001|Induction Therapy|Withdrawal by Subject|3|||
125909716|NCT00644228|452969281|FG000|Induction Therapy|Progression/Relapse|24|||
125909717|NCT00644228|452969282|FG001|Induction Therapy|Progression/Relapse|12|||
125909718|NCT00644228|452969281|FG000|Induction Therapy|Death|3|||
125909719|NCT00644228|452969282|FG001|Induction Therapy|Death|7|||
125909720|NCT00644228|452969281|FG000|Induction Therapy|Not Protocol-Specified|24|||
125909721|NCT00644228|452969282|FG001|Induction Therapy|Not Protocol-Specified|28|||
125909722|NCT00644228|452969281|FG000|Maintenance|Adverse Event|27|||
125909723|NCT00644228|452969282|FG001|Maintenance|Adverse Event|31|||
125909724|NCT00644228|452969281|FG000|Maintenance|Withdrawal by Subject|6|||
125909725|NCT00644228|452969282|FG001|Maintenance|Withdrawal by Subject|4|||
125909726|NCT00644228|452969281|FG000|Maintenance|Progression/Relapse|67|||
125909727|NCT00644228|452969282|FG001|Maintenance|Progression/Relapse|42|||
125909728|NCT00644228|452969281|FG000|Maintenance|Death|3|||
125909729|NCT00644228|452969282|FG001|Maintenance|Death|3|||
125909730|NCT00644228|452969281|FG000|Maintenance|Not Protocol-Specified|14|||
125909731|NCT00644228|452969282|FG001|Maintenance|Not Protocol-Specified|15|||
125909732|NCT00644228|452969281|FG000|Maintenance|On Treatment|26|||
125909733|NCT00644228|452969282|FG001|Maintenance|On Treatment|40|||
125909734|NCT00760084|452969283|FG000|Overall Study|Physician Decision|5|||
125909735|NCT00760084|452969283|FG000|Overall Study|Withdrawal by Subject|2|||
125909736|NCT00760084|452969283|FG000|Overall Study|Progressive Disease|3|||
125909737|NCT03187756|452969284|FG000|Overall Study|Termination of study|4|||
125909738|NCT02567552|452969285|FG000|Overall Study|Adverse Event|0|||
125909739|NCT02567552|452969286|FG001|Overall Study|Adverse Event|1|||
125909740|NCT03635788|452969287|FG000|Step 1|Death|1|||
125909741|NCT03635788|452969288|FG001|Step 1|Death|0|||
125909742|NCT03635788|452969289|FG002|Step 1|Death|0|||
125909743|NCT03635788|452969287|FG000|Step 1|Lost to Follow-up|31|||
125909744|NCT03635788|452969288|FG001|Step 1|Lost to Follow-up|0|||
125909745|NCT03635788|452969289|FG002|Step 1|Lost to Follow-up|0|||
125909746|NCT03635788|452969287|FG000|Step 1|Pregnancy|1|||
125909747|NCT03635788|452969288|FG001|Step 1|Pregnancy|0|||
125909748|NCT03635788|452969289|FG002|Step 1|Pregnancy|0|||
125909749|NCT03635788|452969287|FG000|Step 1|Protocol Violation|8|||
125909750|NCT03635788|452969288|FG001|Step 1|Protocol Violation|0|||
125909751|NCT03635788|452969289|FG002|Step 1|Protocol Violation|0|||
125909752|NCT03635788|452969287|FG000|Step 1|Withdrawal by Subject|13|||
125909753|NCT03635788|452969288|FG001|Step 1|Withdrawal by Subject|0|||
125909754|NCT03635788|452969289|FG002|Step 1|Withdrawal by Subject|0|||
125909755|NCT03635788|452969287|FG000|Step 1|Other reasons|12|||
125909756|NCT03635788|452969288|FG001|Step 1|Other reasons|0|||
125909757|NCT03635788|452969289|FG002|Step 1|Other reasons|0|||
125909758|NCT03635788|452969287|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
125909759|NCT03635788|452969288|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
125909760|NCT03635788|452969289|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
125909761|NCT03635788|452969287|FG000|Step 2|Lost to Follow-up|0|||
125909762|NCT03635788|452969288|FG001|Step 2|Lost to Follow-up|8|||
125909763|NCT03635788|452969289|FG002|Step 2|Lost to Follow-up|15|||
125909764|NCT03635788|452969287|FG000|Step 2|Withdrawal by Subject|0|||
125909765|NCT03635788|452969288|FG001|Step 2|Withdrawal by Subject|6|||
125909766|NCT03635788|452969289|FG002|Step 2|Withdrawal by Subject|6|||
125909767|NCT03635788|452969287|FG000|Step 2|Death|0|||
125909768|NCT03635788|452969288|FG001|Step 2|Death|2|||
125909769|NCT03635788|452969289|FG002|Step 2|Death|0|||
125909770|NCT03635788|452969287|FG000|Step 2|Incarceration|0|||
125909771|NCT03635788|452969288|FG001|Step 2|Incarceration|2|||
125909772|NCT03635788|452969289|FG002|Step 2|Incarceration|0|||
125909773|NCT03635788|452969287|FG000|Step 2|Non-Compliance With Study Requirements|0|||
125909774|NCT03635788|452969288|FG001|Step 2|Non-Compliance With Study Requirements|1|||
125909775|NCT03635788|452969289|FG002|Step 2|Non-Compliance With Study Requirements|1|||
125909776|NCT03635788|452969287|FG000|Step 2|Confounding Medical Condition|0|||
125909777|NCT03635788|452969288|FG001|Step 2|Confounding Medical Condition|0|||
125909778|NCT03635788|452969289|FG002|Step 2|Confounding Medical Condition|1|||
125909779|NCT03635788|452969287|FG000|Step 2|Out Of State With No Plan To Return|0|||
125909780|NCT03635788|452969288|FG001|Step 2|Out Of State With No Plan To Return|1|||
125909781|NCT03635788|452969289|FG002|Step 2|Out Of State With No Plan To Return|0|||
125909782|NCT03635788|452969287|FG000|Step 2|Switched To Injectables|0|||
125909783|NCT03635788|452969288|FG001|Step 2|Switched To Injectables|0|||
125909784|NCT03635788|452969289|FG002|Step 2|Switched To Injectables|1|||
125909785|NCT03635788|452969287|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
125909786|NCT03635788|452969288|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
125909787|NCT03635788|452969289|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
125909788|NCT04382755|452969290|FG000|Overall Study|Withdrawal by Subject|1|||
125909789|NCT04382755|452969291|FG001|Overall Study|Withdrawal by Subject|0|||
125909790|NCT04382755|452969290|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
125909791|NCT04382755|452969291|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
125909792|NCT04382755|452969290|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
125909793|NCT04382755|452969291|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
125909794|NCT04629508|452970692|FG000|Overall Study|Adverse Event|1|||
125909795|NCT04629508|452970692|FG000|Overall Study|Death|2|||
125909796|NCT04629508|452970692|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
125909797|NCT00760214|452970698|FG000|Overall Study|Adverse Event|8|||
125909798|NCT00760214|452970699|FG001|Overall Study|Adverse Event|9|||
125909799|NCT00760214|452970700|FG002|Overall Study|Adverse Event|12|||
125909800|NCT00760214|452970698|FG000|Overall Study|Protocol Violation|3|||
125909801|NCT00760214|452970699|FG001|Overall Study|Protocol Violation|0|||
125909802|NCT00760214|452970700|FG002|Overall Study|Protocol Violation|3|||
125909803|NCT00760214|452970698|FG000|Overall Study|Lost to Follow-up|0|||
125909804|NCT00760214|452970699|FG001|Overall Study|Lost to Follow-up|0|||
125909805|NCT00760214|452970700|FG002|Overall Study|Lost to Follow-up|1|||
125909806|NCT00760214|452970698|FG000|Overall Study|Withdrawal by Subject|12|||
125909807|NCT00760214|452970699|FG001|Overall Study|Withdrawal by Subject|14|||
125909808|NCT00760214|452970700|FG002|Overall Study|Withdrawal by Subject|13|||
125909809|NCT00760214|452970698|FG000|Overall Study|Lack of Efficacy|3|||
125909810|NCT00760214|452970699|FG001|Overall Study|Lack of Efficacy|2|||
126110133|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
126110134|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
126110135|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
126110136|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
126110137|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
125909811|NCT00760214|452970700|FG002|Overall Study|Lack of Efficacy|4|||
125909812|NCT00760214|452970698|FG000|Overall Study|Pregnancy|0|||
125909813|NCT00760214|452970699|FG001|Overall Study|Pregnancy|0|||
125909814|NCT00760214|452970700|FG002|Overall Study|Pregnancy|1|||
125909815|NCT00760214|452970698|FG000|Overall Study|Physician Decision|1|||
125909816|NCT00760214|452970699|FG001|Overall Study|Physician Decision|1|||
125909817|NCT00760214|452970700|FG002|Overall Study|Physician Decision|1|||
125909818|NCT00760214|452970698|FG000|Overall Study|Other|3|||
125909819|NCT00760214|452970699|FG001|Overall Study|Other|4|||
125909820|NCT00760214|452970700|FG002|Overall Study|Other|6|||
125909821|NCT03960554|452970704|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
125909822|NCT03960554|452970705|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
125909823|NCT00736879|452970706|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
125909824|NCT00736879|452970707|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
125909825|NCT00736879|452970708|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
125909826|NCT00736879|452970709|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
125909827|NCT00736879|452970706|FG000|Double Blind Treatment Period|Adverse Event|0|||
125909828|NCT00736879|452970707|FG001|Double Blind Treatment Period|Adverse Event|1|||
125909829|NCT00736879|452970708|FG002|Double Blind Treatment Period|Adverse Event|1|||
125909830|NCT00736879|452970709|FG003|Double Blind Treatment Period|Adverse Event|0|||
125909831|NCT00736879|452970706|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
125909832|NCT00736879|452970707|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
126110138|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
125909833|NCT00736879|452970708|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
125909834|NCT00736879|452970709|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
125909835|NCT00736879|452970706|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
125909836|NCT00736879|452970707|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125909837|NCT00736879|452970708|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
125909838|NCT00736879|452970709|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
125909839|NCT00736879|452970706|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
125909840|NCT00736879|452970707|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
125909841|NCT00736879|452970708|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
125909842|NCT00736879|452970709|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
125909843|NCT00736879|452970706|FG000|Double Blind Treatment Period|No longer met criteria|0|||
125909844|NCT00736879|452970707|FG001|Double Blind Treatment Period|No longer met criteria|1|||
125909845|NCT00736879|452970708|FG002|Double Blind Treatment Period|No longer met criteria|0|||
125909846|NCT00736879|452970709|FG003|Double Blind Treatment Period|No longer met criteria|0|||
125909847|NCT00736879|452970706|FG000|Double Blind Treatment Period|non-specified|0|||
125909848|NCT00736879|452970707|FG001|Double Blind Treatment Period|non-specified|1|||
125909849|NCT00736879|452970708|FG002|Double Blind Treatment Period|non-specified|0|||
125909850|NCT00736879|452970709|FG003|Double Blind Treatment Period|non-specified|0|||
125909851|NCT00736879|452970706|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
125909852|NCT00736879|452970707|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
125909853|NCT00736879|452970708|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
125909854|NCT00736879|452970709|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
125909855|NCT00736879|452970706|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
125909856|NCT00736879|452970707|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
125909857|NCT00736879|452970708|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
125909858|NCT00736879|452970709|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
125909859|NCT01810432|452970710|FG000|Washout|Protocol Violation|0|||
125909860|NCT01810432|452970711|FG001|Washout|Protocol Violation|1|||
125909861|NCT01810432|452970710|FG000|Washout|Adverse Event|1|||
125909862|NCT01810432|452970711|FG001|Washout|Adverse Event|0|||
125909863|NCT01810432|452970710|FG000|Period 2|Withdrawal by Subject|2|||
125909864|NCT01810432|452970711|FG001|Period 2|Withdrawal by Subject|1|||
125909865|NCT01810432|452970710|FG000|Period 2|Physician Decision|1|||
125909866|NCT01810432|452970711|FG001|Period 2|Physician Decision|0|||
125909867|NCT01810432|452970710|FG000|Period 2|Lost to Follow-up|1|||
125909868|NCT01810432|452970711|FG001|Period 2|Lost to Follow-up|1|||
125909869|NCT02360111|452970714|FG000|Overall Study|Death|2|||
125909870|NCT02310321|452970717|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
125909871|NCT02310321|452970718|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
125909872|NCT02310321|452970719|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
125909873|NCT02310321|452970717|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
125909874|NCT02310321|452970718|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
125909875|NCT02310321|452970719|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
125909876|NCT02310321|452970717|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
125909877|NCT02310321|452970718|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
125909878|NCT02310321|452970719|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
125909879|NCT02310321|452970717|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
125909880|NCT02310321|452970718|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
125909881|NCT02310321|452970719|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
125909882|NCT02310321|452970717|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
125909883|NCT02310321|452970718|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
125909884|NCT02310321|452970719|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
125909885|NCT02310321|452970717|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
125909886|NCT02310321|452970718|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
125909887|NCT02310321|452970719|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
125909888|NCT02310321|452970717|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
125909889|NCT02310321|452970718|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
125909890|NCT02310321|452970719|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
125909891|NCT02310321|452970717|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
125909892|NCT02310321|452970718|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
125909893|NCT02310321|452970719|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
125909894|NCT02310321|452970717|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
125909895|NCT02310321|452970718|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
126060659|NCT03150589|453516287|FG000|Overall Study|Adverse Event|7|||
126060660|NCT03150589|453516288|FG001|Overall Study|Adverse Event|6|||
126060661|NCT03150589|453516287|FG000|Overall Study|Protocol Violation|4|||
126060662|NCT03150589|453516288|FG001|Overall Study|Protocol Violation|3|||
126060663|NCT03150589|453516287|FG000|Overall Study|Lost to Follow-up|3|||
126060664|NCT03150589|453516288|FG001|Overall Study|Lost to Follow-up|3|||
126060665|NCT03150589|453516287|FG000|Overall Study|Death|2|||
126060666|NCT03150589|453516288|FG001|Overall Study|Death|3|||
126060667|NCT03150589|453516287|FG000|Overall Study|IP non-compliance and other reasons|12|||
126060668|NCT03150589|453516288|FG001|Overall Study|IP non-compliance and other reasons|3|||
125909896|NCT02310321|452970719|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
125909897|NCT02310321|452970717|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
126060669|NCT01000649|453516291|FG000|Overall Study|Adverse Event|5|||
126060670|NCT01000649|453516292|FG001|Overall Study|Adverse Event|1|||
125909898|NCT02310321|452970718|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
125909899|NCT02310321|452970719|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
126060671|NCT01000649|453516293|FG002|Overall Study|Adverse Event|2|||
126060672|NCT01000649|453516294|FG003|Overall Study|Adverse Event|4|||
126060673|NCT01000649|453516291|FG000|Overall Study|Lost to Follow-up|0|||
125909900|NCT02310321|452970717|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
125909901|NCT02310321|452970718|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
125909902|NCT02310321|452970719|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
125909903|NCT02310321|452970717|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
125909904|NCT02310321|452970718|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
125909905|NCT02310321|452970719|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
125909906|NCT02310321|452970717|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
125909907|NCT02310321|452970718|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
125909908|NCT02310321|452970719|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
125909909|NCT02310321|452970717|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
125909910|NCT02310321|452970718|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
125909911|NCT02310321|452970719|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
125909912|NCT02310321|452970717|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
125909913|NCT02310321|452970718|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
125909914|NCT02310321|452970719|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
125909915|NCT02310321|452970717|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
125909916|NCT02310321|452970718|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
125909917|NCT02310321|452970719|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
125909918|NCT02310321|452970717|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
125909919|NCT02310321|452970718|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
125909920|NCT02310321|452970719|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
125909921|NCT02310321|452970717|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
125909922|NCT02310321|452970718|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
125909923|NCT02310321|452970719|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
125909924|NCT02310321|452970717|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
125909925|NCT02310321|452970718|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
125909926|NCT02310321|452970719|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
125909927|NCT02310321|452970717|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
125909928|NCT02310321|452970718|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
125909929|NCT02310321|452970719|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
125909930|NCT02310321|452970717|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
125909931|NCT02310321|452970718|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
125909932|NCT02310321|452970719|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
125909933|NCT02310321|452970717|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
125909934|NCT02310321|452970718|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
125909935|NCT02310321|452970719|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
125909936|NCT02310321|452970717|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
125909937|NCT02310321|452970718|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
125909938|NCT02310321|452970719|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
125909939|NCT01698905|452970720|FG000|Overall Study|Adverse Event|4|||
125909940|NCT01698905|452970720|FG000|Overall Study|Physician Decision|2|||
125909941|NCT01698905|452970720|FG000|Overall Study|Pregnancy|1|||
125909942|NCT01698905|452970720|FG000|Overall Study|Protocol Violation|1|||
125909943|NCT01698905|452970720|FG000|Overall Study|Subject/guardian decision|2|||
125909944|NCT01698905|452970720|FG000|Overall Study|Death|1|||
125909945|NCT02325791|452970723|FG000|Overall Study|Adverse Event|0|||
125909946|NCT02325791|452970724|FG001|Overall Study|Adverse Event|1|||
125909947|NCT02325791|452970725|FG002|Overall Study|Adverse Event|1|||
125909948|NCT02325791|452970726|FG003|Overall Study|Adverse Event|0|||
125909949|NCT02325791|452970723|FG000|Overall Study|Death|0|||
125909950|NCT02325791|452970724|FG001|Overall Study|Death|3|||
125909951|NCT02325791|452970725|FG002|Overall Study|Death|0|||
125909952|NCT02325791|452970726|FG003|Overall Study|Death|1|||
125909953|NCT02325791|452970723|FG000|Overall Study|Lost to Follow-up|0|||
125909954|NCT02325791|452970724|FG001|Overall Study|Lost to Follow-up|15|||
125909955|NCT02325791|452970725|FG002|Overall Study|Lost to Follow-up|14|||
125909956|NCT02325791|452970726|FG003|Overall Study|Lost to Follow-up|9|||
125909957|NCT02325791|452970723|FG000|Overall Study|Physician Decision|0|||
125909958|NCT02325791|452970724|FG001|Overall Study|Physician Decision|1|||
125909959|NCT02325791|452970725|FG002|Overall Study|Physician Decision|1|||
125909960|NCT02325791|452970726|FG003|Overall Study|Physician Decision|0|||
125909961|NCT02325791|452970723|FG000|Overall Study|Protocol Violation|0|||
125909962|NCT02325791|452970724|FG001|Overall Study|Protocol Violation|0|||
125909963|NCT02325791|452970725|FG002|Overall Study|Protocol Violation|1|||
125909964|NCT02325791|452970726|FG003|Overall Study|Protocol Violation|0|||
125909965|NCT02325791|452970723|FG000|Overall Study|Withdrawal by Subject|0|||
125909966|NCT02325791|452970724|FG001|Overall Study|Withdrawal by Subject|5|||
125909967|NCT02325791|452970725|FG002|Overall Study|Withdrawal by Subject|8|||
125909968|NCT02325791|452970726|FG003|Overall Study|Withdrawal by Subject|16|||
125909969|NCT03953183|452970727|FG000|Overall Study|Physician Decision|0|||
125909970|NCT03953183|452970728|FG001|Overall Study|Physician Decision|1|||
125909971|NCT03953183|452970727|FG000|Overall Study|Withdrawal by Subject|0|||
126060674|NCT01000649|453516292|FG001|Overall Study|Lost to Follow-up|2|||
126060675|NCT01000649|453516293|FG002|Overall Study|Lost to Follow-up|0|||
126060676|NCT01000649|453516294|FG003|Overall Study|Lost to Follow-up|2|||
126060677|NCT00346398|453516295|FG000|Overall Study|Lost to Follow-up|3|||
126060678|NCT00346398|453516296|FG001|Overall Study|Lost to Follow-up|0|||
126060679|NCT00346398|453516295|FG000|Overall Study|Withdrawal by Subject|0|||
126060680|NCT00346398|453516296|FG001|Overall Study|Withdrawal by Subject|2|||
126060681|NCT03979040|453516297|FG000|Overall Study|Withdrawal by Subject|24|||
126060682|NCT03979040|453516298|FG001|Overall Study|Withdrawal by Subject|32|||
126060683|NCT03979040|453516297|FG000|Overall Study|randomized but never started treatment|32|||
126060684|NCT03979040|453516298|FG001|Overall Study|randomized but never started treatment|39|||
126060685|NCT03979040|453516297|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
126060686|NCT03979040|453516298|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
126060687|NCT02607956|453516299|FG000|Double-Blinded Phase|Withdrew Consent|17|||
126060688|NCT02607956|453516300|FG001|Double-Blinded Phase|Withdrew Consent|19|||
126060689|NCT02607956|453516301|FG002|Double-Blinded Phase|Withdrew Consent|0|||
126060690|NCT02607956|453516302|FG003|Double-Blinded Phase|Withdrew Consent|0|||
126060691|NCT02607956|453516299|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
126060692|NCT02607956|453516300|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
126060693|NCT02607956|453516301|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
126060694|NCT02607956|453516302|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
126060695|NCT02607956|453516299|FG000|Double-Blinded Phase|Randomized but never treated|7|||
126060696|NCT02607956|453516300|FG001|Double-Blinded Phase|Randomized but never treated|5|||
126060697|NCT02607956|453516301|FG002|Double-Blinded Phase|Randomized but never treated|0|||
126060698|NCT02607956|453516302|FG003|Double-Blinded Phase|Randomized but never treated|0|||
126060699|NCT02607956|453516299|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
126060700|NCT02607956|453516300|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
126060701|NCT02607956|453516301|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
126060702|NCT02607956|453516302|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
126060703|NCT02607956|453516299|FG000|Double-Blinded Phase|Death|4|||
126060704|NCT02607956|453516300|FG001|Double-Blinded Phase|Death|4|||
126060705|NCT02607956|453516301|FG002|Double-Blinded Phase|Death|0|||
126060706|NCT02607956|453516302|FG003|Double-Blinded Phase|Death|0|||
126060707|NCT02607956|453516299|FG000|Double-Blinded Phase|Adverse Event|4|||
126060708|NCT02607956|453516300|FG001|Double-Blinded Phase|Adverse Event|3|||
126060709|NCT02607956|453516301|FG002|Double-Blinded Phase|Adverse Event|0|||
126060710|NCT02607956|453516302|FG003|Double-Blinded Phase|Adverse Event|0|||
126060711|NCT02607956|453516299|FG000|Double-Blinded Phase|Protocol Violation|3|||
126060712|NCT02607956|453516300|FG001|Double-Blinded Phase|Protocol Violation|1|||
126060713|NCT02607956|453516301|FG002|Double-Blinded Phase|Protocol Violation|0|||
126060714|NCT02607956|453516302|FG003|Double-Blinded Phase|Protocol Violation|0|||
126060715|NCT02607956|453516299|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
126060716|NCT02607956|453516300|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
126060717|NCT02607956|453516301|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
126060718|NCT02607956|453516302|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
126060719|NCT02607956|453516299|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
126060720|NCT02607956|453516300|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
126060721|NCT02607956|453516301|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
126060722|NCT02607956|453516302|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
126060723|NCT02607956|453516299|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
126060724|NCT02607956|453516300|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126060725|NCT02607956|453516301|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
126060726|NCT02607956|453516302|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
126060727|NCT02607956|453516299|FG000|Open-Label Extension Phase|Death|0|||
126060728|NCT02607956|453516300|FG001|Open-Label Extension Phase|Death|0|||
126060729|NCT02607956|453516301|FG002|Open-Label Extension Phase|Death|1|||
126060730|NCT02607956|453516302|FG003|Open-Label Extension Phase|Death|3|||
126060731|NCT02607956|453516299|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
125909972|NCT03953183|452970728|FG001|Overall Study|Withdrawal by Subject|1|||
125909973|NCT00764504|452970729|FG000|Overall Study|Death|12|||
125909974|NCT00764504|452970730|FG001|Overall Study|Death|6|||
125909975|NCT00764504|452970731|FG002|Overall Study|Death|13|||
125909976|NCT00764504|452970729|FG000|Overall Study|Revision of Device|12|||
125909977|NCT00764504|452970730|FG001|Overall Study|Revision of Device|23|||
125909978|NCT00764504|452970731|FG002|Overall Study|Revision of Device|14|||
125909979|NCT00764504|452970729|FG000|Overall Study|Physician Decision|1|||
125909980|NCT00764504|452970730|FG001|Overall Study|Physician Decision|0|||
125909981|NCT00764504|452970731|FG002|Overall Study|Physician Decision|0|||
125909982|NCT00764504|452970729|FG000|Overall Study|Withdrawal by Subject|1|||
125909983|NCT00764504|452970730|FG001|Overall Study|Withdrawal by Subject|7|||
125909984|NCT00764504|452970731|FG002|Overall Study|Withdrawal by Subject|4|||
125909985|NCT00764504|452970729|FG000|Overall Study|Lost to Follow-up|40|||
125909986|NCT00764504|452970730|FG001|Overall Study|Lost to Follow-up|34|||
125909987|NCT00764504|452970731|FG002|Overall Study|Lost to Follow-up|72|||
125909988|NCT01465191|452970732|FG000|Overall Study|Protocol Violation|6|||
125909989|NCT01465191|452970733|FG001|Overall Study|Protocol Violation|3|||
125909990|NCT01465191|452970734|FG002|Overall Study|Protocol Violation|3|||
125909991|NCT01465191|452970732|FG000|Overall Study|Lost to Follow-up|3|||
125909992|NCT01465191|452970733|FG001|Overall Study|Lost to Follow-up|6|||
125909993|NCT01465191|452970734|FG002|Overall Study|Lost to Follow-up|4|||
125909994|NCT04010539|452970735|FG000|Overall Study|Withdrawal by Subject|4|||
125909995|NCT04010539|452970736|FG001|Overall Study|Withdrawal by Subject|1|||
125909996|NCT04010539|452970735|FG000|Overall Study|Physician Decision|0|||
125909997|NCT04010539|452970736|FG001|Overall Study|Physician Decision|2|||
125909998|NCT04010539|452970735|FG000|Overall Study|Lost to Follow-up|10|||
125909999|NCT04010539|452970736|FG001|Overall Study|Lost to Follow-up|14|||
125910000|NCT04010539|452970735|FG000|Overall Study|Adverse Event|3|||
125910001|NCT04010539|452970736|FG001|Overall Study|Adverse Event|0|||
125910002|NCT04010539|452970735|FG000|Overall Study|Participant Did Not Receive IP|0|||
125910003|NCT04010539|452970736|FG001|Overall Study|Participant Did Not Receive IP|1|||
125910004|NCT04010539|452970735|FG000|Overall Study|Protocol Deviation|0|||
125910005|NCT04010539|452970736|FG001|Overall Study|Protocol Deviation|1|||
125910006|NCT04010539|452970735|FG000|Overall Study|Randomized in Error/ Mistake|2|||
125910007|NCT04010539|452970736|FG001|Overall Study|Randomized in Error/ Mistake|0|||
125910008|NCT04010539|452970735|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
126060732|NCT02607956|453516300|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
126060733|NCT02607956|453516301|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
126060734|NCT02607956|453516302|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
126060735|NCT02607956|453516299|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
126060736|NCT02607956|453516300|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
126060737|NCT02607956|453516301|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
126060738|NCT02607956|453516302|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
126060739|NCT02607956|453516299|FG000|Open-Label Extension Phase|Protocol Violation|0|||
126060740|NCT02607956|453516300|FG001|Open-Label Extension Phase|Protocol Violation|0|||
126060741|NCT02607956|453516301|FG002|Open-Label Extension Phase|Protocol Violation|0|||
126060742|NCT02607956|453516302|FG003|Open-Label Extension Phase|Protocol Violation|2|||
126060743|NCT02607956|453516299|FG000|Open-Label Extension Phase|Pregnancy|0|||
126060744|NCT02607956|453516300|FG001|Open-Label Extension Phase|Pregnancy|0|||
126060745|NCT02607956|453516301|FG002|Open-Label Extension Phase|Pregnancy|0|||
126060746|NCT02607956|453516302|FG003|Open-Label Extension Phase|Pregnancy|1|||
126060747|NCT03541369|453516303|FG000|Overall Study|Death|0|||
126060748|NCT03541369|453516304|FG001|Overall Study|Death|0|||
125910009|NCT04010539|452970736|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
125910010|NCT00249288|452970737|FG000|Overall Study|Lost to Follow-up|3|||
125910011|NCT00249288|452970738|FG001|Overall Study|Lost to Follow-up|3|||
126060749|NCT03541369|453516305|FG002|Overall Study|Death|0|||
126060750|NCT03541369|453516306|FG003|Overall Study|Death|0|||
126060751|NCT03541369|453516307|FG004|Overall Study|Death|1|||
125910012|NCT00249288|452970737|FG000|Overall Study|Withdrawal by Subject|2|||
125910013|NCT00249288|452970738|FG001|Overall Study|Withdrawal by Subject|2|||
125910014|NCT03059446|452970739|FG000|Overall Study|Adverse Event|11|||
125910015|NCT03059446|452970739|FG000|Overall Study|Withdrawal of Consent|16|||
125910016|NCT03059446|452970739|FG000|Overall Study|Lost to Follow-up|3|||
125910017|NCT03059446|452970739|FG000|Overall Study|Protocol Violation|1|||
125910018|NCT03059446|452970739|FG000|Overall Study|Study Terminated by Sponsor|131|||
125910019|NCT03059446|452970739|FG000|Overall Study|Reason not Specified|5|||
125910020|NCT02273739|452970740|FG000|Overall Study|Progression of Disease|3|||
126060752|NCT03541369|453516308|FG005|Overall Study|Death|1|||
126060753|NCT03541369|453516309|FG006|Overall Study|Death|0|||
126060754|NCT03541369|453516310|FG007|Overall Study|Death|2|||
126060755|NCT03541369|453516311|FG008|Overall Study|Death|1|||
126060756|NCT03541369|453516312|FG009|Overall Study|Death|2|||
125910021|NCT02273739|452970741|FG001|Overall Study|Progression of Disease|4|||
125910022|NCT02273739|452970742|FG002|Overall Study|Progression of Disease|5|||
125910023|NCT02273739|452970743|FG003|Overall Study|Progression of Disease|2|||
125910024|NCT02273739|452970740|FG000|Overall Study|Death|0|||
125910025|NCT02273739|452970741|FG001|Overall Study|Death|0|||
125910026|NCT02273739|452970742|FG002|Overall Study|Death|0|||
125910027|NCT02273739|452970743|FG003|Overall Study|Death|2|||
125910028|NCT02273739|452970740|FG000|Overall Study|Adverse Event|0|||
125910029|NCT02273739|452970741|FG001|Overall Study|Adverse Event|0|||
125910030|NCT02273739|452970742|FG002|Overall Study|Adverse Event|0|||
125910031|NCT02273739|452970743|FG003|Overall Study|Adverse Event|1|||
125910032|NCT02273739|452970740|FG000|Overall Study|Withdrawal by Subject|0|||
125910033|NCT02273739|452970741|FG001|Overall Study|Withdrawal by Subject|0|||
125910034|NCT02273739|452970742|FG002|Overall Study|Withdrawal by Subject|2|||
125910035|NCT02273739|452970743|FG003|Overall Study|Withdrawal by Subject|1|||
125910036|NCT02273739|452970740|FG000|Overall Study|Physician Decision|0|||
125910037|NCT02273739|452970741|FG001|Overall Study|Physician Decision|0|||
125910038|NCT02273739|452970742|FG002|Overall Study|Physician Decision|0|||
125910039|NCT02273739|452970743|FG003|Overall Study|Physician Decision|1|||
125910040|NCT04795622|452970744|FG000|Overall Study|Adverse Event|1|||
125910041|NCT04795622|452970745|FG001|Overall Study|Adverse Event|0|||
125910042|NCT04795622|452970744|FG000|Overall Study|Withdrawal by Subject|3|||
125910043|NCT04795622|452970745|FG001|Overall Study|Withdrawal by Subject|3|||
125910044|NCT04795622|452970744|FG000|Overall Study|Protocol Violation|0|||
125910045|NCT04795622|452970745|FG001|Overall Study|Protocol Violation|2|||
125910046|NCT04795622|452970744|FG000|Overall Study|Lost to Follow-up|2|||
125910047|NCT04795622|452970745|FG001|Overall Study|Lost to Follow-up|3|||
125910048|NCT04795622|452970744|FG000|Overall Study|Other|7|||
125910049|NCT04795622|452970745|FG001|Overall Study|Other|8|||
125910050|NCT00089674|452970746|FG000|Overall Study|Physician Decision|4|||
125910051|NCT00089674|452970747|FG001|Overall Study|Physician Decision|2|||
125910052|NCT00089674|452970746|FG000|Overall Study|Adverse Event|23|||
125910053|NCT00089674|452970747|FG001|Overall Study|Adverse Event|29|||
125910054|NCT00089674|452970746|FG000|Overall Study|Withdrawal by Subject|143|||
125910055|NCT00089674|452970747|FG001|Overall Study|Withdrawal by Subject|127|||
125910056|NCT00089674|452970746|FG000|Overall Study|Death|43|||
125910057|NCT00089674|452970747|FG001|Overall Study|Death|43|||
125910058|NCT00089674|452970746|FG000|Overall Study|Disease progression|21|||
125910059|NCT00089674|452970747|FG001|Overall Study|Disease progression|23|||
125910060|NCT00089674|452970746|FG000|Overall Study|Ineligibility determined|8|||
125910061|NCT00089674|452970747|FG001|Overall Study|Ineligibility determined|10|||
125910062|NCT00089674|452970746|FG000|Overall Study|Lost to Follow-up|21|||
126060757|NCT03541369|453516313|FG010|Overall Study|Death|1|||
126060758|NCT03541369|453516314|FG011|Overall Study|Death|0|||
126060759|NCT03541369|453516315|FG012|Overall Study|Death|2|||
126060760|NCT03541369|453516316|FG013|Overall Study|Death|1|||
126060761|NCT03541369|453516317|FG014|Overall Study|Death|1|||
126060762|NCT03541369|453516318|FG015|Overall Study|Death|1|||
126060763|NCT03541369|453516319|FG016|Overall Study|Death|0|||
126060764|NCT03541369|453516320|FG017|Overall Study|Death|1|||
126060765|NCT03541369|453516303|FG000|Overall Study|Decision by sponsor|0|||
126060766|NCT03541369|453516304|FG001|Overall Study|Decision by sponsor|0|||
126060767|NCT03541369|453516305|FG002|Overall Study|Decision by sponsor|0|||
126060768|NCT03541369|453516306|FG003|Overall Study|Decision by sponsor|1|||
126060769|NCT03541369|453516307|FG004|Overall Study|Decision by sponsor|0|||
126060770|NCT03541369|453516308|FG005|Overall Study|Decision by sponsor|2|||
126060771|NCT03541369|453516309|FG006|Overall Study|Decision by sponsor|0|||
126060772|NCT03541369|453516310|FG007|Overall Study|Decision by sponsor|1|||
126060773|NCT03541369|453516311|FG008|Overall Study|Decision by sponsor|2|||
126060774|NCT03541369|453516312|FG009|Overall Study|Decision by sponsor|0|||
126060775|NCT03541369|453516313|FG010|Overall Study|Decision by sponsor|0|||
126060776|NCT03541369|453516314|FG011|Overall Study|Decision by sponsor|0|||
126060777|NCT03541369|453516315|FG012|Overall Study|Decision by sponsor|2|||
126060778|NCT03541369|453516316|FG013|Overall Study|Decision by sponsor|2|||
126060779|NCT03541369|453516317|FG014|Overall Study|Decision by sponsor|0|||
126060780|NCT03541369|453516318|FG015|Overall Study|Decision by sponsor|1|||
126060781|NCT03541369|453516319|FG016|Overall Study|Decision by sponsor|1|||
126060782|NCT03541369|453516320|FG017|Overall Study|Decision by sponsor|1|||
126060783|NCT03541369|453516303|FG000|Overall Study|Withdrawal by Subject|0|||
125910063|NCT00089674|452970747|FG001|Overall Study|Lost to Follow-up|17|||
125910064|NCT00089674|452970746|FG000|Overall Study|Noncompliance|7|||
125910065|NCT00089674|452970747|FG001|Overall Study|Noncompliance|3|||
126060784|NCT03541369|453516304|FG001|Overall Study|Withdrawal by Subject|0|||
126060785|NCT03541369|453516305|FG002|Overall Study|Withdrawal by Subject|0|||
125910066|NCT00089674|452970746|FG000|Overall Study|Other|5|||
125910067|NCT00089674|452970747|FG001|Overall Study|Other|9|||
125910068|NCT00089674|452970746|FG000|Overall Study|Requirement for alternative therapy|14|||
126060786|NCT03541369|453516306|FG003|Overall Study|Withdrawal by Subject|0|||
125910069|NCT00089674|452970747|FG001|Overall Study|Requirement for alternative therapy|4|||
125910070|NCT02961218|452970751|FG000|Overall Study|Lost to Follow-up|0|||
125910071|NCT02961218|452970752|FG001|Overall Study|Lost to Follow-up|2|||
126060787|NCT03541369|453516307|FG004|Overall Study|Withdrawal by Subject|0|||
126060788|NCT03541369|453516308|FG005|Overall Study|Withdrawal by Subject|0|||
126060789|NCT03541369|453516309|FG006|Overall Study|Withdrawal by Subject|1|||
125910072|NCT02961218|452970751|FG000|Overall Study|Physician Decision|0|||
125910073|NCT02961218|452970752|FG001|Overall Study|Physician Decision|2|||
125910074|NCT02961218|452970751|FG000|Overall Study|Subject/Guardian Decision|3|||
125910075|NCT02961218|452970752|FG001|Overall Study|Subject/Guardian Decision|1|||
125910076|NCT00591266|452970753|FG000|Overall Study|Adverse Event|2|||
125910077|NCT00591266|452970754|FG001|Overall Study|Adverse Event|2|||
125910078|NCT00591266|452970755|FG002|Overall Study|Adverse Event|3|||
125910079|NCT00591266|452970753|FG000|Overall Study|Lost to Follow-up|0|||
125910080|NCT00591266|452970754|FG001|Overall Study|Lost to Follow-up|1|||
125910081|NCT00591266|452970755|FG002|Overall Study|Lost to Follow-up|0|||
125910082|NCT00591266|452970753|FG000|Overall Study|Protocol Violation|0|||
125910083|NCT00591266|452970754|FG001|Overall Study|Protocol Violation|0|||
125910084|NCT00591266|452970755|FG002|Overall Study|Protocol Violation|1|||
125910085|NCT00591266|452970753|FG000|Overall Study|Withdrawal by Subject|6|||
125910086|NCT00591266|452970754|FG001|Overall Study|Withdrawal by Subject|2|||
125910087|NCT00591266|452970755|FG002|Overall Study|Withdrawal by Subject|5|||
125910088|NCT00591266|452970753|FG000|Overall Study|Lack of Efficacy|0|||
125910089|NCT00591266|452970754|FG001|Overall Study|Lack of Efficacy|2|||
125910090|NCT00591266|452970755|FG002|Overall Study|Lack of Efficacy|0|||
125910091|NCT00591266|452970753|FG000|Overall Study|Other|1|||
125910092|NCT00591266|452970754|FG001|Overall Study|Other|4|||
125910093|NCT00591266|452970755|FG002|Overall Study|Other|5|||
125910094|NCT03488927|452970756|FG000|Overall Study|Withdrawal by Subject|44|||
125910095|NCT03488927|452970757|FG001|Overall Study|Withdrawal by Subject|118|||
125910096|NCT03488927|452970758|FG002|Overall Study|Withdrawal by Subject|217|||
125910097|NCT00901927|452970761|FG000|Overall Study|Lack of Efficacy|1|||
125910098|NCT00901927|452970761|FG000|Overall Study|Protocol Violation|3|||
125910099|NCT00901927|452970761|FG000|Overall Study|Withdrawal by Subject|2|||
125910100|NCT05298306|452970764|FG000|Overall Study|Physician Decision|0|||
125910101|NCT05298306|452970765|FG001|Overall Study|Physician Decision|0|||
125910102|NCT05298306|452970766|FG002|Overall Study|Physician Decision|0|||
125910103|NCT05298306|452970767|FG003|Overall Study|Physician Decision|1|||
125910104|NCT05298306|452970768|FG004|Overall Study|Physician Decision|0|||
125910105|NCT05298306|452970769|FG005|Overall Study|Physician Decision|0|||
125910106|NCT00880165|452970773|FG000|Overall Study|Withdrawal by Subject|27|||
125910107|NCT00880165|452970774|FG001|Overall Study|Withdrawal by Subject|23|||
125910108|NCT00880165|452970773|FG000|Overall Study|Not diagnosed with OSA|14|||
125910109|NCT00880165|452970774|FG001|Overall Study|Not diagnosed with OSA|8|||
125910110|NCT00880165|452970773|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
125910111|NCT00880165|452970774|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
125910112|NCT00880165|452970773|FG000|Overall Study|Lost to follow|9|||
125910113|NCT00880165|452970774|FG001|Overall Study|Lost to follow|15|||
125910114|NCT00667602|452970775|FG000|Overall Study|Withdrawal by Subject|4|||
125910115|NCT00667602|452970776|FG001|Overall Study|Withdrawal by Subject|9|||
125910116|NCT00667602|452970777|FG002|Overall Study|Withdrawal by Subject|10|||
125910117|NCT00667602|452970775|FG000|Overall Study|Lost to Follow-up|4|||
125910118|NCT00667602|452970776|FG001|Overall Study|Lost to Follow-up|5|||
125910119|NCT00667602|452970777|FG002|Overall Study|Lost to Follow-up|6|||
125910120|NCT00667602|452970775|FG000|Overall Study|Administrative reason|0|||
125910121|NCT00667602|452970776|FG001|Overall Study|Administrative reason|0|||
125910122|NCT00667602|452970777|FG002|Overall Study|Administrative reason|2|||
125910123|NCT00667602|452970775|FG000|Overall Study|Protocol Violation|0|||
125910124|NCT00667602|452970776|FG001|Overall Study|Protocol Violation|1|||
125910125|NCT00667602|452970777|FG002|Overall Study|Protocol Violation|0|||
125910126|NCT00973349|452970782|FG000|Overall Study|Adverse Event|0|||
125910127|NCT00973349|452970783|FG001|Overall Study|Adverse Event|0|||
125910128|NCT00973349|452970784|FG002|Overall Study|Adverse Event|0|||
125910129|NCT00973349|452970785|FG003|Overall Study|Adverse Event|0|||
125910130|NCT00973349|452970786|FG004|Overall Study|Adverse Event|1|||
125910131|NCT00973349|452970787|FG005|Overall Study|Adverse Event|0|||
125910132|NCT00973349|452970788|FG006|Overall Study|Adverse Event|0|||
125910133|NCT00973349|452970789|FG007|Overall Study|Adverse Event|0|||
125910134|NCT00973349|452970790|FG008|Overall Study|Adverse Event|1|||
125910135|NCT00973349|452970791|FG009|Overall Study|Adverse Event|0|||
125910136|NCT00973349|452970792|FG010|Overall Study|Adverse Event|0|||
125910137|NCT00973349|452970793|FG011|Overall Study|Adverse Event|0|||
125910138|NCT00973349|452970794|FG012|Overall Study|Adverse Event|0|||
125910139|NCT00973349|452970795|FG013|Overall Study|Adverse Event|0|||
125910140|NCT00973349|452970796|FG014|Overall Study|Adverse Event|1|||
125910141|NCT00973349|452970797|FG015|Overall Study|Adverse Event|0|||
125910142|NCT00973349|452970782|FG000|Overall Study|Withdrawal by Subject|1|||
125910143|NCT00973349|452970783|FG001|Overall Study|Withdrawal by Subject|2|||
125910144|NCT00973349|452970784|FG002|Overall Study|Withdrawal by Subject|2|||
125910145|NCT00973349|452970785|FG003|Overall Study|Withdrawal by Subject|3|||
125910146|NCT00973349|452970786|FG004|Overall Study|Withdrawal by Subject|2|||
125910147|NCT00973349|452970787|FG005|Overall Study|Withdrawal by Subject|0|||
125910148|NCT00973349|452970788|FG006|Overall Study|Withdrawal by Subject|2|||
125910149|NCT00973349|452970789|FG007|Overall Study|Withdrawal by Subject|2|||
125910150|NCT00973349|452970790|FG008|Overall Study|Withdrawal by Subject|0|||
125910151|NCT00973349|452970791|FG009|Overall Study|Withdrawal by Subject|2|||
125910152|NCT00973349|452970792|FG010|Overall Study|Withdrawal by Subject|0|||
125910153|NCT00973349|452970793|FG011|Overall Study|Withdrawal by Subject|1|||
125910154|NCT00973349|452970794|FG012|Overall Study|Withdrawal by Subject|0|||
125910155|NCT00973349|452970795|FG013|Overall Study|Withdrawal by Subject|0|||
125910156|NCT00973349|452970796|FG014|Overall Study|Withdrawal by Subject|0|||
125910157|NCT00973349|452970797|FG015|Overall Study|Withdrawal by Subject|0|||
125910158|NCT00973349|452970782|FG000|Overall Study|Lost to Follow-up|3|||
125910159|NCT00973349|452970783|FG001|Overall Study|Lost to Follow-up|1|||
125910160|NCT00973349|452970784|FG002|Overall Study|Lost to Follow-up|2|||
125910161|NCT00973349|452970785|FG003|Overall Study|Lost to Follow-up|2|||
125910162|NCT00973349|452970786|FG004|Overall Study|Lost to Follow-up|1|||
125910163|NCT00973349|452970787|FG005|Overall Study|Lost to Follow-up|3|||
125910164|NCT00973349|452970788|FG006|Overall Study|Lost to Follow-up|0|||
125910165|NCT00973349|452970789|FG007|Overall Study|Lost to Follow-up|1|||
125910166|NCT00973349|452970790|FG008|Overall Study|Lost to Follow-up|2|||
125910167|NCT00973349|452970791|FG009|Overall Study|Lost to Follow-up|1|||
125910168|NCT00973349|452970792|FG010|Overall Study|Lost to Follow-up|0|||
125910169|NCT00973349|452970793|FG011|Overall Study|Lost to Follow-up|1|||
125910170|NCT00973349|452970794|FG012|Overall Study|Lost to Follow-up|0|||
125910171|NCT00973349|452970795|FG013|Overall Study|Lost to Follow-up|0|||
125910172|NCT00973349|452970796|FG014|Overall Study|Lost to Follow-up|0|||
125910173|NCT00973349|452970797|FG015|Overall Study|Lost to Follow-up|1|||
125910174|NCT00973349|452970782|FG000|Overall Study|Inappropriate enrolment|0|||
125910175|NCT00973349|452970783|FG001|Overall Study|Inappropriate enrolment|0|||
125910176|NCT00973349|452970784|FG002|Overall Study|Inappropriate enrolment|1|||
125910177|NCT00973349|452970785|FG003|Overall Study|Inappropriate enrolment|0|||
125910178|NCT00973349|452970786|FG004|Overall Study|Inappropriate enrolment|0|||
125910179|NCT00973349|452970787|FG005|Overall Study|Inappropriate enrolment|0|||
125910180|NCT00973349|452970788|FG006|Overall Study|Inappropriate enrolment|0|||
125910181|NCT00973349|452970789|FG007|Overall Study|Inappropriate enrolment|0|||
125910182|NCT00973349|452970790|FG008|Overall Study|Inappropriate enrolment|0|||
125910183|NCT00973349|452970791|FG009|Overall Study|Inappropriate enrolment|2|||
125910184|NCT00973349|452970792|FG010|Overall Study|Inappropriate enrolment|0|||
125910185|NCT00973349|452970793|FG011|Overall Study|Inappropriate enrolment|0|||
125910186|NCT00973349|452970794|FG012|Overall Study|Inappropriate enrolment|1|||
125910187|NCT00973349|452970795|FG013|Overall Study|Inappropriate enrolment|0|||
125910188|NCT00973349|452970796|FG014|Overall Study|Inappropriate enrolment|1|||
125910189|NCT00973349|452970797|FG015|Overall Study|Inappropriate enrolment|1|||
125910190|NCT00973349|452970782|FG000|Overall Study|Protocol Violation|0|||
125910191|NCT00973349|452970783|FG001|Overall Study|Protocol Violation|0|||
125910192|NCT00973349|452970784|FG002|Overall Study|Protocol Violation|0|||
125910193|NCT00973349|452970785|FG003|Overall Study|Protocol Violation|0|||
125910194|NCT00973349|452970786|FG004|Overall Study|Protocol Violation|0|||
125910195|NCT00973349|452970787|FG005|Overall Study|Protocol Violation|0|||
125910196|NCT00973349|452970788|FG006|Overall Study|Protocol Violation|0|||
126060790|NCT03541369|453516310|FG007|Overall Study|Withdrawal by Subject|0|||
126060791|NCT03541369|453516311|FG008|Overall Study|Withdrawal by Subject|0|||
126060792|NCT03541369|453516312|FG009|Overall Study|Withdrawal by Subject|0|||
126060793|NCT03541369|453516313|FG010|Overall Study|Withdrawal by Subject|0|||
126060794|NCT03541369|453516314|FG011|Overall Study|Withdrawal by Subject|1|||
126060795|NCT03541369|453516315|FG012|Overall Study|Withdrawal by Subject|0|||
126060796|NCT03541369|453516316|FG013|Overall Study|Withdrawal by Subject|0|||
126060797|NCT03541369|453516317|FG014|Overall Study|Withdrawal by Subject|3|||
126060798|NCT03541369|453516318|FG015|Overall Study|Withdrawal by Subject|0|||
126060799|NCT03541369|453516319|FG016|Overall Study|Withdrawal by Subject|4|||
126060800|NCT03541369|453516320|FG017|Overall Study|Withdrawal by Subject|2|||
126060801|NCT03541369|453516303|FG000|Overall Study|Lost to Follow-up|0|||
126060802|NCT03541369|453516304|FG001|Overall Study|Lost to Follow-up|0|||
126060803|NCT03541369|453516305|FG002|Overall Study|Lost to Follow-up|0|||
126060804|NCT03541369|453516306|FG003|Overall Study|Lost to Follow-up|0|||
125910197|NCT00973349|452970789|FG007|Overall Study|Protocol Violation|0|||
125910198|NCT00973349|452970790|FG008|Overall Study|Protocol Violation|1|||
125910199|NCT00973349|452970791|FG009|Overall Study|Protocol Violation|0|||
126060805|NCT03541369|453516307|FG004|Overall Study|Lost to Follow-up|1|||
126060806|NCT03541369|453516308|FG005|Overall Study|Lost to Follow-up|0|||
126060807|NCT03541369|453516309|FG006|Overall Study|Lost to Follow-up|0|||
126060808|NCT03541369|453516310|FG007|Overall Study|Lost to Follow-up|0|||
125910200|NCT00973349|452970792|FG010|Overall Study|Protocol Violation|0|||
125910201|NCT00973349|452970793|FG011|Overall Study|Protocol Violation|0|||
125910202|NCT00973349|452970794|FG012|Overall Study|Protocol Violation|0|||
125910203|NCT00973349|452970795|FG013|Overall Study|Protocol Violation|0|||
125910204|NCT00973349|452970796|FG014|Overall Study|Protocol Violation|0|||
125910205|NCT00973349|452970797|FG015|Overall Study|Protocol Violation|0|||
125910206|NCT00973349|452970782|FG000|Overall Study|Unable to classify|0|||
125910207|NCT00973349|452970783|FG001|Overall Study|Unable to classify|0|||
125910208|NCT00973349|452970784|FG002|Overall Study|Unable to classify|0|||
125910209|NCT00973349|452970785|FG003|Overall Study|Unable to classify|0|||
125910210|NCT00973349|452970786|FG004|Overall Study|Unable to classify|1|||
125910211|NCT00973349|452970787|FG005|Overall Study|Unable to classify|1|||
125910212|NCT00973349|452970788|FG006|Overall Study|Unable to classify|0|||
125910213|NCT00973349|452970789|FG007|Overall Study|Unable to classify|0|||
125910214|NCT00973349|452970790|FG008|Overall Study|Unable to classify|0|||
125910215|NCT00973349|452970791|FG009|Overall Study|Unable to classify|1|||
125910216|NCT00973349|452970792|FG010|Overall Study|Unable to classify|0|||
125910217|NCT00973349|452970793|FG011|Overall Study|Unable to classify|0|||
125910218|NCT00973349|452970794|FG012|Overall Study|Unable to classify|0|||
126110139|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
126110140|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
126110141|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
126110142|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
126110143|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
126110144|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
126110145|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
126110146|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
126110147|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
126110148|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
126110149|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
126110150|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
126110151|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
126110152|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
126110153|NCT00559585|453697646|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
126110154|NCT00559585|453697647|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
126110155|NCT04195581|453697648|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
126110156|NCT04195581|453697648|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
126110157|NCT04195581|453697648|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
126110158|NCT04195581|453697648|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
126110159|NCT04195581|453697648|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
126110160|NCT04195581|453697648|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
126110161|NCT01237340|453697649|FG000|Overall Study|Adverse Event|3|||
126110162|NCT01237340|453697649|FG000|Overall Study|Withdrawal by Subject|1|||
126110163|NCT01237340|453697649|FG000|Overall Study|Early termination of the trial|36|||
126110164|NCT02876835|453697652|FG000|Treatment Period (51.1 Month)|Other|1|||
126110165|NCT02876835|453697653|FG001|Treatment Period (51.1 Month)|Other|0|||
126110166|NCT02876835|453697652|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
126110167|NCT02876835|453697653|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
126110168|NCT02876835|453697652|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
126110169|NCT02876835|453697653|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
126110170|NCT02876835|453697652|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
125910219|NCT00973349|452970795|FG013|Overall Study|Unable to classify|0|||
126060809|NCT03541369|453516311|FG008|Overall Study|Lost to Follow-up|1|||
126060810|NCT03541369|453516312|FG009|Overall Study|Lost to Follow-up|0|||
126060811|NCT03541369|453516313|FG010|Overall Study|Lost to Follow-up|0|||
126060812|NCT03541369|453516314|FG011|Overall Study|Lost to Follow-up|0|||
126060813|NCT03541369|453516315|FG012|Overall Study|Lost to Follow-up|1|||
126060814|NCT03541369|453516316|FG013|Overall Study|Lost to Follow-up|0|||
126060815|NCT03541369|453516317|FG014|Overall Study|Lost to Follow-up|0|||
126060816|NCT03541369|453516318|FG015|Overall Study|Lost to Follow-up|0|||
126060817|NCT03541369|453516319|FG016|Overall Study|Lost to Follow-up|0|||
126060818|NCT03541369|453516320|FG017|Overall Study|Lost to Follow-up|0|||
126060819|NCT01005914|453516321|FG000|Overall Study|Adverse Event|4|||
126060820|NCT01005914|453516321|FG000|Overall Study|Death|4|||
126060821|NCT01005914|453516321|FG000|Overall Study|Lack of Efficacy|1|||
126060822|NCT01005914|453516321|FG000|Overall Study|Withdrawal by Subject|1|||
126060823|NCT01240785|453516323|FG000|Overall Study|Lost to Follow-up|1|||
126060824|NCT01240785|453516324|FG001|Overall Study|Lost to Follow-up|0|||
126060825|NCT01240785|453516323|FG000|Overall Study|Protocol Violation|0|||
126060826|NCT01240785|453516324|FG001|Overall Study|Protocol Violation|3|||
126060827|NCT00696241|453516325|FG000|Overall Study|Adverse Event|11|||
126060828|NCT00696241|453516326|FG001|Overall Study|Adverse Event|3|||
126060829|NCT00696241|453516327|FG002|Overall Study|Adverse Event|6|||
126060830|NCT00696241|453516328|FG003|Overall Study|Adverse Event|4|||
126060831|NCT00696241|453516329|FG004|Overall Study|Adverse Event|5|||
126060832|NCT00696241|453516325|FG000|Overall Study|Protocol Violation|1|||
126060833|NCT00696241|453516326|FG001|Overall Study|Protocol Violation|1|||
125910220|NCT00973349|452970796|FG014|Overall Study|Unable to classify|0|||
125910221|NCT00973349|452970797|FG015|Overall Study|Unable to classify|0|||
125910222|NCT02301988|452970798|FG000|Overall Study|Withdrawal by Subject|2|||
125910223|NCT02301988|452970799|FG001|Overall Study|Withdrawal by Subject|1|||
126060834|NCT00696241|453516327|FG002|Overall Study|Protocol Violation|2|||
126060835|NCT00696241|453516328|FG003|Overall Study|Protocol Violation|0|||
126060836|NCT00696241|453516329|FG004|Overall Study|Protocol Violation|3|||
126060837|NCT00696241|453516325|FG000|Overall Study|Lost to Follow-up|1|||
126060838|NCT00696241|453516326|FG001|Overall Study|Lost to Follow-up|4|||
126060839|NCT00696241|453516327|FG002|Overall Study|Lost to Follow-up|1|||
126060840|NCT00696241|453516328|FG003|Overall Study|Lost to Follow-up|2|||
126060841|NCT00696241|453516329|FG004|Overall Study|Lost to Follow-up|0|||
126060842|NCT00696241|453516325|FG000|Overall Study|Withdrawal by Subject|4|||
126060843|NCT00696241|453516326|FG001|Overall Study|Withdrawal by Subject|8|||
126060844|NCT00696241|453516327|FG002|Overall Study|Withdrawal by Subject|6|||
126060845|NCT00696241|453516328|FG003|Overall Study|Withdrawal by Subject|1|||
126060846|NCT00696241|453516329|FG004|Overall Study|Withdrawal by Subject|0|||
126060847|NCT00696241|453516325|FG000|Overall Study|Lack of Efficacy|1|||
126060848|NCT00696241|453516326|FG001|Overall Study|Lack of Efficacy|5|||
126060849|NCT00696241|453516327|FG002|Overall Study|Lack of Efficacy|4|||
126060850|NCT00696241|453516328|FG003|Overall Study|Lack of Efficacy|5|||
126060851|NCT00696241|453516329|FG004|Overall Study|Lack of Efficacy|3|||
126060852|NCT00696241|453516325|FG000|Overall Study|Other|6|||
126060853|NCT00696241|453516326|FG001|Overall Study|Other|1|||
126060854|NCT00696241|453516327|FG002|Overall Study|Other|5|||
126060855|NCT00696241|453516328|FG003|Overall Study|Other|2|||
126060856|NCT00696241|453516329|FG004|Overall Study|Other|1|||
126060857|NCT03347396|453516336|FG000|Part A (26 Weeks)|Adverse Event|1|||
126060858|NCT03347396|453516337|FG001|Part A (26 Weeks)|Adverse Event|0|||
126060859|NCT03347396|453516336|FG000|Part A (26 Weeks)|Death|0|||
126060860|NCT03347396|453516337|FG001|Part A (26 Weeks)|Death|1|||
126060861|NCT03347396|453516336|FG000|Part B (149 Weeks)|Adverse Event|1|||
126060862|NCT03347396|453516337|FG001|Part B (149 Weeks)|Adverse Event|1|||
126060863|NCT03347396|453516336|FG000|Part B (149 Weeks)|Death|1|||
126060864|NCT03347396|453516337|FG001|Part B (149 Weeks)|Death|0|||
126060865|NCT03060525|453516338|FG000|Overall Study|moved out of state|1|||
126060866|NCT03060525|453516339|FG001|Overall Study|moved out of state|1|||
126060867|NCT03060525|453516340|FG002|Overall Study|moved out of state|1|||
126060868|NCT03060525|453516341|FG003|Overall Study|moved out of state|1|||
126060869|NCT03060525|453516338|FG000|Overall Study|unable to meet time commitment required of study|2|||
126060870|NCT03060525|453516339|FG001|Overall Study|unable to meet time commitment required of study|3|||
126060871|NCT03060525|453516340|FG002|Overall Study|unable to meet time commitment required of study|3|||
126060872|NCT03060525|453516341|FG003|Overall Study|unable to meet time commitment required of study|1|||
126060873|NCT03060525|453516338|FG000|Overall Study|no longer interested in doing intervention|0|||
125910224|NCT02301988|452970798|FG000|Overall Study|Physician Decision|2|||
126060874|NCT03060525|453516339|FG001|Overall Study|no longer interested in doing intervention|0|||
125910225|NCT02301988|452970799|FG001|Overall Study|Physician Decision|2|||
125910226|NCT02301988|452970798|FG000|Overall Study|Unknown Reason|1|||
125910227|NCT02301988|452970799|FG001|Overall Study|Unknown Reason|3|||
126060875|NCT03060525|453516340|FG002|Overall Study|no longer interested in doing intervention|0|||
126060876|NCT03060525|453516341|FG003|Overall Study|no longer interested in doing intervention|1|||
126060877|NCT01294644|453516347|FG000|Overall Study|Adverse Event|2|||
126060878|NCT01294644|453516348|FG001|Overall Study|Adverse Event|0|||
126060879|NCT01294644|453516349|FG002|Overall Study|Adverse Event|1|||
126060880|NCT01294644|453516347|FG000|Overall Study|Withdrawal by Subject|3|||
126060881|NCT01294644|453516348|FG001|Overall Study|Withdrawal by Subject|7|||
126060882|NCT01294644|453516349|FG002|Overall Study|Withdrawal by Subject|4|||
125910228|NCT02301988|452970798|FG000|Overall Study|Lack of Efficacy|3|||
125910229|NCT02301988|452970799|FG001|Overall Study|Lack of Efficacy|2|||
126060883|NCT01294644|453516347|FG000|Overall Study|Lost to Follow-up|3|||
126060884|NCT01294644|453516348|FG001|Overall Study|Lost to Follow-up|2|||
126060885|NCT01294644|453516349|FG002|Overall Study|Lost to Follow-up|5|||
126060886|NCT01294644|453516347|FG000|Overall Study|Miscellaneous Reason|2|||
125910230|NCT02301988|452970798|FG000|Overall Study|Death|1|||
125910231|NCT02301988|452970799|FG001|Overall Study|Death|0|||
125910232|NCT02301988|452970798|FG000|Overall Study|Adverse Event|1|||
125910233|NCT02301988|452970799|FG001|Overall Study|Adverse Event|1|||
125910234|NCT02750943|452970800|FG000|Overall Study|Lost to Follow-up|1|||
125910235|NCT02750943|452970801|FG001|Overall Study|Lost to Follow-up|2|||
125910236|NCT02750943|452970800|FG000|Overall Study|Withdrawal by Subject|5|||
125910237|NCT02750943|452970801|FG001|Overall Study|Withdrawal by Subject|7|||
125910238|NCT00171054|452970802|FG000|Overall Study|Protocol Violation|1|||
125910239|NCT00171054|452970803|FG001|Overall Study|Protocol Violation|2|||
125910240|NCT00171054|452970802|FG000|Overall Study|Patient withdrew consent|1|||
125910241|NCT00171054|452970803|FG001|Overall Study|Patient withdrew consent|0|||
125910242|NCT00171054|452970802|FG000|Overall Study|Lost to Follow-up|0|||
125910243|NCT00171054|452970803|FG001|Overall Study|Lost to Follow-up|1|||
125910244|NCT00171054|452970802|FG000|Overall Study|Adverse Event|8|||
125910245|NCT00171054|452970803|FG001|Overall Study|Adverse Event|8|||
125910246|NCT00171054|452970802|FG000|Overall Study|Condition no longer required study drug|0|||
125910247|NCT00171054|452970803|FG001|Overall Study|Condition no longer required study drug|1|||
125910248|NCT04669535|452970807|FG000|Overall Study|Death|1|||
125910249|NCT04669535|452970808|FG001|Overall Study|Death|1|||
125910250|NCT04669535|452970809|FG002|Overall Study|Death|0|||
125910251|NCT04669535|452970810|FG003|Overall Study|Death|0|||
125910252|NCT02452697|452970811|FG000|Overall Study|Physician Decision|4|||
125910253|NCT02452697|452970812|FG001|Overall Study|Physician Decision|4|||
125910254|NCT02452697|452970813|FG002|Overall Study|Physician Decision|3|||
125910255|NCT02452697|452970814|FG003|Overall Study|Physician Decision|2|||
125910256|NCT02452697|452970811|FG000|Overall Study|Withdrawal by Subject|1|||
125910257|NCT02452697|452970812|FG001|Overall Study|Withdrawal by Subject|0|||
125910258|NCT02452697|452970813|FG002|Overall Study|Withdrawal by Subject|0|||
125910259|NCT02452697|452970814|FG003|Overall Study|Withdrawal by Subject|0|||
125910260|NCT02452697|452970811|FG000|Overall Study|still in follow-up|2|||
125910261|NCT02452697|452970812|FG001|Overall Study|still in follow-up|2|||
125910262|NCT02452697|452970813|FG002|Overall Study|still in follow-up|1|||
125910263|NCT02452697|452970814|FG003|Overall Study|still in follow-up|3|||
125910264|NCT03552965|452970816|FG000|Overall Study|Death|1|||
125910265|NCT03552965|452970817|FG001|Overall Study|Death|1|||
125910266|NCT03552965|452970816|FG000|Overall Study|Lost to Follow-up|1|||
125910267|NCT03552965|452970817|FG001|Overall Study|Lost to Follow-up|1|||
125910268|NCT03552965|452970816|FG000|Overall Study|Physician Decision|1|||
125910269|NCT03552965|452970817|FG001|Overall Study|Physician Decision|1|||
125910270|NCT03552965|452970816|FG000|Overall Study|Withdrawal by Subject|0|||
125910271|NCT03552965|452970817|FG001|Overall Study|Withdrawal by Subject|2|||
125910272|NCT03552965|452970816|FG000|Overall Study|Continuation not in patient best interest|1|||
125910273|NCT03552965|452970817|FG001|Overall Study|Continuation not in patient best interest|0|||
125910274|NCT03552965|452970816|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
125910275|NCT03552965|452970817|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
125910276|NCT02477696|452970818|FG000|Overall Study|Death|89|||
125910277|NCT02477696|452970819|FG001|Overall Study|Death|106|||
125910278|NCT02477696|452970818|FG000|Overall Study|Lost to Follow-up|7|||
125910279|NCT02477696|452970819|FG001|Overall Study|Lost to Follow-up|5|||
125910280|NCT02477696|452970818|FG000|Overall Study|Withdrawal by Subject|37|||
125910281|NCT02477696|452970819|FG001|Overall Study|Withdrawal by Subject|34|||
125910282|NCT02477696|452970818|FG000|Overall Study|Physician Decision|7|||
125910283|NCT02477696|452970819|FG001|Overall Study|Physician Decision|9|||
125910284|NCT02477696|452970818|FG000|Overall Study|Study terminated by sponsor|103|||
125910285|NCT02477696|452970819|FG001|Overall Study|Study terminated by sponsor|99|||
125910286|NCT02477696|452970818|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
125910287|NCT02477696|452970819|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
125910288|NCT02477696|452970818|FG000|Overall Study|Missing/Unknown|2|||
125910289|NCT02477696|452970819|FG001|Overall Study|Missing/Unknown|0|||
125910290|NCT05419908|452970821|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
125910291|NCT05419908|452970822|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
125910292|NCT05419908|452970821|FG000|Overall Study|Serious Adverse Event|0|||
125910293|NCT05419908|452970822|FG001|Overall Study|Serious Adverse Event|2|||
125910294|NCT05419908|452970821|FG000|Overall Study|Withdrawal by Subject|2|||
125910295|NCT05419908|452970822|FG001|Overall Study|Withdrawal by Subject|0|||
125910296|NCT05419908|452970821|FG000|Overall Study|Miscellaneous|1|||
125910297|NCT05419908|452970822|FG001|Overall Study|Miscellaneous|1|||
125910298|NCT05098938|452970826|FG000|Overall Study|Adverse Event|4|||
125910299|NCT05098938|452970827|FG001|Overall Study|Adverse Event|3|||
125910300|NCT05098938|452970826|FG000|Overall Study|inclusion/exclusion criteria change|11|||
125910301|NCT05098938|452970827|FG001|Overall Study|inclusion/exclusion criteria change|5|||
125910302|NCT05098938|452970826|FG000|Overall Study|lack of compliance|26|||
125910303|NCT05098938|452970827|FG001|Overall Study|lack of compliance|19|||
125910304|NCT05098938|452970826|FG000|Overall Study|Lost to Follow-up|37|||
125910305|NCT05098938|452970827|FG001|Overall Study|Lost to Follow-up|40|||
125910306|NCT05098938|452970826|FG000|Overall Study|Lost in treatment period|17|||
125910307|NCT05098938|452970827|FG001|Overall Study|Lost in treatment period|13|||
125910308|NCT05098938|452970826|FG000|Overall Study|Met an exclusion criterion|0|||
125910309|NCT05098938|452970827|FG001|Overall Study|Met an exclusion criterion|3|||
125910310|NCT05098938|452970826|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
125910311|NCT05098938|452970827|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
125910312|NCT05098938|452970826|FG000|Overall Study|Physician Decision|25|||
125910313|NCT05098938|452970827|FG001|Overall Study|Physician Decision|32|||
125910314|NCT05098938|452970826|FG000|Overall Study|Run in failure in treatment phase|1|||
125910315|NCT05098938|452970827|FG001|Overall Study|Run in failure in treatment phase|1|||
125910316|NCT05098938|452970826|FG000|Overall Study|Withdrawal by Subject|0|||
125910317|NCT05098938|452970827|FG001|Overall Study|Withdrawal by Subject|3|||
125910318|NCT05098938|452970826|FG000|Overall Study|Run-in Failure in early study|505|||
125910319|NCT05098938|452970827|FG001|Overall Study|Run-in Failure in early study|514|||
125910320|NCT05098938|452970826|FG000|Overall Study|IMP delivery missed|1|||
125910321|NCT05098938|452970827|FG001|Overall Study|IMP delivery missed|5|||
125910322|NCT05098938|452970826|FG000|Overall Study|6 months visit was missed|2|||
125910323|NCT05098938|452970827|FG001|Overall Study|6 months visit was missed|0|||
125910324|NCT05098938|452970826|FG000|Overall Study|fit for use was not completed within window|3|||
125910325|NCT05098938|452970827|FG001|Overall Study|fit for use was not completed within window|0|||
125910326|NCT05098938|452970826|FG000|Overall Study|V2 visit was not completed within window|0|||
125910327|NCT05098938|452970827|FG001|Overall Study|V2 visit was not completed within window|1|||
125910328|NCT05098938|452970826|FG000|Overall Study|exclusionary medication use|1|||
125910329|NCT05098938|452970827|FG001|Overall Study|exclusionary medication use|2|||
125910330|NCT05098938|452970826|FG000|Overall Study|change in medication|1|||
125910331|NCT05098938|452970827|FG001|Overall Study|change in medication|0|||
125910332|NCT05098938|452970826|FG000|Overall Study|treatment failure|2|||
125910333|NCT05098938|452970827|FG001|Overall Study|treatment failure|1|||
125910334|NCT02160782|452971968|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
125910335|NCT02160782|452971969|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
125910336|NCT02160782|452971970|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
125910337|NCT02160782|452971971|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
125910338|NCT02160782|452971972|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
125910339|NCT02160782|452971968|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
125910340|NCT02160782|452971969|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
125910341|NCT02160782|452971970|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
125910342|NCT02160782|452971971|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
125910343|NCT02160782|452971972|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
125910344|NCT02160782|452971968|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
125910345|NCT02160782|452971969|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
125910346|NCT02160782|452971970|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
125910347|NCT02160782|452971971|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
125910348|NCT02160782|452971972|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
125910349|NCT02160782|452971968|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
125910350|NCT02160782|452971969|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
125910351|NCT02160782|452971970|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
125910352|NCT02160782|452971971|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
125910353|NCT02160782|452971972|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
125910354|NCT02160782|452971968|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
125910355|NCT02160782|452971969|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
125910356|NCT02160782|452971970|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
125910357|NCT02160782|452971971|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
125910358|NCT02160782|452971972|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
125910359|NCT02160782|452971968|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
125910360|NCT02160782|452971969|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
125910361|NCT02160782|452971970|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
125910362|NCT02160782|452971971|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
125910363|NCT02160782|452971972|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
125910364|NCT02160782|452971968|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
125910365|NCT02160782|452971969|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
125910366|NCT02160782|452971970|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
125910367|NCT02160782|452971971|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
125910368|NCT02160782|452971972|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
126060887|NCT01294644|453516348|FG001|Overall Study|Miscellaneous Reason|1|||
126060888|NCT01294644|453516349|FG002|Overall Study|Miscellaneous Reason|4|||
126060889|NCT02188459|453516350|FG000|Overall Study|Lost to Follow-up|3|||
126060890|NCT02188459|453516351|FG001|Overall Study|Lost to Follow-up|4|||
126060891|NCT02188459|453516350|FG000|Overall Study|Early Termination|0|||
126060892|NCT02188459|453516351|FG001|Overall Study|Early Termination|3|||
126060893|NCT01986348|453516352|FG000|Overall Study|Death|8|||
126060894|NCT01986348|453516353|FG001|Overall Study|Death|22|||
126060895|NCT01986348|453516354|FG002|Overall Study|Death|10|||
126060896|NCT01986348|453516355|FG003|Overall Study|Death|21|||
126060897|NCT01986348|453516352|FG000|Overall Study|Lost to Follow-up|0|||
126060898|NCT01986348|453516353|FG001|Overall Study|Lost to Follow-up|0|||
126060899|NCT01986348|453516354|FG002|Overall Study|Lost to Follow-up|0|||
126060900|NCT01986348|453516355|FG003|Overall Study|Lost to Follow-up|2|||
126060901|NCT01986348|453516352|FG000|Overall Study|Physician Decision|0|||
126060902|NCT01986348|453516353|FG001|Overall Study|Physician Decision|0|||
126060903|NCT01986348|453516354|FG002|Overall Study|Physician Decision|0|||
126060904|NCT01986348|453516355|FG003|Overall Study|Physician Decision|1|||
126060905|NCT01986348|453516352|FG000|Overall Study|Progressive Disease|0|||
125910369|NCT00674973|452971975|FG000|Overall Study|Insufficient Therapeutic Response|77|||
125910370|NCT00674973|452971976|FG001|Overall Study|Insufficient Therapeutic Response|72|||
126060906|NCT01986348|453516353|FG001|Overall Study|Progressive Disease|0|||
126060907|NCT01986348|453516354|FG002|Overall Study|Progressive Disease|2|||
125910371|NCT00674973|452971975|FG000|Overall Study|Refused Treatment|1|||
125910372|NCT00674973|452971976|FG001|Overall Study|Refused Treatment|5|||
125910373|NCT00674973|452971975|FG000|Overall Study|Failure to Return|1|||
125910374|NCT00674973|452971976|FG001|Overall Study|Failure to Return|0|||
125910375|NCT00674973|452971975|FG000|Overall Study|Adverse Event|2|||
125910376|NCT00674973|452971976|FG001|Overall Study|Adverse Event|9|||
125910377|NCT00674973|452971975|FG000|Overall Study|Death|19|||
125910378|NCT00674973|452971976|FG001|Overall Study|Death|15|||
125910379|NCT00674973|452971975|FG000|Overall Study|Protocol Violation|0|||
125910380|NCT00674973|452971976|FG001|Overall Study|Protocol Violation|1|||
125910381|NCT05036369|452971982|FG000|Overall Study|Run In non compliance|1|||
125910382|NCT05036369|452971983|FG001|Overall Study|Run In non compliance|2|||
125910383|NCT05036369|452971982|FG000|Overall Study|Change in eligibility criteria|0|||
125910384|NCT05036369|452971983|FG001|Overall Study|Change in eligibility criteria|1|||
125910385|NCT00401531|452971986|FG000|Overall Study|Adverse Event|2|||
125910386|NCT00401531|452971987|FG001|Overall Study|Adverse Event|0|||
125910387|NCT00401531|452971986|FG000|Overall Study|Protocol Violation|3|||
125910388|NCT00401531|452971987|FG001|Overall Study|Protocol Violation|7|||
125910389|NCT00401531|452971986|FG000|Overall Study|Lost to Follow-up|1|||
125910390|NCT00401531|452971987|FG001|Overall Study|Lost to Follow-up|1|||
125910391|NCT00401531|452971986|FG000|Overall Study|Withdrawal by Subject|3|||
125910392|NCT00401531|452971987|FG001|Overall Study|Withdrawal by Subject|2|||
125910393|NCT01801072|452971988|FG000|Overall Study|Lost to Follow-up|17|||
125910394|NCT01801072|452971989|FG001|Overall Study|Lost to Follow-up|14|||
125910395|NCT01801072|452971988|FG000|Overall Study|Physician Decision|2|||
125910396|NCT01801072|452971989|FG001|Overall Study|Physician Decision|3|||
125910397|NCT01801072|452971988|FG000|Overall Study|Withdrawal by Subject|1|||
125910398|NCT01801072|452971989|FG001|Overall Study|Withdrawal by Subject|0|||
125910399|NCT01801072|452971988|FG000|Overall Study|Protocol Violation|2|||
125910400|NCT01801072|452971989|FG001|Overall Study|Protocol Violation|0|||
125910401|NCT01801072|452971988|FG000|Overall Study|Death|7|||
125910402|NCT01801072|452971989|FG001|Overall Study|Death|8|||
125910403|NCT03906461|452971990|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
125910404|NCT03906461|452971990|FG000|Completed 12-month Follow-up|Missed Visit|6|||
125910405|NCT00510874|452971991|FG000|Overall Study|Withdrawal by Subject|1|||
125910406|NCT00510874|452971992|FG001|Overall Study|Withdrawal by Subject|1|||
125910407|NCT00510874|452971993|FG002|Overall Study|Withdrawal by Subject|0|||
125910408|NCT00510874|452971994|FG003|Overall Study|Withdrawal by Subject|0|||
125910409|NCT00510874|452971995|FG004|Overall Study|Withdrawal by Subject|3|||
125910410|NCT00510874|452971996|FG005|Overall Study|Withdrawal by Subject|0|||
125910411|NCT00510874|452971997|FG006|Overall Study|Withdrawal by Subject|0|||
125910412|NCT00510874|452971991|FG000|Overall Study|Lost to Follow-up|2|||
125910413|NCT00510874|452971992|FG001|Overall Study|Lost to Follow-up|3|||
125910414|NCT00510874|452971993|FG002|Overall Study|Lost to Follow-up|1|||
125910415|NCT00510874|452971994|FG003|Overall Study|Lost to Follow-up|3|||
125910416|NCT00510874|452971995|FG004|Overall Study|Lost to Follow-up|4|||
125910417|NCT00510874|452971996|FG005|Overall Study|Lost to Follow-up|0|||
125910418|NCT00510874|452971997|FG006|Overall Study|Lost to Follow-up|1|||
125910419|NCT00426231|452972000|FG000|Overall Study|Withdrawal by Subject|9|||
125910420|NCT00426231|452972001|FG001|Overall Study|Withdrawal by Subject|12|||
125910421|NCT02423109|452972004|FG000|Lens 1|Adverse Event|1|||
125910422|NCT02423109|452972005|FG001|Lens 1|Adverse Event|0|||
125910423|NCT03956056|452972006|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
125910424|NCT03956056|452972006|FG000|Overall Study|Lack of Efficacy|1|||
125910425|NCT03403374|452972007|FG000|Overall Study|Lost to Follow-up|1|||
125910426|NCT00085709|452972008|FG000|Overall Study|Adverse Event|8|||
125910427|NCT00085709|452972009|FG001|Overall Study|Adverse Event|0|||
125910428|NCT00085709|452972008|FG000|Overall Study|Death|8|||
125910429|NCT00085709|452972009|FG001|Overall Study|Death|2|||
125910430|NCT00085709|452972008|FG000|Overall Study|Refusal unrelated to adverse events|1|||
125910431|NCT00085709|452972009|FG001|Overall Study|Refusal unrelated to adverse events|2|||
125910432|NCT00085709|452972008|FG000|Overall Study|Progression|3|||
125910433|NCT00085709|452972009|FG001|Overall Study|Progression|4|||
125910434|NCT00085709|452972008|FG000|Overall Study|Not protocol specified|12|||
125910435|NCT00085709|452972009|FG001|Overall Study|Not protocol specified|22|||
125910436|NCT00085709|452972008|FG000|Overall Study|Not eligible|19|||
125910437|NCT00085709|452972009|FG001|Overall Study|Not eligible|19|||
125910438|NCT00085709|452972008|FG000|Overall Study|Withdrawal by Subject|2|||
125910439|NCT00085709|452972009|FG001|Overall Study|Withdrawal by Subject|1|||
125910440|NCT00293215|452972010|FG000|Overall Study|Progressive disease|3|||
125910441|NCT00293215|452972011|FG001|Overall Study|Progressive disease|1|||
125910442|NCT00293215|452972010|FG000|Overall Study|Adverse Event|2|||
126110171|NCT02876835|453697653|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
125910443|NCT00293215|452972011|FG001|Overall Study|Adverse Event|2|||
126110172|NCT02540538|453697654|FG000|Overall Study|Pregnancy|0|||
125910444|NCT01229371|452972014|FG000|Overall Study|Withdrawal by Subject|0|||
125910445|NCT01229371|452972015|FG001|Overall Study|Withdrawal by Subject|1|||
125910446|NCT01229371|452972016|FG002|Overall Study|Withdrawal by Subject|0|||
125910447|NCT01229371|452972017|FG003|Overall Study|Withdrawal by Subject|0|||
125910448|NCT04622735|452972018|FG000|Overall Study|Lost to Follow-up|1|||
125910449|NCT04622735|452972019|FG001|Overall Study|Lost to Follow-up|2|||
125910450|NCT04622735|452972020|FG002|Overall Study|Lost to Follow-up|1|||
125910451|NCT04622735|452972018|FG000|Overall Study|Adverse Event|0|||
125910452|NCT04622735|452972019|FG001|Overall Study|Adverse Event|0|||
125910453|NCT04622735|452972020|FG002|Overall Study|Adverse Event|1|||
125910454|NCT04622735|452972018|FG000|Overall Study|Protocol Violation|1|||
125910455|NCT04622735|452972019|FG001|Overall Study|Protocol Violation|0|||
125910456|NCT04622735|452972020|FG002|Overall Study|Protocol Violation|0|||
125910457|NCT05314478|452972021|FG000|Overall Study|Physician Decision|1|||
125910458|NCT02923427|452972022|FG000|Overall Study|convert to laparatomy|2|||
125910459|NCT02923427|452972023|FG001|Overall Study|convert to laparatomy|2|||
125910460|NCT02923427|452972022|FG000|Overall Study|destaturation|1|||
125910461|NCT02923427|452972023|FG001|Overall Study|destaturation|0|||
125910462|NCT02923427|452972022|FG000|Overall Study|can not replace LMA|1|||
125910463|NCT02923427|452972023|FG001|Overall Study|can not replace LMA|0|||
125910464|NCT01325623|452972024|FG000|Overall Study|Withdrawal by Subject|3|||
125910465|NCT01229397|452972025|FG000|Overall Study|Withdrawal by Subject|3|||
125910466|NCT01229397|452972026|FG001|Overall Study|Withdrawal by Subject|3|||
125910467|NCT01229397|452972025|FG000|Overall Study|Lost to Follow-up|7|||
125910468|NCT01229397|452972026|FG001|Overall Study|Lost to Follow-up|6|||
125910469|NCT01229397|452972025|FG000|Overall Study|Migrated/moved from study area|1|||
125910470|NCT01229397|452972026|FG001|Overall Study|Migrated/moved from study area|0|||
125910471|NCT00950911|452972027|FG000|Overall Study|Adverse Event|0|||
125910472|NCT00950911|452972028|FG001|Overall Study|Adverse Event|2|||
125910473|NCT00950911|452972027|FG000|Overall Study|Death|4|||
125910474|NCT00950911|452972028|FG001|Overall Study|Death|6|||
125910475|NCT00950911|452972027|FG000|Overall Study|Disease progression|2|||
125910476|NCT00950911|452972028|FG001|Overall Study|Disease progression|2|||
125910477|NCT00950911|452972027|FG000|Overall Study|Consent withdrawn|1|||
125910478|NCT00950911|452972028|FG001|Overall Study|Consent withdrawn|3|||
125910479|NCT00950911|452972027|FG000|Overall Study|Administrative decision|3|||
125910480|NCT00950911|452972028|FG001|Overall Study|Administrative decision|1|||
125910481|NCT00950911|452972027|FG000|Overall Study|Ineligibility determined|1|||
125910482|NCT00950911|452972028|FG001|Overall Study|Ineligibility determined|0|||
125910483|NCT00950911|452972027|FG000|Overall Study|Noncompliance|1|||
125910484|NCT00950911|452972028|FG001|Overall Study|Noncompliance|0|||
125910485|NCT00950911|452972027|FG000|Overall Study|Poor performance status|0|||
125910486|NCT00950911|452972028|FG001|Overall Study|Poor performance status|1|||
125910487|NCT02476422|452972031|FG000|Overall Study|Subject/guardian decision|0|||
125910488|NCT02476422|452972032|FG001|Overall Study|Subject/guardian decision|1|||
125910489|NCT01134315|452972037|FG000|Overall Study|Adverse Event|1|||
125910490|NCT01134315|452972038|FG001|Overall Study|Adverse Event|2|||
125910491|NCT01134315|452972037|FG000|Overall Study|Other Reason|8|||
125910492|NCT01134315|452972038|FG001|Overall Study|Other Reason|17|||
125910493|NCT02694523|452972039|FG000|Part A|Adverse Event|7|||
125910494|NCT02694523|452972040|FG001|Part A|Adverse Event|3|||
125910495|NCT02694523|452972041|FG002|Part A|Adverse Event|0|||
125910496|NCT02694523|452972042|FG003|Part A|Adverse Event|0|||
125910497|NCT02694523|452972043|FG004|Part A|Adverse Event|0|||
125910498|NCT02694523|452972044|FG005|Part A|Adverse Event|0|||
125910499|NCT02694523|452972045|FG006|Part A|Adverse Event|0|||
125910500|NCT02694523|452972039|FG000|Part A|Protocol Violation|1|||
125910501|NCT02694523|452972040|FG001|Part A|Protocol Violation|0|||
125910502|NCT02694523|452972041|FG002|Part A|Protocol Violation|0|||
125910503|NCT02694523|452972042|FG003|Part A|Protocol Violation|0|||
125910504|NCT02694523|452972043|FG004|Part A|Protocol Violation|0|||
125910505|NCT02694523|452972044|FG005|Part A|Protocol Violation|0|||
126060908|NCT01986348|453516355|FG003|Overall Study|Progressive Disease|0|||
126060909|NCT01986348|453516352|FG000|Overall Study|Withdrawal by Participant|0|||
126060910|NCT01986348|453516353|FG001|Overall Study|Withdrawal by Participant|1|||
126060911|NCT01986348|453516354|FG002|Overall Study|Withdrawal by Participant|2|||
125910506|NCT02694523|452972045|FG006|Part A|Protocol Violation|0|||
125910507|NCT02694523|452972039|FG000|Part A|Lost to Follow-up|1|||
125910508|NCT02694523|452972040|FG001|Part A|Lost to Follow-up|2|||
125910509|NCT02694523|452972041|FG002|Part A|Lost to Follow-up|0|||
125910510|NCT02694523|452972042|FG003|Part A|Lost to Follow-up|0|||
125910511|NCT02694523|452972043|FG004|Part A|Lost to Follow-up|0|||
125910512|NCT02694523|452972044|FG005|Part A|Lost to Follow-up|0|||
125910513|NCT02694523|452972045|FG006|Part A|Lost to Follow-up|0|||
125910514|NCT02694523|452972039|FG000|Part A|Withdrawal by Subject|3|||
125910515|NCT02694523|452972040|FG001|Part A|Withdrawal by Subject|1|||
125910516|NCT02694523|452972041|FG002|Part A|Withdrawal by Subject|0|||
125910517|NCT02694523|452972042|FG003|Part A|Withdrawal by Subject|0|||
126060912|NCT01986348|453516355|FG003|Overall Study|Withdrawal by Participant|1|||
125910518|NCT02694523|452972043|FG004|Part A|Withdrawal by Subject|0|||
125910519|NCT02694523|452972044|FG005|Part A|Withdrawal by Subject|0|||
125910520|NCT02694523|452972045|FG006|Part A|Withdrawal by Subject|0|||
125910521|NCT02694523|452972039|FG000|Part A|Other|1|||
125910522|NCT02694523|452972040|FG001|Part A|Other|1|||
125910523|NCT02694523|452972041|FG002|Part A|Other|0|||
125910524|NCT02694523|452972042|FG003|Part A|Other|0|||
125910525|NCT02694523|452972043|FG004|Part A|Other|0|||
125910526|NCT02694523|452972044|FG005|Part A|Other|0|||
125910527|NCT02694523|452972045|FG006|Part A|Other|0|||
125910528|NCT02694523|452972039|FG000|Part B|Adverse Event|0|||
125910529|NCT02694523|452972040|FG001|Part B|Adverse Event|0|||
125910530|NCT02694523|452972041|FG002|Part B|Adverse Event|7|||
125910531|NCT02694523|452972042|FG003|Part B|Adverse Event|1|||
125910532|NCT02694523|452972043|FG004|Part B|Adverse Event|1|||
125910533|NCT02694523|452972044|FG005|Part B|Adverse Event|2|||
125910534|NCT02694523|452972045|FG006|Part B|Adverse Event|0|||
125910535|NCT02694523|452972039|FG000|Part B|Protocol Violation|0|||
125910536|NCT02694523|452972040|FG001|Part B|Protocol Violation|0|||
125910537|NCT02694523|452972041|FG002|Part B|Protocol Violation|1|||
125910538|NCT02694523|452972042|FG003|Part B|Protocol Violation|0|||
125910539|NCT02694523|452972043|FG004|Part B|Protocol Violation|0|||
125910540|NCT02694523|452972044|FG005|Part B|Protocol Violation|0|||
125910541|NCT02694523|452972045|FG006|Part B|Protocol Violation|0|||
125910542|NCT02694523|452972039|FG000|Part B|Lost to Follow-up|0|||
125910543|NCT02694523|452972040|FG001|Part B|Lost to Follow-up|0|||
125910544|NCT02694523|452972041|FG002|Part B|Lost to Follow-up|2|||
125910545|NCT02694523|452972042|FG003|Part B|Lost to Follow-up|3|||
125910546|NCT02694523|452972043|FG004|Part B|Lost to Follow-up|2|||
125910547|NCT02694523|452972044|FG005|Part B|Lost to Follow-up|0|||
125910548|NCT02694523|452972045|FG006|Part B|Lost to Follow-up|1|||
125910549|NCT02694523|452972039|FG000|Part B|Withdrawal by Subject|0|||
125910550|NCT02694523|452972040|FG001|Part B|Withdrawal by Subject|0|||
125910551|NCT02694523|452972041|FG002|Part B|Withdrawal by Subject|9|||
125910552|NCT02694523|452972042|FG003|Part B|Withdrawal by Subject|0|||
125910553|NCT02694523|452972043|FG004|Part B|Withdrawal by Subject|1|||
125910554|NCT02694523|452972044|FG005|Part B|Withdrawal by Subject|3|||
125910555|NCT02694523|452972045|FG006|Part B|Withdrawal by Subject|0|||
125910556|NCT02694523|452972039|FG000|Part B|Other|0|||
125910557|NCT02694523|452972040|FG001|Part B|Other|0|||
125910558|NCT02694523|452972041|FG002|Part B|Other|1|||
125910559|NCT02694523|452972042|FG003|Part B|Other|0|||
125910560|NCT02694523|452972043|FG004|Part B|Other|0|||
125910561|NCT02694523|452972044|FG005|Part B|Other|0|||
125910562|NCT02694523|452972045|FG006|Part B|Other|1|||
125910563|NCT05896748|452972046|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
125910564|NCT05896748|452972046|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
125910565|NCT05896748|452972046|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
125910566|NCT05896748|452972046|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
125910567|NCT05896748|452972046|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
125910568|NCT01298193|452972047|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
125910569|NCT01298193|452972047|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
125910570|NCT01298193|452972047|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
125910571|NCT01298193|452972047|FG000|Efficacy Phase (Second Cycle)|Death|1|||
125910572|NCT01070043|452972048|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
125910573|NCT01070043|452972049|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
125910574|NCT01070043|452972050|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
125910575|NCT01070043|452972048|FG000|Double-Blind Treatment|Adverse Event|0|||
125910576|NCT01070043|452972049|FG001|Double-Blind Treatment|Adverse Event|0|||
125910577|NCT01070043|452972050|FG002|Double-Blind Treatment|Adverse Event|2|||
125910578|NCT00473746|452972052|FG000|Period 1 (Phase 1)|Adverse Event|1|||
125910579|NCT00473746|452972053|FG001|Period 1 (Phase 1)|Adverse Event|0|||
125910580|NCT00473746|452972054|FG002|Period 1 (Phase 1)|Adverse Event|0|||
125910581|NCT00473746|452972055|FG003|Period 1 (Phase 1)|Adverse Event|0|||
125910582|NCT00473746|452972056|FG004|Period 1 (Phase 1)|Adverse Event|0|||
125910583|NCT00473746|452972052|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125910584|NCT00473746|452972053|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
125910585|NCT00473746|452972054|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125910586|NCT00473746|452972055|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125910587|NCT00473746|452972056|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125910588|NCT00473746|452972052|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
125910589|NCT00473746|452972053|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
125910590|NCT00473746|452972054|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
125910591|NCT00473746|452972055|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
125910592|NCT00473746|452972056|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
125910593|NCT00473746|452972052|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
126110173|NCT02540538|453697655|FG001|Overall Study|Pregnancy|1|||
125910594|NCT00473746|452972053|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
125910595|NCT00473746|452972054|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
125910596|NCT00473746|452972055|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
125910597|NCT00473746|452972056|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
125910598|NCT00473746|452972052|FG000|Period 1 (Phase 1)|Reason not specified|0|||
125910599|NCT00473746|452972053|FG001|Period 1 (Phase 1)|Reason not specified|1|||
125910600|NCT00473746|452972054|FG002|Period 1 (Phase 1)|Reason not specified|0|||
125910601|NCT00473746|452972055|FG003|Period 1 (Phase 1)|Reason not specified|0|||
125910602|NCT00473746|452972056|FG004|Period 1 (Phase 1)|Reason not specified|0|||
125910603|NCT00473746|452972052|FG000|Period 2 (Phase 2)|Adverse Event|0|||
125910604|NCT00473746|452972053|FG001|Period 2 (Phase 2)|Adverse Event|0|||
125910605|NCT00473746|452972054|FG002|Period 2 (Phase 2)|Adverse Event|0|||
125910606|NCT00473746|452972055|FG003|Period 2 (Phase 2)|Adverse Event|0|||
125910607|NCT00473746|452972056|FG004|Period 2 (Phase 2)|Adverse Event|3|||
125910608|NCT00473746|452972052|FG000|Period 2 (Phase 2)|Death|0|||
125910609|NCT00473746|452972053|FG001|Period 2 (Phase 2)|Death|0|||
125910610|NCT00473746|452972054|FG002|Period 2 (Phase 2)|Death|0|||
125910611|NCT00473746|452972055|FG003|Period 2 (Phase 2)|Death|0|||
125910612|NCT00473746|452972056|FG004|Period 2 (Phase 2)|Death|1|||
125910613|NCT00473746|452972052|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
125910614|NCT00473746|452972053|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
125910615|NCT00473746|452972054|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
125910616|NCT00473746|452972055|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
125910617|NCT00473746|452972056|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
125910618|NCT00473746|452972052|FG000|Period 2 (Phase 2)|Reason not specified|0|||
125910619|NCT00473746|452972053|FG001|Period 2 (Phase 2)|Reason not specified|0|||
125910620|NCT00473746|452972054|FG002|Period 2 (Phase 2)|Reason not specified|0|||
125910621|NCT00473746|452972055|FG003|Period 2 (Phase 2)|Reason not specified|0|||
125910622|NCT00473746|452972056|FG004|Period 2 (Phase 2)|Reason not specified|3|||
125910623|NCT00667420|452972057|FG000|Overall Study|Adverse Event|2|||
125910624|NCT00667420|452972057|FG000|Overall Study|Lack of Efficacy|5|||
125910625|NCT00667420|452972057|FG000|Overall Study|Physician Decision|1|||
125910626|NCT00667420|452972057|FG000|Overall Study|Withdrawal by Subject|2|||
125910627|NCT01528215|452972061|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
125910628|NCT01528215|452972062|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
125910629|NCT01528215|452972061|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
125910630|NCT01528215|452972062|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
125910631|NCT01528215|452972061|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
125910632|NCT01528215|452972062|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
125910633|NCT01528215|452972061|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
125910634|NCT01528215|452972062|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
125910635|NCT01462227|452972063|FG000|Second Assignment|Lost to Follow-up|1|||
125910636|NCT01462227|452972064|FG001|Second Assignment|Lost to Follow-up|0|||
125910637|NCT01462227|452972065|FG002|Second Assignment|Lost to Follow-up|0|||
125910638|NCT01462227|452972066|FG003|Second Assignment|Lost to Follow-up|0|||
125910639|NCT01462227|452972063|FG000|Second Assignment|Protocol Violation|0|||
125910640|NCT01462227|452972064|FG001|Second Assignment|Protocol Violation|1|||
125910641|NCT01462227|452972065|FG002|Second Assignment|Protocol Violation|1|||
125910642|NCT01462227|452972066|FG003|Second Assignment|Protocol Violation|0|||
125910643|NCT03538431|452972072|FG000|Overall Study|Physician Decision|0|||
125910644|NCT03538431|452972073|FG001|Overall Study|Physician Decision|1|||
125910645|NCT03538431|452972072|FG000|Overall Study|Withdrawal by Subject|1|||
125910646|NCT03538431|452972073|FG001|Overall Study|Withdrawal by Subject|0|||
125910647|NCT00620464|452972074|FG000|Overall Study|Adverse Event|15|||
125910648|NCT00620464|452972075|FG001|Overall Study|Adverse Event|17|||
125910649|NCT00620464|452972074|FG000|Overall Study|Lost to Follow-up|1|||
125910650|NCT00620464|452972075|FG001|Overall Study|Lost to Follow-up|1|||
125910651|NCT00620464|452972074|FG000|Overall Study|Planning Pregnancy|1|||
125910652|NCT00620464|452972075|FG001|Overall Study|Planning Pregnancy|4|||
125910653|NCT00620464|452972074|FG000|Overall Study|Personal|2|||
125910654|NCT00620464|452972075|FG001|Overall Study|Personal|2|||
125910655|NCT00620464|452972074|FG000|Overall Study|Used prohibited medication|1|||
125910656|NCT00620464|452972075|FG001|Overall Study|Used prohibited medication|0|||
125910657|NCT00586066|452972076|FG000|Overall Study|Lost to Follow-up|6|||
125910658|NCT00586066|452972077|FG001|Overall Study|Lost to Follow-up|3|||
125910659|NCT00586066|452972076|FG000|Overall Study|Lack of Efficacy|5|||
125910660|NCT00586066|452972077|FG001|Overall Study|Lack of Efficacy|3|||
125910661|NCT00586066|452972076|FG000|Overall Study|Adverse Event|2|||
125910662|NCT00586066|452972077|FG001|Overall Study|Adverse Event|2|||
125910663|NCT00586066|452972076|FG000|Overall Study|Physician Decision|1|||
125910664|NCT00586066|452972077|FG001|Overall Study|Physician Decision|0|||
125910665|NCT00586066|452972076|FG000|Overall Study|Withdrawal of consent|4|||
125910666|NCT00586066|452972077|FG001|Overall Study|Withdrawal of consent|2|||
125910667|NCT00467610|452972080|FG000|Overall Study|Withdrawal by Subject|1|||
125910668|NCT04263454|452972081|FG000|Overall Study|Adverse Event|0|||
125910669|NCT04263454|452972082|FG001|Overall Study|Adverse Event|2|||
125910670|NCT04263454|452972081|FG000|Overall Study|Physician Decision|3|||
125910671|NCT04263454|452972082|FG001|Overall Study|Physician Decision|5|||
125910672|NCT04263454|452972081|FG000|Overall Study|Poor Data Quality|0|||
125910673|NCT04263454|452972082|FG001|Overall Study|Poor Data Quality|1|||
125910674|NCT00986479|452972083|FG000|Period 1|Improved mood|1|||
125910675|NCT00986479|452972084|FG001|Period 1|Improved mood|0|||
125910676|NCT00986479|452972083|FG000|Period 1|Administrative reasons|1|||
125910677|NCT00986479|452972084|FG001|Period 1|Administrative reasons|0|||
125910678|NCT00771316|452972089|FG000|Overall Study|Adverse Event|0|||
125910679|NCT00771316|452972090|FG001|Overall Study|Adverse Event|1|||
125910680|NCT00771316|452972089|FG000|Overall Study|Patient withdrew consent|1|||
125910681|NCT00771316|452972090|FG001|Overall Study|Patient withdrew consent|0|||
125910682|NCT00771316|452972089|FG000|Overall Study|Discontinued due to early termination|1|||
125910683|NCT00771316|452972090|FG001|Overall Study|Discontinued due to early termination|0|||
125910684|NCT02027376|452972091|FG000|Overall Study|Death|1|||
125910685|NCT02027376|452972092|FG001|Overall Study|Death|0|||
125910686|NCT02027376|452972093|FG002|Overall Study|Death|0|||
125910687|NCT04755283|452972100|FG000|Overall Study|Withdrawal by Subject|14|||
125910688|NCT04755283|452972101|FG001|Overall Study|Withdrawal by Subject|3|||
125910689|NCT04755283|452972102|FG002|Overall Study|Withdrawal by Subject|6|||
125910690|NCT04755283|452972100|FG000|Overall Study|Lost to Follow-up|0|||
125910691|NCT04755283|452972101|FG001|Overall Study|Lost to Follow-up|0|||
125910692|NCT04755283|452972102|FG002|Overall Study|Lost to Follow-up|1|||
125910693|NCT04755283|452972100|FG000|Overall Study|Death|31|||
125910694|NCT04755283|452972101|FG001|Overall Study|Death|36|||
125910695|NCT04755283|452972102|FG002|Overall Study|Death|34|||
125910696|NCT01828320|452972103|FG000|Overall Study|Lost to Follow-up|1|||
125910697|NCT01828320|452972104|FG001|Overall Study|Lost to Follow-up|3|||
125910698|NCT01828320|452972103|FG000|Overall Study|Withdrawal by Subject|7|||
125910699|NCT01828320|452972104|FG001|Overall Study|Withdrawal by Subject|2|||
125910700|NCT01104701|452973427|FG000|Overall Study|Withdrawal by Subject|0|||
125910701|NCT01104701|452973428|FG001|Overall Study|Withdrawal by Subject|1|||
125910702|NCT01104701|452973429|FG002|Overall Study|Withdrawal by Subject|2|||
125910703|NCT01104701|452973430|FG003|Overall Study|Withdrawal by Subject|1|||
125910704|NCT01104701|452973427|FG000|Overall Study|Adverse Event|0|||
125910705|NCT01104701|452973428|FG001|Overall Study|Adverse Event|0|||
125910706|NCT01104701|452973429|FG002|Overall Study|Adverse Event|0|||
125910707|NCT01104701|452973430|FG003|Overall Study|Adverse Event|1|||
125910708|NCT01104701|452973427|FG000|Overall Study|Physician Decision|0|||
125910709|NCT01104701|452973428|FG001|Overall Study|Physician Decision|2|||
125910710|NCT01104701|452973429|FG002|Overall Study|Physician Decision|0|||
125910711|NCT01104701|452973430|FG003|Overall Study|Physician Decision|0|||
125910712|NCT03437512|452973431|FG000|Randomized|Withdrawal by Subject|0|||
125910713|NCT03437512|452973432|FG001|Randomized|Withdrawal by Subject|2|||
125910714|NCT03437512|452973431|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
125910715|NCT03437512|452973432|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
125910716|NCT01002482|452973433|FG000|Overall Study|Withdrawal by Subject|14|||
125910717|NCT01002482|452973434|FG001|Overall Study|Withdrawal by Subject|21|||
125910718|NCT01002482|452973433|FG000|Overall Study|Included twice|1|||
125910719|NCT01002482|452973434|FG001|Overall Study|Included twice|0|||
125910720|NCT05108922|452973435|FG000|Overall Study|Adverse Event|2|||
125910721|NCT05108922|452973436|FG001|Overall Study|Adverse Event|3|||
125910722|NCT05108922|452973435|FG000|Overall Study|Lost to Follow-up|2|||
125910723|NCT05108922|452973436|FG001|Overall Study|Lost to Follow-up|1|||
125910724|NCT05108922|452973435|FG000|Overall Study|Inadvertent enrollment|0|||
125910725|NCT05108922|452973436|FG001|Overall Study|Inadvertent enrollment|1|||
125910726|NCT05108922|452973435|FG000|Overall Study|Physician Decision|2|||
125910727|NCT05108922|452973436|FG001|Overall Study|Physician Decision|3|||
125910728|NCT05108922|452973435|FG000|Overall Study|Protocol deviation|1|||
125910729|NCT05108922|452973436|FG001|Overall Study|Protocol deviation|0|||
125910730|NCT05108922|452973435|FG000|Overall Study|Screen failure|1|||
125910731|NCT05108922|452973436|FG001|Overall Study|Screen failure|0|||
125910732|NCT05108922|452973435|FG000|Overall Study|Withdrawal by Subject|11|||
125910733|NCT05108922|452973436|FG001|Overall Study|Withdrawal by Subject|8|||
125910734|NCT01795638|452973437|FG000|Overall Study|Death|0|||
125910735|NCT01795638|452973438|FG001|Overall Study|Death|3|||
125910736|NCT01795638|452973437|FG000|Overall Study|transferred to quaternary hospital|2|||
126060913|NCT01986348|453516352|FG000|Overall Study|Study Terminated by Sponsor|0|||
126060914|NCT01986348|453516353|FG001|Overall Study|Study Terminated by Sponsor|0|||
126060915|NCT01986348|453516354|FG002|Overall Study|Study Terminated by Sponsor|0|||
126060916|NCT01986348|453516355|FG003|Overall Study|Study Terminated by Sponsor|3|||
125910737|NCT01795638|452973438|FG001|Overall Study|transferred to quaternary hospital|3|||
125910738|NCT01795638|452973437|FG000|Overall Study|Protocol Violation|3|||
125910739|NCT01795638|452973438|FG001|Overall Study|Protocol Violation|0|||
125910740|NCT01795638|452973437|FG000|Overall Study|discharged from hospital|7|||
126060917|NCT01986348|453516352|FG000|Overall Study|Other-unspecified|0|||
125910741|NCT01795638|452973438|FG001|Overall Study|discharged from hospital|5|||
125910742|NCT01795638|452973437|FG000|Overall Study|Withdrawal by Subject|1|||
126060918|NCT01986348|453516353|FG001|Overall Study|Other-unspecified|1|||
126060919|NCT01986348|453516354|FG002|Overall Study|Other-unspecified|0|||
125910743|NCT01795638|452973438|FG001|Overall Study|Withdrawal by Subject|0|||
125910744|NCT00422097|452973439|FG000|Dose Level 2|Still on treatment|0|||
125910745|NCT00422097|452973440|FG001|Dose Level 2|Still on treatment|1|||
125910746|NCT00422097|452973441|FG002|Dose Level 2|Still on treatment|0|||
125910747|NCT00422097|452973442|FG003|Dose Level 2|Still on treatment|0|||
125910748|NCT00422097|452973443|FG004|Dose Level 2|Still on treatment|0|||
125910749|NCT00422097|452973444|FG005|Dose Level 2|Still on treatment|0|||
125910750|NCT00422097|452973445|FG006|Dose Level 2|Still on treatment|0|||
125910751|NCT00422097|452973446|FG007|Dose Level 2|Still on treatment|0|||
126060920|NCT01986348|453516355|FG003|Overall Study|Other-unspecified|2|||
126060921|NCT02935894|453516356|FG000|Overall Study|Subject dismissed|1|||
126060922|NCT01079949|453516359|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
126060923|NCT01079949|453516360|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
126060924|NCT01079949|453516359|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
126110174|NCT02540538|453697656|FG002|Overall Study|Pregnancy|0|||
125910752|NCT02360995|452973447|FG000|Overall Study|Lost to Follow-up|2|||
125910753|NCT02360995|452973448|FG001|Overall Study|Lost to Follow-up|0|||
125910754|NCT02360995|452973449|FG002|Overall Study|Lost to Follow-up|2|||
125910755|NCT02360995|452973447|FG000|Overall Study|Withdrawal by Subject|0|||
125910756|NCT02360995|452973448|FG001|Overall Study|Withdrawal by Subject|1|||
125910757|NCT02360995|452973449|FG002|Overall Study|Withdrawal by Subject|0|||
125910758|NCT02611960|452973450|FG000|Overall Study|Adverse Event|7|||
125910759|NCT02611960|452973451|FG001|Overall Study|Adverse Event|8|||
125910760|NCT02611960|452973450|FG000|Overall Study|Death|98|||
125910761|NCT02611960|452973451|FG001|Overall Study|Death|92|||
125910762|NCT02611960|452973450|FG000|Overall Study|Withdrawal by Subject|1|||
125910763|NCT02611960|452973451|FG001|Overall Study|Withdrawal by Subject|5|||
125910764|NCT02611960|452973450|FG000|Overall Study|Sponsor Decision|11|||
125910765|NCT02611960|452973451|FG001|Overall Study|Sponsor Decision|11|||
125910766|NCT02395666|452973452|FG000|Overall Study|Physician Decision|3|||
125910767|NCT02395666|452973453|FG001|Overall Study|Physician Decision|0|||
125910768|NCT02395666|452973452|FG000|Overall Study|Lost to Follow-up|1|||
125910769|NCT02395666|452973453|FG001|Overall Study|Lost to Follow-up|0|||
125910770|NCT02395666|452973452|FG000|Overall Study|Withdrawal by Subject|2|||
125910771|NCT02395666|452973453|FG001|Overall Study|Withdrawal by Subject|1|||
125910772|NCT01409434|452973464|FG000|Overall Study|Protocol Violation|4|||
125910773|NCT02213042|452973465|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
125910774|NCT02213042|452973466|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
125910775|NCT02213042|452973467|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
125910776|NCT02213042|452973465|FG000|Overall Study|Adverse Event|2|||
125910777|NCT02213042|452973466|FG001|Overall Study|Adverse Event|1|||
125910778|NCT02213042|452973467|FG002|Overall Study|Adverse Event|0|||
125910779|NCT02213042|452973465|FG000|Overall Study|Withdrawal by Subject|0|||
125910780|NCT02213042|452973466|FG001|Overall Study|Withdrawal by Subject|1|||
125910781|NCT02213042|452973467|FG002|Overall Study|Withdrawal by Subject|1|||
125910782|NCT02213042|452973465|FG000|Overall Study|Protocol Violation|1|||
125910783|NCT02213042|452973466|FG001|Overall Study|Protocol Violation|0|||
125910784|NCT02213042|452973467|FG002|Overall Study|Protocol Violation|0|||
125910785|NCT02213042|452973465|FG000|Overall Study|Investigator discretion|0|||
125910786|NCT02213042|452973466|FG001|Overall Study|Investigator discretion|0|||
125910787|NCT02213042|452973467|FG002|Overall Study|Investigator discretion|1|||
125910788|NCT05061966|452973468|FG000|Overall Study|Lost to Follow-up|13|||
125910789|NCT05061966|452973469|FG001|Overall Study|Lost to Follow-up|13|||
125910790|NCT04073368|452973473|FG000|Overall Study|Adverse Event|2|||
125910791|NCT04073368|452973474|FG001|Overall Study|Adverse Event|0|||
125910792|NCT04073368|452973475|FG002|Overall Study|Adverse Event|1|||
125910793|NCT04073368|452973476|FG003|Overall Study|Adverse Event|1|||
125910794|NCT04073368|452973473|FG000|Overall Study|Withdrawal by Subject|2|||
125910795|NCT04073368|452973474|FG001|Overall Study|Withdrawal by Subject|2|||
125910796|NCT04073368|452973475|FG002|Overall Study|Withdrawal by Subject|1|||
125910797|NCT04073368|452973476|FG003|Overall Study|Withdrawal by Subject|1|||
125910798|NCT04073368|452973473|FG000|Overall Study|Lost to Follow-up|1|||
125910799|NCT04073368|452973474|FG001|Overall Study|Lost to Follow-up|1|||
125910800|NCT04073368|452973475|FG002|Overall Study|Lost to Follow-up|1|||
125910801|NCT04073368|452973476|FG003|Overall Study|Lost to Follow-up|0|||
125910802|NCT04073368|452973473|FG000|Overall Study|Protocol Violation|0|||
125910803|NCT04073368|452973474|FG001|Overall Study|Protocol Violation|1|||
125910804|NCT04073368|452973475|FG002|Overall Study|Protocol Violation|0|||
125910805|NCT04073368|452973476|FG003|Overall Study|Protocol Violation|0|||
125910806|NCT04073368|452973473|FG000|Overall Study|Subject noncompliance|7|||
125910807|NCT04073368|452973474|FG001|Overall Study|Subject noncompliance|4|||
125910808|NCT04073368|452973475|FG002|Overall Study|Subject noncompliance|0|||
125910809|NCT04073368|452973476|FG003|Overall Study|Subject noncompliance|0|||
125910810|NCT02180165|452973480|FG000|Overall Study|Not Treated|0|||
125910811|NCT02180165|452973481|FG001|Overall Study|Not Treated|0|||
125910812|NCT02180165|452973482|FG002|Overall Study|Not Treated|1|||
125910813|NCT02180165|452973483|FG003|Overall Study|Not Treated|0|||
125910814|NCT02180165|452973480|FG000|Overall Study|Adverse Event|7|||
125910815|NCT02180165|452973481|FG001|Overall Study|Adverse Event|0|||
125910816|NCT02180165|452973482|FG002|Overall Study|Adverse Event|18|||
125910817|NCT02180165|452973483|FG003|Overall Study|Adverse Event|3|||
125910818|NCT02180165|452973480|FG000|Overall Study|Lack of Efficacy|0|||
125910819|NCT02180165|452973481|FG001|Overall Study|Lack of Efficacy|1|||
125910820|NCT02180165|452973482|FG002|Overall Study|Lack of Efficacy|3|||
125910821|NCT02180165|452973483|FG003|Overall Study|Lack of Efficacy|2|||
125910822|NCT02180165|452973480|FG000|Overall Study|Physician Decision|1|||
125910823|NCT02180165|452973481|FG001|Overall Study|Physician Decision|0|||
125910824|NCT02180165|452973482|FG002|Overall Study|Physician Decision|5|||
125910825|NCT02180165|452973483|FG003|Overall Study|Physician Decision|0|||
125910826|NCT02180165|452973480|FG000|Overall Study|Withdrawal by Subject|3|||
125910827|NCT02180165|452973481|FG001|Overall Study|Withdrawal by Subject|0|||
126110175|NCT00403754|453697657|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
125910828|NCT02180165|452973482|FG002|Overall Study|Withdrawal by Subject|2|||
125910829|NCT02180165|452973483|FG003|Overall Study|Withdrawal by Subject|1|||
125910830|NCT03875768|452973484|FG000|Overall Study|Lost to Follow-up|16|||
125910831|NCT03875768|452973485|FG001|Overall Study|Lost to Follow-up|13|||
125910832|NCT03875768|452973484|FG000|Overall Study|Withdrawal by Subject|10|||
125910833|NCT03875768|452973485|FG001|Overall Study|Withdrawal by Subject|21|||
125910834|NCT03875768|452973484|FG000|Overall Study|Did not complete assessment|21|||
125910835|NCT03875768|452973485|FG001|Overall Study|Did not complete assessment|12|||
125910836|NCT03875768|452973484|FG000|Overall Study|Became ineligible|1|||
125910837|NCT03875768|452973485|FG001|Overall Study|Became ineligible|0|||
125910838|NCT00737438|452973489|FG000|Overall Study|Withdrawal by Subject|2|||
125910839|NCT00737438|452973489|FG000|Overall Study|Patient ineligible|1|||
125910840|NCT02791594|452973490|FG000|Overall Study|Physician Decision|2|||
125910841|NCT04950166|452973493|FG000|Overall Study|Withdrawal by Subject|1|||
125910842|NCT00857415|452973494|FG000|Overall Study|Image acquisition failure|2|||
125910843|NCT00857415|452973495|FG001|Overall Study|Image acquisition failure|0|||
125910844|NCT00857415|452973494|FG000|Overall Study|Invalid image or not imaged|3|||
126060925|NCT01079949|453516360|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
126060926|NCT01079949|453516359|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
126060927|NCT01079949|453516360|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
126060928|NCT01079949|453516359|FG000|Overall Study|Randomized but not treated|1|||
126060929|NCT01079949|453516360|FG001|Overall Study|Randomized but not treated|0|||
126060930|NCT02144285|453516361|FG000|Overall Study|Withdrawal by Subject|0|||
126060931|NCT02144285|453516362|FG001|Overall Study|Withdrawal by Subject|0|||
126060932|NCT02144285|453516363|FG002|Overall Study|Withdrawal by Subject|0|||
126060933|NCT02144285|453516364|FG003|Overall Study|Withdrawal by Subject|0|||
126060934|NCT02144285|453516365|FG004|Overall Study|Withdrawal by Subject|1|||
126060935|NCT02144285|453516366|FG005|Overall Study|Withdrawal by Subject|0|||
126060936|NCT02144285|453516367|FG006|Overall Study|Withdrawal by Subject|0|||
126060937|NCT02144285|453516368|FG007|Overall Study|Withdrawal by Subject|0|||
126060938|NCT02144285|453516369|FG008|Overall Study|Withdrawal by Subject|0|||
126060939|NCT02144285|453516370|FG009|Overall Study|Withdrawal by Subject|0|||
126060940|NCT01529632|453516371|FG000|Overall Study|Administrative problem|2|||
126060941|NCT01529632|453516372|FG001|Overall Study|Administrative problem|1|||
126060942|NCT01529632|453516371|FG000|Overall Study|Protocol Violation|0|||
126060943|NCT01529632|453516372|FG001|Overall Study|Protocol Violation|1|||
126060944|NCT01529632|453516371|FG000|Overall Study|Adverse Event|1|||
125910845|NCT00857415|452973495|FG001|Overall Study|Invalid image or not imaged|0|||
125910846|NCT00857415|452973494|FG000|Overall Study|Subject still living at end of study|110|||
125910847|NCT00857415|452973495|FG001|Overall Study|Subject still living at end of study|0|||
125910848|NCT00857415|452973494|FG000|Overall Study|Deceased with no autopsy|2|||
125910849|NCT00857415|452973495|FG001|Overall Study|Deceased with no autopsy|0|||
125910850|NCT01130103|452973498|FG000|Randomized Treatment|Adverse Event|1|||
125910851|NCT01130103|452973499|FG001|Randomized Treatment|Adverse Event|1|||
125910852|NCT01130103|452973498|FG000|Randomized Treatment|Lost to Follow-up|1|||
125910853|NCT01130103|452973499|FG001|Randomized Treatment|Lost to Follow-up|0|||
126060945|NCT01529632|453516372|FG001|Overall Study|Adverse Event|1|||
126060946|NCT04919499|453516373|FG000|Overall Study|Adverse Event|0|||
126060947|NCT04919499|453516374|FG001|Overall Study|Adverse Event|0|||
125910854|NCT01130103|452973498|FG000|Randomized Treatment|Protocol Violation|3|||
125910855|NCT01130103|452973499|FG001|Randomized Treatment|Protocol Violation|2|||
125910856|NCT01130103|452973498|FG000|Randomized Treatment|Withdrawal by Subject|1|||
125910857|NCT01130103|452973499|FG001|Randomized Treatment|Withdrawal by Subject|2|||
125910858|NCT01130103|452973498|FG000|Maintenance Treatment|Lack of Efficacy|0|||
125910859|NCT01130103|452973499|FG001|Maintenance Treatment|Lack of Efficacy|1|||
125910860|NCT01130103|452973498|FG000|Maintenance Treatment|Lost to Follow-up|1|||
125910861|NCT01130103|452973499|FG001|Maintenance Treatment|Lost to Follow-up|1|||
125910862|NCT01130103|452973498|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
125910863|NCT01130103|452973499|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
126060948|NCT04919499|453516375|FG002|Overall Study|Adverse Event|0|||
125910864|NCT04508140|452973500|FG000|Overall Study|Adverse Event|2|||
125910865|NCT04508140|452973501|FG001|Overall Study|Adverse Event|2|||
125910866|NCT04508140|452973500|FG000|Overall Study|Withdrawal by Subject|0|||
125910867|NCT04508140|452973501|FG001|Overall Study|Withdrawal by Subject|2|||
125910868|NCT04508140|452973500|FG000|Overall Study|progressive disease|9|||
125910869|NCT04508140|452973501|FG001|Overall Study|progressive disease|3|||
125910870|NCT01199731|452973502|FG000|Overall Study|Adverse Event|0|||
125910871|NCT01199731|452973503|FG001|Overall Study|Adverse Event|1|||
125910872|NCT01199731|452973504|FG002|Overall Study|Adverse Event|0|||
125910873|NCT01199731|452973502|FG000|Overall Study|Study closed/terminated|7|||
125910874|NCT01199731|452973503|FG001|Overall Study|Study closed/terminated|9|||
125910875|NCT01199731|452973504|FG002|Overall Study|Study closed/terminated|7|||
125910876|NCT01199731|452973502|FG000|Overall Study|Lost to Follow-up|0|||
125910877|NCT01199731|452973503|FG001|Overall Study|Lost to Follow-up|0|||
125910878|NCT01199731|452973504|FG002|Overall Study|Lost to Follow-up|2|||
125910879|NCT01199731|452973502|FG000|Overall Study|Physician Decision|0|||
125910880|NCT01199731|452973503|FG001|Overall Study|Physician Decision|1|||
125910881|NCT01199731|452973504|FG002|Overall Study|Physician Decision|1|||
125910882|NCT01199731|452973502|FG000|Overall Study|Withdrawal by Subject|2|||
125910883|NCT01199731|452973503|FG001|Overall Study|Withdrawal by Subject|0|||
125910884|NCT01199731|452973504|FG002|Overall Study|Withdrawal by Subject|0|||
125910885|NCT01822678|452973505|FG000|Overall Study|Withdrawal by Subject|5|||
125910886|NCT01822678|452973506|FG001|Overall Study|Withdrawal by Subject|4|||
125910887|NCT01822678|452973507|FG002|Overall Study|Withdrawal by Subject|4|||
125910888|NCT01822678|452973505|FG000|Overall Study|Adverse Event|4|||
125910889|NCT01822678|452973506|FG001|Overall Study|Adverse Event|3|||
125910890|NCT01822678|452973507|FG002|Overall Study|Adverse Event|1|||
125910891|NCT01822678|452973505|FG000|Overall Study|Lack of Efficacy|3|||
125910892|NCT01822678|452973506|FG001|Overall Study|Lack of Efficacy|6|||
125910893|NCT01822678|452973507|FG002|Overall Study|Lack of Efficacy|5|||
125910894|NCT01822678|452973505|FG000|Overall Study|Lost to Follow-up|0|||
125910895|NCT01822678|452973506|FG001|Overall Study|Lost to Follow-up|2|||
125910896|NCT01822678|452973507|FG002|Overall Study|Lost to Follow-up|1|||
125910897|NCT00943124|452973511|FG000|Period 1|Withdrawal by Subject|1|||
125910898|NCT00943124|452973512|FG001|Period 1|Withdrawal by Subject|1|||
125910899|NCT00943124|452973511|FG000|Period 1|Did Not Follow Study Procedures|1|||
125910900|NCT00943124|452973512|FG001|Period 1|Did Not Follow Study Procedures|0|||
125910901|NCT00943124|452973511|FG000|Period 1|Personal Reasons|0|||
125910902|NCT00943124|452973512|FG001|Period 1|Personal Reasons|1|||
125910903|NCT02992132|452973513|FG000|Overall Study|Adverse Event|4|||
125910904|NCT02992132|452973514|FG001|Overall Study|Adverse Event|1|||
125910905|NCT02992132|452973515|FG002|Overall Study|Adverse Event|3|||
125910906|NCT02992132|452973513|FG000|Overall Study|Lack of Efficacy|2|||
125910907|NCT02992132|452973514|FG001|Overall Study|Lack of Efficacy|0|||
125910908|NCT02992132|452973515|FG002|Overall Study|Lack of Efficacy|0|||
125910909|NCT02992132|452973513|FG000|Overall Study|Non-compliance with study drug|2|||
125910910|NCT02992132|452973514|FG001|Overall Study|Non-compliance with study drug|0|||
126110176|NCT00403754|453697658|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
126110177|NCT00403754|453697659|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
126110178|NCT00403754|453697660|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
126110179|NCT00403754|453697657|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
126110180|NCT00403754|453697658|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
126110181|NCT00403754|453697659|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
126110182|NCT00403754|453697660|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
126110183|NCT03049735|453697665|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
126110184|NCT03049735|453697666|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
126110185|NCT03049735|453697667|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
126110186|NCT03049735|453697665|FG000|Overall Study|Other|5|||
126110187|NCT03049735|453697666|FG001|Overall Study|Other|3|||
126110188|NCT03049735|453697667|FG002|Overall Study|Other|1|||
126110189|NCT03049735|453697665|FG000|Overall Study|Lack of Efficacy|4|||
126110190|NCT03049735|453697666|FG001|Overall Study|Lack of Efficacy|0|||
126110191|NCT03049735|453697667|FG002|Overall Study|Lack of Efficacy|3|||
126110192|NCT03049735|453697665|FG000|Overall Study|Protocol deviation|1|||
126110193|NCT03049735|453697666|FG001|Overall Study|Protocol deviation|0|||
126110194|NCT03049735|453697667|FG002|Overall Study|Protocol deviation|0|||
125910911|NCT02992132|452973515|FG002|Overall Study|Non-compliance with study drug|0|||
125910912|NCT02992132|452973513|FG000|Overall Study|Progressive disease|1|||
125910913|NCT02992132|452973514|FG001|Overall Study|Progressive disease|0|||
125910914|NCT02992132|452973515|FG002|Overall Study|Progressive disease|0|||
125910915|NCT02992132|452973513|FG000|Overall Study|Protocol Violation|2|||
125910916|NCT02992132|452973514|FG001|Overall Study|Protocol Violation|2|||
126110195|NCT03049735|453697665|FG000|Overall Study|Pregnancy|0|||
126110196|NCT03049735|453697666|FG001|Overall Study|Pregnancy|0|||
126110197|NCT03049735|453697667|FG002|Overall Study|Pregnancy|1|||
126110198|NCT03049735|453697665|FG000|Overall Study|Adverse Event|7|||
125910917|NCT02992132|452973515|FG002|Overall Study|Protocol Violation|0|||
126110199|NCT03049735|453697666|FG001|Overall Study|Adverse Event|18|||
125910918|NCT02992132|452973513|FG000|Overall Study|Caregiver withdrew consent|2|||
125910919|NCT02992132|452973514|FG001|Overall Study|Caregiver withdrew consent|3|||
125910920|NCT02992132|452973515|FG002|Overall Study|Caregiver withdrew consent|2|||
125910921|NCT02992132|452973513|FG000|Overall Study|Withdrawal by Subject|0|||
125910922|NCT02992132|452973514|FG001|Overall Study|Withdrawal by Subject|2|||
125910923|NCT02992132|452973515|FG002|Overall Study|Withdrawal by Subject|1|||
125910924|NCT02992132|452973513|FG000|Overall Study|Physician Decision|0|||
125910925|NCT02992132|452973514|FG001|Overall Study|Physician Decision|0|||
125910926|NCT02992132|452973515|FG002|Overall Study|Physician Decision|1|||
125910927|NCT00381381|452973523|FG000|Overall Study|Adverse Event|3|||
125910928|NCT00381381|452973523|FG000|Overall Study|Lost to Follow-up|52|||
125910929|NCT00381381|452973523|FG000|Overall Study|Withdrawal by Subject|9|||
125910930|NCT01916967|452973524|FG000|Overall Study|Adverse Event|0|||
125910931|NCT01916967|452973525|FG001|Overall Study|Adverse Event|0|||
125910932|NCT01916967|452973526|FG002|Overall Study|Adverse Event|2|||
125910933|NCT01916967|452973524|FG000|Overall Study|Lack of Efficacy|0|||
125910934|NCT01916967|452973525|FG001|Overall Study|Lack of Efficacy|0|||
125910935|NCT01916967|452973526|FG002|Overall Study|Lack of Efficacy|6|||
125910936|NCT01916967|452973524|FG000|Overall Study|Physician Decision|0|||
125910937|NCT01916967|452973525|FG001|Overall Study|Physician Decision|0|||
125910938|NCT01916967|452973526|FG002|Overall Study|Physician Decision|1|||
125910939|NCT01916967|452973524|FG000|Overall Study|Protocol Violation|0|||
125910940|NCT01916967|452973525|FG001|Overall Study|Protocol Violation|1|||
125910941|NCT01916967|452973526|FG002|Overall Study|Protocol Violation|0|||
125910942|NCT01437878|452973531|FG000|Overall Study|Withdrawal by Subject|1|||
125910943|NCT01437878|452973532|FG001|Overall Study|Withdrawal by Subject|0|||
125910944|NCT01369615|452973535|FG000|Overall Study|Withdrawal by Subject|0|||
125910945|NCT01369615|452973536|FG001|Overall Study|Withdrawal by Subject|1|||
125910946|NCT01369615|452973535|FG000|Overall Study|Lost to Follow-up|0|||
125910947|NCT01369615|452973536|FG001|Overall Study|Lost to Follow-up|1|||
125910948|NCT03911154|452973537|FG000|Overall Study|Withdrawal by Subject|1|||
125910949|NCT02035475|452973538|FG000|Overall Study|Withdrawal by Subject|4|||
125910950|NCT02035475|452973538|FG000|Overall Study|Physician Decision|1|||
125910951|NCT02035475|452973538|FG000|Overall Study|Equipment Error|1|||
125910952|NCT01231347|452973539|FG000|Overall Study|Full Consent withdrawn|19|||
125910953|NCT01231347|452973540|FG001|Overall Study|Full Consent withdrawn|19|||
125910954|NCT01231347|452973541|FG002|Overall Study|Full Consent withdrawn|11|||
125910955|NCT01231347|452973539|FG000|Overall Study|Lost to Follow-up|4|||
125910956|NCT01231347|452973540|FG001|Overall Study|Lost to Follow-up|2|||
125910957|NCT01231347|452973541|FG002|Overall Study|Lost to Follow-up|2|||
125910958|NCT01231347|452973539|FG000|Overall Study|Death|202|||
125910959|NCT01231347|452973540|FG001|Overall Study|Death|210|||
125910960|NCT01231347|452973541|FG002|Overall Study|Death|101|||
125910961|NCT01231347|452973539|FG000|Overall Study|other event|7|||
125910962|NCT01231347|452973540|FG001|Overall Study|other event|9|||
125910963|NCT01231347|452973541|FG002|Overall Study|other event|3|||
125910964|NCT02322021|452973542|FG000|Core Phase|Adverse Event|1|||
125910965|NCT02322021|452973543|FG001|Core Phase|Adverse Event|3|||
125910966|NCT02322021|452973544|FG002|Core Phase|Adverse Event|4|||
125910967|NCT02322021|452973545|FG003|Core Phase|Adverse Event|2|||
125910968|NCT02322021|452973546|FG004|Core Phase|Adverse Event|0|||
125910969|NCT02322021|452973542|FG000|Core Phase|Participant Choice|4|||
125910970|NCT02322021|452973543|FG001|Core Phase|Participant Choice|5|||
125910971|NCT02322021|452973544|FG002|Core Phase|Participant Choice|4|||
125910972|NCT02322021|452973545|FG003|Core Phase|Participant Choice|2|||
125910973|NCT02322021|452973546|FG004|Core Phase|Participant Choice|0|||
125910974|NCT02322021|452973542|FG000|Core Phase|Lost to Follow-up|0|||
125910975|NCT02322021|452973543|FG001|Core Phase|Lost to Follow-up|0|||
125910976|NCT02322021|452973544|FG002|Core Phase|Lost to Follow-up|0|||
125910977|NCT02322021|452973545|FG003|Core Phase|Lost to Follow-up|1|||
125910978|NCT02322021|452973546|FG004|Core Phase|Lost to Follow-up|0|||
125910979|NCT02322021|452973542|FG000|Core Phase|Other|0|||
125910980|NCT02322021|452973543|FG001|Core Phase|Other|0|||
125910981|NCT02322021|452973544|FG002|Core Phase|Other|1|||
125910982|NCT02322021|452973545|FG003|Core Phase|Other|0|||
125910983|NCT02322021|452973546|FG004|Core Phase|Other|0|||
125910984|NCT02322021|452973542|FG000|Extension Phase|Adverse Event|0|||
125910985|NCT02322021|452973543|FG001|Extension Phase|Adverse Event|0|||
125910986|NCT02322021|452973544|FG002|Extension Phase|Adverse Event|0|||
125910987|NCT02322021|452973545|FG003|Extension Phase|Adverse Event|0|||
125910988|NCT02322021|452973546|FG004|Extension Phase|Adverse Event|3|||
125910989|NCT02322021|452973542|FG000|Extension Phase|Participant Choice|0|||
125910990|NCT02322021|452973543|FG001|Extension Phase|Participant Choice|0|||
125910991|NCT02322021|452973544|FG002|Extension Phase|Participant Choice|0|||
125910992|NCT02322021|452973545|FG003|Extension Phase|Participant Choice|0|||
125910993|NCT02322021|452973546|FG004|Extension Phase|Participant Choice|6|||
125910994|NCT02322021|452973542|FG000|Extension Phase|Other|0|||
125910995|NCT02322021|452973543|FG001|Extension Phase|Other|0|||
125910996|NCT02322021|452973544|FG002|Extension Phase|Other|0|||
125910997|NCT02322021|452973545|FG003|Extension Phase|Other|0|||
125910998|NCT02322021|452973546|FG004|Extension Phase|Other|3|||
125910999|NCT02322021|452973542|FG000|Extension Phase|Lost to Follow-up|0|||
125911000|NCT02322021|452973543|FG001|Extension Phase|Lost to Follow-up|0|||
125911001|NCT02322021|452973544|FG002|Extension Phase|Lost to Follow-up|0|||
125911002|NCT02322021|452973545|FG003|Extension Phase|Lost to Follow-up|0|||
125911003|NCT02322021|452973546|FG004|Extension Phase|Lost to Follow-up|1|||
125911004|NCT02322021|452973542|FG000|Extension Phase|Study terminated by sponsor|0|||
125911005|NCT02322021|452973543|FG001|Extension Phase|Study terminated by sponsor|0|||
125911006|NCT02322021|452973544|FG002|Extension Phase|Study terminated by sponsor|0|||
125911007|NCT02322021|452973545|FG003|Extension Phase|Study terminated by sponsor|0|||
125911008|NCT02322021|452973546|FG004|Extension Phase|Study terminated by sponsor|28|||
125911009|NCT01702571|452973547|FG000|Overall Study|Death|1067|||
125911010|NCT01702571|452973548|FG001|Overall Study|Death|76|||
125911011|NCT01702571|452973547|FG000|Overall Study|Lost to Follow-up|144|||
125911012|NCT01702571|452973548|FG001|Overall Study|Lost to Follow-up|10|||
125911013|NCT01702571|452973547|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
125911014|NCT01702571|452973548|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
125911015|NCT01702571|452973547|FG000|Overall Study|Investigator Decision|5|||
125911016|NCT01702571|452973548|FG001|Overall Study|Investigator Decision|0|||
125911017|NCT01702571|452973547|FG000|Overall Study|Not Classifiable|1|||
125911018|NCT01702571|452973548|FG001|Overall Study|Not Classifiable|0|||
125911019|NCT01702571|452973547|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
125911020|NCT01702571|452973548|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
125911021|NCT01702571|452973547|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
125911022|NCT01702571|452973548|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
125911023|NCT01702571|452973547|FG000|Overall Study|Progressive Disease|3|||
125911024|NCT01702571|452973548|FG001|Overall Study|Progressive Disease|0|||
125911025|NCT01702571|452973547|FG000|Overall Study|Protocol Violation|2|||
125911026|NCT01702571|452973548|FG001|Overall Study|Protocol Violation|0|||
125911027|NCT01702571|452973547|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
125911028|NCT01702571|452973548|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
125911029|NCT01702571|452973547|FG000|Overall Study|Termination By Sponsor|4|||
125911030|NCT01702571|452973548|FG001|Overall Study|Termination By Sponsor|0|||
125911031|NCT01702571|452973547|FG000|Overall Study|Withdrawal by Subject|177|||
125911032|NCT01702571|452973548|FG001|Overall Study|Withdrawal by Subject|29|||
125911033|NCT02047227|452973549|FG000|Overall Study|Adverse Event|2|||
125911034|NCT02047227|452973550|FG001|Overall Study|Adverse Event|4|||
126060949|NCT04919499|453516376|FG003|Overall Study|Adverse Event|0|||
126060950|NCT04919499|453516377|FG004|Overall Study|Adverse Event|2|||
125911035|NCT02047227|452973549|FG000|Overall Study|Lost to Follow-up|0|||
125911036|NCT02047227|452973550|FG001|Overall Study|Lost to Follow-up|3|||
125911037|NCT02047227|452973549|FG000|Overall Study|Protocol Violation|1|||
125911038|NCT02047227|452973550|FG001|Overall Study|Protocol Violation|0|||
125911039|NCT02047227|452973549|FG000|Overall Study|Spontaneous pregnancy|1|||
125911040|NCT02047227|452973550|FG001|Overall Study|Spontaneous pregnancy|0|||
125911041|NCT02047227|452973549|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
125911042|NCT02047227|452973550|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
125911043|NCT02047227|452973549|FG000|Overall Study|No oocytes retrieved|21|||
125911044|NCT02047227|452973550|FG001|Overall Study|No oocytes retrieved|20|||
125911045|NCT02047227|452973549|FG000|Overall Study|No fertilization|61|||
126060951|NCT04919499|453516373|FG000|Overall Study|Not treated|0|||
125911046|NCT02047227|452973550|FG001|Overall Study|No fertilization|51|||
125911047|NCT02047227|452973549|FG000|Overall Study|Intention to freeze all embryos|1|||
125911048|NCT02047227|452973550|FG001|Overall Study|Intention to freeze all embryos|0|||
126060952|NCT04919499|453516374|FG001|Overall Study|Not treated|0|||
126060953|NCT04919499|453516375|FG002|Overall Study|Not treated|0|||
125911049|NCT02047227|452973549|FG000|Overall Study|All embryos discarded|12|||
125911050|NCT02047227|452973550|FG001|Overall Study|All embryos discarded|11|||
125911051|NCT02047227|452973549|FG000|Overall Study|Other|10|||
125911052|NCT02047227|452973550|FG001|Overall Study|Other|9|||
125911053|NCT01977937|452973557|FG000|Overall Study|Withdrawal by Subject|2|||
125911054|NCT01977937|452973558|FG001|Overall Study|Withdrawal by Subject|1|||
125911055|NCT01977937|452973557|FG000|Overall Study|Adverse Event|1|||
125911056|NCT01977937|452973558|FG001|Overall Study|Adverse Event|0|||
125911057|NCT01977937|452973557|FG000|Overall Study|Physician Decision|0|||
125911058|NCT01977937|452973558|FG001|Overall Study|Physician Decision|1|||
125911059|NCT00915356|452973559|FG000|Overall Study|Withdrawal by Subject|1|||
125911060|NCT00915356|452973560|FG001|Overall Study|Withdrawal by Subject|0|||
125911061|NCT00915356|452973561|FG002|Overall Study|Withdrawal by Subject|0|||
125911062|NCT00915356|452973562|FG003|Overall Study|Withdrawal by Subject|0|||
125911063|NCT00915356|452973563|FG004|Overall Study|Withdrawal by Subject|0|||
125911064|NCT02001181|452973566|FG000|Overall Study|Adverse Event|0|||
125911065|NCT02001181|452973567|FG001|Overall Study|Adverse Event|2|||
125911066|NCT02001181|452973566|FG000|Overall Study|Lost to Follow-up|1|||
125911067|NCT02001181|452973567|FG001|Overall Study|Lost to Follow-up|0|||
125911068|NCT02001181|452973566|FG000|Overall Study|Withdrawal by Subject|0|||
125911069|NCT02001181|452973567|FG001|Overall Study|Withdrawal by Subject|1|||
125911070|NCT00292318|452973568|FG000|Overall Study|Study terminated by officials|2|||
125911071|NCT00292318|452973569|FG001|Overall Study|Study terminated by officials|1|||
125911072|NCT01278160|452973570|FG000|Overall Study|Adverse Event|1|||
125911073|NCT01278160|452973571|FG001|Overall Study|Adverse Event|1|||
125911074|NCT01278160|452973570|FG000|Overall Study|Lost to Follow-up|0|||
125911075|NCT01278160|452973571|FG001|Overall Study|Lost to Follow-up|1|||
125911076|NCT01278160|452973570|FG000|Overall Study|Withdrawal by Subject|3|||
125911077|NCT01278160|452973571|FG001|Overall Study|Withdrawal by Subject|2|||
125911078|NCT01278160|452973570|FG000|Overall Study|Unclassified|1|||
125911079|NCT01278160|452973571|FG001|Overall Study|Unclassified|2|||
125911080|NCT02819518|452973574|FG000|Overall Study|Death|9|||
125911081|NCT02819518|452973575|FG001|Overall Study|Death|12|||
125911082|NCT02819518|452973576|FG002|Overall Study|Death|9|||
125911083|NCT02819518|452973577|FG003|Overall Study|Death|475|||
125911084|NCT02819518|452973578|FG004|Overall Study|Death|244|||
125911085|NCT02819518|452973574|FG000|Overall Study|Withdrawal by Subject|0|||
125911086|NCT02819518|452973575|FG001|Overall Study|Withdrawal by Subject|0|||
125911087|NCT02819518|452973576|FG002|Overall Study|Withdrawal by Subject|0|||
125911088|NCT02819518|452973577|FG003|Overall Study|Withdrawal by Subject|25|||
125911089|NCT02819518|452973578|FG004|Overall Study|Withdrawal by Subject|8|||
125911090|NCT02819518|452973574|FG000|Overall Study|Lost to Follow-up|0|||
125911091|NCT02819518|452973575|FG001|Overall Study|Lost to Follow-up|0|||
125911092|NCT02819518|452973576|FG002|Overall Study|Lost to Follow-up|0|||
125911093|NCT02819518|452973577|FG003|Overall Study|Lost to Follow-up|0|||
125911094|NCT02819518|452973578|FG004|Overall Study|Lost to Follow-up|1|||
125911095|NCT02819518|452973574|FG000|Overall Study|Sponsor Decision|1|||
125911096|NCT02819518|452973575|FG001|Overall Study|Sponsor Decision|1|||
125911097|NCT02819518|452973576|FG002|Overall Study|Sponsor Decision|0|||
125911098|NCT02819518|452973577|FG003|Overall Study|Sponsor Decision|34|||
125911099|NCT02819518|452973578|FG004|Overall Study|Sponsor Decision|17|||
125911100|NCT02819518|452973574|FG000|Overall Study|Transferred to extension study|1|||
125911101|NCT02819518|452973575|FG001|Overall Study|Transferred to extension study|1|||
125911102|NCT02819518|452973576|FG002|Overall Study|Transferred to extension study|1|||
125911103|NCT02819518|452973577|FG003|Overall Study|Transferred to extension study|32|||
125911104|NCT02819518|452973578|FG004|Overall Study|Transferred to extension study|11|||
125911105|NCT01505647|452973579|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
125911106|NCT01505647|452973580|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
125911107|NCT01505647|452973579|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
125911108|NCT01505647|452973580|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
125911109|NCT01505647|452973579|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
125911110|NCT01505647|452973580|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
125911111|NCT01505647|452973579|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
125911112|NCT01505647|452973580|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
125911113|NCT01505647|452973579|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
125911114|NCT01505647|452973580|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
125911115|NCT00492050|452973583|FG000|Overall Study|Adverse Event|1|||
125911116|NCT00492050|452973583|FG000|Overall Study|Lack of Efficacy|1|||
125911117|NCT00492050|452973583|FG000|Overall Study|Withdrawal by Subject|3|||
125911118|NCT00492050|452973583|FG000|Overall Study|Unable to collect SCT|2|||
125911119|NCT00492050|452973583|FG000|Overall Study|Progressive Disease|2|||
125911120|NCT00423722|452974972|FG000|Overall Study|Death|4|||
125911121|NCT00423722|452974973|FG001|Overall Study|Death|4|||
125911122|NCT00423722|452974972|FG000|Overall Study|Declined to participate|2|||
125911123|NCT00423722|452974973|FG001|Overall Study|Declined to participate|3|||
125911124|NCT00423722|452974972|FG000|Overall Study|Unable to complete questionnaires|4|||
125911125|NCT00423722|452974973|FG001|Overall Study|Unable to complete questionnaires|4|||
125911126|NCT00423722|452974972|FG000|Overall Study|Withdrawal by Subject|4|||
125911127|NCT00423722|452974973|FG001|Overall Study|Withdrawal by Subject|2|||
125911128|NCT00518687|452974975|FG000|Overall Study|Adverse Event|201|||
125911129|NCT00518687|452974976|FG001|Overall Study|Adverse Event|177|||
125911130|NCT00518687|452974975|FG000|Overall Study|Lost to Follow-up|144|||
125911131|NCT00518687|452974976|FG001|Overall Study|Lost to Follow-up|155|||
125911132|NCT00518687|452974975|FG000|Overall Study|Physician Decision|42|||
125911133|NCT00518687|452974976|FG001|Overall Study|Physician Decision|48|||
125911134|NCT00518687|452974975|FG000|Overall Study|Progressive disease|2|||
125911135|NCT00518687|452974976|FG001|Overall Study|Progressive disease|2|||
125911136|NCT00518687|452974975|FG000|Overall Study|Protocol Violation|8|||
125911137|NCT00518687|452974976|FG001|Overall Study|Protocol Violation|10|||
125911138|NCT00518687|452974975|FG000|Overall Study|Study terminated by sponsor|930|||
125911139|NCT00518687|452974976|FG001|Overall Study|Study terminated by sponsor|918|||
125911140|NCT00518687|452974975|FG000|Overall Study|Withdrawal by Subject|110|||
125911141|NCT00518687|452974976|FG001|Overall Study|Withdrawal by Subject|110|||
126060954|NCT04919499|453516376|FG003|Overall Study|Not treated|1|||
126060955|NCT04919499|453516377|FG004|Overall Study|Not treated|0|||
126060956|NCT03786471|453516378|FG000|Overall Study|Death|254|||
126060957|NCT03786471|453516379|FG001|Overall Study|Death|223|||
126060958|NCT03786471|453516380|FG002|Overall Study|Death|37|||
126060959|NCT03786471|453516378|FG000|Overall Study|Lost to Follow-up|63|||
126060960|NCT03786471|453516379|FG001|Overall Study|Lost to Follow-up|50|||
126060961|NCT03786471|453516380|FG002|Overall Study|Lost to Follow-up|15|||
126060962|NCT03786471|453516378|FG000|Overall Study|Withdrawal by Subject|99|||
126060963|NCT03786471|453516379|FG001|Overall Study|Withdrawal by Subject|81|||
126060964|NCT03786471|453516380|FG002|Overall Study|Withdrawal by Subject|11|||
126060965|NCT00747149|453518038|FG000|Overall Study|Adverse Event|0|||
126060966|NCT00747149|453518039|FG001|Overall Study|Adverse Event|15|||
126060967|NCT00747149|453518038|FG000|Overall Study|Lost to Follow-up|0|||
126060968|NCT00747149|453518039|FG001|Overall Study|Lost to Follow-up|10|||
126060969|NCT00747149|453518038|FG000|Overall Study|Withdrawal by Subject|0|||
126060970|NCT00747149|453518039|FG001|Overall Study|Withdrawal by Subject|6|||
126060971|NCT00747149|453518038|FG000|Overall Study|Did not receive treatment|0|||
126060972|NCT00747149|453518039|FG001|Overall Study|Did not receive treatment|1|||
126060973|NCT00747149|453518038|FG000|Overall Study|Incorrect enrollment|0|||
126060974|NCT00747149|453518039|FG001|Overall Study|Incorrect enrollment|6|||
126060975|NCT00747149|453518038|FG000|Overall Study|Severe non-compliance to protocol|0|||
126060976|NCT00747149|453518039|FG001|Overall Study|Severe non-compliance to protocol|1|||
126060977|NCT00747149|453518038|FG000|Overall Study|Not reported|1|||
126060978|NCT00747149|453518039|FG001|Overall Study|Not reported|4|||
126060979|NCT05522777|453518040|FG000|Overall Study|Lack of Efficacy|1|||
126060980|NCT05522777|453518040|FG000|Overall Study|Withdrawal by Subject|1|||
126060981|NCT01381549|453518041|FG000|Overall Study|Ineligible: No organisms isolated|0|||
126060982|NCT01381549|453518042|FG001|Overall Study|Ineligible: No organisms isolated|0|||
126060983|NCT01381549|453518043|FG002|Overall Study|Ineligible: No organisms isolated|1|||
126060984|NCT01416285|453518044|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
126060985|NCT01416285|453518045|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
126060986|NCT00578344|453518046|FG000|Overall Study|Insurance problems|1|||
126060987|NCT00578344|453518046|FG000|Overall Study|Graft failure|1|||
126060988|NCT02935673|453518047|FG000|Overall Study|Adverse Event|0|||
126060989|NCT02935673|453518048|FG001|Overall Study|Adverse Event|1|||
126060990|NCT02935673|453518049|FG002|Overall Study|Adverse Event|0|||
126060991|NCT02935673|453518047|FG000|Overall Study|Withdrawal by Subject|1|||
126060992|NCT02935673|453518048|FG001|Overall Study|Withdrawal by Subject|2|||
126060993|NCT02935673|453518049|FG002|Overall Study|Withdrawal by Subject|0|||
126060994|NCT04328467|453518050|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
126060995|NCT04328467|453518051|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
126110200|NCT03049735|453697667|FG002|Overall Study|Adverse Event|5|||
126110201|NCT03049735|453697665|FG000|Overall Study|Withdrawal by Subject|10|||
126060996|NCT04328467|453518052|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
126110202|NCT03049735|453697666|FG001|Overall Study|Withdrawal by Subject|3|||
126110203|NCT03049735|453697667|FG002|Overall Study|Withdrawal by Subject|7|||
125911142|NCT01846104|452974978|FG000|Overall Study|Withdrawal by Subject|1|||
126060997|NCT00990184|453518053|FG000|Overall Study|Physician Decision|1|||
126060998|NCT01090739|453518056|FG000|Enrollment|Withdrawal by Subject|24|||
126060999|NCT01090739|453518056|FG000|Enrollment|Protocol Violation|14|||
126061000|NCT01090739|453518056|FG000|Enrollment|Lost to Follow-up|5|||
126061001|NCT01090739|453518056|FG000|Enrollment|Physician Decision|5|||
126110204|NCT03049735|453697665|FG000|Overall Study|Lost to Follow-up|1|||
126110205|NCT03049735|453697666|FG001|Overall Study|Lost to Follow-up|5|||
125911143|NCT00851630|452974982|FG000|Overall Study|Death|2|||
125911144|NCT00851630|452974983|FG001|Overall Study|Death|1|||
125911145|NCT00851630|452974982|FG000|Overall Study|Clinical failure|0|||
125911146|NCT00851630|452974983|FG001|Overall Study|Clinical failure|1|||
125911147|NCT02349061|452974984|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
125911148|NCT02349061|452974985|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
125911149|NCT02349061|452974986|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
125911150|NCT02349061|452974984|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
125911151|NCT02349061|452974985|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
125911152|NCT02349061|452974986|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
125911153|NCT02349061|452974984|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
125911154|NCT02349061|452974985|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
125911155|NCT02349061|452974986|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
125911156|NCT02349061|452974984|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
125911157|NCT02349061|452974985|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
125911158|NCT02349061|452974986|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
125911159|NCT02349061|452974984|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
125911160|NCT02349061|452974985|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
125911161|NCT02349061|452974986|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
125911162|NCT02349061|452974984|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
125911163|NCT02349061|452974985|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
125911164|NCT02349061|452974986|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
125911165|NCT02349061|452974984|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
125911166|NCT02349061|452974985|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
125911167|NCT02349061|452974986|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
125911168|NCT02349061|452974984|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
125911169|NCT02349061|452974985|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
125911170|NCT02349061|452974986|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
125911171|NCT02349061|452974984|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
125911172|NCT02349061|452974985|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
125911173|NCT02349061|452974986|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
126110206|NCT03049735|453697667|FG002|Overall Study|Lost to Follow-up|5|||
126061002|NCT01090739|453518056|FG000|Enrollment|Sponsor termination of site|4|||
126061003|NCT01090739|453518056|FG000|Enrollment|Study implant limit reached|2|||
126061004|NCT01090739|453518056|FG000|Enrollment|Adverse Event|1|||
126061005|NCT01090739|453518056|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
126061006|NCT01090739|453518056|FG000|12 Month Follow-up|Lost to Follow-up|1|||
126061007|NCT01090739|453518056|FG000|12 Month Follow-up|Physician Decision|1|||
125911174|NCT02349061|452974984|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
125911175|NCT02349061|452974985|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
125911176|NCT02349061|452974986|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
125911177|NCT02349061|452974984|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
125911178|NCT02349061|452974985|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
125911179|NCT02349061|452974986|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
125911180|NCT02349061|452974984|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
125911181|NCT02349061|452974985|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
126061008|NCT01090739|453518056|FG000|12 Month Follow-up|Death|1|||
126061009|NCT01090739|453518056|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
126061010|NCT01090739|453518056|FG000|24 Month Follow-up|Lost to Follow-up|1|||
126061011|NCT01090739|453518056|FG000|24 Month Follow-up|Death|1|||
126061012|NCT01090739|453518056|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
126061013|NCT01090739|453518056|FG000|36 Month Follow-up|Visit still pending|17|||
126061014|NCT00441168|453518057|FG000|Treatment Period|Death|3|||
126061015|NCT00441168|453518058|FG001|Treatment Period|Death|0|||
125911182|NCT02349061|452974986|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
125911183|NCT02349061|452974984|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
125911184|NCT02349061|452974985|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
125911185|NCT02349061|452974986|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
126061016|NCT00441168|453518057|FG000|Treatment Period|Adverse Event|1|||
126061017|NCT00441168|453518058|FG001|Treatment Period|Adverse Event|2|||
126061018|NCT00441168|453518057|FG000|Treatment Period|Progressive Disease|0|||
126061019|NCT00441168|453518058|FG001|Treatment Period|Progressive Disease|2|||
125911186|NCT00398411|452974987|FG000|Overall Study|Death|0|||
125911187|NCT00398411|452974988|FG001|Overall Study|Death|1|||
125911188|NCT02095223|452974989|FG000|Overall Study|Withdrawal by Subject|1|||
126061020|NCT00441168|453518057|FG000|Treatment Period|Protocol Violation|0|||
126061021|NCT00441168|453518058|FG001|Treatment Period|Protocol Violation|1|||
126061022|NCT00441168|453518057|FG000|Treatment Period|Lost to Follow-up|0|||
125911189|NCT02095223|452974990|FG001|Overall Study|Withdrawal by Subject|0|||
126061023|NCT00441168|453518058|FG001|Treatment Period|Lost to Follow-up|1|||
125911190|NCT01397162|452974991|FG000|Overall Study|Adverse Event|4|||
125911191|NCT01397162|452974992|FG001|Overall Study|Adverse Event|0|||
125911192|NCT01397162|452974993|FG002|Overall Study|Adverse Event|0|||
125911193|NCT01397162|452974994|FG003|Overall Study|Adverse Event|0|||
125911194|NCT01397162|452974995|FG004|Overall Study|Adverse Event|0|||
125911195|NCT01397162|452974991|FG000|Overall Study|Not yet defined|3|||
125911196|NCT01397162|452974992|FG001|Overall Study|Not yet defined|4|||
125911197|NCT01397162|452974993|FG002|Overall Study|Not yet defined|3|||
125911198|NCT01397162|452974994|FG003|Overall Study|Not yet defined|5|||
125911199|NCT01397162|452974995|FG004|Overall Study|Not yet defined|3|||
125911200|NCT02339285|452974996|FG000|Overall Study|Withdrawal by Subject|0|||
125911201|NCT02339285|452974997|FG001|Overall Study|Withdrawal by Subject|1|||
125911202|NCT02339285|452974998|FG002|Overall Study|Withdrawal by Subject|1|||
125911203|NCT02339285|452974996|FG000|Overall Study|Lost to Follow-up|1|||
125911204|NCT02339285|452974997|FG001|Overall Study|Lost to Follow-up|1|||
125911205|NCT02339285|452974998|FG002|Overall Study|Lost to Follow-up|1|||
125911206|NCT02339285|452974996|FG000|Overall Study|Protocol Deviation|0|||
125911207|NCT02339285|452974997|FG001|Overall Study|Protocol Deviation|1|||
126061024|NCT00441168|453518057|FG000|Treatment Period|Withdrawal by Subject|3|||
125911208|NCT02339285|452974998|FG002|Overall Study|Protocol Deviation|0|||
125911209|NCT00282412|452975001|FG000|Overall Study|Death|2|||
125911210|NCT03061097|452975004|FG000|Overall Study|Withdrawal by Subject|0|||
125911211|NCT03061097|452975005|FG001|Overall Study|Withdrawal by Subject|3|||
125911212|NCT03911713|452975006|FG000|Overall Study|Lost to Follow-up|0|||
125911213|NCT03911713|452975007|FG001|Overall Study|Lost to Follow-up|2|||
125911214|NCT03911713|452975008|FG002|Overall Study|Lost to Follow-up|0|||
125911215|NCT03911713|452975009|FG003|Overall Study|Lost to Follow-up|0|||
125911216|NCT03911713|452975010|FG004|Overall Study|Lost to Follow-up|0|||
125911217|NCT03911713|452975006|FG000|Overall Study|Other|0|||
125911218|NCT03911713|452975007|FG001|Overall Study|Other|0|||
125911219|NCT03911713|452975008|FG002|Overall Study|Other|0|||
125911220|NCT03911713|452975009|FG003|Overall Study|Other|1|||
125911221|NCT03911713|452975010|FG004|Overall Study|Other|0|||
125911222|NCT03911713|452975006|FG000|Overall Study|Randomized, Never Dosed|1|||
125911223|NCT03911713|452975007|FG001|Overall Study|Randomized, Never Dosed|0|||
125911224|NCT03911713|452975008|FG002|Overall Study|Randomized, Never Dosed|0|||
125911225|NCT03911713|452975009|FG003|Overall Study|Randomized, Never Dosed|1|||
125911226|NCT03911713|452975010|FG004|Overall Study|Randomized, Never Dosed|0|||
125911227|NCT02437513|452975011|FG000|Overall Study|Withdrawal by Subject|2|||
125911228|NCT01845818|452975012|FG000|Overall Study|Withdrawal by Subject|0|||
125911229|NCT01845818|452975013|FG001|Overall Study|Withdrawal by Subject|1|||
125911230|NCT01845818|452975012|FG000|Overall Study|Lost to Follow-up|7|||
125911231|NCT01845818|452975013|FG001|Overall Study|Lost to Follow-up|5|||
125911232|NCT01845818|452975012|FG000|Overall Study|Administrative Reasons|3|||
125911233|NCT01845818|452975013|FG001|Overall Study|Administrative Reasons|1|||
125911234|NCT01845818|452975012|FG000|Overall Study|Serious Adverse Event|1|||
125911235|NCT01845818|452975013|FG001|Overall Study|Serious Adverse Event|1|||
125911236|NCT01845818|452975012|FG000|Overall Study|Other|25|||
125911237|NCT01845818|452975013|FG001|Overall Study|Other|8|||
125911238|NCT01845818|452975012|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
125911239|NCT01845818|452975013|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
125911240|NCT01845818|452975012|FG000|Overall Study|No Follow-Up Data Available|4|||
125911241|NCT01845818|452975013|FG001|Overall Study|No Follow-Up Data Available|1|||
125911242|NCT00736957|452975014|FG000|Overall Study|Adverse Event|43|||
125911243|NCT00736957|452975014|FG000|Overall Study|Withdrawal by Subject|49|||
125911244|NCT00736957|452975014|FG000|Overall Study|violation of eligibility criteria|2|||
125911245|NCT00736957|452975014|FG000|Overall Study|did not attend hospital appointments|1|||
125911246|NCT00736957|452975014|FG000|Overall Study|not eligible for Treatment Period I|22|||
125911247|NCT00736957|452975014|FG000|Overall Study|Physician Decision|5|||
125911248|NCT01051466|452975016|FG000|Overall Study|Adverse Event|1|||
125911249|NCT01051466|452975017|FG001|Overall Study|Adverse Event|0|||
125911250|NCT01051466|452975016|FG000|Overall Study|Lost to Follow-up|1|||
125911251|NCT01051466|452975017|FG001|Overall Study|Lost to Follow-up|1|||
125911252|NCT01051466|452975016|FG000|Overall Study|Withdrawal by Subject|5|||
125911253|NCT01051466|452975017|FG001|Overall Study|Withdrawal by Subject|1|||
125911254|NCT01051466|452975016|FG000|Overall Study|Entry Criteria Not Met|0|||
125911255|NCT01051466|452975017|FG001|Overall Study|Entry Criteria Not Met|3|||
125911256|NCT01051466|452975016|FG000|Overall Study|Physician Decision|1|||
125911257|NCT01051466|452975017|FG001|Overall Study|Physician Decision|0|||
125911258|NCT00145600|452975021|FG000|Overall Study|Death|1|||
125911259|NCT00145600|452975022|FG001|Overall Study|Death|2|||
125911260|NCT00145600|452975023|FG002|Overall Study|Death|2|||
125911261|NCT00145600|452975024|FG003|Overall Study|Death|6|||
125911262|NCT00145600|452975021|FG000|Overall Study|Ineligible|3|||
125911263|NCT00145600|452975022|FG001|Overall Study|Ineligible|0|||
125911264|NCT00145600|452975023|FG002|Overall Study|Ineligible|1|||
125911265|NCT00145600|452975024|FG003|Overall Study|Ineligible|5|||
125911266|NCT00145600|452975021|FG000|Overall Study|Lost to Follow-up|2|||
126061025|NCT00441168|453518058|FG001|Treatment Period|Withdrawal by Subject|0|||
126061026|NCT00441168|453518057|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
126061027|NCT00441168|453518058|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
125911267|NCT00145600|452975022|FG001|Overall Study|Lost to Follow-up|6|||
125911268|NCT00145600|452975023|FG002|Overall Study|Lost to Follow-up|2|||
125911269|NCT00145600|452975024|FG003|Overall Study|Lost to Follow-up|4|||
125911270|NCT00145600|452975021|FG000|Overall Study|Noncompliance|1|||
126061028|NCT00441168|453518057|FG000|Treatment Period|refractory disease|1|||
126061029|NCT00441168|453518058|FG001|Treatment Period|refractory disease|0|||
126061030|NCT00441168|453518057|FG000|Follow-up Period|Death|3|||
125911271|NCT00145600|452975022|FG001|Overall Study|Noncompliance|0|||
125911272|NCT00145600|452975023|FG002|Overall Study|Noncompliance|0|||
125911273|NCT00145600|452975024|FG003|Overall Study|Noncompliance|0|||
125911274|NCT00145600|452975021|FG000|Overall Study|Withdrawal by Subject|1|||
126061031|NCT00441168|453518058|FG001|Follow-up Period|Death|0|||
126061032|NCT00441168|453518057|FG000|Follow-up Period|Lost to Follow-up|5|||
125911275|NCT00145600|452975022|FG001|Overall Study|Withdrawal by Subject|2|||
125911276|NCT00145600|452975023|FG002|Overall Study|Withdrawal by Subject|0|||
125911277|NCT00145600|452975024|FG003|Overall Study|Withdrawal by Subject|1|||
125911278|NCT00761579|452975029|FG000|Overall Study|Adverse Event|10|||
125911279|NCT00761579|452975029|FG000|Overall Study|Death|2|||
125911280|NCT00761579|452975029|FG000|Overall Study|Lack of Efficacy|21|||
125911281|NCT00761579|452975029|FG000|Overall Study|Lost to Follow-up|16|||
125911282|NCT00761579|452975029|FG000|Overall Study|Pregnancy|1|||
125911283|NCT00761579|452975029|FG000|Overall Study|Withdrawal by Subject|34|||
125911284|NCT00761579|452975029|FG000|Overall Study|Lack of compliance|2|||
125911285|NCT00761579|452975029|FG000|Overall Study|Protocol deviation|1|||
125911286|NCT00761579|452975029|FG000|Overall Study|Drug overdose|1|||
125911287|NCT00761579|452975029|FG000|Overall Study|Aggravation of depression|1|||
125911288|NCT00761579|452975029|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
125911289|NCT00761579|452975029|FG000|Overall Study|Lost survey form|1|||
125911290|NCT00761579|452975029|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
125911291|NCT02600351|452975030|FG000|Overall Study|Lack of Efficacy|3|||
125911292|NCT02600351|452975031|FG001|Overall Study|Lack of Efficacy|0|||
125911293|NCT02600351|452975032|FG002|Overall Study|Lack of Efficacy|5|||
125911294|NCT02600351|452975033|FG003|Overall Study|Lack of Efficacy|2|||
125911295|NCT02600351|452975030|FG000|Overall Study|Lost to Follow-up|1|||
125911296|NCT02600351|452975031|FG001|Overall Study|Lost to Follow-up|0|||
125911297|NCT02600351|452975032|FG002|Overall Study|Lost to Follow-up|0|||
125911298|NCT02600351|452975033|FG003|Overall Study|Lost to Follow-up|0|||
125911299|NCT02600351|452975030|FG000|Overall Study|Randomized but Not Treated|1|||
125911300|NCT02600351|452975031|FG001|Overall Study|Randomized but Not Treated|0|||
125911301|NCT02600351|452975032|FG002|Overall Study|Randomized but Not Treated|1|||
125911302|NCT02600351|452975033|FG003|Overall Study|Randomized but Not Treated|3|||
125911303|NCT04087213|452975034|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
125911304|NCT04087213|452975034|FG000|In-Facility Introduction|Adverse Event|1|||
125911305|NCT04087213|452975034|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
125911306|NCT04087213|452975034|FG000|Assisted Evaluable Period|Personal reasons|3|||
125911307|NCT04087213|452975034|FG000|Transition Period B|Renal Transplantation|1|||
125911308|NCT02556203|452975041|FG000|Overall Study|Withdrawal by Subject|21|||
125911309|NCT02556203|452975042|FG001|Overall Study|Withdrawal by Subject|21|||
125911310|NCT02556203|452975041|FG000|Overall Study|Lost to Follow-up|5|||
125911311|NCT02556203|452975042|FG001|Overall Study|Lost to Follow-up|5|||
125911312|NCT02556203|452975041|FG000|Overall Study|Adverse Event|1|||
125911313|NCT02556203|452975042|FG001|Overall Study|Adverse Event|0|||
125911314|NCT04587271|452975043|FG000|Overall Study|Lost to Follow-up|2|||
125911315|NCT04587271|452975044|FG001|Overall Study|Lost to Follow-up|2|||
125911316|NCT04587271|452975045|FG002|Overall Study|Lost to Follow-up|0|||
125911317|NCT04587271|452975046|FG003|Overall Study|Lost to Follow-up|2|||
125911318|NCT04587271|452975047|FG004|Overall Study|Lost to Follow-up|2|||
125911319|NCT04587271|452975048|FG005|Overall Study|Lost to Follow-up|0|||
125911320|NCT04587271|452975043|FG000|Overall Study|Caregiver brought child to visits|0|||
125911321|NCT04587271|452975044|FG001|Overall Study|Caregiver brought child to visits|0|||
125911322|NCT04587271|452975045|FG002|Overall Study|Caregiver brought child to visits|0|||
125911323|NCT04587271|452975046|FG003|Overall Study|Caregiver brought child to visits|1|||
125911324|NCT04587271|452975047|FG004|Overall Study|Caregiver brought child to visits|0|||
125911325|NCT04587271|452975048|FG005|Overall Study|Caregiver brought child to visits|0|||
125911326|NCT00777205|452975055|FG000|Overall Study|Lost to Follow-up|25|||
125911327|NCT00777205|452975056|FG001|Overall Study|Lost to Follow-up|9|||
125911328|NCT00777205|452975055|FG000|Overall Study|Withdrawal by Subject|6|||
125911329|NCT00777205|452975056|FG001|Overall Study|Withdrawal by Subject|4|||
125911330|NCT00777205|452975055|FG000|Overall Study|Death|0|||
125911331|NCT00777205|452975056|FG001|Overall Study|Death|2|||
125911332|NCT00777205|452975055|FG000|Overall Study|Protocol Violation|0|||
125911333|NCT00777205|452975056|FG001|Overall Study|Protocol Violation|56|||
125911334|NCT03053271|452975061|FG000|Overall Study|Did not meet randomization criteria|3|||
125911335|NCT03053271|452975061|FG000|Overall Study|Withdrawal by Subject|1|||
125911336|NCT00580970|452975062|FG000|Pre-treatment|Non-compliance|1|||
125911337|NCT00580970|452975062|FG000|Treatment (Lovastatin)|Non-compliance|6|||
125911338|NCT00580970|452975062|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
125911339|NCT00580970|452975062|FG000|Treatment (Lovastatin)|Physician Decision|4|||
125911340|NCT00580970|452975062|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
125911341|NCT00580970|452975062|FG000|Treatment (Lovastatin)|Death|1|||
126061033|NCT00441168|453518058|FG001|Follow-up Period|Lost to Follow-up|6|||
126061034|NCT00441168|453518057|FG000|Follow-up Period|Withdrawal by Subject|3|||
125911342|NCT01086423|452975063|FG000|Overall Study|Protocol Violation|0|||
125911343|NCT01086423|452975064|FG001|Overall Study|Protocol Violation|0|||
125911344|NCT01086423|452975065|FG002|Overall Study|Protocol Violation|1|||
125911345|NCT01086423|452975063|FG000|Overall Study|Migrated/moved from study area|2|||
125911346|NCT01086423|452975064|FG001|Overall Study|Migrated/moved from study area|0|||
125911347|NCT01086423|452975065|FG002|Overall Study|Migrated/moved from study area|4|||
125911348|NCT01086423|452975063|FG000|Overall Study|Adverse event, fatal|1|||
125911349|NCT01086423|452975064|FG001|Overall Study|Adverse event, fatal|1|||
125911350|NCT01086423|452975065|FG002|Overall Study|Adverse event, fatal|0|||
125911351|NCT01086423|452975063|FG000|Overall Study|Adverse event, non-fatal|2|||
126110207|NCT03153111|453697668|FG000|Overall Study|Death|2|||
125911352|NCT01086423|452975064|FG001|Overall Study|Adverse event, non-fatal|1|||
125911353|NCT01086423|452975065|FG002|Overall Study|Adverse event, non-fatal|0|||
126110208|NCT03153111|453697669|FG001|Overall Study|Death|5|||
125911354|NCT01086423|452975063|FG000|Overall Study|Withdrawal by Subject|5|||
125911355|NCT01086423|452975064|FG001|Overall Study|Withdrawal by Subject|1|||
125911356|NCT01086423|452975065|FG002|Overall Study|Withdrawal by Subject|3|||
125911357|NCT01086423|452975063|FG000|Overall Study|Lost to Follow-up|0|||
125911358|NCT01086423|452975064|FG001|Overall Study|Lost to Follow-up|0|||
125911359|NCT01086423|452975065|FG002|Overall Study|Lost to Follow-up|1|||
125911360|NCT04137224|452975067|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
125911361|NCT04137224|452975068|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
125911362|NCT04137224|452975067|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
125911363|NCT04137224|452975068|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
125911364|NCT04137224|452975067|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
125911365|NCT04137224|452975068|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
125911366|NCT01225887|452975069|FG000|Overall Study|Ineligible:required test not done|2|||
125911367|NCT01225887|452975069|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
125911368|NCT01225887|452975069|FG000|Overall Study|Ineligible:inadequate pathology|2|||
125911369|NCT01669928|452975070|FG000|First Intervention|Withdrawal by Subject|3|||
125911370|NCT01669928|452975071|FG001|First Intervention|Withdrawal by Subject|5|||
125911371|NCT00679055|452975074|FG000|Overall Study|Adverse Event|0|||
125911372|NCT00679055|452975075|FG001|Overall Study|Adverse Event|1|||
125911373|NCT00679055|452975074|FG000|Overall Study|Other|0|||
125911374|NCT00679055|452975075|FG001|Overall Study|Other|3|||
125911375|NCT00679055|452975074|FG000|Overall Study|Study Terminated|2|||
125911376|NCT00679055|452975075|FG001|Overall Study|Study Terminated|1|||
125911377|NCT00925990|452975076|FG000|Overall Study|Adverse Event|1|||
125911378|NCT00925990|452975077|FG001|Overall Study|Adverse Event|3|||
125911379|NCT00925990|452975076|FG000|Overall Study|Withdrawal by Subject|2|||
125911380|NCT00925990|452975077|FG001|Overall Study|Withdrawal by Subject|2|||
125911381|NCT00925990|452975076|FG000|Overall Study|Lost to Follow-up|1|||
125911382|NCT00925990|452975077|FG001|Overall Study|Lost to Follow-up|3|||
125911383|NCT00925990|452975076|FG000|Overall Study|Physician Decision|1|||
125911384|NCT00925990|452975077|FG001|Overall Study|Physician Decision|1|||
125911385|NCT00925990|452975076|FG000|Overall Study|moved out of state, missed medication|0|||
125911386|NCT00925990|452975077|FG001|Overall Study|moved out of state, missed medication|2|||
125911387|NCT01912963|452975089|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
125911388|NCT01912963|452975090|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
125911389|NCT01912963|452975091|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
125911390|NCT01912963|452975089|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
125911391|NCT01912963|452975090|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
125911392|NCT01912963|452975091|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
125911393|NCT01912963|452975089|FG000|Overall Study|Adverse Event|0|||
125911394|NCT01912963|452975090|FG001|Overall Study|Adverse Event|1|||
125911395|NCT01912963|452975091|FG002|Overall Study|Adverse Event|1|||
125911396|NCT01912963|452975089|FG000|Overall Study|Withdrawal by Subject|0|||
125911397|NCT01912963|452975090|FG001|Overall Study|Withdrawal by Subject|1|||
125911398|NCT01912963|452975091|FG002|Overall Study|Withdrawal by Subject|0|||
125911399|NCT01912963|452975089|FG000|Overall Study|Sought treatment locally|0|||
125911400|NCT01912963|452975090|FG001|Overall Study|Sought treatment locally|1|||
125911401|NCT01912963|452975091|FG002|Overall Study|Sought treatment locally|0|||
125911402|NCT03112590|452975096|FG000|Overall Study|Adverse Event|0|||
125911403|NCT03112590|452975097|FG001|Overall Study|Adverse Event|1|||
125911404|NCT03112590|452975098|FG002|Overall Study|Adverse Event|0|||
125911405|NCT00843726|452975099|FG000|Overall Study|Death|1|||
125911406|NCT00843726|452975100|FG001|Overall Study|Death|0|||
125911407|NCT00843726|452975099|FG000|Overall Study|Withdrawal by Subject|0|||
125911408|NCT00843726|452975100|FG001|Overall Study|Withdrawal by Subject|1|||
125911409|NCT00406718|452975101|FG000|Overall Study|Withdrawal by Subject|2|||
125911410|NCT00406718|452975102|FG001|Overall Study|Withdrawal by Subject|9|||
125911411|NCT00406718|452975103|FG002|Overall Study|Withdrawal by Subject|4|||
125911412|NCT00406718|452975101|FG000|Overall Study|Lost to Follow-up|2|||
125911413|NCT00406718|452975102|FG001|Overall Study|Lost to Follow-up|5|||
125911414|NCT00406718|452975103|FG002|Overall Study|Lost to Follow-up|4|||
125911415|NCT02898116|452975107|FG000|Overall Study|Adverse Event|1|||
125911416|NCT02898116|452975107|FG000|Overall Study|Progressive disease|1|||
125911417|NCT05597020|452975114|FG000|Washout|Forbidden medication|2|||
125911418|NCT05597020|452975115|FG001|Washout|Forbidden medication|0|||
125911419|NCT05597020|452975114|FG000|Treatment Period II|Advice from primary care physician|1|||
125911420|NCT05597020|452975115|FG001|Treatment Period II|Advice from primary care physician|0|||
125911421|NCT05597020|452975114|FG000|Treatment Period II|Subject lost investigational product|1|||
125911422|NCT05597020|452975115|FG001|Treatment Period II|Subject lost investigational product|0|||
125911423|NCT05597020|452975114|FG000|Treatment Period II|Private reasons|0|||
125911424|NCT05597020|452975115|FG001|Treatment Period II|Private reasons|1|||
125911425|NCT05169567|452975116|FG000|Overall Study|On study treatment|116|||
125911426|NCT05169567|452975117|FG001|Overall Study|On study treatment|128|||
125911427|NCT05169567|452975116|FG000|Overall Study|Lost to Follow-up|1|||
125911428|NCT05169567|452975117|FG001|Overall Study|Lost to Follow-up|0|||
125911429|NCT05169567|452975116|FG000|Overall Study|Withdrawal by Subject|25|||
125911430|NCT05169567|452975117|FG001|Overall Study|Withdrawal by Subject|21|||
125911431|NCT01015131|452975118|FG000|Overall Study|Physician Decision|1|||
125911432|NCT01015131|452975118|FG000|Overall Study|Protocol Violation|1|||
125911433|NCT01015131|452975118|FG000|Overall Study|Withdrawal by Subject|2|||
125911434|NCT01015131|452975118|FG000|Overall Study|Other Protocol Specified Criteria|4|||
125911435|NCT05430022|452975119|FG000|Overall Study|Withdrawal by Subject|4|||
125911436|NCT05430022|452975120|FG001|Overall Study|Withdrawal by Subject|4|||
125911437|NCT02445391|452975129|FG000|Overall Study|No active protocol treatment|3|||
125911438|NCT02445391|452975130|FG001|Overall Study|No active protocol treatment|0|||
125911439|NCT02445391|452975131|FG002|Overall Study|No active protocol treatment|0|||
125911440|NCT02445391|452975129|FG000|Overall Study|Adverse Event|0|||
125911441|NCT02445391|452975130|FG001|Overall Study|Adverse Event|21|||
125911442|NCT02445391|452975131|FG002|Overall Study|Adverse Event|12|||
125911443|NCT02445391|452975129|FG000|Overall Study|Alternative therapy|0|||
125911444|NCT02445391|452975130|FG001|Overall Study|Alternative therapy|0|||
125911445|NCT02445391|452975131|FG002|Overall Study|Alternative therapy|1|||
125911446|NCT02445391|452975129|FG000|Overall Study|Disease progression|0|||
125911447|NCT02445391|452975130|FG001|Overall Study|Disease progression|7|||
125911448|NCT02445391|452975131|FG002|Overall Study|Disease progression|22|||
125911449|NCT02445391|452975129|FG000|Overall Study|Complicating disease|0|||
125911450|NCT02445391|452975130|FG001|Overall Study|Complicating disease|2|||
125911451|NCT02445391|452975131|FG002|Overall Study|Complicating disease|1|||
125911452|NCT02445391|452975129|FG000|Overall Study|Withdrawal by Subject|0|||
125911453|NCT02445391|452975130|FG001|Overall Study|Withdrawal by Subject|4|||
125911454|NCT02445391|452975131|FG002|Overall Study|Withdrawal by Subject|9|||
125911455|NCT02445391|452975129|FG000|Overall Study|Financial issue|0|||
125911456|NCT02445391|452975130|FG001|Overall Study|Financial issue|0|||
125911457|NCT02445391|452975131|FG002|Overall Study|Financial issue|2|||
125911458|NCT02445391|452975129|FG000|Overall Study|Still on treatment|0|||
125911459|NCT02445391|452975130|FG001|Overall Study|Still on treatment|7|||
125911460|NCT02445391|452975131|FG002|Overall Study|Still on treatment|16|||
125911461|NCT02445391|452975129|FG000|Overall Study|Not start protocol therapy|0|||
125911462|NCT02445391|452975130|FG001|Overall Study|Not start protocol therapy|12|||
125911463|NCT02445391|452975131|FG002|Overall Study|Not start protocol therapy|9|||
125911464|NCT05069259|452975135|FG000|Overall Study|Withdrawal by Subject|1|||
125911465|NCT05069259|452975135|FG000|Overall Study|Sponsor decision|1|||
125911466|NCT03148275|452975136|FG000|Overall Study|Death|6|||
125911467|NCT03148275|452975136|FG000|Overall Study|Adverse Event|3|||
125911468|NCT03148275|452975136|FG000|Overall Study|Liver transplant|2|||
125911469|NCT03148275|452975136|FG000|Overall Study|Patient decision|5|||
125911470|NCT03148275|452975136|FG000|Overall Study|transition to commercial drug|1|||
125911471|NCT03148275|452975136|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
125911472|NCT00891462|452976707|FG000|Overall Study|Withdrawal by Subject|9|||
125911473|NCT00891462|452976708|FG001|Overall Study|Withdrawal by Subject|6|||
125911474|NCT00891462|452976709|FG002|Overall Study|Withdrawal by Subject|7|||
125911475|NCT00891462|452976707|FG000|Overall Study|Adverse Event|7|||
125911476|NCT00891462|452976708|FG001|Overall Study|Adverse Event|8|||
125911477|NCT00891462|452976709|FG002|Overall Study|Adverse Event|7|||
125911478|NCT00891462|452976707|FG000|Overall Study|Lack of Efficacy|10|||
126061035|NCT00441168|453518058|FG001|Follow-up Period|Withdrawal by Subject|0|||
125911479|NCT00891462|452976708|FG001|Overall Study|Lack of Efficacy|5|||
125911480|NCT00891462|452976709|FG002|Overall Study|Lack of Efficacy|1|||
125911481|NCT00891462|452976707|FG000|Overall Study|COPD exacerbation|7|||
125911482|NCT00891462|452976708|FG001|Overall Study|COPD exacerbation|4|||
125911483|NCT00891462|452976709|FG002|Overall Study|COPD exacerbation|1|||
125911484|NCT00891462|452976707|FG000|Overall Study|Other Reason|2|||
125911485|NCT00891462|452976708|FG001|Overall Study|Other Reason|5|||
125911486|NCT00891462|452976709|FG002|Overall Study|Other Reason|3|||
125911487|NCT00891462|452976707|FG000|Overall Study|Protocol Violation|2|||
125911488|NCT00891462|452976708|FG001|Overall Study|Protocol Violation|1|||
125911489|NCT00891462|452976709|FG002|Overall Study|Protocol Violation|3|||
125911490|NCT00891462|452976707|FG000|Overall Study|Inclusion/exclusion criteria|0|||
125911491|NCT00891462|452976708|FG001|Overall Study|Inclusion/exclusion criteria|2|||
125911492|NCT00891462|452976709|FG002|Overall Study|Inclusion/exclusion criteria|2|||
125911493|NCT00891462|452976707|FG000|Overall Study|Lost to Follow-up|0|||
125911494|NCT00891462|452976708|FG001|Overall Study|Lost to Follow-up|2|||
125911495|NCT00891462|452976709|FG002|Overall Study|Lost to Follow-up|0|||
125911496|NCT01897714|452976713|FG000|Phase I (Dose Escalation)|Disease progression|3|||
125911497|NCT01897714|452976714|FG001|Phase I (Dose Escalation)|Disease progression|5|||
125911498|NCT01897714|452976715|FG002|Phase I (Dose Escalation)|Disease progression|1|||
125911499|NCT01897714|452976716|FG003|Phase I (Dose Escalation)|Disease progression|3|||
125911500|NCT01897714|452976717|FG004|Phase I (Dose Escalation)|Disease progression|0|||
125911501|NCT01897714|452976718|FG005|Phase I (Dose Escalation)|Disease progression|0|||
125911502|NCT01897714|452976713|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
125911503|NCT01897714|452976714|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
125911504|NCT01897714|452976715|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
125911505|NCT01897714|452976716|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
125911506|NCT01897714|452976717|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
125911507|NCT01897714|452976718|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
125911508|NCT01897714|452976713|FG000|Phase I (Dose Escalation)|Other|0|||
125911509|NCT01897714|452976714|FG001|Phase I (Dose Escalation)|Other|1|||
125911510|NCT01897714|452976715|FG002|Phase I (Dose Escalation)|Other|0|||
125911511|NCT01897714|452976716|FG003|Phase I (Dose Escalation)|Other|0|||
125911512|NCT01897714|452976717|FG004|Phase I (Dose Escalation)|Other|0|||
125911513|NCT01897714|452976718|FG005|Phase I (Dose Escalation)|Other|0|||
125911514|NCT01897714|452976713|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
125911515|NCT01897714|452976714|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
125911516|NCT01897714|452976715|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
125911517|NCT01897714|452976716|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
125911518|NCT01897714|452976717|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
125911519|NCT01897714|452976718|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
125911520|NCT01897714|452976713|FG000|Phase II (MTD)|Lost to Follow-up|0|||
125911521|NCT01897714|452976714|FG001|Phase II (MTD)|Lost to Follow-up|0|||
125911522|NCT01897714|452976715|FG002|Phase II (MTD)|Lost to Follow-up|0|||
125911523|NCT01897714|452976716|FG003|Phase II (MTD)|Lost to Follow-up|0|||
125911524|NCT01897714|452976717|FG004|Phase II (MTD)|Lost to Follow-up|1|||
125911525|NCT01897714|452976718|FG005|Phase II (MTD)|Lost to Follow-up|0|||
125911526|NCT01897714|452976713|FG000|Phase II (MTD)|Death|0|||
125911527|NCT01897714|452976714|FG001|Phase II (MTD)|Death|0|||
125911528|NCT01897714|452976715|FG002|Phase II (MTD)|Death|0|||
125911529|NCT01897714|452976716|FG003|Phase II (MTD)|Death|0|||
125911530|NCT01897714|452976717|FG004|Phase II (MTD)|Death|25|||
125911531|NCT01897714|452976718|FG005|Phase II (MTD)|Death|10|||
125911532|NCT01897714|452976713|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
125911533|NCT01897714|452976714|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
125911534|NCT01897714|452976715|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
125911535|NCT01897714|452976716|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
125911536|NCT01897714|452976717|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
125911537|NCT01897714|452976718|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
125911538|NCT01897714|452976713|FG000|Phase II (MTD)|Other|0|||
125911539|NCT01897714|452976714|FG001|Phase II (MTD)|Other|0|||
125911540|NCT01897714|452976715|FG002|Phase II (MTD)|Other|0|||
125911541|NCT01897714|452976716|FG003|Phase II (MTD)|Other|0|||
125911542|NCT01897714|452976717|FG004|Phase II (MTD)|Other|3|||
125911543|NCT01897714|452976718|FG005|Phase II (MTD)|Other|0|||
125911544|NCT01507298|452976725|FG000|Overall Study|Protocol Violation|0|||
125911545|NCT01507298|452976726|FG001|Overall Study|Protocol Violation|6|||
125911546|NCT00537238|452976727|FG000|Overall Study|Death|1|||
125911547|NCT00537238|452976728|FG001|Overall Study|Death|2|||
125911548|NCT00537238|452976727|FG000|Overall Study|Adverse Event|31|||
125911549|NCT00537238|452976728|FG001|Overall Study|Adverse Event|22|||
125911550|NCT00537238|452976727|FG000|Overall Study|Lack of Efficacy|20|||
125911551|NCT00537238|452976728|FG001|Overall Study|Lack of Efficacy|21|||
125911552|NCT00537238|452976727|FG000|Overall Study|Lost to Follow-up|12|||
125911553|NCT00537238|452976728|FG001|Overall Study|Lost to Follow-up|8|||
125911554|NCT00537238|452976727|FG000|Overall Study|Withdrawal by Subject|51|||
125911555|NCT00537238|452976728|FG001|Overall Study|Withdrawal by Subject|47|||
125911556|NCT00537238|452976727|FG000|Overall Study|Protocol Violation|15|||
125911557|NCT00537238|452976728|FG001|Overall Study|Protocol Violation|19|||
125911558|NCT00537238|452976727|FG000|Overall Study|Does not meet entrance criteria|0|||
125911559|NCT00537238|452976728|FG001|Overall Study|Does not meet entrance criteria|2|||
125911560|NCT00537238|452976727|FG000|Overall Study|Other|44|||
125911561|NCT00537238|452976728|FG001|Overall Study|Other|52|||
125911562|NCT01920555|452976729|FG000|Overall Study|Physician Decision|1|||
125911563|NCT01920555|452976730|FG001|Overall Study|Physician Decision|2|||
125911564|NCT01920555|452976731|FG002|Overall Study|Physician Decision|1|||
125911565|NCT01920555|452976732|FG003|Overall Study|Physician Decision|2|||
125911566|NCT01920555|452976733|FG004|Overall Study|Physician Decision|0|||
125911567|NCT01920555|452976729|FG000|Overall Study|Lack of Efficacy|2|||
125911568|NCT01920555|452976730|FG001|Overall Study|Lack of Efficacy|0|||
125911569|NCT01920555|452976731|FG002|Overall Study|Lack of Efficacy|0|||
125911570|NCT01920555|452976732|FG003|Overall Study|Lack of Efficacy|0|||
125911571|NCT01920555|452976733|FG004|Overall Study|Lack of Efficacy|0|||
125911572|NCT01920555|452976729|FG000|Overall Study|Travel Difficulties|1|||
125911573|NCT01920555|452976730|FG001|Overall Study|Travel Difficulties|1|||
125911574|NCT01920555|452976731|FG002|Overall Study|Travel Difficulties|0|||
125911575|NCT01920555|452976732|FG003|Overall Study|Travel Difficulties|0|||
125911576|NCT01920555|452976733|FG004|Overall Study|Travel Difficulties|1|||
125911577|NCT01920555|452976729|FG000|Overall Study|Lost to Follow-up|0|||
126061036|NCT00441168|453518057|FG000|Follow-up Period|Other|1|||
126061037|NCT00441168|453518058|FG001|Follow-up Period|Other|3|||
126061038|NCT03909100|453518059|FG000|Overall Study|Protocol Deviation|2|||
126061039|NCT03909100|453518059|FG000|Overall Study|Technical Problems|4|||
126061040|NCT03909100|453518059|FG000|Overall Study|Withdrawal by Subject|4|||
126061041|NCT03909100|453518059|FG000|Overall Study|Lost to Follow-up|1|||
126061042|NCT03909100|453518059|FG000|Overall Study|Reason not Specified|4|||
126061043|NCT00807599|453518062|FG000|Overall Study|Not treated on protocol study|0|||
126061044|NCT00807599|453518063|FG001|Overall Study|Not treated on protocol study|0|||
126061045|NCT00807599|453518064|FG002|Overall Study|Not treated on protocol study|2|||
126061046|NCT00807599|453518062|FG000|Overall Study|Adverse Event|0|||
126061047|NCT00807599|453518063|FG001|Overall Study|Adverse Event|0|||
126061048|NCT00807599|453518064|FG002|Overall Study|Adverse Event|5|||
126061049|NCT00807599|453518062|FG000|Overall Study|Inadequate response to induction|0|||
126061050|NCT00807599|453518063|FG001|Overall Study|Inadequate response to induction|0|||
126061051|NCT00807599|453518064|FG002|Overall Study|Inadequate response to induction|9|||
126061052|NCT00807599|453518062|FG000|Overall Study|Withdrawal by Subject|0|||
126061053|NCT00807599|453518063|FG001|Overall Study|Withdrawal by Subject|0|||
126061054|NCT00807599|453518064|FG002|Overall Study|Withdrawal by Subject|1|||
126061055|NCT00795639|453518068|FG000|Overall Study|Death|1|||
126061056|NCT00795639|453518069|FG001|Overall Study|Death|6|||
126061057|NCT00795639|453518068|FG000|Overall Study|Withdrawal by Subject|1|||
126061058|NCT00795639|453518069|FG001|Overall Study|Withdrawal by Subject|3|||
126061059|NCT00795639|453518068|FG000|Overall Study|Pregnancy|1|||
126061060|NCT00795639|453518069|FG001|Overall Study|Pregnancy|0|||
126061061|NCT00795639|453518068|FG000|Overall Study|Adverse Event|5|||
126061062|NCT00795639|453518069|FG001|Overall Study|Adverse Event|2|||
126061063|NCT00795639|453518068|FG000|Overall Study|Other|0|||
126061064|NCT00795639|453518069|FG001|Overall Study|Other|2|||
126061065|NCT00795639|453518068|FG000|Overall Study|Terminated by sponsor|13|||
126061066|NCT00795639|453518069|FG001|Overall Study|Terminated by sponsor|12|||
126061067|NCT00795639|453518068|FG000|Overall Study|Randomized and not treated|0|||
126061068|NCT00795639|453518069|FG001|Overall Study|Randomized and not treated|1|||
126061069|NCT03349476|453518070|FG000|Overall Study|Physician Decision|3|||
126061070|NCT02525744|453518071|FG000|Period 1|Physician Decision|0|||
126061071|NCT02525744|453518072|FG001|Period 1|Physician Decision|0|||
126061072|NCT02525744|453518073|FG002|Period 1|Physician Decision|1|||
126061073|NCT02525744|453518074|FG003|Period 1|Physician Decision|0|||
126061074|NCT02525744|453518071|FG000|Period 3|Adverse Event|0|||
126061075|NCT02525744|453518072|FG001|Period 3|Adverse Event|1|||
126061076|NCT02525744|453518073|FG002|Period 3|Adverse Event|0|||
126061077|NCT02525744|453518074|FG003|Period 3|Adverse Event|0|||
126061078|NCT02525744|453518071|FG000|Period 4|Withdrawal by Subject|1|||
126061079|NCT02525744|453518072|FG001|Period 4|Withdrawal by Subject|0|||
126061080|NCT02525744|453518073|FG002|Period 4|Withdrawal by Subject|0|||
126061081|NCT02525744|453518074|FG003|Period 4|Withdrawal by Subject|0|||
126061082|NCT02525744|453518071|FG000|Period 5|Physician Decision|1|||
126061083|NCT02525744|453518072|FG001|Period 5|Physician Decision|0|||
126061084|NCT02525744|453518073|FG002|Period 5|Physician Decision|0|||
126061085|NCT02525744|453518074|FG003|Period 5|Physician Decision|0|||
126061086|NCT04421456|453518081|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
126061087|NCT04421456|453518082|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
126061088|NCT04421456|453518083|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
125911578|NCT01920555|452976730|FG001|Overall Study|Lost to Follow-up|1|||
125911579|NCT01920555|452976731|FG002|Overall Study|Lost to Follow-up|0|||
125911580|NCT01920555|452976732|FG003|Overall Study|Lost to Follow-up|1|||
125911581|NCT01920555|452976733|FG004|Overall Study|Lost to Follow-up|0|||
125911582|NCT00697073|452976734|FG000|Overall Study|Withdrawal by Subject|2|||
125911583|NCT00697073|452976734|FG000|Overall Study|Pregnancy|1|||
125911584|NCT00697073|452976734|FG000|Overall Study|non compliance and other|6|||
126110209|NCT03153111|453697668|FG000|Overall Study|Lost to Follow-up|1|||
125911585|NCT03265665|452976737|FG000|24-week Data Collection|Withdrawal by Subject|2|||
125911586|NCT03265665|452976738|FG001|24-week Data Collection|Withdrawal by Subject|2|||
125911587|NCT03265665|452976737|FG000|24-week Data Collection|Lost to Follow-up|4|||
125911588|NCT03265665|452976738|FG001|24-week Data Collection|Lost to Follow-up|5|||
125911589|NCT03265665|452976737|FG000|36-week Data Collection|Lost to Follow-up|6|||
125911590|NCT03265665|452976738|FG001|36-week Data Collection|Lost to Follow-up|8|||
125911591|NCT01614600|452976739|FG000|Overall Study|Unacceptable fit|1|||
125911592|NCT01614600|452976739|FG000|Overall Study|Discomfort|1|||
125911593|NCT01614600|452976739|FG000|Overall Study|Unable to remove lens at the end of day|1|||
125911594|NCT01614600|452976739|FG000|Overall Study|Protocol deviation|1|||
125911595|NCT01193660|452976740|FG000|Overall Study|Withdrawal by Subject|2|||
125911596|NCT01193660|452976741|FG001|Overall Study|Withdrawal by Subject|3|||
125911597|NCT01193660|452976742|FG002|Overall Study|Withdrawal by Subject|1|||
125911598|NCT01193660|452976740|FG000|Overall Study|Death|1|||
125911599|NCT01193660|452976741|FG001|Overall Study|Death|0|||
125911600|NCT01193660|452976742|FG002|Overall Study|Death|0|||
125911601|NCT01193660|452976740|FG000|Overall Study|Physician Decision|1|||
125911602|NCT01193660|452976741|FG001|Overall Study|Physician Decision|0|||
125911603|NCT01193660|452976742|FG002|Overall Study|Physician Decision|1|||
125911604|NCT03347188|452976743|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
125911605|NCT03347188|452976744|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
125911606|NCT03347188|452976743|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
125911607|NCT03347188|452976744|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
125911608|NCT03347188|452976743|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
125911609|NCT03347188|452976744|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
125911610|NCT03347188|452976743|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
125911611|NCT03347188|452976744|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
125911612|NCT03347188|452976743|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
125911613|NCT03347188|452976744|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
125911614|NCT03347188|452976743|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
125911615|NCT03347188|452976744|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
125911616|NCT03347188|452976743|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
125911617|NCT03347188|452976744|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
125911618|NCT03347188|452976743|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
125911619|NCT03347188|452976744|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
125911620|NCT02572388|452976747|FG000|Overall Study|Withdrawal by Subject|1|||
125911621|NCT02572388|452976748|FG001|Overall Study|Withdrawal by Subject|1|||
125911622|NCT02572388|452976749|FG002|Overall Study|Withdrawal by Subject|2|||
125911623|NCT02572388|452976750|FG003|Overall Study|Withdrawal by Subject|2|||
125911624|NCT00810108|452976753|FG000|Overall Study|Withdrawal by Subject|1|||
125911625|NCT00810108|452976754|FG001|Overall Study|Withdrawal by Subject|0|||
125911626|NCT02231918|452976755|FG000|Overall Study|Withdrawal by Subject|0|||
125911627|NCT02231918|452976756|FG001|Overall Study|Withdrawal by Subject|1|||
125911628|NCT02231918|452976757|FG002|Overall Study|Withdrawal by Subject|0|||
125911629|NCT02231918|452976755|FG000|Overall Study|Adverse Event|0|||
125911630|NCT02231918|452976756|FG001|Overall Study|Adverse Event|0|||
125911631|NCT02231918|452976757|FG002|Overall Study|Adverse Event|1|||
125911632|NCT00331864|452976763|FG000|Overall Study|Adverse Event|30|||
125911633|NCT00331864|452976764|FG001|Overall Study|Adverse Event|1|||
125911634|NCT00331864|452976763|FG000|Overall Study|Lack of Efficacy|4|||
125911635|NCT00331864|452976764|FG001|Overall Study|Lack of Efficacy|0|||
125911636|NCT00331864|452976763|FG000|Overall Study|Protocol Violation|3|||
125911637|NCT00331864|452976764|FG001|Overall Study|Protocol Violation|0|||
125911638|NCT00331864|452976763|FG000|Overall Study|Withdrawal by Subject|10|||
125911639|NCT00331864|452976764|FG001|Overall Study|Withdrawal by Subject|0|||
125911640|NCT00331864|452976763|FG000|Overall Study|Lost to Follow-up|4|||
125911641|NCT00331864|452976764|FG001|Overall Study|Lost to Follow-up|3|||
125911642|NCT00331864|452976763|FG000|Overall Study|Administrative Problems|1|||
125911643|NCT00331864|452976764|FG001|Overall Study|Administrative Problems|0|||
125911644|NCT00331864|452976763|FG000|Overall Study|Death|6|||
125911645|NCT00331864|452976764|FG001|Overall Study|Death|0|||
125911646|NCT01092507|452976765|FG000|Overall Study|Withdrawal by Subject|2|||
125911647|NCT01092507|452976766|FG001|Overall Study|Withdrawal by Subject|0|||
125911648|NCT01539642|452976767|FG000|Overall Study|Lack of Efficacy|20|||
125911649|NCT01539642|452976768|FG001|Overall Study|Lack of Efficacy|18|||
125911650|NCT01539642|452976767|FG000|Overall Study|Patient ready for early discharge|8|||
125911651|NCT01539642|452976768|FG001|Overall Study|Patient ready for early discharge|7|||
125911652|NCT01539642|452976767|FG000|Overall Study|Adverse Event|6|||
125911653|NCT01539642|452976768|FG001|Overall Study|Adverse Event|4|||
125911654|NCT01539642|452976767|FG000|Overall Study|Withdrawal by Subject|2|||
125911655|NCT01539642|452976768|FG001|Overall Study|Withdrawal by Subject|2|||
125911656|NCT03611010|452976769|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
125911657|NCT03611010|452976770|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
125911658|NCT03611010|452976771|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
125911659|NCT03611010|452976772|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
125911660|NCT00598702|452976773|FG000|Overall Study|Other|0|||
125911661|NCT00598702|452976774|FG001|Overall Study|Other|2|||
125911662|NCT00598702|452976775|FG002|Overall Study|Other|0|||
125911663|NCT00598702|452976776|FG003|Overall Study|Other|0|||
125911664|NCT00598702|452976777|FG004|Overall Study|Other|0|||
125911665|NCT00598702|452976778|FG005|Overall Study|Other|1|||
125911666|NCT00598702|452976779|FG006|Overall Study|Other|0|||
125911667|NCT00598702|452976780|FG007|Overall Study|Other|0|||
125911668|NCT00598702|452976773|FG000|Overall Study|Early discharge from hospital|0|||
125911669|NCT00598702|452976774|FG001|Overall Study|Early discharge from hospital|0|||
125911670|NCT00598702|452976775|FG002|Overall Study|Early discharge from hospital|2|||
125911671|NCT00598702|452976776|FG003|Overall Study|Early discharge from hospital|5|||
125911672|NCT00598702|452976777|FG004|Overall Study|Early discharge from hospital|0|||
125911673|NCT00598702|452976778|FG005|Overall Study|Early discharge from hospital|10|||
125911674|NCT00598702|452976779|FG006|Overall Study|Early discharge from hospital|1|||
125911675|NCT00598702|452976780|FG007|Overall Study|Early discharge from hospital|0|||
125911676|NCT00598702|452976773|FG000|Overall Study|Adverse Event|0|||
125911677|NCT00598702|452976774|FG001|Overall Study|Adverse Event|0|||
125911678|NCT00598702|452976775|FG002|Overall Study|Adverse Event|0|||
125911679|NCT00598702|452976776|FG003|Overall Study|Adverse Event|1|||
125911680|NCT00598702|452976777|FG004|Overall Study|Adverse Event|0|||
125911681|NCT00598702|452976778|FG005|Overall Study|Adverse Event|0|||
125911682|NCT00598702|452976779|FG006|Overall Study|Adverse Event|0|||
125911683|NCT00598702|452976780|FG007|Overall Study|Adverse Event|0|||
125911684|NCT00598702|452976773|FG000|Overall Study|Withdrawal by Subject|0|||
125911685|NCT00598702|452976774|FG001|Overall Study|Withdrawal by Subject|0|||
125911686|NCT00598702|452976775|FG002|Overall Study|Withdrawal by Subject|0|||
125911687|NCT00598702|452976776|FG003|Overall Study|Withdrawal by Subject|1|||
125911688|NCT00598702|452976777|FG004|Overall Study|Withdrawal by Subject|1|||
125911689|NCT00598702|452976778|FG005|Overall Study|Withdrawal by Subject|0|||
125911690|NCT00598702|452976779|FG006|Overall Study|Withdrawal by Subject|0|||
125911691|NCT00598702|452976780|FG007|Overall Study|Withdrawal by Subject|0|||
125911692|NCT00598702|452976773|FG000|Overall Study|Physician Decision|0|||
126061089|NCT04421456|453518081|FG000|Randomized Treatment Period|Adverse Event|0|||
126061090|NCT04421456|453518082|FG001|Randomized Treatment Period|Adverse Event|1|||
126061091|NCT04421456|453518083|FG002|Randomized Treatment Period|Adverse Event|0|||
126061092|NCT04421456|453518081|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
126061093|NCT04421456|453518082|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
126061094|NCT04421456|453518083|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
126061095|NCT04421456|453518081|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
126061096|NCT04421456|453518082|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
126061097|NCT04421456|453518083|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
126061098|NCT04421456|453518081|FG000|Randomized Treatment Period|Participant non-compliance|1|||
126061099|NCT04421456|453518082|FG001|Randomized Treatment Period|Participant non-compliance|1|||
126061100|NCT04421456|453518083|FG002|Randomized Treatment Period|Participant non-compliance|2|||
126061101|NCT04421456|453518081|FG000|Randomized Treatment Period|Other|0|||
126061102|NCT04421456|453518082|FG001|Randomized Treatment Period|Other|1|||
126061103|NCT04421456|453518083|FG002|Randomized Treatment Period|Other|3|||
126061104|NCT00274287|453518084|FG000|Overall Study|Withdrawal by Subject|1|||
126061105|NCT00274287|453518084|FG000|Overall Study|subject non-compliance|1|||
126061106|NCT01777932|453518087|FG000|Overall Study|Disease progression|136|||
126061107|NCT01777932|453518087|FG000|Overall Study|Death|3|||
126061108|NCT01777932|453518087|FG000|Overall Study|Adverse Event|34|||
126061109|NCT01777932|453518087|FG000|Overall Study|Lost to Follow-up|3|||
126061110|NCT01777932|453518087|FG000|Overall Study|Investigator decision|10|||
126061111|NCT01777932|453518087|FG000|Overall Study|Reimbursement limit|9|||
126061112|NCT01777932|453518087|FG000|Overall Study|Patient refused further treatment|10|||
126061113|NCT03031782|453518095|FG000|Treatment Period 1|Lack of Efficacy|3|||
125911693|NCT00598702|452976774|FG001|Overall Study|Physician Decision|0|||
125911694|NCT00598702|452976775|FG002|Overall Study|Physician Decision|0|||
125911695|NCT00598702|452976776|FG003|Overall Study|Physician Decision|0|||
125911696|NCT00598702|452976777|FG004|Overall Study|Physician Decision|1|||
125911697|NCT00598702|452976778|FG005|Overall Study|Physician Decision|0|||
125911698|NCT00598702|452976779|FG006|Overall Study|Physician Decision|0|||
125911699|NCT00598702|452976780|FG007|Overall Study|Physician Decision|0|||
125911700|NCT00598702|452976773|FG000|Overall Study|Dose limiting toxicity|0|||
125911701|NCT00598702|452976774|FG001|Overall Study|Dose limiting toxicity|0|||
125911702|NCT00598702|452976775|FG002|Overall Study|Dose limiting toxicity|0|||
125911703|NCT00598702|452976776|FG003|Overall Study|Dose limiting toxicity|1|||
125911704|NCT00598702|452976777|FG004|Overall Study|Dose limiting toxicity|1|||
125911705|NCT00598702|452976778|FG005|Overall Study|Dose limiting toxicity|1|||
125911706|NCT00598702|452976779|FG006|Overall Study|Dose limiting toxicity|0|||
125911707|NCT00598702|452976780|FG007|Overall Study|Dose limiting toxicity|0|||
125911708|NCT01859143|452976783|FG000|Overall Study|Lost to Follow-up|2|||
125911709|NCT01859143|452976784|FG001|Overall Study|Lost to Follow-up|0|||
125911710|NCT02413372|452976788|FG000|Treatment|Lost to Follow-up|0|||
125911711|NCT02413372|452976789|FG001|Treatment|Lost to Follow-up|2|||
125911712|NCT02413372|452976790|FG002|Treatment|Lost to Follow-up|1|||
125911713|NCT02413372|452976788|FG000|Treatment|Withdrawal by Subject|1|||
125911714|NCT02413372|452976789|FG001|Treatment|Withdrawal by Subject|0|||
125911715|NCT02413372|452976790|FG002|Treatment|Withdrawal by Subject|0|||
125911716|NCT02413372|452976788|FG000|Follow-up|Lost to Follow-up|1|||
125911717|NCT02413372|452976789|FG001|Follow-up|Lost to Follow-up|1|||
125911718|NCT02413372|452976790|FG002|Follow-up|Lost to Follow-up|0|||
126061114|NCT03031782|453518096|FG001|Treatment Period 1|Lack of Efficacy|0|||
126061115|NCT03031782|453518097|FG002|Treatment Period 1|Lack of Efficacy|0|||
126061116|NCT03031782|453518098|FG003|Treatment Period 1|Lack of Efficacy|0|||
126061117|NCT03031782|453518099|FG004|Treatment Period 1|Lack of Efficacy|0|||
126061118|NCT03031782|453518095|FG000|Treatment Period 2|Physician Decision|0|||
126061119|NCT03031782|453518096|FG001|Treatment Period 2|Physician Decision|1|||
126061120|NCT03031782|453518097|FG002|Treatment Period 2|Physician Decision|0|||
126061121|NCT03031782|453518098|FG003|Treatment Period 2|Physician Decision|0|||
126061122|NCT03031782|453518099|FG004|Treatment Period 2|Physician Decision|3|||
125911719|NCT02413372|452976788|FG000|Follow-up|Subject Withdrew Consent|1|||
125911720|NCT02413372|452976789|FG001|Follow-up|Subject Withdrew Consent|0|||
126061123|NCT03031782|453518095|FG000|Treatment Period 2|Lack of Efficacy|0|||
126061124|NCT03031782|453518096|FG001|Treatment Period 2|Lack of Efficacy|1|||
126061125|NCT03031782|453518097|FG002|Treatment Period 2|Lack of Efficacy|0|||
126061126|NCT03031782|453518098|FG003|Treatment Period 2|Lack of Efficacy|0|||
126061127|NCT03031782|453518099|FG004|Treatment Period 2|Lack of Efficacy|1|||
126061128|NCT03031782|453518095|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125911721|NCT02413372|452976790|FG002|Follow-up|Subject Withdrew Consent|1|||
125911722|NCT02413372|452976788|FG000|Follow-up|Subject unable to return for visit|0|||
125911723|NCT02413372|452976789|FG001|Follow-up|Subject unable to return for visit|0|||
125911724|NCT02413372|452976790|FG002|Follow-up|Subject unable to return for visit|1|||
125911725|NCT02943460|452976791|FG000|Blinded Study Phase|Adverse Event|3|||
125911726|NCT02943460|452976792|FG001|Blinded Study Phase|Adverse Event|0|||
125911727|NCT02943460|452976793|FG002|Blinded Study Phase|Adverse Event|0|||
125911728|NCT02943460|452976791|FG000|Blinded Study Phase|Withdrew Consent|0|||
125911729|NCT02943460|452976792|FG001|Blinded Study Phase|Withdrew Consent|1|||
125911730|NCT02943460|452976793|FG002|Blinded Study Phase|Withdrew Consent|0|||
125911731|NCT02943460|452976791|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
125911732|NCT02943460|452976792|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
125911733|NCT02943460|452976793|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
125911734|NCT02943460|452976791|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
125911735|NCT02943460|452976792|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
125911736|NCT02943460|452976793|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
125911737|NCT02943460|452976791|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
125911738|NCT02943460|452976792|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
125911739|NCT02943460|452976793|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
125911740|NCT01925274|452976794|FG000|Overall Study|Death|1|||
125911741|NCT01925274|452976795|FG001|Overall Study|Death|0|||
125911742|NCT01925274|452976796|FG002|Overall Study|Death|0|||
125911743|NCT01925274|452976794|FG000|Overall Study|Lost to Follow-up|0|||
125911744|NCT01925274|452976795|FG001|Overall Study|Lost to Follow-up|1|||
125911745|NCT01925274|452976796|FG002|Overall Study|Lost to Follow-up|0|||
125911746|NCT01925274|452976794|FG000|Overall Study|Withdrawal by Subject|1|||
125911747|NCT01925274|452976795|FG001|Overall Study|Withdrawal by Subject|2|||
125911748|NCT01925274|452976796|FG002|Overall Study|Withdrawal by Subject|0|||
126061129|NCT03031782|453518096|FG001|Treatment Period 2|Withdrawal by Subject|3|||
126061130|NCT03031782|453518097|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126061131|NCT03031782|453518098|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126061132|NCT03031782|453518099|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126061133|NCT03031782|453518095|FG000|Treatment Period 2|Adverse Event|0|||
126061134|NCT03031782|453518096|FG001|Treatment Period 2|Adverse Event|1|||
126061135|NCT03031782|453518097|FG002|Treatment Period 2|Adverse Event|2|||
126061136|NCT03031782|453518098|FG003|Treatment Period 2|Adverse Event|0|||
126061137|NCT03031782|453518099|FG004|Treatment Period 2|Adverse Event|0|||
126061138|NCT03031782|453518095|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126061139|NCT03031782|453518096|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126061140|NCT03031782|453518097|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126061141|NCT03031782|453518098|FG003|Treatment Period 3|Withdrawal by Subject|1|||
126061142|NCT03031782|453518099|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126061143|NCT01930188|453518100|FG000|Overall Study|unclassified|4|||
125911749|NCT01925274|452976794|FG000|Overall Study|Study terminated by sponsor|4|||
125911750|NCT01925274|452976795|FG001|Overall Study|Study terminated by sponsor|0|||
125911751|NCT01925274|452976796|FG002|Overall Study|Study terminated by sponsor|0|||
125911752|NCT01925274|452976794|FG000|Overall Study|Protocol amendment|1|||
125911753|NCT01925274|452976795|FG001|Overall Study|Protocol amendment|3|||
126061144|NCT01930188|453518101|FG001|Overall Study|unclassified|5|||
126061145|NCT01930188|453518102|FG002|Overall Study|unclassified|3|||
126061146|NCT01930188|453518100|FG000|Overall Study|Missing follow-up information|2|||
126061147|NCT01930188|453518101|FG001|Overall Study|Missing follow-up information|2|||
126061148|NCT01930188|453518102|FG002|Overall Study|Missing follow-up information|3|||
125911754|NCT01925274|452976796|FG002|Overall Study|Protocol amendment|6|||
125911755|NCT01031381|452976799|FG000|Overall Study|Physician Decision|3|||
125911756|NCT01031381|452976799|FG000|Overall Study|Withdrawal by Subject|6|||
125911757|NCT00723398|452976800|FG000|Overall Study|Withdrawal by Subject|2|||
125911758|NCT00723398|452976801|FG001|Overall Study|Withdrawal by Subject|6|||
125911759|NCT00723398|452976802|FG002|Overall Study|Withdrawal by Subject|4|||
126061149|NCT01930188|453518100|FG000|Overall Study|Lost to Follow-up|5|||
126061150|NCT01930188|453518101|FG001|Overall Study|Lost to Follow-up|2|||
126061151|NCT01930188|453518102|FG002|Overall Study|Lost to Follow-up|2|||
126061152|NCT01930188|453518100|FG000|Overall Study|Death|2|||
126061153|NCT01930188|453518101|FG001|Overall Study|Death|1|||
126061154|NCT01930188|453518102|FG002|Overall Study|Death|3|||
126061155|NCT01930188|453518100|FG000|Overall Study|Withdrawal by Subject|9|||
126061156|NCT01930188|453518101|FG001|Overall Study|Withdrawal by Subject|11|||
126061157|NCT01930188|453518102|FG002|Overall Study|Withdrawal by Subject|8|||
126061158|NCT02514824|453518103|FG000|Overall Study|Withdrawal by Subject|1|||
126061159|NCT02514824|453518104|FG001|Overall Study|Withdrawal by Subject|0|||
126061160|NCT02514824|453518105|FG002|Overall Study|Withdrawal by Subject|0|||
126061161|NCT02514824|453518106|FG003|Overall Study|Withdrawal by Subject|0|||
126061162|NCT02514824|453518103|FG000|Overall Study|Dose-Limiting Toxicity|0|||
126061163|NCT02514824|453518104|FG001|Overall Study|Dose-Limiting Toxicity|1|||
126061164|NCT02514824|453518105|FG002|Overall Study|Dose-Limiting Toxicity|0|||
126061165|NCT02514824|453518106|FG003|Overall Study|Dose-Limiting Toxicity|0|||
126061166|NCT02170207|453518109|FG000|Overall Study|Case report forms unavailable|5|||
126061167|NCT00886834|453518110|FG000|Overall Study|Protocol Violation|0|||
126061168|NCT00886834|453518111|FG001|Overall Study|Protocol Violation|3|||
126061169|NCT03122860|453518112|FG000|Overall Study|Discontinued Before Treatment|1|||
126061170|NCT03122860|453518113|FG001|Overall Study|Discontinued Before Treatment|1|||
126061171|NCT03122860|453518114|FG002|Overall Study|Discontinued Before Treatment|2|||
126061172|NCT03122860|453518115|FG003|Overall Study|Discontinued Before Treatment|0|||
126061173|NCT03122860|453518116|FG004|Overall Study|Discontinued Before Treatment|1|||
126061174|NCT03122860|453518117|FG005|Overall Study|Discontinued Before Treatment|0|||
126061175|NCT03122860|453518112|FG000|Overall Study|Adverse Event|1|||
126061176|NCT03122860|453518113|FG001|Overall Study|Adverse Event|0|||
126061177|NCT03122860|453518114|FG002|Overall Study|Adverse Event|1|||
126061178|NCT03122860|453518115|FG003|Overall Study|Adverse Event|1|||
126061179|NCT03122860|453518116|FG004|Overall Study|Adverse Event|0|||
126061180|NCT03122860|453518117|FG005|Overall Study|Adverse Event|0|||
126061181|NCT03122860|453518112|FG000|Overall Study|Lost to Follow-up|5|||
125911760|NCT00723398|452976803|FG003|Overall Study|Withdrawal by Subject|4|||
125911761|NCT00723398|452976804|FG004|Overall Study|Withdrawal by Subject|4|||
125911762|NCT00723398|452976800|FG000|Overall Study|Protocol Violation|2|||
125911763|NCT00723398|452976801|FG001|Overall Study|Protocol Violation|1|||
125911764|NCT00723398|452976802|FG002|Overall Study|Protocol Violation|5|||
125911765|NCT00723398|452976803|FG003|Overall Study|Protocol Violation|0|||
125911766|NCT00723398|452976804|FG004|Overall Study|Protocol Violation|0|||
125911767|NCT00723398|452976800|FG000|Overall Study|Physician Decision|2|||
125911768|NCT00723398|452976801|FG001|Overall Study|Physician Decision|2|||
125911769|NCT00723398|452976802|FG002|Overall Study|Physician Decision|5|||
125911770|NCT00723398|452976803|FG003|Overall Study|Physician Decision|0|||
125911771|NCT00723398|452976804|FG004|Overall Study|Physician Decision|1|||
125911772|NCT00723398|452976800|FG000|Overall Study|Adverse Event|0|||
125911773|NCT00723398|452976801|FG001|Overall Study|Adverse Event|5|||
125911774|NCT00723398|452976802|FG002|Overall Study|Adverse Event|3|||
125911775|NCT00723398|452976803|FG003|Overall Study|Adverse Event|1|||
125911776|NCT00723398|452976804|FG004|Overall Study|Adverse Event|4|||
126061182|NCT03122860|453518113|FG001|Overall Study|Lost to Follow-up|2|||
125911777|NCT00723398|452976800|FG000|Overall Study|Lost to Follow-up|0|||
125911778|NCT00723398|452976801|FG001|Overall Study|Lost to Follow-up|1|||
125911779|NCT00723398|452976802|FG002|Overall Study|Lost to Follow-up|0|||
125911780|NCT00723398|452976803|FG003|Overall Study|Lost to Follow-up|0|||
125911781|NCT00723398|452976804|FG004|Overall Study|Lost to Follow-up|0|||
125911782|NCT01578330|452976805|FG000|Overall Study|Adverse Event|2|||
125911783|NCT01578330|452976805|FG000|Overall Study|Protocol Violation|5|||
126061183|NCT03122860|453518114|FG002|Overall Study|Lost to Follow-up|3|||
125911784|NCT01676727|452976806|FG000|Overall Study|Death|18|||
125911785|NCT01676727|452976806|FG000|Overall Study|Withdrawal by Subject|6|||
125911786|NCT01676727|452976806|FG000|Overall Study|Screening failure|5|||
125911787|NCT01676727|452976806|FG000|Overall Study|Not willing to attend 1-year visit|2|||
125911788|NCT01676727|452976806|FG000|Overall Study|Valve explanted|1|||
125911789|NCT03114488|452976807|FG000|Time Period 2|Withdrawal by Subject|1|||
125911790|NCT03114488|452976808|FG001|Time Period 2|Withdrawal by Subject|3|||
125911791|NCT01368432|452976813|FG000|Overall Study|Lost to Follow-up|0|||
125911792|NCT01368432|452976814|FG001|Overall Study|Lost to Follow-up|1|||
125911793|NCT01008150|452976816|FG000|Overall Study|did not receive study drug|1|||
125911794|NCT01008150|452976817|FG001|Overall Study|did not receive study drug|1|||
125911795|NCT01008150|452976818|FG002|Overall Study|did not receive study drug|1|||
125911796|NCT01008150|452976819|FG003|Overall Study|did not receive study drug|0|||
125911797|NCT00437320|452976820|FG000|Overall Study|Participant request|2|||
125911798|NCT00437320|452976821|FG001|Overall Study|Participant request|1|||
125911799|NCT00437320|452976822|FG002|Overall Study|Participant request|4|||
125911800|NCT03845543|452976827|FG000|Overall Study|Death|25|||
125911801|NCT03845543|452976827|FG000|Overall Study|Withdrawal by Subject|2|||
125911802|NCT03845543|452976827|FG000|Overall Study|Lost to Follow-up|12|||
125911803|NCT03845543|452976827|FG000|Overall Study|Adverse Event|17|||
125911804|NCT01400815|452976828|FG000|Overall Study|Adverse Event|3|||
125911805|NCT01400815|452976829|FG001|Overall Study|Adverse Event|0|||
125911806|NCT01400815|452976828|FG000|Overall Study|Death|0|||
125911807|NCT01400815|452976829|FG001|Overall Study|Death|1|||
125911808|NCT01400815|452976828|FG000|Overall Study|Lost to Follow-up|18|||
125911809|NCT01400815|452976829|FG001|Overall Study|Lost to Follow-up|11|||
125911810|NCT01400815|452976828|FG000|Overall Study|Protocol Violation|0|||
125911811|NCT01400815|452976829|FG001|Overall Study|Protocol Violation|1|||
125911812|NCT01400815|452976828|FG000|Overall Study|Physician Decision|1|||
125911813|NCT01400815|452976829|FG001|Overall Study|Physician Decision|0|||
125911814|NCT01400815|452976828|FG000|Overall Study|Withdrawal by Subject|15|||
125911815|NCT01400815|452976829|FG001|Overall Study|Withdrawal by Subject|8|||
125911816|NCT01400815|452976828|FG000|Overall Study|Subject in jail|1|||
125911817|NCT01400815|452976829|FG001|Overall Study|Subject in jail|0|||
125911818|NCT00568685|452976834|FG000|Overall Study|Adverse Event|2|||
125911819|NCT00568685|452976835|FG001|Overall Study|Adverse Event|3|||
125911820|NCT00568685|452976836|FG002|Overall Study|Adverse Event|3|||
125911821|NCT00568685|452976834|FG000|Overall Study|Withdrawal by Subject|7|||
125911822|NCT00568685|452976835|FG001|Overall Study|Withdrawal by Subject|2|||
125911823|NCT00568685|452976836|FG002|Overall Study|Withdrawal by Subject|2|||
125911824|NCT00568685|452976834|FG000|Overall Study|Protocol Violation|1|||
125911825|NCT00568685|452976835|FG001|Overall Study|Protocol Violation|0|||
125911826|NCT00568685|452976836|FG002|Overall Study|Protocol Violation|0|||
125911827|NCT01147172|452976837|FG000|Overall Study|Withdrawal by Subject|2|||
125911828|NCT01147172|452976837|FG000|Overall Study|Lost to Follow-up|2|||
125911829|NCT02787551|452976838|FG000|Core Period: 26 Weeks|Adverse Event|10|||
125911830|NCT02787551|452976839|FG001|Core Period: 26 Weeks|Adverse Event|0|||
125911831|NCT02787551|452976838|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
125911832|NCT02787551|452976839|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
125911833|NCT02787551|452976838|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
125911834|NCT02787551|452976839|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
125911835|NCT02787551|452976838|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
125911836|NCT02787551|452976839|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
125911837|NCT02787551|452976838|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
125911838|NCT02787551|452976839|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
125911839|NCT02787551|452976838|FG000|Core Period: 26 Weeks|Other than specified|3|||
125911840|NCT02787551|452976839|FG001|Core Period: 26 Weeks|Other than specified|1|||
125911841|NCT02787551|452976838|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
125911842|NCT02787551|452976839|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
125911843|NCT02787551|452976838|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
126061184|NCT03122860|453518115|FG003|Overall Study|Lost to Follow-up|3|||
126061185|NCT03122860|453518116|FG004|Overall Study|Lost to Follow-up|5|||
126061186|NCT03122860|453518117|FG005|Overall Study|Lost to Follow-up|4|||
126061187|NCT03122860|453518112|FG000|Overall Study|Subject Non-Compliance|0|||
125911844|NCT02787551|452976839|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
125911845|NCT02787551|452976838|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
125911846|NCT02787551|452976839|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
125911847|NCT01638819|452976840|FG000|Overall Study|Lost to Follow-up|1|||
125911848|NCT01638819|452976841|FG001|Overall Study|Lost to Follow-up|0|||
125911849|NCT00237185|452976842|FG000|Core|Adverse Event|3|||
125911850|NCT00237185|452976843|FG001|Core|Adverse Event|4|||
125911851|NCT00237185|452976842|FG000|Core|Abnormal laboratory value|0|||
125911852|NCT00237185|452976843|FG001|Core|Abnormal laboratory value|4|||
125911853|NCT00237185|452976842|FG000|Core|Abnormal test procedure results|1|||
125911854|NCT00237185|452976843|FG001|Core|Abnormal test procedure results|0|||
125911855|NCT00237185|452976842|FG000|Core|Lack of Efficacy|30|||
125911856|NCT00237185|452976843|FG001|Core|Lack of Efficacy|23|||
125911857|NCT00237185|452976842|FG000|Core|Protocol Violation|1|||
125911858|NCT00237185|452976843|FG001|Core|Protocol Violation|1|||
125911859|NCT00237185|452976842|FG000|Core|Withdrawal by Subject|4|||
126061188|NCT03122860|453518113|FG001|Overall Study|Subject Non-Compliance|0|||
126061189|NCT03122860|453518114|FG002|Overall Study|Subject Non-Compliance|1|||
126061190|NCT03122860|453518115|FG003|Overall Study|Subject Non-Compliance|0|||
126061191|NCT03122860|453518116|FG004|Overall Study|Subject Non-Compliance|0|||
126061192|NCT03122860|453518117|FG005|Overall Study|Subject Non-Compliance|0|||
126061193|NCT03122860|453518112|FG000|Overall Study|Withdrawal by Subject|3|||
126061194|NCT03122860|453518113|FG001|Overall Study|Withdrawal by Subject|2|||
126061195|NCT03122860|453518114|FG002|Overall Study|Withdrawal by Subject|5|||
126061196|NCT03122860|453518115|FG003|Overall Study|Withdrawal by Subject|7|||
126061197|NCT03122860|453518116|FG004|Overall Study|Withdrawal by Subject|9|||
126061198|NCT03122860|453518117|FG005|Overall Study|Withdrawal by Subject|8|||
126061199|NCT01138657|453518118|FG000|Overall Study|Adverse Event|3|||
126061200|NCT01138657|453518119|FG001|Overall Study|Adverse Event|10|||
126061201|NCT01138657|453518118|FG000|Overall Study|Lack of Efficacy|2|||
126061202|NCT01138657|453518119|FG001|Overall Study|Lack of Efficacy|1|||
126061203|NCT01138657|453518118|FG000|Overall Study|Lost to Follow-up|0|||
126061204|NCT01138657|453518119|FG001|Overall Study|Lost to Follow-up|3|||
126061205|NCT01138657|453518118|FG000|Overall Study|Miscellaneous Reasons|3|||
126061206|NCT01138657|453518119|FG001|Overall Study|Miscellaneous Reasons|4|||
126061207|NCT00529529|453518120|FG000|Overall Study|Adverse Event|12|||
126061208|NCT00529529|453518121|FG001|Overall Study|Adverse Event|17|||
126061209|NCT00529529|453518122|FG002|Overall Study|Adverse Event|8|||
126061210|NCT00529529|453518120|FG000|Overall Study|Subject withdrew consent|12|||
126061211|NCT00529529|453518121|FG001|Overall Study|Subject withdrew consent|9|||
126061212|NCT00529529|453518122|FG002|Overall Study|Subject withdrew consent|12|||
126061213|NCT00529529|453518120|FG000|Overall Study|Protocol deviation|8|||
126061214|NCT00529529|453518121|FG001|Overall Study|Protocol deviation|12|||
126061215|NCT00529529|453518122|FG002|Overall Study|Protocol deviation|5|||
126061216|NCT00529529|453518120|FG000|Overall Study|Lost to Follow-up|5|||
126061217|NCT00529529|453518121|FG001|Overall Study|Lost to Follow-up|3|||
126061218|NCT00529529|453518122|FG002|Overall Study|Lost to Follow-up|1|||
126061219|NCT00529529|453518120|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126061220|NCT00529529|453518121|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126061221|NCT00529529|453518122|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126061222|NCT00529529|453518120|FG000|Overall Study|Death|2|||
126061223|NCT00529529|453518121|FG001|Overall Study|Death|0|||
126061224|NCT00529529|453518122|FG002|Overall Study|Death|0|||
126061225|NCT00529529|453518120|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125911860|NCT00237185|452976843|FG001|Core|Withdrawal by Subject|4|||
125911861|NCT00237185|452976842|FG000|Core|Administrative problems|0|||
125911862|NCT00237185|452976843|FG001|Core|Administrative problems|1|||
125911863|NCT00237185|452976842|FG000|Core|Death|4|||
125911864|NCT00237185|452976843|FG001|Core|Death|0|||
125911865|NCT00237185|452976842|FG000|Core|Determined ineligible post randomization|1|||
125911866|NCT00237185|452976843|FG001|Core|Determined ineligible post randomization|0|||
125911867|NCT00237185|452976842|FG000|Extension|Adverse Event|1|||
125911868|NCT00237185|452976843|FG001|Extension|Adverse Event|0|||
125911869|NCT00237185|452976842|FG000|Extension|Abnormal laboratory value|0|||
125911870|NCT00237185|452976843|FG001|Extension|Abnormal laboratory value|1|||
125911871|NCT00237185|452976842|FG000|Extension|Lack of Efficacy|9|||
125911872|NCT00237185|452976843|FG001|Extension|Lack of Efficacy|14|||
125911873|NCT00237185|452976842|FG000|Extension|Condition no longer required study drug|0|||
125911874|NCT00237185|452976843|FG001|Extension|Condition no longer required study drug|1|||
125911875|NCT00237185|452976842|FG000|Extension|Withdrawal by Subject|3|||
125911876|NCT00237185|452976843|FG001|Extension|Withdrawal by Subject|2|||
125911877|NCT00237185|452976842|FG000|Extension|Lost to Follow-up|1|||
125911878|NCT00237185|452976843|FG001|Extension|Lost to Follow-up|0|||
125911879|NCT00237185|452976842|FG000|Extension|Administrative problems|1|||
125911880|NCT00237185|452976843|FG001|Extension|Administrative problems|0|||
125911881|NCT00237185|452976842|FG000|Extension|Death|1|||
125911882|NCT00237185|452976843|FG001|Extension|Death|1|||
125911883|NCT05156073|452976844|FG000|Overall Study|Patient canceled appointment with PCP|1|||
125911884|NCT02891161|452976855|FG000|Study Treatment|Disease Progression|2|||
125911885|NCT02891161|452976856|FG001|Study Treatment|Disease Progression|4|||
125911886|NCT02891161|452976855|FG000|Study Treatment|AE/Side Effects/Complications|1|||
125911887|NCT02891161|452976856|FG001|Study Treatment|AE/Side Effects/Complications|5|||
125911888|NCT02891161|452976855|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
125911889|NCT02891161|452976856|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
125911890|NCT02891161|452976855|FG000|Follow up|Death|4|||
125911891|NCT02891161|452976856|FG001|Follow up|Death|8|||
125911892|NCT02891161|452976855|FG000|Follow up|Refused to Follow up|0|||
125911893|NCT02891161|452976856|FG001|Follow up|Refused to Follow up|2|||
125911894|NCT02891161|452976855|FG000|Follow up|Symptomatic deterioration|0|||
125911895|NCT02891161|452976856|FG001|Follow up|Symptomatic deterioration|1|||
125911896|NCT02891161|452976855|FG000|Follow up|Study terminated|0|||
125911897|NCT02891161|452976856|FG001|Follow up|Study terminated|6|||
125911898|NCT02734433|452976858|FG000|Overall Study|Disease progression|1|||
125911899|NCT02734433|452976859|FG001|Overall Study|Disease progression|5|||
125911900|NCT02734433|452976858|FG000|Overall Study|Clinical progression|0|||
125911901|NCT02734433|452976859|FG001|Overall Study|Clinical progression|1|||
125911902|NCT02734433|452976858|FG000|Overall Study|Withdrawal by Subject|1|||
125911903|NCT02734433|452976859|FG001|Overall Study|Withdrawal by Subject|2|||
125911904|NCT05521906|452976866|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
125911905|NCT05521906|452976867|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
125911906|NCT00560885|452976868|FG000|Overall Study|Death|7|||
125911907|NCT00560885|452976868|FG000|Overall Study|Withdrawal by Subject|1|||
125911908|NCT02887859|452976869|FG000|Overall Study|Ongoing|6|||
125911909|NCT02887859|452976869|FG000|Overall Study|Adverse Event|7|||
125911910|NCT02887859|452976869|FG000|Overall Study|Death|1|||
125911911|NCT02887859|452976869|FG000|Overall Study|Physician Decision|1|||
125911912|NCT03803683|452976870|FG000|Overall Study|Lost to Follow-up|41|||
125911913|NCT03803683|452976871|FG001|Overall Study|Lost to Follow-up|18|||
125911914|NCT03803683|452976872|FG002|Overall Study|Lost to Follow-up|12|||
125911915|NCT03803683|452976870|FG000|Overall Study|Withdrawal by Subject|9|||
125911916|NCT03803683|452976871|FG001|Overall Study|Withdrawal by Subject|1|||
125911917|NCT03803683|452976872|FG002|Overall Study|Withdrawal by Subject|4|||
125911918|NCT00257608|452979071|FG000|Chemotherapy Phase|Adverse Event|138|||
125911919|NCT00257608|452979072|FG001|Chemotherapy Phase|Adverse Event|0|||
125911920|NCT00257608|452979073|FG002|Chemotherapy Phase|Adverse Event|0|||
125911921|NCT00257608|452979071|FG000|Chemotherapy Phase|Disease progression|139|||
125911922|NCT00257608|452979072|FG001|Chemotherapy Phase|Disease progression|0|||
125911923|NCT00257608|452979073|FG002|Chemotherapy Phase|Disease progression|0|||
125911924|NCT00257608|452979071|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
125911925|NCT00257608|452979072|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
125911926|NCT00257608|452979073|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
125911927|NCT00257608|452979071|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
125911928|NCT00257608|452979072|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
125911929|NCT00257608|452979073|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
125911930|NCT00257608|452979071|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
125911931|NCT00257608|452979072|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
125911932|NCT00257608|452979073|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
125911933|NCT00257608|452979071|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
125911934|NCT00257608|452979072|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
125911935|NCT00257608|452979073|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
126061226|NCT00529529|453518121|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126061227|NCT00529529|453518122|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126061228|NCT00529529|453518120|FG000|Overall Study|Administrative problems|1|||
125911936|NCT00257608|452979071|FG000|Chemotherapy Phase|Physician Decision|28|||
125911937|NCT00257608|452979072|FG001|Chemotherapy Phase|Physician Decision|0|||
125911938|NCT00257608|452979073|FG002|Chemotherapy Phase|Physician Decision|0|||
125911939|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Adverse Event|0|||
125911940|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Adverse Event|34|||
125911941|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Adverse Event|38|||
125911942|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Disease progression|0|||
125911943|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Disease progression|204|||
125911944|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Disease progression|168|||
125911945|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
125911946|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
125911947|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
126110210|NCT03153111|453697669|FG001|Overall Study|Lost to Follow-up|0|||
126061229|NCT00529529|453518121|FG001|Overall Study|Administrative problems|0|||
126061230|NCT00529529|453518122|FG002|Overall Study|Administrative problems|3|||
126061231|NCT01020435|453518123|FG000|Overall Study|Lost to Follow-up|0|||
126061232|NCT01020435|453518124|FG001|Overall Study|Lost to Follow-up|1|||
126061233|NCT00103857|453518125|FG000|54-Week Base Study|Adverse Event|12|||
126061234|NCT00103857|453518126|FG001|54-Week Base Study|Adverse Event|9|||
126061235|NCT00103857|453518127|FG002|54-Week Base Study|Adverse Event|11|||
126061236|NCT00103857|453518128|FG003|54-Week Base Study|Adverse Event|6|||
126061237|NCT00103857|453518129|FG004|54-Week Base Study|Adverse Event|5|||
126061238|NCT00103857|453518130|FG005|54-Week Base Study|Adverse Event|11|||
126061239|NCT00103857|453518131|FG006|54-Week Base Study|Adverse Event|3|||
126061240|NCT00103857|453518125|FG000|54-Week Base Study|Death|0|||
126061241|NCT00103857|453518126|FG001|54-Week Base Study|Death|0|||
126061242|NCT00103857|453518127|FG002|54-Week Base Study|Death|0|||
126061243|NCT00103857|453518128|FG003|54-Week Base Study|Death|0|||
126061244|NCT00103857|453518129|FG004|54-Week Base Study|Death|1|||
126061245|NCT00103857|453518130|FG005|54-Week Base Study|Death|1|||
126061246|NCT00103857|453518131|FG006|54-Week Base Study|Death|0|||
126061247|NCT00103857|453518125|FG000|54-Week Base Study|Lack of Efficacy|11|||
126061248|NCT00103857|453518126|FG001|54-Week Base Study|Lack of Efficacy|14|||
126061249|NCT00103857|453518127|FG002|54-Week Base Study|Lack of Efficacy|8|||
126061250|NCT00103857|453518128|FG003|54-Week Base Study|Lack of Efficacy|4|||
126061251|NCT00103857|453518129|FG004|54-Week Base Study|Lack of Efficacy|3|||
126061252|NCT00103857|453518130|FG005|54-Week Base Study|Lack of Efficacy|14|||
126061253|NCT00103857|453518131|FG006|54-Week Base Study|Lack of Efficacy|19|||
126061254|NCT00103857|453518125|FG000|54-Week Base Study|Lost to Follow-up|5|||
126061255|NCT00103857|453518126|FG001|54-Week Base Study|Lost to Follow-up|4|||
126061256|NCT00103857|453518127|FG002|54-Week Base Study|Lost to Follow-up|7|||
126061257|NCT00103857|453518128|FG003|54-Week Base Study|Lost to Follow-up|5|||
126061258|NCT00103857|453518129|FG004|54-Week Base Study|Lost to Follow-up|10|||
126061259|NCT00103857|453518130|FG005|54-Week Base Study|Lost to Follow-up|9|||
126061260|NCT00103857|453518131|FG006|54-Week Base Study|Lost to Follow-up|3|||
126061261|NCT00103857|453518125|FG000|54-Week Base Study|Physician Decision|1|||
126061262|NCT00103857|453518126|FG001|54-Week Base Study|Physician Decision|1|||
126061263|NCT00103857|453518127|FG002|54-Week Base Study|Physician Decision|0|||
126061264|NCT00103857|453518128|FG003|54-Week Base Study|Physician Decision|0|||
126061265|NCT00103857|453518129|FG004|54-Week Base Study|Physician Decision|1|||
126061266|NCT00103857|453518130|FG005|54-Week Base Study|Physician Decision|0|||
126061267|NCT00103857|453518131|FG006|54-Week Base Study|Physician Decision|0|||
126061268|NCT00103857|453518125|FG000|54-Week Base Study|Pregnancy|1|||
126061269|NCT00103857|453518126|FG001|54-Week Base Study|Pregnancy|0|||
126061270|NCT00103857|453518127|FG002|54-Week Base Study|Pregnancy|0|||
126061271|NCT00103857|453518128|FG003|54-Week Base Study|Pregnancy|0|||
126061272|NCT00103857|453518129|FG004|54-Week Base Study|Pregnancy|1|||
126061273|NCT00103857|453518130|FG005|54-Week Base Study|Pregnancy|0|||
126061274|NCT00103857|453518131|FG006|54-Week Base Study|Pregnancy|1|||
126061275|NCT00103857|453518125|FG000|54-Week Base Study|Protocol Violation|6|||
126061276|NCT00103857|453518126|FG001|54-Week Base Study|Protocol Violation|4|||
126061277|NCT00103857|453518127|FG002|54-Week Base Study|Protocol Violation|2|||
126061278|NCT00103857|453518128|FG003|54-Week Base Study|Protocol Violation|4|||
126061279|NCT00103857|453518129|FG004|54-Week Base Study|Protocol Violation|0|||
126061280|NCT00103857|453518130|FG005|54-Week Base Study|Protocol Violation|3|||
126061281|NCT00103857|453518131|FG006|54-Week Base Study|Protocol Violation|3|||
126061282|NCT00103857|453518125|FG000|54-Week Base Study|Withdrawal by Subject|17|||
126061283|NCT00103857|453518126|FG001|54-Week Base Study|Withdrawal by Subject|16|||
126061284|NCT00103857|453518127|FG002|54-Week Base Study|Withdrawal by Subject|16|||
126061285|NCT00103857|453518128|FG003|54-Week Base Study|Withdrawal by Subject|15|||
126061286|NCT00103857|453518129|FG004|54-Week Base Study|Withdrawal by Subject|10|||
126061287|NCT00103857|453518130|FG005|54-Week Base Study|Withdrawal by Subject|15|||
126061288|NCT00103857|453518131|FG006|54-Week Base Study|Withdrawal by Subject|4|||
125911948|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
125911949|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
125911950|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
125911951|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
125911952|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
125911953|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
125911954|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
125911955|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
125911956|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
125911957|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
125911958|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
125911959|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
125911960|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Physician Decision|0|||
125911961|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Physician Decision|8|||
125911962|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Physician Decision|11|||
125911963|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
125911964|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
125911965|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
125911966|NCT00257608|452979071|FG000|Post Chemotherapy Phase|Not treated|0|||
125911967|NCT00257608|452979072|FG001|Post Chemotherapy Phase|Not treated|4|||
125911968|NCT00257608|452979073|FG002|Post Chemotherapy Phase|Not treated|7|||
125911969|NCT02171065|452979074|FG000|Overall Study|Withdrawal by Subject|1|||
125911970|NCT02171065|452979075|FG001|Overall Study|Withdrawal by Subject|0|||
125911971|NCT02171065|452979076|FG002|Overall Study|Withdrawal by Subject|0|||
125911972|NCT02171065|452979074|FG000|Overall Study|Lost to Follow-up|0|||
125911973|NCT02171065|452979075|FG001|Overall Study|Lost to Follow-up|0|||
125911974|NCT02171065|452979076|FG002|Overall Study|Lost to Follow-up|1|||
125911975|NCT02186873|452979079|FG000|Overall Study|Adverse Event|1|||
125911976|NCT02186873|452979080|FG001|Overall Study|Adverse Event|3|||
125911977|NCT02186873|452979079|FG000|Overall Study|Lack of Efficacy|0|||
125911978|NCT02186873|452979080|FG001|Overall Study|Lack of Efficacy|1|||
125911979|NCT02186873|452979079|FG000|Overall Study|Lost to Follow-up|1|||
125911980|NCT02186873|452979080|FG001|Overall Study|Lost to Follow-up|2|||
125911981|NCT02186873|452979079|FG000|Overall Study|Withdrawal by Subject|7|||
125911982|NCT02186873|452979080|FG001|Overall Study|Withdrawal by Subject|2|||
125911983|NCT00195273|452979081|FG000|Overall Study|Adverse Event|9|||
125911984|NCT00195273|452979082|FG001|Overall Study|Adverse Event|9|||
125911985|NCT00195273|452979081|FG000|Overall Study|Protocol deviation|0|||
125911986|NCT00195273|452979082|FG001|Overall Study|Protocol deviation|1|||
125911987|NCT00195273|452979081|FG000|Overall Study|Lack of Efficacy|3|||
125911988|NCT00195273|452979082|FG001|Overall Study|Lack of Efficacy|1|||
126061289|NCT00103857|453518125|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
126061290|NCT00103857|453518126|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
126061291|NCT00103857|453518127|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
125911989|NCT00195273|452979081|FG000|Overall Study|Procedural complications|9|||
125911990|NCT00195273|452979082|FG001|Overall Study|Procedural complications|3|||
125911991|NCT01680965|452979083|FG000|Overall Study|Death|0|||
125911992|NCT01680965|452979084|FG001|Overall Study|Death|0|||
125911993|NCT01680965|452979085|FG002|Overall Study|Death|0|||
126061292|NCT00103857|453518128|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
125911994|NCT01680965|452979086|FG003|Overall Study|Death|6|||
125911995|NCT00595465|452979087|FG000|Overall Study|Adverse Event|4|||
125911996|NCT00595465|452979088|FG001|Overall Study|Adverse Event|3|||
125911997|NCT00595465|452979089|FG002|Overall Study|Adverse Event|3|||
125911998|NCT00595465|452979087|FG000|Overall Study|Pregnancy|0|||
125911999|NCT00595465|452979088|FG001|Overall Study|Pregnancy|0|||
125912000|NCT00595465|452979089|FG002|Overall Study|Pregnancy|1|||
125912001|NCT00595465|452979087|FG000|Overall Study|Protocol Violation|2|||
125912002|NCT00595465|452979088|FG001|Overall Study|Protocol Violation|1|||
125912003|NCT00595465|452979089|FG002|Overall Study|Protocol Violation|0|||
125912004|NCT00595465|452979087|FG000|Overall Study|Lost to Follow-up|0|||
125912005|NCT00595465|452979088|FG001|Overall Study|Lost to Follow-up|0|||
125912006|NCT00595465|452979089|FG002|Overall Study|Lost to Follow-up|2|||
125912007|NCT00595465|452979087|FG000|Overall Study|administrative reason|0|||
125912008|NCT00595465|452979088|FG001|Overall Study|administrative reason|0|||
125912009|NCT00595465|452979089|FG002|Overall Study|administrative reason|1|||
125912010|NCT02595970|452979090|FG000|Overall Study|Withdrawal by Subject|2|||
125912011|NCT02595970|452979090|FG000|Overall Study|Physician Decision|2|||
125912012|NCT02595970|452979090|FG000|Overall Study|Protocol Violation|4|||
125912013|NCT02595970|452979090|FG000|Overall Study|Adverse Event|5|||
125912014|NCT02595970|452979090|FG000|Overall Study|Lack of Efficacy|7|||
125912015|NCT00107783|452979091|FG000|Overall Study|Adverse Event|0|||
125912016|NCT00107783|452979092|FG001|Overall Study|Adverse Event|2|||
125912017|NCT00107783|452979091|FG000|Overall Study|Death|0|||
125912018|NCT00107783|452979092|FG001|Overall Study|Death|1|||
125912019|NCT00107783|452979091|FG000|Overall Study|Withdrawal by Subject|2|||
125912020|NCT00107783|452979092|FG001|Overall Study|Withdrawal by Subject|0|||
125912021|NCT00107783|452979091|FG000|Overall Study|Second hip replacement|1|||
125912022|NCT00107783|452979092|FG001|Overall Study|Second hip replacement|1|||
125912023|NCT01886716|452979093|FG000|Week 1|Lost to Follow-up|0|||
125912024|NCT01886716|452979094|FG001|Week 1|Lost to Follow-up|0|||
125912025|NCT01886716|452979095|FG002|Week 1|Lost to Follow-up|2|||
125912026|NCT01886716|452979096|FG003|Week 1|Lost to Follow-up|2|||
125912027|NCT01886716|452979093|FG000|Week 2|Lost to Follow-up|3|||
125912028|NCT01886716|452979094|FG001|Week 2|Lost to Follow-up|2|||
125912029|NCT01886716|452979095|FG002|Week 2|Lost to Follow-up|1|||
125912030|NCT01886716|452979096|FG003|Week 2|Lost to Follow-up|3|||
125912031|NCT01886716|452979093|FG000|Week 3|Lost to Follow-up|1|||
125912032|NCT01886716|452979094|FG001|Week 3|Lost to Follow-up|1|||
125912033|NCT01886716|452979095|FG002|Week 3|Lost to Follow-up|0|||
125912034|NCT01886716|452979096|FG003|Week 3|Lost to Follow-up|1|||
125912035|NCT04879225|452979097|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
125912036|NCT04879225|452979097|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
125912037|NCT00137631|452979101|FG000|Overall Study|Lost to Follow-up|37|||
125912038|NCT00137631|452979102|FG001|Overall Study|Lost to Follow-up|41|||
126061293|NCT00103857|453518129|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
126061294|NCT00103857|453518130|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
126061295|NCT00103857|453518131|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
125912039|NCT02486302|452979104|FG000|Overall Study|Discontinued prematurely|410|||
125912040|NCT02486302|452979104|FG000|Overall Study|Documentation not completed|255|||
125912041|NCT02486302|452979104|FG000|Overall Study|Excluded due to legal reasons|8|||
125912042|NCT02486302|452979104|FG000|Overall Study|Not treated|3|||
125912043|NCT01871142|452979105|FG000|Overall Study|Adverse Event|1|||
125912044|NCT02063880|452979111|FG000|Overall Study|Death|21|||
125912045|NCT02063880|452979112|FG001|Overall Study|Death|18|||
125912046|NCT02063880|452979111|FG000|Overall Study|Lost to Follow-up|7|||
125912047|NCT02063880|452979112|FG001|Overall Study|Lost to Follow-up|7|||
125912048|NCT02063880|452979111|FG000|Overall Study|Ineligible|0|||
125912049|NCT02063880|452979112|FG001|Overall Study|Ineligible|2|||
125912050|NCT02106910|452979113|FG000|Overall Study|Lost to Follow-up|1|||
125912051|NCT02106910|452979114|FG001|Overall Study|Lost to Follow-up|1|||
125912052|NCT00567593|452979115|FG000|Overall Study|Adverse Event|1|||
125912053|NCT00567593|452979115|FG000|Overall Study|Physician Decision|1|||
125912054|NCT01675427|452979118|FG000|Overall Study|Withdrawal by Subject|7|||
125912055|NCT01675427|452979118|FG000|Overall Study|Participant Refused Sample Collection|18|||
125912056|NCT01675427|452979118|FG000|Overall Study|Sample not Collected by Mistake|2|||
125912057|NCT01675427|452979118|FG000|Overall Study|Lost to Follow-up|5|||
125912058|NCT01675427|452979118|FG000|Overall Study|Other|2|||
125912059|NCT00700570|452979119|FG000|Overall Study|Adverse Event|2|||
125912060|NCT00700570|452979120|FG001|Overall Study|Adverse Event|6|||
125912061|NCT00700570|452979119|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
125912062|NCT00700570|452979120|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
125912063|NCT00700570|452979119|FG000|Overall Study|Disease Progression|8|||
125912064|NCT00700570|452979120|FG001|Overall Study|Disease Progression|11|||
125912065|NCT00700570|452979119|FG000|Overall Study|Withdrawal by Subject|1|||
125912066|NCT00700570|452979120|FG001|Overall Study|Withdrawal by Subject|6|||
125912067|NCT00611533|452979121|FG000|First Intervention (6 Weeks)|Never started study|0|||
125912068|NCT00611533|452979122|FG001|First Intervention (6 Weeks)|Never started study|1|||
125912069|NCT00611533|452979121|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
125912070|NCT00611533|452979122|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125912071|NCT00611533|452979121|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125912072|NCT00611533|452979122|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
125912073|NCT05246397|452979123|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
125912074|NCT04327674|452979129|FG000|Overall Study|Protocol Violation|19|||
125912075|NCT01461980|452979130|FG000|Overall Study|Other|9|||
125912076|NCT01461980|452979131|FG001|Overall Study|Other|8|||
125912077|NCT01461980|452979132|FG002|Overall Study|Other|6|||
125912078|NCT01461980|452979130|FG000|Overall Study|Medication error|7|||
125912079|NCT01461980|452979131|FG001|Overall Study|Medication error|5|||
125912080|NCT01461980|452979132|FG002|Overall Study|Medication error|6|||
125912081|NCT01461980|452979130|FG000|Overall Study|Adverse Event|12|||
125912082|NCT01461980|452979131|FG001|Overall Study|Adverse Event|5|||
125912083|NCT01461980|452979132|FG002|Overall Study|Adverse Event|6|||
125912084|NCT01461980|452979130|FG000|Overall Study|Protocol Violation|12|||
125912085|NCT01461980|452979131|FG001|Overall Study|Protocol Violation|19|||
125912086|NCT01461980|452979132|FG002|Overall Study|Protocol Violation|16|||
125912087|NCT01461980|452979130|FG000|Overall Study|No longer meets eligibility criteria|18|||
125912088|NCT01461980|452979131|FG001|Overall Study|No longer meets eligibility criteria|9|||
125912089|NCT01461980|452979132|FG002|Overall Study|No longer meets eligibility criteria|19|||
125912090|NCT01461980|452979130|FG000|Overall Study|Lost to Follow-up|52|||
125912091|NCT01461980|452979131|FG001|Overall Study|Lost to Follow-up|53|||
125912092|NCT01461980|452979132|FG002|Overall Study|Lost to Follow-up|51|||
125912093|NCT01461980|452979130|FG000|Overall Study|No longer willing to participate|52|||
125912094|NCT01461980|452979131|FG001|Overall Study|No longer willing to participate|38|||
125912095|NCT01461980|452979132|FG002|Overall Study|No longer willing to participate|54|||
125912096|NCT01461980|452979130|FG000|Overall Study|Randomized but not vaccinated|4|||
126061296|NCT00103857|453518125|FG000|54-Week Base Study|patient moved|0|||
125912097|NCT01461980|452979131|FG001|Overall Study|Randomized but not vaccinated|8|||
125912098|NCT01461980|452979132|FG002|Overall Study|Randomized but not vaccinated|7|||
125912099|NCT00122109|452979133|FG000|Overall Study|Did not meet criteria|6|||
125912100|NCT00122109|452979134|FG001|Overall Study|Did not meet criteria|7|||
125912101|NCT00809354|452979140|FG000|Overall Study|Adverse Event|32|||
125912102|NCT00809354|452979141|FG001|Overall Study|Adverse Event|45|||
125912103|NCT00809354|452979142|FG002|Overall Study|Adverse Event|37|||
125912104|NCT00809354|452979143|FG003|Overall Study|Adverse Event|53|||
126061297|NCT00103857|453518126|FG001|54-Week Base Study|patient moved|1|||
126061298|NCT00103857|453518127|FG002|54-Week Base Study|patient moved|1|||
126061299|NCT00103857|453518128|FG003|54-Week Base Study|patient moved|2|||
126061300|NCT00103857|453518129|FG004|54-Week Base Study|patient moved|3|||
126061301|NCT00103857|453518130|FG005|54-Week Base Study|patient moved|1|||
126061302|NCT00103857|453518131|FG006|54-Week Base Study|patient moved|0|||
126061303|NCT00103857|453518125|FG000|54-Week Base Study|non-compliance with study procedures|1|||
126061304|NCT00103857|453518126|FG001|54-Week Base Study|non-compliance with study procedures|2|||
126061305|NCT00103857|453518127|FG002|54-Week Base Study|non-compliance with study procedures|0|||
125912105|NCT00809354|452979144|FG004|Overall Study|Adverse Event|26|||
125912106|NCT00809354|452979145|FG005|Overall Study|Adverse Event|33|||
125912107|NCT00809354|452979146|FG006|Overall Study|Adverse Event|44|||
125912108|NCT00809354|452979147|FG007|Overall Study|Adverse Event|40|||
125912109|NCT00809354|452979148|FG008|Overall Study|Adverse Event|46|||
125912110|NCT00809354|452979149|FG009|Overall Study|Adverse Event|26|||
125912111|NCT00809354|452979140|FG000|Overall Study|Lack of Efficacy|23|||
125912112|NCT00809354|452979141|FG001|Overall Study|Lack of Efficacy|23|||
125912113|NCT00809354|452979142|FG002|Overall Study|Lack of Efficacy|22|||
125912114|NCT00809354|452979143|FG003|Overall Study|Lack of Efficacy|15|||
125912115|NCT00809354|452979144|FG004|Overall Study|Lack of Efficacy|40|||
125912116|NCT00809354|452979145|FG005|Overall Study|Lack of Efficacy|19|||
125912117|NCT00809354|452979146|FG006|Overall Study|Lack of Efficacy|21|||
126110211|NCT03153111|453697668|FG000|Overall Study|Physician Decision|5|||
125912118|NCT00809354|452979147|FG007|Overall Study|Lack of Efficacy|15|||
125912119|NCT00809354|452979148|FG008|Overall Study|Lack of Efficacy|18|||
125912120|NCT00809354|452979149|FG009|Overall Study|Lack of Efficacy|38|||
125912121|NCT00809354|452979140|FG000|Overall Study|Lost to Follow-up|10|||
125912122|NCT00809354|452979141|FG001|Overall Study|Lost to Follow-up|11|||
125912123|NCT00809354|452979142|FG002|Overall Study|Lost to Follow-up|8|||
125912124|NCT00809354|452979143|FG003|Overall Study|Lost to Follow-up|13|||
125912125|NCT00809354|452979144|FG004|Overall Study|Lost to Follow-up|6|||
125912126|NCT00809354|452979145|FG005|Overall Study|Lost to Follow-up|2|||
125912127|NCT00809354|452979146|FG006|Overall Study|Lost to Follow-up|0|||
125912128|NCT00809354|452979147|FG007|Overall Study|Lost to Follow-up|5|||
125912129|NCT00809354|452979148|FG008|Overall Study|Lost to Follow-up|4|||
125912130|NCT00809354|452979149|FG009|Overall Study|Lost to Follow-up|0|||
125912131|NCT00809354|452979140|FG000|Overall Study|Protocol Violation|7|||
125912132|NCT00809354|452979141|FG001|Overall Study|Protocol Violation|14|||
125912133|NCT00809354|452979142|FG002|Overall Study|Protocol Violation|14|||
125912134|NCT00809354|452979143|FG003|Overall Study|Protocol Violation|12|||
125912135|NCT00809354|452979144|FG004|Overall Study|Protocol Violation|14|||
125912136|NCT00809354|452979145|FG005|Overall Study|Protocol Violation|6|||
125912137|NCT00809354|452979146|FG006|Overall Study|Protocol Violation|4|||
126061306|NCT00103857|453518128|FG003|54-Week Base Study|non-compliance with study procedures|0|||
126061307|NCT00103857|453518129|FG004|54-Week Base Study|non-compliance with study procedures|0|||
126061308|NCT00103857|453518130|FG005|54-Week Base Study|non-compliance with study procedures|2|||
126061309|NCT00103857|453518131|FG006|54-Week Base Study|non-compliance with study procedures|0|||
126061310|NCT00103857|453518125|FG000|54-Week Base Study|patient incarcerated|0|||
126061311|NCT00103857|453518126|FG001|54-Week Base Study|patient incarcerated|0|||
126061312|NCT00103857|453518127|FG002|54-Week Base Study|patient incarcerated|0|||
125912138|NCT00809354|452979147|FG007|Overall Study|Protocol Violation|6|||
125912139|NCT00809354|452979148|FG008|Overall Study|Protocol Violation|9|||
125912140|NCT00809354|452979149|FG009|Overall Study|Protocol Violation|3|||
125912141|NCT00809354|452979140|FG000|Overall Study|Withdrawal by Subject|32|||
125912142|NCT00809354|452979141|FG001|Overall Study|Withdrawal by Subject|27|||
125912143|NCT00809354|452979142|FG002|Overall Study|Withdrawal by Subject|31|||
125912144|NCT00809354|452979143|FG003|Overall Study|Withdrawal by Subject|33|||
125912145|NCT00809354|452979144|FG004|Overall Study|Withdrawal by Subject|34|||
125912146|NCT00809354|452979145|FG005|Overall Study|Withdrawal by Subject|29|||
125912147|NCT00809354|452979146|FG006|Overall Study|Withdrawal by Subject|27|||
125912148|NCT00809354|452979147|FG007|Overall Study|Withdrawal by Subject|19|||
125912149|NCT00809354|452979148|FG008|Overall Study|Withdrawal by Subject|18|||
125912150|NCT00809354|452979149|FG009|Overall Study|Withdrawal by Subject|20|||
125912151|NCT00809354|452979140|FG000|Overall Study|Other|10|||
125912152|NCT00809354|452979141|FG001|Overall Study|Other|2|||
126061313|NCT00103857|453518128|FG003|54-Week Base Study|patient incarcerated|0|||
126061314|NCT00103857|453518129|FG004|54-Week Base Study|patient incarcerated|1|||
126061315|NCT00103857|453518130|FG005|54-Week Base Study|patient incarcerated|1|||
126061316|NCT00103857|453518131|FG006|54-Week Base Study|patient incarcerated|0|||
126061317|NCT00103857|453518125|FG000|54-Week Base Study|laboratory reporting error|0|||
126061318|NCT00103857|453518126|FG001|54-Week Base Study|laboratory reporting error|0|||
126061319|NCT00103857|453518127|FG002|54-Week Base Study|laboratory reporting error|0|||
126061320|NCT00103857|453518128|FG003|54-Week Base Study|laboratory reporting error|0|||
126061321|NCT00103857|453518129|FG004|54-Week Base Study|laboratory reporting error|1|||
126061322|NCT00103857|453518130|FG005|54-Week Base Study|laboratory reporting error|0|||
126061323|NCT00103857|453518131|FG006|54-Week Base Study|laboratory reporting error|0|||
126061324|NCT00103857|453518125|FG000|54-Week Base Study|site error|0|||
126061325|NCT00103857|453518126|FG001|54-Week Base Study|site error|0|||
126061326|NCT00103857|453518127|FG002|54-Week Base Study|site error|0|||
126061327|NCT00103857|453518128|FG003|54-Week Base Study|site error|0|||
126061328|NCT00103857|453518129|FG004|54-Week Base Study|site error|0|||
126061329|NCT00103857|453518130|FG005|54-Week Base Study|site error|1|||
126061330|NCT00103857|453518131|FG006|54-Week Base Study|site error|0|||
126061331|NCT00103857|453518125|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
126061332|NCT00103857|453518126|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
126061333|NCT00103857|453518127|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
126061334|NCT00103857|453518128|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
126061335|NCT00103857|453518129|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
126061336|NCT00103857|453518130|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
125912153|NCT00809354|452979142|FG002|Overall Study|Other|7|||
125912154|NCT00809354|452979143|FG003|Overall Study|Other|10|||
125912155|NCT00809354|452979144|FG004|Overall Study|Other|5|||
125912156|NCT00809354|452979145|FG005|Overall Study|Other|3|||
125912157|NCT00809354|452979146|FG006|Overall Study|Other|2|||
125912158|NCT00809354|452979147|FG007|Overall Study|Other|3|||
125912159|NCT00809354|452979148|FG008|Overall Study|Other|4|||
125912160|NCT00809354|452979149|FG009|Overall Study|Other|3|||
125912161|NCT00809354|452979140|FG000|Overall Study|Study terminated by sponsor|138|||
125912162|NCT00809354|452979141|FG001|Overall Study|Study terminated by sponsor|134|||
125912163|NCT00809354|452979142|FG002|Overall Study|Study terminated by sponsor|129|||
126061337|NCT00103857|453518131|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
126061338|NCT00103857|453518125|FG000|50-Week Extension Study|Adverse Event|2|||
126061339|NCT00103857|453518126|FG001|50-Week Extension Study|Adverse Event|3|||
126061340|NCT00103857|453518127|FG002|50-Week Extension Study|Adverse Event|2|||
126061341|NCT00103857|453518128|FG003|50-Week Extension Study|Adverse Event|0|||
126061342|NCT00103857|453518129|FG004|50-Week Extension Study|Adverse Event|1|||
126061343|NCT00103857|453518130|FG005|50-Week Extension Study|Adverse Event|1|||
126061344|NCT00103857|453518131|FG006|50-Week Extension Study|Adverse Event|0|||
126061345|NCT00103857|453518125|FG000|50-Week Extension Study|Death|0|||
126061346|NCT00103857|453518126|FG001|50-Week Extension Study|Death|0|||
126061347|NCT00103857|453518127|FG002|50-Week Extension Study|Death|0|||
126061348|NCT00103857|453518128|FG003|50-Week Extension Study|Death|1|||
126061349|NCT00103857|453518129|FG004|50-Week Extension Study|Death|0|||
126061350|NCT00103857|453518130|FG005|50-Week Extension Study|Death|1|||
126061351|NCT00103857|453518131|FG006|50-Week Extension Study|Death|0|||
126061352|NCT00103857|453518125|FG000|50-Week Extension Study|Lack of Efficacy|26|||
126061353|NCT00103857|453518126|FG001|50-Week Extension Study|Lack of Efficacy|15|||
126061354|NCT00103857|453518127|FG002|50-Week Extension Study|Lack of Efficacy|13|||
126061355|NCT00103857|453518128|FG003|50-Week Extension Study|Lack of Efficacy|16|||
126061356|NCT00103857|453518129|FG004|50-Week Extension Study|Lack of Efficacy|8|||
126061357|NCT00103857|453518130|FG005|50-Week Extension Study|Lack of Efficacy|8|||
126061358|NCT00103857|453518131|FG006|50-Week Extension Study|Lack of Efficacy|0|||
126061359|NCT00103857|453518125|FG000|50-Week Extension Study|Lost to Follow-up|4|||
126061360|NCT00103857|453518126|FG001|50-Week Extension Study|Lost to Follow-up|0|||
126061361|NCT00103857|453518127|FG002|50-Week Extension Study|Lost to Follow-up|1|||
126061362|NCT00103857|453518128|FG003|50-Week Extension Study|Lost to Follow-up|4|||
126061363|NCT00103857|453518129|FG004|50-Week Extension Study|Lost to Follow-up|3|||
126061364|NCT00103857|453518130|FG005|50-Week Extension Study|Lost to Follow-up|3|||
126061365|NCT00103857|453518131|FG006|50-Week Extension Study|Lost to Follow-up|0|||
126061366|NCT00103857|453518125|FG000|50-Week Extension Study|Physician Decision|0|||
126110212|NCT03153111|453697669|FG001|Overall Study|Physician Decision|1|||
126061367|NCT00103857|453518126|FG001|50-Week Extension Study|Physician Decision|1|||
126061368|NCT00103857|453518127|FG002|50-Week Extension Study|Physician Decision|1|||
126061369|NCT00103857|453518128|FG003|50-Week Extension Study|Physician Decision|0|||
126061370|NCT00103857|453518129|FG004|50-Week Extension Study|Physician Decision|0|||
126061371|NCT00103857|453518130|FG005|50-Week Extension Study|Physician Decision|0|||
126061372|NCT00103857|453518131|FG006|50-Week Extension Study|Physician Decision|0|||
126061373|NCT00103857|453518125|FG000|50-Week Extension Study|Pregnancy|0|||
126061374|NCT00103857|453518126|FG001|50-Week Extension Study|Pregnancy|0|||
126061375|NCT00103857|453518127|FG002|50-Week Extension Study|Pregnancy|1|||
126061376|NCT00103857|453518128|FG003|50-Week Extension Study|Pregnancy|0|||
126061377|NCT00103857|453518129|FG004|50-Week Extension Study|Pregnancy|1|||
126061378|NCT00103857|453518130|FG005|50-Week Extension Study|Pregnancy|0|||
126061379|NCT00103857|453518131|FG006|50-Week Extension Study|Pregnancy|0|||
126061380|NCT00103857|453518125|FG000|50-Week Extension Study|Protocol Violation|1|||
126061381|NCT00103857|453518126|FG001|50-Week Extension Study|Protocol Violation|1|||
126061382|NCT00103857|453518127|FG002|50-Week Extension Study|Protocol Violation|1|||
126061383|NCT00103857|453518128|FG003|50-Week Extension Study|Protocol Violation|2|||
126061384|NCT00103857|453518129|FG004|50-Week Extension Study|Protocol Violation|0|||
126061385|NCT00103857|453518130|FG005|50-Week Extension Study|Protocol Violation|1|||
125912164|NCT00809354|452979143|FG003|Overall Study|Study terminated by sponsor|120|||
126061386|NCT00103857|453518131|FG006|50-Week Extension Study|Protocol Violation|0|||
126061387|NCT00103857|453518125|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
125912165|NCT00809354|452979144|FG004|Overall Study|Study terminated by sponsor|126|||
125912166|NCT00809354|452979145|FG005|Overall Study|Study terminated by sponsor|133|||
125912167|NCT00809354|452979146|FG006|Overall Study|Study terminated by sponsor|124|||
125912168|NCT00809354|452979147|FG007|Overall Study|Study terminated by sponsor|148|||
125912169|NCT00809354|452979148|FG008|Overall Study|Study terminated by sponsor|127|||
125912170|NCT00809354|452979149|FG009|Overall Study|Study terminated by sponsor|135|||
125912171|NCT00809354|452979140|FG000|Overall Study|Withdrawn due to pregnancy|0|||
125912172|NCT00809354|452979141|FG001|Overall Study|Withdrawn due to pregnancy|1|||
125912173|NCT00809354|452979142|FG002|Overall Study|Withdrawn due to pregnancy|0|||
125912174|NCT00809354|452979143|FG003|Overall Study|Withdrawn due to pregnancy|0|||
125912175|NCT00809354|452979144|FG004|Overall Study|Withdrawn due to pregnancy|0|||
125912176|NCT00809354|452979145|FG005|Overall Study|Withdrawn due to pregnancy|0|||
125912177|NCT00809354|452979146|FG006|Overall Study|Withdrawn due to pregnancy|0|||
125912178|NCT00809354|452979147|FG007|Overall Study|Withdrawn due to pregnancy|0|||
125912179|NCT00809354|452979148|FG008|Overall Study|Withdrawn due to pregnancy|0|||
125912180|NCT00809354|452979149|FG009|Overall Study|Withdrawn due to pregnancy|0|||
125912181|NCT00809354|452979140|FG000|Overall Study|Randomized but not Treated|3|||
125912182|NCT00809354|452979141|FG001|Overall Study|Randomized but not Treated|1|||
125912183|NCT00809354|452979142|FG002|Overall Study|Randomized but not Treated|6|||
125912184|NCT00809354|452979143|FG003|Overall Study|Randomized but not Treated|0|||
125912185|NCT00809354|452979144|FG004|Overall Study|Randomized but not Treated|5|||
125912186|NCT00809354|452979145|FG005|Overall Study|Randomized but not Treated|0|||
125912187|NCT00809354|452979146|FG006|Overall Study|Randomized but not Treated|1|||
125912188|NCT00809354|452979147|FG007|Overall Study|Randomized but not Treated|1|||
125912189|NCT00809354|452979148|FG008|Overall Study|Randomized but not Treated|2|||
125912190|NCT00809354|452979149|FG009|Overall Study|Randomized but not Treated|1|||
125912191|NCT00809354|452979140|FG000|Overall Study|Death|0|||
125912192|NCT00809354|452979141|FG001|Overall Study|Death|0|||
125912193|NCT00809354|452979142|FG002|Overall Study|Death|0|||
125912194|NCT00809354|452979143|FG003|Overall Study|Death|0|||
125912195|NCT00809354|452979144|FG004|Overall Study|Death|0|||
125912196|NCT00809354|452979145|FG005|Overall Study|Death|0|||
125912197|NCT00809354|452979146|FG006|Overall Study|Death|0|||
125912198|NCT00809354|452979147|FG007|Overall Study|Death|1|||
125912199|NCT00809354|452979148|FG008|Overall Study|Death|0|||
125912200|NCT00809354|452979149|FG009|Overall Study|Death|0|||
125912201|NCT00267189|452979150|FG000|Overall Study|Patient withdrew consent|1|||
125912202|NCT00267189|452979151|FG001|Overall Study|Patient withdrew consent|1|||
125912203|NCT00267189|452979150|FG000|Overall Study|Death|1|||
125912204|NCT00267189|452979151|FG001|Overall Study|Death|0|||
125912205|NCT00267189|452979150|FG000|Overall Study|Missing|3|||
125912206|NCT00267189|452979151|FG001|Overall Study|Missing|0|||
125912207|NCT00100178|452979152|FG000|Overall Study|Lost to Follow-up|0|||
125912208|NCT00100178|452979153|FG001|Overall Study|Lost to Follow-up|6|||
125912209|NCT00100178|452979154|FG002|Overall Study|Lost to Follow-up|5|||
125912210|NCT00100178|452979152|FG000|Overall Study|Adverse Event|2|||
125912211|NCT00100178|452979153|FG001|Overall Study|Adverse Event|2|||
125912212|NCT00100178|452979154|FG002|Overall Study|Adverse Event|1|||
125912213|NCT00100178|452979152|FG000|Overall Study|Withdrawal by Subject|1|||
125912214|NCT00100178|452979153|FG001|Overall Study|Withdrawal by Subject|1|||
125912215|NCT00100178|452979154|FG002|Overall Study|Withdrawal by Subject|1|||
125912216|NCT00100178|452979152|FG000|Overall Study|Physician Decision|6|||
125912217|NCT00100178|452979153|FG001|Overall Study|Physician Decision|1|||
126061388|NCT00103857|453518126|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
126061389|NCT00103857|453518127|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
126061390|NCT00103857|453518128|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
126061391|NCT00103857|453518129|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
126061392|NCT00103857|453518130|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
126061393|NCT00103857|453518131|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
126061394|NCT00103857|453518125|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
126061395|NCT00103857|453518126|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
126061396|NCT00103857|453518127|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
126061397|NCT00103857|453518128|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
126061398|NCT00103857|453518129|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
126061399|NCT00103857|453518130|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
125912218|NCT00100178|452979154|FG002|Overall Study|Physician Decision|3|||
125912219|NCT03257371|452979155|FG000|Overall Study|Lost to Follow-up|1|||
125912220|NCT02477839|452979158|FG000|Overall Study|Adverse Event|0|||
125912221|NCT02477839|452979159|FG001|Overall Study|Adverse Event|1|||
125912222|NCT02477839|452979158|FG000|Overall Study|Protocol Violation|0|||
125912223|NCT02477839|452979159|FG001|Overall Study|Protocol Violation|2|||
125912224|NCT02477839|452979158|FG000|Overall Study|Withdrawal by Subject|3|||
125912225|NCT02477839|452979159|FG001|Overall Study|Withdrawal by Subject|3|||
125912226|NCT02477839|452979158|FG000|Overall Study|Participant had PGS during V6|0|||
125912227|NCT02477839|452979159|FG001|Overall Study|Participant had PGS during V6|1|||
126061400|NCT00103857|453518131|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
126061401|NCT00103857|453518125|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
126061402|NCT00103857|453518126|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
126061403|NCT00103857|453518127|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
126061404|NCT00103857|453518128|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
126061405|NCT00103857|453518129|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
126061406|NCT00103857|453518130|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
126061407|NCT00103857|453518131|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
126061408|NCT00103857|453518125|FG000|50-Week Extension Study|patient moved|0|||
126061409|NCT00103857|453518126|FG001|50-Week Extension Study|patient moved|0|||
126061410|NCT00103857|453518127|FG002|50-Week Extension Study|patient moved|1|||
126061411|NCT00103857|453518128|FG003|50-Week Extension Study|patient moved|2|||
126061412|NCT00103857|453518129|FG004|50-Week Extension Study|patient moved|0|||
126061413|NCT00103857|453518130|FG005|50-Week Extension Study|patient moved|0|||
126061414|NCT00103857|453518131|FG006|50-Week Extension Study|patient moved|0|||
126061415|NCT00103857|453518125|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
126061416|NCT00103857|453518126|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
126061417|NCT00103857|453518127|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
126061418|NCT00103857|453518128|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
126061419|NCT00103857|453518129|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
126061420|NCT00103857|453518130|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
126061421|NCT00103857|453518131|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
126061422|NCT00103857|453518125|FG000|50-Week Extension Study|reason unspecified|0|||
126061423|NCT00103857|453518126|FG001|50-Week Extension Study|reason unspecified|0|||
126061424|NCT00103857|453518127|FG002|50-Week Extension Study|reason unspecified|0|||
126061425|NCT00103857|453518128|FG003|50-Week Extension Study|reason unspecified|0|||
126061426|NCT00103857|453518129|FG004|50-Week Extension Study|reason unspecified|1|||
126061427|NCT00103857|453518130|FG005|50-Week Extension Study|reason unspecified|0|||
126061428|NCT00103857|453518131|FG006|50-Week Extension Study|reason unspecified|0|||
126061429|NCT02132195|453518134|FG000|Initial Assignment|Relapsed|14|||
126061430|NCT02132195|453518135|FG001|Initial Assignment|Relapsed|0|||
126061431|NCT02132195|453518136|FG002|Initial Assignment|Relapsed|0|||
126061432|NCT02132195|453518134|FG000|Rescue Therapy|Relapsed|0|||
126061433|NCT02132195|453518135|FG001|Rescue Therapy|Relapsed|0|||
126061434|NCT02132195|453518136|FG002|Rescue Therapy|Relapsed|7|||
126061435|NCT02132195|453518134|FG000|Rescue Therapy|Physician Decision|0|||
126061436|NCT02132195|453518135|FG001|Rescue Therapy|Physician Decision|0|||
126061437|NCT02132195|453518136|FG002|Rescue Therapy|Physician Decision|1|||
126061438|NCT02132195|453518134|FG000|Rescue Therapy|Withdrawal by Subject|0|||
126061439|NCT02132195|453518135|FG001|Rescue Therapy|Withdrawal by Subject|0|||
126061440|NCT02132195|453518136|FG002|Rescue Therapy|Withdrawal by Subject|1|||
126061441|NCT02132195|453518134|FG000|Rescue Therapy|Adverse Event|0|||
126061442|NCT02132195|453518135|FG001|Rescue Therapy|Adverse Event|0|||
126061443|NCT02132195|453518136|FG002|Rescue Therapy|Adverse Event|2|||
126061444|NCT03065400|453518139|FG000|Overall Study|Adverse Event|1|||
126061445|NCT03065400|453518139|FG000|Overall Study|Physician Decision|3|||
126061446|NCT03065400|453518139|FG000|Overall Study|Withdrawal by Subject|1|||
126089002|NCT01327846|453620048|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
125912228|NCT02477839|452979158|FG000|Overall Study|Parents decided to stop medication|0|||
125912229|NCT02477839|452979159|FG001|Overall Study|Parents decided to stop medication|1|||
125912230|NCT02477839|452979158|FG000|Overall Study|Lack of tolerability|0|||
125912231|NCT02477839|452979159|FG001|Overall Study|Lack of tolerability|1|||
125912232|NCT02477839|452979158|FG000|Overall Study|Exclusion criterion|0|||
125912233|NCT02477839|452979159|FG001|Overall Study|Exclusion criterion|1|||
125912234|NCT01439568|452979166|FG000|Overall Study|Lost to Follow-up|1|||
125912235|NCT01439568|452979167|FG001|Overall Study|Lost to Follow-up|0|||
125912236|NCT01439568|452979166|FG000|Overall Study|Withdrawal by Subject|2|||
125912237|NCT01439568|452979167|FG001|Overall Study|Withdrawal by Subject|2|||
125912238|NCT03198078|452979168|FG000|Overall Study|Adverse Event|0|||
125912239|NCT03198078|452979169|FG001|Overall Study|Adverse Event|1|||
125912240|NCT03198078|452979170|FG002|Overall Study|Adverse Event|2|||
125912241|NCT03198078|452979168|FG000|Overall Study|Lack of Efficacy|0|||
125912242|NCT03198078|452979169|FG001|Overall Study|Lack of Efficacy|0|||
125912243|NCT03198078|452979170|FG002|Overall Study|Lack of Efficacy|3|||
125912244|NCT03198078|452979168|FG000|Overall Study|Lost to Follow-up|1|||
125912245|NCT03198078|452979169|FG001|Overall Study|Lost to Follow-up|0|||
125912246|NCT03198078|452979170|FG002|Overall Study|Lost to Follow-up|0|||
125912247|NCT03198078|452979168|FG000|Overall Study|Pregnancy|0|||
125912248|NCT03198078|452979169|FG001|Overall Study|Pregnancy|1|||
125912249|NCT03198078|452979170|FG002|Overall Study|Pregnancy|0|||
125912250|NCT03198078|452979168|FG000|Overall Study|Withdrawal by Subject|1|||
125912251|NCT03198078|452979169|FG001|Overall Study|Withdrawal by Subject|0|||
125912252|NCT03198078|452979170|FG002|Overall Study|Withdrawal by Subject|2|||
125912253|NCT03198078|452979168|FG000|Overall Study|Withdrawal by Caregiver|1|||
125912254|NCT03198078|452979169|FG001|Overall Study|Withdrawal by Caregiver|3|||
125912255|NCT03198078|452979170|FG002|Overall Study|Withdrawal by Caregiver|5|||
125912256|NCT02607930|452979171|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
125912257|NCT02607930|452979172|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
125912258|NCT02607930|452979173|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
125912259|NCT02607930|452979174|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
125912260|NCT02607930|452979171|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
125912261|NCT02607930|452979172|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
125912262|NCT02607930|452979173|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
125912263|NCT02607930|452979174|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
125912264|NCT02607930|452979171|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
125912265|NCT02607930|452979172|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
125912266|NCT02607930|452979173|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
125912267|NCT02607930|452979174|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
125912268|NCT02607930|452979171|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
125912269|NCT02607930|452979172|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
125912270|NCT02607930|452979173|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
125912271|NCT02607930|452979174|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
125912272|NCT02607930|452979171|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
125912273|NCT02607930|452979172|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
125912274|NCT02607930|452979173|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
125912275|NCT02607930|452979174|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
125912276|NCT02607930|452979171|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
125912277|NCT02607930|452979172|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
125912278|NCT02607930|452979173|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
125912279|NCT02607930|452979174|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
125912280|NCT02607930|452979171|FG000|Double-Blinded Treatment Phase|Death|2|||
125912281|NCT02607930|452979172|FG001|Double-Blinded Treatment Phase|Death|1|||
125912282|NCT02607930|452979173|FG002|Double-Blinded Treatment Phase|Death|0|||
125912283|NCT02607930|452979174|FG003|Double-Blinded Treatment Phase|Death|0|||
125912284|NCT02607930|452979171|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
125912285|NCT02607930|452979172|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
125912286|NCT02607930|452979173|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
125912287|NCT02607930|452979174|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
125912288|NCT02607930|452979171|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
125912289|NCT02607930|452979172|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
125912290|NCT02607930|452979173|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
125912291|NCT02607930|452979174|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
125912292|NCT02607930|452979171|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
125912293|NCT02607930|452979172|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
125912294|NCT02607930|452979173|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
125912295|NCT02607930|452979174|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
125912296|NCT02607930|452979171|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
125912297|NCT02607930|452979172|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
125912298|NCT02607930|452979173|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
125912299|NCT02607930|452979174|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
125912300|NCT02607930|452979171|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
125912301|NCT02607930|452979172|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
125912302|NCT02607930|452979173|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
125912303|NCT02607930|452979174|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
125912304|NCT02607930|452979171|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
125912305|NCT02607930|452979172|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
125912306|NCT02607930|452979173|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
125912307|NCT02607930|452979174|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
125912308|NCT02607930|452979171|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
125912309|NCT02607930|452979172|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
125912310|NCT02607930|452979173|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
125912311|NCT02607930|452979174|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
125912312|NCT02607930|452979171|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
125912313|NCT02607930|452979172|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
125912314|NCT02607930|452979173|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
125912315|NCT02607930|452979174|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
125912316|NCT02607930|452979171|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
125912317|NCT02607930|452979172|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
126061447|NCT03065400|453518139|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
126061448|NCT02102724|453518140|FG000|Overall Study|Lost to Follow-up|1|||
126061449|NCT02102724|453518141|FG001|Overall Study|Lost to Follow-up|0|||
125912318|NCT02607930|452979173|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
125912319|NCT02607930|452979174|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
126061450|NCT02102724|453518140|FG000|Overall Study|surgery for brain aneurysm|1|||
125912320|NCT00566501|452979177|FG000|Overall Study|Adverse Event|68|||
125912321|NCT00566501|452979178|FG001|Overall Study|Adverse Event|59|||
125912322|NCT00566501|452979177|FG000|Overall Study|Medication Non-compliance|5|||
125912323|NCT00566501|452979178|FG001|Overall Study|Medication Non-compliance|0|||
125912324|NCT00566501|452979177|FG000|Overall Study|Protocol Violation|2|||
125912325|NCT00566501|452979178|FG001|Overall Study|Protocol Violation|2|||
125912326|NCT00566501|452979177|FG000|Overall Study|Request of Investigator or Sponsor|6|||
125912327|NCT00566501|452979178|FG001|Overall Study|Request of Investigator or Sponsor|7|||
125912328|NCT00566501|452979177|FG000|Overall Study|Withdrawal by Subject|33|||
125912329|NCT00566501|452979178|FG001|Overall Study|Withdrawal by Subject|30|||
125912330|NCT00566501|452979177|FG000|Overall Study|Lack of Efficacy|8|||
125912331|NCT00566501|452979178|FG001|Overall Study|Lack of Efficacy|3|||
125912332|NCT00566501|452979177|FG000|Overall Study|Other|25|||
125912333|NCT00566501|452979178|FG001|Overall Study|Other|21|||
125912334|NCT01938573|452979179|FG000|Overall Study|Lack of Efficacy|1|||
125912335|NCT01938573|452979180|FG001|Overall Study|Lack of Efficacy|0|||
125912336|NCT01938573|452979179|FG000|Overall Study|Operation at other hospital|1|||
125912337|NCT01938573|452979180|FG001|Overall Study|Operation at other hospital|0|||
125912338|NCT02456103|452979184|FG000|Overall Study|Study Closure|207|||
125912339|NCT02456103|452979184|FG000|Overall Study|Physician Decision|1|||
125912340|NCT02456103|452979184|FG000|Overall Study|Required prohibited medications|5|||
125912341|NCT02456103|452979184|FG000|Overall Study|Protocol Violation|1|||
125912342|NCT02456103|452979184|FG000|Overall Study|Adverse Event|5|||
125912343|NCT02456103|452979184|FG000|Overall Study|Abnormal Laboratory Value|2|||
125912344|NCT02456103|452979184|FG000|Overall Study|Lost to Follow-up|1|||
125912345|NCT02456103|452979184|FG000|Overall Study|Withdrawal by Subject|24|||
125912346|NCT02448810|452979185|FG000|Overall Study|Adverse Event|0|||
125912347|NCT02448810|452979186|FG001|Overall Study|Adverse Event|0|||
125912348|NCT02448810|452979187|FG002|Overall Study|Adverse Event|1|||
125912349|NCT02448810|452979188|FG003|Overall Study|Adverse Event|0|||
125912350|NCT02448810|452979189|FG004|Overall Study|Adverse Event|0|||
125912351|NCT02448810|452979190|FG005|Overall Study|Adverse Event|0|||
125912352|NCT02448810|452979191|FG006|Overall Study|Adverse Event|0|||
125912353|NCT02448810|452979192|FG007|Overall Study|Adverse Event|0|||
125912354|NCT02448810|452979185|FG000|Overall Study|Withdrawal by Subject|0|||
125912355|NCT02448810|452979186|FG001|Overall Study|Withdrawal by Subject|0|||
125912356|NCT02448810|452979187|FG002|Overall Study|Withdrawal by Subject|1|||
125912357|NCT02448810|452979188|FG003|Overall Study|Withdrawal by Subject|0|||
125912358|NCT02448810|452979189|FG004|Overall Study|Withdrawal by Subject|3|||
125912359|NCT02448810|452979190|FG005|Overall Study|Withdrawal by Subject|5|||
125912360|NCT02448810|452979191|FG006|Overall Study|Withdrawal by Subject|0|||
125912361|NCT02448810|452979192|FG007|Overall Study|Withdrawal by Subject|2|||
125912362|NCT02448810|452979185|FG000|Overall Study|Other (study terminated by sponsor)|0|||
125912363|NCT02448810|452979186|FG001|Overall Study|Other (study terminated by sponsor)|0|||
125912364|NCT02448810|452979187|FG002|Overall Study|Other (study terminated by sponsor)|0|||
125912365|NCT02448810|452979188|FG003|Overall Study|Other (study terminated by sponsor)|0|||
125912366|NCT02448810|452979189|FG004|Overall Study|Other (study terminated by sponsor)|4|||
125912367|NCT02448810|452979190|FG005|Overall Study|Other (study terminated by sponsor)|2|||
125912368|NCT02448810|452979191|FG006|Overall Study|Other (study terminated by sponsor)|2|||
125912369|NCT02448810|452979192|FG007|Overall Study|Other (study terminated by sponsor)|1|||
125912370|NCT02448810|452979185|FG000|Overall Study|Death|1|||
125912371|NCT02448810|452979186|FG001|Overall Study|Death|0|||
125912372|NCT02448810|452979187|FG002|Overall Study|Death|1|||
125912373|NCT02448810|452979188|FG003|Overall Study|Death|0|||
125912374|NCT02448810|452979189|FG004|Overall Study|Death|1|||
125912375|NCT02448810|452979190|FG005|Overall Study|Death|0|||
125912376|NCT02448810|452979191|FG006|Overall Study|Death|0|||
125912377|NCT02448810|452979192|FG007|Overall Study|Death|0|||
125912378|NCT02448810|452979185|FG000|Overall Study|Other (Progressive disease)|2|||
125912379|NCT02448810|452979186|FG001|Overall Study|Other (Progressive disease)|2|||
125912380|NCT02448810|452979187|FG002|Overall Study|Other (Progressive disease)|0|||
125912381|NCT02448810|452979188|FG003|Overall Study|Other (Progressive disease)|3|||
125912382|NCT02448810|452979189|FG004|Overall Study|Other (Progressive disease)|23|||
125912383|NCT02448810|452979190|FG005|Overall Study|Other (Progressive disease)|9|||
125912384|NCT02448810|452979191|FG006|Overall Study|Other (Progressive disease)|14|||
125912385|NCT02448810|452979192|FG007|Overall Study|Other (Progressive disease)|5|||
125912386|NCT02448810|452979185|FG000|Overall Study|Lost to Follow-up|0|||
125912387|NCT02448810|452979186|FG001|Overall Study|Lost to Follow-up|1|||
125912388|NCT02448810|452979187|FG002|Overall Study|Lost to Follow-up|0|||
125912389|NCT02448810|452979188|FG003|Overall Study|Lost to Follow-up|0|||
125912390|NCT02448810|452979189|FG004|Overall Study|Lost to Follow-up|0|||
125912391|NCT02448810|452979190|FG005|Overall Study|Lost to Follow-up|0|||
125912392|NCT02448810|452979191|FG006|Overall Study|Lost to Follow-up|0|||
125912393|NCT02448810|452979192|FG007|Overall Study|Lost to Follow-up|0|||
125912394|NCT02448810|452979185|FG000|Overall Study|Other (unspecified)|0|||
125912395|NCT02448810|452979186|FG001|Overall Study|Other (unspecified)|0|||
125912396|NCT02448810|452979187|FG002|Overall Study|Other (unspecified)|0|||
125912397|NCT02448810|452979188|FG003|Overall Study|Other (unspecified)|0|||
125912398|NCT02448810|452979189|FG004|Overall Study|Other (unspecified)|0|||
125912399|NCT02448810|452979190|FG005|Overall Study|Other (unspecified)|0|||
125912400|NCT02448810|452979191|FG006|Overall Study|Other (unspecified)|2|||
125912401|NCT02448810|452979192|FG007|Overall Study|Other (unspecified)|0|||
125912402|NCT00470847|452979197|FG000|Overall Study|Pt still receiving treatment|1|||
125912403|NCT03139279|452979205|FG000|Overall Study|Physician Decision|2|||
125912404|NCT03139279|452979206|FG001|Overall Study|Physician Decision|0|||
125912405|NCT03139279|452979205|FG000|Overall Study|Protocol Violation|5|||
125912406|NCT03139279|452979206|FG001|Overall Study|Protocol Violation|4|||
125912407|NCT03139279|452979205|FG000|Overall Study|Withdrawal by Subject|0|||
125912408|NCT03139279|452979206|FG001|Overall Study|Withdrawal by Subject|2|||
125912409|NCT01090973|452979207|FG000|Overall Study|Disease progression|1|||
125912410|NCT01626495|452979210|FG000|Overall Study|Adverse Event|3|||
125912411|NCT01626495|452979210|FG000|Overall Study|Disease progression|27|||
125912412|NCT01626495|452979210|FG000|Overall Study|Withdrawal by Subject|1|||
125912413|NCT01626495|452979210|FG000|Overall Study|Administrative problem|1|||
125912414|NCT01626495|452979210|FG000|Overall Study|Death|2|||
125912415|NCT01626495|452979210|FG000|Overall Study|Physician Decision|1|||
125912416|NCT01626495|452979210|FG000|Overall Study|New cancer therapy|16|||
125912417|NCT01626495|452979210|FG000|Overall Study|Manufacturing failure|1|||
125912418|NCT01934972|452979211|FG000|Overall Study|Withdrawal by Subject|9|||
125912419|NCT01934972|452979212|FG001|Overall Study|Withdrawal by Subject|6|||
125912420|NCT03131453|452979213|FG000|Overall Study|Study terminated by Sponsor|424|||
125912421|NCT03131453|452979214|FG001|Overall Study|Study terminated by Sponsor|222|||
125912422|NCT03131453|452979215|FG002|Overall Study|Study terminated by Sponsor|438|||
125912423|NCT03131453|452979213|FG000|Overall Study|Withdrawal by Subject|18|||
125912424|NCT03131453|452979214|FG001|Overall Study|Withdrawal by Subject|7|||
125912425|NCT03131453|452979215|FG002|Overall Study|Withdrawal by Subject|13|||
125912426|NCT03131453|452979213|FG000|Overall Study|Adverse Event|10|||
125912427|NCT03131453|452979214|FG001|Overall Study|Adverse Event|3|||
125912428|NCT03131453|452979215|FG002|Overall Study|Adverse Event|3|||
125912429|NCT03131453|452979213|FG000|Overall Study|Lost to Follow-up|1|||
125912430|NCT03131453|452979214|FG001|Overall Study|Lost to Follow-up|0|||
125912431|NCT03131453|452979215|FG002|Overall Study|Lost to Follow-up|1|||
125912432|NCT03131453|452979213|FG000|Overall Study|Physician Decision|1|||
125912433|NCT03131453|452979214|FG001|Overall Study|Physician Decision|0|||
125912434|NCT03131453|452979215|FG002|Overall Study|Physician Decision|1|||
125912435|NCT03131453|452979213|FG000|Overall Study|Non-compliance with study treatment|1|||
125912436|NCT03131453|452979214|FG001|Overall Study|Non-compliance with study treatment|0|||
125912437|NCT03131453|452979215|FG002|Overall Study|Non-compliance with study treatment|0|||
125912438|NCT03131453|452979213|FG000|Overall Study|Technical problems|1|||
125912439|NCT03131453|452979214|FG001|Overall Study|Technical problems|0|||
125912440|NCT03131453|452979215|FG002|Overall Study|Technical problems|0|||
125912441|NCT03131453|452979213|FG000|Overall Study|Protocol deviation|0|||
125912442|NCT03131453|452979214|FG001|Overall Study|Protocol deviation|1|||
125912443|NCT03131453|452979215|FG002|Overall Study|Protocol deviation|0|||
125912444|NCT03438383|452979218|FG000|Overall Study|Protocol Violation|9|||
125912445|NCT03438383|452979219|FG001|Overall Study|Protocol Violation|3|||
125912446|NCT02766465|452979220|FG000|Overall Study|Withdrawal by Subject|0|||
125912447|NCT02766465|452979221|FG001|Overall Study|Withdrawal by Subject|10|||
125912448|NCT02435069|452979222|FG000|Dose Response - First Intervention|Adverse Event|0|||
125912449|NCT02435069|452979223|FG001|Dose Response - First Intervention|Adverse Event|1|||
126061451|NCT02102724|453518141|FG001|Overall Study|surgery for brain aneurysm|1|||
126061452|NCT03072862|453518142|FG000|Overall Study|Withdrawal by Subject|4|||
125912450|NCT02435069|452979224|FG002|Dose Response - First Intervention|Adverse Event|1|||
125912451|NCT02435069|452979225|FG003|Dose Response - First Intervention|Adverse Event|0|||
125912452|NCT02435069|452979226|FG004|Dose Response - First Intervention|Adverse Event|0|||
125912453|NCT02435069|452979222|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
125912454|NCT02435069|452979223|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
125912455|NCT02435069|452979224|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
125912456|NCT02435069|452979225|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
125912457|NCT02435069|452979226|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
125912458|NCT01528033|452979227|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
125912459|NCT01528033|452979228|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
125912460|NCT01528033|452979227|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
125912461|NCT01528033|452979228|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
126061453|NCT03072862|453518142|FG000|Overall Study|Lost to Follow-up|6|||
126061454|NCT03072862|453518142|FG000|Overall Study|Protocol Violation|4|||
126061455|NCT03072862|453518142|FG000|Overall Study|Physician Decision|2|||
126061456|NCT03072862|453518142|FG000|Overall Study|Death|1|||
126061457|NCT03072862|453518142|FG000|Overall Study|Adverse Event|1|||
126061458|NCT02203513|453518143|FG000|Overall Study|Refused further treatment|2|||
126061459|NCT02203513|453518144|FG001|Overall Study|Refused further treatment|0|||
126061460|NCT02203513|453518145|FG002|Overall Study|Refused further treatment|1|||
126061461|NCT02203513|453518146|FG003|Overall Study|Refused further treatment|0|||
126061462|NCT02203513|453518147|FG004|Overall Study|Refused further treatment|0|||
126061463|NCT02203513|453518143|FG000|Overall Study|Switched to alternative treatment|3|||
126061464|NCT02203513|453518144|FG001|Overall Study|Switched to alternative treatment|4|||
126061465|NCT02203513|453518145|FG002|Overall Study|Switched to alternative treatment|0|||
126061466|NCT02203513|453518146|FG003|Overall Study|Switched to alternative treatment|0|||
126061467|NCT02203513|453518147|FG004|Overall Study|Switched to alternative treatment|4|||
125912462|NCT01528033|452979227|FG000|Primary Endpoint Assessment ITT|Death|2|||
125912463|NCT01528033|452979228|FG001|Primary Endpoint Assessment ITT|Death|2|||
125912464|NCT01528033|452979227|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
125912465|NCT01528033|452979228|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
125912466|NCT01528033|452979227|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
125912467|NCT01528033|452979228|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
125912468|NCT01528033|452979227|FG000|Follow Up|No data available|46|||
125912469|NCT01528033|452979228|FG001|Follow Up|No data available|44|||
125912470|NCT02520661|452979229|FG000|Overall Study|Lost to Follow-up|7|||
125912471|NCT02520661|452979230|FG001|Overall Study|Lost to Follow-up|3|||
125912472|NCT02520661|452979229|FG000|Overall Study|Admitted from ED|49|||
125912473|NCT02520661|452979230|FG001|Overall Study|Admitted from ED|48|||
125912474|NCT02520661|452979229|FG000|Overall Study|ED greater than 24 hours|29|||
125912475|NCT02520661|452979230|FG001|Overall Study|ED greater than 24 hours|38|||
125912476|NCT02520661|452979229|FG000|Overall Study|other ineligibility|14|||
125912477|NCT02520661|452979230|FG001|Overall Study|other ineligibility|22|||
125912478|NCT02520661|452979229|FG000|Overall Study|Withdrawal by Subject|7|||
125912479|NCT02520661|452979230|FG001|Overall Study|Withdrawal by Subject|16|||
125912480|NCT02628769|452979234|FG000|First Intervention|Adverse Event|1|||
125912481|NCT02628769|452979235|FG001|First Intervention|Adverse Event|0|||
125912482|NCT02628769|452979234|FG000|First Intervention|Withdrawal by Subject|0|||
125912483|NCT02628769|452979235|FG001|First Intervention|Withdrawal by Subject|1|||
125912484|NCT02628769|452979234|FG000|Second Intervention|Adverse Event|2|||
125912485|NCT02628769|452979235|FG001|Second Intervention|Adverse Event|0|||
125912486|NCT02628769|452979234|FG000|Second Intervention|Physician Decision|0|||
125912487|NCT02628769|452979235|FG001|Second Intervention|Physician Decision|1|||
125912488|NCT02203071|452980582|FG000|Overall Study|Lost to Follow-up|3|||
125912489|NCT02203071|452980583|FG001|Overall Study|Lost to Follow-up|1|||
125912490|NCT03894046|452980584|FG000|Overall Study|Protocol Violation|1|||
125912491|NCT03894046|452980585|FG001|Overall Study|Protocol Violation|0|||
125912492|NCT03894046|452980586|FG002|Overall Study|Protocol Violation|0|||
125912493|NCT03894046|452980584|FG000|Overall Study|Adverse Event|0|||
125912494|NCT03894046|452980585|FG001|Overall Study|Adverse Event|1|||
125912495|NCT03894046|452980586|FG002|Overall Study|Adverse Event|0|||
125912496|NCT03894046|452980584|FG000|Overall Study|Withdrawal by Subject|2|||
125912497|NCT03894046|452980585|FG001|Overall Study|Withdrawal by Subject|3|||
125912498|NCT03894046|452980586|FG002|Overall Study|Withdrawal by Subject|1|||
125912499|NCT03894046|452980584|FG000|Overall Study|Death|15|||
125912500|NCT03894046|452980585|FG001|Overall Study|Death|21|||
125912501|NCT03894046|452980586|FG002|Overall Study|Death|4|||
125912502|NCT03894046|452980584|FG000|Overall Study|No growth of ABC|2|||
125912503|NCT03894046|452980585|FG001|Overall Study|No growth of ABC|1|||
125912504|NCT03894046|452980586|FG002|Overall Study|No growth of ABC|0|||
125912505|NCT03894046|452980584|FG000|Overall Study|Physician Decision|1|||
125912506|NCT03894046|452980585|FG001|Overall Study|Physician Decision|1|||
125912507|NCT03894046|452980586|FG002|Overall Study|Physician Decision|1|||
125912508|NCT03894046|452980584|FG000|Overall Study|Prohibited concomitant medication|1|||
125912509|NCT03894046|452980585|FG001|Overall Study|Prohibited concomitant medication|0|||
125912510|NCT03894046|452980586|FG002|Overall Study|Prohibited concomitant medication|0|||
125912511|NCT03894046|452980584|FG000|Overall Study|Transferred to other arm/group|1|||
125912512|NCT03894046|452980585|FG001|Overall Study|Transferred to other arm/group|1|||
125912513|NCT03894046|452980586|FG002|Overall Study|Transferred to other arm/group|0|||
125912514|NCT02367131|452980587|FG000|Overall Study|Adverse Event|64|||
125912515|NCT02367131|452980587|FG000|Overall Study|No visit since the first visit|3|||
125912516|NCT02367131|452980587|FG000|Overall Study|Request by patient|53|||
125912517|NCT02367131|452980587|FG000|Overall Study|Improvement/remission|2|||
125912518|NCT02367131|452980587|FG000|Overall Study|No change/progressive disease|78|||
125912519|NCT02367131|452980587|FG000|Overall Study|Other than stated above|20|||
126110213|NCT03153111|453697668|FG000|Overall Study|Withdrawal by Subject|3|||
125912520|NCT02367131|452980587|FG000|Overall Study|Not treated|2|||
125912521|NCT01973569|452980588|FG000|Overall Study|Adverse Event|9|||
125912522|NCT01973569|452980589|FG001|Overall Study|Adverse Event|2|||
125912523|NCT01973569|452980590|FG002|Overall Study|Adverse Event|4|||
125912524|NCT01973569|452980588|FG000|Overall Study|Protocol Violation|2|||
125912525|NCT01973569|452980589|FG001|Overall Study|Protocol Violation|1|||
125912526|NCT01973569|452980590|FG002|Overall Study|Protocol Violation|3|||
125912527|NCT01973569|452980588|FG000|Overall Study|Withdrawal by Subject|7|||
125912528|NCT01973569|452980589|FG001|Overall Study|Withdrawal by Subject|5|||
125912529|NCT01973569|452980590|FG002|Overall Study|Withdrawal by Subject|2|||
126110214|NCT03153111|453697669|FG001|Overall Study|Withdrawal by Subject|3|||
125912530|NCT01973569|452980588|FG000|Overall Study|Invasive dental treatment|3|||
125912531|NCT01973569|452980589|FG001|Overall Study|Invasive dental treatment|5|||
125912532|NCT01973569|452980590|FG002|Overall Study|Invasive dental treatment|6|||
125912533|NCT01973569|452980588|FG000|Overall Study|Prohibited concomitant d|1|||
125912534|NCT01973569|452980589|FG001|Overall Study|Prohibited concomitant d|5|||
125912535|NCT01973569|452980590|FG002|Overall Study|Prohibited concomitant d|0|||
125912536|NCT01973569|452980588|FG000|Overall Study|Disease progression|0|||
125912537|NCT01973569|452980589|FG001|Overall Study|Disease progression|3|||
125912538|NCT01973569|452980590|FG002|Overall Study|Disease progression|0|||
125912539|NCT01973569|452980588|FG000|Overall Study|Other|1|||
125912540|NCT01973569|452980589|FG001|Overall Study|Other|1|||
125912541|NCT01973569|452980590|FG002|Overall Study|Other|0|||
125912542|NCT01973569|452980588|FG000|Overall Study|Did not receive study drug|6|||
125912543|NCT01973569|452980589|FG001|Overall Study|Did not receive study drug|3|||
125912544|NCT01973569|452980590|FG002|Overall Study|Did not receive study drug|3|||
125912545|NCT03711266|452980596|FG000|Overall Study|Lost to Follow-up|10|||
125912546|NCT01646073|452980597|FG000|Period A (12 Weeks)|Adverse Event|0|||
125912547|NCT01646073|452980598|FG001|Period A (12 Weeks)|Adverse Event|2|||
125912548|NCT01646073|452980597|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
125912549|NCT01646073|452980598|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
125912550|NCT01646073|452980597|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
125912551|NCT01646073|452980598|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
125912552|NCT01646073|452980597|FG000|Period A (12 Weeks)|Protocol Violation|0|||
125912553|NCT01646073|452980598|FG001|Period A (12 Weeks)|Protocol Violation|1|||
125912554|NCT01646073|452980597|FG000|Period A (12 Weeks)|Other|0|||
125912555|NCT01646073|452980598|FG001|Period A (12 Weeks)|Other|1|||
125912556|NCT01646073|452980597|FG000|Period B (12 Weeks)|Adverse Event|0|||
125912557|NCT01646073|452980598|FG001|Period B (12 Weeks)|Adverse Event|7|||
125912558|NCT01646073|452980597|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
125912559|NCT01646073|452980598|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
125912560|NCT01646073|452980597|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
125912561|NCT01646073|452980598|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
125912562|NCT00057876|452980599|FG000|Overall Study|Adverse Event|8|||
125912563|NCT00057876|452980600|FG001|Overall Study|Adverse Event|8|||
125912564|NCT00057876|452980599|FG000|Overall Study|Death|2|||
125912565|NCT00057876|452980600|FG001|Overall Study|Death|1|||
125912566|NCT00057876|452980599|FG000|Overall Study|Withdrawal by Subject|5|||
125912567|NCT00057876|452980600|FG001|Overall Study|Withdrawal by Subject|6|||
125912568|NCT00057876|452980599|FG000|Overall Study|Lack of Efficacy|10|||
125912569|NCT00057876|452980600|FG001|Overall Study|Lack of Efficacy|8|||
125912570|NCT00057876|452980599|FG000|Overall Study|Ineligible|1|||
125912571|NCT00057876|452980600|FG001|Overall Study|Ineligible|2|||
125912572|NCT00057876|452980599|FG000|Overall Study|other reason|2|||
125912573|NCT00057876|452980600|FG001|Overall Study|other reason|2|||
125912574|NCT00057876|452980599|FG000|Overall Study|other complicating disease|1|||
125912575|NCT00057876|452980600|FG001|Overall Study|other complicating disease|0|||
125912576|NCT01649804|452980605|FG000|Overall Study|Administrative/Other|8|||
125912577|NCT01123850|452980612|FG000|Overall Study|Slow enrollment|45|||
125912578|NCT02083081|452980613|FG000|Overall Study|Lost to Follow-up|31|||
125912579|NCT02083081|452980614|FG001|Overall Study|Lost to Follow-up|9|||
125912580|NCT02028871|452980617|FG000|Overall Study|Positive urine drug screen|1|||
125912581|NCT02028871|452980618|FG001|Overall Study|Positive urine drug screen|1|||
125912582|NCT02028871|452980617|FG000|Overall Study|Withdrawal by Subject|1|||
125912583|NCT02028871|452980618|FG001|Overall Study|Withdrawal by Subject|2|||
125912584|NCT02028871|452980617|FG000|Overall Study|IV placement difficulty|1|||
125912585|NCT02028871|452980618|FG001|Overall Study|IV placement difficulty|0|||
125912586|NCT02028871|452980617|FG000|Overall Study|Current Illness|1|||
125912587|NCT02028871|452980618|FG001|Overall Study|Current Illness|0|||
125912588|NCT01691898|452980619|FG000|Overall Study|Death|34|||
125912589|NCT01691898|452980620|FG001|Overall Study|Death|32|||
125912590|NCT01691898|452980621|FG002|Overall Study|Death|6|||
125912591|NCT01691898|452980622|FG003|Overall Study|Death|3|||
125912592|NCT01691898|452980623|FG004|Overall Study|Death|8|||
125912593|NCT01691898|452980624|FG005|Overall Study|Death|31|||
125912594|NCT01691898|452980619|FG000|Overall Study|Adverse Event|0|||
125912595|NCT01691898|452980620|FG001|Overall Study|Adverse Event|1|||
125912596|NCT01691898|452980621|FG002|Overall Study|Adverse Event|0|||
125912597|NCT01691898|452980622|FG003|Overall Study|Adverse Event|1|||
125912598|NCT01691898|452980623|FG004|Overall Study|Adverse Event|1|||
125912599|NCT01691898|452980624|FG005|Overall Study|Adverse Event|0|||
125912600|NCT01691898|452980619|FG000|Overall Study|Progression of Disease|1|||
125912601|NCT01691898|452980620|FG001|Overall Study|Progression of Disease|2|||
125912602|NCT01691898|452980621|FG002|Overall Study|Progression of Disease|1|||
125912603|NCT01691898|452980622|FG003|Overall Study|Progression of Disease|0|||
125912604|NCT01691898|452980623|FG004|Overall Study|Progression of Disease|0|||
125912605|NCT01691898|452980624|FG005|Overall Study|Progression of Disease|1|||
125912606|NCT01691898|452980619|FG000|Overall Study|Lost to Follow-up|3|||
125912607|NCT01691898|452980620|FG001|Overall Study|Lost to Follow-up|1|||
125912608|NCT01691898|452980621|FG002|Overall Study|Lost to Follow-up|0|||
125912609|NCT01691898|452980622|FG003|Overall Study|Lost to Follow-up|0|||
125912610|NCT01691898|452980623|FG004|Overall Study|Lost to Follow-up|1|||
126061468|NCT02203513|453518143|FG000|Overall Study|Did not receive investigational product (IP)|0|||
125912611|NCT01691898|452980624|FG005|Overall Study|Lost to Follow-up|0|||
125912612|NCT01691898|452980619|FG000|Overall Study|Withdrawal by Subject|9|||
125912613|NCT01691898|452980620|FG001|Overall Study|Withdrawal by Subject|8|||
125912614|NCT01691898|452980621|FG002|Overall Study|Withdrawal by Subject|2|||
125912615|NCT01691898|452980622|FG003|Overall Study|Withdrawal by Subject|1|||
125912616|NCT01691898|452980623|FG004|Overall Study|Withdrawal by Subject|3|||
125912617|NCT01691898|452980624|FG005|Overall Study|Withdrawal by Subject|3|||
125912618|NCT01691898|452980619|FG000|Overall Study|Non-Compliance|0|||
125912619|NCT01691898|452980620|FG001|Overall Study|Non-Compliance|0|||
125912620|NCT01691898|452980621|FG002|Overall Study|Non-Compliance|0|||
125912621|NCT01691898|452980622|FG003|Overall Study|Non-Compliance|0|||
125912622|NCT01691898|452980623|FG004|Overall Study|Non-Compliance|1|||
125912623|NCT01691898|452980624|FG005|Overall Study|Non-Compliance|0|||
125912624|NCT03799211|452980630|FG000|Overall Study|Lost to Follow-up|2|||
125912625|NCT03799211|452980631|FG001|Overall Study|Lost to Follow-up|13|||
125912626|NCT03799211|452980630|FG000|Overall Study|Withdrawal by Subject|2|||
125912627|NCT03799211|452980631|FG001|Overall Study|Withdrawal by Subject|0|||
125912628|NCT00764491|452980632|FG000|Overall Study|Lost to Follow-up|35|||
125912629|NCT00764491|452980633|FG001|Overall Study|Lost to Follow-up|17|||
125912630|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
125912631|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
125912632|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Death|1|||
125912633|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Death|0|||
125912634|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
125912635|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
125912636|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
125912637|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
125912638|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
126110215|NCT03891524|453697670|FG000|Overall Study|Death|0|||
125912639|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
125912640|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
125912641|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
125912642|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
125912643|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
125912644|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
125912645|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
125912646|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
125912647|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
125912648|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
125912649|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
125912650|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
125912651|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
125912652|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
125912653|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
125912654|NCT02927262|452980640|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
125912655|NCT02927262|452980641|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
125912656|NCT02927262|452980640|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
125912657|NCT02927262|452980641|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
125912658|NCT02927262|452980640|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
125912659|NCT02927262|452980641|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
125912660|NCT02927262|452980640|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
125912661|NCT02927262|452980641|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
125912662|NCT00923936|452980642|FG000|Overall Study|progressive disease on study|2|||
125912663|NCT00923936|452980643|FG001|Overall Study|progressive disease on study|1|||
125912664|NCT00923936|452980642|FG000|Overall Study|Adverse Event|2|||
125912665|NCT00923936|452980643|FG001|Overall Study|Adverse Event|1|||
125912666|NCT00923936|452980642|FG000|Overall Study|Lost to follow up|2|||
125912667|NCT00923936|452980643|FG001|Overall Study|Lost to follow up|0|||
125912668|NCT00923936|452980642|FG000|Overall Study|Continuing in follow up period|2|||
125912669|NCT00923936|452980643|FG001|Overall Study|Continuing in follow up period|1|||
125912670|NCT01697358|452980644|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
125912671|NCT01697358|452980645|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
125912672|NCT01697358|452980644|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
125912673|NCT01697358|452980645|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
125912674|NCT01697358|452980644|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
125912675|NCT01697358|452980645|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
125912676|NCT01697358|452980644|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
125912677|NCT01697358|452980645|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
125912678|NCT01697358|452980644|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
125912679|NCT01697358|452980645|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
125912680|NCT01697358|452980644|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
125912681|NCT01697358|452980645|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
125912682|NCT01697358|452980644|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
125912683|NCT01697358|452980645|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
125912684|NCT01697358|452980644|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
125912685|NCT01697358|452980645|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
125912686|NCT01697358|452980644|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
126061469|NCT02203513|453518144|FG001|Overall Study|Did not receive investigational product (IP)|1|||
126061470|NCT02203513|453518145|FG002|Overall Study|Did not receive investigational product (IP)|0|||
126061471|NCT02203513|453518146|FG003|Overall Study|Did not receive investigational product (IP)|0|||
126061472|NCT02203513|453518147|FG004|Overall Study|Did not receive investigational product (IP)|0|||
126061473|NCT02203513|453518143|FG000|Overall Study|Death (unrelated to study therapy)|1|||
126061474|NCT02203513|453518144|FG001|Overall Study|Death (unrelated to study therapy)|3|||
126061475|NCT02203513|453518145|FG002|Overall Study|Death (unrelated to study therapy)|1|||
126110216|NCT03891524|453697671|FG001|Overall Study|Death|0|||
126110217|NCT03891524|453697672|FG002|Overall Study|Death|0|||
125912687|NCT01697358|452980645|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
125912688|NCT01697358|452980644|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
125912689|NCT01697358|452980645|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
125912690|NCT02038452|452980646|FG000|Overall Study|Withdrawal by Subject|7|||
125912691|NCT02038452|452980647|FG001|Overall Study|Withdrawal by Subject|9|||
125912692|NCT02038452|452980646|FG000|Overall Study|Lost to Follow-up|31|||
125912693|NCT02038452|452980647|FG001|Overall Study|Lost to Follow-up|28|||
125912694|NCT01460368|452980650|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125912695|NCT01460368|452980651|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125912696|NCT01460368|452980652|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125912697|NCT01460368|452980653|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125912698|NCT01460368|452980654|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
125912699|NCT01460368|452980655|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125912700|NCT01460368|452980656|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125912701|NCT01460368|452980650|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125912702|NCT01460368|452980651|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
125912703|NCT01460368|452980652|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125912704|NCT01460368|452980653|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125912705|NCT01460368|452980654|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125912706|NCT01460368|452980655|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125912707|NCT01460368|452980656|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
125912708|NCT01460368|452980650|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125912709|NCT01460368|452980651|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
125912710|NCT01460368|452980652|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125912711|NCT01460368|452980653|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125912712|NCT01460368|452980654|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125912713|NCT01460368|452980655|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125912714|NCT01460368|452980656|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125912715|NCT01460368|452980650|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125912716|NCT01460368|452980651|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125912717|NCT01460368|452980652|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
125912718|NCT01460368|452980653|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125912719|NCT01460368|452980654|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125912720|NCT01460368|452980655|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125912721|NCT01460368|452980656|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125912722|NCT01460368|452980650|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125912723|NCT01460368|452980651|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125912724|NCT01460368|452980652|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
125912725|NCT01460368|452980653|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
125912726|NCT01460368|452980654|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125912727|NCT01460368|452980655|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
125912728|NCT01460368|452980656|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125912729|NCT00299182|452980666|FG000|Overall Study|Withdrawal by Subject|0|||
125912730|NCT00299182|452980667|FG001|Overall Study|Withdrawal by Subject|0|||
125912731|NCT00299182|452980668|FG002|Overall Study|Withdrawal by Subject|1|||
125912732|NCT00299182|452980669|FG003|Overall Study|Withdrawal by Subject|0|||
125912733|NCT00299182|452980670|FG004|Overall Study|Withdrawal by Subject|1|||
125912734|NCT00299182|452980671|FG005|Overall Study|Withdrawal by Subject|2|||
125912735|NCT00299182|452980672|FG006|Overall Study|Withdrawal by Subject|0|||
125912736|NCT00299182|452980666|FG000|Overall Study|Chemotherapy Changed|0|||
125912737|NCT00299182|452980667|FG001|Overall Study|Chemotherapy Changed|0|||
125912738|NCT00299182|452980668|FG002|Overall Study|Chemotherapy Changed|1|||
125912739|NCT00299182|452980669|FG003|Overall Study|Chemotherapy Changed|0|||
125912740|NCT00299182|452980670|FG004|Overall Study|Chemotherapy Changed|1|||
125912741|NCT00299182|452980671|FG005|Overall Study|Chemotherapy Changed|0|||
125912742|NCT00299182|452980672|FG006|Overall Study|Chemotherapy Changed|1|||
125912743|NCT00299182|452980666|FG000|Overall Study|Adverse Event|0|||
125912744|NCT00299182|452980667|FG001|Overall Study|Adverse Event|0|||
125912745|NCT00299182|452980668|FG002|Overall Study|Adverse Event|0|||
126061476|NCT02203513|453518146|FG003|Overall Study|Death (unrelated to study therapy)|0|||
126061477|NCT02203513|453518147|FG004|Overall Study|Death (unrelated to study therapy)|2|||
126061478|NCT02203513|453518143|FG000|Overall Study|Lost to Follow-up|0|||
126061479|NCT02203513|453518144|FG001|Overall Study|Lost to Follow-up|0|||
125912746|NCT00299182|452980669|FG003|Overall Study|Adverse Event|0|||
125912747|NCT00299182|452980670|FG004|Overall Study|Adverse Event|0|||
125912748|NCT00299182|452980671|FG005|Overall Study|Adverse Event|1|||
126061480|NCT02203513|453518145|FG002|Overall Study|Lost to Follow-up|1|||
126061481|NCT02203513|453518146|FG003|Overall Study|Lost to Follow-up|1|||
126061482|NCT02203513|453518147|FG004|Overall Study|Lost to Follow-up|0|||
125912749|NCT00299182|452980672|FG006|Overall Study|Adverse Event|0|||
125912750|NCT00299182|452980666|FG000|Overall Study|Not Eligible|0|||
125912751|NCT00299182|452980667|FG001|Overall Study|Not Eligible|0|||
125912752|NCT00299182|452980668|FG002|Overall Study|Not Eligible|0|||
125912753|NCT00299182|452980669|FG003|Overall Study|Not Eligible|0|||
125912754|NCT00299182|452980670|FG004|Overall Study|Not Eligible|1|||
125912755|NCT00299182|452980671|FG005|Overall Study|Not Eligible|0|||
125912756|NCT00299182|452980672|FG006|Overall Study|Not Eligible|0|||
125912757|NCT00304239|452980673|FG000|Overall Study|Protocol Deviations/Violations|15|||
125912758|NCT00304239|452980674|FG001|Overall Study|Protocol Deviations/Violations|0|||
125912759|NCT00304239|452980673|FG000|Overall Study|Adverse Event|2|||
125912760|NCT00304239|452980674|FG001|Overall Study|Adverse Event|0|||
125912761|NCT02979197|452980675|FG000|Overall Study|Adverse Event|4|||
125912762|NCT02979197|452980676|FG001|Overall Study|Adverse Event|2|||
125912763|NCT02979197|452980677|FG002|Overall Study|Adverse Event|0|||
125912764|NCT02979197|452980675|FG000|Overall Study|Protocol Violation|0|||
125912765|NCT02979197|452980676|FG001|Overall Study|Protocol Violation|1|||
125912766|NCT02979197|452980677|FG002|Overall Study|Protocol Violation|0|||
125912767|NCT02979197|452980675|FG000|Overall Study|Subject unable to commit to study dates|0|||
125912768|NCT02979197|452980676|FG001|Overall Study|Subject unable to commit to study dates|1|||
125912769|NCT02979197|452980677|FG002|Overall Study|Subject unable to commit to study dates|0|||
125912770|NCT03643159|452980678|FG000|Overall Study|Adverse Event|1|||
125912771|NCT03643159|452980678|FG000|Overall Study|Withdrawal by Subject|1|||
125912772|NCT01898208|452980681|FG000|Overall Study|Positive blood culture|17|||
125912773|NCT01898208|452980682|FG001|Overall Study|Positive blood culture|23|||
125912774|NCT01898208|452980683|FG002|Overall Study|Positive blood culture|15|||
125912775|NCT01898208|452980681|FG000|Overall Study|Death/comfort care within 24 hours|10|||
125912776|NCT01898208|452980682|FG001|Overall Study|Death/comfort care within 24 hours|9|||
125912777|NCT01898208|452980683|FG002|Overall Study|Death/comfort care within 24 hours|8|||
125912778|NCT01898208|452980681|FG000|Overall Study|Negative Gram Stain|6|||
125912779|NCT01898208|452980682|FG001|Overall Study|Negative Gram Stain|9|||
125912780|NCT01898208|452980683|FG002|Overall Study|Negative Gram Stain|6|||
125912781|NCT01898208|452980681|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
125912782|NCT01898208|452980682|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
125912783|NCT01898208|452980683|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
125912784|NCT01898208|452980681|FG000|Overall Study|System/Technical Error|1|||
125912785|NCT01898208|452980682|FG001|Overall Study|System/Technical Error|2|||
125912786|NCT01898208|452980683|FG002|Overall Study|System/Technical Error|3|||
125912787|NCT01898208|452980681|FG000|Overall Study|Lost to Follow-up|3|||
125912788|NCT01898208|452980682|FG001|Overall Study|Lost to Follow-up|1|||
125912789|NCT01898208|452980683|FG002|Overall Study|Lost to Follow-up|1|||
125912790|NCT01631812|452980684|FG000|Overall Study|Adverse Event|25|||
125912791|NCT01631812|452980684|FG000|Overall Study|Lack of Efficacy|5|||
125912792|NCT01631812|452980684|FG000|Overall Study|Withdrawal by Subject|4|||
125912793|NCT01631812|452980684|FG000|Overall Study|Physician Decision|3|||
125912794|NCT02436681|452980687|FG000|Overall Study|Lost to Follow-up|10|||
125912795|NCT02436681|452980687|FG000|Overall Study|Withdrawal by Subject|2|||
125912796|NCT02436681|452980687|FG000|Overall Study|Death|2|||
125912797|NCT02030938|452980688|FG000|Overall Study|Lost to Follow-up|4|||
125912798|NCT02030938|452980688|FG000|Overall Study|Withdrawal by Subject|1|||
125912799|NCT03954132|452980692|FG000|Overall Study|Adverse Event|2|||
125912800|NCT03954132|452980693|FG001|Overall Study|Adverse Event|0|||
125912801|NCT03954132|452980692|FG000|Overall Study|Patient's wish|5|||
125912802|NCT03954132|452980693|FG001|Overall Study|Patient's wish|0|||
125912803|NCT03954132|452980692|FG000|Overall Study|Lost to Follow-up|10|||
126061483|NCT02513667|453518148|FG000|Overall Study|Withdrawal by Subject|0|||
126061484|NCT02513667|453518149|FG001|Overall Study|Withdrawal by Subject|1|||
126061485|NCT01964547|453518160|FG000|Overall Study|Adverse Event|8|||
126061486|NCT01964547|453518161|FG001|Overall Study|Adverse Event|2|||
126061487|NCT01964547|453518160|FG000|Overall Study|Withdrawal by Subject|4|||
126061488|NCT01964547|453518161|FG001|Overall Study|Withdrawal by Subject|7|||
126061489|NCT01964547|453518160|FG000|Overall Study|Lost to Follow-up|0|||
125912804|NCT03954132|452980693|FG001|Overall Study|Lost to Follow-up|0|||
125912805|NCT03954132|452980692|FG000|Overall Study|Screening failure|0|||
125912806|NCT03954132|452980693|FG001|Overall Study|Screening failure|1|||
125912807|NCT03954132|452980692|FG000|Overall Study|No registration after Visit 1|5|||
125912808|NCT03954132|452980693|FG001|Overall Study|No registration after Visit 1|2|||
125912809|NCT03954132|452980692|FG000|Overall Study|Other reason than listed|2|||
126061490|NCT01964547|453518161|FG001|Overall Study|Lost to Follow-up|1|||
125912810|NCT03954132|452980693|FG001|Overall Study|Other reason than listed|2|||
125912811|NCT03954132|452980692|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
125912812|NCT03954132|452980693|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
125912813|NCT03954132|452980692|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
125912814|NCT03954132|452980693|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
126061491|NCT01964547|453518160|FG000|Overall Study|Withdrawal by Investigator|0|||
126061492|NCT01964547|453518161|FG001|Overall Study|Withdrawal by Investigator|1|||
125912815|NCT00072176|452980694|FG000|Overall Study|Withdrawal by Subject|1|||
125912816|NCT00072176|452980695|FG001|Overall Study|Withdrawal by Subject|0|||
125912817|NCT00072176|452980694|FG000|Overall Study|Protocol Violation|0|||
125912818|NCT00072176|452980695|FG001|Overall Study|Protocol Violation|1|||
125912819|NCT00932737|452980704|FG000|Overall Study|Not treated in second episode|1|||
125912820|NCT00932737|452980705|FG001|Overall Study|Not treated in second episode|0|||
125912821|NCT00932737|452980704|FG000|Overall Study|Adverse Event|0|||
125912822|NCT00932737|452980705|FG001|Overall Study|Adverse Event|1|||
125912823|NCT04399837|452980706|FG000|Overall Study|Other than listed|0|||
125912824|NCT04399837|452980707|FG001|Overall Study|Other than listed|2|||
125912825|NCT04399837|452980708|FG002|Overall Study|Other than listed|2|||
125912826|NCT04399837|452980709|FG003|Overall Study|Other than listed|3|||
125912827|NCT04399837|452980706|FG000|Overall Study|Withdrawal by Subject|1|||
125912828|NCT04399837|452980707|FG001|Overall Study|Withdrawal by Subject|2|||
125912829|NCT04399837|452980708|FG002|Overall Study|Withdrawal by Subject|1|||
125912830|NCT04399837|452980709|FG003|Overall Study|Withdrawal by Subject|1|||
125912831|NCT02024555|452980710|FG000|Overall Study|Lost to Follow-up|1|||
125912832|NCT02024555|452980711|FG001|Overall Study|Lost to Follow-up|1|||
125912833|NCT02024555|452980710|FG000|Overall Study|Withdrawal by Subject|5|||
125912834|NCT02024555|452980711|FG001|Overall Study|Withdrawal by Subject|1|||
125912835|NCT03805646|452980713|FG000|Overall Study|Death|40|||
125912836|NCT03805646|452980714|FG001|Overall Study|Death|49|||
125912837|NCT03805646|452980713|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
125912838|NCT03805646|452980714|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
125912839|NCT03350620|452980718|FG000|Stage 2|Adverse Event|0|||
125912840|NCT03350620|452980719|FG001|Stage 2|Adverse Event|1|||
125912841|NCT03350620|452980720|FG002|Stage 2|Adverse Event|1|||
125912842|NCT03350620|452980718|FG000|Stage 2|Lack of Efficacy|0|||
125912843|NCT03350620|452980719|FG001|Stage 2|Lack of Efficacy|2|||
125912844|NCT03350620|452980720|FG002|Stage 2|Lack of Efficacy|0|||
125912845|NCT03350620|452980718|FG000|Stage 2|Lost to Follow-up|1|||
125912846|NCT03350620|452980719|FG001|Stage 2|Lost to Follow-up|2|||
125912847|NCT03350620|452980720|FG002|Stage 2|Lost to Follow-up|2|||
125912848|NCT03350620|452980718|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
125912849|NCT03350620|452980719|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
125912850|NCT03350620|452980720|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
125912851|NCT01066000|452980721|FG000|Overall Study|Protocol Violation|4|||
125912852|NCT01066000|452980721|FG000|Overall Study|Death|3|||
125912853|NCT01066000|452980721|FG000|Overall Study|Withdrawal by Subject|1|||
125912854|NCT01066000|452980721|FG000|Overall Study|Adverse Event|1|||
125912855|NCT01554397|452980722|FG000|Overall Study|Withdrawal by Subject|1|||
125912856|NCT01554397|452980723|FG001|Overall Study|Withdrawal by Subject|0|||
125912857|NCT01554397|452980722|FG000|Overall Study|Ineligible|7|||
125912858|NCT01554397|452980723|FG001|Overall Study|Ineligible|0|||
125912859|NCT01854658|452982660|FG000|Overall Study|Protocol Violation|6|||
125912860|NCT01854658|452982661|FG001|Overall Study|Protocol Violation|2|||
125912861|NCT01854658|452982662|FG002|Overall Study|Protocol Violation|2|||
125912862|NCT01854658|452982663|FG003|Overall Study|Protocol Violation|1|||
125912863|NCT01854658|452982660|FG000|Overall Study|Physician Decision|7|||
125912864|NCT01854658|452982661|FG001|Overall Study|Physician Decision|5|||
125912865|NCT01854658|452982662|FG002|Overall Study|Physician Decision|2|||
125912866|NCT01854658|452982663|FG003|Overall Study|Physician Decision|4|||
125912867|NCT01854658|452982660|FG000|Overall Study|Lost to Follow-up|8|||
125912868|NCT01854658|452982661|FG001|Overall Study|Lost to Follow-up|9|||
125912869|NCT01854658|452982662|FG002|Overall Study|Lost to Follow-up|8|||
125912870|NCT01854658|452982663|FG003|Overall Study|Lost to Follow-up|4|||
126061493|NCT00912964|453518162|FG000|Overall Study|Eligibility criterion not met|1|||
126061494|NCT00912964|453518163|FG001|Overall Study|Eligibility criterion not met|1|||
125912871|NCT01854658|452982660|FG000|Overall Study|Withdrawal by Subject|28|||
125912872|NCT01854658|452982661|FG001|Overall Study|Withdrawal by Subject|21|||
125912873|NCT01854658|452982662|FG002|Overall Study|Withdrawal by Subject|29|||
125912874|NCT01854658|452982663|FG003|Overall Study|Withdrawal by Subject|15|||
125912875|NCT01854658|452982660|FG000|Overall Study|Protocol-specified criteria|15|||
125912876|NCT01854658|452982661|FG001|Overall Study|Protocol-specified criteria|15|||
125912877|NCT01854658|452982662|FG002|Overall Study|Protocol-specified criteria|10|||
125912878|NCT01854658|452982663|FG003|Overall Study|Protocol-specified criteria|7|||
125912879|NCT01854658|452982660|FG000|Overall Study|Lack of Efficacy|3|||
125912880|NCT01854658|452982661|FG001|Overall Study|Lack of Efficacy|8|||
126061495|NCT00912964|453518164|FG002|Overall Study|Eligibility criterion not met|0|||
126061496|NCT00912964|453518162|FG000|Overall Study|Adverse Event|15|||
125912881|NCT01854658|452982662|FG002|Overall Study|Lack of Efficacy|4|||
125912882|NCT01854658|452982663|FG003|Overall Study|Lack of Efficacy|7|||
125912883|NCT01854658|452982660|FG000|Overall Study|Adverse Event|21|||
125912884|NCT01854658|452982661|FG001|Overall Study|Adverse Event|14|||
125912885|NCT01854658|452982662|FG002|Overall Study|Adverse Event|23|||
125912886|NCT01854658|452982663|FG003|Overall Study|Adverse Event|19|||
125912887|NCT01854658|452982660|FG000|Overall Study|Administrative reasons|5|||
125912888|NCT01854658|452982661|FG001|Overall Study|Administrative reasons|1|||
125912889|NCT01854658|452982662|FG002|Overall Study|Administrative reasons|2|||
125912890|NCT01854658|452982663|FG003|Overall Study|Administrative reasons|2|||
125912891|NCT01858376|452982664|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
125912892|NCT02436304|452982670|FG000|Overall Study|Lost to Follow-up|0|||
125912893|NCT02436304|452982671|FG001|Overall Study|Lost to Follow-up|1|||
125912894|NCT02436304|452982672|FG002|Overall Study|Lost to Follow-up|0|||
125912895|NCT02436304|452982670|FG000|Overall Study|Withdrawal by Subject|0|||
125912896|NCT02436304|452982671|FG001|Overall Study|Withdrawal by Subject|1|||
125912897|NCT02436304|452982672|FG002|Overall Study|Withdrawal by Subject|0|||
125912898|NCT02436304|452982670|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
125912899|NCT02436304|452982671|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
125912900|NCT02436304|452982672|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
125912901|NCT03793556|452982673|FG000|Overall Study|Withdrawal by Subject|12|||
125912902|NCT03793556|452982674|FG001|Overall Study|Withdrawal by Subject|1|||
125912903|NCT03793556|452982673|FG000|Overall Study|Lost to Follow-up|1|||
125912904|NCT03793556|452982674|FG001|Overall Study|Lost to Follow-up|1|||
125912905|NCT04416633|452982675|FG000|Overall Study|Death|1|||
125912906|NCT04416633|452982675|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
125912907|NCT04416633|452982675|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
125912908|NCT04416633|452982675|FG000|Overall Study|Adverse Event|6|||
125912909|NCT04416633|452982675|FG000|Overall Study|Withdrawal by Subject|6|||
125912910|NCT04612790|452982676|FG000|DB Period (Up to 36 Weeks)|Death|1|||
125912911|NCT04612790|452982677|FG001|DB Period (Up to 36 Weeks)|Death|1|||
125912912|NCT04612790|452982678|FG002|DB Period (Up to 36 Weeks)|Death|0|||
125912913|NCT04612790|452982679|FG003|DB Period (Up to 36 Weeks)|Death|0|||
125912914|NCT04612790|452982676|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
125912915|NCT04612790|452982677|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
125912916|NCT04612790|452982678|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
125912917|NCT04612790|452982679|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
125912918|NCT04612790|452982676|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
125912919|NCT04612790|452982677|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
125912920|NCT04612790|452982678|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
125912921|NCT04612790|452982679|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
125912922|NCT04612790|452982676|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
125912923|NCT04612790|452982677|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
125912924|NCT04612790|452982678|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
125912925|NCT04612790|452982679|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
125912926|NCT04612790|452982676|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
125912927|NCT04612790|452982677|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
125912928|NCT04612790|452982678|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
125912929|NCT04612790|452982679|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
125912930|NCT04612790|452982676|FG000|DB Period (Up to 36 Weeks)|Other|1|||
125912931|NCT04612790|452982677|FG001|DB Period (Up to 36 Weeks)|Other|0|||
125912932|NCT04612790|452982678|FG002|DB Period (Up to 36 Weeks)|Other|0|||
125912933|NCT04612790|452982679|FG003|DB Period (Up to 36 Weeks)|Other|0|||
125912934|NCT04612790|452982676|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
125912935|NCT04612790|452982677|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
125912936|NCT04612790|452982678|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
125912937|NCT04612790|452982679|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
125912938|NCT04612790|452982676|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
125912939|NCT04612790|452982677|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
125912940|NCT04612790|452982678|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
125912941|NCT04612790|452982679|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
125912942|NCT04612790|452982676|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
125912943|NCT04612790|452982677|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
125912944|NCT04612790|452982678|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
125912945|NCT04612790|452982679|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
125912946|NCT04612790|452982676|FG000|OLE Period (Up to 1 Year)|Other|0|||
125912947|NCT04612790|452982677|FG001|OLE Period (Up to 1 Year)|Other|0|||
125912948|NCT04612790|452982678|FG002|OLE Period (Up to 1 Year)|Other|0|||
125912949|NCT04612790|452982679|FG003|OLE Period (Up to 1 Year)|Other|1|||
125912950|NCT00785928|452982680|FG000|Treatment Phase|Adverse Event|1|||
125912951|NCT00785928|452982681|FG001|Treatment Phase|Adverse Event|1|||
125912952|NCT00785928|452982682|FG002|Treatment Phase|Adverse Event|2|||
125912953|NCT00785928|452982683|FG003|Treatment Phase|Adverse Event|0|||
125912954|NCT00785928|452982684|FG004|Treatment Phase|Adverse Event|0|||
125912955|NCT00785928|452982685|FG005|Treatment Phase|Adverse Event|0|||
125912956|NCT00785928|452982686|FG006|Treatment Phase|Adverse Event|2|||
125912957|NCT00785928|452982680|FG000|Treatment Phase|Inadequate Response|0|||
125912958|NCT00785928|452982681|FG001|Treatment Phase|Inadequate Response|1|||
125912959|NCT00785928|452982682|FG002|Treatment Phase|Inadequate Response|0|||
125912960|NCT00785928|452982683|FG003|Treatment Phase|Inadequate Response|0|||
125912961|NCT00785928|452982684|FG004|Treatment Phase|Inadequate Response|0|||
125912962|NCT00785928|452982685|FG005|Treatment Phase|Inadequate Response|0|||
125912963|NCT00785928|452982686|FG006|Treatment Phase|Inadequate Response|0|||
125912964|NCT00785928|452982680|FG000|Treatment Phase|Lack of Efficacy|0|||
125912965|NCT00785928|452982681|FG001|Treatment Phase|Lack of Efficacy|1|||
125912966|NCT00785928|452982682|FG002|Treatment Phase|Lack of Efficacy|1|||
125912967|NCT00785928|452982683|FG003|Treatment Phase|Lack of Efficacy|0|||
125912968|NCT00785928|452982684|FG004|Treatment Phase|Lack of Efficacy|0|||
125912969|NCT00785928|452982685|FG005|Treatment Phase|Lack of Efficacy|0|||
125912970|NCT00785928|452982686|FG006|Treatment Phase|Lack of Efficacy|0|||
125912971|NCT00785928|452982680|FG000|Treatment Phase|Physician Decision|0|||
125912972|NCT00785928|452982681|FG001|Treatment Phase|Physician Decision|0|||
125912973|NCT00785928|452982682|FG002|Treatment Phase|Physician Decision|0|||
125912974|NCT00785928|452982683|FG003|Treatment Phase|Physician Decision|0|||
125912975|NCT00785928|452982684|FG004|Treatment Phase|Physician Decision|1|||
125912976|NCT00785928|452982685|FG005|Treatment Phase|Physician Decision|0|||
125912977|NCT00785928|452982686|FG006|Treatment Phase|Physician Decision|0|||
125912978|NCT00785928|452982680|FG000|Treatment Phase|Sponsor Decision|1|||
125912979|NCT00785928|452982681|FG001|Treatment Phase|Sponsor Decision|0|||
125912980|NCT00785928|452982682|FG002|Treatment Phase|Sponsor Decision|0|||
125912981|NCT00785928|452982683|FG003|Treatment Phase|Sponsor Decision|0|||
125912982|NCT00785928|452982684|FG004|Treatment Phase|Sponsor Decision|0|||
125912983|NCT00785928|452982685|FG005|Treatment Phase|Sponsor Decision|0|||
125912984|NCT00785928|452982686|FG006|Treatment Phase|Sponsor Decision|1|||
125912985|NCT00785928|452982680|FG000|Treatment Phase|Withdrawal by Subject|1|||
125912986|NCT00785928|452982681|FG001|Treatment Phase|Withdrawal by Subject|2|||
125912987|NCT00785928|452982682|FG002|Treatment Phase|Withdrawal by Subject|0|||
125912988|NCT00785928|452982683|FG003|Treatment Phase|Withdrawal by Subject|0|||
125912989|NCT00785928|452982684|FG004|Treatment Phase|Withdrawal by Subject|1|||
125912990|NCT00785928|452982685|FG005|Treatment Phase|Withdrawal by Subject|0|||
125912991|NCT00785928|452982686|FG006|Treatment Phase|Withdrawal by Subject|0|||
125912992|NCT00408629|452982691|FG000|Overall Study|Adverse Event|13|||
125912993|NCT00408629|452982692|FG001|Overall Study|Adverse Event|27|||
125912994|NCT00408629|452982691|FG000|Overall Study|Withdrawal by Subject|8|||
125912995|NCT00408629|452982692|FG001|Overall Study|Withdrawal by Subject|4|||
125912996|NCT00408629|452982691|FG000|Overall Study|Lost to Follow-up|1|||
125912997|NCT00408629|452982692|FG001|Overall Study|Lost to Follow-up|1|||
125912998|NCT00408629|452982691|FG000|Overall Study|Lack of Efficacy|63|||
125912999|NCT00408629|452982692|FG001|Overall Study|Lack of Efficacy|73|||
125913000|NCT00408629|452982691|FG000|Overall Study|Protocol Violation|1|||
125913001|NCT00408629|452982692|FG001|Overall Study|Protocol Violation|5|||
125913002|NCT00408629|452982691|FG000|Overall Study|Miscellaneous|11|||
125913003|NCT00408629|452982692|FG001|Overall Study|Miscellaneous|15|||
125913004|NCT00191906|452982693|FG000|Study Period II|Adverse Event|0|||
125913005|NCT00191906|452982694|FG001|Study Period II|Adverse Event|1|||
125913006|NCT00191906|452982695|FG002|Study Period II|Adverse Event|0|||
125913007|NCT00191906|452982696|FG003|Study Period II|Adverse Event|0|||
125913008|NCT00191906|452982693|FG000|Study Period II|Withdrawal by Subject|0|||
125913009|NCT00191906|452982694|FG001|Study Period II|Withdrawal by Subject|3|||
125913010|NCT00191906|452982695|FG002|Study Period II|Withdrawal by Subject|0|||
125913011|NCT00191906|452982696|FG003|Study Period II|Withdrawal by Subject|0|||
125913012|NCT00191906|452982693|FG000|Study Period II|Parent/Caregiver Decision|0|||
125913013|NCT00191906|452982694|FG001|Study Period II|Parent/Caregiver Decision|1|||
125913014|NCT00191906|452982695|FG002|Study Period II|Parent/Caregiver Decision|0|||
125913015|NCT00191906|452982696|FG003|Study Period II|Parent/Caregiver Decision|0|||
125913016|NCT00191906|452982693|FG000|Study Period II|Entry Criteria Exclusion|0|||
125913017|NCT00191906|452982694|FG001|Study Period II|Entry Criteria Exclusion|0|||
125913018|NCT00191906|452982695|FG002|Study Period II|Entry Criteria Exclusion|1|||
125913019|NCT00191906|452982696|FG003|Study Period II|Entry Criteria Exclusion|0|||
125913020|NCT00191906|452982693|FG000|Study Period III|Adverse Event|1|||
125913021|NCT00191906|452982694|FG001|Study Period III|Adverse Event|0|||
125913022|NCT00191906|452982695|FG002|Study Period III|Adverse Event|0|||
125913023|NCT00191906|452982696|FG003|Study Period III|Adverse Event|0|||
125913024|NCT00191906|452982693|FG000|Study Period III|Lost to Follow-up|0|||
125913025|NCT00191906|452982694|FG001|Study Period III|Lost to Follow-up|1|||
125913026|NCT00191906|452982695|FG002|Study Period III|Lost to Follow-up|0|||
125913027|NCT00191906|452982696|FG003|Study Period III|Lost to Follow-up|0|||
125913028|NCT00191906|452982693|FG000|Study Period III|Parent/Caregiver Decision|1|||
125913029|NCT00191906|452982694|FG001|Study Period III|Parent/Caregiver Decision|0|||
125913030|NCT00191906|452982695|FG002|Study Period III|Parent/Caregiver Decision|0|||
125913031|NCT00191906|452982696|FG003|Study Period III|Parent/Caregiver Decision|0|||
125913032|NCT00191906|452982693|FG000|Study Period III|Lack of Efficacy|3|||
125913033|NCT00191906|452982694|FG001|Study Period III|Lack of Efficacy|3|||
125913034|NCT00191906|452982695|FG002|Study Period III|Lack of Efficacy|0|||
125913035|NCT00191906|452982696|FG003|Study Period III|Lack of Efficacy|0|||
125913036|NCT00573937|452982697|FG000|Overall Study|Study Terminated|0|||
125913037|NCT00573937|452982698|FG001|Overall Study|Study Terminated|1|||
125913038|NCT00333801|452982699|FG000|Overall Study|Moved to another state|5|||
125913039|NCT00333801|452982700|FG001|Overall Study|Moved to another state|3|||
125913040|NCT00333801|452982699|FG000|Overall Study|Lost to Follow-up|2|||
125913041|NCT00333801|452982700|FG001|Overall Study|Lost to Follow-up|0|||
125913042|NCT00333801|452982699|FG000|Overall Study|Incarcerated|1|||
125913043|NCT00333801|452982700|FG001|Overall Study|Incarcerated|2|||
125913044|NCT00333801|452982699|FG000|Overall Study|Withdrawal by Subject|0|||
125913045|NCT00333801|452982700|FG001|Overall Study|Withdrawal by Subject|1|||
125913046|NCT04171765|452982701|FG000|Overall Study|Adverse Event|2|||
125913047|NCT04171765|452982702|FG001|Overall Study|Adverse Event|0|||
125913048|NCT04171765|452982703|FG002|Overall Study|Adverse Event|1|||
125913049|NCT04171765|452982704|FG003|Overall Study|Adverse Event|0|||
125913050|NCT04171765|452982701|FG000|Overall Study|Lost to Follow-up|0|||
125913051|NCT04171765|452982702|FG001|Overall Study|Lost to Follow-up|2|||
125913052|NCT04171765|452982703|FG002|Overall Study|Lost to Follow-up|2|||
125913053|NCT04171765|452982704|FG003|Overall Study|Lost to Follow-up|2|||
125913054|NCT04171765|452982701|FG000|Overall Study|Week 58 visit missed|0|||
125913055|NCT04171765|452982702|FG001|Overall Study|Week 58 visit missed|0|||
125913056|NCT04171765|452982703|FG002|Overall Study|Week 58 visit missed|1|||
125913057|NCT04171765|452982704|FG003|Overall Study|Week 58 visit missed|0|||
125913058|NCT04171765|452982701|FG000|Overall Study|Study terminated by sponsor|2|||
125913059|NCT04171765|452982702|FG001|Overall Study|Study terminated by sponsor|0|||
125913060|NCT04171765|452982703|FG002|Overall Study|Study terminated by sponsor|0|||
125913061|NCT04171765|452982704|FG003|Overall Study|Study terminated by sponsor|0|||
125913062|NCT04171765|452982701|FG000|Overall Study|Withdrawal by Subject|1|||
125913063|NCT04171765|452982702|FG001|Overall Study|Withdrawal by Subject|0|||
125913064|NCT04171765|452982703|FG002|Overall Study|Withdrawal by Subject|0|||
125913065|NCT04171765|452982704|FG003|Overall Study|Withdrawal by Subject|3|||
125913066|NCT03633617|452982705|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
125913067|NCT03633617|452982706|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
125913068|NCT03633617|452982707|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913069|NCT03633617|452982708|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913070|NCT03633617|452982709|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913071|NCT03633617|452982710|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913072|NCT03633617|452982711|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913073|NCT03633617|452982712|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913074|NCT03633617|452982713|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913075|NCT03633617|452982714|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913076|NCT03633617|452982715|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125913077|NCT03633617|452982705|FG000|Part A|Unconfirmed early termination visit|1|||
125913078|NCT03633617|452982706|FG001|Part A|Unconfirmed early termination visit|0|||
125913079|NCT03633617|452982707|FG002|Part A|Unconfirmed early termination visit|0|||
125913080|NCT03633617|452982708|FG003|Part A|Unconfirmed early termination visit|0|||
125913081|NCT03633617|452982709|FG004|Part A|Unconfirmed early termination visit|0|||
125913082|NCT03633617|452982710|FG005|Part A|Unconfirmed early termination visit|0|||
125913083|NCT03633617|452982711|FG006|Part A|Unconfirmed early termination visit|0|||
125913084|NCT03633617|452982712|FG007|Part A|Unconfirmed early termination visit|0|||
125913085|NCT03633617|452982713|FG008|Part A|Unconfirmed early termination visit|0|||
125913086|NCT03633617|452982714|FG009|Part A|Unconfirmed early termination visit|0|||
125913087|NCT03633617|452982715|FG010|Part A|Unconfirmed early termination visit|0|||
125913088|NCT03633617|452982705|FG000|Part A|Adverse Event|0|||
125913089|NCT03633617|452982706|FG001|Part A|Adverse Event|1|||
125913090|NCT03633617|452982707|FG002|Part A|Adverse Event|0|||
126061497|NCT00912964|453518163|FG001|Overall Study|Adverse Event|18|||
126061498|NCT00912964|453518164|FG002|Overall Study|Adverse Event|12|||
126061499|NCT00912964|453518162|FG000|Overall Study|Lack of Efficacy|11|||
126061500|NCT00912964|453518163|FG001|Overall Study|Lack of Efficacy|4|||
126061501|NCT00912964|453518164|FG002|Overall Study|Lack of Efficacy|3|||
125913091|NCT03633617|452982708|FG003|Part A|Adverse Event|0|||
125913092|NCT03633617|452982709|FG004|Part A|Adverse Event|0|||
125913093|NCT03633617|452982710|FG005|Part A|Adverse Event|0|||
126061502|NCT00912964|453518162|FG000|Overall Study|Withdrawal by Subject|20|||
126061503|NCT00912964|453518163|FG001|Overall Study|Withdrawal by Subject|12|||
126061504|NCT00912964|453518164|FG002|Overall Study|Withdrawal by Subject|18|||
126061505|NCT00912964|453518162|FG000|Overall Study|Lost to Follow-up|4|||
126061506|NCT00912964|453518163|FG001|Overall Study|Lost to Follow-up|3|||
126061507|NCT00912964|453518164|FG002|Overall Study|Lost to Follow-up|3|||
126061508|NCT00912964|453518162|FG000|Overall Study|Protocol Violation|5|||
126061509|NCT00912964|453518163|FG001|Overall Study|Protocol Violation|3|||
126061510|NCT00912964|453518164|FG002|Overall Study|Protocol Violation|8|||
126061511|NCT00912964|453518162|FG000|Overall Study|Taking exclusionary medications|7|||
126061512|NCT00912964|453518163|FG001|Overall Study|Taking exclusionary medications|4|||
126061513|NCT00912964|453518164|FG002|Overall Study|Taking exclusionary medications|8|||
126061514|NCT00912964|453518162|FG000|Overall Study|Medical History|1|||
126061515|NCT00912964|453518163|FG001|Overall Study|Medical History|0|||
126061516|NCT00912964|453518164|FG002|Overall Study|Medical History|0|||
125913094|NCT03633617|452982711|FG006|Part A|Adverse Event|0|||
125913095|NCT03633617|452982712|FG007|Part A|Adverse Event|0|||
125913096|NCT03633617|452982713|FG008|Part A|Adverse Event|0|||
125913097|NCT03633617|452982714|FG009|Part A|Adverse Event|0|||
125913098|NCT03633617|452982715|FG010|Part A|Adverse Event|0|||
125913099|NCT03633617|452982705|FG000|Part A|Pregnancy|1|||
125913100|NCT03633617|452982706|FG001|Part A|Pregnancy|0|||
125913101|NCT03633617|452982707|FG002|Part A|Pregnancy|0|||
125913102|NCT03633617|452982708|FG003|Part A|Pregnancy|0|||
125913103|NCT03633617|452982709|FG004|Part A|Pregnancy|0|||
125913104|NCT03633617|452982710|FG005|Part A|Pregnancy|0|||
125913105|NCT03633617|452982711|FG006|Part A|Pregnancy|0|||
125913106|NCT03633617|452982712|FG007|Part A|Pregnancy|0|||
125913107|NCT03633617|452982713|FG008|Part A|Pregnancy|0|||
125913108|NCT03633617|452982714|FG009|Part A|Pregnancy|0|||
125913109|NCT03633617|452982715|FG010|Part A|Pregnancy|0|||
125913110|NCT03633617|452982705|FG000|Part A|Withdrawal by Subject|0|||
125913111|NCT03633617|452982706|FG001|Part A|Withdrawal by Subject|1|||
125913112|NCT03633617|452982707|FG002|Part A|Withdrawal by Subject|0|||
125913113|NCT03633617|452982708|FG003|Part A|Withdrawal by Subject|0|||
125913114|NCT03633617|452982709|FG004|Part A|Withdrawal by Subject|0|||
125913115|NCT03633617|452982710|FG005|Part A|Withdrawal by Subject|0|||
125913116|NCT03633617|452982711|FG006|Part A|Withdrawal by Subject|0|||
125913117|NCT03633617|452982712|FG007|Part A|Withdrawal by Subject|0|||
125913118|NCT03633617|452982713|FG008|Part A|Withdrawal by Subject|0|||
125913119|NCT03633617|452982714|FG009|Part A|Withdrawal by Subject|0|||
125913120|NCT03633617|452982715|FG010|Part A|Withdrawal by Subject|0|||
125913121|NCT03633617|452982705|FG000|Part B|Adverse Event|0|||
125913122|NCT03633617|452982706|FG001|Part B|Adverse Event|0|||
125913123|NCT03633617|452982707|FG002|Part B|Adverse Event|2|||
125913124|NCT03633617|452982708|FG003|Part B|Adverse Event|2|||
125913125|NCT03633617|452982709|FG004|Part B|Adverse Event|1|||
125913126|NCT03633617|452982710|FG005|Part B|Adverse Event|0|||
125913127|NCT03633617|452982711|FG006|Part B|Adverse Event|0|||
125913128|NCT03633617|452982712|FG007|Part B|Adverse Event|0|||
126061517|NCT00912964|453518162|FG000|Overall Study|Non-compliance with study procedures|2|||
126061518|NCT00912964|453518163|FG001|Overall Study|Non-compliance with study procedures|0|||
126061519|NCT00912964|453518164|FG002|Overall Study|Non-compliance with study procedures|0|||
126061520|NCT00912964|453518162|FG000|Overall Study|Violation of exclusion criterion|0|||
126061521|NCT00912964|453518163|FG001|Overall Study|Violation of exclusion criterion|0|||
126061522|NCT00912964|453518164|FG002|Overall Study|Violation of exclusion criterion|2|||
126061523|NCT00912964|453518162|FG000|Overall Study|Randomized but never received study drug|0|||
126061524|NCT00912964|453518163|FG001|Overall Study|Randomized but never received study drug|1|||
126061525|NCT00912964|453518164|FG002|Overall Study|Randomized but never received study drug|0|||
126061526|NCT02978716|453518165|FG000|Overall Study|Death|25|||
126061527|NCT02978716|453518166|FG001|Overall Study|Death|13|||
126061528|NCT02978716|453518167|FG002|Overall Study|Death|20|||
126061529|NCT02978716|453518165|FG000|Overall Study|Lost to Follow-up|0|||
126061530|NCT02978716|453518166|FG001|Overall Study|Lost to Follow-up|0|||
126061531|NCT02978716|453518167|FG002|Overall Study|Lost to Follow-up|1|||
126110218|NCT03891524|453697673|FG003|Overall Study|Death|0|||
126061532|NCT02978716|453518165|FG000|Overall Study|Withdrawal by Subject|6|||
126061533|NCT02978716|453518166|FG001|Overall Study|Withdrawal by Subject|4|||
126061534|NCT02978716|453518167|FG002|Overall Study|Withdrawal by Subject|5|||
126061535|NCT02978716|453518165|FG000|Overall Study|Sponsor terminated|2|||
126061536|NCT02978716|453518166|FG001|Overall Study|Sponsor terminated|13|||
126061537|NCT02978716|453518167|FG002|Overall Study|Sponsor terminated|9|||
126061538|NCT02978716|453518165|FG000|Overall Study|Other|1|||
126061539|NCT02978716|453518166|FG001|Overall Study|Other|3|||
126061540|NCT02978716|453518167|FG002|Overall Study|Other|0|||
126061541|NCT00960206|453518168|FG000|Overall Study|Death|7|||
126061542|NCT00960206|453518169|FG001|Overall Study|Death|4|||
126061543|NCT00960206|453518170|FG002|Overall Study|Death|1|||
126061544|NCT00960206|453518168|FG000|Overall Study|Unwilling/Unable to return|1|||
126061545|NCT00960206|453518169|FG001|Overall Study|Unwilling/Unable to return|2|||
126061546|NCT00960206|453518170|FG002|Overall Study|Unwilling/Unable to return|0|||
126061547|NCT00960206|453518168|FG000|Overall Study|Lost to Follow-up|8|||
126061548|NCT00960206|453518169|FG001|Overall Study|Lost to Follow-up|14|||
126061549|NCT00960206|453518170|FG002|Overall Study|Lost to Follow-up|8|||
126061550|NCT00960206|453518168|FG000|Overall Study|Withdrawal by Subject|2|||
126061551|NCT00960206|453518169|FG001|Overall Study|Withdrawal by Subject|4|||
126061552|NCT00960206|453518170|FG002|Overall Study|Withdrawal by Subject|0|||
126061553|NCT00960206|453518168|FG000|Overall Study|Revision of study component|2|||
126061554|NCT00960206|453518169|FG001|Overall Study|Revision of study component|2|||
126061555|NCT00960206|453518170|FG002|Overall Study|Revision of study component|2|||
126061556|NCT00960206|453518168|FG000|Overall Study|Missing 10 year data|20|||
126061557|NCT00960206|453518169|FG001|Overall Study|Missing 10 year data|1|||
126061558|NCT00960206|453518170|FG002|Overall Study|Missing 10 year data|1|||
126061559|NCT02470806|453518171|FG000|Overall Study|Lost to Follow-up|1|||
126061560|NCT02470806|453518172|FG001|Overall Study|Lost to Follow-up|1|||
126061561|NCT02470806|453518171|FG000|Overall Study|Adverse Event|5|||
126061562|NCT02470806|453518172|FG001|Overall Study|Adverse Event|2|||
126061563|NCT02470806|453518171|FG000|Overall Study|Protocol Violation|4|||
126061564|NCT02470806|453518172|FG001|Overall Study|Protocol Violation|11|||
126061565|NCT02470806|453518171|FG000|Overall Study|Physician Decision|0|||
126061566|NCT02470806|453518172|FG001|Overall Study|Physician Decision|3|||
126061567|NCT02470806|453518171|FG000|Overall Study|Withdrawal by Subject|3|||
126110219|NCT03891524|453697674|FG004|Overall Study|Death|0|||
126061568|NCT02470806|453518172|FG001|Overall Study|Withdrawal by Subject|10|||
126061569|NCT02470806|453518171|FG000|Overall Study|Lack of Efficacy|5|||
126061570|NCT02470806|453518172|FG001|Overall Study|Lack of Efficacy|15|||
126061571|NCT01147471|453518173|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
126061572|NCT01147471|453518174|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
126061573|NCT01147471|453518173|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
126061574|NCT01147471|453518174|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
126061575|NCT01147471|453518173|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
126061576|NCT01147471|453518174|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
126061577|NCT01147471|453518173|FG000|3 Month Follow Up|Lost to Follow-up|1|||
126061578|NCT01147471|453518174|FG001|3 Month Follow Up|Lost to Follow-up|1|||
126061579|NCT01147471|453518173|FG000|3 Month Follow Up|Physician Decision|0|||
126061580|NCT01147471|453518174|FG001|3 Month Follow Up|Physician Decision|1|||
126061581|NCT01147471|453518173|FG000|6 Month Follow Up|Lost to Follow-up|4|||
126061582|NCT01147471|453518174|FG001|6 Month Follow Up|Lost to Follow-up|2|||
126061583|NCT03075878|453518179|FG000|Overall Study|Physician Decision|1|||
126061584|NCT00853957|453518180|FG000|Overall Study|Adverse Event|9|||
126061585|NCT00853957|453518181|FG001|Overall Study|Adverse Event|3|||
126061586|NCT00853957|453518180|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126061587|NCT00853957|453518181|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126061588|NCT00853957|453518180|FG000|Overall Study|Subject withdrew consent|4|||
126061589|NCT00853957|453518181|FG001|Overall Study|Subject withdrew consent|5|||
126061590|NCT00853957|453518180|FG000|Overall Study|Lost to Follow-up|1|||
126061591|NCT00853957|453518181|FG001|Overall Study|Lost to Follow-up|6|||
126061592|NCT00853957|453518180|FG000|Overall Study|Protocol deviation|0|||
126061593|NCT00853957|453518181|FG001|Overall Study|Protocol deviation|3|||
126061594|NCT01898299|453518182|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
126061595|NCT01898299|453518183|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
126061596|NCT04520256|453518190|FG000|Overall Study|Lost to Follow-up|6|||
126110220|NCT03891524|453697675|FG005|Overall Study|Death|0|||
126110221|NCT03891524|453697676|FG006|Overall Study|Death|0|||
126110222|NCT03891524|453697677|FG007|Overall Study|Death|1|||
126110223|NCT03891524|453697670|FG000|Overall Study|Withdrawal by Subject|0|||
125913129|NCT03633617|452982713|FG008|Part B|Adverse Event|0|||
125913130|NCT03633617|452982714|FG009|Part B|Adverse Event|0|||
125913131|NCT03633617|452982715|FG010|Part B|Adverse Event|0|||
125913132|NCT03633617|452982705|FG000|Part B|Withdrawal by Subject|0|||
125913133|NCT03633617|452982706|FG001|Part B|Withdrawal by Subject|0|||
125913134|NCT03633617|452982707|FG002|Part B|Withdrawal by Subject|1|||
125913135|NCT03633617|452982708|FG003|Part B|Withdrawal by Subject|0|||
125913136|NCT03633617|452982709|FG004|Part B|Withdrawal by Subject|2|||
125913137|NCT03633617|452982710|FG005|Part B|Withdrawal by Subject|0|||
125913138|NCT03633617|452982711|FG006|Part B|Withdrawal by Subject|0|||
125913139|NCT03633617|452982712|FG007|Part B|Withdrawal by Subject|0|||
125913140|NCT03633617|452982713|FG008|Part B|Withdrawal by Subject|0|||
125913141|NCT03633617|452982714|FG009|Part B|Withdrawal by Subject|0|||
125913142|NCT03633617|452982715|FG010|Part B|Withdrawal by Subject|0|||
126110224|NCT03891524|453697671|FG001|Overall Study|Withdrawal by Subject|1|||
125913143|NCT03633617|452982705|FG000|Part B|Lost to Follow-up|0|||
126061597|NCT04520256|453518191|FG001|Overall Study|Lost to Follow-up|4|||
126061598|NCT04520256|453518192|FG002|Overall Study|Lost to Follow-up|2|||
125913144|NCT03633617|452982706|FG001|Part B|Lost to Follow-up|0|||
125913145|NCT03633617|452982707|FG002|Part B|Lost to Follow-up|0|||
125913146|NCT03633617|452982708|FG003|Part B|Lost to Follow-up|0|||
125913147|NCT03633617|452982709|FG004|Part B|Lost to Follow-up|1|||
126110225|NCT03891524|453697672|FG002|Overall Study|Withdrawal by Subject|2|||
126061599|NCT04520256|453518193|FG003|Overall Study|Lost to Follow-up|3|||
126061600|NCT04520256|453518194|FG004|Overall Study|Lost to Follow-up|6|||
126061601|NCT04520256|453518195|FG005|Overall Study|Lost to Follow-up|6|||
126061602|NCT04520256|453518196|FG006|Overall Study|Lost to Follow-up|4|||
126061603|NCT04520256|453518197|FG007|Overall Study|Lost to Follow-up|6|||
126061604|NCT04520256|453518198|FG008|Overall Study|Lost to Follow-up|1|||
126061605|NCT04520256|453518199|FG009|Overall Study|Lost to Follow-up|3|||
126061606|NCT04520256|453518200|FG010|Overall Study|Lost to Follow-up|3|||
126061607|NCT04520256|453518201|FG011|Overall Study|Lost to Follow-up|2|||
126061608|NCT04520256|453518202|FG012|Overall Study|Lost to Follow-up|5|||
126061609|NCT04520256|453518203|FG013|Overall Study|Lost to Follow-up|3|||
126061610|NCT04520256|453518204|FG014|Overall Study|Lost to Follow-up|3|||
126061611|NCT04520256|453518205|FG015|Overall Study|Lost to Follow-up|6|||
126061612|NCT04520256|453518206|FG016|Overall Study|Lost to Follow-up|6|||
126061613|NCT04520256|453518207|FG017|Overall Study|Lost to Follow-up|4|||
126061614|NCT04520256|453518208|FG018|Overall Study|Lost to Follow-up|3|||
126061615|NCT04520256|453518209|FG019|Overall Study|Lost to Follow-up|3|||
126061616|NCT04520256|453518210|FG020|Overall Study|Lost to Follow-up|7|||
126061617|NCT04520256|453518211|FG021|Overall Study|Lost to Follow-up|3|||
126061618|NCT04520256|453518212|FG022|Overall Study|Lost to Follow-up|3|||
126061619|NCT04520256|453518213|FG023|Overall Study|Lost to Follow-up|8|||
126061620|NCT04520256|453518214|FG024|Overall Study|Lost to Follow-up|5|||
126061621|NCT04520256|453518215|FG025|Overall Study|Lost to Follow-up|4|||
126061622|NCT04520256|453518216|FG026|Overall Study|Lost to Follow-up|3|||
126061623|NCT04520256|453518217|FG027|Overall Study|Lost to Follow-up|4|||
126061624|NCT04520256|453518218|FG028|Overall Study|Lost to Follow-up|3|||
126061625|NCT04520256|453518219|FG029|Overall Study|Lost to Follow-up|4|||
126061626|NCT04520256|453518220|FG030|Overall Study|Lost to Follow-up|4|||
126061627|NCT04520256|453518221|FG031|Overall Study|Lost to Follow-up|4|||
126061628|NCT04369664|453519925|FG000|Overall Study|Physician Decision|1|||
126061629|NCT04369664|453519926|FG001|Overall Study|Physician Decision|0|||
126061630|NCT03840200|453519929|FG000|Overall Study|Death|6|||
126061631|NCT03840200|453519930|FG001|Overall Study|Death|3|||
126061632|NCT03840200|453519931|FG002|Overall Study|Death|6|||
126061633|NCT03840200|453519932|FG003|Overall Study|Death|10|||
126061634|NCT03840200|453519929|FG000|Overall Study|Reason Not Specified|2|||
126061635|NCT03840200|453519930|FG001|Overall Study|Reason Not Specified|2|||
126061636|NCT03840200|453519931|FG002|Overall Study|Reason Not Specified|1|||
126061637|NCT03840200|453519932|FG003|Overall Study|Reason Not Specified|15|||
126061638|NCT03840200|453519929|FG000|Overall Study|Physician Decision|0|||
126061639|NCT03840200|453519930|FG001|Overall Study|Physician Decision|0|||
126061640|NCT03840200|453519931|FG002|Overall Study|Physician Decision|0|||
126061641|NCT03840200|453519932|FG003|Overall Study|Physician Decision|2|||
126061642|NCT03840200|453519929|FG000|Overall Study|Progressive Disease|0|||
126061643|NCT03840200|453519930|FG001|Overall Study|Progressive Disease|0|||
126061644|NCT03840200|453519931|FG002|Overall Study|Progressive Disease|0|||
126061645|NCT03840200|453519932|FG003|Overall Study|Progressive Disease|1|||
126061646|NCT03840200|453519929|FG000|Overall Study|Withdrawal by Subject|0|||
126061647|NCT03840200|453519930|FG001|Overall Study|Withdrawal by Subject|1|||
126061648|NCT03840200|453519931|FG002|Overall Study|Withdrawal by Subject|0|||
126061649|NCT03840200|453519932|FG003|Overall Study|Withdrawal by Subject|2|||
126061650|NCT05487300|453519935|FG000|Overall Study|Withdrawal by Subject|1|||
126061651|NCT05487300|453519936|FG001|Overall Study|Withdrawal by Subject|0|||
126061652|NCT05006703|453519937|FG000|Overall Study|Withdrawal by Subject|1|||
126061653|NCT05006703|453519938|FG001|Overall Study|Withdrawal by Subject|0|||
126061654|NCT05006703|453519937|FG000|Overall Study|Lost to Follow-up|13|||
126061655|NCT05006703|453519938|FG001|Overall Study|Lost to Follow-up|5|||
125913148|NCT03633617|452982710|FG005|Part B|Lost to Follow-up|0|||
126061656|NCT02880293|453519939|FG000|Overall Study|Inevaluable|5|||
126061657|NCT00264576|453519940|FG000|Overall Study|Lost to Follow-up|1|||
126061658|NCT00264576|453519941|FG001|Overall Study|Lost to Follow-up|1|||
126061659|NCT03976102|453519942|FG000|Overall Study|Withdrawal by Subject|4|||
126061660|NCT03976102|453519943|FG001|Overall Study|Withdrawal by Subject|4|||
126061661|NCT03976102|453519942|FG000|Overall Study|Adverse Event|2|||
125913149|NCT03633617|452982711|FG006|Part B|Lost to Follow-up|0|||
125913150|NCT03633617|452982712|FG007|Part B|Lost to Follow-up|0|||
125913151|NCT03633617|452982713|FG008|Part B|Lost to Follow-up|0|||
125913152|NCT03633617|452982714|FG009|Part B|Lost to Follow-up|0|||
125913153|NCT03633617|452982715|FG010|Part B|Lost to Follow-up|0|||
125913154|NCT03633617|452982705|FG000|Part B|Physician Decision|0|||
125913155|NCT03633617|452982706|FG001|Part B|Physician Decision|0|||
125913156|NCT03633617|452982707|FG002|Part B|Physician Decision|0|||
125913157|NCT03633617|452982708|FG003|Part B|Physician Decision|0|||
125913158|NCT03633617|452982709|FG004|Part B|Physician Decision|1|||
125913159|NCT03633617|452982710|FG005|Part B|Physician Decision|0|||
125913160|NCT03633617|452982711|FG006|Part B|Physician Decision|0|||
125913161|NCT03633617|452982712|FG007|Part B|Physician Decision|0|||
125913162|NCT03633617|452982713|FG008|Part B|Physician Decision|0|||
125913163|NCT03633617|452982714|FG009|Part B|Physician Decision|0|||
125913164|NCT03633617|452982715|FG010|Part B|Physician Decision|0|||
125913165|NCT03633617|452982705|FG000|Part B|COVID-19 Restrictions|0|||
125913166|NCT03633617|452982706|FG001|Part B|COVID-19 Restrictions|0|||
125913167|NCT03633617|452982707|FG002|Part B|COVID-19 Restrictions|1|||
125913168|NCT03633617|452982708|FG003|Part B|COVID-19 Restrictions|0|||
125913169|NCT03633617|452982709|FG004|Part B|COVID-19 Restrictions|0|||
125913170|NCT03633617|452982710|FG005|Part B|COVID-19 Restrictions|0|||
125913171|NCT03633617|452982711|FG006|Part B|COVID-19 Restrictions|0|||
125913172|NCT03633617|452982712|FG007|Part B|COVID-19 Restrictions|0|||
125913173|NCT03633617|452982713|FG008|Part B|COVID-19 Restrictions|0|||
125913174|NCT03633617|452982714|FG009|Part B|COVID-19 Restrictions|0|||
125913175|NCT03633617|452982715|FG010|Part B|COVID-19 Restrictions|0|||
125913176|NCT03633617|452982705|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913177|NCT03633617|452982706|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913178|NCT03633617|452982707|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
125913179|NCT03633617|452982708|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913180|NCT03633617|452982709|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913181|NCT03633617|452982710|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913182|NCT03633617|452982711|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913183|NCT03633617|452982712|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913184|NCT03633617|452982713|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913185|NCT03633617|452982714|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913186|NCT03633617|452982715|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125913187|NCT03633617|452982705|FG000|Part C (& Follow-up)|Adverse Event|0|||
125913188|NCT03633617|452982706|FG001|Part C (& Follow-up)|Adverse Event|0|||
125913189|NCT03633617|452982707|FG002|Part C (& Follow-up)|Adverse Event|0|||
125913190|NCT03633617|452982708|FG003|Part C (& Follow-up)|Adverse Event|0|||
125913191|NCT03633617|452982709|FG004|Part C (& Follow-up)|Adverse Event|0|||
125913192|NCT03633617|452982710|FG005|Part C (& Follow-up)|Adverse Event|1|||
125913193|NCT03633617|452982711|FG006|Part C (& Follow-up)|Adverse Event|0|||
126110226|NCT03891524|453697673|FG003|Overall Study|Withdrawal by Subject|1|||
126061662|NCT03976102|453519943|FG001|Overall Study|Adverse Event|4|||
126061663|NCT03976102|453519942|FG000|Overall Study|Not related to Covid-19|9|||
126061664|NCT03976102|453519943|FG001|Overall Study|Not related to Covid-19|13|||
126061665|NCT03976102|453519942|FG000|Overall Study|Lost to Follow-up|0|||
126061666|NCT03976102|453519943|FG001|Overall Study|Lost to Follow-up|2|||
126061667|NCT03976102|453519942|FG000|Overall Study|Death|3|||
126061668|NCT03976102|453519943|FG001|Overall Study|Death|2|||
126061669|NCT03976102|453519942|FG000|Overall Study|Physician Decision|1|||
126061670|NCT03976102|453519943|FG001|Overall Study|Physician Decision|1|||
126061671|NCT00092456|453519944|FG000|Overall Study|Adverse Event|0|||
126061672|NCT00092456|453519945|FG001|Overall Study|Adverse Event|0|||
126061673|NCT00092456|453519946|FG002|Overall Study|Adverse Event|1|||
126061674|NCT00092456|453519947|FG003|Overall Study|Adverse Event|1|||
126061675|NCT00092456|453519944|FG000|Overall Study|Lost to Follow-up|2|||
126061676|NCT00092456|453519945|FG001|Overall Study|Lost to Follow-up|2|||
126061677|NCT00092456|453519946|FG002|Overall Study|Lost to Follow-up|1|||
126061678|NCT00092456|453519947|FG003|Overall Study|Lost to Follow-up|2|||
126061679|NCT00092456|453519944|FG000|Overall Study|Protocol Violation|5|||
126061680|NCT00092456|453519945|FG001|Overall Study|Protocol Violation|7|||
126061681|NCT00092456|453519946|FG002|Overall Study|Protocol Violation|8|||
126061682|NCT00092456|453519947|FG003|Overall Study|Protocol Violation|6|||
126061683|NCT00092456|453519944|FG000|Overall Study|Withdrawal by Subject|13|||
126061684|NCT00092456|453519945|FG001|Overall Study|Withdrawal by Subject|5|||
126061685|NCT00092456|453519946|FG002|Overall Study|Withdrawal by Subject|16|||
126110227|NCT03891524|453697674|FG004|Overall Study|Withdrawal by Subject|2|||
126061686|NCT00092456|453519947|FG003|Overall Study|Withdrawal by Subject|6|||
126061687|NCT00092456|453519944|FG000|Overall Study|Moved|1|||
126061688|NCT00092456|453519945|FG001|Overall Study|Moved|1|||
126061689|NCT00092456|453519946|FG002|Overall Study|Moved|0|||
126061690|NCT00092456|453519947|FG003|Overall Study|Moved|1|||
126061691|NCT00092456|453519944|FG000|Overall Study|Other|4|||
126061692|NCT00092456|453519945|FG001|Overall Study|Other|2|||
126061693|NCT00092456|453519946|FG002|Overall Study|Other|3|||
126061694|NCT00092456|453519947|FG003|Overall Study|Other|0|||
126061695|NCT00451906|453519950|FG000|Overall Study|Adverse Event|515|||
126061696|NCT00451906|453519950|FG000|Overall Study|Lost to Follow-up|31|||
126061697|NCT00451906|453519950|FG000|Overall Study|Withdrawal by Subject|111|||
126061698|NCT00451906|453519950|FG000|Overall Study|Protocol Violation|21|||
126061699|NCT00451906|453519950|FG000|Overall Study|Progressive disease|1328|||
126061700|NCT00451906|453519950|FG000|Overall Study|Termination of the study|108|||
126061701|NCT00451906|453519950|FG000|Overall Study|Other Reasons|121|||
126061702|NCT00451906|453519950|FG000|Overall Study|Did not complete final visit|4|||
126061703|NCT04820023|453519952|FG000|Overall Study|Death|0|||
126061704|NCT04820023|453519953|FG001|Overall Study|Death|0|||
126061705|NCT04820023|453519954|FG002|Overall Study|Death|0|||
126061706|NCT04820023|453519955|FG003|Overall Study|Death|0|||
126061707|NCT04820023|453519956|FG004|Overall Study|Death|0|||
126061708|NCT04820023|453519957|FG005|Overall Study|Death|0|||
126061709|NCT04820023|453519958|FG006|Overall Study|Death|1|||
126061710|NCT04820023|453519959|FG007|Overall Study|Death|0|||
126061711|NCT04820023|453519960|FG008|Overall Study|Death|1|||
126061712|NCT04820023|453519952|FG000|Overall Study|Withdrawal by Subject|1|||
126061713|NCT04820023|453519953|FG001|Overall Study|Withdrawal by Subject|2|||
126061714|NCT04820023|453519954|FG002|Overall Study|Withdrawal by Subject|2|||
126061715|NCT04820023|453519955|FG003|Overall Study|Withdrawal by Subject|1|||
126061716|NCT04820023|453519956|FG004|Overall Study|Withdrawal by Subject|4|||
126061717|NCT04820023|453519957|FG005|Overall Study|Withdrawal by Subject|3|||
126061718|NCT04820023|453519958|FG006|Overall Study|Withdrawal by Subject|3|||
126061719|NCT04820023|453519959|FG007|Overall Study|Withdrawal by Subject|6|||
126061720|NCT04820023|453519960|FG008|Overall Study|Withdrawal by Subject|5|||
126061721|NCT04820023|453519952|FG000|Overall Study|Progressive Disease|3|||
126061722|NCT04820023|453519953|FG001|Overall Study|Progressive Disease|0|||
126061723|NCT04820023|453519954|FG002|Overall Study|Progressive Disease|2|||
126061724|NCT04820023|453519955|FG003|Overall Study|Progressive Disease|2|||
126061725|NCT04820023|453519956|FG004|Overall Study|Progressive Disease|2|||
126061726|NCT04820023|453519957|FG005|Overall Study|Progressive Disease|0|||
126061727|NCT04820023|453519958|FG006|Overall Study|Progressive Disease|1|||
126061728|NCT04820023|453519959|FG007|Overall Study|Progressive Disease|1|||
126061729|NCT04820023|453519960|FG008|Overall Study|Progressive Disease|0|||
126061730|NCT04820023|453519952|FG000|Overall Study|New anti-cancer therapy|0|||
126061731|NCT04820023|453519953|FG001|Overall Study|New anti-cancer therapy|0|||
126061732|NCT04820023|453519954|FG002|Overall Study|New anti-cancer therapy|0|||
126061733|NCT04820023|453519955|FG003|Overall Study|New anti-cancer therapy|0|||
126061734|NCT04820023|453519956|FG004|Overall Study|New anti-cancer therapy|2|||
126061735|NCT04820023|453519957|FG005|Overall Study|New anti-cancer therapy|0|||
126061736|NCT04820023|453519958|FG006|Overall Study|New anti-cancer therapy|0|||
126061737|NCT04820023|453519959|FG007|Overall Study|New anti-cancer therapy|0|||
126061738|NCT04820023|453519960|FG008|Overall Study|New anti-cancer therapy|0|||
126061739|NCT04820023|453519952|FG000|Overall Study|Other|0|||
126061740|NCT04820023|453519953|FG001|Overall Study|Other|1|||
126061741|NCT04820023|453519954|FG002|Overall Study|Other|0|||
125913194|NCT03633617|452982712|FG007|Part C (& Follow-up)|Adverse Event|1|||
125913195|NCT03633617|452982713|FG008|Part C (& Follow-up)|Adverse Event|0|||
125913196|NCT03633617|452982714|FG009|Part C (& Follow-up)|Adverse Event|0|||
125913197|NCT03633617|452982715|FG010|Part C (& Follow-up)|Adverse Event|0|||
125913198|NCT03633617|452982705|FG000|Part C (& Follow-up)|Pregnancy|0|||
125913199|NCT03633617|452982706|FG001|Part C (& Follow-up)|Pregnancy|0|||
125913200|NCT03633617|452982707|FG002|Part C (& Follow-up)|Pregnancy|0|||
125913201|NCT03633617|452982708|FG003|Part C (& Follow-up)|Pregnancy|0|||
125913202|NCT03633617|452982709|FG004|Part C (& Follow-up)|Pregnancy|0|||
125913203|NCT03633617|452982710|FG005|Part C (& Follow-up)|Pregnancy|0|||
125913204|NCT03633617|452982711|FG006|Part C (& Follow-up)|Pregnancy|0|||
125913205|NCT03633617|452982712|FG007|Part C (& Follow-up)|Pregnancy|0|||
125913206|NCT03633617|452982713|FG008|Part C (& Follow-up)|Pregnancy|0|||
125913207|NCT03633617|452982714|FG009|Part C (& Follow-up)|Pregnancy|1|||
125913208|NCT03633617|452982715|FG010|Part C (& Follow-up)|Pregnancy|0|||
125913209|NCT03633617|452982705|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
125913210|NCT03633617|452982706|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
125913211|NCT03633617|452982707|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
125913212|NCT03633617|452982708|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
125913213|NCT03633617|452982709|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
125913214|NCT03633617|452982710|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
125913215|NCT03633617|452982711|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
125913216|NCT03633617|452982712|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
125913217|NCT03633617|452982713|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
125913218|NCT03633617|452982714|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
125913219|NCT03633617|452982715|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
125913220|NCT03633617|452982705|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
125913221|NCT03633617|452982706|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
125913222|NCT03633617|452982707|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
125913223|NCT03633617|452982708|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
125913224|NCT03633617|452982709|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
125913225|NCT03633617|452982710|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
125913226|NCT03633617|452982711|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
125913227|NCT03633617|452982712|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
125913228|NCT03633617|452982713|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
125913229|NCT03633617|452982714|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
125913230|NCT03633617|452982715|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
125913231|NCT03633617|452982705|FG000|Part C (& Follow-up)|Physician Decision|0|||
125913232|NCT03633617|452982706|FG001|Part C (& Follow-up)|Physician Decision|0|||
125913233|NCT03633617|452982707|FG002|Part C (& Follow-up)|Physician Decision|0|||
125913234|NCT03633617|452982708|FG003|Part C (& Follow-up)|Physician Decision|0|||
125913235|NCT03633617|452982709|FG004|Part C (& Follow-up)|Physician Decision|0|||
125913236|NCT03633617|452982710|FG005|Part C (& Follow-up)|Physician Decision|0|||
125913237|NCT03633617|452982711|FG006|Part C (& Follow-up)|Physician Decision|0|||
125913238|NCT03633617|452982712|FG007|Part C (& Follow-up)|Physician Decision|1|||
125913239|NCT03633617|452982713|FG008|Part C (& Follow-up)|Physician Decision|0|||
125913240|NCT03633617|452982714|FG009|Part C (& Follow-up)|Physician Decision|0|||
125913241|NCT03633617|452982715|FG010|Part C (& Follow-up)|Physician Decision|1|||
125913242|NCT03633617|452982705|FG000|Part C (& Follow-up)|COVID-19 related|0|||
125913243|NCT03633617|452982706|FG001|Part C (& Follow-up)|COVID-19 related|0|||
125913244|NCT03633617|452982707|FG002|Part C (& Follow-up)|COVID-19 related|0|||
125913245|NCT03633617|452982708|FG003|Part C (& Follow-up)|COVID-19 related|0|||
125913246|NCT03633617|452982709|FG004|Part C (& Follow-up)|COVID-19 related|0|||
125913247|NCT03633617|452982710|FG005|Part C (& Follow-up)|COVID-19 related|1|||
125913248|NCT03633617|452982711|FG006|Part C (& Follow-up)|COVID-19 related|0|||
125913249|NCT03633617|452982712|FG007|Part C (& Follow-up)|COVID-19 related|0|||
125913250|NCT03633617|452982713|FG008|Part C (& Follow-up)|COVID-19 related|0|||
125913251|NCT03633617|452982714|FG009|Part C (& Follow-up)|COVID-19 related|0|||
125913252|NCT03633617|452982715|FG010|Part C (& Follow-up)|COVID-19 related|0|||
125913253|NCT03633617|452982705|FG000|Part C (& Follow-up)|Protocol Violation|0|||
125913254|NCT03633617|452982706|FG001|Part C (& Follow-up)|Protocol Violation|0|||
125913255|NCT03633617|452982707|FG002|Part C (& Follow-up)|Protocol Violation|0|||
125913256|NCT03633617|452982708|FG003|Part C (& Follow-up)|Protocol Violation|0|||
125913257|NCT03633617|452982709|FG004|Part C (& Follow-up)|Protocol Violation|0|||
125913258|NCT03633617|452982710|FG005|Part C (& Follow-up)|Protocol Violation|0|||
125913259|NCT03633617|452982711|FG006|Part C (& Follow-up)|Protocol Violation|0|||
125913260|NCT03633617|452982712|FG007|Part C (& Follow-up)|Protocol Violation|0|||
125913261|NCT03633617|452982713|FG008|Part C (& Follow-up)|Protocol Violation|0|||
125913262|NCT03633617|452982714|FG009|Part C (& Follow-up)|Protocol Violation|3|||
125913263|NCT03633617|452982715|FG010|Part C (& Follow-up)|Protocol Violation|1|||
125913264|NCT03633617|452982705|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
125913265|NCT03633617|452982706|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
125913266|NCT03633617|452982707|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
125913267|NCT03633617|452982708|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
125913268|NCT03633617|452982709|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
125913269|NCT03633617|452982710|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
125913270|NCT03633617|452982711|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
125913271|NCT03633617|452982712|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
125913272|NCT03633617|452982713|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
125913273|NCT03633617|452982714|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
125913274|NCT03633617|452982715|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
125913275|NCT01890746|452982716|FG000|Overall Study|Death|39|||
125913276|NCT01890746|452982717|FG001|Overall Study|Death|30|||
125913277|NCT01890746|452982716|FG000|Overall Study|Adverse Event|1|||
125913278|NCT01890746|452982717|FG001|Overall Study|Adverse Event|0|||
125913279|NCT01890746|452982716|FG000|Overall Study|Lost to Follow-up|4|||
125913280|NCT01890746|452982717|FG001|Overall Study|Lost to Follow-up|1|||
125913281|NCT01890746|452982716|FG000|Overall Study|Physician Decision|3|||
125913282|NCT01890746|452982717|FG001|Overall Study|Physician Decision|2|||
125913283|NCT01890746|452982716|FG000|Overall Study|Withdrawal by Subject|5|||
125913284|NCT01890746|452982717|FG001|Overall Study|Withdrawal by Subject|8|||
125913285|NCT02642029|452982718|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
125913286|NCT02642029|452982719|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125913287|NCT02642029|452982720|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125913288|NCT02642029|452982721|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125913289|NCT02642029|452982722|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125913290|NCT02642029|452982723|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125913291|NCT02642029|452982718|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125913292|NCT02642029|452982719|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
125913293|NCT02642029|452982720|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125913294|NCT02642029|452982721|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125913295|NCT02642029|452982722|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125913296|NCT02642029|452982723|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125913297|NCT02642029|452982718|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125913298|NCT02642029|452982719|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125913299|NCT02642029|452982720|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125913300|NCT02642029|452982721|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125913301|NCT02642029|452982722|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
125913302|NCT02642029|452982723|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125913303|NCT02642029|452982718|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
125913304|NCT02642029|452982719|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
125913305|NCT02642029|452982720|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
125913306|NCT02642029|452982721|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
125913307|NCT02642029|452982722|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
125913308|NCT02642029|452982723|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
126061742|NCT04820023|453519955|FG003|Overall Study|Other|0|||
126061743|NCT04820023|453519956|FG004|Overall Study|Other|0|||
126061744|NCT04820023|453519957|FG005|Overall Study|Other|0|||
126061745|NCT04820023|453519958|FG006|Overall Study|Other|0|||
126061746|NCT04820023|453519959|FG007|Overall Study|Other|2|||
126061747|NCT04820023|453519960|FG008|Overall Study|Other|0|||
125913309|NCT02642029|452982718|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
125913310|NCT02642029|452982719|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125913311|NCT02642029|452982720|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125913312|NCT02642029|452982721|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125913313|NCT02642029|452982722|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125913314|NCT02642029|452982723|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125913315|NCT02642029|452982718|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
125913316|NCT02642029|452982719|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125913317|NCT02642029|452982720|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125913318|NCT02642029|452982721|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125913319|NCT02642029|452982722|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125913320|NCT02642029|452982723|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125913321|NCT00631696|452982730|FG000|Overall Study|Entered, not randomized to treatment|1|||
125913322|NCT00631696|452982731|FG001|Overall Study|Entered, not randomized to treatment|1|||
125913323|NCT00631696|452982730|FG000|Overall Study|Discontinued after database release date|1|||
125913324|NCT00631696|452982731|FG001|Overall Study|Discontinued after database release date|0|||
125913325|NCT00631696|452982730|FG000|Overall Study|Follow up after database release date|1|||
125913326|NCT00631696|452982731|FG001|Overall Study|Follow up after database release date|0|||
125913327|NCT00631696|452982730|FG000|Overall Study|Lost to Follow-up|7|||
125913328|NCT00631696|452982731|FG001|Overall Study|Lost to Follow-up|10|||
125913329|NCT00631696|452982730|FG000|Overall Study|Withdrawal by Subject|2|||
125913330|NCT00631696|452982731|FG001|Overall Study|Withdrawal by Subject|9|||
125913331|NCT00631696|452982730|FG000|Overall Study|Other|8|||
125913332|NCT00631696|452982731|FG001|Overall Study|Other|8|||
125913333|NCT00631696|452982730|FG000|Overall Study|Protocol Violation|9|||
125913334|NCT00631696|452982731|FG001|Overall Study|Protocol Violation|9|||
125913335|NCT00631696|452982730|FG000|Overall Study|Study terminated by sponsor|3|||
125913336|NCT00631696|452982731|FG001|Overall Study|Study terminated by sponsor|3|||
125913337|NCT00631696|452982730|FG000|Overall Study|Adverse Event|5|||
125913338|NCT00631696|452982731|FG001|Overall Study|Adverse Event|0|||
125913339|NCT01050543|452982733|FG000|Overall Study|Withdrawal by Subject|0|||
125913340|NCT01050543|452982734|FG001|Overall Study|Withdrawal by Subject|2|||
125913341|NCT01050543|452982733|FG000|Overall Study|Protocol Violation|0|||
125913342|NCT01050543|452982734|FG001|Overall Study|Protocol Violation|1|||
125913343|NCT01050543|452982733|FG000|Overall Study|Administrative|4|||
125913344|NCT01050543|452982734|FG001|Overall Study|Administrative|1|||
125913345|NCT00570765|452982735|FG000|DB Phase|Withdrawal by Subject|1|||
125913346|NCT00570765|452982736|FG001|DB Phase|Withdrawal by Subject|0|||
125913347|NCT00570765|452982737|FG002|DB Phase|Withdrawal by Subject|0|||
125913348|NCT00570765|452982738|FG003|DB Phase|Withdrawal by Subject|0|||
125913349|NCT00570765|452982735|FG000|DB Phase|Protocol Violation|0|||
125913350|NCT00570765|452982736|FG001|DB Phase|Protocol Violation|1|||
125913351|NCT00570765|452982737|FG002|DB Phase|Protocol Violation|0|||
125913352|NCT00570765|452982738|FG003|DB Phase|Protocol Violation|0|||
125913353|NCT00570765|452982735|FG000|DB Phase|Adverse Event|3|||
125913354|NCT00570765|452982736|FG001|DB Phase|Adverse Event|6|||
125913355|NCT00570765|452982737|FG002|DB Phase|Adverse Event|0|||
125913356|NCT00570765|452982738|FG003|DB Phase|Adverse Event|0|||
125913357|NCT00570765|452982735|FG000|DB Phase|Did Not Receive Study Drug|0|||
125913358|NCT00570765|452982736|FG001|DB Phase|Did Not Receive Study Drug|0|||
125913359|NCT00570765|452982737|FG002|DB Phase|Did Not Receive Study Drug|1|||
125913360|NCT00570765|452982738|FG003|DB Phase|Did Not Receive Study Drug|0|||
125913361|NCT00570765|452982735|FG000|LTSE Phase|Withdrawal by Subject|0|||
125913362|NCT00570765|452982736|FG001|LTSE Phase|Withdrawal by Subject|0|||
125913363|NCT00570765|452982737|FG002|LTSE Phase|Withdrawal by Subject|0|||
125913364|NCT00570765|452982738|FG003|LTSE Phase|Withdrawal by Subject|1|||
125913365|NCT00570765|452982735|FG000|LTSE Phase|Adverse Event|0|||
125913366|NCT00570765|452982736|FG001|LTSE Phase|Adverse Event|0|||
125913367|NCT00570765|452982737|FG002|LTSE Phase|Adverse Event|0|||
125913368|NCT00570765|452982738|FG003|LTSE Phase|Adverse Event|7|||
125913369|NCT00570765|452982735|FG000|LTSE Phase|Physician Decision|0|||
125913370|NCT00570765|452982736|FG001|LTSE Phase|Physician Decision|0|||
125913371|NCT00570765|452982737|FG002|LTSE Phase|Physician Decision|0|||
125913372|NCT00570765|452982738|FG003|LTSE Phase|Physician Decision|4|||
125913373|NCT03387683|452982739|FG000|Overall Study|In receipt of disallowed medication|1|||
125913374|NCT03387683|452982740|FG001|Overall Study|In receipt of disallowed medication|0|||
125913375|NCT03387683|452982739|FG000|Overall Study|Did not receive treatment|1|||
125913376|NCT03387683|452982740|FG001|Overall Study|Did not receive treatment|0|||
125913377|NCT00875979|452982741|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
125913378|NCT00875979|452982742|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
125913379|NCT00875979|452982741|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
125913380|NCT00875979|452982742|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
125913381|NCT00875979|452982741|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
125913382|NCT00875979|452982742|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
125913383|NCT00875979|452982741|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
125913384|NCT00875979|452982742|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
125913385|NCT00875979|452982741|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
125913386|NCT00875979|452982742|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
125913387|NCT00875979|452982741|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
125913388|NCT00875979|452982742|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
125913389|NCT00875979|452982741|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
125913390|NCT00875979|452982742|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
125913391|NCT00875979|452982741|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
125913392|NCT00875979|452982742|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
125913393|NCT00875979|452982741|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
125913394|NCT00875979|452982742|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
125913395|NCT01104155|452982743|FG000|Overall Study|Adverse Event|15|||
125913396|NCT01104155|452982744|FG001|Overall Study|Adverse Event|8|||
125913397|NCT01104155|452982743|FG000|Overall Study|Participant choice|6|||
125913398|NCT01104155|452982744|FG001|Overall Study|Participant choice|5|||
125913399|NCT01104155|452982743|FG000|Overall Study|Withdrawal of consent|1|||
125913400|NCT01104155|452982744|FG001|Overall Study|Withdrawal of consent|1|||
125913401|NCT01104155|452982743|FG000|Overall Study|Other|3|||
125913402|NCT01104155|452982744|FG001|Overall Study|Other|4|||
125913403|NCT01484132|452982745|FG000|Overall Study|Lost to Follow-up|8|||
125913404|NCT01484132|452982745|FG000|Overall Study|Difficulty with time commitment|2|||
125913405|NCT01484132|452982745|FG000|Overall Study|Ineligible|1|||
125913406|NCT01484132|452982745|FG000|Overall Study|No pre-treatment urine sample collected|1|||
125913407|NCT01484132|452982745|FG000|Overall Study|No post-treatment urine sample collected|10|||
125913408|NCT02808650|452982747|FG000|Overall Study|Death|0|||
125913409|NCT02808650|452982748|FG001|Overall Study|Death|0|||
125913410|NCT02808650|452982749|FG002|Overall Study|Death|0|||
125913411|NCT02808650|452982750|FG003|Overall Study|Death|0|||
125913412|NCT02808650|452982751|FG004|Overall Study|Death|1|||
125913413|NCT02808650|452982747|FG000|Overall Study|Lack of Efficacy|5|||
125913414|NCT02808650|452982748|FG001|Overall Study|Lack of Efficacy|5|||
125913415|NCT02808650|452982749|FG002|Overall Study|Lack of Efficacy|6|||
125913416|NCT02808650|452982750|FG003|Overall Study|Lack of Efficacy|5|||
125913417|NCT02808650|452982751|FG004|Overall Study|Lack of Efficacy|4|||
125913418|NCT02808650|452982747|FG000|Overall Study|Physician Decision|1|||
125913419|NCT02808650|452982748|FG001|Overall Study|Physician Decision|1|||
125913420|NCT02808650|452982749|FG002|Overall Study|Physician Decision|0|||
125913421|NCT02808650|452982750|FG003|Overall Study|Physician Decision|0|||
125913422|NCT02808650|452982751|FG004|Overall Study|Physician Decision|0|||
125913423|NCT02808650|452982747|FG000|Overall Study|Withdrawal by Subject|0|||
125913424|NCT02808650|452982748|FG001|Overall Study|Withdrawal by Subject|0|||
125913425|NCT02808650|452982749|FG002|Overall Study|Withdrawal by Subject|0|||
125913426|NCT02808650|452982750|FG003|Overall Study|Withdrawal by Subject|1|||
125913427|NCT02808650|452982751|FG004|Overall Study|Withdrawal by Subject|1|||
125913428|NCT02939079|452982752|FG000|Overall Study|Adverse Event|2|||
125913429|NCT02939079|452982753|FG001|Overall Study|Adverse Event|1|||
125913430|NCT02939079|452982752|FG000|Overall Study|Lost to Follow-up|0|||
125913431|NCT02939079|452982753|FG001|Overall Study|Lost to Follow-up|2|||
125913432|NCT02939079|452982752|FG000|Overall Study|Protocol Violation|1|||
125913433|NCT02939079|452982753|FG001|Overall Study|Protocol Violation|0|||
125913434|NCT02939079|452982752|FG000|Overall Study|Withdrawal by Subject|0|||
125913435|NCT02939079|452982753|FG001|Overall Study|Withdrawal by Subject|1|||
125913436|NCT02939079|452982752|FG000|Overall Study|relapse during the study|1|||
125913437|NCT02939079|452982753|FG001|Overall Study|relapse during the study|1|||
125913438|NCT04093414|452982754|FG000|3 Month Follow up|Physician Decision|0|||
125913439|NCT04093414|452982755|FG001|3 Month Follow up|Physician Decision|1|||
125913440|NCT04093414|452982754|FG000|6month Follow up|Physician Decision|1|||
125913441|NCT04093414|452982755|FG001|6month Follow up|Physician Decision|3|||
125913442|NCT04209348|452982756|FG000|Overall Study|Lost to Follow-up|1|||
125913443|NCT04209348|452982757|FG001|Overall Study|Lost to Follow-up|0|||
125913444|NCT05394350|452982759|FG000|Overall Study|Death|2|||
125913445|NCT05394350|452982760|FG001|Overall Study|Death|2|||
125913446|NCT05394350|452982761|FG002|Overall Study|Death|4|||
125913447|NCT05394350|452982762|FG003|Overall Study|Death|0|||
125913448|NCT05394350|452982763|FG004|Overall Study|Death|1|||
125913449|NCT05394350|452982764|FG005|Overall Study|Death|0|||
125913450|NCT05394350|452982759|FG000|Overall Study|Study terminated by sponsor|1|||
125913451|NCT05394350|452982760|FG001|Overall Study|Study terminated by sponsor|1|||
125913452|NCT05394350|452982761|FG002|Overall Study|Study terminated by sponsor|7|||
125913453|NCT05394350|452982762|FG003|Overall Study|Study terminated by sponsor|3|||
125913454|NCT05394350|452982763|FG004|Overall Study|Study terminated by sponsor|2|||
125913455|NCT05394350|452982764|FG005|Overall Study|Study terminated by sponsor|4|||
125913456|NCT01336569|452982765|FG000|Overall Study|Lost to Follow-up|4|||
125913457|NCT02963935|452982768|FG000|Overall Study|Adverse Event|12|||
125913458|NCT02963935|452982769|FG001|Overall Study|Adverse Event|6|||
125913459|NCT02963935|452982768|FG000|Overall Study|Protocol Violation|2|||
125913460|NCT02963935|452982769|FG001|Overall Study|Protocol Violation|1|||
125913461|NCT02963935|452982768|FG000|Overall Study|Lack of Efficacy|0|||
125913462|NCT02963935|452982769|FG001|Overall Study|Lack of Efficacy|2|||
125913463|NCT02963935|452982768|FG000|Overall Study|Lost to Follow-up|1|||
125913464|NCT02963935|452982769|FG001|Overall Study|Lost to Follow-up|6|||
125913465|NCT02963935|452982768|FG000|Overall Study|Unclassified|13|||
125913466|NCT02963935|452982769|FG001|Overall Study|Unclassified|22|||
125913467|NCT02770170|452982776|FG000|Overall Study|Withdrawal by Subject|0|||
125913468|NCT02770170|452982777|FG001|Overall Study|Withdrawal by Subject|0|||
125913469|NCT02770170|452982778|FG002|Overall Study|Withdrawal by Subject|0|||
125913470|NCT02770170|452982779|FG003|Overall Study|Withdrawal by Subject|2|||
125913471|NCT02770170|452982776|FG000|Overall Study|due to pregnancy|1|||
125913472|NCT02770170|452982777|FG001|Overall Study|due to pregnancy|0|||
125913473|NCT02770170|452982778|FG002|Overall Study|due to pregnancy|0|||
125913474|NCT02770170|452982779|FG003|Overall Study|due to pregnancy|0|||
125913475|NCT02770170|452982776|FG000|Overall Study|Lack of Efficacy|2|||
125913476|NCT02770170|452982777|FG001|Overall Study|Lack of Efficacy|0|||
125913477|NCT02770170|452982778|FG002|Overall Study|Lack of Efficacy|0|||
125913478|NCT02770170|452982779|FG003|Overall Study|Lack of Efficacy|1|||
125913479|NCT02770170|452982776|FG000|Overall Study|Adverse Event|4|||
125913480|NCT02770170|452982777|FG001|Overall Study|Adverse Event|3|||
125913481|NCT02770170|452982778|FG002|Overall Study|Adverse Event|5|||
125913482|NCT02770170|452982779|FG003|Overall Study|Adverse Event|3|||
125913483|NCT02770170|452982776|FG000|Overall Study|due to disease worsening|0|||
125913484|NCT02770170|452982777|FG001|Overall Study|due to disease worsening|0|||
125913485|NCT02770170|452982778|FG002|Overall Study|due to disease worsening|0|||
125913486|NCT02770170|452982779|FG003|Overall Study|due to disease worsening|1|||
125913487|NCT00445978|452982780|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
125913488|NCT00445978|452982780|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
125913489|NCT00445978|452982780|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
125913490|NCT00445978|452982780|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
125913491|NCT00445978|452982780|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
125913492|NCT00445978|452982780|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
125913493|NCT00445978|452982780|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
125913494|NCT00445978|452982780|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
125913495|NCT00445978|452982780|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
125913496|NCT01822496|452982783|FG000|Overall Study|Protocol Violation|2|||
125913497|NCT01822496|452982784|FG001|Overall Study|Protocol Violation|2|||
125913498|NCT01822496|452982785|FG002|Overall Study|Protocol Violation|0|||
125913499|NCT01822496|452982786|FG003|Overall Study|Protocol Violation|1|||
125913500|NCT01822496|452982783|FG000|Overall Study|Withdrawal by Subject|0|||
125913501|NCT01822496|452982784|FG001|Overall Study|Withdrawal by Subject|0|||
125913502|NCT01822496|452982785|FG002|Overall Study|Withdrawal by Subject|0|||
125913503|NCT01822496|452982786|FG003|Overall Study|Withdrawal by Subject|3|||
125913504|NCT04502979|452982789|FG000|Overall Study|Lost to Follow-up|1|||
125913505|NCT04502979|452982790|FG001|Overall Study|Lost to Follow-up|3|||
126061748|NCT05066230|453519961|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
125913506|NCT04502979|452982789|FG000|Overall Study|Withdrawal by Subject|2|||
125913507|NCT04502979|452982790|FG001|Overall Study|Withdrawal by Subject|1|||
125913508|NCT01558739|452982799|FG000|Overall Study|Adverse Event|7|||
125913509|NCT01558739|452982799|FG000|Overall Study|Withdrawal by Subject|2|||
125913510|NCT01558739|452982799|FG000|Overall Study|Death|3|||
125913511|NCT01558739|452982799|FG000|Overall Study|Disease Progression|4|||
125913512|NCT01558739|452982799|FG000|Overall Study|Protocol Violation|1|||
125913513|NCT02719327|452982803|FG000|Overall Study|Withdrawal by Subject|11|||
126061749|NCT05066230|453519962|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
126061750|NCT05066230|453519961|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
126061751|NCT05066230|453519962|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
126061752|NCT05066230|453519961|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
126061753|NCT05066230|453519962|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
126061754|NCT05066230|453519961|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
126061755|NCT05066230|453519962|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
126061756|NCT05066230|453519961|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
126061757|NCT05066230|453519962|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
126061758|NCT05066230|453519961|FG000|After Week 48|Adverse Event|1|||
126061759|NCT05066230|453519962|FG001|After Week 48|Adverse Event|0|||
126061760|NCT05066230|453519961|FG000|After Week 48|Non-compliance with study schedule|1|||
126061761|NCT05066230|453519962|FG001|After Week 48|Non-compliance with study schedule|0|||
126061762|NCT05066230|453519961|FG000|After Week 48|Withdrawal by Subject|0|||
126061763|NCT05066230|453519962|FG001|After Week 48|Withdrawal by Subject|1|||
126061764|NCT05066230|453519961|FG000|After Week 48|Lost to Follow-up|3|||
126061765|NCT05066230|453519962|FG001|After Week 48|Lost to Follow-up|3|||
126061766|NCT05066230|453519961|FG000|After Week 48|Sponsor Request|115|||
126061767|NCT05066230|453519962|FG001|After Week 48|Sponsor Request|111|||
126061768|NCT02164578|453519963|FG000|Treatment Period|Withdrawal by Subject|3|||
126061769|NCT02164578|453519964|FG001|Treatment Period|Withdrawal by Subject|3|||
126061770|NCT02164578|453519963|FG000|Treatment Period|Adverse Event|13|||
126061771|NCT02164578|453519964|FG001|Treatment Period|Adverse Event|6|||
126061772|NCT02164578|453519963|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
126061773|NCT02164578|453519964|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
126061774|NCT02164578|453519963|FG000|Treatment Period|Protocol Violation|0|||
126061775|NCT02164578|453519964|FG001|Treatment Period|Protocol Violation|2|||
126061776|NCT02164578|453519963|FG000|Extension Period|Withdrawal by Subject|2|||
126061777|NCT02164578|453519964|FG001|Extension Period|Withdrawal by Subject|0|||
126061778|NCT02164578|453519963|FG000|Extension Period|Adverse Event|4|||
126061779|NCT02164578|453519964|FG001|Extension Period|Adverse Event|0|||
126061780|NCT02164578|453519963|FG000|Extension Period|Expiry of study medication|1|||
126061781|NCT02164578|453519964|FG001|Extension Period|Expiry of study medication|0|||
126061782|NCT02164578|453519963|FG000|Extension Period|Protocol Violation|0|||
126061783|NCT02164578|453519964|FG001|Extension Period|Protocol Violation|1|||
126061784|NCT02507297|453519965|FG000|Overall Study|Withdrawal by Subject|1|||
126061785|NCT02507297|453519966|FG001|Overall Study|Withdrawal by Subject|0|||
126061786|NCT02507297|453519965|FG000|Overall Study|Lost to Follow-up|0|||
126061787|NCT02507297|453519966|FG001|Overall Study|Lost to Follow-up|1|||
126061788|NCT01018992|453519967|FG000|Overall Study|Adverse Event|8|||
126061789|NCT01018992|453519968|FG001|Overall Study|Adverse Event|3|||
126061790|NCT01018992|453519967|FG000|Overall Study|Withdrawal by Subject|3|||
126061791|NCT01018992|453519968|FG001|Overall Study|Withdrawal by Subject|8|||
126061792|NCT01018992|453519967|FG000|Overall Study|Protocol Violation|0|||
126061793|NCT01018992|453519968|FG001|Overall Study|Protocol Violation|4|||
126061794|NCT01018992|453519967|FG000|Overall Study|Lost to Follow-up|5|||
126061795|NCT01018992|453519968|FG001|Overall Study|Lost to Follow-up|1|||
126061796|NCT03029585|453519969|FG000|Overall Study|Death|1|||
126061797|NCT03029585|453519970|FG001|Overall Study|Death|1|||
126061798|NCT03029585|453519969|FG000|Overall Study|Withdrawal by Subject|1|||
126061799|NCT03029585|453519970|FG001|Overall Study|Withdrawal by Subject|0|||
126061800|NCT02092285|453519971|FG000|Induction Phase|Adverse Event|7|||
126061801|NCT02092285|453519971|FG000|Induction Phase|Physician Decision|4|||
126061802|NCT02092285|453519971|FG000|Induction Phase|Pregnancy|1|||
126061803|NCT02092285|453519971|FG000|Induction Phase|Relapse/Recurrence|7|||
126061804|NCT02092285|453519971|FG000|Induction Phase|Withdrawal by Subject|2|||
126061805|NCT02092285|453519971|FG000|Induction Phase|Lack of Efficacy|14|||
126061806|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
126061807|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
126061808|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
126110228|NCT03891524|453697675|FG005|Overall Study|Withdrawal by Subject|2|||
126110229|NCT03891524|453697676|FG006|Overall Study|Withdrawal by Subject|2|||
126061809|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
126061810|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
126061811|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
126061812|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
126061813|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
126110230|NCT03891524|453697677|FG007|Overall Study|Withdrawal by Subject|1|||
126110231|NCT00390910|453697678|FG000|Overall Study|Adverse Event|1|||
126110232|NCT00390910|453697679|FG001|Overall Study|Adverse Event|0|||
126061814|NCT02092285|453519971|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
126061815|NCT01825785|453519972|FG000|Overall Study|Adverse Event|0|||
126061816|NCT01825785|453519973|FG001|Overall Study|Adverse Event|0|||
126110233|NCT00390910|453697680|FG002|Overall Study|Adverse Event|0|||
126110234|NCT00390910|453697678|FG000|Overall Study|Lost to Follow-up|0|||
126061817|NCT01825785|453519974|FG002|Overall Study|Adverse Event|0|||
126110235|NCT00390910|453697679|FG001|Overall Study|Lost to Follow-up|1|||
126061818|NCT01825785|453519975|FG003|Overall Study|Adverse Event|0|||
126061819|NCT01825785|453519976|FG004|Overall Study|Adverse Event|1|||
126061820|NCT01825785|453519977|FG005|Overall Study|Adverse Event|0|||
126061821|NCT01825785|453519978|FG006|Overall Study|Adverse Event|0|||
126061822|NCT01825785|453519972|FG000|Overall Study|Withdrawal by Subject|0|||
126061823|NCT01825785|453519973|FG001|Overall Study|Withdrawal by Subject|0|||
126061824|NCT01825785|453519974|FG002|Overall Study|Withdrawal by Subject|0|||
126061825|NCT01825785|453519975|FG003|Overall Study|Withdrawal by Subject|0|||
126061826|NCT01825785|453519976|FG004|Overall Study|Withdrawal by Subject|1|||
126061827|NCT01825785|453519977|FG005|Overall Study|Withdrawal by Subject|1|||
126061828|NCT01825785|453519978|FG006|Overall Study|Withdrawal by Subject|0|||
126061829|NCT01304940|453519980|FG000|Overall Study|not meet symptom severity requirement|3|||
126061830|NCT01304940|453519981|FG001|Overall Study|not meet symptom severity requirement|0|||
126061831|NCT00278395|453519984|FG000|Overall Study|Adverse Event|2|||
126061832|NCT00278395|453519984|FG000|Overall Study|Nonevaluable|1|||
126061833|NCT03740737|453519985|FG000|Overall Study|Protocol deviation|13|||
126061834|NCT03740737|453519986|FG001|Overall Study|Protocol deviation|0|||
126061835|NCT03740737|453519985|FG000|Overall Study|Adverse Event|2|||
126061836|NCT03740737|453519986|FG001|Overall Study|Adverse Event|0|||
126061837|NCT03740737|453519985|FG000|Overall Study|Lost to Follow-up|1|||
126061838|NCT03740737|453519986|FG001|Overall Study|Lost to Follow-up|0|||
126061839|NCT03740737|453519985|FG000|Overall Study|Randomization failure|1|||
126061840|NCT03740737|453519986|FG001|Overall Study|Randomization failure|0|||
126061841|NCT03740737|453519985|FG000|Overall Study|Participant withdrew consent|1|||
126061842|NCT03740737|453519986|FG001|Overall Study|Participant withdrew consent|0|||
126061843|NCT03740737|453519985|FG000|Overall Study|Participant withdrew from trial|2|||
126061844|NCT03740737|453519986|FG001|Overall Study|Participant withdrew from trial|1|||
126061845|NCT01286311|453519988|FG000|Overall Study|Physician did not want outreach sent|14|||
125913514|NCT02719327|452982804|FG001|Overall Study|Withdrawal by Subject|8|||
125913515|NCT01067976|452982807|FG000|Overall Study|Study drug never administered|20|||
125913516|NCT01067976|452982807|FG000|Overall Study|Study prematurely discontinued|2|||
125913517|NCT00566111|452982808|FG000|Overall Study|Adverse Event|0|||
125913518|NCT00566111|452982809|FG001|Overall Study|Adverse Event|2|||
125913519|NCT05268055|452982810|FG000|Overall Study|Lost to Follow-up|68|||
125913520|NCT05268055|452982811|FG001|Overall Study|Lost to Follow-up|68|||
125913521|NCT05268055|452982810|FG000|Overall Study|Withdrawal by Subject|12|||
125913522|NCT05268055|452982811|FG001|Overall Study|Withdrawal by Subject|8|||
125913523|NCT02497612|452984810|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
125913524|NCT02497612|452984811|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
125913525|NCT02497612|452984812|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
125913526|NCT02497612|452984813|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
125913527|NCT02497612|452984810|FG000|Overall Study|Participant's request|2|||
125913528|NCT02497612|452984811|FG001|Overall Study|Participant's request|3|||
125913529|NCT02497612|452984812|FG002|Overall Study|Participant's request|4|||
125913530|NCT02497612|452984813|FG003|Overall Study|Participant's request|1|||
125913531|NCT02497612|452984810|FG000|Overall Study|Investigator's judgement|1|||
125913532|NCT02497612|452984811|FG001|Overall Study|Investigator's judgement|0|||
125913533|NCT02497612|452984812|FG002|Overall Study|Investigator's judgement|0|||
125913534|NCT02497612|452984813|FG003|Overall Study|Investigator's judgement|2|||
125913535|NCT02497612|452984810|FG000|Overall Study|Adverse Event|3|||
125913536|NCT02497612|452984811|FG001|Overall Study|Adverse Event|1|||
125913537|NCT02497612|452984812|FG002|Overall Study|Adverse Event|4|||
125913538|NCT02497612|452984813|FG003|Overall Study|Adverse Event|1|||
125913539|NCT02497612|452984810|FG000|Overall Study|Lost to Follow-up|1|||
125913540|NCT02497612|452984811|FG001|Overall Study|Lost to Follow-up|1|||
125913541|NCT02497612|452984812|FG002|Overall Study|Lost to Follow-up|0|||
126061846|NCT01286311|453519989|FG001|Overall Study|Physician did not want outreach sent|0|||
126061847|NCT02981953|453519995|FG000|Overall Study|Death|9|||
126061848|NCT02981953|453519995|FG000|Overall Study|Withdrawal by Subject|1|||
126061849|NCT02981953|453519995|FG000|Overall Study|Withdrawal to non-compliance|1|||
126061850|NCT02889900|453519996|FG000|Overall Study|Adverse Event|11|||
126061851|NCT02889900|453519996|FG000|Overall Study|Condition under investigation worsened|32|||
126061852|NCT02889900|453519996|FG000|Overall Study|Other|5|||
126061853|NCT02889900|453519996|FG000|Overall Study|Withdrawal by Subject|7|||
126061854|NCT02889900|453519996|FG000|Overall Study|Not treated|2|||
125913542|NCT02497612|452984813|FG003|Overall Study|Lost to Follow-up|1|||
125913543|NCT02497612|452984810|FG000|Overall Study|Other unspecified|1|||
125913544|NCT02497612|452984811|FG001|Overall Study|Other unspecified|1|||
125913545|NCT02497612|452984812|FG002|Overall Study|Other unspecified|2|||
125913546|NCT02497612|452984813|FG003|Overall Study|Other unspecified|0|||
125913547|NCT02497612|452984810|FG000|Overall Study|Not eligible|1|||
125913548|NCT02497612|452984811|FG001|Overall Study|Not eligible|0|||
125913549|NCT02497612|452984812|FG002|Overall Study|Not eligible|0|||
125913550|NCT02497612|452984813|FG003|Overall Study|Not eligible|1|||
125913551|NCT05021081|452984816|FG000|Phase 2|Subject enrolled in error|1|||
125913552|NCT05021081|452984817|FG001|Phase 2|Subject enrolled in error|1|||
125913553|NCT05021081|452984818|FG002|Phase 2|Subject enrolled in error|0|||
125913554|NCT00369122|452984819|FG000|Overall Study|Ineligible|10|||
125913555|NCT00369122|452984819|FG000|Overall Study|No protocol treatment|1|||
125913556|NCT02651467|452984820|FG000|Overall Study|Withdrawal by Subject|0|||
125913557|NCT02651467|452984821|FG001|Overall Study|Withdrawal by Subject|0|||
125913558|NCT02651467|452984822|FG002|Overall Study|Withdrawal by Subject|2|||
125913559|NCT02651467|452984820|FG000|Overall Study|Other (Not specified)|1|||
125913560|NCT02651467|452984821|FG001|Overall Study|Other (Not specified)|0|||
125913561|NCT02651467|452984822|FG002|Overall Study|Other (Not specified)|2|||
125913562|NCT00004635|452984823|FG000|Period One|refused|2|||
125913563|NCT00004635|452984824|FG001|Period One|refused|1|||
125913564|NCT00004635|452984823|FG000|Period One|Withdrawal by Subject|1|||
125913565|NCT00004635|452984824|FG001|Period One|Withdrawal by Subject|1|||
125913566|NCT00004635|452984823|FG000|Period One|Protocol Violation|1|||
125913567|NCT00004635|452984824|FG001|Period One|Protocol Violation|0|||
125913568|NCT00004635|452984823|FG000|Period One|PSA did not go <5 ng/mL|1|||
125913569|NCT00004635|452984824|FG001|Period One|PSA did not go <5 ng/mL|0|||
125913570|NCT00004635|452984823|FG000|Period One|second malignancy|1|||
125913571|NCT00004635|452984824|FG001|Period One|second malignancy|0|||
125913572|NCT00004635|452984823|FG000|Period One|progressed|0|||
125913573|NCT00004635|452984824|FG001|Period One|progressed|2|||
125913574|NCT00004635|452984823|FG000|Period One|health problem|0|||
125913575|NCT00004635|452984824|FG001|Period One|health problem|1|||
125913576|NCT00004635|452984823|FG000|Period One|discrepancy in data entry|0|||
125913577|NCT00004635|452984824|FG001|Period One|discrepancy in data entry|1|||
125913578|NCT00004635|452984823|FG000|Period Two|progression|2|||
125913579|NCT00004635|452984824|FG001|Period Two|progression|3|||
125913580|NCT00004635|452984823|FG000|Period Two|Adverse Event|1|||
125913581|NCT00004635|452984824|FG001|Period Two|Adverse Event|0|||
125913582|NCT00004635|452984823|FG000|Period Two|refused|0|||
125913583|NCT00004635|452984824|FG001|Period Two|refused|2|||
125913584|NCT00004635|452984823|FG000|Period Two|health problem|1|||
125913585|NCT00004635|452984824|FG001|Period Two|health problem|1|||
125913586|NCT00004635|452984823|FG000|Period Two|travel issues|0|||
125913587|NCT00004635|452984824|FG001|Period Two|travel issues|1|||
125913588|NCT00004635|452984823|FG000|Period Two|secondary malignancy|1|||
125913589|NCT00004635|452984824|FG001|Period Two|secondary malignancy|1|||
125913590|NCT00004635|452984823|FG000|Period Two|Lost to Follow-up|1|||
125913591|NCT00004635|452984824|FG001|Period Two|Lost to Follow-up|0|||
125913592|NCT00004635|452984823|FG000|Period Two|discrepancy in data entry|0|||
125913593|NCT00004635|452984824|FG001|Period Two|discrepancy in data entry|1|||
125913594|NCT02024529|452984827|FG000|Overall Study|Withdrawal by Subject|11|||
125913595|NCT02024529|452984828|FG001|Overall Study|Withdrawal by Subject|21|||
125913596|NCT02024529|452984827|FG000|Overall Study|Lost to Follow-up|2|||
125913597|NCT02024529|452984828|FG001|Overall Study|Lost to Follow-up|4|||
125913598|NCT01426438|452984829|FG000|Overall Study|Lost to Follow-up|1|||
125913599|NCT01426438|452984830|FG001|Overall Study|Lost to Follow-up|3|||
125913600|NCT01426438|452984829|FG000|Overall Study|Off study Treatment|9|||
125913601|NCT01426438|452984830|FG001|Overall Study|Off study Treatment|3|||
125913602|NCT01426438|452984829|FG000|Overall Study|Poor scan quality|3|||
125913603|NCT01426438|452984830|FG001|Overall Study|Poor scan quality|2|||
125913604|NCT01426438|452984829|FG000|Overall Study|Missed Scan|2|||
125913605|NCT01426438|452984830|FG001|Overall Study|Missed Scan|2|||
125913606|NCT01134731|452984831|FG000|Overall Study|Adverse Event|3|||
125913607|NCT01134731|452984832|FG001|Overall Study|Adverse Event|2|||
125913608|NCT01134731|452984833|FG002|Overall Study|Adverse Event|1|||
125913609|NCT01134731|452984831|FG000|Overall Study|Physician Decision|2|||
125913610|NCT01134731|452984832|FG001|Overall Study|Physician Decision|2|||
125913611|NCT01134731|452984833|FG002|Overall Study|Physician Decision|2|||
125913612|NCT01134731|452984831|FG000|Overall Study|Lack of Efficacy|0|||
125913613|NCT01134731|452984832|FG001|Overall Study|Lack of Efficacy|0|||
125913614|NCT01134731|452984833|FG002|Overall Study|Lack of Efficacy|1|||
125913615|NCT01134731|452984831|FG000|Overall Study|Withdrawal by Subject|3|||
126061855|NCT03146845|453520001|FG000|Overall Study|Reference ulcer healed|1|||
125913616|NCT01134731|452984832|FG001|Overall Study|Withdrawal by Subject|3|||
125913617|NCT01134731|452984833|FG002|Overall Study|Withdrawal by Subject|1|||
125913618|NCT01134731|452984831|FG000|Overall Study|Lost to Follow-up|5|||
125913619|NCT01134731|452984832|FG001|Overall Study|Lost to Follow-up|4|||
125913620|NCT01134731|452984833|FG002|Overall Study|Lost to Follow-up|3|||
125913621|NCT00676338|452984836|FG000|Overall Study|Adverse Event|6|||
125913622|NCT00676338|452984837|FG001|Overall Study|Adverse Event|6|||
125913623|NCT00676338|452984838|FG002|Overall Study|Adverse Event|5|||
125913624|NCT00676338|452984839|FG003|Overall Study|Adverse Event|1|||
125913625|NCT00676338|452984836|FG000|Overall Study|Lost to Follow-up|4|||
125913626|NCT00676338|452984837|FG001|Overall Study|Lost to Follow-up|1|||
125913627|NCT00676338|452984838|FG002|Overall Study|Lost to Follow-up|3|||
125913628|NCT00676338|452984839|FG003|Overall Study|Lost to Follow-up|4|||
125913629|NCT00676338|452984836|FG000|Overall Study|Physician Decision|3|||
125913630|NCT00676338|452984837|FG001|Overall Study|Physician Decision|3|||
125913631|NCT00676338|452984838|FG002|Overall Study|Physician Decision|2|||
125913632|NCT00676338|452984839|FG003|Overall Study|Physician Decision|3|||
125913633|NCT00676338|452984836|FG000|Overall Study|Protocol Violation|5|||
125913634|NCT00676338|452984837|FG001|Overall Study|Protocol Violation|9|||
125913635|NCT00676338|452984838|FG002|Overall Study|Protocol Violation|2|||
125913636|NCT00676338|452984839|FG003|Overall Study|Protocol Violation|5|||
125913637|NCT00676338|452984836|FG000|Overall Study|Withdrawal by Subject|17|||
125913638|NCT00676338|452984837|FG001|Overall Study|Withdrawal by Subject|9|||
125913639|NCT00676338|452984838|FG002|Overall Study|Withdrawal by Subject|12|||
125913640|NCT00676338|452984839|FG003|Overall Study|Withdrawal by Subject|6|||
125913641|NCT00676338|452984836|FG000|Overall Study|Entry Criteria Not Met|0|||
125913642|NCT00676338|452984837|FG001|Overall Study|Entry Criteria Not Met|2|||
125913643|NCT00676338|452984838|FG002|Overall Study|Entry Criteria Not Met|1|||
125913644|NCT00676338|452984839|FG003|Overall Study|Entry Criteria Not Met|1|||
125913645|NCT00676338|452984836|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
125913646|NCT00676338|452984837|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
125913647|NCT00676338|452984838|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
125913648|NCT00676338|452984839|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
125913649|NCT02122458|452984840|FG000|Overall Study|Withdrawal by Subject|0|||
125913650|NCT02122458|452984841|FG001|Overall Study|Withdrawal by Subject|0|||
125913651|NCT02122458|452984842|FG002|Overall Study|Withdrawal by Subject|0|||
125913652|NCT02122458|452984843|FG003|Overall Study|Withdrawal by Subject|4|||
125913653|NCT02122458|452984844|FG004|Overall Study|Withdrawal by Subject|4|||
125913654|NCT02122458|452984845|FG005|Overall Study|Withdrawal by Subject|4|||
125913655|NCT02122458|452984846|FG006|Overall Study|Withdrawal by Subject|0|||
125913656|NCT02122458|452984840|FG000|Overall Study|Lost to Follow-up|1|||
125913657|NCT02122458|452984841|FG001|Overall Study|Lost to Follow-up|3|||
125913658|NCT02122458|452984842|FG002|Overall Study|Lost to Follow-up|0|||
125913659|NCT02122458|452984843|FG003|Overall Study|Lost to Follow-up|7|||
125913660|NCT02122458|452984844|FG004|Overall Study|Lost to Follow-up|5|||
125913661|NCT02122458|452984845|FG005|Overall Study|Lost to Follow-up|15|||
125913662|NCT02122458|452984846|FG006|Overall Study|Lost to Follow-up|1|||
125913663|NCT02122458|452984840|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
125913664|NCT02122458|452984841|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
125913665|NCT02122458|452984842|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
125913666|NCT02122458|452984843|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
126061856|NCT03146845|453520002|FG001|Overall Study|Reference ulcer healed|0|||
126061857|NCT03146845|453520001|FG000|Overall Study|Physician Decision|1|||
125913667|NCT02122458|452984844|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
125913668|NCT02122458|452984845|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
125913669|NCT02122458|452984846|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
125913670|NCT02122458|452984840|FG000|Overall Study|Adverse Event|1|||
125913671|NCT02122458|452984841|FG001|Overall Study|Adverse Event|0|||
125913672|NCT02122458|452984842|FG002|Overall Study|Adverse Event|0|||
125913673|NCT02122458|452984843|FG003|Overall Study|Adverse Event|0|||
125913674|NCT02122458|452984844|FG004|Overall Study|Adverse Event|0|||
125913675|NCT02122458|452984845|FG005|Overall Study|Adverse Event|0|||
125913676|NCT02122458|452984846|FG006|Overall Study|Adverse Event|0|||
125913677|NCT02122458|452984840|FG000|Overall Study|Experimental Error|0|||
125913678|NCT02122458|452984841|FG001|Overall Study|Experimental Error|0|||
125913679|NCT02122458|452984842|FG002|Overall Study|Experimental Error|0|||
125913680|NCT02122458|452984843|FG003|Overall Study|Experimental Error|0|||
125913681|NCT02122458|452984844|FG004|Overall Study|Experimental Error|3|||
125913682|NCT02122458|452984845|FG005|Overall Study|Experimental Error|0|||
125913683|NCT02122458|452984846|FG006|Overall Study|Experimental Error|0|||
125913684|NCT02122458|452984840|FG000|Overall Study|Deployed or Moved|0|||
125913685|NCT02122458|452984841|FG001|Overall Study|Deployed or Moved|0|||
125913686|NCT02122458|452984842|FG002|Overall Study|Deployed or Moved|0|||
125913687|NCT02122458|452984843|FG003|Overall Study|Deployed or Moved|0|||
125913688|NCT02122458|452984844|FG004|Overall Study|Deployed or Moved|1|||
125913689|NCT02122458|452984845|FG005|Overall Study|Deployed or Moved|0|||
125913690|NCT02122458|452984846|FG006|Overall Study|Deployed or Moved|0|||
125913691|NCT02122458|452984840|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
125913692|NCT02122458|452984841|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
125913693|NCT02122458|452984842|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
125913694|NCT02122458|452984843|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
125913695|NCT02122458|452984844|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
125913696|NCT02122458|452984845|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
125913697|NCT02122458|452984846|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
125913698|NCT02122458|452984840|FG000|Overall Study|Noncompliance|0|||
125913699|NCT02122458|452984841|FG001|Overall Study|Noncompliance|1|||
125913700|NCT02122458|452984842|FG002|Overall Study|Noncompliance|0|||
125913701|NCT02122458|452984843|FG003|Overall Study|Noncompliance|0|||
125913702|NCT02122458|452984844|FG004|Overall Study|Noncompliance|0|||
125913703|NCT02122458|452984845|FG005|Overall Study|Noncompliance|0|||
125913704|NCT02122458|452984846|FG006|Overall Study|Noncompliance|0|||
125913705|NCT00412542|452984847|FG000|Overall Study|Withdrawal by Subject|0|||
125913706|NCT00412542|452984848|FG001|Overall Study|Withdrawal by Subject|2|||
125913707|NCT00412542|452984847|FG000|Overall Study|Not Eligible|0|||
125913708|NCT00412542|452984848|FG001|Overall Study|Not Eligible|1|||
125913709|NCT03161093|452984851|FG000|Overall Study|Protocol Violation|11|||
125913710|NCT03161093|452984852|FG001|Overall Study|Protocol Violation|14|||
125913711|NCT03161093|452984853|FG002|Overall Study|Protocol Violation|6|||
125913712|NCT03161093|452984854|FG003|Overall Study|Protocol Violation|13|||
125913713|NCT03161093|452984855|FG004|Overall Study|Protocol Violation|1|||
125913714|NCT03161093|452984856|FG005|Overall Study|Protocol Violation|0|||
125913715|NCT03161093|452984851|FG000|Overall Study|Adverse Event|5|||
125913716|NCT03161093|452984852|FG001|Overall Study|Adverse Event|21|||
125913717|NCT03161093|452984853|FG002|Overall Study|Adverse Event|16|||
125913718|NCT03161093|452984854|FG003|Overall Study|Adverse Event|35|||
125913719|NCT03161093|452984855|FG004|Overall Study|Adverse Event|2|||
125913720|NCT03161093|452984856|FG005|Overall Study|Adverse Event|1|||
125913721|NCT03161093|452984851|FG000|Overall Study|Lack of Efficacy|9|||
125913722|NCT03161093|452984852|FG001|Overall Study|Lack of Efficacy|13|||
125913723|NCT03161093|452984853|FG002|Overall Study|Lack of Efficacy|9|||
125913724|NCT03161093|452984854|FG003|Overall Study|Lack of Efficacy|24|||
125913725|NCT03161093|452984855|FG004|Overall Study|Lack of Efficacy|4|||
125913726|NCT03161093|452984856|FG005|Overall Study|Lack of Efficacy|1|||
125913727|NCT03161093|452984851|FG000|Overall Study|Physician Decision|0|||
125913728|NCT03161093|452984852|FG001|Overall Study|Physician Decision|1|||
125913729|NCT03161093|452984853|FG002|Overall Study|Physician Decision|0|||
125913730|NCT03161093|452984854|FG003|Overall Study|Physician Decision|2|||
125913731|NCT03161093|452984855|FG004|Overall Study|Physician Decision|17|||
125913732|NCT03161093|452984856|FG005|Overall Study|Physician Decision|15|||
125913733|NCT03161093|452984851|FG000|Overall Study|Withdrawal by Subject|24|||
125913734|NCT03161093|452984852|FG001|Overall Study|Withdrawal by Subject|73|||
125913735|NCT03161093|452984853|FG002|Overall Study|Withdrawal by Subject|44|||
125913736|NCT03161093|452984854|FG003|Overall Study|Withdrawal by Subject|97|||
125913737|NCT03161093|452984855|FG004|Overall Study|Withdrawal by Subject|11|||
125913738|NCT03161093|452984856|FG005|Overall Study|Withdrawal by Subject|10|||
125913739|NCT03161093|452984851|FG000|Overall Study|Lost to Follow-up|3|||
125913740|NCT03161093|452984852|FG001|Overall Study|Lost to Follow-up|12|||
125913741|NCT03161093|452984853|FG002|Overall Study|Lost to Follow-up|4|||
125913742|NCT03161093|452984854|FG003|Overall Study|Lost to Follow-up|7|||
125913743|NCT03161093|452984855|FG004|Overall Study|Lost to Follow-up|8|||
125913744|NCT03161093|452984856|FG005|Overall Study|Lost to Follow-up|13|||
125913745|NCT03161093|452984851|FG000|Overall Study|Death|3|||
125913746|NCT03161093|452984852|FG001|Overall Study|Death|9|||
125913747|NCT03161093|452984853|FG002|Overall Study|Death|7|||
125913748|NCT03161093|452984854|FG003|Overall Study|Death|9|||
125913749|NCT03161093|452984855|FG004|Overall Study|Death|0|||
125913750|NCT03161093|452984856|FG005|Overall Study|Death|0|||
125913751|NCT03161093|452984851|FG000|Overall Study|Unknown - Not reported|0|||
125913752|NCT03161093|452984852|FG001|Overall Study|Unknown - Not reported|1|||
125913753|NCT03161093|452984853|FG002|Overall Study|Unknown - Not reported|0|||
125913754|NCT03161093|452984854|FG003|Overall Study|Unknown - Not reported|0|||
126061858|NCT03146845|453520002|FG001|Overall Study|Physician Decision|0|||
126061859|NCT03146845|453520001|FG000|Overall Study|Adverse Event|1|||
126061860|NCT03146845|453520002|FG001|Overall Study|Adverse Event|0|||
126061861|NCT03146845|453520001|FG000|Overall Study|Withdrawal by Subject|2|||
126061862|NCT03146845|453520002|FG001|Overall Study|Withdrawal by Subject|0|||
126061863|NCT03146845|453520001|FG000|Overall Study|Noncompliance|0|||
126061864|NCT03146845|453520002|FG001|Overall Study|Noncompliance|1|||
126061865|NCT03146845|453520001|FG000|Overall Study|Protocol Violation|0|||
126061866|NCT03146845|453520002|FG001|Overall Study|Protocol Violation|2|||
126061867|NCT03146845|453520001|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
126061868|NCT03146845|453520002|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
126061869|NCT01535261|453520009|FG000|Overall Study|Physician Decision|8|||
126061870|NCT01535261|453520009|FG000|Overall Study|Protocol Violation|3|||
126061871|NCT01535261|453520009|FG000|Overall Study|Death|5|||
126061872|NCT01535261|453520009|FG000|Overall Study|Lost to Follow-up|8|||
126061873|NCT01535261|453520009|FG000|Overall Study|Withdrawal by Subject|14|||
126061874|NCT01535261|453520009|FG000|Overall Study|Adverse Event|12|||
126061875|NCT01757288|453520013|FG000|Overall Study|Consent withdrawal|0|||
126061876|NCT01757288|453520014|FG001|Overall Study|Consent withdrawal|4|||
126061877|NCT01757288|453520015|FG002|Overall Study|Consent withdrawal|4|||
126061878|NCT01757288|453520013|FG000|Overall Study|Patient off study, IRB hold.|0|||
126061879|NCT01757288|453520014|FG001|Overall Study|Patient off study, IRB hold.|0|||
126061880|NCT01757288|453520015|FG002|Overall Study|Patient off study, IRB hold.|1|||
126061881|NCT01757288|453520013|FG000|Overall Study|Patient death prior to starting treatment|0|||
126061882|NCT01757288|453520014|FG001|Overall Study|Patient death prior to starting treatment|0|||
126061883|NCT01757288|453520015|FG002|Overall Study|Patient death prior to starting treatment|1|||
126061884|NCT01757288|453520013|FG000|Overall Study|Wrong medication administered|0|||
126061885|NCT01757288|453520014|FG001|Overall Study|Wrong medication administered|1|||
126061886|NCT01757288|453520015|FG002|Overall Study|Wrong medication administered|0|||
126061887|NCT01757288|453520013|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
126061888|NCT01757288|453520014|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
126061889|NCT01757288|453520015|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
125913755|NCT03161093|452984855|FG004|Overall Study|Unknown - Not reported|0|||
125913756|NCT03161093|452984856|FG005|Overall Study|Unknown - Not reported|1|||
125913757|NCT02124161|452984857|FG000|Overall Study|Other unspecified|0|||
125913758|NCT02124161|452984858|FG001|Overall Study|Other unspecified|1|||
125913759|NCT02124161|452984857|FG000|Overall Study|Death|1|||
125913760|NCT02124161|452984858|FG001|Overall Study|Death|0|||
125913761|NCT02124161|452984857|FG000|Overall Study|Protocol Violation|2|||
125913762|NCT02124161|452984858|FG001|Overall Study|Protocol Violation|1|||
125913763|NCT02124161|452984857|FG000|Overall Study|Withdrawal by Subject|1|||
125913764|NCT02124161|452984858|FG001|Overall Study|Withdrawal by Subject|2|||
125913765|NCT02124161|452984857|FG000|Overall Study|Adverse Event|2|||
125913766|NCT02124161|452984858|FG001|Overall Study|Adverse Event|0|||
125913767|NCT02124161|452984857|FG000|Overall Study|Does not meet entrance criteria|2|||
125913768|NCT02124161|452984858|FG001|Overall Study|Does not meet entrance criteria|3|||
125913769|NCT02124161|452984857|FG000|Overall Study|No longer meets eligibility criteria|5|||
125913770|NCT02124161|452984858|FG001|Overall Study|No longer meets eligibility criteria|4|||
125913771|NCT02124161|452984857|FG000|Overall Study|Lost to Follow-up|3|||
125913772|NCT02124161|452984858|FG001|Overall Study|Lost to Follow-up|4|||
125913773|NCT02517866|452984859|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125913774|NCT02517866|452984860|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125913775|NCT02517866|452984861|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125913776|NCT02517866|452984859|FG000|Overall Study|Significant Protocol Deviation|4|||
125913777|NCT02517866|452984860|FG001|Overall Study|Significant Protocol Deviation|1|||
125913778|NCT02517866|452984861|FG002|Overall Study|Significant Protocol Deviation|0|||
125913779|NCT02517866|452984859|FG000|Overall Study|Lost to Follow-up|1|||
125913780|NCT02517866|452984860|FG001|Overall Study|Lost to Follow-up|0|||
125913781|NCT02517866|452984861|FG002|Overall Study|Lost to Follow-up|0|||
125913782|NCT02517866|452984859|FG000|Overall Study|Voluntary Withdrawal|2|||
125913783|NCT02517866|452984860|FG001|Overall Study|Voluntary Withdrawal|2|||
125913784|NCT02517866|452984861|FG002|Overall Study|Voluntary Withdrawal|0|||
125913785|NCT02517866|452984859|FG000|Overall Study|Investigator Decision|2|||
125913786|NCT02517866|452984860|FG001|Overall Study|Investigator Decision|1|||
125913787|NCT02517866|452984861|FG002|Overall Study|Investigator Decision|0|||
125913788|NCT02517866|452984859|FG000|Overall Study|Reason not specified|2|||
125913789|NCT02517866|452984860|FG001|Overall Study|Reason not specified|0|||
126061890|NCT01757288|453520013|FG000|Overall Study|Not meeting protocol constraints|0|||
126061891|NCT01757288|453520014|FG001|Overall Study|Not meeting protocol constraints|1|||
126061892|NCT01757288|453520015|FG002|Overall Study|Not meeting protocol constraints|1|||
126061893|NCT01757288|453520013|FG000|Overall Study|Multiple missed appointments|0|||
126061894|NCT01757288|453520014|FG001|Overall Study|Multiple missed appointments|1|||
126061895|NCT01757288|453520015|FG002|Overall Study|Multiple missed appointments|0|||
126061896|NCT01757288|453520013|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
126061897|NCT01757288|453520014|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
126061898|NCT01757288|453520015|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
126061899|NCT01757288|453520013|FG000|Overall Study|>2 weeks treatment break|0|||
126061900|NCT01757288|453520014|FG001|Overall Study|>2 weeks treatment break|0|||
126061901|NCT01757288|453520015|FG002|Overall Study|>2 weeks treatment break|1|||
126061902|NCT03875729|453520018|FG000|Overall Study|Adverse Event|0|||
126061903|NCT03875729|453520019|FG001|Overall Study|Adverse Event|5|||
126061904|NCT03875729|453520018|FG000|Overall Study|Withdrawal by Subject|8|||
126061905|NCT03875729|453520019|FG001|Overall Study|Withdrawal by Subject|11|||
126061906|NCT03875729|453520018|FG000|Overall Study|Pregnancy|0|||
126061907|NCT03875729|453520019|FG001|Overall Study|Pregnancy|1|||
126061908|NCT03875729|453520018|FG000|Overall Study|Lost to Follow-up|0|||
126061909|NCT03875729|453520019|FG001|Overall Study|Lost to Follow-up|5|||
126061910|NCT03875729|453520018|FG000|Overall Study|Personal reasons|2|||
126061911|NCT03875729|453520019|FG001|Overall Study|Personal reasons|0|||
126061912|NCT02764320|453520020|FG000|Overall Study|Withdrawal by Subject|35|||
126061913|NCT02764320|453520021|FG001|Overall Study|Withdrawal by Subject|38|||
126061914|NCT02764320|453520020|FG000|Overall Study|Protocol Violation|11|||
126061915|NCT02764320|453520021|FG001|Overall Study|Protocol Violation|6|||
126061916|NCT02764320|453520020|FG000|Overall Study|Adverse Event|2|||
126061917|NCT02764320|453520021|FG001|Overall Study|Adverse Event|0|||
126061918|NCT02764320|453520020|FG000|Overall Study|Health Issues unable to continue|2|||
126061919|NCT02764320|453520021|FG001|Overall Study|Health Issues unable to continue|0|||
126061920|NCT02764320|453520020|FG000|Overall Study|Did not meet inclusion criteria|1|||
126061921|NCT02764320|453520021|FG001|Overall Study|Did not meet inclusion criteria|0|||
126061922|NCT02764320|453520020|FG000|Overall Study|Subject moved|0|||
126061923|NCT02764320|453520021|FG001|Overall Study|Subject moved|2|||
126061924|NCT02764320|453520020|FG000|Overall Study|Overused medication unavailable|0|||
126061925|NCT02764320|453520021|FG001|Overall Study|Overused medication unavailable|1|||
126061926|NCT02764320|453520020|FG000|Overall Study|Seeking care outside site|0|||
126061927|NCT02764320|453520021|FG001|Overall Study|Seeking care outside site|1|||
126061928|NCT02764320|453520020|FG000|Overall Study|Technology barriers|0|||
126061929|NCT02764320|453520021|FG001|Overall Study|Technology barriers|1|||
126061930|NCT01405508|453520024|FG000|Overall Study|AE, non-serious non-fatal|1|||
126061931|NCT01405508|453520025|FG001|Overall Study|AE, non-serious non-fatal|1|||
126061932|NCT01405508|453520026|FG002|Overall Study|AE, non-serious non-fatal|0|||
126061933|NCT01405508|453520027|FG003|Overall Study|AE, non-serious non-fatal|0|||
126061934|NCT00476957|453520032|FG000|Overall Study|Lost to Follow-up|176|||
126061935|NCT00476957|453520033|FG001|Overall Study|Lost to Follow-up|193|||
126061936|NCT02159352|453520034|FG000|Overall Study|Adverse Event|3|||
126061937|NCT02159352|453520035|FG001|Overall Study|Adverse Event|1|||
126061938|NCT02159352|453520034|FG000|Overall Study|Withdrawal by Subject|0|||
126061939|NCT02159352|453520035|FG001|Overall Study|Withdrawal by Subject|1|||
126061940|NCT03246724|453520040|FG000|Overall Study|Withdrawal by Subject|5|||
126061941|NCT03246724|453520041|FG001|Overall Study|Withdrawal by Subject|2|||
126061942|NCT03246724|453520042|FG002|Overall Study|Withdrawal by Subject|4|||
126061943|NCT03246724|453520043|FG003|Overall Study|Withdrawal by Subject|2|||
126061944|NCT03246724|453520040|FG000|Overall Study|Ineligible on day of surgery|7|||
126061945|NCT03246724|453520041|FG001|Overall Study|Ineligible on day of surgery|2|||
126061946|NCT03246724|453520042|FG002|Overall Study|Ineligible on day of surgery|0|||
126061947|NCT03246724|453520043|FG003|Overall Study|Ineligible on day of surgery|3|||
126061948|NCT03246724|453520040|FG000|Overall Study|Study completed before surgical date|2|||
126061949|NCT03246724|453520041|FG001|Overall Study|Study completed before surgical date|1|||
126061950|NCT03246724|453520042|FG002|Overall Study|Study completed before surgical date|8|||
126061951|NCT03246724|453520043|FG003|Overall Study|Study completed before surgical date|1|||
126061952|NCT03246724|453520040|FG000|Overall Study|Transferred to other arm|0|||
126061953|NCT03246724|453520041|FG001|Overall Study|Transferred to other arm|0|||
126061954|NCT03246724|453520042|FG002|Overall Study|Transferred to other arm|1|||
126061955|NCT03246724|453520043|FG003|Overall Study|Transferred to other arm|0|||
126061956|NCT03246724|453520040|FG000|Overall Study|Unable to obtain medication timely|0|||
126061957|NCT03246724|453520041|FG001|Overall Study|Unable to obtain medication timely|2|||
126061958|NCT03246724|453520042|FG002|Overall Study|Unable to obtain medication timely|2|||
126061959|NCT03246724|453520043|FG003|Overall Study|Unable to obtain medication timely|1|||
125913790|NCT02517866|452984861|FG002|Overall Study|Reason not specified|0|||
125913791|NCT01147640|452984863|FG000|Overall Study|Adverse Event|2|||
125913792|NCT01147640|452984864|FG001|Overall Study|Adverse Event|0|||
125913793|NCT01147640|452984863|FG000|Overall Study|Physician Decision|1|||
125913794|NCT01147640|452984864|FG001|Overall Study|Physician Decision|0|||
125913795|NCT01147640|452984863|FG000|Overall Study|Withdrawal by Subject|1|||
125913796|NCT01147640|452984864|FG001|Overall Study|Withdrawal by Subject|0|||
125913797|NCT01147640|452984863|FG000|Overall Study|Lost to Follow-up|0|||
125913798|NCT01147640|452984864|FG001|Overall Study|Lost to Follow-up|1|||
125913799|NCT01147640|452984863|FG000|Overall Study|Didn't meet eligibility criteria|1|||
125913800|NCT01147640|452984864|FG001|Overall Study|Didn't meet eligibility criteria|0|||
125913801|NCT01797731|452984865|FG000|Overall Study|Didn't have proper radiographs required|3|||
125913802|NCT01797731|452984866|FG001|Overall Study|Didn't have proper radiographs required|3|||
125913803|NCT00091442|452984867|FG000|Overall Study|Progressive Disease|220|||
125913804|NCT00091442|452984868|FG001|Overall Study|Progressive Disease|189|||
125913805|NCT00091442|452984867|FG000|Overall Study|Physician Decision|61|||
125913806|NCT00091442|452984868|FG001|Overall Study|Physician Decision|58|||
125913807|NCT00091442|452984867|FG000|Overall Study|Withdrawal by Subject|38|||
125913808|NCT00091442|452984868|FG001|Overall Study|Withdrawal by Subject|46|||
125913809|NCT00091442|452984867|FG000|Overall Study|Adverse Event|29|||
125913810|NCT00091442|452984868|FG001|Overall Study|Adverse Event|48|||
125913811|NCT00091442|452984867|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
125913812|NCT00091442|452984868|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
125913813|NCT00091442|452984867|FG000|Overall Study|Death|9|||
125913814|NCT00091442|452984868|FG001|Overall Study|Death|7|||
125913815|NCT00091442|452984867|FG000|Overall Study|Lost to Follow-up|1|||
125913816|NCT00091442|452984868|FG001|Overall Study|Lost to Follow-up|3|||
125913817|NCT00091442|452984867|FG000|Overall Study|Other|2|||
125913818|NCT00091442|452984868|FG001|Overall Study|Other|6|||
125913819|NCT01954342|452984869|FG000|Overall Study|Missing data from 13-16week study visit|0|||
125913820|NCT01954342|452984870|FG001|Overall Study|Missing data from 13-16week study visit|0|||
125913821|NCT01954342|452984871|FG002|Overall Study|Missing data from 13-16week study visit|0|||
125913822|NCT01954342|452984872|FG003|Overall Study|Missing data from 13-16week study visit|1|||
125913823|NCT01954342|452984869|FG000|Overall Study|Miscarriage|0|||
125913824|NCT01954342|452984870|FG001|Overall Study|Miscarriage|0|||
125913825|NCT01954342|452984871|FG002|Overall Study|Miscarriage|0|||
125913826|NCT01954342|452984872|FG003|Overall Study|Miscarriage|3|||
125913827|NCT01954342|452984869|FG000|Overall Study|Lost to Follow-up|0|||
125913828|NCT01954342|452984870|FG001|Overall Study|Lost to Follow-up|0|||
125913829|NCT01954342|452984871|FG002|Overall Study|Lost to Follow-up|0|||
125913830|NCT01954342|452984872|FG003|Overall Study|Lost to Follow-up|5|||
125913831|NCT01954342|452984869|FG000|Overall Study|Preterm delivery|0|||
125913832|NCT01954342|452984870|FG001|Overall Study|Preterm delivery|0|||
125913833|NCT01954342|452984871|FG002|Overall Study|Preterm delivery|0|||
125913834|NCT01954342|452984872|FG003|Overall Study|Preterm delivery|3|||
125913835|NCT01954342|452984869|FG000|Overall Study|Pre-eclampsia|0|||
125913836|NCT01954342|452984870|FG001|Overall Study|Pre-eclampsia|0|||
125913837|NCT01954342|452984871|FG002|Overall Study|Pre-eclampsia|0|||
125913838|NCT01954342|452984872|FG003|Overall Study|Pre-eclampsia|4|||
125913839|NCT01954342|452984869|FG000|Overall Study|Unreliable Data|0|||
125913840|NCT01954342|452984870|FG001|Overall Study|Unreliable Data|0|||
125913841|NCT01954342|452984871|FG002|Overall Study|Unreliable Data|0|||
125913842|NCT01954342|452984872|FG003|Overall Study|Unreliable Data|2|||
125913843|NCT00629772|452984877|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
125913844|NCT00629772|452984878|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
125913845|NCT00629772|452984877|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
125913846|NCT00629772|452984878|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
125913847|NCT01497275|452984879|FG000|Overall Study|Death|1|||
125913848|NCT01497275|452984879|FG000|Overall Study|Adverse Event|1|||
125913849|NCT01950169|452984880|FG000|Overall Study|Withdrawal by Subject|2|||
125913850|NCT01950169|452984881|FG001|Overall Study|Withdrawal by Subject|8|||
125913851|NCT01950169|452984882|FG002|Overall Study|Withdrawal by Subject|1|||
125913852|NCT01950169|452984880|FG000|Overall Study|Death|1|||
125913853|NCT01950169|452984881|FG001|Overall Study|Death|0|||
125913854|NCT01950169|452984882|FG002|Overall Study|Death|0|||
125913855|NCT01332331|452984894|FG000|Overall Study|Lost to Follow-up|0|||
125913856|NCT01332331|452984895|FG001|Overall Study|Lost to Follow-up|1|||
125913857|NCT01332331|452984894|FG000|Overall Study|Adverse Event|1|||
125913858|NCT01332331|452984895|FG001|Overall Study|Adverse Event|1|||
125913859|NCT01332331|452984894|FG000|Overall Study|Physician Decision|1|||
125913860|NCT01332331|452984895|FG001|Overall Study|Physician Decision|0|||
125913861|NCT04810481|452984897|FG000|Overall Study|Disqualified data sets|10|||
125913862|NCT04810481|452984898|FG001|Overall Study|Disqualified data sets|28|||
125913863|NCT00285818|452984903|FG000|Overall Study|Withdrawal by Subject|3|||
125913864|NCT00285818|452984904|FG001|Overall Study|Withdrawal by Subject|2|||
125913865|NCT00285818|452984903|FG000|Overall Study|Lost to Follow-up|1|||
125913866|NCT00285818|452984904|FG001|Overall Study|Lost to Follow-up|0|||
125913867|NCT01230710|452984909|FG000|Overall Study|Disease Progression|41|||
126061960|NCT03246724|453520040|FG000|Overall Study|Re-consented to participate|0|||
126061961|NCT03246724|453520041|FG001|Overall Study|Re-consented to participate|0|||
126061962|NCT03246724|453520042|FG002|Overall Study|Re-consented to participate|0|||
126061963|NCT03246724|453520043|FG003|Overall Study|Re-consented to participate|1|||
126061964|NCT02255474|453520045|FG000|Overall Study|Lost to Follow-up|1|||
126061965|NCT02255474|453520046|FG001|Overall Study|Lost to Follow-up|1|||
126061966|NCT02255474|453520047|FG002|Overall Study|Lost to Follow-up|3|||
125913868|NCT01230710|452984909|FG000|Overall Study|Lost to Follow-up|3|||
125913869|NCT01230710|452984909|FG000|Overall Study|Death|4|||
125913870|NCT01230710|452984909|FG000|Overall Study|Withdrawal of Consent|1|||
125913871|NCT00464269|452984910|FG000|Overall Study|Lack of Efficacy|1|||
125913872|NCT00464269|452984911|FG001|Overall Study|Lack of Efficacy|0|||
125913873|NCT00464269|452984912|FG002|Overall Study|Lack of Efficacy|0|||
125913874|NCT00464269|452984913|FG003|Overall Study|Lack of Efficacy|0|||
125913875|NCT00464269|452984910|FG000|Overall Study|Lost to Follow-up|0|||
125913876|NCT00464269|452984911|FG001|Overall Study|Lost to Follow-up|4|||
125913877|NCT00464269|452984912|FG002|Overall Study|Lost to Follow-up|0|||
125913878|NCT00464269|452984913|FG003|Overall Study|Lost to Follow-up|1|||
126061967|NCT02255474|453520045|FG000|Overall Study|Withdrawal by Subject|1|||
126061968|NCT02255474|453520046|FG001|Overall Study|Withdrawal by Subject|1|||
125913879|NCT00464269|452984910|FG000|Overall Study|Withdrawal by Subject|0|||
126061969|NCT02255474|453520047|FG002|Overall Study|Withdrawal by Subject|0|||
125913880|NCT00464269|452984911|FG001|Overall Study|Withdrawal by Subject|2|||
125913881|NCT00464269|452984912|FG002|Overall Study|Withdrawal by Subject|1|||
126061970|NCT02010684|453520051|FG000|Overall Study|Lost to Follow-up|8|||
126110236|NCT00390910|453697680|FG002|Overall Study|Lost to Follow-up|5|||
126110237|NCT00390910|453697678|FG000|Overall Study|Withdrawal by Subject|1|||
126110238|NCT00390910|453697679|FG001|Overall Study|Withdrawal by Subject|3|||
125913882|NCT00464269|452984913|FG003|Overall Study|Withdrawal by Subject|1|||
125913883|NCT00464269|452984910|FG000|Overall Study|Other reason|3|||
125913884|NCT00464269|452984911|FG001|Overall Study|Other reason|3|||
125913885|NCT00464269|452984912|FG002|Overall Study|Other reason|1|||
125913886|NCT00464269|452984913|FG003|Overall Study|Other reason|1|||
125913887|NCT00464269|452984910|FG000|Overall Study|AE, serious fatal|0|||
125913888|NCT00464269|452984911|FG001|Overall Study|AE, serious fatal|0|||
125913889|NCT00464269|452984912|FG002|Overall Study|AE, serious fatal|1|||
125913890|NCT00464269|452984913|FG003|Overall Study|AE, serious fatal|1|||
125913891|NCT00464269|452984910|FG000|Overall Study|SAE, non-fatal|0|||
125913892|NCT00464269|452984911|FG001|Overall Study|SAE, non-fatal|0|||
125913893|NCT00464269|452984912|FG002|Overall Study|SAE, non-fatal|0|||
125913894|NCT00464269|452984913|FG003|Overall Study|SAE, non-fatal|1|||
125913895|NCT00464269|452984910|FG000|Overall Study|AE, non-serious non-fatal|2|||
125913896|NCT00464269|452984911|FG001|Overall Study|AE, non-serious non-fatal|8|||
125913897|NCT00464269|452984912|FG002|Overall Study|AE, non-serious non-fatal|3|||
125913898|NCT00464269|452984913|FG003|Overall Study|AE, non-serious non-fatal|4|||
125913899|NCT00464269|452984910|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125913900|NCT00464269|452984911|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125913901|NCT00464269|452984912|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
125913902|NCT00464269|452984913|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125913903|NCT02337738|452984914|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
125913904|NCT02337738|452984915|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
125913905|NCT02337738|452984916|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
125913906|NCT02337738|452984914|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125913907|NCT02337738|452984915|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
125913908|NCT02337738|452984916|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
125913909|NCT02337738|452984914|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
125913910|NCT02337738|452984915|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
125913911|NCT02337738|452984916|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
125913912|NCT02337738|452984914|FG000|Overall Study|Voluntary Withdrawal|10|||
125913913|NCT02337738|452984915|FG001|Overall Study|Voluntary Withdrawal|5|||
125913914|NCT02337738|452984916|FG002|Overall Study|Voluntary Withdrawal|2|||
125913915|NCT02337738|452984914|FG000|Overall Study|Lack of Efficacy|2|||
125913916|NCT02337738|452984915|FG001|Overall Study|Lack of Efficacy|4|||
125913917|NCT02337738|452984916|FG002|Overall Study|Lack of Efficacy|0|||
125913918|NCT02337738|452984914|FG000|Overall Study|Investigator's Judgment|1|||
125913919|NCT02337738|452984915|FG001|Overall Study|Investigator's Judgment|1|||
125913920|NCT02337738|452984916|FG002|Overall Study|Investigator's Judgment|3|||
125913921|NCT00406354|452984917|FG000|All Randomized Patients|Protocol Violation|0|||
125913922|NCT00406354|452984918|FG001|All Randomized Patients|Protocol Violation|0|||
125913923|NCT00406354|452984919|FG002|All Randomized Patients|Protocol Violation|1|||
125913924|NCT00406354|452984917|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
125913925|NCT00406354|452984918|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
125913926|NCT00406354|452984919|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
125913927|NCT00406354|452984917|FG000|All Randomized and Treated Patients|Adverse Event|6|||
125913928|NCT00406354|452984918|FG001|All Randomized and Treated Patients|Adverse Event|2|||
125913929|NCT00406354|452984919|FG002|All Randomized and Treated Patients|Adverse Event|1|||
125913930|NCT00406354|452984917|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
125913931|NCT00406354|452984918|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
125913932|NCT00406354|452984919|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
125913933|NCT00406354|452984917|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
125913934|NCT00406354|452984918|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
126061971|NCT02010684|453520052|FG001|Overall Study|Lost to Follow-up|18|||
126061972|NCT02010684|453520051|FG000|Overall Study|Withdrawal by Subject|4|||
126061973|NCT02010684|453520052|FG001|Overall Study|Withdrawal by Subject|5|||
126061974|NCT02612285|453520053|FG000|Overall Study|Withdrawal by Subject|1|||
126061975|NCT00805441|453520054|FG000|Overall Study|Adverse Event|5|||
126061976|NCT00805441|453520055|FG001|Overall Study|Adverse Event|2|||
125913935|NCT00406354|452984919|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
125913936|NCT00406354|452984917|FG000|All Randomized and Treated Patients|Physician Decision|0|||
125913937|NCT00406354|452984918|FG001|All Randomized and Treated Patients|Physician Decision|0|||
125913938|NCT00406354|452984919|FG002|All Randomized and Treated Patients|Physician Decision|1|||
126061977|NCT00805441|453520054|FG000|Overall Study|Lack of Efficacy|0|||
126061978|NCT00805441|453520055|FG001|Overall Study|Lack of Efficacy|2|||
126061979|NCT00805441|453520054|FG000|Overall Study|Protocol Violation|4|||
125913939|NCT00747461|452984920|FG000|Overall Study|study terminated by sponsor|5|||
125913940|NCT01565642|452984935|FG000|Overall Study|Withdrawal by Subject|2|||
125913941|NCT01565642|452984936|FG001|Overall Study|Withdrawal by Subject|1|||
125913942|NCT00961649|452984938|FG000|Overall Study|Adverse Event|4|||
125913943|NCT00961649|452984939|FG001|Overall Study|Adverse Event|0|||
125913944|NCT00961649|452984940|FG002|Overall Study|Adverse Event|0|||
126061980|NCT00805441|453520055|FG001|Overall Study|Protocol Violation|8|||
126061981|NCT00805441|453520054|FG000|Overall Study|Lost to Follow-up|10|||
126061982|NCT00805441|453520055|FG001|Overall Study|Lost to Follow-up|13|||
126061983|NCT00805441|453520054|FG000|Overall Study|Withdrawal by Subject|15|||
126061984|NCT00805441|453520055|FG001|Overall Study|Withdrawal by Subject|9|||
126061985|NCT00805441|453520054|FG000|Overall Study|Physician Decision|0|||
126061986|NCT00805441|453520055|FG001|Overall Study|Physician Decision|1|||
126061987|NCT00805441|453520054|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
126061988|NCT00805441|453520055|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
126061989|NCT01884571|453520064|FG000|Overall Study|Adverse Event|1|||
126061990|NCT01884571|453520064|FG000|Overall Study|Death|2|||
126061991|NCT01884571|453520064|FG000|Overall Study|Withdrawal by Subject|2|||
126061992|NCT01884571|453520064|FG000|Overall Study|Disease progression|3|||
126061993|NCT00091572|453520065|FG000|Overall Study|Lost to Follow-up|1|||
126061994|NCT00091572|453520066|FG001|Overall Study|Lost to Follow-up|1|||
126061995|NCT00091572|453520065|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
126061996|NCT00091572|453520066|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
126061997|NCT00091572|453520065|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
126061998|NCT00091572|453520066|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
126061999|NCT00091572|453520065|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
126110239|NCT00390910|453697680|FG002|Overall Study|Withdrawal by Subject|2|||
126110240|NCT00390910|453697678|FG000|Overall Study|Migrated/moved from study area|0|||
126110241|NCT00390910|453697679|FG001|Overall Study|Migrated/moved from study area|0|||
126110242|NCT00390910|453697680|FG002|Overall Study|Migrated/moved from study area|3|||
126110243|NCT00174265|453697684|FG000|Overall Study|Adverse Event|7|||
126110244|NCT00174265|453697685|FG001|Overall Study|Adverse Event|4|||
126110245|NCT00174265|453697684|FG000|Overall Study|Lack of Efficacy|2|||
126110246|NCT00174265|453697685|FG001|Overall Study|Lack of Efficacy|2|||
126110247|NCT00174265|453697684|FG000|Overall Study|Withdrawal by Subject|3|||
126110248|NCT00174265|453697685|FG001|Overall Study|Withdrawal by Subject|5|||
126110249|NCT00174265|453697684|FG000|Overall Study|Lost to Follow-up|1|||
126110250|NCT00174265|453697685|FG001|Overall Study|Lost to Follow-up|0|||
126110251|NCT00174265|453697684|FG000|Overall Study|Other (Not specified)|16|||
126110252|NCT00174265|453697685|FG001|Overall Study|Other (Not specified)|10|||
126110253|NCT01572922|453697688|FG000|Overall Study|Adverse Event|1|||
126110254|NCT01572922|453697688|FG000|Overall Study|Protocol Violation|1|||
126110255|NCT01572922|453697688|FG000|Overall Study|Death|1|||
126110256|NCT00445068|453697689|FG000|Overall Study|Disease progression|26|||
126110257|NCT00445068|453697689|FG000|Overall Study|Adverse Event|5|||
126110258|NCT00445068|453697689|FG000|Overall Study|Abnormal laboratory value|2|||
126110259|NCT00445068|453697689|FG000|Overall Study|Withdrawal by Subject|2|||
126110260|NCT00445068|453697689|FG000|Overall Study|Death|1|||
126110261|NCT00447382|453697690|FG000|Overall Study|Adverse Event|1|||
126110262|NCT00447382|453697691|FG001|Overall Study|Adverse Event|1|||
126110263|NCT00447382|453697690|FG000|Overall Study|Lack of Efficacy|1|||
126110264|NCT00447382|453697691|FG001|Overall Study|Lack of Efficacy|0|||
126110265|NCT00447382|453697690|FG000|Overall Study|Protocol Violation|2|||
126110266|NCT00447382|453697691|FG001|Overall Study|Protocol Violation|0|||
126110267|NCT00447382|453697690|FG000|Overall Study|Unclassified|2|||
126110268|NCT00447382|453697691|FG001|Overall Study|Unclassified|5|||
126110269|NCT04600336|453697692|FG000|Initial Treatment|Withdrawal by Subject|1|||
126110270|NCT04600336|453697693|FG001|Initial Treatment|Withdrawal by Subject|2|||
126110271|NCT04600336|453697694|FG002|Initial Treatment|Withdrawal by Subject|0|||
126110272|NCT04600336|453697695|FG003|Initial Treatment|Withdrawal by Subject|0|||
126110273|NCT04600336|453697692|FG000|Initial Treatment|Adverse Event|0|||
126110274|NCT04600336|453697693|FG001|Initial Treatment|Adverse Event|2|||
126110275|NCT04600336|453697694|FG002|Initial Treatment|Adverse Event|0|||
126110276|NCT04600336|453697695|FG003|Initial Treatment|Adverse Event|0|||
126110277|NCT04600336|453697692|FG000|Initial Treatment|Other complicating disease|0|||
126110278|NCT04600336|453697693|FG001|Initial Treatment|Other complicating disease|0|||
126110279|NCT04600336|453697694|FG002|Initial Treatment|Other complicating disease|1|||
126110280|NCT04600336|453697695|FG003|Initial Treatment|Other complicating disease|0|||
126110281|NCT04600336|453697692|FG000|Crossover Treatment|Withdrawal by Subject|0|||
126110282|NCT04600336|453697693|FG001|Crossover Treatment|Withdrawal by Subject|0|||
126110283|NCT04600336|453697694|FG002|Crossover Treatment|Withdrawal by Subject|2|||
126110284|NCT04600336|453697695|FG003|Crossover Treatment|Withdrawal by Subject|1|||
126110285|NCT04600336|453697692|FG000|Crossover Treatment|Adverse Event|0|||
126110286|NCT04600336|453697693|FG001|Crossover Treatment|Adverse Event|0|||
126110287|NCT04600336|453697694|FG002|Crossover Treatment|Adverse Event|1|||
126110288|NCT04600336|453697695|FG003|Crossover Treatment|Adverse Event|1|||
126110289|NCT03144804|453697697|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
126110290|NCT04091451|453697700|FG000|Overall Study|Adverse Event|15|||
126110291|NCT04091451|453697701|FG001|Overall Study|Adverse Event|10|||
126110292|NCT04091451|453697700|FG000|Overall Study|Lost to Follow-up|8|||
126110293|NCT04091451|453697701|FG001|Overall Study|Lost to Follow-up|8|||
126110294|NCT04091451|453697700|FG000|Overall Study|Protocol Violation|5|||
126110295|NCT04091451|453697701|FG001|Overall Study|Protocol Violation|4|||
126110296|NCT04091451|453697700|FG000|Overall Study|Withdrawal by Subject|21|||
126110297|NCT04091451|453697701|FG001|Overall Study|Withdrawal by Subject|27|||
126110298|NCT04091451|453697700|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
126110299|NCT04091451|453697701|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
126110300|NCT04091451|453697700|FG000|Overall Study|Migrated/moved from the study area|3|||
125913945|NCT00961649|452984941|FG003|Overall Study|Adverse Event|2|||
125913946|NCT00961649|452984938|FG000|Overall Study|Inadequate control of IOP|0|||
125913947|NCT00961649|452984939|FG001|Overall Study|Inadequate control of IOP|0|||
125913948|NCT00961649|452984940|FG002|Overall Study|Inadequate control of IOP|0|||
125913949|NCT00961649|452984941|FG003|Overall Study|Inadequate control of IOP|1|||
125913950|NCT00961649|452984938|FG000|Overall Study|Patient has travel plans during holidays|0|||
125913951|NCT00961649|452984939|FG001|Overall Study|Patient has travel plans during holidays|0|||
125913952|NCT00961649|452984940|FG002|Overall Study|Patient has travel plans during holidays|1|||
125913953|NCT00961649|452984941|FG003|Overall Study|Patient has travel plans during holidays|0|||
125913954|NCT00961649|452984938|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
125913955|NCT00961649|452984939|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
125913956|NCT00961649|452984940|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
125913957|NCT00961649|452984941|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
125913958|NCT00961649|452984938|FG000|Overall Study|Study terminated by sponsor|4|||
125913959|NCT00961649|452984939|FG001|Overall Study|Study terminated by sponsor|4|||
125913960|NCT00961649|452984940|FG002|Overall Study|Study terminated by sponsor|4|||
125913961|NCT00961649|452984941|FG003|Overall Study|Study terminated by sponsor|1|||
125913962|NCT02711345|452984942|FG000|Overall Study|Adverse Event|0|||
125913963|NCT02711345|452984943|FG001|Overall Study|Adverse Event|0|||
125913964|NCT02711345|452984944|FG002|Overall Study|Adverse Event|0|||
125913965|NCT02711345|452984945|FG003|Overall Study|Adverse Event|1|||
125913966|NCT02711345|452984946|FG004|Overall Study|Adverse Event|1|||
125913967|NCT02711345|452984947|FG005|Overall Study|Adverse Event|2|||
125913968|NCT02711345|452984948|FG006|Overall Study|Adverse Event|1|||
125913969|NCT02711345|452984949|FG007|Overall Study|Adverse Event|0|||
125913970|NCT02711345|452984950|FG008|Overall Study|Adverse Event|0|||
125913971|NCT02711345|452984951|FG009|Overall Study|Adverse Event|2|||
125913972|NCT02711345|452984942|FG000|Overall Study|Physician Decision|0|||
125913973|NCT02711345|452984943|FG001|Overall Study|Physician Decision|0|||
125913974|NCT02711345|452984944|FG002|Overall Study|Physician Decision|1|||
125913975|NCT02711345|452984945|FG003|Overall Study|Physician Decision|0|||
125913976|NCT02711345|452984946|FG004|Overall Study|Physician Decision|0|||
125913977|NCT02711345|452984947|FG005|Overall Study|Physician Decision|0|||
125913978|NCT02711345|452984948|FG006|Overall Study|Physician Decision|0|||
125913979|NCT02711345|452984949|FG007|Overall Study|Physician Decision|0|||
125913980|NCT02711345|452984950|FG008|Overall Study|Physician Decision|1|||
125913981|NCT02711345|452984951|FG009|Overall Study|Physician Decision|0|||
125913982|NCT02711345|452984942|FG000|Overall Study|Progressive disease|1|||
125913983|NCT02711345|452984943|FG001|Overall Study|Progressive disease|3|||
125913984|NCT02711345|452984944|FG002|Overall Study|Progressive disease|5|||
125913985|NCT02711345|452984945|FG003|Overall Study|Progressive disease|3|||
125913986|NCT02711345|452984946|FG004|Overall Study|Progressive disease|7|||
125913987|NCT02711345|452984947|FG005|Overall Study|Progressive disease|2|||
125913988|NCT02711345|452984948|FG006|Overall Study|Progressive disease|8|||
125913989|NCT02711345|452984949|FG007|Overall Study|Progressive disease|4|||
125913990|NCT02711345|452984950|FG008|Overall Study|Progressive disease|5|||
125913991|NCT02711345|452984951|FG009|Overall Study|Progressive disease|6|||
125913992|NCT02711345|452984942|FG000|Overall Study|Subject/guardian decision|0|||
125913993|NCT02711345|452984943|FG001|Overall Study|Subject/guardian decision|0|||
125913994|NCT02711345|452984944|FG002|Overall Study|Subject/guardian decision|0|||
125913995|NCT02711345|452984945|FG003|Overall Study|Subject/guardian decision|0|||
125913996|NCT02711345|452984946|FG004|Overall Study|Subject/guardian decision|0|||
125913997|NCT02711345|452984947|FG005|Overall Study|Subject/guardian decision|2|||
125913998|NCT02711345|452984948|FG006|Overall Study|Subject/guardian decision|3|||
125913999|NCT02711345|452984949|FG007|Overall Study|Subject/guardian decision|1|||
125914000|NCT02711345|452984950|FG008|Overall Study|Subject/guardian decision|0|||
125914001|NCT02711345|452984951|FG009|Overall Study|Subject/guardian decision|4|||
125914002|NCT02711345|452984942|FG000|Overall Study|Death|1|||
125914003|NCT02711345|452984943|FG001|Overall Study|Death|0|||
126062000|NCT00091572|453520066|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
126062001|NCT00091572|453520065|FG000|Overall Study|Other Reason|6|||
126062002|NCT00091572|453520066|FG001|Overall Study|Other Reason|13|||
126062003|NCT00091572|453520065|FG000|Overall Study|Ongoing (still on treatment)|8|||
126062004|NCT00091572|453520066|FG001|Overall Study|Ongoing (still on treatment)|12|||
126062005|NCT00091572|453520065|FG000|Overall Study|Major Protocol Violation|2|||
126062006|NCT00091572|453520066|FG001|Overall Study|Major Protocol Violation|0|||
126062007|NCT00091572|453520065|FG000|Overall Study|Toxicity (Related AE)|53|||
126062008|NCT00091572|453520066|FG001|Overall Study|Toxicity (Related AE)|9|||
126062009|NCT02158806|453520067|FG000|Overall Study|Death|2|||
126062010|NCT02158806|453520068|FG001|Overall Study|Death|0|||
126062011|NCT02158806|453520067|FG000|Overall Study|Withdrawal by Subject|2|||
126062012|NCT02158806|453520068|FG001|Overall Study|Withdrawal by Subject|0|||
126062013|NCT02158806|453520067|FG000|Overall Study|Lost to Follow-up|0|||
126062014|NCT02158806|453520068|FG001|Overall Study|Lost to Follow-up|3|||
126062015|NCT02158806|453520067|FG000|Overall Study|Moved out of area|0|||
126062016|NCT02158806|453520068|FG001|Overall Study|Moved out of area|1|||
126062017|NCT02158806|453520067|FG000|Overall Study|Transferred to palliative care|0|||
126062018|NCT02158806|453520068|FG001|Overall Study|Transferred to palliative care|1|||
126062019|NCT02340806|453520072|FG000|Overall Study|Protocol Violation|2|||
126062020|NCT02340806|453520073|FG001|Overall Study|Protocol Violation|0|||
126062021|NCT02340806|453520072|FG000|Overall Study|epidural catheter replaced|2|||
126062022|NCT02340806|453520073|FG001|Overall Study|epidural catheter replaced|1|||
126062023|NCT02340806|453520072|FG000|Overall Study|history of chronic pain medication|1|||
126062024|NCT02340806|453520073|FG001|Overall Study|history of chronic pain medication|0|||
126062025|NCT02340806|453520072|FG000|Overall Study|re-dose < 90 min of CSE|1|||
126062026|NCT02340806|453520073|FG001|Overall Study|re-dose < 90 min of CSE|3|||
126062027|NCT00452452|453520074|FG000|Overall Study|Protocol Violation|0|||
126062028|NCT00452452|453520075|FG001|Overall Study|Protocol Violation|0|||
126062029|NCT00452452|453520076|FG002|Overall Study|Protocol Violation|1|||
126062030|NCT00452452|453520074|FG000|Overall Study|Withdrawal by Subject|1|||
126062031|NCT00452452|453520075|FG001|Overall Study|Withdrawal by Subject|0|||
126062032|NCT00452452|453520076|FG002|Overall Study|Withdrawal by Subject|0|||
126062033|NCT00452452|453520074|FG000|Overall Study|Lost to Follow-up|1|||
126062034|NCT00452452|453520075|FG001|Overall Study|Lost to Follow-up|0|||
126062035|NCT00452452|453520076|FG002|Overall Study|Lost to Follow-up|0|||
126062036|NCT04895085|453520077|FG000|Overall Study|Death|1|||
126062037|NCT04895085|453520077|FG000|Overall Study|Withdrawal by Subject|1|||
126062038|NCT04895085|453520077|FG000|Overall Study|No longer eligible: Moved from area|1|||
126062039|NCT04097535|453520082|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
126062040|NCT03070301|453520083|FG000|Overall Study|Progression of disease|16|||
126062041|NCT03070301|453520083|FG000|Overall Study|Physician Decision|3|||
126062042|NCT03070301|453520083|FG000|Overall Study|Withdrawal by Subject|1|||
126089003|NCT01327846|453620049|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
126089004|NCT01327846|453620050|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
126089005|NCT01327846|453620051|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
126089006|NCT01327846|453620048|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
126089007|NCT01327846|453620049|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
126089008|NCT01327846|453620050|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
126089009|NCT01327846|453620051|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
126089010|NCT01327846|453620048|FG000|Core Phase|Lost to Follow-up|3|||
126089011|NCT01327846|453620049|FG001|Core Phase|Lost to Follow-up|3|||
126089012|NCT01327846|453620050|FG002|Core Phase|Lost to Follow-up|4|||
126089013|NCT01327846|453620051|FG003|Core Phase|Lost to Follow-up|5|||
126089014|NCT01327846|453620048|FG000|Extension Phase|Study terminated by sponsor|1073|||
126089015|NCT01327846|453620049|FG001|Extension Phase|Study terminated by sponsor|1124|||
126089016|NCT01327846|453620050|FG002|Extension Phase|Study terminated by sponsor|1067|||
126089017|NCT01327846|453620051|FG003|Extension Phase|Study terminated by sponsor|1660|||
126089018|NCT01327846|453620048|FG000|Extension Phase|Withdrawal by Subject|20|||
126089019|NCT01327846|453620049|FG001|Extension Phase|Withdrawal by Subject|13|||
126089020|NCT01327846|453620050|FG002|Extension Phase|Withdrawal by Subject|19|||
126089021|NCT01327846|453620051|FG003|Extension Phase|Withdrawal by Subject|37|||
126089022|NCT01327846|453620048|FG000|Extension Phase|Lost to Follow-up|4|||
126089023|NCT01327846|453620049|FG001|Extension Phase|Lost to Follow-up|3|||
126089024|NCT01327846|453620050|FG002|Extension Phase|Lost to Follow-up|4|||
126089025|NCT01327846|453620051|FG003|Extension Phase|Lost to Follow-up|7|||
126089026|NCT01327846|453620048|FG000|Extension Phase|Technical Problems|2|||
126089027|NCT01327846|453620049|FG001|Extension Phase|Technical Problems|4|||
126089028|NCT01327846|453620050|FG002|Extension Phase|Technical Problems|2|||
126089029|NCT01327846|453620051|FG003|Extension Phase|Technical Problems|2|||
126089030|NCT04343976|453620052|FG000|Overall Study|Withdrawal by Subject|0|||
126089031|NCT04343976|453620053|FG001|Overall Study|Withdrawal by Subject|1|||
126089032|NCT00594880|453620054|FG000|Overall Study|Withdrawal by Subject|1|||
126089033|NCT00594880|453620055|FG001|Overall Study|Withdrawal by Subject|1|||
126089034|NCT00594880|453620054|FG000|Overall Study|Lost to Follow-up|1|||
126062043|NCT04620733|453521848|FG000|Overall Study|Adverse Event|4|||
126062044|NCT04620733|453521849|FG001|Overall Study|Adverse Event|3|||
126062045|NCT04620733|453521848|FG000|Overall Study|Withdrawal by Subject|2|||
126062046|NCT04620733|453521849|FG001|Overall Study|Withdrawal by Subject|5|||
126062047|NCT04620733|453521848|FG000|Overall Study|Lost to Follow-up|1|||
126062048|NCT04620733|453521849|FG001|Overall Study|Lost to Follow-up|1|||
126062049|NCT04620733|453521848|FG000|Overall Study|Protocol Deviation|1|||
126062050|NCT04620733|453521849|FG001|Overall Study|Protocol Deviation|1|||
126062051|NCT04620733|453521848|FG000|Overall Study|Reason Not Specified|0|||
126062052|NCT04620733|453521849|FG001|Overall Study|Reason Not Specified|1|||
126062053|NCT02659059|453521858|FG000|Overall Study|Other reasons|6|||
126062054|NCT02659059|453521859|FG001|Overall Study|Other reasons|1|||
126062055|NCT02659059|453521858|FG000|Overall Study|Disease Progression|143|||
126062056|NCT02659059|453521859|FG001|Overall Study|Disease Progression|16|||
126062057|NCT02659059|453521858|FG000|Overall Study|Study Drug toxicity|56|||
126062058|NCT02659059|453521859|FG001|Overall Study|Study Drug toxicity|9|||
126062059|NCT02659059|453521858|FG000|Overall Study|Death|3|||
126062060|NCT02659059|453521859|FG001|Overall Study|Death|1|||
125914004|NCT02711345|452984944|FG002|Overall Study|Death|0|||
125914005|NCT02711345|452984945|FG003|Overall Study|Death|0|||
125914006|NCT02711345|452984946|FG004|Overall Study|Death|0|||
125914007|NCT02711345|452984947|FG005|Overall Study|Death|0|||
125914008|NCT02711345|452984948|FG006|Overall Study|Death|0|||
125914009|NCT02711345|452984949|FG007|Overall Study|Death|1|||
125914010|NCT02711345|452984950|FG008|Overall Study|Death|0|||
125914011|NCT02711345|452984951|FG009|Overall Study|Death|0|||
125914012|NCT04043728|452984952|FG000|Overall Study|Lost to Follow-up|1|||
125914013|NCT04043728|452984953|FG001|Overall Study|Lost to Follow-up|2|||
125914014|NCT04043728|452984954|FG002|Overall Study|Lost to Follow-up|0|||
125914015|NCT01033851|452984955|FG000|Overall Study|Withdrawal by Subject|3|||
125914016|NCT01033851|452984956|FG001|Overall Study|Withdrawal by Subject|7|||
125914017|NCT02349542|452984957|FG000|Overall Study|Withdrawal by Subject|5|||
125914018|NCT01011738|452984958|FG000|Overall Study|Death|12|||
125914019|NCT01011738|452984959|FG001|Overall Study|Death|3|||
125914020|NCT01011738|452984960|FG002|Overall Study|Death|0|||
125914021|NCT01011738|452984958|FG000|Overall Study|Unknown reasons|312|||
125914022|NCT01011738|452984959|FG001|Overall Study|Unknown reasons|291|||
125914023|NCT01011738|452984960|FG002|Overall Study|Unknown reasons|17|||
125914024|NCT01163266|452984963|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
125914025|NCT01163266|452984964|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
125914026|NCT01163266|452984965|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
125914027|NCT01163266|452984963|FG000|Overall Study|Lack of Efficacy|1|||
125914028|NCT01163266|452984964|FG001|Overall Study|Lack of Efficacy|3|||
125914029|NCT01163266|452984965|FG002|Overall Study|Lack of Efficacy|1|||
125914030|NCT01163266|452984963|FG000|Overall Study|Noncompliance with Study Drug|0|||
125914031|NCT01163266|452984964|FG001|Overall Study|Noncompliance with Study Drug|2|||
125914032|NCT01163266|452984965|FG002|Overall Study|Noncompliance with Study Drug|0|||
125914033|NCT01163266|452984963|FG000|Overall Study|Protocol Deviations|2|||
125914034|NCT01163266|452984964|FG001|Overall Study|Protocol Deviations|2|||
125914035|NCT01163266|452984965|FG002|Overall Study|Protocol Deviations|5|||
125914036|NCT01163266|452984963|FG000|Overall Study|Withdrawal of Consent|5|||
125914037|NCT01163266|452984964|FG001|Overall Study|Withdrawal of Consent|7|||
125914038|NCT01163266|452984965|FG002|Overall Study|Withdrawal of Consent|3|||
125914039|NCT01163266|452984963|FG000|Overall Study|Lost to Follow-up|7|||
125914040|NCT01163266|452984964|FG001|Overall Study|Lost to Follow-up|7|||
125914041|NCT01163266|452984965|FG002|Overall Study|Lost to Follow-up|10|||
125914042|NCT01163266|452984963|FG000|Overall Study|Other|1|||
125914043|NCT01163266|452984964|FG001|Overall Study|Other|1|||
125914044|NCT01163266|452984965|FG002|Overall Study|Other|2|||
125914045|NCT02586064|452984966|FG000|Overall Study|Other Obligations|6|||
125914046|NCT02586064|452984967|FG001|Overall Study|Other Obligations|6|||
125914047|NCT02586064|452984966|FG000|Overall Study|Other|3|||
125914048|NCT02586064|452984967|FG001|Overall Study|Other|7|||
125914049|NCT02586064|452984966|FG000|Overall Study|Never Started|3|||
126062061|NCT02659059|453521858|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
126062062|NCT02659059|453521859|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
126062063|NCT02659059|453521858|FG000|Overall Study|Participant request to discontinue study treatment|5|||
125914050|NCT02586064|452984967|FG001|Overall Study|Never Started|3|||
125914051|NCT02586064|452984966|FG000|Overall Study|Lost Interest|1|||
125914052|NCT02586064|452984967|FG001|Overall Study|Lost Interest|4|||
125914053|NCT02586064|452984966|FG000|Overall Study|Miscellaneous Life Issues|0|||
125914054|NCT02586064|452984967|FG001|Overall Study|Miscellaneous Life Issues|5|||
125914055|NCT02586064|452984966|FG000|Overall Study|Infrequent Attendance|2|||
125914056|NCT02586064|452984967|FG001|Overall Study|Infrequent Attendance|1|||
125914057|NCT02586064|452984966|FG000|Overall Study|Timed Out|2|||
125914058|NCT02586064|452984967|FG001|Overall Study|Timed Out|0|||
125914059|NCT02586064|452984966|FG000|Overall Study|AUD relapse|0|||
125914060|NCT02586064|452984967|FG001|Overall Study|AUD relapse|2|||
125914061|NCT02586064|452984966|FG000|Overall Study|Legal Issue|1|||
125914062|NCT02586064|452984967|FG001|Overall Study|Legal Issue|0|||
126062064|NCT02659059|453521859|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126062065|NCT02659059|453521858|FG000|Overall Study|Participant withdrew consent|6|||
126062066|NCT02659059|453521859|FG001|Overall Study|Participant withdrew consent|1|||
126062067|NCT04783389|453521867|FG000|Overall Study|Withdrawal by Subject|2|||
126062068|NCT04783389|453521868|FG001|Overall Study|Withdrawal by Subject|0|||
126062069|NCT04783389|453521869|FG002|Overall Study|Withdrawal by Subject|0|||
126062070|NCT04783389|453521867|FG000|Overall Study|Termination of Study by Sponsor|10|||
126062071|NCT04783389|453521868|FG001|Overall Study|Termination of Study by Sponsor|12|||
126062072|NCT04783389|453521869|FG002|Overall Study|Termination of Study by Sponsor|14|||
126062073|NCT02121808|453521874|FG000|Overall Study|Technical problem|3|||
126062074|NCT03072238|453521875|FG000|Overall Study|Withdrawal by Subject|44|||
126062075|NCT03072238|453521876|FG001|Overall Study|Withdrawal by Subject|64|||
126062076|NCT03072238|453521875|FG000|Overall Study|Lost to Follow-up|14|||
126062077|NCT03072238|453521876|FG001|Overall Study|Lost to Follow-up|5|||
126062078|NCT03072238|453521875|FG000|Overall Study|Physician Decision|4|||
126062079|NCT03072238|453521876|FG001|Overall Study|Physician Decision|6|||
126062080|NCT03072238|453521875|FG000|Overall Study|Death|351|||
126062081|NCT03072238|453521876|FG001|Overall Study|Death|318|||
126062082|NCT03072238|453521875|FG000|Overall Study|Progressive Disease|3|||
126062083|NCT03072238|453521876|FG001|Overall Study|Progressive Disease|4|||
126062084|NCT03072238|453521875|FG000|Overall Study|Reason Not Specified|138|||
126062085|NCT03072238|453521876|FG001|Overall Study|Reason Not Specified|150|||
126062086|NCT03924193|453521882|FG000|Overall Study|Adverse Event|10|||
126062087|NCT03924193|453521883|FG001|Overall Study|Adverse Event|0|||
126062088|NCT03924193|453521884|FG002|Overall Study|Adverse Event|10|||
126062089|NCT03924193|453521882|FG000|Overall Study|Withdrawal by Subject|5|||
126062090|NCT03924193|453521883|FG001|Overall Study|Withdrawal by Subject|10|||
126062091|NCT03924193|453521884|FG002|Overall Study|Withdrawal by Subject|2|||
126062092|NCT02489799|453521885|FG000|Overall Study|Lost to Follow-up|4|||
126062093|NCT02489799|453521886|FG001|Overall Study|Lost to Follow-up|1|||
126062094|NCT02489799|453521885|FG000|Overall Study|Failure to Maintain Eligibility|4|||
126062095|NCT02489799|453521886|FG001|Overall Study|Failure to Maintain Eligibility|6|||
126062096|NCT02489799|453521885|FG000|Overall Study|Withdrawal by Subject|1|||
126062097|NCT02489799|453521886|FG001|Overall Study|Withdrawal by Subject|1|||
126062098|NCT02489799|453521885|FG000|Overall Study|Death|0|||
126062099|NCT02489799|453521886|FG001|Overall Study|Death|1|||
126062100|NCT04909593|453521887|FG000|Overall Study|Withdrawal by Subject|1|||
126062101|NCT01241448|453521888|FG000|Overall Study|Adverse Event|1|||
126062102|NCT01241448|453521889|FG001|Overall Study|Adverse Event|0|||
126062103|NCT01241448|453521890|FG002|Overall Study|Adverse Event|2|||
126062104|NCT01241448|453521891|FG003|Overall Study|Adverse Event|2|||
126062105|NCT01241448|453521888|FG000|Overall Study|Lost to Follow-up|2|||
126062106|NCT01241448|453521889|FG001|Overall Study|Lost to Follow-up|1|||
126062107|NCT01241448|453521890|FG002|Overall Study|Lost to Follow-up|1|||
126062108|NCT01241448|453521891|FG003|Overall Study|Lost to Follow-up|1|||
126062109|NCT01241448|453521888|FG000|Overall Study|Physician Decision|0|||
126062110|NCT01241448|453521889|FG001|Overall Study|Physician Decision|2|||
126062111|NCT01241448|453521890|FG002|Overall Study|Physician Decision|0|||
126062112|NCT01241448|453521891|FG003|Overall Study|Physician Decision|0|||
126062113|NCT01241448|453521888|FG000|Overall Study|Protocol Violation|10|||
126062114|NCT01241448|453521889|FG001|Overall Study|Protocol Violation|5|||
126062115|NCT01241448|453521890|FG002|Overall Study|Protocol Violation|3|||
126062116|NCT01241448|453521891|FG003|Overall Study|Protocol Violation|6|||
126062117|NCT01241448|453521888|FG000|Overall Study|Sponsor Decision|17|||
126062118|NCT01241448|453521889|FG001|Overall Study|Sponsor Decision|14|||
126062119|NCT01241448|453521890|FG002|Overall Study|Sponsor Decision|12|||
126062120|NCT01241448|453521891|FG003|Overall Study|Sponsor Decision|6|||
126062121|NCT01241448|453521888|FG000|Overall Study|Withdrawal by Subject|4|||
126062122|NCT01241448|453521889|FG001|Overall Study|Withdrawal by Subject|5|||
126062123|NCT01241448|453521890|FG002|Overall Study|Withdrawal by Subject|3|||
126062124|NCT01241448|453521891|FG003|Overall Study|Withdrawal by Subject|6|||
126062125|NCT01241448|453521888|FG000|Overall Study|Excluded due to data integrity issues|3|||
126062126|NCT01241448|453521889|FG001|Overall Study|Excluded due to data integrity issues|2|||
126062127|NCT01241448|453521890|FG002|Overall Study|Excluded due to data integrity issues|2|||
126062128|NCT01241448|453521891|FG003|Overall Study|Excluded due to data integrity issues|2|||
126062129|NCT02165202|453521895|FG000|Oral Phase|Refused further participation|5|||
126062130|NCT02165202|453521896|FG001|Oral Phase|Refused further participation|1|||
126062131|NCT02165202|453521895|FG000|Oral Phase|Study product Related Toxicity|1|||
126062132|NCT02165202|453521896|FG001|Oral Phase|Study product Related Toxicity|0|||
126062133|NCT02165202|453521895|FG000|Oral Phase|Unable to contact Participant|1|||
126062134|NCT02165202|453521896|FG001|Oral Phase|Unable to contact Participant|1|||
126062135|NCT02165202|453521895|FG000|Oral Phase|Clinical reasons|1|||
126110301|NCT04091451|453697701|FG001|Overall Study|Migrated/moved from the study area|5|||
126062136|NCT02165202|453521896|FG001|Oral Phase|Clinical reasons|0|||
126062137|NCT02165202|453521895|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
126062138|NCT02165202|453521896|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
126062139|NCT02165202|453521895|FG000|Oral Phase|CMC advised termination|1|||
126062140|NCT02165202|453521896|FG001|Oral Phase|CMC advised termination|0|||
126062141|NCT02165202|453521895|FG000|Oral Phase|Relocated, no follow-up planned|1|||
126062142|NCT02165202|453521896|FG001|Oral Phase|Relocated, no follow-up planned|0|||
126062143|NCT02165202|453521895|FG000|Oral Phase|Abnormal EKG|0|||
126062144|NCT02165202|453521896|FG001|Oral Phase|Abnormal EKG|1|||
126062145|NCT02165202|453521895|FG000|Injection Phase|Abnormal Lab Value|5|||
126062146|NCT02165202|453521896|FG001|Injection Phase|Abnormal Lab Value|1|||
126062147|NCT02165202|453521895|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
126062148|NCT02165202|453521896|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
126062149|NCT02165202|453521895|FG000|Injection Phase|Unable to attend within Visit Window|1|||
126062150|NCT02165202|453521896|FG001|Injection Phase|Unable to attend within Visit Window|0|||
126062151|NCT02165202|453521895|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
126062152|NCT02165202|453521896|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
126062153|NCT02165202|453521895|FG000|Injection Phase|End of Study|2|||
125914063|NCT02919696|452984968|FG000|Overall Study|Adverse Event|1|||
125914064|NCT02919696|452984969|FG001|Overall Study|Adverse Event|2|||
125914065|NCT02919696|452984968|FG000|Overall Study|Withdrawal by Subject|2|||
125914066|NCT02919696|452984969|FG001|Overall Study|Withdrawal by Subject|1|||
125914067|NCT02919696|452984968|FG000|Overall Study|Sponsor Decision|1|||
125914068|NCT02919696|452984969|FG001|Overall Study|Sponsor Decision|1|||
125914069|NCT02919696|452984968|FG000|Overall Study|Never Treated|0|||
125914070|NCT02919696|452984969|FG001|Overall Study|Never Treated|1|||
125914071|NCT04308304|452984970|FG000|Overall Study|Withdrawal by Subject|4|||
125914072|NCT04308304|452984971|FG001|Overall Study|Withdrawal by Subject|0|||
125914073|NCT04308304|452984970|FG000|Overall Study|Protocol Violation|1|||
125914074|NCT04308304|452984971|FG001|Overall Study|Protocol Violation|0|||
125914075|NCT00945555|452984972|FG000|Overall Study|Referred to another hospital|5|||
125914076|NCT00945555|452984972|FG000|Overall Study|Worsening condition, intensive care unit|1|||
125914077|NCT00945555|452984972|FG000|Overall Study|Withdrawal by Subject|2|||
125914078|NCT00945555|452984972|FG000|Overall Study|Participant continued treatment at home|1|||
125914079|NCT00945555|452984972|FG000|Overall Study|Death|18|||
125914080|NCT00945555|452984972|FG000|Overall Study|Other|1|||
125914081|NCT02906332|452984977|FG000|Overall Study|Withdrawal by Subject|1|||
125914082|NCT02949700|452984978|FG000|Phase I|Withdrawal by Subject|1|||
125914083|NCT02949700|452984979|FG001|Phase I|Withdrawal by Subject|1|||
125914084|NCT02949700|452984980|FG002|Phase I|Withdrawal by Subject|0|||
125914085|NCT02949700|452984981|FG003|Phase I|Withdrawal by Subject|0|||
125914086|NCT02949700|452984978|FG000|Phase I|Protocol Violation|1|||
125914087|NCT02949700|452984979|FG001|Phase I|Protocol Violation|0|||
125914088|NCT02949700|452984980|FG002|Phase I|Protocol Violation|0|||
125914089|NCT02949700|452984981|FG003|Phase I|Protocol Violation|0|||
125914090|NCT02949700|452984978|FG000|Phase II|Withdrawal by Subject|0|||
125914091|NCT02949700|452984979|FG001|Phase II|Withdrawal by Subject|0|||
125914092|NCT02949700|452984980|FG002|Phase II|Withdrawal by Subject|0|||
125914093|NCT02949700|452984981|FG003|Phase II|Withdrawal by Subject|2|||
125914094|NCT02949700|452984978|FG000|Phase II|Protocol Violation|0|||
125914095|NCT02949700|452984979|FG001|Phase II|Protocol Violation|0|||
125914096|NCT02949700|452984980|FG002|Phase II|Protocol Violation|1|||
125914097|NCT02949700|452984981|FG003|Phase II|Protocol Violation|3|||
125914098|NCT03945266|452984982|FG000|Overall Study|Withdrawal by Subject|1|||
125914099|NCT03945266|452984983|FG001|Overall Study|Withdrawal by Subject|0|||
125914100|NCT03945266|452984982|FG000|Overall Study|Miscarriage|0|||
125914101|NCT03945266|452984983|FG001|Overall Study|Miscarriage|2|||
125914102|NCT03945266|452984982|FG000|Overall Study|Lost to Follow-up|1|||
126062154|NCT02165202|453521896|FG001|Injection Phase|End of Study|1|||
126062155|NCT02165202|453521895|FG000|Injection Phase|Study Product related Toxicity|1|||
126062156|NCT02165202|453521896|FG001|Injection Phase|Study Product related Toxicity|0|||
126062157|NCT02165202|453521895|FG000|Injection Phase|No longer interested|0|||
126062158|NCT02165202|453521896|FG001|Injection Phase|No longer interested|1|||
126062159|NCT02165202|453521895|FG000|Injection Phase|Participant unwilling to comply|1|||
126062160|NCT02165202|453521896|FG001|Injection Phase|Participant unwilling to comply|0|||
126062161|NCT01975701|453521909|FG000|Overall Study|Lost to Follow-up|1|||
126062162|NCT01975701|453521909|FG000|Overall Study|Death|23|||
126062163|NCT01975701|453521909|FG000|Overall Study|Physician Decision|1|||
126062164|NCT01655498|453521910|FG000|Overall Study|Unrelated health issue|2|||
126062165|NCT01655498|453521910|FG000|Overall Study|Protocol Violation|2|||
126062166|NCT01655498|453521910|FG000|Overall Study|Withdrawal by Subject|1|||
126062167|NCT01072149|453521915|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062168|NCT01072149|453521916|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062169|NCT01072149|453521917|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126062170|NCT01072149|453521918|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062171|NCT01072149|453521919|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062172|NCT01072149|453521920|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062173|NCT01072149|453521921|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062174|NCT01072149|453521922|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062175|NCT01072149|453521923|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062176|NCT01072149|453521924|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062177|NCT01072149|453521925|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062178|NCT01072149|453521926|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062179|NCT01072149|453521927|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062180|NCT01072149|453521928|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062181|NCT01072149|453521929|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062182|NCT01072149|453521930|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062183|NCT01072149|453521931|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062184|NCT01072149|453521932|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126062185|NCT01072149|453521915|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062186|NCT01072149|453521916|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062187|NCT01072149|453521917|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062188|NCT01072149|453521918|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062189|NCT01072149|453521919|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062190|NCT01072149|453521920|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062191|NCT01072149|453521921|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062192|NCT01072149|453521922|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062193|NCT01072149|453521923|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062194|NCT01072149|453521924|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062195|NCT01072149|453521925|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062196|NCT01072149|453521926|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062197|NCT01072149|453521927|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062198|NCT01072149|453521928|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062199|NCT01072149|453521929|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062200|NCT01072149|453521930|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062201|NCT01072149|453521931|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126062202|NCT01072149|453521932|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
125914103|NCT03945266|452984983|FG001|Overall Study|Lost to Follow-up|0|||
125914104|NCT01686828|452984984|FG000|Overall Study|Physician Decision|1|||
125914105|NCT01686828|452984985|FG001|Overall Study|Physician Decision|0|||
125914106|NCT01686828|452984986|FG002|Overall Study|Physician Decision|0|||
125914107|NCT01686828|452984987|FG003|Overall Study|Physician Decision|0|||
125914108|NCT01686828|452984984|FG000|Overall Study|New Job|0|||
125914109|NCT01686828|452984985|FG001|Overall Study|New Job|1|||
125914110|NCT01686828|452984986|FG002|Overall Study|New Job|0|||
125914111|NCT01686828|452984987|FG003|Overall Study|New Job|0|||
125914112|NCT01686828|452984984|FG000|Overall Study|Weight Loss|0|||
125914113|NCT01686828|452984985|FG001|Overall Study|Weight Loss|0|||
125914114|NCT01686828|452984986|FG002|Overall Study|Weight Loss|1|||
125914115|NCT01686828|452984987|FG003|Overall Study|Weight Loss|0|||
125914116|NCT02598960|452987011|FG000|Treatment Period|Disease Progression|4|||
125914117|NCT02598960|452987012|FG001|Treatment Period|Disease Progression|4|||
125914118|NCT02598960|452987013|FG002|Treatment Period|Disease Progression|4|||
125914119|NCT02598960|452987014|FG003|Treatment Period|Disease Progression|6|||
125914120|NCT02598960|452987015|FG004|Treatment Period|Disease Progression|8|||
125914121|NCT02598960|452987016|FG005|Treatment Period|Disease Progression|2|||
125914122|NCT02598960|452987017|FG006|Treatment Period|Disease Progression|2|||
125914123|NCT02598960|452987018|FG007|Treatment Period|Disease Progression|3|||
125914124|NCT02598960|452987019|FG008|Treatment Period|Disease Progression|7|||
125914125|NCT02598960|452987020|FG009|Treatment Period|Disease Progression|9|||
125914126|NCT02598960|452987021|FG010|Treatment Period|Disease Progression|7|||
125914127|NCT02598960|452987022|FG011|Treatment Period|Disease Progression|143|||
125914128|NCT02598960|452987023|FG012|Treatment Period|Disease Progression|23|||
125914129|NCT02598960|452987011|FG000|Treatment Period|Study drug toxicity|0|||
125914130|NCT02598960|452987012|FG001|Treatment Period|Study drug toxicity|0|||
125914131|NCT02598960|452987013|FG002|Treatment Period|Study drug toxicity|0|||
125914132|NCT02598960|452987014|FG003|Treatment Period|Study drug toxicity|0|||
125914133|NCT02598960|452987015|FG004|Treatment Period|Study drug toxicity|0|||
125914134|NCT02598960|452987016|FG005|Treatment Period|Study drug toxicity|0|||
125914135|NCT02598960|452987017|FG006|Treatment Period|Study drug toxicity|0|||
126062203|NCT01072149|453521915|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125914136|NCT02598960|452987018|FG007|Treatment Period|Study drug toxicity|0|||
125914137|NCT02598960|452987019|FG008|Treatment Period|Study drug toxicity|0|||
126062204|NCT01072149|453521916|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125914138|NCT02598960|452987020|FG009|Treatment Period|Study drug toxicity|1|||
126062205|NCT01072149|453521917|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125914139|NCT02598960|452987021|FG010|Treatment Period|Study drug toxicity|0|||
125914140|NCT02598960|452987022|FG011|Treatment Period|Study drug toxicity|3|||
125914141|NCT02598960|452987023|FG012|Treatment Period|Study drug toxicity|0|||
125914142|NCT02598960|452987011|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
125914143|NCT02598960|452987012|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
126062206|NCT01072149|453521918|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062207|NCT01072149|453521919|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062208|NCT01072149|453521920|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062209|NCT01072149|453521921|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062210|NCT01072149|453521922|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062211|NCT01072149|453521923|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062212|NCT01072149|453521924|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062213|NCT01072149|453521925|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
126062214|NCT01072149|453521926|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062215|NCT01072149|453521927|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062216|NCT01072149|453521928|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062217|NCT01072149|453521929|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062218|NCT01072149|453521930|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062219|NCT01072149|453521931|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062220|NCT01072149|453521932|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126062221|NCT01072149|453521915|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125914144|NCT02598960|452987013|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
125914145|NCT02598960|452987014|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
125914146|NCT02598960|452987015|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
125914147|NCT02598960|452987016|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
125914148|NCT02598960|452987017|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
125914149|NCT02598960|452987018|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
125914150|NCT02598960|452987019|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
125914151|NCT02598960|452987020|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
125914152|NCT02598960|452987021|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
125914153|NCT02598960|452987022|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
125914154|NCT02598960|452987023|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
125914155|NCT02598960|452987011|FG000|Treatment Period|participant request to discontinue|0|||
125914156|NCT02598960|452987012|FG001|Treatment Period|participant request to discontinue|1|||
125914157|NCT02598960|452987013|FG002|Treatment Period|participant request to discontinue|0|||
125914158|NCT02598960|452987014|FG003|Treatment Period|participant request to discontinue|0|||
125914159|NCT02598960|452987015|FG004|Treatment Period|participant request to discontinue|1|||
125914160|NCT02598960|452987016|FG005|Treatment Period|participant request to discontinue|0|||
125914161|NCT02598960|452987017|FG006|Treatment Period|participant request to discontinue|0|||
125914162|NCT02598960|452987018|FG007|Treatment Period|participant request to discontinue|0|||
125914163|NCT02598960|452987019|FG008|Treatment Period|participant request to discontinue|0|||
125914164|NCT02598960|452987020|FG009|Treatment Period|participant request to discontinue|0|||
125914165|NCT02598960|452987021|FG010|Treatment Period|participant request to discontinue|1|||
125914166|NCT02598960|452987022|FG011|Treatment Period|participant request to discontinue|4|||
125914167|NCT02598960|452987023|FG012|Treatment Period|participant request to discontinue|0|||
125914168|NCT02598960|452987011|FG000|Treatment Period|participant withdrew consent|0|||
125914169|NCT02598960|452987012|FG001|Treatment Period|participant withdrew consent|0|||
125914170|NCT02598960|452987013|FG002|Treatment Period|participant withdrew consent|0|||
125914171|NCT02598960|452987014|FG003|Treatment Period|participant withdrew consent|0|||
125914172|NCT02598960|452987015|FG004|Treatment Period|participant withdrew consent|0|||
125914173|NCT02598960|452987016|FG005|Treatment Period|participant withdrew consent|0|||
125914174|NCT02598960|452987017|FG006|Treatment Period|participant withdrew consent|0|||
125914175|NCT02598960|452987018|FG007|Treatment Period|participant withdrew consent|0|||
125914176|NCT02598960|452987019|FG008|Treatment Period|participant withdrew consent|0|||
125914177|NCT02598960|452987020|FG009|Treatment Period|participant withdrew consent|0|||
125914178|NCT02598960|452987021|FG010|Treatment Period|participant withdrew consent|0|||
125914179|NCT02598960|452987022|FG011|Treatment Period|participant withdrew consent|3|||
125914180|NCT02598960|452987023|FG012|Treatment Period|participant withdrew consent|0|||
125914181|NCT02598960|452987011|FG000|Treatment Period|No longer meets study criteria|0|||
125914182|NCT02598960|452987012|FG001|Treatment Period|No longer meets study criteria|0|||
125914183|NCT02598960|452987013|FG002|Treatment Period|No longer meets study criteria|0|||
125914184|NCT02598960|452987014|FG003|Treatment Period|No longer meets study criteria|0|||
125914185|NCT02598960|452987015|FG004|Treatment Period|No longer meets study criteria|0|||
125914186|NCT02598960|452987016|FG005|Treatment Period|No longer meets study criteria|0|||
125914187|NCT02598960|452987017|FG006|Treatment Period|No longer meets study criteria|0|||
125914188|NCT02598960|452987018|FG007|Treatment Period|No longer meets study criteria|0|||
125914189|NCT02598960|452987019|FG008|Treatment Period|No longer meets study criteria|0|||
125914190|NCT02598960|452987020|FG009|Treatment Period|No longer meets study criteria|0|||
125914191|NCT02598960|452987021|FG010|Treatment Period|No longer meets study criteria|0|||
125914192|NCT02598960|452987022|FG011|Treatment Period|No longer meets study criteria|1|||
125914193|NCT02598960|452987023|FG012|Treatment Period|No longer meets study criteria|0|||
125914194|NCT02598960|452987011|FG000|Treatment Period|Other Reasons|0|||
125914195|NCT02598960|452987012|FG001|Treatment Period|Other Reasons|0|||
125914196|NCT02598960|452987013|FG002|Treatment Period|Other Reasons|0|||
125914197|NCT02598960|452987014|FG003|Treatment Period|Other Reasons|0|||
125914198|NCT02598960|452987015|FG004|Treatment Period|Other Reasons|0|||
125914199|NCT02598960|452987016|FG005|Treatment Period|Other Reasons|0|||
125914200|NCT02598960|452987017|FG006|Treatment Period|Other Reasons|0|||
125914201|NCT02598960|452987018|FG007|Treatment Period|Other Reasons|0|||
125914202|NCT02598960|452987019|FG008|Treatment Period|Other Reasons|0|||
125914203|NCT02598960|452987020|FG009|Treatment Period|Other Reasons|0|||
125914204|NCT02598960|452987021|FG010|Treatment Period|Other Reasons|0|||
125914205|NCT02598960|452987022|FG011|Treatment Period|Other Reasons|0|||
126062222|NCT01072149|453521916|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
125914206|NCT02598960|452987023|FG012|Treatment Period|Other Reasons|1|||
125914207|NCT02598960|452987011|FG000|Participants Entering Follow Up Period|Death|1|||
125914208|NCT02598960|452987012|FG001|Participants Entering Follow Up Period|Death|0|||
125914209|NCT02598960|452987013|FG002|Participants Entering Follow Up Period|Death|0|||
125914210|NCT02598960|452987014|FG003|Participants Entering Follow Up Period|Death|0|||
125914211|NCT02598960|452987015|FG004|Participants Entering Follow Up Period|Death|0|||
126062223|NCT01072149|453521917|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062224|NCT01072149|453521918|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062225|NCT01072149|453521919|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062226|NCT01072149|453521920|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062227|NCT01072149|453521921|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062228|NCT01072149|453521922|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062229|NCT01072149|453521923|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062230|NCT01072149|453521924|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062231|NCT01072149|453521925|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062232|NCT01072149|453521926|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062233|NCT01072149|453521927|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062234|NCT01072149|453521928|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062235|NCT01072149|453521929|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062236|NCT01072149|453521930|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062237|NCT01072149|453521931|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062238|NCT01072149|453521932|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126062239|NCT01072149|453521915|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126110302|NCT04091451|453697700|FG000|Overall Study|Suspected HZ episode|1|||
126110303|NCT04091451|453697701|FG001|Overall Study|Suspected HZ episode|0|||
126110304|NCT03338192|453699317|FG000|Year One to Year Two|High Blood Pressure|7|||
126110305|NCT03338192|453699318|FG001|Year One to Year Two|High Blood Pressure|1|||
126110306|NCT03338192|453699317|FG000|Year One to Year Two|HIV +|1|||
126110307|NCT03338192|453699318|FG001|Year One to Year Two|HIV +|0|||
126110308|NCT03338192|453699317|FG000|Year Two to Year Four|High Blood Pressure|1|||
126110309|NCT03338192|453699318|FG001|Year Two to Year Four|High Blood Pressure|0|||
126110310|NCT03338192|453699317|FG000|Year Two to Year Four|HIV +|2|||
126110311|NCT03338192|453699318|FG001|Year Two to Year Four|HIV +|0|||
126110312|NCT03338192|453699317|FG000|Year Four to Year Six|High Blood Pressure|2|||
126110313|NCT03338192|453699318|FG001|Year Four to Year Six|High Blood Pressure|1|||
126110314|NCT03808688|453699319|FG000|Overall Study|Adverse Event|13|||
126110315|NCT03808688|453699320|FG001|Overall Study|Adverse Event|17|||
126110316|NCT03808688|453699319|FG000|Overall Study|Lack of Efficacy|2|||
126110317|NCT03808688|453699320|FG001|Overall Study|Lack of Efficacy|0|||
126110318|NCT03808688|453699319|FG000|Overall Study|Lost to Follow-up|0|||
126110319|NCT03808688|453699320|FG001|Overall Study|Lost to Follow-up|2|||
126110320|NCT03808688|453699319|FG000|Overall Study|Withdrawal by Subject|1|||
126110321|NCT03808688|453699320|FG001|Overall Study|Withdrawal by Subject|0|||
126110322|NCT03808688|453699319|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
126110323|NCT03808688|453699320|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
126110324|NCT03808688|453699319|FG000|Overall Study|IOP Too High|1|||
126110325|NCT03808688|453699320|FG001|Overall Study|IOP Too High|1|||
126110326|NCT03808688|453699319|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
126110327|NCT03808688|453699320|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
125914212|NCT02598960|452987016|FG005|Participants Entering Follow Up Period|Death|0|||
125914213|NCT02598960|452987017|FG006|Participants Entering Follow Up Period|Death|0|||
125914214|NCT02598960|452987018|FG007|Participants Entering Follow Up Period|Death|0|||
125914215|NCT02598960|452987019|FG008|Participants Entering Follow Up Period|Death|0|||
125914216|NCT02598960|452987020|FG009|Participants Entering Follow Up Period|Death|1|||
125914217|NCT02598960|452987021|FG010|Participants Entering Follow Up Period|Death|0|||
125914218|NCT02598960|452987022|FG011|Participants Entering Follow Up Period|Death|11|||
125914219|NCT02598960|452987023|FG012|Participants Entering Follow Up Period|Death|2|||
125914220|NCT02598960|452987011|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914221|NCT02598960|452987012|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914222|NCT02598960|452987013|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914223|NCT02598960|452987014|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914224|NCT02598960|452987015|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914225|NCT02598960|452987016|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914226|NCT02598960|452987017|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914227|NCT02598960|452987018|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914228|NCT02598960|452987019|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914229|NCT02598960|452987020|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914230|NCT02598960|452987021|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914231|NCT02598960|452987022|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
125914232|NCT02598960|452987023|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
125914233|NCT02598960|452987011|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
125914234|NCT02598960|452987012|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
125914235|NCT02598960|452987013|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
125914236|NCT02598960|452987014|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
125914237|NCT02598960|452987015|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
125914238|NCT02598960|452987016|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
125914239|NCT02598960|452987017|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
125914240|NCT02598960|452987018|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
125914241|NCT02598960|452987019|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
125914242|NCT02598960|452987020|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
125914243|NCT02598960|452987021|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
125914244|NCT02598960|452987022|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
125914245|NCT02598960|452987023|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
125914246|NCT02598960|452987011|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914247|NCT02598960|452987012|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914248|NCT02598960|452987013|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914249|NCT02598960|452987014|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126062240|NCT01072149|453521916|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062241|NCT01072149|453521917|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
126062242|NCT01072149|453521918|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062243|NCT01072149|453521919|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062244|NCT01072149|453521920|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062245|NCT01072149|453521921|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062246|NCT01072149|453521922|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062247|NCT01072149|453521923|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062248|NCT01072149|453521924|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062249|NCT01072149|453521925|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062250|NCT01072149|453521926|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062251|NCT01072149|453521927|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062252|NCT01072149|453521928|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062253|NCT01072149|453521929|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062254|NCT01072149|453521930|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062255|NCT01072149|453521931|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062256|NCT01072149|453521932|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126062257|NCT01072149|453521915|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062258|NCT01072149|453521916|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062259|NCT01072149|453521917|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062260|NCT01072149|453521918|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062261|NCT01072149|453521919|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062262|NCT01072149|453521920|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
126110328|NCT03808688|453699319|FG000|Overall Study|Visit Out of Window|0|||
126110329|NCT03808688|453699320|FG001|Overall Study|Visit Out of Window|1|||
126110330|NCT03808688|453699319|FG000|Overall Study|Medication Non-Compliance|0|||
125914250|NCT02598960|452987015|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914251|NCT02598960|452987016|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914252|NCT02598960|452987017|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914253|NCT02598960|452987018|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914254|NCT02598960|452987019|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914255|NCT02598960|452987020|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914256|NCT02598960|452987021|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914257|NCT02598960|452987022|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
125914258|NCT02598960|452987023|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125914259|NCT02598960|452987011|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
125914260|NCT02598960|452987012|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
125914261|NCT02598960|452987013|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
125914262|NCT02598960|452987014|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
125914263|NCT02598960|452987015|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
125914264|NCT02598960|452987016|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
125914265|NCT02598960|452987017|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
125914266|NCT02598960|452987018|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
125914267|NCT02598960|452987019|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
125914268|NCT02598960|452987020|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
125914269|NCT02598960|452987021|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
125914270|NCT02598960|452987022|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
125914271|NCT02598960|452987023|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
125914272|NCT00734474|452987028|FG000|Overall Study|Entry Criteria Not Met|0|||
125914273|NCT00734474|452987029|FG001|Overall Study|Entry Criteria Not Met|0|||
126062263|NCT01072149|453521921|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062264|NCT01072149|453521922|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
126062265|NCT01072149|453521923|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062266|NCT01072149|453521924|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062267|NCT01072149|453521925|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062268|NCT01072149|453521926|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062269|NCT01072149|453521927|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062270|NCT01072149|453521928|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062271|NCT01072149|453521929|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
125914274|NCT00734474|452987030|FG002|Overall Study|Entry Criteria Not Met|5|||
125914275|NCT00734474|452987031|FG003|Overall Study|Entry Criteria Not Met|0|||
125914276|NCT00734474|452987032|FG004|Overall Study|Entry Criteria Not Met|3|||
125914277|NCT00734474|452987033|FG005|Overall Study|Entry Criteria Not Met|1|||
125914278|NCT00734474|452987034|FG006|Overall Study|Entry Criteria Not Met|0|||
125914279|NCT00734474|452987035|FG007|Overall Study|Entry Criteria Not Met|1|||
125914280|NCT00734474|452987036|FG008|Overall Study|Entry Criteria Not Met|1|||
125914281|NCT00734474|452987028|FG000|Overall Study|Lost to Follow-up|1|||
125914282|NCT00734474|452987029|FG001|Overall Study|Lost to Follow-up|0|||
125914283|NCT00734474|452987030|FG002|Overall Study|Lost to Follow-up|13|||
125914284|NCT00734474|452987031|FG003|Overall Study|Lost to Follow-up|0|||
125914285|NCT00734474|452987032|FG004|Overall Study|Lost to Follow-up|11|||
125914286|NCT00734474|452987033|FG005|Overall Study|Lost to Follow-up|1|||
125914287|NCT00734474|452987034|FG006|Overall Study|Lost to Follow-up|0|||
125914288|NCT00734474|452987035|FG007|Overall Study|Lost to Follow-up|9|||
125914289|NCT00734474|452987036|FG008|Overall Study|Lost to Follow-up|4|||
125914290|NCT00734474|452987028|FG000|Overall Study|Withdrawal by Subject|2|||
125914291|NCT00734474|452987029|FG001|Overall Study|Withdrawal by Subject|1|||
125914292|NCT00734474|452987030|FG002|Overall Study|Withdrawal by Subject|18|||
125914293|NCT00734474|452987031|FG003|Overall Study|Withdrawal by Subject|0|||
125914294|NCT00734474|452987032|FG004|Overall Study|Withdrawal by Subject|24|||
125914295|NCT00734474|452987033|FG005|Overall Study|Withdrawal by Subject|2|||
125914296|NCT00734474|452987034|FG006|Overall Study|Withdrawal by Subject|0|||
125914297|NCT00734474|452987035|FG007|Overall Study|Withdrawal by Subject|36|||
125914298|NCT00734474|452987036|FG008|Overall Study|Withdrawal by Subject|21|||
125914299|NCT00734474|452987028|FG000|Overall Study|Physician Decision|0|||
125914300|NCT00734474|452987029|FG001|Overall Study|Physician Decision|0|||
125914301|NCT00734474|452987030|FG002|Overall Study|Physician Decision|4|||
125914302|NCT00734474|452987031|FG003|Overall Study|Physician Decision|1|||
125914303|NCT00734474|452987032|FG004|Overall Study|Physician Decision|11|||
125914304|NCT00734474|452987033|FG005|Overall Study|Physician Decision|0|||
125914305|NCT00734474|452987034|FG006|Overall Study|Physician Decision|0|||
126062272|NCT01072149|453521930|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
125914306|NCT00734474|452987035|FG007|Overall Study|Physician Decision|9|||
126062273|NCT01072149|453521931|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
125914307|NCT00734474|452987036|FG008|Overall Study|Physician Decision|9|||
125914308|NCT00734474|452987028|FG000|Overall Study|Adverse Event|4|||
125914309|NCT00734474|452987029|FG001|Overall Study|Adverse Event|4|||
125914310|NCT00734474|452987030|FG002|Overall Study|Adverse Event|63|||
125914311|NCT00734474|452987031|FG003|Overall Study|Adverse Event|1|||
125914312|NCT00734474|452987032|FG004|Overall Study|Adverse Event|64|||
125914313|NCT00734474|452987033|FG005|Overall Study|Adverse Event|0|||
126062274|NCT01072149|453521932|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
126062275|NCT01072149|453521915|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
126062276|NCT01072149|453521916|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
126062277|NCT01072149|453521917|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
126062278|NCT01072149|453521918|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
126062279|NCT01072149|453521919|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
126062280|NCT01072149|453521920|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
126062281|NCT01072149|453521921|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
126062282|NCT01072149|453521922|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
126062283|NCT01072149|453521923|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
126062284|NCT01072149|453521924|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
126062285|NCT01072149|453521925|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
126062286|NCT01072149|453521926|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
126062287|NCT01072149|453521927|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
126062288|NCT01072149|453521928|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
126062289|NCT01072149|453521929|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
126062290|NCT01072149|453521930|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
126062291|NCT01072149|453521931|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
126062292|NCT01072149|453521932|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
126062293|NCT01072149|453521915|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062294|NCT01072149|453521916|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062295|NCT01072149|453521917|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062296|NCT01072149|453521918|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062297|NCT01072149|453521919|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062298|NCT01072149|453521920|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062299|NCT01072149|453521921|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062300|NCT01072149|453521922|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125914314|NCT00734474|452987034|FG006|Overall Study|Adverse Event|1|||
125914315|NCT00734474|452987035|FG007|Overall Study|Adverse Event|65|||
125914316|NCT00734474|452987036|FG008|Overall Study|Adverse Event|39|||
125914317|NCT00734474|452987028|FG000|Overall Study|Protocol Violation|0|||
125914318|NCT00734474|452987029|FG001|Overall Study|Protocol Violation|0|||
126062301|NCT01072149|453521923|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125914319|NCT00734474|452987030|FG002|Overall Study|Protocol Violation|4|||
125914320|NCT00734474|452987031|FG003|Overall Study|Protocol Violation|0|||
126062302|NCT01072149|453521924|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062303|NCT01072149|453521925|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125914321|NCT00734474|452987032|FG004|Overall Study|Protocol Violation|3|||
125914322|NCT00734474|452987033|FG005|Overall Study|Protocol Violation|0|||
125914323|NCT00734474|452987034|FG006|Overall Study|Protocol Violation|0|||
126062304|NCT01072149|453521926|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062305|NCT01072149|453521927|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062306|NCT01072149|453521928|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062307|NCT01072149|453521929|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062308|NCT01072149|453521930|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
126062309|NCT01072149|453521931|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062310|NCT01072149|453521932|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126062311|NCT01072149|453521915|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
126062312|NCT01072149|453521916|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
126062313|NCT01072149|453521917|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
126062314|NCT01072149|453521918|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
126062315|NCT01072149|453521919|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
126062316|NCT01072149|453521920|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
126062317|NCT01072149|453521921|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
126062318|NCT01072149|453521922|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
126062319|NCT01072149|453521923|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
126062320|NCT01072149|453521924|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
126062321|NCT01072149|453521925|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
126062322|NCT01072149|453521926|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
126062323|NCT01072149|453521927|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
126062324|NCT01072149|453521928|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
126062325|NCT01072149|453521929|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
126062326|NCT01072149|453521930|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
126062327|NCT01072149|453521931|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
126062328|NCT01072149|453521932|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
126062329|NCT01072149|453521915|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062330|NCT01072149|453521916|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062331|NCT01072149|453521917|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062332|NCT01072149|453521918|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062333|NCT01072149|453521919|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062334|NCT01072149|453521920|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062335|NCT01072149|453521921|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062336|NCT01072149|453521922|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062337|NCT01072149|453521923|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062338|NCT01072149|453521924|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062339|NCT01072149|453521925|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062340|NCT01072149|453521926|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062341|NCT01072149|453521927|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
126062342|NCT01072149|453521928|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062343|NCT01072149|453521929|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062344|NCT01072149|453521930|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062345|NCT01072149|453521931|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062346|NCT01072149|453521932|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126062347|NCT01072149|453521915|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062348|NCT01072149|453521916|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062349|NCT01072149|453521917|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
126062350|NCT01072149|453521918|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062351|NCT01072149|453521919|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062352|NCT01072149|453521920|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062353|NCT01072149|453521921|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062354|NCT01072149|453521922|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062355|NCT01072149|453521923|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062356|NCT01072149|453521924|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062357|NCT01072149|453521925|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062358|NCT01072149|453521926|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062359|NCT01072149|453521927|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062360|NCT01072149|453521928|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
126062361|NCT01072149|453521929|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062362|NCT01072149|453521930|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062363|NCT01072149|453521931|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062364|NCT01072149|453521932|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126062365|NCT02784834|453521935|FG000|Overall Study|Lack of Efficacy|1|||
126062366|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
126062367|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
125914324|NCT00734474|452987035|FG007|Overall Study|Protocol Violation|3|||
126062368|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
126062369|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
126062370|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Adverse Event|7|||
126062371|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Adverse Event|8|||
126062372|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Adverse Event|8|||
126062373|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Adverse Event|9|||
126062374|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
126062375|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
126062376|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
126062377|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
126062378|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
126062379|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
126062380|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
126062381|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
126062382|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Pregnancy|0|||
126062383|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Pregnancy|2|||
126062384|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Pregnancy|2|||
126062385|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Pregnancy|0|||
126062386|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Non-compliance|1|||
126062387|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Non-compliance|0|||
126062388|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Non-compliance|0|||
126062389|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Non-compliance|3|||
126062390|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Other|3|||
126062391|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Other|0|||
126062392|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Other|3|||
126062393|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Other|2|||
126062394|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
126062395|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
126062396|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
126062397|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
126062398|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
126062399|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
126062400|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
126062401|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
126062402|NCT02143713|453521936|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
126062403|NCT02143713|453521937|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
126062404|NCT02143713|453521938|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
126062405|NCT02143713|453521939|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
126062406|NCT02143713|453521936|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
126062407|NCT02143713|453521937|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
126062408|NCT02143713|453521938|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
126062409|NCT02143713|453521939|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
126062410|NCT02143713|453521936|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
126062411|NCT02143713|453521937|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
126062412|NCT02143713|453521938|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
126062413|NCT02143713|453521939|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
126062414|NCT02143713|453521936|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
126062415|NCT02143713|453521937|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
126062416|NCT02143713|453521938|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
126062417|NCT02143713|453521939|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
126062418|NCT02143713|453521936|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
126062419|NCT02143713|453521937|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
126062420|NCT02143713|453521938|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
126062421|NCT02143713|453521939|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
126062422|NCT02143713|453521936|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
126062423|NCT02143713|453521937|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
125914325|NCT00734474|452987036|FG008|Overall Study|Protocol Violation|1|||
126062424|NCT02143713|453521938|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
126062425|NCT02143713|453521939|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
126062426|NCT02143713|453521936|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
126062427|NCT02143713|453521937|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
126062428|NCT02143713|453521938|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
126062429|NCT02143713|453521939|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
126062430|NCT01768572|453521940|FG000|Overall Study|Adverse Event|7|||
126062431|NCT01768572|453521941|FG001|Overall Study|Adverse Event|8|||
126062432|NCT01768572|453521942|FG002|Overall Study|Adverse Event|4|||
126062433|NCT01768572|453521940|FG000|Overall Study|Lack of Efficacy|1|||
126062434|NCT01768572|453521941|FG001|Overall Study|Lack of Efficacy|3|||
126062435|NCT01768572|453521942|FG002|Overall Study|Lack of Efficacy|1|||
126062436|NCT01768572|453521940|FG000|Overall Study|Other, Not due to an adverse event|1|||
126062437|NCT01768572|453521941|FG001|Overall Study|Other, Not due to an adverse event|1|||
126062438|NCT01768572|453521942|FG002|Overall Study|Other, Not due to an adverse event|1|||
126062439|NCT00080119|453521945|FG000|Overall Study|Discontinued because of study closure|0|||
126062440|NCT00080119|453521946|FG001|Overall Study|Discontinued because of study closure|0|||
126062441|NCT00080119|453521947|FG002|Overall Study|Discontinued because of study closure|130|||
126062442|NCT00080119|453521948|FG003|Overall Study|Discontinued because of study closure|141|||
126062443|NCT00080119|453521945|FG000|Overall Study|Unable to get to clinic|24|||
126062444|NCT00080119|453521946|FG001|Overall Study|Unable to get to clinic|24|||
126062445|NCT00080119|453521947|FG002|Overall Study|Unable to get to clinic|7|||
126062446|NCT00080119|453521948|FG003|Overall Study|Unable to get to clinic|1|||
126062447|NCT00080119|453521945|FG000|Overall Study|Consent withdrawn|13|||
126062448|NCT00080119|453521946|FG001|Overall Study|Consent withdrawn|17|||
126062449|NCT00080119|453521947|FG002|Overall Study|Consent withdrawn|4|||
126062450|NCT00080119|453521948|FG003|Overall Study|Consent withdrawn|6|||
126062451|NCT00080119|453521945|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
126062452|NCT00080119|453521946|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
126062453|NCT00080119|453521947|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
126062454|NCT00080119|453521948|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
126062455|NCT00080119|453521945|FG000|Overall Study|Lost to Follow-up|16|||
126062456|NCT00080119|453521946|FG001|Overall Study|Lost to Follow-up|19|||
126062457|NCT00080119|453521947|FG002|Overall Study|Lost to Follow-up|19|||
126062458|NCT00080119|453521948|FG003|Overall Study|Lost to Follow-up|14|||
126062459|NCT01919489|453521950|FG000|Overall Study|Rejected the need of injections|4|||
126062460|NCT01919489|453521951|FG001|Overall Study|Rejected the need of injections|7|||
126062461|NCT01919489|453521950|FG000|Overall Study|Adverse Event|10|||
126062462|NCT01919489|453521951|FG001|Overall Study|Adverse Event|0|||
126062463|NCT01919489|453521950|FG000|Overall Study|Hospital readmission|2|||
126062464|NCT01919489|453521951|FG001|Overall Study|Hospital readmission|9|||
126062465|NCT01919489|453521950|FG000|Overall Study|Death|2|||
126062466|NCT01919489|453521951|FG001|Overall Study|Death|1|||
126062467|NCT01919489|453521950|FG000|Overall Study|Lost to Follow-up|38|||
126062468|NCT01919489|453521951|FG001|Overall Study|Lost to Follow-up|27|||
126062469|NCT01322386|453521952|FG000|Overall Study|Protocol Violation|0|||
126062470|NCT01322386|453521953|FG001|Overall Study|Protocol Violation|1|||
125914326|NCT00734474|452987028|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
125914327|NCT00734474|452987029|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
125914328|NCT00734474|452987030|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125914329|NCT00734474|452987031|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
125914330|NCT00734474|452987032|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125914331|NCT00734474|452987033|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
125914332|NCT00734474|452987034|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
125914333|NCT00734474|452987035|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125914334|NCT00734474|452987036|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125914335|NCT00734474|452987028|FG000|Overall Study|Sponsor Decision|0|||
125914336|NCT00734474|452987029|FG001|Overall Study|Sponsor Decision|0|||
126062471|NCT01322386|453521952|FG000|Overall Study|Physician Decision|0|||
126062472|NCT01322386|453521953|FG001|Overall Study|Physician Decision|1|||
126062473|NCT00871494|453521958|FG000|Overall Study|Protocol Violation|5|||
126062474|NCT00871494|453521958|FG000|Overall Study|Lack of Efficacy|4|||
126062475|NCT00871494|453521958|FG000|Overall Study|Adverse Event|4|||
126062476|NCT00871494|453521958|FG000|Overall Study|Lost to Follow-up|1|||
125914337|NCT00734474|452987030|FG002|Overall Study|Sponsor Decision|0|||
125914338|NCT00734474|452987031|FG003|Overall Study|Sponsor Decision|0|||
126062477|NCT02291861|453521959|FG000|Overall Study|Adverse Event|2|||
126062478|NCT02291861|453521960|FG001|Overall Study|Adverse Event|4|||
126062479|NCT02291861|453521961|FG002|Overall Study|Adverse Event|1|||
126062480|NCT02291861|453521962|FG003|Overall Study|Adverse Event|2|||
126062481|NCT02291861|453521959|FG000|Overall Study|Death|0|||
126062482|NCT02291861|453521960|FG001|Overall Study|Death|0|||
125914339|NCT00734474|452987032|FG004|Overall Study|Sponsor Decision|2|||
126062483|NCT02291861|453521961|FG002|Overall Study|Death|1|||
126062484|NCT02291861|453521962|FG003|Overall Study|Death|1|||
126062485|NCT02291861|453521959|FG000|Overall Study|Protocol Violation|1|||
125914340|NCT00734474|452987033|FG005|Overall Study|Sponsor Decision|0|||
125914341|NCT00734474|452987034|FG006|Overall Study|Sponsor Decision|0|||
125914342|NCT00734474|452987035|FG007|Overall Study|Sponsor Decision|0|||
125914343|NCT00734474|452987036|FG008|Overall Study|Sponsor Decision|0|||
126062486|NCT02291861|453521960|FG001|Overall Study|Protocol Violation|0|||
126062487|NCT02291861|453521961|FG002|Overall Study|Protocol Violation|0|||
126062488|NCT02291861|453521962|FG003|Overall Study|Protocol Violation|1|||
126062489|NCT02291861|453521959|FG000|Overall Study|Withdrawal by Subject|1|||
126062490|NCT02291861|453521960|FG001|Overall Study|Withdrawal by Subject|2|||
126062491|NCT02291861|453521961|FG002|Overall Study|Withdrawal by Subject|1|||
126062492|NCT02291861|453521962|FG003|Overall Study|Withdrawal by Subject|4|||
126062493|NCT02291861|453521959|FG000|Overall Study|Noncompliance|1|||
126062494|NCT02291861|453521960|FG001|Overall Study|Noncompliance|1|||
126062495|NCT02291861|453521961|FG002|Overall Study|Noncompliance|2|||
126062496|NCT02291861|453521962|FG003|Overall Study|Noncompliance|1|||
126062497|NCT02291861|453521959|FG000|Overall Study|Lost to Follow-up|2|||
126062498|NCT02291861|453521960|FG001|Overall Study|Lost to Follow-up|1|||
126062499|NCT02291861|453521961|FG002|Overall Study|Lost to Follow-up|4|||
126062500|NCT02291861|453521962|FG003|Overall Study|Lost to Follow-up|0|||
126062501|NCT02291861|453521959|FG000|Overall Study|Other|0|||
126062502|NCT02291861|453521960|FG001|Overall Study|Other|0|||
126062503|NCT02291861|453521961|FG002|Overall Study|Other|0|||
126062504|NCT02291861|453521962|FG003|Overall Study|Other|1|||
126062505|NCT00963924|453521963|FG000|Overall Study|Adverse Event|1|||
126062506|NCT00963924|453521964|FG001|Overall Study|Adverse Event|0|||
126062507|NCT00963924|453521963|FG000|Overall Study|Withdrawal by Subject|0|||
126062508|NCT00963924|453521964|FG001|Overall Study|Withdrawal by Subject|1|||
126062509|NCT00963924|453521963|FG000|Overall Study|Changed antipsychotic|0|||
126062510|NCT00963924|453521964|FG001|Overall Study|Changed antipsychotic|1|||
126062511|NCT00963924|453521963|FG000|Overall Study|Lost to Follow-up|0|||
126062512|NCT00963924|453521964|FG001|Overall Study|Lost to Follow-up|1|||
126062513|NCT00237809|453521965|FG000|Overall Study|Lost to Follow-up|11|||
126062514|NCT00237809|453521966|FG001|Overall Study|Lost to Follow-up|10|||
126062515|NCT00237809|453521967|FG002|Overall Study|Lost to Follow-up|9|||
126062516|NCT00237809|453521968|FG003|Overall Study|Lost to Follow-up|9|||
126062517|NCT00871715|453521971|FG000|Overall Study|Withdrawal by Subject|6|||
126062518|NCT00871715|453521972|FG001|Overall Study|Withdrawal by Subject|10|||
126062519|NCT00871715|453521973|FG002|Overall Study|Withdrawal by Subject|15|||
126062520|NCT00871715|453521971|FG000|Overall Study|Physician Decision|6|||
126062521|NCT00871715|453521972|FG001|Overall Study|Physician Decision|0|||
126062522|NCT00871715|453521973|FG002|Overall Study|Physician Decision|2|||
126062523|NCT00871715|453521971|FG000|Overall Study|Lost to Follow-up|3|||
126062524|NCT00871715|453521972|FG001|Overall Study|Lost to Follow-up|6|||
126062525|NCT00871715|453521973|FG002|Overall Study|Lost to Follow-up|9|||
126062526|NCT03015220|453521974|FG000|Overall Study|Withdrawal by Subject|3|||
126062527|NCT03015220|453521975|FG001|Overall Study|Withdrawal by Subject|2|||
126062528|NCT03015220|453521976|FG002|Overall Study|Withdrawal by Subject|2|||
126062529|NCT03015220|453521977|FG003|Overall Study|Withdrawal by Subject|2|||
126062530|NCT03015220|453521974|FG000|Overall Study|Lost to Follow-up|0|||
126062531|NCT03015220|453521975|FG001|Overall Study|Lost to Follow-up|0|||
126062532|NCT03015220|453521976|FG002|Overall Study|Lost to Follow-up|1|||
126062533|NCT03015220|453521977|FG003|Overall Study|Lost to Follow-up|0|||
126062534|NCT01670526|453521978|FG000|Overall Study|Withdrawal by Subject|3|||
126062535|NCT01670526|453521979|FG001|Overall Study|Withdrawal by Subject|1|||
126062536|NCT01670526|453521978|FG000|Overall Study|Lost to Follow-up|9|||
126062537|NCT01670526|453521979|FG001|Overall Study|Lost to Follow-up|5|||
126062538|NCT02291549|453521980|FG000|Overall Study|Lost to Follow-up|1|||
126062539|NCT02291549|453521981|FG001|Overall Study|Lost to Follow-up|0|||
126062540|NCT02291549|453521980|FG000|Overall Study|Withdrawal by Subject|0|||
126062541|NCT02291549|453521981|FG001|Overall Study|Withdrawal by Subject|1|||
126062542|NCT01970527|453521983|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
126062543|NCT01970527|453521984|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
126062544|NCT01970527|453521983|FG000|Treatment|Disease progression|0|||
126062545|NCT01970527|453521984|FG001|Treatment|Disease progression|1|||
126062546|NCT01970527|453521983|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
126062547|NCT01970527|453521984|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
126062548|NCT01970527|453521983|FG000|Treatment|Death|0|||
126062549|NCT01970527|453521984|FG001|Treatment|Death|1|||
126062550|NCT01970527|453521983|FG000|Follow-up Clinic Visit|Disease progression|1|||
126062551|NCT01970527|453521984|FG001|Follow-up Clinic Visit|Disease progression|1|||
126062552|NCT01970527|453521983|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
126062553|NCT01970527|453521984|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
126062554|NCT01970527|453521983|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
126062555|NCT01970527|453521984|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
126062556|NCT01115309|453521985|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
126062557|NCT01115309|453521985|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
126062558|NCT01115309|453521985|FG000|Long-term Follow-up|Lost to Follow-up|6|||
126062559|NCT04447287|453521986|FG000|Period 1: Run-in Period|Adverse Event|3|||
126062560|NCT04447287|453521987|FG001|Period 1: Run-in Period|Adverse Event|0|||
126062561|NCT04447287|453521988|FG002|Period 1: Run-in Period|Adverse Event|0|||
126062562|NCT04447287|453521986|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
126062563|NCT04447287|453521987|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
126062564|NCT04447287|453521988|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
126062565|NCT04447287|453521986|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
126062566|NCT04447287|453521987|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
126062567|NCT04447287|453521988|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
126062568|NCT05700851|453521989|FG000|Overall Study|Received a kidney transplant|1|||
126062569|NCT05700851|453521989|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
126062570|NCT05700851|453521989|FG000|Overall Study|Withdrawal by Subject|1|||
126062571|NCT02147093|453521992|FG000|Period 1|Lost to Follow-up|0|||
126062572|NCT02147093|453521993|FG001|Period 1|Lost to Follow-up|1|||
126062573|NCT02147093|453521992|FG000|Period 2|Protocol Violation|2|||
126062574|NCT02147093|453521993|FG001|Period 2|Protocol Violation|0|||
126062575|NCT00655824|453521994|FG000|Overall Study|Adverse Event|3|||
126062576|NCT00655824|453521994|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
126062577|NCT00655824|453521994|FG000|Overall Study|Protocol Violation|1|||
126062578|NCT00655824|453521994|FG000|Overall Study|Withdrawal by Subject|4|||
126062579|NCT00655824|453521994|FG000|Overall Study|Deterioration of Trial Disease|2|||
126062580|NCT00589628|453521995|FG000|Overall Study|Lost to Follow-up|0|||
126062581|NCT00589628|453521996|FG001|Overall Study|Lost to Follow-up|1|||
126062582|NCT03032198|453522004|FG000|Overall Study|Screen Fail|1|||
126062583|NCT01307800|453522005|FG000|Overall Study|Adverse Event|9|||
126062584|NCT01307800|453522006|FG001|Overall Study|Adverse Event|8|||
126062585|NCT01307800|453522007|FG002|Overall Study|Adverse Event|10|||
126062586|NCT01307800|453522008|FG003|Overall Study|Adverse Event|14|||
126062587|NCT01307800|453522005|FG000|Overall Study|Entry Criteria Not Met|0|||
126062588|NCT01307800|453522006|FG001|Overall Study|Entry Criteria Not Met|0|||
126062589|NCT01307800|453522007|FG002|Overall Study|Entry Criteria Not Met|0|||
126062590|NCT01307800|453522008|FG003|Overall Study|Entry Criteria Not Met|2|||
126062591|NCT01307800|453522005|FG000|Overall Study|Lost to Follow-up|5|||
126062592|NCT01307800|453522006|FG001|Overall Study|Lost to Follow-up|6|||
126062593|NCT01307800|453522007|FG002|Overall Study|Lost to Follow-up|2|||
126062594|NCT01307800|453522008|FG003|Overall Study|Lost to Follow-up|8|||
126062595|NCT01307800|453522005|FG000|Overall Study|Perceived Lack of Efficacy|24|||
126062596|NCT01307800|453522006|FG001|Overall Study|Perceived Lack of Efficacy|23|||
126062597|NCT01307800|453522007|FG002|Overall Study|Perceived Lack of Efficacy|20|||
126062598|NCT01307800|453522008|FG003|Overall Study|Perceived Lack of Efficacy|33|||
126062599|NCT01307800|453522005|FG000|Overall Study|Protocol Violation|0|||
126062600|NCT01307800|453522006|FG001|Overall Study|Protocol Violation|3|||
126062601|NCT01307800|453522007|FG002|Overall Study|Protocol Violation|4|||
126062602|NCT01307800|453522008|FG003|Overall Study|Protocol Violation|5|||
126062603|NCT01307800|453522005|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
126062604|NCT01307800|453522006|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
126062605|NCT01307800|453522007|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
126062606|NCT01307800|453522008|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
126062607|NCT01307800|453522005|FG000|Overall Study|Sponsor Decision|6|||
126062608|NCT01307800|453522006|FG001|Overall Study|Sponsor Decision|9|||
126062609|NCT01307800|453522007|FG002|Overall Study|Sponsor Decision|12|||
126062610|NCT01307800|453522008|FG003|Overall Study|Sponsor Decision|28|||
126062611|NCT01307800|453522005|FG000|Overall Study|Withdrawal by Subject|10|||
126062612|NCT01307800|453522006|FG001|Overall Study|Withdrawal by Subject|11|||
126062613|NCT01307800|453522007|FG002|Overall Study|Withdrawal by Subject|8|||
126062614|NCT01307800|453522008|FG003|Overall Study|Withdrawal by Subject|15|||
126062615|NCT01307800|453522005|FG000|Overall Study|Participant Moved|0|||
126062616|NCT01307800|453522006|FG001|Overall Study|Participant Moved|2|||
126062617|NCT01307800|453522007|FG002|Overall Study|Participant Moved|1|||
126062618|NCT01307800|453522008|FG003|Overall Study|Participant Moved|3|||
126062619|NCT00689351|453522009|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
126062620|NCT00689351|453522010|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
126062621|NCT00689351|453522009|FG000|Infant Series of Dosing|Adverse Event|1|||
126062622|NCT00689351|453522010|FG001|Infant Series of Dosing|Adverse Event|0|||
126062623|NCT00689351|453522009|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
126062624|NCT00689351|453522010|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
126062625|NCT00689351|453522009|FG000|After Infant Series|Parent/legal guardian request|1|||
126062626|NCT00689351|453522010|FG001|After Infant Series|Parent/legal guardian request|0|||
126062627|NCT01662505|453522011|FG000|Overall Study|Progressive disease|6|||
126062628|NCT01662505|453522012|FG001|Overall Study|Progressive disease|1|||
126062629|NCT01662505|453522013|FG002|Overall Study|Progressive disease|5|||
126062630|NCT01662505|453522011|FG000|Overall Study|Refused cont. medication|0|||
126062631|NCT01662505|453522012|FG001|Overall Study|Refused cont. medication|0|||
126062632|NCT01662505|453522013|FG002|Overall Study|Refused cont. medication|1|||
126062633|NCT01662505|453522011|FG000|Overall Study|Not specified above|1|||
126062634|NCT01662505|453522012|FG001|Overall Study|Not specified above|3|||
126062635|NCT01662505|453522013|FG002|Overall Study|Not specified above|2|||
126062636|NCT01229176|453522014|FG000|Overall Study|Withdrawal by Subject|0|||
126089035|NCT00594880|453620055|FG001|Overall Study|Lost to Follow-up|0|||
126062637|NCT01229176|453522015|FG001|Overall Study|Withdrawal by Subject|0|||
126062638|NCT01229176|453522016|FG002|Overall Study|Withdrawal by Subject|0|||
126062639|NCT01229176|453522017|FG003|Overall Study|Withdrawal by Subject|1|||
126062640|NCT01229176|453522018|FG004|Overall Study|Withdrawal by Subject|1|||
126062641|NCT01229176|453522019|FG005|Overall Study|Withdrawal by Subject|1|||
126062642|NCT01229176|453522020|FG006|Overall Study|Withdrawal by Subject|0|||
126062643|NCT01229176|453522021|FG007|Overall Study|Withdrawal by Subject|1|||
126062644|NCT01229176|453522014|FG000|Overall Study|Lost to Follow-up|0|||
126062645|NCT01229176|453522015|FG001|Overall Study|Lost to Follow-up|3|||
126062646|NCT01229176|453522016|FG002|Overall Study|Lost to Follow-up|0|||
126062647|NCT01229176|453522017|FG003|Overall Study|Lost to Follow-up|0|||
126062648|NCT01229176|453522018|FG004|Overall Study|Lost to Follow-up|1|||
126062649|NCT01229176|453522019|FG005|Overall Study|Lost to Follow-up|1|||
126062650|NCT01229176|453522020|FG006|Overall Study|Lost to Follow-up|0|||
126062651|NCT01229176|453522021|FG007|Overall Study|Lost to Follow-up|2|||
126062652|NCT00882050|453522029|FG000|Overall Study|Physician Decision|1|||
126062653|NCT00882050|453522030|FG001|Overall Study|Physician Decision|0|||
126062654|NCT00882050|453522031|FG002|Overall Study|Physician Decision|0|||
126062655|NCT02367794|453522032|FG000|Overall Study|Death|252|||
125914344|NCT00734474|452987028|FG000|Overall Study|Death|0|||
125914345|NCT00734474|452987029|FG001|Overall Study|Death|0|||
125914346|NCT00734474|452987030|FG002|Overall Study|Death|1|||
125914347|NCT00734474|452987031|FG003|Overall Study|Death|0|||
125914348|NCT00734474|452987032|FG004|Overall Study|Death|0|||
125914349|NCT00734474|452987033|FG005|Overall Study|Death|0|||
125914350|NCT00734474|452987034|FG006|Overall Study|Death|0|||
125914351|NCT00734474|452987035|FG007|Overall Study|Death|2|||
125914352|NCT00734474|452987036|FG008|Overall Study|Death|1|||
125914353|NCT00734474|452987028|FG000|Overall Study|Lack of Efficacy|0|||
125914354|NCT00734474|452987029|FG001|Overall Study|Lack of Efficacy|0|||
125914355|NCT00734474|452987030|FG002|Overall Study|Lack of Efficacy|4|||
125914356|NCT00734474|452987031|FG003|Overall Study|Lack of Efficacy|0|||
125914357|NCT00734474|452987032|FG004|Overall Study|Lack of Efficacy|0|||
125914358|NCT00734474|452987033|FG005|Overall Study|Lack of Efficacy|0|||
125914359|NCT00734474|452987034|FG006|Overall Study|Lack of Efficacy|0|||
125914360|NCT00734474|452987035|FG007|Overall Study|Lack of Efficacy|4|||
125914361|NCT00734474|452987036|FG008|Overall Study|Lack of Efficacy|6|||
125914362|NCT00385762|452987043|FG000|Overall Study|Adverse Event|1|||
125914363|NCT00385762|452987043|FG000|Overall Study|Lost to Follow-up|1|||
125914364|NCT00573183|452987044|FG000|Overall Study|Lost to Follow-up|52|||
125914365|NCT00573183|452987045|FG001|Overall Study|Lost to Follow-up|50|||
125914366|NCT00573183|452987044|FG000|Overall Study|Withdrawal by Subject|8|||
125914367|NCT00573183|452987045|FG001|Overall Study|Withdrawal by Subject|2|||
125914368|NCT00573183|452987044|FG000|Overall Study|Death|0|||
125914369|NCT00573183|452987045|FG001|Overall Study|Death|1|||
125914370|NCT00573183|452987044|FG000|Overall Study|Adverse Event|2|||
125914371|NCT00573183|452987045|FG001|Overall Study|Adverse Event|0|||
125914372|NCT00573183|452987044|FG000|Overall Study|Incarceration|5|||
125914373|NCT00573183|452987045|FG001|Overall Study|Incarceration|8|||
125914374|NCT00573183|452987044|FG000|Overall Study|Other|5|||
125914375|NCT00573183|452987045|FG001|Overall Study|Other|2|||
125914376|NCT02570074|452987046|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
125914377|NCT02570074|452987047|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
125914378|NCT01856907|452987051|FG000|Overall Study|Pregnancy|0|||
125914379|NCT01856907|452987052|FG001|Overall Study|Pregnancy|1|||
125914380|NCT01856907|452987053|FG002|Overall Study|Pregnancy|0|||
125914381|NCT01856907|452987051|FG000|Overall Study|Pregnancy|0|||
125914382|NCT01856907|452987052|FG001|Overall Study|Pregnancy|1|||
125914383|NCT01856907|452987053|FG002|Overall Study|Pregnancy|0|||
126062656|NCT02367794|453522033|FG001|Overall Study|Death|245|||
126062657|NCT02367794|453522034|FG002|Overall Study|Death|243|||
125914384|NCT01856907|452987051|FG000|Overall Study|Withdrawal by Subject|0|||
125914385|NCT01856907|452987052|FG001|Overall Study|Withdrawal by Subject|1|||
125914386|NCT01856907|452987053|FG002|Overall Study|Withdrawal by Subject|0|||
125914387|NCT01604408|452987054|FG000|Treatment Period 1|Protocol Violation|0|||
125914388|NCT01604408|452987055|FG001|Treatment Period 1|Protocol Violation|1|||
126062658|NCT02367794|453522032|FG000|Overall Study|Lost to Follow-up|1|||
126062659|NCT02367794|453522033|FG001|Overall Study|Lost to Follow-up|2|||
126062660|NCT02367794|453522034|FG002|Overall Study|Lost to Follow-up|2|||
126062661|NCT02367794|453522032|FG000|Overall Study|Physician Decision|0|||
126062662|NCT02367794|453522033|FG001|Overall Study|Physician Decision|5|||
126062663|NCT02367794|453522034|FG002|Overall Study|Physician Decision|3|||
126062664|NCT02367794|453522032|FG000|Overall Study|Protocol Violation|1|||
126062665|NCT02367794|453522033|FG001|Overall Study|Protocol Violation|0|||
125914389|NCT01604408|452987054|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125914390|NCT01604408|452987055|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125914391|NCT01604408|452987054|FG000|Treatment Period 2|Protocol Violation|1|||
125914392|NCT01604408|452987055|FG001|Treatment Period 2|Protocol Violation|0|||
125914393|NCT01604408|452987054|FG000|Treatment Period 2|Adverse Event|0|||
125914394|NCT01604408|452987055|FG001|Treatment Period 2|Adverse Event|1|||
125914395|NCT01604408|452987054|FG000|Treatment Period 3|Protocol Violation|1|||
125914396|NCT01604408|452987055|FG001|Treatment Period 3|Protocol Violation|1|||
125914397|NCT01604408|452987054|FG000|Treatment Period 3|Adverse Event|0|||
125914398|NCT01604408|452987055|FG001|Treatment Period 3|Adverse Event|3|||
125914399|NCT01604408|452987054|FG000|Treatment Period 3|Withdrawal by Subject|3|||
125914400|NCT01604408|452987055|FG001|Treatment Period 3|Withdrawal by Subject|1|||
125914401|NCT01604408|452987054|FG000|Treatment Period 3|Sponsor Decision|1|||
125914402|NCT01604408|452987055|FG001|Treatment Period 3|Sponsor Decision|0|||
125914403|NCT01604408|452987054|FG000|Treatment Period 4|Death|1|||
125914404|NCT01604408|452987055|FG001|Treatment Period 4|Death|0|||
125914405|NCT01604408|452987054|FG000|Treatment Period 4|Withdrawal by Subject|2|||
125914406|NCT01604408|452987055|FG001|Treatment Period 4|Withdrawal by Subject|1|||
125914407|NCT01604408|452987054|FG000|Treatment Period 4|Adverse Event|0|||
125914408|NCT01604408|452987055|FG001|Treatment Period 4|Adverse Event|1|||
125914409|NCT01604408|452987054|FG000|Treatment Period 5|Adverse Event|4|||
125914410|NCT01604408|452987055|FG001|Treatment Period 5|Adverse Event|0|||
125914411|NCT01604408|452987054|FG000|Treatment Period 6|Lost to Follow-up|0|||
125914412|NCT01604408|452987055|FG001|Treatment Period 6|Lost to Follow-up|1|||
125914413|NCT01604408|452987054|FG000|Treatment Period 6|Adverse Event|2|||
125914414|NCT01604408|452987055|FG001|Treatment Period 6|Adverse Event|0|||
125914415|NCT01604408|452987054|FG000|Treatment Period 6|Sponsor decision|0|||
125914416|NCT01604408|452987055|FG001|Treatment Period 6|Sponsor decision|1|||
125914417|NCT01604408|452987054|FG000|Observation Period|Adverse Event|1|||
125914418|NCT01604408|452987055|FG001|Observation Period|Adverse Event|1|||
125914419|NCT01604408|452987054|FG000|Observation Period|Withdrawal by Subject|0|||
125914420|NCT01604408|452987055|FG001|Observation Period|Withdrawal by Subject|2|||
125914421|NCT00722423|452987059|FG000|Overall Study|Protocol Violation|0|||
125914422|NCT00722423|452987060|FG001|Overall Study|Protocol Violation|1|||
125914423|NCT02410551|452987062|FG000|Overall Study|Adverse Event|1|||
125914424|NCT02410551|452987062|FG000|Overall Study|Withdrawal by Subject|1|||
125914425|NCT02410551|452987062|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
125914426|NCT01739309|452987063|FG000|Overall Study|Adverse Event|1|||
125914427|NCT01739309|452987063|FG000|Overall Study|Withdrawal by Subject|1|||
125914428|NCT00986830|452987064|FG000|Overall Study|Death|1|||
125914429|NCT00986830|452987064|FG000|Overall Study|Lost to Follow-up|1|||
125914430|NCT00986830|452987064|FG000|Overall Study|Lack of Efficacy|1|||
125914431|NCT00986830|452987064|FG000|Overall Study|Unable to access sinus with device|5|||
125914432|NCT01495975|452987065|FG000|Overall Study|Lost to Follow-up|1|||
125914433|NCT01495975|452987066|FG001|Overall Study|Lost to Follow-up|0|||
125914434|NCT05085730|452987069|FG000|Overall Study|Withdrawal by Subject|4|||
125914435|NCT05085730|452987069|FG000|Overall Study|Physician Decision|1|||
125914436|NCT05447897|452987070|FG000|Overall Study|Did not participate in survey|2|||
125914437|NCT01453725|452987071|FG000|Overall Study|Adverse Event|3|||
125914438|NCT01453725|452987072|FG001|Overall Study|Adverse Event|3|||
125914439|NCT01453725|452987071|FG000|Overall Study|Lost to Follow-up|4|||
125914440|NCT01453725|452987072|FG001|Overall Study|Lost to Follow-up|0|||
125914441|NCT01453725|452987071|FG000|Overall Study|Non-compliance With Protocol|1|||
125914442|NCT01453725|452987072|FG001|Overall Study|Non-compliance With Protocol|2|||
125914443|NCT01453725|452987071|FG000|Overall Study|Protocol Violation|1|||
125914444|NCT01453725|452987072|FG001|Overall Study|Protocol Violation|0|||
125914445|NCT01453725|452987071|FG000|Overall Study|Withdrawal by Subject|2|||
125914446|NCT01453725|452987072|FG001|Overall Study|Withdrawal by Subject|3|||
125914447|NCT01453725|452987071|FG000|Overall Study|Pregnancy Wish|0|||
125914448|NCT01453725|452987072|FG001|Overall Study|Pregnancy Wish|2|||
125914449|NCT01453725|452987071|FG000|Overall Study|Pregnancy|1|||
125914450|NCT01453725|452987072|FG001|Overall Study|Pregnancy|0|||
125914451|NCT01453725|452987071|FG000|Overall Study|Physician Decision|1|||
125914452|NCT01453725|452987072|FG001|Overall Study|Physician Decision|1|||
125914453|NCT03605212|452987073|FG000|Treatment Period|Adverse Event|1|||
126110331|NCT03808688|453699320|FG001|Overall Study|Medication Non-Compliance|1|||
125914454|NCT03605212|452987074|FG001|Treatment Period|Adverse Event|0|||
125914455|NCT03605212|452987075|FG002|Treatment Period|Adverse Event|0|||
125914456|NCT03605212|452987076|FG003|Treatment Period|Adverse Event|0|||
125914457|NCT03605212|452987077|FG004|Treatment Period|Adverse Event|0|||
125914458|NCT03605212|452987073|FG000|Treatment Period|Physician Decision|0|||
125914459|NCT03605212|452987074|FG001|Treatment Period|Physician Decision|0|||
125914460|NCT03605212|452987075|FG002|Treatment Period|Physician Decision|0|||
125914461|NCT03605212|452987076|FG003|Treatment Period|Physician Decision|0|||
125914462|NCT03605212|452987077|FG004|Treatment Period|Physician Decision|1|||
125914463|NCT01756053|452987078|FG000|Period 1 (10 Days)|Protocol Violation|1|||
125914464|NCT01756053|452987079|FG001|Period 1 (10 Days)|Protocol Violation|1|||
125914465|NCT01756053|452987078|FG000|Period 2 (10 Days)|Protocol Violation|0|||
125914466|NCT01756053|452987079|FG001|Period 2 (10 Days)|Protocol Violation|2|||
125914467|NCT01986140|452987080|FG000|Overall Study|Withdrawal by Subject|31|||
125914468|NCT01986140|452987081|FG001|Overall Study|Withdrawal by Subject|25|||
125914469|NCT01986140|452987080|FG000|Overall Study|alternative treatment|1|||
125914470|NCT01986140|452987081|FG001|Overall Study|alternative treatment|1|||
125914471|NCT01986140|452987080|FG000|Overall Study|found not eligible|3|||
125914472|NCT01986140|452987081|FG001|Overall Study|found not eligible|0|||
125914473|NCT01986140|452987080|FG000|Overall Study|Adverse Event|0|||
125914474|NCT01986140|452987081|FG001|Overall Study|Adverse Event|1|||
125914475|NCT01986140|452987080|FG000|Overall Study|progression disease|0|||
125914476|NCT01986140|452987081|FG001|Overall Study|progression disease|1|||
125914477|NCT01069627|452987088|FG000|Overall Study|Disease progression|7|||
125914478|NCT01069627|452987088|FG000|Overall Study|Adverse Event|12|||
125914479|NCT01069627|452987088|FG000|Overall Study|Protocol Violation|1|||
125914480|NCT00471146|452987089|FG000|Overall Study|Adverse Event|32|||
125914481|NCT00471146|452987090|FG001|Overall Study|Adverse Event|33|||
125914482|NCT00471146|452987089|FG000|Overall Study|Withdrawal by Subject|14|||
125914483|NCT00471146|452987090|FG001|Overall Study|Withdrawal by Subject|11|||
125914484|NCT00471146|452987089|FG000|Overall Study|Death|11|||
125914485|NCT00471146|452987090|FG001|Overall Study|Death|12|||
125914486|NCT00471146|452987089|FG000|Overall Study|Lost to Follow-up|4|||
125914487|NCT00471146|452987090|FG001|Overall Study|Lost to Follow-up|2|||
125914488|NCT00471146|452987089|FG000|Overall Study|Protocol Violation|2|||
125914489|NCT00471146|452987090|FG001|Overall Study|Protocol Violation|2|||
125914490|NCT00471146|452987089|FG000|Overall Study|Objective progression or relapse|84|||
125914491|NCT00471146|452987090|FG001|Overall Study|Objective progression or relapse|87|||
125914492|NCT00471146|452987089|FG000|Overall Study|Global deterioration of health status|12|||
125914493|NCT00471146|452987090|FG001|Overall Study|Global deterioration of health status|14|||
125914494|NCT00471146|452987089|FG000|Overall Study|Randomized but not treated|9|||
125914495|NCT00471146|452987090|FG001|Overall Study|Randomized but not treated|8|||
125914496|NCT00471146|452987089|FG000|Overall Study|Other|4|||
125914497|NCT00471146|452987090|FG001|Overall Study|Other|5|||
125914498|NCT05055128|452987091|FG000|Overall Study|Adverse Event|0|||
125914499|NCT05055128|452987092|FG001|Overall Study|Adverse Event|0|||
125914500|NCT05055128|452987093|FG002|Overall Study|Adverse Event|0|||
125914501|NCT05055128|452987094|FG003|Overall Study|Adverse Event|1|||
125914502|NCT05055128|452987095|FG004|Overall Study|Adverse Event|1|||
125914503|NCT05055128|452987091|FG000|Overall Study|Protocol Violation|0|||
125914504|NCT05055128|452987092|FG001|Overall Study|Protocol Violation|0|||
125914505|NCT05055128|452987093|FG002|Overall Study|Protocol Violation|0|||
125914506|NCT05055128|452987094|FG003|Overall Study|Protocol Violation|1|||
125914507|NCT05055128|452987095|FG004|Overall Study|Protocol Violation|0|||
125914508|NCT05055128|452987091|FG000|Overall Study|Withdrawal by Subject|5|||
125914509|NCT05055128|452987092|FG001|Overall Study|Withdrawal by Subject|2|||
125914510|NCT05055128|452987093|FG002|Overall Study|Withdrawal by Subject|2|||
125914511|NCT05055128|452987094|FG003|Overall Study|Withdrawal by Subject|4|||
125914512|NCT05055128|452987095|FG004|Overall Study|Withdrawal by Subject|2|||
125914513|NCT05055128|452987091|FG000|Overall Study|Randomized By Mistake|0|||
125914514|NCT05055128|452987092|FG001|Overall Study|Randomized By Mistake|1|||
125914515|NCT05055128|452987093|FG002|Overall Study|Randomized By Mistake|0|||
125914516|NCT05055128|452987094|FG003|Overall Study|Randomized By Mistake|0|||
125914517|NCT05055128|452987095|FG004|Overall Study|Randomized By Mistake|0|||
125914518|NCT05055128|452987091|FG000|Overall Study|Other|1|||
125914519|NCT05055128|452987092|FG001|Overall Study|Other|0|||
125914520|NCT05055128|452987093|FG002|Overall Study|Other|0|||
125914521|NCT05055128|452987094|FG003|Overall Study|Other|0|||
125914522|NCT05055128|452987095|FG004|Overall Study|Other|0|||
125914523|NCT01385371|452987096|FG000|Overall Study|Adverse Event|54|||
125914524|NCT01385371|452987097|FG001|Overall Study|Adverse Event|19|||
125914525|NCT01385371|452987096|FG000|Overall Study|Lost to Follow-up|16|||
125914526|NCT01385371|452987097|FG001|Overall Study|Lost to Follow-up|16|||
125914527|NCT01385371|452987096|FG000|Overall Study|Withdrawal by Subject|52|||
125914528|NCT01385371|452987097|FG001|Overall Study|Withdrawal by Subject|39|||
125914529|NCT01385371|452987096|FG000|Overall Study|Protocol Violation|25|||
125914530|NCT01385371|452987097|FG001|Overall Study|Protocol Violation|21|||
125914531|NCT01385371|452987096|FG000|Overall Study|Administrative|2|||
125914532|NCT01385371|452987097|FG001|Overall Study|Administrative|2|||
125914533|NCT00936611|452987098|FG000|Overall Study|Progressive Disease|3|||
125914534|NCT00936611|452987098|FG000|Overall Study|New Systemic Therapy|22|||
126062666|NCT02367794|453522034|FG002|Overall Study|Protocol Violation|1|||
125914535|NCT00936611|452987098|FG000|Overall Study|Lost to Follow-up|1|||
125914536|NCT00936611|452987098|FG000|Overall Study|Withdrawal by Subject|2|||
125914537|NCT00936611|452987098|FG000|Overall Study|Still on Follow-up|1|||
125914538|NCT00936611|452987098|FG000|Overall Study|Still on Active Therapy|7|||
125914539|NCT00936611|452987098|FG000|Overall Study|Ineligible for Study Drug|3|||
125914540|NCT02507973|452987099|FG000|Overall Study|Adverse Event|1|||
125914541|NCT00543543|452987100|FG000|Base Study|Adverse Event|1|||
125914542|NCT00543543|452987101|FG001|Base Study|Adverse Event|11|||
125914543|NCT00543543|452987102|FG002|Base Study|Adverse Event|0|||
125914544|NCT00543543|452987103|FG003|Base Study|Adverse Event|5|||
125914545|NCT00543543|452987100|FG000|Base Study|Lost to Follow-up|12|||
125914546|NCT00543543|452987101|FG001|Base Study|Lost to Follow-up|749|||
126062667|NCT02367794|453522032|FG000|Overall Study|Withdrawal by Subject|25|||
125914547|NCT00543543|452987102|FG002|Base Study|Lost to Follow-up|9|||
125914548|NCT00543543|452987103|FG003|Base Study|Lost to Follow-up|701|||
125914549|NCT00543543|452987100|FG000|Base Study|Physician Decision|0|||
125914550|NCT00543543|452987101|FG001|Base Study|Physician Decision|4|||
125914551|NCT00543543|452987102|FG002|Base Study|Physician Decision|0|||
125914552|NCT00543543|452987103|FG003|Base Study|Physician Decision|7|||
125914553|NCT00543543|452987100|FG000|Base Study|Protocol Violation|0|||
125914554|NCT00543543|452987101|FG001|Base Study|Protocol Violation|6|||
125914555|NCT00543543|452987102|FG002|Base Study|Protocol Violation|0|||
125914556|NCT00543543|452987103|FG003|Base Study|Protocol Violation|6|||
125914557|NCT00543543|452987100|FG000|Base Study|Withdrawal by Subject|7|||
125914558|NCT00543543|452987101|FG001|Base Study|Withdrawal by Subject|482|||
125914559|NCT00543543|452987102|FG002|Base Study|Withdrawal by Subject|5|||
125914560|NCT00543543|452987103|FG003|Base Study|Withdrawal by Subject|503|||
125914561|NCT00543543|452987100|FG000|Extension Study|Adverse Event|0|||
125914562|NCT00543543|452987101|FG001|Extension Study|Adverse Event|0|||
125914563|NCT00543543|452987102|FG002|Extension Study|Adverse Event|0|||
125914564|NCT00543543|452987103|FG003|Extension Study|Adverse Event|5|||
125914565|NCT00543543|452987100|FG000|Extension Study|Lost to Follow-up|0|||
125914566|NCT00543543|452987101|FG001|Extension Study|Lost to Follow-up|0|||
125914567|NCT00543543|452987102|FG002|Extension Study|Lost to Follow-up|0|||
125914568|NCT00543543|452987103|FG003|Extension Study|Lost to Follow-up|77|||
125914569|NCT00543543|452987100|FG000|Extension Study|Physician Decision|0|||
125914570|NCT00543543|452987101|FG001|Extension Study|Physician Decision|0|||
125914571|NCT00543543|452987102|FG002|Extension Study|Physician Decision|0|||
125914572|NCT00543543|452987103|FG003|Extension Study|Physician Decision|7|||
125914573|NCT00543543|452987100|FG000|Extension Study|Pregnancy|0|||
125914574|NCT00543543|452987101|FG001|Extension Study|Pregnancy|0|||
125914575|NCT00543543|452987102|FG002|Extension Study|Pregnancy|0|||
125914576|NCT00543543|452987103|FG003|Extension Study|Pregnancy|6|||
125914577|NCT00543543|452987100|FG000|Extension Study|Protocol Violation|0|||
125914578|NCT00543543|452987101|FG001|Extension Study|Protocol Violation|0|||
125914579|NCT00543543|452987102|FG002|Extension Study|Protocol Violation|0|||
125914580|NCT00543543|452987103|FG003|Extension Study|Protocol Violation|11|||
125914581|NCT00543543|452987100|FG000|Extension Study|Withdrawal by Subject|0|||
125914582|NCT00543543|452987101|FG001|Extension Study|Withdrawal by Subject|0|||
125914583|NCT00543543|452987102|FG002|Extension Study|Withdrawal by Subject|0|||
125914584|NCT00543543|452987103|FG003|Extension Study|Withdrawal by Subject|120|||
126062668|NCT02367794|453522033|FG001|Overall Study|Withdrawal by Subject|12|||
126062669|NCT02367794|453522034|FG002|Overall Study|Withdrawal by Subject|20|||
126062670|NCT02367794|453522032|FG000|Overall Study|Brain metastasis|1|||
126062671|NCT02367794|453522033|FG001|Overall Study|Brain metastasis|0|||
126062672|NCT02367794|453522034|FG002|Overall Study|Brain metastasis|0|||
126062673|NCT02367794|453522032|FG000|Overall Study|Randomized in error|0|||
126062674|NCT02367794|453522033|FG001|Overall Study|Randomized in error|0|||
126062675|NCT02367794|453522034|FG002|Overall Study|Randomized in error|1|||
126062676|NCT02367794|453522032|FG000|Overall Study|Patient unable to receive carboplatin|0|||
126062677|NCT02367794|453522033|FG001|Overall Study|Patient unable to receive carboplatin|0|||
126062678|NCT02367794|453522034|FG002|Overall Study|Patient unable to receive carboplatin|1|||
126062679|NCT02367794|453522032|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
126062680|NCT02367794|453522033|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
126062681|NCT02367794|453522034|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
126062682|NCT02367794|453522032|FG000|Overall Study|Adverse Event|0|||
126062683|NCT02367794|453522033|FG001|Overall Study|Adverse Event|0|||
126062684|NCT02367794|453522034|FG002|Overall Study|Adverse Event|2|||
126062685|NCT02367794|453522032|FG000|Overall Study|Study Terminated By Sponsor|0|||
126062686|NCT02367794|453522033|FG001|Overall Study|Study Terminated By Sponsor|1|||
126062687|NCT02367794|453522034|FG002|Overall Study|Study Terminated By Sponsor|1|||
125914585|NCT01346969|452987104|FG000|Overall Study|Withdrawal by Subject|0|||
126062688|NCT02367794|453522032|FG000|Overall Study|Moved to Roll-Over Study|0|||
126062689|NCT02367794|453522033|FG001|Overall Study|Moved to Roll-Over Study|15|||
126062690|NCT02367794|453522034|FG002|Overall Study|Moved to Roll-Over Study|13|||
125914586|NCT01346969|452987105|FG001|Overall Study|Withdrawal by Subject|0|||
125914587|NCT01346969|452987106|FG002|Overall Study|Withdrawal by Subject|1|||
125914588|NCT01346969|452987107|FG003|Overall Study|Withdrawal by Subject|0|||
125914589|NCT01346969|452987104|FG000|Overall Study|Lost to Follow-up|1|||
125914590|NCT01346969|452987105|FG001|Overall Study|Lost to Follow-up|0|||
125914591|NCT01346969|452987106|FG002|Overall Study|Lost to Follow-up|2|||
125914592|NCT01346969|452987107|FG003|Overall Study|Lost to Follow-up|0|||
125914593|NCT01346969|452987104|FG000|Overall Study|Physician Decision|0|||
126062691|NCT02367794|453522032|FG000|Overall Study|Sponsor Request|60|||
126062692|NCT02367794|453522033|FG001|Overall Study|Sponsor Request|57|||
126062693|NCT02367794|453522034|FG002|Overall Study|Sponsor Request|45|||
126062694|NCT02367794|453522032|FG000|Overall Study|Moved into PTAP Study|0|||
126062695|NCT02367794|453522033|FG001|Overall Study|Moved into PTAP Study|2|||
126062696|NCT02367794|453522034|FG002|Overall Study|Moved into PTAP Study|3|||
126062697|NCT02367794|453522032|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
126062698|NCT02367794|453522033|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
126062699|NCT02367794|453522034|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
126062700|NCT02367794|453522032|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
126062701|NCT02367794|453522033|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
126062702|NCT02367794|453522034|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
126062703|NCT02367794|453522032|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
126062704|NCT02367794|453522033|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
126110332|NCT03329196|453699321|FG000|Overall Study|Adverse Event|10|||
126110333|NCT03329196|453699322|FG001|Overall Study|Adverse Event|5|||
126110334|NCT03329196|453699321|FG000|Overall Study|Physician Decision|2|||
125914594|NCT01346969|452987105|FG001|Overall Study|Physician Decision|0|||
125914595|NCT01346969|452987106|FG002|Overall Study|Physician Decision|0|||
125914596|NCT01346969|452987107|FG003|Overall Study|Physician Decision|1|||
125914597|NCT01346969|452987104|FG000|Overall Study|Randomized but not treated|1|||
125914598|NCT01346969|452987105|FG001|Overall Study|Randomized but not treated|0|||
125914599|NCT01346969|452987106|FG002|Overall Study|Randomized but not treated|0|||
125914600|NCT01346969|452987107|FG003|Overall Study|Randomized but not treated|0|||
125914601|NCT00484094|452987108|FG000|Overall Study|Discontinued|39|||
125914602|NCT00484094|452987108|FG000|Overall Study|Other|3|||
125914603|NCT00586625|452987109|FG000|Overall Study|Adverse Event|6|||
125914604|NCT00586625|452987110|FG001|Overall Study|Adverse Event|6|||
125914605|NCT00586625|452987109|FG000|Overall Study|Protocol Violation|3|||
125914606|NCT00586625|452987110|FG001|Overall Study|Protocol Violation|0|||
125914607|NCT00586625|452987109|FG000|Overall Study|Withdrawal by Subject|32|||
125914608|NCT00586625|452987110|FG001|Overall Study|Withdrawal by Subject|10|||
125914609|NCT00586625|452987109|FG000|Overall Study|Subject non-compliance|0|||
125914610|NCT00586625|452987110|FG001|Overall Study|Subject non-compliance|1|||
125914611|NCT00586625|452987109|FG000|Overall Study|Subject unable to return for visit|2|||
125914612|NCT00586625|452987110|FG001|Overall Study|Subject unable to return for visit|0|||
125914613|NCT00165984|452987111|FG000|Overall Study|Death|15|||
125914614|NCT03553927|452987114|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
125914615|NCT03553927|452987115|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
125914616|NCT03553927|452987114|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
125914617|NCT03553927|452987115|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
125914618|NCT04176705|452987116|FG000|Overall Study|Withdrawal by Subject|4|||
125914619|NCT04176705|452987117|FG001|Overall Study|Withdrawal by Subject|4|||
125914620|NCT04176705|452987116|FG000|Overall Study|Death|1|||
125914621|NCT04176705|452987117|FG001|Overall Study|Death|1|||
125914622|NCT04176705|452987116|FG000|Overall Study|Lost to Follow-up|3|||
125914623|NCT04176705|452987117|FG001|Overall Study|Lost to Follow-up|3|||
125914624|NCT02423772|452987118|FG000|Overall Study|Lost to Follow-up|3|||
125914625|NCT02423772|452987119|FG001|Overall Study|Lost to Follow-up|3|||
125914626|NCT02423772|452987118|FG000|Overall Study|Did not begin intervention|2|||
125914627|NCT02423772|452987119|FG001|Overall Study|Did not begin intervention|5|||
125914628|NCT01193842|452987123|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
125914629|NCT01193842|452987124|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
125914630|NCT01193842|452987125|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
125914631|NCT01193842|452987126|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
125914632|NCT01193842|452987127|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
125914633|NCT01193842|452987123|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
125914634|NCT01193842|452987124|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
125914635|NCT01193842|452987125|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
125914636|NCT01193842|452987126|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
125914637|NCT01193842|452987127|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
125914638|NCT01193842|452987123|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
125914639|NCT01193842|452987124|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
125914640|NCT01193842|452987125|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
125914641|NCT01193842|452987126|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
125914642|NCT01193842|452987127|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
125914643|NCT01193842|452987123|FG000|Phase II: Randomized Groups|Death|0|||
125914644|NCT01193842|452987124|FG001|Phase II: Randomized Groups|Death|0|||
125914645|NCT01193842|452987125|FG002|Phase II: Randomized Groups|Death|0|||
125914646|NCT01193842|452987126|FG003|Phase II: Randomized Groups|Death|1|||
125914647|NCT01193842|452987127|FG004|Phase II: Randomized Groups|Death|1|||
125914648|NCT01193842|452987123|FG000|Phase II: Randomized Groups|Adverse Event|0|||
125914649|NCT01193842|452987124|FG001|Phase II: Randomized Groups|Adverse Event|0|||
125914650|NCT01193842|452987125|FG002|Phase II: Randomized Groups|Adverse Event|0|||
125914651|NCT01193842|452987126|FG003|Phase II: Randomized Groups|Adverse Event|5|||
125914652|NCT01193842|452987127|FG004|Phase II: Randomized Groups|Adverse Event|3|||
125914653|NCT01193842|452987123|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
125914654|NCT01193842|452987124|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
126110335|NCT03329196|453699322|FG001|Overall Study|Physician Decision|2|||
126110336|NCT03329196|453699321|FG000|Overall Study|Withdrawal by Subject|11|||
126110337|NCT03329196|453699322|FG001|Overall Study|Withdrawal by Subject|3|||
125914655|NCT01193842|452987125|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
125914656|NCT01193842|452987126|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
125914657|NCT01193842|452987127|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
125914658|NCT01193842|452987123|FG000|Phase II: Randomized Groups|Ineligible|0|||
125914659|NCT01193842|452987124|FG001|Phase II: Randomized Groups|Ineligible|0|||
125914660|NCT01193842|452987125|FG002|Phase II: Randomized Groups|Ineligible|0|||
125914661|NCT01193842|452987126|FG003|Phase II: Randomized Groups|Ineligible|0|||
125914662|NCT01193842|452987127|FG004|Phase II: Randomized Groups|Ineligible|1|||
125914663|NCT01193842|452987123|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
125914664|NCT01193842|452987124|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
126062705|NCT02367794|453522034|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
126062706|NCT02367794|453522032|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
126062707|NCT02367794|453522033|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
126062708|NCT02367794|453522034|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
126062709|NCT02942771|453522036|FG000|Overall Study|Adverse Event|1|||
126062710|NCT02942771|453522037|FG001|Overall Study|Adverse Event|0|||
126062711|NCT02942771|453522038|FG002|Overall Study|Adverse Event|0|||
126062712|NCT02942771|453522039|FG003|Overall Study|Adverse Event|0|||
126062713|NCT02942771|453522040|FG004|Overall Study|Adverse Event|2|||
125914665|NCT01193842|452987125|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
125914666|NCT01193842|452987126|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
125914667|NCT01193842|452987127|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
125914668|NCT03698331|452987128|FG000|Overall Study|Adverse Event|2|||
125914669|NCT03698331|452987129|FG001|Overall Study|Adverse Event|3|||
125914670|NCT03698331|452987128|FG000|Overall Study|Withdrawal by Subject|1|||
125914671|NCT03698331|452987129|FG001|Overall Study|Withdrawal by Subject|1|||
125914672|NCT03698331|452987128|FG000|Overall Study|Lost to Follow-up|0|||
125914673|NCT03698331|452987129|FG001|Overall Study|Lost to Follow-up|2|||
125914674|NCT03698331|452987128|FG000|Overall Study|Non-compliance with study drug|1|||
125914675|NCT03698331|452987129|FG001|Overall Study|Non-compliance with study drug|0|||
125914676|NCT01467583|452987131|FG000|Overall Study|Death|1|||
125914677|NCT01467583|452987132|FG001|Overall Study|Death|1|||
125914678|NCT01467583|452987133|FG002|Overall Study|Death|0|||
125914679|NCT01467583|452987131|FG000|Overall Study|Withdrawal by Subject|1|||
125914680|NCT01467583|452987132|FG001|Overall Study|Withdrawal by Subject|0|||
125914681|NCT01467583|452987133|FG002|Overall Study|Withdrawal by Subject|0|||
125914682|NCT01467583|452987131|FG000|Overall Study|Protocol Violation|0|||
125914683|NCT01467583|452987132|FG001|Overall Study|Protocol Violation|0|||
125914684|NCT01467583|452987133|FG002|Overall Study|Protocol Violation|2|||
125914685|NCT02130024|452987134|FG000|Overall Study|Adverse Event|10|||
125914686|NCT02130024|452987135|FG001|Overall Study|Adverse Event|11|||
125914687|NCT02130024|452987134|FG000|Overall Study|Death|2|||
125914688|NCT02130024|452987135|FG001|Overall Study|Death|2|||
126062714|NCT02942771|453522036|FG000|Overall Study|Lost to Follow-up|1|||
126062715|NCT02942771|453522037|FG001|Overall Study|Lost to Follow-up|0|||
125914689|NCT02130024|452987134|FG000|Overall Study|Lost to Follow-up|1|||
125914690|NCT02130024|452987135|FG001|Overall Study|Lost to Follow-up|1|||
125914691|NCT02130024|452987134|FG000|Overall Study|Physician Decision|1|||
125914692|NCT02130024|452987135|FG001|Overall Study|Physician Decision|3|||
125914693|NCT02130024|452987134|FG000|Overall Study|Protocol Deviation|4|||
125914694|NCT02130024|452987135|FG001|Overall Study|Protocol Deviation|0|||
126062716|NCT02942771|453522038|FG002|Overall Study|Lost to Follow-up|0|||
126062717|NCT02942771|453522039|FG003|Overall Study|Lost to Follow-up|0|||
126062718|NCT02942771|453522040|FG004|Overall Study|Lost to Follow-up|0|||
125914695|NCT02130024|452987134|FG000|Overall Study|Site Administration Problems|1|||
125914696|NCT02130024|452987135|FG001|Overall Study|Site Administration Problems|0|||
125914697|NCT02130024|452987134|FG000|Overall Study|Subject Withdrew Consent|6|||
125914698|NCT02130024|452987135|FG001|Overall Study|Subject Withdrew Consent|14|||
125914699|NCT05274165|452987139|FG000|Overall Study|Withdrawal by Subject|3|||
125914700|NCT05274165|452987140|FG001|Overall Study|Withdrawal by Subject|3|||
125914701|NCT02484690|452987141|FG000|Overall Study|Adverse Event|1|||
125914702|NCT02484690|452987142|FG001|Overall Study|Adverse Event|3|||
125914703|NCT02484690|452987143|FG002|Overall Study|Adverse Event|0|||
125914704|NCT02484690|452987144|FG003|Overall Study|Adverse Event|0|||
125914705|NCT02484690|452987145|FG004|Overall Study|Adverse Event|5|||
125914706|NCT02484690|452987141|FG000|Overall Study|Death|0|||
125914707|NCT02484690|452987142|FG001|Overall Study|Death|0|||
125914708|NCT02484690|452987143|FG002|Overall Study|Death|0|||
125914709|NCT02484690|452987144|FG003|Overall Study|Death|0|||
125914710|NCT02484690|452987145|FG004|Overall Study|Death|1|||
125914711|NCT02484690|452987141|FG000|Overall Study|Withdrawal by Subject|1|||
125914712|NCT02484690|452987142|FG001|Overall Study|Withdrawal by Subject|3|||
125914713|NCT02484690|452987143|FG002|Overall Study|Withdrawal by Subject|1|||
125914714|NCT02484690|452987144|FG003|Overall Study|Withdrawal by Subject|2|||
125914715|NCT02484690|452987145|FG004|Overall Study|Withdrawal by Subject|0|||
125914716|NCT02484690|452987141|FG000|Overall Study|Physician Decision|2|||
125914717|NCT02484690|452987142|FG001|Overall Study|Physician Decision|0|||
125914718|NCT02484690|452987143|FG002|Overall Study|Physician Decision|1|||
125914719|NCT02484690|452987144|FG003|Overall Study|Physician Decision|0|||
125914720|NCT02484690|452987145|FG004|Overall Study|Physician Decision|0|||
125914721|NCT02484690|452987141|FG000|Overall Study|Lost to Follow-up|0|||
125914722|NCT02484690|452987142|FG001|Overall Study|Lost to Follow-up|0|||
125914723|NCT02484690|452987143|FG002|Overall Study|Lost to Follow-up|1|||
125914724|NCT02484690|452987144|FG003|Overall Study|Lost to Follow-up|0|||
125914725|NCT02484690|452987145|FG004|Overall Study|Lost to Follow-up|0|||
125914726|NCT03360747|452987148|FG000|Overall Study|Voluntary Withdrawal|1|||
125914727|NCT01759511|452987149|FG000|Overall Study|Adverse Event|4|||
125914728|NCT01759511|452987149|FG000|Overall Study|Death|2|||
125914729|NCT01759511|452987149|FG000|Overall Study|Lack of Efficacy|2|||
125914730|NCT01759511|452987149|FG000|Overall Study|Physician Decision|1|||
125914731|NCT01759511|452987149|FG000|Overall Study|Progressive Disease|5|||
125914732|NCT01759511|452987149|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
125914733|NCT01759511|452987149|FG000|Overall Study|Study Terminated by Sponsor|13|||
125914734|NCT01759511|452987149|FG000|Overall Study|Withdrawal by Subject|3|||
125914735|NCT04916769|452987151|FG000|Period 1|Physician Decision|0|||
125914736|NCT04916769|452987152|FG001|Period 1|Physician Decision|0|||
125914737|NCT04916769|452987153|FG002|Period 1|Physician Decision|0|||
125914738|NCT04916769|452987154|FG003|Period 1|Physician Decision|0|||
125914739|NCT04916769|452987155|FG004|Period 1|Physician Decision|0|||
125914740|NCT04916769|452987156|FG005|Period 1|Physician Decision|1|||
125914741|NCT04916769|452987151|FG000|Period 2|Physician Decision|0|||
125914742|NCT04916769|452987152|FG001|Period 2|Physician Decision|1|||
125914743|NCT04916769|452987153|FG002|Period 2|Physician Decision|0|||
125914744|NCT04916769|452987154|FG003|Period 2|Physician Decision|0|||
125914745|NCT04916769|452987155|FG004|Period 2|Physician Decision|0|||
125914746|NCT04916769|452987156|FG005|Period 2|Physician Decision|0|||
125914747|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
125914748|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125914749|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125914750|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125914751|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125914752|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125914753|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125914754|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
125914755|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125914756|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125914757|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125914758|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125914759|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125914760|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125914761|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
125914762|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125914763|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
126062719|NCT02942771|453522036|FG000|Overall Study|Withdrawal by Subject|1|||
126062720|NCT02942771|453522037|FG001|Overall Study|Withdrawal by Subject|0|||
126062721|NCT02942771|453522038|FG002|Overall Study|Withdrawal by Subject|0|||
126062722|NCT02942771|453522039|FG003|Overall Study|Withdrawal by Subject|0|||
125914764|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125914765|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125914766|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125914767|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125914768|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
125914769|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125914770|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125914771|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125914772|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125914773|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125914774|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125914775|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
125914776|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125914777|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125914778|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125914779|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125914780|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125914781|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125914782|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
125914783|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125914784|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125914785|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125914786|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125914787|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125914788|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125914789|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
125914790|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125914791|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125914792|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125914793|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125914794|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125914795|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125914796|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
125914797|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125914798|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125914799|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125914800|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125914801|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125914802|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125914803|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
125914804|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125914805|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125914806|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
126062723|NCT02942771|453522040|FG004|Overall Study|Withdrawal by Subject|2|||
126062724|NCT01186809|453522041|FG000|Overall Study|Death|30|||
126062725|NCT01159600|453522043|FG000|Overall Study|Not treated|0|||
126062726|NCT01159600|453522044|FG001|Overall Study|Not treated|0|||
126062727|NCT01159600|453522045|FG002|Overall Study|Not treated|1|||
126110338|NCT03329196|453699321|FG000|Overall Study|Hepatic function abnormalities|0|||
126110339|NCT03329196|453699322|FG001|Overall Study|Hepatic function abnormalities|1|||
126110340|NCT03329196|453699321|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
126110341|NCT03329196|453699322|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
126110342|NCT03329196|453699321|FG000|Overall Study|Difficult to control Hb|2|||
126110343|NCT03329196|453699322|FG001|Overall Study|Difficult to control Hb|3|||
126110344|NCT03329196|453699321|FG000|Overall Study|Dialysis or renal transplant|13|||
126110345|NCT03329196|453699322|FG001|Overall Study|Dialysis or renal transplant|15|||
126110346|NCT01831544|453699325|FG000|Overall Study|Death|1|||
126110347|NCT01831544|453699325|FG000|Overall Study|Still on original MVAD device|2|||
126110348|NCT04175808|453699326|FG000|Part A|Miscellaneous|2|||
126110349|NCT04175808|453699327|FG001|Part A|Miscellaneous|0|||
126110350|NCT04175808|453699328|FG002|Part A|Miscellaneous|0|||
126110351|NCT04175808|453699329|FG003|Part A|Miscellaneous|0|||
126110352|NCT04175808|453699330|FG004|Part A|Miscellaneous|0|||
126110353|NCT04175808|453699331|FG005|Part A|Miscellaneous|0|||
126110354|NCT04175808|453699332|FG006|Part A|Miscellaneous|0|||
126062728|NCT01159600|453522046|FG003|Overall Study|Not treated|0|||
126062729|NCT01159600|453522047|FG004|Overall Study|Not treated|0|||
126062730|NCT01159600|453522048|FG005|Overall Study|Not treated|1|||
126062731|NCT01159600|453522049|FG006|Overall Study|Not treated|2|||
126062732|NCT01159600|453522050|FG007|Overall Study|Not treated|2|||
126062733|NCT01159600|453522043|FG000|Overall Study|Adverse Event|7|||
126062734|NCT01159600|453522044|FG001|Overall Study|Adverse Event|2|||
126062735|NCT01159600|453522045|FG002|Overall Study|Adverse Event|5|||
126062736|NCT01159600|453522046|FG003|Overall Study|Adverse Event|1|||
126062737|NCT01159600|453522047|FG004|Overall Study|Adverse Event|8|||
126062738|NCT01159600|453522048|FG005|Overall Study|Adverse Event|6|||
126062739|NCT01159600|453522049|FG006|Overall Study|Adverse Event|7|||
126062740|NCT01159600|453522050|FG007|Overall Study|Adverse Event|5|||
126062741|NCT01159600|453522043|FG000|Overall Study|Lack of Efficacy|0|||
126062742|NCT01159600|453522044|FG001|Overall Study|Lack of Efficacy|0|||
126062743|NCT01159600|453522045|FG002|Overall Study|Lack of Efficacy|0|||
126062744|NCT01159600|453522046|FG003|Overall Study|Lack of Efficacy|0|||
126062745|NCT01159600|453522047|FG004|Overall Study|Lack of Efficacy|2|||
126062746|NCT01159600|453522048|FG005|Overall Study|Lack of Efficacy|0|||
126062747|NCT01159600|453522049|FG006|Overall Study|Lack of Efficacy|0|||
125914807|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125914808|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125914809|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125914810|NCT04526509|452987169|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
125914811|NCT04526509|452987170|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125914812|NCT04526509|452987171|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125914813|NCT04526509|452987172|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125914814|NCT04526509|452987173|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125914815|NCT04526509|452987174|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125914816|NCT04526509|452987175|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125914817|NCT04526509|452987169|FG000|Enrolled|Study Terminated by Sponsor|0|||
125914818|NCT04526509|452987170|FG001|Enrolled|Study Terminated by Sponsor|0|||
125914819|NCT04526509|452987171|FG002|Enrolled|Study Terminated by Sponsor|0|||
126062748|NCT01159600|453522050|FG007|Overall Study|Lack of Efficacy|1|||
126062749|NCT01159600|453522043|FG000|Overall Study|Non compliant with protocol|2|||
126062750|NCT01159600|453522044|FG001|Overall Study|Non compliant with protocol|1|||
126062751|NCT01159600|453522045|FG002|Overall Study|Non compliant with protocol|0|||
126062752|NCT01159600|453522046|FG003|Overall Study|Non compliant with protocol|0|||
126062753|NCT01159600|453522047|FG004|Overall Study|Non compliant with protocol|2|||
126062754|NCT01159600|453522048|FG005|Overall Study|Non compliant with protocol|0|||
126062755|NCT01159600|453522049|FG006|Overall Study|Non compliant with protocol|2|||
126062756|NCT01159600|453522050|FG007|Overall Study|Non compliant with protocol|0|||
126062757|NCT01159600|453522043|FG000|Overall Study|Lost to Follow-up|2|||
126062758|NCT01159600|453522044|FG001|Overall Study|Lost to Follow-up|3|||
126062759|NCT01159600|453522045|FG002|Overall Study|Lost to Follow-up|4|||
126062760|NCT01159600|453522046|FG003|Overall Study|Lost to Follow-up|3|||
126062761|NCT01159600|453522047|FG004|Overall Study|Lost to Follow-up|3|||
126062762|NCT01159600|453522048|FG005|Overall Study|Lost to Follow-up|0|||
126062763|NCT01159600|453522049|FG006|Overall Study|Lost to Follow-up|3|||
126062764|NCT01159600|453522050|FG007|Overall Study|Lost to Follow-up|2|||
126110355|NCT04615247|453699333|FG000|Overall Study|Adverse Event|0|||
126110356|NCT04615247|453699334|FG001|Overall Study|Adverse Event|2|||
126110357|NCT04615247|453699333|FG000|Overall Study|Withdrawal by Subject|1|||
126110358|NCT04615247|453699334|FG001|Overall Study|Withdrawal by Subject|1|||
126062765|NCT01159600|453522043|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
126062766|NCT01159600|453522044|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
126062767|NCT01159600|453522045|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
126062768|NCT01159600|453522046|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
126062769|NCT01159600|453522047|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
126062770|NCT01159600|453522048|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
126062771|NCT01159600|453522049|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
126062772|NCT01159600|453522050|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
126062773|NCT01159600|453522043|FG000|Overall Study|Other reason not defined above|3|||
126062774|NCT01159600|453522044|FG001|Overall Study|Other reason not defined above|0|||
126062775|NCT01159600|453522045|FG002|Overall Study|Other reason not defined above|4|||
126062776|NCT01159600|453522046|FG003|Overall Study|Other reason not defined above|2|||
126062777|NCT01159600|453522047|FG004|Overall Study|Other reason not defined above|5|||
126062778|NCT01159600|453522048|FG005|Overall Study|Other reason not defined above|7|||
126062779|NCT01159600|453522049|FG006|Overall Study|Other reason not defined above|3|||
126062780|NCT01159600|453522050|FG007|Overall Study|Other reason not defined above|3|||
126062781|NCT04433091|453522051|FG000|Overall Study|Lost to Follow-up|1|||
126062782|NCT04433091|453522052|FG001|Overall Study|Lost to Follow-up|0|||
126062783|NCT04433091|453522051|FG000|Overall Study|Withdrawn .|2|||
126062784|NCT04433091|453522052|FG001|Overall Study|Withdrawn .|4|||
126062785|NCT01562275|453523682|FG000|Stage 1|Adverse Event|0|||
126062786|NCT01562275|453523683|FG001|Stage 1|Adverse Event|0|||
126062787|NCT01562275|453523684|FG002|Stage 1|Adverse Event|0|||
126062788|NCT01562275|453523685|FG003|Stage 1|Adverse Event|1|||
126062789|NCT01562275|453523686|FG004|Stage 1|Adverse Event|1|||
126062790|NCT01562275|453523687|FG005|Stage 1|Adverse Event|0|||
126062791|NCT01562275|453523688|FG006|Stage 1|Adverse Event|0|||
126062792|NCT01562275|453523689|FG007|Stage 1|Adverse Event|0|||
126062793|NCT01562275|453523690|FG008|Stage 1|Adverse Event|0|||
126062794|NCT01562275|453523691|FG009|Stage 1|Adverse Event|1|||
126062795|NCT01562275|453523692|FG010|Stage 1|Adverse Event|0|||
125914820|NCT04526509|452987172|FG003|Enrolled|Study Terminated by Sponsor|0|||
125914821|NCT04526509|452987173|FG004|Enrolled|Study Terminated by Sponsor|0|||
125914822|NCT04526509|452987174|FG005|Enrolled|Study Terminated by Sponsor|0|||
125914823|NCT04526509|452987175|FG006|Enrolled|Study Terminated by Sponsor|1|||
125914824|NCT04526509|452987169|FG000|Enrolled|Death prior to lymphodepletion|0|||
125914825|NCT04526509|452987170|FG001|Enrolled|Death prior to lymphodepletion|0|||
125914826|NCT04526509|452987171|FG002|Enrolled|Death prior to lymphodepletion|0|||
125914827|NCT04526509|452987172|FG003|Enrolled|Death prior to lymphodepletion|1|||
125914828|NCT04526509|452987173|FG004|Enrolled|Death prior to lymphodepletion|0|||
125914829|NCT04526509|452987174|FG005|Enrolled|Death prior to lymphodepletion|0|||
125914830|NCT04526509|452987175|FG006|Enrolled|Death prior to lymphodepletion|0|||
125914831|NCT04526509|452987169|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125914832|NCT04526509|452987170|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125914833|NCT04526509|452987171|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125914834|NCT04526509|452987172|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
125914835|NCT04526509|452987173|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125914836|NCT04526509|452987174|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125914837|NCT04526509|452987175|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125914838|NCT04526509|452987169|FG000|Enrolled|Physician Decision|0|||
125914839|NCT04526509|452987170|FG001|Enrolled|Physician Decision|1|||
125914840|NCT04526509|452987171|FG002|Enrolled|Physician Decision|0|||
125914841|NCT04526509|452987172|FG003|Enrolled|Physician Decision|0|||
125914842|NCT04526509|452987173|FG004|Enrolled|Physician Decision|0|||
125914843|NCT04526509|452987174|FG005|Enrolled|Physician Decision|0|||
125914844|NCT04526509|452987175|FG006|Enrolled|Physician Decision|0|||
125914845|NCT04340193|452987177|FG000|Overall Study|Other reason|0|||
125914846|NCT04340193|452987178|FG001|Overall Study|Other reason|0|||
125914847|NCT04340193|452987179|FG002|Overall Study|Other reason|1|||
125914848|NCT04340193|452987177|FG000|Overall Study|Disease recurrence|0|||
125914849|NCT04340193|452987178|FG001|Overall Study|Disease recurrence|1|||
125914850|NCT04340193|452987179|FG002|Overall Study|Disease recurrence|0|||
125914851|NCT04340193|452987177|FG000|Overall Study|Study drug toxicity|1|||
125914852|NCT04340193|452987178|FG001|Overall Study|Study drug toxicity|0|||
125914853|NCT04340193|452987179|FG002|Overall Study|Study drug toxicity|0|||
125914854|NCT04340193|452987177|FG000|Overall Study|Disease progression|1|||
125914855|NCT04340193|452987178|FG001|Overall Study|Disease progression|2|||
125914856|NCT04340193|452987179|FG002|Overall Study|Disease progression|3|||
125914857|NCT04340193|452987177|FG000|Overall Study|Administrative reasons by sponsor|0|||
125914858|NCT04340193|452987178|FG001|Overall Study|Administrative reasons by sponsor|1|||
125914859|NCT04340193|452987179|FG002|Overall Study|Administrative reasons by sponsor|0|||
125914860|NCT04340193|452987177|FG000|Overall Study|Adverse Event|1|||
125914861|NCT04340193|452987178|FG001|Overall Study|Adverse Event|1|||
125914862|NCT04340193|452987179|FG002|Overall Study|Adverse Event|0|||
125914863|NCT01386008|452987180|FG000|Overall Study|exited w/o incident /study discontinued|17|||
125914864|NCT01386008|452987180|FG000|Overall Study|Adverse Event|3|||
125914865|NCT03001882|452987181|FG000|Overall Study|Death|1|||
126062796|NCT01562275|453523693|FG011|Stage 1|Adverse Event|0|||
126062797|NCT01562275|453523694|FG012|Stage 1|Adverse Event|0|||
125914866|NCT03001882|452987182|FG001|Overall Study|Death|0|||
126062798|NCT01562275|453523682|FG000|Stage 1|Death|1|||
126062799|NCT01562275|453523683|FG001|Stage 1|Death|0|||
126062800|NCT01562275|453523684|FG002|Stage 1|Death|0|||
126062801|NCT01562275|453523685|FG003|Stage 1|Death|0|||
126062802|NCT01562275|453523686|FG004|Stage 1|Death|0|||
126062803|NCT01562275|453523687|FG005|Stage 1|Death|0|||
125914867|NCT03001882|452987183|FG002|Overall Study|Death|0|||
125914868|NCT03001882|452987184|FG003|Overall Study|Death|3|||
125914869|NCT03001882|452987181|FG000|Overall Study|Participant withdrew consent|0|||
125914870|NCT03001882|452987182|FG001|Overall Study|Participant withdrew consent|1|||
125914871|NCT03001882|452987183|FG002|Overall Study|Participant withdrew consent|0|||
125914872|NCT03001882|452987184|FG003|Overall Study|Participant withdrew consent|5|||
125914873|NCT03001882|452987181|FG000|Overall Study|Other reasons|1|||
125914874|NCT03001882|452987182|FG001|Overall Study|Other reasons|2|||
125914875|NCT03001882|452987183|FG002|Overall Study|Other reasons|0|||
125914876|NCT03001882|452987184|FG003|Overall Study|Other reasons|5|||
125914877|NCT03001882|452987181|FG000|Overall Study|Administrative reason by sponsor|0|||
125914878|NCT03001882|452987182|FG001|Overall Study|Administrative reason by sponsor|0|||
125914879|NCT03001882|452987183|FG002|Overall Study|Administrative reason by sponsor|0|||
125914880|NCT03001882|452987184|FG003|Overall Study|Administrative reason by sponsor|1|||
125914881|NCT03001882|452987181|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
125914882|NCT03001882|452987182|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
125914883|NCT03001882|452987183|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
125914884|NCT03001882|452987184|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
125914885|NCT03001882|452987181|FG000|Overall Study|Not reported|0|||
125914886|NCT03001882|452987182|FG001|Overall Study|Not reported|0|||
125914887|NCT03001882|452987183|FG002|Overall Study|Not reported|0|||
125914888|NCT03001882|452987184|FG003|Overall Study|Not reported|6|||
125914889|NCT03001882|452987181|FG000|Overall Study|Maximum clinical benefit|2|||
125914890|NCT03001882|452987182|FG001|Overall Study|Maximum clinical benefit|3|||
125914891|NCT03001882|452987183|FG002|Overall Study|Maximum clinical benefit|0|||
125914892|NCT03001882|452987184|FG003|Overall Study|Maximum clinical benefit|10|||
125914893|NCT03001882|452987181|FG000|Overall Study|AE unrelated to study drug|3|||
125914894|NCT03001882|452987182|FG001|Overall Study|AE unrelated to study drug|3|||
125914895|NCT03001882|452987183|FG002|Overall Study|AE unrelated to study drug|0|||
125914896|NCT03001882|452987184|FG003|Overall Study|AE unrelated to study drug|11|||
125914897|NCT03001882|452987181|FG000|Overall Study|Study Drug Toxicity|8|||
125914898|NCT03001882|452987182|FG001|Overall Study|Study Drug Toxicity|5|||
125914899|NCT03001882|452987183|FG002|Overall Study|Study Drug Toxicity|0|||
125914900|NCT03001882|452987184|FG003|Overall Study|Study Drug Toxicity|37|||
125914901|NCT03001882|452987181|FG000|Overall Study|Disease progression|16|||
125914902|NCT03001882|452987182|FG001|Overall Study|Disease progression|14|||
126062804|NCT01562275|453523688|FG006|Stage 1|Death|0|||
126062805|NCT01562275|453523689|FG007|Stage 1|Death|0|||
125914903|NCT03001882|452987183|FG002|Overall Study|Disease progression|1|||
125914904|NCT03001882|452987184|FG003|Overall Study|Disease progression|90|||
125914905|NCT00589290|452987185|FG000|Overall Study|Withdrawal by Subject|1|||
125914906|NCT04449861|452987186|FG000|Overall Study|Withdrawal by Subject|4|||
125914907|NCT04449861|452987186|FG000|Overall Study|Lost to Follow-up|5|||
125914908|NCT04449861|452987186|FG000|Overall Study|Death|112|||
125914909|NCT00976677|452987187|FG000|Overall Study|Adverse Event|1|||
125914910|NCT00976677|452987188|FG001|Overall Study|Adverse Event|0|||
125914911|NCT00976677|452987187|FG000|Overall Study|Withdrawal by Subject|0|||
125914912|NCT00976677|452987188|FG001|Overall Study|Withdrawal by Subject|2|||
125914913|NCT00976677|452987187|FG000|Overall Study|Disease progression|1|||
125914914|NCT00976677|452987188|FG001|Overall Study|Disease progression|1|||
125914915|NCT00976677|452987187|FG000|Overall Study|Trial unblinded|2|||
125914916|NCT00976677|452987188|FG001|Overall Study|Trial unblinded|2|||
125914917|NCT00976677|452987187|FG000|Overall Study|Unknown/Missing|1|||
125914918|NCT00976677|452987188|FG001|Overall Study|Unknown/Missing|0|||
125914919|NCT03507400|452987189|FG000|Overall Study|discontinued|5|||
125914920|NCT03507400|452987190|FG001|Overall Study|discontinued|1|||
125914921|NCT03507400|452987189|FG000|Overall Study|Lost to Follow-up|8|||
125914922|NCT03507400|452987190|FG001|Overall Study|Lost to Follow-up|6|||
125914923|NCT03507400|452987189|FG000|Overall Study|Protocol Violation|0|||
125914924|NCT03507400|452987190|FG001|Overall Study|Protocol Violation|1|||
125914925|NCT01555983|452987191|FG000|Overall Study|Withdrawal by Subject|1|||
125914926|NCT01555983|452987192|FG001|Overall Study|Withdrawal by Subject|0|||
125914927|NCT01555983|452987193|FG002|Overall Study|Withdrawal by Subject|0|||
125914928|NCT01555983|452987194|FG003|Overall Study|Withdrawal by Subject|0|||
125914929|NCT01555983|452987195|FG004|Overall Study|Withdrawal by Subject|1|||
126062806|NCT01562275|453523690|FG008|Stage 1|Death|0|||
126062807|NCT01562275|453523691|FG009|Stage 1|Death|0|||
126062808|NCT01562275|453523692|FG010|Stage 1|Death|0|||
126062809|NCT01562275|453523693|FG011|Stage 1|Death|0|||
126062810|NCT01562275|453523694|FG012|Stage 1|Death|0|||
126062811|NCT01562275|453523682|FG000|Stage 1|Non Compliance|0|||
126062812|NCT01562275|453523683|FG001|Stage 1|Non Compliance|0|||
126062813|NCT01562275|453523684|FG002|Stage 1|Non Compliance|1|||
126062814|NCT01562275|453523685|FG003|Stage 1|Non Compliance|0|||
126062815|NCT01562275|453523686|FG004|Stage 1|Non Compliance|0|||
126062816|NCT01562275|453523687|FG005|Stage 1|Non Compliance|0|||
126062817|NCT01562275|453523688|FG006|Stage 1|Non Compliance|0|||
126062818|NCT01562275|453523689|FG007|Stage 1|Non Compliance|0|||
126062819|NCT01562275|453523690|FG008|Stage 1|Non Compliance|0|||
126062820|NCT01562275|453523691|FG009|Stage 1|Non Compliance|0|||
126062821|NCT01562275|453523692|FG010|Stage 1|Non Compliance|0|||
126062822|NCT01562275|453523693|FG011|Stage 1|Non Compliance|0|||
126062823|NCT01562275|453523694|FG012|Stage 1|Non Compliance|0|||
126062824|NCT01562275|453523682|FG000|Stage 1|Physician Decision|0|||
126062825|NCT01562275|453523683|FG001|Stage 1|Physician Decision|0|||
126062826|NCT01562275|453523684|FG002|Stage 1|Physician Decision|0|||
126062827|NCT01562275|453523685|FG003|Stage 1|Physician Decision|0|||
126062828|NCT01562275|453523686|FG004|Stage 1|Physician Decision|1|||
126062829|NCT01562275|453523687|FG005|Stage 1|Physician Decision|0|||
126062830|NCT01562275|453523688|FG006|Stage 1|Physician Decision|1|||
126062831|NCT01562275|453523689|FG007|Stage 1|Physician Decision|0|||
125914930|NCT01555983|452987196|FG005|Overall Study|Withdrawal by Subject|1|||
125914931|NCT00108433|452988683|FG000|Overall Study|Lack of Efficacy|1|||
125914932|NCT00108433|452988684|FG001|Overall Study|Lack of Efficacy|2|||
125914933|NCT00108433|452988683|FG000|Overall Study|Death|3|||
126062832|NCT01562275|453523690|FG008|Stage 1|Physician Decision|1|||
126062833|NCT01562275|453523691|FG009|Stage 1|Physician Decision|0|||
126062834|NCT01562275|453523692|FG010|Stage 1|Physician Decision|0|||
126062835|NCT01562275|453523693|FG011|Stage 1|Physician Decision|0|||
126062836|NCT01562275|453523694|FG012|Stage 1|Physician Decision|0|||
126062837|NCT01562275|453523682|FG000|Stage 1|Progression of Disease|2|||
126062838|NCT01562275|453523683|FG001|Stage 1|Progression of Disease|6|||
125914934|NCT00108433|452988684|FG001|Overall Study|Death|0|||
125914935|NCT00108433|452988683|FG000|Overall Study|Adverse Event|3|||
126062839|NCT01562275|453523684|FG002|Stage 1|Progression of Disease|2|||
125914936|NCT00108433|452988684|FG001|Overall Study|Adverse Event|1|||
126062840|NCT01562275|453523685|FG003|Stage 1|Progression of Disease|1|||
126062841|NCT01562275|453523686|FG004|Stage 1|Progression of Disease|2|||
126062842|NCT01562275|453523687|FG005|Stage 1|Progression of Disease|4|||
126062843|NCT01562275|453523688|FG006|Stage 1|Progression of Disease|1|||
126062844|NCT01562275|453523689|FG007|Stage 1|Progression of Disease|7|||
126062845|NCT01562275|453523690|FG008|Stage 1|Progression of Disease|2|||
126062846|NCT01562275|453523691|FG009|Stage 1|Progression of Disease|5|||
126062847|NCT01562275|453523692|FG010|Stage 1|Progression of Disease|3|||
126062848|NCT01562275|453523693|FG011|Stage 1|Progression of Disease|0|||
126062849|NCT01562275|453523694|FG012|Stage 1|Progression of Disease|0|||
126062850|NCT01562275|453523682|FG000|Stage 1|Withdrawal by Subject|0|||
126062851|NCT01562275|453523683|FG001|Stage 1|Withdrawal by Subject|1|||
126062852|NCT01562275|453523684|FG002|Stage 1|Withdrawal by Subject|0|||
126062853|NCT01562275|453523685|FG003|Stage 1|Withdrawal by Subject|2|||
126062854|NCT01562275|453523686|FG004|Stage 1|Withdrawal by Subject|0|||
126062855|NCT01562275|453523687|FG005|Stage 1|Withdrawal by Subject|0|||
126062856|NCT01562275|453523688|FG006|Stage 1|Withdrawal by Subject|1|||
126062857|NCT01562275|453523689|FG007|Stage 1|Withdrawal by Subject|0|||
126062858|NCT01562275|453523690|FG008|Stage 1|Withdrawal by Subject|0|||
126062859|NCT01562275|453523691|FG009|Stage 1|Withdrawal by Subject|1|||
126062860|NCT01562275|453523692|FG010|Stage 1|Withdrawal by Subject|0|||
126062861|NCT01562275|453523693|FG011|Stage 1|Withdrawal by Subject|0|||
126062862|NCT01562275|453523694|FG012|Stage 1|Withdrawal by Subject|0|||
126062863|NCT01562275|453523682|FG000|Stage 2|Death|0|||
126062864|NCT01562275|453523683|FG001|Stage 2|Death|0|||
126062865|NCT01562275|453523684|FG002|Stage 2|Death|0|||
126062866|NCT01562275|453523685|FG003|Stage 2|Death|0|||
126062867|NCT01562275|453523686|FG004|Stage 2|Death|0|||
126062868|NCT01562275|453523687|FG005|Stage 2|Death|0|||
126062869|NCT01562275|453523688|FG006|Stage 2|Death|0|||
126062870|NCT01562275|453523689|FG007|Stage 2|Death|0|||
126062871|NCT01562275|453523690|FG008|Stage 2|Death|0|||
126062872|NCT01562275|453523691|FG009|Stage 2|Death|0|||
126062873|NCT01562275|453523692|FG010|Stage 2|Death|0|||
126062874|NCT01562275|453523693|FG011|Stage 2|Death|2|||
126062875|NCT01562275|453523694|FG012|Stage 2|Death|1|||
126062876|NCT01562275|453523682|FG000|Stage 2|Progression of Disease|0|||
126062877|NCT01562275|453523683|FG001|Stage 2|Progression of Disease|0|||
126062878|NCT01562275|453523684|FG002|Stage 2|Progression of Disease|0|||
126062879|NCT01562275|453523685|FG003|Stage 2|Progression of Disease|0|||
126062880|NCT01562275|453523686|FG004|Stage 2|Progression of Disease|0|||
126062881|NCT01562275|453523687|FG005|Stage 2|Progression of Disease|0|||
126062882|NCT01562275|453523688|FG006|Stage 2|Progression of Disease|0|||
126062883|NCT01562275|453523689|FG007|Stage 2|Progression of Disease|0|||
126062884|NCT01562275|453523690|FG008|Stage 2|Progression of Disease|0|||
126062885|NCT01562275|453523691|FG009|Stage 2|Progression of Disease|0|||
126062886|NCT01562275|453523692|FG010|Stage 2|Progression of Disease|0|||
126062887|NCT01562275|453523693|FG011|Stage 2|Progression of Disease|12|||
126062888|NCT01562275|453523694|FG012|Stage 2|Progression of Disease|4|||
126062889|NCT01863368|453523695|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
126062890|NCT01863368|453523696|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
126062891|NCT01863368|453523695|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
126062892|NCT01863368|453523696|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
126062893|NCT01863368|453523695|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
126062894|NCT01863368|453523696|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
126062895|NCT01863368|453523695|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
126062896|NCT01863368|453523696|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
126062897|NCT01863368|453523695|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
126062898|NCT01863368|453523696|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
126062899|NCT01863368|453523695|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
126062900|NCT01863368|453523696|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
126062901|NCT03761849|453523699|FG000|Overall Study|transferred to OpenLabelExtension|35|||
126062902|NCT03761849|453523700|FG001|Overall Study|transferred to OpenLabelExtension|34|||
126062903|NCT03761849|453523701|FG002|Overall Study|transferred to OpenLabelExtension|36|||
126062904|NCT03761849|453523702|FG003|Overall Study|transferred to OpenLabelExtension|0|||
126062905|NCT03761849|453523703|FG004|Overall Study|transferred to OpenLabelExtension|0|||
126062906|NCT03761849|453523704|FG005|Overall Study|transferred to OpenLabelExtension|0|||
126062907|NCT03761849|453523699|FG000|Overall Study|Adverse Event|1|||
126062908|NCT03761849|453523700|FG001|Overall Study|Adverse Event|0|||
126062909|NCT03761849|453523701|FG002|Overall Study|Adverse Event|0|||
125914937|NCT00108433|452988683|FG000|Overall Study|Other|14|||
125914938|NCT00108433|452988684|FG001|Overall Study|Other|14|||
125914939|NCT04195906|452988685|FG000|Part 1|Adverse Event|3|||
125914940|NCT04195906|452988686|FG001|Part 1|Adverse Event|7|||
125914941|NCT04195906|452988685|FG000|Part 1|Withdrawal by Subject|0|||
125914942|NCT04195906|452988686|FG001|Part 1|Withdrawal by Subject|1|||
125914943|NCT04195906|452988685|FG000|Part 2|Adverse Event|1|||
125914944|NCT04195906|452988686|FG001|Part 2|Adverse Event|1|||
125914945|NCT04195906|452988685|FG000|Part 2|Withdrawal by Subject|0|||
125914946|NCT04195906|452988686|FG001|Part 2|Withdrawal by Subject|3|||
125914947|NCT04195906|452988685|FG000|Part 2|Other|1|||
125914948|NCT04195906|452988686|FG001|Part 2|Other|3|||
125914949|NCT00371826|452988692|FG000|Core Phase (12 Months)|Adverse Event|15|||
125914950|NCT00371826|452988693|FG001|Core Phase (12 Months)|Adverse Event|4|||
125914951|NCT00371826|452988694|FG002|Core Phase (12 Months)|Adverse Event|9|||
125914952|NCT00371826|452988692|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
125914953|NCT00371826|452988693|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
125914954|NCT00371826|452988694|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
125914955|NCT00371826|452988692|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
125914956|NCT00371826|452988693|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
125914957|NCT00371826|452988694|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
125914958|NCT00371826|452988692|FG000|Core Phase (12 Months)|Protocol Violation|1|||
125914959|NCT00371826|452988693|FG001|Core Phase (12 Months)|Protocol Violation|0|||
125914960|NCT00371826|452988694|FG002|Core Phase (12 Months)|Protocol Violation|1|||
125914961|NCT00371826|452988692|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
125914962|NCT00371826|452988693|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
125914963|NCT00371826|452988694|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
125914964|NCT00371826|452988692|FG000|Core Phase (12 Months)|Administrative problems|1|||
125914965|NCT00371826|452988693|FG001|Core Phase (12 Months)|Administrative problems|0|||
125914966|NCT00371826|452988694|FG002|Core Phase (12 Months)|Administrative problems|8|||
125914967|NCT00371826|452988692|FG000|Core Phase (12 Months)|Graft Loss|0|||
125914968|NCT00371826|452988693|FG001|Core Phase (12 Months)|Graft Loss|1|||
125914969|NCT00371826|452988694|FG002|Core Phase (12 Months)|Graft Loss|0|||
125914970|NCT00371826|452988692|FG000|Extension Phase (24 Months)|Adverse Event|4|||
125914971|NCT00371826|452988693|FG001|Extension Phase (24 Months)|Adverse Event|5|||
125914972|NCT00371826|452988694|FG002|Extension Phase (24 Months)|Adverse Event|0|||
125914973|NCT00371826|452988692|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
125914974|NCT00371826|452988693|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
126062910|NCT03761849|453523702|FG003|Overall Study|Adverse Event|0|||
125914975|NCT00371826|452988694|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
125914976|NCT00371826|452988692|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
125914977|NCT00371826|452988693|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
125914978|NCT00371826|452988694|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
125914979|NCT00371826|452988692|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
125914980|NCT00371826|452988693|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
125914981|NCT00371826|452988694|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
125914982|NCT00371826|452988692|FG000|Extension Phase (24 Months)|Administrative problems|0|||
125914983|NCT00371826|452988693|FG001|Extension Phase (24 Months)|Administrative problems|0|||
125914984|NCT00371826|452988694|FG002|Extension Phase (24 Months)|Administrative problems|2|||
125914985|NCT00428792|452988697|FG000|Overall Study|Lack of Efficacy|1|||
125914986|NCT00428792|452988698|FG001|Overall Study|Lack of Efficacy|3|||
125914987|NCT00428792|452988697|FG000|Overall Study|Lost to Follow-up|0|||
125914988|NCT00428792|452988698|FG001|Overall Study|Lost to Follow-up|1|||
125914989|NCT03270644|452988702|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
125914990|NCT03270644|452988702|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
125914991|NCT00615108|452988704|FG000|Overall Study|Adverse Event|122|||
125914992|NCT00615108|452988704|FG000|Overall Study|Other|370|||
125914993|NCT00615108|452988704|FG000|Overall Study|Lost to Follow-up|15|||
125914994|NCT00354614|452988705|FG000|Overall Study|Lack of Efficacy|28|||
125914995|NCT01500031|452988706|FG000|Overall Study|Death|1|||
125914996|NCT01500031|452988706|FG000|Overall Study|Withdrawal by Subject|4|||
125914997|NCT00917501|452988708|FG000|Overall Study|Lost to Follow-up|4|||
125914998|NCT00917501|452988709|FG001|Overall Study|Lost to Follow-up|1|||
125914999|NCT00917501|452988708|FG000|Overall Study|Withdrawal by Subject|3|||
125915000|NCT00917501|452988709|FG001|Overall Study|Withdrawal by Subject|1|||
125915001|NCT00917501|452988708|FG000|Overall Study|Lack of Efficacy|1|||
125915002|NCT00917501|452988709|FG001|Overall Study|Lack of Efficacy|2|||
125915003|NCT00917501|452988708|FG000|Overall Study|trouble swollowing capsules|0|||
125915004|NCT00917501|452988709|FG001|Overall Study|trouble swollowing capsules|1|||
125915005|NCT05095454|452988710|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
125915006|NCT05095454|452988711|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
125915007|NCT01393301|452988712|FG000|Overall Study|Lost to Follow-up|5|||
125915008|NCT01393301|452988713|FG001|Overall Study|Lost to Follow-up|3|||
125915009|NCT01393301|452988712|FG000|Overall Study|Withdrawal by Subject|2|||
125915010|NCT01393301|452988713|FG001|Overall Study|Withdrawal by Subject|0|||
125915011|NCT01393301|452988712|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
125915012|NCT01393301|452988713|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
125915013|NCT00853073|452988714|FG000|Overall Study|Withdrawal by Subject|3|||
125915014|NCT00853073|452988715|FG001|Overall Study|Withdrawal by Subject|2|||
125915015|NCT02758171|452988716|FG000|Wash-out|Withdrawal by Subject|1|||
125915016|NCT02758171|452988717|FG001|Wash-out|Withdrawal by Subject|0|||
125915017|NCT02758171|452988716|FG000|Wash-out|Other reason|1|||
125915018|NCT02758171|452988717|FG001|Wash-out|Other reason|0|||
125915019|NCT01999114|452988718|FG000|Overall Study|Adverse Event|8|||
125915020|NCT01999114|452988719|FG001|Overall Study|Adverse Event|7|||
125915021|NCT01999114|452988720|FG002|Overall Study|Adverse Event|2|||
125915022|NCT01999114|452988721|FG003|Overall Study|Adverse Event|2|||
125915023|NCT01999114|452988722|FG004|Overall Study|Adverse Event|1|||
125915024|NCT01999114|452988718|FG000|Overall Study|Withdrawal by Subject|0|||
125915025|NCT01999114|452988719|FG001|Overall Study|Withdrawal by Subject|0|||
125915026|NCT01999114|452988720|FG002|Overall Study|Withdrawal by Subject|1|||
125915027|NCT01999114|452988721|FG003|Overall Study|Withdrawal by Subject|0|||
125915028|NCT01999114|452988722|FG004|Overall Study|Withdrawal by Subject|1|||
126062911|NCT03761849|453523703|FG004|Overall Study|Adverse Event|2|||
126062912|NCT03761849|453523704|FG005|Overall Study|Adverse Event|3|||
126062913|NCT03761849|453523699|FG000|Overall Study|Withdrawal by Subject|0|||
126062914|NCT03761849|453523700|FG001|Overall Study|Withdrawal by Subject|0|||
126062915|NCT03761849|453523701|FG002|Overall Study|Withdrawal by Subject|0|||
126062916|NCT03761849|453523702|FG003|Overall Study|Withdrawal by Subject|41|||
126062917|NCT03761849|453523703|FG004|Overall Study|Withdrawal by Subject|43|||
126062918|NCT03761849|453523704|FG005|Overall Study|Withdrawal by Subject|35|||
126062919|NCT03761849|453523699|FG000|Overall Study|Lost to Follow-up|0|||
126062920|NCT03761849|453523700|FG001|Overall Study|Lost to Follow-up|1|||
126062921|NCT03761849|453523701|FG002|Overall Study|Lost to Follow-up|0|||
126062922|NCT03761849|453523702|FG003|Overall Study|Lost to Follow-up|2|||
126062923|NCT03761849|453523703|FG004|Overall Study|Lost to Follow-up|4|||
126062924|NCT03761849|453523704|FG005|Overall Study|Lost to Follow-up|5|||
126062925|NCT03761849|453523699|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
126062926|NCT03761849|453523700|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
126062927|NCT03761849|453523701|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
126062928|NCT03761849|453523702|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
126062929|NCT03761849|453523703|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
126062930|NCT03761849|453523704|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
125915029|NCT01999114|452988718|FG000|Overall Study|Lost to Follow-up|0|||
125915030|NCT01999114|452988719|FG001|Overall Study|Lost to Follow-up|0|||
125915031|NCT01999114|452988720|FG002|Overall Study|Lost to Follow-up|1|||
125915032|NCT01999114|452988721|FG003|Overall Study|Lost to Follow-up|0|||
125915033|NCT01999114|452988722|FG004|Overall Study|Lost to Follow-up|0|||
125915034|NCT01999114|452988718|FG000|Overall Study|Administrative|0|||
125915035|NCT01999114|452988719|FG001|Overall Study|Administrative|0|||
125915036|NCT01999114|452988720|FG002|Overall Study|Administrative|1|||
125915037|NCT01999114|452988721|FG003|Overall Study|Administrative|1|||
125915038|NCT01999114|452988722|FG004|Overall Study|Administrative|2|||
125915039|NCT03643575|452988723|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
125915040|NCT03643575|452988724|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
125915041|NCT03643575|452988725|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
125915042|NCT03643575|452988726|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
125915043|NCT03643575|452988727|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
125915044|NCT03643575|452988728|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
125915045|NCT03643575|452988723|FG000|Washout: 7 Days|Adverse Event|1|||
125915046|NCT03643575|452988724|FG001|Washout: 7 Days|Adverse Event|0|||
125915047|NCT03643575|452988725|FG002|Washout: 7 Days|Adverse Event|0|||
125915048|NCT03643575|452988726|FG003|Washout: 7 Days|Adverse Event|0|||
125915049|NCT03643575|452988727|FG004|Washout: 7 Days|Adverse Event|0|||
125915050|NCT03643575|452988728|FG005|Washout: 7 Days|Adverse Event|0|||
125915051|NCT03643575|452988723|FG000|Washout: 7 Days|Non compliance check in|0|||
125915052|NCT03643575|452988724|FG001|Washout: 7 Days|Non compliance check in|1|||
125915053|NCT03643575|452988725|FG002|Washout: 7 Days|Non compliance check in|0|||
125915054|NCT03643575|452988726|FG003|Washout: 7 Days|Non compliance check in|0|||
125915055|NCT03643575|452988727|FG004|Washout: 7 Days|Non compliance check in|0|||
125915056|NCT03643575|452988728|FG005|Washout: 7 Days|Non compliance check in|0|||
125915057|NCT01309165|452988729|FG000|Overall Study|Lost to Follow-up|4|||
126062931|NCT03761849|453523699|FG000|Overall Study|Physician Decision|0|||
126062932|NCT03761849|453523700|FG001|Overall Study|Physician Decision|0|||
126062933|NCT03761849|453523701|FG002|Overall Study|Physician Decision|0|||
126062934|NCT03761849|453523702|FG003|Overall Study|Physician Decision|1|||
126062935|NCT03761849|453523703|FG004|Overall Study|Physician Decision|4|||
126062936|NCT03761849|453523704|FG005|Overall Study|Physician Decision|4|||
126062937|NCT03761849|453523699|FG000|Overall Study|Death|0|||
126062938|NCT03761849|453523700|FG001|Overall Study|Death|0|||
126062939|NCT03761849|453523701|FG002|Overall Study|Death|0|||
126062940|NCT03761849|453523702|FG003|Overall Study|Death|1|||
126062941|NCT03761849|453523703|FG004|Overall Study|Death|1|||
126062942|NCT03761849|453523704|FG005|Overall Study|Death|3|||
126062943|NCT03761849|453523699|FG000|Overall Study|Protocol Violation|0|||
126062944|NCT03761849|453523700|FG001|Overall Study|Protocol Violation|0|||
126062945|NCT03761849|453523701|FG002|Overall Study|Protocol Violation|0|||
126062946|NCT03761849|453523702|FG003|Overall Study|Protocol Violation|2|||
126062947|NCT03761849|453523703|FG004|Overall Study|Protocol Violation|2|||
126062948|NCT03761849|453523704|FG005|Overall Study|Protocol Violation|1|||
126062949|NCT03761849|453523699|FG000|Overall Study|Participant could not come to site|0|||
126062950|NCT03761849|453523700|FG001|Overall Study|Participant could not come to site|0|||
126062951|NCT03761849|453523701|FG002|Overall Study|Participant could not come to site|0|||
125915058|NCT01309165|452988730|FG001|Overall Study|Lost to Follow-up|3|||
125915059|NCT01309165|452988729|FG000|Overall Study|Return to work|1|||
125915060|NCT01309165|452988730|FG001|Overall Study|Return to work|2|||
125915061|NCT01309165|452988729|FG000|Overall Study|Left country|0|||
125915062|NCT01309165|452988730|FG001|Overall Study|Left country|1|||
125915063|NCT01309165|452988729|FG000|Overall Study|No transportation|0|||
125915064|NCT01309165|452988730|FG001|Overall Study|No transportation|1|||
126062952|NCT03761849|453523702|FG003|Overall Study|Participant could not come to site|0|||
126062953|NCT03761849|453523703|FG004|Overall Study|Participant could not come to site|1|||
126062954|NCT03761849|453523704|FG005|Overall Study|Participant could not come to site|0|||
126062955|NCT03761849|453523699|FG000|Overall Study|SF- safety Finding|0|||
126062956|NCT03761849|453523700|FG001|Overall Study|SF- safety Finding|0|||
126062957|NCT03761849|453523701|FG002|Overall Study|SF- safety Finding|0|||
126062958|NCT03761849|453523702|FG003|Overall Study|SF- safety Finding|0|||
126062959|NCT03761849|453523703|FG004|Overall Study|SF- safety Finding|0|||
126062960|NCT03761849|453523704|FG005|Overall Study|SF- safety Finding|1|||
126062961|NCT03761849|453523699|FG000|Overall Study|Patient did not attend visit|0|||
126062962|NCT03761849|453523700|FG001|Overall Study|Patient did not attend visit|0|||
126062963|NCT03761849|453523701|FG002|Overall Study|Patient did not attend visit|0|||
126110359|NCT02076113|453699337|FG000|Overall Study|Lost to Follow-up|4|||
126110360|NCT02076113|453699338|FG001|Overall Study|Lost to Follow-up|1|||
126110361|NCT02076113|453699337|FG000|Overall Study|Withdrawal by Subject|2|||
126110362|NCT02076113|453699338|FG001|Overall Study|Withdrawal by Subject|3|||
126110363|NCT02076113|453699337|FG000|Overall Study|Death|1|||
126110364|NCT02076113|453699338|FG001|Overall Study|Death|3|||
126110365|NCT02596620|453699341|FG000|Overall Study|Lost to Follow-up|1|||
126110366|NCT02596620|453699342|FG001|Overall Study|Lost to Follow-up|1|||
126110367|NCT01054144|453699343|FG000|Overall Study|Death|2|||
126110368|NCT03801902|453699344|FG000|Overall Study|Did not receive protocol treatment.|1|||
126110369|NCT03801902|453699345|FG001|Overall Study|Did not receive protocol treatment.|0|||
126110370|NCT03801902|453699346|FG002|Overall Study|Did not receive protocol treatment.|0|||
126110371|NCT03801902|453699347|FG003|Overall Study|Did not receive protocol treatment.|0|||
126110372|NCT00528866|453699351|FG000|Overall Study|Protocol Violation|6|||
126110373|NCT01601847|453699352|FG000|Overall Study|Death|1|||
126110374|NCT01601847|453699353|FG001|Overall Study|Death|0|||
126110375|NCT01601847|453699352|FG000|Overall Study|Withdrawal by Subject|11|||
126110376|NCT01601847|453699353|FG001|Overall Study|Withdrawal by Subject|7|||
126110377|NCT01601847|453699352|FG000|Overall Study|Lost to Follow-up|1|||
126110378|NCT01601847|453699353|FG001|Overall Study|Lost to Follow-up|3|||
126110379|NCT01284062|453699354|FG000|Overall Study|Adverse Event|4|||
126110380|NCT01284062|453699355|FG001|Overall Study|Adverse Event|5|||
126110381|NCT01284062|453699356|FG002|Overall Study|Adverse Event|0|||
126110382|NCT01284062|453699357|FG003|Overall Study|Adverse Event|5|||
126110383|NCT01284062|453699354|FG000|Overall Study|Lack of Efficacy|3|||
126110384|NCT01284062|453699355|FG001|Overall Study|Lack of Efficacy|2|||
126110385|NCT01284062|453699356|FG002|Overall Study|Lack of Efficacy|2|||
126110386|NCT01284062|453699357|FG003|Overall Study|Lack of Efficacy|1|||
126110387|NCT01284062|453699354|FG000|Overall Study|Medication error without adverse event|0|||
126110388|NCT01284062|453699355|FG001|Overall Study|Medication error without adverse event|0|||
126110389|NCT01284062|453699356|FG002|Overall Study|Medication error without adverse event|1|||
126110390|NCT01284062|453699357|FG003|Overall Study|Medication error without adverse event|0|||
126110391|NCT01284062|453699354|FG000|Overall Study|Protocol Violation|1|||
126110392|NCT01284062|453699355|FG001|Overall Study|Protocol Violation|0|||
126110393|NCT01284062|453699356|FG002|Overall Study|Protocol Violation|0|||
126110394|NCT01284062|453699357|FG003|Overall Study|Protocol Violation|2|||
126110395|NCT01284062|453699354|FG000|Overall Study|Withdrawal by Subject|3|||
126110396|NCT01284062|453699355|FG001|Overall Study|Withdrawal by Subject|1|||
126110397|NCT01284062|453699356|FG002|Overall Study|Withdrawal by Subject|2|||
126110398|NCT01284062|453699357|FG003|Overall Study|Withdrawal by Subject|5|||
126110399|NCT01284062|453699354|FG000|Overall Study|Other|0|||
126110400|NCT01284062|453699355|FG001|Overall Study|Other|0|||
126110401|NCT01284062|453699356|FG002|Overall Study|Other|0|||
126110402|NCT01284062|453699357|FG003|Overall Study|Other|1|||
126110403|NCT01284062|453699354|FG000|Overall Study|Site Closed|0|||
126110404|NCT01284062|453699355|FG001|Overall Study|Site Closed|0|||
126110405|NCT01284062|453699356|FG002|Overall Study|Site Closed|1|||
126110406|NCT01284062|453699357|FG003|Overall Study|Site Closed|0|||
126110407|NCT02234323|453699358|FG000|All Enrolled|Not Treated: Completed study in database|2|||
126110408|NCT02234323|453699358|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
126110409|NCT02234323|453699358|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
126110410|NCT02234323|453699358|FG000|All Treated|Death|1|||
126110411|NCT02234323|453699358|FG000|All Treated|Physician Decision|5|||
126110412|NCT02234323|453699358|FG000|All Treated|Lack of Efficacy|3|||
126110413|NCT02234323|453699358|FG000|All Treated|Exceeded lab value limit|2|||
126110414|NCT02234323|453699358|FG000|All Treated|Other|7|||
126110415|NCT02644941|453699359|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
126062964|NCT03761849|453523702|FG003|Overall Study|Patient did not attend visit|0|||
126110416|NCT02644941|453699360|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
126110417|NCT04614662|453699361|FG000|Overall Study|Withdrawal by Subject|0|||
126062965|NCT03761849|453523703|FG004|Overall Study|Patient did not attend visit|0|||
126110418|NCT04614662|453699362|FG001|Overall Study|Withdrawal by Subject|1|||
126110419|NCT01717768|453699366|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126110420|NCT01717768|453699367|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
126110421|NCT01717768|453699368|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126110422|NCT01717768|453699369|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126062966|NCT03761849|453523704|FG005|Overall Study|Patient did not attend visit|1|||
126062967|NCT03344458|453523708|FG000|Overall Study|Physician Decision|1|||
126062968|NCT03344458|453523708|FG000|Overall Study|Withdrawal by Subject|16|||
126062969|NCT03344458|453523708|FG000|Overall Study|Other reasons|10|||
126062970|NCT03344458|453523708|FG000|Overall Study|Lost to Follow-up|9|||
126062971|NCT03344458|453523708|FG000|Overall Study|Protocol Violation|3|||
126062972|NCT03840993|453523709|FG000|Overall Study|Adverse Event|1|||
126062973|NCT03840993|453523710|FG001|Overall Study|Adverse Event|0|||
126062974|NCT03840993|453523709|FG000|Overall Study|Lost to Follow-up|4|||
126062975|NCT03840993|453523710|FG001|Overall Study|Lost to Follow-up|0|||
126062976|NCT03840993|453523709|FG000|Overall Study|Physician Decision|0|||
126062977|NCT03840993|453523710|FG001|Overall Study|Physician Decision|1|||
126062978|NCT03840993|453523709|FG000|Overall Study|Pregnancy|0|||
126062979|NCT03840993|453523710|FG001|Overall Study|Pregnancy|1|||
126062980|NCT03840993|453523709|FG000|Overall Study|Withdrawal by Subject|1|||
126062981|NCT03840993|453523710|FG001|Overall Study|Withdrawal by Subject|3|||
125915065|NCT01309165|452988729|FG000|Overall Study|Admitted to hospital for second stroke|1|||
125915066|NCT01309165|452988730|FG001|Overall Study|Admitted to hospital for second stroke|0|||
125915067|NCT01189604|452988731|FG000|Overall Study|Impossible to visit|0|||
125915068|NCT01189604|452988732|FG001|Overall Study|Impossible to visit|0|||
125915069|NCT01189604|452988733|FG002|Overall Study|Impossible to visit|0|||
125915070|NCT01189604|452988734|FG003|Overall Study|Impossible to visit|0|||
125915071|NCT01189604|452988735|FG004|Overall Study|Impossible to visit|0|||
125915072|NCT01189604|452988736|FG005|Overall Study|Impossible to visit|1|||
125915073|NCT01189604|452988737|FG006|Overall Study|Impossible to visit|0|||
125915074|NCT01189604|452988731|FG000|Overall Study|Adverse Event|0|||
125915075|NCT01189604|452988732|FG001|Overall Study|Adverse Event|1|||
125915076|NCT01189604|452988733|FG002|Overall Study|Adverse Event|0|||
125915077|NCT01189604|452988734|FG003|Overall Study|Adverse Event|0|||
126062982|NCT03840993|453523709|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
125915078|NCT01189604|452988735|FG004|Overall Study|Adverse Event|2|||
125915079|NCT01189604|452988736|FG005|Overall Study|Adverse Event|0|||
125915080|NCT01189604|452988737|FG006|Overall Study|Adverse Event|1|||
125915081|NCT01189604|452988731|FG000|Overall Study|Withdrawal by Subject|1|||
125915082|NCT01189604|452988732|FG001|Overall Study|Withdrawal by Subject|0|||
125915083|NCT01189604|452988733|FG002|Overall Study|Withdrawal by Subject|0|||
125915084|NCT01189604|452988734|FG003|Overall Study|Withdrawal by Subject|0|||
125915085|NCT01189604|452988735|FG004|Overall Study|Withdrawal by Subject|0|||
125915086|NCT01189604|452988736|FG005|Overall Study|Withdrawal by Subject|0|||
125915087|NCT01189604|452988737|FG006|Overall Study|Withdrawal by Subject|0|||
125915088|NCT00333840|452988741|FG000|First-line Treatment Period|Adverse Event|38|||
125915089|NCT00333840|452988742|FG001|First-line Treatment Period|Adverse Event|37|||
125915090|NCT00333840|452988743|FG002|First-line Treatment Period|Adverse Event|0|||
125915091|NCT00333840|452988744|FG003|First-line Treatment Period|Adverse Event|0|||
125915092|NCT00333840|452988741|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
125915093|NCT00333840|452988742|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
125915094|NCT00333840|452988743|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
125915095|NCT00333840|452988744|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
125915096|NCT00333840|452988741|FG000|First-line Treatment Period|Abnormal procedure|2|||
125915097|NCT00333840|452988742|FG001|First-line Treatment Period|Abnormal procedure|0|||
125915098|NCT00333840|452988743|FG002|First-line Treatment Period|Abnormal procedure|0|||
125915099|NCT00333840|452988744|FG003|First-line Treatment Period|Abnormal procedure|0|||
125915100|NCT00333840|452988741|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
125915101|NCT00333840|452988742|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
125915102|NCT00333840|452988743|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
125915103|NCT00333840|452988744|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
125915104|NCT00333840|452988741|FG000|First-line Treatment Period|No longer required study drug|21|||
125915105|NCT00333840|452988742|FG001|First-line Treatment Period|No longer required study drug|8|||
125915106|NCT00333840|452988743|FG002|First-line Treatment Period|No longer required study drug|0|||
125915107|NCT00333840|452988744|FG003|First-line Treatment Period|No longer required study drug|0|||
125915108|NCT00333840|452988741|FG000|First-line Treatment Period|Protocol Violation|17|||
125915109|NCT00333840|452988742|FG001|First-line Treatment Period|Protocol Violation|17|||
125915110|NCT00333840|452988743|FG002|First-line Treatment Period|Protocol Violation|0|||
125915111|NCT00333840|452988744|FG003|First-line Treatment Period|Protocol Violation|0|||
125915112|NCT00333840|452988741|FG000|First-line Treatment Period|Subject withdrew consent|57|||
125915113|NCT00333840|452988742|FG001|First-line Treatment Period|Subject withdrew consent|77|||
125915114|NCT00333840|452988743|FG002|First-line Treatment Period|Subject withdrew consent|0|||
125915115|NCT00333840|452988744|FG003|First-line Treatment Period|Subject withdrew consent|0|||
125915116|NCT00333840|452988741|FG000|First-line Treatment Period|Lost to Follow-up|15|||
125915117|NCT00333840|452988742|FG001|First-line Treatment Period|Lost to Follow-up|6|||
125915118|NCT00333840|452988743|FG002|First-line Treatment Period|Lost to Follow-up|0|||
125915119|NCT00333840|452988744|FG003|First-line Treatment Period|Lost to Follow-up|0|||
125915120|NCT00333840|452988741|FG000|First-line Treatment Period|Administrative problems|12|||
125915121|NCT00333840|452988742|FG001|First-line Treatment Period|Administrative problems|6|||
125915122|NCT00333840|452988743|FG002|First-line Treatment Period|Administrative problems|0|||
125915123|NCT00333840|452988744|FG003|First-line Treatment Period|Administrative problems|0|||
125915124|NCT00333840|452988741|FG000|First-line Treatment Period|Death|19|||
125915125|NCT00333840|452988742|FG001|First-line Treatment Period|Death|2|||
125915126|NCT00333840|452988743|FG002|First-line Treatment Period|Death|0|||
125915127|NCT00333840|452988744|FG003|First-line Treatment Period|Death|0|||
125915128|NCT00333840|452988741|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
125915129|NCT00333840|452988742|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
125915130|NCT00333840|452988743|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
125915131|NCT00333840|452988744|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
125915132|NCT00333840|452988741|FG000|Second-line Treatment Period|Adverse Event|0|||
125915133|NCT00333840|452988742|FG001|Second-line Treatment Period|Adverse Event|0|||
125915134|NCT00333840|452988743|FG002|Second-line Treatment Period|Adverse Event|3|||
125915135|NCT00333840|452988744|FG003|Second-line Treatment Period|Adverse Event|34|||
125915136|NCT00333840|452988741|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
125915137|NCT00333840|452988742|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
125915138|NCT00333840|452988743|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
125915139|NCT00333840|452988744|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
125915140|NCT00333840|452988741|FG000|Second-line Treatment Period|Abnormal procedure|0|||
125915141|NCT00333840|452988742|FG001|Second-line Treatment Period|Abnormal procedure|0|||
125915142|NCT00333840|452988743|FG002|Second-line Treatment Period|Abnormal procedure|0|||
125915143|NCT00333840|452988744|FG003|Second-line Treatment Period|Abnormal procedure|1|||
125915144|NCT00333840|452988741|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
125915145|NCT00333840|452988742|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
125915146|NCT00333840|452988743|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
125915147|NCT00333840|452988744|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
125915148|NCT00333840|452988741|FG000|Second-line Treatment Period|No longer required study drug|0|||
125915149|NCT00333840|452988742|FG001|Second-line Treatment Period|No longer required study drug|0|||
125915150|NCT00333840|452988743|FG002|Second-line Treatment Period|No longer required study drug|1|||
125915151|NCT00333840|452988744|FG003|Second-line Treatment Period|No longer required study drug|14|||
125915152|NCT00333840|452988741|FG000|Second-line Treatment Period|Protocol Violation|0|||
125915153|NCT00333840|452988742|FG001|Second-line Treatment Period|Protocol Violation|0|||
126062983|NCT03840993|453523710|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
126062984|NCT00988429|453523711|FG000|Overall Study|Adverse Event|9|||
126062985|NCT00988429|453523712|FG001|Overall Study|Adverse Event|21|||
126062986|NCT00988429|453523713|FG002|Overall Study|Adverse Event|45|||
126062987|NCT00988429|453523711|FG000|Overall Study|Lack of Efficacy|0|||
125915154|NCT00333840|452988743|FG002|Second-line Treatment Period|Protocol Violation|1|||
125915155|NCT00333840|452988744|FG003|Second-line Treatment Period|Protocol Violation|10|||
125915156|NCT00333840|452988741|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
125915157|NCT00333840|452988742|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
125915158|NCT00333840|452988743|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
125915159|NCT00333840|452988744|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
125915160|NCT00333840|452988741|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
125915161|NCT00333840|452988742|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
125915162|NCT00333840|452988743|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
125915163|NCT00333840|452988744|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
125915164|NCT00333840|452988741|FG000|Second-line Treatment Period|Administrative problems|0|||
125915165|NCT00333840|452988742|FG001|Second-line Treatment Period|Administrative problems|0|||
125915166|NCT00333840|452988743|FG002|Second-line Treatment Period|Administrative problems|0|||
125915167|NCT00333840|452988744|FG003|Second-line Treatment Period|Administrative problems|7|||
125915168|NCT00333840|452988741|FG000|Second-line Treatment Period|Death|0|||
125915169|NCT00333840|452988742|FG001|Second-line Treatment Period|Death|0|||
125915170|NCT00333840|452988743|FG002|Second-line Treatment Period|Death|0|||
125915171|NCT00333840|452988744|FG003|Second-line Treatment Period|Death|9|||
125915172|NCT03719586|452988745|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
125915173|NCT03719586|452988746|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
125915174|NCT03719586|452988747|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
125915175|NCT03719586|452988748|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
125915176|NCT00178633|452988750|FG000|Overall Study|Lost to Follow-up|6|||
125915177|NCT00369707|452988751|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
125915178|NCT00369707|452988751|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
125915179|NCT00369707|452988751|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
125915180|NCT00369707|452988751|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
125915181|NCT00369707|452988751|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
125915182|NCT00369707|452988751|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
125915183|NCT00369707|452988751|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
125915184|NCT00369707|452988751|FG000|Follow up for 2 Years After Treatment|Death|1|||
125915185|NCT00369707|452988751|FG000|Follow up for 2 Years After Treatment|Other|2|||
125915186|NCT01254292|452988754|FG000|Comparative Phase|Adverse Event|25|||
125915187|NCT01254292|452988755|FG001|Comparative Phase|Adverse Event|25|||
125915188|NCT01254292|452988754|FG000|Comparative Phase|Lost to Follow-up|3|||
125915189|NCT01254292|452988755|FG001|Comparative Phase|Lost to Follow-up|21|||
125915190|NCT01254292|452988754|FG000|Comparative Phase|Pregnancy|2|||
125915191|NCT01254292|452988755|FG001|Comparative Phase|Pregnancy|6|||
125915192|NCT01254292|452988754|FG000|Comparative Phase|Withdrawal by Subject|20|||
125915193|NCT01254292|452988755|FG001|Comparative Phase|Withdrawal by Subject|21|||
125915194|NCT01254292|452988754|FG000|Comparative Phase|Protocol Violation|1|||
125915195|NCT01254292|452988755|FG001|Comparative Phase|Protocol Violation|2|||
125915196|NCT01254292|452988754|FG000|Comparative Phase|Wish for pregnancy|4|||
125915197|NCT01254292|452988755|FG001|Comparative Phase|Wish for pregnancy|6|||
125915198|NCT01254292|452988754|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
125915199|NCT01254292|452988755|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
125915200|NCT01254292|452988754|FG000|LCS12 Extension Phase|Adverse Event|9|||
125915201|NCT01254292|452988755|FG001|LCS12 Extension Phase|Adverse Event|0|||
125915202|NCT01254292|452988754|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
125915203|NCT01254292|452988755|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
125915204|NCT01254292|452988754|FG000|LCS12 Extension Phase|Other unknown|4|||
125915205|NCT01254292|452988755|FG001|LCS12 Extension Phase|Other unknown|0|||
125915206|NCT01254292|452988754|FG000|LCS12 Extension Phase|Pregnancy|2|||
125915207|NCT01254292|452988755|FG001|LCS12 Extension Phase|Pregnancy|0|||
125915208|NCT01254292|452988754|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
125915209|NCT01254292|452988755|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
125915210|NCT02149875|452988758|FG000|Overall Study|Lost to Follow-up|3|||
125915211|NCT02149875|452988759|FG001|Overall Study|Lost to Follow-up|4|||
125915212|NCT02149875|452988760|FG002|Overall Study|Lost to Follow-up|5|||
125915213|NCT02149875|452988758|FG000|Overall Study|Withdrawal by Subject|3|||
125915214|NCT02149875|452988759|FG001|Overall Study|Withdrawal by Subject|2|||
125915215|NCT02149875|452988760|FG002|Overall Study|Withdrawal by Subject|2|||
125915216|NCT02149875|452988758|FG000|Overall Study|Physician Decision|1|||
125915217|NCT02149875|452988759|FG001|Overall Study|Physician Decision|2|||
125915218|NCT02149875|452988760|FG002|Overall Study|Physician Decision|2|||
125915219|NCT02478372|452988761|FG000|Overall Study|Protocol Violation|12|||
125915220|NCT02478372|452988762|FG001|Overall Study|Protocol Violation|8|||
125915221|NCT02478372|452988761|FG000|Overall Study|Lost to Follow-up|1|||
125915222|NCT02478372|452988762|FG001|Overall Study|Lost to Follow-up|4|||
125915223|NCT02478372|452988761|FG000|Overall Study|Death|0|||
125915224|NCT02478372|452988762|FG001|Overall Study|Death|2|||
125915225|NCT01262573|452988763|FG000|Overall Study|Withdrawal by Subject|0|||
125915226|NCT01262573|452988764|FG001|Overall Study|Withdrawal by Subject|1|||
125915227|NCT03800173|452988771|FG000|Overall Study|Lost to Follow-up|0|||
125915228|NCT03800173|452988772|FG001|Overall Study|Lost to Follow-up|0|||
125915229|NCT03800173|452988773|FG002|Overall Study|Lost to Follow-up|0|||
125915230|NCT03800173|452988774|FG003|Overall Study|Lost to Follow-up|0|||
125915231|NCT03800173|452988775|FG004|Overall Study|Lost to Follow-up|1|||
125915232|NCT02955797|452988776|FG000|Overall Study|Protocol Violation|1|||
125915233|NCT02955797|452988777|FG001|Overall Study|Protocol Violation|0|||
125915234|NCT02955797|452988778|FG002|Overall Study|Protocol Violation|0|||
125915235|NCT02955797|452988779|FG003|Overall Study|Protocol Violation|1|||
125915236|NCT02955797|452988776|FG000|Overall Study|Withdrawal by Subject|2|||
125915237|NCT02955797|452988777|FG001|Overall Study|Withdrawal by Subject|2|||
125915238|NCT02955797|452988778|FG002|Overall Study|Withdrawal by Subject|0|||
125915239|NCT02955797|452988779|FG003|Overall Study|Withdrawal by Subject|1|||
125915240|NCT02955797|452988776|FG000|Overall Study|Lost to Follow-up|0|||
125915241|NCT02955797|452988777|FG001|Overall Study|Lost to Follow-up|1|||
125915242|NCT02955797|452988778|FG002|Overall Study|Lost to Follow-up|0|||
125915243|NCT02955797|452988779|FG003|Overall Study|Lost to Follow-up|0|||
125915244|NCT02081183|452988781|FG000|Overall Study|Lost to Follow-up|0|||
125915245|NCT02081183|452988782|FG001|Overall Study|Lost to Follow-up|1|||
125915246|NCT02081183|452988781|FG000|Overall Study|Protocol Violation|1|||
125915247|NCT02081183|452988782|FG001|Overall Study|Protocol Violation|0|||
125915248|NCT02081183|452988781|FG000|Overall Study|Other|3|||
125915249|NCT02081183|452988782|FG001|Overall Study|Other|3|||
125915250|NCT00910273|452988787|FG000|Overall Study|Lack of Efficacy|6|||
125915251|NCT00910273|452988788|FG001|Overall Study|Lack of Efficacy|9|||
125915252|NCT00910273|452988787|FG000|Overall Study|Adverse Event|1|||
125915253|NCT00910273|452988788|FG001|Overall Study|Adverse Event|1|||
125915254|NCT00910273|452988787|FG000|Overall Study|Withdrawal by Subject|1|||
125915255|NCT00910273|452988788|FG001|Overall Study|Withdrawal by Subject|0|||
125915256|NCT00910273|452988787|FG000|Overall Study|Discontinuation of study by sponsor|8|||
125915257|NCT00910273|452988788|FG001|Overall Study|Discontinuation of study by sponsor|2|||
125915258|NCT00910273|452988787|FG000|Overall Study|Protocol Violation|1|||
125915259|NCT00910273|452988788|FG001|Overall Study|Protocol Violation|0|||
125915260|NCT00910273|452988787|FG000|Overall Study|Lost to Follow-up|1|||
125915261|NCT00910273|452988788|FG001|Overall Study|Lost to Follow-up|1|||
125915262|NCT03841448|452988789|FG000|Double-blind Treatment (DBT) Period|Death|1|||
125915263|NCT03841448|452988790|FG001|Double-blind Treatment (DBT) Period|Death|1|||
125915264|NCT03841448|452988791|FG002|Double-blind Treatment (DBT) Period|Death|0|||
125915265|NCT03841448|452988792|FG003|Double-blind Treatment (DBT) Period|Death|0|||
125915266|NCT03841448|452988789|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
125915267|NCT03841448|452988790|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
125915268|NCT03841448|452988791|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
125915269|NCT03841448|452988792|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
125915270|NCT03841448|452988789|FG000|Open-Label Extension (OLE) Period|Death|0|||
125915271|NCT03841448|452988790|FG001|Open-Label Extension (OLE) Period|Death|0|||
125915272|NCT03841448|452988791|FG002|Open-Label Extension (OLE) Period|Death|0|||
125915273|NCT03841448|452988792|FG003|Open-Label Extension (OLE) Period|Death|1|||
125915274|NCT03841448|452988789|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
125915275|NCT03841448|452988790|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
125915276|NCT03841448|452988791|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
125915277|NCT03841448|452988792|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
125915278|NCT03841448|452988789|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
125915279|NCT03841448|452988790|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
125915280|NCT03841448|452988791|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
125915281|NCT03841448|452988792|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
125915282|NCT03841448|452988789|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
125915283|NCT03841448|452988790|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
125915284|NCT03841448|452988791|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
125915285|NCT03841448|452988792|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
125915286|NCT04128371|452988793|FG000|Overall Study|Lack of Efficacy|1|||
125915287|NCT00968864|452988794|FG000|Overall Study|Protocol exception/ not evaluable|1|||
125915288|NCT00397215|452988797|FG000|Month 0 (Day 0)|Adverse Event|0|||
125915289|NCT00397215|452988798|FG001|Month 0 (Day 0)|Adverse Event|1|||
125915290|NCT00397215|452988799|FG002|Month 0 (Day 0)|Adverse Event|0|||
125915291|NCT00397215|452988800|FG003|Month 0 (Day 0)|Adverse Event|0|||
125915292|NCT00397215|452988797|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
125915293|NCT00397215|452988798|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
125915294|NCT00397215|452988799|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
125915295|NCT00397215|452988800|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
125915296|NCT00397215|452988797|FG000|Month 0 (Day 0)|Other|4|||
125915297|NCT00397215|452988798|FG001|Month 0 (Day 0)|Other|1|||
125915298|NCT00397215|452988799|FG002|Month 0 (Day 0)|Other|3|||
125915299|NCT00397215|452988800|FG003|Month 0 (Day 0)|Other|3|||
125915300|NCT00397215|452988797|FG000|Month 6 (Day 180)|Adverse Event|0|||
125915301|NCT00397215|452988798|FG001|Month 6 (Day 180)|Adverse Event|3|||
125915302|NCT00397215|452988799|FG002|Month 6 (Day 180)|Adverse Event|2|||
125915303|NCT00397215|452988800|FG003|Month 6 (Day 180)|Adverse Event|0|||
125915304|NCT00397215|452988797|FG000|Month 6 (Day 180)|Other|2|||
125915305|NCT00397215|452988798|FG001|Month 6 (Day 180)|Other|0|||
125915306|NCT00397215|452988799|FG002|Month 6 (Day 180)|Other|3|||
125915307|NCT00397215|452988800|FG003|Month 6 (Day 180)|Other|0|||
125915308|NCT02128932|452988801|FG000|Overall Study|Withdrawal by Subject|11|||
125915309|NCT02128932|452988802|FG001|Overall Study|Withdrawal by Subject|7|||
125915310|NCT02128932|452988803|FG002|Overall Study|Withdrawal by Subject|8|||
125915311|NCT02128932|452988801|FG000|Overall Study|Death|2|||
125915312|NCT02128932|452988802|FG001|Overall Study|Death|0|||
125915313|NCT02128932|452988803|FG002|Overall Study|Death|2|||
125915314|NCT02128932|452988801|FG000|Overall Study|Lost to Follow-up|2|||
125915315|NCT02128932|452988802|FG001|Overall Study|Lost to Follow-up|1|||
125915316|NCT02128932|452988803|FG002|Overall Study|Lost to Follow-up|1|||
125915317|NCT02128932|452988801|FG000|Overall Study|No reason for withdrawal|12|||
125915318|NCT02128932|452988802|FG001|Overall Study|No reason for withdrawal|11|||
125915319|NCT02128932|452988803|FG002|Overall Study|No reason for withdrawal|7|||
125915320|NCT01361568|452988808|FG000|Overall Study|Adverse Event|0|||
125915321|NCT01361568|452988809|FG001|Overall Study|Adverse Event|0|||
125915322|NCT01361568|452988810|FG002|Overall Study|Adverse Event|0|||
125915323|NCT01361568|452988811|FG003|Overall Study|Adverse Event|0|||
125915324|NCT01361568|452988812|FG004|Overall Study|Adverse Event|1|||
125915325|NCT01361568|452988813|FG005|Overall Study|Adverse Event|0|||
125915326|NCT01361568|452988808|FG000|Overall Study|Physician Decision|0|||
125915327|NCT01361568|452988809|FG001|Overall Study|Physician Decision|0|||
125915328|NCT01361568|452988810|FG002|Overall Study|Physician Decision|0|||
125915329|NCT01361568|452988811|FG003|Overall Study|Physician Decision|0|||
125915330|NCT01361568|452988812|FG004|Overall Study|Physician Decision|0|||
125915331|NCT01361568|452988813|FG005|Overall Study|Physician Decision|1|||
125915332|NCT01361568|452988808|FG000|Overall Study|Withdrawal by Subject|2|||
125915333|NCT01361568|452988809|FG001|Overall Study|Withdrawal by Subject|1|||
126062988|NCT00988429|453523712|FG001|Overall Study|Lack of Efficacy|0|||
126062989|NCT00988429|453523713|FG002|Overall Study|Lack of Efficacy|1|||
126062990|NCT00988429|453523711|FG000|Overall Study|Non-Compliance with Study Drug|5|||
126062991|NCT00988429|453523712|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126062992|NCT00988429|453523713|FG002|Overall Study|Non-Compliance with Study Drug|3|||
126062993|NCT00988429|453523711|FG000|Overall Study|Physician Decision|1|||
126062994|NCT00988429|453523712|FG001|Overall Study|Physician Decision|0|||
126062995|NCT00988429|453523713|FG002|Overall Study|Physician Decision|3|||
126062996|NCT00988429|453523711|FG000|Overall Study|Pregnancy|2|||
126062997|NCT00988429|453523712|FG001|Overall Study|Pregnancy|1|||
126062998|NCT00988429|453523713|FG002|Overall Study|Pregnancy|0|||
126062999|NCT00988429|453523711|FG000|Overall Study|Protocol Violation|4|||
126063000|NCT00988429|453523712|FG001|Overall Study|Protocol Violation|3|||
126063001|NCT00988429|453523713|FG002|Overall Study|Protocol Violation|3|||
126063002|NCT00988429|453523711|FG000|Overall Study|Withdrawal by Subject|7|||
126063003|NCT00988429|453523712|FG001|Overall Study|Withdrawal by Subject|7|||
126063004|NCT00988429|453523713|FG002|Overall Study|Withdrawal by Subject|12|||
126063005|NCT00988429|453523711|FG000|Overall Study|Administrative Reasons|1|||
125915334|NCT01361568|452988810|FG002|Overall Study|Withdrawal by Subject|0|||
125915335|NCT01361568|452988811|FG003|Overall Study|Withdrawal by Subject|0|||
125915336|NCT01361568|452988812|FG004|Overall Study|Withdrawal by Subject|0|||
125915337|NCT01361568|452988813|FG005|Overall Study|Withdrawal by Subject|1|||
125915338|NCT00657358|452988814|FG000|Overall Study|Lack of Efficacy|6|||
125915339|NCT02959983|452988815|FG000|Overall Study|Protocol Violation|0|||
125915340|NCT02959983|452988816|FG001|Overall Study|Protocol Violation|1|||
125915341|NCT02959983|452988815|FG000|Overall Study|Lack of Efficacy|0|||
125915342|NCT02959983|452988816|FG001|Overall Study|Lack of Efficacy|1|||
125915343|NCT02959983|452988815|FG000|Overall Study|Lost to Follow-up|12|||
125915344|NCT02959983|452988816|FG001|Overall Study|Lost to Follow-up|9|||
125915345|NCT02959983|452988815|FG000|Overall Study|Other|1|||
125915346|NCT02959983|452988816|FG001|Overall Study|Other|1|||
125915347|NCT02959983|452988815|FG000|Overall Study|Physician Decision|1|||
125915348|NCT02959983|452988816|FG001|Overall Study|Physician Decision|0|||
125915349|NCT02959983|452988815|FG000|Overall Study|Adverse Event|5|||
125915350|NCT02959983|452988816|FG001|Overall Study|Adverse Event|1|||
125915351|NCT02959983|452988815|FG000|Overall Study|Withdrawal by Subject|7|||
125915352|NCT02959983|452988816|FG001|Overall Study|Withdrawal by Subject|12|||
125915353|NCT02728596|452988817|FG000|Overall Study|Refusal unrelated to adverse event|3|||
125915354|NCT02728596|452988818|FG001|Overall Study|Refusal unrelated to adverse event|6|||
125915355|NCT02728596|452988819|FG002|Overall Study|Refusal unrelated to adverse event|7|||
125915356|NCT02728596|452988820|FG003|Overall Study|Refusal unrelated to adverse event|7|||
125915357|NCT02728596|452988817|FG000|Overall Study|Death|44|||
125915358|NCT02728596|452988818|FG001|Overall Study|Death|42|||
125915359|NCT02728596|452988819|FG002|Overall Study|Death|123|||
125915360|NCT02728596|452988820|FG003|Overall Study|Death|68|||
125915361|NCT01414608|452988826|FG000|Overall Study|Ineligible|5|||
125915362|NCT01414608|452988827|FG001|Overall Study|Ineligible|2|||
125915363|NCT01736124|452988828|FG000|Post-intervention Assessment|Death|2|||
125915364|NCT01736124|452988829|FG001|Post-intervention Assessment|Death|2|||
125915365|NCT01736124|452988828|FG000|Post-intervention Assessment|lost computer access|1|||
125915366|NCT01736124|452988829|FG001|Post-intervention Assessment|lost computer access|1|||
125915367|NCT01736124|452988828|FG000|Post-intervention Assessment|Moved away|3|||
125915368|NCT01736124|452988829|FG001|Post-intervention Assessment|Moved away|1|||
125915369|NCT01736124|452988828|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
125915370|NCT01736124|452988829|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
125915371|NCT01736124|452988828|FG000|Post-intervention Assessment|Illness|3|||
125915372|NCT01736124|452988829|FG001|Post-intervention Assessment|Illness|2|||
125915373|NCT01736124|452988828|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
125915374|NCT01736124|452988829|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
125915375|NCT01736124|452988828|FG000|Post-intervention Assessment|Temporarily away|3|||
125915376|NCT01736124|452988829|FG001|Post-intervention Assessment|Temporarily away|1|||
125915377|NCT01736124|452988828|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
125915378|NCT01736124|452988829|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
125915379|NCT01736124|452988828|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
125915380|NCT01736124|452988829|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
125915381|NCT01736124|452988828|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
125915382|NCT01736124|452988829|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
125915383|NCT01736124|452988828|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
125915384|NCT01736124|452988829|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
125915385|NCT01736124|452988828|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
125915386|NCT01736124|452988829|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
125915387|NCT01736124|452988828|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
125915388|NCT01736124|452988829|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
125915389|NCT01736124|452988828|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
125915390|NCT01736124|452988829|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
125915391|NCT01736124|452988828|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
125915392|NCT01736124|452988829|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
125915393|NCT01736124|452988828|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
125915394|NCT01736124|452988829|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
125915395|NCT03672643|452988830|FG000|Overall Study|Adverse Event|3|||
125915396|NCT03672643|452988830|FG000|Overall Study|Death|2|||
125915397|NCT03672643|452988830|FG000|Overall Study|Withdrawal by Subject|1|||
125915398|NCT03672643|452988830|FG000|Overall Study|Progressive disease|11|||
125915399|NCT03672643|452988830|FG000|Overall Study|Global deterioration of health status|1|||
125915400|NCT03672643|452988830|FG000|Overall Study|Refused further treatment|7|||
125915401|NCT03672643|452988830|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
125915402|NCT05736224|452988831|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
125915403|NCT02557295|452988832|FG000|Overall Study|Withdrawal by Subject|9|||
125915404|NCT02557295|452988833|FG001|Overall Study|Withdrawal by Subject|2|||
125915405|NCT02557295|452988834|FG002|Overall Study|Withdrawal by Subject|4|||
125915406|NCT02557295|452988835|FG003|Overall Study|Withdrawal by Subject|0|||
125915407|NCT02557295|452988836|FG004|Overall Study|Withdrawal by Subject|0|||
125915408|NCT02557295|452988837|FG005|Overall Study|Withdrawal by Subject|0|||
125915409|NCT02557295|452988838|FG006|Overall Study|Withdrawal by Subject|15|||
125915410|NCT02557295|452988839|FG007|Overall Study|Withdrawal by Subject|1|||
125915411|NCT02557295|452988840|FG008|Overall Study|Withdrawal by Subject|3|||
125915412|NCT02557295|452988832|FG000|Overall Study|Disease Progression|0|||
125915413|NCT02557295|452988833|FG001|Overall Study|Disease Progression|0|||
125915414|NCT02557295|452988834|FG002|Overall Study|Disease Progression|0|||
125915415|NCT02557295|452988835|FG003|Overall Study|Disease Progression|0|||
125915416|NCT02557295|452988836|FG004|Overall Study|Disease Progression|0|||
125915417|NCT02557295|452988837|FG005|Overall Study|Disease Progression|0|||
125915418|NCT02557295|452988838|FG006|Overall Study|Disease Progression|1|||
125915419|NCT02557295|452988839|FG007|Overall Study|Disease Progression|0|||
125915420|NCT02557295|452988840|FG008|Overall Study|Disease Progression|0|||
125915421|NCT02557295|452988832|FG000|Overall Study|Lack of Efficacy|24|||
125915422|NCT02557295|452988833|FG001|Overall Study|Lack of Efficacy|1|||
125915423|NCT02557295|452988834|FG002|Overall Study|Lack of Efficacy|3|||
125915424|NCT02557295|452988835|FG003|Overall Study|Lack of Efficacy|0|||
125915425|NCT02557295|452988836|FG004|Overall Study|Lack of Efficacy|0|||
125915426|NCT02557295|452988837|FG005|Overall Study|Lack of Efficacy|0|||
125915427|NCT02557295|452988838|FG006|Overall Study|Lack of Efficacy|12|||
125915428|NCT02557295|452988839|FG007|Overall Study|Lack of Efficacy|1|||
125915429|NCT02557295|452988840|FG008|Overall Study|Lack of Efficacy|0|||
125915430|NCT02557295|452988832|FG000|Overall Study|Adverse Event|16|||
125915431|NCT02557295|452988833|FG001|Overall Study|Adverse Event|2|||
125915432|NCT02557295|452988834|FG002|Overall Study|Adverse Event|3|||
125915433|NCT02557295|452988835|FG003|Overall Study|Adverse Event|0|||
125915434|NCT02557295|452988836|FG004|Overall Study|Adverse Event|0|||
125915435|NCT02557295|452988837|FG005|Overall Study|Adverse Event|0|||
126063006|NCT00988429|453523712|FG001|Overall Study|Administrative Reasons|2|||
126063007|NCT00988429|453523713|FG002|Overall Study|Administrative Reasons|1|||
125915436|NCT02557295|452988838|FG006|Overall Study|Adverse Event|2|||
125915437|NCT02557295|452988839|FG007|Overall Study|Adverse Event|1|||
125915438|NCT02557295|452988840|FG008|Overall Study|Adverse Event|1|||
125915439|NCT02557295|452988832|FG000|Overall Study|Lost to Follow-up|4|||
125915440|NCT02557295|452988833|FG001|Overall Study|Lost to Follow-up|0|||
125915441|NCT02557295|452988834|FG002|Overall Study|Lost to Follow-up|0|||
126063008|NCT00988429|453523711|FG000|Overall Study|other reasons|8|||
125915442|NCT02557295|452988835|FG003|Overall Study|Lost to Follow-up|0|||
125915443|NCT02557295|452988836|FG004|Overall Study|Lost to Follow-up|0|||
125915444|NCT02557295|452988837|FG005|Overall Study|Lost to Follow-up|0|||
125915445|NCT02557295|452988838|FG006|Overall Study|Lost to Follow-up|9|||
125915446|NCT02557295|452988839|FG007|Overall Study|Lost to Follow-up|0|||
125915447|NCT02557295|452988840|FG008|Overall Study|Lost to Follow-up|0|||
125915448|NCT02557295|452988832|FG000|Overall Study|Study Close|54|||
125915449|NCT02557295|452988833|FG001|Overall Study|Study Close|3|||
125915450|NCT02557295|452988834|FG002|Overall Study|Study Close|5|||
125915451|NCT02557295|452988835|FG003|Overall Study|Study Close|3|||
125915452|NCT02557295|452988836|FG004|Overall Study|Study Close|0|||
125915453|NCT02557295|452988837|FG005|Overall Study|Study Close|0|||
125915454|NCT02557295|452988838|FG006|Overall Study|Study Close|37|||
125915455|NCT02557295|452988839|FG007|Overall Study|Study Close|3|||
125915456|NCT02557295|452988840|FG008|Overall Study|Study Close|19|||
125915457|NCT02557295|452988832|FG000|Overall Study|except for study close|4|||
125915458|NCT02557295|452988833|FG001|Overall Study|except for study close|0|||
125915459|NCT02557295|452988834|FG002|Overall Study|except for study close|0|||
125915460|NCT02557295|452988835|FG003|Overall Study|except for study close|0|||
125915461|NCT02557295|452988836|FG004|Overall Study|except for study close|0|||
125915462|NCT02557295|452988837|FG005|Overall Study|except for study close|0|||
125915463|NCT02557295|452988838|FG006|Overall Study|except for study close|5|||
125915464|NCT02557295|452988839|FG007|Overall Study|except for study close|1|||
125915465|NCT02557295|452988840|FG008|Overall Study|except for study close|0|||
125915466|NCT00639678|452990457|FG000|Overall Study|Withdrawal by Subject|3|||
125915467|NCT00639678|452990458|FG001|Overall Study|Withdrawal by Subject|0|||
125915468|NCT00639678|452990459|FG002|Overall Study|Withdrawal by Subject|4|||
125915469|NCT00639678|452990460|FG003|Overall Study|Withdrawal by Subject|0|||
125915470|NCT00639678|452990457|FG000|Overall Study|Lost to Follow-up|1|||
125915471|NCT00639678|452990458|FG001|Overall Study|Lost to Follow-up|0|||
125915472|NCT00639678|452990459|FG002|Overall Study|Lost to Follow-up|6|||
125915473|NCT00639678|452990460|FG003|Overall Study|Lost to Follow-up|0|||
125915474|NCT00639678|452990457|FG000|Overall Study|Adverse Event|0|||
125915475|NCT00639678|452990458|FG001|Overall Study|Adverse Event|1|||
125915476|NCT00639678|452990459|FG002|Overall Study|Adverse Event|0|||
125915477|NCT00639678|452990460|FG003|Overall Study|Adverse Event|0|||
125915478|NCT00639678|452990457|FG000|Overall Study|Lack of Compliance|0|||
125915479|NCT00639678|452990458|FG001|Overall Study|Lack of Compliance|0|||
125915480|NCT00639678|452990459|FG002|Overall Study|Lack of Compliance|1|||
125915481|NCT00639678|452990460|FG003|Overall Study|Lack of Compliance|0|||
125915482|NCT01926015|452990461|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125915483|NCT01926015|452990462|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125915484|NCT01926015|452990461|FG000|Overall Study|Randomized not treated|2|||
125915485|NCT01926015|452990462|FG001|Overall Study|Randomized not treated|0|||
125915486|NCT01364649|452990463|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
125915487|NCT01364649|452990464|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
125915488|NCT01364649|452990463|FG000|Overall Study|Lack of Efficacy|6|||
125915489|NCT01364649|452990464|FG001|Overall Study|Lack of Efficacy|0|||
125915490|NCT01364649|452990463|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
126063009|NCT00988429|453523712|FG001|Overall Study|other reasons|8|||
125915491|NCT01364649|452990464|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
125915492|NCT01364649|452990463|FG000|Overall Study|Protocol Deviations|4|||
125915493|NCT01364649|452990464|FG001|Overall Study|Protocol Deviations|8|||
125915494|NCT01364649|452990463|FG000|Overall Study|Withdrawal of Consent|9|||
125915495|NCT01364649|452990464|FG001|Overall Study|Withdrawal of Consent|7|||
125915496|NCT01364649|452990463|FG000|Overall Study|Lost to Follow-up|12|||
125915497|NCT01364649|452990464|FG001|Overall Study|Lost to Follow-up|13|||
125915498|NCT01364649|452990463|FG000|Overall Study|Other|4|||
125915499|NCT01364649|452990464|FG001|Overall Study|Other|1|||
125915500|NCT00902668|452990471|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
125915501|NCT01914757|452990472|FG000|Overall Study|Severe non-compliance to protocol|3|||
125915502|NCT01914757|452990473|FG001|Overall Study|Severe non-compliance to protocol|1|||
125915503|NCT01914757|452990474|FG002|Overall Study|Severe non-compliance to protocol|2|||
126063010|NCT00988429|453523713|FG002|Overall Study|other reasons|1|||
125915504|NCT01914757|452990472|FG000|Overall Study|Lost to Follow-up|5|||
125915505|NCT01914757|452990473|FG001|Overall Study|Lost to Follow-up|8|||
125915506|NCT01914757|452990474|FG002|Overall Study|Lost to Follow-up|6|||
125915507|NCT01914757|452990472|FG000|Overall Study|Withdrawal by Subject|15|||
125915508|NCT01914757|452990473|FG001|Overall Study|Withdrawal by Subject|27|||
125915509|NCT01914757|452990474|FG002|Overall Study|Withdrawal by Subject|19|||
125915510|NCT01914757|452990472|FG000|Overall Study|Death|2|||
125915511|NCT01914757|452990473|FG001|Overall Study|Death|2|||
125915512|NCT01914757|452990474|FG002|Overall Study|Death|1|||
125915513|NCT01914757|452990472|FG000|Overall Study|Adverse Event|4|||
125915514|NCT01914757|452990473|FG001|Overall Study|Adverse Event|3|||
125915515|NCT01914757|452990474|FG002|Overall Study|Adverse Event|4|||
125915516|NCT01914757|452990472|FG000|Overall Study|Study specific withdrawal criteria|0|||
125915517|NCT01914757|452990473|FG001|Overall Study|Study specific withdrawal criteria|1|||
125915518|NCT01914757|452990474|FG002|Overall Study|Study specific withdrawal criteria|0|||
125915519|NCT01914757|452990472|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125915520|NCT01914757|452990473|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125915521|NCT01914757|452990474|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
125915522|NCT01914757|452990472|FG000|Overall Study|Other reasons|5|||
125915523|NCT01914757|452990473|FG001|Overall Study|Other reasons|9|||
125915524|NCT01914757|452990474|FG002|Overall Study|Other reasons|4|||
125915525|NCT02833350|452990481|FG000|Overall Study|Adverse Event|0|||
125915526|NCT02833350|452990482|FG001|Overall Study|Adverse Event|3|||
125915527|NCT02833350|452990483|FG002|Overall Study|Adverse Event|4|||
125915528|NCT02833350|452990484|FG003|Overall Study|Adverse Event|4|||
125915529|NCT02833350|452990485|FG004|Overall Study|Adverse Event|1|||
125915530|NCT02833350|452990486|FG005|Overall Study|Adverse Event|0|||
125915531|NCT02833350|452990487|FG006|Overall Study|Adverse Event|1|||
125915532|NCT02833350|452990481|FG000|Overall Study|Death|0|||
125915533|NCT02833350|452990482|FG001|Overall Study|Death|0|||
125915534|NCT02833350|452990483|FG002|Overall Study|Death|1|||
125915535|NCT02833350|452990484|FG003|Overall Study|Death|0|||
125915536|NCT02833350|452990485|FG004|Overall Study|Death|0|||
125915537|NCT02833350|452990486|FG005|Overall Study|Death|0|||
125915538|NCT02833350|452990487|FG006|Overall Study|Death|0|||
125915539|NCT02833350|452990481|FG000|Overall Study|Lack of Efficacy|0|||
125915540|NCT02833350|452990482|FG001|Overall Study|Lack of Efficacy|2|||
125915541|NCT02833350|452990483|FG002|Overall Study|Lack of Efficacy|1|||
125915542|NCT02833350|452990484|FG003|Overall Study|Lack of Efficacy|4|||
125915543|NCT02833350|452990485|FG004|Overall Study|Lack of Efficacy|0|||
125915544|NCT02833350|452990486|FG005|Overall Study|Lack of Efficacy|1|||
125915545|NCT02833350|452990487|FG006|Overall Study|Lack of Efficacy|1|||
125915546|NCT02833350|452990481|FG000|Overall Study|Lost to Follow-up|0|||
125915547|NCT02833350|452990482|FG001|Overall Study|Lost to Follow-up|1|||
125915548|NCT02833350|452990483|FG002|Overall Study|Lost to Follow-up|0|||
125915549|NCT02833350|452990484|FG003|Overall Study|Lost to Follow-up|0|||
125915550|NCT02833350|452990485|FG004|Overall Study|Lost to Follow-up|0|||
125915551|NCT02833350|452990486|FG005|Overall Study|Lost to Follow-up|0|||
125915552|NCT02833350|452990487|FG006|Overall Study|Lost to Follow-up|1|||
125915553|NCT02833350|452990481|FG000|Overall Study|Withdrawal by Subject|3|||
125915554|NCT02833350|452990482|FG001|Overall Study|Withdrawal by Subject|3|||
125915555|NCT02833350|452990483|FG002|Overall Study|Withdrawal by Subject|2|||
125915556|NCT02833350|452990484|FG003|Overall Study|Withdrawal by Subject|0|||
125915557|NCT02833350|452990485|FG004|Overall Study|Withdrawal by Subject|2|||
125915558|NCT02833350|452990486|FG005|Overall Study|Withdrawal by Subject|0|||
125915559|NCT02833350|452990487|FG006|Overall Study|Withdrawal by Subject|2|||
125915560|NCT03342963|452990488|FG000|Overall Study|Adverse Event|1|||
125915561|NCT03342963|452990489|FG001|Overall Study|Adverse Event|2|||
125915562|NCT03342963|452990490|FG002|Overall Study|Adverse Event|0|||
125915563|NCT03342963|452990491|FG003|Overall Study|Adverse Event|0|||
125915564|NCT03342963|452990488|FG000|Overall Study|Withdrawal by Subject|1|||
125915565|NCT03342963|452990489|FG001|Overall Study|Withdrawal by Subject|0|||
125915566|NCT03342963|452990490|FG002|Overall Study|Withdrawal by Subject|0|||
125915567|NCT03342963|452990491|FG003|Overall Study|Withdrawal by Subject|0|||
125915568|NCT04553679|452990492|FG000|Overall Study|Withdrawal by Subject|2|||
125915569|NCT04553679|452990493|FG001|Overall Study|Withdrawal by Subject|0|||
125915570|NCT04553679|452990492|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
125915571|NCT04553679|452990493|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
125915572|NCT02038881|452990494|FG000|Overall Study|Withdrawal by Subject|0|||
125915573|NCT02038881|452990495|FG001|Overall Study|Withdrawal by Subject|0|||
125915574|NCT02038881|452990496|FG002|Overall Study|Withdrawal by Subject|1|||
125915575|NCT02038881|452990494|FG000|Overall Study|Lost to Follow-up|2|||
125915576|NCT02038881|452990495|FG001|Overall Study|Lost to Follow-up|0|||
125915577|NCT02038881|452990496|FG002|Overall Study|Lost to Follow-up|0|||
125915578|NCT02038881|452990494|FG000|Overall Study|incarcerated|1|||
125915579|NCT02038881|452990495|FG001|Overall Study|incarcerated|0|||
125915580|NCT02038881|452990496|FG002|Overall Study|incarcerated|0|||
125915581|NCT03945214|452990497|FG000|Overall Study|Lost to Follow-up|3|||
125915582|NCT03945214|452990498|FG001|Overall Study|Lost to Follow-up|4|||
125915583|NCT03945214|452990499|FG002|Overall Study|Lost to Follow-up|7|||
126063011|NCT01074229|453523714|FG000|Overall Study|Lost to Follow-up|1|||
126063012|NCT01074229|453523715|FG001|Overall Study|Lost to Follow-up|0|||
126063013|NCT01074229|453523716|FG002|Overall Study|Lost to Follow-up|0|||
126063014|NCT01074229|453523714|FG000|Overall Study|Change to open surgical procedure|1|||
126063015|NCT01074229|453523715|FG001|Overall Study|Change to open surgical procedure|3|||
126063016|NCT01074229|453523716|FG002|Overall Study|Change to open surgical procedure|4|||
126063017|NCT02823574|453523722|FG000|Randomization|Disease Progression|0|||
126063018|NCT02823574|453523723|FG001|Randomization|Disease Progression|0|||
126063019|NCT02823574|453523724|FG002|Randomization|Disease Progression|1|||
126063020|NCT02823574|453523725|FG003|Randomization|Disease Progression|0|||
126063021|NCT02823574|453523722|FG000|Randomization|AE unrelated to Study Drug|1|||
126063022|NCT02823574|453523723|FG001|Randomization|AE unrelated to Study Drug|0|||
126110423|NCT01717768|453699370|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126110424|NCT01717768|453699371|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126063023|NCT02823574|453523724|FG002|Randomization|AE unrelated to Study Drug|0|||
126063024|NCT02823574|453523725|FG003|Randomization|AE unrelated to Study Drug|0|||
126063025|NCT02823574|453523722|FG000|Treatment Period|Poor/Non Compliance|1|||
126063026|NCT02823574|453523723|FG001|Treatment Period|Poor/Non Compliance|0|||
126063027|NCT02823574|453523724|FG002|Treatment Period|Poor/Non Compliance|0|||
126063028|NCT02823574|453523725|FG003|Treatment Period|Poor/Non Compliance|1|||
126063029|NCT02823574|453523722|FG000|Treatment Period|Maximum Clinical Benefit|8|||
126063030|NCT02823574|453523723|FG001|Treatment Period|Maximum Clinical Benefit|4|||
126063031|NCT02823574|453523724|FG002|Treatment Period|Maximum Clinical Benefit|7|||
126063032|NCT02823574|453523725|FG003|Treatment Period|Maximum Clinical Benefit|1|||
126063033|NCT02823574|453523722|FG000|Treatment Period|Lost to Follow-up|1|||
126063034|NCT02823574|453523723|FG001|Treatment Period|Lost to Follow-up|1|||
126063035|NCT02823574|453523724|FG002|Treatment Period|Lost to Follow-up|0|||
126063036|NCT02823574|453523725|FG003|Treatment Period|Lost to Follow-up|0|||
126063037|NCT02823574|453523722|FG000|Treatment Period|Participant withdrew consent|4|||
126063038|NCT02823574|453523723|FG001|Treatment Period|Participant withdrew consent|0|||
126063039|NCT02823574|453523724|FG002|Treatment Period|Participant withdrew consent|0|||
126063040|NCT02823574|453523725|FG003|Treatment Period|Participant withdrew consent|1|||
126063041|NCT02823574|453523722|FG000|Treatment Period|Participant request to discontinue|5|||
126063042|NCT02823574|453523723|FG001|Treatment Period|Participant request to discontinue|0|||
126063043|NCT02823574|453523724|FG002|Treatment Period|Participant request to discontinue|3|||
126063044|NCT02823574|453523725|FG003|Treatment Period|Participant request to discontinue|2|||
126063045|NCT02823574|453523722|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
126063046|NCT02823574|453523723|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
126063047|NCT02823574|453523724|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
126063048|NCT02823574|453523725|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
126063049|NCT02823574|453523722|FG000|Treatment Period|Study Drug Toxicity|11|||
126063050|NCT02823574|453523723|FG001|Treatment Period|Study Drug Toxicity|2|||
126063051|NCT02823574|453523724|FG002|Treatment Period|Study Drug Toxicity|14|||
126063052|NCT02823574|453523725|FG003|Treatment Period|Study Drug Toxicity|4|||
126063053|NCT02823574|453523722|FG000|Treatment Period|Disease Progression|113|||
126063054|NCT02823574|453523723|FG001|Treatment Period|Disease Progression|64|||
126063055|NCT02823574|453523724|FG002|Treatment Period|Disease Progression|82|||
126063056|NCT02823574|453523725|FG003|Treatment Period|Disease Progression|43|||
126063057|NCT02823574|453523722|FG000|Treatment Period|Other reasons|5|||
126063058|NCT02823574|453523723|FG001|Treatment Period|Other reasons|9|||
126063059|NCT02823574|453523724|FG002|Treatment Period|Other reasons|3|||
126063060|NCT02823574|453523725|FG003|Treatment Period|Other reasons|6|||
126063061|NCT02823574|453523722|FG000|Treatment Period|Participant no longer meets study criteria|0|||
126063062|NCT02823574|453523723|FG001|Treatment Period|Participant no longer meets study criteria|0|||
126063063|NCT02823574|453523724|FG002|Treatment Period|Participant no longer meets study criteria|1|||
126063064|NCT02823574|453523725|FG003|Treatment Period|Participant no longer meets study criteria|0|||
126063065|NCT02823574|453523722|FG000|Treatment Period|Death|0|||
126063066|NCT02823574|453523723|FG001|Treatment Period|Death|0|||
126063067|NCT02823574|453523724|FG002|Treatment Period|Death|3|||
126063068|NCT02823574|453523725|FG003|Treatment Period|Death|1|||
126063069|NCT00590759|453523726|FG000|Overall Study|Death|52|||
126063070|NCT00590759|453523726|FG000|Overall Study|Lost to Follow-up|28|||
126063071|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
126063072|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
126063073|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
126063074|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
126063075|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Death|0|||
126063076|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Death|0|||
126063077|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Death|1|||
126063078|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Death|0|||
126063079|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
126063080|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
126063081|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
126063082|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
126063083|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
126063084|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
126063085|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
126063086|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
126063087|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
126063088|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
126063089|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
125915584|NCT03945214|452990500|FG003|Overall Study|Lost to Follow-up|4|||
125915585|NCT00850070|452990504|FG000|Overall Study|Lack of Efficacy|1|||
125915586|NCT00850070|452990505|FG001|Overall Study|Lack of Efficacy|1|||
125915587|NCT00850070|452990504|FG000|Overall Study|Adverse Event|2|||
125915588|NCT00850070|452990505|FG001|Overall Study|Adverse Event|0|||
125915589|NCT00074984|452990506|FG000|Overall Study|Death|1|||
125915590|NCT00074984|452990507|FG001|Overall Study|Death|2|||
125915591|NCT00074984|452990506|FG000|Overall Study|Withdrawal by Subject|2|||
125915592|NCT00074984|452990507|FG001|Overall Study|Withdrawal by Subject|3|||
125915593|NCT00074984|452990506|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
125915594|NCT00074984|452990507|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
125915595|NCT01904058|452990512|FG000|Overall Study|Adverse Event|2|||
125915596|NCT01904058|452990513|FG001|Overall Study|Adverse Event|0|||
125915597|NCT01904058|452990514|FG002|Overall Study|Adverse Event|0|||
125915598|NCT01904058|452990515|FG003|Overall Study|Adverse Event|0|||
125915599|NCT01904058|452990512|FG000|Overall Study|Withdrawal by Subject|1|||
126063090|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
126063091|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
126063092|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
125915600|NCT01904058|452990513|FG001|Overall Study|Withdrawal by Subject|0|||
125915601|NCT01904058|452990514|FG002|Overall Study|Withdrawal by Subject|1|||
125915602|NCT01904058|452990515|FG003|Overall Study|Withdrawal by Subject|0|||
125915603|NCT01904058|452990512|FG000|Overall Study|Pregnancy|0|||
125915604|NCT01904058|452990513|FG001|Overall Study|Pregnancy|0|||
125915605|NCT01904058|452990514|FG002|Overall Study|Pregnancy|0|||
125915606|NCT01904058|452990515|FG003|Overall Study|Pregnancy|1|||
125915607|NCT03096483|452990518|FG000|Overall Study|Withdrawal by site|1|||
125915608|NCT02046733|452990522|FG000|Overall Study|never initiated 'treatment visits'|6|||
125915609|NCT02046733|452990523|FG001|Overall Study|never initiated 'treatment visits'|0|||
125915610|NCT04041375|452990528|FG000|Intervention Phase|Withdrawal by Subject|2|||
125915611|NCT04041375|452990529|FG001|Intervention Phase|Withdrawal by Subject|2|||
125915612|NCT04041375|452990528|FG000|Follow-up Phase|Death|2|||
125915613|NCT04041375|452990529|FG001|Follow-up Phase|Death|0|||
125915614|NCT04041375|452990528|FG000|Follow-up Phase|Lost to Follow-up|2|||
125915615|NCT04041375|452990529|FG001|Follow-up Phase|Lost to Follow-up|1|||
125915616|NCT04041375|452990528|FG000|Follow-up Phase|Too ill|3|||
125915617|NCT04041375|452990529|FG001|Follow-up Phase|Too ill|0|||
125915618|NCT04674644|452990535|FG000|Overall Study|with missing data|37|||
125915619|NCT00199875|452990536|FG000|Overall Study|Withdrawal by Subject|0|||
125915620|NCT00199875|452990537|FG001|Overall Study|Withdrawal by Subject|0|||
125915621|NCT00199875|452990538|FG002|Overall Study|Withdrawal by Subject|0|||
125915622|NCT00199875|452990539|FG003|Overall Study|Withdrawal by Subject|0|||
125915623|NCT00199875|452990540|FG004|Overall Study|Withdrawal by Subject|1|||
125915624|NCT01024231|452990544|FG000|Overall Study|Other Reasons|1|||
125915625|NCT01024231|452990545|FG001|Overall Study|Other Reasons|2|||
125915626|NCT01024231|452990546|FG002|Overall Study|Other Reasons|0|||
125915627|NCT01024231|452990547|FG003|Overall Study|Other Reasons|0|||
125915628|NCT01024231|452990548|FG004|Overall Study|Other Reasons|2|||
125915629|NCT01024231|452990549|FG005|Overall Study|Other Reasons|0|||
125915630|NCT01024231|452990550|FG006|Overall Study|Other Reasons|1|||
125915631|NCT01024231|452990544|FG000|Overall Study|Maximum Clinical Benefit|1|||
125915632|NCT01024231|452990545|FG001|Overall Study|Maximum Clinical Benefit|2|||
125915633|NCT01024231|452990546|FG002|Overall Study|Maximum Clinical Benefit|0|||
125915634|NCT01024231|452990547|FG003|Overall Study|Maximum Clinical Benefit|1|||
125915635|NCT01024231|452990548|FG004|Overall Study|Maximum Clinical Benefit|1|||
125915636|NCT01024231|452990549|FG005|Overall Study|Maximum Clinical Benefit|0|||
125915637|NCT01024231|452990550|FG006|Overall Study|Maximum Clinical Benefit|0|||
125915638|NCT01024231|452990544|FG000|Overall Study|Disease Progression|3|||
125915639|NCT01024231|452990545|FG001|Overall Study|Disease Progression|1|||
125915640|NCT01024231|452990546|FG002|Overall Study|Disease Progression|3|||
125915641|NCT01024231|452990547|FG003|Overall Study|Disease Progression|0|||
125915642|NCT01024231|452990548|FG004|Overall Study|Disease Progression|4|||
125915643|NCT01024231|452990549|FG005|Overall Study|Disease Progression|11|||
125915644|NCT01024231|452990550|FG006|Overall Study|Disease Progression|6|||
125915645|NCT01024231|452990544|FG000|Overall Study|AE unrelated to Study Drug|0|||
125915646|NCT01024231|452990545|FG001|Overall Study|AE unrelated to Study Drug|1|||
125915647|NCT01024231|452990546|FG002|Overall Study|AE unrelated to Study Drug|0|||
125915648|NCT01024231|452990547|FG003|Overall Study|AE unrelated to Study Drug|0|||
125915649|NCT01024231|452990548|FG004|Overall Study|AE unrelated to Study Drug|0|||
125915650|NCT01024231|452990549|FG005|Overall Study|AE unrelated to Study Drug|0|||
125915651|NCT01024231|452990550|FG006|Overall Study|AE unrelated to Study Drug|0|||
125915652|NCT01024231|452990544|FG000|Overall Study|No longer meets criteria|0|||
126063093|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
125915653|NCT01024231|452990545|FG001|Overall Study|No longer meets criteria|0|||
125915654|NCT01024231|452990546|FG002|Overall Study|No longer meets criteria|0|||
125915655|NCT01024231|452990547|FG003|Overall Study|No longer meets criteria|0|||
125915656|NCT01024231|452990548|FG004|Overall Study|No longer meets criteria|1|||
126063094|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
125915657|NCT01024231|452990549|FG005|Overall Study|No longer meets criteria|0|||
125915658|NCT01024231|452990550|FG006|Overall Study|No longer meets criteria|1|||
125915659|NCT01024231|452990544|FG000|Overall Study|Study Drug Toxicity|1|||
125915660|NCT01024231|452990545|FG001|Overall Study|Study Drug Toxicity|6|||
125915661|NCT01024231|452990546|FG002|Overall Study|Study Drug Toxicity|6|||
125915662|NCT01024231|452990547|FG003|Overall Study|Study Drug Toxicity|4|||
125915663|NCT01024231|452990548|FG004|Overall Study|Study Drug Toxicity|2|||
125915664|NCT01024231|452990549|FG005|Overall Study|Study Drug Toxicity|0|||
125915665|NCT01024231|452990550|FG006|Overall Study|Study Drug Toxicity|7|||
125915666|NCT01024231|452990544|FG000|Overall Study|Death|6|||
125915667|NCT01024231|452990545|FG001|Overall Study|Death|2|||
125915668|NCT01024231|452990546|FG002|Overall Study|Death|1|||
125915669|NCT01024231|452990547|FG003|Overall Study|Death|0|||
125915670|NCT01024231|452990548|FG004|Overall Study|Death|4|||
125915671|NCT01024231|452990549|FG005|Overall Study|Death|3|||
125915672|NCT01024231|452990550|FG006|Overall Study|Death|5|||
125915673|NCT01024231|452990544|FG000|Overall Study|Lost to Follow-up|0|||
125915674|NCT01024231|452990545|FG001|Overall Study|Lost to Follow-up|0|||
125915675|NCT01024231|452990546|FG002|Overall Study|Lost to Follow-up|0|||
125915676|NCT01024231|452990547|FG003|Overall Study|Lost to Follow-up|0|||
125915677|NCT01024231|452990548|FG004|Overall Study|Lost to Follow-up|0|||
125915678|NCT01024231|452990549|FG005|Overall Study|Lost to Follow-up|0|||
125915679|NCT01024231|452990550|FG006|Overall Study|Lost to Follow-up|1|||
125915680|NCT01024231|452990544|FG000|Overall Study|Withdrew Consent|0|||
125915681|NCT01024231|452990545|FG001|Overall Study|Withdrew Consent|1|||
125915682|NCT01024231|452990546|FG002|Overall Study|Withdrew Consent|0|||
125915683|NCT01024231|452990547|FG003|Overall Study|Withdrew Consent|0|||
125915684|NCT01024231|452990548|FG004|Overall Study|Withdrew Consent|0|||
125915685|NCT01024231|452990549|FG005|Overall Study|Withdrew Consent|0|||
125915686|NCT01024231|452990550|FG006|Overall Study|Withdrew Consent|0|||
125915687|NCT01024231|452990544|FG000|Overall Study|Continuing on Treatment|0|||
126063095|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
126063096|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
126063097|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
126063098|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
126063099|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Other|2|||
126063100|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Other|0|||
126063101|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Other|0|||
126063102|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Other|0|||
126063103|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
126063104|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
126063105|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
126063106|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
126063107|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
126063108|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
126063109|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
126063110|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
126063111|NCT03845517|453523733|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
126063112|NCT03845517|453523734|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
126063113|NCT03845517|453523735|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
126063114|NCT03845517|453523736|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
126063115|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
126063116|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
126063117|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
126063118|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
126063119|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Death|0|||
126063120|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Death|0|||
126063121|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Death|1|||
126063122|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Death|1|||
126063123|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
126063124|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
126063125|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
126063126|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
126063127|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
126110425|NCT01717768|453699372|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125915688|NCT01024231|452990545|FG001|Overall Study|Continuing on Treatment|0|||
125915689|NCT01024231|452990546|FG002|Overall Study|Continuing on Treatment|0|||
125915690|NCT01024231|452990547|FG003|Overall Study|Continuing on Treatment|0|||
125915691|NCT01024231|452990548|FG004|Overall Study|Continuing on Treatment|3|||
125915692|NCT01024231|452990549|FG005|Overall Study|Continuing on Treatment|2|||
125915693|NCT01024231|452990550|FG006|Overall Study|Continuing on Treatment|0|||
125915694|NCT03277690|452990551|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
125915695|NCT03277690|452990552|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
126063128|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
126063129|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
126063130|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
125915696|NCT03277690|452990551|FG000|Dose Titration and Maintenance|Physician Decision|1|||
125915697|NCT03277690|452990552|FG001|Dose Titration and Maintenance|Physician Decision|0|||
125915698|NCT03277690|452990551|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
125915699|NCT03277690|452990552|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
125915700|NCT03277690|452990551|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
125915701|NCT03277690|452990552|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
125915702|NCT03277690|452990551|FG000|Dose Titration and Maintenance|Adverse Event|15|||
125915703|NCT03277690|452990552|FG001|Dose Titration and Maintenance|Adverse Event|0|||
125915704|NCT03277690|452990551|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
125915705|NCT03277690|452990552|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
125915706|NCT03277690|452990551|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
125915707|NCT03277690|452990552|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
125915708|NCT00747812|452990553|FG000|Overall Study|Research Site Staff Relocation|5|||
125915709|NCT00747812|452990554|FG001|Overall Study|Research Site Staff Relocation|3|||
125915710|NCT01013350|452990555|FG000|Overall Study|Lost to Follow-up|15|||
125915711|NCT01013350|452990556|FG001|Overall Study|Lost to Follow-up|95|||
125915712|NCT01013350|452990555|FG000|Overall Study|Adverse Event|0|||
125915713|NCT01013350|452990556|FG001|Overall Study|Adverse Event|1|||
125915714|NCT01013350|452990555|FG000|Overall Study|Physician Decision|4|||
125915715|NCT01013350|452990556|FG001|Overall Study|Physician Decision|20|||
126063131|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
126063132|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
126063133|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
126063134|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
126063135|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Other|1|||
126063136|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Other|0|||
126063137|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Other|1|||
126063138|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Other|0|||
126063139|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
126063140|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
126063141|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
126063142|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
126063143|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
126063144|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
126063145|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
126063146|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
126063147|NCT03845517|453523733|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
126063148|NCT03845517|453523734|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
126063149|NCT03845517|453523735|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
126063150|NCT03845517|453523736|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
126063151|NCT01494467|453523737|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
126063152|NCT01494467|453523738|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
126063153|NCT01494467|453523737|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
126063154|NCT01494467|453523738|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
126063155|NCT01494467|453523737|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
126063156|NCT01494467|453523738|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
126063157|NCT01494467|453523737|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
126063158|NCT01494467|453523738|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
126063159|NCT01494467|453523737|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
126063160|NCT01494467|453523738|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
126063161|NCT01494467|453523737|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
126063162|NCT01494467|453523738|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
126063163|NCT01494467|453523737|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
126063164|NCT01494467|453523738|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
126063165|NCT01494467|453523737|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
126063166|NCT01494467|453523738|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
126063167|NCT01494467|453523737|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
126063168|NCT01494467|453523738|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
126063169|NCT01494467|453523737|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
126063170|NCT01494467|453523738|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
126063171|NCT01494467|453523737|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
126063172|NCT01494467|453523738|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
126063173|NCT01494467|453523737|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
126063174|NCT01494467|453523738|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
126063175|NCT01494467|453523737|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
126063176|NCT01494467|453523738|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
126063177|NCT01494467|453523737|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
126063178|NCT01494467|453523738|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
126063179|NCT00417885|453523739|FG000|Overall Study|Adverse Event|1|||
126063180|NCT00417885|453523739|FG000|Overall Study|Objective Progression or Relapse|3|||
126063181|NCT00417885|453523739|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
126063182|NCT02721147|453523740|FG000|Overall Study|Lost to Follow-up|2|||
126063183|NCT02721147|453523741|FG001|Overall Study|Lost to Follow-up|0|||
126063184|NCT02721147|453523742|FG002|Overall Study|Lost to Follow-up|0|||
126063185|NCT01912599|453523745|FG000|Overall Study|Withdrawal by Subject|0|||
126063186|NCT01912599|453523746|FG001|Overall Study|Withdrawal by Subject|1|||
126063187|NCT03386344|453523747|FG000|Overall Study|Adverse Event|6|||
126063188|NCT03386344|453523748|FG001|Overall Study|Adverse Event|3|||
126063189|NCT03386344|453523749|FG002|Overall Study|Adverse Event|1|||
126063190|NCT03386344|453523747|FG000|Overall Study|Poor Compliance to Protocol|0|||
126063191|NCT03386344|453523748|FG001|Overall Study|Poor Compliance to Protocol|1|||
126063192|NCT03386344|453523749|FG002|Overall Study|Poor Compliance to Protocol|0|||
126063193|NCT03386344|453523747|FG000|Overall Study|Study Terminated by Sponsor|101|||
126063194|NCT03386344|453523748|FG001|Overall Study|Study Terminated by Sponsor|102|||
126063195|NCT03386344|453523749|FG002|Overall Study|Study Terminated by Sponsor|106|||
126063196|NCT03386344|453523747|FG000|Overall Study|Lost to Follow-up|3|||
126063197|NCT03386344|453523748|FG001|Overall Study|Lost to Follow-up|2|||
126063198|NCT03386344|453523749|FG002|Overall Study|Lost to Follow-up|1|||
126063199|NCT03386344|453523747|FG000|Overall Study|At the Participant's own Request|7|||
126063200|NCT03386344|453523748|FG001|Overall Study|At the Participant's own Request|7|||
126063201|NCT03386344|453523749|FG002|Overall Study|At the Participant's own Request|8|||
126063202|NCT03386344|453523747|FG000|Overall Study|Reason not Specified|0|||
126063203|NCT03386344|453523748|FG001|Overall Study|Reason not Specified|1|||
125915716|NCT01013350|452990555|FG000|Overall Study|Withdrawal by Subject|15|||
125915717|NCT01013350|452990556|FG001|Overall Study|Withdrawal by Subject|38|||
125915718|NCT01013350|452990555|FG000|Overall Study|Death|3|||
125915719|NCT01013350|452990556|FG001|Overall Study|Death|5|||
125915720|NCT01013350|452990555|FG000|Overall Study|Participant entered interventional study|0|||
125915721|NCT01013350|452990556|FG001|Overall Study|Participant entered interventional study|8|||
125915722|NCT01013350|452990555|FG000|Overall Study|Other|1|||
125915723|NCT01013350|452990556|FG001|Overall Study|Other|25|||
125915724|NCT01708161|452990557|FG000|Overall Study|Adverse Event|1|||
125915725|NCT01708161|452990558|FG001|Overall Study|Adverse Event|3|||
125915726|NCT01708161|452990559|FG002|Overall Study|Adverse Event|4|||
125915727|NCT01708161|452990560|FG003|Overall Study|Adverse Event|2|||
125915728|NCT01708161|452990561|FG004|Overall Study|Adverse Event|3|||
125915729|NCT01708161|452990562|FG005|Overall Study|Adverse Event|0|||
125915730|NCT01708161|452990557|FG000|Overall Study|Death|0|||
125915731|NCT01708161|452990558|FG001|Overall Study|Death|0|||
125915732|NCT01708161|452990559|FG002|Overall Study|Death|0|||
125915733|NCT01708161|452990560|FG003|Overall Study|Death|1|||
125915734|NCT01708161|452990561|FG004|Overall Study|Death|0|||
125915735|NCT01708161|452990562|FG005|Overall Study|Death|1|||
125915736|NCT01708161|452990557|FG000|Overall Study|Withdrawal by Subject|0|||
125915737|NCT01708161|452990558|FG001|Overall Study|Withdrawal by Subject|1|||
125915738|NCT01708161|452990559|FG002|Overall Study|Withdrawal by Subject|1|||
125915739|NCT01708161|452990560|FG003|Overall Study|Withdrawal by Subject|0|||
125915740|NCT01708161|452990561|FG004|Overall Study|Withdrawal by Subject|0|||
125915741|NCT01708161|452990562|FG005|Overall Study|Withdrawal by Subject|0|||
125915742|NCT01708161|452990557|FG000|Overall Study|Administrative problems|0|||
125915743|NCT01708161|452990558|FG001|Overall Study|Administrative problems|1|||
125915744|NCT01708161|452990559|FG002|Overall Study|Administrative problems|0|||
125915745|NCT01708161|452990560|FG003|Overall Study|Administrative problems|0|||
125915746|NCT01708161|452990561|FG004|Overall Study|Administrative problems|0|||
125915747|NCT01708161|452990562|FG005|Overall Study|Administrative problems|0|||
125915748|NCT01708161|452990557|FG000|Overall Study|Disease progression|3|||
125915749|NCT01708161|452990558|FG001|Overall Study|Disease progression|5|||
125915750|NCT01708161|452990559|FG002|Overall Study|Disease progression|5|||
125915751|NCT01708161|452990560|FG003|Overall Study|Disease progression|13|||
125915752|NCT01708161|452990561|FG004|Overall Study|Disease progression|3|||
125915753|NCT01708161|452990562|FG005|Overall Study|Disease progression|0|||
125915754|NCT02019277|452990563|FG000|Overall Study|Withdrawal by Subject|3|||
125915755|NCT02019277|452990563|FG000|Overall Study|Death|7|||
125915756|NCT02019277|452990563|FG000|Overall Study|Did no Cooperate|1|||
125915757|NCT02019277|452990563|FG000|Overall Study|Adverse Event|1|||
125915758|NCT02633501|452990565|FG000|Overall Study|Adverse Event|0|||
125915759|NCT02633501|452990566|FG001|Overall Study|Adverse Event|0|||
125915760|NCT02633501|452990567|FG002|Overall Study|Adverse Event|1|||
125915761|NCT02633501|452990568|FG003|Overall Study|Adverse Event|0|||
125915762|NCT02633501|452990569|FG004|Overall Study|Adverse Event|1|||
125915763|NCT02633501|452990570|FG005|Overall Study|Adverse Event|1|||
125915764|NCT02633501|452990565|FG000|Overall Study|Withdrawal by Subject|2|||
125915765|NCT02633501|452990566|FG001|Overall Study|Withdrawal by Subject|1|||
125915766|NCT02633501|452990567|FG002|Overall Study|Withdrawal by Subject|2|||
125915767|NCT02633501|452990568|FG003|Overall Study|Withdrawal by Subject|2|||
125915768|NCT02633501|452990569|FG004|Overall Study|Withdrawal by Subject|1|||
125915769|NCT02633501|452990570|FG005|Overall Study|Withdrawal by Subject|3|||
125915770|NCT02633501|452990565|FG000|Overall Study|Various other reasons|0|||
125915771|NCT02633501|452990566|FG001|Overall Study|Various other reasons|2|||
125915772|NCT02633501|452990567|FG002|Overall Study|Various other reasons|4|||
125915773|NCT02633501|452990568|FG003|Overall Study|Various other reasons|1|||
125915774|NCT02633501|452990569|FG004|Overall Study|Various other reasons|7|||
125915775|NCT02633501|452990570|FG005|Overall Study|Various other reasons|11|||
125915776|NCT02633501|452990565|FG000|Overall Study|Lost to Follow-up|0|||
125915777|NCT02633501|452990566|FG001|Overall Study|Lost to Follow-up|0|||
125915778|NCT02633501|452990567|FG002|Overall Study|Lost to Follow-up|0|||
125915779|NCT02633501|452990568|FG003|Overall Study|Lost to Follow-up|1|||
125915780|NCT02633501|452990569|FG004|Overall Study|Lost to Follow-up|2|||
125915781|NCT02633501|452990570|FG005|Overall Study|Lost to Follow-up|0|||
125915782|NCT00395733|452990571|FG000|Period 2|Withdrawal by Subject|1|||
125915783|NCT00395733|452990572|FG001|Period 2|Withdrawal by Subject|2|||
125915784|NCT00395733|452990571|FG000|Period 2|Protocol Violation|0|||
125915785|NCT00395733|452990572|FG001|Period 2|Protocol Violation|1|||
125915786|NCT00395733|452990571|FG000|Period 2|Adverse Event|0|||
125915787|NCT00395733|452990572|FG001|Period 2|Adverse Event|2|||
125915788|NCT00395733|452990571|FG000|Period 2|Technical problems|1|||
125915789|NCT00395733|452990572|FG001|Period 2|Technical problems|0|||
125915790|NCT01672736|452990574|FG000|Overall Study|Available drug expired on 31 May 16|3|||
125915791|NCT02853344|452990579|FG000|Overall Study|Lost to Follow-up|1|||
125915792|NCT02853344|452990580|FG001|Overall Study|Lost to Follow-up|1|||
125915793|NCT02853344|452990579|FG000|Overall Study|Withdrawal by Subject|2|||
125915794|NCT02853344|452990580|FG001|Overall Study|Withdrawal by Subject|4|||
125915795|NCT02853344|452990579|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
125915796|NCT02853344|452990580|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
125915797|NCT02853344|452990579|FG000|Overall Study|Death|70|||
125915798|NCT02853344|452990580|FG001|Overall Study|Death|112|||
125915799|NCT02913612|452990581|FG000|Overall Study|Lost to Follow-up|6|||
125915800|NCT02913612|452990582|FG001|Overall Study|Lost to Follow-up|5|||
125915801|NCT02913612|452990583|FG002|Overall Study|Lost to Follow-up|2|||
125915802|NCT02913612|452990584|FG003|Overall Study|Lost to Follow-up|0|||
125915803|NCT02913612|452990581|FG000|Overall Study|Physician Decision|1|||
125915804|NCT02913612|452990582|FG001|Overall Study|Physician Decision|4|||
125915805|NCT02913612|452990583|FG002|Overall Study|Physician Decision|1|||
125915806|NCT02913612|452990584|FG003|Overall Study|Physician Decision|0|||
125915807|NCT02913612|452990581|FG000|Overall Study|Withdrawal by Subject|2|||
125915808|NCT02913612|452990582|FG001|Overall Study|Withdrawal by Subject|4|||
125915809|NCT02913612|452990583|FG002|Overall Study|Withdrawal by Subject|0|||
125915810|NCT02913612|452990584|FG003|Overall Study|Withdrawal by Subject|0|||
125915811|NCT02913612|452990581|FG000|Overall Study|Hemangioma resolved|1|||
125915812|NCT02913612|452990582|FG001|Overall Study|Hemangioma resolved|0|||
125915813|NCT02913612|452990583|FG002|Overall Study|Hemangioma resolved|0|||
125915814|NCT02913612|452990584|FG003|Overall Study|Hemangioma resolved|0|||
125915815|NCT02913612|452990581|FG000|Overall Study|Local IRB decision|1|||
125915816|NCT02913612|452990582|FG001|Overall Study|Local IRB decision|0|||
125915817|NCT02913612|452990583|FG002|Overall Study|Local IRB decision|0|||
125915818|NCT02913612|452990584|FG003|Overall Study|Local IRB decision|0|||
125915819|NCT02913612|452990581|FG000|Overall Study|Study drug non-compliance|1|||
125915820|NCT02913612|452990582|FG001|Overall Study|Study drug non-compliance|1|||
125915821|NCT02913612|452990583|FG002|Overall Study|Study drug non-compliance|0|||
125915822|NCT02913612|452990584|FG003|Overall Study|Study drug non-compliance|0|||
125915823|NCT02913612|452990581|FG000|Overall Study|Insurance issues|0|||
125915824|NCT02913612|452990582|FG001|Overall Study|Insurance issues|1|||
125915825|NCT02913612|452990583|FG002|Overall Study|Insurance issues|0|||
125915826|NCT02913612|452990584|FG003|Overall Study|Insurance issues|0|||
125915827|NCT02913612|452990581|FG000|Overall Study|Needed to treat second hemangioma|0|||
125915828|NCT02913612|452990582|FG001|Overall Study|Needed to treat second hemangioma|1|||
125915829|NCT02913612|452990583|FG002|Overall Study|Needed to treat second hemangioma|0|||
125915830|NCT02913612|452990584|FG003|Overall Study|Needed to treat second hemangioma|0|||
125915831|NCT02913612|452990581|FG000|Overall Study|Study completion criteria not met|0|||
125915832|NCT02913612|452990582|FG001|Overall Study|Study completion criteria not met|1|||
125915833|NCT02913612|452990583|FG002|Overall Study|Study completion criteria not met|0|||
125915834|NCT02913612|452990584|FG003|Overall Study|Study completion criteria not met|0|||
125915835|NCT02913612|452990581|FG000|Overall Study|Ineligible|0|||
125915836|NCT02913612|452990582|FG001|Overall Study|Ineligible|1|||
125915837|NCT02913612|452990583|FG002|Overall Study|Ineligible|0|||
125915838|NCT02913612|452990584|FG003|Overall Study|Ineligible|0|||
125915839|NCT03452228|452990587|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125915840|NCT03452228|452990588|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
125915841|NCT03452228|452990589|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125915842|NCT03452228|452990587|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125915843|NCT03452228|452990588|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125915844|NCT03452228|452990589|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125915845|NCT03452228|452990587|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
125915846|NCT03452228|452990588|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
125915847|NCT03452228|452990589|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
125915848|NCT03452228|452990587|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125915849|NCT03452228|452990588|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125915850|NCT03452228|452990589|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
125915851|NCT01710046|452990590|FG000|Overall Study|Lost to Follow-up|1|||
125915852|NCT01710046|452990591|FG001|Overall Study|Lost to Follow-up|0|||
125915853|NCT03896165|452990592|FG000|Overall Study|Withdrawal by Subject|2|||
125915854|NCT03181893|452990593|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915855|NCT03181893|452990594|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
125915856|NCT03181893|452990595|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915857|NCT03181893|452990596|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915858|NCT03181893|452990597|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915859|NCT03181893|452990598|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915860|NCT03181893|452990599|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915861|NCT03181893|452990600|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915862|NCT03181893|452990601|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915863|NCT03181893|452990602|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915864|NCT03181893|452990603|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125915865|NCT03181893|452990593|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
125915866|NCT03181893|452990594|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
125915867|NCT03181893|452990595|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915868|NCT03181893|452990596|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915869|NCT03181893|452990597|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915870|NCT03181893|452990598|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915871|NCT03181893|452990599|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915872|NCT03181893|452990600|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915873|NCT03181893|452990601|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915874|NCT03181893|452990602|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915875|NCT03181893|452990603|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125915876|NCT03181893|452990593|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915877|NCT03181893|452990594|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915878|NCT03181893|452990595|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915879|NCT03181893|452990596|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915880|NCT03181893|452990597|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915881|NCT03181893|452990598|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915882|NCT03181893|452990599|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915883|NCT03181893|452990600|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
125915884|NCT03181893|452990601|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
125915885|NCT03181893|452990602|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915886|NCT03181893|452990603|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125915887|NCT03181893|452990593|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915888|NCT03181893|452990594|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915889|NCT03181893|452990595|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915890|NCT03181893|452990596|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915891|NCT03181893|452990597|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915892|NCT03181893|452990598|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915893|NCT03181893|452990599|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915894|NCT03181893|452990600|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915895|NCT03181893|452990601|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915896|NCT03181893|452990602|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
125915897|NCT03181893|452990603|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125915898|NCT03181893|452990593|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915899|NCT03181893|452990594|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915900|NCT03181893|452990595|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915901|NCT03181893|452990596|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915902|NCT03181893|452990597|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915903|NCT03181893|452990598|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915904|NCT03181893|452990599|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915905|NCT03181893|452990600|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915906|NCT03181893|452990601|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915907|NCT03181893|452990602|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125915908|NCT03181893|452990603|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
125915909|NCT03673046|452992334|FG000|Overall Study|Adverse Event|1|||
125915910|NCT03673046|452992335|FG001|Overall Study|Adverse Event|1|||
125915911|NCT03673046|452992334|FG000|Overall Study|Withdrawal by Subject|8|||
125915912|NCT03673046|452992335|FG001|Overall Study|Withdrawal by Subject|2|||
125915913|NCT03817879|452992336|FG000|Overall Study|Drop out|5|||
125915914|NCT03817879|452992337|FG001|Overall Study|Drop out|12|||
125915915|NCT03817879|452992336|FG000|Overall Study|Withdrawal by Subject|0|||
125915916|NCT03817879|452992337|FG001|Overall Study|Withdrawal by Subject|1|||
125915917|NCT01896050|452992340|FG000|Overall Study|Adverse Event|37|||
125915918|NCT01896050|452992341|FG001|Overall Study|Adverse Event|2|||
125915919|NCT01896050|452992340|FG000|Overall Study|Death|1|||
125915920|NCT01896050|452992341|FG001|Overall Study|Death|0|||
125915921|NCT00392015|452992342|FG000|Overall Study|Lost to Follow-up|2|||
125915922|NCT00392015|452992343|FG001|Overall Study|Lost to Follow-up|0|||
125915923|NCT00392015|452992344|FG002|Overall Study|Lost to Follow-up|2|||
125915924|NCT00392015|452992345|FG003|Overall Study|Lost to Follow-up|1|||
125915925|NCT00392015|452992346|FG004|Overall Study|Lost to Follow-up|1|||
125915926|NCT00392015|452992347|FG005|Overall Study|Lost to Follow-up|0|||
125915927|NCT00392015|452992342|FG000|Overall Study|Withdrawal by Subject|0|||
125915928|NCT00392015|452992343|FG001|Overall Study|Withdrawal by Subject|0|||
125915929|NCT00392015|452992344|FG002|Overall Study|Withdrawal by Subject|2|||
125915930|NCT00392015|452992345|FG003|Overall Study|Withdrawal by Subject|0|||
125915931|NCT00392015|452992346|FG004|Overall Study|Withdrawal by Subject|0|||
125915932|NCT00392015|452992347|FG005|Overall Study|Withdrawal by Subject|0|||
125915933|NCT00392015|452992342|FG000|Overall Study|Adverse Event|0|||
125915934|NCT00392015|452992343|FG001|Overall Study|Adverse Event|0|||
125915935|NCT00392015|452992344|FG002|Overall Study|Adverse Event|0|||
125915936|NCT00392015|452992345|FG003|Overall Study|Adverse Event|0|||
125915937|NCT00392015|452992346|FG004|Overall Study|Adverse Event|1|||
125915938|NCT00392015|452992347|FG005|Overall Study|Adverse Event|0|||
125915939|NCT00392015|452992342|FG000|Overall Study|Previous trial recipient|0|||
125915940|NCT00392015|452992343|FG001|Overall Study|Previous trial recipient|0|||
125915941|NCT00392015|452992344|FG002|Overall Study|Previous trial recipient|0|||
125915942|NCT00392015|452992345|FG003|Overall Study|Previous trial recipient|0|||
125915943|NCT00392015|452992346|FG004|Overall Study|Previous trial recipient|1|||
125915944|NCT00392015|452992347|FG005|Overall Study|Previous trial recipient|0|||
125915945|NCT02180724|452992348|FG000|Overall Study|Death|26|||
125915946|NCT02180724|452992349|FG001|Overall Study|Death|1|||
125915947|NCT02180724|452992348|FG000|Overall Study|Lost to Follow-up|3|||
125915948|NCT02180724|452992349|FG001|Overall Study|Lost to Follow-up|1|||
125915949|NCT02180724|452992348|FG000|Overall Study|Withdrawal by Subject|4|||
125915950|NCT02180724|452992349|FG001|Overall Study|Withdrawal by Subject|2|||
125915951|NCT02180724|452992348|FG000|Overall Study|PI Decision|5|||
125915952|NCT02180724|452992349|FG001|Overall Study|PI Decision|2|||
125915953|NCT02180724|452992348|FG000|Overall Study|Study terminated by sponsor|54|||
125915954|NCT02180724|452992349|FG001|Overall Study|Study terminated by sponsor|8|||
125915955|NCT03693300|452992350|FG000|Overall Study|Withdrawal by Subject|6|||
125915956|NCT03693300|452992351|FG001|Overall Study|Withdrawal by Subject|0|||
125915957|NCT03693300|452992350|FG000|Overall Study|Death|50|||
125915958|NCT03693300|452992351|FG001|Overall Study|Death|2|||
125915959|NCT03693300|452992350|FG000|Overall Study|Lost to Follow-up|2|||
125915960|NCT03693300|452992351|FG001|Overall Study|Lost to Follow-up|0|||
125915961|NCT02206048|452992352|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
125915962|NCT02925923|452992356|FG000|Overall Study|blood samples hemolyzed|0|||
125915963|NCT02925923|452992357|FG001|Overall Study|blood samples hemolyzed|2|||
125915964|NCT00866788|452992358|FG000|Overall Study|Adverse Event|0|||
125915965|NCT00866788|452992359|FG001|Overall Study|Adverse Event|2|||
125915966|NCT00866788|452992360|FG002|Overall Study|Adverse Event|0|||
125915967|NCT00866788|452992361|FG003|Overall Study|Adverse Event|1|||
126063204|NCT03386344|453523749|FG002|Overall Study|Reason not Specified|0|||
126063205|NCT01280721|453523750|FG000|Overall Study|Adverse Event|4|||
125915968|NCT00866788|452992358|FG000|Overall Study|Lost to Follow-up|1|||
125915969|NCT00866788|452992359|FG001|Overall Study|Lost to Follow-up|1|||
125915970|NCT00866788|452992360|FG002|Overall Study|Lost to Follow-up|0|||
125915971|NCT00866788|452992361|FG003|Overall Study|Lost to Follow-up|2|||
125915972|NCT00866788|452992358|FG000|Overall Study|Withdrawal by Subject|2|||
126063206|NCT01280721|453523750|FG000|Overall Study|Physician Decision|3|||
126063207|NCT01280721|453523750|FG000|Overall Study|Withdrawal by Subject|6|||
125915973|NCT00866788|452992359|FG001|Overall Study|Withdrawal by Subject|1|||
125915974|NCT00866788|452992360|FG002|Overall Study|Withdrawal by Subject|0|||
125915975|NCT00866788|452992361|FG003|Overall Study|Withdrawal by Subject|1|||
125915976|NCT00866788|452992358|FG000|Overall Study|Pregnancy|0|||
125915977|NCT00866788|452992359|FG001|Overall Study|Pregnancy|1|||
125915978|NCT00866788|452992360|FG002|Overall Study|Pregnancy|0|||
125915979|NCT00866788|452992361|FG003|Overall Study|Pregnancy|0|||
125915980|NCT00866788|452992358|FG000|Overall Study|Disease progression|3|||
125915981|NCT00866788|452992359|FG001|Overall Study|Disease progression|1|||
125915982|NCT00866788|452992360|FG002|Overall Study|Disease progression|1|||
125915983|NCT00866788|452992361|FG003|Overall Study|Disease progression|0|||
125915984|NCT00866788|452992358|FG000|Overall Study|Physician Decision|0|||
125915985|NCT00866788|452992359|FG001|Overall Study|Physician Decision|0|||
125915986|NCT00866788|452992360|FG002|Overall Study|Physician Decision|1|||
125915987|NCT00866788|452992361|FG003|Overall Study|Physician Decision|1|||
125915988|NCT02742441|452992365|FG000|Overall Study|Lost to Follow-up|4|||
125915989|NCT02742441|452992366|FG001|Overall Study|Lost to Follow-up|4|||
125915990|NCT02742441|452992365|FG000|Overall Study|Withdrawal by Subject|2|||
125915991|NCT02742441|452992366|FG001|Overall Study|Withdrawal by Subject|2|||
125915992|NCT02742441|452992365|FG000|Overall Study|Adverse Event|0|||
125915993|NCT02742441|452992366|FG001|Overall Study|Adverse Event|2|||
125915994|NCT04806503|452992372|FG000|Overall Study|Lost to Follow-up|0|||
125915995|NCT04806503|452992373|FG001|Overall Study|Lost to Follow-up|0|||
125915996|NCT04806503|452992374|FG002|Overall Study|Lost to Follow-up|1|||
125915997|NCT04806503|452992375|FG003|Overall Study|Lost to Follow-up|0|||
125915998|NCT04806503|452992376|FG004|Overall Study|Lost to Follow-up|0|||
125915999|NCT04806503|452992372|FG000|Overall Study|Withdrawal by Subject|1|||
125916000|NCT04806503|452992373|FG001|Overall Study|Withdrawal by Subject|0|||
125916001|NCT04806503|452992374|FG002|Overall Study|Withdrawal by Subject|1|||
125916002|NCT04806503|452992375|FG003|Overall Study|Withdrawal by Subject|1|||
125916003|NCT04806503|452992376|FG004|Overall Study|Withdrawal by Subject|1|||
125916004|NCT04806503|452992372|FG000|Overall Study|Adverse Event|1|||
125916005|NCT04806503|452992373|FG001|Overall Study|Adverse Event|1|||
125916006|NCT04806503|452992374|FG002|Overall Study|Adverse Event|0|||
125916007|NCT04806503|452992375|FG003|Overall Study|Adverse Event|1|||
125916008|NCT04806503|452992376|FG004|Overall Study|Adverse Event|0|||
125916009|NCT03589469|452992377|FG000|Overall Study|Withdrawal by Subject|8|||
125916010|NCT03589469|452992377|FG000|Overall Study|Physician Decision|20|||
126063208|NCT01280721|453523750|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
126063209|NCT01280721|453523750|FG000|Overall Study|No tolerability for the lowest dose|2|||
126063210|NCT00248794|453523751|FG000|Overall Study|Lost to Follow-up|6|||
126063211|NCT00248794|453523752|FG001|Overall Study|Lost to Follow-up|8|||
126063212|NCT00248794|453523753|FG002|Overall Study|Lost to Follow-up|3|||
126063213|NCT03449979|453523754|FG000|Overall Study|Technical difficulty|0|||
126063214|NCT03449979|453523755|FG001|Overall Study|Technical difficulty|0|||
126063215|NCT03449979|453523756|FG002|Overall Study|Technical difficulty|0|||
126063216|NCT03449979|453523757|FG003|Overall Study|Technical difficulty|1|||
126063217|NCT02632747|453523758|FG000|Wash-out Period|Adverse Event|1|||
126063218|NCT02632747|453523759|FG001|Wash-out Period|Adverse Event|0|||
126063219|NCT02069379|453523760|FG000|Baseline Measurements|Lost to Follow-up|1|||
126063220|NCT02069379|453523761|FG001|Baseline Measurements|Lost to Follow-up|0|||
126063221|NCT02069379|453523762|FG002|Baseline Measurements|Lost to Follow-up|0|||
126063222|NCT02069379|453523763|FG003|Baseline Measurements|Lost to Follow-up|0|||
126063223|NCT02069379|453523760|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
126063224|NCT02069379|453523761|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
126063225|NCT02069379|453523762|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
126063226|NCT02069379|453523763|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
126063227|NCT02069379|453523760|FG000|First Treatment Arm|Lost to Follow-up|0|||
126063228|NCT02069379|453523761|FG001|First Treatment Arm|Lost to Follow-up|1|||
126063229|NCT02069379|453523762|FG002|First Treatment Arm|Lost to Follow-up|1|||
126063230|NCT02069379|453523763|FG003|First Treatment Arm|Lost to Follow-up|0|||
126063231|NCT02069379|453523760|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
126063232|NCT02069379|453523761|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
126063233|NCT02069379|453523762|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
126063234|NCT02069379|453523763|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
126063235|NCT02069379|453523760|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
126063236|NCT02069379|453523761|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
126063237|NCT02069379|453523762|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
126063238|NCT02069379|453523763|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
126063239|NCT02069379|453523760|FG000|Second Treatment Arm|Lost to Follow-up|0|||
126063240|NCT02069379|453523761|FG001|Second Treatment Arm|Lost to Follow-up|0|||
126063241|NCT02069379|453523762|FG002|Second Treatment Arm|Lost to Follow-up|1|||
126063242|NCT02069379|453523763|FG003|Second Treatment Arm|Lost to Follow-up|0|||
126063243|NCT00700999|453523764|FG000|Overall Study|Lost to Follow-up|7|||
125916011|NCT03589469|452992377|FG000|Overall Study|Death|97|||
125916012|NCT03589469|452992377|FG000|Overall Study|Lost to Follow-up|8|||
125916013|NCT03589469|452992377|FG000|Overall Study|Miscellaneous|1|||
125916014|NCT02008318|452992382|FG000|Overall Study|Adverse Event|4|||
125916015|NCT02008318|452992383|FG001|Overall Study|Adverse Event|0|||
125916016|NCT02008318|452992382|FG000|Overall Study|Physician Decision|2|||
125916017|NCT02008318|452992383|FG001|Overall Study|Physician Decision|0|||
125916018|NCT02008318|452992382|FG000|Overall Study|Progressive Disease|2|||
125916019|NCT02008318|452992383|FG001|Overall Study|Progressive Disease|0|||
125916020|NCT02008318|452992382|FG000|Overall Study|Protocol Violation|1|||
125916021|NCT02008318|452992383|FG001|Overall Study|Protocol Violation|1|||
125916022|NCT02008318|452992382|FG000|Overall Study|Withdrawal by Subject|3|||
125916023|NCT02008318|452992383|FG001|Overall Study|Withdrawal by Subject|0|||
125916024|NCT02281773|452992384|FG000|Overall Study|Adverse Event|6|||
125916025|NCT02281773|452992385|FG001|Overall Study|Adverse Event|1|||
125916026|NCT02281773|452992386|FG002|Overall Study|Adverse Event|4|||
125916027|NCT02281773|452992387|FG003|Overall Study|Adverse Event|8|||
125916028|NCT02281773|452992388|FG004|Overall Study|Adverse Event|9|||
125916029|NCT02281773|452992384|FG000|Overall Study|Protocol Violation|1|||
125916030|NCT02281773|452992385|FG001|Overall Study|Protocol Violation|0|||
125916031|NCT02281773|452992386|FG002|Overall Study|Protocol Violation|0|||
125916032|NCT02281773|452992387|FG003|Overall Study|Protocol Violation|2|||
125916033|NCT02281773|452992388|FG004|Overall Study|Protocol Violation|2|||
125916034|NCT02281773|452992384|FG000|Overall Study|Lost to Follow-up|2|||
125916035|NCT02281773|452992385|FG001|Overall Study|Lost to Follow-up|2|||
125916036|NCT02281773|452992386|FG002|Overall Study|Lost to Follow-up|6|||
125916037|NCT02281773|452992387|FG003|Overall Study|Lost to Follow-up|2|||
125916038|NCT02281773|452992388|FG004|Overall Study|Lost to Follow-up|10|||
125916039|NCT02281773|452992384|FG000|Overall Study|Withdrawal by Subject|2|||
125916040|NCT02281773|452992385|FG001|Overall Study|Withdrawal by Subject|8|||
125916041|NCT02281773|452992386|FG002|Overall Study|Withdrawal by Subject|6|||
125916042|NCT02281773|452992387|FG003|Overall Study|Withdrawal by Subject|6|||
125916043|NCT02281773|452992388|FG004|Overall Study|Withdrawal by Subject|8|||
125916044|NCT02281773|452992384|FG000|Overall Study|Other Reason|0|||
125916045|NCT02281773|452992385|FG001|Overall Study|Other Reason|4|||
125916046|NCT02281773|452992386|FG002|Overall Study|Other Reason|2|||
125916047|NCT02281773|452992387|FG003|Overall Study|Other Reason|3|||
125916048|NCT02281773|452992388|FG004|Overall Study|Other Reason|1|||
125916049|NCT00231842|452992389|FG000|Overall Study|Withdrawal by Subject|3|||
125916050|NCT00231842|452992389|FG000|Overall Study|Did not complete the last 3 cycle|8|||
125916051|NCT05439941|452992390|FG000|Overall Study|Lack of Efficacy|8|||
125916052|NCT05439941|452992391|FG001|Overall Study|Lack of Efficacy|5|||
125916053|NCT05439941|452992392|FG002|Overall Study|Lack of Efficacy|3|||
125916054|NCT05439941|452992390|FG000|Overall Study|Treatment Failure|0|||
125916055|NCT05439941|452992391|FG001|Overall Study|Treatment Failure|1|||
125916056|NCT05439941|452992392|FG002|Overall Study|Treatment Failure|0|||
125916057|NCT05439941|452992390|FG000|Overall Study|Adverse Event|1|||
125916058|NCT05439941|452992391|FG001|Overall Study|Adverse Event|3|||
125916059|NCT05439941|452992392|FG002|Overall Study|Adverse Event|0|||
125916060|NCT05439941|452992390|FG000|Overall Study|Adverse Event - Parent Study|1|||
125916061|NCT05439941|452992391|FG001|Overall Study|Adverse Event - Parent Study|0|||
125916062|NCT05439941|452992392|FG002|Overall Study|Adverse Event - Parent Study|0|||
125916063|NCT05439941|452992390|FG000|Overall Study|Pregnancy|1|||
125916064|NCT05439941|452992391|FG001|Overall Study|Pregnancy|0|||
125916065|NCT05439941|452992392|FG002|Overall Study|Pregnancy|0|||
125916066|NCT05439941|452992390|FG000|Overall Study|Withdrawal by Subject|9|||
125916067|NCT05439941|452992391|FG001|Overall Study|Withdrawal by Subject|6|||
125916068|NCT05439941|452992392|FG002|Overall Study|Withdrawal by Subject|10|||
125916069|NCT05439941|452992390|FG000|Overall Study|Non-Compliance|1|||
125916070|NCT05439941|452992391|FG001|Overall Study|Non-Compliance|1|||
125916071|NCT05439941|452992392|FG002|Overall Study|Non-Compliance|1|||
125916072|NCT05439941|452992390|FG000|Overall Study|Lost to Follow-up|2|||
125916073|NCT05439941|452992391|FG001|Overall Study|Lost to Follow-up|2|||
125916074|NCT05439941|452992392|FG002|Overall Study|Lost to Follow-up|0|||
125916075|NCT05439941|452992390|FG000|Overall Study|Physician Decision|1|||
125916076|NCT05439941|452992391|FG001|Overall Study|Physician Decision|0|||
125916077|NCT05439941|452992392|FG002|Overall Study|Physician Decision|0|||
125916078|NCT05439941|452992390|FG000|Overall Study|Trial Termination by Sponsor|78|||
125916079|NCT05439941|452992391|FG001|Overall Study|Trial Termination by Sponsor|83|||
125916080|NCT05439941|452992392|FG002|Overall Study|Trial Termination by Sponsor|65|||
125916081|NCT05439941|452992390|FG000|Overall Study|Other than Reasons Listed|2|||
125916082|NCT05439941|452992391|FG001|Overall Study|Other than Reasons Listed|1|||
125916083|NCT05439941|452992392|FG002|Overall Study|Other than Reasons Listed|0|||
125916084|NCT02422303|452992393|FG000|Overall Study|Lost to Follow-up|1|||
125916085|NCT02422303|452992394|FG001|Overall Study|Lost to Follow-up|1|||
125916086|NCT02899299|452992396|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
125916087|NCT02899299|452992397|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
125916088|NCT02899299|452992396|FG000|Pre-treatment|Participant withdrew consent|1|||
125916089|NCT02899299|452992397|FG001|Pre-treatment|Participant withdrew consent|11|||
125916090|NCT02899299|452992396|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
125916091|NCT02899299|452992397|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
125916092|NCT02899299|452992396|FG000|Pre-treatment|Not reported|0|||
125916093|NCT02899299|452992397|FG001|Pre-treatment|Not reported|1|||
125916094|NCT02899299|452992396|FG000|Treatment|Disease Progression|182|||
125916095|NCT02899299|452992397|FG001|Treatment|Disease Progression|43|||
125916096|NCT02899299|452992396|FG000|Treatment|Study Drug Toxicity|60|||
125916097|NCT02899299|452992397|FG001|Treatment|Study Drug Toxicity|24|||
125916098|NCT02899299|452992396|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
125916099|NCT02899299|452992397|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
125916100|NCT02899299|452992396|FG000|Treatment|Participant request to discontinue Study treatment|4|||
125916101|NCT02899299|452992397|FG001|Treatment|Participant request to discontinue Study treatment|10|||
125916102|NCT02899299|452992396|FG000|Treatment|Participant withdrew consent|6|||
125916103|NCT02899299|452992397|FG001|Treatment|Participant withdrew consent|3|||
125916104|NCT02899299|452992396|FG000|Treatment|Lost to Follow-up|0|||
125916105|NCT02899299|452992397|FG001|Treatment|Lost to Follow-up|2|||
125916106|NCT02899299|452992396|FG000|Treatment|Maximum Clinical Benefit|11|||
125916107|NCT02899299|452992397|FG001|Treatment|Maximum Clinical Benefit|2|||
125916108|NCT02899299|452992396|FG000|Treatment|Poor/Non-compliance|1|||
125916109|NCT02899299|452992397|FG001|Treatment|Poor/Non-compliance|0|||
125916110|NCT02899299|452992396|FG000|Treatment|Participant no longer meets Study criteria|4|||
125916111|NCT02899299|452992397|FG001|Treatment|Participant no longer meets Study criteria|0|||
125916112|NCT02899299|452992396|FG000|Treatment|Administrative reason by Sponsor|2|||
125916113|NCT02899299|452992397|FG001|Treatment|Administrative reason by Sponsor|0|||
125916114|NCT02899299|452992396|FG000|Treatment|Other reasons|12|||
125916115|NCT02899299|452992397|FG001|Treatment|Other reasons|2|||
125916116|NCT02899299|452992396|FG000|Treatment|Not reported|7|||
125916117|NCT02899299|452992397|FG001|Treatment|Not reported|0|||
125916118|NCT00313300|452992398|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
125916119|NCT00313300|452992399|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
125916120|NCT00313300|452992400|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
125916121|NCT00313300|452992401|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
125916122|NCT00313300|452992402|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
125916123|NCT00313300|452992398|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
125916124|NCT00313300|452992399|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
125916125|NCT00313300|452992400|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
125916126|NCT00313300|452992401|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
125916127|NCT00313300|452992402|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
125916128|NCT00313300|452992398|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
125916129|NCT00313300|452992399|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
125916130|NCT00313300|452992400|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
125916131|NCT00313300|452992401|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
125916132|NCT00313300|452992402|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
125916133|NCT00313300|452992398|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
125916134|NCT00313300|452992399|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
125916135|NCT00313300|452992400|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
125916136|NCT00313300|452992401|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
125916137|NCT00313300|452992402|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
125916138|NCT00313300|452992398|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
125916139|NCT00313300|452992399|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
125916140|NCT00313300|452992400|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
125916141|NCT00313300|452992401|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
125916142|NCT00313300|452992402|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
125916143|NCT00313300|452992398|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
125916144|NCT00313300|452992399|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
125916145|NCT00313300|452992400|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
125916146|NCT00313300|452992401|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
125916147|NCT00313300|452992402|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
125916148|NCT00313300|452992398|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
125916149|NCT00313300|452992399|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
125916150|NCT00313300|452992400|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
125916151|NCT00313300|452992401|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
125916152|NCT00313300|452992402|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
125916153|NCT00313300|452992398|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
125916154|NCT00313300|452992399|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
125916155|NCT00313300|452992400|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
125916156|NCT00313300|452992401|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
125916157|NCT00313300|452992402|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
125916158|NCT00313300|452992398|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
125916159|NCT00313300|452992399|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
125916160|NCT00313300|452992400|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
125916161|NCT00313300|452992401|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
125916162|NCT00313300|452992402|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
125916163|NCT00313300|452992398|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
125916164|NCT00313300|452992399|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
125916165|NCT00313300|452992400|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
125916166|NCT00313300|452992401|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
125916167|NCT00313300|452992402|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
125916168|NCT00313300|452992398|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
125916169|NCT00313300|452992399|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
125916170|NCT00313300|452992400|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
125916171|NCT00313300|452992401|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
125916172|NCT00313300|452992402|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
125916173|NCT00313300|452992398|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
125916174|NCT00313300|452992399|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
125916175|NCT00313300|452992400|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
125916176|NCT00313300|452992401|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
125916177|NCT00313300|452992402|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
125916178|NCT00313300|452992398|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
125916179|NCT00313300|452992399|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
125916180|NCT00313300|452992400|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
125916181|NCT00313300|452992401|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
125916182|NCT00313300|452992402|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
125916183|NCT00313300|452992398|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
125916184|NCT00313300|452992399|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
125916185|NCT00313300|452992400|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
125916186|NCT00313300|452992401|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
125916187|NCT00313300|452992402|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
125916188|NCT00313300|452992398|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
125916189|NCT00313300|452992399|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
125916190|NCT00313300|452992400|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
125916191|NCT00313300|452992401|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
125916192|NCT00313300|452992402|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
125916193|NCT00313300|452992398|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
125916194|NCT00313300|452992399|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
125916195|NCT00313300|452992400|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
125916196|NCT00313300|452992401|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
125916197|NCT00313300|452992402|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
125916198|NCT00313300|452992398|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
125916199|NCT00313300|452992399|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
125916200|NCT00313300|452992400|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
125916201|NCT00313300|452992401|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
125916202|NCT00313300|452992402|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
125916203|NCT00313300|452992398|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
125916204|NCT00313300|452992399|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
125916205|NCT00313300|452992400|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
125916206|NCT00313300|452992401|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
125916207|NCT00313300|452992402|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
125916208|NCT00313300|452992398|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
125916209|NCT00313300|452992399|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
125916210|NCT00313300|452992400|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
125916211|NCT00313300|452992401|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
125916212|NCT00313300|452992402|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
125916213|NCT00313300|452992398|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
125916214|NCT00313300|452992399|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
125916215|NCT00313300|452992400|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
125916216|NCT00313300|452992401|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
125916217|NCT00313300|452992402|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
125916218|NCT00313300|452992398|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
125916219|NCT00313300|452992399|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
125916220|NCT00313300|452992400|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
125916221|NCT00313300|452992401|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
125916222|NCT00313300|452992402|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
125916223|NCT02336373|452992403|FG000|Overall Study|Protocol closed early|4|||
125916224|NCT02336373|452992403|FG000|Overall Study|Physician Decision|14|||
125916225|NCT00850343|452992404|FG000|Overall Study|Withdrawal by Subject|11|||
125916226|NCT00850343|452992405|FG001|Overall Study|Withdrawal by Subject|0|||
125916227|NCT00850343|452992406|FG002|Overall Study|Withdrawal by Subject|3|||
125916228|NCT00850343|452992407|FG003|Overall Study|Withdrawal by Subject|2|||
125916229|NCT00850343|452992404|FG000|Overall Study|Adverse Event|15|||
125916230|NCT00850343|452992405|FG001|Overall Study|Adverse Event|2|||
125916231|NCT00850343|452992406|FG002|Overall Study|Adverse Event|6|||
125916232|NCT00850343|452992407|FG003|Overall Study|Adverse Event|6|||
125916233|NCT00850343|452992404|FG000|Overall Study|Pregnancy|0|||
125916234|NCT00850343|452992405|FG001|Overall Study|Pregnancy|0|||
125916235|NCT00850343|452992406|FG002|Overall Study|Pregnancy|0|||
125916236|NCT00850343|452992407|FG003|Overall Study|Pregnancy|1|||
125916237|NCT00850343|452992404|FG000|Overall Study|Lack of Efficacy|17|||
125916238|NCT00850343|452992405|FG001|Overall Study|Lack of Efficacy|0|||
125916239|NCT00850343|452992406|FG002|Overall Study|Lack of Efficacy|3|||
125916240|NCT00850343|452992407|FG003|Overall Study|Lack of Efficacy|2|||
126063244|NCT00700999|453523765|FG001|Overall Study|Lost to Follow-up|7|||
126063245|NCT00700999|453523764|FG000|Overall Study|Excluded - did not meet study criteria|0|||
126063246|NCT00700999|453523765|FG001|Overall Study|Excluded - did not meet study criteria|1|||
126063247|NCT00700999|453523764|FG000|Overall Study|Withdrawal by Subject|8|||
126063248|NCT00700999|453523765|FG001|Overall Study|Withdrawal by Subject|1|||
126063249|NCT03481725|453523766|FG000|Overall Study|Withdrawal by Subject|1|||
126063250|NCT03481725|453523767|FG001|Overall Study|Withdrawal by Subject|0|||
126063251|NCT03651271|453523770|FG000|Overall Study|Death|4|||
125916241|NCT00850343|452992404|FG000|Overall Study|Non-compliance with Study Procedures|1|||
125916242|NCT00850343|452992405|FG001|Overall Study|Non-compliance with Study Procedures|0|||
125916243|NCT00850343|452992406|FG002|Overall Study|Non-compliance with Study Procedures|1|||
125916244|NCT00850343|452992407|FG003|Overall Study|Non-compliance with Study Procedures|1|||
125916245|NCT00850343|452992404|FG000|Overall Study|Physician Decision|2|||
125916246|NCT00850343|452992405|FG001|Overall Study|Physician Decision|1|||
125916247|NCT00850343|452992406|FG002|Overall Study|Physician Decision|1|||
125916248|NCT00850343|452992407|FG003|Overall Study|Physician Decision|1|||
125916249|NCT00246753|452992412|FG000|Overall Study|Withdrawal by Subject|2|||
125916250|NCT00246753|452992412|FG000|Overall Study|Physician Decision|2|||
125916251|NCT00246753|452992412|FG000|Overall Study|Adverse Event|2|||
125916252|NCT00246753|452992412|FG000|Overall Study|Unacceptable toxicity|2|||
125916253|NCT02764333|452992419|FG000|Overall Study|Ineligible|1|||
125916254|NCT00617851|452992423|FG000|Overall Study|Death|0|||
125916255|NCT00617851|452992424|FG001|Overall Study|Death|0|||
125916256|NCT00617851|452992425|FG002|Overall Study|Death|0|||
125916257|NCT00617851|452992426|FG003|Overall Study|Death|1|||
125916258|NCT00617851|452992423|FG000|Overall Study|Withdrawal by Subject|14|||
125916259|NCT00617851|452992424|FG001|Overall Study|Withdrawal by Subject|7|||
125916260|NCT00617851|452992425|FG002|Overall Study|Withdrawal by Subject|12|||
125916261|NCT00617851|452992426|FG003|Overall Study|Withdrawal by Subject|4|||
125916262|NCT00617851|452992423|FG000|Overall Study|Lost to Follow-up|27|||
125916263|NCT00617851|452992424|FG001|Overall Study|Lost to Follow-up|29|||
125916264|NCT00617851|452992425|FG002|Overall Study|Lost to Follow-up|31|||
125916265|NCT00617851|452992426|FG003|Overall Study|Lost to Follow-up|19|||
125916266|NCT00617851|452992423|FG000|Overall Study|Inappropriate Enrollment|5|||
126063252|NCT03651271|453523771|FG001|Overall Study|Death|37|||
126063253|NCT03651271|453523772|FG002|Overall Study|Death|0|||
125916267|NCT00617851|452992424|FG001|Overall Study|Inappropriate Enrollment|4|||
125916268|NCT00617851|452992425|FG002|Overall Study|Inappropriate Enrollment|1|||
125916269|NCT00617851|452992426|FG003|Overall Study|Inappropriate Enrollment|1|||
125916270|NCT00617851|452992423|FG000|Overall Study|Unable to classify|1|||
126063254|NCT03651271|453523773|FG003|Overall Study|Death|2|||
125916271|NCT00617851|452992424|FG001|Overall Study|Unable to classify|0|||
125916272|NCT00617851|452992425|FG002|Overall Study|Unable to classify|1|||
126063255|NCT03651271|453523774|FG004|Overall Study|Death|6|||
126063256|NCT03651271|453523770|FG000|Overall Study|Lost to Follow-up|1|||
126063257|NCT03651271|453523771|FG001|Overall Study|Lost to Follow-up|5|||
126063258|NCT03651271|453523772|FG002|Overall Study|Lost to Follow-up|0|||
126063259|NCT03651271|453523773|FG003|Overall Study|Lost to Follow-up|1|||
126063260|NCT03651271|453523774|FG004|Overall Study|Lost to Follow-up|0|||
126063261|NCT03651271|453523770|FG000|Overall Study|Physician Decision|0|||
126063262|NCT03651271|453523771|FG001|Overall Study|Physician Decision|2|||
126063263|NCT03651271|453523772|FG002|Overall Study|Physician Decision|0|||
126063264|NCT03651271|453523773|FG003|Overall Study|Physician Decision|0|||
126063265|NCT03651271|453523774|FG004|Overall Study|Physician Decision|0|||
126063266|NCT03651271|453523770|FG000|Overall Study|Withdrawal by Subject|1|||
126063267|NCT03651271|453523771|FG001|Overall Study|Withdrawal by Subject|15|||
126063268|NCT03651271|453523772|FG002|Overall Study|Withdrawal by Subject|0|||
126063269|NCT03651271|453523773|FG003|Overall Study|Withdrawal by Subject|0|||
126063270|NCT03651271|453523774|FG004|Overall Study|Withdrawal by Subject|1|||
126063271|NCT03651271|453523770|FG000|Overall Study|Patient medically unable to continue|0|||
126063272|NCT03651271|453523771|FG001|Overall Study|Patient medically unable to continue|0|||
126063273|NCT03651271|453523772|FG002|Overall Study|Patient medically unable to continue|0|||
126063274|NCT03651271|453523773|FG003|Overall Study|Patient medically unable to continue|1|||
126063275|NCT03651271|453523774|FG004|Overall Study|Patient medically unable to continue|0|||
126063276|NCT00821093|453523775|FG000|Overall Study|Adverse Event|20|||
126063277|NCT00821093|453523776|FG001|Overall Study|Adverse Event|12|||
126063278|NCT00821093|453523775|FG000|Overall Study|Withdrawal by Subject|9|||
126063279|NCT00821093|453523776|FG001|Overall Study|Withdrawal by Subject|13|||
126063280|NCT00821093|453523775|FG000|Overall Study|Lost to Follow-up|9|||
126063281|NCT00821093|453523776|FG001|Overall Study|Lost to Follow-up|3|||
126063282|NCT00821093|453523775|FG000|Overall Study|Protocol deviation|3|||
126063283|NCT00821093|453523776|FG001|Overall Study|Protocol deviation|6|||
126063284|NCT00821093|453523775|FG000|Overall Study|Abnormal laboratory value(s)|2|||
126063285|NCT00821093|453523776|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126063286|NCT00821093|453523775|FG000|Overall Study|Lack of Efficacy|2|||
126063287|NCT00821093|453523776|FG001|Overall Study|Lack of Efficacy|2|||
126063288|NCT00821093|453523775|FG000|Overall Study|Death|2|||
126063289|NCT00821093|453523776|FG001|Overall Study|Death|1|||
126063290|NCT00821093|453523775|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126063291|NCT00821093|453523776|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126063292|NCT00821093|453523775|FG000|Overall Study|Administrative problems|1|||
126063293|NCT00821093|453523776|FG001|Overall Study|Administrative problems|2|||
126063294|NCT03444155|453523777|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
126063295|NCT03444155|453523778|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
126063296|NCT01864200|453523785|FG000|Overall Study|Lost to Follow-up|1|||
126063297|NCT01864200|453523786|FG001|Overall Study|Lost to Follow-up|3|||
126063298|NCT01864200|453523785|FG000|Overall Study|Protocol Violation|1|||
126063299|NCT01864200|453523786|FG001|Overall Study|Protocol Violation|0|||
126063300|NCT02991118|453523787|FG000|Overall Study|Death|3|||
126063301|NCT02991118|453523788|FG001|Overall Study|Death|8|||
126063302|NCT02991118|453523787|FG000|Overall Study|Protocol Violation|0|||
126063303|NCT02991118|453523788|FG001|Overall Study|Protocol Violation|3|||
126063304|NCT02991118|453523787|FG000|Overall Study|Physician Decision|0|||
126063305|NCT02991118|453523788|FG001|Overall Study|Physician Decision|1|||
126063306|NCT02991118|453523787|FG000|Overall Study|Moved out of the country|0|||
126063307|NCT02991118|453523788|FG001|Overall Study|Moved out of the country|1|||
126063308|NCT02991118|453523787|FG000|Overall Study|Adverse Event|2|||
126063309|NCT02991118|453523788|FG001|Overall Study|Adverse Event|2|||
126063310|NCT02991118|453523787|FG000|Overall Study|Withdrawal by Subject|1|||
126063311|NCT02991118|453523788|FG001|Overall Study|Withdrawal by Subject|7|||
126063312|NCT02991118|453523787|FG000|Overall Study|Could not attend study visits|0|||
126063313|NCT02991118|453523788|FG001|Overall Study|Could not attend study visits|1|||
126063314|NCT02991118|453523787|FG000|Overall Study|Lost to Follow-up|1|||
126063315|NCT02991118|453523788|FG001|Overall Study|Lost to Follow-up|9|||
126063316|NCT00595959|453523789|FG000|Overall Study|Withdrawal by Subject|1|||
126063317|NCT00595959|453523789|FG000|Overall Study|Lost to Follow-up|1|||
126063318|NCT02077374|453523793|FG000|Overall Study|Withdrawal by Subject|0|||
126063319|NCT02077374|453523794|FG001|Overall Study|Withdrawal by Subject|1|||
126063320|NCT02077374|453523793|FG000|Overall Study|Protocol Violation|0|||
126063321|NCT02077374|453523794|FG001|Overall Study|Protocol Violation|1|||
126063322|NCT00446095|453523795|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
126063323|NCT00446095|453523796|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
126063324|NCT00446095|453523797|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
126063325|NCT00446095|453523798|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
126063326|NCT00446095|453523799|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
126063327|NCT00446095|453523795|FG000|Phase II (8 Weeks)|Adverse Event|0|||
126063328|NCT00446095|453523796|FG001|Phase II (8 Weeks)|Adverse Event|1|||
126063329|NCT00446095|453523797|FG002|Phase II (8 Weeks)|Adverse Event|1|||
126063330|NCT00446095|453523798|FG003|Phase II (8 Weeks)|Adverse Event|0|||
125916273|NCT00617851|452992426|FG003|Overall Study|Unable to classify|0|||
125916274|NCT01788046|452992437|FG000|Overall Study|Withdrawal by Subject|12|||
125916275|NCT01788046|452992438|FG001|Overall Study|Withdrawal by Subject|12|||
125916276|NCT01788046|452992437|FG000|Overall Study|Lost to Follow-up|12|||
125916277|NCT01788046|452992438|FG001|Overall Study|Lost to Follow-up|19|||
125916278|NCT01788046|452992437|FG000|Overall Study|Death|7|||
125916279|NCT01788046|452992438|FG001|Overall Study|Death|5|||
125916280|NCT01788046|452992437|FG000|Overall Study|Protocol Specified Criteria|25|||
125916281|NCT01788046|452992438|FG001|Overall Study|Protocol Specified Criteria|1|||
125916282|NCT01031706|452992441|FG000|Overall Study|Adverse Event|1|||
125916283|NCT01031706|452992442|FG001|Overall Study|Adverse Event|0|||
125916284|NCT01031706|452992441|FG000|Overall Study|Withdrawal by Subject|1|||
125916285|NCT01031706|452992442|FG001|Overall Study|Withdrawal by Subject|1|||
125916286|NCT03626168|452992446|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125916287|NCT03626168|452992447|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125916288|NCT03626168|452992446|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
125916289|NCT03626168|452992447|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
125916290|NCT03626168|452992446|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125916291|NCT03626168|452992447|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
125916292|NCT02248701|452992448|FG000|Overall Study|Withdrawal by Subject|2|||
125916293|NCT02248701|452992449|FG001|Overall Study|Withdrawal by Subject|1|||
125916294|NCT02248701|452992448|FG000|Overall Study|Physician Decision|0|||
125916295|NCT02248701|452992449|FG001|Overall Study|Physician Decision|1|||
125916296|NCT02248701|452992448|FG000|Overall Study|Adverse Event|1|||
125916297|NCT02248701|452992449|FG001|Overall Study|Adverse Event|0|||
125916298|NCT02248701|452992448|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
125916299|NCT02248701|452992449|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
125916300|NCT00808483|452992450|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
125916301|NCT00808483|452992451|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
125916302|NCT00808483|452992450|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
125916303|NCT00808483|452992451|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
125916304|NCT00808483|452992450|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
125916305|NCT00808483|452992451|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
125916306|NCT02357979|452992452|FG000|Overall Study|Lost to Follow-up|5|||
125916307|NCT02357979|452992453|FG001|Overall Study|Lost to Follow-up|5|||
125916308|NCT00880542|452992454|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
125916309|NCT00880542|452992454|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
125916310|NCT00880542|452992454|FG000|REP: Surgical Resection|progressive disease|1|||
125916311|NCT05047770|452992455|FG000|Overall Study|Withdrawal by Subject|15|||
125916312|NCT05047770|452992456|FG001|Overall Study|Withdrawal by Subject|10|||
125916313|NCT05047770|452992457|FG002|Overall Study|Withdrawal by Subject|6|||
125916314|NCT05047770|452992458|FG003|Overall Study|Withdrawal by Subject|12|||
125916315|NCT05047770|452992455|FG000|Overall Study|Lost to Follow-up|7|||
125916316|NCT05047770|452992456|FG001|Overall Study|Lost to Follow-up|5|||
125916317|NCT05047770|452992457|FG002|Overall Study|Lost to Follow-up|12|||
125916318|NCT05047770|452992458|FG003|Overall Study|Lost to Follow-up|13|||
125916319|NCT05047770|452992455|FG000|Overall Study|Other|1|||
125916320|NCT05047770|452992456|FG001|Overall Study|Other|0|||
125916321|NCT05047770|452992457|FG002|Overall Study|Other|1|||
125916322|NCT05047770|452992458|FG003|Overall Study|Other|0|||
125916323|NCT04289623|452992461|FG000|Wave 1 Emails|Email was not delivered|268|||
125916324|NCT04289623|452992462|FG001|Wave 1 Emails|Email was not delivered|257|||
125916325|NCT04289623|452992463|FG002|Wave 1 Emails|Email was not delivered|0|||
125916326|NCT04289623|452992464|FG003|Wave 1 Emails|Email was not delivered|0|||
125916327|NCT04289623|452992465|FG004|Wave 1 Emails|Email was not delivered|0|||
125916328|NCT04289623|452992466|FG005|Wave 1 Emails|Email was not delivered|0|||
125916329|NCT03758443|452992467|FG000|Induction Period|Adverse Event|2|||
125916330|NCT03758443|452992468|FG001|Induction Period|Adverse Event|4|||
125916331|NCT03758443|452992469|FG002|Induction Period|Adverse Event|2|||
125916332|NCT03758443|452992470|FG003|Induction Period|Adverse Event|3|||
125916333|NCT03758443|452992467|FG000|Induction Period|Physician Decision|1|||
125916334|NCT03758443|452992468|FG001|Induction Period|Physician Decision|1|||
125916335|NCT03758443|452992469|FG002|Induction Period|Physician Decision|3|||
125916336|NCT03758443|452992470|FG003|Induction Period|Physician Decision|0|||
125916337|NCT03758443|452992467|FG000|Induction Period|Protocol Violation|0|||
125916338|NCT03758443|452992468|FG001|Induction Period|Protocol Violation|0|||
125916339|NCT03758443|452992469|FG002|Induction Period|Protocol Violation|0|||
125916340|NCT03758443|452992470|FG003|Induction Period|Protocol Violation|1|||
125916341|NCT03758443|452992467|FG000|Induction Period|Withdrawal by Subject|3|||
125916342|NCT03758443|452992468|FG001|Induction Period|Withdrawal by Subject|2|||
125916343|NCT03758443|452992469|FG002|Induction Period|Withdrawal by Subject|2|||
125916344|NCT03758443|452992470|FG003|Induction Period|Withdrawal by Subject|4|||
125916345|NCT03758443|452992467|FG000|Extended Induction Period|Adverse Event|1|||
125916346|NCT03758443|452992468|FG001|Extended Induction Period|Adverse Event|1|||
125916347|NCT03758443|452992469|FG002|Extended Induction Period|Adverse Event|0|||
125916348|NCT03758443|452992470|FG003|Extended Induction Period|Adverse Event|1|||
125916349|NCT03758443|452992467|FG000|Extended Induction Period|Lost to Follow-up|1|||
125916350|NCT03758443|452992468|FG001|Extended Induction Period|Lost to Follow-up|0|||
125916351|NCT03758443|452992469|FG002|Extended Induction Period|Lost to Follow-up|0|||
125916352|NCT03758443|452992470|FG003|Extended Induction Period|Lost to Follow-up|0|||
125916353|NCT03758443|452992467|FG000|Extended Induction Period|Physician Decision|2|||
125916354|NCT03758443|452992468|FG001|Extended Induction Period|Physician Decision|1|||
125916355|NCT03758443|452992469|FG002|Extended Induction Period|Physician Decision|2|||
125916356|NCT03758443|452992470|FG003|Extended Induction Period|Physician Decision|2|||
125916357|NCT03758443|452992467|FG000|Extended Induction Period|Protocol Violation|0|||
125916358|NCT03758443|452992468|FG001|Extended Induction Period|Protocol Violation|0|||
125916359|NCT03758443|452992469|FG002|Extended Induction Period|Protocol Violation|0|||
125916360|NCT03758443|452992470|FG003|Extended Induction Period|Protocol Violation|1|||
126063331|NCT00446095|453523799|FG004|Phase II (8 Weeks)|Adverse Event|0|||
126063332|NCT00446095|453523795|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
126063333|NCT00446095|453523796|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
126063334|NCT00446095|453523797|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
126063335|NCT00446095|453523798|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
126063336|NCT00446095|453523799|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
126063337|NCT00446095|453523795|FG000|Phase II (8 Weeks)|Physician Decision|1|||
126063338|NCT00446095|453523796|FG001|Phase II (8 Weeks)|Physician Decision|0|||
126063339|NCT00446095|453523797|FG002|Phase II (8 Weeks)|Physician Decision|0|||
126063340|NCT00446095|453523798|FG003|Phase II (8 Weeks)|Physician Decision|0|||
126063341|NCT00446095|453523799|FG004|Phase II (8 Weeks)|Physician Decision|0|||
126063342|NCT00446095|453523795|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
126063343|NCT00446095|453523796|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
126063344|NCT00446095|453523797|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
126063345|NCT00446095|453523798|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
126063346|NCT00446095|453523799|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
126063347|NCT00446095|453523795|FG000|Phase II (8 Weeks)|Ongoing|0|||
126063348|NCT00446095|453523796|FG001|Phase II (8 Weeks)|Ongoing|0|||
126063349|NCT00446095|453523797|FG002|Phase II (8 Weeks)|Ongoing|1|||
126063350|NCT00446095|453523798|FG003|Phase II (8 Weeks)|Ongoing|0|||
126063351|NCT00446095|453523799|FG004|Phase II (8 Weeks)|Ongoing|0|||
126063352|NCT00446095|453523795|FG000|Phase I (28 Days)|Adverse Event|0|||
126063353|NCT00446095|453523796|FG001|Phase I (28 Days)|Adverse Event|0|||
126063354|NCT00446095|453523797|FG002|Phase I (28 Days)|Adverse Event|0|||
126063355|NCT00446095|453523798|FG003|Phase I (28 Days)|Adverse Event|1|||
126063356|NCT00446095|453523799|FG004|Phase I (28 Days)|Adverse Event|0|||
126063357|NCT00446095|453523795|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
126063358|NCT00446095|453523796|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
126063359|NCT00446095|453523797|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
126063360|NCT00446095|453523798|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
126063361|NCT00446095|453523799|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
126063362|NCT00409747|453523800|FG000|Overall Study|Withdrawal by Subject|1|||
126063363|NCT01916109|453523803|FG000|Overall Study|Withdrawal by Subject|1|||
126063364|NCT00636168|453523806|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
126063365|NCT00636168|453523807|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
126063366|NCT00636168|453523806|FG000|Randomized to Study Drug|Adverse Event|1|||
126063367|NCT00636168|453523807|FG001|Randomized to Study Drug|Adverse Event|0|||
126063368|NCT00636168|453523806|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
126063369|NCT00636168|453523807|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
126063370|NCT00636168|453523806|FG000|Treated With Study Drug|Recurrence of disease|135|||
126063371|NCT00636168|453523807|FG001|Treated With Study Drug|Recurrence of disease|282|||
126063372|NCT00636168|453523806|FG000|Treated With Study Drug|Adverse Event|250|||
126063373|NCT00636168|453523807|FG001|Treated With Study Drug|Adverse Event|22|||
126063374|NCT00636168|453523806|FG000|Treated With Study Drug|Participant withdrew consent|16|||
126063375|NCT00636168|453523807|FG001|Treated With Study Drug|Participant withdrew consent|21|||
126063376|NCT00636168|453523806|FG000|Treated With Study Drug|Poor/non-compliance|1|||
126063377|NCT00636168|453523807|FG001|Treated With Study Drug|Poor/non-compliance|3|||
126063378|NCT00636168|453523806|FG000|Treated With Study Drug|Death|3|||
126063379|NCT00636168|453523807|FG001|Treated With Study Drug|Death|0|||
126063380|NCT00636168|453523806|FG000|Treated With Study Drug|Pregnancy|1|||
126063381|NCT00636168|453523807|FG001|Treated With Study Drug|Pregnancy|0|||
126063382|NCT00636168|453523806|FG000|Treated With Study Drug|No longer meets study criteria|1|||
126063383|NCT00636168|453523807|FG001|Treated With Study Drug|No longer meets study criteria|0|||
126063384|NCT00636168|453523806|FG000|Treated With Study Drug|Other reason|1|||
126063385|NCT00636168|453523807|FG001|Treated With Study Drug|Other reason|3|||
126063386|NCT00636168|453523806|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
126063387|NCT00636168|453523807|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
126063388|NCT00636168|453523806|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
126063389|NCT00636168|453523807|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
126063390|NCT00636168|453523806|FG000|Long Term Follow-Up|Death|8|||
126063391|NCT00636168|453523807|FG001|Long Term Follow-Up|Death|9|||
126063392|NCT02707952|453523810|FG000|Overall Study|Adverse Event|1|||
126063393|NCT02707952|453523811|FG001|Overall Study|Adverse Event|0|||
126063394|NCT02707952|453523812|FG002|Overall Study|Adverse Event|0|||
126063395|NCT02707952|453523813|FG003|Overall Study|Adverse Event|0|||
126063396|NCT02707952|453523810|FG000|Overall Study|Lost to Follow-up|1|||
126063397|NCT02707952|453523811|FG001|Overall Study|Lost to Follow-up|0|||
126063398|NCT02707952|453523812|FG002|Overall Study|Lost to Follow-up|0|||
126063399|NCT02707952|453523813|FG003|Overall Study|Lost to Follow-up|0|||
126063400|NCT02707952|453523810|FG000|Overall Study|Withdrawal by Subject|0|||
126063401|NCT02707952|453523811|FG001|Overall Study|Withdrawal by Subject|1|||
125916361|NCT03758443|452992467|FG000|Extended Induction Period|Withdrawal by Subject|8|||
125916362|NCT03758443|452992468|FG001|Extended Induction Period|Withdrawal by Subject|1|||
125916363|NCT03758443|452992469|FG002|Extended Induction Period|Withdrawal by Subject|7|||
125916364|NCT03758443|452992470|FG003|Extended Induction Period|Withdrawal by Subject|3|||
125916365|NCT03758443|452992467|FG000|Extended Induction Period|Miscellaneous|1|||
125916366|NCT03758443|452992468|FG001|Extended Induction Period|Miscellaneous|0|||
125916367|NCT03758443|452992469|FG002|Extended Induction Period|Miscellaneous|0|||
125916368|NCT03758443|452992470|FG003|Extended Induction Period|Miscellaneous|0|||
125916369|NCT03758443|452992467|FG000|Maintenance Period|Adverse Event|1|||
125916370|NCT03758443|452992468|FG001|Maintenance Period|Adverse Event|2|||
125916371|NCT03758443|452992469|FG002|Maintenance Period|Adverse Event|0|||
125916372|NCT03758443|452992470|FG003|Maintenance Period|Adverse Event|0|||
125916373|NCT03758443|452992467|FG000|Maintenance Period|Lost to Follow-up|0|||
125916374|NCT03758443|452992468|FG001|Maintenance Period|Lost to Follow-up|0|||
125916375|NCT03758443|452992469|FG002|Maintenance Period|Lost to Follow-up|0|||
125916376|NCT03758443|452992470|FG003|Maintenance Period|Lost to Follow-up|1|||
125916377|NCT03758443|452992467|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
125916378|NCT03758443|452992468|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
125916379|NCT03758443|452992469|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
125916380|NCT03758443|452992470|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
125916381|NCT03758443|452992467|FG000|Maintenance Period|Protocol Violation|0|||
125916382|NCT03758443|452992468|FG001|Maintenance Period|Protocol Violation|1|||
125916383|NCT03758443|452992469|FG002|Maintenance Period|Protocol Violation|0|||
125916384|NCT03758443|452992470|FG003|Maintenance Period|Protocol Violation|0|||
125916385|NCT03758443|452992467|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
125916386|NCT03758443|452992468|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
125916387|NCT03758443|452992469|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
125916388|NCT03758443|452992470|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
125916389|NCT03758443|452992467|FG000|Maintenance Period|Withdrawal by Subject|1|||
125916390|NCT03758443|452992468|FG001|Maintenance Period|Withdrawal by Subject|0|||
126063402|NCT02707952|453523812|FG002|Overall Study|Withdrawal by Subject|2|||
126063403|NCT02707952|453523813|FG003|Overall Study|Withdrawal by Subject|0|||
126063404|NCT02006641|453523814|FG000|Overall Study|Withdrawal before treatment|2|||
126063405|NCT02006641|453523815|FG001|Overall Study|Withdrawal before treatment|5|||
126063406|NCT02006641|453523816|FG002|Overall Study|Withdrawal before treatment|3|||
126063407|NCT02006641|453523814|FG000|Overall Study|Adverse Event|15|||
126063408|NCT02006641|453523815|FG001|Overall Study|Adverse Event|11|||
126063409|NCT02006641|453523816|FG002|Overall Study|Adverse Event|15|||
126063410|NCT02006641|453523814|FG000|Overall Study|Protocol Violation|0|||
126063411|NCT02006641|453523815|FG001|Overall Study|Protocol Violation|2|||
126063412|NCT02006641|453523816|FG002|Overall Study|Protocol Violation|2|||
126063413|NCT02006641|453523814|FG000|Overall Study|Lost to Follow-up|0|||
126063414|NCT02006641|453523815|FG001|Overall Study|Lost to Follow-up|1|||
126063415|NCT02006641|453523816|FG002|Overall Study|Lost to Follow-up|0|||
126063416|NCT02006641|453523814|FG000|Overall Study|Withdrawal by Subject|7|||
126063417|NCT02006641|453523815|FG001|Overall Study|Withdrawal by Subject|12|||
126063418|NCT02006641|453523816|FG002|Overall Study|Withdrawal by Subject|11|||
125916391|NCT03758443|452992469|FG002|Maintenance Period|Withdrawal by Subject|1|||
125916392|NCT03758443|452992470|FG003|Maintenance Period|Withdrawal by Subject|1|||
125916393|NCT03758443|452992467|FG000|Maintenance Period|Miscellaneous|0|||
125916394|NCT03758443|452992468|FG001|Maintenance Period|Miscellaneous|0|||
125916395|NCT03758443|452992469|FG002|Maintenance Period|Miscellaneous|1|||
126063419|NCT02006641|453523814|FG000|Overall Study|Other reason: patient didn't show up|1|||
125916396|NCT03758443|452992470|FG003|Maintenance Period|Miscellaneous|0|||
125916397|NCT01436396|452992471|FG000|Overall Study|Protocol Violation|7|||
126063420|NCT02006641|453523815|FG001|Overall Study|Other reason: patient didn't show up|0|||
126063421|NCT02006641|453523816|FG002|Overall Study|Other reason: patient didn't show up|0|||
126063422|NCT02006641|453523814|FG000|Overall Study|Other reason:patient didn't want to come|0|||
126063423|NCT02006641|453523815|FG001|Overall Study|Other reason:patient didn't want to come|0|||
126063424|NCT02006641|453523816|FG002|Overall Study|Other reason:patient didn't want to come|1|||
126063425|NCT02006641|453523814|FG000|Overall Study|Other reason: patient has moved|1|||
126063426|NCT02006641|453523815|FG001|Overall Study|Other reason: patient has moved|0|||
126063427|NCT02006641|453523816|FG002|Overall Study|Other reason: patient has moved|1|||
126063428|NCT02006641|453523814|FG000|Overall Study|Other reason: caregiver in hospital|0|||
126063429|NCT02006641|453523815|FG001|Overall Study|Other reason: caregiver in hospital|1|||
126063430|NCT02006641|453523816|FG002|Overall Study|Other reason: caregiver in hospital|0|||
126063431|NCT02006641|453523814|FG000|Overall Study|Other reason: patient's wife has died|0|||
126063432|NCT02006641|453523815|FG001|Overall Study|Other reason: patient's wife has died|0|||
126063433|NCT02006641|453523816|FG002|Overall Study|Other reason: patient's wife has died|1|||
126063434|NCT02006641|453523814|FG000|Overall Study|Other reason: hospitalisation|0|||
126063435|NCT02006641|453523815|FG001|Overall Study|Other reason: hospitalisation|1|||
126063436|NCT02006641|453523816|FG002|Overall Study|Other reason: hospitalisation|0|||
126063437|NCT02006641|453523814|FG000|Overall Study|Other reason: caregiver impossibility|0|||
126063438|NCT02006641|453523815|FG001|Overall Study|Other reason: caregiver impossibility|0|||
126063439|NCT02006641|453523816|FG002|Overall Study|Other reason: caregiver impossibility|1|||
126063440|NCT02006641|453523814|FG000|Overall Study|Other reason: protocol non-compliance|0|||
126063441|NCT02006641|453523815|FG001|Overall Study|Other reason: protocol non-compliance|0|||
126063442|NCT02006641|453523816|FG002|Overall Study|Other reason: protocol non-compliance|1|||
126063443|NCT01287832|453523817|FG000|Overall Study|Adverse Event|1|||
126063444|NCT01287832|453523818|FG001|Overall Study|Adverse Event|0|||
126063445|NCT01287832|453523817|FG000|Overall Study|Death|0|||
126063446|NCT01287832|453523818|FG001|Overall Study|Death|1|||
126063447|NCT04749797|453523820|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
126063448|NCT04749797|453523821|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
126063449|NCT04749797|453523822|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
126063450|NCT00632736|453523823|FG000|Overall Study|Adverse Event|104|||
126063451|NCT00632736|453523823|FG000|Overall Study|Lost to Follow-up|15|||
126063452|NCT00632736|453523823|FG000|Overall Study|Protocol Violation|14|||
126063453|NCT00632736|453523823|FG000|Overall Study|Withdrawal by Subject|99|||
126063454|NCT00632736|453523823|FG000|Overall Study|Lack of Efficacy|5|||
126063455|NCT00632736|453523823|FG000|Overall Study|Sponsor terminated study|5|||
126063456|NCT00632736|453523823|FG000|Overall Study|Non-compliance|10|||
126063457|NCT00632736|453523823|FG000|Overall Study|Other|16|||
126063458|NCT01441596|453523824|FG000|Overall Study|Other reason not defined below|0|||
126063459|NCT01441596|453523825|FG001|Overall Study|Other reason not defined below|2|||
126063460|NCT01441596|453523826|FG002|Overall Study|Other reason not defined below|1|||
126063461|NCT01441596|453523824|FG000|Overall Study|Withdrawal by Subject|4|||
126063462|NCT01441596|453523825|FG001|Overall Study|Withdrawal by Subject|0|||
126063463|NCT01441596|453523826|FG002|Overall Study|Withdrawal by Subject|2|||
126063464|NCT01441596|453523824|FG000|Overall Study|Not treated|0|||
126063465|NCT01441596|453523825|FG001|Overall Study|Not treated|1|||
126063466|NCT01441596|453523826|FG002|Overall Study|Not treated|1|||
126063467|NCT01794689|453523830|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
126063468|NCT01794689|453523831|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
126063469|NCT01794689|453523832|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
126063470|NCT01794689|453523833|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
126063471|NCT01794689|453523830|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
126063472|NCT01794689|453523831|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
126063473|NCT01794689|453523832|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
126063474|NCT01794689|453523833|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
126063475|NCT01794689|453523830|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
126063476|NCT01794689|453523831|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
126063477|NCT01794689|453523832|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
126063478|NCT01794689|453523833|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
126063479|NCT01794689|453523830|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
126063480|NCT01794689|453523831|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
126063481|NCT01794689|453523832|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
126063482|NCT01794689|453523833|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
126063483|NCT01697956|453523834|FG000|Overall Study|Protocol Violation|1|||
126063484|NCT01697956|453523835|FG001|Overall Study|Protocol Violation|1|||
126063485|NCT03100370|453523846|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126063486|NCT03100370|453523847|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126063487|NCT03100370|453523848|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126063488|NCT03100370|453523849|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126063489|NCT03100370|453523850|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126063490|NCT03100370|453523851|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126063491|NCT02892019|453523852|FG000|Overall Study|randomized but not treated|0|||
125916398|NCT01436396|452992472|FG001|Overall Study|Protocol Violation|5|||
125916399|NCT01436396|452992471|FG000|Overall Study|Adverse Event|1|||
125916400|NCT01436396|452992472|FG001|Overall Study|Adverse Event|2|||
125916401|NCT01436396|452992471|FG000|Overall Study|Withdrawal by Subject|19|||
125916402|NCT01436396|452992472|FG001|Overall Study|Withdrawal by Subject|29|||
125916403|NCT01436396|452992471|FG000|Overall Study|Serious adverse event|2|||
125916404|NCT01436396|452992472|FG001|Overall Study|Serious adverse event|3|||
125916405|NCT01436396|452992471|FG000|Overall Study|Lost to Follow-up|3|||
125916406|NCT01436396|452992472|FG001|Overall Study|Lost to Follow-up|3|||
125916407|NCT01772160|452992476|FG000|Overall Study|Death|3|||
125916408|NCT01772160|452992476|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
125916409|NCT01772160|452992476|FG000|Overall Study|Consent withdrawal|3|||
125916410|NCT01772160|452992476|FG000|Overall Study|Migrated / moved from the study area|4|||
125916411|NCT01772160|452992476|FG000|Overall Study|Lost to Follow-up|30|||
125916412|NCT01772160|452992476|FG000|Overall Study|Other|5|||
125916413|NCT01522248|452992477|FG000|Overall Study|Lost to Follow-up|1|||
125916414|NCT01522248|452992478|FG001|Overall Study|Lost to Follow-up|0|||
125916415|NCT00538291|452992479|FG000|Overall Study|Adverse Event|2|||
125916416|NCT00538291|452992479|FG000|Overall Study|Withdrawal by Subject|1|||
125916417|NCT00591344|452992480|FG000|Overall Study|Transportation issues|1|||
125916418|NCT00591344|452992481|FG001|Overall Study|Transportation issues|0|||
125916419|NCT00591344|452992480|FG000|Overall Study|Moved out of state|1|||
125916420|NCT00591344|452992481|FG001|Overall Study|Moved out of state|0|||
125916421|NCT00591344|452992480|FG000|Overall Study|Medical complications|1|||
125916422|NCT00591344|452992481|FG001|Overall Study|Medical complications|3|||
125916423|NCT00591344|452992480|FG000|Overall Study|Underwent DBS|2|||
125916424|NCT00591344|452992481|FG001|Overall Study|Underwent DBS|2|||
125916425|NCT00591344|452992480|FG000|Overall Study|Death|0|||
125916426|NCT00591344|452992481|FG001|Overall Study|Death|1|||
125916427|NCT00591344|452992480|FG000|Overall Study|Lost to Follow-up|0|||
125916428|NCT00591344|452992481|FG001|Overall Study|Lost to Follow-up|1|||
126063492|NCT02892019|453523853|FG001|Overall Study|randomized but not treated|1|||
126063493|NCT02892019|453523852|FG000|Overall Study|Withdrawal by Subject|0|||
126063494|NCT02892019|453523853|FG001|Overall Study|Withdrawal by Subject|1|||
126063495|NCT02892019|453523852|FG000|Overall Study|Adverse Event|1|||
126063496|NCT02892019|453523853|FG001|Overall Study|Adverse Event|1|||
126063497|NCT01766206|453523854|FG000|Overall Study|Withdrawal by Subject|22|||
126063498|NCT01766206|453523854|FG000|Overall Study|Lost to Follow-up|10|||
126063499|NCT01766206|453523854|FG000|Overall Study|Inappropriate enrollment|18|||
126063500|NCT01766206|453523854|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
126063501|NCT01313663|453523855|FG000|Overall Study|Study Closed/Terminated|2|||
126063502|NCT01313663|453523856|FG001|Overall Study|Study Closed/Terminated|4|||
126063503|NCT01313663|453523855|FG000|Overall Study|Lost to Follow-up|0|||
126063504|NCT01313663|453523856|FG001|Overall Study|Lost to Follow-up|1|||
126063505|NCT01313663|453523855|FG000|Overall Study|Physician Decision|0|||
126063506|NCT01313663|453523856|FG001|Overall Study|Physician Decision|2|||
126063507|NCT01313663|453523855|FG000|Overall Study|Withdrawal by Subject|2|||
126063508|NCT01313663|453523856|FG001|Overall Study|Withdrawal by Subject|1|||
126063509|NCT01020487|453525785|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
126063510|NCT01020487|453525786|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
126063511|NCT01020487|453525787|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
126063512|NCT01020487|453525785|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
126063513|NCT01020487|453525786|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
126063514|NCT01020487|453525787|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
126063515|NCT01020487|453525785|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
126063516|NCT01020487|453525786|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
126063517|NCT01020487|453525787|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
126063518|NCT01020487|453525785|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
126063519|NCT01020487|453525786|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
125916429|NCT00591344|452992480|FG000|Overall Study|Did not want to come off medication|0|||
125916430|NCT00591344|452992481|FG001|Overall Study|Did not want to come off medication|1|||
126063520|NCT01020487|453525787|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
126063521|NCT01020487|453525785|FG000|Part 2 Open-label Period|Adverse Event|0|||
126063522|NCT01020487|453525786|FG001|Part 2 Open-label Period|Adverse Event|4|||
126063523|NCT01020487|453525787|FG002|Part 2 Open-label Period|Adverse Event|1|||
126063524|NCT04049578|453525788|FG000|Overall Study|Physician Decision|1|||
126063525|NCT02400749|453525789|FG000|Week 0 -16|Withdrawal by Subject|5|||
125916431|NCT00694707|452992482|FG000|Overall Study|Did Not Receive Treatment|0|||
125916432|NCT00694707|452992483|FG001|Overall Study|Did Not Receive Treatment|0|||
125916433|NCT00694707|452992484|FG002|Overall Study|Did Not Receive Treatment|1|||
125916434|NCT00694707|452992485|FG003|Overall Study|Did Not Receive Treatment|1|||
125916435|NCT00694707|452992486|FG004|Overall Study|Did Not Receive Treatment|1|||
125916436|NCT00694707|452992482|FG000|Overall Study|Adverse Event|22|||
125916437|NCT00694707|452992483|FG001|Overall Study|Adverse Event|14|||
125916438|NCT00694707|452992484|FG002|Overall Study|Adverse Event|8|||
125916439|NCT00694707|452992485|FG003|Overall Study|Adverse Event|12|||
125916440|NCT00694707|452992486|FG004|Overall Study|Adverse Event|13|||
125916441|NCT00694707|452992482|FG000|Overall Study|Insufficient Therapeutic Response|33|||
125916442|NCT00694707|452992483|FG001|Overall Study|Insufficient Therapeutic Response|18|||
125916443|NCT00694707|452992484|FG002|Overall Study|Insufficient Therapeutic Response|17|||
125916444|NCT00694707|452992485|FG003|Overall Study|Insufficient Therapeutic Response|15|||
125916445|NCT00694707|452992486|FG004|Overall Study|Insufficient Therapeutic Response|10|||
125916446|NCT00694707|452992482|FG000|Overall Study|Protocol Violation|1|||
125916447|NCT00694707|452992483|FG001|Overall Study|Protocol Violation|2|||
125916448|NCT00694707|452992484|FG002|Overall Study|Protocol Violation|1|||
125916449|NCT00694707|452992485|FG003|Overall Study|Protocol Violation|3|||
125916450|NCT00694707|452992486|FG004|Overall Study|Protocol Violation|1|||
125916451|NCT00694707|452992482|FG000|Overall Study|Withdrawal of Consent|14|||
125916452|NCT00694707|452992483|FG001|Overall Study|Withdrawal of Consent|18|||
125916453|NCT00694707|452992484|FG002|Overall Study|Withdrawal of Consent|22|||
125916454|NCT00694707|452992485|FG003|Overall Study|Withdrawal of Consent|16|||
125916455|NCT00694707|452992486|FG004|Overall Study|Withdrawal of Consent|15|||
125916456|NCT00694707|452992482|FG000|Overall Study|Lost to Follow-up|0|||
125916457|NCT00694707|452992483|FG001|Overall Study|Lost to Follow-up|1|||
125916458|NCT00694707|452992484|FG002|Overall Study|Lost to Follow-up|2|||
125916459|NCT00694707|452992485|FG003|Overall Study|Lost to Follow-up|0|||
125916460|NCT00694707|452992486|FG004|Overall Study|Lost to Follow-up|0|||
125916461|NCT00694707|452992482|FG000|Overall Study|Jeopardizing Parole Status|1|||
125916462|NCT00694707|452992483|FG001|Overall Study|Jeopardizing Parole Status|0|||
125916463|NCT00694707|452992484|FG002|Overall Study|Jeopardizing Parole Status|0|||
125916464|NCT00694707|452992485|FG003|Overall Study|Jeopardizing Parole Status|0|||
125916465|NCT00694707|452992486|FG004|Overall Study|Jeopardizing Parole Status|0|||
125916466|NCT00694707|452992482|FG000|Overall Study|Death in the Family|1|||
125916467|NCT00694707|452992483|FG001|Overall Study|Death in the Family|0|||
125916468|NCT00694707|452992484|FG002|Overall Study|Death in the Family|0|||
125916469|NCT00694707|452992485|FG003|Overall Study|Death in the Family|0|||
125916470|NCT00694707|452992486|FG004|Overall Study|Death in the Family|0|||
125916471|NCT00694707|452992482|FG000|Overall Study|Arrest by Police|0|||
125916472|NCT00694707|452992483|FG001|Overall Study|Arrest by Police|1|||
125916473|NCT00694707|452992484|FG002|Overall Study|Arrest by Police|0|||
125916474|NCT00694707|452992485|FG003|Overall Study|Arrest by Police|0|||
125916475|NCT00694707|452992486|FG004|Overall Study|Arrest by Police|0|||
125916476|NCT00694707|452992482|FG000|Overall Study|Administrative Reasons|0|||
125916477|NCT00694707|452992483|FG001|Overall Study|Administrative Reasons|1|||
125916478|NCT00694707|452992484|FG002|Overall Study|Administrative Reasons|0|||
125916479|NCT00694707|452992485|FG003|Overall Study|Administrative Reasons|2|||
125916480|NCT00694707|452992486|FG004|Overall Study|Administrative Reasons|0|||
125916481|NCT00694707|452992482|FG000|Overall Study|Notification of Past Head Injury|0|||
125916482|NCT00694707|452992483|FG001|Overall Study|Notification of Past Head Injury|0|||
125916483|NCT00694707|452992484|FG002|Overall Study|Notification of Past Head Injury|0|||
125916484|NCT00694707|452992485|FG003|Overall Study|Notification of Past Head Injury|1|||
125916485|NCT00694707|452992486|FG004|Overall Study|Notification of Past Head Injury|0|||
125916486|NCT00973674|452992494|FG000|Overall Study|Protocol Violation|2|||
125916487|NCT00973674|452992495|FG001|Overall Study|Protocol Violation|0|||
125916488|NCT02713204|452992496|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
125916489|NCT02713204|452992497|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125916490|NCT02713204|452992498|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
125916491|NCT02713204|452992499|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125916492|NCT02713204|452992500|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125916493|NCT02713204|452992501|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125916494|NCT02713204|452992502|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125916495|NCT02713204|452992503|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125916496|NCT02713204|452992496|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125916497|NCT02713204|452992497|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125916498|NCT02713204|452992498|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
125916499|NCT02713204|452992499|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125916500|NCT02713204|452992500|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125916501|NCT02713204|452992501|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125916502|NCT02713204|452992502|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125916503|NCT02713204|452992503|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125916504|NCT02713204|452992496|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125916505|NCT02713204|452992497|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
125916506|NCT02713204|452992498|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125916507|NCT02713204|452992499|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125916508|NCT02713204|452992500|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125916509|NCT02713204|452992501|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125916510|NCT02713204|452992502|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125916511|NCT02713204|452992503|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125916512|NCT02713204|452992496|FG000|From Week 12 up to Week 36|Adverse Event|1|||
126063526|NCT02400749|453525790|FG001|Week 0 -16|Withdrawal by Subject|5|||
126063527|NCT02400749|453525789|FG000|Week 0 -16|Adverse Event|3|||
126063528|NCT02400749|453525790|FG001|Week 0 -16|Adverse Event|1|||
126063529|NCT02400749|453525789|FG000|Week 0 -16|Lost to Follow-up|2|||
126063530|NCT02400749|453525790|FG001|Week 0 -16|Lost to Follow-up|0|||
126063531|NCT02400749|453525789|FG000|Week 0 -16|Protocol Violation|1|||
125916513|NCT02713204|452992497|FG001|From Week 12 up to Week 36|Adverse Event|0|||
125916514|NCT02713204|452992498|FG002|From Week 12 up to Week 36|Adverse Event|0|||
126063532|NCT02400749|453525790|FG001|Week 0 -16|Protocol Violation|0|||
126063533|NCT02400749|453525789|FG000|Week 17 - 32|Withdrawal by Subject|3|||
126063534|NCT02400749|453525790|FG001|Week 17 - 32|Withdrawal by Subject|2|||
126063535|NCT02400749|453525789|FG000|Week 17 - 32|Adverse Event|2|||
126063536|NCT02400749|453525790|FG001|Week 17 - 32|Adverse Event|1|||
126063537|NCT00307489|453525793|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
126063538|NCT00307489|453525794|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
126063539|NCT00307489|453525793|FG000|Baseline Through Week 48|Physician Decision|1|||
126063540|NCT00307489|453525794|FG001|Baseline Through Week 48|Physician Decision|0|||
126063541|NCT00307489|453525793|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
126063542|NCT00307489|453525794|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
126063543|NCT00307489|453525793|FG000|Week 48 Through Week 168|Adverse Event|1|||
126063544|NCT00307489|453525794|FG001|Week 48 Through Week 168|Adverse Event|0|||
126063545|NCT00307489|453525793|FG000|Week 48 Through Week 168|Physician Decision|1|||
126063546|NCT00307489|453525794|FG001|Week 48 Through Week 168|Physician Decision|0|||
126063547|NCT00307489|453525793|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
126063548|NCT00307489|453525794|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
126063549|NCT00307489|453525793|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
126063550|NCT00307489|453525794|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
126063551|NCT00307489|453525793|FG000|Week 48 Through Week 168|Death|0|||
126063552|NCT00307489|453525794|FG001|Week 48 Through Week 168|Death|1|||
126063553|NCT00307489|453525793|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
126063554|NCT00307489|453525794|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
126063555|NCT00307489|453525793|FG000|Week 48 Through Week 168|Seroconversion|1|||
126063556|NCT00307489|453525794|FG001|Week 48 Through Week 168|Seroconversion|0|||
126063557|NCT04425252|453525795|FG000|Overall Study|Withdrawal by Subject|2|||
126063558|NCT04425252|453525796|FG001|Overall Study|Withdrawal by Subject|1|||
126063559|NCT04425252|453525795|FG000|Overall Study|Lost to Follow-up|1|||
126110426|NCT01717768|453699373|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126110427|NCT01717768|453699374|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126110428|NCT01717768|453699375|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126110429|NCT01717768|453699376|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126110430|NCT01717768|453699377|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126110431|NCT01717768|453699366|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110432|NCT01717768|453699367|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110433|NCT01717768|453699368|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110434|NCT01717768|453699369|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110435|NCT01717768|453699370|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110436|NCT01717768|453699371|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110437|NCT01717768|453699372|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110438|NCT01717768|453699373|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110439|NCT01717768|453699374|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110440|NCT01717768|453699375|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110441|NCT01717768|453699376|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126110442|NCT01717768|453699377|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
126110443|NCT01717768|453699366|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110444|NCT01717768|453699367|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110445|NCT01717768|453699368|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110446|NCT01717768|453699369|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110447|NCT01717768|453699370|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110448|NCT01717768|453699371|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110449|NCT01717768|453699372|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110450|NCT01717768|453699373|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
126110451|NCT01717768|453699374|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110452|NCT01717768|453699375|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110453|NCT01717768|453699376|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110454|NCT01717768|453699377|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126110455|NCT01717768|453699366|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110456|NCT01717768|453699367|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110457|NCT01717768|453699368|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110458|NCT01717768|453699369|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110459|NCT01717768|453699370|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110460|NCT01717768|453699371|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110461|NCT01717768|453699372|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110462|NCT01717768|453699373|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110463|NCT01717768|453699374|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126063560|NCT04425252|453525796|FG001|Overall Study|Lost to Follow-up|0|||
126063561|NCT04425252|453525795|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
126063562|NCT04425252|453525796|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
126063563|NCT01945593|453525800|FG000|Overall Study|Adverse Event|0|||
126063564|NCT01945593|453525801|FG001|Overall Study|Adverse Event|0|||
126063565|NCT01945593|453525802|FG002|Overall Study|Adverse Event|0|||
126063566|NCT01945593|453525803|FG003|Overall Study|Adverse Event|5|||
126063567|NCT01945593|453525800|FG000|Overall Study|Physician Decision|0|||
126063568|NCT01945593|453525801|FG001|Overall Study|Physician Decision|0|||
126063569|NCT01945593|453525802|FG002|Overall Study|Physician Decision|1|||
126063570|NCT01945593|453525803|FG003|Overall Study|Physician Decision|1|||
126063571|NCT01945593|453525800|FG000|Overall Study|Withdrawal by Subject|0|||
126063572|NCT01945593|453525801|FG001|Overall Study|Withdrawal by Subject|2|||
126063573|NCT01945593|453525802|FG002|Overall Study|Withdrawal by Subject|0|||
126063574|NCT01945593|453525803|FG003|Overall Study|Withdrawal by Subject|4|||
126063575|NCT01945593|453525800|FG000|Overall Study|Protocol Violation|0|||
126063576|NCT01945593|453525801|FG001|Overall Study|Protocol Violation|2|||
126063577|NCT01945593|453525802|FG002|Overall Study|Protocol Violation|1|||
126063578|NCT01945593|453525803|FG003|Overall Study|Protocol Violation|3|||
126063579|NCT01945593|453525800|FG000|Overall Study|Death|0|||
126063580|NCT01945593|453525801|FG001|Overall Study|Death|0|||
126063581|NCT01945593|453525802|FG002|Overall Study|Death|1|||
126063582|NCT01945593|453525803|FG003|Overall Study|Death|0|||
126063583|NCT01945593|453525800|FG000|Overall Study|Other: Terminated|0|||
126063584|NCT01945593|453525801|FG001|Overall Study|Other: Terminated|0|||
126063585|NCT01945593|453525802|FG002|Overall Study|Other: Terminated|0|||
126063586|NCT01945593|453525803|FG003|Overall Study|Other: Terminated|1|||
126063587|NCT01945593|453525800|FG000|Overall Study|Other: Surgical Procedure|0|||
126063588|NCT01945593|453525801|FG001|Overall Study|Other: Surgical Procedure|2|||
126063589|NCT01945593|453525802|FG002|Overall Study|Other: Surgical Procedure|0|||
126063590|NCT01945593|453525803|FG003|Overall Study|Other: Surgical Procedure|6|||
126063591|NCT01945593|453525800|FG000|Overall Study|Other: Screen Failure|0|||
126063592|NCT01945593|453525801|FG001|Overall Study|Other: Screen Failure|2|||
126063593|NCT01945593|453525802|FG002|Overall Study|Other: Screen Failure|0|||
126063594|NCT01945593|453525803|FG003|Overall Study|Other: Screen Failure|0|||
126063595|NCT02446015|453525804|FG000|Overall Study|Adverse Event|0|||
126063596|NCT02446015|453525805|FG001|Overall Study|Adverse Event|1|||
126063597|NCT02446015|453525804|FG000|Overall Study|Withdrawal by Subject|1|||
126063598|NCT02446015|453525805|FG001|Overall Study|Withdrawal by Subject|0|||
126063599|NCT02964234|453525807|FG000|Overall Study|Lost to Follow-up|22|||
126063600|NCT02964234|453525808|FG001|Overall Study|Lost to Follow-up|13|||
126063601|NCT02163499|453525811|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
125916515|NCT02713204|452992499|FG003|From Week 12 up to Week 36|Adverse Event|1|||
125916516|NCT02713204|452992500|FG004|From Week 12 up to Week 36|Adverse Event|1|||
125916517|NCT02713204|452992501|FG005|From Week 12 up to Week 36|Adverse Event|0|||
125916518|NCT02713204|452992502|FG006|From Week 12 up to Week 36|Adverse Event|2|||
125916519|NCT02713204|452992503|FG007|From Week 12 up to Week 36|Adverse Event|1|||
125916520|NCT02713204|452992496|FG000|From Week 12 up to Week 36|Death|0|||
125916521|NCT02713204|452992497|FG001|From Week 12 up to Week 36|Death|0|||
125916522|NCT02713204|452992498|FG002|From Week 12 up to Week 36|Death|0|||
125916523|NCT02713204|452992499|FG003|From Week 12 up to Week 36|Death|1|||
125916524|NCT02713204|452992500|FG004|From Week 12 up to Week 36|Death|0|||
125916525|NCT02713204|452992501|FG005|From Week 12 up to Week 36|Death|1|||
125916526|NCT02713204|452992502|FG006|From Week 12 up to Week 36|Death|0|||
125916527|NCT02713204|452992503|FG007|From Week 12 up to Week 36|Death|3|||
125916528|NCT02713204|452992496|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
125916529|NCT02713204|452992497|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
125916530|NCT02713204|452992498|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
125916531|NCT02713204|452992499|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
125916532|NCT02713204|452992500|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
125916533|NCT02713204|452992501|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
125916534|NCT02713204|452992502|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
125916535|NCT02713204|452992503|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
125916536|NCT02713204|452992496|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
125916537|NCT02713204|452992497|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
125916538|NCT02713204|452992498|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
125916539|NCT02713204|452992499|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
125916540|NCT02713204|452992500|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
125916541|NCT02713204|452992501|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
125916542|NCT02713204|452992502|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
125916543|NCT02713204|452992503|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
125916544|NCT03000569|452992505|FG000|Overall Study|Withdrawal by Subject|1|||
125916545|NCT03000569|452992506|FG001|Overall Study|Withdrawal by Subject|0|||
125916546|NCT04815031|452992507|FG000|Overall Study|No adverse event information (missing information)|33|||
125916547|NCT04122534|452992508|FG000|Overall Study|Lost to Follow-up|4|||
125916548|NCT01254630|452992512|FG000|Overall Study|Adverse Event|36|||
125916549|NCT01254630|452992513|FG001|Overall Study|Adverse Event|15|||
125916550|NCT01254630|452992514|FG002|Overall Study|Adverse Event|40|||
125916551|NCT01254630|452992515|FG003|Overall Study|Adverse Event|8|||
125916552|NCT01254630|452992512|FG000|Overall Study|Death|461|||
125916553|NCT01254630|452992513|FG001|Overall Study|Death|151|||
125916554|NCT01254630|452992514|FG002|Overall Study|Death|478|||
125916555|NCT01254630|452992515|FG003|Overall Study|Death|139|||
125916556|NCT01254630|452992512|FG000|Overall Study|Lost to Follow-up|80|||
125916557|NCT01254630|452992513|FG001|Overall Study|Lost to Follow-up|26|||
125916558|NCT01254630|452992514|FG002|Overall Study|Lost to Follow-up|89|||
125916559|NCT01254630|452992515|FG003|Overall Study|Lost to Follow-up|32|||
125916560|NCT01254630|452992512|FG000|Overall Study|Physician Decision|24|||
125916561|NCT01254630|452992513|FG001|Overall Study|Physician Decision|8|||
125916562|NCT01254630|452992514|FG002|Overall Study|Physician Decision|16|||
125916563|NCT01254630|452992515|FG003|Overall Study|Physician Decision|7|||
125916564|NCT01254630|452992512|FG000|Overall Study|Withdrawal by Subject|201|||
125916565|NCT01254630|452992513|FG001|Overall Study|Withdrawal by Subject|94|||
125916566|NCT01254630|452992514|FG002|Overall Study|Withdrawal by Subject|188|||
125916567|NCT01254630|452992515|FG003|Overall Study|Withdrawal by Subject|89|||
125916568|NCT01254630|452992512|FG000|Overall Study|Study terminated by sponsor|0|||
125916569|NCT01254630|452992513|FG001|Overall Study|Study terminated by sponsor|994|||
125916570|NCT01254630|452992514|FG002|Overall Study|Study terminated by sponsor|0|||
126063602|NCT02163499|453525811|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
126063603|NCT02163499|453525811|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
126063604|NCT02163499|453525811|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
126063605|NCT02163499|453525811|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
126063606|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
126063607|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
126063608|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
125916571|NCT01254630|452992515|FG003|Overall Study|Study terminated by sponsor|1010|||
125916572|NCT01254630|452992512|FG000|Overall Study|Status not recorded|0|||
125916573|NCT01254630|452992513|FG001|Overall Study|Status not recorded|0|||
125916574|NCT01254630|452992514|FG002|Overall Study|Status not recorded|1|||
125916575|NCT01254630|452992515|FG003|Overall Study|Status not recorded|0|||
125916576|NCT02020577|452992516|FG000|Overall Study|Progressive disease|3|||
125916577|NCT02020577|452992517|FG001|Overall Study|Progressive disease|38|||
125916578|NCT02020577|452992516|FG000|Overall Study|Other AE or clinical progression|0|||
125916579|NCT02020577|452992517|FG001|Overall Study|Other AE or clinical progression|15|||
125916580|NCT02020577|452992516|FG000|Overall Study|Withdrawal by Subject|0|||
125916581|NCT02020577|452992517|FG001|Overall Study|Withdrawal by Subject|1|||
125916582|NCT02020577|452992516|FG000|Overall Study|Other than stated above|0|||
125916583|NCT02020577|452992517|FG001|Overall Study|Other than stated above|1|||
125916584|NCT00761631|452992518|FG000|Overall Study|Parent/legal guardian request|8|||
125916585|NCT00761631|452992519|FG001|Overall Study|Parent/legal guardian request|3|||
125916586|NCT00761631|452992520|FG002|Overall Study|Parent/legal guardian request|8|||
125916587|NCT00761631|452992521|FG003|Overall Study|Parent/legal guardian request|0|||
125916588|NCT00761631|452992522|FG004|Overall Study|Parent/legal guardian request|5|||
125916589|NCT00761631|452992523|FG005|Overall Study|Parent/legal guardian request|0|||
125916590|NCT00761631|452992518|FG000|Overall Study|Lost to Follow-up|2|||
125916591|NCT00761631|452992519|FG001|Overall Study|Lost to Follow-up|4|||
125916592|NCT00761631|452992520|FG002|Overall Study|Lost to Follow-up|7|||
125916593|NCT00761631|452992521|FG003|Overall Study|Lost to Follow-up|1|||
125916594|NCT00761631|452992522|FG004|Overall Study|Lost to Follow-up|6|||
125916595|NCT00761631|452992523|FG005|Overall Study|Lost to Follow-up|1|||
125916596|NCT00761631|452992518|FG000|Overall Study|Protocol Violation|2|||
125916597|NCT00761631|452992519|FG001|Overall Study|Protocol Violation|0|||
125916598|NCT00761631|452992520|FG002|Overall Study|Protocol Violation|0|||
125916599|NCT00761631|452992521|FG003|Overall Study|Protocol Violation|1|||
125916600|NCT00761631|452992522|FG004|Overall Study|Protocol Violation|5|||
125916601|NCT00761631|452992523|FG005|Overall Study|Protocol Violation|1|||
125916602|NCT00761631|452992518|FG000|Overall Study|Randomized, not treated|1|||
125916603|NCT00761631|452992519|FG001|Overall Study|Randomized, not treated|0|||
125916604|NCT00761631|452992520|FG002|Overall Study|Randomized, not treated|0|||
125916605|NCT00761631|452992521|FG003|Overall Study|Randomized, not treated|0|||
125916606|NCT00761631|452992522|FG004|Overall Study|Randomized, not treated|0|||
125916607|NCT00761631|452992523|FG005|Overall Study|Randomized, not treated|0|||
125916608|NCT00761631|452992518|FG000|Overall Study|Failed to return|1|||
125916609|NCT00761631|452992519|FG001|Overall Study|Failed to return|0|||
125916610|NCT00761631|452992520|FG002|Overall Study|Failed to return|1|||
125916611|NCT00761631|452992521|FG003|Overall Study|Failed to return|1|||
125916612|NCT00761631|452992522|FG004|Overall Study|Failed to return|5|||
125916613|NCT00761631|452992523|FG005|Overall Study|Failed to return|2|||
125916614|NCT00761631|452992518|FG000|Overall Study|Physician Decision|1|||
125916615|NCT00761631|452992519|FG001|Overall Study|Physician Decision|0|||
125916616|NCT00761631|452992520|FG002|Overall Study|Physician Decision|0|||
125916617|NCT00761631|452992521|FG003|Overall Study|Physician Decision|0|||
125916618|NCT00761631|452992522|FG004|Overall Study|Physician Decision|0|||
125916619|NCT00761631|452992523|FG005|Overall Study|Physician Decision|0|||
125916620|NCT00761631|452992518|FG000|Overall Study|Other|0|||
125916621|NCT00761631|452992519|FG001|Overall Study|Other|0|||
125916622|NCT00761631|452992520|FG002|Overall Study|Other|0|||
125916623|NCT00761631|452992521|FG003|Overall Study|Other|0|||
125916624|NCT00761631|452992522|FG004|Overall Study|Other|1|||
125916625|NCT00761631|452992523|FG005|Overall Study|Other|1|||
125916626|NCT01863953|452993975|FG000|Overall Study|Adverse Event|0|||
125916627|NCT01863953|452993976|FG001|Overall Study|Adverse Event|0|||
125916628|NCT01863953|452993977|FG002|Overall Study|Adverse Event|1|||
125916629|NCT01824342|452993979|FG000|Overall Study|Withdrawal by Subject|0|||
125916630|NCT01824342|452993980|FG001|Overall Study|Withdrawal by Subject|3|||
125916631|NCT01824342|452993979|FG000|Overall Study|Adverse Event|1|||
125916632|NCT01824342|452993980|FG001|Overall Study|Adverse Event|1|||
125916633|NCT01824342|452993979|FG000|Overall Study|Disease Progression|1|||
126063609|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
125916634|NCT01824342|452993980|FG001|Overall Study|Disease Progression|1|||
125916635|NCT01824342|452993979|FG000|Overall Study|Physician Decision|5|||
125916636|NCT01824342|452993980|FG001|Overall Study|Physician Decision|0|||
125916637|NCT01824342|452993979|FG000|Overall Study|Death|2|||
125916638|NCT01824342|452993980|FG001|Overall Study|Death|0|||
125916639|NCT02202837|452993981|FG000|Overall Study|Enbrel treatment discontinued|36|||
125916640|NCT02202837|452993982|FG001|Overall Study|Enbrel treatment discontinued|4|||
126063610|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
125916641|NCT02202837|452993981|FG000|Overall Study|Other|10|||
125916642|NCT02202837|452993982|FG001|Overall Study|Other|0|||
125916643|NCT02202837|452993981|FG000|Overall Study|Lost to Follow-up|7|||
125916644|NCT02202837|452993982|FG001|Overall Study|Lost to Follow-up|1|||
125916645|NCT02104752|452993984|FG000|Overall Study|Withdrawal by Subject|1|||
125916646|NCT02104752|452993985|FG001|Overall Study|Withdrawal by Subject|0|||
125916647|NCT02104752|452993984|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
125916648|NCT02104752|452993985|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
125916649|NCT01313858|452993986|FG000|Overall Study|Premature Treatment Termination|251|||
125916650|NCT01313858|452993987|FG001|Overall Study|Premature Treatment Termination|219|||
125916651|NCT01313858|452993988|FG002|Overall Study|Premature Treatment Termination|191|||
125916652|NCT01313858|452993986|FG000|Overall Study|Lost to Follow-up|35|||
125916653|NCT01313858|452993987|FG001|Overall Study|Lost to Follow-up|51|||
125916654|NCT01313858|452993988|FG002|Overall Study|Lost to Follow-up|47|||
125916655|NCT01626456|452994000|FG000|Overall Study|Withdrawal by Subject|21|||
125916656|NCT01626456|452994001|FG001|Overall Study|Withdrawal by Subject|46|||
125916657|NCT01626456|452994000|FG000|Overall Study|Adverse Event|2|||
125916658|NCT01626456|452994001|FG001|Overall Study|Adverse Event|27|||
125916659|NCT01626456|452994000|FG000|Overall Study|Lost to Follow-up|2|||
125916660|NCT01626456|452994001|FG001|Overall Study|Lost to Follow-up|27|||
125916661|NCT01626456|452994000|FG000|Overall Study|Lack of Efficacy|6|||
125916662|NCT01626456|452994001|FG001|Overall Study|Lack of Efficacy|7|||
125916663|NCT01626456|452994000|FG000|Overall Study|Physician Decision|1|||
125916664|NCT01626456|452994001|FG001|Overall Study|Physician Decision|4|||
125916665|NCT01626456|452994000|FG000|Overall Study|Protocol Violation|1|||
125916666|NCT01626456|452994001|FG001|Overall Study|Protocol Violation|1|||
125916667|NCT01626456|452994000|FG000|Overall Study|Site Closure|2|||
125916668|NCT01626456|452994001|FG001|Overall Study|Site Closure|3|||
125916669|NCT01626456|452994000|FG000|Overall Study|Incarceration|0|||
125916670|NCT01626456|452994001|FG001|Overall Study|Incarceration|2|||
125916671|NCT02468232|452994002|FG000|Core Part of Study|Adverse Event|0|||
125916672|NCT02468232|452994003|FG001|Core Part of Study|Adverse Event|1|||
125916673|NCT02468232|452994004|FG002|Core Part of Study|Adverse Event|0|||
125916674|NCT02468232|452994005|FG003|Core Part of Study|Adverse Event|0|||
125916675|NCT02468232|452994002|FG000|Core Part of Study|Death|20|||
125916676|NCT02468232|452994003|FG001|Core Part of Study|Death|17|||
125916677|NCT02468232|452994004|FG002|Core Part of Study|Death|0|||
125916678|NCT02468232|452994005|FG003|Core Part of Study|Death|0|||
125916679|NCT02468232|452994002|FG000|Core Part of Study|Technical Problems|1|||
125916680|NCT02468232|452994003|FG001|Core Part of Study|Technical Problems|1|||
125916681|NCT02468232|452994004|FG002|Core Part of Study|Technical Problems|0|||
125916682|NCT02468232|452994005|FG003|Core Part of Study|Technical Problems|0|||
125916683|NCT02468232|452994002|FG000|OLE Part of Study|Adverse Event|0|||
125916684|NCT02468232|452994003|FG001|OLE Part of Study|Adverse Event|0|||
125916685|NCT02468232|452994004|FG002|OLE Part of Study|Adverse Event|4|||
125916686|NCT02468232|452994005|FG003|OLE Part of Study|Adverse Event|5|||
125916687|NCT02468232|452994002|FG000|OLE Part of Study|Death|0|||
125916688|NCT02468232|452994003|FG001|OLE Part of Study|Death|0|||
125916689|NCT02468232|452994004|FG002|OLE Part of Study|Death|4|||
125916690|NCT02468232|452994005|FG003|OLE Part of Study|Death|2|||
125916691|NCT02468232|452994002|FG000|OLE Part of Study|Physician Decision|0|||
125916692|NCT02468232|452994003|FG001|OLE Part of Study|Physician Decision|0|||
125916693|NCT02468232|452994004|FG002|OLE Part of Study|Physician Decision|4|||
125916694|NCT02468232|452994005|FG003|OLE Part of Study|Physician Decision|0|||
125916695|NCT02468232|452994002|FG000|OLE Part of Study|Subject/Guardian decision|0|||
125916696|NCT02468232|452994003|FG001|OLE Part of Study|Subject/Guardian decision|0|||
125916697|NCT02468232|452994004|FG002|OLE Part of Study|Subject/Guardian decision|2|||
125916698|NCT02468232|452994005|FG003|OLE Part of Study|Subject/Guardian decision|5|||
126063611|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
126063612|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
126063613|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
125916699|NCT00506662|452994006|FG000|Overall Study|Adverse Event|0|||
125916700|NCT00506662|452994007|FG001|Overall Study|Adverse Event|2|||
125916701|NCT00506662|452994006|FG000|Overall Study|Lack of Efficacy|1|||
125916702|NCT00506662|452994007|FG001|Overall Study|Lack of Efficacy|0|||
125916703|NCT00506662|452994006|FG000|Overall Study|Protocol Violation|2|||
125916704|NCT00506662|452994007|FG001|Overall Study|Protocol Violation|4|||
125916705|NCT00506662|452994006|FG000|Overall Study|Trial terminated|10|||
125916706|NCT00506662|452994007|FG001|Overall Study|Trial terminated|16|||
125916707|NCT00506662|452994006|FG000|Overall Study|Not recorded|4|||
125916708|NCT00506662|452994007|FG001|Overall Study|Not recorded|6|||
125916709|NCT01200524|452994011|FG000|Overall Study|Withdrawal by Subject|1|||
125916710|NCT01200524|452994012|FG001|Overall Study|Withdrawal by Subject|1|||
125916711|NCT01200524|452994013|FG002|Overall Study|Withdrawal by Subject|3|||
125916712|NCT01200524|452994011|FG000|Overall Study|Adverse Event|1|||
125916713|NCT01200524|452994012|FG001|Overall Study|Adverse Event|0|||
125916714|NCT01200524|452994013|FG002|Overall Study|Adverse Event|0|||
125916715|NCT01200524|452994011|FG000|Overall Study|Non availability of study nurse|0|||
125916716|NCT01200524|452994012|FG001|Overall Study|Non availability of study nurse|0|||
125916717|NCT01200524|452994013|FG002|Overall Study|Non availability of study nurse|1|||
125916718|NCT01303861|452994014|FG000|Overall Study|Lost to Follow-up|34|||
125916719|NCT01303861|452994015|FG001|Overall Study|Lost to Follow-up|14|||
125916720|NCT01303861|452994016|FG002|Overall Study|Lost to Follow-up|27|||
125916721|NCT01303861|452994017|FG003|Overall Study|Lost to Follow-up|31|||
125916722|NCT01303861|452994014|FG000|Overall Study|Lack of Efficacy|3|||
126063614|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
125916723|NCT01303861|452994015|FG001|Overall Study|Lack of Efficacy|2|||
125916724|NCT01303861|452994016|FG002|Overall Study|Lack of Efficacy|1|||
126063615|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Death|8|||
126063616|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
126063617|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
126063618|NCT02163499|453525811|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
126063619|NCT01540474|453525812|FG000|Vaccination Period|Lost to Follow-up|0|||
126063620|NCT01540474|453525813|FG001|Vaccination Period|Lost to Follow-up|1|||
125916725|NCT01303861|452994017|FG003|Overall Study|Lack of Efficacy|0|||
125916726|NCT01303861|452994014|FG000|Overall Study|Withdrawal by Subject|16|||
125916727|NCT01303861|452994015|FG001|Overall Study|Withdrawal by Subject|8|||
125916728|NCT01303861|452994016|FG002|Overall Study|Withdrawal by Subject|8|||
125916729|NCT01303861|452994017|FG003|Overall Study|Withdrawal by Subject|23|||
125916730|NCT01303861|452994014|FG000|Overall Study|Adverse Event|4|||
125916731|NCT01303861|452994015|FG001|Overall Study|Adverse Event|1|||
125916732|NCT01303861|452994016|FG002|Overall Study|Adverse Event|0|||
125916733|NCT01303861|452994017|FG003|Overall Study|Adverse Event|5|||
125916734|NCT01303861|452994014|FG000|Overall Study|Pregnancy|1|||
125916735|NCT01303861|452994015|FG001|Overall Study|Pregnancy|0|||
125916736|NCT01303861|452994016|FG002|Overall Study|Pregnancy|0|||
125916737|NCT01303861|452994017|FG003|Overall Study|Pregnancy|0|||
125916738|NCT02476201|452994021|FG000|Overall Study|Unable to program MPP|9|||
125916739|NCT02476201|452994021|FG000|Overall Study|Study echo not performed|5|||
125916740|NCT02476201|452994021|FG000|Overall Study|Adverse Event|4|||
125916741|NCT02476201|452994021|FG000|Overall Study|Death|2|||
125916742|NCT02476201|452994021|FG000|Overall Study|Lost to Follow-up|2|||
125916743|NCT02476201|452994021|FG000|Overall Study|MPP programmed to OFF|2|||
125916744|NCT02476201|452994021|FG000|Overall Study|Withdrawal by Subject|1|||
125916745|NCT02476201|452994021|FG000|Overall Study|Unsuccessful implant|1|||
125916746|NCT03840174|452994026|FG000|Overall Study|Withdrawal by Subject|1|||
125916747|NCT03840174|452994027|FG001|Overall Study|Withdrawal by Subject|0|||
125916748|NCT03840174|452994028|FG002|Overall Study|Withdrawal by Subject|0|||
125916749|NCT03840174|452994029|FG003|Overall Study|Withdrawal by Subject|0|||
125916750|NCT00131508|452994032|FG000|Overall Study|Disease progression|0|||
125916751|NCT00131508|452994033|FG001|Overall Study|Disease progression|2|||
125916752|NCT00131508|452994032|FG000|Overall Study|Non-Compliance|2|||
125916753|NCT00131508|452994033|FG001|Overall Study|Non-Compliance|4|||
125916754|NCT00131508|452994032|FG000|Overall Study|Withdrawal by Subject|1|||
125916755|NCT00131508|452994033|FG001|Overall Study|Withdrawal by Subject|2|||
125916756|NCT01268150|452994043|FG000|Treatment Phase|Progression of disease|18|||
125916757|NCT01268150|452994043|FG000|Treatment Phase|Adverse Event|3|||
125916758|NCT01268150|452994043|FG000|Treatment Phase|Withdrawal by Subject|3|||
125916759|NCT01268150|452994043|FG000|Treatment Phase|Other|4|||
125916760|NCT01268150|452994043|FG000|Extension Phase|Adverse Event|3|||
125916761|NCT01268150|452994043|FG000|Extension Phase|Disease progression|18|||
125916762|NCT01268150|452994043|FG000|Extension Phase|Other|6|||
125916763|NCT03725852|452994044|FG000|Overall Study|Death|1|||
125916764|NCT03725852|452994045|FG001|Overall Study|Death|0|||
125916765|NCT03725852|452994044|FG000|Overall Study|Withdrawal by Subject|1|||
125916766|NCT03725852|452994045|FG001|Overall Study|Withdrawal by Subject|0|||
125916767|NCT03725852|452994044|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
125916768|NCT03725852|452994045|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
125916769|NCT04738734|452994047|FG000|Overall Study|Withdrawal by Subject|2|||
125916770|NCT04738734|452994048|FG001|Overall Study|Withdrawal by Subject|4|||
125916771|NCT04738734|452994047|FG000|Overall Study|Lost to Follow-up|5|||
125916772|NCT04738734|452994048|FG001|Overall Study|Lost to Follow-up|2|||
125916773|NCT04738734|452994047|FG000|Overall Study|Physician Decision|0|||
125916774|NCT04738734|452994048|FG001|Overall Study|Physician Decision|1|||
125916775|NCT04738734|452994047|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
125916776|NCT04738734|452994048|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
125916777|NCT02435147|452994051|FG000|Overall Study|non-evaluable DXA scan|11|||
125916778|NCT00116428|452994052|FG000|Overall Study|Withdrawal by Subject|2|||
125916779|NCT00116428|452994053|FG001|Overall Study|Withdrawal by Subject|5|||
125916780|NCT00116428|452994052|FG000|Overall Study|Did not meet inclusion criteria|1|||
125916781|NCT00116428|452994053|FG001|Overall Study|Did not meet inclusion criteria|0|||
125916782|NCT00669396|452994054|FG000|Overall Study|Lost to Follow-up|10|||
125916783|NCT00669396|452994055|FG001|Overall Study|Lost to Follow-up|12|||
125916784|NCT04402060|452994056|FG000|Overall Study|Death|1|||
125916785|NCT04402060|452994057|FG001|Overall Study|Death|12|||
125916786|NCT04402060|452994058|FG002|Overall Study|Death|7|||
125916787|NCT04402060|452994056|FG000|Overall Study|Adverse Event|0|||
125916788|NCT04402060|452994057|FG001|Overall Study|Adverse Event|0|||
125916789|NCT04402060|452994058|FG002|Overall Study|Adverse Event|1|||
125916790|NCT04402060|452994056|FG000|Overall Study|Withdrawal by Subject|0|||
125916791|NCT04402060|452994057|FG001|Overall Study|Withdrawal by Subject|1|||
125916792|NCT04402060|452994058|FG002|Overall Study|Withdrawal by Subject|2|||
125916793|NCT04402060|452994056|FG000|Overall Study|Sponsor Request|0|||
125916794|NCT04402060|452994057|FG001|Overall Study|Sponsor Request|2|||
125916795|NCT04402060|452994058|FG002|Overall Study|Sponsor Request|0|||
125916796|NCT04402060|452994056|FG000|Overall Study|Physician Decision|0|||
125916797|NCT04402060|452994057|FG001|Overall Study|Physician Decision|0|||
125916798|NCT04402060|452994058|FG002|Overall Study|Physician Decision|1|||
125916799|NCT04402060|452994056|FG000|Overall Study|Other|0|||
125916800|NCT04402060|452994057|FG001|Overall Study|Other|1|||
125916801|NCT04402060|452994058|FG002|Overall Study|Other|0|||
125916802|NCT01297920|452994061|FG000|Overall Study|Adverse Event|42|||
125916803|NCT01297920|452994062|FG001|Overall Study|Adverse Event|10|||
125916804|NCT01297920|452994063|FG002|Overall Study|Adverse Event|38|||
125916805|NCT01297920|452994061|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
125916806|NCT01297920|452994062|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
125916807|NCT01297920|452994063|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
125916808|NCT01297920|452994061|FG000|Overall Study|Noncompliance|1|||
125916809|NCT01297920|452994062|FG001|Overall Study|Noncompliance|0|||
125916810|NCT01297920|452994063|FG002|Overall Study|Noncompliance|0|||
125916811|NCT01297920|452994061|FG000|Overall Study|Protocol Violation|1|||
125916812|NCT01297920|452994062|FG001|Overall Study|Protocol Violation|3|||
125916813|NCT01297920|452994063|FG002|Overall Study|Protocol Violation|0|||
125916814|NCT01297920|452994061|FG000|Overall Study|Inadequate Control of IOP|7|||
125916815|NCT01297920|452994062|FG001|Overall Study|Inadequate Control of IOP|9|||
125916816|NCT01297920|452994063|FG002|Overall Study|Inadequate Control of IOP|17|||
125916817|NCT01297920|452994061|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
125916818|NCT01297920|452994062|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
125916819|NCT01297920|452994063|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
125916820|NCT00474760|452994065|FG000|Overall Study|Death|0|||
125916821|NCT00474760|452994066|FG001|Overall Study|Death|0|||
125916822|NCT00474760|452994067|FG002|Overall Study|Death|0|||
125916823|NCT00474760|452994068|FG003|Overall Study|Death|0|||
125916824|NCT00474760|452994069|FG004|Overall Study|Death|2|||
125916825|NCT00474760|452994070|FG005|Overall Study|Death|0|||
125916826|NCT00474760|452994071|FG006|Overall Study|Death|0|||
125916827|NCT00474760|452994065|FG000|Overall Study|Adverse Event|0|||
125916828|NCT00474760|452994066|FG001|Overall Study|Adverse Event|0|||
125916829|NCT00474760|452994067|FG002|Overall Study|Adverse Event|0|||
125916830|NCT00474760|452994068|FG003|Overall Study|Adverse Event|0|||
125916831|NCT00474760|452994069|FG004|Overall Study|Adverse Event|1|||
125916832|NCT00474760|452994070|FG005|Overall Study|Adverse Event|7|||
125916833|NCT00474760|452994071|FG006|Overall Study|Adverse Event|0|||
125916834|NCT00474760|452994065|FG000|Overall Study|Laboratory abnormality|0|||
125916835|NCT00474760|452994066|FG001|Overall Study|Laboratory abnormality|0|||
125916836|NCT00474760|452994067|FG002|Overall Study|Laboratory abnormality|0|||
125916837|NCT00474760|452994068|FG003|Overall Study|Laboratory abnormality|0|||
125916838|NCT00474760|452994069|FG004|Overall Study|Laboratory abnormality|0|||
125916839|NCT00474760|452994070|FG005|Overall Study|Laboratory abnormality|1|||
125916840|NCT00474760|452994071|FG006|Overall Study|Laboratory abnormality|0|||
125916841|NCT00474760|452994065|FG000|Overall Study|Withdrawal by Subject|0|||
125916842|NCT00474760|452994066|FG001|Overall Study|Withdrawal by Subject|0|||
125916843|NCT00474760|452994067|FG002|Overall Study|Withdrawal by Subject|0|||
125916844|NCT00474760|452994068|FG003|Overall Study|Withdrawal by Subject|1|||
125916845|NCT00474760|452994069|FG004|Overall Study|Withdrawal by Subject|0|||
125916846|NCT00474760|452994070|FG005|Overall Study|Withdrawal by Subject|1|||
125916847|NCT00474760|452994071|FG006|Overall Study|Withdrawal by Subject|1|||
125916848|NCT00474760|452994065|FG000|Overall Study|Other|0|||
125916849|NCT00474760|452994066|FG001|Overall Study|Other|1|||
125916850|NCT00474760|452994067|FG002|Overall Study|Other|0|||
125916851|NCT00474760|452994068|FG003|Overall Study|Other|0|||
125916852|NCT00474760|452994069|FG004|Overall Study|Other|1|||
125916853|NCT00474760|452994070|FG005|Overall Study|Other|0|||
125916854|NCT00474760|452994071|FG006|Overall Study|Other|0|||
125916855|NCT00474760|452994065|FG000|Overall Study|Progressive disease|3|||
125916856|NCT00474760|452994066|FG001|Overall Study|Progressive disease|2|||
125916857|NCT00474760|452994067|FG002|Overall Study|Progressive disease|3|||
125916858|NCT00474760|452994068|FG003|Overall Study|Progressive disease|2|||
125916859|NCT00474760|452994069|FG004|Overall Study|Progressive disease|8|||
125916860|NCT00474760|452994070|FG005|Overall Study|Progressive disease|20|||
125916861|NCT00474760|452994071|FG006|Overall Study|Progressive disease|7|||
125916862|NCT00474760|452994065|FG000|Overall Study|Terminated by sponsor|0|||
125916863|NCT00474760|452994066|FG001|Overall Study|Terminated by sponsor|0|||
125916864|NCT00474760|452994067|FG002|Overall Study|Terminated by sponsor|0|||
125916865|NCT00474760|452994068|FG003|Overall Study|Terminated by sponsor|0|||
125916866|NCT00474760|452994069|FG004|Overall Study|Terminated by sponsor|0|||
125916867|NCT00474760|452994070|FG005|Overall Study|Terminated by sponsor|0|||
125916868|NCT00474760|452994071|FG006|Overall Study|Terminated by sponsor|2|||
125916869|NCT00331422|452994074|FG000|Overall Study|Did not receive entire study regimen|5|||
125916870|NCT02345226|452994075|FG000|Double-Blind Phase|Adverse Event|5|||
125916871|NCT02345226|452994076|FG001|Double-Blind Phase|Adverse Event|6|||
125916872|NCT02345226|452994075|FG000|Double-Blind Phase|Death|3|||
126063621|NCT01540474|453525814|FG002|Vaccination Period|Lost to Follow-up|0|||
125916873|NCT02345226|452994076|FG001|Double-Blind Phase|Death|0|||
125916874|NCT02345226|452994075|FG000|Double-Blind Phase|Pregnancy|0|||
125916875|NCT02345226|452994076|FG001|Double-Blind Phase|Pregnancy|1|||
125916876|NCT02345226|452994075|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125916877|NCT02345226|452994076|FG001|Double-Blind Phase|Lack of Efficacy|0|||
125916878|NCT02345226|452994075|FG000|Double-Blind Phase|Investigator's Discretion|4|||
125916879|NCT02345226|452994076|FG001|Double-Blind Phase|Investigator's Discretion|3|||
125916880|NCT02345226|452994075|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
126063622|NCT01540474|453525815|FG003|Vaccination Period|Lost to Follow-up|0|||
126063623|NCT00857311|453525816|FG000|Overall Study|Lost to Follow-up|1|||
126063624|NCT00857311|453525817|FG001|Overall Study|Lost to Follow-up|0|||
126063625|NCT00857311|453525818|FG002|Overall Study|Lost to Follow-up|0|||
126063626|NCT00857311|453525819|FG003|Overall Study|Lost to Follow-up|0|||
126063627|NCT04454125|453525820|FG000|Overall Study|Lost to Follow-up|0|||
126063628|NCT04454125|453525821|FG001|Overall Study|Lost to Follow-up|1|||
126063629|NCT01587703|453525822|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
126063630|NCT01587703|453525823|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125916881|NCT02345226|452994076|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
125916882|NCT02345226|452994075|FG000|Double-Blind Phase|Withdrew Consent|41|||
125916883|NCT02345226|452994076|FG001|Double-Blind Phase|Withdrew Consent|39|||
125916884|NCT02345226|452994075|FG000|Double-Blind Phase|Lost to Follow-up|12|||
125916885|NCT02345226|452994076|FG001|Double-Blind Phase|Lost to Follow-up|16|||
125916886|NCT02345226|452994075|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
125916887|NCT02345226|452994076|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
125916888|NCT02345226|452994075|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125916889|NCT02345226|452994076|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
125916890|NCT03386474|452994086|FG000|Overall Study|Death|1|||
125916891|NCT03386474|452994087|FG001|Overall Study|Death|0|||
125916892|NCT03386474|452994086|FG000|Overall Study|Adverse Event|0|||
125916893|NCT03386474|452994087|FG001|Overall Study|Adverse Event|1|||
125916894|NCT02282358|452994088|FG000|Overall Study|Nonevaluable|1|||
125916895|NCT02155881|452994089|FG000|Overall Study|Withdrawal by Subject|0|||
125916896|NCT02155881|452994090|FG001|Overall Study|Withdrawal by Subject|2|||
125916897|NCT02155881|452994089|FG000|Overall Study|Inappropriately randomized|2|||
125916898|NCT02155881|452994090|FG001|Overall Study|Inappropriately randomized|2|||
125916899|NCT04357782|452994091|FG000|Overall Study|Discharged from hospital|1|||
125916900|NCT04357782|452994092|FG001|Overall Study|Discharged from hospital|0|||
125916901|NCT04357782|452994091|FG000|Overall Study|Death|0|||
125916902|NCT04357782|452994092|FG001|Overall Study|Death|2|||
125916903|NCT01786148|452994093|FG000|Overall Study|Lost to Follow-up|21|||
125916904|NCT01786148|452994094|FG001|Overall Study|Lost to Follow-up|13|||
125916905|NCT01786148|452994093|FG000|Overall Study|Death|0|||
125916906|NCT01786148|452994094|FG001|Overall Study|Death|1|||
125916907|NCT01786148|452994093|FG000|Overall Study|Withdrawal by Subject|0|||
125916908|NCT01786148|452994094|FG001|Overall Study|Withdrawal by Subject|7|||
125916909|NCT01786148|452994093|FG000|Overall Study|Incarceration|1|||
125916910|NCT01786148|452994094|FG001|Overall Study|Incarceration|1|||
125916911|NCT03780543|452994096|FG000|Overall Study|Adverse Event|1|||
125916912|NCT03780543|452994097|FG001|Overall Study|Adverse Event|0|||
125916913|NCT03780543|452994098|FG002|Overall Study|Adverse Event|2|||
125916914|NCT03780543|452994096|FG000|Overall Study|Lost to Follow-up|2|||
125916915|NCT03780543|452994097|FG001|Overall Study|Lost to Follow-up|0|||
125916916|NCT03780543|452994098|FG002|Overall Study|Lost to Follow-up|1|||
125916917|NCT03780543|452994096|FG000|Overall Study|Study terminated by Sponsor|8|||
125916918|NCT03780543|452994097|FG001|Overall Study|Study terminated by Sponsor|7|||
125916919|NCT03780543|452994098|FG002|Overall Study|Study terminated by Sponsor|13|||
125916920|NCT03780543|452994096|FG000|Overall Study|Withdrawal by Subject|1|||
125916921|NCT03780543|452994097|FG001|Overall Study|Withdrawal by Subject|8|||
125916922|NCT03780543|452994098|FG002|Overall Study|Withdrawal by Subject|1|||
125916923|NCT03780543|452994096|FG000|Overall Study|Noncompliance with study drug|1|||
125916924|NCT03780543|452994097|FG001|Overall Study|Noncompliance with study drug|0|||
125916925|NCT03780543|452994098|FG002|Overall Study|Noncompliance with study drug|0|||
126110464|NCT01717768|453699375|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
125916926|NCT00066729|452994104|FG000|Overall Study|Lost to Follow-up|1|||
125916927|NCT00066729|452994104|FG000|Overall Study|Disease progression|1|||
125916928|NCT04032652|452994109|FG000|Overall Study|The study was terminated and the PI has|1|||
125916929|NCT04032652|452994110|FG001|Overall Study|The study was terminated and the PI has|1|||
125916930|NCT06238362|452994111|FG000|Overall Study|Insufficient total sleep time|1|||
125916931|NCT06238362|452994112|FG001|Overall Study|Insufficient total sleep time|0|||
125916932|NCT06238362|452994111|FG000|Overall Study|Inadequate signal quality|1|||
125916933|NCT06238362|452994112|FG001|Overall Study|Inadequate signal quality|0|||
125916934|NCT05136690|452994113|FG000|Period 1|Withdrawal by Subject|0|||
125916935|NCT05136690|452994114|FG001|Period 1|Withdrawal by Subject|1|||
126063631|NCT01587703|453525824|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063632|NCT01587703|453525825|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125916936|NCT05136690|452994113|FG000|Period 2|Lost to Follow-up|0|||
125916937|NCT05136690|452994114|FG001|Period 2|Lost to Follow-up|3|||
125916938|NCT05136690|452994113|FG000|Period 2|Withdrawal by Subject|0|||
125916939|NCT05136690|452994114|FG001|Period 2|Withdrawal by Subject|1|||
125916940|NCT00531934|452996118|FG000|Overall Study|Adverse Event|4|||
125916941|NCT00531934|452996119|FG001|Overall Study|Adverse Event|8|||
125916942|NCT00531934|452996118|FG000|Overall Study|Progression|52|||
125916943|NCT00531934|452996119|FG001|Overall Study|Progression|42|||
125916944|NCT00531934|452996118|FG000|Overall Study|Death|7|||
125916945|NCT00531934|452996119|FG001|Overall Study|Death|10|||
125916946|NCT00531934|452996118|FG000|Overall Study|Withdrawal by Subject|1|||
125916947|NCT00531934|452996119|FG001|Overall Study|Withdrawal by Subject|1|||
125916948|NCT00531934|452996118|FG000|Overall Study|Other|2|||
125916949|NCT00531934|452996119|FG001|Overall Study|Other|2|||
125916950|NCT01543698|452996124|FG000|Phase 1b|Disease progression|2|||
125916951|NCT01543698|452996125|FG001|Phase 1b|Disease progression|4|||
125916952|NCT01543698|452996126|FG002|Phase 1b|Disease progression|3|||
125916953|NCT01543698|452996127|FG003|Phase 1b|Disease progression|2|||
125916954|NCT01543698|452996128|FG004|Phase 1b|Disease progression|10|||
125916955|NCT01543698|452996129|FG005|Phase 1b|Disease progression|6|||
125916956|NCT01543698|452996130|FG006|Phase 1b|Disease progression|5|||
125916957|NCT01543698|452996131|FG007|Phase 1b|Disease progression|3|||
125916958|NCT01543698|452996132|FG008|Phase 1b|Disease progression|4|||
125916959|NCT01543698|452996133|FG009|Phase 1b|Disease progression|5|||
125916960|NCT01543698|452996134|FG010|Phase 1b|Disease progression|1|||
125916961|NCT01543698|452996135|FG011|Phase 1b|Disease progression|0|||
125916962|NCT01543698|452996136|FG012|Phase 1b|Disease progression|0|||
125916963|NCT01543698|452996137|FG013|Phase 1b|Disease progression|0|||
125916964|NCT01543698|452996138|FG014|Phase 1b|Disease progression|0|||
125916965|NCT01543698|452996124|FG000|Phase 1b|Death|0|||
125916966|NCT01543698|452996125|FG001|Phase 1b|Death|0|||
125916967|NCT01543698|452996126|FG002|Phase 1b|Death|1|||
125916968|NCT01543698|452996127|FG003|Phase 1b|Death|1|||
125916969|NCT01543698|452996128|FG004|Phase 1b|Death|0|||
125916970|NCT01543698|452996129|FG005|Phase 1b|Death|0|||
125916971|NCT01543698|452996130|FG006|Phase 1b|Death|0|||
125916972|NCT01543698|452996131|FG007|Phase 1b|Death|0|||
125916973|NCT01543698|452996132|FG008|Phase 1b|Death|0|||
125916974|NCT01543698|452996133|FG009|Phase 1b|Death|0|||
125916975|NCT01543698|452996134|FG010|Phase 1b|Death|1|||
125916976|NCT01543698|452996135|FG011|Phase 1b|Death|0|||
125916977|NCT01543698|452996136|FG012|Phase 1b|Death|0|||
125916978|NCT01543698|452996137|FG013|Phase 1b|Death|0|||
125916979|NCT01543698|452996138|FG014|Phase 1b|Death|0|||
125916980|NCT01543698|452996124|FG000|Phase 1b|Withdrawal by Subject|0|||
125916981|NCT01543698|452996125|FG001|Phase 1b|Withdrawal by Subject|1|||
125916982|NCT01543698|452996126|FG002|Phase 1b|Withdrawal by Subject|0|||
125916983|NCT01543698|452996127|FG003|Phase 1b|Withdrawal by Subject|1|||
126063633|NCT01587703|453525826|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063634|NCT01587703|453525827|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063635|NCT01587703|453525828|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063636|NCT01587703|453525829|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063637|NCT01587703|453525830|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063638|NCT01587703|453525831|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063639|NCT01587703|453525832|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063640|NCT01587703|453525833|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063641|NCT01587703|453525834|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063642|NCT01587703|453525835|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063643|NCT01587703|453525836|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063644|NCT01587703|453525837|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063645|NCT01587703|453525838|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063646|NCT01587703|453525839|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063647|NCT01587703|453525840|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126063648|NCT01587703|453525822|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063649|NCT01587703|453525823|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063650|NCT01587703|453525824|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063651|NCT01587703|453525825|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063652|NCT01587703|453525826|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063653|NCT01587703|453525827|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
126063654|NCT01587703|453525828|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063655|NCT01587703|453525829|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
126063656|NCT01587703|453525830|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063657|NCT01587703|453525831|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063658|NCT01587703|453525832|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063659|NCT01587703|453525833|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063660|NCT01587703|453525834|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063661|NCT01587703|453525835|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063662|NCT01587703|453525836|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063663|NCT01587703|453525837|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063664|NCT01587703|453525838|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063665|NCT01587703|453525839|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063666|NCT01587703|453525840|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126063667|NCT01587703|453525822|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063668|NCT01587703|453525823|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063669|NCT01587703|453525824|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063670|NCT01587703|453525825|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063671|NCT01587703|453525826|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063672|NCT01587703|453525827|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063673|NCT01587703|453525828|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
126063674|NCT01587703|453525829|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125916984|NCT01543698|452996128|FG004|Phase 1b|Withdrawal by Subject|0|||
125916985|NCT01543698|452996129|FG005|Phase 1b|Withdrawal by Subject|0|||
125916986|NCT01543698|452996130|FG006|Phase 1b|Withdrawal by Subject|1|||
125916987|NCT01543698|452996131|FG007|Phase 1b|Withdrawal by Subject|0|||
125916988|NCT01543698|452996132|FG008|Phase 1b|Withdrawal by Subject|0|||
125916989|NCT01543698|452996133|FG009|Phase 1b|Withdrawal by Subject|0|||
125916990|NCT01543698|452996134|FG010|Phase 1b|Withdrawal by Subject|0|||
125916991|NCT01543698|452996135|FG011|Phase 1b|Withdrawal by Subject|0|||
125916992|NCT01543698|452996136|FG012|Phase 1b|Withdrawal by Subject|0|||
125916993|NCT01543698|452996137|FG013|Phase 1b|Withdrawal by Subject|0|||
125916994|NCT01543698|452996138|FG014|Phase 1b|Withdrawal by Subject|0|||
125916995|NCT01543698|452996124|FG000|Phase 1b|Adverse Event|1|||
125916996|NCT01543698|452996125|FG001|Phase 1b|Adverse Event|0|||
125916997|NCT01543698|452996126|FG002|Phase 1b|Adverse Event|0|||
125916998|NCT01543698|452996127|FG003|Phase 1b|Adverse Event|1|||
125916999|NCT01543698|452996128|FG004|Phase 1b|Adverse Event|2|||
125917000|NCT01543698|452996129|FG005|Phase 1b|Adverse Event|2|||
125917001|NCT01543698|452996130|FG006|Phase 1b|Adverse Event|0|||
125917002|NCT01543698|452996131|FG007|Phase 1b|Adverse Event|0|||
125917003|NCT01543698|452996132|FG008|Phase 1b|Adverse Event|1|||
125917004|NCT01543698|452996133|FG009|Phase 1b|Adverse Event|1|||
125917005|NCT01543698|452996134|FG010|Phase 1b|Adverse Event|2|||
125917006|NCT01543698|452996135|FG011|Phase 1b|Adverse Event|0|||
125917007|NCT01543698|452996136|FG012|Phase 1b|Adverse Event|0|||
125917008|NCT01543698|452996137|FG013|Phase 1b|Adverse Event|0|||
125917009|NCT01543698|452996138|FG014|Phase 1b|Adverse Event|0|||
125917010|NCT01543698|452996124|FG000|Phase 1b|Administrative problems|1|||
125917011|NCT01543698|452996125|FG001|Phase 1b|Administrative problems|0|||
125917012|NCT01543698|452996126|FG002|Phase 1b|Administrative problems|0|||
125917013|NCT01543698|452996127|FG003|Phase 1b|Administrative problems|0|||
125917014|NCT01543698|452996128|FG004|Phase 1b|Administrative problems|1|||
125917015|NCT01543698|452996129|FG005|Phase 1b|Administrative problems|0|||
125917016|NCT01543698|452996130|FG006|Phase 1b|Administrative problems|0|||
125917017|NCT01543698|452996131|FG007|Phase 1b|Administrative problems|1|||
125917018|NCT01543698|452996132|FG008|Phase 1b|Administrative problems|0|||
125917019|NCT01543698|452996133|FG009|Phase 1b|Administrative problems|0|||
125917020|NCT01543698|452996134|FG010|Phase 1b|Administrative problems|2|||
125917021|NCT01543698|452996135|FG011|Phase 1b|Administrative problems|0|||
125917022|NCT01543698|452996136|FG012|Phase 1b|Administrative problems|0|||
125917023|NCT01543698|452996137|FG013|Phase 1b|Administrative problems|0|||
125917024|NCT01543698|452996138|FG014|Phase 1b|Administrative problems|0|||
125917025|NCT01543698|452996124|FG000|Phase 1b|Protocol Violation|2|||
125917026|NCT01543698|452996125|FG001|Phase 1b|Protocol Violation|0|||
125917027|NCT01543698|452996126|FG002|Phase 1b|Protocol Violation|0|||
125917028|NCT01543698|452996127|FG003|Phase 1b|Protocol Violation|0|||
125917029|NCT01543698|452996128|FG004|Phase 1b|Protocol Violation|0|||
125917030|NCT01543698|452996129|FG005|Phase 1b|Protocol Violation|0|||
125917031|NCT01543698|452996130|FG006|Phase 1b|Protocol Violation|0|||
125917032|NCT01543698|452996131|FG007|Phase 1b|Protocol Violation|0|||
125917033|NCT01543698|452996132|FG008|Phase 1b|Protocol Violation|0|||
125917034|NCT01543698|452996133|FG009|Phase 1b|Protocol Violation|0|||
125917035|NCT01543698|452996134|FG010|Phase 1b|Protocol Violation|0|||
125917036|NCT01543698|452996135|FG011|Phase 1b|Protocol Violation|0|||
125917037|NCT01543698|452996136|FG012|Phase 1b|Protocol Violation|0|||
125917038|NCT01543698|452996137|FG013|Phase 1b|Protocol Violation|0|||
125917039|NCT01543698|452996138|FG014|Phase 1b|Protocol Violation|0|||
125917040|NCT01543698|452996124|FG000|Phase 2|Protocol Violation|0|||
125917041|NCT01543698|452996125|FG001|Phase 2|Protocol Violation|0|||
125917042|NCT01543698|452996126|FG002|Phase 2|Protocol Violation|0|||
125917043|NCT01543698|452996127|FG003|Phase 2|Protocol Violation|0|||
125917044|NCT01543698|452996128|FG004|Phase 2|Protocol Violation|0|||
125917045|NCT01543698|452996129|FG005|Phase 2|Protocol Violation|0|||
125917046|NCT01543698|452996130|FG006|Phase 2|Protocol Violation|0|||
125917047|NCT01543698|452996131|FG007|Phase 2|Protocol Violation|0|||
125917048|NCT01543698|452996132|FG008|Phase 2|Protocol Violation|0|||
125917049|NCT01543698|452996133|FG009|Phase 2|Protocol Violation|0|||
125917050|NCT01543698|452996134|FG010|Phase 2|Protocol Violation|0|||
125917051|NCT01543698|452996135|FG011|Phase 2|Protocol Violation|0|||
126063675|NCT01587703|453525830|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063676|NCT01587703|453525831|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125917052|NCT01543698|452996136|FG012|Phase 2|Protocol Violation|1|||
125917053|NCT01543698|452996137|FG013|Phase 2|Protocol Violation|0|||
125917054|NCT01543698|452996138|FG014|Phase 2|Protocol Violation|0|||
125917055|NCT01543698|452996124|FG000|Phase 2|Disease progression|0|||
125917056|NCT01543698|452996125|FG001|Phase 2|Disease progression|0|||
125917057|NCT01543698|452996126|FG002|Phase 2|Disease progression|0|||
125917058|NCT01543698|452996127|FG003|Phase 2|Disease progression|0|||
125917059|NCT01543698|452996128|FG004|Phase 2|Disease progression|0|||
125917060|NCT01543698|452996129|FG005|Phase 2|Disease progression|0|||
125917061|NCT01543698|452996130|FG006|Phase 2|Disease progression|0|||
125917062|NCT01543698|452996131|FG007|Phase 2|Disease progression|0|||
125917063|NCT01543698|452996132|FG008|Phase 2|Disease progression|0|||
126110465|NCT01717768|453699376|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110466|NCT01717768|453699377|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126110467|NCT01843218|453699384|FG000|Overall Study|Withdrawal by Subject|5|||
126110468|NCT01906346|453699385|FG000|Overall Study|AEs|1|||
126110469|NCT04226833|453699386|FG000|Overall Study|Death|0|||
126110470|NCT04226833|453699387|FG001|Overall Study|Death|0|||
126110471|NCT04226833|453699388|FG002|Overall Study|Death|1|||
126110472|NCT04226833|453699389|FG003|Overall Study|Death|0|||
126110473|NCT03829319|453699396|FG000|Overall Study|Sponsor's Decision|4|||
126110474|NCT03829319|453699397|FG001|Overall Study|Sponsor's Decision|90|||
126110475|NCT03829319|453699398|FG002|Overall Study|Sponsor's Decision|102|||
126110476|NCT03829319|453699396|FG000|Overall Study|Withdrawal by Subject|1|||
126110477|NCT03829319|453699397|FG001|Overall Study|Withdrawal by Subject|5|||
126110478|NCT03829319|453699398|FG002|Overall Study|Withdrawal by Subject|4|||
126110479|NCT03829319|453699396|FG000|Overall Study|Physician Decision|0|||
126110480|NCT03829319|453699397|FG001|Overall Study|Physician Decision|3|||
126110481|NCT03829319|453699398|FG002|Overall Study|Physician Decision|0|||
126110482|NCT03829319|453699396|FG000|Overall Study|Lost to Follow-up|0|||
126110483|NCT03829319|453699397|FG001|Overall Study|Lost to Follow-up|0|||
126110484|NCT03829319|453699398|FG002|Overall Study|Lost to Follow-up|1|||
126110485|NCT03829319|453699396|FG000|Overall Study|Death|8|||
126110486|NCT03829319|453699397|FG001|Overall Study|Death|277|||
126110487|NCT03829319|453699398|FG002|Overall Study|Death|266|||
126110488|NCT04498832|453699399|FG000|Overall Study|Adverse Event|1|||
126110489|NCT04498832|453699400|FG001|Overall Study|Adverse Event|3|||
126110490|NCT04498832|453699399|FG000|Overall Study|Withdrawal by Subject|0|||
126110491|NCT04498832|453699400|FG001|Overall Study|Withdrawal by Subject|1|||
126110492|NCT05579990|453699406|FG000|Overall Study|Lost to Follow-up|3|||
126110493|NCT03231943|453699410|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110494|NCT03231943|453699411|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
126110495|NCT03231943|453699412|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
126110496|NCT03231943|453699413|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110497|NCT03231943|453699414|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110498|NCT03231943|453699415|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110499|NCT03231943|453699416|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110500|NCT03231943|453699417|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110501|NCT03231943|453699418|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110502|NCT03231943|453699419|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110503|NCT03231943|453699420|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110504|NCT03231943|453699421|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110505|NCT03231943|453699422|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126110506|NCT03231943|453699410|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110507|NCT03231943|453699411|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
126110508|NCT03231943|453699412|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110509|NCT03231943|453699413|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110510|NCT03231943|453699414|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110511|NCT03231943|453699415|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110512|NCT03231943|453699416|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125917064|NCT01543698|452996133|FG009|Phase 2|Disease progression|0|||
125917065|NCT01543698|452996134|FG010|Phase 2|Disease progression|0|||
126063677|NCT01587703|453525832|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063678|NCT01587703|453525833|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063679|NCT01587703|453525834|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063680|NCT01587703|453525835|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063681|NCT01587703|453525836|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063682|NCT01587703|453525837|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063683|NCT01587703|453525838|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063684|NCT01587703|453525839|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063685|NCT01587703|453525840|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126063686|NCT01587703|453525822|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
126063687|NCT01587703|453525823|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
126063688|NCT01587703|453525824|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
126063689|NCT01587703|453525825|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
126063690|NCT01587703|453525826|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
126063691|NCT01587703|453525827|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
126063692|NCT01587703|453525828|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
126063693|NCT01587703|453525829|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
126063694|NCT01587703|453525830|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063695|NCT01587703|453525831|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063696|NCT01587703|453525832|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063697|NCT01587703|453525833|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063698|NCT01587703|453525834|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063699|NCT01587703|453525835|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063700|NCT01587703|453525836|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063701|NCT01587703|453525837|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063702|NCT01587703|453525838|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063703|NCT01587703|453525839|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063704|NCT01587703|453525840|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126063705|NCT01587703|453525822|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063706|NCT01587703|453525823|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063707|NCT01587703|453525824|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063708|NCT01587703|453525825|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063709|NCT01587703|453525826|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063710|NCT01587703|453525827|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063711|NCT01587703|453525828|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063712|NCT01587703|453525829|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063713|NCT01587703|453525830|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
126063714|NCT01587703|453525831|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
126063715|NCT01587703|453525832|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
126063716|NCT01587703|453525833|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063717|NCT01587703|453525834|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125917066|NCT01543698|452996135|FG011|Phase 2|Disease progression|10|||
125917067|NCT01543698|452996136|FG012|Phase 2|Disease progression|21|||
125917068|NCT01543698|452996137|FG013|Phase 2|Disease progression|30|||
125917069|NCT01543698|452996138|FG014|Phase 2|Disease progression|25|||
125917070|NCT01543698|452996124|FG000|Phase 2|Death|0|||
125917071|NCT01543698|452996125|FG001|Phase 2|Death|0|||
125917072|NCT01543698|452996126|FG002|Phase 2|Death|0|||
125917073|NCT01543698|452996127|FG003|Phase 2|Death|0|||
125917074|NCT01543698|452996128|FG004|Phase 2|Death|0|||
125917075|NCT01543698|452996129|FG005|Phase 2|Death|0|||
125917076|NCT01543698|452996130|FG006|Phase 2|Death|0|||
125917077|NCT01543698|452996131|FG007|Phase 2|Death|0|||
125917078|NCT01543698|452996132|FG008|Phase 2|Death|0|||
125917079|NCT01543698|452996133|FG009|Phase 2|Death|0|||
126063718|NCT01587703|453525835|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063719|NCT01587703|453525836|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063720|NCT01587703|453525837|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125917080|NCT01543698|452996134|FG010|Phase 2|Death|0|||
126063721|NCT01587703|453525838|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063722|NCT01587703|453525839|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063723|NCT01587703|453525840|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126063724|NCT01587703|453525822|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063725|NCT01587703|453525823|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125917081|NCT01543698|452996135|FG011|Phase 2|Death|0|||
125917082|NCT01543698|452996136|FG012|Phase 2|Death|1|||
125917083|NCT01543698|452996137|FG013|Phase 2|Death|1|||
125917084|NCT01543698|452996138|FG014|Phase 2|Death|1|||
125917085|NCT01543698|452996124|FG000|Phase 2|Administrative problems|0|||
125917086|NCT01543698|452996125|FG001|Phase 2|Administrative problems|0|||
125917087|NCT01543698|452996126|FG002|Phase 2|Administrative problems|0|||
125917088|NCT01543698|452996127|FG003|Phase 2|Administrative problems|0|||
125917089|NCT01543698|452996128|FG004|Phase 2|Administrative problems|0|||
125917090|NCT01543698|452996129|FG005|Phase 2|Administrative problems|0|||
125917091|NCT01543698|452996130|FG006|Phase 2|Administrative problems|0|||
125917092|NCT01543698|452996131|FG007|Phase 2|Administrative problems|0|||
125917093|NCT01543698|452996132|FG008|Phase 2|Administrative problems|0|||
125917094|NCT01543698|452996133|FG009|Phase 2|Administrative problems|0|||
125917095|NCT01543698|452996134|FG010|Phase 2|Administrative problems|0|||
125917096|NCT01543698|452996135|FG011|Phase 2|Administrative problems|0|||
125917097|NCT01543698|452996136|FG012|Phase 2|Administrative problems|0|||
125917098|NCT01543698|452996137|FG013|Phase 2|Administrative problems|3|||
125917099|NCT01543698|452996138|FG014|Phase 2|Administrative problems|1|||
125917100|NCT01543698|452996124|FG000|Phase 2|Withdrawal by Subject|0|||
125917101|NCT01543698|452996125|FG001|Phase 2|Withdrawal by Subject|0|||
125917102|NCT01543698|452996126|FG002|Phase 2|Withdrawal by Subject|0|||
125917103|NCT01543698|452996127|FG003|Phase 2|Withdrawal by Subject|0|||
125917104|NCT01543698|452996128|FG004|Phase 2|Withdrawal by Subject|0|||
125917105|NCT01543698|452996129|FG005|Phase 2|Withdrawal by Subject|0|||
126110513|NCT03231943|453699417|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110514|NCT03231943|453699418|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110515|NCT03231943|453699419|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110516|NCT03231943|453699420|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110517|NCT03231943|453699421|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110518|NCT03231943|453699422|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126110519|NCT03231943|453699410|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
126110520|NCT03231943|453699411|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110521|NCT03231943|453699412|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110522|NCT03231943|453699413|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110523|NCT03231943|453699414|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110524|NCT03231943|453699415|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110525|NCT03231943|453699416|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110526|NCT03231943|453699417|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110527|NCT03231943|453699418|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110528|NCT03231943|453699419|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110529|NCT03231943|453699420|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110530|NCT03231943|453699421|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110531|NCT03231943|453699422|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126110532|NCT03231943|453699410|FG000|Part 2|Adverse Event|0|||
126110533|NCT03231943|453699411|FG001|Part 2|Adverse Event|0|||
126110534|NCT03231943|453699412|FG002|Part 2|Adverse Event|0|||
126110535|NCT03231943|453699413|FG003|Part 2|Adverse Event|0|||
126110536|NCT03231943|453699414|FG004|Part 2|Adverse Event|0|||
126110537|NCT03231943|453699415|FG005|Part 2|Adverse Event|0|||
126110538|NCT03231943|453699416|FG006|Part 2|Adverse Event|0|||
126110539|NCT03231943|453699417|FG007|Part 2|Adverse Event|0|||
126110540|NCT03231943|453699418|FG008|Part 2|Adverse Event|0|||
126110541|NCT03231943|453699419|FG009|Part 2|Adverse Event|0|||
126110542|NCT03231943|453699420|FG010|Part 2|Adverse Event|1|||
126110543|NCT03231943|453699421|FG011|Part 2|Adverse Event|0|||
126110544|NCT03231943|453699422|FG012|Part 2|Adverse Event|0|||
126110545|NCT03231943|453699410|FG000|Part 2|Withdrawal by Subject|0|||
126110546|NCT03231943|453699411|FG001|Part 2|Withdrawal by Subject|0|||
126110547|NCT03231943|453699412|FG002|Part 2|Withdrawal by Subject|0|||
126110548|NCT03231943|453699413|FG003|Part 2|Withdrawal by Subject|0|||
126110549|NCT03231943|453699414|FG004|Part 2|Withdrawal by Subject|0|||
126110550|NCT03231943|453699415|FG005|Part 2|Withdrawal by Subject|0|||
126110551|NCT03231943|453699416|FG006|Part 2|Withdrawal by Subject|0|||
126110552|NCT03231943|453699417|FG007|Part 2|Withdrawal by Subject|0|||
126110553|NCT03231943|453699418|FG008|Part 2|Withdrawal by Subject|0|||
126110554|NCT03231943|453699419|FG009|Part 2|Withdrawal by Subject|0|||
126110555|NCT03231943|453699420|FG010|Part 2|Withdrawal by Subject|0|||
126110556|NCT03231943|453699421|FG011|Part 2|Withdrawal by Subject|1|||
126110557|NCT03231943|453699422|FG012|Part 2|Withdrawal by Subject|0|||
126110558|NCT04824521|453699425|FG000|Overall Study|Lost to Follow-up|1|||
126110559|NCT04124614|453699427|FG000|Placebo Run-in Period|Not Randomized|34|||
126110560|NCT04124614|453699428|FG001|Placebo Run-in Period|Not Randomized|0|||
126110561|NCT04124614|453699429|FG002|Placebo Run-in Period|Not Randomized|0|||
126110562|NCT04124614|453699427|FG000|Double Blind Treatment Period|Adverse Event|0|||
126110563|NCT04124614|453699428|FG001|Double Blind Treatment Period|Adverse Event|7|||
126110564|NCT04124614|453699429|FG002|Double Blind Treatment Period|Adverse Event|22|||
126110565|NCT04124614|453699427|FG000|Double Blind Treatment Period|Death|0|||
126110566|NCT04124614|453699428|FG001|Double Blind Treatment Period|Death|0|||
126110567|NCT04124614|453699429|FG002|Double Blind Treatment Period|Death|1|||
126110568|NCT04124614|453699427|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
126110569|NCT04124614|453699428|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
126110570|NCT04124614|453699429|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
126110571|NCT04124614|453699427|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
126110572|NCT04124614|453699428|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
126110573|NCT04124614|453699429|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
126110574|NCT04124614|453699427|FG000|Double Blind Treatment Period|Physician Decision|0|||
126110575|NCT04124614|453699428|FG001|Double Blind Treatment Period|Physician Decision|0|||
126110576|NCT04124614|453699429|FG002|Double Blind Treatment Period|Physician Decision|3|||
126110577|NCT04124614|453699427|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
126110578|NCT04124614|453699428|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
126110579|NCT04124614|453699429|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
126110580|NCT04124614|453699427|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
126110581|NCT04124614|453699428|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
126063726|NCT01587703|453525824|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063727|NCT01587703|453525825|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063728|NCT01587703|453525826|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063729|NCT01587703|453525827|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063730|NCT01587703|453525828|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063731|NCT01587703|453525829|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063732|NCT01587703|453525830|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
126063733|NCT01587703|453525831|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063734|NCT01587703|453525832|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
126063735|NCT01587703|453525833|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063736|NCT01587703|453525834|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063737|NCT01587703|453525835|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063738|NCT01587703|453525836|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063739|NCT01587703|453525837|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063740|NCT01587703|453525838|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063741|NCT01587703|453525839|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063742|NCT01587703|453525840|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126063743|NCT01587703|453525822|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063744|NCT01587703|453525823|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063745|NCT01587703|453525824|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063746|NCT01587703|453525825|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063747|NCT01587703|453525826|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063748|NCT01587703|453525827|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063749|NCT01587703|453525828|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063750|NCT01587703|453525829|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063751|NCT01587703|453525830|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063752|NCT01587703|453525831|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
126063753|NCT01587703|453525832|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
126063754|NCT01587703|453525833|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063755|NCT01587703|453525834|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063756|NCT01587703|453525835|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063757|NCT01587703|453525836|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063758|NCT01587703|453525837|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063759|NCT01587703|453525838|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063760|NCT01587703|453525839|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063761|NCT01587703|453525840|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126063762|NCT01587703|453525822|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063763|NCT01587703|453525823|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063764|NCT01587703|453525824|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063765|NCT01587703|453525825|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063766|NCT01587703|453525826|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063767|NCT01587703|453525827|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063768|NCT01587703|453525828|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063769|NCT01587703|453525829|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063770|NCT01587703|453525830|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
126063771|NCT01587703|453525831|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063772|NCT01587703|453525832|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063773|NCT01587703|453525833|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063774|NCT01587703|453525834|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063775|NCT01587703|453525835|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063776|NCT01587703|453525836|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063777|NCT01587703|453525837|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063778|NCT01587703|453525838|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063779|NCT01587703|453525839|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063780|NCT01587703|453525840|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126063781|NCT01587703|453525822|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063782|NCT01587703|453525823|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063783|NCT01587703|453525824|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063784|NCT01587703|453525825|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063785|NCT01587703|453525826|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063786|NCT01587703|453525827|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063787|NCT01587703|453525828|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063788|NCT01587703|453525829|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063789|NCT01587703|453525830|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063790|NCT01587703|453525831|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063791|NCT01587703|453525832|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063792|NCT01587703|453525833|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063793|NCT01587703|453525834|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063794|NCT01587703|453525835|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063795|NCT01587703|453525836|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063796|NCT01587703|453525837|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063797|NCT01587703|453525838|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063798|NCT01587703|453525839|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126063799|NCT01587703|453525840|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
126063800|NCT01587703|453525822|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063801|NCT01587703|453525823|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063802|NCT01587703|453525824|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063803|NCT01587703|453525825|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063804|NCT01587703|453525826|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063805|NCT01587703|453525827|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063806|NCT01587703|453525828|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063807|NCT01587703|453525829|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063808|NCT01587703|453525830|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063809|NCT01587703|453525831|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063810|NCT01587703|453525832|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063811|NCT01587703|453525833|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063812|NCT01587703|453525834|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063813|NCT01587703|453525835|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063814|NCT01587703|453525836|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063815|NCT01587703|453525837|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063816|NCT01587703|453525838|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126063817|NCT01587703|453525839|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
126063818|NCT01587703|453525840|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
126063819|NCT01587703|453525822|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063820|NCT01587703|453525823|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063821|NCT01587703|453525824|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063822|NCT01587703|453525825|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063823|NCT01587703|453525826|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063824|NCT01587703|453525827|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063825|NCT01587703|453525828|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063826|NCT01587703|453525829|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063827|NCT01587703|453525830|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063828|NCT01587703|453525831|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063829|NCT01587703|453525832|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063830|NCT01587703|453525833|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063831|NCT01587703|453525834|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063832|NCT01587703|453525835|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063833|NCT01587703|453525836|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063834|NCT01587703|453525837|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
126063835|NCT01587703|453525838|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063836|NCT01587703|453525839|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063837|NCT01587703|453525840|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126063838|NCT01587703|453525822|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063839|NCT01587703|453525823|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063840|NCT01587703|453525824|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063841|NCT01587703|453525825|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063842|NCT01587703|453525826|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063843|NCT01587703|453525827|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063844|NCT01587703|453525828|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063845|NCT01587703|453525829|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063846|NCT01587703|453525830|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063847|NCT01587703|453525831|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063848|NCT01587703|453525832|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063849|NCT01587703|453525833|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
126063850|NCT01587703|453525834|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063851|NCT01587703|453525835|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063852|NCT01587703|453525836|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
126063853|NCT01587703|453525837|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063854|NCT01587703|453525838|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063855|NCT01587703|453525839|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063856|NCT01587703|453525840|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126063857|NCT01587703|453525822|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063858|NCT01587703|453525823|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125917106|NCT01543698|452996130|FG006|Phase 2|Withdrawal by Subject|0|||
125917107|NCT01543698|452996131|FG007|Phase 2|Withdrawal by Subject|0|||
125917108|NCT01543698|452996132|FG008|Phase 2|Withdrawal by Subject|0|||
125917109|NCT01543698|452996133|FG009|Phase 2|Withdrawal by Subject|0|||
125917110|NCT01543698|452996134|FG010|Phase 2|Withdrawal by Subject|0|||
125917111|NCT01543698|452996135|FG011|Phase 2|Withdrawal by Subject|0|||
125917112|NCT01543698|452996136|FG012|Phase 2|Withdrawal by Subject|0|||
125917113|NCT01543698|452996137|FG013|Phase 2|Withdrawal by Subject|3|||
125917114|NCT01543698|452996138|FG014|Phase 2|Withdrawal by Subject|1|||
125917115|NCT01543698|452996124|FG000|Phase 2|Adverse Event|0|||
126063859|NCT01587703|453525824|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125917116|NCT01543698|452996125|FG001|Phase 2|Adverse Event|0|||
125917117|NCT01543698|452996126|FG002|Phase 2|Adverse Event|0|||
126110582|NCT04124614|453699429|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
126110583|NCT04124614|453699427|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
126110584|NCT04124614|453699428|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
126110585|NCT04124614|453699429|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
126110586|NCT02021292|453700306|FG000|Overall Study|Physician Decision|0|||
126110587|NCT02021292|453700307|FG001|Overall Study|Physician Decision|1|||
126110588|NCT02021292|453700306|FG000|Overall Study|Lost to Follow-up|0|||
126110589|NCT02021292|453700307|FG001|Overall Study|Lost to Follow-up|1|||
126110590|NCT02021292|453700306|FG000|Overall Study|Death|0|||
126110591|NCT02021292|453700307|FG001|Overall Study|Death|1|||
126110592|NCT04147234|453700308|FG000|Overall Study|Clinical deterioration|0|||
126110593|NCT04147234|453700309|FG001|Overall Study|Clinical deterioration|0|||
125917118|NCT01543698|452996127|FG003|Phase 2|Adverse Event|0|||
125917119|NCT01543698|452996128|FG004|Phase 2|Adverse Event|0|||
125917120|NCT01543698|452996129|FG005|Phase 2|Adverse Event|0|||
125917121|NCT01543698|452996130|FG006|Phase 2|Adverse Event|0|||
126110594|NCT04147234|453700310|FG002|Overall Study|Clinical deterioration|1|||
126110595|NCT04147234|453700311|FG003|Overall Study|Clinical deterioration|0|||
126110596|NCT04147234|453700312|FG004|Overall Study|Clinical deterioration|0|||
126110597|NCT04147234|453700313|FG005|Overall Study|Clinical deterioration|0|||
126110598|NCT04147234|453700314|FG006|Overall Study|Clinical deterioration|0|||
126110599|NCT04147234|453700308|FG000|Overall Study|Withdrawal by Subject|0|||
126110600|NCT04147234|453700309|FG001|Overall Study|Withdrawal by Subject|1|||
126110601|NCT04147234|453700310|FG002|Overall Study|Withdrawal by Subject|1|||
126110602|NCT04147234|453700311|FG003|Overall Study|Withdrawal by Subject|0|||
126110603|NCT04147234|453700312|FG004|Overall Study|Withdrawal by Subject|0|||
126110604|NCT04147234|453700313|FG005|Overall Study|Withdrawal by Subject|0|||
126110605|NCT04147234|453700314|FG006|Overall Study|Withdrawal by Subject|0|||
126110606|NCT04147234|453700308|FG000|Overall Study|Clinical disease progression|1|||
126110607|NCT04147234|453700309|FG001|Overall Study|Clinical disease progression|3|||
126110608|NCT04147234|453700310|FG002|Overall Study|Clinical disease progression|1|||
126110609|NCT04147234|453700311|FG003|Overall Study|Clinical disease progression|1|||
126110610|NCT04147234|453700312|FG004|Overall Study|Clinical disease progression|0|||
126110611|NCT04147234|453700313|FG005|Overall Study|Clinical disease progression|1|||
126110612|NCT04147234|453700314|FG006|Overall Study|Clinical disease progression|0|||
126110613|NCT04147234|453700308|FG000|Overall Study|Objective disease progression|6|||
126110614|NCT04147234|453700309|FG001|Overall Study|Objective disease progression|4|||
126110615|NCT04147234|453700310|FG002|Overall Study|Objective disease progression|3|||
126110616|NCT04147234|453700311|FG003|Overall Study|Objective disease progression|3|||
126110617|NCT04147234|453700312|FG004|Overall Study|Objective disease progression|5|||
126110618|NCT04147234|453700313|FG005|Overall Study|Objective disease progression|2|||
126110619|NCT04147234|453700314|FG006|Overall Study|Objective disease progression|3|||
126110620|NCT04147234|453700308|FG000|Overall Study|Adverse Event|0|||
126110621|NCT04147234|453700309|FG001|Overall Study|Adverse Event|0|||
126110622|NCT04147234|453700310|FG002|Overall Study|Adverse Event|0|||
126110623|NCT04147234|453700311|FG003|Overall Study|Adverse Event|0|||
126110624|NCT04147234|453700312|FG004|Overall Study|Adverse Event|1|||
126110625|NCT04147234|453700313|FG005|Overall Study|Adverse Event|0|||
126110626|NCT04147234|453700314|FG006|Overall Study|Adverse Event|0|||
126110627|NCT05972733|453700315|FG000|Overall Study|Lost to Follow-up|2|||
126110628|NCT05972733|453700315|FG000|Overall Study|Withdrawal by Subject|1|||
126110629|NCT04982588|453700318|FG000|Overall Study|Withdrawal by Subject|2|||
126110630|NCT02366728|453700320|FG000|Overall Study|Death|0|||
126110631|NCT02366728|453700321|FG001|Overall Study|Death|0|||
126110632|NCT02366728|453700322|FG002|Overall Study|Death|1|||
126110633|NCT02366728|453700320|FG000|Overall Study|Adverse Event|1|||
126110634|NCT02366728|453700321|FG001|Overall Study|Adverse Event|0|||
126110635|NCT02366728|453700322|FG002|Overall Study|Adverse Event|0|||
126110636|NCT02366728|453700320|FG000|Overall Study|Screen Failure|2|||
126110637|NCT02366728|453700321|FG001|Overall Study|Screen Failure|1|||
126110638|NCT02366728|453700322|FG002|Overall Study|Screen Failure|0|||
126110639|NCT02366728|453700320|FG000|Overall Study|Only yielded 2 vaccines|1|||
126110640|NCT02366728|453700321|FG001|Overall Study|Only yielded 2 vaccines|0|||
126110641|NCT02366728|453700322|FG002|Overall Study|Only yielded 2 vaccines|0|||
125917122|NCT01543698|452996131|FG007|Phase 2|Adverse Event|0|||
126110642|NCT00992511|453700323|FG000|Overall Study|Migrated/moved from study area|1|||
126110643|NCT00992511|453700324|FG001|Overall Study|Migrated/moved from study area|0|||
125917123|NCT01543698|452996132|FG008|Phase 2|Adverse Event|0|||
126110644|NCT00992511|453700325|FG002|Overall Study|Migrated/moved from study area|1|||
126110645|NCT00992511|453700326|FG003|Overall Study|Migrated/moved from study area|2|||
126110646|NCT00992511|453700323|FG000|Overall Study|Lost to Follow-up|1|||
126110647|NCT00992511|453700324|FG001|Overall Study|Lost to Follow-up|0|||
126110648|NCT00992511|453700325|FG002|Overall Study|Lost to Follow-up|0|||
126110649|NCT00992511|453700326|FG003|Overall Study|Lost to Follow-up|2|||
126110650|NCT00992511|453700323|FG000|Overall Study|Withdrawal by Subject|0|||
126110651|NCT00992511|453700324|FG001|Overall Study|Withdrawal by Subject|0|||
126063860|NCT01587703|453525825|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063861|NCT01587703|453525826|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063862|NCT01587703|453525827|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063863|NCT01587703|453525828|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063864|NCT01587703|453525829|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063865|NCT01587703|453525830|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063866|NCT01587703|453525831|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063867|NCT01587703|453525832|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063868|NCT01587703|453525833|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
126063869|NCT01587703|453525834|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
126063870|NCT01587703|453525835|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
126063871|NCT01587703|453525836|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
126063872|NCT01587703|453525837|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
126063873|NCT01587703|453525838|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
126063874|NCT01587703|453525839|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063875|NCT01587703|453525840|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126063876|NCT01587703|453525822|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063877|NCT01587703|453525823|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063878|NCT01587703|453525824|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063879|NCT01587703|453525825|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063880|NCT01587703|453525826|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063881|NCT01587703|453525827|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063882|NCT01587703|453525828|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063883|NCT01587703|453525829|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063884|NCT01587703|453525830|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063885|NCT01587703|453525831|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063886|NCT01587703|453525832|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063887|NCT01587703|453525833|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
126063888|NCT01587703|453525834|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
126063889|NCT01587703|453525835|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
126063890|NCT01587703|453525836|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
126063891|NCT01587703|453525837|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
126063892|NCT01587703|453525838|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
126063893|NCT01587703|453525839|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063894|NCT01587703|453525840|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
126063895|NCT01587703|453525822|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063896|NCT01587703|453525823|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063897|NCT01587703|453525824|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063898|NCT01587703|453525825|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063899|NCT01587703|453525826|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063900|NCT01587703|453525827|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063901|NCT01587703|453525828|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063902|NCT01587703|453525829|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063903|NCT01587703|453525830|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063904|NCT01587703|453525831|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063905|NCT01587703|453525832|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063906|NCT01587703|453525833|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
126063907|NCT01587703|453525834|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063908|NCT01587703|453525835|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063909|NCT01587703|453525836|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063910|NCT01587703|453525837|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063911|NCT01587703|453525838|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126110652|NCT00992511|453700325|FG002|Overall Study|Withdrawal by Subject|1|||
126110653|NCT00992511|453700326|FG003|Overall Study|Withdrawal by Subject|1|||
125917124|NCT01543698|452996133|FG009|Phase 2|Adverse Event|0|||
125917125|NCT01543698|452996134|FG010|Phase 2|Adverse Event|0|||
125917126|NCT01543698|452996135|FG011|Phase 2|Adverse Event|1|||
125917127|NCT01543698|452996136|FG012|Phase 2|Adverse Event|3|||
125917128|NCT01543698|452996137|FG013|Phase 2|Adverse Event|5|||
125917129|NCT01543698|452996138|FG014|Phase 2|Adverse Event|14|||
125917130|NCT00150709|452996139|FG000|Overall Study|Protocol Violation|7|||
125917131|NCT00150709|452996140|FG001|Overall Study|Protocol Violation|8|||
125917132|NCT00150709|452996141|FG002|Overall Study|Protocol Violation|3|||
125917133|NCT00150709|452996142|FG003|Overall Study|Protocol Violation|1|||
125917134|NCT00150709|452996139|FG000|Overall Study|Adverse Event|8|||
125917135|NCT00150709|452996140|FG001|Overall Study|Adverse Event|2|||
125917136|NCT00150709|452996141|FG002|Overall Study|Adverse Event|2|||
125917137|NCT00150709|452996142|FG003|Overall Study|Adverse Event|3|||
125917138|NCT00150709|452996139|FG000|Overall Study|Lack of Efficacy|6|||
125917139|NCT00150709|452996140|FG001|Overall Study|Lack of Efficacy|11|||
125917140|NCT00150709|452996141|FG002|Overall Study|Lack of Efficacy|9|||
125917141|NCT00150709|452996142|FG003|Overall Study|Lack of Efficacy|0|||
125917142|NCT00150709|452996139|FG000|Overall Study|Withdrawal by Subject|7|||
125917143|NCT00150709|452996140|FG001|Overall Study|Withdrawal by Subject|10|||
125917144|NCT00150709|452996141|FG002|Overall Study|Withdrawal by Subject|5|||
125917145|NCT00150709|452996142|FG003|Overall Study|Withdrawal by Subject|0|||
125917146|NCT00150709|452996139|FG000|Overall Study|Lost to Follow-up|3|||
125917147|NCT00150709|452996140|FG001|Overall Study|Lost to Follow-up|2|||
125917148|NCT00150709|452996141|FG002|Overall Study|Lost to Follow-up|0|||
125917149|NCT00150709|452996142|FG003|Overall Study|Lost to Follow-up|0|||
125917150|NCT00150709|452996139|FG000|Overall Study|Sponsor decision|0|||
125917151|NCT00150709|452996140|FG001|Overall Study|Sponsor decision|0|||
125917152|NCT00150709|452996141|FG002|Overall Study|Sponsor decision|0|||
125917153|NCT00150709|452996142|FG003|Overall Study|Sponsor decision|1|||
125917154|NCT00150709|452996139|FG000|Overall Study|Site/Investigator discontinued the study|5|||
125917155|NCT00150709|452996140|FG001|Overall Study|Site/Investigator discontinued the study|5|||
125917156|NCT00150709|452996141|FG002|Overall Study|Site/Investigator discontinued the study|2|||
125917157|NCT00150709|452996142|FG003|Overall Study|Site/Investigator discontinued the study|0|||
125917158|NCT00150709|452996139|FG000|Overall Study|Decision of parent(s)|1|||
125917159|NCT00150709|452996140|FG001|Overall Study|Decision of parent(s)|2|||
125917160|NCT00150709|452996141|FG002|Overall Study|Decision of parent(s)|0|||
125917161|NCT00150709|452996142|FG003|Overall Study|Decision of parent(s)|0|||
125917162|NCT00150709|452996139|FG000|Overall Study|Decision of parent(s) and investigator|3|||
125917163|NCT00150709|452996140|FG001|Overall Study|Decision of parent(s) and investigator|0|||
125917164|NCT00150709|452996141|FG002|Overall Study|Decision of parent(s) and investigator|0|||
125917165|NCT00150709|452996142|FG003|Overall Study|Decision of parent(s) and investigator|0|||
125917166|NCT00150709|452996139|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
125917167|NCT00150709|452996140|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
125917168|NCT00150709|452996141|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
125917169|NCT00150709|452996142|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
125917170|NCT00150709|452996139|FG000|Overall Study|Investigator decision|1|||
125917171|NCT00150709|452996140|FG001|Overall Study|Investigator decision|0|||
125917172|NCT00150709|452996141|FG002|Overall Study|Investigator decision|0|||
125917173|NCT00150709|452996142|FG003|Overall Study|Investigator decision|1|||
125917174|NCT00150709|452996139|FG000|Overall Study|Subject relocated|2|||
126110654|NCT04498169|453700327|FG000|Study Completion|Adverse Event|1|||
126110655|NCT04498169|453700328|FG001|Study Completion|Adverse Event|1|||
126063912|NCT01587703|453525839|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063913|NCT01587703|453525840|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126063914|NCT01714947|453525841|FG000|Part B|Progressive Disease|3|||
126063915|NCT01922102|453525842|FG000|Overall Study|Withdrawal by Subject|7|||
126063916|NCT01922102|453525843|FG001|Overall Study|Withdrawal by Subject|3|||
126063917|NCT01922102|453525844|FG002|Overall Study|Withdrawal by Subject|7|||
126063918|NCT01922102|453525842|FG000|Overall Study|Physician Decision|0|||
126063919|NCT01922102|453525843|FG001|Overall Study|Physician Decision|2|||
126063920|NCT01922102|453525844|FG002|Overall Study|Physician Decision|1|||
126063921|NCT01922102|453525842|FG000|Overall Study|Adverse Event|1|||
126063922|NCT01922102|453525843|FG001|Overall Study|Adverse Event|2|||
126063923|NCT01922102|453525844|FG002|Overall Study|Adverse Event|0|||
126063924|NCT01922102|453525842|FG000|Overall Study|Lost to Follow-up|1|||
126063925|NCT01922102|453525843|FG001|Overall Study|Lost to Follow-up|0|||
126063926|NCT01922102|453525844|FG002|Overall Study|Lost to Follow-up|0|||
126063927|NCT01922102|453525842|FG000|Overall Study|Administrative problems|0|||
126063928|NCT01922102|453525843|FG001|Overall Study|Administrative problems|2|||
126063929|NCT01922102|453525844|FG002|Overall Study|Administrative problems|0|||
126063930|NCT01799993|453525848|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
126063931|NCT01799993|453525849|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
126063932|NCT01799993|453525848|FG000|Overall Study|Death|61|||
126063933|NCT01799993|453525849|FG001|Overall Study|Death|45|||
126063934|NCT01799993|453525848|FG000|Overall Study|Withdrawal by Subject|23|||
126063935|NCT01799993|453525849|FG001|Overall Study|Withdrawal by Subject|24|||
126063936|NCT01799993|453525848|FG000|Overall Study|Lost to Follow-up|5|||
126063937|NCT01799993|453525849|FG001|Overall Study|Lost to Follow-up|8|||
126063938|NCT01799993|453525848|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
126063939|NCT01799993|453525849|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
126063940|NCT01799993|453525848|FG000|Overall Study|Protocol driven decision point|0|||
126063941|NCT01799993|453525849|FG001|Overall Study|Protocol driven decision point|3|||
126063942|NCT01799993|453525848|FG000|Overall Study|Protocol Violation|1|||
126063943|NCT01799993|453525849|FG001|Overall Study|Protocol Violation|1|||
126063944|NCT01799993|453525848|FG000|Overall Study|Deterioration of general conditions|2|||
126063945|NCT01799993|453525849|FG001|Overall Study|Deterioration of general conditions|0|||
126063946|NCT01799993|453525848|FG000|Overall Study|Screen failure|0|||
126063947|NCT01799993|453525849|FG001|Overall Study|Screen failure|1|||
126063948|NCT01799993|453525848|FG000|Overall Study|Adverse Event|1|||
126063949|NCT01799993|453525849|FG001|Overall Study|Adverse Event|0|||
126063950|NCT01799993|453525848|FG000|Overall Study|Lack of Efficacy|1|||
126063951|NCT01799993|453525849|FG001|Overall Study|Lack of Efficacy|0|||
126063952|NCT01799993|453525848|FG000|Overall Study|Recovery|0|||
126063953|NCT01799993|453525849|FG001|Overall Study|Recovery|1|||
126063954|NCT01799993|453525848|FG000|Overall Study|Logistical difficulties|1|||
126063955|NCT01799993|453525849|FG001|Overall Study|Logistical difficulties|0|||
126063956|NCT01799993|453525848|FG000|Overall Study|Protocol deviation|1|||
126063957|NCT01799993|453525849|FG001|Overall Study|Protocol deviation|0|||
126063958|NCT01799993|453525848|FG000|Overall Study|Non-compliance with medical device|1|||
126063959|NCT01799993|453525849|FG001|Overall Study|Non-compliance with medical device|0|||
126063960|NCT01799993|453525848|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126063961|NCT01799993|453525849|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126063962|NCT01799993|453525848|FG000|Overall Study|Other|1|||
126063963|NCT01799993|453525849|FG001|Overall Study|Other|0|||
126063964|NCT01799993|453525848|FG000|Overall Study|Subject didn't return for follow-up|0|||
126063965|NCT01799993|453525849|FG001|Overall Study|Subject didn't return for follow-up|1|||
126063966|NCT04271254|453525850|FG000|Overall Study|Withdrawal by Subject|3|||
126063967|NCT04410445|453525851|FG000|Overall Study|Lost to Follow-up|3|||
126063968|NCT04410445|453525852|FG001|Overall Study|Lost to Follow-up|9|||
126110656|NCT02993523|453700329|FG000|Overall Study|Withdrew Consent|0|||
126063969|NCT04410445|453525851|FG000|Overall Study|Withdrawal by Subject|27|||
126063970|NCT04410445|453525852|FG001|Overall Study|Withdrawal by Subject|15|||
126063971|NCT01123356|453525853|FG000|Overall Study|Adverse Event|2|||
126063972|NCT01123356|453525853|FG000|Overall Study|Lack of Efficacy|4|||
126063973|NCT01123356|453525853|FG000|Overall Study|Withdrawal by Subject|1|||
126063974|NCT03262389|453525856|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
126063975|NCT03262389|453525856|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
126063976|NCT03262389|453525856|FG000|Overall Study|opted out of PET/MR|1|||
126063977|NCT01190436|453525857|FG000|Overall Study|Lost to Follow-up|35|||
126063978|NCT01190436|453525857|FG000|Overall Study|Other|4|||
126063979|NCT01052272|453525858|FG000|Overall Study|Death|0|||
126063980|NCT01052272|453525859|FG001|Overall Study|Death|0|||
126063981|NCT01052272|453525860|FG002|Overall Study|Death|1|||
126110657|NCT02993523|453700330|FG001|Overall Study|Withdrew Consent|0|||
125917175|NCT00150709|452996140|FG001|Overall Study|Subject relocated|2|||
125917176|NCT00150709|452996141|FG002|Overall Study|Subject relocated|1|||
125917177|NCT00150709|452996142|FG003|Overall Study|Subject relocated|0|||
125917178|NCT00150709|452996139|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
125917179|NCT00150709|452996140|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
125917180|NCT00150709|452996141|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
125917181|NCT00150709|452996142|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
125917182|NCT00150709|452996139|FG000|Overall Study|Convenience|0|||
125917183|NCT00150709|452996140|FG001|Overall Study|Convenience|1|||
125917184|NCT00150709|452996141|FG002|Overall Study|Convenience|0|||
125917185|NCT00150709|452996142|FG003|Overall Study|Convenience|0|||
125917186|NCT00150709|452996139|FG000|Overall Study|Subject entered new drug study|0|||
125917187|NCT00150709|452996140|FG001|Overall Study|Subject entered new drug study|1|||
125917188|NCT00150709|452996141|FG002|Overall Study|Subject entered new drug study|0|||
125917189|NCT00150709|452996142|FG003|Overall Study|Subject entered new drug study|0|||
125917190|NCT00150709|452996139|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
125917191|NCT00150709|452996140|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
125917192|NCT00150709|452996141|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
125917193|NCT00150709|452996142|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
125917194|NCT00150709|452996139|FG000|Overall Study|Lack of ease of swallowing|0|||
125917195|NCT00150709|452996140|FG001|Overall Study|Lack of ease of swallowing|1|||
125917196|NCT00150709|452996141|FG002|Overall Study|Lack of ease of swallowing|0|||
125917197|NCT00150709|452996142|FG003|Overall Study|Lack of ease of swallowing|0|||
125917198|NCT02975336|452996143|FG000|DBPC (52 Weeks)|Adverse Event|16|||
125917199|NCT02975336|452996144|FG001|DBPC (52 Weeks)|Adverse Event|17|||
125917200|NCT02975336|452996145|FG002|DBPC (52 Weeks)|Adverse Event|13|||
125917201|NCT02975336|452996146|FG003|DBPC (52 Weeks)|Adverse Event|18|||
125917202|NCT02975336|452996147|FG004|DBPC (52 Weeks)|Adverse Event|0|||
125917203|NCT02975336|452996148|FG005|DBPC (52 Weeks)|Adverse Event|0|||
125917204|NCT02975336|452996149|FG006|DBPC (52 Weeks)|Adverse Event|0|||
125917205|NCT02975336|452996150|FG007|DBPC (52 Weeks)|Adverse Event|0|||
125917206|NCT02975336|452996143|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
125917207|NCT02975336|452996144|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
125917208|NCT02975336|452996145|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
125917209|NCT02975336|452996146|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
125917210|NCT02975336|452996147|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
125917211|NCT02975336|452996148|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
125917212|NCT02975336|452996149|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
125917213|NCT02975336|452996150|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
125917214|NCT02975336|452996143|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
125917215|NCT02975336|452996144|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
125917216|NCT02975336|452996145|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
125917217|NCT02975336|452996146|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
125917218|NCT02975336|452996147|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
125917219|NCT02975336|452996148|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
125917220|NCT02975336|452996149|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
125917221|NCT02975336|452996150|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
125917222|NCT02975336|452996143|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
125917223|NCT02975336|452996144|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
125917224|NCT02975336|452996145|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
125917225|NCT02975336|452996146|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
125917226|NCT02975336|452996147|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
125917227|NCT02975336|452996148|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
125917228|NCT02975336|452996149|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
125917229|NCT02975336|452996150|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
125917230|NCT02975336|452996143|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
125917231|NCT02975336|452996144|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125917232|NCT02975336|452996145|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
125917233|NCT02975336|452996146|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
125917234|NCT02975336|452996147|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125917235|NCT02975336|452996148|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125917236|NCT02975336|452996149|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125917237|NCT02975336|452996150|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125917238|NCT02975336|452996143|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
126063982|NCT01052272|453525861|FG003|Overall Study|Death|1|||
126063983|NCT01052272|453525858|FG000|Overall Study|Physician Decision|0|||
125917239|NCT02975336|452996144|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
125917240|NCT02975336|452996145|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
125917241|NCT02975336|452996146|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
125917242|NCT02975336|452996147|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
125917243|NCT02975336|452996148|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
125917244|NCT02975336|452996149|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
125917245|NCT02975336|452996150|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
125917246|NCT02975336|452996143|FG000|LTE (104 Weeks)|Adverse Event|0|||
125917247|NCT02975336|452996144|FG001|LTE (104 Weeks)|Adverse Event|0|||
126063984|NCT01052272|453525859|FG001|Overall Study|Physician Decision|1|||
126063985|NCT01052272|453525860|FG002|Overall Study|Physician Decision|0|||
126063986|NCT01052272|453525861|FG003|Overall Study|Physician Decision|0|||
126063987|NCT01052272|453525858|FG000|Overall Study|patient refuses follow-up|5|||
126063988|NCT01052272|453525859|FG001|Overall Study|patient refuses follow-up|4|||
126063989|NCT01052272|453525860|FG002|Overall Study|patient refuses follow-up|2|||
126063990|NCT01052272|453525861|FG003|Overall Study|patient refuses follow-up|4|||
126063991|NCT01052272|453525858|FG000|Overall Study|Withdrawal by Subject|0|||
126063992|NCT01052272|453525859|FG001|Overall Study|Withdrawal by Subject|2|||
126063993|NCT01052272|453525860|FG002|Overall Study|Withdrawal by Subject|3|||
126063994|NCT01052272|453525861|FG003|Overall Study|Withdrawal by Subject|2|||
126063995|NCT01052272|453525858|FG000|Overall Study|placed in long-term care|0|||
126063996|NCT01052272|453525859|FG001|Overall Study|placed in long-term care|0|||
126063997|NCT01052272|453525860|FG002|Overall Study|placed in long-term care|1|||
126063998|NCT01052272|453525861|FG003|Overall Study|placed in long-term care|0|||
126063999|NCT01052272|453525858|FG000|Overall Study|decline in health|0|||
126064000|NCT01052272|453525859|FG001|Overall Study|decline in health|0|||
126064001|NCT01052272|453525860|FG002|Overall Study|decline in health|1|||
126064002|NCT01052272|453525861|FG003|Overall Study|decline in health|0|||
126064003|NCT01722097|453525863|FG000|Overall Study|Patient sheets not returned|6|||
126064004|NCT01722097|453525864|FG001|Overall Study|Patient sheets not returned|5|||
126064005|NCT02009332|453525865|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126064006|NCT02009332|453525866|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
126064007|NCT02009332|453525867|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126064008|NCT02009332|453525868|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126064009|NCT02009332|453525869|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126064010|NCT02009332|453525870|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126064011|NCT02009332|453525865|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126064012|NCT02009332|453525866|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126064013|NCT02009332|453525867|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126064014|NCT02009332|453525868|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126064015|NCT02009332|453525869|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
126064016|NCT02009332|453525870|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126064017|NCT02009332|453525865|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126064018|NCT02009332|453525866|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126064019|NCT02009332|453525867|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126064020|NCT02009332|453525868|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126064021|NCT02009332|453525869|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126064022|NCT02009332|453525870|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
126064023|NCT04739306|453525871|FG000|Main Study Period|Adverse Event|6|||
126064024|NCT04739306|453525872|FG001|Main Study Period|Adverse Event|7|||
126064025|NCT04739306|453525871|FG000|Main Study Period|Lost to Follow-up|4|||
126064026|NCT04739306|453525872|FG001|Main Study Period|Lost to Follow-up|6|||
126064027|NCT04739306|453525871|FG000|Main Study Period|Physician Decision|1|||
126064028|NCT04739306|453525872|FG001|Main Study Period|Physician Decision|1|||
126064029|NCT04739306|453525871|FG000|Main Study Period|Withdrawal by Subject|8|||
126064030|NCT04739306|453525872|FG001|Main Study Period|Withdrawal by Subject|6|||
126064031|NCT04739306|453525871|FG000|Main Study Period|Protocol Violation|0|||
126064032|NCT04739306|453525872|FG001|Main Study Period|Protocol Violation|1|||
126064033|NCT04739306|453525871|FG000|Main Study Period|War in Ukraine|1|||
126064034|NCT04739306|453525872|FG001|Main Study Period|War in Ukraine|1|||
126064035|NCT01077284|453525873|FG000|Overall Study|Adverse Event|2|||
126064036|NCT01077284|453525874|FG001|Overall Study|Adverse Event|0|||
126064037|NCT01077284|453525875|FG002|Overall Study|Adverse Event|1|||
126064038|NCT01077284|453525873|FG000|Overall Study|Lost to Follow-up|1|||
126064039|NCT01077284|453525874|FG001|Overall Study|Lost to Follow-up|2|||
126064040|NCT01077284|453525875|FG002|Overall Study|Lost to Follow-up|0|||
126064041|NCT01077284|453525873|FG000|Overall Study|Withdrawal by Subject|2|||
126064042|NCT01077284|453525874|FG001|Overall Study|Withdrawal by Subject|3|||
126064043|NCT01077284|453525875|FG002|Overall Study|Withdrawal by Subject|1|||
126064044|NCT01077284|453525873|FG000|Overall Study|Other|0|||
126064045|NCT01077284|453525874|FG001|Overall Study|Other|0|||
126064046|NCT01077284|453525875|FG002|Overall Study|Other|1|||
126064047|NCT01180400|453525876|FG000|Overall Study|Withdrawal by Subject|5|||
126064048|NCT01180400|453525877|FG001|Overall Study|Withdrawal by Subject|6|||
126064049|NCT01180400|453525876|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126064050|NCT01180400|453525877|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
126064051|NCT01180400|453525876|FG000|Overall Study|Adverse Event|12|||
126064052|NCT01180400|453525877|FG001|Overall Study|Adverse Event|10|||
126064053|NCT01180400|453525876|FG000|Overall Study|Severe non-compliance to protocol|1|||
126064054|NCT01180400|453525877|FG001|Overall Study|Severe non-compliance to protocol|2|||
126064055|NCT01180400|453525876|FG000|Overall Study|Condition under investigation worsened|2|||
126064056|NCT01180400|453525877|FG001|Overall Study|Condition under investigation worsened|1|||
126064057|NCT01180400|453525876|FG000|Overall Study|Lack of Efficacy|2|||
125917248|NCT02975336|452996145|FG002|LTE (104 Weeks)|Adverse Event|0|||
125917249|NCT02975336|452996146|FG003|LTE (104 Weeks)|Adverse Event|0|||
125917250|NCT02975336|452996147|FG004|LTE (104 Weeks)|Adverse Event|7|||
125917251|NCT02975336|452996148|FG005|LTE (104 Weeks)|Adverse Event|4|||
125917252|NCT02975336|452996149|FG006|LTE (104 Weeks)|Adverse Event|2|||
125917253|NCT02975336|452996150|FG007|LTE (104 Weeks)|Adverse Event|0|||
125917254|NCT02975336|452996143|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
125917255|NCT02975336|452996144|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
125917256|NCT02975336|452996145|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
125917257|NCT02975336|452996146|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
125917258|NCT02975336|452996147|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
125917259|NCT02975336|452996148|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
125917260|NCT02975336|452996149|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
125917261|NCT02975336|452996150|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
125917262|NCT02975336|452996143|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
125917263|NCT02975336|452996144|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
125917264|NCT02975336|452996145|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
125917265|NCT02975336|452996146|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
125917266|NCT02975336|452996147|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
125917267|NCT02975336|452996148|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
125917268|NCT02975336|452996149|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
125917269|NCT02975336|452996150|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
125917270|NCT02975336|452996143|FG000|LTE (104 Weeks)|Other|0|||
125917271|NCT02975336|452996144|FG001|LTE (104 Weeks)|Other|0|||
125917272|NCT02975336|452996145|FG002|LTE (104 Weeks)|Other|0|||
125917273|NCT02975336|452996146|FG003|LTE (104 Weeks)|Other|0|||
125917274|NCT02975336|452996147|FG004|LTE (104 Weeks)|Other|55|||
125917275|NCT02975336|452996148|FG005|LTE (104 Weeks)|Other|63|||
125917276|NCT02975336|452996149|FG006|LTE (104 Weeks)|Other|76|||
125917277|NCT02975336|452996150|FG007|LTE (104 Weeks)|Other|72|||
125917278|NCT04015336|452996151|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
125917279|NCT01816074|452996156|FG000|Phase 1|Time commitment issues|0|||
125917280|NCT01816074|452996157|FG001|Phase 1|Time commitment issues|0|||
125917281|NCT01816074|452996158|FG002|Phase 1|Time commitment issues|1|||
125917282|NCT01816074|452996159|FG003|Phase 1|Time commitment issues|0|||
125917283|NCT01816074|452996156|FG000|Phase 2|Time commitment Issues|0|||
125917284|NCT01816074|452996157|FG001|Phase 2|Time commitment Issues|2|||
125917285|NCT01816074|452996158|FG002|Phase 2|Time commitment Issues|0|||
125917286|NCT01816074|452996159|FG003|Phase 2|Time commitment Issues|0|||
125917287|NCT01816074|452996156|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
125917288|NCT01816074|452996157|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
125917289|NCT01816074|452996158|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
125917290|NCT01816074|452996159|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
125917291|NCT01816074|452996156|FG000|Phase 2|Physician Decision|0|||
125917292|NCT01816074|452996157|FG001|Phase 2|Physician Decision|0|||
125917293|NCT01816074|452996158|FG002|Phase 2|Physician Decision|0|||
125917294|NCT01816074|452996159|FG003|Phase 2|Physician Decision|1|||
125917295|NCT01816074|452996156|FG000|Phase 2|Withdrawal by Subject|1|||
125917296|NCT01816074|452996157|FG001|Phase 2|Withdrawal by Subject|0|||
125917297|NCT01816074|452996158|FG002|Phase 2|Withdrawal by Subject|0|||
125917298|NCT01816074|452996159|FG003|Phase 2|Withdrawal by Subject|0|||
125917299|NCT01868503|452996160|FG000|Overall Study|Withdrawal by Subject|1|||
125917300|NCT01868503|452996160|FG000|Overall Study|Protocol Violation|1|||
125917301|NCT03650556|452996161|FG000|Overall Study|Death|2|||
125917302|NCT03650556|452996161|FG000|Overall Study|Withdrawal by Subject|20|||
125917303|NCT03650556|452996161|FG000|Overall Study|Physician Decision|2|||
125917304|NCT03650556|452996161|FG000|Overall Study|Lost to Follow-up|8|||
125917305|NCT03650556|452996161|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
125917306|NCT03650556|452996161|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
125917307|NCT00691301|452996162|FG000|Overall Study|Adverse Event|10|||
125917308|NCT00691301|452996162|FG000|Overall Study|Death|2|||
125917309|NCT00691301|452996162|FG000|Overall Study|Lack of Efficacy|32|||
125917310|NCT00691301|452996162|FG000|Overall Study|Withdrawal by Subject|4|||
125917311|NCT00691301|452996162|FG000|Overall Study|Concurrent illness|2|||
125917312|NCT00691301|452996162|FG000|Overall Study|other reason|3|||
125917313|NCT00691301|452996162|FG000|Overall Study|Did not initiate study treatment|1|||
125917314|NCT01823146|452996163|FG000|Overall Study|Withdrawal by Subject|0|||
125917315|NCT01823146|452996164|FG001|Overall Study|Withdrawal by Subject|1|||
125917316|NCT01823146|452996163|FG000|Overall Study|Lost to Follow-up|2|||
125917317|NCT01823146|452996164|FG001|Overall Study|Lost to Follow-up|1|||
125917318|NCT00463580|452996165|FG000|Overall Study|Lost to Follow-up|1|||
125917319|NCT00463580|452996166|FG001|Overall Study|Lost to Follow-up|0|||
125917320|NCT00463580|452996165|FG000|Overall Study|Schedule conflict|2|||
125917321|NCT00463580|452996166|FG001|Overall Study|Schedule conflict|0|||
125917322|NCT00463580|452996165|FG000|Overall Study|Medical/psychiatric complications|0|||
125917323|NCT00463580|452996166|FG001|Overall Study|Medical/psychiatric complications|2|||
125917324|NCT03917459|452996167|FG000|Overall Study|Adverse Event|1|||
125917325|NCT03917459|452996168|FG001|Overall Study|Adverse Event|0|||
126110658|NCT02993523|453700331|FG002|Overall Study|Withdrew Consent|2|||
126110659|NCT02993523|453700332|FG003|Overall Study|Withdrew Consent|9|||
126110660|NCT02993523|453700333|FG004|Overall Study|Withdrew Consent|0|||
125917326|NCT03917459|452996167|FG000|Overall Study|Withdrawal by Subject|0|||
126110661|NCT02993523|453700329|FG000|Overall Study|Lost to Follow-up|0|||
126110662|NCT02993523|453700330|FG001|Overall Study|Lost to Follow-up|0|||
125917327|NCT03917459|452996168|FG001|Overall Study|Withdrawal by Subject|1|||
125917328|NCT00491764|452996169|FG000|Overall Study|Adverse Event|1|||
125917329|NCT00491764|452996170|FG001|Overall Study|Adverse Event|2|||
125917330|NCT00491764|452996171|FG002|Overall Study|Adverse Event|4|||
125917331|NCT00491764|452996172|FG003|Overall Study|Adverse Event|4|||
125917332|NCT00491764|452996173|FG004|Overall Study|Adverse Event|0|||
125917333|NCT00491764|452996174|FG005|Overall Study|Adverse Event|1|||
125917334|NCT00491764|452996169|FG000|Overall Study|Lost to Follow-up|0|||
125917335|NCT00491764|452996170|FG001|Overall Study|Lost to Follow-up|1|||
125917336|NCT00491764|452996171|FG002|Overall Study|Lost to Follow-up|0|||
125917337|NCT00491764|452996172|FG003|Overall Study|Lost to Follow-up|1|||
125917338|NCT00491764|452996173|FG004|Overall Study|Lost to Follow-up|0|||
125917339|NCT00491764|452996174|FG005|Overall Study|Lost to Follow-up|3|||
125917340|NCT00491764|452996169|FG000|Overall Study|Withdrawal by Subject|2|||
125917341|NCT00491764|452996170|FG001|Overall Study|Withdrawal by Subject|3|||
125917342|NCT00491764|452996171|FG002|Overall Study|Withdrawal by Subject|1|||
125917343|NCT00491764|452996172|FG003|Overall Study|Withdrawal by Subject|2|||
125917344|NCT00491764|452996173|FG004|Overall Study|Withdrawal by Subject|2|||
125917345|NCT00491764|452996174|FG005|Overall Study|Withdrawal by Subject|4|||
125917346|NCT00491764|452996169|FG000|Overall Study|Non Compliance with the Protocol|1|||
125917347|NCT00491764|452996170|FG001|Overall Study|Non Compliance with the Protocol|0|||
125917348|NCT00491764|452996171|FG002|Overall Study|Non Compliance with the Protocol|0|||
125917349|NCT00491764|452996172|FG003|Overall Study|Non Compliance with the Protocol|0|||
125917350|NCT00491764|452996173|FG004|Overall Study|Non Compliance with the Protocol|0|||
125917351|NCT00491764|452996174|FG005|Overall Study|Non Compliance with the Protocol|0|||
125917352|NCT00491764|452996169|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
125917353|NCT00491764|452996170|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
125917354|NCT00491764|452996171|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
125917355|NCT00491764|452996172|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
125917356|NCT00491764|452996173|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
125917357|NCT00491764|452996174|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
125917358|NCT00491764|452996169|FG000|Overall Study|Administrative|1|||
125917359|NCT00491764|452996170|FG001|Overall Study|Administrative|0|||
125917360|NCT00491764|452996171|FG002|Overall Study|Administrative|2|||
125917361|NCT00491764|452996172|FG003|Overall Study|Administrative|1|||
125917362|NCT00491764|452996173|FG004|Overall Study|Administrative|0|||
125917363|NCT00491764|452996174|FG005|Overall Study|Administrative|0|||
125917364|NCT00697788|452996177|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125917365|NCT00697788|452996178|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
125917366|NCT00697788|452996179|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125917367|NCT00697788|452996180|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125917368|NCT00697788|452996181|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125917369|NCT00697788|452996182|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125917370|NCT00697788|452996183|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125917371|NCT00697788|452996184|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125917372|NCT00697788|452996177|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125917373|NCT00697788|452996178|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125917374|NCT00697788|452996179|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125917375|NCT00697788|452996180|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125917376|NCT00697788|452996181|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
125917377|NCT00697788|452996182|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125917378|NCT00697788|452996183|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125917379|NCT00697788|452996184|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
126064058|NCT01180400|453525877|FG001|Overall Study|Lack of Efficacy|0|||
126064059|NCT01180400|453525876|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126064060|NCT01180400|453525877|FG001|Overall Study|Study-specific withdrawal criteria|2|||
126064061|NCT01180400|453525876|FG000|Overall Study|Lost to Follow-up|2|||
125917380|NCT00075218|452996193|FG000|Double-Blind Treatment|Adverse Event|23|||
125917381|NCT00075218|452996194|FG001|Double-Blind Treatment|Adverse Event|4|||
125917382|NCT00075218|452996195|FG002|Double-Blind Treatment|Adverse Event|0|||
125917383|NCT00075218|452996193|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
125917384|NCT00075218|452996194|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
125917385|NCT00075218|452996195|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
125917386|NCT00075218|452996193|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
125917387|NCT00075218|452996194|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
125917388|NCT00075218|452996195|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
125917389|NCT00075218|452996193|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
125917390|NCT00075218|452996194|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
125917391|NCT00075218|452996195|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
125917392|NCT00075218|452996193|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
125917393|NCT00075218|452996194|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
125917394|NCT00075218|452996195|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
125917395|NCT00075218|452996193|FG000|Double-Blind Treatment|No study medication taken|2|||
125917396|NCT00075218|452996194|FG001|Double-Blind Treatment|No study medication taken|0|||
125917397|NCT00075218|452996195|FG002|Double-Blind Treatment|No study medication taken|0|||
125917398|NCT00075218|452996193|FG000|Open-Label Treatment|Lack of Efficacy|0|||
125917399|NCT00075218|452996194|FG001|Open-Label Treatment|Lack of Efficacy|0|||
125917400|NCT00075218|452996195|FG002|Open-Label Treatment|Lack of Efficacy|174|||
125917401|NCT00075218|452996193|FG000|Open-Label Treatment|Adverse Event|0|||
126064062|NCT01180400|453525877|FG001|Overall Study|Lost to Follow-up|3|||
126064063|NCT01180400|453525876|FG000|Overall Study|Other|0|||
126064064|NCT01180400|453525877|FG001|Overall Study|Other|1|||
126064065|NCT00096278|453525879|FG000|Overall Study|No follow-up data|15|||
126064066|NCT00096278|453525880|FG001|Overall Study|No follow-up data|18|||
126064067|NCT00096278|453525879|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
126064068|NCT00096278|453525880|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
126064069|NCT02877680|453525889|FG000|Overall Study|Lost to Follow-up|1|||
126064070|NCT02877680|453525890|FG001|Overall Study|Lost to Follow-up|1|||
126064071|NCT01133678|453525891|FG000|Overall Study|Death|1|||
126064072|NCT01133678|453525892|FG001|Overall Study|Death|1|||
126064073|NCT05104242|453525893|FG000|Overall Study|Withdrawal by Subject|1|||
126064074|NCT05104242|453525894|FG001|Overall Study|Withdrawal by Subject|5|||
126064075|NCT05104242|453525893|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
126064076|NCT05104242|453525894|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
126064077|NCT00424476|453525896|FG000|Overall Study|Withdrawal by Subject|7|||
126064078|NCT00424476|453525897|FG001|Overall Study|Withdrawal by Subject|6|||
126064079|NCT00424476|453525898|FG002|Overall Study|Withdrawal by Subject|3|||
126064080|NCT00424476|453525896|FG000|Overall Study|Adverse Event|19|||
126064081|NCT00424476|453525897|FG001|Overall Study|Adverse Event|16|||
126064082|NCT00424476|453525898|FG002|Overall Study|Adverse Event|15|||
126064083|NCT00424476|453525896|FG000|Overall Study|Lack of Efficacy|16|||
126064084|NCT00424476|453525897|FG001|Overall Study|Lack of Efficacy|12|||
126064085|NCT00424476|453525898|FG002|Overall Study|Lack of Efficacy|12|||
126064086|NCT00424476|453525896|FG000|Overall Study|Lack of Compliance|1|||
126064087|NCT00424476|453525897|FG001|Overall Study|Lack of Compliance|1|||
126064088|NCT00424476|453525898|FG002|Overall Study|Lack of Compliance|1|||
126064089|NCT00424476|453525896|FG000|Overall Study|Lost to Follow-up|4|||
126064090|NCT00424476|453525897|FG001|Overall Study|Lost to Follow-up|6|||
126064091|NCT00424476|453525898|FG002|Overall Study|Lost to Follow-up|3|||
126064092|NCT00424476|453525896|FG000|Overall Study|Protocol Violation|7|||
126064093|NCT00424476|453525897|FG001|Overall Study|Protocol Violation|2|||
126064094|NCT00424476|453525898|FG002|Overall Study|Protocol Violation|3|||
126064095|NCT00424476|453525896|FG000|Overall Study|Physician Decision|3|||
126064096|NCT00424476|453525897|FG001|Overall Study|Physician Decision|2|||
126064097|NCT00424476|453525898|FG002|Overall Study|Physician Decision|3|||
126064098|NCT00424476|453525896|FG000|Overall Study|Other|4|||
126064099|NCT00424476|453525897|FG001|Overall Study|Other|3|||
126064100|NCT00424476|453525898|FG002|Overall Study|Other|9|||
126064101|NCT02574286|453525899|FG000|Overall Study|Adverse Event|3|||
126064102|NCT02574286|453525899|FG000|Overall Study|Withdrawal by Subject|2|||
126064103|NCT01280656|453525900|FG000|Overall Study|Adverse Event|1|||
126064104|NCT01280656|453525901|FG001|Overall Study|Adverse Event|14|||
126064105|NCT01280656|453525902|FG002|Overall Study|Adverse Event|13|||
126064106|NCT01280656|453525900|FG000|Overall Study|Lack of Efficacy|1|||
126064107|NCT01280656|453525901|FG001|Overall Study|Lack of Efficacy|22|||
126064108|NCT01280656|453525902|FG002|Overall Study|Lack of Efficacy|38|||
126064109|NCT01280656|453525900|FG000|Overall Study|Treatment shortening (RGT)|0|||
126064110|NCT01280656|453525901|FG001|Overall Study|Treatment shortening (RGT)|4|||
126064111|NCT01280656|453525902|FG002|Overall Study|Treatment shortening (RGT)|5|||
126064112|NCT01280656|453525900|FG000|Overall Study|Other|1|||
126064113|NCT01280656|453525901|FG001|Overall Study|Other|7|||
126064114|NCT01280656|453525902|FG002|Overall Study|Other|7|||
126064115|NCT00736502|453525903|FG000|Overall Study|Adverse Event|22|||
126110663|NCT02993523|453700331|FG002|Overall Study|Lost to Follow-up|3|||
126110664|NCT02993523|453700332|FG003|Overall Study|Lost to Follow-up|6|||
126110665|NCT02993523|453700333|FG004|Overall Study|Lost to Follow-up|0|||
126110666|NCT02993523|453700329|FG000|Overall Study|Death|1|||
126110667|NCT02993523|453700330|FG001|Overall Study|Death|1|||
126110668|NCT02993523|453700331|FG002|Overall Study|Death|138|||
126110669|NCT02993523|453700332|FG003|Overall Study|Death|222|||
126110670|NCT02993523|453700333|FG004|Overall Study|Death|6|||
126110671|NCT02993523|453700329|FG000|Overall Study|Reason not Specified|0|||
126110672|NCT02993523|453700330|FG001|Overall Study|Reason not Specified|0|||
126110673|NCT02993523|453700331|FG002|Overall Study|Reason not Specified|1|||
126110674|NCT02993523|453700332|FG003|Overall Study|Reason not Specified|1|||
126110675|NCT02993523|453700333|FG004|Overall Study|Reason not Specified|0|||
126110676|NCT03694418|453700334|FG000|Overall Study|Lost to Follow-up|115|||
126110677|NCT03694418|453700335|FG001|Overall Study|Lost to Follow-up|23|||
126110678|NCT03694418|453700336|FG002|Overall Study|Lost to Follow-up|12|||
125917402|NCT00075218|452996194|FG001|Open-Label Treatment|Adverse Event|0|||
125917403|NCT00075218|452996195|FG002|Open-Label Treatment|Adverse Event|51|||
125917404|NCT00075218|452996193|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
126110679|NCT03694418|453700337|FG003|Overall Study|Lost to Follow-up|12|||
126110680|NCT03694418|453700338|FG004|Overall Study|Lost to Follow-up|13|||
126110681|NCT01136811|453700341|FG000|Overall Study|Physician Decision|11|||
126110682|NCT01009554|453700342|FG000|Overall Study|Adverse Event|1|||
126110683|NCT01009554|453700343|FG001|Overall Study|Adverse Event|1|||
126110684|NCT01009554|453700342|FG000|Overall Study|Withdrawal by Subject|1|||
126110685|NCT01009554|453700343|FG001|Overall Study|Withdrawal by Subject|3|||
126110686|NCT01009554|453700342|FG000|Overall Study|Noncompliant with Study Product|0|||
126110687|NCT01009554|453700343|FG001|Overall Study|Noncompliant with Study Product|3|||
126110688|NCT01605253|453700344|FG000|Overall Study|Physician Decision|3|||
126110689|NCT01605253|453700345|FG001|Overall Study|Physician Decision|2|||
126110690|NCT01605253|453700344|FG000|Overall Study|Lost to Follow-up|3|||
126110691|NCT01605253|453700345|FG001|Overall Study|Lost to Follow-up|1|||
126110692|NCT05560763|453700356|FG000|Overall Study|Withdrawal by Subject|4|||
126110693|NCT02673619|453700357|FG000|Overall Study|Lost to Follow-up|1|||
126110694|NCT02673619|453700358|FG001|Overall Study|Lost to Follow-up|0|||
126110695|NCT02673619|453700359|FG002|Overall Study|Lost to Follow-up|0|||
126110696|NCT02673619|453700360|FG003|Overall Study|Lost to Follow-up|0|||
126110697|NCT02673619|453700357|FG000|Overall Study|Withdrawal by Subject|1|||
126110698|NCT02673619|453700358|FG001|Overall Study|Withdrawal by Subject|1|||
126110699|NCT02673619|453700359|FG002|Overall Study|Withdrawal by Subject|1|||
126110700|NCT02673619|453700360|FG003|Overall Study|Withdrawal by Subject|0|||
126110701|NCT02673619|453700357|FG000|Overall Study|Adverse Event|0|||
125917405|NCT00075218|452996194|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
125917406|NCT00075218|452996195|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
125917407|NCT00075218|452996193|FG000|Open-Label Treatment|Decision of Sponsor|0|||
125917408|NCT00075218|452996194|FG001|Open-Label Treatment|Decision of Sponsor|0|||
125917409|NCT00075218|452996195|FG002|Open-Label Treatment|Decision of Sponsor|8|||
125917410|NCT00075218|452996193|FG000|Open-Label Treatment|Protocol Violation|0|||
125917411|NCT00075218|452996194|FG001|Open-Label Treatment|Protocol Violation|0|||
125917412|NCT00075218|452996195|FG002|Open-Label Treatment|Protocol Violation|1|||
125917413|NCT00075218|452996193|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
125917414|NCT00075218|452996194|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
125917415|NCT00075218|452996195|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
125917416|NCT00845858|452996198|FG000|Overall Study|Withdrawal by Subject|5|||
125917417|NCT00845858|452996199|FG001|Overall Study|Withdrawal by Subject|1|||
125917418|NCT00845858|452996200|FG002|Overall Study|Withdrawal by Subject|1|||
125917419|NCT00845858|452996198|FG000|Overall Study|Adverse Event|3|||
125917420|NCT00845858|452996199|FG001|Overall Study|Adverse Event|8|||
125917421|NCT00845858|452996200|FG002|Overall Study|Adverse Event|4|||
125917422|NCT00845858|452996198|FG000|Overall Study|Protocol Violation|0|||
125917423|NCT00845858|452996199|FG001|Overall Study|Protocol Violation|0|||
125917424|NCT00845858|452996200|FG002|Overall Study|Protocol Violation|1|||
125917425|NCT00845858|452996198|FG000|Overall Study|not eligible|0|||
125917426|NCT00845858|452996199|FG001|Overall Study|not eligible|3|||
125917427|NCT00845858|452996200|FG002|Overall Study|not eligible|2|||
125917428|NCT02191137|452996201|FG000|Treatment|Death|4|||
125917429|NCT02191137|452996201|FG000|Treatment|Withdrawal by Subject|3|||
125917430|NCT02191137|452996201|FG000|Treatment|Adverse Event|2|||
125917431|NCT02191137|452996201|FG000|Treatment|Other|1|||
125917432|NCT02191137|452996201|FG000|Follow-up|Lost to Follow-up|2|||
125917433|NCT02191137|452996201|FG000|Follow-up|Ongoing/unknown|2|||
125917434|NCT02191137|452996201|FG000|Follow-up|Adverse Event|1|||
125917435|NCT01811225|452996202|FG000|Treatment Period 1|Adverse Event|2|||
125917436|NCT01811225|452996203|FG001|Treatment Period 1|Adverse Event|3|||
125917437|NCT01811225|452996202|FG000|Treatment Period 1|Lost to Follow-up|12|||
125917438|NCT01811225|452996203|FG001|Treatment Period 1|Lost to Follow-up|8|||
125917439|NCT01811225|452996202|FG000|Treatment Period 1|transporation|1|||
125917440|NCT01811225|452996203|FG001|Treatment Period 1|transporation|0|||
125917441|NCT01811225|452996202|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
125917442|NCT01811225|452996203|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
125917443|NCT01811225|452996202|FG000|Treatment Period 2|Lost to Follow-up|1|||
125917444|NCT01811225|452996203|FG001|Treatment Period 2|Lost to Follow-up|2|||
125917445|NCT01811225|452996202|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
125917446|NCT01811225|452996203|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
125917447|NCT02158975|452996204|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
125917448|NCT02840721|452996207|FG000|Treatment Period|Adverse Event|1|||
125917449|NCT02840721|452996207|FG000|Follow-Up|Lack of Efficacy|1|||
125917450|NCT02840721|452996207|FG000|Follow-Up|Withdrawal by Subject|4|||
125917451|NCT02840721|452996207|FG000|Follow-Up|Withdrawal of Consent|2|||
125917452|NCT01967173|452996208|FG000|Overall Study|Lost to Follow-up|5|||
125917453|NCT01967173|452996209|FG001|Overall Study|Lost to Follow-up|3|||
125917454|NCT01967173|452996210|FG002|Overall Study|Lost to Follow-up|2|||
125917455|NCT01967173|452996211|FG003|Overall Study|Lost to Follow-up|4|||
125917456|NCT01967173|452996212|FG004|Overall Study|Lost to Follow-up|8|||
125917457|NCT01967173|452996213|FG005|Overall Study|Lost to Follow-up|12|||
125917458|NCT01967173|452996214|FG006|Overall Study|Lost to Follow-up|6|||
125917459|NCT01967173|452996215|FG007|Overall Study|Lost to Follow-up|8|||
125917460|NCT01967173|452996208|FG000|Overall Study|Physician Decision|2|||
125917461|NCT01967173|452996209|FG001|Overall Study|Physician Decision|0|||
125917462|NCT01967173|452996210|FG002|Overall Study|Physician Decision|2|||
125917463|NCT01967173|452996211|FG003|Overall Study|Physician Decision|1|||
125917464|NCT01967173|452996212|FG004|Overall Study|Physician Decision|1|||
125917465|NCT01967173|452996213|FG005|Overall Study|Physician Decision|1|||
125917466|NCT01967173|452996214|FG006|Overall Study|Physician Decision|1|||
125917467|NCT01967173|452996215|FG007|Overall Study|Physician Decision|0|||
125917468|NCT01967173|452996208|FG000|Overall Study|Lack of Efficacy|2|||
125917469|NCT01967173|452996209|FG001|Overall Study|Lack of Efficacy|0|||
125917470|NCT01967173|452996210|FG002|Overall Study|Lack of Efficacy|2|||
125917471|NCT01967173|452996211|FG003|Overall Study|Lack of Efficacy|2|||
125917472|NCT01967173|452996212|FG004|Overall Study|Lack of Efficacy|0|||
125917473|NCT01967173|452996213|FG005|Overall Study|Lack of Efficacy|1|||
125917474|NCT01967173|452996214|FG006|Overall Study|Lack of Efficacy|0|||
125917475|NCT01967173|452996215|FG007|Overall Study|Lack of Efficacy|2|||
125917476|NCT01967173|452996208|FG000|Overall Study|Pregnancy|0|||
125917477|NCT01967173|452996209|FG001|Overall Study|Pregnancy|0|||
125917478|NCT01967173|452996210|FG002|Overall Study|Pregnancy|0|||
125917479|NCT01967173|452996211|FG003|Overall Study|Pregnancy|0|||
125917480|NCT01967173|452996212|FG004|Overall Study|Pregnancy|0|||
125917481|NCT01967173|452996213|FG005|Overall Study|Pregnancy|0|||
125917482|NCT01967173|452996214|FG006|Overall Study|Pregnancy|1|||
125917483|NCT01967173|452996215|FG007|Overall Study|Pregnancy|1|||
126110702|NCT02673619|453700358|FG001|Overall Study|Adverse Event|0|||
126110703|NCT02673619|453700359|FG002|Overall Study|Adverse Event|1|||
126110704|NCT02673619|453700360|FG003|Overall Study|Adverse Event|0|||
126110705|NCT02673619|453700357|FG000|Overall Study|Lack of Efficacy|0|||
126110706|NCT02673619|453700358|FG001|Overall Study|Lack of Efficacy|0|||
126110707|NCT02673619|453700359|FG002|Overall Study|Lack of Efficacy|1|||
126110708|NCT02673619|453700360|FG003|Overall Study|Lack of Efficacy|0|||
126110709|NCT04225806|453700361|FG000|Overall Study|Trial termination|15|||
126110710|NCT02408861|453700364|FG000|Overall Study|Death|0|||
126110711|NCT02408861|453700365|FG001|Overall Study|Death|3|||
126110712|NCT02408861|453700366|FG002|Overall Study|Death|1|||
126110713|NCT02408861|453700367|FG003|Overall Study|Death|2|||
126110714|NCT02408861|453700368|FG004|Overall Study|Death|4|||
126110715|NCT02408861|453700369|FG005|Overall Study|Death|1|||
126110716|NCT02408861|453700370|FG006|Overall Study|Death|0|||
126110717|NCT02408861|453700364|FG000|Overall Study|Lost to Follow-up|0|||
126110718|NCT02408861|453700365|FG001|Overall Study|Lost to Follow-up|0|||
126110719|NCT02408861|453700366|FG002|Overall Study|Lost to Follow-up|1|||
126110720|NCT02408861|453700367|FG003|Overall Study|Lost to Follow-up|1|||
126110721|NCT02408861|453700368|FG004|Overall Study|Lost to Follow-up|4|||
126110722|NCT02408861|453700369|FG005|Overall Study|Lost to Follow-up|2|||
126110723|NCT02408861|453700370|FG006|Overall Study|Lost to Follow-up|1|||
126110724|NCT02408861|453700364|FG000|Overall Study|Disease Progression|0|||
126110725|NCT02408861|453700365|FG001|Overall Study|Disease Progression|0|||
126110726|NCT02408861|453700366|FG002|Overall Study|Disease Progression|1|||
126110727|NCT02408861|453700367|FG003|Overall Study|Disease Progression|0|||
126110728|NCT02408861|453700368|FG004|Overall Study|Disease Progression|3|||
126110729|NCT02408861|453700369|FG005|Overall Study|Disease Progression|1|||
126110730|NCT02408861|453700370|FG006|Overall Study|Disease Progression|1|||
126110731|NCT02408861|453700364|FG000|Overall Study|Adverse Event|1|||
126110732|NCT02408861|453700365|FG001|Overall Study|Adverse Event|0|||
126110733|NCT02408861|453700366|FG002|Overall Study|Adverse Event|1|||
126110734|NCT02408861|453700367|FG003|Overall Study|Adverse Event|0|||
126110735|NCT02408861|453700368|FG004|Overall Study|Adverse Event|2|||
126110736|NCT02408861|453700369|FG005|Overall Study|Adverse Event|0|||
126110737|NCT02408861|453700370|FG006|Overall Study|Adverse Event|0|||
126110738|NCT02408861|453700364|FG000|Overall Study|Physician Decision|1|||
126110739|NCT02408861|453700365|FG001|Overall Study|Physician Decision|1|||
126110740|NCT02408861|453700366|FG002|Overall Study|Physician Decision|1|||
126110741|NCT02408861|453700367|FG003|Overall Study|Physician Decision|0|||
126110742|NCT02408861|453700368|FG004|Overall Study|Physician Decision|0|||
126110743|NCT02408861|453700369|FG005|Overall Study|Physician Decision|1|||
126110744|NCT02408861|453700370|FG006|Overall Study|Physician Decision|0|||
126110745|NCT02408861|453700364|FG000|Overall Study|Protocol Violation|1|||
126110746|NCT02408861|453700365|FG001|Overall Study|Protocol Violation|0|||
126110747|NCT02408861|453700366|FG002|Overall Study|Protocol Violation|0|||
126110748|NCT02408861|453700367|FG003|Overall Study|Protocol Violation|0|||
126110749|NCT02408861|453700368|FG004|Overall Study|Protocol Violation|0|||
126110750|NCT02408861|453700369|FG005|Overall Study|Protocol Violation|0|||
126110751|NCT02408861|453700370|FG006|Overall Study|Protocol Violation|0|||
126110752|NCT02408861|453700364|FG000|Overall Study|Withdrawal by Subject|0|||
126110753|NCT02408861|453700365|FG001|Overall Study|Withdrawal by Subject|0|||
126110754|NCT02408861|453700366|FG002|Overall Study|Withdrawal by Subject|0|||
126110755|NCT02408861|453700367|FG003|Overall Study|Withdrawal by Subject|0|||
126110756|NCT02408861|453700368|FG004|Overall Study|Withdrawal by Subject|1|||
126110757|NCT02408861|453700369|FG005|Overall Study|Withdrawal by Subject|1|||
126110758|NCT02408861|453700370|FG006|Overall Study|Withdrawal by Subject|0|||
126110759|NCT02408861|453700364|FG000|Overall Study|Other Treatment|0|||
126110760|NCT02408861|453700365|FG001|Overall Study|Other Treatment|0|||
126110761|NCT02408861|453700366|FG002|Overall Study|Other Treatment|0|||
126110762|NCT02408861|453700367|FG003|Overall Study|Other Treatment|0|||
126110763|NCT02408861|453700368|FG004|Overall Study|Other Treatment|0|||
126110764|NCT02408861|453700369|FG005|Overall Study|Other Treatment|1|||
126110765|NCT02408861|453700370|FG006|Overall Study|Other Treatment|1|||
125917484|NCT01967173|452996208|FG000|Overall Study|Adverse Event|0|||
126110766|NCT03756350|453701874|FG000|Overall Study|Lost to Follow-up|1|||
126110767|NCT01096342|453701876|FG000|Overall Study|Protocol Violation|1|||
126110768|NCT03434353|453701877|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
126110769|NCT03434353|453701878|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
126110770|NCT03434353|453701879|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
126110771|NCT03434353|453701880|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
126110772|NCT03434353|453701881|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
126110773|NCT03434353|453701877|FG000|Overall Study|Withdrew consent|1|||
126110774|NCT03434353|453701878|FG001|Overall Study|Withdrew consent|0|||
126110775|NCT03434353|453701879|FG002|Overall Study|Withdrew consent|3|||
125917485|NCT01967173|452996209|FG001|Overall Study|Adverse Event|0|||
126110776|NCT03434353|453701880|FG003|Overall Study|Withdrew consent|0|||
126110777|NCT03434353|453701881|FG004|Overall Study|Withdrew consent|0|||
126110778|NCT03434353|453701877|FG000|Overall Study|Adverse Event|1|||
126110779|NCT03434353|453701878|FG001|Overall Study|Adverse Event|0|||
125917486|NCT01967173|452996210|FG002|Overall Study|Adverse Event|0|||
125917487|NCT01967173|452996211|FG003|Overall Study|Adverse Event|0|||
125917488|NCT01967173|452996212|FG004|Overall Study|Adverse Event|0|||
125917489|NCT01967173|452996213|FG005|Overall Study|Adverse Event|0|||
125917490|NCT01967173|452996214|FG006|Overall Study|Adverse Event|0|||
125917491|NCT01967173|452996215|FG007|Overall Study|Adverse Event|1|||
125917492|NCT01967173|452996208|FG000|Overall Study|Withdrawal by Subject|15|||
125917493|NCT01967173|452996209|FG001|Overall Study|Withdrawal by Subject|14|||
125917494|NCT01967173|452996210|FG002|Overall Study|Withdrawal by Subject|10|||
125917495|NCT01967173|452996211|FG003|Overall Study|Withdrawal by Subject|7|||
125917496|NCT01967173|452996212|FG004|Overall Study|Withdrawal by Subject|8|||
125917497|NCT01967173|452996213|FG005|Overall Study|Withdrawal by Subject|9|||
125917498|NCT01967173|452996214|FG006|Overall Study|Withdrawal by Subject|10|||
125917499|NCT01967173|452996215|FG007|Overall Study|Withdrawal by Subject|12|||
125917500|NCT00423514|452996216|FG000|Overall Study|Ineligible|1|||
125917501|NCT00423514|452996217|FG001|Overall Study|Ineligible|0|||
125917502|NCT03685123|452996218|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
125917503|NCT03685123|452996219|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
125917504|NCT03685123|452996220|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
125917505|NCT03685123|452996218|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
125917506|NCT03685123|452996219|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
125917507|NCT03685123|452996220|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
125917508|NCT03685123|452996218|FG000|Weight Loss Phase|Lost to Follow-up|1|||
125917509|NCT03685123|452996219|FG001|Weight Loss Phase|Lost to Follow-up|0|||
125917510|NCT03685123|452996220|FG002|Weight Loss Phase|Lost to Follow-up|0|||
125917511|NCT03685123|452996218|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
125917512|NCT03685123|452996219|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
125917513|NCT03685123|452996220|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
125917514|NCT03685123|452996218|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
125917515|NCT03685123|452996219|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
125917516|NCT03685123|452996220|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
125917517|NCT03685123|452996218|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
125917518|NCT03685123|452996219|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
125917519|NCT03685123|452996220|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
125917520|NCT00400764|452996221|FG000|Phase Ib|Adverse Event|1|||
125917521|NCT00400764|452996222|FG001|Phase Ib|Adverse Event|0|||
125917522|NCT00400764|452996223|FG002|Phase Ib|Adverse Event|0|||
125917523|NCT00400764|452996224|FG003|Phase Ib|Adverse Event|0|||
125917524|NCT00400764|452996225|FG004|Phase Ib|Adverse Event|0|||
125917525|NCT00400764|452996221|FG000|Phase Ib|Death|1|||
125917526|NCT00400764|452996222|FG001|Phase Ib|Death|0|||
125917527|NCT00400764|452996223|FG002|Phase Ib|Death|0|||
125917528|NCT00400764|452996224|FG003|Phase Ib|Death|0|||
125917529|NCT00400764|452996225|FG004|Phase Ib|Death|0|||
125917530|NCT00400764|452996221|FG000|Phase Ib|Disease Progression|4|||
125917531|NCT00400764|452996222|FG001|Phase Ib|Disease Progression|4|||
125917532|NCT00400764|452996223|FG002|Phase Ib|Disease Progression|0|||
125917533|NCT00400764|452996224|FG003|Phase Ib|Disease Progression|0|||
125917534|NCT00400764|452996225|FG004|Phase Ib|Disease Progression|0|||
125917535|NCT00400764|452996221|FG000|Phase II|Death|0|||
125917536|NCT00400764|452996222|FG001|Phase II|Death|0|||
125917537|NCT00400764|452996223|FG002|Phase II|Death|1|||
125917538|NCT00400764|452996224|FG003|Phase II|Death|2|||
125917539|NCT00400764|452996225|FG004|Phase II|Death|0|||
125917540|NCT00400764|452996221|FG000|Phase II|Lost to Follow-up|0|||
125917541|NCT00400764|452996222|FG001|Phase II|Lost to Follow-up|0|||
125917542|NCT00400764|452996223|FG002|Phase II|Lost to Follow-up|1|||
125917543|NCT00400764|452996224|FG003|Phase II|Lost to Follow-up|0|||
125917544|NCT00400764|452996225|FG004|Phase II|Lost to Follow-up|0|||
125917545|NCT00400764|452996221|FG000|Phase II|Physician Decision|0|||
125917546|NCT00400764|452996222|FG001|Phase II|Physician Decision|0|||
125917547|NCT00400764|452996223|FG002|Phase II|Physician Decision|1|||
125917548|NCT00400764|452996224|FG003|Phase II|Physician Decision|1|||
125917549|NCT00400764|452996225|FG004|Phase II|Physician Decision|0|||
125917550|NCT00400764|452996221|FG000|Phase II|Sponsor's decision to terminate|0|||
125917551|NCT00400764|452996222|FG001|Phase II|Sponsor's decision to terminate|0|||
125917552|NCT00400764|452996223|FG002|Phase II|Sponsor's decision to terminate|18|||
125917553|NCT00400764|452996224|FG003|Phase II|Sponsor's decision to terminate|22|||
125917554|NCT00400764|452996225|FG004|Phase II|Sponsor's decision to terminate|11|||
125917555|NCT00400764|452996221|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
125917556|NCT00400764|452996222|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
125917557|NCT00400764|452996223|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
125917558|NCT00400764|452996224|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
125917559|NCT00400764|452996225|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
125917560|NCT00400764|452996221|FG000|Phase II|Withdrawal by Subject|0|||
125917561|NCT00400764|452996222|FG001|Phase II|Withdrawal by Subject|0|||
125917562|NCT00400764|452996223|FG002|Phase II|Withdrawal by Subject|1|||
125917563|NCT00400764|452996224|FG003|Phase II|Withdrawal by Subject|1|||
125917564|NCT00400764|452996225|FG004|Phase II|Withdrawal by Subject|0|||
125917565|NCT02628938|452996226|FG000|Overall Study|Did not attend the follow up recall|2|||
125917566|NCT02628938|452996227|FG001|Overall Study|Did not attend the follow up recall|2|||
125917567|NCT02628938|452996228|FG002|Overall Study|Did not attend the follow up recall|1|||
125917568|NCT02628938|452996226|FG000|Overall Study|Failure to comply with the instructions|3|||
125917569|NCT02628938|452996227|FG001|Overall Study|Failure to comply with the instructions|0|||
125917570|NCT02628938|452996228|FG002|Overall Study|Failure to comply with the instructions|3|||
125917571|NCT03113916|452996229|FG000|Overall Study|Withdrawal by Subject|9|||
125917572|NCT03113916|452996230|FG001|Overall Study|Withdrawal by Subject|7|||
125917573|NCT03113916|452996229|FG000|Overall Study|Pregnancy|1|||
125917574|NCT03113916|452996230|FG001|Overall Study|Pregnancy|3|||
125917575|NCT03113916|452996229|FG000|Overall Study|Lost to Follow-up|1|||
125917576|NCT03113916|452996230|FG001|Overall Study|Lost to Follow-up|2|||
125917577|NCT00241358|452996231|FG000|Overall Study|Determined to be not ineligible|0|||
125917578|NCT00241358|452996232|FG001|Overall Study|Determined to be not ineligible|1|||
125917579|NCT00241358|452996233|FG002|Overall Study|Determined to be not ineligible|1|||
125917580|NCT00621959|452996234|FG000|Overall Study|Adverse Event|4|||
125917581|NCT00621959|452996235|FG001|Overall Study|Adverse Event|2|||
125917582|NCT00621959|452996234|FG000|Overall Study|Lack of Efficacy|1|||
125917583|NCT00621959|452996235|FG001|Overall Study|Lack of Efficacy|1|||
125917584|NCT00621959|452996234|FG000|Overall Study|Lost to Follow-up|0|||
125917585|NCT00621959|452996235|FG001|Overall Study|Lost to Follow-up|2|||
125917586|NCT00621959|452996234|FG000|Overall Study|Withdrawal by Subject|1|||
125917587|NCT00621959|452996235|FG001|Overall Study|Withdrawal by Subject|1|||
125917588|NCT00621959|452996234|FG000|Overall Study|Other|1|||
125917589|NCT00621959|452996235|FG001|Overall Study|Other|3|||
125917590|NCT01758523|452996236|FG000|Overall Study|Adverse Event|2|||
125917591|NCT01758523|452996237|FG001|Overall Study|Adverse Event|1|||
125917592|NCT01758523|452996236|FG000|Overall Study|Lack of Efficacy|4|||
125917593|NCT01758523|452996237|FG001|Overall Study|Lack of Efficacy|2|||
125917594|NCT01758523|452996236|FG000|Overall Study|Lost to Follow-up|3|||
125917595|NCT01758523|452996237|FG001|Overall Study|Lost to Follow-up|4|||
125917596|NCT01758523|452996236|FG000|Overall Study|Withdrawal by Subject|12|||
125917597|NCT01758523|452996237|FG001|Overall Study|Withdrawal by Subject|7|||
125917598|NCT00590135|452996238|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
125917599|NCT03439657|452996239|FG000|Overall Study|Adverse Event|2|||
125917600|NCT03439657|452996240|FG001|Overall Study|Adverse Event|3|||
125917601|NCT03439657|452996239|FG000|Overall Study|Lost to Follow-up|1|||
125917602|NCT03439657|452996240|FG001|Overall Study|Lost to Follow-up|0|||
125917603|NCT03439657|452996239|FG000|Overall Study|Protocol Violation|1|||
125917604|NCT03439657|452996240|FG001|Overall Study|Protocol Violation|1|||
125917605|NCT03439657|452996239|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
125917606|NCT03439657|452996240|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
125917607|NCT02663908|452996241|FG000|Overall Study|Withdrawal by Subject|8|||
125917608|NCT02663908|452996242|FG001|Overall Study|Withdrawal by Subject|5|||
125917609|NCT02663908|452996241|FG000|Overall Study|Lost to Follow-up|1|||
125917610|NCT02663908|452996242|FG001|Overall Study|Lost to Follow-up|5|||
125917611|NCT02663908|452996241|FG000|Overall Study|Adverse Event|13|||
125917612|NCT02663908|452996242|FG001|Overall Study|Adverse Event|11|||
125917613|NCT02663908|452996241|FG000|Overall Study|Protocol Violation|1|||
125917614|NCT02663908|452996242|FG001|Overall Study|Protocol Violation|2|||
125917615|NCT02663908|452996241|FG000|Overall Study|Lack of therapeutic response|2|||
125917616|NCT02663908|452996242|FG001|Overall Study|Lack of therapeutic response|0|||
125917617|NCT02663908|452996241|FG000|Overall Study|COVID-19|1|||
125917618|NCT02663908|452996242|FG001|Overall Study|COVID-19|0|||
125917619|NCT02663908|452996241|FG000|Overall Study|Site closed|1|||
125917620|NCT02663908|452996242|FG001|Overall Study|Site closed|0|||
125917621|NCT02663908|452996241|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
125917622|NCT02663908|452996242|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
125917623|NCT02663908|452996241|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
125917624|NCT02663908|452996242|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
125917625|NCT02663908|452996241|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
125917626|NCT02663908|452996242|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
125917627|NCT02663908|452996241|FG000|Overall Study|Death|1|||
125917628|NCT02663908|452996242|FG001|Overall Study|Death|0|||
125917629|NCT02663908|452996241|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
125917630|NCT02663908|452996242|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
125917631|NCT02663908|452996241|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
125917632|NCT02663908|452996242|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
125917633|NCT03308786|452996244|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
125917634|NCT00370071|452996247|FG000|Overall Study|Withdrawal by Subject|2|||
125917635|NCT00289016|452996250|FG000|Overall Study|Disease Progression|29|||
125917636|NCT00289016|452996250|FG000|Overall Study|Death|2|||
125917637|NCT00289016|452996250|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
126110780|NCT03434353|453701879|FG002|Overall Study|Adverse Event|0|||
126110781|NCT03434353|453701880|FG003|Overall Study|Adverse Event|0|||
126110782|NCT03434353|453701881|FG004|Overall Study|Adverse Event|1|||
125917638|NCT00289016|452996250|FG000|Overall Study|Withdrawal by Subject|2|||
125917639|NCT00289016|452996250|FG000|Overall Study|Adverse Event|1|||
125917640|NCT00289016|452996250|FG000|Overall Study|Other|1|||
125917641|NCT00319501|452996251|FG000|Double-blind Period|Withdrawal by Subject|0|||
125917642|NCT00319501|452996252|FG001|Double-blind Period|Withdrawal by Subject|3|||
125917643|NCT00319501|452996251|FG000|Double-blind Period|Sponsor Request|1|||
125917644|NCT00319501|452996252|FG001|Double-blind Period|Sponsor Request|0|||
125917645|NCT00319501|452996251|FG000|Double-blind Period|Did not receive treatment|42|||
125917646|NCT00319501|452996252|FG001|Double-blind Period|Did not receive treatment|29|||
125917647|NCT00319501|452996251|FG000|Open-label Period|Adverse Event|5|||
125917648|NCT00319501|452996252|FG001|Open-label Period|Adverse Event|0|||
125917649|NCT00319501|452996251|FG000|Open-label Period|Protocol Violation|6|||
125917650|NCT00319501|452996252|FG001|Open-label Period|Protocol Violation|0|||
125917651|NCT00319501|452996251|FG000|Open-label Period|Withdrawal by Subject|38|||
125917652|NCT00319501|452996252|FG001|Open-label Period|Withdrawal by Subject|0|||
125917653|NCT00319501|452996251|FG000|Open-label Period|Principal Investigator decision|6|||
125917654|NCT00319501|452996252|FG001|Open-label Period|Principal Investigator decision|0|||
125917655|NCT00319501|452996251|FG000|Open-label Period|Sponsor request|12|||
125917656|NCT00319501|452996252|FG001|Open-label Period|Sponsor request|0|||
125917657|NCT00319501|452996251|FG000|Open-label Period|Lost to Follow-up|5|||
125917658|NCT00319501|452996252|FG001|Open-label Period|Lost to Follow-up|0|||
125917659|NCT00319501|452996251|FG000|Open-label Period|Did not receive treatment|33|||
125917660|NCT00319501|452996252|FG001|Open-label Period|Did not receive treatment|0|||
125917661|NCT00319501|452996251|FG000|Open-label Period|Other|11|||
125917662|NCT00319501|452996252|FG001|Open-label Period|Other|0|||
125917663|NCT00319501|452996251|FG000|Open-label Extension Period|Adverse Event|2|||
125917664|NCT00319501|452996252|FG001|Open-label Extension Period|Adverse Event|0|||
125917665|NCT00319501|452996251|FG000|Open-label Extension Period|Did not receive treatment|18|||
125917666|NCT00319501|452996252|FG001|Open-label Extension Period|Did not receive treatment|0|||
125917667|NCT00319501|452996251|FG000|Open-label Extension Period|Other|1|||
125917668|NCT00319501|452996252|FG001|Open-label Extension Period|Other|0|||
125917669|NCT00319501|452996251|FG000|Open-label Extension Period|Principal investigator decision|2|||
125917670|NCT00319501|452996252|FG001|Open-label Extension Period|Principal investigator decision|0|||
125917671|NCT00319501|452996251|FG000|Open-label Extension Period|Sponsor request|26|||
125917672|NCT00319501|452996252|FG001|Open-label Extension Period|Sponsor request|0|||
125917673|NCT00319501|452996251|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
125917674|NCT00319501|452996252|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
125917675|NCT02764697|452996258|FG000|Overall Study|Lack of Efficacy|3|||
125917676|NCT00302107|452996259|FG000|Overall Study|Lost to Follow-up|6|||
125917677|NCT00302107|452996260|FG001|Overall Study|Lost to Follow-up|5|||
125917678|NCT00302107|452996259|FG000|Overall Study|Protocol Violation|1|||
125917679|NCT00302107|452996260|FG001|Overall Study|Protocol Violation|0|||
125917680|NCT00302107|452996259|FG000|Overall Study|Relocation|0|||
125917681|NCT00302107|452996260|FG001|Overall Study|Relocation|1|||
125917682|NCT00302107|452996259|FG000|Overall Study|Withdrawal by Subject|0|||
125917683|NCT00302107|452996260|FG001|Overall Study|Withdrawal by Subject|3|||
125917684|NCT00302107|452996259|FG000|Overall Study|Adverse Event|1|||
125917685|NCT00302107|452996260|FG001|Overall Study|Adverse Event|0|||
125917686|NCT01790932|452996261|FG000|Overall Study|Disease Progression|41|||
125917687|NCT01790932|452996261|FG000|Overall Study|Adverse Event|7|||
125917688|NCT01790932|452996261|FG000|Overall Study|Physician Decision|1|||
125917689|NCT01790932|452996261|FG000|Overall Study|Withdrawal by Subject|1|||
125917690|NCT04223973|452996262|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
125917691|NCT04223973|452996263|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
125917692|NCT04223973|452996262|FG000|Overall Study|Adverse Event|4|||
125917693|NCT04223973|452996263|FG001|Overall Study|Adverse Event|0|||
125917694|NCT04223973|452996262|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
125917695|NCT04223973|452996263|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
125917696|NCT04223973|452996262|FG000|Overall Study|Physician Decision|1|||
125917697|NCT04223973|452996263|FG001|Overall Study|Physician Decision|1|||
125917698|NCT04223973|452996262|FG000|Overall Study|Withdrawal by Subject|0|||
125917699|NCT04223973|452996263|FG001|Overall Study|Withdrawal by Subject|1|||
125917700|NCT01441180|452996264|FG000|Overall Study|Lost to Follow-up|1|||
125917701|NCT01441180|452996265|FG001|Overall Study|Lost to Follow-up|1|||
125917702|NCT01441180|452996266|FG002|Overall Study|Lost to Follow-up|1|||
126110783|NCT03434353|453701877|FG000|Overall Study|Lost to Follow-up|2|||
126110784|NCT03434353|453701878|FG001|Overall Study|Lost to Follow-up|0|||
125917703|NCT01441180|452996264|FG000|Overall Study|Discontinued|0|||
126110785|NCT03434353|453701879|FG002|Overall Study|Lost to Follow-up|0|||
125917704|NCT01441180|452996265|FG001|Overall Study|Discontinued|0|||
125917705|NCT01441180|452996266|FG002|Overall Study|Discontinued|2|||
125917706|NCT01402011|452996271|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
125917707|NCT01402011|452996272|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
125917708|NCT01402011|452996273|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
125917709|NCT01402011|452996271|FG000|Active Treatment Period|Withdrawal by Subject|1|||
125917710|NCT01402011|452996272|FG001|Active Treatment Period|Withdrawal by Subject|3|||
125917711|NCT01402011|452996273|FG002|Active Treatment Period|Withdrawal by Subject|0|||
125917712|NCT01402011|452996271|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
125917713|NCT01402011|452996272|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
125917714|NCT01402011|452996273|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
125917715|NCT02612129|452996275|FG000|Single Dose Treatment Period|Screening Failure|1|||
125917716|NCT02612129|452996276|FG001|Single Dose Treatment Period|Screening Failure|0|||
125917717|NCT02612129|452996277|FG002|Single Dose Treatment Period|Screening Failure|0|||
125917718|NCT02612129|452996275|FG000|Continuous Treatment Period|Early Escape|0|||
125917719|NCT02612129|452996276|FG001|Continuous Treatment Period|Early Escape|2|||
125917720|NCT02612129|452996277|FG002|Continuous Treatment Period|Early Escape|0|||
125917721|NCT02612129|452996275|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
125917722|NCT02612129|452996276|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
125917723|NCT02612129|452996277|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
125917724|NCT02612129|452996275|FG000|Continuous Treatment Period|Safety Reasons|0|||
125917725|NCT02612129|452996276|FG001|Continuous Treatment Period|Safety Reasons|3|||
125917726|NCT02612129|452996277|FG002|Continuous Treatment Period|Safety Reasons|0|||
125917727|NCT02612129|452996275|FG000|Continuous Treatment Period|Death|0|||
125917728|NCT02612129|452996276|FG001|Continuous Treatment Period|Death|1|||
125917729|NCT02612129|452996277|FG002|Continuous Treatment Period|Death|0|||
125917730|NCT02612129|452996275|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
125917731|NCT02612129|452996276|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
125917732|NCT02612129|452996277|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
125917733|NCT02110238|452997886|FG000|12 Week Pivotal Phase|Adverse Event|3|||
125917734|NCT02110238|452997887|FG001|12 Week Pivotal Phase|Adverse Event|0|||
125917735|NCT02110238|452997886|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
125917736|NCT02110238|452997887|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
125917737|NCT02110238|452997886|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
125917738|NCT02110238|452997887|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
125917739|NCT02110238|452997886|FG000|12 Week Pivotal Phase|Physician Decision|0|||
125917740|NCT02110238|452997887|FG001|12 Week Pivotal Phase|Physician Decision|2|||
125917741|NCT02110238|452997886|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
125917742|NCT02110238|452997887|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
125917743|NCT02110238|452997886|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
125917744|NCT02110238|452997887|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
125917745|NCT02110238|452997886|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
125917746|NCT02110238|452997887|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
125917747|NCT02110238|452997886|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
125917748|NCT02110238|452997887|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
125917749|NCT02110238|452997886|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
125917750|NCT02110238|452997887|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
125917751|NCT02110238|452997886|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
125917752|NCT02110238|452997887|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
125917753|NCT02110238|452997886|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
125917754|NCT02110238|452997887|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
125917755|NCT01419626|452997894|FG000|Overall Study|Protocol Violation|3|||
125917756|NCT01419626|452997895|FG001|Overall Study|Protocol Violation|2|||
125917757|NCT01419626|452997896|FG002|Overall Study|Protocol Violation|2|||
125917758|NCT01419626|452997894|FG000|Overall Study|Withdrawal by Subject|1|||
125917759|NCT01419626|452997895|FG001|Overall Study|Withdrawal by Subject|0|||
125917760|NCT01419626|452997896|FG002|Overall Study|Withdrawal by Subject|0|||
125917761|NCT01419626|452997894|FG000|Overall Study|Lost to Follow-up|0|||
125917762|NCT01419626|452997895|FG001|Overall Study|Lost to Follow-up|1|||
125917763|NCT01419626|452997896|FG002|Overall Study|Lost to Follow-up|1|||
125917764|NCT01365052|452997897|FG000|Overall Study|Adverse Event|4|||
125917765|NCT01365052|452997898|FG001|Overall Study|Adverse Event|4|||
125917766|NCT01145625|452997899|FG000|Overall Study|Lost to Follow-up|8|||
125917767|NCT01145625|452997900|FG001|Overall Study|Lost to Follow-up|9|||
125917768|NCT01145625|452997899|FG000|Overall Study|Adverse Event|6|||
125917769|NCT01145625|452997900|FG001|Overall Study|Adverse Event|4|||
125917770|NCT01145625|452997899|FG000|Overall Study|Protocol Violation|3|||
125917771|NCT01145625|452997900|FG001|Overall Study|Protocol Violation|1|||
125917772|NCT01145625|452997899|FG000|Overall Study|Withdrawal by Subject|7|||
125917773|NCT01145625|452997900|FG001|Overall Study|Withdrawal by Subject|16|||
125917774|NCT01145625|452997899|FG000|Overall Study|Pregnancy|0|||
125917775|NCT01145625|452997900|FG001|Overall Study|Pregnancy|1|||
125917776|NCT03080454|452997901|FG000|Baseline|Adverse Event|2|||
125917777|NCT03080454|452997901|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
126110786|NCT03434353|453701880|FG003|Overall Study|Lost to Follow-up|0|||
125917778|NCT03080454|452997901|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
125917779|NCT00216476|452997902|FG000|Overall Study|Withdrawal by Subject|59|||
125917780|NCT00216476|452997903|FG001|Overall Study|Withdrawal by Subject|72|||
125917781|NCT00216476|452997904|FG002|Overall Study|Withdrawal by Subject|9|||
125917782|NCT00216476|452997902|FG000|Overall Study|Lost to Follow-up|10|||
125917783|NCT00216476|452997903|FG001|Overall Study|Lost to Follow-up|9|||
125917784|NCT00216476|452997904|FG002|Overall Study|Lost to Follow-up|1|||
125917785|NCT00216476|452997902|FG000|Overall Study|Adverse Event|6|||
125917786|NCT00216476|452997903|FG001|Overall Study|Adverse Event|10|||
125917787|NCT00216476|452997904|FG002|Overall Study|Adverse Event|1|||
125917788|NCT00216476|452997902|FG000|Overall Study|Lack of Efficacy|4|||
125917789|NCT00216476|452997903|FG001|Overall Study|Lack of Efficacy|3|||
125917790|NCT00216476|452997904|FG002|Overall Study|Lack of Efficacy|0|||
125917791|NCT00216476|452997902|FG000|Overall Study|Death|2|||
125917792|NCT00216476|452997903|FG001|Overall Study|Death|0|||
125917793|NCT00216476|452997904|FG002|Overall Study|Death|0|||
125917794|NCT00216476|452997902|FG000|Overall Study|Pregnancy|0|||
125917795|NCT00216476|452997903|FG001|Overall Study|Pregnancy|1|||
125917796|NCT00216476|452997904|FG002|Overall Study|Pregnancy|1|||
125917797|NCT00216476|452997902|FG000|Overall Study|Other|0|||
125917798|NCT00216476|452997903|FG001|Overall Study|Other|0|||
125917799|NCT00216476|452997904|FG002|Overall Study|Other|1|||
125917800|NCT00216476|452997902|FG000|Overall Study|Refuses Injection|11|||
125917801|NCT00216476|452997903|FG001|Overall Study|Refuses Injection|0|||
125917802|NCT00216476|452997904|FG002|Overall Study|Refuses Injection|0|||
125917803|NCT00216476|452997902|FG000|Overall Study|No Further Need for Treatment|3|||
125917804|NCT00216476|452997903|FG001|Overall Study|No Further Need for Treatment|4|||
125917805|NCT00216476|452997904|FG002|Overall Study|No Further Need for Treatment|1|||
125917806|NCT00216476|452997902|FG000|Overall Study|Non-compliance|0|||
125917807|NCT00216476|452997903|FG001|Overall Study|Non-compliance|4|||
125917808|NCT00216476|452997904|FG002|Overall Study|Non-compliance|1|||
125917809|NCT00216476|452997902|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
125917810|NCT00216476|452997903|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
125917811|NCT00216476|452997904|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
125917812|NCT00216476|452997902|FG000|Overall Study|Administrative Reasons|1|||
125917813|NCT00216476|452997903|FG001|Overall Study|Administrative Reasons|1|||
125917814|NCT00216476|452997904|FG002|Overall Study|Administrative Reasons|0|||
125917815|NCT00216476|452997902|FG000|Overall Study|Protocol Deviation|5|||
125917816|NCT00216476|452997903|FG001|Overall Study|Protocol Deviation|1|||
125917817|NCT00216476|452997904|FG002|Overall Study|Protocol Deviation|0|||
125917818|NCT00216476|452997902|FG000|Overall Study|Patient Moved|2|||
125917819|NCT00216476|452997903|FG001|Overall Study|Patient Moved|2|||
125917820|NCT00216476|452997904|FG002|Overall Study|Patient Moved|0|||
125917821|NCT02202980|452997907|FG000|Overall Study|Lack of Efficacy|1|||
125917822|NCT02202980|452997908|FG001|Overall Study|Lack of Efficacy|0|||
125917823|NCT02202980|452997909|FG002|Overall Study|Lack of Efficacy|7|||
125917824|NCT02202980|452997910|FG003|Overall Study|Lack of Efficacy|0|||
125917825|NCT02202980|452997911|FG004|Overall Study|Lack of Efficacy|3|||
125917826|NCT02202980|452997912|FG005|Overall Study|Lack of Efficacy|1|||
125917827|NCT02202980|452997913|FG006|Overall Study|Lack of Efficacy|11|||
125917828|NCT02202980|452997914|FG007|Overall Study|Lack of Efficacy|2|||
125917829|NCT02202980|452997915|FG008|Overall Study|Lack of Efficacy|2|||
125917830|NCT02202980|452997916|FG009|Overall Study|Lack of Efficacy|0|||
125917831|NCT02202980|452997917|FG010|Overall Study|Lack of Efficacy|0|||
125917832|NCT02202980|452997918|FG011|Overall Study|Lack of Efficacy|3|||
125917833|NCT02202980|452997919|FG012|Overall Study|Lack of Efficacy|10|||
125917834|NCT02202980|452997920|FG013|Overall Study|Lack of Efficacy|0|||
125917835|NCT02202980|452997907|FG000|Overall Study|Protocol Violation|0|||
125917836|NCT02202980|452997908|FG001|Overall Study|Protocol Violation|0|||
125917837|NCT02202980|452997909|FG002|Overall Study|Protocol Violation|0|||
125917838|NCT02202980|452997910|FG003|Overall Study|Protocol Violation|3|||
125917839|NCT02202980|452997911|FG004|Overall Study|Protocol Violation|3|||
125917840|NCT02202980|452997912|FG005|Overall Study|Protocol Violation|0|||
125917841|NCT02202980|452997913|FG006|Overall Study|Protocol Violation|0|||
125917842|NCT02202980|452997914|FG007|Overall Study|Protocol Violation|0|||
125917843|NCT02202980|452997915|FG008|Overall Study|Protocol Violation|0|||
125917844|NCT02202980|452997916|FG009|Overall Study|Protocol Violation|0|||
125917845|NCT02202980|452997917|FG010|Overall Study|Protocol Violation|0|||
125917846|NCT02202980|452997918|FG011|Overall Study|Protocol Violation|0|||
125917847|NCT02202980|452997919|FG012|Overall Study|Protocol Violation|0|||
125917848|NCT02202980|452997920|FG013|Overall Study|Protocol Violation|0|||
125917849|NCT02202980|452997907|FG000|Overall Study|Lost to Follow-up|0|||
125917850|NCT02202980|452997908|FG001|Overall Study|Lost to Follow-up|1|||
125917851|NCT02202980|452997909|FG002|Overall Study|Lost to Follow-up|1|||
125917852|NCT02202980|452997910|FG003|Overall Study|Lost to Follow-up|1|||
125917853|NCT02202980|452997911|FG004|Overall Study|Lost to Follow-up|0|||
125917854|NCT02202980|452997912|FG005|Overall Study|Lost to Follow-up|0|||
125917855|NCT02202980|452997913|FG006|Overall Study|Lost to Follow-up|0|||
125917856|NCT02202980|452997914|FG007|Overall Study|Lost to Follow-up|1|||
125917857|NCT02202980|452997915|FG008|Overall Study|Lost to Follow-up|1|||
125917858|NCT02202980|452997916|FG009|Overall Study|Lost to Follow-up|0|||
125917859|NCT02202980|452997917|FG010|Overall Study|Lost to Follow-up|0|||
125917860|NCT02202980|452997918|FG011|Overall Study|Lost to Follow-up|0|||
125917861|NCT02202980|452997919|FG012|Overall Study|Lost to Follow-up|1|||
125917862|NCT02202980|452997920|FG013|Overall Study|Lost to Follow-up|0|||
125917863|NCT02202980|452997907|FG000|Overall Study|Withdrew Consent|0|||
125917864|NCT02202980|452997908|FG001|Overall Study|Withdrew Consent|1|||
125917865|NCT02202980|452997909|FG002|Overall Study|Withdrew Consent|2|||
125917866|NCT02202980|452997910|FG003|Overall Study|Withdrew Consent|0|||
125917867|NCT02202980|452997911|FG004|Overall Study|Withdrew Consent|0|||
125917868|NCT02202980|452997912|FG005|Overall Study|Withdrew Consent|0|||
125917869|NCT02202980|452997913|FG006|Overall Study|Withdrew Consent|0|||
126064116|NCT00736502|453525903|FG000|Overall Study|Lack of Efficacy|16|||
126064117|NCT00736502|453525903|FG000|Overall Study|Lost to Follow-up|27|||
126064118|NCT00866619|453525904|FG000|Overall Study|Adverse Event|112|||
126064119|NCT00866619|453525905|FG001|Overall Study|Adverse Event|106|||
126064120|NCT00866619|453525906|FG002|Overall Study|Adverse Event|47|||
126064121|NCT00866619|453525907|FG003|Overall Study|Adverse Event|44|||
126064122|NCT00866619|453525904|FG000|Overall Study|Protocol Violation|2|||
126064123|NCT00866619|453525905|FG001|Overall Study|Protocol Violation|39|||
126064124|NCT00866619|453525906|FG002|Overall Study|Protocol Violation|2|||
126064125|NCT00866619|453525907|FG003|Overall Study|Protocol Violation|17|||
126064126|NCT00866619|453525904|FG000|Overall Study|Withdrawal by Subject|587|||
126064127|NCT00866619|453525905|FG001|Overall Study|Withdrawal by Subject|295|||
126064128|NCT00866619|453525906|FG002|Overall Study|Withdrawal by Subject|272|||
126064129|NCT00866619|453525907|FG003|Overall Study|Withdrawal by Subject|144|||
126064130|NCT00866619|453525904|FG000|Overall Study|Lost to Follow-up|1145|||
126064131|NCT00866619|453525905|FG001|Overall Study|Lost to Follow-up|830|||
126064132|NCT00866619|453525906|FG002|Overall Study|Lost to Follow-up|568|||
126064133|NCT00866619|453525907|FG003|Overall Study|Lost to Follow-up|425|||
126064134|NCT00645411|453525908|FG000|Overall Study|Adverse Event|0|||
126064135|NCT00645411|453525909|FG001|Overall Study|Adverse Event|0|||
126064136|NCT00645411|453525910|FG002|Overall Study|Adverse Event|0|||
126064137|NCT00645411|453525911|FG003|Overall Study|Adverse Event|2|||
126064138|NCT00645411|453525908|FG000|Overall Study|Withdrawal by Subject|2|||
126064139|NCT00645411|453525909|FG001|Overall Study|Withdrawal by Subject|1|||
126064140|NCT00645411|453525910|FG002|Overall Study|Withdrawal by Subject|19|||
126064141|NCT00645411|453525911|FG003|Overall Study|Withdrawal by Subject|21|||
126064142|NCT00645411|453525908|FG000|Overall Study|Lost to Follow-up|10|||
126064143|NCT00645411|453525909|FG001|Overall Study|Lost to Follow-up|5|||
126064144|NCT00645411|453525910|FG002|Overall Study|Lost to Follow-up|124|||
126064145|NCT00645411|453525911|FG003|Overall Study|Lost to Follow-up|75|||
126064146|NCT00645411|453525908|FG000|Overall Study|Protocol Violation|1|||
126064147|NCT00645411|453525909|FG001|Overall Study|Protocol Violation|0|||
126064148|NCT00645411|453525910|FG002|Overall Study|Protocol Violation|1|||
126064149|NCT00645411|453525911|FG003|Overall Study|Protocol Violation|0|||
126064150|NCT00645411|453525908|FG000|Overall Study|Inappropriate enrollment|0|||
126064151|NCT00645411|453525909|FG001|Overall Study|Inappropriate enrollment|0|||
126064152|NCT00645411|453525910|FG002|Overall Study|Inappropriate enrollment|4|||
126064153|NCT00645411|453525911|FG003|Overall Study|Inappropriate enrollment|1|||
126064154|NCT00645411|453525908|FG000|Overall Study|Unable to classify|0|||
126064155|NCT00645411|453525909|FG001|Overall Study|Unable to classify|0|||
126064156|NCT00645411|453525910|FG002|Overall Study|Unable to classify|3|||
126064157|NCT00645411|453525911|FG003|Overall Study|Unable to classify|4|||
126064158|NCT03987074|453525912|FG000|Overall Study|Withdrew Consent|1|||
126064159|NCT03987074|453525913|FG001|Overall Study|Withdrew Consent|1|||
126064160|NCT03987074|453525914|FG002|Overall Study|Withdrew Consent|0|||
126064161|NCT03987074|453525915|FG003|Overall Study|Withdrew Consent|2|||
126064162|NCT03987074|453525916|FG004|Overall Study|Withdrew Consent|1|||
126064163|NCT03987074|453525912|FG000|Overall Study|Adverse Event|2|||
126064164|NCT03987074|453525913|FG001|Overall Study|Adverse Event|1|||
126064165|NCT03987074|453525914|FG002|Overall Study|Adverse Event|0|||
126064166|NCT03987074|453525915|FG003|Overall Study|Adverse Event|0|||
126064167|NCT03987074|453525916|FG004|Overall Study|Adverse Event|1|||
126064168|NCT03987074|453525912|FG000|Overall Study|Lost to Follow-up|0|||
126064169|NCT03987074|453525913|FG001|Overall Study|Lost to Follow-up|0|||
126064170|NCT03987074|453525914|FG002|Overall Study|Lost to Follow-up|1|||
126064171|NCT03987074|453525915|FG003|Overall Study|Lost to Follow-up|1|||
126064172|NCT03987074|453525916|FG004|Overall Study|Lost to Follow-up|0|||
126064173|NCT03987074|453525912|FG000|Overall Study|Investigator's Discretion|0|||
126064174|NCT03987074|453525913|FG001|Overall Study|Investigator's Discretion|0|||
126064175|NCT03987074|453525914|FG002|Overall Study|Investigator's Discretion|0|||
126064176|NCT03987074|453525915|FG003|Overall Study|Investigator's Discretion|1|||
126064177|NCT03987074|453525916|FG004|Overall Study|Investigator's Discretion|0|||
126064178|NCT02138838|453525917|FG000|Overall Study|Study Closure|7|||
126064179|NCT02138838|453525918|FG001|Overall Study|Study Closure|6|||
125917870|NCT02202980|452997914|FG007|Overall Study|Withdrew Consent|0|||
125917871|NCT02202980|452997915|FG008|Overall Study|Withdrew Consent|1|||
126064180|NCT02138838|453525917|FG000|Overall Study|Withdrawal by Subject|1|||
126064181|NCT02138838|453525918|FG001|Overall Study|Withdrawal by Subject|5|||
126064182|NCT02993926|453525921|FG000|Enantone Treatment Phase|Adverse Event|1|||
126064183|NCT02993926|453525922|FG001|Enantone Treatment Phase|Adverse Event|0|||
126064184|NCT02993926|453525923|FG002|Enantone Treatment Phase|Adverse Event|0|||
126064185|NCT02993926|453525921|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
126064186|NCT02993926|453525922|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
126064187|NCT02993926|453525923|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
126064188|NCT02993926|453525921|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
126064189|NCT02993926|453525922|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
126064190|NCT02993926|453525923|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
126064191|NCT02993926|453525921|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
126064192|NCT02993926|453525922|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
126064193|NCT02993926|453525923|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
126064194|NCT01867307|453525925|FG000|Overall Study|Protocol Violation|2|||
126064195|NCT01867307|453525926|FG001|Overall Study|Protocol Violation|0|||
126064196|NCT01867307|453525925|FG000|Overall Study|Other Adverse Event|1|||
126064197|NCT01867307|453525926|FG001|Overall Study|Other Adverse Event|3|||
126064198|NCT00518206|453525927|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
126064199|NCT00518206|453525928|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
126064200|NCT00518206|453525927|FG000|Overall Study|Withdrawal by Subject|2|||
126064201|NCT00518206|453525928|FG001|Overall Study|Withdrawal by Subject|0|||
126064202|NCT00518206|453525927|FG000|Overall Study|Drug Supply Issue|1|||
126064203|NCT00518206|453525928|FG001|Overall Study|Drug Supply Issue|0|||
126064204|NCT00518206|453525927|FG000|Overall Study|Reason Unknown|1|||
126064205|NCT00518206|453525928|FG001|Overall Study|Reason Unknown|0|||
126064206|NCT00518206|453525927|FG000|Overall Study|Completion Status Unknown|1|||
126064207|NCT00518206|453525928|FG001|Overall Study|Completion Status Unknown|0|||
126064208|NCT01199302|453525931|FG000|Overall Study|Adverse Event|1|||
126064209|NCT01199302|453525932|FG001|Overall Study|Adverse Event|1|||
126064210|NCT01199302|453525933|FG002|Overall Study|Adverse Event|2|||
126064211|NCT01199302|453525934|FG003|Overall Study|Adverse Event|0|||
126064212|NCT01199302|453525931|FG000|Overall Study|Withdrawal by Subject|2|||
126064213|NCT01199302|453525932|FG001|Overall Study|Withdrawal by Subject|2|||
126064214|NCT01199302|453525933|FG002|Overall Study|Withdrawal by Subject|3|||
126064215|NCT01199302|453525934|FG003|Overall Study|Withdrawal by Subject|0|||
126064216|NCT01199302|453525931|FG000|Overall Study|Disease Progression|3|||
126064217|NCT01199302|453525932|FG001|Overall Study|Disease Progression|4|||
126064218|NCT01199302|453525933|FG002|Overall Study|Disease Progression|4|||
126064219|NCT01199302|453525934|FG003|Overall Study|Disease Progression|2|||
126064220|NCT01199302|453525931|FG000|Overall Study|Study Termination|13|||
126064221|NCT01199302|453525932|FG001|Overall Study|Study Termination|8|||
126064222|NCT01199302|453525933|FG002|Overall Study|Study Termination|11|||
126064223|NCT01199302|453525934|FG003|Overall Study|Study Termination|9|||
126064224|NCT01199302|453525931|FG000|Overall Study|Lost to Follow-up|0|||
126064225|NCT01199302|453525932|FG001|Overall Study|Lost to Follow-up|1|||
126064226|NCT01199302|453525933|FG002|Overall Study|Lost to Follow-up|0|||
126064227|NCT01199302|453525934|FG003|Overall Study|Lost to Follow-up|0|||
126064228|NCT01199302|453525931|FG000|Overall Study|Other|1|||
126064229|NCT01199302|453525932|FG001|Overall Study|Other|0|||
126064230|NCT01199302|453525933|FG002|Overall Study|Other|0|||
126064231|NCT01199302|453525934|FG003|Overall Study|Other|0|||
126064232|NCT00608959|453527658|FG000|Part 1|Did not meet eligibility criteria|1|||
126064233|NCT01005602|453527661|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
126064234|NCT01005602|453527662|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
126064235|NCT01248715|453527663|FG000|Overall Study|Not influenza positive|501|||
126064236|NCT01248715|453527664|FG001|Overall Study|Not influenza positive|510|||
126064237|NCT03409276|453527670|FG000|Overall Study|Withdrawal by Subject|0|||
126064238|NCT03409276|453527671|FG001|Overall Study|Withdrawal by Subject|0|||
126064239|NCT03409276|453527672|FG002|Overall Study|Withdrawal by Subject|0|||
126064240|NCT03409276|453527673|FG003|Overall Study|Withdrawal by Subject|0|||
126064241|NCT03409276|453527674|FG004|Overall Study|Withdrawal by Subject|1|||
126064242|NCT03409276|453527670|FG000|Overall Study|Lost to Follow-up|0|||
126064243|NCT03409276|453527671|FG001|Overall Study|Lost to Follow-up|0|||
126064244|NCT03409276|453527672|FG002|Overall Study|Lost to Follow-up|0|||
126064245|NCT03409276|453527673|FG003|Overall Study|Lost to Follow-up|2|||
126064246|NCT03409276|453527674|FG004|Overall Study|Lost to Follow-up|2|||
126064247|NCT03605745|453527675|FG000|Overall Study|Study was terminated for business reasons|47|||
126064248|NCT01279447|453527676|FG000|Overall Study|Lost to Follow-up|3|||
126064249|NCT01279447|453527677|FG001|Overall Study|Lost to Follow-up|1|||
126064250|NCT01215253|453527678|FG000|Overall Study|Withdrawal by Subject|57|||
126064251|NCT01215253|453527679|FG001|Overall Study|Withdrawal by Subject|35|||
126064252|NCT01215253|453527678|FG000|Overall Study|Physician Decision|9|||
126064253|NCT01215253|453527679|FG001|Overall Study|Physician Decision|12|||
126064254|NCT01215253|453527678|FG000|Overall Study|Lost to Follow-up|6|||
126064255|NCT01215253|453527679|FG001|Overall Study|Lost to Follow-up|4|||
126064256|NCT01215253|453527678|FG000|Overall Study|Other|14|||
126064257|NCT01215253|453527679|FG001|Overall Study|Other|12|||
126064258|NCT00828139|453527684|FG000|Overall Study|Adverse Event|8|||
125917872|NCT02202980|452997916|FG009|Overall Study|Withdrew Consent|0|||
125917873|NCT02202980|452997917|FG010|Overall Study|Withdrew Consent|0|||
125917874|NCT02202980|452997918|FG011|Overall Study|Withdrew Consent|0|||
125917875|NCT02202980|452997919|FG012|Overall Study|Withdrew Consent|0|||
125917876|NCT02202980|452997920|FG013|Overall Study|Withdrew Consent|0|||
125917877|NCT00696800|452997921|FG000|Overall Study|Adverse Event|16|||
125917878|NCT00696800|452997922|FG001|Overall Study|Adverse Event|3|||
125917879|NCT00696800|452997921|FG000|Overall Study|Insufficient compliance with medication|2|||
125917880|NCT00696800|452997922|FG001|Overall Study|Insufficient compliance with medication|1|||
125917881|NCT00696800|452997921|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
125917882|NCT00696800|452997922|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
125917883|NCT00696800|452997921|FG000|Overall Study|Insufficient ovarian response|4|||
125917884|NCT00696800|452997922|FG001|Overall Study|Insufficient ovarian response|1|||
125917885|NCT00696800|452997921|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
125917886|NCT00696800|452997922|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
125917887|NCT00696800|452997921|FG000|Overall Study|Too high ovarian response|6|||
125917888|NCT00696800|452997922|FG001|Overall Study|Too high ovarian response|1|||
125917889|NCT00696800|452997921|FG000|Overall Study|No/too few/bad quality oocytes|4|||
125917890|NCT00696800|452997922|FG001|Overall Study|No/too few/bad quality oocytes|3|||
125917891|NCT00696800|452997921|FG000|Overall Study|No/abnormal fertilization|11|||
125917892|NCT00696800|452997922|FG001|Overall Study|No/abnormal fertilization|13|||
125917893|NCT00696800|452997921|FG000|Overall Study|No/too few/bad quality embryos|24|||
125917894|NCT00696800|452997922|FG001|Overall Study|No/too few/bad quality embryos|18|||
125917895|NCT00696800|452997921|FG000|Overall Study|Other Reasons|5|||
125917896|NCT00696800|452997922|FG001|Overall Study|Other Reasons|3|||
125917897|NCT00696800|452997921|FG000|Overall Study|Not treated|1|||
125917898|NCT00696800|452997922|FG001|Overall Study|Not treated|2|||
125917899|NCT05224141|452997927|FG000|Overall Study|Ongoing|75|||
125917900|NCT05224141|452997928|FG001|Overall Study|Ongoing|88|||
125917901|NCT05224141|452997927|FG000|Overall Study|Withdrawal by Subject|2|||
125917902|NCT05224141|452997928|FG001|Overall Study|Withdrawal by Subject|4|||
125917903|NCT05224141|452997927|FG000|Overall Study|Death|153|||
125917904|NCT05224141|452997928|FG001|Overall Study|Death|138|||
125917905|NCT02404220|452997932|FG000|Overall Study|Adverse Event|0|||
125917906|NCT02404220|452997933|FG001|Overall Study|Adverse Event|0|||
125917907|NCT02404220|452997934|FG002|Overall Study|Adverse Event|1|||
125917908|NCT02404220|452997935|FG003|Overall Study|Adverse Event|0|||
125917909|NCT02404220|452997932|FG000|Overall Study|Death|5|||
125917910|NCT02404220|452997933|FG001|Overall Study|Death|5|||
125917911|NCT02404220|452997934|FG002|Overall Study|Death|3|||
125917912|NCT02404220|452997935|FG003|Overall Study|Death|8|||
125917913|NCT02404220|452997932|FG000|Overall Study|Progressive Disease|0|||
125917914|NCT02404220|452997933|FG001|Overall Study|Progressive Disease|0|||
125917915|NCT02404220|452997934|FG002|Overall Study|Progressive Disease|1|||
125917916|NCT02404220|452997935|FG003|Overall Study|Progressive Disease|1|||
125917917|NCT02404220|452997932|FG000|Overall Study|Study Terminated by Sponsor|0|||
125917918|NCT02404220|452997933|FG001|Overall Study|Study Terminated by Sponsor|0|||
125917919|NCT02404220|452997934|FG002|Overall Study|Study Terminated by Sponsor|2|||
125917920|NCT02404220|452997935|FG003|Overall Study|Study Terminated by Sponsor|1|||
125917921|NCT02404220|452997932|FG000|Overall Study|Withdrawal by Subject|0|||
125917922|NCT02404220|452997933|FG001|Overall Study|Withdrawal by Subject|1|||
125917923|NCT02404220|452997934|FG002|Overall Study|Withdrawal by Subject|0|||
125917924|NCT02404220|452997935|FG003|Overall Study|Withdrawal by Subject|0|||
125917925|NCT02404220|452997932|FG000|Overall Study|Enrolled but Never Treated|0|||
125917926|NCT02404220|452997933|FG001|Overall Study|Enrolled but Never Treated|2|||
125917927|NCT02404220|452997934|FG002|Overall Study|Enrolled but Never Treated|0|||
125917928|NCT02404220|452997935|FG003|Overall Study|Enrolled but Never Treated|0|||
125917929|NCT03469934|452997938|FG000|Overall Study|Withdrawal by Subject|0|||
125917930|NCT03469934|452997939|FG001|Overall Study|Withdrawal by Subject|1|||
125917931|NCT02329080|452997940|FG000|Overall Study|Adverse Event|1|||
125917932|NCT02329080|452997940|FG000|Overall Study|Death|4|||
126110787|NCT03434353|453701881|FG004|Overall Study|Lost to Follow-up|0|||
125917933|NCT02329080|452997940|FG000|Overall Study|Lack of Efficacy|22|||
125917934|NCT02329080|452997940|FG000|Overall Study|Lost to Follow-up|1|||
125917935|NCT02329080|452997940|FG000|Overall Study|Physician Decision|2|||
125917936|NCT02329080|452997940|FG000|Overall Study|Partial response|4|||
125917937|NCT02329080|452997940|FG000|Overall Study|Complete response|4|||
126110788|NCT04906616|453701882|FG000|Overall Study|Divorce|3|||
125917938|NCT00071396|452997953|FG000|Overall Study|Withdrawal by Subject|1|||
125917939|NCT00071396|452997953|FG000|Overall Study|Physician Decision|2|||
125917940|NCT03082261|452997954|FG000|Overall Study|Death|4|||
125917941|NCT03082261|452997954|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
125917942|NCT03082261|452997954|FG000|Overall Study|Insurance denial|1|||
125917943|NCT03082261|452997954|FG000|Overall Study|Peripheral lead added|1|||
125917944|NCT03082261|452997954|FG000|Overall Study|Withdrawal by Subject|40|||
125917945|NCT03082261|452997954|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
126110789|NCT04906616|453701883|FG001|Overall Study|Divorce|2|||
126064259|NCT00828139|453527685|FG001|Overall Study|Adverse Event|1|||
126064260|NCT00828139|453527686|FG002|Overall Study|Adverse Event|10|||
125917946|NCT03082261|452997954|FG000|Overall Study|Subject implanted with device other than study device|1|||
125917947|NCT03082261|452997954|FG000|Overall Study|Lost to Follow-up|14|||
125917948|NCT03082261|452997954|FG000|Overall Study|Subject moved to a different state|1|||
125917949|NCT03082261|452997954|FG000|Overall Study|Subject non-compliance|2|||
125917950|NCT03082261|452997954|FG000|Overall Study|Subject participation terminated by investigator|9|||
125917951|NCT03082261|452997954|FG000|Overall Study|Subject participation terminated by sponsor|4|||
125917952|NCT03082261|452997954|FG000|Overall Study|System explant|19|||
125917953|NCT03082261|452997954|FG000|Overall Study|Unable to place lead(s)|2|||
125917954|NCT03082261|452997954|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
125917955|NCT02639546|452997955|FG000|Overall Study|Death|2|||
125917956|NCT02639546|452997956|FG001|Overall Study|Death|2|||
125917957|NCT02639546|452997957|FG002|Overall Study|Death|1|||
125917958|NCT02639546|452997958|FG003|Overall Study|Death|2|||
125917959|NCT02639546|452997959|FG004|Overall Study|Death|2|||
125917960|NCT02639546|452997960|FG005|Overall Study|Death|2|||
125917961|NCT02639546|452997961|FG006|Overall Study|Death|0|||
125917962|NCT02639546|452997962|FG007|Overall Study|Death|0|||
125917963|NCT02639546|452997955|FG000|Overall Study|Lost to Follow-up|0|||
125917964|NCT02639546|452997956|FG001|Overall Study|Lost to Follow-up|0|||
125917965|NCT02639546|452997957|FG002|Overall Study|Lost to Follow-up|1|||
125917966|NCT02639546|452997958|FG003|Overall Study|Lost to Follow-up|0|||
125917967|NCT02639546|452997959|FG004|Overall Study|Lost to Follow-up|1|||
125917968|NCT02639546|452997960|FG005|Overall Study|Lost to Follow-up|1|||
125917969|NCT02639546|452997961|FG006|Overall Study|Lost to Follow-up|0|||
125917970|NCT02639546|452997962|FG007|Overall Study|Lost to Follow-up|1|||
125917971|NCT02639546|452997955|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
125917972|NCT02639546|452997956|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
125917973|NCT02639546|452997957|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
125917974|NCT02639546|452997958|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
125917975|NCT02639546|452997959|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
125917976|NCT02639546|452997960|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
125917977|NCT02639546|452997961|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
125917978|NCT02639546|452997962|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
125917979|NCT02639546|452997955|FG000|Overall Study|Study Terminated By Sponsor|0|||
125917980|NCT02639546|452997956|FG001|Overall Study|Study Terminated By Sponsor|2|||
125917981|NCT02639546|452997957|FG002|Overall Study|Study Terminated By Sponsor|3|||
125917982|NCT02639546|452997958|FG003|Overall Study|Study Terminated By Sponsor|4|||
125917983|NCT02639546|452997959|FG004|Overall Study|Study Terminated By Sponsor|4|||
125917984|NCT02639546|452997960|FG005|Overall Study|Study Terminated By Sponsor|3|||
125917985|NCT02639546|452997961|FG006|Overall Study|Study Terminated By Sponsor|3|||
125917986|NCT02639546|452997962|FG007|Overall Study|Study Terminated By Sponsor|9|||
125917987|NCT02639546|452997955|FG000|Overall Study|Withdrawal by Subject|2|||
125917988|NCT02639546|452997956|FG001|Overall Study|Withdrawal by Subject|2|||
125917989|NCT02639546|452997957|FG002|Overall Study|Withdrawal by Subject|1|||
125917990|NCT02639546|452997958|FG003|Overall Study|Withdrawal by Subject|0|||
125917991|NCT02639546|452997959|FG004|Overall Study|Withdrawal by Subject|0|||
125917992|NCT02639546|452997960|FG005|Overall Study|Withdrawal by Subject|1|||
125917993|NCT02639546|452997961|FG006|Overall Study|Withdrawal by Subject|2|||
125917994|NCT02639546|452997962|FG007|Overall Study|Withdrawal by Subject|1|||
125917995|NCT01032174|452997965|FG000|Overall Study|Adverse Event|0|||
125917996|NCT01032174|452997966|FG001|Overall Study|Adverse Event|1|||
125917997|NCT00113087|452997968|FG000|Overall Study|Death or Transplant|14|||
125917998|NCT00113087|452997969|FG001|Overall Study|Death or Transplant|16|||
125917999|NCT00113087|452997968|FG000|Overall Study|Family or MD withdrew subject|10|||
125918000|NCT00113087|452997969|FG001|Overall Study|Family or MD withdrew subject|5|||
125918001|NCT01281137|452997970|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
125918002|NCT01281137|452997971|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
125918003|NCT01281137|452997970|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
125918004|NCT01281137|452997971|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
125918005|NCT01281137|452997970|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
125918006|NCT01281137|452997971|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
125918007|NCT01281137|452997970|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
125918008|NCT01281137|452997971|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
125918009|NCT01281137|452997970|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
125918010|NCT01281137|452997971|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
125918011|NCT00386607|452997974|FG000|Core|Adverse Event|40|||
125918012|NCT00386607|452997975|FG001|Core|Adverse Event|0|||
125918013|NCT00386607|452997974|FG000|Core|Abnormal laboratory value(s)|3|||
125918014|NCT00386607|452997975|FG001|Core|Abnormal laboratory value(s)|0|||
125918015|NCT00386607|452997974|FG000|Core|Unsatisfactory therapeutic effect|23|||
125918016|NCT00386607|452997975|FG001|Core|Unsatisfactory therapeutic effect|0|||
125918017|NCT00386607|452997974|FG000|Core|Condition no longer requires study drug|4|||
125918018|NCT00386607|452997975|FG001|Core|Condition no longer requires study drug|0|||
125918019|NCT00386607|452997974|FG000|Core|Patient withdrew consent|15|||
125918020|NCT00386607|452997975|FG001|Core|Patient withdrew consent|0|||
125918021|NCT00386607|452997974|FG000|Core|Lost to Follow-up|23|||
125918022|NCT00386607|452997975|FG001|Core|Lost to Follow-up|0|||
125918023|NCT00386607|452997974|FG000|Core|Administrative problems|1|||
125918024|NCT00386607|452997975|FG001|Core|Administrative problems|0|||
125918025|NCT00386607|452997974|FG000|Core|Protocol Deviation|6|||
125918026|NCT00386607|452997975|FG001|Core|Protocol Deviation|0|||
125918027|NCT00386607|452997974|FG000|Extension|Adverse Event|0|||
125918028|NCT00386607|452997975|FG001|Extension|Adverse Event|6|||
125918029|NCT00386607|452997974|FG000|Extension|Abnormal laboratory value(s)|0|||
125918030|NCT00386607|452997975|FG001|Extension|Abnormal laboratory value(s)|1|||
125918031|NCT00386607|452997974|FG000|Extension|Administrative problems|0|||
125918032|NCT00386607|452997975|FG001|Extension|Administrative problems|1|||
125918033|NCT00386607|452997974|FG000|Extension|Lost to Follow-up|0|||
125918034|NCT00386607|452997975|FG001|Extension|Lost to Follow-up|3|||
125918035|NCT00386607|452997974|FG000|Extension|Patient withdrew consent|0|||
125918036|NCT00386607|452997975|FG001|Extension|Patient withdrew consent|5|||
125918037|NCT00386607|452997974|FG000|Extension|Unsatisfactory therapeutic effect|0|||
125918038|NCT00386607|452997975|FG001|Extension|Unsatisfactory therapeutic effect|1|||
125918039|NCT04251273|452997978|FG000|Overall Study|Lost to Follow-up|331|||
125918040|NCT04251273|452997979|FG001|Overall Study|Lost to Follow-up|290|||
125918041|NCT01986907|452997980|FG000|Overall Study|Adverse Event|11|||
125918042|NCT01986907|452997980|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
125918043|NCT01986907|452997980|FG000|Overall Study|Protocol Violation|4|||
125918044|NCT01986907|452997980|FG000|Overall Study|Withdrawal by Subject|76|||
125918045|NCT01986907|452997980|FG000|Overall Study|Lost to Follow-up|38|||
125918046|NCT01986907|452997980|FG000|Overall Study|Death|9|||
125918047|NCT00810693|452997981|FG000|Treatment Period|Adverse Event|8|||
125918048|NCT00810693|452997982|FG001|Treatment Period|Adverse Event|1|||
125918049|NCT00810693|452997983|FG002|Treatment Period|Adverse Event|7|||
125918050|NCT00810693|452997981|FG000|Treatment Period|Death|0|||
125918051|NCT00810693|452997982|FG001|Treatment Period|Death|1|||
125918052|NCT00810693|452997983|FG002|Treatment Period|Death|2|||
125918053|NCT00810693|452997981|FG000|Treatment Period|Lack of Efficacy|0|||
125918054|NCT00810693|452997982|FG001|Treatment Period|Lack of Efficacy|0|||
125918055|NCT00810693|452997983|FG002|Treatment Period|Lack of Efficacy|1|||
125918056|NCT00810693|452997981|FG000|Treatment Period|Lost to Follow-up|1|||
125918057|NCT00810693|452997982|FG001|Treatment Period|Lost to Follow-up|0|||
125918058|NCT00810693|452997983|FG002|Treatment Period|Lost to Follow-up|0|||
125918059|NCT00810693|452997981|FG000|Treatment Period|Non-compliance|1|||
125918060|NCT00810693|452997982|FG001|Treatment Period|Non-compliance|0|||
125918061|NCT00810693|452997983|FG002|Treatment Period|Non-compliance|0|||
125918062|NCT00810693|452997981|FG000|Treatment Period|Protocol Violation|1|||
125918063|NCT00810693|452997982|FG001|Treatment Period|Protocol Violation|2|||
125918064|NCT00810693|452997983|FG002|Treatment Period|Protocol Violation|2|||
125918065|NCT00810693|452997981|FG000|Treatment Period|Withdrawal by Subject|6|||
125918066|NCT00810693|452997982|FG001|Treatment Period|Withdrawal by Subject|2|||
125918067|NCT00810693|452997983|FG002|Treatment Period|Withdrawal by Subject|3|||
125918068|NCT00810693|452997981|FG000|Treatment Period|Not treated|0|||
125918069|NCT00810693|452997982|FG001|Treatment Period|Not treated|1|||
125918070|NCT00810693|452997983|FG002|Treatment Period|Not treated|1|||
125918071|NCT00810693|452997981|FG000|Follow-up Period (FUP)|Adverse Event|3|||
125918072|NCT00810693|452997982|FG001|Follow-up Period (FUP)|Adverse Event|1|||
125918073|NCT00810693|452997983|FG002|Follow-up Period (FUP)|Adverse Event|1|||
125918074|NCT00810693|452997981|FG000|Follow-up Period (FUP)|Death|2|||
125918075|NCT00810693|452997982|FG001|Follow-up Period (FUP)|Death|0|||
126064261|NCT00828139|453527687|FG003|Overall Study|Adverse Event|5|||
126064262|NCT00828139|453527684|FG000|Overall Study|Death|2|||
126064263|NCT00828139|453527685|FG001|Overall Study|Death|1|||
125918076|NCT00810693|452997983|FG002|Follow-up Period (FUP)|Death|1|||
125918077|NCT00810693|452997981|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
125918078|NCT00810693|452997982|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
125918079|NCT00810693|452997983|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
125918080|NCT00810693|452997981|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
125918081|NCT00810693|452997982|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
125918082|NCT00810693|452997983|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
125918083|NCT00810693|452997981|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
125918084|NCT00810693|452997982|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
125918085|NCT00810693|452997983|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
125918086|NCT03212690|452997984|FG000|Overall Study|Protocol Violation|1|||
125918087|NCT04203797|452997992|FG000|Overall Study|Adverse Event|1|||
125918088|NCT04203797|452997993|FG001|Overall Study|Adverse Event|0|||
126064264|NCT00828139|453527686|FG002|Overall Study|Death|0|||
126064265|NCT00828139|453527687|FG003|Overall Study|Death|2|||
125918089|NCT04203797|452997992|FG000|Overall Study|Did not complete End of Study follow-up|1|||
125918090|NCT04203797|452997993|FG001|Overall Study|Did not complete End of Study follow-up|0|||
125918091|NCT00516074|452997994|FG000|Overall Study|Adverse Event|0|||
125918092|NCT00516074|452997995|FG001|Overall Study|Adverse Event|1|||
125918093|NCT00516074|452997994|FG000|Overall Study|Subject Decision|4|||
125918094|NCT00516074|452997995|FG001|Overall Study|Subject Decision|2|||
125918095|NCT00516074|452997994|FG000|Overall Study|Loss of Glucose Control|2|||
125918096|NCT00516074|452997995|FG001|Overall Study|Loss of Glucose Control|0|||
125918097|NCT00633750|452997997|FG000|Overall Study|Adverse Event|2|||
125918098|NCT00633750|452997997|FG000|Overall Study|Withdrawal by Subject|3|||
125918099|NCT02215096|452998000|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
125918100|NCT02215096|452998001|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
125918101|NCT02215096|452998002|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
125918102|NCT02215096|452998003|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
125918103|NCT02215096|452998004|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
125918104|NCT02215096|452998000|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125918105|NCT02215096|452998001|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125918106|NCT02215096|452998002|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125918107|NCT02215096|452998003|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125918108|NCT02215096|452998004|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
125918109|NCT02215096|452998000|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
125918110|NCT02215096|452998001|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
125918111|NCT02215096|452998002|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
125918112|NCT02215096|452998003|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
125918113|NCT02215096|452998004|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
125918114|NCT02215096|452998000|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
125918115|NCT02215096|452998001|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
125918116|NCT02215096|452998002|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
125918117|NCT02215096|452998003|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
125918118|NCT02215096|452998004|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
125918119|NCT00287365|452998005|FG000|Overall Study|sample not acquired|13|||
125918120|NCT02298023|452998006|FG000|Overall Study|Withdrawal by Subject|1|||
125918121|NCT02298023|452998007|FG001|Overall Study|Withdrawal by Subject|0|||
125918122|NCT02298023|452998008|FG002|Overall Study|Withdrawal by Subject|0|||
125918123|NCT03307785|452998012|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
125918124|NCT03307785|452998013|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
125918125|NCT03307785|452998014|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
125918126|NCT03307785|452998015|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
125918127|NCT03307785|452998016|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
125918128|NCT03307785|452998017|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
125918129|NCT03307785|452998018|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
125918130|NCT03307785|452998019|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
125918131|NCT03307785|452998020|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
125918132|NCT03307785|452998021|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
125918133|NCT03307785|452998022|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
125918134|NCT03307785|452998012|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
125918135|NCT03307785|452998013|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
125918136|NCT03307785|452998014|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918137|NCT03307785|452998015|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918138|NCT03307785|452998016|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918139|NCT03307785|452998017|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918140|NCT03307785|452998018|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918141|NCT03307785|452998019|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918142|NCT03307785|452998020|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918143|NCT03307785|452998021|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918144|NCT03307785|452998022|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125918145|NCT03307785|452998012|FG000|Part A: Up to 28.5 Months|Death|4|||
125918146|NCT03307785|452998013|FG001|Part A: Up to 28.5 Months|Death|4|||
125918147|NCT03307785|452998014|FG002|Part A: Up to 28.5 Months|Death|0|||
125918148|NCT03307785|452998015|FG003|Part A: Up to 28.5 Months|Death|0|||
125918149|NCT03307785|452998016|FG004|Part A: Up to 28.5 Months|Death|0|||
125918150|NCT03307785|452998017|FG005|Part A: Up to 28.5 Months|Death|0|||
126110790|NCT02464228|453701884|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
125918151|NCT03307785|452998018|FG006|Part A: Up to 28.5 Months|Death|0|||
125918152|NCT03307785|452998019|FG007|Part A: Up to 28.5 Months|Death|0|||
125918153|NCT03307785|452998020|FG008|Part A: Up to 28.5 Months|Death|0|||
125918154|NCT03307785|452998021|FG009|Part A: Up to 28.5 Months|Death|0|||
125918155|NCT03307785|452998022|FG010|Part A: Up to 28.5 Months|Death|0|||
125918156|NCT03307785|452998012|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
125918157|NCT03307785|452998013|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
125918158|NCT03307785|452998014|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
125918159|NCT03307785|452998015|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
125918160|NCT03307785|452998016|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
125918161|NCT03307785|452998017|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
125918162|NCT03307785|452998018|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
125918163|NCT03307785|452998019|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
125918164|NCT03307785|452998020|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
125918165|NCT03307785|452998021|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
125918166|NCT03307785|452998022|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
125918167|NCT03307785|452998012|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918168|NCT03307785|452998013|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918169|NCT03307785|452998014|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
125918170|NCT03307785|452998015|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918171|NCT03307785|452998016|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918172|NCT03307785|452998017|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918173|NCT03307785|452998018|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918174|NCT03307785|452998019|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918175|NCT03307785|452998020|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918176|NCT03307785|452998021|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918177|NCT03307785|452998022|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
125918178|NCT03307785|452998012|FG000|Part B: Up to Approx. 66 Months|Death|0|||
125918179|NCT03307785|452998013|FG001|Part B: Up to Approx. 66 Months|Death|0|||
125918180|NCT03307785|452998014|FG002|Part B: Up to Approx. 66 Months|Death|7|||
125918181|NCT03307785|452998015|FG003|Part B: Up to Approx. 66 Months|Death|0|||
125918182|NCT03307785|452998016|FG004|Part B: Up to Approx. 66 Months|Death|0|||
125918183|NCT03307785|452998017|FG005|Part B: Up to Approx. 66 Months|Death|0|||
125918184|NCT03307785|452998018|FG006|Part B: Up to Approx. 66 Months|Death|0|||
125918185|NCT03307785|452998019|FG007|Part B: Up to Approx. 66 Months|Death|0|||
125918186|NCT03307785|452998020|FG008|Part B: Up to Approx. 66 Months|Death|0|||
125918187|NCT03307785|452998021|FG009|Part B: Up to Approx. 66 Months|Death|0|||
125918188|NCT03307785|452998022|FG010|Part B: Up to Approx. 66 Months|Death|0|||
125918189|NCT03307785|452998012|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918190|NCT03307785|452998013|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918191|NCT03307785|452998014|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
125918192|NCT03307785|452998015|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918193|NCT03307785|452998016|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918194|NCT03307785|452998017|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918195|NCT03307785|452998018|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918196|NCT03307785|452998019|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918197|NCT03307785|452998020|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918198|NCT03307785|452998021|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918199|NCT03307785|452998022|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125918200|NCT03307785|452998012|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918201|NCT03307785|452998013|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918202|NCT03307785|452998014|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
125918203|NCT03307785|452998015|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918204|NCT03307785|452998016|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918205|NCT03307785|452998017|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918206|NCT03307785|452998018|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918207|NCT03307785|452998019|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918208|NCT03307785|452998020|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918209|NCT03307785|452998021|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918210|NCT03307785|452998022|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125918211|NCT03307785|452998012|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918212|NCT03307785|452998013|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918213|NCT03307785|452998014|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
125918214|NCT03307785|452998015|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918215|NCT03307785|452998016|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918216|NCT03307785|452998017|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918217|NCT03307785|452998018|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918218|NCT03307785|452998019|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918219|NCT03307785|452998020|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918220|NCT03307785|452998021|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918221|NCT03307785|452998022|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125918222|NCT03307785|452998012|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918223|NCT03307785|452998013|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918224|NCT03307785|452998014|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918225|NCT03307785|452998015|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
125918226|NCT03307785|452998016|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
125918227|NCT03307785|452998017|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918228|NCT03307785|452998018|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918229|NCT03307785|452998019|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918230|NCT03307785|452998020|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918231|NCT03307785|452998021|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918232|NCT03307785|452998022|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125918233|NCT03307785|452998012|FG000|Part C: Up to Approx. 60 Months|Death|0|||
125918234|NCT03307785|452998013|FG001|Part C: Up to Approx. 60 Months|Death|0|||
125918235|NCT03307785|452998014|FG002|Part C: Up to Approx. 60 Months|Death|0|||
125918236|NCT03307785|452998015|FG003|Part C: Up to Approx. 60 Months|Death|2|||
125918237|NCT03307785|452998016|FG004|Part C: Up to Approx. 60 Months|Death|5|||
125918238|NCT03307785|452998017|FG005|Part C: Up to Approx. 60 Months|Death|0|||
125918239|NCT03307785|452998018|FG006|Part C: Up to Approx. 60 Months|Death|0|||
125918240|NCT03307785|452998019|FG007|Part C: Up to Approx. 60 Months|Death|0|||
125918241|NCT03307785|452998020|FG008|Part C: Up to Approx. 60 Months|Death|0|||
125918242|NCT03307785|452998021|FG009|Part C: Up to Approx. 60 Months|Death|0|||
125918243|NCT03307785|452998022|FG010|Part C: Up to Approx. 60 Months|Death|0|||
125918244|NCT03307785|452998012|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918245|NCT03307785|452998013|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918246|NCT03307785|452998014|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918247|NCT03307785|452998015|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
125918248|NCT03307785|452998016|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918249|NCT03307785|452998017|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918250|NCT03307785|452998018|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918251|NCT03307785|452998019|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918252|NCT03307785|452998020|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918253|NCT03307785|452998021|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918254|NCT03307785|452998022|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125918255|NCT03307785|452998012|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918256|NCT03307785|452998013|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918257|NCT03307785|452998014|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918258|NCT03307785|452998015|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918259|NCT03307785|452998016|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
125918260|NCT03307785|452998017|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918261|NCT03307785|452998018|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918262|NCT03307785|452998019|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918263|NCT03307785|452998020|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918264|NCT03307785|452998021|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918265|NCT03307785|452998022|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125918266|NCT03307785|452998012|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918267|NCT03307785|452998013|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918268|NCT03307785|452998014|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918269|NCT03307785|452998015|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918270|NCT03307785|452998016|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918271|NCT03307785|452998017|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
125918272|NCT03307785|452998018|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918273|NCT03307785|452998019|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918274|NCT03307785|452998020|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918275|NCT03307785|452998021|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918276|NCT03307785|452998022|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125918277|NCT03307785|452998012|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
125918278|NCT03307785|452998013|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
125918279|NCT03307785|452998014|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
125918280|NCT03307785|452998015|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
125918281|NCT03307785|452998016|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
125918282|NCT03307785|452998017|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
125918283|NCT03307785|452998018|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
125918284|NCT03307785|452998019|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
125918285|NCT03307785|452998020|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
125918286|NCT03307785|452998021|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
125918287|NCT03307785|452998022|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
125918288|NCT03307785|452998012|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918289|NCT03307785|452998013|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918290|NCT03307785|452998014|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918291|NCT03307785|452998015|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918292|NCT03307785|452998016|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918293|NCT03307785|452998017|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
125918294|NCT03307785|452998018|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918295|NCT03307785|452998019|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918296|NCT03307785|452998020|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918297|NCT03307785|452998021|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918298|NCT03307785|452998022|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125918299|NCT03307785|452998012|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918300|NCT03307785|452998013|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918301|NCT03307785|452998014|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918302|NCT03307785|452998015|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918303|NCT03307785|452998016|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918304|NCT03307785|452998017|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
125918305|NCT03307785|452998018|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918306|NCT03307785|452998019|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918307|NCT03307785|452998020|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918308|NCT03307785|452998021|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918309|NCT03307785|452998022|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125918310|NCT03307785|452998012|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918311|NCT03307785|452998013|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918312|NCT03307785|452998014|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918313|NCT03307785|452998015|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918314|NCT03307785|452998016|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918315|NCT03307785|452998017|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
125918316|NCT03307785|452998018|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918317|NCT03307785|452998019|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918318|NCT03307785|452998020|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918319|NCT03307785|452998021|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918320|NCT03307785|452998022|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125918321|NCT03307785|452998012|FG000|Part E: Up to 4.4 Months|Death|0|||
125918322|NCT03307785|452998013|FG001|Part E: Up to 4.4 Months|Death|0|||
125918323|NCT03307785|452998014|FG002|Part E: Up to 4.4 Months|Death|0|||
125918324|NCT03307785|452998015|FG003|Part E: Up to 4.4 Months|Death|0|||
125918325|NCT03307785|452998016|FG004|Part E: Up to 4.4 Months|Death|0|||
125918326|NCT03307785|452998017|FG005|Part E: Up to 4.4 Months|Death|0|||
125918327|NCT03307785|452998018|FG006|Part E: Up to 4.4 Months|Death|1|||
125918328|NCT03307785|452998019|FG007|Part E: Up to 4.4 Months|Death|0|||
125918329|NCT03307785|452998020|FG008|Part E: Up to 4.4 Months|Death|0|||
125918330|NCT03307785|452998021|FG009|Part E: Up to 4.4 Months|Death|0|||
125918331|NCT03307785|452998022|FG010|Part E: Up to 4.4 Months|Death|0|||
125918332|NCT03307785|452998012|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
125918333|NCT03307785|452998013|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
125918334|NCT03307785|452998014|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
125918335|NCT03307785|452998015|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
125918336|NCT03307785|452998016|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
126064266|NCT00828139|453527684|FG000|Overall Study|Refusal unrelated to toxicity|3|||
126064267|NCT00828139|453527685|FG001|Overall Study|Refusal unrelated to toxicity|4|||
126064268|NCT00828139|453527686|FG002|Overall Study|Refusal unrelated to toxicity|5|||
126064269|NCT00828139|453527687|FG003|Overall Study|Refusal unrelated to toxicity|3|||
126064270|NCT00828139|453527684|FG000|Overall Study|Disease Progression|24|||
126064271|NCT00828139|453527685|FG001|Overall Study|Disease Progression|33|||
126064272|NCT00828139|453527686|FG002|Overall Study|Disease Progression|35|||
126064273|NCT00828139|453527687|FG003|Overall Study|Disease Progression|39|||
126064274|NCT00828139|453527684|FG000|Overall Study|Other|4|||
126064275|NCT00828139|453527685|FG001|Overall Study|Other|2|||
126064276|NCT00828139|453527686|FG002|Overall Study|Other|5|||
126064277|NCT00828139|453527687|FG003|Overall Study|Other|2|||
126064278|NCT01320683|453527688|FG000|Overall Study|Positive antibody response|1|||
126064279|NCT00759681|453527689|FG000|Overall Study|Death|2|||
126064280|NCT00759681|453527690|FG001|Overall Study|Death|5|||
126064281|NCT00759681|453527689|FG000|Overall Study|Lost to Follow-up|8|||
126064282|NCT00759681|453527690|FG001|Overall Study|Lost to Follow-up|5|||
126064283|NCT00476151|453527691|FG000|Overall Study|Adverse Event|0|||
126064284|NCT00476151|453527692|FG001|Overall Study|Adverse Event|2|||
126064285|NCT00476151|453527691|FG000|Overall Study|Protocol Violation|1|||
126064286|NCT00476151|453527692|FG001|Overall Study|Protocol Violation|3|||
126064287|NCT00476151|453527691|FG000|Overall Study|Withdrawal by Subject|2|||
126064288|NCT00476151|453527692|FG001|Overall Study|Withdrawal by Subject|0|||
126064289|NCT00476151|453527691|FG000|Overall Study|Physician Decision|0|||
126064290|NCT00476151|453527692|FG001|Overall Study|Physician Decision|2|||
126064291|NCT02005484|453527697|FG000|Overall Study|Death|1|||
126064292|NCT02005484|453527697|FG000|Overall Study|Disease progression|1|||
126064293|NCT02005484|453527697|FG000|Overall Study|Changed to a Different Study|1|||
126064294|NCT02005484|453527697|FG000|Overall Study|Sponsor decision|1|||
126064295|NCT01129011|453527698|FG000|Overall Study|Adverse Event|20|||
126064296|NCT01129011|453527699|FG001|Overall Study|Adverse Event|30|||
126064297|NCT01129011|453527698|FG000|Overall Study|Withdrawal by Subject|24|||
126064298|NCT01129011|453527699|FG001|Overall Study|Withdrawal by Subject|8|||
126064299|NCT01129011|453527698|FG000|Overall Study|Lost to Follow-up|6|||
126064300|NCT01129011|453527699|FG001|Overall Study|Lost to Follow-up|7|||
126064301|NCT01129011|453527698|FG000|Overall Study|Duodenal Ulcer|2|||
126064302|NCT01129011|453527699|FG001|Overall Study|Duodenal Ulcer|8|||
126064303|NCT01129011|453527698|FG000|Overall Study|misc|7|||
126064304|NCT01129011|453527699|FG001|Overall Study|misc|4|||
126064305|NCT01113541|453527703|FG000|Overall Study|Withdrawal by Subject|1|||
126064306|NCT01113541|453527703|FG000|Overall Study|Protocol Violation|1|||
126064307|NCT01113541|453527703|FG000|Overall Study|Study Terminated by Sponsor|7|||
126064308|NCT01113541|453527703|FG000|Overall Study|Adverse Event|4|||
126064309|NCT03745651|453527704|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
126064310|NCT03745651|453527705|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
126064311|NCT03745651|453527706|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126064312|NCT03745651|453527707|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126064313|NCT03745651|453527708|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126064314|NCT03745651|453527709|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126064315|NCT03745651|453527710|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126064316|NCT03745651|453527704|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
126064317|NCT03745651|453527705|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
126064318|NCT03745651|453527706|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
126064319|NCT03745651|453527707|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126064320|NCT03745651|453527708|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125918337|NCT03307785|452998017|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
125918338|NCT03307785|452998018|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
125918339|NCT03307785|452998019|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
125918340|NCT03307785|452998020|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
125918341|NCT03307785|452998021|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
125918342|NCT03307785|452998022|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
125918343|NCT03307785|452998012|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
125918344|NCT03307785|452998013|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
125918345|NCT03307785|452998014|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
125918346|NCT03307785|452998015|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
125918347|NCT03307785|452998016|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
126064321|NCT03745651|453527709|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126064322|NCT03745651|453527710|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126064323|NCT03745651|453527704|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
126064324|NCT03745651|453527705|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125918348|NCT03307785|452998017|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
125918349|NCT03307785|452998018|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
125918350|NCT03307785|452998019|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
125918351|NCT03307785|452998020|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
125918352|NCT03307785|452998021|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
125918353|NCT03307785|452998022|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
125918354|NCT03021304|452998023|FG000|Overall Study|Lack of Efficacy|1|||
125918355|NCT00492531|452998025|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
125918356|NCT00492531|452998026|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
125918357|NCT02569671|452998028|FG000|Overall Study|Lost to Follow-up|2|||
125918358|NCT02569671|452998029|FG001|Overall Study|Lost to Follow-up|1|||
125918359|NCT02569671|452998028|FG000|Overall Study|Withdrawal by Subject|1|||
125918360|NCT02569671|452998029|FG001|Overall Study|Withdrawal by Subject|3|||
125918361|NCT00825682|452999472|FG000|Overall Study|personal reasons/ inconvenience|13|||
125918362|NCT00825682|452999473|FG001|Overall Study|personal reasons/ inconvenience|5|||
125918363|NCT00316719|452999474|FG000|Overall Study|Adverse Event|0|||
125918364|NCT00316719|452999475|FG001|Overall Study|Adverse Event|6|||
125918365|NCT00316719|452999474|FG000|Overall Study|Consent withdrawn|2|||
125918366|NCT00316719|452999475|FG001|Overall Study|Consent withdrawn|0|||
125918367|NCT01644565|452999478|FG000|Overall Study|Undisclosed Medical History|1|||
125918368|NCT01644565|452999479|FG001|Overall Study|Undisclosed Medical History|0|||
125918369|NCT01644565|452999480|FG002|Overall Study|Undisclosed Medical History|0|||
125918370|NCT01644565|452999481|FG003|Overall Study|Undisclosed Medical History|0|||
125918371|NCT01644565|452999482|FG004|Overall Study|Undisclosed Medical History|0|||
126110791|NCT02464228|453701885|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
126110792|NCT02464228|453701886|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
126110793|NCT02464228|453701887|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
126110794|NCT02464228|453701884|FG000|Overall Study|Physician Decision|2|||
126110795|NCT02464228|453701885|FG001|Overall Study|Physician Decision|0|||
126110796|NCT02464228|453701886|FG002|Overall Study|Physician Decision|1|||
126110797|NCT02464228|453701887|FG003|Overall Study|Physician Decision|0|||
126110798|NCT02464228|453701884|FG000|Overall Study|Miscellaneous|1|||
126110799|NCT02464228|453701885|FG001|Overall Study|Miscellaneous|0|||
126110800|NCT02464228|453701886|FG002|Overall Study|Miscellaneous|1|||
126110801|NCT02464228|453701887|FG003|Overall Study|Miscellaneous|0|||
126110802|NCT02464228|453701884|FG000|Overall Study|Adverse Event|9|||
126110803|NCT02464228|453701885|FG001|Overall Study|Adverse Event|0|||
126110804|NCT02464228|453701886|FG002|Overall Study|Adverse Event|3|||
126110805|NCT02464228|453701887|FG003|Overall Study|Adverse Event|0|||
126110806|NCT02464228|453701884|FG000|Overall Study|Withdrawal by Subject|1|||
126110807|NCT02464228|453701885|FG001|Overall Study|Withdrawal by Subject|1|||
126110808|NCT02464228|453701886|FG002|Overall Study|Withdrawal by Subject|1|||
126110809|NCT02464228|453701887|FG003|Overall Study|Withdrawal by Subject|0|||
126110810|NCT02464228|453701884|FG000|Overall Study|Disease Progression|22|||
126110811|NCT02464228|453701885|FG001|Overall Study|Disease Progression|12|||
126110812|NCT02464228|453701886|FG002|Overall Study|Disease Progression|5|||
126110813|NCT02464228|453701887|FG003|Overall Study|Disease Progression|2|||
126110814|NCT01990534|453701888|FG000|Overall Study|Death|22|||
125918372|NCT01644565|452999483|FG005|Overall Study|Undisclosed Medical History|0|||
125918373|NCT01644565|452999484|FG006|Overall Study|Undisclosed Medical History|0|||
125918374|NCT01644565|452999485|FG007|Overall Study|Undisclosed Medical History|0|||
125918375|NCT01644565|452999486|FG008|Overall Study|Undisclosed Medical History|0|||
125918376|NCT01644565|452999478|FG000|Overall Study|Lost to Follow-up|0|||
125918377|NCT01644565|452999479|FG001|Overall Study|Lost to Follow-up|0|||
125918378|NCT01644565|452999480|FG002|Overall Study|Lost to Follow-up|0|||
125918379|NCT01644565|452999481|FG003|Overall Study|Lost to Follow-up|1|||
125918380|NCT01644565|452999482|FG004|Overall Study|Lost to Follow-up|0|||
125918381|NCT01644565|452999483|FG005|Overall Study|Lost to Follow-up|0|||
125918382|NCT01644565|452999484|FG006|Overall Study|Lost to Follow-up|0|||
125918383|NCT01644565|452999485|FG007|Overall Study|Lost to Follow-up|2|||
125918384|NCT01644565|452999486|FG008|Overall Study|Lost to Follow-up|0|||
125918385|NCT01644565|452999478|FG000|Overall Study|Family emergency|0|||
125918386|NCT01644565|452999479|FG001|Overall Study|Family emergency|0|||
125918387|NCT01644565|452999480|FG002|Overall Study|Family emergency|0|||
125918388|NCT01644565|452999481|FG003|Overall Study|Family emergency|0|||
125918389|NCT01644565|452999482|FG004|Overall Study|Family emergency|1|||
125918390|NCT01644565|452999483|FG005|Overall Study|Family emergency|0|||
125918391|NCT01644565|452999484|FG006|Overall Study|Family emergency|0|||
125918392|NCT01644565|452999485|FG007|Overall Study|Family emergency|0|||
125918393|NCT01644565|452999486|FG008|Overall Study|Family emergency|0|||
125918394|NCT01644565|452999478|FG000|Overall Study|Relocation|0|||
126110815|NCT01990534|453701888|FG000|Overall Study|Progressive disease|3|||
126110816|NCT01990534|453701888|FG000|Overall Study|Protocol Violation|1|||
126110817|NCT01990534|453701888|FG000|Overall Study|Withdrawal of Informed Consent|2|||
125918395|NCT01644565|452999479|FG001|Overall Study|Relocation|0|||
125918396|NCT01644565|452999480|FG002|Overall Study|Relocation|0|||
125918397|NCT01644565|452999481|FG003|Overall Study|Relocation|0|||
125918398|NCT01644565|452999482|FG004|Overall Study|Relocation|0|||
125918399|NCT01644565|452999483|FG005|Overall Study|Relocation|0|||
125918400|NCT01644565|452999484|FG006|Overall Study|Relocation|0|||
125918401|NCT01644565|452999485|FG007|Overall Study|Relocation|0|||
125918402|NCT01644565|452999486|FG008|Overall Study|Relocation|1|||
125918403|NCT01550289|452999487|FG000|Overall Study|Protocol Violation|1|||
125918404|NCT01550289|452999488|FG001|Overall Study|Protocol Violation|0|||
125918405|NCT01550289|452999487|FG000|Overall Study|Lost to Follow-up|1|||
125918406|NCT01550289|452999488|FG001|Overall Study|Lost to Follow-up|1|||
125918407|NCT01550289|452999487|FG000|Overall Study|Withdrawal by Subject|11|||
125918408|NCT01550289|452999488|FG001|Overall Study|Withdrawal by Subject|3|||
125918409|NCT00094172|452999494|FG000|Overall Study|Adverse Event|0|||
125918410|NCT00094172|452999495|FG001|Overall Study|Adverse Event|1|||
125918411|NCT00094172|452999494|FG000|Overall Study|Lost to Follow-up|2|||
125918412|NCT00094172|452999495|FG001|Overall Study|Lost to Follow-up|0|||
125918413|NCT00094172|452999494|FG000|Overall Study|Protocol Violation|0|||
125918414|NCT00094172|452999495|FG001|Overall Study|Protocol Violation|1|||
125918415|NCT00094172|452999494|FG000|Overall Study|Withdrawal by Subject|10|||
125918416|NCT00094172|452999495|FG001|Overall Study|Withdrawal by Subject|5|||
125918417|NCT00094172|452999494|FG000|Overall Study|Primary endpoint met.|1|||
125918418|NCT00094172|452999495|FG001|Overall Study|Primary endpoint met.|0|||
125918419|NCT00094172|452999494|FG000|Overall Study|Started other MS therapy due to disease|1|||
125918420|NCT00094172|452999495|FG001|Overall Study|Started other MS therapy due to disease|0|||
125918421|NCT00713323|452999496|FG000|Overall Study|Adverse Event|75|||
125918422|NCT00713323|452999496|FG000|Overall Study|Withdrawal by Subject|15|||
125918423|NCT00713323|452999496|FG000|Overall Study|Lost to Follow-up|11|||
125918424|NCT00713323|452999496|FG000|Overall Study|Lack of Efficacy|36|||
125918425|NCT00713323|452999496|FG000|Overall Study|Low creatine clearance at screening|1|||
125918426|NCT00713323|452999496|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
125918427|NCT00713323|452999496|FG000|Overall Study|Surgery cured allodynic pain|1|||
125918428|NCT00713323|452999496|FG000|Overall Study|Pain free|1|||
125918429|NCT00713323|452999496|FG000|Overall Study|Non-compliance|1|||
125918430|NCT00713323|452999496|FG000|Overall Study|Pain resolved|1|||
125918431|NCT00713323|452999496|FG000|Overall Study|Subject travelling to USA|1|||
125918432|NCT00713323|452999496|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
125918433|NCT00713323|452999496|FG000|Overall Study|Treatment that may interact with Sativex|1|||
125918434|NCT02478632|452999497|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
125918435|NCT02478632|452999498|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
125918436|NCT02478632|452999497|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
125918437|NCT02478632|452999498|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
125918438|NCT02478632|452999497|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
125918439|NCT02478632|452999498|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
125918440|NCT04622306|452999499|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
125918441|NCT04622306|452999500|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
125918442|NCT04622306|452999501|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
125918443|NCT04622306|452999502|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
125918444|NCT04622306|452999503|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
125918445|NCT04622306|452999504|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
125918446|NCT04622306|452999499|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
125918447|NCT04622306|452999500|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
125918448|NCT04622306|452999501|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
125918449|NCT04622306|452999502|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
125918450|NCT04622306|452999503|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
125918451|NCT04622306|452999504|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
125918452|NCT00864721|452999505|FG000|Overall Study|Patient request|11|||
125918453|NCT00864721|452999505|FG000|Overall Study|Hospitalized|1|||
125918454|NCT00864721|452999505|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
125918455|NCT00864721|452999505|FG000|Overall Study|Adverse Event|21|||
125918456|NCT00736944|452999506|FG000|Induction|Death|1|||
125918457|NCT00736944|452999506|FG000|Definitive Treatment|Physician Decision|1|||
125918458|NCT05350410|452999507|FG000|Overall Study|Withdrawal by Subject|1|||
125918459|NCT01601132|452999508|FG000|Overall Study|Patient withdrew consent|1|||
125918460|NCT01601132|452999508|FG000|Overall Study|Protocol deviation|1|||
125918461|NCT04889222|452999512|FG000|Overall Study|Did not meet eligibility criteria|8|||
125918462|NCT04889222|452999512|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
125918463|NCT04889222|452999512|FG000|Overall Study|Did not proceed due to time constraints|5|||
125918464|NCT01609231|452999513|FG000|Overall Study|Adverse Event|1|||
125918465|NCT01609231|452999514|FG001|Overall Study|Adverse Event|3|||
125918466|NCT01609231|452999513|FG000|Overall Study|Physician Decision|1|||
125918467|NCT01609231|452999514|FG001|Overall Study|Physician Decision|0|||
125918468|NCT01609231|452999513|FG000|Overall Study|Withdrawal by Subject|1|||
125918469|NCT01609231|452999514|FG001|Overall Study|Withdrawal by Subject|0|||
125918470|NCT01180647|452999515|FG000|Overall Study|Lost to Follow-up|5|||
126110818|NCT01990534|453701888|FG000|Overall Study|Symptomatic Deterioration|1|||
126110819|NCT01990534|453701888|FG000|Overall Study|Withdrawal by Subject|3|||
125918471|NCT01180647|452999516|FG001|Overall Study|Lost to Follow-up|6|||
125918472|NCT00702689|452999523|FG000|Overall Study|Withdrawal by Subject|4|||
125918473|NCT00702689|452999523|FG000|Overall Study|Recurrent malignancy|1|||
125918474|NCT00702689|452999523|FG000|Overall Study|Adverse Event|1|||
125918475|NCT02846324|452999527|FG000|Overall Study|Other|1|||
125918476|NCT02846324|452999528|FG001|Overall Study|Other|0|||
125918477|NCT02846324|452999529|FG002|Overall Study|Other|0|||
125918478|NCT02846324|452999530|FG003|Overall Study|Other|0|||
125918479|NCT02846324|452999527|FG000|Overall Study|Withdrawal by Subject|1|||
125918480|NCT02846324|452999528|FG001|Overall Study|Withdrawal by Subject|0|||
125918481|NCT02846324|452999529|FG002|Overall Study|Withdrawal by Subject|4|||
125918482|NCT02846324|452999530|FG003|Overall Study|Withdrawal by Subject|0|||
125918483|NCT01927627|452999538|FG000|Overall Study|Adverse Event|3|||
125918484|NCT01927627|452999538|FG000|Overall Study|Lack of Efficacy|1|||
125918485|NCT01927627|452999538|FG000|Overall Study|Financial Concerns|1|||
125918486|NCT00467857|452999539|FG000|Overall Study|Adverse Event|1|||
125918487|NCT00467857|452999540|FG001|Overall Study|Adverse Event|0|||
125918488|NCT00467857|452999539|FG000|Overall Study|Withdrew consent|2|||
125918489|NCT00467857|452999540|FG001|Overall Study|Withdrew consent|0|||
125918490|NCT00467857|452999539|FG000|Overall Study|Death|0|||
125918491|NCT00467857|452999540|FG001|Overall Study|Death|1|||
125918492|NCT00467857|452999539|FG000|Overall Study|Discharged from court service|0|||
125918493|NCT00467857|452999540|FG001|Overall Study|Discharged from court service|1|||
125918494|NCT00467857|452999539|FG000|Overall Study|Emergency care required|0|||
125918495|NCT00467857|452999540|FG001|Overall Study|Emergency care required|1|||
125918496|NCT00467857|452999539|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
125918497|NCT00467857|452999540|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
125918498|NCT00467857|452999539|FG000|Overall Study|Discontinuation reason missing|0|||
125918499|NCT00467857|452999540|FG001|Overall Study|Discontinuation reason missing|3|||
125918500|NCT00338104|452999541|FG000|Overall Study|Protocol Violation|2|||
125918501|NCT00338104|452999542|FG001|Overall Study|Protocol Violation|1|||
125918502|NCT00338104|452999543|FG002|Overall Study|Protocol Violation|3|||
125918503|NCT03666624|452999548|FG000|Overall Study|participant grieving over recent death of parent|1|||
125918504|NCT03666624|452999549|FG001|Overall Study|participant grieving over recent death of parent|0|||
125918505|NCT00569270|452999550|FG000|Period: First Intervention|Protocol Violation|0|||
125918506|NCT00569270|452999551|FG001|Period: First Intervention|Protocol Violation|1|||
125918507|NCT00447005|452999552|FG000|Overall Study|Adverse Event|1|||
125918508|NCT00447005|452999552|FG000|Overall Study|Lack of Efficacy|11|||
125918509|NCT03822182|452999553|FG000|Overall Study|Protocol Violation|0|||
125918510|NCT03822182|452999554|FG001|Overall Study|Protocol Violation|1|||
125918511|NCT03822182|452999555|FG002|Overall Study|Protocol Violation|1|||
125918512|NCT00810355|452999556|FG000|Overall Study|Lost to Follow-up|13|||
125918513|NCT00810355|452999557|FG001|Overall Study|Lost to Follow-up|17|||
125918514|NCT00810355|452999558|FG002|Overall Study|Lost to Follow-up|11|||
125918515|NCT00810355|452999556|FG000|Overall Study|Withdrawal by Subject|1|||
125918516|NCT00810355|452999557|FG001|Overall Study|Withdrawal by Subject|0|||
125918517|NCT00810355|452999558|FG002|Overall Study|Withdrawal by Subject|0|||
125918518|NCT01484275|452999559|FG000|Overall Study|Study terminated by sponsor|28|||
125918519|NCT01484275|452999560|FG001|Overall Study|Study terminated by sponsor|32|||
125918520|NCT01484275|452999559|FG000|Overall Study|Other|10|||
125918521|NCT01484275|452999560|FG001|Overall Study|Other|0|||
125918522|NCT01484275|452999559|FG000|Overall Study|Death|3|||
125918523|NCT01484275|452999560|FG001|Overall Study|Death|4|||
125918524|NCT01484275|452999559|FG000|Overall Study|Withdrawal by Subject|1|||
125918525|NCT01484275|452999560|FG001|Overall Study|Withdrawal by Subject|5|||
125918526|NCT01484275|452999559|FG000|Overall Study|Lost to Follow-up|1|||
125918527|NCT01484275|452999560|FG001|Overall Study|Lost to Follow-up|1|||
125918528|NCT00003487|452999561|FG000|Overall Study|Not evaluable|2|||
125918529|NCT04154930|452999564|FG000|Overall Study|Withdrawal by Subject|15|||
125918530|NCT04154930|452999565|FG001|Overall Study|Withdrawal by Subject|6|||
125918531|NCT04154930|452999564|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
125918532|NCT04154930|452999565|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
125918533|NCT04154930|452999564|FG000|Overall Study|Lost to Follow-up|14|||
125918534|NCT04154930|452999565|FG001|Overall Study|Lost to Follow-up|6|||
125918535|NCT04154930|452999564|FG000|Overall Study|Other|6|||
125918536|NCT04154930|452999565|FG001|Overall Study|Other|0|||
125918537|NCT03855228|452999569|FG000|Overall Study|Adverse Event|2|||
126064325|NCT03745651|453527706|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
126064326|NCT03745651|453527707|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126064327|NCT03745651|453527708|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126064328|NCT03745651|453527709|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126064329|NCT03745651|453527710|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126064330|NCT03745651|453527704|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125918538|NCT03855228|452999570|FG001|Overall Study|Adverse Event|4|||
125918539|NCT03855228|452999571|FG002|Overall Study|Adverse Event|4|||
125918540|NCT03855228|452999572|FG003|Overall Study|Adverse Event|8|||
125918541|NCT03855228|452999569|FG000|Overall Study|Treatment Failure|1|||
125918542|NCT03855228|452999570|FG001|Overall Study|Treatment Failure|2|||
125918543|NCT03855228|452999571|FG002|Overall Study|Treatment Failure|1|||
125918544|NCT03855228|452999572|FG003|Overall Study|Treatment Failure|8|||
125918545|NCT03855228|452999569|FG000|Overall Study|Lost to Follow-up|0|||
125918546|NCT03855228|452999570|FG001|Overall Study|Lost to Follow-up|0|||
125918547|NCT03855228|452999571|FG002|Overall Study|Lost to Follow-up|0|||
125918548|NCT03855228|452999572|FG003|Overall Study|Lost to Follow-up|1|||
125918549|NCT03855228|452999569|FG000|Overall Study|Protocol Violation|0|||
125918550|NCT03855228|452999570|FG001|Overall Study|Protocol Violation|1|||
125918551|NCT03855228|452999571|FG002|Overall Study|Protocol Violation|2|||
125918552|NCT03855228|452999572|FG003|Overall Study|Protocol Violation|1|||
125918553|NCT03855228|452999569|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
125918554|NCT03855228|452999570|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
125918555|NCT03855228|452999571|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
125918556|NCT03855228|452999572|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
125918557|NCT00843856|452999573|FG000|Overall Study|Lost to Follow-up|1|||
125918558|NCT00843856|452999574|FG001|Overall Study|Lost to Follow-up|2|||
125918559|NCT01893203|452999576|FG000|Overall Study|Withdrawal by Subject|1|||
125918560|NCT04729621|452999577|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
125918561|NCT04729621|452999578|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
125918562|NCT04729621|452999579|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
125918563|NCT04729621|452999580|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
125918564|NCT04729621|452999581|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
125918565|NCT04729621|452999577|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
125918566|NCT04729621|452999578|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
125918567|NCT04729621|452999579|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
125918568|NCT04729621|452999580|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
125918569|NCT04729621|452999581|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
125918570|NCT04729621|452999577|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
125918571|NCT04729621|452999578|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
125918572|NCT04729621|452999579|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
125918573|NCT04729621|452999580|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
125918574|NCT04729621|452999581|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
125918575|NCT04729621|452999577|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125918576|NCT04729621|452999578|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125918577|NCT04729621|452999579|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
125918578|NCT04729621|452999580|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
125918579|NCT04729621|452999581|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
125918580|NCT04729621|452999577|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
125918581|NCT04729621|452999578|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
125918582|NCT04729621|452999579|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
125918583|NCT04729621|452999580|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
125918584|NCT04729621|452999581|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
125918585|NCT04729621|452999577|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
125918586|NCT04729621|452999578|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
125918587|NCT04729621|452999579|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
125918588|NCT04729621|452999580|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
125918589|NCT04729621|452999581|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
125918590|NCT02130297|452999585|FG000|Overall Study|Lost to Follow-up|4|||
125918591|NCT01999868|452999595|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
125918592|NCT01999868|452999596|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
125918593|NCT01999868|452999597|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
125918594|NCT01999868|452999595|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
125918595|NCT01999868|452999596|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
125918596|NCT01999868|452999597|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
125918597|NCT01999868|452999595|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
125918598|NCT01999868|452999596|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
125918599|NCT01999868|452999597|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
125918600|NCT01999868|452999595|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
125918601|NCT01999868|452999596|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
125918602|NCT01999868|452999597|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
125918603|NCT01999868|452999595|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
125918604|NCT01999868|452999596|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
125918605|NCT01999868|452999597|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
125918606|NCT01999868|452999595|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
125918607|NCT01999868|452999596|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
125918608|NCT01999868|452999597|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
125918609|NCT01999868|452999595|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
125918610|NCT01999868|452999596|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
125918611|NCT01999868|452999597|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
125918612|NCT01999868|452999595|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
125918613|NCT01999868|452999596|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
125918614|NCT01999868|452999597|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
125918615|NCT01999868|452999595|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
125918616|NCT01999868|452999596|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
126064331|NCT03745651|453527705|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
126064332|NCT03745651|453527706|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126064333|NCT03745651|453527707|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126064334|NCT03745651|453527708|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126064335|NCT03745651|453527709|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126064336|NCT03745651|453527710|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125918617|NCT01999868|452999597|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
125918618|NCT01999868|452999595|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
125918619|NCT01999868|452999596|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
125918620|NCT01999868|452999597|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
125918621|NCT01999868|452999595|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
125918622|NCT01999868|452999596|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
125918623|NCT01999868|452999597|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
125918624|NCT01999868|452999595|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
125918625|NCT01999868|452999596|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
125918626|NCT01999868|452999597|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
125918627|NCT01999868|452999595|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
125918628|NCT01999868|452999596|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
125918629|NCT01999868|452999597|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
125918630|NCT01999868|452999595|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
125918631|NCT01999868|452999596|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
125918632|NCT01999868|452999597|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
125918633|NCT01999868|452999595|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
125918634|NCT01999868|452999596|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
125918635|NCT01999868|452999597|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
125918636|NCT00450255|452999603|FG000|Overall Study|Prior RFA ablation of liver|1|||
125918637|NCT01696071|452999604|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
125918638|NCT01696071|452999605|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
125918639|NCT00678080|452999611|FG000|Overall Study|Physician Decision|2|||
125918640|NCT00678080|452999612|FG001|Overall Study|Physician Decision|0|||
125918641|NCT00678080|452999611|FG000|Overall Study|Lost to Follow-up|1|||
125918642|NCT00678080|452999612|FG001|Overall Study|Lost to Follow-up|0|||
125918643|NCT00678080|452999611|FG000|Overall Study|Withdrawal by Subject|0|||
125918644|NCT00678080|452999612|FG001|Overall Study|Withdrawal by Subject|1|||
125918645|NCT01757535|452999613|FG000|Overall Study|Disease Relapse|151|||
125918646|NCT01757535|452999614|FG001|Overall Study|Disease Relapse|181|||
125918647|NCT01757535|452999613|FG000|Overall Study|Other Reasons|28|||
125918648|NCT01757535|452999614|FG001|Overall Study|Other Reasons|27|||
125918649|NCT01757535|452999613|FG000|Overall Study|Adverse Event|31|||
125918650|NCT01757535|452999614|FG001|Overall Study|Adverse Event|11|||
125918651|NCT01757535|452999613|FG000|Overall Study|Withdrew Consent|19|||
125918652|NCT01757535|452999614|FG001|Overall Study|Withdrew Consent|13|||
125918653|NCT01757535|452999613|FG000|Overall Study|Physician Decision|7|||
125918654|NCT01757535|452999614|FG001|Overall Study|Physician Decision|0|||
125918655|NCT01757535|452999613|FG000|Overall Study|Death|2|||
125918656|NCT01757535|452999614|FG001|Overall Study|Death|2|||
125918657|NCT03487549|452999615|FG000|Overall Study|Protocol Violation|0|||
125918658|NCT03487549|452999616|FG001|Overall Study|Protocol Violation|1|||
125918659|NCT03487549|452999615|FG000|Overall Study|Lost to Follow-up|2|||
125918660|NCT03487549|452999616|FG001|Overall Study|Lost to Follow-up|1|||
125918661|NCT03487549|452999615|FG000|Overall Study|Withdrawal by Subject|2|||
125918662|NCT03487549|452999616|FG001|Overall Study|Withdrawal by Subject|0|||
125918663|NCT03730012|452999617|FG000|Overall Study|Adverse Event|0|||
125918664|NCT03730012|452999618|FG001|Overall Study|Adverse Event|1|||
125918665|NCT03730012|452999617|FG000|Overall Study|Lack of Efficacy|1|||
125918666|NCT03730012|452999618|FG001|Overall Study|Lack of Efficacy|5|||
125918667|NCT03730012|452999617|FG000|Overall Study|Withdrawal by Subject|0|||
125918668|NCT03730012|452999618|FG001|Overall Study|Withdrawal by Subject|1|||
125918669|NCT03730012|452999617|FG000|Overall Study|Miscellaneous|2|||
125918670|NCT03730012|452999618|FG001|Overall Study|Miscellaneous|1|||
125918671|NCT05147428|452999619|FG000|Overall Study|Removed prior to mailing|289|||
125918672|NCT05147428|452999620|FG001|Overall Study|Removed prior to mailing|306|||
125918673|NCT05147428|452999621|FG002|Overall Study|Removed prior to mailing|270|||
125918674|NCT05147428|452999619|FG000|Overall Study|Died or disenrolled during blackout period|239|||
125918675|NCT05147428|452999620|FG001|Overall Study|Died or disenrolled during blackout period|278|||
125918676|NCT05147428|452999621|FG002|Overall Study|Died or disenrolled during blackout period|273|||
125918677|NCT03320057|453001512|FG000|Overall Study|Lost to Follow-up|4|||
125918678|NCT03320057|453001513|FG001|Overall Study|Lost to Follow-up|17|||
125918679|NCT03320057|453001512|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
125918680|NCT03320057|453001513|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
125918681|NCT01367002|453001516|FG000|Overall Study|Withdrawal by Subject|1|||
125918682|NCT01367002|453001517|FG001|Overall Study|Withdrawal by Subject|0|||
125918683|NCT01367002|453001516|FG000|Overall Study|Physician Decision|0|||
125918684|NCT01367002|453001517|FG001|Overall Study|Physician Decision|2|||
125918685|NCT00717093|453001519|FG000|Overall Study|Adverse Event|19|||
125918686|NCT00717093|453001520|FG001|Overall Study|Adverse Event|9|||
126110820|NCT01990534|453701888|FG000|Overall Study|Reason not Specified|2|||
126110821|NCT01990534|453701888|FG000|Overall Study|Lost to Follow-up|1|||
125918687|NCT00717093|453001519|FG000|Overall Study|Lack of Efficacy|3|||
125918688|NCT00717093|453001520|FG001|Overall Study|Lack of Efficacy|13|||
125918689|NCT00717093|453001519|FG000|Overall Study|Lost to Follow-up|9|||
125918690|NCT00717093|453001520|FG001|Overall Study|Lost to Follow-up|6|||
125918691|NCT00717093|453001519|FG000|Overall Study|Withdrawal by Subject|12|||
125918692|NCT00717093|453001520|FG001|Overall Study|Withdrawal by Subject|19|||
125918693|NCT00717093|453001519|FG000|Overall Study|Other|0|||
125918694|NCT00717093|453001520|FG001|Overall Study|Other|1|||
125918695|NCT00717093|453001519|FG000|Overall Study|Randomized but not treated|1|||
125918696|NCT00717093|453001520|FG001|Overall Study|Randomized but not treated|0|||
125918697|NCT01516437|453001521|FG000|Overall Study|Reason not specified|0|||
125918698|NCT01516437|453001522|FG001|Overall Study|Reason not specified|0|||
125918699|NCT01516437|453001523|FG002|Overall Study|Reason not specified|1|||
125918700|NCT01516437|453001524|FG003|Overall Study|Reason not specified|1|||
125918701|NCT00217620|453001525|FG000|Overall Study|Adverse Event|2|||
125918702|NCT00217620|453001525|FG000|Overall Study|Progression|31|||
125918703|NCT00217620|453001525|FG000|Overall Study|Not Protocol Specified|4|||
125918704|NCT00217620|453001525|FG000|Overall Study|Ineligible|13|||
125918705|NCT00217620|453001525|FG000|Overall Study|Never received treatment|1|||
125918706|NCT02468674|453001530|FG000|Overall Study|Adverse Event|0|||
125918707|NCT02468674|453001531|FG001|Overall Study|Adverse Event|0|||
125918708|NCT02468674|453001532|FG002|Overall Study|Adverse Event|0|||
125918709|NCT02468674|453001533|FG003|Overall Study|Adverse Event|1|||
125918710|NCT02468674|453001534|FG004|Overall Study|Adverse Event|0|||
125918711|NCT02468674|453001535|FG005|Overall Study|Adverse Event|1|||
125918712|NCT02468674|453001536|FG006|Overall Study|Adverse Event|0|||
125918713|NCT02468674|453001537|FG007|Overall Study|Adverse Event|0|||
125918714|NCT02468674|453001538|FG008|Overall Study|Adverse Event|0|||
125918715|NCT02468674|453001530|FG000|Overall Study|Lost to Follow-up|1|||
125918716|NCT02468674|453001531|FG001|Overall Study|Lost to Follow-up|0|||
125918717|NCT02468674|453001532|FG002|Overall Study|Lost to Follow-up|0|||
125918718|NCT02468674|453001533|FG003|Overall Study|Lost to Follow-up|0|||
125918719|NCT02468674|453001534|FG004|Overall Study|Lost to Follow-up|0|||
125918720|NCT02468674|453001535|FG005|Overall Study|Lost to Follow-up|0|||
125918721|NCT02468674|453001536|FG006|Overall Study|Lost to Follow-up|0|||
125918722|NCT02468674|453001537|FG007|Overall Study|Lost to Follow-up|1|||
125918723|NCT02468674|453001538|FG008|Overall Study|Lost to Follow-up|1|||
125918724|NCT02468674|453001530|FG000|Overall Study|Physician Decision|0|||
125918725|NCT02468674|453001531|FG001|Overall Study|Physician Decision|0|||
125918726|NCT02468674|453001532|FG002|Overall Study|Physician Decision|0|||
125918727|NCT02468674|453001533|FG003|Overall Study|Physician Decision|0|||
125918728|NCT02468674|453001534|FG004|Overall Study|Physician Decision|0|||
125918729|NCT02468674|453001535|FG005|Overall Study|Physician Decision|0|||
125918730|NCT02468674|453001536|FG006|Overall Study|Physician Decision|1|||
125918731|NCT02468674|453001537|FG007|Overall Study|Physician Decision|0|||
125918732|NCT02468674|453001538|FG008|Overall Study|Physician Decision|0|||
125918733|NCT02468674|453001530|FG000|Overall Study|Patient/Guardian Decision|0|||
125918734|NCT02468674|453001531|FG001|Overall Study|Patient/Guardian Decision|0|||
125918735|NCT02468674|453001532|FG002|Overall Study|Patient/Guardian Decision|0|||
125918736|NCT02468674|453001533|FG003|Overall Study|Patient/Guardian Decision|0|||
125918737|NCT02468674|453001534|FG004|Overall Study|Patient/Guardian Decision|1|||
125918738|NCT02468674|453001535|FG005|Overall Study|Patient/Guardian Decision|0|||
125918739|NCT02468674|453001536|FG006|Overall Study|Patient/Guardian Decision|0|||
125918740|NCT02468674|453001537|FG007|Overall Study|Patient/Guardian Decision|2|||
125918741|NCT02468674|453001538|FG008|Overall Study|Patient/Guardian Decision|1|||
125918742|NCT02468674|453001530|FG000|Overall Study|Protocol Deviation|0|||
125918743|NCT02468674|453001531|FG001|Overall Study|Protocol Deviation|0|||
125918744|NCT02468674|453001532|FG002|Overall Study|Protocol Deviation|0|||
125918745|NCT02468674|453001533|FG003|Overall Study|Protocol Deviation|0|||
125918746|NCT02468674|453001534|FG004|Overall Study|Protocol Deviation|0|||
125918747|NCT02468674|453001535|FG005|Overall Study|Protocol Deviation|0|||
125918748|NCT02468674|453001536|FG006|Overall Study|Protocol Deviation|0|||
125918749|NCT02468674|453001537|FG007|Overall Study|Protocol Deviation|1|||
125918750|NCT02468674|453001538|FG008|Overall Study|Protocol Deviation|1|||
125918751|NCT01897454|453001539|FG000|Overall Study|Withdrawal by Subject|1|||
125918752|NCT03689530|453001546|FG000|Overall Study|Withdrawal by Subject|53|||
125918753|NCT03689530|453001547|FG001|Overall Study|Withdrawal by Subject|16|||
125918754|NCT01392443|453001548|FG000|Overall Study|Disease progression|30|||
125918755|NCT01392443|453001548|FG000|Overall Study|Adverse Event|24|||
125918756|NCT01392443|453001548|FG000|Overall Study|Death|7|||
125918757|NCT01392443|453001548|FG000|Overall Study|Withdrawal by Subject|5|||
125918758|NCT01392443|453001548|FG000|Overall Study|Lost to Follow-up|1|||
125918759|NCT01392443|453001548|FG000|Overall Study|Protocol Violation|1|||
125918760|NCT01977794|453001551|FG000|Overall Study|Adverse Event|2|||
125918761|NCT01977794|453001552|FG001|Overall Study|Adverse Event|2|||
125918762|NCT01977794|453001551|FG000|Overall Study|Lost to Follow-up|2|||
125918763|NCT01977794|453001552|FG001|Overall Study|Lost to Follow-up|1|||
125918764|NCT01977794|453001551|FG000|Overall Study|Protocol Violation|1|||
125918765|NCT01977794|453001552|FG001|Overall Study|Protocol Violation|0|||
125918766|NCT01977794|453001551|FG000|Overall Study|Death|1|||
125918767|NCT01977794|453001552|FG001|Overall Study|Death|1|||
125918768|NCT01977794|453001551|FG000|Overall Study|Withdrew consent|2|||
125918769|NCT01977794|453001552|FG001|Overall Study|Withdrew consent|1|||
125918770|NCT01977794|453001551|FG000|Overall Study|Other|0|||
125918771|NCT01977794|453001552|FG001|Overall Study|Other|1|||
125918772|NCT00533897|453001555|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
125918773|NCT00533897|453001556|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
125918774|NCT00533897|453001557|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
125918775|NCT00533897|453001558|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
125918776|NCT00533897|453001559|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
125918777|NCT00533897|453001560|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
125918778|NCT00533897|453001561|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
125918779|NCT00533897|453001562|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
125918780|NCT00533897|453001555|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
125918781|NCT00533897|453001556|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125918782|NCT00533897|453001557|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125918783|NCT00533897|453001558|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125918784|NCT00533897|453001559|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125918785|NCT00533897|453001560|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125918786|NCT00533897|453001561|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125918787|NCT00533897|453001562|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125918788|NCT00533897|453001555|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
125918789|NCT00533897|453001556|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125918790|NCT00533897|453001557|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125918791|NCT00533897|453001558|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125918792|NCT00533897|453001559|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125918793|NCT00533897|453001560|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125918794|NCT00533897|453001561|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125918795|NCT00533897|453001562|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125918796|NCT00533897|453001555|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
125918797|NCT00533897|453001556|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125918798|NCT00533897|453001557|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125918799|NCT00533897|453001558|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125918800|NCT00533897|453001559|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125918801|NCT00533897|453001560|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125918802|NCT00533897|453001561|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125918803|NCT00533897|453001562|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125918804|NCT00533897|453001555|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
125918805|NCT00533897|453001556|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125918806|NCT00533897|453001557|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125918807|NCT00533897|453001558|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125918808|NCT00533897|453001559|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125918809|NCT00533897|453001560|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125918810|NCT00533897|453001561|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125918811|NCT00533897|453001562|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125918812|NCT00533897|453001555|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
125918813|NCT00533897|453001556|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125918814|NCT00533897|453001557|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125918815|NCT00533897|453001558|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125918816|NCT00533897|453001559|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125918817|NCT00533897|453001560|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125918818|NCT00533897|453001561|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125918819|NCT00533897|453001562|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125918820|NCT00533897|453001555|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125918821|NCT00533897|453001556|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
125918822|NCT00533897|453001557|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
125918823|NCT00533897|453001558|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125918824|NCT00533897|453001559|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125918825|NCT00533897|453001560|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125918826|NCT00533897|453001561|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125918827|NCT00533897|453001562|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125918828|NCT00533897|453001555|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125918829|NCT00533897|453001556|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125918830|NCT00533897|453001557|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
125918831|NCT00533897|453001558|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125918832|NCT00533897|453001559|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125918833|NCT00533897|453001560|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125918834|NCT00533897|453001561|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125918835|NCT00533897|453001562|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125918836|NCT00533897|453001555|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125918837|NCT00533897|453001556|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125918838|NCT00533897|453001557|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125918839|NCT00533897|453001558|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125918840|NCT00533897|453001559|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125918841|NCT00533897|453001560|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
125918842|NCT00533897|453001561|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125918843|NCT00533897|453001562|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125918844|NCT00533897|453001555|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125918845|NCT00533897|453001556|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125918846|NCT00533897|453001557|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125918847|NCT00533897|453001558|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125918848|NCT00533897|453001559|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125918849|NCT00533897|453001560|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
125918850|NCT00533897|453001561|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125918851|NCT00533897|453001562|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125918852|NCT00533897|453001555|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125918853|NCT00533897|453001556|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125918854|NCT00533897|453001557|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125918855|NCT00533897|453001558|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125918856|NCT00533897|453001559|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125918857|NCT00533897|453001560|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125918858|NCT00533897|453001561|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
125918859|NCT00533897|453001562|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
125918860|NCT00533897|453001555|FG000|Long Term Extension (LTE)|Death|0|||
125918861|NCT00533897|453001556|FG001|Long Term Extension (LTE)|Death|0|||
125918862|NCT00533897|453001557|FG002|Long Term Extension (LTE)|Death|0|||
125918863|NCT00533897|453001558|FG003|Long Term Extension (LTE)|Death|0|||
125918864|NCT00533897|453001559|FG004|Long Term Extension (LTE)|Death|0|||
125918865|NCT00533897|453001560|FG005|Long Term Extension (LTE)|Death|0|||
125918866|NCT00533897|453001561|FG006|Long Term Extension (LTE)|Death|1|||
125918867|NCT00533897|453001562|FG007|Long Term Extension (LTE)|Death|3|||
125918868|NCT00533897|453001555|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
125918869|NCT00533897|453001556|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
125918870|NCT00533897|453001557|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
125918871|NCT00533897|453001558|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
125918872|NCT00533897|453001559|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
125918873|NCT00533897|453001560|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
125918874|NCT00533897|453001561|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
125918875|NCT00533897|453001562|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
125918876|NCT00533897|453001555|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125918877|NCT00533897|453001556|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125918878|NCT00533897|453001557|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125918879|NCT00533897|453001558|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125918880|NCT00533897|453001559|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125918881|NCT00533897|453001560|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125918882|NCT00533897|453001561|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
125918883|NCT00533897|453001562|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125918884|NCT00533897|453001555|FG000|Long Term Extension (LTE)|Adverse Event|0|||
125918885|NCT00533897|453001556|FG001|Long Term Extension (LTE)|Adverse Event|0|||
125918886|NCT00533897|453001557|FG002|Long Term Extension (LTE)|Adverse Event|0|||
125918887|NCT00533897|453001558|FG003|Long Term Extension (LTE)|Adverse Event|0|||
125918888|NCT00533897|453001559|FG004|Long Term Extension (LTE)|Adverse Event|0|||
125918889|NCT00533897|453001560|FG005|Long Term Extension (LTE)|Adverse Event|0|||
125918890|NCT00533897|453001561|FG006|Long Term Extension (LTE)|Adverse Event|2|||
125918891|NCT00533897|453001562|FG007|Long Term Extension (LTE)|Adverse Event|5|||
125918892|NCT00533897|453001555|FG000|Long Term Extension (LTE)|Pregnancy|0|||
125918893|NCT00533897|453001556|FG001|Long Term Extension (LTE)|Pregnancy|0|||
125918894|NCT00533897|453001557|FG002|Long Term Extension (LTE)|Pregnancy|0|||
125918895|NCT00533897|453001558|FG003|Long Term Extension (LTE)|Pregnancy|0|||
125918896|NCT00533897|453001559|FG004|Long Term Extension (LTE)|Pregnancy|0|||
125918897|NCT00533897|453001560|FG005|Long Term Extension (LTE)|Pregnancy|0|||
125918898|NCT00533897|453001561|FG006|Long Term Extension (LTE)|Pregnancy|0|||
125918899|NCT00533897|453001562|FG007|Long Term Extension (LTE)|Pregnancy|2|||
125918900|NCT00533897|453001555|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
125918901|NCT00533897|453001556|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
125918902|NCT00533897|453001557|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
125918903|NCT00533897|453001558|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
125918904|NCT00533897|453001559|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
126110822|NCT00234494|453701889|FG000|Overall Study|Protocol Violation|2|||
125918905|NCT00533897|453001560|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
125918906|NCT00533897|453001561|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
125918907|NCT00533897|453001562|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
125918908|NCT00533897|453001555|FG000|Long Term Extension (LTE)|Other|0|||
125918909|NCT00533897|453001556|FG001|Long Term Extension (LTE)|Other|0|||
125918910|NCT00533897|453001557|FG002|Long Term Extension (LTE)|Other|0|||
125918911|NCT00533897|453001558|FG003|Long Term Extension (LTE)|Other|0|||
125918912|NCT00533897|453001559|FG004|Long Term Extension (LTE)|Other|0|||
125918913|NCT00533897|453001560|FG005|Long Term Extension (LTE)|Other|0|||
125918914|NCT00533897|453001561|FG006|Long Term Extension (LTE)|Other|1|||
125918915|NCT00533897|453001562|FG007|Long Term Extension (LTE)|Other|6|||
125918916|NCT02555683|453001563|FG000|Overall Study|Physician Decision|1|||
125918917|NCT02555683|453001564|FG001|Overall Study|Physician Decision|0|||
125918918|NCT02555683|453001565|FG002|Overall Study|Physician Decision|2|||
125918919|NCT02555683|453001563|FG000|Overall Study|Lost to Follow-up|2|||
125918920|NCT02555683|453001564|FG001|Overall Study|Lost to Follow-up|1|||
125918921|NCT02555683|453001565|FG002|Overall Study|Lost to Follow-up|2|||
125918922|NCT02555683|453001563|FG000|Overall Study|Technical Problems|1|||
125918923|NCT02555683|453001564|FG001|Overall Study|Technical Problems|1|||
125918924|NCT02555683|453001565|FG002|Overall Study|Technical Problems|0|||
125918925|NCT02555683|453001563|FG000|Overall Study|Protocol deviation|0|||
125918926|NCT02555683|453001564|FG001|Overall Study|Protocol deviation|1|||
125918927|NCT02555683|453001565|FG002|Overall Study|Protocol deviation|0|||
125918928|NCT02555683|453001563|FG000|Overall Study|Lack of Efficacy|2|||
125918929|NCT02555683|453001564|FG001|Overall Study|Lack of Efficacy|0|||
125918930|NCT02555683|453001565|FG002|Overall Study|Lack of Efficacy|0|||
125918931|NCT02555683|453001563|FG000|Overall Study|Death|0|||
125918932|NCT02555683|453001564|FG001|Overall Study|Death|1|||
125918933|NCT02555683|453001565|FG002|Overall Study|Death|2|||
125918934|NCT02555683|453001563|FG000|Overall Study|Adverse Event|1|||
125918935|NCT02555683|453001564|FG001|Overall Study|Adverse Event|0|||
125918936|NCT02555683|453001565|FG002|Overall Study|Adverse Event|1|||
125918937|NCT02555683|453001563|FG000|Overall Study|Subject/guardian decision|12|||
125918938|NCT02555683|453001564|FG001|Overall Study|Subject/guardian decision|12|||
125918939|NCT02555683|453001565|FG002|Overall Study|Subject/guardian decision|22|||
125918940|NCT02555683|453001563|FG000|Overall Study|Death post Treatment/safety period|0|||
125918941|NCT02555683|453001564|FG001|Overall Study|Death post Treatment/safety period|1|||
125918942|NCT02555683|453001565|FG002|Overall Study|Death post Treatment/safety period|0|||
125918943|NCT05074667|453001566|FG000|Overall Study|Death|1|||
125918944|NCT05074667|453001566|FG000|Overall Study|Withdrawal by Subject|4|||
125918945|NCT05074667|453001566|FG000|Overall Study|Lost to Follow-up|10|||
125918946|NCT01826604|453001568|FG000|Overall Study|Lost to Follow-up|8|||
125918947|NCT01826604|453001569|FG001|Overall Study|Lost to Follow-up|9|||
125918948|NCT00491075|453001570|FG000|Overall Study|Withdrawal by Subject|1|||
125918949|NCT00491075|453001570|FG000|Overall Study|Physician Decision|1|||
125918950|NCT00827502|453001571|FG000|Overall Study|randomized but not treated|11|||
125918951|NCT00827502|453001571|FG000|Overall Study|Adverse Event|1|||
125918952|NCT00827502|453001571|FG000|Overall Study|Lost to Follow-up|4|||
125918953|NCT00827502|453001571|FG000|Overall Study|Withdrawal by Subject|5|||
125918954|NCT01705730|453001572|FG000|Overall Study|Lack of Efficacy|1|||
125918955|NCT01705730|453001572|FG000|Overall Study|Adverse Event|3|||
125918956|NCT01705730|453001572|FG000|Overall Study|Lost to Follow-up|1|||
125918957|NCT01705730|453001572|FG000|Overall Study|Reason not Specified|4|||
125918958|NCT03228433|453001573|FG000|Overall Study|Lost to Follow-up|1|||
125918959|NCT03228433|453001574|FG001|Overall Study|Lost to Follow-up|0|||
125918960|NCT03228433|453001575|FG002|Overall Study|Lost to Follow-up|0|||
125918961|NCT03228433|453001576|FG003|Overall Study|Lost to Follow-up|0|||
125918962|NCT03228433|453001577|FG004|Overall Study|Lost to Follow-up|0|||
125918963|NCT03228433|453001578|FG005|Overall Study|Lost to Follow-up|0|||
125918964|NCT03228433|453001573|FG000|Overall Study|Positive alcohol test|0|||
125918965|NCT03228433|453001574|FG001|Overall Study|Positive alcohol test|0|||
125918966|NCT03228433|453001575|FG002|Overall Study|Positive alcohol test|0|||
125918967|NCT03228433|453001576|FG003|Overall Study|Positive alcohol test|1|||
125918968|NCT03228433|453001577|FG004|Overall Study|Positive alcohol test|0|||
125918969|NCT03228433|453001578|FG005|Overall Study|Positive alcohol test|0|||
125918970|NCT01773733|453001579|FG000|Overall Study|Adverse Event|3286|||
125918971|NCT01773733|453001580|FG001|Overall Study|Adverse Event|540|||
125918972|NCT01773733|453001579|FG000|Overall Study|Pregnancy|28|||
125918973|NCT01773733|453001580|FG001|Overall Study|Pregnancy|0|||
125918974|NCT01773733|453001579|FG000|Overall Study|Other different categories of not compl|55415|||
125918975|NCT01773733|453001580|FG001|Overall Study|Other different categories of not compl|7781|||
125918976|NCT01030536|453001583|FG000|Overall Study|Withdrawal by Subject|0|||
125918977|NCT01030536|453001584|FG001|Overall Study|Withdrawal by Subject|0|||
125918978|NCT01030536|453001585|FG002|Overall Study|Withdrawal by Subject|1|||
125918979|NCT01030536|453001586|FG003|Overall Study|Withdrawal by Subject|0|||
125918980|NCT01030536|453001587|FG004|Overall Study|Withdrawal by Subject|0|||
125918981|NCT01030536|453001583|FG000|Overall Study|undefined|1|||
125918982|NCT01030536|453001584|FG001|Overall Study|undefined|0|||
125918983|NCT01030536|453001585|FG002|Overall Study|undefined|1|||
125918984|NCT01030536|453001586|FG003|Overall Study|undefined|1|||
125918985|NCT01030536|453001587|FG004|Overall Study|undefined|0|||
125918986|NCT01030536|453001583|FG000|Overall Study|Adverse Event|0|||
125918987|NCT01030536|453001584|FG001|Overall Study|Adverse Event|3|||
125918988|NCT01030536|453001585|FG002|Overall Study|Adverse Event|1|||
125918989|NCT01030536|453001586|FG003|Overall Study|Adverse Event|0|||
125918990|NCT01030536|453001587|FG004|Overall Study|Adverse Event|1|||
125918991|NCT01030536|453001583|FG000|Overall Study|Progressive disease|6|||
125918992|NCT01030536|453001584|FG001|Overall Study|Progressive disease|2|||
125918993|NCT01030536|453001585|FG002|Overall Study|Progressive disease|3|||
125918994|NCT01030536|453001586|FG003|Overall Study|Progressive disease|2|||
125918995|NCT01030536|453001587|FG004|Overall Study|Progressive disease|0|||
125918996|NCT01030536|453001583|FG000|Overall Study|Death|0|||
125918997|NCT01030536|453001584|FG001|Overall Study|Death|1|||
125918998|NCT01030536|453001585|FG002|Overall Study|Death|0|||
125918999|NCT01030536|453001586|FG003|Overall Study|Death|0|||
125919000|NCT01030536|453001587|FG004|Overall Study|Death|0|||
125919001|NCT01330030|453001590|FG000|Overall Study|Lost to Follow-up|16|||
125919002|NCT01330030|453001591|FG001|Overall Study|Lost to Follow-up|17|||
125919003|NCT01146912|453001592|FG000|Overall Study|Already received influenza vaccination|817|||
125919004|NCT01146912|453001593|FG001|Overall Study|Already received influenza vaccination|822|||
125919005|NCT01146912|453001594|FG002|Overall Study|Already received influenza vaccination|13|||
125919006|NCT01146912|453001595|FG003|Overall Study|Already received influenza vaccination|15|||
125919007|NCT01146912|453001596|FG004|Overall Study|Already received influenza vaccination|41|||
125919008|NCT01146912|453001597|FG005|Overall Study|Already received influenza vaccination|61|||
125919009|NCT01146912|453001598|FG006|Overall Study|Already received influenza vaccination|56|||
125919010|NCT01146912|453001599|FG007|Overall Study|Already received influenza vaccination|0|||
125919011|NCT01146912|453001592|FG000|Overall Study|< 14 weeks gestational age|0|||
125919012|NCT01146912|453001593|FG001|Overall Study|< 14 weeks gestational age|0|||
125919013|NCT01146912|453001594|FG002|Overall Study|< 14 weeks gestational age|3|||
125919014|NCT01146912|453001595|FG003|Overall Study|< 14 weeks gestational age|2|||
125919015|NCT01146912|453001596|FG004|Overall Study|< 14 weeks gestational age|0|||
125919016|NCT01146912|453001597|FG005|Overall Study|< 14 weeks gestational age|0|||
125919017|NCT01146912|453001598|FG006|Overall Study|< 14 weeks gestational age|0|||
125919018|NCT01146912|453001599|FG007|Overall Study|< 14 weeks gestational age|0|||
125919019|NCT01146912|453001592|FG000|Overall Study|Duplicate patient|0|||
125919020|NCT01146912|453001593|FG001|Overall Study|Duplicate patient|0|||
125919021|NCT01146912|453001594|FG002|Overall Study|Duplicate patient|1|||
125919022|NCT01146912|453001595|FG003|Overall Study|Duplicate patient|0|||
125919023|NCT01146912|453001596|FG004|Overall Study|Duplicate patient|0|||
125919024|NCT01146912|453001597|FG005|Overall Study|Duplicate patient|0|||
125919025|NCT01146912|453001598|FG006|Overall Study|Duplicate patient|0|||
125919026|NCT01146912|453001599|FG007|Overall Study|Duplicate patient|0|||
125919027|NCT04891978|453001605|FG000|Baseline|Protocol Violation|2|||
125919028|NCT04891978|453001606|FG001|Baseline|Protocol Violation|1|||
125919029|NCT04891978|453001607|FG002|Baseline|Protocol Violation|0|||
125919030|NCT04891978|453001605|FG000|Baseline|Missing AIRQ|1|||
125919031|NCT04891978|453001606|FG001|Baseline|Missing AIRQ|0|||
125919032|NCT04891978|453001607|FG002|Baseline|Missing AIRQ|0|||
125919033|NCT04891978|453001605|FG000|Baseline|Did not attend a baseline visit|0|||
125919034|NCT04891978|453001606|FG001|Baseline|Did not attend a baseline visit|0|||
125919035|NCT04891978|453001607|FG002|Baseline|Did not attend a baseline visit|9|||
125919036|NCT01781975|453001613|FG000|Overall Study|Death|1|||
125919037|NCT01781975|453001614|FG001|Overall Study|Death|0|||
125919038|NCT01781975|453001613|FG000|Overall Study|Withdrawal by Subject|1|||
125919039|NCT01781975|453001614|FG001|Overall Study|Withdrawal by Subject|1|||
125919040|NCT01622231|453001615|FG000|Overall Study|Physician Decision|1|||
125919041|NCT01622231|453001615|FG000|Overall Study|Withdrawal by Subject|1|||
125919042|NCT02589405|453001617|FG000|Overall Study|Adverse Event|3|||
125919043|NCT02589405|453001617|FG000|Overall Study|Withdrawal by Subject|1|||
125919044|NCT02905149|453001619|FG000|Overall Study|Lost to Follow-up|2|||
125919045|NCT02905149|453001620|FG001|Overall Study|Lost to Follow-up|0|||
125919046|NCT02264639|453001622|FG000|Overall Study|Death (after completing single-dose phase)|1|||
125919047|NCT02264639|453001623|FG001|Overall Study|Death (after completing single-dose phase)|0|||
125919048|NCT02264639|453001624|FG002|Overall Study|Death (after completing single-dose phase)|0|||
125919049|NCT02264639|453001625|FG003|Overall Study|Death (after completing single-dose phase)|0|||
125919050|NCT02264639|453001626|FG004|Overall Study|Death (after completing single-dose phase)|0|||
125919051|NCT02264639|453001622|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
125919052|NCT02264639|453001623|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
125919053|NCT02264639|453001624|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
125919054|NCT02264639|453001625|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
125919055|NCT02264639|453001626|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
125919056|NCT02264639|453001622|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
125919057|NCT02264639|453001623|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
125919058|NCT02264639|453001624|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
126110823|NCT01521897|453701896|FG000|Overall Study|Protocol Violation|18|||
125919059|NCT02264639|453001625|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
125919060|NCT02264639|453001626|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
125919061|NCT02264639|453001622|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
125919062|NCT02264639|453001623|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
125919063|NCT02264639|453001624|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
125919064|NCT02264639|453001625|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
125919065|NCT02264639|453001626|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
125919066|NCT00839852|453001627|FG000|Overall Study|Adverse Event|10|||
125919067|NCT00839852|453001627|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125919068|NCT00839852|453001627|FG000|Overall Study|Protocol Violation|9|||
125919069|NCT00839852|453001627|FG000|Overall Study|Withdrawal of Consent|16|||
125919070|NCT00839852|453001627|FG000|Overall Study|Lost to Follow-up|7|||
125919071|NCT00839852|453001627|FG000|Overall Study|Lack of Compliance While in Jail|1|||
125919072|NCT00839852|453001627|FG000|Overall Study|Pregnancy|1|||
125919073|NCT02761733|453001628|FG000|Overall Study|Death|3|||
125919074|NCT02761733|453001629|FG001|Overall Study|Death|5|||
125919075|NCT02761733|453001630|FG002|Overall Study|Death|1|||
125919076|NCT02761733|453001631|FG003|Overall Study|Death|1|||
125919077|NCT02761733|453001628|FG000|Overall Study|Lost to Follow-up|6|||
125919078|NCT02761733|453001629|FG001|Overall Study|Lost to Follow-up|7|||
125919079|NCT02761733|453001630|FG002|Overall Study|Lost to Follow-up|0|||
125919080|NCT02761733|453001631|FG003|Overall Study|Lost to Follow-up|3|||
125919081|NCT02761733|453001628|FG000|Overall Study|Physician Decision|4|||
125919082|NCT02761733|453001629|FG001|Overall Study|Physician Decision|0|||
125919083|NCT02761733|453001630|FG002|Overall Study|Physician Decision|0|||
125919084|NCT02761733|453001631|FG003|Overall Study|Physician Decision|0|||
125919085|NCT02761733|453001628|FG000|Overall Study|Withdrawal by Subject|2|||
125919086|NCT02761733|453001629|FG001|Overall Study|Withdrawal by Subject|0|||
125919087|NCT02761733|453001630|FG002|Overall Study|Withdrawal by Subject|0|||
125919088|NCT02761733|453001631|FG003|Overall Study|Withdrawal by Subject|0|||
125919089|NCT02761733|453001628|FG000|Overall Study|Discharged from Study Site|10|||
125919090|NCT02761733|453001629|FG001|Overall Study|Discharged from Study Site|9|||
125919091|NCT02761733|453001630|FG002|Overall Study|Discharged from Study Site|25|||
125919092|NCT02761733|453001631|FG003|Overall Study|Discharged from Study Site|11|||
125919093|NCT02761733|453001628|FG000|Overall Study|Cognitive Impairment|5|||
125919094|NCT02761733|453001629|FG001|Overall Study|Cognitive Impairment|0|||
125919095|NCT02761733|453001630|FG002|Overall Study|Cognitive Impairment|1|||
125919096|NCT02761733|453001631|FG003|Overall Study|Cognitive Impairment|0|||
125919097|NCT04295772|453001634|FG000|Overall Study|Protocol Violation|1|||
125919098|NCT04295772|453001635|FG001|Overall Study|Protocol Violation|0|||
125919099|NCT04295772|453001634|FG000|Overall Study|Ongoing for safety monitoring|14|||
125919100|NCT04295772|453001635|FG001|Overall Study|Ongoing for safety monitoring|1|||
125919101|NCT04295772|453001634|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
125919102|NCT04295772|453001635|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
125919103|NCT02716805|453001636|FG000|Overall Study|Progressive disease|2|||
125919104|NCT02716805|453001637|FG001|Overall Study|Progressive disease|0|||
125919105|NCT02716805|453001638|FG002|Overall Study|Progressive disease|0|||
125919106|NCT02716805|453001639|FG003|Overall Study|Progressive disease|0|||
125919107|NCT03576495|453001649|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
125919108|NCT03576495|453001650|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
125919109|NCT02635776|453001651|FG000|Overall Study|Physician Decision|1|||
125919110|NCT02635776|453001652|FG001|Overall Study|Physician Decision|0|||
125919111|NCT02635776|453001651|FG000|Overall Study|Adverse Event|51|||
125919112|NCT02635776|453001652|FG001|Overall Study|Adverse Event|3|||
125919113|NCT02635776|453001651|FG000|Overall Study|Withdrawal by Subject|41|||
125919114|NCT02635776|453001652|FG001|Overall Study|Withdrawal by Subject|7|||
125919115|NCT02635776|453001651|FG000|Overall Study|Lost to Follow-up|4|||
125919116|NCT02635776|453001652|FG001|Overall Study|Lost to Follow-up|0|||
125919117|NCT02635776|453001651|FG000|Overall Study|Other reasons|5|||
125919118|NCT02635776|453001652|FG001|Overall Study|Other reasons|1|||
125919119|NCT00660673|453001654|FG000|Overall Study|Adverse Event|84|||
125919120|NCT00660673|453001654|FG000|Overall Study|Lack of Efficacy|7|||
125919121|NCT00660673|453001654|FG000|Overall Study|Withdrawal by Subject|22|||
125919122|NCT00660673|453001654|FG000|Overall Study|Administrative|2|||
125919123|NCT00660673|453001654|FG000|Overall Study|Protocol Violation|2|||
125919124|NCT03208127|453001655|FG000|Overall Study|Death|1|||
125919125|NCT00579098|453001656|FG000|Overall Study|Lost to Follow-up|2|||
125919126|NCT00579098|453001657|FG001|Overall Study|Lost to Follow-up|0|||
125919127|NCT00579098|453001656|FG000|Overall Study|Adverse Event|2|||
125919128|NCT00579098|453001657|FG001|Overall Study|Adverse Event|3|||
125919129|NCT00579098|453001656|FG000|Overall Study|Withdrawal by Subject|2|||
125919130|NCT00579098|453001657|FG001|Overall Study|Withdrawal by Subject|3|||
125919131|NCT00579098|453001656|FG000|Overall Study|AF returned after ablation|3|||
125919132|NCT00579098|453001657|FG001|Overall Study|AF returned after ablation|2|||
125919133|NCT02121522|453001662|FG000|Overall Study|Adverse Event|1|||
125919134|NCT01903031|453001664|FG000|Overall Study|Not Able to Attend Clinic|1|||
125919135|NCT01903031|453001665|FG001|Overall Study|Not Able to Attend Clinic|1|||
125919136|NCT01903031|453001666|FG002|Overall Study|Not Able to Attend Clinic|0|||
125919137|NCT01903031|453001664|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
125919138|NCT01903031|453001665|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
125919139|NCT01903031|453001666|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
125919140|NCT01903031|453001664|FG000|Overall Study|Adverse Event|0|||
125919141|NCT01903031|453001665|FG001|Overall Study|Adverse Event|1|||
125919142|NCT01903031|453001666|FG002|Overall Study|Adverse Event|0|||
125919143|NCT01903031|453001664|FG000|Overall Study|Withdrawal by Subject|0|||
125919144|NCT01903031|453001665|FG001|Overall Study|Withdrawal by Subject|1|||
125919145|NCT01903031|453001666|FG002|Overall Study|Withdrawal by Subject|1|||
125919146|NCT01903031|453001664|FG000|Overall Study|Protocol Violation|0|||
125919147|NCT01903031|453001665|FG001|Overall Study|Protocol Violation|0|||
125919148|NCT01903031|453001666|FG002|Overall Study|Protocol Violation|2|||
125919149|NCT01903031|453001664|FG000|Overall Study|Lost to Follow-up|0|||
125919150|NCT01903031|453001665|FG001|Overall Study|Lost to Follow-up|0|||
125919151|NCT01903031|453001666|FG002|Overall Study|Lost to Follow-up|1|||
125919152|NCT01903031|453001664|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
125919153|NCT01903031|453001665|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
125919154|NCT01903031|453001666|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
125919155|NCT03540030|453001667|FG000|Overall Study|Withdrawal by Subject|2|||
125919156|NCT03540030|453001668|FG001|Overall Study|Withdrawal by Subject|1|||
125919157|NCT03540030|453001667|FG000|Overall Study|screen fail|7|||
125919158|NCT03540030|453001668|FG001|Overall Study|screen fail|1|||
125919159|NCT03540030|453001667|FG000|Overall Study|never had surgery after signing consent|9|||
125919160|NCT03540030|453001668|FG001|Overall Study|never had surgery after signing consent|1|||
125919161|NCT00347360|453001675|FG000|Overall Study|Adverse Event|1|||
125919162|NCT00347360|453001676|FG001|Overall Study|Adverse Event|2|||
125919163|NCT00347360|453001677|FG002|Overall Study|Adverse Event|0|||
125919164|NCT00347360|453001678|FG003|Overall Study|Adverse Event|4|||
125919165|NCT00347360|453001679|FG004|Overall Study|Adverse Event|1|||
125919166|NCT00347360|453001680|FG005|Overall Study|Adverse Event|2|||
125919167|NCT00347360|453001681|FG006|Overall Study|Adverse Event|2|||
125919168|NCT00347360|453001682|FG007|Overall Study|Adverse Event|0|||
125919169|NCT00347360|453001683|FG008|Overall Study|Adverse Event|2|||
125919170|NCT00347360|453001684|FG009|Overall Study|Adverse Event|3|||
125919171|NCT00347360|453001685|FG010|Overall Study|Adverse Event|3|||
126110824|NCT01521897|453701896|FG000|Overall Study|Lost to Follow-up|5|||
126110825|NCT03308942|453701903|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
125919172|NCT00347360|453001686|FG011|Overall Study|Adverse Event|1|||
125919173|NCT00347360|453001687|FG012|Overall Study|Adverse Event|3|||
125919174|NCT00347360|453001688|FG013|Overall Study|Adverse Event|2|||
125919175|NCT00347360|453001689|FG014|Overall Study|Adverse Event|2|||
125919176|NCT00347360|453001675|FG000|Overall Study|Lost to Follow-up|0|||
125919177|NCT00347360|453001676|FG001|Overall Study|Lost to Follow-up|0|||
125919178|NCT00347360|453001677|FG002|Overall Study|Lost to Follow-up|0|||
125919179|NCT00347360|453001678|FG003|Overall Study|Lost to Follow-up|2|||
125919180|NCT00347360|453001679|FG004|Overall Study|Lost to Follow-up|1|||
125919181|NCT00347360|453001680|FG005|Overall Study|Lost to Follow-up|1|||
125919182|NCT00347360|453001681|FG006|Overall Study|Lost to Follow-up|0|||
125919183|NCT00347360|453001682|FG007|Overall Study|Lost to Follow-up|1|||
125919184|NCT00347360|453001683|FG008|Overall Study|Lost to Follow-up|1|||
125919185|NCT00347360|453001684|FG009|Overall Study|Lost to Follow-up|2|||
125919186|NCT00347360|453001685|FG010|Overall Study|Lost to Follow-up|0|||
125919187|NCT00347360|453001686|FG011|Overall Study|Lost to Follow-up|0|||
125919188|NCT00347360|453001687|FG012|Overall Study|Lost to Follow-up|1|||
125919189|NCT00347360|453001688|FG013|Overall Study|Lost to Follow-up|0|||
125919190|NCT00347360|453001689|FG014|Overall Study|Lost to Follow-up|0|||
125919191|NCT00347360|453001675|FG000|Overall Study|Protocol Violation|2|||
125919192|NCT00347360|453001676|FG001|Overall Study|Protocol Violation|3|||
125919193|NCT00347360|453001677|FG002|Overall Study|Protocol Violation|1|||
125919194|NCT00347360|453001678|FG003|Overall Study|Protocol Violation|2|||
125919195|NCT00347360|453001679|FG004|Overall Study|Protocol Violation|1|||
125919196|NCT00347360|453001680|FG005|Overall Study|Protocol Violation|2|||
125919197|NCT00347360|453001681|FG006|Overall Study|Protocol Violation|0|||
125919198|NCT00347360|453001682|FG007|Overall Study|Protocol Violation|0|||
125919199|NCT00347360|453001683|FG008|Overall Study|Protocol Violation|1|||
125919200|NCT00347360|453001684|FG009|Overall Study|Protocol Violation|2|||
125919201|NCT00347360|453001685|FG010|Overall Study|Protocol Violation|0|||
125919202|NCT00347360|453001686|FG011|Overall Study|Protocol Violation|0|||
125919203|NCT00347360|453001687|FG012|Overall Study|Protocol Violation|0|||
125919204|NCT00347360|453001688|FG013|Overall Study|Protocol Violation|1|||
125919205|NCT00347360|453001689|FG014|Overall Study|Protocol Violation|0|||
125919206|NCT00347360|453001675|FG000|Overall Study|Withdrawal by Subject|0|||
125919207|NCT00347360|453001676|FG001|Overall Study|Withdrawal by Subject|1|||
125919208|NCT00347360|453001677|FG002|Overall Study|Withdrawal by Subject|2|||
125919209|NCT00347360|453001678|FG003|Overall Study|Withdrawal by Subject|4|||
125919210|NCT00347360|453001679|FG004|Overall Study|Withdrawal by Subject|1|||
125919211|NCT00347360|453001680|FG005|Overall Study|Withdrawal by Subject|2|||
125919212|NCT00347360|453001681|FG006|Overall Study|Withdrawal by Subject|1|||
125919213|NCT00347360|453001682|FG007|Overall Study|Withdrawal by Subject|1|||
125919214|NCT00347360|453001683|FG008|Overall Study|Withdrawal by Subject|1|||
125919215|NCT00347360|453001684|FG009|Overall Study|Withdrawal by Subject|1|||
125919216|NCT00347360|453001685|FG010|Overall Study|Withdrawal by Subject|0|||
125919217|NCT00347360|453001686|FG011|Overall Study|Withdrawal by Subject|3|||
125919218|NCT00347360|453001687|FG012|Overall Study|Withdrawal by Subject|4|||
125919219|NCT00347360|453001688|FG013|Overall Study|Withdrawal by Subject|2|||
125919220|NCT00347360|453001689|FG014|Overall Study|Withdrawal by Subject|1|||
125919221|NCT00347360|453001675|FG000|Overall Study|Lack of Efficacy|1|||
125919222|NCT00347360|453001676|FG001|Overall Study|Lack of Efficacy|1|||
125919223|NCT00347360|453001677|FG002|Overall Study|Lack of Efficacy|3|||
125919224|NCT00347360|453001678|FG003|Overall Study|Lack of Efficacy|1|||
125919225|NCT00347360|453001679|FG004|Overall Study|Lack of Efficacy|0|||
125919226|NCT00347360|453001680|FG005|Overall Study|Lack of Efficacy|1|||
125919227|NCT00347360|453001681|FG006|Overall Study|Lack of Efficacy|0|||
125919228|NCT00347360|453001682|FG007|Overall Study|Lack of Efficacy|1|||
125919229|NCT00347360|453001683|FG008|Overall Study|Lack of Efficacy|1|||
125919230|NCT00347360|453001684|FG009|Overall Study|Lack of Efficacy|0|||
125919231|NCT00347360|453001685|FG010|Overall Study|Lack of Efficacy|0|||
125919232|NCT00347360|453001686|FG011|Overall Study|Lack of Efficacy|0|||
125919233|NCT00347360|453001687|FG012|Overall Study|Lack of Efficacy|0|||
125919234|NCT00347360|453001688|FG013|Overall Study|Lack of Efficacy|0|||
125919235|NCT00347360|453001689|FG014|Overall Study|Lack of Efficacy|0|||
125919236|NCT00347360|453001675|FG000|Overall Study|Reason not listed/blank|1|||
125919237|NCT00347360|453001676|FG001|Overall Study|Reason not listed/blank|0|||
125919238|NCT00347360|453001677|FG002|Overall Study|Reason not listed/blank|0|||
125919239|NCT00347360|453001678|FG003|Overall Study|Reason not listed/blank|0|||
125919240|NCT00347360|453001679|FG004|Overall Study|Reason not listed/blank|0|||
125919241|NCT00347360|453001680|FG005|Overall Study|Reason not listed/blank|0|||
125919242|NCT00347360|453001681|FG006|Overall Study|Reason not listed/blank|1|||
125919243|NCT00347360|453001682|FG007|Overall Study|Reason not listed/blank|0|||
125919244|NCT00347360|453001683|FG008|Overall Study|Reason not listed/blank|0|||
125919245|NCT00347360|453001684|FG009|Overall Study|Reason not listed/blank|0|||
125919246|NCT00347360|453001685|FG010|Overall Study|Reason not listed/blank|0|||
125919247|NCT00347360|453001686|FG011|Overall Study|Reason not listed/blank|0|||
125919248|NCT00347360|453001687|FG012|Overall Study|Reason not listed/blank|0|||
125919249|NCT00347360|453001688|FG013|Overall Study|Reason not listed/blank|1|||
125919250|NCT00347360|453001689|FG014|Overall Study|Reason not listed/blank|0|||
125919251|NCT00347360|453001675|FG000|Overall Study|Per sponsors instruction|0|||
125919252|NCT00347360|453001676|FG001|Overall Study|Per sponsors instruction|1|||
125919253|NCT00347360|453001677|FG002|Overall Study|Per sponsors instruction|0|||
125919254|NCT00347360|453001678|FG003|Overall Study|Per sponsors instruction|0|||
125919255|NCT00347360|453001679|FG004|Overall Study|Per sponsors instruction|0|||
125919256|NCT00347360|453001680|FG005|Overall Study|Per sponsors instruction|0|||
125919257|NCT00347360|453001681|FG006|Overall Study|Per sponsors instruction|0|||
125919258|NCT00347360|453001682|FG007|Overall Study|Per sponsors instruction|0|||
125919259|NCT00347360|453001683|FG008|Overall Study|Per sponsors instruction|0|||
125919260|NCT00347360|453001684|FG009|Overall Study|Per sponsors instruction|0|||
125919261|NCT00347360|453001685|FG010|Overall Study|Per sponsors instruction|0|||
125919262|NCT00347360|453001686|FG011|Overall Study|Per sponsors instruction|0|||
125919263|NCT00347360|453001687|FG012|Overall Study|Per sponsors instruction|0|||
125919264|NCT00347360|453001688|FG013|Overall Study|Per sponsors instruction|0|||
125919265|NCT00347360|453001689|FG014|Overall Study|Per sponsors instruction|0|||
125919266|NCT00347360|453001675|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
125919267|NCT00347360|453001676|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
125919268|NCT00347360|453001677|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
125919269|NCT00347360|453001678|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
125919270|NCT00347360|453001679|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
125919271|NCT00347360|453001680|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
125919272|NCT00347360|453001681|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
125919273|NCT00347360|453001682|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
125919274|NCT00347360|453001683|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
125919275|NCT00347360|453001684|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
125919276|NCT00347360|453001685|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
125919277|NCT00347360|453001686|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
125919278|NCT00347360|453001687|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
125919279|NCT00347360|453001688|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
125919280|NCT00347360|453001689|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
125919281|NCT00347360|453001675|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
125919282|NCT00347360|453001676|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
125919283|NCT00347360|453001677|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
125919284|NCT00347360|453001678|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
125919285|NCT00347360|453001679|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
125919286|NCT00347360|453001680|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
125919287|NCT00347360|453001681|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
125919288|NCT00347360|453001682|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
125919289|NCT00347360|453001683|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
125919290|NCT00347360|453001684|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
125919291|NCT00347360|453001685|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
125919292|NCT00347360|453001686|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
125919293|NCT00347360|453001687|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
125919294|NCT00347360|453001688|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
125919295|NCT00347360|453001689|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
125919296|NCT00347360|453001675|FG000|Overall Study|Abnormal lab values|0|||
125919297|NCT00347360|453001676|FG001|Overall Study|Abnormal lab values|0|||
125919298|NCT00347360|453001677|FG002|Overall Study|Abnormal lab values|0|||
125919299|NCT00347360|453001678|FG003|Overall Study|Abnormal lab values|0|||
125919300|NCT00347360|453001679|FG004|Overall Study|Abnormal lab values|0|||
125919301|NCT00347360|453001680|FG005|Overall Study|Abnormal lab values|0|||
125919302|NCT00347360|453001681|FG006|Overall Study|Abnormal lab values|1|||
125919303|NCT00347360|453001682|FG007|Overall Study|Abnormal lab values|0|||
125919304|NCT00347360|453001683|FG008|Overall Study|Abnormal lab values|0|||
125919305|NCT00347360|453001684|FG009|Overall Study|Abnormal lab values|0|||
125919306|NCT00347360|453001685|FG010|Overall Study|Abnormal lab values|0|||
125919307|NCT00347360|453001686|FG011|Overall Study|Abnormal lab values|0|||
125919308|NCT00347360|453001687|FG012|Overall Study|Abnormal lab values|0|||
125919309|NCT00347360|453001688|FG013|Overall Study|Abnormal lab values|0|||
125919310|NCT00347360|453001689|FG014|Overall Study|Abnormal lab values|0|||
125919311|NCT00347360|453001675|FG000|Overall Study|PI recommended early withdrawal|0|||
125919312|NCT00347360|453001676|FG001|Overall Study|PI recommended early withdrawal|0|||
125919313|NCT00347360|453001677|FG002|Overall Study|PI recommended early withdrawal|0|||
125919314|NCT00347360|453001678|FG003|Overall Study|PI recommended early withdrawal|0|||
125919315|NCT00347360|453001679|FG004|Overall Study|PI recommended early withdrawal|0|||
125919316|NCT00347360|453001680|FG005|Overall Study|PI recommended early withdrawal|0|||
125919317|NCT00347360|453001681|FG006|Overall Study|PI recommended early withdrawal|0|||
125919318|NCT00347360|453001682|FG007|Overall Study|PI recommended early withdrawal|0|||
125919319|NCT00347360|453001683|FG008|Overall Study|PI recommended early withdrawal|0|||
125919320|NCT00347360|453001684|FG009|Overall Study|PI recommended early withdrawal|1|||
125919321|NCT00347360|453001685|FG010|Overall Study|PI recommended early withdrawal|0|||
125919322|NCT00347360|453001686|FG011|Overall Study|PI recommended early withdrawal|0|||
125919323|NCT00347360|453001687|FG012|Overall Study|PI recommended early withdrawal|0|||
125919324|NCT00347360|453001688|FG013|Overall Study|PI recommended early withdrawal|0|||
125919325|NCT00347360|453001689|FG014|Overall Study|PI recommended early withdrawal|0|||
125919326|NCT00347360|453001675|FG000|Overall Study|Did not meet criteria before ABPM|0|||
125919327|NCT00347360|453001676|FG001|Overall Study|Did not meet criteria before ABPM|0|||
125919328|NCT00347360|453001677|FG002|Overall Study|Did not meet criteria before ABPM|0|||
125919329|NCT00347360|453001678|FG003|Overall Study|Did not meet criteria before ABPM|0|||
125919330|NCT00347360|453001679|FG004|Overall Study|Did not meet criteria before ABPM|0|||
125919331|NCT00347360|453001680|FG005|Overall Study|Did not meet criteria before ABPM|0|||
125919332|NCT00347360|453001681|FG006|Overall Study|Did not meet criteria before ABPM|0|||
125919333|NCT00347360|453001682|FG007|Overall Study|Did not meet criteria before ABPM|0|||
125919334|NCT00347360|453001683|FG008|Overall Study|Did not meet criteria before ABPM|0|||
125919335|NCT00347360|453001684|FG009|Overall Study|Did not meet criteria before ABPM|0|||
125919336|NCT00347360|453001685|FG010|Overall Study|Did not meet criteria before ABPM|1|||
125919337|NCT00347360|453001686|FG011|Overall Study|Did not meet criteria before ABPM|0|||
125919338|NCT00347360|453001687|FG012|Overall Study|Did not meet criteria before ABPM|0|||
125919339|NCT00347360|453001688|FG013|Overall Study|Did not meet criteria before ABPM|0|||
125919340|NCT00347360|453001689|FG014|Overall Study|Did not meet criteria before ABPM|0|||
125919341|NCT00347360|453001675|FG000|Overall Study|Randomized in error|0|||
125919342|NCT00347360|453001676|FG001|Overall Study|Randomized in error|0|||
125919343|NCT00347360|453001677|FG002|Overall Study|Randomized in error|0|||
125919344|NCT00347360|453001678|FG003|Overall Study|Randomized in error|0|||
125919345|NCT00347360|453001679|FG004|Overall Study|Randomized in error|0|||
125919346|NCT00347360|453001680|FG005|Overall Study|Randomized in error|0|||
125919347|NCT00347360|453001681|FG006|Overall Study|Randomized in error|0|||
125919348|NCT00347360|453001682|FG007|Overall Study|Randomized in error|0|||
125919349|NCT00347360|453001683|FG008|Overall Study|Randomized in error|0|||
125919350|NCT00347360|453001684|FG009|Overall Study|Randomized in error|0|||
125919351|NCT00347360|453001685|FG010|Overall Study|Randomized in error|0|||
125919352|NCT00347360|453001686|FG011|Overall Study|Randomized in error|1|||
125919353|NCT00347360|453001687|FG012|Overall Study|Randomized in error|0|||
125919354|NCT00347360|453001688|FG013|Overall Study|Randomized in error|0|||
125919355|NCT00347360|453001689|FG014|Overall Study|Randomized in error|0|||
125919356|NCT00347360|453001675|FG000|Overall Study|Failed inclusion criteria #4|0|||
125919357|NCT00347360|453001676|FG001|Overall Study|Failed inclusion criteria #4|0|||
125919358|NCT00347360|453001677|FG002|Overall Study|Failed inclusion criteria #4|0|||
125919359|NCT00347360|453001678|FG003|Overall Study|Failed inclusion criteria #4|0|||
125919360|NCT00347360|453001679|FG004|Overall Study|Failed inclusion criteria #4|0|||
125919361|NCT00347360|453001680|FG005|Overall Study|Failed inclusion criteria #4|0|||
125919362|NCT00347360|453001681|FG006|Overall Study|Failed inclusion criteria #4|0|||
125919363|NCT00347360|453001682|FG007|Overall Study|Failed inclusion criteria #4|0|||
125919364|NCT00347360|453001683|FG008|Overall Study|Failed inclusion criteria #4|0|||
125919365|NCT00347360|453001684|FG009|Overall Study|Failed inclusion criteria #4|0|||
125919366|NCT00347360|453001685|FG010|Overall Study|Failed inclusion criteria #4|0|||
125919367|NCT00347360|453001686|FG011|Overall Study|Failed inclusion criteria #4|1|||
125919368|NCT00347360|453001687|FG012|Overall Study|Failed inclusion criteria #4|0|||
125919369|NCT00347360|453001688|FG013|Overall Study|Failed inclusion criteria #4|0|||
125919370|NCT00347360|453001689|FG014|Overall Study|Failed inclusion criteria #4|0|||
125919371|NCT00347360|453001675|FG000|Overall Study|Prolonged duration between visits|0|||
125919372|NCT00347360|453001676|FG001|Overall Study|Prolonged duration between visits|0|||
125919373|NCT00347360|453001677|FG002|Overall Study|Prolonged duration between visits|0|||
125919374|NCT00347360|453001678|FG003|Overall Study|Prolonged duration between visits|0|||
125919375|NCT00347360|453001679|FG004|Overall Study|Prolonged duration between visits|0|||
125919376|NCT00347360|453001680|FG005|Overall Study|Prolonged duration between visits|0|||
125919377|NCT00347360|453001681|FG006|Overall Study|Prolonged duration between visits|0|||
125919378|NCT00347360|453001682|FG007|Overall Study|Prolonged duration between visits|0|||
125919379|NCT00347360|453001683|FG008|Overall Study|Prolonged duration between visits|0|||
125919380|NCT00347360|453001684|FG009|Overall Study|Prolonged duration between visits|0|||
125919381|NCT00347360|453001685|FG010|Overall Study|Prolonged duration between visits|0|||
125919382|NCT00347360|453001686|FG011|Overall Study|Prolonged duration between visits|0|||
125919383|NCT00347360|453001687|FG012|Overall Study|Prolonged duration between visits|1|||
125919384|NCT00347360|453001688|FG013|Overall Study|Prolonged duration between visits|0|||
125919385|NCT00347360|453001689|FG014|Overall Study|Prolonged duration between visits|0|||
125919386|NCT00347360|453001675|FG000|Overall Study|Subject left town, ran out of study drug|0|||
125919387|NCT00347360|453001676|FG001|Overall Study|Subject left town, ran out of study drug|0|||
125919388|NCT00347360|453001677|FG002|Overall Study|Subject left town, ran out of study drug|0|||
125919389|NCT00347360|453001678|FG003|Overall Study|Subject left town, ran out of study drug|0|||
125919390|NCT00347360|453001679|FG004|Overall Study|Subject left town, ran out of study drug|0|||
125919391|NCT00347360|453001680|FG005|Overall Study|Subject left town, ran out of study drug|0|||
125919392|NCT00347360|453001681|FG006|Overall Study|Subject left town, ran out of study drug|0|||
125919393|NCT00347360|453001682|FG007|Overall Study|Subject left town, ran out of study drug|0|||
125919394|NCT00347360|453001683|FG008|Overall Study|Subject left town, ran out of study drug|0|||
125919395|NCT00347360|453001684|FG009|Overall Study|Subject left town, ran out of study drug|0|||
125919396|NCT00347360|453001685|FG010|Overall Study|Subject left town, ran out of study drug|0|||
125919397|NCT00347360|453001686|FG011|Overall Study|Subject left town, ran out of study drug|0|||
125919398|NCT00347360|453001687|FG012|Overall Study|Subject left town, ran out of study drug|0|||
125919399|NCT00347360|453001688|FG013|Overall Study|Subject left town, ran out of study drug|1|||
125919400|NCT00347360|453001689|FG014|Overall Study|Subject left town, ran out of study drug|0|||
125919401|NCT00347360|453001675|FG000|Overall Study|Subject refuse to sign updated consent|0|||
125919402|NCT00347360|453001676|FG001|Overall Study|Subject refuse to sign updated consent|0|||
125919403|NCT00347360|453001677|FG002|Overall Study|Subject refuse to sign updated consent|0|||
125919404|NCT00347360|453001678|FG003|Overall Study|Subject refuse to sign updated consent|0|||
125919405|NCT00347360|453001679|FG004|Overall Study|Subject refuse to sign updated consent|0|||
125919406|NCT00347360|453001680|FG005|Overall Study|Subject refuse to sign updated consent|0|||
125919407|NCT00347360|453001681|FG006|Overall Study|Subject refuse to sign updated consent|0|||
125919408|NCT00347360|453001682|FG007|Overall Study|Subject refuse to sign updated consent|0|||
125919409|NCT00347360|453001683|FG008|Overall Study|Subject refuse to sign updated consent|0|||
125919410|NCT00347360|453001684|FG009|Overall Study|Subject refuse to sign updated consent|0|||
125919411|NCT00347360|453001685|FG010|Overall Study|Subject refuse to sign updated consent|0|||
125919412|NCT00347360|453001686|FG011|Overall Study|Subject refuse to sign updated consent|0|||
125919413|NCT00347360|453001687|FG012|Overall Study|Subject refuse to sign updated consent|0|||
125919414|NCT00347360|453001688|FG013|Overall Study|Subject refuse to sign updated consent|0|||
125919415|NCT00347360|453001689|FG014|Overall Study|Subject refuse to sign updated consent|1|||
126110826|NCT03308942|453701904|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
126110827|NCT03308942|453701905|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
126110828|NCT03308942|453701906|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
126110829|NCT03308942|453701907|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
126110830|NCT03308942|453701903|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
126110831|NCT03308942|453701904|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
126110832|NCT03308942|453701905|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
126110833|NCT03308942|453701906|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
126110834|NCT03308942|453701907|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
126110835|NCT03308942|453701903|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
126110836|NCT03308942|453701904|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
126110837|NCT03308942|453701905|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
126110838|NCT03308942|453701906|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
126110839|NCT03308942|453701907|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
126110840|NCT03308942|453701903|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
126110841|NCT03308942|453701904|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
126110842|NCT03308942|453701905|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
126110843|NCT03308942|453701906|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
126110844|NCT03308942|453701907|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
126110845|NCT03308942|453701903|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
126110846|NCT03308942|453701904|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
126110847|NCT03308942|453701905|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
126110848|NCT03308942|453701906|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
126110849|NCT03308942|453701907|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
126110850|NCT03308942|453701903|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125919416|NCT00347360|453001675|FG000|Overall Study|Visits conflicted with new job|0|||
125919417|NCT00347360|453001676|FG001|Overall Study|Visits conflicted with new job|0|||
125919418|NCT00347360|453001677|FG002|Overall Study|Visits conflicted with new job|0|||
125919419|NCT00347360|453001678|FG003|Overall Study|Visits conflicted with new job|0|||
125919420|NCT00347360|453001679|FG004|Overall Study|Visits conflicted with new job|0|||
125919421|NCT00347360|453001680|FG005|Overall Study|Visits conflicted with new job|0|||
125919422|NCT00347360|453001681|FG006|Overall Study|Visits conflicted with new job|1|||
125919423|NCT00347360|453001682|FG007|Overall Study|Visits conflicted with new job|0|||
125919424|NCT00347360|453001683|FG008|Overall Study|Visits conflicted with new job|0|||
125919425|NCT00347360|453001684|FG009|Overall Study|Visits conflicted with new job|0|||
125919426|NCT00347360|453001685|FG010|Overall Study|Visits conflicted with new job|0|||
125919427|NCT00347360|453001686|FG011|Overall Study|Visits conflicted with new job|0|||
125919428|NCT00347360|453001687|FG012|Overall Study|Visits conflicted with new job|0|||
125919429|NCT00347360|453001688|FG013|Overall Study|Visits conflicted with new job|0|||
125919430|NCT00347360|453001689|FG014|Overall Study|Visits conflicted with new job|0|||
125919431|NCT00913380|453001695|FG000|Clinical Outcomes|Lost to Follow-up|6|||
125919432|NCT00913380|453001696|FG001|Clinical Outcomes|Lost to Follow-up|6|||
125919433|NCT00806351|453001697|FG000|Overall Study|Death|5|||
125919434|NCT00806351|453001698|FG001|Overall Study|Death|4|||
125919435|NCT02187744|453001699|FG000|Study|Participant refused further follow-up|1|||
125919436|NCT02187744|453001700|FG001|Study|Participant refused further follow-up|0|||
125919437|NCT02187744|453001699|FG000|Study|Other|2|||
125919438|NCT02187744|453001700|FG001|Study|Other|1|||
125919439|NCT02187744|453001699|FG000|Study|Lost to Follow-up|0|||
125919440|NCT02187744|453001700|FG001|Study|Lost to Follow-up|2|||
125919441|NCT02187744|453001699|FG000|Study|Related adverse event, not serious|0|||
125919442|NCT02187744|453001700|FG001|Study|Related adverse event, not serious|2|||
125919443|NCT02187744|453001699|FG000|Study|Death|1|||
125919444|NCT02187744|453001700|FG001|Study|Death|0|||
125919445|NCT02187744|453001699|FG000|Study|Related adverse event, serious non-fatal|0|||
125919446|NCT02187744|453001700|FG001|Study|Related adverse event, serious non-fatal|1|||
125919447|NCT02187744|453001699|FG000|Treatment|Death|1|||
125919448|NCT02187744|453001700|FG001|Treatment|Death|0|||
125919449|NCT02187744|453001699|FG000|Treatment|Related adverse event, serious non-fatal|0|||
125919450|NCT02187744|453001700|FG001|Treatment|Related adverse event, serious non-fatal|1|||
125919451|NCT02187744|453001699|FG000|Treatment|Related adverse event, not serious|0|||
125919452|NCT02187744|453001700|FG001|Treatment|Related adverse event, not serious|2|||
125919453|NCT02187744|453001699|FG000|Treatment|Lost to Follow-up|0|||
125919454|NCT02187744|453001700|FG001|Treatment|Lost to Follow-up|1|||
125919455|NCT02187744|453001699|FG000|Treatment|Other|2|||
125919456|NCT02187744|453001700|FG001|Treatment|Other|0|||
125919457|NCT02187744|453001699|FG000|Treatment|Participant refused continued treatment|1|||
125919458|NCT02187744|453001700|FG001|Treatment|Participant refused continued treatment|1|||
125919459|NCT00508755|453001706|FG000|Overall Study|Withdrawal by Subject|1|||
125919460|NCT02004522|453001712|FG000|Overall Study|Adverse Event|55|||
125919461|NCT02004522|453001713|FG001|Overall Study|Adverse Event|6|||
125919462|NCT02004522|453001712|FG000|Overall Study|Withdrawal by Subject|13|||
125919463|NCT02004522|453001713|FG001|Overall Study|Withdrawal by Subject|7|||
125919464|NCT02004522|453001712|FG000|Overall Study|Death|12|||
125919465|NCT02004522|453001713|FG001|Overall Study|Death|3|||
125919466|NCT02004522|453001712|FG000|Overall Study|Physician Decision|3|||
125919467|NCT02004522|453001713|FG001|Overall Study|Physician Decision|4|||
125919468|NCT02004522|453001712|FG000|Overall Study|Protocol Violation|1|||
125919469|NCT02004522|453001713|FG001|Overall Study|Protocol Violation|0|||
125919470|NCT02004522|453001712|FG000|Overall Study|Other is reason listed by PI|4|||
125919471|NCT02004522|453001713|FG001|Overall Study|Other is reason listed by PI|1|||
125919472|NCT02004522|453001712|FG000|Overall Study|Never Dosed|2|||
125919473|NCT02004522|453001713|FG001|Overall Study|Never Dosed|4|||
125919474|NCT02004522|453001712|FG000|Overall Study|Disease Progression|35|||
125919475|NCT02004522|453001713|FG001|Overall Study|Disease Progression|31|||
125919476|NCT02004522|453001712|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
125919477|NCT02004522|453001713|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
125919478|NCT01787331|453001714|FG000|Overall Study|Physician Decision|1|||
125919479|NCT01787331|453001714|FG000|Overall Study|Withdrawal by Subject|1|||
125919480|NCT04680052|453003023|FG000|Overall Study|Ongoing|244|||
125919481|NCT04680052|453003024|FG001|Overall Study|Ongoing|229|||
125919482|NCT04680052|453003025|FG002|Overall Study|Ongoing|39|||
126110851|NCT03308942|453701904|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
126110852|NCT03308942|453701905|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
126110853|NCT03308942|453701906|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
126110854|NCT03308942|453701907|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
126110855|NCT03308942|453701903|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
126110856|NCT03308942|453701904|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
126110857|NCT03308942|453701905|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
126110858|NCT03308942|453701906|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
126110859|NCT03308942|453701907|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
126110860|NCT02194062|453701908|FG000|Overall Study|Lost to Follow-up|2|||
126110861|NCT02194062|453701909|FG001|Overall Study|Lost to Follow-up|2|||
125919483|NCT04680052|453003026|FG003|Overall Study|Ongoing|46|||
125919484|NCT04680052|453003023|FG000|Overall Study|Death|15|||
125919485|NCT04680052|453003024|FG001|Overall Study|Death|22|||
125919486|NCT04680052|453003025|FG002|Overall Study|Death|7|||
125919487|NCT04680052|453003026|FG003|Overall Study|Death|1|||
125919488|NCT04680052|453003023|FG000|Overall Study|Lost to Follow-up|3|||
125919489|NCT04680052|453003024|FG001|Overall Study|Lost to Follow-up|2|||
125919490|NCT04680052|453003025|FG002|Overall Study|Lost to Follow-up|0|||
125919491|NCT04680052|453003026|FG003|Overall Study|Lost to Follow-up|1|||
125919492|NCT04680052|453003023|FG000|Overall Study|Withdrawal by Subject|11|||
125919493|NCT04680052|453003024|FG001|Overall Study|Withdrawal by Subject|19|||
125919494|NCT04680052|453003025|FG002|Overall Study|Withdrawal by Subject|7|||
125919495|NCT04680052|453003026|FG003|Overall Study|Withdrawal by Subject|5|||
125919496|NCT04680052|453003023|FG000|Overall Study|Missing|0|||
125919497|NCT04680052|453003024|FG001|Overall Study|Missing|1|||
125919498|NCT04680052|453003025|FG002|Overall Study|Missing|0|||
125919499|NCT04680052|453003026|FG003|Overall Study|Missing|0|||
125919500|NCT04680052|453003023|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
125919501|NCT04680052|453003024|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
125919502|NCT04680052|453003025|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
125919503|NCT04680052|453003026|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
125919504|NCT04680052|453003023|FG000|Overall Study|Physician Decision|0|||
125919505|NCT04680052|453003024|FG001|Overall Study|Physician Decision|1|||
125919506|NCT04680052|453003025|FG002|Overall Study|Physician Decision|0|||
125919507|NCT04680052|453003026|FG003|Overall Study|Physician Decision|0|||
125919508|NCT01546207|453003027|FG000|Overall Study|Death|1|||
125919509|NCT03019185|453003034|FG000|Overall Study|Lost to Follow-up|3|||
125919510|NCT03019185|453003035|FG001|Overall Study|Lost to Follow-up|0|||
125919511|NCT03019185|453003036|FG002|Overall Study|Lost to Follow-up|2|||
125919512|NCT03019185|453003034|FG000|Overall Study|Withdrawal by Subject|1|||
125919513|NCT03019185|453003035|FG001|Overall Study|Withdrawal by Subject|1|||
125919514|NCT03019185|453003036|FG002|Overall Study|Withdrawal by Subject|0|||
125919515|NCT03019185|453003034|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
125919516|NCT03019185|453003035|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
125919517|NCT03019185|453003036|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
125919518|NCT03019185|453003034|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
126110862|NCT02194062|453701910|FG002|Overall Study|Lost to Follow-up|5|||
126110863|NCT02276872|453701911|FG000|Overall Study|Adverse Event|1|||
126110864|NCT02276872|453701912|FG001|Overall Study|Adverse Event|0|||
126110865|NCT02276872|453701913|FG002|Overall Study|Adverse Event|0|||
126110866|NCT00867113|453701917|FG000|Treatment Period|Adverse Event|15|||
126110867|NCT00867113|453701917|FG000|Treatment Period|Death|2|||
125919519|NCT03019185|453003035|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
125919520|NCT03019185|453003036|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
125919521|NCT03355365|453003039|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
126110868|NCT00867113|453701917|FG000|Treatment Period|Withdrawal by Subject|19|||
126110869|NCT00867113|453701917|FG000|Treatment Period|Lost to Follow-up|3|||
126110870|NCT00867113|453701917|FG000|Treatment Period|Administrative problems|1|||
126110871|NCT00867113|453701917|FG000|Treatment Period|Disease progression/relapse|1|||
126110872|NCT00867113|453701917|FG000|Treatment Period|Protocol Violation|4|||
126110873|NCT00867113|453701917|FG000|Post Treatment After Survival Follow-up|Death|1|||
126110874|NCT00867113|453701917|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
126110875|NCT00867113|453701917|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
126110876|NCT00867113|453701917|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
126110877|NCT00448435|453701921|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
126110878|NCT00448435|453701922|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
126110879|NCT01387230|453701923|FG000|Overall Study|Adverse Event|0|||
126110880|NCT01387230|453701924|FG001|Overall Study|Adverse Event|1|||
126110881|NCT01387230|453701925|FG002|Overall Study|Adverse Event|3|||
126110882|NCT01387230|453701923|FG000|Overall Study|Lack of Efficacy|8|||
126110883|NCT01387230|453701924|FG001|Overall Study|Lack of Efficacy|5|||
126110884|NCT01387230|453701925|FG002|Overall Study|Lack of Efficacy|4|||
126110885|NCT01387230|453701923|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
126110886|NCT01387230|453701924|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
126110887|NCT01387230|453701925|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
126110888|NCT01387230|453701923|FG000|Overall Study|Lost to Follow-up|0|||
126110889|NCT01387230|453701924|FG001|Overall Study|Lost to Follow-up|0|||
126110890|NCT01387230|453701925|FG002|Overall Study|Lost to Follow-up|1|||
126110891|NCT01387230|453701923|FG000|Overall Study|Withdrawal by Subject|4|||
126110892|NCT01387230|453701924|FG001|Overall Study|Withdrawal by Subject|1|||
126110893|NCT01387230|453701925|FG002|Overall Study|Withdrawal by Subject|0|||
126110894|NCT02066051|453701930|FG000|Overall Study|Subject developed active GVHD|1|||
126110895|NCT03027557|453701934|FG000|Overall Study|Adverse Event|1|||
126110896|NCT03027557|453701935|FG001|Overall Study|Adverse Event|0|||
126110897|NCT03027557|453701936|FG002|Overall Study|Adverse Event|0|||
126110898|NCT01610687|453701937|FG000|Overall Study|Lack of Efficacy|26|||
126110899|NCT01610687|453701937|FG000|Overall Study|Adverse Event|18|||
126110900|NCT01610687|453701937|FG000|Overall Study|Moved out of area|6|||
126110901|NCT01610687|453701937|FG000|Overall Study|Withdrawal by Subject|7|||
126110902|NCT01610687|453701937|FG000|Overall Study|Lost to Follow-up|4|||
125919522|NCT03355365|453003040|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
125919523|NCT03355365|453003039|FG000|Year 1, First Intervention|Protocol Violation|1|||
125919524|NCT03355365|453003040|FG001|Year 1, First Intervention|Protocol Violation|0|||
125919525|NCT03355365|453003039|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
125919526|NCT03355365|453003040|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
125919527|NCT03355365|453003039|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
125919528|NCT03355365|453003040|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
125919529|NCT03355365|453003039|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
125919530|NCT03355365|453003040|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
125919531|NCT03355365|453003039|FG000|Year 2, Crossover Intervention|severe COVID|0|||
125919532|NCT03355365|453003040|FG001|Year 2, Crossover Intervention|severe COVID|1|||
125919533|NCT03355365|453003039|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
125919534|NCT03355365|453003040|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
125919535|NCT00142935|453003041|FG000|Overall Study|Other reason|1|||
125919536|NCT00142935|453003042|FG001|Overall Study|Other reason|1|||
125919537|NCT00142935|453003043|FG002|Overall Study|Other reason|1|||
126110903|NCT01610687|453701937|FG000|Overall Study|Symptom control without study medication|2|||
126110904|NCT01610687|453701937|FG000|Overall Study|Unable to make journey|1|||
125919538|NCT00142935|453003041|FG000|Overall Study|Lost to Follow-up|2|||
125919539|NCT00142935|453003042|FG001|Overall Study|Lost to Follow-up|5|||
125919540|NCT00142935|453003043|FG002|Overall Study|Lost to Follow-up|5|||
125919541|NCT00142935|453003041|FG000|Overall Study|Death|0|||
125919542|NCT00142935|453003042|FG001|Overall Study|Death|2|||
125919543|NCT00142935|453003043|FG002|Overall Study|Death|1|||
125919544|NCT00705289|453003046|FG000|Overall Study|Subject or treating physician's choice|131|||
125919545|NCT02601027|453003050|FG000|Registration to Surgery|Withdrawal by Subject|20|||
125919546|NCT02601027|453003051|FG001|Registration to Surgery|Withdrawal by Subject|10|||
125919547|NCT02609828|453003052|FG000|Overall Study|Adverse Event|8|||
125919548|NCT02609828|453003053|FG001|Overall Study|Adverse Event|1|||
125919549|NCT02609828|453003054|FG002|Overall Study|Adverse Event|0|||
125919550|NCT02609828|453003055|FG003|Overall Study|Adverse Event|6|||
125919551|NCT02609828|453003052|FG000|Overall Study|Death|15|||
126110905|NCT01610687|453701937|FG000|Overall Study|Death|1|||
126110906|NCT01610687|453701937|FG000|Overall Study|Cannabis affecting job|1|||
126110907|NCT01610687|453701937|FG000|Overall Study|Felt more alter without study medication|1|||
126110908|NCT03836807|453701938|FG000|Overall Study|Physician Decision|1|||
126110909|NCT03836807|453701939|FG001|Overall Study|Physician Decision|0|||
126110910|NCT02430051|453701940|FG000|Overall Study|Withdrawal by Subject|6|||
126110911|NCT02430051|453701941|FG001|Overall Study|Withdrawal by Subject|3|||
125919552|NCT02609828|453003053|FG001|Overall Study|Death|1|||
125919553|NCT02609828|453003054|FG002|Overall Study|Death|1|||
125919554|NCT02609828|453003055|FG003|Overall Study|Death|19|||
125919555|NCT02609828|453003052|FG000|Overall Study|Insufficient clinical response|2|||
125919556|NCT02609828|453003053|FG001|Overall Study|Insufficient clinical response|1|||
125919557|NCT02609828|453003054|FG002|Overall Study|Insufficient clinical response|0|||
125919558|NCT02609828|453003055|FG003|Overall Study|Insufficient clinical response|0|||
125919559|NCT02609828|453003052|FG000|Overall Study|Lost to Follow-up|0|||
125919560|NCT02609828|453003053|FG001|Overall Study|Lost to Follow-up|0|||
125919561|NCT02609828|453003054|FG002|Overall Study|Lost to Follow-up|0|||
125919562|NCT02609828|453003055|FG003|Overall Study|Lost to Follow-up|1|||
125919563|NCT02609828|453003052|FG000|Overall Study|Protocol Violation|2|||
125919564|NCT02609828|453003053|FG001|Overall Study|Protocol Violation|0|||
125919565|NCT02609828|453003054|FG002|Overall Study|Protocol Violation|0|||
125919566|NCT02609828|453003055|FG003|Overall Study|Protocol Violation|1|||
125919567|NCT02609828|453003052|FG000|Overall Study|Withdrawal by Subject|12|||
125919568|NCT02609828|453003053|FG001|Overall Study|Withdrawal by Subject|1|||
125919569|NCT02609828|453003054|FG002|Overall Study|Withdrawal by Subject|0|||
125919570|NCT02609828|453003055|FG003|Overall Study|Withdrawal by Subject|10|||
125919571|NCT02609828|453003052|FG000|Overall Study|Other|3|||
125919572|NCT02609828|453003053|FG001|Overall Study|Other|0|||
125919573|NCT02609828|453003054|FG002|Overall Study|Other|0|||
125919574|NCT02609828|453003055|FG003|Overall Study|Other|6|||
125919575|NCT02609828|453003052|FG000|Overall Study|Randomized but not treated|1|||
125919576|NCT02609828|453003053|FG001|Overall Study|Randomized but not treated|0|||
125919577|NCT02609828|453003054|FG002|Overall Study|Randomized but not treated|0|||
125919578|NCT02609828|453003055|FG003|Overall Study|Randomized but not treated|0|||
125919579|NCT02980783|453003056|FG000|Overall Study|Lost to Follow-up|1|||
125919580|NCT01540838|453003057|FG000|Overall Study|Open nasogastric tube|9|||
125919581|NCT01540838|453003058|FG001|Overall Study|Open nasogastric tube|7|||
125919582|NCT01540838|453003057|FG000|Overall Study|Treatment doses missing|8|||
125919583|NCT01540838|453003058|FG001|Overall Study|Treatment doses missing|12|||
125919584|NCT01540838|453003057|FG000|Overall Study|Additional antibiotic treatment|1|||
125919585|NCT01540838|453003058|FG001|Overall Study|Additional antibiotic treatment|2|||
125919586|NCT01540838|453003057|FG000|Overall Study|Died before treatment initiation|1|||
125919587|NCT01540838|453003058|FG001|Overall Study|Died before treatment initiation|1|||
125919588|NCT01540838|453003057|FG000|Overall Study|Not BM. Other treatment|3|||
126110912|NCT02430051|453701940|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
126110913|NCT02430051|453701941|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
126110914|NCT02430051|453701940|FG000|Overall Study|Protocol Violation|1|||
126110915|NCT02430051|453701941|FG001|Overall Study|Protocol Violation|0|||
126110916|NCT01272947|453701942|FG000|Overall Study|Abnormal Laboratory Value|2|||
126110917|NCT01272947|453701943|FG001|Overall Study|Abnormal Laboratory Value|2|||
126110918|NCT02019420|453701945|FG000|Overall Study|Did not receive study drug|2|||
126110919|NCT02019420|453701946|FG001|Overall Study|Did not receive study drug|2|||
126110920|NCT02019420|453701945|FG000|Overall Study|Withdrawal by Subject|1|||
126110921|NCT02019420|453701946|FG001|Overall Study|Withdrawal by Subject|3|||
126110922|NCT02019420|453701945|FG000|Overall Study|At request of sponsor or investigator|0|||
126110923|NCT02019420|453701946|FG001|Overall Study|At request of sponsor or investigator|1|||
126110924|NCT02019420|453701945|FG000|Overall Study|Death|104|||
126110925|NCT02019420|453701946|FG001|Overall Study|Death|99|||
126110926|NCT02019420|453701945|FG000|Overall Study|Transferred to other care facility|1|||
126110927|NCT02019420|453701946|FG001|Overall Study|Transferred to other care facility|1|||
126110928|NCT02510560|453701947|FG000|Overall Study|Discontinued from Treatment|27|||
126110929|NCT02510560|453701948|FG001|Overall Study|Discontinued from Treatment|18|||
126110930|NCT02510560|453701949|FG002|Overall Study|Discontinued from Treatment|19|||
126110931|NCT02510560|453701947|FG000|Overall Study|Other|4|||
126110932|NCT02510560|453701948|FG001|Overall Study|Other|4|||
126110933|NCT02510560|453701949|FG002|Overall Study|Other|3|||
126110934|NCT02554903|453701950|FG000|Overall Study|Death|1|||
126110935|NCT02554903|453701951|FG001|Overall Study|Death|1|||
126110936|NCT02554903|453701950|FG000|Overall Study|Physician Decision|2|||
126110937|NCT02554903|453701951|FG001|Overall Study|Physician Decision|2|||
125919589|NCT01540838|453003058|FG001|Overall Study|Not BM. Other treatment|1|||
125919590|NCT02130570|453003059|FG000|Overall Study|Death|3|||
126110938|NCT02554903|453701950|FG000|Overall Study|Heart Transplant|1|||
126110939|NCT02554903|453701951|FG001|Overall Study|Heart Transplant|2|||
126110940|NCT02742766|453701952|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110941|NCT02742766|453701953|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110942|NCT02742766|453701954|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110943|NCT02742766|453701955|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125919591|NCT02130570|453003060|FG001|Overall Study|Death|5|||
125919592|NCT02130570|453003059|FG000|Overall Study|Withdrawal by Subject|6|||
125919593|NCT02130570|453003060|FG001|Overall Study|Withdrawal by Subject|3|||
125919594|NCT02130570|453003059|FG000|Overall Study|Part of practice that discontinued study|0|||
126110944|NCT02742766|453701956|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110945|NCT02742766|453701957|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110946|NCT02742766|453701958|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110947|NCT02742766|453701959|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110948|NCT02742766|453701960|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110949|NCT02742766|453701961|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110950|NCT02742766|453701962|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110951|NCT02742766|453701963|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110952|NCT02742766|453701964|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110953|NCT02742766|453701965|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
126110954|NCT02742766|453701966|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110955|NCT02742766|453701967|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110956|NCT02742766|453701968|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110957|NCT02742766|453701969|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110958|NCT02742766|453701970|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126110959|NCT02742766|453701952|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110960|NCT02742766|453701953|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110961|NCT02742766|453701954|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110962|NCT02742766|453701955|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
125919595|NCT02130570|453003060|FG001|Overall Study|Part of practice that discontinued study|5|||
125919596|NCT01696695|453003061|FG000|Overall Study|Disease progression|373|||
125919597|NCT01696695|453003061|FG000|Overall Study|Death|29|||
125919598|NCT01696695|453003061|FG000|Overall Study|Adverse Event|74|||
125919599|NCT01696695|453003061|FG000|Overall Study|Withdrawal by Subject|92|||
125919600|NCT01696695|453003061|FG000|Overall Study|Lost to Follow-up|48|||
125919601|NCT01696695|453003061|FG000|Overall Study|Other|74|||
125919602|NCT01696695|453003061|FG000|Overall Study|Major Protocol Violation|192|||
125919603|NCT03173313|453003064|FG000|Overall Study|Lost to Follow-up|2|||
125919604|NCT03173313|453003065|FG001|Overall Study|Lost to Follow-up|3|||
125919605|NCT03173313|453003064|FG000|Overall Study|Withdrawal by Subject|0|||
125919606|NCT03173313|453003065|FG001|Overall Study|Withdrawal by Subject|1|||
125919607|NCT03173313|453003064|FG000|Overall Study|Death|5|||
125919608|NCT03173313|453003065|FG001|Overall Study|Death|0|||
125919609|NCT03173313|453003064|FG000|Overall Study|Physician Decision|1|||
125919610|NCT03173313|453003065|FG001|Overall Study|Physician Decision|0|||
125919611|NCT03173313|453003064|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
125919612|NCT03173313|453003065|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
125919613|NCT03173313|453003064|FG000|Overall Study|Bone Fracture|1|||
125919614|NCT03173313|453003065|FG001|Overall Study|Bone Fracture|0|||
125919615|NCT03863197|453003066|FG000|Overall Study|Lost to Follow-up|2|||
125919616|NCT03863197|453003067|FG001|Overall Study|Lost to Follow-up|3|||
125919617|NCT03863197|453003066|FG000|Overall Study|Withdrawal by Subject|4|||
125919618|NCT03863197|453003067|FG001|Overall Study|Withdrawal by Subject|0|||
125919619|NCT03863197|453003066|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
125919620|NCT03863197|453003067|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
125919621|NCT01065597|453003075|FG000|Overall Study|Adverse Event|1|||
125919622|NCT00413244|453003077|FG000|Overall Study|Withdrawal by Subject|10|||
125919623|NCT00413244|453003078|FG001|Overall Study|Withdrawal by Subject|1|||
125919624|NCT02805972|453003082|FG000|Washout Period|Lost to Follow-up|3|||
125919625|NCT02805972|453003083|FG001|Washout Period|Lost to Follow-up|0|||
125919626|NCT01206166|453003084|FG000|Overall Study|No evaluable data|2|||
125919627|NCT01206166|453003085|FG001|Overall Study|No evaluable data|3|||
125919628|NCT00932126|453003086|FG000|Overall Study|Adverse Event|0|||
125919629|NCT00932126|453003087|FG001|Overall Study|Adverse Event|0|||
125919630|NCT00932126|453003088|FG002|Overall Study|Adverse Event|0|||
125919631|NCT00932126|453003089|FG003|Overall Study|Adverse Event|0|||
125919632|NCT00932126|453003090|FG004|Overall Study|Adverse Event|0|||
125919633|NCT00932126|453003091|FG005|Overall Study|Adverse Event|0|||
125919634|NCT00932126|453003092|FG006|Overall Study|Adverse Event|1|||
126110963|NCT02742766|453701956|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110964|NCT02742766|453701957|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110965|NCT02742766|453701958|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110966|NCT02742766|453701959|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
125919635|NCT00932126|453003093|FG007|Overall Study|Adverse Event|2|||
125919636|NCT00932126|453003086|FG000|Overall Study|Protocol Violation|0|||
125919637|NCT00932126|453003087|FG001|Overall Study|Protocol Violation|0|||
125919638|NCT00932126|453003088|FG002|Overall Study|Protocol Violation|0|||
125919639|NCT00932126|453003089|FG003|Overall Study|Protocol Violation|0|||
125919640|NCT00932126|453003090|FG004|Overall Study|Protocol Violation|1|||
125919641|NCT00932126|453003091|FG005|Overall Study|Protocol Violation|0|||
125919642|NCT00932126|453003092|FG006|Overall Study|Protocol Violation|0|||
125919643|NCT00932126|453003093|FG007|Overall Study|Protocol Violation|0|||
125919644|NCT00932126|453003086|FG000|Overall Study|Withdrawal by Subject|0|||
125919645|NCT00932126|453003087|FG001|Overall Study|Withdrawal by Subject|0|||
125919646|NCT00932126|453003088|FG002|Overall Study|Withdrawal by Subject|1|||
125919647|NCT00932126|453003089|FG003|Overall Study|Withdrawal by Subject|0|||
125919648|NCT00932126|453003090|FG004|Overall Study|Withdrawal by Subject|0|||
125919649|NCT00932126|453003091|FG005|Overall Study|Withdrawal by Subject|0|||
125919650|NCT00932126|453003092|FG006|Overall Study|Withdrawal by Subject|0|||
125919651|NCT00932126|453003093|FG007|Overall Study|Withdrawal by Subject|1|||
125919652|NCT00932126|453003086|FG000|Overall Study|Objective progression or relapse|3|||
125919653|NCT00932126|453003087|FG001|Overall Study|Objective progression or relapse|3|||
125919654|NCT00932126|453003088|FG002|Overall Study|Objective progression or relapse|2|||
125919655|NCT00932126|453003089|FG003|Overall Study|Objective progression or relapse|3|||
125919656|NCT00932126|453003090|FG004|Overall Study|Objective progression or relapse|3|||
125919657|NCT00932126|453003091|FG005|Overall Study|Objective progression or relapse|3|||
125919658|NCT00932126|453003092|FG006|Overall Study|Objective progression or relapse|3|||
125919659|NCT00932126|453003093|FG007|Overall Study|Objective progression or relapse|5|||
125919660|NCT00932126|453003086|FG000|Overall Study|Other|0|||
125919661|NCT00932126|453003087|FG001|Overall Study|Other|0|||
125919662|NCT00932126|453003088|FG002|Overall Study|Other|0|||
125919663|NCT00932126|453003089|FG003|Overall Study|Other|0|||
126064337|NCT03745651|453527704|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
126064338|NCT03745651|453527705|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
125919664|NCT00932126|453003090|FG004|Overall Study|Other|1|||
125919665|NCT00932126|453003091|FG005|Overall Study|Other|0|||
125919666|NCT00932126|453003092|FG006|Overall Study|Other|1|||
125919667|NCT00932126|453003093|FG007|Overall Study|Other|2|||
125919668|NCT00066365|453003094|FG000|Overall Study|Adverse Event|1|||
125919669|NCT00066365|453003095|FG001|Overall Study|Adverse Event|0|||
125919670|NCT00066365|453003094|FG000|Overall Study|Lack of Efficacy|15|||
125919671|NCT00066365|453003095|FG001|Overall Study|Lack of Efficacy|12|||
125919672|NCT00066365|453003094|FG000|Overall Study|Physician Decision|1|||
125919673|NCT00066365|453003095|FG001|Overall Study|Physician Decision|0|||
125919674|NCT00066365|453003094|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
125919675|NCT00066365|453003095|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
125919676|NCT00066365|453003094|FG000|Overall Study|Ineligible|4|||
125919677|NCT00066365|453003095|FG001|Overall Study|Ineligible|2|||
125919678|NCT00788073|453003097|FG000|STX209 Then Placebo|Adverse Event|1|||
125919679|NCT00788073|453003098|FG001|STX209 Then Placebo|Adverse Event|0|||
125919680|NCT00788073|453003097|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
125919681|NCT00788073|453003098|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
125919682|NCT00788073|453003097|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
125919683|NCT00788073|453003098|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
125919684|NCT00788073|453003097|FG000|STX209 Then Placebo|unable to return due to travel|0|||
125919685|NCT00788073|453003098|FG001|STX209 Then Placebo|unable to return due to travel|1|||
125919686|NCT00788073|453003097|FG000|Placebo Then STX209|Adverse Event|2|||
125919687|NCT00788073|453003098|FG001|Placebo Then STX209|Adverse Event|0|||
125919688|NCT00788073|453003097|FG000|Placebo Then STX209|Protocol Violation|0|||
125919689|NCT00788073|453003098|FG001|Placebo Then STX209|Protocol Violation|1|||
125919690|NCT03608254|453003099|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
125919691|NCT03608254|453003099|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
125919692|NCT00239590|453003101|FG000|Randomized|Lost to Follow-up|0|||
125919693|NCT00239590|453003102|FG001|Randomized|Lost to Follow-up|1|||
125919694|NCT00239590|453003101|FG000|Randomized|Withdrawal by Subject|0|||
125919695|NCT00239590|453003102|FG001|Randomized|Withdrawal by Subject|1|||
125919696|NCT00239590|453003101|FG000|Completed Study Protocol|Adverse Event|1|||
125919697|NCT00239590|453003102|FG001|Completed Study Protocol|Adverse Event|1|||
125919698|NCT00239590|453003101|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
125919699|NCT00239590|453003102|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
125919700|NCT02362269|453003105|FG000|Overall Study|Moved|1|||
125919701|NCT02362269|453003106|FG001|Overall Study|Moved|0|||
125919702|NCT02362269|453003105|FG000|Overall Study|Lost to Follow-up|0|||
125919703|NCT02362269|453003106|FG001|Overall Study|Lost to Follow-up|6|||
125919704|NCT02058693|453003116|FG000|Phase 1|Withdrawal by Subject|3|||
125919705|NCT02058693|453003117|FG001|Phase 1|Withdrawal by Subject|2|||
125919706|NCT02058693|453003116|FG000|Phase 1|Adverse Event|0|||
125919707|NCT02058693|453003117|FG001|Phase 1|Adverse Event|1|||
125919708|NCT02058693|453003116|FG000|Phase 1|Lack of Efficacy|1|||
125919709|NCT02058693|453003117|FG001|Phase 1|Lack of Efficacy|0|||
125919710|NCT02058693|453003116|FG000|Phase 1|Physician Decision|1|||
125919711|NCT02058693|453003117|FG001|Phase 1|Physician Decision|1|||
125919712|NCT02058693|453003116|FG000|Phase 2|Withdrawal by Subject|0|||
125919713|NCT02058693|453003117|FG001|Phase 2|Withdrawal by Subject|2|||
125919714|NCT00722800|453003118|FG000|Overall Study|Withdrawal by Subject|1|||
125919715|NCT00722800|453003119|FG001|Overall Study|Withdrawal by Subject|0|||
125919716|NCT00722800|453003118|FG000|Overall Study|Physician Decision|1|||
125919717|NCT00722800|453003119|FG001|Overall Study|Physician Decision|0|||
125919718|NCT01449539|453003120|FG000|Overall Study|Withdrawal by Subject|3|||
125919719|NCT01449539|453003120|FG000|Overall Study|Toxicity not study related|1|||
125919720|NCT01972568|453003121|FG000|Overall Study|Other events|3|||
125919721|NCT01972568|453003122|FG001|Overall Study|Other events|0|||
125919722|NCT01972568|453003123|FG002|Overall Study|Other events|0|||
125919723|NCT01972568|453003121|FG000|Overall Study|Lack of Efficacy|0|||
125919724|NCT01972568|453003122|FG001|Overall Study|Lack of Efficacy|1|||
125919725|NCT01972568|453003123|FG002|Overall Study|Lack of Efficacy|2|||
125919726|NCT01972568|453003121|FG000|Overall Study|Protocol Violation|1|||
125919727|NCT01972568|453003122|FG001|Overall Study|Protocol Violation|2|||
125919728|NCT01972568|453003123|FG002|Overall Study|Protocol Violation|2|||
125919729|NCT01972568|453003121|FG000|Overall Study|Withdrawal by Subject|6|||
125919730|NCT01972568|453003122|FG001|Overall Study|Withdrawal by Subject|3|||
125919731|NCT01972568|453003123|FG002|Overall Study|Withdrawal by Subject|7|||
125919732|NCT01972568|453003121|FG000|Overall Study|Lost to Follow-up|1|||
125919733|NCT01972568|453003122|FG001|Overall Study|Lost to Follow-up|0|||
125919734|NCT01972568|453003123|FG002|Overall Study|Lost to Follow-up|0|||
125919735|NCT01972568|453003121|FG000|Overall Study|Adverse Event|5|||
125919736|NCT01972568|453003122|FG001|Overall Study|Adverse Event|6|||
125919737|NCT01972568|453003123|FG002|Overall Study|Adverse Event|5|||
125919738|NCT02572401|453003124|FG000|Overall Study|Lost to Follow-up|5|||
125919739|NCT02572401|453003125|FG001|Overall Study|Lost to Follow-up|8|||
125919740|NCT02572401|453003126|FG002|Overall Study|Lost to Follow-up|9|||
125919741|NCT02572401|453003127|FG003|Overall Study|Lost to Follow-up|9|||
125919742|NCT02572401|453003124|FG000|Overall Study|Death|0|||
125919743|NCT02572401|453003125|FG001|Overall Study|Death|0|||
125919744|NCT02572401|453003126|FG002|Overall Study|Death|0|||
125919745|NCT02572401|453003127|FG003|Overall Study|Death|1|||
125919746|NCT00306189|453003128|FG000|Overall Study|Physician Decision|0|||
125919747|NCT00306189|453003129|FG001|Overall Study|Physician Decision|0|||
125919748|NCT00306189|453003130|FG002|Overall Study|Physician Decision|0|||
125919749|NCT00306189|453003131|FG003|Overall Study|Physician Decision|1|||
125919750|NCT00306189|453003128|FG000|Overall Study|Adverse Event|3|||
125919751|NCT00306189|453003129|FG001|Overall Study|Adverse Event|3|||
125919752|NCT00306189|453003130|FG002|Overall Study|Adverse Event|2|||
125919753|NCT00306189|453003131|FG003|Overall Study|Adverse Event|2|||
125919754|NCT00306189|453003128|FG000|Overall Study|Withdrawal by Subject|4|||
125919755|NCT00306189|453003129|FG001|Overall Study|Withdrawal by Subject|2|||
125919756|NCT00306189|453003130|FG002|Overall Study|Withdrawal by Subject|8|||
125919757|NCT00306189|453003131|FG003|Overall Study|Withdrawal by Subject|1|||
125919758|NCT00306189|453003128|FG000|Overall Study|Ineligibility determined|1|||
125919759|NCT00306189|453003129|FG001|Overall Study|Ineligibility determined|1|||
125919760|NCT00306189|453003130|FG002|Overall Study|Ineligibility determined|1|||
125919761|NCT00306189|453003131|FG003|Overall Study|Ineligibility determined|1|||
125919762|NCT00306189|453003128|FG000|Overall Study|Other|1|||
125919763|NCT00306189|453003129|FG001|Overall Study|Other|0|||
125919764|NCT00306189|453003130|FG002|Overall Study|Other|0|||
125919765|NCT00306189|453003131|FG003|Overall Study|Other|0|||
125919766|NCT00945893|453003132|FG000|Overall Study|Lost to Follow-up|2|||
125919767|NCT00945893|453003133|FG001|Overall Study|Lost to Follow-up|8|||
125919768|NCT00945893|453003132|FG000|Overall Study|Withdrawal of consent|1|||
125919769|NCT00945893|453003133|FG001|Overall Study|Withdrawal of consent|2|||
125919770|NCT00667875|453003134|FG000|Overall Study|Adverse Event|0|||
125919771|NCT00667875|453003135|FG001|Overall Study|Adverse Event|2|||
125919772|NCT00667875|453003136|FG002|Overall Study|Adverse Event|6|||
125919773|NCT00667875|453003134|FG000|Overall Study|Withdrawal by Subject|10|||
125919774|NCT00667875|453003135|FG001|Overall Study|Withdrawal by Subject|9|||
125919775|NCT00667875|453003136|FG002|Overall Study|Withdrawal by Subject|7|||
125919776|NCT00437983|453003137|FG000|Overall Study|Adverse Event|6|||
125919777|NCT00437983|453003138|FG001|Overall Study|Adverse Event|6|||
125919778|NCT00437983|453003137|FG000|Overall Study|Protocol Violation|2|||
125919779|NCT00437983|453003138|FG001|Overall Study|Protocol Violation|1|||
125919780|NCT00437983|453003137|FG000|Overall Study|Withdrawal by Subject|5|||
125919781|NCT00437983|453003138|FG001|Overall Study|Withdrawal by Subject|6|||
125919782|NCT00672646|453003141|FG000|Overall Study|Lost to Follow-up|0|||
125919783|NCT00672646|453003142|FG001|Overall Study|Lost to Follow-up|1|||
125919784|NCT00672646|453003143|FG002|Overall Study|Lost to Follow-up|2|||
125919785|NCT00672646|453003141|FG000|Overall Study|Withdrawal by Subject|0|||
125919786|NCT00672646|453003142|FG001|Overall Study|Withdrawal by Subject|0|||
125919787|NCT00672646|453003143|FG002|Overall Study|Withdrawal by Subject|1|||
125919788|NCT00142298|453003144|FG000|Overall Study|Adverse Event|10|||
125919789|NCT00142298|453003145|FG001|Overall Study|Adverse Event|10|||
125919790|NCT00142298|453003146|FG002|Overall Study|Adverse Event|1|||
125919791|NCT00142298|453003147|FG003|Overall Study|Adverse Event|5|||
125919792|NCT00142298|453003148|FG004|Overall Study|Adverse Event|2|||
125919793|NCT00142298|453003149|FG005|Overall Study|Adverse Event|2|||
125919794|NCT00142298|453003150|FG006|Overall Study|Adverse Event|0|||
125919795|NCT00142298|453003151|FG007|Overall Study|Adverse Event|0|||
125919796|NCT00142298|453003152|FG008|Overall Study|Adverse Event|0|||
125919797|NCT00142298|453003153|FG009|Overall Study|Adverse Event|0|||
125919798|NCT00142298|453003144|FG000|Overall Study|Clinical disease progression|1|||
125919799|NCT00142298|453003145|FG001|Overall Study|Clinical disease progression|0|||
125919800|NCT00142298|453003146|FG002|Overall Study|Clinical disease progression|0|||
125919801|NCT00142298|453003147|FG003|Overall Study|Clinical disease progression|0|||
125919802|NCT00142298|453003148|FG004|Overall Study|Clinical disease progression|0|||
125919803|NCT00142298|453003149|FG005|Overall Study|Clinical disease progression|0|||
125919804|NCT00142298|453003150|FG006|Overall Study|Clinical disease progression|0|||
125919805|NCT00142298|453003151|FG007|Overall Study|Clinical disease progression|0|||
125919806|NCT00142298|453003152|FG008|Overall Study|Clinical disease progression|0|||
125919807|NCT00142298|453003153|FG009|Overall Study|Clinical disease progression|0|||
125919808|NCT00142298|453003144|FG000|Overall Study|Death|1|||
125919809|NCT00142298|453003145|FG001|Overall Study|Death|1|||
125919810|NCT00142298|453003146|FG002|Overall Study|Death|1|||
125919811|NCT00142298|453003147|FG003|Overall Study|Death|0|||
125919812|NCT00142298|453003148|FG004|Overall Study|Death|0|||
125919813|NCT00142298|453003149|FG005|Overall Study|Death|6|||
125919814|NCT00142298|453003150|FG006|Overall Study|Death|0|||
125919815|NCT00142298|453003151|FG007|Overall Study|Death|0|||
125919816|NCT00142298|453003152|FG008|Overall Study|Death|0|||
125919817|NCT00142298|453003153|FG009|Overall Study|Death|0|||
125919818|NCT00142298|453003144|FG000|Overall Study|Lack of Efficacy|44|||
125919819|NCT00142298|453003145|FG001|Overall Study|Lack of Efficacy|62|||
125919820|NCT00142298|453003146|FG002|Overall Study|Lack of Efficacy|9|||
125919821|NCT00142298|453003147|FG003|Overall Study|Lack of Efficacy|12|||
125919822|NCT00142298|453003148|FG004|Overall Study|Lack of Efficacy|1|||
125919823|NCT00142298|453003149|FG005|Overall Study|Lack of Efficacy|0|||
125919824|NCT00142298|453003150|FG006|Overall Study|Lack of Efficacy|0|||
125919825|NCT00142298|453003151|FG007|Overall Study|Lack of Efficacy|1|||
125919826|NCT00142298|453003152|FG008|Overall Study|Lack of Efficacy|0|||
125919827|NCT00142298|453003153|FG009|Overall Study|Lack of Efficacy|0|||
125919828|NCT00142298|453003144|FG000|Overall Study|Non-compliance|15|||
125919829|NCT00142298|453003145|FG001|Overall Study|Non-compliance|13|||
125919830|NCT00142298|453003146|FG002|Overall Study|Non-compliance|0|||
125919831|NCT00142298|453003147|FG003|Overall Study|Non-compliance|6|||
125919832|NCT00142298|453003148|FG004|Overall Study|Non-compliance|1|||
125919833|NCT00142298|453003149|FG005|Overall Study|Non-compliance|0|||
125919834|NCT00142298|453003150|FG006|Overall Study|Non-compliance|0|||
125919835|NCT00142298|453003151|FG007|Overall Study|Non-compliance|3|||
125919836|NCT00142298|453003152|FG008|Overall Study|Non-compliance|3|||
125919837|NCT00142298|453003153|FG009|Overall Study|Non-compliance|0|||
125919838|NCT00142298|453003144|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
125919839|NCT00142298|453003145|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
125919840|NCT00142298|453003146|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
125919841|NCT00142298|453003147|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
125919842|NCT00142298|453003148|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
125919843|NCT00142298|453003149|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
125919844|NCT00142298|453003150|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
125919845|NCT00142298|453003151|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
125919846|NCT00142298|453003152|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
125919847|NCT00142298|453003153|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
125919848|NCT00142298|453003144|FG000|Overall Study|Pregnancy|4|||
125919849|NCT00142298|453003145|FG001|Overall Study|Pregnancy|4|||
125919850|NCT00142298|453003146|FG002|Overall Study|Pregnancy|2|||
125919851|NCT00142298|453003147|FG003|Overall Study|Pregnancy|3|||
125919852|NCT00142298|453003148|FG004|Overall Study|Pregnancy|0|||
125919853|NCT00142298|453003149|FG005|Overall Study|Pregnancy|0|||
125919854|NCT00142298|453003150|FG006|Overall Study|Pregnancy|0|||
125919855|NCT00142298|453003151|FG007|Overall Study|Pregnancy|0|||
125919856|NCT00142298|453003152|FG008|Overall Study|Pregnancy|1|||
125919857|NCT00142298|453003153|FG009|Overall Study|Pregnancy|0|||
125919858|NCT00142298|453003144|FG000|Overall Study|Virologic breakthrough|19|||
125919859|NCT00142298|453003145|FG001|Overall Study|Virologic breakthrough|23|||
125919860|NCT00142298|453003146|FG002|Overall Study|Virologic breakthrough|9|||
125919861|NCT00142298|453003147|FG003|Overall Study|Virologic breakthrough|7|||
125919862|NCT00142298|453003148|FG004|Overall Study|Virologic breakthrough|2|||
125919863|NCT00142298|453003149|FG005|Overall Study|Virologic breakthrough|3|||
125919864|NCT00142298|453003150|FG006|Overall Study|Virologic breakthrough|3|||
125919865|NCT00142298|453003151|FG007|Overall Study|Virologic breakthrough|0|||
125919866|NCT00142298|453003152|FG008|Overall Study|Virologic breakthrough|0|||
125919867|NCT00142298|453003153|FG009|Overall Study|Virologic breakthrough|0|||
125919868|NCT00142298|453003144|FG000|Overall Study|Other- not specified|0|||
125919869|NCT00142298|453003145|FG001|Overall Study|Other- not specified|3|||
125919870|NCT00142298|453003146|FG002|Overall Study|Other- not specified|0|||
125919871|NCT00142298|453003147|FG003|Overall Study|Other- not specified|1|||
125919872|NCT00142298|453003148|FG004|Overall Study|Other- not specified|0|||
125919873|NCT00142298|453003149|FG005|Overall Study|Other- not specified|0|||
125919874|NCT00142298|453003150|FG006|Overall Study|Other- not specified|0|||
125919875|NCT00142298|453003151|FG007|Overall Study|Other- not specified|0|||
125919876|NCT00142298|453003152|FG008|Overall Study|Other- not specified|0|||
125919877|NCT00142298|453003153|FG009|Overall Study|Other- not specified|0|||
125919878|NCT00142298|453003144|FG000|Overall Study|Lost to Follow-up|0|||
125919879|NCT00142298|453003145|FG001|Overall Study|Lost to Follow-up|0|||
126110967|NCT02742766|453701960|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
125919880|NCT00142298|453003146|FG002|Overall Study|Lost to Follow-up|0|||
125919881|NCT00142298|453003147|FG003|Overall Study|Lost to Follow-up|0|||
125919882|NCT00142298|453003148|FG004|Overall Study|Lost to Follow-up|0|||
125919883|NCT00142298|453003149|FG005|Overall Study|Lost to Follow-up|0|||
125919884|NCT00142298|453003150|FG006|Overall Study|Lost to Follow-up|2|||
125919885|NCT00142298|453003151|FG007|Overall Study|Lost to Follow-up|0|||
125919886|NCT00142298|453003152|FG008|Overall Study|Lost to Follow-up|0|||
125919887|NCT00142298|453003153|FG009|Overall Study|Lost to Follow-up|0|||
125919888|NCT00142298|453003144|FG000|Overall Study|Treatment Failure|0|||
125919889|NCT00142298|453003145|FG001|Overall Study|Treatment Failure|0|||
125919890|NCT00142298|453003146|FG002|Overall Study|Treatment Failure|0|||
125919891|NCT00142298|453003147|FG003|Overall Study|Treatment Failure|0|||
125919892|NCT00142298|453003148|FG004|Overall Study|Treatment Failure|0|||
125919893|NCT00142298|453003149|FG005|Overall Study|Treatment Failure|2|||
125919894|NCT00142298|453003150|FG006|Overall Study|Treatment Failure|2|||
125919895|NCT00142298|453003151|FG007|Overall Study|Treatment Failure|0|||
125919896|NCT00142298|453003152|FG008|Overall Study|Treatment Failure|0|||
125919897|NCT00142298|453003153|FG009|Overall Study|Treatment Failure|0|||
125919898|NCT00300274|453003154|FG000|Overall Study|Withdrawal by Subject|12|||
125919899|NCT00300274|453003155|FG001|Overall Study|Withdrawal by Subject|3|||
125919900|NCT00300274|453003156|FG002|Overall Study|Withdrawal by Subject|14|||
125919901|NCT00300274|453003154|FG000|Overall Study|Lost to Follow-up|3|||
125919902|NCT00300274|453003155|FG001|Overall Study|Lost to Follow-up|4|||
125919903|NCT00300274|453003156|FG002|Overall Study|Lost to Follow-up|5|||
125919904|NCT00300274|453003154|FG000|Overall Study|Death|31|||
125919905|NCT00300274|453003155|FG001|Overall Study|Death|20|||
125919906|NCT00300274|453003156|FG002|Overall Study|Death|25|||
125919907|NCT00300274|453003154|FG000|Overall Study|Re-transplant|0|||
125919908|NCT00300274|453003155|FG001|Overall Study|Re-transplant|0|||
125919909|NCT00300274|453003156|FG002|Overall Study|Re-transplant|1|||
125919910|NCT04439201|453003157|FG000|Overall Study|Ineligible|2|||
125919911|NCT04439201|453003157|FG000|Overall Study|Never start protocol therapy|1|||
125919912|NCT04439201|453003157|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
125919913|NCT04439201|453003157|FG000|Overall Study|Mutation status not confirmed|4|||
125919914|NCT04439201|453003157|FG000|Overall Study|Adverse Event|1|||
125919915|NCT04439201|453003157|FG000|Overall Study|Death|7|||
125919916|NCT04439201|453003157|FG000|Overall Study|Withdrawal by Subject|2|||
125919917|NCT04439201|453003157|FG000|Overall Study|Disease progression|20|||
125919918|NCT04439201|453003157|FG000|Overall Study|Alternative therapy|1|||
125919919|NCT04439201|453003157|FG000|Overall Study|Physician Decision|1|||
125919920|NCT06956170|453004601|FG000|Overall Study|Death|2|||
125919921|NCT06956170|453004602|FG001|Overall Study|Death|1|||
125919922|NCT06956170|453004601|FG000|Overall Study|Withdrawal by Subject|1|||
125919923|NCT06956170|453004602|FG001|Overall Study|Withdrawal by Subject|0|||
125919924|NCT06956170|453004601|FG000|Overall Study|Ongoing|7|||
125919925|NCT06956170|453004602|FG001|Overall Study|Ongoing|10|||
125919926|NCT02400333|453004603|FG000|Overall Study|Withdrawal by Subject|0|||
125919927|NCT02400333|453004604|FG001|Overall Study|Withdrawal by Subject|1|||
125919928|NCT02400333|453004605|FG002|Overall Study|Withdrawal by Subject|0|||
125919929|NCT02400333|453004606|FG003|Overall Study|Withdrawal by Subject|1|||
125919930|NCT02400333|453004603|FG000|Overall Study|Protocol Violation|1|||
125919931|NCT02400333|453004604|FG001|Overall Study|Protocol Violation|0|||
125919932|NCT02400333|453004605|FG002|Overall Study|Protocol Violation|2|||
125919933|NCT02400333|453004606|FG003|Overall Study|Protocol Violation|1|||
125919934|NCT02280304|453004612|FG000|Overall Study|Lost to Follow-up|7|||
125919935|NCT02280304|453004613|FG001|Overall Study|Lost to Follow-up|8|||
125919936|NCT03372096|453004619|FG000|Overall Study|Study Closed|8|||
125919937|NCT01947582|453004626|FG000|Overall Study|Withdrawal by Subject|1|||
125919938|NCT01603355|453004627|FG000|Overall Study|Lack of Efficacy|2|||
125919939|NCT00434954|453004628|FG000|Overall Study|Adverse Event|17|||
125919940|NCT00434954|453004629|FG001|Overall Study|Adverse Event|2|||
125919941|NCT00434954|453004628|FG000|Overall Study|Entry criteria not met|14|||
125919942|NCT00434954|453004629|FG001|Overall Study|Entry criteria not met|16|||
125919943|NCT00434954|453004628|FG000|Overall Study|Lost to Follow-up|0|||
125919944|NCT00434954|453004629|FG001|Overall Study|Lost to Follow-up|1|||
125919945|NCT00434954|453004628|FG000|Overall Study|Physician Decision|6|||
125919946|NCT00434954|453004629|FG001|Overall Study|Physician Decision|3|||
125919947|NCT00434954|453004628|FG000|Overall Study|Protocol Violation|36|||
125919948|NCT00434954|453004629|FG001|Overall Study|Protocol Violation|27|||
125919949|NCT00434954|453004628|FG000|Overall Study|Sponsor decision|1|||
125919950|NCT00434954|453004629|FG001|Overall Study|Sponsor decision|0|||
125919951|NCT00434954|453004628|FG000|Overall Study|Subject decision|8|||
125919952|NCT00434954|453004629|FG001|Overall Study|Subject decision|22|||
125919953|NCT00894166|453004630|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
125919954|NCT00894166|453004631|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
125919955|NCT00894166|453004632|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
125919956|NCT00894166|453004633|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
125919957|NCT00894166|453004634|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
125919958|NCT00894166|453004635|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
125919959|NCT00894166|453004636|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
125919960|NCT00894166|453004637|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
125919961|NCT00894166|453004630|FG000|Overall Study|Death|0|||
125919962|NCT00894166|453004631|FG001|Overall Study|Death|0|||
125919963|NCT00894166|453004632|FG002|Overall Study|Death|0|||
125919964|NCT00894166|453004633|FG003|Overall Study|Death|1|||
125919965|NCT00894166|453004634|FG004|Overall Study|Death|0|||
125919966|NCT00894166|453004635|FG005|Overall Study|Death|0|||
125919967|NCT00894166|453004636|FG006|Overall Study|Death|0|||
125919968|NCT00894166|453004637|FG007|Overall Study|Death|0|||
125919969|NCT03750955|453004644|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
125919970|NCT03750955|453004645|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
125919971|NCT03750955|453004644|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
125919972|NCT03750955|453004645|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
125919973|NCT01952145|453004650|FG000|Overall Study|Protocol Violation|2|||
125919974|NCT01952145|453004651|FG001|Overall Study|Protocol Violation|1|||
125919975|NCT01952145|453004650|FG000|Overall Study|Death|0|||
125919976|NCT01952145|453004651|FG001|Overall Study|Death|1|||
125919977|NCT01952145|453004650|FG000|Overall Study|Adverse Event|9|||
125919978|NCT01952145|453004651|FG001|Overall Study|Adverse Event|0|||
125919979|NCT01952145|453004650|FG000|Overall Study|Withdrawal Criteria|16|||
125919980|NCT01952145|453004651|FG001|Overall Study|Withdrawal Criteria|11|||
125919981|NCT01952145|453004650|FG000|Overall Study|Unclassified|1|||
125919982|NCT01952145|453004651|FG001|Overall Study|Unclassified|1|||
125919983|NCT03758066|453004652|FG000|Overall Study|Lost to Follow-up|14|||
125919984|NCT04138810|453004656|FG000|Overall Study|Withdrawal by Subject|0|||
125919985|NCT04138810|453004657|FG001|Overall Study|Withdrawal by Subject|1|||
125919986|NCT04138810|453004656|FG000|Overall Study|Subject cancelled surgery|1|||
125919987|NCT04138810|453004657|FG001|Overall Study|Subject cancelled surgery|0|||
125919988|NCT01786668|453004658|FG000|Overall Study|Adverse Event|0|||
125919989|NCT01786668|453004659|FG001|Overall Study|Adverse Event|1|||
125919990|NCT01786668|453004660|FG002|Overall Study|Adverse Event|1|||
125919991|NCT01786668|453004661|FG003|Overall Study|Adverse Event|2|||
125919992|NCT01786668|453004658|FG000|Overall Study|Withdrawal by Subject|0|||
125919993|NCT01786668|453004659|FG001|Overall Study|Withdrawal by Subject|0|||
125919994|NCT01786668|453004660|FG002|Overall Study|Withdrawal by Subject|3|||
125919995|NCT01786668|453004661|FG003|Overall Study|Withdrawal by Subject|1|||
125919996|NCT01786668|453004658|FG000|Overall Study|Pregnancy|0|||
125919997|NCT01786668|453004659|FG001|Overall Study|Pregnancy|0|||
125919998|NCT01786668|453004660|FG002|Overall Study|Pregnancy|0|||
125919999|NCT01786668|453004661|FG003|Overall Study|Pregnancy|1|||
125920000|NCT01786668|453004658|FG000|Overall Study|Lost to Follow-up|1|||
125920001|NCT01786668|453004659|FG001|Overall Study|Lost to Follow-up|0|||
125920002|NCT01786668|453004660|FG002|Overall Study|Lost to Follow-up|1|||
125920003|NCT01786668|453004661|FG003|Overall Study|Lost to Follow-up|0|||
125920004|NCT00762385|453004664|FG000|First Intervention|Lens Issue|1|||
125920005|NCT00762385|453004665|FG001|First Intervention|Lens Issue|1|||
125920006|NCT00762385|453004664|FG000|First Intervention|Lost to Follow-up|0|||
125920007|NCT00762385|453004665|FG001|First Intervention|Lost to Follow-up|2|||
125920008|NCT00762385|453004664|FG000|First Intervention|Ineligible|1|||
125920009|NCT00762385|453004665|FG001|First Intervention|Ineligible|0|||
125920010|NCT00762385|453004664|FG000|First Intervention|Protocol Violation|0|||
125920011|NCT00762385|453004665|FG001|First Intervention|Protocol Violation|1|||
125920012|NCT00762385|453004664|FG000|Second Intervention|Protocol Violation|3|||
125920013|NCT00762385|453004665|FG001|Second Intervention|Protocol Violation|3|||
125920014|NCT00493025|453004666|FG000|Overall Study|Physician Decision|19|||
125920015|NCT03068455|453004667|FG000|Pre-treatment Period|Disease progression|0|||
125920016|NCT03068455|453004668|FG001|Pre-treatment Period|Disease progression|1|||
125920017|NCT03068455|453004667|FG000|Pre-treatment Period|Participant withdrew consent|1|||
125920018|NCT03068455|453004668|FG001|Pre-treatment Period|Participant withdrew consent|1|||
125920019|NCT03068455|453004667|FG000|Pre-treatment Period|Poor/non-compliance|0|||
125920020|NCT03068455|453004668|FG001|Pre-treatment Period|Poor/non-compliance|1|||
125920021|NCT03068455|453004667|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
125920022|NCT03068455|453004668|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
125920023|NCT03068455|453004667|FG000|Pre-treatment Period|Not reported|2|||
125920024|NCT03068455|453004668|FG001|Pre-treatment Period|Not reported|1|||
125920025|NCT03068455|453004667|FG000|Treatment Period|Disease progression|166|||
125920026|NCT03068455|453004668|FG001|Treatment Period|Disease progression|208|||
125920027|NCT03068455|453004667|FG000|Treatment Period|Study drug toxicity|317|||
125920028|NCT03068455|453004668|FG001|Treatment Period|Study drug toxicity|104|||
125920029|NCT03068455|453004667|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
125920030|NCT03068455|453004668|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
125920031|NCT03068455|453004667|FG000|Treatment Period|Participant request to stop therapy|33|||
125920032|NCT03068455|453004668|FG001|Treatment Period|Participant request to stop therapy|20|||
125920033|NCT03068455|453004667|FG000|Treatment Period|Participant withdrew consent|5|||
125920034|NCT03068455|453004668|FG001|Treatment Period|Participant withdrew consent|10|||
125920035|NCT03068455|453004667|FG000|Treatment Period|Poor/non-compliance|3|||
125920036|NCT03068455|453004668|FG001|Treatment Period|Poor/non-compliance|0|||
125920037|NCT03068455|453004667|FG000|Treatment Period|Participant no longer meets study criteria|1|||
125920038|NCT03068455|453004668|FG001|Treatment Period|Participant no longer meets study criteria|3|||
125920039|NCT03068455|453004667|FG000|Treatment Period|Other reasons|12|||
125920040|NCT03068455|453004668|FG001|Treatment Period|Other reasons|4|||
125920041|NCT05338216|453004669|FG000|Overall Study|Withdrawal by Subject|1|||
125920042|NCT05338216|453004670|FG001|Overall Study|Withdrawal by Subject|1|||
125920043|NCT00446251|453004671|FG000|Overall Study|On-study Transplants|2|||
125920044|NCT00446251|453004671|FG000|Overall Study|Rituximab Infusion Reaction|2|||
125920045|NCT00446251|453004671|FG000|Overall Study|Lost to Follow-up|1|||
125920046|NCT04545060|453004674|FG000|Overall Study|Adverse Event|0|||
125920047|NCT04545060|453004675|FG001|Overall Study|Adverse Event|1|||
125920048|NCT04545060|453004674|FG000|Overall Study|Death|0|||
125920049|NCT04545060|453004675|FG001|Overall Study|Death|5|||
125920050|NCT04545060|453004674|FG000|Overall Study|Lost to Follow-up|10|||
125920051|NCT04545060|453004675|FG001|Overall Study|Lost to Follow-up|13|||
125920052|NCT04545060|453004674|FG000|Overall Study|Physician Decision|3|||
125920053|NCT04545060|453004675|FG001|Overall Study|Physician Decision|0|||
125920054|NCT04545060|453004674|FG000|Overall Study|Withdrawal by Subject|17|||
125920055|NCT04545060|453004675|FG001|Overall Study|Withdrawal by Subject|22|||
125920056|NCT00619177|453004678|FG000|Overall Study|Adverse Event|18|||
125920057|NCT00619177|453004678|FG000|Overall Study|Lost to Follow-up|2|||
125920058|NCT00619177|453004678|FG000|Overall Study|Lack of Efficacy|1|||
125920059|NCT00619177|453004678|FG000|Overall Study|Missing termination information|481|||
125920060|NCT00619177|453004678|FG000|Overall Study|Not specified reasons|6|||
125920061|NCT02319837|453004679|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
125920062|NCT02319837|453004680|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
125920063|NCT02319837|453004681|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
125920064|NCT02319837|453004679|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
125920065|NCT02319837|453004680|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
125920066|NCT02319837|453004681|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
125920067|NCT02319837|453004679|FG000|Study Treatment Phase|Adverse Event|73|||
125920068|NCT02319837|453004680|FG001|Study Treatment Phase|Adverse Event|36|||
125920069|NCT02319837|453004681|FG002|Study Treatment Phase|Adverse Event|63|||
125920070|NCT02319837|453004679|FG000|Study Treatment Phase|Development of castration resistance|0|||
125920071|NCT02319837|453004680|FG001|Study Treatment Phase|Development of castration resistance|2|||
125920072|NCT02319837|453004681|FG002|Study Treatment Phase|Development of castration resistance|0|||
125920073|NCT02319837|453004679|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
125920074|NCT02319837|453004680|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
125920075|NCT02319837|453004681|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
125920076|NCT02319837|453004679|FG000|Study Treatment Phase|Protocol Violation|2|||
125920077|NCT02319837|453004680|FG001|Study Treatment Phase|Protocol Violation|2|||
125920078|NCT02319837|453004681|FG002|Study Treatment Phase|Protocol Violation|1|||
125920079|NCT02319837|453004679|FG000|Study Treatment Phase|Lost to Follow-up|0|||
125920080|NCT02319837|453004680|FG001|Study Treatment Phase|Lost to Follow-up|1|||
125920081|NCT02319837|453004681|FG002|Study Treatment Phase|Lost to Follow-up|0|||
125920082|NCT02319837|453004679|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
125920083|NCT02319837|453004680|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
125920084|NCT02319837|453004681|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
125920085|NCT02319837|453004679|FG000|Study Treatment Phase|Other|0|||
125920086|NCT02319837|453004680|FG001|Study Treatment Phase|Other|1|||
125920087|NCT02319837|453004681|FG002|Study Treatment Phase|Other|0|||
125920088|NCT02319837|453004679|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
125920089|NCT02319837|453004680|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
125920090|NCT02319837|453004681|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
125920091|NCT02319837|453004679|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
125920092|NCT02319837|453004680|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
125920093|NCT02319837|453004681|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
125920094|NCT02319837|453004679|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
125920095|NCT02319837|453004680|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
125920096|NCT02319837|453004681|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
125920097|NCT02319837|453004679|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
125920098|NCT02319837|453004680|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
125920099|NCT02319837|453004681|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
125920100|NCT02319837|453004679|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
125920101|NCT02319837|453004680|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
125920102|NCT02319837|453004681|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
125920103|NCT02319837|453004679|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
125920104|NCT02319837|453004680|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
125920105|NCT02319837|453004681|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
125920106|NCT02319837|453004679|FG000|Long-Term Follow-Up Phase|Death|33|||
125920107|NCT02319837|453004680|FG001|Long-Term Follow-Up Phase|Death|54|||
125920108|NCT02319837|453004681|FG002|Long-Term Follow-Up Phase|Death|42|||
125920109|NCT00753766|453004686|FG000|Overall Study|Physician Decision|1|||
125920110|NCT00753766|453004687|FG001|Overall Study|Physician Decision|0|||
125920111|NCT04545554|453004688|FG000|Overall Study|Withdrawal by Subject|0|||
125920112|NCT04545554|453004689|FG001|Overall Study|Withdrawal by Subject|0|||
125920113|NCT04545554|453004690|FG002|Overall Study|Withdrawal by Subject|0|||
125920114|NCT04545554|453004691|FG003|Overall Study|Withdrawal by Subject|1|||
125920115|NCT04545554|453004692|FG004|Overall Study|Withdrawal by Subject|0|||
125920116|NCT04545554|453004693|FG005|Overall Study|Withdrawal by Subject|0|||
125920117|NCT00494299|453004694|FG000|Overall Study|Adverse Event|93|||
125920118|NCT00494299|453004695|FG001|Overall Study|Adverse Event|13|||
125920119|NCT00494299|453004694|FG000|Overall Study|Lost to Follow-up|1|||
125920120|NCT00494299|453004695|FG001|Overall Study|Lost to Follow-up|0|||
125920121|NCT00494299|453004694|FG000|Overall Study|Physician Decision|0|||
125920122|NCT00494299|453004695|FG001|Overall Study|Physician Decision|2|||
125920123|NCT00494299|453004694|FG000|Overall Study|Protocol Violation|1|||
125920124|NCT00494299|453004695|FG001|Overall Study|Protocol Violation|2|||
125920125|NCT00494299|453004694|FG000|Overall Study|Withdrawal by Subject|8|||
125920126|NCT00494299|453004695|FG001|Overall Study|Withdrawal by Subject|3|||
125920127|NCT00494299|453004694|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
125920128|NCT00494299|453004695|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
125920129|NCT00494299|453004694|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
125920130|NCT00494299|453004695|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
125920131|NCT00494299|453004694|FG000|Overall Study|Site Closed by Sponsor|6|||
125920132|NCT00494299|453004695|FG001|Overall Study|Site Closed by Sponsor|0|||
125920133|NCT00494299|453004694|FG000|Overall Study|Protocol Driven Decision Point|11|||
125920134|NCT00494299|453004695|FG001|Overall Study|Protocol Driven Decision Point|22|||
125920135|NCT05213481|453004698|FG000|Overall Study|Adverse Event|3|||
125920136|NCT05213481|453004698|FG000|Overall Study|Lost to Follow-up|1|||
125920137|NCT00415168|453004699|FG000|Overall Study|Death|26|||
125920138|NCT00415168|453004699|FG000|Overall Study|Lost to Follow-up|3|||
125920139|NCT00415168|453004699|FG000|Overall Study|Physician Decision|13|||
125920140|NCT00415168|453004699|FG000|Overall Study|Sponsor Decision|4|||
125920141|NCT00415168|453004699|FG000|Overall Study|Withdrawal by Subject|6|||
125920142|NCT02925117|453004704|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
125920143|NCT02925117|453004705|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
125920144|NCT02925117|453004706|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
125920145|NCT02925117|453004707|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
125920146|NCT02925117|453004708|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125920147|NCT02925117|453004709|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125920148|NCT02925117|453004710|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125920149|NCT02925117|453004711|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125920150|NCT02925117|453004712|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125920151|NCT02925117|453004713|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125920152|NCT02925117|453004714|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125920153|NCT02925117|453004715|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125920154|NCT02925117|453004704|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
125920155|NCT02925117|453004705|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
125920156|NCT02925117|453004706|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
125920157|NCT02925117|453004707|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920158|NCT02925117|453004708|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920159|NCT02925117|453004709|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920160|NCT02925117|453004710|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920161|NCT02925117|453004711|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920162|NCT02925117|453004712|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920163|NCT02925117|453004713|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920164|NCT02925117|453004714|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920165|NCT02925117|453004715|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125920166|NCT02925117|453004704|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
125920167|NCT02925117|453004705|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
125920168|NCT02925117|453004706|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920169|NCT02925117|453004707|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920170|NCT02925117|453004708|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920171|NCT02925117|453004709|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920172|NCT02925117|453004710|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920173|NCT02925117|453004711|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920174|NCT02925117|453004712|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920175|NCT02925117|453004713|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920176|NCT02925117|453004714|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920177|NCT02925117|453004715|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125920178|NCT02925117|453004704|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
125920179|NCT02925117|453004705|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
125920180|NCT02925117|453004706|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
125920181|NCT02925117|453004707|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
125920182|NCT02925117|453004708|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
125920183|NCT02925117|453004709|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
125920184|NCT02925117|453004710|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
125920185|NCT02925117|453004711|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
125920186|NCT02925117|453004712|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
125920187|NCT02925117|453004713|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
125920188|NCT02925117|453004714|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
125920189|NCT02925117|453004715|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
125920190|NCT02925117|453004704|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920191|NCT02925117|453004705|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920192|NCT02925117|453004706|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920193|NCT02925117|453004707|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920194|NCT02925117|453004708|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920195|NCT02925117|453004709|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
125920196|NCT02925117|453004710|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920197|NCT02925117|453004711|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920198|NCT02925117|453004712|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920199|NCT02925117|453004713|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125920200|NCT02925117|453004714|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
125920201|NCT02925117|453004715|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
125920202|NCT02925117|453004704|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125920203|NCT02925117|453004705|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125920204|NCT02925117|453004706|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125920205|NCT02925117|453004707|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125920206|NCT02925117|453004708|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125920207|NCT02925117|453004709|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
125920208|NCT02925117|453004710|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
125920209|NCT02925117|453004711|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
125920210|NCT02925117|453004712|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
125920211|NCT02925117|453004713|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
125920212|NCT02925117|453004714|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
125920213|NCT02925117|453004715|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
125920214|NCT02925117|453004704|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125920215|NCT02925117|453004705|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125920216|NCT02925117|453004706|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125920217|NCT02925117|453004707|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125920218|NCT02925117|453004708|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125920219|NCT02925117|453004709|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
125920220|NCT02925117|453004710|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125920221|NCT02925117|453004711|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125920222|NCT02925117|453004712|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125920223|NCT02925117|453004713|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125920224|NCT02925117|453004714|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125920225|NCT02925117|453004715|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125920226|NCT02925117|453004704|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
125920227|NCT02925117|453004705|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
125920228|NCT02925117|453004706|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
125920229|NCT02925117|453004707|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
125920230|NCT02925117|453004708|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
125920231|NCT02925117|453004709|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
125920232|NCT02925117|453004710|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
125920233|NCT02925117|453004711|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
125920234|NCT02925117|453004712|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
125920235|NCT02925117|453004713|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
125920236|NCT02925117|453004714|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
125920237|NCT02925117|453004715|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
125920238|NCT02059408|453004720|FG000|Overall Study|Did not get tested|0|||
125920239|NCT02059408|453004721|FG001|Overall Study|Did not get tested|330|||
125920240|NCT02059408|453004722|FG002|Overall Study|Did not get tested|358|||
125920241|NCT01681472|453004724|FG000|Overall Study|Adverse Event|0|||
125920242|NCT01681472|453004725|FG001|Overall Study|Adverse Event|1|||
125920243|NCT01681472|453004726|FG002|Overall Study|Adverse Event|0|||
125920244|NCT01681472|453004727|FG003|Overall Study|Adverse Event|0|||
125920245|NCT01187433|453004735|FG000|Overall Study|Protocol Violation|6|||
125920246|NCT01187433|453004736|FG001|Overall Study|Protocol Violation|2|||
125920247|NCT01187433|453004735|FG000|Overall Study|Withdrawal by Subject|5|||
125920248|NCT01187433|453004736|FG001|Overall Study|Withdrawal by Subject|2|||
125920249|NCT00242216|453004742|FG000|Overall Study|Lost to Follow-up|12|||
125920250|NCT00242216|453004743|FG001|Overall Study|Lost to Follow-up|17|||
125920251|NCT00242216|453004742|FG000|Overall Study|Death|4|||
125920252|NCT00242216|453004743|FG001|Overall Study|Death|2|||
125920253|NCT00242216|453004742|FG000|Overall Study|Lack of Efficacy|1|||
125920254|NCT00242216|453004743|FG001|Overall Study|Lack of Efficacy|2|||
125920255|NCT00242216|453004742|FG000|Overall Study|no medicaiton dispensed|1|||
125920256|NCT00242216|453004743|FG001|Overall Study|no medicaiton dispensed|1|||
125920257|NCT03128047|453004744|FG000|Overall Study|Withdrawal by Subject|1|||
125920258|NCT01995825|453006654|FG000|Overall Study|Withdrawal by Subject|1|||
125920259|NCT01995825|453006655|FG001|Overall Study|Withdrawal by Subject|0|||
125920260|NCT01385566|453006656|FG000|Overall Study|Lost to Follow-up|1|||
125920261|NCT01385566|453006657|FG001|Overall Study|Lost to Follow-up|0|||
125920262|NCT01385566|453006658|FG002|Overall Study|Lost to Follow-up|0|||
125920263|NCT01385566|453006659|FG003|Overall Study|Lost to Follow-up|0|||
125920264|NCT01385566|453006660|FG004|Overall Study|Lost to Follow-up|0|||
125920265|NCT01385566|453006661|FG005|Overall Study|Lost to Follow-up|0|||
125920266|NCT01385566|453006656|FG000|Overall Study|Withdrawal by Subject|0|||
125920267|NCT01385566|453006657|FG001|Overall Study|Withdrawal by Subject|0|||
125920268|NCT01385566|453006658|FG002|Overall Study|Withdrawal by Subject|0|||
125920269|NCT01385566|453006659|FG003|Overall Study|Withdrawal by Subject|1|||
125920270|NCT01385566|453006660|FG004|Overall Study|Withdrawal by Subject|0|||
125920271|NCT01385566|453006661|FG005|Overall Study|Withdrawal by Subject|0|||
125920272|NCT00403234|453006664|FG000|Overall Study|Withdrawal by Subject|0|||
125920273|NCT00403234|453006665|FG001|Overall Study|Withdrawal by Subject|1|||
125920274|NCT00403234|453006666|FG002|Overall Study|Withdrawal by Subject|0|||
125920275|NCT00403234|453006667|FG003|Overall Study|Withdrawal by Subject|0|||
125920276|NCT00403234|453006664|FG000|Overall Study|Adverse Event|1|||
125920277|NCT00403234|453006665|FG001|Overall Study|Adverse Event|0|||
125920278|NCT00403234|453006666|FG002|Overall Study|Adverse Event|1|||
125920279|NCT00403234|453006667|FG003|Overall Study|Adverse Event|0|||
125920280|NCT00560105|453006670|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
125920281|NCT00560105|453006671|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
125920282|NCT00283400|453006674|FG000|Overall Study|Withdrawal by Subject|1|||
125920283|NCT00283400|453006675|FG001|Overall Study|Withdrawal by Subject|1|||
125920284|NCT00283400|453006676|FG002|Overall Study|Withdrawal by Subject|0|||
125920285|NCT00283400|453006677|FG003|Overall Study|Withdrawal by Subject|0|||
125920286|NCT00283400|453006674|FG000|Overall Study|Death|1|||
125920287|NCT00283400|453006675|FG001|Overall Study|Death|0|||
125920288|NCT00283400|453006676|FG002|Overall Study|Death|1|||
125920289|NCT00283400|453006677|FG003|Overall Study|Death|0|||
125920290|NCT01034631|453006679|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
125920291|NCT01034631|453006680|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
125920292|NCT01034631|453006681|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
125920293|NCT01034631|453006679|FG000|Phase II|Not Evaluable per protocol|0|||
125920294|NCT01034631|453006680|FG001|Phase II|Not Evaluable per protocol|0|||
125920295|NCT01034631|453006681|FG002|Phase II|Not Evaluable per protocol|2|||
125920296|NCT01034631|453006679|FG000|Phase II|Determined Ineligible per protocol|0|||
125920297|NCT01034631|453006680|FG001|Phase II|Determined Ineligible per protocol|1|||
125920298|NCT01034631|453006681|FG002|Phase II|Determined Ineligible per protocol|0|||
125920299|NCT01560403|453006682|FG000|Overall Study|Lost to Follow-up|0|||
125920300|NCT01560403|453006683|FG001|Overall Study|Lost to Follow-up|1|||
125920301|NCT04218695|453006684|FG000|Overall Study|Adverse Event|1|||
125920302|NCT04218695|453006685|FG001|Overall Study|Adverse Event|0|||
125920303|NCT00983437|453006686|FG000|Overall Study|Adverse Event|9|||
125920304|NCT00983437|453006686|FG000|Overall Study|Lack of Efficacy|1|||
125920305|NCT00983437|453006686|FG000|Overall Study|Withdrawal by Subject|8|||
125920306|NCT00983437|453006686|FG000|Overall Study|Noncompliance to Study Procedures|1|||
125920307|NCT00983437|453006686|FG000|Overall Study|Lost to Follow-up|2|||
125920308|NCT00983437|453006686|FG000|Overall Study|Other Reason|26|||
125920309|NCT01890473|453006687|FG000|Overall Study|Lost to Follow-up|1|||
125920310|NCT01890473|453006688|FG001|Overall Study|Lost to Follow-up|0|||
125920311|NCT01890473|453006687|FG000|Overall Study|Poor/non-compliance|1|||
125920312|NCT01890473|453006688|FG001|Overall Study|Poor/non-compliance|0|||
125920313|NCT04019288|453006689|FG000|Overall Study|Death|1|||
125920314|NCT04019288|453006690|FG001|Overall Study|Death|0|||
125920315|NCT04019288|453006691|FG002|Overall Study|Death|0|||
125920316|NCT03166735|453006692|FG000|Overall Study|Not Treated|1|||
125920317|NCT03166735|453006693|FG001|Overall Study|Not Treated|0|||
125920318|NCT03166735|453006694|FG002|Overall Study|Not Treated|0|||
125920319|NCT03166735|453006695|FG003|Overall Study|Not Treated|0|||
125920320|NCT03166735|453006696|FG004|Overall Study|Not Treated|0|||
125920321|NCT03166735|453006692|FG000|Overall Study|follow-up not completed as planned|0|||
125920322|NCT03166735|453006693|FG001|Overall Study|follow-up not completed as planned|1|||
125920323|NCT03166735|453006694|FG002|Overall Study|follow-up not completed as planned|1|||
125920324|NCT03166735|453006695|FG003|Overall Study|follow-up not completed as planned|0|||
125920325|NCT03166735|453006696|FG004|Overall Study|follow-up not completed as planned|1|||
125920326|NCT03166735|453006692|FG000|Overall Study|Withdrawal by Subject|0|||
125920327|NCT03166735|453006693|FG001|Overall Study|Withdrawal by Subject|0|||
125920328|NCT03166735|453006694|FG002|Overall Study|Withdrawal by Subject|1|||
125920329|NCT03166735|453006695|FG003|Overall Study|Withdrawal by Subject|1|||
125920330|NCT03166735|453006696|FG004|Overall Study|Withdrawal by Subject|2|||
125920331|NCT03166735|453006692|FG000|Overall Study|Lost to Follow-up|0|||
125920332|NCT03166735|453006693|FG001|Overall Study|Lost to Follow-up|2|||
125920333|NCT03166735|453006694|FG002|Overall Study|Lost to Follow-up|1|||
125920334|NCT03166735|453006695|FG003|Overall Study|Lost to Follow-up|0|||
125920335|NCT03166735|453006696|FG004|Overall Study|Lost to Follow-up|1|||
125920336|NCT00934089|453006697|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
125920337|NCT00934089|453006698|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
125920338|NCT00934089|453006697|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
125920339|NCT00934089|453006698|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
125920340|NCT00003473|453006699|FG000|Overall Study|Three patients were not evaluable.|3|||
125920341|NCT00040365|453006707|FG000|Overall Study|Death|1|||
125920342|NCT00040365|453006707|FG000|Overall Study|Progressive disease|7|||
125920343|NCT00040365|453006707|FG000|Overall Study|Lost to Follow-up|3|||
125920344|NCT00541931|453006708|FG000|Overall Study|Adverse Event|1|||
125920345|NCT00541931|453006709|FG001|Overall Study|Adverse Event|0|||
125920346|NCT00541931|453006708|FG000|Overall Study|Lost to Follow-up|3|||
125920347|NCT00541931|453006709|FG001|Overall Study|Lost to Follow-up|3|||
125920348|NCT00541931|453006708|FG000|Overall Study|Withdrawal by Subject|1|||
125920349|NCT00541931|453006709|FG001|Overall Study|Withdrawal by Subject|0|||
125920350|NCT00541931|453006708|FG000|Overall Study|Transportation Issue|0|||
125920351|NCT00541931|453006709|FG001|Overall Study|Transportation Issue|1|||
125920352|NCT00680017|453006710|FG000|Overall Study|Adverse Event|13|||
125920353|NCT00680017|453006711|FG001|Overall Study|Adverse Event|7|||
125920354|NCT00680017|453006710|FG000|Overall Study|Withdrawal by Subject|2|||
125920355|NCT00680017|453006711|FG001|Overall Study|Withdrawal by Subject|5|||
125920356|NCT00680017|453006710|FG000|Overall Study|Lost to Follow-up|2|||
125920357|NCT00680017|453006711|FG001|Overall Study|Lost to Follow-up|0|||
125920358|NCT05154578|453006713|FG000|Overall Study|Withdrawal by Subject|2|||
125920359|NCT05154578|453006714|FG001|Overall Study|Withdrawal by Subject|3|||
125920360|NCT05154578|453006715|FG002|Overall Study|Withdrawal by Subject|2|||
125920361|NCT05154578|453006716|FG003|Overall Study|Withdrawal by Subject|4|||
125920362|NCT05154578|453006717|FG004|Overall Study|Withdrawal by Subject|0|||
125920363|NCT05154578|453006713|FG000|Overall Study|Lost to Follow-up|0|||
125920364|NCT05154578|453006714|FG001|Overall Study|Lost to Follow-up|1|||
125920365|NCT05154578|453006715|FG002|Overall Study|Lost to Follow-up|0|||
125920366|NCT05154578|453006716|FG003|Overall Study|Lost to Follow-up|3|||
125920367|NCT05154578|453006717|FG004|Overall Study|Lost to Follow-up|0|||
125920368|NCT05154578|453006713|FG000|Overall Study|Adverse Event|0|||
125920369|NCT05154578|453006714|FG001|Overall Study|Adverse Event|0|||
125920370|NCT05154578|453006715|FG002|Overall Study|Adverse Event|0|||
125920371|NCT05154578|453006716|FG003|Overall Study|Adverse Event|1|||
125920372|NCT05154578|453006717|FG004|Overall Study|Adverse Event|0|||
125920373|NCT05154578|453006713|FG000|Overall Study|Relocated to another province|0|||
125920374|NCT05154578|453006714|FG001|Overall Study|Relocated to another province|0|||
125920375|NCT05154578|453006715|FG002|Overall Study|Relocated to another province|1|||
125920376|NCT05154578|453006716|FG003|Overall Study|Relocated to another province|0|||
125920377|NCT05154578|453006717|FG004|Overall Study|Relocated to another province|1|||
125920378|NCT05154578|453006713|FG000|Overall Study|Baby loss|0|||
125920379|NCT05154578|453006714|FG001|Overall Study|Baby loss|1|||
125920380|NCT05154578|453006715|FG002|Overall Study|Baby loss|0|||
125920381|NCT05154578|453006716|FG003|Overall Study|Baby loss|0|||
125920382|NCT05154578|453006717|FG004|Overall Study|Baby loss|0|||
125920383|NCT04572633|453006723|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
125920384|NCT02924571|453006724|FG000|Overall Study|Lost to Follow-up|1|||
125920385|NCT02924571|453006725|FG001|Overall Study|Lost to Follow-up|1|||
125920386|NCT02924571|453006726|FG002|Overall Study|Lost to Follow-up|0|||
125920387|NCT01180985|453006731|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
125920388|NCT01180985|453006732|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
125920389|NCT00129272|453006737|FG000|Overall Study|Lost to Follow-up|12|||
125920390|NCT00129272|453006738|FG001|Overall Study|Lost to Follow-up|11|||
125920391|NCT00129272|453006737|FG000|Overall Study|Withdrawal by Subject|5|||
125920392|NCT00129272|453006738|FG001|Overall Study|Withdrawal by Subject|11|||
125920393|NCT03345914|453006739|FG000|Overall Study|Transition to another study at week 16|80|||
125920394|NCT03345914|453006740|FG001|Overall Study|Transition to another study at week 16|86|||
125920395|NCT03345914|453006741|FG002|Overall Study|Transition to another study at week 16|78|||
125920396|NCT03345914|453006739|FG000|Overall Study|Transition to OLE during follow-up|37|||
125920397|NCT03345914|453006740|FG001|Overall Study|Transition to OLE during follow-up|33|||
125920398|NCT03345914|453006741|FG002|Overall Study|Transition to OLE during follow-up|39|||
125920399|NCT03345914|453006739|FG000|Overall Study|Physician Decision|0|||
125920400|NCT03345914|453006740|FG001|Overall Study|Physician Decision|1|||
125920401|NCT03345914|453006741|FG002|Overall Study|Physician Decision|1|||
125920402|NCT03345914|453006739|FG000|Overall Study|Withdrawal by Subject|5|||
125920403|NCT03345914|453006740|FG001|Overall Study|Withdrawal by Subject|1|||
125920404|NCT03345914|453006741|FG002|Overall Study|Withdrawal by Subject|2|||
125920405|NCT03345914|453006739|FG000|Overall Study|Other|1|||
125920406|NCT03345914|453006740|FG001|Overall Study|Other|1|||
125920407|NCT03345914|453006741|FG002|Overall Study|Other|1|||
125920408|NCT03345914|453006739|FG000|Overall Study|Ongoing|0|||
125920409|NCT03345914|453006740|FG001|Overall Study|Ongoing|0|||
125920410|NCT03345914|453006741|FG002|Overall Study|Ongoing|1|||
125920411|NCT03570697|453006742|FG000|Overall Study|Lost to Follow-up|0|||
125920412|NCT03570697|453006743|FG001|Overall Study|Lost to Follow-up|1|||
125920413|NCT03570697|453006742|FG000|Overall Study|Death|2|||
125920414|NCT03570697|453006743|FG001|Overall Study|Death|0|||
125920415|NCT03570697|453006742|FG000|Overall Study|Withdrawal by Subject|4|||
125920416|NCT03570697|453006743|FG001|Overall Study|Withdrawal by Subject|2|||
125920417|NCT01849783|453006744|FG000|Overall Study|Adverse Event|5|||
125920418|NCT01849783|453006744|FG000|Overall Study|Death|2|||
125920419|NCT01849783|453006744|FG000|Overall Study|Physician Decision|1|||
125920420|NCT01849783|453006744|FG000|Overall Study|Withdrawal by Subject|1|||
125920421|NCT01849783|453006744|FG000|Overall Study|Unable to comply|2|||
125920422|NCT01849783|453006744|FG000|Overall Study|Disease progression|11|||
125920423|NCT01776840|453006745|FG000|Overall Study|Lost to Follow-up|12|||
125920424|NCT01776840|453006746|FG001|Overall Study|Lost to Follow-up|7|||
125920425|NCT01776840|453006745|FG000|Overall Study|Withdrawal by Subject|32|||
125920426|NCT01776840|453006746|FG001|Overall Study|Withdrawal by Subject|48|||
125920427|NCT01776840|453006745|FG000|Overall Study|Sponsor decision|89|||
125920428|NCT01776840|453006746|FG001|Overall Study|Sponsor decision|87|||
125920429|NCT03948581|453006748|FG000|Overall Study|Lost to Follow-up|0|||
125920430|NCT03948581|453006749|FG001|Overall Study|Lost to Follow-up|1|||
125920431|NCT03641339|453006750|FG000|Overall Study|Physician Decision|1|||
125920432|NCT03641339|453006751|FG001|Overall Study|Physician Decision|0|||
125920433|NCT03641339|453006752|FG002|Overall Study|Physician Decision|0|||
125920434|NCT03641339|453006753|FG003|Overall Study|Physician Decision|0|||
125920435|NCT03641339|453006754|FG004|Overall Study|Physician Decision|0|||
125920436|NCT03641339|453006755|FG005|Overall Study|Physician Decision|0|||
125920437|NCT03641339|453006750|FG000|Overall Study|Withdrawal by Subject|0|||
125920438|NCT03641339|453006751|FG001|Overall Study|Withdrawal by Subject|2|||
125920439|NCT03641339|453006752|FG002|Overall Study|Withdrawal by Subject|0|||
125920440|NCT03641339|453006753|FG003|Overall Study|Withdrawal by Subject|2|||
125920441|NCT03641339|453006754|FG004|Overall Study|Withdrawal by Subject|0|||
125920442|NCT03641339|453006755|FG005|Overall Study|Withdrawal by Subject|1|||
125920443|NCT01876420|453006757|FG000|Overall Study|Missed 30 day visit|1|||
125920444|NCT04515394|453006758|FG000|Overall Study|Participant did not receive treatment|1|||
125920445|NCT01042678|453006759|FG000|Overall Study|Physician Decision|1|||
125920446|NCT01042678|453006760|FG001|Overall Study|Physician Decision|0|||
125920447|NCT01042678|453006761|FG002|Overall Study|Physician Decision|0|||
125920448|NCT01042678|453006762|FG003|Overall Study|Physician Decision|0|||
125920449|NCT01042678|453006763|FG004|Overall Study|Physician Decision|0|||
125920450|NCT01042678|453006764|FG005|Overall Study|Physician Decision|0|||
125920451|NCT01058655|453006767|FG000|Overall Study|Withdrawal by Subject|1|||
125920452|NCT01058655|453006768|FG001|Overall Study|Withdrawal by Subject|0|||
125920453|NCT01058655|453006769|FG002|Overall Study|Withdrawal by Subject|3|||
125920454|NCT01058655|453006770|FG003|Overall Study|Withdrawal by Subject|4|||
125920455|NCT01058655|453006767|FG000|Overall Study|Prolonged Treatment Delay|0|||
125920456|NCT01058655|453006768|FG001|Overall Study|Prolonged Treatment Delay|0|||
125920457|NCT01058655|453006769|FG002|Overall Study|Prolonged Treatment Delay|0|||
125920458|NCT01058655|453006770|FG003|Overall Study|Prolonged Treatment Delay|2|||
125920459|NCT01058655|453006767|FG000|Overall Study|Symptomatic Deterioration|0|||
125920460|NCT01058655|453006768|FG001|Overall Study|Symptomatic Deterioration|0|||
125920461|NCT01058655|453006769|FG002|Overall Study|Symptomatic Deterioration|0|||
125920462|NCT01058655|453006770|FG003|Overall Study|Symptomatic Deterioration|1|||
125920463|NCT01058655|453006767|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
125920464|NCT01058655|453006768|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
125920465|NCT01058655|453006769|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
125920466|NCT01058655|453006770|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
125920467|NCT01058655|453006767|FG000|Overall Study|Death|0|||
125920468|NCT01058655|453006768|FG001|Overall Study|Death|1|||
125920469|NCT01058655|453006769|FG002|Overall Study|Death|1|||
125920470|NCT01058655|453006770|FG003|Overall Study|Death|0|||
125920471|NCT01058655|453006767|FG000|Overall Study|Disease Progression|1|||
125920472|NCT01058655|453006768|FG001|Overall Study|Disease Progression|2|||
125920473|NCT01058655|453006769|FG002|Overall Study|Disease Progression|4|||
125920474|NCT01058655|453006770|FG003|Overall Study|Disease Progression|24|||
125920475|NCT01058655|453006767|FG000|Overall Study|Other|0|||
125920476|NCT01058655|453006768|FG001|Overall Study|Other|0|||
125920477|NCT01058655|453006769|FG002|Overall Study|Other|0|||
125920478|NCT01058655|453006770|FG003|Overall Study|Other|4|||
125920479|NCT04472429|453006774|FG000|Randomized Period|Ongoing|90|||
125920480|NCT04472429|453006775|FG001|Randomized Period|Ongoing|40|||
125920481|NCT04472429|453006776|FG002|Randomized Period|Ongoing|0|||
125920482|NCT04472429|453006774|FG000|Randomized Period|Death|52|||
125920483|NCT04472429|453006775|FG001|Randomized Period|Death|37|||
125920484|NCT04472429|453006776|FG002|Randomized Period|Death|0|||
125920485|NCT04472429|453006774|FG000|Randomized Period|Lost to Follow-up|4|||
125920486|NCT04472429|453006775|FG001|Randomized Period|Lost to Follow-up|0|||
125920487|NCT04472429|453006776|FG002|Randomized Period|Lost to Follow-up|0|||
125920488|NCT04472429|453006774|FG000|Randomized Period|Physician Decision|1|||
125920489|NCT04472429|453006775|FG001|Randomized Period|Physician Decision|2|||
125920490|NCT04472429|453006776|FG002|Randomized Period|Physician Decision|0|||
125920491|NCT04472429|453006774|FG000|Randomized Period|Withdrawal by Subject|6|||
125920492|NCT04472429|453006775|FG001|Randomized Period|Withdrawal by Subject|5|||
125920493|NCT04472429|453006776|FG002|Randomized Period|Withdrawal by Subject|0|||
125920494|NCT04472429|453006774|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
125920495|NCT04472429|453006775|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
125920496|NCT04472429|453006776|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
125920497|NCT04472429|453006774|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
125920498|NCT04472429|453006775|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
125920499|NCT04472429|453006776|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
125920500|NCT04472429|453006774|FG000|Open-label Monotherapy Period|Ongoing|0|||
125920501|NCT04472429|453006775|FG001|Open-label Monotherapy Period|Ongoing|0|||
125920502|NCT04472429|453006776|FG002|Open-label Monotherapy Period|Ongoing|32|||
125920503|NCT04472429|453006774|FG000|Open-label Monotherapy Period|Death|0|||
125920504|NCT04472429|453006775|FG001|Open-label Monotherapy Period|Death|0|||
125920505|NCT04472429|453006776|FG002|Open-label Monotherapy Period|Death|35|||
125920506|NCT04472429|453006774|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
125920507|NCT04472429|453006775|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
125920508|NCT04472429|453006776|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
125920509|NCT01416272|453006779|FG000|Overall Study|Unacceptable distance visual acuity|2|||
125920510|NCT01416272|453006779|FG000|Overall Study|Lost to Follow-up|1|||
125920511|NCT01416272|453006779|FG000|Overall Study|Study related complaints|1|||
125920512|NCT01313312|453006780|FG000|Overall Study|Adverse Event|5|||
125920513|NCT01313312|453006780|FG000|Overall Study|Withdrawal by Subject|18|||
125920514|NCT01313312|453006780|FG000|Overall Study|Lack of Efficacy|3|||
125920515|NCT01313312|453006780|FG000|Overall Study|Investigator Decision|1|||
125920516|NCT01313312|453006780|FG000|Overall Study|Observational Phase|1|||
125920517|NCT01313312|453006780|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
125920518|NCT01313312|453006780|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
125920519|NCT00892047|453006781|FG000|Overall Study|Adverse Event|2|||
125920520|NCT00892047|453006782|FG001|Overall Study|Adverse Event|2|||
125920521|NCT00892047|453006781|FG000|Overall Study|subject burden|2|||
125920522|NCT00892047|453006782|FG001|Overall Study|subject burden|3|||
125920523|NCT00892047|453006781|FG000|Overall Study|Lack of Efficacy|0|||
125920524|NCT00892047|453006782|FG001|Overall Study|Lack of Efficacy|2|||
125920525|NCT05306977|453006783|FG000|Overall Study|Withdrawal by Subject|1|||
125920526|NCT01387789|453006789|FG000|Overall Study|Adverse Event|5|||
125920527|NCT01387789|453006789|FG000|Overall Study|Lack of Efficacy|2|||
125920528|NCT01387789|453006789|FG000|Overall Study|Lost to Follow-up|1|||
125920529|NCT00181155|453006790|FG000|Overall Study|Physician Decision|1|||
125920530|NCT00181155|453006791|FG001|Overall Study|Physician Decision|0|||
125920531|NCT00181155|453006790|FG000|Overall Study|Withdrawal by Subject|1|||
125920532|NCT00181155|453006791|FG001|Overall Study|Withdrawal by Subject|0|||
125920533|NCT01788228|453006792|FG000|Overall Study|Migrated/moved from study area|1|||
125920534|NCT01788228|453006793|FG001|Overall Study|Migrated/moved from study area|0|||
125920535|NCT01548287|453006796|FG000|Screening|No reason provided|0|||
125920536|NCT01548287|453006797|FG001|Screening|No reason provided|0|||
125920537|NCT01548287|453006798|FG002|Screening|No reason provided|0|||
125920538|NCT01548287|453006799|FG003|Screening|No reason provided|0|||
125920539|NCT01548287|453006800|FG004|Screening|No reason provided|9|||
125920540|NCT01548287|453006796|FG000|Screening|Did not meet eligibility criteria|0|||
125920541|NCT01548287|453006797|FG001|Screening|Did not meet eligibility criteria|0|||
125920542|NCT01548287|453006798|FG002|Screening|Did not meet eligibility criteria|0|||
125920543|NCT01548287|453006799|FG003|Screening|Did not meet eligibility criteria|0|||
125920544|NCT01548287|453006800|FG004|Screening|Did not meet eligibility criteria|74|||
125920545|NCT01548287|453006796|FG000|Randomized Period|Did not meet inclusion criteria|0|||
125920546|NCT01548287|453006797|FG001|Randomized Period|Did not meet inclusion criteria|0|||
125920547|NCT01548287|453006798|FG002|Randomized Period|Did not meet inclusion criteria|2|||
125920548|NCT01548287|453006799|FG003|Randomized Period|Did not meet inclusion criteria|0|||
125920549|NCT01548287|453006800|FG004|Randomized Period|Did not meet inclusion criteria|0|||
125920550|NCT01548287|453006796|FG000|Randomized Period|Adverse Event|0|||
125920551|NCT01548287|453006797|FG001|Randomized Period|Adverse Event|2|||
125920552|NCT01548287|453006798|FG002|Randomized Period|Adverse Event|5|||
125920553|NCT01548287|453006799|FG003|Randomized Period|Adverse Event|0|||
125920554|NCT01548287|453006800|FG004|Randomized Period|Adverse Event|0|||
125920555|NCT00289783|453006807|FG000|Primary Phase|Adverse Event|10|||
125920556|NCT00289783|453006808|FG001|Primary Phase|Adverse Event|1|||
125920557|NCT00289783|453006807|FG000|Primary Phase|Protocol Violation|27|||
125920558|NCT00289783|453006808|FG001|Primary Phase|Protocol Violation|6|||
125920559|NCT00289783|453006807|FG000|Primary Phase|Withdrawal by Subject|93|||
125920560|NCT00289783|453006808|FG001|Primary Phase|Withdrawal by Subject|40|||
125920561|NCT00289783|453006807|FG000|Primary Phase|Lost to Follow-up|60|||
125920562|NCT00289783|453006808|FG001|Primary Phase|Lost to Follow-up|14|||
125920563|NCT00289783|453006807|FG000|Primary Phase|Migration from the study area|26|||
125920564|NCT00289783|453006808|FG001|Primary Phase|Migration from the study area|10|||
125920565|NCT00289783|453006807|FG000|Primary Phase|Other|32|||
125920566|NCT00289783|453006808|FG001|Primary Phase|Other|12|||
125920567|NCT00289783|453006807|FG000|Fourth Dose Phase|Adverse Event|1|||
125920568|NCT00289783|453006808|FG001|Fourth Dose Phase|Adverse Event|0|||
125920569|NCT00289783|453006807|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
125920570|NCT00289783|453006808|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
125920571|NCT00289783|453006807|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
125920572|NCT00289783|453006808|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
125920573|NCT00289783|453006807|FG000|Fourth Dose Phase|Migration from the study area|1|||
125920574|NCT00289783|453006808|FG001|Fourth Dose Phase|Migration from the study area|1|||
125920575|NCT00289783|453006807|FG000|Fourth Dose Phase|Other|22|||
125920576|NCT00289783|453006808|FG001|Fourth Dose Phase|Other|10|||
125920577|NCT00566995|453006811|FG000|Overall Study|Toxicity|4|||
125920578|NCT00566995|453006811|FG000|Overall Study|Withdrew consent|3|||
125920579|NCT00594659|453006819|FG000|Overall Study|Lost to Follow-up|13|||
125920580|NCT00594659|453006820|FG001|Overall Study|Lost to Follow-up|9|||
125920581|NCT00594659|453006821|FG002|Overall Study|Lost to Follow-up|7|||
125920582|NCT00660699|453006822|FG000|Overall Study|Withdrawal by Subject|2|||
125920583|NCT05358444|453006833|FG000|Overall Study|Withdrawal by Subject|0|||
125920584|NCT05358444|453006834|FG001|Overall Study|Withdrawal by Subject|1|||
125920585|NCT05358444|453006833|FG000|Overall Study|Lost to Follow-up|0|||
125920586|NCT05358444|453006834|FG001|Overall Study|Lost to Follow-up|3|||
125920587|NCT01752985|453006835|FG000|Treatment Period|Subject request to discontinue treatment|1|||
125920588|NCT01752985|453006836|FG001|Treatment Period|Subject request to discontinue treatment|0|||
125920589|NCT01752985|453006837|FG002|Treatment Period|Subject request to discontinue treatment|1|||
125920590|NCT01752985|453006835|FG000|Treatment Period|Subject no longer meets study criteria|0|||
125920591|NCT01752985|453006836|FG001|Treatment Period|Subject no longer meets study criteria|1|||
125920592|NCT01752985|453006837|FG002|Treatment Period|Subject no longer meets study criteria|1|||
125920593|NCT01752985|453006835|FG000|Treatment Period|Adverse Event|2|||
125920594|NCT01752985|453006836|FG001|Treatment Period|Adverse Event|1|||
125920595|NCT01752985|453006837|FG002|Treatment Period|Adverse Event|2|||
125920596|NCT01752985|453006835|FG000|Treatment Period|Withdrawal by Subject|1|||
125920597|NCT01752985|453006836|FG001|Treatment Period|Withdrawal by Subject|1|||
125920598|NCT01752985|453006837|FG002|Treatment Period|Withdrawal by Subject|0|||
125920599|NCT01752985|453006835|FG000|Treatment Period|Lost to Follow-up|0|||
125920600|NCT01752985|453006836|FG001|Treatment Period|Lost to Follow-up|0|||
125920601|NCT01752985|453006837|FG002|Treatment Period|Lost to Follow-up|1|||
125920602|NCT04092582|453008247|FG000|Overall Study|Death|1|||
125920603|NCT04092582|453008248|FG001|Overall Study|Death|1|||
125920604|NCT04092582|453008247|FG000|Overall Study|Withdrawal by Subject|4|||
125920605|NCT04092582|453008248|FG001|Overall Study|Withdrawal by Subject|1|||
125920606|NCT04092582|453008247|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
125920607|NCT04092582|453008248|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
125920608|NCT02025621|453008254|FG000|Overall Study|Withdrawal by Subject|1|||
125920609|NCT02025621|453008255|FG001|Overall Study|Withdrawal by Subject|0|||
125920610|NCT02025621|453008254|FG000|Overall Study|Death|0|||
125920611|NCT02025621|453008255|FG001|Overall Study|Death|1|||
125920612|NCT02025621|453008254|FG000|Overall Study|No longer eligible|10|||
125920613|NCT02025621|453008255|FG001|Overall Study|No longer eligible|15|||
125920614|NCT02025621|453008254|FG000|Overall Study|Surgery initiated before infusion|3|||
125920615|NCT02025621|453008255|FG001|Overall Study|Surgery initiated before infusion|3|||
125920616|NCT00739674|453008256|FG000|Overall Study|Screening failures|19|||
125920617|NCT00739674|453008257|FG001|Overall Study|Screening failures|17|||
125920618|NCT00739674|453008256|FG000|Overall Study|Site 212 removal|19|||
125920619|NCT00739674|453008257|FG001|Overall Study|Site 212 removal|13|||
125920620|NCT00739674|453008256|FG000|Overall Study|No follow-up data|33|||
125920621|NCT00739674|453008257|FG001|Overall Study|No follow-up data|18|||
125920622|NCT00739674|453008256|FG000|Overall Study|Dietician consultation >30 days|1|||
125920623|NCT00739674|453008257|FG001|Overall Study|Dietician consultation >30 days|9|||
125920624|NCT00739674|453008256|FG000|Overall Study|Adverse Event|22|||
125920625|NCT00739674|453008257|FG001|Overall Study|Adverse Event|13|||
125920626|NCT00739674|453008256|FG000|Overall Study|Death|1|||
125920627|NCT00739674|453008257|FG001|Overall Study|Death|0|||
125920628|NCT00739674|453008256|FG000|Overall Study|Lack of Efficacy|1|||
125920629|NCT00739674|453008257|FG001|Overall Study|Lack of Efficacy|0|||
125920630|NCT00739674|453008256|FG000|Overall Study|Lost to Follow-up|52|||
125920631|NCT00739674|453008257|FG001|Overall Study|Lost to Follow-up|30|||
125920632|NCT00739674|453008256|FG000|Overall Study|Protocol Violation|5|||
125920633|NCT00739674|453008257|FG001|Overall Study|Protocol Violation|5|||
125920634|NCT00739674|453008256|FG000|Overall Study|Withdrawal by Subject|9|||
125920635|NCT00739674|453008257|FG001|Overall Study|Withdrawal by Subject|9|||
125920636|NCT00739674|453008256|FG000|Overall Study|Reason missing|2|||
125920637|NCT00739674|453008257|FG001|Overall Study|Reason missing|0|||
125920638|NCT00739674|453008256|FG000|Overall Study|Clinic closed|6|||
125920639|NCT00739674|453008257|FG001|Overall Study|Clinic closed|4|||
125920640|NCT00739674|453008256|FG000|Overall Study|Patient moved|3|||
125920641|NCT00739674|453008257|FG001|Overall Study|Patient moved|2|||
125920642|NCT00739674|453008256|FG000|Overall Study|Non compliant|4|||
125920643|NCT00739674|453008257|FG001|Overall Study|Non compliant|0|||
125920644|NCT00739674|453008256|FG000|Overall Study|Unable to attend visit|3|||
125920645|NCT00739674|453008257|FG001|Overall Study|Unable to attend visit|1|||
125920646|NCT00739674|453008256|FG000|Overall Study|Home monitoring off meds|1|||
125920647|NCT00739674|453008257|FG001|Overall Study|Home monitoring off meds|0|||
125920648|NCT00739674|453008256|FG000|Overall Study|Erectile dysfunction|0|||
125920649|NCT00739674|453008257|FG001|Overall Study|Erectile dysfunction|1|||
125920650|NCT04805541|453008259|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
125920651|NCT01945281|453008264|FG000|Overall Study|Adverse Event|1|||
125920652|NCT01945281|453008265|FG001|Overall Study|Adverse Event|0|||
125920653|NCT01945281|453008264|FG000|Overall Study|Death|3|||
125920654|NCT01945281|453008265|FG001|Overall Study|Death|3|||
125920655|NCT01945281|453008264|FG000|Overall Study|Physician Decision|1|||
125920656|NCT01945281|453008265|FG001|Overall Study|Physician Decision|1|||
125920657|NCT01945281|453008264|FG000|Overall Study|Technical Problems|1|||
125920658|NCT01945281|453008265|FG001|Overall Study|Technical Problems|0|||
125920659|NCT04401423|453008266|FG000|Overall Study|Withdrawal by Subject|3|||
125920660|NCT04401423|453008267|FG001|Overall Study|Withdrawal by Subject|1|||
125920661|NCT04401423|453008266|FG000|Overall Study|Physician Decision|2|||
125920662|NCT04401423|453008267|FG001|Overall Study|Physician Decision|1|||
125920663|NCT01020981|453008270|FG000|Overall Study|Did not return mailed survey|74|||
125920664|NCT01020981|453008271|FG001|Overall Study|Did not return mailed survey|58|||
125920665|NCT01020981|453008270|FG000|Overall Study|Survey returned undeliverable|8|||
125920666|NCT01020981|453008271|FG001|Overall Study|Survey returned undeliverable|32|||
125920667|NCT01020981|453008270|FG000|Overall Study|Participant declined to complete survey|2|||
125920668|NCT01020981|453008271|FG001|Overall Study|Participant declined to complete survey|0|||
125920669|NCT00799383|453008276|FG000|Overall Study|Protocol Violation|1|||
125920670|NCT00799383|453008277|FG001|Overall Study|Protocol Violation|1|||
125920671|NCT00799383|453008276|FG000|Overall Study|Adverse Event|0|||
125920672|NCT00799383|453008277|FG001|Overall Study|Adverse Event|1|||
125920673|NCT00799383|453008276|FG000|Overall Study|Lost to Follow-up|1|||
125920674|NCT00799383|453008277|FG001|Overall Study|Lost to Follow-up|2|||
125920675|NCT00799383|453008276|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
125920676|NCT00799383|453008277|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
125920677|NCT00799383|453008276|FG000|Overall Study|Withdrawal by Subject|0|||
125920678|NCT00799383|453008277|FG001|Overall Study|Withdrawal by Subject|1|||
125920679|NCT00726986|453008278|FG000|Induction Phase|Adverse Event|4|||
125920680|NCT00726986|453008278|FG000|Induction Phase|Withdrawal by Subject|2|||
125920681|NCT00726986|453008278|FG000|Induction Phase|Death|2|||
125920682|NCT00726986|453008278|FG000|Induction Phase|Lack of Efficacy|5|||
125920683|NCT00726986|453008278|FG000|Induction Phase|Secondary Disease|2|||
125920684|NCT00726986|453008278|FG000|Maintenance Phase|Adverse Event|1|||
125920685|NCT00726986|453008278|FG000|Maintenance Phase|Lack of Efficacy|2|||
125920686|NCT00612040|453008279|FG000|Overall Study|Adverse Event|0|||
125920687|NCT00612040|453008280|FG001|Overall Study|Adverse Event|2|||
125920688|NCT00612040|453008281|FG002|Overall Study|Adverse Event|1|||
125920689|NCT00612040|453008279|FG000|Overall Study|Protocol Violation|1|||
125920690|NCT00612040|453008280|FG001|Overall Study|Protocol Violation|2|||
125920691|NCT00612040|453008281|FG002|Overall Study|Protocol Violation|1|||
125920692|NCT00612040|453008279|FG000|Overall Study|Lack of Efficacy|2|||
125920693|NCT00612040|453008280|FG001|Overall Study|Lack of Efficacy|1|||
125920694|NCT00612040|453008281|FG002|Overall Study|Lack of Efficacy|0|||
125920695|NCT00612040|453008279|FG000|Overall Study|Unclassified|2|||
125920696|NCT00612040|453008280|FG001|Overall Study|Unclassified|2|||
125920697|NCT00612040|453008281|FG002|Overall Study|Unclassified|5|||
125920698|NCT01086033|453008282|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
125920699|NCT01086033|453008282|FG000|Overall Study|Lost to Follow-up|86|||
125920700|NCT01086033|453008282|FG000|Overall Study|Adverse Event|42|||
125920701|NCT01086033|453008282|FG000|Overall Study|Withdrawal by Subject|41|||
125920702|NCT01086033|453008282|FG000|Overall Study|Other|14|||
125920703|NCT01086033|453008282|FG000|Overall Study|Other|13|||
125920704|NCT01086033|453008282|FG000|Overall Study|AE and Withdrew Consent|5|||
125920705|NCT01086033|453008282|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
125920706|NCT01086033|453008282|FG000|Overall Study|Withdrew consent and Other Reason|4|||
125920707|NCT01086033|453008282|FG000|Overall Study|AE and Lack of Efficacy|4|||
125920708|NCT01086033|453008282|FG000|Overall Study|Death|1|||
125920709|NCT01086033|453008282|FG000|Overall Study|AE and Lost to Follow-up|1|||
125920710|NCT01086033|453008282|FG000|Overall Study|AE and Other Reason|1|||
125920711|NCT01086033|453008282|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
125920712|NCT03478657|453008286|FG000|Overall Study|Withdrawal by Subject|0|||
125920713|NCT03478657|453008287|FG001|Overall Study|Withdrawal by Subject|1|||
125920714|NCT02590003|453008288|FG000|Overall Study|Death|1|||
125920715|NCT02590003|453008289|FG001|Overall Study|Death|2|||
125920716|NCT03330288|453008296|FG000|Overall Study|Other reason|1|||
125920717|NCT03330288|453008297|FG001|Overall Study|Other reason|1|||
125920718|NCT03330288|453008296|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
125920719|NCT03330288|453008297|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
125920720|NCT03330288|453008296|FG000|Overall Study|Adverse Event|1|||
125920721|NCT03330288|453008297|FG001|Overall Study|Adverse Event|0|||
125920722|NCT03330288|453008296|FG000|Overall Study|Withdrawal by Subject|1|||
125920723|NCT03330288|453008297|FG001|Overall Study|Withdrawal by Subject|0|||
125920724|NCT03330288|453008296|FG000|Overall Study|Lost to Follow-up|26|||
125920725|NCT03330288|453008297|FG001|Overall Study|Lost to Follow-up|7|||
125920726|NCT01719783|453008303|FG000|Dose 2|Physician Decision|1|||
125920727|NCT01719783|453008304|FG001|Dose 2|Physician Decision|0|||
125920728|NCT01254331|453008306|FG000|Initial Phase|Adverse Event|3|||
125920729|NCT01254331|453008306|FG000|Initial Phase|Withdrawal by Subject|1|||
125920730|NCT01254331|453008306|FG000|Initial Phase|Pregnancy|1|||
125920731|NCT01254331|453008306|FG000|Extension Phase|Lack of Efficacy|1|||
125920732|NCT01254331|453008306|FG000|Extension Phase|Lost to Follow-up|3|||
125920733|NCT01443078|453008307|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
125920734|NCT01443078|453008307|FG000|Overall Study|Withdrawal by Subject|1|||
125920735|NCT01443078|453008307|FG000|Overall Study|Patient had brain mets|1|||
125920736|NCT01612858|453008308|FG000|Overall Study|Withdrawal by Subject|5|||
125920737|NCT01612858|453008309|FG001|Overall Study|Withdrawal by Subject|1|||
125920738|NCT03988088|453008316|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
125920739|NCT03988088|453008317|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
125920740|NCT03988088|453008318|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
125920741|NCT03988088|453008319|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
125920742|NCT03988088|453008316|FG000|Open-Label Addendum|Lost to Follow-up|0|||
125920743|NCT03988088|453008317|FG001|Open-Label Addendum|Lost to Follow-up|0|||
125920744|NCT03988088|453008318|FG002|Open-Label Addendum|Lost to Follow-up|1|||
125920745|NCT03988088|453008319|FG003|Open-Label Addendum|Lost to Follow-up|0|||
125920746|NCT02993757|453008323|FG000|Overall Study|Non compliance with the protocol|155|||
125920747|NCT02993757|453008324|FG001|Overall Study|Non compliance with the protocol|170|||
125920748|NCT02993757|453008323|FG000|Overall Study|Lost to Follow-up|1|||
125920749|NCT02993757|453008324|FG001|Overall Study|Lost to Follow-up|0|||
125920750|NCT02993757|453008323|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
125920751|NCT02993757|453008324|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
125920752|NCT02762578|453008327|FG000|Overall Study|Adverse Event|1|||
125920753|NCT02762578|453008328|FG001|Overall Study|Adverse Event|6|||
125920754|NCT02762578|453008327|FG000|Overall Study|Protocol Violation|4|||
125920755|NCT02762578|453008328|FG001|Overall Study|Protocol Violation|2|||
125920756|NCT02762578|453008327|FG000|Overall Study|Withdrawal by Subject|4|||
125920757|NCT02762578|453008328|FG001|Overall Study|Withdrawal by Subject|2|||
125920758|NCT02762578|453008327|FG000|Overall Study|Unclassified|6|||
125920759|NCT02762578|453008328|FG001|Overall Study|Unclassified|0|||
125920760|NCT00259610|453008329|FG000|Overall Study|Withdrawal by Subject|33|||
125920761|NCT00259610|453008330|FG001|Overall Study|Withdrawal by Subject|25|||
125920762|NCT00259610|453008331|FG002|Overall Study|Withdrawal by Subject|29|||
125920763|NCT00259610|453008332|FG003|Overall Study|Withdrawal by Subject|19|||
125920764|NCT00259610|453008329|FG000|Overall Study|Lost to Follow-up|19|||
125920765|NCT00259610|453008330|FG001|Overall Study|Lost to Follow-up|8|||
125920766|NCT00259610|453008331|FG002|Overall Study|Lost to Follow-up|18|||
125920767|NCT00259610|453008332|FG003|Overall Study|Lost to Follow-up|15|||
125920768|NCT00259610|453008329|FG000|Overall Study|Physician Decision|6|||
125920769|NCT00259610|453008330|FG001|Overall Study|Physician Decision|4|||
125920770|NCT00259610|453008331|FG002|Overall Study|Physician Decision|7|||
125920771|NCT00259610|453008332|FG003|Overall Study|Physician Decision|2|||
125920772|NCT00259610|453008329|FG000|Overall Study|Death|1|||
125920773|NCT00259610|453008330|FG001|Overall Study|Death|1|||
125920774|NCT00259610|453008331|FG002|Overall Study|Death|2|||
125920775|NCT00259610|453008332|FG003|Overall Study|Death|0|||
125920776|NCT00259610|453008329|FG000|Overall Study|non medical reason|6|||
125920777|NCT00259610|453008330|FG001|Overall Study|non medical reason|2|||
125920778|NCT00259610|453008331|FG002|Overall Study|non medical reason|10|||
125920779|NCT00259610|453008332|FG003|Overall Study|non medical reason|3|||
125920780|NCT00259610|453008329|FG000|Overall Study|Adverse Event|3|||
125920781|NCT00259610|453008330|FG001|Overall Study|Adverse Event|4|||
125920782|NCT00259610|453008331|FG002|Overall Study|Adverse Event|5|||
125920783|NCT00259610|453008332|FG003|Overall Study|Adverse Event|2|||
125920784|NCT00259610|453008329|FG000|Overall Study|Serious Adverse Event|8|||
125920785|NCT00259610|453008330|FG001|Overall Study|Serious Adverse Event|2|||
125920786|NCT00259610|453008331|FG002|Overall Study|Serious Adverse Event|2|||
125920787|NCT00259610|453008332|FG003|Overall Study|Serious Adverse Event|2|||
125920788|NCT00957580|453008335|FG000|Overall Study|Ongoing at data cut-off|0|||
125920789|NCT00957580|453008336|FG001|Overall Study|Ongoing at data cut-off|1|||
125920790|NCT00957580|453008337|FG002|Overall Study|Ongoing at data cut-off|0|||
125920791|NCT00957580|453008335|FG000|Overall Study|Enrolled but not treated|0|||
125920792|NCT00957580|453008336|FG001|Overall Study|Enrolled but not treated|1|||
125920793|NCT00957580|453008337|FG002|Overall Study|Enrolled but not treated|0|||
125920794|NCT01090492|453008338|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
125920795|NCT01090492|453008339|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
125920796|NCT01090492|453008340|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
125920797|NCT01090492|453008341|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
125920798|NCT01090492|453008342|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
125920799|NCT01090492|453008343|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
125920800|NCT01090492|453008344|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
125920801|NCT01090492|453008345|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
125920802|NCT01090492|453008338|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125920803|NCT01090492|453008339|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
125920804|NCT01090492|453008340|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125920805|NCT01090492|453008341|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125920806|NCT01090492|453008342|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125920807|NCT01090492|453008343|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125920808|NCT01090492|453008344|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125920809|NCT01090492|453008345|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
125920810|NCT01090492|453008338|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920811|NCT01090492|453008339|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920812|NCT01090492|453008340|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
125920813|NCT01090492|453008341|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920814|NCT01090492|453008342|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920815|NCT01090492|453008343|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920816|NCT01090492|453008344|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920817|NCT01090492|453008345|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920818|NCT01090492|453008338|FG000|First Intervention Period (4 Weeks)|Other|0|||
125920819|NCT01090492|453008339|FG001|First Intervention Period (4 Weeks)|Other|0|||
125920820|NCT01090492|453008340|FG002|First Intervention Period (4 Weeks)|Other|1|||
125920821|NCT01090492|453008341|FG003|First Intervention Period (4 Weeks)|Other|1|||
125920822|NCT01090492|453008342|FG004|First Intervention Period (4 Weeks)|Other|2|||
125920823|NCT01090492|453008343|FG005|First Intervention Period (4 Weeks)|Other|0|||
125920824|NCT01090492|453008344|FG006|First Intervention Period (4 Weeks)|Other|0|||
125920825|NCT01090492|453008345|FG007|First Intervention Period (4 Weeks)|Other|0|||
125920826|NCT01090492|453008338|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
125920827|NCT01090492|453008339|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
125920828|NCT01090492|453008340|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
125920829|NCT01090492|453008341|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
125920830|NCT01090492|453008342|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
125920831|NCT01090492|453008343|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
125920832|NCT01090492|453008344|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
125920833|NCT01090492|453008345|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
125920834|NCT01090492|453008338|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
125920835|NCT01090492|453008339|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
125920836|NCT01090492|453008340|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
125920837|NCT01090492|453008341|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
125920838|NCT01090492|453008342|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
125920839|NCT01090492|453008343|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
125920840|NCT01090492|453008344|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
125920841|NCT01090492|453008345|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
125920842|NCT01090492|453008338|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
125920843|NCT01090492|453008339|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
125920844|NCT01090492|453008340|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
125920845|NCT01090492|453008341|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
125920846|NCT01090492|453008342|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
125920847|NCT01090492|453008343|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
125920848|NCT01090492|453008344|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
125920849|NCT01090492|453008345|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
125920850|NCT01090492|453008338|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125920851|NCT01090492|453008339|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
125920852|NCT01090492|453008340|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125920853|NCT01090492|453008341|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125920854|NCT01090492|453008342|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125920855|NCT01090492|453008343|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125920856|NCT01090492|453008344|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125920857|NCT01090492|453008345|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125920858|NCT01090492|453008338|FG000|Second Intervention Period (4 Weeks)|Other|0|||
125920859|NCT01090492|453008339|FG001|Second Intervention Period (4 Weeks)|Other|1|||
125920860|NCT01090492|453008340|FG002|Second Intervention Period (4 Weeks)|Other|1|||
125920861|NCT01090492|453008341|FG003|Second Intervention Period (4 Weeks)|Other|0|||
125920862|NCT01090492|453008342|FG004|Second Intervention Period (4 Weeks)|Other|0|||
125920863|NCT01090492|453008343|FG005|Second Intervention Period (4 Weeks)|Other|0|||
125920864|NCT01090492|453008344|FG006|Second Intervention Period (4 Weeks)|Other|0|||
125920865|NCT01090492|453008345|FG007|Second Intervention Period (4 Weeks)|Other|0|||
125920866|NCT01090492|453008338|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
125920867|NCT01090492|453008339|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
125920868|NCT01090492|453008340|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
125920869|NCT01090492|453008341|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
125920870|NCT01090492|453008342|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
125920871|NCT01090492|453008343|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
125920872|NCT01090492|453008344|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
125920873|NCT01090492|453008345|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
125920874|NCT01090492|453008338|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920875|NCT01090492|453008339|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920876|NCT01090492|453008340|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920877|NCT01090492|453008341|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920878|NCT01090492|453008342|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920879|NCT01090492|453008343|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920880|NCT01090492|453008344|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
125920881|NCT01090492|453008345|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125920882|NCT03113071|453008346|FG000|Overall Study|Withdrawal by Subject|1|||
125920883|NCT03113071|453008347|FG001|Overall Study|Withdrawal by Subject|0|||
125920884|NCT01602120|453008348|FG000|Overall Study|Adverse Event|3|||
125920885|NCT01602120|453008349|FG001|Overall Study|Adverse Event|6|||
125920886|NCT01602120|453008350|FG002|Overall Study|Adverse Event|0|||
125920887|NCT01602120|453008351|FG003|Overall Study|Adverse Event|2|||
125920888|NCT01602120|453008348|FG000|Overall Study|Death|0|||
125920889|NCT01602120|453008349|FG001|Overall Study|Death|4|||
125920890|NCT01602120|453008350|FG002|Overall Study|Death|0|||
125920891|NCT01602120|453008351|FG003|Overall Study|Death|0|||
125920892|NCT01602120|453008348|FG000|Overall Study|Lost to Follow-up|0|||
125920893|NCT01602120|453008349|FG001|Overall Study|Lost to Follow-up|1|||
125920894|NCT01602120|453008350|FG002|Overall Study|Lost to Follow-up|0|||
125920895|NCT01602120|453008351|FG003|Overall Study|Lost to Follow-up|1|||
125920896|NCT01602120|453008348|FG000|Overall Study|Protocol Violation|1|||
125920897|NCT01602120|453008349|FG001|Overall Study|Protocol Violation|1|||
125920898|NCT01602120|453008350|FG002|Overall Study|Protocol Violation|0|||
125920899|NCT01602120|453008351|FG003|Overall Study|Protocol Violation|0|||
125920900|NCT01602120|453008348|FG000|Overall Study|Non-compliance|0|||
125920901|NCT01602120|453008349|FG001|Overall Study|Non-compliance|3|||
125920902|NCT01602120|453008350|FG002|Overall Study|Non-compliance|0|||
125920903|NCT01602120|453008351|FG003|Overall Study|Non-compliance|1|||
125920904|NCT01602120|453008348|FG000|Overall Study|Withdrawal by Subject|8|||
125920905|NCT01602120|453008349|FG001|Overall Study|Withdrawal by Subject|17|||
125920906|NCT01602120|453008350|FG002|Overall Study|Withdrawal by Subject|0|||
125920907|NCT01602120|453008351|FG003|Overall Study|Withdrawal by Subject|3|||
125920908|NCT01602120|453008348|FG000|Overall Study|Study Terminated by Sponsor|12|||
125920909|NCT01602120|453008349|FG001|Overall Study|Study Terminated by Sponsor|24|||
125920910|NCT01602120|453008350|FG002|Overall Study|Study Terminated by Sponsor|17|||
125920911|NCT01602120|453008351|FG003|Overall Study|Study Terminated by Sponsor|44|||
125920912|NCT01602120|453008348|FG000|Overall Study|Physician Decision|2|||
125920913|NCT01602120|453008349|FG001|Overall Study|Physician Decision|3|||
125920914|NCT01602120|453008350|FG002|Overall Study|Physician Decision|0|||
125920915|NCT01602120|453008351|FG003|Overall Study|Physician Decision|0|||
125920916|NCT01602120|453008348|FG000|Overall Study|Unspecified Reason|3|||
125920917|NCT01602120|453008349|FG001|Overall Study|Unspecified Reason|1|||
125920918|NCT01602120|453008350|FG002|Overall Study|Unspecified Reason|0|||
125920919|NCT01602120|453008351|FG003|Overall Study|Unspecified Reason|2|||
125920920|NCT01611155|453008352|FG000|Overall Study|Adverse Event|1|||
125920921|NCT01611155|453008353|FG001|Overall Study|Adverse Event|1|||
125920922|NCT01611155|453008352|FG000|Overall Study|Refused further treatment|6|||
125920923|NCT01611155|453008353|FG001|Overall Study|Refused further treatment|4|||
125920924|NCT01611155|453008352|FG000|Overall Study|Disease progression|1|||
125920925|NCT01611155|453008353|FG001|Overall Study|Disease progression|0|||
125920926|NCT01611155|453008352|FG000|Overall Study|Withdrawal by Subject|1|||
125920927|NCT01611155|453008353|FG001|Overall Study|Withdrawal by Subject|0|||
125920928|NCT01611155|453008352|FG000|Overall Study|Alternative treatment|0|||
125920929|NCT01611155|453008353|FG001|Overall Study|Alternative treatment|1|||
125920930|NCT01611155|453008352|FG000|Overall Study|Ineligible patient|0|||
125920931|NCT01611155|453008353|FG001|Overall Study|Ineligible patient|1|||
125920932|NCT00868608|453008360|FG000|Overall Study|Withdrawal by Subject|3|||
125920933|NCT00868608|453008361|FG001|Overall Study|Withdrawal by Subject|1|||
125920934|NCT00868608|453008362|FG002|Overall Study|Withdrawal by Subject|0|||
125920935|NCT00868608|453008360|FG000|Overall Study|Lost to Follow-up|3|||
125920936|NCT00868608|453008361|FG001|Overall Study|Lost to Follow-up|0|||
125920937|NCT00868608|453008362|FG002|Overall Study|Lost to Follow-up|1|||
125920938|NCT00868608|453008360|FG000|Overall Study|Death|16|||
125920939|NCT00868608|453008361|FG001|Overall Study|Death|2|||
125920940|NCT00868608|453008362|FG002|Overall Study|Death|4|||
125920941|NCT00868608|453008360|FG000|Overall Study|Other - Unspecified|1|||
125920942|NCT00868608|453008361|FG001|Overall Study|Other - Unspecified|0|||
125920943|NCT00868608|453008362|FG002|Overall Study|Other - Unspecified|0|||
125920944|NCT03344796|453008363|FG000|Overall Study|Lost to Follow-up|0|||
125920945|NCT03344796|453008364|FG001|Overall Study|Lost to Follow-up|0|||
125920946|NCT03344796|453008365|FG002|Overall Study|Lost to Follow-up|0|||
125920947|NCT03344796|453008366|FG003|Overall Study|Lost to Follow-up|0|||
125920948|NCT03344796|453008367|FG004|Overall Study|Lost to Follow-up|0|||
125920949|NCT03344796|453008368|FG005|Overall Study|Lost to Follow-up|2|||
126110968|NCT02742766|453701961|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
125920950|NCT01999179|453008369|FG000|Overall Study|Adverse Event|1|||
125920951|NCT01999179|453008369|FG000|Overall Study|Lost to Follow-up|1|||
125920952|NCT01999179|453008369|FG000|Overall Study|Change in Therapy|3|||
125920953|NCT01999179|453008369|FG000|Overall Study|New catheter|2|||
125920954|NCT02564796|453008370|FG000|Overall Study|Physician Decision|2|||
125920955|NCT02564796|453008371|FG001|Overall Study|Physician Decision|2|||
125920956|NCT02900976|453008378|FG000|Overall Study|Adverse Event|0|||
125920957|NCT02900976|453008379|FG001|Overall Study|Adverse Event|1|||
125920958|NCT02900976|453008378|FG000|Overall Study|Physician Decision|0|||
125920959|NCT02900976|453008379|FG001|Overall Study|Physician Decision|2|||
125920960|NCT02900976|453008378|FG000|Overall Study|Progressive disease|0|||
125920961|NCT02900976|453008379|FG001|Overall Study|Progressive disease|6|||
125920962|NCT04997304|453008380|FG000|Overall Study|Lost to Follow-up|11|||
125920963|NCT04997304|453008380|FG000|Overall Study|Death|1|||
125920964|NCT04997304|453008380|FG000|Overall Study|Withdrawal by Subject|14|||
125920965|NCT06934993|453008381|FG000|Overall Study|Withdrawal by Subject|29|||
125920966|NCT06934993|453008381|FG000|Overall Study|elevated postoperative creatinine level|11|||
125920967|NCT06934993|453008381|FG000|Overall Study|Death|3|||
125920968|NCT01594281|453009728|FG000|Interventional Core Phase|Protocol Deviation|1|||
125920969|NCT01594281|453009729|FG001|Interventional Core Phase|Protocol Deviation|0|||
125920970|NCT01594281|453009730|FG002|Interventional Core Phase|Protocol Deviation|0|||
125920971|NCT01594281|453009728|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
125920972|NCT01594281|453009729|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
125920973|NCT01594281|453009730|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
125920974|NCT01594281|453009728|FG000|Interventional Core Phase|Death|1|||
125920975|NCT01594281|453009729|FG001|Interventional Core Phase|Death|1|||
125920976|NCT01594281|453009730|FG002|Interventional Core Phase|Death|2|||
125920977|NCT01594281|453009728|FG000|Interventional Core Phase|Lost to Follow-up|1|||
125920978|NCT01594281|453009729|FG001|Interventional Core Phase|Lost to Follow-up|4|||
125920979|NCT01594281|453009730|FG002|Interventional Core Phase|Lost to Follow-up|1|||
125920980|NCT01594281|453009728|FG000|Interventional Core Phase|Adverse Event|4|||
125920981|NCT01594281|453009729|FG001|Interventional Core Phase|Adverse Event|4|||
125920982|NCT01594281|453009730|FG002|Interventional Core Phase|Adverse Event|4|||
125920983|NCT01594281|453009728|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
125920984|NCT01594281|453009729|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
125920985|NCT01594281|453009730|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
125920986|NCT01594281|453009728|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
125920987|NCT01594281|453009729|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
125920988|NCT01594281|453009730|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
125920989|NCT01594281|453009728|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
125920990|NCT01594281|453009729|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
125920991|NCT01594281|453009730|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
125920992|NCT01871532|453009731|FG000|Overall Study|Withdrawal by Subject|1|||
125920993|NCT01871532|453009732|FG001|Overall Study|Withdrawal by Subject|2|||
125920994|NCT02195583|453009734|FG000|Overall Study|Lost to Follow-up|1|||
125920995|NCT02195583|453009734|FG000|Overall Study|Withdrawal by Subject|4|||
125920996|NCT02195583|453009734|FG000|Overall Study|Adverse Event|2|||
125920997|NCT02195583|453009734|FG000|Overall Study|Other Reason|2|||
125920998|NCT01709513|453009735|FG000|Overall Study|Randomized but not treated|0|||
125920999|NCT01709513|453009736|FG001|Overall Study|Randomized but not treated|1|||
125921000|NCT01709513|453009737|FG002|Overall Study|Randomized but not treated|0|||
125921001|NCT01709513|453009735|FG000|Overall Study|Adverse Event|16|||
125921002|NCT01709513|453009736|FG001|Overall Study|Adverse Event|31|||
126110969|NCT02742766|453701962|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
125921003|NCT01709513|453009737|FG002|Overall Study|Adverse Event|23|||
126110970|NCT02742766|453701963|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110971|NCT02742766|453701964|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
126110972|NCT02742766|453701965|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
125921004|NCT01709513|453009735|FG000|Overall Study|Poor compliance to protocol|2|||
125921005|NCT01709513|453009736|FG001|Overall Study|Poor compliance to protocol|0|||
125921006|NCT01709513|453009737|FG002|Overall Study|Poor compliance to protocol|0|||
125921007|NCT01709513|453009735|FG000|Overall Study|Other|3|||
125921008|NCT01709513|453009736|FG001|Overall Study|Other|11|||
125921009|NCT01709513|453009737|FG002|Overall Study|Other|7|||
125921010|NCT01543958|453009738|FG000|Overall Study|Loss to follow-up|3|||
125921011|NCT01543958|453009738|FG000|Overall Study|ART initiation|1|||
125921012|NCT02165215|453009745|FG000|Induction Phase|Adverse Event|1|||
125921013|NCT02165215|453009746|FG001|Induction Phase|Adverse Event|0|||
125921014|NCT02165215|453009747|FG002|Induction Phase|Adverse Event|0|||
125921015|NCT02165215|453009745|FG000|Induction Phase|Withdrawal by Subject|10|||
125921016|NCT02165215|453009746|FG001|Induction Phase|Withdrawal by Subject|0|||
125921017|NCT02165215|453009747|FG002|Induction Phase|Withdrawal by Subject|0|||
125921018|NCT02165215|453009745|FG000|Induction Phase|Protocol Violation|1|||
125921019|NCT02165215|453009746|FG001|Induction Phase|Protocol Violation|0|||
125921020|NCT02165215|453009747|FG002|Induction Phase|Protocol Violation|0|||
125921021|NCT02165215|453009745|FG000|Induction Phase|Physician Decision|1|||
125921022|NCT02165215|453009746|FG001|Induction Phase|Physician Decision|0|||
125921023|NCT02165215|453009747|FG002|Induction Phase|Physician Decision|0|||
125921024|NCT02165215|453009745|FG000|Induction Phase|Lack of Efficacy|2|||
125921025|NCT02165215|453009746|FG001|Induction Phase|Lack of Efficacy|0|||
125921026|NCT02165215|453009747|FG002|Induction Phase|Lack of Efficacy|0|||
125921027|NCT02165215|453009745|FG000|Induction Phase|Non-Compliance|2|||
125921028|NCT02165215|453009746|FG001|Induction Phase|Non-Compliance|0|||
125921029|NCT02165215|453009747|FG002|Induction Phase|Non-Compliance|0|||
125921030|NCT02165215|453009745|FG000|Induction Phase|Lost to Follow-up|6|||
125921031|NCT02165215|453009746|FG001|Induction Phase|Lost to Follow-up|0|||
125921032|NCT02165215|453009747|FG002|Induction Phase|Lost to Follow-up|0|||
125921033|NCT02165215|453009745|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125921034|NCT02165215|453009746|FG001|Maintenance Phase|Withdrawal by Subject|7|||
125921035|NCT02165215|453009747|FG002|Maintenance Phase|Withdrawal by Subject|3|||
125921036|NCT02165215|453009745|FG000|Maintenance Phase|Multiple reasons|0|||
125921037|NCT02165215|453009746|FG001|Maintenance Phase|Multiple reasons|2|||
125921038|NCT02165215|453009747|FG002|Maintenance Phase|Multiple reasons|1|||
125921039|NCT02165215|453009745|FG000|Maintenance Phase|Lost to Follow-up|0|||
125921040|NCT02165215|453009746|FG001|Maintenance Phase|Lost to Follow-up|2|||
125921041|NCT02165215|453009747|FG002|Maintenance Phase|Lost to Follow-up|0|||
125921042|NCT02165215|453009745|FG000|Maintenance Phase|Adverse Event|0|||
125921043|NCT02165215|453009746|FG001|Maintenance Phase|Adverse Event|1|||
125921044|NCT02165215|453009747|FG002|Maintenance Phase|Adverse Event|1|||
125921045|NCT00064337|453009748|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
125921046|NCT00064337|453009748|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
125921047|NCT00064337|453009748|FG000|PBSCC or Induction/PBSCC|Progression|3|||
125921048|NCT00064337|453009748|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
125921049|NCT00064337|453009748|FG000|PBSCC or Induction/PBSCC|Death|2|||
125921050|NCT00064337|453009748|FG000|Transplant|Adverse Event|9|||
125921051|NCT00064337|453009748|FG000|Transplant|Not protocol-specified|5|||
125921052|NCT00064337|453009748|FG000|Transplant|Death|3|||
125921053|NCT00064337|453009748|FG000|Transplant|Patient Refusal|2|||
125921054|NCT00064337|453009748|FG000|Transplant|Progression|2|||
125921055|NCT00064337|453009748|FG000|Maintenance|Adverse Event|3|||
125921056|NCT00064337|453009748|FG000|Maintenance|Progression|2|||
125921057|NCT00064337|453009748|FG000|Maintenance|On treatment at time of analysis|2|||
125921058|NCT00064337|453009748|FG000|Maintenance|Not protocol-specified|2|||
125921059|NCT00064337|453009748|FG000|Maintenance|Death|1|||
125921060|NCT02279420|453009749|FG000|Overall Study|Lost to Follow-up|23|||
125921061|NCT05096221|453009752|FG000|Part 2|Physician Decision|0|||
125921062|NCT05096221|453009753|FG001|Part 2|Physician Decision|1|||
125921063|NCT04678661|453009754|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
125921064|NCT04678661|453009755|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
126110973|NCT02742766|453701966|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
125921065|NCT04678661|453009754|FG000|Overall Study|Protocol Violation|2|||
125921066|NCT04678661|453009755|FG001|Overall Study|Protocol Violation|0|||
125921067|NCT04678661|453009754|FG000|Overall Study|Withdrawal by Subject|1|||
125921068|NCT04678661|453009755|FG001|Overall Study|Withdrawal by Subject|0|||
125921069|NCT04678661|453009754|FG000|Overall Study|Lost to Follow-up|2|||
125921070|NCT04678661|453009755|FG001|Overall Study|Lost to Follow-up|0|||
125921071|NCT04678661|453009754|FG000|Overall Study|Death|2|||
125921072|NCT04678661|453009755|FG001|Overall Study|Death|0|||
125921073|NCT01397890|453009756|FG000|Overall Study|Withdrawal by Subject|7|||
125921074|NCT01397890|453009757|FG001|Overall Study|Withdrawal by Subject|11|||
125921075|NCT01397890|453009756|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
125921076|NCT01397890|453009757|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
125921077|NCT01397890|453009756|FG000|Overall Study|Death|2|||
125921078|NCT01397890|453009757|FG001|Overall Study|Death|3|||
125921079|NCT01397890|453009756|FG000|Overall Study|Lost to Follow-up|1|||
125921080|NCT01397890|453009757|FG001|Overall Study|Lost to Follow-up|4|||
125921081|NCT01397890|453009756|FG000|Overall Study|Condition under Investigation Worsened|1|||
125921082|NCT01397890|453009757|FG001|Overall Study|Condition under Investigation Worsened|3|||
126110974|NCT02742766|453701967|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
125921083|NCT01397890|453009756|FG000|Overall Study|Adverse Event|1|||
125921084|NCT01397890|453009757|FG001|Overall Study|Adverse Event|2|||
125921085|NCT01397890|453009756|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
125921086|NCT01397890|453009757|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
125921087|NCT01397890|453009756|FG000|Overall Study|Others|2|||
125921088|NCT01397890|453009757|FG001|Overall Study|Others|1|||
125921089|NCT03741062|453009758|FG000|Overall Study|Protocol Violation|1|||
125921090|NCT03741062|453009759|FG001|Overall Study|Protocol Violation|0|||
125921091|NCT03417219|453009760|FG000|Overall Study|Lost to Follow-up|0|||
125921092|NCT03417219|453009761|FG001|Overall Study|Lost to Follow-up|3|||
125921093|NCT02021331|453009762|FG000|Overall Study|Adverse Event|0|||
125921094|NCT02021331|453009763|FG001|Overall Study|Adverse Event|2|||
125921095|NCT00762229|453009764|FG000|Overall Study|Lost to Follow-up|1|||
125921096|NCT00762229|453009765|FG001|Overall Study|Lost to Follow-up|1|||
125921097|NCT00762229|453009764|FG000|Overall Study|did not recveive intervention|0|||
125921098|NCT00762229|453009765|FG001|Overall Study|did not recveive intervention|1|||
125921099|NCT00319553|453009768|FG000|Overall Study|Protocol Violation|1|||
125921100|NCT00319553|453009769|FG001|Overall Study|Protocol Violation|2|||
125921101|NCT00319553|453009768|FG000|Overall Study|Lost to Follow-up|2|||
125921102|NCT00319553|453009769|FG001|Overall Study|Lost to Follow-up|1|||
125921103|NCT00319553|453009768|FG000|Overall Study|Withdrawal by Subject|1|||
125921104|NCT00319553|453009769|FG001|Overall Study|Withdrawal by Subject|1|||
125921105|NCT01896102|453009772|FG000|Overall Study|Death|1|||
125921106|NCT01896102|453009772|FG000|Overall Study|Participant to receive allogenic transplant|2|||
125921107|NCT00885846|453009774|FG000|Overall Study|Withdrawal by Subject|2|||
125921108|NCT00885846|453009775|FG001|Overall Study|Withdrawal by Subject|5|||
125921109|NCT00885846|453009776|FG002|Overall Study|Withdrawal by Subject|2|||
125921110|NCT00444912|453009785|FG000|Overall Study|Death|1|||
125921111|NCT00444912|453009786|FG001|Overall Study|Death|2|||
125921112|NCT00444912|453009785|FG000|Overall Study|Lost to Follow-up|1|||
125921113|NCT00444912|453009786|FG001|Overall Study|Lost to Follow-up|0|||
125921114|NCT00444912|453009785|FG000|Overall Study|Participant Failed Mobilization|1|||
125921115|NCT00444912|453009786|FG001|Overall Study|Participant Failed Mobilization|0|||
125921116|NCT01281865|453009787|FG000|Overall Study|Adverse Event|1|||
125921117|NCT01281865|453009788|FG001|Overall Study|Adverse Event|1|||
125921118|NCT01281865|453009787|FG000|Overall Study|Withdrawal by Subject|1|||
125921119|NCT01281865|453009788|FG001|Overall Study|Withdrawal by Subject|0|||
125921120|NCT01281865|453009787|FG000|Overall Study|Lack of Efficacy|1|||
125921121|NCT01281865|453009788|FG001|Overall Study|Lack of Efficacy|0|||
125921122|NCT02747875|453009789|FG000|Overall Study|Physician Decision|1|||
125921123|NCT02747875|453009790|FG001|Overall Study|Physician Decision|0|||
125921124|NCT02747875|453009789|FG000|Overall Study|Adverse Event|0|||
125921125|NCT02747875|453009790|FG001|Overall Study|Adverse Event|1|||
125921126|NCT01768286|453009796|FG000|Overall Study|Randomized But Not Treated|0|||
125921127|NCT01768286|453009797|FG001|Overall Study|Randomized But Not Treated|0|||
125921128|NCT01768286|453009798|FG002|Overall Study|Randomized But Not Treated|1|||
125921129|NCT01768286|453009799|FG003|Overall Study|Randomized But Not Treated|0|||
125921130|NCT01768286|453009796|FG000|Overall Study|Lack of Efficacy|7|||
125921131|NCT01768286|453009797|FG001|Overall Study|Lack of Efficacy|4|||
125921132|NCT01768286|453009798|FG002|Overall Study|Lack of Efficacy|0|||
125921133|NCT01768286|453009799|FG003|Overall Study|Lack of Efficacy|1|||
125921134|NCT01768286|453009796|FG000|Overall Study|Withdrew Consent|0|||
125921135|NCT01768286|453009797|FG001|Overall Study|Withdrew Consent|0|||
125921136|NCT01768286|453009798|FG002|Overall Study|Withdrew Consent|1|||
125921137|NCT01768286|453009799|FG003|Overall Study|Withdrew Consent|0|||
125921138|NCT02699593|453009801|FG000|Period 1|Unsatisfactory Visual Response|0|||
125921139|NCT02699593|453009802|FG001|Period 1|Unsatisfactory Visual Response|1|||
125921140|NCT02699593|453009801|FG000|Period 1|Torn Contact Len|4|||
125921141|NCT02699593|453009802|FG001|Period 1|Torn Contact Len|3|||
125921142|NCT02699593|453009801|FG000|Period 1|Protocol Violation|0|||
125921143|NCT02699593|453009802|FG001|Period 1|Protocol Violation|1|||
125921144|NCT02699593|453009801|FG000|Period 1|Withdrawal by Subject|0|||
125921145|NCT02699593|453009802|FG001|Period 1|Withdrawal by Subject|1|||
125921146|NCT02699593|453009801|FG000|Period 1|Adverse Event|1|||
125921147|NCT02699593|453009802|FG001|Period 1|Adverse Event|1|||
125921148|NCT02699593|453009801|FG000|Period 2|Adverse Event|1|||
125921149|NCT02699593|453009802|FG001|Period 2|Adverse Event|1|||
125921150|NCT02699593|453009801|FG000|Period 2|Lost Contact Lens|0|||
125921151|NCT02699593|453009802|FG001|Period 2|Lost Contact Lens|1|||
125921152|NCT02699593|453009801|FG000|Period 2|Torn Contact Lens|1|||
125921153|NCT02699593|453009802|FG001|Period 2|Torn Contact Lens|0|||
125921154|NCT00911547|453009803|FG000|Overall Study|Adverse Event|8|||
125921155|NCT00911547|453009804|FG001|Overall Study|Adverse Event|27|||
125921156|NCT00911547|453009805|FG002|Overall Study|Adverse Event|11|||
125921157|NCT00911547|453009806|FG003|Overall Study|Adverse Event|6|||
125921158|NCT00911547|453009803|FG000|Overall Study|Lost to Follow-up|0|||
125921159|NCT00911547|453009804|FG001|Overall Study|Lost to Follow-up|0|||
125921160|NCT00911547|453009805|FG002|Overall Study|Lost to Follow-up|2|||
125921161|NCT00911547|453009806|FG003|Overall Study|Lost to Follow-up|1|||
125921162|NCT00911547|453009803|FG000|Overall Study|Protocol Violation|0|||
125921163|NCT00911547|453009804|FG001|Overall Study|Protocol Violation|5|||
125921164|NCT00911547|453009805|FG002|Overall Study|Protocol Violation|5|||
125921165|NCT00911547|453009806|FG003|Overall Study|Protocol Violation|1|||
125921166|NCT00911547|453009803|FG000|Overall Study|Withdrawal by Subject|3|||
125921167|NCT00911547|453009804|FG001|Overall Study|Withdrawal by Subject|10|||
125921168|NCT00911547|453009805|FG002|Overall Study|Withdrawal by Subject|4|||
125921169|NCT00911547|453009806|FG003|Overall Study|Withdrawal by Subject|8|||
125921170|NCT00915278|453009807|FG000|Overall Study|Death|1|||
125921171|NCT00915278|453009808|FG001|Overall Study|Death|0|||
125921172|NCT00915278|453009809|FG002|Overall Study|Death|0|||
125921173|NCT00915278|453009810|FG003|Overall Study|Death|0|||
125921174|NCT00915278|453009811|FG004|Overall Study|Death|0|||
125921175|NCT00915278|453009812|FG005|Overall Study|Death|0|||
125921176|NCT00915278|453009807|FG000|Overall Study|Lost to Follow-up|0|||
125921177|NCT00915278|453009808|FG001|Overall Study|Lost to Follow-up|1|||
125921178|NCT00915278|453009809|FG002|Overall Study|Lost to Follow-up|0|||
125921179|NCT00915278|453009810|FG003|Overall Study|Lost to Follow-up|0|||
125921180|NCT00915278|453009811|FG004|Overall Study|Lost to Follow-up|0|||
125921181|NCT00915278|453009812|FG005|Overall Study|Lost to Follow-up|0|||
125921182|NCT00915278|453009807|FG000|Overall Study|Withdrawal by Subject|0|||
125921183|NCT00915278|453009808|FG001|Overall Study|Withdrawal by Subject|1|||
125921184|NCT00915278|453009809|FG002|Overall Study|Withdrawal by Subject|0|||
125921185|NCT00915278|453009810|FG003|Overall Study|Withdrawal by Subject|0|||
125921186|NCT00915278|453009811|FG004|Overall Study|Withdrawal by Subject|1|||
125921187|NCT00915278|453009812|FG005|Overall Study|Withdrawal by Subject|4|||
125921188|NCT00915278|453009807|FG000|Overall Study|Adverse Event|4|||
125921189|NCT00915278|453009808|FG001|Overall Study|Adverse Event|1|||
125921190|NCT00915278|453009809|FG002|Overall Study|Adverse Event|0|||
125921191|NCT00915278|453009810|FG003|Overall Study|Adverse Event|0|||
125921192|NCT00915278|453009811|FG004|Overall Study|Adverse Event|0|||
125921193|NCT00915278|453009812|FG005|Overall Study|Adverse Event|0|||
125921194|NCT00915278|453009807|FG000|Overall Study|Progressive disease/clinical progression|0|||
125921195|NCT00915278|453009808|FG001|Overall Study|Progressive disease/clinical progression|0|||
125921196|NCT00915278|453009809|FG002|Overall Study|Progressive disease/clinical progression|0|||
125921197|NCT00915278|453009810|FG003|Overall Study|Progressive disease/clinical progression|3|||
125921198|NCT00915278|453009811|FG004|Overall Study|Progressive disease/clinical progression|1|||
125921199|NCT00915278|453009812|FG005|Overall Study|Progressive disease/clinical progression|2|||
125921200|NCT00915278|453009807|FG000|Overall Study|Infusion related AEs|0|||
125921201|NCT00915278|453009808|FG001|Overall Study|Infusion related AEs|0|||
125921202|NCT00915278|453009809|FG002|Overall Study|Infusion related AEs|0|||
125921203|NCT00915278|453009810|FG003|Overall Study|Infusion related AEs|0|||
125921204|NCT00915278|453009811|FG004|Overall Study|Infusion related AEs|0|||
125921205|NCT00915278|453009812|FG005|Overall Study|Infusion related AEs|2|||
125921206|NCT00915278|453009807|FG000|Overall Study|Admission to hospice|0|||
125921207|NCT00915278|453009808|FG001|Overall Study|Admission to hospice|0|||
125921208|NCT00915278|453009809|FG002|Overall Study|Admission to hospice|1|||
125921209|NCT00915278|453009810|FG003|Overall Study|Admission to hospice|0|||
125921210|NCT00915278|453009811|FG004|Overall Study|Admission to hospice|0|||
125921211|NCT00915278|453009812|FG005|Overall Study|Admission to hospice|0|||
125921212|NCT00453063|453009817|FG000|Overall Study|Adverse Event|1|||
125921213|NCT00453063|453009818|FG001|Overall Study|Adverse Event|2|||
125921214|NCT00453063|453009817|FG000|Overall Study|Withdrawal by Subject|1|||
125921215|NCT00453063|453009818|FG001|Overall Study|Withdrawal by Subject|1|||
125921216|NCT00453063|453009817|FG000|Overall Study|Protocol Violation|1|||
125921217|NCT00453063|453009818|FG001|Overall Study|Protocol Violation|0|||
125921218|NCT03128411|453009821|FG000|Treatment Phase|Adverse Event|21|||
125921219|NCT03128411|453009821|FG000|Treatment Phase|Physician Decision|1|||
125921220|NCT03128411|453009821|FG000|Treatment Phase|Other|2|||
125921221|NCT03128411|453009821|FG000|Long Term Follow-up Phase|Death|2|||
125921222|NCT00228384|453009822|FG000|Overall Study|Death|9|||
125921223|NCT00228384|453009823|FG001|Overall Study|Death|3|||
125921224|NCT00228384|453009822|FG000|Overall Study|Lost to Follow-up|6|||
125921225|NCT00228384|453009823|FG001|Overall Study|Lost to Follow-up|10|||
125921226|NCT00228384|453009822|FG000|Overall Study|Surgical Intervention (bypass)|5|||
125921227|NCT00228384|453009823|FG001|Overall Study|Surgical Intervention (bypass)|5|||
125921228|NCT00228384|453009822|FG000|Overall Study|Withdrawal by Subject|9|||
125921229|NCT00228384|453009823|FG001|Overall Study|Withdrawal by Subject|10|||
125921230|NCT00228384|453009822|FG000|Overall Study|Physician Decision|0|||
125921231|NCT00228384|453009823|FG001|Overall Study|Physician Decision|1|||
125921232|NCT01785069|453009827|FG000|Overall Study|Implanted with nonstudy device|1|||
125921233|NCT01785069|453009828|FG001|Overall Study|Implanted with nonstudy device|2|||
125921234|NCT01785069|453009829|FG002|Overall Study|Implanted with nonstudy device|1|||
125921235|NCT01785069|453009830|FG003|Overall Study|Implanted with nonstudy device|0|||
125921236|NCT01785069|453009827|FG000|Overall Study|Death|0|||
125921237|NCT01785069|453009828|FG001|Overall Study|Death|0|||
125921238|NCT01785069|453009829|FG002|Overall Study|Death|2|||
125921239|NCT01785069|453009830|FG003|Overall Study|Death|0|||
125921240|NCT01785069|453009827|FG000|Overall Study|Subject choice|2|||
125921241|NCT01785069|453009828|FG001|Overall Study|Subject choice|2|||
125921242|NCT01785069|453009829|FG002|Overall Study|Subject choice|0|||
125921243|NCT01785069|453009830|FG003|Overall Study|Subject choice|1|||
125921244|NCT01785069|453009827|FG000|Overall Study|Lost to Follow-up|1|||
125921245|NCT01785069|453009828|FG001|Overall Study|Lost to Follow-up|2|||
125921246|NCT01785069|453009829|FG002|Overall Study|Lost to Follow-up|4|||
125921247|NCT01785069|453009830|FG003|Overall Study|Lost to Follow-up|1|||
125921248|NCT01785069|453009827|FG000|Overall Study|Reason not Specified|1|||
125921249|NCT01785069|453009828|FG001|Overall Study|Reason not Specified|2|||
125921250|NCT01785069|453009829|FG002|Overall Study|Reason not Specified|1|||
125921251|NCT01785069|453009830|FG003|Overall Study|Reason not Specified|4|||
125921252|NCT01785069|453009827|FG000|Overall Study|Not evaluable|7|||
125921253|NCT01785069|453009828|FG001|Overall Study|Not evaluable|4|||
125921254|NCT01785069|453009829|FG002|Overall Study|Not evaluable|5|||
125921255|NCT01785069|453009830|FG003|Overall Study|Not evaluable|8|||
125921256|NCT01453361|453009832|FG000|Overall Study|Disease Progression|6|||
125921257|NCT01453361|453009832|FG000|Overall Study|Screen-Failures|10|||
125921258|NCT04560998|453009833|FG000|Overall Study|Withdrawal by Subject|18|||
125921259|NCT04560998|453009834|FG001|Overall Study|Withdrawal by Subject|12|||
125921260|NCT04560998|453009833|FG000|Overall Study|Lost to Follow-up|8|||
125921261|NCT04560998|453009834|FG001|Overall Study|Lost to Follow-up|5|||
125921262|NCT04560998|453009833|FG000|Overall Study|Physician Decision|4|||
125921263|NCT04560998|453009834|FG001|Overall Study|Physician Decision|0|||
125921264|NCT01798004|453011452|FG000|Overall Study|Death|2|||
125921265|NCT01798004|453011452|FG000|Overall Study|Lack of Efficacy|8|||
125921266|NCT01798004|453011452|FG000|Overall Study|Physician Decision|25|||
125921267|NCT01798004|453011452|FG000|Overall Study|Withdrawal by Subject|4|||
125921268|NCT01798004|453011452|FG000|Overall Study|Ineligible|4|||
125921269|NCT01798004|453011452|FG000|Overall Study|Patient/parent refusal|7|||
125921270|NCT01798004|453011452|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
125921271|NCT01798004|453011452|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
125921272|NCT03539081|453011460|FG000|Overall Study|Withdrawal by Subject|2|||
125921273|NCT03539081|453011461|FG001|Overall Study|Withdrawal by Subject|3|||
125921274|NCT03539081|453011462|FG002|Overall Study|Withdrawal by Subject|0|||
125921275|NCT03539081|453011460|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
125921276|NCT03539081|453011461|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
125921277|NCT03539081|453011462|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
125921278|NCT01673867|453011466|FG000|Randomization|Adverse event unrelated to study drug|1|||
125921279|NCT01673867|453011467|FG001|Randomization|Adverse event unrelated to study drug|0|||
125921280|NCT01673867|453011466|FG000|Randomization|Participant request to discontinue study treatment|0|||
125921281|NCT01673867|453011467|FG001|Randomization|Participant request to discontinue study treatment|4|||
125921282|NCT01673867|453011466|FG000|Randomization|Withdrawal by participant|0|||
125921283|NCT01673867|453011467|FG001|Randomization|Withdrawal by participant|12|||
125921284|NCT01673867|453011466|FG000|Randomization|Lost to Follow-up|0|||
125921285|NCT01673867|453011467|FG001|Randomization|Lost to Follow-up|1|||
125921286|NCT01673867|453011466|FG000|Randomization|Participant no longer meets study criteria|4|||
125921287|NCT01673867|453011467|FG001|Randomization|Participant no longer meets study criteria|5|||
125921288|NCT01673867|453011466|FG000|Treatment|Disease Progression|208|||
125921289|NCT01673867|453011467|FG001|Treatment|Disease Progression|178|||
125921290|NCT01673867|453011466|FG000|Treatment|Study Drug Toxicity|23|||
125921291|NCT01673867|453011467|FG001|Treatment|Study Drug Toxicity|43|||
125921292|NCT01673867|453011466|FG000|Treatment|Death|2|||
125921293|NCT01673867|453011467|FG001|Treatment|Death|3|||
125921294|NCT01673867|453011466|FG000|Treatment|Adverse event unrelated to study drug|23|||
125921295|NCT01673867|453011467|FG001|Treatment|Adverse event unrelated to study drug|10|||
125921296|NCT01673867|453011466|FG000|Treatment|Participant request to discontinue study treatment|7|||
125921297|NCT01673867|453011467|FG001|Treatment|Participant request to discontinue study treatment|17|||
125921298|NCT01673867|453011466|FG000|Treatment|Withdrawal by participant|5|||
125921299|NCT01673867|453011467|FG001|Treatment|Withdrawal by participant|5|||
125921300|NCT01673867|453011466|FG000|Treatment|Maximum clinical benefit|1|||
125921301|NCT01673867|453011467|FG001|Treatment|Maximum clinical benefit|10|||
125921302|NCT01673867|453011466|FG000|Treatment|Participant no longer meets study criteria|2|||
125921303|NCT01673867|453011467|FG001|Treatment|Participant no longer meets study criteria|0|||
125921304|NCT01673867|453011466|FG000|Treatment|Administrative reason by sponsor|3|||
125921305|NCT01673867|453011467|FG001|Treatment|Administrative reason by sponsor|0|||
125921306|NCT01673867|453011466|FG000|Treatment|Other reason|11|||
125921307|NCT01673867|453011467|FG001|Treatment|Other reason|2|||
125921308|NCT02550106|453011470|FG000|Overall Study|Adverse Event|1|||
125921309|NCT02550106|453011470|FG000|Overall Study|Lack of Efficacy|3|||
125921310|NCT02550106|453011470|FG000|Overall Study|Protocol Violation|6|||
125921311|NCT02550106|453011470|FG000|Overall Study|Withdrawal by Subject|2|||
125921312|NCT00926328|453011471|FG000|Overall Study|Lost to Follow-up|12|||
126064339|NCT03745651|453527706|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
126064340|NCT03745651|453527707|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126064341|NCT03745651|453527708|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126064342|NCT03745651|453527709|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126064343|NCT03745651|453527710|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125921313|NCT00926328|453011472|FG001|Overall Study|Lost to Follow-up|14|||
125921314|NCT00289133|453011473|FG000|Overall Study|Non-study device implanted|12|||
125921315|NCT00289133|453011474|FG001|Overall Study|Non-study device implanted|0|||
125921316|NCT00289133|453011473|FG000|Overall Study|Protocol Violation|32|||
125921317|NCT00289133|453011474|FG001|Overall Study|Protocol Violation|38|||
125921318|NCT00289133|453011473|FG000|Overall Study|Withdrawal by Subject|9|||
125921319|NCT00289133|453011474|FG001|Overall Study|Withdrawal by Subject|10|||
125921320|NCT00289133|453011473|FG000|Overall Study|Death|5|||
125921321|NCT00289133|453011474|FG001|Overall Study|Death|10|||
125921322|NCT00289133|453011473|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
125921323|NCT00289133|453011474|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
125921324|NCT00289133|453011473|FG000|Overall Study|Physician Decision|41|||
125921325|NCT00289133|453011474|FG001|Overall Study|Physician Decision|45|||
125921326|NCT00289133|453011473|FG000|Overall Study|Revision|8|||
125921327|NCT00289133|453011474|FG001|Overall Study|Revision|6|||
125921328|NCT00289133|453011473|FG000|Overall Study|Lost to Follow-up|92|||
125921329|NCT00289133|453011474|FG001|Overall Study|Lost to Follow-up|115|||
125921330|NCT03094169|453011478|FG000|Overall Study|Lack of Efficacy|0|||
125921331|NCT03094169|453011479|FG001|Overall Study|Lack of Efficacy|0|||
125921332|NCT03094169|453011480|FG002|Overall Study|Lack of Efficacy|0|||
125921333|NCT03094169|453011481|FG003|Overall Study|Lack of Efficacy|0|||
125921334|NCT03094169|453011482|FG004|Overall Study|Lack of Efficacy|0|||
125921335|NCT03094169|453011483|FG005|Overall Study|Lack of Efficacy|0|||
125921336|NCT03094169|453011484|FG006|Overall Study|Lack of Efficacy|0|||
125921337|NCT03094169|453011485|FG007|Overall Study|Lack of Efficacy|21|||
125921338|NCT03094169|453011478|FG000|Overall Study|Adverse Event|0|||
125921339|NCT03094169|453011479|FG001|Overall Study|Adverse Event|0|||
125921340|NCT03094169|453011480|FG002|Overall Study|Adverse Event|0|||
125921341|NCT03094169|453011481|FG003|Overall Study|Adverse Event|0|||
125921342|NCT03094169|453011482|FG004|Overall Study|Adverse Event|0|||
125921343|NCT03094169|453011483|FG005|Overall Study|Adverse Event|0|||
125921344|NCT03094169|453011484|FG006|Overall Study|Adverse Event|0|||
125921345|NCT03094169|453011485|FG007|Overall Study|Adverse Event|2|||
125921346|NCT03094169|453011478|FG000|Overall Study|Withdrawal by Subject|0|||
125921347|NCT03094169|453011479|FG001|Overall Study|Withdrawal by Subject|0|||
125921348|NCT03094169|453011480|FG002|Overall Study|Withdrawal by Subject|0|||
125921349|NCT03094169|453011481|FG003|Overall Study|Withdrawal by Subject|0|||
125921350|NCT03094169|453011482|FG004|Overall Study|Withdrawal by Subject|0|||
125921351|NCT03094169|453011483|FG005|Overall Study|Withdrawal by Subject|0|||
125921352|NCT03094169|453011484|FG006|Overall Study|Withdrawal by Subject|1|||
125921353|NCT03094169|453011485|FG007|Overall Study|Withdrawal by Subject|1|||
125921354|NCT03094169|453011478|FG000|Overall Study|Trial Termination|0|||
125921355|NCT03094169|453011479|FG001|Overall Study|Trial Termination|0|||
125921356|NCT03094169|453011480|FG002|Overall Study|Trial Termination|0|||
125921357|NCT03094169|453011481|FG003|Overall Study|Trial Termination|0|||
125921358|NCT03094169|453011482|FG004|Overall Study|Trial Termination|0|||
125921359|NCT03094169|453011483|FG005|Overall Study|Trial Termination|0|||
125921360|NCT03094169|453011484|FG006|Overall Study|Trial Termination|0|||
125921361|NCT03094169|453011485|FG007|Overall Study|Trial Termination|1|||
125921362|NCT04645953|453011486|FG000|Overall Study|Lost to Follow-up|2|||
125921363|NCT04645953|453011487|FG001|Overall Study|Lost to Follow-up|1|||
125921364|NCT04645953|453011488|FG002|Overall Study|Lost to Follow-up|1|||
125921365|NCT04645953|453011486|FG000|Overall Study|Withdrawal by Subject|0|||
125921366|NCT04645953|453011487|FG001|Overall Study|Withdrawal by Subject|1|||
125921367|NCT04645953|453011488|FG002|Overall Study|Withdrawal by Subject|0|||
125921368|NCT04645953|453011486|FG000|Overall Study|Physician Decision|0|||
125921369|NCT04645953|453011487|FG001|Overall Study|Physician Decision|1|||
125921370|NCT04645953|453011488|FG002|Overall Study|Physician Decision|0|||
125921371|NCT04645953|453011486|FG000|Overall Study|Discontinued Prior to Dosing|0|||
125921372|NCT04645953|453011487|FG001|Overall Study|Discontinued Prior to Dosing|0|||
125921373|NCT04645953|453011488|FG002|Overall Study|Discontinued Prior to Dosing|2|||
125921374|NCT04613375|453011489|FG000|Overall Study|Death|198|||
125921375|NCT04613375|453011489|FG000|Overall Study|Withdrawal by Subject|3|||
125921376|NCT00002651|453011490|FG000|Induction|Adverse Event|44|||
125921377|NCT00002651|453011491|FG001|Induction|Adverse Event|0|||
125921378|NCT00002651|453011492|FG002|Induction|Adverse Event|0|||
125921379|NCT00002651|453011490|FG000|Induction|Refusal unrelated to adverse event|50|||
125921380|NCT00002651|453011491|FG001|Induction|Refusal unrelated to adverse event|0|||
125921381|NCT00002651|453011492|FG002|Induction|Refusal unrelated to adverse event|0|||
125921382|NCT00002651|453011490|FG000|Induction|Progression/relapse|274|||
125921383|NCT00002651|453011491|FG001|Induction|Progression/relapse|0|||
125921384|NCT00002651|453011492|FG002|Induction|Progression/relapse|0|||
125921385|NCT00002651|453011490|FG000|Induction|Death|62|||
125921386|NCT00002651|453011491|FG001|Induction|Death|0|||
125921387|NCT00002651|453011492|FG002|Induction|Death|0|||
125921388|NCT00002651|453011490|FG000|Induction|Other|823|||
125921389|NCT00002651|453011491|FG001|Induction|Other|0|||
125921390|NCT00002651|453011492|FG002|Induction|Other|0|||
125921391|NCT00002651|453011490|FG000|Induction|not eligible|90|||
125921392|NCT00002651|453011491|FG001|Induction|not eligible|0|||
125921393|NCT00002651|453011492|FG002|Induction|not eligible|0|||
125921394|NCT00002651|453011490|FG000|Consolidation and Randomization|Adverse Event|0|||
125921395|NCT00002651|453011491|FG001|Consolidation and Randomization|Adverse Event|36|||
125921396|NCT00002651|453011492|FG002|Consolidation and Randomization|Adverse Event|14|||
125921397|NCT00002651|453011490|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
125921398|NCT00002651|453011491|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
125921399|NCT00002651|453011492|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
125921400|NCT00002651|453011490|FG000|Consolidation and Randomization|Progression/relapse|0|||
125921401|NCT00002651|453011491|FG001|Consolidation and Randomization|Progression/relapse|295|||
125921402|NCT00002651|453011492|FG002|Consolidation and Randomization|Progression/relapse|298|||
125921403|NCT00002651|453011490|FG000|Consolidation and Randomization|Death|0|||
125921404|NCT00002651|453011491|FG001|Consolidation and Randomization|Death|38|||
125921405|NCT00002651|453011492|FG002|Consolidation and Randomization|Death|48|||
125921406|NCT00002651|453011490|FG000|Consolidation and Randomization|Other|0|||
125921407|NCT00002651|453011491|FG001|Consolidation and Randomization|Other|314|||
125921408|NCT00002651|453011492|FG002|Consolidation and Randomization|Other|313|||
125921409|NCT00002651|453011490|FG000|Consolidation and Randomization|not eligible|0|||
125921410|NCT00002651|453011491|FG001|Consolidation and Randomization|not eligible|102|||
125921411|NCT00002651|453011492|FG002|Consolidation and Randomization|not eligible|112|||
125921412|NCT02763462|453011498|FG000|Overall Study|Protocol Violation|6|||
125921413|NCT00261807|453011499|FG000|Overall Study|Lost to Follow-up|2|||
125921414|NCT00261807|453011499|FG000|Overall Study|Adverse Event|2|||
125921415|NCT00261807|453011499|FG000|Overall Study|Death|1|||
125921416|NCT00261807|453011499|FG000|Overall Study|Protocol Violation|2|||
125921417|NCT00675948|453011502|FG000|Overall Study|Adverse Event|23|||
125921418|NCT00675948|453011503|FG001|Overall Study|Adverse Event|1|||
125921419|NCT00675948|453011502|FG000|Overall Study|Lack of Efficacy|3|||
125921420|NCT00675948|453011503|FG001|Overall Study|Lack of Efficacy|0|||
125921421|NCT00675948|453011502|FG000|Overall Study|Withdrawal by Subject|7|||
125921422|NCT00675948|453011503|FG001|Overall Study|Withdrawal by Subject|0|||
125921423|NCT00675948|453011502|FG000|Overall Study|Lost to Follow-up|2|||
125921424|NCT00675948|453011503|FG001|Overall Study|Lost to Follow-up|0|||
125921425|NCT00675948|453011502|FG000|Overall Study|Protocol Violation|1|||
125921426|NCT00675948|453011503|FG001|Overall Study|Protocol Violation|0|||
125921427|NCT00675948|453011502|FG000|Overall Study|Pain under control|1|||
125921428|NCT00675948|453011503|FG001|Overall Study|Pain under control|0|||
125921429|NCT00675948|453011502|FG000|Overall Study|Sponsor decision|0|||
125921430|NCT00675948|453011503|FG001|Overall Study|Sponsor decision|1|||
125921431|NCT00675948|453011502|FG000|Overall Study|Patient died|1|||
125921432|NCT00675948|453011503|FG001|Overall Study|Patient died|0|||
125921433|NCT00675948|453011502|FG000|Overall Study|Patient unable to comply with diaries|1|||
125921434|NCT00675948|453011503|FG001|Overall Study|Patient unable to comply with diaries|0|||
125921435|NCT00675948|453011502|FG000|Overall Study|Patient feels unable to take medication|0|||
125921436|NCT00675948|453011503|FG001|Overall Study|Patient feels unable to take medication|1|||
125921437|NCT05209360|453011504|FG000|Overall Study|Withdrawal by Subject|0|||
125921438|NCT05209360|453011505|FG001|Overall Study|Withdrawal by Subject|0|||
125921439|NCT05209360|453011506|FG002|Overall Study|Withdrawal by Subject|1|||
125921440|NCT05209360|453011507|FG003|Overall Study|Withdrawal by Subject|0|||
125921441|NCT05209360|453011508|FG004|Overall Study|Withdrawal by Subject|0|||
125921442|NCT05209360|453011509|FG005|Overall Study|Withdrawal by Subject|0|||
125921443|NCT02527161|453011510|FG000|Overall Study|Failed MRI|52|||
125921444|NCT02527161|453011510|FG000|Overall Study|Withdrawal by Subject|19|||
125921445|NCT02527161|453011510|FG000|Overall Study|Delay in or unfit for surgery|16|||
125921446|NCT02527161|453011510|FG000|Overall Study|MRI contraindication|6|||
125921447|NCT02527161|453011510|FG000|Overall Study|Consent violation|4|||
125921448|NCT02527161|453011510|FG000|Overall Study|Only Recruited to Part A|27|||
125921449|NCT02527161|453011510|FG000|Overall Study|Physician Decision|1|||
125921450|NCT02527161|453011510|FG000|Overall Study|Adverse Event|1|||
125921451|NCT02527161|453011510|FG000|Overall Study|Lost to Follow-up|6|||
125921452|NCT02100514|453011511|FG000|Treatment Period|Adverse Event|0|||
125921453|NCT02100514|453011512|FG001|Treatment Period|Adverse Event|5|||
125921454|NCT02100514|453011513|FG002|Treatment Period|Adverse Event|0|||
125921455|NCT02100514|453011514|FG003|Treatment Period|Adverse Event|0|||
125921456|NCT02100514|453011515|FG004|Treatment Period|Adverse Event|0|||
125921457|NCT02100514|453011511|FG000|Treatment Period|Death|2|||
125921458|NCT02100514|453011512|FG001|Treatment Period|Death|2|||
125921459|NCT02100514|453011513|FG002|Treatment Period|Death|0|||
125921460|NCT02100514|453011514|FG003|Treatment Period|Death|0|||
125921461|NCT02100514|453011515|FG004|Treatment Period|Death|0|||
125921462|NCT02100514|453011511|FG000|Treatment Period|Lost to Follow-up|5|||
125921463|NCT02100514|453011512|FG001|Treatment Period|Lost to Follow-up|17|||
125921464|NCT02100514|453011513|FG002|Treatment Period|Lost to Follow-up|0|||
125921465|NCT02100514|453011514|FG003|Treatment Period|Lost to Follow-up|0|||
125921466|NCT02100514|453011515|FG004|Treatment Period|Lost to Follow-up|0|||
125921467|NCT02100514|453011511|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
125921468|NCT02100514|453011512|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
125921469|NCT02100514|453011513|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
125921470|NCT02100514|453011514|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
125921471|NCT02100514|453011515|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
125921472|NCT02100514|453011511|FG000|Treatment Period|Protocol Violation|1|||
125921473|NCT02100514|453011512|FG001|Treatment Period|Protocol Violation|1|||
125921474|NCT02100514|453011513|FG002|Treatment Period|Protocol Violation|0|||
125921475|NCT02100514|453011514|FG003|Treatment Period|Protocol Violation|0|||
125921476|NCT02100514|453011515|FG004|Treatment Period|Protocol Violation|0|||
125921477|NCT02100514|453011511|FG000|Treatment Period|Withdrawal by Subject|12|||
125921478|NCT02100514|453011512|FG001|Treatment Period|Withdrawal by Subject|37|||
125921479|NCT02100514|453011513|FG002|Treatment Period|Withdrawal by Subject|0|||
125921480|NCT02100514|453011514|FG003|Treatment Period|Withdrawal by Subject|0|||
125921481|NCT02100514|453011515|FG004|Treatment Period|Withdrawal by Subject|0|||
125921482|NCT02100514|453011511|FG000|Treatment Period|Other|9|||
125921483|NCT02100514|453011512|FG001|Treatment Period|Other|11|||
125921484|NCT02100514|453011513|FG002|Treatment Period|Other|0|||
125921485|NCT02100514|453011514|FG003|Treatment Period|Other|0|||
125921486|NCT02100514|453011515|FG004|Treatment Period|Other|0|||
125921487|NCT02100514|453011511|FG000|Extension Period|Withdrew consent|0|||
125921488|NCT02100514|453011512|FG001|Extension Period|Withdrew consent|0|||
125921489|NCT02100514|453011513|FG002|Extension Period|Withdrew consent|2|||
125921490|NCT02100514|453011514|FG003|Extension Period|Withdrew consent|0|||
125921491|NCT02100514|453011515|FG004|Extension Period|Withdrew consent|0|||
125921492|NCT00724932|453011516|FG000|Overall Study|Lost to Follow-up|1|||
125921493|NCT00724932|453011517|FG001|Overall Study|Lost to Follow-up|0|||
125921494|NCT00724932|453011516|FG000|Overall Study|Not treated|4|||
125921495|NCT00724932|453011517|FG001|Overall Study|Not treated|3|||
125921496|NCT01081678|453011518|FG000|Overall Study|Ineligibility Determined|0|||
125921497|NCT01081678|453011519|FG001|Overall Study|Ineligibility Determined|0|||
125921498|NCT01081678|453011520|FG002|Overall Study|Ineligibility Determined|1|||
125921499|NCT01081678|453011521|FG003|Overall Study|Ineligibility Determined|1|||
125921500|NCT01081678|453011518|FG000|Overall Study|Noncompliance|3|||
125921501|NCT01081678|453011519|FG001|Overall Study|Noncompliance|4|||
125921502|NCT01081678|453011520|FG002|Overall Study|Noncompliance|5|||
125921503|NCT01081678|453011521|FG003|Overall Study|Noncompliance|2|||
125921504|NCT01081678|453011518|FG000|Overall Study|Adverse Event|2|||
125921505|NCT01081678|453011519|FG001|Overall Study|Adverse Event|1|||
125921506|NCT01081678|453011520|FG002|Overall Study|Adverse Event|2|||
125921507|NCT01081678|453011521|FG003|Overall Study|Adverse Event|2|||
125921508|NCT01081678|453011518|FG000|Overall Study|Withdrawal by Subject|15|||
125921509|NCT01081678|453011519|FG001|Overall Study|Withdrawal by Subject|7|||
125921510|NCT01081678|453011520|FG002|Overall Study|Withdrawal by Subject|17|||
125921511|NCT01081678|453011521|FG003|Overall Study|Withdrawal by Subject|14|||
125921512|NCT01081678|453011518|FG000|Overall Study|Administrative Decision|1|||
125921513|NCT01081678|453011519|FG001|Overall Study|Administrative Decision|0|||
125921514|NCT01081678|453011520|FG002|Overall Study|Administrative Decision|0|||
125921515|NCT01081678|453011521|FG003|Overall Study|Administrative Decision|1|||
125921516|NCT01081678|453011518|FG000|Overall Study|Lost to Follow-up|4|||
125921517|NCT01081678|453011519|FG001|Overall Study|Lost to Follow-up|1|||
125921518|NCT01081678|453011520|FG002|Overall Study|Lost to Follow-up|4|||
125921519|NCT01081678|453011521|FG003|Overall Study|Lost to Follow-up|3|||
125921520|NCT01081678|453011518|FG000|Overall Study|Death|2|||
125921521|NCT01081678|453011519|FG001|Overall Study|Death|2|||
125921522|NCT01081678|453011520|FG002|Overall Study|Death|2|||
125921523|NCT01081678|453011521|FG003|Overall Study|Death|6|||
125921524|NCT01081678|453011518|FG000|Overall Study|Other|0|||
125921525|NCT01081678|453011519|FG001|Overall Study|Other|1|||
125921526|NCT01081678|453011520|FG002|Overall Study|Other|0|||
125921527|NCT01081678|453011521|FG003|Overall Study|Other|0|||
125921528|NCT01702805|453011522|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
125921529|NCT01702805|453011523|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
125921530|NCT01702805|453011522|FG000|Overall Study|Incomplete Follow-up|18|||
125921531|NCT01702805|453011523|FG001|Overall Study|Incomplete Follow-up|15|||
125921532|NCT01702805|453011522|FG000|Overall Study|Vital Status Assessment Only|40|||
125921533|NCT01702805|453011523|FG001|Overall Study|Vital Status Assessment Only|39|||
125921534|NCT01702805|453011522|FG000|Overall Study|Lost to Follow-up|5|||
125921535|NCT01702805|453011523|FG001|Overall Study|Lost to Follow-up|5|||
125921536|NCT02499783|453011524|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
125921537|NCT02499783|453011525|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
125921538|NCT02499783|453011526|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
125921539|NCT02499783|453011524|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
125921540|NCT02499783|453011525|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
125921541|NCT02499783|453011526|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
125921542|NCT02499783|453011524|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
125921543|NCT02499783|453011525|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
125921544|NCT02499783|453011526|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
125921545|NCT02499783|453011524|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
125921546|NCT02499783|453011525|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
125921547|NCT02499783|453011526|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
125921548|NCT02499783|453011524|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
125921549|NCT02499783|453011525|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
125921550|NCT02499783|453011526|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
125921551|NCT02499783|453011524|FG000|DB Period: Weeks 0-8|Other|1|||
125921552|NCT02499783|453011525|FG001|DB Period: Weeks 0-8|Other|1|||
125921553|NCT02499783|453011526|FG002|DB Period: Weeks 0-8|Other|0|||
125921554|NCT02499783|453011524|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
125921555|NCT02499783|453011525|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
125921556|NCT02499783|453011526|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
125921557|NCT02499783|453011524|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
125921558|NCT02499783|453011525|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
125921559|NCT02499783|453011526|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
125921560|NCT02499783|453011524|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
125921561|NCT02499783|453011525|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
125921562|NCT02499783|453011526|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
125921563|NCT02499783|453011524|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
125921564|NCT02499783|453011525|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
125921565|NCT02499783|453011526|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
125921566|NCT01866293|453011527|FG000|Overall Study|Adverse Event|2|||
125921567|NCT04457336|453011528|FG000|Period 2: Part A|Withdrawal by Subject|0|||
125921568|NCT04457336|453011529|FG001|Period 2: Part A|Withdrawal by Subject|1|||
125921569|NCT04457336|453011530|FG002|Period 2: Part A|Withdrawal by Subject|1|||
125921570|NCT04457336|453011531|FG003|Period 2: Part A|Withdrawal by Subject|1|||
125921571|NCT04457336|453011532|FG004|Period 2: Part A|Withdrawal by Subject|0|||
125921572|NCT04457336|453011533|FG005|Period 2: Part A|Withdrawal by Subject|0|||
125921573|NCT04457336|453011534|FG006|Period 2: Part A|Withdrawal by Subject|0|||
125921574|NCT04457336|453011535|FG007|Period 2: Part A|Withdrawal by Subject|0|||
125921575|NCT04457336|453011528|FG000|Period 2: Part A|Adverse Event|0|||
125921576|NCT04457336|453011529|FG001|Period 2: Part A|Adverse Event|0|||
125921577|NCT04457336|453011530|FG002|Period 2: Part A|Adverse Event|1|||
125921578|NCT04457336|453011531|FG003|Period 2: Part A|Adverse Event|1|||
125921579|NCT04457336|453011532|FG004|Period 2: Part A|Adverse Event|0|||
125921580|NCT04457336|453011533|FG005|Period 2: Part A|Adverse Event|0|||
125921581|NCT04457336|453011534|FG006|Period 2: Part A|Adverse Event|0|||
125921582|NCT04457336|453011535|FG007|Period 2: Part A|Adverse Event|0|||
125921583|NCT04457336|453011528|FG000|Period 2: Part A|Study Terminated|0|||
125921584|NCT04457336|453011529|FG001|Period 2: Part A|Study Terminated|0|||
125921585|NCT04457336|453011530|FG002|Period 2: Part A|Study Terminated|1|||
125921586|NCT04457336|453011531|FG003|Period 2: Part A|Study Terminated|0|||
125921587|NCT04457336|453011532|FG004|Period 2: Part A|Study Terminated|0|||
125921588|NCT04457336|453011533|FG005|Period 2: Part A|Study Terminated|0|||
125921589|NCT04457336|453011534|FG006|Period 2: Part A|Study Terminated|0|||
125921590|NCT04457336|453011535|FG007|Period 2: Part A|Study Terminated|0|||
125921591|NCT04457336|453011528|FG000|Period 2: Part A|Protocol Violation|0|||
125921592|NCT04457336|453011529|FG001|Period 2: Part A|Protocol Violation|1|||
125921593|NCT04457336|453011530|FG002|Period 2: Part A|Protocol Violation|0|||
125921594|NCT04457336|453011531|FG003|Period 2: Part A|Protocol Violation|0|||
125921595|NCT04457336|453011532|FG004|Period 2: Part A|Protocol Violation|0|||
125921596|NCT04457336|453011533|FG005|Period 2: Part A|Protocol Violation|0|||
125921597|NCT04457336|453011534|FG006|Period 2: Part A|Protocol Violation|0|||
125921598|NCT04457336|453011535|FG007|Period 2: Part A|Protocol Violation|0|||
125921599|NCT04457336|453011528|FG000|Period 2: Part A|Lost to Follow-up|0|||
125921600|NCT04457336|453011529|FG001|Period 2: Part A|Lost to Follow-up|1|||
125921601|NCT04457336|453011530|FG002|Period 2: Part A|Lost to Follow-up|0|||
125921602|NCT04457336|453011531|FG003|Period 2: Part A|Lost to Follow-up|0|||
125921603|NCT04457336|453011532|FG004|Period 2: Part A|Lost to Follow-up|0|||
125921604|NCT04457336|453011533|FG005|Period 2: Part A|Lost to Follow-up|0|||
125921605|NCT04457336|453011534|FG006|Period 2: Part A|Lost to Follow-up|0|||
125921606|NCT04457336|453011535|FG007|Period 2: Part A|Lost to Follow-up|0|||
125921607|NCT04457336|453011528|FG000|Period 2: Part A|Other|0|||
125921608|NCT04457336|453011529|FG001|Period 2: Part A|Other|1|||
125921609|NCT04457336|453011530|FG002|Period 2: Part A|Other|0|||
125921610|NCT04457336|453011531|FG003|Period 2: Part A|Other|0|||
125921611|NCT04457336|453011532|FG004|Period 2: Part A|Other|0|||
125921612|NCT04457336|453011533|FG005|Period 2: Part A|Other|0|||
125921613|NCT04457336|453011534|FG006|Period 2: Part A|Other|0|||
125921614|NCT04457336|453011535|FG007|Period 2: Part A|Other|0|||
125921615|NCT04457336|453011528|FG000|Period 2: Part A|Physician Decision|0|||
125921616|NCT04457336|453011529|FG001|Period 2: Part A|Physician Decision|0|||
125921617|NCT04457336|453011530|FG002|Period 2: Part A|Physician Decision|0|||
125921618|NCT04457336|453011531|FG003|Period 2: Part A|Physician Decision|1|||
125921619|NCT04457336|453011532|FG004|Period 2: Part A|Physician Decision|0|||
125921620|NCT04457336|453011533|FG005|Period 2: Part A|Physician Decision|0|||
125921621|NCT04457336|453011534|FG006|Period 2: Part A|Physician Decision|0|||
125921622|NCT04457336|453011535|FG007|Period 2: Part A|Physician Decision|0|||
125921623|NCT04457336|453011528|FG000|Period 3: Part B|Study Terminated|0|||
125921624|NCT04457336|453011529|FG001|Period 3: Part B|Study Terminated|0|||
125921625|NCT04457336|453011530|FG002|Period 3: Part B|Study Terminated|0|||
125921626|NCT04457336|453011531|FG003|Period 3: Part B|Study Terminated|0|||
125921627|NCT04457336|453011532|FG004|Period 3: Part B|Study Terminated|1|||
125921628|NCT04457336|453011533|FG005|Period 3: Part B|Study Terminated|10|||
125921629|NCT04457336|453011534|FG006|Period 3: Part B|Study Terminated|13|||
125921630|NCT04457336|453011535|FG007|Period 3: Part B|Study Terminated|0|||
125921631|NCT04457336|453011528|FG000|Period 3: Part B|Withdrawal by Subject|0|||
125921632|NCT04457336|453011529|FG001|Period 3: Part B|Withdrawal by Subject|0|||
125921633|NCT04457336|453011530|FG002|Period 3: Part B|Withdrawal by Subject|0|||
125921634|NCT04457336|453011531|FG003|Period 3: Part B|Withdrawal by Subject|0|||
125921635|NCT04457336|453011532|FG004|Period 3: Part B|Withdrawal by Subject|0|||
125921636|NCT04457336|453011533|FG005|Period 3: Part B|Withdrawal by Subject|1|||
125921637|NCT04457336|453011534|FG006|Period 3: Part B|Withdrawal by Subject|2|||
125921638|NCT04457336|453011535|FG007|Period 3: Part B|Withdrawal by Subject|0|||
125921639|NCT04457336|453011528|FG000|Period 4: Part C|Study Terminated|0|||
125921640|NCT04457336|453011529|FG001|Period 4: Part C|Study Terminated|0|||
125921641|NCT04457336|453011530|FG002|Period 4: Part C|Study Terminated|0|||
125921642|NCT04457336|453011531|FG003|Period 4: Part C|Study Terminated|0|||
125921643|NCT04457336|453011532|FG004|Period 4: Part C|Study Terminated|0|||
125921644|NCT04457336|453011533|FG005|Period 4: Part C|Study Terminated|0|||
125921645|NCT04457336|453011534|FG006|Period 4: Part C|Study Terminated|0|||
125921646|NCT04457336|453011535|FG007|Period 4: Part C|Study Terminated|30|||
125921647|NCT04457336|453011528|FG000|Period 4: Part C|Adverse Event|0|||
125921648|NCT04457336|453011529|FG001|Period 4: Part C|Adverse Event|0|||
125921649|NCT04457336|453011530|FG002|Period 4: Part C|Adverse Event|0|||
125921650|NCT04457336|453011531|FG003|Period 4: Part C|Adverse Event|0|||
125921651|NCT04457336|453011532|FG004|Period 4: Part C|Adverse Event|0|||
125921652|NCT04457336|453011533|FG005|Period 4: Part C|Adverse Event|0|||
125921653|NCT04457336|453011534|FG006|Period 4: Part C|Adverse Event|0|||
125921654|NCT04457336|453011535|FG007|Period 4: Part C|Adverse Event|2|||
125921655|NCT04457336|453011528|FG000|Period 4: Part C|Site Terminated|0|||
125921656|NCT04457336|453011529|FG001|Period 4: Part C|Site Terminated|0|||
125921657|NCT04457336|453011530|FG002|Period 4: Part C|Site Terminated|0|||
125921658|NCT04457336|453011531|FG003|Period 4: Part C|Site Terminated|0|||
125921659|NCT04457336|453011532|FG004|Period 4: Part C|Site Terminated|0|||
125921660|NCT04457336|453011533|FG005|Period 4: Part C|Site Terminated|0|||
125921661|NCT04457336|453011534|FG006|Period 4: Part C|Site Terminated|0|||
125921662|NCT04457336|453011535|FG007|Period 4: Part C|Site Terminated|1|||
125921663|NCT04457336|453011528|FG000|Period 4: Part C|Other|0|||
125921664|NCT04457336|453011529|FG001|Period 4: Part C|Other|0|||
125921665|NCT04457336|453011530|FG002|Period 4: Part C|Other|0|||
125921666|NCT04457336|453011531|FG003|Period 4: Part C|Other|0|||
125921667|NCT04457336|453011532|FG004|Period 4: Part C|Other|0|||
125921668|NCT04457336|453011533|FG005|Period 4: Part C|Other|0|||
125921669|NCT04457336|453011534|FG006|Period 4: Part C|Other|0|||
125921670|NCT04457336|453011535|FG007|Period 4: Part C|Other|2|||
125921671|NCT04457336|453011528|FG000|Period 4: Part C|Withdrawal by Subject|0|||
125921672|NCT04457336|453011529|FG001|Period 4: Part C|Withdrawal by Subject|0|||
125921673|NCT04457336|453011530|FG002|Period 4: Part C|Withdrawal by Subject|0|||
125921674|NCT04457336|453011531|FG003|Period 4: Part C|Withdrawal by Subject|0|||
125921675|NCT04457336|453011532|FG004|Period 4: Part C|Withdrawal by Subject|0|||
125921676|NCT04457336|453011533|FG005|Period 4: Part C|Withdrawal by Subject|0|||
125921677|NCT04457336|453011534|FG006|Period 4: Part C|Withdrawal by Subject|0|||
125921678|NCT04457336|453011535|FG007|Period 4: Part C|Withdrawal by Subject|3|||
125921679|NCT04447794|453011538|FG000|Overall Study|Lost to Follow-up|2|||
125921680|NCT04447794|453011539|FG001|Overall Study|Lost to Follow-up|3|||
125921681|NCT04447794|453011540|FG002|Overall Study|Lost to Follow-up|8|||
125921682|NCT04447794|453011538|FG000|Overall Study|Withdrawal by Subject|1|||
125921683|NCT04447794|453011539|FG001|Overall Study|Withdrawal by Subject|1|||
125921684|NCT04447794|453011540|FG002|Overall Study|Withdrawal by Subject|0|||
125921685|NCT02571075|453011541|FG000|Overall Study|Lost to Follow-up|20|||
125921686|NCT02571075|453011542|FG001|Overall Study|Lost to Follow-up|24|||
125921687|NCT02693119|453011545|FG000|Open-Label Period|Withdrawal by Subject|0|||
125921688|NCT02693119|453011546|FG001|Open-Label Period|Withdrawal by Subject|1|||
125921689|NCT00963937|453011549|FG000|Overall Study|Protocol Violation|1|||
125921690|NCT00963937|453011550|FG001|Overall Study|Protocol Violation|1|||
125921691|NCT00963937|453011551|FG002|Overall Study|Protocol Violation|0|||
125921692|NCT00963937|453011549|FG000|Overall Study|Physician Decision|18|||
125921693|NCT00963937|453011550|FG001|Overall Study|Physician Decision|10|||
125921694|NCT00963937|453011551|FG002|Overall Study|Physician Decision|4|||
125921695|NCT01350492|453011552|FG000|Intervention|Lost to Follow-up|2|||
125921696|NCT01350492|453011553|FG001|Intervention|Lost to Follow-up|5|||
125921697|NCT01350492|453011552|FG000|Intervention|Withdrawal by Subject|3|||
125921698|NCT01350492|453011553|FG001|Intervention|Withdrawal by Subject|1|||
125921699|NCT01350492|453011552|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
125921700|NCT01350492|453011553|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
125921701|NCT01350492|453011552|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
126064344|NCT03745651|453527704|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
126064345|NCT03745651|453527705|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
126064346|NCT03745651|453527706|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
126064347|NCT03745651|453527707|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
126064348|NCT03745651|453527708|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
126064349|NCT03745651|453527709|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
126064350|NCT03745651|453527710|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
126064351|NCT03745651|453527704|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126064352|NCT03745651|453527705|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126064353|NCT03745651|453527706|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126064354|NCT03745651|453527707|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126064355|NCT03745651|453527708|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126064356|NCT03745651|453527709|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
126064357|NCT03745651|453527710|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126064358|NCT03745651|453527704|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126064359|NCT03745651|453527705|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126064360|NCT03745651|453527706|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126064361|NCT03745651|453527707|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
126064362|NCT03745651|453527708|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126064363|NCT03745651|453527709|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
126064364|NCT03745651|453527710|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
126064365|NCT03745651|453527704|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126064366|NCT03745651|453527705|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126064367|NCT03745651|453527706|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126064368|NCT03745651|453527707|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
126064369|NCT03745651|453527708|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
126064370|NCT03745651|453527709|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
126064371|NCT03745651|453527710|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
126064372|NCT03745651|453527704|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126064373|NCT03745651|453527705|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126064374|NCT03745651|453527706|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126064375|NCT03745651|453527707|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
126064376|NCT03745651|453527708|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126064377|NCT03745651|453527709|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
126064378|NCT03745651|453527710|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
126064379|NCT03745651|453527704|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126064380|NCT03745651|453527705|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126064381|NCT03745651|453527706|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126064382|NCT03745651|453527707|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
126064383|NCT03745651|453527708|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126064384|NCT03745651|453527709|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126064385|NCT03745651|453527710|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
126064386|NCT03745651|453527704|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126064387|NCT03745651|453527705|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126064388|NCT03745651|453527706|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126064389|NCT03745651|453527707|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126064390|NCT03745651|453527708|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126064391|NCT03745651|453527709|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
126064392|NCT03745651|453527710|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126064393|NCT03745651|453527704|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126064394|NCT03745651|453527705|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126064395|NCT03745651|453527706|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126064396|NCT03745651|453527707|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
126064397|NCT03745651|453527708|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
126064398|NCT03745651|453527709|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
126064399|NCT03745651|453527710|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
126064400|NCT03745651|453527704|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
126064401|NCT03745651|453527705|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
126064402|NCT03745651|453527706|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
126064403|NCT03745651|453527707|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
126064404|NCT03745651|453527708|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
126064405|NCT03745651|453527709|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
126064406|NCT03745651|453527710|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
126064407|NCT02309892|453527713|FG000|Overall Study|Physician Decision|1|||
125921702|NCT01350492|453011553|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
125921703|NCT04203498|453011556|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
125921704|NCT04203498|453011557|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
125921705|NCT04203498|453011556|FG000|Overall Study|Withdrawal of patient consent|7|||
125921706|NCT04203498|453011557|FG001|Overall Study|Withdrawal of patient consent|2|||
125921707|NCT04203498|453011556|FG000|Overall Study|Adverse Event|4|||
125921708|NCT04203498|453011557|FG001|Overall Study|Adverse Event|1|||
125921709|NCT04203498|453011556|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
125921710|NCT04203498|453011557|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
125921711|NCT04203498|453011556|FG000|Overall Study|Did not receive IMP|2|||
125921712|NCT04203498|453011557|FG001|Overall Study|Did not receive IMP|0|||
125921713|NCT00939640|453011558|FG000|Overall Study|Physician Decision|1|||
125921714|NCT01235689|453011564|FG000|Overall Study|Adverse Event|12|||
125921715|NCT01235689|453011565|FG001|Overall Study|Adverse Event|16|||
125921716|NCT01235689|453011564|FG000|Overall Study|Lack of Efficacy|12|||
125921717|NCT01235689|453011565|FG001|Overall Study|Lack of Efficacy|5|||
125921718|NCT01235689|453011564|FG000|Overall Study|Withdrawal by Subject|3|||
125921719|NCT01235689|453011565|FG001|Overall Study|Withdrawal by Subject|4|||
125921720|NCT01235689|453011564|FG000|Overall Study|Lost to Follow-up|1|||
125921721|NCT01235689|453011565|FG001|Overall Study|Lost to Follow-up|2|||
125921722|NCT01235689|453011564|FG000|Overall Study|Miscellaneous|1|||
125921723|NCT01235689|453011565|FG001|Overall Study|Miscellaneous|5|||
125921724|NCT02106975|453011566|FG000|Overall Study|Death|25|||
125921725|NCT02106975|453011567|FG001|Overall Study|Death|39|||
125921726|NCT02935842|453011569|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
125921727|NCT02935842|453011570|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
125921728|NCT02935842|453011571|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
125921729|NCT02935842|453011572|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
125921730|NCT02935842|453011569|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
125921731|NCT02935842|453011570|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
125921732|NCT02935842|453011571|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
125921733|NCT02935842|453011572|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
125921734|NCT02935842|453011569|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
125921735|NCT02935842|453011570|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
125921736|NCT02935842|453011571|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
125921737|NCT02935842|453011572|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
125921738|NCT02935842|453011569|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
125921739|NCT02935842|453011570|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
125921740|NCT02935842|453011571|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
125921741|NCT02935842|453011572|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
125921742|NCT02935842|453011569|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
125921743|NCT02935842|453011570|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
125921744|NCT02935842|453011571|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
125921745|NCT02935842|453011572|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
125921746|NCT01201785|453011573|FG000|Overall Study|Lost to Follow-up|16|||
125921747|NCT04545385|453011574|FG000|Overall Study|Withdrawal by Subject|2|||
125921748|NCT04545385|453011575|FG001|Overall Study|Withdrawal by Subject|0|||
125921749|NCT04545385|453011574|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
125921750|NCT04545385|453011575|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
125921751|NCT04545385|453011574|FG000|Overall Study|Study termination|10|||
125921752|NCT04545385|453011575|FG001|Overall Study|Study termination|10|||
125921753|NCT04545385|453011574|FG000|Overall Study|Sponsor decision|2|||
125921754|NCT04545385|453011575|FG001|Overall Study|Sponsor decision|2|||
125921755|NCT04545385|453011574|FG000|Overall Study|Other than specified|1|||
125921756|NCT04545385|453011575|FG001|Overall Study|Other than specified|0|||
125921757|NCT00939770|453011576|FG000|Overall Study|Adverse Event|1|||
125921758|NCT00939770|453011577|FG001|Overall Study|Adverse Event|1|||
125921759|NCT00939770|453011578|FG002|Overall Study|Adverse Event|0|||
125921760|NCT00939770|453011579|FG003|Overall Study|Adverse Event|0|||
125921761|NCT00939770|453011580|FG004|Overall Study|Adverse Event|6|||
125921762|NCT00939770|453011581|FG005|Overall Study|Adverse Event|2|||
125921763|NCT00939770|453011582|FG006|Overall Study|Adverse Event|1|||
125921764|NCT00939770|453011583|FG007|Overall Study|Adverse Event|1|||
125921765|NCT00939770|453011576|FG000|Overall Study|Lack of Efficacy|4|||
125921766|NCT00939770|453011577|FG001|Overall Study|Lack of Efficacy|6|||
125921767|NCT00939770|453011578|FG002|Overall Study|Lack of Efficacy|13|||
125921768|NCT00939770|453011579|FG003|Overall Study|Lack of Efficacy|9|||
125921769|NCT00939770|453011580|FG004|Overall Study|Lack of Efficacy|16|||
125921770|NCT00939770|453011581|FG005|Overall Study|Lack of Efficacy|8|||
125921771|NCT00939770|453011582|FG006|Overall Study|Lack of Efficacy|11|||
125921772|NCT00939770|453011583|FG007|Overall Study|Lack of Efficacy|1|||
125921773|NCT00939770|453011576|FG000|Overall Study|Lost to Follow-up|0|||
125921774|NCT00939770|453011577|FG001|Overall Study|Lost to Follow-up|0|||
125921775|NCT00939770|453011578|FG002|Overall Study|Lost to Follow-up|0|||
125921776|NCT00939770|453011579|FG003|Overall Study|Lost to Follow-up|0|||
125921777|NCT00939770|453011580|FG004|Overall Study|Lost to Follow-up|1|||
125921778|NCT00939770|453011581|FG005|Overall Study|Lost to Follow-up|0|||
125921779|NCT00939770|453011582|FG006|Overall Study|Lost to Follow-up|0|||
125921780|NCT00939770|453011583|FG007|Overall Study|Lost to Follow-up|0|||
125921781|NCT00939770|453011576|FG000|Overall Study|Physician Decision|0|||
125921782|NCT00939770|453011577|FG001|Overall Study|Physician Decision|0|||
125921783|NCT00939770|453011578|FG002|Overall Study|Physician Decision|2|||
125921784|NCT00939770|453011579|FG003|Overall Study|Physician Decision|0|||
125921785|NCT00939770|453011580|FG004|Overall Study|Physician Decision|7|||
125921786|NCT00939770|453011581|FG005|Overall Study|Physician Decision|1|||
125921787|NCT00939770|453011582|FG006|Overall Study|Physician Decision|0|||
125921788|NCT00939770|453011583|FG007|Overall Study|Physician Decision|6|||
125921789|NCT00939770|453011576|FG000|Overall Study|Protocol Violation|0|||
125921790|NCT00939770|453011577|FG001|Overall Study|Protocol Violation|0|||
125921791|NCT00939770|453011578|FG002|Overall Study|Protocol Violation|0|||
125921792|NCT00939770|453011579|FG003|Overall Study|Protocol Violation|0|||
125921793|NCT00939770|453011580|FG004|Overall Study|Protocol Violation|1|||
125921794|NCT00939770|453011581|FG005|Overall Study|Protocol Violation|0|||
125921795|NCT00939770|453011582|FG006|Overall Study|Protocol Violation|0|||
125921796|NCT00939770|453011583|FG007|Overall Study|Protocol Violation|0|||
125921797|NCT00939770|453011576|FG000|Overall Study|Withdrawal by Subject|0|||
125921798|NCT00939770|453011577|FG001|Overall Study|Withdrawal by Subject|1|||
125921799|NCT00939770|453011578|FG002|Overall Study|Withdrawal by Subject|5|||
125921800|NCT00939770|453011579|FG003|Overall Study|Withdrawal by Subject|2|||
125921801|NCT00939770|453011580|FG004|Overall Study|Withdrawal by Subject|6|||
125921802|NCT00939770|453011581|FG005|Overall Study|Withdrawal by Subject|0|||
125921803|NCT00939770|453011582|FG006|Overall Study|Withdrawal by Subject|2|||
125921804|NCT00939770|453011583|FG007|Overall Study|Withdrawal by Subject|2|||
125921805|NCT00191139|453011584|FG000|Overall Study|Adverse Event|2|||
125921806|NCT00191139|453011585|FG001|Overall Study|Adverse Event|6|||
125921807|NCT00191139|453011584|FG000|Overall Study|Death|2|||
125921808|NCT00191139|453011585|FG001|Overall Study|Death|0|||
125921809|NCT00191139|453011584|FG000|Overall Study|Withdrawal by Subject|0|||
125921810|NCT00191139|453011585|FG001|Overall Study|Withdrawal by Subject|3|||
125921811|NCT00191139|453011584|FG000|Overall Study|Disease Progression|0|||
125921812|NCT00191139|453011585|FG001|Overall Study|Disease Progression|1|||
125921813|NCT00191139|453011584|FG000|Overall Study|Other|1|||
125921814|NCT00191139|453011585|FG001|Overall Study|Other|2|||
125921815|NCT01817530|453011590|FG000|Overall Study|Exclusionary Medication Received|0|||
125921816|NCT01817530|453011591|FG001|Overall Study|Exclusionary Medication Received|0|||
125921817|NCT01817530|453011592|FG002|Overall Study|Exclusionary Medication Received|0|||
125921818|NCT01817530|453011593|FG003|Overall Study|Exclusionary Medication Received|0|||
125921819|NCT01817530|453011594|FG004|Overall Study|Exclusionary Medication Received|1|||
125921820|NCT01817530|453011595|FG005|Overall Study|Exclusionary Medication Received|0|||
125921821|NCT01817530|453011596|FG006|Overall Study|Exclusionary Medication Received|0|||
125921822|NCT01817530|453011597|FG007|Overall Study|Exclusionary Medication Received|0|||
125921823|NCT01817530|453011590|FG000|Overall Study|Adverse Event|6|||
125921824|NCT01817530|453011591|FG001|Overall Study|Adverse Event|3|||
125921825|NCT01817530|453011592|FG002|Overall Study|Adverse Event|2|||
125921826|NCT01817530|453011593|FG003|Overall Study|Adverse Event|5|||
125921827|NCT01817530|453011594|FG004|Overall Study|Adverse Event|0|||
125921828|NCT01817530|453011595|FG005|Overall Study|Adverse Event|10|||
125921829|NCT01817530|453011596|FG006|Overall Study|Adverse Event|5|||
125921830|NCT01817530|453011597|FG007|Overall Study|Adverse Event|8|||
125921831|NCT01817530|453011590|FG000|Overall Study|Subject Noncompliant|3|||
125921832|NCT01817530|453011591|FG001|Overall Study|Subject Noncompliant|1|||
125921833|NCT01817530|453011592|FG002|Overall Study|Subject Noncompliant|0|||
125921834|NCT01817530|453011593|FG003|Overall Study|Subject Noncompliant|4|||
125921835|NCT01817530|453011594|FG004|Overall Study|Subject Noncompliant|0|||
125921836|NCT01817530|453011595|FG005|Overall Study|Subject Noncompliant|1|||
125921837|NCT01817530|453011596|FG006|Overall Study|Subject Noncompliant|1|||
125921838|NCT01817530|453011597|FG007|Overall Study|Subject Noncompliant|1|||
125921839|NCT01817530|453011590|FG000|Overall Study|Lack of Efficacy|1|||
125921840|NCT01817530|453011591|FG001|Overall Study|Lack of Efficacy|0|||
125921841|NCT01817530|453011592|FG002|Overall Study|Lack of Efficacy|0|||
125921842|NCT01817530|453011593|FG003|Overall Study|Lack of Efficacy|0|||
125921843|NCT01817530|453011594|FG004|Overall Study|Lack of Efficacy|0|||
125921844|NCT01817530|453011595|FG005|Overall Study|Lack of Efficacy|1|||
125921845|NCT01817530|453011596|FG006|Overall Study|Lack of Efficacy|0|||
125921846|NCT01817530|453011597|FG007|Overall Study|Lack of Efficacy|1|||
125921847|NCT01817530|453011590|FG000|Overall Study|Pregnancy|0|||
125921848|NCT01817530|453011591|FG001|Overall Study|Pregnancy|0|||
125921849|NCT01817530|453011592|FG002|Overall Study|Pregnancy|0|||
125921850|NCT01817530|453011593|FG003|Overall Study|Pregnancy|0|||
125921851|NCT01817530|453011594|FG004|Overall Study|Pregnancy|0|||
125921852|NCT01817530|453011595|FG005|Overall Study|Pregnancy|1|||
125921853|NCT01817530|453011596|FG006|Overall Study|Pregnancy|0|||
125921854|NCT01817530|453011597|FG007|Overall Study|Pregnancy|0|||
125921855|NCT01817530|453011590|FG000|Overall Study|Other|0|||
126110975|NCT02742766|453701968|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110976|NCT02742766|453701969|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110977|NCT02742766|453701970|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
126110978|NCT04936841|453701973|FG000|Overall Study|Death|1|||
126110979|NCT01395316|453701976|FG000|Overall Study|Lost to Follow-up|2|||
126110980|NCT01395316|453701976|FG000|Overall Study|poor MRI quality|1|||
126110981|NCT03359590|453701978|FG000|First Intervention|Withdrawal by Subject|1|||
126110982|NCT03359590|453701979|FG001|First Intervention|Withdrawal by Subject|1|||
126110983|NCT03359590|453701978|FG000|First Intervention|Protocol Violation|0|||
126110984|NCT03359590|453701979|FG001|First Intervention|Protocol Violation|1|||
126110985|NCT02846532|453701980|FG000|Overall Study|Lost to Follow-up|0|||
126110986|NCT02846532|453701981|FG001|Overall Study|Lost to Follow-up|1|||
126110987|NCT02846532|453701982|FG002|Overall Study|Lost to Follow-up|1|||
126110988|NCT02846532|453701980|FG000|Overall Study|Withdrawal by Subject|1|||
126110989|NCT02846532|453701981|FG001|Overall Study|Withdrawal by Subject|2|||
126110990|NCT02846532|453701982|FG002|Overall Study|Withdrawal by Subject|0|||
126110991|NCT03951220|453701983|FG000|Overall Study|Withdrawal by Subject|9|||
126110992|NCT03951220|453701984|FG001|Overall Study|Withdrawal by Subject|2|||
126110993|NCT03951220|453701985|FG002|Overall Study|Withdrawal by Subject|0|||
126110994|NCT06132425|453701986|FG000|Overall Study|Withdrawal by Subject|3|||
126110995|NCT06132425|453701987|FG001|Overall Study|Withdrawal by Subject|0|||
126110996|NCT06132425|453701986|FG000|Overall Study|Did not follow study instructions|0|||
126110997|NCT06132425|453701987|FG001|Overall Study|Did not follow study instructions|2|||
126110998|NCT06132425|453701986|FG000|Overall Study|Lost to Follow-up|3|||
126110999|NCT06132425|453701987|FG001|Overall Study|Lost to Follow-up|5|||
126111000|NCT01019980|453701989|FG000|Overall Study|Drug not available.|2|||
126111001|NCT01019980|453701990|FG001|Overall Study|Drug not available.|0|||
126111002|NCT02038920|453701991|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
126111003|NCT02038920|453701992|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
126111004|NCT02038920|453701993|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
126111005|NCT02038920|453701994|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
126111006|NCT02038920|453701995|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
126111007|NCT02038920|453701996|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
126111008|NCT02038920|453701991|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
126111009|NCT02038920|453701992|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126111010|NCT02038920|453701993|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126111011|NCT02038920|453701994|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126111012|NCT02038920|453701995|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126111013|NCT02038920|453701996|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126111014|NCT02038920|453701991|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
126111015|NCT02038920|453701992|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
126111016|NCT02038920|453701993|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
126111017|NCT02038920|453701994|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
126111018|NCT02038920|453701995|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
126111019|NCT02038920|453701996|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
126111020|NCT02038920|453701991|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
126111021|NCT02038920|453701992|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
126111022|NCT02038920|453701993|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
126111023|NCT02038920|453701994|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
126111024|NCT02038920|453701995|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
126111025|NCT02038920|453701996|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
126111026|NCT02038920|453701991|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126111027|NCT02038920|453701992|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126111028|NCT02038920|453701993|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
126111029|NCT02038920|453701994|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126111030|NCT02038920|453701995|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126111031|NCT02038920|453701996|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126111032|NCT02038920|453701991|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
126111033|NCT02038920|453701992|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
126111034|NCT02038920|453701993|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
126111035|NCT02038920|453701994|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
126111036|NCT02038920|453701995|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
125921856|NCT01817530|453011591|FG001|Overall Study|Other|1|||
125921857|NCT01817530|453011592|FG002|Overall Study|Other|0|||
125921858|NCT01817530|453011593|FG003|Overall Study|Other|0|||
125921859|NCT01817530|453011594|FG004|Overall Study|Other|1|||
126111037|NCT02038920|453701996|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
126111038|NCT02038920|453701991|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125921860|NCT01817530|453011595|FG005|Overall Study|Other|0|||
125921861|NCT01817530|453011596|FG006|Overall Study|Other|5|||
125921862|NCT01817530|453011597|FG007|Overall Study|Other|0|||
125921863|NCT01817530|453011590|FG000|Overall Study|Surgery or Invasive Intervention|1|||
125921864|NCT01817530|453011591|FG001|Overall Study|Surgery or Invasive Intervention|0|||
125921865|NCT01817530|453011592|FG002|Overall Study|Surgery or Invasive Intervention|0|||
125921866|NCT01817530|453011593|FG003|Overall Study|Surgery or Invasive Intervention|0|||
125921867|NCT01817530|453011594|FG004|Overall Study|Surgery or Invasive Intervention|1|||
125921868|NCT01817530|453011595|FG005|Overall Study|Surgery or Invasive Intervention|1|||
125921869|NCT01817530|453011596|FG006|Overall Study|Surgery or Invasive Intervention|1|||
125921870|NCT01817530|453011597|FG007|Overall Study|Surgery or Invasive Intervention|0|||
125921871|NCT01817530|453011590|FG000|Overall Study|Consent Withdrawn by Subject|3|||
125921872|NCT01817530|453011591|FG001|Overall Study|Consent Withdrawn by Subject|4|||
125921873|NCT01817530|453011592|FG002|Overall Study|Consent Withdrawn by Subject|7|||
125921874|NCT01817530|453011593|FG003|Overall Study|Consent Withdrawn by Subject|3|||
125921875|NCT01817530|453011594|FG004|Overall Study|Consent Withdrawn by Subject|5|||
125921876|NCT01817530|453011595|FG005|Overall Study|Consent Withdrawn by Subject|3|||
125921877|NCT01817530|453011596|FG006|Overall Study|Consent Withdrawn by Subject|3|||
125921878|NCT01817530|453011597|FG007|Overall Study|Consent Withdrawn by Subject|10|||
125921879|NCT01817530|453011590|FG000|Overall Study|Lost to Follow-up|1|||
125921880|NCT01817530|453011591|FG001|Overall Study|Lost to Follow-up|4|||
125921881|NCT01817530|453011592|FG002|Overall Study|Lost to Follow-up|2|||
125921882|NCT01817530|453011593|FG003|Overall Study|Lost to Follow-up|1|||
125921883|NCT01817530|453011594|FG004|Overall Study|Lost to Follow-up|3|||
125921884|NCT01817530|453011595|FG005|Overall Study|Lost to Follow-up|2|||
125921885|NCT01817530|453011596|FG006|Overall Study|Lost to Follow-up|8|||
125921886|NCT01817530|453011597|FG007|Overall Study|Lost to Follow-up|4|||
125921887|NCT03846804|453011598|FG000|Overall Study|Refused blood draw|1|||
125921888|NCT03846804|453011598|FG000|Overall Study|Protocol Violation|1|||
125921889|NCT00404235|453011599|FG000|Overall Study|Withdrawal by Subject|1|||
125921890|NCT00404235|453011600|FG001|Overall Study|Withdrawal by Subject|2|||
125921891|NCT00345839|453011601|FG000|Overall Study|Withdrawal by Subject|91|||
125921892|NCT00345839|453011602|FG001|Overall Study|Withdrawal by Subject|98|||
125921893|NCT00345839|453011601|FG000|Overall Study|Lost to Follow-up|58|||
125921894|NCT00345839|453011602|FG001|Overall Study|Lost to Follow-up|61|||
125921895|NCT03298867|453011605|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
125921896|NCT03298867|453011606|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
125921897|NCT03298867|453011605|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
125921898|NCT03298867|453011606|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
125921899|NCT03298867|453011605|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
125921900|NCT03298867|453011606|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
125921901|NCT03298867|453011605|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
125921902|NCT03298867|453011606|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
125921903|NCT03298867|453011605|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
125921904|NCT03298867|453011606|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
125921905|NCT03298867|453011605|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
125921906|NCT03298867|453011606|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
125921907|NCT03298867|453011605|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
125921908|NCT03298867|453011606|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
125921909|NCT03298867|453011605|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
125921910|NCT03298867|453011606|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
125921911|NCT03298867|453011605|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
125921912|NCT03298867|453011606|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
125921913|NCT00743483|453011607|FG000|Baseline Period|Physician Decision|1|||
125921914|NCT00743483|453011607|FG000|Treatment Period|Adverse Event|1|||
125921915|NCT01466153|453011608|FG000|Overall Study|Disease Progression|2|||
125921916|NCT01466153|453011609|FG001|Overall Study|Disease Progression|2|||
125921917|NCT01466153|453011610|FG002|Overall Study|Disease Progression|0|||
125921918|NCT01466153|453011608|FG000|Overall Study|Adverse Event|14|||
125921919|NCT01466153|453011609|FG001|Overall Study|Adverse Event|13|||
125921920|NCT01466153|453011610|FG002|Overall Study|Adverse Event|17|||
125921921|NCT01466153|453011608|FG000|Overall Study|Withdrawal of Consent|2|||
125921922|NCT01466153|453011609|FG001|Overall Study|Withdrawal of Consent|0|||
125921923|NCT01466153|453011610|FG002|Overall Study|Withdrawal of Consent|0|||
125921924|NCT01466153|453011608|FG000|Overall Study|Investigator Discretion|3|||
125921925|NCT01466153|453011609|FG001|Overall Study|Investigator Discretion|2|||
125921926|NCT01466153|453011610|FG002|Overall Study|Investigator Discretion|2|||
125921927|NCT01466153|453011608|FG000|Overall Study|Randomized-Not Treated|2|||
125921928|NCT01466153|453011609|FG001|Overall Study|Randomized-Not Treated|3|||
125921929|NCT01466153|453011610|FG002|Overall Study|Randomized-Not Treated|4|||
125921930|NCT01466153|453011608|FG000|Overall Study|Other-Unspecified|6|||
125921931|NCT01466153|453011609|FG001|Overall Study|Other-Unspecified|4|||
125921932|NCT01466153|453011610|FG002|Overall Study|Other-Unspecified|2|||
125971424|NCT01358526|453182852|FG002|Open-label Titration Period|Adverse Event|0|||
126111039|NCT02038920|453701992|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
126111040|NCT02038920|453701993|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125921933|NCT01513343|453012965|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
125921934|NCT01513343|453012966|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
125921935|NCT01513343|453012965|FG000|Post Data Collection|Dropped/withdrew from study|7|||
125921936|NCT01513343|453012966|FG001|Post Data Collection|Dropped/withdrew from study|1|||
125921937|NCT01513343|453012965|FG000|Post Data Collection|Lost to Follow-up|10|||
125921938|NCT01513343|453012966|FG001|Post Data Collection|Lost to Follow-up|23|||
125921939|NCT01513343|453012965|FG000|6-month Follow-up|Lost to Follow-up|28|||
125921940|NCT01513343|453012966|FG001|6-month Follow-up|Lost to Follow-up|17|||
125921941|NCT01513343|453012965|FG000|12-month Follow-up|Lost to Follow-up|10|||
125921942|NCT01513343|453012966|FG001|12-month Follow-up|Lost to Follow-up|3|||
125921943|NCT01921387|453012967|FG000|Overall Study|Adverse Event|1|||
125921944|NCT01706146|453012969|FG000|Overall Study|Withdrawal by Subject|1|||
125921945|NCT01706146|453012969|FG000|Overall Study|Adverse Event|3|||
125921946|NCT01706146|453012969|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
125921947|NCT02582983|453012970|FG000|Overall Study|Death|3|||
125921948|NCT02582983|453012970|FG000|Overall Study|Withdrawal by Subject|2|||
125921949|NCT02582983|453012970|FG000|Overall Study|Adverse Event|1|||
125921950|NCT01007812|453012975|FG000|Period 1, One Week|Lost to Follow-up|0|||
125921951|NCT01007812|453012976|FG001|Period 1, One Week|Lost to Follow-up|1|||
125921952|NCT01007812|453012975|FG000|Period 1, One Week|Discomfort|1|||
125921953|NCT01007812|453012976|FG001|Period 1, One Week|Discomfort|0|||
125921954|NCT01091974|453012977|FG000|Overall Study|Did not start intervention|3|||
125921955|NCT01091974|453012978|FG001|Overall Study|Did not start intervention|1|||
125921956|NCT01091974|453012979|FG002|Overall Study|Did not start intervention|3|||
125921957|NCT01091974|453012980|FG003|Overall Study|Did not start intervention|1|||
125921958|NCT01091974|453012977|FG000|Overall Study|resumed sleep medication|0|||
125921959|NCT01091974|453012978|FG001|Overall Study|resumed sleep medication|0|||
125921960|NCT01091974|453012979|FG002|Overall Study|resumed sleep medication|1|||
125921961|NCT01091974|453012980|FG003|Overall Study|resumed sleep medication|2|||
125921962|NCT01091974|453012977|FG000|Overall Study|Withdrawal by Subject|1|||
125921963|NCT01091974|453012978|FG001|Overall Study|Withdrawal by Subject|3|||
125921964|NCT01091974|453012979|FG002|Overall Study|Withdrawal by Subject|2|||
125921965|NCT01091974|453012980|FG003|Overall Study|Withdrawal by Subject|2|||
125921966|NCT01091974|453012977|FG000|Overall Study|side-effects|1|||
125921967|NCT01091974|453012978|FG001|Overall Study|side-effects|1|||
125921968|NCT01091974|453012979|FG002|Overall Study|side-effects|0|||
125921969|NCT01091974|453012980|FG003|Overall Study|side-effects|2|||
125921970|NCT00555971|453012982|FG000|Overall Study|Adverse Event|1|||
125921971|NCT00555971|453012983|FG001|Overall Study|Adverse Event|1|||
125921972|NCT00518284|453012984|FG000|Overall Study|Adverse Event|0|||
125921973|NCT00518284|453012985|FG001|Overall Study|Adverse Event|1|||
125921974|NCT00518284|453012986|FG002|Overall Study|Adverse Event|0|||
125921975|NCT00518284|453012987|FG003|Overall Study|Adverse Event|0|||
125921976|NCT00518284|453012984|FG000|Overall Study|Study Termination|0|||
125921977|NCT00518284|453012985|FG001|Overall Study|Study Termination|2|||
125921978|NCT00518284|453012986|FG002|Overall Study|Study Termination|1|||
125921979|NCT00518284|453012987|FG003|Overall Study|Study Termination|2|||
125921980|NCT02571777|453012988|FG000|Overall Study|Subject/guardian decision|34|||
125921981|NCT02571777|453012989|FG001|Overall Study|Subject/guardian decision|26|||
125921982|NCT02571777|453012990|FG002|Overall Study|Subject/guardian decision|26|||
125921983|NCT02571777|453012991|FG003|Overall Study|Subject/guardian decision|25|||
125921984|NCT02571777|453012992|FG004|Overall Study|Subject/guardian decision|27|||
125921985|NCT02571777|453012988|FG000|Overall Study|Protocol Deviation|2|||
125921986|NCT02571777|453012989|FG001|Overall Study|Protocol Deviation|3|||
125921987|NCT02571777|453012990|FG002|Overall Study|Protocol Deviation|4|||
125921988|NCT02571777|453012991|FG003|Overall Study|Protocol Deviation|8|||
125921989|NCT02571777|453012992|FG004|Overall Study|Protocol Deviation|4|||
125921990|NCT02571777|453012988|FG000|Overall Study|Death|1|||
125921991|NCT02571777|453012989|FG001|Overall Study|Death|1|||
125921992|NCT02571777|453012990|FG002|Overall Study|Death|4|||
125921993|NCT02571777|453012991|FG003|Overall Study|Death|0|||
125921994|NCT02571777|453012992|FG004|Overall Study|Death|0|||
125921995|NCT02571777|453012988|FG000|Overall Study|Lost to Follow-up|1|||
125921996|NCT02571777|453012989|FG001|Overall Study|Lost to Follow-up|1|||
125921997|NCT02571777|453012990|FG002|Overall Study|Lost to Follow-up|2|||
125921998|NCT02571777|453012991|FG003|Overall Study|Lost to Follow-up|0|||
125921999|NCT02571777|453012992|FG004|Overall Study|Lost to Follow-up|1|||
125922000|NCT02571777|453012988|FG000|Overall Study|Physician Decision|1|||
125922001|NCT02571777|453012989|FG001|Overall Study|Physician Decision|7|||
125922002|NCT02571777|453012990|FG002|Overall Study|Physician Decision|5|||
125922003|NCT02571777|453012991|FG003|Overall Study|Physician Decision|2|||
125922004|NCT02571777|453012992|FG004|Overall Study|Physician Decision|4|||
125922005|NCT02571777|453012988|FG000|Overall Study|Pregnancy|0|||
125922006|NCT02571777|453012989|FG001|Overall Study|Pregnancy|0|||
125922007|NCT02571777|453012990|FG002|Overall Study|Pregnancy|0|||
125922008|NCT02571777|453012991|FG003|Overall Study|Pregnancy|2|||
125922009|NCT02571777|453012992|FG004|Overall Study|Pregnancy|0|||
125922010|NCT00801632|453012993|FG000|Overall Study|Re-transplant|1|||
125922011|NCT03095612|453012996|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125922012|NCT03095612|453012997|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
125922013|NCT03095612|453012998|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125922014|NCT03095612|453012999|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125922015|NCT03095612|453013000|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125922016|NCT03095612|453013001|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125922017|NCT03095612|453013002|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125922018|NCT00621582|453013003|FG000|Overall Study|Adverse Event|7|||
125922019|NCT00621582|453013003|FG000|Overall Study|Protocol Violation|57|||
125922020|NCT00621582|453013003|FG000|Overall Study|Lost to Follow-up|24|||
125922021|NCT00621582|453013003|FG000|Overall Study|issues not identified by investigators|18|||
125922022|NCT01387932|453013005|FG000|Randomized and Treated|Physician Decision|3|||
125922023|NCT01387932|453013006|FG001|Randomized and Treated|Physician Decision|2|||
125922024|NCT01387932|453013005|FG000|Randomized and Treated|Withdrawal by Subject|4|||
125922025|NCT01387932|453013006|FG001|Randomized and Treated|Withdrawal by Subject|2|||
125922026|NCT01387932|453013005|FG000|Survival Follow-up|Liver Transplant|24|||
125922027|NCT01387932|453013006|FG001|Survival Follow-up|Liver Transplant|28|||
125922028|NCT01387932|453013005|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
125922029|NCT01387932|453013006|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
125922030|NCT01387932|453013005|FG000|Survival Follow-up|Withdrawal by Subject|2|||
125922031|NCT01387932|453013006|FG001|Survival Follow-up|Withdrawal by Subject|4|||
125922032|NCT01387932|453013005|FG000|Survival Follow-up|Lost to Follow-up|6|||
125922033|NCT01387932|453013006|FG001|Survival Follow-up|Lost to Follow-up|5|||
125922034|NCT00205881|453013007|FG000|Overall Study|Withdrawal by Subject|16|||
125922035|NCT00389597|453013011|FG000|Overall Study|Lost to Follow-up|8|||
125922036|NCT00389597|453013012|FG001|Overall Study|Lost to Follow-up|6|||
125922037|NCT00389597|453013013|FG002|Overall Study|Lost to Follow-up|4|||
125922038|NCT00389597|453013014|FG003|Overall Study|Lost to Follow-up|6|||
125922039|NCT00005044|453013015|FG000|Overall Study|Protocol Violation|37|||
125922040|NCT00005044|453013016|FG001|Overall Study|Protocol Violation|46|||
125922041|NCT00005044|453013015|FG000|Overall Study|Withdrawal by Subject|1|||
125922042|NCT00005044|453013016|FG001|Overall Study|Withdrawal by Subject|5|||
125922043|NCT00005044|453013015|FG000|Overall Study|No protocol treatment|0|||
125922044|NCT00005044|453013016|FG001|Overall Study|No protocol treatment|1|||
125922045|NCT04431453|453013017|FG000|Overall Study|Withdrew Consent|0|||
125922046|NCT04431453|453013018|FG001|Overall Study|Withdrew Consent|1|||
125922047|NCT04431453|453013019|FG002|Overall Study|Withdrew Consent|0|||
125922048|NCT04431453|453013020|FG003|Overall Study|Withdrew Consent|2|||
125922049|NCT04431453|453013021|FG004|Overall Study|Withdrew Consent|0|||
125922050|NCT04431453|453013022|FG005|Overall Study|Withdrew Consent|0|||
125922051|NCT04431453|453013023|FG006|Overall Study|Withdrew Consent|0|||
125922052|NCT04431453|453013024|FG007|Overall Study|Withdrew Consent|0|||
125922053|NCT04431453|453013017|FG000|Overall Study|Death|1|||
125922054|NCT04431453|453013018|FG001|Overall Study|Death|0|||
125922055|NCT04431453|453013019|FG002|Overall Study|Death|0|||
125922056|NCT04431453|453013020|FG003|Overall Study|Death|0|||
125922057|NCT04431453|453013021|FG004|Overall Study|Death|0|||
125922058|NCT04431453|453013022|FG005|Overall Study|Death|0|||
125922059|NCT04431453|453013023|FG006|Overall Study|Death|0|||
125922060|NCT04431453|453013024|FG007|Overall Study|Death|1|||
125922061|NCT04431453|453013017|FG000|Overall Study|Lost to Follow-up|0|||
125922062|NCT04431453|453013018|FG001|Overall Study|Lost to Follow-up|0|||
125922063|NCT04431453|453013019|FG002|Overall Study|Lost to Follow-up|1|||
125922064|NCT04431453|453013020|FG003|Overall Study|Lost to Follow-up|1|||
125922065|NCT04431453|453013021|FG004|Overall Study|Lost to Follow-up|0|||
125922066|NCT04431453|453013022|FG005|Overall Study|Lost to Follow-up|0|||
125922067|NCT04431453|453013023|FG006|Overall Study|Lost to Follow-up|0|||
125922068|NCT04431453|453013024|FG007|Overall Study|Lost to Follow-up|0|||
125922069|NCT04431453|453013017|FG000|Overall Study|Enrolled but Never Treated|0|||
125922070|NCT04431453|453013018|FG001|Overall Study|Enrolled but Never Treated|0|||
125922071|NCT04431453|453013019|FG002|Overall Study|Enrolled but Never Treated|0|||
125922072|NCT04431453|453013020|FG003|Overall Study|Enrolled but Never Treated|0|||
125922073|NCT04431453|453013021|FG004|Overall Study|Enrolled but Never Treated|1|||
125922074|NCT04431453|453013022|FG005|Overall Study|Enrolled but Never Treated|0|||
125922075|NCT04431453|453013023|FG006|Overall Study|Enrolled but Never Treated|0|||
125922076|NCT04431453|453013024|FG007|Overall Study|Enrolled but Never Treated|0|||
125922077|NCT03546062|453013025|FG000|Overall Study|Adverse Event|6|||
125922078|NCT03546062|453013026|FG001|Overall Study|Adverse Event|5|||
125922079|NCT03546062|453013027|FG002|Overall Study|Adverse Event|8|||
125922080|NCT02083965|453013029|FG000|Treatment Period|Other|1|||
125922081|NCT02083965|453013030|FG001|Treatment Period|Other|0|||
125922082|NCT04502433|453013031|FG000|Overall Study|Death|2|||
125922083|NCT04502433|453013032|FG001|Overall Study|Death|4|||
125922084|NCT04502433|453013031|FG000|Overall Study|Lost to Follow-up|1|||
125922085|NCT04502433|453013032|FG001|Overall Study|Lost to Follow-up|0|||
125922086|NCT04502433|453013031|FG000|Overall Study|Physician Decision|0|||
125922087|NCT04502433|453013032|FG001|Overall Study|Physician Decision|1|||
126064408|NCT02309892|453527714|FG001|Overall Study|Physician Decision|0|||
126064409|NCT02309892|453527715|FG002|Overall Study|Physician Decision|0|||
126064410|NCT02309892|453527716|FG003|Overall Study|Physician Decision|0|||
126064411|NCT02309892|453527717|FG004|Overall Study|Physician Decision|0|||
126064412|NCT02309892|453527718|FG005|Overall Study|Physician Decision|0|||
126064413|NCT02309892|453527719|FG006|Overall Study|Physician Decision|0|||
126064414|NCT02309892|453527713|FG000|Overall Study|Adverse Event|1|||
126064415|NCT02309892|453527714|FG001|Overall Study|Adverse Event|0|||
126064416|NCT02309892|453527715|FG002|Overall Study|Adverse Event|1|||
126064417|NCT02309892|453527716|FG003|Overall Study|Adverse Event|0|||
126064418|NCT02309892|453527717|FG004|Overall Study|Adverse Event|0|||
126064419|NCT02309892|453527718|FG005|Overall Study|Adverse Event|0|||
126064420|NCT02309892|453527719|FG006|Overall Study|Adverse Event|0|||
126064421|NCT02309892|453527713|FG000|Overall Study|Progressive Disease|0|||
126064422|NCT02309892|453527714|FG001|Overall Study|Progressive Disease|1|||
126064423|NCT02309892|453527715|FG002|Overall Study|Progressive Disease|0|||
126064424|NCT02309892|453527716|FG003|Overall Study|Progressive Disease|0|||
126064425|NCT02309892|453527717|FG004|Overall Study|Progressive Disease|1|||
126064426|NCT02309892|453527718|FG005|Overall Study|Progressive Disease|0|||
126064427|NCT02309892|453527719|FG006|Overall Study|Progressive Disease|0|||
126064428|NCT02309892|453527713|FG000|Overall Study|Death|0|||
126064429|NCT02309892|453527714|FG001|Overall Study|Death|0|||
126064430|NCT02309892|453527715|FG002|Overall Study|Death|0|||
126064431|NCT02309892|453527716|FG003|Overall Study|Death|0|||
126064432|NCT02309892|453527717|FG004|Overall Study|Death|0|||
126064433|NCT02309892|453527718|FG005|Overall Study|Death|1|||
126064434|NCT02309892|453527719|FG006|Overall Study|Death|0|||
126064435|NCT01894620|453527720|FG000|Overall Study|Withdrawal by Subject|0|||
126064436|NCT01894620|453527721|FG001|Overall Study|Withdrawal by Subject|1|||
126064437|NCT01901302|453527722|FG000|Overall Study|Adverse Event|2|||
126064438|NCT01901302|453527723|FG001|Overall Study|Adverse Event|1|||
126064439|NCT01901302|453527722|FG000|Overall Study|Lack of Efficacy|0|||
126064440|NCT01901302|453527723|FG001|Overall Study|Lack of Efficacy|2|||
126064441|NCT01901302|453527722|FG000|Overall Study|Study Terminated by Sponsor|23|||
126064442|NCT01901302|453527723|FG001|Overall Study|Study Terminated by Sponsor|20|||
126064443|NCT01901302|453527722|FG000|Overall Study|Withdrawal by Subject|2|||
126064444|NCT01901302|453527723|FG001|Overall Study|Withdrawal by Subject|0|||
126064445|NCT01124916|453527724|FG000|Overall Study|Lost to Follow-up|3|||
126064446|NCT01124916|453527725|FG001|Overall Study|Lost to Follow-up|2|||
126064447|NCT00657709|453527731|FG000|Overall Study|AE or Death|7|||
126064448|NCT00657709|453527732|FG001|Overall Study|AE or Death|7|||
126064449|NCT00657709|453527733|FG002|Overall Study|AE or Death|6|||
126064450|NCT00657709|453527734|FG003|Overall Study|AE or Death|7|||
126064451|NCT00657709|453527735|FG004|Overall Study|AE or Death|1|||
126064452|NCT00657709|453527731|FG000|Overall Study|Withdrawal by Subject|7|||
126064453|NCT00657709|453527732|FG001|Overall Study|Withdrawal by Subject|15|||
126064454|NCT00657709|453527733|FG002|Overall Study|Withdrawal by Subject|15|||
126064455|NCT00657709|453527734|FG003|Overall Study|Withdrawal by Subject|5|||
126064456|NCT00657709|453527735|FG004|Overall Study|Withdrawal by Subject|9|||
126064457|NCT00657709|453527731|FG000|Overall Study|Lost to Follow-up|9|||
126064458|NCT00657709|453527732|FG001|Overall Study|Lost to Follow-up|9|||
126064459|NCT00657709|453527733|FG002|Overall Study|Lost to Follow-up|7|||
126064460|NCT00657709|453527734|FG003|Overall Study|Lost to Follow-up|1|||
126064461|NCT00657709|453527735|FG004|Overall Study|Lost to Follow-up|21|||
126064462|NCT00657709|453527731|FG000|Overall Study|Protocol Violation|0|||
126064463|NCT00657709|453527732|FG001|Overall Study|Protocol Violation|2|||
126064464|NCT00657709|453527733|FG002|Overall Study|Protocol Violation|0|||
126064465|NCT00657709|453527734|FG003|Overall Study|Protocol Violation|1|||
126064466|NCT00657709|453527735|FG004|Overall Study|Protocol Violation|2|||
126064467|NCT05265247|453527736|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
126064468|NCT05265247|453527737|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
126064469|NCT05265247|453527736|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
126064470|NCT05265247|453527737|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
126064471|NCT05265247|453527736|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
126064472|NCT05265247|453527737|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
126064473|NCT01029925|453527738|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
126064474|NCT01029925|453527738|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
126064475|NCT01029925|453527738|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
126064476|NCT00134056|453527748|FG000|Randomization|Not eligible for assigned treatment|22|||
126064477|NCT00134056|453527749|FG001|Randomization|Not eligible for assigned treatment|20|||
126064478|NCT00134056|453527748|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
126064479|NCT00134056|453527749|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
126064480|NCT00134056|453527748|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
125922088|NCT02369016|453013035|FG000|Overall Study|AE associated with clinical disease progression|2|||
125922089|NCT02369016|453013036|FG001|Overall Study|AE associated with clinical disease progression|1|||
125922090|NCT02369016|453013035|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
125922091|NCT02369016|453013036|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
125922092|NCT02369016|453013035|FG000|Overall Study|Progressive disease - clinical progression|1|||
125922093|NCT02369016|453013036|FG001|Overall Study|Progressive disease - clinical progression|4|||
125922094|NCT02369016|453013035|FG000|Overall Study|withdrawal by patient|4|||
125922095|NCT02369016|453013036|FG001|Overall Study|withdrawal by patient|0|||
125922096|NCT02369016|453013035|FG000|Overall Study|Progressive disease - radiological progression|6|||
125922097|NCT02369016|453013036|FG001|Overall Study|Progressive disease - radiological progression|2|||
125922098|NCT01702961|453013037|FG000|Overall Study|Additional treatment|3|||
125922099|NCT01702961|453013037|FG000|Overall Study|Progressive disease|5|||
125922100|NCT01702961|453013037|FG000|Overall Study|Relapse|20|||
125922101|NCT01702961|453013037|FG000|Overall Study|Death|6|||
125922102|NCT01702961|453013037|FG000|Overall Study|Lost to Follow-up|2|||
125922103|NCT01702961|453013037|FG000|Overall Study|Ongoing|11|||
125922104|NCT02229383|453013038|FG000|Overall Study|Adverse Event|7|||
125922105|NCT02229383|453013039|FG001|Overall Study|Adverse Event|4|||
125922106|NCT02229383|453013038|FG000|Overall Study|Death|0|||
125922107|NCT02229383|453013039|FG001|Overall Study|Death|1|||
125922108|NCT02229383|453013038|FG000|Overall Study|Lost to Follow-up|5|||
125922109|NCT02229383|453013039|FG001|Overall Study|Lost to Follow-up|3|||
125922110|NCT02229383|453013038|FG000|Overall Study|Withdrawal by Subject|4|||
125922111|NCT02229383|453013039|FG001|Overall Study|Withdrawal by Subject|6|||
125922112|NCT02229383|453013038|FG000|Overall Study|Did not receive treatment|1|||
125922113|NCT02229383|453013039|FG001|Overall Study|Did not receive treatment|0|||
125922114|NCT02229383|453013038|FG000|Overall Study|Other|3|||
125922115|NCT02229383|453013039|FG001|Overall Study|Other|8|||
125922116|NCT00674362|453013042|FG000|Double Blind|Adverse Event|6|||
125922117|NCT00674362|453013043|FG001|Double Blind|Adverse Event|6|||
125922118|NCT00674362|453013042|FG000|Double Blind|Lack of Efficacy|2|||
125922119|NCT00674362|453013043|FG001|Double Blind|Lack of Efficacy|6|||
125922120|NCT00674362|453013042|FG000|Double Blind|Loss of efficacy|0|||
125922121|NCT00674362|453013043|FG001|Double Blind|Loss of efficacy|1|||
125922122|NCT00674362|453013042|FG000|Double Blind|Withdrawal by Subject|4|||
125922123|NCT00674362|453013043|FG001|Double Blind|Withdrawal by Subject|3|||
125922124|NCT00674362|453013042|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
125922125|NCT00674362|453013043|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
125922126|NCT00674362|453013042|FG000|Double Blind|Other: Surgery|0|||
125922127|NCT00674362|453013043|FG001|Double Blind|Other: Surgery|1|||
125922128|NCT00674362|453013042|FG000|Open Label|Adverse Event|1|||
125922129|NCT00674362|453013043|FG001|Open Label|Adverse Event|0|||
125922130|NCT00674362|453013042|FG000|Open Label|Other: Subject moved to extension study|1|||
125922131|NCT00674362|453013043|FG001|Open Label|Other: Subject moved to extension study|0|||
125922132|NCT00923156|453013044|FG000|Overall Study|Adverse Event|0|||
125922133|NCT00923156|453013045|FG001|Overall Study|Adverse Event|2|||
125922134|NCT00923156|453013046|FG002|Overall Study|Adverse Event|1|||
125922135|NCT00923156|453013044|FG000|Overall Study|Abnormal laboratory values|0|||
125922136|NCT00923156|453013045|FG001|Overall Study|Abnormal laboratory values|0|||
125922137|NCT00923156|453013046|FG002|Overall Study|Abnormal laboratory values|1|||
125922138|NCT00923156|453013044|FG000|Overall Study|Withdrawal by Subject|0|||
125922139|NCT00923156|453013045|FG001|Overall Study|Withdrawal by Subject|1|||
125922140|NCT00923156|453013046|FG002|Overall Study|Withdrawal by Subject|0|||
125922141|NCT00923156|453013044|FG000|Overall Study|Death|0|||
125922142|NCT00923156|453013045|FG001|Overall Study|Death|1|||
125922143|NCT00923156|453013046|FG002|Overall Study|Death|0|||
125922144|NCT00923156|453013044|FG000|Overall Study|Lack of Efficacy|0|||
125922145|NCT00923156|453013045|FG001|Overall Study|Lack of Efficacy|0|||
125922146|NCT00923156|453013046|FG002|Overall Study|Lack of Efficacy|1|||
125922147|NCT01201850|453013049|FG000|Overall Study|Tumor progression|4|||
125922148|NCT03137537|453013050|FG000|Overall Study|Adverse Event|0|||
125922149|NCT03137537|453013051|FG001|Overall Study|Adverse Event|1|||
125922150|NCT03386448|453013052|FG000|Overall Study|Adverse Event|0|||
125922151|NCT03386448|453013053|FG001|Overall Study|Adverse Event|2|||
125922152|NCT03338010|453013056|FG000|Overall Study|Withdrawal by Subject|14|||
125922153|NCT03338010|453013057|FG001|Overall Study|Withdrawal by Subject|8|||
125922154|NCT03338010|453013056|FG000|Overall Study|Lost to Follow-up|4|||
125922155|NCT03338010|453013057|FG001|Overall Study|Lost to Follow-up|2|||
125922156|NCT03338010|453013056|FG000|Overall Study|Adverse Event|3|||
125922157|NCT03338010|453013057|FG001|Overall Study|Adverse Event|2|||
125922158|NCT03338010|453013056|FG000|Overall Study|Physician Decision|2|||
125922159|NCT03338010|453013057|FG001|Overall Study|Physician Decision|2|||
125922160|NCT03338010|453013056|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125922161|NCT03338010|453013057|FG001|Overall Study|Non-Compliance with Study Drug|3|||
126064481|NCT00134056|453527749|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
125922162|NCT03338010|453013056|FG000|Overall Study|Protocol Violation|0|||
126064482|NCT00134056|453527748|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
125922163|NCT03338010|453013057|FG001|Overall Study|Protocol Violation|1|||
125922164|NCT01146665|453013058|FG000|Overall Study|Withdrawal by Subject|10|||
125922165|NCT01146665|453013059|FG001|Overall Study|Withdrawal by Subject|16|||
125922166|NCT02465515|453013060|FG000|Overall Study|Investigator site closed|4|||
125922167|NCT02465515|453013061|FG001|Overall Study|Investigator site closed|5|||
125922168|NCT02465515|453013060|FG000|Overall Study|Withdrawal by Subject|74|||
125922169|NCT02465515|453013061|FG001|Overall Study|Withdrawal by Subject|43|||
125922170|NCT02465515|453013060|FG000|Overall Study|Physician Decision|8|||
125922171|NCT02465515|453013061|FG001|Overall Study|Physician Decision|12|||
125922172|NCT02465515|453013060|FG000|Overall Study|Lost to Follow-up|68|||
125922173|NCT02465515|453013061|FG001|Overall Study|Lost to Follow-up|51|||
125922174|NCT00293033|453013062|FG000|Open-label Titration Period|Adverse Event|10|||
125922175|NCT00293033|453013062|FG000|Open-label Titration Period|Death|3|||
125922176|NCT00293033|453013062|FG000|Open-label Titration Period|Lack of Efficacy|5|||
125922177|NCT00293033|453013062|FG000|Open-label Titration Period|Protocol Violation|2|||
125922178|NCT00293033|453013062|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
125922179|NCT00293033|453013062|FG000|Open-label Titration Period|Noncompliance and other|27|||
125922180|NCT00293033|453013062|FG000|Double-blind Treatment Period|Adverse Event|3|||
125922181|NCT00293033|453013062|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
125922182|NCT00293033|453013062|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
125922183|NCT00293033|453013062|FG000|Double-blind Treatment Period|Noncompliance|4|||
125922184|NCT00816595|453013063|FG000|Overall Study|Withdrawal by Subject|2|||
125922185|NCT00816595|453013064|FG001|Overall Study|Withdrawal by Subject|0|||
125922186|NCT00679432|453013067|FG000|Overall Study|Adverse Event|5|||
125922187|NCT00679432|453013068|FG001|Overall Study|Adverse Event|6|||
125922188|NCT00679432|453013069|FG002|Overall Study|Adverse Event|10|||
125922189|NCT00679432|453013070|FG003|Overall Study|Adverse Event|7|||
125922190|NCT00679432|453013067|FG000|Overall Study|Protocol Violation|1|||
125922191|NCT00679432|453013068|FG001|Overall Study|Protocol Violation|1|||
125922192|NCT00679432|453013069|FG002|Overall Study|Protocol Violation|2|||
125922193|NCT00679432|453013070|FG003|Overall Study|Protocol Violation|1|||
125922194|NCT00679432|453013067|FG000|Overall Study|Withdrawal by Subject|8|||
125922195|NCT00679432|453013068|FG001|Overall Study|Withdrawal by Subject|11|||
125922196|NCT00679432|453013069|FG002|Overall Study|Withdrawal by Subject|10|||
125922197|NCT00679432|453013070|FG003|Overall Study|Withdrawal by Subject|9|||
125922198|NCT00679432|453013067|FG000|Overall Study|Lost to Follow-up|1|||
125922199|NCT00679432|453013068|FG001|Overall Study|Lost to Follow-up|5|||
125922200|NCT00679432|453013069|FG002|Overall Study|Lost to Follow-up|4|||
125922201|NCT00679432|453013070|FG003|Overall Study|Lost to Follow-up|2|||
125922202|NCT00679432|453013067|FG000|Overall Study|Physician Decision|3|||
125922203|NCT00679432|453013068|FG001|Overall Study|Physician Decision|2|||
125922204|NCT00679432|453013069|FG002|Overall Study|Physician Decision|2|||
125922205|NCT00679432|453013070|FG003|Overall Study|Physician Decision|2|||
125922206|NCT00679432|453013067|FG000|Overall Study|Sponsor decision|1|||
125922207|NCT00679432|453013068|FG001|Overall Study|Sponsor decision|0|||
125922208|NCT00679432|453013069|FG002|Overall Study|Sponsor decision|0|||
125922209|NCT00679432|453013070|FG003|Overall Study|Sponsor decision|0|||
125922210|NCT00679432|453013067|FG000|Overall Study|Lack of Efficacy|13|||
125922211|NCT00679432|453013068|FG001|Overall Study|Lack of Efficacy|9|||
125922212|NCT00679432|453013069|FG002|Overall Study|Lack of Efficacy|14|||
125922213|NCT00679432|453013070|FG003|Overall Study|Lack of Efficacy|8|||
125922214|NCT00679432|453013067|FG000|Overall Study|Infectious colitis, normal histology|5|||
125922215|NCT00679432|453013068|FG001|Overall Study|Infectious colitis, normal histology|4|||
125922216|NCT00679432|453013069|FG002|Overall Study|Infectious colitis, normal histology|8|||
125922217|NCT00679432|453013070|FG003|Overall Study|Infectious colitis, normal histology|3|||
125922218|NCT00679432|453013067|FG000|Overall Study|Randomization error, return to prior Rx|0|||
125922219|NCT00679432|453013068|FG001|Overall Study|Randomization error, return to prior Rx|0|||
125922220|NCT00679432|453013069|FG002|Overall Study|Randomization error, return to prior Rx|3|||
125922221|NCT00679432|453013070|FG003|Overall Study|Randomization error, return to prior Rx|0|||
125922222|NCT02339584|453013071|FG000|Overall Study|Adverse Event|11|||
125922223|NCT02339584|453013072|FG001|Overall Study|Adverse Event|7|||
125922224|NCT02339584|453013071|FG000|Overall Study|Lack of Efficacy|0|||
125922225|NCT02339584|453013072|FG001|Overall Study|Lack of Efficacy|1|||
125922226|NCT02339584|453013071|FG000|Overall Study|Physician Decision|1|||
125922227|NCT02339584|453013072|FG001|Overall Study|Physician Decision|2|||
125922228|NCT02339584|453013071|FG000|Overall Study|Protocol Violation|1|||
125922229|NCT02339584|453013072|FG001|Overall Study|Protocol Violation|1|||
125922230|NCT02339584|453013071|FG000|Overall Study|Withdrawal by Subject|2|||
125922231|NCT02339584|453013072|FG001|Overall Study|Withdrawal by Subject|4|||
125922232|NCT00873912|453013073|FG000|Overall Study|Withdrawal by Subject|1|||
125922233|NCT00873912|453013074|FG001|Overall Study|Withdrawal by Subject|0|||
125922234|NCT00873912|453013073|FG000|Overall Study|Lost to Follow-up|2|||
125922235|NCT00873912|453013074|FG001|Overall Study|Lost to Follow-up|0|||
125922236|NCT01980940|453013078|FG000|Overall Study|Protocol Violation|0|||
125922237|NCT01980940|453013079|FG001|Overall Study|Protocol Violation|0|||
125922238|NCT01980940|453013080|FG002|Overall Study|Protocol Violation|0|||
125922239|NCT01980940|453013081|FG003|Overall Study|Protocol Violation|0|||
125922240|NCT01980940|453013082|FG004|Overall Study|Protocol Violation|0|||
125922241|NCT01980940|453013083|FG005|Overall Study|Protocol Violation|2|||
125922242|NCT01980940|453013084|FG006|Overall Study|Protocol Violation|0|||
125922243|NCT01980940|453013085|FG007|Overall Study|Protocol Violation|0|||
125922244|NCT02323113|453015270|FG000|Overall Study|Adverse Event|3|||
125922245|NCT02323113|453015271|FG001|Overall Study|Adverse Event|3|||
125922246|NCT02323113|453015272|FG002|Overall Study|Adverse Event|2|||
125922247|NCT02323113|453015273|FG003|Overall Study|Adverse Event|5|||
125922248|NCT02323113|453015274|FG004|Overall Study|Adverse Event|8|||
125922249|NCT02323113|453015275|FG005|Overall Study|Adverse Event|3|||
125922250|NCT02323113|453015276|FG006|Overall Study|Adverse Event|6|||
125922251|NCT02323113|453015277|FG007|Overall Study|Adverse Event|0|||
125922252|NCT02323113|453015270|FG000|Overall Study|Progressive Disease|0|||
125922253|NCT02323113|453015271|FG001|Overall Study|Progressive Disease|1|||
125922254|NCT02323113|453015272|FG002|Overall Study|Progressive Disease|1|||
125922255|NCT02323113|453015273|FG003|Overall Study|Progressive Disease|0|||
125922256|NCT02323113|453015274|FG004|Overall Study|Progressive Disease|0|||
125922257|NCT02323113|453015275|FG005|Overall Study|Progressive Disease|3|||
125922258|NCT02323113|453015276|FG006|Overall Study|Progressive Disease|0|||
125922259|NCT02323113|453015277|FG007|Overall Study|Progressive Disease|0|||
125922260|NCT02323113|453015270|FG000|Overall Study|Symptomatic Deterioration|0|||
125922261|NCT02323113|453015271|FG001|Overall Study|Symptomatic Deterioration|0|||
125922262|NCT02323113|453015272|FG002|Overall Study|Symptomatic Deterioration|1|||
125922263|NCT02323113|453015273|FG003|Overall Study|Symptomatic Deterioration|0|||
125922264|NCT02323113|453015274|FG004|Overall Study|Symptomatic Deterioration|1|||
125922265|NCT02323113|453015275|FG005|Overall Study|Symptomatic Deterioration|0|||
125922266|NCT02323113|453015276|FG006|Overall Study|Symptomatic Deterioration|0|||
125922267|NCT02323113|453015277|FG007|Overall Study|Symptomatic Deterioration|0|||
125922268|NCT02323113|453015270|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
126111041|NCT02038920|453701994|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125922269|NCT02323113|453015271|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
125922270|NCT02323113|453015272|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125922271|NCT02323113|453015273|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
125922272|NCT02323113|453015274|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
125922273|NCT02323113|453015275|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
125922274|NCT02323113|453015276|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
125922275|NCT02323113|453015277|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
125922276|NCT02323113|453015270|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125922277|NCT02323113|453015271|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
125922278|NCT02323113|453015272|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125922279|NCT02323113|453015273|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125922280|NCT02323113|453015274|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125922281|NCT02323113|453015275|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125922282|NCT02323113|453015276|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125922283|NCT02323113|453015277|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125922284|NCT03281577|453015278|FG000|Overall Study|Adverse Event|0|||
125922285|NCT03281577|453015279|FG001|Overall Study|Adverse Event|0|||
125922286|NCT03281577|453015280|FG002|Overall Study|Adverse Event|0|||
125922287|NCT03281577|453015281|FG003|Overall Study|Adverse Event|1|||
125922288|NCT03281577|453015278|FG000|Overall Study|Withdrawal by Subject|1|||
125922289|NCT03281577|453015279|FG001|Overall Study|Withdrawal by Subject|0|||
125922290|NCT03281577|453015280|FG002|Overall Study|Withdrawal by Subject|0|||
125922291|NCT03281577|453015281|FG003|Overall Study|Withdrawal by Subject|0|||
125922292|NCT00443261|453015282|FG000|Overall Study|Death|1|||
125922293|NCT01663532|453015283|FG000|Overall Study|Lost to Follow-up|9|||
125922294|NCT01663532|453015284|FG001|Overall Study|Lost to Follow-up|10|||
125922295|NCT01663532|453015283|FG000|Overall Study|Adverse Event|7|||
125922296|NCT01663532|453015284|FG001|Overall Study|Adverse Event|13|||
125922297|NCT01663532|453015283|FG000|Overall Study|Met Withdrawal Criteria|7|||
125922298|NCT01663532|453015284|FG001|Overall Study|Met Withdrawal Criteria|6|||
125922299|NCT01663532|453015283|FG000|Overall Study|Physician Decision|1|||
125922300|NCT01663532|453015284|FG001|Overall Study|Physician Decision|1|||
125922301|NCT01663532|453015283|FG000|Overall Study|Withdrawal by Subject|35|||
125922302|NCT01663532|453015284|FG001|Overall Study|Withdrawal by Subject|17|||
125922303|NCT01663532|453015283|FG000|Overall Study|Lack of Efficacy|15|||
125922304|NCT01663532|453015284|FG001|Overall Study|Lack of Efficacy|60|||
126111042|NCT02038920|453701995|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125922305|NCT01433991|453015286|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
125922306|NCT01433991|453015287|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
125922307|NCT01433991|453015288|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
125922308|NCT01433991|453015289|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
125922309|NCT01433991|453015286|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
125922310|NCT01433991|453015287|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
125922311|NCT01433991|453015288|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
125922312|NCT01433991|453015289|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
125922313|NCT01433991|453015286|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
125922314|NCT01433991|453015287|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
125922315|NCT01433991|453015288|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
125922316|NCT01433991|453015289|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
125922317|NCT01433991|453015286|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
125922318|NCT01433991|453015287|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
125922319|NCT01433991|453015288|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
125922320|NCT01433991|453015289|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
125922321|NCT01433991|453015286|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
125922322|NCT01433991|453015287|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
125922323|NCT01433991|453015288|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
125922324|NCT01433991|453015289|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
125922325|NCT01433991|453015286|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
125922326|NCT01433991|453015287|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
125922327|NCT01433991|453015288|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
125922328|NCT01433991|453015289|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
125922329|NCT01433991|453015286|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
125922330|NCT01433991|453015287|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
125922331|NCT01433991|453015288|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
125922332|NCT01433991|453015289|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
125922333|NCT00844831|453015290|FG000|Overall Study|Withdrawal by Subject|4|||
125922334|NCT00844831|453015290|FG000|Overall Study|Adverse Event|1|||
125922335|NCT00844831|453015290|FG000|Overall Study|Physician Decision|1|||
125922336|NCT00354744|453015293|FG000|Overall Study|Adverse Event|2|||
125922337|NCT00354744|453015293|FG000|Overall Study|Death|2|||
125922338|NCT00354744|453015293|FG000|Overall Study|Lack of Efficacy|11|||
125922339|NCT00354744|453015293|FG000|Overall Study|Lost to Follow-up|2|||
125922340|NCT00354744|453015293|FG000|Overall Study|Physician Decision|11|||
125922341|NCT00354744|453015293|FG000|Overall Study|Withdrawal by Subject|14|||
125922342|NCT01193530|453015294|FG000|Overall Study|Withdrawal by Subject|2|||
125922343|NCT01193530|453015295|FG001|Overall Study|Withdrawal by Subject|2|||
125922344|NCT01193530|453015294|FG000|Overall Study|Began Contraindicated Therapy|1|||
125922345|NCT01193530|453015295|FG001|Overall Study|Began Contraindicated Therapy|0|||
125922346|NCT01193530|453015294|FG000|Overall Study|Lost Light Box|0|||
125922347|NCT01193530|453015295|FG001|Overall Study|Lost Light Box|1|||
125922348|NCT01193530|453015294|FG000|Overall Study|Returned home - out of state|0|||
125922349|NCT01193530|453015295|FG001|Overall Study|Returned home - out of state|1|||
125922350|NCT01193530|453015294|FG000|Overall Study|Non-Compliance|0|||
125922351|NCT01193530|453015295|FG001|Overall Study|Non-Compliance|1|||
125922352|NCT03305575|453015302|FG000|Overall Study|Physician Decision|1|||
125922353|NCT03305575|453015303|FG001|Overall Study|Physician Decision|0|||
125922354|NCT03486223|453015316|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
125922355|NCT03486223|453015317|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
125922356|NCT01819831|453015318|FG000|Overall Study|Withdrawal by Subject|1|||
125922357|NCT01749137|453015319|FG000|Overall Study|Adverse Event|4|||
125922358|NCT01749137|453015320|FG001|Overall Study|Adverse Event|4|||
125922359|NCT01749137|453015319|FG000|Overall Study|Lost to Follow-up|2|||
125922360|NCT01749137|453015320|FG001|Overall Study|Lost to Follow-up|3|||
125922361|NCT01749137|453015319|FG000|Overall Study|Physician Decision|1|||
125922362|NCT01749137|453015320|FG001|Overall Study|Physician Decision|0|||
125922363|NCT01749137|453015319|FG000|Overall Study|Withdrawal by Subject|8|||
125922364|NCT01749137|453015320|FG001|Overall Study|Withdrawal by Subject|4|||
125922365|NCT02587234|453015336|FG000|Overall Study|Withdrawal by Subject|1|||
125922366|NCT02587234|453015337|FG001|Overall Study|Withdrawal by Subject|1|||
125922367|NCT02587234|453015336|FG000|Overall Study|Lost to Follow-up|0|||
125922368|NCT02587234|453015337|FG001|Overall Study|Lost to Follow-up|2|||
125922369|NCT03068130|453015342|FG000|Overall Study|Adverse Event|19|||
125922370|NCT03068130|453015342|FG000|Overall Study|Death|14|||
125922371|NCT03068130|453015342|FG000|Overall Study|Lost to Follow-up|4|||
125922372|NCT03068130|453015342|FG000|Overall Study|Withdrawal by Subject|26|||
125922373|NCT03068130|453015342|FG000|Overall Study|Administrative Reasons|3|||
125922374|NCT03068130|453015342|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
125922375|NCT03068130|453015342|FG000|Overall Study|Study terminated by sponsor|194|||
125922376|NCT01153347|453015343|FG000|Overall Study|Withdrawal by Subject|7|||
125922377|NCT01153347|453015344|FG001|Overall Study|Withdrawal by Subject|7|||
125922378|NCT01153347|453015345|FG002|Overall Study|Withdrawal by Subject|7|||
125922379|NCT01153347|453015346|FG003|Overall Study|Withdrawal by Subject|7|||
125922380|NCT01153347|453015343|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125922381|NCT01153347|453015344|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125922382|NCT01153347|453015345|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
125922383|NCT01153347|453015346|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125922384|NCT01153347|453015343|FG000|Overall Study|Adverse Event|3|||
125922385|NCT01153347|453015344|FG001|Overall Study|Adverse Event|9|||
125922386|NCT01153347|453015345|FG002|Overall Study|Adverse Event|21|||
125922387|NCT01153347|453015346|FG003|Overall Study|Adverse Event|7|||
125922388|NCT01153347|453015343|FG000|Overall Study|Severe non-compliance to protocol|6|||
125922389|NCT01153347|453015344|FG001|Overall Study|Severe non-compliance to protocol|7|||
125922390|NCT01153347|453015345|FG002|Overall Study|Severe non-compliance to protocol|4|||
125922391|NCT01153347|453015346|FG003|Overall Study|Severe non-compliance to protocol|3|||
125922392|NCT01153347|453015343|FG000|Overall Study|Condition under investigation worsened|1|||
125922393|NCT01153347|453015344|FG001|Overall Study|Condition under investigation worsened|1|||
125922394|NCT01153347|453015345|FG002|Overall Study|Condition under investigation worsened|0|||
125922395|NCT01153347|453015346|FG003|Overall Study|Condition under investigation worsened|0|||
125922396|NCT01153347|453015343|FG000|Overall Study|Lack of Efficacy|2|||
125922397|NCT01153347|453015344|FG001|Overall Study|Lack of Efficacy|2|||
125922398|NCT01153347|453015345|FG002|Overall Study|Lack of Efficacy|0|||
125922399|NCT01153347|453015346|FG003|Overall Study|Lack of Efficacy|4|||
125922400|NCT01153347|453015343|FG000|Overall Study|Study-specific withdrawal criteria|4|||
125922401|NCT01153347|453015344|FG001|Overall Study|Study-specific withdrawal criteria|3|||
125922402|NCT01153347|453015345|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125922403|NCT01153347|453015346|FG003|Overall Study|Study-specific withdrawal criteria|2|||
125922404|NCT01153347|453015343|FG000|Overall Study|Lost to Follow-up|4|||
125922405|NCT01153347|453015344|FG001|Overall Study|Lost to Follow-up|9|||
125922406|NCT01153347|453015345|FG002|Overall Study|Lost to Follow-up|11|||
125922407|NCT01153347|453015346|FG003|Overall Study|Lost to Follow-up|8|||
125922408|NCT01153347|453015343|FG000|Overall Study|Other|5|||
125922409|NCT01153347|453015344|FG001|Overall Study|Other|5|||
125922410|NCT01153347|453015345|FG002|Overall Study|Other|4|||
125922411|NCT01153347|453015346|FG003|Overall Study|Other|0|||
125922412|NCT01153347|453015343|FG000|Overall Study|Death|1|||
125922413|NCT01153347|453015344|FG001|Overall Study|Death|0|||
125922414|NCT01153347|453015345|FG002|Overall Study|Death|0|||
125922415|NCT01153347|453015346|FG003|Overall Study|Death|0|||
125922416|NCT03130257|453015347|FG000|Overall Study|Withdrawal by Subject|1|||
125922417|NCT03130257|453015348|FG001|Overall Study|Withdrawal by Subject|0|||
125922418|NCT03130257|453015349|FG002|Overall Study|Withdrawal by Subject|2|||
125922419|NCT00297830|453015350|FG000|6 Month Visit|Death|1|||
125922420|NCT00297830|453015351|FG001|6 Month Visit|Death|0|||
125922421|NCT00297830|453015352|FG002|6 Month Visit|Death|2|||
125922422|NCT00297830|453015350|FG000|6 Month Visit|Withdrawal by Subject|2|||
125922423|NCT00297830|453015351|FG001|6 Month Visit|Withdrawal by Subject|1|||
125922424|NCT00297830|453015352|FG002|6 Month Visit|Withdrawal by Subject|1|||
125922425|NCT00297830|453015350|FG000|6 Month Visit|Adverse Event|0|||
125922426|NCT00297830|453015351|FG001|6 Month Visit|Adverse Event|1|||
125922427|NCT00297830|453015352|FG002|6 Month Visit|Adverse Event|0|||
125922428|NCT00297830|453015350|FG000|12 Month Visit|Lost to Follow-up|1|||
125922429|NCT00297830|453015351|FG001|12 Month Visit|Lost to Follow-up|0|||
125922430|NCT00297830|453015352|FG002|12 Month Visit|Lost to Follow-up|0|||
125922431|NCT00297830|453015350|FG000|12 Month Visit|Adverse Event|0|||
125922432|NCT00297830|453015351|FG001|12 Month Visit|Adverse Event|3|||
125922433|NCT00297830|453015352|FG002|12 Month Visit|Adverse Event|0|||
125922434|NCT00297830|453015350|FG000|12 Month Visit|Withdrawal by Subject|0|||
125922435|NCT00297830|453015351|FG001|12 Month Visit|Withdrawal by Subject|3|||
125922436|NCT00297830|453015352|FG002|12 Month Visit|Withdrawal by Subject|0|||
125922437|NCT01751178|453015355|FG000|Overall Study|Adverse Event|2|||
125922438|NCT01751178|453015356|FG001|Overall Study|Adverse Event|0|||
126111043|NCT02038920|453701996|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
126111044|NCT02038920|453701991|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
126111045|NCT02038920|453701992|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
126111046|NCT02038920|453701993|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125922439|NCT01751178|453015357|FG002|Overall Study|Adverse Event|0|||
125922440|NCT01751178|453015355|FG000|Overall Study|Other Reason (unknown)|1|||
125922441|NCT01751178|453015356|FG001|Overall Study|Other Reason (unknown)|0|||
125922442|NCT01751178|453015357|FG002|Overall Study|Other Reason (unknown)|2|||
125922443|NCT00289991|453015358|FG000|Overall Study|Death|35|||
125922444|NCT00289991|453015359|FG001|Overall Study|Death|38|||
125922445|NCT00289991|453015358|FG000|Overall Study|Adverse Event|15|||
125922446|NCT00289991|453015359|FG001|Overall Study|Adverse Event|13|||
125922447|NCT00289991|453015358|FG000|Overall Study|Failure of prophylaxis|1|||
125922448|NCT00289991|453015359|FG001|Overall Study|Failure of prophylaxis|1|||
125922449|NCT00289991|453015358|FG000|Overall Study|Fungal breakthrough infection|0|||
125922450|NCT00289991|453015359|FG001|Overall Study|Fungal breakthrough infection|1|||
125922451|NCT00289991|453015358|FG000|Overall Study|Lost to Follow-up|0|||
125922452|NCT00289991|453015359|FG001|Overall Study|Lost to Follow-up|1|||
125922453|NCT00289991|453015358|FG000|Overall Study|Withdrawal by Subject|2|||
125922454|NCT00289991|453015359|FG001|Overall Study|Withdrawal by Subject|12|||
125922455|NCT00289991|453015358|FG000|Overall Study|Other|5|||
125922456|NCT00289991|453015359|FG001|Overall Study|Other|14|||
125922457|NCT01606007|453015368|FG000|Overall Study|Reason 'Other' in the protocol|0|||
125922458|NCT01606007|453015369|FG001|Overall Study|Reason 'Other' in the protocol|1|||
125922459|NCT01606007|453015370|FG002|Overall Study|Reason 'Other' in the protocol|1|||
125922460|NCT01606007|453015368|FG000|Overall Study|Pregnancy|0|||
125922461|NCT01606007|453015369|FG001|Overall Study|Pregnancy|1|||
125922462|NCT01606007|453015370|FG002|Overall Study|Pregnancy|1|||
125922463|NCT01606007|453015368|FG000|Overall Study|Withdrawal by Subject|8|||
125922464|NCT01606007|453015369|FG001|Overall Study|Withdrawal by Subject|6|||
125922465|NCT01606007|453015370|FG002|Overall Study|Withdrawal by Subject|1|||
125922466|NCT01606007|453015368|FG000|Overall Study|Adverse Event|0|||
125922467|NCT01606007|453015369|FG001|Overall Study|Adverse Event|1|||
125922468|NCT01606007|453015370|FG002|Overall Study|Adverse Event|1|||
125922469|NCT01606007|453015368|FG000|Overall Study|discontinue study treatment|0|||
125922470|NCT01606007|453015369|FG001|Overall Study|discontinue study treatment|2|||
125922471|NCT01606007|453015370|FG002|Overall Study|discontinue study treatment|1|||
125922472|NCT01606007|453015368|FG000|Overall Study|Lost to Follow-up|6|||
125922473|NCT01606007|453015369|FG001|Overall Study|Lost to Follow-up|8|||
125922474|NCT01606007|453015370|FG002|Overall Study|Lost to Follow-up|5|||
125922475|NCT01606007|453015368|FG000|Overall Study|Poor/Non-compliance|1|||
125922476|NCT01606007|453015369|FG001|Overall Study|Poor/Non-compliance|0|||
125922477|NCT01606007|453015370|FG002|Overall Study|Poor/Non-compliance|0|||
125922478|NCT00781274|453015378|FG000|Overall Study|Withdrawal by Subject|2|||
125922479|NCT02021773|453015379|FG000|Overall Study|Adverse Event|1|||
125922480|NCT02021773|453015380|FG001|Overall Study|Adverse Event|4|||
125922481|NCT02021773|453015381|FG002|Overall Study|Adverse Event|3|||
125922482|NCT02021773|453015379|FG000|Overall Study|Lack of Efficacy|2|||
125922483|NCT02021773|453015380|FG001|Overall Study|Lack of Efficacy|2|||
125922484|NCT02021773|453015381|FG002|Overall Study|Lack of Efficacy|2|||
125922485|NCT02021773|453015379|FG000|Overall Study|Protocol Violation|2|||
125922486|NCT02021773|453015380|FG001|Overall Study|Protocol Violation|3|||
125922487|NCT02021773|453015381|FG002|Overall Study|Protocol Violation|1|||
125922488|NCT02021773|453015379|FG000|Overall Study|Withdrawal by Subject|3|||
125922489|NCT02021773|453015380|FG001|Overall Study|Withdrawal by Subject|4|||
125922490|NCT02021773|453015381|FG002|Overall Study|Withdrawal by Subject|5|||
125922491|NCT02021773|453015379|FG000|Overall Study|Lost to Follow-up|1|||
125922492|NCT02021773|453015380|FG001|Overall Study|Lost to Follow-up|3|||
125922493|NCT02021773|453015381|FG002|Overall Study|Lost to Follow-up|0|||
125922494|NCT02021773|453015379|FG000|Overall Study|Reason not specified|3|||
125922495|NCT02021773|453015380|FG001|Overall Study|Reason not specified|0|||
125922496|NCT02021773|453015381|FG002|Overall Study|Reason not specified|0|||
125922497|NCT02243696|453015382|FG000|Overall Study|Death|282|||
125922498|NCT02243696|453015382|FG000|Overall Study|Withdrawal by Subject|79|||
125922499|NCT02243696|453015382|FG000|Overall Study|Lost to Follow-up|57|||
125922500|NCT02243696|453015382|FG000|Overall Study|Subject No Longer has Study System|42|||
125922501|NCT02243696|453015382|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
125922502|NCT02243696|453015382|FG000|Overall Study|Study Terminated for EP PASSION|961|||
125922503|NCT01534962|453015383|FG000|Overall Study|Randomized but did not start treatment|2|||
125922504|NCT01534962|453015384|FG001|Overall Study|Randomized but did not start treatment|0|||
125922505|NCT01534962|453015385|FG002|Overall Study|Randomized but did not start treatment|0|||
125922506|NCT01534962|453015386|FG003|Overall Study|Randomized but did not start treatment|1|||
125922507|NCT01534962|453015383|FG000|Overall Study|Discontinued at AF recurrence|35|||
125922508|NCT01534962|453015384|FG001|Overall Study|Discontinued at AF recurrence|26|||
125922509|NCT01534962|453015385|FG002|Overall Study|Discontinued at AF recurrence|24|||
125922510|NCT01534962|453015386|FG003|Overall Study|Discontinued at AF recurrence|31|||
125922511|NCT00282984|453015387|FG000|Overall Study|Death|2|||
125922512|NCT00282984|453015388|FG001|Overall Study|Death|5|||
125922513|NCT00282984|453015387|FG000|Overall Study|Adverse Event|8|||
125922514|NCT00282984|453015388|FG001|Overall Study|Adverse Event|5|||
125922515|NCT00282984|453015387|FG000|Overall Study|Lack of Efficacy|0|||
125922516|NCT00282984|453015388|FG001|Overall Study|Lack of Efficacy|2|||
125922517|NCT00282984|453015387|FG000|Overall Study|Lost to Follow-up|14|||
125922518|NCT00282984|453015388|FG001|Overall Study|Lost to Follow-up|10|||
125922519|NCT00282984|453015387|FG000|Overall Study|Withdrawal by Participant|22|||
125922520|NCT00282984|453015388|FG001|Overall Study|Withdrawal by Participant|34|||
125922521|NCT00282984|453015387|FG000|Overall Study|Participant stopped study medication|2|||
125922522|NCT00282984|453015388|FG001|Overall Study|Participant stopped study medication|2|||
125922523|NCT00282984|453015387|FG000|Overall Study|Participant only allowed phone follow-up|0|||
125922524|NCT00282984|453015388|FG001|Overall Study|Participant only allowed phone follow-up|1|||
125922525|NCT00282984|453015387|FG000|Overall Study|Participant used antipsychosis meds|0|||
125922526|NCT00282984|453015388|FG001|Overall Study|Participant used antipsychosis meds|1|||
125922527|NCT00282984|453015387|FG000|Overall Study|lack of motivation|1|||
125922528|NCT00282984|453015388|FG001|Overall Study|lack of motivation|0|||
125922529|NCT00282984|453015387|FG000|Overall Study|in prison|0|||
125922530|NCT00282984|453015388|FG001|Overall Study|in prison|1|||
125922531|NCT00282984|453015387|FG000|Overall Study|Protocol Violation|2|||
125922532|NCT00282984|453015388|FG001|Overall Study|Protocol Violation|0|||
125922533|NCT00087607|453015389|FG000|Overall Study|Adverse Event|14|||
125922534|NCT00087607|453015390|FG001|Overall Study|Adverse Event|24|||
125922535|NCT00087607|453015389|FG000|Overall Study|Death|0|||
125922536|NCT00087607|453015390|FG001|Overall Study|Death|1|||
125922537|NCT00087607|453015389|FG000|Overall Study|Insufficient Therapeutic Response|53|||
125922538|NCT00087607|453015390|FG001|Overall Study|Insufficient Therapeutic Response|42|||
125922539|NCT00087607|453015389|FG000|Overall Study|Failure to return|21|||
125922540|NCT00087607|453015390|FG001|Overall Study|Failure to return|17|||
125922541|NCT00087607|453015389|FG000|Overall Study|Withdrew Consent|12|||
125922542|NCT00087607|453015390|FG001|Overall Study|Withdrew Consent|16|||
125922543|NCT00087607|453015389|FG000|Overall Study|Administrative|12|||
125922544|NCT00087607|453015390|FG001|Overall Study|Administrative|12|||
125922545|NCT00087607|453015389|FG000|Overall Study|Refused Treatment|5|||
125922546|NCT00087607|453015390|FG001|Overall Study|Refused Treatment|7|||
125922547|NCT00087607|453015389|FG000|Overall Study|Other Protocol Violation|5|||
125922548|NCT00087607|453015390|FG001|Overall Study|Other Protocol Violation|2|||
125922549|NCT00087607|453015389|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
125922550|NCT00087607|453015390|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125922551|NCT00190671|453015391|FG000|Overall Study|Satisfactory Response|4|||
125922552|NCT00190671|453015392|FG001|Overall Study|Satisfactory Response|7|||
125922553|NCT00190671|453015391|FG000|Overall Study|Lack of Efficacy|19|||
125922554|NCT00190671|453015392|FG001|Overall Study|Lack of Efficacy|24|||
125922555|NCT00190671|453015391|FG000|Overall Study|Death from Study Disease|1|||
125922556|NCT00190671|453015392|FG001|Overall Study|Death from Study Disease|1|||
125922557|NCT00190671|453015391|FG000|Overall Study|Adverse Event|3|||
125922558|NCT00190671|453015392|FG001|Overall Study|Adverse Event|2|||
125922559|NCT00190671|453015391|FG000|Overall Study|Clinical Relapse|0|||
125922560|NCT00190671|453015392|FG001|Overall Study|Clinical Relapse|1|||
125922561|NCT00190671|453015391|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
125922562|NCT00190671|453015392|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
125922563|NCT00190671|453015391|FG000|Overall Study|Death from Other Causes|0|||
125922564|NCT00190671|453015392|FG001|Overall Study|Death from Other Causes|2|||
125922565|NCT00190671|453015391|FG000|Overall Study|Protocol Violation|0|||
125922566|NCT00190671|453015392|FG001|Overall Study|Protocol Violation|1|||
125922567|NCT00190671|453015391|FG000|Overall Study|Withdrawal by Subject|0|||
125922568|NCT00190671|453015392|FG001|Overall Study|Withdrawal by Subject|2|||
125922569|NCT00191269|453015393|FG000|Overall Study|Protocol Violation|0|||
125922570|NCT00191269|453015394|FG001|Overall Study|Protocol Violation|2|||
125922571|NCT00191269|453015393|FG000|Overall Study|Adverse Event|1|||
125922572|NCT00191269|453015394|FG001|Overall Study|Adverse Event|4|||
125922573|NCT00191269|453015393|FG000|Overall Study|Progression of Disease|4|||
125922574|NCT00191269|453015394|FG001|Overall Study|Progression of Disease|42|||
125922575|NCT00191269|453015393|FG000|Overall Study|Lack of Efficacy|1|||
125922576|NCT00191269|453015394|FG001|Overall Study|Lack of Efficacy|5|||
125922577|NCT00191269|453015393|FG000|Overall Study|Withdrawal by Subject|0|||
125922578|NCT00191269|453015394|FG001|Overall Study|Withdrawal by Subject|1|||
125922579|NCT00191269|453015393|FG000|Overall Study|Pathologic Aggrevation|0|||
125922580|NCT00191269|453015394|FG001|Overall Study|Pathologic Aggrevation|1|||
125922581|NCT00191269|453015393|FG000|Overall Study|Physician Decision|0|||
125922582|NCT00191269|453015394|FG001|Overall Study|Physician Decision|3|||
125922583|NCT02151110|453015400|FG000|Overall Study|Withdrawal by Subject|0|||
125922584|NCT02151110|453015401|FG001|Overall Study|Withdrawal by Subject|0|||
125922585|NCT02151110|453015402|FG002|Overall Study|Withdrawal by Subject|0|||
125922586|NCT02151110|453015403|FG003|Overall Study|Withdrawal by Subject|0|||
125922587|NCT02151110|453015404|FG004|Overall Study|Withdrawal by Subject|0|||
125922588|NCT02151110|453015405|FG005|Overall Study|Withdrawal by Subject|0|||
125922589|NCT02151110|453015406|FG006|Overall Study|Withdrawal by Subject|0|||
125922590|NCT02151110|453015407|FG007|Overall Study|Withdrawal by Subject|1|||
125922591|NCT02151110|453015400|FG000|Overall Study|Lost to Follow-up|0|||
125922592|NCT02151110|453015401|FG001|Overall Study|Lost to Follow-up|0|||
125922593|NCT02151110|453015402|FG002|Overall Study|Lost to Follow-up|0|||
125922594|NCT02151110|453015403|FG003|Overall Study|Lost to Follow-up|0|||
125922595|NCT02151110|453015404|FG004|Overall Study|Lost to Follow-up|0|||
125922596|NCT02151110|453015405|FG005|Overall Study|Lost to Follow-up|0|||
125922597|NCT02151110|453015406|FG006|Overall Study|Lost to Follow-up|0|||
125922598|NCT02151110|453015407|FG007|Overall Study|Lost to Follow-up|2|||
125922599|NCT02015754|453015408|FG000|Overall Study|Disease progression|5|||
125922600|NCT02015754|453015408|FG000|Overall Study|Change in treatment modality|5|||
125922601|NCT02015754|453015408|FG000|Overall Study|Lost to Follow-up|1|||
125922602|NCT01128842|453015409|FG000|Overall Study|Adverse Event|1|||
125922603|NCT01128842|453015409|FG000|Overall Study|Disease Progression|6|||
125922604|NCT04528732|453015410|FG000|Overall Study|Death|1|||
125922605|NCT04528732|453015411|FG001|Overall Study|Death|0|||
125922606|NCT04528732|453015412|FG002|Overall Study|Death|1|||
125922607|NCT04528732|453015410|FG000|Overall Study|Lost to Follow-up|0|||
125922608|NCT04528732|453015411|FG001|Overall Study|Lost to Follow-up|1|||
125922609|NCT04528732|453015412|FG002|Overall Study|Lost to Follow-up|2|||
125922610|NCT05399641|453015419|FG000|Overall Study|Adverse Event|0|||
125922611|NCT05399641|453015420|FG001|Overall Study|Adverse Event|1|||
125922612|NCT05399641|453015421|FG002|Overall Study|Adverse Event|1|||
125922613|NCT05399641|453015419|FG000|Overall Study|Lost to Follow-up|1|||
125922614|NCT05399641|453015420|FG001|Overall Study|Lost to Follow-up|2|||
125922615|NCT05399641|453015421|FG002|Overall Study|Lost to Follow-up|2|||
125922616|NCT05399641|453015419|FG000|Overall Study|Physician Decision|1|||
125922617|NCT05399641|453015420|FG001|Overall Study|Physician Decision|3|||
125922618|NCT05399641|453015421|FG002|Overall Study|Physician Decision|3|||
125922619|NCT05399641|453015419|FG000|Overall Study|Withdrawal by Subject|4|||
125922620|NCT05399641|453015420|FG001|Overall Study|Withdrawal by Subject|11|||
125922621|NCT05399641|453015421|FG002|Overall Study|Withdrawal by Subject|7|||
125922622|NCT05399641|453015419|FG000|Overall Study|Reason not defined|3|||
125922623|NCT05399641|453015420|FG001|Overall Study|Reason not defined|5|||
125922624|NCT05399641|453015421|FG002|Overall Study|Reason not defined|6|||
125922625|NCT02094677|453015422|FG000|Overall Study|Screening|3|||
125922626|NCT02094677|453015423|FG001|Overall Study|Screening|1|||
125922627|NCT01300650|453015424|FG000|Overall Study|Adverse Event|1|||
125922628|NCT00668707|453015431|FG000|Overall Study|Cancer Recurrence|58|||
125922629|NCT00668707|453015432|FG001|Overall Study|Cancer Recurrence|58|||
125922630|NCT00668707|453015431|FG000|Overall Study|Withdrawal by Subject|117|||
125922631|NCT00668707|453015432|FG001|Overall Study|Withdrawal by Subject|100|||
125922632|NCT00668707|453015431|FG000|Overall Study|Lost to Follow-up|3|||
125922633|NCT00668707|453015432|FG001|Overall Study|Lost to Follow-up|6|||
125922634|NCT00668707|453015431|FG000|Overall Study|Protocol Violation|10|||
125922635|NCT00668707|453015432|FG001|Overall Study|Protocol Violation|12|||
125922636|NCT00668707|453015431|FG000|Overall Study|Death|11|||
125922637|NCT00668707|453015432|FG001|Overall Study|Death|4|||
125922638|NCT04066023|453015433|FG000|Overall Study|Adverse Event|0|||
125922639|NCT04066023|453015434|FG001|Overall Study|Adverse Event|0|||
125922640|NCT04066023|453015435|FG002|Overall Study|Adverse Event|1|||
125922641|NCT04066023|453015433|FG000|Overall Study|Sponsor decision|3|||
125922642|NCT04066023|453015434|FG001|Overall Study|Sponsor decision|6|||
125922643|NCT04066023|453015435|FG002|Overall Study|Sponsor decision|2|||
125922644|NCT04066023|453015433|FG000|Overall Study|Physician Decision|0|||
125922645|NCT04066023|453015434|FG001|Overall Study|Physician Decision|0|||
125922646|NCT04066023|453015435|FG002|Overall Study|Physician Decision|1|||
125922647|NCT04066023|453015433|FG000|Overall Study|Lost to Follow-up|0|||
125922648|NCT04066023|453015434|FG001|Overall Study|Lost to Follow-up|1|||
125922649|NCT04066023|453015435|FG002|Overall Study|Lost to Follow-up|1|||
125922650|NCT04066023|453015433|FG000|Overall Study|Noncompliance|0|||
125922651|NCT04066023|453015434|FG001|Overall Study|Noncompliance|1|||
125922652|NCT04066023|453015435|FG002|Overall Study|Noncompliance|1|||
125922653|NCT03583697|453015436|FG000|Overall Study|Withdrawal by Subject|0|||
125922654|NCT03583697|453015437|FG001|Overall Study|Withdrawal by Subject|0|||
125922655|NCT03583697|453015438|FG002|Overall Study|Withdrawal by Subject|1|||
125922656|NCT03583697|453015436|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
125922657|NCT03583697|453015437|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
125922658|NCT03583697|453015438|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
125922659|NCT00114530|453015439|FG000|Overall Study|Death|3|||
125922660|NCT00114530|453015440|FG001|Overall Study|Death|11|||
125922661|NCT00114530|453015439|FG000|Overall Study|Lost to Follow-up|1|||
125922662|NCT00114530|453015440|FG001|Overall Study|Lost to Follow-up|1|||
125922663|NCT00114530|453015439|FG000|Overall Study|Physician Decision|1|||
125922664|NCT00114530|453015440|FG001|Overall Study|Physician Decision|1|||
125922665|NCT00114530|453015439|FG000|Overall Study|Withdrawal by Subject|2|||
125922666|NCT00114530|453015440|FG001|Overall Study|Withdrawal by Subject|6|||
125922667|NCT00114530|453015439|FG000|Overall Study|Breast Cancer|1|||
125922668|NCT00114530|453015440|FG001|Overall Study|Breast Cancer|0|||
125922669|NCT00114530|453015439|FG000|Overall Study|Subject decision after endpoint failure|0|||
125922670|NCT00114530|453015440|FG001|Overall Study|Subject decision after endpoint failure|1|||
125922671|NCT00114530|453015439|FG000|Overall Study|Ineligible|1|||
125922672|NCT00114530|453015440|FG001|Overall Study|Ineligible|0|||
125922673|NCT00365508|453015443|FG000|Overall Study|Lost to Follow-up|139|||
125922674|NCT00365508|453015444|FG001|Overall Study|Lost to Follow-up|154|||
125922675|NCT00751933|453015445|FG000|Overall Study|Withdrawal by Subject|0|||
125922676|NCT00751933|453015446|FG001|Overall Study|Withdrawal by Subject|1|||
125922677|NCT00751933|453015447|FG002|Overall Study|Withdrawal by Subject|0|||
125922678|NCT00751933|453015448|FG003|Overall Study|Withdrawal by Subject|0|||
125922679|NCT00751933|453015445|FG000|Overall Study|Physician Decision|0|||
125922680|NCT00751933|453015446|FG001|Overall Study|Physician Decision|0|||
125922681|NCT00751933|453015447|FG002|Overall Study|Physician Decision|1|||
125922682|NCT00751933|453015448|FG003|Overall Study|Physician Decision|1|||
125922683|NCT02538029|453015450|FG000|Overall Study|unable to complete cognitive assessments|1|||
125922684|NCT02538029|453015451|FG001|Overall Study|unable to complete cognitive assessments|0|||
125922685|NCT02538029|453015452|FG002|Overall Study|unable to complete cognitive assessments|1|||
125922686|NCT05248867|453015454|FG000|Double-blind Period|Lost to Follow-up|0|||
125922687|NCT05248867|453015455|FG001|Double-blind Period|Lost to Follow-up|3|||
125922688|NCT05248867|453015456|FG002|Double-blind Period|Lost to Follow-up|0|||
125922689|NCT05248867|453015457|FG003|Double-blind Period|Lost to Follow-up|0|||
125922690|NCT05248867|453015458|FG004|Double-blind Period|Lost to Follow-up|0|||
125922691|NCT05248867|453015459|FG005|Double-blind Period|Lost to Follow-up|0|||
125922692|NCT05248867|453015454|FG000|Double-blind Period|Withdrawal by Subject|5|||
125922693|NCT05248867|453015455|FG001|Double-blind Period|Withdrawal by Subject|14|||
125922694|NCT05248867|453015456|FG002|Double-blind Period|Withdrawal by Subject|0|||
125922695|NCT05248867|453015457|FG003|Double-blind Period|Withdrawal by Subject|0|||
125922696|NCT05248867|453015458|FG004|Double-blind Period|Withdrawal by Subject|0|||
125922697|NCT05248867|453015459|FG005|Double-blind Period|Withdrawal by Subject|0|||
125922698|NCT05248867|453015454|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125922699|NCT05248867|453015455|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
125922700|NCT05248867|453015456|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125922701|NCT05248867|453015457|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125922702|NCT05248867|453015458|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125922703|NCT05248867|453015459|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125922704|NCT05248867|453015454|FG000|Double-blind Period|Other, not specified|3|||
125922705|NCT05248867|453015455|FG001|Double-blind Period|Other, not specified|8|||
125922706|NCT05248867|453015456|FG002|Double-blind Period|Other, not specified|0|||
125922707|NCT05248867|453015457|FG003|Double-blind Period|Other, not specified|0|||
125922708|NCT05248867|453015458|FG004|Double-blind Period|Other, not specified|0|||
125922709|NCT05248867|453015459|FG005|Double-blind Period|Other, not specified|0|||
125922710|NCT05248867|453015454|FG000|Open-label Period|Withdrawal by Subject|0|||
125922711|NCT05248867|453015455|FG001|Open-label Period|Withdrawal by Subject|0|||
125922712|NCT05248867|453015456|FG002|Open-label Period|Withdrawal by Subject|3|||
125922713|NCT05248867|453015457|FG003|Open-label Period|Withdrawal by Subject|1|||
125922714|NCT05248867|453015458|FG004|Open-label Period|Withdrawal by Subject|7|||
125922715|NCT05248867|453015459|FG005|Open-label Period|Withdrawal by Subject|9|||
125922716|NCT05248867|453015454|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125922717|NCT05248867|453015455|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125922718|NCT05248867|453015456|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125922719|NCT05248867|453015457|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
125922720|NCT05248867|453015458|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125922721|NCT05248867|453015459|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125922722|NCT05248867|453015454|FG000|Open-label Period|Lost to Follow-up|0|||
125922723|NCT05248867|453015455|FG001|Open-label Period|Lost to Follow-up|0|||
125922724|NCT05248867|453015456|FG002|Open-label Period|Lost to Follow-up|0|||
125922725|NCT05248867|453015457|FG003|Open-label Period|Lost to Follow-up|0|||
125922726|NCT05248867|453015458|FG004|Open-label Period|Lost to Follow-up|5|||
125922727|NCT05248867|453015459|FG005|Open-label Period|Lost to Follow-up|2|||
125922728|NCT05248867|453015454|FG000|Open-label Period|COVID-19 Infection|0|||
125922729|NCT05248867|453015455|FG001|Open-label Period|COVID-19 Infection|0|||
125922730|NCT05248867|453015456|FG002|Open-label Period|COVID-19 Infection|0|||
125922731|NCT05248867|453015457|FG003|Open-label Period|COVID-19 Infection|0|||
125922732|NCT05248867|453015458|FG004|Open-label Period|COVID-19 Infection|1|||
125922733|NCT05248867|453015459|FG005|Open-label Period|COVID-19 Infection|0|||
125922734|NCT05248867|453015454|FG000|Open-label Period|Other, not specified|0|||
125922735|NCT05248867|453015455|FG001|Open-label Period|Other, not specified|0|||
125922736|NCT05248867|453015456|FG002|Open-label Period|Other, not specified|0|||
125922737|NCT05248867|453015457|FG003|Open-label Period|Other, not specified|0|||
125922738|NCT05248867|453015458|FG004|Open-label Period|Other, not specified|4|||
125922739|NCT05248867|453015459|FG005|Open-label Period|Other, not specified|0|||
125922740|NCT01064310|453015460|FG000|Period 1|Adverse Event|7|||
125922741|NCT01064310|453015461|FG001|Period 1|Adverse Event|10|||
125922742|NCT01064310|453015462|FG002|Period 1|Adverse Event|0|||
125922743|NCT01064310|453015460|FG000|Period 1|Physician Decision|1|||
125922744|NCT01064310|453015461|FG001|Period 1|Physician Decision|0|||
125922745|NCT01064310|453015462|FG002|Period 1|Physician Decision|0|||
125922746|NCT01064310|453015460|FG000|Period 1|Withdrawal by Subject|2|||
125922747|NCT01064310|453015461|FG001|Period 1|Withdrawal by Subject|2|||
125922748|NCT01064310|453015462|FG002|Period 1|Withdrawal by Subject|0|||
125922749|NCT01064310|453015460|FG000|Period 1|Lack of Efficacy|3|||
125922750|NCT01064310|453015461|FG001|Period 1|Lack of Efficacy|5|||
125922751|NCT01064310|453015462|FG002|Period 1|Lack of Efficacy|0|||
125922752|NCT01064310|453015460|FG000|Period 1|Entered Open-label Period|1|||
125922753|NCT01064310|453015461|FG001|Period 1|Entered Open-label Period|1|||
125922754|NCT01064310|453015462|FG002|Period 1|Entered Open-label Period|0|||
125922755|NCT01064310|453015460|FG000|Period 2|Adverse Event|2|||
125922756|NCT01064310|453015461|FG001|Period 2|Adverse Event|1|||
125922757|NCT01064310|453015462|FG002|Period 2|Adverse Event|0|||
125922758|NCT01064310|453015460|FG000|Period 2|Physician Decision|0|||
125922759|NCT01064310|453015461|FG001|Period 2|Physician Decision|1|||
125922760|NCT01064310|453015462|FG002|Period 2|Physician Decision|0|||
125922761|NCT01064310|453015460|FG000|Period 2|Entered Open-label Period|1|||
125922762|NCT01064310|453015461|FG001|Period 2|Entered Open-label Period|0|||
125922763|NCT01064310|453015462|FG002|Period 2|Entered Open-label Period|0|||
125922764|NCT01064310|453015460|FG000|Period 2|Lack of Efficacy|1|||
125922765|NCT01064310|453015461|FG001|Period 2|Lack of Efficacy|4|||
125922766|NCT01064310|453015462|FG002|Period 2|Lack of Efficacy|0|||
125922767|NCT01064310|453015460|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
125922768|NCT01064310|453015461|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
125922769|NCT01064310|453015462|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
125922770|NCT01064310|453015460|FG000|Open Label Pazopinib|Adverse Event|0|||
125922771|NCT01064310|453015461|FG001|Open Label Pazopinib|Adverse Event|0|||
125922772|NCT01064310|453015462|FG002|Open Label Pazopinib|Adverse Event|12|||
125922773|NCT01064310|453015460|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
125922774|NCT01064310|453015461|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
125922775|NCT01064310|453015462|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
125922776|NCT01064310|453015460|FG000|Open Label Pazopinib|Physician Decision|0|||
125922777|NCT01064310|453015461|FG001|Open Label Pazopinib|Physician Decision|0|||
125922778|NCT01064310|453015462|FG002|Open Label Pazopinib|Physician Decision|20|||
125922779|NCT00873015|453015464|FG000|Overall Study|Withdrawal by Subject|0|||
125922780|NCT00873015|453015465|FG001|Overall Study|Withdrawal by Subject|1|||
125922781|NCT00873015|453015466|FG002|Overall Study|Withdrawal by Subject|0|||
125922782|NCT00873015|453015467|FG003|Overall Study|Withdrawal by Subject|0|||
125922783|NCT01382212|453015470|FG000|Overall Study|Kidney transplant|1|||
125922784|NCT01382212|453015470|FG000|Overall Study|Withdrew consent|1|||
125922785|NCT01084083|453015471|FG000|Overall Study|Adverse Event|5|||
125922786|NCT01084083|453015471|FG000|Overall Study|Death|1|||
125922787|NCT01084083|453015471|FG000|Overall Study|Withdrawal by Subject|2|||
125922788|NCT01084083|453015471|FG000|Overall Study|Complicating disease|1|||
125922789|NCT01084083|453015471|FG000|Overall Study|Other|2|||
125922790|NCT01084083|453015471|FG000|Overall Study|Never started assigned therapy|1|||
125922791|NCT01273597|453015472|FG000|Overall Study|Adverse Event|5|||
125922792|NCT01273597|453015472|FG000|Overall Study|Underwent Kidney Transplantation|2|||
125922793|NCT01273597|453015472|FG000|Overall Study|Reason Not Reported|1|||
125922794|NCT01088997|453015474|FG000|Overall Study|Physician Decision|1|||
125922795|NCT01088997|453015475|FG001|Overall Study|Physician Decision|1|||
125922796|NCT01088997|453015474|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
125922797|NCT01088997|453015475|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
125922798|NCT01088997|453015474|FG000|Overall Study|Excluded prior to receiving drug|1|||
125922799|NCT01088997|453015475|FG001|Overall Study|Excluded prior to receiving drug|1|||
125922800|NCT05695209|453015478|FG000|3-months|Withdrawal by Subject|2|||
125922801|NCT05695209|453015479|FG001|3-months|Withdrawal by Subject|0|||
125922802|NCT05695209|453015478|FG000|3-months|Unable to contact for 3-month data collection|0|||
125922803|NCT05695209|453015479|FG001|3-months|Unable to contact for 3-month data collection|1|||
125922804|NCT05695209|453015478|FG000|6-months|Lost to Follow-up|1|||
125922805|NCT05695209|453015479|FG001|6-months|Lost to Follow-up|1|||
125971425|NCT01358526|453182850|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
125971426|NCT01358526|453182851|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
125971427|NCT01358526|453182852|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
125971428|NCT01358526|453182850|FG000|Open-label Titration Period|Lost to Follow-up|25|||
125971429|NCT01358526|453182851|FG001|Open-label Titration Period|Lost to Follow-up|0|||
125971430|NCT01358526|453182852|FG002|Open-label Titration Period|Lost to Follow-up|0|||
125971431|NCT01358526|453182850|FG000|Open-label Titration Period|Lack of Efficacy|107|||
125971432|NCT01358526|453182851|FG001|Open-label Titration Period|Lack of Efficacy|0|||
125971433|NCT01358526|453182852|FG002|Open-label Titration Period|Lack of Efficacy|0|||
125971434|NCT01358526|453182850|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
125971435|NCT01358526|453182851|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
125971436|NCT01358526|453182852|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
125971437|NCT01358526|453182850|FG000|Open-label Titration Period|Administrative|8|||
125971438|NCT01358526|453182851|FG001|Open-label Titration Period|Administrative|0|||
125971439|NCT01358526|453182852|FG002|Open-label Titration Period|Administrative|0|||
125971440|NCT01358526|453182850|FG000|Open-label Titration Period|Did not qualify|178|||
125971441|NCT01358526|453182851|FG001|Open-label Titration Period|Did not qualify|0|||
125971442|NCT01358526|453182852|FG002|Open-label Titration Period|Did not qualify|0|||
125971443|NCT01358526|453182850|FG000|Double-blind Phase|Adverse Event|0|||
125971444|NCT01358526|453182851|FG001|Double-blind Phase|Adverse Event|24|||
125971445|NCT01358526|453182852|FG002|Double-blind Phase|Adverse Event|23|||
125971446|NCT01358526|453182850|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125971447|NCT01358526|453182851|FG001|Double-blind Phase|Withdrawal by Subject|10|||
125971448|NCT01358526|453182852|FG002|Double-blind Phase|Withdrawal by Subject|8|||
125971449|NCT01358526|453182850|FG000|Double-blind Phase|Lost to Follow-up|0|||
125971450|NCT01358526|453182851|FG001|Double-blind Phase|Lost to Follow-up|4|||
125971451|NCT01358526|453182852|FG002|Double-blind Phase|Lost to Follow-up|1|||
125971452|NCT01358526|453182850|FG000|Double-blind Phase|Lack of Efficacy|0|||
125922806|NCT03749447|453016934|FG000|Overall Study|Adverse Event|11|||
125922807|NCT03749447|453016935|FG001|Overall Study|Adverse Event|3|||
125922808|NCT03749447|453016934|FG000|Overall Study|Death|1|||
125922809|NCT03749447|453016935|FG001|Overall Study|Death|1|||
125922810|NCT03749447|453016934|FG000|Overall Study|Lost to Follow-up|2|||
125922811|NCT03749447|453016935|FG001|Overall Study|Lost to Follow-up|2|||
125922812|NCT03749447|453016934|FG000|Overall Study|Reason Not Specified|0|||
125922813|NCT03749447|453016935|FG001|Overall Study|Reason Not Specified|3|||
125922814|NCT03749447|453016934|FG000|Overall Study|Physician Decision|4|||
125922815|NCT03749447|453016935|FG001|Overall Study|Physician Decision|3|||
125922816|NCT03749447|453016934|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
125922817|NCT03749447|453016935|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
125922818|NCT03749447|453016934|FG000|Overall Study|Study Terminated By Sponsor|112|||
125922819|NCT03749447|453016935|FG001|Overall Study|Study Terminated By Sponsor|105|||
125922820|NCT03749447|453016934|FG000|Overall Study|Withdrawal by Subject|12|||
125922821|NCT03749447|453016935|FG001|Overall Study|Withdrawal by Subject|6|||
125922822|NCT03749447|453016934|FG000|Overall Study|Non-compliance With Study Drug|0|||
125922823|NCT03749447|453016935|FG001|Overall Study|Non-compliance With Study Drug|1|||
125922824|NCT05996718|453016936|FG000|Overall Study|Lost to Follow-up|3|||
125922825|NCT01218113|453016937|FG000|Overall Study|Withdrawal by Subject|1|||
125922826|NCT01218113|453016938|FG001|Overall Study|Withdrawal by Subject|0|||
125922827|NCT01218113|453016939|FG002|Overall Study|Withdrawal by Subject|1|||
125922828|NCT01218113|453016937|FG000|Overall Study|Lost to Follow-up|4|||
125922829|NCT01218113|453016938|FG001|Overall Study|Lost to Follow-up|1|||
125922830|NCT01218113|453016939|FG002|Overall Study|Lost to Follow-up|4|||
125922831|NCT01218113|453016937|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
125922832|NCT01218113|453016938|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
125922833|NCT01218113|453016939|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
125922834|NCT01713686|453016940|FG000|Overall Study|Lost to Follow-up|9|||
125922835|NCT01713686|453016940|FG000|Overall Study|Withdrawal by Subject|6|||
125922836|NCT04840615|453016941|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
125922837|NCT04840615|453016942|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
125922838|NCT04840615|453016943|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
125922839|NCT00967668|453016944|FG000|Overall Study|Withdrawal by Subject|13|||
125922840|NCT00967668|453016945|FG001|Overall Study|Withdrawal by Subject|8|||
125922841|NCT00967668|453016946|FG002|Overall Study|Withdrawal by Subject|8|||
125922842|NCT00967668|453016944|FG000|Overall Study|Death|0|||
125922843|NCT00967668|453016945|FG001|Overall Study|Death|2|||
125922844|NCT00967668|453016946|FG002|Overall Study|Death|4|||
125922845|NCT00967668|453016944|FG000|Overall Study|Removed due to behavior|1|||
125922846|NCT00967668|453016945|FG001|Overall Study|Removed due to behavior|1|||
125922847|NCT00967668|453016946|FG002|Overall Study|Removed due to behavior|2|||
125922848|NCT00967668|453016944|FG000|Overall Study|Refused Year 2|11|||
125922849|NCT00967668|453016945|FG001|Overall Study|Refused Year 2|6|||
125922850|NCT00967668|453016946|FG002|Overall Study|Refused Year 2|4|||
125922851|NCT00967668|453016944|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
125922852|NCT00967668|453016945|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
125922853|NCT00967668|453016946|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
125922854|NCT00967668|453016944|FG000|Overall Study|Lost to Follow-up|15|||
125922855|NCT00967668|453016945|FG001|Overall Study|Lost to Follow-up|9|||
125922856|NCT00967668|453016946|FG002|Overall Study|Lost to Follow-up|16|||
125922857|NCT00967668|453016944|FG000|Overall Study|Refused 12-mo assessment|3|||
125922858|NCT00967668|453016945|FG001|Overall Study|Refused 12-mo assessment|1|||
125922859|NCT00967668|453016946|FG002|Overall Study|Refused 12-mo assessment|9|||
125922860|NCT00967668|453016944|FG000|Overall Study|Pregnancy|1|||
125922861|NCT00967668|453016945|FG001|Overall Study|Pregnancy|0|||
125922862|NCT00967668|453016946|FG002|Overall Study|Pregnancy|0|||
125922863|NCT00115739|453016948|FG000|Overall Study|Lost to Follow-up|3|||
125922864|NCT00709761|453016951|FG000|Overall Study|Withdrawal by Subject|8|||
125922865|NCT00709761|453016951|FG000|Overall Study|study closed/terminated|17|||
125922866|NCT00709761|453016951|FG000|Overall Study|Lost to Follow-up|2|||
125922867|NCT00259649|453016952|FG000|Overall Study|Lost to Follow-up|7|||
125922868|NCT00259649|453016952|FG000|Overall Study|irregular menses|3|||
125922869|NCT01918774|453016955|FG000|Overall Study|Lost prior to first CBTw session|4|||
125922870|NCT01918774|453016955|FG000|Overall Study|Lost to Follow-up|1|||
125922871|NCT01606800|453016956|FG000|Overall Study|Adverse Event|3|||
125922872|NCT01606800|453016957|FG001|Overall Study|Adverse Event|1|||
125922873|NCT01606800|453016956|FG000|Overall Study|Participant withdrew consent|0|||
125922874|NCT01606800|453016957|FG001|Overall Study|Participant withdrew consent|1|||
125922875|NCT01606800|453016956|FG000|Overall Study|Missing completion status|2|||
125922876|NCT01606800|453016957|FG001|Overall Study|Missing completion status|0|||
125922877|NCT03311724|453016958|FG000|Overall Study|Physician Decision|0|||
125922878|NCT03311724|453016959|FG001|Overall Study|Physician Decision|0|||
125922879|NCT03311724|453016960|FG002|Overall Study|Physician Decision|0|||
125922880|NCT03311724|453016961|FG003|Overall Study|Physician Decision|1|||
125922881|NCT03311724|453016958|FG000|Overall Study|Protocol Violation|1|||
125922882|NCT03311724|453016959|FG001|Overall Study|Protocol Violation|0|||
125922883|NCT03311724|453016960|FG002|Overall Study|Protocol Violation|1|||
125922884|NCT03311724|453016961|FG003|Overall Study|Protocol Violation|0|||
125922885|NCT03311724|453016958|FG000|Overall Study|Withdrawal by Subject|1|||
125922886|NCT03311724|453016959|FG001|Overall Study|Withdrawal by Subject|1|||
125922887|NCT03311724|453016960|FG002|Overall Study|Withdrawal by Subject|0|||
125922888|NCT03311724|453016961|FG003|Overall Study|Withdrawal by Subject|0|||
125922889|NCT03311724|453016958|FG000|Overall Study|Lost to Follow-up|1|||
125922890|NCT03311724|453016959|FG001|Overall Study|Lost to Follow-up|0|||
125922891|NCT03311724|453016960|FG002|Overall Study|Lost to Follow-up|0|||
125922892|NCT03311724|453016961|FG003|Overall Study|Lost to Follow-up|0|||
125922893|NCT03311724|453016958|FG000|Overall Study|Sponsor Decision|0|||
125922894|NCT03311724|453016959|FG001|Overall Study|Sponsor Decision|0|||
125922895|NCT03311724|453016960|FG002|Overall Study|Sponsor Decision|1|||
125922896|NCT03311724|453016961|FG003|Overall Study|Sponsor Decision|0|||
125922897|NCT03535844|453016962|FG000|Overall Study|Withdrawal by Subject|0|||
125922898|NCT03535844|453016963|FG001|Overall Study|Withdrawal by Subject|1|||
125922899|NCT02835820|453016966|FG000|Overall Study|Baseline Screen Failure|0|||
125922900|NCT02835820|453016967|FG001|Overall Study|Baseline Screen Failure|3|||
125922901|NCT00160693|453016971|FG000|Overall Study|Adverse Event|97|||
125922902|NCT00160693|453016971|FG000|Overall Study|Lack of Efficacy|30|||
125922903|NCT00160693|453016971|FG000|Overall Study|Protocol Violation|24|||
125922904|NCT00160693|453016971|FG000|Overall Study|Lost to Follow-up|15|||
125922905|NCT00160693|453016971|FG000|Overall Study|Withdrawal by Subject|54|||
125922906|NCT00160693|453016971|FG000|Overall Study|Study terminated by sponsor|15|||
125922907|NCT03039283|453016974|FG000|Overall Study|Protocol Violation|2|||
125922908|NCT01867424|453016975|FG000|Overall Study|Patient noncompliance|2|||
125922909|NCT01867424|453016976|FG001|Overall Study|Patient noncompliance|1|||
125922910|NCT01056653|453016977|FG000|Overall Study|Lost to Follow-up|0|||
125922911|NCT01056653|453016978|FG001|Overall Study|Lost to Follow-up|0|||
125922912|NCT01056653|453016979|FG002|Overall Study|Lost to Follow-up|2|||
125922913|NCT03727230|453016980|FG000|Overall Study|Lost to Follow-up|12|||
125922914|NCT04377620|453016981|FG000|Overall Study|Death|42|||
125922915|NCT04377620|453016982|FG001|Overall Study|Death|48|||
125922916|NCT04377620|453016983|FG002|Overall Study|Death|36|||
125922917|NCT04377620|453016981|FG000|Overall Study|Withdrawal by Subject|0|||
125922918|NCT04377620|453016982|FG001|Overall Study|Withdrawal by Subject|2|||
125922919|NCT04377620|453016983|FG002|Overall Study|Withdrawal by Subject|0|||
125922920|NCT00288054|453016987|FG000|Overall Study|Protocol Violation|2|||
125922921|NCT00288054|453016987|FG000|Overall Study|Lack of Efficacy|16|||
125922922|NCT00288054|453016987|FG000|Overall Study|Adverse Event|3|||
125922923|NCT00288054|453016987|FG000|Overall Study|Withdrawal by Subject|1|||
125922924|NCT00288054|453016987|FG000|Overall Study|Not protocol specified|2|||
125922925|NCT03733470|453016992|FG000|Overall Study|PI Decision|1|||
125922926|NCT03733470|453016993|FG001|Overall Study|PI Decision|1|||
125922927|NCT01010061|453016994|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
125922928|NCT01010061|453016995|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
125922929|NCT01010061|453016994|FG000|Overall Study|Disease Progression|2|||
125922930|NCT01010061|453016995|FG001|Overall Study|Disease Progression|8|||
125922931|NCT01010061|453016994|FG000|Overall Study|Withdrew Consent|5|||
125922932|NCT01010061|453016995|FG001|Overall Study|Withdrew Consent|1|||
125922933|NCT01010061|453016994|FG000|Overall Study|Death|3|||
125922934|NCT01010061|453016995|FG001|Overall Study|Death|6|||
125922935|NCT01010061|453016994|FG000|Overall Study|Administrative/Other|0|||
125922936|NCT01010061|453016995|FG001|Overall Study|Administrative/Other|1|||
125922937|NCT01010061|453016994|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
125922938|NCT01010061|453016995|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
125922939|NCT01010061|453016994|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125922940|NCT01010061|453016995|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125922941|NCT01010061|453016994|FG000|Overall Study|Violation of Selection Criteria|0|||
125922942|NCT01010061|453016995|FG001|Overall Study|Violation of Selection Criteria|1|||
125922943|NCT01010061|453016994|FG000|Overall Study|Did Not Receive Treatment|2|||
125922944|NCT01010061|453016995|FG001|Overall Study|Did Not Receive Treatment|2|||
125922945|NCT03470441|453016996|FG000|Overall Study|Death|0|||
125922946|NCT03470441|453016997|FG001|Overall Study|Death|1|||
125922947|NCT03470441|453016998|FG002|Overall Study|Death|1|||
125922948|NCT03470441|453016999|FG003|Overall Study|Death|0|||
125922949|NCT03470441|453016996|FG000|Overall Study|Adverse Event|0|||
125922950|NCT03470441|453016997|FG001|Overall Study|Adverse Event|0|||
125922951|NCT03470441|453016998|FG002|Overall Study|Adverse Event|0|||
125922952|NCT03470441|453016999|FG003|Overall Study|Adverse Event|1|||
125922953|NCT03470441|453016996|FG000|Overall Study|Withdrawal by Subject|1|||
125922954|NCT03470441|453016997|FG001|Overall Study|Withdrawal by Subject|4|||
125922955|NCT03470441|453016998|FG002|Overall Study|Withdrawal by Subject|1|||
125922956|NCT03470441|453016999|FG003|Overall Study|Withdrawal by Subject|3|||
125922957|NCT03768414|453017000|FG000|Overall Study|Adverse Event or side effects|72|||
125922958|NCT03768414|453017001|FG001|Overall Study|Adverse Event or side effects|28|||
125922959|NCT03768414|453017000|FG000|Overall Study|Refusal unrelated to adverse event|33|||
125922960|NCT03768414|453017001|FG001|Overall Study|Refusal unrelated to adverse event|33|||
125922961|NCT03768414|453017000|FG000|Overall Study|Progression/relapse|132|||
125922962|NCT03768414|453017001|FG001|Overall Study|Progression/relapse|60|||
125922963|NCT03768414|453017000|FG000|Overall Study|Death|9|||
125922964|NCT03768414|453017001|FG001|Overall Study|Death|6|||
125922965|NCT03768414|453017000|FG000|Overall Study|Other - not protocol specified|45|||
125922966|NCT03768414|453017001|FG001|Overall Study|Other - not protocol specified|18|||
125922967|NCT03768414|453017000|FG000|Overall Study|Reason under review|3|||
125922968|NCT03768414|453017001|FG001|Overall Study|Reason under review|2|||
125922969|NCT02197520|453017008|FG000|Period 1|Withdrawal by Subject|1|||
125922970|NCT02197520|453017009|FG001|Period 1|Withdrawal by Subject|0|||
125922971|NCT02197520|453017008|FG000|Period 2|Adverse Event|0|||
125922972|NCT02197520|453017009|FG001|Period 2|Adverse Event|2|||
125922973|NCT02197520|453017008|FG000|Period 2|Withdrawal by Subject|1|||
125922974|NCT02197520|453017009|FG001|Period 2|Withdrawal by Subject|0|||
125922975|NCT01306942|453017010|FG000|Phase I|Adverse Event|2|||
125922976|NCT01306942|453017011|FG001|Phase I|Adverse Event|2|||
125922977|NCT01306942|453017012|FG002|Phase I|Adverse Event|0|||
125922978|NCT01306942|453017013|FG003|Phase I|Adverse Event|0|||
125922979|NCT01306942|453017010|FG000|Phase I|Physician Decision|3|||
125922980|NCT01306942|453017011|FG001|Phase I|Physician Decision|1|||
125922981|NCT01306942|453017012|FG002|Phase I|Physician Decision|0|||
125922982|NCT01306942|453017013|FG003|Phase I|Physician Decision|0|||
125922983|NCT01306942|453017010|FG000|Phase II|Adverse Event|0|||
125922984|NCT01306942|453017011|FG001|Phase II|Adverse Event|0|||
125922985|NCT01306942|453017012|FG002|Phase II|Adverse Event|0|||
125922986|NCT01306942|453017013|FG003|Phase II|Adverse Event|6|||
125922987|NCT01306942|453017010|FG000|Phase II|Physician Decision|2|||
125922988|NCT01306942|453017011|FG001|Phase II|Physician Decision|0|||
125922989|NCT01306942|453017012|FG002|Phase II|Physician Decision|0|||
125922990|NCT01306942|453017013|FG003|Phase II|Physician Decision|5|||
125922991|NCT01306942|453017010|FG000|Phase II|Withdrawal by Subject|0|||
125922992|NCT01306942|453017011|FG001|Phase II|Withdrawal by Subject|0|||
125922993|NCT01306942|453017012|FG002|Phase II|Withdrawal by Subject|0|||
125922994|NCT01306942|453017013|FG003|Phase II|Withdrawal by Subject|2|||
125922995|NCT01306942|453017010|FG000|Phase II|Death|0|||
125922996|NCT01306942|453017011|FG001|Phase II|Death|0|||
125922997|NCT01306942|453017012|FG002|Phase II|Death|0|||
125922998|NCT01306942|453017013|FG003|Phase II|Death|1|||
125922999|NCT01306942|453017010|FG000|Phase II|Not finished treatment|0|||
125923000|NCT01306942|453017011|FG001|Phase II|Not finished treatment|0|||
125923001|NCT01306942|453017012|FG002|Phase II|Not finished treatment|0|||
125923002|NCT01306942|453017013|FG003|Phase II|Not finished treatment|1|||
125923003|NCT01306942|453017010|FG000|Phase II|Protocol Violation|0|||
125923004|NCT01306942|453017011|FG001|Phase II|Protocol Violation|0|||
125923005|NCT01306942|453017012|FG002|Phase II|Protocol Violation|0|||
125923006|NCT01306942|453017013|FG003|Phase II|Protocol Violation|1|||
125923007|NCT02217878|453017014|FG000|Overall Study|required morphine due to chest pain|1|||
125923008|NCT02217878|453017015|FG001|Overall Study|required morphine due to chest pain|2|||
125923009|NCT02217878|453017014|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
125923010|NCT02217878|453017015|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
125923011|NCT00334958|453017016|FG000|Overall Study|Medication Noncompliance|0|||
125923012|NCT00334958|453017017|FG001|Overall Study|Medication Noncompliance|3|||
125923013|NCT00334958|453017016|FG000|Overall Study|Protocol Violation|2|||
125923014|NCT00334958|453017017|FG001|Overall Study|Protocol Violation|2|||
125923015|NCT00334958|453017016|FG000|Overall Study|Request of the investigator or sponsor|0|||
125923016|NCT00334958|453017017|FG001|Overall Study|Request of the investigator or sponsor|1|||
125923017|NCT00334958|453017016|FG000|Overall Study|Withdrawal by Subject|7|||
125923018|NCT00334958|453017017|FG001|Overall Study|Withdrawal by Subject|4|||
125923019|NCT00334958|453017016|FG000|Overall Study|Adverse Event|27|||
125923020|NCT00334958|453017017|FG001|Overall Study|Adverse Event|12|||
125923021|NCT00334958|453017016|FG000|Overall Study|Other|1|||
126111047|NCT02038920|453701994|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
126111048|NCT02038920|453701995|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125923022|NCT00334958|453017017|FG001|Overall Study|Other|2|||
125923023|NCT03408483|453017023|FG000|Overall Study|Physician Decision|3|||
125923024|NCT03408483|453017024|FG001|Overall Study|Physician Decision|3|||
125923025|NCT03408483|453017023|FG000|Overall Study|Lost to Follow-up|3|||
125923026|NCT03408483|453017024|FG001|Overall Study|Lost to Follow-up|0|||
125923027|NCT00478231|453017025|FG000|Overall Study|Death|7|||
125923028|NCT00478231|453017025|FG000|Overall Study|Lack of Efficacy|47|||
125923029|NCT00478231|453017025|FG000|Overall Study|Lost to Follow-up|7|||
125923030|NCT00478231|453017025|FG000|Overall Study|Withdrawal by Subject|6|||
125923031|NCT00478231|453017025|FG000|Overall Study|Other|9|||
125923032|NCT00478231|453017025|FG000|Overall Study|Adverse Event|5|||
125923033|NCT00478231|453017025|FG000|Overall Study|Randomized, not treated|3|||
125923034|NCT00824720|453017027|FG000|Overall Study|failed plug insertion|3|||
125923035|NCT00824720|453017028|FG001|Overall Study|failed plug insertion|1|||
125923036|NCT00824720|453017029|FG002|Overall Study|failed plug insertion|0|||
125923037|NCT00824720|453017027|FG000|Overall Study|Protocol Violation|0|||
125923038|NCT00824720|453017028|FG001|Overall Study|Protocol Violation|0|||
126111049|NCT02038920|453701996|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
126111050|NCT02038920|453701991|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126111051|NCT02038920|453701992|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126111052|NCT02038920|453701993|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126111053|NCT02038920|453701994|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126111054|NCT02038920|453701995|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126111055|NCT02038920|453701996|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
126111056|NCT02038920|453701991|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126111057|NCT02038920|453701992|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126111058|NCT02038920|453701993|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126111059|NCT02038920|453701994|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126111060|NCT02038920|453701995|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126111061|NCT02038920|453701996|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
126111062|NCT02038920|453701991|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126111063|NCT02038920|453701992|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126111064|NCT02038920|453701993|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126111065|NCT02038920|453701994|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126111066|NCT02038920|453701995|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126111067|NCT02038920|453701996|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
126111068|NCT02038920|453701991|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126111069|NCT02038920|453701992|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126111070|NCT02038920|453701993|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126111071|NCT02038920|453701994|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126111072|NCT02038920|453701995|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126111073|NCT02038920|453701996|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
126111074|NCT02383589|453701997|FG000|Treatment Period|Adverse Event|1|||
126111075|NCT02383589|453701998|FG001|Treatment Period|Adverse Event|3|||
126111076|NCT02383589|453701997|FG000|Treatment Period|Lost to Follow-up|0|||
126111077|NCT02383589|453701998|FG001|Treatment Period|Lost to Follow-up|1|||
126111078|NCT02383589|453701997|FG000|Treatment Period|Withdrawal by Subject|0|||
126111079|NCT02383589|453701998|FG001|Treatment Period|Withdrawal by Subject|5|||
126111080|NCT02383589|453701997|FG000|Treatment Period|Non-compliance with study drug|0|||
126111081|NCT02383589|453701998|FG001|Treatment Period|Non-compliance with study drug|1|||
126111082|NCT02383589|453701997|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
126111083|NCT02383589|453701998|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
126111084|NCT02383589|453701997|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
126111085|NCT02383589|453701998|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
126111086|NCT02383589|453701997|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
126111087|NCT02383589|453701998|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
126111088|NCT00047320|453701999|FG000|Overall Study|Lack of Efficacy|8|||
126111089|NCT00047320|453701999|FG000|Overall Study|Lost to Follow-up|1|||
126111090|NCT00047320|453701999|FG000|Overall Study|Physician Decision|8|||
126111091|NCT00047320|453701999|FG000|Overall Study|Withdrawal by Subject|9|||
126111092|NCT00047320|453701999|FG000|Overall Study|Ineligible|2|||
126111093|NCT04376060|453702000|FG000|Overall Study|Physician Decision|1|||
126111094|NCT02818920|453702001|FG000|Overall Study|Unresectable|4|||
126111095|NCT02818920|453702001|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
126111096|NCT02818920|453702001|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
126111097|NCT02818920|453702001|FG000|Overall Study|Adverse Event|3|||
126111098|NCT02818920|453702001|FG000|Overall Study|Developed Other Disease|1|||
126111099|NCT02818920|453702001|FG000|Overall Study|Refused Further Treatment|1|||
126111100|NCT07052682|453702002|FG000|Overall Study|Withdrawal by Subject|4|||
126111101|NCT05460273|453702003|FG000|Overall Study|Death|43|||
126111102|NCT05460273|453702004|FG001|Overall Study|Death|9|||
126111103|NCT05460273|453702003|FG000|Overall Study|Lost to Follow-up|7|||
126111104|NCT05460273|453702004|FG001|Overall Study|Lost to Follow-up|0|||
126111105|NCT05460273|453702003|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
126111106|NCT05460273|453702004|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
125923039|NCT00824720|453017029|FG002|Overall Study|Protocol Violation|1|||
126111107|NCT04890054|453703583|FG000|Overall Study|Lost to Follow-up|202|||
126111108|NCT04890054|453703584|FG001|Overall Study|Lost to Follow-up|219|||
126111109|NCT01940354|453703585|FG000|Overall Study|Withdrawal by Subject|4|||
126111110|NCT01940354|453703586|FG001|Overall Study|Withdrawal by Subject|2|||
126111111|NCT03872453|453703587|FG000|Overall Study|Adverse Event|1|||
126111112|NCT03872453|453703588|FG001|Overall Study|Adverse Event|1|||
126111113|NCT03872453|453703589|FG002|Overall Study|Adverse Event|0|||
126111114|NCT03872453|453703590|FG003|Overall Study|Adverse Event|0|||
126111115|NCT03872453|453703587|FG000|Overall Study|Lost to Follow-up|8|||
126111116|NCT03872453|453703588|FG001|Overall Study|Lost to Follow-up|7|||
126111117|NCT03872453|453703589|FG002|Overall Study|Lost to Follow-up|4|||
126111118|NCT03872453|453703590|FG003|Overall Study|Lost to Follow-up|4|||
125923040|NCT02777333|453017035|FG000|Overall Study|Withdrawal by Subject|0|||
125923041|NCT02777333|453017036|FG001|Overall Study|Withdrawal by Subject|1|||
125923042|NCT02777333|453017035|FG000|Overall Study|Lost to Follow-up|0|||
125923043|NCT02777333|453017036|FG001|Overall Study|Lost to Follow-up|1|||
125923044|NCT00837811|453017037|FG000|Overall Study|Adverse Event|4|||
125923045|NCT00837811|453017038|FG001|Overall Study|Adverse Event|6|||
125923046|NCT00837811|453017039|FG002|Overall Study|Adverse Event|0|||
125923047|NCT00837811|453017037|FG000|Overall Study|Death|1|||
125923048|NCT00837811|453017038|FG001|Overall Study|Death|1|||
125923049|NCT00837811|453017039|FG002|Overall Study|Death|0|||
125923050|NCT00837811|453017037|FG000|Overall Study|Lack of Efficacy|0|||
125923051|NCT00837811|453017038|FG001|Overall Study|Lack of Efficacy|11|||
125923052|NCT00837811|453017039|FG002|Overall Study|Lack of Efficacy|0|||
125923053|NCT00837811|453017037|FG000|Overall Study|Lost to Follow-up|1|||
125923054|NCT00837811|453017038|FG001|Overall Study|Lost to Follow-up|3|||
125923055|NCT00837811|453017039|FG002|Overall Study|Lost to Follow-up|0|||
125923056|NCT00837811|453017037|FG000|Overall Study|Physician Decision|0|||
125923057|NCT00837811|453017038|FG001|Overall Study|Physician Decision|2|||
125923058|NCT00837811|453017039|FG002|Overall Study|Physician Decision|1|||
125923059|NCT00837811|453017037|FG000|Overall Study|Withdrawal by Subject|1|||
125923060|NCT00837811|453017038|FG001|Overall Study|Withdrawal by Subject|9|||
125923061|NCT00837811|453017039|FG002|Overall Study|Withdrawal by Subject|0|||
125923062|NCT00837811|453017037|FG000|Overall Study|Sponsor Decision|0|||
125923063|NCT00837811|453017038|FG001|Overall Study|Sponsor Decision|2|||
125923064|NCT00837811|453017039|FG002|Overall Study|Sponsor Decision|0|||
125923065|NCT04731363|453017040|FG000|Overall Study|Could not obtain samples|0|||
125923066|NCT04731363|453017041|FG001|Overall Study|Could not obtain samples|1|||
125923067|NCT04731363|453017042|FG002|Overall Study|Could not obtain samples|0|||
125923068|NCT04731363|453017043|FG003|Overall Study|Could not obtain samples|0|||
125923069|NCT04731363|453017040|FG000|Overall Study|Physician Decision|0|||
125923070|NCT04731363|453017041|FG001|Overall Study|Physician Decision|1|||
125923071|NCT04731363|453017042|FG002|Overall Study|Physician Decision|0|||
125923072|NCT04731363|453017043|FG003|Overall Study|Physician Decision|0|||
125923073|NCT02513394|453017044|FG000|Overall Study|Withdrawal by Subject|11|||
125923074|NCT02513394|453017045|FG001|Overall Study|Withdrawal by Subject|23|||
125923075|NCT02513394|453017044|FG000|Overall Study|Ineligible|1|||
125923076|NCT02513394|453017045|FG001|Overall Study|Ineligible|0|||
125923077|NCT04292743|453017046|FG000|Overall Study|Physician Decision|1|||
125923078|NCT04292743|453017047|FG001|Overall Study|Physician Decision|3|||
125923079|NCT04292743|453017048|FG002|Overall Study|Physician Decision|0|||
125923080|NCT04292743|453017049|FG003|Overall Study|Physician Decision|0|||
125923081|NCT04292743|453017046|FG000|Overall Study|Withdrawal by Subject|0|||
125923082|NCT04292743|453017047|FG001|Overall Study|Withdrawal by Subject|5|||
125923083|NCT04292743|453017048|FG002|Overall Study|Withdrawal by Subject|0|||
125923084|NCT04292743|453017049|FG003|Overall Study|Withdrawal by Subject|0|||
125923085|NCT04292743|453017046|FG000|Overall Study|Death|0|||
125923086|NCT04292743|453017047|FG001|Overall Study|Death|1|||
125923087|NCT04292743|453017048|FG002|Overall Study|Death|0|||
125923088|NCT04292743|453017049|FG003|Overall Study|Death|0|||
125923089|NCT04292743|453017046|FG000|Overall Study|Progression of Disease|2|||
125923090|NCT04292743|453017047|FG001|Overall Study|Progression of Disease|5|||
125923091|NCT04292743|453017048|FG002|Overall Study|Progression of Disease|0|||
125923092|NCT04292743|453017049|FG003|Overall Study|Progression of Disease|0|||
125923093|NCT04292743|453017046|FG000|Overall Study|No Treatment per protocol|0|||
125923094|NCT04292743|453017047|FG001|Overall Study|No Treatment per protocol|2|||
125923095|NCT04292743|453017048|FG002|Overall Study|No Treatment per protocol|0|||
125923096|NCT04292743|453017049|FG003|Overall Study|No Treatment per protocol|0|||
125923097|NCT05766423|453017050|FG000|Overall Study|Withdrawal by Subject|1|||
125923098|NCT05766423|453017051|FG001|Overall Study|Withdrawal by Subject|0|||
125923099|NCT05766423|453017050|FG000|Overall Study|Consented, not scheduled|3|||
125923100|NCT05766423|453017051|FG001|Overall Study|Consented, not scheduled|5|||
125923101|NCT00688753|453019187|FG000|Overall Study|Disease progression|55|||
125923102|NCT00688753|453019187|FG000|Overall Study|Missing|1|||
125923103|NCT00688753|453019187|FG000|Overall Study|Death|9|||
125923104|NCT00688753|453019187|FG000|Overall Study|Withdrawal by Subject|3|||
125923105|NCT00688753|453019187|FG000|Overall Study|Adverse Event|20|||
125923106|NCT00688753|453019187|FG000|Overall Study|Protocol Violation|1|||
125923107|NCT00688753|453019187|FG000|Overall Study|Lost to Follow-up|3|||
125923108|NCT03187197|453019189|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
125923109|NCT03187197|453019190|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
125923110|NCT03187197|453019191|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
125923111|NCT03187197|453019189|FG000|Overall Study|Withdrawal by Subject|8|||
125923112|NCT03187197|453019190|FG001|Overall Study|Withdrawal by Subject|63|||
125923113|NCT03187197|453019191|FG002|Overall Study|Withdrawal by Subject|4|||
125923114|NCT03187197|453019189|FG000|Overall Study|Lost to Follow-up|1|||
125923115|NCT03187197|453019190|FG001|Overall Study|Lost to Follow-up|60|||
125923116|NCT03187197|453019191|FG002|Overall Study|Lost to Follow-up|7|||
125923117|NCT03187197|453019189|FG000|Overall Study|Adverse Event|6|||
125923118|NCT03187197|453019190|FG001|Overall Study|Adverse Event|29|||
125923119|NCT03187197|453019191|FG002|Overall Study|Adverse Event|0|||
125923120|NCT03187197|453019189|FG000|Overall Study|Death|0|||
125923121|NCT03187197|453019190|FG001|Overall Study|Death|11|||
126111119|NCT03872453|453703587|FG000|Overall Study|Never Treated Migraine|19|||
126111120|NCT03872453|453703588|FG001|Overall Study|Never Treated Migraine|17|||
126111121|NCT03872453|453703589|FG002|Overall Study|Never Treated Migraine|13|||
126111122|NCT03872453|453703590|FG003|Overall Study|Never Treated Migraine|12|||
126111123|NCT03872453|453703587|FG000|Overall Study|Pregnancy|1|||
126111124|NCT03872453|453703588|FG001|Overall Study|Pregnancy|0|||
126111125|NCT03872453|453703589|FG002|Overall Study|Pregnancy|0|||
126111126|NCT03872453|453703590|FG003|Overall Study|Pregnancy|0|||
126111127|NCT03872453|453703587|FG000|Overall Study|Protocol Deviation|2|||
126111128|NCT03872453|453703588|FG001|Overall Study|Protocol Deviation|0|||
126111129|NCT03872453|453703589|FG002|Overall Study|Protocol Deviation|0|||
126111130|NCT03872453|453703590|FG003|Overall Study|Protocol Deviation|2|||
126111131|NCT03872453|453703587|FG000|Overall Study|Withdrawal by Subject|0|||
126111132|NCT03872453|453703588|FG001|Overall Study|Withdrawal by Subject|1|||
126111133|NCT03872453|453703589|FG002|Overall Study|Withdrawal by Subject|2|||
126111134|NCT03872453|453703590|FG003|Overall Study|Withdrawal by Subject|0|||
126111135|NCT03872453|453703587|FG000|Overall Study|Other Than Specified|1|||
126111136|NCT03872453|453703588|FG001|Overall Study|Other Than Specified|0|||
126111137|NCT03872453|453703589|FG002|Overall Study|Other Than Specified|0|||
126111138|NCT03872453|453703590|FG003|Overall Study|Other Than Specified|0|||
126111139|NCT00352885|453703591|FG000|Overall Study|Withdrawal by Subject|0|||
126111140|NCT00352885|453703592|FG001|Overall Study|Withdrawal by Subject|3|||
126111141|NCT00352885|453703591|FG000|Overall Study|Development of major depression|0|||
126111142|NCT00352885|453703592|FG001|Overall Study|Development of major depression|1|||
126111143|NCT00352885|453703591|FG000|Overall Study|Progression of metastatic melanoma|5|||
126111144|NCT00352885|453703592|FG001|Overall Study|Progression of metastatic melanoma|3|||
126111145|NCT00352885|453703591|FG000|Overall Study|Side effects of IL-2 administration|1|||
126111146|NCT00352885|453703592|FG001|Overall Study|Side effects of IL-2 administration|0|||
126111147|NCT03873493|453703593|FG000|Overall Study|Withdrawal by Subject|1|||
126111148|NCT03873493|453703593|FG000|Overall Study|Death|9|||
126111149|NCT03873493|453703593|FG000|Overall Study|Lost to Follow-up|1|||
126111150|NCT03873493|453703593|FG000|Overall Study|Study Terminated by Sponsor|1|||
126111151|NCT03873493|453703593|FG000|Overall Study|Other|2|||
126111152|NCT00440700|453703597|FG000|Overall Study|Withdrawal by Subject|8|||
126111153|NCT00440700|453703598|FG001|Overall Study|Withdrawal by Subject|8|||
126111154|NCT00440700|453703599|FG002|Overall Study|Withdrawal by Subject|4|||
126111155|NCT01423812|453703600|FG000|Overall Study|Lost to Follow-up|2|||
126111156|NCT01423812|453703601|FG001|Overall Study|Lost to Follow-up|2|||
126111157|NCT01423812|453703600|FG000|Overall Study|Withdrawal by Subject|1|||
126111158|NCT01423812|453703601|FG001|Overall Study|Withdrawal by Subject|2|||
126111159|NCT01179672|453703602|FG000|Overall Study|Adverse Event|17|||
126111160|NCT01179672|453703603|FG001|Overall Study|Adverse Event|8|||
126111161|NCT01179672|453703602|FG000|Overall Study|Withdrawal by Subject|10|||
126111162|NCT01179672|453703603|FG001|Overall Study|Withdrawal by Subject|12|||
126111163|NCT01179672|453703602|FG000|Overall Study|Entry Criteria Not Met|0|||
126111164|NCT01179672|453703603|FG001|Overall Study|Entry Criteria Not Met|2|||
126111165|NCT01179672|453703602|FG000|Overall Study|Lost to Follow-up|0|||
126111166|NCT01179672|453703603|FG001|Overall Study|Lost to Follow-up|1|||
126111167|NCT01179672|453703602|FG000|Overall Study|Protocol Violation|2|||
126111168|NCT01179672|453703603|FG001|Overall Study|Protocol Violation|2|||
126111169|NCT01179672|453703602|FG000|Overall Study|Physician Decision|1|||
126111170|NCT01179672|453703603|FG001|Overall Study|Physician Decision|1|||
126111171|NCT02748018|453703606|FG000|Study Period|Adverse Event|1|||
126111172|NCT02748018|453703607|FG001|Study Period|Adverse Event|3|||
126111173|NCT02748018|453703608|FG002|Study Period|Adverse Event|4|||
126111174|NCT02748018|453703609|FG003|Study Period|Adverse Event|0|||
126111175|NCT02748018|453703610|FG004|Study Period|Adverse Event|3|||
126111176|NCT02748018|453703611|FG005|Study Period|Adverse Event|3|||
126111177|NCT02748018|453703606|FG000|Study Period|Withdrawal by Subject|7|||
126111178|NCT02748018|453703607|FG001|Study Period|Withdrawal by Subject|4|||
126111179|NCT02748018|453703608|FG002|Study Period|Withdrawal by Subject|4|||
126111180|NCT02748018|453703609|FG003|Study Period|Withdrawal by Subject|11|||
126111181|NCT02748018|453703610|FG004|Study Period|Withdrawal by Subject|12|||
126111182|NCT02748018|453703611|FG005|Study Period|Withdrawal by Subject|10|||
126111183|NCT02748018|453703606|FG000|Study Period|Pregnancy|0|||
126111184|NCT02748018|453703607|FG001|Study Period|Pregnancy|1|||
126111185|NCT02748018|453703608|FG002|Study Period|Pregnancy|0|||
126111186|NCT02748018|453703609|FG003|Study Period|Pregnancy|0|||
126111187|NCT02748018|453703610|FG004|Study Period|Pregnancy|1|||
126111188|NCT02748018|453703611|FG005|Study Period|Pregnancy|0|||
126111189|NCT02748018|453703606|FG000|Study Period|Physician Decision|2|||
126111190|NCT02748018|453703607|FG001|Study Period|Physician Decision|2|||
126111191|NCT02748018|453703608|FG002|Study Period|Physician Decision|1|||
126111192|NCT02748018|453703609|FG003|Study Period|Physician Decision|0|||
126111193|NCT02748018|453703610|FG004|Study Period|Physician Decision|2|||
126111194|NCT02748018|453703611|FG005|Study Period|Physician Decision|0|||
126111195|NCT02748018|453703606|FG000|Study Period|Lost to Follow-up|0|||
126111196|NCT02748018|453703607|FG001|Study Period|Lost to Follow-up|0|||
126111197|NCT02748018|453703608|FG002|Study Period|Lost to Follow-up|0|||
125923122|NCT03187197|453019191|FG002|Overall Study|Death|0|||
125923123|NCT03187197|453019189|FG000|Overall Study|Administrative problem|1|||
125923124|NCT03187197|453019190|FG001|Overall Study|Administrative problem|1|||
125923125|NCT03187197|453019191|FG002|Overall Study|Administrative problem|0|||
125923126|NCT03187197|453019189|FG000|Overall Study|Reason not listed|2|||
125923127|NCT03187197|453019190|FG001|Overall Study|Reason not listed|54|||
125923128|NCT03187197|453019191|FG002|Overall Study|Reason not listed|1|||
125923129|NCT03187197|453019189|FG000|Overall Study|Missing|1|||
125923130|NCT03187197|453019190|FG001|Overall Study|Missing|32|||
125923131|NCT03187197|453019191|FG002|Overall Study|Missing|3|||
125923132|NCT03187197|453019189|FG000|Overall Study|Status missing|2|||
125923133|NCT03187197|453019190|FG001|Overall Study|Status missing|33|||
125923134|NCT03187197|453019191|FG002|Overall Study|Status missing|3|||
125923135|NCT03187197|453019189|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
125923136|NCT03187197|453019190|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
125923137|NCT03187197|453019191|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
125923138|NCT02385045|453019192|FG000|Overall Study|Endoscopy could not be completed|4|||
125923139|NCT02200211|453019193|FG000|Overall Study|Lost to Follow-up|7|||
125923140|NCT02200211|453019194|FG001|Overall Study|Lost to Follow-up|7|||
125923141|NCT02200211|453019195|FG002|Overall Study|Lost to Follow-up|1|||
125923142|NCT02200211|453019196|FG003|Overall Study|Lost to Follow-up|2|||
125923143|NCT02200211|453019193|FG000|Overall Study|Withdrawal by Subject|1|||
125923144|NCT02200211|453019194|FG001|Overall Study|Withdrawal by Subject|0|||
125923145|NCT02200211|453019195|FG002|Overall Study|Withdrawal by Subject|0|||
125923146|NCT02200211|453019196|FG003|Overall Study|Withdrawal by Subject|0|||
125923147|NCT00042289|453019197|FG000|Overall Study|Lost to Follow-up|3|||
125923148|NCT00042289|453019198|FG001|Overall Study|Lost to Follow-up|0|||
125923149|NCT00042289|453019199|FG002|Overall Study|Lost to Follow-up|0|||
125923150|NCT00042289|453019200|FG003|Overall Study|Lost to Follow-up|1|||
125923151|NCT00042289|453019201|FG004|Overall Study|Lost to Follow-up|3|||
125923152|NCT00042289|453019202|FG005|Overall Study|Lost to Follow-up|3|||
125923153|NCT00042289|453019203|FG006|Overall Study|Lost to Follow-up|6|||
125923154|NCT00042289|453019204|FG007|Overall Study|Lost to Follow-up|1|||
125923155|NCT00042289|453019205|FG008|Overall Study|Lost to Follow-up|1|||
125923156|NCT00042289|453019206|FG009|Overall Study|Lost to Follow-up|0|||
125923157|NCT00042289|453019207|FG010|Overall Study|Lost to Follow-up|0|||
125923158|NCT00042289|453019208|FG011|Overall Study|Lost to Follow-up|0|||
125923159|NCT00042289|453019209|FG012|Overall Study|Lost to Follow-up|0|||
125923160|NCT00042289|453019210|FG013|Overall Study|Lost to Follow-up|0|||
125923161|NCT00042289|453019211|FG014|Overall Study|Lost to Follow-up|0|||
125923162|NCT00042289|453019212|FG015|Overall Study|Lost to Follow-up|1|||
125923163|NCT00042289|453019213|FG016|Overall Study|Lost to Follow-up|1|||
125923164|NCT00042289|453019214|FG017|Overall Study|Lost to Follow-up|0|||
125923165|NCT00042289|453019215|FG018|Overall Study|Lost to Follow-up|3|||
125923166|NCT00042289|453019216|FG019|Overall Study|Lost to Follow-up|2|||
125923167|NCT00042289|453019217|FG020|Overall Study|Lost to Follow-up|0|||
125923168|NCT00042289|453019218|FG021|Overall Study|Lost to Follow-up|0|||
125923169|NCT00042289|453019219|FG022|Overall Study|Lost to Follow-up|0|||
125923170|NCT00042289|453019220|FG023|Overall Study|Lost to Follow-up|0|||
125923171|NCT00042289|453019221|FG024|Overall Study|Lost to Follow-up|0|||
125923172|NCT00042289|453019222|FG025|Overall Study|Lost to Follow-up|0|||
126111198|NCT02748018|453703609|FG003|Study Period|Lost to Follow-up|2|||
125923173|NCT00042289|453019223|FG026|Overall Study|Lost to Follow-up|2|||
125923174|NCT00042289|453019224|FG027|Overall Study|Lost to Follow-up|2|||
125923175|NCT00042289|453019225|FG028|Overall Study|Lost to Follow-up|2|||
125923176|NCT00042289|453019226|FG029|Overall Study|Lost to Follow-up|0|||
125923177|NCT00042289|453019227|FG030|Overall Study|Lost to Follow-up|0|||
125923178|NCT00042289|453019228|FG031|Overall Study|Lost to Follow-up|2|||
125923179|NCT00042289|453019229|FG032|Overall Study|Lost to Follow-up|1|||
125923180|NCT00042289|453019230|FG033|Overall Study|Lost to Follow-up|1|||
126111199|NCT02748018|453703610|FG004|Study Period|Lost to Follow-up|0|||
126111200|NCT02748018|453703611|FG005|Study Period|Lost to Follow-up|1|||
125923181|NCT00042289|453019231|FG034|Overall Study|Lost to Follow-up|1|||
125923182|NCT00042289|453019232|FG035|Overall Study|Lost to Follow-up|2|||
126111201|NCT02748018|453703606|FG000|Continuation Period|Adverse Event|2|||
125923183|NCT00042289|453019233|FG036|Overall Study|Lost to Follow-up|1|||
125923184|NCT00042289|453019234|FG037|Overall Study|Lost to Follow-up|1|||
125923185|NCT00042289|453019235|FG038|Overall Study|Lost to Follow-up|0|||
125923186|NCT00042289|453019236|FG039|Overall Study|Lost to Follow-up|5|||
125923187|NCT00042289|453019237|FG040|Overall Study|Lost to Follow-up|0|||
125923188|NCT00042289|453019238|FG041|Overall Study|Lost to Follow-up|2|||
125923189|NCT00042289|453019239|FG042|Overall Study|Lost to Follow-up|2|||
126111202|NCT02748018|453703607|FG001|Continuation Period|Adverse Event|0|||
125923190|NCT00042289|453019240|FG043|Overall Study|Lost to Follow-up|0|||
125923191|NCT00042289|453019241|FG044|Overall Study|Lost to Follow-up|0|||
125923192|NCT00042289|453019242|FG045|Overall Study|Lost to Follow-up|1|||
125923193|NCT00042289|453019243|FG046|Overall Study|Lost to Follow-up|0|||
125923194|NCT00042289|453019197|FG000|Overall Study|Other reason|0|||
125923195|NCT00042289|453019198|FG001|Overall Study|Other reason|0|||
125923196|NCT00042289|453019199|FG002|Overall Study|Other reason|0|||
126111203|NCT02748018|453703608|FG002|Continuation Period|Adverse Event|1|||
126111204|NCT02748018|453703609|FG003|Continuation Period|Adverse Event|1|||
126111205|NCT02748018|453703610|FG004|Continuation Period|Adverse Event|1|||
126111206|NCT02748018|453703611|FG005|Continuation Period|Adverse Event|4|||
126111207|NCT02748018|453703606|FG000|Continuation Period|Withdrawal by Subject|3|||
126111208|NCT02748018|453703607|FG001|Continuation Period|Withdrawal by Subject|5|||
126111209|NCT02748018|453703608|FG002|Continuation Period|Withdrawal by Subject|3|||
126111210|NCT02748018|453703609|FG003|Continuation Period|Withdrawal by Subject|9|||
126111211|NCT02748018|453703610|FG004|Continuation Period|Withdrawal by Subject|11|||
126111212|NCT02748018|453703611|FG005|Continuation Period|Withdrawal by Subject|1|||
126111213|NCT02748018|453703606|FG000|Continuation Period|Lost to Follow-up|0|||
126111214|NCT02748018|453703607|FG001|Continuation Period|Lost to Follow-up|2|||
126111215|NCT02748018|453703608|FG002|Continuation Period|Lost to Follow-up|1|||
126111216|NCT02748018|453703609|FG003|Continuation Period|Lost to Follow-up|0|||
126111217|NCT02748018|453703610|FG004|Continuation Period|Lost to Follow-up|1|||
126111218|NCT02748018|453703611|FG005|Continuation Period|Lost to Follow-up|0|||
126111219|NCT02748018|453703606|FG000|Continuation Period|Pregnancy|1|||
126111220|NCT02748018|453703607|FG001|Continuation Period|Pregnancy|2|||
126111221|NCT02748018|453703608|FG002|Continuation Period|Pregnancy|0|||
126111222|NCT02748018|453703609|FG003|Continuation Period|Pregnancy|0|||
126111223|NCT02748018|453703610|FG004|Continuation Period|Pregnancy|0|||
126111224|NCT02748018|453703611|FG005|Continuation Period|Pregnancy|0|||
126111225|NCT02748018|453703606|FG000|Continuation Period|Physician Decision|0|||
126111226|NCT02748018|453703607|FG001|Continuation Period|Physician Decision|1|||
126111227|NCT02748018|453703608|FG002|Continuation Period|Physician Decision|2|||
126111228|NCT02748018|453703609|FG003|Continuation Period|Physician Decision|0|||
126111229|NCT02748018|453703610|FG004|Continuation Period|Physician Decision|2|||
126111230|NCT02748018|453703611|FG005|Continuation Period|Physician Decision|1|||
126111231|NCT02748018|453703606|FG000|Continuation Period|Protocol Violation|0|||
126111232|NCT02748018|453703607|FG001|Continuation Period|Protocol Violation|1|||
126111233|NCT02748018|453703608|FG002|Continuation Period|Protocol Violation|0|||
126111234|NCT02748018|453703609|FG003|Continuation Period|Protocol Violation|0|||
126111235|NCT02748018|453703610|FG004|Continuation Period|Protocol Violation|0|||
126111236|NCT02748018|453703611|FG005|Continuation Period|Protocol Violation|0|||
126111237|NCT02315898|453703612|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
126111238|NCT02315898|453703613|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
126111239|NCT02315898|453703614|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
126111240|NCT02315898|453703615|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
126111241|NCT00578786|453703625|FG000|Overall Study|Adverse Event|27|||
126111242|NCT00578786|453703626|FG001|Overall Study|Adverse Event|37|||
126111243|NCT00578786|453703627|FG002|Overall Study|Adverse Event|17|||
126111244|NCT00578786|453703625|FG000|Overall Study|Lack of Efficacy|2|||
126111245|NCT00578786|453703626|FG001|Overall Study|Lack of Efficacy|5|||
126111246|NCT00578786|453703627|FG002|Overall Study|Lack of Efficacy|2|||
126111247|NCT00578786|453703625|FG000|Overall Study|Early Escape from Prior Study|2|||
126111248|NCT00578786|453703626|FG001|Overall Study|Early Escape from Prior Study|1|||
126111249|NCT00578786|453703627|FG002|Overall Study|Early Escape from Prior Study|2|||
126111250|NCT00578786|453703625|FG000|Overall Study|Withdrawal by Subject|7|||
126111251|NCT00578786|453703626|FG001|Overall Study|Withdrawal by Subject|8|||
126111252|NCT00578786|453703627|FG002|Overall Study|Withdrawal by Subject|5|||
126111253|NCT00578786|453703625|FG000|Overall Study|Protocol Violation|0|||
126111254|NCT00578786|453703626|FG001|Overall Study|Protocol Violation|3|||
126111255|NCT00578786|453703627|FG002|Overall Study|Protocol Violation|1|||
126111256|NCT00578786|453703625|FG000|Overall Study|Physician Decision|1|||
126111257|NCT00578786|453703626|FG001|Overall Study|Physician Decision|0|||
126111258|NCT00578786|453703627|FG002|Overall Study|Physician Decision|1|||
126111259|NCT00578786|453703625|FG000|Overall Study|Sponsor Decision|0|||
126111260|NCT00578786|453703626|FG001|Overall Study|Sponsor Decision|0|||
126111261|NCT00578786|453703627|FG002|Overall Study|Sponsor Decision|1|||
126111262|NCT00578786|453703625|FG000|Overall Study|Lost to Follow-up|0|||
125923197|NCT00042289|453019200|FG003|Overall Study|Other reason|2|||
125923198|NCT00042289|453019201|FG004|Overall Study|Other reason|0|||
125923199|NCT00042289|453019202|FG005|Overall Study|Other reason|0|||
126111263|NCT00578786|453703626|FG001|Overall Study|Lost to Follow-up|4|||
126111264|NCT00578786|453703627|FG002|Overall Study|Lost to Follow-up|0|||
126111265|NCT00578786|453703625|FG000|Overall Study|Pregnancy|0|||
126111266|NCT00578786|453703626|FG001|Overall Study|Pregnancy|1|||
126111267|NCT00578786|453703627|FG002|Overall Study|Pregnancy|0|||
126111268|NCT00578786|453703625|FG000|Overall Study|Not Otherwise Specified|0|||
126111269|NCT00578786|453703626|FG001|Overall Study|Not Otherwise Specified|4|||
126111270|NCT00578786|453703627|FG002|Overall Study|Not Otherwise Specified|1|||
125923200|NCT00042289|453019203|FG006|Overall Study|Other reason|0|||
126111271|NCT00578786|453703625|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
126111272|NCT00578786|453703626|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
126111273|NCT00578786|453703627|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
125923201|NCT00042289|453019204|FG007|Overall Study|Other reason|0|||
125923202|NCT00042289|453019205|FG008|Overall Study|Other reason|0|||
125923203|NCT00042289|453019206|FG009|Overall Study|Other reason|0|||
125923204|NCT00042289|453019207|FG010|Overall Study|Other reason|0|||
125923205|NCT00042289|453019208|FG011|Overall Study|Other reason|0|||
125923206|NCT00042289|453019209|FG012|Overall Study|Other reason|0|||
125923207|NCT00042289|453019210|FG013|Overall Study|Other reason|0|||
125923208|NCT00042289|453019211|FG014|Overall Study|Other reason|0|||
125923209|NCT00042289|453019212|FG015|Overall Study|Other reason|0|||
125923210|NCT00042289|453019213|FG016|Overall Study|Other reason|0|||
125923211|NCT00042289|453019214|FG017|Overall Study|Other reason|0|||
125923212|NCT00042289|453019215|FG018|Overall Study|Other reason|1|||
125923213|NCT00042289|453019216|FG019|Overall Study|Other reason|0|||
125923214|NCT00042289|453019217|FG020|Overall Study|Other reason|0|||
125923215|NCT00042289|453019218|FG021|Overall Study|Other reason|0|||
125923216|NCT00042289|453019219|FG022|Overall Study|Other reason|0|||
125923217|NCT00042289|453019220|FG023|Overall Study|Other reason|1|||
125923218|NCT00042289|453019221|FG024|Overall Study|Other reason|0|||
125923219|NCT00042289|453019222|FG025|Overall Study|Other reason|0|||
125923220|NCT00042289|453019223|FG026|Overall Study|Other reason|1|||
125923221|NCT00042289|453019224|FG027|Overall Study|Other reason|0|||
125923222|NCT00042289|453019225|FG028|Overall Study|Other reason|3|||
125923223|NCT00042289|453019226|FG029|Overall Study|Other reason|0|||
125923224|NCT00042289|453019227|FG030|Overall Study|Other reason|0|||
125923225|NCT00042289|453019228|FG031|Overall Study|Other reason|1|||
125923226|NCT00042289|453019229|FG032|Overall Study|Other reason|0|||
125923227|NCT00042289|453019230|FG033|Overall Study|Other reason|1|||
125923228|NCT00042289|453019231|FG034|Overall Study|Other reason|0|||
125923229|NCT00042289|453019232|FG035|Overall Study|Other reason|2|||
125923230|NCT00042289|453019233|FG036|Overall Study|Other reason|0|||
125923231|NCT00042289|453019234|FG037|Overall Study|Other reason|0|||
125923232|NCT00042289|453019235|FG038|Overall Study|Other reason|0|||
125923233|NCT00042289|453019236|FG039|Overall Study|Other reason|0|||
125923234|NCT00042289|453019237|FG040|Overall Study|Other reason|0|||
125923235|NCT00042289|453019238|FG041|Overall Study|Other reason|0|||
125923236|NCT00042289|453019239|FG042|Overall Study|Other reason|0|||
125923237|NCT00042289|453019240|FG043|Overall Study|Other reason|1|||
125923238|NCT00042289|453019241|FG044|Overall Study|Other reason|0|||
125923239|NCT00042289|453019242|FG045|Overall Study|Other reason|0|||
125923240|NCT00042289|453019243|FG046|Overall Study|Other reason|0|||
125923241|NCT00042289|453019197|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125923242|NCT00042289|453019198|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125923243|NCT00042289|453019199|FG002|Overall Study|Severe debilitation, unable to continue|0|||
125923244|NCT00042289|453019200|FG003|Overall Study|Severe debilitation, unable to continue|0|||
125923245|NCT00042289|453019201|FG004|Overall Study|Severe debilitation, unable to continue|0|||
125923246|NCT00042289|453019202|FG005|Overall Study|Severe debilitation, unable to continue|0|||
125923247|NCT00042289|453019203|FG006|Overall Study|Severe debilitation, unable to continue|0|||
125923248|NCT00042289|453019204|FG007|Overall Study|Severe debilitation, unable to continue|0|||
125923249|NCT00042289|453019205|FG008|Overall Study|Severe debilitation, unable to continue|0|||
125923250|NCT00042289|453019206|FG009|Overall Study|Severe debilitation, unable to continue|0|||
125923251|NCT00042289|453019207|FG010|Overall Study|Severe debilitation, unable to continue|0|||
125923252|NCT00042289|453019208|FG011|Overall Study|Severe debilitation, unable to continue|0|||
125923253|NCT00042289|453019209|FG012|Overall Study|Severe debilitation, unable to continue|0|||
125923254|NCT00042289|453019210|FG013|Overall Study|Severe debilitation, unable to continue|0|||
125923255|NCT00042289|453019211|FG014|Overall Study|Severe debilitation, unable to continue|0|||
125923256|NCT00042289|453019212|FG015|Overall Study|Severe debilitation, unable to continue|0|||
125923257|NCT00042289|453019213|FG016|Overall Study|Severe debilitation, unable to continue|0|||
125923258|NCT00042289|453019214|FG017|Overall Study|Severe debilitation, unable to continue|0|||
125923259|NCT00042289|453019215|FG018|Overall Study|Severe debilitation, unable to continue|0|||
125923260|NCT00042289|453019216|FG019|Overall Study|Severe debilitation, unable to continue|0|||
125923261|NCT00042289|453019217|FG020|Overall Study|Severe debilitation, unable to continue|0|||
125923262|NCT00042289|453019218|FG021|Overall Study|Severe debilitation, unable to continue|1|||
126111274|NCT05105789|453703628|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
126111275|NCT00323297|453703631|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
125923263|NCT00042289|453019219|FG022|Overall Study|Severe debilitation, unable to continue|0|||
125923264|NCT00042289|453019220|FG023|Overall Study|Severe debilitation, unable to continue|1|||
125923265|NCT00042289|453019221|FG024|Overall Study|Severe debilitation, unable to continue|0|||
125923266|NCT00042289|453019222|FG025|Overall Study|Severe debilitation, unable to continue|0|||
125923267|NCT00042289|453019223|FG026|Overall Study|Severe debilitation, unable to continue|0|||
125923268|NCT00042289|453019224|FG027|Overall Study|Severe debilitation, unable to continue|1|||
125923269|NCT00042289|453019225|FG028|Overall Study|Severe debilitation, unable to continue|0|||
125923270|NCT00042289|453019226|FG029|Overall Study|Severe debilitation, unable to continue|0|||
125923271|NCT00042289|453019227|FG030|Overall Study|Severe debilitation, unable to continue|0|||
125923272|NCT00042289|453019228|FG031|Overall Study|Severe debilitation, unable to continue|1|||
125923273|NCT00042289|453019229|FG032|Overall Study|Severe debilitation, unable to continue|1|||
125923274|NCT00042289|453019230|FG033|Overall Study|Severe debilitation, unable to continue|0|||
125923275|NCT00042289|453019231|FG034|Overall Study|Severe debilitation, unable to continue|0|||
125923276|NCT00042289|453019232|FG035|Overall Study|Severe debilitation, unable to continue|0|||
125923277|NCT00042289|453019233|FG036|Overall Study|Severe debilitation, unable to continue|0|||
125923278|NCT00042289|453019234|FG037|Overall Study|Severe debilitation, unable to continue|0|||
125923279|NCT00042289|453019235|FG038|Overall Study|Severe debilitation, unable to continue|0|||
125923280|NCT00042289|453019236|FG039|Overall Study|Severe debilitation, unable to continue|0|||
125923281|NCT00042289|453019237|FG040|Overall Study|Severe debilitation, unable to continue|0|||
125923282|NCT00042289|453019238|FG041|Overall Study|Severe debilitation, unable to continue|0|||
125923283|NCT00042289|453019239|FG042|Overall Study|Severe debilitation, unable to continue|0|||
125923284|NCT00042289|453019240|FG043|Overall Study|Severe debilitation, unable to continue|0|||
125923285|NCT00042289|453019241|FG044|Overall Study|Severe debilitation, unable to continue|0|||
125923286|NCT00042289|453019242|FG045|Overall Study|Severe debilitation, unable to continue|0|||
125923287|NCT00042289|453019243|FG046|Overall Study|Severe debilitation, unable to continue|0|||
125923288|NCT00042289|453019197|FG000|Overall Study|Site closed|0|||
125923289|NCT00042289|453019198|FG001|Overall Study|Site closed|0|||
125923290|NCT00042289|453019199|FG002|Overall Study|Site closed|0|||
125923291|NCT00042289|453019200|FG003|Overall Study|Site closed|0|||
125923292|NCT00042289|453019201|FG004|Overall Study|Site closed|0|||
125923293|NCT00042289|453019202|FG005|Overall Study|Site closed|0|||
125923294|NCT00042289|453019203|FG006|Overall Study|Site closed|0|||
125923295|NCT00042289|453019204|FG007|Overall Study|Site closed|0|||
125923296|NCT00042289|453019205|FG008|Overall Study|Site closed|0|||
125923297|NCT00042289|453019206|FG009|Overall Study|Site closed|0|||
125923298|NCT00042289|453019207|FG010|Overall Study|Site closed|0|||
125923299|NCT00042289|453019208|FG011|Overall Study|Site closed|0|||
125923300|NCT00042289|453019209|FG012|Overall Study|Site closed|0|||
125923301|NCT00042289|453019210|FG013|Overall Study|Site closed|0|||
125923302|NCT00042289|453019211|FG014|Overall Study|Site closed|0|||
125923303|NCT00042289|453019212|FG015|Overall Study|Site closed|0|||
125923304|NCT00042289|453019213|FG016|Overall Study|Site closed|0|||
125923305|NCT00042289|453019214|FG017|Overall Study|Site closed|0|||
125923306|NCT00042289|453019215|FG018|Overall Study|Site closed|0|||
125923307|NCT00042289|453019216|FG019|Overall Study|Site closed|0|||
125923308|NCT00042289|453019217|FG020|Overall Study|Site closed|0|||
125923309|NCT00042289|453019218|FG021|Overall Study|Site closed|0|||
125923310|NCT00042289|453019219|FG022|Overall Study|Site closed|0|||
125923311|NCT00042289|453019220|FG023|Overall Study|Site closed|0|||
125923312|NCT00042289|453019221|FG024|Overall Study|Site closed|0|||
125923313|NCT00042289|453019222|FG025|Overall Study|Site closed|0|||
125923314|NCT00042289|453019223|FG026|Overall Study|Site closed|0|||
125923315|NCT00042289|453019224|FG027|Overall Study|Site closed|0|||
125923316|NCT00042289|453019225|FG028|Overall Study|Site closed|0|||
125923317|NCT00042289|453019226|FG029|Overall Study|Site closed|0|||
125923318|NCT00042289|453019227|FG030|Overall Study|Site closed|0|||
125923319|NCT00042289|453019228|FG031|Overall Study|Site closed|3|||
125923320|NCT00042289|453019229|FG032|Overall Study|Site closed|0|||
125923321|NCT00042289|453019230|FG033|Overall Study|Site closed|0|||
125923322|NCT00042289|453019231|FG034|Overall Study|Site closed|0|||
125923323|NCT00042289|453019232|FG035|Overall Study|Site closed|0|||
125923324|NCT00042289|453019233|FG036|Overall Study|Site closed|1|||
125923325|NCT00042289|453019234|FG037|Overall Study|Site closed|0|||
125923326|NCT00042289|453019235|FG038|Overall Study|Site closed|0|||
125923327|NCT00042289|453019236|FG039|Overall Study|Site closed|0|||
125923328|NCT00042289|453019237|FG040|Overall Study|Site closed|0|||
125923329|NCT00042289|453019238|FG041|Overall Study|Site closed|0|||
125923330|NCT00042289|453019239|FG042|Overall Study|Site closed|1|||
125923331|NCT00042289|453019240|FG043|Overall Study|Site closed|0|||
125923332|NCT00042289|453019241|FG044|Overall Study|Site closed|0|||
125923333|NCT00042289|453019242|FG045|Overall Study|Site closed|0|||
125923334|NCT00042289|453019243|FG046|Overall Study|Site closed|0|||
125923335|NCT00042289|453019197|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
125923336|NCT00042289|453019198|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
125923337|NCT00042289|453019199|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
125923338|NCT00042289|453019200|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
125923339|NCT00042289|453019201|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
125923340|NCT00042289|453019202|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
125923341|NCT00042289|453019203|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
125923342|NCT00042289|453019204|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
125923343|NCT00042289|453019205|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
125923344|NCT00042289|453019206|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
125923345|NCT00042289|453019207|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
125923346|NCT00042289|453019208|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
125923347|NCT00042289|453019209|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
125923348|NCT00042289|453019210|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
126111276|NCT00323297|453703632|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
126111277|NCT00323297|453703631|FG000|Part A (Double Blind Randomized)|Death|0|||
126111278|NCT00323297|453703632|FG001|Part A (Double Blind Randomized)|Death|1|||
126111279|NCT00323297|453703631|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
126111280|NCT00323297|453703632|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
126111281|NCT00323297|453703631|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
126111282|NCT00323297|453703632|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
126111283|NCT00323297|453703631|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
126111284|NCT00323297|453703632|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
126111285|NCT00323297|453703631|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
126111286|NCT00323297|453703632|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
126111287|NCT00323297|453703631|FG000|Part B (Open-label)|Death|0|||
126111288|NCT00323297|453703632|FG001|Part B (Open-label)|Death|1|||
126111289|NCT00323297|453703631|FG000|Part B (Open-label)|Reason unspecified|0|||
126111290|NCT00323297|453703632|FG001|Part B (Open-label)|Reason unspecified|1|||
126111291|NCT00323297|453703631|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
126111292|NCT00323297|453703632|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
126111293|NCT00323297|453703631|FG000|Part B (Open-label)|Lack of Efficacy|3|||
126111294|NCT00323297|453703632|FG001|Part B (Open-label)|Lack of Efficacy|1|||
126111295|NCT00323297|453703631|FG000|Part B (Open-label)|Adverse Event|5|||
126111296|NCT00323297|453703632|FG001|Part B (Open-label)|Adverse Event|5|||
126111297|NCT00323297|453703631|FG000|Part B (Open-label)|Protocol Violation|0|||
126111298|NCT00323297|453703632|FG001|Part B (Open-label)|Protocol Violation|1|||
126111299|NCT01003990|453703633|FG000|Overall Study|Adverse Event|8|||
126111300|NCT01003990|453703634|FG001|Overall Study|Adverse Event|5|||
125923349|NCT00042289|453019211|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
125923350|NCT00042289|453019212|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
125923351|NCT00042289|453019213|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
125923352|NCT00042289|453019214|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
125923353|NCT00042289|453019215|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
125923354|NCT00042289|453019216|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
125923355|NCT00042289|453019217|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
125923356|NCT00042289|453019218|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
125923357|NCT00042289|453019219|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
125923358|NCT00042289|453019220|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
125923359|NCT00042289|453019221|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
125923360|NCT00042289|453019222|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
125923361|NCT00042289|453019223|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
125923362|NCT00042289|453019224|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
125923363|NCT00042289|453019225|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
125923364|NCT00042289|453019226|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
125923365|NCT00042289|453019227|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
125923366|NCT00042289|453019228|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
125923367|NCT00042289|453019229|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
125923368|NCT00042289|453019230|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
125923369|NCT00042289|453019231|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
125923370|NCT00042289|453019232|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
125923371|NCT00042289|453019233|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
125923372|NCT00042289|453019234|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
125923373|NCT00042289|453019235|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
125923374|NCT00042289|453019236|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
125923375|NCT00042289|453019237|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
125923376|NCT00042289|453019238|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
125923377|NCT00042289|453019239|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
125923378|NCT00042289|453019240|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
125923379|NCT00042289|453019241|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
125923380|NCT00042289|453019242|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
125923381|NCT00042289|453019243|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
125923382|NCT00042289|453019197|FG000|Overall Study|Protocol Violation|0|||
125923383|NCT00042289|453019198|FG001|Overall Study|Protocol Violation|0|||
126111301|NCT01003990|453703635|FG002|Overall Study|Adverse Event|11|||
126111302|NCT01003990|453703633|FG000|Overall Study|Death|0|||
126111303|NCT01003990|453703634|FG001|Overall Study|Death|8|||
126111304|NCT01003990|453703635|FG002|Overall Study|Death|1|||
126111305|NCT01003990|453703633|FG000|Overall Study|Lack of Efficacy|10|||
126111306|NCT01003990|453703634|FG001|Overall Study|Lack of Efficacy|2|||
126111307|NCT01003990|453703635|FG002|Overall Study|Lack of Efficacy|3|||
126111308|NCT01003990|453703633|FG000|Overall Study|Lost to Follow-up|30|||
125923384|NCT00042289|453019199|FG002|Overall Study|Protocol Violation|0|||
125923385|NCT00042289|453019200|FG003|Overall Study|Protocol Violation|0|||
125923386|NCT00042289|453019201|FG004|Overall Study|Protocol Violation|0|||
125923387|NCT00042289|453019202|FG005|Overall Study|Protocol Violation|1|||
125923388|NCT00042289|453019203|FG006|Overall Study|Protocol Violation|0|||
125923389|NCT00042289|453019204|FG007|Overall Study|Protocol Violation|1|||
125923390|NCT00042289|453019205|FG008|Overall Study|Protocol Violation|0|||
125923391|NCT00042289|453019206|FG009|Overall Study|Protocol Violation|0|||
125923392|NCT00042289|453019207|FG010|Overall Study|Protocol Violation|0|||
125923393|NCT00042289|453019208|FG011|Overall Study|Protocol Violation|0|||
125923394|NCT00042289|453019209|FG012|Overall Study|Protocol Violation|0|||
125923395|NCT00042289|453019210|FG013|Overall Study|Protocol Violation|0|||
125923396|NCT00042289|453019211|FG014|Overall Study|Protocol Violation|0|||
125923397|NCT00042289|453019212|FG015|Overall Study|Protocol Violation|0|||
125923398|NCT00042289|453019213|FG016|Overall Study|Protocol Violation|0|||
125923399|NCT00042289|453019214|FG017|Overall Study|Protocol Violation|0|||
125923400|NCT00042289|453019215|FG018|Overall Study|Protocol Violation|0|||
125923401|NCT00042289|453019216|FG019|Overall Study|Protocol Violation|0|||
125923402|NCT00042289|453019217|FG020|Overall Study|Protocol Violation|0|||
125923403|NCT00042289|453019218|FG021|Overall Study|Protocol Violation|0|||
125923404|NCT00042289|453019219|FG022|Overall Study|Protocol Violation|0|||
125923405|NCT00042289|453019220|FG023|Overall Study|Protocol Violation|1|||
125923406|NCT00042289|453019221|FG024|Overall Study|Protocol Violation|1|||
125923407|NCT00042289|453019222|FG025|Overall Study|Protocol Violation|0|||
125923408|NCT00042289|453019223|FG026|Overall Study|Protocol Violation|2|||
125923409|NCT00042289|453019224|FG027|Overall Study|Protocol Violation|0|||
125923410|NCT00042289|453019225|FG028|Overall Study|Protocol Violation|0|||
125923411|NCT00042289|453019226|FG029|Overall Study|Protocol Violation|0|||
125923412|NCT00042289|453019227|FG030|Overall Study|Protocol Violation|1|||
125923413|NCT00042289|453019228|FG031|Overall Study|Protocol Violation|0|||
125923414|NCT00042289|453019229|FG032|Overall Study|Protocol Violation|0|||
125923415|NCT00042289|453019230|FG033|Overall Study|Protocol Violation|0|||
125923416|NCT00042289|453019231|FG034|Overall Study|Protocol Violation|0|||
125923417|NCT00042289|453019232|FG035|Overall Study|Protocol Violation|0|||
125923418|NCT00042289|453019233|FG036|Overall Study|Protocol Violation|0|||
125923419|NCT00042289|453019234|FG037|Overall Study|Protocol Violation|0|||
125923420|NCT00042289|453019235|FG038|Overall Study|Protocol Violation|0|||
125923421|NCT00042289|453019236|FG039|Overall Study|Protocol Violation|0|||
125923422|NCT00042289|453019237|FG040|Overall Study|Protocol Violation|0|||
125923423|NCT00042289|453019238|FG041|Overall Study|Protocol Violation|1|||
125923424|NCT00042289|453019239|FG042|Overall Study|Protocol Violation|1|||
125923425|NCT00042289|453019240|FG043|Overall Study|Protocol Violation|1|||
125923426|NCT00042289|453019241|FG044|Overall Study|Protocol Violation|0|||
125923427|NCT00042289|453019242|FG045|Overall Study|Protocol Violation|0|||
125923428|NCT00042289|453019243|FG046|Overall Study|Protocol Violation|0|||
125923429|NCT00042289|453019197|FG000|Overall Study|Withdrawal by Subject|4|||
125923430|NCT00042289|453019198|FG001|Overall Study|Withdrawal by Subject|1|||
125923431|NCT00042289|453019199|FG002|Overall Study|Withdrawal by Subject|0|||
125923432|NCT00042289|453019200|FG003|Overall Study|Withdrawal by Subject|2|||
125923433|NCT00042289|453019201|FG004|Overall Study|Withdrawal by Subject|0|||
125923434|NCT00042289|453019202|FG005|Overall Study|Withdrawal by Subject|2|||
125923435|NCT00042289|453019203|FG006|Overall Study|Withdrawal by Subject|0|||
125923436|NCT00042289|453019204|FG007|Overall Study|Withdrawal by Subject|0|||
125923437|NCT00042289|453019205|FG008|Overall Study|Withdrawal by Subject|0|||
125923438|NCT00042289|453019206|FG009|Overall Study|Withdrawal by Subject|1|||
125923439|NCT00042289|453019207|FG010|Overall Study|Withdrawal by Subject|0|||
125923440|NCT00042289|453019208|FG011|Overall Study|Withdrawal by Subject|0|||
125923441|NCT00042289|453019209|FG012|Overall Study|Withdrawal by Subject|2|||
125923442|NCT00042289|453019210|FG013|Overall Study|Withdrawal by Subject|0|||
125923443|NCT00042289|453019211|FG014|Overall Study|Withdrawal by Subject|0|||
125923444|NCT00042289|453019212|FG015|Overall Study|Withdrawal by Subject|0|||
125923445|NCT00042289|453019213|FG016|Overall Study|Withdrawal by Subject|0|||
125923446|NCT00042289|453019214|FG017|Overall Study|Withdrawal by Subject|0|||
125923447|NCT00042289|453019215|FG018|Overall Study|Withdrawal by Subject|0|||
125923448|NCT00042289|453019216|FG019|Overall Study|Withdrawal by Subject|0|||
125923449|NCT00042289|453019217|FG020|Overall Study|Withdrawal by Subject|0|||
125923450|NCT00042289|453019218|FG021|Overall Study|Withdrawal by Subject|1|||
125923451|NCT00042289|453019219|FG022|Overall Study|Withdrawal by Subject|1|||
125923452|NCT00042289|453019220|FG023|Overall Study|Withdrawal by Subject|1|||
125923453|NCT00042289|453019221|FG024|Overall Study|Withdrawal by Subject|0|||
125923454|NCT00042289|453019222|FG025|Overall Study|Withdrawal by Subject|0|||
125923455|NCT00042289|453019223|FG026|Overall Study|Withdrawal by Subject|1|||
125923456|NCT00042289|453019224|FG027|Overall Study|Withdrawal by Subject|0|||
125923457|NCT00042289|453019225|FG028|Overall Study|Withdrawal by Subject|2|||
125923458|NCT00042289|453019226|FG029|Overall Study|Withdrawal by Subject|0|||
125923459|NCT00042289|453019227|FG030|Overall Study|Withdrawal by Subject|0|||
125923460|NCT00042289|453019228|FG031|Overall Study|Withdrawal by Subject|1|||
125923461|NCT00042289|453019229|FG032|Overall Study|Withdrawal by Subject|2|||
126111309|NCT01003990|453703634|FG001|Overall Study|Lost to Follow-up|12|||
126111310|NCT01003990|453703635|FG002|Overall Study|Lost to Follow-up|7|||
126111311|NCT01003990|453703633|FG000|Overall Study|Reasons Not Identified|14|||
126111312|NCT01003990|453703634|FG001|Overall Study|Reasons Not Identified|13|||
126111313|NCT01003990|453703635|FG002|Overall Study|Reasons Not Identified|8|||
126111314|NCT01003990|453703633|FG000|Overall Study|Poor/Non-compliance|4|||
126111315|NCT01003990|453703634|FG001|Overall Study|Poor/Non-compliance|3|||
126111316|NCT01003990|453703635|FG002|Overall Study|Poor/Non-compliance|2|||
126111317|NCT01003990|453703633|FG000|Overall Study|Pregnancy|10|||
126111318|NCT01003990|453703634|FG001|Overall Study|Pregnancy|2|||
126111319|NCT01003990|453703635|FG002|Overall Study|Pregnancy|4|||
126111320|NCT01003990|453703633|FG000|Overall Study|No Longer Met Study Criteria|4|||
126111321|NCT01003990|453703634|FG001|Overall Study|No Longer Met Study Criteria|1|||
126111322|NCT01003990|453703635|FG002|Overall Study|No Longer Met Study Criteria|0|||
126111323|NCT01003990|453703633|FG000|Overall Study|Subject Withdrew Consent|12|||
126111324|NCT01003990|453703634|FG001|Overall Study|Subject Withdrew Consent|5|||
126111325|NCT01003990|453703635|FG002|Overall Study|Subject Withdrew Consent|7|||
126111326|NCT00634010|453703640|FG000|Overall Study|Adverse Event|2|||
126111327|NCT00634010|453703641|FG001|Overall Study|Adverse Event|5|||
126111328|NCT00634010|453703640|FG000|Overall Study|Withdrawal by Subject|5|||
126111329|NCT00634010|453703641|FG001|Overall Study|Withdrawal by Subject|6|||
126111330|NCT00634010|453703640|FG000|Overall Study|Physician Decision|1|||
126111331|NCT00634010|453703641|FG001|Overall Study|Physician Decision|1|||
126111332|NCT00634010|453703640|FG000|Overall Study|Disease Progression|1|||
126111333|NCT00634010|453703641|FG001|Overall Study|Disease Progression|1|||
126111334|NCT00634010|453703640|FG000|Overall Study|Non-Compliant|1|||
126111335|NCT00634010|453703641|FG001|Overall Study|Non-Compliant|1|||
126111336|NCT01822522|453703644|FG000|Overall Study|Adverse Event|1|||
126111337|NCT01822522|453703645|FG001|Overall Study|Adverse Event|1|||
126111338|NCT01822522|453703646|FG002|Overall Study|Adverse Event|1|||
126111339|NCT01822522|453703647|FG003|Overall Study|Adverse Event|0|||
126111340|NCT01822522|453703648|FG004|Overall Study|Adverse Event|0|||
126111341|NCT01822522|453703649|FG005|Overall Study|Adverse Event|1|||
126111342|NCT01822522|453703644|FG000|Overall Study|Death|3|||
126111343|NCT01822522|453703645|FG001|Overall Study|Death|0|||
126111344|NCT01822522|453703646|FG002|Overall Study|Death|2|||
126111345|NCT01822522|453703647|FG003|Overall Study|Death|0|||
126111346|NCT01822522|453703648|FG004|Overall Study|Death|0|||
126111347|NCT01822522|453703649|FG005|Overall Study|Death|0|||
126111348|NCT01822522|453703644|FG000|Overall Study|Lost to Follow-up|0|||
126111349|NCT01822522|453703645|FG001|Overall Study|Lost to Follow-up|0|||
126111350|NCT01822522|453703646|FG002|Overall Study|Lost to Follow-up|1|||
126111351|NCT01822522|453703647|FG003|Overall Study|Lost to Follow-up|1|||
126111352|NCT01822522|453703648|FG004|Overall Study|Lost to Follow-up|0|||
126111353|NCT01822522|453703649|FG005|Overall Study|Lost to Follow-up|1|||
126111354|NCT01822522|453703644|FG000|Overall Study|Withdrawal by Subject|0|||
126111355|NCT01822522|453703645|FG001|Overall Study|Withdrawal by Subject|0|||
126111356|NCT01822522|453703646|FG002|Overall Study|Withdrawal by Subject|0|||
126111357|NCT01822522|453703647|FG003|Overall Study|Withdrawal by Subject|1|||
126111358|NCT01822522|453703648|FG004|Overall Study|Withdrawal by Subject|0|||
126111359|NCT01822522|453703649|FG005|Overall Study|Withdrawal by Subject|0|||
126111360|NCT01822522|453703644|FG000|Overall Study|Lack of Efficacy|0|||
126111361|NCT01822522|453703645|FG001|Overall Study|Lack of Efficacy|0|||
126111362|NCT01822522|453703646|FG002|Overall Study|Lack of Efficacy|0|||
126111363|NCT01822522|453703647|FG003|Overall Study|Lack of Efficacy|0|||
126111364|NCT01822522|453703648|FG004|Overall Study|Lack of Efficacy|0|||
126111365|NCT01822522|453703649|FG005|Overall Study|Lack of Efficacy|2|||
126111366|NCT00890929|453703650|FG000|Overall Study|Death before treatment|2|||
126111367|NCT00890929|453703650|FG000|Overall Study|Withdrawal by Subject|3|||
126111368|NCT00890929|453703650|FG000|Overall Study|Physician Decision|1|||
125923462|NCT00042289|453019230|FG033|Overall Study|Withdrawal by Subject|1|||
125923463|NCT00042289|453019231|FG034|Overall Study|Withdrawal by Subject|0|||
125923464|NCT00042289|453019232|FG035|Overall Study|Withdrawal by Subject|0|||
125923465|NCT00042289|453019233|FG036|Overall Study|Withdrawal by Subject|0|||
125923466|NCT00042289|453019234|FG037|Overall Study|Withdrawal by Subject|1|||
126111369|NCT01006265|453703651|FG000|Overall Study|Lost to Follow-up|1|||
126111370|NCT01006265|453703652|FG001|Overall Study|Lost to Follow-up|0|||
126111371|NCT01006265|453703653|FG002|Overall Study|Lost to Follow-up|1|||
126111372|NCT01006265|453703654|FG003|Overall Study|Lost to Follow-up|0|||
126111373|NCT01006265|453703651|FG000|Overall Study|Withdrawal by Subject|4|||
126111374|NCT01006265|453703652|FG001|Overall Study|Withdrawal by Subject|7|||
126111375|NCT01006265|453703653|FG002|Overall Study|Withdrawal by Subject|5|||
125923467|NCT00042289|453019235|FG038|Overall Study|Withdrawal by Subject|0|||
125923468|NCT00042289|453019236|FG039|Overall Study|Withdrawal by Subject|0|||
125923469|NCT00042289|453019237|FG040|Overall Study|Withdrawal by Subject|0|||
126111376|NCT01006265|453703654|FG003|Overall Study|Withdrawal by Subject|5|||
126111377|NCT01006265|453703651|FG000|Overall Study|Administrative reason|1|||
126111378|NCT01006265|453703652|FG001|Overall Study|Administrative reason|2|||
126111379|NCT01006265|453703653|FG002|Overall Study|Administrative reason|3|||
126111380|NCT01006265|453703654|FG003|Overall Study|Administrative reason|0|||
125923470|NCT00042289|453019238|FG041|Overall Study|Withdrawal by Subject|0|||
125923471|NCT00042289|453019239|FG042|Overall Study|Withdrawal by Subject|1|||
125923472|NCT00042289|453019240|FG043|Overall Study|Withdrawal by Subject|0|||
125923473|NCT00042289|453019241|FG044|Overall Study|Withdrawal by Subject|0|||
125923474|NCT00042289|453019242|FG045|Overall Study|Withdrawal by Subject|0|||
125923475|NCT00042289|453019243|FG046|Overall Study|Withdrawal by Subject|0|||
125923476|NCT00745823|453019244|FG000|Overall Study|Adverse Event|5|||
125923477|NCT00745823|453019245|FG001|Overall Study|Adverse Event|3|||
125923478|NCT00745823|453019244|FG000|Overall Study|Lack of Efficacy|20|||
125923479|NCT00745823|453019245|FG001|Overall Study|Lack of Efficacy|6|||
125923480|NCT00745823|453019244|FG000|Overall Study|Lost to Follow-up|10|||
125923481|NCT00745823|453019245|FG001|Overall Study|Lost to Follow-up|11|||
125923482|NCT00745823|453019244|FG000|Overall Study|Physician Decision|10|||
125923483|NCT00745823|453019245|FG001|Overall Study|Physician Decision|5|||
125923484|NCT00745823|453019244|FG000|Overall Study|Pregnancy|0|||
125923485|NCT00745823|453019245|FG001|Overall Study|Pregnancy|4|||
125923486|NCT00745823|453019244|FG000|Overall Study|Withdrawal by Subject|14|||
125923487|NCT00745823|453019245|FG001|Overall Study|Withdrawal by Subject|8|||
125923488|NCT00745823|453019244|FG000|Overall Study|Study Terminated by Sponsor|326|||
125923489|NCT00745823|453019245|FG001|Overall Study|Study Terminated by Sponsor|349|||
125923490|NCT01687998|453019246|FG000|Overall Study|Withdrawal by Subject|49|||
125923491|NCT01687998|453019247|FG001|Overall Study|Withdrawal by Subject|51|||
125923492|NCT01687998|453019246|FG000|Overall Study|Known to be Alive at Study End|54|||
125923493|NCT01687998|453019247|FG001|Overall Study|Known to be Alive at Study End|62|||
125923494|NCT01687998|453019246|FG000|Overall Study|Lost to Follow-up|9|||
125923495|NCT01687998|453019247|FG001|Overall Study|Lost to Follow-up|7|||
125923496|NCT00717197|453019254|FG000|Overall Study|Unable to purchase study drug|5|||
125923497|NCT00717197|453019254|FG000|Overall Study|Tumor Progression|1|||
125923498|NCT00717197|453019254|FG000|Overall Study|Physician Decision|1|||
125923499|NCT00982137|453019255|FG000|Overall Study|Lost to Follow-up|0|||
125923500|NCT00982137|453019256|FG001|Overall Study|Lost to Follow-up|0|||
125923501|NCT00982137|453019257|FG002|Overall Study|Lost to Follow-up|0|||
125923502|NCT00982137|453019258|FG003|Overall Study|Lost to Follow-up|1|||
125923503|NCT00982137|453019255|FG000|Overall Study|Withdrawal by Subject|0|||
125923504|NCT00982137|453019256|FG001|Overall Study|Withdrawal by Subject|1|||
125923505|NCT00982137|453019257|FG002|Overall Study|Withdrawal by Subject|0|||
125923506|NCT00982137|453019258|FG003|Overall Study|Withdrawal by Subject|0|||
125923507|NCT00612690|453019267|FG000|Overall Study|Lost to Follow-up|72|||
125923508|NCT00612690|453019268|FG001|Overall Study|Lost to Follow-up|98|||
125923509|NCT00612690|453019267|FG000|Overall Study|Withdrawal by Subject|32|||
125923510|NCT00612690|453019268|FG001|Overall Study|Withdrawal by Subject|20|||
125923511|NCT00612690|453019267|FG000|Overall Study|Withdrawal by Site|11|||
125923512|NCT00612690|453019268|FG001|Overall Study|Withdrawal by Site|0|||
125923513|NCT00787891|453019270|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
125923514|NCT00787891|453019271|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
125923515|NCT00787891|453019270|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
125923516|NCT00787891|453019271|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
125923517|NCT00787891|453019270|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
125923518|NCT00787891|453019271|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
125923519|NCT00787891|453019270|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
125923520|NCT00787891|453019271|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
125923521|NCT00787891|453019270|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
125923522|NCT00787891|453019271|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
125923523|NCT00787891|453019270|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
125923524|NCT00787891|453019271|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
125923525|NCT00787891|453019270|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
125923526|NCT00787891|453019271|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
125923527|NCT00787891|453019270|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
125923528|NCT00787891|453019271|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
125923529|NCT00787891|453019270|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
125923530|NCT00787891|453019271|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
125923531|NCT00787891|453019270|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
125923532|NCT00787891|453019271|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
125923533|NCT02955602|453019272|FG000|Overall Study|Adverse Event|0|||
125923534|NCT02955602|453019273|FG001|Overall Study|Adverse Event|3|||
125923535|NCT02955602|453019274|FG002|Overall Study|Adverse Event|0|||
125923536|NCT02955602|453019272|FG000|Overall Study|Withdrawal of informed consent|1|||
126111381|NCT00132496|453703657|FG000|Overall Study|Withdrawal by Subject|1|||
125923537|NCT02955602|453019273|FG001|Overall Study|Withdrawal of informed consent|3|||
125923538|NCT02955602|453019274|FG002|Overall Study|Withdrawal of informed consent|2|||
126111382|NCT00132496|453703658|FG001|Overall Study|Withdrawal by Subject|2|||
125923539|NCT02955602|453019272|FG000|Overall Study|Lost to Follow-up|0|||
125923540|NCT02955602|453019273|FG001|Overall Study|Lost to Follow-up|0|||
125923541|NCT02955602|453019274|FG002|Overall Study|Lost to Follow-up|1|||
125923542|NCT02955602|453019272|FG000|Overall Study|Other|0|||
125923543|NCT02955602|453019273|FG001|Overall Study|Other|1|||
125923544|NCT02955602|453019274|FG002|Overall Study|Other|3|||
125923545|NCT02980601|453019277|FG000|Overall Study|Lost to Follow-up|2|||
125923546|NCT02980601|453019278|FG001|Overall Study|Lost to Follow-up|2|||
125923547|NCT02980601|453019277|FG000|Overall Study|Death|0|||
125923548|NCT02980601|453019278|FG001|Overall Study|Death|1|||
125923549|NCT02980601|453019277|FG000|Overall Study|Graft loss|1|||
125923550|NCT02980601|453019278|FG001|Overall Study|Graft loss|0|||
125923551|NCT02980601|453019277|FG000|Overall Study|Failed to sign consent|2|||
125923552|NCT02980601|453019278|FG001|Overall Study|Failed to sign consent|0|||
125923553|NCT01575769|453019279|FG000|Overall Study|Adverse Event|1|||
125923554|NCT01575769|453019279|FG000|Overall Study|Study terminated by sponsor|40|||
125923555|NCT03156543|453019282|FG000|Overall Study|Withdrawal by Subject|1|||
125923556|NCT03156543|453019283|FG001|Overall Study|Withdrawal by Subject|0|||
125923557|NCT00674700|453019284|FG000|Year 1|Adverse Event|17|||
125923558|NCT00674700|453019285|FG001|Year 1|Adverse Event|20|||
125923559|NCT00674700|453019286|FG002|Year 1|Adverse Event|5|||
125923560|NCT00674700|453019284|FG000|Year 1|Withdrawal by Subject|7|||
125923561|NCT00674700|453019285|FG001|Year 1|Withdrawal by Subject|7|||
125923562|NCT00674700|453019286|FG002|Year 1|Withdrawal by Subject|6|||
125923563|NCT00674700|453019284|FG000|Year 1|Any other reason not above-mentioned|7|||
125923564|NCT00674700|453019285|FG001|Year 1|Any other reason not above-mentioned|7|||
125923565|NCT00674700|453019286|FG002|Year 1|Any other reason not above-mentioned|6|||
125923566|NCT00674700|453019284|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
125923567|NCT00674700|453019285|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
125923568|NCT00674700|453019286|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
125923569|NCT00674700|453019284|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
125923570|NCT00674700|453019285|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
125923571|NCT00674700|453019286|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
125923572|NCT00674700|453019284|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
125923573|NCT00674700|453019285|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
125923574|NCT00674700|453019286|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
125923575|NCT00395304|453019287|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125923576|NCT00395304|453019288|FG001|Treatment Period 1|Withdrawal by Subject|3|||
125923577|NCT00395304|453019289|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125923578|NCT00395304|453019290|FG003|Treatment Period 1|Withdrawal by Subject|2|||
125923579|NCT00395304|453019291|FG004|Treatment Period 1|Withdrawal by Subject|1|||
125923580|NCT00395304|453019292|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125923581|NCT00395304|453019287|FG000|Treatment Period 1|Lost to Follow-up|1|||
125923582|NCT00395304|453019288|FG001|Treatment Period 1|Lost to Follow-up|0|||
125923583|NCT00395304|453019289|FG002|Treatment Period 1|Lost to Follow-up|0|||
125923584|NCT00395304|453019290|FG003|Treatment Period 1|Lost to Follow-up|1|||
125923585|NCT00395304|453019291|FG004|Treatment Period 1|Lost to Follow-up|0|||
125923586|NCT00395304|453019292|FG005|Treatment Period 1|Lost to Follow-up|1|||
125923587|NCT00395304|453019287|FG000|Treatment Period 1|Physician Decision|0|||
125923588|NCT00395304|453019288|FG001|Treatment Period 1|Physician Decision|1|||
125923589|NCT00395304|453019289|FG002|Treatment Period 1|Physician Decision|0|||
125923590|NCT00395304|453019290|FG003|Treatment Period 1|Physician Decision|0|||
125923591|NCT00395304|453019291|FG004|Treatment Period 1|Physician Decision|0|||
125923592|NCT00395304|453019292|FG005|Treatment Period 1|Physician Decision|0|||
125923593|NCT00395304|453019287|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125923594|NCT00395304|453019288|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125923595|NCT00395304|453019289|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125923596|NCT00395304|453019290|FG003|Treatment Period 2|Withdrawal by Subject|1|||
125923597|NCT00395304|453019291|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125923598|NCT00395304|453019292|FG005|Treatment Period 2|Withdrawal by Subject|2|||
125923599|NCT00395304|453019287|FG000|Treatment Period 2|Lost to Follow-up|0|||
125923600|NCT00395304|453019288|FG001|Treatment Period 2|Lost to Follow-up|3|||
125923601|NCT00395304|453019289|FG002|Treatment Period 2|Lost to Follow-up|0|||
125923602|NCT00395304|453019290|FG003|Treatment Period 2|Lost to Follow-up|0|||
125923603|NCT00395304|453019291|FG004|Treatment Period 2|Lost to Follow-up|0|||
125923604|NCT00395304|453019292|FG005|Treatment Period 2|Lost to Follow-up|0|||
125923605|NCT00395304|453019287|FG000|Treatment Period 2|Physician Decision|0|||
125923606|NCT00395304|453019288|FG001|Treatment Period 2|Physician Decision|0|||
125923607|NCT00395304|453019289|FG002|Treatment Period 2|Physician Decision|1|||
125923608|NCT00395304|453019290|FG003|Treatment Period 2|Physician Decision|0|||
125923609|NCT00395304|453019291|FG004|Treatment Period 2|Physician Decision|0|||
125923610|NCT00395304|453019292|FG005|Treatment Period 2|Physician Decision|0|||
125923611|NCT00395304|453019287|FG000|Treatment Period 2|Other|0|||
125923612|NCT00395304|453019288|FG001|Treatment Period 2|Other|1|||
125923613|NCT00395304|453019289|FG002|Treatment Period 2|Other|0|||
126111383|NCT00132496|453703657|FG000|Overall Study|Physician Decision|1|||
125923614|NCT00395304|453019290|FG003|Treatment Period 2|Other|0|||
125923615|NCT00395304|453019291|FG004|Treatment Period 2|Other|0|||
125923616|NCT00395304|453019292|FG005|Treatment Period 2|Other|0|||
125923617|NCT00395304|453019287|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125923618|NCT00395304|453019288|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125923619|NCT00395304|453019289|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125923620|NCT00395304|453019290|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125923621|NCT00395304|453019291|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125923622|NCT00395304|453019292|FG005|Treatment Period 3|Withdrawal by Subject|1|||
125923623|NCT00395304|453019287|FG000|Treatment Period 3|Lost to Follow-up|1|||
125923624|NCT00395304|453019288|FG001|Treatment Period 3|Lost to Follow-up|1|||
125923625|NCT00395304|453019289|FG002|Treatment Period 3|Lost to Follow-up|0|||
125923626|NCT00395304|453019290|FG003|Treatment Period 3|Lost to Follow-up|0|||
125923627|NCT00395304|453019291|FG004|Treatment Period 3|Lost to Follow-up|0|||
125923628|NCT00395304|453019292|FG005|Treatment Period 3|Lost to Follow-up|0|||
125923629|NCT00395304|453019287|FG000|Treatment Period 3|Physician Decision|0|||
125923630|NCT00395304|453019288|FG001|Treatment Period 3|Physician Decision|1|||
125923631|NCT00395304|453019289|FG002|Treatment Period 3|Physician Decision|0|||
125923632|NCT00395304|453019290|FG003|Treatment Period 3|Physician Decision|0|||
125923633|NCT00395304|453019291|FG004|Treatment Period 3|Physician Decision|0|||
125923634|NCT00395304|453019292|FG005|Treatment Period 3|Physician Decision|0|||
125923635|NCT00395304|453019287|FG000|Treatment Period 3|Other|0|||
125923636|NCT00395304|453019288|FG001|Treatment Period 3|Other|0|||
125923637|NCT00395304|453019289|FG002|Treatment Period 3|Other|0|||
125923638|NCT00395304|453019290|FG003|Treatment Period 3|Other|1|||
125923639|NCT00395304|453019291|FG004|Treatment Period 3|Other|0|||
125923640|NCT00395304|453019292|FG005|Treatment Period 3|Other|0|||
125923641|NCT03797014|453019294|FG000|Overall Study|Withdrawal by Subject|1|||
125923642|NCT03797014|453019294|FG000|Overall Study|Lost to Follow-up|1|||
125923643|NCT03797014|453019294|FG000|Overall Study|Protocol Violation|1|||
125923644|NCT01970397|453019295|FG000|Overall Study|Adverse Event|0|||
125923645|NCT01970397|453019296|FG001|Overall Study|Adverse Event|1|||
125923646|NCT01970397|453019295|FG000|Overall Study|Lost to Follow-up|0|||
125923647|NCT01970397|453019296|FG001|Overall Study|Lost to Follow-up|1|||
125923648|NCT01970397|453019295|FG000|Overall Study|Personal Reasons|1|||
125923649|NCT01970397|453019296|FG001|Overall Study|Personal Reasons|2|||
125923650|NCT01970397|453019295|FG000|Overall Study|Protocol Violation|1|||
125923651|NCT01970397|453019296|FG001|Overall Study|Protocol Violation|1|||
125923652|NCT01389817|453019299|FG000|Overall Study|Physician Decision|1|||
125923653|NCT01389817|453019300|FG001|Overall Study|Physician Decision|0|||
125923654|NCT01389817|453019299|FG000|Overall Study|Lost to Follow-up|1|||
125923655|NCT01389817|453019300|FG001|Overall Study|Lost to Follow-up|0|||
125923656|NCT01389817|453019299|FG000|Overall Study|Withdrawal by Subject|2|||
125923657|NCT01389817|453019300|FG001|Overall Study|Withdrawal by Subject|0|||
125923658|NCT02871297|453019303|FG000|Overall Study|Adverse Event|34|||
125923659|NCT02871297|453019303|FG000|Overall Study|Lack of Efficacy|10|||
125923660|NCT02871297|453019303|FG000|Overall Study|Non-compliance with study drug|15|||
125923661|NCT02871297|453019303|FG000|Overall Study|Protocol Violation|3|||
125923662|NCT02871297|453019303|FG000|Overall Study|Withdrawal by Subject|20|||
125923663|NCT02871297|453019303|FG000|Overall Study|Lost to Follow-up|13|||
125923664|NCT02871297|453019303|FG000|Overall Study|Rolled over to 13546A|2|||
125923665|NCT02871297|453019303|FG000|Overall Study|Other than specified|39|||
125923666|NCT01434667|453019307|FG000|Overall Study|Lost to Follow-up|5|||
125923667|NCT01434667|453019308|FG001|Overall Study|Lost to Follow-up|10|||
125923668|NCT04115839|453019309|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
125923669|NCT04115839|453019310|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
125923670|NCT04115839|453019311|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
125923671|NCT04115839|453019312|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
125923672|NCT04115839|453019313|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
125923673|NCT04115839|453019314|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
125923674|NCT04115839|453019315|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
125923675|NCT04115839|453019309|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
125923676|NCT04115839|453019310|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
125923677|NCT04115839|453019311|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
125923678|NCT04115839|453019312|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
125923679|NCT04115839|453019313|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
125923680|NCT04115839|453019314|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
125923681|NCT04115839|453019315|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
125923682|NCT04115839|453019309|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
125923683|NCT04115839|453019310|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125923684|NCT04115839|453019311|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125923685|NCT04115839|453019312|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125923686|NCT04115839|453019313|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125923687|NCT04115839|453019314|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125923688|NCT04115839|453019315|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125923689|NCT04115839|453019309|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125923690|NCT04115839|453019310|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125923691|NCT04115839|453019311|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
126111384|NCT00132496|453703658|FG001|Overall Study|Physician Decision|0|||
126111385|NCT01093625|453703663|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
126111386|NCT01093625|453703664|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
126111387|NCT01093625|453703663|FG000|2-Week Visit|Withdrawal by Subject|1|||
126111388|NCT01093625|453703664|FG001|2-Week Visit|Withdrawal by Subject|0|||
126111389|NCT01093625|453703663|FG000|1-Month Visit|Lost to Follow-up|2|||
126111390|NCT01093625|453703664|FG001|1-Month Visit|Lost to Follow-up|0|||
126111391|NCT01093625|453703663|FG000|3-Month Visit|Lost to Follow-up|2|||
126111392|NCT01093625|453703664|FG001|3-Month Visit|Lost to Follow-up|0|||
126111393|NCT01093625|453703663|FG000|6-Month Visit|Withdrawal by Subject|6|||
126111394|NCT01093625|453703664|FG001|6-Month Visit|Withdrawal by Subject|7|||
126111395|NCT01093625|453703663|FG000|6-Month Visit|Lost to Follow-up|2|||
126111396|NCT01093625|453703664|FG001|6-Month Visit|Lost to Follow-up|2|||
126111397|NCT01093625|453703663|FG000|1-Year Visit|Lost to Follow-up|5|||
126111398|NCT01093625|453703664|FG001|1-Year Visit|Lost to Follow-up|3|||
126111399|NCT02014740|453703665|FG000|Overall Study|Lost to Follow-up|4|||
126111400|NCT02014740|453703666|FG001|Overall Study|Lost to Follow-up|4|||
126111401|NCT02014740|453703665|FG000|Overall Study|Withdrawal by Subject|2|||
126111402|NCT02014740|453703666|FG001|Overall Study|Withdrawal by Subject|1|||
126111403|NCT01431534|453703667|FG000|Treatment Phase|Adverse Event|0|||
126111404|NCT01431534|453703668|FG001|Treatment Phase|Adverse Event|0|||
126111405|NCT01431534|453703669|FG002|Treatment Phase|Adverse Event|1|||
126111406|NCT01431534|453703667|FG000|Treatment Phase|Progressive Disease|4|||
126111407|NCT01431534|453703668|FG001|Treatment Phase|Progressive Disease|3|||
126111408|NCT01431534|453703669|FG002|Treatment Phase|Progressive Disease|10|||
126111409|NCT04427501|453703672|FG000|Overall Study|Death|0|||
126111410|NCT04427501|453703673|FG001|Overall Study|Death|0|||
126111411|NCT04427501|453703674|FG002|Overall Study|Death|0|||
126111412|NCT04427501|453703675|FG003|Overall Study|Death|0|||
126111413|NCT04427501|453703676|FG004|Overall Study|Death|0|||
126111414|NCT04427501|453703677|FG005|Overall Study|Death|15|||
126111415|NCT04427501|453703678|FG006|Overall Study|Death|0|||
126111416|NCT04427501|453703679|FG007|Overall Study|Death|0|||
126111417|NCT04427501|453703680|FG008|Overall Study|Death|0|||
126111418|NCT04427501|453703681|FG009|Overall Study|Death|0|||
126111419|NCT04427501|453703682|FG010|Overall Study|Death|0|||
126111420|NCT04427501|453703683|FG011|Overall Study|Death|0|||
126111421|NCT04427501|453703672|FG000|Overall Study|Lost to Follow-up|5|||
125923692|NCT04115839|453019312|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125923693|NCT04115839|453019313|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125923694|NCT04115839|453019314|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125923695|NCT04115839|453019315|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125923696|NCT04115839|453019309|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
125923697|NCT04115839|453019310|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
125923698|NCT04115839|453019311|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
125923699|NCT04115839|453019312|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
125923700|NCT04115839|453019313|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
125923701|NCT04115839|453019314|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
125923702|NCT04115839|453019315|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
125923703|NCT04115839|453019309|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125923704|NCT04115839|453019310|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125923705|NCT04115839|453019311|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125923706|NCT04115839|453019312|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
125923707|NCT04115839|453019313|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
125923708|NCT04115839|453019314|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125923709|NCT04115839|453019315|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125923710|NCT02966028|453019316|FG000|Overall Study|Adverse Event|7|||
125923711|NCT02966028|453019317|FG001|Overall Study|Adverse Event|13|||
125923712|NCT02966028|453019318|FG002|Overall Study|Adverse Event|10|||
126111422|NCT04427501|453703673|FG001|Overall Study|Lost to Follow-up|1|||
126111423|NCT04427501|453703674|FG002|Overall Study|Lost to Follow-up|2|||
126111424|NCT04427501|453703675|FG003|Overall Study|Lost to Follow-up|0|||
125923713|NCT02966028|453019316|FG000|Overall Study|Physician Decision|1|||
125923714|NCT02966028|453019317|FG001|Overall Study|Physician Decision|0|||
125923715|NCT02966028|453019318|FG002|Overall Study|Physician Decision|2|||
125923716|NCT02966028|453019316|FG000|Overall Study|Withdrawal by Subject|7|||
126111425|NCT04427501|453703676|FG004|Overall Study|Lost to Follow-up|2|||
126111426|NCT04427501|453703677|FG005|Overall Study|Lost to Follow-up|11|||
126111427|NCT04427501|453703678|FG006|Overall Study|Lost to Follow-up|10|||
126111428|NCT04427501|453703679|FG007|Overall Study|Lost to Follow-up|10|||
126111429|NCT04427501|453703680|FG008|Overall Study|Lost to Follow-up|2|||
126111430|NCT04427501|453703681|FG009|Overall Study|Lost to Follow-up|5|||
126111431|NCT04427501|453703682|FG010|Overall Study|Lost to Follow-up|2|||
126111432|NCT04427501|453703683|FG011|Overall Study|Lost to Follow-up|0|||
126111433|NCT04427501|453703672|FG000|Overall Study|Physician Decision|0|||
126111434|NCT04427501|453703673|FG001|Overall Study|Physician Decision|3|||
126111435|NCT04427501|453703674|FG002|Overall Study|Physician Decision|0|||
125923717|NCT02966028|453019317|FG001|Overall Study|Withdrawal by Subject|5|||
125923718|NCT02966028|453019318|FG002|Overall Study|Withdrawal by Subject|5|||
125923719|NCT02966028|453019316|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
125923720|NCT02966028|453019317|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
125923721|NCT02966028|453019318|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
125923722|NCT02034110|453019319|FG000|Overall Study|Physician Decision|0|||
125923723|NCT02034110|453019320|FG001|Overall Study|Physician Decision|0|||
125923724|NCT02034110|453019321|FG002|Overall Study|Physician Decision|0|||
125923725|NCT02034110|453019322|FG003|Overall Study|Physician Decision|0|||
125923726|NCT02034110|453019323|FG004|Overall Study|Physician Decision|2|||
125923727|NCT02034110|453019324|FG005|Overall Study|Physician Decision|0|||
125923728|NCT02034110|453019325|FG006|Overall Study|Physician Decision|1|||
125923729|NCT02034110|453019326|FG007|Overall Study|Physician Decision|0|||
125923730|NCT02034110|453019319|FG000|Overall Study|Lost to Follow-up|1|||
125923731|NCT02034110|453019320|FG001|Overall Study|Lost to Follow-up|0|||
125923732|NCT02034110|453019321|FG002|Overall Study|Lost to Follow-up|0|||
125923733|NCT02034110|453019322|FG003|Overall Study|Lost to Follow-up|0|||
125923734|NCT02034110|453019323|FG004|Overall Study|Lost to Follow-up|1|||
125923735|NCT02034110|453019324|FG005|Overall Study|Lost to Follow-up|0|||
125923736|NCT02034110|453019325|FG006|Overall Study|Lost to Follow-up|1|||
125923737|NCT02034110|453019326|FG007|Overall Study|Lost to Follow-up|0|||
125923738|NCT02034110|453019319|FG000|Overall Study|Withdrawal by Subject|5|||
125923739|NCT02034110|453019320|FG001|Overall Study|Withdrawal by Subject|7|||
125923740|NCT02034110|453019321|FG002|Overall Study|Withdrawal by Subject|0|||
125923741|NCT02034110|453019322|FG003|Overall Study|Withdrawal by Subject|3|||
125923742|NCT02034110|453019323|FG004|Overall Study|Withdrawal by Subject|7|||
125923743|NCT02034110|453019324|FG005|Overall Study|Withdrawal by Subject|0|||
125923744|NCT02034110|453019325|FG006|Overall Study|Withdrawal by Subject|3|||
125923745|NCT02034110|453019326|FG007|Overall Study|Withdrawal by Subject|1|||
125923746|NCT02034110|453019319|FG000|Overall Study|Study closed by sponsor|6|||
125923747|NCT02034110|453019320|FG001|Overall Study|Study closed by sponsor|2|||
125923748|NCT02034110|453019321|FG002|Overall Study|Study closed by sponsor|0|||
125923749|NCT02034110|453019322|FG003|Overall Study|Study closed by sponsor|6|||
125923750|NCT02034110|453019323|FG004|Overall Study|Study closed by sponsor|7|||
125923751|NCT02034110|453019324|FG005|Overall Study|Study closed by sponsor|0|||
125923752|NCT02034110|453019325|FG006|Overall Study|Study closed by sponsor|42|||
125923753|NCT02034110|453019326|FG007|Overall Study|Study closed by sponsor|0|||
126064483|NCT00134056|453527749|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
126064484|NCT00134056|453527748|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
126064485|NCT00134056|453527749|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
126064486|NCT02555397|453527753|FG000|Overall Study|Withdrawal by Subject|1|||
126064487|NCT02555397|453527754|FG001|Overall Study|Withdrawal by Subject|0|||
126064488|NCT02555397|453527755|FG002|Overall Study|Withdrawal by Subject|0|||
126064489|NCT02555397|453527756|FG003|Overall Study|Withdrawal by Subject|0|||
126111436|NCT04427501|453703675|FG003|Overall Study|Physician Decision|0|||
126111437|NCT04427501|453703676|FG004|Overall Study|Physician Decision|0|||
126111438|NCT04427501|453703677|FG005|Overall Study|Physician Decision|0|||
125923754|NCT00621985|453019327|FG000|Dexamethasone Admission|Adverse Event|1|||
125923755|NCT01877265|453019331|FG000|Treatment Period 1|Sponsor Decision|0|||
125923756|NCT01877265|453019332|FG001|Treatment Period 1|Sponsor Decision|0|||
125923757|NCT01877265|453019333|FG002|Treatment Period 1|Sponsor Decision|1|||
125923758|NCT01877265|453019334|FG003|Treatment Period 1|Sponsor Decision|0|||
125923759|NCT01877265|453019335|FG004|Treatment Period 1|Sponsor Decision|0|||
125923760|NCT01877265|453019336|FG005|Treatment Period 1|Sponsor Decision|0|||
125923761|NCT01877265|453019331|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125923762|NCT01877265|453019332|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125923763|NCT01877265|453019333|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125923764|NCT01877265|453019334|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125923765|NCT01877265|453019335|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125923766|NCT01877265|453019336|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
125923767|NCT01877265|453019331|FG000|Treatment Period 3|Lost to Follow-up|1|||
125923768|NCT01877265|453019332|FG001|Treatment Period 3|Lost to Follow-up|0|||
125923769|NCT01877265|453019333|FG002|Treatment Period 3|Lost to Follow-up|0|||
125923770|NCT01877265|453019334|FG003|Treatment Period 3|Lost to Follow-up|0|||
125923771|NCT01877265|453019335|FG004|Treatment Period 3|Lost to Follow-up|0|||
125923772|NCT01877265|453019336|FG005|Treatment Period 3|Lost to Follow-up|0|||
125923773|NCT00691015|453019337|FG000|Overall Study|Refused further treatment|1|||
125923774|NCT04160195|453019340|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
125923775|NCT04160195|453019341|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
125923776|NCT00684593|453019347|FG000|Overall Study|Adverse Event|0|||
125923777|NCT00684593|453019348|FG001|Overall Study|Adverse Event|2|||
125923778|NCT05386680|453019351|FG000|Overall Study|Guardian decision|2|||
126064490|NCT02555397|453527757|FG004|Overall Study|Withdrawal by Subject|0|||
126111439|NCT04427501|453703678|FG006|Overall Study|Physician Decision|2|||
125923779|NCT01847274|453019352|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
125923780|NCT01847274|453019353|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
125923781|NCT01847274|453019354|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
125923782|NCT01847274|453019355|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
125923783|NCT01847274|453019356|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125923784|NCT01847274|453019357|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125923785|NCT01847274|453019358|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125923786|NCT01847274|453019359|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125923787|NCT01847274|453019360|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125923788|NCT01847274|453019361|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125923789|NCT01847274|453019362|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125923790|NCT01847274|453019352|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
125923791|NCT01847274|453019353|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
125923792|NCT01847274|453019354|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
125923793|NCT01847274|453019355|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
125923794|NCT01847274|453019356|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125923795|NCT01847274|453019357|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125923796|NCT01847274|453019358|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125923797|NCT01847274|453019359|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125923798|NCT01847274|453019360|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125923799|NCT01847274|453019361|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125923800|NCT01847274|453019362|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125923801|NCT01847274|453019352|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
125923802|NCT01847274|453019353|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
125923803|NCT01847274|453019354|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
125923804|NCT01847274|453019355|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
125923805|NCT01847274|453019356|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125923806|NCT01847274|453019357|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125923807|NCT01847274|453019358|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125923808|NCT01847274|453019359|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125923809|NCT01847274|453019360|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125923810|NCT01847274|453019361|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125923811|NCT01847274|453019362|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125923812|NCT01847274|453019352|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923813|NCT01847274|453019353|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923814|NCT01847274|453019354|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923815|NCT01847274|453019355|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
125923816|NCT01847274|453019356|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923817|NCT01847274|453019357|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923818|NCT01847274|453019358|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923819|NCT01847274|453019359|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923820|NCT01847274|453019360|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923821|NCT01847274|453019361|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923822|NCT01847274|453019362|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125923823|NCT01847274|453019352|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
125923824|NCT01847274|453019353|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
125923825|NCT01847274|453019354|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
125923826|NCT01847274|453019355|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
125923827|NCT01847274|453019356|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125923828|NCT01847274|453019357|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125923829|NCT01847274|453019358|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125923830|NCT01847274|453019359|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125923831|NCT01847274|453019360|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125923832|NCT01847274|453019361|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125923833|NCT01847274|453019362|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125923834|NCT01847274|453019352|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
125923835|NCT01847274|453019353|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
125923836|NCT01847274|453019354|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
125923837|NCT01847274|453019355|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
125923838|NCT01847274|453019356|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125923839|NCT01847274|453019357|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125923840|NCT01847274|453019358|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
126111440|NCT04427501|453703679|FG007|Overall Study|Physician Decision|0|||
126111441|NCT04427501|453703680|FG008|Overall Study|Physician Decision|0|||
126111442|NCT04427501|453703681|FG009|Overall Study|Physician Decision|0|||
126111443|NCT04427501|453703682|FG010|Overall Study|Physician Decision|0|||
126111444|NCT04427501|453703683|FG011|Overall Study|Physician Decision|0|||
126111445|NCT04427501|453703672|FG000|Overall Study|Withdrawal by Subject|9|||
126111446|NCT04427501|453703673|FG001|Overall Study|Withdrawal by Subject|2|||
126111447|NCT04427501|453703674|FG002|Overall Study|Withdrawal by Subject|2|||
126111448|NCT04427501|453703675|FG003|Overall Study|Withdrawal by Subject|3|||
126111449|NCT04427501|453703676|FG004|Overall Study|Withdrawal by Subject|7|||
126111450|NCT04427501|453703677|FG005|Overall Study|Withdrawal by Subject|25|||
126111451|NCT04427501|453703678|FG006|Overall Study|Withdrawal by Subject|15|||
126111452|NCT04427501|453703679|FG007|Overall Study|Withdrawal by Subject|7|||
126111453|NCT04427501|453703680|FG008|Overall Study|Withdrawal by Subject|4|||
126111454|NCT04427501|453703681|FG009|Overall Study|Withdrawal by Subject|1|||
126111455|NCT04427501|453703682|FG010|Overall Study|Withdrawal by Subject|4|||
126111456|NCT04427501|453703683|FG011|Overall Study|Withdrawal by Subject|0|||
126111457|NCT04427501|453703672|FG000|Overall Study|Other - as reported by the investigator|1|||
126111458|NCT04427501|453703673|FG001|Overall Study|Other - as reported by the investigator|0|||
126111459|NCT04427501|453703674|FG002|Overall Study|Other - as reported by the investigator|0|||
126111460|NCT04427501|453703675|FG003|Overall Study|Other - as reported by the investigator|0|||
126111461|NCT04427501|453703676|FG004|Overall Study|Other - as reported by the investigator|0|||
126111462|NCT04427501|453703677|FG005|Overall Study|Other - as reported by the investigator|6|||
126111463|NCT04427501|453703678|FG006|Overall Study|Other - as reported by the investigator|6|||
126111464|NCT04427501|453703679|FG007|Overall Study|Other - as reported by the investigator|0|||
126111465|NCT04427501|453703680|FG008|Overall Study|Other - as reported by the investigator|0|||
126111466|NCT04427501|453703681|FG009|Overall Study|Other - as reported by the investigator|0|||
126111467|NCT04427501|453703682|FG010|Overall Study|Other - as reported by the investigator|0|||
126111468|NCT04427501|453703683|FG011|Overall Study|Other - as reported by the investigator|0|||
126111469|NCT04427501|453703672|FG000|Overall Study|Other|0|||
126111470|NCT04427501|453703673|FG001|Overall Study|Other|0|||
126111471|NCT04427501|453703674|FG002|Overall Study|Other|0|||
126111472|NCT04427501|453703675|FG003|Overall Study|Other|0|||
126111473|NCT04427501|453703676|FG004|Overall Study|Other|0|||
126111474|NCT04427501|453703677|FG005|Overall Study|Other|0|||
126111475|NCT04427501|453703678|FG006|Overall Study|Other|0|||
126111476|NCT04427501|453703679|FG007|Overall Study|Other|0|||
126111477|NCT04427501|453703680|FG008|Overall Study|Other|0|||
126111478|NCT04427501|453703681|FG009|Overall Study|Other|0|||
126111479|NCT04427501|453703682|FG010|Overall Study|Other|0|||
126111480|NCT04427501|453703683|FG011|Overall Study|Other|1|||
126111481|NCT00999713|453703684|FG000|Overall Study|Physician Decision|2|||
126111482|NCT00999713|453703685|FG001|Overall Study|Physician Decision|0|||
126111483|NCT00639223|453703686|FG000|Overall Study|Lost to Follow-up|0|||
125923841|NCT01847274|453019359|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125923842|NCT01847274|453019360|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125923843|NCT01847274|453019361|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125923844|NCT01847274|453019362|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125923845|NCT01847274|453019352|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
125923846|NCT01847274|453019353|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
125923847|NCT01847274|453019354|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
125923848|NCT01847274|453019355|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
125923849|NCT01847274|453019356|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125923850|NCT01847274|453019357|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125923851|NCT01847274|453019358|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125923852|NCT01847274|453019359|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125923853|NCT01847274|453019360|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125923854|NCT01847274|453019361|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125923855|NCT01847274|453019362|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125923856|NCT01847274|453019352|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923857|NCT01847274|453019353|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923858|NCT01847274|453019354|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126111484|NCT00639223|453703687|FG001|Overall Study|Lost to Follow-up|2|||
126111485|NCT03739437|453703688|FG000|Overall Study|Lost to Follow-up|2|||
126111486|NCT03739437|453703689|FG001|Overall Study|Lost to Follow-up|5|||
126111487|NCT04598477|453703690|FG000|Overall Study|Adverse Event|2|||
126111488|NCT04598477|453703691|FG001|Overall Study|Adverse Event|0|||
126111489|NCT04598477|453703690|FG000|Overall Study|Death|0|||
126111490|NCT04598477|453703691|FG001|Overall Study|Death|1|||
126111491|NCT04598477|453703690|FG000|Overall Study|Lost to Follow-up|1|||
126111492|NCT04598477|453703691|FG001|Overall Study|Lost to Follow-up|0|||
126111493|NCT04598477|453703690|FG000|Overall Study|Physician Decision|7|||
126111494|NCT04598477|453703691|FG001|Overall Study|Physician Decision|2|||
126111495|NCT04598477|453703690|FG000|Overall Study|Pregnancy|0|||
126111496|NCT04598477|453703691|FG001|Overall Study|Pregnancy|1|||
126111497|NCT04598477|453703690|FG000|Overall Study|Requires Prohibited Medication|0|||
126111498|NCT04598477|453703691|FG001|Overall Study|Requires Prohibited Medication|1|||
126111499|NCT04598477|453703690|FG000|Overall Study|Study Terminated by Sponsor|18|||
126111500|NCT04598477|453703691|FG001|Overall Study|Study Terminated by Sponsor|12|||
126111501|NCT04598477|453703690|FG000|Overall Study|Withdrawal by Subject|16|||
126111502|NCT04598477|453703691|FG001|Overall Study|Withdrawal by Subject|12|||
126111503|NCT04598477|453703690|FG000|Overall Study|Other|15|||
126111504|NCT04598477|453703691|FG001|Overall Study|Other|8|||
126111505|NCT02499770|453703697|FG000|Overall Study|Death|17|||
126111506|NCT02499770|453703698|FG001|Overall Study|Death|56|||
126111507|NCT02499770|453703697|FG000|Overall Study|Study completion|1|||
126111508|NCT02499770|453703698|FG001|Overall Study|Study completion|10|||
126111509|NCT02499770|453703697|FG000|Overall Study|Withdrawal by Subject|0|||
126111510|NCT02499770|453703698|FG001|Overall Study|Withdrawal by Subject|7|||
126111511|NCT02499770|453703697|FG000|Overall Study|Lost to Follow-up|0|||
126111512|NCT02499770|453703698|FG001|Overall Study|Lost to Follow-up|2|||
126111513|NCT02499770|453703697|FG000|Overall Study|Subject declined further treatment|1|||
126111514|NCT02499770|453703698|FG001|Overall Study|Subject declined further treatment|0|||
126111515|NCT02499770|453703697|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
126111516|NCT02499770|453703698|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
126111517|NCT02499770|453703697|FG000|Overall Study|Randomized but not enrolled|0|||
126111518|NCT02499770|453703698|FG001|Overall Study|Randomized but not enrolled|1|||
126111519|NCT01298518|453703702|FG000|Overall Study|Withdrawal by Subject|0|||
126111520|NCT01298518|453703703|FG001|Overall Study|Withdrawal by Subject|0|||
126111521|NCT01298518|453703704|FG002|Overall Study|Withdrawal by Subject|1|||
126111522|NCT02273726|453703705|FG000|Overall Study|Death|70|||
126111523|NCT02273726|453703706|FG001|Overall Study|Death|62|||
126111524|NCT02273726|453703705|FG000|Overall Study|Withdrawal by Subject|41|||
126111525|NCT02273726|453703706|FG001|Overall Study|Withdrawal by Subject|29|||
126111526|NCT02273726|453703705|FG000|Overall Study|Kidney transplant|31|||
126111527|NCT02273726|453703706|FG001|Overall Study|Kidney transplant|39|||
126111528|NCT02273726|453703705|FG000|Overall Study|Physician Decision|30|||
126111529|NCT02273726|453703706|FG001|Overall Study|Physician Decision|15|||
126111530|NCT02273726|453703705|FG000|Overall Study|Adverse Event|27|||
126111531|NCT02273726|453703706|FG001|Overall Study|Adverse Event|9|||
126111532|NCT02273726|453703705|FG000|Overall Study|Lost to Follow-up|6|||
126111533|NCT02273726|453703706|FG001|Overall Study|Lost to Follow-up|3|||
126111534|NCT02273726|453703705|FG000|Overall Study|Lack of Efficacy|6|||
126111535|NCT02273726|453703706|FG001|Overall Study|Lack of Efficacy|1|||
126111536|NCT02273726|453703705|FG000|Overall Study|Protocol Violation|4|||
126111537|NCT02273726|453703706|FG001|Overall Study|Protocol Violation|0|||
126111538|NCT02273726|453703705|FG000|Overall Study|Other than specified|28|||
126111539|NCT02273726|453703706|FG001|Overall Study|Other than specified|30|||
126111540|NCT02129205|453703713|FG000|Overall Study|Withdrawal by Subject|0|||
125923859|NCT01847274|453019355|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923860|NCT01847274|453019356|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923861|NCT01847274|453019357|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
125923862|NCT01847274|453019358|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923863|NCT01847274|453019359|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923864|NCT01847274|453019360|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923865|NCT01847274|453019361|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923866|NCT01847274|453019362|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125923867|NCT01847274|453019352|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923868|NCT01847274|453019353|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923869|NCT01847274|453019354|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923870|NCT01847274|453019355|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923871|NCT01847274|453019356|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
125923872|NCT01847274|453019357|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923873|NCT01847274|453019358|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923874|NCT01847274|453019359|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923875|NCT01847274|453019360|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923876|NCT01847274|453019361|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125971453|NCT01358526|453182851|FG001|Double-blind Phase|Lack of Efficacy|31|||
126111541|NCT02129205|453703714|FG001|Overall Study|Withdrawal by Subject|0|||
126111542|NCT02129205|453703715|FG002|Overall Study|Withdrawal by Subject|0|||
126111543|NCT02129205|453703716|FG003|Overall Study|Withdrawal by Subject|0|||
126111544|NCT02129205|453703717|FG004|Overall Study|Withdrawal by Subject|1|||
126111545|NCT02129205|453703718|FG005|Overall Study|Withdrawal by Subject|1|||
126111546|NCT02129205|453703719|FG006|Overall Study|Withdrawal by Subject|1|||
126111547|NCT02129205|453703720|FG007|Overall Study|Withdrawal by Subject|0|||
126111548|NCT02129205|453703721|FG008|Overall Study|Withdrawal by Subject|1|||
126111549|NCT02129205|453703722|FG009|Overall Study|Withdrawal by Subject|0|||
126111550|NCT02129205|453703713|FG000|Overall Study|Other|1|||
126111551|NCT02129205|453703714|FG001|Overall Study|Other|0|||
126111552|NCT02129205|453703715|FG002|Overall Study|Other|0|||
126111553|NCT02129205|453703716|FG003|Overall Study|Other|0|||
126111554|NCT02129205|453703717|FG004|Overall Study|Other|2|||
126111555|NCT02129205|453703718|FG005|Overall Study|Other|3|||
126111556|NCT02129205|453703719|FG006|Overall Study|Other|3|||
126111557|NCT02129205|453703720|FG007|Overall Study|Other|2|||
126111558|NCT02129205|453703721|FG008|Overall Study|Other|1|||
126111559|NCT02129205|453703722|FG009|Overall Study|Other|0|||
126111560|NCT00866697|453703733|FG000|Overall Study|Study closed/terminated|156|||
126111561|NCT00866697|453703734|FG001|Overall Study|Study closed/terminated|138|||
126111562|NCT00866697|453703733|FG000|Overall Study|Lost to Follow-up|22|||
125923877|NCT01847274|453019362|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125923878|NCT01847274|453019352|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923879|NCT01847274|453019353|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923880|NCT01847274|453019354|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923881|NCT01847274|453019355|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923882|NCT01847274|453019356|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923883|NCT01847274|453019357|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923884|NCT01847274|453019358|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
125923885|NCT01847274|453019359|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923886|NCT01847274|453019360|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923887|NCT01847274|453019361|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923888|NCT01847274|453019362|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125923889|NCT01847274|453019352|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923890|NCT01847274|453019353|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923891|NCT01847274|453019354|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923892|NCT01847274|453019355|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923893|NCT01847274|453019356|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923894|NCT01847274|453019357|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923895|NCT01847274|453019358|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
125923896|NCT01847274|453019359|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923897|NCT01847274|453019360|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923898|NCT01847274|453019361|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923899|NCT01847274|453019362|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125923900|NCT01847274|453019352|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923901|NCT01847274|453019353|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923902|NCT01847274|453019354|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923903|NCT01847274|453019355|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923904|NCT01847274|453019356|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923905|NCT01847274|453019357|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923906|NCT01847274|453019358|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
125923907|NCT01847274|453019359|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923908|NCT01847274|453019360|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923909|NCT01847274|453019361|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923910|NCT01847274|453019362|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125923911|NCT01847274|453019352|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125923912|NCT01847274|453019353|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125923913|NCT01847274|453019354|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125923914|NCT01847274|453019355|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125923915|NCT01847274|453019356|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125923916|NCT01847274|453019357|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125923917|NCT01847274|453019358|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125923918|NCT01847274|453019359|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
125923919|NCT01847274|453019360|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
125923920|NCT01847274|453019361|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
125923921|NCT01847274|453019362|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
125923922|NCT01847274|453019352|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125923923|NCT01847274|453019353|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125923924|NCT01847274|453019354|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125923925|NCT01847274|453019355|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126111563|NCT00866697|453703734|FG001|Overall Study|Lost to Follow-up|28|||
126111564|NCT00866697|453703733|FG000|Overall Study|Physician Decision|3|||
126111565|NCT00866697|453703734|FG001|Overall Study|Physician Decision|5|||
126111566|NCT00866697|453703733|FG000|Overall Study|Withdrawal by Subject|33|||
126111567|NCT00866697|453703734|FG001|Overall Study|Withdrawal by Subject|57|||
126111568|NCT02906787|453703737|FG000|Overall Study|Withdrawal by Subject|12|||
125923926|NCT01847274|453019356|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125923927|NCT01847274|453019357|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125923928|NCT01847274|453019358|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125923929|NCT01847274|453019359|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
125923930|NCT01847274|453019360|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125923931|NCT01847274|453019361|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
125923932|NCT01847274|453019362|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125923933|NCT01847274|453019352|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125923934|NCT01847274|453019353|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125923935|NCT01847274|453019354|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125923936|NCT01847274|453019355|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125923937|NCT01847274|453019356|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125923938|NCT01847274|453019357|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125923939|NCT01847274|453019358|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125923940|NCT01847274|453019359|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
125923941|NCT01847274|453019360|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125923942|NCT01847274|453019361|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
125923943|NCT01847274|453019362|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
125923944|NCT01847274|453019352|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923945|NCT01847274|453019353|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923946|NCT01847274|453019354|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923947|NCT01847274|453019355|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923948|NCT01847274|453019356|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923949|NCT01847274|453019357|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923950|NCT01847274|453019358|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923951|NCT01847274|453019359|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923952|NCT01847274|453019360|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923953|NCT01847274|453019361|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
125923954|NCT01847274|453019362|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125923955|NCT01203098|453019372|FG000|Overall Study|Adverse Event|3|||
125923956|NCT01203098|453019373|FG001|Overall Study|Adverse Event|1|||
125923957|NCT01203098|453019374|FG002|Overall Study|Adverse Event|7|||
125923958|NCT01203098|453019372|FG000|Overall Study|Lost to Follow-up|0|||
125923959|NCT01203098|453019373|FG001|Overall Study|Lost to Follow-up|0|||
125923960|NCT01203098|453019374|FG002|Overall Study|Lost to Follow-up|1|||
125923961|NCT01203098|453019372|FG000|Overall Study|Physician Decision|2|||
125923962|NCT01203098|453019373|FG001|Overall Study|Physician Decision|2|||
125923963|NCT01203098|453019374|FG002|Overall Study|Physician Decision|0|||
125923964|NCT01203098|453019372|FG000|Overall Study|Withdrawal by Subject|1|||
125923965|NCT01203098|453019373|FG001|Overall Study|Withdrawal by Subject|1|||
125923966|NCT01203098|453019374|FG002|Overall Study|Withdrawal by Subject|3|||
125923967|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
125923968|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
125923969|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
125923970|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
125923971|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
125923972|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
125923973|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
125923974|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
125923975|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
125923976|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
125923977|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
125923978|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
125923979|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
125923980|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
125923981|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
125923982|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
125923983|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
125923984|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
125923985|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
125923986|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
125923987|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
125923988|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
125923989|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
125923990|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
126064491|NCT00537914|453527761|FG000|Overall Study|Death|1|||
126064492|NCT00537914|453527761|FG000|Overall Study|Adverse Event|7|||
125923991|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
125923992|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
125923993|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
125923994|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
125923995|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
125923996|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
125923997|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
125923998|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
125923999|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
125924000|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
125924001|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
125924002|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
125924003|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
125924004|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
125924005|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
125924006|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
125924007|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
125924008|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
125924009|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
125924010|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
125924011|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
125924012|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
125924013|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
125924014|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
125924015|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
125924016|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
125924017|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
125924018|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
125924019|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
125924020|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
125924021|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
125924022|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
125924023|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
125924024|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
125924025|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
125924026|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
125924027|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
125924028|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
125924029|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
125924030|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
125924031|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
125924032|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
125924033|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
125924034|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
125924035|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
125924036|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
125924037|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Change of location|0|||
125924038|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Change of location|0|||
125924039|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Change of location|0|||
125924040|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Change of location|1|||
125924041|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Change of location|0|||
125924042|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
125924043|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
125924044|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
125924045|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
125924046|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
125924047|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
125924048|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
125924049|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
125924050|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
125924051|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
125924052|NCT00730405|453019377|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
126064493|NCT00537914|453527761|FG000|Overall Study|Treatment failure|10|||
126089036|NCT01371708|453620056|FG000|Overall Study|Insufficient clinical response|3|||
125924053|NCT00730405|453019378|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
125924054|NCT00730405|453019379|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
125924055|NCT00730405|453019380|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
125924056|NCT00730405|453019381|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
125924057|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
125924058|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
125924059|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
125924060|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
125924061|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
125924062|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
125924063|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
125924064|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
125924065|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
125924066|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
125924067|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
125924068|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
125924069|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
125924070|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
125924071|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
125924072|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Death|0|||
125924073|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Death|1|||
125924074|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Death|0|||
125924075|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Death|1|||
125924076|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Death|0|||
125924077|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Change of location|1|||
125924078|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Change of location|1|||
125924079|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Change of location|0|||
125924080|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Change of location|1|||
125924081|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Change of location|0|||
125924082|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
125924083|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
125924084|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
125924085|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
125924086|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
125924087|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
125924088|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
125924089|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
125924090|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
125924091|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
125924092|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
125924093|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
125924094|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
125924095|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
125924096|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
125924097|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
125924098|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
125924099|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
125924100|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
125924101|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
125924102|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
125924103|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
125924104|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
125924105|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
125924106|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
125924107|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
125924108|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
125924109|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
125924110|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
125924111|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
125924112|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
125924113|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
125924114|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
125924115|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
125924116|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
125924117|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
125924118|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
125924119|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
125924120|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
125924121|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
126064494|NCT00537914|453527761|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
126064495|NCT00537914|453527761|FG000|Overall Study|Lost to Follow-up|19|||
126064496|NCT00537914|453527761|FG000|Overall Study|Withdrawal of informed consent|59|||
126064497|NCT02312258|453527762|FG000|Overall Study|Lost to Follow-up|8|||
126064498|NCT02312258|453527763|FG001|Overall Study|Lost to Follow-up|8|||
126064499|NCT02312258|453527762|FG000|Overall Study|Withdrawal by Patient|49|||
126064500|NCT02312258|453527763|FG001|Overall Study|Withdrawal by Patient|76|||
126064501|NCT02312258|453527762|FG000|Overall Study|Reason not Specified|107|||
126064502|NCT02312258|453527763|FG001|Overall Study|Reason not Specified|159|||
126064503|NCT02312258|453527762|FG000|Overall Study|Missing|2|||
126064504|NCT02312258|453527763|FG001|Overall Study|Missing|1|||
126064505|NCT02312258|453527762|FG000|Overall Study|Death|115|||
126064506|NCT02312258|453527763|FG001|Overall Study|Death|181|||
126064507|NCT01468597|453527765|FG000|Overall Study|Found ineligible|17|||
126064508|NCT01468597|453527765|FG000|Overall Study|concomitant valves|12|||
126064509|NCT01468597|453527765|FG000|Overall Study|off-pump CABG|1|||
126064510|NCT01468597|453527765|FG000|Overall Study|no platelet function data|5|||
126064511|NCT02260154|453527766|FG000|Overall Study|Screening failure|2|||
126064512|NCT02561195|453527768|FG000|Vaccination 1 to 3|Adverse Event|4|||
126064513|NCT02561195|453527769|FG001|Vaccination 1 to 3|Adverse Event|5|||
126064514|NCT02561195|453527770|FG002|Vaccination 1 to 3|Adverse Event|0|||
126064515|NCT02561195|453527771|FG003|Vaccination 1 to 3|Adverse Event|3|||
126064516|NCT02561195|453527772|FG004|Vaccination 1 to 3|Adverse Event|4|||
126064517|NCT02561195|453527773|FG005|Vaccination 1 to 3|Adverse Event|0|||
126064518|NCT02561195|453527774|FG006|Vaccination 1 to 3|Adverse Event|0|||
126064519|NCT02561195|453527775|FG007|Vaccination 1 to 3|Adverse Event|0|||
126111569|NCT02906787|453703738|FG001|Overall Study|Withdrawal by Subject|10|||
125924122|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
125924123|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
125924124|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
125924125|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
125924126|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
125924127|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
125924128|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
125924129|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
125924130|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
125924131|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
125924132|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Missing|0|||
125924133|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Missing|0|||
125924134|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Missing|2|||
125924135|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Missing|0|||
125924136|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Missing|0|||
125924137|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
125924138|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
125924139|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
125924140|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
125924141|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
125924142|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
125924143|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
125924144|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
125924145|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
125924146|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
125924147|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
125924148|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
125924149|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
125924150|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
125924151|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
125924152|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
126064520|NCT02561195|453527776|FG008|Vaccination 1 to 3|Adverse Event|0|||
126064521|NCT02561195|453527777|FG009|Vaccination 1 to 3|Adverse Event|0|||
126064522|NCT02561195|453527778|FG010|Vaccination 1 to 3|Adverse Event|0|||
126064523|NCT02561195|453527779|FG011|Vaccination 1 to 3|Adverse Event|0|||
126064524|NCT02561195|453527780|FG012|Vaccination 1 to 3|Adverse Event|0|||
126064525|NCT02561195|453527781|FG013|Vaccination 1 to 3|Adverse Event|0|||
126064526|NCT02561195|453527768|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
126111570|NCT02906787|453703737|FG000|Overall Study|Missed|24|||
126111571|NCT02906787|453703738|FG001|Overall Study|Missed|22|||
126111572|NCT04275297|453703739|FG000|Overall Study|Lost to Follow-up|1|||
126111573|NCT04275297|453703740|FG001|Overall Study|Lost to Follow-up|1|||
126111574|NCT04435782|453703743|FG000|Overall Study|Study terminated by sponsor|4|||
125924153|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
125924154|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
125924155|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
125924156|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
125924157|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
125924158|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
125924159|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
125924160|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
125924161|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
125924162|NCT00730405|453019377|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
125924163|NCT00730405|453019378|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
125924164|NCT00730405|453019379|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
125924165|NCT00730405|453019380|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
125924166|NCT00730405|453019381|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
125924167|NCT03851705|453019382|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
125924168|NCT03851705|453019383|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125924169|NCT03851705|453019384|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125924170|NCT03851705|453019385|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125924171|NCT03851705|453019382|FG000|Part 1: Double-Blind Period|Other reason|1|||
125924172|NCT03851705|453019383|FG001|Part 1: Double-Blind Period|Other reason|0|||
125924173|NCT03851705|453019384|FG002|Part 1: Double-Blind Period|Other reason|0|||
125924174|NCT03851705|453019385|FG003|Part 1: Double-Blind Period|Other reason|0|||
125924175|NCT03851705|453019382|FG000|Part 2: Open-Label Period|Other reason|0|||
125924176|NCT03851705|453019383|FG001|Part 2: Open-Label Period|Other reason|0|||
125924177|NCT03851705|453019384|FG002|Part 2: Open-Label Period|Other reason|0|||
125924178|NCT03851705|453019385|FG003|Part 2: Open-Label Period|Other reason|1|||
125924179|NCT03851705|453019382|FG000|Part 2: Open-Label Period|Death|0|||
125924180|NCT03851705|453019383|FG001|Part 2: Open-Label Period|Death|0|||
125924181|NCT03851705|453019384|FG002|Part 2: Open-Label Period|Death|3|||
125924182|NCT03851705|453019385|FG003|Part 2: Open-Label Period|Death|0|||
125924183|NCT03851705|453019382|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
125924184|NCT03851705|453019383|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
125924185|NCT03851705|453019384|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
125924186|NCT03851705|453019385|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
125924187|NCT01496807|453019389|FG000|Overall Study|Progressive Disease|21|||
125924188|NCT01496807|453019389|FG000|Overall Study|Participant preference/toxicity|8|||
125924189|NCT01496807|453019389|FG000|Overall Study|Change in diagnosis|1|||
125924190|NCT02591290|453019396|FG000|Overall Study|Withdrawal by Subject|2|||
125924191|NCT00913497|453019397|FG000|Overall Study|Adverse Event|1|||
125924192|NCT00913497|453019397|FG000|Overall Study|Withdrawal by Subject|2|||
125924193|NCT02002091|453019404|FG000|Screening|Lost to Follow-up|10|||
125924194|NCT02002091|453019405|FG001|Screening|Lost to Follow-up|12|||
125924195|NCT02002091|453019404|FG000|Screening|Death|3|||
125924196|NCT02002091|453019405|FG001|Screening|Death|2|||
125924197|NCT00369824|453019406|FG000|Overall Study|Adverse Event|0|||
125924198|NCT00369824|453019407|FG001|Overall Study|Adverse Event|2|||
125924199|NCT00369824|453019408|FG002|Overall Study|Adverse Event|0|||
125924200|NCT00369824|453019409|FG003|Overall Study|Adverse Event|0|||
125924201|NCT00369824|453019410|FG004|Overall Study|Adverse Event|1|||
125924202|NCT00369824|453019411|FG005|Overall Study|Adverse Event|0|||
125924203|NCT00369824|453019406|FG000|Overall Study|Protocol Violation|0|||
125924204|NCT00369824|453019407|FG001|Overall Study|Protocol Violation|1|||
125924205|NCT00369824|453019408|FG002|Overall Study|Protocol Violation|0|||
125924206|NCT00369824|453019409|FG003|Overall Study|Protocol Violation|1|||
125924207|NCT00369824|453019410|FG004|Overall Study|Protocol Violation|1|||
125924208|NCT00369824|453019411|FG005|Overall Study|Protocol Violation|0|||
126064527|NCT02561195|453527769|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
126064528|NCT02561195|453527770|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
126064529|NCT02561195|453527771|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
126064530|NCT02561195|453527772|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
126064531|NCT02561195|453527773|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
125924209|NCT00369824|453019406|FG000|Overall Study|Withdrawal by Subject|9|||
126064532|NCT02561195|453527774|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
126064533|NCT02561195|453527775|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
126064534|NCT02561195|453527776|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
126064535|NCT02561195|453527777|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
126064536|NCT02561195|453527778|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
125924210|NCT00369824|453019407|FG001|Overall Study|Withdrawal by Subject|5|||
125924211|NCT00369824|453019408|FG002|Overall Study|Withdrawal by Subject|5|||
126064537|NCT02561195|453527779|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
125924212|NCT00369824|453019409|FG003|Overall Study|Withdrawal by Subject|4|||
125924213|NCT00369824|453019410|FG004|Overall Study|Withdrawal by Subject|6|||
125924214|NCT00369824|453019411|FG005|Overall Study|Withdrawal by Subject|2|||
125924215|NCT00369824|453019406|FG000|Overall Study|Lost to Follow-up|6|||
125924216|NCT00369824|453019407|FG001|Overall Study|Lost to Follow-up|11|||
125924217|NCT00369824|453019408|FG002|Overall Study|Lost to Follow-up|7|||
125924218|NCT00369824|453019409|FG003|Overall Study|Lost to Follow-up|8|||
125924219|NCT00369824|453019410|FG004|Overall Study|Lost to Follow-up|9|||
125924220|NCT00369824|453019411|FG005|Overall Study|Lost to Follow-up|6|||
125924221|NCT00369824|453019406|FG000|Overall Study|Other|0|||
125924222|NCT00369824|453019407|FG001|Overall Study|Other|0|||
125924223|NCT00369824|453019408|FG002|Overall Study|Other|0|||
125924224|NCT00369824|453019409|FG003|Overall Study|Other|2|||
125924225|NCT00369824|453019410|FG004|Overall Study|Other|1|||
125924226|NCT00369824|453019411|FG005|Overall Study|Other|3|||
125924227|NCT01390649|453019412|FG000|Overall Study|Physician Decision|1|||
125924228|NCT03385564|453019414|FG000|Overall Study|Adverse Event|0|||
125924229|NCT03385564|453019415|FG001|Overall Study|Adverse Event|0|||
125924230|NCT03385564|453019416|FG002|Overall Study|Adverse Event|3|||
125924231|NCT03385564|453019417|FG003|Overall Study|Adverse Event|3|||
125924232|NCT03385564|453019414|FG000|Overall Study|Other than listed|0|||
125924233|NCT03385564|453019415|FG001|Overall Study|Other than listed|0|||
125924234|NCT03385564|453019416|FG002|Overall Study|Other than listed|0|||
125924235|NCT03385564|453019417|FG003|Overall Study|Other than listed|5|||
125924236|NCT03385564|453019414|FG000|Overall Study|Withdrawal by Subject|0|||
125924237|NCT03385564|453019415|FG001|Overall Study|Withdrawal by Subject|1|||
125924238|NCT03385564|453019416|FG002|Overall Study|Withdrawal by Subject|1|||
125924239|NCT03385564|453019417|FG003|Overall Study|Withdrawal by Subject|0|||
125924240|NCT03385564|453019414|FG000|Overall Study|Lack of Efficacy|0|||
125924241|NCT03385564|453019415|FG001|Overall Study|Lack of Efficacy|0|||
125924242|NCT03385564|453019416|FG002|Overall Study|Lack of Efficacy|0|||
125924243|NCT03385564|453019417|FG003|Overall Study|Lack of Efficacy|1|||
125924244|NCT03385564|453019414|FG000|Overall Study|Death|0|||
125924245|NCT03385564|453019415|FG001|Overall Study|Death|0|||
125924246|NCT03385564|453019416|FG002|Overall Study|Death|1|||
125924247|NCT03385564|453019417|FG003|Overall Study|Death|0|||
125924248|NCT00622401|453019418|FG000|Overall Study|Disease progression prior to treatment|3|||
125924249|NCT00622401|453019419|FG001|Overall Study|Disease progression prior to treatment|2|||
125924250|NCT00622401|453019420|FG002|Overall Study|Disease progression prior to treatment|0|||
125924251|NCT00590720|453021664|FG000|Overall Study|Lost to Follow-up|1|||
125924252|NCT00590720|453021665|FG001|Overall Study|Lost to Follow-up|0|||
125924253|NCT00590720|453021664|FG000|Overall Study|Withdrawal by Subject|0|||
125924254|NCT00590720|453021665|FG001|Overall Study|Withdrawal by Subject|1|||
125924255|NCT01001377|453021666|FG000|Overall Study|Ineligibility determined|2|||
125924256|NCT01001377|453021667|FG001|Overall Study|Ineligibility determined|0|||
125924257|NCT01001377|453021666|FG000|Overall Study|Withdrawal by Subject|19|||
125924258|NCT01001377|453021667|FG001|Overall Study|Withdrawal by Subject|20|||
125924259|NCT01001377|453021666|FG000|Overall Study|Lost to Follow-up|14|||
125924260|NCT01001377|453021667|FG001|Overall Study|Lost to Follow-up|17|||
125924261|NCT01001377|453021666|FG000|Overall Study|Death|391|||
125924262|NCT01001377|453021667|FG001|Overall Study|Death|384|||
125924263|NCT02193867|453021670|FG000|Overall Study|Death|2|||
125924264|NCT02193867|453021670|FG000|Overall Study|Sponsor Study Termination|2|||
125924265|NCT03616600|453021671|FG000|Overall Study|Withdrawal by Subject|1|||
125924266|NCT03616600|453021672|FG001|Overall Study|Withdrawal by Subject|0|||
125924267|NCT03600818|453021673|FG000|Overall Study|Adverse Event|4|||
125924268|NCT03600818|453021674|FG001|Overall Study|Adverse Event|7|||
125924269|NCT03600818|453021673|FG000|Overall Study|Lack of Efficacy|9|||
125924270|NCT03600818|453021674|FG001|Overall Study|Lack of Efficacy|4|||
125924271|NCT03600818|453021673|FG000|Overall Study|Withdrawal by Subject|4|||
125924272|NCT03600818|453021674|FG001|Overall Study|Withdrawal by Subject|3|||
126064538|NCT02561195|453527780|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
126064539|NCT02561195|453527781|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
126064540|NCT02561195|453527768|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125924273|NCT03600818|453021673|FG000|Overall Study|Other-unspecified|5|||
125924274|NCT03600818|453021674|FG001|Overall Study|Other-unspecified|3|||
125924275|NCT03600818|453021673|FG000|Overall Study|Randomized and not treated|0|||
125924276|NCT03600818|453021674|FG001|Overall Study|Randomized and not treated|1|||
125924277|NCT02849678|453021676|FG000|Overall Study|Protocol Violation|3|||
125924278|NCT02849678|453021677|FG001|Overall Study|Protocol Violation|6|||
125924279|NCT01488370|453021678|FG000|Overall Study|Protocol Violation|0|||
125924280|NCT01488370|453021679|FG001|Overall Study|Protocol Violation|1|||
126064541|NCT02561195|453527769|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
125924281|NCT01488370|453021680|FG002|Overall Study|Protocol Violation|1|||
125924282|NCT01471171|453021681|FG000|Treatment Period 1|Adverse Event|4|||
125924283|NCT01471171|453021682|FG001|Treatment Period 1|Adverse Event|1|||
125924284|NCT01471171|453021681|FG000|Treatment Period 2|Adverse Event|1|||
125924285|NCT01471171|453021682|FG001|Treatment Period 2|Adverse Event|0|||
125924286|NCT03478930|453021684|FG000|Overall Study|Adverse Event|0|||
126111575|NCT01310803|453705780|FG000|Overall Study|Subject terminated by Sponsor|1|||
126111576|NCT01310803|453705781|FG001|Overall Study|Subject terminated by Sponsor|0|||
126111577|NCT01306890|453705782|FG000|Overall Study|Adverse Event|2|||
126111578|NCT01306890|453705782|FG000|Overall Study|Death|1223|||
126111579|NCT01306890|453705782|FG000|Overall Study|Lost to Follow-up|58|||
126111580|NCT01306890|453705782|FG000|Overall Study|Withdrawal by Subject|88|||
126111581|NCT01306890|453705782|FG000|Overall Study|Unspecified reasons|104|||
126111582|NCT01306890|453705782|FG000|Overall Study|Study Termination|3|||
126111583|NCT01306890|453705782|FG000|Overall Study|No discontinuation documentation|41|||
126111584|NCT03739762|453705787|FG000|Overall Study|Lost to Follow-up|1|||
126111585|NCT03739762|453705788|FG001|Overall Study|Lost to Follow-up|1|||
126111586|NCT03739762|453705787|FG000|Overall Study|Withdrawal by Subject|2|||
126111587|NCT03739762|453705788|FG001|Overall Study|Withdrawal by Subject|6|||
126111588|NCT01131351|453705790|FG000|Overall Study|Adverse Event|0|||
126111589|NCT01131351|453705791|FG001|Overall Study|Adverse Event|2|||
126111590|NCT01131351|453705790|FG000|Overall Study|Protocol Deviation|0|||
126111591|NCT01131351|453705791|FG001|Overall Study|Protocol Deviation|1|||
126111592|NCT02294682|453705792|FG000|Overall Study|Could not swallow pills|1|||
126111593|NCT02294682|453705793|FG001|Overall Study|Could not swallow pills|0|||
126111594|NCT03422172|453705796|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
126111595|NCT03422172|453705796|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
126111596|NCT03422172|453705796|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
126111597|NCT03383289|453705797|FG000|Overall Study|Death|83|||
126111598|NCT03383289|453705798|FG001|Overall Study|Death|78|||
126111599|NCT03383289|453705797|FG000|Overall Study|discharge from facility|84|||
126111600|NCT03383289|453705798|FG001|Overall Study|discharge from facility|84|||
126111601|NCT03383289|453705797|FG000|Overall Study|Withdrawal by Subject|4|||
126111602|NCT03383289|453705798|FG001|Overall Study|Withdrawal by Subject|1|||
126111603|NCT00059839|453705801|FG000|Overall Study|Death|1|||
126111604|NCT00059839|453705802|FG001|Overall Study|Death|1|||
126111605|NCT00059839|453705801|FG000|Overall Study|Lack of Efficacy|6|||
126111606|NCT00059839|453705802|FG001|Overall Study|Lack of Efficacy|5|||
126111607|NCT00059839|453705801|FG000|Overall Study|Lost to Follow-up|2|||
126111608|NCT00059839|453705802|FG001|Overall Study|Lost to Follow-up|0|||
126111609|NCT00059839|453705801|FG000|Overall Study|Physician Decision|1|||
126111610|NCT00059839|453705802|FG001|Overall Study|Physician Decision|2|||
126111611|NCT00059839|453705801|FG000|Overall Study|Withdrawal by Subject|1|||
126111612|NCT00059839|453705802|FG001|Overall Study|Withdrawal by Subject|6|||
126111613|NCT00059839|453705801|FG000|Overall Study|Ineligible|1|||
126111614|NCT00059839|453705802|FG001|Overall Study|Ineligible|3|||
126111615|NCT00129623|453705803|FG000|Overall Study|Adverse Event|3|||
126111616|NCT00129623|453705804|FG001|Overall Study|Adverse Event|7|||
126111617|NCT00129623|453705803|FG000|Overall Study|Refused Treatment|5|||
126111618|NCT00129623|453705804|FG001|Overall Study|Refused Treatment|3|||
126111619|NCT00129623|453705803|FG000|Overall Study|Failure to Return|1|||
126111620|NCT00129623|453705804|FG001|Overall Study|Failure to Return|1|||
126111621|NCT00129623|453705803|FG000|Overall Study|Relocated job out of state|1|||
126111622|NCT00129623|453705804|FG001|Overall Study|Relocated job out of state|0|||
126111623|NCT00129623|453705803|FG000|Overall Study|Uncertainty to return|0|||
126111624|NCT00129623|453705804|FG001|Overall Study|Uncertainty to return|1|||
126111625|NCT03155373|453705805|FG000|Overall Study|No longer required surgery|1|||
126111626|NCT03155373|453705805|FG000|Overall Study|Protocol Violation|1|||
126111627|NCT03155373|453705805|FG000|Overall Study|Death|2|||
126111628|NCT03155373|453705805|FG000|Overall Study|Withdrawal by Subject|3|||
126064542|NCT02561195|453527770|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064543|NCT02561195|453527771|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
126064544|NCT02561195|453527772|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
126064545|NCT02561195|453527773|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
126064546|NCT02561195|453527774|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064547|NCT02561195|453527775|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064548|NCT02561195|453527776|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064549|NCT02561195|453527777|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064550|NCT02561195|453527778|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064551|NCT02561195|453527779|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064552|NCT02561195|453527780|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064553|NCT02561195|453527781|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126064554|NCT02561195|453527768|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
126064555|NCT02561195|453527769|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
126064556|NCT02561195|453527770|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
126064557|NCT02561195|453527771|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
126064558|NCT02561195|453527772|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
126064559|NCT02561195|453527773|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
126111629|NCT05352048|453705810|FG000|Overall Study|Lost to Follow-up|1|||
126111630|NCT05352048|453705810|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
125924287|NCT03478930|453021685|FG001|Overall Study|Adverse Event|1|||
125924288|NCT03478930|453021684|FG000|Overall Study|Lack of Efficacy|3|||
125924289|NCT03478930|453021685|FG001|Overall Study|Lack of Efficacy|3|||
125924290|NCT03478930|453021684|FG000|Overall Study|Withdrawal by Subject|6|||
125924291|NCT03478930|453021685|FG001|Overall Study|Withdrawal by Subject|5|||
125924292|NCT04189081|453021686|FG000|Overall Study|Lost to Follow-up|1|||
125924293|NCT04189081|453021687|FG001|Overall Study|Lost to Follow-up|0|||
125924294|NCT04189081|453021688|FG002|Overall Study|Lost to Follow-up|0|||
125924295|NCT04189081|453021686|FG000|Overall Study|Withdrawal by Subject|0|||
125924296|NCT04189081|453021687|FG001|Overall Study|Withdrawal by Subject|0|||
125924297|NCT04189081|453021688|FG002|Overall Study|Withdrawal by Subject|1|||
125924298|NCT00705484|453021693|FG000|Overall Study|Adverse Event|28|||
125924299|NCT00705484|453021694|FG001|Overall Study|Adverse Event|27|||
125924300|NCT00705484|453021693|FG000|Overall Study|Lost to Follow-up|169|||
125924301|NCT00705484|453021694|FG001|Overall Study|Lost to Follow-up|250|||
125924302|NCT00705484|453021693|FG000|Overall Study|Withdrawal by Subject|96|||
125924303|NCT00705484|453021694|FG001|Overall Study|Withdrawal by Subject|72|||
125924304|NCT00705484|453021693|FG000|Overall Study|Administrative|89|||
125924305|NCT00705484|453021694|FG001|Overall Study|Administrative|59|||
125924306|NCT02228460|453021698|FG000|Overall Study|Adverse Event|1|||
125924307|NCT02228460|453021698|FG000|Overall Study|Lost to Follow-up|1|||
125924308|NCT01243892|453021699|FG000|Overall Study|Did not meet eligibility criteria|2|||
125924309|NCT01243892|453021700|FG001|Overall Study|Did not meet eligibility criteria|0|||
125924310|NCT03982368|453021708|FG000|Overall Study|Adverse Event|6|||
125924311|NCT03982368|453021709|FG001|Overall Study|Adverse Event|4|||
125924312|NCT03982368|453021710|FG002|Overall Study|Adverse Event|3|||
125924313|NCT03982368|453021708|FG000|Overall Study|Lost to Follow-up|2|||
125924314|NCT03982368|453021709|FG001|Overall Study|Lost to Follow-up|1|||
126064560|NCT02561195|453527774|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
126064561|NCT02561195|453527775|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
126064562|NCT02561195|453527776|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
125924315|NCT03982368|453021710|FG002|Overall Study|Lost to Follow-up|0|||
125924316|NCT03982368|453021708|FG000|Overall Study|Withdrawal by Subject|1|||
125924317|NCT03982368|453021709|FG001|Overall Study|Withdrawal by Subject|2|||
125924318|NCT03982368|453021710|FG002|Overall Study|Withdrawal by Subject|0|||
125924319|NCT03982368|453021708|FG000|Overall Study|unknow|4|||
125924320|NCT03982368|453021709|FG001|Overall Study|unknow|0|||
125924321|NCT03982368|453021710|FG002|Overall Study|unknow|2|||
125924322|NCT03706079|453021711|FG000|Predecessor Study|Death|0|||
125924323|NCT03706079|453021712|FG001|Predecessor Study|Death|2|||
125924324|NCT03706079|453021713|FG002|Predecessor Study|Death|0|||
125924325|NCT03706079|453021714|FG003|Predecessor Study|Death|1|||
125924326|NCT03706079|453021715|FG004|Predecessor Study|Death|0|||
125924327|NCT03706079|453021716|FG005|Predecessor Study|Death|0|||
125924328|NCT03706079|453021711|FG000|Predecessor Study|Lost to Follow-up|5|||
125924329|NCT03706079|453021712|FG001|Predecessor Study|Lost to Follow-up|2|||
125924330|NCT03706079|453021713|FG002|Predecessor Study|Lost to Follow-up|0|||
125924331|NCT03706079|453021714|FG003|Predecessor Study|Lost to Follow-up|0|||
125924332|NCT03706079|453021715|FG004|Predecessor Study|Lost to Follow-up|1|||
126064563|NCT02561195|453527777|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
126064564|NCT02561195|453527778|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
126064565|NCT02561195|453527779|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
126064566|NCT02561195|453527780|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
126064567|NCT02561195|453527781|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
126064568|NCT02561195|453527768|FG000|Vaccination 1 to 3|Other|7|||
126064569|NCT02561195|453527769|FG001|Vaccination 1 to 3|Other|3|||
126064570|NCT02561195|453527770|FG002|Vaccination 1 to 3|Other|1|||
126064571|NCT02561195|453527771|FG003|Vaccination 1 to 3|Other|7|||
126064572|NCT02561195|453527772|FG004|Vaccination 1 to 3|Other|5|||
126064573|NCT02561195|453527773|FG005|Vaccination 1 to 3|Other|1|||
126064574|NCT02561195|453527774|FG006|Vaccination 1 to 3|Other|0|||
126064575|NCT02561195|453527775|FG007|Vaccination 1 to 3|Other|0|||
126064576|NCT02561195|453527776|FG008|Vaccination 1 to 3|Other|0|||
126064577|NCT02561195|453527777|FG009|Vaccination 1 to 3|Other|0|||
126064578|NCT02561195|453527778|FG010|Vaccination 1 to 3|Other|0|||
126064579|NCT02561195|453527779|FG011|Vaccination 1 to 3|Other|0|||
126064580|NCT02561195|453527780|FG012|Vaccination 1 to 3|Other|0|||
126064581|NCT02561195|453527781|FG013|Vaccination 1 to 3|Other|0|||
126111631|NCT01214187|453705811|FG000|Overall Study|Adverse Event|6|||
126111632|NCT01214187|453705812|FG001|Overall Study|Adverse Event|2|||
125924333|NCT03706079|453021716|FG005|Predecessor Study|Lost to Follow-up|0|||
125924334|NCT03706079|453021711|FG000|Predecessor Study|Withdrawal by Subject|8|||
125924335|NCT03706079|453021712|FG001|Predecessor Study|Withdrawal by Subject|15|||
125924336|NCT03706079|453021713|FG002|Predecessor Study|Withdrawal by Subject|0|||
125924337|NCT03706079|453021714|FG003|Predecessor Study|Withdrawal by Subject|5|||
125924338|NCT03706079|453021715|FG004|Predecessor Study|Withdrawal by Subject|2|||
125924339|NCT03706079|453021716|FG005|Predecessor Study|Withdrawal by Subject|0|||
126064582|NCT02561195|453527768|FG000|Vaccination 1 to 3|Protocol Violation|1|||
126064583|NCT02561195|453527769|FG001|Vaccination 1 to 3|Protocol Violation|0|||
126064584|NCT02561195|453527770|FG002|Vaccination 1 to 3|Protocol Violation|1|||
125924340|NCT03706079|453021711|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
125924341|NCT03706079|453021712|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
125924342|NCT03706079|453021713|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
125924343|NCT03706079|453021714|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
125924344|NCT03706079|453021715|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
125924345|NCT03706079|453021716|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
125924346|NCT03706079|453021711|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125924347|NCT03706079|453021712|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125924348|NCT03706079|453021713|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125924349|NCT03706079|453021714|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125924350|NCT03706079|453021715|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125924351|NCT03706079|453021716|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
125924352|NCT03706079|453021711|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
125924353|NCT03706079|453021712|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
125924354|NCT03706079|453021713|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
125924355|NCT03706079|453021714|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
125924356|NCT03706079|453021715|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
125924357|NCT03706079|453021716|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
125924358|NCT03706079|453021711|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
125924359|NCT03706079|453021712|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
125924360|NCT03706079|453021713|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
125924361|NCT03706079|453021714|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
125924362|NCT03706079|453021715|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
125924363|NCT03706079|453021716|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
125924364|NCT03706079|453021711|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
125924365|NCT03706079|453021712|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
125924366|NCT03706079|453021713|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
125924367|NCT03706079|453021714|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
125924368|NCT03706079|453021715|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
125924369|NCT03706079|453021716|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
125924370|NCT03706079|453021711|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
125924371|NCT03706079|453021712|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
125924372|NCT03706079|453021713|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
125924373|NCT03706079|453021714|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
125924374|NCT03706079|453021715|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
125924375|NCT03706079|453021716|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
125924376|NCT03706079|453021711|FG000|Long Term Extension (DESTINATION)|Death|8|||
125924377|NCT03706079|453021712|FG001|Long Term Extension (DESTINATION)|Death|2|||
125924378|NCT03706079|453021713|FG002|Long Term Extension (DESTINATION)|Death|2|||
125924379|NCT03706079|453021714|FG003|Long Term Extension (DESTINATION)|Death|1|||
125924380|NCT03706079|453021715|FG004|Long Term Extension (DESTINATION)|Death|0|||
125924381|NCT03706079|453021716|FG005|Long Term Extension (DESTINATION)|Death|0|||
125924382|NCT00329238|453021717|FG000|Overall Study|Adverse Event|147|||
125924383|NCT00329238|453021718|FG001|Overall Study|Adverse Event|129|||
125924384|NCT00329238|453021717|FG000|Overall Study|Protocol Violation|23|||
125924385|NCT00329238|453021718|FG001|Overall Study|Protocol Violation|34|||
125924386|NCT00329238|453021717|FG000|Overall Study|Lost to Follow-up|2|||
125924387|NCT00329238|453021718|FG001|Overall Study|Lost to Follow-up|6|||
125924388|NCT00329238|453021717|FG000|Overall Study|Withdrawal by Subject|64|||
125924389|NCT00329238|453021718|FG001|Overall Study|Withdrawal by Subject|58|||
125924390|NCT00329238|453021717|FG000|Overall Study|Other reason (not specified)|40|||
125924391|NCT00329238|453021718|FG001|Overall Study|Other reason (not specified)|54|||
125924392|NCT05393895|453021721|FG000|Overall Study|Adverse Event|2|||
125924393|NCT05393895|453021722|FG001|Overall Study|Adverse Event|3|||
125924394|NCT05393895|453021721|FG000|Overall Study|Lost to Follow-up|4|||
125924395|NCT05393895|453021722|FG001|Overall Study|Lost to Follow-up|3|||
125924396|NCT05393895|453021721|FG000|Overall Study|Protocol Violation|1|||
125924397|NCT05393895|453021722|FG001|Overall Study|Protocol Violation|0|||
125924398|NCT05393895|453021721|FG000|Overall Study|Withdrawal by Subject|1|||
125924399|NCT05393895|453021722|FG001|Overall Study|Withdrawal by Subject|4|||
125924400|NCT00968513|453021725|FG000|Overall Study|Death|4|||
125924401|NCT00968513|453021726|FG001|Overall Study|Death|10|||
125924402|NCT00968513|453021727|FG002|Overall Study|Death|15|||
125924403|NCT05537883|453021728|FG000|Overall Study|revisional surgery|4|||
126064585|NCT02561195|453527771|FG003|Vaccination 1 to 3|Protocol Violation|2|||
126064586|NCT02561195|453527772|FG004|Vaccination 1 to 3|Protocol Violation|5|||
125924404|NCT05537883|453021729|FG001|Overall Study|revisional surgery|2|||
125924405|NCT05537883|453021728|FG000|Overall Study|surgeries were cancelled|0|||
125924406|NCT05537883|453021729|FG001|Overall Study|surgeries were cancelled|2|||
125924407|NCT05537883|453021728|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
125924408|NCT05537883|453021729|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
125924409|NCT01302834|453021730|FG000|Overall Study|Protocol Violation|17|||
125924410|NCT01302834|453021731|FG001|Overall Study|Protocol Violation|23|||
126064587|NCT02561195|453527773|FG005|Vaccination 1 to 3|Protocol Violation|2|||
126064588|NCT02561195|453527774|FG006|Vaccination 1 to 3|Protocol Violation|0|||
126064589|NCT02561195|453527775|FG007|Vaccination 1 to 3|Protocol Violation|0|||
126064590|NCT02561195|453527776|FG008|Vaccination 1 to 3|Protocol Violation|0|||
126064591|NCT02561195|453527777|FG009|Vaccination 1 to 3|Protocol Violation|0|||
126064592|NCT02561195|453527778|FG010|Vaccination 1 to 3|Protocol Violation|0|||
126064593|NCT02561195|453527779|FG011|Vaccination 1 to 3|Protocol Violation|0|||
126064594|NCT02561195|453527780|FG012|Vaccination 1 to 3|Protocol Violation|0|||
126064595|NCT02561195|453527781|FG013|Vaccination 1 to 3|Protocol Violation|0|||
126064596|NCT02561195|453527768|FG000|Vaccination 1 to 3|Death|2|||
126064597|NCT02561195|453527769|FG001|Vaccination 1 to 3|Death|1|||
126064598|NCT02561195|453527770|FG002|Vaccination 1 to 3|Death|0|||
126064599|NCT02561195|453527771|FG003|Vaccination 1 to 3|Death|2|||
126064600|NCT02561195|453527772|FG004|Vaccination 1 to 3|Death|0|||
126064601|NCT02561195|453527773|FG005|Vaccination 1 to 3|Death|0|||
126064602|NCT02561195|453527774|FG006|Vaccination 1 to 3|Death|0|||
126064603|NCT02561195|453527775|FG007|Vaccination 1 to 3|Death|0|||
126064604|NCT02561195|453527776|FG008|Vaccination 1 to 3|Death|0|||
126064605|NCT02561195|453527777|FG009|Vaccination 1 to 3|Death|0|||
126064606|NCT02561195|453527778|FG010|Vaccination 1 to 3|Death|0|||
126064607|NCT02561195|453527779|FG011|Vaccination 1 to 3|Death|0|||
126064608|NCT02561195|453527780|FG012|Vaccination 1 to 3|Death|0|||
126064609|NCT02561195|453527781|FG013|Vaccination 1 to 3|Death|0|||
126064610|NCT02561195|453527768|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
126064611|NCT02561195|453527769|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
126064612|NCT02561195|453527770|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
126064613|NCT02561195|453527771|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
126064614|NCT02561195|453527772|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
126064615|NCT02561195|453527773|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064616|NCT02561195|453527774|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064617|NCT02561195|453527775|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064618|NCT02561195|453527776|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064619|NCT02561195|453527777|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064620|NCT02561195|453527778|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064621|NCT02561195|453527779|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064622|NCT02561195|453527780|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064623|NCT02561195|453527781|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
126064624|NCT02561195|453527768|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
126064625|NCT02561195|453527769|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
126064626|NCT02561195|453527770|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
126064627|NCT02561195|453527771|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
126064628|NCT02561195|453527772|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
126064629|NCT02561195|453527773|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
126064630|NCT02561195|453527774|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
126064631|NCT02561195|453527775|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
126064632|NCT02561195|453527776|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
126064633|NCT02561195|453527777|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
126064634|NCT02561195|453527778|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
126064635|NCT02561195|453527779|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
126064636|NCT02561195|453527780|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
126064637|NCT02561195|453527781|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
126064638|NCT02561195|453527768|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126064639|NCT02561195|453527769|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126064640|NCT02561195|453527770|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126064641|NCT02561195|453527771|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125924411|NCT01302834|453021730|FG000|Overall Study|HIV positive|1|||
126064642|NCT02561195|453527772|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126064643|NCT02561195|453527773|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126064644|NCT02561195|453527774|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125924412|NCT01302834|453021731|FG001|Overall Study|HIV positive|3|||
126064645|NCT02561195|453527775|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126064646|NCT02561195|453527776|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
126064647|NCT02561195|453527777|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
126064648|NCT02561195|453527778|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
126064649|NCT02561195|453527779|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
126064650|NCT02561195|453527780|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
126064651|NCT02561195|453527781|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126064652|NCT02561195|453527768|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
126111633|NCT01214187|453705811|FG000|Overall Study|Death|1|||
126111634|NCT01214187|453705812|FG001|Overall Study|Death|1|||
126111635|NCT01214187|453705811|FG000|Overall Study|Withdrawal by Subject|0|||
126111636|NCT01214187|453705812|FG001|Overall Study|Withdrawal by Subject|3|||
126111637|NCT01233869|453705820|FG000|Initial Treatment Period (24 Months)|Death|1|||
126111638|NCT01233869|453705821|FG001|Initial Treatment Period (24 Months)|Death|0|||
126111639|NCT01233869|453705822|FG002|Initial Treatment Period (24 Months)|Death|0|||
126111640|NCT01233869|453705823|FG003|Initial Treatment Period (24 Months)|Death|0|||
126111641|NCT01233869|453705820|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
126111642|NCT01233869|453705821|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
126111643|NCT01233869|453705822|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
126111644|NCT01233869|453705823|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
126111645|NCT01233869|453705820|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
126111646|NCT01233869|453705821|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
126111647|NCT01233869|453705822|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
126111648|NCT01233869|453705823|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
126111649|NCT01233869|453705820|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
126111650|NCT01233869|453705821|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
126111651|NCT01233869|453705822|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
126111652|NCT01233869|453705823|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
126111653|NCT01233869|453705820|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
126111654|NCT01233869|453705821|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
126111655|NCT01233869|453705822|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
126111656|NCT01233869|453705823|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
126111657|NCT01233869|453705820|FG000|Extended Treatment Period (46 Months)|Other|3|||
126111658|NCT01233869|453705821|FG001|Extended Treatment Period (46 Months)|Other|0|||
126111659|NCT01233869|453705822|FG002|Extended Treatment Period (46 Months)|Other|0|||
126111660|NCT01233869|453705823|FG003|Extended Treatment Period (46 Months)|Other|3|||
126111661|NCT01233869|453705820|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
126111662|NCT01233869|453705821|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
126111663|NCT01233869|453705822|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
126111664|NCT01233869|453705823|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
126111665|NCT03678103|453705824|FG000|Overall Study|Withdrawn prior to completion|4|||
126111666|NCT00537485|453705825|FG000|Overall Study|Adverse Event|10|||
126111667|NCT00537485|453705826|FG001|Overall Study|Adverse Event|5|||
126111668|NCT00537485|453705825|FG000|Overall Study|Withdrawal by Subject|3|||
126111669|NCT00537485|453705826|FG001|Overall Study|Withdrawal by Subject|2|||
126111670|NCT00537485|453705825|FG000|Overall Study|Withdrawal by Subject|1|||
126111671|NCT00537485|453705826|FG001|Overall Study|Withdrawal by Subject|3|||
126111672|NCT00537485|453705825|FG000|Overall Study|Physician Decision|1|||
126111673|NCT00537485|453705826|FG001|Overall Study|Physician Decision|0|||
126111674|NCT01241552|453705832|FG000|Overall Study|Lack of Efficacy|1|||
126111675|NCT01241552|453705833|FG001|Overall Study|Lack of Efficacy|0|||
126111676|NCT01241552|453705834|FG002|Overall Study|Lack of Efficacy|0|||
126111677|NCT01241552|453705835|FG003|Overall Study|Lack of Efficacy|0|||
126111678|NCT01241552|453705832|FG000|Overall Study|Death|26|||
126111679|NCT01241552|453705833|FG001|Overall Study|Death|30|||
126111680|NCT01241552|453705834|FG002|Overall Study|Death|20|||
126111681|NCT01241552|453705835|FG003|Overall Study|Death|25|||
126111682|NCT01241552|453705832|FG000|Overall Study|Adverse Event|1|||
126111683|NCT01241552|453705833|FG001|Overall Study|Adverse Event|1|||
126111684|NCT01241552|453705834|FG002|Overall Study|Adverse Event|0|||
126111685|NCT01241552|453705835|FG003|Overall Study|Adverse Event|0|||
126111686|NCT01241552|453705832|FG000|Overall Study|Technical Problems|2|||
126111687|NCT01241552|453705833|FG001|Overall Study|Technical Problems|0|||
126111688|NCT01241552|453705834|FG002|Overall Study|Technical Problems|2|||
126111689|NCT01241552|453705835|FG003|Overall Study|Technical Problems|2|||
126111690|NCT01241552|453705832|FG000|Overall Study|Progressive Disease|0|||
126111691|NCT01241552|453705833|FG001|Overall Study|Progressive Disease|0|||
126111692|NCT01241552|453705834|FG002|Overall Study|Progressive Disease|1|||
126111693|NCT01241552|453705835|FG003|Overall Study|Progressive Disease|2|||
126111694|NCT01241552|453705832|FG000|Overall Study|Protocol Violation|0|||
126111695|NCT01241552|453705833|FG001|Overall Study|Protocol Violation|2|||
126111696|NCT01241552|453705834|FG002|Overall Study|Protocol Violation|6|||
126111697|NCT01241552|453705835|FG003|Overall Study|Protocol Violation|1|||
126111698|NCT01241552|453705832|FG000|Overall Study|Withdrawal by Subject|7|||
126111699|NCT01241552|453705833|FG001|Overall Study|Withdrawal by Subject|15|||
126111700|NCT01241552|453705834|FG002|Overall Study|Withdrawal by Subject|14|||
126111701|NCT01241552|453705835|FG003|Overall Study|Withdrawal by Subject|15|||
126111702|NCT01241552|453705832|FG000|Overall Study|Physician Decision|2|||
126111703|NCT01241552|453705833|FG001|Overall Study|Physician Decision|4|||
126111704|NCT01241552|453705834|FG002|Overall Study|Physician Decision|2|||
126111705|NCT01241552|453705835|FG003|Overall Study|Physician Decision|3|||
126111706|NCT01241552|453705832|FG000|Overall Study|Lost to Follow-up|2|||
126111707|NCT01241552|453705833|FG001|Overall Study|Lost to Follow-up|11|||
125924413|NCT01328431|453021732|FG000|Baseline|Protocol Violation|0|||
125924414|NCT01328431|453021733|FG001|Baseline|Protocol Violation|2|||
125924415|NCT01328431|453021732|FG000|1 Month (1M)|Lost to Follow-up|55|||
125924416|NCT01328431|453021733|FG001|1 Month (1M)|Lost to Follow-up|58|||
125924417|NCT01328431|453021732|FG000|3 Month (3M)|Death|2|||
125924418|NCT01328431|453021733|FG001|3 Month (3M)|Death|2|||
126111708|NCT01241552|453705834|FG002|Overall Study|Lost to Follow-up|15|||
126111709|NCT01241552|453705835|FG003|Overall Study|Lost to Follow-up|16|||
125924419|NCT01328431|453021732|FG000|3 Month (3M)|Lost to Follow-up|75|||
125924420|NCT01328431|453021733|FG001|3 Month (3M)|Lost to Follow-up|70|||
125924421|NCT01328431|453021732|FG000|12 Month (12M)|Death|2|||
125924422|NCT01328431|453021733|FG001|12 Month (12M)|Death|6|||
125924423|NCT01328431|453021732|FG000|12 Month (12M)|Lost to Follow-up|82|||
125924424|NCT01328431|453021733|FG001|12 Month (12M)|Lost to Follow-up|91|||
125924425|NCT05379231|453021734|FG000|Home Visit|Withdrawal by Subject|2|||
125924426|NCT05379231|453021734|FG000|In-lab Visit|Withdrawal by Subject|2|||
125924427|NCT02296320|453021741|FG000|Overall Study|Withdrawal by Subject|4|||
125924428|NCT02296320|453021742|FG001|Overall Study|Withdrawal by Subject|0|||
125924429|NCT02296320|453021743|FG002|Overall Study|Withdrawal by Subject|2|||
125924430|NCT02296320|453021741|FG000|Overall Study|Death|24|||
125924431|NCT02296320|453021742|FG001|Overall Study|Death|3|||
125924432|NCT02296320|453021743|FG002|Overall Study|Death|27|||
125924433|NCT02296320|453021741|FG000|Overall Study|Lost to Follow-up|5|||
125924434|NCT02296320|453021742|FG001|Overall Study|Lost to Follow-up|2|||
125924435|NCT02296320|453021743|FG002|Overall Study|Lost to Follow-up|7|||
125924436|NCT02296320|453021741|FG000|Overall Study|Not treated|2|||
125924437|NCT02296320|453021742|FG001|Overall Study|Not treated|0|||
125924438|NCT02296320|453021743|FG002|Overall Study|Not treated|0|||
125924439|NCT02296320|453021741|FG000|Overall Study|Not - specified|0|||
125924440|NCT02296320|453021742|FG001|Overall Study|Not - specified|0|||
125924441|NCT02296320|453021743|FG002|Overall Study|Not - specified|1|||
125924442|NCT01874054|453021746|FG000|Overall Study|Withdrawal by Subject|3|||
125924443|NCT01874054|453021746|FG000|Overall Study|Study Termination by Sponsor|42|||
125924444|NCT01874054|453021746|FG000|Overall Study|Lost to Follow-up|5|||
125924445|NCT01874054|453021746|FG000|Overall Study|Death|5|||
125924446|NCT00702923|453021747|FG000|Overall Study|Adverse Event|1|||
125924447|NCT03087643|453021752|FG000|Overall Study|Withdrawal by Subject|2|||
125924448|NCT03087643|453021753|FG001|Overall Study|Withdrawal by Subject|4|||
125924449|NCT03087643|453021752|FG000|Overall Study|Death|2|||
125924450|NCT03087643|453021753|FG001|Overall Study|Death|2|||
125924451|NCT02083783|453021757|FG000|Overall Study|Withdrawal by Subject|1|||
125924452|NCT02083783|453021758|FG001|Overall Study|Withdrawal by Subject|0|||
125924453|NCT01546883|453021761|FG000|Overall Study|Withdrawal by Subject|3|||
125924454|NCT01546883|453021761|FG000|Overall Study|Adverse Event|4|||
125924455|NCT01546883|453021761|FG000|Overall Study|Lost to Follow-up|2|||
125924456|NCT01546883|453021761|FG000|Overall Study|early closure of study|2|||
125924457|NCT01546883|453021761|FG000|Overall Study|other unrelated illness|1|||
125924458|NCT02256631|453021765|FG000|Overall Study|Lost to Follow-up|1|||
125924459|NCT02256631|453021766|FG001|Overall Study|Lost to Follow-up|1|||
125924460|NCT02256631|453021767|FG002|Overall Study|Lost to Follow-up|0|||
125924461|NCT02256631|453021768|FG003|Overall Study|Lost to Follow-up|2|||
125924462|NCT02256631|453021769|FG004|Overall Study|Lost to Follow-up|0|||
125924463|NCT02256631|453021770|FG005|Overall Study|Lost to Follow-up|4|||
125924464|NCT02256631|453021771|FG006|Overall Study|Lost to Follow-up|1|||
125924465|NCT02256631|453021765|FG000|Overall Study|Withdrawal by Subject|0|||
125924466|NCT02256631|453021766|FG001|Overall Study|Withdrawal by Subject|0|||
125924467|NCT02256631|453021767|FG002|Overall Study|Withdrawal by Subject|0|||
125924468|NCT02256631|453021768|FG003|Overall Study|Withdrawal by Subject|1|||
125924469|NCT02256631|453021769|FG004|Overall Study|Withdrawal by Subject|1|||
125924470|NCT02256631|453021770|FG005|Overall Study|Withdrawal by Subject|0|||
125924471|NCT02256631|453021771|FG006|Overall Study|Withdrawal by Subject|1|||
125924472|NCT02256631|453021765|FG000|Overall Study|Unable to get to clinic|0|||
125924473|NCT02256631|453021766|FG001|Overall Study|Unable to get to clinic|2|||
125924474|NCT02256631|453021767|FG002|Overall Study|Unable to get to clinic|0|||
125924475|NCT02256631|453021768|FG003|Overall Study|Unable to get to clinic|1|||
125924476|NCT02256631|453021769|FG004|Overall Study|Unable to get to clinic|0|||
125924477|NCT02256631|453021770|FG005|Overall Study|Unable to get to clinic|1|||
125924478|NCT02256631|453021771|FG006|Overall Study|Unable to get to clinic|2|||
125924479|NCT01427972|453021772|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924480|NCT01427972|453021773|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126111710|NCT01296035|453705837|FG000|Overall Study|Withdrawal by Subject|1|||
126111711|NCT05696236|453705842|FG000|Overall Study|Lost to Follow-up|1|||
125924481|NCT01427972|453021774|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924482|NCT01427972|453021775|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924483|NCT01427972|453021776|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924484|NCT01427972|453021777|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924485|NCT01427972|453021778|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924486|NCT01427972|453021779|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
125924487|NCT01427972|453021780|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924488|NCT01427972|453021781|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126064653|NCT02561195|453527769|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064654|NCT02561195|453527770|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064655|NCT02561195|453527771|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064656|NCT02561195|453527772|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064657|NCT02561195|453527773|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064658|NCT02561195|453527774|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064659|NCT02561195|453527775|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064660|NCT02561195|453527776|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064661|NCT02561195|453527777|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064662|NCT02561195|453527778|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064663|NCT02561195|453527779|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064664|NCT02561195|453527780|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
126064665|NCT02561195|453527781|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
126064666|NCT02561195|453527768|FG000|Extension Stage (Vaccination 4)|Death|0|||
126064667|NCT02561195|453527769|FG001|Extension Stage (Vaccination 4)|Death|0|||
126064668|NCT02561195|453527770|FG002|Extension Stage (Vaccination 4)|Death|0|||
126064669|NCT02561195|453527771|FG003|Extension Stage (Vaccination 4)|Death|0|||
126064670|NCT02561195|453527772|FG004|Extension Stage (Vaccination 4)|Death|0|||
126064671|NCT02561195|453527773|FG005|Extension Stage (Vaccination 4)|Death|0|||
126064672|NCT02561195|453527774|FG006|Extension Stage (Vaccination 4)|Death|0|||
126064673|NCT02561195|453527775|FG007|Extension Stage (Vaccination 4)|Death|0|||
126064674|NCT02561195|453527776|FG008|Extension Stage (Vaccination 4)|Death|0|||
126064675|NCT02561195|453527777|FG009|Extension Stage (Vaccination 4)|Death|1|||
126064676|NCT02561195|453527778|FG010|Extension Stage (Vaccination 4)|Death|0|||
126064677|NCT02561195|453527779|FG011|Extension Stage (Vaccination 4)|Death|0|||
126064678|NCT02561195|453527780|FG012|Extension Stage (Vaccination 4)|Death|0|||
126064679|NCT02561195|453527781|FG013|Extension Stage (Vaccination 4)|Death|0|||
126064680|NCT02561195|453527768|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126064681|NCT02561195|453527769|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126064682|NCT02561195|453527770|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126064683|NCT02561195|453527771|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126064684|NCT02561195|453527772|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126064685|NCT02561195|453527773|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126064686|NCT02561195|453527774|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
126064687|NCT02561195|453527775|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
126064688|NCT02561195|453527776|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126064689|NCT02561195|453527777|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126064690|NCT02561195|453527778|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
126064691|NCT02561195|453527779|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
126064692|NCT02561195|453527780|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
126064693|NCT02561195|453527781|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
126064694|NCT02561195|453527768|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064695|NCT02561195|453527769|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064696|NCT02561195|453527770|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064697|NCT02561195|453527771|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064698|NCT02561195|453527772|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064699|NCT02561195|453527773|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064700|NCT02561195|453527774|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064701|NCT02561195|453527775|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064702|NCT02561195|453527776|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064703|NCT02561195|453527777|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064704|NCT02561195|453527778|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126064705|NCT02561195|453527779|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
126064706|NCT02561195|453527780|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
126064707|NCT02561195|453527781|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
126064708|NCT02561195|453527768|FG000|Extension Stage (Vaccination 4)|Other|0|||
126064709|NCT02561195|453527769|FG001|Extension Stage (Vaccination 4)|Other|0|||
126064710|NCT02561195|453527770|FG002|Extension Stage (Vaccination 4)|Other|0|||
126064711|NCT02561195|453527771|FG003|Extension Stage (Vaccination 4)|Other|0|||
126064712|NCT02561195|453527772|FG004|Extension Stage (Vaccination 4)|Other|0|||
126064713|NCT02561195|453527773|FG005|Extension Stage (Vaccination 4)|Other|0|||
126064714|NCT02561195|453527774|FG006|Extension Stage (Vaccination 4)|Other|0|||
126064715|NCT02561195|453527775|FG007|Extension Stage (Vaccination 4)|Other|0|||
126064716|NCT02561195|453527776|FG008|Extension Stage (Vaccination 4)|Other|0|||
126064717|NCT02561195|453527777|FG009|Extension Stage (Vaccination 4)|Other|0|||
126064718|NCT02561195|453527778|FG010|Extension Stage (Vaccination 4)|Other|2|||
126064719|NCT02561195|453527779|FG011|Extension Stage (Vaccination 4)|Other|2|||
126111712|NCT05696236|453705843|FG001|Overall Study|Lost to Follow-up|0|||
126111713|NCT05696236|453705842|FG000|Overall Study|Later determined to not be eligible for participation|0|||
126111714|NCT05696236|453705843|FG001|Overall Study|Later determined to not be eligible for participation|1|||
126111715|NCT05696236|453705842|FG000|Overall Study|Withdrawal by Subject|2|||
126111716|NCT05696236|453705843|FG001|Overall Study|Withdrawal by Subject|2|||
125924489|NCT01427972|453021782|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924490|NCT01427972|453021783|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125924491|NCT01427972|453021772|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924492|NCT01427972|453021773|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924493|NCT01427972|453021774|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924494|NCT01427972|453021775|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924495|NCT01427972|453021776|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924496|NCT01427972|453021777|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
125924497|NCT01427972|453021778|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924498|NCT01427972|453021779|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924499|NCT01427972|453021780|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924500|NCT01427972|453021781|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924501|NCT01427972|453021782|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924502|NCT01427972|453021783|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125924503|NCT01427972|453021772|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924504|NCT01427972|453021773|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
125924505|NCT01427972|453021774|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924506|NCT01427972|453021775|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924507|NCT01427972|453021776|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924508|NCT01427972|453021777|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924509|NCT01427972|453021778|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924510|NCT01427972|453021779|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924511|NCT01427972|453021780|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924512|NCT01427972|453021781|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924513|NCT01427972|453021782|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924514|NCT01427972|453021783|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125924515|NCT00530946|453021784|FG000|Overall Study|Adverse Event|1|||
125924516|NCT00530946|453021785|FG001|Overall Study|Adverse Event|2|||
125924517|NCT00530946|453021786|FG002|Overall Study|Adverse Event|1|||
125924518|NCT00530946|453021787|FG003|Overall Study|Adverse Event|1|||
125924519|NCT00530946|453021784|FG000|Overall Study|Protocol Violation|0|||
125924520|NCT00530946|453021785|FG001|Overall Study|Protocol Violation|0|||
125924521|NCT00530946|453021786|FG002|Overall Study|Protocol Violation|0|||
125924522|NCT00530946|453021787|FG003|Overall Study|Protocol Violation|1|||
125924523|NCT00530946|453021784|FG000|Overall Study|Noncompliance|1|||
125924524|NCT00530946|453021785|FG001|Overall Study|Noncompliance|0|||
125924525|NCT00530946|453021786|FG002|Overall Study|Noncompliance|0|||
125924526|NCT00530946|453021787|FG003|Overall Study|Noncompliance|0|||
125924527|NCT00457301|453021788|FG000|Overall Study|Withdrawal by Subject|3|||
125924528|NCT00457301|453021789|FG001|Overall Study|Withdrawal by Subject|3|||
125924529|NCT00457301|453021788|FG000|Overall Study|Censored out of the study|15|||
125924530|NCT00457301|453021789|FG001|Overall Study|Censored out of the study|14|||
125924531|NCT00457301|453021788|FG000|Overall Study|Death|5|||
125924532|NCT00457301|453021789|FG001|Overall Study|Death|7|||
125924533|NCT00880009|453021790|FG000|Overall Study|Study terminated by sponsor|14|||
125924534|NCT00880009|453021790|FG000|Overall Study|Withdrawal by Subject|1|||
125924535|NCT00880009|453021790|FG000|Overall Study|Protocol Violation|1|||
125924536|NCT02378961|453021791|FG000|Overall Study|Lack of Efficacy|4|||
125924537|NCT02378961|453021792|FG001|Overall Study|Lack of Efficacy|2|||
125924538|NCT02378961|453021793|FG002|Overall Study|Lack of Efficacy|0|||
125924539|NCT02378961|453021794|FG003|Overall Study|Lack of Efficacy|1|||
125924540|NCT02378961|453021791|FG000|Overall Study|Death|0|||
125924541|NCT02378961|453021792|FG001|Overall Study|Death|0|||
125924542|NCT02378961|453021793|FG002|Overall Study|Death|1|||
125924543|NCT02378961|453021794|FG003|Overall Study|Death|0|||
125924544|NCT01253408|453021795|FG000|Overall Study|Adverse Event|0|||
125924545|NCT01253408|453021796|FG001|Overall Study|Adverse Event|1|||
125924546|NCT01253408|453021797|FG002|Overall Study|Adverse Event|0|||
125924547|NCT03035409|453021799|FG000|Overall Study|Adverse Event|5|||
125924548|NCT03035409|453021799|FG000|Overall Study|Death|2|||
125924549|NCT03035409|453021799|FG000|Overall Study|Withdrawal by Subject|2|||
125924550|NCT03035409|453021799|FG000|Overall Study|Non compliance|4|||
125924551|NCT03035409|453021799|FG000|Overall Study|Patient was jittery|1|||
125924552|NCT03035409|453021799|FG000|Overall Study|Did not like Questionnaire|1|||
125924553|NCT03035409|453021799|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
125924554|NCT03035409|453021799|FG000|Overall Study|Did not like taking drugs|1|||
125924555|NCT01552694|453021800|FG000|Overall Study|Lost to Follow-up|0|||
125924556|NCT01552694|453021801|FG001|Overall Study|Lost to Follow-up|1|||
125924557|NCT01552694|453021800|FG000|Overall Study|Protocol Violation|0|||
125924558|NCT01552694|453021801|FG001|Overall Study|Protocol Violation|1|||
125924559|NCT03724032|453021803|FG000|Overall Study|Physician Decision|1|||
125924560|NCT03724032|453021804|FG001|Overall Study|Physician Decision|0|||
125924561|NCT03724032|453021805|FG002|Overall Study|Physician Decision|0|||
125924562|NCT03724032|453021803|FG000|Overall Study|Protocol Violation|2|||
125924563|NCT03724032|453021804|FG001|Overall Study|Protocol Violation|2|||
125924564|NCT03724032|453021805|FG002|Overall Study|Protocol Violation|1|||
125924565|NCT00001880|453021809|FG000|Overall Study|Death|14|||
125924566|NCT02657369|453021810|FG000|Overall Study|Death|27|||
125924567|NCT02657369|453021810|FG000|Overall Study|Study terminated by sponsor|7|||
125924568|NCT00361569|453021811|FG000|Overall Study|Protocol Violation|3|||
125924569|NCT00361569|453021812|FG001|Overall Study|Protocol Violation|2|||
125924570|NCT00361569|453021813|FG002|Overall Study|Protocol Violation|4|||
125924571|NCT00361569|453021814|FG003|Overall Study|Protocol Violation|2|||
125924572|NCT00361569|453021811|FG000|Overall Study|Withdrawal by Subject|2|||
125924573|NCT00361569|453021812|FG001|Overall Study|Withdrawal by Subject|1|||
125924574|NCT00361569|453021813|FG002|Overall Study|Withdrawal by Subject|9|||
125924575|NCT00361569|453021814|FG003|Overall Study|Withdrawal by Subject|14|||
125924576|NCT00361569|453021811|FG000|Overall Study|Adverse Event|3|||
125924577|NCT00361569|453021812|FG001|Overall Study|Adverse Event|5|||
125924578|NCT00361569|453021813|FG002|Overall Study|Adverse Event|2|||
125924579|NCT00361569|453021814|FG003|Overall Study|Adverse Event|2|||
125924580|NCT00361569|453021811|FG000|Overall Study|Lost to Follow-up|2|||
125924581|NCT00361569|453021812|FG001|Overall Study|Lost to Follow-up|3|||
125924582|NCT00361569|453021813|FG002|Overall Study|Lost to Follow-up|3|||
125924583|NCT00361569|453021814|FG003|Overall Study|Lost to Follow-up|2|||
125924584|NCT00361569|453021811|FG000|Overall Study|Not specified by investigator|2|||
125924585|NCT00361569|453021812|FG001|Overall Study|Not specified by investigator|0|||
125924586|NCT00361569|453021813|FG002|Overall Study|Not specified by investigator|0|||
125924587|NCT00361569|453021814|FG003|Overall Study|Not specified by investigator|1|||
125924588|NCT02639065|453021815|FG000|Study Treatment|Disease Progression|13|||
125924589|NCT02639065|453021815|FG000|Study Treatment|Adverse Event|9|||
125924590|NCT02639065|453021815|FG000|Study Treatment|Withdrawal by Subject|1|||
125924591|NCT02639065|453021815|FG000|Follow up|Subject refused to follow up|1|||
125924592|NCT02639065|453021815|FG000|Follow up|Symptomatic Deterioration|2|||
125924593|NCT02639065|453021815|FG000|Follow up|Death|2|||
125924594|NCT02639065|453021815|FG000|Follow up|Study Terminated|1|||
125924595|NCT02639065|453021815|FG000|Follow up|Disease Progression|3|||
125924596|NCT00481078|453021816|FG000|Overall Study|Progression of disease|11|||
125924597|NCT00481078|453021817|FG001|Overall Study|Progression of disease|11|||
125924598|NCT00481078|453021816|FG000|Overall Study|Adverse Event|15|||
125924599|NCT00481078|453021817|FG001|Overall Study|Adverse Event|3|||
125924600|NCT00481078|453021816|FG000|Overall Study|Death|5|||
125924601|NCT00481078|453021817|FG001|Overall Study|Death|3|||
125924602|NCT00481078|453021816|FG000|Overall Study|Intercurrent illness|1|||
125924603|NCT00481078|453021817|FG001|Overall Study|Intercurrent illness|0|||
125924604|NCT00481078|453021816|FG000|Overall Study|Withdrawal by Subject|7|||
125924605|NCT00481078|453021817|FG001|Overall Study|Withdrawal by Subject|1|||
125924606|NCT00481078|453021816|FG000|Overall Study|Information not available|1|||
125924607|NCT00481078|453021817|FG001|Overall Study|Information not available|0|||
125924608|NCT00481078|453021816|FG000|Overall Study|Received other treatment|2|||
125924609|NCT00481078|453021817|FG001|Overall Study|Received other treatment|1|||
125924610|NCT00481078|453021816|FG000|Overall Study|Brain metastasis|0|||
125924611|NCT00481078|453021817|FG001|Overall Study|Brain metastasis|1|||
125924612|NCT01558271|453021818|FG000|Overall Study|Adverse Event|6|||
125924613|NCT01558271|453021819|FG001|Overall Study|Adverse Event|3|||
125924614|NCT01558271|453021820|FG002|Overall Study|Adverse Event|4|||
125924615|NCT01558271|453021818|FG000|Overall Study|Lost to Follow-up|1|||
125924616|NCT01558271|453021819|FG001|Overall Study|Lost to Follow-up|0|||
125924617|NCT01558271|453021820|FG002|Overall Study|Lost to Follow-up|0|||
125924618|NCT01558271|453021818|FG000|Overall Study|Protocol Violation|1|||
125924619|NCT01558271|453021819|FG001|Overall Study|Protocol Violation|0|||
125924620|NCT01558271|453021820|FG002|Overall Study|Protocol Violation|0|||
125924621|NCT01558271|453021818|FG000|Overall Study|Withdrawal by Subject|10|||
125924622|NCT01558271|453021819|FG001|Overall Study|Withdrawal by Subject|6|||
125924623|NCT01558271|453021820|FG002|Overall Study|Withdrawal by Subject|12|||
125924624|NCT01558271|453021818|FG000|Overall Study|Physician Decision|0|||
125924625|NCT01558271|453021819|FG001|Overall Study|Physician Decision|2|||
125924626|NCT01558271|453021820|FG002|Overall Study|Physician Decision|1|||
125924627|NCT01845831|453021821|FG000|Inpatient Phase|Withdrawal by Subject|1|||
125924628|NCT01845831|453021822|FG001|Inpatient Phase|Withdrawal by Subject|1|||
125924629|NCT01845831|453021823|FG002|Inpatient Phase|Withdrawal by Subject|0|||
125924630|NCT01845831|453021824|FG003|Inpatient Phase|Withdrawal by Subject|0|||
125924631|NCT01845831|453021825|FG004|Inpatient Phase|Withdrawal by Subject|0|||
125924632|NCT02610725|453021826|FG000|Overall Study|Lost to Follow-up|197|||
125924633|NCT02610725|453021826|FG000|Overall Study|self-reported contraindication|9|||
125924634|NCT04094883|453021827|FG000|Overall Study|Withdrawal by Subject|1|||
125924635|NCT00826943|453021828|FG000|Overall Study|Withdrawal by Subject|0|||
125924636|NCT00826943|453021829|FG001|Overall Study|Withdrawal by Subject|0|||
125924637|NCT00826943|453021830|FG002|Overall Study|Withdrawal by Subject|0|||
125924638|NCT00826943|453021831|FG003|Overall Study|Withdrawal by Subject|0|||
125924639|NCT00826943|453021832|FG004|Overall Study|Withdrawal by Subject|1|||
125924640|NCT00826943|453021833|FG005|Overall Study|Withdrawal by Subject|0|||
125924641|NCT01348165|453021834|FG000|Overall Study|Adverse Event|0|||
125924642|NCT01348165|453021835|FG001|Overall Study|Adverse Event|0|||
125924643|NCT01348165|453021836|FG002|Overall Study|Adverse Event|0|||
125924644|NCT01348165|453021837|FG003|Overall Study|Adverse Event|0|||
125924645|NCT01348165|453021838|FG004|Overall Study|Adverse Event|0|||
125924646|NCT01348165|453021839|FG005|Overall Study|Adverse Event|0|||
125924647|NCT01348165|453021840|FG006|Overall Study|Adverse Event|1|||
125924648|NCT01594762|453021841|FG000|Overall Study|Withdrawal by Subject|1|||
125924649|NCT01594762|453021842|FG001|Overall Study|Withdrawal by Subject|0|||
125924650|NCT01594762|453021841|FG000|Overall Study|Lost to Follow-up|10|||
125924651|NCT01594762|453021842|FG001|Overall Study|Lost to Follow-up|10|||
125924652|NCT01446289|453021843|FG000|Overall Study|Withdrawal by Subject|1|||
125924653|NCT01446289|453021844|FG001|Overall Study|Withdrawal by Subject|0|||
125924654|NCT01446289|453021845|FG002|Overall Study|Withdrawal by Subject|1|||
125924655|NCT01446289|453021846|FG003|Overall Study|Withdrawal by Subject|0|||
125924656|NCT02302807|453021847|FG000|Overall Study|Withdrawal by Subject|28|||
125924657|NCT02302807|453021848|FG001|Overall Study|Withdrawal by Subject|11|||
125924658|NCT02302807|453021847|FG000|Overall Study|Lost to Follow-up|4|||
125924659|NCT02302807|453021848|FG001|Overall Study|Lost to Follow-up|6|||
125924660|NCT02302807|453021847|FG000|Overall Study|Death|397|||
125924661|NCT02302807|453021848|FG001|Overall Study|Death|385|||
125924662|NCT02302807|453021847|FG000|Overall Study|Study Terminated By Sponsor|35|||
125924663|NCT02302807|453021848|FG001|Overall Study|Study Terminated By Sponsor|64|||
125924664|NCT02302807|453021847|FG000|Overall Study|Physician Decision|0|||
125924665|NCT02302807|453021848|FG001|Overall Study|Physician Decision|1|||
125924666|NCT03329573|453021849|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
125924667|NCT03329573|453021850|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
125924668|NCT03329573|453021851|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
125924669|NCT03329573|453021852|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
125924670|NCT03329573|453021849|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
125924671|NCT03329573|453021850|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
125924672|NCT03329573|453021851|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125924673|NCT03329573|453021852|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125924674|NCT03329573|453021849|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
125924675|NCT03329573|453021850|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
125924676|NCT03329573|453021851|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
125924677|NCT03329573|453021852|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
125924678|NCT03329573|453021849|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
125924679|NCT03329573|453021850|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
125924680|NCT03329573|453021851|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
125924681|NCT03329573|453021852|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
125924682|NCT03307967|453021855|FG000|Overall Study|Lost to Follow-up|4|||
125924683|NCT02166905|453021856|FG000|Overall Study|Withdrawal by Subject|1|||
125924684|NCT02166905|453021857|FG001|Overall Study|Withdrawal by Subject|0|||
125924685|NCT02166905|453021858|FG002|Overall Study|Withdrawal by Subject|0|||
125924686|NCT02166905|453021859|FG003|Overall Study|Withdrawal by Subject|0|||
125924687|NCT02617628|453021860|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
125924688|NCT02617628|453021861|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
125924689|NCT05243641|453021865|FG000|Overall Study|Adverse Event|3|||
125924690|NCT05243641|453021866|FG001|Overall Study|Adverse Event|0|||
125924691|NCT05243641|453021867|FG002|Overall Study|Adverse Event|0|||
126064720|NCT02561195|453527780|FG012|Extension Stage (Vaccination 4)|Other|1|||
126064721|NCT02561195|453527781|FG013|Extension Stage (Vaccination 4)|Other|0|||
126064722|NCT02561195|453527768|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126064723|NCT02561195|453527769|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126064724|NCT02561195|453527770|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126064725|NCT02561195|453527771|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126064726|NCT02561195|453527772|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125924692|NCT05243641|453021868|FG003|Overall Study|Adverse Event|1|||
125924693|NCT05243641|453021869|FG004|Overall Study|Adverse Event|0|||
125924694|NCT05243641|453021870|FG005|Overall Study|Adverse Event|0|||
125924695|NCT05243641|453021865|FG000|Overall Study|Disease progression|4|||
125924696|NCT05243641|453021866|FG001|Overall Study|Disease progression|0|||
125924697|NCT05243641|453021867|FG002|Overall Study|Disease progression|0|||
125924698|NCT05243641|453021868|FG003|Overall Study|Disease progression|2|||
125924699|NCT05243641|453021869|FG004|Overall Study|Disease progression|0|||
125924700|NCT05243641|453021870|FG005|Overall Study|Disease progression|0|||
125924701|NCT04518306|453021871|FG000|Double-Blind Period|Run in failure|0|||
125924702|NCT04518306|453021872|FG001|Double-Blind Period|Run in failure|0|||
126064727|NCT02561195|453527773|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126064728|NCT02561195|453527774|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
126064729|NCT02561195|453527775|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125924703|NCT04518306|453021873|FG002|Double-Blind Period|Run in failure|1|||
125924704|NCT04518306|453021871|FG000|Double-Blind Period|Adverse Event|0|||
125924705|NCT04518306|453021872|FG001|Double-Blind Period|Adverse Event|2|||
125924706|NCT04518306|453021873|FG002|Double-Blind Period|Adverse Event|2|||
125924707|NCT04518306|453021871|FG000|Double-Blind Period|Lost to Follow-up|1|||
125924708|NCT04518306|453021872|FG001|Double-Blind Period|Lost to Follow-up|2|||
125924709|NCT04518306|453021873|FG002|Double-Blind Period|Lost to Follow-up|2|||
125924710|NCT04518306|453021871|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
125924711|NCT04518306|453021872|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
125924712|NCT04518306|453021873|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
125924713|NCT04518306|453021871|FG000|Double-Blind Period|Other|0|||
125924714|NCT04518306|453021872|FG001|Double-Blind Period|Other|2|||
125924715|NCT04518306|453021873|FG002|Double-Blind Period|Other|0|||
125924716|NCT04518306|453021871|FG000|Double-Blind Period|Missing|0|||
125924717|NCT04518306|453021872|FG001|Double-Blind Period|Missing|1|||
125924718|NCT04518306|453021873|FG002|Double-Blind Period|Missing|0|||
125924719|NCT05372419|453021874|FG000|Overall Study|Protocol Deviation|1|||
125924720|NCT05372419|453021874|FG000|Overall Study|Withdrawal by Subject|5|||
125924721|NCT05372419|453021874|FG000|Overall Study|Lost to Follow-up|7|||
125924722|NCT02801331|453021875|FG000|Overall Study|Transferred to another hospital|8|||
125924723|NCT02801331|453021876|FG001|Overall Study|Transferred to another hospital|7|||
125924724|NCT02801331|453021875|FG000|Overall Study|Withdrawal by Subject|0|||
125924725|NCT02801331|453021876|FG001|Overall Study|Withdrawal by Subject|4|||
125924726|NCT02801331|453021875|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
125924727|NCT02801331|453021876|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
125924728|NCT03253744|453021878|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
125924729|NCT03253744|453021879|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
125924730|NCT03253744|453021880|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
125924731|NCT03253744|453021881|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
125924732|NCT04698187|453021885|FG000|Overall Study|Withdrawal by Subject|7|||
125924733|NCT04698187|453021885|FG000|Overall Study|Death|21|||
125924734|NCT04698187|453021885|FG000|Overall Study|Sponsor Decision|15|||
125924735|NCT04698187|453021885|FG000|Overall Study|In-transit Disease|1|||
125924736|NCT03904043|453021886|FG000|Overall Study|Adverse Event|1|||
125924737|NCT03904043|453021887|FG001|Overall Study|Adverse Event|1|||
125924738|NCT03904043|453021886|FG000|Overall Study|Withdrawal by Subject|1|||
125924739|NCT03904043|453021887|FG001|Overall Study|Withdrawal by Subject|0|||
125924740|NCT03904043|453021886|FG000|Overall Study|Non-compliance|1|||
125924741|NCT03904043|453021887|FG001|Overall Study|Non-compliance|0|||
125924742|NCT03904043|453021886|FG000|Overall Study|Did not start treatment|1|||
125924743|NCT03904043|453021887|FG001|Overall Study|Did not start treatment|0|||
125924744|NCT01133522|453021888|FG000|Overall Study|Withdrawal by Subject|0|||
125924745|NCT01133522|453021889|FG001|Overall Study|Withdrawal by Subject|1|||
125924746|NCT01133522|453021890|FG002|Overall Study|Withdrawal by Subject|0|||
125924747|NCT01133522|453021891|FG003|Overall Study|Withdrawal by Subject|1|||
125924748|NCT01133522|453021892|FG004|Overall Study|Withdrawal by Subject|0|||
125924749|NCT01133522|453021893|FG005|Overall Study|Withdrawal by Subject|0|||
125924750|NCT01133522|453021894|FG006|Overall Study|Withdrawal by Subject|0|||
125924751|NCT01133522|453021895|FG007|Overall Study|Withdrawal by Subject|0|||
125924752|NCT01133522|453021896|FG008|Overall Study|Withdrawal by Subject|0|||
125924753|NCT01133522|453021897|FG009|Overall Study|Withdrawal by Subject|0|||
125924754|NCT01133522|453021888|FG000|Overall Study|Physician Decision|0|||
125924755|NCT01133522|453021889|FG001|Overall Study|Physician Decision|0|||
125924756|NCT01133522|453021890|FG002|Overall Study|Physician Decision|0|||
125924757|NCT01133522|453021891|FG003|Overall Study|Physician Decision|0|||
125924758|NCT01133522|453021892|FG004|Overall Study|Physician Decision|1|||
125924759|NCT01133522|453021893|FG005|Overall Study|Physician Decision|0|||
125924760|NCT01133522|453021894|FG006|Overall Study|Physician Decision|0|||
125924761|NCT01133522|453021895|FG007|Overall Study|Physician Decision|0|||
125924762|NCT01133522|453021896|FG008|Overall Study|Physician Decision|0|||
125924763|NCT01133522|453021897|FG009|Overall Study|Physician Decision|0|||
125924764|NCT02469298|453023402|FG000|Overall Study|Protocol Violation|0|||
125924765|NCT02469298|453023403|FG001|Overall Study|Protocol Violation|1|||
126064730|NCT02561195|453527776|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126064731|NCT02561195|453527777|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125924766|NCT02469298|453023404|FG002|Overall Study|Protocol Violation|1|||
125924767|NCT02469298|453023405|FG003|Overall Study|Protocol Violation|0|||
125924768|NCT02469298|453023402|FG000|Overall Study|Lost to Follow-up|1|||
125924769|NCT02469298|453023403|FG001|Overall Study|Lost to Follow-up|0|||
125924770|NCT02469298|453023404|FG002|Overall Study|Lost to Follow-up|1|||
125924771|NCT02469298|453023405|FG003|Overall Study|Lost to Follow-up|0|||
125924772|NCT02469298|453023402|FG000|Overall Study|Physician Decision|0|||
125924773|NCT02469298|453023403|FG001|Overall Study|Physician Decision|0|||
126064732|NCT02561195|453527778|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
125924774|NCT02469298|453023404|FG002|Overall Study|Physician Decision|0|||
125924775|NCT02469298|453023405|FG003|Overall Study|Physician Decision|1|||
125924776|NCT02469298|453023402|FG000|Overall Study|Withdrawal by Subject|0|||
125924777|NCT02469298|453023403|FG001|Overall Study|Withdrawal by Subject|0|||
125924778|NCT02469298|453023404|FG002|Overall Study|Withdrawal by Subject|0|||
125924779|NCT02469298|453023405|FG003|Overall Study|Withdrawal by Subject|1|||
125924780|NCT02954237|453023408|FG000|Overall Study|Withdrawal by Subject|25|||
125924781|NCT02954237|453023408|FG000|Overall Study|Missed visit|16|||
125924782|NCT02954237|453023408|FG000|Overall Study|Death|2|||
125924783|NCT02853604|453023409|FG000|Overall Study|Withdrawal by Subject|12|||
125924784|NCT02853604|453023410|FG001|Overall Study|Withdrawal by Subject|35|||
125924785|NCT02853604|453023409|FG000|Overall Study|Lost to Follow-up|4|||
125924786|NCT02853604|453023410|FG001|Overall Study|Lost to Follow-up|8|||
125924787|NCT02853604|453023409|FG000|Overall Study|Death|1|||
125924788|NCT02853604|453023410|FG001|Overall Study|Death|5|||
125924789|NCT02853604|453023409|FG000|Overall Study|Miscellaneous|11|||
125924790|NCT02853604|453023410|FG001|Overall Study|Miscellaneous|2|||
125924791|NCT02853604|453023409|FG000|Overall Study|Progressive Disease|0|||
125924792|NCT02853604|453023410|FG001|Overall Study|Progressive Disease|2|||
125924793|NCT00964860|453023411|FG000|Overall Study|Withdrawal by Subject|0|||
125924794|NCT00964860|453023412|FG001|Overall Study|Withdrawal by Subject|1|||
125924795|NCT03716024|453023413|FG000|Overall Study|Randomized, not Treated|7|||
125924796|NCT03716024|453023414|FG001|Overall Study|Randomized, not Treated|8|||
125924797|NCT03716024|453023413|FG000|Overall Study|Adverse Event|1|||
125924798|NCT03716024|453023414|FG001|Overall Study|Adverse Event|2|||
125924799|NCT03716024|453023413|FG000|Overall Study|Treatment Failure|1|||
125924800|NCT03716024|453023414|FG001|Overall Study|Treatment Failure|0|||
125924801|NCT03716024|453023413|FG000|Overall Study|Lost to Follow-up|2|||
125924802|NCT03716024|453023414|FG001|Overall Study|Lost to Follow-up|6|||
125924803|NCT03716024|453023413|FG000|Overall Study|Withdrawal by Subject|0|||
125924804|NCT03716024|453023414|FG001|Overall Study|Withdrawal by Subject|1|||
125924805|NCT03716024|453023413|FG000|Overall Study|Missing Reason|0|||
125924806|NCT03716024|453023414|FG001|Overall Study|Missing Reason|1|||
125924807|NCT00867568|453023415|FG000|Overall Study|Lack of Efficacy|10|||
125924808|NCT00867568|453023415|FG000|Overall Study|Adverse Event|4|||
125924809|NCT00867568|453023415|FG000|Overall Study|Withdrawal by Subject|1|||
125924810|NCT04343261|453023416|FG000|Overall Study|Adverse Event|1|||
125924811|NCT04343261|453023416|FG000|Overall Study|received inadequate amount of antibodies|7|||
125924812|NCT04623216|453023421|FG000|Overall Study|Death|5|||
125924813|NCT04623216|453023422|FG001|Overall Study|Death|2|||
125924814|NCT04623216|453023423|FG002|Overall Study|Death|0|||
125924815|NCT04623216|453023424|FG003|Overall Study|Death|0|||
125924816|NCT04623216|453023421|FG000|Overall Study|Terminated by Sponsor|3|||
125924817|NCT04623216|453023422|FG001|Overall Study|Terminated by Sponsor|2|||
125924818|NCT04623216|453023423|FG002|Overall Study|Terminated by Sponsor|2|||
125924819|NCT04623216|453023424|FG003|Overall Study|Terminated by Sponsor|0|||
125924820|NCT04623216|453023421|FG000|Overall Study|Physician Decision|1|||
125924821|NCT04623216|453023422|FG001|Overall Study|Physician Decision|0|||
125924822|NCT04623216|453023423|FG002|Overall Study|Physician Decision|0|||
125924823|NCT04623216|453023424|FG003|Overall Study|Physician Decision|0|||
125924824|NCT01651039|453023425|FG000|Overall Study|Non-evaluables|5|||
125924825|NCT01651039|453023425|FG000|Overall Study|Physician Decision|2|||
125924826|NCT01651039|453023425|FG000|Overall Study|Withdrawal by Subject|1|||
125924827|NCT01651039|453023425|FG000|Overall Study|Progressive Disease|22|||
125924828|NCT04930965|453023428|FG000|Overall Study|Lost to Follow-up|7|||
125924829|NCT04930965|453023429|FG001|Overall Study|Lost to Follow-up|5|||
125924830|NCT02059395|453023430|FG000|Overall Study|Lost to Follow-up|2|||
125924831|NCT02059395|453023431|FG001|Overall Study|Lost to Follow-up|4|||
125924832|NCT00134082|453023432|FG000|Overall Study|Adverse Event|2|||
125924833|NCT00134082|453023432|FG000|Overall Study|Death|1|||
125924834|NCT00044083|453023433|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
125924835|NCT00044083|453023434|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
125924836|NCT00044083|453023433|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
125924837|NCT00044083|453023434|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
125924838|NCT00044083|453023433|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
125924839|NCT00044083|453023434|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
125924840|NCT00044083|453023433|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
125924841|NCT00044083|453023434|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
125924842|NCT00044083|453023433|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
125924843|NCT00044083|453023434|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
125924844|NCT00044083|453023433|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
125924845|NCT00044083|453023434|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
125924846|NCT00044083|453023433|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
125924847|NCT00044083|453023434|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
125924848|NCT00044083|453023433|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
125924849|NCT00044083|453023434|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
125924850|NCT00044083|453023433|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
125924851|NCT00044083|453023434|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
125924852|NCT00044083|453023433|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
125924853|NCT00044083|453023434|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
125924854|NCT00119106|453023435|FG000|Overall Study|HIV infected at baseline|179|||
125924855|NCT00119106|453023436|FG001|Overall Study|HIV infected at baseline|178|||
125924856|NCT03066804|453023437|FG000|Overall Study|Physician Decision|0|||
125924857|NCT03066804|453023438|FG001|Overall Study|Physician Decision|4|||
125924858|NCT03066804|453023437|FG000|Overall Study|Death|23|||
125924859|NCT03066804|453023438|FG001|Overall Study|Death|17|||
125924860|NCT03066804|453023437|FG000|Overall Study|Withdrawal by Subject|19|||
125924861|NCT03066804|453023438|FG001|Overall Study|Withdrawal by Subject|25|||
125924862|NCT03066804|453023437|FG000|Overall Study|Lost to Follow-up|2|||
125924863|NCT03066804|453023438|FG001|Overall Study|Lost to Follow-up|0|||
125924864|NCT03066804|453023437|FG000|Overall Study|Adverse Event|2|||
125924865|NCT03066804|453023438|FG001|Overall Study|Adverse Event|3|||
125924866|NCT03066804|453023437|FG000|Overall Study|Technical problems|5|||
125924867|NCT03066804|453023438|FG001|Overall Study|Technical problems|1|||
125924868|NCT03310021|453023440|FG000|Overall Study|Withdrawal by Subject|0|||
125924869|NCT03310021|453023441|FG001|Overall Study|Withdrawal by Subject|0|||
125924870|NCT03310021|453023442|FG002|Overall Study|Withdrawal by Subject|0|||
125924871|NCT03310021|453023443|FG003|Overall Study|Withdrawal by Subject|0|||
125924872|NCT03310021|453023444|FG004|Overall Study|Withdrawal by Subject|0|||
125924873|NCT03310021|453023445|FG005|Overall Study|Withdrawal by Subject|0|||
125924874|NCT03310021|453023446|FG006|Overall Study|Withdrawal by Subject|1|||
125924875|NCT03310021|453023447|FG007|Overall Study|Withdrawal by Subject|0|||
125924876|NCT03310021|453023448|FG008|Overall Study|Withdrawal by Subject|0|||
125924877|NCT03310021|453023449|FG009|Overall Study|Withdrawal by Subject|0|||
125924878|NCT03310021|453023450|FG010|Overall Study|Withdrawal by Subject|0|||
125924879|NCT03310021|453023451|FG011|Overall Study|Withdrawal by Subject|0|||
125924880|NCT03310021|453023452|FG012|Overall Study|Withdrawal by Subject|0|||
125924881|NCT03310021|453023453|FG013|Overall Study|Withdrawal by Subject|0|||
125924882|NCT03310021|453023454|FG014|Overall Study|Withdrawal by Subject|0|||
125924883|NCT03310021|453023455|FG015|Overall Study|Withdrawal by Subject|0|||
125924884|NCT03310021|453023456|FG016|Overall Study|Withdrawal by Subject|0|||
125924885|NCT03310021|453023457|FG017|Overall Study|Withdrawal by Subject|0|||
125924886|NCT03310021|453023458|FG018|Overall Study|Withdrawal by Subject|0|||
125924887|NCT03310021|453023459|FG019|Overall Study|Withdrawal by Subject|0|||
125924888|NCT03310021|453023440|FG000|Overall Study|Lost to Follow-up|0|||
125924889|NCT03310021|453023441|FG001|Overall Study|Lost to Follow-up|0|||
125924890|NCT03310021|453023442|FG002|Overall Study|Lost to Follow-up|0|||
125924891|NCT03310021|453023443|FG003|Overall Study|Lost to Follow-up|0|||
125924892|NCT03310021|453023444|FG004|Overall Study|Lost to Follow-up|0|||
125924893|NCT03310021|453023445|FG005|Overall Study|Lost to Follow-up|0|||
125924894|NCT03310021|453023446|FG006|Overall Study|Lost to Follow-up|0|||
125924895|NCT03310021|453023447|FG007|Overall Study|Lost to Follow-up|0|||
125924896|NCT03310021|453023448|FG008|Overall Study|Lost to Follow-up|0|||
125924897|NCT03310021|453023449|FG009|Overall Study|Lost to Follow-up|0|||
125924898|NCT03310021|453023450|FG010|Overall Study|Lost to Follow-up|1|||
125924899|NCT03310021|453023451|FG011|Overall Study|Lost to Follow-up|0|||
125924900|NCT03310021|453023452|FG012|Overall Study|Lost to Follow-up|0|||
125924901|NCT03310021|453023453|FG013|Overall Study|Lost to Follow-up|0|||
125924902|NCT03310021|453023454|FG014|Overall Study|Lost to Follow-up|0|||
125924903|NCT03310021|453023455|FG015|Overall Study|Lost to Follow-up|0|||
125924904|NCT03310021|453023456|FG016|Overall Study|Lost to Follow-up|0|||
125924905|NCT03310021|453023457|FG017|Overall Study|Lost to Follow-up|0|||
125924906|NCT03310021|453023458|FG018|Overall Study|Lost to Follow-up|0|||
125924907|NCT03310021|453023459|FG019|Overall Study|Lost to Follow-up|0|||
125924908|NCT03953820|453023465|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
125924909|NCT03953820|453023466|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
125924910|NCT03953820|453023467|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
125924911|NCT03953820|453023465|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
126111717|NCT01829360|453705846|FG000|Overall Study|Protocol Violation|0|||
125924912|NCT03953820|453023466|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
125924913|NCT03953820|453023467|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
125924914|NCT00799422|453023469|FG000|First Week of Wear|Lost to Follow-up|0|||
125924915|NCT00799422|453023470|FG001|First Week of Wear|Lost to Follow-up|0|||
125924916|NCT00799422|453023471|FG002|First Week of Wear|Lost to Follow-up|1|||
125924917|NCT00799422|453023472|FG003|First Week of Wear|Lost to Follow-up|0|||
125924918|NCT00799422|453023473|FG004|First Week of Wear|Lost to Follow-up|0|||
125924919|NCT00799422|453023474|FG005|First Week of Wear|Lost to Follow-up|0|||
125924920|NCT00799422|453023469|FG000|First Week of Wear|Adverse Event|0|||
125924921|NCT00799422|453023470|FG001|First Week of Wear|Adverse Event|0|||
125924922|NCT00799422|453023471|FG002|First Week of Wear|Adverse Event|0|||
125924923|NCT00799422|453023472|FG003|First Week of Wear|Adverse Event|1|||
125924924|NCT00799422|453023473|FG004|First Week of Wear|Adverse Event|0|||
125924925|NCT00799422|453023474|FG005|First Week of Wear|Adverse Event|0|||
125924926|NCT00622284|453023475|FG000|Overall Study|Lack of Efficacy|45|||
125924927|NCT00622284|453023476|FG001|Overall Study|Lack of Efficacy|15|||
125924928|NCT00622284|453023475|FG000|Overall Study|Adverse Event|61|||
125924929|NCT00622284|453023476|FG001|Overall Study|Adverse Event|90|||
125924930|NCT00622284|453023475|FG000|Overall Study|Protocol Violation|12|||
125924931|NCT00622284|453023476|FG001|Overall Study|Protocol Violation|5|||
125924932|NCT00622284|453023475|FG000|Overall Study|Lost to Follow-up|11|||
125924933|NCT00622284|453023476|FG001|Overall Study|Lost to Follow-up|13|||
125924934|NCT00622284|453023475|FG000|Overall Study|Withdrawal by Subject|27|||
125924935|NCT00622284|453023476|FG001|Overall Study|Withdrawal by Subject|24|||
125924936|NCT00622284|453023475|FG000|Overall Study|Other reason (not specified)|33|||
125924937|NCT00622284|453023476|FG001|Overall Study|Other reason (not specified)|24|||
125924938|NCT03322631|453023483|FG000|Overall Study|Withdrawal by Subject|0|||
125924939|NCT03322631|453023484|FG001|Overall Study|Withdrawal by Subject|1|||
125924940|NCT03322631|453023485|FG002|Overall Study|Withdrawal by Subject|0|||
125924941|NCT03322631|453023486|FG003|Overall Study|Withdrawal by Subject|0|||
125924942|NCT03322631|453023483|FG000|Overall Study|Adverse Event|0|||
125924943|NCT03322631|453023484|FG001|Overall Study|Adverse Event|0|||
125924944|NCT03322631|453023485|FG002|Overall Study|Adverse Event|1|||
125924945|NCT03322631|453023486|FG003|Overall Study|Adverse Event|0|||
125924946|NCT02412618|453023488|FG000|Overall Study|Withdrawal by Subject|1|||
125924947|NCT02412618|453023489|FG001|Overall Study|Withdrawal by Subject|1|||
125924948|NCT02412618|453023488|FG000|Overall Study|Expulsion|1|||
125924949|NCT02412618|453023489|FG001|Overall Study|Expulsion|1|||
125924950|NCT01217801|453023490|FG000|Period 1|Protocol Violation|1|||
125924951|NCT01217801|453023491|FG001|Period 1|Protocol Violation|1|||
125924952|NCT01217801|453023490|FG000|Period 1|Withdrawal by Subject|0|||
125924953|NCT01217801|453023491|FG001|Period 1|Withdrawal by Subject|1|||
125924954|NCT00291577|453023496|FG000|Overall Study|Adverse Event|1|||
125924955|NCT00291577|453023496|FG000|Overall Study|Other|4|||
125924956|NCT00291577|453023496|FG000|Overall Study|Withdrawal by Subject|2|||
125924957|NCT00291577|453023496|FG000|Overall Study|Lack of Efficacy|14|||
125924958|NCT04967443|453023500|FG000|Open Label Treatment|Death|1|||
125924959|NCT04967443|453023501|FG001|Open Label Treatment|Death|0|||
125924960|NCT04967443|453023502|FG002|Open Label Treatment|Death|0|||
125924961|NCT04967443|453023503|FG003|Open Label Treatment|Death|0|||
125924962|NCT04967443|453023504|FG004|Open Label Treatment|Death|0|||
125924963|NCT04967443|453023505|FG005|Open Label Treatment|Death|0|||
125924964|NCT04967443|453023506|FG006|Open Label Treatment|Death|0|||
125924965|NCT04967443|453023507|FG007|Open Label Treatment|Death|0|||
125924966|NCT04967443|453023500|FG000|Open Label Treatment|Lost to Follow-up|0|||
125924967|NCT04967443|453023501|FG001|Open Label Treatment|Lost to Follow-up|0|||
125924968|NCT04967443|453023502|FG002|Open Label Treatment|Lost to Follow-up|1|||
125924969|NCT04967443|453023503|FG003|Open Label Treatment|Lost to Follow-up|0|||
125924970|NCT04967443|453023504|FG004|Open Label Treatment|Lost to Follow-up|0|||
125924971|NCT04967443|453023505|FG005|Open Label Treatment|Lost to Follow-up|0|||
125924972|NCT04967443|453023506|FG006|Open Label Treatment|Lost to Follow-up|0|||
125924973|NCT04967443|453023507|FG007|Open Label Treatment|Lost to Follow-up|0|||
125924974|NCT04967443|453023500|FG000|Open Label Treatment|Withdrawal by Subject|0|||
125924975|NCT04967443|453023501|FG001|Open Label Treatment|Withdrawal by Subject|1|||
125924976|NCT04967443|453023502|FG002|Open Label Treatment|Withdrawal by Subject|0|||
125924977|NCT04967443|453023503|FG003|Open Label Treatment|Withdrawal by Subject|1|||
125924978|NCT04967443|453023504|FG004|Open Label Treatment|Withdrawal by Subject|0|||
125924979|NCT04967443|453023505|FG005|Open Label Treatment|Withdrawal by Subject|1|||
125924980|NCT04967443|453023506|FG006|Open Label Treatment|Withdrawal by Subject|2|||
125924981|NCT04967443|453023507|FG007|Open Label Treatment|Withdrawal by Subject|3|||
125924982|NCT04967443|453023500|FG000|Follow-Up|Death|1|||
125924983|NCT04967443|453023501|FG001|Follow-Up|Death|0|||
125924984|NCT04967443|453023502|FG002|Follow-Up|Death|0|||
125924985|NCT04967443|453023503|FG003|Follow-Up|Death|0|||
125924986|NCT04967443|453023504|FG004|Follow-Up|Death|0|||
125924987|NCT04967443|453023505|FG005|Follow-Up|Death|0|||
125924988|NCT04967443|453023506|FG006|Follow-Up|Death|0|||
125924989|NCT04967443|453023507|FG007|Follow-Up|Death|0|||
125924990|NCT04967443|453023500|FG000|Follow-Up|Lost to Follow-up|0|||
125924991|NCT04967443|453023501|FG001|Follow-Up|Lost to Follow-up|0|||
125924992|NCT04967443|453023502|FG002|Follow-Up|Lost to Follow-up|1|||
125924993|NCT04967443|453023503|FG003|Follow-Up|Lost to Follow-up|1|||
125924994|NCT04967443|453023504|FG004|Follow-Up|Lost to Follow-up|0|||
125924995|NCT04967443|453023505|FG005|Follow-Up|Lost to Follow-up|0|||
125924996|NCT04967443|453023506|FG006|Follow-Up|Lost to Follow-up|0|||
125924997|NCT04967443|453023507|FG007|Follow-Up|Lost to Follow-up|0|||
125924998|NCT04967443|453023500|FG000|Follow-Up|Withdrawal by Subject|0|||
125924999|NCT04967443|453023501|FG001|Follow-Up|Withdrawal by Subject|1|||
125925000|NCT04967443|453023502|FG002|Follow-Up|Withdrawal by Subject|0|||
125925001|NCT04967443|453023503|FG003|Follow-Up|Withdrawal by Subject|1|||
125925002|NCT04967443|453023504|FG004|Follow-Up|Withdrawal by Subject|0|||
125925003|NCT04967443|453023505|FG005|Follow-Up|Withdrawal by Subject|1|||
125925004|NCT04967443|453023506|FG006|Follow-Up|Withdrawal by Subject|2|||
125925005|NCT04967443|453023507|FG007|Follow-Up|Withdrawal by Subject|3|||
126111718|NCT01829360|453705847|FG001|Overall Study|Protocol Violation|0|||
126111719|NCT01829360|453705848|FG002|Overall Study|Protocol Violation|1|||
126111720|NCT01829360|453705849|FG003|Overall Study|Protocol Violation|0|||
126111721|NCT01145495|453705852|FG000|Overall Study|Adverse Event|6|||
126111722|NCT01145495|453705852|FG000|Overall Study|Withdrawal by Subject|6|||
126111723|NCT01145495|453705852|FG000|Overall Study|Disease progression after respone|2|||
126111724|NCT01886313|453705855|FG000|Overall Study|Adverse Event|1|||
126111725|NCT01886313|453705856|FG001|Overall Study|Adverse Event|1|||
126111726|NCT03838198|453705857|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
126111727|NCT03838198|453705858|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
126111728|NCT03838198|453705859|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
126111729|NCT03838198|453705860|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
126111730|NCT03838198|453705857|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
126111731|NCT03838198|453705858|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
126111732|NCT03838198|453705859|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
126111733|NCT03838198|453705860|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
126111734|NCT02378220|453705861|FG000|Overall Study|Death|6|||
126111735|NCT02378220|453705862|FG001|Overall Study|Death|1|||
126111736|NCT00312221|453705863|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
126111737|NCT00312221|453705864|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
126111738|NCT00312221|453705865|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
126111739|NCT00312221|453705866|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
126111740|NCT00312221|453705863|FG000|Open-label Run-in Period|Adverse Event|74|||
126111741|NCT00312221|453705864|FG001|Open-label Run-in Period|Adverse Event|0|||
126111742|NCT00312221|453705865|FG002|Open-label Run-in Period|Adverse Event|0|||
126111743|NCT00312221|453705866|FG003|Open-label Run-in Period|Adverse Event|0|||
126111744|NCT00312221|453705863|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
126111745|NCT00312221|453705864|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
126111746|NCT00312221|453705865|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
126111747|NCT00312221|453705866|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
126111748|NCT00312221|453705863|FG000|Open-label Run-in Period|Administrative|42|||
126111749|NCT00312221|453705864|FG001|Open-label Run-in Period|Administrative|0|||
126111750|NCT00312221|453705865|FG002|Open-label Run-in Period|Administrative|0|||
126111751|NCT00312221|453705866|FG003|Open-label Run-in Period|Administrative|0|||
126111752|NCT00312221|453705863|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
126111753|NCT00312221|453705864|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
126111754|NCT00312221|453705865|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
126111755|NCT00312221|453705866|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
126111756|NCT00312221|453705863|FG000|Open-label Run-in Period|Did not qualify|5|||
126111757|NCT00312221|453705864|FG001|Open-label Run-in Period|Did not qualify|0|||
126111758|NCT00312221|453705865|FG002|Open-label Run-in Period|Did not qualify|0|||
126111759|NCT00312221|453705866|FG003|Open-label Run-in Period|Did not qualify|0|||
126111760|NCT00312221|453705863|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126111761|NCT00312221|453705864|FG001|Double-blind Phase|Withdrawal by Subject|6|||
126111762|NCT00312221|453705865|FG002|Double-blind Phase|Withdrawal by Subject|8|||
126111763|NCT00312221|453705866|FG003|Double-blind Phase|Withdrawal by Subject|7|||
126111764|NCT00312221|453705863|FG000|Double-blind Phase|Adverse Event|0|||
126111765|NCT00312221|453705864|FG001|Double-blind Phase|Adverse Event|10|||
126111766|NCT00312221|453705865|FG002|Double-blind Phase|Adverse Event|19|||
126111767|NCT00312221|453705866|FG003|Double-blind Phase|Adverse Event|18|||
126111768|NCT00312221|453705863|FG000|Double-blind Phase|Lost to Follow-up|0|||
126111769|NCT00312221|453705864|FG001|Double-blind Phase|Lost to Follow-up|0|||
126111770|NCT00312221|453705865|FG002|Double-blind Phase|Lost to Follow-up|2|||
126111771|NCT00312221|453705866|FG003|Double-blind Phase|Lost to Follow-up|2|||
126111772|NCT00312221|453705863|FG000|Double-blind Phase|Administrative|0|||
126111773|NCT00312221|453705864|FG001|Double-blind Phase|Administrative|26|||
126111774|NCT00312221|453705865|FG002|Double-blind Phase|Administrative|37|||
126111775|NCT00312221|453705866|FG003|Double-blind Phase|Administrative|33|||
126111776|NCT00312221|453705863|FG000|Double-blind Phase|Lack of Efficacy|0|||
126111777|NCT00312221|453705864|FG001|Double-blind Phase|Lack of Efficacy|17|||
126111778|NCT00312221|453705865|FG002|Double-blind Phase|Lack of Efficacy|6|||
126111779|NCT00312221|453705866|FG003|Double-blind Phase|Lack of Efficacy|10|||
126111780|NCT02060721|453705867|FG000|Overall Study|Lost to Follow-up|1|||
126111781|NCT02060721|453705867|FG000|Overall Study|Physician Decision|2|||
126111782|NCT02060721|453705867|FG000|Overall Study|Death|14|||
126111783|NCT02060721|453705867|FG000|Overall Study|Withdrawal by Subject|2|||
126111784|NCT02060721|453705867|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
126111785|NCT00117507|453705868|FG000|Overall Study|Adverse Event|4|||
126111786|NCT00117507|453705868|FG000|Overall Study|Abnormal laboratory values|3|||
126111787|NCT00117507|453705868|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126111788|NCT00117507|453705868|FG000|Overall Study|Patient withdrew consent|4|||
126111789|NCT00117507|453705868|FG000|Overall Study|Death|3|||
125925006|NCT04502693|453023508|FG000|Overall Study|Adverse Event|7|||
125925007|NCT04502693|453023509|FG001|Overall Study|Adverse Event|6|||
125925008|NCT04502693|453023510|FG002|Overall Study|Adverse Event|11|||
125925009|NCT04502693|453023511|FG003|Overall Study|Adverse Event|1|||
125925010|NCT04502693|453023508|FG000|Overall Study|Lost to Follow-up|32|||
125925011|NCT04502693|453023509|FG001|Overall Study|Lost to Follow-up|36|||
125925012|NCT04502693|453023510|FG002|Overall Study|Lost to Follow-up|69|||
125925013|NCT04502693|453023511|FG003|Overall Study|Lost to Follow-up|4|||
125925014|NCT04502693|453023508|FG000|Overall Study|Protocol Violation|8|||
125925015|NCT04502693|453023509|FG001|Overall Study|Protocol Violation|8|||
125925016|NCT04502693|453023510|FG002|Overall Study|Protocol Violation|16|||
125925017|NCT04502693|453023511|FG003|Overall Study|Protocol Violation|1|||
125925018|NCT04502693|453023508|FG000|Overall Study|Withdrawal by Subject|46|||
125925019|NCT04502693|453023509|FG001|Overall Study|Withdrawal by Subject|38|||
125925020|NCT04502693|453023510|FG002|Overall Study|Withdrawal by Subject|54|||
125925021|NCT04502693|453023511|FG003|Overall Study|Withdrawal by Subject|7|||
125925022|NCT04502693|453023508|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
125925023|NCT04502693|453023509|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
125925024|NCT04502693|453023510|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
125925025|NCT04502693|453023511|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125925026|NCT04502693|453023508|FG000|Overall Study|Other|1|||
125925027|NCT04502693|453023509|FG001|Overall Study|Other|0|||
125925028|NCT04502693|453023510|FG002|Overall Study|Other|1|||
125925029|NCT04502693|453023511|FG003|Overall Study|Other|1|||
125925030|NCT00602797|453023512|FG000|Overall Study|Adverse Event|1|||
125925031|NCT03943147|453023516|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
125925032|NCT03943147|453023517|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
125925033|NCT03943147|453023516|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
125925034|NCT03943147|453023517|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
125925035|NCT03943147|453023516|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
125925036|NCT03943147|453023517|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
125925037|NCT03943147|453023516|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
125925038|NCT03943147|453023517|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
125925039|NCT03943147|453023516|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
125925040|NCT03943147|453023517|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
125925041|NCT03943147|453023516|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
125925042|NCT03943147|453023517|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
125925043|NCT02756013|453023518|FG000|Overall Study|Adverse Event|1|||
125925044|NCT02756013|453023518|FG000|Overall Study|Hypersensitivity|1|||
125925045|NCT01318993|453023519|FG000|Overall Study|Adverse Event|53|||
125925046|NCT01318993|453023519|FG000|Overall Study|Lack of Efficacy|121|||
126064733|NCT02561195|453527779|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
126064734|NCT02561195|453527780|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126064735|NCT02561195|453527781|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
126064736|NCT03905512|453527782|FG000|Overall Study|Withdrawal by Subject|9|||
126064737|NCT03905512|453527783|FG001|Overall Study|Withdrawal by Subject|8|||
126064738|NCT03905512|453527782|FG000|Overall Study|Adverse Event|1|||
126064739|NCT03905512|453527783|FG001|Overall Study|Adverse Event|2|||
126064740|NCT03905512|453527782|FG000|Overall Study|Lost to Follow-up|4|||
126064741|NCT03905512|453527783|FG001|Overall Study|Lost to Follow-up|3|||
126064742|NCT03905512|453527782|FG000|Overall Study|Other than Specified|7|||
126064743|NCT03905512|453527783|FG001|Overall Study|Other than Specified|4|||
126064744|NCT03560206|453527786|FG000|Overall Study|Lost to Follow-up|19|||
126064745|NCT03560206|453527787|FG001|Overall Study|Lost to Follow-up|11|||
126064746|NCT03560206|453527786|FG000|Overall Study|Withdrawal by Subject|2|||
126064747|NCT03560206|453527787|FG001|Overall Study|Withdrawal by Subject|4|||
126064748|NCT03560206|453527786|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
126064749|NCT03560206|453527787|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
126064750|NCT03560206|453527786|FG000|Overall Study|Busy schedule|14|||
126064751|NCT03560206|453527787|FG001|Overall Study|Busy schedule|2|||
126064752|NCT03560206|453527786|FG000|Overall Study|patients' new health condition such as cancer|10|||
126064753|NCT03560206|453527787|FG001|Overall Study|patients' new health condition such as cancer|1|||
126064754|NCT03138499|453527790|FG000|Overall Study|Lost to Follow-up|1|||
126064755|NCT03138499|453527791|FG001|Overall Study|Lost to Follow-up|0|||
126064756|NCT03138499|453527790|FG000|Overall Study|Participants withdrew consent|1|||
126064757|NCT03138499|453527791|FG001|Overall Study|Participants withdrew consent|0|||
126064758|NCT03138499|453527790|FG000|Overall Study|Participant discontinued study before treatment|0|||
126064759|NCT03138499|453527791|FG001|Overall Study|Participant discontinued study before treatment|1|||
126064760|NCT03138499|453527790|FG000|Overall Study|Disease Progression|2|||
125925047|NCT01318993|453023519|FG000|Overall Study|Protocol Violation|3|||
125925048|NCT01318993|453023519|FG000|Overall Study|Protocol based stopping criteria|6|||
125925049|NCT01318993|453023519|FG000|Overall Study|Study closed or terminated|174|||
125925050|NCT01318993|453023519|FG000|Overall Study|Lost to Follow-up|4|||
125925051|NCT01318993|453023519|FG000|Overall Study|Physician Decision|13|||
126111790|NCT00866723|453705869|FG000|Overall Study|Withdrawal by Subject|1|||
126111791|NCT00866723|453705869|FG000|Overall Study|Disease Progression|4|||
126111792|NCT01271803|453705870|FG000|Overall Study|Progressive disease|0|||
126111793|NCT01271803|453705871|FG001|Overall Study|Progressive disease|0|||
126111794|NCT01271803|453705872|FG002|Overall Study|Progressive disease|2|||
126111795|NCT01271803|453705870|FG000|Overall Study|Death|53|||
126111796|NCT01271803|453705871|FG001|Overall Study|Death|34|||
126111797|NCT01271803|453705872|FG002|Overall Study|Death|0|||
126111798|NCT01271803|453705870|FG000|Overall Study|Withdrawal by Subject|1|||
126111799|NCT01271803|453705871|FG001|Overall Study|Withdrawal by Subject|5|||
126111800|NCT01271803|453705872|FG002|Overall Study|Withdrawal by Subject|0|||
126111801|NCT01271803|453705870|FG000|Overall Study|Lost to Follow-up|1|||
126111802|NCT01271803|453705871|FG001|Overall Study|Lost to Follow-up|0|||
125925052|NCT01318993|453023519|FG000|Overall Study|Withdrawal by Subject|24|||
125925053|NCT00629707|453023522|FG000|Overall Study|Withdrawal by Subject|0|||
125925054|NCT00629707|453023523|FG001|Overall Study|Withdrawal by Subject|1|||
126064761|NCT03138499|453527791|FG001|Overall Study|Disease Progression|6|||
126064762|NCT03138499|453527790|FG000|Overall Study|Study drug toxicity|2|||
126064763|NCT03138499|453527791|FG001|Overall Study|Study drug toxicity|2|||
126064764|NCT03138499|453527790|FG000|Overall Study|Participant request to discontinue study treatment|1|||
126064765|NCT03138499|453527791|FG001|Overall Study|Participant request to discontinue study treatment|1|||
126064766|NCT03138499|453527790|FG000|Overall Study|Other reasons|2|||
126064767|NCT03138499|453527791|FG001|Overall Study|Other reasons|0|||
126064768|NCT01334606|453527794|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
126064769|NCT02674399|453527795|FG000|Overall Study|Lost to Follow-up|2|||
126064770|NCT02674399|453527796|FG001|Overall Study|Lost to Follow-up|0|||
126064771|NCT01661972|453527797|FG000|Overall Study|Adverse Event|1|||
126064772|NCT01661972|453527798|FG001|Overall Study|Adverse Event|2|||
126064773|NCT01661972|453527797|FG000|Overall Study|Death during Treatment period|1|||
126064774|NCT01661972|453527798|FG001|Overall Study|Death during Treatment period|1|||
126064775|NCT01661972|453527797|FG000|Overall Study|Withdrawal by Subject|0|||
126064776|NCT01661972|453527798|FG001|Overall Study|Withdrawal by Subject|1|||
126064777|NCT01084772|453527799|FG000|Baseline|Withdrawal by Subject|7|||
126064778|NCT01084772|453527800|FG001|Baseline|Withdrawal by Subject|6|||
126064779|NCT01084772|453527799|FG000|3 Months|Death|1|||
126064780|NCT01084772|453527800|FG001|3 Months|Death|0|||
126064781|NCT01084772|453527799|FG000|3 Months|Study Termination|2|||
126064782|NCT01084772|453527800|FG001|3 Months|Study Termination|2|||
126064783|NCT01084772|453527799|FG000|1 Year|Withdrawal by Subject|0|||
126064784|NCT01084772|453527800|FG001|1 Year|Withdrawal by Subject|1|||
126064785|NCT01084772|453527799|FG000|1 Year|Lost to Follow-up|3|||
126064786|NCT01084772|453527800|FG001|1 Year|Lost to Follow-up|0|||
126064787|NCT01084772|453527799|FG000|1 Year|Study Termination|0|||
126064788|NCT01084772|453527800|FG001|1 Year|Study Termination|7|||
126064789|NCT01084772|453527799|FG000|2 Years|Withdrawal by Subject|1|||
126064790|NCT01084772|453527800|FG001|2 Years|Withdrawal by Subject|0|||
126064791|NCT01084772|453527799|FG000|2 Years|Lost to Follow-up|5|||
126064792|NCT01084772|453527800|FG001|2 Years|Lost to Follow-up|2|||
126064793|NCT01084772|453527799|FG000|2 Years|Study Termination|3|||
126064794|NCT01084772|453527800|FG001|2 Years|Study Termination|2|||
126064795|NCT01634165|453527812|FG000|Period 2|Adverse Event|0|||
126064796|NCT01634165|453527813|FG001|Period 2|Adverse Event|1|||
126064797|NCT01634165|453527814|FG002|Period 2|Adverse Event|0|||
126064798|NCT01634165|453527815|FG003|Period 2|Adverse Event|0|||
126064799|NCT03820024|453527816|FG000|Overall Study|Physician Decision|1|||
126064800|NCT03820024|453527817|FG001|Overall Study|Physician Decision|2|||
126064801|NCT05379400|453529081|FG000|Overall Study|Lost to Follow-up|1|||
126064802|NCT05379400|453529082|FG001|Overall Study|Lost to Follow-up|1|||
126064803|NCT03978130|453529084|FG000|Overall Study|Lost to Follow-up|13|||
126064804|NCT03978130|453529085|FG001|Overall Study|Lost to Follow-up|14|||
126064805|NCT03978130|453529084|FG000|Overall Study|Withdrawal by Subject|12|||
126064806|NCT03978130|453529085|FG001|Overall Study|Withdrawal by Subject|2|||
126064807|NCT03978130|453529084|FG000|Overall Study|Adverse Event|2|||
126064808|NCT03978130|453529085|FG001|Overall Study|Adverse Event|1|||
126064809|NCT00515112|453529086|FG000|Overall Study|Death|0|||
126064810|NCT00515112|453529087|FG001|Overall Study|Death|1|||
126064811|NCT00515112|453529086|FG000|Overall Study|The study was terminated|3|||
126064812|NCT00515112|453529087|FG001|Overall Study|The study was terminated|2|||
126064813|NCT00304278|453529089|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
126064814|NCT00304278|453529089|FG000|Overall Study|PT had medical condition preventing TX|1|||
126111803|NCT01271803|453705872|FG002|Overall Study|Lost to Follow-up|0|||
126111804|NCT01862640|453705876|FG000|Overall Study|Adverse Event|4|||
126064815|NCT00409006|453529092|FG000|Overall Study|Death|15|||
126064816|NCT00409006|453529093|FG001|Overall Study|Death|6|||
126064817|NCT00409006|453529092|FG000|Overall Study|Lost to Follow-up|1|||
126064818|NCT00409006|453529093|FG001|Overall Study|Lost to Follow-up|2|||
126064819|NCT00409006|453529092|FG000|Overall Study|Withdrawal by Subject|3|||
126111805|NCT01862640|453705877|FG001|Overall Study|Adverse Event|10|||
126111806|NCT01862640|453705878|FG002|Overall Study|Adverse Event|6|||
126111807|NCT01862640|453705879|FG003|Overall Study|Adverse Event|8|||
125925055|NCT00629707|453023522|FG000|Overall Study|Physician Decision|0|||
125925056|NCT00629707|453023523|FG001|Overall Study|Physician Decision|1|||
125925057|NCT00074152|453023524|FG000|Overall Study|Death|21|||
125925058|NCT00074152|453023525|FG001|Overall Study|Death|9|||
125925059|NCT00074152|453023524|FG000|Overall Study|Lack of Efficacy|34|||
125925060|NCT00074152|453023525|FG001|Overall Study|Lack of Efficacy|24|||
125925061|NCT03547583|453023526|FG000|Overall Study|Adverse Event|16|||
125925062|NCT03547583|453023527|FG001|Overall Study|Adverse Event|11|||
125925063|NCT03547583|453023528|FG002|Overall Study|Adverse Event|10|||
125925064|NCT03547583|453023526|FG000|Overall Study|Death|11|||
125925065|NCT03547583|453023527|FG001|Overall Study|Death|7|||
125925066|NCT03547583|453023528|FG002|Overall Study|Death|4|||
125925067|NCT03547583|453023526|FG000|Overall Study|Lost to Follow-up|1|||
125925068|NCT03547583|453023527|FG001|Overall Study|Lost to Follow-up|0|||
125925069|NCT03547583|453023528|FG002|Overall Study|Lost to Follow-up|0|||
125925070|NCT03547583|453023526|FG000|Overall Study|Non-compliance with study drug|0|||
125925071|NCT03547583|453023527|FG001|Overall Study|Non-compliance with study drug|0|||
125925072|NCT03547583|453023528|FG002|Overall Study|Non-compliance with study drug|1|||
125925073|NCT03547583|453023526|FG000|Overall Study|Physician Decision|1|||
125925074|NCT03547583|453023527|FG001|Overall Study|Physician Decision|0|||
125925075|NCT03547583|453023528|FG002|Overall Study|Physician Decision|3|||
125925076|NCT03547583|453023526|FG000|Overall Study|Protocol Violation|2|||
125925077|NCT03547583|453023527|FG001|Overall Study|Protocol Violation|1|||
125925078|NCT03547583|453023528|FG002|Overall Study|Protocol Violation|1|||
125925079|NCT03547583|453023526|FG000|Overall Study|Withdrawal by Subject|12|||
125925080|NCT03547583|453023527|FG001|Overall Study|Withdrawal by Subject|19|||
125925081|NCT03547583|453023528|FG002|Overall Study|Withdrawal by Subject|10|||
125925082|NCT03547583|453023526|FG000|Overall Study|Other|2|||
125925083|NCT03547583|453023527|FG001|Overall Study|Other|2|||
125925084|NCT03547583|453023528|FG002|Overall Study|Other|3|||
125925085|NCT00382252|453023529|FG000|Overall Study|Death|4|||
125925086|NCT00382252|453023529|FG000|Overall Study|Protocol Violation|8|||
125925087|NCT00382252|453023529|FG000|Overall Study|Not treated by RFA|1|||
125925088|NCT05570500|453023534|FG000|Overall Study|Lost to Follow-up|7|||
125925089|NCT05570500|453023535|FG001|Overall Study|Lost to Follow-up|5|||
125925090|NCT04706091|453023536|FG000|Treatment 2|Withdrawal by Subject|1|||
125925091|NCT04706091|453023537|FG001|Treatment 2|Withdrawal by Subject|0|||
125925092|NCT02612727|453023538|FG000|Overall Study|Parent request|4|||
125925093|NCT02612727|453023539|FG001|Overall Study|Parent request|1|||
125925094|NCT02612727|453023538|FG000|Overall Study|Needed treatment incompatible with PT|1|||
125925095|NCT02612727|453023539|FG001|Overall Study|Needed treatment incompatible with PT|1|||
125925096|NCT02612727|453023538|FG000|Overall Study|Direct hyperbilirubinemia|0|||
125925097|NCT02612727|453023539|FG001|Overall Study|Direct hyperbilirubinemia|2|||
125925098|NCT01063868|453023540|FG000|Overall Study|Adverse Event|9|||
125925099|NCT01063868|453023541|FG001|Overall Study|Adverse Event|7|||
125925100|NCT01063868|453023540|FG000|Overall Study|Withdrawal by Subject|3|||
125925101|NCT01063868|453023541|FG001|Overall Study|Withdrawal by Subject|1|||
125925102|NCT01063868|453023540|FG000|Overall Study|Study Terminated By Sponsor|23|||
125925103|NCT01063868|453023541|FG001|Overall Study|Study Terminated By Sponsor|4|||
125925104|NCT02578316|453023544|FG000|Extension Phase|Progression of disease|6|||
125925105|NCT03278873|453023545|FG000|Overall Study|Withdrawal by Subject|0|||
125925106|NCT03278873|453023546|FG001|Overall Study|Withdrawal by Subject|1|||
125925107|NCT03278873|453023547|FG002|Overall Study|Withdrawal by Subject|0|||
125925108|NCT03278873|453023548|FG003|Overall Study|Withdrawal by Subject|0|||
125925109|NCT03278873|453023545|FG000|Overall Study|Sponsor's decision|0|||
125925110|NCT03278873|453023546|FG001|Overall Study|Sponsor's decision|1|||
125925111|NCT03278873|453023547|FG002|Overall Study|Sponsor's decision|0|||
125925112|NCT03278873|453023548|FG003|Overall Study|Sponsor's decision|0|||
125925113|NCT03278873|453023545|FG000|Overall Study|Early Termination|2|||
125925114|NCT03278873|453023546|FG001|Overall Study|Early Termination|6|||
125925115|NCT03278873|453023547|FG002|Overall Study|Early Termination|0|||
125925116|NCT03278873|453023548|FG003|Overall Study|Early Termination|4|||
125925117|NCT03278873|453023545|FG000|Overall Study|Lost to Follow-up|0|||
125925118|NCT03278873|453023546|FG001|Overall Study|Lost to Follow-up|0|||
125925119|NCT03278873|453023547|FG002|Overall Study|Lost to Follow-up|2|||
125925120|NCT03278873|453023548|FG003|Overall Study|Lost to Follow-up|0|||
125925121|NCT03278873|453023545|FG000|Overall Study|The patient decided to withdraw via email|1|||
125925122|NCT03278873|453023546|FG001|Overall Study|The patient decided to withdraw via email|0|||
125925123|NCT03278873|453023547|FG002|Overall Study|The patient decided to withdraw via email|0|||
125925124|NCT03278873|453023548|FG003|Overall Study|The patient decided to withdraw via email|0|||
125925125|NCT03278873|453023545|FG000|Overall Study|The patient was unresponsive to contact|0|||
125925126|NCT03278873|453023546|FG001|Overall Study|The patient was unresponsive to contact|0|||
125925127|NCT03278873|453023547|FG002|Overall Study|The patient was unresponsive to contact|0|||
125925128|NCT03278873|453023548|FG003|Overall Study|The patient was unresponsive to contact|4|||
125925129|NCT03278873|453023545|FG000|Overall Study|The patient wished to participate no longer|0|||
125925130|NCT03278873|453023546|FG001|Overall Study|The patient wished to participate no longer|1|||
125925131|NCT03278873|453023547|FG002|Overall Study|The patient wished to participate no longer|0|||
125925132|NCT03278873|453023548|FG003|Overall Study|The patient wished to participate no longer|0|||
125925133|NCT03278873|453023545|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
125925134|NCT03278873|453023546|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
125925135|NCT03278873|453023547|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
125925136|NCT03278873|453023548|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
125925137|NCT04362072|453023554|FG000|Treatment|Adverse Event|1|||
125925138|NCT04362072|453023554|FG000|Treatment|Death|9|||
125925139|NCT04362072|453023554|FG000|Treatment|Physician Decision|2|||
125925140|NCT04362072|453023554|FG000|Treatment|Progressive disease|27|||
125925141|NCT04362072|453023554|FG000|Treatment|Withdrawal by Subject|4|||
125925142|NCT04362072|453023554|FG000|Treatment|Global deterioration of health status|1|||
125925143|NCT04362072|453023554|FG000|Treatment|Switched to commercial Lorlatinib|13|||
125925144|NCT04362072|453023554|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
125925145|NCT04362072|453023554|FG000|Treatment|Other|3|||
125925146|NCT04362072|453023554|FG000|Follow up|Death|2|||
125925147|NCT04362072|453023554|FG000|Follow up|Other|2|||
125925148|NCT00381485|453025415|FG000|Open-Label Run-In Period|Adverse Event|9|||
125925149|NCT00381485|453025416|FG001|Open-Label Run-In Period|Adverse Event|0|||
125925150|NCT00381485|453025417|FG002|Open-Label Run-In Period|Adverse Event|0|||
125925151|NCT00381485|453025418|FG003|Open-Label Run-In Period|Adverse Event|0|||
125925152|NCT00381485|453025415|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
125925153|NCT00381485|453025416|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
125925154|NCT00381485|453025417|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
125925155|NCT00381485|453025418|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
125925156|NCT00381485|453025415|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
125925157|NCT00381485|453025416|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
125925158|NCT00381485|453025417|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
125925159|NCT00381485|453025418|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
125925160|NCT00381485|453025415|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
125925161|NCT00381485|453025416|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
125925162|NCT00381485|453025417|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
125925163|NCT00381485|453025418|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
125925164|NCT00381485|453025415|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
125925165|NCT00381485|453025416|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
125925166|NCT00381485|453025417|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
125925167|NCT00381485|453025418|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
125925168|NCT00381485|453025415|FG000|Open-Label Run-In Period|Treatment failure|1|||
125925169|NCT00381485|453025416|FG001|Open-Label Run-In Period|Treatment failure|0|||
125925170|NCT00381485|453025417|FG002|Open-Label Run-In Period|Treatment failure|0|||
125925171|NCT00381485|453025418|FG003|Open-Label Run-In Period|Treatment failure|0|||
125925172|NCT00381485|453025415|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125925173|NCT00381485|453025416|FG001|Double-Blind Treatment Period|Adverse Event|2|||
125925174|NCT00381485|453025417|FG002|Double-Blind Treatment Period|Adverse Event|2|||
125925175|NCT00381485|453025418|FG003|Double-Blind Treatment Period|Adverse Event|5|||
125925176|NCT00381485|453025415|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125925177|NCT00381485|453025416|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
125925178|NCT00381485|453025417|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
125925179|NCT00381485|453025418|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
125925180|NCT00381485|453025415|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125925181|NCT00381485|453025416|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
125925182|NCT00381485|453025417|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
125925183|NCT00381485|453025418|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
125925184|NCT00381485|453025415|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
125925185|NCT00381485|453025416|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
125925186|NCT00381485|453025417|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
125925187|NCT00381485|453025418|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
125925188|NCT00381485|453025415|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
125925189|NCT00381485|453025416|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
125925190|NCT00381485|453025417|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
125925191|NCT00381485|453025418|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
125925192|NCT00381485|453025415|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
125925193|NCT00381485|453025416|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
125925194|NCT00381485|453025417|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
125925195|NCT00381485|453025418|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
125925196|NCT00381485|453025415|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
125925197|NCT00381485|453025416|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
125925198|NCT00381485|453025417|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
125925199|NCT00381485|453025418|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
125925200|NCT00381485|453025415|FG000|Double-Blind Treatment Period|Administrative|0|||
125925201|NCT00381485|453025416|FG001|Double-Blind Treatment Period|Administrative|1|||
125925202|NCT00381485|453025417|FG002|Double-Blind Treatment Period|Administrative|0|||
125925203|NCT00381485|453025418|FG003|Double-Blind Treatment Period|Administrative|1|||
125925204|NCT01235351|453025419|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
125925205|NCT01235351|453025420|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
125925206|NCT01898806|453025424|FG000|Overall Study|Withdrawal by Subject|2|||
125925207|NCT01898806|453025424|FG000|Overall Study|Physician Decision|1|||
125925208|NCT00126191|453025425|FG000|Overall Study|Physician Decision|0|||
125925209|NCT00126191|453025426|FG001|Overall Study|Physician Decision|1|||
125925210|NCT00126191|453025425|FG000|Overall Study|Death|0|||
125925211|NCT00126191|453025426|FG001|Overall Study|Death|1|||
125925212|NCT01648101|453025427|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
125925213|NCT01648101|453025428|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
125925214|NCT01648101|453025429|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
125925215|NCT01648101|453025427|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
125925216|NCT01648101|453025428|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
125925217|NCT01648101|453025429|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
125925218|NCT01648101|453025427|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
125925219|NCT01648101|453025428|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
125925220|NCT01648101|453025429|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
125925221|NCT01648101|453025427|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
125925222|NCT01648101|453025428|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
125925223|NCT01648101|453025429|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
125925224|NCT01648101|453025427|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
125925225|NCT01648101|453025428|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
125925226|NCT01648101|453025429|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
125925227|NCT01648101|453025427|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
125925228|NCT01648101|453025428|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
125925229|NCT01648101|453025429|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
125925230|NCT01648101|453025427|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
125925231|NCT01648101|453025428|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
125925232|NCT01648101|453025429|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
125925233|NCT01648101|453025427|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
125925234|NCT01648101|453025428|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
125925235|NCT01648101|453025429|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
125925236|NCT01648101|453025427|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
125925237|NCT01648101|453025428|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
125925238|NCT01648101|453025429|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
125925239|NCT01648101|453025427|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
125925240|NCT01648101|453025428|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
125925241|NCT01648101|453025429|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
125925242|NCT01648101|453025427|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
125925243|NCT01648101|453025428|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
125925244|NCT01648101|453025429|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
125925245|NCT03003390|453025430|FG000|Overall Study|Physician Decision|2|||
125925246|NCT03003390|453025431|FG001|Overall Study|Physician Decision|0|||
125925247|NCT03003390|453025430|FG000|Overall Study|Parent refused intervention|2|||
125925248|NCT03003390|453025431|FG001|Overall Study|Parent refused intervention|0|||
125925249|NCT00307294|453025445|FG000|Overall Study|Withdrawal by Subject|1|||
125925250|NCT00290888|453025449|FG000|Overall Study|Physician Decision|3|||
125925251|NCT00290888|453025450|FG001|Overall Study|Physician Decision|1|||
125925252|NCT03000439|453025451|FG000|Open Label Part 1|Adverse Event|6|||
125925253|NCT03000439|453025452|FG001|Open Label Part 1|Adverse Event|0|||
125925254|NCT03000439|453025453|FG002|Open Label Part 1|Adverse Event|0|||
125925255|NCT03000439|453025454|FG003|Open Label Part 1|Adverse Event|0|||
125925256|NCT03000439|453025451|FG000|Open Label Part 1|Other|2|||
125925257|NCT03000439|453025452|FG001|Open Label Part 1|Other|0|||
125925258|NCT03000439|453025453|FG002|Open Label Part 1|Other|0|||
125925259|NCT03000439|453025454|FG003|Open Label Part 1|Other|0|||
125925260|NCT03000439|453025451|FG000|Open Label Part 1|Insufficient clinical response|16|||
125925261|NCT03000439|453025452|FG001|Open Label Part 1|Insufficient clinical response|0|||
125925262|NCT03000439|453025453|FG002|Open Label Part 1|Insufficient clinical response|0|||
125925263|NCT03000439|453025454|FG003|Open Label Part 1|Insufficient clinical response|0|||
125925264|NCT03000439|453025451|FG000|Open Label Part 2|Other|0|||
125925265|NCT03000439|453025452|FG001|Open Label Part 2|Other|5|||
125925266|NCT03000439|453025453|FG002|Open Label Part 2|Other|0|||
125925267|NCT03000439|453025454|FG003|Open Label Part 2|Other|0|||
125925268|NCT03000439|453025451|FG000|Open Label Part 2|Insufficient clinical response|0|||
125925269|NCT03000439|453025452|FG001|Open Label Part 2|Insufficient clinical response|12|||
125925270|NCT03000439|453025453|FG002|Open Label Part 2|Insufficient clinical response|0|||
126111808|NCT01862640|453705876|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
126111809|NCT01862640|453705877|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
126111810|NCT01862640|453705878|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
126111811|NCT01862640|453705879|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
126111812|NCT01862640|453705876|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
126111813|NCT01862640|453705877|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
126111814|NCT01862640|453705878|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
126111815|NCT01862640|453705879|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
126111816|NCT01862640|453705876|FG000|Overall Study|Withdrawal by Subject|2|||
126111817|NCT01862640|453705877|FG001|Overall Study|Withdrawal by Subject|4|||
126111818|NCT01862640|453705878|FG002|Overall Study|Withdrawal by Subject|8|||
126111819|NCT01862640|453705879|FG003|Overall Study|Withdrawal by Subject|5|||
126111820|NCT01862640|453705876|FG000|Overall Study|Protocol Deviation|0|||
126111821|NCT01862640|453705877|FG001|Overall Study|Protocol Deviation|0|||
126111822|NCT01862640|453705878|FG002|Overall Study|Protocol Deviation|1|||
126111823|NCT01862640|453705879|FG003|Overall Study|Protocol Deviation|0|||
126111824|NCT05211739|453705880|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
126111825|NCT05211739|453705881|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
126111826|NCT05211739|453705880|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
126111827|NCT05211739|453705881|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
126111828|NCT05211739|453705880|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
126111829|NCT05211739|453705881|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
126111830|NCT05211739|453705880|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
126111831|NCT05211739|453705881|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
126111832|NCT02178553|453705884|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
126111833|NCT02178553|453705885|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
126111834|NCT02178553|453705884|FG000|Overall Study|Physician Decision|0|||
126111835|NCT02178553|453705885|FG001|Overall Study|Physician Decision|4|||
126111836|NCT02178553|453705884|FG000|Overall Study|Technical problem with injection|1|||
126111837|NCT02178553|453705885|FG001|Overall Study|Technical problem with injection|3|||
126111838|NCT01975428|453705886|FG000|Overall Study|Lost to Follow-up|17|||
126111839|NCT01975428|453705887|FG001|Overall Study|Lost to Follow-up|4|||
126111840|NCT01975428|453705886|FG000|Overall Study|Withdrawal by Subject|3|||
126111841|NCT01975428|453705887|FG001|Overall Study|Withdrawal by Subject|10|||
126111842|NCT02187809|453705888|FG000|Overall Study|The study was terminated|3|||
126111843|NCT05085665|453705889|FG000|Overall Study|Physician Decision|2|||
125925271|NCT03000439|453025454|FG003|Open Label Part 2|Insufficient clinical response|0|||
125925272|NCT03000439|453025451|FG000|Double Blind Phase|Adverse Event|0|||
126111844|NCT01641809|453705890|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
126111845|NCT01641809|453705891|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
126111846|NCT01641809|453705892|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
126111847|NCT01641809|453705893|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
126111848|NCT01641809|453705890|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
126111849|NCT01641809|453705891|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
126111850|NCT01641809|453705892|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
126111851|NCT01641809|453705893|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
126111852|NCT01641809|453705890|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
126111853|NCT01641809|453705891|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
126111854|NCT01641809|453705892|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
126111855|NCT01641809|453705893|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
126111856|NCT01641809|453705890|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
126111857|NCT01641809|453705891|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
126111858|NCT01641809|453705892|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
126111859|NCT01641809|453705893|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
126111860|NCT01641809|453705890|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
126111861|NCT01641809|453705891|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
126111862|NCT01641809|453705892|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
126111863|NCT01641809|453705893|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
125925273|NCT03000439|453025452|FG001|Double Blind Phase|Adverse Event|0|||
125925274|NCT03000439|453025453|FG002|Double Blind Phase|Adverse Event|2|||
125925275|NCT03000439|453025454|FG003|Double Blind Phase|Adverse Event|1|||
126111864|NCT01641809|453705890|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
126111865|NCT01641809|453705891|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
126111866|NCT01641809|453705892|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
126111867|NCT01641809|453705893|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
126111868|NCT01641809|453705890|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
125925276|NCT03000439|453025451|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
125925277|NCT03000439|453025452|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
125925278|NCT03000439|453025453|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
125925279|NCT03000439|453025454|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
125925280|NCT03000439|453025451|FG000|Double Blind Phase|Other|0|||
125925281|NCT03000439|453025452|FG001|Double Blind Phase|Other|0|||
125925282|NCT03000439|453025453|FG002|Double Blind Phase|Other|10|||
125925283|NCT03000439|453025454|FG003|Double Blind Phase|Other|11|||
125925284|NCT03000439|453025451|FG000|Double Blind Phase|Insufficient clinical response|0|||
125925285|NCT03000439|453025452|FG001|Double Blind Phase|Insufficient clinical response|0|||
125925286|NCT03000439|453025453|FG002|Double Blind Phase|Insufficient clinical response|0|||
125925287|NCT03000439|453025454|FG003|Double Blind Phase|Insufficient clinical response|2|||
125925288|NCT02370160|453025455|FG000|Overall Study|Death|3|||
126064820|NCT00409006|453529093|FG001|Overall Study|Withdrawal by Subject|2|||
126064821|NCT00409006|453529092|FG000|Overall Study|Physician Decision|1|||
126064822|NCT00409006|453529093|FG001|Overall Study|Physician Decision|2|||
126064823|NCT00228813|453529094|FG000|Overall Study|Death|4|||
126064824|NCT00507429|453529095|FG000|Treatment Phase|Disease Progression|12|||
126064825|NCT00507429|453529096|FG001|Treatment Phase|Disease Progression|5|||
125925289|NCT02370160|453025456|FG001|Overall Study|Death|4|||
125925290|NCT02370160|453025457|FG002|Overall Study|Death|1|||
125925291|NCT04487730|453025460|FG000|Overall Study|Withdrawal by Subject|3|||
125925292|NCT04487730|453025461|FG001|Overall Study|Withdrawal by Subject|1|||
125925293|NCT04487730|453025460|FG000|Overall Study|Lost to Follow-up|0|||
125925294|NCT04487730|453025461|FG001|Overall Study|Lost to Follow-up|1|||
125925295|NCT04487730|453025460|FG000|Overall Study|Physician Decision|0|||
125925296|NCT04487730|453025461|FG001|Overall Study|Physician Decision|1|||
125925297|NCT01581931|453025462|FG000|Washout|Adverse Event|0|||
125925298|NCT01581931|453025463|FG001|Washout|Adverse Event|1|||
125925299|NCT03292588|453025470|FG000|Overall Study|Death|1|||
125925300|NCT03292588|453025471|FG001|Overall Study|Death|0|||
125925301|NCT03292588|453025470|FG000|Overall Study|Lost to Follow-up|12|||
125925302|NCT03292588|453025471|FG001|Overall Study|Lost to Follow-up|16|||
125925303|NCT03292588|453025470|FG000|Overall Study|Physician Decision|0|||
125925304|NCT03292588|453025471|FG001|Overall Study|Physician Decision|1|||
125925305|NCT03292588|453025470|FG000|Overall Study|Withdrawal by Subject|4|||
125925306|NCT03292588|453025471|FG001|Overall Study|Withdrawal by Subject|4|||
125925307|NCT03292588|453025470|FG000|Overall Study|Move out of town|1|||
125925308|NCT03292588|453025471|FG001|Overall Study|Move out of town|0|||
125925309|NCT03292588|453025470|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
125925310|NCT03292588|453025471|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
125925311|NCT00592384|453025472|FG000|Overall Study|Withdrawal by Subject|5|||
125925312|NCT00592384|453025473|FG001|Overall Study|Withdrawal by Subject|6|||
125925313|NCT02151591|453025474|FG000|Overall Study|Lost to Follow-up|6|||
125925314|NCT02151591|453025475|FG001|Overall Study|Lost to Follow-up|3|||
125925315|NCT03633695|453025481|FG000|Overall Study|Lost to Follow-up|4|||
125925316|NCT03633695|453025482|FG001|Overall Study|Lost to Follow-up|5|||
125925317|NCT03633695|453025481|FG000|Overall Study|Discontinued|8|||
125925318|NCT03633695|453025482|FG001|Overall Study|Discontinued|4|||
125925319|NCT04932096|453025490|FG000|Overall Study|Withdrawal by Subject|1|||
125925320|NCT04932096|453025491|FG001|Overall Study|Withdrawal by Subject|1|||
125925321|NCT04932096|453025490|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
125925322|NCT04932096|453025491|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
125925323|NCT03766581|453025495|FG000|Randomization|Other reasons|2|||
125925324|NCT03766581|453025496|FG001|Randomization|Other reasons|1|||
125925325|NCT03766581|453025497|FG002|Randomization|Other reasons|0|||
125925326|NCT03766581|453025498|FG003|Randomization|Other reasons|1|||
125925327|NCT03766581|453025499|FG004|Randomization|Other reasons|0|||
125925328|NCT03766581|453025500|FG005|Randomization|Other reasons|0|||
126064826|NCT00507429|453529095|FG000|Treatment Phase|Adverse Event|12|||
126064827|NCT00507429|453529096|FG001|Treatment Phase|Adverse Event|5|||
126064828|NCT00507429|453529095|FG000|Treatment Phase|Withdrawal by Subject|3|||
126064829|NCT00507429|453529096|FG001|Treatment Phase|Withdrawal by Subject|3|||
126064830|NCT00507429|453529095|FG000|Treatment Phase|Physician Decision|4|||
126064831|NCT00507429|453529096|FG001|Treatment Phase|Physician Decision|2|||
126064832|NCT00507429|453529095|FG000|Treatment Phase|Other|6|||
126064833|NCT00507429|453529096|FG001|Treatment Phase|Other|3|||
126064834|NCT00507429|453529095|FG000|Maintenance Phase|Progressive Disease|14|||
126064835|NCT00507429|453529096|FG001|Maintenance Phase|Progressive Disease|0|||
126064836|NCT04025762|453529098|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
125925329|NCT03766581|453025501|FG006|Randomization|Other reasons|0|||
125925330|NCT03766581|453025502|FG007|Randomization|Other reasons|0|||
125925331|NCT03766581|453025495|FG000|Randomization|Participant no longer meets study criteria|5|||
126064837|NCT04025762|453529099|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
126064838|NCT01131325|453529106|FG000|Overall Study|Adverse Event|1|||
126064839|NCT01131325|453529106|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
126064840|NCT03884478|453529107|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
126064841|NCT03884478|453529108|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
125925332|NCT03766581|453025496|FG001|Randomization|Participant no longer meets study criteria|3|||
125925333|NCT03766581|453025497|FG002|Randomization|Participant no longer meets study criteria|4|||
125925334|NCT03766581|453025498|FG003|Randomization|Participant no longer meets study criteria|0|||
125925335|NCT03766581|453025499|FG004|Randomization|Participant no longer meets study criteria|2|||
125925336|NCT03766581|453025500|FG005|Randomization|Participant no longer meets study criteria|3|||
125925337|NCT03766581|453025501|FG006|Randomization|Participant no longer meets study criteria|0|||
125925338|NCT03766581|453025502|FG007|Randomization|Participant no longer meets study criteria|1|||
125925339|NCT03766581|453025495|FG000|Randomization|Participant request to discontinue study treatment|1|||
125925340|NCT03766581|453025496|FG001|Randomization|Participant request to discontinue study treatment|0|||
125925341|NCT03766581|453025497|FG002|Randomization|Participant request to discontinue study treatment|0|||
125925342|NCT03766581|453025498|FG003|Randomization|Participant request to discontinue study treatment|0|||
125925343|NCT03766581|453025499|FG004|Randomization|Participant request to discontinue study treatment|1|||
125925344|NCT03766581|453025500|FG005|Randomization|Participant request to discontinue study treatment|2|||
125925345|NCT03766581|453025501|FG006|Randomization|Participant request to discontinue study treatment|0|||
125925346|NCT03766581|453025502|FG007|Randomization|Participant request to discontinue study treatment|0|||
125925347|NCT03766581|453025495|FG000|Randomization|Participant withdrew consent|1|||
125925348|NCT03766581|453025496|FG001|Randomization|Participant withdrew consent|0|||
125925349|NCT03766581|453025497|FG002|Randomization|Participant withdrew consent|1|||
125925350|NCT03766581|453025498|FG003|Randomization|Participant withdrew consent|2|||
125925351|NCT03766581|453025499|FG004|Randomization|Participant withdrew consent|1|||
125925352|NCT03766581|453025500|FG005|Randomization|Participant withdrew consent|1|||
125925353|NCT03766581|453025501|FG006|Randomization|Participant withdrew consent|0|||
125925354|NCT03766581|453025502|FG007|Randomization|Participant withdrew consent|0|||
125925355|NCT03766581|453025495|FG000|Treatment|Adverse Event|82|||
125925356|NCT03766581|453025496|FG001|Treatment|Adverse Event|44|||
125925357|NCT03766581|453025497|FG002|Treatment|Adverse Event|47|||
125925358|NCT03766581|453025498|FG003|Treatment|Adverse Event|46|||
125925359|NCT03766581|453025499|FG004|Treatment|Adverse Event|50|||
125925360|NCT03766581|453025500|FG005|Treatment|Adverse Event|77|||
125925361|NCT03766581|453025501|FG006|Treatment|Adverse Event|5|||
125925362|NCT03766581|453025502|FG007|Treatment|Adverse Event|2|||
125925363|NCT03766581|453025495|FG000|Treatment|Participant request to discontinue treatment|34|||
125925364|NCT03766581|453025496|FG001|Treatment|Participant request to discontinue treatment|6|||
125925365|NCT03766581|453025497|FG002|Treatment|Participant request to discontinue treatment|10|||
125925366|NCT03766581|453025498|FG003|Treatment|Participant request to discontinue treatment|10|||
125925367|NCT03766581|453025499|FG004|Treatment|Participant request to discontinue treatment|14|||
125925368|NCT03766581|453025500|FG005|Treatment|Participant request to discontinue treatment|15|||
125925369|NCT03766581|453025501|FG006|Treatment|Participant request to discontinue treatment|0|||
125925370|NCT03766581|453025502|FG007|Treatment|Participant request to discontinue treatment|1|||
125925371|NCT03766581|453025495|FG000|Treatment|Participant withdrew consent|11|||
125925372|NCT03766581|453025496|FG001|Treatment|Participant withdrew consent|4|||
125925373|NCT03766581|453025497|FG002|Treatment|Participant withdrew consent|5|||
125925374|NCT03766581|453025498|FG003|Treatment|Participant withdrew consent|5|||
125925375|NCT03766581|453025499|FG004|Treatment|Participant withdrew consent|4|||
125925376|NCT03766581|453025500|FG005|Treatment|Participant withdrew consent|4|||
125925377|NCT03766581|453025501|FG006|Treatment|Participant withdrew consent|0|||
125925378|NCT03766581|453025502|FG007|Treatment|Participant withdrew consent|0|||
125925379|NCT03766581|453025495|FG000|Treatment|Death|1|||
125925380|NCT03766581|453025496|FG001|Treatment|Death|0|||
125925381|NCT03766581|453025497|FG002|Treatment|Death|0|||
125925382|NCT03766581|453025498|FG003|Treatment|Death|0|||
125925383|NCT03766581|453025499|FG004|Treatment|Death|0|||
125925384|NCT03766581|453025500|FG005|Treatment|Death|0|||
125925385|NCT03766581|453025501|FG006|Treatment|Death|0|||
125925386|NCT03766581|453025502|FG007|Treatment|Death|0|||
125925387|NCT03766581|453025495|FG000|Treatment|Lost to Follow-up|1|||
125925388|NCT03766581|453025496|FG001|Treatment|Lost to Follow-up|0|||
125925389|NCT03766581|453025497|FG002|Treatment|Lost to Follow-up|0|||
125925390|NCT03766581|453025498|FG003|Treatment|Lost to Follow-up|1|||
125925391|NCT03766581|453025499|FG004|Treatment|Lost to Follow-up|0|||
125925392|NCT03766581|453025500|FG005|Treatment|Lost to Follow-up|0|||
125925393|NCT03766581|453025501|FG006|Treatment|Lost to Follow-up|0|||
125925394|NCT03766581|453025502|FG007|Treatment|Lost to Follow-up|0|||
125925395|NCT03766581|453025495|FG000|Treatment|Poor/Non compliance|2|||
125925396|NCT03766581|453025496|FG001|Treatment|Poor/Non compliance|2|||
125925397|NCT03766581|453025497|FG002|Treatment|Poor/Non compliance|1|||
125925398|NCT03766581|453025498|FG003|Treatment|Poor/Non compliance|1|||
125925399|NCT03766581|453025499|FG004|Treatment|Poor/Non compliance|1|||
125925400|NCT03766581|453025500|FG005|Treatment|Poor/Non compliance|1|||
125925401|NCT03766581|453025501|FG006|Treatment|Poor/Non compliance|0|||
125925402|NCT03766581|453025502|FG007|Treatment|Poor/Non compliance|0|||
125925403|NCT03766581|453025495|FG000|Treatment|Participant no longer meets study criteria|9|||
125925404|NCT03766581|453025496|FG001|Treatment|Participant no longer meets study criteria|1|||
125925405|NCT03766581|453025497|FG002|Treatment|Participant no longer meets study criteria|5|||
125925406|NCT03766581|453025498|FG003|Treatment|Participant no longer meets study criteria|4|||
125925407|NCT03766581|453025499|FG004|Treatment|Participant no longer meets study criteria|4|||
125925408|NCT03766581|453025500|FG005|Treatment|Participant no longer meets study criteria|4|||
125925409|NCT03766581|453025501|FG006|Treatment|Participant no longer meets study criteria|2|||
125925410|NCT03766581|453025502|FG007|Treatment|Participant no longer meets study criteria|0|||
125925411|NCT03766581|453025495|FG000|Treatment|Other reasons|13|||
125925412|NCT03766581|453025496|FG001|Treatment|Other reasons|8|||
125925413|NCT03766581|453025497|FG002|Treatment|Other reasons|3|||
125925414|NCT03766581|453025498|FG003|Treatment|Other reasons|7|||
125925415|NCT03766581|453025499|FG004|Treatment|Other reasons|3|||
125925416|NCT03766581|453025500|FG005|Treatment|Other reasons|3|||
125925417|NCT03766581|453025501|FG006|Treatment|Other reasons|0|||
125925418|NCT03766581|453025502|FG007|Treatment|Other reasons|0|||
125925419|NCT02732119|453025503|FG000|Phase I|Adverse Event|1|||
125925420|NCT02732119|453025504|FG001|Phase I|Adverse Event|3|||
125925421|NCT02732119|453025505|FG002|Phase I|Adverse Event|1|||
125925422|NCT02732119|453025506|FG003|Phase I|Adverse Event|0|||
125925423|NCT02732119|453025507|FG004|Phase I|Adverse Event|0|||
125925424|NCT02732119|453025503|FG000|Phase I|Progressive disease|7|||
125925425|NCT02732119|453025504|FG001|Phase I|Progressive disease|3|||
125925426|NCT02732119|453025505|FG002|Phase I|Progressive disease|2|||
125925427|NCT02732119|453025506|FG003|Phase I|Progressive disease|0|||
125925428|NCT02732119|453025507|FG004|Phase I|Progressive disease|0|||
125925429|NCT02732119|453025503|FG000|Phase I|Protocol deviation|0|||
125925430|NCT02732119|453025504|FG001|Phase I|Protocol deviation|1|||
125925431|NCT02732119|453025505|FG002|Phase I|Protocol deviation|0|||
125925432|NCT02732119|453025506|FG003|Phase I|Protocol deviation|0|||
125925433|NCT02732119|453025507|FG004|Phase I|Protocol deviation|0|||
125925434|NCT02732119|453025503|FG000|Phase I|Physician Decision|0|||
125925435|NCT02732119|453025504|FG001|Phase I|Physician Decision|3|||
125925436|NCT02732119|453025505|FG002|Phase I|Physician Decision|4|||
125925437|NCT02732119|453025506|FG003|Phase I|Physician Decision|0|||
125925438|NCT02732119|453025507|FG004|Phase I|Physician Decision|0|||
125925439|NCT02732119|453025503|FG000|Phase II|Adverse Event|0|||
125925440|NCT02732119|453025504|FG001|Phase II|Adverse Event|0|||
125925441|NCT02732119|453025505|FG002|Phase II|Adverse Event|0|||
125925442|NCT02732119|453025506|FG003|Phase II|Adverse Event|3|||
125925443|NCT02732119|453025507|FG004|Phase II|Adverse Event|3|||
125925444|NCT02732119|453025503|FG000|Phase II|Death|0|||
125925445|NCT02732119|453025504|FG001|Phase II|Death|0|||
125925446|NCT02732119|453025505|FG002|Phase II|Death|0|||
125925447|NCT02732119|453025506|FG003|Phase II|Death|1|||
125925448|NCT02732119|453025507|FG004|Phase II|Death|0|||
125925449|NCT02732119|453025503|FG000|Phase II|Progressive dissease|0|||
125925450|NCT02732119|453025504|FG001|Phase II|Progressive dissease|0|||
125925451|NCT02732119|453025505|FG002|Phase II|Progressive dissease|0|||
125925452|NCT02732119|453025506|FG003|Phase II|Progressive dissease|30|||
125925453|NCT02732119|453025507|FG004|Phase II|Progressive dissease|23|||
125925454|NCT02732119|453025503|FG000|Phase II|Study terminated by sponsor|0|||
125925455|NCT02732119|453025504|FG001|Phase II|Study terminated by sponsor|0|||
125925456|NCT02732119|453025505|FG002|Phase II|Study terminated by sponsor|0|||
125925457|NCT02732119|453025506|FG003|Phase II|Study terminated by sponsor|2|||
125925458|NCT02732119|453025507|FG004|Phase II|Study terminated by sponsor|2|||
125925459|NCT02732119|453025503|FG000|Phase II|Other|0|||
125925460|NCT02732119|453025504|FG001|Phase II|Other|0|||
125925461|NCT02732119|453025505|FG002|Phase II|Other|0|||
125925462|NCT02732119|453025506|FG003|Phase II|Other|2|||
125925463|NCT02732119|453025507|FG004|Phase II|Other|0|||
125925464|NCT02732119|453025503|FG000|Phase II|Physician Decision|0|||
125925465|NCT02732119|453025504|FG001|Phase II|Physician Decision|0|||
125925466|NCT02732119|453025505|FG002|Phase II|Physician Decision|0|||
125925467|NCT02732119|453025506|FG003|Phase II|Physician Decision|8|||
125925468|NCT02732119|453025507|FG004|Phase II|Physician Decision|5|||
125925469|NCT00520936|453025508|FG000|Overall Study|Physician Decision|0|||
125925470|NCT00520936|453025509|FG001|Overall Study|Physician Decision|2|||
125925471|NCT00520936|453025510|FG002|Overall Study|Physician Decision|1|||
125925472|NCT00520936|453025511|FG003|Overall Study|Physician Decision|0|||
125925473|NCT00520936|453025512|FG004|Overall Study|Physician Decision|0|||
125925474|NCT00520936|453025513|FG005|Overall Study|Physician Decision|0|||
125925475|NCT00520936|453025514|FG006|Overall Study|Physician Decision|0|||
125925476|NCT00520936|453025515|FG007|Overall Study|Physician Decision|0|||
125925477|NCT00520936|453025508|FG000|Overall Study|Withdrawal by Subject|0|||
125925478|NCT00520936|453025509|FG001|Overall Study|Withdrawal by Subject|0|||
125925479|NCT00520936|453025510|FG002|Overall Study|Withdrawal by Subject|0|||
125925480|NCT00520936|453025511|FG003|Overall Study|Withdrawal by Subject|0|||
125925481|NCT00520936|453025512|FG004|Overall Study|Withdrawal by Subject|0|||
125925482|NCT00520936|453025513|FG005|Overall Study|Withdrawal by Subject|0|||
125925483|NCT00520936|453025514|FG006|Overall Study|Withdrawal by Subject|0|||
125925484|NCT00520936|453025515|FG007|Overall Study|Withdrawal by Subject|1|||
125925485|NCT00520936|453025508|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
125925486|NCT00520936|453025509|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
125925487|NCT00520936|453025510|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
125925488|NCT00520936|453025511|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
125925489|NCT00520936|453025512|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
125925490|NCT00520936|453025513|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
125925491|NCT00520936|453025514|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
125925492|NCT00520936|453025515|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
125925493|NCT00520936|453025508|FG000|Overall Study|Death|0|||
125925494|NCT00520936|453025509|FG001|Overall Study|Death|0|||
125925495|NCT00520936|453025510|FG002|Overall Study|Death|0|||
125925496|NCT00520936|453025511|FG003|Overall Study|Death|0|||
125925497|NCT00520936|453025512|FG004|Overall Study|Death|0|||
125925498|NCT00520936|453025513|FG005|Overall Study|Death|0|||
125925499|NCT00520936|453025514|FG006|Overall Study|Death|1|||
125925500|NCT00520936|453025515|FG007|Overall Study|Death|0|||
125925501|NCT00520936|453025508|FG000|Overall Study|Protocol Violation|0|||
125925502|NCT00520936|453025509|FG001|Overall Study|Protocol Violation|1|||
125925503|NCT00520936|453025510|FG002|Overall Study|Protocol Violation|1|||
125925504|NCT00520936|453025511|FG003|Overall Study|Protocol Violation|0|||
125925505|NCT00520936|453025512|FG004|Overall Study|Protocol Violation|1|||
125925506|NCT00520936|453025513|FG005|Overall Study|Protocol Violation|0|||
125925507|NCT00520936|453025514|FG006|Overall Study|Protocol Violation|1|||
125925508|NCT00520936|453025515|FG007|Overall Study|Protocol Violation|0|||
125925509|NCT05275400|453025520|FG000|Treatment Period|Adverse Event|7|||
125925510|NCT05275400|453025521|FG001|Treatment Period|Adverse Event|1|||
125925511|NCT05275400|453025520|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
125925512|NCT05275400|453025521|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
125925513|NCT05275400|453025520|FG000|Treatment Period|Death|5|||
125925514|NCT05275400|453025521|FG001|Treatment Period|Death|2|||
125925515|NCT05275400|453025520|FG000|Treatment Period|Protocol Violation|1|||
125925516|NCT05275400|453025521|FG001|Treatment Period|Protocol Violation|0|||
125925517|NCT05275400|453025520|FG000|Treatment Period|Physician Decision|5|||
125925518|NCT05275400|453025521|FG001|Treatment Period|Physician Decision|4|||
125925519|NCT05275400|453025520|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
125925520|NCT05275400|453025521|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
125925521|NCT05275400|453025520|FG000|Treatment Period|Withdrawal by Subject|30|||
125925522|NCT05275400|453025521|FG001|Treatment Period|Withdrawal by Subject|12|||
125925523|NCT05275400|453025520|FG000|Treatment Period|Lost to Follow-up|1|||
125925524|NCT05275400|453025521|FG001|Treatment Period|Lost to Follow-up|5|||
125925525|NCT05275400|453025520|FG000|Treatment Period|Lack of Efficacy|1|||
125925526|NCT05275400|453025521|FG001|Treatment Period|Lack of Efficacy|0|||
126064842|NCT03884478|453529109|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
126064843|NCT03884478|453529107|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
126064844|NCT03884478|453529108|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
126064845|NCT03884478|453529109|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
126064846|NCT03884478|453529107|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
126064847|NCT03884478|453529108|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
126064848|NCT03884478|453529109|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
126064849|NCT03884478|453529107|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
126064850|NCT03884478|453529108|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
126064851|NCT03884478|453529109|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
126064852|NCT02213094|453529112|FG000|Overall Study|Adverse Event|1|||
126064853|NCT02213094|453529113|FG001|Overall Study|Adverse Event|0|||
126064854|NCT01807234|453529114|FG000|Overall Study|Lost to Follow-up|2|||
126064855|NCT01807234|453529115|FG001|Overall Study|Lost to Follow-up|5|||
126064856|NCT01807234|453529116|FG002|Overall Study|Lost to Follow-up|1|||
126064857|NCT01807234|453529117|FG003|Overall Study|Lost to Follow-up|1|||
125925527|NCT05275400|453025520|FG000|Treatment Period|Sponsor Decision|1|||
125925528|NCT05275400|453025521|FG001|Treatment Period|Sponsor Decision|0|||
125925529|NCT05275400|453025520|FG000|Follow-Up Period|Death|2|||
125925530|NCT05275400|453025521|FG001|Follow-Up Period|Death|0|||
125925531|NCT05275400|453025520|FG000|Follow-Up Period|Protocol Violation|1|||
125925532|NCT05275400|453025521|FG001|Follow-Up Period|Protocol Violation|0|||
125925533|NCT05275400|453025520|FG000|Follow-Up Period|Withdrawal by Subject|3|||
125925534|NCT05275400|453025521|FG001|Follow-Up Period|Withdrawal by Subject|0|||
125925535|NCT02585960|453025522|FG000|PK/Safety Assessment Period|Physician Decision|0|||
125925536|NCT02585960|453025523|FG001|PK/Safety Assessment Period|Physician Decision|1|||
125925537|NCT02585960|453025524|FG002|PK/Safety Assessment Period|Physician Decision|0|||
125925538|NCT02585960|453025522|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
126064858|NCT01807234|453529118|FG004|Overall Study|Lost to Follow-up|1|||
126064859|NCT01807234|453529119|FG005|Overall Study|Lost to Follow-up|2|||
125925539|NCT02585960|453025523|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
125925540|NCT02585960|453025524|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
125925541|NCT02585960|453025522|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
125925542|NCT02585960|453025523|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
125925543|NCT02585960|453025524|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
125925544|NCT02585960|453025522|FG000|PK/Safety Assessment Period|Other|4|||
125925545|NCT02585960|453025523|FG001|PK/Safety Assessment Period|Other|4|||
125925546|NCT02585960|453025524|FG002|PK/Safety Assessment Period|Other|0|||
125925547|NCT02585960|453025522|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
125925548|NCT02585960|453025523|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
125925549|NCT02585960|453025524|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
125925550|NCT02585960|453025522|FG000|PK/Safety Assessment Period|Screen Failure|0|||
125925551|NCT02585960|453025523|FG001|PK/Safety Assessment Period|Screen Failure|0|||
125925552|NCT02585960|453025524|FG002|PK/Safety Assessment Period|Screen Failure|1|||
125925553|NCT02585960|453025522|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
125925554|NCT02585960|453025523|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
125925555|NCT02585960|453025524|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
125925556|NCT02585960|453025522|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
125925557|NCT02585960|453025523|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
125925558|NCT02585960|453025524|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
125925559|NCT03639935|453025525|FG000|Overall Study|Death|3|||
125925560|NCT03639935|453025525|FG000|Overall Study|Adverse Event|1|||
125925561|NCT06333613|453025526|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
125925562|NCT03648541|453025529|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
125925563|NCT03648541|453025530|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
125925564|NCT03648541|453025529|FG000|Re-induction Period Only|Lack of Efficacy|7|||
125925565|NCT03648541|453025530|FG001|Re-induction Period Only|Lack of Efficacy|0|||
125925566|NCT03648541|453025529|FG000|Maintenance Period Only|Missing|0|||
125925567|NCT03648541|453025530|FG001|Maintenance Period Only|Missing|1|||
125925568|NCT03648541|453025529|FG000|Maintenance Period Only|Other not listed below|0|||
125925569|NCT03648541|453025530|FG001|Maintenance Period Only|Other not listed below|4|||
125925570|NCT03648541|453025529|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
125925571|NCT03648541|453025530|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
125925572|NCT03648541|453025529|FG000|Maintenance Period Only|Protocol Violation|0|||
125925573|NCT03648541|453025530|FG001|Maintenance Period Only|Protocol Violation|1|||
125925574|NCT03648541|453025529|FG000|Maintenance Period Only|Lack of Efficacy|0|||
125925575|NCT03648541|453025530|FG001|Maintenance Period Only|Lack of Efficacy|18|||
125925576|NCT03648541|453025529|FG000|Maintenance Period Only|Adverse Event|0|||
125925577|NCT03648541|453025530|FG001|Maintenance Period Only|Adverse Event|4|||
125925578|NCT03648541|453025529|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
125925579|NCT03648541|453025530|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
125925580|NCT02197247|453025533|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
125925581|NCT02197247|453025533|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
125925582|NCT02197247|453025533|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
125925583|NCT02197247|453025533|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
125925584|NCT02197247|453025533|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
125925585|NCT02197247|453025533|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
125925586|NCT02197247|453025533|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
125925587|NCT02197247|453025533|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
125925588|NCT01619423|453025534|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
125925589|NCT01619423|453025535|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
125925590|NCT01619423|453025536|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
125925591|NCT01619423|453025537|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
125925592|NCT02340975|453025547|FG000|Overall Study|Death|6|||
125925593|NCT02340975|453025548|FG001|Overall Study|Death|23|||
125925594|NCT02340975|453025549|FG002|Overall Study|Death|21|||
125925595|NCT02340975|453025550|FG003|Overall Study|Death|7|||
125925596|NCT02340975|453025551|FG004|Overall Study|Death|21|||
125925597|NCT02340975|453025552|FG005|Overall Study|Death|13|||
125925598|NCT02340975|453025547|FG000|Overall Study|Lost to Follow-up|0|||
125925599|NCT02340975|453025548|FG001|Overall Study|Lost to Follow-up|0|||
125925600|NCT02340975|453025549|FG002|Overall Study|Lost to Follow-up|0|||
125925601|NCT02340975|453025550|FG003|Overall Study|Lost to Follow-up|0|||
125925602|NCT02340975|453025551|FG004|Overall Study|Lost to Follow-up|2|||
125925603|NCT02340975|453025552|FG005|Overall Study|Lost to Follow-up|0|||
125925604|NCT02340975|453025547|FG000|Overall Study|Withdrawal by Subject|0|||
125925605|NCT02340975|453025548|FG001|Overall Study|Withdrawal by Subject|0|||
125925606|NCT02340975|453025549|FG002|Overall Study|Withdrawal by Subject|3|||
125925607|NCT02340975|453025550|FG003|Overall Study|Withdrawal by Subject|3|||
125925608|NCT02340975|453025551|FG004|Overall Study|Withdrawal by Subject|2|||
125925609|NCT02340975|453025552|FG005|Overall Study|Withdrawal by Subject|0|||
125925610|NCT02340975|453025547|FG000|Overall Study|Other|0|||
125925611|NCT02340975|453025548|FG001|Overall Study|Other|4|||
125925612|NCT02340975|453025549|FG002|Overall Study|Other|0|||
125925613|NCT02340975|453025550|FG003|Overall Study|Other|2|||
125925614|NCT02340975|453025551|FG004|Overall Study|Other|0|||
125925615|NCT02340975|453025552|FG005|Overall Study|Other|6|||
125925616|NCT02099708|453025560|FG000|Overall Study|Data Not Available|30|||
125925617|NCT02099708|453025560|FG000|Overall Study|Lost to Follow-up|141|||
125925618|NCT02099708|453025560|FG000|Overall Study|Other|29|||
125925619|NCT05466682|453025564|FG000|Overall Study|Withdrawal by Subject|0|||
125925620|NCT05466682|453025565|FG001|Overall Study|Withdrawal by Subject|2|||
125925621|NCT05466682|453025564|FG000|Overall Study|Lost to Follow-up|2|||
125925622|NCT05466682|453025565|FG001|Overall Study|Lost to Follow-up|1|||
125925623|NCT01697566|453025566|FG000|Overall Study|Withdrawal by Subject|0|||
125925624|NCT01697566|453025567|FG001|Overall Study|Withdrawal by Subject|0|||
125925625|NCT01697566|453025568|FG002|Overall Study|Withdrawal by Subject|1|||
125925626|NCT01697566|453025569|FG003|Overall Study|Withdrawal by Subject|1|||
125925627|NCT01697566|453025566|FG000|Overall Study|Final biopsy not obtained|0|||
125925628|NCT01697566|453025567|FG001|Overall Study|Final biopsy not obtained|0|||
125925629|NCT01697566|453025568|FG002|Overall Study|Final biopsy not obtained|1|||
125925630|NCT01697566|453025569|FG003|Overall Study|Final biopsy not obtained|0|||
125925631|NCT01930123|453025570|FG000|Overall Study|Adverse Event|1|||
125925632|NCT01930123|453025571|FG001|Overall Study|Adverse Event|0|||
125925633|NCT01930123|453025570|FG000|Overall Study|Physician Decision|21|||
125925634|NCT01930123|453025571|FG001|Overall Study|Physician Decision|8|||
125925635|NCT01930123|453025570|FG000|Overall Study|Withdrawal by Subject|1|||
125925636|NCT01930123|453025571|FG001|Overall Study|Withdrawal by Subject|0|||
125925637|NCT01447433|453025574|FG000|Overall Study|Lost to Follow-up|0|||
125925638|NCT01447433|453025575|FG001|Overall Study|Lost to Follow-up|2|||
125925639|NCT01447433|453025574|FG000|Overall Study|Withdrawal by Subject|3|||
125925640|NCT01447433|453025575|FG001|Overall Study|Withdrawal by Subject|3|||
125925641|NCT01447433|453025574|FG000|Overall Study|Protocol Violation|1|||
125925642|NCT01447433|453025575|FG001|Overall Study|Protocol Violation|1|||
125925643|NCT00036270|453025576|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
125925644|NCT00036270|453025577|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
125925645|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
125925646|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
125925647|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
125925648|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
125925649|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
125925650|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
125925651|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Other|277|||
125925652|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Other|288|||
125925653|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
125925654|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
125925655|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
125925656|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
125925657|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
125925658|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
125925659|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
125925660|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
125925661|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
125925662|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
125925663|NCT00036270|453025576|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
125925664|NCT00036270|453025577|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
125925665|NCT01578187|453025578|FG000|Usability Phase|Withdrawal by Subject|1|||
125925666|NCT01964430|453025579|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
125925667|NCT01964430|453025580|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
125925668|NCT01964430|453025579|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
125925669|NCT01964430|453025580|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
125925670|NCT01964430|453025579|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
125925671|NCT01964430|453025580|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
125925672|NCT01964430|453025579|FG000|Treatment Period|Adverse Event|71|||
125925673|NCT01964430|453025580|FG001|Treatment Period|Adverse Event|37|||
125925674|NCT01964430|453025579|FG000|Treatment Period|Withdrawal by Subject|36|||
125925675|NCT01964430|453025580|FG001|Treatment Period|Withdrawal by Subject|27|||
125925676|NCT01964430|453025579|FG000|Treatment Period|Death|1|||
125925677|NCT01964430|453025580|FG001|Treatment Period|Death|3|||
125925678|NCT01964430|453025579|FG000|Treatment Period|Protocol Deviation|0|||
125925679|NCT01964430|453025580|FG001|Treatment Period|Protocol Deviation|1|||
125925680|NCT01964430|453025579|FG000|Treatment Period|Physician Decision|5|||
126064860|NCT01807234|453529114|FG000|Overall Study|Withdrawal by Subject|3|||
126064861|NCT01807234|453529115|FG001|Overall Study|Withdrawal by Subject|1|||
126064862|NCT01807234|453529116|FG002|Overall Study|Withdrawal by Subject|1|||
126064863|NCT01807234|453529117|FG003|Overall Study|Withdrawal by Subject|1|||
126064864|NCT01807234|453529118|FG004|Overall Study|Withdrawal by Subject|2|||
126064865|NCT01807234|453529119|FG005|Overall Study|Withdrawal by Subject|1|||
126064866|NCT01807234|453529114|FG000|Overall Study|Lack of Efficacy|0|||
126064867|NCT01807234|453529115|FG001|Overall Study|Lack of Efficacy|0|||
126064868|NCT01807234|453529116|FG002|Overall Study|Lack of Efficacy|0|||
125925681|NCT01964430|453025580|FG001|Treatment Period|Physician Decision|4|||
125925682|NCT01964430|453025579|FG000|Treatment Period|Disease Relapse|28|||
125925683|NCT01964430|453025580|FG001|Treatment Period|Disease Relapse|38|||
125925684|NCT01964430|453025579|FG000|Treatment Period|Other reasons|1|||
125925685|NCT01964430|453025580|FG001|Treatment Period|Other reasons|3|||
125925686|NCT02516163|453025581|FG000|Overall Study|Withdrawal by Subject|1|||
125925687|NCT02516163|453025581|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
125925688|NCT02516163|453025581|FG000|Overall Study|Unfit/delay in surgery|3|||
125925689|NCT02516163|453025581|FG000|Overall Study|Use of incorrect measurement technique|5|||
125925690|NCT02516163|453025581|FG000|Overall Study|Data not recorded|2|||
125925691|NCT02516163|453025581|FG000|Overall Study|MRI contraindication exclusion|6|||
125925692|NCT02801396|453025582|FG000|Period 1|Withdrawal by Subject|0|||
125925693|NCT02801396|453025583|FG001|Period 1|Withdrawal by Subject|0|||
125925694|NCT02801396|453025584|FG002|Period 1|Withdrawal by Subject|0|||
125925695|NCT02801396|453025585|FG003|Period 1|Withdrawal by Subject|0|||
125925696|NCT02801396|453025586|FG004|Period 1|Withdrawal by Subject|1|||
125925697|NCT02801396|453025587|FG005|Period 1|Withdrawal by Subject|0|||
125925698|NCT01658072|453025590|FG000|Overall Study|Protocol Violation|4|||
125925699|NCT01658072|453025591|FG001|Overall Study|Protocol Violation|2|||
125925700|NCT03208244|453025592|FG000|Overall Study|Death|1|||
125925701|NCT01709162|453025593|FG000|Overall Study|Disease progression|3|||
125925702|NCT01709162|453025594|FG001|Overall Study|Disease progression|3|||
125925703|NCT01709162|453025593|FG000|Overall Study|Study drug toxicity|2|||
125925704|NCT01709162|453025594|FG001|Overall Study|Study drug toxicity|0|||
125925705|NCT01709162|453025593|FG000|Overall Study|Administrative reason by sponsor|0|||
125925706|NCT01709162|453025594|FG001|Overall Study|Administrative reason by sponsor|1|||
125925707|NCT01709162|453025593|FG000|Overall Study|Other|1|||
125925708|NCT01709162|453025594|FG001|Overall Study|Other|0|||
125925709|NCT01709162|453025593|FG000|Overall Study|Withdrawal by Subject|0|||
125925710|NCT01709162|453025594|FG001|Overall Study|Withdrawal by Subject|1|||
125925711|NCT02405780|453025602|FG000|Period I|Adverse Event|8|||
125925712|NCT02405780|453025603|FG001|Period I|Adverse Event|0|||
125925713|NCT02405780|453025604|FG002|Period I|Adverse Event|3|||
125925714|NCT02405780|453025605|FG003|Period I|Adverse Event|7|||
125925715|NCT02405780|453025602|FG000|Period I|Medical reasons|1|||
125925716|NCT02405780|453025603|FG001|Period I|Medical reasons|1|||
125925717|NCT02405780|453025604|FG002|Period I|Medical reasons|0|||
125925718|NCT02405780|453025605|FG003|Period I|Medical reasons|1|||
125925719|NCT02405780|453025602|FG000|Period I|Screening Failure|1|||
125925720|NCT02405780|453025603|FG001|Period I|Screening Failure|0|||
125925721|NCT02405780|453025604|FG002|Period I|Screening Failure|1|||
125925722|NCT02405780|453025605|FG003|Period I|Screening Failure|0|||
125925723|NCT02405780|453025602|FG000|Period I|Withdrawal by Subject|9|||
125925724|NCT02405780|453025603|FG001|Period I|Withdrawal by Subject|1|||
125925725|NCT02405780|453025604|FG002|Period I|Withdrawal by Subject|3|||
125925726|NCT02405780|453025605|FG003|Period I|Withdrawal by Subject|4|||
125925727|NCT02405780|453025602|FG000|Period I|Non-compliance with study procedures|8|||
125925728|NCT02405780|453025603|FG001|Period I|Non-compliance with study procedures|6|||
125925729|NCT02405780|453025604|FG002|Period I|Non-compliance with study procedures|8|||
125925730|NCT02405780|453025605|FG003|Period I|Non-compliance with study procedures|11|||
125925731|NCT02405780|453025602|FG000|Period II|Adverse Event|3|||
125925732|NCT02405780|453025603|FG001|Period II|Adverse Event|5|||
125925733|NCT02405780|453025604|FG002|Period II|Adverse Event|4|||
125925734|NCT02405780|453025605|FG003|Period II|Adverse Event|11|||
125925735|NCT02405780|453025602|FG000|Period II|Medical reason|0|||
125925736|NCT02405780|453025603|FG001|Period II|Medical reason|1|||
125925737|NCT02405780|453025604|FG002|Period II|Medical reason|0|||
125925738|NCT02405780|453025605|FG003|Period II|Medical reason|0|||
125925739|NCT02405780|453025602|FG000|Period II|Pregnancy|0|||
125925740|NCT02405780|453025603|FG001|Period II|Pregnancy|0|||
125925741|NCT02405780|453025604|FG002|Period II|Pregnancy|1|||
125925742|NCT02405780|453025605|FG003|Period II|Pregnancy|0|||
126064869|NCT01807234|453529117|FG003|Overall Study|Lack of Efficacy|0|||
126064870|NCT01807234|453529118|FG004|Overall Study|Lack of Efficacy|1|||
126064871|NCT01807234|453529119|FG005|Overall Study|Lack of Efficacy|1|||
126064872|NCT00538629|453529120|FG000|Overall Study|At subject's request|1|||
126064873|NCT00538629|453529120|FG000|Overall Study|Adverse Event|2|||
126064874|NCT00538629|453529120|FG000|Overall Study|Lack of Efficacy|12|||
126064875|NCT00538629|453529120|FG000|Overall Study|Lost to Follow-up|6|||
125925743|NCT02405780|453025602|FG000|Period II|Withdrawal by Subject|7|||
125925744|NCT02405780|453025603|FG001|Period II|Withdrawal by Subject|4|||
125925745|NCT02405780|453025604|FG002|Period II|Withdrawal by Subject|0|||
125925746|NCT02405780|453025605|FG003|Period II|Withdrawal by Subject|3|||
125925747|NCT02405780|453025602|FG000|Period II|Non-compliance with study procedures|5|||
125925748|NCT02405780|453025603|FG001|Period II|Non-compliance with study procedures|2|||
125925749|NCT02405780|453025604|FG002|Period II|Non-compliance with study procedures|7|||
125925750|NCT02405780|453025605|FG003|Period II|Non-compliance with study procedures|4|||
125925751|NCT01654536|453025606|FG000|Overall Study|Lost to Follow-up|5|||
125925752|NCT01654536|453025607|FG001|Overall Study|Lost to Follow-up|5|||
126064876|NCT00538629|453529120|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
125925753|NCT01654536|453025606|FG000|Overall Study|Physician Decision|12|||
125925754|NCT01654536|453025607|FG001|Overall Study|Physician Decision|8|||
125925755|NCT01654536|453025606|FG000|Overall Study|Withdrawal by Subject|27|||
125925756|NCT01654536|453025607|FG001|Overall Study|Withdrawal by Subject|25|||
125925757|NCT03736447|453025614|FG000|Overall Study|Adverse Event|5|||
125925758|NCT03736447|453025615|FG001|Overall Study|Adverse Event|1|||
125925759|NCT03736447|453025614|FG000|Overall Study|Withdrawal by Subject|5|||
125925760|NCT03736447|453025615|FG001|Overall Study|Withdrawal by Subject|1|||
125925761|NCT03736447|453025614|FG000|Overall Study|Lost to Follow-up|1|||
125925762|NCT03736447|453025615|FG001|Overall Study|Lost to Follow-up|0|||
125925763|NCT03736447|453025614|FG000|Overall Study|Physician Decision|1|||
125925764|NCT03736447|453025615|FG001|Overall Study|Physician Decision|0|||
125925765|NCT03736447|453025614|FG000|Overall Study|Continued commitment to study treatment|3|||
125925766|NCT03736447|453025615|FG001|Overall Study|Continued commitment to study treatment|0|||
125925767|NCT03736447|453025614|FG000|Overall Study|Taste aversion to study product|0|||
125925768|NCT03736447|453025615|FG001|Overall Study|Taste aversion to study product|1|||
125925769|NCT02619175|453025616|FG000|Overall Study|Withdrawal by Subject|1|||
125925770|NCT02619175|453025617|FG001|Overall Study|Withdrawal by Subject|0|||
125925771|NCT02619175|453025616|FG000|Overall Study|foot pain|1|||
125925772|NCT02619175|453025617|FG001|Overall Study|foot pain|0|||
125925773|NCT01664533|453027368|FG000|Overall Study|Death|42|||
125925774|NCT01664533|453027368|FG000|Overall Study|Lost to Follow-up|3|||
125925775|NCT01664533|453027368|FG000|Overall Study|Study termination|9|||
125925776|NCT01664533|453027368|FG000|Overall Study|Protocol Violation|3|||
125925777|NCT03291808|453027369|FG000|Overall Study|Lost to Follow-up|6|||
125925778|NCT03291808|453027369|FG000|Overall Study|Research burden|4|||
125925779|NCT01892293|453027378|FG000|Overall Study|Apheresed but not treated|4|||
125925780|NCT03602482|453027383|FG000|Overall Study|Withdrawal by Subject|6|||
125925781|NCT03602482|453027384|FG001|Overall Study|Withdrawal by Subject|7|||
125925782|NCT03602482|453027385|FG002|Overall Study|Withdrawal by Subject|0|||
125925783|NCT03602482|453027386|FG003|Overall Study|Withdrawal by Subject|0|||
125925784|NCT02397278|453027387|FG000|Overall Study|Withdrawal by Subject|0|||
125925785|NCT02397278|453027388|FG001|Overall Study|Withdrawal by Subject|2|||
125925786|NCT02397278|453027387|FG000|Overall Study|Deemed ineligible following surgery|1|||
125925787|NCT02397278|453027388|FG001|Overall Study|Deemed ineligible following surgery|1|||
125925788|NCT00599924|453027389|FG000|Overall Study|Lack of Efficacy|3|||
125925789|NCT00599924|453027390|FG001|Overall Study|Lack of Efficacy|5|||
125925790|NCT00599924|453027391|FG002|Overall Study|Lack of Efficacy|1|||
125925791|NCT00599924|453027392|FG003|Overall Study|Lack of Efficacy|2|||
125925792|NCT00599924|453027393|FG004|Overall Study|Lack of Efficacy|3|||
125925793|NCT00599924|453027394|FG005|Overall Study|Lack of Efficacy|2|||
125925794|NCT00599924|453027395|FG006|Overall Study|Lack of Efficacy|0|||
125925795|NCT00599924|453027389|FG000|Overall Study|Adverse Event|0|||
125925796|NCT00599924|453027390|FG001|Overall Study|Adverse Event|0|||
125925797|NCT00599924|453027391|FG002|Overall Study|Adverse Event|0|||
125925798|NCT00599924|453027392|FG003|Overall Study|Adverse Event|2|||
125925799|NCT00599924|453027393|FG004|Overall Study|Adverse Event|0|||
125925800|NCT00599924|453027394|FG005|Overall Study|Adverse Event|0|||
125925801|NCT00599924|453027395|FG006|Overall Study|Adverse Event|2|||
125925802|NCT00599924|453027389|FG000|Overall Study|Death|0|||
125925803|NCT00599924|453027390|FG001|Overall Study|Death|0|||
125925804|NCT00599924|453027391|FG002|Overall Study|Death|0|||
125925805|NCT00599924|453027392|FG003|Overall Study|Death|2|||
125925806|NCT00599924|453027393|FG004|Overall Study|Death|0|||
125925807|NCT00599924|453027394|FG005|Overall Study|Death|2|||
125925808|NCT00599924|453027395|FG006|Overall Study|Death|1|||
125925809|NCT00599924|453027389|FG000|Overall Study|Protocol Violation|0|||
125925810|NCT00599924|453027390|FG001|Overall Study|Protocol Violation|0|||
125925811|NCT00599924|453027391|FG002|Overall Study|Protocol Violation|0|||
125925812|NCT00599924|453027392|FG003|Overall Study|Protocol Violation|1|||
125925813|NCT00599924|453027393|FG004|Overall Study|Protocol Violation|0|||
125925814|NCT00599924|453027394|FG005|Overall Study|Protocol Violation|0|||
125925815|NCT00599924|453027395|FG006|Overall Study|Protocol Violation|0|||
125925816|NCT00599924|453027389|FG000|Overall Study|Withdrawal by Subject|0|||
125925817|NCT00599924|453027390|FG001|Overall Study|Withdrawal by Subject|0|||
126064877|NCT00555620|453529122|FG000|Overall Study|Death|0|||
126064878|NCT00555620|453529123|FG001|Overall Study|Death|1|||
126064879|NCT00555620|453529124|FG002|Overall Study|Death|0|||
126064880|NCT00555620|453529125|FG003|Overall Study|Death|0|||
126064881|NCT00555620|453529126|FG004|Overall Study|Death|0|||
125925818|NCT00599924|453027391|FG002|Overall Study|Withdrawal by Subject|1|||
125925819|NCT00599924|453027392|FG003|Overall Study|Withdrawal by Subject|0|||
125925820|NCT00599924|453027393|FG004|Overall Study|Withdrawal by Subject|1|||
125925821|NCT00599924|453027394|FG005|Overall Study|Withdrawal by Subject|0|||
125925822|NCT00599924|453027395|FG006|Overall Study|Withdrawal by Subject|0|||
125925823|NCT00599924|453027389|FG000|Overall Study|Other|0|||
125925824|NCT00599924|453027390|FG001|Overall Study|Other|0|||
125925825|NCT00599924|453027391|FG002|Overall Study|Other|0|||
126064882|NCT00555620|453529127|FG005|Overall Study|Death|1|||
126064883|NCT00555620|453529122|FG000|Overall Study|Study terminated by sponsor|0|||
125925826|NCT00599924|453027392|FG003|Overall Study|Other|1|||
125925827|NCT00599924|453027393|FG004|Overall Study|Other|2|||
125925828|NCT00599924|453027394|FG005|Overall Study|Other|0|||
125925829|NCT00599924|453027395|FG006|Overall Study|Other|2|||
125925830|NCT01806298|453027396|FG000|Overall Study|Adverse Event|3|||
125925831|NCT01806298|453027396|FG000|Overall Study|Protocol Non-compliance|1|||
125925832|NCT01806298|453027396|FG000|Overall Study|Withdrawal by Subject|1|||
125925833|NCT01806298|453027396|FG000|Overall Study|Other|5|||
125925834|NCT02601469|453027397|FG000|Overall Study|Enrolled in Error|1|||
125925835|NCT02601469|453027398|FG001|Overall Study|Enrolled in Error|0|||
125925836|NCT02820753|453027399|FG000|2 Month|Withdrawal by Subject|3|||
125925837|NCT02820753|453027400|FG001|2 Month|Withdrawal by Subject|3|||
125925838|NCT02820753|453027399|FG000|2 Month|Lost to Follow-up|24|||
125925839|NCT02820753|453027400|FG001|2 Month|Lost to Follow-up|26|||
125925840|NCT02820753|453027399|FG000|2 Month|Stopped per NIH Hold|51|||
125925841|NCT02820753|453027400|FG001|2 Month|Stopped per NIH Hold|13|||
125925842|NCT02820753|453027399|FG000|6 Month|Withdrawal by Subject|2|||
125925843|NCT02820753|453027400|FG001|6 Month|Withdrawal by Subject|2|||
125925844|NCT02820753|453027399|FG000|6 Month|Lost to Follow-up|20|||
125925845|NCT02820753|453027400|FG001|6 Month|Lost to Follow-up|27|||
125925846|NCT02820753|453027399|FG000|6 Month|Stopped per NIH Hold|81|||
125925847|NCT02820753|453027400|FG001|6 Month|Stopped per NIH Hold|81|||
125925848|NCT02820753|453027399|FG000|6 Month|Death|0|||
125925849|NCT02820753|453027400|FG001|6 Month|Death|1|||
125925850|NCT02161731|453027404|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
125925851|NCT02161731|453027405|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
125925852|NCT02161731|453027404|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
125925853|NCT02161731|453027405|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
125925854|NCT01408485|453027406|FG000|Overall Study|Withdrawal by Subject|21|||
125925855|NCT01397084|453027411|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
125925856|NCT01397084|453027411|FG000|Overall Study|Protocol Violation|2|||
125925857|NCT01397084|453027411|FG000|Overall Study|Adverse Event|2|||
125925858|NCT01397084|453027411|FG000|Overall Study|Withdrawal by Subject|1|||
125925859|NCT01397084|453027411|FG000|Overall Study|Lost to Follow-up|1|||
125925860|NCT01397084|453027411|FG000|Overall Study|Used other proton pump inhibitor|1|||
125925861|NCT00618072|453027414|FG000|Overall Study|Lost to Follow-up|2|||
125925862|NCT00618072|453027415|FG001|Overall Study|Lost to Follow-up|0|||
125925863|NCT00618072|453027416|FG002|Overall Study|Lost to Follow-up|3|||
125925864|NCT00618072|453027414|FG000|Overall Study|Physician Decision|0|||
125925865|NCT00618072|453027415|FG001|Overall Study|Physician Decision|1|||
125925866|NCT00618072|453027416|FG002|Overall Study|Physician Decision|1|||
125925867|NCT02380677|453027417|FG000|Overall Study|Adverse Event|0|||
125925868|NCT02380677|453027418|FG001|Overall Study|Adverse Event|0|||
125925869|NCT02380677|453027419|FG002|Overall Study|Adverse Event|0|||
125925870|NCT02380677|453027420|FG003|Overall Study|Adverse Event|1|||
125925871|NCT02380677|453027421|FG004|Overall Study|Adverse Event|1|||
125925872|NCT02380677|453027422|FG005|Overall Study|Adverse Event|4|||
125925873|NCT02380677|453027423|FG006|Overall Study|Adverse Event|2|||
125925874|NCT02380677|453027424|FG007|Overall Study|Adverse Event|2|||
125925875|NCT02380677|453027425|FG008|Overall Study|Adverse Event|2|||
125925876|NCT02380677|453027426|FG009|Overall Study|Adverse Event|1|||
125925877|NCT02380677|453027427|FG010|Overall Study|Adverse Event|2|||
125925878|NCT02380677|453027428|FG011|Overall Study|Adverse Event|1|||
125925879|NCT02380677|453027417|FG000|Overall Study|Physician Decision|1|||
125925880|NCT02380677|453027418|FG001|Overall Study|Physician Decision|0|||
125925881|NCT02380677|453027419|FG002|Overall Study|Physician Decision|1|||
125925882|NCT02380677|453027420|FG003|Overall Study|Physician Decision|1|||
125925883|NCT02380677|453027421|FG004|Overall Study|Physician Decision|0|||
125925884|NCT02380677|453027422|FG005|Overall Study|Physician Decision|0|||
125925885|NCT02380677|453027423|FG006|Overall Study|Physician Decision|0|||
125925886|NCT02380677|453027424|FG007|Overall Study|Physician Decision|0|||
125925887|NCT02380677|453027425|FG008|Overall Study|Physician Decision|0|||
125925888|NCT02380677|453027426|FG009|Overall Study|Physician Decision|0|||
125925889|NCT02380677|453027427|FG010|Overall Study|Physician Decision|0|||
125925890|NCT02380677|453027428|FG011|Overall Study|Physician Decision|0|||
125925891|NCT02380677|453027417|FG000|Overall Study|Lack of Efficacy|0|||
125925892|NCT02380677|453027418|FG001|Overall Study|Lack of Efficacy|1|||
125925893|NCT02380677|453027419|FG002|Overall Study|Lack of Efficacy|2|||
125925894|NCT02380677|453027420|FG003|Overall Study|Lack of Efficacy|0|||
125925895|NCT02380677|453027421|FG004|Overall Study|Lack of Efficacy|4|||
125925896|NCT02380677|453027422|FG005|Overall Study|Lack of Efficacy|1|||
125925897|NCT02380677|453027423|FG006|Overall Study|Lack of Efficacy|1|||
125925898|NCT02380677|453027424|FG007|Overall Study|Lack of Efficacy|2|||
125925899|NCT02380677|453027425|FG008|Overall Study|Lack of Efficacy|2|||
125925900|NCT02380677|453027426|FG009|Overall Study|Lack of Efficacy|0|||
125925901|NCT02380677|453027427|FG010|Overall Study|Lack of Efficacy|2|||
125925902|NCT02380677|453027428|FG011|Overall Study|Lack of Efficacy|1|||
125925903|NCT02380677|453027417|FG000|Overall Study|Withdrawal by Subject|0|||
125925904|NCT02380677|453027418|FG001|Overall Study|Withdrawal by Subject|0|||
125925905|NCT02380677|453027419|FG002|Overall Study|Withdrawal by Subject|0|||
126111869|NCT01641809|453705891|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
126111870|NCT01641809|453705892|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
126111871|NCT01641809|453705893|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
126111872|NCT01641809|453705890|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
126111873|NCT01641809|453705891|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
126111874|NCT01641809|453705892|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
126111875|NCT01641809|453705893|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
126111876|NCT01641809|453705890|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
126111877|NCT01641809|453705891|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
126111878|NCT01641809|453705892|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
126111879|NCT01641809|453705893|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
126111880|NCT01641809|453705890|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
126111881|NCT01641809|453705891|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
126111882|NCT01641809|453705892|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
126111883|NCT01641809|453705893|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
126111884|NCT01641809|453705890|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
126111885|NCT01641809|453705891|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
126111886|NCT01641809|453705892|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
126111887|NCT01641809|453705893|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
126111888|NCT01641809|453705890|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
126111889|NCT01641809|453705891|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
126111890|NCT01641809|453705892|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
126111891|NCT01641809|453705893|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
126111892|NCT01641809|453705890|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
126111893|NCT01641809|453705891|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
126111894|NCT01641809|453705892|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
126111895|NCT01641809|453705893|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
126111896|NCT01641809|453705890|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
126111897|NCT01641809|453705891|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
126111898|NCT01641809|453705892|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
126111899|NCT01641809|453705893|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
126111900|NCT01641809|453705890|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
126111901|NCT01641809|453705891|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
126111902|NCT01641809|453705892|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
126111903|NCT01641809|453705893|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
126111904|NCT01641809|453705890|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
126111905|NCT01641809|453705891|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
126111906|NCT01641809|453705892|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
126111907|NCT01641809|453705893|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
126111908|NCT01641809|453705890|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
126111909|NCT01641809|453705891|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
126111910|NCT01641809|453705892|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
126111911|NCT01641809|453705893|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
126111912|NCT01641809|453705890|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
126111913|NCT01641809|453705891|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
126111914|NCT01641809|453705892|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
126111915|NCT01641809|453705893|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
126111916|NCT03690141|453705896|FG000|Overall Study|Adverse Event|5|||
126111917|NCT03690141|453705896|FG000|Overall Study|Withdrawal by Subject|3|||
126111918|NCT03690141|453705896|FG000|Overall Study|Physician Decision|4|||
126111919|NCT03690141|453705896|FG000|Overall Study|Disease progression|4|||
126111920|NCT01251120|453705897|FG000|Overall Study|Lack of Efficacy|0|||
126111921|NCT01251120|453705898|FG001|Overall Study|Lack of Efficacy|1|||
126111922|NCT01807923|453705899|FG000|Overall Study|Adverse Event|2|||
126111923|NCT01807923|453705900|FG001|Overall Study|Adverse Event|1|||
126111924|NCT01807923|453705901|FG002|Overall Study|Adverse Event|2|||
126111925|NCT01807923|453705899|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126111926|NCT01807923|453705900|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
126111927|NCT01807923|453705901|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
126111928|NCT01807923|453705899|FG000|Overall Study|Physician Decision|0|||
126111929|NCT01807923|453705900|FG001|Overall Study|Physician Decision|0|||
125925906|NCT02380677|453027420|FG003|Overall Study|Withdrawal by Subject|0|||
125925907|NCT02380677|453027421|FG004|Overall Study|Withdrawal by Subject|0|||
125925908|NCT02380677|453027422|FG005|Overall Study|Withdrawal by Subject|0|||
126111930|NCT01807923|453705901|FG002|Overall Study|Physician Decision|1|||
126111931|NCT01807923|453705899|FG000|Overall Study|Not Eligible (Genotype)|0|||
126111932|NCT01807923|453705900|FG001|Overall Study|Not Eligible (Genotype)|0|||
126111933|NCT01807923|453705901|FG002|Overall Study|Not Eligible (Genotype)|1|||
125925909|NCT02380677|453027423|FG006|Overall Study|Withdrawal by Subject|0|||
126064884|NCT00555620|453529123|FG001|Overall Study|Study terminated by sponsor|0|||
126064885|NCT00555620|453529124|FG002|Overall Study|Study terminated by sponsor|1|||
126064886|NCT00555620|453529125|FG003|Overall Study|Study terminated by sponsor|0|||
126064887|NCT00555620|453529126|FG004|Overall Study|Study terminated by sponsor|0|||
126064888|NCT00555620|453529127|FG005|Overall Study|Study terminated by sponsor|0|||
126064889|NCT00555620|453529122|FG000|Overall Study|Adverse Event|0|||
126064890|NCT00555620|453529123|FG001|Overall Study|Adverse Event|0|||
126064891|NCT00555620|453529124|FG002|Overall Study|Adverse Event|1|||
126064892|NCT00555620|453529125|FG003|Overall Study|Adverse Event|5|||
126064893|NCT00555620|453529126|FG004|Overall Study|Adverse Event|0|||
126064894|NCT00555620|453529127|FG005|Overall Study|Adverse Event|1|||
126064895|NCT00555620|453529122|FG000|Overall Study|Objective progression or relapse|6|||
126064896|NCT00555620|453529123|FG001|Overall Study|Objective progression or relapse|5|||
126064897|NCT00555620|453529124|FG002|Overall Study|Objective progression or relapse|12|||
126064898|NCT00555620|453529125|FG003|Overall Study|Objective progression or relapse|17|||
126064899|NCT00555620|453529126|FG004|Overall Study|Objective progression or relapse|3|||
126064900|NCT00555620|453529127|FG005|Overall Study|Objective progression or relapse|16|||
126064901|NCT00555620|453529122|FG000|Overall Study|Participant refused treatment|0|||
126064902|NCT00555620|453529123|FG001|Overall Study|Participant refused treatment|1|||
126064903|NCT00555620|453529124|FG002|Overall Study|Participant refused treatment|1|||
126064904|NCT00555620|453529125|FG003|Overall Study|Participant refused treatment|0|||
126064905|NCT00555620|453529126|FG004|Overall Study|Participant refused treatment|0|||
126064906|NCT00555620|453529127|FG005|Overall Study|Participant refused treatment|1|||
126064907|NCT00555620|453529122|FG000|Overall Study|Other|0|||
126064908|NCT00555620|453529123|FG001|Overall Study|Other|0|||
126064909|NCT00555620|453529124|FG002|Overall Study|Other|0|||
126064910|NCT00555620|453529125|FG003|Overall Study|Other|1|||
126064911|NCT00555620|453529126|FG004|Overall Study|Other|0|||
126064912|NCT00555620|453529127|FG005|Overall Study|Other|3|||
126064913|NCT05203822|453529128|FG000|Overall Study|Adverse Event|1|||
126064914|NCT05203822|453529128|FG000|Overall Study|Withdrawal by Subject|1|||
126064915|NCT01345253|453529130|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
126064916|NCT01345253|453529131|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
126064917|NCT01345253|453529130|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
126064918|NCT01345253|453529131|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
126064919|NCT01345253|453529130|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
126064920|NCT01345253|453529131|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
126064921|NCT01345253|453529130|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
126064922|NCT01345253|453529131|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
126064923|NCT01345253|453529130|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
126064924|NCT01345253|453529131|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
126064925|NCT01345253|453529130|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
126064926|NCT01345253|453529131|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
126064927|NCT01345253|453529130|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
126064928|NCT01345253|453529131|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
126064929|NCT01345253|453529130|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
126064930|NCT01345253|453529131|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
126064931|NCT01345253|453529130|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
126064932|NCT01345253|453529131|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
126064933|NCT01345253|453529130|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
126064934|NCT01345253|453529131|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
126064935|NCT01345253|453529130|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
126064936|NCT01345253|453529131|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
126064937|NCT01345253|453529130|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
126064938|NCT01345253|453529131|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
126064939|NCT01345253|453529130|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
126064940|NCT01345253|453529131|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
126064941|NCT01345253|453529130|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
126064942|NCT01345253|453529131|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
126064943|NCT01345253|453529130|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
126064944|NCT01345253|453529131|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
126064945|NCT01767376|453529138|FG000|Overall Study|Lost to Follow-up|3|||
126064946|NCT01767376|453529139|FG001|Overall Study|Lost to Follow-up|2|||
126064947|NCT01767376|453529140|FG002|Overall Study|Lost to Follow-up|0|||
126064948|NCT01767376|453529138|FG000|Overall Study|Withdrawal by Subject|1|||
126064949|NCT01767376|453529139|FG001|Overall Study|Withdrawal by Subject|1|||
126064950|NCT01767376|453529140|FG002|Overall Study|Withdrawal by Subject|0|||
126064951|NCT00946088|453529141|FG000|Overall Study|Withdrawal by Subject|0|||
126064952|NCT00946088|453529142|FG001|Overall Study|Withdrawal by Subject|1|||
126064953|NCT04883541|453529143|FG000|Overall Study|Not attending regular yoga class|16|||
126064954|NCT04883541|453529144|FG001|Overall Study|Not attending regular yoga class|0|||
125925910|NCT02380677|453027424|FG007|Overall Study|Withdrawal by Subject|0|||
125925911|NCT02380677|453027425|FG008|Overall Study|Withdrawal by Subject|0|||
125925912|NCT02380677|453027426|FG009|Overall Study|Withdrawal by Subject|1|||
125925913|NCT02380677|453027427|FG010|Overall Study|Withdrawal by Subject|0|||
125925914|NCT02380677|453027428|FG011|Overall Study|Withdrawal by Subject|3|||
125925915|NCT02380677|453027417|FG000|Overall Study|Other|0|||
125925916|NCT02380677|453027418|FG001|Overall Study|Other|0|||
125925917|NCT02380677|453027419|FG002|Overall Study|Other|0|||
125925918|NCT02380677|453027420|FG003|Overall Study|Other|1|||
125925919|NCT02380677|453027421|FG004|Overall Study|Other|1|||
125925920|NCT02380677|453027422|FG005|Overall Study|Other|1|||
125925921|NCT02380677|453027423|FG006|Overall Study|Other|0|||
125925922|NCT02380677|453027424|FG007|Overall Study|Other|0|||
125925923|NCT02380677|453027425|FG008|Overall Study|Other|0|||
125925924|NCT02380677|453027426|FG009|Overall Study|Other|0|||
125925925|NCT02380677|453027427|FG010|Overall Study|Other|0|||
125925926|NCT02380677|453027428|FG011|Overall Study|Other|0|||
125925927|NCT00840450|453027435|FG000|Overall Study|Adverse Event|1|||
125925928|NCT00840450|453027435|FG000|Overall Study|Lack of Efficacy|2|||
125925929|NCT00617123|453027436|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
125925930|NCT00617123|453027437|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
125925931|NCT00617123|453027436|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
125925932|NCT00617123|453027437|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
125925933|NCT00617123|453027436|FG000|Referral Screening Period|Adverse Event|0|||
125925934|NCT00617123|453027437|FG001|Referral Screening Period|Adverse Event|1|||
125925935|NCT00617123|453027436|FG000|Study Treatment Period|Withdrawal by Subject|8|||
125925936|NCT00617123|453027437|FG001|Study Treatment Period|Withdrawal by Subject|12|||
125925937|NCT00617123|453027436|FG000|Study Treatment Period|Adverse Event|7|||
125925938|NCT00617123|453027437|FG001|Study Treatment Period|Adverse Event|3|||
125925939|NCT00617123|453027436|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
125925940|NCT00617123|453027437|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
125925941|NCT00617123|453027436|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
125925942|NCT00617123|453027437|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
125925943|NCT00133952|453027439|FG000|Overall Study|Adverse Event|1|||
125925944|NCT00133952|453027440|FG001|Overall Study|Adverse Event|2|||
125925945|NCT00133952|453027439|FG000|Overall Study|Death|3|||
125925946|NCT00133952|453027440|FG001|Overall Study|Death|2|||
125925947|NCT00133952|453027439|FG000|Overall Study|Lost to Follow-up|9|||
125925948|NCT00133952|453027440|FG001|Overall Study|Lost to Follow-up|14|||
125925949|NCT00133952|453027439|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
125925950|NCT00133952|453027440|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
125925951|NCT00133952|453027439|FG000|Overall Study|Protocol Violation|1|||
125925952|NCT00133952|453027440|FG001|Overall Study|Protocol Violation|1|||
125925953|NCT00133952|453027439|FG000|Overall Study|Withdrawal by Subject|20|||
125925954|NCT00133952|453027440|FG001|Overall Study|Withdrawal by Subject|4|||
125925955|NCT00133952|453027439|FG000|Overall Study|Physician Decision|4|||
125925956|NCT00133952|453027440|FG001|Overall Study|Physician Decision|3|||
125925957|NCT00133952|453027439|FG000|Overall Study|Sponsor Decision|0|||
125925958|NCT00133952|453027440|FG001|Overall Study|Sponsor Decision|1|||
125925959|NCT02170298|453027441|FG000|Overall Study|Withdrawal by Subject|0|||
125925960|NCT02170298|453027442|FG001|Overall Study|Withdrawal by Subject|1|||
125925961|NCT02170298|453027441|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
125925962|NCT02170298|453027442|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
125925963|NCT01976338|453027444|FG000|Overall Study|Physician Decision|0|||
125925964|NCT01976338|453027445|FG001|Overall Study|Physician Decision|1|||
125925965|NCT01976338|453027444|FG000|Overall Study|Lost to Follow-up|3|||
125925966|NCT01976338|453027445|FG001|Overall Study|Lost to Follow-up|0|||
125925967|NCT01976338|453027444|FG000|Overall Study|Withdrawal by Subject|5|||
125925968|NCT01976338|453027445|FG001|Overall Study|Withdrawal by Subject|2|||
125925969|NCT01976338|453027444|FG000|Overall Study|Adverse Event|5|||
125925970|NCT01976338|453027445|FG001|Overall Study|Adverse Event|1|||
125925971|NCT00777608|453027446|FG000|Overall Study|Lost to Follow-up|1|||
125925972|NCT00777608|453027447|FG001|Overall Study|Lost to Follow-up|1|||
125925973|NCT00777608|453027446|FG000|Overall Study|Withdrawal by Subject|1|||
125925974|NCT00777608|453027447|FG001|Overall Study|Withdrawal by Subject|3|||
125925975|NCT00777608|453027446|FG000|Overall Study|Protocol Violation|1|||
125925976|NCT00777608|453027447|FG001|Overall Study|Protocol Violation|0|||
125925977|NCT00777608|453027446|FG000|Overall Study|Investigator Decision|1|||
125925978|NCT00777608|453027447|FG001|Overall Study|Investigator Decision|2|||
125925979|NCT04213079|453027448|FG000|Overall Study|Lost to Follow-up|0|||
125925980|NCT04213079|453027449|FG001|Overall Study|Lost to Follow-up|2|||
125925981|NCT00003479|453027451|FG000|Overall Study|Not evaluable|3|||
125925982|NCT02128113|453027452|FG000|Overall Study|Withdrawal by Subject|3|||
125925983|NCT02128113|453027453|FG001|Overall Study|Withdrawal by Subject|1|||
125925984|NCT02128113|453027454|FG002|Overall Study|Withdrawal by Subject|0|||
125925985|NCT02128113|453027452|FG000|Overall Study|Protocol Violation|0|||
125925986|NCT02128113|453027453|FG001|Overall Study|Protocol Violation|1|||
126111934|NCT01807923|453705899|FG000|Overall Study|Randomized But Not Treated|3|||
126111935|NCT01807923|453705900|FG001|Overall Study|Randomized But Not Treated|2|||
126111936|NCT01807923|453705901|FG002|Overall Study|Randomized But Not Treated|5|||
126111937|NCT02558231|453705903|FG000|Overall Study|Death|4|||
126111938|NCT02558231|453705904|FG001|Overall Study|Death|12|||
126111939|NCT02558231|453705903|FG000|Overall Study|Lost to Follow-up|7|||
126111940|NCT02558231|453705904|FG001|Overall Study|Lost to Follow-up|4|||
126111941|NCT02558231|453705903|FG000|Overall Study|Withdrawal by Subject|7|||
126111942|NCT02558231|453705904|FG001|Overall Study|Withdrawal by Subject|4|||
126111943|NCT02558231|453705903|FG000|Overall Study|Physician Decision|7|||
126111944|NCT02558231|453705904|FG001|Overall Study|Physician Decision|5|||
126111945|NCT02558231|453705903|FG000|Overall Study|Sponsor Decision|0|||
126111946|NCT02558231|453705904|FG001|Overall Study|Sponsor Decision|1|||
126111947|NCT04233164|453705907|FG000|Overall Study|Unable to obtain specimen|0|||
126111948|NCT04233164|453705908|FG001|Overall Study|Unable to obtain specimen|1|||
126111949|NCT01840605|453705909|FG000|Overall Study|Adverse Event|0|||
126111950|NCT01840605|453705910|FG001|Overall Study|Adverse Event|1|||
126111951|NCT01840605|453705909|FG000|Overall Study|Physician Decision|2|||
126111952|NCT01840605|453705910|FG001|Overall Study|Physician Decision|1|||
126111953|NCT03065023|453705912|FG000|Overall Study|Progressive Disease|0|||
126111954|NCT03065023|453705913|FG001|Overall Study|Progressive Disease|1|||
126111955|NCT03065023|453705914|FG002|Overall Study|Progressive Disease|0|||
126111956|NCT03065023|453705915|FG003|Overall Study|Progressive Disease|0|||
126111957|NCT03065023|453705916|FG004|Overall Study|Progressive Disease|0|||
126111958|NCT03065023|453705912|FG000|Overall Study|Death|2|||
126111959|NCT03065023|453705913|FG001|Overall Study|Death|0|||
126111960|NCT03065023|453705914|FG002|Overall Study|Death|1|||
126111961|NCT03065023|453705915|FG003|Overall Study|Death|1|||
126111962|NCT03065023|453705916|FG004|Overall Study|Death|0|||
126111963|NCT03065023|453705912|FG000|Overall Study|Lost to Follow-up|0|||
126111964|NCT03065023|453705913|FG001|Overall Study|Lost to Follow-up|1|||
126111965|NCT03065023|453705914|FG002|Overall Study|Lost to Follow-up|0|||
126111966|NCT03065023|453705915|FG003|Overall Study|Lost to Follow-up|0|||
126111967|NCT03065023|453705916|FG004|Overall Study|Lost to Follow-up|0|||
126111968|NCT03065023|453705912|FG000|Overall Study|Participant Decision|0|||
126111969|NCT03065023|453705913|FG001|Overall Study|Participant Decision|0|||
126111970|NCT03065023|453705914|FG002|Overall Study|Participant Decision|0|||
126111971|NCT03065023|453705915|FG003|Overall Study|Participant Decision|1|||
126111972|NCT03065023|453705916|FG004|Overall Study|Participant Decision|0|||
126111973|NCT03065023|453705912|FG000|Overall Study|Withdrawal by Subject|0|||
126111974|NCT03065023|453705913|FG001|Overall Study|Withdrawal by Subject|0|||
126111975|NCT03065023|453705914|FG002|Overall Study|Withdrawal by Subject|0|||
126111976|NCT03065023|453705915|FG003|Overall Study|Withdrawal by Subject|1|||
126111977|NCT03065023|453705916|FG004|Overall Study|Withdrawal by Subject|0|||
126111978|NCT04029961|453705917|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
126111979|NCT04029961|453705918|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
126111980|NCT04029961|453705917|FG000|Overall Study|Change in Treatment Course|0|||
126111981|NCT04029961|453705918|FG001|Overall Study|Change in Treatment Course|1|||
126111982|NCT03427125|453705919|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
126111983|NCT03427125|453705920|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
126111984|NCT03427125|453705921|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
126111985|NCT05975840|453705922|FG000|Overall Study|Other|1|||
126111986|NCT05975840|453705923|FG001|Overall Study|Other|0|||
126111987|NCT05975840|453705924|FG002|Overall Study|Other|0|||
126111988|NCT05975840|453705925|FG003|Overall Study|Other|0|||
126111989|NCT05975840|453705926|FG004|Overall Study|Other|1|||
126111990|NCT05975840|453705927|FG005|Overall Study|Other|0|||
126111991|NCT05975840|453705928|FG006|Overall Study|Other|0|||
126111992|NCT05975840|453705929|FG007|Overall Study|Other|0|||
126111993|NCT05975840|453705922|FG000|Overall Study|Lost to Follow-up|3|||
126111994|NCT05975840|453705923|FG001|Overall Study|Lost to Follow-up|6|||
126111995|NCT05975840|453705924|FG002|Overall Study|Lost to Follow-up|3|||
126111996|NCT05975840|453705925|FG003|Overall Study|Lost to Follow-up|1|||
126111997|NCT05975840|453705926|FG004|Overall Study|Lost to Follow-up|4|||
126111998|NCT05975840|453705927|FG005|Overall Study|Lost to Follow-up|1|||
126111999|NCT05975840|453705928|FG006|Overall Study|Lost to Follow-up|2|||
126112000|NCT05975840|453705929|FG007|Overall Study|Lost to Follow-up|4|||
126112001|NCT05975840|453705922|FG000|Overall Study|Migrated/moved from the study area|1|||
126112002|NCT05975840|453705923|FG001|Overall Study|Migrated/moved from the study area|0|||
126112003|NCT05975840|453705924|FG002|Overall Study|Migrated/moved from the study area|0|||
126112004|NCT05975840|453705925|FG003|Overall Study|Migrated/moved from the study area|0|||
126112005|NCT05975840|453705926|FG004|Overall Study|Migrated/moved from the study area|0|||
126112006|NCT05975840|453705927|FG005|Overall Study|Migrated/moved from the study area|0|||
126112007|NCT05975840|453705928|FG006|Overall Study|Migrated/moved from the study area|0|||
126112008|NCT05975840|453705929|FG007|Overall Study|Migrated/moved from the study area|0|||
126112009|NCT05975840|453705922|FG000|Overall Study|Withdrawal by Subject|0|||
126112010|NCT05975840|453705923|FG001|Overall Study|Withdrawal by Subject|5|||
126112011|NCT05975840|453705924|FG002|Overall Study|Withdrawal by Subject|2|||
126112012|NCT05975840|453705925|FG003|Overall Study|Withdrawal by Subject|2|||
126112013|NCT05975840|453705926|FG004|Overall Study|Withdrawal by Subject|0|||
126112014|NCT05975840|453705927|FG005|Overall Study|Withdrawal by Subject|2|||
126112015|NCT05975840|453705928|FG006|Overall Study|Withdrawal by Subject|2|||
126112016|NCT05975840|453705929|FG007|Overall Study|Withdrawal by Subject|1|||
126112017|NCT05975840|453705922|FG000|Overall Study|Protocol Violation|0|||
126112018|NCT05975840|453705923|FG001|Overall Study|Protocol Violation|1|||
126112019|NCT05975840|453705924|FG002|Overall Study|Protocol Violation|0|||
126112020|NCT05975840|453705925|FG003|Overall Study|Protocol Violation|0|||
126112021|NCT05975840|453705926|FG004|Overall Study|Protocol Violation|0|||
126112022|NCT05975840|453705927|FG005|Overall Study|Protocol Violation|0|||
126112023|NCT05975840|453705928|FG006|Overall Study|Protocol Violation|0|||
126112024|NCT05975840|453705929|FG007|Overall Study|Protocol Violation|0|||
126112025|NCT05975840|453705922|FG000|Overall Study|Adverse Event|0|||
126112026|NCT05975840|453705923|FG001|Overall Study|Adverse Event|0|||
126112027|NCT05975840|453705924|FG002|Overall Study|Adverse Event|0|||
126112028|NCT05975840|453705925|FG003|Overall Study|Adverse Event|1|||
126112029|NCT05975840|453705926|FG004|Overall Study|Adverse Event|0|||
126112030|NCT05975840|453705927|FG005|Overall Study|Adverse Event|0|||
126112031|NCT05975840|453705928|FG006|Overall Study|Adverse Event|0|||
126112032|NCT05975840|453705929|FG007|Overall Study|Adverse Event|0|||
126112033|NCT05975840|453705922|FG000|Overall Study|Death|0|||
126112034|NCT05975840|453705923|FG001|Overall Study|Death|1|||
126112035|NCT05975840|453705924|FG002|Overall Study|Death|0|||
126112036|NCT05975840|453705925|FG003|Overall Study|Death|0|||
126112037|NCT05975840|453705926|FG004|Overall Study|Death|0|||
126112038|NCT05975840|453705927|FG005|Overall Study|Death|0|||
126064955|NCT04883541|453529143|FG000|Overall Study|Not attending the pregnancy school|0|||
126064956|NCT04883541|453529144|FG001|Overall Study|Not attending the pregnancy school|9|||
126064957|NCT00648895|453529152|FG000|Overall Study|Lack of Efficacy|0|||
126064958|NCT00648895|453529153|FG001|Overall Study|Lack of Efficacy|1|||
126064959|NCT02865083|453529154|FG000|Overall Study|Early Termination|3|||
126064960|NCT02865083|453529155|FG001|Overall Study|Early Termination|1|||
126064961|NCT00841321|453529156|FG000|Overall Study|Lost to Follow-up|1|||
126064962|NCT00841321|453529157|FG001|Overall Study|Lost to Follow-up|1|||
126064963|NCT00841321|453529156|FG000|Overall Study|Adverse Event|0|||
126064964|NCT00841321|453529157|FG001|Overall Study|Adverse Event|2|||
126064965|NCT01358175|453529158|FG000|Overall Study|Death|1|||
126064966|NCT01358175|453529159|FG001|Overall Study|Death|0|||
126064967|NCT01358175|453529160|FG002|Overall Study|Death|1|||
126064968|NCT01358175|453529158|FG000|Overall Study|Withdrawal by Subject|9|||
126064969|NCT01358175|453529159|FG001|Overall Study|Withdrawal by Subject|5|||
126064970|NCT01358175|453529160|FG002|Overall Study|Withdrawal by Subject|10|||
126064971|NCT01358175|453529158|FG000|Overall Study|Technical issues|0|||
126064972|NCT01358175|453529159|FG001|Overall Study|Technical issues|1|||
126064973|NCT01358175|453529160|FG002|Overall Study|Technical issues|0|||
126064974|NCT01358175|453529158|FG000|Overall Study|Pregnancy|0|||
126064975|NCT01358175|453529159|FG001|Overall Study|Pregnancy|1|||
126064976|NCT01358175|453529160|FG002|Overall Study|Pregnancy|0|||
126064977|NCT01358175|453529158|FG000|Overall Study|Physician Decision|1|||
126064978|NCT01358175|453529159|FG001|Overall Study|Physician Decision|0|||
126064979|NCT01358175|453529160|FG002|Overall Study|Physician Decision|0|||
126064980|NCT01358175|453529158|FG000|Overall Study|Non Compliance with Study Treatment|0|||
126064981|NCT01358175|453529159|FG001|Overall Study|Non Compliance with Study Treatment|1|||
126064982|NCT01358175|453529160|FG002|Overall Study|Non Compliance with Study Treatment|1|||
126064983|NCT01358175|453529158|FG000|Overall Study|Lost to Follow-up|1|||
126064984|NCT01358175|453529159|FG001|Overall Study|Lost to Follow-up|1|||
126064985|NCT01358175|453529160|FG002|Overall Study|Lost to Follow-up|3|||
126064986|NCT01358175|453529158|FG000|Overall Study|Lack of Efficacy|3|||
126064987|NCT01358175|453529159|FG001|Overall Study|Lack of Efficacy|8|||
126064988|NCT01358175|453529160|FG002|Overall Study|Lack of Efficacy|6|||
126064989|NCT01358175|453529158|FG000|Overall Study|Adverse Event|6|||
126064990|NCT01358175|453529159|FG001|Overall Study|Adverse Event|11|||
126064991|NCT01358175|453529160|FG002|Overall Study|Adverse Event|11|||
126064992|NCT02379078|453529161|FG000|Overall Study|Lost to Follow-up|33|||
126064993|NCT02379078|453529162|FG001|Overall Study|Lost to Follow-up|30|||
126064994|NCT02379078|453529161|FG000|Overall Study|Withdrawal by Subject|6|||
126112039|NCT05975840|453705928|FG006|Overall Study|Death|0|||
126064995|NCT02379078|453529162|FG001|Overall Study|Withdrawal by Subject|5|||
126112040|NCT05975840|453705929|FG007|Overall Study|Death|1|||
126112041|NCT01130051|453705932|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
126112042|NCT01130051|453705933|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
126064996|NCT04908488|453529163|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
126064997|NCT04908488|453529164|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
126064998|NCT04908488|453529163|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
126112043|NCT01130051|453705932|FG000|Washout Period of 14 Days|Protocol Violation|1|||
126112044|NCT01130051|453705933|FG001|Washout Period of 14 Days|Protocol Violation|1|||
126112045|NCT04252287|453705934|FG000|Overall Study|Death|5|||
126112046|NCT04252287|453705935|FG001|Overall Study|Death|3|||
126112047|NCT04252287|453705934|FG000|Overall Study|Lost to Follow-up|4|||
126112048|NCT04252287|453705935|FG001|Overall Study|Lost to Follow-up|6|||
126112049|NCT04252287|453705934|FG000|Overall Study|Withdrawal by Subject|19|||
126112050|NCT04252287|453705935|FG001|Overall Study|Withdrawal by Subject|16|||
126112051|NCT04252287|453705934|FG000|Overall Study|Protocol Violation|3|||
126112052|NCT04252287|453705935|FG001|Overall Study|Protocol Violation|4|||
126112053|NCT02877927|453705936|FG000|Overall Study|Adverse Event|1|||
126112054|NCT02877927|453705937|FG001|Overall Study|Adverse Event|0|||
126112055|NCT02877927|453705936|FG000|Overall Study|Lost to Follow-up|37|||
126112056|NCT02877927|453705937|FG001|Overall Study|Lost to Follow-up|38|||
126112057|NCT02877927|453705936|FG000|Overall Study|Withdrawal by Subject|11|||
126112058|NCT02877927|453705937|FG001|Overall Study|Withdrawal by Subject|12|||
126112059|NCT02877927|453705936|FG000|Overall Study|Physician Decision|0|||
126112060|NCT02877927|453705937|FG001|Overall Study|Physician Decision|1|||
126112061|NCT02877927|453705936|FG000|Overall Study|Missed EOT/PTE Visit|5|||
126112062|NCT02877927|453705937|FG001|Overall Study|Missed EOT/PTE Visit|6|||
126112063|NCT00708175|453705938|FG000|Overall Study|Adverse Event|4|||
126112064|NCT00708175|453705939|FG001|Overall Study|Adverse Event|5|||
126112065|NCT00708175|453705938|FG000|Overall Study|Protocol Violation|2|||
126112066|NCT00708175|453705939|FG001|Overall Study|Protocol Violation|3|||
126112067|NCT00708175|453705938|FG000|Overall Study|Lost to Follow-up|5|||
126112068|NCT00708175|453705939|FG001|Overall Study|Lost to Follow-up|3|||
126112069|NCT00708175|453705938|FG000|Overall Study|Withdrawal by Subject|5|||
126112070|NCT00708175|453705939|FG001|Overall Study|Withdrawal by Subject|7|||
126112071|NCT00708175|453705938|FG000|Overall Study|BMD loss >7%|2|||
126112072|NCT00708175|453705939|FG001|Overall Study|BMD loss >7%|3|||
126112073|NCT03672461|453705943|FG000|Overall Study|COVID Related|4|||
126112074|NCT03672461|453705944|FG001|Overall Study|COVID Related|2|||
126112075|NCT03672461|453705943|FG000|Overall Study|Adverse Event|2|||
126112076|NCT03672461|453705944|FG001|Overall Study|Adverse Event|0|||
126112077|NCT03672461|453705943|FG000|Overall Study|Serious Adverse Event|0|||
126112078|NCT03672461|453705944|FG001|Overall Study|Serious Adverse Event|1|||
126112079|NCT03672461|453705943|FG000|Overall Study|Too Busy|3|||
126112080|NCT03672461|453705944|FG001|Overall Study|Too Busy|1|||
126112081|NCT03672461|453705943|FG000|Overall Study|Lost to Follow-up|1|||
126112082|NCT03672461|453705944|FG001|Overall Study|Lost to Follow-up|2|||
126112083|NCT03672461|453705943|FG000|Overall Study|Family|2|||
126112084|NCT03672461|453705944|FG001|Overall Study|Family|2|||
126112085|NCT03672461|453705943|FG000|Overall Study|No remote technology access|0|||
125925987|NCT02128113|453027454|FG002|Overall Study|Protocol Violation|0|||
125925988|NCT02128113|453027452|FG000|Overall Study|Surgery cancelled|0|||
125925989|NCT02128113|453027453|FG001|Overall Study|Surgery cancelled|1|||
126112086|NCT03672461|453705944|FG001|Overall Study|No remote technology access|1|||
126112087|NCT03672461|453705943|FG000|Overall Study|Withdrawal by Subject|1|||
126112088|NCT03672461|453705944|FG001|Overall Study|Withdrawal by Subject|0|||
126112089|NCT03672461|453705943|FG000|Overall Study|Cannot tolerate intervention|1|||
126112090|NCT03672461|453705944|FG001|Overall Study|Cannot tolerate intervention|0|||
126112091|NCT03672461|453705943|FG000|Overall Study|Incomplete outcome data|6|||
126112092|NCT03672461|453705944|FG001|Overall Study|Incomplete outcome data|1|||
126112093|NCT01444651|453707604|FG000|Overall Study|Adverse Event|3|||
126112094|NCT01444651|453707605|FG001|Overall Study|Adverse Event|2|||
126112095|NCT01444651|453707604|FG000|Overall Study|Lost to Follow-up|5|||
126112096|NCT01444651|453707605|FG001|Overall Study|Lost to Follow-up|5|||
126112097|NCT01444651|453707604|FG000|Overall Study|Non-fasting|2|||
126112098|NCT01444651|453707605|FG001|Overall Study|Non-fasting|1|||
126112099|NCT01444651|453707604|FG000|Overall Study|Missing data|1|||
126112100|NCT01444651|453707605|FG001|Overall Study|Missing data|1|||
126112101|NCT03047551|453707606|FG000|Overall Study|Did not receive TAS|1|||
126112102|NCT03047551|453707607|FG001|Overall Study|Did not receive TAS|0|||
126112103|NCT03047551|453707606|FG000|Overall Study|Physician Decision|1|||
126112104|NCT03047551|453707607|FG001|Overall Study|Physician Decision|0|||
126112105|NCT03047551|453707606|FG000|Overall Study|Withdrawal by Subject|0|||
126112106|NCT03047551|453707607|FG001|Overall Study|Withdrawal by Subject|1|||
126112107|NCT03047551|453707606|FG000|Overall Study|Probe malfunction|0|||
125925990|NCT02128113|453027454|FG002|Overall Study|Surgery cancelled|0|||
125925991|NCT02128113|453027452|FG000|Overall Study|Adverse Event|0|||
125925992|NCT02128113|453027453|FG001|Overall Study|Adverse Event|0|||
125925993|NCT02128113|453027454|FG002|Overall Study|Adverse Event|1|||
126112108|NCT03047551|453707607|FG001|Overall Study|Probe malfunction|1|||
126112109|NCT03047551|453707606|FG000|Overall Study|Ineligible|0|||
126112110|NCT03047551|453707607|FG001|Overall Study|Ineligible|1|||
126112111|NCT00726622|453707608|FG000|Overall Study|Withdrawal by Subject|16|||
126112112|NCT00726622|453707609|FG001|Overall Study|Withdrawal by Subject|2|||
126112113|NCT00726622|453707608|FG000|Overall Study|Physician Decision|0|||
126112114|NCT00726622|453707609|FG001|Overall Study|Physician Decision|1|||
125925994|NCT01061177|453027455|FG000|Overall Study|Adverse Event|117|||
126112115|NCT00726622|453707608|FG000|Overall Study|Metastasis|2|||
126112116|NCT00726622|453707609|FG001|Overall Study|Metastasis|0|||
126112117|NCT02462928|453707610|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
126112118|NCT02462928|453707611|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
126112119|NCT02462928|453707612|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
126112120|NCT02462928|453707610|FG000|Overall Study|Adverse Event|47|||
126112121|NCT02462928|453707611|FG001|Overall Study|Adverse Event|51|||
126112122|NCT02462928|453707612|FG002|Overall Study|Adverse Event|25|||
126112123|NCT02462928|453707610|FG000|Overall Study|Lack of Efficacy|3|||
125925995|NCT01061177|453027455|FG000|Overall Study|Withdrawal by Subject|27|||
125925996|NCT01061177|453027455|FG000|Overall Study|Disease progression|17|||
125925997|NCT01061177|453027455|FG000|Overall Study|Protocol Violation|11|||
125925998|NCT01061177|453027455|FG000|Overall Study|Lost to Follow-up|9|||
125925999|NCT01061177|453027455|FG000|Overall Study|New cancer therapy|9|||
125926000|NCT01061177|453027455|FG000|Overall Study|Abnormal laboratory values|6|||
125926001|NCT01061177|453027455|FG000|Overall Study|Abnormal test procedure results|4|||
125926002|NCT01061177|453027455|FG000|Overall Study|Administratie problems|4|||
125926003|NCT01061177|453027455|FG000|Overall Study|Death|4|||
125926004|NCT00299104|453027456|FG000|Treatment Period|Adverse Event|14|||
125926005|NCT00299104|453027457|FG001|Treatment Period|Adverse Event|9|||
125926006|NCT00299104|453027458|FG002|Treatment Period|Adverse Event|7|||
125926007|NCT00299104|453027456|FG000|Treatment Period|Death|1|||
125926008|NCT00299104|453027457|FG001|Treatment Period|Death|1|||
125926009|NCT00299104|453027458|FG002|Treatment Period|Death|1|||
125926010|NCT00299104|453027456|FG000|Treatment Period|Insufficient therapeutic response|34|||
125926011|NCT00299104|453027457|FG001|Treatment Period|Insufficient therapeutic response|13|||
125926012|NCT00299104|453027458|FG002|Treatment Period|Insufficient therapeutic response|8|||
125926013|NCT00299104|453027456|FG000|Treatment Period|Failure to return|9|||
125926014|NCT00299104|453027457|FG001|Treatment Period|Failure to return|8|||
125926015|NCT00299104|453027458|FG002|Treatment Period|Failure to return|8|||
125926016|NCT00299104|453027456|FG000|Treatment Period|Violation of selection criteria|1|||
125926017|NCT00299104|453027457|FG001|Treatment Period|Violation of selection criteria|2|||
125926018|NCT00299104|453027458|FG002|Treatment Period|Violation of selection criteria|0|||
125926019|NCT00299104|453027456|FG000|Treatment Period|Protocol Violation|1|||
125926020|NCT00299104|453027457|FG001|Treatment Period|Protocol Violation|1|||
125926021|NCT00299104|453027458|FG002|Treatment Period|Protocol Violation|0|||
125926022|NCT00299104|453027456|FG000|Treatment Period|Refused treatment|9|||
125926023|NCT00299104|453027457|FG001|Treatment Period|Refused treatment|2|||
125926024|NCT00299104|453027458|FG002|Treatment Period|Refused treatment|2|||
125926025|NCT00299104|453027456|FG000|Treatment Period|Withdrew consent|14|||
125926026|NCT00299104|453027457|FG001|Treatment Period|Withdrew consent|19|||
125926027|NCT00299104|453027458|FG002|Treatment Period|Withdrew consent|9|||
125926028|NCT00299104|453027456|FG000|Treatment Period|Administrative reasons|106|||
125926029|NCT00299104|453027457|FG001|Treatment Period|Administrative reasons|120|||
125926030|NCT00299104|453027458|FG002|Treatment Period|Administrative reasons|137|||
125926031|NCT00299104|453027456|FG000|Safety Follow-Up (SFU) Period|Death|3|||
125926032|NCT00299104|453027457|FG001|Safety Follow-Up (SFU) Period|Death|2|||
125926033|NCT00299104|453027458|FG002|Safety Follow-Up (SFU) Period|Death|1|||
126112124|NCT02462928|453707611|FG001|Overall Study|Lack of Efficacy|8|||
126112125|NCT02462928|453707612|FG002|Overall Study|Lack of Efficacy|3|||
125926034|NCT00299104|453027456|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
125926035|NCT00299104|453027457|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
125926036|NCT00299104|453027458|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
125926037|NCT00299104|453027456|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
125926038|NCT00299104|453027457|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
125926039|NCT00299104|453027458|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
125926040|NCT00299104|453027456|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
125926041|NCT00299104|453027457|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
125926042|NCT00299104|453027458|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
125926043|NCT00299104|453027456|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
125926044|NCT00299104|453027457|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
126112126|NCT02462928|453707610|FG000|Overall Study|Lost to Follow-up|4|||
126112127|NCT02462928|453707611|FG001|Overall Study|Lost to Follow-up|4|||
126112128|NCT02462928|453707612|FG002|Overall Study|Lost to Follow-up|1|||
125926045|NCT00299104|453027458|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
125926046|NCT00299104|453027456|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
125926047|NCT00299104|453027457|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
125926048|NCT00299104|453027458|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
125926049|NCT00299104|453027456|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
125926050|NCT00299104|453027457|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
125926051|NCT00299104|453027458|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
125926052|NCT00299104|453027456|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
125926053|NCT00299104|453027457|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
125926054|NCT00299104|453027458|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
126112129|NCT02462928|453707610|FG000|Overall Study|Withdrawal by Patient|31|||
125926055|NCT00587054|453027468|FG000|Overall Study|Patient not treated|9|||
125926056|NCT00601458|453027475|FG000|Overall Study|Dosing Error|1|||
125926057|NCT00601458|453027476|FG001|Overall Study|Dosing Error|0|||
125926058|NCT00601458|453027477|FG002|Overall Study|Dosing Error|0|||
125926059|NCT00601458|453027475|FG000|Overall Study|Incomplete Data|0|||
125926060|NCT00601458|453027476|FG001|Overall Study|Incomplete Data|2|||
125926061|NCT00601458|453027477|FG002|Overall Study|Incomplete Data|0|||
125926062|NCT00601458|453027475|FG000|Overall Study|Protocol Violation|3|||
125926063|NCT00601458|453027476|FG001|Overall Study|Protocol Violation|2|||
125926064|NCT00601458|453027477|FG002|Overall Study|Protocol Violation|1|||
125926065|NCT00601458|453027475|FG000|Overall Study|Early Termination|0|||
125926066|NCT00601458|453027476|FG001|Overall Study|Early Termination|1|||
125926067|NCT00601458|453027477|FG002|Overall Study|Early Termination|1|||
125926068|NCT00370032|453027478|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
125926069|NCT00370032|453027479|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
125926070|NCT00370032|453027478|FG000|Washout Period|Withdrawal by Subject|0|||
125926071|NCT00370032|453027479|FG001|Washout Period|Withdrawal by Subject|1|||
125926072|NCT00370032|453027478|FG000|Washout Period|Lost to Follow-up|0|||
125926073|NCT00370032|453027479|FG001|Washout Period|Lost to Follow-up|1|||
125926074|NCT00370032|453027478|FG000|Washout Period|Adverse Event|1|||
125926075|NCT00370032|453027479|FG001|Washout Period|Adverse Event|0|||
125926076|NCT00370032|453027478|FG000|Follow-up Period|Withdrawal by Subject|1|||
125926077|NCT00370032|453027479|FG001|Follow-up Period|Withdrawal by Subject|0|||
125926078|NCT04584645|453027480|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
125926079|NCT04584645|453027481|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
125926080|NCT00390468|453027482|FG000|Overall Study|Protocol Violation|2|||
125926081|NCT00390468|453027482|FG000|Overall Study|Lack of Efficacy|1|||
125926082|NCT03129100|453027485|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
125926083|NCT03129100|453027486|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
125926084|NCT03129100|453027487|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
125926085|NCT03129100|453027488|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
125926086|NCT03129100|453027489|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
125926087|NCT03129100|453027490|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
125926088|NCT03129100|453027491|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
125926089|NCT03129100|453027492|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
125926090|NCT03129100|453027493|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
125926091|NCT03129100|453027494|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
125926092|NCT03129100|453027495|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
125926093|NCT03129100|453027496|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
125926094|NCT03129100|453027497|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
125926095|NCT03129100|453027498|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
125926096|NCT03129100|453027499|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
125926097|NCT03129100|453027500|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
125926098|NCT03129100|453027501|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
125926099|NCT03129100|453027502|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
125926100|NCT03129100|453027503|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
125926101|NCT03129100|453027504|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
125926102|NCT03129100|453027505|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
125926103|NCT03129100|453027506|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
125926104|NCT03129100|453027507|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
125926105|NCT03129100|453027508|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
125926106|NCT03129100|453027509|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
125926107|NCT03129100|453027510|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
125926108|NCT03129100|453027485|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
125926109|NCT03129100|453027486|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926110|NCT03129100|453027487|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926111|NCT03129100|453027488|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926112|NCT03129100|453027489|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926113|NCT03129100|453027490|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926114|NCT03129100|453027491|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926115|NCT03129100|453027492|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926116|NCT03129100|453027493|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926117|NCT03129100|453027494|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926118|NCT03129100|453027495|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926119|NCT03129100|453027496|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926120|NCT03129100|453027497|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926121|NCT03129100|453027498|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926122|NCT03129100|453027499|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926123|NCT03129100|453027500|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926124|NCT03129100|453027501|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926125|NCT03129100|453027502|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926126|NCT03129100|453027503|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926127|NCT03129100|453027504|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926128|NCT03129100|453027505|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926129|NCT03129100|453027506|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926130|NCT03129100|453027507|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926131|NCT03129100|453027508|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926132|NCT03129100|453027509|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926133|NCT03129100|453027510|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125926134|NCT03129100|453027485|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
125926135|NCT03129100|453027486|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
125926136|NCT03129100|453027487|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926137|NCT03129100|453027488|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926138|NCT03129100|453027489|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926139|NCT03129100|453027490|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926140|NCT03129100|453027491|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926141|NCT03129100|453027492|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926142|NCT03129100|453027493|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926143|NCT03129100|453027494|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926144|NCT03129100|453027495|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926145|NCT03129100|453027496|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926146|NCT03129100|453027497|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926147|NCT03129100|453027498|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926148|NCT03129100|453027499|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926149|NCT03129100|453027500|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926150|NCT03129100|453027501|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926151|NCT03129100|453027502|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926152|NCT03129100|453027503|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926153|NCT03129100|453027504|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926154|NCT03129100|453027505|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926155|NCT03129100|453027506|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926156|NCT03129100|453027507|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926157|NCT03129100|453027508|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926158|NCT03129100|453027509|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926159|NCT03129100|453027510|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125926160|NCT03129100|453027485|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
125926161|NCT03129100|453027486|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
125926162|NCT03129100|453027487|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926163|NCT03129100|453027488|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926164|NCT03129100|453027489|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926165|NCT03129100|453027490|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926166|NCT03129100|453027491|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926167|NCT03129100|453027492|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926168|NCT03129100|453027493|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926169|NCT03129100|453027494|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926170|NCT03129100|453027495|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926171|NCT03129100|453027496|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926172|NCT03129100|453027497|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926173|NCT03129100|453027498|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926174|NCT03129100|453027499|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926175|NCT03129100|453027500|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926176|NCT03129100|453027501|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926177|NCT03129100|453027502|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926178|NCT03129100|453027503|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926179|NCT03129100|453027504|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926180|NCT03129100|453027505|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926181|NCT03129100|453027506|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926182|NCT03129100|453027507|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926183|NCT03129100|453027508|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926184|NCT03129100|453027509|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926185|NCT03129100|453027510|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125926186|NCT03129100|453027485|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926187|NCT03129100|453027486|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
125926188|NCT03129100|453027487|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926189|NCT03129100|453027488|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926190|NCT03129100|453027489|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926191|NCT03129100|453027490|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926192|NCT03129100|453027491|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926193|NCT03129100|453027492|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926194|NCT03129100|453027493|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926195|NCT03129100|453027494|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926196|NCT03129100|453027495|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926197|NCT03129100|453027496|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
126112130|NCT02462928|453707611|FG001|Overall Study|Withdrawal by Patient|21|||
126112131|NCT02462928|453707612|FG002|Overall Study|Withdrawal by Patient|21|||
126112132|NCT02462928|453707610|FG000|Overall Study|Protocol Violation|0|||
126112133|NCT02462928|453707611|FG001|Overall Study|Protocol Violation|1|||
126112134|NCT02462928|453707612|FG002|Overall Study|Protocol Violation|0|||
126112135|NCT02462928|453707610|FG000|Overall Study|Reason not Specified|4|||
126112136|NCT02462928|453707611|FG001|Overall Study|Reason not Specified|6|||
126112137|NCT02462928|453707612|FG002|Overall Study|Reason not Specified|5|||
126112138|NCT01493557|453707613|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
126112139|NCT01493557|453707614|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
126112140|NCT01493557|453707615|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
126112141|NCT01493557|453707613|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
126112142|NCT01493557|453707614|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
126112143|NCT01493557|453707615|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
126112144|NCT01493557|453707613|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
126112145|NCT01493557|453707614|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
126112146|NCT01493557|453707615|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
126112147|NCT01493557|453707613|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
126112148|NCT01493557|453707614|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
126112149|NCT01493557|453707615|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
126112150|NCT01493557|453707613|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
126112151|NCT01493557|453707614|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
126112152|NCT01493557|453707615|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
126112153|NCT01493557|453707613|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
126112154|NCT01493557|453707614|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
126112155|NCT01493557|453707615|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
126112156|NCT01493557|453707613|FG000|Not Randomized to Management Strategies|Early termination|0|||
126112157|NCT01493557|453707614|FG001|Not Randomized to Management Strategies|Early termination|0|||
126112158|NCT01493557|453707615|FG002|Not Randomized to Management Strategies|Early termination|34|||
126112159|NCT01493557|453707613|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
126112160|NCT01493557|453707614|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
126112161|NCT01493557|453707615|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
126112162|NCT01493557|453707613|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
126112163|NCT01493557|453707614|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
126112164|NCT01493557|453707615|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
126112165|NCT01493557|453707613|FG000|Randomized to Management Strategies|Other adverse event|8|||
126112166|NCT01493557|453707614|FG001|Randomized to Management Strategies|Other adverse event|5|||
126112167|NCT01493557|453707615|FG002|Randomized to Management Strategies|Other adverse event|0|||
126112168|NCT01493557|453707613|FG000|Randomized to Management Strategies|Protocol Violation|3|||
126112169|NCT01493557|453707614|FG001|Randomized to Management Strategies|Protocol Violation|0|||
126112170|NCT01493557|453707615|FG002|Randomized to Management Strategies|Protocol Violation|0|||
126112171|NCT01493557|453707613|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
126112172|NCT01493557|453707614|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
126112173|NCT01493557|453707615|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
126112174|NCT01493557|453707613|FG000|Randomized to Management Strategies|Other than stated above|1|||
126112175|NCT01493557|453707614|FG001|Randomized to Management Strategies|Other than stated above|3|||
126112176|NCT01493557|453707615|FG002|Randomized to Management Strategies|Other than stated above|0|||
126112177|NCT01493557|453707613|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
126112178|NCT01493557|453707614|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
126112179|NCT01493557|453707615|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
126112180|NCT01493557|453707613|FG000|Adding the Second Strategy|Other adverse event|1|||
126112181|NCT01493557|453707614|FG001|Adding the Second Strategy|Other adverse event|2|||
126112182|NCT01493557|453707615|FG002|Adding the Second Strategy|Other adverse event|0|||
126112183|NCT01493557|453707613|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
126112184|NCT01493557|453707614|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
126112185|NCT01493557|453707615|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
126112186|NCT01890148|453707625|FG000|Overall Study|Adverse Event|1|||
126112187|NCT01170039|453707628|FG000|Overall Study|Withdrawal by Subject|5|||
126112188|NCT01170039|453707629|FG001|Overall Study|Withdrawal by Subject|3|||
126112189|NCT01170039|453707628|FG000|Overall Study|Lack of funding, drug not available|3|||
126112190|NCT01170039|453707629|FG001|Overall Study|Lack of funding, drug not available|3|||
126112191|NCT00727649|453707630|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
126112192|NCT00727649|453707631|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
126112193|NCT00727649|453707630|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
126112194|NCT00727649|453707631|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
126112195|NCT00727649|453707630|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
125926198|NCT03129100|453027497|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926199|NCT03129100|453027498|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926200|NCT03129100|453027499|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926201|NCT03129100|453027500|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926202|NCT03129100|453027501|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926203|NCT03129100|453027502|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926204|NCT03129100|453027503|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926205|NCT03129100|453027504|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926206|NCT03129100|453027505|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926207|NCT03129100|453027506|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926208|NCT03129100|453027507|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926209|NCT03129100|453027508|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926210|NCT03129100|453027509|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926211|NCT03129100|453027510|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
125926212|NCT03129100|453027485|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926213|NCT03129100|453027486|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926214|NCT03129100|453027487|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
125926215|NCT03129100|453027488|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
125926216|NCT03129100|453027489|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926217|NCT03129100|453027490|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
125926218|NCT03129100|453027491|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926219|NCT03129100|453027492|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926220|NCT03129100|453027493|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926221|NCT03129100|453027494|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926222|NCT03129100|453027495|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926223|NCT03129100|453027496|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926224|NCT03129100|453027497|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926225|NCT03129100|453027498|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926226|NCT03129100|453027499|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926227|NCT03129100|453027500|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926228|NCT03129100|453027501|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926229|NCT03129100|453027502|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926230|NCT03129100|453027503|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926231|NCT03129100|453027504|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926232|NCT03129100|453027505|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926233|NCT03129100|453027506|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926234|NCT03129100|453027507|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926235|NCT03129100|453027508|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926236|NCT03129100|453027509|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926237|NCT03129100|453027510|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125926238|NCT03129100|453027485|FG000|Period2 Extension Period (Group A and B)|Death|0|||
125926239|NCT03129100|453027486|FG001|Period2 Extension Period (Group A and B)|Death|0|||
125926240|NCT03129100|453027487|FG002|Period2 Extension Period (Group A and B)|Death|1|||
125926241|NCT03129100|453027488|FG003|Period2 Extension Period (Group A and B)|Death|0|||
125926242|NCT03129100|453027489|FG004|Period2 Extension Period (Group A and B)|Death|0|||
125926243|NCT03129100|453027490|FG005|Period2 Extension Period (Group A and B)|Death|0|||
125926244|NCT03129100|453027491|FG006|Period2 Extension Period (Group A and B)|Death|0|||
125926245|NCT03129100|453027492|FG007|Period2 Extension Period (Group A and B)|Death|0|||
125926246|NCT03129100|453027493|FG008|Period2 Extension Period (Group A and B)|Death|0|||
125926247|NCT03129100|453027494|FG009|Period2 Extension Period (Group A and B)|Death|0|||
125926248|NCT03129100|453027495|FG010|Period2 Extension Period (Group A and B)|Death|0|||
125926249|NCT03129100|453027496|FG011|Period2 Extension Period (Group A and B)|Death|0|||
126064999|NCT04908488|453529164|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
126065000|NCT00901459|453529168|FG000|Overall Study|Withdrawal by Subject|6|||
126065001|NCT04765046|453529169|FG000|Overall Study|Screen Failure|2|||
126065002|NCT04765046|453529169|FG000|Overall Study|Withdrawal by Subject|4|||
126065003|NCT04765046|453529169|FG000|Overall Study|Physician Decision|4|||
126065004|NCT04765046|453529169|FG000|Overall Study|Surgery Cancelled|8|||
126065005|NCT02959866|453529171|FG000|Overall Study|Withdrawal by Subject|1|||
126065006|NCT00952523|453529172|FG000|Overall Study|Withdrawal by Subject|7|||
126065007|NCT00848198|453529173|FG000|Overall Study|Incomplete Case Report Forms|15|||
126065008|NCT03708744|453529177|FG000|Overall Study|Withdrawal by Subject|0|||
126065009|NCT03708744|453529178|FG001|Overall Study|Withdrawal by Subject|0|||
126112196|NCT00727649|453707631|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
125926250|NCT03129100|453027497|FG012|Period2 Extension Period (Group A and B)|Death|0|||
126065010|NCT03708744|453529179|FG002|Overall Study|Withdrawal by Subject|1|||
126065011|NCT03708744|453529180|FG003|Overall Study|Withdrawal by Subject|0|||
126112197|NCT00727649|453707630|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
125926251|NCT03129100|453027498|FG013|Period2 Extension Period (Group A and B)|Death|0|||
126065012|NCT04930263|453529181|FG000|Overall Study|Withdrawal by Subject|3|||
126065013|NCT04930263|453529182|FG001|Overall Study|Withdrawal by Subject|5|||
126065014|NCT03529942|453529183|FG000|Overall Study|Withdrawal by Subject|13|||
126065015|NCT03529942|453529183|FG000|Overall Study|Physician Decision|1|||
126065016|NCT03529942|453529183|FG000|Overall Study|Lost to Follow-up|7|||
126065017|NCT03529942|453529183|FG000|Overall Study|Needle inserted but no drug administered|1|||
126065018|NCT03529942|453529183|FG000|Overall Study|Personal reasons|1|||
126065019|NCT00850993|453529184|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
126065020|NCT00850993|453529185|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
126065021|NCT00850993|453529186|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
126065022|NCT00850993|453529187|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
126065023|NCT03839355|453529188|FG000|Overall Study|Withdrawal by Subject|1|||
126065024|NCT03839355|453529189|FG001|Overall Study|Withdrawal by Subject|0|||
126065025|NCT00658632|453529195|FG000|Overall Study|Adverse Event|13|||
126065026|NCT00658632|453529196|FG001|Overall Study|Adverse Event|11|||
126065027|NCT00658632|453529195|FG000|Overall Study|Lost to Follow-up|25|||
126065028|NCT00658632|453529196|FG001|Overall Study|Lost to Follow-up|23|||
126065029|NCT00658632|453529195|FG000|Overall Study|Withdrawal by Subject|10|||
126065030|NCT00658632|453529196|FG001|Overall Study|Withdrawal by Subject|7|||
126065031|NCT00658632|453529195|FG000|Overall Study|Lack of Efficacy|0|||
126065032|NCT00658632|453529196|FG001|Overall Study|Lack of Efficacy|1|||
126065033|NCT00658632|453529195|FG000|Overall Study|Withdrawal of consent|8|||
126065034|NCT00658632|453529196|FG001|Overall Study|Withdrawal of consent|14|||
126065035|NCT00658632|453529195|FG000|Overall Study|Pregnancy|1|||
126065036|NCT00658632|453529196|FG001|Overall Study|Pregnancy|1|||
126065037|NCT00658632|453529195|FG000|Overall Study|Other|7|||
126065038|NCT00658632|453529196|FG001|Overall Study|Other|8|||
126065039|NCT01699178|453529197|FG000|Overall Study|Adverse Event|1|||
126065040|NCT01699178|453529198|FG001|Overall Study|Adverse Event|5|||
126065041|NCT01699178|453529197|FG000|Overall Study|Lost to Follow-up|1|||
126065042|NCT01699178|453529198|FG001|Overall Study|Lost to Follow-up|6|||
126065043|NCT01699178|453529197|FG000|Overall Study|Non-compliance with Study Drug|3|||
126065044|NCT01699178|453529198|FG001|Overall Study|Non-compliance with Study Drug|1|||
126065045|NCT01699178|453529197|FG000|Overall Study|Physician Decision|1|||
126065046|NCT01699178|453529198|FG001|Overall Study|Physician Decision|0|||
126065047|NCT01699178|453529197|FG000|Overall Study|Withdrawal by Subject|4|||
126065048|NCT01699178|453529198|FG001|Overall Study|Withdrawal by Subject|12|||
126065049|NCT01699178|453529197|FG000|Overall Study|Hematocrit >54%|1|||
126065050|NCT01699178|453529198|FG001|Overall Study|Hematocrit >54%|1|||
126065051|NCT01699178|453529197|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
126065052|NCT01699178|453529198|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
126065053|NCT01699178|453529197|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
126065054|NCT01699178|453529198|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
126065055|NCT00760877|453530649|FG000|Overall Study|Protocol Violation|1|||
126065056|NCT00760877|453530650|FG001|Overall Study|Protocol Violation|0|||
126065057|NCT00760877|453530649|FG000|Overall Study|Non-compliance with protocol treatment|2|||
126065058|NCT00760877|453530650|FG001|Overall Study|Non-compliance with protocol treatment|1|||
126065059|NCT00760877|453530649|FG000|Overall Study|Pregnancy|1|||
126065060|NCT00760877|453530650|FG001|Overall Study|Pregnancy|4|||
126065061|NCT00760877|453530649|FG000|Overall Study|Death|2|||
126065062|NCT00760877|453530650|FG001|Overall Study|Death|1|||
126065063|NCT00760877|453530649|FG000|Overall Study|Withdrawal by Subject|7|||
126065064|NCT00760877|453530650|FG001|Overall Study|Withdrawal by Subject|3|||
126065065|NCT00760877|453530649|FG000|Overall Study|Adverse Event|19|||
126065066|NCT00760877|453530650|FG001|Overall Study|Adverse Event|12|||
126065067|NCT00760877|453530649|FG000|Overall Study|Participant diagnosed with AML|0|||
126065068|NCT00760877|453530650|FG001|Overall Study|Participant diagnosed with AML|1|||
126065069|NCT00760877|453530649|FG000|Overall Study|Participant not eligible to cross-over|0|||
126065070|NCT00760877|453530650|FG001|Overall Study|Participant not eligible to cross-over|1|||
126065071|NCT00760877|453530649|FG000|Overall Study|Physician Decision|1|||
126065072|NCT00760877|453530650|FG001|Overall Study|Physician Decision|2|||
126065073|NCT00760877|453530649|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
126065074|NCT00760877|453530650|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
126065075|NCT00760877|453530649|FG000|Overall Study|Treatment failure|1|||
126065076|NCT00760877|453530650|FG001|Overall Study|Treatment failure|0|||
126065077|NCT00711555|453530653|FG000|Overall Study|Adverse Event|3|||
126065078|NCT00946998|453530654|FG000|Overall Study|Exited prior to first outcome assessment|5|||
126065079|NCT00946998|453530655|FG001|Overall Study|Exited prior to first outcome assessment|3|||
126065080|NCT00668746|453530659|FG000|Overall Study|Lost to Follow-up|2|||
126065081|NCT00668746|453530660|FG001|Overall Study|Lost to Follow-up|1|||
126065082|NCT01816165|453530662|FG000|Overall Study|Adverse Event|1|||
126065083|NCT01816165|453530663|FG001|Overall Study|Adverse Event|0|||
126065084|NCT01816165|453530664|FG002|Overall Study|Adverse Event|0|||
126065085|NCT01816165|453530665|FG003|Overall Study|Adverse Event|0|||
126112198|NCT00727649|453707631|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
126112199|NCT00727649|453707630|FG000|Second Intervention (4-weeks)|Death|1|||
126112200|NCT00727649|453707631|FG001|Second Intervention (4-weeks)|Death|0|||
126112201|NCT00727649|453707630|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
126112202|NCT00727649|453707631|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
126112203|NCT00727649|453707630|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
126112204|NCT00727649|453707631|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
126112205|NCT00832117|453707634|FG000|Overall Study|Death|1|||
126112206|NCT00832117|453707634|FG000|Overall Study|Disease Progression|11|||
126112207|NCT00404066|453707635|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
126112208|NCT00404066|453707635|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
126112209|NCT01524133|453707638|FG000|Treatment Phase|Withdrawal by Subject|13|||
126112210|NCT01524133|453707639|FG001|Treatment Phase|Withdrawal by Subject|28|||
126112211|NCT01524133|453707640|FG002|Treatment Phase|Withdrawal by Subject|31|||
126112212|NCT01524133|453707638|FG000|Treatment Phase|Physician Decision|6|||
126112213|NCT01524133|453707639|FG001|Treatment Phase|Physician Decision|3|||
126112214|NCT01524133|453707640|FG002|Treatment Phase|Physician Decision|3|||
126112215|NCT01524133|453707638|FG000|Treatment Phase|Lost to Follow-up|0|||
126112216|NCT01524133|453707639|FG001|Treatment Phase|Lost to Follow-up|1|||
126112217|NCT01524133|453707640|FG002|Treatment Phase|Lost to Follow-up|2|||
126112218|NCT01524133|453707638|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
126112219|NCT01524133|453707639|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
126112220|NCT01524133|453707640|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
126112221|NCT01524133|453707638|FG000|Overall Study 52 Weeks|Physician Decision|1|||
126112222|NCT01524133|453707639|FG001|Overall Study 52 Weeks|Physician Decision|0|||
126112223|NCT01524133|453707640|FG002|Overall Study 52 Weeks|Physician Decision|2|||
126112224|NCT01524133|453707638|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
126112225|NCT01524133|453707639|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
126112226|NCT01524133|453707640|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
126112227|NCT03842163|453707645|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
126112228|NCT03842163|453707645|FG000|Overall Study|Scintigraphy was not performed|44|||
126112229|NCT03829241|453707646|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
126112230|NCT03829241|453707647|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
126112231|NCT03829241|453707646|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
126112232|NCT03829241|453707647|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
126112233|NCT03829241|453707646|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
126112234|NCT03829241|453707647|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
126112235|NCT03829241|453707646|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
126112236|NCT03829241|453707647|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
126112237|NCT03829241|453707646|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
126112238|NCT03829241|453707647|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
126112239|NCT03829241|453707646|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
126112240|NCT03829241|453707647|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
126112241|NCT03829241|453707646|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
126112242|NCT03829241|453707647|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
126112243|NCT03829241|453707646|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
126112244|NCT03829241|453707647|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
126112245|NCT03829241|453707646|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
126112246|NCT03829241|453707647|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
126112247|NCT03829241|453707646|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
126112248|NCT03829241|453707647|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
126112249|NCT03829241|453707646|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
126112250|NCT03829241|453707647|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
126112251|NCT03829241|453707646|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
126112252|NCT03829241|453707647|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
126112253|NCT03829241|453707646|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
126112254|NCT03829241|453707647|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
126112255|NCT03829241|453707646|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
126112256|NCT03829241|453707647|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
126112257|NCT00698451|453707648|FG000|Overall Study|Adverse Event|22|||
126112258|NCT00698451|453707648|FG000|Overall Study|Physician Decision|2|||
126112259|NCT00698451|453707648|FG000|Overall Study|Protocol Violation|6|||
126112260|NCT00698451|453707648|FG000|Overall Study|Withdrawal by Subject|6|||
126112261|NCT00698451|453707648|FG000|Overall Study|Disease progression|3|||
126112262|NCT02224599|453707649|FG000|Overall Study|Physician Decision|1|||
126112263|NCT02224599|453707649|FG000|Overall Study|Progression of Disease|1|||
126112264|NCT01187550|453707650|FG000|Overall Study|Protocol Violation|3|||
126112265|NCT01187550|453707651|FG001|Overall Study|Protocol Violation|1|||
126112266|NCT01187550|453707650|FG000|Overall Study|Other|3|||
126112267|NCT01187550|453707651|FG001|Overall Study|Other|0|||
126112268|NCT01187550|453707650|FG000|Overall Study|Randomized but not treated|8|||
125926252|NCT03129100|453027499|FG014|Period2 Extension Period (Group A and B)|Death|0|||
125926253|NCT03129100|453027500|FG015|Period2 Extension Period (Group A and B)|Death|0|||
125926254|NCT03129100|453027501|FG016|Period2 Extension Period (Group A and B)|Death|0|||
125926255|NCT03129100|453027502|FG017|Period2 Extension Period (Group A and B)|Death|0|||
125926256|NCT03129100|453027503|FG018|Period2 Extension Period (Group A and B)|Death|0|||
125926257|NCT03129100|453027504|FG019|Period2 Extension Period (Group A and B)|Death|0|||
125926258|NCT03129100|453027505|FG020|Period2 Extension Period (Group A and B)|Death|0|||
125926259|NCT03129100|453027506|FG021|Period2 Extension Period (Group A and B)|Death|0|||
125926260|NCT03129100|453027507|FG022|Period2 Extension Period (Group A and B)|Death|0|||
125926261|NCT03129100|453027508|FG023|Period2 Extension Period (Group A and B)|Death|0|||
125926262|NCT03129100|453027509|FG024|Period2 Extension Period (Group A and B)|Death|0|||
125926263|NCT03129100|453027510|FG025|Period2 Extension Period (Group A and B)|Death|0|||
125926264|NCT03129100|453027485|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926265|NCT03129100|453027486|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926266|NCT03129100|453027487|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
125926267|NCT03129100|453027488|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
125926268|NCT03129100|453027489|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
125926269|NCT03129100|453027490|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
125926270|NCT03129100|453027491|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
125926271|NCT03129100|453027492|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926272|NCT03129100|453027493|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926273|NCT03129100|453027494|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926274|NCT03129100|453027495|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926275|NCT03129100|453027496|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926276|NCT03129100|453027497|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926277|NCT03129100|453027498|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926278|NCT03129100|453027499|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926279|NCT03129100|453027500|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926280|NCT03129100|453027501|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926281|NCT03129100|453027502|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926282|NCT03129100|453027503|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926283|NCT03129100|453027504|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926284|NCT03129100|453027505|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926285|NCT03129100|453027506|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926286|NCT03129100|453027507|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926287|NCT03129100|453027508|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926288|NCT03129100|453027509|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926289|NCT03129100|453027510|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125926290|NCT03129100|453027485|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926291|NCT03129100|453027486|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926292|NCT03129100|453027487|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
125926293|NCT03129100|453027488|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926294|NCT03129100|453027489|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926295|NCT03129100|453027490|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926296|NCT03129100|453027491|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926297|NCT03129100|453027492|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926298|NCT03129100|453027493|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926299|NCT03129100|453027494|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926300|NCT03129100|453027495|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926301|NCT03129100|453027496|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926302|NCT03129100|453027497|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926303|NCT03129100|453027498|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926304|NCT03129100|453027499|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926305|NCT03129100|453027500|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926306|NCT03129100|453027501|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926307|NCT03129100|453027502|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926308|NCT03129100|453027503|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926309|NCT03129100|453027504|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926310|NCT03129100|453027505|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926311|NCT03129100|453027506|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126112269|NCT01187550|453707651|FG001|Overall Study|Randomized but not treated|0|||
126112270|NCT00733304|453707652|FG000|Overall Study|Adverse Event|3|||
125926312|NCT03129100|453027507|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126112271|NCT00733304|453707653|FG001|Overall Study|Adverse Event|0|||
125926313|NCT03129100|453027508|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926314|NCT03129100|453027509|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926315|NCT03129100|453027510|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125926316|NCT03129100|453027485|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926317|NCT03129100|453027486|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926318|NCT03129100|453027487|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
125926319|NCT03129100|453027488|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926320|NCT03129100|453027489|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926321|NCT03129100|453027490|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926322|NCT03129100|453027491|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926323|NCT03129100|453027492|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926324|NCT03129100|453027493|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926325|NCT03129100|453027494|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926326|NCT03129100|453027495|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926327|NCT03129100|453027496|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926328|NCT03129100|453027497|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926329|NCT03129100|453027498|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926330|NCT03129100|453027499|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926331|NCT03129100|453027500|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926332|NCT03129100|453027501|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926333|NCT03129100|453027502|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926334|NCT03129100|453027503|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926335|NCT03129100|453027504|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926336|NCT03129100|453027505|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926337|NCT03129100|453027506|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926338|NCT03129100|453027507|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926339|NCT03129100|453027508|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926340|NCT03129100|453027509|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926341|NCT03129100|453027510|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125926342|NCT03129100|453027485|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926343|NCT03129100|453027486|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926344|NCT03129100|453027487|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
125926345|NCT03129100|453027488|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926346|NCT03129100|453027489|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926347|NCT03129100|453027490|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926348|NCT03129100|453027491|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926349|NCT03129100|453027492|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926350|NCT03129100|453027493|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926351|NCT03129100|453027494|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926352|NCT03129100|453027495|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926353|NCT03129100|453027496|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926354|NCT03129100|453027497|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926355|NCT03129100|453027498|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926356|NCT03129100|453027499|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926357|NCT03129100|453027500|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926358|NCT03129100|453027501|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926359|NCT03129100|453027502|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926360|NCT03129100|453027503|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926361|NCT03129100|453027504|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926362|NCT03129100|453027505|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926363|NCT03129100|453027506|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926364|NCT03129100|453027507|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926365|NCT03129100|453027508|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926366|NCT03129100|453027509|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926367|NCT03129100|453027510|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125926368|NCT03129100|453027485|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926369|NCT03129100|453027486|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926370|NCT03129100|453027487|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926371|NCT03129100|453027488|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926372|NCT03129100|453027489|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
125926373|NCT03129100|453027490|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
125926374|NCT03129100|453027491|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
125926375|NCT03129100|453027492|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926376|NCT03129100|453027493|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926377|NCT03129100|453027494|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926378|NCT03129100|453027495|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926379|NCT03129100|453027496|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926380|NCT03129100|453027497|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926381|NCT03129100|453027498|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926382|NCT03129100|453027499|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926383|NCT03129100|453027500|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926384|NCT03129100|453027501|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926385|NCT03129100|453027502|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926386|NCT03129100|453027503|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926387|NCT03129100|453027504|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926388|NCT03129100|453027505|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926389|NCT03129100|453027506|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926390|NCT03129100|453027507|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926391|NCT03129100|453027508|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926392|NCT03129100|453027509|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926393|NCT03129100|453027510|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125926394|NCT03129100|453027485|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926395|NCT03129100|453027486|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926396|NCT03129100|453027487|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926397|NCT03129100|453027488|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926398|NCT03129100|453027489|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926399|NCT03129100|453027490|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926400|NCT03129100|453027491|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926401|NCT03129100|453027492|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926402|NCT03129100|453027493|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926403|NCT03129100|453027494|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
125926404|NCT03129100|453027495|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926405|NCT03129100|453027496|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926406|NCT03129100|453027497|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926407|NCT03129100|453027498|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926408|NCT03129100|453027499|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926409|NCT03129100|453027500|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926410|NCT03129100|453027501|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926411|NCT03129100|453027502|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926412|NCT03129100|453027503|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926413|NCT03129100|453027504|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926414|NCT03129100|453027505|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926415|NCT03129100|453027506|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926416|NCT03129100|453027507|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926417|NCT03129100|453027508|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926418|NCT03129100|453027509|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926419|NCT03129100|453027510|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125926420|NCT03129100|453027485|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926421|NCT03129100|453027486|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926422|NCT03129100|453027487|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926423|NCT03129100|453027488|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926424|NCT03129100|453027489|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926425|NCT03129100|453027490|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926426|NCT03129100|453027491|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926427|NCT03129100|453027492|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926428|NCT03129100|453027493|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126112272|NCT00733304|453707654|FG002|Overall Study|Adverse Event|0|||
125926429|NCT03129100|453027494|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926430|NCT03129100|453027495|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926431|NCT03129100|453027496|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
125926432|NCT03129100|453027497|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926433|NCT03129100|453027498|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926434|NCT03129100|453027499|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926435|NCT03129100|453027500|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926436|NCT03129100|453027501|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126112273|NCT00733304|453707652|FG000|Overall Study|Lack of Efficacy|0|||
126112274|NCT00733304|453707653|FG001|Overall Study|Lack of Efficacy|0|||
126112275|NCT00733304|453707654|FG002|Overall Study|Lack of Efficacy|2|||
126112276|NCT00733304|453707652|FG000|Overall Study|Lost to Follow-up|0|||
126112277|NCT00733304|453707653|FG001|Overall Study|Lost to Follow-up|1|||
126112278|NCT00733304|453707654|FG002|Overall Study|Lost to Follow-up|0|||
126112279|NCT00733304|453707652|FG000|Overall Study|Physician Decision|3|||
126112280|NCT00733304|453707653|FG001|Overall Study|Physician Decision|1|||
126112281|NCT00733304|453707654|FG002|Overall Study|Physician Decision|3|||
126112282|NCT00733304|453707652|FG000|Overall Study|Withdrawal by Subject|1|||
126112283|NCT00733304|453707653|FG001|Overall Study|Withdrawal by Subject|1|||
126112284|NCT00733304|453707654|FG002|Overall Study|Withdrawal by Subject|0|||
126112285|NCT02616614|453707664|FG000|Overall Study|Withdrawal by Subject|10|||
126112286|NCT02616614|453707665|FG001|Overall Study|Withdrawal by Subject|5|||
126112287|NCT02616614|453707666|FG002|Overall Study|Withdrawal by Subject|6|||
126112288|NCT02616614|453707664|FG000|Overall Study|Physician Decision|2|||
126112289|NCT02616614|453707665|FG001|Overall Study|Physician Decision|1|||
126112290|NCT02616614|453707666|FG002|Overall Study|Physician Decision|0|||
126112291|NCT02616614|453707664|FG000|Overall Study|Adverse Event|1|||
126112292|NCT02616614|453707665|FG001|Overall Study|Adverse Event|4|||
126112293|NCT02616614|453707666|FG002|Overall Study|Adverse Event|1|||
126112294|NCT02616614|453707664|FG000|Overall Study|Protocol Violation|0|||
126112295|NCT02616614|453707665|FG001|Overall Study|Protocol Violation|3|||
126112296|NCT02616614|453707666|FG002|Overall Study|Protocol Violation|1|||
126112297|NCT02616614|453707664|FG000|Overall Study|Prohibited Medication|12|||
126112298|NCT02616614|453707665|FG001|Overall Study|Prohibited Medication|9|||
126112299|NCT02616614|453707666|FG002|Overall Study|Prohibited Medication|5|||
126112300|NCT02616614|453707664|FG000|Overall Study|More than 3 applications missed|6|||
126112301|NCT02616614|453707665|FG001|Overall Study|More than 3 applications missed|8|||
126112302|NCT02616614|453707666|FG002|Overall Study|More than 3 applications missed|1|||
126112303|NCT02616614|453707664|FG000|Overall Study|Lost to Follow-up|31|||
126112304|NCT02616614|453707665|FG001|Overall Study|Lost to Follow-up|28|||
126112305|NCT02616614|453707666|FG002|Overall Study|Lost to Follow-up|13|||
126112306|NCT02616614|453707664|FG000|Overall Study|Pregnancy|2|||
126112307|NCT02616614|453707665|FG001|Overall Study|Pregnancy|0|||
126112308|NCT02616614|453707666|FG002|Overall Study|Pregnancy|1|||
126112309|NCT02616614|453707664|FG000|Overall Study|Other|1|||
126112310|NCT02616614|453707665|FG001|Overall Study|Other|2|||
126112311|NCT02616614|453707666|FG002|Overall Study|Other|1|||
126112312|NCT00596934|453707667|FG000|Overall Study|Protocol Violation|1|||
126112313|NCT00596934|453707667|FG000|Overall Study|Withdrawal by Subject|1|||
126112314|NCT02445755|453707668|FG000|Overall Study|Withdrawal by Subject|2|||
126112315|NCT02445755|453707668|FG000|Overall Study|Protocol Violation|6|||
126112316|NCT02445755|453707668|FG000|Overall Study|Screen Failure|5|||
126112317|NCT03239483|453707669|FG000|Overall Study|Lost to Follow-up|1|||
126112318|NCT03239483|453707670|FG001|Overall Study|Lost to Follow-up|0|||
126112319|NCT03239483|453707669|FG000|Overall Study|Withdrawal by Subject|1|||
126112320|NCT03239483|453707670|FG001|Overall Study|Withdrawal by Subject|0|||
126112321|NCT04464265|453707671|FG000|Overall Study|Physician Decision|2|||
126112322|NCT00974090|453707676|FG000|Period 1: Double Blind Period|Adverse Event|2|||
126112323|NCT00974090|453707677|FG001|Period 1: Double Blind Period|Adverse Event|1|||
126112324|NCT00974090|453707676|FG000|Period 1: Double Blind Period|Physician Decision|1|||
125926437|NCT03129100|453027502|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926438|NCT03129100|453027503|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926439|NCT03129100|453027504|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926440|NCT03129100|453027505|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926441|NCT03129100|453027506|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926442|NCT03129100|453027507|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926443|NCT03129100|453027508|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926444|NCT03129100|453027509|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926445|NCT03129100|453027510|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125926446|NCT03129100|453027485|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926447|NCT03129100|453027486|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926448|NCT03129100|453027487|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126112325|NCT00974090|453707677|FG001|Period 1: Double Blind Period|Physician Decision|0|||
126112326|NCT00974090|453707676|FG000|Period 2: Open-label Period|Adverse Event|4|||
126112327|NCT00974090|453707677|FG001|Period 2: Open-label Period|Adverse Event|6|||
126112328|NCT00974090|453707676|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
126112329|NCT00974090|453707677|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
126112330|NCT00974090|453707676|FG000|Period 2: Open-label Period|Physician Decision|0|||
126112331|NCT00974090|453707677|FG001|Period 2: Open-label Period|Physician Decision|3|||
126112332|NCT00974090|453707676|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
126112333|NCT00974090|453707677|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
126112334|NCT03189862|453707678|FG000|Overall Study|Withdrawal by Subject|1|||
126112335|NCT03189862|453707679|FG001|Overall Study|Withdrawal by Subject|0|||
126112336|NCT03189862|453707678|FG000|Overall Study|Lost to Follow-up|54|||
125926449|NCT03129100|453027488|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926450|NCT03129100|453027489|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926451|NCT03129100|453027490|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926452|NCT03129100|453027491|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926453|NCT03129100|453027492|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926454|NCT03129100|453027493|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926455|NCT03129100|453027494|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926456|NCT03129100|453027495|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926457|NCT03129100|453027496|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
125926458|NCT03129100|453027497|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
125926459|NCT03129100|453027498|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
125926460|NCT03129100|453027499|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
125926461|NCT03129100|453027500|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926462|NCT03129100|453027501|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926463|NCT03129100|453027502|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926464|NCT03129100|453027503|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926465|NCT03129100|453027504|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926466|NCT03129100|453027505|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926467|NCT03129100|453027506|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926468|NCT03129100|453027507|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926469|NCT03129100|453027508|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926470|NCT03129100|453027509|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926471|NCT03129100|453027510|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125926472|NCT03129100|453027485|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926473|NCT03129100|453027486|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926474|NCT03129100|453027487|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926475|NCT03129100|453027488|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926476|NCT03129100|453027489|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926477|NCT03129100|453027490|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926478|NCT03129100|453027491|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926479|NCT03129100|453027492|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926480|NCT03129100|453027493|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926481|NCT03129100|453027494|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926482|NCT03129100|453027495|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926483|NCT03129100|453027496|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
125926484|NCT03129100|453027497|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926485|NCT03129100|453027498|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
125926486|NCT03129100|453027499|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
125926487|NCT03129100|453027500|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926488|NCT03129100|453027501|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926489|NCT03129100|453027502|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926490|NCT03129100|453027503|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926491|NCT03129100|453027504|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926492|NCT03129100|453027505|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126065086|NCT01263223|453530671|FG000|Period 2|Withdrawal by Subject|0|||
126065087|NCT01263223|453530672|FG001|Period 2|Withdrawal by Subject|1|||
126065088|NCT01263223|453530671|FG000|7-day Follow-up|Withdrawal by Subject|0|||
126065089|NCT01263223|453530672|FG001|7-day Follow-up|Withdrawal by Subject|1|||
126065090|NCT01263223|453530671|FG000|7-day Follow-up|Lost to Follow-up|1|||
126065091|NCT01263223|453530672|FG001|7-day Follow-up|Lost to Follow-up|0|||
126065092|NCT04175834|453530674|FG000|Overall Study|Withdrawal by Subject|1|||
126065093|NCT04175834|453530675|FG001|Overall Study|Withdrawal by Subject|0|||
126065094|NCT01322347|453530676|FG000|Overall Study|Adverse Event|7|||
126065095|NCT01322347|453530677|FG001|Overall Study|Adverse Event|2|||
126065096|NCT01322347|453530676|FG000|Overall Study|Death|5|||
126065097|NCT01322347|453530677|FG001|Overall Study|Death|3|||
126065098|NCT01322347|453530676|FG000|Overall Study|Physician Decision|2|||
126065099|NCT01322347|453530677|FG001|Overall Study|Physician Decision|1|||
126065100|NCT01322347|453530676|FG000|Overall Study|Protocol Violation|5|||
126065101|NCT01322347|453530677|FG001|Overall Study|Protocol Violation|2|||
126065102|NCT01322347|453530676|FG000|Overall Study|Withdrawal by Subject|1|||
126065103|NCT01322347|453530677|FG001|Overall Study|Withdrawal by Subject|4|||
126065104|NCT01322347|453530676|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
126065105|NCT01322347|453530677|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
126065106|NCT01322347|453530676|FG000|Overall Study|blood transfusion|5|||
126065107|NCT01322347|453530677|FG001|Overall Study|blood transfusion|5|||
125926493|NCT03129100|453027506|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926494|NCT03129100|453027507|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926495|NCT03129100|453027508|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926496|NCT03129100|453027509|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926497|NCT03129100|453027510|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125926498|NCT03129100|453027485|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926499|NCT03129100|453027486|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926500|NCT03129100|453027487|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926501|NCT03129100|453027488|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926502|NCT03129100|453027489|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926503|NCT03129100|453027490|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926504|NCT03129100|453027491|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926505|NCT03129100|453027492|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926506|NCT03129100|453027493|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926507|NCT03129100|453027494|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926508|NCT03129100|453027495|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926509|NCT03129100|453027496|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926510|NCT03129100|453027497|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926511|NCT03129100|453027498|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926512|NCT03129100|453027499|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926513|NCT03129100|453027500|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
125926514|NCT03129100|453027501|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926515|NCT03129100|453027502|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926516|NCT03129100|453027503|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926517|NCT03129100|453027504|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926518|NCT03129100|453027505|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926519|NCT03129100|453027506|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926520|NCT03129100|453027507|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926521|NCT03129100|453027508|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926522|NCT03129100|453027509|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926523|NCT03129100|453027510|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125926524|NCT03129100|453027485|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926525|NCT03129100|453027486|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926526|NCT03129100|453027487|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926527|NCT03129100|453027488|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926528|NCT03129100|453027489|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926529|NCT03129100|453027490|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926530|NCT03129100|453027491|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926531|NCT03129100|453027492|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926532|NCT03129100|453027493|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926533|NCT03129100|453027494|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926534|NCT03129100|453027495|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926535|NCT03129100|453027496|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926536|NCT03129100|453027497|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
125926537|NCT03129100|453027498|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926538|NCT03129100|453027499|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
125926539|NCT03129100|453027500|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
125926540|NCT03129100|453027501|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926541|NCT03129100|453027502|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926542|NCT03129100|453027503|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926543|NCT03129100|453027504|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926544|NCT03129100|453027505|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926545|NCT03129100|453027506|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926546|NCT03129100|453027507|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926547|NCT03129100|453027508|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926548|NCT03129100|453027509|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926549|NCT03129100|453027510|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125926550|NCT03129100|453027485|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926551|NCT03129100|453027486|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126112337|NCT03189862|453707679|FG001|Overall Study|Lost to Follow-up|62|||
126112338|NCT00056862|453707680|FG000|Overall Study|Protocol Violation|1|||
126112339|NCT00056862|453707681|FG001|Overall Study|Protocol Violation|0|||
126112340|NCT00728481|453707682|FG000|Overall Study|Withdrawal by Subject|0|||
126112341|NCT00728481|453707683|FG001|Overall Study|Withdrawal by Subject|1|||
126112342|NCT00728481|453707682|FG000|Overall Study|Adverse Event|0|||
125926552|NCT03129100|453027487|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126112343|NCT00728481|453707683|FG001|Overall Study|Adverse Event|1|||
126112344|NCT00728481|453707682|FG000|Overall Study|Study medication non-compliance|0|||
126112345|NCT00728481|453707683|FG001|Overall Study|Study medication non-compliance|2|||
126112346|NCT00728481|453707682|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
126112347|NCT00728481|453707683|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
126112348|NCT00778622|453707684|FG000|Overall Study|Adverse Event|5|||
126112349|NCT00778622|453707685|FG001|Overall Study|Adverse Event|4|||
126112350|NCT00778622|453707686|FG002|Overall Study|Adverse Event|7|||
126112351|NCT00778622|453707684|FG000|Overall Study|Withdrawal by Subject|4|||
126112352|NCT00778622|453707685|FG001|Overall Study|Withdrawal by Subject|5|||
126112353|NCT00778622|453707686|FG002|Overall Study|Withdrawal by Subject|5|||
126112354|NCT00778622|453707684|FG000|Overall Study|Lost to Follow-up|3|||
126112355|NCT00778622|453707685|FG001|Overall Study|Lost to Follow-up|3|||
126112356|NCT00778622|453707686|FG002|Overall Study|Lost to Follow-up|2|||
126112357|NCT00778622|453707684|FG000|Overall Study|Protocol Violation|0|||
126112358|NCT00778622|453707685|FG001|Overall Study|Protocol Violation|3|||
126112359|NCT00778622|453707686|FG002|Overall Study|Protocol Violation|0|||
126112360|NCT00778622|453707684|FG000|Overall Study|Lack of Efficacy|2|||
126112361|NCT00778622|453707685|FG001|Overall Study|Lack of Efficacy|0|||
126112362|NCT00778622|453707686|FG002|Overall Study|Lack of Efficacy|0|||
126112363|NCT00778622|453707684|FG000|Overall Study|immigration|1|||
126112364|NCT00778622|453707685|FG001|Overall Study|immigration|0|||
126112365|NCT00778622|453707686|FG002|Overall Study|immigration|0|||
126112366|NCT00778622|453707684|FG000|Overall Study|Other|1|||
126112367|NCT00778622|453707685|FG001|Overall Study|Other|0|||
126112368|NCT00778622|453707686|FG002|Overall Study|Other|1|||
126112369|NCT01505010|453707687|FG000|Overall Study|Protocol Violation|0|||
126112370|NCT01505010|453707688|FG001|Overall Study|Protocol Violation|1|||
126112371|NCT01505010|453707687|FG000|Overall Study|Lost to Follow-up|0|||
126112372|NCT01505010|453707688|FG001|Overall Study|Lost to Follow-up|1|||
126112373|NCT00108069|453707696|FG000|Overall Study|Never rec'd study drug|0|||
126112374|NCT00108069|453707697|FG001|Overall Study|Never rec'd study drug|1|||
126112375|NCT00108069|453707696|FG000|Overall Study|Adverse Event|1|||
126112376|NCT00108069|453707697|FG001|Overall Study|Adverse Event|1|||
126112377|NCT00108069|453707696|FG000|Overall Study|Withdrawal by Subject|1|||
126112378|NCT00108069|453707697|FG001|Overall Study|Withdrawal by Subject|0|||
126112379|NCT00108069|453707696|FG000|Overall Study|Death|1|||
126112380|NCT00108069|453707697|FG001|Overall Study|Death|0|||
126112381|NCT00108069|453707696|FG000|Overall Study|Progessive disease|27|||
126112382|NCT00108069|453707697|FG001|Overall Study|Progessive disease|11|||
126112383|NCT01910116|453707699|FG000|Overall Study|Adverse Event|0|||
126112384|NCT01910116|453707700|FG001|Overall Study|Adverse Event|3|||
126112385|NCT01910116|453707699|FG000|Overall Study|Lack of Efficacy|3|||
126112386|NCT01910116|453707700|FG001|Overall Study|Lack of Efficacy|4|||
126112387|NCT01910116|453707699|FG000|Overall Study|Lost to Follow-up|1|||
125926553|NCT03129100|453027488|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926554|NCT03129100|453027489|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926555|NCT03129100|453027490|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926556|NCT03129100|453027491|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926557|NCT03129100|453027492|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926558|NCT03129100|453027493|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926559|NCT03129100|453027494|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926560|NCT03129100|453027495|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926561|NCT03129100|453027496|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926562|NCT03129100|453027497|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926563|NCT03129100|453027498|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926564|NCT03129100|453027499|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126112388|NCT01910116|453707700|FG001|Overall Study|Lost to Follow-up|0|||
126112389|NCT01910116|453707699|FG000|Overall Study|Protocol Violation|1|||
126112390|NCT01910116|453707700|FG001|Overall Study|Protocol Violation|2|||
125926565|NCT03129100|453027500|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926566|NCT03129100|453027501|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926567|NCT03129100|453027502|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
125926568|NCT03129100|453027503|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926569|NCT03129100|453027504|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
126112391|NCT01910116|453707699|FG000|Overall Study|Withdrawal by Subject|8|||
126112392|NCT01910116|453707700|FG001|Overall Study|Withdrawal by Subject|3|||
126112393|NCT01910116|453707699|FG000|Overall Study|uncertain allocation|1|||
126112394|NCT01910116|453707700|FG001|Overall Study|uncertain allocation|3|||
126112395|NCT01910116|453707699|FG000|Overall Study|incomplete data|0|||
126112396|NCT01910116|453707700|FG001|Overall Study|incomplete data|1|||
126112397|NCT02469896|453707701|FG000|Overall Study|Withdrawal by Subject|2|||
126112398|NCT02469896|453707702|FG001|Overall Study|Withdrawal by Subject|0|||
126112399|NCT01130974|453707703|FG000|Overall Study|Protocol Violation|10|||
126112400|NCT01130974|453707704|FG001|Overall Study|Protocol Violation|10|||
126112401|NCT01130974|453707703|FG000|Overall Study|Withdrawal by Subject|0|||
126112402|NCT01130974|453707704|FG001|Overall Study|Withdrawal by Subject|1|||
125926570|NCT03129100|453027505|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926571|NCT03129100|453027506|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926572|NCT03129100|453027507|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926573|NCT03129100|453027508|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926574|NCT03129100|453027509|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926575|NCT03129100|453027510|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125926576|NCT03129100|453027485|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926577|NCT03129100|453027486|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926578|NCT03129100|453027487|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926579|NCT03129100|453027488|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926580|NCT03129100|453027489|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926581|NCT03129100|453027490|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926582|NCT03129100|453027491|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926583|NCT03129100|453027492|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926584|NCT03129100|453027493|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926585|NCT03129100|453027494|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926586|NCT03129100|453027495|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926587|NCT03129100|453027496|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926588|NCT03129100|453027497|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926589|NCT03129100|453027498|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926590|NCT03129100|453027499|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926591|NCT03129100|453027500|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926592|NCT03129100|453027501|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926593|NCT03129100|453027502|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926594|NCT03129100|453027503|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926595|NCT03129100|453027504|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926596|NCT03129100|453027505|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
125926597|NCT03129100|453027506|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926598|NCT03129100|453027507|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926599|NCT03129100|453027508|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926600|NCT03129100|453027509|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926601|NCT03129100|453027510|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125926602|NCT03129100|453027485|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
125926603|NCT03129100|453027486|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
125926604|NCT03129100|453027487|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
125926605|NCT03129100|453027488|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
125926606|NCT03129100|453027489|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
125926607|NCT03129100|453027490|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
125926608|NCT03129100|453027491|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
125926609|NCT03129100|453027492|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
125926610|NCT03129100|453027493|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
125926611|NCT03129100|453027494|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
125926612|NCT03129100|453027495|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
125926613|NCT03129100|453027496|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
125926614|NCT03129100|453027497|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
125926615|NCT03129100|453027498|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
125926616|NCT03129100|453027499|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
125926617|NCT03129100|453027500|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
125926618|NCT03129100|453027501|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
125926619|NCT03129100|453027502|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
125926620|NCT03129100|453027503|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
125926621|NCT03129100|453027504|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
125926622|NCT03129100|453027505|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
125926623|NCT03129100|453027506|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
125926624|NCT03129100|453027507|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
125926625|NCT03129100|453027508|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
125926626|NCT03129100|453027509|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
125926627|NCT03129100|453027510|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
125926628|NCT03129100|453027485|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926629|NCT03129100|453027486|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926630|NCT03129100|453027487|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926631|NCT03129100|453027488|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926632|NCT03129100|453027489|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926633|NCT03129100|453027490|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926634|NCT03129100|453027491|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926635|NCT03129100|453027492|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926636|NCT03129100|453027493|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926637|NCT03129100|453027494|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926638|NCT03129100|453027495|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926639|NCT03129100|453027496|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926640|NCT03129100|453027497|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926641|NCT03129100|453027498|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926642|NCT03129100|453027499|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926643|NCT03129100|453027500|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926644|NCT03129100|453027501|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926645|NCT03129100|453027502|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926646|NCT03129100|453027503|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926647|NCT03129100|453027504|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926648|NCT03129100|453027505|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
125926649|NCT03129100|453027506|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926650|NCT03129100|453027507|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926651|NCT03129100|453027508|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926652|NCT03129100|453027509|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926653|NCT03129100|453027510|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125926654|NCT03129100|453027485|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
125926655|NCT03129100|453027486|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
125926656|NCT03129100|453027487|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
125926657|NCT03129100|453027488|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
125926658|NCT03129100|453027489|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
125926659|NCT03129100|453027490|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
125926660|NCT03129100|453027491|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
125926661|NCT03129100|453027492|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
125926662|NCT03129100|453027493|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
125926663|NCT03129100|453027494|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
125926664|NCT03129100|453027495|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
125926665|NCT03129100|453027496|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
125926666|NCT03129100|453027497|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
125926667|NCT03129100|453027498|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
125926668|NCT03129100|453027499|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
125926669|NCT03129100|453027500|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
125926670|NCT03129100|453027501|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
125926671|NCT03129100|453027502|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
125926672|NCT03129100|453027503|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
125926673|NCT03129100|453027504|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
125926674|NCT03129100|453027505|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
125926675|NCT03129100|453027506|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
125926676|NCT03129100|453027507|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
125926677|NCT03129100|453027508|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
125926678|NCT03129100|453027509|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
125926679|NCT03129100|453027510|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
125926680|NCT03129100|453027485|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926681|NCT03129100|453027486|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926682|NCT03129100|453027487|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926683|NCT03129100|453027488|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926684|NCT03129100|453027489|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926685|NCT03129100|453027490|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926686|NCT03129100|453027491|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926687|NCT03129100|453027492|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926688|NCT03129100|453027493|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926689|NCT03129100|453027494|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926690|NCT03129100|453027495|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926691|NCT03129100|453027496|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926692|NCT03129100|453027497|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926693|NCT03129100|453027498|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926694|NCT03129100|453027499|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926695|NCT03129100|453027500|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926696|NCT03129100|453027501|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926697|NCT03129100|453027502|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926698|NCT03129100|453027503|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926699|NCT03129100|453027504|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926700|NCT03129100|453027505|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926701|NCT03129100|453027506|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926702|NCT03129100|453027507|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926703|NCT03129100|453027508|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125926704|NCT03129100|453027509|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
125926705|NCT03129100|453027510|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
125926706|NCT03129100|453027485|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126065108|NCT01322347|453530676|FG000|Overall Study|sponsor decision|1|||
125926707|NCT03129100|453027486|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126065109|NCT01322347|453530677|FG001|Overall Study|sponsor decision|3|||
126112403|NCT01130974|453707703|FG000|Overall Study|Ineligibility criteria|5|||
126112404|NCT01130974|453707704|FG001|Overall Study|Ineligibility criteria|2|||
126112405|NCT02536755|453707705|FG000|Overall Study|Adverse Event|4|||
126112406|NCT02301936|453707706|FG000|Overall Study|Lost to Follow-up|1|||
126112407|NCT02301936|453707707|FG001|Overall Study|Lost to Follow-up|0|||
126112408|NCT04014361|453707710|FG000|Period 2|Physician Decision|0|||
126112409|NCT04014361|453707711|FG001|Period 2|Physician Decision|0|||
126112410|NCT04014361|453707712|FG002|Period 2|Physician Decision|0|||
126112411|NCT04014361|453707713|FG003|Period 2|Physician Decision|1|||
126112412|NCT04014361|453707714|FG004|Period 2|Physician Decision|0|||
126112413|NCT04014361|453707715|FG005|Period 2|Physician Decision|0|||
126112414|NCT04014361|453707716|FG006|Period 2|Physician Decision|0|||
126112415|NCT04014361|453707717|FG007|Period 2|Physician Decision|0|||
126112416|NCT03610165|453707723|FG000|Overall Study|Device didn't work|0|||
126112417|NCT03610165|453707724|FG001|Overall Study|Device didn't work|1|||
126112418|NCT01810016|453707725|FG000|Overall Study|Progressive disease|1|||
126112419|NCT01810016|453707726|FG001|Overall Study|Progressive disease|1|||
126112420|NCT01810016|453707727|FG002|Overall Study|Progressive disease|0|||
126112421|NCT01810016|453707725|FG000|Overall Study|Death|0|||
126112422|NCT01810016|453707726|FG001|Overall Study|Death|0|||
126112423|NCT01810016|453707727|FG002|Overall Study|Death|1|||
126112424|NCT03828292|453707728|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126112425|NCT03828292|453707729|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
126112426|NCT03828292|453707730|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126112427|NCT03828292|453707731|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126112428|NCT03828292|453707732|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126112429|NCT03828292|453707733|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126112430|NCT03828292|453707728|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126112431|NCT03828292|453707729|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126112432|NCT03828292|453707730|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
126112433|NCT03828292|453707731|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126112434|NCT03828292|453707732|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126112435|NCT03828292|453707733|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126112436|NCT03828292|453707728|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126112437|NCT03828292|453707729|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126112438|NCT03828292|453707730|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126112439|NCT03828292|453707731|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
126112440|NCT03828292|453707732|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126112441|NCT03828292|453707733|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126112442|NCT03828292|453707728|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126112443|NCT03828292|453707729|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126112444|NCT03828292|453707730|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126112445|NCT03828292|453707731|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
126112446|NCT03828292|453707732|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126112447|NCT03828292|453707733|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126112448|NCT03828292|453707728|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
126112449|NCT03828292|453707729|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
126112450|NCT03828292|453707730|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
126112451|NCT03828292|453707731|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
126112452|NCT03828292|453707732|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
126112453|NCT03828292|453707733|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
126112454|NCT04667247|453707736|FG000|Overall Study|Withdrawal by Subject|0|||
126112455|NCT04667247|453707737|FG001|Overall Study|Withdrawal by Subject|1|||
126112456|NCT06950879|453707738|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
126112457|NCT01436071|453709434|FG000|Overall Study|Adverse Event|1|||
126112458|NCT01436071|453709435|FG001|Overall Study|Adverse Event|0|||
126112459|NCT01436071|453709434|FG000|Overall Study|Lack of Efficacy|16|||
126112460|NCT01436071|453709435|FG001|Overall Study|Lack of Efficacy|7|||
126112461|NCT01436071|453709434|FG000|Overall Study|Protocol Violation|0|||
126112462|NCT01436071|453709435|FG001|Overall Study|Protocol Violation|1|||
126112463|NCT01436071|453709434|FG000|Overall Study|Lost to Follow-up|3|||
126112464|NCT01436071|453709435|FG001|Overall Study|Lost to Follow-up|1|||
126112465|NCT01436071|453709434|FG000|Overall Study|Physician Decision|1|||
126112466|NCT01436071|453709435|FG001|Overall Study|Physician Decision|0|||
126112467|NCT01436071|453709434|FG000|Overall Study|Withdrawal by Subject|2|||
126112468|NCT01436071|453709435|FG001|Overall Study|Withdrawal by Subject|2|||
126112469|NCT01436071|453709434|FG000|Overall Study|Did Not Receive Trial Medication|3|||
126112470|NCT01436071|453709435|FG001|Overall Study|Did Not Receive Trial Medication|3|||
126112471|NCT01215175|453709444|FG000|Overall Study|Lost to Follow-up|0|||
126112472|NCT01215175|453709445|FG001|Overall Study|Lost to Follow-up|1|||
126112473|NCT01215175|453709446|FG002|Overall Study|Lost to Follow-up|0|||
126112474|NCT01215175|453709447|FG003|Overall Study|Lost to Follow-up|1|||
126112475|NCT01215175|453709448|FG004|Overall Study|Lost to Follow-up|0|||
125926708|NCT03129100|453027487|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926709|NCT03129100|453027488|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926710|NCT03129100|453027489|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926711|NCT03129100|453027490|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926712|NCT03129100|453027491|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926713|NCT03129100|453027492|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926714|NCT03129100|453027493|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926715|NCT03129100|453027494|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926716|NCT03129100|453027495|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926717|NCT03129100|453027496|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926718|NCT03129100|453027497|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926719|NCT03129100|453027498|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926720|NCT03129100|453027499|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926721|NCT03129100|453027500|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926722|NCT03129100|453027501|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926723|NCT03129100|453027502|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926724|NCT03129100|453027503|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926725|NCT03129100|453027504|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926726|NCT03129100|453027505|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926727|NCT03129100|453027506|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926728|NCT03129100|453027507|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125926729|NCT03129100|453027508|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
125926730|NCT03129100|453027509|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
125926731|NCT03129100|453027510|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
125926732|NCT03129100|453027485|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926733|NCT03129100|453027486|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926734|NCT03129100|453027487|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926735|NCT03129100|453027488|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926736|NCT03129100|453027489|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926737|NCT03129100|453027490|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926738|NCT03129100|453027491|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926739|NCT03129100|453027492|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926740|NCT03129100|453027493|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926741|NCT03129100|453027494|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926742|NCT03129100|453027495|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926743|NCT03129100|453027496|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926744|NCT03129100|453027497|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926745|NCT03129100|453027498|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926746|NCT03129100|453027499|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926747|NCT03129100|453027500|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926748|NCT03129100|453027501|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926749|NCT03129100|453027502|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926750|NCT03129100|453027503|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926751|NCT03129100|453027504|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926752|NCT03129100|453027505|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926753|NCT03129100|453027506|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926754|NCT03129100|453027507|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926755|NCT03129100|453027508|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926756|NCT03129100|453027509|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
125926757|NCT03129100|453027510|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125926758|NCT03129100|453027485|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926759|NCT03129100|453027486|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926760|NCT03129100|453027487|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926761|NCT03129100|453027488|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926762|NCT03129100|453027489|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926763|NCT03129100|453027490|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926764|NCT03129100|453027491|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926765|NCT03129100|453027492|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926766|NCT03129100|453027493|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926767|NCT03129100|453027494|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926768|NCT03129100|453027495|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926769|NCT03129100|453027496|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926770|NCT03129100|453027497|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126065110|NCT01322347|453530676|FG000|Overall Study|ineligible|6|||
126065111|NCT01322347|453530677|FG001|Overall Study|ineligible|3|||
126065112|NCT01322347|453530676|FG000|Overall Study|kidney transplant|3|||
125926771|NCT03129100|453027498|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926772|NCT03129100|453027499|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926773|NCT03129100|453027500|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926774|NCT03129100|453027501|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926775|NCT03129100|453027502|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926776|NCT03129100|453027503|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926777|NCT03129100|453027504|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926778|NCT03129100|453027505|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926779|NCT03129100|453027506|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926780|NCT03129100|453027507|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926781|NCT03129100|453027508|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926782|NCT03129100|453027509|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125926783|NCT03129100|453027510|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
125926784|NCT03129100|453027485|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
125926785|NCT03129100|453027486|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
125926786|NCT03129100|453027487|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
125926787|NCT03129100|453027488|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
125926788|NCT03129100|453027489|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
125926789|NCT03129100|453027490|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
125926790|NCT03129100|453027491|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
125926791|NCT03129100|453027492|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
125926792|NCT03129100|453027493|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
125926793|NCT03129100|453027494|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
125926794|NCT03129100|453027495|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
125926795|NCT03129100|453027496|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
125926796|NCT03129100|453027497|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
125926797|NCT03129100|453027498|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
125926798|NCT03129100|453027499|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
125926799|NCT03129100|453027500|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
125926800|NCT03129100|453027501|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
125926801|NCT03129100|453027502|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
125926802|NCT03129100|453027503|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
125926803|NCT03129100|453027504|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
125926804|NCT03129100|453027505|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
125926805|NCT03129100|453027506|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
125926806|NCT03129100|453027507|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
125926807|NCT03129100|453027508|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
125926808|NCT03129100|453027509|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
125926809|NCT03129100|453027510|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
125926810|NCT01587001|453027511|FG000|Overall Study|Lost to Follow-up|2|||
125926811|NCT01587001|453027512|FG001|Overall Study|Lost to Follow-up|0|||
125926812|NCT01587001|453027511|FG000|Overall Study|Insufficient samples to complete testing|4|||
125926813|NCT01587001|453027512|FG001|Overall Study|Insufficient samples to complete testing|1|||
125926814|NCT03845985|453027513|FG000|Overall Study|Lost to Follow-up|2|||
125926815|NCT03845985|453027514|FG001|Overall Study|Lost to Follow-up|1|||
125926816|NCT03845985|453027513|FG000|Overall Study|Physician Decision|1|||
125926817|NCT03845985|453027514|FG001|Overall Study|Physician Decision|0|||
125926818|NCT03845985|453027513|FG000|Overall Study|Withdrawal by Subject|4|||
125926819|NCT03845985|453027514|FG001|Overall Study|Withdrawal by Subject|1|||
125926820|NCT03334539|453027517|FG000|Overall Study|Adverse Event|3|||
125926821|NCT03334539|453027518|FG001|Overall Study|Adverse Event|5|||
125926822|NCT03334539|453027519|FG002|Overall Study|Adverse Event|0|||
126065113|NCT01322347|453530677|FG001|Overall Study|kidney transplant|1|||
126065114|NCT01322347|453530676|FG000|Overall Study|study drug withheld > 12 wks|0|||
126065115|NCT01322347|453530677|FG001|Overall Study|study drug withheld > 12 wks|1|||
126065116|NCT01322347|453530676|FG000|Overall Study|moved/changed dialysis|2|||
126065117|NCT01322347|453530677|FG001|Overall Study|moved/changed dialysis|4|||
126065118|NCT01369147|453530679|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
126065119|NCT01369147|453530680|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
125926823|NCT03334539|453027517|FG000|Overall Study|Withdrawal by Subject|0|||
125926824|NCT03334539|453027518|FG001|Overall Study|Withdrawal by Subject|1|||
125926825|NCT03334539|453027519|FG002|Overall Study|Withdrawal by Subject|1|||
126065120|NCT01369147|453530681|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
126065121|NCT04239911|453530682|FG000|Overall Study|Lost to Follow-up|2|||
126065122|NCT04239911|453530683|FG001|Overall Study|Lost to Follow-up|1|||
126065123|NCT03345407|453530688|FG000|Overall Study|Withdrawal by Subject|11|||
125926826|NCT03334539|453027517|FG000|Overall Study|Administrative Reasons|1|||
125926827|NCT03334539|453027518|FG001|Overall Study|Administrative Reasons|0|||
125926828|NCT03334539|453027519|FG002|Overall Study|Administrative Reasons|0|||
126065124|NCT03345407|453530689|FG001|Overall Study|Withdrawal by Subject|1|||
126065125|NCT03345407|453530690|FG002|Overall Study|Withdrawal by Subject|5|||
126065126|NCT03345407|453530691|FG003|Overall Study|Withdrawal by Subject|6|||
126065127|NCT03345407|453530692|FG004|Overall Study|Withdrawal by Subject|3|||
125926829|NCT03334539|453027517|FG000|Overall Study|Hypertension Not Controlled|0|||
125926830|NCT03334539|453027518|FG001|Overall Study|Hypertension Not Controlled|1|||
125926831|NCT03334539|453027519|FG002|Overall Study|Hypertension Not Controlled|0|||
125926832|NCT00968201|453027520|FG000|Base Study - (Period II)|Adverse Event|8|||
125926833|NCT00968201|453027521|FG001|Base Study - (Period II)|Adverse Event|0|||
125926834|NCT00968201|453027522|FG002|Base Study - (Period II)|Adverse Event|16|||
125926835|NCT00968201|453027520|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
125926836|NCT00968201|453027521|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
125926837|NCT00968201|453027522|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
125926838|NCT00968201|453027520|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
125926839|NCT00968201|453027521|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
125926840|NCT00968201|453027522|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
125926841|NCT00968201|453027520|FG000|Base Study - (Period II)|Protocol Violation|12|||
125926842|NCT00968201|453027521|FG001|Base Study - (Period II)|Protocol Violation|0|||
125926843|NCT00968201|453027522|FG002|Base Study - (Period II)|Protocol Violation|12|||
125926844|NCT00968201|453027520|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
125926845|NCT00968201|453027521|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
125926846|NCT00968201|453027522|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
125926847|NCT00968201|453027520|FG000|Base Study - (Period II)|Site Error|0|||
125926848|NCT00968201|453027521|FG001|Base Study - (Period II)|Site Error|0|||
125926849|NCT00968201|453027522|FG002|Base Study - (Period II)|Site Error|1|||
125926850|NCT00968201|453027520|FG000|Extension Study - (Period III)|Adverse Event|0|||
125926851|NCT00968201|453027521|FG001|Extension Study - (Period III)|Adverse Event|5|||
125926852|NCT00968201|453027522|FG002|Extension Study - (Period III)|Adverse Event|22|||
125926853|NCT00968201|453027520|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
125926854|NCT00968201|453027521|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
125926855|NCT00968201|453027522|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
125926856|NCT00968201|453027520|FG000|Extension Study - (Period III)|Protocol Violation|0|||
125926857|NCT00968201|453027521|FG001|Extension Study - (Period III)|Protocol Violation|17|||
125926858|NCT00968201|453027522|FG002|Extension Study - (Period III)|Protocol Violation|14|||
125926859|NCT00968201|453027520|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
125926860|NCT00968201|453027521|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
125926861|NCT00968201|453027522|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
125926862|NCT00968201|453027520|FG000|Extension Study - (Period III)|Patient Relocated|0|||
125926863|NCT00968201|453027521|FG001|Extension Study - (Period III)|Patient Relocated|1|||
125926864|NCT00968201|453027522|FG002|Extension Study - (Period III)|Patient Relocated|1|||
125926865|NCT00968201|453027520|FG000|Extension Study - (Period III)|Noncompliance|0|||
125926866|NCT00968201|453027521|FG001|Extension Study - (Period III)|Noncompliance|0|||
125926867|NCT00968201|453027522|FG002|Extension Study - (Period III)|Noncompliance|3|||
125926868|NCT00968201|453027520|FG000|Extension Study - (Period III)|Other|0|||
125926869|NCT00968201|453027521|FG001|Extension Study - (Period III)|Other|0|||
125926870|NCT00968201|453027522|FG002|Extension Study - (Period III)|Other|2|||
125926871|NCT00968201|453027520|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
125926872|NCT00968201|453027521|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
125926873|NCT00968201|453027522|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
125926874|NCT04974697|453027523|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
125926875|NCT04974697|453027523|FG000|Overall Study|Lens discomfort|1|||
125926876|NCT03706456|453027525|FG000|Overall Study|Adverse Event|1|||
125926877|NCT03706456|453027525|FG000|Overall Study|Lack of Efficacy|2|||
125926878|NCT02784431|453027526|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
125926879|NCT02784431|453027526|FG000|Overall Study|Early Study Termination|19|||
125926880|NCT03302234|453027529|FG000|Overall Study|Death|191|||
125926881|NCT03302234|453027530|FG001|Overall Study|Death|192|||
125926882|NCT03302234|453027529|FG000|Overall Study|Withdrawal by Subject|2|||
125926883|NCT03302234|453027530|FG001|Overall Study|Withdrawal by Subject|2|||
125926884|NCT03302234|453027529|FG000|Overall Study|Sponsor Decision|90|||
125926885|NCT03302234|453027530|FG001|Overall Study|Sponsor Decision|89|||
125926886|NCT03302234|453027529|FG000|Overall Study|Laryngeal carcinoma|0|||
125926887|NCT03302234|453027530|FG001|Overall Study|Laryngeal carcinoma|1|||
125926888|NCT03302234|453027529|FG000|Overall Study|Not Reported|1|||
125926889|NCT03302234|453027530|FG001|Overall Study|Not Reported|0|||
125926890|NCT02795832|453027531|FG000|Overall Study|Adverse Event|0|||
125926891|NCT02795832|453027532|FG001|Overall Study|Adverse Event|0|||
125926892|NCT02795832|453027533|FG002|Overall Study|Adverse Event|0|||
125926893|NCT02795832|453027534|FG003|Overall Study|Adverse Event|0|||
125926894|NCT02795832|453027535|FG004|Overall Study|Adverse Event|0|||
125926895|NCT02795832|453027536|FG005|Overall Study|Adverse Event|3|||
125926896|NCT04523220|453027537|FG000|Main Treatment Period|Physician Decision|1|||
125926897|NCT04523220|453027538|FG001|Main Treatment Period|Physician Decision|1|||
125926898|NCT04523220|453027539|FG002|Main Treatment Period|Physician Decision|0|||
125926899|NCT04523220|453027537|FG000|Main Treatment Period|Other|5|||
125926900|NCT04523220|453027538|FG001|Main Treatment Period|Other|2|||
125926901|NCT04523220|453027539|FG002|Main Treatment Period|Other|4|||
125926902|NCT04523220|453027537|FG000|Main Treatment Period|Subject Decision|5|||
125926903|NCT04523220|453027538|FG001|Main Treatment Period|Subject Decision|7|||
125926904|NCT04523220|453027539|FG002|Main Treatment Period|Subject Decision|3|||
125926905|NCT04523220|453027537|FG000|Main Treatment Period|Death|5|||
125926906|NCT04523220|453027538|FG001|Main Treatment Period|Death|11|||
125926907|NCT04523220|453027539|FG002|Main Treatment Period|Death|4|||
125926908|NCT04523220|453027537|FG000|Main Treatment Period|Adverse Event|11|||
125926909|NCT04523220|453027538|FG001|Main Treatment Period|Adverse Event|9|||
125926910|NCT04523220|453027539|FG002|Main Treatment Period|Adverse Event|9|||
125926911|NCT04523220|453027537|FG000|Main Treatment Period|Withdrawal by Subject|3|||
125926912|NCT04523220|453027538|FG001|Main Treatment Period|Withdrawal by Subject|3|||
125926913|NCT04523220|453027539|FG002|Main Treatment Period|Withdrawal by Subject|4|||
125926914|NCT04523220|453027537|FG000|Main Treatment Period|Study drug never adminstered|10|||
125926915|NCT04523220|453027538|FG001|Main Treatment Period|Study drug never adminstered|3|||
125926916|NCT04523220|453027539|FG002|Main Treatment Period|Study drug never adminstered|5|||
125926917|NCT04523220|453027537|FG000|Extension Treatment Period|Physician Decision|1|||
125926918|NCT04523220|453027538|FG001|Extension Treatment Period|Physician Decision|0|||
125926919|NCT04523220|453027539|FG002|Extension Treatment Period|Physician Decision|3|||
125926920|NCT04523220|453027537|FG000|Extension Treatment Period|Other|2|||
125926921|NCT04523220|453027538|FG001|Extension Treatment Period|Other|6|||
125926922|NCT04523220|453027539|FG002|Extension Treatment Period|Other|6|||
125926923|NCT04523220|453027537|FG000|Extension Treatment Period|Subject Decision|5|||
125926924|NCT04523220|453027538|FG001|Extension Treatment Period|Subject Decision|2|||
125926925|NCT04523220|453027539|FG002|Extension Treatment Period|Subject Decision|4|||
125926926|NCT04523220|453027537|FG000|Extension Treatment Period|Death|6|||
125926927|NCT04523220|453027538|FG001|Extension Treatment Period|Death|4|||
125926928|NCT04523220|453027539|FG002|Extension Treatment Period|Death|7|||
125926929|NCT04523220|453027537|FG000|Extension Treatment Period|Adverse Event|6|||
125926930|NCT04523220|453027538|FG001|Extension Treatment Period|Adverse Event|7|||
125926931|NCT04523220|453027539|FG002|Extension Treatment Period|Adverse Event|9|||
125926932|NCT04523220|453027537|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
125926933|NCT04523220|453027538|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
125926934|NCT04523220|453027539|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
125926935|NCT04523220|453027537|FG000|Extension Treatment Period|Study drug never administered|0|||
125926936|NCT04523220|453027538|FG001|Extension Treatment Period|Study drug never administered|1|||
125926937|NCT04523220|453027539|FG002|Extension Treatment Period|Study drug never administered|0|||
125926938|NCT00256750|453027542|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
125926939|NCT00256750|453027543|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
125926940|NCT00256750|453027544|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
125926941|NCT00256750|453027542|FG000|Transplanted Pre-Treatment|Other|2|||
125926942|NCT00256750|453027543|FG001|Transplanted Pre-Treatment|Other|0|||
125926943|NCT00256750|453027544|FG002|Transplanted Pre-Treatment|Other|0|||
125926944|NCT00256750|453027542|FG000|Transplanted Pre-Treatment|Death|1|||
125926945|NCT00256750|453027543|FG001|Transplanted Pre-Treatment|Death|0|||
125926946|NCT00256750|453027544|FG002|Transplanted Pre-Treatment|Death|0|||
125926947|NCT00256750|453027542|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
125926948|NCT00256750|453027543|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
125926949|NCT00256750|453027544|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
125926950|NCT00256750|453027542|FG000|Post-Transplant Treated (12 Months)|Death|3|||
125926951|NCT00256750|453027543|FG001|Post-Transplant Treated (12 Months)|Death|2|||
125926952|NCT00256750|453027544|FG002|Post-Transplant Treated (12 Months)|Death|4|||
125926953|NCT00256750|453027542|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
125926954|NCT00256750|453027543|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
125926955|NCT00256750|453027544|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
125926956|NCT00256750|453027542|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
125926957|NCT00256750|453027543|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
125926958|NCT00256750|453027544|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
125926959|NCT00256750|453027542|FG000|Post-Transplant Treated (12 Months)|Other|5|||
125926960|NCT00256750|453027543|FG001|Post-Transplant Treated (12 Months)|Other|4|||
125926961|NCT00256750|453027544|FG002|Post-Transplant Treated (12 Months)|Other|2|||
125926962|NCT00256750|453027542|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
125926963|NCT00256750|453027543|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
125926964|NCT00256750|453027544|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
125926965|NCT00256750|453027542|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
125926966|NCT00256750|453027543|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
125926967|NCT00256750|453027544|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
125926968|NCT00256750|453027542|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
125926969|NCT00256750|453027543|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
125926970|NCT00256750|453027544|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
125926971|NCT00256750|453027542|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
125926972|NCT00256750|453027543|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
125926973|NCT00256750|453027544|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
125926974|NCT00256750|453027542|FG000|Post-Transplant Treated (24 Months)|Death|3|||
125926975|NCT00256750|453027543|FG001|Post-Transplant Treated (24 Months)|Death|0|||
125926976|NCT00256750|453027544|FG002|Post-Transplant Treated (24 Months)|Death|0|||
125926977|NCT00256750|453027542|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
125926978|NCT00256750|453027543|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
125926979|NCT00256750|453027544|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
125926980|NCT00256750|453027542|FG000|Post-Transplant Treated (24 Months)|Other|2|||
125926981|NCT00256750|453027543|FG001|Post-Transplant Treated (24 Months)|Other|0|||
125926982|NCT00256750|453027544|FG002|Post-Transplant Treated (24 Months)|Other|1|||
125926983|NCT00256750|453027542|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
125926984|NCT00256750|453027543|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
125926985|NCT00256750|453027544|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
125926986|NCT00256750|453027542|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
125926987|NCT00256750|453027543|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
125926988|NCT00256750|453027544|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
125926989|NCT00256750|453027542|FG000|Post-Transplant Treated (36 Months)|Death|0|||
125926990|NCT00256750|453027543|FG001|Post-Transplant Treated (36 Months)|Death|2|||
125926991|NCT00256750|453027544|FG002|Post-Transplant Treated (36 Months)|Death|1|||
125926992|NCT00256750|453027542|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
125926993|NCT00256750|453027543|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
125926994|NCT00256750|453027544|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
125926995|NCT00256750|453027542|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
125926996|NCT00256750|453027543|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
125926997|NCT00256750|453027544|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
125926998|NCT00256750|453027542|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
125926999|NCT00256750|453027543|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
125927000|NCT00256750|453027544|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
125927001|NCT00256750|453027542|FG000|Post-Transplant Treated (36 Months)|Other|0|||
125927002|NCT00256750|453027543|FG001|Post-Transplant Treated (36 Months)|Other|1|||
125927003|NCT00256750|453027544|FG002|Post-Transplant Treated (36 Months)|Other|1|||
125927004|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
125927005|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
125927006|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
125927007|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
125927008|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
125927009|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
125927010|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
125927011|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
125927012|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
125927013|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
125927014|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
125927015|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
125927016|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
125927017|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
125927018|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
125927019|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
125927020|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
125927021|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
125927022|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
125927023|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
125927024|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
125927025|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
125927026|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
125927027|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
125927028|NCT00256750|453027542|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
125927029|NCT00256750|453027543|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
125927030|NCT00256750|453027544|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
125927031|NCT01197560|453027545|FG000|Overall Study|Adverse Event|6|||
125927032|NCT01197560|453027546|FG001|Overall Study|Adverse Event|8|||
125927033|NCT01197560|453027545|FG000|Overall Study|Death|3|||
125927034|NCT01197560|453027546|FG001|Overall Study|Death|5|||
125927035|NCT01197560|453027545|FG000|Overall Study|Withdrawal by Subject|1|||
125927036|NCT01197560|453027546|FG001|Overall Study|Withdrawal by Subject|1|||
125927037|NCT01197560|453027545|FG000|Overall Study|Disease progression|40|||
125927038|NCT01197560|453027546|FG001|Overall Study|Disease progression|35|||
125927039|NCT01197560|453027545|FG000|Overall Study|Miscellaneous|4|||
125927040|NCT01197560|453027546|FG001|Overall Study|Miscellaneous|3|||
125927041|NCT01197560|453027545|FG000|Overall Study|Missing|0|||
125927042|NCT01197560|453027546|FG001|Overall Study|Missing|1|||
125927043|NCT02006719|453027547|FG000|Overall Study|Withdrawal by Subject|10|||
125927044|NCT02006719|453027548|FG001|Overall Study|Withdrawal by Subject|2|||
125927045|NCT02006719|453027547|FG000|Overall Study|Lost to Follow-up|5|||
125927046|NCT02006719|453027548|FG001|Overall Study|Lost to Follow-up|1|||
125927047|NCT02006719|453027547|FG000|Overall Study|Protocol Violation|2|||
125927048|NCT02006719|453027548|FG001|Overall Study|Protocol Violation|0|||
125927049|NCT02006719|453027547|FG000|Overall Study|Adverse Event|1|||
125927050|NCT02006719|453027548|FG001|Overall Study|Adverse Event|1|||
125927051|NCT02006719|453027547|FG000|Overall Study|Other/Unknown|0|||
125927052|NCT02006719|453027548|FG001|Overall Study|Other/Unknown|1|||
125927053|NCT04659161|453027549|FG000|Overall Study|Adverse Event|10|||
125927054|NCT04659161|453027550|FG001|Overall Study|Adverse Event|6|||
125927055|NCT04659161|453027549|FG000|Overall Study|Withdrawal by Subject|13|||
125927056|NCT04659161|453027550|FG001|Overall Study|Withdrawal by Subject|12|||
125927057|NCT04659161|453027549|FG000|Overall Study|Other|9|||
125927058|NCT04659161|453027550|FG001|Overall Study|Other|8|||
125927059|NCT02197130|453027551|FG000|Overall Study|Adverse Event|13|||
125927060|NCT02197130|453027552|FG001|Overall Study|Adverse Event|4|||
125927061|NCT02197130|453027553|FG002|Overall Study|Adverse Event|23|||
125927062|NCT02197130|453027551|FG000|Overall Study|Death|0|||
125927063|NCT02197130|453027552|FG001|Overall Study|Death|1|||
125927064|NCT02197130|453027553|FG002|Overall Study|Death|0|||
125927065|NCT02197130|453027551|FG000|Overall Study|Lost to Follow-up|2|||
125927066|NCT02197130|453027552|FG001|Overall Study|Lost to Follow-up|0|||
125927067|NCT02197130|453027553|FG002|Overall Study|Lost to Follow-up|1|||
125927068|NCT02197130|453027551|FG000|Overall Study|Does not meet entrance criteria|0|||
125927069|NCT02197130|453027552|FG001|Overall Study|Does not meet entrance criteria|0|||
125927070|NCT02197130|453027553|FG002|Overall Study|Does not meet entrance criteria|1|||
125927071|NCT02197130|453027551|FG000|Overall Study|Withdrawal by Subject|0|||
125927072|NCT02197130|453027552|FG001|Overall Study|Withdrawal by Subject|3|||
125927073|NCT02197130|453027553|FG002|Overall Study|Withdrawal by Subject|4|||
125927074|NCT02197130|453027551|FG000|Overall Study|Other|1|||
125927075|NCT02197130|453027552|FG001|Overall Study|Other|0|||
125927076|NCT02197130|453027553|FG002|Overall Study|Other|3|||
125927077|NCT03338998|453027555|FG000|Treatment Period|Withdrawal by Subject|1|||
125927078|NCT03338998|453027556|FG001|Treatment Period|Withdrawal by Subject|1|||
125927079|NCT03338998|453027555|FG000|Treatment Period|Adverse Event|0|||
125927080|NCT03338998|453027556|FG001|Treatment Period|Adverse Event|2|||
125927081|NCT03338998|453027555|FG000|Treatment Period|Protocol deviation|1|||
125927082|NCT03338998|453027556|FG001|Treatment Period|Protocol deviation|0|||
125927083|NCT03338998|453027555|FG000|Treatment Period|Physician Decision|2|||
125927084|NCT03338998|453027556|FG001|Treatment Period|Physician Decision|0|||
125927085|NCT03338998|453027555|FG000|Treatment Period|Subject failed swallow test|4|||
125927086|NCT03338998|453027556|FG001|Treatment Period|Subject failed swallow test|0|||
125927087|NCT03338998|453027555|FG000|Safety Follow-Up Period|Adverse Event|0|||
125927088|NCT03338998|453027556|FG001|Safety Follow-Up Period|Adverse Event|1|||
125927089|NCT03338998|453027555|FG000|Safety Follow-Up Period|Protocol deviation|1|||
125927090|NCT03338998|453027556|FG001|Safety Follow-Up Period|Protocol deviation|0|||
125927091|NCT03338998|453027555|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
125927092|NCT03338998|453027556|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
125927093|NCT03288129|453027557|FG000|Overall Study|Adverse Event|10|||
125927094|NCT03288129|453027557|FG000|Overall Study|Lost to Follow-up|3|||
125927095|NCT03288129|453027557|FG000|Overall Study|Withdrawal by Subject|3|||
125927096|NCT03288129|453027557|FG000|Overall Study|Withdrawal of consent/assent|1|||
125927097|NCT03288129|453027557|FG000|Overall Study|Other|5|||
125927098|NCT00558558|453027562|FG000|Overall Study|Unable to swallow|1|||
125927099|NCT00558558|453027562|FG000|Overall Study|Withdrawal by Subject|1|||
125927100|NCT00558558|453027562|FG000|Overall Study|Lack of Efficacy|4|||
125927101|NCT01473836|453029407|FG000|Overall Study|Adverse Event|4|||
125927102|NCT01473836|453029407|FG000|Overall Study|Lack of Efficacy|1|||
125927103|NCT01473836|453029407|FG000|Overall Study|Does not meet entrance criteria|1|||
125927104|NCT03364023|453029408|FG000|Overall Study|Lost to Follow-up|3|||
125927105|NCT03364023|453029408|FG000|Overall Study|Death|14|||
125927106|NCT00105469|453029411|FG000|Overall Study|Adverse Event|9|||
125927107|NCT00105469|453029412|FG001|Overall Study|Adverse Event|8|||
125927108|NCT00105469|453029411|FG000|Overall Study|Protocol Violation|4|||
125927109|NCT00105469|453029412|FG001|Overall Study|Protocol Violation|0|||
125927110|NCT00105469|453029411|FG000|Overall Study|Withdrawal by Subject|2|||
125927111|NCT00105469|453029412|FG001|Overall Study|Withdrawal by Subject|3|||
125927112|NCT00105469|453029411|FG000|Overall Study|Lost to Follow-up|1|||
125927113|NCT00105469|453029412|FG001|Overall Study|Lost to Follow-up|0|||
125927114|NCT00105469|453029411|FG000|Overall Study|Lack of Efficacy|2|||
125927115|NCT00105469|453029412|FG001|Overall Study|Lack of Efficacy|0|||
125927116|NCT00105469|453029411|FG000|Overall Study|Other Reason|4|||
125927117|NCT00105469|453029412|FG001|Overall Study|Other Reason|0|||
125927118|NCT03808545|453029414|FG000|Overall Study|Withdrawal by Subject|1|||
125927119|NCT03808545|453029415|FG001|Overall Study|Withdrawal by Subject|1|||
125927120|NCT00980057|453029420|FG000|Overall Study|Death|13|||
125927121|NCT00980057|453029421|FG001|Overall Study|Death|3|||
125927122|NCT00980057|453029420|FG000|Overall Study|Adverse Event|0|||
125927123|NCT00980057|453029421|FG001|Overall Study|Adverse Event|1|||
125927124|NCT00980057|453029420|FG000|Overall Study|Physician Decision|4|||
125927125|NCT00980057|453029421|FG001|Overall Study|Physician Decision|0|||
125927126|NCT00980057|453029420|FG000|Overall Study|Lost to Follow-up|1|||
125927127|NCT00980057|453029421|FG001|Overall Study|Lost to Follow-up|0|||
125927128|NCT00980057|453029420|FG000|Overall Study|Withdrawal by Subject|1|||
125927129|NCT00980057|453029421|FG001|Overall Study|Withdrawal by Subject|1|||
125927130|NCT04980040|453029422|FG000|Overall Study|Violated the Inclusion Criteria|260|||
125927131|NCT04980040|453029422|FG000|Overall Study|Violated the Administration & Dosage|225|||
125927132|NCT04980040|453029422|FG000|Overall Study|Lost to Safety-Follow-up|4|||
125927133|NCT04980040|453029422|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
125927134|NCT01315678|453029423|FG000|Overall Study|Withdrawal by Subject|7|||
125927135|NCT01315678|453029424|FG001|Overall Study|Withdrawal by Subject|3|||
125927136|NCT01315678|453029423|FG000|Overall Study|Adverse Event|3|||
125927137|NCT01315678|453029424|FG001|Overall Study|Adverse Event|1|||
125927138|NCT01315678|453029423|FG000|Overall Study|Lost to Follow-up|1|||
125927139|NCT01315678|453029424|FG001|Overall Study|Lost to Follow-up|0|||
125927140|NCT01315678|453029423|FG000|Overall Study|similar reason to those listed above|3|||
125927141|NCT01315678|453029424|FG001|Overall Study|similar reason to those listed above|2|||
125927142|NCT00062374|453029428|FG000|Overall Study|Not treated|12|||
125927143|NCT03555591|453029429|FG000|Overall Study|Protocol Violation|77|||
125927144|NCT01532414|453029430|FG000|Overall Study|Lost to Follow-up|3|||
125927145|NCT01532414|453029431|FG001|Overall Study|Lost to Follow-up|0|||
125927146|NCT01532414|453029432|FG002|Overall Study|Lost to Follow-up|1|||
125927147|NCT01532414|453029430|FG000|Overall Study|Withdrawal by Subject|3|||
125927148|NCT01532414|453029431|FG001|Overall Study|Withdrawal by Subject|0|||
125927149|NCT01532414|453029432|FG002|Overall Study|Withdrawal by Subject|0|||
125927150|NCT01532414|453029430|FG000|Overall Study|No V6 semen sample|0|||
125927151|NCT01532414|453029431|FG001|Overall Study|No V6 semen sample|1|||
125927152|NCT01532414|453029432|FG002|Overall Study|No V6 semen sample|0|||
125927153|NCT01532414|453029430|FG000|Overall Study|Adverse Event|0|||
125927154|NCT01532414|453029431|FG001|Overall Study|Adverse Event|1|||
125927155|NCT01532414|453029432|FG002|Overall Study|Adverse Event|1|||
125927156|NCT01532414|453029430|FG000|Overall Study|Unable to complete 24 hour PK|0|||
125927157|NCT01532414|453029431|FG001|Overall Study|Unable to complete 24 hour PK|0|||
125927158|NCT01532414|453029432|FG002|Overall Study|Unable to complete 24 hour PK|1|||
125927159|NCT01532414|453029430|FG000|Overall Study|Withdrawn by sponsor|1|||
125927160|NCT01532414|453029431|FG001|Overall Study|Withdrawn by sponsor|0|||
125927161|NCT01532414|453029432|FG002|Overall Study|Withdrawn by sponsor|0|||
125927162|NCT00187486|453029433|FG000|Overall Study|Protocol Violation|1|||
125927163|NCT00578812|453029437|FG000|Overall Study|Not treated|6|||
125927164|NCT00578812|453029438|FG001|Overall Study|Not treated|7|||
125927165|NCT00617773|453029439|FG000|Overall Study|Physician Decision|1|||
125927166|NCT00617773|453029439|FG000|Overall Study|Lack of compliance with the protocol|1|||
125927167|NCT00617773|453029439|FG000|Overall Study|Withdrawal by Subject|1|||
125927168|NCT00617773|453029439|FG000|Overall Study|Death|1|||
125927169|NCT00617773|453029439|FG000|Overall Study|Progressive disease|19|||
125927170|NCT00617773|453029439|FG000|Overall Study|Protocol Violation|1|||
125927171|NCT03217175|453029442|FG000|Overall Study|Physician Decision|4|||
125927172|NCT03217175|453029443|FG001|Overall Study|Physician Decision|1|||
125927173|NCT05035550|453029455|FG000|Overall Study|Withdrawal by Subject|3|||
125927174|NCT05035550|453029456|FG001|Overall Study|Withdrawal by Subject|0|||
125927175|NCT01751867|453029457|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
125927176|NCT01751867|453029458|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
125927177|NCT01751867|453029457|FG000|Overall Study|Diease Progression|4|||
125927178|NCT01751867|453029458|FG001|Overall Study|Diease Progression|18|||
125927179|NCT01751867|453029457|FG000|Overall Study|Adverse Event|8|||
125927180|NCT01751867|453029458|FG001|Overall Study|Adverse Event|15|||
125927181|NCT01751867|453029457|FG000|Overall Study|Poor Compliance|0|||
125927182|NCT01751867|453029458|FG001|Overall Study|Poor Compliance|5|||
125927183|NCT01751867|453029457|FG000|Overall Study|Withdrawal by Subject|3|||
125927184|NCT01751867|453029458|FG001|Overall Study|Withdrawal by Subject|1|||
125927185|NCT01751867|453029457|FG000|Overall Study|Physician Decision|4|||
125927186|NCT01751867|453029458|FG001|Overall Study|Physician Decision|7|||
125927187|NCT01751867|453029457|FG000|Overall Study|Protocol Violation|0|||
125927188|NCT01751867|453029458|FG001|Overall Study|Protocol Violation|2|||
125927189|NCT01751867|453029457|FG000|Overall Study|Death|0|||
125927190|NCT01751867|453029458|FG001|Overall Study|Death|5|||
125927191|NCT01751867|453029457|FG000|Overall Study|Other|11|||
125927192|NCT01751867|453029458|FG001|Overall Study|Other|37|||
125927193|NCT01751867|453029457|FG000|Overall Study|Randomized but not treated.|2|||
125927194|NCT01751867|453029458|FG001|Overall Study|Randomized but not treated.|1|||
125927195|NCT01806545|453029459|FG000|Overall Study|Adverse Event|2|||
125927196|NCT01806545|453029460|FG001|Overall Study|Adverse Event|3|||
125927197|NCT01806545|453029459|FG000|Overall Study|Lost to Follow-up|1|||
125927198|NCT01806545|453029460|FG001|Overall Study|Lost to Follow-up|0|||
126065128|NCT03345407|453530693|FG005|Overall Study|Withdrawal by Subject|6|||
126065129|NCT03345407|453530694|FG006|Overall Study|Withdrawal by Subject|16|||
125927199|NCT01806545|453029459|FG000|Overall Study|Withdrawal by Subject|3|||
125927200|NCT01806545|453029460|FG001|Overall Study|Withdrawal by Subject|2|||
125927201|NCT01396148|453029461|FG000|Overall Study|Patient Decision|1|||
125927202|NCT00884312|453029464|FG000|Overall Study|Non-fatal Progressive Disease|0|||
125927203|NCT00884312|453029465|FG001|Overall Study|Non-fatal Progressive Disease|8|||
125927204|NCT00884312|453029464|FG000|Overall Study|Fatal Progressive Disease|0|||
125927205|NCT00884312|453029465|FG001|Overall Study|Fatal Progressive Disease|1|||
125927206|NCT00884312|453029464|FG000|Overall Study|Non-fatal Adverse Event|1|||
125927207|NCT00884312|453029465|FG001|Overall Study|Non-fatal Adverse Event|0|||
125927208|NCT00884312|453029464|FG000|Overall Study|Fatal Adverse Event|1|||
125927209|NCT00884312|453029465|FG001|Overall Study|Fatal Adverse Event|4|||
125927210|NCT00884312|453029464|FG000|Overall Study|Withdrawal by Subject|0|||
125927211|NCT00884312|453029465|FG001|Overall Study|Withdrawal by Subject|6|||
125927212|NCT00884312|453029464|FG000|Overall Study|Physician Decision|0|||
125927213|NCT00884312|453029465|FG001|Overall Study|Physician Decision|1|||
125927214|NCT00884312|453029464|FG000|Overall Study|Other|0|||
125927215|NCT00884312|453029465|FG001|Overall Study|Other|4|||
125927216|NCT00884312|453029464|FG000|Overall Study|Did Not Receive Study Drug|0|||
125927217|NCT00884312|453029465|FG001|Overall Study|Did Not Receive Study Drug|1|||
125927218|NCT00224042|453029466|FG000|Overall Study|Adverse Event|2|||
125927219|NCT00224042|453029467|FG001|Overall Study|Adverse Event|1|||
125927220|NCT00224042|453029466|FG000|Overall Study|Protocol Violation|0|||
125927221|NCT00224042|453029467|FG001|Overall Study|Protocol Violation|1|||
125927222|NCT00224042|453029466|FG000|Overall Study|Physician Decision|0|||
125927223|NCT00224042|453029467|FG001|Overall Study|Physician Decision|1|||
125927224|NCT00224042|453029466|FG000|Overall Study|Did not meet lab incusion criteria|2|||
125927225|NCT00224042|453029467|FG001|Overall Study|Did not meet lab incusion criteria|3|||
125927226|NCT00224042|453029466|FG000|Overall Study|Other|2|||
125927227|NCT00224042|453029467|FG001|Overall Study|Other|0|||
125927228|NCT03052725|453029468|FG000|Overall Study|Adverse Event|2|||
125927229|NCT03052725|453029469|FG001|Overall Study|Adverse Event|0|||
125927230|NCT03052725|453029468|FG000|Overall Study|Withdrawal by Subject|3|||
125927231|NCT03052725|453029469|FG001|Overall Study|Withdrawal by Subject|4|||
125927232|NCT03052725|453029468|FG000|Overall Study|Pregnancy|0|||
125927233|NCT03052725|453029469|FG001|Overall Study|Pregnancy|1|||
125927234|NCT03052725|453029468|FG000|Overall Study|Site closure|0|||
125927235|NCT03052725|453029469|FG001|Overall Study|Site closure|1|||
125927236|NCT03052725|453029468|FG000|Overall Study|Study terminated by sponsor|143|||
125927237|NCT03052725|453029469|FG001|Overall Study|Study terminated by sponsor|144|||
125927238|NCT00847379|453029474|FG000|Overall Study|Study terminated by Sponsor|59|||
125927239|NCT00847379|453029475|FG001|Overall Study|Study terminated by Sponsor|57|||
125927240|NCT00847379|453029476|FG002|Overall Study|Study terminated by Sponsor|57|||
125927241|NCT02969369|453029477|FG000|Study|Adverse Event|1|||
125927242|NCT02969369|453029478|FG001|Study|Adverse Event|6|||
125927243|NCT02969369|453029477|FG000|Study|Lack of Efficacy|0|||
125927244|NCT02969369|453029478|FG001|Study|Lack of Efficacy|1|||
125927245|NCT02969369|453029477|FG000|Study|Lost to Follow-up|0|||
125927246|NCT02969369|453029478|FG001|Study|Lost to Follow-up|1|||
125927247|NCT02969369|453029477|FG000|Study|Withdrawal by Subject|3|||
125927248|NCT02969369|453029478|FG001|Study|Withdrawal by Subject|5|||
125927249|NCT02969369|453029477|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
125927250|NCT02969369|453029478|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
125927251|NCT02969369|453029477|FG000|Double-blind Period|Adverse Event|1|||
125927252|NCT02969369|453029478|FG001|Double-blind Period|Adverse Event|5|||
125927253|NCT02969369|453029477|FG000|Double-blind Period|Lost to Follow-up|0|||
125927254|NCT02969369|453029478|FG001|Double-blind Period|Lost to Follow-up|1|||
126065130|NCT03345407|453530688|FG000|Overall Study|Physician Decision|3|||
126065131|NCT03345407|453530689|FG001|Overall Study|Physician Decision|1|||
125927255|NCT02969369|453029477|FG000|Double-blind Period|Withdrawal by Subject|2|||
125927256|NCT02969369|453029478|FG001|Double-blind Period|Withdrawal by Subject|3|||
125927257|NCT02969369|453029477|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
125927258|NCT02969369|453029478|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
125927259|NCT02969369|453029477|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
125927260|NCT02969369|453029478|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
125927261|NCT02969369|453029477|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
125927262|NCT02969369|453029478|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
125927263|NCT02969369|453029477|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
125927264|NCT02969369|453029478|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
125927265|NCT00521014|453029479|FG000|Overall Study|Inevaluable, not treated|1|||
125927266|NCT02794883|453029480|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
125927267|NCT02794883|453029481|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
125927268|NCT02794883|453029482|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
125927269|NCT02794883|453029480|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
125927270|NCT02794883|453029481|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
125927271|NCT02794883|453029482|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
125927272|NCT02794883|453029480|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
125927273|NCT02794883|453029481|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
125927274|NCT02794883|453029482|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
125927275|NCT02794883|453029480|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
125927276|NCT02794883|453029481|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
125927277|NCT02794883|453029482|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
125927278|NCT02794883|453029480|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
125927279|NCT02794883|453029481|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
125927280|NCT02794883|453029482|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
125927281|NCT02794883|453029480|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
125927282|NCT02794883|453029481|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
125927283|NCT02794883|453029482|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
125927284|NCT02794883|453029480|FG000|Follow-up Period (up to 2 Years)|Death|12|||
125927285|NCT02794883|453029481|FG001|Follow-up Period (up to 2 Years)|Death|10|||
125927286|NCT02794883|453029482|FG002|Follow-up Period (up to 2 Years)|Death|10|||
125927287|NCT00003499|453029483|FG000|Overall Study|Not evaluable|8|||
125927288|NCT02864498|453029488|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
125927289|NCT02864498|453029489|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
125927290|NCT02864498|453029490|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
125927291|NCT02864498|453029488|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
125927292|NCT02864498|453029489|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
125927293|NCT02864498|453029490|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
125927294|NCT02864498|453029488|FG000|Overall Study|Investigator Discretion|0|||
125927295|NCT02864498|453029489|FG001|Overall Study|Investigator Discretion|2|||
125927296|NCT02864498|453029490|FG002|Overall Study|Investigator Discretion|1|||
125927297|NCT02864498|453029488|FG000|Overall Study|Lost to Follow-up|8|||
125927298|NCT02864498|453029489|FG001|Overall Study|Lost to Follow-up|6|||
125927299|NCT02864498|453029490|FG002|Overall Study|Lost to Follow-up|3|||
125927300|NCT02864498|453029488|FG000|Overall Study|Lack of Efficacy|5|||
125927301|NCT02864498|453029489|FG001|Overall Study|Lack of Efficacy|3|||
125927302|NCT02864498|453029490|FG002|Overall Study|Lack of Efficacy|3|||
125927303|NCT02864498|453029488|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
125927304|NCT02864498|453029489|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
125927305|NCT02864498|453029490|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
125927306|NCT02864498|453029488|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
125927307|NCT02864498|453029489|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
125927308|NCT02864498|453029490|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
125927309|NCT02864498|453029488|FG000|Overall Study|Subject moved out of the country.|0|||
125927310|NCT02864498|453029489|FG001|Overall Study|Subject moved out of the country.|0|||
125927311|NCT02864498|453029490|FG002|Overall Study|Subject moved out of the country.|1|||
125927312|NCT01812174|453029491|FG000|Overall Study|Death|1|||
125927313|NCT01812174|453029492|FG001|Overall Study|Death|0|||
125927314|NCT01812174|453029491|FG000|Overall Study|Protocol Violation|2|||
125927315|NCT01812174|453029492|FG001|Overall Study|Protocol Violation|0|||
125927316|NCT00851747|453029502|FG000|Overall Study|Physician Decision|6|||
125927317|NCT00851747|453029503|FG001|Overall Study|Physician Decision|6|||
125927318|NCT00851747|453029504|FG002|Overall Study|Physician Decision|6|||
125927319|NCT01854710|453029505|FG000|Overall Study|Withdrawal by Subject|2|||
125927320|NCT01854710|453029506|FG001|Overall Study|Withdrawal by Subject|1|||
125927321|NCT01854710|453029507|FG002|Overall Study|Withdrawal by Subject|0|||
125927322|NCT01854710|453029508|FG003|Overall Study|Withdrawal by Subject|0|||
125927323|NCT01854710|453029509|FG004|Overall Study|Withdrawal by Subject|0|||
125927324|NCT01854710|453029510|FG005|Overall Study|Withdrawal by Subject|0|||
125927325|NCT01854710|453029505|FG000|Overall Study|CRI procedural error|2|||
125927326|NCT01854710|453029506|FG001|Overall Study|CRI procedural error|2|||
125927327|NCT01854710|453029507|FG002|Overall Study|CRI procedural error|2|||
126065132|NCT03345407|453530690|FG002|Overall Study|Physician Decision|0|||
125927328|NCT01854710|453029508|FG003|Overall Study|CRI procedural error|2|||
125927329|NCT01854710|453029509|FG004|Overall Study|CRI procedural error|2|||
125927330|NCT01854710|453029510|FG005|Overall Study|CRI procedural error|2|||
125927331|NCT01844518|453029513|FG000|Overall Study|Adverse Event|7|||
125927332|NCT01844518|453029514|FG001|Overall Study|Adverse Event|1|||
125927333|NCT01844518|453029513|FG000|Overall Study|Lack of Efficacy|17|||
125927334|NCT01844518|453029514|FG001|Overall Study|Lack of Efficacy|5|||
125927335|NCT01844518|453029513|FG000|Overall Study|Participant's request to discontinue|4|||
125927336|NCT01844518|453029514|FG001|Overall Study|Participant's request to discontinue|1|||
125927337|NCT01844518|453029513|FG000|Overall Study|Poor/Non-compliance|1|||
125927338|NCT01844518|453029514|FG001|Overall Study|Poor/Non-compliance|0|||
125927339|NCT01844518|453029513|FG000|Overall Study|No Longer Met Study Criteria|2|||
126065133|NCT03345407|453530691|FG003|Overall Study|Physician Decision|0|||
126065134|NCT03345407|453530692|FG004|Overall Study|Physician Decision|1|||
126065135|NCT03345407|453530693|FG005|Overall Study|Physician Decision|2|||
126065136|NCT03345407|453530694|FG006|Overall Study|Physician Decision|3|||
126065137|NCT03345407|453530688|FG000|Overall Study|Lost to Follow-up|2|||
126065138|NCT03345407|453530689|FG001|Overall Study|Lost to Follow-up|0|||
126065139|NCT03345407|453530690|FG002|Overall Study|Lost to Follow-up|1|||
126065140|NCT03345407|453530691|FG003|Overall Study|Lost to Follow-up|0|||
126065141|NCT03345407|453530692|FG004|Overall Study|Lost to Follow-up|1|||
126065142|NCT03345407|453530693|FG005|Overall Study|Lost to Follow-up|2|||
126065143|NCT03345407|453530694|FG006|Overall Study|Lost to Follow-up|3|||
126065144|NCT03345407|453530688|FG000|Overall Study|Protocol-defined stopping criteria|9|||
126065145|NCT03345407|453530689|FG001|Overall Study|Protocol-defined stopping criteria|0|||
126065146|NCT03345407|453530690|FG002|Overall Study|Protocol-defined stopping criteria|0|||
126065147|NCT03345407|453530691|FG003|Overall Study|Protocol-defined stopping criteria|0|||
126065148|NCT03345407|453530692|FG004|Overall Study|Protocol-defined stopping criteria|2|||
126065149|NCT03345407|453530693|FG005|Overall Study|Protocol-defined stopping criteria|1|||
126065150|NCT03345407|453530694|FG006|Overall Study|Protocol-defined stopping criteria|1|||
126065151|NCT03345407|453530688|FG000|Overall Study|Protocol Violation|2|||
126065152|NCT03345407|453530689|FG001|Overall Study|Protocol Violation|0|||
126065153|NCT03345407|453530690|FG002|Overall Study|Protocol Violation|0|||
126065154|NCT03345407|453530691|FG003|Overall Study|Protocol Violation|0|||
126065155|NCT03345407|453530692|FG004|Overall Study|Protocol Violation|1|||
126065156|NCT03345407|453530693|FG005|Overall Study|Protocol Violation|0|||
126065157|NCT03345407|453530694|FG006|Overall Study|Protocol Violation|3|||
126065158|NCT03345407|453530688|FG000|Overall Study|Lack of Efficacy|1|||
126065159|NCT03345407|453530689|FG001|Overall Study|Lack of Efficacy|1|||
126065160|NCT03345407|453530690|FG002|Overall Study|Lack of Efficacy|1|||
126065161|NCT03345407|453530691|FG003|Overall Study|Lack of Efficacy|1|||
126065162|NCT03345407|453530692|FG004|Overall Study|Lack of Efficacy|1|||
126065163|NCT03345407|453530693|FG005|Overall Study|Lack of Efficacy|0|||
126065164|NCT03345407|453530694|FG006|Overall Study|Lack of Efficacy|3|||
126065165|NCT03345407|453530688|FG000|Overall Study|Adverse Event|4|||
126065166|NCT03345407|453530689|FG001|Overall Study|Adverse Event|0|||
126065167|NCT03345407|453530690|FG002|Overall Study|Adverse Event|5|||
126065168|NCT03345407|453530691|FG003|Overall Study|Adverse Event|4|||
126065169|NCT03345407|453530692|FG004|Overall Study|Adverse Event|6|||
126065170|NCT03345407|453530693|FG005|Overall Study|Adverse Event|5|||
126065171|NCT03345407|453530694|FG006|Overall Study|Adverse Event|16|||
126065172|NCT00379210|453530695|FG000|Overall Study|Withdrawal by Subject|10|||
126065173|NCT00379210|453530696|FG001|Overall Study|Withdrawal by Subject|7|||
126065174|NCT01762345|453530697|FG000|Overall Study|Adverse Event|5|||
126065175|NCT01762345|453530697|FG000|Overall Study|Protocol Violation|2|||
126065176|NCT01525875|453530698|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
126065177|NCT01525875|453530699|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
126065178|NCT01525875|453530698|FG000|Open-label Period|Lost to Follow-up|0|||
126065179|NCT01525875|453530699|FG001|Open-label Period|Lost to Follow-up|2|||
126065180|NCT05072795|453530700|FG000|Overall Study|Lost to Follow-up|5|||
126065181|NCT01107912|453530703|FG000|Period 1|Adverse Event|0|||
126065182|NCT01107912|453530704|FG001|Period 1|Adverse Event|0|||
126065183|NCT01107912|453530705|FG002|Period 1|Adverse Event|0|||
126065184|NCT01107912|453530706|FG003|Period 1|Adverse Event|0|||
126065185|NCT01107912|453530707|FG004|Period 1|Adverse Event|2|||
126065186|NCT01107912|453530708|FG005|Period 1|Adverse Event|0|||
126065187|NCT01107912|453530703|FG000|Period 1|Physician Decision|0|||
126065188|NCT01107912|453530704|FG001|Period 1|Physician Decision|0|||
126065189|NCT01107912|453530705|FG002|Period 1|Physician Decision|0|||
126065190|NCT01107912|453530706|FG003|Period 1|Physician Decision|0|||
126065191|NCT01107912|453530707|FG004|Period 1|Physician Decision|1|||
126065192|NCT01107912|453530708|FG005|Period 1|Physician Decision|0|||
126065193|NCT01107912|453530703|FG000|Period 1|Withdrawal by Subject|1|||
126065194|NCT01107912|453530704|FG001|Period 1|Withdrawal by Subject|0|||
126065195|NCT01107912|453530705|FG002|Period 1|Withdrawal by Subject|0|||
126065196|NCT01107912|453530706|FG003|Period 1|Withdrawal by Subject|0|||
126065197|NCT01107912|453530707|FG004|Period 1|Withdrawal by Subject|0|||
126065198|NCT01107912|453530708|FG005|Period 1|Withdrawal by Subject|0|||
126065199|NCT01107912|453530703|FG000|Period 2|Physician Decision|0|||
126065200|NCT01107912|453530704|FG001|Period 2|Physician Decision|0|||
126065201|NCT01107912|453530705|FG002|Period 2|Physician Decision|1|||
126065202|NCT01107912|453530706|FG003|Period 2|Physician Decision|0|||
126065203|NCT01107912|453530707|FG004|Period 2|Physician Decision|0|||
126065204|NCT01107912|453530708|FG005|Period 2|Physician Decision|0|||
126065205|NCT01107912|453530703|FG000|Period 3|Adverse Event|0|||
126065206|NCT01107912|453530704|FG001|Period 3|Adverse Event|1|||
126065207|NCT01107912|453530705|FG002|Period 3|Adverse Event|1|||
126065208|NCT01107912|453530706|FG003|Period 3|Adverse Event|0|||
126065209|NCT01107912|453530707|FG004|Period 3|Adverse Event|0|||
126065210|NCT01107912|453530708|FG005|Period 3|Adverse Event|0|||
126065211|NCT01107912|453530703|FG000|Period 3|Withdrawal by Subject|0|||
126065212|NCT01107912|453530704|FG001|Period 3|Withdrawal by Subject|0|||
126065213|NCT01107912|453530705|FG002|Period 3|Withdrawal by Subject|0|||
126065214|NCT01107912|453530706|FG003|Period 3|Withdrawal by Subject|1|||
126065215|NCT01107912|453530707|FG004|Period 3|Withdrawal by Subject|0|||
126065216|NCT01107912|453530708|FG005|Period 3|Withdrawal by Subject|0|||
126065217|NCT01601821|453530709|FG000|Overall Study|Death|2|||
126065218|NCT01601821|453530710|FG001|Overall Study|Death|5|||
126065219|NCT01601821|453530709|FG000|Overall Study|Protocol Violation|2|||
126065220|NCT01601821|453530710|FG001|Overall Study|Protocol Violation|2|||
126065221|NCT01601821|453530709|FG000|Overall Study|Lost to Follow-up|6|||
126065222|NCT01601821|453530710|FG001|Overall Study|Lost to Follow-up|14|||
126065223|NCT01601821|453530709|FG000|Overall Study|Withdrawal by Subject|1|||
126065224|NCT01601821|453530710|FG001|Overall Study|Withdrawal by Subject|0|||
126065225|NCT01601821|453530709|FG000|Overall Study|Graft Loss|6|||
126065226|NCT01601821|453530710|FG001|Overall Study|Graft Loss|6|||
126065227|NCT01601821|453530709|FG000|Overall Study|Study Events|7|||
126065228|NCT01601821|453530710|FG001|Overall Study|Study Events|1|||
126065229|NCT01601821|453530709|FG000|Overall Study|Other|5|||
126065230|NCT01601821|453530710|FG001|Overall Study|Other|1|||
126065231|NCT00753896|453530719|FG000|Overall Study|Adverse Event|4|||
126065232|NCT00753896|453530719|FG000|Overall Study|Death|1|||
126065233|NCT00753896|453530719|FG000|Overall Study|Lost to Follow-up|2|||
126065234|NCT00753896|453530719|FG000|Overall Study|Protocol Violation|1|||
126065235|NCT00753896|453530719|FG000|Overall Study|Withdrawal by Subject|4|||
126065236|NCT00753896|453530719|FG000|Overall Study|Entry Criteria Not Met|4|||
126065237|NCT01989156|453530720|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
126065238|NCT01989156|453530721|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
126065239|NCT01989156|453530722|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
126065240|NCT01989156|453530720|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
126065241|NCT01989156|453530721|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
126065242|NCT01989156|453530722|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
126065243|NCT01989156|453530720|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
126065244|NCT01989156|453530721|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
126065245|NCT01989156|453530722|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
126065246|NCT01989156|453530720|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
126065247|NCT01989156|453530721|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
126065248|NCT01989156|453530722|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
126065249|NCT01989156|453530720|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
126065250|NCT01989156|453530721|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
126065251|NCT01989156|453530722|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
126065252|NCT01989156|453530720|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
126065253|NCT01989156|453530721|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
126065254|NCT01989156|453530722|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
126065255|NCT01989156|453530720|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
126065256|NCT01989156|453530721|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
126065257|NCT01989156|453530722|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
126065258|NCT01989156|453530720|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
126065259|NCT01989156|453530721|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
126065260|NCT01989156|453530722|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
126065261|NCT01721109|453530726|FG000|Overall Study|Lack of Efficacy|1|||
126065262|NCT01721109|453530726|FG000|Overall Study|Non- Compliance with Study Drug|3|||
126065263|NCT01721109|453530726|FG000|Overall Study|Withdrew Consent|1|||
126065264|NCT01721109|453530726|FG000|Overall Study|Lost to Follow-up|2|||
126065265|NCT04362176|453530727|FG000|Overall Study|Lost to Follow-up|5|||
126065266|NCT04362176|453530728|FG001|Overall Study|Lost to Follow-up|8|||
126065267|NCT04362176|453530727|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
126065268|NCT04362176|453530728|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
126065269|NCT00742560|453530729|FG000|Overall Study|Adverse Event|0|||
126065270|NCT00742560|453530730|FG001|Overall Study|Adverse Event|0|||
126065271|NCT00742560|453530731|FG002|Overall Study|Adverse Event|1|||
126065272|NCT00742560|453530732|FG003|Overall Study|Adverse Event|1|||
126065273|NCT00742560|453530733|FG004|Overall Study|Adverse Event|1|||
126065274|NCT00742560|453530729|FG000|Overall Study|Death|0|||
126065275|NCT00742560|453530730|FG001|Overall Study|Death|2|||
126065276|NCT00742560|453530731|FG002|Overall Study|Death|0|||
126065277|NCT00742560|453530732|FG003|Overall Study|Death|2|||
126065278|NCT00742560|453530733|FG004|Overall Study|Death|3|||
125927340|NCT01844518|453029514|FG001|Overall Study|No Longer Met Study Criteria|0|||
125927341|NCT01844518|453029513|FG000|Overall Study|Withdrawal by Subject|9|||
125927342|NCT01844518|453029514|FG001|Overall Study|Withdrawal by Subject|0|||
125927343|NCT01844518|453029513|FG000|Overall Study|Pregnancy|1|||
126065279|NCT00742560|453530729|FG000|Overall Study|Subject's Decision|1|||
125927344|NCT01844518|453029514|FG001|Overall Study|Pregnancy|0|||
125927345|NCT00571948|453029516|FG000|Overall Study|Lost to Follow-up|2|||
126065280|NCT00742560|453530730|FG001|Overall Study|Subject's Decision|0|||
126065281|NCT00742560|453530731|FG002|Overall Study|Subject's Decision|2|||
125927346|NCT00571948|453029517|FG001|Overall Study|Lost to Follow-up|0|||
125927347|NCT00571948|453029516|FG000|Overall Study|Withdrawal by Subject|1|||
125927348|NCT00571948|453029517|FG001|Overall Study|Withdrawal by Subject|2|||
125927349|NCT00571948|453029516|FG000|Overall Study|Protocol Violation|3|||
125927350|NCT00571948|453029517|FG001|Overall Study|Protocol Violation|3|||
125927351|NCT00571948|453029516|FG000|Overall Study|infant refused study meal|3|||
125927352|NCT00571948|453029517|FG001|Overall Study|infant refused study meal|4|||
125927353|NCT00571948|453029516|FG000|Overall Study|Parent were afraid of blood colection|2|||
125927354|NCT00571948|453029517|FG001|Overall Study|Parent were afraid of blood colection|5|||
125927355|NCT04112784|453029518|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
125927356|NCT04112784|453029518|FG000|Overall Study|Screen Failures|4|||
125927357|NCT00221403|453029519|FG000|Overall Study|Protocol Violation|1|||
125927358|NCT00221403|453029520|FG001|Overall Study|Protocol Violation|0|||
125927359|NCT00221403|453029521|FG002|Overall Study|Protocol Violation|0|||
125927360|NCT00221403|453029519|FG000|Overall Study|Physician Decision|1|||
125927361|NCT00221403|453029520|FG001|Overall Study|Physician Decision|0|||
125927362|NCT00221403|453029521|FG002|Overall Study|Physician Decision|0|||
125927363|NCT00221403|453029519|FG000|Overall Study|Withdrawal by Subject|0|||
125927364|NCT00221403|453029520|FG001|Overall Study|Withdrawal by Subject|3|||
125927365|NCT00221403|453029521|FG002|Overall Study|Withdrawal by Subject|0|||
125927366|NCT00221403|453029519|FG000|Overall Study|Lack of Efficacy|0|||
125927367|NCT00221403|453029520|FG001|Overall Study|Lack of Efficacy|1|||
125927368|NCT00221403|453029521|FG002|Overall Study|Lack of Efficacy|0|||
125927369|NCT00221403|453029519|FG000|Overall Study|Adverse Event|0|||
125927370|NCT00221403|453029520|FG001|Overall Study|Adverse Event|1|||
125927371|NCT00221403|453029521|FG002|Overall Study|Adverse Event|0|||
125927372|NCT02010775|453029522|FG000|Overall Study|Adverse Event|0|||
125927373|NCT02010775|453029523|FG001|Overall Study|Adverse Event|0|||
125927374|NCT02010775|453029524|FG002|Overall Study|Adverse Event|0|||
125927375|NCT02010775|453029525|FG003|Overall Study|Adverse Event|0|||
125927376|NCT02010775|453029526|FG004|Overall Study|Adverse Event|1|||
125927377|NCT02010775|453029522|FG000|Overall Study|Pregnancy|0|||
125927378|NCT02010775|453029523|FG001|Overall Study|Pregnancy|0|||
125927379|NCT02010775|453029524|FG002|Overall Study|Pregnancy|2|||
125927380|NCT02010775|453029525|FG003|Overall Study|Pregnancy|0|||
125927381|NCT02010775|453029526|FG004|Overall Study|Pregnancy|0|||
125927382|NCT02010775|453029522|FG000|Overall Study|Lost to Follow-up|2|||
125927383|NCT02010775|453029523|FG001|Overall Study|Lost to Follow-up|0|||
125927384|NCT02010775|453029524|FG002|Overall Study|Lost to Follow-up|0|||
125927385|NCT02010775|453029525|FG003|Overall Study|Lost to Follow-up|1|||
125927386|NCT02010775|453029526|FG004|Overall Study|Lost to Follow-up|1|||
125927387|NCT02010775|453029522|FG000|Overall Study|Personal Reasons|3|||
125927388|NCT02010775|453029523|FG001|Overall Study|Personal Reasons|3|||
125927389|NCT02010775|453029524|FG002|Overall Study|Personal Reasons|1|||
125927390|NCT02010775|453029525|FG003|Overall Study|Personal Reasons|2|||
125927391|NCT02010775|453029526|FG004|Overall Study|Personal Reasons|4|||
125927392|NCT02030041|453029527|FG000|Overall Study|Withdrawal by Subject|2|||
125927393|NCT02030041|453029528|FG001|Overall Study|Withdrawal by Subject|2|||
125927394|NCT02030041|453029529|FG002|Overall Study|Withdrawal by Subject|1|||
125927395|NCT05201703|453029530|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
125927396|NCT05201703|453029531|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
125927397|NCT05201703|453029530|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
125927398|NCT05201703|453029531|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
125927399|NCT00393029|453029532|FG000|Overall Study|Not treated|0|||
125927400|NCT00393029|453029533|FG001|Overall Study|Not treated|1|||
125927401|NCT03715530|453029534|FG000|Overall Study|Lost to Follow-up|3|||
125927402|NCT03715530|453029535|FG001|Overall Study|Lost to Follow-up|1|||
125927403|NCT03715530|453029536|FG002|Overall Study|Lost to Follow-up|2|||
125927404|NCT01929343|453029537|FG000|Overall Study|Physician Decision|0|||
125927405|NCT01929343|453029538|FG001|Overall Study|Physician Decision|2|||
125927406|NCT01929343|453029539|FG002|Overall Study|Physician Decision|0|||
125927407|NCT01929343|453029537|FG000|Overall Study|Withdrawal by Subject|1|||
125927408|NCT01929343|453029538|FG001|Overall Study|Withdrawal by Subject|0|||
125927409|NCT01929343|453029539|FG002|Overall Study|Withdrawal by Subject|0|||
125927410|NCT00211510|453029544|FG000|Overall Study|Physician Decision|3|||
125927411|NCT00211510|453029545|FG001|Overall Study|Physician Decision|1|||
125927412|NCT00211510|453029544|FG000|Overall Study|Withdrawal by Subject|3|||
125927413|NCT00211510|453029545|FG001|Overall Study|Withdrawal by Subject|1|||
125927414|NCT01737697|453029548|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927415|NCT01737697|453029549|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
125927416|NCT01737697|453029550|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927417|NCT01737697|453029551|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
125927418|NCT01737697|453029552|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
125927419|NCT01737697|453029553|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927420|NCT01737697|453029554|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927421|NCT01737697|453029555|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927422|NCT01737697|453029556|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126112476|NCT01678209|453709449|FG000|Overall Study|could not scan twice|1|||
125927423|NCT01737697|453029557|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927424|NCT01737697|453029558|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927425|NCT01737697|453029559|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927426|NCT01737697|453029560|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927427|NCT01737697|453029561|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927428|NCT01737697|453029562|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125927429|NCT01737697|453029548|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
126112477|NCT01678209|453709450|FG001|Overall Study|could not scan twice|1|||
125927430|NCT01737697|453029549|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
125927431|NCT01737697|453029550|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
125927432|NCT01737697|453029551|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927433|NCT01737697|453029552|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927434|NCT01737697|453029553|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927435|NCT01737697|453029554|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927436|NCT01737697|453029555|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927437|NCT01737697|453029556|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927438|NCT01737697|453029557|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927439|NCT01737697|453029558|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927440|NCT01737697|453029559|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927441|NCT01737697|453029560|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927442|NCT01737697|453029561|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927443|NCT01737697|453029562|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125927444|NCT01737697|453029548|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927445|NCT01737697|453029549|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927446|NCT01737697|453029550|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927447|NCT01737697|453029551|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
125927448|NCT01737697|453029552|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927449|NCT01737697|453029553|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927450|NCT01737697|453029554|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927451|NCT01737697|453029555|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927452|NCT01737697|453029556|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927453|NCT01737697|453029557|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927454|NCT01737697|453029558|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927455|NCT01737697|453029559|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927456|NCT01737697|453029560|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927457|NCT01737697|453029561|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927458|NCT01737697|453029562|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
125927459|NCT01737697|453029548|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927460|NCT01737697|453029549|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
125927461|NCT01737697|453029550|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927462|NCT01737697|453029551|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927463|NCT01737697|453029552|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927464|NCT01737697|453029553|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927465|NCT01737697|453029554|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927466|NCT01737697|453029555|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927467|NCT01737697|453029556|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927468|NCT01737697|453029557|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927469|NCT01737697|453029558|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927470|NCT01737697|453029559|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927471|NCT01737697|453029560|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927472|NCT01737697|453029561|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927473|NCT01737697|453029562|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125927474|NCT01737697|453029548|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927475|NCT01737697|453029549|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927476|NCT01737697|453029550|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927477|NCT01737697|453029551|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927478|NCT01737697|453029552|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
125927479|NCT01737697|453029553|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927480|NCT01737697|453029554|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927481|NCT01737697|453029555|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927482|NCT01737697|453029556|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927483|NCT01737697|453029557|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927484|NCT01737697|453029558|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927485|NCT01737697|453029559|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927486|NCT01737697|453029560|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927487|NCT01737697|453029561|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927488|NCT01737697|453029562|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125927489|NCT01737697|453029548|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927490|NCT01737697|453029549|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
125927491|NCT01737697|453029550|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
125927492|NCT01737697|453029551|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
125927493|NCT01737697|453029552|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
125927494|NCT01737697|453029553|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927495|NCT01737697|453029554|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927496|NCT01737697|453029555|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927497|NCT01737697|453029556|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927498|NCT01737697|453029557|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927499|NCT01737697|453029558|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927500|NCT01737697|453029559|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927501|NCT01737697|453029560|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927502|NCT01737697|453029561|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927503|NCT01737697|453029562|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125927504|NCT01737697|453029548|FG000|Subacute Phase|Adverse Event|0|||
125927505|NCT01737697|453029549|FG001|Subacute Phase|Adverse Event|0|||
125927506|NCT01737697|453029550|FG002|Subacute Phase|Adverse Event|0|||
125927507|NCT01737697|453029551|FG003|Subacute Phase|Adverse Event|0|||
125927508|NCT01737697|453029552|FG004|Subacute Phase|Adverse Event|0|||
125927509|NCT01737697|453029553|FG005|Subacute Phase|Adverse Event|1|||
125927510|NCT01737697|453029554|FG006|Subacute Phase|Adverse Event|1|||
125927511|NCT01737697|453029555|FG007|Subacute Phase|Adverse Event|1|||
125927512|NCT01737697|453029556|FG008|Subacute Phase|Adverse Event|1|||
125927513|NCT01737697|453029557|FG009|Subacute Phase|Adverse Event|1|||
125927514|NCT01737697|453029558|FG010|Subacute Phase|Adverse Event|4|||
125927515|NCT01737697|453029559|FG011|Subacute Phase|Adverse Event|1|||
125927516|NCT01737697|453029560|FG012|Subacute Phase|Adverse Event|1|||
125927517|NCT01737697|453029561|FG013|Subacute Phase|Adverse Event|0|||
125927518|NCT01737697|453029562|FG014|Subacute Phase|Adverse Event|0|||
125927519|NCT01737697|453029548|FG000|Subacute Phase|Withdrawal by Subject|0|||
125927520|NCT01737697|453029549|FG001|Subacute Phase|Withdrawal by Subject|0|||
125927521|NCT01737697|453029550|FG002|Subacute Phase|Withdrawal by Subject|0|||
125927522|NCT01737697|453029551|FG003|Subacute Phase|Withdrawal by Subject|0|||
125927523|NCT01737697|453029552|FG004|Subacute Phase|Withdrawal by Subject|0|||
125927524|NCT01737697|453029553|FG005|Subacute Phase|Withdrawal by Subject|1|||
125927525|NCT01737697|453029554|FG006|Subacute Phase|Withdrawal by Subject|0|||
125927526|NCT01737697|453029555|FG007|Subacute Phase|Withdrawal by Subject|2|||
125927527|NCT01737697|453029556|FG008|Subacute Phase|Withdrawal by Subject|0|||
125927528|NCT01737697|453029557|FG009|Subacute Phase|Withdrawal by Subject|1|||
125927529|NCT01737697|453029558|FG010|Subacute Phase|Withdrawal by Subject|0|||
125927530|NCT01737697|453029559|FG011|Subacute Phase|Withdrawal by Subject|1|||
125927531|NCT01737697|453029560|FG012|Subacute Phase|Withdrawal by Subject|1|||
125927532|NCT01737697|453029561|FG013|Subacute Phase|Withdrawal by Subject|1|||
125927533|NCT01737697|453029562|FG014|Subacute Phase|Withdrawal by Subject|0|||
125927534|NCT01737697|453029548|FG000|Subacute Phase|Lost to Follow-up|0|||
125927535|NCT01737697|453029549|FG001|Subacute Phase|Lost to Follow-up|0|||
125927536|NCT01737697|453029550|FG002|Subacute Phase|Lost to Follow-up|0|||
125927537|NCT01737697|453029551|FG003|Subacute Phase|Lost to Follow-up|0|||
125927538|NCT01737697|453029552|FG004|Subacute Phase|Lost to Follow-up|0|||
125927539|NCT01737697|453029553|FG005|Subacute Phase|Lost to Follow-up|0|||
125927540|NCT01737697|453029554|FG006|Subacute Phase|Lost to Follow-up|0|||
125927541|NCT01737697|453029555|FG007|Subacute Phase|Lost to Follow-up|0|||
125927542|NCT01737697|453029556|FG008|Subacute Phase|Lost to Follow-up|0|||
125927543|NCT01737697|453029557|FG009|Subacute Phase|Lost to Follow-up|0|||
125927544|NCT01737697|453029558|FG010|Subacute Phase|Lost to Follow-up|0|||
125927545|NCT01737697|453029559|FG011|Subacute Phase|Lost to Follow-up|0|||
125927546|NCT01737697|453029560|FG012|Subacute Phase|Lost to Follow-up|0|||
125927547|NCT01737697|453029561|FG013|Subacute Phase|Lost to Follow-up|0|||
125927548|NCT01737697|453029562|FG014|Subacute Phase|Lost to Follow-up|1|||
125927549|NCT01737697|453029548|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
125927550|NCT01737697|453029549|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
125927551|NCT01737697|453029550|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
125927552|NCT01737697|453029551|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
125927553|NCT01737697|453029552|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
125927554|NCT01737697|453029553|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
125927555|NCT01737697|453029554|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
125927556|NCT01737697|453029555|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
125927557|NCT01737697|453029556|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
126065282|NCT00742560|453530732|FG003|Overall Study|Subject's Decision|3|||
126065283|NCT00742560|453530733|FG004|Overall Study|Subject's Decision|3|||
126065284|NCT00742560|453530729|FG000|Overall Study|Investigator's Decision|0|||
126065285|NCT00742560|453530730|FG001|Overall Study|Investigator's Decision|0|||
125927558|NCT01737697|453029557|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
125927559|NCT01737697|453029558|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
125927560|NCT01737697|453029559|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
125927561|NCT01737697|453029560|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
125927562|NCT01737697|453029561|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
125927563|NCT01737697|453029562|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
125927564|NCT01737697|453029548|FG000|Subacute Phase|Protocol Violation|0|||
125927565|NCT01737697|453029549|FG001|Subacute Phase|Protocol Violation|0|||
125927566|NCT01737697|453029550|FG002|Subacute Phase|Protocol Violation|0|||
125927567|NCT01737697|453029551|FG003|Subacute Phase|Protocol Violation|0|||
125927568|NCT01737697|453029552|FG004|Subacute Phase|Protocol Violation|0|||
125927569|NCT01737697|453029553|FG005|Subacute Phase|Protocol Violation|1|||
125927570|NCT01737697|453029554|FG006|Subacute Phase|Protocol Violation|0|||
125927571|NCT01737697|453029555|FG007|Subacute Phase|Protocol Violation|0|||
125927572|NCT01737697|453029556|FG008|Subacute Phase|Protocol Violation|0|||
125927573|NCT01737697|453029557|FG009|Subacute Phase|Protocol Violation|0|||
125927574|NCT01737697|453029558|FG010|Subacute Phase|Protocol Violation|1|||
125927575|NCT01737697|453029559|FG011|Subacute Phase|Protocol Violation|0|||
125927576|NCT01737697|453029560|FG012|Subacute Phase|Protocol Violation|0|||
125927577|NCT01737697|453029561|FG013|Subacute Phase|Protocol Violation|0|||
125927578|NCT01737697|453029562|FG014|Subacute Phase|Protocol Violation|0|||
125927579|NCT01737697|453029548|FG000|Subacute Phase|Physician Decision|0|||
125927580|NCT01737697|453029549|FG001|Subacute Phase|Physician Decision|0|||
125927581|NCT01737697|453029550|FG002|Subacute Phase|Physician Decision|0|||
125927582|NCT01737697|453029551|FG003|Subacute Phase|Physician Decision|0|||
125927583|NCT01737697|453029552|FG004|Subacute Phase|Physician Decision|0|||
125927584|NCT01737697|453029553|FG005|Subacute Phase|Physician Decision|0|||
125927585|NCT01737697|453029554|FG006|Subacute Phase|Physician Decision|0|||
125927586|NCT01737697|453029555|FG007|Subacute Phase|Physician Decision|0|||
125927587|NCT01737697|453029556|FG008|Subacute Phase|Physician Decision|1|||
125927588|NCT01737697|453029557|FG009|Subacute Phase|Physician Decision|0|||
125927589|NCT01737697|453029558|FG010|Subacute Phase|Physician Decision|0|||
125927590|NCT01737697|453029559|FG011|Subacute Phase|Physician Decision|0|||
125927591|NCT01737697|453029560|FG012|Subacute Phase|Physician Decision|0|||
125927592|NCT01737697|453029561|FG013|Subacute Phase|Physician Decision|0|||
125927593|NCT01737697|453029562|FG014|Subacute Phase|Physician Decision|0|||
125927594|NCT01737697|453029548|FG000|Subacute Phase|Death|0|||
125927595|NCT01737697|453029549|FG001|Subacute Phase|Death|0|||
125927596|NCT01737697|453029550|FG002|Subacute Phase|Death|0|||
125927597|NCT01737697|453029551|FG003|Subacute Phase|Death|0|||
125927598|NCT01737697|453029552|FG004|Subacute Phase|Death|0|||
125927599|NCT01737697|453029553|FG005|Subacute Phase|Death|0|||
125927600|NCT01737697|453029554|FG006|Subacute Phase|Death|0|||
125927601|NCT01737697|453029555|FG007|Subacute Phase|Death|0|||
125927602|NCT01737697|453029556|FG008|Subacute Phase|Death|0|||
125927603|NCT01737697|453029557|FG009|Subacute Phase|Death|0|||
125927604|NCT01737697|453029558|FG010|Subacute Phase|Death|1|||
125927605|NCT01737697|453029559|FG011|Subacute Phase|Death|0|||
125927606|NCT01737697|453029560|FG012|Subacute Phase|Death|0|||
125927607|NCT01737697|453029561|FG013|Subacute Phase|Death|0|||
125927608|NCT01737697|453029562|FG014|Subacute Phase|Death|0|||
125927609|NCT03648983|453029567|FG000|Overall Study|Study was terminated due to PI departure|95|||
125927610|NCT01269463|453029568|FG000|First Intervention|Withdrawal by Subject|1|||
125927611|NCT01269463|453029569|FG001|First Intervention|Withdrawal by Subject|0|||
125927612|NCT01269463|453029568|FG000|First Intervention|Adverse Event|1|||
125927613|NCT01269463|453029569|FG001|First Intervention|Adverse Event|0|||
125927614|NCT01269463|453029568|FG000|First Intervention|Lack of Efficacy|0|||
125927615|NCT01269463|453029569|FG001|First Intervention|Lack of Efficacy|1|||
125927616|NCT01269463|453029568|FG000|First Intervention|Physician Decision|0|||
125927617|NCT01269463|453029569|FG001|First Intervention|Physician Decision|1|||
125927618|NCT04404361|453029573|FG000|Overall Study|Death|12|||
125927619|NCT04404361|453029574|FG001|Overall Study|Death|12|||
125927620|NCT04404361|453029573|FG000|Overall Study|Withdrawal by Subject|13|||
125927621|NCT04404361|453029574|FG001|Overall Study|Withdrawal by Subject|5|||
125927622|NCT04404361|453029573|FG000|Overall Study|Lost to Follow-up|6|||
125927623|NCT04404361|453029574|FG001|Overall Study|Lost to Follow-up|3|||
125927624|NCT04404361|453029573|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
125927625|NCT04404361|453029574|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
125927626|NCT02862171|453029575|FG000|Overall Study|Death|1|||
125927627|NCT02862171|453029575|FG000|Overall Study|Lost to Follow-up|13|||
125927628|NCT02862171|453029575|FG000|Overall Study|Withdrawal by Subject|57|||
125927629|NCT02862171|453029575|FG000|Overall Study|Non-compliance|4|||
125927630|NCT02862171|453029575|FG000|Overall Study|HIV-1 seroconversion|18|||
125927631|NCT02549937|453029577|FG000|Overall Study|Death|0|||
125927632|NCT02549937|453029578|FG001|Overall Study|Death|1|||
125927633|NCT02549937|453029579|FG002|Overall Study|Death|0|||
125927634|NCT02549937|453029580|FG003|Overall Study|Death|1|||
125927635|NCT02549937|453029581|FG004|Overall Study|Death|0|||
125927636|NCT02549937|453029582|FG005|Overall Study|Death|8|||
125927637|NCT02549937|453029583|FG006|Overall Study|Death|0|||
125927638|NCT02549937|453029584|FG007|Overall Study|Death|0|||
125927639|NCT02549937|453029585|FG008|Overall Study|Death|19|||
125927640|NCT02549937|453029577|FG000|Overall Study|No follow up required|3|||
125927641|NCT02549937|453029578|FG001|Overall Study|No follow up required|6|||
125927642|NCT02549937|453029579|FG002|Overall Study|No follow up required|3|||
125927643|NCT02549937|453029580|FG003|Overall Study|No follow up required|8|||
126112478|NCT01678209|453709451|FG002|Overall Study|could not scan twice|1|||
126112479|NCT01678209|453709449|FG000|Overall Study|scheduling conflicts|0|||
126112480|NCT01678209|453709450|FG001|Overall Study|scheduling conflicts|0|||
126112481|NCT01678209|453709451|FG002|Overall Study|scheduling conflicts|1|||
126112482|NCT01678209|453709449|FG000|Overall Study|screen fail|16|||
126112483|NCT01678209|453709450|FG001|Overall Study|screen fail|17|||
126112484|NCT01678209|453709451|FG002|Overall Study|screen fail|16|||
126112485|NCT00702845|453709452|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
126112486|NCT00702845|453709453|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
126112487|NCT00702845|453709452|FG000|Overall Study|Too high ovarian response|5|||
126112488|NCT00702845|453709453|FG001|Overall Study|Too high ovarian response|1|||
126112489|NCT00702845|453709452|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
126112490|NCT00702845|453709453|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
126112491|NCT00702845|453709452|FG000|Overall Study|Insufficient ovarian response|1|||
126112492|NCT00702845|453709453|FG001|Overall Study|Insufficient ovarian response|0|||
126112493|NCT00702845|453709452|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
126112494|NCT00702845|453709453|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
126112495|NCT00702845|453709452|FG000|Overall Study|No or abnormal fertilization|4|||
126112496|NCT00702845|453709453|FG001|Overall Study|No or abnormal fertilization|2|||
126112497|NCT00702845|453709452|FG000|Overall Study|Patient's decision|2|||
126112498|NCT00702845|453709453|FG001|Overall Study|Patient's decision|1|||
125927644|NCT02549937|453029581|FG004|Overall Study|No follow up required|12|||
125927645|NCT02549937|453029582|FG005|Overall Study|No follow up required|21|||
125927646|NCT02549937|453029583|FG006|Overall Study|No follow up required|9|||
125927647|NCT02549937|453029584|FG007|Overall Study|No follow up required|11|||
125927648|NCT02549937|453029585|FG008|Overall Study|No follow up required|0|||
125927649|NCT02549937|453029577|FG000|Overall Study|Other|0|||
125927650|NCT02549937|453029578|FG001|Overall Study|Other|0|||
125927651|NCT02549937|453029579|FG002|Overall Study|Other|0|||
125927652|NCT02549937|453029580|FG003|Overall Study|Other|0|||
125927653|NCT02549937|453029581|FG004|Overall Study|Other|1|||
125927654|NCT02549937|453029582|FG005|Overall Study|Other|0|||
125927655|NCT02549937|453029583|FG006|Overall Study|Other|3|||
125927656|NCT02549937|453029584|FG007|Overall Study|Other|2|||
125927657|NCT02549937|453029585|FG008|Overall Study|Other|3|||
125927658|NCT02549937|453029577|FG000|Overall Study|Lost to Follow-up|0|||
125927659|NCT02549937|453029578|FG001|Overall Study|Lost to Follow-up|0|||
125927660|NCT02549937|453029579|FG002|Overall Study|Lost to Follow-up|0|||
125927661|NCT02549937|453029580|FG003|Overall Study|Lost to Follow-up|0|||
125927662|NCT02549937|453029581|FG004|Overall Study|Lost to Follow-up|0|||
125927663|NCT02549937|453029582|FG005|Overall Study|Lost to Follow-up|0|||
125927664|NCT02549937|453029583|FG006|Overall Study|Lost to Follow-up|0|||
125927665|NCT02549937|453029584|FG007|Overall Study|Lost to Follow-up|0|||
125927666|NCT02549937|453029585|FG008|Overall Study|Lost to Follow-up|3|||
125927667|NCT02549937|453029577|FG000|Overall Study|Withdrawal by Subject|0|||
125927668|NCT02549937|453029578|FG001|Overall Study|Withdrawal by Subject|0|||
125927669|NCT02549937|453029579|FG002|Overall Study|Withdrawal by Subject|0|||
125927670|NCT02549937|453029580|FG003|Overall Study|Withdrawal by Subject|0|||
125927671|NCT02549937|453029581|FG004|Overall Study|Withdrawal by Subject|0|||
125927672|NCT02549937|453029582|FG005|Overall Study|Withdrawal by Subject|1|||
125927673|NCT02549937|453029583|FG006|Overall Study|Withdrawal by Subject|4|||
125927674|NCT02549937|453029584|FG007|Overall Study|Withdrawal by Subject|3|||
125927675|NCT02549937|453029585|FG008|Overall Study|Withdrawal by Subject|2|||
125927676|NCT02549937|453029577|FG000|Overall Study|Sponsor Decision|0|||
125927677|NCT02549937|453029578|FG001|Overall Study|Sponsor Decision|0|||
125927678|NCT02549937|453029579|FG002|Overall Study|Sponsor Decision|0|||
125927679|NCT02549937|453029580|FG003|Overall Study|Sponsor Decision|0|||
125927680|NCT02549937|453029581|FG004|Overall Study|Sponsor Decision|0|||
125927681|NCT02549937|453029582|FG005|Overall Study|Sponsor Decision|0|||
125927682|NCT02549937|453029583|FG006|Overall Study|Sponsor Decision|0|||
125927683|NCT02549937|453029584|FG007|Overall Study|Sponsor Decision|0|||
125927684|NCT02549937|453029585|FG008|Overall Study|Sponsor Decision|6|||
125927685|NCT03930797|453029586|FG000|Overall Study|Lost to Follow-up|3|||
125927686|NCT03930797|453029587|FG001|Overall Study|Lost to Follow-up|10|||
125927687|NCT00662012|453029588|FG000|Overall Study|Lost to Follow-up|85|||
125927688|NCT00662012|453029588|FG000|Overall Study|Death|1|||
125927689|NCT00662012|453029588|FG000|Overall Study|Withdrawal by Subject|1|||
125927690|NCT02144012|453029591|FG000|Overall Study|Adverse Event|1|||
125927691|NCT02144012|453029592|FG001|Overall Study|Adverse Event|0|||
125927692|NCT02144012|453029591|FG000|Overall Study|Death|1|||
125927693|NCT02144012|453029592|FG001|Overall Study|Death|0|||
125927694|NCT02144012|453029591|FG000|Overall Study|Withdrawal by Subject|11|||
126112499|NCT00702845|453709452|FG000|Overall Study|Not randomized|0|||
126112500|NCT00702845|453709453|FG001|Overall Study|Not randomized|1|||
126112501|NCT02973425|453709457|FG000|Overall Study|Lost to Follow-up|49|||
125927695|NCT02144012|453029592|FG001|Overall Study|Withdrawal by Subject|3|||
125927696|NCT02144012|453029591|FG000|Overall Study|Study Terminated by Sponsor|18|||
125927697|NCT02144012|453029592|FG001|Overall Study|Study Terminated by Sponsor|12|||
125927698|NCT02144012|453029591|FG000|Overall Study|Other|3|||
125927699|NCT02144012|453029592|FG001|Overall Study|Other|0|||
125927700|NCT02915016|453029593|FG000|Overall Study|Lost to Follow-up|4|||
125927701|NCT02915016|453029594|FG001|Overall Study|Lost to Follow-up|2|||
125927702|NCT02915016|453029595|FG002|Overall Study|Lost to Follow-up|5|||
125927703|NCT02915016|453029596|FG003|Overall Study|Lost to Follow-up|3|||
125927704|NCT02915016|453029597|FG004|Overall Study|Lost to Follow-up|5|||
125927705|NCT02915016|453029598|FG005|Overall Study|Lost to Follow-up|2|||
125927706|NCT02915016|453029599|FG006|Overall Study|Lost to Follow-up|8|||
125927707|NCT02915016|453029600|FG007|Overall Study|Lost to Follow-up|2|||
125927708|NCT02915016|453029593|FG000|Overall Study|Physician Decision|0|||
125927709|NCT02915016|453029594|FG001|Overall Study|Physician Decision|0|||
125927710|NCT02915016|453029595|FG002|Overall Study|Physician Decision|1|||
125927711|NCT02915016|453029596|FG003|Overall Study|Physician Decision|0|||
125927712|NCT02915016|453029597|FG004|Overall Study|Physician Decision|0|||
125927713|NCT02915016|453029598|FG005|Overall Study|Physician Decision|1|||
125927714|NCT02915016|453029599|FG006|Overall Study|Physician Decision|2|||
125927715|NCT02915016|453029600|FG007|Overall Study|Physician Decision|0|||
125927716|NCT02915016|453029593|FG000|Overall Study|Withdrawal by Subject|2|||
125927717|NCT02915016|453029594|FG001|Overall Study|Withdrawal by Subject|0|||
125927718|NCT02915016|453029595|FG002|Overall Study|Withdrawal by Subject|1|||
125927719|NCT02915016|453029596|FG003|Overall Study|Withdrawal by Subject|0|||
125927720|NCT02915016|453029597|FG004|Overall Study|Withdrawal by Subject|1|||
125927721|NCT02915016|453029598|FG005|Overall Study|Withdrawal by Subject|3|||
125927722|NCT02915016|453029599|FG006|Overall Study|Withdrawal by Subject|1|||
125927723|NCT02915016|453029600|FG007|Overall Study|Withdrawal by Subject|1|||
125927724|NCT02915016|453029593|FG000|Overall Study|Elected not to continue|0|||
125927725|NCT02915016|453029594|FG001|Overall Study|Elected not to continue|0|||
125927726|NCT02915016|453029595|FG002|Overall Study|Elected not to continue|0|||
125927727|NCT02915016|453029596|FG003|Overall Study|Elected not to continue|1|||
125927728|NCT02915016|453029597|FG004|Overall Study|Elected not to continue|0|||
125927729|NCT02915016|453029598|FG005|Overall Study|Elected not to continue|0|||
125927730|NCT02915016|453029599|FG006|Overall Study|Elected not to continue|1|||
125927731|NCT02915016|453029600|FG007|Overall Study|Elected not to continue|0|||
125927732|NCT02915016|453029593|FG000|Overall Study|HIV infection|1|||
125927733|NCT02915016|453029594|FG001|Overall Study|HIV infection|1|||
125927734|NCT02915016|453029595|FG002|Overall Study|HIV infection|1|||
125927735|NCT02915016|453029596|FG003|Overall Study|HIV infection|0|||
125927736|NCT02915016|453029597|FG004|Overall Study|HIV infection|1|||
125927737|NCT02915016|453029598|FG005|Overall Study|HIV infection|0|||
125927738|NCT02915016|453029599|FG006|Overall Study|HIV infection|0|||
125927739|NCT02915016|453029600|FG007|Overall Study|HIV infection|0|||
125927740|NCT02915016|453029593|FG000|Overall Study|Participant unable to adhere|0|||
125927741|NCT02915016|453029594|FG001|Overall Study|Participant unable to adhere|0|||
125927742|NCT02915016|453029595|FG002|Overall Study|Participant unable to adhere|0|||
125927743|NCT02915016|453029596|FG003|Overall Study|Participant unable to adhere|0|||
125927744|NCT02915016|453029597|FG004|Overall Study|Participant unable to adhere|0|||
125927745|NCT02915016|453029598|FG005|Overall Study|Participant unable to adhere|0|||
125927746|NCT02915016|453029599|FG006|Overall Study|Participant unable to adhere|0|||
125927747|NCT02915016|453029600|FG007|Overall Study|Participant unable to adhere|1|||
125927748|NCT05255068|453030540|FG000|Overall Study|Lost to Follow-up|0|||
125927749|NCT05255068|453030541|FG001|Overall Study|Lost to Follow-up|1|||
125927750|NCT00907777|453030544|FG000|Overall Study|Withdrawal by Subject|0|||
125927751|NCT00907777|453030545|FG001|Overall Study|Withdrawal by Subject|1|||
125927752|NCT02674529|453030546|FG000|Overall Study|Lost to Follow-up|1|||
125927753|NCT02674529|453030547|FG001|Overall Study|Lost to Follow-up|2|||
125927754|NCT02674529|453030546|FG000|Overall Study|Withdrawal by Subject|2|||
125927755|NCT02674529|453030547|FG001|Overall Study|Withdrawal by Subject|1|||
125927756|NCT02674529|453030546|FG000|Overall Study|Physician Decision|0|||
125927757|NCT02674529|453030547|FG001|Overall Study|Physician Decision|1|||
125927758|NCT02674529|453030546|FG000|Overall Study|Protocol Violation|0|||
125927759|NCT02674529|453030547|FG001|Overall Study|Protocol Violation|1|||
125927760|NCT02891850|453030548|FG000|Overall Study|Adverse Event|3|||
125927761|NCT02891850|453030549|FG001|Overall Study|Adverse Event|0|||
125927762|NCT02891850|453030548|FG000|Overall Study|Death|0|||
125927763|NCT02891850|453030549|FG001|Overall Study|Death|4|||
125927764|NCT02891850|453030548|FG000|Overall Study|Physician Decision|1|||
125927765|NCT02891850|453030549|FG001|Overall Study|Physician Decision|0|||
125927766|NCT02891850|453030548|FG000|Overall Study|Pregnancy|1|||
125927767|NCT02891850|453030549|FG001|Overall Study|Pregnancy|0|||
125927768|NCT02891850|453030548|FG000|Overall Study|Withdrawal by Subject|2|||
125927769|NCT02891850|453030549|FG001|Overall Study|Withdrawal by Subject|3|||
125927770|NCT00331682|453030552|FG000|Overall Study|Adverse Event|1|||
125927771|NCT00573469|453030553|FG000|Overall Study|Adverse Event|1|||
125927772|NCT00573469|453030554|FG001|Overall Study|Adverse Event|1|||
125927773|NCT00573469|453030555|FG002|Overall Study|Adverse Event|1|||
125927774|NCT00573469|453030553|FG000|Overall Study|Withdrawal by Subject|0|||
125927775|NCT00573469|453030554|FG001|Overall Study|Withdrawal by Subject|2|||
125927776|NCT00573469|453030555|FG002|Overall Study|Withdrawal by Subject|0|||
125927777|NCT00573469|453030553|FG000|Overall Study|Other|5|||
125927778|NCT00573469|453030554|FG001|Overall Study|Other|1|||
125927779|NCT00573469|453030555|FG002|Overall Study|Other|3|||
125927780|NCT00004978|453030556|FG000|Overall Study|Death|107|||
125927781|NCT00004978|453030557|FG001|Overall Study|Death|116|||
125927782|NCT00004978|453030556|FG000|Overall Study|Lost to Follow-up|101|||
125927783|NCT00004978|453030557|FG001|Overall Study|Lost to Follow-up|108|||
125927784|NCT00004978|453030556|FG000|Overall Study|Withdrawal by Subject|17|||
125927785|NCT00004978|453030557|FG001|Overall Study|Withdrawal by Subject|26|||
125927786|NCT00004978|453030556|FG000|Overall Study|site closure - not in analysis cohort|19|||
125927787|NCT00004978|453030557|FG001|Overall Study|site closure - not in analysis cohort|20|||
125927788|NCT03761277|453030558|FG000|Enrollment to Implant|Screen Failure|17|||
125927789|NCT03761277|453030558|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
125927790|NCT03761277|453030558|FG000|Enrollment to Implant|Physician Decision|2|||
125927791|NCT03761277|453030558|FG000|Enrollment to Implant|Site Closure|3|||
125927792|NCT03761277|453030558|FG000|Enrollment to Implant|Sponsor Request|2|||
125927793|NCT03761277|453030558|FG000|Post-Implant to 6 Months|Adverse Event|2|||
125927794|NCT03761277|453030558|FG000|Post-Implant to 6 Months|Death|1|||
125927795|NCT03761277|453030558|FG000|Post-Implant to 6 Months|Site Closure|2|||
125927796|NCT03761277|453030558|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
125927797|NCT03761277|453030558|FG000|6 Months to 12 Months|Physician Decision|2|||
125927798|NCT03761277|453030558|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
125927799|NCT01508650|453030559|FG000|Overall Study|Lost to Follow-up|0|||
125927800|NCT01508650|453030560|FG001|Overall Study|Lost to Follow-up|3|||
125927801|NCT02064894|453030561|FG000|Overall Study|Withdrawal by Subject|43|||
125927802|NCT02064894|453030562|FG001|Overall Study|Withdrawal by Subject|102|||
125927803|NCT02064894|453030563|FG002|Overall Study|Withdrawal by Subject|115|||
125927804|NCT02548650|453030566|FG000|Triple Therapy|Adverse Event|1|||
125927805|NCT02548650|453030567|FG001|Triple Therapy|Adverse Event|0|||
125927806|NCT02548650|453030566|FG000|Triple Therapy|Withdrawal by Subject|0|||
125927807|NCT02548650|453030567|FG001|Triple Therapy|Withdrawal by Subject|4|||
125927808|NCT02548650|453030566|FG000|Double Therapy|Adverse Event|1|||
125927809|NCT02548650|453030567|FG001|Double Therapy|Adverse Event|1|||
125927810|NCT02548650|453030566|FG000|Double Therapy|Withdrawal by Subject|0|||
125927811|NCT02548650|453030567|FG001|Double Therapy|Withdrawal by Subject|1|||
125927812|NCT01539538|453030568|FG000|Overall Study|Adverse Event|13|||
125927813|NCT01539538|453030569|FG001|Overall Study|Adverse Event|18|||
125927814|NCT01539538|453030568|FG000|Overall Study|Lack of Efficacy|13|||
125927815|NCT01539538|453030569|FG001|Overall Study|Lack of Efficacy|16|||
125927816|NCT01539538|453030568|FG000|Overall Study|Withdrawal by Subject|2|||
125927817|NCT01539538|453030569|FG001|Overall Study|Withdrawal by Subject|3|||
125927818|NCT01539538|453030568|FG000|Overall Study|PCA no longer required or PCA problem|3|||
125927819|NCT01539538|453030569|FG001|Overall Study|PCA no longer required or PCA problem|7|||
125927820|NCT01909674|453030570|FG000|Overall Study|Withdrawal by Subject|5|||
125927821|NCT01909674|453030571|FG001|Overall Study|Withdrawal by Subject|2|||
125927822|NCT00378378|453030572|FG000|Overall Study|Withdrawal by Subject|0|||
125927823|NCT00378378|453030573|FG001|Overall Study|Withdrawal by Subject|1|||
125927824|NCT00378378|453030574|FG002|Overall Study|Withdrawal by Subject|0|||
125927825|NCT00378378|453030572|FG000|Overall Study|Treatment Failure|0|||
125927826|NCT00378378|453030573|FG001|Overall Study|Treatment Failure|0|||
125927827|NCT00378378|453030574|FG002|Overall Study|Treatment Failure|1|||
125927828|NCT00378378|453030572|FG000|Overall Study|Non-compliance with protocol|0|||
125927829|NCT00378378|453030573|FG001|Overall Study|Non-compliance with protocol|0|||
125927830|NCT00378378|453030574|FG002|Overall Study|Non-compliance with protocol|1|||
125927831|NCT00407797|453030575|FG000|Overall Study|Lost to Follow-up|2|||
125927832|NCT00407797|453030575|FG000|Overall Study|Adverse Event|6|||
125927833|NCT00407797|453030575|FG000|Overall Study|Other|7|||
125927834|NCT00407797|453030575|FG000|Overall Study|Withdrawal by Subject|3|||
125927835|NCT00553644|453030576|FG000|Overall Study|Adverse Event|17|||
125927836|NCT00553644|453030576|FG000|Overall Study|Withdrawal by Subject|4|||
125927837|NCT00553644|453030576|FG000|Overall Study|Physician Decision|1|||
125927838|NCT00553644|453030576|FG000|Overall Study|Alternative therapy|6|||
125927839|NCT01537393|453030577|FG000|Overall Study|Exclude prior to study|32|||
125927840|NCT01537393|453030578|FG001|Overall Study|Exclude prior to study|44|||
125927841|NCT01537393|453030577|FG000|Overall Study|Death|20|||
125927842|NCT01537393|453030578|FG001|Overall Study|Death|32|||
125927843|NCT01537393|453030577|FG000|Overall Study|Withdrawal by Subject|18|||
125927844|NCT01537393|453030578|FG001|Overall Study|Withdrawal by Subject|17|||
125927845|NCT01537393|453030577|FG000|Overall Study|Lost to Follow-up|53|||
125927846|NCT01537393|453030578|FG001|Overall Study|Lost to Follow-up|48|||
125927847|NCT01537393|453030577|FG000|Overall Study|Failure - Regrafted|28|||
125927848|NCT01537393|453030578|FG001|Overall Study|Failure - Regrafted|43|||
125927849|NCT01537393|453030577|FG000|Overall Study|Failure - Not regrafted|2|||
125927850|NCT01537393|453030578|FG001|Overall Study|Failure - Not regrafted|6|||
125927851|NCT01537393|453030577|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
125927852|NCT01537393|453030578|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
125927853|NCT00317356|453030594|FG000|Overall Study|Adverse Event|0|||
125927854|NCT00317356|453030595|FG001|Overall Study|Adverse Event|0|||
125927855|NCT00317356|453030596|FG002|Overall Study|Adverse Event|1|||
125927856|NCT00317356|453030597|FG003|Overall Study|Adverse Event|0|||
125927857|NCT00317356|453030594|FG000|Overall Study|Lack of Efficacy|1|||
125927858|NCT00317356|453030595|FG001|Overall Study|Lack of Efficacy|1|||
125927859|NCT00317356|453030596|FG002|Overall Study|Lack of Efficacy|0|||
125927860|NCT00317356|453030597|FG003|Overall Study|Lack of Efficacy|3|||
126065286|NCT00742560|453530731|FG002|Overall Study|Investigator's Decision|4|||
126065287|NCT00742560|453530732|FG003|Overall Study|Investigator's Decision|1|||
126065288|NCT00742560|453530733|FG004|Overall Study|Investigator's Decision|0|||
126065289|NCT00742560|453530729|FG000|Overall Study|Disease Progression|1|||
126065290|NCT00742560|453530730|FG001|Overall Study|Disease Progression|0|||
126065291|NCT00742560|453530731|FG002|Overall Study|Disease Progression|5|||
126065292|NCT00742560|453530732|FG003|Overall Study|Disease Progression|17|||
126065293|NCT00742560|453530733|FG004|Overall Study|Disease Progression|16|||
126065294|NCT00742560|453530729|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
126065295|NCT00742560|453530730|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
126065296|NCT00742560|453530731|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
126065297|NCT00742560|453530732|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
126065298|NCT00742560|453530733|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
126065299|NCT00742560|453530729|FG000|Overall Study|Other|0|||
126065300|NCT00742560|453530730|FG001|Overall Study|Other|1|||
126065301|NCT00742560|453530731|FG002|Overall Study|Other|8|||
126065302|NCT00742560|453530732|FG003|Overall Study|Other|9|||
126065303|NCT00742560|453530733|FG004|Overall Study|Other|9|||
126065304|NCT00742560|453530729|FG000|Overall Study|MIssing|0|||
126065305|NCT00742560|453530730|FG001|Overall Study|MIssing|0|||
126065306|NCT00742560|453530731|FG002|Overall Study|MIssing|0|||
126065307|NCT00742560|453530732|FG003|Overall Study|MIssing|0|||
126065308|NCT00742560|453530733|FG004|Overall Study|MIssing|1|||
126065309|NCT01426217|453530735|FG000|Overall Study|lost sample|8|||
126065310|NCT01426217|453530736|FG001|Overall Study|lost sample|14|||
126065311|NCT01536795|453530737|FG000|Overall Study|Lost to Follow-up|0|||
126065312|NCT01536795|453530738|FG001|Overall Study|Lost to Follow-up|2|||
126065313|NCT01536795|453530737|FG000|Overall Study|Lack of Efficacy|1|||
126065314|NCT01536795|453530738|FG001|Overall Study|Lack of Efficacy|0|||
126065315|NCT01812837|453530739|FG000|Overall Study|Lost to Follow-up|1|||
126065316|NCT01812837|453530740|FG001|Overall Study|Lost to Follow-up|1|||
126065317|NCT01812837|453530741|FG002|Overall Study|Lost to Follow-up|0|||
126065318|NCT01812837|453530739|FG000|Overall Study|Protocol Violation|1|||
126065319|NCT01812837|453530740|FG001|Overall Study|Protocol Violation|0|||
126065320|NCT01812837|453530741|FG002|Overall Study|Protocol Violation|0|||
126065321|NCT05008224|453530743|FG000|Overall Study|Death|3|||
126065322|NCT05008224|453530743|FG000|Overall Study|Lost to Follow-up|2|||
126065323|NCT05008224|453530743|FG000|Overall Study|Did Not Continue on Extension Study|39|||
126065324|NCT05008224|453530743|FG000|Overall Study|Transferred to Extension Study|100|||
126065325|NCT05008224|453530743|FG000|Overall Study|Withdrawal by Subject|2|||
126065326|NCT05234632|453530744|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
126065327|NCT05234632|453530745|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
126065328|NCT05234632|453530744|FG000|Overall Study|Withdrawal by Subject|2|||
126065329|NCT05234632|453530745|FG001|Overall Study|Withdrawal by Subject|0|||
126065330|NCT05234632|453530744|FG000|Overall Study|Adverse Event|0|||
126065331|NCT05234632|453530745|FG001|Overall Study|Adverse Event|4|||
126065332|NCT05234632|453530744|FG000|Overall Study|Physician Decision|1|||
126065333|NCT05234632|453530745|FG001|Overall Study|Physician Decision|1|||
126065334|NCT05234632|453530744|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
126065335|NCT05234632|453530745|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
126065336|NCT05234632|453530744|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
126065337|NCT05234632|453530745|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
126065338|NCT02991456|453530747|FG000|Overall Study|Adverse Event|2|||
126065339|NCT02991456|453530748|FG001|Overall Study|Adverse Event|0|||
126065340|NCT02991456|453530747|FG000|Overall Study|Lost to Follow-up|0|||
126065341|NCT02991456|453530748|FG001|Overall Study|Lost to Follow-up|2|||
126065342|NCT02991456|453530747|FG000|Overall Study|Withdrawal by Subject|1|||
126065343|NCT02991456|453530748|FG001|Overall Study|Withdrawal by Subject|0|||
126065344|NCT00321555|453530750|FG000|Overall Study|Developed antibodies|1|||
126065345|NCT00321555|453530750|FG000|Overall Study|Switched to alternative treatment|3|||
126065346|NCT00321555|453530750|FG000|Overall Study|Physician Decision|1|||
126112502|NCT02973425|453709458|FG001|Overall Study|Lost to Follow-up|53|||
125927861|NCT00317356|453030594|FG000|Overall Study|Physician Decision|0|||
126065347|NCT00321555|453530750|FG000|Overall Study|Disease progression on study|1|||
126065348|NCT02066389|453530752|FG000|Overall Study|Adverse Event|1|||
126065349|NCT02066389|453530753|FG001|Overall Study|Adverse Event|1|||
126065350|NCT02066389|453530754|FG002|Overall Study|Adverse Event|1|||
126065351|NCT02066389|453530755|FG003|Overall Study|Adverse Event|1|||
126065352|NCT02066389|453530756|FG004|Overall Study|Adverse Event|5|||
126065353|NCT02066389|453530757|FG005|Overall Study|Adverse Event|1|||
126112503|NCT03876171|453709459|FG000|Overall Study|Withdrawal by Subject|3|||
126112504|NCT03876171|453709460|FG001|Overall Study|Withdrawal by Subject|3|||
125927862|NCT00317356|453030595|FG001|Overall Study|Physician Decision|1|||
125927863|NCT00317356|453030596|FG002|Overall Study|Physician Decision|0|||
125927864|NCT00317356|453030597|FG003|Overall Study|Physician Decision|0|||
125927865|NCT01949506|453030598|FG000|Overall Study|Physician Decision|1|||
125927866|NCT04212650|453030600|FG000|Overall Study|Withdrawal by Subject|1|||
125927867|NCT04212650|453030601|FG001|Overall Study|Withdrawal by Subject|0|||
125927868|NCT05475236|453030610|FG000|Overall Study|Withdrawal by Subject|0|||
125927869|NCT05475236|453030611|FG001|Overall Study|Withdrawal by Subject|1|||
125927870|NCT05425745|453030618|FG000|Overall Study|Withdrawal of Consent|3|||
125927871|NCT05425745|453030619|FG001|Overall Study|Withdrawal of Consent|3|||
125927872|NCT05425745|453030618|FG000|Overall Study|Death|2|||
125927873|NCT05425745|453030619|FG001|Overall Study|Death|3|||
125927874|NCT05425745|453030618|FG000|Overall Study|Lost to Follow-up|1|||
125927875|NCT05425745|453030619|FG001|Overall Study|Lost to Follow-up|2|||
125927876|NCT05425745|453030618|FG000|Overall Study|Adverse Event|0|||
125927877|NCT05425745|453030619|FG001|Overall Study|Adverse Event|1|||
125927878|NCT05425745|453030618|FG000|Overall Study|Did not return for end of study visit|0|||
125927879|NCT05425745|453030619|FG001|Overall Study|Did not return for end of study visit|1|||
125927880|NCT05425745|453030618|FG000|Overall Study|End of study visit completed by phone|1|||
125927881|NCT05425745|453030619|FG001|Overall Study|End of study visit completed by phone|0|||
125927882|NCT05425745|453030618|FG000|Overall Study|Subject decision|1|||
125927883|NCT05425745|453030619|FG001|Overall Study|Subject decision|0|||
125927884|NCT00540514|453032425|FG000|Overall Study|Still on treatment|3|||
125927885|NCT00540514|453032426|FG001|Overall Study|Still on treatment|0|||
125927886|NCT00540514|453032425|FG000|Overall Study|Unacceptable Toxicity|61|||
125927887|NCT00540514|453032426|FG001|Overall Study|Unacceptable Toxicity|62|||
125927888|NCT00540514|453032425|FG000|Overall Study|Adverse Event|20|||
125927889|NCT00540514|453032426|FG001|Overall Study|Adverse Event|24|||
125927890|NCT00540514|453032425|FG000|Overall Study|Physician Decision|86|||
125927891|NCT00540514|453032426|FG001|Overall Study|Physician Decision|99|||
125927892|NCT00540514|453032425|FG000|Overall Study|Protocol Deviation|3|||
125927893|NCT00540514|453032426|FG001|Overall Study|Protocol Deviation|4|||
125927894|NCT00540514|453032425|FG000|Overall Study|Lost to Follow-up|1|||
125927895|NCT00540514|453032426|FG001|Overall Study|Lost to Follow-up|1|||
125927896|NCT00540514|453032425|FG000|Overall Study|Withdrawal by Subject|65|||
125927897|NCT00540514|453032426|FG001|Overall Study|Withdrawal by Subject|67|||
125927898|NCT00540514|453032425|FG000|Overall Study|Excluded prior to treatment|7|||
125927899|NCT00540514|453032426|FG001|Overall Study|Excluded prior to treatment|7|||
125927900|NCT00540514|453032425|FG000|Overall Study|Paclitaxel not available|0|||
125927901|NCT00540514|453032426|FG001|Overall Study|Paclitaxel not available|2|||
125927902|NCT02501473|453032427|FG000|Overall Study|Study Terminated|2|||
125927903|NCT02501473|453032428|FG001|Overall Study|Study Terminated|3|||
125927904|NCT02501473|453032429|FG002|Overall Study|Study Terminated|7|||
125927905|NCT02501473|453032430|FG003|Overall Study|Study Terminated|9|||
125927906|NCT02501473|453032431|FG004|Overall Study|Study Terminated|2|||
125927907|NCT02501473|453032432|FG005|Overall Study|Study Terminated|10|||
125927908|NCT02501473|453032433|FG006|Overall Study|Study Terminated|1|||
125927909|NCT02501473|453032434|FG007|Overall Study|Study Terminated|0|||
125927910|NCT02501473|453032427|FG000|Overall Study|Withdrawal by Subject|0|||
125927911|NCT02501473|453032428|FG001|Overall Study|Withdrawal by Subject|0|||
125927912|NCT02501473|453032429|FG002|Overall Study|Withdrawal by Subject|3|||
125927913|NCT02501473|453032430|FG003|Overall Study|Withdrawal by Subject|3|||
125927914|NCT02501473|453032431|FG004|Overall Study|Withdrawal by Subject|2|||
125927915|NCT02501473|453032432|FG005|Overall Study|Withdrawal by Subject|2|||
125927916|NCT02501473|453032433|FG006|Overall Study|Withdrawal by Subject|0|||
125927917|NCT02501473|453032434|FG007|Overall Study|Withdrawal by Subject|0|||
125927918|NCT02501473|453032427|FG000|Overall Study|Death|0|||
125927919|NCT02501473|453032428|FG001|Overall Study|Death|0|||
125927920|NCT02501473|453032429|FG002|Overall Study|Death|1|||
125927921|NCT02501473|453032430|FG003|Overall Study|Death|1|||
125927922|NCT02501473|453032431|FG004|Overall Study|Death|0|||
125927923|NCT02501473|453032432|FG005|Overall Study|Death|1|||
126112505|NCT03876171|453709459|FG000|Overall Study|Re-arrest|0|||
126112506|NCT03876171|453709460|FG001|Overall Study|Re-arrest|4|||
126112507|NCT03503513|453709465|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
125927924|NCT02501473|453032433|FG006|Overall Study|Death|0|||
126112508|NCT03503513|453709465|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
125927925|NCT02501473|453032434|FG007|Overall Study|Death|0|||
125927926|NCT02501473|453032427|FG000|Overall Study|Lost to Follow-up|1|||
125927927|NCT02501473|453032428|FG001|Overall Study|Lost to Follow-up|0|||
125927928|NCT02501473|453032429|FG002|Overall Study|Lost to Follow-up|1|||
125927929|NCT02501473|453032430|FG003|Overall Study|Lost to Follow-up|0|||
125927930|NCT02501473|453032431|FG004|Overall Study|Lost to Follow-up|0|||
125927931|NCT02501473|453032432|FG005|Overall Study|Lost to Follow-up|1|||
125927932|NCT02501473|453032433|FG006|Overall Study|Lost to Follow-up|0|||
125927933|NCT02501473|453032434|FG007|Overall Study|Lost to Follow-up|0|||
125927934|NCT02501473|453032427|FG000|Overall Study|Reason not specified|0|||
125927935|NCT02501473|453032428|FG001|Overall Study|Reason not specified|0|||
125927936|NCT02501473|453032429|FG002|Overall Study|Reason not specified|1|||
125927937|NCT02501473|453032430|FG003|Overall Study|Reason not specified|1|||
125927938|NCT02501473|453032431|FG004|Overall Study|Reason not specified|0|||
125927939|NCT02501473|453032432|FG005|Overall Study|Reason not specified|0|||
125927940|NCT02501473|453032433|FG006|Overall Study|Reason not specified|0|||
125927941|NCT02501473|453032434|FG007|Overall Study|Reason not specified|0|||
125927942|NCT00630396|453032438|FG000|Overall Study|Death|4|||
125927943|NCT00630396|453032438|FG000|Overall Study|Lost to Follow-up|3|||
125927944|NCT02990910|453032441|FG000|Overall Study|Lack of Efficacy|6|||
125927945|NCT02990910|453032442|FG001|Overall Study|Lack of Efficacy|10|||
125927946|NCT00790023|453032447|FG000|Overall Study|Adverse Event|2|||
125927947|NCT00790023|453032448|FG001|Overall Study|Adverse Event|1|||
125927948|NCT00790023|453032449|FG002|Overall Study|Adverse Event|4|||
125927949|NCT00790023|453032447|FG000|Overall Study|Protocol Violation|2|||
125927950|NCT00790023|453032448|FG001|Overall Study|Protocol Violation|4|||
125927951|NCT00790023|453032449|FG002|Overall Study|Protocol Violation|2|||
125927952|NCT00790023|453032447|FG000|Overall Study|Withdrawal by Subject|2|||
125927953|NCT00790023|453032448|FG001|Overall Study|Withdrawal by Subject|0|||
125927954|NCT00790023|453032449|FG002|Overall Study|Withdrawal by Subject|6|||
125927955|NCT00790023|453032447|FG000|Overall Study|Lost to Follow-up|0|||
125927956|NCT00790023|453032448|FG001|Overall Study|Lost to Follow-up|0|||
125927957|NCT00790023|453032449|FG002|Overall Study|Lost to Follow-up|1|||
125927958|NCT00790023|453032447|FG000|Overall Study|Other|5|||
125927959|NCT00790023|453032448|FG001|Overall Study|Other|5|||
125927960|NCT00790023|453032449|FG002|Overall Study|Other|8|||
125927961|NCT01338792|453032450|FG000|Overall Study|Adverse Event|2|||
125927962|NCT01338792|453032450|FG000|Overall Study|Death|1|||
125927963|NCT01338792|453032450|FG000|Overall Study|Withdrawal by Subject|1|||
125927964|NCT02468414|453032451|FG000|Overall Study|Early Study Termination by Sponsor|1|||
125927965|NCT02468414|453032452|FG001|Overall Study|Early Study Termination by Sponsor|0|||
125927966|NCT02468414|453032451|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
125927967|NCT02468414|453032452|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
125927968|NCT02468414|453032451|FG000|Overall Study|Screen Failure|1|||
125927969|NCT02468414|453032452|FG001|Overall Study|Screen Failure|0|||
125927970|NCT01652703|453032453|FG000|Overall Study|Withdrawal by Subject|0|||
125927971|NCT01652703|453032454|FG001|Overall Study|Withdrawal by Subject|1|||
125927972|NCT01652703|453032455|FG002|Overall Study|Withdrawal by Subject|3|||
125927973|NCT01652703|453032456|FG003|Overall Study|Withdrawal by Subject|1|||
125927974|NCT01652703|453032457|FG004|Overall Study|Withdrawal by Subject|0|||
125927975|NCT01652703|453032458|FG005|Overall Study|Withdrawal by Subject|1|||
125927976|NCT01652703|453032453|FG000|Overall Study|Other|0|||
125927977|NCT01652703|453032454|FG001|Overall Study|Other|0|||
125927978|NCT01652703|453032455|FG002|Overall Study|Other|0|||
125927979|NCT01652703|453032456|FG003|Overall Study|Other|1|||
125927980|NCT01652703|453032457|FG004|Overall Study|Other|1|||
125927981|NCT01652703|453032458|FG005|Overall Study|Other|1|||
125927982|NCT02155608|453032462|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
125927983|NCT02155608|453032463|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
125927984|NCT02155608|453032462|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
125927985|NCT02155608|453032463|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
125927986|NCT00543140|453032465|FG000|Overall Study|Lost to Follow-up|33|||
125927987|NCT00543140|453032465|FG000|Overall Study|Withdrawal by Subject|13|||
125927988|NCT00543140|453032465|FG000|Overall Study|Protocol Violation|10|||
125927989|NCT00543140|453032465|FG000|Overall Study|Insufficient weight loss|10|||
125927990|NCT00543140|453032465|FG000|Overall Study|SAE leading to explant of SAGB|3|||
126065354|NCT02066389|453530752|FG000|Overall Study|Withdrawal by Subject|4|||
126065355|NCT02066389|453530753|FG001|Overall Study|Withdrawal by Subject|0|||
126065356|NCT02066389|453530754|FG002|Overall Study|Withdrawal by Subject|5|||
125927991|NCT00543140|453032465|FG000|Overall Study|Death|1|||
125927992|NCT00543140|453032465|FG000|Overall Study|Subject moved|1|||
125927993|NCT00543140|453032465|FG000|Overall Study|Conversion to different procedure|1|||
125927994|NCT04532164|453032468|FG000|Overall Study|Adverse Event|1|||
126065357|NCT02066389|453530755|FG003|Overall Study|Withdrawal by Subject|1|||
126065358|NCT02066389|453530756|FG004|Overall Study|Withdrawal by Subject|1|||
125927995|NCT04532164|453032468|FG000|Overall Study|Protocol Violation|5|||
125927996|NCT04532164|453032468|FG000|Overall Study|Lost to Follow-up|1|||
126065359|NCT02066389|453530757|FG005|Overall Study|Withdrawal by Subject|2|||
125927997|NCT04532164|453032468|FG000|Overall Study|Found to be Ineligible|3|||
125927998|NCT04532164|453032468|FG000|Overall Study|Withdrawal by Subject|14|||
125927999|NCT02599129|453032469|FG000|Overall Study|Lack of Efficacy|2|||
125928000|NCT02599129|453032470|FG001|Overall Study|Lack of Efficacy|2|||
125928001|NCT02599129|453032469|FG000|Overall Study|Lost to Follow-up|1|||
125928002|NCT02599129|453032470|FG001|Overall Study|Lost to Follow-up|0|||
125928003|NCT02599129|453032469|FG000|Overall Study|Withdrawal by Subject|2|||
125928004|NCT02599129|453032470|FG001|Overall Study|Withdrawal by Subject|1|||
125928005|NCT01029795|453032478|FG000|Overall Study|Entry Criteria Not Met|2|||
125928006|NCT01029795|453032479|FG001|Overall Study|Entry Criteria Not Met|1|||
125928007|NCT01029795|453032478|FG000|Overall Study|Physician Decision|2|||
125928008|NCT01029795|453032479|FG001|Overall Study|Physician Decision|1|||
125928009|NCT01029795|453032478|FG000|Overall Study|Sponsor Decision|11|||
125928010|NCT01029795|453032479|FG001|Overall Study|Sponsor Decision|17|||
125928011|NCT01029795|453032478|FG000|Overall Study|Withdrawal by Subject|1|||
125928012|NCT01029795|453032479|FG001|Overall Study|Withdrawal by Subject|3|||
125928013|NCT00429273|453032480|FG000|Overall Study|Lost to Follow-up|1|||
125928014|NCT00429273|453032481|FG001|Overall Study|Lost to Follow-up|2|||
125928015|NCT00429273|453032482|FG002|Overall Study|Lost to Follow-up|2|||
125928016|NCT00429273|453032480|FG000|Overall Study|Physician Decision|6|||
125928017|NCT00429273|453032481|FG001|Overall Study|Physician Decision|5|||
125928018|NCT00429273|453032482|FG002|Overall Study|Physician Decision|5|||
125928019|NCT00429273|453032480|FG000|Overall Study|Adverse Event|1|||
125928020|NCT00429273|453032481|FG001|Overall Study|Adverse Event|1|||
125928021|NCT00429273|453032482|FG002|Overall Study|Adverse Event|2|||
125928022|NCT01438957|453032483|FG000|Overall Study|Physician Decision|1|||
125928023|NCT01438957|453032484|FG001|Overall Study|Physician Decision|1|||
125928024|NCT01438957|453032485|FG002|Overall Study|Physician Decision|0|||
125928025|NCT01438957|453032486|FG003|Overall Study|Physician Decision|1|||
125928026|NCT01438957|453032487|FG004|Overall Study|Physician Decision|0|||
125928027|NCT02495168|453032489|FG000|Overall Study|Other than Specified|18|||
125928028|NCT02495168|453032490|FG001|Overall Study|Other than Specified|22|||
125928029|NCT02495168|453032491|FG002|Overall Study|Other than Specified|5|||
125928030|NCT02495168|453032489|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
125928031|NCT02495168|453032490|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
125928032|NCT02495168|453032491|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
125928033|NCT02495168|453032489|FG000|Overall Study|Physician Decision|1|||
125928034|NCT02495168|453032490|FG001|Overall Study|Physician Decision|1|||
125928035|NCT02495168|453032491|FG002|Overall Study|Physician Decision|0|||
125928036|NCT02495168|453032489|FG000|Overall Study|Lost to Follow-up|10|||
125928037|NCT02495168|453032490|FG001|Overall Study|Lost to Follow-up|6|||
125928038|NCT02495168|453032491|FG002|Overall Study|Lost to Follow-up|1|||
125928039|NCT02495168|453032489|FG000|Overall Study|Withdrawal by Subject|1|||
125928040|NCT02495168|453032490|FG001|Overall Study|Withdrawal by Subject|4|||
125928041|NCT02495168|453032491|FG002|Overall Study|Withdrawal by Subject|2|||
125928042|NCT02495168|453032489|FG000|Overall Study|Protocol Violation|0|||
125928043|NCT02495168|453032490|FG001|Overall Study|Protocol Violation|10|||
125928044|NCT02495168|453032491|FG002|Overall Study|Protocol Violation|1|||
125928045|NCT02495168|453032489|FG000|Overall Study|Adverse Event|4|||
125928046|NCT02495168|453032490|FG001|Overall Study|Adverse Event|8|||
125928047|NCT02495168|453032491|FG002|Overall Study|Adverse Event|3|||
125928048|NCT02495168|453032489|FG000|Overall Study|Lack of Efficacy|0|||
125928049|NCT02495168|453032490|FG001|Overall Study|Lack of Efficacy|0|||
125928050|NCT02495168|453032491|FG002|Overall Study|Lack of Efficacy|3|||
125928051|NCT00727025|453032492|FG000|Overall Study|Physician Decision|23|||
125928052|NCT02270957|453032493|FG000|Overall Study|Lack of Efficacy|2|||
125928053|NCT02270957|453032494|FG001|Overall Study|Lack of Efficacy|4|||
125928054|NCT02270957|453032493|FG000|Overall Study|Adverse Event|2|||
125928055|NCT02270957|453032494|FG001|Overall Study|Adverse Event|0|||
125928056|NCT01051323|453032499|FG000|Overall Study|Discontinuation of treatment|103|||
125928057|NCT01051323|453032499|FG000|Overall Study|Transplantation|28|||
125928058|NCT01051323|453032499|FG000|Overall Study|Dialysis dependency|22|||
125928059|NCT01051323|453032499|FG000|Overall Study|Withdrawal by Subject|13|||
125928060|NCT01051323|453032499|FG000|Overall Study|Lost to Follow-up|31|||
125928061|NCT01051323|453032499|FG000|Overall Study|Death|129|||
125928062|NCT01051323|453032499|FG000|Overall Study|Hospitalization|28|||
125928063|NCT01051323|453032499|FG000|Overall Study|Other|148|||
125928064|NCT01051323|453032499|FG000|Overall Study|Missing|37|||
125928065|NCT01233258|453032502|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
125928066|NCT01233258|453032503|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
126065360|NCT02066389|453530752|FG000|Overall Study|Lost to Follow-up|0|||
126065361|NCT02066389|453530753|FG001|Overall Study|Lost to Follow-up|0|||
126065362|NCT02066389|453530754|FG002|Overall Study|Lost to Follow-up|0|||
126065363|NCT02066389|453530755|FG003|Overall Study|Lost to Follow-up|1|||
125928067|NCT01233258|453032504|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
125928068|NCT01233258|453032505|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
125928069|NCT01233258|453032506|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
125928070|NCT01233258|453032507|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
125928071|NCT01233258|453032502|FG000|First Intervention (6 Months)|Protocol Violation|0|||
125928072|NCT01233258|453032503|FG001|First Intervention (6 Months)|Protocol Violation|0|||
125928073|NCT01233258|453032504|FG002|First Intervention (6 Months)|Protocol Violation|1|||
125928074|NCT01233258|453032505|FG003|First Intervention (6 Months)|Protocol Violation|0|||
125928075|NCT01233258|453032506|FG004|First Intervention (6 Months)|Protocol Violation|0|||
125928076|NCT01233258|453032507|FG005|First Intervention (6 Months)|Protocol Violation|0|||
125928077|NCT01233258|453032502|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
125928078|NCT01233258|453032503|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
126112509|NCT03503513|453709465|FG000|Overall Study|Physician Decision|3|||
126112510|NCT03503513|453709465|FG000|Overall Study|Withdrawal by Subject|2|||
126112511|NCT03503513|453709465|FG000|Overall Study|Lost to Follow-up|1|||
126112512|NCT00929656|453709466|FG000|Overall Study|Lost to Follow-up|0|||
126112513|NCT00929656|453709467|FG001|Overall Study|Lost to Follow-up|1|||
126112514|NCT00607880|453709468|FG000|Overall Study|Unable to place port due to occlusion|1|||
126112515|NCT00607880|453709469|FG001|Overall Study|Unable to place port due to occlusion|0|||
126112516|NCT00908583|453709470|FG000|Phase 1|Withdrawal by Subject|1|||
126112517|NCT00908583|453709470|FG000|Phase 1|Adverse Event|4|||
126112518|NCT00908583|453709470|FG000|Phase 2|Physician Decision|1|||
126112519|NCT00908583|453709470|FG000|Phase 2|Adverse Event|1|||
126112520|NCT00908583|453709470|FG000|Phase 3|Adverse Event|2|||
126112521|NCT00908583|453709470|FG000|Phase 4|Adverse Event|1|||
126112522|NCT00908583|453709470|FG000|Phase 4|Physician Decision|1|||
126112523|NCT00908583|453709470|FG000|Phase 5|Adverse Event|3|||
126112524|NCT00993954|453709471|FG000|Overall Study|Protocol Violation|21|||
126112525|NCT00993954|453709472|FG001|Overall Study|Protocol Violation|2|||
126112526|NCT00860951|453709473|FG000|Overall Study|Withdrawal by Subject|2|||
126112527|NCT00860951|453709473|FG000|Overall Study|Lost to Follow-up|5|||
126112528|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
126112529|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
126112530|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
126112531|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
126112532|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
126112533|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
126112534|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
126112535|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
126112536|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
126112537|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
126112538|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
126112539|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
126112540|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
126112541|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
126112542|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
126112543|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
126112544|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
126112545|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
126112546|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
126112547|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
126112548|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
126112549|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
126112550|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
126112551|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
126112552|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
126112553|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
126112554|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
126112555|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
126112556|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
126112557|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
126112558|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
126112559|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
126112560|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
126112561|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
126112562|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
126112563|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
126112564|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
126112565|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
126112566|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
126112567|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
126112568|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
126112569|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
126112570|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
126112571|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
126112572|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
126112573|NCT03627767|453709474|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
125971454|NCT01358526|453182852|FG002|Double-blind Phase|Lack of Efficacy|73|||
125928079|NCT01233258|453032504|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
125928080|NCT01233258|453032505|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
125928081|NCT01233258|453032506|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
125928082|NCT01233258|453032507|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
125928083|NCT01637272|453032508|FG000|Overall Study|Adverse Event|6|||
125928084|NCT01637272|453032508|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125928085|NCT01637272|453032508|FG000|Overall Study|Withdrawal by Subject|3|||
125928086|NCT01637272|453032508|FG000|Overall Study|Lost to Follow-up|2|||
125928087|NCT01637272|453032508|FG000|Overall Study|completed core, did not enter ext. phase|4|||
125928088|NCT01637272|453032508|FG000|Overall Study|Administrative problems|1|||
125928089|NCT01637272|453032508|FG000|Overall Study|Protocol Violation|2|||
126065364|NCT02066389|453530756|FG004|Overall Study|Lost to Follow-up|1|||
126065365|NCT02066389|453530757|FG005|Overall Study|Lost to Follow-up|1|||
126065366|NCT02066389|453530752|FG000|Overall Study|Randomized in Error|0|||
126065367|NCT02066389|453530753|FG001|Overall Study|Randomized in Error|0|||
126065368|NCT02066389|453530754|FG002|Overall Study|Randomized in Error|0|||
126065369|NCT02066389|453530755|FG003|Overall Study|Randomized in Error|0|||
126065370|NCT02066389|453530756|FG004|Overall Study|Randomized in Error|0|||
126065371|NCT02066389|453530757|FG005|Overall Study|Randomized in Error|1|||
126065372|NCT01755598|453530762|FG000|Overall Study|Other|109|||
126065373|NCT01755598|453530763|FG001|Overall Study|Other|109|||
126065374|NCT01755598|453530762|FG000|Overall Study|Lost to Follow-up|32|||
126065375|NCT01755598|453530763|FG001|Overall Study|Lost to Follow-up|43|||
126065376|NCT01755598|453530762|FG000|Overall Study|Migrated/moved from study area|76|||
126065377|NCT01755598|453530763|FG001|Overall Study|Migrated/moved from study area|65|||
126065378|NCT01755598|453530762|FG000|Overall Study|Withdrawal by Subject|22|||
126065379|NCT01755598|453530763|FG001|Overall Study|Withdrawal by Subject|31|||
126065380|NCT01755598|453530762|FG000|Overall Study|Protocol Violation|7|||
126065381|NCT01755598|453530763|FG001|Overall Study|Protocol Violation|7|||
126065382|NCT01755598|453530762|FG000|Overall Study|Adverse Event|19|||
126065383|NCT01755598|453530763|FG001|Overall Study|Adverse Event|28|||
126065384|NCT02924051|453530766|FG000|Overall Study|Withdrawal by Subject|1|||
126065385|NCT02924051|453530767|FG001|Overall Study|Withdrawal by Subject|9|||
126065386|NCT03547167|453530772|FG000|Overall Study|Withdrawal by Subject|34|||
126065387|NCT03547167|453530773|FG001|Overall Study|Withdrawal by Subject|12|||
126065388|NCT03547167|453530772|FG000|Overall Study|Screen Failure|0|||
126065389|NCT03547167|453530773|FG001|Overall Study|Screen Failure|1|||
126065390|NCT03547167|453530772|FG000|Overall Study|Lost to Follow-up|59|||
126065391|NCT03547167|453530773|FG001|Overall Study|Lost to Follow-up|15|||
126065392|NCT03547167|453530772|FG000|Overall Study|Death|4|||
126065393|NCT03547167|453530773|FG001|Overall Study|Death|2|||
126065394|NCT00738400|453530777|FG000|Overall Study|Adverse Event|3|||
126065395|NCT00738400|453530778|FG001|Overall Study|Adverse Event|1|||
126065396|NCT00738400|453530777|FG000|Overall Study|Withdrawal by Subject|0|||
126065397|NCT00738400|453530778|FG001|Overall Study|Withdrawal by Subject|1|||
126065398|NCT00738400|453530777|FG000|Overall Study|Lack of Efficacy|0|||
126065399|NCT00738400|453530778|FG001|Overall Study|Lack of Efficacy|1|||
126065400|NCT00738400|453530777|FG000|Overall Study|Lost to Follow-up|0|||
126065401|NCT00738400|453530778|FG001|Overall Study|Lost to Follow-up|3|||
126065402|NCT00738400|453530777|FG000|Overall Study|Protocol Violation|1|||
126065403|NCT00738400|453530778|FG001|Overall Study|Protocol Violation|0|||
126065404|NCT00738400|453530777|FG000|Overall Study|Non-compliant with study medication|0|||
126065405|NCT00738400|453530778|FG001|Overall Study|Non-compliant with study medication|1|||
126065406|NCT00508144|453530779|FG000|Overall Study|Not eligible|6|||
126065407|NCT00508144|453530779|FG000|Overall Study|Death|5|||
126065408|NCT02009865|453530780|FG000|Overall Study|Adverse Event|0|||
126065409|NCT02009865|453530781|FG001|Overall Study|Adverse Event|2|||
126065410|NCT02009865|453530780|FG000|Overall Study|Protocol Violation|0|||
126065411|NCT02009865|453530781|FG001|Overall Study|Protocol Violation|2|||
126065412|NCT02009865|453530780|FG000|Overall Study|Withdrawal by Subject|1|||
126065413|NCT02009865|453530781|FG001|Overall Study|Withdrawal by Subject|1|||
126065414|NCT01760876|453530782|FG000|Overall Study|Non-cardiac death (head injury)|1|||
126065415|NCT01760876|453530782|FG000|Overall Study|Carcinoma of prostate|1|||
126065416|NCT01760876|453530782|FG000|Overall Study|Impaired renal function|1|||
126065417|NCT01760876|453530782|FG000|Overall Study|Major depression|1|||
126065418|NCT01760876|453530782|FG000|Overall Study|Very poor baseline OCT quality|2|||
126065419|NCT01517282|453530785|FG000|Overall Study|Consent withdrawn|0|||
126065420|NCT01517282|453530786|FG001|Overall Study|Consent withdrawn|1|||
126065421|NCT01517282|453530787|FG002|Overall Study|Consent withdrawn|1|||
126065422|NCT01517282|453530788|FG003|Overall Study|Consent withdrawn|1|||
125928090|NCT01496612|453032509|FG000|1st Intervention|Adverse Event|1|||
125928091|NCT01496612|453032510|FG001|1st Intervention|Adverse Event|0|||
126065423|NCT01517282|453530785|FG000|Overall Study|Physician Decision|1|||
126065424|NCT01517282|453530786|FG001|Overall Study|Physician Decision|0|||
126065425|NCT01517282|453530787|FG002|Overall Study|Physician Decision|0|||
126065426|NCT01517282|453530788|FG003|Overall Study|Physician Decision|0|||
126065427|NCT00525915|453530789|FG000|Overall Study|Non-Compliance|0|||
126065428|NCT00525915|453530790|FG001|Overall Study|Non-Compliance|1|||
125928092|NCT01496612|453032509|FG000|1st Intervention|Withdrawal by Subject|1|||
125928093|NCT01496612|453032510|FG001|1st Intervention|Withdrawal by Subject|0|||
125928094|NCT03708328|453032515|FG000|Overall Study|Death|3|||
125928095|NCT03708328|453032516|FG001|Overall Study|Death|3|||
125928096|NCT03708328|453032517|FG002|Overall Study|Death|4|||
125928097|NCT03708328|453032518|FG003|Overall Study|Death|2|||
125928098|NCT03708328|453032519|FG004|Overall Study|Death|2|||
125928099|NCT03708328|453032520|FG005|Overall Study|Death|13|||
125928100|NCT03708328|453032521|FG006|Overall Study|Death|26|||
125928101|NCT03708328|453032522|FG007|Overall Study|Death|18|||
125928102|NCT03708328|453032523|FG008|Overall Study|Death|13|||
125928103|NCT03708328|453032524|FG009|Overall Study|Death|8|||
125928104|NCT03708328|453032515|FG000|Overall Study|Lost to Follow-up|0|||
125928105|NCT03708328|453032516|FG001|Overall Study|Lost to Follow-up|1|||
125928106|NCT03708328|453032517|FG002|Overall Study|Lost to Follow-up|0|||
125928107|NCT03708328|453032518|FG003|Overall Study|Lost to Follow-up|1|||
125928108|NCT03708328|453032519|FG004|Overall Study|Lost to Follow-up|0|||
125928109|NCT03708328|453032520|FG005|Overall Study|Lost to Follow-up|3|||
125928110|NCT03708328|453032521|FG006|Overall Study|Lost to Follow-up|3|||
125928111|NCT03708328|453032522|FG007|Overall Study|Lost to Follow-up|0|||
125928112|NCT03708328|453032523|FG008|Overall Study|Lost to Follow-up|0|||
125928113|NCT03708328|453032524|FG009|Overall Study|Lost to Follow-up|1|||
125928114|NCT03708328|453032515|FG000|Overall Study|Physician Decision|0|||
125928115|NCT03708328|453032516|FG001|Overall Study|Physician Decision|0|||
125928116|NCT03708328|453032517|FG002|Overall Study|Physician Decision|0|||
125928117|NCT03708328|453032518|FG003|Overall Study|Physician Decision|0|||
125928118|NCT03708328|453032519|FG004|Overall Study|Physician Decision|0|||
125928119|NCT03708328|453032520|FG005|Overall Study|Physician Decision|1|||
125928120|NCT03708328|453032521|FG006|Overall Study|Physician Decision|0|||
125928121|NCT03708328|453032522|FG007|Overall Study|Physician Decision|0|||
125928122|NCT03708328|453032523|FG008|Overall Study|Physician Decision|0|||
125928123|NCT03708328|453032524|FG009|Overall Study|Physician Decision|0|||
125928124|NCT03708328|453032515|FG000|Overall Study|Withdrawal by Subject|0|||
125928125|NCT03708328|453032516|FG001|Overall Study|Withdrawal by Subject|0|||
125928126|NCT03708328|453032517|FG002|Overall Study|Withdrawal by Subject|0|||
125928127|NCT03708328|453032518|FG003|Overall Study|Withdrawal by Subject|0|||
125928128|NCT03708328|453032519|FG004|Overall Study|Withdrawal by Subject|1|||
125928129|NCT03708328|453032520|FG005|Overall Study|Withdrawal by Subject|0|||
125928130|NCT03708328|453032521|FG006|Overall Study|Withdrawal by Subject|2|||
125928131|NCT03708328|453032522|FG007|Overall Study|Withdrawal by Subject|4|||
125928132|NCT03708328|453032523|FG008|Overall Study|Withdrawal by Subject|1|||
125928133|NCT03708328|453032524|FG009|Overall Study|Withdrawal by Subject|5|||
125928134|NCT03708328|453032515|FG000|Overall Study|Study Closed Locally|0|||
125928135|NCT03708328|453032516|FG001|Overall Study|Study Closed Locally|0|||
125928136|NCT03708328|453032517|FG002|Overall Study|Study Closed Locally|0|||
125928137|NCT03708328|453032518|FG003|Overall Study|Study Closed Locally|0|||
125928138|NCT03708328|453032519|FG004|Overall Study|Study Closed Locally|0|||
125928139|NCT03708328|453032520|FG005|Overall Study|Study Closed Locally|0|||
125928140|NCT03708328|453032521|FG006|Overall Study|Study Closed Locally|0|||
125928141|NCT03708328|453032522|FG007|Overall Study|Study Closed Locally|1|||
125928142|NCT03708328|453032523|FG008|Overall Study|Study Closed Locally|0|||
125928143|NCT03708328|453032524|FG009|Overall Study|Study Closed Locally|0|||
125928144|NCT03708328|453032515|FG000|Overall Study|Study Ended By Sponsor|0|||
125928145|NCT03708328|453032516|FG001|Overall Study|Study Ended By Sponsor|0|||
125928146|NCT03708328|453032517|FG002|Overall Study|Study Ended By Sponsor|0|||
125928147|NCT03708328|453032518|FG003|Overall Study|Study Ended By Sponsor|0|||
125928148|NCT03708328|453032519|FG004|Overall Study|Study Ended By Sponsor|0|||
125928149|NCT03708328|453032520|FG005|Overall Study|Study Ended By Sponsor|1|||
125928150|NCT03708328|453032521|FG006|Overall Study|Study Ended By Sponsor|0|||
125928151|NCT03708328|453032522|FG007|Overall Study|Study Ended By Sponsor|1|||
125928152|NCT03708328|453032523|FG008|Overall Study|Study Ended By Sponsor|0|||
125928153|NCT03708328|453032524|FG009|Overall Study|Study Ended By Sponsor|0|||
125928154|NCT03708328|453032515|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928155|NCT03708328|453032516|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928156|NCT03708328|453032517|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928157|NCT03708328|453032518|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928158|NCT03708328|453032519|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928159|NCT03708328|453032520|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928160|NCT03708328|453032521|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928161|NCT03708328|453032522|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928162|NCT03708328|453032523|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
125928163|NCT03708328|453032524|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125928164|NCT02605824|453032525|FG000|Overall Study|Physician Decision|1|||
125928165|NCT02605824|453032526|FG001|Overall Study|Physician Decision|0|||
125928166|NCT02695329|453032530|FG000|Overall Study|Adverse Event|1|||
125928167|NCT02695329|453032531|FG001|Overall Study|Adverse Event|0|||
125928168|NCT02695329|453032530|FG000|Overall Study|Poor X-ray quality for measurement|4|||
125928169|NCT02695329|453032531|FG001|Overall Study|Poor X-ray quality for measurement|5|||
125928170|NCT00843024|453032532|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
125928171|NCT00843024|453032533|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
125928172|NCT00843024|453032534|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
125928173|NCT00843024|453032535|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
125928174|NCT00843024|453032536|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
125928175|NCT00843024|453032537|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
125928176|NCT00843024|453032532|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
125928177|NCT00843024|453032533|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
125928178|NCT00843024|453032534|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
125928179|NCT00843024|453032535|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
125928180|NCT00843024|453032536|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
125928181|NCT00843024|453032537|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
125928182|NCT00843024|453032532|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
125928183|NCT00843024|453032533|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
125928184|NCT00843024|453032534|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
125928185|NCT00843024|453032535|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
125928186|NCT00843024|453032536|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
125928187|NCT00843024|453032537|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
125928188|NCT00843024|453032532|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
125928189|NCT00843024|453032533|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
125928190|NCT00843024|453032534|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
125928191|NCT00843024|453032535|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
125928192|NCT00843024|453032536|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
125928193|NCT00843024|453032537|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
125928194|NCT00843024|453032532|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
125928195|NCT00843024|453032533|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
125928196|NCT00843024|453032534|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
125928197|NCT00843024|453032535|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
125928198|NCT00843024|453032536|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
125928199|NCT00843024|453032537|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
125928200|NCT00843024|453032532|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125928201|NCT00843024|453032533|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
125928202|NCT00843024|453032534|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125928203|NCT00843024|453032535|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125928204|NCT00843024|453032536|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125928205|NCT00843024|453032537|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125928206|NCT00843024|453032532|FG000|Single-blind Placebo Run-In Phase|Other|0|||
125928207|NCT00843024|453032533|FG001|Single-blind Placebo Run-In Phase|Other|1|||
125928208|NCT00843024|453032534|FG002|Single-blind Placebo Run-In Phase|Other|0|||
125928209|NCT00843024|453032535|FG003|Single-blind Placebo Run-In Phase|Other|0|||
125928210|NCT00843024|453032536|FG004|Single-blind Placebo Run-In Phase|Other|0|||
125928211|NCT00843024|453032537|FG005|Single-blind Placebo Run-In Phase|Other|0|||
125928212|NCT00843024|453032532|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
125928213|NCT00843024|453032533|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
125928214|NCT00843024|453032534|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
125928215|NCT00843024|453032535|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
125928216|NCT00843024|453032536|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
125928217|NCT00843024|453032537|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
125928218|NCT00843024|453032532|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125928219|NCT00843024|453032533|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
125928220|NCT00843024|453032534|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
125928221|NCT00843024|453032535|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
125928222|NCT00843024|453032536|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
125928223|NCT00843024|453032537|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
125928224|NCT00843024|453032532|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125928225|NCT00843024|453032533|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125928226|NCT00843024|453032534|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125928227|NCT00843024|453032535|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
125928228|NCT00843024|453032536|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125928229|NCT00843024|453032537|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
125928230|NCT00843024|453032532|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
125928231|NCT00843024|453032533|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
125928232|NCT00843024|453032534|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
125928233|NCT00843024|453032535|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
125928234|NCT00843024|453032536|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
125928235|NCT00843024|453032537|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
125928236|NCT00843024|453032532|FG000|Double-blind Treatment Phase|Physician Decision|0|||
125928237|NCT00843024|453032533|FG001|Double-blind Treatment Phase|Physician Decision|0|||
125928238|NCT00843024|453032534|FG002|Double-blind Treatment Phase|Physician Decision|0|||
125928239|NCT00843024|453032535|FG003|Double-blind Treatment Phase|Physician Decision|3|||
125928240|NCT00843024|453032536|FG004|Double-blind Treatment Phase|Physician Decision|1|||
125928241|NCT00843024|453032537|FG005|Double-blind Treatment Phase|Physician Decision|1|||
125928242|NCT00843024|453032532|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125928243|NCT00843024|453032533|FG001|Double-blind Treatment Phase|Adverse Event|0|||
125928244|NCT00843024|453032534|FG002|Double-blind Treatment Phase|Adverse Event|0|||
125928245|NCT00843024|453032535|FG003|Double-blind Treatment Phase|Adverse Event|0|||
125928246|NCT00843024|453032536|FG004|Double-blind Treatment Phase|Adverse Event|1|||
125928247|NCT00843024|453032537|FG005|Double-blind Treatment Phase|Adverse Event|1|||
125928248|NCT00843024|453032532|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
125928249|NCT00843024|453032533|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
125928250|NCT00843024|453032534|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
125928251|NCT00843024|453032535|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
125928252|NCT00843024|453032536|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
125928253|NCT00843024|453032537|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
125928254|NCT01032837|453032538|FG000|Overall Study|Adverse event/internal illness|0|||
125928255|NCT01032837|453032539|FG001|Overall Study|Adverse event/internal illness|1|||
125928256|NCT01032837|453032540|FG002|Overall Study|Adverse event/internal illness|0|||
125928257|NCT01032837|453032541|FG003|Overall Study|Adverse event/internal illness|1|||
125928258|NCT01032837|453032538|FG000|Overall Study|Withdrew consent|0|||
125928259|NCT01032837|453032539|FG001|Overall Study|Withdrew consent|2|||
125928260|NCT01032837|453032540|FG002|Overall Study|Withdrew consent|0|||
125928261|NCT01032837|453032541|FG003|Overall Study|Withdrew consent|1|||
125928262|NCT01032837|453032538|FG000|Overall Study|Failed to return|0|||
125928263|NCT01032837|453032539|FG001|Overall Study|Failed to return|0|||
125928264|NCT01032837|453032540|FG002|Overall Study|Failed to return|1|||
125928265|NCT01032837|453032541|FG003|Overall Study|Failed to return|0|||
125928266|NCT01032837|453032538|FG000|Overall Study|Refused treatment|0|||
125928267|NCT01032837|453032539|FG001|Overall Study|Refused treatment|0|||
125928268|NCT01032837|453032540|FG002|Overall Study|Refused treatment|0|||
125928269|NCT01032837|453032541|FG003|Overall Study|Refused treatment|1|||
125928270|NCT02439138|453032543|FG000|Overall Study|Adverse Event|1|||
125928271|NCT02439138|453032543|FG000|Overall Study|PI decision to terminate the study|2|||
125928272|NCT00006237|453032548|FG000|Overall Study|Adverse Event|39|||
125928273|NCT00006237|453032549|FG001|Overall Study|Adverse Event|29|||
125928274|NCT00006237|453032548|FG000|Overall Study|Death|1|||
125928275|NCT00006237|453032549|FG001|Overall Study|Death|0|||
125928276|NCT00006237|453032548|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
125928277|NCT00006237|453032549|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
125928278|NCT00006237|453032548|FG000|Overall Study|Progression/relapse|54|||
125928279|NCT00006237|453032549|FG001|Overall Study|Progression/relapse|2|||
125928280|NCT00006237|453032548|FG000|Overall Study|Not eligible|9|||
125928281|NCT00006237|453032549|FG001|Overall Study|Not eligible|20|||
125928282|NCT00006237|453032548|FG000|Overall Study|Withdrawal by Subject|0|||
125928283|NCT00006237|453032549|FG001|Overall Study|Withdrawal by Subject|1|||
125928284|NCT00006237|453032548|FG000|Overall Study|Not protocol specified|14|||
125928285|NCT00006237|453032549|FG001|Overall Study|Not protocol specified|5|||
125928286|NCT01846416|453032552|FG000|Treatment Phase|Death|2|||
125928287|NCT01846416|453032553|FG001|Treatment Phase|Death|9|||
125928288|NCT01846416|453032554|FG002|Treatment Phase|Death|1|||
125928289|NCT01846416|453032552|FG000|Treatment Phase|Withdrawal by Subject|2|||
125928290|NCT01846416|453032553|FG001|Treatment Phase|Withdrawal by Subject|4|||
125928291|NCT01846416|453032554|FG002|Treatment Phase|Withdrawal by Subject|2|||
125928292|NCT01846416|453032552|FG000|Treatment Phase|Other|1|||
125928293|NCT01846416|453032553|FG001|Treatment Phase|Other|5|||
125928294|NCT01846416|453032554|FG002|Treatment Phase|Other|1|||
125928295|NCT01846416|453032552|FG000|Treatment Phase|Physician Decision|1|||
125928296|NCT01846416|453032553|FG001|Treatment Phase|Physician Decision|2|||
125928297|NCT01846416|453032554|FG002|Treatment Phase|Physician Decision|0|||
125928298|NCT01846416|453032552|FG000|Treatment Phase|Adverse Event|3|||
125928299|NCT01846416|453032553|FG001|Treatment Phase|Adverse Event|4|||
125928300|NCT01846416|453032554|FG002|Treatment Phase|Adverse Event|0|||
125928301|NCT01846416|453032552|FG000|Treatment Phase|Non-compliance|0|||
125928302|NCT01846416|453032553|FG001|Treatment Phase|Non-compliance|2|||
125928303|NCT01846416|453032554|FG002|Treatment Phase|Non-compliance|0|||
125928304|NCT01846416|453032552|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
125928305|NCT01846416|453032553|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
125928306|NCT01846416|453032554|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
125928307|NCT01846416|453032552|FG000|Treatment Phase|Progressive Disease|21|||
125928308|NCT01846416|453032553|FG001|Treatment Phase|Progressive Disease|63|||
125928309|NCT01846416|453032554|FG002|Treatment Phase|Progressive Disease|9|||
125928310|NCT01846416|453032552|FG000|Survival Follow-up|Death|21|||
125928311|NCT01846416|453032553|FG001|Survival Follow-up|Death|62|||
125928312|NCT01846416|453032554|FG002|Survival Follow-up|Death|9|||
125928313|NCT01846416|453032552|FG000|Survival Follow-up|Lost to Follow-up|0|||
125928314|NCT01846416|453032553|FG001|Survival Follow-up|Lost to Follow-up|2|||
125928315|NCT01846416|453032554|FG002|Survival Follow-up|Lost to Follow-up|2|||
125928316|NCT01846416|453032552|FG000|Survival Follow-up|Withdrawal by Subject|2|||
125928317|NCT01846416|453032553|FG001|Survival Follow-up|Withdrawal by Subject|7|||
125928318|NCT01846416|453032554|FG002|Survival Follow-up|Withdrawal by Subject|0|||
125928319|NCT01846416|453032552|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
125928320|NCT01846416|453032553|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
125928321|NCT01846416|453032554|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
125928322|NCT01846416|453032552|FG000|Survival Follow-up|Other|3|||
125928323|NCT01846416|453032553|FG001|Survival Follow-up|Other|1|||
125928324|NCT01846416|453032554|FG002|Survival Follow-up|Other|1|||
125928325|NCT01962896|453032557|FG000|Overall Study|Lack of Efficacy|4|||
125928326|NCT02837783|453032558|FG000|Overall Study|Adverse Event|1|||
125928327|NCT02837783|453032559|FG001|Overall Study|Adverse Event|0|||
125928328|NCT02837783|453032558|FG000|Overall Study|Other, Not Specified|1|||
125928329|NCT02837783|453032559|FG001|Overall Study|Other, Not Specified|2|||
125928330|NCT01487200|453032560|FG000|Overall Study|Withdrawal by Subject|0|||
125928331|NCT01487200|453032561|FG001|Overall Study|Withdrawal by Subject|1|||
125928332|NCT01487200|453032562|FG002|Overall Study|Withdrawal by Subject|0|||
125928333|NCT01487200|453032563|FG003|Overall Study|Withdrawal by Subject|0|||
125928334|NCT02216591|453032564|FG000|Overall Study|Lost to Follow-up|0|||
125928335|NCT02216591|453032565|FG001|Overall Study|Lost to Follow-up|1|||
125928336|NCT02207244|453032566|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
125928337|NCT02207244|453032567|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
125928338|NCT02207244|453032568|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
125928339|NCT02207244|453032569|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125928340|NCT02207244|453032570|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125928341|NCT02207244|453032571|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125928342|NCT02207244|453032572|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125928343|NCT02207244|453032573|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125928344|NCT02207244|453032574|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125928345|NCT02207244|453032575|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125928346|NCT02207244|453032576|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125928347|NCT02207244|453032566|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
125928348|NCT02207244|453032567|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928349|NCT02207244|453032568|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
125928350|NCT02207244|453032569|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928351|NCT02207244|453032570|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928352|NCT02207244|453032571|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928353|NCT02207244|453032572|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928354|NCT02207244|453032573|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928355|NCT02207244|453032574|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928356|NCT02207244|453032575|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928357|NCT02207244|453032576|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125928358|NCT02207244|453032566|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
125928359|NCT02207244|453032567|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
125928360|NCT02207244|453032568|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
125928361|NCT02207244|453032569|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125928362|NCT02207244|453032570|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125928363|NCT02207244|453032571|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125928364|NCT02207244|453032572|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125928365|NCT02207244|453032573|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125928366|NCT02207244|453032574|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125928367|NCT02207244|453032575|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125928368|NCT02207244|453032576|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125928369|NCT02207244|453032566|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
125928370|NCT02207244|453032567|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
125928371|NCT02207244|453032568|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125928372|NCT02207244|453032569|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125928373|NCT02207244|453032570|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125928374|NCT02207244|453032571|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125928375|NCT02207244|453032572|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125928376|NCT02207244|453032573|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125928377|NCT02207244|453032574|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126112574|NCT03627767|453709475|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
126112575|NCT03627767|453709476|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
126112576|NCT03627767|453709477|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
126112577|NCT03627767|453709478|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
126112578|NCT03627767|453709474|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
126112579|NCT03627767|453709475|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
126112580|NCT03627767|453709476|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
126112581|NCT03627767|453709477|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
126112582|NCT03627767|453709478|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
126112583|NCT03627767|453709474|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126112584|NCT03627767|453709475|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126112585|NCT03627767|453709476|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
126112586|NCT03627767|453709477|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
126112587|NCT03627767|453709478|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126112588|NCT03627767|453709474|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
126112589|NCT03627767|453709475|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
126112590|NCT03627767|453709476|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
126112591|NCT03627767|453709477|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
126112592|NCT03627767|453709478|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
126112593|NCT03627767|453709474|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
126112594|NCT03627767|453709475|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
126112595|NCT03627767|453709476|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
126112596|NCT03627767|453709477|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
126112597|NCT03627767|453709478|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
126112598|NCT03627767|453709474|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
126112599|NCT03627767|453709475|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
126112600|NCT03627767|453709476|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
126112601|NCT03627767|453709477|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
126112602|NCT03627767|453709478|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
126112603|NCT03627767|453709474|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
126112604|NCT03627767|453709475|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
126112605|NCT03627767|453709476|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
126112606|NCT03627767|453709477|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
126112607|NCT03627767|453709478|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
126112608|NCT03627767|453709474|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
126112609|NCT03627767|453709475|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
126112610|NCT03627767|453709476|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
126112611|NCT03627767|453709477|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
126112612|NCT03627767|453709478|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
126112613|NCT03627767|453709474|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
126112614|NCT03627767|453709475|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125928378|NCT02207244|453032575|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125928379|NCT02207244|453032576|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125928380|NCT02207244|453032566|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
126112615|NCT03627767|453709476|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
126112616|NCT03627767|453709477|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
126112617|NCT03627767|453709478|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
126112618|NCT03627767|453709474|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
126112619|NCT03627767|453709475|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
126112620|NCT03627767|453709476|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
126112621|NCT03627767|453709477|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
126112622|NCT03627767|453709478|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
126112623|NCT03627767|453709474|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
126112624|NCT03627767|453709475|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
126112625|NCT03627767|453709476|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
126112626|NCT03627767|453709477|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
126112627|NCT03627767|453709478|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
126112628|NCT01873417|453709479|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
126112629|NCT01873417|453709479|FG000|Overall Study|Adverse Event|24|||
126112630|NCT01873417|453709479|FG000|Overall Study|Lost to Follow-up|2|||
125928381|NCT02207244|453032567|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
125928382|NCT02207244|453032568|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
125928383|NCT02207244|453032569|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125928384|NCT02207244|453032570|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126112631|NCT01873417|453709479|FG000|Overall Study|Withdrawal by Subject|2|||
125928385|NCT02207244|453032571|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125928386|NCT02207244|453032572|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125928387|NCT02207244|453032573|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125928388|NCT02207244|453032574|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125928389|NCT02207244|453032575|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125928390|NCT02207244|453032576|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125928391|NCT02207244|453032566|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928392|NCT02207244|453032567|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
125928393|NCT02207244|453032568|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
125928394|NCT02207244|453032569|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928395|NCT02207244|453032570|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928396|NCT02207244|453032571|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928397|NCT02207244|453032572|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928398|NCT02207244|453032573|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928399|NCT02207244|453032574|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928400|NCT02207244|453032575|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928401|NCT02207244|453032576|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125928402|NCT02207244|453032566|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928403|NCT02207244|453032567|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
125928404|NCT02207244|453032568|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928405|NCT02207244|453032569|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928406|NCT02207244|453032570|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928407|NCT02207244|453032571|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928408|NCT02207244|453032572|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928409|NCT02207244|453032573|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928410|NCT02207244|453032574|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928411|NCT02207244|453032575|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928412|NCT02207244|453032576|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
125928413|NCT02207244|453032566|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928414|NCT02207244|453032567|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928415|NCT02207244|453032568|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928416|NCT02207244|453032569|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928417|NCT02207244|453032570|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
125928418|NCT02207244|453032571|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
125928419|NCT02207244|453032572|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928420|NCT02207244|453032573|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928421|NCT02207244|453032574|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928422|NCT02207244|453032575|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928423|NCT02207244|453032576|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125928424|NCT02207244|453032566|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928425|NCT02207244|453032567|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928426|NCT02207244|453032568|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928427|NCT02207244|453032569|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928428|NCT02207244|453032570|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928429|NCT02207244|453032571|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
125928430|NCT02207244|453032572|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928431|NCT02207244|453032573|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928432|NCT02207244|453032574|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928433|NCT02207244|453032575|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928434|NCT02207244|453032576|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125928435|NCT02207244|453032566|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125928436|NCT02207244|453032567|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125928437|NCT02207244|453032568|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125928438|NCT02207244|453032569|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
125928439|NCT02207244|453032570|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
125928440|NCT02207244|453032571|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
125928441|NCT02207244|453032572|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125928442|NCT02207244|453032573|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126065429|NCT00525915|453530789|FG000|Overall Study|Disease Progression|5|||
126065430|NCT00525915|453530790|FG001|Overall Study|Disease Progression|6|||
126065431|NCT00525915|453530789|FG000|Overall Study|Withdrawal by Subject|1|||
126065432|NCT00525915|453530790|FG001|Overall Study|Withdrawal by Subject|0|||
126065433|NCT00525915|453530789|FG000|Overall Study|Refused Surgery|1|||
126065434|NCT00525915|453530790|FG001|Overall Study|Refused Surgery|2|||
126065435|NCT00525915|453530789|FG000|Overall Study|Unrelated illness|1|||
126065436|NCT00525915|453530790|FG001|Overall Study|Unrelated illness|0|||
126065437|NCT03122548|453530792|FG000|Overall Study|Death|2|||
125928443|NCT02207244|453032574|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126065438|NCT03122548|453530792|FG000|Overall Study|Progression - subject went into hospice|1|||
125928444|NCT02207244|453032575|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125928445|NCT02207244|453032576|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125928446|NCT02207244|453032566|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125928447|NCT02207244|453032567|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125928448|NCT02207244|453032568|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125928449|NCT02207244|453032569|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
125928450|NCT02207244|453032570|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
125928451|NCT02207244|453032571|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
125928452|NCT02207244|453032572|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125928453|NCT02207244|453032573|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125928454|NCT02207244|453032574|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125928455|NCT02207244|453032575|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125928456|NCT02207244|453032576|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125928457|NCT02207244|453032566|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928458|NCT02207244|453032567|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928459|NCT02207244|453032568|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928460|NCT02207244|453032569|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
125928461|NCT02207244|453032570|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928462|NCT02207244|453032571|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
125928463|NCT02207244|453032572|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928464|NCT02207244|453032573|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928465|NCT02207244|453032574|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928466|NCT02207244|453032575|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928467|NCT02207244|453032576|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125928468|NCT02207244|453032566|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928469|NCT02207244|453032567|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928470|NCT02207244|453032568|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928471|NCT02207244|453032569|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
125928472|NCT02207244|453032570|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928473|NCT02207244|453032571|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928474|NCT02207244|453032572|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928475|NCT02207244|453032573|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928476|NCT02207244|453032574|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928477|NCT02207244|453032575|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928478|NCT02207244|453032576|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
125928479|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125928480|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125928481|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125928482|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125928483|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125928484|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125928485|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
125928486|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
125928487|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
125928488|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
125928489|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125928490|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928491|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928492|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928493|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928494|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928495|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928496|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928497|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
125928498|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928499|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928500|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125928501|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125928502|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125928503|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125928504|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125928505|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125928506|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125928507|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
125928508|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
125928509|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
125928510|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
125928511|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125928512|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125928513|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125928514|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125928515|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125928516|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125928517|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125928518|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
125928519|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
125928520|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125928521|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
125928522|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125928523|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125928524|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125928525|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125928526|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125928527|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125928528|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125928529|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
125928530|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
125928531|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
125928532|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
125928533|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125928534|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928535|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928536|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928537|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928538|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928539|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928540|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928541|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
125928542|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
125928543|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928544|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125928545|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928546|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928547|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928548|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928549|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928550|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928551|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928552|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928553|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
125928554|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928555|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125928556|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928557|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928558|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928559|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928560|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928561|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928562|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928563|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
125928564|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928565|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928566|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125928567|NCT02207244|453032566|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126065439|NCT03122548|453530792|FG000|Overall Study|Study Terminated by Sponsor|2|||
126065440|NCT02332889|453530795|FG000|Overall Study|Physician Decision|1|||
126065441|NCT05356130|453532105|FG000|Overall Study|Withdrawal by Subject|0|||
126065442|NCT05356130|453532106|FG001|Overall Study|Withdrawal by Subject|0|||
126065443|NCT05356130|453532107|FG002|Overall Study|Withdrawal by Subject|3|||
125928568|NCT02207244|453032567|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126065444|NCT03141177|453532108|FG000|Overall Study|Death|62|||
126112632|NCT01873417|453709479|FG000|Overall Study|Physician Decision|3|||
126112633|NCT00785044|453709480|FG000|Overall Study|Dosed at non-participating sites|152|||
126112634|NCT00785044|453709480|FG000|Overall Study|Death|77|||
126112635|NCT00785044|453709480|FG000|Overall Study|Lost to Follow-up|266|||
126112636|NCT00785044|453709480|FG000|Overall Study|Withdrawal by Subject|1|||
126112637|NCT00385203|453709481|FG000|Overall Study|Adverse Event|5|||
126112638|NCT00385203|453709482|FG001|Overall Study|Adverse Event|4|||
126112639|NCT00385203|453709481|FG000|Overall Study|Death|1|||
126112640|NCT00385203|453709482|FG001|Overall Study|Death|0|||
126112641|NCT00385203|453709481|FG000|Overall Study|Condition under investigation worsened|18|||
125928569|NCT02207244|453032568|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125928570|NCT02207244|453032569|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125928571|NCT02207244|453032570|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125928572|NCT02207244|453032571|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125928573|NCT02207244|453032572|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
125928574|NCT02207244|453032573|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125928575|NCT02207244|453032574|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125928576|NCT02207244|453032575|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125928577|NCT02207244|453032576|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125928578|NCT02207244|453032566|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125928579|NCT02207244|453032567|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126065445|NCT03141177|453532109|FG001|Overall Study|Death|13|||
126065446|NCT03141177|453532110|FG002|Overall Study|Death|84|||
126065447|NCT03141177|453532108|FG000|Overall Study|Participant withdrew consent|9|||
126065448|NCT03141177|453532109|FG001|Overall Study|Participant withdrew consent|2|||
126065449|NCT03141177|453532110|FG002|Overall Study|Participant withdrew consent|13|||
126065450|NCT03141177|453532108|FG000|Overall Study|Not reported|1|||
126065451|NCT03141177|453532109|FG001|Overall Study|Not reported|0|||
126065452|NCT03141177|453532110|FG002|Overall Study|Not reported|1|||
126065453|NCT03141177|453532108|FG000|Overall Study|Lost to Follow-up|2|||
126065454|NCT03141177|453532109|FG001|Overall Study|Lost to Follow-up|1|||
126065455|NCT03141177|453532110|FG002|Overall Study|Lost to Follow-up|1|||
126065456|NCT03141177|453532108|FG000|Overall Study|Other reasons|4|||
126065457|NCT03141177|453532109|FG001|Overall Study|Other reasons|0|||
126065458|NCT03141177|453532110|FG002|Overall Study|Other reasons|11|||
126065459|NCT03141177|453532108|FG000|Overall Study|Participants did not start treatment period|3|||
126065460|NCT03141177|453532109|FG001|Overall Study|Participants did not start treatment period|0|||
126065461|NCT03141177|453532110|FG002|Overall Study|Participants did not start treatment period|8|||
126112642|NCT00385203|453709482|FG001|Overall Study|Condition under investigation worsened|3|||
126112643|NCT00385203|453709481|FG000|Overall Study|Incorrect enrollment|2|||
125928580|NCT02207244|453032568|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125928581|NCT02207244|453032569|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125928582|NCT02207244|453032570|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125928583|NCT02207244|453032571|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125928584|NCT02207244|453032572|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125928585|NCT02207244|453032573|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125928586|NCT02207244|453032574|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
125928587|NCT02207244|453032575|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125928588|NCT02207244|453032576|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
125928589|NCT02207244|453032566|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928590|NCT02207244|453032567|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928591|NCT02207244|453032568|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928592|NCT02207244|453032569|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928593|NCT02207244|453032570|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928594|NCT02207244|453032571|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928595|NCT02207244|453032572|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928596|NCT02207244|453032573|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928597|NCT02207244|453032574|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
125928598|NCT02207244|453032575|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125928599|NCT02207244|453032576|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
125928600|NCT02207244|453032566|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126065462|NCT03020914|453532113|FG000|Overall Study|Surgery Cancelled|1|||
126112644|NCT00385203|453709482|FG001|Overall Study|Incorrect enrollment|0|||
126065463|NCT03020914|453532114|FG001|Overall Study|Surgery Cancelled|0|||
126065464|NCT02109172|453532119|FG000|Overall Study|Withdrawal by Subject|1|||
126065465|NCT02109172|453532120|FG001|Overall Study|Withdrawal by Subject|0|||
126112645|NCT01798992|453709483|FG000|Overall Study|Administrative withdrawal|0|||
126112646|NCT01798992|453709484|FG001|Overall Study|Administrative withdrawal|1|||
126112647|NCT01798992|453709485|FG002|Overall Study|Administrative withdrawal|0|||
125928601|NCT02207244|453032567|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125928602|NCT02207244|453032568|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125928603|NCT02207244|453032569|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125928604|NCT02207244|453032570|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125928605|NCT02207244|453032571|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125928606|NCT02207244|453032572|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125928607|NCT02207244|453032573|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125928608|NCT02207244|453032574|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
125928609|NCT02207244|453032575|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125928610|NCT02207244|453032576|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
125928611|NCT02207244|453032566|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928612|NCT02207244|453032567|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928613|NCT02207244|453032568|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928614|NCT02207244|453032569|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928615|NCT02207244|453032570|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928616|NCT02207244|453032571|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928617|NCT02207244|453032572|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928618|NCT02207244|453032573|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928619|NCT02207244|453032574|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
125928620|NCT02207244|453032575|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125928621|NCT02207244|453032576|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
125928622|NCT02207244|453032566|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
125928623|NCT02207244|453032567|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
125928624|NCT02207244|453032568|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
125928625|NCT02207244|453032569|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
125928626|NCT02207244|453032570|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
125928627|NCT02207244|453032571|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
125928628|NCT02207244|453032572|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
125928629|NCT02207244|453032573|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
125928630|NCT02207244|453032574|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
125928631|NCT02207244|453032575|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
125928632|NCT02207244|453032576|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
125928633|NCT02207244|453032566|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
125928634|NCT02207244|453032567|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
125928635|NCT02207244|453032568|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
125928636|NCT02207244|453032569|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
125928637|NCT02207244|453032570|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
125928638|NCT02207244|453032571|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
125928639|NCT02207244|453032572|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
125928640|NCT02207244|453032573|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
125928641|NCT02207244|453032574|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
125928642|NCT02207244|453032575|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
125928643|NCT02207244|453032576|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
125928644|NCT02207244|453032566|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928645|NCT02207244|453032567|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928646|NCT02207244|453032568|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928647|NCT02207244|453032569|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928648|NCT02207244|453032570|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928649|NCT02207244|453032571|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928650|NCT02207244|453032572|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928651|NCT02207244|453032573|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928652|NCT02207244|453032574|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928653|NCT02207244|453032575|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125928654|NCT02207244|453032576|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
125928655|NCT00039130|453032577|FG000|Overall Study|Adverse Event|11|||
125928656|NCT00039130|453032577|FG000|Overall Study|Death|9|||
125928657|NCT00039130|453032577|FG000|Overall Study|Withdrawal by Subject|3|||
125928658|NCT00039130|453032577|FG000|Overall Study|Progression|2|||
125928659|NCT00039130|453032577|FG000|Overall Study|Subsequent treatment|2|||
125928660|NCT00039130|453032577|FG000|Overall Study|Physician Decision|3|||
125928661|NCT01866930|453032578|FG000|Treatment Period|Other|1|||
125928662|NCT01866930|453032579|FG001|Treatment Period|Other|0|||
125928663|NCT01866930|453032578|FG000|Treatment Period|Death|0|||
125928664|NCT01866930|453032579|FG001|Treatment Period|Death|2|||
125928665|NCT01866930|453032578|FG000|Treatment Period|Poor/non compliance|0|||
125928666|NCT01866930|453032579|FG001|Treatment Period|Poor/non compliance|2|||
125928667|NCT01866930|453032578|FG000|Treatment Period|No longer meets study criteria|0|||
125928668|NCT01866930|453032579|FG001|Treatment Period|No longer meets study criteria|1|||
125928669|NCT01866930|453032578|FG000|Treatment Period|Withdrawal by Subject|2|||
125928670|NCT01866930|453032579|FG001|Treatment Period|Withdrawal by Subject|8|||
125928671|NCT01866930|453032578|FG000|Treatment Period|Lack of Efficacy|1|||
125928672|NCT01866930|453032579|FG001|Treatment Period|Lack of Efficacy|9|||
125928673|NCT01866930|453032578|FG000|Treatment Period|Adverse Event|4|||
125928674|NCT01866930|453032579|FG001|Treatment Period|Adverse Event|12|||
125928675|NCT01866930|453032578|FG000|Treatment Period|Lost to Follow-up|1|||
125928676|NCT01866930|453032579|FG001|Treatment Period|Lost to Follow-up|1|||
125928677|NCT01866930|453032578|FG000|Follow-up Period|Lost to Follow-up|1|||
125928678|NCT01866930|453032579|FG001|Follow-up Period|Lost to Follow-up|1|||
125928679|NCT01866930|453032578|FG000|Follow-up Period|Other|1|||
125928680|NCT01866930|453032579|FG001|Follow-up Period|Other|5|||
125928681|NCT01866930|453032578|FG000|Follow-up Period|No longer required per protocol|1|||
125928682|NCT01866930|453032579|FG001|Follow-up Period|No longer required per protocol|0|||
125928683|NCT01866930|453032578|FG000|Follow-up Period|Withdrawal by Subject|3|||
125928684|NCT01866930|453032579|FG001|Follow-up Period|Withdrawal by Subject|3|||
125928685|NCT00279305|453032582|FG000|Overall Study|Pregnancy|1|||
125928686|NCT00279305|453032583|FG001|Overall Study|Pregnancy|0|||
125928687|NCT00279305|453032582|FG000|Overall Study|Withdrawal by Subject|2|||
125928688|NCT00279305|453032583|FG001|Overall Study|Withdrawal by Subject|0|||
125928689|NCT00279305|453032582|FG000|Overall Study|Dificulting establishing IV|1|||
125928690|NCT00279305|453032583|FG001|Overall Study|Dificulting establishing IV|0|||
125928691|NCT00279305|453032582|FG000|Overall Study|FDA Safety Alert|4|||
125928692|NCT00279305|453032583|FG001|Overall Study|FDA Safety Alert|1|||
125928693|NCT00621153|453032592|FG000|Overall Study|Safety Reason|8|||
125928694|NCT00621153|453032593|FG001|Overall Study|Safety Reason|7|||
125928695|NCT00621153|453032592|FG000|Overall Study|Adverse Event|3|||
125928696|NCT00621153|453032593|FG001|Overall Study|Adverse Event|2|||
125928697|NCT00621153|453032592|FG000|Overall Study|Lost to Follow-up|5|||
125928698|NCT00621153|453032593|FG001|Overall Study|Lost to Follow-up|1|||
125928699|NCT00621153|453032592|FG000|Overall Study|Withdrawal by Subject|4|||
125928700|NCT00621153|453032593|FG001|Overall Study|Withdrawal by Subject|5|||
125928701|NCT00753415|453032594|FG000|Part A|Disease progression|1|||
125928702|NCT00753415|453032595|FG001|Part A|Disease progression|0|||
125928703|NCT00753415|453032596|FG002|Part A|Disease progression|1|||
125928704|NCT00753415|453032597|FG003|Part A|Disease progression|2|||
125928705|NCT00753415|453032598|FG004|Part A|Disease progression|0|||
125928706|NCT00753415|453032599|FG005|Part A|Disease progression|0|||
125928707|NCT00753415|453032600|FG006|Part A|Disease progression|0|||
125928708|NCT00753415|453032601|FG007|Part A|Disease progression|0|||
125928709|NCT00753415|453032602|FG008|Part A|Disease progression|0|||
125928710|NCT00753415|453032603|FG009|Part A|Disease progression|0|||
125928711|NCT00753415|453032594|FG000|Part A|Withdrawal by Subject|0|||
125928712|NCT00753415|453032595|FG001|Part A|Withdrawal by Subject|0|||
125928713|NCT00753415|453032596|FG002|Part A|Withdrawal by Subject|1|||
125928714|NCT00753415|453032597|FG003|Part A|Withdrawal by Subject|0|||
125928715|NCT00753415|453032598|FG004|Part A|Withdrawal by Subject|0|||
125928716|NCT00753415|453032599|FG005|Part A|Withdrawal by Subject|0|||
125928717|NCT00753415|453032600|FG006|Part A|Withdrawal by Subject|0|||
125928718|NCT00753415|453032601|FG007|Part A|Withdrawal by Subject|0|||
125928719|NCT00753415|453032602|FG008|Part A|Withdrawal by Subject|0|||
125928720|NCT00753415|453032603|FG009|Part A|Withdrawal by Subject|0|||
125928721|NCT00753415|453032594|FG000|Part B|Lost to Follow-up|0|||
125928722|NCT00753415|453032595|FG001|Part B|Lost to Follow-up|0|||
125928723|NCT00753415|453032596|FG002|Part B|Lost to Follow-up|0|||
125928724|NCT00753415|453032597|FG003|Part B|Lost to Follow-up|0|||
125928725|NCT00753415|453032598|FG004|Part B|Lost to Follow-up|0|||
125928726|NCT00753415|453032599|FG005|Part B|Lost to Follow-up|0|||
125928727|NCT00753415|453032600|FG006|Part B|Lost to Follow-up|0|||
125928728|NCT00753415|453032601|FG007|Part B|Lost to Follow-up|1|||
125928729|NCT00753415|453032602|FG008|Part B|Lost to Follow-up|1|||
125928730|NCT00753415|453032603|FG009|Part B|Lost to Follow-up|0|||
125928731|NCT00753415|453032594|FG000|Part B|Disease progression|0|||
125928732|NCT00753415|453032595|FG001|Part B|Disease progression|0|||
125928733|NCT00753415|453032596|FG002|Part B|Disease progression|0|||
125928734|NCT00753415|453032597|FG003|Part B|Disease progression|0|||
125928735|NCT00753415|453032598|FG004|Part B|Disease progression|0|||
125928736|NCT00753415|453032599|FG005|Part B|Disease progression|0|||
125928737|NCT00753415|453032600|FG006|Part B|Disease progression|0|||
126112648|NCT01798992|453709486|FG003|Overall Study|Administrative withdrawal|1|||
126112649|NCT01798992|453709483|FG000|Overall Study|Lost to Follow-up|0|||
125928738|NCT00753415|453032601|FG007|Part B|Disease progression|0|||
125928739|NCT00753415|453032602|FG008|Part B|Disease progression|2|||
125928740|NCT00753415|453032603|FG009|Part B|Disease progression|1|||
125928741|NCT03919799|453032604|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
125928742|NCT03919799|453032605|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
125928743|NCT03919799|453032606|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
125928744|NCT03919799|453032607|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
125928745|NCT03919799|453032608|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
125928746|NCT03919799|453032604|FG000|DB Period (28 Weeks)|Adverse Event|1|||
125928747|NCT03919799|453032605|FG001|DB Period (28 Weeks)|Adverse Event|1|||
125928748|NCT03919799|453032606|FG002|DB Period (28 Weeks)|Adverse Event|1|||
125928749|NCT03919799|453032607|FG003|DB Period (28 Weeks)|Adverse Event|0|||
125928750|NCT03919799|453032608|FG004|DB Period (28 Weeks)|Adverse Event|0|||
126112650|NCT01798992|453709484|FG001|Overall Study|Lost to Follow-up|1|||
125928751|NCT03919799|453032604|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
125928752|NCT03919799|453032605|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
125928753|NCT03919799|453032606|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
125928754|NCT03919799|453032607|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
125928755|NCT03919799|453032608|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
125928756|NCT03919799|453032604|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
125928757|NCT03919799|453032605|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
125928758|NCT03919799|453032606|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
125928759|NCT03919799|453032607|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
125928760|NCT03919799|453032608|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
125928761|NCT03919799|453032604|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
125928762|NCT03919799|453032605|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
125928763|NCT03919799|453032606|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
125928764|NCT03919799|453032607|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
125928765|NCT03919799|453032608|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
125928766|NCT04023526|453034809|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
125928767|NCT04023526|453034810|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
125928768|NCT04023526|453034809|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
125928769|NCT04023526|453034810|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
125928770|NCT01411774|453034823|FG000|Overall Study|Withdrawal by Subject|0|||
125928771|NCT01411774|453034824|FG001|Overall Study|Withdrawal by Subject|3|||
125928772|NCT00056316|453034825|FG000|Overall Study|Withdrawal by Subject|2|||
125928773|NCT00056316|453034826|FG001|Overall Study|Withdrawal by Subject|2|||
125928774|NCT00056316|453034825|FG000|Overall Study|Death/NH placement of pt|1|||
125928775|NCT00056316|453034826|FG001|Overall Study|Death/NH placement of pt|1|||
125928776|NCT00903695|453034831|FG000|Overall Study|medical exclusion after 1st testing|1|||
125928777|NCT00903695|453034832|FG001|Overall Study|medical exclusion after 1st testing|0|||
125928778|NCT00903695|453034831|FG000|Overall Study|lung cancer|1|||
125928779|NCT00903695|453034832|FG001|Overall Study|lung cancer|0|||
125928780|NCT03902574|453034842|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
125928781|NCT03902574|453034843|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
125928782|NCT03902574|453034844|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
125928783|NCT02269241|453034847|FG000|Overall Study|Lost to Follow-up|269|||
125928784|NCT02269241|453034847|FG000|Overall Study|Withdrawal by Subject|155|||
125928785|NCT02269241|453034847|FG000|Overall Study|Protocol Violation|1|||
125928786|NCT02269241|453034847|FG000|Overall Study|Physician Decision|7|||
125928787|NCT02269241|453034847|FG000|Overall Study|Pregnancy|15|||
125928788|NCT02269241|453034847|FG000|Overall Study|Wish for pregnancy|5|||
125928789|NCT02269241|453034847|FG000|Overall Study|Development of an exclusion criteria|16|||
125928790|NCT02269241|453034847|FG000|Overall Study|Adverse Event|113|||
125928791|NCT02269241|453034847|FG000|Overall Study|At the specific request of the sponsor|20|||
125928792|NCT02269241|453034847|FG000|Overall Study|Several reasons not classified|53|||
125928793|NCT02269241|453034847|FG000|Overall Study|Screening failures|546|||
125928794|NCT01218204|453034850|FG000|Part B Washout|Adverse Event|0|||
125928795|NCT01218204|453034851|FG001|Part B Washout|Adverse Event|1|||
125928796|NCT01218204|453034852|FG002|Part B Washout|Adverse Event|0|||
125928797|NCT01218204|453034853|FG003|Part B Washout|Adverse Event|0|||
125928798|NCT01218204|453034850|FG000|Part B Washout|Lost to Follow-up|0|||
125928799|NCT01218204|453034851|FG001|Part B Washout|Lost to Follow-up|2|||
125928800|NCT01218204|453034852|FG002|Part B Washout|Lost to Follow-up|0|||
125928801|NCT01218204|453034853|FG003|Part B Washout|Lost to Follow-up|0|||
125928802|NCT01218204|453034850|FG000|Part B Washout|Physician Decision|0|||
125928803|NCT01218204|453034851|FG001|Part B Washout|Physician Decision|14|||
125928804|NCT01218204|453034852|FG002|Part B Washout|Physician Decision|0|||
125928805|NCT01218204|453034853|FG003|Part B Washout|Physician Decision|0|||
125928806|NCT01218204|453034850|FG000|Part B Washout|Withdrawal by Subject|0|||
125928807|NCT01218204|453034851|FG001|Part B Washout|Withdrawal by Subject|14|||
125928808|NCT01218204|453034852|FG002|Part B Washout|Withdrawal by Subject|0|||
125928809|NCT01218204|453034853|FG003|Part B Washout|Withdrawal by Subject|0|||
125928810|NCT01218204|453034850|FG000|Part B Washout|Reached defined stopping criteria|0|||
125928811|NCT01218204|453034851|FG001|Part B Washout|Reached defined stopping criteria|2|||
125928812|NCT01218204|453034852|FG002|Part B Washout|Reached defined stopping criteria|0|||
125928813|NCT01218204|453034853|FG003|Part B Washout|Reached defined stopping criteria|0|||
125928814|NCT01218204|453034850|FG000|Part B Washout|Did not meet continuation criteria|0|||
125928815|NCT01218204|453034851|FG001|Part B Washout|Did not meet continuation criteria|112|||
125928816|NCT01218204|453034852|FG002|Part B Washout|Did not meet continuation criteria|0|||
125928817|NCT01218204|453034853|FG003|Part B Washout|Did not meet continuation criteria|0|||
125928818|NCT01218204|453034850|FG000|Part B Run-in|Adverse Event|0|||
126112651|NCT01798992|453709485|FG002|Overall Study|Lost to Follow-up|1|||
125928819|NCT01218204|453034851|FG001|Part B Run-in|Adverse Event|0|||
125928820|NCT01218204|453034852|FG002|Part B Run-in|Adverse Event|1|||
125928821|NCT01218204|453034853|FG003|Part B Run-in|Adverse Event|0|||
125928822|NCT01218204|453034850|FG000|Part B Run-in|Protocol Violation|0|||
125928823|NCT01218204|453034851|FG001|Part B Run-in|Protocol Violation|0|||
126112652|NCT01798992|453709486|FG003|Overall Study|Lost to Follow-up|0|||
125928824|NCT01218204|453034852|FG002|Part B Run-in|Protocol Violation|2|||
125928825|NCT01218204|453034853|FG003|Part B Run-in|Protocol Violation|0|||
125928826|NCT01218204|453034850|FG000|Part B Run-in|Withdrawal by Subject|0|||
125928827|NCT01218204|453034851|FG001|Part B Run-in|Withdrawal by Subject|0|||
125928828|NCT01218204|453034852|FG002|Part B Run-in|Withdrawal by Subject|3|||
125928829|NCT01218204|453034853|FG003|Part B Run-in|Withdrawal by Subject|0|||
125928830|NCT01218204|453034850|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
125928831|NCT01218204|453034851|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
125928832|NCT01218204|453034852|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
125928833|NCT01218204|453034853|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
125928834|NCT01218204|453034850|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
125928835|NCT01218204|453034851|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
125928836|NCT01218204|453034852|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
125928837|NCT01218204|453034853|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
125928838|NCT00127660|453034854|FG000|Overall Study|Protocol Violation|3|||
125928839|NCT00127660|453034855|FG001|Overall Study|Protocol Violation|3|||
125928840|NCT00127660|453034856|FG002|Overall Study|Protocol Violation|5|||
125928841|NCT00127660|453034857|FG003|Overall Study|Protocol Violation|0|||
125928842|NCT00489541|453034858|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
125928843|NCT00489541|453034859|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
125928844|NCT00489541|453034858|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
125928845|NCT00489541|453034859|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
125928846|NCT00489541|453034858|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
125928847|NCT00489541|453034859|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
125928848|NCT00489541|453034858|FG000|12-Month Clinical Follow-up|Death|3|||
125928849|NCT00489541|453034859|FG001|12-Month Clinical Follow-up|Death|2|||
125928850|NCT00489541|453034858|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
125928851|NCT00489541|453034859|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
125928852|NCT00489541|453034858|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
125928853|NCT00489541|453034859|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
125928854|NCT05147350|453034864|FG000|Overall Study|Death|2|||
125928855|NCT05147350|453034865|FG001|Overall Study|Death|3|||
125928856|NCT05147350|453034866|FG002|Overall Study|Death|3|||
125928857|NCT05147350|453034867|FG003|Overall Study|Death|2|||
125928858|NCT05147350|453034868|FG004|Overall Study|Death|2|||
125928859|NCT05147350|453034869|FG005|Overall Study|Death|1|||
125928860|NCT05147350|453034870|FG006|Overall Study|Death|1|||
125928861|NCT05147350|453034871|FG007|Overall Study|Death|3|||
125928862|NCT05147350|453034864|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
125928863|NCT05147350|453034865|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
125928864|NCT05147350|453034866|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
125928865|NCT05147350|453034867|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
125928866|NCT05147350|453034868|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
125928867|NCT05147350|453034869|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
125928868|NCT05147350|453034870|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
125928869|NCT05147350|453034871|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
125928870|NCT05147350|453034864|FG000|Overall Study|Withdrawal by Subject|0|||
125928871|NCT05147350|453034865|FG001|Overall Study|Withdrawal by Subject|0|||
125928872|NCT05147350|453034866|FG002|Overall Study|Withdrawal by Subject|3|||
125928873|NCT05147350|453034867|FG003|Overall Study|Withdrawal by Subject|1|||
125928874|NCT05147350|453034868|FG004|Overall Study|Withdrawal by Subject|1|||
125928875|NCT05147350|453034869|FG005|Overall Study|Withdrawal by Subject|0|||
125928876|NCT05147350|453034870|FG006|Overall Study|Withdrawal by Subject|1|||
125928877|NCT05147350|453034871|FG007|Overall Study|Withdrawal by Subject|0|||
125928878|NCT05147350|453034864|FG000|Overall Study|Other Reasons|0|||
125928879|NCT05147350|453034865|FG001|Overall Study|Other Reasons|0|||
125928880|NCT05147350|453034866|FG002|Overall Study|Other Reasons|2|||
125928881|NCT05147350|453034867|FG003|Overall Study|Other Reasons|0|||
125928882|NCT05147350|453034868|FG004|Overall Study|Other Reasons|0|||
125928883|NCT05147350|453034869|FG005|Overall Study|Other Reasons|2|||
125928884|NCT05147350|453034870|FG006|Overall Study|Other Reasons|1|||
126065466|NCT02109172|453532121|FG002|Overall Study|Withdrawal by Subject|0|||
126065467|NCT02109172|453532122|FG003|Overall Study|Withdrawal by Subject|1|||
126065468|NCT02109172|453532123|FG004|Overall Study|Withdrawal by Subject|0|||
125928885|NCT05147350|453034871|FG007|Overall Study|Other Reasons|1|||
125928886|NCT04390191|453034872|FG000|Overall Study|Withdrawal by Subject|1|||
125928887|NCT04390191|453034873|FG001|Overall Study|Withdrawal by Subject|0|||
125928888|NCT03978832|453034878|FG000|Overall Study|Adverse Event|1|||
125928889|NCT03978832|453034878|FG000|Overall Study|Lost to Follow-up|1|||
125928890|NCT03978832|453034878|FG000|Overall Study|Withdrawal by Subject|6|||
125928891|NCT03978832|453034878|FG000|Overall Study|Physician Decision|2|||
125928892|NCT03978832|453034878|FG000|Overall Study|did not pass screening criteria|44|||
125928893|NCT02042183|453034879|FG000|Overall Study|Physician Decision|7|||
125928894|NCT02042183|453034880|FG001|Overall Study|Physician Decision|2|||
125928895|NCT02042183|453034879|FG000|Overall Study|Lack of Efficacy|4|||
126065469|NCT02109172|453532124|FG005|Overall Study|Withdrawal by Subject|0|||
125928896|NCT02042183|453034880|FG001|Overall Study|Lack of Efficacy|3|||
125928897|NCT02042183|453034879|FG000|Overall Study|Non-compliance with Study Drug|2|||
125928898|NCT02042183|453034880|FG001|Overall Study|Non-compliance with Study Drug|3|||
125928899|NCT02042183|453034879|FG000|Overall Study|Adverse Event|17|||
125928900|NCT02042183|453034880|FG001|Overall Study|Adverse Event|6|||
125928901|NCT02042183|453034879|FG000|Overall Study|Other|3|||
125928902|NCT02042183|453034880|FG001|Overall Study|Other|3|||
125928903|NCT02042183|453034879|FG000|Overall Study|Withdrawal by Subject|21|||
125928904|NCT02042183|453034880|FG001|Overall Study|Withdrawal by Subject|16|||
125928905|NCT02042183|453034879|FG000|Overall Study|Site Terminated by Sponsor|2|||
125928906|NCT02042183|453034880|FG001|Overall Study|Site Terminated by Sponsor|1|||
125928907|NCT02042183|453034879|FG000|Overall Study|Lost to Follow-up|9|||
125928908|NCT02042183|453034880|FG001|Overall Study|Lost to Follow-up|2|||
125928909|NCT01727297|453034881|FG000|Overall Study|Death|13|||
125928910|NCT01727297|453034882|FG001|Overall Study|Death|0|||
125928911|NCT01727297|453034881|FG000|Overall Study|Protocol Violation|1|||
125928912|NCT01727297|453034882|FG001|Overall Study|Protocol Violation|10|||
125928913|NCT01727297|453034881|FG000|Overall Study|Adverse Event|3|||
125928914|NCT01727297|453034882|FG001|Overall Study|Adverse Event|1|||
125928915|NCT01727297|453034881|FG000|Overall Study|Lost to Follow-up|11|||
125928916|NCT01727297|453034882|FG001|Overall Study|Lost to Follow-up|0|||
125928917|NCT01727297|453034881|FG000|Overall Study|Withdrawal by Subject|26|||
125928918|NCT01727297|453034882|FG001|Overall Study|Withdrawal by Subject|27|||
125928919|NCT01727297|453034881|FG000|Overall Study|Physician Decision|19|||
125928920|NCT01727297|453034882|FG001|Overall Study|Physician Decision|5|||
125928921|NCT01727297|453034881|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
125928922|NCT01727297|453034882|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
125928923|NCT01192516|453034883|FG000|Overall Study|Lost to Follow-up|7|||
125928924|NCT01192516|453034884|FG001|Overall Study|Lost to Follow-up|10|||
125928925|NCT01192516|453034885|FG002|Overall Study|Lost to Follow-up|7|||
125928926|NCT01192516|453034883|FG000|Overall Study|Withdrawal by Subject|4|||
125928927|NCT01192516|453034884|FG001|Overall Study|Withdrawal by Subject|4|||
125928928|NCT01192516|453034885|FG002|Overall Study|Withdrawal by Subject|1|||
125928929|NCT01192516|453034883|FG000|Overall Study|started new treatment|5|||
125928930|NCT01192516|453034884|FG001|Overall Study|started new treatment|1|||
125928931|NCT01192516|453034885|FG002|Overall Study|started new treatment|0|||
125928932|NCT01192516|453034883|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
125928933|NCT01192516|453034884|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
125928934|NCT01192516|453034885|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
125928935|NCT01256008|453034886|FG000|Overall Study|Lost to Follow-up|6|||
125928936|NCT01256008|453034887|FG001|Overall Study|Lost to Follow-up|4|||
125928937|NCT01256008|453034888|FG002|Overall Study|Lost to Follow-up|11|||
125928938|NCT01256008|453034886|FG000|Overall Study|Withdrawal by Subject|2|||
125928939|NCT01256008|453034887|FG001|Overall Study|Withdrawal by Subject|3|||
125928940|NCT01256008|453034888|FG002|Overall Study|Withdrawal by Subject|10|||
125928941|NCT02244606|453034889|FG000|Overall Study|Adverse Event|0|||
125928942|NCT02244606|453034890|FG001|Overall Study|Adverse Event|1|||
125928943|NCT02244606|453034891|FG002|Overall Study|Adverse Event|1|||
125928944|NCT02244606|453034892|FG003|Overall Study|Adverse Event|0|||
125928945|NCT02244606|453034889|FG000|Overall Study|Lost to Follow-up|2|||
125928946|NCT02244606|453034890|FG001|Overall Study|Lost to Follow-up|2|||
125928947|NCT02244606|453034891|FG002|Overall Study|Lost to Follow-up|1|||
125928948|NCT02244606|453034892|FG003|Overall Study|Lost to Follow-up|0|||
125928949|NCT02244606|453034889|FG000|Overall Study|Protocol Violation|0|||
125928950|NCT02244606|453034890|FG001|Overall Study|Protocol Violation|0|||
125928951|NCT02244606|453034891|FG002|Overall Study|Protocol Violation|0|||
125928952|NCT02244606|453034892|FG003|Overall Study|Protocol Violation|1|||
125928953|NCT02244606|453034889|FG000|Overall Study|Withdrawal by Subject|1|||
125928954|NCT02244606|453034890|FG001|Overall Study|Withdrawal by Subject|1|||
125928955|NCT02244606|453034891|FG002|Overall Study|Withdrawal by Subject|0|||
125928956|NCT02244606|453034892|FG003|Overall Study|Withdrawal by Subject|0|||
125928957|NCT02244606|453034889|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
125928958|NCT02244606|453034890|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
125928959|NCT02244606|453034891|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
125928960|NCT02244606|453034892|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
125928961|NCT03782792|453034897|FG000|Overall Study|Patient left the country|0|||
125928962|NCT03782792|453034898|FG001|Overall Study|Patient left the country|1|||
125928963|NCT03782792|453034897|FG000|Overall Study|Withdrawal by Subject|1|||
125928964|NCT03782792|453034898|FG001|Overall Study|Withdrawal by Subject|2|||
125928965|NCT00814164|453034900|FG000|Overall Study|Progression|7|||
125928966|NCT00814164|453034900|FG000|Overall Study|not stated|7|||
125928967|NCT00814164|453034900|FG000|Overall Study|Death|5|||
125928968|NCT02321800|453034901|FG000|Overall Study|Withdrawal by Subject|3|||
125928969|NCT02321800|453034902|FG001|Overall Study|Withdrawal by Subject|3|||
125928970|NCT02321800|453034901|FG000|Overall Study|Death|1|||
125928971|NCT02321800|453034902|FG001|Overall Study|Death|0|||
125928972|NCT02321800|453034901|FG000|Overall Study|Protocol Violation|1|||
125928973|NCT02321800|453034902|FG001|Overall Study|Protocol Violation|0|||
125928974|NCT02321800|453034901|FG000|Overall Study|Lost to Follow-up|10|||
125928975|NCT02321800|453034902|FG001|Overall Study|Lost to Follow-up|4|||
125928976|NCT02321800|453034901|FG000|Overall Study|Adverse Event|2|||
125928977|NCT02321800|453034902|FG001|Overall Study|Adverse Event|3|||
125928978|NCT02321800|453034901|FG000|Overall Study|Other, Miscellaneous|3|||
125928979|NCT02321800|453034902|FG001|Overall Study|Other, Miscellaneous|1|||
125928980|NCT00982878|453034906|FG000|Overall Study|Physician Decision|1|||
125928981|NCT03132220|453034912|FG000|Overall Study|Lost to Follow-up|17|||
125928982|NCT03132220|453034913|FG001|Overall Study|Lost to Follow-up|8|||
125928983|NCT03132220|453034912|FG000|Overall Study|Withdrawal by Subject|1|||
125928984|NCT03132220|453034913|FG001|Overall Study|Withdrawal by Subject|4|||
125928985|NCT01169493|453034914|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
125928986|NCT01169493|453034915|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
125928987|NCT01169493|453034916|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
125928988|NCT01169493|453034917|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
125928989|NCT01169493|453034918|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
125928990|NCT01169493|453034919|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
125928991|NCT01169493|453034914|FG000|Period 3 (6 Months)|Adverse Event|0|||
125928992|NCT01169493|453034915|FG001|Period 3 (6 Months)|Adverse Event|1|||
125928993|NCT01169493|453034916|FG002|Period 3 (6 Months)|Adverse Event|0|||
125928994|NCT01169493|453034917|FG003|Period 3 (6 Months)|Adverse Event|0|||
125928995|NCT01169493|453034918|FG004|Period 3 (6 Months)|Adverse Event|0|||
125928996|NCT01169493|453034919|FG005|Period 3 (6 Months)|Adverse Event|0|||
125928997|NCT01169493|453034914|FG000|Period 3 (6 Months)|Physician Decision|0|||
125928998|NCT01169493|453034915|FG001|Period 3 (6 Months)|Physician Decision|1|||
125928999|NCT01169493|453034916|FG002|Period 3 (6 Months)|Physician Decision|1|||
125929000|NCT01169493|453034917|FG003|Period 3 (6 Months)|Physician Decision|0|||
125929001|NCT01169493|453034918|FG004|Period 3 (6 Months)|Physician Decision|0|||
125929002|NCT01169493|453034919|FG005|Period 3 (6 Months)|Physician Decision|0|||
125929003|NCT05228132|453034920|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
125929004|NCT05228132|453034920|FG000|Overall Study|Adverse Event|3|||
125929005|NCT05228132|453034920|FG000|Overall Study|Lost to Follow-up|1|||
125929006|NCT05228132|453034920|FG000|Overall Study|Arteriovenous-fistula mature|1|||
125929007|NCT01336764|453034921|FG000|Overall Study|Withdrawal by Subject|5|||
125929008|NCT01336764|453034922|FG001|Overall Study|Withdrawal by Subject|5|||
125929009|NCT02627144|453034925|FG000|Overall Study|Serious adverse event|32|||
125929010|NCT02627144|453034925|FG000|Overall Study|Cancer progression|171|||
125929011|NCT02627144|453034925|FG000|Overall Study|Death from cancer|20|||
125929012|NCT02627144|453034925|FG000|Overall Study|Death from other cause|8|||
125929013|NCT02627144|453034925|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
125929014|NCT02627144|453034925|FG000|Overall Study|Administrative reasons|65|||
125929015|NCT02627144|453034925|FG000|Overall Study|Lost to Follow-up|8|||
125929016|NCT02627144|453034925|FG000|Overall Study|Enrolled, not treated|6|||
125929017|NCT02627144|453034925|FG000|Overall Study|Other|17|||
125929018|NCT01906008|453034933|FG000|Overall Study|Lost to Follow-up|2|||
125929019|NCT01906008|453034934|FG001|Overall Study|Lost to Follow-up|0|||
125929020|NCT01906008|453034933|FG000|Overall Study|Oxaliplatin toxicity|2|||
125929021|NCT01906008|453034934|FG001|Overall Study|Oxaliplatin toxicity|0|||
125929022|NCT01906008|453034933|FG000|Overall Study|Protocol Violation|0|||
125929023|NCT01906008|453034934|FG001|Overall Study|Protocol Violation|1|||
125929024|NCT01906008|453034933|FG000|Overall Study|Withdrawal by Subject|1|||
125929025|NCT01906008|453034934|FG001|Overall Study|Withdrawal by Subject|5|||
125929026|NCT01906008|453034933|FG000|Overall Study|Did not start study med|3|||
125929027|NCT01906008|453034934|FG001|Overall Study|Did not start study med|4|||
125929028|NCT01906008|453034933|FG000|Overall Study|Oxaliplatin stops|10|||
125929029|NCT01906008|453034934|FG001|Overall Study|Oxaliplatin stops|8|||
125929030|NCT01906008|453034933|FG000|Overall Study|Hospice|1|||
125929031|NCT01906008|453034934|FG001|Overall Study|Hospice|0|||
125929032|NCT01906008|453034933|FG000|Overall Study|Physician Decision|3|||
125929033|NCT01906008|453034934|FG001|Overall Study|Physician Decision|3|||
125929034|NCT01906008|453034933|FG000|Overall Study|Lack of compliance of study med|5|||
126112653|NCT01798992|453709483|FG000|Overall Study|Insufficient biopsy tissue|0|||
126112654|NCT01798992|453709484|FG001|Overall Study|Insufficient biopsy tissue|0|||
126112655|NCT01798992|453709485|FG002|Overall Study|Insufficient biopsy tissue|1|||
125929035|NCT01906008|453034934|FG001|Overall Study|Lack of compliance of study med|3|||
125929036|NCT01906008|453034933|FG000|Overall Study|Adverse Event|0|||
125929037|NCT01906008|453034934|FG001|Overall Study|Adverse Event|3|||
125929038|NCT00730132|453034935|FG000|Overall Study|Protocol Violation|154|||
125929039|NCT00730132|453034935|FG000|Overall Study|Death|1|||
125929040|NCT01626391|453034936|FG000|Overall Study|Physician Decision|1|||
125929041|NCT01626391|453034937|FG001|Overall Study|Physician Decision|0|||
125929042|NCT01626391|453034936|FG000|Overall Study|Withdrawal by Subject|1|||
125929043|NCT01626391|453034937|FG001|Overall Study|Withdrawal by Subject|0|||
125929044|NCT02220205|453034940|FG000|Overall Study|Withdrawal by Subject|1|||
125929045|NCT02220205|453034941|FG001|Overall Study|Withdrawal by Subject|0|||
126112656|NCT01798992|453709486|FG003|Overall Study|Insufficient biopsy tissue|0|||
126112657|NCT03823404|453709487|FG000|Overall Study|Lost to Follow-up|1|||
125929046|NCT00420927|453034942|FG000|Period 1|Adverse Event|19|||
125929047|NCT00420927|453034943|FG001|Period 1|Adverse Event|15|||
125929048|NCT00420927|453034944|FG002|Period 1|Adverse Event|0|||
125929049|NCT00420927|453034945|FG003|Period 1|Adverse Event|0|||
125929050|NCT00420927|453034946|FG004|Period 1|Adverse Event|0|||
125929051|NCT00420927|453034947|FG005|Period 1|Adverse Event|0|||
125929052|NCT00420927|453034948|FG006|Period 1|Adverse Event|0|||
125929053|NCT00420927|453034942|FG000|Period 1|Withdrawal by Subject|7|||
125929054|NCT00420927|453034943|FG001|Period 1|Withdrawal by Subject|12|||
125929055|NCT00420927|453034944|FG002|Period 1|Withdrawal by Subject|0|||
125929056|NCT00420927|453034945|FG003|Period 1|Withdrawal by Subject|0|||
125929057|NCT00420927|453034946|FG004|Period 1|Withdrawal by Subject|0|||
125929058|NCT00420927|453034947|FG005|Period 1|Withdrawal by Subject|0|||
125929059|NCT00420927|453034948|FG006|Period 1|Withdrawal by Subject|0|||
125929060|NCT00420927|453034942|FG000|Period 1|Lost to Follow-up|8|||
125929061|NCT00420927|453034943|FG001|Period 1|Lost to Follow-up|6|||
125929062|NCT00420927|453034944|FG002|Period 1|Lost to Follow-up|0|||
125929063|NCT00420927|453034945|FG003|Period 1|Lost to Follow-up|0|||
125929064|NCT00420927|453034946|FG004|Period 1|Lost to Follow-up|0|||
125929065|NCT00420927|453034947|FG005|Period 1|Lost to Follow-up|0|||
125929066|NCT00420927|453034948|FG006|Period 1|Lost to Follow-up|0|||
125929067|NCT00420927|453034942|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
125929068|NCT00420927|453034943|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
125929069|NCT00420927|453034944|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
125929070|NCT00420927|453034945|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
125929071|NCT00420927|453034946|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
125929072|NCT00420927|453034947|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
125929073|NCT00420927|453034948|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
125929074|NCT00420927|453034942|FG000|Period 1|Death|2|||
125929075|NCT00420927|453034943|FG001|Period 1|Death|0|||
125929076|NCT00420927|453034944|FG002|Period 1|Death|0|||
125929077|NCT00420927|453034945|FG003|Period 1|Death|0|||
125929078|NCT00420927|453034946|FG004|Period 1|Death|0|||
125929079|NCT00420927|453034947|FG005|Period 1|Death|0|||
125929080|NCT00420927|453034948|FG006|Period 1|Death|0|||
125929081|NCT00420927|453034942|FG000|Period 1|Subject moved/relocated|0|||
125929082|NCT00420927|453034943|FG001|Period 1|Subject moved/relocated|2|||
125929083|NCT00420927|453034944|FG002|Period 1|Subject moved/relocated|0|||
125929084|NCT00420927|453034945|FG003|Period 1|Subject moved/relocated|0|||
125929085|NCT00420927|453034946|FG004|Period 1|Subject moved/relocated|0|||
125929086|NCT00420927|453034947|FG005|Period 1|Subject moved/relocated|0|||
125929087|NCT00420927|453034948|FG006|Period 1|Subject moved/relocated|0|||
125929088|NCT00420927|453034942|FG000|Period 1|Noncompliant with study drug|1|||
125929089|NCT00420927|453034943|FG001|Period 1|Noncompliant with study drug|1|||
125929090|NCT00420927|453034944|FG002|Period 1|Noncompliant with study drug|0|||
125929091|NCT00420927|453034945|FG003|Period 1|Noncompliant with study drug|0|||
125929092|NCT00420927|453034946|FG004|Period 1|Noncompliant with study drug|0|||
125929093|NCT00420927|453034947|FG005|Period 1|Noncompliant with study drug|0|||
125929094|NCT00420927|453034948|FG006|Period 1|Noncompliant with study drug|0|||
126065470|NCT02109172|453532119|FG000|Overall Study|Adverse Event|0|||
126065471|NCT02109172|453532120|FG001|Overall Study|Adverse Event|0|||
126065472|NCT02109172|453532121|FG002|Overall Study|Adverse Event|1|||
126065473|NCT02109172|453532122|FG003|Overall Study|Adverse Event|0|||
126065474|NCT02109172|453532123|FG004|Overall Study|Adverse Event|0|||
126065475|NCT02109172|453532124|FG005|Overall Study|Adverse Event|1|||
126065476|NCT02109172|453532119|FG000|Overall Study|Death|0|||
126065477|NCT02109172|453532120|FG001|Overall Study|Death|0|||
126065478|NCT02109172|453532121|FG002|Overall Study|Death|0|||
126065479|NCT02109172|453532122|FG003|Overall Study|Death|0|||
126065480|NCT02109172|453532123|FG004|Overall Study|Death|1|||
126065481|NCT02109172|453532124|FG005|Overall Study|Death|0|||
126065482|NCT02011568|453532125|FG000|Overall Study|Withdrawal by Subject|8|||
126065483|NCT02011568|453532126|FG001|Overall Study|Withdrawal by Subject|10|||
126065484|NCT02011568|453532125|FG000|Overall Study|Physician Decision|1|||
126065485|NCT02011568|453532126|FG001|Overall Study|Physician Decision|3|||
126065486|NCT03696342|453532129|FG000|Overall Study|Lost to Follow-up|1|||
126065487|NCT03696342|453532130|FG001|Overall Study|Lost to Follow-up|0|||
126065488|NCT05361304|453532133|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
126065489|NCT05361304|453532134|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
126065490|NCT05361304|453532133|FG000|Overall Study|COVID-19 Related|1|||
126065491|NCT05361304|453532134|FG001|Overall Study|COVID-19 Related|2|||
126065492|NCT05361304|453532133|FG000|Overall Study|Withdrawal by Subject|1|||
125929095|NCT00420927|453034942|FG000|Period 1|Randomization error|1|||
125929096|NCT00420927|453034943|FG001|Period 1|Randomization error|0|||
126065493|NCT05361304|453532134|FG001|Overall Study|Withdrawal by Subject|0|||
126065494|NCT02409732|453532135|FG000|Overall Study|Withdrawal by Subject|4|||
126065495|NCT02409732|453532135|FG000|Overall Study|Lost to Follow-up|2|||
126065496|NCT00376259|453532136|FG000|Overall Study|Sponsor request - study termination|21|||
126065497|NCT00376259|453532137|FG001|Overall Study|Sponsor request - study termination|21|||
125929097|NCT00420927|453034944|FG002|Period 1|Randomization error|0|||
125929098|NCT00420927|453034945|FG003|Period 1|Randomization error|0|||
125929099|NCT00420927|453034946|FG004|Period 1|Randomization error|0|||
125929100|NCT00420927|453034947|FG005|Period 1|Randomization error|0|||
125929101|NCT00420927|453034948|FG006|Period 1|Randomization error|0|||
125929102|NCT00420927|453034942|FG000|Period 1|Suspected tuberculosis/positive test|1|||
125929103|NCT00420927|453034943|FG001|Period 1|Suspected tuberculosis/positive test|1|||
125929104|NCT00420927|453034944|FG002|Period 1|Suspected tuberculosis/positive test|0|||
125929105|NCT00420927|453034945|FG003|Period 1|Suspected tuberculosis/positive test|0|||
125929106|NCT00420927|453034946|FG004|Period 1|Suspected tuberculosis/positive test|0|||
125929107|NCT00420927|453034947|FG005|Period 1|Suspected tuberculosis/positive test|0|||
125929108|NCT00420927|453034948|FG006|Period 1|Suspected tuberculosis/positive test|0|||
125929109|NCT00420927|453034942|FG000|Period 1|Study site closure|0|||
125929110|NCT00420927|453034943|FG001|Period 1|Study site closure|1|||
125929111|NCT00420927|453034944|FG002|Period 1|Study site closure|0|||
125929112|NCT00420927|453034945|FG003|Period 1|Study site closure|0|||
125929113|NCT00420927|453034946|FG004|Period 1|Study site closure|0|||
125929114|NCT00420927|453034947|FG005|Period 1|Study site closure|0|||
125929115|NCT00420927|453034948|FG006|Period 1|Study site closure|0|||
125929116|NCT00420927|453034942|FG000|Period 1|Subject received new diagnosis|0|||
125929117|NCT00420927|453034943|FG001|Period 1|Subject received new diagnosis|2|||
125929118|NCT00420927|453034944|FG002|Period 1|Subject received new diagnosis|0|||
125929119|NCT00420927|453034945|FG003|Period 1|Subject received new diagnosis|0|||
125929120|NCT00420927|453034946|FG004|Period 1|Subject received new diagnosis|0|||
125929121|NCT00420927|453034947|FG005|Period 1|Subject received new diagnosis|0|||
125929122|NCT00420927|453034948|FG006|Period 1|Subject received new diagnosis|0|||
125929123|NCT00420927|453034942|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
125929124|NCT00420927|453034943|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
125929125|NCT00420927|453034944|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
125929126|NCT00420927|453034945|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
125929127|NCT00420927|453034946|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
125929128|NCT00420927|453034947|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
125929129|NCT00420927|453034948|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
125929130|NCT00420927|453034942|FG000|Period 1|Failed to meet entry criteria|8|||
125929131|NCT00420927|453034943|FG001|Period 1|Failed to meet entry criteria|7|||
125929132|NCT00420927|453034944|FG002|Period 1|Failed to meet entry criteria|0|||
125929133|NCT00420927|453034945|FG003|Period 1|Failed to meet entry criteria|0|||
125929134|NCT00420927|453034946|FG004|Period 1|Failed to meet entry criteria|0|||
125929135|NCT00420927|453034947|FG005|Period 1|Failed to meet entry criteria|0|||
125929136|NCT00420927|453034948|FG006|Period 1|Failed to meet entry criteria|0|||
125929137|NCT00420927|453034942|FG000|Period 1|Took prohibited medication|1|||
125929138|NCT00420927|453034943|FG001|Period 1|Took prohibited medication|3|||
125929139|NCT00420927|453034944|FG002|Period 1|Took prohibited medication|0|||
125929140|NCT00420927|453034945|FG003|Period 1|Took prohibited medication|0|||
125929141|NCT00420927|453034946|FG004|Period 1|Took prohibited medication|0|||
125929142|NCT00420927|453034947|FG005|Period 1|Took prohibited medication|0|||
125929143|NCT00420927|453034948|FG006|Period 1|Took prohibited medication|0|||
125929144|NCT00420927|453034942|FG000|Period 2|Adverse Event|0|||
125929145|NCT00420927|453034943|FG001|Period 2|Adverse Event|0|||
125929146|NCT00420927|453034944|FG002|Period 2|Adverse Event|7|||
125929147|NCT00420927|453034945|FG003|Period 2|Adverse Event|3|||
125929148|NCT00420927|453034946|FG004|Period 2|Adverse Event|17|||
125929149|NCT00420927|453034947|FG005|Period 2|Adverse Event|6|||
125929150|NCT00420927|453034948|FG006|Period 2|Adverse Event|20|||
125929151|NCT00420927|453034942|FG000|Period 2|Withdrawal by Subject|0|||
125929152|NCT00420927|453034943|FG001|Period 2|Withdrawal by Subject|0|||
125929153|NCT00420927|453034944|FG002|Period 2|Withdrawal by Subject|1|||
125929154|NCT00420927|453034945|FG003|Period 2|Withdrawal by Subject|3|||
125929155|NCT00420927|453034946|FG004|Period 2|Withdrawal by Subject|11|||
125929156|NCT00420927|453034947|FG005|Period 2|Withdrawal by Subject|2|||
125929157|NCT00420927|453034948|FG006|Period 2|Withdrawal by Subject|12|||
125929158|NCT00420927|453034942|FG000|Period 2|Lost to Follow-up|0|||
125929159|NCT00420927|453034943|FG001|Period 2|Lost to Follow-up|0|||
125929160|NCT00420927|453034944|FG002|Period 2|Lost to Follow-up|2|||
125929161|NCT00420927|453034945|FG003|Period 2|Lost to Follow-up|2|||
125929162|NCT00420927|453034946|FG004|Period 2|Lost to Follow-up|6|||
125929163|NCT00420927|453034947|FG005|Period 2|Lost to Follow-up|3|||
125929164|NCT00420927|453034948|FG006|Period 2|Lost to Follow-up|9|||
125929165|NCT00420927|453034942|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
125929166|NCT00420927|453034943|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
125929167|NCT00420927|453034944|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
125929168|NCT00420927|453034945|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
125929169|NCT00420927|453034946|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
125929170|NCT00420927|453034947|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
125929171|NCT00420927|453034948|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
125929172|NCT00420927|453034942|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
126065498|NCT00376259|453532136|FG000|Overall Study|Patient request|1|||
125929173|NCT00420927|453034943|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
125929174|NCT00420927|453034944|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
125929175|NCT00420927|453034945|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
125929176|NCT00420927|453034946|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
125929177|NCT00420927|453034947|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
125929178|NCT00420927|453034948|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
125929179|NCT00420927|453034942|FG000|Period 2|Subject unable to find transportation|0|||
125929180|NCT00420927|453034943|FG001|Period 2|Subject unable to find transportation|0|||
125929181|NCT00420927|453034944|FG002|Period 2|Subject unable to find transportation|0|||
125929182|NCT00420927|453034945|FG003|Period 2|Subject unable to find transportation|0|||
125929183|NCT00420927|453034946|FG004|Period 2|Subject unable to find transportation|0|||
125929184|NCT00420927|453034947|FG005|Period 2|Subject unable to find transportation|0|||
125929185|NCT00420927|453034948|FG006|Period 2|Subject unable to find transportation|1|||
125929186|NCT00420927|453034942|FG000|Period 2|Physician Decision|0|||
125929187|NCT00420927|453034943|FG001|Period 2|Physician Decision|0|||
125929188|NCT00420927|453034944|FG002|Period 2|Physician Decision|0|||
125929189|NCT00420927|453034945|FG003|Period 2|Physician Decision|0|||
125929190|NCT00420927|453034946|FG004|Period 2|Physician Decision|1|||
125929191|NCT00420927|453034947|FG005|Period 2|Physician Decision|1|||
125929192|NCT00420927|453034948|FG006|Period 2|Physician Decision|0|||
125929193|NCT00420927|453034942|FG000|Period 2|Sponsor decision|0|||
125929194|NCT00420927|453034943|FG001|Period 2|Sponsor decision|0|||
125929195|NCT00420927|453034944|FG002|Period 2|Sponsor decision|1|||
125929196|NCT00420927|453034945|FG003|Period 2|Sponsor decision|0|||
125929197|NCT00420927|453034946|FG004|Period 2|Sponsor decision|0|||
125929198|NCT00420927|453034947|FG005|Period 2|Sponsor decision|0|||
125929199|NCT00420927|453034948|FG006|Period 2|Sponsor decision|1|||
125929200|NCT00420927|453034942|FG000|Period 2|Randomization error|0|||
125929201|NCT00420927|453034943|FG001|Period 2|Randomization error|0|||
125929202|NCT00420927|453034944|FG002|Period 2|Randomization error|0|||
125929203|NCT00420927|453034945|FG003|Period 2|Randomization error|0|||
125929204|NCT00420927|453034946|FG004|Period 2|Randomization error|1|||
125929205|NCT00420927|453034947|FG005|Period 2|Randomization error|1|||
125929206|NCT00420927|453034948|FG006|Period 2|Randomization error|0|||
125929207|NCT00420927|453034942|FG000|Period 2|Noncompliant with study drug|0|||
125929208|NCT00420927|453034943|FG001|Period 2|Noncompliant with study drug|0|||
125929209|NCT00420927|453034944|FG002|Period 2|Noncompliant with study drug|0|||
125929210|NCT00420927|453034945|FG003|Period 2|Noncompliant with study drug|1|||
125929211|NCT00420927|453034946|FG004|Period 2|Noncompliant with study drug|0|||
125929212|NCT00420927|453034947|FG005|Period 2|Noncompliant with study drug|0|||
125929213|NCT00420927|453034948|FG006|Period 2|Noncompliant with study drug|2|||
125929214|NCT00420927|453034942|FG000|Period 2|Methotrexate intolerance|0|||
125929215|NCT00420927|453034943|FG001|Period 2|Methotrexate intolerance|0|||
125929216|NCT00420927|453034944|FG002|Period 2|Methotrexate intolerance|0|||
125929217|NCT00420927|453034945|FG003|Period 2|Methotrexate intolerance|0|||
125929218|NCT00420927|453034946|FG004|Period 2|Methotrexate intolerance|0|||
125929219|NCT00420927|453034947|FG005|Period 2|Methotrexate intolerance|0|||
125929220|NCT00420927|453034948|FG006|Period 2|Methotrexate intolerance|1|||
125929221|NCT00420927|453034942|FG000|Period 2|Took prohibited medication|0|||
125929222|NCT00420927|453034943|FG001|Period 2|Took prohibited medication|0|||
125929223|NCT00420927|453034944|FG002|Period 2|Took prohibited medication|0|||
125929224|NCT00420927|453034945|FG003|Period 2|Took prohibited medication|0|||
125929225|NCT00420927|453034946|FG004|Period 2|Took prohibited medication|1|||
125929226|NCT00420927|453034947|FG005|Period 2|Took prohibited medication|0|||
125929227|NCT00420927|453034948|FG006|Period 2|Took prohibited medication|0|||
125929228|NCT01465997|453034949|FG000|Overall Study|Adverse Event|12|||
125929229|NCT01465997|453034950|FG001|Overall Study|Adverse Event|22|||
125929230|NCT01465997|453034949|FG000|Overall Study|Lack of Efficacy|13|||
125929231|NCT01465997|453034950|FG001|Overall Study|Lack of Efficacy|1|||
125929232|NCT01465997|453034949|FG000|Overall Study|Protocol Violation|1|||
125929233|NCT01465997|453034950|FG001|Overall Study|Protocol Violation|4|||
125929234|NCT01465997|453034949|FG000|Overall Study|Lost to Follow-up|6|||
125929235|NCT01465997|453034950|FG001|Overall Study|Lost to Follow-up|9|||
125929236|NCT01465997|453034949|FG000|Overall Study|Withdrawal by Subject|32|||
125929237|NCT01465997|453034950|FG001|Overall Study|Withdrawal by Subject|35|||
125929238|NCT01465997|453034949|FG000|Overall Study|investigator's decision|1|||
125929239|NCT01465997|453034950|FG001|Overall Study|investigator's decision|1|||
125929240|NCT01465997|453034949|FG000|Overall Study|Death|0|||
125929241|NCT01465997|453034950|FG001|Overall Study|Death|1|||
125929242|NCT01465997|453034949|FG000|Overall Study|sponsor's decision|1|||
125929243|NCT01465997|453034950|FG001|Overall Study|sponsor's decision|1|||
125929244|NCT01465997|453034949|FG000|Overall Study|subject withdrew consent|1|||
125929245|NCT01465997|453034950|FG001|Overall Study|subject withdrew consent|0|||
125929246|NCT01465997|453034949|FG000|Overall Study|local lab unblinded site|1|||
125929247|NCT01465997|453034950|FG001|Overall Study|local lab unblinded site|0|||
125929248|NCT01465997|453034949|FG000|Overall Study|withdrew before follow-up|0|||
125929249|NCT01465997|453034950|FG001|Overall Study|withdrew before follow-up|13|||
125929250|NCT01465997|453034949|FG000|Overall Study|decision by site staff|0|||
125929251|NCT01465997|453034950|FG001|Overall Study|decision by site staff|1|||
125929252|NCT01465997|453034949|FG000|Overall Study|subject left participation SP0993|0|||
125929253|NCT01465997|453034950|FG001|Overall Study|subject left participation SP0993|1|||
125929254|NCT02246660|453034951|FG000|Overall Study|Withdrawal by Subject|0|||
125929255|NCT02246660|453034952|FG001|Overall Study|Withdrawal by Subject|1|||
125929256|NCT02246660|453034953|FG002|Overall Study|Withdrawal by Subject|0|||
125929257|NCT02246660|453034951|FG000|Overall Study|Death|0|||
125929258|NCT02246660|453034952|FG001|Overall Study|Death|0|||
125929259|NCT02246660|453034953|FG002|Overall Study|Death|1|||
125929260|NCT03018704|453034954|FG000|Overall Study|Lost to Follow-up|1|||
125929261|NCT03018704|453034955|FG001|Overall Study|Lost to Follow-up|1|||
125929262|NCT00642460|453034956|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
125929263|NCT00642460|453034957|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
125929264|NCT00642460|453034958|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
125929265|NCT00642460|453034959|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
125929266|NCT00642460|453034960|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
125929267|NCT00642460|453034961|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
125929268|NCT00642460|453034956|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
125929269|NCT00642460|453034957|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125929270|NCT00642460|453034958|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125929271|NCT00642460|453034959|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125929272|NCT00642460|453034960|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125929273|NCT00642460|453034961|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125929274|NCT00642460|453034956|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
125929275|NCT00642460|453034957|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
125929276|NCT00642460|453034958|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
125929277|NCT00642460|453034959|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
126065499|NCT00376259|453532137|FG001|Overall Study|Patient request|0|||
126065500|NCT01877720|453532138|FG000|Overall Study|Adverse Event|1|||
126065501|NCT01877720|453532139|FG001|Overall Study|Adverse Event|0|||
126065502|NCT00447499|453532140|FG000|Overall Study|Adverse Event|1|||
126065503|NCT00447499|453532140|FG000|Overall Study|Patient Decision|4|||
126065504|NCT00447499|453532140|FG000|Overall Study|Sponsor Decision|1|||
126065505|NCT00447499|453532140|FG000|Overall Study|Physician Decision|1|||
126065506|NCT02068352|453532142|FG000|Overall Study|Lost to Follow-up|0|||
126065507|NCT02068352|453532143|FG001|Overall Study|Lost to Follow-up|2|||
126065508|NCT02068352|453532144|FG002|Overall Study|Lost to Follow-up|0|||
126065509|NCT02068352|453532142|FG000|Overall Study|Adverse Event|4|||
126065510|NCT02068352|453532143|FG001|Overall Study|Adverse Event|2|||
126065511|NCT02068352|453532144|FG002|Overall Study|Adverse Event|7|||
126065512|NCT02068352|453532142|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
126065513|NCT02068352|453532143|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
126065514|NCT02068352|453532144|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
126065515|NCT02068352|453532142|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
126065516|NCT02068352|453532143|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
126065517|NCT02068352|453532144|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
126065518|NCT02068352|453532142|FG000|Overall Study|Protocol Deviation|0|||
126065519|NCT02068352|453532143|FG001|Overall Study|Protocol Deviation|0|||
126065520|NCT02068352|453532144|FG002|Overall Study|Protocol Deviation|1|||
126065521|NCT03960437|453532145|FG000|Overall Study|Removed by PI|4|||
126065522|NCT03960437|453532145|FG000|Overall Study|Lost to Follow-up|2|||
126065523|NCT03960437|453532145|FG000|Overall Study|Withdrawal by Subject|1|||
126065524|NCT03960437|453532145|FG000|Overall Study|Death|2|||
126065525|NCT00473512|453532148|FG000|Period 1 (Phase 1)|Adverse Event|0|||
126065526|NCT00473512|453532149|FG001|Period 1 (Phase 1)|Adverse Event|0|||
126065527|NCT00473512|453532150|FG002|Period 1 (Phase 1)|Adverse Event|0|||
126065528|NCT00473512|453532151|FG003|Period 1 (Phase 1)|Adverse Event|5|||
126065529|NCT00473512|453532152|FG004|Period 1 (Phase 1)|Adverse Event|0|||
126065530|NCT00473512|453532148|FG000|Period 1 (Phase 1)|Death|0|||
126065531|NCT00473512|453532149|FG001|Period 1 (Phase 1)|Death|0|||
126065532|NCT00473512|453532150|FG002|Period 1 (Phase 1)|Death|0|||
126065533|NCT00473512|453532151|FG003|Period 1 (Phase 1)|Death|1|||
126065534|NCT00473512|453532152|FG004|Period 1 (Phase 1)|Death|0|||
126065535|NCT00473512|453532148|FG000|Period 1 (Phase 1)|Disease Progression|1|||
125929278|NCT00642460|453034960|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
125929279|NCT00642460|453034961|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
126065536|NCT00473512|453532149|FG001|Period 1 (Phase 1)|Disease Progression|1|||
126065537|NCT00473512|453532150|FG002|Period 1 (Phase 1)|Disease Progression|0|||
126065538|NCT00473512|453532151|FG003|Period 1 (Phase 1)|Disease Progression|10|||
126065539|NCT00473512|453532152|FG004|Period 1 (Phase 1)|Disease Progression|1|||
126065540|NCT00473512|453532148|FG000|Period 1 (Phase 1)|Other|0|||
126065541|NCT00473512|453532149|FG001|Period 1 (Phase 1)|Other|0|||
126065542|NCT00473512|453532150|FG002|Period 1 (Phase 1)|Other|0|||
126065543|NCT00473512|453532151|FG003|Period 1 (Phase 1)|Other|1|||
126065544|NCT00473512|453532152|FG004|Period 1 (Phase 1)|Other|0|||
126065545|NCT00473512|453532148|FG000|Period 2 (Phase 2)|Adverse Event|0|||
125929280|NCT00642460|453034956|FG000|Part II: Open-Label Up to Week 92|Death|0|||
125929281|NCT00642460|453034957|FG001|Part II: Open-Label Up to Week 92|Death|1|||
125929282|NCT00642460|453034958|FG002|Part II: Open-Label Up to Week 92|Death|0|||
125929283|NCT00642460|453034959|FG003|Part II: Open-Label Up to Week 92|Death|2|||
125929284|NCT00642460|453034960|FG004|Part II: Open-Label Up to Week 92|Death|0|||
125929285|NCT00642460|453034961|FG005|Part II: Open-Label Up to Week 92|Death|0|||
125929286|NCT00642460|453034956|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
125929287|NCT00642460|453034957|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
125929288|NCT00642460|453034958|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
125929289|NCT00642460|453034959|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
125929290|NCT00642460|453034960|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
125929291|NCT00642460|453034961|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
125929292|NCT00642460|453034956|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
125929293|NCT00642460|453034957|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
125929294|NCT00642460|453034958|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125929295|NCT00642460|453034959|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125929296|NCT00642460|453034960|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125929297|NCT00642460|453034961|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125929298|NCT00642460|453034956|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
125929299|NCT00642460|453034957|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
125929300|NCT00642460|453034958|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
125929301|NCT00642460|453034959|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
125929302|NCT00642460|453034960|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
125929303|NCT00642460|453034961|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
125929304|NCT00642460|453034956|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125929305|NCT00642460|453034957|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125929306|NCT00642460|453034958|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125929307|NCT00642460|453034959|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
125929308|NCT00642460|453034960|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125929309|NCT00642460|453034961|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125929310|NCT00642460|453034956|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
125929311|NCT00642460|453034957|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
125929312|NCT00642460|453034958|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
125929313|NCT00642460|453034959|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
125929314|NCT00642460|453034960|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
125929315|NCT00642460|453034961|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
125929316|NCT00642460|453034956|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
125929317|NCT00642460|453034957|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
125929318|NCT00642460|453034958|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
125929319|NCT00642460|453034959|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
125929320|NCT00642460|453034960|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
125929321|NCT00642460|453034961|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
125929322|NCT00642460|453034956|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
125929323|NCT00642460|453034957|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
125929324|NCT00642460|453034958|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
125929325|NCT00642460|453034959|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
125929326|NCT00642460|453034960|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
125929327|NCT00642460|453034961|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
125929328|NCT00642460|453034956|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
125929329|NCT00642460|453034957|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
125929330|NCT00642460|453034958|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
126112658|NCT03823404|453709488|FG001|Overall Study|Lost to Follow-up|2|||
126112659|NCT03823404|453709489|FG002|Overall Study|Lost to Follow-up|3|||
126112660|NCT03823404|453709487|FG000|Overall Study|Protocol Violation|2|||
126112661|NCT03823404|453709488|FG001|Overall Study|Protocol Violation|0|||
126112662|NCT03823404|453709489|FG002|Overall Study|Protocol Violation|2|||
126112663|NCT03823404|453709487|FG000|Overall Study|Adverse Event|35|||
125929331|NCT00642460|453034959|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
125929332|NCT00642460|453034960|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
125929333|NCT00642460|453034961|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
125929334|NCT00642460|453034956|FG000|Part III: Open-Label Up to Week 260|Other|0|||
125929335|NCT00642460|453034957|FG001|Part III: Open-Label Up to Week 260|Other|0|||
125929336|NCT00642460|453034958|FG002|Part III: Open-Label Up to Week 260|Other|0|||
125929337|NCT00642460|453034959|FG003|Part III: Open-Label Up to Week 260|Other|0|||
125929338|NCT00642460|453034960|FG004|Part III: Open-Label Up to Week 260|Other|2|||
125929339|NCT00642460|453034961|FG005|Part III: Open-Label Up to Week 260|Other|2|||
126112664|NCT03823404|453709488|FG001|Overall Study|Adverse Event|38|||
126112665|NCT03823404|453709489|FG002|Overall Study|Adverse Event|8|||
126112666|NCT03823404|453709487|FG000|Overall Study|Withdrawal by Subject|38|||
126112667|NCT03823404|453709488|FG001|Overall Study|Withdrawal by Subject|40|||
126112668|NCT03823404|453709489|FG002|Overall Study|Withdrawal by Subject|35|||
126112669|NCT03823404|453709487|FG000|Overall Study|Death|4|||
126112670|NCT03823404|453709488|FG001|Overall Study|Death|0|||
126112671|NCT03823404|453709489|FG002|Overall Study|Death|0|||
126112672|NCT03823404|453709487|FG000|Overall Study|Other: Various reasons provided|5|||
126112673|NCT03823404|453709488|FG001|Overall Study|Other: Various reasons provided|5|||
126112674|NCT03823404|453709489|FG002|Overall Study|Other: Various reasons provided|6|||
126112675|NCT02308007|453709490|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
126112676|NCT02308007|453709491|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
126112677|NCT02308007|453709492|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
126112678|NCT02308007|453709490|FG000|Overall Study|Positive for STD at Baseline|7|||
126112679|NCT02308007|453709491|FG001|Overall Study|Positive for STD at Baseline|11|||
126112680|NCT02308007|453709492|FG002|Overall Study|Positive for STD at Baseline|7|||
126112681|NCT02308007|453709490|FG000|Overall Study|Lost to Follow-up|3|||
126112682|NCT02308007|453709491|FG001|Overall Study|Lost to Follow-up|0|||
126112683|NCT02308007|453709492|FG002|Overall Study|Lost to Follow-up|1|||
126112684|NCT00528567|453709497|FG000|Overall Study|Death|4|||
126112685|NCT00528567|453709498|FG001|Overall Study|Death|5|||
126112686|NCT00528567|453709497|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
126112687|NCT00528567|453709498|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
126112688|NCT00528567|453709497|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
126112689|NCT00528567|453709498|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
126112690|NCT00528567|453709497|FG000|Overall Study|Violation Criteria at Entry|3|||
126112691|NCT00528567|453709498|FG001|Overall Study|Violation Criteria at Entry|17|||
126112692|NCT00528567|453709497|FG000|Overall Study|Withdrew Consent|59|||
126112693|NCT00528567|453709498|FG001|Overall Study|Withdrew Consent|55|||
126112694|NCT00528567|453709497|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
126112695|NCT00528567|453709498|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
126112696|NCT00528567|453709497|FG000|Overall Study|Failure to Return|1|||
126112697|NCT00528567|453709498|FG001|Overall Study|Failure to Return|4|||
126112698|NCT00528567|453709497|FG000|Overall Study|Other Protocol Violation|5|||
126112699|NCT00528567|453709498|FG001|Overall Study|Other Protocol Violation|21|||
126112700|NCT00528567|453709497|FG000|Overall Study|Administrative/Other|22|||
126112701|NCT00528567|453709498|FG001|Overall Study|Administrative/Other|75|||
126112702|NCT03085758|453709503|FG000|Overall Study|Death|26|||
126112703|NCT03085758|453709504|FG001|Overall Study|Death|24|||
126112704|NCT03085758|453709505|FG002|Overall Study|Death|53|||
126112705|NCT03085758|453709503|FG000|Overall Study|Lost to Follow-up|1|||
126112706|NCT03085758|453709504|FG001|Overall Study|Lost to Follow-up|1|||
126112707|NCT03085758|453709505|FG002|Overall Study|Lost to Follow-up|1|||
126112708|NCT03085758|453709503|FG000|Overall Study|Withdrawal by Subject|2|||
126112709|NCT03085758|453709504|FG001|Overall Study|Withdrawal by Subject|2|||
126112710|NCT03085758|453709505|FG002|Overall Study|Withdrawal by Subject|1|||
126112711|NCT03085758|453709503|FG000|Overall Study|Refusal to recall it up to day 90|0|||
126112712|NCT03085758|453709504|FG001|Overall Study|Refusal to recall it up to day 90|0|||
126112713|NCT03085758|453709505|FG002|Overall Study|Refusal to recall it up to day 90|1|||
126112714|NCT03085758|453709503|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
126112715|NCT03085758|453709504|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
126112716|NCT03085758|453709505|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
126112717|NCT04004429|453709506|FG000|Overall Study|Protocol Violation|1|||
126112718|NCT04004429|453709507|FG001|Overall Study|Protocol Violation|0|||
126112719|NCT04004429|453709508|FG002|Overall Study|Protocol Violation|0|||
126112720|NCT04004429|453709506|FG000|Overall Study|Physician Decision|0|||
126112721|NCT04004429|453709507|FG001|Overall Study|Physician Decision|1|||
126112722|NCT04004429|453709508|FG002|Overall Study|Physician Decision|1|||
126112723|NCT04004429|453709506|FG000|Overall Study|Withdrawal by Subject|1|||
126112724|NCT04004429|453709507|FG001|Overall Study|Withdrawal by Subject|1|||
126112725|NCT04004429|453709508|FG002|Overall Study|Withdrawal by Subject|1|||
126112726|NCT00631189|453709509|FG000|Initial Phase|Protocol Violation|347|||
126112727|NCT00631189|453709510|FG001|Initial Phase|Protocol Violation|0|||
126112728|NCT00631189|453709511|FG002|Initial Phase|Protocol Violation|0|||
126112729|NCT00631189|453709512|FG003|Initial Phase|Protocol Violation|0|||
126112730|NCT00631189|453709509|FG000|Initial Phase|Withdrawal by Subject|4|||
126112731|NCT00631189|453709510|FG001|Initial Phase|Withdrawal by Subject|0|||
126112732|NCT00631189|453709511|FG002|Initial Phase|Withdrawal by Subject|0|||
126112733|NCT00631189|453709512|FG003|Initial Phase|Withdrawal by Subject|0|||
126112734|NCT00631189|453709509|FG000|Treatment Phase|Withdrawal by Subject|0|||
126112735|NCT00631189|453709510|FG001|Treatment Phase|Withdrawal by Subject|2|||
126112736|NCT00631189|453709511|FG002|Treatment Phase|Withdrawal by Subject|1|||
126112737|NCT00631189|453709512|FG003|Treatment Phase|Withdrawal by Subject|1|||
126112738|NCT00631189|453709509|FG000|Treatment Phase|Protocol Violation|0|||
126112739|NCT00631189|453709510|FG001|Treatment Phase|Protocol Violation|1|||
126112740|NCT00631189|453709511|FG002|Treatment Phase|Protocol Violation|6|||
126065546|NCT00473512|453532149|FG001|Period 2 (Phase 2)|Adverse Event|0|||
126065547|NCT00473512|453532150|FG002|Period 2 (Phase 2)|Adverse Event|0|||
126065548|NCT00473512|453532151|FG003|Period 2 (Phase 2)|Adverse Event|1|||
126065549|NCT00473512|453532152|FG004|Period 2 (Phase 2)|Adverse Event|0|||
126065550|NCT00473512|453532148|FG000|Period 2 (Phase 2)|Death|0|||
126065551|NCT00473512|453532149|FG001|Period 2 (Phase 2)|Death|0|||
126065552|NCT00473512|453532150|FG002|Period 2 (Phase 2)|Death|0|||
126065553|NCT00473512|453532151|FG003|Period 2 (Phase 2)|Death|1|||
126065554|NCT00473512|453532152|FG004|Period 2 (Phase 2)|Death|1|||
126065555|NCT00473512|453532148|FG000|Period 2 (Phase 2)|Disease Progression|0|||
126065556|NCT00473512|453532149|FG001|Period 2 (Phase 2)|Disease Progression|2|||
126065557|NCT00473512|453532150|FG002|Period 2 (Phase 2)|Disease Progression|2|||
126065558|NCT00473512|453532151|FG003|Period 2 (Phase 2)|Disease Progression|17|||
126065559|NCT00473512|453532152|FG004|Period 2 (Phase 2)|Disease Progression|1|||
126065560|NCT00473512|453532148|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
126065561|NCT00473512|453532149|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
126065562|NCT00473512|453532150|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
126065563|NCT00473512|453532151|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
126065564|NCT00473512|453532152|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
126065565|NCT00473512|453532148|FG000|Period 2 (Phase 2)|Other|1|||
126065566|NCT00473512|453532149|FG001|Period 2 (Phase 2)|Other|0|||
126065567|NCT00473512|453532150|FG002|Period 2 (Phase 2)|Other|0|||
126065568|NCT00473512|453532151|FG003|Period 2 (Phase 2)|Other|3|||
126065569|NCT00473512|453532152|FG004|Period 2 (Phase 2)|Other|0|||
126065570|NCT00267956|453532153|FG000|Controlled Period|Adverse Event|4|||
126065571|NCT00267956|453532154|FG001|Controlled Period|Adverse Event|1|||
126065572|NCT00267956|453532155|FG002|Controlled Period|Adverse Event|0|||
126065573|NCT00267956|453532156|FG003|Controlled Period|Adverse Event|0|||
126065574|NCT00267956|453532153|FG000|Controlled Period|Lack of Efficacy|4|||
126065575|NCT00267956|453532154|FG001|Controlled Period|Lack of Efficacy|2|||
126065576|NCT00267956|453532155|FG002|Controlled Period|Lack of Efficacy|0|||
126065577|NCT00267956|453532156|FG003|Controlled Period|Lack of Efficacy|0|||
126065578|NCT00267956|453532153|FG000|Controlled Period|Lost to Follow-up|2|||
126065579|NCT00267956|453532154|FG001|Controlled Period|Lost to Follow-up|0|||
126065580|NCT00267956|453532155|FG002|Controlled Period|Lost to Follow-up|0|||
126065581|NCT00267956|453532156|FG003|Controlled Period|Lost to Follow-up|0|||
126065582|NCT00267956|453532153|FG000|Controlled Period|Withdrew consent|3|||
126065583|NCT00267956|453532154|FG001|Controlled Period|Withdrew consent|1|||
126065584|NCT00267956|453532155|FG002|Controlled Period|Withdrew consent|0|||
126065585|NCT00267956|453532156|FG003|Controlled Period|Withdrew consent|0|||
126065586|NCT00267956|453532153|FG000|After Controlled Period|Adverse Event|0|||
126065587|NCT00267956|453532154|FG001|After Controlled Period|Adverse Event|0|||
126065588|NCT00267956|453532155|FG002|After Controlled Period|Adverse Event|2|||
126065589|NCT00267956|453532156|FG003|After Controlled Period|Adverse Event|1|||
126065590|NCT00267956|453532153|FG000|After Controlled Period|Lack of Efficacy|0|||
126065591|NCT00267956|453532154|FG001|After Controlled Period|Lack of Efficacy|0|||
126065592|NCT00267956|453532155|FG002|After Controlled Period|Lack of Efficacy|1|||
126065593|NCT00267956|453532156|FG003|After Controlled Period|Lack of Efficacy|1|||
126065594|NCT00267956|453532153|FG000|After Controlled Period|Lost to Follow-up|0|||
126065595|NCT00267956|453532154|FG001|After Controlled Period|Lost to Follow-up|0|||
126065596|NCT00267956|453532155|FG002|After Controlled Period|Lost to Follow-up|1|||
126065597|NCT00267956|453532156|FG003|After Controlled Period|Lost to Follow-up|0|||
126065598|NCT00267956|453532153|FG000|After Controlled Period|Withdrew consent|0|||
126065599|NCT00267956|453532154|FG001|After Controlled Period|Withdrew consent|0|||
126065600|NCT00267956|453532155|FG002|After Controlled Period|Withdrew consent|1|||
126065601|NCT00267956|453532156|FG003|After Controlled Period|Withdrew consent|0|||
126065602|NCT02246647|453532157|FG000|Overall Study|Withdrawal by Subject|1|||
126065603|NCT02246647|453532158|FG001|Overall Study|Withdrawal by Subject|1|||
126065604|NCT01012999|453532159|FG000|Overall Study|Protocol Violation|1|||
126065605|NCT03557307|453532160|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
126065606|NCT03557307|453532160|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
126065607|NCT03557307|453532160|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
126065608|NCT03557307|453532160|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
126065609|NCT03557307|453532160|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
126065610|NCT03557307|453532160|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
126065611|NCT03557307|453532160|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
126065612|NCT03557307|453532160|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
126065613|NCT03557307|453532160|FG000|Period 2: Maintenance Phase|Death|3|||
126065614|NCT03557307|453532160|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
126065615|NCT03557307|453532160|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
126065616|NCT03557307|453532160|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
126065617|NCT03557307|453532160|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
126065618|NCT03557307|453532160|FG000|Period 2: Maintenance Phase|other|3|||
126065619|NCT03184519|453532161|FG000|Overall Study|Lost to Follow-up|6|||
126112741|NCT00631189|453709512|FG003|Treatment Phase|Protocol Violation|2|||
126112742|NCT00631189|453709509|FG000|Treatment Phase|Adverse Event|0|||
125929340|NCT00642460|453034956|FG000|Part III: Open-Label Up to Week 260|Death|0|||
125929341|NCT00642460|453034957|FG001|Part III: Open-Label Up to Week 260|Death|0|||
125929342|NCT00642460|453034958|FG002|Part III: Open-Label Up to Week 260|Death|0|||
125929343|NCT00642460|453034959|FG003|Part III: Open-Label Up to Week 260|Death|0|||
125929344|NCT00642460|453034960|FG004|Part III: Open-Label Up to Week 260|Death|0|||
125929345|NCT00642460|453034961|FG005|Part III: Open-Label Up to Week 260|Death|3|||
125929346|NCT00642460|453034956|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125929347|NCT00642460|453034957|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
126065620|NCT03184519|453532161|FG000|Overall Study|Physician Decision|21|||
126065621|NCT00584909|453532163|FG000|Overall Study|Adverse Event|4|||
126065622|NCT02256553|453532166|FG000|Period I|Adverse Event|5|||
126065623|NCT02256553|453532166|FG000|Period I|Protocol Violation|1|||
126065624|NCT02256553|453532166|FG000|Period II|Adverse Event|1|||
126065625|NCT02256553|453532166|FG000|Period II|Subject Moved|1|||
126065626|NCT02256553|453532166|FG000|Period III|Adverse Event|3|||
126065627|NCT02092909|453532167|FG000|Overall Study|Adverse Event|0|||
126065628|NCT02092909|453532168|FG001|Overall Study|Adverse Event|0|||
126065629|NCT02092909|453532169|FG002|Overall Study|Adverse Event|4|||
126065630|NCT02092909|453532170|FG003|Overall Study|Adverse Event|2|||
126065631|NCT02092909|453532167|FG000|Overall Study|Lack of Efficacy|0|||
126065632|NCT02092909|453532168|FG001|Overall Study|Lack of Efficacy|2|||
126065633|NCT02092909|453532169|FG002|Overall Study|Lack of Efficacy|1|||
126065634|NCT02092909|453532170|FG003|Overall Study|Lack of Efficacy|0|||
126065635|NCT02092909|453532167|FG000|Overall Study|Withdrawal by Subject|0|||
126065636|NCT02092909|453532168|FG001|Overall Study|Withdrawal by Subject|0|||
126065637|NCT02092909|453532169|FG002|Overall Study|Withdrawal by Subject|2|||
126065638|NCT02092909|453532170|FG003|Overall Study|Withdrawal by Subject|1|||
126065639|NCT02092909|453532167|FG000|Overall Study|Study terminated by Sponsor|0|||
126065640|NCT02092909|453532168|FG001|Overall Study|Study terminated by Sponsor|0|||
126065641|NCT02092909|453532169|FG002|Overall Study|Study terminated by Sponsor|0|||
126065642|NCT02092909|453532170|FG003|Overall Study|Study terminated by Sponsor|2|||
126065643|NCT02092909|453532167|FG000|Overall Study|Miscellaneous|1|||
126065644|NCT02092909|453532168|FG001|Overall Study|Miscellaneous|1|||
126065645|NCT02092909|453532169|FG002|Overall Study|Miscellaneous|2|||
126065646|NCT02092909|453532170|FG003|Overall Study|Miscellaneous|1|||
126065647|NCT03436797|453532171|FG000|Main Study|Withdrawal by Subject|2|||
126065648|NCT03436797|453532171|FG000|Main Study|Adverse Event|4|||
126065649|NCT03436797|453532171|FG000|Main Study|Lost to Follow-up|1|||
126065650|NCT03436797|453532171|FG000|Main Study|Death|1|||
126065651|NCT03436797|453532171|FG000|Main Study|Non-Specific|2|||
126065652|NCT03436797|453532171|FG000|Extended Dosing|Patient decision|1|||
126065653|NCT04626128|453532174|FG000|Overall Study|Withdrawal by Subject|0|||
126065654|NCT04626128|453532175|FG001|Overall Study|Withdrawal by Subject|1|||
126065655|NCT04626128|453532176|FG002|Overall Study|Withdrawal by Subject|0|||
126065656|NCT04626128|453532177|FG003|Overall Study|Withdrawal by Subject|0|||
126065657|NCT01182285|453532178|FG000|First Intervention Week 1-10|Disease progression|1|||
126065658|NCT01182285|453532179|FG001|First Intervention Week 1-10|Disease progression|0|||
126065659|NCT01182285|453532180|FG002|First Intervention Week 1-10|Disease progression|0|||
126065660|NCT01182285|453532178|FG000|First Intervention Week 1-10|Adverse Event|1|||
126065661|NCT01182285|453532179|FG001|First Intervention Week 1-10|Adverse Event|0|||
126065662|NCT01182285|453532180|FG002|First Intervention Week 1-10|Adverse Event|0|||
126065663|NCT01182285|453532178|FG000|First Intervention Week 1-10|Non-compliance|1|||
126065664|NCT01182285|453532179|FG001|First Intervention Week 1-10|Non-compliance|0|||
126065665|NCT01182285|453532180|FG002|First Intervention Week 1-10|Non-compliance|0|||
126065666|NCT01182285|453532178|FG000|Third Intervention Week 11-52|Disease Progression|0|||
126065667|NCT01182285|453532179|FG001|Third Intervention Week 11-52|Disease Progression|0|||
126065668|NCT01182285|453532180|FG002|Third Intervention Week 11-52|Disease Progression|6|||
126065669|NCT01182285|453532178|FG000|Third Intervention Week 11-52|Other|0|||
126065670|NCT01182285|453532179|FG001|Third Intervention Week 11-52|Other|0|||
126065671|NCT01182285|453532180|FG002|Third Intervention Week 11-52|Other|2|||
126065672|NCT01951105|453532183|FG000|Overall Study|Adverse Event|0|||
126065673|NCT01951105|453532184|FG001|Overall Study|Adverse Event|5|||
126065674|NCT01951105|453532185|FG002|Overall Study|Adverse Event|0|||
126065675|NCT01951105|453532183|FG000|Overall Study|Lost to Follow-up|0|||
126065676|NCT01951105|453532184|FG001|Overall Study|Lost to Follow-up|1|||
126065677|NCT01951105|453532185|FG002|Overall Study|Lost to Follow-up|0|||
126065678|NCT01951105|453532183|FG000|Overall Study|Protocol Violation|1|||
126065679|NCT01951105|453532184|FG001|Overall Study|Protocol Violation|1|||
126065680|NCT01951105|453532185|FG002|Overall Study|Protocol Violation|1|||
126065681|NCT01951105|453532183|FG000|Overall Study|Withdrawal by Subject|0|||
126065682|NCT01951105|453532184|FG001|Overall Study|Withdrawal by Subject|3|||
126065683|NCT01951105|453532185|FG002|Overall Study|Withdrawal by Subject|1|||
126065684|NCT03209492|453532186|FG000|Overall Study|Case Report Forms Uncollected|5|||
126065685|NCT00442559|453532189|FG000|Overall Study|Lost to Follow-up|32|||
126065686|NCT00442559|453532190|FG001|Overall Study|Lost to Follow-up|34|||
126065687|NCT00442559|453532189|FG000|Overall Study|Protocol Violation|1|||
126065688|NCT00442559|453532190|FG001|Overall Study|Protocol Violation|1|||
125929348|NCT00642460|453034958|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125929349|NCT00642460|453034959|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125929350|NCT00642460|453034960|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125929351|NCT00642460|453034961|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
125929352|NCT00642460|453034956|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125929353|NCT00642460|453034957|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125929354|NCT00642460|453034958|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125929355|NCT00642460|453034959|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125929356|NCT00642460|453034960|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
125929357|NCT00642460|453034961|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
125929358|NCT00320411|453034965|FG000|Overall Study|No investigational product admin.|4|||
125929359|NCT02557646|453034968|FG000|Overall Study|Adverse Event|40|||
125929360|NCT02557646|453034968|FG000|Overall Study|Death|1|||
125929361|NCT02557646|453034968|FG000|Overall Study|Lack of Efficacy|186|||
125929362|NCT02557646|453034968|FG000|Overall Study|Withdrawal by Subject|18|||
125929363|NCT02557646|453034968|FG000|Overall Study|Lost to Follow-up|17|||
125929364|NCT02557646|453034968|FG000|Overall Study|Other|14|||
125929365|NCT00518986|453034969|FG000|Overall Study|Adverse Event|12|||
125929366|NCT00518986|453034970|FG001|Overall Study|Adverse Event|7|||
125929367|NCT00518986|453034969|FG000|Overall Study|Lack of Efficacy|0|||
125929368|NCT00518986|453034970|FG001|Overall Study|Lack of Efficacy|2|||
125929369|NCT00518986|453034969|FG000|Overall Study|Lost to Follow-up|3|||
125929370|NCT00518986|453034970|FG001|Overall Study|Lost to Follow-up|2|||
125929371|NCT00518986|453034969|FG000|Overall Study|Physician Decision|0|||
125929372|NCT00518986|453034970|FG001|Overall Study|Physician Decision|3|||
125929373|NCT00518986|453034969|FG000|Overall Study|Protocol Violation|5|||
125929374|NCT00518986|453034970|FG001|Overall Study|Protocol Violation|7|||
125929375|NCT00518986|453034969|FG000|Overall Study|Withdrawal by Subject|4|||
126065689|NCT00442559|453532189|FG000|Overall Study|Withdrawal by Subject|1|||
126065690|NCT00442559|453532190|FG001|Overall Study|Withdrawal by Subject|0|||
126065691|NCT02604199|453532200|FG000|Overall Study|Pregnancy|0|||
126065692|NCT02604199|453532201|FG001|Overall Study|Pregnancy|0|||
126065693|NCT02604199|453532202|FG002|Overall Study|Pregnancy|0|||
126065694|NCT02604199|453532203|FG003|Overall Study|Pregnancy|1|||
126065695|NCT02604199|453532200|FG000|Overall Study|Study terminated by sponsor|0|||
126065696|NCT02604199|453532201|FG001|Overall Study|Study terminated by sponsor|2|||
126065697|NCT02604199|453532202|FG002|Overall Study|Study terminated by sponsor|0|||
126065698|NCT02604199|453532203|FG003|Overall Study|Study terminated by sponsor|2|||
126065699|NCT02604199|453532200|FG000|Overall Study|Withdrawal by Subject|0|||
126065700|NCT02604199|453532201|FG001|Overall Study|Withdrawal by Subject|1|||
126065701|NCT02604199|453532202|FG002|Overall Study|Withdrawal by Subject|0|||
126065702|NCT02604199|453532203|FG003|Overall Study|Withdrawal by Subject|0|||
126065703|NCT02812706|453532204|FG000|Phase 1|Adverse Event|0|||
126065704|NCT02812706|453532205|FG001|Phase 1|Adverse Event|2|||
126065705|NCT02812706|453532206|FG002|Phase 1|Adverse Event|0|||
126065706|NCT02812706|453532204|FG000|Phase 1|Progressive disease|3|||
126065707|NCT02812706|453532205|FG001|Phase 1|Progressive disease|3|||
126065708|NCT02812706|453532206|FG002|Phase 1|Progressive disease|0|||
126065709|NCT02812706|453532204|FG000|Phase 2|Adverse Event|0|||
126065710|NCT02812706|453532205|FG001|Phase 2|Adverse Event|0|||
126065711|NCT02812706|453532206|FG002|Phase 2|Adverse Event|2|||
126065712|NCT02812706|453532204|FG000|Phase 2|Progressive disease|0|||
126065713|NCT02812706|453532205|FG001|Phase 2|Progressive disease|0|||
126065714|NCT02812706|453532206|FG002|Phase 2|Progressive disease|22|||
126065715|NCT02812706|453532204|FG000|Phase 2|Other-Unspecified|0|||
126065716|NCT02812706|453532205|FG001|Phase 2|Other-Unspecified|0|||
126065717|NCT02812706|453532206|FG002|Phase 2|Other-Unspecified|4|||
126065718|NCT03166215|453532212|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
126065719|NCT03166215|453532213|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
126065720|NCT03166215|453532214|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
126065721|NCT03166215|453532212|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
126065722|NCT03166215|453532213|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
126065723|NCT03166215|453532214|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
126065724|NCT02632045|453532215|FG000|Overall Study|Withdrawal by Subject|1|||
126065725|NCT02632045|453532216|FG001|Overall Study|Withdrawal by Subject|2|||
126065726|NCT05878522|453532217|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065727|NCT05878522|453532218|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065728|NCT05878522|453532219|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065729|NCT05878522|453532220|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065730|NCT05878522|453532221|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065731|NCT05878522|453532222|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125929376|NCT00518986|453034970|FG001|Overall Study|Withdrawal by Subject|4|||
125929377|NCT00518986|453034969|FG000|Overall Study|Non-Specific|2|||
125929378|NCT00518986|453034970|FG001|Overall Study|Non-Specific|1|||
126112743|NCT00631189|453709510|FG001|Treatment Phase|Adverse Event|3|||
125929379|NCT02088047|453034971|FG000|Overall Study|Withdrawal by Subject|1|||
125929380|NCT02088047|453034972|FG001|Overall Study|Withdrawal by Subject|0|||
125929381|NCT04605484|453034975|FG000|Overall Study|Lost to Follow-up|0|||
125929382|NCT04605484|453034976|FG001|Overall Study|Lost to Follow-up|1|||
125929383|NCT04605484|453034977|FG002|Overall Study|Lost to Follow-up|1|||
125929384|NCT04605484|453034975|FG000|Overall Study|Other|0|||
125929385|NCT04605484|453034976|FG001|Overall Study|Other|1|||
125929386|NCT04605484|453034977|FG002|Overall Study|Other|0|||
125929387|NCT04171531|453034978|FG000|Overall Study|Lost to Follow-up|4|||
125929388|NCT04171531|453034979|FG001|Overall Study|Lost to Follow-up|5|||
125929389|NCT04171531|453034978|FG000|Overall Study|Consent only through 6 months|1|||
125929390|NCT04171531|453034979|FG001|Overall Study|Consent only through 6 months|1|||
125929391|NCT04171531|453034978|FG000|Overall Study|Insurance did not cover procedure|0|||
125929392|NCT04171531|453034979|FG001|Overall Study|Insurance did not cover procedure|1|||
125929393|NCT04171531|453034978|FG000|Overall Study|Physician Decision|0|||
125929394|NCT04171531|453034979|FG001|Overall Study|Physician Decision|3|||
125929395|NCT04171531|453034978|FG000|Overall Study|Withdrawal by Subject|1|||
125929396|NCT04171531|453034979|FG001|Overall Study|Withdrawal by Subject|5|||
125929397|NCT05683249|453034980|FG000|Overall Study|Adverse Event|3|||
125929398|NCT05683249|453034981|FG001|Overall Study|Adverse Event|1|||
125929399|NCT05683249|453034980|FG000|Overall Study|Lack of Efficacy|0|||
125929400|NCT05683249|453034981|FG001|Overall Study|Lack of Efficacy|2|||
125929401|NCT05683249|453034980|FG000|Overall Study|Lost to Follow-up|6|||
125929402|NCT05683249|453034981|FG001|Overall Study|Lost to Follow-up|5|||
125929403|NCT05683249|453034980|FG000|Overall Study|Non-compliance with Study Drug|2|||
125929404|NCT05683249|453034981|FG001|Overall Study|Non-compliance with Study Drug|0|||
126065732|NCT05878522|453532223|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065733|NCT05878522|453532224|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065734|NCT05878522|453532225|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
126065735|NCT05878522|453532226|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065736|NCT05878522|453532227|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065737|NCT05878522|453532228|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126065738|NCT05878522|453532217|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
126065739|NCT05878522|453532218|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065740|NCT05878522|453532219|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065741|NCT05878522|453532220|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065742|NCT05878522|453532221|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065743|NCT05878522|453532222|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065744|NCT05878522|453532223|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065745|NCT05878522|453532224|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065746|NCT05878522|453532225|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065747|NCT05878522|453532226|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
126065748|NCT05878522|453532227|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065749|NCT05878522|453532228|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126065750|NCT05878522|453532217|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065751|NCT05878522|453532218|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
126065752|NCT05878522|453532219|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065753|NCT05878522|453532220|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
126065754|NCT05878522|453532221|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065755|NCT05878522|453532222|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065756|NCT05878522|453532223|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065757|NCT05878522|453532224|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065758|NCT05878522|453532225|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065759|NCT05878522|453532226|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065760|NCT05878522|453532227|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065761|NCT05878522|453532228|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126065762|NCT05878522|453532217|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065763|NCT05878522|453532218|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065764|NCT05878522|453532219|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065765|NCT05878522|453532220|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065766|NCT05878522|453532221|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
126065767|NCT05878522|453532222|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065768|NCT05878522|453532223|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065769|NCT05878522|453532224|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065770|NCT05878522|453532225|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065771|NCT05878522|453532226|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065772|NCT05878522|453532227|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065773|NCT05878522|453532228|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126065774|NCT02252172|453532229|FG000|Overall Study|Lost to Follow-up|3|||
126065775|NCT02252172|453532230|FG001|Overall Study|Lost to Follow-up|1|||
126065776|NCT02252172|453532229|FG000|Overall Study|Ongoing|276|||
126065777|NCT02252172|453532230|FG001|Overall Study|Ongoing|298|||
125929405|NCT05683249|453034980|FG000|Overall Study|Protocol Violation|6|||
125929406|NCT05683249|453034981|FG001|Overall Study|Protocol Violation|3|||
125929407|NCT05683249|453034980|FG000|Overall Study|Withdrawal by Subject|9|||
125929408|NCT05683249|453034981|FG001|Overall Study|Withdrawal by Subject|8|||
125929409|NCT05683249|453034980|FG000|Overall Study|Other|0|||
125929410|NCT05683249|453034981|FG001|Overall Study|Other|2|||
125929411|NCT04862585|453034982|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
125929412|NCT04862585|453034983|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
125929413|NCT04862585|453034982|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
125929414|NCT04862585|453034983|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
125929415|NCT04862585|453034982|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
125929416|NCT04862585|453034983|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
125929417|NCT04862585|453034982|FG000|Overall Study|one withdrew without providing a reason|0|||
125929418|NCT04862585|453034983|FG001|Overall Study|one withdrew without providing a reason|1|||
125929419|NCT03366337|453034984|FG000|Overall Study|Lost to Follow-up|1|||
125929420|NCT03366337|453034985|FG001|Overall Study|Lost to Follow-up|0|||
125929421|NCT03366337|453034986|FG002|Overall Study|Lost to Follow-up|1|||
125929422|NCT03366337|453034987|FG003|Overall Study|Lost to Follow-up|0|||
125929423|NCT03366337|453034984|FG000|Overall Study|Withdrawal by Subject|2|||
125929424|NCT03366337|453034985|FG001|Overall Study|Withdrawal by Subject|0|||
125929425|NCT03366337|453034986|FG002|Overall Study|Withdrawal by Subject|1|||
125929426|NCT03366337|453034987|FG003|Overall Study|Withdrawal by Subject|1|||
125929427|NCT05229406|453034988|FG000|Overall Study|Withdrawal by Subject|1|||
125929428|NCT05229406|453034989|FG001|Overall Study|Withdrawal by Subject|2|||
125929429|NCT00459953|453034990|FG000|Overall Study|not analyzed-household member in study|1|||
125929430|NCT00459953|453034991|FG001|Overall Study|not analyzed-household member in study|1|||
125929431|NCT00496470|453034992|FG000|Overall Study|Adverse Event|8|||
125929432|NCT00496470|453034993|FG001|Overall Study|Adverse Event|10|||
125929433|NCT00496470|453034992|FG000|Overall Study|Withdrawal by Subject|5|||
125929434|NCT00496470|453034993|FG001|Overall Study|Withdrawal by Subject|12|||
125929435|NCT00496470|453034992|FG000|Overall Study|Incorrectly enrolled|13|||
125929436|NCT00496470|453034993|FG001|Overall Study|Incorrectly enrolled|5|||
125929437|NCT00496470|453034992|FG000|Overall Study|Other reason|0|||
125929438|NCT00496470|453034993|FG001|Overall Study|Other reason|2|||
125929439|NCT00040664|453034994|FG000|Overall Study|Adverse Event|12|||
125929440|NCT00040664|453034995|FG001|Overall Study|Adverse Event|3|||
125929441|NCT00040664|453034996|FG002|Overall Study|Adverse Event|2|||
125929442|NCT00040664|453034997|FG003|Overall Study|Adverse Event|7|||
125929443|NCT00040664|453034994|FG000|Overall Study|Lack of Efficacy|9|||
125929444|NCT00040664|453034995|FG001|Overall Study|Lack of Efficacy|2|||
125929445|NCT00040664|453034996|FG002|Overall Study|Lack of Efficacy|3|||
125929446|NCT00040664|453034997|FG003|Overall Study|Lack of Efficacy|4|||
125929447|NCT00040664|453034994|FG000|Overall Study|Insufficient CD4 response|1|||
125929448|NCT00040664|453034995|FG001|Overall Study|Insufficient CD4 response|0|||
125929449|NCT00040664|453034996|FG002|Overall Study|Insufficient CD4 response|1|||
125929450|NCT00040664|453034997|FG003|Overall Study|Insufficient CD4 response|0|||
125929451|NCT00040664|453034994|FG000|Overall Study|Lost to Follow-up|4|||
125929452|NCT00040664|453034995|FG001|Overall Study|Lost to Follow-up|2|||
125929453|NCT00040664|453034996|FG002|Overall Study|Lost to Follow-up|0|||
125929454|NCT00040664|453034997|FG003|Overall Study|Lost to Follow-up|2|||
125929455|NCT00040664|453034994|FG000|Overall Study|Protocol Violation|2|||
125929456|NCT00040664|453034995|FG001|Overall Study|Protocol Violation|1|||
125929457|NCT00040664|453034996|FG002|Overall Study|Protocol Violation|0|||
125929458|NCT00040664|453034997|FG003|Overall Study|Protocol Violation|1|||
125929459|NCT00040664|453034994|FG000|Overall Study|Withdrawal by Subject|7|||
125929460|NCT00040664|453034995|FG001|Overall Study|Withdrawal by Subject|0|||
125929461|NCT00040664|453034996|FG002|Overall Study|Withdrawal by Subject|3|||
125929462|NCT00040664|453034997|FG003|Overall Study|Withdrawal by Subject|4|||
125929463|NCT00040664|453034994|FG000|Overall Study|Pregnancy|3|||
125929464|NCT00040664|453034995|FG001|Overall Study|Pregnancy|0|||
125929465|NCT00040664|453034996|FG002|Overall Study|Pregnancy|0|||
125929466|NCT00040664|453034997|FG003|Overall Study|Pregnancy|3|||
125929467|NCT00040664|453034994|FG000|Overall Study|Medication adherence/compliance problems|8|||
125929468|NCT00040664|453034995|FG001|Overall Study|Medication adherence/compliance problems|2|||
125929469|NCT00040664|453034996|FG002|Overall Study|Medication adherence/compliance problems|1|||
125929470|NCT00040664|453034997|FG003|Overall Study|Medication adherence/compliance problems|5|||
125929471|NCT00040664|453034994|FG000|Overall Study|Poor taste|2|||
125929472|NCT00040664|453034995|FG001|Overall Study|Poor taste|0|||
125929473|NCT00040664|453034996|FG002|Overall Study|Poor taste|2|||
125929474|NCT00040664|453034997|FG003|Overall Study|Poor taste|0|||
125929475|NCT00040664|453034994|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
125929476|NCT00040664|453034995|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
125929477|NCT00040664|453034996|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
125929478|NCT00040664|453034997|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
125929479|NCT00040664|453034994|FG000|Overall Study|Change of formulation|2|||
125929480|NCT00040664|453034995|FG001|Overall Study|Change of formulation|2|||
125929481|NCT00040664|453034996|FG002|Overall Study|Change of formulation|0|||
125929482|NCT00040664|453034997|FG003|Overall Study|Change of formulation|0|||
125929483|NCT00040664|453034994|FG000|Overall Study|Non-viability of oral suspension|1|||
125929484|NCT00040664|453034995|FG001|Overall Study|Non-viability of oral suspension|0|||
125929485|NCT00040664|453034996|FG002|Overall Study|Non-viability of oral suspension|1|||
125929486|NCT00040664|453034997|FG003|Overall Study|Non-viability of oral suspension|0|||
125929487|NCT04419714|453034998|FG000|Overall Study|Technical Fault|5|||
125929488|NCT04419714|453034998|FG000|Overall Study|Protocol Deviation|2|||
125929489|NCT04419714|453034998|FG000|Overall Study|Withdrawal by Subject|1|||
125929490|NCT02324569|453036662|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125929491|NCT02324569|453036663|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
125929492|NCT02324569|453036662|FG000|Overall Study|Voluntary Withdrawal|3|||
125929493|NCT02324569|453036663|FG001|Overall Study|Voluntary Withdrawal|6|||
125929494|NCT02324569|453036662|FG000|Overall Study|Lack of Efficacy|2|||
125929495|NCT02324569|453036663|FG001|Overall Study|Lack of Efficacy|3|||
125929496|NCT02324569|453036662|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
125929497|NCT02324569|453036663|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
125929498|NCT02324569|453036662|FG000|Overall Study|Inconvenient Schedule|2|||
125929499|NCT02324569|453036663|FG001|Overall Study|Inconvenient Schedule|0|||
125929500|NCT01943292|453036664|FG000|Overall Study|Withdrawal by Subject|1|||
125929501|NCT01943292|453036665|FG001|Overall Study|Withdrawal by Subject|0|||
125929502|NCT01943292|453036666|FG002|Overall Study|Withdrawal by Subject|0|||
125929503|NCT00911820|453036667|FG000|Overall Study|RECIST progression|12|||
125929504|NCT00911820|453036668|FG001|Overall Study|RECIST progression|8|||
125929505|NCT00911820|453036667|FG000|Overall Study|Adverse Event|8|||
125929506|NCT00911820|453036668|FG001|Overall Study|Adverse Event|8|||
125929507|NCT00911820|453036667|FG000|Overall Study|Clinical Progression|7|||
125929508|NCT00911820|453036668|FG001|Overall Study|Clinical Progression|5|||
125929509|NCT00911820|453036667|FG000|Overall Study|Physician Decision|5|||
125929510|NCT00911820|453036668|FG001|Overall Study|Physician Decision|9|||
125929511|NCT00911820|453036667|FG000|Overall Study|Decline in Performance Status|4|||
125929512|NCT00911820|453036668|FG001|Overall Study|Decline in Performance Status|2|||
125929513|NCT00911820|453036667|FG000|Overall Study|Withdrawal by Subject|3|||
125929514|NCT00911820|453036668|FG001|Overall Study|Withdrawal by Subject|4|||
125929515|NCT00911820|453036667|FG000|Overall Study|Death|1|||
125929516|NCT00911820|453036668|FG001|Overall Study|Death|2|||
125929517|NCT00911820|453036667|FG000|Overall Study|Pursue surgery|1|||
125929518|NCT00911820|453036668|FG001|Overall Study|Pursue surgery|1|||
125929519|NCT00911820|453036667|FG000|Overall Study|Pursue Radiation|1|||
125929520|NCT00911820|453036668|FG001|Overall Study|Pursue Radiation|0|||
125929521|NCT00911820|453036667|FG000|Overall Study|Still on Therapy|2|||
125929522|NCT00911820|453036668|FG001|Overall Study|Still on Therapy|2|||
125929523|NCT00911820|453036667|FG000|Overall Study|Pathology Not Confirmed|1|||
125929524|NCT00911820|453036668|FG001|Overall Study|Pathology Not Confirmed|0|||
125929525|NCT00911820|453036667|FG000|Overall Study|Withdraw before Receive Treatment|0|||
125929526|NCT00911820|453036668|FG001|Overall Study|Withdraw before Receive Treatment|2|||
125929527|NCT00638378|453036669|FG000|Overall Study|Death|2|||
125929528|NCT00638378|453036669|FG000|Overall Study|Adverse Event|1|||
125929529|NCT00638378|453036669|FG000|Overall Study|Disease progression|15|||
125929530|NCT00638378|453036669|FG000|Overall Study|Physician Decision|4|||
125929531|NCT03098550|453036676|FG000|Overall Study|Disease Progression|30|||
125929532|NCT03098550|453036677|FG001|Overall Study|Disease Progression|19|||
125929533|NCT03098550|453036678|FG002|Overall Study|Disease Progression|41|||
125929534|NCT03098550|453036676|FG000|Overall Study|Study Drug Toxicity|2|||
125929535|NCT03098550|453036677|FG001|Overall Study|Study Drug Toxicity|1|||
125929536|NCT03098550|453036678|FG002|Overall Study|Study Drug Toxicity|0|||
125929537|NCT03098550|453036676|FG000|Overall Study|Death|1|||
126065778|NCT05740371|453532231|FG000|Overall Study|Death|1|||
126065779|NCT01613599|453532233|FG000|Overall Study|Death|9|||
125929538|NCT03098550|453036677|FG001|Overall Study|Death|0|||
126065780|NCT01613599|453532233|FG000|Overall Study|Lost to Follow-up|5|||
126065781|NCT01613599|453532233|FG000|Overall Study|Withdrawal by Subject|8|||
125929539|NCT03098550|453036678|FG002|Overall Study|Death|0|||
125929540|NCT03098550|453036676|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
125929541|NCT03098550|453036677|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
125929542|NCT03098550|453036678|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
125929543|NCT03098550|453036676|FG000|Overall Study|Administrative reason by sponsor|0|||
125929544|NCT03098550|453036677|FG001|Overall Study|Administrative reason by sponsor|0|||
125929545|NCT03098550|453036678|FG002|Overall Study|Administrative reason by sponsor|1|||
125929546|NCT03098550|453036676|FG000|Overall Study|Other reasons|2|||
125929547|NCT03098550|453036677|FG001|Overall Study|Other reasons|0|||
125929548|NCT03098550|453036678|FG002|Overall Study|Other reasons|0|||
125929549|NCT00759031|453036685|FG000|First Intervention (1 Day)|Physician Decision|1|||
125929550|NCT00759031|453036686|FG001|First Intervention (1 Day)|Physician Decision|0|||
126065782|NCT01613599|453532233|FG000|Overall Study|Reason not specified|3|||
125929551|NCT00759031|453036685|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
125929552|NCT00759031|453036686|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
125929553|NCT00759031|453036685|FG000|First Intervention (1 Day)|Screening failure|1|||
125929554|NCT00759031|453036686|FG001|First Intervention (1 Day)|Screening failure|0|||
125929555|NCT00309387|453036689|FG000|Overall Study|Death|72|||
125929556|NCT00309387|453036690|FG001|Overall Study|Death|73|||
125929557|NCT00309387|453036689|FG000|Overall Study|Lost to Follow-up|70|||
125929558|NCT00309387|453036690|FG001|Overall Study|Lost to Follow-up|86|||
125929559|NCT02483520|453036692|FG000|Overall Study|Lost to Follow-up|3|||
125929560|NCT02483520|453036693|FG001|Overall Study|Lost to Follow-up|4|||
125929561|NCT02483520|453036692|FG000|Overall Study|Withdrawal by Subject|4|||
125929562|NCT02483520|453036693|FG001|Overall Study|Withdrawal by Subject|14|||
125929563|NCT02483520|453036692|FG000|Overall Study|Hospitalized|2|||
125929564|NCT02483520|453036693|FG001|Overall Study|Hospitalized|3|||
125929565|NCT02483520|453036692|FG000|Overall Study|Moved to LTC|2|||
125929566|NCT02483520|453036693|FG001|Overall Study|Moved to LTC|3|||
125929567|NCT04492618|453036695|FG000|Overall Study|Withdrawal by Subject|1|||
125929568|NCT01401283|453036696|FG000|Overall Study|surgery cancelled|5|||
125929569|NCT01401283|453036697|FG001|Overall Study|surgery cancelled|8|||
125929570|NCT01401283|453036696|FG000|Overall Study|preoperative arrhythmia|5|||
125929571|NCT01401283|453036697|FG001|Overall Study|preoperative arrhythmia|0|||
125929572|NCT01401283|453036696|FG000|Overall Study|no central venous access|0|||
125929573|NCT01401283|453036697|FG001|Overall Study|no central venous access|1|||
125929574|NCT01401283|453036696|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
125929575|NCT01401283|453036697|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
125929576|NCT03489720|453036698|FG000|Overall Study|Withdrawal by Subject|2|||
125929577|NCT03489720|453036699|FG001|Overall Study|Withdrawal by Subject|0|||
125929578|NCT02101060|453036705|FG000|Overall Study|Adverse Event|1|||
125929579|NCT02101060|453036706|FG001|Overall Study|Adverse Event|0|||
125929580|NCT02101060|453036705|FG000|Overall Study|Withdrawal by Subject|1|||
125929581|NCT02101060|453036706|FG001|Overall Study|Withdrawal by Subject|1|||
125929582|NCT02101060|453036705|FG000|Overall Study|Lost to Follow-up|3|||
125929583|NCT02101060|453036706|FG001|Overall Study|Lost to Follow-up|3|||
125929584|NCT03462082|453036708|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125929585|NCT03462082|453036709|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125929586|NCT03462082|453036710|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125929587|NCT03462082|453036711|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125929588|NCT03462082|453036712|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125929589|NCT03462082|453036713|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125929590|NCT03462082|453036714|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
125929591|NCT03462082|453036715|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
125929592|NCT00166114|453036718|FG000|Overall Study|Protocol Violation|2|||
125929593|NCT00166114|453036719|FG001|Overall Study|Protocol Violation|1|||
125929594|NCT00166114|453036718|FG000|Overall Study|Withdrawal by Subject|10|||
125929595|NCT00166114|453036719|FG001|Overall Study|Withdrawal by Subject|4|||
125929596|NCT00166114|453036718|FG000|Overall Study|Adverse Event|2|||
125929597|NCT00166114|453036719|FG001|Overall Study|Adverse Event|1|||
125929598|NCT00545168|453036726|FG000|Overall Study|Lost to Follow-up|5|||
125929599|NCT00545168|453036727|FG001|Overall Study|Lost to Follow-up|5|||
125929600|NCT00545168|453036728|FG002|Overall Study|Lost to Follow-up|5|||
125929601|NCT00545168|453036726|FG000|Overall Study|Withdrawal by Subject|9|||
125929602|NCT00545168|453036727|FG001|Overall Study|Withdrawal by Subject|0|||
125929603|NCT00545168|453036728|FG002|Overall Study|Withdrawal by Subject|13|||
125929604|NCT00545168|453036726|FG000|Overall Study|Protocol Violation|1|||
125929605|NCT00545168|453036727|FG001|Overall Study|Protocol Violation|0|||
125929606|NCT00545168|453036728|FG002|Overall Study|Protocol Violation|1|||
125929607|NCT00545168|453036726|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
125929608|NCT00545168|453036727|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
125929609|NCT00545168|453036728|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
125929610|NCT01987505|453036734|FG000|Overall Study|Other|9|||
125929611|NCT01987505|453036734|FG000|Overall Study|Withdrawal by Subject|2|||
126065783|NCT01075815|453532235|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
126065784|NCT01075815|453532236|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
126065785|NCT01075815|453532235|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
126065786|NCT01075815|453532236|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
125929612|NCT01987505|453036734|FG000|Overall Study|Other Reason|2|||
125929613|NCT01987505|453036734|FG000|Overall Study|Lost to Follow-up|15|||
125929614|NCT01987505|453036734|FG000|Overall Study|Investigator Decision|2|||
125929615|NCT01987505|453036734|FG000|Overall Study|Death|4|||
125929616|NCT05131646|453036735|FG000|Overall Study|Withdrawal by Subject|1|||
126112744|NCT00631189|453709511|FG002|Treatment Phase|Adverse Event|2|||
125929617|NCT05131646|453036736|FG001|Overall Study|Withdrawal by Subject|0|||
125929618|NCT05131646|453036737|FG002|Overall Study|Withdrawal by Subject|0|||
125929619|NCT03266107|453036738|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
125929620|NCT03266107|453036738|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
125929621|NCT03266107|453036738|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
125929622|NCT03266107|453036738|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
125929623|NCT03454997|453036739|FG000|Overall Study|Staff Coach - Left Oranization|1|||
125929624|NCT03454997|453036740|FG001|Overall Study|Staff Coach - Left Oranization|1|||
125929625|NCT03454997|453036739|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
125929626|NCT03454997|453036740|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
125929627|NCT03454997|453036739|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
125929628|NCT03454997|453036740|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
125929629|NCT03454997|453036739|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
125929630|NCT03454997|453036740|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
125929631|NCT03454997|453036739|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
125929632|NCT03454997|453036740|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
125929633|NCT03454997|453036739|FG000|Overall Study|Client with SMI - Left organization|0|||
125929634|NCT03454997|453036740|FG001|Overall Study|Client with SMI - Left organization|1|||
125929635|NCT03454997|453036739|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
125929636|NCT03454997|453036740|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
125929637|NCT01191801|453036743|FG000|Overall Study|Death|36|||
125929638|NCT01191801|453036744|FG001|Overall Study|Death|12|||
125929639|NCT01191801|453036743|FG000|Overall Study|Lack of Efficacy|176|||
125929640|NCT01191801|453036744|FG001|Overall Study|Lack of Efficacy|258|||
125929641|NCT01191801|453036743|FG000|Overall Study|Adverse Event|9|||
125929642|NCT01191801|453036744|FG001|Overall Study|Adverse Event|8|||
125929643|NCT01191801|453036743|FG000|Overall Study|Protocol Violation|2|||
125929644|NCT01191801|453036744|FG001|Overall Study|Protocol Violation|4|||
125929645|NCT01191801|453036743|FG000|Overall Study|Physician Decision|47|||
125929646|NCT01191801|453036744|FG001|Overall Study|Physician Decision|24|||
125929647|NCT01191801|453036743|FG000|Overall Study|Withdrawal by Subject|1|||
125929648|NCT01191801|453036744|FG001|Overall Study|Withdrawal by Subject|4|||
125929649|NCT01191801|453036743|FG000|Overall Study|Not Provided|45|||
125929650|NCT01191801|453036744|FG001|Overall Study|Not Provided|27|||
125929651|NCT00299975|453036753|FG000|Overall Study|Adverse Event|1|||
125929652|NCT00299975|453036754|FG001|Overall Study|Adverse Event|0|||
125929653|NCT00299975|453036755|FG002|Overall Study|Adverse Event|2|||
125929654|NCT00299975|453036753|FG000|Overall Study|Pregnancy|0|||
125929655|NCT00299975|453036754|FG001|Overall Study|Pregnancy|0|||
125929656|NCT00299975|453036755|FG002|Overall Study|Pregnancy|1|||
125929657|NCT00299975|453036753|FG000|Overall Study|Lack of Efficacy|1|||
125929658|NCT00299975|453036754|FG001|Overall Study|Lack of Efficacy|0|||
125929659|NCT00299975|453036755|FG002|Overall Study|Lack of Efficacy|1|||
125929660|NCT00299975|453036753|FG000|Overall Study|Lost to Follow-up|1|||
125929661|NCT00299975|453036754|FG001|Overall Study|Lost to Follow-up|0|||
125929662|NCT00299975|453036755|FG002|Overall Study|Lost to Follow-up|0|||
125929663|NCT00299975|453036753|FG000|Overall Study|Withdrawal by Subject|0|||
125929664|NCT00299975|453036754|FG001|Overall Study|Withdrawal by Subject|1|||
125929665|NCT00299975|453036755|FG002|Overall Study|Withdrawal by Subject|3|||
125929666|NCT00299975|453036753|FG000|Overall Study|Physician Decision|0|||
125929667|NCT00299975|453036754|FG001|Overall Study|Physician Decision|0|||
125929668|NCT00299975|453036755|FG002|Overall Study|Physician Decision|1|||
125929669|NCT04448171|453036757|FG000|Overall Study|Procedure Cancelled|1|||
125929670|NCT04448171|453036758|FG001|Overall Study|Procedure Cancelled|0|||
125929671|NCT04448171|453036757|FG000|Overall Study|Protocol Violation|1|||
125929672|NCT04448171|453036758|FG001|Overall Study|Protocol Violation|0|||
125929673|NCT00660309|453036761|FG000|Overall Study|Adverse Event|2|||
125929674|NCT00660309|453036762|FG001|Overall Study|Adverse Event|0|||
125929675|NCT00660309|453036761|FG000|Overall Study|Withdrawal by Subject|0|||
125929676|NCT00660309|453036762|FG001|Overall Study|Withdrawal by Subject|3|||
125929677|NCT02573311|453036765|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
125929678|NCT02573311|453036766|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
125929679|NCT02573311|453036765|FG000|Disposition for Part 2|Physician Decision|25|||
125929680|NCT02573311|453036766|FG001|Disposition for Part 2|Physician Decision|7|||
125929681|NCT02573311|453036765|FG000|Disposition for Part 2|Adverse Event|36|||
125929682|NCT02573311|453036766|FG001|Disposition for Part 2|Adverse Event|5|||
125929683|NCT02573311|453036765|FG000|Disposition for Part 2|Lost to Follow-up|76|||
125929684|NCT02573311|453036766|FG001|Disposition for Part 2|Lost to Follow-up|7|||
125929685|NCT02573311|453036765|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
125929686|NCT02573311|453036766|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
125929687|NCT02573311|453036765|FG000|Disposition for Part 2|Investigator decision|0|||
125929688|NCT02573311|453036766|FG001|Disposition for Part 2|Investigator decision|1|||
125929689|NCT02573311|453036765|FG000|Disposition for Part 2|Other than specified above|13|||
125929690|NCT02573311|453036766|FG001|Disposition for Part 2|Other than specified above|3|||
125929691|NCT01370356|453036768|FG000|Overall Study|Death|1|||
125929692|NCT01370356|453036769|FG001|Overall Study|Death|0|||
125929693|NCT01370356|453036768|FG000|Overall Study|Lack of Efficacy|6|||
125929694|NCT01370356|453036769|FG001|Overall Study|Lack of Efficacy|28|||
125929695|NCT01370356|453036768|FG000|Overall Study|Lost to Follow-up|76|||
125929696|NCT01370356|453036769|FG001|Overall Study|Lost to Follow-up|81|||
125929697|NCT01370356|453036768|FG000|Overall Study|Withdrawal by Subject|54|||
126112745|NCT00631189|453709512|FG003|Treatment Phase|Adverse Event|4|||
126112746|NCT00631189|453709509|FG000|Treatment Phase|Lost to Follow-up|0|||
126112747|NCT00631189|453709510|FG001|Treatment Phase|Lost to Follow-up|1|||
126112748|NCT00631189|453709511|FG002|Treatment Phase|Lost to Follow-up|0|||
126112749|NCT00631189|453709512|FG003|Treatment Phase|Lost to Follow-up|0|||
126112750|NCT00631189|453709509|FG000|Treatment Phase|Pregnancy|0|||
126112751|NCT00631189|453709510|FG001|Treatment Phase|Pregnancy|0|||
126112752|NCT00631189|453709511|FG002|Treatment Phase|Pregnancy|1|||
126112753|NCT00631189|453709512|FG003|Treatment Phase|Pregnancy|0|||
126112754|NCT00631189|453709509|FG000|Treatment Phase|patient did not take pravastatin|0|||
126112755|NCT00631189|453709510|FG001|Treatment Phase|patient did not take pravastatin|0|||
126112756|NCT00631189|453709511|FG002|Treatment Phase|patient did not take pravastatin|1|||
126112757|NCT00631189|453709512|FG003|Treatment Phase|patient did not take pravastatin|0|||
126112758|NCT01122576|453709513|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
126112759|NCT01122576|453709514|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
126112760|NCT01122576|453709515|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
126112761|NCT01122576|453709513|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
125929698|NCT01370356|453036769|FG001|Overall Study|Withdrawal by Subject|59|||
125929699|NCT01370356|453036768|FG000|Overall Study|Reason not specified|39|||
125929700|NCT01370356|453036769|FG001|Overall Study|Reason not specified|43|||
125929701|NCT01370356|453036768|FG000|Overall Study|Protocol Violation|3|||
125929702|NCT01370356|453036769|FG001|Overall Study|Protocol Violation|3|||
125929703|NCT01370356|453036768|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
125929704|NCT01370356|453036769|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
125929705|NCT01370356|453036768|FG000|Overall Study|AE Not Related to Study Drug|1|||
125929706|NCT01370356|453036769|FG001|Overall Study|AE Not Related to Study Drug|4|||
125929707|NCT02925494|453036770|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
125929708|NCT02925494|453036771|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
125929709|NCT02925494|453036772|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
125929710|NCT02925494|453036773|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
125929711|NCT02925494|453036770|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
125929712|NCT02925494|453036771|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125929713|NCT02925494|453036772|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
125929714|NCT02925494|453036773|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
125929715|NCT02925494|453036770|FG000|Post-Treatment Follow-Up Period|Other|1|||
125929716|NCT02925494|453036771|FG001|Post-Treatment Follow-Up Period|Other|4|||
125929717|NCT02925494|453036772|FG002|Post-Treatment Follow-Up Period|Other|3|||
125929718|NCT02925494|453036773|FG003|Post-Treatment Follow-Up Period|Other|6|||
125929719|NCT02925494|453036770|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
125929720|NCT02925494|453036771|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
125929721|NCT02925494|453036772|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
125929722|NCT02925494|453036773|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
125929723|NCT02925494|453036770|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
125929724|NCT02925494|453036771|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
125929725|NCT02925494|453036772|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
125929726|NCT02925494|453036773|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
125929727|NCT02925494|453036770|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125929728|NCT02925494|453036771|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125929729|NCT02925494|453036772|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
125929730|NCT02925494|453036773|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
125929731|NCT02925494|453036770|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
125929732|NCT02925494|453036771|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
125929733|NCT02925494|453036772|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
125929734|NCT02925494|453036773|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
125929735|NCT06149247|453036778|FG000|Overall Study|Adverse Event|0|||
125929736|NCT06149247|453036779|FG001|Overall Study|Adverse Event|1|||
125929737|NCT05182125|453036780|FG000|Overall Study|Withdrawal by Subject|0|||
125929738|NCT05182125|453036781|FG001|Overall Study|Withdrawal by Subject|0|||
125929739|NCT05182125|453036782|FG002|Overall Study|Withdrawal by Subject|0|||
125929740|NCT05182125|453036783|FG003|Overall Study|Withdrawal by Subject|0|||
125929741|NCT05182125|453036784|FG004|Overall Study|Withdrawal by Subject|2|||
125929742|NCT05182125|453036785|FG005|Overall Study|Withdrawal by Subject|0|||
126112762|NCT01122576|453709514|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
126112763|NCT01122576|453709515|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
126112764|NCT01122576|453709513|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
125929743|NCT05182125|453036780|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
125929744|NCT05182125|453036781|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
125929745|NCT05182125|453036782|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
125929746|NCT05182125|453036783|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
125929747|NCT05182125|453036784|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
125929748|NCT05182125|453036785|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
125929749|NCT05182125|453036780|FG000|Overall Study|Death|0|||
125929750|NCT05182125|453036781|FG001|Overall Study|Death|0|||
125929751|NCT05182125|453036782|FG002|Overall Study|Death|0|||
125929752|NCT05182125|453036783|FG003|Overall Study|Death|0|||
125929753|NCT05182125|453036784|FG004|Overall Study|Death|1|||
125929754|NCT05182125|453036785|FG005|Overall Study|Death|0|||
125929755|NCT05182125|453036780|FG000|Overall Study|Health Contact Follow-up|5|||
125929756|NCT05182125|453036781|FG001|Overall Study|Health Contact Follow-up|5|||
125929757|NCT05182125|453036782|FG002|Overall Study|Health Contact Follow-up|2|||
125929758|NCT05182125|453036783|FG003|Overall Study|Health Contact Follow-up|9|||
125929759|NCT05182125|453036784|FG004|Overall Study|Health Contact Follow-up|7|||
125929760|NCT05182125|453036785|FG005|Overall Study|Health Contact Follow-up|2|||
125929761|NCT01218243|453036786|FG000|Overall Study|Lack of Efficacy|1|||
125929762|NCT01218243|453036787|FG001|Overall Study|Lack of Efficacy|1|||
125929763|NCT01218243|453036786|FG000|Overall Study|Lost to Follow-up|3|||
125929764|NCT01218243|453036787|FG001|Overall Study|Lost to Follow-up|3|||
125929765|NCT01218243|453036786|FG000|Overall Study|Protocol Violation|5|||
125929766|NCT01218243|453036787|FG001|Overall Study|Protocol Violation|10|||
125929767|NCT02615145|453036789|FG000|Overall Study|Did Not Start Treatment|0|||
125929768|NCT02615145|453036790|FG001|Overall Study|Did Not Start Treatment|0|||
125929769|NCT02615145|453036791|FG002|Overall Study|Did Not Start Treatment|1|||
125929770|NCT02615145|453036792|FG003|Overall Study|Did Not Start Treatment|1|||
125929771|NCT02615145|453036789|FG000|Overall Study|Failure to Return|20|||
125929772|NCT02615145|453036790|FG001|Overall Study|Failure to Return|10|||
125929773|NCT02615145|453036791|FG002|Overall Study|Failure to Return|7|||
125929774|NCT02615145|453036792|FG003|Overall Study|Failure to Return|0|||
125929775|NCT02615145|453036789|FG000|Overall Study|Death|2|||
125929776|NCT02615145|453036790|FG001|Overall Study|Death|3|||
125929777|NCT02615145|453036791|FG002|Overall Study|Death|0|||
125929778|NCT02615145|453036792|FG003|Overall Study|Death|0|||
125929779|NCT02615145|453036789|FG000|Overall Study|Other, Not Specified|5|||
125929780|NCT02615145|453036790|FG001|Overall Study|Other, Not Specified|2|||
125929781|NCT02615145|453036791|FG002|Overall Study|Other, Not Specified|0|||
125929782|NCT02615145|453036792|FG003|Overall Study|Other, Not Specified|0|||
125929783|NCT03727347|453036793|FG000|Overall Study|Withdrawal by Subject|2|||
125929784|NCT03727347|453036793|FG000|Overall Study|Lost to Follow-up|1|||
125929785|NCT03200860|453036794|FG000|Overall Study|Withdrawal by Subject|1|||
125929786|NCT03200860|453036795|FG001|Overall Study|Withdrawal by Subject|0|||
125929787|NCT01744197|453036797|FG000|Overall Study|Received 1 patch|2|||
125929788|NCT01744197|453036798|FG001|Overall Study|Received 1 patch|1|||
125929789|NCT01744197|453036797|FG000|Overall Study|No patch received|2|||
125929790|NCT01744197|453036798|FG001|Overall Study|No patch received|2|||
125929791|NCT04342897|453036799|FG000|Overall Study|Death|7|||
125929792|NCT04342897|453036800|FG001|Overall Study|Death|4|||
126065787|NCT01075815|453532235|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
126065788|NCT01075815|453532236|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
126065789|NCT00617708|453532237|FG000|Overall Study|Adverse Event|0|||
126065790|NCT00617708|453532238|FG001|Overall Study|Adverse Event|6|||
126065791|NCT00617708|453532239|FG002|Overall Study|Adverse Event|9|||
126065792|NCT00617708|453532237|FG000|Overall Study|Withdrawal by Subject|1|||
126065793|NCT00617708|453532238|FG001|Overall Study|Withdrawal by Subject|1|||
126065794|NCT00617708|453532239|FG002|Overall Study|Withdrawal by Subject|7|||
126065795|NCT00617708|453532237|FG000|Overall Study|Death|0|||
126065796|NCT00617708|453532238|FG001|Overall Study|Death|6|||
126065797|NCT00617708|453532239|FG002|Overall Study|Death|5|||
126065798|NCT00617708|453532237|FG000|Overall Study|Progression/Relapse|7|||
126065799|NCT00617708|453532238|FG001|Overall Study|Progression/Relapse|40|||
126065800|NCT00617708|453532239|FG002|Overall Study|Progression/Relapse|36|||
126065801|NCT00617708|453532237|FG000|Overall Study|Not protocol specified|1|||
126065802|NCT00617708|453532238|FG001|Overall Study|Not protocol specified|4|||
126065803|NCT00617708|453532239|FG002|Overall Study|Not protocol specified|2|||
126065804|NCT00617708|453532237|FG000|Overall Study|Not eligible|1|||
126065805|NCT00617708|453532238|FG001|Overall Study|Not eligible|3|||
125929793|NCT04342897|453036799|FG000|Overall Study|Lost to Follow-up|6|||
125929794|NCT04342897|453036800|FG001|Overall Study|Lost to Follow-up|6|||
125929795|NCT04342897|453036799|FG000|Overall Study|Withdrawal by Subject|1|||
125929796|NCT04342897|453036800|FG001|Overall Study|Withdrawal by Subject|2|||
125929797|NCT03199274|453036802|FG000|Overall Study|Withdrawal by Subject|4|||
125929798|NCT03199274|453036803|FG001|Overall Study|Withdrawal by Subject|0|||
125929799|NCT03199274|453036802|FG000|Overall Study|Lost to Follow-up|0|||
126065806|NCT00617708|453532239|FG002|Overall Study|Not eligible|5|||
126065807|NCT02058992|453532240|FG000|Overall Study|Lost to Follow-up|4|||
125929800|NCT03199274|453036803|FG001|Overall Study|Lost to Follow-up|1|||
125929801|NCT03199274|453036802|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
125929802|NCT03199274|453036803|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
125929803|NCT02846779|453036806|FG000|Overall Study|Lost Enrollment|83|||
125929804|NCT02846779|453036807|FG001|Overall Study|Lost Enrollment|82|||
125929805|NCT02846779|453036808|FG002|Overall Study|Lost Enrollment|86|||
125929806|NCT02846779|453036806|FG000|Overall Study|Less than 31 days of follow-up|56|||
125929807|NCT02846779|453036807|FG001|Overall Study|Less than 31 days of follow-up|45|||
125929808|NCT02846779|453036808|FG002|Overall Study|Less than 31 days of follow-up|52|||
125929809|NCT01325584|453036813|FG000|Overall Study|Death|1|||
125929810|NCT00887978|453036814|FG000|Overall Study|Adverse Event|18|||
125929811|NCT00887978|453036815|FG001|Overall Study|Adverse Event|5|||
125929812|NCT00887978|453036814|FG000|Overall Study|Clinical Worsening|4|||
125929813|NCT00887978|453036815|FG001|Overall Study|Clinical Worsening|4|||
125929814|NCT00887978|453036814|FG000|Overall Study|Death|2|||
125929815|NCT00887978|453036815|FG001|Overall Study|Death|3|||
125929816|NCT00887978|453036814|FG000|Overall Study|Withdrawal by Subject|1|||
125929817|NCT00887978|453036815|FG001|Overall Study|Withdrawal by Subject|2|||
125929818|NCT00887978|453036814|FG000|Overall Study|Lost to Follow-up|0|||
125929819|NCT00887978|453036815|FG001|Overall Study|Lost to Follow-up|1|||
125929820|NCT02239978|453037780|FG000|Overall Study|Withdrawal by Subject|2|||
125929821|NCT02239978|453037781|FG001|Overall Study|Withdrawal by Subject|0|||
125929822|NCT01852110|453037793|FG000|Overall Study|Adverse Event|12|||
125929823|NCT01852110|453037794|FG001|Overall Study|Adverse Event|5|||
125929824|NCT01852110|453037795|FG002|Overall Study|Adverse Event|0|||
125929825|NCT01852110|453037796|FG003|Overall Study|Adverse Event|0|||
125929826|NCT01852110|453037797|FG004|Overall Study|Adverse Event|0|||
125929827|NCT01852110|453037798|FG005|Overall Study|Adverse Event|0|||
125929828|NCT01852110|453037793|FG000|Overall Study|Lost to Follow-up|1|||
125929829|NCT01852110|453037794|FG001|Overall Study|Lost to Follow-up|3|||
125929830|NCT01852110|453037795|FG002|Overall Study|Lost to Follow-up|0|||
125929831|NCT01852110|453037796|FG003|Overall Study|Lost to Follow-up|0|||
125929832|NCT01852110|453037797|FG004|Overall Study|Lost to Follow-up|0|||
125929833|NCT01852110|453037798|FG005|Overall Study|Lost to Follow-up|0|||
125929834|NCT01852110|453037793|FG000|Overall Study|Non-compliance with Study Drug|2|||
125929835|NCT01852110|453037794|FG001|Overall Study|Non-compliance with Study Drug|1|||
125929836|NCT01852110|453037795|FG002|Overall Study|Non-compliance with Study Drug|0|||
125929837|NCT01852110|453037796|FG003|Overall Study|Non-compliance with Study Drug|0|||
125929838|NCT01852110|453037797|FG004|Overall Study|Non-compliance with Study Drug|0|||
125929839|NCT01852110|453037798|FG005|Overall Study|Non-compliance with Study Drug|0|||
125929840|NCT01852110|453037793|FG000|Overall Study|Physician Decision|1|||
125929841|NCT01852110|453037794|FG001|Overall Study|Physician Decision|0|||
125929842|NCT01852110|453037795|FG002|Overall Study|Physician Decision|0|||
125929843|NCT01852110|453037796|FG003|Overall Study|Physician Decision|0|||
125929844|NCT01852110|453037797|FG004|Overall Study|Physician Decision|0|||
125929845|NCT01852110|453037798|FG005|Overall Study|Physician Decision|0|||
125929846|NCT01852110|453037793|FG000|Overall Study|Protocol Violation|0|||
125929847|NCT01852110|453037794|FG001|Overall Study|Protocol Violation|1|||
125929848|NCT01852110|453037795|FG002|Overall Study|Protocol Violation|0|||
125929849|NCT01852110|453037796|FG003|Overall Study|Protocol Violation|0|||
125929850|NCT01852110|453037797|FG004|Overall Study|Protocol Violation|0|||
125929851|NCT01852110|453037798|FG005|Overall Study|Protocol Violation|0|||
125929852|NCT01852110|453037793|FG000|Overall Study|Study Terminated by Sponsor|30|||
125929853|NCT01852110|453037794|FG001|Overall Study|Study Terminated by Sponsor|32|||
125929854|NCT01852110|453037795|FG002|Overall Study|Study Terminated by Sponsor|0|||
125929855|NCT01852110|453037796|FG003|Overall Study|Study Terminated by Sponsor|0|||
125929856|NCT01852110|453037797|FG004|Overall Study|Study Terminated by Sponsor|0|||
125929857|NCT01852110|453037798|FG005|Overall Study|Study Terminated by Sponsor|0|||
125929858|NCT01852110|453037793|FG000|Overall Study|Withdrawal by Subject|4|||
125929859|NCT01852110|453037794|FG001|Overall Study|Withdrawal by Subject|4|||
125929860|NCT01852110|453037795|FG002|Overall Study|Withdrawal by Subject|0|||
125929861|NCT01852110|453037796|FG003|Overall Study|Withdrawal by Subject|0|||
125929862|NCT01852110|453037797|FG004|Overall Study|Withdrawal by Subject|0|||
125929863|NCT01852110|453037798|FG005|Overall Study|Withdrawal by Subject|0|||
125929864|NCT00171730|453037802|FG000|Overall Study|Adverse Event|3|||
125929865|NCT00171730|453037802|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
125929866|NCT00171730|453037802|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
125929867|NCT00171730|453037802|FG000|Overall Study|Withdrawal by Subject|3|||
125929868|NCT05025241|453037803|FG000|Screening|Failed Screening|5|||
125929869|NCT05025241|453037803|FG000|Treatment and Follow Up|Adverse Event|3|||
125929870|NCT01053221|453037804|FG000|Overall Study|The study was closed prematurely|5|||
125929871|NCT01053221|453037805|FG001|Overall Study|The study was closed prematurely|9|||
125929872|NCT02266225|453037806|FG000|Overall Study|Lost to Follow-up|2|||
125929873|NCT02266225|453037806|FG000|Overall Study|Death|1|||
125929874|NCT02266225|453037806|FG000|Overall Study|Withdrawal by Subject|13|||
125929875|NCT05288062|453037811|FG000|Overall Study|Ineligible|0|||
125929876|NCT05288062|453037812|FG001|Overall Study|Ineligible|0|||
125929877|NCT05288062|453037813|FG002|Overall Study|Ineligible|1|||
125929878|NCT05288062|453037814|FG003|Overall Study|Ineligible|0|||
125929879|NCT05288062|453037811|FG000|Overall Study|Withdrawal by Subject|0|||
125929880|NCT05288062|453037812|FG001|Overall Study|Withdrawal by Subject|0|||
125929881|NCT05288062|453037813|FG002|Overall Study|Withdrawal by Subject|1|||
125929882|NCT05288062|453037814|FG003|Overall Study|Withdrawal by Subject|0|||
125929883|NCT01217814|453037815|FG000|Overall Study|Adverse Event|1|||
125929884|NCT01217814|453037816|FG001|Overall Study|Adverse Event|1|||
125929885|NCT01217814|453037817|FG002|Overall Study|Adverse Event|0|||
125929886|NCT01217814|453037815|FG000|Overall Study|Lack of Efficacy|0|||
125929887|NCT01217814|453037816|FG001|Overall Study|Lack of Efficacy|0|||
125929888|NCT01217814|453037817|FG002|Overall Study|Lack of Efficacy|1|||
125929889|NCT00729651|453037818|FG000|Overall Study|Withdrawal by Subject|5|||
125929890|NCT00729651|453037819|FG001|Overall Study|Withdrawal by Subject|6|||
125929891|NCT00729651|453037818|FG000|Overall Study|Lost to Follow-up|5|||
125929892|NCT00729651|453037819|FG001|Overall Study|Lost to Follow-up|4|||
125929893|NCT00729651|453037818|FG000|Overall Study|Protocol Violation|0|||
125929894|NCT00729651|453037819|FG001|Overall Study|Protocol Violation|1|||
125929895|NCT00729651|453037818|FG000|Overall Study|Adverse Event|7|||
125929896|NCT00729651|453037819|FG001|Overall Study|Adverse Event|3|||
125929897|NCT00729651|453037818|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
125929898|NCT00729651|453037819|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
125929899|NCT00729651|453037818|FG000|Overall Study|Subject's private reason|2|||
125929900|NCT00729651|453037819|FG001|Overall Study|Subject's private reason|0|||
125929901|NCT01049308|453037820|FG000|Pill Counts|Withdrawal by Subject|83|||
125929902|NCT03926169|453037825|FG000|Period A|Adverse Event|2|||
125929903|NCT03926169|453037826|FG001|Period A|Adverse Event|2|||
125929904|NCT03926169|453037827|FG002|Period A|Adverse Event|1|||
125929905|NCT03926169|453037825|FG000|Period A|Withdrawal by Subject|2|||
125929906|NCT03926169|453037826|FG001|Period A|Withdrawal by Subject|2|||
125929907|NCT03926169|453037827|FG002|Period A|Withdrawal by Subject|2|||
125929908|NCT03926169|453037825|FG000|Period A|Lost to Follow-up|3|||
125929909|NCT03926169|453037826|FG001|Period A|Lost to Follow-up|1|||
125929910|NCT03926169|453037827|FG002|Period A|Lost to Follow-up|0|||
125929911|NCT03926169|453037825|FG000|Period A|Lack of Efficacy|0|||
125929912|NCT03926169|453037826|FG001|Period A|Lack of Efficacy|2|||
125929913|NCT03926169|453037827|FG002|Period A|Lack of Efficacy|2|||
125929914|NCT03926169|453037825|FG000|Period A|COVID-19 Infection|0|||
125929915|NCT03926169|453037826|FG001|Period A|COVID-19 Infection|1|||
125929916|NCT03926169|453037827|FG002|Period A|COVID-19 Infection|0|||
125929917|NCT03926169|453037825|FG000|Period A|COVID-19 Logistical Restrictions|0|||
125929918|NCT03926169|453037826|FG001|Period A|COVID-19 Logistical Restrictions|2|||
125929919|NCT03926169|453037827|FG002|Period A|COVID-19 Logistical Restrictions|1|||
125929920|NCT03926169|453037825|FG000|Period A|Other, Not Specified|1|||
125929921|NCT03926169|453037826|FG001|Period A|Other, Not Specified|0|||
125929922|NCT03926169|453037827|FG002|Period A|Other, Not Specified|0|||
125929923|NCT03926169|453037825|FG000|Period B|Adverse Event|3|||
125929924|NCT03926169|453037826|FG001|Period B|Adverse Event|1|||
125929925|NCT03926169|453037827|FG002|Period B|Adverse Event|1|||
125929926|NCT03926169|453037825|FG000|Period B|Withdrawal by Subject|1|||
125929927|NCT03926169|453037826|FG001|Period B|Withdrawal by Subject|3|||
125929928|NCT03926169|453037827|FG002|Period B|Withdrawal by Subject|0|||
125929929|NCT03926169|453037825|FG000|Period B|Lack of Efficacy|3|||
125929930|NCT03926169|453037826|FG001|Period B|Lack of Efficacy|1|||
125929931|NCT03926169|453037827|FG002|Period B|Lack of Efficacy|1|||
125929932|NCT03926169|453037825|FG000|Period B|Lost to Follow-up|1|||
125929933|NCT03926169|453037826|FG001|Period B|Lost to Follow-up|1|||
125929934|NCT03926169|453037827|FG002|Period B|Lost to Follow-up|4|||
125929935|NCT03926169|453037825|FG000|Period B|Other, Not Specified|62|||
125929936|NCT03926169|453037826|FG001|Period B|Other, Not Specified|57|||
125929937|NCT03926169|453037827|FG002|Period B|Other, Not Specified|65|||
126065808|NCT02058992|453532240|FG000|Overall Study|Protocol Violation|92|||
126065809|NCT02058992|453532240|FG000|Overall Study|CRF Uncollected|20|||
126065810|NCT03503188|453532241|FG000|Overall Study|Non eligible in the sub study|0|||
126065811|NCT03503188|453532242|FG001|Overall Study|Non eligible in the sub study|1|||
126065812|NCT03747575|453532249|FG000|Overall Study|Withdrawal by Subject|6|||
126065813|NCT03747575|453532250|FG001|Overall Study|Withdrawal by Subject|3|||
126065814|NCT03747575|453532249|FG000|Overall Study|Lost to Follow-up|3|||
126065815|NCT03747575|453532250|FG001|Overall Study|Lost to Follow-up|3|||
126065816|NCT03747575|453532249|FG000|Overall Study|Adverse Event|0|||
125929938|NCT01950741|453037838|FG000|Overall Study|Lost to Follow-up|1|||
125929939|NCT01950741|453037838|FG000|Overall Study|Death|1|||
125929940|NCT01950741|453037838|FG000|Overall Study|Withdrawal by Subject|1|||
125929941|NCT02521870|453037839|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929942|NCT02521870|453037840|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
125929943|NCT02521870|453037841|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929944|NCT02521870|453037842|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929945|NCT02521870|453037843|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929946|NCT02521870|453037844|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929947|NCT02521870|453037845|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126065817|NCT03747575|453532250|FG001|Overall Study|Adverse Event|1|||
125929948|NCT02521870|453037846|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929949|NCT02521870|453037847|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929950|NCT02521870|453037848|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929951|NCT02521870|453037849|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929952|NCT02521870|453037850|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125929953|NCT02521870|453037839|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
126112765|NCT01122576|453709514|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
126112766|NCT01122576|453709515|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
126112767|NCT00381563|453709520|FG000|Overall Study|Withdrawal by Subject|5|||
126112768|NCT00381563|453709521|FG001|Overall Study|Withdrawal by Subject|5|||
126112769|NCT00381563|453709520|FG000|Overall Study|Lost to Follow-up|2|||
126112770|NCT00381563|453709521|FG001|Overall Study|Lost to Follow-up|0|||
126112771|NCT00381563|453709520|FG000|Overall Study|Protocol Violation|0|||
126112772|NCT00381563|453709521|FG001|Overall Study|Protocol Violation|1|||
126112773|NCT00931944|453709523|FG000|Overall Study|Adverse Event|4|||
126112774|NCT00931944|453709523|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
126112775|NCT00931944|453709523|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
126112776|NCT00931944|453709523|FG000|Overall Study|Death|28|||
126112777|NCT00931944|453709523|FG000|Overall Study|Other|2|||
126112778|NCT01132612|453709524|FG000|Overall Study|Death|0|||
126112779|NCT01132612|453709525|FG001|Overall Study|Death|0|||
126112780|NCT01132612|453709526|FG002|Overall Study|Death|1|||
126112781|NCT01132612|453709524|FG000|Overall Study|Protocol deviation|0|||
126112782|NCT01132612|453709525|FG001|Overall Study|Protocol deviation|0|||
126112783|NCT01132612|453709526|FG002|Overall Study|Protocol deviation|3|||
126112784|NCT01132612|453709524|FG000|Overall Study|Lost to Follow-up|2|||
126112785|NCT01132612|453709525|FG001|Overall Study|Lost to Follow-up|2|||
126112786|NCT01132612|453709526|FG002|Overall Study|Lost to Follow-up|7|||
126112787|NCT01132612|453709524|FG000|Overall Study|Adverse Event|5|||
126112788|NCT01132612|453709525|FG001|Overall Study|Adverse Event|2|||
126112789|NCT01132612|453709526|FG002|Overall Study|Adverse Event|15|||
126112790|NCT01132612|453709524|FG000|Overall Study|Withdrawal by Subject|5|||
126112791|NCT01132612|453709525|FG001|Overall Study|Withdrawal by Subject|8|||
126112792|NCT01132612|453709526|FG002|Overall Study|Withdrawal by Subject|19|||
126112793|NCT01132612|453709524|FG000|Overall Study|Administrative problems|5|||
126112794|NCT01132612|453709525|FG001|Overall Study|Administrative problems|1|||
126112795|NCT01132612|453709526|FG002|Overall Study|Administrative problems|52|||
126112796|NCT01132612|453709524|FG000|Overall Study|Lack of Efficacy|23|||
126112797|NCT01132612|453709525|FG001|Overall Study|Lack of Efficacy|22|||
126112798|NCT01132612|453709526|FG002|Overall Study|Lack of Efficacy|73|||
126112799|NCT02252536|453709527|FG000|Overall Study|Lost to Follow-up|5|||
126112800|NCT02252536|453709528|FG001|Overall Study|Lost to Follow-up|3|||
126112801|NCT01438151|453709531|FG000|Overall Study|study terminated|8|||
126112802|NCT00006392|453709538|FG000|Overall Study|Ineligible|11|||
126112803|NCT00006392|453709539|FG001|Overall Study|Ineligible|3|||
126112804|NCT00006392|453709540|FG002|Overall Study|Ineligible|5|||
126112805|NCT00006392|453709541|FG003|Overall Study|Ineligible|5|||
126112806|NCT00006392|453709538|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
126112807|NCT00006392|453709539|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
126112808|NCT00006392|453709540|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
126112809|NCT00006392|453709541|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
126112810|NCT02545322|453709543|FG000|Overall Study|Withdrawal by Subject|3|||
126112811|NCT00995007|453709544|FG000|Overall Study|Withdrew consent|1|||
126112812|NCT00995007|453709545|FG001|Overall Study|Withdrew consent|0|||
126112813|NCT00995007|453709544|FG000|Overall Study|Refused further treatment|8|||
126112814|NCT00995007|453709545|FG001|Overall Study|Refused further treatment|2|||
126112815|NCT00995007|453709544|FG000|Overall Study|Toxicity|8|||
126112816|NCT00995007|453709545|FG001|Overall Study|Toxicity|0|||
126112817|NCT03606980|453709546|FG000|Overall Study|Lost to Follow-up|3|||
126112818|NCT03606980|453709547|FG001|Overall Study|Lost to Follow-up|2|||
126112819|NCT03606980|453709548|FG002|Overall Study|Lost to Follow-up|3|||
126112820|NCT03606980|453709546|FG000|Overall Study|Withdrawal by Subject|1|||
126112821|NCT03606980|453709547|FG001|Overall Study|Withdrawal by Subject|0|||
126112822|NCT03606980|453709548|FG002|Overall Study|Withdrawal by Subject|4|||
126112823|NCT01294150|453709551|FG000|Overall Study|Physician Decision|2|||
126112824|NCT01294150|453709552|FG001|Overall Study|Physician Decision|2|||
126112825|NCT03675776|453709553|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
126112826|NCT03675776|453709554|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
126112827|NCT03675776|453709555|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
126112828|NCT03675776|453709553|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
126112829|NCT03675776|453709554|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
126112830|NCT03675776|453709555|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
126112831|NCT02401412|453709556|FG000|Overall Study|Lost to Follow-up|1|||
126112832|NCT02401412|453709557|FG001|Overall Study|Lost to Follow-up|0|||
126112833|NCT02401412|453709556|FG000|Overall Study|Discontinued Intervention|15|||
126112834|NCT02401412|453709557|FG001|Overall Study|Discontinued Intervention|21|||
126112835|NCT02401412|453709556|FG000|Overall Study|Withdrawal by Subject|4|||
126112836|NCT02401412|453709557|FG001|Overall Study|Withdrawal by Subject|4|||
126112837|NCT02401412|453709556|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
126112838|NCT02401412|453709557|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
126112839|NCT02401412|453709556|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
126112840|NCT02401412|453709557|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
126112841|NCT01351623|453709558|FG000|Overall Study|Protocol Violation|2|||
126112842|NCT01351623|453709558|FG000|Overall Study|Adverse Event|4|||
126112843|NCT01351623|453709558|FG000|Overall Study|Withdrawal by Subject|1|||
126112844|NCT01351623|453709558|FG000|Overall Study|Death|2|||
126112845|NCT00387764|453709560|FG000|Overall Study|Adverse Event|12|||
126112846|NCT00387764|453709560|FG000|Overall Study|Withdrawal by Subject|8|||
126112847|NCT00387764|453709560|FG000|Overall Study|Sponsor Terminated Study|1|||
125929954|NCT02521870|453037840|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
125929955|NCT02521870|453037841|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
126112848|NCT00387764|453709560|FG000|Overall Study|Physician Decision|1|||
126112849|NCT00387764|453709560|FG000|Overall Study|Other|2|||
126112850|NCT00387764|453709560|FG000|Overall Study|Death|7|||
126112851|NCT01184053|453709561|FG000|Overall Study|progression while on treatment|3|||
126112852|NCT04399122|453709562|FG000|Overall Study|Lost to Follow-up|2|||
125929956|NCT02521870|453037842|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
125929957|NCT02521870|453037843|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
125929958|NCT02521870|453037844|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
125929959|NCT02521870|453037845|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
125929960|NCT02521870|453037846|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
125929961|NCT02521870|453037847|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
125929962|NCT02521870|453037848|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
125929963|NCT02521870|453037849|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
125929964|NCT02521870|453037850|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
125929965|NCT02521870|453037839|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
125929966|NCT02521870|453037840|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
125929967|NCT02521870|453037841|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
125929968|NCT02521870|453037842|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
125929969|NCT02521870|453037843|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
125929970|NCT02521870|453037844|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
125929971|NCT02521870|453037845|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
125929972|NCT02521870|453037846|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
125929973|NCT02521870|453037847|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
125929974|NCT02521870|453037848|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
125929975|NCT02521870|453037849|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
125929976|NCT02521870|453037850|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
125929977|NCT02521870|453037839|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125929978|NCT02521870|453037840|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125929979|NCT02521870|453037841|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125929980|NCT02521870|453037842|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125929981|NCT02521870|453037843|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
125929982|NCT02521870|453037844|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
126112853|NCT04399122|453709563|FG001|Overall Study|Lost to Follow-up|0|||
126112854|NCT04399122|453709562|FG000|Overall Study|Withdrawal by Subject|1|||
126112855|NCT04399122|453709563|FG001|Overall Study|Withdrawal by Subject|0|||
125929983|NCT02521870|453037845|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
125929984|NCT02521870|453037846|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125929985|NCT02521870|453037847|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
125929986|NCT02521870|453037848|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
125929987|NCT02521870|453037849|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
125929988|NCT02521870|453037850|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125929989|NCT02521870|453037839|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
125929990|NCT02521870|453037840|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
125929991|NCT02521870|453037841|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
125929992|NCT02521870|453037842|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
125929993|NCT02521870|453037843|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
125929994|NCT02521870|453037844|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
125929995|NCT02521870|453037845|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
125929996|NCT02521870|453037846|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
125929997|NCT02521870|453037847|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
125929998|NCT02521870|453037848|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
125929999|NCT02521870|453037849|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
125930000|NCT02521870|453037850|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
125930001|NCT02521870|453037839|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
125930002|NCT02521870|453037840|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
125930003|NCT02521870|453037841|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
125930004|NCT02521870|453037842|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
125930005|NCT02521870|453037843|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
125930006|NCT02521870|453037844|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
125930007|NCT02521870|453037845|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
125930008|NCT02521870|453037846|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
125930009|NCT02521870|453037847|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
126112856|NCT01174238|453709566|FG000|Overall Study|Lost to Follow-up|2|||
126112857|NCT01102803|453709567|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
126112858|NCT01102803|453709568|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
125930010|NCT02521870|453037848|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
125930011|NCT02521870|453037849|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
125930012|NCT02521870|453037850|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
125930013|NCT02521870|453037839|FG000|Phase 2: Dose Expansion|Death|0|||
125930014|NCT02521870|453037840|FG001|Phase 2: Dose Expansion|Death|0|||
125930015|NCT02521870|453037841|FG002|Phase 2: Dose Expansion|Death|0|||
125930016|NCT02521870|453037842|FG003|Phase 2: Dose Expansion|Death|0|||
125930017|NCT02521870|453037843|FG004|Phase 2: Dose Expansion|Death|1|||
125930018|NCT02521870|453037844|FG005|Phase 2: Dose Expansion|Death|1|||
125930019|NCT02521870|453037845|FG006|Phase 2: Dose Expansion|Death|3|||
125930020|NCT02521870|453037846|FG007|Phase 2: Dose Expansion|Death|1|||
125930021|NCT02521870|453037847|FG008|Phase 2: Dose Expansion|Death|1|||
125930022|NCT02521870|453037848|FG009|Phase 2: Dose Expansion|Death|5|||
125930023|NCT02521870|453037849|FG010|Phase 2: Dose Expansion|Death|2|||
125930024|NCT02521870|453037850|FG011|Phase 2: Dose Expansion|Death|2|||
125930025|NCT02521870|453037839|FG000|Phase 2: Dose Expansion|Other|0|||
125930026|NCT02521870|453037840|FG001|Phase 2: Dose Expansion|Other|0|||
125930027|NCT02521870|453037841|FG002|Phase 2: Dose Expansion|Other|0|||
125930028|NCT02521870|453037842|FG003|Phase 2: Dose Expansion|Other|0|||
125930029|NCT02521870|453037843|FG004|Phase 2: Dose Expansion|Other|10|||
125930030|NCT02521870|453037844|FG005|Phase 2: Dose Expansion|Other|3|||
125930031|NCT02521870|453037845|FG006|Phase 2: Dose Expansion|Other|2|||
125930032|NCT02521870|453037846|FG007|Phase 2: Dose Expansion|Other|0|||
125930033|NCT02521870|453037847|FG008|Phase 2: Dose Expansion|Other|10|||
125930034|NCT02521870|453037848|FG009|Phase 2: Dose Expansion|Other|5|||
125930035|NCT02521870|453037849|FG010|Phase 2: Dose Expansion|Other|1|||
125930036|NCT02521870|453037850|FG011|Phase 2: Dose Expansion|Other|7|||
125930037|NCT02521870|453037839|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930038|NCT02521870|453037840|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930039|NCT02521870|453037841|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930040|NCT02521870|453037842|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930041|NCT02521870|453037843|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
125930042|NCT02521870|453037844|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930043|NCT02521870|453037845|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930044|NCT02521870|453037846|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930045|NCT02521870|453037847|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930046|NCT02521870|453037848|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930047|NCT02521870|453037849|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930048|NCT02521870|453037850|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125930049|NCT02521870|453037839|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930050|NCT02521870|453037840|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930051|NCT02521870|453037841|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930052|NCT02521870|453037842|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930053|NCT02521870|453037843|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
125930054|NCT02521870|453037844|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930055|NCT02521870|453037845|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930056|NCT02521870|453037846|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930057|NCT02521870|453037847|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930058|NCT02521870|453037848|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930059|NCT02521870|453037849|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930060|NCT02521870|453037850|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125930061|NCT00519831|453037851|FG000|Overall Study|Adverse Event|3|||
125930062|NCT02854631|453037852|FG000|Overall Study|Adverse Event|1|||
125930063|NCT02854631|453037853|FG001|Overall Study|Adverse Event|2|||
125930064|NCT02854631|453037852|FG000|Overall Study|Withdrew Consent|3|||
125930065|NCT02854631|453037853|FG001|Overall Study|Withdrew Consent|2|||
125930066|NCT02854631|453037852|FG000|Overall Study|Investigator's Discretion|2|||
125930067|NCT02854631|453037853|FG001|Overall Study|Investigator's Discretion|0|||
125930068|NCT02854631|453037852|FG000|Overall Study|Death|12|||
125930069|NCT02854631|453037853|FG001|Overall Study|Death|8|||
125930070|NCT02854631|453037852|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
125930071|NCT02854631|453037853|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
125930072|NCT02854631|453037852|FG000|Overall Study|Protocol Violation|0|||
125930073|NCT02854631|453037853|FG001|Overall Study|Protocol Violation|1|||
125930074|NCT02854631|453037852|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
125930075|NCT02854631|453037853|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
125930076|NCT02854631|453037852|FG000|Overall Study|Lost to Follow-up|4|||
125930077|NCT02854631|453037853|FG001|Overall Study|Lost to Follow-up|2|||
125930078|NCT00844896|453037854|FG000|Overall Study|Lost to Follow-up|12|||
125930079|NCT00844896|453037855|FG001|Overall Study|Lost to Follow-up|16|||
125930080|NCT00844896|453037854|FG000|Overall Study|Parents did not have time to complete|0|||
125930081|NCT00844896|453037855|FG001|Overall Study|Parents did not have time to complete|1|||
125930082|NCT02233647|453037856|FG000|Overall Study|Adverse Event|1|||
125930083|NCT01835587|453037860|FG000|Overall Study|Disease Recurrence or Relapse|0|||
125930084|NCT01835587|453037861|FG001|Overall Study|Disease Recurrence or Relapse|3|||
125930085|NCT01835587|453037862|FG002|Overall Study|Disease Recurrence or Relapse|0|||
125930086|NCT01835587|453037863|FG003|Overall Study|Disease Recurrence or Relapse|3|||
125930087|NCT01835587|453037860|FG000|Overall Study|Withdrawal by Subject|2|||
125930088|NCT01835587|453037861|FG001|Overall Study|Withdrawal by Subject|0|||
125930089|NCT01835587|453037862|FG002|Overall Study|Withdrawal by Subject|0|||
125930090|NCT01835587|453037863|FG003|Overall Study|Withdrawal by Subject|3|||
125930091|NCT01835587|453037860|FG000|Overall Study|Adverse Event|0|||
125930092|NCT01835587|453037861|FG001|Overall Study|Adverse Event|0|||
125930093|NCT01835587|453037862|FG002|Overall Study|Adverse Event|2|||
125930094|NCT01835587|453037863|FG003|Overall Study|Adverse Event|2|||
125930095|NCT01835587|453037860|FG000|Overall Study|Death|0|||
125930096|NCT01835587|453037861|FG001|Overall Study|Death|0|||
125930097|NCT01835587|453037862|FG002|Overall Study|Death|0|||
125930098|NCT01835587|453037863|FG003|Overall Study|Death|1|||
125930099|NCT01835587|453037860|FG000|Overall Study|Miscellaneous|0|||
125930100|NCT01835587|453037861|FG001|Overall Study|Miscellaneous|1|||
125930101|NCT01835587|453037862|FG002|Overall Study|Miscellaneous|0|||
125930102|NCT01835587|453037863|FG003|Overall Study|Miscellaneous|0|||
125930103|NCT02634320|453037865|FG000|Overall Study|Adverse Event|2|||
125930104|NCT02634320|453037865|FG000|Overall Study|Lost to Follow-up|3|||
125930105|NCT02634320|453037865|FG000|Overall Study|Moved out of area|2|||
125930106|NCT02634320|453037865|FG000|Overall Study|Out of window for study visits|1|||
125930107|NCT02634320|453037865|FG000|Overall Study|Protocol Violation|1|||
125930108|NCT02634320|453037865|FG000|Overall Study|Withdrawal by Subject|5|||
125930109|NCT02634320|453037865|FG000|Overall Study|Lack of Efficacy|2|||
125930110|NCT00357968|453037869|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
125930111|NCT00357968|453037870|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
125930112|NCT00357968|453037869|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
125930113|NCT00357968|453037870|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
125930114|NCT04656691|453037873|FG000|Overall Study|Adverse Event|1|||
125930115|NCT05980182|453037886|FG000|Overall Study|Lost to Follow-up|10|||
125930116|NCT04600921|453037887|FG000|Overall Study|Withdrawal by Subject|3|||
125930117|NCT04600921|453037888|FG001|Overall Study|Withdrawal by Subject|5|||
125930118|NCT04600921|453037887|FG000|Overall Study|Death|0|||
125930119|NCT04600921|453037888|FG001|Overall Study|Death|1|||
125930120|NCT00410046|453039850|FG000|Overall Study|Adverse Event|3|||
125930121|NCT00410046|453039850|FG000|Overall Study|Withdrawal by Subject|1|||
125930122|NCT00410046|453039850|FG000|Overall Study|Lost to Follow-up|1|||
125930123|NCT01384760|453039852|FG000|Overall Study|Lost to Follow-up|0|||
125930124|NCT01384760|453039853|FG001|Overall Study|Lost to Follow-up|6|||
125930125|NCT01384760|453039852|FG000|Overall Study|Protocol Violation|16|||
125930126|NCT01384760|453039853|FG001|Overall Study|Protocol Violation|0|||
125930127|NCT00963547|453039854|FG000|Overall Study|Adverse Event|0|||
125930128|NCT00963547|453039855|FG001|Overall Study|Adverse Event|1|||
125930129|NCT00963547|453039856|FG002|Overall Study|Adverse Event|0|||
125930130|NCT00963547|453039857|FG003|Overall Study|Adverse Event|1|||
125930131|NCT00963547|453039858|FG004|Overall Study|Adverse Event|0|||
125930132|NCT00963547|453039859|FG005|Overall Study|Adverse Event|0|||
125930133|NCT00963547|453039860|FG006|Overall Study|Adverse Event|0|||
125930134|NCT00963547|453039854|FG000|Overall Study|Physician Decision|1|||
125930135|NCT00963547|453039855|FG001|Overall Study|Physician Decision|1|||
125930136|NCT00963547|453039856|FG002|Overall Study|Physician Decision|0|||
125930137|NCT00963547|453039857|FG003|Overall Study|Physician Decision|0|||
125930138|NCT00963547|453039858|FG004|Overall Study|Physician Decision|0|||
125930139|NCT00963547|453039859|FG005|Overall Study|Physician Decision|0|||
125930140|NCT00963547|453039860|FG006|Overall Study|Physician Decision|0|||
125930141|NCT00963547|453039854|FG000|Overall Study|Progressive Disease|3|||
125930142|NCT00963547|453039855|FG001|Overall Study|Progressive Disease|8|||
125930143|NCT00963547|453039856|FG002|Overall Study|Progressive Disease|9|||
125930144|NCT00963547|453039857|FG003|Overall Study|Progressive Disease|5|||
125930145|NCT00963547|453039858|FG004|Overall Study|Progressive Disease|0|||
125930146|NCT00963547|453039859|FG005|Overall Study|Progressive Disease|0|||
125930147|NCT00963547|453039860|FG006|Overall Study|Progressive Disease|0|||
125930148|NCT00963547|453039854|FG000|Overall Study|Withdrawal by Subject|0|||
126065818|NCT03005106|453532251|FG000|Overall Study|Lost to Follow-up|16|||
125930149|NCT00963547|453039855|FG001|Overall Study|Withdrawal by Subject|0|||
125930150|NCT00963547|453039856|FG002|Overall Study|Withdrawal by Subject|3|||
125930151|NCT00963547|453039857|FG003|Overall Study|Withdrawal by Subject|0|||
125930152|NCT00963547|453039858|FG004|Overall Study|Withdrawal by Subject|0|||
125930153|NCT00963547|453039859|FG005|Overall Study|Withdrawal by Subject|0|||
125930154|NCT00963547|453039860|FG006|Overall Study|Withdrawal by Subject|0|||
126065819|NCT03005106|453532251|FG000|Overall Study|Adverse Event|1|||
125930155|NCT00963547|453039854|FG000|Overall Study|Reason Unknown|0|||
125930156|NCT00963547|453039855|FG001|Overall Study|Reason Unknown|1|||
125930157|NCT00963547|453039856|FG002|Overall Study|Reason Unknown|0|||
125930158|NCT00963547|453039857|FG003|Overall Study|Reason Unknown|0|||
125930159|NCT00963547|453039858|FG004|Overall Study|Reason Unknown|0|||
125930160|NCT00963547|453039859|FG005|Overall Study|Reason Unknown|0|||
125930161|NCT00963547|453039860|FG006|Overall Study|Reason Unknown|0|||
125930162|NCT00482612|453039867|FG000|In-treatment Period|No study medication administered|0|||
125930163|NCT00482612|453039868|FG001|In-treatment Period|No study medication administered|0|||
125930164|NCT00482612|453039869|FG002|In-treatment Period|No study medication administered|1|||
125930165|NCT00482612|453039870|FG003|In-treatment Period|No study medication administered|0|||
125930166|NCT00482612|453039867|FG000|Follow-up Period|Other|4|||
125930167|NCT00482612|453039868|FG001|Follow-up Period|Other|2|||
125930168|NCT00482612|453039869|FG002|Follow-up Period|Other|1|||
125930169|NCT00482612|453039870|FG003|Follow-up Period|Other|2|||
125930170|NCT00482612|453039867|FG000|Follow-up Period|Lack of compliance|0|||
125930171|NCT00482612|453039868|FG001|Follow-up Period|Lack of compliance|0|||
125930172|NCT00482612|453039869|FG002|Follow-up Period|Lack of compliance|1|||
125930173|NCT00482612|453039870|FG003|Follow-up Period|Lack of compliance|0|||
125930174|NCT00482612|453039867|FG000|Follow-up Period|Lost to Follow-up|0|||
125930175|NCT00482612|453039868|FG001|Follow-up Period|Lost to Follow-up|4|||
125930176|NCT00482612|453039869|FG002|Follow-up Period|Lost to Follow-up|2|||
125930177|NCT00482612|453039870|FG003|Follow-up Period|Lost to Follow-up|1|||
125930178|NCT00482612|453039867|FG000|Follow-up Period|Adverse Event|4|||
125930179|NCT00482612|453039868|FG001|Follow-up Period|Adverse Event|7|||
125930180|NCT00482612|453039869|FG002|Follow-up Period|Adverse Event|9|||
125930181|NCT00482612|453039870|FG003|Follow-up Period|Adverse Event|0|||
125930182|NCT00482612|453039867|FG000|Follow-up Period|Lack of Efficacy|2|||
125930183|NCT00482612|453039868|FG001|Follow-up Period|Lack of Efficacy|0|||
125930184|NCT00482612|453039869|FG002|Follow-up Period|Lack of Efficacy|1|||
125930185|NCT00482612|453039870|FG003|Follow-up Period|Lack of Efficacy|0|||
125930186|NCT00482612|453039867|FG000|Follow-up Period|Withdrawal by Subject|3|||
125930187|NCT00482612|453039868|FG001|Follow-up Period|Withdrawal by Subject|5|||
125930188|NCT00482612|453039869|FG002|Follow-up Period|Withdrawal by Subject|7|||
125930189|NCT00482612|453039870|FG003|Follow-up Period|Withdrawal by Subject|2|||
125930190|NCT00482612|453039867|FG000|Follow-up Period|Reasons not related to trial|1|||
125930191|NCT00482612|453039868|FG001|Follow-up Period|Reasons not related to trial|0|||
125930192|NCT00482612|453039869|FG002|Follow-up Period|Reasons not related to trial|1|||
125930193|NCT00482612|453039870|FG003|Follow-up Period|Reasons not related to trial|3|||
125930194|NCT01366521|453039871|FG000|Overall Study|Adverse Event|1|||
125930195|NCT01366521|453039872|FG001|Overall Study|Adverse Event|0|||
125930196|NCT01366521|453039873|FG002|Overall Study|Adverse Event|0|||
125930197|NCT01366521|453039874|FG003|Overall Study|Adverse Event|0|||
125930198|NCT01366521|453039871|FG000|Overall Study|Protocol Violation|0|||
125930199|NCT01366521|453039872|FG001|Overall Study|Protocol Violation|0|||
125930200|NCT01366521|453039873|FG002|Overall Study|Protocol Violation|1|||
125930201|NCT01366521|453039874|FG003|Overall Study|Protocol Violation|0|||
125930202|NCT01366521|453039871|FG000|Overall Study|Physician Decision|0|||
125930203|NCT01366521|453039872|FG001|Overall Study|Physician Decision|0|||
125930204|NCT01366521|453039873|FG002|Overall Study|Physician Decision|1|||
125930205|NCT01366521|453039874|FG003|Overall Study|Physician Decision|0|||
125930206|NCT01366521|453039871|FG000|Overall Study|Withdrawal by Subject|0|||
125930207|NCT01366521|453039872|FG001|Overall Study|Withdrawal by Subject|1|||
125930208|NCT01366521|453039873|FG002|Overall Study|Withdrawal by Subject|0|||
125930209|NCT01366521|453039874|FG003|Overall Study|Withdrawal by Subject|0|||
125930210|NCT00684307|453039875|FG000|Overall Study|Adverse Event|11|||
125930211|NCT00684307|453039876|FG001|Overall Study|Adverse Event|6|||
125930212|NCT00684307|453039877|FG002|Overall Study|Adverse Event|15|||
125930213|NCT00684307|453039878|FG003|Overall Study|Adverse Event|16|||
125930214|NCT00684307|453039879|FG004|Overall Study|Adverse Event|8|||
125930215|NCT00684307|453039875|FG000|Overall Study|Development of increasing Liver Function|0|||
125930216|NCT00684307|453039876|FG001|Overall Study|Development of increasing Liver Function|2|||
125930217|NCT00684307|453039877|FG002|Overall Study|Development of increasing Liver Function|0|||
125930218|NCT00684307|453039878|FG003|Overall Study|Development of increasing Liver Function|1|||
125930219|NCT00684307|453039879|FG004|Overall Study|Development of increasing Liver Function|0|||
125930220|NCT00684307|453039875|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
125930221|NCT00684307|453039876|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
125930222|NCT00684307|453039877|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
125930223|NCT00684307|453039878|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
125930224|NCT00684307|453039879|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
125930225|NCT00684307|453039875|FG000|Overall Study|Incorrect enrolment or randomization|4|||
125930226|NCT00684307|453039876|FG001|Overall Study|Incorrect enrolment or randomization|0|||
125930227|NCT00684307|453039877|FG002|Overall Study|Incorrect enrolment or randomization|0|||
125930228|NCT00684307|453039878|FG003|Overall Study|Incorrect enrolment or randomization|0|||
125930229|NCT00684307|453039879|FG004|Overall Study|Incorrect enrolment or randomization|0|||
125930230|NCT00684307|453039875|FG000|Overall Study|Interupted IP for more than 7 days|0|||
125930231|NCT00684307|453039876|FG001|Overall Study|Interupted IP for more than 7 days|4|||
125930232|NCT00684307|453039877|FG002|Overall Study|Interupted IP for more than 7 days|1|||
125930233|NCT00684307|453039878|FG003|Overall Study|Interupted IP for more than 7 days|3|||
125930234|NCT00684307|453039879|FG004|Overall Study|Interupted IP for more than 7 days|3|||
125930235|NCT00684307|453039875|FG000|Overall Study|Severe non compliance to protocol|1|||
126112859|NCT01102803|453709567|FG000|Post to Follow-Up|Lost to Follow-up|1|||
126112860|NCT01102803|453709568|FG001|Post to Follow-Up|Lost to Follow-up|3|||
126112861|NCT02684279|453709569|FG000|Overall Study|Adverse Event|87|||
126112862|NCT02684279|453709569|FG000|Overall Study|Lack of Efficacy|4|||
126112863|NCT02684279|453709569|FG000|Overall Study|Lost to Follow-up|61|||
126112864|NCT02684279|453709569|FG000|Overall Study|Protocol Violation|6|||
126112865|NCT02684279|453709569|FG000|Overall Study|Pregnancy|8|||
126112866|NCT02684279|453709569|FG000|Overall Study|Withdrawal by Subject|92|||
126112867|NCT02684279|453709569|FG000|Overall Study|non-compliance with study drug|9|||
126112868|NCT02684279|453709569|FG000|Overall Study|non compliance with study visits|2|||
126112869|NCT02684279|453709569|FG000|Overall Study|subject to have surgery|1|||
126112870|NCT02684279|453709569|FG000|Overall Study|family emergency|1|||
125930236|NCT00684307|453039876|FG001|Overall Study|Severe non compliance to protocol|0|||
125930237|NCT00684307|453039877|FG002|Overall Study|Severe non compliance to protocol|0|||
125930238|NCT00684307|453039878|FG003|Overall Study|Severe non compliance to protocol|1|||
126112871|NCT02684279|453709569|FG000|Overall Study|Site closures|7|||
126112872|NCT02684279|453709569|FG000|Overall Study|Physician Decision|1|||
126112873|NCT02733185|453709570|FG000|Overall Study|Withdrawal by Subject|12|||
126112874|NCT02733185|453709571|FG001|Overall Study|Withdrawal by Subject|10|||
126112875|NCT02733185|453709572|FG002|Overall Study|Withdrawal by Subject|17|||
126112876|NCT02733185|453709573|FG003|Overall Study|Withdrawal by Subject|21|||
126112877|NCT02733185|453709570|FG000|Overall Study|Death|46|||
126112878|NCT02733185|453709571|FG001|Overall Study|Death|34|||
126112879|NCT02733185|453709572|FG002|Overall Study|Death|35|||
126112880|NCT02733185|453709573|FG003|Overall Study|Death|43|||
126112881|NCT02733185|453709570|FG000|Overall Study|Lost to Follow-up|17|||
126112882|NCT02733185|453709571|FG001|Overall Study|Lost to Follow-up|18|||
126112883|NCT02733185|453709572|FG002|Overall Study|Lost to Follow-up|16|||
125930239|NCT00684307|453039879|FG004|Overall Study|Severe non compliance to protocol|2|||
125930240|NCT00684307|453039875|FG000|Overall Study|Participant not willing to continue|7|||
125930241|NCT00684307|453039876|FG001|Overall Study|Participant not willing to continue|10|||
125930242|NCT00684307|453039877|FG002|Overall Study|Participant not willing to continue|11|||
125930243|NCT00684307|453039878|FG003|Overall Study|Participant not willing to continue|5|||
125930244|NCT00684307|453039879|FG004|Overall Study|Participant not willing to continue|8|||
125930245|NCT00684307|453039875|FG000|Overall Study|Criteria from the CSR|0|||
125930246|NCT00684307|453039876|FG001|Overall Study|Criteria from the CSR|0|||
125930247|NCT00684307|453039877|FG002|Overall Study|Criteria from the CSR|1|||
125930248|NCT00684307|453039878|FG003|Overall Study|Criteria from the CSR|3|||
125930249|NCT00684307|453039879|FG004|Overall Study|Criteria from the CSR|3|||
125930250|NCT00660023|453039880|FG000|Overall Study|Adverse Event|2|||
125930251|NCT00660023|453039880|FG000|Overall Study|Death|8|||
125930252|NCT00660023|453039880|FG000|Overall Study|Blood Transfusion|5|||
125930253|NCT00660023|453039880|FG000|Overall Study|Renal Transplantation|3|||
125930254|NCT00660023|453039880|FG000|Overall Study|Withdrawal by Subject|1|||
125930255|NCT00660023|453039880|FG000|Overall Study|Missed Pregnancy Test|1|||
125930256|NCT00660023|453039880|FG000|Overall Study|Other Screening Failure|9|||
125930257|NCT04180488|453039881|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
125930258|NCT04180488|453039882|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
125930259|NCT04180488|453039883|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
125930260|NCT04180488|453039884|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
125930261|NCT04180488|453039885|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
126112884|NCT02733185|453709573|FG003|Overall Study|Lost to Follow-up|11|||
126112885|NCT02593786|453709574|FG000|Overall Study|Disease progression|12|||
126112886|NCT02593786|453709575|FG001|Overall Study|Disease progression|16|||
126112887|NCT02593786|453709576|FG002|Overall Study|Disease progression|10|||
126112888|NCT02593786|453709577|FG003|Overall Study|Disease progression|7|||
126112889|NCT02593786|453709574|FG000|Overall Study|Study drug toxicity|1|||
126112890|NCT02593786|453709575|FG001|Overall Study|Study drug toxicity|0|||
126112891|NCT02593786|453709576|FG002|Overall Study|Study drug toxicity|0|||
126112892|NCT02593786|453709577|FG003|Overall Study|Study drug toxicity|0|||
125930262|NCT04180488|453039886|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
125930263|NCT04180488|453039881|FG000|Overall Study|Withdrawal by Subject|8|||
125930264|NCT04180488|453039882|FG001|Overall Study|Withdrawal by Subject|4|||
125930265|NCT04180488|453039883|FG002|Overall Study|Withdrawal by Subject|5|||
125930266|NCT04180488|453039884|FG003|Overall Study|Withdrawal by Subject|2|||
125930267|NCT04180488|453039885|FG004|Overall Study|Withdrawal by Subject|8|||
125930268|NCT04180488|453039886|FG005|Overall Study|Withdrawal by Subject|6|||
125930269|NCT04180488|453039881|FG000|Overall Study|Adverse Event|3|||
125930270|NCT04180488|453039882|FG001|Overall Study|Adverse Event|2|||
125930271|NCT04180488|453039883|FG002|Overall Study|Adverse Event|0|||
125930272|NCT04180488|453039884|FG003|Overall Study|Adverse Event|0|||
125930273|NCT04180488|453039885|FG004|Overall Study|Adverse Event|0|||
126112893|NCT02593786|453709574|FG000|Overall Study|Adverse event unrelated to study drug|1|||
126112894|NCT02593786|453709575|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126112895|NCT02593786|453709576|FG002|Overall Study|Adverse event unrelated to study drug|1|||
126112896|NCT02593786|453709577|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126112897|NCT02593786|453709574|FG000|Overall Study|Participant request to discontinue study therapy|0|||
126112898|NCT02593786|453709575|FG001|Overall Study|Participant request to discontinue study therapy|2|||
126112899|NCT02593786|453709576|FG002|Overall Study|Participant request to discontinue study therapy|0|||
126112900|NCT02593786|453709577|FG003|Overall Study|Participant request to discontinue study therapy|0|||
126112901|NCT02593786|453709574|FG000|Overall Study|Other reasons|1|||
126112902|NCT02593786|453709575|FG001|Overall Study|Other reasons|1|||
126112903|NCT02593786|453709576|FG002|Overall Study|Other reasons|0|||
126112904|NCT02593786|453709577|FG003|Overall Study|Other reasons|5|||
126112905|NCT00835120|453709578|FG000|Overall Study|Lack of Efficacy|1|||
126112906|NCT00835120|453709578|FG000|Overall Study|Lost to Follow-up|3|||
126112907|NCT00835120|453709578|FG000|Overall Study|Adverse Event|2|||
126112908|NCT00835120|453709578|FG000|Overall Study|Withdrawal by Subject|2|||
126112909|NCT01624259|453709579|FG000|Overall Study|Adverse Event|18|||
126112910|NCT01624259|453709580|FG001|Overall Study|Adverse Event|18|||
125930274|NCT04180488|453039886|FG005|Overall Study|Adverse Event|0|||
125930275|NCT04180488|453039881|FG000|Overall Study|Poor compliance to protocol|0|||
125930276|NCT04180488|453039882|FG001|Overall Study|Poor compliance to protocol|0|||
125930277|NCT04180488|453039883|FG002|Overall Study|Poor compliance to protocol|1|||
125930278|NCT04180488|453039884|FG003|Overall Study|Poor compliance to protocol|0|||
126112911|NCT01624259|453709579|FG000|Overall Study|Protocol Violation|1|||
126112912|NCT01624259|453709580|FG001|Overall Study|Protocol Violation|2|||
126112913|NCT01624259|453709579|FG000|Overall Study|Withdrawal by Subject|5|||
126112914|NCT01624259|453709580|FG001|Overall Study|Withdrawal by Subject|7|||
126112915|NCT01624259|453709579|FG000|Overall Study|Physician Decision|1|||
126112916|NCT01624259|453709580|FG001|Overall Study|Physician Decision|1|||
126112917|NCT01624259|453709579|FG000|Overall Study|Lost to Follow-up|2|||
126112918|NCT01624259|453709580|FG001|Overall Study|Lost to Follow-up|3|||
126112919|NCT01624259|453709579|FG000|Overall Study|Abnormal laboratory measure|3|||
126112920|NCT01624259|453709580|FG001|Overall Study|Abnormal laboratory measure|0|||
126112921|NCT00671554|453709584|FG000|Overall Study|Disease progression|3|||
126112922|NCT01479829|453709585|FG000|Overall Study|Withdrawal by Subject|8|||
126112923|NCT01479829|453709586|FG001|Overall Study|Withdrawal by Subject|10|||
126112924|NCT00601250|453709587|FG000|Overall Study|Adverse Event|3|||
126112925|NCT00601250|453709588|FG001|Overall Study|Adverse Event|9|||
126112926|NCT00601250|453709587|FG000|Overall Study|Protocol Violation|3|||
126112927|NCT00601250|453709588|FG001|Overall Study|Protocol Violation|2|||
126112928|NCT00601250|453709587|FG000|Overall Study|Lost to Follow-up|2|||
126112929|NCT00601250|453709588|FG001|Overall Study|Lost to Follow-up|6|||
126112930|NCT00601250|453709587|FG000|Overall Study|Withdrawal by Subject|4|||
126112931|NCT00601250|453709588|FG001|Overall Study|Withdrawal by Subject|13|||
126112932|NCT00601250|453709587|FG000|Overall Study|Other incl. lack of efficacy|2|||
126112933|NCT00601250|453709588|FG001|Overall Study|Other incl. lack of efficacy|9|||
126112934|NCT01791803|453709590|FG000|Overall Study|Withdrawal by Subject|0|||
126112935|NCT01791803|453709591|FG001|Overall Study|Withdrawal by Subject|0|||
126112936|NCT01791803|453709592|FG002|Overall Study|Withdrawal by Subject|0|||
126112937|NCT01791803|453709593|FG003|Overall Study|Withdrawal by Subject|2|||
126112938|NCT01791803|453709590|FG000|Overall Study|Physician Decision|0|||
126112939|NCT01791803|453709591|FG001|Overall Study|Physician Decision|2|||
126112940|NCT01791803|453709592|FG002|Overall Study|Physician Decision|0|||
126112941|NCT01791803|453709593|FG003|Overall Study|Physician Decision|1|||
126112942|NCT01791803|453709590|FG000|Overall Study|Death|0|||
126112943|NCT01791803|453709591|FG001|Overall Study|Death|0|||
126112944|NCT01791803|453709592|FG002|Overall Study|Death|2|||
126112945|NCT01791803|453709593|FG003|Overall Study|Death|2|||
126112946|NCT04752475|453711192|FG000|Overall Study|Withdrawal by Subject|1|||
126112947|NCT04752475|453711193|FG001|Overall Study|Withdrawal by Subject|1|||
126112948|NCT00594516|453711198|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
125930279|NCT04180488|453039885|FG004|Overall Study|Poor compliance to protocol|0|||
126112949|NCT00594516|453711199|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
126112950|NCT00594516|453711200|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
126112951|NCT00594516|453711198|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
126112952|NCT00594516|453711199|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
126112953|NCT00594516|453711200|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
126112954|NCT00594516|453711198|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
125930280|NCT04180488|453039886|FG005|Overall Study|Poor compliance to protocol|0|||
125930281|NCT02430311|453039887|FG000|Part A|Adverse Event|0|||
126112955|NCT00594516|453711199|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
126112956|NCT00594516|453711200|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
125930282|NCT02430311|453039888|FG001|Part A|Adverse Event|1|||
125930283|NCT02430311|453039887|FG000|Part A|Withdrawal by Subject|1|||
126112957|NCT00594516|453711198|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
126112958|NCT00594516|453711199|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
126112959|NCT00594516|453711200|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
126112960|NCT00594516|453711198|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
126112961|NCT00594516|453711199|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
126112962|NCT00594516|453711200|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
126112963|NCT00594516|453711198|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
126112964|NCT00594516|453711199|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
126112965|NCT00594516|453711200|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
126112966|NCT00594516|453711198|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
126112967|NCT00594516|453711199|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
126112968|NCT00594516|453711200|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
126112969|NCT00594516|453711198|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
126112970|NCT00594516|453711199|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
126112971|NCT00594516|453711200|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
126112972|NCT00594516|453711198|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
126112973|NCT00594516|453711199|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
126112974|NCT00594516|453711200|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
126112975|NCT00088907|453711201|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
126112976|NCT00088907|453711202|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
126112977|NCT00088907|453711201|FG000|Randomized Study (Step 1)|Adverse Event|14|||
126112978|NCT00088907|453711202|FG001|Randomized Study (Step 1)|Adverse Event|19|||
126112979|NCT00088907|453711201|FG000|Randomized Study (Step 1)|Death|11|||
126112980|NCT00088907|453711202|FG001|Randomized Study (Step 1)|Death|12|||
126112981|NCT00088907|453711201|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
126112982|NCT00088907|453711202|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
126112983|NCT00088907|453711201|FG000|Randomized Study (Step 1)|complicating disease|3|||
126112984|NCT00088907|453711202|FG001|Randomized Study (Step 1)|complicating disease|1|||
126112985|NCT00088907|453711201|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
126112986|NCT00088907|453711202|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
126112987|NCT00088907|453711201|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
126112988|NCT00088907|453711202|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
126112989|NCT00088907|453711201|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
126112990|NCT00088907|453711202|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
126112991|NCT00088907|453711201|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
126112992|NCT00088907|453711202|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
126112993|NCT00088907|453711201|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
126112994|NCT00088907|453711202|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
126112995|NCT00088907|453711201|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
126112996|NCT00088907|453711202|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
126112997|NCT03426787|453711207|FG000|Overall Study|Withdrawal by Subject|6|||
126112998|NCT03426787|453711207|FG000|Overall Study|Lost to Follow-up|7|||
126112999|NCT03426787|453711207|FG000|Overall Study|Unrelated to intervention death|1|||
126113000|NCT04641299|453711208|FG000|Overall Study|Adverse Event|0|||
126113001|NCT04641299|453711209|FG001|Overall Study|Adverse Event|0|||
126113002|NCT04641299|453711210|FG002|Overall Study|Adverse Event|2|||
126113003|NCT04641299|453711211|FG003|Overall Study|Adverse Event|0|||
126113004|NCT04641299|453711208|FG000|Overall Study|Lost to Follow-up|0|||
126113005|NCT04641299|453711209|FG001|Overall Study|Lost to Follow-up|1|||
126113006|NCT04641299|453711210|FG002|Overall Study|Lost to Follow-up|0|||
126113007|NCT04641299|453711211|FG003|Overall Study|Lost to Follow-up|0|||
126113008|NCT04641299|453711208|FG000|Overall Study|Withdrawal by Subject|1|||
126113009|NCT04641299|453711209|FG001|Overall Study|Withdrawal by Subject|0|||
126113010|NCT04641299|453711210|FG002|Overall Study|Withdrawal by Subject|0|||
126113011|NCT04641299|453711211|FG003|Overall Study|Withdrawal by Subject|0|||
126113012|NCT04641299|453711208|FG000|Overall Study|Reason not given|1|||
126113013|NCT04641299|453711209|FG001|Overall Study|Reason not given|0|||
126113014|NCT04641299|453711210|FG002|Overall Study|Reason not given|0|||
126113015|NCT04641299|453711211|FG003|Overall Study|Reason not given|0|||
126113016|NCT01016964|453711214|FG000|Overall Study|Lost to Follow-up|3|||
125930284|NCT02430311|453039888|FG001|Part A|Withdrawal by Subject|0|||
125930285|NCT02430311|453039887|FG000|Part B|Meet study-specific withdrawal criteria|6|||
125930286|NCT02430311|453039888|FG001|Part B|Meet study-specific withdrawal criteria|6|||
125930287|NCT02430311|453039887|FG000|Part B|Withdrawal by Subject|2|||
125930288|NCT02430311|453039888|FG001|Part B|Withdrawal by Subject|2|||
126113017|NCT01016964|453711215|FG001|Overall Study|Lost to Follow-up|3|||
126113018|NCT01448213|453711216|FG000|Overall Study|Lost to Follow-up|12|||
126113019|NCT01448213|453711217|FG001|Overall Study|Lost to Follow-up|10|||
126113020|NCT01448213|453711216|FG000|Overall Study|Adverse Event|4|||
126113021|NCT01448213|453711217|FG001|Overall Study|Adverse Event|10|||
126113022|NCT01448213|453711216|FG000|Overall Study|Protocol Violation|1|||
126113023|NCT01448213|453711217|FG001|Overall Study|Protocol Violation|2|||
126113024|NCT01330914|453711218|FG000|Overall Study|Withdrawal by Subject|4|||
126113025|NCT01330914|453711218|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
126113026|NCT00659529|453711221|FG000|Overall Study|Withdrawal by Subject|4|||
125930289|NCT02430311|453039887|FG000|Part B|Adverse Event|1|||
125930290|NCT02430311|453039888|FG001|Part B|Adverse Event|0|||
125930291|NCT02430311|453039887|FG000|Part B|Death|1|||
125930292|NCT02430311|453039888|FG001|Part B|Death|0|||
125930293|NCT03506815|453039889|FG000|Overall Study|Adverse Event|8|||
125930294|NCT03506815|453039890|FG001|Overall Study|Adverse Event|0|||
125930295|NCT03506815|453039889|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
125930296|NCT03506815|453039890|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
125930297|NCT03506815|453039889|FG000|Overall Study|Protocol Violation|1|||
125930298|NCT03506815|453039890|FG001|Overall Study|Protocol Violation|0|||
125930299|NCT03506815|453039889|FG000|Overall Study|Elective Surgery|1|||
125930300|NCT03506815|453039890|FG001|Overall Study|Elective Surgery|0|||
125930301|NCT04160091|453039893|FG000|Overall Study|Terminated by Sponsor|7|||
125930302|NCT04160091|453039894|FG001|Overall Study|Terminated by Sponsor|3|||
125930303|NCT04160091|453039895|FG002|Overall Study|Terminated by Sponsor|5|||
125930304|NCT04160091|453039896|FG003|Overall Study|Terminated by Sponsor|2|||
125930305|NCT04160091|453039893|FG000|Overall Study|Noncompliance|0|||
125930306|NCT04160091|453039894|FG001|Overall Study|Noncompliance|0|||
125930307|NCT04160091|453039895|FG002|Overall Study|Noncompliance|0|||
125930308|NCT04160091|453039896|FG003|Overall Study|Noncompliance|1|||
125930309|NCT04160091|453039893|FG000|Overall Study|Withdrawal by Subject|0|||
125930310|NCT04160091|453039894|FG001|Overall Study|Withdrawal by Subject|0|||
125930311|NCT04160091|453039895|FG002|Overall Study|Withdrawal by Subject|0|||
125930312|NCT04160091|453039896|FG003|Overall Study|Withdrawal by Subject|1|||
125930313|NCT00381095|453039902|FG000|Overall Study|Death|3|||
125930314|NCT00381095|453039903|FG001|Overall Study|Death|4|||
125930315|NCT00381095|453039902|FG000|Overall Study|Lack of Efficacy|2|||
125930316|NCT00381095|453039903|FG001|Overall Study|Lack of Efficacy|4|||
125930317|NCT00381095|453039902|FG000|Overall Study|Other|2|||
125930318|NCT00381095|453039903|FG001|Overall Study|Other|2|||
125930319|NCT00381095|453039902|FG000|Overall Study|Protocol Violation|1|||
125930320|NCT00381095|453039903|FG001|Overall Study|Protocol Violation|1|||
125930321|NCT00381095|453039902|FG000|Overall Study|Withdrawal by Subject|3|||
125930322|NCT00381095|453039903|FG001|Overall Study|Withdrawal by Subject|3|||
125930323|NCT00381095|453039902|FG000|Overall Study|Adverse Event|2|||
125930324|NCT00381095|453039903|FG001|Overall Study|Adverse Event|7|||
125930325|NCT01104493|453039904|FG000|Overall Study|Lost to Follow-up|0|||
125930326|NCT01104493|453039905|FG001|Overall Study|Lost to Follow-up|2|||
125930327|NCT01342796|453039907|FG000|Overall Study|Withdrawal by Subject|2|||
125930328|NCT01342796|453039908|FG001|Overall Study|Withdrawal by Subject|0|||
125930329|NCT01342796|453039907|FG000|Overall Study|Lost to Follow-up|0|||
125930330|NCT01342796|453039908|FG001|Overall Study|Lost to Follow-up|3|||
125930331|NCT01342796|453039907|FG000|Overall Study|Inappropriate enrollment|1|||
125930332|NCT01342796|453039908|FG001|Overall Study|Inappropriate enrollment|0|||
125930333|NCT01599234|453039914|FG000|Overall Study|Adverse Event|9|||
125930334|NCT01599234|453039915|FG001|Overall Study|Adverse Event|5|||
125930335|NCT01599234|453039914|FG000|Overall Study|Withdrawal by Subject|2|||
125930336|NCT01599234|453039915|FG001|Overall Study|Withdrawal by Subject|1|||
125930337|NCT01599234|453039914|FG000|Overall Study|Lost to Follow-up|1|||
125930338|NCT01599234|453039915|FG001|Overall Study|Lost to Follow-up|2|||
125930339|NCT01599234|453039914|FG000|Overall Study|Lack of Efficacy|2|||
125930340|NCT01599234|453039915|FG001|Overall Study|Lack of Efficacy|4|||
125930341|NCT01599234|453039914|FG000|Overall Study|Unable to operate spray|1|||
125930342|NCT01599234|453039915|FG001|Overall Study|Unable to operate spray|0|||
125930343|NCT01599234|453039914|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
125930344|NCT01599234|453039915|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
125930345|NCT01599234|453039914|FG000|Overall Study|Death|1|||
125930346|NCT01599234|453039915|FG001|Overall Study|Death|0|||
125930347|NCT01599234|453039914|FG000|Overall Study|Patient would not stop driving|1|||
125930348|NCT01599234|453039915|FG001|Overall Study|Patient would not stop driving|0|||
125930349|NCT01599234|453039914|FG000|Overall Study|Contra-indication discovered|0|||
125930350|NCT01599234|453039915|FG001|Overall Study|Contra-indication discovered|1|||
125930351|NCT01599234|453039914|FG000|Overall Study|Pregnancy|0|||
125930352|NCT01599234|453039915|FG001|Overall Study|Pregnancy|1|||
125930353|NCT02899988|453039920|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
125930354|NCT02899988|453039921|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
125930355|NCT02899988|453039922|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930356|NCT02899988|453039923|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930357|NCT02899988|453039924|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930358|NCT02899988|453039925|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930359|NCT02899988|453039926|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930360|NCT02899988|453039927|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930361|NCT02899988|453039928|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930362|NCT02899988|453039929|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930363|NCT02899988|453039930|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125930364|NCT02899988|453039920|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
125930365|NCT02899988|453039921|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
125930366|NCT02899988|453039922|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
125930367|NCT02899988|453039923|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
125930368|NCT02899988|453039924|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
125930369|NCT02899988|453039925|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
125930370|NCT02899988|453039926|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
125930371|NCT02899988|453039927|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
125930372|NCT02899988|453039928|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
125930373|NCT02899988|453039929|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
125930374|NCT02899988|453039930|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
125930375|NCT02899988|453039920|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
125930376|NCT02899988|453039921|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
125930377|NCT02899988|453039922|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
125930378|NCT02899988|453039923|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
125930379|NCT02899988|453039924|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
125930380|NCT02899988|453039925|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
125930381|NCT02899988|453039926|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
125930382|NCT02899988|453039927|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
125930383|NCT02899988|453039928|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
125930384|NCT02899988|453039929|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
125930385|NCT02899988|453039930|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
125930386|NCT02899988|453039920|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
125930387|NCT02899988|453039921|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
125930388|NCT02899988|453039922|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
125930389|NCT02899988|453039923|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
125930390|NCT02899988|453039924|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
125930391|NCT02899988|453039925|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
125930392|NCT02899988|453039926|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
125930393|NCT02899988|453039927|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
125930394|NCT02899988|453039928|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
125930395|NCT02899988|453039929|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
125930396|NCT02899988|453039930|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
125930397|NCT02899988|453039920|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930398|NCT02899988|453039921|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930399|NCT02899988|453039922|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930400|NCT02899988|453039923|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930401|NCT02899988|453039924|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930402|NCT02899988|453039925|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
125930403|NCT02899988|453039926|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930404|NCT02899988|453039927|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
125930405|NCT02899988|453039928|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930406|NCT02899988|453039929|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930407|NCT02899988|453039930|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125930408|NCT02899988|453039920|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125930409|NCT02899988|453039921|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125930410|NCT02899988|453039922|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125930411|NCT02899988|453039923|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125930412|NCT02899988|453039924|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
125930413|NCT02899988|453039925|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125930414|NCT02899988|453039926|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
125930415|NCT02899988|453039927|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
125930416|NCT02899988|453039928|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
125930417|NCT02899988|453039929|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125930418|NCT02899988|453039930|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
125930419|NCT02433483|453039931|FG000|Overall Study|Unacceptable toxicity|1|||
125930420|NCT02433483|453039931|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
125930421|NCT04271605|453039935|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
125930422|NCT02485301|453039936|FG000|Overall Study|Serious Adverse Events|2|||
125930423|NCT02485301|453039937|FG001|Overall Study|Serious Adverse Events|1|||
125930424|NCT02485301|453039936|FG000|Overall Study|Protocol Violation|0|||
125930425|NCT02485301|453039937|FG001|Overall Study|Protocol Violation|1|||
125930426|NCT02485301|453039936|FG000|Overall Study|Withdrawal by Subject|6|||
125930427|NCT02485301|453039937|FG001|Overall Study|Withdrawal by Subject|7|||
125930428|NCT02485301|453039936|FG000|Overall Study|Migrated/moved from study area|10|||
125930429|NCT02485301|453039937|FG001|Overall Study|Migrated/moved from study area|19|||
125930430|NCT02485301|453039936|FG000|Overall Study|Lost to Follow-up|17|||
125930431|NCT02485301|453039937|FG001|Overall Study|Lost to Follow-up|17|||
125930432|NCT02485301|453039936|FG000|Overall Study|Other|3|||
125930433|NCT02485301|453039937|FG001|Overall Study|Other|4|||
125930434|NCT01059825|453039938|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
126065820|NCT03005106|453532251|FG000|Overall Study|Physician Decision|1|||
126065821|NCT03005106|453532251|FG000|Overall Study|Death|2|||
126113027|NCT00659529|453711221|FG000|Overall Study|Protocol Violation|3|||
126113028|NCT00659529|453711221|FG000|Overall Study|Screen failure|9|||
126113029|NCT00763971|453711222|FG000|Overall Study|Adverse Event|5|||
126113030|NCT00763971|453711223|FG001|Overall Study|Adverse Event|2|||
126113031|NCT00763971|453711224|FG002|Overall Study|Adverse Event|4|||
126113032|NCT00763971|453711222|FG000|Overall Study|Protocol Violation|3|||
126113033|NCT00763971|453711223|FG001|Overall Study|Protocol Violation|3|||
126113034|NCT00763971|453711224|FG002|Overall Study|Protocol Violation|2|||
126113035|NCT00763971|453711222|FG000|Overall Study|Withdrawal by Subject|4|||
126113036|NCT00763971|453711223|FG001|Overall Study|Withdrawal by Subject|5|||
126113037|NCT00763971|453711224|FG002|Overall Study|Withdrawal by Subject|5|||
126113038|NCT00763971|453711222|FG000|Overall Study|Lost to Follow-up|0|||
126113039|NCT00763971|453711223|FG001|Overall Study|Lost to Follow-up|1|||
126113040|NCT00763971|453711224|FG002|Overall Study|Lost to Follow-up|0|||
126113041|NCT00763971|453711222|FG000|Overall Study|Lack of Efficacy|11|||
126113042|NCT00763971|453711223|FG001|Overall Study|Lack of Efficacy|22|||
126113043|NCT00763971|453711224|FG002|Overall Study|Lack of Efficacy|54|||
126113044|NCT00763971|453711222|FG000|Overall Study|Unable to swallow capsule|2|||
126113045|NCT00763971|453711223|FG001|Overall Study|Unable to swallow capsule|1|||
126113046|NCT00763971|453711224|FG002|Overall Study|Unable to swallow capsule|1|||
126113047|NCT00763971|453711222|FG000|Overall Study|Personal reason|3|||
126113048|NCT00763971|453711223|FG001|Overall Study|Personal reason|0|||
126113049|NCT00763971|453711224|FG002|Overall Study|Personal reason|0|||
126113050|NCT00763971|453711222|FG000|Overall Study|Exclusion criteria met|1|||
126113051|NCT00763971|453711223|FG001|Overall Study|Exclusion criteria met|0|||
126113052|NCT00763971|453711224|FG002|Overall Study|Exclusion criteria met|0|||
126113053|NCT00763971|453711222|FG000|Overall Study|Sponsor decision|1|||
126113054|NCT00763971|453711223|FG001|Overall Study|Sponsor decision|0|||
126113055|NCT00763971|453711224|FG002|Overall Study|Sponsor decision|0|||
126113056|NCT00763971|453711222|FG000|Overall Study|Due to holiday season|2|||
126113057|NCT00763971|453711223|FG001|Overall Study|Due to holiday season|0|||
126113058|NCT00763971|453711224|FG002|Overall Study|Due to holiday season|1|||
126113059|NCT00763971|453711222|FG000|Overall Study|Randomization error|0|||
126113060|NCT00763971|453711223|FG001|Overall Study|Randomization error|0|||
126113061|NCT00763971|453711224|FG002|Overall Study|Randomization error|1|||
126113062|NCT00763971|453711222|FG000|Overall Study|Medical monitor decision|0|||
126113063|NCT00763971|453711223|FG001|Overall Study|Medical monitor decision|0|||
126113064|NCT00763971|453711224|FG002|Overall Study|Medical monitor decision|1|||
126113065|NCT00763971|453711222|FG000|Overall Study|Moved to another country|0|||
126113066|NCT00763971|453711223|FG001|Overall Study|Moved to another country|1|||
126113067|NCT00763971|453711224|FG002|Overall Study|Moved to another country|0|||
126113068|NCT00763971|453711222|FG000|Overall Study|Subject wanted dose reduction|0|||
126113069|NCT00763971|453711223|FG001|Overall Study|Subject wanted dose reduction|1|||
126113070|NCT00763971|453711224|FG002|Overall Study|Subject wanted dose reduction|0|||
126113071|NCT00763971|453711222|FG000|Overall Study|Lack of availability|0|||
126113072|NCT00763971|453711223|FG001|Overall Study|Lack of availability|1|||
126113073|NCT00763971|453711224|FG002|Overall Study|Lack of availability|0|||
125930435|NCT01059825|453039939|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125930436|NCT01059825|453039940|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125930437|NCT01059825|453039941|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125930438|NCT01059825|453039942|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125930439|NCT01059825|453039943|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125930440|NCT01059825|453039944|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
125930441|NCT01059825|453039938|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125930442|NCT01059825|453039939|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125930443|NCT01059825|453039940|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125930444|NCT01059825|453039941|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125930445|NCT01059825|453039942|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125930446|NCT01059825|453039943|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125930447|NCT01059825|453039944|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
125930448|NCT01059825|453039938|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
125930449|NCT01059825|453039939|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
125930450|NCT01059825|453039940|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
126113074|NCT00763971|453711222|FG000|Overall Study|Performed final visit on phone|0|||
126113075|NCT00763971|453711223|FG001|Overall Study|Performed final visit on phone|1|||
126113076|NCT00763971|453711224|FG002|Overall Study|Performed final visit on phone|0|||
126113077|NCT00763971|453711222|FG000|Overall Study|Participation in 489-326 required|1|||
126113078|NCT00763971|453711223|FG001|Overall Study|Participation in 489-326 required|0|||
126113079|NCT00763971|453711224|FG002|Overall Study|Participation in 489-326 required|0|||
126113080|NCT04439071|453711226|FG000|Overall Study|Lost to Follow-up|0|||
126113081|NCT04439071|453711227|FG001|Overall Study|Lost to Follow-up|3|||
126113082|NCT04439071|453711226|FG000|Overall Study|Withdrawal by Subject|3|||
126113083|NCT04439071|453711227|FG001|Overall Study|Withdrawal by Subject|8|||
126113084|NCT04439071|453711226|FG000|Overall Study|Death|6|||
125930451|NCT01059825|453039941|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
125930452|NCT01059825|453039942|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
125930453|NCT01059825|453039943|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
125930454|NCT01059825|453039944|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
125930455|NCT01059825|453039938|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125930456|NCT01059825|453039939|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125930457|NCT01059825|453039940|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125930458|NCT01059825|453039941|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125930459|NCT01059825|453039942|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125930460|NCT01059825|453039943|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125930461|NCT01059825|453039944|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
125930462|NCT01059825|453039938|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
125930463|NCT01059825|453039939|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
125930464|NCT01059825|453039940|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
125930465|NCT01059825|453039941|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
125930466|NCT01059825|453039942|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
125930467|NCT01059825|453039943|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
125930468|NCT01059825|453039944|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
125930469|NCT01059825|453039938|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
125930470|NCT01059825|453039939|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
125930471|NCT01059825|453039940|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
125930472|NCT01059825|453039941|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
125930473|NCT01059825|453039942|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
125930474|NCT01059825|453039943|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
125930475|NCT01059825|453039944|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
125930476|NCT01059825|453039938|FG000|Treatment Period|Lost to Follow-up|2|||
125930477|NCT01059825|453039939|FG001|Treatment Period|Lost to Follow-up|1|||
125930478|NCT01059825|453039940|FG002|Treatment Period|Lost to Follow-up|0|||
125930479|NCT01059825|453039941|FG003|Treatment Period|Lost to Follow-up|1|||
125930480|NCT01059825|453039942|FG004|Treatment Period|Lost to Follow-up|2|||
125930481|NCT01059825|453039943|FG005|Treatment Period|Lost to Follow-up|0|||
125930482|NCT01059825|453039944|FG006|Treatment Period|Lost to Follow-up|0|||
125930483|NCT01059825|453039938|FG000|Treatment Period|Withdrawal by Subject|3|||
125930484|NCT01059825|453039939|FG001|Treatment Period|Withdrawal by Subject|0|||
125930485|NCT01059825|453039940|FG002|Treatment Period|Withdrawal by Subject|1|||
125930486|NCT01059825|453039941|FG003|Treatment Period|Withdrawal by Subject|5|||
125930487|NCT01059825|453039942|FG004|Treatment Period|Withdrawal by Subject|4|||
125930488|NCT01059825|453039943|FG005|Treatment Period|Withdrawal by Subject|1|||
125930489|NCT01059825|453039944|FG006|Treatment Period|Withdrawal by Subject|0|||
125930490|NCT01059825|453039938|FG000|Treatment Period|Other reason not specified|1|||
125930491|NCT01059825|453039939|FG001|Treatment Period|Other reason not specified|2|||
125930492|NCT01059825|453039940|FG002|Treatment Period|Other reason not specified|1|||
125930493|NCT01059825|453039941|FG003|Treatment Period|Other reason not specified|2|||
125930494|NCT01059825|453039942|FG004|Treatment Period|Other reason not specified|0|||
125930495|NCT01059825|453039943|FG005|Treatment Period|Other reason not specified|0|||
125930496|NCT01059825|453039944|FG006|Treatment Period|Other reason not specified|0|||
125930497|NCT01059825|453039938|FG000|Treatment Period|Protocol Violation|0|||
125930498|NCT01059825|453039939|FG001|Treatment Period|Protocol Violation|0|||
125930499|NCT01059825|453039940|FG002|Treatment Period|Protocol Violation|1|||
125930500|NCT01059825|453039941|FG003|Treatment Period|Protocol Violation|1|||
125930501|NCT01059825|453039942|FG004|Treatment Period|Protocol Violation|1|||
125930502|NCT01059825|453039943|FG005|Treatment Period|Protocol Violation|1|||
125930503|NCT01059825|453039944|FG006|Treatment Period|Protocol Violation|0|||
125930504|NCT01059825|453039938|FG000|Treatment Period|Adverse event related to study drug|1|||
125930505|NCT01059825|453039939|FG001|Treatment Period|Adverse event related to study drug|0|||
125930506|NCT01059825|453039940|FG002|Treatment Period|Adverse event related to study drug|1|||
125930507|NCT01059825|453039941|FG003|Treatment Period|Adverse event related to study drug|1|||
125930508|NCT01059825|453039942|FG004|Treatment Period|Adverse event related to study drug|0|||
125930509|NCT01059825|453039943|FG005|Treatment Period|Adverse event related to study drug|0|||
125930510|NCT01059825|453039944|FG006|Treatment Period|Adverse event related to study drug|0|||
125930511|NCT01059825|453039938|FG000|Treatment Period|Insufficient clinical response|3|||
125930512|NCT01059825|453039939|FG001|Treatment Period|Insufficient clinical response|0|||
125930513|NCT01059825|453039940|FG002|Treatment Period|Insufficient clinical response|0|||
126065822|NCT00321672|453532254|FG000|Overall Study|Withdrawal by Subject|5|||
125930514|NCT01059825|453039941|FG003|Treatment Period|Insufficient clinical response|0|||
125930515|NCT01059825|453039942|FG004|Treatment Period|Insufficient clinical response|0|||
125930516|NCT01059825|453039943|FG005|Treatment Period|Insufficient clinical response|0|||
125930517|NCT01059825|453039944|FG006|Treatment Period|Insufficient clinical response|0|||
125930518|NCT01059825|453039938|FG000|Treatment Period|Adverse event not related to study drug|0|||
125930519|NCT01059825|453039939|FG001|Treatment Period|Adverse event not related to study drug|1|||
126065823|NCT00321672|453532255|FG001|Overall Study|Withdrawal by Subject|1|||
126113085|NCT04439071|453711227|FG001|Overall Study|Death|4|||
126113086|NCT04439071|453711226|FG000|Overall Study|Other than specified|3|||
126113087|NCT04439071|453711227|FG001|Overall Study|Other than specified|3|||
125930520|NCT01059825|453039940|FG002|Treatment Period|Adverse event not related to study drug|2|||
125930521|NCT01059825|453039941|FG003|Treatment Period|Adverse event not related to study drug|1|||
125930522|NCT01059825|453039942|FG004|Treatment Period|Adverse event not related to study drug|1|||
125930523|NCT01059825|453039943|FG005|Treatment Period|Adverse event not related to study drug|1|||
125930524|NCT01059825|453039944|FG006|Treatment Period|Adverse event not related to study drug|0|||
125930525|NCT03342690|453039945|FG000|Overall Study|Missing Information|9|||
125930526|NCT03342690|453039945|FG000|Overall Study|Protocol Violation|16|||
125930527|NCT00549302|453039948|FG000|Double-Blind|Death|2|||
125930528|NCT00549302|453039949|FG001|Double-Blind|Death|9|||
126113088|NCT04439071|453711226|FG000|Overall Study|Randomized but not treated|2|||
126113089|NCT04439071|453711227|FG001|Overall Study|Randomized but not treated|0|||
126113090|NCT00024167|453711230|FG000|Overall Study|Death|53|||
125930529|NCT00549302|453039950|FG002|Double-Blind|Death|0|||
125930530|NCT00549302|453039948|FG000|Double-Blind|Adverse Event|3|||
125930531|NCT00549302|453039949|FG001|Double-Blind|Adverse Event|16|||
125930532|NCT00549302|453039950|FG002|Double-Blind|Adverse Event|0|||
125930533|NCT00549302|453039948|FG000|Double-Blind|Withdrawal by Subject|3|||
125930534|NCT00549302|453039949|FG001|Double-Blind|Withdrawal by Subject|8|||
125930535|NCT00549302|453039950|FG002|Double-Blind|Withdrawal by Subject|0|||
125930536|NCT00549302|453039948|FG000|Double-Blind|Investigator Decision|1|||
125930537|NCT00549302|453039949|FG001|Double-Blind|Investigator Decision|5|||
125930538|NCT00549302|453039950|FG002|Double-Blind|Investigator Decision|0|||
126113091|NCT00024167|453711231|FG001|Overall Study|Death|47|||
126113092|NCT01109173|453711232|FG000|Overall Study|Adverse Event|15|||
126113093|NCT01109173|453711233|FG001|Overall Study|Adverse Event|17|||
126113094|NCT01109173|453711234|FG002|Overall Study|Adverse Event|9|||
126113095|NCT01109173|453711235|FG003|Overall Study|Adverse Event|6|||
126113096|NCT01109173|453711232|FG000|Overall Study|Lost to Follow-up|0|||
126113097|NCT01109173|453711233|FG001|Overall Study|Lost to Follow-up|1|||
126113098|NCT01109173|453711234|FG002|Overall Study|Lost to Follow-up|0|||
126113099|NCT01109173|453711235|FG003|Overall Study|Lost to Follow-up|0|||
126113100|NCT01109173|453711232|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
126113101|NCT01109173|453711233|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
126113102|NCT01109173|453711234|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
126113103|NCT01109173|453711235|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
126113104|NCT01109173|453711232|FG000|Overall Study|Noncompliance|0|||
126113105|NCT01109173|453711233|FG001|Overall Study|Noncompliance|1|||
126113106|NCT01109173|453711234|FG002|Overall Study|Noncompliance|0|||
126113107|NCT01109173|453711235|FG003|Overall Study|Noncompliance|0|||
126113108|NCT01109173|453711232|FG000|Overall Study|Treatment Failure|25|||
126113109|NCT01109173|453711233|FG001|Overall Study|Treatment Failure|32|||
126113110|NCT01109173|453711234|FG002|Overall Study|Treatment Failure|69|||
126113111|NCT01109173|453711235|FG003|Overall Study|Treatment Failure|64|||
126113112|NCT01109173|453711232|FG000|Overall Study|Protocol Violation|4|||
126113113|NCT01109173|453711233|FG001|Overall Study|Protocol Violation|5|||
126113114|NCT01109173|453711234|FG002|Overall Study|Protocol Violation|1|||
126113115|NCT01109173|453711235|FG003|Overall Study|Protocol Violation|2|||
126113116|NCT01109173|453711232|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
126113117|NCT01109173|453711233|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
126113118|NCT01109173|453711234|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
126113119|NCT01109173|453711235|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
126113120|NCT01109173|453711232|FG000|Overall Study|Not Specifiied|5|||
126113121|NCT01109173|453711233|FG001|Overall Study|Not Specifiied|4|||
125930539|NCT00549302|453039948|FG000|Double-Blind|Sponsor Decision|0|||
125930540|NCT00549302|453039949|FG001|Double-Blind|Sponsor Decision|1|||
125930541|NCT00549302|453039950|FG002|Double-Blind|Sponsor Decision|0|||
125930542|NCT00549302|453039948|FG000|Double-Blind|Lost to Follow-up|1|||
125930543|NCT00549302|453039949|FG001|Double-Blind|Lost to Follow-up|2|||
125930544|NCT00549302|453039950|FG002|Double-Blind|Lost to Follow-up|0|||
125930545|NCT00549302|453039948|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
125930546|NCT00549302|453039949|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
125930547|NCT00549302|453039950|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
125930548|NCT00549302|453039948|FG000|Double-Blind|New condition or starts new therapy|0|||
126113122|NCT01109173|453711234|FG002|Overall Study|Not Specifiied|9|||
126113123|NCT01109173|453711235|FG003|Overall Study|Not Specifiied|14|||
126113124|NCT01186796|453711245|FG000|Overall Study|Adverse Event|3|||
126113125|NCT01186796|453711246|FG001|Overall Study|Adverse Event|0|||
126113126|NCT01186796|453711245|FG000|Overall Study|Withdrawal by Subject|1|||
126113127|NCT01186796|453711246|FG001|Overall Study|Withdrawal by Subject|1|||
126113128|NCT01186796|453711245|FG000|Overall Study|Protocol Violation|0|||
126113129|NCT01186796|453711246|FG001|Overall Study|Protocol Violation|1|||
125930549|NCT00549302|453039949|FG001|Double-Blind|New condition or starts new therapy|2|||
126113130|NCT02459769|453711247|FG000|Overall Study|Withdrawal by Subject|7|||
125930550|NCT00549302|453039950|FG002|Double-Blind|New condition or starts new therapy|0|||
125930551|NCT00549302|453039948|FG000|Open-Label|Adverse Event|0|||
125930552|NCT00549302|453039949|FG001|Open-Label|Adverse Event|0|||
125930553|NCT00549302|453039950|FG002|Open-Label|Adverse Event|11|||
125930554|NCT00549302|453039948|FG000|Open-Label|Death|0|||
125930555|NCT00549302|453039949|FG001|Open-Label|Death|0|||
125930556|NCT00549302|453039950|FG002|Open-Label|Death|40|||
125930557|NCT00549302|453039948|FG000|Open-Label|Investigator Decision|0|||
125930558|NCT00549302|453039949|FG001|Open-Label|Investigator Decision|0|||
125930559|NCT00549302|453039950|FG002|Open-Label|Investigator Decision|5|||
125930560|NCT00549302|453039948|FG000|Open-Label|Lost to Follow-up|0|||
125930561|NCT00549302|453039949|FG001|Open-Label|Lost to Follow-up|0|||
125930562|NCT00549302|453039950|FG002|Open-Label|Lost to Follow-up|2|||
125930563|NCT00549302|453039948|FG000|Open-Label|Other|0|||
125930564|NCT00549302|453039949|FG001|Open-Label|Other|0|||
125930565|NCT00549302|453039950|FG002|Open-Label|Other|3|||
125930566|NCT00549302|453039948|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
125930567|NCT00549302|453039949|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
125930568|NCT00549302|453039950|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
125930569|NCT00549302|453039948|FG000|Open-Label|Withdrawal by Subject|0|||
125930570|NCT00549302|453039949|FG001|Open-Label|Withdrawal by Subject|0|||
125930571|NCT00549302|453039950|FG002|Open-Label|Withdrawal by Subject|6|||
125930572|NCT03585504|453039951|FG000|Overall Study|Lost to Follow-up|26|||
125930573|NCT03585504|453039952|FG001|Overall Study|Lost to Follow-up|29|||
125930574|NCT01414114|453039953|FG000|Overall Study|Adverse Event|2|||
125930575|NCT01414114|453039953|FG000|Overall Study|Withdrawal by Subject|1|||
125930576|NCT01414114|453039953|FG000|Overall Study|Other|2|||
125930577|NCT00105482|453039954|FG000|Overall Study|Adverse Event|1|||
125930578|NCT00105482|453039955|FG001|Overall Study|Adverse Event|1|||
125930579|NCT00105482|453039954|FG000|Overall Study|Lost to Follow-up|26|||
125930580|NCT00105482|453039955|FG001|Overall Study|Lost to Follow-up|17|||
125930581|NCT00105482|453039954|FG000|Overall Study|Withdrawal by Subject|0|||
125930582|NCT00105482|453039955|FG001|Overall Study|Withdrawal by Subject|1|||
125930583|NCT00105482|453039954|FG000|Overall Study|Lost Interest|29|||
125930584|NCT00105482|453039955|FG001|Overall Study|Lost Interest|32|||
125930585|NCT00105482|453039954|FG000|Overall Study|Scheduling Conflict|2|||
125930586|NCT00105482|453039955|FG001|Overall Study|Scheduling Conflict|3|||
125930587|NCT00105482|453039954|FG000|Overall Study|Withdrawn by PI|1|||
125930588|NCT00105482|453039955|FG001|Overall Study|Withdrawn by PI|1|||
125930589|NCT05620563|453039956|FG000|Overall Study|Adverse Event|3|||
125930590|NCT05620563|453039957|FG001|Overall Study|Adverse Event|1|||
125930591|NCT05620563|453039956|FG000|Overall Study|Lost to Follow-up|0|||
125930592|NCT05620563|453039957|FG001|Overall Study|Lost to Follow-up|2|||
125930593|NCT05620563|453039956|FG000|Overall Study|Protocol Deviation|1|||
125930594|NCT05620563|453039957|FG001|Overall Study|Protocol Deviation|2|||
125930595|NCT05620563|453039956|FG000|Overall Study|Withdrawal by Subject|3|||
125930596|NCT05620563|453039957|FG001|Overall Study|Withdrawal by Subject|3|||
125930597|NCT05620563|453039956|FG000|Overall Study|Physician Decision|0|||
125930598|NCT05620563|453039957|FG001|Overall Study|Physician Decision|1|||
125930599|NCT04626297|453039963|FG000|Overall Study|Adverse Event|5|||
125930600|NCT04626297|453039964|FG001|Overall Study|Adverse Event|3|||
125930601|NCT04626297|453039963|FG000|Overall Study|Lost to Follow-up|7|||
125930602|NCT04626297|453039964|FG001|Overall Study|Lost to Follow-up|3|||
125930603|NCT04626297|453039963|FG000|Overall Study|Protocol Violation|5|||
126065824|NCT00321672|453532256|FG002|Overall Study|Withdrawal by Subject|2|||
126065825|NCT00321672|453532257|FG003|Overall Study|Withdrawal by Subject|0|||
126065826|NCT00321672|453532254|FG000|Overall Study|Noncompliance|1|||
126065827|NCT00321672|453532255|FG001|Overall Study|Noncompliance|2|||
126065828|NCT00321672|453532256|FG002|Overall Study|Noncompliance|1|||
126065829|NCT00321672|453532257|FG003|Overall Study|Noncompliance|0|||
125930604|NCT04626297|453039964|FG001|Overall Study|Protocol Violation|1|||
125930605|NCT04626297|453039963|FG000|Overall Study|Withdrawal by Subject|20|||
125930606|NCT04626297|453039964|FG001|Overall Study|Withdrawal by Subject|6|||
126065830|NCT00321672|453532254|FG000|Overall Study|Adverse Event|1|||
125930607|NCT04626297|453039963|FG000|Overall Study|Sponsor decision|2|||
125930608|NCT04626297|453039964|FG001|Overall Study|Sponsor decision|1|||
125930609|NCT00743340|453039967|FG000|Overall Study|Study medication non-compliance|1|||
125930610|NCT00743340|453039967|FG000|Overall Study|Lost to Follow-up|1|||
125930611|NCT00743340|453039967|FG000|Overall Study|Withdrawal from the Study|5|||
125930612|NCT00743340|453039967|FG000|Overall Study|Protocol Violation|1|||
125930613|NCT00743340|453039967|FG000|Overall Study|Virologic failure|8|||
125930614|NCT00743340|453039967|FG000|Overall Study|Pregnancy|1|||
126065831|NCT00321672|453532255|FG001|Overall Study|Adverse Event|1|||
125930615|NCT00743340|453039967|FG000|Overall Study|Rolled over to other Gilead Study|23|||
125930616|NCT00743340|453039967|FG000|Overall Study|Participant Relocated|1|||
125930617|NCT01425281|453039968|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
125930618|NCT01425281|453039969|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
125930619|NCT01425281|453039968|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
125930620|NCT01425281|453039969|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
125930621|NCT01425281|453039968|FG000|At 180-day Clinical Follow-up|Death|0|||
126113131|NCT02459769|453711248|FG001|Overall Study|Withdrawal by Subject|4|||
126113132|NCT02459769|453711249|FG002|Overall Study|Withdrawal by Subject|8|||
126113133|NCT02459769|453711250|FG003|Overall Study|Withdrawal by Subject|5|||
126113134|NCT02459769|453711247|FG000|Overall Study|Lost to Follow-up|1|||
126113135|NCT02459769|453711248|FG001|Overall Study|Lost to Follow-up|0|||
126113136|NCT02459769|453711249|FG002|Overall Study|Lost to Follow-up|1|||
126113137|NCT02459769|453711250|FG003|Overall Study|Lost to Follow-up|0|||
126113138|NCT01287364|453711251|FG000|Overall Study|Adverse Event|0|||
126113139|NCT01287364|453711252|FG001|Overall Study|Adverse Event|3|||
126113140|NCT01287364|453711251|FG000|Overall Study|Protocol Violation|5|||
126113141|NCT01287364|453711252|FG001|Overall Study|Protocol Violation|5|||
126113142|NCT01287364|453711251|FG000|Overall Study|Other Reason|4|||
126113143|NCT01287364|453711252|FG001|Overall Study|Other Reason|2|||
126113144|NCT00962390|453711257|FG000|Overall Study|Adverse Event|0|||
126113145|NCT00962390|453711258|FG001|Overall Study|Adverse Event|0|||
126113146|NCT00962390|453711259|FG002|Overall Study|Adverse Event|3|||
126113147|NCT00962390|453711260|FG003|Overall Study|Adverse Event|1|||
126113148|NCT00962390|453711257|FG000|Overall Study|Lost to Follow-up|2|||
126113149|NCT00962390|453711258|FG001|Overall Study|Lost to Follow-up|2|||
126113150|NCT00962390|453711259|FG002|Overall Study|Lost to Follow-up|0|||
126113151|NCT00962390|453711260|FG003|Overall Study|Lost to Follow-up|0|||
126113152|NCT00962390|453711257|FG000|Overall Study|Protocol Violation|1|||
126113153|NCT00962390|453711258|FG001|Overall Study|Protocol Violation|0|||
126113154|NCT00962390|453711259|FG002|Overall Study|Protocol Violation|0|||
126113155|NCT00962390|453711260|FG003|Overall Study|Protocol Violation|0|||
126113156|NCT00962390|453711257|FG000|Overall Study|Withdrawal by Subject|1|||
126113157|NCT00962390|453711258|FG001|Overall Study|Withdrawal by Subject|1|||
126113158|NCT00962390|453711259|FG002|Overall Study|Withdrawal by Subject|1|||
126113159|NCT00962390|453711260|FG003|Overall Study|Withdrawal by Subject|0|||
126113160|NCT03740997|453711268|FG000|Overall Study|Withdrawal by Subject|1|||
126113161|NCT03740997|453711269|FG001|Overall Study|Withdrawal by Subject|0|||
126113162|NCT03740997|453711268|FG000|Overall Study|Participant was unable to complete study procedures|1|||
126113163|NCT03740997|453711269|FG001|Overall Study|Participant was unable to complete study procedures|0|||
126113164|NCT01026142|453711270|FG000|Overall Study|Death|136|||
126113165|NCT01026142|453711271|FG001|Overall Study|Death|134|||
126113166|NCT01026142|453711270|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
126113167|NCT01026142|453711271|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
126113168|NCT01829425|453711272|FG000|Overall Study|Withdrawal by Subject|4|||
126113169|NCT01829425|453711273|FG001|Overall Study|Withdrawal by Subject|3|||
126113170|NCT01829425|453711272|FG000|Overall Study|Lost to Follow-up|2|||
126113171|NCT01829425|453711273|FG001|Overall Study|Lost to Follow-up|1|||
126113172|NCT04178967|453711274|FG000|Induction Period|Adverse Event|4|||
126113173|NCT04178967|453711275|FG001|Induction Period|Adverse Event|6|||
126113174|NCT04178967|453711276|FG002|Induction Period|Adverse Event|0|||
126113175|NCT04178967|453711277|FG003|Induction Period|Adverse Event|0|||
126113176|NCT04178967|453711278|FG004|Induction Period|Adverse Event|0|||
126113177|NCT04178967|453711279|FG005|Induction Period|Adverse Event|0|||
126113178|NCT04178967|453711280|FG006|Induction Period|Adverse Event|0|||
126113179|NCT04178967|453711281|FG007|Induction Period|Adverse Event|0|||
126113180|NCT04178967|453711282|FG008|Induction Period|Adverse Event|0|||
126113181|NCT04178967|453711283|FG009|Induction Period|Adverse Event|0|||
126113182|NCT04178967|453711284|FG010|Induction Period|Adverse Event|0|||
126113183|NCT04178967|453711274|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
126113184|NCT04178967|453711275|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
126113185|NCT04178967|453711276|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
126113186|NCT04178967|453711277|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
126113187|NCT04178967|453711278|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
126113188|NCT04178967|453711279|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
126113189|NCT04178967|453711280|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
126113190|NCT04178967|453711281|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
126113191|NCT04178967|453711282|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
126113192|NCT04178967|453711283|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
126113193|NCT04178967|453711284|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
126113194|NCT04178967|453711274|FG000|Induction Period|Lack of Efficacy|4|||
126113195|NCT04178967|453711275|FG001|Induction Period|Lack of Efficacy|1|||
126113196|NCT04178967|453711276|FG002|Induction Period|Lack of Efficacy|0|||
126113197|NCT04178967|453711277|FG003|Induction Period|Lack of Efficacy|0|||
126113198|NCT04178967|453711278|FG004|Induction Period|Lack of Efficacy|0|||
126113199|NCT04178967|453711279|FG005|Induction Period|Lack of Efficacy|0|||
126113200|NCT04178967|453711280|FG006|Induction Period|Lack of Efficacy|0|||
126113201|NCT04178967|453711281|FG007|Induction Period|Lack of Efficacy|0|||
126113202|NCT04178967|453711282|FG008|Induction Period|Lack of Efficacy|0|||
126113203|NCT04178967|453711283|FG009|Induction Period|Lack of Efficacy|0|||
126113204|NCT04178967|453711284|FG010|Induction Period|Lack of Efficacy|0|||
126113205|NCT04178967|453711274|FG000|Induction Period|Protocol Violation|0|||
126113206|NCT04178967|453711275|FG001|Induction Period|Protocol Violation|6|||
126113207|NCT04178967|453711276|FG002|Induction Period|Protocol Violation|0|||
126113208|NCT04178967|453711277|FG003|Induction Period|Protocol Violation|0|||
126065832|NCT00321672|453532256|FG002|Overall Study|Adverse Event|0|||
126065833|NCT00321672|453532257|FG003|Overall Study|Adverse Event|0|||
126065834|NCT00321672|453532254|FG000|Overall Study|Lack of Efficacy|1|||
126065835|NCT00321672|453532255|FG001|Overall Study|Lack of Efficacy|1|||
126065836|NCT00321672|453532256|FG002|Overall Study|Lack of Efficacy|0|||
126065837|NCT00321672|453532257|FG003|Overall Study|Lack of Efficacy|0|||
126065838|NCT00321672|453532254|FG000|Overall Study|Lost to Follow-up|2|||
126065839|NCT00321672|453532255|FG001|Overall Study|Lost to Follow-up|0|||
126065840|NCT00321672|453532256|FG002|Overall Study|Lost to Follow-up|4|||
126065841|NCT00321672|453532257|FG003|Overall Study|Lost to Follow-up|2|||
126065842|NCT00321672|453532254|FG000|Overall Study|Death|1|||
126065843|NCT00321672|453532255|FG001|Overall Study|Death|0|||
126065844|NCT00321672|453532256|FG002|Overall Study|Death|0|||
126065845|NCT00321672|453532257|FG003|Overall Study|Death|0|||
126065846|NCT00321672|453532254|FG000|Overall Study|Too far to travel for visits|1|||
126065847|NCT00321672|453532255|FG001|Overall Study|Too far to travel for visits|0|||
126065848|NCT00321672|453532256|FG002|Overall Study|Too far to travel for visits|0|||
126065849|NCT00321672|453532257|FG003|Overall Study|Too far to travel for visits|0|||
126065850|NCT00321672|453532254|FG000|Overall Study|Incarcerated|0|||
126065851|NCT00321672|453532255|FG001|Overall Study|Incarcerated|0|||
126065852|NCT00321672|453532256|FG002|Overall Study|Incarcerated|2|||
126065853|NCT00321672|453532257|FG003|Overall Study|Incarcerated|0|||
126065854|NCT00321672|453532254|FG000|Overall Study|Moved out of state|0|||
126065855|NCT00321672|453532255|FG001|Overall Study|Moved out of state|1|||
126065856|NCT00321672|453532256|FG002|Overall Study|Moved out of state|1|||
126065857|NCT00321672|453532257|FG003|Overall Study|Moved out of state|0|||
126065858|NCT00321672|453532254|FG000|Overall Study|Protocol Violation|0|||
126065859|NCT00321672|453532255|FG001|Overall Study|Protocol Violation|0|||
126065860|NCT00321672|453532256|FG002|Overall Study|Protocol Violation|1|||
126065861|NCT00321672|453532257|FG003|Overall Study|Protocol Violation|0|||
126065862|NCT00321672|453532254|FG000|Overall Study|Diagnosis of testicular cancer|0|||
126065863|NCT00321672|453532255|FG001|Overall Study|Diagnosis of testicular cancer|1|||
126065864|NCT00321672|453532256|FG002|Overall Study|Diagnosis of testicular cancer|0|||
126065865|NCT00321672|453532257|FG003|Overall Study|Diagnosis of testicular cancer|0|||
126065866|NCT00321672|453532254|FG000|Overall Study|Extensive travel required for new job|0|||
126065867|NCT00321672|453532255|FG001|Overall Study|Extensive travel required for new job|1|||
126065868|NCT00321672|453532256|FG002|Overall Study|Extensive travel required for new job|0|||
126065869|NCT00321672|453532257|FG003|Overall Study|Extensive travel required for new job|0|||
126065870|NCT01549951|453532261|FG000|Overall Study|Adverse Event|15|||
126065871|NCT01549951|453532261|FG000|Overall Study|Withdrawal by Subject|2|||
126065872|NCT01549951|453532261|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
126065873|NCT01549951|453532261|FG000|Overall Study|Progressive disease|29|||
126065874|NCT01549951|453532261|FG000|Overall Study|Symptomatic deterioration|1|||
126065875|NCT01549951|453532261|FG000|Overall Study|Other|2|||
126065876|NCT02312245|453532262|FG000|Overall Study|Death|0|||
126065877|NCT02312245|453532263|FG001|Overall Study|Death|0|||
126065878|NCT02312245|453532264|FG002|Overall Study|Death|0|||
126065879|NCT02312245|453532265|FG003|Overall Study|Death|1|||
126065880|NCT02312245|453532262|FG000|Overall Study|Withdrawal by Subject|1|||
126065881|NCT02312245|453532263|FG001|Overall Study|Withdrawal by Subject|1|||
126065882|NCT02312245|453532264|FG002|Overall Study|Withdrawal by Subject|0|||
126065883|NCT02312245|453532265|FG003|Overall Study|Withdrawal by Subject|2|||
126065884|NCT02312245|453532262|FG000|Overall Study|Alternative Therapy|1|||
126065885|NCT02312245|453532263|FG001|Overall Study|Alternative Therapy|0|||
126065886|NCT02312245|453532264|FG002|Overall Study|Alternative Therapy|0|||
126065887|NCT02312245|453532265|FG003|Overall Study|Alternative Therapy|0|||
126065888|NCT02312245|453532262|FG000|Overall Study|Progression|0|||
126065889|NCT02312245|453532263|FG001|Overall Study|Progression|0|||
126065890|NCT02312245|453532264|FG002|Overall Study|Progression|0|||
126065891|NCT02312245|453532265|FG003|Overall Study|Progression|5|||
126065892|NCT02312245|453532262|FG000|Overall Study|Patient went to hospice|0|||
126065893|NCT02312245|453532263|FG001|Overall Study|Patient went to hospice|0|||
126065894|NCT02312245|453532264|FG002|Overall Study|Patient went to hospice|0|||
126065895|NCT02312245|453532265|FG003|Overall Study|Patient went to hospice|1|||
126065896|NCT02312245|453532262|FG000|Overall Study|Ineligible|1|||
126065897|NCT02312245|453532263|FG001|Overall Study|Ineligible|0|||
126065898|NCT02312245|453532264|FG002|Overall Study|Ineligible|0|||
126065899|NCT02312245|453532265|FG003|Overall Study|Ineligible|0|||
126065900|NCT03689452|453532271|FG000|Overall Study|Lost to Follow-up|1|||
126065901|NCT03689452|453532272|FG001|Overall Study|Lost to Follow-up|1|||
126065902|NCT02676778|453532273|FG000|Overall Study|Disease Progression|7|||
126065903|NCT02676778|453532274|FG001|Overall Study|Disease Progression|3|||
126065904|NCT02676778|453532275|FG002|Overall Study|Disease Progression|1|||
126065905|NCT02676778|453532273|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
126065906|NCT02676778|453532274|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
126065907|NCT02676778|453532275|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
126065908|NCT02676778|453532273|FG000|Overall Study|Withdrawal by Subject|3|||
126065909|NCT02676778|453532274|FG001|Overall Study|Withdrawal by Subject|2|||
126113209|NCT04178967|453711278|FG004|Induction Period|Protocol Violation|0|||
126113210|NCT04178967|453711279|FG005|Induction Period|Protocol Violation|0|||
126113211|NCT04178967|453711280|FG006|Induction Period|Protocol Violation|0|||
126113212|NCT04178967|453711281|FG007|Induction Period|Protocol Violation|0|||
126113213|NCT04178967|453711282|FG008|Induction Period|Protocol Violation|0|||
125930622|NCT01425281|453039969|FG001|At 180-day Clinical Follow-up|Death|1|||
125930623|NCT01425281|453039968|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
125930624|NCT01425281|453039969|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
125930625|NCT01425281|453039968|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
125930626|NCT01425281|453039969|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
125930627|NCT01425281|453039968|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
125930628|NCT01425281|453039969|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
125930629|NCT01425281|453039968|FG000|At 2-year Clinical Follow-up|Death|2|||
125930630|NCT01425281|453039969|FG001|At 2-year Clinical Follow-up|Death|0|||
125930631|NCT01425281|453039968|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
125930632|NCT01425281|453039969|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
125930633|NCT01425281|453039968|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
125930634|NCT01425281|453039969|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
125930635|NCT01425281|453039968|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
125930636|NCT01425281|453039969|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
125930637|NCT01425281|453039968|FG000|At 3-year Clinical Follow-up|Death|2|||
125930638|NCT01425281|453039969|FG001|At 3-year Clinical Follow-up|Death|3|||
125930639|NCT01425281|453039968|FG000|At 4-year Clinical Follow-up|Death|7|||
125930640|NCT01425281|453039969|FG001|At 4-year Clinical Follow-up|Death|3|||
125930641|NCT01425281|453039968|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
125930642|NCT01425281|453039969|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
125930643|NCT01425281|453039968|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
125930644|NCT01425281|453039969|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
125930645|NCT01425281|453039968|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
125930646|NCT01425281|453039969|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
125930647|NCT01425281|453039968|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
125930648|NCT01425281|453039969|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
125930649|NCT01425281|453039968|FG000|At 5-year Clinical Follow-up|Death|2|||
125930650|NCT01425281|453039969|FG001|At 5-year Clinical Follow-up|Death|0|||
125930651|NCT01425281|453039968|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
125930652|NCT01425281|453039969|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
125930653|NCT01425281|453039968|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
125930654|NCT01425281|453039969|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
125930655|NCT01425281|453039968|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
125930656|NCT01425281|453039969|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
125930657|NCT02706691|453039971|FG000|Overall Study|Adverse Event|1|||
125930658|NCT01402492|453039972|FG000|Overall Study|Withdrawal by Subject|17|||
125930659|NCT01402492|453039973|FG001|Overall Study|Withdrawal by Subject|11|||
125930660|NCT01402492|453039974|FG002|Overall Study|Withdrawal by Subject|11|||
125930661|NCT01402492|453039972|FG000|Overall Study|Adverse Event|2|||
125930662|NCT01402492|453039973|FG001|Overall Study|Adverse Event|3|||
125930663|NCT01402492|453039974|FG002|Overall Study|Adverse Event|4|||
125930664|NCT01402492|453039972|FG000|Overall Study|Physician Decision|0|||
125930665|NCT01402492|453039973|FG001|Overall Study|Physician Decision|3|||
125930666|NCT01402492|453039974|FG002|Overall Study|Physician Decision|0|||
125930667|NCT01402492|453039972|FG000|Overall Study|Incarcerated (N=3)|2|||
126113214|NCT04178967|453711283|FG009|Induction Period|Protocol Violation|0|||
126113215|NCT04178967|453711284|FG010|Induction Period|Protocol Violation|0|||
126113216|NCT04178967|453711274|FG000|Induction Period|Withdrawal by Subject|6|||
126113217|NCT04178967|453711275|FG001|Induction Period|Withdrawal by Subject|4|||
126113218|NCT04178967|453711276|FG002|Induction Period|Withdrawal by Subject|0|||
125930668|NCT01402492|453039973|FG001|Overall Study|Incarcerated (N=3)|0|||
125930669|NCT01402492|453039974|FG002|Overall Study|Incarcerated (N=3)|1|||
125930670|NCT03167411|453039975|FG000|Overall Study|Adverse Event|0|||
125930671|NCT03167411|453039976|FG001|Overall Study|Adverse Event|1|||
125930672|NCT02651922|453039980|FG000|Overall Study|due to exclusion criteria|2|||
125930673|NCT01605877|453039981|FG000|Overall Study|Withdrawal by Subject|1|||
125930674|NCT00600483|453039990|FG000|Overall Study|Lost to Follow-up|26|||
125930675|NCT00600483|453039991|FG001|Overall Study|Lost to Follow-up|47|||
125930676|NCT00600483|453039990|FG000|Overall Study|Randomized but not treated|10|||
125930677|NCT00600483|453039991|FG001|Overall Study|Randomized but not treated|0|||
125930678|NCT01482884|453039997|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
125930679|NCT01482884|453039998|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
125930680|NCT01482884|453039997|FG000|Overall Study|Protocol Violation|1|||
126113219|NCT04178967|453711277|FG003|Induction Period|Withdrawal by Subject|0|||
126113220|NCT04178967|453711278|FG004|Induction Period|Withdrawal by Subject|0|||
126113221|NCT04178967|453711279|FG005|Induction Period|Withdrawal by Subject|0|||
125930681|NCT01482884|453039998|FG001|Overall Study|Protocol Violation|0|||
125930682|NCT01482884|453039997|FG000|Overall Study|Lost to Follow-up|2|||
125930683|NCT01482884|453039998|FG001|Overall Study|Lost to Follow-up|2|||
125930684|NCT01482884|453039997|FG000|Overall Study|Lack of Efficacy|0|||
125930685|NCT01482884|453039998|FG001|Overall Study|Lack of Efficacy|1|||
125930686|NCT01482884|453039997|FG000|Overall Study|Adverse Event|2|||
126065910|NCT02676778|453532275|FG002|Overall Study|Withdrawal by Subject|0|||
126065911|NCT02676778|453532273|FG000|Overall Study|Other|4|||
126065912|NCT02676778|453532274|FG001|Overall Study|Other|3|||
126065913|NCT02676778|453532275|FG002|Overall Study|Other|0|||
126065914|NCT02676778|453532273|FG000|Overall Study|Adverse Event|2|||
126065915|NCT02676778|453532274|FG001|Overall Study|Adverse Event|3|||
126065916|NCT02676778|453532275|FG002|Overall Study|Adverse Event|0|||
126065917|NCT01288729|453532279|FG000|Overall Study|Withdrawal by Subject|1|||
126065918|NCT01288729|453532280|FG001|Overall Study|Withdrawal by Subject|0|||
126065919|NCT04448561|453532281|FG000|Overall Study|Noncompliance|1|||
126065920|NCT04448561|453532282|FG001|Overall Study|Noncompliance|0|||
126065921|NCT01730118|453533434|FG000|Dose Escalation|Death on study|5|||
126065922|NCT01730118|453533435|FG001|Dose Escalation|Death on study|7|||
126065923|NCT01730118|453533436|FG002|Dose Escalation|Death on study|2|||
126065924|NCT01730118|453533437|FG003|Dose Escalation|Death on study|6|||
126065925|NCT01730118|453533438|FG004|Dose Escalation|Death on study|0|||
126065926|NCT01730118|453533439|FG005|Dose Escalation|Death on study|0|||
126065927|NCT01730118|453533440|FG006|Dose Escalation|Death on study|0|||
126065928|NCT01730118|453533434|FG000|Dose Escalation|Died before treatment|0|||
126065929|NCT01730118|453533435|FG001|Dose Escalation|Died before treatment|0|||
126065930|NCT01730118|453533436|FG002|Dose Escalation|Died before treatment|0|||
126065931|NCT01730118|453533437|FG003|Dose Escalation|Died before treatment|0|||
126065932|NCT01730118|453533438|FG004|Dose Escalation|Died before treatment|0|||
126065933|NCT01730118|453533439|FG005|Dose Escalation|Died before treatment|0|||
126065934|NCT01730118|453533440|FG006|Dose Escalation|Died before treatment|1|||
126065935|NCT01730118|453533434|FG000|Dose Escalation|Chose to start a different treatment|1|||
126065936|NCT01730118|453533435|FG001|Dose Escalation|Chose to start a different treatment|0|||
126065937|NCT01730118|453533436|FG002|Dose Escalation|Chose to start a different treatment|0|||
126065938|NCT01730118|453533437|FG003|Dose Escalation|Chose to start a different treatment|0|||
126065939|NCT01730118|453533438|FG004|Dose Escalation|Chose to start a different treatment|0|||
126065940|NCT01730118|453533439|FG005|Dose Escalation|Chose to start a different treatment|0|||
126065941|NCT01730118|453533440|FG006|Dose Escalation|Chose to start a different treatment|0|||
126065942|NCT01730118|453533434|FG000|Dose Escalation|Withdrawal by Subject|0|||
126065943|NCT01730118|453533435|FG001|Dose Escalation|Withdrawal by Subject|0|||
126065944|NCT01730118|453533436|FG002|Dose Escalation|Withdrawal by Subject|1|||
126065945|NCT01730118|453533437|FG003|Dose Escalation|Withdrawal by Subject|0|||
126065946|NCT01730118|453533438|FG004|Dose Escalation|Withdrawal by Subject|0|||
126065947|NCT01730118|453533439|FG005|Dose Escalation|Withdrawal by Subject|0|||
126065948|NCT01730118|453533440|FG006|Dose Escalation|Withdrawal by Subject|0|||
126065949|NCT01730118|453533434|FG000|Dose Escalation|Disease progression prior to treatment|0|||
126065950|NCT01730118|453533435|FG001|Dose Escalation|Disease progression prior to treatment|0|||
126065951|NCT01730118|453533436|FG002|Dose Escalation|Disease progression prior to treatment|0|||
126065952|NCT01730118|453533437|FG003|Dose Escalation|Disease progression prior to treatment|0|||
126065953|NCT01730118|453533438|FG004|Dose Escalation|Disease progression prior to treatment|0|||
126065954|NCT01730118|453533439|FG005|Dose Escalation|Disease progression prior to treatment|0|||
126065955|NCT01730118|453533440|FG006|Dose Escalation|Disease progression prior to treatment|1|||
126065956|NCT01730118|453533434|FG000|Dose Expansion|Death|0|||
126065957|NCT01730118|453533435|FG001|Dose Expansion|Death|0|||
126065958|NCT01730118|453533436|FG002|Dose Expansion|Death|0|||
126065959|NCT01730118|453533437|FG003|Dose Expansion|Death|0|||
126065960|NCT01730118|453533438|FG004|Dose Expansion|Death|1|||
126065961|NCT01730118|453533439|FG005|Dose Expansion|Death|0|||
126065962|NCT01730118|453533440|FG006|Dose Expansion|Death|0|||
126065963|NCT01730118|453533434|FG000|Dose Expansion|Other medical condition|0|||
126065964|NCT01730118|453533435|FG001|Dose Expansion|Other medical condition|0|||
126065965|NCT01730118|453533436|FG002|Dose Expansion|Other medical condition|0|||
126065966|NCT01730118|453533437|FG003|Dose Expansion|Other medical condition|0|||
125930687|NCT01482884|453039998|FG001|Overall Study|Adverse Event|1|||
126065967|NCT01730118|453533438|FG004|Dose Expansion|Other medical condition|1|||
126065968|NCT01730118|453533439|FG005|Dose Expansion|Other medical condition|0|||
126065969|NCT01730118|453533440|FG006|Dose Expansion|Other medical condition|0|||
126065970|NCT01730118|453533434|FG000|Dose Expansion|Withdrawal by Subject|0|||
126065971|NCT01730118|453533435|FG001|Dose Expansion|Withdrawal by Subject|0|||
126065972|NCT01730118|453533436|FG002|Dose Expansion|Withdrawal by Subject|0|||
126065973|NCT01730118|453533437|FG003|Dose Expansion|Withdrawal by Subject|0|||
126065974|NCT01730118|453533438|FG004|Dose Expansion|Withdrawal by Subject|1|||
126065975|NCT01730118|453533439|FG005|Dose Expansion|Withdrawal by Subject|0|||
125930688|NCT01482884|453039997|FG000|Overall Study|Withdrawal by Subject|8|||
126065976|NCT01730118|453533440|FG006|Dose Expansion|Withdrawal by Subject|0|||
126065977|NCT01730118|453533434|FG000|Dose Expansion|Disease progression|0|||
125930689|NCT01482884|453039998|FG001|Overall Study|Withdrawal by Subject|13|||
125930690|NCT04102020|453039999|FG000|Overall Study|Adverse Event|1|||
125930691|NCT04102020|453040000|FG001|Overall Study|Adverse Event|0|||
125930692|NCT04102020|453040001|FG002|Overall Study|Adverse Event|0|||
125930693|NCT04102020|453040002|FG003|Overall Study|Adverse Event|1|||
125930694|NCT04102020|453040003|FG004|Overall Study|Adverse Event|0|||
125930695|NCT04102020|453039999|FG000|Overall Study|Withdrawal by Subject|0|||
125930696|NCT04102020|453040000|FG001|Overall Study|Withdrawal by Subject|1|||
125930697|NCT04102020|453040001|FG002|Overall Study|Withdrawal by Subject|1|||
125930698|NCT04102020|453040002|FG003|Overall Study|Withdrawal by Subject|1|||
125930699|NCT04102020|453040003|FG004|Overall Study|Withdrawal by Subject|1|||
125930700|NCT04102020|453039999|FG000|Overall Study|Death|1|||
125930701|NCT04102020|453040000|FG001|Overall Study|Death|4|||
125930702|NCT04102020|453040001|FG002|Overall Study|Death|1|||
125930703|NCT04102020|453040002|FG003|Overall Study|Death|1|||
125930704|NCT04102020|453040003|FG004|Overall Study|Death|0|||
125930705|NCT04102020|453039999|FG000|Overall Study|Physician Decision|1|||
125930706|NCT04102020|453040000|FG001|Overall Study|Physician Decision|2|||
125930707|NCT04102020|453040001|FG002|Overall Study|Physician Decision|2|||
125930708|NCT04102020|453040002|FG003|Overall Study|Physician Decision|0|||
125930709|NCT04102020|453040003|FG004|Overall Study|Physician Decision|1|||
125930710|NCT04102020|453039999|FG000|Overall Study|COVID-19 Infection|1|||
125930711|NCT04102020|453040000|FG001|Overall Study|COVID-19 Infection|0|||
125930712|NCT04102020|453040001|FG002|Overall Study|COVID-19 Infection|0|||
125930713|NCT04102020|453040002|FG003|Overall Study|COVID-19 Infection|0|||
125930714|NCT04102020|453040003|FG004|Overall Study|COVID-19 Infection|0|||
125930715|NCT04102020|453039999|FG000|Overall Study|Not disclosed|5|||
125930716|NCT04102020|453040000|FG001|Overall Study|Not disclosed|3|||
125930717|NCT04102020|453040001|FG002|Overall Study|Not disclosed|8|||
125930718|NCT04102020|453040002|FG003|Overall Study|Not disclosed|0|||
125930719|NCT04102020|453040003|FG004|Overall Study|Not disclosed|1|||
125930720|NCT04102020|453039999|FG000|Overall Study|MIssing|1|||
125930721|NCT04102020|453040000|FG001|Overall Study|MIssing|0|||
125930722|NCT04102020|453040001|FG002|Overall Study|MIssing|1|||
125930723|NCT04102020|453040002|FG003|Overall Study|MIssing|1|||
125930724|NCT04102020|453040003|FG004|Overall Study|MIssing|1|||
125930725|NCT04102020|453039999|FG000|Overall Study|Continuing in ongoing study|13|||
125930726|NCT04102020|453040000|FG001|Overall Study|Continuing in ongoing study|13|||
125930727|NCT04102020|453040001|FG002|Overall Study|Continuing in ongoing study|7|||
125930728|NCT04102020|453040002|FG003|Overall Study|Continuing in ongoing study|26|||
125930729|NCT04102020|453040003|FG004|Overall Study|Continuing in ongoing study|12|||
125930730|NCT00996216|453042290|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
125930731|NCT00996216|453042290|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
125930732|NCT00996216|453042290|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
125930733|NCT00793403|453042293|FG000|Overall Study|Other|73|||
125930734|NCT00842712|453042296|FG000|Safety Run-in Part|Adverse Event|0|||
125930735|NCT00842712|453042297|FG001|Safety Run-in Part|Adverse Event|1|||
125930736|NCT00842712|453042298|FG002|Safety Run-in Part|Adverse Event|0|||
125930737|NCT00842712|453042299|FG003|Safety Run-in Part|Adverse Event|0|||
125930738|NCT00842712|453042300|FG004|Safety Run-in Part|Adverse Event|0|||
125930739|NCT00842712|453042301|FG005|Safety Run-in Part|Adverse Event|0|||
125930740|NCT00842712|453042302|FG006|Safety Run-in Part|Adverse Event|0|||
125930741|NCT00842712|453042296|FG000|Safety Run-in Part|Progressive disease|3|||
125930742|NCT00842712|453042297|FG001|Safety Run-in Part|Progressive disease|1|||
125930743|NCT00842712|453042298|FG002|Safety Run-in Part|Progressive disease|0|||
125930744|NCT00842712|453042299|FG003|Safety Run-in Part|Progressive disease|1|||
125930745|NCT00842712|453042300|FG004|Safety Run-in Part|Progressive disease|0|||
125930746|NCT00842712|453042301|FG005|Safety Run-in Part|Progressive disease|0|||
125930747|NCT00842712|453042302|FG006|Safety Run-in Part|Progressive disease|0|||
125930748|NCT00842712|453042296|FG000|Randomized Part|Randomized but not treated|0|||
125930749|NCT00842712|453042297|FG001|Randomized Part|Randomized but not treated|0|||
125930750|NCT00842712|453042298|FG002|Randomized Part|Randomized but not treated|0|||
125930751|NCT00842712|453042299|FG003|Randomized Part|Randomized but not treated|0|||
125930752|NCT00842712|453042300|FG004|Randomized Part|Randomized but not treated|0|||
125930753|NCT00842712|453042301|FG005|Randomized Part|Randomized but not treated|1|||
125930754|NCT00842712|453042302|FG006|Randomized Part|Randomized but not treated|4|||
125930755|NCT00842712|453042296|FG000|Randomized Part|Ongoing at cut-off date|0|||
125930756|NCT00842712|453042297|FG001|Randomized Part|Ongoing at cut-off date|0|||
125930757|NCT00842712|453042298|FG002|Randomized Part|Ongoing at cut-off date|0|||
125930758|NCT00842712|453042299|FG003|Randomized Part|Ongoing at cut-off date|0|||
125930759|NCT00842712|453042300|FG004|Randomized Part|Ongoing at cut-off date|0|||
125930760|NCT00842712|453042301|FG005|Randomized Part|Ongoing at cut-off date|0|||
125930761|NCT00842712|453042302|FG006|Randomized Part|Ongoing at cut-off date|2|||
125930762|NCT00085631|453042307|FG000|Overall Study|Missing Data|4|||
125930763|NCT00085631|453042308|FG001|Overall Study|Missing Data|11|||
125930764|NCT00085631|453042309|FG002|Overall Study|Missing Data|7|||
125930765|NCT00411645|453042310|FG000|Overall Study|Consent Withdrawn|13|||
125930766|NCT00411645|453042311|FG001|Overall Study|Consent Withdrawn|22|||
125930767|NCT00411645|453042310|FG000|Overall Study|Death|56|||
125930768|NCT00411645|453042311|FG001|Overall Study|Death|135|||
125930769|NCT00411645|453042310|FG000|Overall Study|Investigator/Sponsor Decision|10|||
125930770|NCT00411645|453042311|FG001|Overall Study|Investigator/Sponsor Decision|7|||
125930771|NCT00411645|453042310|FG000|Overall Study|Lost to Follow-up|2|||
125930772|NCT00411645|453042311|FG001|Overall Study|Lost to Follow-up|0|||
125930773|NCT00779467|453042312|FG000|Overall Study|Lack of Efficacy|11|||
125930774|NCT00779467|453042313|FG001|Overall Study|Lack of Efficacy|2|||
125930775|NCT00779467|453042314|FG002|Overall Study|Lack of Efficacy|6|||
125930776|NCT00779467|453042315|FG003|Overall Study|Lack of Efficacy|11|||
125930777|NCT00779467|453042312|FG000|Overall Study|failed inclusion criteria|3|||
125930778|NCT00779467|453042313|FG001|Overall Study|failed inclusion criteria|3|||
125930779|NCT00779467|453042314|FG002|Overall Study|failed inclusion criteria|1|||
125930780|NCT00779467|453042315|FG003|Overall Study|failed inclusion criteria|2|||
125930781|NCT00779467|453042312|FG000|Overall Study|missing data|1|||
125930782|NCT00779467|453042313|FG001|Overall Study|missing data|0|||
125930783|NCT00779467|453042314|FG002|Overall Study|missing data|1|||
125930784|NCT00779467|453042315|FG003|Overall Study|missing data|4|||
125930785|NCT00779467|453042312|FG000|Overall Study|technical issue|0|||
125930786|NCT00779467|453042313|FG001|Overall Study|technical issue|0|||
125930787|NCT00779467|453042314|FG002|Overall Study|technical issue|2|||
125930788|NCT00779467|453042315|FG003|Overall Study|technical issue|1|||
125930789|NCT00779467|453042312|FG000|Overall Study|unavailable research staff|0|||
125930790|NCT00779467|453042313|FG001|Overall Study|unavailable research staff|0|||
125930791|NCT00779467|453042314|FG002|Overall Study|unavailable research staff|0|||
125930792|NCT00779467|453042315|FG003|Overall Study|unavailable research staff|1|||
125930793|NCT04118166|453042318|FG000|Overall Study|Adverse Event|1|||
125930794|NCT03521934|453042325|FG000|Overall Study|Death|65|||
125930795|NCT03521934|453042326|FG001|Overall Study|Death|73|||
125930796|NCT03521934|453042325|FG000|Overall Study|Withdrawal by Subject|18|||
125930797|NCT03521934|453042326|FG001|Overall Study|Withdrawal by Subject|23|||
125930798|NCT03521934|453042325|FG000|Overall Study|Site Terminated by Sponsor|39|||
125930799|NCT03521934|453042326|FG001|Overall Study|Site Terminated by Sponsor|35|||
125930800|NCT03521934|453042325|FG000|Overall Study|Study Terminated by Sponsor|483|||
125930801|NCT03521934|453042326|FG001|Overall Study|Study Terminated by Sponsor|477|||
125930802|NCT03521934|453042325|FG000|Overall Study|Reason not Specified|3|||
125930803|NCT03521934|453042326|FG001|Overall Study|Reason not Specified|6|||
125930804|NCT05048784|453042327|FG000|Period 1|Adverse Event|3|||
125930805|NCT05048784|453042328|FG001|Period 1|Adverse Event|1|||
125930806|NCT05048784|453042329|FG002|Period 1|Adverse Event|0|||
125930807|NCT05048784|453042330|FG003|Period 1|Adverse Event|0|||
125930808|NCT05048784|453042327|FG000|Period 2|Lost to Follow-up|0|||
125930809|NCT05048784|453042328|FG001|Period 2|Lost to Follow-up|1|||
125930810|NCT05048784|453042329|FG002|Period 2|Lost to Follow-up|0|||
125930811|NCT05048784|453042330|FG003|Period 2|Lost to Follow-up|0|||
125930812|NCT03020160|453042331|FG000|Overall Study|Withdrawal by Subject|1|||
125930813|NCT03020160|453042332|FG001|Overall Study|Withdrawal by Subject|0|||
125930814|NCT01513473|453042333|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
125930815|NCT01513473|453042334|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
125930816|NCT01513473|453042333|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
125930817|NCT01513473|453042334|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
125930818|NCT01513473|453042333|FG000|Main Trial (26 Weeks)|Unclassified|0|||
125930819|NCT01513473|453042334|FG001|Main Trial (26 Weeks)|Unclassified|2|||
125930820|NCT01513473|453042333|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
125930821|NCT01513473|453042334|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
125930822|NCT01513473|453042333|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
125930823|NCT01513473|453042334|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
125930824|NCT02708121|453042335|FG000|Overall Study|Withdrawn by Study Team|1|||
125930825|NCT02708121|453042336|FG001|Overall Study|Withdrawn by Study Team|1|||
125930826|NCT02708121|453042335|FG000|Overall Study|Withdrawal by Subject|0|||
125930827|NCT02708121|453042336|FG001|Overall Study|Withdrawal by Subject|4|||
125930828|NCT01833520|453042341|FG000|Overall Study|Lack of Efficacy|3|||
125930829|NCT01833520|453042342|FG001|Overall Study|Lack of Efficacy|3|||
125930830|NCT01833520|453042343|FG002|Overall Study|Lack of Efficacy|8|||
125930831|NCT01833520|453042344|FG003|Overall Study|Lack of Efficacy|3|||
125930832|NCT02743520|453042345|FG000|Overall Study|Withdrawal by Subject|1|||
125930833|NCT01749514|453042346|FG000|Overall Study|Lost to Follow-up|0|||
125930834|NCT01749514|453042347|FG001|Overall Study|Lost to Follow-up|0|||
125930835|NCT01749514|453042348|FG002|Overall Study|Lost to Follow-up|0|||
125930836|NCT01749514|453042349|FG003|Overall Study|Lost to Follow-up|0|||
125930837|NCT01749514|453042350|FG004|Overall Study|Lost to Follow-up|0|||
125930838|NCT01749514|453042351|FG005|Overall Study|Lost to Follow-up|0|||
125930839|NCT01749514|453042352|FG006|Overall Study|Lost to Follow-up|0|||
125930840|NCT01749514|453042353|FG007|Overall Study|Lost to Follow-up|1|||
125930841|NCT01749514|453042346|FG000|Overall Study|Withdrawal by Subject|0|||
125930842|NCT01749514|453042347|FG001|Overall Study|Withdrawal by Subject|0|||
125930843|NCT01749514|453042348|FG002|Overall Study|Withdrawal by Subject|0|||
125930844|NCT01749514|453042349|FG003|Overall Study|Withdrawal by Subject|0|||
126113222|NCT04178967|453711280|FG006|Induction Period|Withdrawal by Subject|0|||
126113223|NCT04178967|453711281|FG007|Induction Period|Withdrawal by Subject|0|||
126113224|NCT04178967|453711282|FG008|Induction Period|Withdrawal by Subject|0|||
126113225|NCT04178967|453711283|FG009|Induction Period|Withdrawal by Subject|0|||
126113226|NCT04178967|453711284|FG010|Induction Period|Withdrawal by Subject|0|||
126113227|NCT04178967|453711274|FG000|Induction Period|Lost to Follow-up|2|||
126113228|NCT04178967|453711275|FG001|Induction Period|Lost to Follow-up|0|||
126113229|NCT04178967|453711276|FG002|Induction Period|Lost to Follow-up|0|||
126113230|NCT04178967|453711277|FG003|Induction Period|Lost to Follow-up|0|||
126113231|NCT04178967|453711278|FG004|Induction Period|Lost to Follow-up|0|||
126113232|NCT04178967|453711279|FG005|Induction Period|Lost to Follow-up|0|||
126113233|NCT04178967|453711280|FG006|Induction Period|Lost to Follow-up|0|||
126113234|NCT04178967|453711281|FG007|Induction Period|Lost to Follow-up|0|||
126113235|NCT04178967|453711282|FG008|Induction Period|Lost to Follow-up|0|||
126113236|NCT04178967|453711283|FG009|Induction Period|Lost to Follow-up|0|||
126113237|NCT04178967|453711284|FG010|Induction Period|Lost to Follow-up|0|||
126113238|NCT04178967|453711274|FG000|Induction Period|Participant Missed Study Visits|0|||
126113239|NCT04178967|453711275|FG001|Induction Period|Participant Missed Study Visits|1|||
126113240|NCT04178967|453711276|FG002|Induction Period|Participant Missed Study Visits|0|||
126113241|NCT04178967|453711277|FG003|Induction Period|Participant Missed Study Visits|0|||
126113242|NCT04178967|453711278|FG004|Induction Period|Participant Missed Study Visits|0|||
126113243|NCT04178967|453711279|FG005|Induction Period|Participant Missed Study Visits|0|||
126113244|NCT04178967|453711280|FG006|Induction Period|Participant Missed Study Visits|0|||
126113245|NCT04178967|453711281|FG007|Induction Period|Participant Missed Study Visits|0|||
126113246|NCT04178967|453711282|FG008|Induction Period|Participant Missed Study Visits|0|||
126113247|NCT04178967|453711283|FG009|Induction Period|Participant Missed Study Visits|0|||
126113248|NCT04178967|453711284|FG010|Induction Period|Participant Missed Study Visits|0|||
126113249|NCT04178967|453711274|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
126113250|NCT04178967|453711275|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
126113251|NCT04178967|453711276|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
126113252|NCT04178967|453711277|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
126113253|NCT04178967|453711278|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
126113254|NCT04178967|453711279|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
126113255|NCT04178967|453711280|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
126113256|NCT04178967|453711281|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
126113257|NCT04178967|453711282|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
126113258|NCT04178967|453711283|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
126113259|NCT04178967|453711284|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
126113260|NCT04178967|453711274|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113261|NCT04178967|453711275|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113262|NCT04178967|453711276|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113263|NCT04178967|453711277|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113264|NCT04178967|453711278|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113265|NCT04178967|453711279|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
126113266|NCT04178967|453711280|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113267|NCT04178967|453711281|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113268|NCT04178967|453711282|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113269|NCT04178967|453711283|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113270|NCT04178967|453711284|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126113271|NCT04178967|453711274|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113272|NCT04178967|453711275|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113273|NCT04178967|453711276|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113274|NCT04178967|453711277|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
126113275|NCT04178967|453711278|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113276|NCT04178967|453711279|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113277|NCT04178967|453711280|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113278|NCT04178967|453711281|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113279|NCT04178967|453711282|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113280|NCT04178967|453711283|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125930845|NCT01749514|453042350|FG004|Overall Study|Withdrawal by Subject|0|||
125930846|NCT01749514|453042351|FG005|Overall Study|Withdrawal by Subject|1|||
125930847|NCT01749514|453042352|FG006|Overall Study|Withdrawal by Subject|0|||
125930848|NCT01749514|453042353|FG007|Overall Study|Withdrawal by Subject|1|||
125930849|NCT01749514|453042346|FG000|Overall Study|Not Reported|0|||
126113281|NCT04178967|453711284|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126113282|NCT04178967|453711274|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113283|NCT04178967|453711275|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113284|NCT04178967|453711276|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113285|NCT04178967|453711277|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
125930850|NCT01749514|453042347|FG001|Overall Study|Not Reported|0|||
125930851|NCT01749514|453042348|FG002|Overall Study|Not Reported|0|||
125930852|NCT01749514|453042349|FG003|Overall Study|Not Reported|0|||
125930853|NCT01749514|453042350|FG004|Overall Study|Not Reported|0|||
125930854|NCT01749514|453042351|FG005|Overall Study|Not Reported|0|||
125930855|NCT01749514|453042352|FG006|Overall Study|Not Reported|0|||
126065978|NCT01730118|453533435|FG001|Dose Expansion|Disease progression|0|||
125930856|NCT01749514|453042353|FG007|Overall Study|Not Reported|5|||
125930857|NCT00938639|453042354|FG000|Overall Study|Moved away from study area|0|||
125930858|NCT00938639|453042355|FG001|Overall Study|Moved away from study area|1|||
125930859|NCT00938639|453042354|FG000|Overall Study|Lost to Follow-up|1|||
125930860|NCT00938639|453042355|FG001|Overall Study|Lost to Follow-up|2|||
125930861|NCT00938639|453042354|FG000|Overall Study|Family issues|1|||
125930862|NCT00938639|453042355|FG001|Overall Study|Family issues|1|||
125930863|NCT00938639|453042354|FG000|Overall Study|Participant noncompliance|1|||
125930864|NCT00938639|453042355|FG001|Overall Study|Participant noncompliance|0|||
125930865|NCT02509156|453042358|FG000|Randomized Phase|Death|1|||
125930866|NCT02509156|453042359|FG001|Randomized Phase|Death|0|||
125930867|NCT02509156|453042358|FG000|Randomized Phase|Withdrawal by Subject|1|||
125930868|NCT02509156|453042359|FG001|Randomized Phase|Withdrawal by Subject|1|||
125930869|NCT02547649|453042360|FG000|Overall Study|Lost to Follow-up|3|||
125930870|NCT02547649|453042361|FG001|Overall Study|Lost to Follow-up|1|||
125930871|NCT02547649|453042362|FG002|Overall Study|Lost to Follow-up|1|||
125930872|NCT02547649|453042360|FG000|Overall Study|Not vaccinated|0|||
125930873|NCT02547649|453042361|FG001|Overall Study|Not vaccinated|0|||
125930874|NCT02547649|453042362|FG002|Overall Study|Not vaccinated|1|||
125930875|NCT02547649|453042360|FG000|Overall Study|Withdrawal by Subject|0|||
125930876|NCT02547649|453042361|FG001|Overall Study|Withdrawal by Subject|4|||
125930877|NCT02547649|453042362|FG002|Overall Study|Withdrawal by Subject|2|||
125930878|NCT04326231|453042363|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
125930879|NCT01750242|453042368|FG000|Overall Study|Unreadable Images|3|||
125930880|NCT01484197|453042371|FG000|Treatment Period 1|Adverse Event|1|||
125930881|NCT01484197|453042372|FG001|Treatment Period 1|Adverse Event|0|||
125930882|NCT01484197|453042373|FG002|Treatment Period 1|Adverse Event|0|||
125930883|NCT01484197|453042374|FG003|Treatment Period 1|Adverse Event|0|||
125930884|NCT01484197|453042371|FG000|Treatment Period 2|Subject withdrew consent|0|||
125930885|NCT01484197|453042372|FG001|Treatment Period 2|Subject withdrew consent|0|||
125930886|NCT01484197|453042373|FG002|Treatment Period 2|Subject withdrew consent|0|||
125930887|NCT01484197|453042374|FG003|Treatment Period 2|Subject withdrew consent|1|||
125930888|NCT01678911|453042384|FG000|Second Intervention|Lost to Follow-up|2|||
125930889|NCT01678911|453042385|FG001|Second Intervention|Lost to Follow-up|0|||
125930890|NCT01980992|453042386|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
125930891|NCT01980992|453042387|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
126065979|NCT01730118|453533436|FG002|Dose Expansion|Disease progression|0|||
126065980|NCT01730118|453533437|FG003|Dose Expansion|Disease progression|0|||
125930892|NCT01980992|453042386|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
125930893|NCT01980992|453042387|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
125930894|NCT01980992|453042386|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
125930895|NCT01980992|453042387|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
125930896|NCT01980992|453042386|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
125930897|NCT01980992|453042387|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
125930898|NCT01980992|453042386|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
125930899|NCT01980992|453042387|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
125930900|NCT01980992|453042386|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
125930901|NCT01980992|453042387|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
125930902|NCT01366209|453042392|FG000|Overall Study|Adverse Event|6|||
125930903|NCT01366209|453042393|FG001|Overall Study|Adverse Event|7|||
125930904|NCT01366209|453042392|FG000|Overall Study|Withdrawal by Subject|4|||
125930905|NCT01366209|453042393|FG001|Overall Study|Withdrawal by Subject|4|||
125930906|NCT01366209|453042392|FG000|Overall Study|Death|12|||
125930907|NCT01366209|453042393|FG001|Overall Study|Death|19|||
125930908|NCT01366209|453042392|FG000|Overall Study|Lung transplantation|6|||
125930909|NCT01366209|453042393|FG001|Overall Study|Lung transplantation|1|||
125930910|NCT01366209|453042392|FG000|Overall Study|Lost to Follow-up|2|||
125930911|NCT01366209|453042393|FG001|Overall Study|Lost to Follow-up|1|||
125930912|NCT01366209|453042392|FG000|Overall Study|Physician Decision|1|||
125930913|NCT01366209|453042393|FG001|Overall Study|Physician Decision|0|||
125930914|NCT01366209|453042392|FG000|Overall Study|Sponsors decision|0|||
125930915|NCT01366209|453042393|FG001|Overall Study|Sponsors decision|1|||
126065981|NCT01730118|453533438|FG004|Dose Expansion|Disease progression|0|||
125930916|NCT01366209|453042392|FG000|Overall Study|Withdrew consent|4|||
125930917|NCT01366209|453042393|FG001|Overall Study|Withdrew consent|3|||
125930918|NCT02670837|453042394|FG000|Overall Study|Death|2|||
125930919|NCT02670837|453042395|FG001|Overall Study|Death|0|||
125930920|NCT02670837|453042396|FG002|Overall Study|Death|0|||
126065982|NCT01730118|453533439|FG005|Dose Expansion|Disease progression|1|||
125930921|NCT01985867|453042397|FG000|Overall Study|Lost to Follow-up|3|||
126113286|NCT04178967|453711278|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113287|NCT04178967|453711279|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113288|NCT04178967|453711280|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
126113289|NCT04178967|453711281|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113290|NCT04178967|453711282|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113291|NCT04178967|453711283|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113292|NCT04178967|453711284|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
126113293|NCT04178967|453711274|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126113294|NCT04178967|453711275|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126113295|NCT04178967|453711276|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126113296|NCT04178967|453711277|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126113297|NCT04178967|453711278|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
126113298|NCT04178967|453711279|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
126113299|NCT04178967|453711280|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126113300|NCT04178967|453711281|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
126113301|NCT04178967|453711282|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126113302|NCT04178967|453711283|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126113303|NCT04178967|453711284|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126113304|NCT04178967|453711274|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126113305|NCT04178967|453711275|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126113306|NCT04178967|453711276|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
126113307|NCT04178967|453711277|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
126113308|NCT04178967|453711278|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
126113309|NCT04178967|453711279|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
126113310|NCT04178967|453711280|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
126113311|NCT04178967|453711281|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
126113312|NCT04178967|453711282|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126113313|NCT04178967|453711283|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126113314|NCT04178967|453711284|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126113315|NCT04178967|453711274|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126113316|NCT04178967|453711275|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126113317|NCT04178967|453711276|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126113318|NCT04178967|453711277|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
126113319|NCT04178967|453711278|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126113320|NCT04178967|453711279|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
126113321|NCT04178967|453711280|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
126113322|NCT04178967|453711281|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
126113323|NCT04178967|453711282|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126113324|NCT04178967|453711283|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126113325|NCT04178967|453711284|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126113326|NCT04178967|453711274|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113327|NCT04178967|453711275|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113328|NCT04178967|453711276|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113329|NCT04178967|453711277|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113330|NCT04178967|453711278|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113331|NCT04178967|453711279|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113332|NCT04178967|453711280|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113333|NCT04178967|453711281|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113334|NCT04178967|453711282|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
126113335|NCT04178967|453711283|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
126113336|NCT04178967|453711284|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
126113337|NCT04178967|453711274|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126113338|NCT04178967|453711275|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126113339|NCT04178967|453711276|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126113340|NCT04178967|453711277|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126113341|NCT04178967|453711278|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126113342|NCT04178967|453711279|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126113343|NCT04178967|453711280|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126113344|NCT04178967|453711281|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126113345|NCT04178967|453711282|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
126113346|NCT04178967|453711283|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
126113347|NCT04178967|453711284|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
126113348|NCT04178967|453711274|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113349|NCT04178967|453711275|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113350|NCT04178967|453711276|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125930922|NCT01985867|453042398|FG001|Overall Study|Lost to Follow-up|4|||
125930923|NCT01985867|453042397|FG000|Overall Study|Adverse Event|3|||
125930924|NCT01985867|453042398|FG001|Overall Study|Adverse Event|2|||
125930925|NCT01985867|453042397|FG000|Overall Study|Lack of Efficacy|1|||
125930926|NCT01985867|453042398|FG001|Overall Study|Lack of Efficacy|0|||
125930927|NCT00211809|453042403|FG000|Overall Study|Lack of Efficacy|1|||
125930928|NCT00211809|453042403|FG000|Overall Study|Lost to Follow-up|2|||
125930929|NCT00211809|453042403|FG000|Overall Study|Pregnancy|1|||
125930930|NCT00211809|453042403|FG000|Overall Study|side effects|2|||
125930931|NCT04294472|453042404|FG000|Overall Study|Adverse Event|0|||
125930932|NCT04294472|453042405|FG001|Overall Study|Adverse Event|1|||
125930933|NCT04294472|453042406|FG002|Overall Study|Adverse Event|1|||
125930934|NCT04294472|453042404|FG000|Overall Study|Randomized but not treated|0|||
125930935|NCT04294472|453042405|FG001|Overall Study|Randomized but not treated|1|||
125930936|NCT04294472|453042406|FG002|Overall Study|Randomized but not treated|1|||
125930937|NCT02603419|453042412|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125930938|NCT02603419|453042413|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
125930939|NCT02603419|453042414|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125930940|NCT02603419|453042415|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125930941|NCT02603419|453042416|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125930942|NCT02603419|453042417|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125930943|NCT02603419|453042412|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
125930944|NCT02603419|453042413|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
125930945|NCT02603419|453042414|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
125930946|NCT02603419|453042415|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
125930947|NCT02603419|453042416|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
125930948|NCT02603419|453042417|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
125930949|NCT02603419|453042412|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
125930950|NCT02603419|453042413|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
125930951|NCT02603419|453042414|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
125930952|NCT02603419|453042415|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
125930953|NCT02603419|453042416|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
125930954|NCT02603419|453042417|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
125930955|NCT02603419|453042412|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125930956|NCT02603419|453042413|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125930957|NCT02603419|453042414|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125930958|NCT02603419|453042415|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
126065983|NCT01730118|453533440|FG006|Dose Expansion|Disease progression|0|||
125930959|NCT02603419|453042416|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
125930960|NCT02603419|453042417|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125930961|NCT02603419|453042412|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125930962|NCT02603419|453042413|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
125930963|NCT02603419|453042414|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125930964|NCT02603419|453042415|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125930965|NCT02603419|453042416|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125930966|NCT02603419|453042417|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125930967|NCT02603419|453042412|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
125930968|NCT02603419|453042413|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
125930969|NCT02603419|453042414|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
125930970|NCT02603419|453042415|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
125930971|NCT02603419|453042416|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
125930972|NCT02603419|453042417|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
125930973|NCT02603419|453042412|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125930974|NCT02603419|453042413|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125930975|NCT02603419|453042414|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125930976|NCT02603419|453042415|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
125930977|NCT02603419|453042416|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125930978|NCT02603419|453042417|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125930979|NCT02603419|453042412|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125930980|NCT02603419|453042413|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125930981|NCT02603419|453042414|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125930982|NCT02603419|453042415|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125930983|NCT02603419|453042416|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125930984|NCT02603419|453042417|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
125930985|NCT02603419|453042412|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125930986|NCT02603419|453042413|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
126065984|NCT01730118|453533434|FG000|Dose Expansion|Inability to return|0|||
126113351|NCT04178967|453711277|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113352|NCT04178967|453711278|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113353|NCT04178967|453711279|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113354|NCT04178967|453711280|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113355|NCT04178967|453711281|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113356|NCT04178967|453711282|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113357|NCT04178967|453711283|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
126113358|NCT04178967|453711284|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126113359|NCT04178967|453711274|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126113360|NCT04178967|453711275|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126113361|NCT04178967|453711276|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126113362|NCT04178967|453711277|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126113363|NCT04178967|453711278|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126113364|NCT04178967|453711279|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126113365|NCT04178967|453711280|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126113366|NCT04178967|453711281|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126113367|NCT04178967|453711282|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
126113368|NCT04178967|453711283|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
126113369|NCT04178967|453711284|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
126113370|NCT04178967|453711274|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113371|NCT04178967|453711275|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113372|NCT04178967|453711276|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113373|NCT04178967|453711277|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113374|NCT04178967|453711278|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113375|NCT04178967|453711279|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113376|NCT04178967|453711280|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113377|NCT04178967|453711281|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113378|NCT04178967|453711282|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113379|NCT04178967|453711283|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
126113380|NCT04178967|453711284|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126113381|NCT04178967|453711274|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113382|NCT04178967|453711275|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113383|NCT04178967|453711276|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113384|NCT04178967|453711277|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113385|NCT04178967|453711278|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113386|NCT04178967|453711279|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113387|NCT04178967|453711280|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113388|NCT04178967|453711281|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113389|NCT04178967|453711282|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113390|NCT04178967|453711283|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
126113391|NCT04178967|453711284|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126113392|NCT03681951|453711285|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
126113393|NCT03681951|453711286|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126113394|NCT03681951|453711287|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126113395|NCT03681951|453711288|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125930987|NCT02603419|453042414|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125930988|NCT02603419|453042415|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125930989|NCT02603419|453042416|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125930990|NCT02603419|453042417|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
125930991|NCT02603419|453042412|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125930992|NCT02603419|453042413|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125930993|NCT02603419|453042414|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125930994|NCT02603419|453042415|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125930995|NCT02603419|453042416|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125930996|NCT02603419|453042417|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
125930997|NCT02289417|453042419|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
125930998|NCT02289417|453042420|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125930999|NCT02289417|453042421|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
125931000|NCT02289417|453042422|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125931001|NCT02289417|453042423|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125931002|NCT02289417|453042424|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125931003|NCT02289417|453042425|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125931004|NCT02289417|453042426|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125931005|NCT02289417|453042427|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125931006|NCT02289417|453042419|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
125931007|NCT02289417|453042420|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
125931008|NCT02289417|453042421|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
125931009|NCT02289417|453042422|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125931010|NCT02289417|453042423|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125931011|NCT02289417|453042424|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125931012|NCT02289417|453042425|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125931013|NCT02289417|453042426|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125931014|NCT02289417|453042427|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125931015|NCT02289417|453042419|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125931016|NCT02289417|453042420|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
125931017|NCT02289417|453042421|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125931018|NCT02289417|453042422|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125931019|NCT02289417|453042423|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125931020|NCT02289417|453042424|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125931021|NCT02289417|453042425|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125931022|NCT02289417|453042426|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125931023|NCT02289417|453042427|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125931024|NCT02289417|453042419|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
125931025|NCT02289417|453042420|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125931026|NCT02289417|453042421|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125931027|NCT02289417|453042422|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125931028|NCT02289417|453042423|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125931029|NCT02289417|453042424|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125931030|NCT02289417|453042425|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125931031|NCT02289417|453042426|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125931032|NCT02289417|453042427|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125931033|NCT02289417|453042419|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
125931034|NCT02289417|453042420|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
125931035|NCT02289417|453042421|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
125931036|NCT02289417|453042422|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
125931037|NCT02289417|453042423|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
125931038|NCT02289417|453042424|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
125931039|NCT02289417|453042425|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
125931040|NCT02289417|453042426|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
125931041|NCT02289417|453042427|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
125931042|NCT02289417|453042419|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125931043|NCT02289417|453042420|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125931044|NCT02289417|453042421|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
125931045|NCT02289417|453042422|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125931046|NCT02289417|453042423|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125931047|NCT02289417|453042424|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125931048|NCT02289417|453042425|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125931049|NCT02289417|453042426|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125931050|NCT02289417|453042427|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125931051|NCT02289417|453042419|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
125931052|NCT02289417|453042420|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
125931053|NCT02289417|453042421|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
125931054|NCT02289417|453042422|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
125931055|NCT02289417|453042423|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
125931056|NCT02289417|453042424|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
125931057|NCT02289417|453042425|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
125931058|NCT02289417|453042426|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
125931059|NCT02289417|453042427|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
125931060|NCT02289417|453042419|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125931061|NCT02289417|453042420|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125931062|NCT02289417|453042421|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
125931063|NCT02289417|453042422|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125931064|NCT02289417|453042423|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
125931065|NCT02289417|453042424|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
125931066|NCT02289417|453042425|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125931067|NCT02289417|453042426|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125931068|NCT02289417|453042427|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125931069|NCT02289417|453042419|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125931070|NCT02289417|453042420|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125931071|NCT02289417|453042421|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125931072|NCT02289417|453042422|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125931073|NCT02289417|453042423|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125931074|NCT02289417|453042424|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125931075|NCT02289417|453042425|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
125931076|NCT02289417|453042426|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125931077|NCT02289417|453042427|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125931078|NCT02289417|453042419|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125931079|NCT02289417|453042420|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125931080|NCT02289417|453042421|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125931081|NCT02289417|453042422|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
125931082|NCT02289417|453042423|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125931083|NCT02289417|453042424|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125931084|NCT02289417|453042425|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
125931085|NCT02289417|453042426|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125931086|NCT02289417|453042427|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125931087|NCT02289417|453042419|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
125931088|NCT02289417|453042420|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
125931089|NCT02289417|453042421|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
125931090|NCT02289417|453042422|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
125931091|NCT02289417|453042423|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
125931092|NCT02289417|453042424|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
125931093|NCT02289417|453042425|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
125931094|NCT02289417|453042426|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
125931095|NCT02289417|453042427|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
125931096|NCT02289417|453042419|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125931097|NCT02289417|453042420|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125931098|NCT02289417|453042421|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125931099|NCT02289417|453042422|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125931100|NCT02289417|453042423|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125931101|NCT02289417|453042424|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125931102|NCT02289417|453042425|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125931103|NCT02289417|453042426|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
125931104|NCT02289417|453042427|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
125931105|NCT02289417|453042419|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125931106|NCT02289417|453042420|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125931107|NCT02289417|453042421|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125931108|NCT02289417|453042422|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125931109|NCT02289417|453042423|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125931110|NCT02289417|453042424|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125931111|NCT02289417|453042425|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125931112|NCT02289417|453042426|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
125931113|NCT02289417|453042427|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
125931114|NCT02289417|453042419|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
125931115|NCT02289417|453042420|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
125931116|NCT02289417|453042421|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
125931117|NCT02289417|453042422|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
125931118|NCT02289417|453042423|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
125931119|NCT02289417|453042424|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
125931120|NCT02289417|453042425|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
125931121|NCT02289417|453042426|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
125931122|NCT02289417|453042427|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
125931123|NCT04786990|453042428|FG000|Overall Study|Withdrawal by Subject|1|||
125931124|NCT04786990|453042428|FG000|Overall Study|Adverse Event|1|||
125931125|NCT04786990|453042428|FG000|Overall Study|Lost to Follow-up|1|||
125931126|NCT04786990|453042428|FG000|Overall Study|Noncompliance|1|||
125931127|NCT04786990|453042428|FG000|Overall Study|Unable to complete site visits|1|||
125931128|NCT04786990|453042428|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
125931129|NCT01782222|453042431|FG000|Overall Study|Adverse Event|4|||
125931130|NCT01782222|453042432|FG001|Overall Study|Adverse Event|5|||
125931131|NCT01782222|453042433|FG002|Overall Study|Adverse Event|3|||
125931132|NCT01782222|453042431|FG000|Overall Study|Lack of Efficacy|2|||
125931133|NCT01782222|453042432|FG001|Overall Study|Lack of Efficacy|1|||
125931134|NCT01782222|453042433|FG002|Overall Study|Lack of Efficacy|0|||
125931135|NCT01782222|453042431|FG000|Overall Study|Protocol Violation|1|||
125931136|NCT01782222|453042432|FG001|Overall Study|Protocol Violation|0|||
125931137|NCT01782222|453042433|FG002|Overall Study|Protocol Violation|0|||
125931138|NCT01782222|453042431|FG000|Overall Study|Withdrawal by Subject|1|||
125931139|NCT01782222|453042432|FG001|Overall Study|Withdrawal by Subject|4|||
125931140|NCT01782222|453042433|FG002|Overall Study|Withdrawal by Subject|1|||
125931141|NCT01782222|453042431|FG000|Overall Study|Moved to other state|0|||
125931142|NCT01782222|453042432|FG001|Overall Study|Moved to other state|1|||
125931143|NCT01782222|453042433|FG002|Overall Study|Moved to other state|0|||
125931144|NCT01756898|453042437|FG000|Overall Study|Adverse Event|7|||
125931145|NCT01756898|453042438|FG001|Overall Study|Adverse Event|1|||
125931146|NCT01756898|453042439|FG002|Overall Study|Adverse Event|0|||
125931147|NCT01756898|453042440|FG003|Overall Study|Adverse Event|0|||
125931148|NCT01756898|453042437|FG000|Overall Study|Lack of Efficacy|4|||
125931149|NCT01756898|453042438|FG001|Overall Study|Lack of Efficacy|7|||
125931150|NCT01756898|453042439|FG002|Overall Study|Lack of Efficacy|6|||
125931151|NCT01756898|453042440|FG003|Overall Study|Lack of Efficacy|6|||
125931152|NCT01756898|453042437|FG000|Overall Study|Lost to Follow-up|2|||
125931153|NCT01756898|453042438|FG001|Overall Study|Lost to Follow-up|4|||
125931154|NCT01756898|453042439|FG002|Overall Study|Lost to Follow-up|2|||
125931155|NCT01756898|453042440|FG003|Overall Study|Lost to Follow-up|3|||
125931156|NCT01756898|453042437|FG000|Overall Study|Protocol Violation|1|||
125931157|NCT01756898|453042438|FG001|Overall Study|Protocol Violation|2|||
125931158|NCT01756898|453042439|FG002|Overall Study|Protocol Violation|2|||
125931159|NCT01756898|453042440|FG003|Overall Study|Protocol Violation|1|||
125931160|NCT01756898|453042437|FG000|Overall Study|Withdrew Consent|5|||
125931161|NCT01756898|453042438|FG001|Overall Study|Withdrew Consent|3|||
125931162|NCT01756898|453042439|FG002|Overall Study|Withdrew Consent|5|||
125931163|NCT01756898|453042440|FG003|Overall Study|Withdrew Consent|6|||
125931164|NCT01756898|453042437|FG000|Overall Study|Other|0|||
125931165|NCT01756898|453042438|FG001|Overall Study|Other|2|||
125931166|NCT01756898|453042439|FG002|Overall Study|Other|2|||
125931167|NCT01756898|453042440|FG003|Overall Study|Other|0|||
125931168|NCT01500694|453042441|FG000|Overall Study|Adverse Event|4|||
125931169|NCT01500694|453042442|FG001|Overall Study|Adverse Event|3|||
125931170|NCT01500694|453042441|FG000|Overall Study|Protocol Violation|0|||
125931171|NCT01500694|453042442|FG001|Overall Study|Protocol Violation|1|||
125931172|NCT01500694|453042441|FG000|Overall Study|Withdrawal by Subject|23|||
125931173|NCT01500694|453042442|FG001|Overall Study|Withdrawal by Subject|14|||
125931174|NCT01500694|453042441|FG000|Overall Study|Lost to Follow-up|2|||
125931175|NCT01500694|453042442|FG001|Overall Study|Lost to Follow-up|3|||
125931176|NCT01500694|453042441|FG000|Overall Study|Lack of Efficacy|14|||
125931177|NCT01500694|453042442|FG001|Overall Study|Lack of Efficacy|5|||
125931178|NCT01500694|453042441|FG000|Overall Study|Other|9|||
125931179|NCT01500694|453042442|FG001|Overall Study|Other|3|||
125931180|NCT00496054|453042445|FG000|Overall Study|Adverse Event|1|||
125931181|NCT00496054|453042445|FG000|Overall Study|Lost to Follow-up|7|||
125931182|NCT03572062|453042448|FG000|Overall Study|Adverse Event|0|||
125931183|NCT03572062|453042449|FG001|Overall Study|Adverse Event|0|||
125931184|NCT03572062|453042450|FG002|Overall Study|Adverse Event|0|||
125931185|NCT03572062|453042451|FG003|Overall Study|Adverse Event|0|||
125931186|NCT03572062|453042452|FG004|Overall Study|Adverse Event|0|||
125931187|NCT03572062|453042453|FG005|Overall Study|Adverse Event|0|||
125931188|NCT03572062|453042454|FG006|Overall Study|Adverse Event|0|||
125931189|NCT03572062|453042455|FG007|Overall Study|Adverse Event|0|||
125931190|NCT03572062|453042456|FG008|Overall Study|Adverse Event|1|||
125931191|NCT03572062|453042457|FG009|Overall Study|Adverse Event|3|||
125931192|NCT03572062|453042448|FG000|Overall Study|Death|0|||
125931193|NCT03572062|453042449|FG001|Overall Study|Death|0|||
125931194|NCT03572062|453042450|FG002|Overall Study|Death|0|||
125931195|NCT03572062|453042451|FG003|Overall Study|Death|0|||
125931196|NCT03572062|453042452|FG004|Overall Study|Death|0|||
125931197|NCT03572062|453042453|FG005|Overall Study|Death|1|||
125931198|NCT03572062|453042454|FG006|Overall Study|Death|0|||
125931199|NCT03572062|453042455|FG007|Overall Study|Death|0|||
125931200|NCT03572062|453042456|FG008|Overall Study|Death|0|||
125931201|NCT03572062|453042457|FG009|Overall Study|Death|0|||
125931202|NCT03572062|453042448|FG000|Overall Study|Lost to Follow-up|0|||
126113396|NCT03681951|453711289|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126113397|NCT03681951|453711290|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126113398|NCT03681951|453711291|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126113399|NCT03681951|453711292|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126113400|NCT03681951|453711285|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
126113401|NCT03681951|453711286|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126113402|NCT03681951|453711287|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126113403|NCT03681951|453711288|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125931203|NCT03572062|453042449|FG001|Overall Study|Lost to Follow-up|0|||
125931204|NCT03572062|453042450|FG002|Overall Study|Lost to Follow-up|0|||
125931205|NCT03572062|453042451|FG003|Overall Study|Lost to Follow-up|0|||
125931206|NCT03572062|453042452|FG004|Overall Study|Lost to Follow-up|0|||
125931207|NCT03572062|453042453|FG005|Overall Study|Lost to Follow-up|1|||
125931208|NCT03572062|453042454|FG006|Overall Study|Lost to Follow-up|1|||
125931209|NCT03572062|453042455|FG007|Overall Study|Lost to Follow-up|0|||
125931210|NCT03572062|453042456|FG008|Overall Study|Lost to Follow-up|0|||
125931211|NCT03572062|453042457|FG009|Overall Study|Lost to Follow-up|0|||
125931212|NCT03572062|453042448|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125931213|NCT03572062|453042449|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125931214|NCT03572062|453042450|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125931215|NCT03572062|453042451|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125931216|NCT03572062|453042452|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
126113404|NCT03681951|453711289|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126113405|NCT03681951|453711290|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126113406|NCT03681951|453711291|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126113407|NCT03681951|453711292|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126113408|NCT03681951|453711285|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
126113409|NCT03681951|453711286|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126113410|NCT03681951|453711287|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126113411|NCT03681951|453711288|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126113412|NCT03681951|453711289|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126113413|NCT03681951|453711290|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126113414|NCT03681951|453711291|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126113415|NCT03681951|453711292|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126113416|NCT00628251|453711293|FG000|Randomised Part|Withdrawal by Subject|0|||
126113417|NCT00628251|453711294|FG001|Randomised Part|Withdrawal by Subject|0|||
126113418|NCT00628251|453711295|FG002|Randomised Part|Withdrawal by Subject|1|||
126113419|NCT00628251|453711293|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
126113420|NCT00628251|453711294|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
126113421|NCT00628251|453711295|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
126113422|NCT00628251|453711293|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
126113423|NCT00628251|453711294|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
126113424|NCT00628251|453711295|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
126113425|NCT00628251|453711293|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
126113426|NCT00628251|453711294|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
126113427|NCT00628251|453711295|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
126113428|NCT00628251|453711293|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
126113429|NCT00628251|453711294|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
126113430|NCT00628251|453711295|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
126113431|NCT00628251|453711293|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
126113432|NCT00628251|453711294|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
126113433|NCT00628251|453711295|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
126113434|NCT01020448|453711296|FG000|Pre-assignment|Adverse Event|6|||
126113435|NCT01020448|453711296|FG000|Pre-assignment|Withdrawal by Subject|5|||
126113436|NCT01020448|453711296|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
126113437|NCT01020448|453711296|FG000|Treatment|Adverse Event|11|||
126113438|NCT01020448|453711296|FG000|Treatment|Consent Withdrawn|3|||
126113439|NCT01020448|453711296|FG000|Treatment|Disease Progression|2|||
126113440|NCT01020448|453711296|FG000|Treatment|Lack of Efficacy|8|||
126113441|NCT01020448|453711296|FG000|Treatment|Lost to Follow-up|2|||
126113442|NCT00041067|453711297|FG000|Overall Study|Adverse Event|20|||
126113443|NCT00041067|453711297|FG000|Overall Study|Progression|19|||
126113444|NCT00041067|453711297|FG000|Overall Study|Patient refusal|12|||
126113445|NCT00041067|453711297|FG000|Overall Study|Other reasons|23|||
126113446|NCT00041067|453711297|FG000|Overall Study|Ineligible|2|||
126113447|NCT01968070|453711299|FG000|Period 1|Withdrawal by Subject|0|||
126113448|NCT01968070|453711300|FG001|Period 1|Withdrawal by Subject|1|||
126113449|NCT01968070|453711301|FG002|Period 1|Withdrawal by Subject|0|||
126113450|NCT01968070|453711302|FG003|Period 1|Withdrawal by Subject|0|||
126113451|NCT01968070|453711303|FG004|Period 1|Withdrawal by Subject|0|||
126113452|NCT01968070|453711304|FG005|Period 1|Withdrawal by Subject|0|||
126113453|NCT01968070|453711305|FG006|Period 1|Withdrawal by Subject|1|||
126113454|NCT01968070|453711306|FG007|Period 1|Withdrawal by Subject|0|||
126113455|NCT01968070|453711307|FG008|Period 1|Withdrawal by Subject|0|||
126113456|NCT01968070|453711308|FG009|Period 1|Withdrawal by Subject|0|||
126113457|NCT01968070|453711309|FG010|Period 1|Withdrawal by Subject|0|||
126113458|NCT01968070|453711310|FG011|Period 1|Withdrawal by Subject|0|||
126113459|NCT01968070|453711311|FG012|Period 1|Withdrawal by Subject|0|||
125931217|NCT03572062|453042453|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125931218|NCT03572062|453042454|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
125931219|NCT03572062|453042455|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125931220|NCT03572062|453042456|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
125931221|NCT03572062|453042457|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
126113460|NCT01968070|453711312|FG013|Period 1|Withdrawal by Subject|0|||
126113461|NCT01968070|453711313|FG014|Period 1|Withdrawal by Subject|0|||
126113462|NCT01968070|453711314|FG015|Period 1|Withdrawal by Subject|1|||
126113463|NCT01968070|453711315|FG016|Period 1|Withdrawal by Subject|0|||
126113464|NCT01968070|453711316|FG017|Period 1|Withdrawal by Subject|0|||
126113465|NCT01968070|453711299|FG000|Period 1|Protocol Violation|0|||
125931222|NCT03572062|453042448|FG000|Overall Study|Study Terminated By Sponsor|0|||
126113466|NCT01968070|453711300|FG001|Period 1|Protocol Violation|0|||
125931223|NCT03572062|453042449|FG001|Overall Study|Study Terminated By Sponsor|0|||
125931224|NCT03572062|453042450|FG002|Overall Study|Study Terminated By Sponsor|0|||
125931225|NCT03572062|453042451|FG003|Overall Study|Study Terminated By Sponsor|0|||
125931226|NCT03572062|453042452|FG004|Overall Study|Study Terminated By Sponsor|0|||
125931227|NCT03572062|453042453|FG005|Overall Study|Study Terminated By Sponsor|0|||
125931228|NCT03572062|453042454|FG006|Overall Study|Study Terminated By Sponsor|0|||
125931229|NCT03572062|453042455|FG007|Overall Study|Study Terminated By Sponsor|0|||
125931230|NCT03572062|453042456|FG008|Overall Study|Study Terminated By Sponsor|29|||
125931231|NCT03572062|453042457|FG009|Overall Study|Study Terminated By Sponsor|27|||
125931232|NCT03572062|453042448|FG000|Overall Study|Physician Decision|0|||
125931233|NCT03572062|453042449|FG001|Overall Study|Physician Decision|0|||
125931234|NCT03572062|453042450|FG002|Overall Study|Physician Decision|0|||
125931235|NCT03572062|453042451|FG003|Overall Study|Physician Decision|0|||
125931236|NCT03572062|453042452|FG004|Overall Study|Physician Decision|0|||
125931237|NCT03572062|453042453|FG005|Overall Study|Physician Decision|0|||
125931238|NCT03572062|453042454|FG006|Overall Study|Physician Decision|0|||
125931239|NCT03572062|453042455|FG007|Overall Study|Physician Decision|0|||
125931240|NCT03572062|453042456|FG008|Overall Study|Physician Decision|1|||
125931241|NCT03572062|453042457|FG009|Overall Study|Physician Decision|0|||
125931242|NCT03572062|453042448|FG000|Overall Study|Withdrawal by Subject|0|||
125931243|NCT03572062|453042449|FG001|Overall Study|Withdrawal by Subject|0|||
125931244|NCT03572062|453042450|FG002|Overall Study|Withdrawal by Subject|0|||
125931245|NCT03572062|453042451|FG003|Overall Study|Withdrawal by Subject|0|||
125931246|NCT03572062|453042452|FG004|Overall Study|Withdrawal by Subject|0|||
125931247|NCT03572062|453042453|FG005|Overall Study|Withdrawal by Subject|0|||
125931248|NCT03572062|453042454|FG006|Overall Study|Withdrawal by Subject|0|||
125931249|NCT03572062|453042455|FG007|Overall Study|Withdrawal by Subject|0|||
125931250|NCT03572062|453042456|FG008|Overall Study|Withdrawal by Subject|0|||
125931251|NCT03572062|453042457|FG009|Overall Study|Withdrawal by Subject|1|||
125931252|NCT03572062|453042448|FG000|Overall Study|Randomized But Not Treated|0|||
125931253|NCT03572062|453042449|FG001|Overall Study|Randomized But Not Treated|0|||
125931254|NCT03572062|453042450|FG002|Overall Study|Randomized But Not Treated|0|||
125931255|NCT03572062|453042451|FG003|Overall Study|Randomized But Not Treated|0|||
125931256|NCT03572062|453042452|FG004|Overall Study|Randomized But Not Treated|1|||
125931257|NCT03572062|453042453|FG005|Overall Study|Randomized But Not Treated|2|||
125931258|NCT03572062|453042454|FG006|Overall Study|Randomized But Not Treated|0|||
125931259|NCT03572062|453042455|FG007|Overall Study|Randomized But Not Treated|1|||
125931260|NCT03572062|453042456|FG008|Overall Study|Randomized But Not Treated|0|||
125931261|NCT03572062|453042457|FG009|Overall Study|Randomized But Not Treated|0|||
125931262|NCT01858389|453042458|FG000|Overall Study|Death|1|||
125931263|NCT01858389|453042459|FG001|Overall Study|Death|3|||
125931264|NCT01858389|453042458|FG000|Overall Study|Study terminated by sponsor|0|||
125931265|NCT01858389|453042459|FG001|Overall Study|Study terminated by sponsor|2|||
125931266|NCT01858389|453042458|FG000|Overall Study|Withdrawal by Subject|0|||
125931267|NCT01858389|453042459|FG001|Overall Study|Withdrawal by Subject|1|||
125931268|NCT01858389|453042458|FG000|Overall Study|Progressive disease|10|||
125931269|NCT01858389|453042459|FG001|Overall Study|Progressive disease|11|||
125931270|NCT01858389|453042458|FG000|Overall Study|Other|2|||
125931271|NCT01858389|453042459|FG001|Overall Study|Other|4|||
125931272|NCT01858389|453042458|FG000|Overall Study|Adverse Event|3|||
125931273|NCT01858389|453042459|FG001|Overall Study|Adverse Event|1|||
125931274|NCT01858389|453042458|FG000|Overall Study|Did not receive treatment|0|||
125931275|NCT01858389|453042459|FG001|Overall Study|Did not receive treatment|3|||
125931276|NCT00471328|453042460|FG000|Core Phase|Adverse Event|18|||
125931277|NCT00471328|453042461|FG001|Core Phase|Adverse Event|6|||
125931278|NCT00471328|453042460|FG000|Core Phase|Death|8|||
125931279|NCT00471328|453042461|FG001|Core Phase|Death|4|||
125931280|NCT00471328|453042460|FG000|Core Phase|Withdrawal by Subject|2|||
125931281|NCT00471328|453042461|FG001|Core Phase|Withdrawal by Subject|2|||
125931282|NCT00471328|453042460|FG000|Core Phase|Abnormal laboratory value|1|||
126065985|NCT01730118|453533435|FG001|Dose Expansion|Inability to return|0|||
126065986|NCT01730118|453533436|FG002|Dose Expansion|Inability to return|0|||
126065987|NCT01730118|453533437|FG003|Dose Expansion|Inability to return|0|||
125931283|NCT00471328|453042461|FG001|Core Phase|Abnormal laboratory value|0|||
125931284|NCT00471328|453042460|FG000|Core Phase|Disease Progression|78|||
125931285|NCT00471328|453042461|FG001|Core Phase|Disease Progression|53|||
125931286|NCT00471328|453042460|FG000|Core Phase|Administrative Problem|0|||
125931287|NCT00471328|453042461|FG001|Core Phase|Administrative Problem|1|||
125931288|NCT00471328|453042460|FG000|Core Phase|Protocol Deviation|0|||
125931289|NCT00471328|453042461|FG001|Core Phase|Protocol Deviation|1|||
125931290|NCT00471328|453042460|FG000|Extension Phase|Adverse Event|3|||
125931291|NCT00471328|453042461|FG001|Extension Phase|Adverse Event|12|||
125931292|NCT00471328|453042460|FG000|Extension Phase|Withdrawal by Subject|0|||
125931293|NCT00471328|453042461|FG001|Extension Phase|Withdrawal by Subject|2|||
125931294|NCT00471328|453042460|FG000|Extension Phase|Death|1|||
125931295|NCT00471328|453042461|FG001|Extension Phase|Death|7|||
125931296|NCT00471328|453042460|FG000|Extension Phase|Protocol Deviation|3|||
125931297|NCT00471328|453042461|FG001|Extension Phase|Protocol Deviation|1|||
125931298|NCT00471328|453042460|FG000|Extension Phase|Treatment duration as per protocol|0|||
126113467|NCT01968070|453711301|FG002|Period 1|Protocol Violation|0|||
125931299|NCT00471328|453042461|FG001|Extension Phase|Treatment duration as per protocol|1|||
125931300|NCT00471328|453042460|FG000|Extension Phase|Disease Progression|32|||
125931301|NCT00471328|453042461|FG001|Extension Phase|Disease Progression|44|||
125931302|NCT00471328|453042460|FG000|Extension Phase|New cancer Therapy|1|||
125931303|NCT00471328|453042461|FG001|Extension Phase|New cancer Therapy|0|||
125931304|NCT00471328|453042460|FG000|Extension Phase|Administrative Problem|1|||
125931305|NCT00471328|453042461|FG001|Extension Phase|Administrative Problem|0|||
125931306|NCT04051008|453042462|FG000|Overall Study|Withdrawal by Subject|2|||
125931307|NCT04051008|453042463|FG001|Overall Study|Withdrawal by Subject|0|||
125931308|NCT04051008|453042464|FG002|Overall Study|Withdrawal by Subject|1|||
125931309|NCT00458211|453042465|FG000|Overall Study|Lack of Efficacy|12|||
125931310|NCT00458211|453042465|FG000|Overall Study|Withdrawal by Subject|2|||
125931311|NCT00458211|453042465|FG000|Overall Study|Protocol Violation|2|||
125931312|NCT00687323|453042471|FG000|Overall Study|Death|25|||
125931313|NCT00687323|453042471|FG000|Overall Study|Withdrawal by Subject|1|||
125931314|NCT00687323|453042471|FG000|Overall Study|Excluded from efficacy evaluations|6|||
125931315|NCT00687323|453042471|FG000|Overall Study|Screen failure|148|||
125931316|NCT02132130|453042472|FG000|Overall Study|Lost to Follow-up|0|||
125931317|NCT02132130|453042473|FG001|Overall Study|Lost to Follow-up|2|||
125931318|NCT02132130|453042474|FG002|Overall Study|Lost to Follow-up|0|||
125931319|NCT02132130|453042475|FG003|Overall Study|Lost to Follow-up|0|||
125931320|NCT02132130|453042472|FG000|Overall Study|Withdrawal by Subject|0|||
125931321|NCT02132130|453042473|FG001|Overall Study|Withdrawal by Subject|0|||
125931322|NCT02132130|453042474|FG002|Overall Study|Withdrawal by Subject|0|||
125931323|NCT02132130|453042475|FG003|Overall Study|Withdrawal by Subject|1|||
125931324|NCT03310775|453042478|FG000|Overall Study|Lost to Follow-up|2|||
125931325|NCT03310775|453042479|FG001|Overall Study|Lost to Follow-up|3|||
125931326|NCT03310775|453042478|FG000|Overall Study|aggravation of depression|0|||
125931327|NCT03310775|453042479|FG001|Overall Study|aggravation of depression|1|||
125931328|NCT00838578|453042484|FG000|Overall Study|Protocol Violation|2|||
125931329|NCT00646776|453042485|FG000|Overall Study|Adverse Event|1|||
125931330|NCT00646776|453042486|FG001|Overall Study|Adverse Event|9|||
125931331|NCT00646776|453042485|FG000|Overall Study|Investigator discretion|0|||
125931332|NCT00646776|453042486|FG001|Overall Study|Investigator discretion|4|||
125931333|NCT00126568|453042487|FG000|Overall Study|Death|2|||
125931334|NCT00580606|453042491|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
125931335|NCT00580606|453042492|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
125931336|NCT00580606|453042491|FG000|Open Label (OL)|Withdrawal by Subject|4|||
125931337|NCT00580606|453042492|FG001|Open Label (OL)|Withdrawal by Subject|6|||
125931338|NCT00580606|453042491|FG000|Open Label (OL)|Dosing Symptoms|0|||
125931339|NCT00580606|453042492|FG001|Open Label (OL)|Dosing Symptoms|1|||
125931340|NCT00580606|453042491|FG000|Open Label (OL)|Lost to Follow-up|0|||
125931341|NCT00580606|453042492|FG001|Open Label (OL)|Lost to Follow-up|1|||
125931342|NCT00580606|453042491|FG000|Open Label (OL)|Pregnancy|0|||
125931343|NCT00580606|453042492|FG001|Open Label (OL)|Pregnancy|1|||
125931344|NCT00580606|453042491|FG000|Open Label (OL)|Non-compliance|2|||
125931345|NCT00580606|453042492|FG001|Open Label (OL)|Non-compliance|0|||
125931346|NCT00580606|453042491|FG000|Open Label (OL)|Physician Decision|1|||
125931347|NCT00580606|453042492|FG001|Open Label (OL)|Physician Decision|1|||
125931348|NCT00580606|453042491|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
125931349|NCT00580606|453042492|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
125931350|NCT05353985|453042493|FG000|Overall Study|Adverse Event|5|||
125931351|NCT05353985|453042494|FG001|Overall Study|Adverse Event|7|||
125931352|NCT05353985|453042493|FG000|Overall Study|Lost to Follow-up|1|||
125931353|NCT05353985|453042494|FG001|Overall Study|Lost to Follow-up|1|||
125931354|NCT05353985|453042493|FG000|Overall Study|Protocol Violation|1|||
125931355|NCT05353985|453042494|FG001|Overall Study|Protocol Violation|0|||
125931356|NCT05353985|453042493|FG000|Overall Study|Withdrawal by Subject|13|||
125931357|NCT05353985|453042494|FG001|Overall Study|Withdrawal by Subject|17|||
125931358|NCT05353985|453042493|FG000|Overall Study|Reason Not Specified|1|||
125931359|NCT05353985|453042494|FG001|Overall Study|Reason Not Specified|0|||
125931360|NCT05353985|453042493|FG000|Overall Study|Randomized in Error & Not Treated|0|||
125931361|NCT05353985|453042494|FG001|Overall Study|Randomized in Error & Not Treated|1|||
125931362|NCT04847557|453042495|FG000|Overall Study|Adverse Event|1|||
125931363|NCT04847557|453042496|FG001|Overall Study|Adverse Event|0|||
125931364|NCT04847557|453042495|FG000|Overall Study|Death|19|||
125931365|NCT04847557|453042496|FG001|Overall Study|Death|15|||
125931366|NCT04847557|453042495|FG000|Overall Study|Lost to Follow-up|3|||
125931367|NCT04847557|453042496|FG001|Overall Study|Lost to Follow-up|6|||
125931368|NCT04847557|453042495|FG000|Overall Study|Physician Decision|1|||
125931369|NCT04847557|453042496|FG001|Overall Study|Physician Decision|0|||
125931370|NCT04847557|453042495|FG000|Overall Study|Protocol Violation|0|||
125931371|NCT04847557|453042496|FG001|Overall Study|Protocol Violation|1|||
125931372|NCT04847557|453042495|FG000|Overall Study|Withdrawal by Subject|8|||
125931373|NCT04847557|453042496|FG001|Overall Study|Withdrawal by Subject|14|||
125931374|NCT01549860|453044587|FG000|Overall Study|Withdrawal by Subject|1|||
125931375|NCT01549860|453044588|FG001|Overall Study|Withdrawal by Subject|0|||
126113468|NCT01968070|453711302|FG003|Period 1|Protocol Violation|1|||
126113469|NCT01968070|453711303|FG004|Period 1|Protocol Violation|1|||
126113470|NCT01968070|453711304|FG005|Period 1|Protocol Violation|0|||
126113471|NCT01968070|453711305|FG006|Period 1|Protocol Violation|0|||
126113472|NCT01968070|453711306|FG007|Period 1|Protocol Violation|0|||
126113473|NCT01968070|453711307|FG008|Period 1|Protocol Violation|0|||
126113474|NCT01968070|453711308|FG009|Period 1|Protocol Violation|0|||
126065988|NCT01730118|453533438|FG004|Dose Expansion|Inability to return|0|||
126065989|NCT01730118|453533439|FG005|Dose Expansion|Inability to return|1|||
126065990|NCT01730118|453533440|FG006|Dose Expansion|Inability to return|0|||
126065991|NCT01730118|453533434|FG000|Dose Expansion|Physician Decision|0|||
126065992|NCT01730118|453533435|FG001|Dose Expansion|Physician Decision|0|||
126065993|NCT01730118|453533436|FG002|Dose Expansion|Physician Decision|0|||
126065994|NCT01730118|453533437|FG003|Dose Expansion|Physician Decision|0|||
126065995|NCT01730118|453533438|FG004|Dose Expansion|Physician Decision|0|||
126065996|NCT01730118|453533439|FG005|Dose Expansion|Physician Decision|1|||
126065997|NCT01730118|453533440|FG006|Dose Expansion|Physician Decision|0|||
126065998|NCT00489489|453533441|FG000|Overall Study|Not treated due to protocol violation|0|||
126065999|NCT00489489|453533442|FG001|Overall Study|Not treated due to protocol violation|1|||
126066000|NCT00489489|453533443|FG002|Overall Study|Not treated due to protocol violation|1|||
126066001|NCT00489489|453533441|FG000|Overall Study|Adverse Event|1|||
126066002|NCT00489489|453533442|FG001|Overall Study|Adverse Event|1|||
126066003|NCT00489489|453533443|FG002|Overall Study|Adverse Event|1|||
126066004|NCT00489489|453533441|FG000|Overall Study|Protocol Violation|1|||
126066005|NCT00489489|453533442|FG001|Overall Study|Protocol Violation|0|||
126066006|NCT00489489|453533443|FG002|Overall Study|Protocol Violation|1|||
126066007|NCT00489489|453533441|FG000|Overall Study|Progressive disease|0|||
126066008|NCT00489489|453533442|FG001|Overall Study|Progressive disease|1|||
126066009|NCT00489489|453533443|FG002|Overall Study|Progressive disease|0|||
126066010|NCT00489489|453533441|FG000|Overall Study|Participant did not wish to continue|1|||
126066011|NCT00489489|453533442|FG001|Overall Study|Participant did not wish to continue|1|||
126066012|NCT00489489|453533443|FG002|Overall Study|Participant did not wish to continue|0|||
126066013|NCT00489489|453533441|FG000|Overall Study|Other than above|0|||
126066014|NCT00489489|453533442|FG001|Overall Study|Other than above|1|||
126066015|NCT00489489|453533443|FG002|Overall Study|Other than above|0|||
126066016|NCT04851587|453533446|FG000|Overall Study|Lost to Follow-up|18|||
126066017|NCT02101554|453533450|FG000|Overall Study|Protocol Violation|0|||
126066018|NCT02101554|453533451|FG001|Overall Study|Protocol Violation|1|||
126066019|NCT02101554|453533452|FG002|Overall Study|Protocol Violation|0|||
126066020|NCT02101554|453533450|FG000|Overall Study|Insufficient Clinical Response|0|||
126066021|NCT02101554|453533451|FG001|Overall Study|Insufficient Clinical Response|2|||
126066022|NCT02101554|453533452|FG002|Overall Study|Insufficient Clinical Response|0|||
126066023|NCT02101554|453533450|FG000|Overall Study|Adverse Event|2|||
126066024|NCT02101554|453533451|FG001|Overall Study|Adverse Event|1|||
126066025|NCT02101554|453533452|FG002|Overall Study|Adverse Event|1|||
126066026|NCT02101554|453533450|FG000|Overall Study|Lost to Follow-up|0|||
126066027|NCT02101554|453533451|FG001|Overall Study|Lost to Follow-up|1|||
126066028|NCT02101554|453533452|FG002|Overall Study|Lost to Follow-up|0|||
126066029|NCT02101554|453533450|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
126066030|NCT02101554|453533451|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
126066031|NCT02101554|453533452|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
126066032|NCT01350102|453533453|FG000|Overall Study|Adverse Event|0|||
126066033|NCT01350102|453533454|FG001|Overall Study|Adverse Event|0|||
126066034|NCT01350102|453533455|FG002|Overall Study|Adverse Event|1|||
126066035|NCT01350102|453533456|FG003|Overall Study|Adverse Event|0|||
126066036|NCT02136797|453533459|FG000|Overall Study|Not Treated|8|||
126066037|NCT04523571|453533460|FG000|Received 2 Doses|Withdrawal by Subject|0|||
126066038|NCT04523571|453533461|FG001|Received 2 Doses|Withdrawal by Subject|0|||
126066039|NCT04523571|453533462|FG002|Received 2 Doses|Withdrawal by Subject|0|||
126066040|NCT04523571|453533463|FG003|Received 2 Doses|Withdrawal by Subject|1|||
126066041|NCT04523571|453533464|FG004|Received 2 Doses|Withdrawal by Subject|1|||
126066042|NCT04523571|453533465|FG005|Received 2 Doses|Withdrawal by Subject|0|||
126066043|NCT04523571|453533460|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
126066044|NCT04523571|453533461|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
126066045|NCT04523571|453533462|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
126066046|NCT04523571|453533463|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
126066047|NCT04523571|453533464|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
126066048|NCT04523571|453533465|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
126066049|NCT04523571|453533460|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126066050|NCT04523571|453533461|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126066051|NCT04523571|453533462|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126066052|NCT04523571|453533463|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126113475|NCT01968070|453711309|FG010|Period 1|Protocol Violation|0|||
126113476|NCT01968070|453711310|FG011|Period 1|Protocol Violation|0|||
125931376|NCT01549860|453044587|FG000|Overall Study|Physician Decision|1|||
125931377|NCT01549860|453044588|FG001|Overall Study|Physician Decision|1|||
125931378|NCT01327885|453044589|FG000|Overall Study|Disease progression-according to RECIST|173|||
125931379|NCT01327885|453044590|FG001|Overall Study|Disease progression-according to RECIST|165|||
125931380|NCT01327885|453044589|FG000|Overall Study|Clinical progression|24|||
125931381|NCT01327885|453044590|FG001|Overall Study|Clinical progression|27|||
125931382|NCT01327885|453044589|FG000|Overall Study|Adverse Event|14|||
125931383|NCT01327885|453044590|FG001|Overall Study|Adverse Event|10|||
125931384|NCT01327885|453044589|FG000|Overall Study|Subject choice|5|||
126066053|NCT04523571|453533464|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126066054|NCT04523571|453533465|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
126066055|NCT04523571|453533460|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
126066056|NCT04523571|453533461|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
126066057|NCT04523571|453533462|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
126066058|NCT04523571|453533463|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
126066059|NCT04523571|453533464|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
126066060|NCT04523571|453533465|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
126066061|NCT03694210|453533467|FG000|Overall Study|Death|1|||
126066062|NCT03694210|453533467|FG000|Overall Study|Screen Failure|7|||
126066063|NCT04385849|453533468|FG000|Overall Study|Lost to Follow-up|1|||
126066064|NCT04385849|453533469|FG001|Overall Study|Lost to Follow-up|0|||
126066065|NCT01375777|453533470|FG000|Overall Study|Withdrawal by Subject|0|||
126066066|NCT01375777|453533471|FG001|Overall Study|Withdrawal by Subject|2|||
126066067|NCT01375777|453533472|FG002|Overall Study|Withdrawal by Subject|1|||
126066068|NCT01375777|453533473|FG003|Overall Study|Withdrawal by Subject|0|||
126066069|NCT01375777|453533474|FG004|Overall Study|Withdrawal by Subject|1|||
126066070|NCT01375777|453533475|FG005|Overall Study|Withdrawal by Subject|1|||
126066071|NCT01375777|453533476|FG006|Overall Study|Withdrawal by Subject|1|||
126066072|NCT01375777|453533477|FG007|Overall Study|Withdrawal by Subject|2|||
126066073|NCT01375777|453533478|FG008|Overall Study|Withdrawal by Subject|1|||
126066074|NCT01375777|453533470|FG000|Overall Study|Lost to Follow-up|1|||
126066075|NCT01375777|453533471|FG001|Overall Study|Lost to Follow-up|0|||
126066076|NCT01375777|453533472|FG002|Overall Study|Lost to Follow-up|0|||
126066077|NCT01375777|453533473|FG003|Overall Study|Lost to Follow-up|0|||
126066078|NCT01375777|453533474|FG004|Overall Study|Lost to Follow-up|0|||
126066079|NCT01375777|453533475|FG005|Overall Study|Lost to Follow-up|0|||
126066080|NCT01375777|453533476|FG006|Overall Study|Lost to Follow-up|1|||
126066081|NCT01375777|453533477|FG007|Overall Study|Lost to Follow-up|0|||
126066082|NCT01375777|453533478|FG008|Overall Study|Lost to Follow-up|0|||
126066083|NCT01375777|453533470|FG000|Overall Study|Other|1|||
126066084|NCT01375777|453533471|FG001|Overall Study|Other|1|||
126066085|NCT01375777|453533472|FG002|Overall Study|Other|0|||
126066086|NCT01375777|453533473|FG003|Overall Study|Other|0|||
126066087|NCT01375777|453533474|FG004|Overall Study|Other|0|||
126066088|NCT01375777|453533475|FG005|Overall Study|Other|0|||
126066089|NCT01375777|453533476|FG006|Overall Study|Other|0|||
126066090|NCT01375777|453533477|FG007|Overall Study|Other|0|||
126066091|NCT01375777|453533478|FG008|Overall Study|Other|1|||
126066092|NCT05878990|453533479|FG000|Overall Study|Lost to Follow-up|7|||
126066093|NCT05878990|453533479|FG000|Overall Study|Withdrawal by Subject|1|||
126066094|NCT01838499|453533484|FG000|Overall Study|Protocol Violation|0|||
126066095|NCT01838499|453533485|FG001|Overall Study|Protocol Violation|1|||
126066096|NCT01838499|453533484|FG000|Overall Study|Lost to Follow-up|2|||
126066097|NCT01838499|453533485|FG001|Overall Study|Lost to Follow-up|4|||
126066098|NCT01838499|453533484|FG000|Overall Study|Lack of Efficacy|1|||
126066099|NCT01838499|453533485|FG001|Overall Study|Lack of Efficacy|2|||
126066100|NCT01838499|453533484|FG000|Overall Study|Adverse Event|2|||
126066101|NCT01838499|453533485|FG001|Overall Study|Adverse Event|1|||
126066102|NCT01838499|453533484|FG000|Overall Study|Withdrawal by Subject|19|||
126066103|NCT01838499|453533485|FG001|Overall Study|Withdrawal by Subject|9|||
126066104|NCT03614923|453533486|FG000|Overall Study|Withdrawal by Subject|2|||
126066105|NCT03614923|453533487|FG001|Overall Study|Withdrawal by Subject|1|||
126066106|NCT03614923|453533488|FG002|Overall Study|Withdrawal by Subject|1|||
126066107|NCT03614923|453533486|FG000|Overall Study|Adverse Event|0|||
126066108|NCT03614923|453533487|FG001|Overall Study|Adverse Event|2|||
126066109|NCT03614923|453533488|FG002|Overall Study|Adverse Event|1|||
126066110|NCT03614923|453533486|FG000|Overall Study|Lost to Follow-up|1|||
126066111|NCT03614923|453533487|FG001|Overall Study|Lost to Follow-up|0|||
126066112|NCT03614923|453533488|FG002|Overall Study|Lost to Follow-up|1|||
126066113|NCT03614923|453533486|FG000|Overall Study|Lack of Efficacy|2|||
126066114|NCT03614923|453533487|FG001|Overall Study|Lack of Efficacy|0|||
126066115|NCT03614923|453533488|FG002|Overall Study|Lack of Efficacy|1|||
126066116|NCT03614923|453533486|FG000|Overall Study|Non-compliance|0|||
126066117|NCT03614923|453533487|FG001|Overall Study|Non-compliance|1|||
126066118|NCT03614923|453533488|FG002|Overall Study|Non-compliance|0|||
126066119|NCT03614923|453533486|FG000|Overall Study|Other|0|||
126066120|NCT03614923|453533487|FG001|Overall Study|Other|1|||
126066121|NCT03614923|453533488|FG002|Overall Study|Other|1|||
125931385|NCT01327885|453044590|FG001|Overall Study|Subject choice|10|||
125931386|NCT01327885|453044589|FG000|Overall Study|Other|8|||
125931387|NCT01327885|453044590|FG001|Overall Study|Other|6|||
125931388|NCT01327885|453044589|FG000|Overall Study|Withdrawal of consent from study|3|||
125931389|NCT01327885|453044590|FG001|Overall Study|Withdrawal of consent from study|4|||
125931390|NCT01327885|453044589|FG000|Overall Study|Not treated|1|||
125931391|NCT01327885|453044590|FG001|Overall Study|Not treated|1|||
125931392|NCT01327885|453044589|FG000|Overall Study|Administrative decision|0|||
125931393|NCT01327885|453044590|FG001|Overall Study|Administrative decision|1|||
125931394|NCT01349790|453044591|FG000|Overall Study|Investigator Judgement|3|||
125931395|NCT01349790|453044591|FG000|Overall Study|Death|2|||
125931396|NCT01349790|453044591|FG000|Overall Study|Withdrawal by Patient|2|||
125931397|NCT01349790|453044591|FG000|Overall Study|Adverse Event|1|||
125931398|NCT01349790|453044591|FG000|Overall Study|Lost to Follow-up|1|||
125931399|NCT02085785|453044594|FG000|Overall Study|Withdrawal by Subject|2|||
125931400|NCT02085785|453044595|FG001|Overall Study|Withdrawal by Subject|1|||
125931401|NCT02085785|453044594|FG000|Overall Study|Lost to Follow-up|0|||
125931402|NCT02085785|453044595|FG001|Overall Study|Lost to Follow-up|1|||
125931403|NCT02692703|453044596|FG000|Overall Study|Lost to Follow-up|1|||
125931404|NCT02692703|453044596|FG000|Overall Study|Other|1|||
125931405|NCT00885105|453044597|FG000|Overall Study|Withdrawal by Subject|0|||
125931406|NCT00885105|453044598|FG001|Overall Study|Withdrawal by Subject|8|||
125931407|NCT00885105|453044597|FG000|Overall Study|Adverse Event|1|||
125931408|NCT00885105|453044598|FG001|Overall Study|Adverse Event|0|||
125931409|NCT00885105|453044597|FG000|Overall Study|Protocol Violation|0|||
125931410|NCT00885105|453044598|FG001|Overall Study|Protocol Violation|2|||
125931411|NCT03519932|453044599|FG000|First Intervention|Adverse Event|1|||
125931412|NCT03519932|453044600|FG001|First Intervention|Adverse Event|3|||
125931413|NCT00284050|453044601|FG000|Overall Study|Adverse Event|1|||
125931414|NCT00284050|453044602|FG001|Overall Study|Adverse Event|1|||
125931415|NCT00284050|453044603|FG002|Overall Study|Adverse Event|1|||
125931416|NCT00284050|453044601|FG000|Overall Study|Lack of Efficacy|0|||
125931417|NCT00284050|453044602|FG001|Overall Study|Lack of Efficacy|1|||
125931418|NCT00284050|453044603|FG002|Overall Study|Lack of Efficacy|3|||
125931419|NCT00284050|453044601|FG000|Overall Study|Protocol Violation|0|||
125931420|NCT00284050|453044602|FG001|Overall Study|Protocol Violation|1|||
125931421|NCT00284050|453044603|FG002|Overall Study|Protocol Violation|2|||
125931422|NCT00284050|453044601|FG000|Overall Study|Withdrawal by Subject|2|||
125931423|NCT00284050|453044602|FG001|Overall Study|Withdrawal by Subject|2|||
125931424|NCT00284050|453044603|FG002|Overall Study|Withdrawal by Subject|2|||
125931425|NCT00284050|453044601|FG000|Overall Study|Lost to Follow-up|1|||
125931426|NCT00284050|453044602|FG001|Overall Study|Lost to Follow-up|0|||
125931427|NCT00284050|453044603|FG002|Overall Study|Lost to Follow-up|1|||
125931428|NCT00284050|453044601|FG000|Overall Study|Death|1|||
125931429|NCT00284050|453044602|FG001|Overall Study|Death|0|||
125931430|NCT00284050|453044603|FG002|Overall Study|Death|0|||
125931431|NCT02573350|453044606|FG000|Overall Study|Lost to Follow-up|2|||
125931432|NCT02573350|453044607|FG001|Overall Study|Lost to Follow-up|1|||
125931433|NCT02573350|453044606|FG000|Overall Study|Adverse Event|3|||
125931434|NCT02573350|453044607|FG001|Overall Study|Adverse Event|4|||
125931435|NCT02573350|453044606|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
125931436|NCT02573350|453044607|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
125931437|NCT02573350|453044606|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
125931438|NCT02573350|453044607|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
125931439|NCT02573350|453044606|FG000|Overall Study|Subject withdrew consent to participate|6|||
125931440|NCT02573350|453044607|FG001|Overall Study|Subject withdrew consent to participate|1|||
125931441|NCT02573350|453044606|FG000|Overall Study|Protocol Deviation|1|||
125931442|NCT02573350|453044607|FG001|Overall Study|Protocol Deviation|1|||
125931443|NCT01979016|453044609|FG000|Overall Study|Withdrawal by Subject|2|||
125931444|NCT01979016|453044610|FG001|Overall Study|Withdrawal by Subject|0|||
125931445|NCT01979016|453044609|FG000|Overall Study|Adverse Event|0|||
125931446|NCT01979016|453044610|FG001|Overall Study|Adverse Event|1|||
125931447|NCT04983264|453044611|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
125931448|NCT04983264|453044612|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
125931449|NCT04983264|453044613|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
125931450|NCT04983264|453044611|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
125931451|NCT04983264|453044612|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
125931452|NCT04983264|453044613|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
125931453|NCT02551731|453044616|FG000|Overall Study|Withdrawal by Subject|2|||
125931454|NCT03765918|453044625|FG000|Overall Study|Death|109|||
125931455|NCT03765918|453044626|FG001|Overall Study|Death|127|||
125931456|NCT03765918|453044625|FG000|Overall Study|Lost to Follow-up|2|||
125931457|NCT03765918|453044626|FG001|Overall Study|Lost to Follow-up|3|||
125931458|NCT03765918|453044625|FG000|Overall Study|Withdrawal by Subject|12|||
125931459|NCT03765918|453044626|FG001|Overall Study|Withdrawal by Subject|16|||
125931460|NCT03765918|453044625|FG000|Overall Study|Participants Ongoing|240|||
125931461|NCT03765918|453044626|FG001|Overall Study|Participants Ongoing|205|||
125931462|NCT04202965|453044627|FG000|Overall Study|Adverse Event|3|||
125931463|NCT04202965|453044627|FG000|Overall Study|Did not meet inclusion criteria|1|||
125931464|NCT00006903|453044628|FG000|Overall Study|Still receiving treatment|0|||
125931465|NCT00006903|453044629|FG001|Overall Study|Still receiving treatment|0|||
125931466|NCT00006903|453044630|FG002|Overall Study|Still receiving treatment|1|||
125931467|NCT00006903|453044628|FG000|Overall Study|Refused further treatment|0|||
125931468|NCT00006903|453044629|FG001|Overall Study|Refused further treatment|2|||
125931469|NCT00006903|453044630|FG002|Overall Study|Refused further treatment|1|||
125931470|NCT00006903|453044628|FG000|Overall Study|Adverse Event|0|||
125931471|NCT00006903|453044629|FG001|Overall Study|Adverse Event|0|||
125931472|NCT00006903|453044630|FG002|Overall Study|Adverse Event|1|||
125931473|NCT00006903|453044628|FG000|Overall Study|Death|0|||
125931474|NCT00006903|453044629|FG001|Overall Study|Death|1|||
125931475|NCT00006903|453044630|FG002|Overall Study|Death|0|||
125931476|NCT00006903|453044628|FG000|Overall Study|Patient never treated|0|||
125931477|NCT00006903|453044629|FG001|Overall Study|Patient never treated|0|||
125931478|NCT00006903|453044630|FG002|Overall Study|Patient never treated|1|||
125931479|NCT00006903|453044628|FG000|Overall Study|Ineligible|10|||
125931480|NCT00006903|453044629|FG001|Overall Study|Ineligible|1|||
125931481|NCT00006903|453044630|FG002|Overall Study|Ineligible|2|||
125931482|NCT00553514|453044631|FG000|Overall Study|Protocol deviation|0|||
125931483|NCT00553514|453044632|FG001|Overall Study|Protocol deviation|0|||
125931484|NCT00553514|453044633|FG002|Overall Study|Protocol deviation|0|||
125931485|NCT00553514|453044634|FG003|Overall Study|Protocol deviation|1|||
125931486|NCT00553514|453044635|FG004|Overall Study|Protocol deviation|0|||
125931487|NCT00553514|453044631|FG000|Overall Study|Lack of ovarian response|4|||
125931488|NCT00553514|453044632|FG001|Overall Study|Lack of ovarian response|5|||
125931489|NCT00553514|453044633|FG002|Overall Study|Lack of ovarian response|5|||
125931490|NCT00553514|453044634|FG003|Overall Study|Lack of ovarian response|5|||
125931491|NCT00553514|453044635|FG004|Overall Study|Lack of ovarian response|6|||
125931492|NCT00553514|453044631|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
125931493|NCT00553514|453044632|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
125931494|NCT00553514|453044633|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125931495|NCT00553514|453044634|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
125931496|NCT00553514|453044635|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
125931497|NCT00553514|453044631|FG000|Overall Study|Risk of multiple pregnancy|0|||
125931498|NCT00553514|453044632|FG001|Overall Study|Risk of multiple pregnancy|2|||
125931499|NCT00553514|453044633|FG002|Overall Study|Risk of multiple pregnancy|0|||
125931500|NCT00553514|453044634|FG003|Overall Study|Risk of multiple pregnancy|1|||
125931501|NCT00553514|453044635|FG004|Overall Study|Risk of multiple pregnancy|0|||
125931502|NCT00553514|453044631|FG000|Overall Study|Other|1|||
125931503|NCT00553514|453044632|FG001|Overall Study|Other|1|||
125931504|NCT00553514|453044633|FG002|Overall Study|Other|0|||
125931505|NCT00553514|453044634|FG003|Overall Study|Other|0|||
125931506|NCT00553514|453044635|FG004|Overall Study|Other|1|||
125931507|NCT01442675|453044638|FG000|Overall Study|Protocol Violation|6|||
125931508|NCT01442675|453044638|FG000|Overall Study|Lost to Follow-up|2|||
125931509|NCT01442675|453044638|FG000|Overall Study|Withdrawal by Subject|4|||
125931510|NCT01919723|453044639|FG000|Overall Study|Blood Samples Hemolyzed|2|||
125931511|NCT01919723|453044640|FG001|Overall Study|Blood Samples Hemolyzed|2|||
125931512|NCT00752232|453044641|FG000|Overall Study|Protocol Violation|0|||
125931513|NCT00752232|453044642|FG001|Overall Study|Protocol Violation|0|||
125931514|NCT00752232|453044643|FG002|Overall Study|Protocol Violation|0|||
125931515|NCT00752232|453044644|FG003|Overall Study|Protocol Violation|0|||
125931516|NCT00752232|453044645|FG004|Overall Study|Protocol Violation|0|||
125931517|NCT00752232|453044646|FG005|Overall Study|Protocol Violation|1|||
125931518|NCT00752232|453044647|FG006|Overall Study|Protocol Violation|0|||
125931519|NCT00752232|453044641|FG000|Overall Study|Caregiver request|2|||
125931520|NCT00752232|453044642|FG001|Overall Study|Caregiver request|0|||
125931521|NCT00752232|453044643|FG002|Overall Study|Caregiver request|0|||
125931522|NCT00752232|453044644|FG003|Overall Study|Caregiver request|0|||
125931523|NCT00752232|453044645|FG004|Overall Study|Caregiver request|1|||
125931524|NCT00752232|453044646|FG005|Overall Study|Caregiver request|0|||
125931525|NCT00752232|453044647|FG006|Overall Study|Caregiver request|0|||
125931526|NCT00752232|453044641|FG000|Overall Study|Investigator request|0|||
125931527|NCT00752232|453044642|FG001|Overall Study|Investigator request|0|||
125931528|NCT00752232|453044643|FG002|Overall Study|Investigator request|0|||
125931529|NCT00752232|453044644|FG003|Overall Study|Investigator request|0|||
125931530|NCT00752232|453044645|FG004|Overall Study|Investigator request|1|||
125931531|NCT00752232|453044646|FG005|Overall Study|Investigator request|0|||
125931532|NCT00752232|453044647|FG006|Overall Study|Investigator request|0|||
125931533|NCT00752232|453044641|FG000|Overall Study|Subject request|0|||
125931534|NCT00752232|453044642|FG001|Overall Study|Subject request|0|||
125931535|NCT00752232|453044643|FG002|Overall Study|Subject request|1|||
125931536|NCT00752232|453044644|FG003|Overall Study|Subject request|0|||
125931537|NCT00752232|453044645|FG004|Overall Study|Subject request|0|||
125931538|NCT00752232|453044646|FG005|Overall Study|Subject request|0|||
125931539|NCT00752232|453044647|FG006|Overall Study|Subject request|0|||
126113477|NCT01968070|453711311|FG012|Period 1|Protocol Violation|0|||
126113478|NCT01968070|453711312|FG013|Period 1|Protocol Violation|0|||
126113479|NCT01968070|453711313|FG014|Period 1|Protocol Violation|0|||
126113480|NCT01968070|453711314|FG015|Period 1|Protocol Violation|0|||
126113481|NCT01968070|453711315|FG016|Period 1|Protocol Violation|0|||
126113482|NCT01968070|453711316|FG017|Period 1|Protocol Violation|0|||
126113483|NCT01968070|453711299|FG000|Period 1|Lost to Follow-up|0|||
126113484|NCT01968070|453711300|FG001|Period 1|Lost to Follow-up|0|||
126113485|NCT01968070|453711301|FG002|Period 1|Lost to Follow-up|0|||
126113486|NCT01968070|453711302|FG003|Period 1|Lost to Follow-up|1|||
126113487|NCT01968070|453711303|FG004|Period 1|Lost to Follow-up|0|||
126113488|NCT01968070|453711304|FG005|Period 1|Lost to Follow-up|0|||
126113489|NCT01968070|453711305|FG006|Period 1|Lost to Follow-up|0|||
126113490|NCT01968070|453711306|FG007|Period 1|Lost to Follow-up|0|||
126113491|NCT01968070|453711307|FG008|Period 1|Lost to Follow-up|0|||
126113492|NCT01968070|453711308|FG009|Period 1|Lost to Follow-up|0|||
126113493|NCT01968070|453711309|FG010|Period 1|Lost to Follow-up|0|||
126113494|NCT01968070|453711310|FG011|Period 1|Lost to Follow-up|0|||
126113495|NCT01968070|453711311|FG012|Period 1|Lost to Follow-up|0|||
126113496|NCT01968070|453711312|FG013|Period 1|Lost to Follow-up|0|||
126113497|NCT01968070|453711313|FG014|Period 1|Lost to Follow-up|0|||
126113498|NCT01968070|453711314|FG015|Period 1|Lost to Follow-up|0|||
126113499|NCT01968070|453711315|FG016|Period 1|Lost to Follow-up|0|||
126113500|NCT01968070|453711316|FG017|Period 1|Lost to Follow-up|0|||
126113501|NCT01968070|453711299|FG000|Period 1|Adverse Event|0|||
126113502|NCT01968070|453711300|FG001|Period 1|Adverse Event|0|||
126113503|NCT01968070|453711301|FG002|Period 1|Adverse Event|0|||
126113504|NCT01968070|453711302|FG003|Period 1|Adverse Event|0|||
126113505|NCT01968070|453711303|FG004|Period 1|Adverse Event|0|||
126113506|NCT01968070|453711304|FG005|Period 1|Adverse Event|0|||
126113507|NCT01968070|453711305|FG006|Period 1|Adverse Event|1|||
126113508|NCT01968070|453711306|FG007|Period 1|Adverse Event|0|||
126113509|NCT01968070|453711307|FG008|Period 1|Adverse Event|0|||
126113510|NCT01968070|453711308|FG009|Period 1|Adverse Event|0|||
126113511|NCT01968070|453711309|FG010|Period 1|Adverse Event|0|||
126113512|NCT01968070|453711310|FG011|Period 1|Adverse Event|0|||
126113513|NCT01968070|453711311|FG012|Period 1|Adverse Event|0|||
126113514|NCT01968070|453711312|FG013|Period 1|Adverse Event|0|||
126113515|NCT01968070|453711313|FG014|Period 1|Adverse Event|0|||
126113516|NCT01968070|453711314|FG015|Period 1|Adverse Event|0|||
126113517|NCT01968070|453711315|FG016|Period 1|Adverse Event|0|||
126113518|NCT01968070|453711316|FG017|Period 1|Adverse Event|0|||
126113519|NCT01968070|453711299|FG000|Period 1|Physician Decision|0|||
126113520|NCT01968070|453711300|FG001|Period 1|Physician Decision|0|||
126113521|NCT01968070|453711301|FG002|Period 1|Physician Decision|0|||
126113522|NCT01968070|453711302|FG003|Period 1|Physician Decision|0|||
126113523|NCT01968070|453711303|FG004|Period 1|Physician Decision|0|||
126113524|NCT01968070|453711304|FG005|Period 1|Physician Decision|0|||
126113525|NCT01968070|453711305|FG006|Period 1|Physician Decision|0|||
126113526|NCT01968070|453711306|FG007|Period 1|Physician Decision|0|||
126113527|NCT01968070|453711307|FG008|Period 1|Physician Decision|0|||
126113528|NCT01968070|453711308|FG009|Period 1|Physician Decision|0|||
126113529|NCT01968070|453711309|FG010|Period 1|Physician Decision|0|||
126113530|NCT01968070|453711310|FG011|Period 1|Physician Decision|1|||
126113531|NCT01968070|453711311|FG012|Period 1|Physician Decision|0|||
126113532|NCT01968070|453711312|FG013|Period 1|Physician Decision|0|||
126113533|NCT01968070|453711313|FG014|Period 1|Physician Decision|0|||
126113534|NCT01968070|453711314|FG015|Period 1|Physician Decision|0|||
126113535|NCT01968070|453711315|FG016|Period 1|Physician Decision|0|||
126113536|NCT01968070|453711316|FG017|Period 1|Physician Decision|0|||
126113537|NCT01968070|453711299|FG000|Period 2|Withdrawal by Subject|0|||
126113538|NCT01968070|453711300|FG001|Period 2|Withdrawal by Subject|0|||
126113539|NCT01968070|453711301|FG002|Period 2|Withdrawal by Subject|0|||
126113540|NCT01968070|453711302|FG003|Period 2|Withdrawal by Subject|0|||
126113541|NCT01968070|453711303|FG004|Period 2|Withdrawal by Subject|1|||
126113542|NCT01968070|453711304|FG005|Period 2|Withdrawal by Subject|0|||
126113543|NCT01968070|453711305|FG006|Period 2|Withdrawal by Subject|0|||
126113544|NCT01968070|453711306|FG007|Period 2|Withdrawal by Subject|0|||
126113545|NCT01968070|453711307|FG008|Period 2|Withdrawal by Subject|0|||
126113546|NCT01968070|453711308|FG009|Period 2|Withdrawal by Subject|0|||
126113547|NCT01968070|453711309|FG010|Period 2|Withdrawal by Subject|0|||
126113548|NCT01968070|453711310|FG011|Period 2|Withdrawal by Subject|0|||
126113549|NCT01968070|453711311|FG012|Period 2|Withdrawal by Subject|0|||
126113550|NCT01968070|453711312|FG013|Period 2|Withdrawal by Subject|0|||
126113551|NCT01968070|453711313|FG014|Period 2|Withdrawal by Subject|0|||
126113552|NCT01968070|453711314|FG015|Period 2|Withdrawal by Subject|0|||
126113553|NCT01968070|453711315|FG016|Period 2|Withdrawal by Subject|0|||
126113554|NCT01968070|453711316|FG017|Period 2|Withdrawal by Subject|0|||
126113555|NCT00882310|453711320|FG000|Overall Study|Screen Failure|10|||
126113556|NCT00882310|453711320|FG000|Overall Study|Never received treatment|1|||
126113557|NCT00882310|453711320|FG000|Overall Study|Death|6|||
126113558|NCT00882310|453711320|FG000|Overall Study|Progression of disease|4|||
126113559|NCT00882310|453711320|FG000|Overall Study|Adverse Event|1|||
125931540|NCT00752232|453044641|FG000|Overall Study|Group home admission|0|||
125931541|NCT00752232|453044642|FG001|Overall Study|Group home admission|0|||
125931542|NCT00752232|453044643|FG002|Overall Study|Group home admission|0|||
125931543|NCT00752232|453044644|FG003|Overall Study|Group home admission|1|||
125931544|NCT00752232|453044645|FG004|Overall Study|Group home admission|0|||
125931545|NCT00752232|453044646|FG005|Overall Study|Group home admission|0|||
125931546|NCT00752232|453044647|FG006|Overall Study|Group home admission|0|||
125931547|NCT00752232|453044641|FG000|Overall Study|Caregiver could not attend the subject|0|||
125931548|NCT00752232|453044642|FG001|Overall Study|Caregiver could not attend the subject|0|||
125931549|NCT00752232|453044643|FG002|Overall Study|Caregiver could not attend the subject|0|||
125931550|NCT00752232|453044644|FG003|Overall Study|Caregiver could not attend the subject|0|||
125931551|NCT00752232|453044645|FG004|Overall Study|Caregiver could not attend the subject|1|||
125931552|NCT00752232|453044646|FG005|Overall Study|Caregiver could not attend the subject|0|||
125931553|NCT00752232|453044647|FG006|Overall Study|Caregiver could not attend the subject|0|||
125931554|NCT04502589|453044648|FG000|Overall Study|Physician Decision|1|||
125931555|NCT04502589|453044649|FG001|Overall Study|Physician Decision|0|||
125931556|NCT00555321|453044650|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
125931557|NCT00555321|453044651|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
125931558|NCT00555321|453044652|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
125931559|NCT00555321|453044653|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
125931560|NCT00555321|453044654|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
125931561|NCT00555321|453044650|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
125931562|NCT00555321|453044651|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
125931563|NCT00555321|453044652|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
125931564|NCT00555321|453044653|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
125931565|NCT00555321|453044654|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
125931566|NCT00555321|453044650|FG000|Treatment Phase up to 12-months|Death|2|||
125931567|NCT00555321|453044651|FG001|Treatment Phase up to 12-months|Death|1|||
125931568|NCT00555321|453044652|FG002|Treatment Phase up to 12-months|Death|4|||
125931569|NCT00555321|453044653|FG003|Treatment Phase up to 12-months|Death|0|||
125931570|NCT00555321|453044654|FG004|Treatment Phase up to 12-months|Death|0|||
125931571|NCT00555321|453044650|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
125931572|NCT00555321|453044651|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
125931573|NCT00555321|453044652|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
125931574|NCT00555321|453044653|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
125931575|NCT00555321|453044654|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
125931576|NCT00555321|453044650|FG000|Treatment Phase up to 12-months|Other Reason|1|||
125931577|NCT00555321|453044651|FG001|Treatment Phase up to 12-months|Other Reason|3|||
125931578|NCT00555321|453044652|FG002|Treatment Phase up to 12-months|Other Reason|2|||
125931579|NCT00555321|453044653|FG003|Treatment Phase up to 12-months|Other Reason|0|||
125931580|NCT00555321|453044654|FG004|Treatment Phase up to 12-months|Other Reason|0|||
125931581|NCT00555321|453044650|FG000|Treatment Phase up to 12-months|Never treated|2|||
125931582|NCT00555321|453044651|FG001|Treatment Phase up to 12-months|Never treated|3|||
125931583|NCT00555321|453044652|FG002|Treatment Phase up to 12-months|Never treated|1|||
125931584|NCT00555321|453044653|FG003|Treatment Phase up to 12-months|Never treated|0|||
125931585|NCT00555321|453044654|FG004|Treatment Phase up to 12-months|Never treated|4|||
125931586|NCT00555321|453044650|FG000|Long-term Extension Phase|Adverse Event|2|||
125931587|NCT00555321|453044651|FG001|Long-term Extension Phase|Adverse Event|5|||
125931588|NCT00555321|453044652|FG002|Long-term Extension Phase|Adverse Event|2|||
125931589|NCT00555321|453044653|FG003|Long-term Extension Phase|Adverse Event|1|||
125931590|NCT00555321|453044654|FG004|Long-term Extension Phase|Adverse Event|0|||
125931591|NCT00555321|453044650|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
125931592|NCT00555321|453044651|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
125931593|NCT00555321|453044652|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
125931594|NCT00555321|453044653|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
125931595|NCT00555321|453044654|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
125931596|NCT00555321|453044650|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
125931597|NCT00555321|453044651|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
125931598|NCT00555321|453044652|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
125931599|NCT00555321|453044653|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
125931600|NCT00555321|453044654|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
125931601|NCT00555321|453044650|FG000|Long-term Extension Phase|Death|2|||
125931602|NCT00555321|453044651|FG001|Long-term Extension Phase|Death|0|||
125931603|NCT00555321|453044652|FG002|Long-term Extension Phase|Death|0|||
125931604|NCT00555321|453044653|FG003|Long-term Extension Phase|Death|3|||
125931605|NCT00555321|453044654|FG004|Long-term Extension Phase|Death|0|||
125931606|NCT00555321|453044650|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
125931607|NCT00555321|453044651|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
125931608|NCT00555321|453044652|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
125931609|NCT00555321|453044653|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
125931610|NCT00555321|453044654|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
125931611|NCT00555321|453044650|FG000|Long-term Extension Phase|Other Reason|1|||
125931612|NCT00555321|453044651|FG001|Long-term Extension Phase|Other Reason|0|||
125931613|NCT00555321|453044652|FG002|Long-term Extension Phase|Other Reason|2|||
125931614|NCT00555321|453044653|FG003|Long-term Extension Phase|Other Reason|0|||
125931615|NCT00555321|453044654|FG004|Long-term Extension Phase|Other Reason|0|||
125931616|NCT00160251|453044655|FG000|Prior to Amendment 2|Adverse Event|2|||
125931617|NCT00160251|453044656|FG001|Prior to Amendment 2|Adverse Event|1|||
125931618|NCT00160251|453044657|FG002|Prior to Amendment 2|Adverse Event|3|||
125931619|NCT00160251|453044658|FG003|Prior to Amendment 2|Adverse Event|1|||
125931620|NCT00160251|453044659|FG004|Prior to Amendment 2|Adverse Event|1|||
125931621|NCT00160251|453044660|FG005|Prior to Amendment 2|Adverse Event|1|||
125931622|NCT00160251|453044661|FG006|Prior to Amendment 2|Adverse Event|1|||
125931623|NCT00160251|453044662|FG007|Prior to Amendment 2|Adverse Event|0|||
125931624|NCT00160251|453044655|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
125931625|NCT00160251|453044656|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
125931626|NCT00160251|453044657|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
125931627|NCT00160251|453044658|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
125931628|NCT00160251|453044659|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
125931629|NCT00160251|453044660|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
125931630|NCT00160251|453044661|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
125931631|NCT00160251|453044662|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
125931632|NCT00160251|453044655|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
125931633|NCT00160251|453044656|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
125931634|NCT00160251|453044657|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
125931635|NCT00160251|453044658|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
125931636|NCT00160251|453044659|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
125931637|NCT00160251|453044660|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
125931638|NCT00160251|453044661|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
125931639|NCT00160251|453044662|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
125931640|NCT00160251|453044655|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
125931641|NCT00160251|453044656|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
125931642|NCT00160251|453044657|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
125931643|NCT00160251|453044658|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
125931644|NCT00160251|453044659|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
125931645|NCT00160251|453044660|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
125931646|NCT00160251|453044661|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
125931647|NCT00160251|453044662|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
125931648|NCT00160251|453044655|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
125931649|NCT00160251|453044656|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
125931650|NCT00160251|453044657|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
125931651|NCT00160251|453044658|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
125931652|NCT00160251|453044659|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
125931653|NCT00160251|453044660|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
125931654|NCT00160251|453044661|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
125931655|NCT00160251|453044662|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
125931656|NCT00160251|453044655|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
125931657|NCT00160251|453044656|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
125931658|NCT00160251|453044657|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
125931659|NCT00160251|453044658|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
125931660|NCT00160251|453044659|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
125931661|NCT00160251|453044660|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
125931662|NCT00160251|453044661|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
125931663|NCT00160251|453044662|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
125931664|NCT00160251|453044655|FG000|Post-amendment 2|Adverse Event|0|||
125931665|NCT00160251|453044656|FG001|Post-amendment 2|Adverse Event|0|||
125931666|NCT00160251|453044657|FG002|Post-amendment 2|Adverse Event|0|||
125931667|NCT00160251|453044658|FG003|Post-amendment 2|Adverse Event|0|||
125931668|NCT00160251|453044659|FG004|Post-amendment 2|Adverse Event|0|||
125931669|NCT00160251|453044660|FG005|Post-amendment 2|Adverse Event|0|||
125931670|NCT00160251|453044661|FG006|Post-amendment 2|Adverse Event|0|||
125931671|NCT00160251|453044662|FG007|Post-amendment 2|Adverse Event|20|||
125931672|NCT00160251|453044655|FG000|Post-amendment 2|Lack of Efficacy|0|||
125931673|NCT00160251|453044656|FG001|Post-amendment 2|Lack of Efficacy|0|||
125931674|NCT00160251|453044657|FG002|Post-amendment 2|Lack of Efficacy|0|||
125931675|NCT00160251|453044658|FG003|Post-amendment 2|Lack of Efficacy|0|||
125931676|NCT00160251|453044659|FG004|Post-amendment 2|Lack of Efficacy|0|||
125931677|NCT00160251|453044660|FG005|Post-amendment 2|Lack of Efficacy|0|||
125931678|NCT00160251|453044661|FG006|Post-amendment 2|Lack of Efficacy|0|||
125931679|NCT00160251|453044662|FG007|Post-amendment 2|Lack of Efficacy|24|||
125931680|NCT00160251|453044655|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125931681|NCT00160251|453044656|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
126066122|NCT01107353|453533489|FG000|Overall Study|Positive Drug Screen|1|||
125931682|NCT00160251|453044657|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125931683|NCT00160251|453044658|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125931684|NCT00160251|453044659|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125931685|NCT00160251|453044660|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125931686|NCT00160251|453044661|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125931687|NCT00160251|453044662|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
125931688|NCT00582166|453044665|FG000|Overall Study|Death|1|||
125931689|NCT00582166|453044665|FG000|Overall Study|Ineligible pathology|1|||
125931690|NCT02532972|453044666|FG000|Overall Study|Withdrawal by Subject|1|||
125931691|NCT01606436|453044667|FG000|Overall Study|Withdrawal by Subject|0|||
125931692|NCT01606436|453044668|FG001|Overall Study|Withdrawal by Subject|0|||
125931693|NCT01606436|453044669|FG002|Overall Study|Withdrawal by Subject|1|||
125931694|NCT01606436|453044670|FG003|Overall Study|Withdrawal by Subject|1|||
125931695|NCT01606436|453044671|FG004|Overall Study|Withdrawal by Subject|1|||
125931696|NCT01606436|453044672|FG005|Overall Study|Withdrawal by Subject|0|||
125931697|NCT01606436|453044667|FG000|Overall Study|Adverse Event|0|||
125931698|NCT01606436|453044668|FG001|Overall Study|Adverse Event|0|||
125931699|NCT01606436|453044669|FG002|Overall Study|Adverse Event|1|||
125931700|NCT01606436|453044670|FG003|Overall Study|Adverse Event|0|||
125931701|NCT01606436|453044671|FG004|Overall Study|Adverse Event|0|||
125931702|NCT01606436|453044672|FG005|Overall Study|Adverse Event|0|||
125931703|NCT01606436|453044667|FG000|Overall Study|Sponsor Decision|0|||
125931704|NCT01606436|453044668|FG001|Overall Study|Sponsor Decision|0|||
125931705|NCT01606436|453044669|FG002|Overall Study|Sponsor Decision|0|||
125931706|NCT01606436|453044670|FG003|Overall Study|Sponsor Decision|1|||
125931707|NCT01606436|453044671|FG004|Overall Study|Sponsor Decision|0|||
125931708|NCT01606436|453044672|FG005|Overall Study|Sponsor Decision|0|||
125931709|NCT02859454|453044673|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
125931710|NCT01025752|453044674|FG000|Overall Study|Lost to Follow-up|7|||
125931711|NCT01025752|453044675|FG001|Overall Study|Lost to Follow-up|10|||
125931712|NCT01025752|453044674|FG000|Overall Study|Physician Decision|1|||
125931713|NCT01025752|453044675|FG001|Overall Study|Physician Decision|3|||
125931714|NCT01417234|453044678|FG000|Overall Study|Subject non-compliant|3|||
125931715|NCT00023764|453044679|FG000|Overall Study|Other|1|||
125931716|NCT00023764|453044679|FG000|Overall Study|Adverse Event|4|||
125931717|NCT00023764|453044679|FG000|Overall Study|Withdrawal by Subject|1|||
125931718|NCT00023764|453044679|FG000|Overall Study|Progression of disease|6|||
125931719|NCT00023764|453044679|FG000|Overall Study|patient received other treatment|1|||
125931720|NCT00023764|453044679|FG000|Overall Study|delay in obtaining staging images|1|||
125931721|NCT03334448|453044685|FG000|Washout|Personal Reason|0|||
125931722|NCT03334448|453044686|FG001|Washout|Personal Reason|1|||
125931723|NCT03334448|453044687|FG002|Washout|Personal Reason|0|||
125931724|NCT03334448|453044688|FG003|Washout|Personal Reason|0|||
125931725|NCT03334448|453044685|FG000|Washout|Protocol Violation|0|||
125931726|NCT03334448|453044686|FG001|Washout|Protocol Violation|0|||
125931727|NCT03334448|453044687|FG002|Washout|Protocol Violation|0|||
125931728|NCT03334448|453044688|FG003|Washout|Protocol Violation|1|||
125931729|NCT02496611|453044691|FG000|Overall Study|Lost to Follow-up|2|||
125931730|NCT02496611|453044692|FG001|Overall Study|Lost to Follow-up|1|||
125931731|NCT02496611|453044691|FG000|Overall Study|Withdrawal by Subject|5|||
125931732|NCT02496611|453044692|FG001|Overall Study|Withdrawal by Subject|2|||
125931733|NCT02850965|453044693|FG000|Overall Study|Other than listed|3|||
125931734|NCT02850965|453044694|FG001|Overall Study|Other than listed|4|||
125931735|NCT02850965|453044693|FG000|Overall Study|Protocol Violation|0|||
125931736|NCT02850965|453044694|FG001|Overall Study|Protocol Violation|2|||
125931737|NCT02850965|453044693|FG000|Overall Study|Lost to Follow-up|5|||
125931738|NCT02850965|453044694|FG001|Overall Study|Lost to Follow-up|3|||
125931739|NCT02850965|453044693|FG000|Overall Study|Lack of Efficacy|4|||
125931740|NCT02850965|453044694|FG001|Overall Study|Lack of Efficacy|8|||
125931741|NCT02850965|453044693|FG000|Overall Study|Adverse Event|3|||
125931742|NCT02850965|453044694|FG001|Overall Study|Adverse Event|2|||
125931743|NCT02850965|453044693|FG000|Overall Study|Withdrawal by Subject|3|||
125931744|NCT02850965|453044694|FG001|Overall Study|Withdrawal by Subject|4|||
125931745|NCT02850965|453044693|FG000|Overall Study|Physician Decision|0|||
125931746|NCT02850965|453044694|FG001|Overall Study|Physician Decision|1|||
125931747|NCT02850965|453044693|FG000|Overall Study|Randomized but not treated|0|||
125931748|NCT02850965|453044694|FG001|Overall Study|Randomized but not treated|1|||
125931749|NCT02788357|453044697|FG000|Overall Study|Lost to Follow-up|3|||
125931750|NCT02788357|453044698|FG001|Overall Study|Lost to Follow-up|0|||
125931751|NCT00371137|453044699|FG000|Overall Study|Adverse Event|20|||
125931752|NCT00371137|453044700|FG001|Overall Study|Adverse Event|35|||
125931753|NCT00371137|453044701|FG002|Overall Study|Adverse Event|42|||
125931754|NCT00371137|453044699|FG000|Overall Study|Withdrawal by Subject|11|||
125931755|NCT00371137|453044700|FG001|Overall Study|Withdrawal by Subject|10|||
125931756|NCT00371137|453044701|FG002|Overall Study|Withdrawal by Subject|15|||
125931757|NCT00371137|453044699|FG000|Overall Study|Lost to Follow-up|6|||
125931758|NCT00371137|453044700|FG001|Overall Study|Lost to Follow-up|3|||
125931759|NCT00371137|453044701|FG002|Overall Study|Lost to Follow-up|5|||
125931760|NCT00371137|453044699|FG000|Overall Study|Lack of Efficacy|30|||
126113560|NCT04246801|453711323|FG000|Overall Study|Adverse Event|1|||
126113561|NCT04246801|453711324|FG001|Overall Study|Adverse Event|1|||
126113562|NCT04246801|453711323|FG000|Overall Study|Protocol Violation|1|||
126113563|NCT04246801|453711324|FG001|Overall Study|Protocol Violation|1|||
126113564|NCT04246801|453711323|FG000|Overall Study|Lack of Efficacy|0|||
126113565|NCT04246801|453711324|FG001|Overall Study|Lack of Efficacy|2|||
126113566|NCT04246801|453711323|FG000|Overall Study|Lost to Follow-up|1|||
126113567|NCT04246801|453711324|FG001|Overall Study|Lost to Follow-up|1|||
126113568|NCT04246801|453711323|FG000|Overall Study|Withdrawal by Subject|2|||
126113569|NCT04246801|453711324|FG001|Overall Study|Withdrawal by Subject|1|||
126113570|NCT03684642|453711325|FG000|Overall Study|Adverse Event|6|||
126113571|NCT03684642|453711326|FG001|Overall Study|Adverse Event|15|||
126113572|NCT03684642|453711327|FG002|Overall Study|Adverse Event|11|||
126113573|NCT03684642|453711325|FG000|Overall Study|Withdrawal by Subject|35|||
126113574|NCT03684642|453711326|FG001|Overall Study|Withdrawal by Subject|53|||
126113575|NCT03684642|453711327|FG002|Overall Study|Withdrawal by Subject|23|||
126113576|NCT03684642|453711325|FG000|Overall Study|Lack of Efficacy|0|||
126113577|NCT03684642|453711326|FG001|Overall Study|Lack of Efficacy|0|||
126113578|NCT03684642|453711327|FG002|Overall Study|Lack of Efficacy|1|||
126113579|NCT03684642|453711325|FG000|Overall Study|Poor compliance to protocol|0|||
126113580|NCT03684642|453711326|FG001|Overall Study|Poor compliance to protocol|4|||
126113581|NCT03684642|453711327|FG002|Overall Study|Poor compliance to protocol|1|||
126113582|NCT03684642|453711325|FG000|Overall Study|Other than specified|62|||
126113583|NCT03684642|453711326|FG001|Overall Study|Other than specified|60|||
126113584|NCT03684642|453711327|FG002|Overall Study|Other than specified|67|||
126113585|NCT03684642|453711325|FG000|Overall Study|Randomized and not treated|0|||
126113586|NCT03684642|453711326|FG001|Overall Study|Randomized and not treated|0|||
126113587|NCT03684642|453711327|FG002|Overall Study|Randomized and not treated|1|||
126113588|NCT03684642|453711325|FG000|Overall Study|Missing completion status but alive at last contact|0|||
126113589|NCT03684642|453711326|FG001|Overall Study|Missing completion status but alive at last contact|1|||
126113590|NCT03684642|453711327|FG002|Overall Study|Missing completion status but alive at last contact|2|||
126113591|NCT04201821|453711336|FG000|Overall Study|Withdrawal by Subject|2|||
126113592|NCT01326728|453711337|FG000|Overall Study|Death|13|||
126113593|NCT01326728|453711338|FG001|Overall Study|Death|0|||
126113594|NCT01326728|453711337|FG000|Overall Study|Early closure of study|34|||
126113595|NCT01326728|453711338|FG001|Overall Study|Early closure of study|9|||
126113596|NCT03785678|453711339|FG000|Overall Study|Death|44|||
126113597|NCT03785678|453711340|FG001|Overall Study|Death|42|||
126113598|NCT03785678|453711339|FG000|Overall Study|Lost to Follow-up|4|||
126113599|NCT03785678|453711340|FG001|Overall Study|Lost to Follow-up|2|||
126113600|NCT03785678|453711339|FG000|Overall Study|Physician Decision|0|||
126113601|NCT03785678|453711340|FG001|Overall Study|Physician Decision|2|||
126113602|NCT03785678|453711339|FG000|Overall Study|Withdrawal by Subject|5|||
126113603|NCT03785678|453711340|FG001|Overall Study|Withdrawal by Subject|3|||
126113604|NCT02374021|453711344|FG000|Overall Study|Adverse Event|1|||
126113605|NCT02374021|453711345|FG001|Overall Study|Adverse Event|0|||
126113606|NCT02374021|453711344|FG000|Overall Study|Lost to Follow-up|3|||
126113607|NCT02374021|453711345|FG001|Overall Study|Lost to Follow-up|2|||
126113608|NCT02374021|453711344|FG000|Overall Study|Physician Decision|0|||
126113609|NCT02374021|453711345|FG001|Overall Study|Physician Decision|3|||
125931761|NCT00371137|453044700|FG001|Overall Study|Lack of Efficacy|12|||
125931762|NCT00371137|453044701|FG002|Overall Study|Lack of Efficacy|13|||
125931763|NCT00371137|453044699|FG000|Overall Study|Sponsor Decision|2|||
125931764|NCT00371137|453044700|FG001|Overall Study|Sponsor Decision|1|||
125931765|NCT00371137|453044701|FG002|Overall Study|Sponsor Decision|2|||
125931766|NCT00371137|453044699|FG000|Overall Study|Physician Decision|1|||
125931767|NCT00371137|453044700|FG001|Overall Study|Physician Decision|1|||
125931768|NCT00371137|453044701|FG002|Overall Study|Physician Decision|1|||
125931769|NCT00371137|453044699|FG000|Overall Study|Protocol Violation|2|||
125931770|NCT00371137|453044700|FG001|Overall Study|Protocol Violation|1|||
125931771|NCT00371137|453044701|FG002|Overall Study|Protocol Violation|1|||
125931772|NCT00833794|453044702|FG000|Open-label Phase|Adverse Event|225|||
125931773|NCT00833794|453044703|FG001|Open-label Phase|Adverse Event|0|||
125931774|NCT00833794|453044702|FG000|Open-label Phase|Lack of Efficacy|28|||
125931775|NCT00833794|453044703|FG001|Open-label Phase|Lack of Efficacy|0|||
125931776|NCT00833794|453044702|FG000|Open-label Phase|Withdrawal by Subject|48|||
126113610|NCT02374021|453711344|FG000|Overall Study|Withdrawal by Subject|6|||
126113611|NCT02374021|453711345|FG001|Overall Study|Withdrawal by Subject|5|||
126113612|NCT02374021|453711344|FG000|Overall Study|Poor Adherence|0|||
126113613|NCT02374021|453711345|FG001|Overall Study|Poor Adherence|1|||
125931777|NCT00833794|453044703|FG001|Open-label Phase|Withdrawal by Subject|0|||
126113614|NCT02374021|453711344|FG000|Overall Study|Scan protocol not followed|0|||
126113615|NCT02374021|453711345|FG001|Overall Study|Scan protocol not followed|1|||
126113616|NCT02374021|453711344|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
126113617|NCT02374021|453711345|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
125931778|NCT00833794|453044702|FG000|Open-label Phase|Physician Decision|20|||
125931779|NCT00833794|453044703|FG001|Open-label Phase|Physician Decision|0|||
125931780|NCT00833794|453044702|FG000|Open-label Phase|Administrative reason|1|||
125931781|NCT00833794|453044703|FG001|Open-label Phase|Administrative reason|0|||
125931782|NCT00833794|453044702|FG000|Open-label Phase|Protocol Violation|47|||
125931783|NCT00833794|453044703|FG001|Open-label Phase|Protocol Violation|0|||
125931784|NCT00833794|453044702|FG000|Open-label Phase|Did not complete wash-out period|12|||
125931785|NCT00833794|453044703|FG001|Open-label Phase|Did not complete wash-out period|0|||
125931786|NCT00833794|453044702|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
125931787|NCT00833794|453044703|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
125931788|NCT00833794|453044702|FG000|Double-blind Phase|Adverse Event|44|||
125931789|NCT00833794|453044703|FG001|Double-blind Phase|Adverse Event|11|||
125931790|NCT00833794|453044702|FG000|Double-blind Phase|Lack of Efficacy|34|||
125931791|NCT00833794|453044703|FG001|Double-blind Phase|Lack of Efficacy|22|||
125931792|NCT00833794|453044702|FG000|Double-blind Phase|Withdrawal by Subject|23|||
125931793|NCT00833794|453044703|FG001|Double-blind Phase|Withdrawal by Subject|6|||
125931794|NCT00833794|453044702|FG000|Double-blind Phase|Physician Decision|4|||
125931795|NCT00833794|453044703|FG001|Double-blind Phase|Physician Decision|7|||
125931796|NCT00833794|453044702|FG000|Double-blind Phase|Administrative reason|1|||
125931797|NCT00833794|453044703|FG001|Double-blind Phase|Administrative reason|3|||
125931798|NCT02007109|453044704|FG000|Overall Study|Diary not returned or excluded|102|||
125931799|NCT02007109|453044704|FG000|Overall Study|Excluded - Age<7yo|9|||
125931800|NCT01918085|453044705|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
125931801|NCT01918085|453044706|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
125931802|NCT00679302|453044707|FG000|Overall Study|Lost to Follow-up|8|||
125931803|NCT00679302|453044708|FG001|Overall Study|Lost to Follow-up|4|||
125931804|NCT03031678|453044711|FG000|Overall Study|Study closed prior to completion|1|||
125931805|NCT00439244|453044712|FG000|Overall Study|Adverse Event|5|||
125931806|NCT00439244|453044713|FG001|Overall Study|Adverse Event|2|||
125931807|NCT00439244|453044714|FG002|Overall Study|Adverse Event|3|||
125931808|NCT00439244|453044712|FG000|Overall Study|Withdrawal by Subject|3|||
125931809|NCT00439244|453044713|FG001|Overall Study|Withdrawal by Subject|1|||
125931810|NCT00439244|453044714|FG002|Overall Study|Withdrawal by Subject|2|||
125931811|NCT00439244|453044712|FG000|Overall Study|Lost to Follow-up|2|||
125931812|NCT00439244|453044713|FG001|Overall Study|Lost to Follow-up|1|||
125931813|NCT00439244|453044714|FG002|Overall Study|Lost to Follow-up|2|||
125931814|NCT00439244|453044712|FG000|Overall Study|Death|0|||
125931815|NCT00439244|453044713|FG001|Overall Study|Death|1|||
125931816|NCT00439244|453044714|FG002|Overall Study|Death|0|||
125931817|NCT00439244|453044712|FG000|Overall Study|Protocol Violation|0|||
125931818|NCT00439244|453044713|FG001|Overall Study|Protocol Violation|1|||
125931819|NCT00439244|453044714|FG002|Overall Study|Protocol Violation|0|||
125931820|NCT00439244|453044712|FG000|Overall Study|Administrative problems|1|||
125931821|NCT00439244|453044713|FG001|Overall Study|Administrative problems|0|||
125931822|NCT00439244|453044714|FG002|Overall Study|Administrative problems|0|||
125931823|NCT03655691|453044715|FG000|Overall Study|Adverse Event|0|||
125931824|NCT03655691|453044716|FG001|Overall Study|Adverse Event|0|||
125931825|NCT03655691|453044717|FG002|Overall Study|Adverse Event|1|||
125931826|NCT03655691|453044715|FG000|Overall Study|Lost to Follow-up|1|||
125931827|NCT03655691|453044716|FG001|Overall Study|Lost to Follow-up|1|||
125931828|NCT03655691|453044717|FG002|Overall Study|Lost to Follow-up|2|||
125931829|NCT03655691|453044715|FG000|Overall Study|Protocol Violation|0|||
125931830|NCT03655691|453044716|FG001|Overall Study|Protocol Violation|1|||
125931831|NCT03655691|453044717|FG002|Overall Study|Protocol Violation|0|||
125931832|NCT03655691|453044715|FG000|Overall Study|Withdrawal by Subject|1|||
125931833|NCT03655691|453044716|FG001|Overall Study|Withdrawal by Subject|1|||
125931834|NCT03655691|453044717|FG002|Overall Study|Withdrawal by Subject|0|||
125931835|NCT01753856|453044718|FG000|Overall Study|Adverse Event|1|||
125931836|NCT01753856|453044719|FG001|Overall Study|Adverse Event|0|||
125931837|NCT01753856|453044718|FG000|Overall Study|Withdrawal by Subject|0|||
125931838|NCT01753856|453044719|FG001|Overall Study|Withdrawal by Subject|2|||
125931839|NCT01753856|453044718|FG000|Overall Study|Sponsor Decision|2|||
125931840|NCT01753856|453044719|FG001|Overall Study|Sponsor Decision|0|||
125931841|NCT00434330|453044720|FG000|Overall Study|Adverse Event|0|||
125931842|NCT00434330|453044721|FG001|Overall Study|Adverse Event|0|||
125931843|NCT00434330|453044722|FG002|Overall Study|Adverse Event|1|||
126066123|NCT01107353|453533490|FG001|Overall Study|Positive Drug Screen|0|||
125931844|NCT00434330|453044723|FG003|Overall Study|Adverse Event|0|||
125931845|NCT00434330|453044724|FG004|Overall Study|Adverse Event|0|||
125931846|NCT00434330|453044725|FG005|Overall Study|Adverse Event|0|||
125931847|NCT00434330|453044720|FG000|Overall Study|Death|1|||
125931848|NCT00434330|453044721|FG001|Overall Study|Death|0|||
125931849|NCT00434330|453044722|FG002|Overall Study|Death|0|||
125931850|NCT00434330|453044723|FG003|Overall Study|Death|0|||
125931851|NCT00434330|453044724|FG004|Overall Study|Death|1|||
125931852|NCT00434330|453044725|FG005|Overall Study|Death|1|||
125931853|NCT00434330|453044720|FG000|Overall Study|Withdrawal by Subject|0|||
125931854|NCT00434330|453044721|FG001|Overall Study|Withdrawal by Subject|0|||
125931855|NCT00434330|453044722|FG002|Overall Study|Withdrawal by Subject|1|||
125931856|NCT00434330|453044723|FG003|Overall Study|Withdrawal by Subject|1|||
126066124|NCT01136733|453533491|FG000|Phase 1b|Adverse Event|0|||
126066125|NCT01136733|453533492|FG001|Phase 1b|Adverse Event|3|||
125931857|NCT00434330|453044724|FG004|Overall Study|Withdrawal by Subject|0|||
125931858|NCT00434330|453044725|FG005|Overall Study|Withdrawal by Subject|0|||
125931859|NCT00434330|453044720|FG000|Overall Study|Renal transplant|0|||
125931860|NCT00434330|453044721|FG001|Overall Study|Renal transplant|0|||
125931861|NCT00434330|453044722|FG002|Overall Study|Renal transplant|0|||
125931862|NCT00434330|453044723|FG003|Overall Study|Renal transplant|1|||
125931863|NCT00434330|453044724|FG004|Overall Study|Renal transplant|0|||
125931864|NCT00434330|453044725|FG005|Overall Study|Renal transplant|0|||
125931865|NCT00434330|453044720|FG000|Overall Study|Subject Not Compliant With Study|0|||
125931866|NCT00434330|453044721|FG001|Overall Study|Subject Not Compliant With Study|0|||
125931867|NCT00434330|453044722|FG002|Overall Study|Subject Not Compliant With Study|1|||
125931868|NCT00434330|453044723|FG003|Overall Study|Subject Not Compliant With Study|0|||
125931869|NCT00434330|453044724|FG004|Overall Study|Subject Not Compliant With Study|0|||
125931870|NCT00434330|453044725|FG005|Overall Study|Subject Not Compliant With Study|0|||
125931871|NCT05109442|453044728|FG000|Overall Study|Withdrawal by Subject|0|||
125931872|NCT05109442|453044729|FG001|Overall Study|Withdrawal by Subject|0|||
125931873|NCT05109442|453044730|FG002|Overall Study|Withdrawal by Subject|1|||
125931874|NCT05109442|453044731|FG003|Overall Study|Withdrawal by Subject|0|||
125931875|NCT05109442|453044732|FG004|Overall Study|Withdrawal by Subject|0|||
125931876|NCT05109442|453044733|FG005|Overall Study|Withdrawal by Subject|0|||
125931877|NCT05109442|453044728|FG000|Overall Study|Adverse Event|0|||
125931878|NCT05109442|453044729|FG001|Overall Study|Adverse Event|1|||
125931879|NCT05109442|453044730|FG002|Overall Study|Adverse Event|5|||
125931880|NCT05109442|453044731|FG003|Overall Study|Adverse Event|0|||
125931881|NCT05109442|453044732|FG004|Overall Study|Adverse Event|0|||
125931882|NCT05109442|453044733|FG005|Overall Study|Adverse Event|2|||
125931883|NCT05109442|453044728|FG000|Overall Study|Death|0|||
125931884|NCT05109442|453044729|FG001|Overall Study|Death|0|||
125931885|NCT05109442|453044730|FG002|Overall Study|Death|4|||
125931886|NCT05109442|453044731|FG003|Overall Study|Death|0|||
125931887|NCT05109442|453044732|FG004|Overall Study|Death|0|||
125931888|NCT05109442|453044733|FG005|Overall Study|Death|1|||
125931889|NCT05109442|453044728|FG000|Overall Study|Physician Decision|1|||
125931890|NCT05109442|453044729|FG001|Overall Study|Physician Decision|0|||
125931891|NCT05109442|453044730|FG002|Overall Study|Physician Decision|1|||
125931892|NCT05109442|453044731|FG003|Overall Study|Physician Decision|0|||
125931893|NCT05109442|453044732|FG004|Overall Study|Physician Decision|0|||
125931894|NCT05109442|453044733|FG005|Overall Study|Physician Decision|2|||
125931895|NCT05109442|453044728|FG000|Overall Study|Other than listed|0|||
125931896|NCT05109442|453044729|FG001|Overall Study|Other than listed|0|||
125931897|NCT05109442|453044730|FG002|Overall Study|Other than listed|9|||
125931898|NCT05109442|453044731|FG003|Overall Study|Other than listed|2|||
125931899|NCT05109442|453044732|FG004|Overall Study|Other than listed|0|||
125931900|NCT05109442|453044733|FG005|Overall Study|Other than listed|8|||
125931901|NCT05109442|453044728|FG000|Overall Study|Lack of Efficacy|3|||
125931902|NCT05109442|453044729|FG001|Overall Study|Lack of Efficacy|5|||
125931903|NCT05109442|453044730|FG002|Overall Study|Lack of Efficacy|29|||
125931904|NCT05109442|453044731|FG003|Overall Study|Lack of Efficacy|10|||
125931905|NCT05109442|453044732|FG004|Overall Study|Lack of Efficacy|11|||
125931906|NCT05109442|453044733|FG005|Overall Study|Lack of Efficacy|17|||
125931907|NCT04853225|453044734|FG000|Overall Study|Withdrawal by Subject|81|||
125931908|NCT04853225|453044735|FG001|Overall Study|Withdrawal by Subject|4|||
125931909|NCT04853225|453044736|FG002|Overall Study|Withdrawal by Subject|1|||
125931910|NCT04853225|453044734|FG000|Overall Study|Physician Decision|12|||
125931911|NCT04853225|453044735|FG001|Overall Study|Physician Decision|4|||
125931912|NCT04853225|453044736|FG002|Overall Study|Physician Decision|1|||
125931913|NCT04853225|453044734|FG000|Overall Study|Lost to Follow-up|50|||
125931914|NCT04853225|453044735|FG001|Overall Study|Lost to Follow-up|0|||
125931915|NCT04853225|453044736|FG002|Overall Study|Lost to Follow-up|0|||
125931916|NCT04853225|453044734|FG000|Overall Study|Other|102|||
125931917|NCT04853225|453044735|FG001|Overall Study|Other|11|||
125931918|NCT04853225|453044736|FG002|Overall Study|Other|5|||
125931919|NCT04853225|453044734|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
125931920|NCT04853225|453044735|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
125931921|NCT04853225|453044736|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
125931922|NCT04853225|453044734|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
125931923|NCT04853225|453044735|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
125931924|NCT04853225|453044736|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
125931925|NCT03918447|453044737|FG000|Overall Study|Death|1|||
125931926|NCT03918447|453044738|FG001|Overall Study|Death|0|||
125931927|NCT03918447|453044737|FG000|Overall Study|Lost to Follow-up|13|||
125931928|NCT03918447|453044738|FG001|Overall Study|Lost to Follow-up|6|||
125931929|NCT03918447|453044737|FG000|Overall Study|Withdrawal by Subject|19|||
125931930|NCT03918447|453044738|FG001|Overall Study|Withdrawal by Subject|17|||
125931931|NCT03918447|453044737|FG000|Overall Study|Study Terminated by Sponsor|195|||
125931932|NCT03918447|453044738|FG001|Overall Study|Study Terminated by Sponsor|197|||
125931933|NCT03918447|453044737|FG000|Overall Study|Reason not Specified|0|||
125931934|NCT03918447|453044738|FG001|Overall Study|Reason not Specified|1|||
125931935|NCT03278613|453044739|FG000|Overall Study|Lost to Follow-up|3|||
125931936|NCT03278613|453044740|FG001|Overall Study|Lost to Follow-up|1|||
125931937|NCT01405456|453044741|FG000|Overall Study|Lost to Follow-up|2|||
125931938|NCT01405456|453044742|FG001|Overall Study|Lost to Follow-up|1|||
125931939|NCT01405456|453044741|FG000|Overall Study|Physician Decision|1|||
125931940|NCT01405456|453044742|FG001|Overall Study|Physician Decision|0|||
125931941|NCT02167893|453044743|FG000|Overall Study|Investigator transferred|85|||
125931942|NCT02167893|453044743|FG000|Overall Study|Investigator health reasons|10|||
125931943|NCT02167893|453044743|FG000|Overall Study|Case report forms not collected|68|||
125931944|NCT04818840|453044744|FG000|Overall Study|Lost to Follow-up|0|||
125931945|NCT04818840|453044745|FG001|Overall Study|Lost to Follow-up|5|||
125931946|NCT04818840|453044744|FG000|Overall Study|Physician Decision|1|||
125931947|NCT04818840|453044745|FG001|Overall Study|Physician Decision|0|||
125931948|NCT04818840|453044744|FG000|Overall Study|Site Terminated by Sponsor|0|||
125931949|NCT04818840|453044745|FG001|Overall Study|Site Terminated by Sponsor|3|||
125931950|NCT04818840|453044744|FG000|Overall Study|Study Terminated by Sponsor|43|||
125931951|NCT04818840|453044745|FG001|Overall Study|Study Terminated by Sponsor|7|||
125931952|NCT04818840|453044744|FG000|Overall Study|Withdrawal by Subject|0|||
125931953|NCT04818840|453044745|FG001|Overall Study|Withdrawal by Subject|1|||
125931954|NCT00793598|453046174|FG000|Overall Study|Patient Request|0|||
125931955|NCT00793598|453046175|FG001|Overall Study|Patient Request|1|||
125931956|NCT00793598|453046176|FG002|Overall Study|Patient Request|0|||
125931957|NCT00793598|453046177|FG003|Overall Study|Patient Request|0|||
125931958|NCT00793598|453046178|FG004|Overall Study|Patient Request|0|||
125931959|NCT00793598|453046179|FG005|Overall Study|Patient Request|0|||
125931960|NCT00793598|453046180|FG006|Overall Study|Patient Request|0|||
125931961|NCT00793598|453046181|FG007|Overall Study|Patient Request|0|||
125931962|NCT00793598|453046174|FG000|Overall Study|Protocol Violation|0|||
125931963|NCT00793598|453046175|FG001|Overall Study|Protocol Violation|0|||
125931964|NCT00793598|453046176|FG002|Overall Study|Protocol Violation|0|||
125931965|NCT00793598|453046177|FG003|Overall Study|Protocol Violation|0|||
125931966|NCT00793598|453046178|FG004|Overall Study|Protocol Violation|0|||
125931967|NCT00793598|453046179|FG005|Overall Study|Protocol Violation|0|||
125931968|NCT00793598|453046180|FG006|Overall Study|Protocol Violation|0|||
125931969|NCT00793598|453046181|FG007|Overall Study|Protocol Violation|1|||
125931970|NCT00793598|453046174|FG000|Overall Study|Subject not dosed|0|||
125931971|NCT00793598|453046175|FG001|Overall Study|Subject not dosed|0|||
125931972|NCT00793598|453046176|FG002|Overall Study|Subject not dosed|0|||
125931973|NCT00793598|453046177|FG003|Overall Study|Subject not dosed|0|||
125931974|NCT00793598|453046178|FG004|Overall Study|Subject not dosed|0|||
125931975|NCT00793598|453046179|FG005|Overall Study|Subject not dosed|1|||
125931976|NCT00793598|453046180|FG006|Overall Study|Subject not dosed|0|||
125931977|NCT00793598|453046181|FG007|Overall Study|Subject not dosed|0|||
125931978|NCT02310568|453046184|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
125931979|NCT02310568|453046185|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
125931980|NCT02310568|453046186|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
125931981|NCT02310568|453046187|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
125931982|NCT02310568|453046188|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
125931983|NCT02310568|453046184|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
125931984|NCT02310568|453046185|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
125931985|NCT02310568|453046186|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
125931986|NCT02310568|453046187|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
125931987|NCT02310568|453046188|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
125931988|NCT02310568|453046184|FG000|Stage 1 ( 4 Weeks)|Other|1|||
125931989|NCT02310568|453046185|FG001|Stage 1 ( 4 Weeks)|Other|1|||
125931990|NCT02310568|453046186|FG002|Stage 1 ( 4 Weeks)|Other|0|||
125931991|NCT02310568|453046187|FG003|Stage 1 ( 4 Weeks)|Other|0|||
125931992|NCT02310568|453046188|FG004|Stage 1 ( 4 Weeks)|Other|0|||
125931993|NCT02310568|453046184|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
125931994|NCT02310568|453046185|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
125931995|NCT02310568|453046186|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
125931996|NCT02310568|453046187|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
125931997|NCT02310568|453046188|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
125931998|NCT02310568|453046184|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
125931999|NCT02310568|453046185|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
125932000|NCT02310568|453046186|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
125932001|NCT02310568|453046187|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
125932002|NCT02310568|453046188|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
125932003|NCT02310568|453046184|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
125932004|NCT02310568|453046185|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
125932005|NCT02310568|453046186|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
125932006|NCT02310568|453046187|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
125932007|NCT02310568|453046188|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
125932008|NCT02310568|453046184|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
125932009|NCT02310568|453046185|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
126066126|NCT01136733|453533493|FG002|Phase 1b|Adverse Event|1|||
126066127|NCT01136733|453533494|FG003|Phase 1b|Adverse Event|0|||
125932010|NCT02310568|453046186|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
125932011|NCT02310568|453046187|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
125932012|NCT02310568|453046188|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
125932013|NCT02310568|453046184|FG000|Stage 2 (4 Weeks)|Other|0|||
125932014|NCT02310568|453046185|FG001|Stage 2 (4 Weeks)|Other|1|||
125932015|NCT02310568|453046186|FG002|Stage 2 (4 Weeks)|Other|1|||
125932016|NCT02310568|453046187|FG003|Stage 2 (4 Weeks)|Other|0|||
125932017|NCT02310568|453046188|FG004|Stage 2 (4 Weeks)|Other|0|||
125932018|NCT02310568|453046184|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
125932019|NCT02310568|453046185|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
125932020|NCT02310568|453046186|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
125932021|NCT02310568|453046187|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
125932022|NCT02310568|453046188|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
125932023|NCT02310568|453046184|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
125932024|NCT02310568|453046185|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
125932025|NCT02310568|453046186|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
125932026|NCT02310568|453046187|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
125932027|NCT02310568|453046188|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
125932028|NCT02310568|453046184|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
125932029|NCT02310568|453046185|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
125932030|NCT02310568|453046186|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
125932031|NCT02310568|453046187|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
125932032|NCT02310568|453046188|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
125932033|NCT02989194|453046194|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
125932034|NCT02989194|453046195|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
125932035|NCT02989194|453046196|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
125932036|NCT02989194|453046194|FG000|Overall Study|Lost to Follow-up|0|||
125932037|NCT02989194|453046195|FG001|Overall Study|Lost to Follow-up|1|||
125932038|NCT02989194|453046196|FG002|Overall Study|Lost to Follow-up|0|||
125932039|NCT02989194|453046194|FG000|Overall Study|Withdrawal by Subject|0|||
125932040|NCT02989194|453046195|FG001|Overall Study|Withdrawal by Subject|1|||
125932041|NCT02989194|453046196|FG002|Overall Study|Withdrawal by Subject|0|||
125932042|NCT01224431|453046199|FG000|Overall Study|not randomized|0|||
125932043|NCT01224431|453046200|FG001|Overall Study|not randomized|4|||
125932044|NCT01224431|453046199|FG000|Overall Study|no video record|0|||
125932045|NCT01224431|453046200|FG001|Overall Study|no video record|1|||
125932046|NCT03824912|453046207|FG000|Overall Study|Lost to Follow-up|18|||
125932047|NCT03824912|453046208|FG001|Overall Study|Lost to Follow-up|15|||
125932048|NCT03824912|453046209|FG002|Overall Study|Lost to Follow-up|8|||
125932049|NCT03824912|453046207|FG000|Overall Study|Negative Baseline Culture Result|118|||
125932050|NCT03824912|453046208|FG001|Overall Study|Negative Baseline Culture Result|112|||
125932051|NCT03824912|453046209|FG002|Overall Study|Negative Baseline Culture Result|57|||
125932052|NCT03824912|453046207|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125932053|NCT03824912|453046208|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125932054|NCT03824912|453046209|FG002|Overall Study|Non-Compliance with Study Drug|1|||
125932055|NCT03824912|453046207|FG000|Overall Study|Protocol Violation|1|||
125932056|NCT03824912|453046208|FG001|Overall Study|Protocol Violation|4|||
125932057|NCT03824912|453046209|FG002|Overall Study|Protocol Violation|1|||
125932058|NCT03824912|453046207|FG000|Overall Study|Withdrawal by Subject|3|||
125932059|NCT03824912|453046208|FG001|Overall Study|Withdrawal by Subject|2|||
125932060|NCT03824912|453046209|FG002|Overall Study|Withdrawal by Subject|1|||
125932061|NCT03824912|453046207|FG000|Overall Study|Participation in another study|0|||
125932062|NCT03824912|453046208|FG001|Overall Study|Participation in another study|1|||
125932063|NCT03824912|453046209|FG002|Overall Study|Participation in another study|0|||
125932064|NCT02511184|453046210|FG000|Overall Study|Death|1|||
125932065|NCT02511184|453046211|FG001|Overall Study|Death|0|||
125932066|NCT02511184|453046210|FG000|Overall Study|Lost to Follow-up|0|||
125932067|NCT02511184|453046211|FG001|Overall Study|Lost to Follow-up|1|||
125932068|NCT02511184|453046210|FG000|Overall Study|Study terminated by sponsor|1|||
125932069|NCT02511184|453046211|FG001|Overall Study|Study terminated by sponsor|5|||
125932070|NCT02511184|453046210|FG000|Overall Study|Withdrawal by Subject|0|||
125932071|NCT02511184|453046211|FG001|Overall Study|Withdrawal by Subject|1|||
125932072|NCT02041286|453046218|FG000|Overall Study|Adverse Event|1|||
125932073|NCT02254486|453046223|FG000|Overall Study|Adverse Event|1|||
125932074|NCT02254486|453046224|FG001|Overall Study|Adverse Event|1|||
125932075|NCT02254486|453046223|FG000|Overall Study|Lack of Efficacy|1|||
125932076|NCT02254486|453046224|FG001|Overall Study|Lack of Efficacy|0|||
125932077|NCT02254486|453046223|FG000|Overall Study|Lost to Follow-up|2|||
125932078|NCT02254486|453046224|FG001|Overall Study|Lost to Follow-up|4|||
125932079|NCT02254486|453046223|FG000|Overall Study|Protocol Violation|1|||
126113618|NCT01667107|453711346|FG000|Overall Study|Adverse Event|4|||
125932080|NCT02254486|453046224|FG001|Overall Study|Protocol Violation|2|||
125932081|NCT02254486|453046223|FG000|Overall Study|Withdrawal by Subject|17|||
125932082|NCT02254486|453046224|FG001|Overall Study|Withdrawal by Subject|15|||
126113619|NCT01667107|453711347|FG001|Overall Study|Adverse Event|3|||
125932083|NCT02254486|453046223|FG000|Overall Study|GFR<60mL/min|16|||
125932084|NCT02254486|453046224|FG001|Overall Study|GFR<60mL/min|21|||
125932085|NCT02254486|453046223|FG000|Overall Study|Various|12|||
125932086|NCT02254486|453046224|FG001|Overall Study|Various|12|||
125932087|NCT01350414|453046231|FG000|Overall Study|Lost to Follow-up|13|||
125932088|NCT01350414|453046231|FG000|Overall Study|Withdrawal by Subject|4|||
125932089|NCT01350414|453046231|FG000|Overall Study|Physician Decision|2|||
125932090|NCT04166435|453046232|FG000|Overall Study|2 patients ineligible for response|2|||
125932091|NCT03033394|453046236|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
125932092|NCT03033394|453046236|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
125932093|NCT03033394|453046236|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
125932094|NCT03033394|453046236|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
125932095|NCT03033394|453046236|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
125932096|NCT02036294|453046237|FG000|Overall Study|Death|7|||
125932097|NCT02036294|453046238|FG001|Overall Study|Death|8|||
125932098|NCT02036294|453046237|FG000|Overall Study|Withdrawal by Subject|2|||
125932099|NCT02036294|453046238|FG001|Overall Study|Withdrawal by Subject|3|||
125932100|NCT00356369|453046239|FG000|Active Phase|Withdrawal by Subject|2|||
125932101|NCT00356369|453046240|FG001|Active Phase|Withdrawal by Subject|1|||
125932102|NCT02117648|453046244|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
125932103|NCT02117648|453046244|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
125932104|NCT02117648|453046244|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
125932105|NCT02117648|453046244|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
125932106|NCT02117648|453046244|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
125932107|NCT02117648|453046244|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
125932108|NCT02117648|453046244|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
125932109|NCT02117648|453046244|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
125932110|NCT02117648|453046244|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
125932111|NCT02117648|453046244|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
125932112|NCT02117648|453046244|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
125932113|NCT02407704|453046260|FG000|Overall Study|Lost to Follow-up|0|||
125932114|NCT02407704|453046261|FG001|Overall Study|Lost to Follow-up|0|||
125932115|NCT02407704|453046262|FG002|Overall Study|Lost to Follow-up|0|||
125932116|NCT02407704|453046263|FG003|Overall Study|Lost to Follow-up|2|||
125932117|NCT02407704|453046260|FG000|Overall Study|Protocol Violation|0|||
125932118|NCT02407704|453046261|FG001|Overall Study|Protocol Violation|0|||
125932119|NCT02407704|453046262|FG002|Overall Study|Protocol Violation|0|||
125932120|NCT02407704|453046263|FG003|Overall Study|Protocol Violation|1|||
125932121|NCT02407704|453046260|FG000|Overall Study|Withdrawal by Subject|0|||
125932122|NCT02407704|453046261|FG001|Overall Study|Withdrawal by Subject|0|||
125932123|NCT02407704|453046262|FG002|Overall Study|Withdrawal by Subject|1|||
125932124|NCT02407704|453046263|FG003|Overall Study|Withdrawal by Subject|0|||
125932125|NCT03944954|453046264|FG000|Overall Study|Withdrawal by Subject|22|||
125932126|NCT03944954|453046265|FG001|Overall Study|Withdrawal by Subject|4|||
125932127|NCT03944954|453046264|FG000|Overall Study|Lost to Follow-up|18|||
125932128|NCT03944954|453046265|FG001|Overall Study|Lost to Follow-up|0|||
125932129|NCT03944954|453046264|FG000|Overall Study|Failed Medical Screening|7|||
125932130|NCT03944954|453046265|FG001|Overall Study|Failed Medical Screening|0|||
125932131|NCT02730455|453046266|FG000|Overall Study|Death|5|||
125932132|NCT02730455|453046267|FG001|Overall Study|Death|6|||
125932133|NCT02730455|453046268|FG002|Overall Study|Death|4|||
125932134|NCT02730455|453046266|FG000|Overall Study|Consent withdrawn|2|||
125932135|NCT02730455|453046267|FG001|Overall Study|Consent withdrawn|4|||
125932136|NCT02730455|453046268|FG002|Overall Study|Consent withdrawn|1|||
125932137|NCT02730455|453046266|FG000|Overall Study|Lost to Follow-up|3|||
125932138|NCT02730455|453046267|FG001|Overall Study|Lost to Follow-up|1|||
125932139|NCT02730455|453046268|FG002|Overall Study|Lost to Follow-up|4|||
125932140|NCT02730455|453046266|FG000|Overall Study|Other|1|||
125932141|NCT02730455|453046267|FG001|Overall Study|Other|1|||
125932142|NCT02730455|453046268|FG002|Overall Study|Other|2|||
125932143|NCT02730455|453046266|FG000|Overall Study|Other|2|||
125932144|NCT02730455|453046267|FG001|Overall Study|Other|2|||
126066128|NCT01136733|453533495|FG004|Phase 1b|Adverse Event|0|||
126066129|NCT01136733|453533496|FG005|Phase 1b|Adverse Event|0|||
125932145|NCT02730455|453046268|FG002|Overall Study|Other|0|||
125932146|NCT02268084|453046275|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
125932147|NCT02268084|453046276|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
125932148|NCT02268084|453046275|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
125932149|NCT02268084|453046276|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
125932150|NCT05227027|453046277|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
125932151|NCT05227027|453046278|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
125932152|NCT01683383|453046279|FG000|Overall Study|Infant was not transported|1|||
125932153|NCT01683383|453046280|FG001|Overall Study|Infant was not transported|0|||
126066130|NCT01136733|453533497|FG006|Phase 1b|Adverse Event|0|||
126113620|NCT01667107|453711346|FG000|Overall Study|Tolerability issues|0|||
126113621|NCT01667107|453711347|FG001|Overall Study|Tolerability issues|2|||
126113622|NCT01667107|453711346|FG000|Overall Study|Protocol Violation|0|||
126113623|NCT01667107|453711347|FG001|Overall Study|Protocol Violation|1|||
126113624|NCT01667107|453711346|FG000|Overall Study|Lack of Efficacy|0|||
126113625|NCT01667107|453711347|FG001|Overall Study|Lack of Efficacy|1|||
126113626|NCT01162239|453711348|FG000|Treatment Phase|Withdrawal by Subject|1|||
126113627|NCT01162239|453711349|FG001|Treatment Phase|Withdrawal by Subject|3|||
126113628|NCT01162239|453711350|FG002|Treatment Phase|Withdrawal by Subject|2|||
126113629|NCT01162239|453711351|FG003|Treatment Phase|Withdrawal by Subject|3|||
126113630|NCT01162239|453711348|FG000|Treatment Phase|Death|0|||
126113631|NCT01162239|453711349|FG001|Treatment Phase|Death|0|||
126113632|NCT01162239|453711350|FG002|Treatment Phase|Death|0|||
126113633|NCT01162239|453711351|FG003|Treatment Phase|Death|1|||
126113634|NCT01162239|453711348|FG000|Treatment Phase|Lost to Follow-up|5|||
126113635|NCT01162239|453711349|FG001|Treatment Phase|Lost to Follow-up|4|||
126113636|NCT01162239|453711350|FG002|Treatment Phase|Lost to Follow-up|2|||
126113637|NCT01162239|453711351|FG003|Treatment Phase|Lost to Follow-up|1|||
126113638|NCT01162239|453711348|FG000|Extended Follow-up|Lost to Follow-up|8|||
126113639|NCT01162239|453711349|FG001|Extended Follow-up|Lost to Follow-up|13|||
126113640|NCT01162239|453711350|FG002|Extended Follow-up|Lost to Follow-up|8|||
126113641|NCT01162239|453711351|FG003|Extended Follow-up|Lost to Follow-up|6|||
126113642|NCT00228566|453711352|FG000|Overall Study|Adverse Event|31|||
126113643|NCT00228566|453711352|FG000|Overall Study|Lack of Efficacy|14|||
126113644|NCT00228566|453711352|FG000|Overall Study|Lost to Follow-up|16|||
126113645|NCT00228566|453711352|FG000|Overall Study|Physician Decision|5|||
126113646|NCT00228566|453711352|FG000|Overall Study|Withdrawal by Subject|4|||
126113647|NCT00228566|453711352|FG000|Overall Study|Miscellaneous|1|||
126113648|NCT04448756|453711353|FG000|Overall Study|Adverse Event|0|||
126113649|NCT04448756|453711354|FG001|Overall Study|Adverse Event|1|||
126113650|NCT04448756|453711355|FG002|Overall Study|Adverse Event|0|||
126113651|NCT04448756|453711353|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
126113652|NCT04448756|453711354|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
126113653|NCT04448756|453711355|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
126113654|NCT04448756|453711353|FG000|Overall Study|Withdrawal by Subject|0|||
126113655|NCT04448756|453711354|FG001|Overall Study|Withdrawal by Subject|3|||
126113656|NCT04448756|453711355|FG002|Overall Study|Withdrawal by Subject|1|||
126113657|NCT04448756|453711353|FG000|Overall Study|Death|2|||
126113658|NCT04448756|453711354|FG001|Overall Study|Death|1|||
126113659|NCT04448756|453711355|FG002|Overall Study|Death|0|||
126113660|NCT00232141|453711356|FG000|Overall Study|Adverse Event|9|||
126113661|NCT00232141|453711357|FG001|Overall Study|Adverse Event|4|||
126113662|NCT00232141|453711356|FG000|Overall Study|Lack of Efficacy|0|||
126113663|NCT00232141|453711357|FG001|Overall Study|Lack of Efficacy|3|||
126113664|NCT00232141|453711356|FG000|Overall Study|Lost to Follow-up|9|||
126113665|NCT00232141|453711357|FG001|Overall Study|Lost to Follow-up|6|||
126113666|NCT00232141|453711356|FG000|Overall Study|Other|8|||
126113667|NCT00232141|453711357|FG001|Overall Study|Other|10|||
126113668|NCT00232141|453711356|FG000|Overall Study|Withdrawal by Subject|5|||
126113669|NCT00232141|453711357|FG001|Overall Study|Withdrawal by Subject|3|||
125932154|NCT00855920|453046281|FG000|Overall Study|Protocol Violation|0|||
125932155|NCT00855920|453046282|FG001|Overall Study|Protocol Violation|0|||
125932156|NCT00855920|453046283|FG002|Overall Study|Protocol Violation|2|||
125932157|NCT00855920|453046281|FG000|Overall Study|Adverse Event|2|||
125932158|NCT00855920|453046282|FG001|Overall Study|Adverse Event|1|||
125932159|NCT00855920|453046283|FG002|Overall Study|Adverse Event|1|||
126113670|NCT04572854|453711358|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
126113671|NCT04572854|453711359|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
126113672|NCT04572854|453711360|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
126113673|NCT04572854|453711361|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
126113674|NCT04572854|453711358|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
126113675|NCT04572854|453711359|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
126113676|NCT04572854|453711360|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
125932160|NCT00855920|453046281|FG000|Overall Study|Lack of Efficacy|2|||
125932161|NCT00855920|453046282|FG001|Overall Study|Lack of Efficacy|2|||
126113677|NCT04572854|453711361|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
126113678|NCT01093326|453711363|FG000|Overall Study|Death|0|||
126113679|NCT01093326|453711364|FG001|Overall Study|Death|1|||
126113680|NCT01093326|453711365|FG002|Overall Study|Death|0|||
126113681|NCT01093326|453711363|FG000|Overall Study|Lack of Efficacy|7|||
126113682|NCT01093326|453711364|FG001|Overall Study|Lack of Efficacy|6|||
125932162|NCT00855920|453046283|FG002|Overall Study|Lack of Efficacy|2|||
126113683|NCT01093326|453711365|FG002|Overall Study|Lack of Efficacy|3|||
125932163|NCT00855920|453046281|FG000|Overall Study|Withdrawal by Subject|2|||
126113684|NCT01093326|453711363|FG000|Overall Study|Lost to Follow-up|2|||
126113685|NCT01093326|453711364|FG001|Overall Study|Lost to Follow-up|5|||
126113686|NCT01093326|453711365|FG002|Overall Study|Lost to Follow-up|4|||
126113687|NCT01093326|453711363|FG000|Overall Study|Physician Decision|3|||
125932164|NCT00855920|453046282|FG001|Overall Study|Withdrawal by Subject|3|||
125932165|NCT00855920|453046283|FG002|Overall Study|Withdrawal by Subject|2|||
125932166|NCT00855920|453046281|FG000|Overall Study|Lost to Follow-up|1|||
125932167|NCT00855920|453046282|FG001|Overall Study|Lost to Follow-up|0|||
125932168|NCT00855920|453046283|FG002|Overall Study|Lost to Follow-up|2|||
125932169|NCT00855920|453046281|FG000|Overall Study|Death|0|||
125932170|NCT00855920|453046282|FG001|Overall Study|Death|1|||
125932171|NCT00855920|453046283|FG002|Overall Study|Death|0|||
125932172|NCT00855920|453046281|FG000|Overall Study|Decision by the sponsor|0|||
125932173|NCT00855920|453046282|FG001|Overall Study|Decision by the sponsor|1|||
125932174|NCT00855920|453046283|FG002|Overall Study|Decision by the sponsor|1|||
125932175|NCT00855920|453046281|FG000|Overall Study|Other than specified above|1|||
125932176|NCT00855920|453046282|FG001|Overall Study|Other than specified above|1|||
125932177|NCT00855920|453046283|FG002|Overall Study|Other than specified above|1|||
125932178|NCT00996307|453046284|FG000|Overall Study|Adverse Event|0|||
125932179|NCT00996307|453046285|FG001|Overall Study|Adverse Event|1|||
125932180|NCT00996307|453046286|FG002|Overall Study|Adverse Event|0|||
125932181|NCT00996307|453046287|FG003|Overall Study|Adverse Event|0|||
125932182|NCT00996307|453046284|FG000|Overall Study|Withdrawal by Subject|3|||
125932183|NCT00996307|453046285|FG001|Overall Study|Withdrawal by Subject|2|||
125932184|NCT00996307|453046286|FG002|Overall Study|Withdrawal by Subject|5|||
125932185|NCT00996307|453046287|FG003|Overall Study|Withdrawal by Subject|5|||
125932186|NCT00996307|453046284|FG000|Overall Study|Lost to Follow-up|13|||
125932187|NCT00996307|453046285|FG001|Overall Study|Lost to Follow-up|13|||
125932188|NCT00996307|453046286|FG002|Overall Study|Lost to Follow-up|7|||
125932189|NCT00996307|453046287|FG003|Overall Study|Lost to Follow-up|15|||
125932190|NCT00996307|453046284|FG000|Overall Study|Administrative reason|0|||
125932191|NCT00996307|453046285|FG001|Overall Study|Administrative reason|1|||
125932192|NCT00996307|453046286|FG002|Overall Study|Administrative reason|0|||
125932193|NCT00996307|453046287|FG003|Overall Study|Administrative reason|0|||
125932194|NCT00996307|453046284|FG000|Overall Study|Unable to classify|4|||
125932195|NCT00996307|453046285|FG001|Overall Study|Unable to classify|0|||
125932196|NCT00996307|453046286|FG002|Overall Study|Unable to classify|2|||
125932197|NCT00996307|453046287|FG003|Overall Study|Unable to classify|1|||
125932198|NCT01365910|453046288|FG000|Overall Study|Withdrawal by Subject|7|||
125932199|NCT01365910|453046288|FG000|Overall Study|disease progression|18|||
125932200|NCT01365910|453046288|FG000|Overall Study|Adverse Event|3|||
125932201|NCT01365910|453046288|FG000|Overall Study|other complicating disease|1|||
126066131|NCT01136733|453533491|FG000|Phase 1b|Participant Choice|0|||
126066132|NCT01136733|453533492|FG001|Phase 1b|Participant Choice|0|||
126066133|NCT01136733|453533493|FG002|Phase 1b|Participant Choice|1|||
126066134|NCT01136733|453533494|FG003|Phase 1b|Participant Choice|0|||
126066135|NCT01136733|453533495|FG004|Phase 1b|Participant Choice|0|||
126066136|NCT01136733|453533496|FG005|Phase 1b|Participant Choice|0|||
126066137|NCT01136733|453533497|FG006|Phase 1b|Participant Choice|0|||
126066138|NCT01136733|453533491|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
126066139|NCT01136733|453533492|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
126066140|NCT01136733|453533493|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
126066141|NCT01136733|453533494|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
126066142|NCT01136733|453533495|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
126066143|NCT01136733|453533496|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
126066144|NCT01136733|453533497|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
126066145|NCT01136733|453533491|FG000|Phase 1b|Clinical Progression|1|||
126066146|NCT01136733|453533492|FG001|Phase 1b|Clinical Progression|1|||
126066147|NCT01136733|453533493|FG002|Phase 1b|Clinical Progression|0|||
126066148|NCT01136733|453533494|FG003|Phase 1b|Clinical Progression|0|||
126066149|NCT01136733|453533495|FG004|Phase 1b|Clinical Progression|0|||
126066150|NCT01136733|453533496|FG005|Phase 1b|Clinical Progression|0|||
126066151|NCT01136733|453533497|FG006|Phase 1b|Clinical Progression|0|||
126066152|NCT01136733|453533491|FG000|Phase 2|Disease Progression|0|||
126066153|NCT01136733|453533492|FG001|Phase 2|Disease Progression|0|||
126066154|NCT01136733|453533493|FG002|Phase 2|Disease Progression|0|||
126066155|NCT01136733|453533494|FG003|Phase 2|Disease Progression|0|||
125932202|NCT01365910|453046288|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
125932203|NCT00536198|453046289|FG000|Overall Study|Lost to Follow-up|15|||
125932204|NCT00536198|453046290|FG001|Overall Study|Lost to Follow-up|14|||
125932205|NCT00536198|453046289|FG000|Overall Study|Withdrawal by Subject|16|||
125932206|NCT00536198|453046290|FG001|Overall Study|Withdrawal by Subject|12|||
125932207|NCT00536198|453046289|FG000|Overall Study|Adverse Event|2|||
125932208|NCT00536198|453046290|FG001|Overall Study|Adverse Event|2|||
126066156|NCT01136733|453533495|FG004|Phase 2|Disease Progression|30|||
125932209|NCT00536198|453046289|FG000|Overall Study|Rescue|3|||
125932210|NCT00536198|453046290|FG001|Overall Study|Rescue|9|||
125932211|NCT00536198|453046289|FG000|Overall Study|Pregnancy|1|||
125932212|NCT00536198|453046290|FG001|Overall Study|Pregnancy|1|||
125932213|NCT00536198|453046289|FG000|Overall Study|Protocol Violation|0|||
126066157|NCT01136733|453533496|FG005|Phase 2|Disease Progression|32|||
126066158|NCT01136733|453533497|FG006|Phase 2|Disease Progression|38|||
126066159|NCT01136733|453533491|FG000|Phase 2|Adverse Event|0|||
126066160|NCT01136733|453533492|FG001|Phase 2|Adverse Event|0|||
125932214|NCT00536198|453046290|FG001|Overall Study|Protocol Violation|1|||
125932215|NCT02013791|453046291|FG000|Period 1|Lost to Follow-up|0|||
125932216|NCT02013791|453046292|FG001|Period 1|Lost to Follow-up|0|||
125932217|NCT02013791|453046293|FG002|Period 1|Lost to Follow-up|0|||
125932218|NCT02013791|453046294|FG003|Period 1|Lost to Follow-up|1|||
125932219|NCT02013791|453046295|FG004|Period 1|Lost to Follow-up|0|||
125932220|NCT02013791|453046296|FG005|Period 1|Lost to Follow-up|0|||
125932221|NCT02013791|453046297|FG006|Period 1|Lost to Follow-up|1|||
125932222|NCT02013791|453046298|FG007|Period 1|Lost to Follow-up|1|||
125932223|NCT02013791|453046299|FG008|Period 1|Lost to Follow-up|0|||
125932224|NCT02013791|453046291|FG000|Period 1|Other Miscellaneous Reasons|0|||
125932225|NCT02013791|453046292|FG001|Period 1|Other Miscellaneous Reasons|2|||
125932226|NCT02013791|453046293|FG002|Period 1|Other Miscellaneous Reasons|0|||
125932227|NCT02013791|453046294|FG003|Period 1|Other Miscellaneous Reasons|0|||
125932228|NCT02013791|453046295|FG004|Period 1|Other Miscellaneous Reasons|0|||
125932229|NCT02013791|453046296|FG005|Period 1|Other Miscellaneous Reasons|0|||
125932230|NCT02013791|453046297|FG006|Period 1|Other Miscellaneous Reasons|0|||
125932231|NCT02013791|453046298|FG007|Period 1|Other Miscellaneous Reasons|0|||
125932232|NCT02013791|453046299|FG008|Period 1|Other Miscellaneous Reasons|0|||
125932233|NCT03798483|453046300|FG000|Overall Study|Lost to Follow-up|2|||
125932234|NCT00640601|453046302|FG000|Overall Study|Adverse Event|43|||
125932235|NCT00640601|453046302|FG000|Overall Study|Withdrawal by Subject|20|||
125932236|NCT00640601|453046302|FG000|Overall Study|Protocol Violation|6|||
125932237|NCT00640601|453046302|FG000|Overall Study|Lack of Efficacy|16|||
125932238|NCT00640601|453046302|FG000|Overall Study|Lost to Follow-up|9|||
125932239|NCT00640601|453046302|FG000|Overall Study|Physician Decision|8|||
125932240|NCT00640601|453046302|FG000|Overall Study|treatment naive, combination therapy|10|||
125932241|NCT01691781|453046308|FG000|Overall Study|Withdrawal by Subject|4|||
125932242|NCT01691781|453046309|FG001|Overall Study|Withdrawal by Subject|3|||
125932243|NCT01691781|453046308|FG000|Overall Study|Physician Decision|1|||
125932244|NCT01691781|453046309|FG001|Overall Study|Physician Decision|1|||
125932245|NCT01691781|453046308|FG000|Overall Study|Protocol Violation|2|||
125932246|NCT01691781|453046309|FG001|Overall Study|Protocol Violation|2|||
125932247|NCT01691781|453046308|FG000|Overall Study|Adverse Event|0|||
125932248|NCT01691781|453046309|FG001|Overall Study|Adverse Event|1|||
125932249|NCT01927367|453046310|FG000|Overall Study|Withdrawal by Subject|7|||
125932250|NCT01927367|453046311|FG001|Overall Study|Withdrawal by Subject|4|||
125932251|NCT01927367|453046310|FG000|Overall Study|No baseline data|0|||
125932252|NCT01927367|453046311|FG001|Overall Study|No baseline data|1|||
125932253|NCT00598832|453046314|FG000|Overall Study|Lack of Efficacy|3|||
125932254|NCT00598832|453046315|FG001|Overall Study|Lack of Efficacy|7|||
125932255|NCT00598832|453046314|FG000|Overall Study|Adverse Event|6|||
125932256|NCT00598832|453046315|FG001|Overall Study|Adverse Event|2|||
125932257|NCT00598832|453046314|FG000|Overall Study|Withdrawal by Subject|25|||
125932258|NCT00598832|453046315|FG001|Overall Study|Withdrawal by Subject|36|||
125932259|NCT00598832|453046314|FG000|Overall Study|Protocol Violation|0|||
125932260|NCT00598832|453046315|FG001|Overall Study|Protocol Violation|2|||
125932261|NCT00598832|453046314|FG000|Overall Study|Lost to Follow-up|24|||
125932262|NCT00598832|453046315|FG001|Overall Study|Lost to Follow-up|29|||
125932263|NCT00598832|453046314|FG000|Overall Study|Pregnancy|2|||
125932264|NCT00598832|453046315|FG001|Overall Study|Pregnancy|2|||
125932265|NCT00598832|453046314|FG000|Overall Study|Physician Decision|1|||
125932266|NCT00598832|453046315|FG001|Overall Study|Physician Decision|4|||
125932267|NCT00598832|453046314|FG000|Overall Study|Non compliance|1|||
125932268|NCT00598832|453046315|FG001|Overall Study|Non compliance|0|||
125932269|NCT02760069|453046316|FG000|Overall Study|Withdrawal by Subject|0|||
125932270|NCT02760069|453046317|FG001|Overall Study|Withdrawal by Subject|1|||
125932271|NCT02760069|453046318|FG002|Overall Study|Withdrawal by Subject|1|||
125932272|NCT03064451|453046320|FG000|Overall Study|Lost to Follow-up|1|||
125932273|NCT03064451|453046320|FG000|Overall Study|Mapping Failure|4|||
125932274|NCT03064451|453046320|FG000|Overall Study|Exited prior to procedure|8|||
125932275|NCT03064451|453046320|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
126113688|NCT01093326|453711364|FG001|Overall Study|Physician Decision|1|||
126113689|NCT01093326|453711365|FG002|Overall Study|Physician Decision|3|||
126113690|NCT01093326|453711363|FG000|Overall Study|Withdrawal by Subject|30|||
126113691|NCT01093326|453711364|FG001|Overall Study|Withdrawal by Subject|27|||
125932276|NCT00850564|453046325|FG000|Overall Study|Withdrawal by Subject|2|||
125932277|NCT05355805|453046326|FG000|Overall Study|Lost to Follow-up|6|||
125932278|NCT05355805|453046327|FG001|Overall Study|Lost to Follow-up|11|||
125932279|NCT05355805|453046328|FG002|Overall Study|Lost to Follow-up|10|||
125932280|NCT05355805|453046329|FG003|Overall Study|Lost to Follow-up|6|||
125932281|NCT05355805|453046326|FG000|Overall Study|Decision by Sponsor|0|||
125932282|NCT05355805|453046327|FG001|Overall Study|Decision by Sponsor|0|||
125932283|NCT05355805|453046328|FG002|Overall Study|Decision by Sponsor|1|||
125932284|NCT05355805|453046329|FG003|Overall Study|Decision by Sponsor|0|||
125932285|NCT05355805|453046326|FG000|Overall Study|Withdrawal by Subject|7|||
125932286|NCT05355805|453046327|FG001|Overall Study|Withdrawal by Subject|14|||
125932287|NCT05355805|453046328|FG002|Overall Study|Withdrawal by Subject|15|||
125932288|NCT05355805|453046329|FG003|Overall Study|Withdrawal by Subject|13|||
125932289|NCT02154490|453048064|FG000|Overall Study|No tissue submitted|23|||
125932290|NCT02154490|453048064|FG000|Overall Study|No biomarker results|167|||
125932291|NCT02154490|453048064|FG000|Overall Study|Not assigned to a sub-study|270|||
125932292|NCT02154490|453048064|FG000|Overall Study|Did not register to a sub-study|749|||
125932293|NCT02961751|453048065|FG000|Overall Study|Lost to Follow-up|11|||
125932294|NCT02961751|453048065|FG000|Overall Study|Physician Decision|2|||
125932295|NCT02961751|453048065|FG000|Overall Study|Not Eligible at Enrollment|1|||
125932296|NCT02961751|453048065|FG000|Overall Study|Protocol Violation|1|||
125932297|NCT02373202|453048066|FG000|Overall Study|Adverse Event|2|||
125932298|NCT02373202|453048067|FG001|Overall Study|Adverse Event|5|||
125932299|NCT02373202|453048068|FG002|Overall Study|Adverse Event|2|||
125932300|NCT02373202|453048069|FG003|Overall Study|Adverse Event|1|||
125932301|NCT02373202|453048066|FG000|Overall Study|Lack of Efficacy|0|||
125932302|NCT02373202|453048067|FG001|Overall Study|Lack of Efficacy|0|||
125932303|NCT02373202|453048068|FG002|Overall Study|Lack of Efficacy|1|||
125932304|NCT02373202|453048069|FG003|Overall Study|Lack of Efficacy|0|||
125932305|NCT02373202|453048066|FG000|Overall Study|Other|0|||
125932306|NCT02373202|453048067|FG001|Overall Study|Other|1|||
125932307|NCT02373202|453048068|FG002|Overall Study|Other|0|||
125932308|NCT02373202|453048069|FG003|Overall Study|Other|0|||
125932309|NCT01411228|453048071|FG000|Overall Study|Lost to Follow-up|0|||
125932310|NCT01411228|453048072|FG001|Overall Study|Lost to Follow-up|0|||
125932311|NCT01411228|453048073|FG002|Overall Study|Lost to Follow-up|1|||
125932312|NCT01411228|453048071|FG000|Overall Study|Withdrawal by Subject|1|||
125932313|NCT01411228|453048072|FG001|Overall Study|Withdrawal by Subject|0|||
125932314|NCT01411228|453048073|FG002|Overall Study|Withdrawal by Subject|0|||
125932315|NCT03909295|453048074|FG000|Overall Study|Adverse Event|2|||
125932316|NCT03909295|453048074|FG000|Overall Study|Study terminated by sponsor|50|||
125932317|NCT01752907|453048078|FG000|Overall Study|Withdrawal by Subject|4|||
125932318|NCT01752907|453048079|FG001|Overall Study|Withdrawal by Subject|10|||
125932319|NCT01752907|453048078|FG000|Overall Study|Lost to Follow-up|2|||
125932320|NCT01752907|453048079|FG001|Overall Study|Lost to Follow-up|1|||
125932321|NCT01752907|453048078|FG000|Overall Study|Decision by Sponsor|6|||
125932322|NCT01752907|453048079|FG001|Overall Study|Decision by Sponsor|9|||
125932323|NCT00609492|453048086|FG000|Overall Study|Withdrawal by Subject|0|||
125932324|NCT00609492|453048087|FG001|Overall Study|Withdrawal by Subject|2|||
125932325|NCT00609492|453048088|FG002|Overall Study|Withdrawal by Subject|3|||
125932326|NCT00609492|453048086|FG000|Overall Study|Lost to Follow-up|1|||
125932327|NCT00609492|453048087|FG001|Overall Study|Lost to Follow-up|1|||
125932328|NCT00609492|453048088|FG002|Overall Study|Lost to Follow-up|4|||
125932329|NCT00720434|453048089|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
125932330|NCT00720434|453048090|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
125932331|NCT00720434|453048091|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
125932332|NCT00720434|453048092|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
125932333|NCT00720434|453048089|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
125932334|NCT00720434|453048090|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
125932335|NCT00720434|453048091|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
125932336|NCT00720434|453048092|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
125932337|NCT00720434|453048089|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
125932338|NCT00720434|453048090|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
125932339|NCT00720434|453048091|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
125932340|NCT00720434|453048092|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
125932341|NCT00720434|453048089|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
125932342|NCT00720434|453048090|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
125932343|NCT00720434|453048091|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
125932344|NCT00720434|453048092|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
125932345|NCT00720434|453048089|FG000|Open-Label Period (Week 5-72)|Other|4|||
125932346|NCT00720434|453048090|FG001|Open-Label Period (Week 5-72)|Other|3|||
125932347|NCT00720434|453048091|FG002|Open-Label Period (Week 5-72)|Other|3|||
125932348|NCT00720434|453048092|FG003|Open-Label Period (Week 5-72)|Other|2|||
125932349|NCT03510884|453048095|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
125932350|NCT03510884|453048096|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
125932351|NCT03510884|453048097|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
125932352|NCT03510884|453048098|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
125932353|NCT03510884|453048095|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
125932354|NCT03510884|453048096|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
125932355|NCT03510884|453048097|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
125932356|NCT03510884|453048098|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
125932357|NCT03510884|453048095|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
125932358|NCT03510884|453048096|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
125932359|NCT03510884|453048097|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
125932360|NCT03510884|453048098|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
125932361|NCT03510884|453048095|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
126113692|NCT01093326|453711365|FG002|Overall Study|Withdrawal by Subject|26|||
126113693|NCT01093326|453711363|FG000|Overall Study|Adverse Event|2|||
126113694|NCT01093326|453711364|FG001|Overall Study|Adverse Event|1|||
126113695|NCT01093326|453711365|FG002|Overall Study|Adverse Event|4|||
126113696|NCT01093326|453711363|FG000|Overall Study|Other|0|||
126113697|NCT01093326|453711364|FG001|Overall Study|Other|0|||
126113698|NCT01093326|453711365|FG002|Overall Study|Other|1|||
126113699|NCT01444456|453711366|FG000|Overall Study|Withdrawal by Subject|21|||
126113700|NCT01444456|453711366|FG000|Overall Study|Physician Decision|9|||
126113701|NCT01444456|453711366|FG000|Overall Study|Lost to Follow-up|37|||
126113702|NCT01444456|453711366|FG000|Overall Study|Death|73|||
126113703|NCT01444456|453711366|FG000|Overall Study|Ineligibility determined|23|||
126113704|NCT01444456|453711366|FG000|Overall Study|Other|18|||
126113705|NCT01444456|453711366|FG000|Overall Study|Not treated|104|||
126113706|NCT04263896|453711367|FG000|Overall Study|Withdrawal by Subject|2|||
126113707|NCT04263896|453711368|FG001|Overall Study|Withdrawal by Subject|4|||
126113708|NCT04263896|453711367|FG000|Overall Study|converted to open procedure|0|||
126113709|NCT04263896|453711368|FG001|Overall Study|converted to open procedure|1|||
126113710|NCT04263896|453711367|FG000|Overall Study|Lost to Follow-up|9|||
126113711|NCT04263896|453711368|FG001|Overall Study|Lost to Follow-up|11|||
126113712|NCT04263896|453711367|FG000|Overall Study|surveys lost in mail|5|||
126113713|NCT04263896|453711368|FG001|Overall Study|surveys lost in mail|3|||
126113714|NCT04263896|453711367|FG000|Overall Study|excluded from analysis|1|||
126113715|NCT04263896|453711368|FG001|Overall Study|excluded from analysis|0|||
126113716|NCT04313153|453712552|FG000|Overall Study|Adverse Event (includes Death)|14|||
126113717|NCT04313153|453712553|FG001|Overall Study|Adverse Event (includes Death)|19|||
126113718|NCT04313153|453712554|FG002|Overall Study|Adverse Event (includes Death)|10|||
126113719|NCT04313153|453712552|FG000|Overall Study|Physician Decision|4|||
126113720|NCT04313153|453712553|FG001|Overall Study|Physician Decision|2|||
126113721|NCT04313153|453712554|FG002|Overall Study|Physician Decision|1|||
126113722|NCT04313153|453712552|FG000|Overall Study|Withdrawal by Subject|7|||
126113723|NCT04313153|453712553|FG001|Overall Study|Withdrawal by Subject|6|||
126113724|NCT04313153|453712554|FG002|Overall Study|Withdrawal by Subject|2|||
126113725|NCT04313153|453712552|FG000|Overall Study|Lack of Efficacy|3|||
126113726|NCT04313153|453712553|FG001|Overall Study|Lack of Efficacy|3|||
126113727|NCT04313153|453712554|FG002|Overall Study|Lack of Efficacy|0|||
126113728|NCT04313153|453712552|FG000|Overall Study|Lost to Follow-up|1|||
126113729|NCT04313153|453712553|FG001|Overall Study|Lost to Follow-up|0|||
126113730|NCT04313153|453712554|FG002|Overall Study|Lost to Follow-up|2|||
126113731|NCT04313153|453712552|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
126113732|NCT04313153|453712553|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
126113733|NCT04313153|453712554|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
126113734|NCT04313153|453712552|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
126113735|NCT04313153|453712553|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
126113736|NCT04313153|453712554|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
126113737|NCT04313153|453712552|FG000|Overall Study|Change in Dialysis Modality|0|||
126113738|NCT04313153|453712553|FG001|Overall Study|Change in Dialysis Modality|1|||
126113739|NCT04313153|453712554|FG002|Overall Study|Change in Dialysis Modality|2|||
126113740|NCT04313153|453712552|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
125932362|NCT03510884|453048096|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
125932363|NCT03510884|453048097|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
125932364|NCT03510884|453048098|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
125932365|NCT03510884|453048095|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
125932366|NCT03510884|453048096|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
125932367|NCT03510884|453048097|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
125932368|NCT03510884|453048098|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
125932369|NCT03510884|453048095|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
125932370|NCT03510884|453048096|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
125932371|NCT03510884|453048097|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
125932372|NCT03510884|453048098|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
125932373|NCT03510884|453048095|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
125932374|NCT03510884|453048096|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
126113741|NCT04313153|453712553|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
126113742|NCT04313153|453712554|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
126113743|NCT04313153|453712552|FG000|Overall Study|Other|5|||
126113744|NCT04313153|453712553|FG001|Overall Study|Other|3|||
126113745|NCT04313153|453712554|FG002|Overall Study|Other|2|||
126113746|NCT05586269|453712555|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
126113747|NCT05586269|453712556|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
126113748|NCT05586269|453712557|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
125932375|NCT03510884|453048097|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
125932376|NCT03510884|453048098|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
125932377|NCT03510884|453048095|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
125932378|NCT03510884|453048096|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
125932379|NCT03510884|453048097|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
125932380|NCT03510884|453048098|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
125932381|NCT03510884|453048095|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
125932382|NCT03510884|453048096|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
125932383|NCT03510884|453048097|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
125932384|NCT03510884|453048098|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
125932385|NCT03510884|453048095|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
125932386|NCT03510884|453048096|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
125932387|NCT03510884|453048097|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
125932388|NCT03510884|453048098|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
125932389|NCT00856284|453048099|FG000|Overall Study|Hyperglycemic rescue|231|||
125932390|NCT00856284|453048100|FG001|Overall Study|Hyperglycemic rescue|201|||
125932391|NCT00856284|453048101|FG002|Overall Study|Hyperglycemic rescue|235|||
125932392|NCT00856284|453048099|FG000|Overall Study|Adverse Event|60|||
125932393|NCT00856284|453048100|FG001|Overall Study|Adverse Event|74|||
125932394|NCT00856284|453048101|FG002|Overall Study|Adverse Event|82|||
125932395|NCT00856284|453048099|FG000|Overall Study|Major protocol deviation|24|||
125932396|NCT00856284|453048100|FG001|Overall Study|Major protocol deviation|16|||
125932397|NCT00856284|453048101|FG002|Overall Study|Major protocol deviation|15|||
125932398|NCT00856284|453048099|FG000|Overall Study|Lost to Follow-up|20|||
125932399|NCT00856284|453048100|FG001|Overall Study|Lost to Follow-up|22|||
125932400|NCT00856284|453048101|FG002|Overall Study|Lost to Follow-up|28|||
125932401|NCT00856284|453048099|FG000|Overall Study|Voluntary withdrawal|48|||
125932402|NCT00856284|453048100|FG001|Overall Study|Voluntary withdrawal|52|||
125932403|NCT00856284|453048101|FG002|Overall Study|Voluntary withdrawal|62|||
125932404|NCT00856284|453048099|FG000|Overall Study|Pregnancy|1|||
125932405|NCT00856284|453048100|FG001|Overall Study|Pregnancy|2|||
125932406|NCT00856284|453048101|FG002|Overall Study|Pregnancy|0|||
125932407|NCT00856284|453048099|FG000|Overall Study|Investigator discretion|9|||
125932408|NCT00856284|453048100|FG001|Overall Study|Investigator discretion|8|||
125932409|NCT00856284|453048101|FG002|Overall Study|Investigator discretion|10|||
125932410|NCT00856284|453048099|FG000|Overall Study|Other|15|||
125932411|NCT00856284|453048100|FG001|Overall Study|Other|17|||
125932412|NCT00856284|453048101|FG002|Overall Study|Other|14|||
125932413|NCT00856284|453048099|FG000|Overall Study|Randomized in error|0|||
125932414|NCT00856284|453048100|FG001|Overall Study|Randomized in error|0|||
125932415|NCT00856284|453048101|FG002|Overall Study|Randomized in error|1|||
125932416|NCT02904512|453048104|FG000|Overall Study|Withdrawal by Subject|1|||
125932417|NCT02904512|453048105|FG001|Overall Study|Withdrawal by Subject|0|||
125932418|NCT02904512|453048104|FG000|Overall Study|Transferred to ICU|1|||
125932419|NCT02904512|453048105|FG001|Overall Study|Transferred to ICU|0|||
125932420|NCT02904512|453048104|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
125932421|NCT02904512|453048105|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
125932422|NCT03138889|453048112|FG000|Overall Study|Withdrawal by Subject|5|||
125932423|NCT03138889|453048113|FG001|Overall Study|Withdrawal by Subject|5|||
125932424|NCT03138889|453048114|FG002|Overall Study|Withdrawal by Subject|0|||
125932425|NCT03138889|453048115|FG003|Overall Study|Withdrawal by Subject|2|||
125932426|NCT03138889|453048116|FG004|Overall Study|Withdrawal by Subject|1|||
125932427|NCT03138889|453048117|FG005|Overall Study|Withdrawal by Subject|3|||
125932428|NCT03138889|453048118|FG006|Overall Study|Withdrawal by Subject|0|||
125932429|NCT03138889|453048119|FG007|Overall Study|Withdrawal by Subject|1|||
125932430|NCT01963403|453048124|FG000|Overall Study|Lost to Follow-up|2|||
125932431|NCT01963403|453048125|FG001|Overall Study|Lost to Follow-up|3|||
125932432|NCT01963403|453048124|FG000|Overall Study|Implant removal|0|||
125932433|NCT01963403|453048125|FG001|Overall Study|Implant removal|1|||
125932434|NCT02289690|453048130|FG000|Overall Study|Adverse Event Related to Progression|0|||
125932435|NCT02289690|453048131|FG001|Overall Study|Adverse Event Related to Progression|1|||
125932436|NCT02289690|453048132|FG002|Overall Study|Adverse Event Related to Progression|1|||
125932437|NCT02289690|453048133|FG003|Overall Study|Adverse Event Related to Progression|0|||
125932438|NCT02289690|453048134|FG004|Overall Study|Adverse Event Related to Progression|1|||
125932439|NCT02289690|453048135|FG005|Overall Study|Adverse Event Related to Progression|0|||
125932440|NCT02289690|453048136|FG006|Overall Study|Adverse Event Related to Progression|1|||
125932441|NCT02289690|453048137|FG007|Overall Study|Adverse Event Related to Progression|0|||
125932442|NCT02289690|453048138|FG008|Overall Study|Adverse Event Related to Progression|0|||
125932443|NCT02289690|453048139|FG009|Overall Study|Adverse Event Related to Progression|0|||
125932444|NCT02289690|453048130|FG000|Overall Study|Withdrawal by Subject|1|||
125932445|NCT02289690|453048131|FG001|Overall Study|Withdrawal by Subject|0|||
125932446|NCT02289690|453048132|FG002|Overall Study|Withdrawal by Subject|0|||
125932447|NCT02289690|453048133|FG003|Overall Study|Withdrawal by Subject|0|||
125932448|NCT02289690|453048134|FG004|Overall Study|Withdrawal by Subject|1|||
125932449|NCT02289690|453048135|FG005|Overall Study|Withdrawal by Subject|1|||
125932450|NCT02289690|453048136|FG006|Overall Study|Withdrawal by Subject|0|||
125932451|NCT02289690|453048137|FG007|Overall Study|Withdrawal by Subject|0|||
125932452|NCT02289690|453048138|FG008|Overall Study|Withdrawal by Subject|4|||
125932453|NCT02289690|453048139|FG009|Overall Study|Withdrawal by Subject|2|||
125932454|NCT02289690|453048130|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
125932455|NCT02289690|453048131|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
125932456|NCT02289690|453048132|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
125932457|NCT02289690|453048133|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
125932458|NCT02289690|453048134|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
125932459|NCT02289690|453048135|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
125932460|NCT02289690|453048136|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
125932461|NCT02289690|453048137|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
125932462|NCT02289690|453048138|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
125932463|NCT02289690|453048139|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
125932464|NCT02289690|453048130|FG000|Overall Study|Lost to Follow-up|0|||
125932465|NCT02289690|453048131|FG001|Overall Study|Lost to Follow-up|0|||
125932466|NCT02289690|453048132|FG002|Overall Study|Lost to Follow-up|0|||
125932467|NCT02289690|453048133|FG003|Overall Study|Lost to Follow-up|0|||
125932468|NCT02289690|453048134|FG004|Overall Study|Lost to Follow-up|0|||
125932469|NCT02289690|453048135|FG005|Overall Study|Lost to Follow-up|0|||
125932470|NCT02289690|453048136|FG006|Overall Study|Lost to Follow-up|0|||
125932471|NCT02289690|453048137|FG007|Overall Study|Lost to Follow-up|1|||
125932472|NCT02289690|453048138|FG008|Overall Study|Lost to Follow-up|0|||
125932473|NCT02289690|453048139|FG009|Overall Study|Lost to Follow-up|2|||
125932474|NCT02289690|453048130|FG000|Overall Study|Death|0|||
125932475|NCT02289690|453048131|FG001|Overall Study|Death|0|||
125932476|NCT02289690|453048132|FG002|Overall Study|Death|0|||
125932477|NCT02289690|453048133|FG003|Overall Study|Death|0|||
125932478|NCT02289690|453048134|FG004|Overall Study|Death|0|||
125932479|NCT02289690|453048135|FG005|Overall Study|Death|0|||
125932480|NCT02289690|453048136|FG006|Overall Study|Death|0|||
125932481|NCT02289690|453048137|FG007|Overall Study|Death|49|||
125932482|NCT02289690|453048138|FG008|Overall Study|Death|45|||
125932483|NCT02289690|453048139|FG009|Overall Study|Death|41|||
125932484|NCT02289690|453048130|FG000|Overall Study|Sponsor Discontinued Study|0|||
125932485|NCT02289690|453048131|FG001|Overall Study|Sponsor Discontinued Study|0|||
125932486|NCT02289690|453048132|FG002|Overall Study|Sponsor Discontinued Study|0|||
125932487|NCT02289690|453048133|FG003|Overall Study|Sponsor Discontinued Study|0|||
125932488|NCT02289690|453048134|FG004|Overall Study|Sponsor Discontinued Study|0|||
125932489|NCT02289690|453048135|FG005|Overall Study|Sponsor Discontinued Study|0|||
125932490|NCT02289690|453048136|FG006|Overall Study|Sponsor Discontinued Study|0|||
125932491|NCT02289690|453048137|FG007|Overall Study|Sponsor Discontinued Study|9|||
125932492|NCT02289690|453048138|FG008|Overall Study|Sponsor Discontinued Study|7|||
125932493|NCT02289690|453048139|FG009|Overall Study|Sponsor Discontinued Study|15|||
125932494|NCT02289690|453048130|FG000|Overall Study|Other|0|||
125932495|NCT02289690|453048131|FG001|Overall Study|Other|0|||
125932496|NCT02289690|453048132|FG002|Overall Study|Other|0|||
125932497|NCT02289690|453048133|FG003|Overall Study|Other|1|||
125932498|NCT02289690|453048134|FG004|Overall Study|Other|1|||
125932499|NCT02289690|453048135|FG005|Overall Study|Other|0|||
125932500|NCT02289690|453048136|FG006|Overall Study|Other|1|||
125932501|NCT02289690|453048137|FG007|Overall Study|Other|2|||
125932502|NCT02289690|453048138|FG008|Overall Study|Other|3|||
125932503|NCT02289690|453048139|FG009|Overall Study|Other|1|||
125932504|NCT04016285|453048142|FG000|Overall Study|Did not progress to surgery|2|||
125932505|NCT04016285|453048143|FG001|Overall Study|Did not progress to surgery|5|||
125932506|NCT04016285|453048142|FG000|Overall Study|Failed to collect outcome data|5|||
125932507|NCT04016285|453048143|FG001|Overall Study|Failed to collect outcome data|3|||
125932508|NCT00267046|453048146|FG000|Overall Study|Disease progression|4|||
125932509|NCT00267046|453048147|FG001|Overall Study|Disease progression|2|||
125932510|NCT00267046|453048146|FG000|Overall Study|Chemotoxicity|2|||
125932511|NCT00267046|453048147|FG001|Overall Study|Chemotoxicity|0|||
125932512|NCT00267046|453048146|FG000|Overall Study|Open-label palifermin|2|||
125932513|NCT00267046|453048147|FG001|Overall Study|Open-label palifermin|7|||
125932514|NCT00267046|453048146|FG000|Overall Study|Surgery|3|||
125932515|NCT00267046|453048147|FG001|Overall Study|Surgery|1|||
125932516|NCT00267046|453048146|FG000|Overall Study|Withdrawal by Subject|1|||
125932517|NCT00267046|453048147|FG001|Overall Study|Withdrawal by Subject|0|||
125932518|NCT00267046|453048146|FG000|Overall Study|Radiation|0|||
125932519|NCT00267046|453048147|FG001|Overall Study|Radiation|1|||
125932520|NCT00460408|453048148|FG000|Overall Study|Adverse Event|1|||
125932521|NCT00460408|453048149|FG001|Overall Study|Adverse Event|0|||
125932522|NCT00460408|453048150|FG002|Overall Study|Adverse Event|0|||
125932523|NCT00460408|453048151|FG003|Overall Study|Adverse Event|0|||
125932524|NCT00460408|453048148|FG000|Overall Study|Death|7|||
125932525|NCT00460408|453048149|FG001|Overall Study|Death|0|||
125932526|NCT00460408|453048150|FG002|Overall Study|Death|0|||
125932527|NCT00460408|453048151|FG003|Overall Study|Death|0|||
125932528|NCT00460408|453048148|FG000|Overall Study|Lost to Follow-up|11|||
125932529|NCT00460408|453048149|FG001|Overall Study|Lost to Follow-up|0|||
125932530|NCT00460408|453048150|FG002|Overall Study|Lost to Follow-up|1|||
125932531|NCT00460408|453048151|FG003|Overall Study|Lost to Follow-up|0|||
125932532|NCT00460408|453048148|FG000|Overall Study|Withdrawal by Subject|31|||
125932533|NCT00460408|453048149|FG001|Overall Study|Withdrawal by Subject|0|||
125932534|NCT00460408|453048150|FG002|Overall Study|Withdrawal by Subject|0|||
125932535|NCT00460408|453048151|FG003|Overall Study|Withdrawal by Subject|0|||
125932536|NCT00460408|453048148|FG000|Overall Study|Insufficient clinical response|5|||
125932537|NCT00460408|453048149|FG001|Overall Study|Insufficient clinical response|1|||
125932538|NCT00460408|453048150|FG002|Overall Study|Insufficient clinical response|5|||
125932539|NCT00460408|453048151|FG003|Overall Study|Insufficient clinical response|0|||
125932540|NCT00460408|453048148|FG000|Overall Study|Other|12|||
125932541|NCT00460408|453048149|FG001|Overall Study|Other|2|||
125932542|NCT00460408|453048150|FG002|Overall Study|Other|0|||
125932543|NCT00460408|453048151|FG003|Overall Study|Other|0|||
125932544|NCT00865124|453048152|FG000|Overall Study|Physician Decision|2|||
125932545|NCT00865124|453048153|FG001|Overall Study|Physician Decision|1|||
125932546|NCT00865124|453048154|FG002|Overall Study|Physician Decision|0|||
125932547|NCT00865124|453048152|FG000|Overall Study|Withdrawn consent|2|||
125932548|NCT00865124|453048153|FG001|Overall Study|Withdrawn consent|0|||
125932549|NCT00865124|453048154|FG002|Overall Study|Withdrawn consent|0|||
125932550|NCT01442493|453048162|FG000|Overall Study|withdrawn from study|3|||
125932551|NCT01442493|453048163|FG001|Overall Study|withdrawn from study|2|||
125932552|NCT01986985|453048168|FG000|Overall Study|Withdrawal by Subject|4|||
125932553|NCT01986985|453048168|FG000|Overall Study|Scan not completed due to malfunction|3|||
125932554|NCT03042533|453048169|FG000|Overall Study|MD left program|1|||
125932555|NCT03042533|453048170|FG001|Overall Study|MD left program|4|||
125932556|NCT03042533|453048171|FG002|Overall Study|MD left program|1|||
125932557|NCT01111149|453048177|FG000|Overall Study|Protocol Violation|1|||
125932558|NCT01111149|453048178|FG001|Overall Study|Protocol Violation|1|||
125932559|NCT01111149|453048179|FG002|Overall Study|Protocol Violation|2|||
125932560|NCT01111149|453048177|FG000|Overall Study|Withdrawal by Subject|1|||
125932561|NCT01111149|453048178|FG001|Overall Study|Withdrawal by Subject|0|||
125932562|NCT01111149|453048179|FG002|Overall Study|Withdrawal by Subject|2|||
125932563|NCT00759954|453048180|FG000|Overall Study|Personal reason|1|||
125932564|NCT00759954|453048181|FG001|Overall Study|Personal reason|0|||
125932565|NCT00759954|453048180|FG000|Overall Study|Adverse Event|1|||
125932566|NCT00759954|453048181|FG001|Overall Study|Adverse Event|2|||
125932567|NCT00137046|453048182|FG000|Overall Study|Death|2|||
125932568|NCT00137046|453048183|FG001|Overall Study|Death|1|||
125932569|NCT00137046|453048182|FG000|Overall Study|Adverse Event|16|||
125932570|NCT00137046|453048183|FG001|Overall Study|Adverse Event|5|||
125932571|NCT00137046|453048182|FG000|Overall Study|Laboratory Abnormality|2|||
125932572|NCT00137046|453048183|FG001|Overall Study|Laboratory Abnormality|0|||
125932573|NCT00137046|453048182|FG000|Overall Study|Lack of Efficacy|13|||
125932574|NCT00137046|453048183|FG001|Overall Study|Lack of Efficacy|1|||
125932575|NCT00137046|453048182|FG000|Overall Study|Lost to Follow-up|8|||
125932576|NCT00137046|453048183|FG001|Overall Study|Lost to Follow-up|24|||
125932577|NCT00137046|453048182|FG000|Overall Study|Other|23|||
125932578|NCT00137046|453048183|FG001|Overall Study|Other|19|||
126066161|NCT01136733|453533493|FG002|Phase 2|Adverse Event|0|||
126066162|NCT01136733|453533494|FG003|Phase 2|Adverse Event|0|||
126066163|NCT01136733|453533495|FG004|Phase 2|Adverse Event|11|||
126066164|NCT01136733|453533496|FG005|Phase 2|Adverse Event|13|||
126066165|NCT01136733|453533497|FG006|Phase 2|Adverse Event|5|||
126066166|NCT01136733|453533491|FG000|Phase 2|Participant Choice|0|||
126066167|NCT01136733|453533492|FG001|Phase 2|Participant Choice|0|||
126066168|NCT01136733|453533493|FG002|Phase 2|Participant Choice|0|||
125932579|NCT00137046|453048182|FG000|Overall Study|Withdrawal by Subject|33|||
125932580|NCT00137046|453048183|FG001|Overall Study|Withdrawal by Subject|42|||
125932581|NCT00137046|453048182|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
126066169|NCT01136733|453533494|FG003|Phase 2|Participant Choice|0|||
125932582|NCT00137046|453048183|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
125932583|NCT00137046|453048182|FG000|Overall Study|Withdrew prior to study treatment|1|||
125932584|NCT00137046|453048183|FG001|Overall Study|Withdrew prior to study treatment|1|||
125932585|NCT02725710|453048188|FG000|Overall Study|Lost to Follow-up|1|||
125932586|NCT02725710|453048189|FG001|Overall Study|Lost to Follow-up|0|||
125932587|NCT01666782|453048192|FG000|Overall Study|Received 2 doses of vaccine|0|||
125932588|NCT01666782|453048193|FG001|Overall Study|Received 2 doses of vaccine|1|||
125932589|NCT01666782|453048192|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
125932590|NCT01666782|453048193|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
125932591|NCT03681405|453048205|FG000|Overall Study|Found to be ineligible after randomized|1|||
125932592|NCT03681405|453048206|FG001|Overall Study|Found to be ineligible after randomized|0|||
126066170|NCT01136733|453533495|FG004|Phase 2|Participant Choice|3|||
126066171|NCT01136733|453533496|FG005|Phase 2|Participant Choice|0|||
125932593|NCT03978520|453048207|FG000|Overall Study|Adverse Event|2|||
125932594|NCT03978520|453048208|FG001|Overall Study|Adverse Event|5|||
125932595|NCT03978520|453048209|FG002|Overall Study|Adverse Event|3|||
125932596|NCT03978520|453048210|FG003|Overall Study|Adverse Event|5|||
125932597|NCT03978520|453048211|FG004|Overall Study|Adverse Event|6|||
125932598|NCT03978520|453048207|FG000|Overall Study|Withdrawal by Subject|10|||
125932599|NCT03978520|453048208|FG001|Overall Study|Withdrawal by Subject|4|||
125932600|NCT03978520|453048209|FG002|Overall Study|Withdrawal by Subject|5|||
125932601|NCT03978520|453048210|FG003|Overall Study|Withdrawal by Subject|6|||
125932602|NCT03978520|453048211|FG004|Overall Study|Withdrawal by Subject|5|||
125932603|NCT03978520|453048207|FG000|Overall Study|Lost to Follow-up|2|||
125932604|NCT03978520|453048208|FG001|Overall Study|Lost to Follow-up|2|||
125932605|NCT03978520|453048209|FG002|Overall Study|Lost to Follow-up|2|||
125932606|NCT03978520|453048210|FG003|Overall Study|Lost to Follow-up|0|||
125932607|NCT03978520|453048211|FG004|Overall Study|Lost to Follow-up|1|||
125932608|NCT03978520|453048207|FG000|Overall Study|COVID-19 infection|0|||
125932609|NCT03978520|453048208|FG001|Overall Study|COVID-19 infection|1|||
125932610|NCT03978520|453048209|FG002|Overall Study|COVID-19 infection|0|||
125932611|NCT03978520|453048210|FG003|Overall Study|COVID-19 infection|0|||
125932612|NCT03978520|453048211|FG004|Overall Study|COVID-19 infection|0|||
125932613|NCT03978520|453048207|FG000|Overall Study|Other, not specified|9|||
125932614|NCT03978520|453048208|FG001|Overall Study|Other, not specified|4|||
125932615|NCT03978520|453048209|FG002|Overall Study|Other, not specified|1|||
125932616|NCT03978520|453048210|FG003|Overall Study|Other, not specified|1|||
125932617|NCT03978520|453048211|FG004|Overall Study|Other, not specified|2|||
125932618|NCT03978520|453048207|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
125932619|NCT03978520|453048208|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
125932620|NCT03978520|453048209|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
125932621|NCT03978520|453048210|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
125932622|NCT03978520|453048211|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
125932623|NCT01648205|453048219|FG000|Placebo|Pregnancy|1|||
125932624|NCT01648205|453048219|FG000|Placebo|Withdrawal by Subject|1|||
125932625|NCT01648205|453048219|FG000|Placebo|Protocol Violation|2|||
125932626|NCT01648205|453048219|FG000|Ranolazine|Death|1|||
125932627|NCT01648205|453048219|FG000|Ranolazine|Withdrawal by Subject|1|||
125932628|NCT01648205|453048219|FG000|Ranolazine|Protocol Violation|3|||
125932629|NCT02142959|453048227|FG000|Overall Study|Adverse Event|1|||
125932630|NCT02142959|453048228|FG001|Overall Study|Adverse Event|0|||
125932631|NCT02142959|453048229|FG002|Overall Study|Adverse Event|0|||
125932632|NCT02142959|453048227|FG000|Overall Study|Death|0|||
125932633|NCT02142959|453048228|FG001|Overall Study|Death|1|||
125932634|NCT02142959|453048229|FG002|Overall Study|Death|0|||
125932635|NCT02142959|453048227|FG000|Overall Study|Withdrawal by Subject|3|||
125932636|NCT02142959|453048228|FG001|Overall Study|Withdrawal by Subject|1|||
125932637|NCT02142959|453048229|FG002|Overall Study|Withdrawal by Subject|3|||
125932638|NCT02142959|453048227|FG000|Overall Study|Administrative Reasons|1|||
125932639|NCT02142959|453048228|FG001|Overall Study|Administrative Reasons|0|||
125932640|NCT02142959|453048229|FG002|Overall Study|Administrative Reasons|1|||
125932641|NCT02142959|453048227|FG000|Overall Study|Missing|0|||
125932642|NCT02142959|453048228|FG001|Overall Study|Missing|1|||
125932643|NCT02142959|453048229|FG002|Overall Study|Missing|0|||
125932644|NCT02142959|453048227|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
125932645|NCT02142959|453048228|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
125932646|NCT02142959|453048229|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
125932647|NCT02142959|453048227|FG000|Overall Study|Patient didn't complete end of study visit|0|||
125932648|NCT02142959|453048228|FG001|Overall Study|Patient didn't complete end of study visit|0|||
125932649|NCT02142959|453048229|FG002|Overall Study|Patient didn't complete end of study visit|1|||
125932650|NCT03547687|453048230|FG000|Overall Study|Withdrawal by Subject|1|||
125932651|NCT03547687|453048230|FG000|Overall Study|Death|1|||
125932652|NCT04557371|453048233|FG000|Overall Study|Covid-19-related|0|||
125932653|NCT04557371|453048234|FG001|Overall Study|Covid-19-related|1|||
125932654|NCT04557371|453048235|FG002|Overall Study|Covid-19-related|0|||
125932655|NCT04557371|453048233|FG000|Overall Study|Withdrawal by Subject|0|||
125932656|NCT04557371|453048234|FG001|Overall Study|Withdrawal by Subject|1|||
125932657|NCT04557371|453048235|FG002|Overall Study|Withdrawal by Subject|0|||
125932658|NCT04557371|453048233|FG000|Overall Study|Adverse Event|1|||
125932659|NCT04557371|453048234|FG001|Overall Study|Adverse Event|0|||
126113749|NCT05586269|453712558|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
125932660|NCT04557371|453048235|FG002|Overall Study|Adverse Event|0|||
125932661|NCT03694821|453048236|FG000|Overall Study|Study terminated|4|||
125932662|NCT03694821|453048237|FG001|Overall Study|Study terminated|8|||
125932663|NCT03694821|453048238|FG002|Overall Study|Study terminated|4|||
125932664|NCT02700815|453049947|FG000|Overall Study|Adverse Event|0|||
125932665|NCT02700815|453049948|FG001|Overall Study|Adverse Event|6|||
125932666|NCT02700815|453049949|FG002|Overall Study|Adverse Event|2|||
125932667|NCT02700815|453049950|FG003|Overall Study|Adverse Event|3|||
125932668|NCT02700815|453049947|FG000|Overall Study|Lack of Efficacy|0|||
125932669|NCT02700815|453049948|FG001|Overall Study|Lack of Efficacy|0|||
125932670|NCT02700815|453049949|FG002|Overall Study|Lack of Efficacy|1|||
125932671|NCT02700815|453049950|FG003|Overall Study|Lack of Efficacy|2|||
125932672|NCT02700815|453049947|FG000|Overall Study|Lost to Follow-up|1|||
125932673|NCT02700815|453049948|FG001|Overall Study|Lost to Follow-up|0|||
125932674|NCT02700815|453049949|FG002|Overall Study|Lost to Follow-up|0|||
125932675|NCT02700815|453049950|FG003|Overall Study|Lost to Follow-up|1|||
125932676|NCT02700815|453049947|FG000|Overall Study|Refusal to continue medication|0|||
125932677|NCT02700815|453049948|FG001|Overall Study|Refusal to continue medication|1|||
125932678|NCT02700815|453049949|FG002|Overall Study|Refusal to continue medication|0|||
125932679|NCT02700815|453049950|FG003|Overall Study|Refusal to continue medication|1|||
125932680|NCT02700815|453049947|FG000|Overall Study|Withdrawal by Subject|0|||
125932681|NCT02700815|453049948|FG001|Overall Study|Withdrawal by Subject|0|||
125932682|NCT02700815|453049949|FG002|Overall Study|Withdrawal by Subject|1|||
125932683|NCT02700815|453049950|FG003|Overall Study|Withdrawal by Subject|0|||
125932684|NCT00524368|453049951|FG000|Overall Study|Adverse Event|10|||
125932685|NCT00524368|453049952|FG001|Overall Study|Adverse Event|12|||
125932686|NCT00524368|453049951|FG000|Overall Study|Lost to Follow-up|9|||
125932687|NCT00524368|453049952|FG001|Overall Study|Lost to Follow-up|13|||
125932688|NCT00524368|453049951|FG000|Overall Study|Withdrawal by Subject|4|||
125932689|NCT00524368|453049952|FG001|Overall Study|Withdrawal by Subject|5|||
125932690|NCT00524368|453049951|FG000|Overall Study|Non-compliant|8|||
125932691|NCT00524368|453049952|FG001|Overall Study|Non-compliant|9|||
125932692|NCT00524368|453049951|FG000|Overall Study|Reached a Virologic Endpoint|3|||
125932693|NCT00524368|453049952|FG001|Overall Study|Reached a Virologic Endpoint|2|||
125932694|NCT00524368|453049951|FG000|Overall Study|Sponsor's Decision|2|||
125932695|NCT00524368|453049952|FG001|Overall Study|Sponsor's Decision|0|||
125932696|NCT00524368|453049951|FG000|Overall Study|Ineligible to Continue the study|2|||
125932697|NCT00524368|453049952|FG001|Overall Study|Ineligible to Continue the study|5|||
125932698|NCT00524368|453049951|FG000|Overall Study|Other|3|||
125932699|NCT00524368|453049952|FG001|Overall Study|Other|2|||
125932700|NCT00531232|453049953|FG000|Overall Study|Investigator decision|0|||
125932701|NCT00531232|453049954|FG001|Overall Study|Investigator decision|0|||
125932702|NCT00531232|453049955|FG002|Overall Study|Investigator decision|4|||
125932703|NCT00531232|453049953|FG000|Overall Study|Participants refused further treatment|0|||
125932704|NCT00531232|453049954|FG001|Overall Study|Participants refused further treatment|1|||
125932705|NCT00531232|453049955|FG002|Overall Study|Participants refused further treatment|2|||
125932706|NCT00531232|453049953|FG000|Overall Study|Adverse events (AEs)|1|||
125932707|NCT00531232|453049954|FG001|Overall Study|Adverse events (AEs)|2|||
125932708|NCT00531232|453049955|FG002|Overall Study|Adverse events (AEs)|2|||
125932709|NCT00531232|453049953|FG000|Overall Study|Treatment failure|1|||
125932710|NCT00531232|453049954|FG001|Overall Study|Treatment failure|3|||
125932711|NCT00531232|453049955|FG002|Overall Study|Treatment failure|7|||
125932712|NCT00531232|453049953|FG000|Overall Study|Disease recurrence|0|||
126066172|NCT01136733|453533497|FG006|Phase 2|Participant Choice|1|||
126066173|NCT01136733|453533491|FG000|Phase 2|Administrative-Withdrew Consent|0|||
126066174|NCT01136733|453533492|FG001|Phase 2|Administrative-Withdrew Consent|0|||
125932713|NCT00531232|453049954|FG001|Overall Study|Disease recurrence|0|||
125932714|NCT00531232|453049955|FG002|Overall Study|Disease recurrence|1|||
125932715|NCT00531232|453049953|FG000|Overall Study|Deceased|2|||
125932716|NCT00531232|453049954|FG001|Overall Study|Deceased|2|||
125932717|NCT00531232|453049955|FG002|Overall Study|Deceased|2|||
125932718|NCT00531232|453049953|FG000|Overall Study|Withdrawal by Subject|0|||
125932719|NCT00531232|453049954|FG001|Overall Study|Withdrawal by Subject|1|||
125932720|NCT00531232|453049955|FG002|Overall Study|Withdrawal by Subject|2|||
125932721|NCT00531232|453049953|FG000|Overall Study|Other|0|||
125932722|NCT00531232|453049954|FG001|Overall Study|Other|0|||
125932723|NCT00531232|453049955|FG002|Overall Study|Other|5|||
125932724|NCT02345850|453049969|FG000|Overall Study|Not transplanted|10|||
125932725|NCT02345850|453049970|FG001|Overall Study|Not transplanted|5|||
125932726|NCT02345850|453049971|FG002|Overall Study|Not transplanted|4|||
125932727|NCT02345850|453049969|FG000|Overall Study|Lost to Follow-up|2|||
125932728|NCT02345850|453049970|FG001|Overall Study|Lost to Follow-up|3|||
125932729|NCT02345850|453049971|FG002|Overall Study|Lost to Follow-up|2|||
125932730|NCT02345850|453049969|FG000|Overall Study|Withdrawal by Subject|1|||
125932731|NCT02345850|453049970|FG001|Overall Study|Withdrawal by Subject|0|||
125932732|NCT02345850|453049971|FG002|Overall Study|Withdrawal by Subject|0|||
125932733|NCT01991067|453049973|FG000|Overall Study|Lost to Follow-up|6|||
125932734|NCT01991067|453049974|FG001|Overall Study|Lost to Follow-up|5|||
125932735|NCT02670083|453049976|FG000|Overall Study|Adverse Event|16|||
125932736|NCT02670083|453049977|FG001|Overall Study|Adverse Event|13|||
125932737|NCT02670083|453049976|FG000|Overall Study|Death|4|||
125932738|NCT02670083|453049977|FG001|Overall Study|Death|6|||
125932739|NCT02670083|453049976|FG000|Overall Study|Lost to Follow-up|2|||
125932740|NCT02670083|453049977|FG001|Overall Study|Lost to Follow-up|2|||
125932741|NCT02670083|453049976|FG000|Overall Study|Multiple Reasons|9|||
125932742|NCT02670083|453049977|FG001|Overall Study|Multiple Reasons|9|||
125932743|NCT02670083|453049976|FG000|Overall Study|Physician Decision|0|||
125932744|NCT02670083|453049977|FG001|Overall Study|Physician Decision|2|||
125932745|NCT02670083|453049976|FG000|Overall Study|Study Terminated By Sponsor|257|||
125932746|NCT02670083|453049977|FG001|Overall Study|Study Terminated By Sponsor|254|||
125932747|NCT02670083|453049976|FG000|Overall Study|Symptomatic Deterioration|0|||
125932748|NCT02670083|453049977|FG001|Overall Study|Symptomatic Deterioration|2|||
125932749|NCT02670083|453049976|FG000|Overall Study|Withdrawal by Subject|32|||
125932750|NCT02670083|453049977|FG001|Overall Study|Withdrawal by Subject|31|||
125932751|NCT02670083|453049976|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125932752|NCT02670083|453049977|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125932753|NCT02014597|453049978|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
125932754|NCT02014597|453049979|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
125932755|NCT00464087|453049982|FG000|Overall Study|No PCI per inclusion criteria|0|||
125932756|NCT00464087|453049983|FG001|Overall Study|No PCI per inclusion criteria|0|||
125932757|NCT00464087|453049984|FG002|Overall Study|No PCI per inclusion criteria|29|||
125932758|NCT02057406|453049985|FG000|Overall Study|Physician Decision|0|||
125932759|NCT02057406|453049986|FG001|Overall Study|Physician Decision|0|||
125932760|NCT02057406|453049987|FG002|Overall Study|Physician Decision|2|||
125932761|NCT02057406|453049985|FG000|Overall Study|Withdrawal by Subject|0|||
125932762|NCT02057406|453049986|FG001|Overall Study|Withdrawal by Subject|2|||
125932763|NCT02057406|453049987|FG002|Overall Study|Withdrawal by Subject|0|||
125932764|NCT02057406|453049985|FG000|Overall Study|Lost to Follow-up|0|||
125932765|NCT02057406|453049986|FG001|Overall Study|Lost to Follow-up|0|||
125932766|NCT02057406|453049987|FG002|Overall Study|Lost to Follow-up|1|||
125932767|NCT02057406|453049985|FG000|Overall Study|Death|1|||
125932768|NCT02057406|453049986|FG001|Overall Study|Death|0|||
125932769|NCT02057406|453049987|FG002|Overall Study|Death|0|||
125932770|NCT02057406|453049985|FG000|Overall Study|Protocol Violation|0|||
125932771|NCT02057406|453049986|FG001|Overall Study|Protocol Violation|1|||
125932772|NCT02057406|453049987|FG002|Overall Study|Protocol Violation|0|||
125932773|NCT02057406|453049985|FG000|Overall Study|Patient transportation issues|0|||
125932774|NCT02057406|453049986|FG001|Overall Study|Patient transportation issues|0|||
125932775|NCT02057406|453049987|FG002|Overall Study|Patient transportation issues|1|||
125932776|NCT02425046|453049988|FG000|Overall Study|Lost to Follow-up|52|||
125932777|NCT02425046|453049989|FG001|Overall Study|Lost to Follow-up|50|||
125932778|NCT02425046|453049990|FG002|Overall Study|Lost to Follow-up|56|||
125932779|NCT02425046|453049988|FG000|Overall Study|Withdrawal by Subject|16|||
125932780|NCT02425046|453049989|FG001|Overall Study|Withdrawal by Subject|12|||
125932781|NCT02425046|453049990|FG002|Overall Study|Withdrawal by Subject|0|||
125932782|NCT00931762|453049991|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
125932783|NCT00931762|453049991|FG000|Overall Study|Administrative Problems|5|||
125932784|NCT00931762|453049991|FG000|Overall Study|Death|1|||
125932785|NCT00931762|453049991|FG000|Overall Study|Disease Progression|3|||
125932786|NCT00931762|453049991|FG000|Overall Study|Adverse Event (s)|11|||
125932787|NCT00931762|453049991|FG000|Overall Study|Subject withdrew consent|13|||
125932788|NCT02692716|453049994|FG000|Overall Study|Lost to Follow-up|2|||
125932789|NCT02692716|453049995|FG001|Overall Study|Lost to Follow-up|5|||
125932790|NCT02692716|453049994|FG000|Overall Study|Withdrawal by Subject|3|||
125932791|NCT02692716|453049995|FG001|Overall Study|Withdrawal by Subject|1|||
125932792|NCT02664441|453050000|FG000|Randomization|Withdrawal by Subject|0|||
125932793|NCT02664441|453050001|FG001|Randomization|Withdrawal by Subject|1|||
125932794|NCT02664441|453050000|FG000|36-week Randomized Trial|Adverse Event|2|||
125932795|NCT02664441|453050001|FG001|36-week Randomized Trial|Adverse Event|0|||
125932796|NCT02664441|453050000|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
125932797|NCT02664441|453050001|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
125932798|NCT02664441|453050000|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
125932799|NCT02664441|453050001|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
125932800|NCT02664441|453050000|FG000|18-week Open Label Extension|Adverse Event|1|||
125932801|NCT02664441|453050001|FG001|18-week Open Label Extension|Adverse Event|0|||
125932802|NCT02664441|453050000|FG000|18-week Open Label Extension|Physician Decision|1|||
125932803|NCT02664441|453050001|FG001|18-week Open Label Extension|Physician Decision|0|||
125932804|NCT02664441|453050000|FG000|18-week Open Label Extension|Death|1|||
125932805|NCT02664441|453050001|FG001|18-week Open Label Extension|Death|0|||
125932806|NCT02664441|453050000|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
125932807|NCT02664441|453050001|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
125932808|NCT02782780|453050002|FG000|Overall Study|dropped out after randomization.|7|||
125932809|NCT02782780|453050003|FG001|Overall Study|dropped out after randomization.|5|||
125932810|NCT02782780|453050002|FG000|Overall Study|Protocol Violation|0|||
125932811|NCT02782780|453050003|FG001|Overall Study|Protocol Violation|2|||
125932812|NCT03562481|453050004|FG000|First Intervention|Lost to Follow-up|1|||
125932813|NCT03562481|453050005|FG001|First Intervention|Lost to Follow-up|0|||
125932814|NCT01413191|453050006|FG000|Overall Study|Lost to Follow-up|5|||
125932815|NCT01413191|453050006|FG000|Overall Study|Disease Progression|5|||
125932816|NCT01413191|453050006|FG000|Overall Study|Death|1|||
125932817|NCT03654651|453050007|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126113750|NCT05586269|453712555|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
126113751|NCT05586269|453712556|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
125932818|NCT03654651|453050008|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
125932819|NCT01702454|453050009|FG000|Overall Study|Consent withdrawal|0|||
125932820|NCT01702454|453050010|FG001|Overall Study|Consent withdrawal|1|||
125932821|NCT01702454|453050009|FG000|Overall Study|Migrated/moved from study area|0|||
125932822|NCT01702454|453050010|FG001|Overall Study|Migrated/moved from study area|1|||
125932823|NCT01702454|453050009|FG000|Overall Study|Lost to Follow-up|3|||
125932824|NCT01702454|453050010|FG001|Overall Study|Lost to Follow-up|6|||
125932825|NCT03247530|453050015|FG000|Overall Study|Withdrawal by caregiver|19|||
125932826|NCT03247530|453050016|FG001|Overall Study|Withdrawal by caregiver|8|||
125932827|NCT03247530|453050017|FG002|Overall Study|Withdrawal by caregiver|10|||
125932828|NCT03247530|453050015|FG000|Overall Study|Lost to Follow-up|3|||
125932829|NCT03247530|453050016|FG001|Overall Study|Lost to Follow-up|9|||
125932830|NCT03247530|453050017|FG002|Overall Study|Lost to Follow-up|6|||
125932831|NCT03247530|453050015|FG000|Overall Study|Adverse Event|2|||
125932832|NCT03247530|453050016|FG001|Overall Study|Adverse Event|5|||
125932833|NCT03247530|453050017|FG002|Overall Study|Adverse Event|2|||
125932834|NCT03247530|453050015|FG000|Overall Study|Failure to follow procedure|1|||
125932835|NCT03247530|453050016|FG001|Overall Study|Failure to follow procedure|1|||
125932836|NCT03247530|453050017|FG002|Overall Study|Failure to follow procedure|1|||
125932837|NCT03247530|453050015|FG000|Overall Study|Withdrawal by Subject|1|||
125932838|NCT03247530|453050016|FG001|Overall Study|Withdrawal by Subject|1|||
125932839|NCT03247530|453050017|FG002|Overall Study|Withdrawal by Subject|0|||
125932840|NCT03247530|453050015|FG000|Overall Study|Study medication misuse|0|||
125932841|NCT03247530|453050016|FG001|Overall Study|Study medication misuse|1|||
125932842|NCT03247530|453050017|FG002|Overall Study|Study medication misuse|0|||
125932843|NCT03247530|453050015|FG000|Overall Study|Other, multiple categories|1|||
125932844|NCT03247530|453050016|FG001|Overall Study|Other, multiple categories|3|||
125932845|NCT03247530|453050017|FG002|Overall Study|Other, multiple categories|1|||
125932846|NCT01124422|453050018|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
125932847|NCT01124422|453050019|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
125932848|NCT01124422|453050020|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
125932849|NCT01124422|453050018|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
125932850|NCT01124422|453050019|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
125932851|NCT01124422|453050020|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
125932852|NCT01124422|453050018|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
125932853|NCT01124422|453050019|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
125932854|NCT01124422|453050020|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
125932855|NCT01124422|453050018|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
125932856|NCT01124422|453050019|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
125932857|NCT01124422|453050020|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
125932858|NCT01124422|453050018|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
125932859|NCT01124422|453050019|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
125932860|NCT01124422|453050020|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
125932861|NCT01124422|453050018|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
125932862|NCT01124422|453050019|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
125932863|NCT01124422|453050020|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
125932864|NCT01124422|453050018|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
125932865|NCT01124422|453050019|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
125932866|NCT01124422|453050020|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
125932867|NCT01124422|453050018|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
125932868|NCT01124422|453050019|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
125932869|NCT01124422|453050020|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
125932870|NCT01124422|453050018|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
125932871|NCT01124422|453050019|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
125932872|NCT01124422|453050020|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
125932873|NCT01124422|453050018|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
125932874|NCT01124422|453050019|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
125932875|NCT01124422|453050020|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
125932876|NCT03454893|453050023|FG000|Overall Study|Study Terminated by the Sponsor|5|||
125932877|NCT03454893|453050023|FG000|Overall Study|Did not pass screening|4|||
125932878|NCT02288559|453050024|FG000|Overall Study|Adverse Event|1|||
125932879|NCT02288559|453050025|FG001|Overall Study|Adverse Event|1|||
125932880|NCT02288559|453050026|FG002|Overall Study|Adverse Event|5|||
125932881|NCT02288559|453050027|FG003|Overall Study|Adverse Event|0|||
125932882|NCT02288559|453050024|FG000|Overall Study|Death|0|||
125932883|NCT02288559|453050025|FG001|Overall Study|Death|0|||
125932884|NCT02288559|453050026|FG002|Overall Study|Death|1|||
125932885|NCT02288559|453050027|FG003|Overall Study|Death|0|||
125932886|NCT02288559|453050024|FG000|Overall Study|Lost to Follow-up|0|||
125932887|NCT02288559|453050025|FG001|Overall Study|Lost to Follow-up|0|||
125932888|NCT02288559|453050026|FG002|Overall Study|Lost to Follow-up|0|||
125932889|NCT02288559|453050027|FG003|Overall Study|Lost to Follow-up|1|||
125932890|NCT02288559|453050024|FG000|Overall Study|Withdrawal by Subject|0|||
125932891|NCT02288559|453050025|FG001|Overall Study|Withdrawal by Subject|0|||
125932892|NCT02288559|453050026|FG002|Overall Study|Withdrawal by Subject|2|||
125932893|NCT02288559|453050027|FG003|Overall Study|Withdrawal by Subject|1|||
125932894|NCT02288559|453050024|FG000|Overall Study|Reason Not Specified|0|||
125932895|NCT02288559|453050025|FG001|Overall Study|Reason Not Specified|0|||
125932896|NCT02288559|453050026|FG002|Overall Study|Reason Not Specified|3|||
125932897|NCT02288559|453050027|FG003|Overall Study|Reason Not Specified|0|||
125932898|NCT00372112|453050032|FG000|Overall Study|Adverse Event|0|||
125932899|NCT00372112|453050033|FG001|Overall Study|Adverse Event|1|||
125932900|NCT00372112|453050034|FG002|Overall Study|Adverse Event|1|||
126113752|NCT05586269|453712557|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
125932901|NCT00372112|453050035|FG003|Overall Study|Adverse Event|1|||
125932902|NCT00372112|453050032|FG000|Overall Study|Withdrawal by Subject|0|||
125932903|NCT00372112|453050033|FG001|Overall Study|Withdrawal by Subject|0|||
125932904|NCT00372112|453050034|FG002|Overall Study|Withdrawal by Subject|2|||
125932905|NCT00372112|453050035|FG003|Overall Study|Withdrawal by Subject|1|||
125932906|NCT00372112|453050032|FG000|Overall Study|Exacerbation|0|||
125932907|NCT00372112|453050033|FG001|Overall Study|Exacerbation|0|||
125932908|NCT00372112|453050034|FG002|Overall Study|Exacerbation|0|||
125932909|NCT00372112|453050035|FG003|Overall Study|Exacerbation|1|||
125932910|NCT00372112|453050032|FG000|Overall Study|PR >240 at Visit 3|0|||
125932911|NCT00372112|453050033|FG001|Overall Study|PR >240 at Visit 3|0|||
125932912|NCT00372112|453050034|FG002|Overall Study|PR >240 at Visit 3|0|||
125932913|NCT00372112|453050035|FG003|Overall Study|PR >240 at Visit 3|1|||
125932914|NCT00372112|453050032|FG000|Overall Study|Hepatitis B|1|||
125932915|NCT00372112|453050033|FG001|Overall Study|Hepatitis B|0|||
125932916|NCT00372112|453050034|FG002|Overall Study|Hepatitis B|0|||
125932917|NCT00372112|453050035|FG003|Overall Study|Hepatitis B|0|||
125932918|NCT00372112|453050032|FG000|Overall Study|Other-protocol violation|0|||
125932919|NCT00372112|453050033|FG001|Overall Study|Other-protocol violation|0|||
125932920|NCT00372112|453050034|FG002|Overall Study|Other-protocol violation|1|||
125932921|NCT00372112|453050035|FG003|Overall Study|Other-protocol violation|0|||
125932922|NCT04649060|453050050|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
125932923|NCT04649060|453050051|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
125932924|NCT04649060|453050050|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
125932925|NCT04649060|453050051|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
125932926|NCT04649060|453050050|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
125932927|NCT04649060|453050051|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
125932928|NCT04649060|453050050|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
125932929|NCT04649060|453050051|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
125932930|NCT04649060|453050050|FG000|Arm A/Arm B Treatment|Patient Request|1|||
125932931|NCT04649060|453050051|FG001|Arm A/Arm B Treatment|Patient Request|0|||
125932932|NCT04649060|453050050|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
125932933|NCT04649060|453050051|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
125932934|NCT04649060|453050050|FG000|Arm A/Arm B Treatment|Other|1|||
125932935|NCT04649060|453050051|FG001|Arm A/Arm B Treatment|Other|0|||
125932936|NCT04649060|453050050|FG000|Crossover (Arm B)|Adverse Event|0|||
125932937|NCT04649060|453050051|FG001|Crossover (Arm B)|Adverse Event|1|||
125932938|NCT04649060|453050050|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
125932939|NCT04649060|453050051|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
125932940|NCT03235154|453050052|FG000|Overall Study|Withdrawal by Subject|1|||
125932941|NCT03235154|453050052|FG000|Overall Study|Adverse Event|1|||
125932942|NCT03235154|453050052|FG000|Overall Study|Lost to Follow-up|2|||
125932943|NCT02326025|453050053|FG000|Overall Study|Adverse Event|3|||
125932944|NCT02326025|453050054|FG001|Overall Study|Adverse Event|0|||
125932945|NCT02326025|453050053|FG000|Overall Study|Physician Decision|1|||
125932946|NCT02326025|453050054|FG001|Overall Study|Physician Decision|2|||
125932947|NCT02326025|453050053|FG000|Overall Study|Physician and Participant Decision|1|||
125932948|NCT02326025|453050054|FG001|Overall Study|Physician and Participant Decision|0|||
125932949|NCT02326025|453050053|FG000|Overall Study|Withdrawal by Subject|0|||
125932950|NCT02326025|453050054|FG001|Overall Study|Withdrawal by Subject|2|||
125932951|NCT02326025|453050053|FG000|Overall Study|Protocol Violation|0|||
125932952|NCT02326025|453050054|FG001|Overall Study|Protocol Violation|1|||
125932953|NCT00001723|453050055|FG000|Overall Study|Lack of Efficacy|6|||
125932954|NCT00001723|453050056|FG001|Overall Study|Lack of Efficacy|7|||
125932955|NCT00001723|453050055|FG000|Overall Study|Lack of family interest|4|||
125932956|NCT00001723|453050056|FG001|Overall Study|Lack of family interest|5|||
125932957|NCT00001723|453050055|FG000|Overall Study|Lost to Follow-up|2|||
125932958|NCT00001723|453050056|FG001|Overall Study|Lost to Follow-up|2|||
125932959|NCT00001723|453050055|FG000|Overall Study|medication intolerance|1|||
125932960|NCT00001723|453050056|FG001|Overall Study|medication intolerance|2|||
125932961|NCT02643082|453050057|FG000|Period 1|Adverse Event|1|||
125932962|NCT02643082|453050058|FG001|Period 1|Adverse Event|0|||
125932963|NCT01324999|453050059|FG000|Overall Study|Adverse Event|3|||
125932964|NCT01324999|453050059|FG000|Overall Study|Withdrawal by Subject|2|||
125932965|NCT00276744|453050060|FG000|PART A|Reason unknown|98|||
125932966|NCT01714635|453050063|FG000|Overall Study|Discontinued|1|||
125932967|NCT01714635|453050064|FG001|Overall Study|Discontinued|0|||
125932968|NCT01714635|453050065|FG002|Overall Study|Discontinued|2|||
125932969|NCT01714635|453050063|FG000|Overall Study|Missed 6-month exam|1|||
125932970|NCT01714635|453050064|FG001|Overall Study|Missed 6-month exam|0|||
125932971|NCT01714635|453050065|FG002|Overall Study|Missed 6-month exam|0|||
125932972|NCT00230607|453050066|FG000|Overall Study|Other|3|||
125932973|NCT02860169|453050067|FG000|Part A|Withdrawal by Subject|1|||
125932974|NCT02860169|453050067|FG000|Part A|Other (Screening failure)|6|||
125932975|NCT02860169|453050067|FG000|Part A|Other (Survey not completed)|3|||
125932976|NCT02860169|453050067|FG000|Part A|Other (did not completed consent)|1|||
125932977|NCT02860169|453050067|FG000|Part B|Other (Screening failure)|10|||
125932978|NCT02860169|453050067|FG000|Part B|Withdrawal by Subject|1|||
125932979|NCT02860169|453050067|FG000|Part C|Other (Screening failure)|1|||
125932980|NCT03667924|453050068|FG000|Baseline Completed|Lost to Follow-up|0|||
125932981|NCT03667924|453050069|FG001|Baseline Completed|Lost to Follow-up|2|||
125932982|NCT03667924|453050070|FG002|Baseline Completed|Lost to Follow-up|0|||
125932983|NCT03667924|453050068|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
125932984|NCT03667924|453050069|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
125932985|NCT03667924|453050070|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
125932986|NCT03667924|453050068|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
125932987|NCT03667924|453050069|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
125932988|NCT03667924|453050070|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
125932989|NCT03667924|453050068|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
125932990|NCT03667924|453050069|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
125932991|NCT03667924|453050070|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
125932992|NCT03667924|453050068|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
125932993|NCT03667924|453050069|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
125932994|NCT03667924|453050070|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
125932995|NCT03667924|453050068|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
125932996|NCT03667924|453050069|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
125932997|NCT03667924|453050070|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
125932998|NCT03667924|453050068|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
125932999|NCT03667924|453050069|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
125933000|NCT03667924|453050070|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
125933001|NCT02547454|453050074|FG000|Overall Study|Due to hemodialysis|53|||
125933002|NCT02547454|453050074|FG000|Overall Study|Due to transplantation|1|||
125933003|NCT02547454|453050074|FG000|Overall Study|Due to no further need to treat|4|||
125933004|NCT02547454|453050074|FG000|Overall Study|Death|38|||
125933005|NCT02547454|453050074|FG000|Overall Study|Lost to Follow-up|26|||
125933006|NCT02547454|453050074|FG000|Overall Study|Other|39|||
125933007|NCT02547454|453050074|FG000|Overall Study|No data|11|||
125933008|NCT00203996|453050078|FG000|Overall Study|Lost to Follow-up|0|||
125933009|NCT00203996|453050079|FG001|Overall Study|Lost to Follow-up|0|||
125933010|NCT00203996|453050080|FG002|Overall Study|Lost to Follow-up|0|||
125933011|NCT00203996|453050081|FG003|Overall Study|Lost to Follow-up|1|||
125933012|NCT00203996|453050082|FG004|Overall Study|Lost to Follow-up|0|||
125933013|NCT00203996|453050083|FG005|Overall Study|Lost to Follow-up|0|||
125933014|NCT00203996|453050084|FG006|Overall Study|Lost to Follow-up|0|||
125933015|NCT00203996|453050085|FG007|Overall Study|Lost to Follow-up|0|||
125933016|NCT00203996|453050086|FG008|Overall Study|Lost to Follow-up|0|||
125933017|NCT00203996|453050087|FG009|Overall Study|Lost to Follow-up|0|||
125933018|NCT00203996|453050078|FG000|Overall Study|Protocol Violation|0|||
125933019|NCT00203996|453050079|FG001|Overall Study|Protocol Violation|0|||
125933020|NCT00203996|453050080|FG002|Overall Study|Protocol Violation|0|||
125933021|NCT00203996|453050081|FG003|Overall Study|Protocol Violation|6|||
125933022|NCT00203996|453050082|FG004|Overall Study|Protocol Violation|1|||
125933023|NCT00203996|453050083|FG005|Overall Study|Protocol Violation|0|||
125933024|NCT00203996|453050084|FG006|Overall Study|Protocol Violation|0|||
125933025|NCT00203996|453050085|FG007|Overall Study|Protocol Violation|0|||
125933026|NCT00203996|453050086|FG008|Overall Study|Protocol Violation|0|||
125933027|NCT00203996|453050087|FG009|Overall Study|Protocol Violation|0|||
125933028|NCT00203996|453050078|FG000|Overall Study|Physician Decision|0|||
125933029|NCT00203996|453050079|FG001|Overall Study|Physician Decision|0|||
125933030|NCT00203996|453050080|FG002|Overall Study|Physician Decision|0|||
125933031|NCT00203996|453050081|FG003|Overall Study|Physician Decision|2|||
125933032|NCT00203996|453050082|FG004|Overall Study|Physician Decision|0|||
125933033|NCT00203996|453050083|FG005|Overall Study|Physician Decision|0|||
125933034|NCT00203996|453050084|FG006|Overall Study|Physician Decision|0|||
125933035|NCT00203996|453050085|FG007|Overall Study|Physician Decision|0|||
125933036|NCT00203996|453050086|FG008|Overall Study|Physician Decision|0|||
125933037|NCT00203996|453050087|FG009|Overall Study|Physician Decision|1|||
126113753|NCT05586269|453712558|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
126113754|NCT02113579|453712559|FG000|Overall Study|Adverse Event|1|||
126113755|NCT02113579|453712560|FG001|Overall Study|Adverse Event|0|||
126113756|NCT02113579|453712559|FG000|Overall Study|Withdrawal by Subject|3|||
126113757|NCT02113579|453712560|FG001|Overall Study|Withdrawal by Subject|2|||
126113758|NCT02113579|453712559|FG000|Overall Study|Lost to Follow-up|6|||
126113759|NCT02113579|453712560|FG001|Overall Study|Lost to Follow-up|2|||
126113760|NCT02217436|453712561|FG000|Overall Study|Protocol Violation|1|||
126113761|NCT02217436|453712562|FG001|Overall Study|Protocol Violation|1|||
126113762|NCT02217436|453712561|FG000|Overall Study|Incomplete data|0|||
126113763|NCT02217436|453712562|FG001|Overall Study|Incomplete data|1|||
126113764|NCT01920594|453712565|FG000|Overall Study|Adverse Event|4|||
126113765|NCT01920594|453712566|FG001|Overall Study|Adverse Event|2|||
126113766|NCT01920594|453712565|FG000|Overall Study|Lost to Follow-up|1|||
126113767|NCT01920594|453712566|FG001|Overall Study|Lost to Follow-up|0|||
126113768|NCT01920594|453712565|FG000|Overall Study|Recovery|2|||
126113769|NCT01920594|453712566|FG001|Overall Study|Recovery|0|||
126113770|NCT01920594|453712565|FG000|Overall Study|Investigator discretion|0|||
126113771|NCT01920594|453712566|FG001|Overall Study|Investigator discretion|1|||
126113772|NCT00928564|453712567|FG000|Overall Study|Lost to Follow-up|6|||
126113773|NCT00928564|453712568|FG001|Overall Study|Lost to Follow-up|0|||
126113774|NCT02460497|453712572|FG000|Overall Study|Participant Requested Withdrawal|4|||
126113775|NCT02460497|453712572|FG000|Overall Study|Non-Compliance|1|||
126113776|NCT02460497|453712572|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
126113777|NCT02460497|453712572|FG000|Overall Study|Lost to Follow-up|2|||
126113778|NCT02460497|453712572|FG000|Overall Study|Investigator Decision|1|||
126113779|NCT02012296|453712577|FG000|Overall Study|Lack of Efficacy|0|||
126113780|NCT02012296|453712578|FG001|Overall Study|Lack of Efficacy|0|||
126113781|NCT02012296|453712579|FG002|Overall Study|Lack of Efficacy|15|||
126113782|NCT02012296|453712577|FG000|Overall Study|Adverse Event|0|||
126113783|NCT02012296|453712578|FG001|Overall Study|Adverse Event|0|||
126113784|NCT02012296|453712579|FG002|Overall Study|Adverse Event|2|||
126113785|NCT02012296|453712577|FG000|Overall Study|Early study closure|0|||
126113786|NCT02012296|453712578|FG001|Overall Study|Early study closure|0|||
126113787|NCT02012296|453712579|FG002|Overall Study|Early study closure|5|||
126113788|NCT02012296|453712577|FG000|Overall Study|Protocol Violation|0|||
126113789|NCT02012296|453712578|FG001|Overall Study|Protocol Violation|1|||
126113790|NCT02012296|453712579|FG002|Overall Study|Protocol Violation|0|||
126113791|NCT02615470|453712580|FG000|Overall Study|Lost to Follow-up|21|||
126113792|NCT02615470|453712581|FG001|Overall Study|Lost to Follow-up|32|||
126113793|NCT01650285|453712583|FG000|Overall Study|Adverse Event|1|||
126113794|NCT00907257|453712590|FG000|Overall Study|Adverse Event|0|||
126113795|NCT00907257|453712591|FG001|Overall Study|Adverse Event|4|||
126113796|NCT00907257|453712590|FG000|Overall Study|Protocol Violation|1|||
126113797|NCT00907257|453712591|FG001|Overall Study|Protocol Violation|2|||
126113798|NCT00907257|453712590|FG000|Overall Study|Lost to Follow-up|3|||
126113799|NCT00907257|453712591|FG001|Overall Study|Lost to Follow-up|3|||
126113800|NCT00907257|453712590|FG000|Overall Study|Withdrawal by Subject|1|||
126113801|NCT00907257|453712591|FG001|Overall Study|Withdrawal by Subject|2|||
126113802|NCT00907257|453712590|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
126113803|NCT00907257|453712591|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
126113804|NCT00907257|453712590|FG000|Overall Study|Moved|1|||
126113805|NCT00907257|453712591|FG001|Overall Study|Moved|0|||
126113806|NCT00907257|453712590|FG000|Overall Study|Personal Reasons|6|||
126113807|NCT00907257|453712591|FG001|Overall Study|Personal Reasons|1|||
126113808|NCT04163900|453712592|FG000|Overall Study|Radiological disease progression|112|||
126113809|NCT04163900|453712593|FG001|Overall Study|Radiological disease progression|127|||
126113810|NCT04163900|453712592|FG000|Overall Study|Study closure|98|||
126113811|NCT04163900|453712593|FG001|Overall Study|Study closure|133|||
126113812|NCT04163900|453712592|FG000|Overall Study|Adverse Event|78|||
126113813|NCT04163900|453712593|FG001|Overall Study|Adverse Event|32|||
126113814|NCT04163900|453712592|FG000|Overall Study|Withdrawal by Subject|37|||
126113815|NCT04163900|453712593|FG001|Overall Study|Withdrawal by Subject|34|||
126113816|NCT04163900|453712592|FG000|Overall Study|Death|29|||
126113817|NCT04163900|453712593|FG001|Overall Study|Death|16|||
126113818|NCT04163900|453712592|FG000|Overall Study|Physician Decision|17|||
126113819|NCT04163900|453712593|FG001|Overall Study|Physician Decision|25|||
126113820|NCT04163900|453712592|FG000|Overall Study|Clinical disease progression|14|||
126113821|NCT04163900|453712593|FG001|Overall Study|Clinical disease progression|13|||
126113822|NCT04163900|453712592|FG000|Overall Study|Protocol Violation|3|||
126113823|NCT04163900|453712593|FG001|Overall Study|Protocol Violation|4|||
126113824|NCT04163900|453712592|FG000|Overall Study|Lost to Follow-up|0|||
126113825|NCT04163900|453712593|FG001|Overall Study|Lost to Follow-up|1|||
126113826|NCT00283049|453712594|FG000|Overall Study|Adverse Event|6|||
126113827|NCT00283049|453712595|FG001|Overall Study|Adverse Event|1|||
126113828|NCT00283049|453712596|FG002|Overall Study|Adverse Event|4|||
126113829|NCT00283049|453712594|FG000|Overall Study|Protocol Violation|3|||
126113830|NCT00283049|453712595|FG001|Overall Study|Protocol Violation|0|||
126113831|NCT00283049|453712596|FG002|Overall Study|Protocol Violation|3|||
126113832|NCT00283049|453712594|FG000|Overall Study|Death|1|||
125933038|NCT00203996|453050078|FG000|Overall Study|CPAP machine malfunction|0|||
125933039|NCT00203996|453050079|FG001|Overall Study|CPAP machine malfunction|0|||
125933040|NCT00203996|453050080|FG002|Overall Study|CPAP machine malfunction|0|||
125933041|NCT00203996|453050081|FG003|Overall Study|CPAP machine malfunction|1|||
125933042|NCT00203996|453050082|FG004|Overall Study|CPAP machine malfunction|0|||
125933043|NCT00203996|453050083|FG005|Overall Study|CPAP machine malfunction|0|||
125933044|NCT00203996|453050084|FG006|Overall Study|CPAP machine malfunction|0|||
125933045|NCT00203996|453050085|FG007|Overall Study|CPAP machine malfunction|0|||
125933046|NCT00203996|453050086|FG008|Overall Study|CPAP machine malfunction|0|||
125933047|NCT00203996|453050087|FG009|Overall Study|CPAP machine malfunction|0|||
125933048|NCT00203996|453050078|FG000|Overall Study|Scheduling issue|0|||
125933049|NCT00203996|453050079|FG001|Overall Study|Scheduling issue|0|||
125933050|NCT00203996|453050080|FG002|Overall Study|Scheduling issue|0|||
125933051|NCT00203996|453050081|FG003|Overall Study|Scheduling issue|0|||
125933052|NCT00203996|453050082|FG004|Overall Study|Scheduling issue|0|||
125933053|NCT00203996|453050083|FG005|Overall Study|Scheduling issue|0|||
125933054|NCT00203996|453050084|FG006|Overall Study|Scheduling issue|0|||
125933055|NCT00203996|453050085|FG007|Overall Study|Scheduling issue|2|||
125933056|NCT00203996|453050086|FG008|Overall Study|Scheduling issue|0|||
125933057|NCT00203996|453050087|FG009|Overall Study|Scheduling issue|0|||
125933058|NCT03789318|453050088|FG000|Overall Study|Adverse Event|0|||
125933059|NCT03789318|453050089|FG001|Overall Study|Adverse Event|0|||
125933060|NCT03789318|453050090|FG002|Overall Study|Adverse Event|1|||
125933061|NCT03789318|453050091|FG003|Overall Study|Adverse Event|1|||
125933062|NCT03789318|453050092|FG004|Overall Study|Adverse Event|0|||
125933063|NCT03789318|453050088|FG000|Overall Study|Lost to Follow-up|0|||
125933064|NCT03789318|453050089|FG001|Overall Study|Lost to Follow-up|0|||
125933065|NCT03789318|453050090|FG002|Overall Study|Lost to Follow-up|1|||
125933066|NCT03789318|453050091|FG003|Overall Study|Lost to Follow-up|0|||
125933067|NCT03789318|453050092|FG004|Overall Study|Lost to Follow-up|0|||
125933068|NCT03789318|453050088|FG000|Overall Study|Withdrawal by Subject|0|||
125933069|NCT03789318|453050089|FG001|Overall Study|Withdrawal by Subject|0|||
125933070|NCT03789318|453050090|FG002|Overall Study|Withdrawal by Subject|1|||
125933071|NCT03789318|453050091|FG003|Overall Study|Withdrawal by Subject|0|||
125933072|NCT03789318|453050092|FG004|Overall Study|Withdrawal by Subject|0|||
125933073|NCT03700671|453050093|FG000|Overall Study|Lack of Efficacy|1|||
125933074|NCT03700671|453050094|FG001|Overall Study|Lack of Efficacy|2|||
125933075|NCT01774968|453050095|FG000|Overall Study|Adverse Event|4|||
125933076|NCT01774968|453050096|FG001|Overall Study|Adverse Event|4|||
125933077|NCT01774968|453050095|FG000|Overall Study|Death|0|||
125933078|NCT01774968|453050096|FG001|Overall Study|Death|1|||
125933079|NCT01774968|453050095|FG000|Overall Study|Lost to Follow-up|1|||
125933080|NCT01774968|453050096|FG001|Overall Study|Lost to Follow-up|3|||
125933081|NCT01774968|453050095|FG000|Overall Study|Physician Decision|5|||
125933082|NCT01774968|453050096|FG001|Overall Study|Physician Decision|1|||
125933083|NCT01774968|453050095|FG000|Overall Study|Protocol Violation|14|||
125933084|NCT01774968|453050096|FG001|Overall Study|Protocol Violation|13|||
125933085|NCT01774968|453050095|FG000|Overall Study|Sponsor Decision|0|||
125933086|NCT01774968|453050096|FG001|Overall Study|Sponsor Decision|2|||
125933087|NCT01774968|453050095|FG000|Overall Study|Withdrawal by Subject|6|||
125933088|NCT01774968|453050096|FG001|Overall Study|Withdrawal by Subject|11|||
125933089|NCT01937559|453050099|FG000|Overall Study|Physician Decision|3|||
125933090|NCT01937559|453050100|FG001|Overall Study|Physician Decision|3|||
125933091|NCT01937559|453050101|FG002|Overall Study|Physician Decision|0|||
125933092|NCT01937559|453050099|FG000|Overall Study|Withdrawal by Subject|6|||
125933093|NCT01937559|453050100|FG001|Overall Study|Withdrawal by Subject|4|||
125933094|NCT01937559|453050101|FG002|Overall Study|Withdrawal by Subject|0|||
125933095|NCT01937559|453050099|FG000|Overall Study|screen fail|2|||
126113833|NCT00283049|453712595|FG001|Overall Study|Death|1|||
125933096|NCT01937559|453050100|FG001|Overall Study|screen fail|4|||
125933097|NCT01937559|453050101|FG002|Overall Study|screen fail|0|||
125933098|NCT00754624|453051668|FG000|Overall Study|Adverse Event|16|||
125933099|NCT00754624|453051668|FG000|Overall Study|Death|1|||
125933100|NCT00754624|453051668|FG000|Overall Study|Physician Decision|8|||
125933101|NCT00754624|453051668|FG000|Overall Study|Protocol Violation|1|||
125933102|NCT00754624|453051668|FG000|Overall Study|Withdrawal by Subject|28|||
125933103|NCT00754624|453051668|FG000|Overall Study|Various|12|||
125933104|NCT00754624|453051668|FG000|Overall Study|Lost to Follow-up|3|||
125933105|NCT00418314|453051669|FG000|Overall Study|Withdrawal by Subject|1|||
125933106|NCT00418314|453051670|FG001|Overall Study|Withdrawal by Subject|2|||
125933107|NCT01402544|453051674|FG000|Overall Study|Withdrawal by Subject|6|||
125933108|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Death|3|||
125933109|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Death|3|||
125933110|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Death|0|||
125933111|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Death|0|||
125933112|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
125933113|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
125933114|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
125933115|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
125933116|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
125933117|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
125933118|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
125933119|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
125933120|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
125933121|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
125933122|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
125933123|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
125933124|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
125933125|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
125933126|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
125933127|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
125933128|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
125933129|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
125933130|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
125933131|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
125933132|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
125933133|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
125933134|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
125933135|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
125933136|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Other|6|||
125933137|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Other|3|||
125933138|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Other|0|||
125933139|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Other|0|||
125933140|NCT02051608|453051677|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
125933141|NCT02051608|453051678|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
125933142|NCT02051608|453051679|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
125933143|NCT02051608|453051680|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
125933144|NCT02051608|453051677|FG000|Part 2: Open-label Extension|Adverse Event|0|||
125933145|NCT02051608|453051678|FG001|Part 2: Open-label Extension|Adverse Event|0|||
125933146|NCT02051608|453051679|FG002|Part 2: Open-label Extension|Adverse Event|6|||
125933147|NCT02051608|453051680|FG003|Part 2: Open-label Extension|Adverse Event|8|||
125933148|NCT02051608|453051677|FG000|Part 2: Open-label Extension|Death|0|||
125933149|NCT02051608|453051678|FG001|Part 2: Open-label Extension|Death|0|||
125933150|NCT02051608|453051679|FG002|Part 2: Open-label Extension|Death|7|||
126066175|NCT01136733|453533493|FG002|Phase 2|Administrative-Withdrew Consent|0|||
126066176|NCT01136733|453533494|FG003|Phase 2|Administrative-Withdrew Consent|0|||
126066177|NCT01136733|453533495|FG004|Phase 2|Administrative-Withdrew Consent|1|||
126066178|NCT01136733|453533496|FG005|Phase 2|Administrative-Withdrew Consent|0|||
126066179|NCT01136733|453533497|FG006|Phase 2|Administrative-Withdrew Consent|0|||
126066180|NCT01136733|453533491|FG000|Phase 2|Other|0|||
125933151|NCT02051608|453051680|FG003|Part 2: Open-label Extension|Death|4|||
125933152|NCT02051608|453051677|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
125933153|NCT02051608|453051678|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
125933154|NCT02051608|453051679|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
125933155|NCT02051608|453051680|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
125933156|NCT02051608|453051677|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
125933157|NCT02051608|453051678|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
125933158|NCT02051608|453051679|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
125933159|NCT02051608|453051680|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
125933160|NCT02051608|453051677|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125933161|NCT02051608|453051678|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125933162|NCT02051608|453051679|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
125933163|NCT02051608|453051680|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
125933164|NCT02051608|453051677|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
125933165|NCT02051608|453051678|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
125933166|NCT02051608|453051679|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
125933167|NCT02051608|453051680|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
125933168|NCT02051608|453051677|FG000|Part 2: Open-label Extension|Physician Decision|0|||
125933169|NCT02051608|453051678|FG001|Part 2: Open-label Extension|Physician Decision|0|||
125933170|NCT02051608|453051679|FG002|Part 2: Open-label Extension|Physician Decision|8|||
125933171|NCT02051608|453051680|FG003|Part 2: Open-label Extension|Physician Decision|5|||
125933172|NCT02051608|453051677|FG000|Part 2: Open-label Extension|Other|0|||
125933173|NCT02051608|453051678|FG001|Part 2: Open-label Extension|Other|0|||
125933174|NCT02051608|453051679|FG002|Part 2: Open-label Extension|Other|9|||
125933175|NCT02051608|453051680|FG003|Part 2: Open-label Extension|Other|9|||
125933176|NCT04876274|453051681|FG000|Overall Study|Lost to Follow-up|9|||
125933177|NCT04876274|453051682|FG001|Overall Study|Lost to Follow-up|12|||
126066181|NCT01136733|453533492|FG001|Phase 2|Other|0|||
126066182|NCT01136733|453533493|FG002|Phase 2|Other|0|||
126066183|NCT01136733|453533494|FG003|Phase 2|Other|0|||
126113834|NCT00283049|453712596|FG002|Overall Study|Death|1|||
126113835|NCT00283049|453712594|FG000|Overall Study|Lack of Efficacy|0|||
126113836|NCT00283049|453712595|FG001|Overall Study|Lack of Efficacy|1|||
125933178|NCT01948050|453051683|FG000|Overall Study|Withdrawal by Subject|0|||
125933179|NCT01948050|453051684|FG001|Overall Study|Withdrawal by Subject|1|||
125933180|NCT03303079|453051685|FG000|Overall Study|Adverse Event|0|||
125933181|NCT03303079|453051686|FG001|Overall Study|Adverse Event|1|||
125933182|NCT03303079|453051687|FG002|Overall Study|Adverse Event|3|||
125933183|NCT03303079|453051685|FG000|Overall Study|Protocol Violation|5|||
125933184|NCT03303079|453051686|FG001|Overall Study|Protocol Violation|4|||
125933185|NCT03303079|453051687|FG002|Overall Study|Protocol Violation|7|||
125933186|NCT03303079|453051685|FG000|Overall Study|Withdrawal by Subject|2|||
125933187|NCT03303079|453051686|FG001|Overall Study|Withdrawal by Subject|4|||
125933188|NCT03303079|453051687|FG002|Overall Study|Withdrawal by Subject|2|||
125933189|NCT03303079|453051685|FG000|Overall Study|Other than specified|0|||
125933190|NCT03303079|453051686|FG001|Overall Study|Other than specified|2|||
125933191|NCT03303079|453051687|FG002|Overall Study|Other than specified|0|||
125933192|NCT02005445|453051688|FG000|Overall Study|Dual study enrollment|0|||
125933193|NCT02005445|453051689|FG001|Overall Study|Dual study enrollment|1|||
125933194|NCT01314443|453051690|FG000|Overall Study|Withdrawal by Subject|2|||
125933195|NCT01314443|453051691|FG001|Overall Study|Withdrawal by Subject|1|||
125933196|NCT01314443|453051692|FG002|Overall Study|Withdrawal by Subject|1|||
125933197|NCT01314443|453051693|FG003|Overall Study|Withdrawal by Subject|1|||
125933198|NCT01314443|453051690|FG000|Overall Study|Protocol Violation|2|||
125933199|NCT01314443|453051691|FG001|Overall Study|Protocol Violation|2|||
125933200|NCT01314443|453051692|FG002|Overall Study|Protocol Violation|1|||
125933201|NCT01314443|453051693|FG003|Overall Study|Protocol Violation|1|||
125933202|NCT00449540|453051695|FG000|Pretreatment Phase|No migraine experienced|66|||
125933203|NCT00449540|453051696|FG001|Pretreatment Phase|No migraine experienced|0|||
125933204|NCT00449540|453051697|FG002|Pretreatment Phase|No migraine experienced|0|||
125933205|NCT00449540|453051695|FG000|Treatment Phase|did not experience or treat migraine|0|||
125933206|NCT00449540|453051696|FG001|Treatment Phase|did not experience or treat migraine|20|||
125933207|NCT00449540|453051697|FG002|Treatment Phase|did not experience or treat migraine|17|||
125933208|NCT02709785|453051698|FG000|Overall Study|Withdrawal by Subject|1|||
125933209|NCT02709785|453051699|FG001|Overall Study|Withdrawal by Subject|2|||
125933210|NCT02709785|453051700|FG002|Overall Study|Withdrawal by Subject|1|||
125933211|NCT00010374|453051701|FG000|Overall Study|False positive phrenic nerve test|1|||
125933212|NCT01961323|453051702|FG000|Overall Study|Withdrawal by Subject|7|||
125933213|NCT01961323|453051702|FG000|Overall Study|Lost to Follow-up|8|||
125933214|NCT01961323|453051702|FG000|Overall Study|screen failure|34|||
125933215|NCT02746874|453051705|FG000|Overall Study|Withdrawal by Subject|0|||
125933216|NCT02746874|453051706|FG001|Overall Study|Withdrawal by Subject|1|||
125933217|NCT02746874|453051705|FG000|Overall Study|Surgery Date Changed|0|||
125933218|NCT02746874|453051706|FG001|Overall Study|Surgery Date Changed|2|||
125933219|NCT02320149|453051709|FG000|Overall Study|Adverse Event|3|||
125933220|NCT02320149|453051710|FG001|Overall Study|Adverse Event|7|||
125933221|NCT02320149|453051709|FG000|Overall Study|Withdrawal of Consent|28|||
125933222|NCT02320149|453051710|FG001|Overall Study|Withdrawal of Consent|32|||
125933223|NCT02320149|453051709|FG000|Overall Study|Lost to Follow-up|21|||
125933224|NCT02320149|453051710|FG001|Overall Study|Lost to Follow-up|34|||
125933225|NCT02320149|453051709|FG000|Overall Study|Protocol Violation|2|||
125933226|NCT02320149|453051710|FG001|Overall Study|Protocol Violation|1|||
125933227|NCT02320149|453051709|FG000|Overall Study|Noncompliance with Study Treatment|7|||
125933228|NCT02320149|453051710|FG001|Overall Study|Noncompliance with Study Treatment|2|||
125933229|NCT02320149|453051709|FG000|Overall Study|Lack of Efficacy|0|||
125933230|NCT02320149|453051710|FG001|Overall Study|Lack of Efficacy|1|||
125933231|NCT02320149|453051709|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125933232|NCT02320149|453051710|FG001|Overall Study|Other Miscellaneous Reasons|3|||
125933233|NCT01156311|453051714|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
125933234|NCT01156311|453051715|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
125933235|NCT01156311|453051716|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
125933236|NCT01156311|453051717|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
125933237|NCT01156311|453051714|FG000|2-Month Monotherapy Period|Physician Decision|0|||
125933238|NCT01156311|453051715|FG001|2-Month Monotherapy Period|Physician Decision|1|||
125933239|NCT01156311|453051716|FG002|2-Month Monotherapy Period|Physician Decision|0|||
125933240|NCT01156311|453051717|FG003|2-Month Monotherapy Period|Physician Decision|0|||
125933241|NCT01156311|453051714|FG000|2-Month Monotherapy Period|Other|1|||
125933242|NCT01156311|453051715|FG001|2-Month Monotherapy Period|Other|0|||
125933243|NCT01156311|453051716|FG002|2-Month Monotherapy Period|Other|0|||
125933244|NCT01156311|453051717|FG003|2-Month Monotherapy Period|Other|0|||
125933245|NCT01156311|453051714|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
125933246|NCT01156311|453051715|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
125933247|NCT01156311|453051716|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
125933248|NCT01156311|453051717|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
125933249|NCT01156311|453051714|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
126113837|NCT00283049|453712596|FG002|Overall Study|Lack of Efficacy|1|||
126113838|NCT00283049|453712594|FG000|Overall Study|Lost to Follow-up|4|||
126113839|NCT00283049|453712595|FG001|Overall Study|Lost to Follow-up|2|||
126113840|NCT00283049|453712596|FG002|Overall Study|Lost to Follow-up|5|||
126113841|NCT00283049|453712594|FG000|Overall Study|Withdrawal by Subject|26|||
126113842|NCT00283049|453712595|FG001|Overall Study|Withdrawal by Subject|24|||
126113843|NCT00283049|453712596|FG002|Overall Study|Withdrawal by Subject|19|||
126113844|NCT00283049|453712594|FG000|Overall Study|Discontinuation of Study|18|||
126113845|NCT00283049|453712595|FG001|Overall Study|Discontinuation of Study|16|||
126113846|NCT00283049|453712596|FG002|Overall Study|Discontinuation of Study|20|||
126113847|NCT00283049|453712594|FG000|Overall Study|No longer requires study treatment|0|||
126113848|NCT00283049|453712595|FG001|Overall Study|No longer requires study treatment|0|||
126113849|NCT00283049|453712596|FG002|Overall Study|No longer requires study treatment|1|||
126113850|NCT01830855|453712597|FG000|Overall Study|Other|7|||
126113851|NCT01830855|453712598|FG001|Overall Study|Other|1|||
126113852|NCT01830855|453712599|FG002|Overall Study|Other|4|||
126113853|NCT01830855|453712600|FG003|Overall Study|Other|4|||
126113854|NCT01830855|453712597|FG000|Overall Study|Medication error without associated AE|1|||
126113855|NCT01830855|453712598|FG001|Overall Study|Medication error without associated AE|0|||
126113856|NCT01830855|453712599|FG002|Overall Study|Medication error without associated AE|0|||
126113857|NCT01830855|453712600|FG003|Overall Study|Medication error without associated AE|1|||
126113858|NCT01830855|453712597|FG000|Overall Study|Pregnancy|3|||
126113859|NCT01830855|453712598|FG001|Overall Study|Pregnancy|1|||
126113860|NCT01830855|453712599|FG002|Overall Study|Pregnancy|2|||
126113861|NCT01830855|453712600|FG003|Overall Study|Pregnancy|1|||
126113862|NCT01830855|453712597|FG000|Overall Study|No longer meets eligibility criteria|11|||
126113863|NCT01830855|453712598|FG001|Overall Study|No longer meets eligibility criteria|2|||
126113864|NCT01830855|453712599|FG002|Overall Study|No longer meets eligibility criteria|3|||
126113865|NCT01830855|453712600|FG003|Overall Study|No longer meets eligibility criteria|5|||
126113866|NCT01830855|453712597|FG000|Overall Study|Adverse Event|11|||
126113867|NCT01830855|453712598|FG001|Overall Study|Adverse Event|5|||
126113868|NCT01830855|453712599|FG002|Overall Study|Adverse Event|6|||
125933250|NCT01156311|453051715|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
125933251|NCT01156311|453051716|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
125933252|NCT01156311|453051717|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
125933253|NCT01156311|453051714|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
125933254|NCT01156311|453051715|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
125933255|NCT01156311|453051716|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
125933256|NCT01156311|453051717|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
125933257|NCT01156311|453051714|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
125933258|NCT01156311|453051715|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
125933259|NCT01156311|453051716|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
125933260|NCT01156311|453051717|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
125933261|NCT01156311|453051714|FG000|6-month Add-on Therapy Period|Other|0|||
125933262|NCT01156311|453051715|FG001|6-month Add-on Therapy Period|Other|0|||
125933263|NCT01156311|453051716|FG002|6-month Add-on Therapy Period|Other|1|||
125933264|NCT01156311|453051717|FG003|6-month Add-on Therapy Period|Other|2|||
125933265|NCT01741701|453051718|FG000|Overall Study|Adverse Event|5|||
125933266|NCT01741701|453051719|FG001|Overall Study|Adverse Event|1|||
125933267|NCT01741701|453051718|FG000|Overall Study|Withdrawal by Subject|0|||
125933268|NCT01741701|453051719|FG001|Overall Study|Withdrawal by Subject|1|||
125933269|NCT00487747|453051720|FG000|Overall Study|Adverse Event|1|||
125933270|NCT00487747|453051720|FG000|Overall Study|Lost to Follow-up|9|||
125933271|NCT00487747|453051720|FG000|Overall Study|Lack of Efficacy|1|||
126066184|NCT01136733|453533495|FG004|Phase 2|Other|6|||
126066185|NCT01136733|453533496|FG005|Phase 2|Other|7|||
126066186|NCT01136733|453533497|FG006|Phase 2|Other|6|||
126066187|NCT03360071|453533499|FG000|Overall Study|Lost to Follow-up|1|||
126066188|NCT03360071|453533500|FG001|Overall Study|Lost to Follow-up|0|||
126066189|NCT02368691|453533504|FG000|Overall Study|Death|13|||
126066190|NCT02368691|453533504|FG000|Overall Study|Lack of Efficacy|15|||
126066191|NCT02368691|453533504|FG000|Overall Study|Physician Decision|4|||
126066192|NCT03314233|453533507|FG000|Overall Study|No longer eligible at time of delivery|1|||
126066193|NCT01114217|453533509|FG000|Overall Study|Adverse Event|5|||
126066194|NCT01114217|453533510|FG001|Overall Study|Adverse Event|3|||
126066195|NCT01114217|453533509|FG000|Overall Study|Lost to Follow-up|17|||
126066196|NCT01114217|453533510|FG001|Overall Study|Lost to Follow-up|33|||
126066197|NCT01114217|453533509|FG000|Overall Study|Withdrawal by Subject|21|||
126066198|NCT01114217|453533510|FG001|Overall Study|Withdrawal by Subject|28|||
125933272|NCT01830972|453051721|FG000|Part II|Withdrawal by Subject|2|||
125933273|NCT01830972|453051722|FG001|Part II|Withdrawal by Subject|2|||
126066199|NCT01114217|453533509|FG000|Overall Study|Other-Clerical Error|3|||
126066200|NCT01114217|453533510|FG001|Overall Study|Other-Clerical Error|0|||
126066201|NCT01114217|453533509|FG000|Overall Study|Other-Early termination|6|||
126113869|NCT01830855|453712600|FG003|Overall Study|Adverse Event|3|||
126113870|NCT01830855|453712597|FG000|Overall Study|Protocol deviation|10|||
125933274|NCT01830972|453051721|FG000|Part III|Withdrawal by Subject|1|||
125933275|NCT01830972|453051722|FG001|Part III|Withdrawal by Subject|0|||
125933276|NCT01830972|453051721|FG000|Part III|Noncompliance|1|||
125933277|NCT01830972|453051722|FG001|Part III|Noncompliance|0|||
125933278|NCT01830972|453051721|FG000|Part IV|Withdrawal by Subject|2|||
125933279|NCT01830972|453051722|FG001|Part IV|Withdrawal by Subject|1|||
125933280|NCT01830972|453051721|FG000|Part IV|Non-Compliance|1|||
125933281|NCT01830972|453051722|FG001|Part IV|Non-Compliance|0|||
125933282|NCT01907815|453051725|FG000|Overall Study|Withdrawal by Subject|1|||
125933283|NCT01907815|453051726|FG001|Overall Study|Withdrawal by Subject|0|||
125933284|NCT02205814|453051727|FG000|Overall Study|Lost to Follow-up|0|||
125933285|NCT02205814|453051728|FG001|Overall Study|Lost to Follow-up|0|||
125933286|NCT02205814|453051729|FG002|Overall Study|Lost to Follow-up|0|||
125933287|NCT02205814|453051730|FG003|Overall Study|Lost to Follow-up|1|||
125933288|NCT02205814|453051727|FG000|Overall Study|Lack of Efficacy|1|||
125933289|NCT02205814|453051728|FG001|Overall Study|Lack of Efficacy|0|||
125933290|NCT02205814|453051729|FG002|Overall Study|Lack of Efficacy|1|||
125933291|NCT02205814|453051730|FG003|Overall Study|Lack of Efficacy|1|||
125933292|NCT02205814|453051727|FG000|Overall Study|Physician Decision|0|||
125933293|NCT02205814|453051728|FG001|Overall Study|Physician Decision|0|||
125933294|NCT02205814|453051729|FG002|Overall Study|Physician Decision|1|||
125933295|NCT02205814|453051730|FG003|Overall Study|Physician Decision|0|||
125933296|NCT02205814|453051727|FG000|Overall Study|Protocol Violation|1|||
125933297|NCT02205814|453051728|FG001|Overall Study|Protocol Violation|0|||
125933298|NCT02205814|453051729|FG002|Overall Study|Protocol Violation|0|||
125933299|NCT02205814|453051730|FG003|Overall Study|Protocol Violation|1|||
125933300|NCT02205814|453051727|FG000|Overall Study|Withdrawal by Subject|0|||
125933301|NCT02205814|453051728|FG001|Overall Study|Withdrawal by Subject|1|||
125933302|NCT02205814|453051729|FG002|Overall Study|Withdrawal by Subject|2|||
125933303|NCT02205814|453051730|FG003|Overall Study|Withdrawal by Subject|1|||
125933304|NCT02205814|453051727|FG000|Overall Study|not compliant with study procedures|0|||
125933305|NCT02205814|453051728|FG001|Overall Study|not compliant with study procedures|0|||
125933306|NCT02205814|453051729|FG002|Overall Study|not compliant with study procedures|1|||
125933307|NCT02205814|453051730|FG003|Overall Study|not compliant with study procedures|0|||
125933308|NCT01426373|453051731|FG000|Overall Study|Adverse Event|6|||
125933309|NCT01426373|453051731|FG000|Overall Study|Lost to Follow-up|14|||
125933310|NCT01426373|453051731|FG000|Overall Study|Participant Convenience|10|||
125933311|NCT01426373|453051731|FG000|Overall Study|Miscellaneous Reasons|4|||
125933312|NCT04952402|453051732|FG000|Overall Study|Lost to Follow-up|1|||
125933313|NCT04952402|453051733|FG001|Overall Study|Lost to Follow-up|3|||
125933314|NCT04952402|453051732|FG000|Overall Study|Lack Of Venous Access|0|||
125933315|NCT04952402|453051733|FG001|Overall Study|Lack Of Venous Access|1|||
125933316|NCT04997161|453051740|FG000|Overall Study|Study terminated by sponsor|3|||
125933317|NCT04044716|453051741|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
125933318|NCT04044716|453051742|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
125933319|NCT04044716|453051743|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
125933320|NCT04044716|453051741|FG000|Overall Study|Lost to Follow-up|2|||
125933321|NCT04044716|453051742|FG001|Overall Study|Lost to Follow-up|3|||
125933322|NCT04044716|453051743|FG002|Overall Study|Lost to Follow-up|0|||
125933323|NCT01018186|453051744|FG000|2-week Run-in Period|Protocol Violation|1|||
125933324|NCT01018186|453051745|FG001|2-week Run-in Period|Protocol Violation|0|||
125933325|NCT01018186|453051746|FG002|2-week Run-in Period|Protocol Violation|0|||
125933326|NCT01018186|453051747|FG003|2-week Run-in Period|Protocol Violation|0|||
125933327|NCT01018186|453051744|FG000|2-week Run-in Period|Lost to Follow-up|2|||
125933328|NCT01018186|453051745|FG001|2-week Run-in Period|Lost to Follow-up|0|||
125933329|NCT01018186|453051746|FG002|2-week Run-in Period|Lost to Follow-up|0|||
125933330|NCT01018186|453051747|FG003|2-week Run-in Period|Lost to Follow-up|0|||
125933331|NCT01018186|453051744|FG000|2-week Run-in Period|Physician Decision|3|||
125933332|NCT01018186|453051745|FG001|2-week Run-in Period|Physician Decision|0|||
125933333|NCT01018186|453051746|FG002|2-week Run-in Period|Physician Decision|0|||
125933334|NCT01018186|453051747|FG003|2-week Run-in Period|Physician Decision|0|||
125933335|NCT01018186|453051744|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
125933336|NCT01018186|453051745|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125933337|NCT01018186|453051746|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125933338|NCT01018186|453051747|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
125933339|NCT01018186|453051744|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
125933340|NCT01018186|453051745|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125933341|NCT01018186|453051746|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125933342|NCT01018186|453051747|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125933343|NCT01018186|453051744|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
125933344|NCT01018186|453051745|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
125933345|NCT01018186|453051746|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
125933346|NCT01018186|453051747|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
125933347|NCT01018186|453051744|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
125933348|NCT01018186|453051745|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
125933349|NCT01018186|453051746|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
125933350|NCT01018186|453051747|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
125933351|NCT01018186|453051744|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
125933352|NCT01018186|453051745|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
125933353|NCT01018186|453051746|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
125933354|NCT01018186|453051747|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
125933355|NCT01018186|453051744|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
125933356|NCT01018186|453051745|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
125933357|NCT01018186|453051746|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
125933358|NCT01018186|453051747|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
125933359|NCT01018186|453051744|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
125933360|NCT01018186|453051745|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
125933361|NCT01018186|453051746|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
125933362|NCT01018186|453051747|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
125933363|NCT01018186|453051744|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
125933364|NCT01018186|453051745|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
125933365|NCT01018186|453051746|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
125933366|NCT01018186|453051747|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
125933367|NCT01018186|453051744|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125933368|NCT01018186|453051745|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
125933369|NCT01018186|453051746|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
125933370|NCT01018186|453051747|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
125933371|NCT03049280|453051748|FG000|Overall Study|Physician Decision|1|||
125933372|NCT03552198|453051749|FG000|Overall Study|Lost to Follow-up|42|||
125933373|NCT03552198|453051750|FG001|Overall Study|Lost to Follow-up|48|||
125933374|NCT03552198|453051751|FG002|Overall Study|Lost to Follow-up|15|||
125933375|NCT03552198|453051752|FG003|Overall Study|Lost to Follow-up|19|||
125933376|NCT03552198|453051749|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
125933377|NCT03552198|453051750|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
125933378|NCT03552198|453051751|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
125933379|NCT03552198|453051752|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
125933380|NCT03552198|453051749|FG000|Overall Study|Did not receive air alerts|1|||
125933381|NCT03552198|453051750|FG001|Overall Study|Did not receive air alerts|0|||
125933382|NCT03552198|453051751|FG002|Overall Study|Did not receive air alerts|0|||
125933383|NCT03552198|453051752|FG003|Overall Study|Did not receive air alerts|1|||
125933384|NCT03060629|453051758|FG000|Overall Study|Death|4|||
125933385|NCT03060629|453051759|FG001|Overall Study|Death|5|||
125933386|NCT03060629|453051758|FG000|Overall Study|Withdrawal by Subject|50|||
125933387|NCT03060629|453051759|FG001|Overall Study|Withdrawal by Subject|35|||
125933388|NCT03060629|453051758|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
125933389|NCT03060629|453051759|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
125933390|NCT03060629|453051758|FG000|Overall Study|Participant Relocate|15|||
125933391|NCT03060629|453051759|FG001|Overall Study|Participant Relocate|15|||
125933392|NCT03060629|453051758|FG000|Overall Study|Unable to Contact Participant|34|||
125933393|NCT03060629|453051759|FG001|Overall Study|Unable to Contact Participant|23|||
125933394|NCT03060629|453051758|FG000|Overall Study|Investigator Decision|7|||
125933395|NCT03060629|453051759|FG001|Overall Study|Investigator Decision|7|||
125933396|NCT03060629|453051758|FG000|Overall Study|Study Terminated by Sponsor|1100|||
125933397|NCT03060629|453051759|FG001|Overall Study|Study Terminated by Sponsor|1123|||
125933398|NCT03060629|453051758|FG000|Overall Study|Other|4|||
125933399|NCT03060629|453051759|FG001|Overall Study|Other|4|||
125933400|NCT02505867|453051760|FG000|Overall Study|Lack of Efficacy|6|||
125933401|NCT02505867|453051761|FG001|Overall Study|Lack of Efficacy|6|||
125933402|NCT01862874|453051762|FG000|Overall Study|Randomized not treated|1|||
125933403|NCT01862874|453051763|FG001|Overall Study|Randomized not treated|0|||
125933404|NCT01862874|453051762|FG000|Overall Study|Adverse Event|0|||
125933405|NCT01862874|453051763|FG001|Overall Study|Adverse Event|3|||
125933406|NCT01862874|453051762|FG000|Overall Study|Lost to Follow-up|26|||
125933407|NCT01862874|453051763|FG001|Overall Study|Lost to Follow-up|29|||
125933408|NCT01862874|453051762|FG000|Overall Study|Physician Decision|5|||
125933409|NCT01862874|453051763|FG001|Overall Study|Physician Decision|3|||
125933410|NCT01862874|453051762|FG000|Overall Study|Withdrawn by parent/guardian|1|||
125933411|NCT01862874|453051763|FG001|Overall Study|Withdrawn by parent/guardian|1|||
125933412|NCT01862874|453051762|FG000|Overall Study|Withdrawal by Subject|46|||
125933413|NCT01862874|453051763|FG001|Overall Study|Withdrawal by Subject|40|||
125933414|NCT01862874|453051762|FG000|Overall Study|Death|0|||
125933415|NCT01862874|453051763|FG001|Overall Study|Death|1|||
125933416|NCT02743871|453051767|FG000|Overall Study|Lost to Follow-up|0|||
125933417|NCT02743871|453051768|FG001|Overall Study|Lost to Follow-up|0|||
125933418|NCT02743871|453051769|FG002|Overall Study|Lost to Follow-up|0|||
125933419|NCT02743871|453051770|FG003|Overall Study|Lost to Follow-up|1|||
125933420|NCT02743871|453051771|FG004|Overall Study|Lost to Follow-up|0|||
125933421|NCT02743871|453051772|FG005|Overall Study|Lost to Follow-up|0|||
125933422|NCT02743871|453051773|FG006|Overall Study|Lost to Follow-up|1|||
125933423|NCT02743871|453051774|FG007|Overall Study|Lost to Follow-up|0|||
125933424|NCT02743871|453051775|FG008|Overall Study|Lost to Follow-up|0|||
125933425|NCT02743871|453051776|FG009|Overall Study|Lost to Follow-up|0|||
125933426|NCT02743871|453051777|FG010|Overall Study|Lost to Follow-up|0|||
125933427|NCT02743871|453051778|FG011|Overall Study|Lost to Follow-up|2|||
125933428|NCT02743871|453051779|FG012|Overall Study|Lost to Follow-up|0|||
125933429|NCT02743871|453051780|FG013|Overall Study|Lost to Follow-up|0|||
125933430|NCT02743871|453051767|FG000|Overall Study|Withdrawal by Subject|0|||
125933431|NCT02743871|453051768|FG001|Overall Study|Withdrawal by Subject|0|||
125933432|NCT02743871|453051769|FG002|Overall Study|Withdrawal by Subject|0|||
125933433|NCT02743871|453051770|FG003|Overall Study|Withdrawal by Subject|0|||
125933434|NCT02743871|453051771|FG004|Overall Study|Withdrawal by Subject|0|||
125933435|NCT02743871|453051772|FG005|Overall Study|Withdrawal by Subject|0|||
125933436|NCT02743871|453051773|FG006|Overall Study|Withdrawal by Subject|0|||
125933437|NCT02743871|453051774|FG007|Overall Study|Withdrawal by Subject|0|||
125933438|NCT02743871|453051775|FG008|Overall Study|Withdrawal by Subject|0|||
125933439|NCT02743871|453051776|FG009|Overall Study|Withdrawal by Subject|0|||
125933440|NCT02743871|453051777|FG010|Overall Study|Withdrawal by Subject|1|||
125933441|NCT02743871|453051778|FG011|Overall Study|Withdrawal by Subject|0|||
125933442|NCT02743871|453051779|FG012|Overall Study|Withdrawal by Subject|12|||
125933443|NCT02743871|453051780|FG013|Overall Study|Withdrawal by Subject|6|||
125933444|NCT02743871|453051767|FG000|Overall Study|Adverse Event|1|||
125933445|NCT02743871|453051768|FG001|Overall Study|Adverse Event|0|||
125933446|NCT02743871|453051769|FG002|Overall Study|Adverse Event|0|||
125933447|NCT02743871|453051770|FG003|Overall Study|Adverse Event|0|||
125933448|NCT02743871|453051771|FG004|Overall Study|Adverse Event|0|||
125933449|NCT02743871|453051772|FG005|Overall Study|Adverse Event|0|||
125933450|NCT02743871|453051773|FG006|Overall Study|Adverse Event|0|||
125933451|NCT02743871|453051774|FG007|Overall Study|Adverse Event|0|||
125933452|NCT02743871|453051775|FG008|Overall Study|Adverse Event|0|||
125933453|NCT02743871|453051776|FG009|Overall Study|Adverse Event|0|||
125933454|NCT02743871|453051777|FG010|Overall Study|Adverse Event|0|||
125933455|NCT02743871|453051778|FG011|Overall Study|Adverse Event|0|||
125933456|NCT02743871|453051779|FG012|Overall Study|Adverse Event|0|||
125933457|NCT02743871|453051780|FG013|Overall Study|Adverse Event|0|||
125933458|NCT02743871|453051767|FG000|Overall Study|Other|0|||
125933459|NCT02743871|453051768|FG001|Overall Study|Other|0|||
125933460|NCT02743871|453051769|FG002|Overall Study|Other|0|||
125933461|NCT02743871|453051770|FG003|Overall Study|Other|0|||
125933462|NCT02743871|453051771|FG004|Overall Study|Other|0|||
125933463|NCT02743871|453051772|FG005|Overall Study|Other|0|||
125933464|NCT02743871|453051773|FG006|Overall Study|Other|0|||
125933465|NCT02743871|453051774|FG007|Overall Study|Other|0|||
125933466|NCT02743871|453051775|FG008|Overall Study|Other|0|||
125933467|NCT02743871|453051776|FG009|Overall Study|Other|0|||
125933468|NCT02743871|453051777|FG010|Overall Study|Other|0|||
125933469|NCT02743871|453051778|FG011|Overall Study|Other|1|||
125933470|NCT02743871|453051779|FG012|Overall Study|Other|1|||
125933471|NCT02743871|453051780|FG013|Overall Study|Other|1|||
125933472|NCT02743871|453051767|FG000|Overall Study|Protocol Violation|0|||
125933473|NCT02743871|453051768|FG001|Overall Study|Protocol Violation|0|||
125933474|NCT02743871|453051769|FG002|Overall Study|Protocol Violation|0|||
125933475|NCT02743871|453051770|FG003|Overall Study|Protocol Violation|0|||
125933476|NCT02743871|453051771|FG004|Overall Study|Protocol Violation|0|||
125933477|NCT02743871|453051772|FG005|Overall Study|Protocol Violation|0|||
125933478|NCT02743871|453051773|FG006|Overall Study|Protocol Violation|0|||
125933479|NCT02743871|453051774|FG007|Overall Study|Protocol Violation|0|||
125933480|NCT02743871|453051775|FG008|Overall Study|Protocol Violation|0|||
125933481|NCT02743871|453051776|FG009|Overall Study|Protocol Violation|0|||
125933482|NCT02743871|453051777|FG010|Overall Study|Protocol Violation|0|||
125933483|NCT02743871|453051778|FG011|Overall Study|Protocol Violation|0|||
125933484|NCT02743871|453051779|FG012|Overall Study|Protocol Violation|2|||
125933485|NCT02743871|453051780|FG013|Overall Study|Protocol Violation|0|||
126113871|NCT01830855|453712598|FG001|Overall Study|Protocol deviation|5|||
126113872|NCT01830855|453712599|FG002|Overall Study|Protocol deviation|6|||
125933486|NCT02848651|453051781|FG000|Overall Study|Death|85|||
125933487|NCT02848651|453051781|FG000|Overall Study|Lost to Follow-up|1|||
125933488|NCT02848651|453051781|FG000|Overall Study|Non-Compliance|1|||
125933489|NCT02848651|453051781|FG000|Overall Study|Symptomatic Deterioration|1|||
125933490|NCT02848651|453051781|FG000|Overall Study|Physician Decision|4|||
125933491|NCT02848651|453051781|FG000|Overall Study|Withdrawal by Subject|14|||
125933492|NCT00897104|453051788|FG000|Overall Study|Lost to Follow-up|12|||
125933493|NCT00897104|453051789|FG001|Overall Study|Lost to Follow-up|17|||
125933494|NCT00897104|453051790|FG002|Overall Study|Lost to Follow-up|2|||
125933495|NCT00897104|453051788|FG000|Overall Study|Pregnancy|0|||
125933496|NCT00897104|453051789|FG001|Overall Study|Pregnancy|1|||
125933497|NCT00897104|453051790|FG002|Overall Study|Pregnancy|0|||
125933498|NCT00897104|453051788|FG000|Overall Study|Protocol Violation|0|||
125933499|NCT00897104|453051789|FG001|Overall Study|Protocol Violation|1|||
125933500|NCT00897104|453051790|FG002|Overall Study|Protocol Violation|0|||
125933501|NCT00897104|453051788|FG000|Overall Study|Withdrawal by Subject|23|||
126113873|NCT01830855|453712600|FG003|Overall Study|Protocol deviation|6|||
126113874|NCT01830855|453712597|FG000|Overall Study|Withdrawal by Subject|33|||
126113875|NCT01830855|453712598|FG001|Overall Study|Withdrawal by Subject|14|||
126113876|NCT01830855|453712599|FG002|Overall Study|Withdrawal by Subject|10|||
126113877|NCT01830855|453712600|FG003|Overall Study|Withdrawal by Subject|12|||
126113878|NCT01830855|453712597|FG000|Overall Study|No longer willing to participate|32|||
126113879|NCT01830855|453712598|FG001|Overall Study|No longer willing to participate|13|||
126113880|NCT01830855|453712599|FG002|Overall Study|No longer willing to participate|12|||
126113881|NCT01830855|453712600|FG003|Overall Study|No longer willing to participate|17|||
126113882|NCT01830855|453712597|FG000|Overall Study|Lost to Follow-up|47|||
126113883|NCT01830855|453712598|FG001|Overall Study|Lost to Follow-up|20|||
126113884|NCT01830855|453712599|FG002|Overall Study|Lost to Follow-up|23|||
126113885|NCT01830855|453712600|FG003|Overall Study|Lost to Follow-up|33|||
126113886|NCT01667081|453712601|FG000|Overall Study|Death|43|||
126113887|NCT01667081|453712602|FG001|Overall Study|Death|3|||
126113888|NCT01667081|453712601|FG000|Overall Study|Lost to Follow-up|99|||
126113889|NCT01667081|453712602|FG001|Overall Study|Lost to Follow-up|48|||
126113890|NCT01667081|453712601|FG000|Overall Study|Physician Decision|16|||
126113891|NCT01667081|453712602|FG001|Overall Study|Physician Decision|2|||
126113892|NCT01667081|453712601|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
126113893|NCT01667081|453712602|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
126113894|NCT01667081|453712601|FG000|Overall Study|Withdrawal by Subject|90|||
125933502|NCT00897104|453051789|FG001|Overall Study|Withdrawal by Subject|27|||
125933503|NCT00897104|453051790|FG002|Overall Study|Withdrawal by Subject|3|||
125933504|NCT00897104|453051788|FG000|Overall Study|Abnormal Prestudy Labs|2|||
125933505|NCT00897104|453051789|FG001|Overall Study|Abnormal Prestudy Labs|0|||
125933506|NCT00897104|453051790|FG002|Overall Study|Abnormal Prestudy Labs|0|||
125933507|NCT00897104|453051788|FG000|Overall Study|Abnormal Baseline ECG|2|||
125933508|NCT00897104|453051789|FG001|Overall Study|Abnormal Baseline ECG|2|||
125933509|NCT00897104|453051790|FG002|Overall Study|Abnormal Baseline ECG|0|||
125933510|NCT00897104|453051788|FG000|Overall Study|Need for Concom. Med.|0|||
125933511|NCT00897104|453051789|FG001|Overall Study|Need for Concom. Med.|1|||
125933512|NCT00897104|453051790|FG002|Overall Study|Need for Concom. Med.|1|||
125933513|NCT00897104|453051788|FG000|Overall Study|Lack of Migraine Attack|20|||
125933514|NCT00897104|453051789|FG001|Overall Study|Lack of Migraine Attack|22|||
125933515|NCT00897104|453051790|FG002|Overall Study|Lack of Migraine Attack|1|||
125933516|NCT00897104|453051788|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
125933517|NCT00897104|453051789|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125933518|NCT00897104|453051790|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125933519|NCT00897104|453051788|FG000|Overall Study|Other|3|||
125933520|NCT00897104|453051789|FG001|Overall Study|Other|0|||
125933521|NCT00897104|453051790|FG002|Overall Study|Other|0|||
125933522|NCT00897104|453051788|FG000|Overall Study|Protocol Violation|1|||
125933523|NCT00897104|453051789|FG001|Overall Study|Protocol Violation|0|||
125933524|NCT00897104|453051790|FG002|Overall Study|Protocol Violation|0|||
125933525|NCT00897104|453051788|FG000|Overall Study|Withdrawal by Subject|0|||
125933526|NCT00897104|453051789|FG001|Overall Study|Withdrawal by Subject|0|||
125933527|NCT00897104|453051790|FG002|Overall Study|Withdrawal by Subject|1|||
125933528|NCT01059799|453051795|FG000|Overall Study|Adverse Event|2|||
125933529|NCT01059799|453051796|FG001|Overall Study|Adverse Event|3|||
125933530|NCT01059799|453051795|FG000|Overall Study|Lack of Efficacy|1|||
125933531|NCT01059799|453051796|FG001|Overall Study|Lack of Efficacy|0|||
125933532|NCT01059799|453051795|FG000|Overall Study|Protocol Violation|3|||
125933533|NCT01059799|453051796|FG001|Overall Study|Protocol Violation|2|||
125933534|NCT01059799|453051795|FG000|Overall Study|Withdrawal criteria|13|||
125933535|NCT01059799|453051796|FG001|Overall Study|Withdrawal criteria|2|||
125933536|NCT01059799|453051795|FG000|Overall Study|Other|12|||
125933537|NCT01059799|453051796|FG001|Overall Study|Other|3|||
125933538|NCT00750204|453051797|FG000|Overall Study|study halted prematurely|1|||
125933539|NCT00750204|453051798|FG001|Overall Study|study halted prematurely|1|||
125933540|NCT00662363|453051799|FG000|Overall Study|Withdrawal by Subject|6|||
125933541|NCT00662363|453051800|FG001|Overall Study|Withdrawal by Subject|5|||
125933542|NCT00662363|453051799|FG000|Overall Study|Adverse Event|0|||
126113895|NCT01667081|453712602|FG001|Overall Study|Withdrawal by Subject|35|||
126113896|NCT00930722|453712603|FG000|Overall Study|Lost to Follow-up|16|||
125933543|NCT00662363|453051800|FG001|Overall Study|Adverse Event|3|||
125933544|NCT00662363|453051799|FG000|Overall Study|Discharged early from rehab|4|||
125933545|NCT00662363|453051800|FG001|Overall Study|Discharged early from rehab|1|||
125933546|NCT00662363|453051799|FG000|Overall Study|Protocol Violation|1|||
125933547|NCT00662363|453051800|FG001|Overall Study|Protocol Violation|1|||
125933548|NCT01428453|453051801|FG000|Overall Study|Adverse Event|2|||
125933549|NCT01428453|453051802|FG001|Overall Study|Adverse Event|7|||
125933550|NCT01428453|453051801|FG000|Overall Study|Protocol Violation|1|||
125933551|NCT01428453|453051802|FG001|Overall Study|Protocol Violation|0|||
125933552|NCT01428453|453051801|FG000|Overall Study|Lost to Follow-up|0|||
125933553|NCT01428453|453051802|FG001|Overall Study|Lost to Follow-up|1|||
125933554|NCT01428453|453051801|FG000|Overall Study|Withdrawal by Subject|3|||
125933555|NCT01428453|453051802|FG001|Overall Study|Withdrawal by Subject|1|||
125933556|NCT00477971|453051805|FG000|Overall Study|Disease progression|6|||
125933557|NCT00477971|453051806|FG001|Overall Study|Disease progression|0|||
125933558|NCT00477971|453051805|FG000|Overall Study|Withdrawal by Subject|3|||
125933559|NCT00477971|453051806|FG001|Overall Study|Withdrawal by Subject|1|||
125933560|NCT00477971|453051805|FG000|Overall Study|Adverse Event|3|||
125933561|NCT00477971|453051806|FG001|Overall Study|Adverse Event|0|||
125933562|NCT00477971|453051805|FG000|Overall Study|Death|2|||
125933563|NCT00477971|453051806|FG001|Overall Study|Death|4|||
125933564|NCT00477971|453051805|FG000|Overall Study|Alternative treatment|3|||
125933565|NCT00477971|453051806|FG001|Overall Study|Alternative treatment|1|||
125933566|NCT01317160|453051807|FG000|Overall Study|Incorrect inclusion|1|||
125933567|NCT01317160|453051808|FG001|Overall Study|Incorrect inclusion|1|||
125933568|NCT01317160|453051807|FG000|Overall Study|Lost to Follow-up|3|||
125933569|NCT01317160|453051808|FG001|Overall Study|Lost to Follow-up|3|||
125933570|NCT01317160|453051807|FG000|Overall Study|Withdrawal by Subject|0|||
125933571|NCT01317160|453051808|FG001|Overall Study|Withdrawal by Subject|2|||
125933572|NCT04203238|453054026|FG000|Overall Study|Withdrawal by Subject|1|||
125933573|NCT04203238|453054027|FG001|Overall Study|Withdrawal by Subject|1|||
125933574|NCT04203238|453054026|FG000|Overall Study|Covid-19|3|||
125933575|NCT04203238|453054027|FG001|Overall Study|Covid-19|0|||
125933576|NCT01955733|453054028|FG000|Period 1|Lost to Follow-up|1|||
125933577|NCT01955733|453054029|FG001|Period 1|Lost to Follow-up|0|||
125933578|NCT01955733|453054030|FG002|Period 1|Lost to Follow-up|0|||
125933579|NCT01955733|453054028|FG000|Period 2|Adverse Event|1|||
125933580|NCT01955733|453054029|FG001|Period 2|Adverse Event|0|||
125933581|NCT01955733|453054030|FG002|Period 2|Adverse Event|0|||
125933582|NCT01955733|453054028|FG000|Period 2|Physician Decision|0|||
125933583|NCT01955733|453054029|FG001|Period 2|Physician Decision|0|||
125933584|NCT01955733|453054030|FG002|Period 2|Physician Decision|1|||
125933585|NCT01955733|453054028|FG000|Period 2|Withdrawal by Subject|1|||
125933586|NCT01955733|453054029|FG001|Period 2|Withdrawal by Subject|3|||
125933587|NCT01955733|453054030|FG002|Period 2|Withdrawal by Subject|2|||
125933588|NCT01955733|453054028|FG000|Period 2|Study terminated by sponsor|8|||
125933589|NCT01955733|453054029|FG001|Period 2|Study terminated by sponsor|14|||
125933590|NCT01955733|453054030|FG002|Period 2|Study terminated by sponsor|16|||
125933591|NCT01955733|453054028|FG000|Period 2|Lost to Follow-up|2|||
125933592|NCT01955733|453054029|FG001|Period 2|Lost to Follow-up|0|||
125933593|NCT01955733|453054030|FG002|Period 2|Lost to Follow-up|0|||
125933594|NCT01955733|453054028|FG000|Period 2|Other not defined above|0|||
125933595|NCT01955733|453054029|FG001|Period 2|Other not defined above|2|||
125933596|NCT01955733|453054030|FG002|Period 2|Other not defined above|2|||
125933597|NCT00733408|453054031|FG000|Overall Study|Adverse Event|4|||
125933598|NCT01134783|453054032|FG000|Overall Study|Pregnancy|16|||
125933599|NCT01134783|453054033|FG001|Overall Study|Pregnancy|8|||
125933600|NCT01134783|453054032|FG000|Overall Study|Withdrawal by Subject|15|||
125933601|NCT01134783|453054033|FG001|Overall Study|Withdrawal by Subject|9|||
125933602|NCT01134783|453054032|FG000|Overall Study|Lost to Follow-up|5|||
125933603|NCT01134783|453054033|FG001|Overall Study|Lost to Follow-up|20|||
125933604|NCT04221009|453054035|FG000|Overall Study|Withdrawal by Subject|4|||
125933605|NCT02762266|453054036|FG000|Overall Study|Physician Decision|2|||
125933606|NCT02762266|453054037|FG001|Overall Study|Physician Decision|0|||
125933607|NCT01438424|453054038|FG000|Overall Study|Continuing treatment|29|||
125933608|NCT01438424|453054038|FG000|Overall Study|Minimal virologic response|95|||
125933609|NCT01438424|453054038|FG000|Overall Study|Not identified|55|||
125933610|NCT01438424|453054038|FG000|Overall Study|Withdrawal by Subject|104|||
125933611|NCT01438424|453054038|FG000|Overall Study|Progression of chronic hepatitis B|22|||
125933612|NCT01438424|453054038|FG000|Overall Study|Death|22|||
125933613|NCT01438424|453054038|FG000|Overall Study|Adverse Event|17|||
125933614|NCT01438424|453054038|FG000|Overall Study|Lost to Follow-up|17|||
125933615|NCT01438424|453054038|FG000|Overall Study|Abnormal laboratory test result|14|||
125933616|NCT01438424|453054038|FG000|Overall Study|Need for drug prohibited by protocol|14|||
125933617|NCT01438424|453054038|FG000|Overall Study|Pregnancy|7|||
125933618|NCT01438424|453054038|FG000|Overall Study|No longer met inclusion criteria|1|||
125933619|NCT01438424|453054038|FG000|Overall Study|Participant noncompliance|20|||
125933620|NCT04232124|453054039|FG000|Overall Study|Lost to Follow-up|3|||
126066202|NCT01114217|453533510|FG001|Overall Study|Other-Early termination|10|||
125933621|NCT02392247|453054042|FG000|Overall Study|Withdrawal by Subject|1|||
125933622|NCT02392247|453054042|FG000|Overall Study|Surgery cancelled; no data|1|||
125933623|NCT03010254|453054043|FG000|Overall Study|Adverse Event|0|||
125933624|NCT03010254|453054044|FG001|Overall Study|Adverse Event|1|||
125933625|NCT03010254|453054043|FG000|Overall Study|Lost to Follow-up|4|||
125933626|NCT03010254|453054044|FG001|Overall Study|Lost to Follow-up|0|||
125933627|NCT03010254|453054043|FG000|Overall Study|Withdrawal by Subject|1|||
125933628|NCT03010254|453054044|FG001|Overall Study|Withdrawal by Subject|1|||
125933629|NCT03010254|453054043|FG000|Overall Study|Other|2|||
125933630|NCT03010254|453054044|FG001|Overall Study|Other|3|||
125933631|NCT01404325|453054045|FG000|Overall Study|Lost to Follow-up|1|||
125933632|NCT01404325|453054046|FG001|Overall Study|Lost to Follow-up|0|||
125933633|NCT01404325|453054045|FG000|Overall Study|Death|2|||
125933634|NCT01404325|453054046|FG001|Overall Study|Death|0|||
125933635|NCT01404325|453054045|FG000|Overall Study|Graft loss/Retransplantation|1|||
125933636|NCT01404325|453054046|FG001|Overall Study|Graft loss/Retransplantation|0|||
125933637|NCT01404325|453054045|FG000|Overall Study|non-specified reason|0|||
125933638|NCT01404325|453054046|FG001|Overall Study|non-specified reason|2|||
125933639|NCT02141282|453054052|FG000|Overall Study|Adverse event, not related to progression|8|||
125933640|NCT02141282|453054053|FG001|Overall Study|Adverse event, not related to progression|1|||
125933641|NCT02141282|453054054|FG002|Overall Study|Adverse event, not related to progression|3|||
125933642|NCT02141282|453054055|FG003|Overall Study|Adverse event, not related to progression|1|||
125933643|NCT02141282|453054052|FG000|Overall Study|Adverse event, related to progression|1|||
125933644|NCT02141282|453054053|FG001|Overall Study|Adverse event, related to progression|0|||
125933645|NCT02141282|453054054|FG002|Overall Study|Adverse event, related to progression|2|||
125933646|NCT02141282|453054055|FG003|Overall Study|Adverse event, related to progression|0|||
125933647|NCT02141282|453054052|FG000|Overall Study|COVID-19 infection|1|||
125933648|NCT02141282|453054053|FG001|Overall Study|COVID-19 infection|0|||
125933649|NCT02141282|453054054|FG002|Overall Study|COVID-19 infection|0|||
125933650|NCT02141282|453054055|FG003|Overall Study|COVID-19 infection|0|||
125933651|NCT02141282|453054052|FG000|Overall Study|Lost to Follow-up|0|||
125933652|NCT02141282|453054053|FG001|Overall Study|Lost to Follow-up|0|||
125933653|NCT02141282|453054054|FG002|Overall Study|Lost to Follow-up|4|||
125933654|NCT02141282|453054055|FG003|Overall Study|Lost to Follow-up|2|||
125933655|NCT02141282|453054052|FG000|Overall Study|Other, not specified|14|||
125933656|NCT02141282|453054053|FG001|Overall Study|Other, not specified|11|||
125933657|NCT02141282|453054054|FG002|Overall Study|Other, not specified|23|||
125933658|NCT02141282|453054055|FG003|Overall Study|Other, not specified|9|||
125933659|NCT02141282|453054052|FG000|Overall Study|Progressive disease, Richter's|4|||
125933660|NCT02141282|453054053|FG001|Overall Study|Progressive disease, Richter's|1|||
125933661|NCT02141282|453054054|FG002|Overall Study|Progressive disease, Richter's|1|||
125933662|NCT02141282|453054055|FG003|Overall Study|Progressive disease, Richter's|1|||
125933663|NCT02141282|453054052|FG000|Overall Study|Progressive disease per protocol|12|||
125933664|NCT02141282|453054053|FG001|Overall Study|Progressive disease per protocol|7|||
125933665|NCT02141282|453054054|FG002|Overall Study|Progressive disease per protocol|9|||
126066203|NCT01114217|453533509|FG000|Overall Study|Other-Procedure|1|||
126066204|NCT01114217|453533510|FG001|Overall Study|Other-Procedure|1|||
126066205|NCT01114217|453533509|FG000|Overall Study|Other-Pregnancy|2|||
126066206|NCT01114217|453533510|FG001|Overall Study|Other-Pregnancy|4|||
126066207|NCT01114217|453533509|FG000|Overall Study|Other-Protocol Violation|1|||
126066208|NCT01114217|453533510|FG001|Overall Study|Other-Protocol Violation|3|||
126066209|NCT01114217|453533509|FG000|Overall Study|Other-Lack of Efficacy|1|||
126066210|NCT01114217|453533510|FG001|Overall Study|Other-Lack of Efficacy|0|||
126066211|NCT01114217|453533509|FG000|Overall Study|Other-Non Compliance|2|||
126066212|NCT01114217|453533510|FG001|Overall Study|Other-Non Compliance|0|||
126066213|NCT01114217|453533509|FG000|Overall Study|Other-Physician Decision|1|||
126066214|NCT01114217|453533510|FG001|Overall Study|Other-Physician Decision|1|||
126066215|NCT01114217|453533509|FG000|Overall Study|Other-Sponsor Decision|10|||
126066216|NCT01114217|453533510|FG001|Overall Study|Other-Sponsor Decision|12|||
126066217|NCT01114217|453533509|FG000|Overall Study|Other-Study Termination|0|||
126066218|NCT01114217|453533510|FG001|Overall Study|Other-Study Termination|1|||
126066219|NCT01114217|453533509|FG000|Overall Study|Other-Study Withdrawn|1|||
126066220|NCT01114217|453533510|FG001|Overall Study|Other-Study Withdrawn|1|||
126066221|NCT01114217|453533509|FG000|Overall Study|Other-Site Stopped Communicating|2|||
126066222|NCT01114217|453533510|FG001|Overall Study|Other-Site Stopped Communicating|0|||
126066223|NCT01114217|453533509|FG000|Overall Study|Other-Lost to Follow-up|1|||
126066224|NCT01114217|453533510|FG001|Overall Study|Other-Lost to Follow-up|0|||
126066225|NCT01114217|453533509|FG000|Overall Study|Other-Withdrawal by Subject|1|||
126066226|NCT01114217|453533510|FG001|Overall Study|Other-Withdrawal by Subject|1|||
126066227|NCT01183013|453533511|FG000|Overall Study|Adverse Event|6|||
126066228|NCT01183013|453533512|FG001|Overall Study|Adverse Event|8|||
126066229|NCT01183013|453533513|FG002|Overall Study|Adverse Event|5|||
126066230|NCT01183013|453533514|FG003|Overall Study|Adverse Event|5|||
126066231|NCT01183013|453533515|FG004|Overall Study|Adverse Event|10|||
126066232|NCT01183013|453533516|FG005|Overall Study|Adverse Event|10|||
125933666|NCT02141282|453054055|FG003|Overall Study|Progressive disease per protocol|2|||
126066233|NCT01183013|453533517|FG006|Overall Study|Adverse Event|6|||
126066234|NCT01183013|453533511|FG000|Overall Study|Lack of Efficacy|3|||
126066235|NCT01183013|453533512|FG001|Overall Study|Lack of Efficacy|2|||
126066236|NCT01183013|453533513|FG002|Overall Study|Lack of Efficacy|1|||
126066237|NCT01183013|453533514|FG003|Overall Study|Lack of Efficacy|2|||
126066238|NCT01183013|453533515|FG004|Overall Study|Lack of Efficacy|1|||
126066239|NCT01183013|453533516|FG005|Overall Study|Lack of Efficacy|2|||
126066240|NCT01183013|453533517|FG006|Overall Study|Lack of Efficacy|0|||
125933667|NCT02141282|453054052|FG000|Overall Study|Stem cell transplant|1|||
125933668|NCT02141282|453054053|FG001|Overall Study|Stem cell transplant|0|||
125933669|NCT02141282|453054054|FG002|Overall Study|Stem cell transplant|1|||
125933670|NCT02141282|453054055|FG003|Overall Study|Stem cell transplant|0|||
125933671|NCT02141282|453054052|FG000|Overall Study|Study terminated by Sponsor|0|||
125933672|NCT02141282|453054053|FG001|Overall Study|Study terminated by Sponsor|1|||
125933673|NCT02141282|453054054|FG002|Overall Study|Study terminated by Sponsor|0|||
125933674|NCT02141282|453054055|FG003|Overall Study|Study terminated by Sponsor|0|||
125933675|NCT02141282|453054052|FG000|Overall Study|Subject non-compliance|0|||
125933676|NCT02141282|453054053|FG001|Overall Study|Subject non-compliance|0|||
125933677|NCT02141282|453054054|FG002|Overall Study|Subject non-compliance|1|||
125933678|NCT02141282|453054055|FG003|Overall Study|Subject non-compliance|0|||
125933679|NCT02141282|453054052|FG000|Overall Study|Withdrew consent|2|||
125933680|NCT02141282|453054053|FG001|Overall Study|Withdrew consent|0|||
125933681|NCT02141282|453054054|FG002|Overall Study|Withdrew consent|4|||
125933682|NCT02141282|453054055|FG003|Overall Study|Withdrew consent|0|||
125933683|NCT03312933|453054056|FG000|Overall Study|Protocol Violation|15|||
125933684|NCT03312933|453054056|FG000|Overall Study|Lost to Follow-up|36|||
125933685|NCT03312933|453054056|FG000|Overall Study|Withdrawal by Subject|3|||
125933686|NCT00224055|453054062|FG000|Overall Study|Adverse Event|9|||
125933687|NCT00224055|453054063|FG001|Overall Study|Adverse Event|3|||
125933688|NCT00224055|453054062|FG000|Overall Study|Lost to Follow-up|1|||
125933689|NCT00224055|453054063|FG001|Overall Study|Lost to Follow-up|2|||
125933690|NCT00224055|453054062|FG000|Overall Study|Protocol Violation|1|||
125933691|NCT00224055|453054063|FG001|Overall Study|Protocol Violation|1|||
125933692|NCT00224055|453054062|FG000|Overall Study|Inclusion Violation|3|||
125933693|NCT00224055|453054063|FG001|Overall Study|Inclusion Violation|6|||
125933694|NCT00224055|453054062|FG000|Overall Study|Withdrawal by Subject|0|||
126066241|NCT01183013|453533511|FG000|Overall Study|Protocol Violation|5|||
126066242|NCT01183013|453533512|FG001|Overall Study|Protocol Violation|2|||
126066243|NCT01183013|453533513|FG002|Overall Study|Protocol Violation|4|||
126066244|NCT01183013|453533514|FG003|Overall Study|Protocol Violation|0|||
126066245|NCT01183013|453533515|FG004|Overall Study|Protocol Violation|4|||
126066246|NCT01183013|453533516|FG005|Overall Study|Protocol Violation|3|||
126066247|NCT01183013|453533517|FG006|Overall Study|Protocol Violation|3|||
126066248|NCT01183013|453533511|FG000|Overall Study|Lost to Follow-up|7|||
126066249|NCT01183013|453533512|FG001|Overall Study|Lost to Follow-up|3|||
126066250|NCT01183013|453533513|FG002|Overall Study|Lost to Follow-up|4|||
126066251|NCT01183013|453533514|FG003|Overall Study|Lost to Follow-up|3|||
126066252|NCT01183013|453533515|FG004|Overall Study|Lost to Follow-up|2|||
126066253|NCT01183013|453533516|FG005|Overall Study|Lost to Follow-up|6|||
126066254|NCT01183013|453533517|FG006|Overall Study|Lost to Follow-up|5|||
126066255|NCT01183013|453533511|FG000|Overall Study|Withdrawal by Subject|9|||
126066256|NCT01183013|453533512|FG001|Overall Study|Withdrawal by Subject|13|||
126066257|NCT01183013|453533513|FG002|Overall Study|Withdrawal by Subject|10|||
126066258|NCT01183013|453533514|FG003|Overall Study|Withdrawal by Subject|8|||
126066259|NCT01183013|453533515|FG004|Overall Study|Withdrawal by Subject|7|||
126066260|NCT01183013|453533516|FG005|Overall Study|Withdrawal by Subject|9|||
126066261|NCT01183013|453533517|FG006|Overall Study|Withdrawal by Subject|10|||
126066262|NCT01183013|453533511|FG000|Overall Study|Reasons other than stated above|15|||
126066263|NCT01183013|453533512|FG001|Overall Study|Reasons other than stated above|11|||
126066264|NCT01183013|453533513|FG002|Overall Study|Reasons other than stated above|17|||
126066265|NCT01183013|453533514|FG003|Overall Study|Reasons other than stated above|12|||
126066266|NCT01183013|453533515|FG004|Overall Study|Reasons other than stated above|12|||
126066267|NCT01183013|453533516|FG005|Overall Study|Reasons other than stated above|15|||
126066268|NCT01183013|453533517|FG006|Overall Study|Reasons other than stated above|13|||
126066269|NCT02722278|453533520|FG000|Overall Study|Withdrawal by Subject|5|||
126066270|NCT02722278|453533521|FG001|Overall Study|Withdrawal by Subject|3|||
126066271|NCT02722278|453533520|FG000|Overall Study|Adverse Event|4|||
126066272|NCT02722278|453533521|FG001|Overall Study|Adverse Event|1|||
126066273|NCT02722278|453533520|FG000|Overall Study|Lost to Follow-up|2|||
126066274|NCT02722278|453533521|FG001|Overall Study|Lost to Follow-up|0|||
126066275|NCT02722278|453533520|FG000|Overall Study|Protocol Violation|1|||
126066276|NCT02722278|453533521|FG001|Overall Study|Protocol Violation|0|||
126066277|NCT02722278|453533520|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
126066278|NCT02722278|453533521|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
126066279|NCT02722278|453533520|FG000|Overall Study|Subject declined after tx assignment|0|||
126066280|NCT02722278|453533521|FG001|Overall Study|Subject declined after tx assignment|1|||
126066281|NCT02722278|453533520|FG000|Overall Study|Site closure not study related|0|||
126066282|NCT02722278|453533521|FG001|Overall Study|Site closure not study related|1|||
126066283|NCT04175392|453533522|FG000|Overall Study|Withdrawal by Subject|3|||
125933695|NCT00224055|453054063|FG001|Overall Study|Withdrawal by Subject|2|||
125933696|NCT00224055|453054062|FG000|Overall Study|Other|1|||
126066284|NCT04175392|453533523|FG001|Overall Study|Withdrawal by Subject|2|||
126066285|NCT02727998|453533524|FG000|Overall Study|Lost to Follow-up|3|||
126066286|NCT02727998|453533525|FG001|Overall Study|Lost to Follow-up|3|||
126066287|NCT02727998|453533524|FG000|Overall Study|Withdrawal by Subject|0|||
125933697|NCT00224055|453054063|FG001|Overall Study|Other|0|||
125933698|NCT04317066|453054064|FG000|Overall Study|Sponsor decision|5|||
125933699|NCT04317066|453054064|FG000|Overall Study|Death|2|||
125933700|NCT00848081|453054067|FG000|Overall Study|Adverse Event|6|||
125933701|NCT00848081|453054068|FG001|Overall Study|Adverse Event|7|||
125933702|NCT00848081|453054067|FG000|Overall Study|Protocol Violation|8|||
125933703|NCT00848081|453054068|FG001|Overall Study|Protocol Violation|5|||
125933704|NCT00848081|453054067|FG000|Overall Study|Lost to Follow-up|1|||
125933705|NCT00848081|453054068|FG001|Overall Study|Lost to Follow-up|0|||
125933706|NCT00848081|453054067|FG000|Overall Study|Physician Decision|0|||
125933707|NCT00848081|453054068|FG001|Overall Study|Physician Decision|3|||
125933708|NCT00848081|453054067|FG000|Overall Study|Withdrawal by Subject|5|||
125933709|NCT00848081|453054068|FG001|Overall Study|Withdrawal by Subject|3|||
125933710|NCT02064868|453054069|FG000|Overall Study|Lost to Follow-up|14|||
125933711|NCT02064868|453054070|FG001|Overall Study|Lost to Follow-up|8|||
125933712|NCT02064868|453054069|FG000|Overall Study|Physician Decision|1|||
125933713|NCT02064868|453054070|FG001|Overall Study|Physician Decision|0|||
125933714|NCT02064868|453054069|FG000|Overall Study|Withdrawal by Subject|14|||
125933715|NCT02064868|453054070|FG001|Overall Study|Withdrawal by Subject|3|||
125933716|NCT02064868|453054069|FG000|Overall Study|Technical Problems or Missing|5|||
125933717|NCT02064868|453054070|FG001|Overall Study|Technical Problems or Missing|2|||
125933718|NCT01500629|453054073|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
125933719|NCT01500629|453054074|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
125933720|NCT00588848|453054075|FG000|Overall Study|Physician Decision|0|||
125933721|NCT00588848|453054076|FG001|Overall Study|Physician Decision|3|||
125933722|NCT00589914|453054077|FG000|Overall Study|Adverse Event|19|||
125933723|NCT00589914|453054078|FG001|Overall Study|Adverse Event|10|||
125933724|NCT00589914|453054077|FG000|Overall Study|Death|2|||
125933725|NCT00589914|453054078|FG001|Overall Study|Death|0|||
125933726|NCT00589914|453054077|FG000|Overall Study|Lack of Efficacy|40|||
125933727|NCT00589914|453054078|FG001|Overall Study|Lack of Efficacy|43|||
125933728|NCT00589914|453054077|FG000|Overall Study|Lost to Follow-up|11|||
125933729|NCT00589914|453054078|FG001|Overall Study|Lost to Follow-up|18|||
125933730|NCT00589914|453054077|FG000|Overall Study|Pregnancy|1|||
125933731|NCT00589914|453054078|FG001|Overall Study|Pregnancy|0|||
125933732|NCT00589914|453054077|FG000|Overall Study|Withdrawal by Subject|55|||
125933733|NCT00589914|453054078|FG001|Overall Study|Withdrawal by Subject|49|||
125933734|NCT00589914|453054077|FG000|Overall Study|Other|22|||
125933735|NCT00589914|453054078|FG001|Overall Study|Other|17|||
125933736|NCT00531050|453054079|FG000|Part 1: Period 1|Adverse Event|0|||
125933737|NCT00531050|453054080|FG001|Part 1: Period 1|Adverse Event|1|||
125933738|NCT00531050|453054081|FG002|Part 1: Period 1|Adverse Event|0|||
125933739|NCT00531050|453054082|FG003|Part 1: Period 1|Adverse Event|0|||
125933740|NCT00531050|453054083|FG004|Part 1: Period 1|Adverse Event|0|||
125933741|NCT00531050|453054084|FG005|Part 1: Period 1|Adverse Event|0|||
125933742|NCT00531050|453054079|FG000|Part 1: Period 1|Protocol Deviation|0|||
125933743|NCT00531050|453054080|FG001|Part 1: Period 1|Protocol Deviation|0|||
125933744|NCT00531050|453054081|FG002|Part 1: Period 1|Protocol Deviation|0|||
125933745|NCT00531050|453054082|FG003|Part 1: Period 1|Protocol Deviation|1|||
125933746|NCT00531050|453054083|FG004|Part 1: Period 1|Protocol Deviation|0|||
125933747|NCT00531050|453054084|FG005|Part 1: Period 1|Protocol Deviation|0|||
125933748|NCT00531050|453054079|FG000|Part 1: Period 3|Adverse Event|1|||
125933749|NCT00531050|453054080|FG001|Part 1: Period 3|Adverse Event|0|||
125933750|NCT00531050|453054081|FG002|Part 1: Period 3|Adverse Event|0|||
125933751|NCT00531050|453054082|FG003|Part 1: Period 3|Adverse Event|0|||
125933752|NCT00531050|453054083|FG004|Part 1: Period 3|Adverse Event|0|||
125933753|NCT00531050|453054084|FG005|Part 1: Period 3|Adverse Event|0|||
125933754|NCT00531050|453054079|FG000|Part 2: Period 1|Adverse Event|0|||
125933755|NCT00531050|453054080|FG001|Part 2: Period 1|Adverse Event|0|||
125933756|NCT00531050|453054081|FG002|Part 2: Period 1|Adverse Event|0|||
125933757|NCT00531050|453054082|FG003|Part 2: Period 1|Adverse Event|0|||
125933758|NCT00531050|453054083|FG004|Part 2: Period 1|Adverse Event|0|||
125933759|NCT00531050|453054084|FG005|Part 2: Period 1|Adverse Event|1|||
125933760|NCT00531050|453054079|FG000|Part 2: Period 3|Abnormal test procedure|1|||
125933761|NCT00531050|453054080|FG001|Part 2: Period 3|Abnormal test procedure|0|||
126066288|NCT02727998|453533525|FG001|Overall Study|Withdrawal by Subject|1|||
126066289|NCT02105688|453533526|FG000|Part A: Double-Blind|Adverse Event|1|||
125933762|NCT00531050|453054081|FG002|Part 2: Period 3|Abnormal test procedure|0|||
125933763|NCT00531050|453054082|FG003|Part 2: Period 3|Abnormal test procedure|0|||
125933764|NCT00531050|453054083|FG004|Part 2: Period 3|Abnormal test procedure|0|||
125933765|NCT00531050|453054084|FG005|Part 2: Period 3|Abnormal test procedure|1|||
125933766|NCT02233309|453054086|FG000|Overall Study|Physician Decision|5|||
125933767|NCT00799487|453054093|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
125933768|NCT00799487|453054094|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
125933769|NCT00799487|453054095|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
125933770|NCT00799487|453054093|FG000|Dose Adjustment Period|Adverse Event|2|||
125933771|NCT00799487|453054094|FG001|Dose Adjustment Period|Adverse Event|0|||
125933772|NCT00799487|453054095|FG002|Dose Adjustment Period|Adverse Event|0|||
125933773|NCT00799487|453054093|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
125933774|NCT00799487|453054094|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
125933775|NCT00799487|453054095|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
125933776|NCT00799487|453054093|FG000|Dose Adjustment Period|Investigator Discretion|2|||
125933777|NCT00799487|453054094|FG001|Dose Adjustment Period|Investigator Discretion|0|||
125933778|NCT00799487|453054095|FG002|Dose Adjustment Period|Investigator Discretion|0|||
125933779|NCT00799487|453054093|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
125933780|NCT00799487|453054094|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
125933781|NCT00799487|453054095|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
125933782|NCT00799487|453054093|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
125933783|NCT00799487|453054094|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
125933784|NCT00799487|453054095|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
125933785|NCT00799487|453054093|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
125933786|NCT00799487|453054094|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
125933787|NCT00799487|453054095|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
125933788|NCT00799487|453054093|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
125933789|NCT00799487|453054094|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
125933790|NCT00799487|453054095|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
125933791|NCT00799487|453054093|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
125933792|NCT00799487|453054094|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
125933793|NCT00799487|453054095|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
125933794|NCT00799487|453054093|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
125933795|NCT00799487|453054094|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
125933796|NCT00799487|453054095|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
125933797|NCT00799487|453054093|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
125933798|NCT00799487|453054094|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
125933799|NCT00799487|453054095|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
125933800|NCT00799487|453054093|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
125933801|NCT00799487|453054094|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
125933802|NCT00799487|453054095|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
125933803|NCT01828281|453054096|FG000|Overall Study|Withdrawal by Subject|1|||
125933804|NCT01828281|453054097|FG001|Overall Study|Withdrawal by Subject|0|||
125933805|NCT00142584|453054098|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
125933806|NCT00142584|453054099|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
125933807|NCT00142584|453054098|FG000|Overall Study|Withdrawal by Subject|30|||
125933808|NCT00142584|453054099|FG001|Overall Study|Withdrawal by Subject|16|||
125933809|NCT00142584|453054098|FG000|Overall Study|Lost to Follow-up|22|||
125933810|NCT00142584|453054099|FG001|Overall Study|Lost to Follow-up|12|||
125933811|NCT00142584|453054098|FG000|Overall Study|Adverse Event|14|||
125933812|NCT00142584|453054099|FG001|Overall Study|Adverse Event|5|||
125933813|NCT00142584|453054098|FG000|Overall Study|Protocol Violation|4|||
125933814|NCT00142584|453054099|FG001|Overall Study|Protocol Violation|7|||
125933815|NCT00142584|453054098|FG000|Overall Study|Treatment Failure|2|||
125933816|NCT00142584|453054099|FG001|Overall Study|Treatment Failure|0|||
125933817|NCT03070782|453054101|FG000|Overall Study|Adverse Event|3|||
125933818|NCT03070782|453054102|FG001|Overall Study|Adverse Event|0|||
125933819|NCT03070782|453054103|FG002|Overall Study|Adverse Event|3|||
125933820|NCT03070782|453054104|FG003|Overall Study|Adverse Event|1|||
125933821|NCT03070782|453054105|FG004|Overall Study|Adverse Event|6|||
125933822|NCT03070782|453054106|FG005|Overall Study|Adverse Event|2|||
125933823|NCT03070782|453054101|FG000|Overall Study|Withdrawal by Subject|2|||
125933824|NCT03070782|453054102|FG001|Overall Study|Withdrawal by Subject|1|||
125933825|NCT03070782|453054103|FG002|Overall Study|Withdrawal by Subject|1|||
125933826|NCT03070782|453054104|FG003|Overall Study|Withdrawal by Subject|0|||
125933827|NCT03070782|453054105|FG004|Overall Study|Withdrawal by Subject|4|||
125933828|NCT03070782|453054106|FG005|Overall Study|Withdrawal by Subject|3|||
125933829|NCT03070782|453054101|FG000|Overall Study|Reason Not Specified|2|||
125933830|NCT03070782|453054102|FG001|Overall Study|Reason Not Specified|0|||
125933831|NCT03070782|453054103|FG002|Overall Study|Reason Not Specified|0|||
125933832|NCT03070782|453054104|FG003|Overall Study|Reason Not Specified|1|||
125933833|NCT03070782|453054105|FG004|Overall Study|Reason Not Specified|2|||
125933834|NCT03070782|453054106|FG005|Overall Study|Reason Not Specified|1|||
125933835|NCT03070782|453054101|FG000|Overall Study|Ineligibility|0|||
125933836|NCT03070782|453054102|FG001|Overall Study|Ineligibility|0|||
125933837|NCT03070782|453054103|FG002|Overall Study|Ineligibility|0|||
126113897|NCT00930722|453712603|FG000|Overall Study|No longer willing to participate|9|||
126113898|NCT00930722|453712603|FG000|Overall Study|Study terminated by sponsor|2|||
125933838|NCT03070782|453054104|FG003|Overall Study|Ineligibility|1|||
126113899|NCT03034460|453712604|FG000|Overall Study|Adverse Event|0|||
126113900|NCT03034460|453712605|FG001|Overall Study|Adverse Event|1|||
125933839|NCT03070782|453054105|FG004|Overall Study|Ineligibility|0|||
125933840|NCT03070782|453054106|FG005|Overall Study|Ineligibility|1|||
125933841|NCT03070782|453054101|FG000|Overall Study|Pregnancy|0|||
125933842|NCT03070782|453054102|FG001|Overall Study|Pregnancy|0|||
125933843|NCT03070782|453054103|FG002|Overall Study|Pregnancy|0|||
125933844|NCT03070782|453054104|FG003|Overall Study|Pregnancy|1|||
125933845|NCT03070782|453054105|FG004|Overall Study|Pregnancy|0|||
125933846|NCT03070782|453054106|FG005|Overall Study|Pregnancy|0|||
125933847|NCT03070782|453054101|FG000|Overall Study|Investigator Judgement|0|||
125933848|NCT03070782|453054102|FG001|Overall Study|Investigator Judgement|0|||
125933849|NCT03070782|453054103|FG002|Overall Study|Investigator Judgement|0|||
125933850|NCT03070782|453054104|FG003|Overall Study|Investigator Judgement|1|||
125933851|NCT03070782|453054105|FG004|Overall Study|Investigator Judgement|0|||
125933852|NCT03070782|453054106|FG005|Overall Study|Investigator Judgement|0|||
125933853|NCT01083576|453054107|FG000|Overall Study|Treatment Failure|6|||
125933854|NCT01083576|453054108|FG001|Overall Study|Treatment Failure|1|||
125933855|NCT02875860|453054110|FG000|Overall Study|Withdrawal by Subject|0|||
125933856|NCT02875860|453054111|FG001|Overall Study|Withdrawal by Subject|1|||
125933857|NCT01881776|453054112|FG000|Overall Study|Lost to Follow-up|1|||
125933858|NCT01881776|453054113|FG001|Overall Study|Lost to Follow-up|2|||
125933859|NCT01881776|453054114|FG002|Overall Study|Lost to Follow-up|1|||
125933860|NCT01881776|453054112|FG000|Overall Study|Protocol Violation|0|||
125933861|NCT01881776|453054113|FG001|Overall Study|Protocol Violation|2|||
125933862|NCT01881776|453054114|FG002|Overall Study|Protocol Violation|1|||
125933863|NCT00726661|453054115|FG000|Overall Study|Lost to Follow-up|36|||
125933864|NCT00726661|453054116|FG001|Overall Study|Lost to Follow-up|11|||
125933865|NCT00726661|453054115|FG000|Overall Study|Withdrawal by Subject|17|||
125933866|NCT00726661|453054116|FG001|Overall Study|Withdrawal by Subject|13|||
125933867|NCT00726661|453054115|FG000|Overall Study|Trial terminated by sponsor|214|||
125933868|NCT00726661|453054116|FG001|Overall Study|Trial terminated by sponsor|187|||
125933869|NCT00726661|453054115|FG000|Overall Study|Death|475|||
125933870|NCT00726661|453054116|FG001|Overall Study|Death|159|||
125933871|NCT00726661|453054115|FG000|Overall Study|Physician Decision|25|||
125933872|NCT00726661|453054116|FG001|Overall Study|Physician Decision|13|||
125933873|NCT00726661|453054115|FG000|Overall Study|Other|47|||
125933874|NCT00726661|453054116|FG001|Overall Study|Other|35|||
125933875|NCT01285310|453054117|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
125933876|NCT01285310|453054118|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
125933877|NCT01285310|453054119|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
125933878|NCT01285310|453054120|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
125933879|NCT01285310|453054121|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
125933880|NCT01285310|453054117|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
125933881|NCT01285310|453054118|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
125933882|NCT01285310|453054119|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
125933883|NCT01285310|453054120|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
125933884|NCT01285310|453054121|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
125933885|NCT01285310|453054117|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
125933886|NCT01285310|453054118|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
125933887|NCT01285310|453054119|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
125933888|NCT01285310|453054120|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
125933889|NCT01285310|453054121|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
125933890|NCT01285310|453054117|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
125933891|NCT01285310|453054118|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
125933892|NCT01285310|453054119|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
125933893|NCT01285310|453054120|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
125933894|NCT01285310|453054121|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
125933895|NCT01285310|453054117|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
125933896|NCT01285310|453054118|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
125933897|NCT01285310|453054119|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
125933898|NCT01285310|453054120|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
125933899|NCT01285310|453054121|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
125933900|NCT01285310|453054117|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
125933901|NCT01285310|453054118|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
125933902|NCT01285310|453054119|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
125933903|NCT01285310|453054120|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
125933904|NCT01285310|453054121|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
125933905|NCT01285310|453054117|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
125933906|NCT01285310|453054118|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
125933907|NCT01285310|453054119|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
126066290|NCT02105688|453533527|FG001|Part A: Double-Blind|Adverse Event|0|||
125933908|NCT01285310|453054120|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
125933909|NCT01285310|453054121|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
125933910|NCT01285310|453054117|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
125933911|NCT01285310|453054118|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
125933912|NCT01285310|453054119|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
125933913|NCT01285310|453054120|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
125933914|NCT01285310|453054121|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
125933915|NCT01285310|453054117|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
125933916|NCT01285310|453054118|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
125933917|NCT01285310|453054119|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
125933918|NCT01285310|453054120|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
125933919|NCT01285310|453054121|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
125933920|NCT01285310|453054117|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
125933921|NCT01285310|453054118|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
125933922|NCT01285310|453054119|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
125933923|NCT01285310|453054120|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
125933924|NCT01285310|453054121|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
125933925|NCT01285310|453054117|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
125933926|NCT01285310|453054118|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
125933927|NCT01285310|453054119|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
125933928|NCT01285310|453054120|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
125933929|NCT01285310|453054121|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
125933930|NCT01285310|453054117|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
125933931|NCT01285310|453054118|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
125933932|NCT01285310|453054119|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
125933933|NCT01285310|453054120|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
125933934|NCT01285310|453054121|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
125933935|NCT00143403|453054122|FG000|Overall Study|Adverse Event|3|||
125933936|NCT00143403|453054123|FG001|Overall Study|Adverse Event|8|||
125933937|NCT00143403|453054122|FG000|Overall Study|Death|1|||
125933938|NCT00143403|453054123|FG001|Overall Study|Death|0|||
125933939|NCT00143403|453054122|FG000|Overall Study|Withdrawal by Subject|3|||
125933940|NCT00143403|453054123|FG001|Overall Study|Withdrawal by Subject|12|||
125933941|NCT00143403|453054122|FG000|Overall Study|Relapse|15|||
125933942|NCT00143403|453054123|FG001|Overall Study|Relapse|7|||
125933943|NCT00143403|453054122|FG000|Overall Study|Protocol Violation|2|||
125933944|NCT00143403|453054123|FG001|Overall Study|Protocol Violation|2|||
125933945|NCT00143403|453054122|FG000|Overall Study|specified by site|4|||
125933946|NCT00143403|453054123|FG001|Overall Study|specified by site|9|||
125933947|NCT00143403|453054122|FG000|Overall Study|Randomized Not Treated|7|||
125933948|NCT00143403|453054123|FG001|Overall Study|Randomized Not Treated|8|||
125933949|NCT00514540|453054124|FG000|First-Line Chemo|Withdrawal by Subject|1|||
125933950|NCT00514540|453054124|FG000|First-Line Chemo|Protocol Violation|7|||
125933951|NCT00514540|453054124|FG000|Second-Line|Physician/Patient Decision|31|||
125933952|NCT00587639|453054125|FG000|Overall Study|Withdrawal by Subject|1|||
125933953|NCT03402386|453054126|FG000|Overall Study|Adverse Event|3|||
125933954|NCT03402386|453054126|FG000|Overall Study|Physician Decision|1|||
125933955|NCT03402386|453054126|FG000|Overall Study|Difficult to control Hb|2|||
125933956|NCT01996982|453054129|FG000|Overall Study|PI/team left institution|7|||
125933957|NCT01574326|453054130|FG000|Overall Study|Randomized but not treated|0|||
125933958|NCT01574326|453054131|FG001|Overall Study|Randomized but not treated|1|||
125933959|NCT01574326|453054130|FG000|Overall Study|Withdrawal by Participant|2|||
125933960|NCT01574326|453054131|FG001|Overall Study|Withdrawal by Participant|4|||
125933961|NCT01574326|453054130|FG000|Overall Study|Physician Decision|5|||
125933962|NCT01574326|453054131|FG001|Overall Study|Physician Decision|3|||
125933963|NCT01574326|453054130|FG000|Overall Study|Adverse Event|1|||
125933964|NCT01574326|453054131|FG001|Overall Study|Adverse Event|3|||
125933965|NCT01574326|453054130|FG000|Overall Study|Other: Mainly kidney transplant|8|||
125933966|NCT01574326|453054131|FG001|Overall Study|Other: Mainly kidney transplant|8|||
125933967|NCT01195415|453054150|FG000|Overall Study|No repeat biopsy due to progression|2|||
125933968|NCT00533845|453054151|FG000|Overall Study|Physician Decision|1|||
125933969|NCT00533845|453054152|FG001|Overall Study|Physician Decision|0|||
125933970|NCT00005937|453054155|FG000|Overall Study|Lack of Efficacy|5|||
125933971|NCT01288469|453054156|FG000|Overall Study|Adverse Event|4|||
125933972|NCT01288469|453054157|FG001|Overall Study|Adverse Event|1|||
125933973|NCT01288469|453054158|FG002|Overall Study|Adverse Event|1|||
126113901|NCT03034460|453712604|FG000|Overall Study|Withdrawal by Subject|2|||
125933974|NCT01288469|453054156|FG000|Overall Study|Poor compliance to protocol|0|||
125933975|NCT01288469|453054157|FG001|Overall Study|Poor compliance to protocol|1|||
125933976|NCT01288469|453054158|FG002|Overall Study|Poor compliance to protocol|0|||
126113902|NCT03034460|453712605|FG001|Overall Study|Withdrawal by Subject|2|||
125933977|NCT01288469|453054156|FG000|Overall Study|Participant Moved|1|||
125933978|NCT01288469|453054157|FG001|Overall Study|Participant Moved|0|||
125933979|NCT01288469|453054158|FG002|Overall Study|Participant Moved|0|||
125933980|NCT01288469|453054156|FG000|Overall Study|Consent withdrawn by subject|1|||
125933981|NCT01288469|453054157|FG001|Overall Study|Consent withdrawn by subject|1|||
125933982|NCT01288469|453054158|FG002|Overall Study|Consent withdrawn by subject|1|||
125933983|NCT01288469|453054156|FG000|Overall Study|Exclusion criteria finally met|1|||
125933984|NCT01288469|453054157|FG001|Overall Study|Exclusion criteria finally met|0|||
125933985|NCT01288469|453054158|FG002|Overall Study|Exclusion criteria finally met|0|||
125933986|NCT00255047|453054159|FG000|Overall Study|Serious Adverse Events|2|||
125933987|NCT00255047|453054160|FG001|Overall Study|Serious Adverse Events|1|||
125933988|NCT00255047|453054161|FG002|Overall Study|Serious Adverse Events|2|||
125933989|NCT00255047|453054162|FG003|Overall Study|Serious Adverse Events|1|||
125933990|NCT00255047|453054159|FG000|Overall Study|Adverse Event|0|||
125933991|NCT00255047|453054160|FG001|Overall Study|Adverse Event|3|||
125933992|NCT00255047|453054161|FG002|Overall Study|Adverse Event|2|||
125933993|NCT00255047|453054162|FG003|Overall Study|Adverse Event|1|||
125933994|NCT00255047|453054159|FG000|Overall Study|Protocol Violation|13|||
125933995|NCT00255047|453054160|FG001|Overall Study|Protocol Violation|13|||
125933996|NCT00255047|453054161|FG002|Overall Study|Protocol Violation|16|||
125933997|NCT00255047|453054162|FG003|Overall Study|Protocol Violation|20|||
125933998|NCT00255047|453054159|FG000|Overall Study|Lost to Follow-up|9|||
125933999|NCT00255047|453054160|FG001|Overall Study|Lost to Follow-up|8|||
125934000|NCT00255047|453054161|FG002|Overall Study|Lost to Follow-up|5|||
125934001|NCT00255047|453054162|FG003|Overall Study|Lost to Follow-up|6|||
125934002|NCT00255047|453054159|FG000|Overall Study|Withdrawal by Subject|24|||
125934003|NCT00255047|453054160|FG001|Overall Study|Withdrawal by Subject|23|||
125934004|NCT00255047|453054161|FG002|Overall Study|Withdrawal by Subject|25|||
125934005|NCT00255047|453054162|FG003|Overall Study|Withdrawal by Subject|18|||
125934006|NCT01574612|453054163|FG000|Overall Study|Adverse Event|3|||
125934007|NCT01574612|453054163|FG000|Overall Study|non compliant with drug|2|||
125934008|NCT01574612|453054163|FG000|Overall Study|Withdrawal by Subject|1|||
125934009|NCT01574612|453054163|FG000|Overall Study|Lost to Follow-up|2|||
125934010|NCT02452398|453054164|FG000|Overall Study|Adverse Event|1|||
125934011|NCT02452398|453054164|FG000|Overall Study|Lost to Follow-up|28|||
125934012|NCT02452398|453054164|FG000|Overall Study|Physician Decision|2|||
125934013|NCT02452398|453054164|FG000|Overall Study|Withdrawal by Subject|6|||
125934014|NCT02452398|453054164|FG000|Overall Study|Moved away|4|||
125934015|NCT01957644|453054167|FG000|Overall Study|Adverse Event|4|||
125934016|NCT01957644|453054168|FG001|Overall Study|Adverse Event|2|||
125934017|NCT01957644|453054169|FG002|Overall Study|Adverse Event|0|||
125934018|NCT01957644|453054170|FG003|Overall Study|Adverse Event|0|||
125934019|NCT01957644|453054171|FG004|Overall Study|Adverse Event|1|||
125934020|NCT01957644|453054167|FG000|Overall Study|Progressive disease / relapse|0|||
125934021|NCT01957644|453054168|FG001|Overall Study|Progressive disease / relapse|1|||
125934022|NCT01957644|453054169|FG002|Overall Study|Progressive disease / relapse|0|||
125934023|NCT01957644|453054170|FG003|Overall Study|Progressive disease / relapse|1|||
125934024|NCT01957644|453054171|FG004|Overall Study|Progressive disease / relapse|0|||
125934025|NCT01957644|453054167|FG000|Overall Study|Other reason|1|||
125934026|NCT01957644|453054168|FG001|Overall Study|Other reason|2|||
125934027|NCT01957644|453054169|FG002|Overall Study|Other reason|1|||
125934028|NCT01957644|453054170|FG003|Overall Study|Other reason|1|||
125934029|NCT01957644|453054171|FG004|Overall Study|Other reason|0|||
125934030|NCT01957644|453054167|FG000|Overall Study|Withdrawal by Subject|1|||
125934031|NCT01957644|453054168|FG001|Overall Study|Withdrawal by Subject|0|||
125934032|NCT01957644|453054169|FG002|Overall Study|Withdrawal by Subject|0|||
125934033|NCT01957644|453054170|FG003|Overall Study|Withdrawal by Subject|0|||
125934034|NCT01957644|453054171|FG004|Overall Study|Withdrawal by Subject|0|||
125934035|NCT01957644|453054167|FG000|Overall Study|Protocol Violation|0|||
125934036|NCT01957644|453054168|FG001|Overall Study|Protocol Violation|1|||
125934037|NCT01957644|453054169|FG002|Overall Study|Protocol Violation|0|||
125934038|NCT01957644|453054170|FG003|Overall Study|Protocol Violation|0|||
125934039|NCT01957644|453054171|FG004|Overall Study|Protocol Violation|0|||
125934040|NCT00927784|453054172|FG000|Overall Study|Death|1|||
125934041|NCT00927784|453054173|FG001|Overall Study|Death|0|||
125934042|NCT00927784|453054172|FG000|Overall Study|Withdrawal by Subject|1|||
125934043|NCT00927784|453054173|FG001|Overall Study|Withdrawal by Subject|0|||
125934044|NCT02170051|453054174|FG000|Overall Study|Withdrawal by Subject|10|||
125934045|NCT02170051|453054175|FG001|Overall Study|Withdrawal by Subject|10|||
125934046|NCT02170051|453054174|FG000|Overall Study|Lost to Follow-up|1|||
125934047|NCT02170051|453054175|FG001|Overall Study|Lost to Follow-up|3|||
125934048|NCT01867021|453054176|FG000|Overall Study|Adverse Event|0|||
125934049|NCT01867021|453054177|FG001|Overall Study|Adverse Event|1|||
125934050|NCT01867021|453054176|FG000|Overall Study|Not Eligible|0|||
126113903|NCT03034460|453712604|FG000|Overall Study|Personal Reasons|1|||
125934051|NCT01867021|453054177|FG001|Overall Study|Not Eligible|1|||
125934052|NCT01867021|453054176|FG000|Overall Study|Death|1|||
125934053|NCT01867021|453054177|FG001|Overall Study|Death|0|||
125934054|NCT01867021|453054176|FG000|Overall Study|Lost to Follow-up|0|||
125934055|NCT01867021|453054177|FG001|Overall Study|Lost to Follow-up|2|||
125934056|NCT01867021|453054176|FG000|Overall Study|Withdrawal by Subject|1|||
125934057|NCT01867021|453054177|FG001|Overall Study|Withdrawal by Subject|6|||
125934058|NCT00881712|453054178|FG000|Overall Study|Death|1|||
125934059|NCT00881712|453054179|FG001|Overall Study|Death|0|||
125934060|NCT00881712|453054180|FG002|Overall Study|Death|0|||
125934061|NCT00881712|453054178|FG000|Overall Study|Withdrawal by Subject|1|||
125934062|NCT00881712|453054179|FG001|Overall Study|Withdrawal by Subject|0|||
125934063|NCT00881712|453054180|FG002|Overall Study|Withdrawal by Subject|0|||
125934064|NCT01782495|453054188|FG000|Overall Study|Adverse Event|0|||
125934065|NCT01782495|453054189|FG001|Overall Study|Adverse Event|0|||
125934066|NCT01782495|453054190|FG002|Overall Study|Adverse Event|0|||
125934067|NCT01782495|453054191|FG003|Overall Study|Adverse Event|0|||
125934068|NCT01782495|453054192|FG004|Overall Study|Adverse Event|0|||
125934069|NCT01782495|453054193|FG005|Overall Study|Adverse Event|0|||
125934070|NCT01782495|453054194|FG006|Overall Study|Adverse Event|0|||
125934071|NCT01782495|453054195|FG007|Overall Study|Adverse Event|2|||
125934072|NCT01782495|453054196|FG008|Overall Study|Adverse Event|0|||
125934073|NCT01782495|453054197|FG009|Overall Study|Adverse Event|0|||
125934074|NCT01782495|453054198|FG010|Overall Study|Adverse Event|0|||
125934075|NCT01782495|453054188|FG000|Overall Study|Withdrew Consent|0|||
125934076|NCT01782495|453054189|FG001|Overall Study|Withdrew Consent|1|||
125934077|NCT01782495|453054190|FG002|Overall Study|Withdrew Consent|0|||
125934078|NCT01782495|453054191|FG003|Overall Study|Withdrew Consent|0|||
125934079|NCT01782495|453054192|FG004|Overall Study|Withdrew Consent|0|||
125934080|NCT01782495|453054193|FG005|Overall Study|Withdrew Consent|0|||
125934081|NCT01782495|453054194|FG006|Overall Study|Withdrew Consent|0|||
125934082|NCT01782495|453054195|FG007|Overall Study|Withdrew Consent|1|||
125934083|NCT01782495|453054196|FG008|Overall Study|Withdrew Consent|0|||
125934084|NCT01782495|453054197|FG009|Overall Study|Withdrew Consent|0|||
125934085|NCT01782495|453054198|FG010|Overall Study|Withdrew Consent|0|||
125934086|NCT00071513|453054199|FG000|Intervention Component|Withdrawal by Subject|2|||
125934087|NCT00071513|453054200|FG001|Intervention Component|Withdrawal by Subject|3|||
125934088|NCT00071513|453054199|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
125934089|NCT00071513|453054200|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
125934090|NCT02260921|453054201|FG000|Overall Study|Adverse Event|1|||
125934091|NCT02260921|453054202|FG001|Overall Study|Adverse Event|0|||
125934092|NCT02260921|453054201|FG000|Overall Study|Lost to Follow-up|4|||
125934093|NCT02260921|453054202|FG001|Overall Study|Lost to Follow-up|3|||
125934094|NCT02260921|453054201|FG000|Overall Study|Withdraw Consent|4|||
125934095|NCT02260921|453054202|FG001|Overall Study|Withdraw Consent|1|||
125934096|NCT02260921|453054201|FG000|Overall Study|Death|1|||
125934097|NCT02260921|453054202|FG001|Overall Study|Death|0|||
125934098|NCT02260921|453054201|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
125934099|NCT02260921|453054202|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
125934100|NCT01244425|453054203|FG000|Overall Study|Withdrawal by Subject|2|||
125934101|NCT01244425|453054204|FG001|Overall Study|Withdrawal by Subject|2|||
125934102|NCT01244425|453054203|FG000|Overall Study|Adverse Event|1|||
125934103|NCT01244425|453054204|FG001|Overall Study|Adverse Event|1|||
125934104|NCT02744391|453054205|FG000|Overall Study|Lost to Follow-up|9|||
125934105|NCT02744391|453054205|FG000|Overall Study|Physician Decision|2|||
125934106|NCT02744391|453054205|FG000|Overall Study|Withdrawal by Subject|3|||
125934107|NCT01996709|453054206|FG000|Overall Study|Withdrawal by Subject|1|||
125934108|NCT01996709|453054207|FG001|Overall Study|Withdrawal by Subject|0|||
125934109|NCT01996709|453054206|FG000|Overall Study|Lost to Follow-up|3|||
125934110|NCT01996709|453054207|FG001|Overall Study|Lost to Follow-up|0|||
125934111|NCT01996709|453054206|FG000|Overall Study|Subject Non-Compliant|1|||
125934112|NCT01996709|453054207|FG001|Overall Study|Subject Non-Compliant|0|||
125934113|NCT01996709|453054206|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
125934114|NCT01996709|453054207|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
125934115|NCT02480114|453054212|FG000|Overall Study|Not completing surveys|3|||
125934116|NCT02480114|453054213|FG001|Overall Study|Not completing surveys|2|||
125934117|NCT02480114|453054212|FG000|Overall Study|Withdrawal by Subject|2|||
125934118|NCT02480114|453054213|FG001|Overall Study|Withdrawal by Subject|4|||
125934119|NCT02480114|453054212|FG000|Overall Study|Disease progression|3|||
125934120|NCT02480114|453054213|FG001|Overall Study|Disease progression|0|||
125934121|NCT02480114|453054212|FG000|Overall Study|Improper completion of survey|1|||
125934122|NCT02480114|453054213|FG001|Overall Study|Improper completion of survey|1|||
125934123|NCT02480114|453054212|FG000|Overall Study|Not eligible|0|||
125934124|NCT02480114|453054213|FG001|Overall Study|Not eligible|1|||
125934125|NCT01535053|453054214|FG000|Overall Study|Ineligible|1|||
125934126|NCT01535053|453054215|FG001|Overall Study|Ineligible|2|||
125934127|NCT00512707|453054216|FG000|Overall Study|Lost to Follow-up|5|||
125934128|NCT00512707|453054217|FG001|Overall Study|Lost to Follow-up|11|||
125934129|NCT00512707|453054216|FG000|Overall Study|Developed skin irritation|2|||
126066291|NCT02105688|453533526|FG000|Part A: Double-Blind|Death|0|||
126066292|NCT02105688|453533527|FG001|Part A: Double-Blind|Death|1|||
126066293|NCT02105688|453533526|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
125934130|NCT00512707|453054217|FG001|Overall Study|Developed skin irritation|1|||
125934131|NCT00512707|453054216|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
125934132|NCT00512707|453054217|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
125934133|NCT00512707|453054216|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
125934134|NCT00512707|453054217|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
125934135|NCT04405037|453054218|FG000|Overall Study|Withdrawal by Subject|1|||
125934136|NCT04405037|453054219|FG001|Overall Study|Withdrawal by Subject|0|||
125934137|NCT04405037|453054218|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
126066294|NCT02105688|453533527|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
125934138|NCT04405037|453054219|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
125934139|NCT02759471|453054220|FG000|Overall Study|discomfort|2|||
125934140|NCT02879305|453054221|FG000|Overall Study|Investigator Site Closed|55|||
125934141|NCT02879305|453054222|FG001|Overall Study|Investigator Site Closed|57|||
125934142|NCT02879305|453054221|FG000|Overall Study|Withdrawal by Subject|44|||
125934143|NCT02879305|453054222|FG001|Overall Study|Withdrawal by Subject|42|||
125934144|NCT02879305|453054221|FG000|Overall Study|Lost to Follow-up|17|||
125934145|NCT02879305|453054222|FG001|Overall Study|Lost to Follow-up|12|||
125934146|NCT02879305|453054221|FG000|Overall Study|Other|1|||
125934147|NCT02879305|453054222|FG001|Overall Study|Other|0|||
125934148|NCT02329730|453055840|FG000|Overall Study|Protocol Violation|0|||
125934149|NCT02329730|453055841|FG001|Overall Study|Protocol Violation|0|||
125934150|NCT02329730|453055842|FG002|Overall Study|Protocol Violation|0|||
125934151|NCT02329730|453055843|FG003|Overall Study|Protocol Violation|0|||
125934152|NCT02329730|453055844|FG004|Overall Study|Protocol Violation|2|||
125934153|NCT02329730|453055845|FG005|Overall Study|Protocol Violation|2|||
125934154|NCT02329730|453055846|FG006|Overall Study|Protocol Violation|0|||
125934155|NCT02329730|453055847|FG007|Overall Study|Protocol Violation|0|||
125934156|NCT02329730|453055848|FG008|Overall Study|Protocol Violation|0|||
125934157|NCT02329730|453055849|FG009|Overall Study|Protocol Violation|0|||
125934158|NCT02329730|453055850|FG010|Overall Study|Protocol Violation|0|||
125934159|NCT02329730|453055851|FG011|Overall Study|Protocol Violation|0|||
125934160|NCT02329730|453055840|FG000|Overall Study|Withdrawal by Subject|0|||
125934161|NCT02329730|453055841|FG001|Overall Study|Withdrawal by Subject|0|||
125934162|NCT02329730|453055842|FG002|Overall Study|Withdrawal by Subject|0|||
125934163|NCT02329730|453055843|FG003|Overall Study|Withdrawal by Subject|0|||
125934164|NCT02329730|453055844|FG004|Overall Study|Withdrawal by Subject|1|||
125934165|NCT02329730|453055845|FG005|Overall Study|Withdrawal by Subject|0|||
125934166|NCT02329730|453055846|FG006|Overall Study|Withdrawal by Subject|1|||
125934167|NCT02329730|453055847|FG007|Overall Study|Withdrawal by Subject|1|||
125934168|NCT02329730|453055848|FG008|Overall Study|Withdrawal by Subject|1|||
125934169|NCT02329730|453055849|FG009|Overall Study|Withdrawal by Subject|1|||
125934170|NCT02329730|453055850|FG010|Overall Study|Withdrawal by Subject|0|||
125934171|NCT02329730|453055851|FG011|Overall Study|Withdrawal by Subject|0|||
125934172|NCT02068443|453055854|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125934173|NCT02068443|453055855|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
125934174|NCT02068443|453055856|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
125934175|NCT02068443|453055854|FG000|Overall Study|Voluntary Withdrawal|4|||
125934176|NCT02068443|453055855|FG001|Overall Study|Voluntary Withdrawal|0|||
125934177|NCT02068443|453055856|FG002|Overall Study|Voluntary Withdrawal|1|||
125934178|NCT02068443|453055854|FG000|Overall Study|Lack of Efficacy|2|||
125934179|NCT02068443|453055855|FG001|Overall Study|Lack of Efficacy|1|||
125934180|NCT02068443|453055856|FG002|Overall Study|Lack of Efficacy|0|||
125934181|NCT02068443|453055854|FG000|Overall Study|Other Reason Not Specified|1|||
125934182|NCT02068443|453055855|FG001|Overall Study|Other Reason Not Specified|0|||
125934183|NCT02068443|453055856|FG002|Overall Study|Other Reason Not Specified|0|||
125934184|NCT01986855|453055857|FG000|Overall Study|Adverse Event|1|||
125934185|NCT01986855|453055858|FG001|Overall Study|Adverse Event|0|||
125934186|NCT01986855|453055859|FG002|Overall Study|Adverse Event|0|||
125934187|NCT01986855|453055857|FG000|Overall Study|Death|3|||
125934188|NCT01986855|453055858|FG001|Overall Study|Death|4|||
125934189|NCT01986855|453055859|FG002|Overall Study|Death|4|||
125934190|NCT01986855|453055857|FG000|Overall Study|Lost to Follow-up|2|||
125934191|NCT01986855|453055858|FG001|Overall Study|Lost to Follow-up|1|||
125934192|NCT01986855|453055859|FG002|Overall Study|Lost to Follow-up|0|||
125934193|NCT01986855|453055857|FG000|Overall Study|Screen Failure|0|||
125934194|NCT01986855|453055858|FG001|Overall Study|Screen Failure|1|||
125934195|NCT01986855|453055859|FG002|Overall Study|Screen Failure|0|||
125934196|NCT01986855|453055857|FG000|Overall Study|Participant Moved|0|||
125934197|NCT01986855|453055858|FG001|Overall Study|Participant Moved|0|||
126113904|NCT03034460|453712605|FG001|Overall Study|Personal Reasons|0|||
125934198|NCT01986855|453055859|FG002|Overall Study|Participant Moved|2|||
125934199|NCT01986855|453055857|FG000|Overall Study|Withdrawal by Subject|7|||
125934200|NCT01986855|453055858|FG001|Overall Study|Withdrawal by Subject|8|||
125934201|NCT01986855|453055859|FG002|Overall Study|Withdrawal by Subject|5|||
125934202|NCT00664742|453055860|FG000|Overall Study|Withdrawn due to adverse events|3|||
125934203|NCT00664742|453055860|FG000|Overall Study|Withdrawal by Subject|31|||
125934204|NCT00664742|453055860|FG000|Overall Study|Lost to Follow-up|92|||
125934205|NCT00710710|453055861|FG000|Overall Study|Consent withdrawn|2|||
125934206|NCT00710710|453055862|FG001|Overall Study|Consent withdrawn|2|||
125934207|NCT00710710|453055861|FG000|Overall Study|Protocol Violation|0|||
125934208|NCT00710710|453055862|FG001|Overall Study|Protocol Violation|1|||
125934209|NCT00710710|453055861|FG000|Overall Study|Adverse Event|3|||
125934210|NCT00710710|453055862|FG001|Overall Study|Adverse Event|3|||
125934211|NCT00710710|453055861|FG000|Overall Study|Progressive disease|40|||
125934212|NCT00710710|453055862|FG001|Overall Study|Progressive disease|38|||
125934213|NCT00715078|453055863|FG000|Overall Study|Death|29|||
125934214|NCT00715078|453055864|FG001|Overall Study|Death|36|||
125934215|NCT00715078|453055865|FG002|Overall Study|Death|36|||
125934216|NCT00715078|453055863|FG000|Overall Study|Withdrawal by Subject|1|||
125934217|NCT00715078|453055864|FG001|Overall Study|Withdrawal by Subject|0|||
125934218|NCT00715078|453055865|FG002|Overall Study|Withdrawal by Subject|1|||
125934219|NCT00715078|453055863|FG000|Overall Study|Unable to start due to disease prog.|0|||
125934220|NCT00715078|453055864|FG001|Overall Study|Unable to start due to disease prog.|0|||
125934221|NCT00715078|453055865|FG002|Overall Study|Unable to start due to disease prog.|1|||
125934222|NCT01529346|453055866|FG000|Overall Study|Lost to Follow-up|2|||
125934223|NCT01529346|453055867|FG001|Overall Study|Lost to Follow-up|0|||
125934224|NCT01529346|453055868|FG002|Overall Study|Lost to Follow-up|1|||
125934225|NCT01529346|453055869|FG003|Overall Study|Lost to Follow-up|0|||
125934226|NCT01529346|453055870|FG004|Overall Study|Lost to Follow-up|0|||
125934227|NCT01529346|453055866|FG000|Overall Study|Other|0|||
125934228|NCT01529346|453055867|FG001|Overall Study|Other|1|||
125934229|NCT01529346|453055868|FG002|Overall Study|Other|1|||
125934230|NCT01529346|453055869|FG003|Overall Study|Other|0|||
125934231|NCT01529346|453055870|FG004|Overall Study|Other|0|||
125934232|NCT02892760|453055871|FG000|Overall Study|Withdrawal by Subject|3|||
125934233|NCT00386776|453055876|FG000|Overall Study|Withdrawal by Subject|8|||
125934234|NCT01499667|453055877|FG000|Overall Study|administrative problems|4|||
125934235|NCT01499667|453055878|FG001|Overall Study|administrative problems|5|||
125934236|NCT01499667|453055879|FG002|Overall Study|administrative problems|5|||
125934237|NCT01499667|453055877|FG000|Overall Study|Protocol Violation|1|||
125934238|NCT01499667|453055878|FG001|Overall Study|Protocol Violation|3|||
125934239|NCT01499667|453055879|FG002|Overall Study|Protocol Violation|2|||
125934240|NCT01499667|453055877|FG000|Overall Study|Adverse Event|0|||
125934241|NCT01499667|453055878|FG001|Overall Study|Adverse Event|2|||
125934242|NCT01499667|453055879|FG002|Overall Study|Adverse Event|2|||
125934243|NCT01499667|453055877|FG000|Overall Study|Withdrawal by Subject|2|||
125934244|NCT01499667|453055878|FG001|Overall Study|Withdrawal by Subject|1|||
125934245|NCT01499667|453055879|FG002|Overall Study|Withdrawal by Subject|1|||
125934246|NCT01499667|453055877|FG000|Overall Study|Lack of Efficacy|2|||
125934247|NCT01499667|453055878|FG001|Overall Study|Lack of Efficacy|0|||
125934248|NCT01499667|453055879|FG002|Overall Study|Lack of Efficacy|0|||
125934249|NCT02902965|453055883|FG000|Overall Study|Withdrawal by Subject|10|||
125934250|NCT02673489|453055884|FG000|Treatment Period|Lost to Follow-up|3|||
125934251|NCT02673489|453055885|FG001|Treatment Period|Lost to Follow-up|0|||
125934252|NCT02673489|453055884|FG000|Treatment Period|Participant request to discontinue|1|||
125934253|NCT02673489|453055885|FG001|Treatment Period|Participant request to discontinue|1|||
125934254|NCT02673489|453055884|FG000|Treatment Period|Participant moved to another province|1|||
125934255|NCT02673489|453055885|FG001|Treatment Period|Participant moved to another province|0|||
125934256|NCT02673489|453055884|FG000|Treatment Period|Participant was incarcerated|0|||
125934257|NCT02673489|453055885|FG001|Treatment Period|Participant was incarcerated|1|||
125934258|NCT02673489|453055884|FG000|Treatment Period|Adverse Event|0|||
125934259|NCT02673489|453055885|FG001|Treatment Period|Adverse Event|1|||
125934260|NCT02673489|453055884|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
125934261|NCT02673489|453055885|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
125934262|NCT02673489|453055884|FG000|Follow Up Period|Unable to return for follow-up|0|||
125934263|NCT02673489|453055885|FG001|Follow Up Period|Unable to return for follow-up|1|||
125934264|NCT02259582|453055886|FG000|Overall Study|Physician Decision|0|||
125934265|NCT02259582|453055887|FG001|Overall Study|Physician Decision|1|||
125934266|NCT02259582|453055888|FG002|Overall Study|Physician Decision|0|||
125934267|NCT02259582|453055886|FG000|Overall Study|Death|0|||
125934268|NCT02259582|453055887|FG001|Overall Study|Death|0|||
125934269|NCT02259582|453055888|FG002|Overall Study|Death|1|||
125934270|NCT02259582|453055886|FG000|Overall Study|Adverse Event|1|||
125934271|NCT02259582|453055887|FG001|Overall Study|Adverse Event|0|||
125934272|NCT02259582|453055888|FG002|Overall Study|Adverse Event|1|||
125934273|NCT02259582|453055886|FG000|Overall Study|Withdrawal by Subject|0|||
125934274|NCT02259582|453055887|FG001|Overall Study|Withdrawal by Subject|0|||
125934275|NCT02259582|453055888|FG002|Overall Study|Withdrawal by Subject|1|||
125934276|NCT02259582|453055886|FG000|Overall Study|Disease progression|14|||
125934277|NCT02259582|453055887|FG001|Overall Study|Disease progression|15|||
125934278|NCT02259582|453055888|FG002|Overall Study|Disease progression|17|||
125934279|NCT02259582|453055886|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
125934280|NCT02259582|453055887|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
125934281|NCT02259582|453055888|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
125934282|NCT00232817|453055889|FG000|Overall Study|Protocol Violation|2|||
125934283|NCT00232817|453055890|FG001|Overall Study|Protocol Violation|1|||
125934284|NCT04481750|453055891|FG000|Period 1 (Fasted)|Adverse Event|0|||
126066295|NCT02105688|453533526|FG000|Part A: Double-Blind|Physician Decision|0|||
126066296|NCT02105688|453533527|FG001|Part A: Double-Blind|Physician Decision|1|||
125934285|NCT04481750|453055892|FG001|Period 1 (Fasted)|Adverse Event|0|||
125934286|NCT04481750|453055893|FG002|Period 1 (Fasted)|Adverse Event|1|||
125934287|NCT04481750|453055894|FG003|Period 1 (Fasted)|Adverse Event|0|||
125934288|NCT04481750|453055895|FG004|Period 1 (Fasted)|Adverse Event|0|||
125934289|NCT04481750|453055896|FG005|Period 1 (Fasted)|Adverse Event|0|||
125934290|NCT04481750|453055897|FG006|Period 1 (Fasted)|Adverse Event|0|||
125934291|NCT04481750|453055898|FG007|Period 1 (Fasted)|Adverse Event|0|||
125934292|NCT04481750|453055899|FG008|Period 1 (Fasted)|Adverse Event|0|||
125934293|NCT04481750|453055900|FG009|Period 1 (Fasted)|Adverse Event|0|||
125934294|NCT04481750|453055901|FG010|Period 1 (Fasted)|Adverse Event|0|||
125934295|NCT03263442|453055902|FG000|Inpatient Phase|Death|1|||
125934296|NCT03263442|453055903|FG001|Inpatient Phase|Death|0|||
125934297|NCT03263442|453055902|FG000|Inpatient Phase|Withdrawal by Subject|1|||
125934298|NCT03263442|453055903|FG001|Inpatient Phase|Withdrawal by Subject|0|||
125934299|NCT03263442|453055902|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
125934300|NCT03263442|453055903|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
125934301|NCT03263442|453055902|FG000|1-month Follow-Up|Lost to Follow-up|1|||
125934302|NCT03263442|453055903|FG001|1-month Follow-Up|Lost to Follow-up|0|||
125934303|NCT03263442|453055902|FG000|3-month Follow-Up|Lost to Follow-up|1|||
125934304|NCT03263442|453055903|FG001|3-month Follow-Up|Lost to Follow-up|3|||
125934305|NCT03263442|453055902|FG000|6-month Follow-Up|Lost to Follow-up|2|||
125934306|NCT03263442|453055903|FG001|6-month Follow-Up|Lost to Follow-up|2|||
125934307|NCT00475176|453055904|FG000|Overall Study|Adverse Event|2|||
125934308|NCT00475176|453055904|FG000|Overall Study|Withdrawal by Subject|1|||
125934309|NCT00475176|453055904|FG000|Overall Study|Protocol Violation|1|||
125934310|NCT01463878|453055905|FG000|Overall Study|no longer met criteria for tube feed|2|||
125934311|NCT01463878|453055906|FG001|Overall Study|no longer met criteria for tube feed|2|||
125934312|NCT03804879|453055907|FG000|Overall Study|Adverse Event|3|||
125934313|NCT03804879|453055908|FG001|Overall Study|Adverse Event|0|||
125934314|NCT03804879|453055907|FG000|Overall Study|Study Terminated By Sponsor|10|||
125934315|NCT03804879|453055908|FG001|Overall Study|Study Terminated By Sponsor|12|||
125934316|NCT03804879|453055907|FG000|Overall Study|Withdrawal by Subject|3|||
125934317|NCT03804879|453055908|FG001|Overall Study|Withdrawal by Subject|1|||
125934318|NCT02436889|453055909|FG000|Overall Study|No improvement in symptoms|1|||
125934319|NCT02436889|453055910|FG001|Overall Study|No improvement in symptoms|0|||
125934320|NCT02436889|453055909|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
125934321|NCT02436889|453055910|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
125934322|NCT01585428|453055911|FG000|Overall Study|Death during treatment|1|||
125934323|NCT01585428|453055912|FG001|Overall Study|Death during treatment|0|||
125934324|NCT01084174|453055913|FG000|Overall Study|gastrointestinal symptoms|1|||
125934325|NCT01084174|453055914|FG001|Overall Study|gastrointestinal symptoms|1|||
125934326|NCT01084174|453055913|FG000|Overall Study|Eosinophilic esophagitis|0|||
125934327|NCT01084174|453055914|FG001|Overall Study|Eosinophilic esophagitis|1|||
125934328|NCT01084174|453055913|FG000|Overall Study|Anaphylaxis|0|||
125934329|NCT01084174|453055914|FG001|Overall Study|Anaphylaxis|1|||
125934330|NCT01084174|453055913|FG000|Overall Study|Participant noncompliance|0|||
125934331|NCT01084174|453055914|FG001|Overall Study|Participant noncompliance|1|||
125934332|NCT01034462|453055915|FG000|Overall Study|Adverse Event|7|||
125934333|NCT01034462|453055916|FG001|Overall Study|Adverse Event|17|||
125934334|NCT01034462|453055915|FG000|Overall Study|Lack of Efficacy|4|||
125934335|NCT01034462|453055916|FG001|Overall Study|Lack of Efficacy|4|||
125934336|NCT01034462|453055915|FG000|Overall Study|Protocol Violation|10|||
125934337|NCT01034462|453055916|FG001|Overall Study|Protocol Violation|7|||
125934338|NCT01034462|453055915|FG000|Overall Study|Withdrawal by Subject|9|||
125934339|NCT01034462|453055916|FG001|Overall Study|Withdrawal by Subject|8|||
125934340|NCT01034462|453055915|FG000|Overall Study|Lost to Follow-up|14|||
125934341|NCT01034462|453055916|FG001|Overall Study|Lost to Follow-up|16|||
125934342|NCT01034462|453055915|FG000|Overall Study|Other reasons|1|||
125934343|NCT01034462|453055916|FG001|Overall Study|Other reasons|2|||
125934344|NCT01594125|453055917|FG000|Overall Study|Withdrawal by Subject|1|||
125934345|NCT01594125|453055918|FG001|Overall Study|Withdrawal by Subject|0|||
125934346|NCT01594125|453055919|FG002|Overall Study|Withdrawal by Subject|0|||
125934347|NCT01594125|453055920|FG003|Overall Study|Withdrawal by Subject|1|||
125934348|NCT01594125|453055921|FG004|Overall Study|Withdrawal by Subject|0|||
125934349|NCT01594125|453055917|FG000|Overall Study|Progressive Disease|3|||
125934350|NCT01594125|453055918|FG001|Overall Study|Progressive Disease|12|||
125934351|NCT01594125|453055919|FG002|Overall Study|Progressive Disease|3|||
125934352|NCT01594125|453055920|FG003|Overall Study|Progressive Disease|3|||
125934353|NCT01594125|453055921|FG004|Overall Study|Progressive Disease|7|||
125934354|NCT01484873|453055922|FG000|Overall Study|Withdrawal by Subject|2|||
125934355|NCT03527966|453055923|FG000|Overall Study|Lost to Follow-up|3|||
125934356|NCT03527966|453055924|FG001|Overall Study|Lost to Follow-up|0|||
125934357|NCT00558025|453055925|FG000|Overall Study|Adverse Event|1|||
126113905|NCT00295633|453712606|FG000|Overall Study|Lack of Efficacy|19|||
126113906|NCT00295633|453712607|FG001|Overall Study|Lack of Efficacy|7|||
125934358|NCT00558025|453055926|FG001|Overall Study|Adverse Event|1|||
125934359|NCT00558025|453055925|FG000|Overall Study|Withdrawal by Subject|2|||
125934360|NCT00558025|453055926|FG001|Overall Study|Withdrawal by Subject|2|||
125934361|NCT00558025|453055925|FG000|Overall Study|Protocol Violation|1|||
125934362|NCT00558025|453055926|FG001|Overall Study|Protocol Violation|0|||
125934363|NCT03315208|453055929|FG000|Overall Study|Lost to Follow-up|11|||
125934364|NCT03315208|453055930|FG001|Overall Study|Lost to Follow-up|6|||
125934365|NCT03315208|453055929|FG000|Overall Study|Withdrawal by Subject|2|||
125934366|NCT03315208|453055930|FG001|Overall Study|Withdrawal by Subject|0|||
125934367|NCT00276159|453055936|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
125934368|NCT00333866|453055939|FG000|Overall Study|Adverse Event|23|||
125934369|NCT00333866|453055940|FG001|Overall Study|Adverse Event|37|||
125934370|NCT00333866|453055941|FG002|Overall Study|Adverse Event|38|||
125934371|NCT00333866|453055942|FG003|Overall Study|Adverse Event|47|||
125934372|NCT00333866|453055939|FG000|Overall Study|Other|3|||
125934373|NCT00333866|453055940|FG001|Overall Study|Other|2|||
125934374|NCT00333866|453055941|FG002|Overall Study|Other|2|||
125934375|NCT00333866|453055942|FG003|Overall Study|Other|2|||
125934376|NCT00333866|453055939|FG000|Overall Study|Lack of Efficacy|8|||
125934377|NCT00333866|453055940|FG001|Overall Study|Lack of Efficacy|6|||
125934378|NCT00333866|453055941|FG002|Overall Study|Lack of Efficacy|3|||
125934379|NCT00333866|453055942|FG003|Overall Study|Lack of Efficacy|5|||
125934380|NCT00333866|453055939|FG000|Overall Study|Lost to Follow-up|1|||
125934381|NCT00333866|453055940|FG001|Overall Study|Lost to Follow-up|2|||
125934382|NCT00333866|453055941|FG002|Overall Study|Lost to Follow-up|2|||
125934383|NCT00333866|453055942|FG003|Overall Study|Lost to Follow-up|2|||
125934384|NCT00333866|453055939|FG000|Overall Study|Withdrawal by Subject|8|||
125934385|NCT00333866|453055940|FG001|Overall Study|Withdrawal by Subject|14|||
125934386|NCT00333866|453055941|FG002|Overall Study|Withdrawal by Subject|4|||
125934387|NCT00333866|453055942|FG003|Overall Study|Withdrawal by Subject|9|||
125934388|NCT00333866|453055939|FG000|Overall Study|Randomized but not Treated|5|||
125934389|NCT00333866|453055940|FG001|Overall Study|Randomized but not Treated|3|||
125934390|NCT00333866|453055941|FG002|Overall Study|Randomized but not Treated|2|||
125934391|NCT00333866|453055942|FG003|Overall Study|Randomized but not Treated|1|||
125934392|NCT01359449|453055953|FG000|Overall Study|Lost to Follow-up|1|||
125934393|NCT01359449|453055954|FG001|Overall Study|Lost to Follow-up|0|||
125934394|NCT01359449|453055953|FG000|Overall Study|Protocol Violation|0|||
125934395|NCT01359449|453055954|FG001|Overall Study|Protocol Violation|2|||
125934396|NCT01359449|453055953|FG000|Overall Study|Withdrawal by Subject|3|||
125934397|NCT01359449|453055954|FG001|Overall Study|Withdrawal by Subject|2|||
125934398|NCT02393547|453055961|FG000|Overall Study|Adverse Event|2|||
125934399|NCT02393547|453055961|FG000|Overall Study|Withdrawal by Subject|3|||
125934400|NCT02393547|453055961|FG000|Overall Study|Lost to Follow-up|1|||
125934401|NCT02927431|453055962|FG000|Overall Study|Withdrawal by Subject|0|||
125934402|NCT02927431|453055963|FG001|Overall Study|Withdrawal by Subject|0|||
125934403|NCT02927431|453055964|FG002|Overall Study|Withdrawal by Subject|1|||
125934404|NCT00673465|453055965|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934405|NCT00673465|453055966|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934406|NCT00673465|453055967|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934407|NCT00673465|453055968|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934408|NCT00673465|453055969|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
125934409|NCT00673465|453055970|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
125934410|NCT00673465|453055971|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934411|NCT00673465|453055972|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934412|NCT00673465|453055973|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934413|NCT00673465|453055974|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934414|NCT00673465|453055975|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934415|NCT00673465|453055976|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
125934416|NCT00673465|453055965|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934417|NCT00673465|453055966|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934418|NCT00673465|453055967|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934419|NCT00673465|453055968|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934420|NCT00673465|453055969|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
125934421|NCT00673465|453055970|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934422|NCT00673465|453055971|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934423|NCT00673465|453055972|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934424|NCT00673465|453055973|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934425|NCT00673465|453055974|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934426|NCT00673465|453055975|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934427|NCT00673465|453055976|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
125934428|NCT01829191|453055977|FG000|Overall Study|Relocation|0|||
125934429|NCT01829191|453055978|FG001|Overall Study|Relocation|1|||
125934430|NCT01829191|453055977|FG000|Overall Study|Lens discomfort|0|||
125934431|NCT01829191|453055978|FG001|Overall Study|Lens discomfort|3|||
125934432|NCT01829191|453055977|FG000|Overall Study|Lens handling difficulty|1|||
125934433|NCT01829191|453055978|FG001|Overall Study|Lens handling difficulty|4|||
125934434|NCT01829191|453055977|FG000|Overall Study|Protocol Violation|4|||
125934435|NCT01829191|453055978|FG001|Overall Study|Protocol Violation|1|||
125934436|NCT01829191|453055977|FG000|Overall Study|Withdrawal by Subject|2|||
125934437|NCT01829191|453055978|FG001|Overall Study|Withdrawal by Subject|3|||
125934438|NCT01829191|453055977|FG000|Overall Study|Lost to Follow-up|0|||
125934439|NCT01829191|453055978|FG001|Overall Study|Lost to Follow-up|1|||
125934440|NCT01829191|453055977|FG000|Overall Study|Subject was fit for ortho - k|0|||
125934441|NCT01829191|453055978|FG001|Overall Study|Subject was fit for ortho - k|1|||
125934442|NCT00429104|453055979|FG000|Overall Study|Protocol Violation|1|||
125934443|NCT01276353|453055980|FG000|Double-blind|Adverse Event|2|||
125934444|NCT01276353|453055981|FG001|Double-blind|Adverse Event|0|||
125934445|NCT01276353|453055980|FG000|Double-blind|Withdrawal by Subject|1|||
125934446|NCT01276353|453055981|FG001|Double-blind|Withdrawal by Subject|0|||
125934447|NCT01276353|453055980|FG000|Extension|Adverse Event|2|||
125934448|NCT01276353|453055981|FG001|Extension|Adverse Event|5|||
125934449|NCT01276353|453055980|FG000|Extension|Withdrawal by Subject|1|||
125934450|NCT01276353|453055981|FG001|Extension|Withdrawal by Subject|2|||
125934451|NCT01276353|453055980|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
125934452|NCT01276353|453055981|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
125934453|NCT01276353|453055980|FG000|Extension|Physician Decision|1|||
125934454|NCT01276353|453055981|FG001|Extension|Physician Decision|0|||
125934455|NCT01276353|453055980|FG000|Extension|Prohibited concomitant medications|0|||
125934456|NCT01276353|453055981|FG001|Extension|Prohibited concomitant medications|1|||
125934457|NCT01896531|453055983|FG000|Overall Study|Death|57|||
125934458|NCT01896531|453055984|FG001|Overall Study|Death|59|||
125934459|NCT01896531|453055983|FG000|Overall Study|Lost to Follow-up|3|||
125934460|NCT01896531|453055984|FG001|Overall Study|Lost to Follow-up|0|||
125934461|NCT01896531|453055983|FG000|Overall Study|Non-compliance|0|||
125934462|NCT01896531|453055984|FG001|Overall Study|Non-compliance|1|||
125934463|NCT01896531|453055983|FG000|Overall Study|Study Ended by Sponsor|7|||
125934464|NCT01896531|453055984|FG001|Overall Study|Study Ended by Sponsor|20|||
125934465|NCT01896531|453055983|FG000|Overall Study|Withdrawal by Subject|3|||
125934466|NCT01896531|453055984|FG001|Overall Study|Withdrawal by Subject|2|||
125934467|NCT01896531|453055983|FG000|Overall Study|Death Prior to Treatment|1|||
125934468|NCT01896531|453055984|FG001|Overall Study|Death Prior to Treatment|0|||
125934469|NCT01405742|453055988|FG000|Overall Study|Lost to Follow-up|1|||
125934470|NCT01405742|453055989|FG001|Overall Study|Lost to Follow-up|0|||
125934471|NCT03672747|453055991|FG000|Overall Study|Lost to Follow-up|1|||
125934472|NCT03672747|453055992|FG001|Overall Study|Lost to Follow-up|1|||
125934473|NCT03672747|453055993|FG002|Overall Study|Lost to Follow-up|2|||
125934474|NCT03672747|453055994|FG003|Overall Study|Lost to Follow-up|2|||
125934475|NCT03672747|453055995|FG004|Overall Study|Lost to Follow-up|2|||
125934476|NCT03672747|453055996|FG005|Overall Study|Lost to Follow-up|1|||
125934477|NCT03428360|453055997|FG000|Overall Study|Informed consent withdrawn|5|||
125934478|NCT03428360|453055997|FG000|Overall Study|Withdrawal by Subject|4|||
125934479|NCT03428360|453055997|FG000|Overall Study|Lost to Follow-up|5|||
125934480|NCT03428360|453055997|FG000|Overall Study|Physician Decision|2|||
125934481|NCT03428360|453055997|FG000|Overall Study|Informed consent withdrawn|5|||
125934482|NCT03428360|453055997|FG000|Overall Study|Study terminated by sponsor|10|||
125934483|NCT03428360|453055997|FG000|Overall Study|Non-compliant with study|1|||
125934484|NCT03428360|453055997|FG000|Overall Study|Non-compliant with study drug|3|||
125934485|NCT03428360|453055997|FG000|Overall Study|Death|3|||
125934486|NCT03428360|453055997|FG000|Overall Study|Adverse Event|1|||
125934487|NCT03428360|453055997|FG000|Overall Study|Not on antiepileptic drug|1|||
125934488|NCT04772755|453056003|FG000|Overall Study|Withdrawal by Subject|1|||
125934489|NCT04772755|453056004|FG001|Overall Study|Withdrawal by Subject|0|||
125934490|NCT04772755|453056003|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
125934491|NCT04772755|453056004|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
125934492|NCT01905657|453056005|FG000|Overall Study|Adverse Event|23|||
125934493|NCT01905657|453056006|FG001|Overall Study|Adverse Event|17|||
125934494|NCT01905657|453056007|FG002|Overall Study|Adverse Event|18|||
125934495|NCT01905657|453056005|FG000|Overall Study|Clinical Progression|103|||
125934496|NCT01905657|453056006|FG001|Overall Study|Clinical Progression|78|||
125934497|NCT01905657|453056007|FG002|Overall Study|Clinical Progression|59|||
125934498|NCT01905657|453056005|FG000|Overall Study|Death|40|||
125934499|NCT01905657|453056006|FG001|Overall Study|Death|43|||
125934500|NCT01905657|453056007|FG002|Overall Study|Death|47|||
125934501|NCT01905657|453056005|FG000|Overall Study|Excluded Medication|13|||
125934502|NCT01905657|453056006|FG001|Overall Study|Excluded Medication|16|||
125934503|NCT01905657|453056007|FG002|Overall Study|Excluded Medication|9|||
125934504|NCT01905657|453056005|FG000|Overall Study|Lost to Follow-up|1|||
125934505|NCT01905657|453056006|FG001|Overall Study|Lost to Follow-up|2|||
125934506|NCT01905657|453056007|FG002|Overall Study|Lost to Follow-up|1|||
125934507|NCT01905657|453056005|FG000|Overall Study|Physician Decision|5|||
125934508|NCT01905657|453056006|FG001|Overall Study|Physician Decision|8|||
125934509|NCT01905657|453056007|FG002|Overall Study|Physician Decision|12|||
125934510|NCT01905657|453056005|FG000|Overall Study|Protocol Violation|2|||
125934511|NCT01905657|453056006|FG001|Overall Study|Protocol Violation|1|||
126113907|NCT00295633|453712608|FG002|Overall Study|Lack of Efficacy|16|||
125934512|NCT01905657|453056007|FG002|Overall Study|Protocol Violation|1|||
125934513|NCT01905657|453056005|FG000|Overall Study|Screen Failure|0|||
125934514|NCT01905657|453056006|FG001|Overall Study|Screen Failure|1|||
125934515|NCT01905657|453056007|FG002|Overall Study|Screen Failure|0|||
125934516|NCT01905657|453056005|FG000|Overall Study|Withdrawal by Subject|15|||
125934517|NCT01905657|453056006|FG001|Overall Study|Withdrawal by Subject|21|||
125934518|NCT01905657|453056007|FG002|Overall Study|Withdrawal by Subject|53|||
125934519|NCT01905657|453056005|FG000|Overall Study|Sponsor Decision|1|||
125934520|NCT01905657|453056006|FG001|Overall Study|Sponsor Decision|0|||
125934521|NCT01905657|453056007|FG002|Overall Study|Sponsor Decision|0|||
125934522|NCT03032705|453056009|FG000|Overall Study|Lost to Follow-up|16|||
125934523|NCT03032705|453056010|FG001|Overall Study|Lost to Follow-up|17|||
125934524|NCT03032705|453056009|FG000|Overall Study|did not quality|6|||
125934525|NCT03032705|453056010|FG001|Overall Study|did not quality|6|||
125934526|NCT02825992|453057838|FG000|Overall Study|Withdrawal by Subject|4|||
125934527|NCT02825992|453057838|FG000|Overall Study|Lost to Follow-up|2|||
125934528|NCT02825992|453057838|FG000|Overall Study|Procedure terminated|2|||
125934529|NCT02279173|453057839|FG000|Overall Study|Protocol-specified Criteria|67|||
125934530|NCT02279173|453057839|FG000|Overall Study|Withdrawal by Subject|20|||
125934531|NCT02279173|453057839|FG000|Overall Study|Decision by Sponsor|4|||
125934532|NCT02279173|453057839|FG000|Overall Study|Lost to Follow-up|3|||
125934533|NCT00157950|453057840|FG000|Overall Study|Death|1|||
125934534|NCT00157950|453057841|FG001|Overall Study|Death|0|||
125934535|NCT00293254|453057842|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
125934536|NCT00293254|453057843|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
125934537|NCT00293254|453057842|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
125934538|NCT00293254|453057843|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
125934539|NCT00293254|453057842|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
125934540|NCT00293254|453057843|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
125934541|NCT00293254|453057842|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
125934542|NCT00293254|453057843|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
125934543|NCT00293254|453057842|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
125934544|NCT00293254|453057843|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
125934545|NCT00293254|453057842|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
125934546|NCT00293254|453057843|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
125934547|NCT00293254|453057842|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
125934548|NCT00293254|453057843|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
125934549|NCT00293254|453057842|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
125934550|NCT00293254|453057843|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
125934551|NCT00293254|453057842|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
125934552|NCT00293254|453057843|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
125934553|NCT00293254|453057842|FG000|Extension - Double-Blind Week 49-156|Death|4|||
125934554|NCT00293254|453057843|FG001|Extension - Double-Blind Week 49-156|Death|1|||
125934555|NCT00293254|453057842|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
125934556|NCT00293254|453057843|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
125934557|NCT00293254|453057842|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
125934558|NCT00293254|453057843|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
125934559|NCT00293254|453057842|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
125934560|NCT00293254|453057843|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
125934561|NCT00293254|453057842|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
125934562|NCT00293254|453057843|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
125934563|NCT00293254|453057842|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
125934564|NCT00293254|453057843|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
125934565|NCT00293254|453057842|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
125934566|NCT00293254|453057843|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
125934567|NCT00293254|453057842|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
125934568|NCT00293254|453057843|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
125934569|NCT00293254|453057842|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
125934570|NCT00293254|453057843|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
125934571|NCT00293254|453057842|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
125934572|NCT00293254|453057843|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
125934573|NCT00293254|453057842|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
125934574|NCT00293254|453057843|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
125934575|NCT00293254|453057842|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
125934576|NCT00293254|453057843|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
125934577|NCT00293254|453057842|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
125934578|NCT00293254|453057843|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
125934579|NCT00293254|453057842|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
125934580|NCT00293254|453057843|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
125934581|NCT00293254|453057842|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
125934582|NCT00293254|453057843|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
125934583|NCT00293254|453057842|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
125934584|NCT00293254|453057843|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
126066297|NCT02105688|453533526|FG000|Part A: Double-Blind|Status Unknown|0|||
125934585|NCT00293254|453057842|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
125934586|NCT00293254|453057843|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
125934587|NCT00293254|453057842|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
125934588|NCT00293254|453057843|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
125934589|NCT02335489|453057844|FG000|Overall Study|Sponsor terminated study|4|||
125934590|NCT02335489|453057844|FG000|Overall Study|Lost to Follow-up|1|||
125934591|NCT02335489|453057844|FG000|Overall Study|Withdrawal by Subject|2|||
125934592|NCT02335489|453057844|FG000|Overall Study|Physician Decision|2|||
125934593|NCT02335489|453057844|FG000|Overall Study|Lack of Efficacy|1|||
125934594|NCT02564042|453057845|FG000|Overall Study|Adverse Event|4|||
125934595|NCT02564042|453057846|FG001|Overall Study|Adverse Event|4|||
125934596|NCT02564042|453057847|FG002|Overall Study|Adverse Event|3|||
125934597|NCT02564042|453057848|FG003|Overall Study|Adverse Event|0|||
125934598|NCT02564042|453057849|FG004|Overall Study|Adverse Event|0|||
125934599|NCT02564042|453057850|FG005|Overall Study|Adverse Event|1|||
125934600|NCT02564042|453057845|FG000|Overall Study|Lost to Follow-up|1|||
125934601|NCT02564042|453057846|FG001|Overall Study|Lost to Follow-up|1|||
125934602|NCT02564042|453057847|FG002|Overall Study|Lost to Follow-up|1|||
125934603|NCT02564042|453057848|FG003|Overall Study|Lost to Follow-up|0|||
125934604|NCT02564042|453057849|FG004|Overall Study|Lost to Follow-up|1|||
125934605|NCT02564042|453057850|FG005|Overall Study|Lost to Follow-up|1|||
125934606|NCT02564042|453057845|FG000|Overall Study|Physician Decision|1|||
125934607|NCT02564042|453057846|FG001|Overall Study|Physician Decision|0|||
125934608|NCT02564042|453057847|FG002|Overall Study|Physician Decision|0|||
125934609|NCT02564042|453057848|FG003|Overall Study|Physician Decision|1|||
125934610|NCT02564042|453057849|FG004|Overall Study|Physician Decision|0|||
125934611|NCT02564042|453057850|FG005|Overall Study|Physician Decision|0|||
125934612|NCT02564042|453057845|FG000|Overall Study|Withdrawal by Subject|5|||
125934613|NCT02564042|453057846|FG001|Overall Study|Withdrawal by Subject|3|||
125934614|NCT02564042|453057847|FG002|Overall Study|Withdrawal by Subject|2|||
125934615|NCT02564042|453057848|FG003|Overall Study|Withdrawal by Subject|2|||
125934616|NCT02564042|453057849|FG004|Overall Study|Withdrawal by Subject|10|||
125934617|NCT02564042|453057850|FG005|Overall Study|Withdrawal by Subject|12|||
125934618|NCT01356966|453057851|FG000|Overall Study|Withdrawal by Subject|1|||
125934619|NCT01356966|453057852|FG001|Overall Study|Withdrawal by Subject|2|||
125934620|NCT01356966|453057851|FG000|Overall Study|Physician Decision|1|||
125934621|NCT01356966|453057852|FG001|Overall Study|Physician Decision|0|||
125934622|NCT01549392|453057853|FG000|Overall Study|Withdrawal by Subject|1|||
125934623|NCT01549392|453057854|FG001|Overall Study|Withdrawal by Subject|0|||
125934624|NCT02743806|453057855|FG000|Overall Study|Adverse Event|9|||
125934625|NCT02743806|453057855|FG000|Overall Study|Lost to Follow-up|8|||
125934626|NCT02743806|453057855|FG000|Overall Study|Voluntary Withdrawal|54|||
125934627|NCT02743806|453057855|FG000|Overall Study|Study Termination|65|||
125934628|NCT02743806|453057855|FG000|Overall Study|Pregnancy|6|||
125934629|NCT02743806|453057855|FG000|Overall Study|No Longer Clinically Benefiting|27|||
125934630|NCT02743806|453057855|FG000|Overall Study|Reason Not Specified|12|||
125934631|NCT04273217|453057857|FG000|Overall Study|Lost to Follow-up|0|||
125934632|NCT04273217|453057858|FG001|Overall Study|Lost to Follow-up|0|||
125934633|NCT04273217|453057859|FG002|Overall Study|Lost to Follow-up|0|||
125934634|NCT04273217|453057860|FG003|Overall Study|Lost to Follow-up|0|||
125934635|NCT04273217|453057861|FG004|Overall Study|Lost to Follow-up|0|||
125934636|NCT04273217|453057862|FG005|Overall Study|Lost to Follow-up|1|||
125934637|NCT04273217|453057857|FG000|Overall Study|Participant non-compliance|0|||
125934638|NCT04273217|453057858|FG001|Overall Study|Participant non-compliance|0|||
125934639|NCT04273217|453057859|FG002|Overall Study|Participant non-compliance|0|||
125934640|NCT04273217|453057860|FG003|Overall Study|Participant non-compliance|0|||
125934641|NCT04273217|453057861|FG004|Overall Study|Participant non-compliance|1|||
125934642|NCT04273217|453057862|FG005|Overall Study|Participant non-compliance|0|||
126113908|NCT00295633|453712606|FG000|Overall Study|Withdrawal of consent by subject|16|||
126113909|NCT00295633|453712607|FG001|Overall Study|Withdrawal of consent by subject|16|||
126113910|NCT00295633|453712608|FG002|Overall Study|Withdrawal of consent by subject|26|||
126113911|NCT00295633|453712606|FG000|Overall Study|Adverse Event|9|||
125934643|NCT04273217|453057857|FG000|Overall Study|Positive urine drug screen|1|||
125934644|NCT04273217|453057858|FG001|Overall Study|Positive urine drug screen|0|||
125934645|NCT04273217|453057859|FG002|Overall Study|Positive urine drug screen|1|||
125934646|NCT04273217|453057860|FG003|Overall Study|Positive urine drug screen|0|||
125934647|NCT04273217|453057861|FG004|Overall Study|Positive urine drug screen|0|||
125934648|NCT04273217|453057862|FG005|Overall Study|Positive urine drug screen|1|||
125934649|NCT00849381|453057863|FG000|Overall Study|Adverse Event|1|||
125934650|NCT00849381|453057863|FG000|Overall Study|Lost to Follow-up|129|||
126113912|NCT00295633|453712607|FG001|Overall Study|Adverse Event|17|||
125934651|NCT00849381|453057863|FG000|Overall Study|Protocol Violation|5|||
125934652|NCT00849381|453057863|FG000|Overall Study|Withdrawal by Subject|6|||
125934653|NCT00849381|453057863|FG000|Overall Study|Other|4|||
125934654|NCT00303498|453057864|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
125934655|NCT00303498|453057865|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
125934656|NCT00303498|453057864|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
125934657|NCT00303498|453057865|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
125934658|NCT00303498|453057864|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
125934659|NCT00303498|453057865|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
125934660|NCT00303498|453057864|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
125934661|NCT00303498|453057865|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
125934662|NCT00303498|453057864|FG000|Run-In-Phase (10 Weeks)|Other|4|||
125934663|NCT00303498|453057865|FG001|Run-In-Phase (10 Weeks)|Other|1|||
125934664|NCT00303498|453057864|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
125934665|NCT00303498|453057865|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
125934666|NCT00303498|453057864|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
125934667|NCT00303498|453057865|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
125934668|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
125934669|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
125934670|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Death|1|||
125934671|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Death|0|||
125934672|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
125934673|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
125934674|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
125934675|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
125934676|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
125934677|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
125934678|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
125934679|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
125934680|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Other|1|||
125934681|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Other|0|||
125934682|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
125934683|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
125934684|NCT00303498|453057864|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
125934685|NCT00303498|453057865|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
125934686|NCT02618434|453057867|FG000|Overall Study|Withdrawal by Subject|0|||
125934687|NCT02618434|453057868|FG001|Overall Study|Withdrawal by Subject|2|||
125934688|NCT02618434|453057869|FG002|Overall Study|Withdrawal by Subject|3|||
125934689|NCT02618434|453057867|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
125934690|NCT02618434|453057868|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
125934691|NCT02618434|453057869|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
125934692|NCT02618434|453057867|FG000|Overall Study|Lost to Follow-up|3|||
125934693|NCT02618434|453057868|FG001|Overall Study|Lost to Follow-up|1|||
125934694|NCT02618434|453057869|FG002|Overall Study|Lost to Follow-up|3|||
125934695|NCT02618434|453057867|FG000|Overall Study|Adverse Event|1|||
125934696|NCT02618434|453057868|FG001|Overall Study|Adverse Event|0|||
125934697|NCT02618434|453057869|FG002|Overall Study|Adverse Event|12|||
125934698|NCT02618434|453057867|FG000|Overall Study|Physician Decision|0|||
125934699|NCT02618434|453057868|FG001|Overall Study|Physician Decision|1|||
125934700|NCT02618434|453057869|FG002|Overall Study|Physician Decision|0|||
125934701|NCT02618434|453057867|FG000|Overall Study|Protocol Violation|0|||
125934702|NCT02618434|453057868|FG001|Overall Study|Protocol Violation|0|||
125934703|NCT02618434|453057869|FG002|Overall Study|Protocol Violation|1|||
125934704|NCT02618434|453057867|FG000|Overall Study|Other, Multiple categories|1|||
125934705|NCT02618434|453057868|FG001|Overall Study|Other, Multiple categories|1|||
125934706|NCT02618434|453057869|FG002|Overall Study|Other, Multiple categories|1|||
125934707|NCT01988103|453057874|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
125934708|NCT01988103|453057875|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
125934709|NCT01988103|453057876|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
125934710|NCT01988103|453057877|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
125934711|NCT01988103|453057878|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
125934712|NCT01988103|453057874|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
125934713|NCT01988103|453057875|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
125934714|NCT01988103|453057876|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
125934715|NCT01988103|453057877|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
125934716|NCT01988103|453057878|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
125934717|NCT01988103|453057874|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
125934718|NCT01988103|453057875|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
125934719|NCT01988103|453057876|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
125934720|NCT01988103|453057877|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
125934721|NCT01988103|453057878|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
125934722|NCT01988103|453057874|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
125934723|NCT01988103|453057875|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
125934724|NCT01988103|453057876|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
125934725|NCT01988103|453057877|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
125934726|NCT01988103|453057878|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
125934727|NCT01988103|453057874|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
125934728|NCT01988103|453057875|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
125934729|NCT01988103|453057876|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
125934730|NCT01988103|453057877|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
125934731|NCT01988103|453057878|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
125934732|NCT01988103|453057874|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
125934733|NCT01988103|453057875|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
125934734|NCT01988103|453057876|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
125934735|NCT01988103|453057877|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
125934736|NCT01988103|453057878|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
125934737|NCT01988103|453057874|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
125934738|NCT01988103|453057875|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
125934739|NCT01988103|453057876|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
125934740|NCT01988103|453057877|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
125934741|NCT01988103|453057878|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
125934742|NCT03590041|453057879|FG000|Overall Study|Protocol Violation|4|||
125934743|NCT03590041|453057880|FG001|Overall Study|Protocol Violation|3|||
125934744|NCT03590041|453057879|FG000|Overall Study|No session data recorded|14|||
125934745|NCT03590041|453057880|FG001|Overall Study|No session data recorded|2|||
125934746|NCT02289898|453057884|FG000|Overall Study|Death|5|||
125934747|NCT02289898|453057885|FG001|Overall Study|Death|4|||
125934748|NCT02289898|453057886|FG002|Overall Study|Death|3|||
125934749|NCT02289898|453057884|FG000|Overall Study|Physician Decision|2|||
125934750|NCT02289898|453057885|FG001|Overall Study|Physician Decision|5|||
125934751|NCT02289898|453057886|FG002|Overall Study|Physician Decision|2|||
125934752|NCT02289898|453057884|FG000|Overall Study|Withdrawal by Subject|0|||
125934753|NCT02289898|453057885|FG001|Overall Study|Withdrawal by Subject|4|||
125934754|NCT02289898|453057886|FG002|Overall Study|Withdrawal by Subject|1|||
125934755|NCT02289898|453057884|FG000|Overall Study|Adverse Event|3|||
125934756|NCT02289898|453057885|FG001|Overall Study|Adverse Event|5|||
125934757|NCT02289898|453057886|FG002|Overall Study|Adverse Event|5|||
125934758|NCT02289898|453057884|FG000|Overall Study|Disease progression|34|||
125934759|NCT02289898|453057885|FG001|Overall Study|Disease progression|28|||
125934760|NCT02289898|453057886|FG002|Overall Study|Disease progression|34|||
125934761|NCT02289898|453057884|FG000|Overall Study|Use of another anticancer therapy|0|||
125934762|NCT02289898|453057885|FG001|Overall Study|Use of another anticancer therapy|0|||
125934763|NCT02289898|453057886|FG002|Overall Study|Use of another anticancer therapy|1|||
125934764|NCT02289898|453057884|FG000|Overall Study|Other|8|||
125934765|NCT02289898|453057885|FG001|Overall Study|Other|7|||
125934766|NCT02289898|453057886|FG002|Overall Study|Other|10|||
125934767|NCT00103142|453057892|FG000|Overall Study|Adverse Event|1|||
125934768|NCT00103142|453057893|FG001|Overall Study|Adverse Event|0|||
125934769|NCT00103142|453057892|FG000|Overall Study|Progression of disease|2|||
125934770|NCT00103142|453057893|FG001|Overall Study|Progression of disease|1|||
125934771|NCT02598076|453057895|FG000|Overall Study|Lost to Follow-up|2|||
125934772|NCT02598076|453057896|FG001|Overall Study|Lost to Follow-up|3|||
125934773|NCT01946425|453057897|FG000|Overall Study|Protocol Violation|1|||
125934774|NCT01946425|453057898|FG001|Overall Study|Protocol Violation|0|||
125934775|NCT01946425|453057897|FG000|Overall Study|Withdrawal by Subject|1|||
125934776|NCT01946425|453057898|FG001|Overall Study|Withdrawal by Subject|0|||
125934777|NCT02956486|453057901|FG000|Core Phase|Adverse Event|51|||
125934778|NCT02956486|453057902|FG001|Core Phase|Adverse Event|88|||
125934779|NCT02956486|453057903|FG002|Core Phase|Adverse Event|0|||
125934780|NCT02956486|453057901|FG000|Core Phase|Lost to Follow-up|8|||
125934781|NCT02956486|453057902|FG001|Core Phase|Lost to Follow-up|6|||
125934782|NCT02956486|453057903|FG002|Core Phase|Lost to Follow-up|0|||
125934783|NCT02956486|453057901|FG000|Core Phase|Inadequate therapeutic effect|4|||
125934784|NCT02956486|453057902|FG001|Core Phase|Inadequate therapeutic effect|5|||
125934785|NCT02956486|453057903|FG002|Core Phase|Inadequate therapeutic effect|0|||
125934786|NCT02956486|453057901|FG000|Core Phase|Withdrawal by Subject|101|||
125934787|NCT02956486|453057902|FG001|Core Phase|Withdrawal by Subject|104|||
125934788|NCT02956486|453057903|FG002|Core Phase|Withdrawal by Subject|0|||
125934789|NCT02956486|453057901|FG000|Core Phase|Study terminated by sponsor|888|||
125934790|NCT02956486|453057902|FG001|Core Phase|Study terminated by sponsor|848|||
125934791|NCT02956486|453057903|FG002|Core Phase|Study terminated by sponsor|0|||
125934792|NCT02956486|453057901|FG000|Core Phase|Other|27|||
125934793|NCT02956486|453057902|FG001|Core Phase|Other|18|||
125934794|NCT02956486|453057903|FG002|Core Phase|Other|0|||
125934795|NCT02956486|453057901|FG000|Core Phase|Not treated|0|||
125934796|NCT02956486|453057902|FG001|Core Phase|Not treated|3|||
125934797|NCT02956486|453057903|FG002|Core Phase|Not treated|0|||
125934798|NCT02956486|453057901|FG000|Extension Phase|Adverse Event|0|||
125934799|NCT02956486|453057902|FG001|Extension Phase|Adverse Event|0|||
125934800|NCT02956486|453057903|FG002|Extension Phase|Adverse Event|2|||
125934801|NCT02956486|453057901|FG000|Extension Phase|Study terminated by sponsor|0|||
126113913|NCT00295633|453712608|FG002|Overall Study|Adverse Event|9|||
125934802|NCT02956486|453057902|FG001|Extension Phase|Study terminated by sponsor|0|||
125934803|NCT02956486|453057903|FG002|Extension Phase|Study terminated by sponsor|16|||
125934804|NCT02956486|453057901|FG000|Extension Phase|Not Treated|0|||
125934805|NCT02956486|453057902|FG001|Extension Phase|Not Treated|0|||
125934806|NCT02956486|453057903|FG002|Extension Phase|Not Treated|1|||
125934807|NCT00422591|453057904|FG000|Overall Study|Physician Decision|4|||
125934808|NCT00422591|453057904|FG000|Overall Study|Withdrawal by Subject|2|||
125934809|NCT02659631|453057905|FG000|Overall Study|Lost to Follow-up|0|||
125934810|NCT02659631|453057906|FG001|Overall Study|Lost to Follow-up|0|||
125934811|NCT02659631|453057907|FG002|Overall Study|Lost to Follow-up|2|||
125934812|NCT02659631|453057908|FG003|Overall Study|Lost to Follow-up|0|||
125934813|NCT02659631|453057909|FG004|Overall Study|Lost to Follow-up|0|||
125934814|NCT02659631|453057910|FG005|Overall Study|Lost to Follow-up|1|||
125934815|NCT02659631|453057911|FG006|Overall Study|Lost to Follow-up|0|||
125934816|NCT02659631|453057912|FG007|Overall Study|Lost to Follow-up|0|||
125934817|NCT02659631|453057913|FG008|Overall Study|Lost to Follow-up|0|||
125934818|NCT02659631|453057914|FG009|Overall Study|Lost to Follow-up|0|||
125934819|NCT02659631|453057905|FG000|Overall Study|Withdrawal prior to treatment|0|||
125934820|NCT02659631|453057906|FG001|Overall Study|Withdrawal prior to treatment|0|||
125934821|NCT02659631|453057907|FG002|Overall Study|Withdrawal prior to treatment|0|||
125934822|NCT02659631|453057908|FG003|Overall Study|Withdrawal prior to treatment|0|||
125934823|NCT02659631|453057909|FG004|Overall Study|Withdrawal prior to treatment|1|||
125934824|NCT02659631|453057910|FG005|Overall Study|Withdrawal prior to treatment|0|||
125934825|NCT02659631|453057911|FG006|Overall Study|Withdrawal prior to treatment|0|||
125934826|NCT02659631|453057912|FG007|Overall Study|Withdrawal prior to treatment|0|||
125934827|NCT02659631|453057913|FG008|Overall Study|Withdrawal prior to treatment|0|||
125934828|NCT02659631|453057914|FG009|Overall Study|Withdrawal prior to treatment|0|||
125934829|NCT02659631|453057905|FG000|Overall Study|Participant refused further follow-up|0|||
125934830|NCT02659631|453057906|FG001|Overall Study|Participant refused further follow-up|0|||
125934831|NCT02659631|453057907|FG002|Overall Study|Participant refused further follow-up|0|||
125934832|NCT02659631|453057908|FG003|Overall Study|Participant refused further follow-up|1|||
125934833|NCT02659631|453057909|FG004|Overall Study|Participant refused further follow-up|0|||
125934834|NCT02659631|453057910|FG005|Overall Study|Participant refused further follow-up|0|||
125934835|NCT02659631|453057911|FG006|Overall Study|Participant refused further follow-up|0|||
125934836|NCT02659631|453057912|FG007|Overall Study|Participant refused further follow-up|0|||
125934837|NCT02659631|453057913|FG008|Overall Study|Participant refused further follow-up|1|||
125934838|NCT02659631|453057914|FG009|Overall Study|Participant refused further follow-up|0|||
125934839|NCT02659631|453057905|FG000|Overall Study|Death (follow-up phase)|1|||
125934840|NCT02659631|453057906|FG001|Overall Study|Death (follow-up phase)|2|||
125934841|NCT02659631|453057907|FG002|Overall Study|Death (follow-up phase)|1|||
125934842|NCT02659631|453057908|FG003|Overall Study|Death (follow-up phase)|1|||
125934843|NCT02659631|453057909|FG004|Overall Study|Death (follow-up phase)|3|||
125934844|NCT02659631|453057910|FG005|Overall Study|Death (follow-up phase)|2|||
125934845|NCT02659631|453057911|FG006|Overall Study|Death (follow-up phase)|0|||
125934846|NCT02659631|453057912|FG007|Overall Study|Death (follow-up phase)|3|||
125934847|NCT02659631|453057913|FG008|Overall Study|Death (follow-up phase)|1|||
125934848|NCT02659631|453057914|FG009|Overall Study|Death (follow-up phase)|0|||
125934849|NCT02659631|453057905|FG000|Overall Study|Death (treatment phase)|0|||
125934850|NCT02659631|453057906|FG001|Overall Study|Death (treatment phase)|0|||
125934851|NCT02659631|453057907|FG002|Overall Study|Death (treatment phase)|0|||
125934852|NCT02659631|453057908|FG003|Overall Study|Death (treatment phase)|0|||
125934853|NCT02659631|453057909|FG004|Overall Study|Death (treatment phase)|1|||
125934854|NCT02659631|453057910|FG005|Overall Study|Death (treatment phase)|0|||
125934855|NCT02659631|453057911|FG006|Overall Study|Death (treatment phase)|1|||
125934856|NCT02659631|453057912|FG007|Overall Study|Death (treatment phase)|0|||
125934857|NCT02659631|453057913|FG008|Overall Study|Death (treatment phase)|0|||
125934858|NCT02659631|453057914|FG009|Overall Study|Death (treatment phase)|0|||
125934859|NCT02377466|453057915|FG000|Overall Study|Other: Randomized and not treated|0|||
125934860|NCT02377466|453057916|FG001|Overall Study|Other: Randomized and not treated|2|||
125934861|NCT02485574|453057925|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
125934862|NCT00563381|453057933|FG000|Overall Study|Adverse Event|264|||
125934863|NCT00563381|453057934|FG001|Overall Study|Adverse Event|292|||
125934864|NCT00563381|453057933|FG000|Overall Study|Protocol Violation|66|||
125934865|NCT00563381|453057934|FG001|Overall Study|Protocol Violation|74|||
125934866|NCT00563381|453057933|FG000|Overall Study|Lost to Follow-up|7|||
125934867|NCT00563381|453057934|FG001|Overall Study|Lost to Follow-up|15|||
125934868|NCT00563381|453057933|FG000|Overall Study|Withdrawal by Subject|192|||
125934869|NCT00563381|453057934|FG001|Overall Study|Withdrawal by Subject|209|||
125934870|NCT00563381|453057933|FG000|Overall Study|Lack of Efficacy|32|||
125934871|NCT00563381|453057934|FG001|Overall Study|Lack of Efficacy|24|||
125934872|NCT00563381|453057933|FG000|Overall Study|Individual different reasons|24|||
125934873|NCT00563381|453057934|FG001|Overall Study|Individual different reasons|34|||
125934874|NCT00110149|453057935|FG000|Overall Study|Physician Decision|3|||
125934875|NCT00667368|453057938|FG000|Overall Study|Lost to Follow-up|176|||
125934876|NCT00667368|453057939|FG001|Overall Study|Lost to Follow-up|155|||
125934877|NCT00667368|453057938|FG000|Overall Study|Discontinued early|24|||
125934878|NCT00667368|453057939|FG001|Overall Study|Discontinued early|17|||
125934879|NCT01957553|453057942|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
125934880|NCT01957553|453057943|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
125934881|NCT01957553|453057942|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
125934882|NCT01957553|453057943|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
125934883|NCT01957553|453057942|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
125934884|NCT01957553|453057943|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
125934885|NCT01957553|453057942|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
125934886|NCT01957553|453057943|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
125934887|NCT01957553|453057942|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
125934888|NCT01957553|453057943|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
125934889|NCT01957553|453057942|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
125934890|NCT01957553|453057943|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
125934891|NCT01957553|453057942|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
125934892|NCT01957553|453057943|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
125934893|NCT01957553|453057942|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
125934894|NCT01957553|453057943|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
125934895|NCT01957553|453057942|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
125934896|NCT01957553|453057943|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
125934897|NCT00732615|453057944|FG000|Overall Study|Withdrawal by Subject|3|||
125934898|NCT00732615|453057945|FG001|Overall Study|Withdrawal by Subject|1|||
125934899|NCT00732615|453057944|FG000|Overall Study|Lost to Follow-up|0|||
125934900|NCT00732615|453057945|FG001|Overall Study|Lost to Follow-up|1|||
125934901|NCT00732615|453057944|FG000|Overall Study|Adverse Event|0|||
125934902|NCT00732615|453057945|FG001|Overall Study|Adverse Event|2|||
125934903|NCT00732615|453057944|FG000|Overall Study|Physician Decision|3|||
125934904|NCT00732615|453057945|FG001|Overall Study|Physician Decision|0|||
125934905|NCT00732615|453057944|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
125934906|NCT00732615|453057945|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
125934907|NCT01333059|453057948|FG000|Overall Study|Physician Decision|3|||
125934908|NCT01333059|453057949|FG001|Overall Study|Physician Decision|3|||
125934909|NCT01333059|453057948|FG000|Overall Study|Protocol Violation|3|||
125934910|NCT01333059|453057949|FG001|Overall Study|Protocol Violation|0|||
125934911|NCT03566823|453057950|FG000|Overall Study|Lack of Efficacy|0|||
125934912|NCT03566823|453057951|FG001|Overall Study|Lack of Efficacy|1|||
125934913|NCT03566823|453057952|FG002|Overall Study|Lack of Efficacy|0|||
125934914|NCT03566823|453057950|FG000|Overall Study|Withdrawal by Subject|1|||
125934915|NCT03566823|453057951|FG001|Overall Study|Withdrawal by Subject|2|||
125934916|NCT03566823|453057952|FG002|Overall Study|Withdrawal by Subject|0|||
125934917|NCT03566823|453057950|FG000|Overall Study|Adverse Event|1|||
125934918|NCT03566823|453057951|FG001|Overall Study|Adverse Event|0|||
125934919|NCT03566823|453057952|FG002|Overall Study|Adverse Event|2|||
125934920|NCT02733367|453057953|FG000|Overall Study|Withdrawal by Subject|6|||
125934921|NCT01348347|453057954|FG000|Overall Study|Withdrawal by Subject|1|||
125934922|NCT01348347|453057955|FG001|Overall Study|Withdrawal by Subject|1|||
125934923|NCT01348347|453057956|FG002|Overall Study|Withdrawal by Subject|1|||
125934924|NCT01348347|453057954|FG000|Overall Study|Progressive disease|2|||
125934925|NCT01348347|453057955|FG001|Overall Study|Progressive disease|5|||
125934926|NCT01348347|453057956|FG002|Overall Study|Progressive disease|5|||
125934927|NCT00748033|453057960|FG000|Overall Study|Adverse Event|0|||
125934928|NCT00748033|453057961|FG001|Overall Study|Adverse Event|1|||
125934929|NCT00191789|453057962|FG000|Overall Study|Adverse Event|5|||
125934930|NCT00191789|453057962|FG000|Overall Study|Patient: Satisfactory Response|5|||
125934931|NCT00191789|453057962|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
125934932|NCT00191789|453057962|FG000|Overall Study|Withdrawal by Subject|4|||
125934933|NCT00191789|453057962|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
125934934|NCT00191789|453057962|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
125934935|NCT00191789|453057962|FG000|Overall Study|Death - Not Study-Drug Related|1|||
125934936|NCT03241342|453057968|FG000|Overall Study|Adverse Event|5|||
125934937|NCT03241342|453057969|FG001|Overall Study|Adverse Event|8|||
125934938|NCT03241342|453057970|FG002|Overall Study|Adverse Event|4|||
125934939|NCT03241342|453057968|FG000|Overall Study|Lack of Efficacy|0|||
125934940|NCT03241342|453057969|FG001|Overall Study|Lack of Efficacy|0|||
125934941|NCT03241342|453057970|FG002|Overall Study|Lack of Efficacy|1|||
125934942|NCT03241342|453057968|FG000|Overall Study|noncompliance with study drug|2|||
125934943|NCT03241342|453057969|FG001|Overall Study|noncompliance with study drug|1|||
125934944|NCT03241342|453057970|FG002|Overall Study|noncompliance with study drug|1|||
125934945|NCT03241342|453057968|FG000|Overall Study|sponsor decision|0|||
125934946|NCT03241342|453057969|FG001|Overall Study|sponsor decision|1|||
125934947|NCT03241342|453057970|FG002|Overall Study|sponsor decision|2|||
125934948|NCT03241342|453057968|FG000|Overall Study|not reported|15|||
125934949|NCT03241342|453057969|FG001|Overall Study|not reported|21|||
125934950|NCT03241342|453057970|FG002|Overall Study|not reported|19|||
125934951|NCT01846611|453057971|FG000|Overall Study|Lost to Follow-up|4|||
125934952|NCT01846611|453057972|FG001|Overall Study|Lost to Follow-up|6|||
125934953|NCT01846611|453057971|FG000|Overall Study|Withdrawal by Subject|15|||
125934954|NCT01846611|453057972|FG001|Overall Study|Withdrawal by Subject|19|||
125934955|NCT01846611|453057971|FG000|Overall Study|Other|19|||
125934956|NCT01846611|453057972|FG001|Overall Study|Other|18|||
125934957|NCT02671422|453057976|FG000|Overall Study|Lost to Follow-up|1|||
125934958|NCT02671422|453057976|FG000|Overall Study|Adverse Event|68|||
125934959|NCT02671422|453057976|FG000|Overall Study|Lack of Efficacy|1|||
125934960|NCT02671422|453057976|FG000|Overall Study|Lost to Follow-up|4|||
125934961|NCT02671422|453057976|FG000|Overall Study|Withdrawal by Subject|7|||
125934962|NCT02671422|453057976|FG000|Overall Study|Progressive Disease|156|||
125934963|NCT02671422|453057976|FG000|Overall Study|Worsening of Disease|4|||
125934964|NCT02671422|453057976|FG000|Overall Study|Sponsor decision|5|||
125934965|NCT02671422|453057976|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
125934966|NCT02671422|453057976|FG000|Overall Study|Not treated with Vargatef®|3|||
125934967|NCT02671422|453057976|FG000|Overall Study|Other not defined above|3|||
125934968|NCT04702997|453057977|FG000|Overall Study|Withdrawal by Subject|1|||
125934969|NCT04702997|453057978|FG001|Overall Study|Withdrawal by Subject|1|||
125934970|NCT03915496|453057979|FG000|Overall Study|Adverse Event|2|||
125934971|NCT03915496|453057980|FG001|Overall Study|Adverse Event|1|||
125934972|NCT03915496|453057981|FG002|Overall Study|Adverse Event|2|||
125934973|NCT00001596|453059499|FG000|Overall Study|Death|1|||
125934974|NCT00001596|453059500|FG001|Overall Study|Death|0|||
125934975|NCT00001596|453059499|FG000|Overall Study|Withdrawal by Subject|3|||
125934976|NCT00001596|453059500|FG001|Overall Study|Withdrawal by Subject|1|||
125934977|NCT00001596|453059499|FG000|Overall Study|Study Termination|12|||
125934978|NCT00001596|453059500|FG001|Overall Study|Study Termination|9|||
125934979|NCT00001596|453059499|FG000|Overall Study|Adverse Event|1|||
125934980|NCT00001596|453059500|FG001|Overall Study|Adverse Event|0|||
125934981|NCT00180414|453059506|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
125934982|NCT00180414|453059507|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
125934983|NCT02927080|453059508|FG000|Overall Study|Withdrawal by Subject|0|||
125934984|NCT02927080|453059509|FG001|Overall Study|Withdrawal by Subject|0|||
125934985|NCT02927080|453059510|FG002|Overall Study|Withdrawal by Subject|0|||
125934986|NCT02927080|453059511|FG003|Overall Study|Withdrawal by Subject|0|||
125934987|NCT02927080|453059512|FG004|Overall Study|Withdrawal by Subject|1|||
125934988|NCT02927080|453059513|FG005|Overall Study|Withdrawal by Subject|0|||
125934989|NCT02927080|453059514|FG006|Overall Study|Withdrawal by Subject|1|||
125934990|NCT02927080|453059515|FG007|Overall Study|Withdrawal by Subject|1|||
125934991|NCT02927080|453059516|FG008|Overall Study|Withdrawal by Subject|0|||
125934992|NCT02927080|453059517|FG009|Overall Study|Withdrawal by Subject|2|||
125934993|NCT02927080|453059508|FG000|Overall Study|Willingness to comply with protocol|0|||
125934994|NCT02927080|453059509|FG001|Overall Study|Willingness to comply with protocol|0|||
125934995|NCT02927080|453059510|FG002|Overall Study|Willingness to comply with protocol|0|||
125934996|NCT02927080|453059511|FG003|Overall Study|Willingness to comply with protocol|0|||
125934997|NCT02927080|453059512|FG004|Overall Study|Willingness to comply with protocol|0|||
125934998|NCT02927080|453059513|FG005|Overall Study|Willingness to comply with protocol|0|||
125934999|NCT02927080|453059514|FG006|Overall Study|Willingness to comply with protocol|0|||
125935000|NCT02927080|453059515|FG007|Overall Study|Willingness to comply with protocol|0|||
125935001|NCT02927080|453059516|FG008|Overall Study|Willingness to comply with protocol|0|||
125935002|NCT02927080|453059517|FG009|Overall Study|Willingness to comply with protocol|1|||
125935003|NCT02927080|453059508|FG000|Overall Study|Study terminated by Sponsor|0|||
125935004|NCT02927080|453059509|FG001|Overall Study|Study terminated by Sponsor|0|||
125935005|NCT02927080|453059510|FG002|Overall Study|Study terminated by Sponsor|0|||
125935006|NCT02927080|453059511|FG003|Overall Study|Study terminated by Sponsor|0|||
125935007|NCT02927080|453059512|FG004|Overall Study|Study terminated by Sponsor|0|||
125935008|NCT02927080|453059513|FG005|Overall Study|Study terminated by Sponsor|0|||
125935009|NCT02927080|453059514|FG006|Overall Study|Study terminated by Sponsor|6|||
125935010|NCT02927080|453059515|FG007|Overall Study|Study terminated by Sponsor|7|||
126066298|NCT02105688|453533527|FG001|Part A: Double-Blind|Status Unknown|2|||
126066299|NCT02105688|453533526|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
126066300|NCT02105688|453533527|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
126066301|NCT02105688|453533526|FG000|Part B: Observational Follow-up|Death|2|||
125935011|NCT02927080|453059516|FG008|Overall Study|Study terminated by Sponsor|2|||
125935012|NCT02927080|453059517|FG009|Overall Study|Study terminated by Sponsor|3|||
125935013|NCT02927080|453059508|FG000|Overall Study|Adverse Event|0|||
125935014|NCT02927080|453059509|FG001|Overall Study|Adverse Event|1|||
126066302|NCT02105688|453533527|FG001|Part B: Observational Follow-up|Death|1|||
125935015|NCT02927080|453059510|FG002|Overall Study|Adverse Event|0|||
125935016|NCT02927080|453059511|FG003|Overall Study|Adverse Event|0|||
125935017|NCT02927080|453059512|FG004|Overall Study|Adverse Event|0|||
125935018|NCT02927080|453059513|FG005|Overall Study|Adverse Event|0|||
125935019|NCT02927080|453059514|FG006|Overall Study|Adverse Event|0|||
125935020|NCT02927080|453059515|FG007|Overall Study|Adverse Event|1|||
126066303|NCT02105688|453533526|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
126113914|NCT00295633|453712606|FG000|Overall Study|Lost to Follow-up|6|||
126113915|NCT00295633|453712607|FG001|Overall Study|Lost to Follow-up|11|||
126113916|NCT00295633|453712608|FG002|Overall Study|Lost to Follow-up|7|||
126113917|NCT00295633|453712606|FG000|Overall Study|Physician Decision|9|||
126113918|NCT00295633|453712607|FG001|Overall Study|Physician Decision|10|||
126113919|NCT00295633|453712608|FG002|Overall Study|Physician Decision|8|||
126113920|NCT00295633|453712606|FG000|Overall Study|Poor/Noncompliance|2|||
126113921|NCT00295633|453712607|FG001|Overall Study|Poor/Noncompliance|2|||
126113922|NCT00295633|453712608|FG002|Overall Study|Poor/Noncompliance|6|||
126113923|NCT00295633|453712606|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
126113924|NCT00295633|453712607|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
126113925|NCT00295633|453712608|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
126113926|NCT00295633|453712606|FG000|Overall Study|Death|1|||
126113927|NCT00295633|453712607|FG001|Overall Study|Death|1|||
125935021|NCT02927080|453059516|FG008|Overall Study|Adverse Event|0|||
125935022|NCT02927080|453059517|FG009|Overall Study|Adverse Event|1|||
125935023|NCT02927080|453059508|FG000|Overall Study|Other|0|||
125935024|NCT02927080|453059509|FG001|Overall Study|Other|0|||
125935025|NCT02927080|453059510|FG002|Overall Study|Other|0|||
125935026|NCT02927080|453059511|FG003|Overall Study|Other|0|||
125935027|NCT02927080|453059512|FG004|Overall Study|Other|0|||
125935028|NCT02927080|453059513|FG005|Overall Study|Other|0|||
125935029|NCT02927080|453059514|FG006|Overall Study|Other|1|||
125935030|NCT02927080|453059515|FG007|Overall Study|Other|0|||
125935031|NCT02927080|453059516|FG008|Overall Study|Other|1|||
125935032|NCT02927080|453059517|FG009|Overall Study|Other|0|||
125935033|NCT01199289|453059518|FG000|Overall Study|Ineligibility determined|2|||
125935034|NCT01199289|453059519|FG001|Overall Study|Ineligibility determined|1|||
125935035|NCT01199289|453059520|FG002|Overall Study|Ineligibility determined|0|||
126066304|NCT02105688|453533527|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
126066305|NCT02105688|453533526|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
126066306|NCT02105688|453533527|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
126066307|NCT02105688|453533526|FG000|Part B: Observational Follow-up|Physician Decision|3|||
126066308|NCT02105688|453533527|FG001|Part B: Observational Follow-up|Physician Decision|1|||
126066309|NCT01757171|453533531|FG000|Overall Study|Adverse Event|5|||
126066310|NCT01757171|453533532|FG001|Overall Study|Adverse Event|1|||
126066311|NCT01757171|453533531|FG000|Overall Study|Disease Progression|1|||
126066312|NCT01757171|453533532|FG001|Overall Study|Disease Progression|0|||
126066313|NCT01757171|453533531|FG000|Overall Study|Hospitalization|1|||
126066314|NCT01757171|453533532|FG001|Overall Study|Hospitalization|0|||
126066315|NCT01757171|453533531|FG000|Overall Study|ECOG decline|1|||
126066316|NCT01757171|453533532|FG001|Overall Study|ECOG decline|0|||
126066317|NCT00512902|453533534|FG000|Overall Study|Adverse Event|7|||
126066318|NCT00512902|453533534|FG000|Overall Study|Lost to Follow-up|1|||
126066319|NCT03019289|453533535|FG000|Overall Study|Adverse Event|1|||
126066320|NCT03019289|453533536|FG001|Overall Study|Adverse Event|0|||
126066321|NCT03019289|453533537|FG002|Overall Study|Adverse Event|0|||
126066322|NCT03019289|453533538|FG003|Overall Study|Adverse Event|0|||
126066323|NCT03019289|453533539|FG004|Overall Study|Adverse Event|0|||
126066324|NCT03019289|453533540|FG005|Overall Study|Adverse Event|0|||
126066325|NCT03019289|453533541|FG006|Overall Study|Adverse Event|0|||
126066326|NCT03019289|453533542|FG007|Overall Study|Adverse Event|0|||
126066327|NCT03019289|453533543|FG008|Overall Study|Adverse Event|1|||
126066328|NCT03019289|453533535|FG000|Overall Study|Other|1|||
126066329|NCT03019289|453533536|FG001|Overall Study|Other|0|||
126066330|NCT03019289|453533537|FG002|Overall Study|Other|0|||
126066331|NCT03019289|453533538|FG003|Overall Study|Other|0|||
126066332|NCT03019289|453533539|FG004|Overall Study|Other|0|||
126066333|NCT03019289|453533540|FG005|Overall Study|Other|0|||
126066334|NCT03019289|453533541|FG006|Overall Study|Other|0|||
126066335|NCT03019289|453533542|FG007|Overall Study|Other|0|||
126066336|NCT03019289|453533543|FG008|Overall Study|Other|0|||
126066337|NCT00070317|453533546|FG000|Overall Study|Inevaluable (Never Treated)|1|||
126066338|NCT00070317|453533546|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
126066339|NCT00070317|453533546|FG000|Overall Study|Ineligible required test not done|1|||
126066340|NCT00070317|453533546|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
126066341|NCT00070317|453533546|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
126066342|NCT01429285|453533547|FG000|Overall Study|Protocol Violation|9|||
126066343|NCT01429285|453533548|FG001|Overall Study|Protocol Violation|4|||
126113928|NCT00295633|453712608|FG002|Overall Study|Death|0|||
126113929|NCT00295633|453712606|FG000|Overall Study|Administrative reason by sponsor|0|||
125935036|NCT01199289|453059521|FG003|Overall Study|Ineligibility determined|0|||
126066344|NCT01429285|453533547|FG000|Overall Study|Missing Data|5|||
126066345|NCT01429285|453533548|FG001|Overall Study|Missing Data|3|||
126066346|NCT01429285|453533547|FG000|Overall Study|Erroneously Enrolled Twice|8|||
126066347|NCT01429285|453533548|FG001|Overall Study|Erroneously Enrolled Twice|2|||
125935037|NCT01199289|453059518|FG000|Overall Study|Protocol Violation|1|||
125935038|NCT01199289|453059519|FG001|Overall Study|Protocol Violation|0|||
125935039|NCT01199289|453059520|FG002|Overall Study|Protocol Violation|0|||
125935040|NCT01199289|453059521|FG003|Overall Study|Protocol Violation|1|||
125935041|NCT01199289|453059518|FG000|Overall Study|Noncompliance|1|||
125935042|NCT01199289|453059519|FG001|Overall Study|Noncompliance|0|||
125935043|NCT01199289|453059520|FG002|Overall Study|Noncompliance|2|||
125935044|NCT01199289|453059521|FG003|Overall Study|Noncompliance|0|||
125935045|NCT01199289|453059518|FG000|Overall Study|Adverse Event|0|||
125935046|NCT01199289|453059519|FG001|Overall Study|Adverse Event|3|||
125935047|NCT01199289|453059520|FG002|Overall Study|Adverse Event|1|||
125935048|NCT01199289|453059521|FG003|Overall Study|Adverse Event|4|||
125935049|NCT01199289|453059518|FG000|Overall Study|Full consent withdrawn|2|||
125935050|NCT01199289|453059519|FG001|Overall Study|Full consent withdrawn|2|||
125935051|NCT01199289|453059520|FG002|Overall Study|Full consent withdrawn|2|||
125935052|NCT01199289|453059521|FG003|Overall Study|Full consent withdrawn|3|||
125935053|NCT01199289|453059518|FG000|Overall Study|Administrative decision|0|||
125935054|NCT01199289|453059519|FG001|Overall Study|Administrative decision|0|||
125935055|NCT01199289|453059520|FG002|Overall Study|Administrative decision|0|||
125935056|NCT01199289|453059521|FG003|Overall Study|Administrative decision|1|||
125935057|NCT01199289|453059518|FG000|Overall Study|Lost to Follow-up|0|||
125935058|NCT01199289|453059519|FG001|Overall Study|Lost to Follow-up|0|||
125935059|NCT01199289|453059520|FG002|Overall Study|Lost to Follow-up|0|||
125935060|NCT01199289|453059521|FG003|Overall Study|Lost to Follow-up|1|||
125935061|NCT01199289|453059518|FG000|Overall Study|Protocol-specified criteria|3|||
125935062|NCT01199289|453059519|FG001|Overall Study|Protocol-specified criteria|0|||
125935063|NCT01199289|453059520|FG002|Overall Study|Protocol-specified criteria|0|||
125935064|NCT01199289|453059521|FG003|Overall Study|Protocol-specified criteria|1|||
125935065|NCT01199289|453059518|FG000|Overall Study|Pregnancy|0|||
125935066|NCT01199289|453059519|FG001|Overall Study|Pregnancy|1|||
125935067|NCT01199289|453059520|FG002|Overall Study|Pregnancy|0|||
125935068|NCT01199289|453059521|FG003|Overall Study|Pregnancy|1|||
125935069|NCT00127712|453059525|FG000|Overall Study|Adverse Event|3|||
125935070|NCT00127712|453059526|FG001|Overall Study|Adverse Event|0|||
125935071|NCT00127712|453059525|FG000|Overall Study|Lack of GI access to continue|2|||
125935072|NCT00127712|453059526|FG001|Overall Study|Lack of GI access to continue|0|||
125935073|NCT00759863|453059527|FG000|Overall Study|Death, moved, or lost contact|20|||
125935074|NCT00759863|453059528|FG001|Overall Study|Death, moved, or lost contact|18|||
125935075|NCT00503308|453059532|FG000|Overall Study|Protocol Violation|2|||
125935076|NCT00503308|453059533|FG001|Overall Study|Protocol Violation|1|||
125935077|NCT00311623|453059540|FG000|Overall Study|Physician Decision|0|||
125935078|NCT00311623|453059541|FG001|Overall Study|Physician Decision|0|||
125935079|NCT00311623|453059542|FG002|Overall Study|Physician Decision|2|||
125935080|NCT03998189|453059543|FG000|Overall Study|Lack of Efficacy|0|||
125935081|NCT03998189|453059544|FG001|Overall Study|Lack of Efficacy|1|||
125935082|NCT03227029|453059545|FG000|Overall Study|Child Wheezed (no treatment)|0|||
125935083|NCT03227029|453059546|FG001|Overall Study|Child Wheezed (no treatment)|1|||
125935084|NCT03227029|453059547|FG002|Overall Study|Child Wheezed (no treatment)|0|||
125935085|NCT03227029|453059545|FG000|Overall Study|No post RSV season visit due to COVID|3|||
125935086|NCT03227029|453059546|FG001|Overall Study|No post RSV season visit due to COVID|3|||
125935087|NCT03227029|453059547|FG002|Overall Study|No post RSV season visit due to COVID|2|||
125935088|NCT03227029|453059545|FG000|Overall Study|Not able to get to clinic|0|||
125935089|NCT03227029|453059546|FG001|Overall Study|Not able to get to clinic|0|||
125935090|NCT03227029|453059547|FG002|Overall Study|Not able to get to clinic|1|||
125935091|NCT03227029|453059545|FG000|Overall Study|Withdrawal by Subject|1|||
125935092|NCT03227029|453059546|FG001|Overall Study|Withdrawal by Subject|0|||
125935093|NCT03227029|453059547|FG002|Overall Study|Withdrawal by Subject|0|||
125935094|NCT03227029|453059545|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
125935095|NCT03227029|453059546|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
125935096|NCT03227029|453059547|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
125935097|NCT03414424|453059548|FG000|Overall Study|Screened out after consent|0|||
125935098|NCT03414424|453059549|FG001|Overall Study|Screened out after consent|2|||
125935099|NCT03414424|453059548|FG000|Overall Study|Lost to Follow-up|0|||
125935100|NCT03414424|453059549|FG001|Overall Study|Lost to Follow-up|1|||
125935101|NCT01949051|453059555|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
125935102|NCT01949051|453059556|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
125935103|NCT01949051|453059557|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
125935104|NCT01949051|453059558|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
126066348|NCT01885559|453533549|FG000|Overall Study|Lost to Follow-up|15|||
125935105|NCT01949051|453059559|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
125935106|NCT01949051|453059560|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
125935107|NCT01949051|453059555|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
125935108|NCT01949051|453059556|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125935109|NCT01949051|453059557|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126066349|NCT01885559|453533550|FG001|Overall Study|Lost to Follow-up|16|||
125935110|NCT01949051|453059558|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125935111|NCT01949051|453059559|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125935112|NCT01949051|453059560|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125935113|NCT01949051|453059555|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125935114|NCT01949051|453059556|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125935115|NCT01949051|453059557|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125935116|NCT01949051|453059558|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125935117|NCT01949051|453059559|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125935118|NCT01949051|453059560|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
125935119|NCT01949051|453059555|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125935120|NCT01949051|453059556|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
125935121|NCT01949051|453059557|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125935122|NCT01949051|453059558|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125935123|NCT01949051|453059559|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125935124|NCT01949051|453059560|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125935125|NCT01949051|453059555|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125935126|NCT01949051|453059556|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125935127|NCT01949051|453059557|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
125935128|NCT01949051|453059558|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125935129|NCT01949051|453059559|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125935130|NCT01949051|453059560|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125935131|NCT01782859|453059562|FG000|Overall Study|Protocol Violation|6|||
125935132|NCT01782859|453059563|FG001|Overall Study|Protocol Violation|6|||
125935133|NCT01782859|453059562|FG000|Overall Study|Withdrawal by Subject|0|||
125935134|NCT01782859|453059563|FG001|Overall Study|Withdrawal by Subject|1|||
126066350|NCT01885559|453533549|FG000|Overall Study|Less than full participation|9|||
126066351|NCT01885559|453533550|FG001|Overall Study|Less than full participation|19|||
126066352|NCT01885559|453533549|FG000|Overall Study|Protocol Violation|0|||
126066353|NCT01885559|453533550|FG001|Overall Study|Protocol Violation|1|||
126066354|NCT01123200|453533552|FG000|Overall Study|Withdrawal by Subject|1|||
126066355|NCT00732498|453533556|FG000|Overall Study|Ineligible|1|||
126066356|NCT00732498|453533556|FG000|Overall Study|Adverse Event|2|||
126066357|NCT00732498|453533556|FG000|Overall Study|Physician Decision|3|||
126066358|NCT03394508|453533559|FG000|Overall Study|Protocol Violation|0|||
126066359|NCT03394508|453533560|FG001|Overall Study|Protocol Violation|3|||
126113930|NCT00295633|453712607|FG001|Overall Study|Administrative reason by sponsor|0|||
126113931|NCT00295633|453712608|FG002|Overall Study|Administrative reason by sponsor|1|||
126113932|NCT00419120|453712609|FG000|Long Term Follow up Period|study ongoing|10|||
126113933|NCT01754857|453712618|FG000|Overall Study|Adverse Event|7|||
126113934|NCT01754857|453712618|FG000|Overall Study|Disease progression|3|||
126113935|NCT01754857|453712618|FG000|Overall Study|Physician Decision|2|||
126113936|NCT01754857|453712618|FG000|Overall Study|Withdrawal by Subject|3|||
126113937|NCT01754857|453712618|FG000|Overall Study|other complicating disease|1|||
126113938|NCT01754857|453712618|FG000|Overall Study|ineligible to continue onto maintenance|1|||
126113939|NCT01754857|453712618|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
126113940|NCT01754857|453712618|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
126113941|NCT01509079|453712619|FG000|Overall Study|Lack of Efficacy|0|||
126113942|NCT01509079|453712620|FG001|Overall Study|Lack of Efficacy|2|||
126113943|NCT01509079|453712619|FG000|Overall Study|started an excluded medication|0|||
126066360|NCT03394508|453533559|FG000|Overall Study|Lost to Follow-up|1|||
126113944|NCT01509079|453712620|FG001|Overall Study|started an excluded medication|1|||
126113945|NCT01399190|453712623|FG000|Overall Study|Not Eligible for Final Analysis|5|||
125935135|NCT02611778|453059566|FG000|Overall Study|Withdrawal by Subject|2|||
125935136|NCT02611778|453059567|FG001|Overall Study|Withdrawal by Subject|8|||
125935137|NCT02611778|453059566|FG000|Overall Study|Adverse Event|1|||
125935138|NCT02611778|453059567|FG001|Overall Study|Adverse Event|2|||
125935139|NCT02611778|453059566|FG000|Overall Study|Death|2|||
125935140|NCT02611778|453059567|FG001|Overall Study|Death|1|||
125935141|NCT02611778|453059566|FG000|Overall Study|Protocol Violation|1|||
125935142|NCT02611778|453059567|FG001|Overall Study|Protocol Violation|0|||
125935143|NCT02611778|453059566|FG000|Overall Study|Lost to Follow-up|3|||
125935144|NCT02611778|453059567|FG001|Overall Study|Lost to Follow-up|1|||
125935145|NCT02611778|453059566|FG000|Overall Study|Need for alternative treatment|1|||
125935146|NCT02611778|453059567|FG001|Overall Study|Need for alternative treatment|0|||
125935147|NCT02611778|453059566|FG000|Overall Study|Other Reason|2|||
125935148|NCT02611778|453059567|FG001|Overall Study|Other Reason|1|||
125935149|NCT00022633|453059568|FG000|Overall Study|Adverse Event|11|||
125935150|NCT00022633|453059569|FG001|Overall Study|Adverse Event|1|||
125935151|NCT00022633|453059568|FG000|Overall Study|Refusal unrelated to adverse event|1|||
125935152|NCT00022633|453059569|FG001|Overall Study|Refusal unrelated to adverse event|0|||
125935153|NCT00022633|453059568|FG000|Overall Study|Progression/relapse|9|||
125935154|NCT00022633|453059569|FG001|Overall Study|Progression/relapse|2|||
125935155|NCT00022633|453059568|FG000|Overall Study|Death|4|||
125935156|NCT00022633|453059569|FG001|Overall Study|Death|0|||
125935157|NCT00022633|453059568|FG000|Overall Study|Other - not protocol specified|3|||
125935158|NCT00022633|453059569|FG001|Overall Study|Other - not protocol specified|2|||
125935159|NCT00022633|453059568|FG000|Overall Study|Ineligible|4|||
126066361|NCT03394508|453533560|FG001|Overall Study|Lost to Follow-up|0|||
126113946|NCT01399190|453712623|FG000|Overall Study|Adverse Event|8|||
126113947|NCT01399190|453712623|FG000|Overall Study|Participant's Request|5|||
126113948|NCT01399190|453712623|FG000|Overall Study|Physician Decision|2|||
126113949|NCT00436618|453712627|FG000|Overall Study|Withdrawal by Subject|5|||
126113950|NCT00436618|453712628|FG001|Overall Study|Withdrawal by Subject|8|||
126113951|NCT00436618|453712629|FG002|Overall Study|Withdrawal by Subject|11|||
126113952|NCT00436618|453712627|FG000|Overall Study|Adverse Event|8|||
126113953|NCT00436618|453712628|FG001|Overall Study|Adverse Event|8|||
126113954|NCT00436618|453712629|FG002|Overall Study|Adverse Event|9|||
126113955|NCT00436618|453712627|FG000|Overall Study|Alternate Treatment|3|||
126113956|NCT00436618|453712628|FG001|Overall Study|Alternate Treatment|4|||
126113957|NCT00436618|453712629|FG002|Overall Study|Alternate Treatment|12|||
126113958|NCT00436618|453712627|FG000|Overall Study|Other Medical Problems|3|||
126113959|NCT00436618|453712628|FG001|Overall Study|Other Medical Problems|1|||
126113960|NCT00436618|453712629|FG002|Overall Study|Other Medical Problems|7|||
126113961|NCT00436618|453712627|FG000|Overall Study|Death|4|||
126113962|NCT00436618|453712628|FG001|Overall Study|Death|2|||
126113963|NCT00436618|453712629|FG002|Overall Study|Death|3|||
126113964|NCT00436618|453712627|FG000|Overall Study|New Primary or Other Reasons|6|||
126113965|NCT00436618|453712628|FG001|Overall Study|New Primary or Other Reasons|2|||
126113966|NCT00436618|453712629|FG002|Overall Study|New Primary or Other Reasons|12|||
126113967|NCT00436618|453712627|FG000|Overall Study|Still on treatment|1|||
126113968|NCT00436618|453712628|FG001|Overall Study|Still on treatment|2|||
126113969|NCT00436618|453712629|FG002|Overall Study|Still on treatment|7|||
126113970|NCT00698204|453712630|FG000|Overall Study|Withdrawal by Subject|1|||
126113971|NCT00698204|453712631|FG001|Overall Study|Withdrawal by Subject|0|||
126113972|NCT00314249|453712632|FG000|Overall Study|Adverse Event|73|||
126113973|NCT00314249|453712633|FG001|Overall Study|Adverse Event|94|||
126113974|NCT00314249|453712632|FG000|Overall Study|Lack of Efficacy|33|||
126113975|NCT00314249|453712633|FG001|Overall Study|Lack of Efficacy|24|||
126113976|NCT00314249|453712632|FG000|Overall Study|Withdrawal by Subject|21|||
126113977|NCT00314249|453712633|FG001|Overall Study|Withdrawal by Subject|28|||
126113978|NCT00314249|453712632|FG000|Overall Study|Lost to Follow-up|15|||
126113979|NCT00314249|453712633|FG001|Overall Study|Lost to Follow-up|9|||
126113980|NCT00314249|453712632|FG000|Overall Study|Physician Decision|1|||
126113981|NCT00314249|453712633|FG001|Overall Study|Physician Decision|1|||
126113982|NCT00314249|453712632|FG000|Overall Study|Withdrawn for other reasons|4|||
126113983|NCT00314249|453712633|FG001|Overall Study|Withdrawn for other reasons|1|||
126113984|NCT00314249|453712632|FG000|Overall Study|Non-Compliant|5|||
126113985|NCT00314249|453712633|FG001|Overall Study|Non-Compliant|6|||
126113986|NCT01949155|453712634|FG000|Overall Study|Lost to Follow-up|1|||
126113987|NCT01949155|453712635|FG001|Overall Study|Lost to Follow-up|0|||
126113988|NCT01949155|453712634|FG000|Overall Study|Protocol Violation|1|||
126113989|NCT01949155|453712635|FG001|Overall Study|Protocol Violation|0|||
126113990|NCT00210184|453712636|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
126113991|NCT01118325|453712639|FG000|Overall Study|Adverse Event|1|||
126113992|NCT01118325|453712640|FG001|Overall Study|Adverse Event|0|||
126113993|NCT01118325|453712641|FG002|Overall Study|Adverse Event|1|||
126113994|NCT03334409|453712642|FG000|Overall Study|Did not meet inclusion criteria|1|||
126113995|NCT03334409|453712643|FG001|Overall Study|Did not meet inclusion criteria|0|||
126113996|NCT00975715|453712644|FG000|Titration Period|Adverse Event|6|||
126113997|NCT00975715|453712645|FG001|Titration Period|Adverse Event|0|||
126113998|NCT00975715|453712644|FG000|Titration Period|Protocol Violation|1|||
126113999|NCT00975715|453712645|FG001|Titration Period|Protocol Violation|0|||
126114000|NCT00975715|453712644|FG000|Maintenance Period|Adverse Event|2|||
126114001|NCT00975715|453712645|FG001|Maintenance Period|Adverse Event|1|||
126114002|NCT01674712|453712647|FG000|Overall Study|Adverse Event|5|||
126114003|NCT01674712|453712648|FG001|Overall Study|Adverse Event|6|||
125935160|NCT00022633|453059569|FG001|Overall Study|Ineligible|0|||
125935161|NCT00770289|453059576|FG000|Overall Study|Other|6|||
125935162|NCT03325075|453059579|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
125935163|NCT03325075|453059580|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
125935164|NCT03325075|453059581|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
125935165|NCT03325075|453059582|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
126114004|NCT01674712|453712649|FG002|Overall Study|Adverse Event|3|||
126114005|NCT01674712|453712650|FG003|Overall Study|Adverse Event|4|||
125935166|NCT03325075|453059579|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
126114006|NCT01674712|453712651|FG004|Overall Study|Adverse Event|6|||
126114007|NCT01674712|453712647|FG000|Overall Study|Lost to Follow-up|1|||
126114008|NCT01674712|453712648|FG001|Overall Study|Lost to Follow-up|0|||
125935167|NCT03325075|453059580|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
126114009|NCT01674712|453712649|FG002|Overall Study|Lost to Follow-up|0|||
126114010|NCT01674712|453712650|FG003|Overall Study|Lost to Follow-up|0|||
126114011|NCT01674712|453712651|FG004|Overall Study|Lost to Follow-up|0|||
126114012|NCT01674712|453712647|FG000|Overall Study|Protocol Violation|2|||
126114013|NCT01674712|453712648|FG001|Overall Study|Protocol Violation|0|||
126114014|NCT01674712|453712649|FG002|Overall Study|Protocol Violation|0|||
126114015|NCT01674712|453712650|FG003|Overall Study|Protocol Violation|0|||
126114016|NCT01674712|453712651|FG004|Overall Study|Protocol Violation|0|||
126114017|NCT01674712|453712647|FG000|Overall Study|Withdrawal by Subject|2|||
126114018|NCT01674712|453712648|FG001|Overall Study|Withdrawal by Subject|2|||
126114019|NCT01674712|453712649|FG002|Overall Study|Withdrawal by Subject|5|||
126114020|NCT01674712|453712650|FG003|Overall Study|Withdrawal by Subject|4|||
126114021|NCT01674712|453712651|FG004|Overall Study|Withdrawal by Subject|3|||
126114022|NCT01674712|453712647|FG000|Overall Study|Administrative|0|||
126114023|NCT01674712|453712648|FG001|Overall Study|Administrative|1|||
126114024|NCT01674712|453712649|FG002|Overall Study|Administrative|0|||
126114025|NCT01674712|453712650|FG003|Overall Study|Administrative|0|||
126114026|NCT01674712|453712651|FG004|Overall Study|Administrative|1|||
126114027|NCT01674712|453712647|FG000|Overall Study|Lack of Efficacy|0|||
126114028|NCT01674712|453712648|FG001|Overall Study|Lack of Efficacy|0|||
126114029|NCT01674712|453712649|FG002|Overall Study|Lack of Efficacy|1|||
126114030|NCT01674712|453712650|FG003|Overall Study|Lack of Efficacy|0|||
126114031|NCT01674712|453712651|FG004|Overall Study|Lack of Efficacy|1|||
126114032|NCT03974334|453712652|FG000|Overall Study|Lost to Follow-up|1|||
126114033|NCT01379573|453712659|FG000|Overall Study|Lost to Follow-up|1|||
126114034|NCT01379573|453712659|FG000|Overall Study|Screen Failure|10|||
126114035|NCT00770770|453712664|FG000|Overall Study|Lost to Follow-up|1|||
126114036|NCT00770770|453712665|FG001|Overall Study|Lost to Follow-up|0|||
126114037|NCT00770770|453712664|FG000|Overall Study|Withdrawal by Subject|1|||
126114038|NCT00770770|453712665|FG001|Overall Study|Withdrawal by Subject|0|||
126114039|NCT00770770|453712664|FG000|Overall Study|Death|0|||
126114040|NCT00770770|453712665|FG001|Overall Study|Death|1|||
126114041|NCT00770770|453712664|FG000|Overall Study|Study Terminated|8|||
126114042|NCT00770770|453712665|FG001|Overall Study|Study Terminated|0|||
126114043|NCT05372653|453712667|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
126114044|NCT05372653|453712668|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
126114045|NCT05372653|453712667|FG000|Overall Study|Adverse Event|0|||
126114046|NCT05372653|453712668|FG001|Overall Study|Adverse Event|1|||
126114047|NCT00711529|453712675|FG000|Overall Study|Protocol Violation|2|||
126114048|NCT00711529|453712676|FG001|Overall Study|Protocol Violation|0|||
126114049|NCT00711529|453712675|FG000|Overall Study|Withdrawal by Subject|2|||
126114050|NCT00711529|453712676|FG001|Overall Study|Withdrawal by Subject|6|||
126114051|NCT01230554|453712681|FG000|Overall Study|Lost to Follow-up|2|||
126114052|NCT01230554|453712681|FG000|Overall Study|Inability to maintain visit schedule|1|||
126114053|NCT00685685|453712682|FG000|Washout Period of 7 Days|Adverse Event|2|||
126114054|NCT00685685|453712683|FG001|Washout Period of 7 Days|Adverse Event|0|||
126114055|NCT00685685|453712682|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126114056|NCT00685685|453712683|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126114057|NCT02966223|453712686|FG000|Overall Study|Physician Decision|3|||
126114058|NCT02966223|453712686|FG000|Overall Study|Withdrawal by Subject|11|||
126114059|NCT02966223|453712686|FG000|Overall Study|Lost to Follow-up|1|||
126114060|NCT02003014|453712687|FG000|Overall Study|Case report forms uncollected|9|||
126114061|NCT02003014|453712687|FG000|Overall Study|Treatment started after contract period|1|||
126114062|NCT02003014|453712687|FG000|Overall Study|Patient did not visit the study site|5|||
126114063|NCT02003014|453712687|FG000|Overall Study|Investigator's transfer|4|||
126114064|NCT01660451|453712690|FG000|Overall Study|Protocol Violation|0|||
126114065|NCT01660451|453712691|FG001|Overall Study|Protocol Violation|1|||
126114066|NCT01660451|453712692|FG002|Overall Study|Protocol Violation|1|||
126114067|NCT01660451|453712690|FG000|Overall Study|AE not associated with clinical disease progression|13|||
126114068|NCT01660451|453712691|FG001|Overall Study|AE not associated with clinical disease progression|10|||
126114069|NCT01660451|453712692|FG002|Overall Study|AE not associated with clinical disease progression|40|||
126114070|NCT01660451|453712690|FG000|Overall Study|AE associated with clinical disease progression|1|||
126114071|NCT01660451|453712691|FG001|Overall Study|AE associated with clinical disease progression|3|||
126114072|NCT01660451|453712692|FG002|Overall Study|AE associated with clinical disease progression|11|||
126114073|NCT01660451|453712690|FG000|Overall Study|Sponsor Decision|0|||
126114074|NCT01660451|453712691|FG001|Overall Study|Sponsor Decision|0|||
126114075|NCT01660451|453712692|FG002|Overall Study|Sponsor Decision|1|||
126114076|NCT01660451|453712690|FG000|Overall Study|Protocol Deviation|0|||
126114077|NCT01660451|453712691|FG001|Overall Study|Protocol Deviation|0|||
126114078|NCT01660451|453712692|FG002|Overall Study|Protocol Deviation|1|||
126114079|NCT01660451|453712690|FG000|Overall Study|Physician Decision|1|||
126114080|NCT01660451|453712691|FG001|Overall Study|Physician Decision|2|||
126114081|NCT01660451|453712692|FG002|Overall Study|Physician Decision|5|||
126114082|NCT01660451|453712690|FG000|Overall Study|Withdrawal by Subject|1|||
126114083|NCT01660451|453712691|FG001|Overall Study|Withdrawal by Subject|1|||
126114084|NCT01660451|453712692|FG002|Overall Study|Withdrawal by Subject|20|||
126114085|NCT01660451|453712690|FG000|Overall Study|Trial closure.|0|||
126114086|NCT01660451|453712691|FG001|Overall Study|Trial closure.|0|||
126114087|NCT01660451|453712692|FG002|Overall Study|Trial closure.|1|||
126114088|NCT01660451|453712690|FG000|Overall Study|Switching to other therapy|0|||
126114089|NCT01660451|453712691|FG001|Overall Study|Switching to other therapy|1|||
126114090|NCT01660451|453712692|FG002|Overall Study|Switching to other therapy|1|||
126114091|NCT01660451|453712690|FG000|Overall Study|Progressive disease - clinical progression|4|||
125935168|NCT03325075|453059581|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
125935169|NCT03325075|453059582|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
125935170|NCT03325075|453059579|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
125935171|NCT03325075|453059580|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
125935172|NCT03325075|453059581|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
125935173|NCT03325075|453059582|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
125935174|NCT00495170|453059585|FG000|Overall Study|Lost to Follow-up|9|||
125935175|NCT00495170|453059585|FG000|Overall Study|Withdrawal by Subject|3|||
125935176|NCT00495170|453059585|FG000|Overall Study|Inappropriate staging|8|||
125935177|NCT01408914|453059586|FG000|Overall Study|Could not complete tx in protocol period|5|||
125935178|NCT01408914|453059587|FG001|Overall Study|Could not complete tx in protocol period|5|||
125935179|NCT01408914|453059588|FG002|Overall Study|Could not complete tx in protocol period|6|||
125935180|NCT01408914|453059586|FG000|Overall Study|Lost to Follow-up|4|||
125935181|NCT01408914|453059587|FG001|Overall Study|Lost to Follow-up|1|||
125935182|NCT01408914|453059588|FG002|Overall Study|Lost to Follow-up|2|||
125935183|NCT01408914|453059586|FG000|Overall Study|Physician Decision|1|||
125935184|NCT01408914|453059587|FG001|Overall Study|Physician Decision|1|||
125935185|NCT01408914|453059588|FG002|Overall Study|Physician Decision|0|||
125935186|NCT01408914|453059586|FG000|Overall Study|Withdrawal by Subject|1|||
125935187|NCT01408914|453059587|FG001|Overall Study|Withdrawal by Subject|0|||
125935188|NCT01408914|453059588|FG002|Overall Study|Withdrawal by Subject|1|||
125935189|NCT01408914|453059586|FG000|Overall Study|Moved out of study jurisdiction|1|||
125935190|NCT01408914|453059587|FG001|Overall Study|Moved out of study jurisdiction|1|||
125935191|NCT01408914|453059588|FG002|Overall Study|Moved out of study jurisdiction|0|||
125935192|NCT01408914|453059586|FG000|Overall Study|Late exclusion|0|||
125935193|NCT01408914|453059587|FG001|Overall Study|Late exclusion|3|||
125935194|NCT01408914|453059588|FG002|Overall Study|Late exclusion|3|||
125935195|NCT01408914|453059586|FG000|Overall Study|Change in local TB/HIV norms|0|||
125935196|NCT01408914|453059587|FG001|Overall Study|Change in local TB/HIV norms|1|||
125935197|NCT01408914|453059588|FG002|Overall Study|Change in local TB/HIV norms|1|||
125935198|NCT00330616|453059589|FG000|Overall Study|Adverse Event|13|||
125935199|NCT00330616|453059589|FG000|Overall Study|Lack of Efficacy|1|||
125935200|NCT00330616|453059589|FG000|Overall Study|Lost to Follow-up|2|||
125935201|NCT00330616|453059589|FG000|Overall Study|Withdrawal by Subject|4|||
125935202|NCT00330616|453059589|FG000|Overall Study|Other|1|||
125935203|NCT00811473|453059594|FG000|Overall Study|Adverse Event|3|||
125935204|NCT00811473|453059595|FG001|Overall Study|Adverse Event|12|||
125935205|NCT00811473|453059594|FG000|Overall Study|Lost to Follow-up|5|||
125935206|NCT00811473|453059595|FG001|Overall Study|Lost to Follow-up|1|||
125935207|NCT00811473|453059594|FG000|Overall Study|Withdrawal by Subject|2|||
125935208|NCT00811473|453059595|FG001|Overall Study|Withdrawal by Subject|4|||
125935209|NCT00811473|453059594|FG000|Overall Study|Severe non-compliance to protocol|2|||
125935210|NCT00811473|453059595|FG001|Overall Study|Severe non-compliance to protocol|4|||
125935211|NCT00811473|453059594|FG000|Overall Study|Lack of therapeutic response|4|||
125935212|NCT00811473|453059595|FG001|Overall Study|Lack of therapeutic response|1|||
125935213|NCT00811473|453059594|FG000|Overall Study|Condition under investigation worsened|1|||
125935214|NCT00811473|453059595|FG001|Overall Study|Condition under investigation worsened|3|||
125935215|NCT00811473|453059594|FG000|Overall Study|Other 2|4|||
125935216|NCT00811473|453059595|FG001|Overall Study|Other 2|1|||
125935217|NCT00811473|453059594|FG000|Overall Study|Incorrect Enrollment|1|||
125935218|NCT00811473|453059595|FG001|Overall Study|Incorrect Enrollment|0|||
125935219|NCT00811473|453059594|FG000|Overall Study|Safety Reasons|1|||
125935220|NCT00811473|453059595|FG001|Overall Study|Safety Reasons|0|||
125935221|NCT01585194|453059599|FG000|Overall Study|Withdrawal by Subject|1|||
125935222|NCT01585194|453059599|FG000|Overall Study|Physician Decision|2|||
125935223|NCT01585194|453059599|FG000|Overall Study|Lack of insurance|1|||
125935224|NCT00993291|453059600|FG000|Overall Study|Withdrawal by Subject|1|||
125935225|NCT01922089|453059603|FG000|Overall Study|Adverse Event|18|||
125935226|NCT01922089|453059604|FG001|Overall Study|Adverse Event|13|||
125935227|NCT01922089|453059603|FG000|Overall Study|Protocol Deviation|10|||
125935228|NCT01922089|453059604|FG001|Overall Study|Protocol Deviation|7|||
125935229|NCT01922089|453059603|FG000|Overall Study|Withdrawal by Subject|3|||
125935230|NCT01922089|453059604|FG001|Overall Study|Withdrawal by Subject|4|||
125935231|NCT01922089|453059603|FG000|Overall Study|administrative problems|4|||
125935232|NCT01922089|453059604|FG001|Overall Study|administrative problems|1|||
125935233|NCT01922089|453059603|FG000|Overall Study|Physician Decision|2|||
125935234|NCT01922089|453059604|FG001|Overall Study|Physician Decision|3|||
125935235|NCT01922089|453059603|FG000|Overall Study|Death|2|||
125935236|NCT01922089|453059604|FG001|Overall Study|Death|1|||
125935237|NCT01922089|453059603|FG000|Overall Study|Lost to Follow-up|0|||
125935238|NCT01922089|453059604|FG001|Overall Study|Lost to Follow-up|1|||
125935239|NCT01129960|453059614|FG000|Overall Study|Withdrawal by Subject|3|||
125935240|NCT01129960|453059615|FG001|Overall Study|Withdrawal by Subject|0|||
125935241|NCT01129960|453059616|FG002|Overall Study|Withdrawal by Subject|3|||
125935242|NCT01129960|453059617|FG003|Overall Study|Withdrawal by Subject|2|||
125935243|NCT01129960|453059614|FG000|Overall Study|Lack of Efficacy|1|||
125935244|NCT01129960|453059615|FG001|Overall Study|Lack of Efficacy|1|||
125935245|NCT01129960|453059616|FG002|Overall Study|Lack of Efficacy|1|||
125935246|NCT01129960|453059617|FG003|Overall Study|Lack of Efficacy|1|||
125935247|NCT01129960|453059614|FG000|Overall Study|Adverse Event|23|||
125935248|NCT01129960|453059615|FG001|Overall Study|Adverse Event|16|||
125935249|NCT01129960|453059616|FG002|Overall Study|Adverse Event|16|||
125935250|NCT01129960|453059617|FG003|Overall Study|Adverse Event|7|||
125935251|NCT01129960|453059614|FG000|Overall Study|Protocol Violation|1|||
125935252|NCT01129960|453059615|FG001|Overall Study|Protocol Violation|2|||
125935253|NCT01129960|453059616|FG002|Overall Study|Protocol Violation|3|||
125935254|NCT01129960|453059617|FG003|Overall Study|Protocol Violation|0|||
125935255|NCT01129960|453059614|FG000|Overall Study|Lost to Follow-up|0|||
125935256|NCT01129960|453059615|FG001|Overall Study|Lost to Follow-up|2|||
125935257|NCT01129960|453059616|FG002|Overall Study|Lost to Follow-up|3|||
125935258|NCT01129960|453059617|FG003|Overall Study|Lost to Follow-up|3|||
125935259|NCT01129960|453059614|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
125935260|NCT01129960|453059615|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
125935261|NCT01129960|453059616|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
125935262|NCT01129960|453059617|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
125935263|NCT01129960|453059614|FG000|Overall Study|Physician Decision|1|||
125935264|NCT01129960|453059615|FG001|Overall Study|Physician Decision|0|||
125935265|NCT01129960|453059616|FG002|Overall Study|Physician Decision|0|||
125935266|NCT01129960|453059617|FG003|Overall Study|Physician Decision|0|||
125935267|NCT01129960|453059614|FG000|Overall Study|Pregnancy|1|||
125935268|NCT01129960|453059615|FG001|Overall Study|Pregnancy|0|||
125935269|NCT01129960|453059616|FG002|Overall Study|Pregnancy|0|||
125935270|NCT01129960|453059617|FG003|Overall Study|Pregnancy|0|||
125935271|NCT00165776|453059618|FG000|Overall Study|Lack of Efficacy|0|||
125935272|NCT00165776|453059619|FG001|Overall Study|Lack of Efficacy|0|||
125935273|NCT00165776|453059620|FG002|Overall Study|Lack of Efficacy|0|||
125935274|NCT00165776|453059621|FG003|Overall Study|Lack of Efficacy|1|||
125935275|NCT00165776|453059618|FG000|Overall Study|Withdrawal by Subject|4|||
125935276|NCT00165776|453059619|FG001|Overall Study|Withdrawal by Subject|1|||
125935277|NCT00165776|453059620|FG002|Overall Study|Withdrawal by Subject|2|||
125935278|NCT00165776|453059621|FG003|Overall Study|Withdrawal by Subject|0|||
125935279|NCT00165776|453059618|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
125935280|NCT00165776|453059619|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
125935281|NCT00165776|453059620|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
125935282|NCT00165776|453059621|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
125935283|NCT02622321|453059624|FG000|Overall Study|Withdrawal by Subject|2|||
125935284|NCT02622321|453059625|FG001|Overall Study|Withdrawal by Subject|0|||
125935285|NCT02622321|453059626|FG002|Overall Study|Withdrawal by Subject|0|||
125935286|NCT02622321|453059627|FG003|Overall Study|Withdrawal by Subject|0|||
125935287|NCT02622321|453059624|FG000|Overall Study|Death|0|||
125935288|NCT02622321|453059625|FG001|Overall Study|Death|0|||
125935289|NCT02622321|453059626|FG002|Overall Study|Death|1|||
125935290|NCT02622321|453059627|FG003|Overall Study|Death|0|||
125935291|NCT02622321|453059624|FG000|Overall Study|Physician Decision|1|||
125935292|NCT02622321|453059625|FG001|Overall Study|Physician Decision|0|||
125935293|NCT02622321|453059626|FG002|Overall Study|Physician Decision|0|||
125935294|NCT02622321|453059627|FG003|Overall Study|Physician Decision|0|||
125935295|NCT01958008|453059630|FG000|Overall Study|Worsening of disease under study|0|||
125935296|NCT01958008|453059631|FG001|Overall Study|Worsening of disease under study|0|||
125935297|NCT01958008|453059632|FG002|Overall Study|Worsening of disease under study|1|||
125935298|NCT01958008|453059633|FG003|Overall Study|Worsening of disease under study|0|||
125935299|NCT01958008|453059630|FG000|Overall Study|Other adverse event|1|||
125935300|NCT01958008|453059631|FG001|Overall Study|Other adverse event|0|||
125935301|NCT01958008|453059632|FG002|Overall Study|Other adverse event|0|||
125935302|NCT01958008|453059633|FG003|Overall Study|Other adverse event|0|||
125935303|NCT00241280|453059634|FG000|Overall Study|Adverse Event|2|||
125935304|NCT00241280|453059635|FG001|Overall Study|Adverse Event|6|||
125935305|NCT00241280|453059634|FG000|Overall Study|Discomfort|11|||
125935306|NCT00241280|453059635|FG001|Overall Study|Discomfort|16|||
125935307|NCT00241280|453059634|FG000|Overall Study|Pregnancy|1|||
125935308|NCT00241280|453059635|FG001|Overall Study|Pregnancy|5|||
125935309|NCT00241280|453059634|FG000|Overall Study|Lost to Follow-up|5|||
125935310|NCT00241280|453059635|FG001|Overall Study|Lost to Follow-up|8|||
125935311|NCT00241280|453059634|FG000|Overall Study|Withdrawal by Subject|7|||
125935312|NCT00241280|453059635|FG001|Overall Study|Withdrawal by Subject|4|||
125935313|NCT00241280|453059634|FG000|Overall Study|Protocol Violation|4|||
125935314|NCT00241280|453059635|FG001|Overall Study|Protocol Violation|10|||
125935315|NCT00241280|453059634|FG000|Overall Study|Relocation|4|||
125935316|NCT00241280|453059635|FG001|Overall Study|Relocation|4|||
125935317|NCT00241280|453059634|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
125935318|NCT00241280|453059635|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
125935319|NCT00241280|453059634|FG000|Overall Study|Unsatisfactory Visual Response|1|||
125935320|NCT00241280|453059635|FG001|Overall Study|Unsatisfactory Visual Response|1|||
125935321|NCT00241280|453059634|FG000|Overall Study|Diabetic|1|||
125935322|NCT00241280|453059635|FG001|Overall Study|Diabetic|0|||
125935323|NCT00241280|453059634|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
125935324|NCT00241280|453059635|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
125935325|NCT00241280|453059634|FG000|Overall Study|Dispensed incorrect test article|1|||
125935326|NCT00241280|453059635|FG001|Overall Study|Dispensed incorrect test article|2|||
125935327|NCT00241280|453059634|FG000|Overall Study|Unacceptable Fit|0|||
125935328|NCT00241280|453059635|FG001|Overall Study|Unacceptable Fit|1|||
125935329|NCT00241280|453059634|FG000|Overall Study|Scheduling Conflict|0|||
125935330|NCT00241280|453059635|FG001|Overall Study|Scheduling Conflict|2|||
125935331|NCT00241280|453059634|FG000|Overall Study|History of Ocular Surgery|0|||
125935332|NCT00241280|453059635|FG001|Overall Study|History of Ocular Surgery|1|||
125935333|NCT00241280|453059634|FG000|Overall Study|Coating on Lens|1|||
125935334|NCT00241280|453059635|FG001|Overall Study|Coating on Lens|0|||
125935335|NCT00241280|453059634|FG000|Overall Study|Excessive Dryness|0|||
125935336|NCT00241280|453059635|FG001|Overall Study|Excessive Dryness|1|||
125935337|NCT00965718|453059636|FG000|Overall Study|Withdrawal by Subject|4|||
125935338|NCT01414855|453059639|FG000|Overall Study|Death|17|||
125935339|NCT01414855|453059639|FG000|Overall Study|Lost to Follow-up|5|||
125935340|NCT01414855|453059639|FG000|Overall Study|Withdrawal by Subject|7|||
125935341|NCT04851314|453059640|FG000|Overall Study|Unable to complete research set-up procedures|0|||
125935342|NCT04851314|453059641|FG001|Overall Study|Unable to complete research set-up procedures|2|||
125935343|NCT04851314|453059640|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
125935344|NCT04851314|453059641|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
125935345|NCT01850524|453059642|FG000|Overall Study|Lost to Follow-up|5|||
125935346|NCT01850524|453059643|FG001|Overall Study|Lost to Follow-up|10|||
125935347|NCT01850524|453059642|FG000|Overall Study|Withdrawal by Subject|24|||
125935348|NCT01850524|453059643|FG001|Overall Study|Withdrawal by Subject|22|||
125935349|NCT01850524|453059642|FG000|Overall Study|Reason not Specified|142|||
125935350|NCT01850524|453059643|FG001|Overall Study|Reason not Specified|141|||
125935351|NCT00368355|453059644|FG000|Overall Study|Adverse Event|1|||
125935352|NCT00368355|453059645|FG001|Overall Study|Adverse Event|0|||
125935353|NCT00368355|453059644|FG000|Overall Study|Death|2|||
125935354|NCT00368355|453059645|FG001|Overall Study|Death|4|||
125935355|NCT00368355|453059644|FG000|Overall Study|Relapse|6|||
125935356|NCT00368355|453059645|FG001|Overall Study|Relapse|10|||
125935357|NCT00368355|453059644|FG000|Overall Study|Subsequent transplant|0|||
125935358|NCT00368355|453059645|FG001|Overall Study|Subsequent transplant|3|||
125935359|NCT00368355|453059644|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
125935360|NCT00368355|453059645|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
125935361|NCT03358290|453059647|FG000|Overall Study|Study discontinued by Sponsor|0|||
125935362|NCT03358290|453059648|FG001|Overall Study|Study discontinued by Sponsor|1|||
125935363|NCT03358290|453059649|FG002|Overall Study|Study discontinued by Sponsor|1|||
125935364|NCT03358290|453059650|FG003|Overall Study|Study discontinued by Sponsor|0|||
125935365|NCT03358290|453059651|FG004|Overall Study|Study discontinued by Sponsor|0|||
125935366|NCT03358290|453059647|FG000|Overall Study|Adverse Event|0|||
125935367|NCT03358290|453059648|FG001|Overall Study|Adverse Event|0|||
125935368|NCT03358290|453059649|FG002|Overall Study|Adverse Event|1|||
125935369|NCT03358290|453059650|FG003|Overall Study|Adverse Event|2|||
125935370|NCT03358290|453059651|FG004|Overall Study|Adverse Event|0|||
125935371|NCT03358290|453059647|FG000|Overall Study|Withdrawal by Subject|0|||
125935372|NCT03358290|453059648|FG001|Overall Study|Withdrawal by Subject|0|||
125935373|NCT03358290|453059649|FG002|Overall Study|Withdrawal by Subject|0|||
125935374|NCT03358290|453059650|FG003|Overall Study|Withdrawal by Subject|0|||
125935375|NCT03358290|453059651|FG004|Overall Study|Withdrawal by Subject|1|||
125935376|NCT02999854|453059658|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
125935377|NCT02999854|453059659|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
125935378|NCT02999854|453059658|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
125935379|NCT02999854|453059659|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
125935380|NCT02999854|453059658|FG000|Active Study Phase (up to 18 Months)|Death|7|||
125935381|NCT02999854|453059659|FG001|Active Study Phase (up to 18 Months)|Death|5|||
125935382|NCT02999854|453059658|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
125935383|NCT02999854|453059659|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
125935384|NCT02999854|453059658|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
125935385|NCT02999854|453059659|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
125935386|NCT02999854|453059658|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
125935387|NCT02999854|453059659|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
125935388|NCT02999854|453059658|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
125935389|NCT02999854|453059659|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
125935390|NCT02999854|453059658|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
125935391|NCT02999854|453059659|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
125935392|NCT04140292|453059660|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
125935393|NCT04140292|453059661|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
125935394|NCT00459667|453059662|FG000|Overall Study|Adverse Event|9|||
125935395|NCT00459667|453059663|FG001|Overall Study|Adverse Event|12|||
125935396|NCT00459667|453059664|FG002|Overall Study|Adverse Event|8|||
125935397|NCT00459667|453059662|FG000|Overall Study|Lost to Follow-up|5|||
125935398|NCT00459667|453059663|FG001|Overall Study|Lost to Follow-up|9|||
125935399|NCT00459667|453059664|FG002|Overall Study|Lost to Follow-up|3|||
125935400|NCT00459667|453059662|FG000|Overall Study|Pregnancy|1|||
125935401|NCT00459667|453059663|FG001|Overall Study|Pregnancy|1|||
125935402|NCT00459667|453059664|FG002|Overall Study|Pregnancy|1|||
125935403|NCT00459667|453059662|FG000|Overall Study|Protocol Violation|1|||
125935404|NCT00459667|453059663|FG001|Overall Study|Protocol Violation|0|||
125935405|NCT00459667|453059664|FG002|Overall Study|Protocol Violation|0|||
125935406|NCT00459667|453059662|FG000|Overall Study|Withdrawal by Subject|3|||
125935407|NCT00459667|453059663|FG001|Overall Study|Withdrawal by Subject|5|||
125935408|NCT00459667|453059664|FG002|Overall Study|Withdrawal by Subject|5|||
125935409|NCT00459667|453059662|FG000|Overall Study|Other disease modifying treatment|1|||
125935410|NCT00459667|453059663|FG001|Overall Study|Other disease modifying treatment|2|||
125935411|NCT00459667|453059664|FG002|Overall Study|Other disease modifying treatment|1|||
126066362|NCT03214198|453533563|FG000|Overall Study|Case Report Forms Uncollected|18|||
126066363|NCT03214198|453533563|FG000|Overall Study|Protocol Deviation|18|||
126066364|NCT04295499|453533564|FG000|Overall Study|moving out of state|1|||
125935412|NCT00459667|453059662|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
125935413|NCT00459667|453059663|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
125935414|NCT00459667|453059664|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
125935415|NCT00459667|453059662|FG000|Overall Study|No treatment administered|6|||
125935416|NCT00459667|453059663|FG001|Overall Study|No treatment administered|3|||
125935417|NCT00459667|453059664|FG002|Overall Study|No treatment administered|1|||
125935418|NCT01013701|453059665|FG000|Overall Study|study prematurely terminated|7|||
125935419|NCT04080297|453059666|FG000|Overall Study|Adverse Event|1|||
125935420|NCT04080297|453059667|FG001|Overall Study|Adverse Event|3|||
125935421|NCT04080297|453059666|FG000|Overall Study|concurrent illness|1|||
125935422|NCT04080297|453059667|FG001|Overall Study|concurrent illness|0|||
125935423|NCT02626520|453059668|FG000|Overall Study|Physician Decision|1|||
125935424|NCT02626520|453059669|FG001|Overall Study|Physician Decision|1|||
125935425|NCT02626520|453059668|FG000|Overall Study|Adverse Event|0|||
125935426|NCT02626520|453059669|FG001|Overall Study|Adverse Event|4|||
125935427|NCT02626520|453059668|FG000|Overall Study|Lack of Efficacy|0|||
125935428|NCT02626520|453059669|FG001|Overall Study|Lack of Efficacy|2|||
125935429|NCT02626520|453059668|FG000|Overall Study|Did not start protocol therapy|0|||
125935430|NCT02626520|453059669|FG001|Overall Study|Did not start protocol therapy|2|||
125935431|NCT02626520|453059668|FG000|Overall Study|Study terminated|0|||
125935432|NCT02626520|453059669|FG001|Overall Study|Study terminated|1|||
125935433|NCT02200445|453059670|FG000|Overall Study|Lack of Efficacy|1|||
125935434|NCT02200445|453059671|FG001|Overall Study|Lack of Efficacy|2|||
125935435|NCT02200445|453059672|FG002|Overall Study|Lack of Efficacy|2|||
125935436|NCT02200445|453059670|FG000|Overall Study|Adverse Event|0|||
125935437|NCT02200445|453059671|FG001|Overall Study|Adverse Event|2|||
125935438|NCT02200445|453059672|FG002|Overall Study|Adverse Event|0|||
125935439|NCT01386554|453059673|FG000|Overall Study|Lost to Follow-up|0|||
125935440|NCT01386554|453059674|FG001|Overall Study|Lost to Follow-up|0|||
125935441|NCT01386554|453059675|FG002|Overall Study|Lost to Follow-up|1|||
125935442|NCT01386554|453059673|FG000|Overall Study|Adverse Event|2|||
125935443|NCT01386554|453059674|FG001|Overall Study|Adverse Event|5|||
125935444|NCT01386554|453059675|FG002|Overall Study|Adverse Event|2|||
125935445|NCT01386554|453059673|FG000|Overall Study|Progressive disease|1|||
125935446|NCT01386554|453059674|FG001|Overall Study|Progressive disease|2|||
125935447|NCT01386554|453059675|FG002|Overall Study|Progressive disease|2|||
125935448|NCT01386554|453059673|FG000|Overall Study|Administration of live vaccines|0|||
125935449|NCT01386554|453059674|FG001|Overall Study|Administration of live vaccines|1|||
125935450|NCT01386554|453059675|FG002|Overall Study|Administration of live vaccines|0|||
125935451|NCT01386554|453059673|FG000|Overall Study|Investigator discretion|0|||
125935452|NCT01386554|453059674|FG001|Overall Study|Investigator discretion|0|||
125935453|NCT01386554|453059675|FG002|Overall Study|Investigator discretion|1|||
125935454|NCT01386554|453059673|FG000|Overall Study|Reason not collected|0|||
125935455|NCT01386554|453059674|FG001|Overall Study|Reason not collected|1|||
125935456|NCT01386554|453059675|FG002|Overall Study|Reason not collected|0|||
125935457|NCT03334903|453059676|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
125935458|NCT03334903|453059677|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
125935459|NCT03334903|453059676|FG000|Overall Study|Protocol Violation|1|||
125935460|NCT03334903|453059677|FG001|Overall Study|Protocol Violation|3|||
125935461|NCT03334903|453059676|FG000|Overall Study|Surgery postponed|1|||
125935462|NCT03334903|453059677|FG001|Overall Study|Surgery postponed|0|||
125935463|NCT03334903|453059676|FG000|Overall Study|Adverse Event|1|||
125935464|NCT03334903|453059677|FG001|Overall Study|Adverse Event|1|||
125935465|NCT03334903|453059676|FG000|Overall Study|Withdrawal by Subject|0|||
125935466|NCT03334903|453059677|FG001|Overall Study|Withdrawal by Subject|1|||
125935467|NCT00353262|453059678|FG000|Overall Study|Adverse Event|8|||
125935468|NCT00353262|453059678|FG000|Overall Study|Withdrawal by Subject|2|||
126114092|NCT01660451|453712691|FG001|Overall Study|Progressive disease - clinical progression|10|||
126114093|NCT01660451|453712692|FG002|Overall Study|Progressive disease - clinical progression|9|||
126114094|NCT01660451|453712690|FG000|Overall Study|Progressive disease - radiological progression|12|||
126114095|NCT01660451|453712691|FG001|Overall Study|Progressive disease - radiological progression|23|||
126114096|NCT01660451|453712692|FG002|Overall Study|Progressive disease - radiological progression|50|||
126114097|NCT01660451|453712690|FG000|Overall Study|Death|1|||
126114098|NCT01660451|453712691|FG001|Overall Study|Death|0|||
126114099|NCT01660451|453712692|FG002|Overall Study|Death|1|||
126114100|NCT01660451|453712690|FG000|Overall Study|Other|0|||
126114101|NCT01660451|453712691|FG001|Overall Study|Other|0|||
125935469|NCT00353262|453059678|FG000|Overall Study|Insufficient Therapeutic Response|13|||
125935470|NCT00353262|453059678|FG000|Overall Study|Progression|1|||
125935471|NCT00353262|453059678|FG000|Overall Study|Surgery|4|||
125935472|NCT00353262|453059678|FG000|Overall Study|Break from Chemotherapy|1|||
125935473|NCT00463346|453061493|FG000|Overall Study|Withdrawal by Subject|3|||
125935474|NCT00463346|453061494|FG001|Overall Study|Withdrawal by Subject|3|||
125935475|NCT02642614|453061496|FG000|Overall Study|Adverse Event|1|||
125935476|NCT02642614|453061497|FG001|Overall Study|Adverse Event|1|||
125935477|NCT02642614|453061498|FG002|Overall Study|Adverse Event|2|||
125935478|NCT02642614|453061499|FG003|Overall Study|Adverse Event|2|||
125935479|NCT02642614|453061496|FG000|Overall Study|Lost to Follow-up|1|||
125935480|NCT02642614|453061497|FG001|Overall Study|Lost to Follow-up|0|||
125935481|NCT02642614|453061498|FG002|Overall Study|Lost to Follow-up|0|||
125935482|NCT02642614|453061499|FG003|Overall Study|Lost to Follow-up|0|||
125935483|NCT02642614|453061496|FG000|Overall Study|Withdrawal by Subject|1|||
125935484|NCT02642614|453061497|FG001|Overall Study|Withdrawal by Subject|1|||
125935485|NCT02642614|453061498|FG002|Overall Study|Withdrawal by Subject|0|||
125935486|NCT02642614|453061499|FG003|Overall Study|Withdrawal by Subject|0|||
125935487|NCT04067544|453061500|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
125935488|NCT00967798|453061501|FG000|Overall Study|Withdrawal by Subject|5|||
125935489|NCT00967798|453061502|FG001|Overall Study|Withdrawal by Subject|2|||
125935490|NCT00967798|453061501|FG000|Overall Study|Lost to Follow-up|4|||
125935491|NCT00967798|453061502|FG001|Overall Study|Lost to Follow-up|1|||
125935492|NCT01320085|453061503|FG000|Overall Study|Disease Progression|26|||
125935493|NCT01320085|453061504|FG001|Overall Study|Disease Progression|93|||
125935494|NCT01320085|453061505|FG002|Overall Study|Disease Progression|17|||
125935495|NCT01320085|453061503|FG000|Overall Study|Adverse Event|12|||
125935496|NCT01320085|453061504|FG001|Overall Study|Adverse Event|20|||
125935497|NCT01320085|453061505|FG002|Overall Study|Adverse Event|5|||
125935498|NCT01320085|453061503|FG000|Overall Study|Withdrawal by Subject|2|||
125935499|NCT01320085|453061504|FG001|Overall Study|Withdrawal by Subject|4|||
125935500|NCT01320085|453061505|FG002|Overall Study|Withdrawal by Subject|1|||
125935501|NCT01320085|453061503|FG000|Overall Study|Protocol Deviation|1|||
125935502|NCT01320085|453061504|FG001|Overall Study|Protocol Deviation|0|||
125935503|NCT01320085|453061505|FG002|Overall Study|Protocol Deviation|1|||
125935504|NCT01320085|453061503|FG000|Overall Study|Administrative problems|0|||
125935505|NCT01320085|453061504|FG001|Overall Study|Administrative problems|0|||
125935506|NCT01320085|453061505|FG002|Overall Study|Administrative problems|1|||
125935507|NCT03316131|453061506|FG000|Treatment Period 2|Protocol deviation|1|||
125935508|NCT03316131|453061507|FG001|Treatment Period 2|Protocol deviation|0|||
125935509|NCT02282020|453061515|FG000|Overall Study|Objective Disease Progression|128|||
125935510|NCT02282020|453061516|FG001|Overall Study|Objective Disease Progression|30|||
125935511|NCT02282020|453061515|FG000|Overall Study|Adverse Event|18|||
125935512|NCT02282020|453061516|FG001|Overall Study|Adverse Event|15|||
125935513|NCT02282020|453061515|FG000|Overall Study|Withdrawal by Subject|7|||
125935514|NCT02282020|453061516|FG001|Overall Study|Withdrawal by Subject|10|||
125935515|NCT02282020|453061515|FG000|Overall Study|Miscellaneous|5|||
125935516|NCT02282020|453061516|FG001|Overall Study|Miscellaneous|19|||
125935517|NCT02282020|453061515|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
125935518|NCT02282020|453061516|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
125935519|NCT02282020|453061515|FG000|Overall Study|Developed Discontinuation Criteria|0|||
125935520|NCT02282020|453061516|FG001|Overall Study|Developed Discontinuation Criteria|2|||
125935521|NCT02282020|453061515|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
125935522|NCT02282020|453061516|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
125935523|NCT00708162|453061517|FG000|Randomized Phase|Randomized but Not Treated|7|||
125935524|NCT00708162|453061518|FG001|Randomized Phase|Randomized but Not Treated|5|||
125935525|NCT00708162|453061517|FG000|Randomized Phase|Participant Noncompliance|40|||
125935526|NCT00708162|453061518|FG001|Randomized Phase|Participant Noncompliance|32|||
125935527|NCT00708162|453061517|FG000|Randomized Phase|Lost to Follow-up|34|||
125935528|NCT00708162|453061518|FG001|Randomized Phase|Lost to Follow-up|34|||
125935529|NCT00708162|453061517|FG000|Randomized Phase|Withdrew Consent|31|||
125935530|NCT00708162|453061518|FG001|Randomized Phase|Withdrew Consent|22|||
125935531|NCT00708162|453061517|FG000|Randomized Phase|Lack of Efficacy|14|||
125935532|NCT00708162|453061518|FG001|Randomized Phase|Lack of Efficacy|19|||
125935533|NCT00708162|453061517|FG000|Randomized Phase|Protocol Violation|10|||
126114102|NCT01660451|453712692|FG002|Overall Study|Other|1|||
125935534|NCT00708162|453061518|FG001|Randomized Phase|Protocol Violation|11|||
125935535|NCT00708162|453061517|FG000|Randomized Phase|Adverse Event|8|||
125935536|NCT00708162|453061518|FG001|Randomized Phase|Adverse Event|12|||
125935537|NCT00708162|453061517|FG000|Randomized Phase|Investigator's Discretion|7|||
125935538|NCT00708162|453061518|FG001|Randomized Phase|Investigator's Discretion|10|||
125935539|NCT00708162|453061517|FG000|Randomized Phase|Death|2|||
125935540|NCT00708162|453061518|FG001|Randomized Phase|Death|9|||
125935541|NCT00708162|453061517|FG000|Randomized Phase|Pregnancy|3|||
125935542|NCT00708162|453061518|FG001|Randomized Phase|Pregnancy|0|||
125935543|NCT00708162|453061517|FG000|Open-Label Phase|Lost to Follow-up|10|||
126114103|NCT02281357|453712693|FG000|Overall Study|Adverse Event|2|||
126114104|NCT02281357|453712694|FG001|Overall Study|Adverse Event|1|||
126114105|NCT02281357|453712693|FG000|Overall Study|Lost to Follow-up|1|||
126114106|NCT02281357|453712694|FG001|Overall Study|Lost to Follow-up|0|||
126114107|NCT02281357|453712693|FG000|Overall Study|Withdrawal by Subject|4|||
126114108|NCT02281357|453712694|FG001|Overall Study|Withdrawal by Subject|3|||
126114109|NCT00523718|453713734|FG000|Overall Study|Withdrawal by Subject|1|||
126114110|NCT00523718|453713735|FG001|Overall Study|Withdrawal by Subject|0|||
125935544|NCT00708162|453061518|FG001|Open-Label Phase|Lost to Follow-up|8|||
125935545|NCT00708162|453061517|FG000|Open-Label Phase|Withdrew Consent|12|||
125935546|NCT00708162|453061518|FG001|Open-Label Phase|Withdrew Consent|6|||
125935547|NCT00708162|453061517|FG000|Open-Label Phase|Participant Noncompliance|7|||
125935548|NCT00708162|453061518|FG001|Open-Label Phase|Participant Noncompliance|7|||
125935549|NCT00708162|453061517|FG000|Open-Label Phase|Lack of Efficacy|7|||
125935550|NCT00708162|453061518|FG001|Open-Label Phase|Lack of Efficacy|4|||
125935551|NCT00708162|453061517|FG000|Open-Label Phase|Investigator's Discretion|3|||
125935552|NCT00708162|453061518|FG001|Open-Label Phase|Investigator's Discretion|2|||
125935553|NCT00708162|453061517|FG000|Open-Label Phase|Death|3|||
125935554|NCT00708162|453061518|FG001|Open-Label Phase|Death|1|||
125935555|NCT00708162|453061517|FG000|Open-Label Phase|Adverse Event|1|||
125935556|NCT00708162|453061518|FG001|Open-Label Phase|Adverse Event|2|||
125935557|NCT00708162|453061517|FG000|Open-Label Phase|Other|1|||
125935558|NCT00708162|453061518|FG001|Open-Label Phase|Other|0|||
125935559|NCT00708643|453061519|FG000|Overall Study|Adverse Event|0|||
125935560|NCT00708643|453061520|FG001|Overall Study|Adverse Event|1|||
125935561|NCT00503009|453061521|FG000|Overall Study|Protocol Violation|1|||
125935562|NCT00503009|453061522|FG001|Overall Study|Protocol Violation|0|||
125935563|NCT00503009|453061523|FG002|Overall Study|Protocol Violation|1|||
125935564|NCT00503009|453061521|FG000|Overall Study|Withdrawal by Subject|0|||
125935565|NCT00503009|453061522|FG001|Overall Study|Withdrawal by Subject|1|||
125935566|NCT00503009|453061523|FG002|Overall Study|Withdrawal by Subject|1|||
125935567|NCT00503009|453061521|FG000|Overall Study|Physician Decision|0|||
125935568|NCT00503009|453061522|FG001|Overall Study|Physician Decision|1|||
125935569|NCT00503009|453061523|FG002|Overall Study|Physician Decision|1|||
125935570|NCT01349803|453061524|FG000|Overall Study|Adverse Event|0|||
125935571|NCT01349803|453061525|FG001|Overall Study|Adverse Event|0|||
125935572|NCT01349803|453061526|FG002|Overall Study|Adverse Event|0|||
125935573|NCT01349803|453061527|FG003|Overall Study|Adverse Event|2|||
125935574|NCT01349803|453061524|FG000|Overall Study|Withdrawal by Subject|1|||
125935575|NCT01349803|453061525|FG001|Overall Study|Withdrawal by Subject|0|||
125935576|NCT01349803|453061526|FG002|Overall Study|Withdrawal by Subject|0|||
125935577|NCT01349803|453061527|FG003|Overall Study|Withdrawal by Subject|0|||
125935578|NCT01349803|453061524|FG000|Overall Study|Protocol-specified criteria|0|||
125935579|NCT01349803|453061525|FG001|Overall Study|Protocol-specified criteria|1|||
125935580|NCT01349803|453061526|FG002|Overall Study|Protocol-specified criteria|3|||
125935581|NCT01349803|453061527|FG003|Overall Study|Protocol-specified criteria|0|||
125935582|NCT01710033|453061528|FG000|Stage 2|Adverse Event|0|||
125935583|NCT01710033|453061529|FG001|Stage 2|Adverse Event|0|||
125935584|NCT01710033|453061530|FG002|Stage 2|Adverse Event|0|||
125935585|NCT01710033|453061531|FG003|Stage 2|Adverse Event|0|||
125935586|NCT01710033|453061532|FG004|Stage 2|Adverse Event|1|||
125935587|NCT00100815|453061533|FG000|Overall Study|Progression|24|||
125935588|NCT00100815|453061533|FG000|Overall Study|Adverse Event|18|||
125935589|NCT00100815|453061533|FG000|Overall Study|Death|4|||
125935590|NCT00100815|453061533|FG000|Overall Study|Other|3|||
125935591|NCT01647282|453061535|FG000|Overall Study|Physician Decision|7|||
125935592|NCT01647282|453061536|FG001|Overall Study|Physician Decision|5|||
125935593|NCT01244906|453061538|FG000|Overall Study|Death|2|||
125935594|NCT01244906|453061538|FG000|Overall Study|Progression of disease post treatment|6|||
125935595|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
125935596|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
125935597|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
125935598|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
125935599|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
126114111|NCT00523718|453713734|FG000|Overall Study|Protocol Violation|2|||
125935600|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
125935601|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
125935602|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
125935603|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
125935604|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
125935605|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
125935606|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
125935607|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
125935608|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
125935609|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
125935610|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
125935611|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
125935612|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
125935613|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
125935614|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
125935615|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
125935616|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
125935617|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
125935618|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
125935619|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
125935620|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
125935621|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
125935622|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
125935623|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
125935624|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
125935625|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
125935626|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
125935627|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
125935628|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
125935629|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
125935630|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
125935631|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
125935632|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
125935633|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
125935634|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
125935635|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
125935636|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
125935637|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
125935638|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
125935639|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
125935640|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
125935641|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
125935642|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
125935643|NCT03720470|453061539|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125935644|NCT03720470|453061540|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125935645|NCT03720470|453061541|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125935646|NCT03720470|453061542|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125935647|NCT03720470|453061543|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125935648|NCT03720470|453061544|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
125935649|NCT03720470|453061539|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
125935650|NCT03720470|453061540|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
125935651|NCT03720470|453061541|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
125935652|NCT03720470|453061542|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
125935653|NCT03720470|453061543|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
125935654|NCT03720470|453061544|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
125935655|NCT03720470|453061539|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125935656|NCT03720470|453061540|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125935657|NCT03720470|453061541|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
125935658|NCT03720470|453061542|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125935659|NCT03720470|453061543|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125935660|NCT03720470|453061544|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125935661|NCT03720470|453061539|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
125935662|NCT03720470|453061540|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
125935663|NCT03720470|453061541|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
125935664|NCT03720470|453061542|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
125935665|NCT03720470|453061543|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
125935666|NCT03720470|453061544|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
125935667|NCT03720470|453061539|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125935668|NCT03720470|453061540|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125935669|NCT03720470|453061541|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125935670|NCT03720470|453061542|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125935671|NCT03720470|453061543|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125935672|NCT03720470|453061544|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
125935673|NCT03720470|453061539|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125935674|NCT03720470|453061540|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125935675|NCT03720470|453061541|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
125935676|NCT03720470|453061542|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125935677|NCT03720470|453061543|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125935678|NCT03720470|453061544|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125935679|NCT03720470|453061539|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
125935680|NCT03720470|453061540|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
125935681|NCT03720470|453061541|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
125935682|NCT03720470|453061542|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
125935683|NCT03720470|453061543|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
125935684|NCT03720470|453061544|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
125935685|NCT03720470|453061539|FG000|Treatment Period: Final 4 Weeks|Other|0|||
125935686|NCT03720470|453061540|FG001|Treatment Period: Final 4 Weeks|Other|1|||
125935687|NCT03720470|453061541|FG002|Treatment Period: Final 4 Weeks|Other|0|||
125935688|NCT03720470|453061542|FG003|Treatment Period: Final 4 Weeks|Other|2|||
125935689|NCT03720470|453061543|FG004|Treatment Period: Final 4 Weeks|Other|1|||
125935690|NCT03720470|453061544|FG005|Treatment Period: Final 4 Weeks|Other|0|||
125935691|NCT00460031|453061545|FG000|Overall Study|Adverse Event|5|||
125935692|NCT00460031|453061545|FG000|Overall Study|Withdrawal by Subject|5|||
125935693|NCT00460031|453061545|FG000|Overall Study|Death|1|||
125935694|NCT00644995|453061546|FG000|Overall Study|Lost to Follow-up|1|||
125935695|NCT00644995|453061547|FG001|Overall Study|Lost to Follow-up|4|||
125935696|NCT00644995|453061546|FG000|Overall Study|Refused|1|||
125935697|NCT00644995|453061547|FG001|Overall Study|Refused|0|||
125935698|NCT02772081|453061548|FG000|Overall Study|Physician Decision|1|||
125935699|NCT02772081|453061549|FG001|Overall Study|Physician Decision|1|||
125935700|NCT02772081|453061548|FG000|Overall Study|Death|1|||
125935701|NCT02772081|453061549|FG001|Overall Study|Death|1|||
125935702|NCT01291173|453061553|FG000|Overall Study|Adverse Event|0|||
125935703|NCT01291173|453061554|FG001|Overall Study|Adverse Event|3|||
125935704|NCT01291173|453061555|FG002|Overall Study|Adverse Event|1|||
125935705|NCT01291173|453061556|FG003|Overall Study|Adverse Event|3|||
125935706|NCT01291173|453061553|FG000|Overall Study|Protocol Violation|7|||
125935707|NCT01291173|453061554|FG001|Overall Study|Protocol Violation|2|||
125935708|NCT01291173|453061555|FG002|Overall Study|Protocol Violation|2|||
125935709|NCT01291173|453061556|FG003|Overall Study|Protocol Violation|5|||
125935710|NCT01291173|453061553|FG000|Overall Study|Withdrawal by Subject|6|||
125935711|NCT01291173|453061554|FG001|Overall Study|Withdrawal by Subject|4|||
125935712|NCT01291173|453061555|FG002|Overall Study|Withdrawal by Subject|4|||
125935713|NCT01291173|453061556|FG003|Overall Study|Withdrawal by Subject|2|||
125935714|NCT01291173|453061553|FG000|Overall Study|Lost to Follow-up|4|||
125935715|NCT01291173|453061554|FG001|Overall Study|Lost to Follow-up|6|||
125935716|NCT01291173|453061555|FG002|Overall Study|Lost to Follow-up|3|||
125935717|NCT01291173|453061556|FG003|Overall Study|Lost to Follow-up|2|||
125935718|NCT01291173|453061553|FG000|Overall Study|Unable to meet visit schedule|0|||
125935719|NCT01291173|453061554|FG001|Overall Study|Unable to meet visit schedule|0|||
125935720|NCT01291173|453061555|FG002|Overall Study|Unable to meet visit schedule|1|||
125935721|NCT01291173|453061556|FG003|Overall Study|Unable to meet visit schedule|0|||
125935722|NCT01291173|453061553|FG000|Overall Study|Lack of compliance|0|||
125935723|NCT01291173|453061554|FG001|Overall Study|Lack of compliance|0|||
125935724|NCT01291173|453061555|FG002|Overall Study|Lack of compliance|0|||
125935725|NCT01291173|453061556|FG003|Overall Study|Lack of compliance|1|||
125935726|NCT01291173|453061553|FG000|Overall Study|Subject was unblinded|0|||
125935727|NCT01291173|453061554|FG001|Overall Study|Subject was unblinded|0|||
125935728|NCT01291173|453061555|FG002|Overall Study|Subject was unblinded|1|||
125935729|NCT01291173|453061556|FG003|Overall Study|Subject was unblinded|0|||
125935730|NCT01291173|453061553|FG000|Overall Study|Excluded therapy|0|||
125935731|NCT01291173|453061554|FG001|Overall Study|Excluded therapy|0|||
125935732|NCT01291173|453061555|FG002|Overall Study|Excluded therapy|1|||
125935733|NCT01291173|453061556|FG003|Overall Study|Excluded therapy|0|||
125935734|NCT00390858|453061557|FG000|Overall Study|Adverse Event|6|||
125935735|NCT00390858|453061558|FG001|Overall Study|Adverse Event|2|||
125935736|NCT00390858|453061557|FG000|Overall Study|Lack of Efficacy|0|||
125935737|NCT00390858|453061558|FG001|Overall Study|Lack of Efficacy|1|||
125935738|NCT00390858|453061557|FG000|Overall Study|Withdrawal by Subject|3|||
125935739|NCT00390858|453061558|FG001|Overall Study|Withdrawal by Subject|4|||
125935740|NCT01113801|453061559|FG000|Overall Study|Adverse Event|4|||
125935741|NCT01113801|453061560|FG001|Overall Study|Adverse Event|0|||
125935742|NCT01113801|453061561|FG002|Overall Study|Adverse Event|2|||
125935743|NCT01113801|453061562|FG003|Overall Study|Adverse Event|6|||
125935744|NCT01113801|453061559|FG000|Overall Study|Death|4|||
125935745|NCT01113801|453061560|FG001|Overall Study|Death|5|||
125935746|NCT01113801|453061561|FG002|Overall Study|Death|3|||
125935747|NCT01113801|453061562|FG003|Overall Study|Death|4|||
125935748|NCT01113801|453061559|FG000|Overall Study|Protocol Violation|0|||
125935749|NCT01113801|453061560|FG001|Overall Study|Protocol Violation|1|||
125935750|NCT01113801|453061561|FG002|Overall Study|Protocol Violation|0|||
125935751|NCT01113801|453061562|FG003|Overall Study|Protocol Violation|0|||
125935752|NCT01113801|453061559|FG000|Overall Study|Withdrawal by Subject|9|||
125935753|NCT01113801|453061560|FG001|Overall Study|Withdrawal by Subject|7|||
125935754|NCT01113801|453061561|FG002|Overall Study|Withdrawal by Subject|7|||
125935755|NCT01113801|453061562|FG003|Overall Study|Withdrawal by Subject|8|||
125935756|NCT01113801|453061559|FG000|Overall Study|Physician Decision|2|||
125935757|NCT01113801|453061560|FG001|Overall Study|Physician Decision|2|||
125935758|NCT01113801|453061561|FG002|Overall Study|Physician Decision|3|||
125935759|NCT01113801|453061562|FG003|Overall Study|Physician Decision|3|||
125935760|NCT01113801|453061559|FG000|Overall Study|Sponsor Decision|15|||
125935761|NCT01113801|453061560|FG001|Overall Study|Sponsor Decision|21|||
125935762|NCT01113801|453061561|FG002|Overall Study|Sponsor Decision|20|||
125935763|NCT01113801|453061562|FG003|Overall Study|Sponsor Decision|15|||
125935764|NCT01113801|453061559|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
125935765|NCT01113801|453061560|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
125935766|NCT01113801|453061561|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
125935767|NCT01113801|453061562|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
125935768|NCT02728895|453061563|FG000|Overall Study|Other|1|||
125935769|NCT02728895|453061564|FG001|Overall Study|Other|2|||
125935770|NCT02728895|453061563|FG000|Overall Study|Withdrawal by Subject|0|||
125935771|NCT02728895|453061564|FG001|Overall Study|Withdrawal by Subject|3|||
125935772|NCT01506479|453061565|FG000|Overall Study|Lost to Follow-up|1|||
125935773|NCT01506479|453061566|FG001|Overall Study|Lost to Follow-up|2|||
125935774|NCT01506479|453061567|FG002|Overall Study|Lost to Follow-up|2|||
125935775|NCT01506479|453061565|FG000|Overall Study|Withdrawal by Subject|1|||
125935776|NCT01506479|453061566|FG001|Overall Study|Withdrawal by Subject|2|||
125935777|NCT01506479|453061567|FG002|Overall Study|Withdrawal by Subject|1|||
125935778|NCT01506479|453061565|FG000|Overall Study|Missing assessment|1|||
125935779|NCT01506479|453061566|FG001|Overall Study|Missing assessment|0|||
125935780|NCT01506479|453061567|FG002|Overall Study|Missing assessment|0|||
125935781|NCT01506479|453061565|FG000|Overall Study|Adverse Event|0|||
125935782|NCT01506479|453061566|FG001|Overall Study|Adverse Event|1|||
125935783|NCT01506479|453061567|FG002|Overall Study|Adverse Event|0|||
125935784|NCT02426892|453061568|FG000|Overall Study|Adverse Event|2|||
125935785|NCT02426892|453061568|FG000|Overall Study|Lack of Efficacy|17|||
125935786|NCT02426892|453061568|FG000|Overall Study|Withdrawal by Subject|1|||
125935787|NCT02763189|453061571|FG000|Overall Study|Device failure|0|||
125935788|NCT02763189|453061572|FG001|Overall Study|Device failure|2|||
125935789|NCT02049957|453061577|FG000|Overall Study|Progressive Disease|5|||
125935790|NCT02049957|453061578|FG001|Overall Study|Progressive Disease|4|||
125935791|NCT02049957|453061579|FG002|Overall Study|Progressive Disease|2|||
125935792|NCT02049957|453061580|FG003|Overall Study|Progressive Disease|2|||
125935793|NCT02049957|453061581|FG004|Overall Study|Progressive Disease|6|||
125935794|NCT02049957|453061582|FG005|Overall Study|Progressive Disease|35|||
125935795|NCT02049957|453061583|FG006|Overall Study|Progressive Disease|7|||
125935796|NCT02049957|453061584|FG007|Overall Study|Progressive Disease|26|||
125935797|NCT02049957|453061585|FG008|Overall Study|Progressive Disease|6|||
125935798|NCT02049957|453061577|FG000|Overall Study|Adverse Event|1|||
125935799|NCT02049957|453061578|FG001|Overall Study|Adverse Event|1|||
125935800|NCT02049957|453061579|FG002|Overall Study|Adverse Event|1|||
125935801|NCT02049957|453061580|FG003|Overall Study|Adverse Event|0|||
125935802|NCT02049957|453061581|FG004|Overall Study|Adverse Event|0|||
125935803|NCT02049957|453061582|FG005|Overall Study|Adverse Event|5|||
125935804|NCT02049957|453061583|FG006|Overall Study|Adverse Event|0|||
125935805|NCT02049957|453061584|FG007|Overall Study|Adverse Event|6|||
125935806|NCT02049957|453061585|FG008|Overall Study|Adverse Event|1|||
125935807|NCT02049957|453061577|FG000|Overall Study|Study Terminated by Sponsor|0|||
125935808|NCT02049957|453061578|FG001|Overall Study|Study Terminated by Sponsor|1|||
125935809|NCT02049957|453061579|FG002|Overall Study|Study Terminated by Sponsor|0|||
125935810|NCT02049957|453061580|FG003|Overall Study|Study Terminated by Sponsor|0|||
125935811|NCT02049957|453061581|FG004|Overall Study|Study Terminated by Sponsor|0|||
125935812|NCT02049957|453061582|FG005|Overall Study|Study Terminated by Sponsor|0|||
125935813|NCT02049957|453061583|FG006|Overall Study|Study Terminated by Sponsor|1|||
125935814|NCT02049957|453061584|FG007|Overall Study|Study Terminated by Sponsor|0|||
125935815|NCT02049957|453061585|FG008|Overall Study|Study Terminated by Sponsor|0|||
125935816|NCT02049957|453061577|FG000|Overall Study|Withdrawal by Subject|0|||
125935817|NCT02049957|453061578|FG001|Overall Study|Withdrawal by Subject|0|||
125935818|NCT02049957|453061579|FG002|Overall Study|Withdrawal by Subject|0|||
125935819|NCT02049957|453061580|FG003|Overall Study|Withdrawal by Subject|1|||
125935820|NCT02049957|453061581|FG004|Overall Study|Withdrawal by Subject|0|||
125935821|NCT02049957|453061582|FG005|Overall Study|Withdrawal by Subject|2|||
125935822|NCT02049957|453061583|FG006|Overall Study|Withdrawal by Subject|0|||
125935823|NCT02049957|453061584|FG007|Overall Study|Withdrawal by Subject|3|||
125935824|NCT02049957|453061585|FG008|Overall Study|Withdrawal by Subject|1|||
125935825|NCT02049957|453061577|FG000|Overall Study|Physician Decision|0|||
125935826|NCT02049957|453061578|FG001|Overall Study|Physician Decision|0|||
125935827|NCT02049957|453061579|FG002|Overall Study|Physician Decision|0|||
125935828|NCT02049957|453061580|FG003|Overall Study|Physician Decision|0|||
125935829|NCT02049957|453061581|FG004|Overall Study|Physician Decision|0|||
125935830|NCT02049957|453061582|FG005|Overall Study|Physician Decision|1|||
125935831|NCT02049957|453061583|FG006|Overall Study|Physician Decision|0|||
125935832|NCT02049957|453061584|FG007|Overall Study|Physician Decision|0|||
125935833|NCT02049957|453061585|FG008|Overall Study|Physician Decision|0|||
125935834|NCT03557151|453061586|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
125935835|NCT03557151|453061587|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
125935836|NCT03557151|453061586|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
125935837|NCT03557151|453061587|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
125935838|NCT03557151|453061586|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
125935839|NCT03557151|453061587|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
125935840|NCT01414075|453061588|FG000|Overall Study|Adverse Event|1|||
125935841|NCT01414075|453061589|FG001|Overall Study|Adverse Event|0|||
125935842|NCT01414075|453061590|FG002|Overall Study|Adverse Event|1|||
125935843|NCT01414075|453061591|FG003|Overall Study|Adverse Event|0|||
125935844|NCT01414075|453061588|FG000|Overall Study|Death|1|||
125935845|NCT01414075|453061589|FG001|Overall Study|Death|0|||
125935846|NCT01414075|453061590|FG002|Overall Study|Death|0|||
125935847|NCT01414075|453061591|FG003|Overall Study|Death|1|||
125935848|NCT01414075|453061588|FG000|Overall Study|Withdrawal by Subject|0|||
125935849|NCT01414075|453061589|FG001|Overall Study|Withdrawal by Subject|0|||
125935850|NCT01414075|453061590|FG002|Overall Study|Withdrawal by Subject|0|||
125935851|NCT01414075|453061591|FG003|Overall Study|Withdrawal by Subject|1|||
125935852|NCT01414075|453061588|FG000|Overall Study|Other than specified|1|||
125935853|NCT01414075|453061589|FG001|Overall Study|Other than specified|0|||
125935854|NCT01414075|453061590|FG002|Overall Study|Other than specified|1|||
125935855|NCT01414075|453061591|FG003|Overall Study|Other than specified|0|||
125935856|NCT04903626|453061596|FG000|Overall Study|Lost to Follow-up|6|||
125935857|NCT04903626|453061596|FG000|Overall Study|Withdrawal by Subject|1|||
125935858|NCT04903626|453061596|FG000|Overall Study|Other, Not Specified|1|||
125935859|NCT00573534|453061597|FG000|Overall Study|oppositional behavior|3|||
125935860|NCT00467259|453061604|FG000|Overall Study|Adverse Event|24|||
125935861|NCT00467259|453061605|FG001|Overall Study|Adverse Event|90|||
125935862|NCT00467259|453061604|FG000|Overall Study|Protocol Violation|1|||
125935863|NCT00467259|453061605|FG001|Overall Study|Protocol Violation|7|||
125935864|NCT00467259|453061604|FG000|Overall Study|Withdrawal by Subject|34|||
125935865|NCT00467259|453061605|FG001|Overall Study|Withdrawal by Subject|108|||
125935866|NCT00467259|453061604|FG000|Overall Study|Physician Decision|0|||
125935867|NCT00467259|453061605|FG001|Overall Study|Physician Decision|2|||
125935868|NCT00467259|453061604|FG000|Overall Study|Lost to Follow-up|14|||
125935869|NCT00467259|453061605|FG001|Overall Study|Lost to Follow-up|34|||
125935870|NCT00467259|453061604|FG000|Overall Study|Site Closed|2|||
125935871|NCT00467259|453061605|FG001|Overall Study|Site Closed|1|||
125935872|NCT04285879|453061608|FG000|Overall Study|Lost to Follow-up|1|||
125935873|NCT04285879|453061609|FG001|Overall Study|Lost to Follow-up|8|||
125935874|NCT04285879|453061608|FG000|Overall Study|medical/surgical exclusion|16|||
125935875|NCT04285879|453061609|FG001|Overall Study|medical/surgical exclusion|0|||
125935876|NCT01634360|453061611|FG000|Overall Study|Adverse Event|10|||
125935877|NCT01634360|453061612|FG001|Overall Study|Adverse Event|34|||
125935878|NCT01634360|453061611|FG000|Overall Study|subject withdrew consent|13|||
125935879|NCT01634360|453061612|FG001|Overall Study|subject withdrew consent|23|||
125935880|NCT01634360|453061611|FG000|Overall Study|Protocol Violation|1|||
125935881|NCT01634360|453061612|FG001|Overall Study|Protocol Violation|1|||
125935882|NCT01634360|453061611|FG000|Overall Study|Lack of Efficacy|4|||
125935883|NCT01634360|453061612|FG001|Overall Study|Lack of Efficacy|14|||
125935884|NCT01634360|453061611|FG000|Overall Study|Other|3|||
126066365|NCT04295499|453533565|FG001|Overall Study|moving out of state|0|||
126066366|NCT04295499|453533564|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
126066367|NCT04295499|453533565|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
126066368|NCT02135445|453533566|FG000|Overall Study|Lost to Follow-up|1|||
126066369|NCT02135445|453533567|FG001|Overall Study|Lost to Follow-up|0|||
125935885|NCT01634360|453061612|FG001|Overall Study|Other|20|||
125935886|NCT01634360|453061611|FG000|Overall Study|Study termination by sponsor|18|||
125935887|NCT01634360|453061612|FG001|Overall Study|Study termination by sponsor|44|||
125935888|NCT02028065|453061613|FG000|Randomization Through Start Treatment|Not treated|1|||
125935889|NCT02028065|453061614|FG001|Randomization Through Start Treatment|Not treated|3|||
125935890|NCT02028065|453061615|FG002|Randomization Through Start Treatment|Not treated|3|||
125935891|NCT02028065|453061613|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
125935892|NCT02028065|453061614|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
125935893|NCT02028065|453061615|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
125935894|NCT02028065|453061613|FG000|Treatment Through Study Completion|Physician Decision|1|||
125935895|NCT02028065|453061614|FG001|Treatment Through Study Completion|Physician Decision|0|||
125935896|NCT02028065|453061615|FG002|Treatment Through Study Completion|Physician Decision|0|||
125935897|NCT02028065|453061613|FG000|Treatment Through Study Completion|Protocol Violation|1|||
125935898|NCT02028065|453061614|FG001|Treatment Through Study Completion|Protocol Violation|4|||
125935899|NCT02028065|453061615|FG002|Treatment Through Study Completion|Protocol Violation|0|||
125935900|NCT02028065|453061613|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
125935901|NCT02028065|453061614|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
125935902|NCT02028065|453061615|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
125935903|NCT02028065|453061613|FG000|Treatment Through Study Completion|Adverse Event|3|||
125935904|NCT02028065|453061614|FG001|Treatment Through Study Completion|Adverse Event|3|||
125935905|NCT02028065|453061615|FG002|Treatment Through Study Completion|Adverse Event|5|||
125935906|NCT00877383|453061619|FG000|Overall Study|Adverse Event|13|||
125935907|NCT00877383|453061620|FG001|Overall Study|Adverse Event|14|||
125935908|NCT00877383|453061619|FG000|Overall Study|Lost to Follow-up|5|||
125935909|NCT00877383|453061620|FG001|Overall Study|Lost to Follow-up|3|||
125935910|NCT00877383|453061619|FG000|Overall Study|Subject withdrew consent|3|||
125935911|NCT00877383|453061620|FG001|Overall Study|Subject withdrew consent|12|||
125935912|NCT00877383|453061619|FG000|Overall Study|Subject no longer requires study drug|2|||
125935913|NCT00877383|453061620|FG001|Overall Study|Subject no longer requires study drug|0|||
125935914|NCT00877383|453061619|FG000|Overall Study|Administrative problems|2|||
125935915|NCT00877383|453061620|FG001|Overall Study|Administrative problems|0|||
125935916|NCT00877383|453061619|FG000|Overall Study|Protocol deviation|2|||
125935917|NCT00877383|453061620|FG001|Overall Study|Protocol deviation|6|||
125935918|NCT00877383|453061619|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125935919|NCT00877383|453061620|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125935920|NCT00877383|453061619|FG000|Overall Study|Death|1|||
125935921|NCT00877383|453061620|FG001|Overall Study|Death|2|||
125935922|NCT02107482|453061621|FG000|Overall Study|inconveinence|2|||
125935923|NCT02107482|453061621|FG000|Overall Study|Lost to Follow-up|1|||
125935924|NCT02107482|453061621|FG000|Overall Study|Lack of Efficacy|1|||
125935925|NCT04868890|453061628|FG000|Overall Study|Death|2|||
125935926|NCT04868890|453061629|FG001|Overall Study|Death|1|||
125935927|NCT04868890|453061628|FG000|Overall Study|Withdrawal by Subject|1|||
125935928|NCT04868890|453061629|FG001|Overall Study|Withdrawal by Subject|5|||
125935929|NCT00867009|453061630|FG000|Induction Period|Nonserious Adverse Event|5|||
125935930|NCT00867009|453061630|FG000|Induction Period|Serious Adverse Event|10|||
125935931|NCT00867009|453061630|FG000|Induction Period|Death due to serious adverse event|6|||
125935932|NCT00867009|453061630|FG000|Induction Period|Death due to Study Disease|4|||
125935933|NCT00867009|453061630|FG000|Induction Period|Protocol Violation|1|||
125935934|NCT00867009|453061630|FG000|Induction Period|Withdrawal by Subject|8|||
125935935|NCT00867009|453061630|FG000|Induction Period|Physician Decision|3|||
125935936|NCT00867009|453061630|FG000|Induction Period|Progressive Disease (PD)|25|||
125935937|NCT00867009|453061630|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
125935938|NCT01339429|453061638|FG000|Overall Study|Withdrawal by Subject|1|||
125935939|NCT01339429|453061638|FG000|Overall Study|Physician Decision|3|||
125935940|NCT01085591|453061639|FG000|Overall Study|Adverse Event|0|||
125935941|NCT01085591|453061640|FG001|Overall Study|Adverse Event|1|||
125935942|NCT01085591|453061641|FG002|Overall Study|Adverse Event|3|||
125935943|NCT01085591|453061639|FG000|Overall Study|Physician Decision|1|||
125935944|NCT01085591|453061640|FG001|Overall Study|Physician Decision|0|||
125935945|NCT01085591|453061641|FG002|Overall Study|Physician Decision|1|||
125935946|NCT01085591|453061639|FG000|Overall Study|Withdrawal by Subject|0|||
125935947|NCT01085591|453061640|FG001|Overall Study|Withdrawal by Subject|2|||
125935948|NCT01085591|453061641|FG002|Overall Study|Withdrawal by Subject|1|||
125935949|NCT01085591|453061639|FG000|Overall Study|Lost to Follow-up|0|||
125935950|NCT01085591|453061640|FG001|Overall Study|Lost to Follow-up|1|||
125935951|NCT01085591|453061641|FG002|Overall Study|Lost to Follow-up|1|||
125935952|NCT01085591|453061639|FG000|Overall Study|Protocol Violation|1|||
125935953|NCT01085591|453061640|FG001|Overall Study|Protocol Violation|1|||
125935954|NCT01085591|453061641|FG002|Overall Study|Protocol Violation|1|||
125935955|NCT01085591|453061639|FG000|Overall Study|Other|0|||
125935956|NCT01085591|453061640|FG001|Overall Study|Other|1|||
125935957|NCT01085591|453061641|FG002|Overall Study|Other|0|||
125935958|NCT01085591|453061639|FG000|Overall Study|Not Properly Consented|1|||
125935959|NCT01085591|453061640|FG001|Overall Study|Not Properly Consented|0|||
125935960|NCT01085591|453061641|FG002|Overall Study|Not Properly Consented|0|||
125935961|NCT00396591|453061642|FG000|Overall Study|Disease Progression|13|||
125935962|NCT00396591|453061642|FG000|Overall Study|Adverse Event|2|||
125935963|NCT00396591|453061642|FG000|Overall Study|Participant request|1|||
125935964|NCT00556712|453061643|FG000|Overall Study|Adverse Event|7|||
125935965|NCT00556712|453061644|FG001|Overall Study|Adverse Event|19|||
125935966|NCT00556712|453061643|FG000|Overall Study|Death|5|||
125935967|NCT00556712|453061644|FG001|Overall Study|Death|10|||
125935968|NCT00556712|453061643|FG000|Overall Study|Progressive Disease|383|||
125935969|NCT00556712|453061644|FG001|Overall Study|Progressive Disease|320|||
125935970|NCT00556712|453061643|FG000|Overall Study|Protocol Violation|3|||
125935971|NCT00556712|453061644|FG001|Overall Study|Protocol Violation|2|||
125935972|NCT00556712|453061643|FG000|Overall Study|Refused Treatment|17|||
125935973|NCT00556712|453061644|FG001|Overall Study|Refused Treatment|16|||
125935974|NCT00556712|453061643|FG000|Overall Study|Failure to Return|2|||
125935975|NCT00556712|453061644|FG001|Overall Study|Failure to Return|3|||
125935976|NCT00556712|453061643|FG000|Overall Study|Other|2|||
125935977|NCT00556712|453061644|FG001|Overall Study|Other|2|||
125935978|NCT00556712|453061643|FG000|Overall Study|Ongoing at Data Cutoff|32|||
125935979|NCT00556712|453061644|FG001|Overall Study|Ongoing at Data Cutoff|66|||
125935980|NCT00818662|453061648|FG000|Overall Study|Adverse Event|5|||
125935981|NCT00818662|453061649|FG001|Overall Study|Adverse Event|14|||
125935982|NCT00818662|453061650|FG002|Overall Study|Adverse Event|4|||
125935983|NCT00818662|453061651|FG003|Overall Study|Adverse Event|3|||
125935984|NCT00818662|453061648|FG000|Overall Study|Withdrawal by Subject|5|||
125935985|NCT00818662|453061649|FG001|Overall Study|Withdrawal by Subject|4|||
125935986|NCT00818662|453061650|FG002|Overall Study|Withdrawal by Subject|2|||
125935987|NCT00818662|453061651|FG003|Overall Study|Withdrawal by Subject|2|||
125935988|NCT00818662|453061648|FG000|Overall Study|Death|1|||
125935989|NCT00818662|453061649|FG001|Overall Study|Death|3|||
125935990|NCT00818662|453061650|FG002|Overall Study|Death|0|||
125935991|NCT00818662|453061651|FG003|Overall Study|Death|0|||
125935992|NCT00818662|453061648|FG000|Overall Study|Physician Decision|1|||
125935993|NCT00818662|453061649|FG001|Overall Study|Physician Decision|0|||
125935994|NCT00818662|453061650|FG002|Overall Study|Physician Decision|0|||
125935995|NCT00818662|453061651|FG003|Overall Study|Physician Decision|0|||
125935996|NCT00818662|453061648|FG000|Overall Study|Lost to Follow-up|0|||
125935997|NCT00818662|453061649|FG001|Overall Study|Lost to Follow-up|0|||
125935998|NCT00818662|453061650|FG002|Overall Study|Lost to Follow-up|0|||
125935999|NCT00818662|453061651|FG003|Overall Study|Lost to Follow-up|1|||
125936000|NCT00818662|453061648|FG000|Overall Study|Unwilling or Unable to Participate|4|||
125936001|NCT00818662|453061649|FG001|Overall Study|Unwilling or Unable to Participate|6|||
125936002|NCT00818662|453061650|FG002|Overall Study|Unwilling or Unable to Participate|2|||
125936003|NCT00818662|453061651|FG003|Overall Study|Unwilling or Unable to Participate|4|||
125936004|NCT00818662|453061648|FG000|Overall Study|Protocol Violation|1|||
125936005|NCT00818662|453061649|FG001|Overall Study|Protocol Violation|1|||
125936006|NCT00818662|453061650|FG002|Overall Study|Protocol Violation|0|||
125936007|NCT00818662|453061651|FG003|Overall Study|Protocol Violation|0|||
125936008|NCT00818662|453061648|FG000|Overall Study|Requires a Prohibited Medication|1|||
125936009|NCT00818662|453061649|FG001|Overall Study|Requires a Prohibited Medication|0|||
125936010|NCT00818662|453061650|FG002|Overall Study|Requires a Prohibited Medication|0|||
125936011|NCT00818662|453061651|FG003|Overall Study|Requires a Prohibited Medication|0|||
125936012|NCT00818662|453061648|FG000|Overall Study|Safety Risk|1|||
125936013|NCT00818662|453061649|FG001|Overall Study|Safety Risk|1|||
125936014|NCT00818662|453061650|FG002|Overall Study|Safety Risk|0|||
125936015|NCT00818662|453061651|FG003|Overall Study|Safety Risk|1|||
125936016|NCT00818662|453061648|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
125936017|NCT00818662|453061649|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
125936018|NCT00818662|453061650|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
125936019|NCT00818662|453061651|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
125936020|NCT00818662|453061648|FG000|Overall Study|Participant's health declined|0|||
125936021|NCT00818662|453061649|FG001|Overall Study|Participant's health declined|0|||
125936022|NCT00818662|453061650|FG002|Overall Study|Participant's health declined|0|||
125936023|NCT00818662|453061651|FG003|Overall Study|Participant's health declined|1|||
125936024|NCT00818662|453061648|FG000|Overall Study|Caregiver to pursue other treatment|0|||
125936025|NCT00818662|453061649|FG001|Overall Study|Caregiver to pursue other treatment|1|||
126066370|NCT02135445|453533566|FG000|Overall Study|Withdrawal by Subject|1|||
126066371|NCT02135445|453533567|FG001|Overall Study|Withdrawal by Subject|0|||
126066372|NCT03050372|453534873|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
126066373|NCT03050372|453534874|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
126066374|NCT03050372|453534873|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
126066375|NCT03050372|453534874|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
125936026|NCT00818662|453061650|FG002|Overall Study|Caregiver to pursue other treatment|0|||
125936027|NCT00818662|453061651|FG003|Overall Study|Caregiver to pursue other treatment|0|||
125936028|NCT00818662|453061648|FG000|Overall Study|Moving out of state|0|||
126066376|NCT02543294|453534877|FG000|Overall Study|Lost to Follow-up|3|||
126066377|NCT02543294|453534877|FG000|Overall Study|Physician Decision|2|||
126114112|NCT00523718|453713735|FG001|Overall Study|Protocol Violation|0|||
125936029|NCT00818662|453061649|FG001|Overall Study|Moving out of state|0|||
125936030|NCT00818662|453061650|FG002|Overall Study|Moving out of state|0|||
125936031|NCT00818662|453061651|FG003|Overall Study|Moving out of state|1|||
125936032|NCT00818662|453061648|FG000|Overall Study|Declined move to another study site|1|||
125936033|NCT00818662|453061649|FG001|Overall Study|Declined move to another study site|0|||
125936034|NCT00818662|453061650|FG002|Overall Study|Declined move to another study site|0|||
125936035|NCT00818662|453061651|FG003|Overall Study|Declined move to another study site|0|||
125936036|NCT00818662|453061648|FG000|Overall Study|Change in living situation|0|||
125936037|NCT00818662|453061649|FG001|Overall Study|Change in living situation|0|||
126114113|NCT02060383|453713736|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
126114114|NCT02060383|453713737|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
126114115|NCT02060383|453713738|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
126114116|NCT02060383|453713739|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
125936038|NCT00818662|453061650|FG002|Overall Study|Change in living situation|0|||
125936039|NCT00818662|453061651|FG003|Overall Study|Change in living situation|1|||
125936040|NCT00818662|453061648|FG000|Overall Study|Study partner decision|0|||
125936041|NCT00818662|453061649|FG001|Overall Study|Study partner decision|0|||
126114117|NCT02060383|453713740|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
126114118|NCT02060383|453713736|FG000|Core Phase|Adverse Event|2|||
126114119|NCT02060383|453713737|FG001|Core Phase|Adverse Event|0|||
126114120|NCT02060383|453713738|FG002|Core Phase|Adverse Event|0|||
126114121|NCT02060383|453713739|FG003|Core Phase|Adverse Event|2|||
126114122|NCT02060383|453713740|FG004|Core Phase|Adverse Event|6|||
126114123|NCT02060383|453713736|FG000|Core Phase|Administrative problems|0|||
126114124|NCT02060383|453713737|FG001|Core Phase|Administrative problems|1|||
126114125|NCT02060383|453713738|FG002|Core Phase|Administrative problems|0|||
126114126|NCT02060383|453713739|FG003|Core Phase|Administrative problems|0|||
125936042|NCT00818662|453061650|FG002|Overall Study|Study partner decision|0|||
125936043|NCT00818662|453061651|FG003|Overall Study|Study partner decision|1|||
125936044|NCT00818662|453061648|FG000|Overall Study|Admitted to long term nursing care|0|||
125936045|NCT00818662|453061649|FG001|Overall Study|Admitted to long term nursing care|1|||
125936046|NCT00818662|453061650|FG002|Overall Study|Admitted to long term nursing care|0|||
125936047|NCT00818662|453061651|FG003|Overall Study|Admitted to long term nursing care|0|||
125936048|NCT01472081|453061652|FG000|Overall Study|Continuing treatment at time of analysis|1|||
125936049|NCT01472081|453061653|FG001|Overall Study|Continuing treatment at time of analysis|4|||
125936050|NCT01472081|453061654|FG002|Overall Study|Continuing treatment at time of analysis|1|||
125936051|NCT01472081|453061655|FG003|Overall Study|Continuing treatment at time of analysis|8|||
125936052|NCT01472081|453061656|FG004|Overall Study|Continuing treatment at time of analysis|9|||
125936053|NCT01472081|453061657|FG005|Overall Study|Continuing treatment at time of analysis|0|||
125936054|NCT01472081|453061652|FG000|Overall Study|Disease Progression|4|||
125936055|NCT01472081|453061653|FG001|Overall Study|Disease Progression|10|||
125936056|NCT01472081|453061654|FG002|Overall Study|Disease Progression|12|||
125936057|NCT01472081|453061655|FG003|Overall Study|Disease Progression|31|||
125936058|NCT01472081|453061656|FG004|Overall Study|Disease Progression|22|||
125936059|NCT01472081|453061657|FG005|Overall Study|Disease Progression|3|||
125936060|NCT01472081|453061652|FG000|Overall Study|Study drug toxicity|2|||
125936061|NCT01472081|453061653|FG001|Overall Study|Study drug toxicity|9|||
125936062|NCT01472081|453061654|FG002|Overall Study|Study drug toxicity|4|||
125936063|NCT01472081|453061655|FG003|Overall Study|Study drug toxicity|6|||
125936064|NCT01472081|453061656|FG004|Overall Study|Study drug toxicity|13|||
125936065|NCT01472081|453061657|FG005|Overall Study|Study drug toxicity|2|||
125936066|NCT01472081|453061652|FG000|Overall Study|Death|0|||
125936067|NCT01472081|453061653|FG001|Overall Study|Death|0|||
125936068|NCT01472081|453061654|FG002|Overall Study|Death|0|||
125936069|NCT01472081|453061655|FG003|Overall Study|Death|0|||
125936070|NCT01472081|453061656|FG004|Overall Study|Death|1|||
125936071|NCT01472081|453061657|FG005|Overall Study|Death|0|||
125936072|NCT01472081|453061652|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
125936073|NCT01472081|453061653|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
125936074|NCT01472081|453061654|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
125936075|NCT01472081|453061655|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
125936076|NCT01472081|453061656|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
125936077|NCT01472081|453061657|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
125936078|NCT01472081|453061652|FG000|Overall Study|Withdrawal by Subject|0|||
125936079|NCT01472081|453061653|FG001|Overall Study|Withdrawal by Subject|0|||
125936080|NCT01472081|453061654|FG002|Overall Study|Withdrawal by Subject|0|||
125936081|NCT01472081|453061655|FG003|Overall Study|Withdrawal by Subject|0|||
125936082|NCT01472081|453061656|FG004|Overall Study|Withdrawal by Subject|0|||
125936083|NCT01472081|453061657|FG005|Overall Study|Withdrawal by Subject|1|||
125936084|NCT01472081|453061652|FG000|Overall Study|Poor/non-compliance|0|||
125936085|NCT01472081|453061653|FG001|Overall Study|Poor/non-compliance|0|||
125936086|NCT01472081|453061654|FG002|Overall Study|Poor/non-compliance|1|||
125936087|NCT01472081|453061655|FG003|Overall Study|Poor/non-compliance|0|||
126114127|NCT02060383|453713740|FG004|Core Phase|Administrative problems|0|||
125936088|NCT01472081|453061656|FG004|Overall Study|Poor/non-compliance|1|||
125936089|NCT01472081|453061657|FG005|Overall Study|Poor/non-compliance|0|||
125936090|NCT01472081|453061652|FG000|Overall Study|No longer meets study criteria|0|||
125936091|NCT01472081|453061653|FG001|Overall Study|No longer meets study criteria|0|||
126114128|NCT02060383|453713736|FG000|Core Phase|Protocol Violation|0|||
126114129|NCT02060383|453713737|FG001|Core Phase|Protocol Violation|0|||
126114130|NCT02060383|453713738|FG002|Core Phase|Protocol Violation|0|||
125936092|NCT01472081|453061654|FG002|Overall Study|No longer meets study criteria|1|||
125936093|NCT01472081|453061655|FG003|Overall Study|No longer meets study criteria|0|||
125936094|NCT01472081|453061656|FG004|Overall Study|No longer meets study criteria|0|||
126114131|NCT02060383|453713739|FG003|Core Phase|Protocol Violation|1|||
125936095|NCT01472081|453061657|FG005|Overall Study|No longer meets study criteria|0|||
125936096|NCT01472081|453061652|FG000|Overall Study|Subject request to discontinue treatment|0|||
125936097|NCT01472081|453061653|FG001|Overall Study|Subject request to discontinue treatment|3|||
125936098|NCT01472081|453061654|FG002|Overall Study|Subject request to discontinue treatment|1|||
125936099|NCT01472081|453061655|FG003|Overall Study|Subject request to discontinue treatment|1|||
125936100|NCT01472081|453061656|FG004|Overall Study|Subject request to discontinue treatment|0|||
125936101|NCT01472081|453061657|FG005|Overall Study|Subject request to discontinue treatment|0|||
125936102|NCT03605303|453061658|FG000|Period 1|Study Terminated|2|||
125936103|NCT03605303|453061659|FG001|Period 1|Study Terminated|1|||
125936104|NCT01572909|453063393|FG000|Overall Study|Adverse Event|7|||
125936105|NCT01572909|453063394|FG001|Overall Study|Adverse Event|2|||
125936106|NCT01572909|453063393|FG000|Overall Study|Death|3|||
125936107|NCT01572909|453063394|FG001|Overall Study|Death|1|||
125936108|NCT01572909|453063393|FG000|Overall Study|Lost to Follow-up|8|||
125936109|NCT01572909|453063394|FG001|Overall Study|Lost to Follow-up|7|||
125936110|NCT01572909|453063393|FG000|Overall Study|Physician Decision|1|||
125936111|NCT01572909|453063394|FG001|Overall Study|Physician Decision|1|||
125936112|NCT01572909|453063393|FG000|Overall Study|Technical Issues|1|||
125936113|NCT01572909|453063394|FG001|Overall Study|Technical Issues|0|||
125936114|NCT01572909|453063393|FG000|Overall Study|Withdrawal by Subject|12|||
125936115|NCT01572909|453063394|FG001|Overall Study|Withdrawal by Subject|11|||
125936116|NCT01572909|453063393|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
125936117|NCT01572909|453063394|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
125936118|NCT03641651|453063395|FG000|Overall Study|organizational issues at one study site|1|||
125936119|NCT04779489|453063396|FG000|Overall Study|Physician Decision|1|||
125936120|NCT00623727|453063397|FG000|Double Blind (DB)|Adverse Event|1|||
125936121|NCT00623727|453063398|FG001|Double Blind (DB)|Adverse Event|3|||
125936122|NCT00623727|453063397|FG000|Double Blind (DB)|Physician Decision|0|||
125936123|NCT00623727|453063398|FG001|Double Blind (DB)|Physician Decision|1|||
125936124|NCT00623727|453063397|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
125936125|NCT00623727|453063398|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
125936126|NCT00623727|453063397|FG000|Double Blind (DB)|Lack of Efficacy|2|||
125936127|NCT00623727|453063398|FG001|Double Blind (DB)|Lack of Efficacy|2|||
125936128|NCT00623727|453063397|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
125936129|NCT00623727|453063398|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
125936130|NCT00623727|453063397|FG000|Double Blind (DB)|Lost to Follow-up|1|||
125936131|NCT00623727|453063398|FG001|Double Blind (DB)|Lost to Follow-up|1|||
125936132|NCT00623727|453063397|FG000|Double Blind (DB)|Protocol Violation|2|||
125936133|NCT00623727|453063398|FG001|Double Blind (DB)|Protocol Violation|2|||
125936134|NCT00623727|453063397|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
125936135|NCT00623727|453063398|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
125936136|NCT00623727|453063397|FG000|Open Label Follow-up|Study termination|0|||
125936137|NCT00623727|453063398|FG001|Open Label Follow-up|Study termination|6|||
125936138|NCT00623727|453063397|FG000|Open Label Follow-up|Participant convenience|0|||
125936139|NCT00623727|453063398|FG001|Open Label Follow-up|Participant convenience|1|||
125936140|NCT00951665|453063399|FG000|Phase 1b|Adverse Event|2|||
125936141|NCT00951665|453063400|FG001|Phase 1b|Adverse Event|1|||
125936142|NCT00951665|453063401|FG002|Phase 1b|Adverse Event|0|||
125936143|NCT00951665|453063402|FG003|Phase 1b|Adverse Event|1|||
125936144|NCT00951665|453063403|FG004|Phase 1b|Adverse Event|0|||
125936145|NCT00951665|453063404|FG005|Phase 1b|Adverse Event|0|||
125936146|NCT00951665|453063399|FG000|Phase 1b|Death|1|||
125936147|NCT00951665|453063400|FG001|Phase 1b|Death|0|||
125936148|NCT00951665|453063401|FG002|Phase 1b|Death|2|||
125936149|NCT00951665|453063402|FG003|Phase 1b|Death|0|||
125936150|NCT00951665|453063403|FG004|Phase 1b|Death|0|||
125936151|NCT00951665|453063404|FG005|Phase 1b|Death|0|||
125936152|NCT00951665|453063399|FG000|Phase 1b|Physician Decision|4|||
125936153|NCT00951665|453063400|FG001|Phase 1b|Physician Decision|0|||
125936154|NCT00951665|453063401|FG002|Phase 1b|Physician Decision|1|||
126114132|NCT02060383|453713740|FG004|Core Phase|Protocol Violation|0|||
126114133|NCT02060383|453713736|FG000|Core Phase|Withdrawal by Subject|0|||
125936155|NCT00951665|453063402|FG003|Phase 1b|Physician Decision|0|||
125936156|NCT00951665|453063403|FG004|Phase 1b|Physician Decision|0|||
126114134|NCT02060383|453713737|FG001|Core Phase|Withdrawal by Subject|0|||
126114135|NCT02060383|453713738|FG002|Core Phase|Withdrawal by Subject|0|||
126114136|NCT02060383|453713739|FG003|Core Phase|Withdrawal by Subject|4|||
125936157|NCT00951665|453063404|FG005|Phase 1b|Physician Decision|0|||
125936158|NCT00951665|453063399|FG000|Phase 1b|Withdrawal by Subject|0|||
125936159|NCT00951665|453063400|FG001|Phase 1b|Withdrawal by Subject|1|||
126114137|NCT02060383|453713740|FG004|Core Phase|Withdrawal by Subject|2|||
125936160|NCT00951665|453063401|FG002|Phase 1b|Withdrawal by Subject|0|||
125936161|NCT00951665|453063402|FG003|Phase 1b|Withdrawal by Subject|0|||
125936162|NCT00951665|453063403|FG004|Phase 1b|Withdrawal by Subject|0|||
125936163|NCT00951665|453063404|FG005|Phase 1b|Withdrawal by Subject|0|||
125936164|NCT00951665|453063399|FG000|Phase 1b|Disease Progression|13|||
125936165|NCT00951665|453063400|FG001|Phase 1b|Disease Progression|2|||
125936166|NCT00951665|453063401|FG002|Phase 1b|Disease Progression|14|||
125936167|NCT00951665|453063402|FG003|Phase 1b|Disease Progression|0|||
125936168|NCT00951665|453063403|FG004|Phase 1b|Disease Progression|0|||
125936169|NCT00951665|453063404|FG005|Phase 1b|Disease Progression|0|||
125936170|NCT00951665|453063399|FG000|Phase 1b|Protocol Violation|2|||
125936171|NCT00951665|453063400|FG001|Phase 1b|Protocol Violation|0|||
125936172|NCT00951665|453063401|FG002|Phase 1b|Protocol Violation|0|||
125936173|NCT00951665|453063402|FG003|Phase 1b|Protocol Violation|0|||
125936174|NCT00951665|453063403|FG004|Phase 1b|Protocol Violation|0|||
125936175|NCT00951665|453063404|FG005|Phase 1b|Protocol Violation|0|||
125936176|NCT00951665|453063399|FG000|Phase 2a|Adverse Event|0|||
125936177|NCT00951665|453063400|FG001|Phase 2a|Adverse Event|0|||
125936178|NCT00951665|453063401|FG002|Phase 2a|Adverse Event|0|||
125936179|NCT00951665|453063402|FG003|Phase 2a|Adverse Event|0|||
125936180|NCT00951665|453063403|FG004|Phase 2a|Adverse Event|2|||
125936181|NCT00951665|453063404|FG005|Phase 2a|Adverse Event|0|||
125936182|NCT00951665|453063399|FG000|Phase 2a|Death|0|||
125936183|NCT00951665|453063400|FG001|Phase 2a|Death|0|||
125936184|NCT00951665|453063401|FG002|Phase 2a|Death|0|||
125936185|NCT00951665|453063402|FG003|Phase 2a|Death|0|||
125936186|NCT00951665|453063403|FG004|Phase 2a|Death|1|||
125936187|NCT00951665|453063404|FG005|Phase 2a|Death|1|||
125936188|NCT00951665|453063399|FG000|Phase 2a|Lost to Follow-up|0|||
125936189|NCT00951665|453063400|FG001|Phase 2a|Lost to Follow-up|0|||
125936190|NCT00951665|453063401|FG002|Phase 2a|Lost to Follow-up|0|||
125936191|NCT00951665|453063402|FG003|Phase 2a|Lost to Follow-up|0|||
125936192|NCT00951665|453063403|FG004|Phase 2a|Lost to Follow-up|1|||
125936193|NCT00951665|453063404|FG005|Phase 2a|Lost to Follow-up|0|||
125936194|NCT00951665|453063399|FG000|Phase 2a|Physician Decision|0|||
125936195|NCT00951665|453063400|FG001|Phase 2a|Physician Decision|0|||
125936196|NCT00951665|453063401|FG002|Phase 2a|Physician Decision|0|||
125936197|NCT00951665|453063402|FG003|Phase 2a|Physician Decision|0|||
125936198|NCT00951665|453063403|FG004|Phase 2a|Physician Decision|0|||
125936199|NCT00951665|453063404|FG005|Phase 2a|Physician Decision|1|||
125936200|NCT00951665|453063399|FG000|Phase 2a|Withdrawal by Subject|0|||
125936201|NCT00951665|453063400|FG001|Phase 2a|Withdrawal by Subject|0|||
125936202|NCT00951665|453063401|FG002|Phase 2a|Withdrawal by Subject|0|||
125936203|NCT00951665|453063402|FG003|Phase 2a|Withdrawal by Subject|0|||
125936204|NCT00951665|453063403|FG004|Phase 2a|Withdrawal by Subject|2|||
125936205|NCT00951665|453063404|FG005|Phase 2a|Withdrawal by Subject|0|||
125936206|NCT00951665|453063399|FG000|Phase 2a|Disease Progression|0|||
125936207|NCT00951665|453063400|FG001|Phase 2a|Disease Progression|0|||
125936208|NCT00951665|453063401|FG002|Phase 2a|Disease Progression|0|||
125936209|NCT00951665|453063402|FG003|Phase 2a|Disease Progression|0|||
125936210|NCT00951665|453063403|FG004|Phase 2a|Disease Progression|6|||
125936211|NCT00951665|453063404|FG005|Phase 2a|Disease Progression|5|||
125936212|NCT02723084|453063405|FG000|Overall Study|Withdrawal by Subject|1|||
125936213|NCT02723084|453063406|FG001|Overall Study|Withdrawal by Subject|1|||
125936214|NCT02723084|453063405|FG000|Overall Study|Lost to Follow-up|3|||
125936215|NCT02723084|453063406|FG001|Overall Study|Lost to Follow-up|0|||
125936216|NCT00501293|453063407|FG000|Optimization Period|Enrolled in error|1|||
125936217|NCT00501293|453063408|FG001|Optimization Period|Enrolled in error|0|||
125936218|NCT00501293|453063407|FG000|Maintenance Period|Withdrawal by Subject|14|||
125936219|NCT00501293|453063408|FG001|Maintenance Period|Withdrawal by Subject|13|||
125936220|NCT00501293|453063407|FG000|Maintenance Period|Lost to Follow-up|12|||
125936221|NCT00501293|453063408|FG001|Maintenance Period|Lost to Follow-up|7|||
125936222|NCT00501293|453063407|FG000|Maintenance Period|Adverse Event|6|||
125936223|NCT00501293|453063408|FG001|Maintenance Period|Adverse Event|6|||
125936224|NCT00501293|453063407|FG000|Maintenance Period|Protocol Violation|2|||
125936225|NCT00501293|453063408|FG001|Maintenance Period|Protocol Violation|1|||
125936226|NCT00501293|453063407|FG000|Maintenance Period|Lack of Efficacy|4|||
125936227|NCT00501293|453063408|FG001|Maintenance Period|Lack of Efficacy|1|||
125936228|NCT00501293|453063407|FG000|Maintenance Period|Noncompliant with study medication|5|||
125936229|NCT00501293|453063408|FG001|Maintenance Period|Noncompliant with study medication|0|||
125936230|NCT00501293|453063407|FG000|Maintenance Period|Went into rehabilitation|1|||
125936231|NCT00501293|453063408|FG001|Maintenance Period|Went into rehabilitation|0|||
125936232|NCT00501293|453063407|FG000|Maintenance Period|Would not wear patch|1|||
125936233|NCT00501293|453063408|FG001|Maintenance Period|Would not wear patch|0|||
125936234|NCT00501293|453063407|FG000|Maintenance Period|Application site reaction|1|||
125936235|NCT00501293|453063408|FG001|Maintenance Period|Application site reaction|0|||
125936236|NCT02450903|453063410|FG000|Overall Study|Adverse Event|3|||
125936237|NCT02450903|453063410|FG000|Overall Study|Progressive disease|15|||
125936238|NCT02450903|453063410|FG000|Overall Study|Switched to commercial drug|1|||
125936239|NCT02450903|453063410|FG000|Overall Study|Subject/guardian decision|1|||
125936240|NCT01164956|453063411|FG000|Overall Study|Side Effects|1|||
125936241|NCT01164956|453063412|FG001|Overall Study|Side Effects|0|||
125936242|NCT01164956|453063413|FG002|Overall Study|Side Effects|1|||
125936243|NCT01409564|453063414|FG000|Overall Study|low medication compliance|4|||
125936244|NCT01409564|453063415|FG001|Overall Study|low medication compliance|3|||
125936245|NCT01409564|453063414|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
125936246|NCT01409564|453063415|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
125936247|NCT00082355|453063416|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
125936248|NCT00082355|453063416|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
125936249|NCT00082355|453063416|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
125936250|NCT03020407|453063424|FG000|Overall Study|Withdrawal by Subject|2|||
125936251|NCT03020407|453063425|FG001|Overall Study|Withdrawal by Subject|1|||
125936252|NCT03020407|453063424|FG000|Overall Study|Lost to Follow-up|2|||
125936253|NCT03020407|453063425|FG001|Overall Study|Lost to Follow-up|3|||
125936254|NCT03020407|453063424|FG000|Overall Study|Protocol Violation|0|||
125936255|NCT03020407|453063425|FG001|Overall Study|Protocol Violation|1|||
125936256|NCT02699554|453063426|FG000|Overall Study|Lost to Follow-up|9|||
125936257|NCT00788151|453063427|FG000|Overall Study|Other adverse event|0|||
125936258|NCT00788151|453063428|FG001|Overall Study|Other adverse event|2|||
125936259|NCT00788151|453063427|FG000|Overall Study|Protocol Violation|0|||
125936260|NCT00788151|453063428|FG001|Overall Study|Protocol Violation|1|||
125936261|NCT00788151|453063427|FG000|Overall Study|Withdrawal by Subject|13|||
125936262|NCT00788151|453063428|FG001|Overall Study|Withdrawal by Subject|6|||
125936263|NCT00788151|453063427|FG000|Overall Study|Enrolled but not treated|1|||
125936264|NCT00788151|453063428|FG001|Overall Study|Enrolled but not treated|1|||
125936265|NCT02169739|453063429|FG000|Overall Study|Lost to Follow-up|0|||
125936266|NCT02169739|453063430|FG001|Overall Study|Lost to Follow-up|4|||
125936267|NCT00453921|453063439|FG000|Overall Study|Withdrawal by Subject|1|||
125936268|NCT00453921|453063440|FG001|Overall Study|Withdrawal by Subject|1|||
125936269|NCT00453921|453063441|FG002|Overall Study|Withdrawal by Subject|1|||
125936270|NCT00453921|453063442|FG003|Overall Study|Withdrawal by Subject|1|||
125936271|NCT00453921|453063439|FG000|Overall Study|Lost to Follow-up|0|||
125936272|NCT00453921|453063440|FG001|Overall Study|Lost to Follow-up|0|||
125936273|NCT00453921|453063441|FG002|Overall Study|Lost to Follow-up|1|||
125936274|NCT00453921|453063442|FG003|Overall Study|Lost to Follow-up|0|||
125936275|NCT04532099|453063443|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
125936276|NCT04532099|453063444|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
125936277|NCT04532099|453063445|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
125936278|NCT02066233|453063450|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
125936279|NCT02066233|453063451|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
125936280|NCT03103919|453063453|FG000|Overall Study|Adverse Event|2|||
125936281|NCT03103919|453063454|FG001|Overall Study|Adverse Event|2|||
125936282|NCT02436356|453063455|FG000|Overall Study|Excluded by MRI Screening|0|||
125936283|NCT02436356|453063456|FG001|Overall Study|Excluded by MRI Screening|0|||
125936284|NCT02436356|453063457|FG002|Overall Study|Excluded by MRI Screening|2|||
125936285|NCT02436356|453063455|FG000|Overall Study|Lost to Follow-up|0|||
125936286|NCT02436356|453063456|FG001|Overall Study|Lost to Follow-up|1|||
125936287|NCT02436356|453063457|FG002|Overall Study|Lost to Follow-up|0|||
125936288|NCT02436356|453063455|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
125936289|NCT02436356|453063456|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
125936290|NCT02436356|453063457|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
125936291|NCT02436356|453063455|FG000|Overall Study|Excluded due to other medical conditions|3|||
125936292|NCT02436356|453063456|FG001|Overall Study|Excluded due to other medical conditions|0|||
125936293|NCT02436356|453063457|FG002|Overall Study|Excluded due to other medical conditions|0|||
125936294|NCT02436356|453063455|FG000|Overall Study|Withdrawal by Subject|1|||
125936295|NCT02436356|453063456|FG001|Overall Study|Withdrawal by Subject|0|||
125936296|NCT02436356|453063457|FG002|Overall Study|Withdrawal by Subject|0|||
125936297|NCT04577118|453063458|FG000|Overall Study|Withdrawal by Subject|4|||
125936298|NCT00810407|453063459|FG000|Overall Study|Protocol Violation|3|||
125936299|NCT00810407|453063459|FG000|Overall Study|No Visit After First Day of Treatment|3|||
125936300|NCT00674661|453063462|FG000|Overall Study|Other|5|||
125936301|NCT00674661|453063463|FG001|Overall Study|Other|7|||
125936302|NCT00674661|453063462|FG000|Overall Study|Lost to Follow-up|6|||
125936303|NCT00674661|453063463|FG001|Overall Study|Lost to Follow-up|3|||
126066378|NCT02543294|453534877|FG000|Overall Study|Withdrawal by Subject|7|||
126066379|NCT03672188|453534878|FG000|Overall Study|Withdrawal by Subject|0|||
126066380|NCT03672188|453534879|FG001|Overall Study|Withdrawal by Subject|0|||
126066381|NCT03672188|453534880|FG002|Overall Study|Withdrawal by Subject|0|||
126066382|NCT03672188|453534881|FG003|Overall Study|Withdrawal by Subject|3|||
126066383|NCT03672188|453534882|FG004|Overall Study|Withdrawal by Subject|0|||
126066384|NCT03672188|453534883|FG005|Overall Study|Withdrawal by Subject|0|||
126066385|NCT03672188|453534884|FG006|Overall Study|Withdrawal by Subject|0|||
126066386|NCT03672188|453534885|FG007|Overall Study|Withdrawal by Subject|0|||
126066387|NCT03672188|453534886|FG008|Overall Study|Withdrawal by Subject|0|||
126066388|NCT03672188|453534887|FG009|Overall Study|Withdrawal by Subject|0|||
126066389|NCT03672188|453534888|FG010|Overall Study|Withdrawal by Subject|0|||
126066390|NCT03672188|453534889|FG011|Overall Study|Withdrawal by Subject|0|||
126066391|NCT03672188|453534890|FG012|Overall Study|Withdrawal by Subject|0|||
125936304|NCT00674661|453063462|FG000|Overall Study|Withdrawal by Subject|0|||
125936305|NCT00674661|453063463|FG001|Overall Study|Withdrawal by Subject|5|||
126066392|NCT03672188|453534891|FG013|Overall Study|Withdrawal by Subject|0|||
126066393|NCT03672188|453534892|FG014|Overall Study|Withdrawal by Subject|0|||
125936306|NCT03108027|453063465|FG000|Period 1|Subject/Guardian Decision|0|||
125936307|NCT03108027|453063466|FG001|Period 1|Subject/Guardian Decision|0|||
125936308|NCT03108027|453063467|FG002|Period 1|Subject/Guardian Decision|0|||
125936309|NCT03108027|453063468|FG003|Period 1|Subject/Guardian Decision|2|||
125936310|NCT03108027|453063469|FG004|Period 1|Subject/Guardian Decision|0|||
125936311|NCT03108027|453063470|FG005|Period 1|Subject/Guardian Decision|0|||
125936312|NCT03108027|453063465|FG000|Period 3|Adverse Event|0|||
125936313|NCT03108027|453063466|FG001|Period 3|Adverse Event|1|||
125936314|NCT03108027|453063467|FG002|Period 3|Adverse Event|0|||
125936315|NCT03108027|453063468|FG003|Period 3|Adverse Event|0|||
125936316|NCT03108027|453063469|FG004|Period 3|Adverse Event|0|||
125936317|NCT03108027|453063470|FG005|Period 3|Adverse Event|0|||
125936318|NCT02574247|453063471|FG000|Overall Study|Withdrawal by Subject|1|||
125936319|NCT02574247|453063472|FG001|Overall Study|Withdrawal by Subject|0|||
125936320|NCT02574247|453063473|FG002|Overall Study|Withdrawal by Subject|0|||
125936321|NCT02574247|453063471|FG000|Overall Study|Did not meet inclusion criteria|4|||
125936322|NCT02574247|453063472|FG001|Overall Study|Did not meet inclusion criteria|3|||
125936323|NCT02574247|453063473|FG002|Overall Study|Did not meet inclusion criteria|5|||
125936324|NCT00268996|453063474|FG000|Overall Study|Adverse Event|11|||
125936325|NCT00268996|453063475|FG001|Overall Study|Adverse Event|7|||
125936326|NCT00268996|453063474|FG000|Overall Study|Lost to Follow-up|3|||
125936327|NCT00268996|453063475|FG001|Overall Study|Lost to Follow-up|1|||
125936328|NCT00268996|453063474|FG000|Overall Study|Withdrawal by Subject|5|||
125936329|NCT00268996|453063475|FG001|Overall Study|Withdrawal by Subject|11|||
125936330|NCT00268996|453063474|FG000|Overall Study|Non-compliance|1|||
125936331|NCT00268996|453063475|FG001|Overall Study|Non-compliance|0|||
125936332|NCT00268996|453063474|FG000|Overall Study|Other|1|||
125936333|NCT00268996|453063475|FG001|Overall Study|Other|1|||
125936334|NCT04210310|453063476|FG000|Overall Study|Lost to Follow-up|32|||
125936335|NCT04210310|453063477|FG001|Overall Study|Lost to Follow-up|1|||
125936336|NCT03198234|453063478|FG000|Overall Study|Relapse of primary disease|0|||
125936337|NCT03198234|453063479|FG001|Overall Study|Relapse of primary disease|1|||
125936338|NCT03198234|453063480|FG002|Overall Study|Relapse of primary disease|0|||
125936339|NCT01340898|453063481|FG000|Primary Phase|Serious Adverse Events|0|||
125936340|NCT01340898|453063482|FG001|Primary Phase|Serious Adverse Events|0|||
125936341|NCT01340898|453063483|FG002|Primary Phase|Serious Adverse Events|1|||
125936342|NCT01340898|453063481|FG000|Primary Phase|Withdrawal by Subject|8|||
125936343|NCT01340898|453063482|FG001|Primary Phase|Withdrawal by Subject|7|||
125936344|NCT01340898|453063483|FG002|Primary Phase|Withdrawal by Subject|5|||
125936345|NCT01340898|453063481|FG000|Primary Phase|Migrated/moved from study area|4|||
125936346|NCT01340898|453063482|FG001|Primary Phase|Migrated/moved from study area|1|||
125936347|NCT01340898|453063483|FG002|Primary Phase|Migrated/moved from study area|0|||
125936348|NCT01340898|453063481|FG000|Primary Phase|Lost to Follow-up|4|||
125936349|NCT01340898|453063482|FG001|Primary Phase|Lost to Follow-up|1|||
125936350|NCT01340898|453063483|FG002|Primary Phase|Lost to Follow-up|0|||
125936351|NCT01340898|453063481|FG000|Booster Phase|Withdrawal by Subject|3|||
125936352|NCT01340898|453063482|FG001|Booster Phase|Withdrawal by Subject|0|||
125936353|NCT01340898|453063483|FG002|Booster Phase|Withdrawal by Subject|4|||
125936354|NCT01340898|453063481|FG000|Booster Phase|Migrated/moved from study area|3|||
125936355|NCT01340898|453063482|FG001|Booster Phase|Migrated/moved from study area|0|||
125936356|NCT01340898|453063483|FG002|Booster Phase|Migrated/moved from study area|0|||
125936357|NCT01340898|453063481|FG000|Booster Phase|Lost to Follow-up|4|||
125936358|NCT01340898|453063482|FG001|Booster Phase|Lost to Follow-up|2|||
125936359|NCT01340898|453063483|FG002|Booster Phase|Lost to Follow-up|3|||
125936360|NCT02056340|453063484|FG000|Overall Study|Lost to Follow-up|5|||
125936361|NCT02056340|453063485|FG001|Overall Study|Lost to Follow-up|5|||
125936362|NCT02056340|453063484|FG000|Overall Study|Withdrawal by Subject|2|||
125936363|NCT02056340|453063485|FG001|Overall Study|Withdrawal by Subject|6|||
125936364|NCT04900220|453063486|FG000|Overall Study|Lost to Follow-up|1|||
125936365|NCT04900220|453063487|FG001|Overall Study|Lost to Follow-up|1|||
125936366|NCT01214629|453063489|FG000|Overall Study|Progressive Disease|1|||
125936367|NCT01214629|453063490|FG001|Overall Study|Progressive Disease|1|||
125936368|NCT01214629|453063491|FG002|Overall Study|Progressive Disease|0|||
125936369|NCT01214629|453063492|FG003|Overall Study|Progressive Disease|1|||
125936370|NCT01214629|453063493|FG004|Overall Study|Progressive Disease|2|||
125936371|NCT01214629|453063494|FG005|Overall Study|Progressive Disease|3|||
125936372|NCT01214629|453063495|FG006|Overall Study|Progressive Disease|1|||
125936373|NCT01214629|453063496|FG007|Overall Study|Progressive Disease|1|||
125936374|NCT01214629|453063497|FG008|Overall Study|Progressive Disease|1|||
125936375|NCT01214629|453063498|FG009|Overall Study|Progressive Disease|5|||
125936376|NCT01214629|453063499|FG010|Overall Study|Progressive Disease|1|||
125936377|NCT01214629|453063489|FG000|Overall Study|Adverse Event|0|||
125936378|NCT01214629|453063490|FG001|Overall Study|Adverse Event|0|||
125936379|NCT01214629|453063491|FG002|Overall Study|Adverse Event|0|||
125936380|NCT01214629|453063492|FG003|Overall Study|Adverse Event|1|||
125936381|NCT01214629|453063493|FG004|Overall Study|Adverse Event|0|||
125936382|NCT01214629|453063494|FG005|Overall Study|Adverse Event|1|||
125936383|NCT01214629|453063495|FG006|Overall Study|Adverse Event|0|||
125936384|NCT01214629|453063496|FG007|Overall Study|Adverse Event|0|||
125936385|NCT01214629|453063497|FG008|Overall Study|Adverse Event|0|||
125936386|NCT01214629|453063498|FG009|Overall Study|Adverse Event|1|||
125936387|NCT01214629|453063499|FG010|Overall Study|Adverse Event|0|||
125936388|NCT01214629|453063489|FG000|Overall Study|Physician Decision|0|||
125936389|NCT01214629|453063490|FG001|Overall Study|Physician Decision|0|||
125936390|NCT01214629|453063491|FG002|Overall Study|Physician Decision|0|||
125936391|NCT01214629|453063492|FG003|Overall Study|Physician Decision|0|||
125936392|NCT01214629|453063493|FG004|Overall Study|Physician Decision|0|||
125936393|NCT01214629|453063494|FG005|Overall Study|Physician Decision|0|||
125936394|NCT01214629|453063495|FG006|Overall Study|Physician Decision|0|||
125936395|NCT01214629|453063496|FG007|Overall Study|Physician Decision|0|||
125936396|NCT01214629|453063497|FG008|Overall Study|Physician Decision|0|||
125936397|NCT01214629|453063498|FG009|Overall Study|Physician Decision|0|||
125936398|NCT01214629|453063499|FG010|Overall Study|Physician Decision|1|||
125936399|NCT01214629|453063489|FG000|Overall Study|Withdrawal by Subject|0|||
126114138|NCT02060383|453713736|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
126114139|NCT02060383|453713737|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
126114140|NCT02060383|453713738|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
126114141|NCT02060383|453713739|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
126114142|NCT02060383|453713740|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
126114143|NCT02060383|453713736|FG000|Extension Phase|Adverse Event|1|||
125936400|NCT01214629|453063490|FG001|Overall Study|Withdrawal by Subject|0|||
125936401|NCT01214629|453063491|FG002|Overall Study|Withdrawal by Subject|0|||
125936402|NCT01214629|453063492|FG003|Overall Study|Withdrawal by Subject|0|||
125936403|NCT01214629|453063493|FG004|Overall Study|Withdrawal by Subject|0|||
125936404|NCT01214629|453063494|FG005|Overall Study|Withdrawal by Subject|0|||
125936405|NCT01214629|453063495|FG006|Overall Study|Withdrawal by Subject|0|||
125936406|NCT01214629|453063496|FG007|Overall Study|Withdrawal by Subject|0|||
125936407|NCT01214629|453063497|FG008|Overall Study|Withdrawal by Subject|0|||
125936408|NCT01214629|453063498|FG009|Overall Study|Withdrawal by Subject|1|||
125936409|NCT01214629|453063499|FG010|Overall Study|Withdrawal by Subject|0|||
125936410|NCT02669433|453063503|FG000|Overall Study|Protocol Violation|0|||
125936411|NCT02669433|453063504|FG001|Overall Study|Protocol Violation|4|||
125936412|NCT02669433|453063505|FG002|Overall Study|Protocol Violation|1|||
125936413|NCT02669433|453063503|FG000|Overall Study|Disease Progression|1|||
126066394|NCT03672188|453534878|FG000|Overall Study|Death|0|||
126066395|NCT03672188|453534879|FG001|Overall Study|Death|0|||
126066396|NCT03672188|453534880|FG002|Overall Study|Death|0|||
126066397|NCT03672188|453534881|FG003|Overall Study|Death|0|||
126066398|NCT03672188|453534882|FG004|Overall Study|Death|0|||
126066399|NCT03672188|453534883|FG005|Overall Study|Death|0|||
126066400|NCT03672188|453534884|FG006|Overall Study|Death|0|||
126066401|NCT03672188|453534885|FG007|Overall Study|Death|0|||
126066402|NCT03672188|453534886|FG008|Overall Study|Death|0|||
126066403|NCT03672188|453534887|FG009|Overall Study|Death|0|||
126066404|NCT03672188|453534888|FG010|Overall Study|Death|0|||
126066405|NCT03672188|453534889|FG011|Overall Study|Death|0|||
126066406|NCT03672188|453534890|FG012|Overall Study|Death|1|||
126066407|NCT03672188|453534891|FG013|Overall Study|Death|0|||
126066408|NCT03672188|453534892|FG014|Overall Study|Death|0|||
126066409|NCT03672188|453534878|FG000|Overall Study|Lost to Follow-up|0|||
126066410|NCT03672188|453534879|FG001|Overall Study|Lost to Follow-up|0|||
126066411|NCT03672188|453534880|FG002|Overall Study|Lost to Follow-up|1|||
126066412|NCT03672188|453534881|FG003|Overall Study|Lost to Follow-up|0|||
126066413|NCT03672188|453534882|FG004|Overall Study|Lost to Follow-up|0|||
126066414|NCT03672188|453534883|FG005|Overall Study|Lost to Follow-up|0|||
126066415|NCT03672188|453534884|FG006|Overall Study|Lost to Follow-up|0|||
126066416|NCT03672188|453534885|FG007|Overall Study|Lost to Follow-up|0|||
126066417|NCT03672188|453534886|FG008|Overall Study|Lost to Follow-up|0|||
126066418|NCT03672188|453534887|FG009|Overall Study|Lost to Follow-up|0|||
126066419|NCT03672188|453534888|FG010|Overall Study|Lost to Follow-up|0|||
126114144|NCT02060383|453713737|FG001|Extension Phase|Adverse Event|1|||
126114145|NCT02060383|453713738|FG002|Extension Phase|Adverse Event|2|||
125936414|NCT02669433|453063504|FG001|Overall Study|Disease Progression|0|||
125936415|NCT02669433|453063505|FG002|Overall Study|Disease Progression|0|||
125936416|NCT02669433|453063503|FG000|Overall Study|Physician Decision|1|||
126066420|NCT03672188|453534889|FG011|Overall Study|Lost to Follow-up|0|||
126066421|NCT03672188|453534890|FG012|Overall Study|Lost to Follow-up|0|||
126066422|NCT03672188|453534891|FG013|Overall Study|Lost to Follow-up|0|||
126066423|NCT03672188|453534892|FG014|Overall Study|Lost to Follow-up|0|||
126066424|NCT00396409|453534898|FG000|Period 1 - 2007|Adverse Event|0|||
126066425|NCT00396409|453534899|FG001|Period 1 - 2007|Adverse Event|1|||
126066426|NCT00396409|453534898|FG000|Period 1 - 2007|Lack of Efficacy|0|||
126066427|NCT00396409|453534899|FG001|Period 1 - 2007|Lack of Efficacy|1|||
126066428|NCT00396409|453534898|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
126114146|NCT02060383|453713739|FG003|Extension Phase|Adverse Event|0|||
125936417|NCT02669433|453063504|FG001|Overall Study|Physician Decision|1|||
126066429|NCT00396409|453534899|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
126066430|NCT00396409|453534898|FG000|Period 1 - 2007|Lost to Follow-up|2|||
125936418|NCT02669433|453063505|FG002|Overall Study|Physician Decision|0|||
125936419|NCT02669433|453063503|FG000|Overall Study|Adverse Event|6|||
125936420|NCT02669433|453063504|FG001|Overall Study|Adverse Event|7|||
125936421|NCT02669433|453063505|FG002|Overall Study|Adverse Event|10|||
125936422|NCT02669433|453063503|FG000|Overall Study|Sponsor Termination|1|||
125936423|NCT02669433|453063504|FG001|Overall Study|Sponsor Termination|0|||
125936424|NCT02669433|453063505|FG002|Overall Study|Sponsor Termination|1|||
125936425|NCT02669433|453063503|FG000|Overall Study|Withdrawal by Subject|5|||
125936426|NCT02669433|453063504|FG001|Overall Study|Withdrawal by Subject|1|||
125936427|NCT02669433|453063505|FG002|Overall Study|Withdrawal by Subject|0|||
125936428|NCT02669433|453063503|FG000|Overall Study|Withdrawal by Caregiver|1|||
125936429|NCT02669433|453063504|FG001|Overall Study|Withdrawal by Caregiver|0|||
125936430|NCT02669433|453063505|FG002|Overall Study|Withdrawal by Caregiver|2|||
125936431|NCT02669433|453063503|FG000|Overall Study|Death|0|||
125936432|NCT02669433|453063504|FG001|Overall Study|Death|1|||
125936433|NCT02669433|453063505|FG002|Overall Study|Death|1|||
125936434|NCT00576927|453063506|FG000|Clinical Assessment|Lack of Efficacy|24|||
125936435|NCT00576927|453063506|FG000|Clinical Assessment|Death|1|||
125936436|NCT00576927|453063506|FG000|Clinical Assessment|Withdrawal by Subject|10|||
125936437|NCT00576927|453063506|FG000|Clinical Assessment|Physician Decision|1|||
125936438|NCT00576927|453063506|FG000|Baseline|Physician Decision|9|||
125936439|NCT00576927|453063506|FG000|Baseline|Medication Change by PCP of subject|1|||
125936440|NCT00576927|453063506|FG000|Baseline|Withdrawal by Subject|3|||
125936441|NCT00576927|453063506|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
125936442|NCT00576927|453063506|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
125936443|NCT00576927|453063506|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
125936444|NCT00576927|453063506|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
125936445|NCT00576927|453063506|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
125936446|NCT03266094|453063507|FG000|Overall Study|Lost to Follow-up|1|||
125936447|NCT03266094|453063507|FG000|Overall Study|Withdrawal by Subject|1|||
125936448|NCT03128892|453063508|FG000|Overall Study|Withdrawal by Subject|2|||
125936449|NCT03128892|453063508|FG000|Overall Study|Physician Decision|1|||
125936450|NCT00459108|453063510|FG000|Overall Study|Withdrawal by Subject|5|||
125936451|NCT00459108|453063510|FG000|Overall Study|Adverse Event|3|||
125936452|NCT00459108|453063510|FG000|Overall Study|Death|2|||
125936453|NCT00459108|453063510|FG000|Overall Study|Progression|1|||
125936454|NCT03473808|453063515|FG000|Overall Study|Withdrawal by Subject|1|||
125936455|NCT02157298|453063516|FG000|Overall Study|Adverse Event|1|||
125936456|NCT02157298|453063517|FG001|Overall Study|Adverse Event|0|||
125936457|NCT02157298|453063516|FG000|Overall Study|Subject no longer meets study criteria|1|||
125936458|NCT02157298|453063517|FG001|Overall Study|Subject no longer meets study criteria|2|||
125936459|NCT02157298|453063516|FG000|Overall Study|Poor/Non-compliance|1|||
125936460|NCT02157298|453063517|FG001|Overall Study|Poor/Non-compliance|0|||
125936461|NCT02157298|453063516|FG000|Overall Study|Withdrawal by Subject|1|||
125936462|NCT02157298|453063517|FG001|Overall Study|Withdrawal by Subject|0|||
125936463|NCT03171415|453063518|FG000|Overall Study|Lost to Follow-up|0|||
125936464|NCT03171415|453063519|FG001|Overall Study|Lost to Follow-up|0|||
125936465|NCT03171415|453063520|FG002|Overall Study|Lost to Follow-up|0|||
125936466|NCT03171415|453063521|FG003|Overall Study|Lost to Follow-up|0|||
125936467|NCT03171415|453063522|FG004|Overall Study|Lost to Follow-up|2|||
125936468|NCT04059094|453063523|FG000|Overall Study|Adverse Event|0|||
125936469|NCT04059094|453063524|FG001|Overall Study|Adverse Event|0|||
125936470|NCT04059094|453063525|FG002|Overall Study|Adverse Event|0|||
125936471|NCT04059094|453063526|FG003|Overall Study|Adverse Event|0|||
125936472|NCT04059094|453063527|FG004|Overall Study|Adverse Event|1|||
125936473|NCT04059094|453063523|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
125936474|NCT04059094|453063524|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
125936475|NCT04059094|453063525|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
125936476|NCT04059094|453063526|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
125936477|NCT04059094|453063527|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
125936478|NCT03715764|453063530|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
125936479|NCT03715764|453063531|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
125936480|NCT03715764|453063530|FG000|3 Month Follow-up|Lost to Follow-up|2|||
125936481|NCT03715764|453063531|FG001|3 Month Follow-up|Lost to Follow-up|2|||
125936482|NCT03715764|453063530|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
125936483|NCT03715764|453063531|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
125936484|NCT03715764|453063530|FG000|6 Month Follow-up|Lost to Follow-up|3|||
125936485|NCT03715764|453063531|FG001|6 Month Follow-up|Lost to Follow-up|0|||
125936486|NCT03715764|453063530|FG000|12 Month Follow-up|Lost to Follow-up|2|||
126066431|NCT00396409|453534899|FG001|Period 1 - 2007|Lost to Follow-up|3|||
126066432|NCT00396409|453534898|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
126066433|NCT00396409|453534899|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
126066434|NCT00396409|453534898|FG000|Period 2 - 2008|Protocol Violation|1|||
126066435|NCT00396409|453534899|FG001|Period 2 - 2008|Protocol Violation|0|||
126066436|NCT00396409|453534898|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
126066437|NCT00396409|453534899|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
126066438|NCT00396409|453534898|FG000|Period 2 - 2008|Lost to Follow-up|3|||
126066439|NCT00396409|453534899|FG001|Period 2 - 2008|Lost to Follow-up|1|||
126066440|NCT04203199|453534902|FG000|First Intervention Period|Lost to Follow-up|0|||
126066441|NCT04203199|453534903|FG001|First Intervention Period|Lost to Follow-up|1|||
126066442|NCT04203199|453534902|FG000|Second Intervention Period|Medication change|1|||
126066443|NCT04203199|453534903|FG001|Second Intervention Period|Medication change|0|||
126066444|NCT03320941|453534904|FG000|Overall Study|subject/guardian decision|0|||
126066445|NCT03320941|453534905|FG001|Overall Study|subject/guardian decision|0|||
126066446|NCT03320941|453534906|FG002|Overall Study|subject/guardian decision|0|||
126066447|NCT03320941|453534907|FG003|Overall Study|subject/guardian decision|1|||
126066448|NCT03320941|453534908|FG004|Overall Study|subject/guardian decision|0|||
126066449|NCT00472199|453534909|FG000|Overall Study|Adverse Event|19|||
126066450|NCT00472199|453534910|FG001|Overall Study|Adverse Event|23|||
126066451|NCT00472199|453534909|FG000|Overall Study|Lack of Efficacy|4|||
126066452|NCT00472199|453534910|FG001|Overall Study|Lack of Efficacy|25|||
126066453|NCT00472199|453534909|FG000|Overall Study|Lost to Follow-up|2|||
126066454|NCT00472199|453534910|FG001|Overall Study|Lost to Follow-up|4|||
126066455|NCT00472199|453534909|FG000|Overall Study|Protocol Violation|3|||
126066456|NCT00472199|453534910|FG001|Overall Study|Protocol Violation|2|||
126066457|NCT00472199|453534909|FG000|Overall Study|Withdrawal by Subject|6|||
126066458|NCT00472199|453534910|FG001|Overall Study|Withdrawal by Subject|5|||
126066459|NCT00472199|453534909|FG000|Overall Study|personal reason|0|||
126066460|NCT00472199|453534910|FG001|Overall Study|personal reason|1|||
126066461|NCT00472199|453534909|FG000|Overall Study|patient was asymptomatic|1|||
126114147|NCT02060383|453713740|FG004|Extension Phase|Adverse Event|1|||
126114148|NCT02060383|453713736|FG000|Extension Phase|Withdrawal by Subject|0|||
125936487|NCT03715764|453063531|FG001|12 Month Follow-up|Lost to Follow-up|3|||
125936488|NCT03715764|453063530|FG000|12 Month Follow-up|Pregnancy|0|||
125936489|NCT03715764|453063531|FG001|12 Month Follow-up|Pregnancy|1|||
125936490|NCT03715764|453063530|FG000|12 Month Follow-up|Surgery|2|||
125936491|NCT03715764|453063531|FG001|12 Month Follow-up|Surgery|0|||
125936492|NCT03715764|453063530|FG000|12 Month Follow-up|Wrong address|1|||
125936493|NCT03715764|453063531|FG001|12 Month Follow-up|Wrong address|0|||
125936494|NCT03715764|453063530|FG000|12 Month Follow-up|No symptoms|1|||
125936495|NCT03715764|453063531|FG001|12 Month Follow-up|No symptoms|0|||
125936496|NCT03715764|453063530|FG000|12 Month Follow-up|Changed primary care centre|0|||
125936497|NCT03715764|453063531|FG001|12 Month Follow-up|Changed primary care centre|1|||
125936498|NCT00492115|453063542|FG000|Overall Study|Withdrawal by Subject|3|||
125936499|NCT00492115|453063543|FG001|Overall Study|Withdrawal by Subject|4|||
125936500|NCT03564145|453063544|FG000|Overall Study|Adverse Event|4|||
125936501|NCT03564145|453063544|FG000|Overall Study|Lost to Follow-up|21|||
125936502|NCT03564145|453063544|FG000|Overall Study|Protocol Violation|2|||
125936503|NCT03564145|453063544|FG000|Overall Study|Withdrawal by Subject|48|||
125936504|NCT03564145|453063544|FG000|Overall Study|Study Terminated by Sponsor|146|||
125936505|NCT03564145|453063544|FG000|Overall Study|Physician Decision|1|||
125936506|NCT03564145|453063544|FG000|Overall Study|Other Than Specified|1|||
125936507|NCT03564145|453063544|FG000|Overall Study|Pregnancy|1|||
125936508|NCT01031069|453063547|FG000|Overall Study|Serious Adverse Event|0|||
125936509|NCT01031069|453063548|FG001|Overall Study|Serious Adverse Event|1|||
125936510|NCT01031069|453063549|FG002|Overall Study|Serious Adverse Event|0|||
125936511|NCT01031069|453063550|FG003|Overall Study|Serious Adverse Event|0|||
125936512|NCT01031069|453063547|FG000|Overall Study|Withdrawal by Subject|2|||
125936513|NCT01031069|453063548|FG001|Overall Study|Withdrawal by Subject|3|||
125936514|NCT01031069|453063549|FG002|Overall Study|Withdrawal by Subject|18|||
125936515|NCT01031069|453063550|FG003|Overall Study|Withdrawal by Subject|18|||
125936516|NCT01031069|453063547|FG000|Overall Study|Migrated/moved from study area|1|||
125936517|NCT01031069|453063548|FG001|Overall Study|Migrated/moved from study area|2|||
125936518|NCT01031069|453063549|FG002|Overall Study|Migrated/moved from study area|1|||
125936519|NCT01031069|453063550|FG003|Overall Study|Migrated/moved from study area|1|||
125936520|NCT01031069|453063547|FG000|Overall Study|Lost to Follow-up|9|||
125936521|NCT01031069|453063548|FG001|Overall Study|Lost to Follow-up|5|||
125936522|NCT01031069|453063549|FG002|Overall Study|Lost to Follow-up|21|||
125936523|NCT01031069|453063550|FG003|Overall Study|Lost to Follow-up|15|||
125936524|NCT01031069|453063547|FG000|Overall Study|Other|0|||
125936525|NCT01031069|453063548|FG001|Overall Study|Other|0|||
125936526|NCT01031069|453063549|FG002|Overall Study|Other|1|||
125936527|NCT01031069|453063550|FG003|Overall Study|Other|0|||
125936528|NCT05286307|453063551|FG000|Overall Study|Incomplete outcome assessments|2|||
126066462|NCT00472199|453534910|FG001|Overall Study|patient was asymptomatic|0|||
126066463|NCT01014013|453534911|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
126066464|NCT01014013|453534912|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
126066465|NCT01014013|453534911|FG000|Overall Study|Clinical adverse experience|4|||
126066466|NCT01014013|453534912|FG001|Overall Study|Clinical adverse experience|2|||
126066467|NCT01014013|453534911|FG000|Overall Study|Laboratory adverse experience|1|||
126114149|NCT02060383|453713737|FG001|Extension Phase|Withdrawal by Subject|1|||
125936529|NCT05286307|453063552|FG001|Overall Study|Incomplete outcome assessments|1|||
125936530|NCT05286307|453063551|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
125936531|NCT05286307|453063552|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
125936532|NCT05286307|453063551|FG000|Overall Study|Lost to follow up at 6 months|25|||
125936533|NCT05286307|453063552|FG001|Overall Study|Lost to follow up at 6 months|35|||
125936534|NCT05286307|453063551|FG000|Overall Study|Study medication not available|1|||
125936535|NCT05286307|453063552|FG001|Overall Study|Study medication not available|1|||
125936536|NCT01103284|453063553|FG000|Overall Study|Death|2|||
125936537|NCT01103284|453063554|FG001|Overall Study|Death|0|||
125936538|NCT01103284|453063553|FG000|Overall Study|Lost to Follow-up|9|||
125936539|NCT01103284|453063554|FG001|Overall Study|Lost to Follow-up|10|||
125936540|NCT01103284|453063553|FG000|Overall Study|Pregnancy|3|||
125936541|NCT01103284|453063554|FG001|Overall Study|Pregnancy|1|||
125936542|NCT01103284|453063553|FG000|Overall Study|Protocol Violation|12|||
125936543|NCT01103284|453063554|FG001|Overall Study|Protocol Violation|5|||
125936544|NCT01103284|453063553|FG000|Overall Study|Adverse Event|0|||
125936545|NCT01103284|453063554|FG001|Overall Study|Adverse Event|5|||
125936546|NCT01103284|453063553|FG000|Overall Study|Withdrawal by Subject|14|||
125936547|NCT01103284|453063554|FG001|Overall Study|Withdrawal by Subject|18|||
125936548|NCT01103284|453063553|FG000|Overall Study|Dermal Hypersensitivity|0|||
125936549|NCT01103284|453063554|FG001|Overall Study|Dermal Hypersensitivity|1|||
125936550|NCT01103284|453063553|FG000|Overall Study|Termination by the Sponsor|0|||
125936551|NCT01103284|453063554|FG001|Overall Study|Termination by the Sponsor|1|||
125936552|NCT01103284|453063553|FG000|Overall Study|Not described|2|||
125936553|NCT01103284|453063554|FG001|Overall Study|Not described|1|||
125936554|NCT01103284|453063553|FG000|Overall Study|Missing CRF entries for study completion|0|||
125936555|NCT01103284|453063554|FG001|Overall Study|Missing CRF entries for study completion|2|||
125936556|NCT05024058|453065713|FG000|Treatment|Study terminated by sponsor|5|||
125936557|NCT05024058|453065714|FG001|Treatment|Study terminated by sponsor|6|||
125936558|NCT05024058|453065715|FG002|Treatment|Study terminated by sponsor|4|||
125936559|NCT05024058|453065716|FG003|Treatment|Study terminated by sponsor|2|||
125936560|NCT05024058|453065717|FG004|Treatment|Study terminated by sponsor|3|||
125936561|NCT05024058|453065718|FG005|Treatment|Study terminated by sponsor|3|||
125936562|NCT05024058|453065719|FG006|Treatment|Study terminated by sponsor|1|||
125936563|NCT05024058|453065720|FG007|Treatment|Study terminated by sponsor|3|||
125936564|NCT05024058|453065721|FG008|Treatment|Study terminated by sponsor|6|||
125936565|NCT05024058|453065722|FG009|Treatment|Study terminated by sponsor|6|||
125936566|NCT05024058|453065713|FG000|Follow-up|Withdrawal by Subject|1|||
125936567|NCT05024058|453065714|FG001|Follow-up|Withdrawal by Subject|0|||
125936568|NCT05024058|453065715|FG002|Follow-up|Withdrawal by Subject|1|||
125936569|NCT05024058|453065716|FG003|Follow-up|Withdrawal by Subject|0|||
125936570|NCT05024058|453065717|FG004|Follow-up|Withdrawal by Subject|0|||
125936571|NCT05024058|453065718|FG005|Follow-up|Withdrawal by Subject|0|||
125936572|NCT05024058|453065719|FG006|Follow-up|Withdrawal by Subject|0|||
125936573|NCT05024058|453065720|FG007|Follow-up|Withdrawal by Subject|1|||
125936574|NCT05024058|453065721|FG008|Follow-up|Withdrawal by Subject|0|||
125936575|NCT05024058|453065722|FG009|Follow-up|Withdrawal by Subject|1|||
125936576|NCT02734810|453065726|FG000|Overall Study|Adverse Event|1|||
125936577|NCT02734810|453065727|FG001|Overall Study|Adverse Event|0|||
125936578|NCT02734810|453065726|FG000|Overall Study|Lack of Efficacy|1|||
125936579|NCT02734810|453065727|FG001|Overall Study|Lack of Efficacy|0|||
125936580|NCT01104636|453065733|FG000|Overall Study|Lack of Efficacy|43|||
125936581|NCT01104636|453065733|FG000|Overall Study|Lost to Follow-up|24|||
125936582|NCT01104636|453065733|FG000|Overall Study|Withdrawal by Subject|4|||
125936583|NCT01104636|453065733|FG000|Overall Study|Other|43|||
125936584|NCT01104636|453065733|FG000|Overall Study|Study terminated by sponsor|1|||
125936585|NCT01104636|453065733|FG000|Overall Study|Pregnancy|2|||
125936586|NCT01104636|453065733|FG000|Overall Study|Adverse Event|40|||
125936587|NCT01104636|453065733|FG000|Overall Study|Ongoing|21|||
125936588|NCT01706003|453065734|FG000|Overall Study|Withdrawal by Subject|2|||
125936589|NCT01706003|453065735|FG001|Overall Study|Withdrawal by Subject|0|||
125936590|NCT01706003|453065734|FG000|Overall Study|Not scheduled|3|||
125936591|NCT01706003|453065735|FG001|Overall Study|Not scheduled|0|||
125936592|NCT01706003|453065734|FG000|Overall Study|Lost to Follow-up|6|||
125936593|NCT01706003|453065735|FG001|Overall Study|Lost to Follow-up|4|||
125936594|NCT00407563|453065738|FG000|Overall Study|Patient continues on treatment|1|||
125936595|NCT00696696|453065739|FG000|Overall Study|Adverse Event|5|||
125936596|NCT00696696|453065739|FG000|Overall Study|Withdrawal by Subject|8|||
125936597|NCT00696696|453065739|FG000|Overall Study|Physician Decision|2|||
125936598|NCT00696696|453065739|FG000|Overall Study|Death|3|||
125936599|NCT03055260|453065740|FG000|Overall Study|Withdrawal by Subject|1|||
125936600|NCT03055260|453065741|FG001|Overall Study|Withdrawal by Subject|0|||
125936601|NCT02507505|453065742|FG000|Overall Study|Withdrawal by Subject|13|||
126114150|NCT02060383|453713738|FG002|Extension Phase|Withdrawal by Subject|0|||
125936602|NCT02507505|453065743|FG001|Overall Study|Withdrawal by Subject|11|||
125936603|NCT02507505|453065742|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
125936604|NCT02507505|453065743|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
126114151|NCT02060383|453713739|FG003|Extension Phase|Withdrawal by Subject|0|||
125936605|NCT02507505|453065742|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
125936606|NCT02507505|453065743|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
125936607|NCT02507505|453065742|FG000|Overall Study|Death before receipt of anesthesia|0|||
125936608|NCT02507505|453065743|FG001|Overall Study|Death before receipt of anesthesia|1|||
125936609|NCT03182829|453065744|FG000|Overall Study|Protocol Violation|12|||
125936610|NCT03182829|453065745|FG001|Overall Study|Protocol Violation|12|||
125936611|NCT03182829|453065744|FG000|Overall Study|Other|4|||
125936612|NCT03182829|453065745|FG001|Overall Study|Other|3|||
125936613|NCT00254540|453065746|FG000|Overall Study|Adverse Event|6|||
125936614|NCT00254540|453065747|FG001|Overall Study|Adverse Event|7|||
125936615|NCT00254540|453065746|FG000|Overall Study|Lack of Efficacy|13|||
125936616|NCT00254540|453065747|FG001|Overall Study|Lack of Efficacy|13|||
125936617|NCT00254540|453065746|FG000|Overall Study|Death|0|||
125936618|NCT00254540|453065747|FG001|Overall Study|Death|1|||
125936619|NCT00254540|453065746|FG000|Overall Study|Laboratory Test Abnormality|0|||
125936620|NCT00254540|453065747|FG001|Overall Study|Laboratory Test Abnormality|1|||
125936621|NCT00225251|453065748|FG000|Overall Study|Withdrawal by Subject|1|||
125936622|NCT00225251|453065749|FG001|Overall Study|Withdrawal by Subject|1|||
125936623|NCT03045328|453065755|FG000|Overall Study|Withdrawal by Subject|2|||
125936624|NCT00592839|453065756|FG000|Overall Study|Withdrawal by Subject|1|||
125936625|NCT00592839|453065757|FG001|Overall Study|Withdrawal by Subject|1|||
125936626|NCT00592839|453065758|FG002|Overall Study|Withdrawal by Subject|3|||
125936627|NCT00592839|453065756|FG000|Overall Study|Protocol Violation|1|||
125936628|NCT00592839|453065757|FG001|Overall Study|Protocol Violation|1|||
126066468|NCT01014013|453534912|FG001|Overall Study|Laboratory adverse experience|1|||
126066469|NCT01014013|453534911|FG000|Overall Study|Protocol Violation|1|||
125936629|NCT00592839|453065758|FG002|Overall Study|Protocol Violation|2|||
125936630|NCT00592839|453065756|FG000|Overall Study|Adverse Event|0|||
125936631|NCT00592839|453065757|FG001|Overall Study|Adverse Event|1|||
125936632|NCT00592839|453065758|FG002|Overall Study|Adverse Event|0|||
125936633|NCT00592839|453065756|FG000|Overall Study|Lost to Follow-up|0|||
125936634|NCT00592839|453065757|FG001|Overall Study|Lost to Follow-up|1|||
125936635|NCT00592839|453065758|FG002|Overall Study|Lost to Follow-up|1|||
125936636|NCT01313767|453065759|FG000|Overall Study|Adverse Event|1|||
125936637|NCT01313767|453065760|FG001|Overall Study|Adverse Event|0|||
125936638|NCT01313767|453065759|FG000|Overall Study|Lost to Follow-up|1|||
125936639|NCT01313767|453065760|FG001|Overall Study|Lost to Follow-up|0|||
125936640|NCT01313767|453065759|FG000|Overall Study|Withdrawal by Subject|2|||
125936641|NCT01313767|453065760|FG001|Overall Study|Withdrawal by Subject|1|||
125936642|NCT01313767|453065759|FG000|Overall Study|Protocol Violation|3|||
125936643|NCT01313767|453065760|FG001|Overall Study|Protocol Violation|1|||
125936644|NCT01287897|453065766|FG000|Overall Study|Adverse Event|5|||
125936645|NCT01287897|453065767|FG001|Overall Study|Adverse Event|3|||
125936646|NCT01287897|453065768|FG002|Overall Study|Adverse Event|6|||
125936647|NCT01287897|453065769|FG003|Overall Study|Adverse Event|4|||
125936648|NCT01287897|453065766|FG000|Overall Study|Lack of Efficacy|2|||
125936649|NCT01287897|453065767|FG001|Overall Study|Lack of Efficacy|0|||
125936650|NCT01287897|453065768|FG002|Overall Study|Lack of Efficacy|0|||
125936651|NCT01287897|453065769|FG003|Overall Study|Lack of Efficacy|0|||
125936652|NCT01287897|453065766|FG000|Overall Study|Protocol Violation|1|||
125936653|NCT01287897|453065767|FG001|Overall Study|Protocol Violation|1|||
126066470|NCT01014013|453534912|FG001|Overall Study|Protocol Violation|3|||
126066471|NCT01014013|453534911|FG000|Overall Study|Withdrawal by Subject|7|||
125936654|NCT01287897|453065768|FG002|Overall Study|Protocol Violation|0|||
125936655|NCT01287897|453065769|FG003|Overall Study|Protocol Violation|1|||
125936656|NCT01287897|453065766|FG000|Overall Study|Lost to Follow-up|0|||
125936657|NCT01287897|453065767|FG001|Overall Study|Lost to Follow-up|0|||
126066472|NCT01014013|453534912|FG001|Overall Study|Withdrawal by Subject|4|||
126066473|NCT01014013|453534911|FG000|Overall Study|Clinical/microbiologic failure|1|||
126066474|NCT01014013|453534912|FG001|Overall Study|Clinical/microbiologic failure|2|||
126066475|NCT01014013|453534911|FG000|Overall Study|Pathogen culture = no growth|26|||
126066476|NCT01014013|453534912|FG001|Overall Study|Pathogen culture = no growth|34|||
125936658|NCT01287897|453065768|FG002|Overall Study|Lost to Follow-up|2|||
125936659|NCT01287897|453065769|FG003|Overall Study|Lost to Follow-up|0|||
125936660|NCT01287897|453065766|FG000|Overall Study|Withdrawal by Subject|1|||
125936661|NCT01287897|453065767|FG001|Overall Study|Withdrawal by Subject|5|||
125936662|NCT01287897|453065768|FG002|Overall Study|Withdrawal by Subject|3|||
125936663|NCT01287897|453065769|FG003|Overall Study|Withdrawal by Subject|2|||
125936664|NCT01287897|453065766|FG000|Overall Study|Not consented properly|0|||
125936665|NCT01287897|453065767|FG001|Overall Study|Not consented properly|1|||
125936666|NCT01287897|453065768|FG002|Overall Study|Not consented properly|0|||
125936667|NCT01287897|453065769|FG003|Overall Study|Not consented properly|0|||
125936668|NCT01287897|453065766|FG000|Overall Study|Not meeting entrance criteria|1|||
125936669|NCT01287897|453065767|FG001|Overall Study|Not meeting entrance criteria|1|||
126066477|NCT01014013|453534911|FG000|Overall Study|Negative urine culture|2|||
125936670|NCT01287897|453065768|FG002|Overall Study|Not meeting entrance criteria|0|||
125936671|NCT01287897|453065769|FG003|Overall Study|Not meeting entrance criteria|0|||
125936672|NCT01287897|453065766|FG000|Overall Study|Other|1|||
125936673|NCT01287897|453065767|FG001|Overall Study|Other|0|||
125936674|NCT01287897|453065768|FG002|Overall Study|Other|1|||
125936675|NCT01287897|453065769|FG003|Overall Study|Other|0|||
125936676|NCT00249444|453065770|FG000|Overall Study|Lost to Follow-up|2|||
125936677|NCT00249444|453065771|FG001|Overall Study|Lost to Follow-up|2|||
125936678|NCT00249444|453065770|FG000|Overall Study|non-compliant|9|||
125936679|NCT00249444|453065771|FG001|Overall Study|non-compliant|11|||
125936680|NCT00249444|453065770|FG000|Overall Study|Adverse Event|1|||
125936681|NCT00249444|453065771|FG001|Overall Study|Adverse Event|1|||
125936682|NCT00249444|453065770|FG000|Overall Study|life event|0|||
125936683|NCT00249444|453065771|FG001|Overall Study|life event|1|||
125936684|NCT00936910|453065774|FG000|Overall Study|Lack of Efficacy|3|||
125936685|NCT00412854|453065775|FG000|Overall Study|Withdrawn due to adverse events|1|||
125936686|NCT00412854|453065776|FG001|Overall Study|Withdrawn due to adverse events|5|||
125936687|NCT00412854|453065775|FG000|Overall Study|Withdrawn for other reasons|13|||
125936688|NCT00412854|453065776|FG001|Overall Study|Withdrawn for other reasons|11|||
125936689|NCT04483011|453065780|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
125936690|NCT04483011|453065781|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
125936691|NCT03518073|453065782|FG000|Overall Study|Adverse Event|2|||
125936692|NCT03518073|453065783|FG001|Overall Study|Adverse Event|4|||
125936693|NCT03518073|453065784|FG002|Overall Study|Adverse Event|2|||
125936694|NCT03518073|453065782|FG000|Overall Study|Death|2|||
125936695|NCT03518073|453065783|FG001|Overall Study|Death|1|||
125936696|NCT03518073|453065784|FG002|Overall Study|Death|3|||
125936697|NCT03518073|453065782|FG000|Overall Study|Lost to Follow-up|1|||
125936698|NCT03518073|453065783|FG001|Overall Study|Lost to Follow-up|0|||
125936699|NCT03518073|453065784|FG002|Overall Study|Lost to Follow-up|1|||
125936700|NCT03518073|453065782|FG000|Overall Study|Physician Decision|5|||
125936701|NCT03518073|453065783|FG001|Overall Study|Physician Decision|0|||
125936702|NCT03518073|453065784|FG002|Overall Study|Physician Decision|2|||
125936703|NCT03518073|453065782|FG000|Overall Study|Progressive disease|1|||
125936704|NCT03518073|453065783|FG001|Overall Study|Progressive disease|1|||
125936705|NCT03518073|453065784|FG002|Overall Study|Progressive disease|1|||
125936706|NCT03518073|453065782|FG000|Overall Study|Protocol Violation|1|||
125936707|NCT03518073|453065783|FG001|Overall Study|Protocol Violation|0|||
125936708|NCT03518073|453065784|FG002|Overall Study|Protocol Violation|0|||
125936709|NCT03518073|453065782|FG000|Overall Study|Withdrawal by Subject|30|||
125936710|NCT03518073|453065783|FG001|Overall Study|Withdrawal by Subject|34|||
125936711|NCT03518073|453065784|FG002|Overall Study|Withdrawal by Subject|29|||
125936712|NCT03518073|453065782|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
125936713|NCT03518073|453065783|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
125936714|NCT03518073|453065784|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
125936715|NCT03518073|453065782|FG000|Overall Study|Covid-19|1|||
125936716|NCT03518073|453065783|FG001|Overall Study|Covid-19|2|||
125936717|NCT03518073|453065784|FG002|Overall Study|Covid-19|1|||
125936718|NCT03045081|453065785|FG000|Overall Study|Withdrawal by Subject|6|||
125936719|NCT03045081|453065786|FG001|Overall Study|Withdrawal by Subject|11|||
125936720|NCT01853046|453065787|FG000|Overall Study|Withdrawal by Subject|1|||
125936721|NCT01853046|453065788|FG001|Overall Study|Withdrawal by Subject|1|||
125936722|NCT01853046|453065787|FG000|Overall Study|Adverse Event|4|||
125936723|NCT01853046|453065788|FG001|Overall Study|Adverse Event|2|||
125936724|NCT01853046|453065787|FG000|Overall Study|Disease progression|13|||
125936725|NCT01853046|453065788|FG001|Overall Study|Disease progression|3|||
125936726|NCT01485640|453065789|FG000|Overall Study|Adverse Event|10|||
125936727|NCT01485640|453065789|FG000|Overall Study|Lack of Efficacy|2|||
125936728|NCT01485640|453065789|FG000|Overall Study|Protocol Violation|1|||
125936729|NCT01485640|453065789|FG000|Overall Study|Withdrawal by Subject|14|||
125936730|NCT01485640|453065789|FG000|Overall Study|Terminated by Sponsor|95|||
125936731|NCT00065507|453065793|FG000|Overall Study|Death|16|||
125936732|NCT00065507|453065794|FG001|Overall Study|Death|17|||
125936733|NCT00065507|453065793|FG000|Overall Study|Adverse Event|4|||
125936734|NCT00065507|453065794|FG001|Overall Study|Adverse Event|3|||
125936735|NCT00065507|453065793|FG000|Overall Study|Lack of Efficacy|0|||
125936736|NCT00065507|453065794|FG001|Overall Study|Lack of Efficacy|6|||
125936737|NCT00065507|453065793|FG000|Overall Study|Poor/Non-compliance|3|||
125936738|NCT00065507|453065794|FG001|Overall Study|Poor/Non-compliance|2|||
125936739|NCT00065507|453065793|FG000|Overall Study|Lost to Follow-up|3|||
125936740|NCT00065507|453065794|FG001|Overall Study|Lost to Follow-up|0|||
125936741|NCT00065507|453065793|FG000|Overall Study|Subject Withdrew Consent|2|||
125936742|NCT00065507|453065794|FG001|Overall Study|Subject Withdrew Consent|1|||
125936743|NCT00065507|453065793|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
125936744|NCT00065507|453065794|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
125936745|NCT03635957|453065795|FG000|Run-In Period|Lost to Follow-up|1|||
125936746|NCT03635957|453065795|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
125936747|NCT00350636|453065796|FG000|Overall Study|Adverse Event|19|||
125936748|NCT00350636|453065797|FG001|Overall Study|Adverse Event|13|||
125936749|NCT00350636|453065796|FG000|Overall Study|Protocol Violation|1|||
125936750|NCT00350636|453065797|FG001|Overall Study|Protocol Violation|3|||
125936751|NCT00350636|453065796|FG000|Overall Study|Withdrawal by Subject|13|||
125936752|NCT00350636|453065797|FG001|Overall Study|Withdrawal by Subject|17|||
125936753|NCT00350636|453065796|FG000|Overall Study|Lost to Follow-up|9|||
125936754|NCT00350636|453065797|FG001|Overall Study|Lost to Follow-up|8|||
125936755|NCT00350636|453065796|FG000|Overall Study|Physician Decision|0|||
125936756|NCT00350636|453065797|FG001|Overall Study|Physician Decision|2|||
125936757|NCT00350636|453065796|FG000|Overall Study|Other|1|||
125936758|NCT00350636|453065797|FG001|Overall Study|Other|2|||
125936759|NCT01042236|453065800|FG000|Treatment Period 1|Adverse Event|0|||
125936760|NCT01042236|453065801|FG001|Treatment Period 1|Adverse Event|1|||
125936761|NCT01042236|453065802|FG002|Treatment Period 1|Adverse Event|0|||
125936762|NCT01042236|453065803|FG003|Treatment Period 1|Adverse Event|0|||
125936763|NCT01042236|453065804|FG004|Treatment Period 1|Adverse Event|1|||
125936764|NCT01042236|453065805|FG005|Treatment Period 1|Adverse Event|0|||
125936765|NCT01042236|453065800|FG000|Treatment Period 3|Adverse Event|0|||
125936766|NCT01042236|453065801|FG001|Treatment Period 3|Adverse Event|0|||
125936767|NCT01042236|453065802|FG002|Treatment Period 3|Adverse Event|0|||
125936768|NCT01042236|453065803|FG003|Treatment Period 3|Adverse Event|1|||
125936769|NCT01042236|453065804|FG004|Treatment Period 3|Adverse Event|0|||
125936770|NCT01042236|453065805|FG005|Treatment Period 3|Adverse Event|0|||
125936771|NCT01042236|453065800|FG000|Treatment Period 3|Protocol Violation|0|||
125936772|NCT01042236|453065801|FG001|Treatment Period 3|Protocol Violation|0|||
125936773|NCT01042236|453065802|FG002|Treatment Period 3|Protocol Violation|0|||
125936774|NCT01042236|453065803|FG003|Treatment Period 3|Protocol Violation|1|||
125936775|NCT01042236|453065804|FG004|Treatment Period 3|Protocol Violation|0|||
125936776|NCT01042236|453065805|FG005|Treatment Period 3|Protocol Violation|0|||
125936777|NCT00227903|453065806|FG000|Overall Study|Withdrawal by Subject|2|||
125936778|NCT00227903|453065807|FG001|Overall Study|Withdrawal by Subject|5|||
125936779|NCT00227903|453065806|FG000|Overall Study|Subject moved out of area|1|||
125936780|NCT00227903|453065807|FG001|Overall Study|Subject moved out of area|2|||
125936781|NCT00227903|453065806|FG000|Overall Study|Lost to Follow-up|1|||
125936782|NCT00227903|453065807|FG001|Overall Study|Lost to Follow-up|3|||
125936783|NCT00227903|453065806|FG000|Overall Study|Miscarriage|1|||
125936784|NCT00227903|453065807|FG001|Overall Study|Miscarriage|0|||
125936785|NCT01475331|453065808|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
125936786|NCT01475331|453065809|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
125936787|NCT01475331|453065808|FG000|Overall Study|excessive main duct communication|1|||
125936788|NCT01475331|453065809|FG001|Overall Study|excessive main duct communication|1|||
125936789|NCT01475331|453065808|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
125936790|NCT01475331|453065809|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
125936791|NCT01475331|453065808|FG000|Overall Study|Sign of malignancy during the procedure|2|||
125936792|NCT01475331|453065809|FG001|Overall Study|Sign of malignancy during the procedure|0|||
125936793|NCT01475331|453065808|FG000|Overall Study|cyst found to be prohibitively small|0|||
125936794|NCT01475331|453065809|FG001|Overall Study|cyst found to be prohibitively small|1|||
125936795|NCT01525550|453065810|FG000|Overall Study|Lost to Follow-up|8|||
125936796|NCT01525550|453065811|FG001|Overall Study|Lost to Follow-up|2|||
125936797|NCT01525550|453065810|FG000|Overall Study|Death|19|||
125936798|NCT01525550|453065811|FG001|Overall Study|Death|28|||
125936799|NCT01525550|453065810|FG000|Overall Study|Other|0|||
125936800|NCT01525550|453065811|FG001|Overall Study|Other|4|||
125936801|NCT01525550|453065810|FG000|Overall Study|Sponsor's Decision|30|||
125936802|NCT01525550|453065811|FG001|Overall Study|Sponsor's Decision|11|||
125936803|NCT01525550|453065810|FG000|Overall Study|Withdrawal by Subject|4|||
125936804|NCT01525550|453065811|FG001|Overall Study|Withdrawal by Subject|0|||
125936805|NCT02411292|453065816|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
125936806|NCT02411292|453065816|FG000|Overall Study|Death|2|||
125936807|NCT02411292|453065816|FG000|Overall Study|Lost to Follow-up|3|||
125936808|NCT02232425|453065819|FG000|Overall Study|Lost to Follow-up|6|||
125936809|NCT02232425|453065820|FG001|Overall Study|Lost to Follow-up|2|||
125936810|NCT02232425|453065819|FG000|Overall Study|Adverse Event|2|||
125936811|NCT02232425|453065820|FG001|Overall Study|Adverse Event|0|||
126114152|NCT02060383|453713740|FG004|Extension Phase|Withdrawal by Subject|2|||
125936812|NCT02232425|453065819|FG000|Overall Study|Withdrawal by Subject|5|||
125936813|NCT02232425|453065820|FG001|Overall Study|Withdrawal by Subject|6|||
125936814|NCT02232425|453065819|FG000|Overall Study|Lack of Efficacy|1|||
125936815|NCT02232425|453065820|FG001|Overall Study|Lack of Efficacy|0|||
125936816|NCT00665353|453065821|FG000|Study Step 1|Adverse Event|1|||
125936817|NCT00665353|453065821|FG000|Study Step 1|Withdrawal by Subject|2|||
125936818|NCT00665353|453065821|FG000|Study Step 2|Lost to Follow-up|2|||
125936819|NCT00665353|453065821|FG000|Study Step 2|Lack of Efficacy|12|||
125936820|NCT00498602|453065822|FG000|Overall Study|Death|0|||
125936821|NCT00498602|453065823|FG001|Overall Study|Death|0|||
125936822|NCT00498602|453065824|FG002|Overall Study|Death|0|||
125936823|NCT00498602|453065825|FG003|Overall Study|Death|0|||
125936824|NCT00498602|453065826|FG004|Overall Study|Death|0|||
125936825|NCT00498602|453065827|FG005|Overall Study|Death|1|||
125936826|NCT00498602|453065828|FG006|Overall Study|Death|0|||
125936827|NCT00498602|453065822|FG000|Overall Study|Lack of Efficacy|1|||
125936828|NCT00498602|453065823|FG001|Overall Study|Lack of Efficacy|0|||
125936829|NCT00498602|453065824|FG002|Overall Study|Lack of Efficacy|0|||
125936830|NCT00498602|453065825|FG003|Overall Study|Lack of Efficacy|0|||
125936831|NCT00498602|453065826|FG004|Overall Study|Lack of Efficacy|0|||
125936832|NCT00498602|453065827|FG005|Overall Study|Lack of Efficacy|0|||
125936833|NCT00498602|453065828|FG006|Overall Study|Lack of Efficacy|0|||
125936834|NCT00498602|453065822|FG000|Overall Study|Lost to Follow-up|0|||
125936835|NCT00498602|453065823|FG001|Overall Study|Lost to Follow-up|2|||
125936836|NCT00498602|453065824|FG002|Overall Study|Lost to Follow-up|0|||
125936837|NCT00498602|453065825|FG003|Overall Study|Lost to Follow-up|2|||
125936838|NCT00498602|453065826|FG004|Overall Study|Lost to Follow-up|0|||
125936839|NCT00498602|453065827|FG005|Overall Study|Lost to Follow-up|0|||
125936840|NCT00498602|453065828|FG006|Overall Study|Lost to Follow-up|0|||
125936841|NCT00498602|453065822|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125936842|NCT00498602|453065823|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125936843|NCT00498602|453065824|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
125936844|NCT00498602|453065825|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
125936845|NCT00498602|453065826|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125936846|NCT00498602|453065827|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125936847|NCT00498602|453065828|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125936848|NCT00498602|453065822|FG000|Overall Study|AE not related to Study Drug|1|||
125936849|NCT00498602|453065823|FG001|Overall Study|AE not related to Study Drug|3|||
125936850|NCT00498602|453065824|FG002|Overall Study|AE not related to Study Drug|0|||
125936851|NCT00498602|453065825|FG003|Overall Study|AE not related to Study Drug|0|||
125936852|NCT00498602|453065826|FG004|Overall Study|AE not related to Study Drug|2|||
125936853|NCT00498602|453065827|FG005|Overall Study|AE not related to Study Drug|2|||
125936854|NCT00498602|453065828|FG006|Overall Study|AE not related to Study Drug|1|||
125936855|NCT00498602|453065822|FG000|Overall Study|Caregiver Request|2|||
125936856|NCT00498602|453065823|FG001|Overall Study|Caregiver Request|2|||
125936857|NCT00498602|453065824|FG002|Overall Study|Caregiver Request|2|||
125936858|NCT00498602|453065825|FG003|Overall Study|Caregiver Request|0|||
125936859|NCT00498602|453065826|FG004|Overall Study|Caregiver Request|1|||
125936860|NCT00498602|453065827|FG005|Overall Study|Caregiver Request|2|||
125936861|NCT00498602|453065828|FG006|Overall Study|Caregiver Request|0|||
125936862|NCT00498602|453065822|FG000|Overall Study|Investigator Request|0|||
125936863|NCT00498602|453065823|FG001|Overall Study|Investigator Request|0|||
125936864|NCT00498602|453065824|FG002|Overall Study|Investigator Request|1|||
125936865|NCT00498602|453065825|FG003|Overall Study|Investigator Request|0|||
125936866|NCT00498602|453065826|FG004|Overall Study|Investigator Request|0|||
125936867|NCT00498602|453065827|FG005|Overall Study|Investigator Request|0|||
125936868|NCT00498602|453065828|FG006|Overall Study|Investigator Request|0|||
125936869|NCT00498602|453065822|FG000|Overall Study|Subject Request|3|||
125936870|NCT00498602|453065823|FG001|Overall Study|Subject Request|0|||
125936871|NCT00498602|453065824|FG002|Overall Study|Subject Request|1|||
125936872|NCT00498602|453065825|FG003|Overall Study|Subject Request|1|||
125936873|NCT00498602|453065826|FG004|Overall Study|Subject Request|1|||
125936874|NCT00498602|453065827|FG005|Overall Study|Subject Request|4|||
125936875|NCT00498602|453065828|FG006|Overall Study|Subject Request|1|||
125936876|NCT00498602|453065822|FG000|Overall Study|Other|2|||
125936877|NCT00498602|453065823|FG001|Overall Study|Other|3|||
125936878|NCT00498602|453065824|FG002|Overall Study|Other|1|||
125936879|NCT00498602|453065825|FG003|Overall Study|Other|0|||
125936880|NCT00498602|453065826|FG004|Overall Study|Other|0|||
125936881|NCT00498602|453065827|FG005|Overall Study|Other|3|||
125936882|NCT00498602|453065828|FG006|Overall Study|Other|0|||
125936883|NCT02632552|453065829|FG000|Overall Study|Lost to Follow-up|14|||
125936884|NCT02632552|453065830|FG001|Overall Study|Lost to Follow-up|8|||
125936885|NCT02632552|453065829|FG000|Overall Study|Withdrawal by Subject|2|||
125936886|NCT02632552|453065830|FG001|Overall Study|Withdrawal by Subject|0|||
125936887|NCT02632552|453065829|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
125936888|NCT02632552|453065830|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
125936889|NCT01846507|453065831|FG000|Overall Study|Lost to Follow-up|4|||
125936890|NCT01846507|453065831|FG000|Overall Study|Protocol Violation|1|||
125936891|NCT01846507|453065831|FG000|Overall Study|Missing data|2|||
125936892|NCT00450450|453065832|FG000|Overall Study|Death|1|||
125936893|NCT00450450|453065833|FG001|Overall Study|Death|3|||
125936894|NCT00450450|453065832|FG000|Overall Study|Relapse|2|||
125936895|NCT00450450|453065833|FG001|Overall Study|Relapse|0|||
125936896|NCT00450450|453065832|FG000|Overall Study|Missing Data|2|||
125936897|NCT00450450|453065833|FG001|Overall Study|Missing Data|0|||
125936898|NCT03318315|453065834|FG000|Overall Study|Lost to Follow-up|3|||
125936899|NCT03318315|453065835|FG001|Overall Study|Lost to Follow-up|2|||
126066478|NCT01014013|453534912|FG001|Overall Study|Negative urine culture|0|||
125936900|NCT03318315|453065836|FG002|Overall Study|Lost to Follow-up|1|||
125936901|NCT03318315|453065834|FG000|Overall Study|Protocol Violation|1|||
125936902|NCT03318315|453065835|FG001|Overall Study|Protocol Violation|1|||
125936903|NCT03318315|453065836|FG002|Overall Study|Protocol Violation|1|||
125936904|NCT03318315|453065834|FG000|Overall Study|Withdrawal by Subject|0|||
125936905|NCT03318315|453065835|FG001|Overall Study|Withdrawal by Subject|0|||
125936906|NCT03318315|453065836|FG002|Overall Study|Withdrawal by Subject|2|||
125936907|NCT01187043|453065837|FG000|Overall Study|Adverse Event|0|||
125936908|NCT01187043|453065838|FG001|Overall Study|Adverse Event|0|||
125936909|NCT01187043|453065839|FG002|Overall Study|Adverse Event|0|||
125936910|NCT01187043|453065840|FG003|Overall Study|Adverse Event|0|||
125936911|NCT01187043|453065841|FG004|Overall Study|Adverse Event|1|||
125936912|NCT01187043|453065837|FG000|Overall Study|Unable to make scheduled visits|1|||
125936913|NCT01187043|453065838|FG001|Overall Study|Unable to make scheduled visits|0|||
125936914|NCT01187043|453065839|FG002|Overall Study|Unable to make scheduled visits|4|||
125936915|NCT01187043|453065840|FG003|Overall Study|Unable to make scheduled visits|0|||
125936916|NCT01187043|453065841|FG004|Overall Study|Unable to make scheduled visits|1|||
125936917|NCT02196558|453065842|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
125936918|NCT02196558|453065843|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
125936919|NCT02196558|453065844|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
125936920|NCT02196558|453065842|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
125936921|NCT02196558|453065843|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
125936922|NCT02196558|453065844|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
125936923|NCT02196558|453065842|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
125936924|NCT02196558|453065843|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
125936925|NCT02196558|453065844|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
125936926|NCT02196558|453065842|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
125936927|NCT02196558|453065843|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
125936928|NCT02196558|453065844|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
125936929|NCT02196558|453065842|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
125936930|NCT02196558|453065843|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
125936931|NCT02196558|453065844|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
125936932|NCT01338493|453065845|FG000|Enrolled|Withdrawal by Subject|1|||
125936933|NCT01338493|453065845|FG000|Enrolled|Patient not implanted|4|||
125936934|NCT01338493|453065845|FG000|Discharge|Death|1|||
125936935|NCT01338493|453065845|FG000|Discharge|Missed visit|1|||
125936936|NCT01338493|453065845|FG000|6 Months Follow up|Lost to Follow-up|11|||
125936937|NCT01338493|453065845|FG000|6 Months Follow up|Missed visit|8|||
125936938|NCT01338493|453065845|FG000|12 Months Follow up|Lost to Follow-up|9|||
125936939|NCT01705652|453065847|FG000|Overall Study|Adverse Event|1|||
125936940|NCT01705652|453065848|FG001|Overall Study|Adverse Event|0|||
125936941|NCT01705652|453065847|FG000|Overall Study|Withdrawal by Subject|1|||
125936942|NCT01705652|453065848|FG001|Overall Study|Withdrawal by Subject|2|||
125936943|NCT01705652|453065847|FG000|Overall Study|non-compliance|1|||
125936944|NCT01705652|453065848|FG001|Overall Study|non-compliance|1|||
125936945|NCT00541034|453065849|FG000|Overall Study|Non-Compliance|3|||
125936946|NCT00656474|453065850|FG000|Overall Study|Other Reason|1|||
125936947|NCT01962207|453065851|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
125936948|NCT01962207|453065852|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
125936949|NCT01962207|453065853|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
125936950|NCT01962207|453065854|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
125936951|NCT01962207|453065851|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
125936952|NCT01962207|453065852|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
125936953|NCT01962207|453065853|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
125936954|NCT01962207|453065854|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
125936955|NCT01962207|453065851|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
125936956|NCT01962207|453065852|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
125936957|NCT01962207|453065853|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
125936958|NCT01962207|453065854|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
125936959|NCT01962207|453065851|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
125936960|NCT01962207|453065852|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
125936961|NCT01962207|453065853|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
125936962|NCT01962207|453065854|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
125936963|NCT01962207|453065851|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
125936964|NCT01962207|453065852|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
125936965|NCT01962207|453065853|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
125936966|NCT01962207|453065854|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
125936967|NCT01962207|453065851|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
125936968|NCT01962207|453065852|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
125936969|NCT01962207|453065853|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
125936970|NCT01962207|453065854|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
125936971|NCT00847704|453065855|FG000|Overall Study|Withdrawal by Subject|1|||
125936972|NCT03036072|453065858|FG000|Overall Study|Death|0|||
125936973|NCT03036072|453065859|FG001|Overall Study|Death|1|||
125936974|NCT03036072|453065858|FG000|Overall Study|Withdrawal by Subject|0|||
125936975|NCT03036072|453065859|FG001|Overall Study|Withdrawal by Subject|1|||
125936976|NCT03036072|453065858|FG000|Overall Study|Physician Decision|0|||
125936977|NCT03036072|453065859|FG001|Overall Study|Physician Decision|1|||
125936978|NCT02484729|453065860|FG000|Overall Study|Failure of IntelliCap Error|0|||
125936979|NCT02484729|453065861|FG001|Overall Study|Failure of IntelliCap Error|0|||
125936980|NCT02484729|453065862|FG002|Overall Study|Failure of IntelliCap Error|0|||
125936981|NCT02484729|453065863|FG003|Overall Study|Failure of IntelliCap Error|0|||
125936982|NCT02484729|453065864|FG004|Overall Study|Failure of IntelliCap Error|0|||
125936983|NCT02484729|453065865|FG005|Overall Study|Failure of IntelliCap Error|0|||
125936984|NCT02484729|453065866|FG006|Overall Study|Failure of IntelliCap Error|0|||
125936985|NCT02484729|453065867|FG007|Overall Study|Failure of IntelliCap Error|0|||
125936986|NCT02484729|453065868|FG008|Overall Study|Failure of IntelliCap Error|0|||
125936987|NCT02484729|453065869|FG009|Overall Study|Failure of IntelliCap Error|1|||
125936988|NCT02111850|453065872|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936989|NCT02111850|453065873|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936990|NCT02111850|453065874|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936991|NCT02111850|453065875|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936992|NCT02111850|453065876|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
125936993|NCT02111850|453065877|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936994|NCT02111850|453065878|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936995|NCT02111850|453065879|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936996|NCT02111850|453065880|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936997|NCT02111850|453065881|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936998|NCT02111850|453065882|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125936999|NCT02625259|453065883|FG000|First Intervention (Day 1)|Other|0|||
125937000|NCT02625259|453065884|FG001|First Intervention (Day 1)|Other|0|||
125937001|NCT02625259|453065885|FG002|First Intervention (Day 1)|Other|1|||
125937002|NCT02625259|453065886|FG003|First Intervention (Day 1)|Other|0|||
125937003|NCT02625259|453065887|FG004|First Intervention (Day 1)|Other|0|||
125937004|NCT02625259|453065883|FG000|First Intervention (Day 1)|Adverse Event|2|||
125937005|NCT02625259|453065884|FG001|First Intervention (Day 1)|Adverse Event|1|||
125937006|NCT02625259|453065885|FG002|First Intervention (Day 1)|Adverse Event|0|||
125937007|NCT02625259|453065886|FG003|First Intervention (Day 1)|Adverse Event|0|||
125937008|NCT02625259|453065887|FG004|First Intervention (Day 1)|Adverse Event|0|||
125937009|NCT02625259|453065883|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
125937010|NCT02625259|453065884|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
125937011|NCT02625259|453065885|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
125937012|NCT02625259|453065886|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
125937013|NCT02625259|453065887|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
125937014|NCT01980875|453065888|FG000|Overall Study|Withdrew Consent|1|||
125937015|NCT01980875|453065889|FG001|Overall Study|Withdrew Consent|1|||
125937016|NCT01980875|453065890|FG002|Overall Study|Withdrew Consent|1|||
125937017|NCT01980875|453065888|FG000|Overall Study|Study Terminated by Sponsor|7|||
125937018|NCT01980875|453065889|FG001|Overall Study|Study Terminated by Sponsor|24|||
125937019|NCT01980875|453065890|FG002|Overall Study|Study Terminated by Sponsor|22|||
125937020|NCT01980875|453065888|FG000|Overall Study|Lost to Follow-up|0|||
125937021|NCT01980875|453065889|FG001|Overall Study|Lost to Follow-up|0|||
125937022|NCT01980875|453065890|FG002|Overall Study|Lost to Follow-up|1|||
125937023|NCT00665847|453065891|FG000|Overall Study|Adverse Event|8|||
125937024|NCT00665847|453065891|FG000|Overall Study|Withdrawal by Subject|2|||
125937025|NCT00665847|453065891|FG000|Overall Study|Subject non-compliant|8|||
125937026|NCT00665847|453065891|FG000|Overall Study|Subject reached a virologic endpoint|4|||
125937027|NCT00665847|453065891|FG000|Overall Study|Resistance to TMC125|1|||
125937028|NCT00665847|453065891|FG000|Overall Study|Subject ineligible to continue the trial|1|||
125937029|NCT00665847|453065891|FG000|Overall Study|Switch to Commercial Medication|1|||
125937030|NCT02663674|453065896|FG000|Overall Study|Lost to Follow-up|5|||
125937031|NCT02663674|453065897|FG001|Overall Study|Lost to Follow-up|4|||
125937032|NCT02663674|453065896|FG000|Overall Study|Withdrawal by Subject|1|||
125937033|NCT02663674|453065897|FG001|Overall Study|Withdrawal by Subject|4|||
125937034|NCT02663674|453065896|FG000|Overall Study|Physician Decision|1|||
125937035|NCT02663674|453065897|FG001|Overall Study|Physician Decision|1|||
125937036|NCT02663674|453065896|FG000|Overall Study|Other Event (Health Related)|0|||
125937037|NCT02663674|453065897|FG001|Overall Study|Other Event (Health Related)|1|||
125937038|NCT00397982|453067655|FG000|Overall Study|Withdrawal by Subject|1|||
125937039|NCT00397982|453067655|FG000|Overall Study|Adverse Event|1|||
125937040|NCT00397982|453067655|FG000|Overall Study|noncompliance|1|||
125937041|NCT00397982|453067655|FG000|Overall Study|Unrelated health issues|1|||
125937042|NCT04244786|453067656|FG000|Overall Study|Adverse Event|0|||
125937043|NCT04244786|453067657|FG001|Overall Study|Adverse Event|0|||
125937044|NCT04244786|453067658|FG002|Overall Study|Adverse Event|2|||
125937045|NCT04244786|453067656|FG000|Overall Study|Withdrawal by Subject|0|||
125937046|NCT04244786|453067657|FG001|Overall Study|Withdrawal by Subject|0|||
125937047|NCT04244786|453067658|FG002|Overall Study|Withdrawal by Subject|5|||
125937048|NCT00613938|453067665|FG000|Overall Study|Withdrawal by Subject|2|||
125937049|NCT00613938|453067666|FG001|Overall Study|Withdrawal by Subject|4|||
125937050|NCT00613938|453067667|FG002|Overall Study|Withdrawal by Subject|9|||
125937051|NCT00613938|453067668|FG003|Overall Study|Withdrawal by Subject|9|||
125937052|NCT00613938|453067665|FG000|Overall Study|Adverse Event|1|||
125937053|NCT00613938|453067666|FG001|Overall Study|Adverse Event|4|||
125937054|NCT00613938|453067667|FG002|Overall Study|Adverse Event|8|||
125937055|NCT00613938|453067668|FG003|Overall Study|Adverse Event|5|||
125937056|NCT00613938|453067665|FG000|Overall Study|Lack of Efficacy|16|||
125937057|NCT00613938|453067666|FG001|Overall Study|Lack of Efficacy|18|||
125937058|NCT00613938|453067667|FG002|Overall Study|Lack of Efficacy|5|||
125937059|NCT00613938|453067668|FG003|Overall Study|Lack of Efficacy|9|||
125937060|NCT00613938|453067665|FG000|Overall Study|Other|1|||
125937061|NCT00613938|453067666|FG001|Overall Study|Other|2|||
125937062|NCT00613938|453067667|FG002|Overall Study|Other|1|||
125937063|NCT00613938|453067668|FG003|Overall Study|Other|3|||
125937064|NCT02636868|453067669|FG000|Overall Study|Death|0|||
125937065|NCT02636868|453067670|FG001|Overall Study|Death|1|||
125937066|NCT02636868|453067671|FG002|Overall Study|Death|2|||
125937067|NCT03220217|453067672|FG000|Overall Study|Withdrawal by Subject|0|||
125937068|NCT03220217|453067673|FG001|Overall Study|Withdrawal by Subject|1|||
125937069|NCT03220217|453067674|FG002|Overall Study|Withdrawal by Subject|0|||
125937070|NCT03220217|453067672|FG000|Overall Study|Subject Missed Procedure|0|||
125937071|NCT03220217|453067673|FG001|Overall Study|Subject Missed Procedure|0|||
125937072|NCT03220217|453067674|FG002|Overall Study|Subject Missed Procedure|1|||
125937073|NCT03025542|453067675|FG000|Overall Study|Adverse Event|0|||
125937074|NCT03025542|453067676|FG001|Overall Study|Adverse Event|2|||
125937075|NCT03025542|453067675|FG000|Overall Study|Lost to Follow-up|1|||
125937076|NCT03025542|453067676|FG001|Overall Study|Lost to Follow-up|0|||
125937077|NCT03025542|453067675|FG000|Overall Study|Withdrawal by Subject|1|||
125937078|NCT03025542|453067676|FG001|Overall Study|Withdrawal by Subject|0|||
125937079|NCT03745937|453067677|FG000|Overall Study|Withdrawal by Subject|0|||
125937080|NCT03745937|453067678|FG001|Overall Study|Withdrawal by Subject|0|||
125937081|NCT03745937|453067679|FG002|Overall Study|Withdrawal by Subject|0|||
125937082|NCT03745937|453067680|FG003|Overall Study|Withdrawal by Subject|1|||
125937083|NCT03745937|453067677|FG000|Overall Study|Not-specifed|0|||
125937084|NCT03745937|453067678|FG001|Overall Study|Not-specifed|1|||
125937085|NCT03745937|453067679|FG002|Overall Study|Not-specifed|0|||
125937086|NCT03745937|453067680|FG003|Overall Study|Not-specifed|1|||
125937087|NCT00488345|453067683|FG000|Overall Study|Adverse Event|0|||
125937088|NCT00488345|453067684|FG001|Overall Study|Adverse Event|1|||
125937089|NCT00488345|453067685|FG002|Overall Study|Adverse Event|1|||
125937090|NCT00488345|453067683|FG000|Overall Study|Unable to administer antibiotics at home|0|||
125937091|NCT00488345|453067684|FG001|Overall Study|Unable to administer antibiotics at home|1|||
125937092|NCT00488345|453067685|FG002|Overall Study|Unable to administer antibiotics at home|0|||
125937093|NCT00488345|453067683|FG000|Overall Study|Institutional Review Board review|0|||
125937094|NCT00488345|453067684|FG001|Overall Study|Institutional Review Board review|0|||
125937095|NCT00488345|453067685|FG002|Overall Study|Institutional Review Board review|1|||
125937096|NCT00488345|453067683|FG000|Overall Study|Surgical team recommendation|0|||
125937097|NCT00488345|453067684|FG001|Overall Study|Surgical team recommendation|1|||
125937098|NCT00488345|453067685|FG002|Overall Study|Surgical team recommendation|0|||
125937099|NCT00488345|453067683|FG000|Overall Study|Parent/legal guardian request|0|||
125937100|NCT00488345|453067684|FG001|Overall Study|Parent/legal guardian request|1|||
125937101|NCT00488345|453067685|FG002|Overall Study|Parent/legal guardian request|1|||
125937102|NCT02057198|453067697|FG000|Overall Study|Death|0|||
125937103|NCT02057198|453067698|FG001|Overall Study|Death|0|||
125937104|NCT02057198|453067699|FG002|Overall Study|Death|1|||
125937105|NCT02057198|453067697|FG000|Overall Study|Discharged early; lost to followup|0|||
125937106|NCT02057198|453067698|FG001|Overall Study|Discharged early; lost to followup|1|||
125937107|NCT02057198|453067699|FG002|Overall Study|Discharged early; lost to followup|0|||
125937108|NCT02345811|453067703|FG000|First Intervention|Withdrawal by Subject|1|||
125937109|NCT02345811|453067704|FG001|First Intervention|Withdrawal by Subject|1|||
125937110|NCT02877082|453067705|FG000|Overall Study|Trial was closed early|5|||
125937111|NCT02489344|453067706|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
125937112|NCT02489344|453067706|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
125937113|NCT02489344|453067706|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
125937114|NCT02489344|453067706|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
125937115|NCT03480750|453067707|FG000|Overall Study|Withdrawal by Subject|0|||
125937116|NCT03480750|453067708|FG001|Overall Study|Withdrawal by Subject|1|||
125937117|NCT03480750|453067709|FG002|Overall Study|Withdrawal by Subject|0|||
125937118|NCT03480750|453067710|FG003|Overall Study|Withdrawal by Subject|0|||
125937119|NCT03480750|453067711|FG004|Overall Study|Withdrawal by Subject|0|||
125937120|NCT03480750|453067712|FG005|Overall Study|Withdrawal by Subject|0|||
125937121|NCT03480750|453067707|FG000|Overall Study|The interruption in Trientine shippment|0|||
125937122|NCT03480750|453067708|FG001|Overall Study|The interruption in Trientine shippment|0|||
125937123|NCT03480750|453067709|FG002|Overall Study|The interruption in Trientine shippment|0|||
125937124|NCT03480750|453067710|FG003|Overall Study|The interruption in Trientine shippment|0|||
125937125|NCT03480750|453067711|FG004|Overall Study|The interruption in Trientine shippment|0|||
125937126|NCT03480750|453067712|FG005|Overall Study|The interruption in Trientine shippment|1|||
125937127|NCT01132482|453067713|FG000|Overall Study|Adverse Event|1|||
125937128|NCT01132482|453067714|FG001|Overall Study|Adverse Event|0|||
125937129|NCT03683758|453067715|FG000|Overall Study|Non-study commitment conflict|1|||
125937130|NCT03683758|453067716|FG001|Overall Study|Non-study commitment conflict|3|||
125937131|NCT03683758|453067715|FG000|Overall Study|Illness preventing participation|1|||
125937132|NCT03683758|453067716|FG001|Overall Study|Illness preventing participation|0|||
125937133|NCT03683758|453067715|FG000|Overall Study|Adverse Event|1|||
125937134|NCT03683758|453067716|FG001|Overall Study|Adverse Event|0|||
125937135|NCT00723892|453067717|FG000|Overall Study|Participant not tracked|33|||
125937136|NCT00723892|453067718|FG001|Overall Study|Participant not tracked|35|||
125937137|NCT00723892|453067717|FG000|Overall Study|Virological criterion|24|||
125937138|NCT00723892|453067718|FG001|Overall Study|Virological criterion|9|||
125937139|NCT00723892|453067717|FG000|Overall Study|Withdrawal by Subject|6|||
125937140|NCT00723892|453067718|FG001|Overall Study|Withdrawal by Subject|9|||
125937141|NCT00723892|453067717|FG000|Overall Study|End planned|11|||
125937142|NCT00723892|453067718|FG001|Overall Study|End planned|7|||
125937143|NCT00723892|453067717|FG000|Overall Study|Bad tolerance|5|||
125937144|NCT00723892|453067718|FG001|Overall Study|Bad tolerance|5|||
125937145|NCT00723892|453067717|FG000|Overall Study|Multiple reasons|17|||
125937146|NCT00723892|453067718|FG001|Overall Study|Multiple reasons|12|||
125937147|NCT00723892|453067717|FG000|Overall Study|Other|6|||
125937148|NCT00723892|453067718|FG001|Overall Study|Other|3|||
125937149|NCT00723892|453067717|FG000|Overall Study|Study end|1|||
125937150|NCT00723892|453067718|FG001|Overall Study|Study end|3|||
125937151|NCT00723892|453067717|FG000|Overall Study|Weight loss|1|||
125937152|NCT00723892|453067718|FG001|Overall Study|Weight loss|3|||
125937153|NCT00723892|453067717|FG000|Overall Study|Alcohol abuse|0|||
125937154|NCT00723892|453067718|FG001|Overall Study|Alcohol abuse|1|||
125937155|NCT00723892|453067717|FG000|Overall Study|Intercurrent infection|2|||
125937156|NCT00723892|453067718|FG001|Overall Study|Intercurrent infection|0|||
125937157|NCT00723892|453067717|FG000|Overall Study|Drug addiction|1|||
125937158|NCT00723892|453067718|FG001|Overall Study|Drug addiction|0|||
125937159|NCT01172847|453067723|FG000|Overall Study|Withdrawal by Subject|3|||
125937160|NCT01163279|453067725|FG000|Overall Study|Withdrawal by Subject|2|||
125937161|NCT01163279|453067726|FG001|Overall Study|Withdrawal by Subject|0|||
125937162|NCT01601626|453067727|FG000|Overall Study|Death|1|||
125937163|NCT01601626|453067728|FG001|Overall Study|Death|1|||
125937164|NCT01601626|453067729|FG002|Overall Study|Death|1|||
125937165|NCT01601626|453067727|FG000|Overall Study|Lost to Follow-up|1|||
125937166|NCT01601626|453067728|FG001|Overall Study|Lost to Follow-up|2|||
125937167|NCT01601626|453067729|FG002|Overall Study|Lost to Follow-up|0|||
125937168|NCT01601626|453067727|FG000|Overall Study|Unable to Get to Clinic|0|||
125937169|NCT01601626|453067728|FG001|Overall Study|Unable to Get to Clinic|1|||
125937170|NCT01601626|453067729|FG002|Overall Study|Unable to Get to Clinic|0|||
125937171|NCT01601626|453067727|FG000|Overall Study|Withdrawal by Subject|0|||
125937172|NCT01601626|453067728|FG001|Overall Study|Withdrawal by Subject|1|||
125937173|NCT01601626|453067729|FG002|Overall Study|Withdrawal by Subject|1|||
125937174|NCT01601626|453067727|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
125937175|NCT01601626|453067728|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
126066479|NCT01014013|453534911|FG000|Overall Study|Pathogen resistant|7|||
126066480|NCT01014013|453534912|FG001|Overall Study|Pathogen resistant|4|||
125937176|NCT01601626|453067729|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
125937177|NCT00546637|453067732|FG000|Overall Study|Adverse Event|46|||
125937178|NCT00546637|453067733|FG001|Overall Study|Adverse Event|20|||
125937179|NCT00546637|453067732|FG000|Overall Study|Lack of Efficacy|5|||
125937180|NCT00546637|453067733|FG001|Overall Study|Lack of Efficacy|5|||
126066481|NCT01014013|453534911|FG000|Overall Study|Physician Decision|0|||
126066482|NCT01014013|453534912|FG001|Overall Study|Physician Decision|1|||
126066483|NCT01014013|453534911|FG000|Overall Study|Another antibiotic therapy required|0|||
126066484|NCT01014013|453534912|FG001|Overall Study|Another antibiotic therapy required|1|||
126066485|NCT01014013|453534911|FG000|Overall Study|Appendectomy|1|||
126066486|NCT01014013|453534912|FG001|Overall Study|Appendectomy|0|||
125937181|NCT00546637|453067732|FG000|Overall Study|Lost to Follow-up|2|||
125937182|NCT00546637|453067733|FG001|Overall Study|Lost to Follow-up|2|||
125937183|NCT00546637|453067732|FG000|Overall Study|Other|10|||
125937184|NCT00546637|453067733|FG001|Overall Study|Other|12|||
125937185|NCT00546637|453067732|FG000|Overall Study|Withdrawal by Subject|7|||
125937186|NCT00546637|453067733|FG001|Overall Study|Withdrawal by Subject|9|||
125937187|NCT00546637|453067732|FG000|Overall Study|Randomized, but not treated|3|||
125937188|NCT00546637|453067733|FG001|Overall Study|Randomized, but not treated|1|||
125937189|NCT01074450|453067734|FG000|First Intervention|Emesis in Dosing Interval|0|||
125937190|NCT01074450|453067735|FG001|First Intervention|Emesis in Dosing Interval|2|||
125937191|NCT01074450|453067734|FG000|Second Intervention|Protocol Violation|1|||
125937192|NCT01074450|453067735|FG001|Second Intervention|Protocol Violation|0|||
125937193|NCT01074450|453067734|FG000|Second Intervention|Physician Decision|0|||
125937194|NCT01074450|453067735|FG001|Second Intervention|Physician Decision|1|||
125937195|NCT04984993|453067736|FG000|Overall Study|Withdrawal by Subject|8|||
125937196|NCT04984993|453067737|FG001|Overall Study|Withdrawal by Subject|2|||
125937197|NCT04984993|453067736|FG000|Overall Study|Lost to Follow-up|2|||
125937198|NCT04984993|453067737|FG001|Overall Study|Lost to Follow-up|2|||
125937199|NCT04984993|453067736|FG000|Overall Study|Both patients moved to another country|4|||
125937200|NCT04984993|453067737|FG001|Overall Study|Both patients moved to another country|0|||
125937201|NCT02865187|453067740|FG000|Overall Study|Lost to Follow-up|12|||
125937202|NCT02865187|453067741|FG001|Overall Study|Lost to Follow-up|7|||
125937203|NCT02865187|453067740|FG000|Overall Study|Adverse Event|1|||
125937204|NCT02865187|453067741|FG001|Overall Study|Adverse Event|0|||
125937205|NCT02710045|453067744|FG000|Overall Study|Death|1|||
125937206|NCT02710045|453067745|FG001|Overall Study|Death|2|||
125937207|NCT02710045|453067746|FG002|Overall Study|Death|0|||
125937208|NCT02710045|453067744|FG000|Overall Study|Withdrawal by Subject|6|||
125937209|NCT02710045|453067745|FG001|Overall Study|Withdrawal by Subject|6|||
125937210|NCT02710045|453067746|FG002|Overall Study|Withdrawal by Subject|2|||
125937211|NCT02710045|453067744|FG000|Overall Study|Protocol Violation|1|||
125937212|NCT02710045|453067745|FG001|Overall Study|Protocol Violation|2|||
125937213|NCT02710045|453067746|FG002|Overall Study|Protocol Violation|3|||
125937214|NCT02710045|453067744|FG000|Overall Study|Lost to Follow-up|3|||
125937215|NCT02710045|453067745|FG001|Overall Study|Lost to Follow-up|6|||
125937216|NCT02710045|453067746|FG002|Overall Study|Lost to Follow-up|7|||
125937217|NCT02710045|453067744|FG000|Overall Study|Physician Decision|0|||
125937218|NCT02710045|453067745|FG001|Overall Study|Physician Decision|0|||
125937219|NCT02710045|453067746|FG002|Overall Study|Physician Decision|1|||
125937220|NCT02710045|453067744|FG000|Overall Study|Poor Attendance|0|||
125937221|NCT02710045|453067745|FG001|Overall Study|Poor Attendance|1|||
125937222|NCT02710045|453067746|FG002|Overall Study|Poor Attendance|0|||
125937223|NCT03178773|453067747|FG000|Overall Study|Death|0|||
125937224|NCT03178773|453067748|FG001|Overall Study|Death|1|||
125937225|NCT03178773|453067747|FG000|Overall Study|Lost to Follow-up|29|||
125937226|NCT03178773|453067748|FG001|Overall Study|Lost to Follow-up|25|||
125937227|NCT03178773|453067747|FG000|Overall Study|Withdrawal by Subject|10|||
125937228|NCT03178773|453067748|FG001|Overall Study|Withdrawal by Subject|14|||
125937229|NCT01382446|453067749|FG000|Overall Study|Withdrawal by Subject|0|||
125937230|NCT01382446|453067750|FG001|Overall Study|Withdrawal by Subject|1|||
125937231|NCT01382446|453067749|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
125937232|NCT01382446|453067750|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
125937233|NCT02707991|453067751|FG000|Overall Study|Protocol Violation|1|||
125937234|NCT02707991|453067752|FG001|Overall Study|Protocol Violation|0|||
125937235|NCT02707991|453067751|FG000|Overall Study|Became ineligible|0|||
125937236|NCT02707991|453067752|FG001|Overall Study|Became ineligible|1|||
125937237|NCT00451321|453067757|FG000|Overall Study|Lost to Follow-up|3|||
125937238|NCT00451321|453067758|FG001|Overall Study|Lost to Follow-up|3|||
125937239|NCT00451321|453067759|FG002|Overall Study|Lost to Follow-up|1|||
125937240|NCT00451321|453067760|FG003|Overall Study|Lost to Follow-up|3|||
125937241|NCT00451321|453067761|FG004|Overall Study|Lost to Follow-up|0|||
125937242|NCT00451321|453067762|FG005|Overall Study|Lost to Follow-up|1|||
125937243|NCT00451321|453067763|FG006|Overall Study|Lost to Follow-up|0|||
125937244|NCT00451321|453067764|FG007|Overall Study|Lost to Follow-up|0|||
125937245|NCT00451321|453067757|FG000|Overall Study|Withdrawal by Subject|3|||
125937246|NCT00451321|453067758|FG001|Overall Study|Withdrawal by Subject|1|||
125937247|NCT00451321|453067759|FG002|Overall Study|Withdrawal by Subject|0|||
125937248|NCT00451321|453067760|FG003|Overall Study|Withdrawal by Subject|4|||
125937249|NCT00451321|453067761|FG004|Overall Study|Withdrawal by Subject|0|||
125937250|NCT00451321|453067762|FG005|Overall Study|Withdrawal by Subject|0|||
125937251|NCT00451321|453067763|FG006|Overall Study|Withdrawal by Subject|0|||
125937252|NCT00451321|453067764|FG007|Overall Study|Withdrawal by Subject|0|||
126114153|NCT02060383|453713736|FG000|Extension Phase|Administrative problems|1|||
126114154|NCT02060383|453713737|FG001|Extension Phase|Administrative problems|0|||
125937253|NCT00451321|453067757|FG000|Overall Study|Study closed/terminated|1|||
125937254|NCT00451321|453067758|FG001|Overall Study|Study closed/terminated|1|||
125937255|NCT00451321|453067759|FG002|Overall Study|Study closed/terminated|17|||
125937256|NCT00451321|453067760|FG003|Overall Study|Study closed/terminated|5|||
125937257|NCT00451321|453067761|FG004|Overall Study|Study closed/terminated|7|||
125937258|NCT00451321|453067762|FG005|Overall Study|Study closed/terminated|7|||
125937259|NCT00451321|453067763|FG006|Overall Study|Study closed/terminated|5|||
125937260|NCT00451321|453067764|FG007|Overall Study|Study closed/terminated|3|||
125937261|NCT00451321|453067757|FG000|Overall Study|Sponsor decision to amend protocol|0|||
125937262|NCT00451321|453067758|FG001|Overall Study|Sponsor decision to amend protocol|0|||
125937263|NCT00451321|453067759|FG002|Overall Study|Sponsor decision to amend protocol|0|||
125937264|NCT00451321|453067760|FG003|Overall Study|Sponsor decision to amend protocol|0|||
125937265|NCT00451321|453067761|FG004|Overall Study|Sponsor decision to amend protocol|0|||
125937266|NCT00451321|453067762|FG005|Overall Study|Sponsor decision to amend protocol|1|||
125937267|NCT00451321|453067763|FG006|Overall Study|Sponsor decision to amend protocol|1|||
125937268|NCT00451321|453067764|FG007|Overall Study|Sponsor decision to amend protocol|3|||
125937269|NCT01166763|453067768|FG000|Overall Study|Withdrawal by Subject|3|||
125937270|NCT01528254|453067769|FG000|Overall Study|Administrative problems|96|||
125937271|NCT01528254|453067770|FG001|Overall Study|Administrative problems|94|||
125937272|NCT01528254|453067769|FG000|Overall Study|Adverse Event|28|||
125937273|NCT01528254|453067770|FG001|Overall Study|Adverse Event|44|||
125937274|NCT01528254|453067769|FG000|Overall Study|Lost to Follow-up|17|||
125937275|NCT01528254|453067770|FG001|Overall Study|Lost to Follow-up|24|||
125937276|NCT01528254|453067769|FG000|Overall Study|Death|13|||
125937277|NCT01528254|453067770|FG001|Overall Study|Death|9|||
125937278|NCT01528254|453067769|FG000|Overall Study|Protocol deviation|9|||
125937279|NCT01528254|453067770|FG001|Overall Study|Protocol deviation|19|||
125937280|NCT01528254|453067769|FG000|Overall Study|New therapy for study indication|8|||
125937281|NCT01528254|453067770|FG001|Overall Study|New therapy for study indication|6|||
125937282|NCT01528254|453067769|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125937283|NCT01528254|453067770|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125937284|NCT01528254|453067769|FG000|Overall Study|Withdrawal by Subject|5|||
125937285|NCT01528254|453067770|FG001|Overall Study|Withdrawal by Subject|4|||
125937286|NCT01528254|453067769|FG000|Overall Study|Abnormal laboratory value(s)|3|||
125937287|NCT01528254|453067770|FG001|Overall Study|Abnormal laboratory value(s)|7|||
125937288|NCT01528254|453067769|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125937289|NCT01528254|453067770|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125937290|NCT01528254|453067769|FG000|Overall Study|No longer requires study drug|1|||
125937291|NCT01528254|453067770|FG001|Overall Study|No longer requires study drug|1|||
125937292|NCT04339296|453067771|FG000|Overall Study|Refuse to participate after allocation|1|||
125937293|NCT04339296|453067772|FG001|Overall Study|Refuse to participate after allocation|1|||
125937294|NCT04339296|453067771|FG000|Overall Study|Withdrew after completion of baseline|2|||
125937295|NCT04339296|453067772|FG001|Overall Study|Withdrew after completion of baseline|1|||
125937296|NCT04339296|453067771|FG000|Overall Study|Lost to Follow-up|0|||
125937297|NCT04339296|453067772|FG001|Overall Study|Lost to Follow-up|4|||
125937298|NCT04339296|453067771|FG000|Overall Study|Discontinued intervention|5|||
125937299|NCT04339296|453067772|FG001|Overall Study|Discontinued intervention|3|||
125937300|NCT01909479|453067773|FG000|From Baseline to Week 26|Adverse Event|3|||
125937301|NCT01909479|453067774|FG001|From Baseline to Week 26|Adverse Event|2|||
125937302|NCT01909479|453067773|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
125937303|NCT01909479|453067774|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
125937304|NCT01909479|453067773|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
125937305|NCT01909479|453067774|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
125937306|NCT01909479|453067773|FG000|26 - 52 Weeks|Adverse Event|0|||
125937307|NCT01909479|453067774|FG001|26 - 52 Weeks|Adverse Event|1|||
125937308|NCT01909479|453067773|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
125937309|NCT01909479|453067774|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
125937310|NCT01909479|453067773|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
125937311|NCT01909479|453067774|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
125937312|NCT01909479|453067773|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
125937313|NCT01909479|453067774|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
125937314|NCT01909479|453067773|FG000|52 Weeks to End of Study|Adverse Event|2|||
125937315|NCT01909479|453067774|FG001|52 Weeks to End of Study|Adverse Event|1|||
125937316|NCT01909479|453067773|FG000|52 Weeks to End of Study|Death|0|||
125937317|NCT01909479|453067774|FG001|52 Weeks to End of Study|Death|1|||
125937318|NCT01909479|453067773|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
125937319|NCT01909479|453067774|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
125937320|NCT01909479|453067773|FG000|52 Weeks to End of Study|Protocol Violation|1|||
125937321|NCT01909479|453067774|FG001|52 Weeks to End of Study|Protocol Violation|0|||
125937322|NCT01909479|453067773|FG000|52 Weeks to End of Study|Progressive disease|1|||
125937323|NCT01909479|453067774|FG001|52 Weeks to End of Study|Progressive disease|1|||
125937324|NCT01909479|453067773|FG000|52 Weeks to End of Study|Personal reasons|2|||
125937325|NCT01909479|453067774|FG001|52 Weeks to End of Study|Personal reasons|1|||
125937326|NCT01909479|453067773|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
125937327|NCT01909479|453067774|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
125937328|NCT01909479|453067773|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
125937329|NCT01909479|453067774|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
125937330|NCT01909479|453067773|FG000|52 Weeks to End of Study|Lack of contact|1|||
125937331|NCT01909479|453067774|FG001|52 Weeks to End of Study|Lack of contact|0|||
125937332|NCT01909479|453067773|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
125937333|NCT01909479|453067774|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
125937334|NCT01909479|453067773|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
125937335|NCT01909479|453067774|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
125937336|NCT04446377|453067775|FG000|Overall Study|Withdrawal by Subject|6|||
125937337|NCT04446377|453067776|FG001|Overall Study|Withdrawal by Subject|1|||
126066487|NCT01014013|453534911|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
126066488|NCT01014013|453534912|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
125937338|NCT04446377|453067775|FG000|Overall Study|Physician Decision|1|||
125937339|NCT04446377|453067776|FG001|Overall Study|Physician Decision|1|||
125937340|NCT04446377|453067775|FG000|Overall Study|Lost to Follow-up|0|||
125937341|NCT04446377|453067776|FG001|Overall Study|Lost to Follow-up|2|||
125937342|NCT04446377|453067775|FG000|Overall Study|Not eligible|0|||
125937343|NCT04446377|453067776|FG001|Overall Study|Not eligible|1|||
125937344|NCT00737282|453067779|FG000|Overall Study|Study prematurely terminated|175|||
125937345|NCT02810392|453067781|FG000|Overall Study|Subject too ill to continue|1|||
125937346|NCT02810392|453067782|FG001|Overall Study|Subject too ill to continue|0|||
125937347|NCT02810392|453067781|FG000|Overall Study|COVID 19 research restrictions|0|||
125937348|NCT02810392|453067782|FG001|Overall Study|COVID 19 research restrictions|1|||
125937349|NCT00840294|453067783|FG000|Overall Study|Withdrawal by Subject|2|||
125937350|NCT00840294|453067784|FG001|Overall Study|Withdrawal by Subject|1|||
125937351|NCT00840294|453067783|FG000|Overall Study|Protocol Violation|1|||
125937352|NCT00840294|453067784|FG001|Overall Study|Protocol Violation|3|||
125937353|NCT00840294|453067783|FG000|Overall Study|Illness|0|||
125937354|NCT00840294|453067784|FG001|Overall Study|Illness|1|||
125937355|NCT04387435|453067785|FG000|Overall Study|Physician Decision|1|||
125937356|NCT03855280|453067786|FG000|Treatment Phase|Adverse Event|1|||
125937357|NCT03855280|453067786|FG000|Treatment Phase|Withdrawal by Subject|1|||
125937358|NCT03855280|453067786|FG000|Continuation Phase|Protocol Violation|1|||
125937359|NCT03855280|453067786|FG000|Continuation Phase|Adverse Event|1|||
125937360|NCT03855280|453067786|FG000|Continuation Phase|Sponsor Concluded Study|1|||
125937361|NCT00969150|453067794|FG000|Overall Study|Adverse Event|4|||
125937362|NCT00969150|453067795|FG001|Overall Study|Adverse Event|14|||
125937363|NCT00969150|453067794|FG000|Overall Study|Lack of Efficacy|1|||
125937364|NCT00969150|453067795|FG001|Overall Study|Lack of Efficacy|1|||
125937365|NCT00969150|453067794|FG000|Overall Study|Protocol Violation|9|||
125937366|NCT00969150|453067795|FG001|Overall Study|Protocol Violation|12|||
125937367|NCT00969150|453067794|FG000|Overall Study|Withdrawal by Subject|13|||
125937368|NCT00969150|453067795|FG001|Overall Study|Withdrawal by Subject|9|||
125937369|NCT00969150|453067794|FG000|Overall Study|Lost to Follow-up|5|||
125937370|NCT00969150|453067795|FG001|Overall Study|Lost to Follow-up|4|||
125937371|NCT00969150|453067794|FG000|Overall Study|Other reasons|1|||
125937372|NCT00969150|453067795|FG001|Overall Study|Other reasons|0|||
125937373|NCT00461682|453067798|FG000|Overall Study|Protocol Violation|1|||
125937374|NCT00883116|453067799|FG000|Overall Study|Adverse event unrelated to study drug|5|||
125937375|NCT00883116|453067800|FG001|Overall Study|Adverse event unrelated to study drug|10|||
125937376|NCT00883116|453067799|FG000|Overall Study|Death|6|||
125937377|NCT00883116|453067800|FG001|Overall Study|Death|2|||
125937378|NCT00883116|453067799|FG000|Overall Study|Disease progression|130|||
125937379|NCT00883116|453067800|FG001|Overall Study|Disease progression|128|||
125937380|NCT00883116|453067799|FG000|Overall Study|Lost to Follow-up|0|||
125937381|NCT00883116|453067800|FG001|Overall Study|Lost to Follow-up|1|||
125937382|NCT00883116|453067799|FG000|Overall Study|Maximum clinical benefit|13|||
125937383|NCT00883116|453067800|FG001|Overall Study|Maximum clinical benefit|46|||
125937384|NCT00883116|453067799|FG000|Overall Study|Not identified|3|||
125937385|NCT00883116|453067800|FG001|Overall Study|Not identified|6|||
125937386|NCT00883116|453067799|FG000|Overall Study|Study drug toxicity|36|||
125937387|NCT00883116|453067800|FG001|Overall Study|Study drug toxicity|16|||
125937388|NCT00883116|453067799|FG000|Overall Study|Withdrawal by Subject|14|||
125937389|NCT00883116|453067800|FG001|Overall Study|Withdrawal by Subject|8|||
125937390|NCT00883116|453067799|FG000|Overall Study|No longer meets study criteria|2|||
125937391|NCT00883116|453067800|FG001|Overall Study|No longer meets study criteria|2|||
125937392|NCT01361464|453067801|FG000|Overall Study|Death|1|||
125937393|NCT01361464|453067801|FG000|Overall Study|Withdrawal by Subject|2|||
125937394|NCT00513474|453067807|FG000|Overall Study|Death|6|||
125937395|NCT00513474|453067808|FG001|Overall Study|Death|9|||
125937396|NCT00513474|453067807|FG000|Overall Study|Participant Withdrew Consent|1|||
125937397|NCT00513474|453067808|FG001|Overall Study|Participant Withdrew Consent|0|||
125937398|NCT01853826|453069693|FG000|Overall Study|Patients who switched to commercial drug|11|||
125937399|NCT01853826|453069693|FG000|Overall Study|Patient refused to continue medication|21|||
125937400|NCT01853826|453069693|FG000|Overall Study|Lost to Follow-up|2|||
125937401|NCT01853826|453069693|FG000|Overall Study|Non-compliant with protocol|4|||
125937402|NCT01853826|453069693|FG000|Overall Study|Other adverse events (AE)|62|||
125937403|NCT01853826|453069693|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
125937404|NCT01853826|453069693|FG000|Overall Study|Progressive disease|342|||
125937405|NCT01853826|453069693|FG000|Overall Study|Other than listed|13|||
125937406|NCT01853826|453069693|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
125937407|NCT02081690|453069695|FG000|Overall Study|Death|3|||
125937408|NCT02081690|453069695|FG000|Overall Study|Physician Decision|3|||
125937409|NCT02081690|453069695|FG000|Overall Study|Withdrawal by Subject|1|||
126066489|NCT00316121|453534913|FG000|Overall Study|Death|1|||
126066490|NCT00316121|453534914|FG001|Overall Study|Death|0|||
125937410|NCT03204981|453069697|FG000|Overall Study|Physician Decision|2|||
125937411|NCT03204981|453069697|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
125937412|NCT00982488|453069698|FG000|Overall Study|Administrative reason by sponsor|81|||
125937413|NCT00982488|453069699|FG001|Overall Study|Administrative reason by sponsor|3|||
125937414|NCT00982488|453069700|FG002|Overall Study|Administrative reason by sponsor|11|||
125937415|NCT00982488|453069701|FG003|Overall Study|Administrative reason by sponsor|0|||
125937416|NCT00982488|453069702|FG004|Overall Study|Administrative reason by sponsor|0|||
125937417|NCT00982488|453069698|FG000|Overall Study|Adverse event unrelated to study drug|5|||
125937418|NCT00982488|453069699|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125937419|NCT00982488|453069700|FG002|Overall Study|Adverse event unrelated to study drug|0|||
125937420|NCT00982488|453069701|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125937421|NCT00982488|453069702|FG004|Overall Study|Adverse event unrelated to study drug|0|||
125937422|NCT00982488|453069698|FG000|Overall Study|Death|11|||
125937423|NCT00982488|453069699|FG001|Overall Study|Death|0|||
125937424|NCT00982488|453069700|FG002|Overall Study|Death|2|||
125937425|NCT00982488|453069701|FG003|Overall Study|Death|0|||
125937426|NCT00982488|453069702|FG004|Overall Study|Death|0|||
125937427|NCT00982488|453069698|FG000|Overall Study|Disease progression|30|||
125937428|NCT00982488|453069699|FG001|Overall Study|Disease progression|5|||
125937429|NCT00982488|453069700|FG002|Overall Study|Disease progression|10|||
125937430|NCT00982488|453069701|FG003|Overall Study|Disease progression|1|||
125937431|NCT00982488|453069702|FG004|Overall Study|Disease progression|1|||
125937432|NCT00982488|453069698|FG000|Overall Study|Lost to Follow-up|1|||
125937433|NCT00982488|453069699|FG001|Overall Study|Lost to Follow-up|0|||
125937434|NCT00982488|453069700|FG002|Overall Study|Lost to Follow-up|0|||
125937435|NCT00982488|453069701|FG003|Overall Study|Lost to Follow-up|0|||
125937436|NCT00982488|453069702|FG004|Overall Study|Lost to Follow-up|0|||
125937437|NCT00982488|453069698|FG000|Overall Study|Maximum clinical benefit|1|||
125937438|NCT00982488|453069699|FG001|Overall Study|Maximum clinical benefit|1|||
125937439|NCT00982488|453069700|FG002|Overall Study|Maximum clinical benefit|1|||
125937440|NCT00982488|453069701|FG003|Overall Study|Maximum clinical benefit|0|||
125937441|NCT00982488|453069702|FG004|Overall Study|Maximum clinical benefit|0|||
125937442|NCT00982488|453069698|FG000|Overall Study|Other|15|||
125937443|NCT00982488|453069699|FG001|Overall Study|Other|1|||
125937444|NCT00982488|453069700|FG002|Overall Study|Other|3|||
125937445|NCT00982488|453069701|FG003|Overall Study|Other|1|||
125937446|NCT00982488|453069702|FG004|Overall Study|Other|0|||
125937447|NCT00982488|453069698|FG000|Overall Study|Poor compliance/noncompliance|0|||
125937448|NCT00982488|453069699|FG001|Overall Study|Poor compliance/noncompliance|1|||
125937449|NCT00982488|453069700|FG002|Overall Study|Poor compliance/noncompliance|0|||
125937450|NCT00982488|453069701|FG003|Overall Study|Poor compliance/noncompliance|0|||
125937451|NCT00982488|453069702|FG004|Overall Study|Poor compliance/noncompliance|0|||
125937452|NCT00982488|453069698|FG000|Overall Study|Stem cell transplant|2|||
125937453|NCT00982488|453069699|FG001|Overall Study|Stem cell transplant|0|||
125937454|NCT00982488|453069700|FG002|Overall Study|Stem cell transplant|0|||
125937455|NCT00982488|453069701|FG003|Overall Study|Stem cell transplant|1|||
125937456|NCT00982488|453069702|FG004|Overall Study|Stem cell transplant|0|||
125937457|NCT00982488|453069698|FG000|Overall Study|Study drug toxicity|34|||
125937458|NCT00982488|453069699|FG001|Overall Study|Study drug toxicity|1|||
125937459|NCT00982488|453069700|FG002|Overall Study|Study drug toxicity|6|||
125937460|NCT00982488|453069701|FG003|Overall Study|Study drug toxicity|0|||
125937461|NCT00982488|453069702|FG004|Overall Study|Study drug toxicity|0|||
125937462|NCT00982488|453069698|FG000|Overall Study|Withdrawal by Subject|5|||
126066491|NCT00316121|453534913|FG000|Overall Study|Lost to Follow-up|14|||
126066492|NCT00316121|453534914|FG001|Overall Study|Lost to Follow-up|8|||
125937463|NCT00982488|453069699|FG001|Overall Study|Withdrawal by Subject|1|||
125937464|NCT00982488|453069700|FG002|Overall Study|Withdrawal by Subject|1|||
125937465|NCT00982488|453069701|FG003|Overall Study|Withdrawal by Subject|0|||
125937466|NCT00982488|453069702|FG004|Overall Study|Withdrawal by Subject|0|||
125937467|NCT00903617|453069703|FG000|Overall Study|Adverse Event|0|||
125937468|NCT00903617|453069704|FG001|Overall Study|Adverse Event|1|||
125937469|NCT00903617|453069705|FG002|Overall Study|Adverse Event|1|||
125937470|NCT00903617|453069706|FG003|Overall Study|Adverse Event|0|||
125937471|NCT00903617|453069703|FG000|Overall Study|Protocol-defined stopping criteria|0|||
125937472|NCT00903617|453069704|FG001|Overall Study|Protocol-defined stopping criteria|2|||
125937473|NCT00903617|453069705|FG002|Overall Study|Protocol-defined stopping criteria|0|||
125937474|NCT00903617|453069706|FG003|Overall Study|Protocol-defined stopping criteria|0|||
125937475|NCT00903617|453069703|FG000|Overall Study|Lost to Follow-up|2|||
125937476|NCT00903617|453069704|FG001|Overall Study|Lost to Follow-up|0|||
125937477|NCT00903617|453069705|FG002|Overall Study|Lost to Follow-up|1|||
125937478|NCT00903617|453069706|FG003|Overall Study|Lost to Follow-up|1|||
125937479|NCT00903617|453069703|FG000|Overall Study|Withdrawal by Subject|1|||
125937480|NCT00903617|453069704|FG001|Overall Study|Withdrawal by Subject|2|||
125937481|NCT00903617|453069705|FG002|Overall Study|Withdrawal by Subject|3|||
125937482|NCT00903617|453069706|FG003|Overall Study|Withdrawal by Subject|0|||
126066493|NCT00316121|453534913|FG000|Overall Study|Withdrawal by Subject|2|||
125937483|NCT02355691|453069707|FG000|Overall Study|Loss of Research Personnel|7|||
125937484|NCT02355691|453069708|FG001|Overall Study|Loss of Research Personnel|9|||
125937485|NCT00462761|453069709|FG000|Overall Study|Adverse Event|6|||
125937486|NCT00462761|453069709|FG000|Overall Study|Withdrawal by Subject|9|||
125937487|NCT00462761|453069709|FG000|Overall Study|Physician Decision|5|||
125937488|NCT00462761|453069709|FG000|Overall Study|Disease progression|43|||
125937489|NCT00462761|453069709|FG000|Overall Study|Death|12|||
125937490|NCT00462761|453069709|FG000|Overall Study|Other|1|||
125937491|NCT03060447|453069710|FG000|Overall Study|Withdrawal by Subject|2|||
125937492|NCT03060447|453069711|FG001|Overall Study|Withdrawal by Subject|0|||
125937493|NCT00573755|453069712|FG000|Overall Study|Still receiving treatment|1|||
125937494|NCT00573755|453069713|FG001|Overall Study|Still receiving treatment|0|||
125937495|NCT03274440|453069717|FG000|Overall Study|Time commitment too great|1|||
125937496|NCT03274440|453069718|FG001|Overall Study|Time commitment too great|0|||
125937497|NCT03274440|453069719|FG002|Overall Study|Time commitment too great|0|||
125937498|NCT03274440|453069720|FG003|Overall Study|Time commitment too great|1|||
125937499|NCT03274440|453069721|FG004|Overall Study|Time commitment too great|0|||
125937500|NCT03274440|453069722|FG005|Overall Study|Time commitment too great|0|||
125937501|NCT01110707|453069723|FG000|Overall Study|Protocol Violation|0|||
125937502|NCT01110707|453069724|FG001|Overall Study|Protocol Violation|3|||
125937503|NCT02968563|453069729|FG000|Overall Study|Adverse Event|0|||
125937504|NCT02968563|453069730|FG001|Overall Study|Adverse Event|6|||
125937505|NCT02968563|453069729|FG000|Overall Study|Death|1|||
125937506|NCT02968563|453069730|FG001|Overall Study|Death|1|||
125937507|NCT02968563|453069729|FG000|Overall Study|Lost to Follow-up|0|||
125937508|NCT02968563|453069730|FG001|Overall Study|Lost to Follow-up|1|||
125937509|NCT02369341|453069731|FG000|Overall Study|Migrated/moved from study area|1|||
125937510|NCT02369341|453069732|FG001|Overall Study|Migrated/moved from study area|0|||
125937511|NCT03287804|453069733|FG000|Overall Study|Death|1|||
125937512|NCT03287804|453069733|FG000|Overall Study|Physician Decision|2|||
125937513|NCT03287804|453069733|FG000|Overall Study|Progressive disease|8|||
125937514|NCT02733991|453069735|FG000|Overall Study|Adverse Event|1|||
125937515|NCT02733991|453069736|FG001|Overall Study|Adverse Event|0|||
125937516|NCT02733991|453069735|FG000|Overall Study|Withdrawal by Subject|0|||
125937517|NCT02733991|453069736|FG001|Overall Study|Withdrawal by Subject|5|||
125937518|NCT01928329|453069739|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
125937519|NCT01928329|453069740|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
125937520|NCT01928329|453069739|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
125937521|NCT01928329|453069740|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
125937522|NCT01928329|453069739|FG000|Overall Study|Adverse Event|5|||
125937523|NCT01928329|453069740|FG001|Overall Study|Adverse Event|3|||
125937524|NCT01928329|453069739|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
125937525|NCT01928329|453069740|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
125937526|NCT01928329|453069739|FG000|Overall Study|Withdrawal by Subject|1|||
125937527|NCT01928329|453069740|FG001|Overall Study|Withdrawal by Subject|5|||
125937528|NCT01928329|453069739|FG000|Overall Study|Physician Decision|1|||
125937529|NCT01928329|453069740|FG001|Overall Study|Physician Decision|1|||
125937530|NCT03187262|453069741|FG000|Induction|Lack of Efficacy|2|||
125937531|NCT03187262|453069741|FG000|Induction|Progressive Disease|4|||
125937532|NCT03187262|453069741|FG000|Consolidation|Progressive Disease|5|||
125937533|NCT02604212|453069744|FG000|Overall Study|Study Terminated by Sponsor|2|||
125937534|NCT02604212|453069745|FG001|Overall Study|Study Terminated by Sponsor|1|||
125937535|NCT02604212|453069746|FG002|Overall Study|Study Terminated by Sponsor|3|||
125937536|NCT02604212|453069747|FG003|Overall Study|Study Terminated by Sponsor|3|||
125937537|NCT02604212|453069744|FG000|Overall Study|Withdrawal by Subject|0|||
125937538|NCT02604212|453069745|FG001|Overall Study|Withdrawal by Subject|0|||
125937539|NCT02604212|453069746|FG002|Overall Study|Withdrawal by Subject|1|||
125937540|NCT02604212|453069747|FG003|Overall Study|Withdrawal by Subject|0|||
125937541|NCT01119131|453069750|FG000|Overall Study|Adverse Event|1|||
125937542|NCT01119131|453069751|FG001|Overall Study|Adverse Event|1|||
125937543|NCT01119131|453069752|FG002|Overall Study|Adverse Event|1|||
125937544|NCT01119131|453069750|FG000|Overall Study|Non-Compliance|1|||
125937545|NCT01119131|453069751|FG001|Overall Study|Non-Compliance|0|||
125937546|NCT01119131|453069752|FG002|Overall Study|Non-Compliance|4|||
125937547|NCT01119131|453069750|FG000|Overall Study|Physician Decision|0|||
125937548|NCT01119131|453069751|FG001|Overall Study|Physician Decision|0|||
125937549|NCT01119131|453069752|FG002|Overall Study|Physician Decision|1|||
125937550|NCT00909389|453069755|FG000|Overall Study|Adverse Event|6|||
125937551|NCT00909389|453069755|FG000|Overall Study|Death|4|||
125937552|NCT00909389|453069755|FG000|Overall Study|Poor Compliance|16|||
125937553|NCT00909389|453069755|FG000|Overall Study|Lost to Follow-up|4|||
125937554|NCT00909389|453069755|FG000|Overall Study|No Information|103|||
125937555|NCT00003492|453069756|FG000|Overall Study|Not evaluable|6|||
125937556|NCT00597766|453069759|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
125937557|NCT00597766|453069760|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
125937558|NCT00597766|453069761|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
125937559|NCT00597766|453069759|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
125937560|NCT00597766|453069760|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
125937561|NCT00597766|453069761|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
125937562|NCT00383149|453069773|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
125937563|NCT00383149|453069773|FG000|Overall Study|Death|2|||
125937564|NCT00383149|453069773|FG000|Overall Study|Disease Progression|38|||
125937565|NCT00383149|453069773|FG000|Overall Study|Lost to Follow-up|1|||
125937566|NCT00383149|453069773|FG000|Overall Study|Other|1|||
125937567|NCT00383149|453069773|FG000|Overall Study|Study Drug Toxicity|4|||
125937568|NCT00383149|453069773|FG000|Overall Study|Request to Discontinue Treatment|4|||
125937569|NCT00383149|453069773|FG000|Overall Study|Participant Withdrew Consent|1|||
125937570|NCT00453544|453069774|FG000|Overall Study|Withdrawal by Subject|1|||
125937571|NCT00453544|453069775|FG001|Overall Study|Withdrawal by Subject|0|||
125937572|NCT00453544|453069776|FG002|Overall Study|Withdrawal by Subject|0|||
125937573|NCT00453544|453069777|FG003|Overall Study|Withdrawal by Subject|0|||
125937574|NCT00453544|453069774|FG000|Overall Study|Primary outcome measure not completed|1|||
125937575|NCT00453544|453069775|FG001|Overall Study|Primary outcome measure not completed|1|||
125937576|NCT00453544|453069776|FG002|Overall Study|Primary outcome measure not completed|0|||
125937577|NCT00453544|453069777|FG003|Overall Study|Primary outcome measure not completed|1|||
125937578|NCT02457910|453069778|FG000|Overall Study|Withdrawal by Subject|0|||
125937579|NCT02457910|453069779|FG001|Overall Study|Withdrawal by Subject|0|||
125937580|NCT02457910|453069780|FG002|Overall Study|Withdrawal by Subject|0|||
125937581|NCT02457910|453069781|FG003|Overall Study|Withdrawal by Subject|0|||
125937582|NCT02457910|453069782|FG004|Overall Study|Withdrawal by Subject|0|||
125937583|NCT02457910|453069783|FG005|Overall Study|Withdrawal by Subject|1|||
125937584|NCT02457910|453069778|FG000|Overall Study|Adverse Event|0|||
125937585|NCT02457910|453069779|FG001|Overall Study|Adverse Event|2|||
125937586|NCT02457910|453069780|FG002|Overall Study|Adverse Event|1|||
125937587|NCT02457910|453069781|FG003|Overall Study|Adverse Event|1|||
125937588|NCT02457910|453069782|FG004|Overall Study|Adverse Event|1|||
125937589|NCT02457910|453069783|FG005|Overall Study|Adverse Event|3|||
125937590|NCT02457910|453069778|FG000|Overall Study|Disease progression|3|||
125937591|NCT02457910|453069779|FG001|Overall Study|Disease progression|3|||
125937592|NCT02457910|453069780|FG002|Overall Study|Disease progression|1|||
125937593|NCT02457910|453069781|FG003|Overall Study|Disease progression|1|||
125937594|NCT02457910|453069782|FG004|Overall Study|Disease progression|4|||
125937595|NCT02457910|453069783|FG005|Overall Study|Disease progression|6|||
125937596|NCT02457910|453069778|FG000|Overall Study|Other complicating illness|0|||
125937597|NCT02457910|453069779|FG001|Overall Study|Other complicating illness|0|||
125937598|NCT02457910|453069780|FG002|Overall Study|Other complicating illness|0|||
125937599|NCT02457910|453069781|FG003|Overall Study|Other complicating illness|0|||
125937600|NCT02457910|453069782|FG004|Overall Study|Other complicating illness|0|||
125937601|NCT02457910|453069783|FG005|Overall Study|Other complicating illness|1|||
125937602|NCT02457910|453069778|FG000|Overall Study|Death|0|||
125937603|NCT02457910|453069779|FG001|Overall Study|Death|0|||
125937604|NCT02457910|453069780|FG002|Overall Study|Death|1|||
125937605|NCT02457910|453069781|FG003|Overall Study|Death|0|||
125937606|NCT02457910|453069782|FG004|Overall Study|Death|0|||
125937607|NCT02457910|453069783|FG005|Overall Study|Death|0|||
125937608|NCT00619801|453069784|FG000|Overall Study|Lack of Efficacy|0|||
125937609|NCT00619801|453069785|FG001|Overall Study|Lack of Efficacy|1|||
125937610|NCT00619801|453069784|FG000|Overall Study|Withdrawal by Subject|1|||
125937611|NCT00619801|453069785|FG001|Overall Study|Withdrawal by Subject|1|||
126066494|NCT00316121|453534914|FG001|Overall Study|Withdrawal by Subject|0|||
126066495|NCT00316121|453534913|FG000|Overall Study|Reason is missing|1|||
126066496|NCT00316121|453534914|FG001|Overall Study|Reason is missing|0|||
126066497|NCT00316121|453534913|FG000|Overall Study|Subject relocated|1|||
126066498|NCT00316121|453534914|FG001|Overall Study|Subject relocated|1|||
126066499|NCT00316121|453534913|FG000|Overall Study|Subject refused to return|1|||
126066500|NCT00316121|453534914|FG001|Overall Study|Subject refused to return|0|||
126066501|NCT00316121|453534913|FG000|Overall Study|Subject no show for visit x 3|1|||
126066502|NCT00316121|453534914|FG001|Overall Study|Subject no show for visit x 3|0|||
126114155|NCT02060383|453713738|FG002|Extension Phase|Administrative problems|0|||
126114156|NCT02060383|453713739|FG003|Extension Phase|Administrative problems|0|||
126114157|NCT02060383|453713740|FG004|Extension Phase|Administrative problems|0|||
126114158|NCT02060383|453713736|FG000|Extension Phase|Death|0|||
126066503|NCT00316121|453534913|FG000|Overall Study|Subject did not have 24 month visit|1|||
126066504|NCT00316121|453534914|FG001|Overall Study|Subject did not have 24 month visit|0|||
126066505|NCT02305797|453534915|FG000|Overall Study|Adverse Event|11|||
126066506|NCT02305797|453534916|FG001|Overall Study|Adverse Event|2|||
126066507|NCT02305797|453534915|FG000|Overall Study|Withdrawal by Subject|9|||
126066508|NCT02305797|453534916|FG001|Overall Study|Withdrawal by Subject|10|||
126114159|NCT02060383|453713737|FG001|Extension Phase|Death|0|||
126066509|NCT02305797|453534915|FG000|Overall Study|Lack of Efficacy|6|||
126066510|NCT02305797|453534916|FG001|Overall Study|Lack of Efficacy|0|||
125937612|NCT00619801|453069784|FG000|Overall Study|Loss of efficacy|0|||
125937613|NCT00619801|453069785|FG001|Overall Study|Loss of efficacy|1|||
125937614|NCT03721276|453069788|FG000|Overall Study|Lost to Follow-up|5|||
125937615|NCT03721276|453069789|FG001|Overall Study|Lost to Follow-up|3|||
125937616|NCT03721276|453069788|FG000|Overall Study|Adverse Event|0|||
125937617|NCT03721276|453069789|FG001|Overall Study|Adverse Event|1|||
125937618|NCT01829230|453069794|FG000|Overall Study|Protocol Violation|0|||
125937619|NCT01829230|453069795|FG001|Overall Study|Protocol Violation|2|||
125937620|NCT01829230|453069794|FG000|Overall Study|Withdrawal by Subject|0|||
125937621|NCT01829230|453069795|FG001|Overall Study|Withdrawal by Subject|1|||
125937622|NCT01829230|453069794|FG000|Overall Study|Lost to Follow-up|1|||
125937623|NCT01829230|453069795|FG001|Overall Study|Lost to Follow-up|1|||
125937624|NCT04501666|453069801|FG000|Overall Study|Physician Decision|0|||
125937625|NCT04501666|453069802|FG001|Overall Study|Physician Decision|1|||
125937626|NCT04501666|453069801|FG000|Overall Study|Adverse Event|12|||
125937627|NCT04501666|453069802|FG001|Overall Study|Adverse Event|4|||
125937628|NCT04501666|453069801|FG000|Overall Study|Subject's request|10|||
125937629|NCT04501666|453069802|FG001|Overall Study|Subject's request|6|||
125937630|NCT04501666|453069801|FG000|Overall Study|Protocol Deviation|2|||
125937631|NCT04501666|453069802|FG001|Overall Study|Protocol Deviation|1|||
125937632|NCT04501666|453069801|FG000|Overall Study|Other-- site permanently closing|0|||
125937633|NCT04501666|453069802|FG001|Overall Study|Other-- site permanently closing|1|||
125937634|NCT04128267|453069803|FG000|Overall Study|Withdrawal by Subject|6|||
125937635|NCT04128267|453069803|FG000|Overall Study|Death|2|||
125937636|NCT04128267|453069803|FG000|Overall Study|Disease progression|1|||
125937637|NCT04128267|453069803|FG000|Overall Study|Participant had other medical issues|4|||
125937638|NCT04128267|453069803|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
125937639|NCT03021265|453069804|FG000|Overall Study|Adverse Event|29|||
125937640|NCT03021265|453069804|FG000|Overall Study|Lack of Efficacy|3|||
125937641|NCT03021265|453069804|FG000|Overall Study|Improved|17|||
125937642|NCT03021265|453069804|FG000|Overall Study|Lost to Follow-up|67|||
125937643|NCT03021265|453069804|FG000|Overall Study|No reason given|2|||
125937644|NCT03021265|453069804|FG000|Overall Study|No visit since the first visit|4|||
125937645|NCT01722071|453069805|FG000|Overall Study|Protocol Violation|1|||
125937646|NCT01722071|453069806|FG001|Overall Study|Protocol Violation|0|||
125937647|NCT00642941|453069807|FG000|Overall Study|Physician Decision|3|||
125937648|NCT00642941|453069808|FG001|Overall Study|Physician Decision|1|||
125937649|NCT00642941|453069809|FG002|Overall Study|Physician Decision|0|||
125937650|NCT00642941|453069810|FG003|Overall Study|Physician Decision|0|||
125937651|NCT00642941|453069811|FG004|Overall Study|Physician Decision|0|||
125937652|NCT00642941|453069812|FG005|Overall Study|Physician Decision|0|||
125937653|NCT00642941|453069813|FG006|Overall Study|Physician Decision|1|||
125937654|NCT00642941|453069814|FG007|Overall Study|Physician Decision|0|||
125937655|NCT00642941|453069815|FG008|Overall Study|Physician Decision|0|||
125937656|NCT00642941|453069816|FG009|Overall Study|Physician Decision|1|||
125937657|NCT00642941|453069817|FG010|Overall Study|Physician Decision|0|||
125937658|NCT00642941|453069818|FG011|Overall Study|Physician Decision|1|||
125937659|NCT00642941|453069807|FG000|Overall Study|Death|4|||
125937660|NCT00642941|453069808|FG001|Overall Study|Death|0|||
125937661|NCT00642941|453069809|FG002|Overall Study|Death|1|||
125937662|NCT00642941|453069810|FG003|Overall Study|Death|1|||
125937663|NCT00642941|453069811|FG004|Overall Study|Death|2|||
125937664|NCT00642941|453069812|FG005|Overall Study|Death|1|||
125937665|NCT00642941|453069813|FG006|Overall Study|Death|0|||
125937666|NCT00642941|453069814|FG007|Overall Study|Death|0|||
125937667|NCT00642941|453069815|FG008|Overall Study|Death|0|||
125937668|NCT00642941|453069816|FG009|Overall Study|Death|0|||
125937669|NCT00642941|453069817|FG010|Overall Study|Death|0|||
125937670|NCT00642941|453069818|FG011|Overall Study|Death|1|||
125937671|NCT00642941|453069807|FG000|Overall Study|Study closed by Sponsor|0|||
125937672|NCT00642941|453069808|FG001|Overall Study|Study closed by Sponsor|1|||
125937673|NCT00642941|453069809|FG002|Overall Study|Study closed by Sponsor|0|||
125937674|NCT00642941|453069810|FG003|Overall Study|Study closed by Sponsor|0|||
125937675|NCT00642941|453069811|FG004|Overall Study|Study closed by Sponsor|0|||
125937676|NCT00642941|453069812|FG005|Overall Study|Study closed by Sponsor|0|||
125937677|NCT00642941|453069813|FG006|Overall Study|Study closed by Sponsor|0|||
125937678|NCT00642941|453069814|FG007|Overall Study|Study closed by Sponsor|0|||
125937679|NCT00642941|453069815|FG008|Overall Study|Study closed by Sponsor|0|||
125937680|NCT00642941|453069816|FG009|Overall Study|Study closed by Sponsor|0|||
125937681|NCT00642941|453069817|FG010|Overall Study|Study closed by Sponsor|0|||
125937682|NCT00642941|453069818|FG011|Overall Study|Study closed by Sponsor|0|||
125937683|NCT00642941|453069807|FG000|Overall Study|Withdrawal by Subject|1|||
125937684|NCT00642941|453069808|FG001|Overall Study|Withdrawal by Subject|0|||
125937685|NCT00642941|453069809|FG002|Overall Study|Withdrawal by Subject|0|||
125937686|NCT00642941|453069810|FG003|Overall Study|Withdrawal by Subject|2|||
125937687|NCT00642941|453069811|FG004|Overall Study|Withdrawal by Subject|0|||
125937688|NCT00642941|453069812|FG005|Overall Study|Withdrawal by Subject|0|||
125937689|NCT00642941|453069813|FG006|Overall Study|Withdrawal by Subject|2|||
125937690|NCT00642941|453069814|FG007|Overall Study|Withdrawal by Subject|0|||
125937691|NCT00642941|453069815|FG008|Overall Study|Withdrawal by Subject|1|||
125937692|NCT00642941|453069816|FG009|Overall Study|Withdrawal by Subject|0|||
125937693|NCT00642941|453069817|FG010|Overall Study|Withdrawal by Subject|0|||
125937694|NCT00642941|453069818|FG011|Overall Study|Withdrawal by Subject|1|||
125937695|NCT00642941|453069807|FG000|Overall Study|Protocol Violation|0|||
125937696|NCT00642941|453069808|FG001|Overall Study|Protocol Violation|0|||
125937697|NCT00642941|453069809|FG002|Overall Study|Protocol Violation|0|||
125937698|NCT00642941|453069810|FG003|Overall Study|Protocol Violation|0|||
125937699|NCT00642941|453069811|FG004|Overall Study|Protocol Violation|0|||
125937700|NCT00642941|453069812|FG005|Overall Study|Protocol Violation|0|||
126114160|NCT02060383|453713738|FG002|Extension Phase|Death|1|||
126114161|NCT02060383|453713739|FG003|Extension Phase|Death|0|||
126114162|NCT02060383|453713740|FG004|Extension Phase|Death|1|||
126114163|NCT02060383|453713736|FG000|Extension Phase|Protocol Violation|0|||
126114164|NCT02060383|453713737|FG001|Extension Phase|Protocol Violation|0|||
126114165|NCT02060383|453713738|FG002|Extension Phase|Protocol Violation|0|||
126114166|NCT02060383|453713739|FG003|Extension Phase|Protocol Violation|0|||
126114167|NCT02060383|453713740|FG004|Extension Phase|Protocol Violation|1|||
126114168|NCT00332839|453713741|FG000|Core (Months 0 - 12)|Administrative problems|1|||
126114169|NCT00332839|453713742|FG001|Core (Months 0 - 12)|Administrative problems|1|||
126114170|NCT00332839|453713741|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
126114171|NCT00332839|453713742|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
126114172|NCT00332839|453713741|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
126114173|NCT00332839|453713742|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
126114174|NCT00332839|453713741|FG000|Core (Months 0 - 12)|Adverse Event|5|||
126114175|NCT00332839|453713742|FG001|Core (Months 0 - 12)|Adverse Event|15|||
126114176|NCT00332839|453713741|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
126114177|NCT00332839|453713742|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
126114178|NCT00332839|453713741|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
126114179|NCT00332839|453713742|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
126114180|NCT00332839|453713741|FG000|Follow-up (Months 12 - 60)|Death|1|||
126114181|NCT00332839|453713742|FG001|Follow-up (Months 12 - 60)|Death|1|||
126114182|NCT02020863|453713744|FG000|Overall Study|Discovery of Metastatic disease|4|||
126114183|NCT02020863|453713744|FG000|Overall Study|Team chose not to place an a line|1|||
126114184|NCT03523728|453713748|FG000|Stage 1 (24 Months)|Adverse Event|2|||
126114185|NCT03523728|453713749|FG001|Stage 1 (24 Months)|Adverse Event|2|||
126114186|NCT03523728|453713750|FG002|Stage 1 (24 Months)|Adverse Event|4|||
126114187|NCT03523728|453713751|FG003|Stage 1 (24 Months)|Adverse Event|0|||
126114188|NCT03523728|453713752|FG004|Stage 1 (24 Months)|Adverse Event|0|||
126114189|NCT03523728|453713748|FG000|Stage 1 (24 Months)|Progressive disease|0|||
126114190|NCT03523728|453713749|FG001|Stage 1 (24 Months)|Progressive disease|0|||
126114191|NCT03523728|453713750|FG002|Stage 1 (24 Months)|Progressive disease|1|||
126114192|NCT03523728|453713751|FG003|Stage 1 (24 Months)|Progressive disease|0|||
126114193|NCT03523728|453713752|FG004|Stage 1 (24 Months)|Progressive disease|0|||
126114194|NCT03523728|453713748|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
126114195|NCT03523728|453713749|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
126114196|NCT03523728|453713750|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
126114197|NCT03523728|453713751|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
126114198|NCT03523728|453713752|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
126114199|NCT03523728|453713748|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
126114200|NCT03523728|453713749|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
126114201|NCT03523728|453713750|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
126114202|NCT03523728|453713751|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
126114203|NCT03523728|453713752|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
126114204|NCT03523728|453713748|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
126114205|NCT03523728|453713749|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
126114206|NCT03523728|453713750|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
126114207|NCT03523728|453713751|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
126114208|NCT03523728|453713752|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
126114209|NCT03523728|453713748|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
126114210|NCT03523728|453713749|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
126114211|NCT03523728|453713750|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
126114212|NCT03523728|453713751|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
125937701|NCT00642941|453069813|FG006|Overall Study|Protocol Violation|1|||
125937702|NCT00642941|453069814|FG007|Overall Study|Protocol Violation|0|||
125937703|NCT00642941|453069815|FG008|Overall Study|Protocol Violation|0|||
125937704|NCT00642941|453069816|FG009|Overall Study|Protocol Violation|0|||
125937705|NCT00642941|453069817|FG010|Overall Study|Protocol Violation|0|||
125937706|NCT00642941|453069818|FG011|Overall Study|Protocol Violation|0|||
125937707|NCT00642941|453069807|FG000|Overall Study|Adverse Event|1|||
125937708|NCT00642941|453069808|FG001|Overall Study|Adverse Event|1|||
125937709|NCT00642941|453069809|FG002|Overall Study|Adverse Event|0|||
125937710|NCT00642941|453069810|FG003|Overall Study|Adverse Event|0|||
125937711|NCT00642941|453069811|FG004|Overall Study|Adverse Event|0|||
126114213|NCT03523728|453713752|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
126114214|NCT03523728|453713748|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
126114215|NCT03523728|453713749|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
126114216|NCT03523728|453713750|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
125937712|NCT00642941|453069812|FG005|Overall Study|Adverse Event|0|||
125937713|NCT00642941|453069813|FG006|Overall Study|Adverse Event|1|||
126114217|NCT03523728|453713751|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
126114218|NCT03523728|453713752|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
125937714|NCT00642941|453069814|FG007|Overall Study|Adverse Event|1|||
125937715|NCT00642941|453069815|FG008|Overall Study|Adverse Event|0|||
125937716|NCT00642941|453069816|FG009|Overall Study|Adverse Event|1|||
125937717|NCT00642941|453069817|FG010|Overall Study|Adverse Event|0|||
126114219|NCT03523728|453713748|FG000|Stage 2 (24 Months)|Adverse Event|0|||
126114220|NCT03523728|453713749|FG001|Stage 2 (24 Months)|Adverse Event|0|||
126114221|NCT03523728|453713750|FG002|Stage 2 (24 Months)|Adverse Event|0|||
126114222|NCT03523728|453713751|FG003|Stage 2 (24 Months)|Adverse Event|1|||
126114223|NCT03523728|453713752|FG004|Stage 2 (24 Months)|Adverse Event|2|||
126114224|NCT03523728|453713748|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125937718|NCT00642941|453069818|FG011|Overall Study|Adverse Event|0|||
125937719|NCT00642941|453069807|FG000|Overall Study|Other|1|||
125937720|NCT00642941|453069808|FG001|Overall Study|Other|1|||
125937721|NCT00642941|453069809|FG002|Overall Study|Other|1|||
125937722|NCT00642941|453069810|FG003|Overall Study|Other|1|||
125937723|NCT00642941|453069811|FG004|Overall Study|Other|0|||
125937724|NCT00642941|453069812|FG005|Overall Study|Other|1|||
125937725|NCT00642941|453069813|FG006|Overall Study|Other|0|||
125937726|NCT00642941|453069814|FG007|Overall Study|Other|1|||
125937727|NCT00642941|453069815|FG008|Overall Study|Other|0|||
125937728|NCT00642941|453069816|FG009|Overall Study|Other|0|||
125937729|NCT00642941|453069817|FG010|Overall Study|Other|0|||
125937730|NCT00642941|453069818|FG011|Overall Study|Other|1|||
125937731|NCT00642941|453069807|FG000|Overall Study|Disease progression|60|||
125937732|NCT00642941|453069808|FG001|Overall Study|Disease progression|50|||
125937733|NCT00642941|453069809|FG002|Overall Study|Disease progression|5|||
125937734|NCT00642941|453069810|FG003|Overall Study|Disease progression|36|||
125937735|NCT00642941|453069811|FG004|Overall Study|Disease progression|23|||
125937736|NCT00642941|453069812|FG005|Overall Study|Disease progression|39|||
125937737|NCT00642941|453069813|FG006|Overall Study|Disease progression|18|||
125937738|NCT00642941|453069814|FG007|Overall Study|Disease progression|12|||
125937739|NCT00642941|453069815|FG008|Overall Study|Disease progression|10|||
125937740|NCT00642941|453069816|FG009|Overall Study|Disease progression|7|||
125937741|NCT00642941|453069817|FG010|Overall Study|Disease progression|12|||
125937742|NCT00642941|453069818|FG011|Overall Study|Disease progression|7|||
125937743|NCT01614067|453069819|FG000|Overall Study|Pregnancy|1|||
125937744|NCT01614067|453069820|FG001|Overall Study|Pregnancy|0|||
125937745|NCT01614067|453069819|FG000|Overall Study|Physician Decision|6|||
125937746|NCT01614067|453069820|FG001|Overall Study|Physician Decision|5|||
125937747|NCT01614067|453069819|FG000|Overall Study|Withdrawal by Subject|0|||
125937748|NCT01614067|453069820|FG001|Overall Study|Withdrawal by Subject|1|||
125937749|NCT01614067|453069819|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
125937750|NCT01614067|453069820|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
125937751|NCT01505868|453069821|FG000|Overall Study|Withdrawal by Subject|1|||
125937752|NCT01505868|453069822|FG001|Overall Study|Withdrawal by Subject|0|||
125937753|NCT01505868|453069823|FG002|Overall Study|Withdrawal by Subject|0|||
125937754|NCT01505868|453069824|FG003|Overall Study|Withdrawal by Subject|0|||
125937755|NCT01505868|453069825|FG004|Overall Study|Withdrawal by Subject|0|||
125937756|NCT02289079|453069826|FG000|Overall Study|Physician Decision|2|||
125937757|NCT02289079|453069827|FG001|Overall Study|Physician Decision|0|||
125937758|NCT02289079|453069826|FG000|Overall Study|Lost to Follow-up|0|||
125937759|NCT02289079|453069827|FG001|Overall Study|Lost to Follow-up|1|||
125937760|NCT00553150|453069828|FG000|Overall Study|Withdrawal by Subject|0|||
125937761|NCT00553150|453069829|FG001|Overall Study|Withdrawal by Subject|0|||
125937762|NCT00553150|453069830|FG002|Overall Study|Withdrawal by Subject|0|||
125937763|NCT00553150|453069831|FG003|Overall Study|Withdrawal by Subject|2|||
125937764|NCT00553150|453069828|FG000|Overall Study|Protocol Violation|0|||
125937765|NCT00553150|453069829|FG001|Overall Study|Protocol Violation|0|||
125937766|NCT00553150|453069830|FG002|Overall Study|Protocol Violation|0|||
125937767|NCT00553150|453069831|FG003|Overall Study|Protocol Violation|1|||
125937768|NCT00553150|453069828|FG000|Overall Study|Ineligible|0|||
126066511|NCT02305797|453534915|FG000|Overall Study|Lost to Follow-up|5|||
126066512|NCT02305797|453534916|FG001|Overall Study|Lost to Follow-up|11|||
126066513|NCT02305797|453534915|FG000|Overall Study|Pregnancy|0|||
126066514|NCT02305797|453534916|FG001|Overall Study|Pregnancy|2|||
126066515|NCT02305797|453534915|FG000|Overall Study|Noncompliance|14|||
126066516|NCT02305797|453534916|FG001|Overall Study|Noncompliance|12|||
126066517|NCT02305797|453534915|FG000|Overall Study|Reason not collected|0|||
126066518|NCT02305797|453534916|FG001|Overall Study|Reason not collected|1|||
126114225|NCT03523728|453713749|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
126114226|NCT03523728|453713750|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
126114227|NCT03523728|453713751|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125937769|NCT00553150|453069829|FG001|Overall Study|Ineligible|0|||
125937770|NCT00553150|453069830|FG002|Overall Study|Ineligible|0|||
125937771|NCT00553150|453069831|FG003|Overall Study|Ineligible|1|||
125937772|NCT03061331|453069832|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
125937773|NCT03061331|453069833|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
125937774|NCT02998840|453069834|FG000|Overall Study|Lost to Follow-up|1|||
125937775|NCT02998840|453069835|FG001|Overall Study|Lost to Follow-up|1|||
125937776|NCT02998840|453069836|FG002|Overall Study|Lost to Follow-up|2|||
125937777|NCT02998840|453069837|FG003|Overall Study|Lost to Follow-up|3|||
125937778|NCT02998840|453069834|FG000|Overall Study|Withdrawal by Subject|1|||
126066519|NCT00460577|453534919|FG000|Overall Study|Protocol Violation|2|||
126066520|NCT00460577|453534920|FG001|Overall Study|Protocol Violation|6|||
125937779|NCT02998840|453069835|FG001|Overall Study|Withdrawal by Subject|1|||
125937780|NCT02998840|453069836|FG002|Overall Study|Withdrawal by Subject|0|||
125937781|NCT02998840|453069837|FG003|Overall Study|Withdrawal by Subject|1|||
125937782|NCT02998840|453069834|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
125937783|NCT02998840|453069835|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
125937784|NCT02998840|453069836|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
125937785|NCT02998840|453069837|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
125937786|NCT01686633|453069838|FG000|Overall Study|Lack of Efficacy|33|||
125937787|NCT01686633|453069839|FG001|Overall Study|Lack of Efficacy|13|||
125937788|NCT01686633|453069840|FG002|Overall Study|Lack of Efficacy|11|||
125937789|NCT01686633|453069838|FG000|Overall Study|Withdrawal by Subject|8|||
125937790|NCT01686633|453069839|FG001|Overall Study|Withdrawal by Subject|8|||
125937791|NCT01686633|453069840|FG002|Overall Study|Withdrawal by Subject|5|||
125937792|NCT01686633|453069838|FG000|Overall Study|Physician Decision|3|||
125937793|NCT01686633|453069839|FG001|Overall Study|Physician Decision|4|||
125937794|NCT01686633|453069840|FG002|Overall Study|Physician Decision|4|||
125937795|NCT01686633|453069838|FG000|Overall Study|Adverse Event|4|||
125937796|NCT01686633|453069839|FG001|Overall Study|Adverse Event|3|||
125937797|NCT01686633|453069840|FG002|Overall Study|Adverse Event|3|||
125937798|NCT01686633|453069838|FG000|Overall Study|Protocol Violation|2|||
125937799|NCT01686633|453069839|FG001|Overall Study|Protocol Violation|3|||
125937800|NCT01686633|453069840|FG002|Overall Study|Protocol Violation|0|||
125937801|NCT01686633|453069838|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
125937802|NCT01686633|453069839|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
125937803|NCT01686633|453069840|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
125937804|NCT01686633|453069838|FG000|Overall Study|Lost to Follow-up|0|||
125937805|NCT01686633|453069839|FG001|Overall Study|Lost to Follow-up|1|||
125937806|NCT01686633|453069840|FG002|Overall Study|Lost to Follow-up|1|||
125937807|NCT00195676|453069842|FG000|Period O - Open-label Treatment|Adverse Event|82|||
125937808|NCT00195676|453069842|FG000|Period O - Open-label Treatment|Death|6|||
125937809|NCT00195676|453069842|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
125937810|NCT00195676|453069842|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
125937811|NCT00195676|453069842|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
125937812|NCT00195676|453069842|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
125937813|NCT00195676|453069842|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
125937814|NCT00195676|453069842|FG000|Period O - Open-label Treatment|Other reasons|68|||
125937815|NCT00195676|453069842|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
125937816|NCT00195676|453069842|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
125937817|NCT00195676|453069842|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
125937818|NCT00195676|453069842|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
125937819|NCT00195676|453069842|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
125937820|NCT00195676|453069842|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
125937821|NCT00195676|453069842|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
125937822|NCT00195676|453069842|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
125937823|NCT00195676|453069842|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
125937824|NCT00195676|453069842|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
125937825|NCT00195676|453069842|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
125937826|NCT00195676|453069842|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
125937827|NCT00195676|453069842|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
125937828|NCT01189812|453069843|FG000|Overall Study|Withdrawal by Subject|2|||
125937829|NCT01189812|453069844|FG001|Overall Study|Withdrawal by Subject|3|||
125937830|NCT01189812|453069843|FG000|Overall Study|Adverse Event|1|||
125937831|NCT01189812|453069844|FG001|Overall Study|Adverse Event|0|||
125937832|NCT01189812|453069843|FG000|Overall Study|Out of Window|4|||
125937833|NCT01189812|453069844|FG001|Overall Study|Out of Window|3|||
125937834|NCT01189812|453069843|FG000|Overall Study|Moved out of State|1|||
125937835|NCT01189812|453069844|FG001|Overall Study|Moved out of State|2|||
125937836|NCT00616655|453069845|FG000|Overall Study|Adverse Event|10|||
125937837|NCT00616655|453069846|FG001|Overall Study|Adverse Event|7|||
125937838|NCT00616655|453069847|FG002|Overall Study|Adverse Event|12|||
125937839|NCT00616655|453069845|FG000|Overall Study|Lack of Efficacy|5|||
125937840|NCT00616655|453069846|FG001|Overall Study|Lack of Efficacy|5|||
125937841|NCT00616655|453069847|FG002|Overall Study|Lack of Efficacy|5|||
125937842|NCT00616655|453069845|FG000|Overall Study|Lost to Follow-up|3|||
125937843|NCT00616655|453069846|FG001|Overall Study|Lost to Follow-up|12|||
125937844|NCT00616655|453069847|FG002|Overall Study|Lost to Follow-up|10|||
125937845|NCT00616655|453069845|FG000|Overall Study|Protocol Violation|2|||
125937846|NCT00616655|453069846|FG001|Overall Study|Protocol Violation|4|||
125937847|NCT00616655|453069847|FG002|Overall Study|Protocol Violation|3|||
125937848|NCT00616655|453069845|FG000|Overall Study|Withdrawal by Subject|9|||
125937849|NCT00616655|453069846|FG001|Overall Study|Withdrawal by Subject|7|||
125937850|NCT00616655|453069847|FG002|Overall Study|Withdrawal by Subject|11|||
126066521|NCT02213458|453534921|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
125937851|NCT00616655|453069845|FG000|Overall Study|Does not meet in/ex criteria|0|||
125937852|NCT00616655|453069846|FG001|Overall Study|Does not meet in/ex criteria|0|||
125937853|NCT00616655|453069847|FG002|Overall Study|Does not meet in/ex criteria|2|||
125937854|NCT00616655|453069845|FG000|Overall Study|Other|6|||
125937855|NCT00616655|453069846|FG001|Overall Study|Other|6|||
125937856|NCT00616655|453069847|FG002|Overall Study|Other|5|||
125937857|NCT03761147|453069848|FG000|Overall Study|Withdrawal by Subject|6|||
125937858|NCT03761147|453069849|FG001|Overall Study|Withdrawal by Subject|1|||
125937859|NCT03761147|453069848|FG000|Overall Study|Adverse Event|1|||
125937860|NCT03761147|453069849|FG001|Overall Study|Adverse Event|3|||
125937861|NCT01026792|453069851|FG000|Overall Study|Protocol Violation|1|||
125937862|NCT00309842|453069852|FG000|Overall Study|Lost to Follow-up|1|||
125937863|NCT00423150|453069853|FG000|Overall Study|Adverse Event|11|||
125937864|NCT00423150|453069853|FG000|Overall Study|Progression of disease being studied|69|||
125937865|NCT00423150|453069853|FG000|Overall Study|Withdrawal by Subject|1|||
125937866|NCT00423150|453069853|FG000|Overall Study|Non-compliance with protocol|1|||
125937867|NCT00423150|453069853|FG000|Overall Study|Administrative|4|||
125937868|NCT02554812|453069854|FG000|Overall Study|Adverse Event|2|||
125937869|NCT02554812|453069855|FG001|Overall Study|Adverse Event|5|||
125937870|NCT02554812|453069856|FG002|Overall Study|Adverse Event|3|||
125937871|NCT02554812|453069857|FG003|Overall Study|Adverse Event|0|||
125937872|NCT02554812|453069858|FG004|Overall Study|Adverse Event|5|||
125937873|NCT02554812|453069859|FG005|Overall Study|Adverse Event|0|||
125937874|NCT02554812|453069860|FG006|Overall Study|Adverse Event|1|||
125937875|NCT02554812|453069861|FG007|Overall Study|Adverse Event|6|||
125937876|NCT02554812|453069862|FG008|Overall Study|Adverse Event|2|||
125937877|NCT02554812|453069863|FG009|Overall Study|Adverse Event|2|||
125937878|NCT02554812|453069864|FG010|Overall Study|Adverse Event|1|||
125937879|NCT02554812|453069865|FG011|Overall Study|Adverse Event|2|||
125937880|NCT02554812|453069866|FG012|Overall Study|Adverse Event|0|||
125937881|NCT02554812|453069867|FG013|Overall Study|Adverse Event|3|||
125937882|NCT02554812|453069868|FG014|Overall Study|Adverse Event|2|||
125937883|NCT02554812|453069869|FG015|Overall Study|Adverse Event|1|||
125937884|NCT02554812|453069870|FG016|Overall Study|Adverse Event|0|||
125937885|NCT02554812|453069871|FG017|Overall Study|Adverse Event|1|||
125937886|NCT02554812|453069872|FG018|Overall Study|Adverse Event|0|||
125937887|NCT02554812|453069873|FG019|Overall Study|Adverse Event|0|||
125937888|NCT02554812|453069874|FG020|Overall Study|Adverse Event|0|||
125937889|NCT02554812|453069875|FG021|Overall Study|Adverse Event|2|||
125937890|NCT02554812|453069876|FG022|Overall Study|Adverse Event|1|||
125937891|NCT02554812|453069877|FG023|Overall Study|Adverse Event|1|||
125937892|NCT02554812|453069878|FG024|Overall Study|Adverse Event|1|||
125937893|NCT02554812|453069879|FG025|Overall Study|Adverse Event|2|||
125937894|NCT02554812|453069880|FG026|Overall Study|Adverse Event|1|||
125937895|NCT02554812|453069854|FG000|Overall Study|Death|1|||
125937896|NCT02554812|453069855|FG001|Overall Study|Death|2|||
125937897|NCT02554812|453069856|FG002|Overall Study|Death|2|||
125937898|NCT02554812|453069857|FG003|Overall Study|Death|2|||
125937899|NCT02554812|453069858|FG004|Overall Study|Death|0|||
125937900|NCT02554812|453069859|FG005|Overall Study|Death|1|||
125937901|NCT02554812|453069860|FG006|Overall Study|Death|1|||
125937902|NCT02554812|453069861|FG007|Overall Study|Death|1|||
125937903|NCT02554812|453069862|FG008|Overall Study|Death|0|||
125937904|NCT02554812|453069863|FG009|Overall Study|Death|0|||
125937905|NCT02554812|453069864|FG010|Overall Study|Death|0|||
125937906|NCT02554812|453069865|FG011|Overall Study|Death|0|||
125937907|NCT02554812|453069866|FG012|Overall Study|Death|0|||
125937908|NCT02554812|453069867|FG013|Overall Study|Death|0|||
125937909|NCT02554812|453069868|FG014|Overall Study|Death|1|||
125937910|NCT02554812|453069869|FG015|Overall Study|Death|1|||
125937911|NCT02554812|453069870|FG016|Overall Study|Death|1|||
125937912|NCT02554812|453069871|FG017|Overall Study|Death|0|||
125937913|NCT02554812|453069872|FG018|Overall Study|Death|1|||
125937914|NCT02554812|453069873|FG019|Overall Study|Death|2|||
125937915|NCT02554812|453069874|FG020|Overall Study|Death|0|||
126066522|NCT02213458|453534922|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
126066523|NCT02213458|453534921|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
126066524|NCT02213458|453534922|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
126066525|NCT02213458|453534921|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
125937916|NCT02554812|453069875|FG021|Overall Study|Death|1|||
125937917|NCT02554812|453069876|FG022|Overall Study|Death|1|||
125937918|NCT02554812|453069877|FG023|Overall Study|Death|0|||
125937919|NCT02554812|453069878|FG024|Overall Study|Death|0|||
125937920|NCT02554812|453069879|FG025|Overall Study|Death|0|||
125937921|NCT02554812|453069880|FG026|Overall Study|Death|0|||
125937922|NCT02554812|453069854|FG000|Overall Study|Lost to Follow-up|0|||
125937923|NCT02554812|453069855|FG001|Overall Study|Lost to Follow-up|1|||
125937924|NCT02554812|453069856|FG002|Overall Study|Lost to Follow-up|0|||
125937925|NCT02554812|453069857|FG003|Overall Study|Lost to Follow-up|0|||
125937926|NCT02554812|453069858|FG004|Overall Study|Lost to Follow-up|0|||
125937927|NCT02554812|453069859|FG005|Overall Study|Lost to Follow-up|0|||
126066526|NCT02213458|453534922|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
126066527|NCT02213458|453534921|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
126066528|NCT02213458|453534922|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
126066529|NCT02213458|453534921|FG000|Overall Study|Refused re-consent|6|||
126066530|NCT02213458|453534922|FG001|Overall Study|Refused re-consent|0|||
126066531|NCT02213458|453534921|FG000|Overall Study|Lost to Follow-up|2|||
126066532|NCT02213458|453534922|FG001|Overall Study|Lost to Follow-up|2|||
126066533|NCT02213458|453534921|FG000|Overall Study|Withdrawal by Subject|26|||
126066534|NCT02213458|453534922|FG001|Overall Study|Withdrawal by Subject|8|||
126066535|NCT00910871|453534923|FG000|Overall Study|Adverse Event|5|||
126066536|NCT00910871|453534923|FG000|Overall Study|Death|12|||
126066537|NCT00910871|453534923|FG000|Overall Study|Lost to Follow-up|8|||
126066538|NCT00910871|453534923|FG000|Overall Study|Protocol Violation|11|||
126066539|NCT00910871|453534923|FG000|Overall Study|Withdrawal by Subject|12|||
126066540|NCT00910871|453534923|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
126066541|NCT00910871|453534923|FG000|Overall Study|Undefined|1|||
126066542|NCT01878253|453534924|FG000|Overall Study|Death|1|||
126114228|NCT03523728|453713752|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
126114229|NCT03523728|453713748|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
125937928|NCT02554812|453069860|FG006|Overall Study|Lost to Follow-up|0|||
125937929|NCT02554812|453069861|FG007|Overall Study|Lost to Follow-up|0|||
125937930|NCT02554812|453069862|FG008|Overall Study|Lost to Follow-up|0|||
125937931|NCT02554812|453069863|FG009|Overall Study|Lost to Follow-up|0|||
126114230|NCT03523728|453713749|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
126114231|NCT03523728|453713750|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
126114232|NCT03523728|453713751|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
126114233|NCT03523728|453713752|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
126114234|NCT03523728|453713748|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
126114235|NCT03523728|453713749|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
126114236|NCT03523728|453713750|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
126114237|NCT03523728|453713751|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
126114238|NCT03523728|453713752|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
126114239|NCT03523728|453713748|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
126114240|NCT03523728|453713749|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
126114241|NCT03523728|453713750|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
126114242|NCT03523728|453713751|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
126114243|NCT03523728|453713752|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
126114244|NCT00621751|453713753|FG000|Overall Study|Adverse Event|0|||
125937932|NCT02554812|453069864|FG010|Overall Study|Lost to Follow-up|0|||
125937933|NCT02554812|453069865|FG011|Overall Study|Lost to Follow-up|0|||
125937934|NCT02554812|453069866|FG012|Overall Study|Lost to Follow-up|0|||
125937935|NCT02554812|453069867|FG013|Overall Study|Lost to Follow-up|0|||
125937936|NCT02554812|453069868|FG014|Overall Study|Lost to Follow-up|0|||
125937937|NCT02554812|453069869|FG015|Overall Study|Lost to Follow-up|0|||
125937938|NCT02554812|453069870|FG016|Overall Study|Lost to Follow-up|0|||
125937939|NCT02554812|453069871|FG017|Overall Study|Lost to Follow-up|0|||
125937940|NCT02554812|453069872|FG018|Overall Study|Lost to Follow-up|0|||
125937941|NCT02554812|453069873|FG019|Overall Study|Lost to Follow-up|0|||
125937942|NCT02554812|453069874|FG020|Overall Study|Lost to Follow-up|0|||
125937943|NCT02554812|453069875|FG021|Overall Study|Lost to Follow-up|0|||
125937944|NCT02554812|453069876|FG022|Overall Study|Lost to Follow-up|0|||
125937945|NCT02554812|453069877|FG023|Overall Study|Lost to Follow-up|0|||
125937946|NCT02554812|453069878|FG024|Overall Study|Lost to Follow-up|0|||
125937947|NCT02554812|453069879|FG025|Overall Study|Lost to Follow-up|0|||
125937948|NCT02554812|453069880|FG026|Overall Study|Lost to Follow-up|0|||
125937949|NCT02554812|453069854|FG000|Overall Study|Global deterioration of health status|4|||
125937950|NCT02554812|453069855|FG001|Overall Study|Global deterioration of health status|3|||
125937951|NCT02554812|453069856|FG002|Overall Study|Global deterioration of health status|3|||
125937952|NCT02554812|453069857|FG003|Overall Study|Global deterioration of health status|2|||
125937953|NCT02554812|453069858|FG004|Overall Study|Global deterioration of health status|5|||
125937954|NCT02554812|453069859|FG005|Overall Study|Global deterioration of health status|0|||
125937955|NCT02554812|453069860|FG006|Overall Study|Global deterioration of health status|2|||
125937956|NCT02554812|453069861|FG007|Overall Study|Global deterioration of health status|1|||
125937957|NCT02554812|453069862|FG008|Overall Study|Global deterioration of health status|1|||
125937958|NCT02554812|453069863|FG009|Overall Study|Global deterioration of health status|1|||
125937959|NCT02554812|453069864|FG010|Overall Study|Global deterioration of health status|2|||
125937960|NCT02554812|453069865|FG011|Overall Study|Global deterioration of health status|1|||
125937961|NCT02554812|453069866|FG012|Overall Study|Global deterioration of health status|0|||
125937962|NCT02554812|453069867|FG013|Overall Study|Global deterioration of health status|0|||
126114245|NCT00621751|453713754|FG001|Overall Study|Adverse Event|1|||
126114246|NCT01950247|453713756|FG000|Overall Study|Withdrawal by Subject|28|||
125937963|NCT02554812|453069868|FG014|Overall Study|Global deterioration of health status|0|||
126066543|NCT01878253|453534924|FG000|Overall Study|SIdus System Removal|3|||
126066544|NCT01878253|453534924|FG000|Overall Study|Withdrawal by Subject|1|||
125937964|NCT02554812|453069869|FG015|Overall Study|Global deterioration of health status|1|||
125937965|NCT02554812|453069870|FG016|Overall Study|Global deterioration of health status|0|||
125937966|NCT02554812|453069871|FG017|Overall Study|Global deterioration of health status|0|||
125937967|NCT02554812|453069872|FG018|Overall Study|Global deterioration of health status|0|||
125937968|NCT02554812|453069873|FG019|Overall Study|Global deterioration of health status|0|||
125937969|NCT02554812|453069874|FG020|Overall Study|Global deterioration of health status|0|||
125937970|NCT02554812|453069875|FG021|Overall Study|Global deterioration of health status|0|||
125937971|NCT02554812|453069876|FG022|Overall Study|Global deterioration of health status|0|||
125937972|NCT02554812|453069877|FG023|Overall Study|Global deterioration of health status|0|||
125937973|NCT02554812|453069878|FG024|Overall Study|Global deterioration of health status|0|||
125937974|NCT02554812|453069879|FG025|Overall Study|Global deterioration of health status|0|||
125937975|NCT02554812|453069880|FG026|Overall Study|Global deterioration of health status|0|||
125937976|NCT02554812|453069854|FG000|Overall Study|Progressive disease|20|||
125937977|NCT02554812|453069855|FG001|Overall Study|Progressive disease|16|||
125937978|NCT02554812|453069856|FG002|Overall Study|Progressive disease|19|||
125937979|NCT02554812|453069857|FG003|Overall Study|Progressive disease|18|||
125937980|NCT02554812|453069858|FG004|Overall Study|Progressive disease|21|||
125937981|NCT02554812|453069859|FG005|Overall Study|Progressive disease|15|||
125937982|NCT02554812|453069860|FG006|Overall Study|Progressive disease|6|||
125937983|NCT02554812|453069861|FG007|Overall Study|Progressive disease|13|||
125937984|NCT02554812|453069862|FG008|Overall Study|Progressive disease|6|||
125937985|NCT02554812|453069863|FG009|Overall Study|Progressive disease|6|||
125937986|NCT02554812|453069864|FG010|Overall Study|Progressive disease|8|||
125937987|NCT02554812|453069865|FG011|Overall Study|Progressive disease|8|||
125937988|NCT02554812|453069866|FG012|Overall Study|Progressive disease|6|||
125937989|NCT02554812|453069867|FG013|Overall Study|Progressive disease|10|||
125937990|NCT02554812|453069868|FG014|Overall Study|Progressive disease|20|||
125937991|NCT02554812|453069869|FG015|Overall Study|Progressive disease|6|||
125937992|NCT02554812|453069870|FG016|Overall Study|Progressive disease|3|||
125937993|NCT02554812|453069871|FG017|Overall Study|Progressive disease|3|||
125937994|NCT02554812|453069872|FG018|Overall Study|Progressive disease|11|||
125937995|NCT02554812|453069873|FG019|Overall Study|Progressive disease|7|||
125937996|NCT02554812|453069874|FG020|Overall Study|Progressive disease|11|||
125937997|NCT02554812|453069875|FG021|Overall Study|Progressive disease|6|||
125937998|NCT02554812|453069876|FG022|Overall Study|Progressive disease|9|||
125937999|NCT02554812|453069877|FG023|Overall Study|Progressive disease|9|||
125938000|NCT02554812|453069878|FG024|Overall Study|Progressive disease|4|||
125938001|NCT02554812|453069879|FG025|Overall Study|Progressive disease|5|||
125938002|NCT02554812|453069880|FG026|Overall Study|Progressive disease|5|||
125938003|NCT02554812|453069854|FG000|Overall Study|Other|0|||
125938004|NCT02554812|453069855|FG001|Overall Study|Other|0|||
125938005|NCT02554812|453069856|FG002|Overall Study|Other|2|||
125938006|NCT02554812|453069857|FG003|Overall Study|Other|3|||
125938007|NCT02554812|453069858|FG004|Overall Study|Other|2|||
125938008|NCT02554812|453069859|FG005|Overall Study|Other|1|||
125938009|NCT02554812|453069860|FG006|Overall Study|Other|0|||
125938010|NCT02554812|453069861|FG007|Overall Study|Other|0|||
125938011|NCT02554812|453069862|FG008|Overall Study|Other|1|||
125938012|NCT02554812|453069863|FG009|Overall Study|Other|1|||
125938013|NCT02554812|453069864|FG010|Overall Study|Other|0|||
125938014|NCT02554812|453069865|FG011|Overall Study|Other|0|||
125938015|NCT02554812|453069866|FG012|Overall Study|Other|1|||
125938016|NCT02554812|453069867|FG013|Overall Study|Other|0|||
125938017|NCT02554812|453069868|FG014|Overall Study|Other|1|||
125938018|NCT02554812|453069869|FG015|Overall Study|Other|0|||
125938019|NCT02554812|453069870|FG016|Overall Study|Other|0|||
125938020|NCT02554812|453069871|FG017|Overall Study|Other|0|||
125938021|NCT02554812|453069872|FG018|Overall Study|Other|0|||
125938022|NCT02554812|453069873|FG019|Overall Study|Other|0|||
125938023|NCT02554812|453069874|FG020|Overall Study|Other|0|||
125938024|NCT02554812|453069875|FG021|Overall Study|Other|2|||
125938025|NCT02554812|453069876|FG022|Overall Study|Other|0|||
125938026|NCT02554812|453069877|FG023|Overall Study|Other|0|||
125938027|NCT02554812|453069878|FG024|Overall Study|Other|0|||
125938028|NCT02554812|453069879|FG025|Overall Study|Other|0|||
125938029|NCT02554812|453069880|FG026|Overall Study|Other|0|||
125938030|NCT02554812|453069854|FG000|Overall Study|Withdrawal by Subject|1|||
125938031|NCT02554812|453069855|FG001|Overall Study|Withdrawal by Subject|0|||
125938032|NCT02554812|453069856|FG002|Overall Study|Withdrawal by Subject|0|||
125938033|NCT02554812|453069857|FG003|Overall Study|Withdrawal by Subject|2|||
125938034|NCT02554812|453069858|FG004|Overall Study|Withdrawal by Subject|2|||
125938035|NCT02554812|453069859|FG005|Overall Study|Withdrawal by Subject|3|||
125938036|NCT02554812|453069860|FG006|Overall Study|Withdrawal by Subject|0|||
125938037|NCT02554812|453069861|FG007|Overall Study|Withdrawal by Subject|0|||
125938038|NCT02554812|453069862|FG008|Overall Study|Withdrawal by Subject|1|||
125938039|NCT02554812|453069863|FG009|Overall Study|Withdrawal by Subject|1|||
125938040|NCT02554812|453069864|FG010|Overall Study|Withdrawal by Subject|0|||
125938041|NCT02554812|453069865|FG011|Overall Study|Withdrawal by Subject|1|||
125938042|NCT02554812|453069866|FG012|Overall Study|Withdrawal by Subject|1|||
125938043|NCT02554812|453069867|FG013|Overall Study|Withdrawal by Subject|1|||
125938044|NCT02554812|453069868|FG014|Overall Study|Withdrawal by Subject|1|||
125938045|NCT02554812|453069869|FG015|Overall Study|Withdrawal by Subject|1|||
125938046|NCT02554812|453069870|FG016|Overall Study|Withdrawal by Subject|3|||
125938047|NCT02554812|453069871|FG017|Overall Study|Withdrawal by Subject|1|||
125938048|NCT02554812|453069872|FG018|Overall Study|Withdrawal by Subject|0|||
125938049|NCT02554812|453069873|FG019|Overall Study|Withdrawal by Subject|2|||
125938050|NCT02554812|453069874|FG020|Overall Study|Withdrawal by Subject|0|||
125938051|NCT02554812|453069875|FG021|Overall Study|Withdrawal by Subject|1|||
125938052|NCT02554812|453069876|FG022|Overall Study|Withdrawal by Subject|0|||
125938053|NCT02554812|453069877|FG023|Overall Study|Withdrawal by Subject|1|||
125938054|NCT02554812|453069878|FG024|Overall Study|Withdrawal by Subject|0|||
126066545|NCT01878253|453534924|FG000|Overall Study|Lost to Follow-up|2|||
126066546|NCT01878253|453534924|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
126066547|NCT04043806|453534925|FG000|Overall Study|Commercial drug is available for participants|13|||
126066548|NCT04043806|453534925|FG000|Overall Study|Physician Decision|2|||
126066549|NCT04043806|453534925|FG000|Overall Study|Other|12|||
126066550|NCT04043806|453534925|FG000|Overall Study|Adverse Event|2|||
126066551|NCT04043806|453534925|FG000|Overall Study|Lost to Follow-up|6|||
126066552|NCT04043806|453534925|FG000|Overall Study|Other non-compliance|2|||
126066553|NCT04043806|453534925|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
126066554|NCT04043806|453534925|FG000|Overall Study|Never Dosed|1|||
126066555|NCT01622088|453534926|FG000|Overall Study|Adverse Event|20|||
125938055|NCT02554812|453069879|FG025|Overall Study|Withdrawal by Subject|0|||
125938056|NCT02554812|453069880|FG026|Overall Study|Withdrawal by Subject|1|||
125938057|NCT02554812|453069854|FG000|Overall Study|Physician Decision|1|||
125938058|NCT02554812|453069855|FG001|Overall Study|Physician Decision|0|||
125938059|NCT02554812|453069856|FG002|Overall Study|Physician Decision|0|||
125938060|NCT02554812|453069857|FG003|Overall Study|Physician Decision|1|||
125938061|NCT02554812|453069858|FG004|Overall Study|Physician Decision|0|||
125938062|NCT02554812|453069859|FG005|Overall Study|Physician Decision|1|||
125938063|NCT02554812|453069860|FG006|Overall Study|Physician Decision|0|||
125938064|NCT02554812|453069861|FG007|Overall Study|Physician Decision|0|||
125938065|NCT02554812|453069862|FG008|Overall Study|Physician Decision|0|||
125938066|NCT02554812|453069863|FG009|Overall Study|Physician Decision|0|||
125938067|NCT02554812|453069864|FG010|Overall Study|Physician Decision|1|||
125938068|NCT02554812|453069865|FG011|Overall Study|Physician Decision|0|||
125938069|NCT02554812|453069866|FG012|Overall Study|Physician Decision|0|||
125938070|NCT02554812|453069867|FG013|Overall Study|Physician Decision|0|||
125938071|NCT02554812|453069868|FG014|Overall Study|Physician Decision|0|||
125938072|NCT02554812|453069869|FG015|Overall Study|Physician Decision|0|||
125938073|NCT02554812|453069870|FG016|Overall Study|Physician Decision|1|||
125938074|NCT02554812|453069871|FG017|Overall Study|Physician Decision|1|||
125938075|NCT02554812|453069872|FG018|Overall Study|Physician Decision|0|||
125938076|NCT02554812|453069873|FG019|Overall Study|Physician Decision|1|||
125938077|NCT02554812|453069874|FG020|Overall Study|Physician Decision|1|||
125938078|NCT02554812|453069875|FG021|Overall Study|Physician Decision|0|||
125938079|NCT02554812|453069876|FG022|Overall Study|Physician Decision|1|||
125938080|NCT02554812|453069877|FG023|Overall Study|Physician Decision|0|||
125938081|NCT02554812|453069878|FG024|Overall Study|Physician Decision|0|||
125938082|NCT02554812|453069879|FG025|Overall Study|Physician Decision|0|||
125938083|NCT02554812|453069880|FG026|Overall Study|Physician Decision|0|||
125938084|NCT02554812|453069854|FG000|Overall Study|Study terminated by sponsor|0|||
125938085|NCT02554812|453069855|FG001|Overall Study|Study terminated by sponsor|0|||
125938086|NCT02554812|453069856|FG002|Overall Study|Study terminated by sponsor|0|||
125938087|NCT02554812|453069857|FG003|Overall Study|Study terminated by sponsor|0|||
125938088|NCT02554812|453069858|FG004|Overall Study|Study terminated by sponsor|0|||
125938089|NCT02554812|453069859|FG005|Overall Study|Study terminated by sponsor|0|||
125938090|NCT02554812|453069860|FG006|Overall Study|Study terminated by sponsor|0|||
125938091|NCT02554812|453069861|FG007|Overall Study|Study terminated by sponsor|0|||
125938092|NCT02554812|453069862|FG008|Overall Study|Study terminated by sponsor|0|||
125938093|NCT02554812|453069863|FG009|Overall Study|Study terminated by sponsor|0|||
126066556|NCT01622088|453534926|FG000|Overall Study|Lost to Follow-up|1|||
125938094|NCT02554812|453069864|FG010|Overall Study|Study terminated by sponsor|0|||
125938095|NCT02554812|453069865|FG011|Overall Study|Study terminated by sponsor|0|||
125938096|NCT02554812|453069866|FG012|Overall Study|Study terminated by sponsor|0|||
125938097|NCT02554812|453069867|FG013|Overall Study|Study terminated by sponsor|0|||
125938098|NCT02554812|453069868|FG014|Overall Study|Study terminated by sponsor|0|||
125938099|NCT02554812|453069869|FG015|Overall Study|Study terminated by sponsor|0|||
125938100|NCT02554812|453069870|FG016|Overall Study|Study terminated by sponsor|0|||
125938101|NCT02554812|453069871|FG017|Overall Study|Study terminated by sponsor|0|||
125938102|NCT02554812|453069872|FG018|Overall Study|Study terminated by sponsor|0|||
125938103|NCT02554812|453069873|FG019|Overall Study|Study terminated by sponsor|0|||
125938104|NCT02554812|453069874|FG020|Overall Study|Study terminated by sponsor|0|||
125938105|NCT02554812|453069875|FG021|Overall Study|Study terminated by sponsor|0|||
125938106|NCT02554812|453069876|FG022|Overall Study|Study terminated by sponsor|0|||
126066557|NCT01622088|453534926|FG000|Overall Study|Withdrawal by Subject|20|||
126066558|NCT01622088|453534926|FG000|Overall Study|Investigator Decision|1|||
126066559|NCT01622088|453534926|FG000|Overall Study|Death|53|||
126066560|NCT01622088|453534926|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
126066561|NCT04799587|453534928|FG000|Overall Study|Withdrawal by Subject|0|||
126066562|NCT04799587|453534929|FG001|Overall Study|Withdrawal by Subject|1|||
126066563|NCT04598776|453534930|FG000|Overall Study|Protocol Violation|5|||
126066564|NCT04598776|453534930|FG000|Overall Study|Physician Decision|4|||
126066565|NCT06312566|453534937|FG000|Overall Study|Protocol Violation|0|||
126066566|NCT06312566|453534938|FG001|Overall Study|Protocol Violation|1|||
126066567|NCT04736472|453534939|FG000|Overall Study|Lost to Follow-up|1|||
126066568|NCT04736472|453534940|FG001|Overall Study|Lost to Follow-up|0|||
126066569|NCT04736472|453534941|FG002|Overall Study|Lost to Follow-up|0|||
126066570|NCT04736472|453534939|FG000|Overall Study|Withdrawal by Subject|2|||
126066571|NCT04736472|453534940|FG001|Overall Study|Withdrawal by Subject|0|||
126114247|NCT01950247|453713757|FG001|Overall Study|Withdrawal by Subject|13|||
126114248|NCT01950247|453713756|FG000|Overall Study|Lost to Follow-up|18|||
125938107|NCT02554812|453069877|FG023|Overall Study|Study terminated by sponsor|0|||
125938108|NCT02554812|453069878|FG024|Overall Study|Study terminated by sponsor|1|||
125938109|NCT02554812|453069879|FG025|Overall Study|Study terminated by sponsor|0|||
125938110|NCT02554812|453069880|FG026|Overall Study|Study terminated by sponsor|0|||
125938111|NCT02554812|453069854|FG000|Overall Study|No longer meets eligibility criteria|0|||
125938112|NCT02554812|453069855|FG001|Overall Study|No longer meets eligibility criteria|1|||
125938113|NCT02554812|453069856|FG002|Overall Study|No longer meets eligibility criteria|0|||
125938114|NCT02554812|453069857|FG003|Overall Study|No longer meets eligibility criteria|0|||
125938115|NCT02554812|453069858|FG004|Overall Study|No longer meets eligibility criteria|0|||
125938116|NCT02554812|453069859|FG005|Overall Study|No longer meets eligibility criteria|0|||
125938117|NCT02554812|453069860|FG006|Overall Study|No longer meets eligibility criteria|0|||
125938118|NCT02554812|453069861|FG007|Overall Study|No longer meets eligibility criteria|0|||
125938119|NCT02554812|453069862|FG008|Overall Study|No longer meets eligibility criteria|0|||
125938120|NCT02554812|453069863|FG009|Overall Study|No longer meets eligibility criteria|0|||
125938121|NCT02554812|453069864|FG010|Overall Study|No longer meets eligibility criteria|0|||
125938122|NCT02554812|453069865|FG011|Overall Study|No longer meets eligibility criteria|0|||
125938123|NCT02554812|453069866|FG012|Overall Study|No longer meets eligibility criteria|0|||
125938124|NCT02554812|453069867|FG013|Overall Study|No longer meets eligibility criteria|0|||
125938125|NCT02554812|453069868|FG014|Overall Study|No longer meets eligibility criteria|0|||
125938126|NCT02554812|453069869|FG015|Overall Study|No longer meets eligibility criteria|0|||
125938127|NCT02554812|453069870|FG016|Overall Study|No longer meets eligibility criteria|0|||
125938128|NCT02554812|453069871|FG017|Overall Study|No longer meets eligibility criteria|0|||
125938129|NCT02554812|453069872|FG018|Overall Study|No longer meets eligibility criteria|0|||
125938130|NCT02554812|453069873|FG019|Overall Study|No longer meets eligibility criteria|0|||
125938131|NCT02554812|453069874|FG020|Overall Study|No longer meets eligibility criteria|0|||
125938132|NCT02554812|453069875|FG021|Overall Study|No longer meets eligibility criteria|0|||
125938133|NCT02554812|453069876|FG022|Overall Study|No longer meets eligibility criteria|0|||
125938134|NCT02554812|453069877|FG023|Overall Study|No longer meets eligibility criteria|0|||
125938135|NCT02554812|453069878|FG024|Overall Study|No longer meets eligibility criteria|0|||
125938136|NCT02554812|453069879|FG025|Overall Study|No longer meets eligibility criteria|0|||
125938137|NCT02554812|453069880|FG026|Overall Study|No longer meets eligibility criteria|0|||
125938138|NCT00605813|453071125|FG000|Overall Study|Protocol Violation|25|||
125938139|NCT02132767|453071128|FG000|Overall Study|Death|3|||
125938140|NCT02132767|453071129|FG001|Overall Study|Death|2|||
125938141|NCT02132767|453071128|FG000|Overall Study|Withdrawal by Subject|10|||
125938142|NCT02132767|453071129|FG001|Overall Study|Withdrawal by Subject|9|||
125938143|NCT02132767|453071128|FG000|Overall Study|Lost to Follow-up|4|||
125938144|NCT02132767|453071129|FG001|Overall Study|Lost to Follow-up|4|||
125938145|NCT00778700|453071132|FG000|Overall Study|Adverse Event|6|||
125938146|NCT00778700|453071133|FG001|Overall Study|Adverse Event|1|||
125938147|NCT00778700|453071134|FG002|Overall Study|Adverse Event|3|||
125938148|NCT00778700|453071135|FG003|Overall Study|Adverse Event|5|||
125938149|NCT00778700|453071132|FG000|Overall Study|Protocol Violation|1|||
125938150|NCT00778700|453071133|FG001|Overall Study|Protocol Violation|1|||
125938151|NCT00778700|453071134|FG002|Overall Study|Protocol Violation|0|||
125938152|NCT00778700|453071135|FG003|Overall Study|Protocol Violation|0|||
126066572|NCT04736472|453534941|FG002|Overall Study|Withdrawal by Subject|0|||
126066573|NCT04736472|453534939|FG000|Overall Study|Protocol Violation|48|||
125938153|NCT00778700|453071132|FG000|Overall Study|Subject Withdrew Consent|6|||
125938154|NCT00778700|453071133|FG001|Overall Study|Subject Withdrew Consent|4|||
125938155|NCT00778700|453071134|FG002|Overall Study|Subject Withdrew Consent|1|||
125938156|NCT00778700|453071135|FG003|Overall Study|Subject Withdrew Consent|4|||
125938157|NCT00778700|453071132|FG000|Overall Study|Lost to Follow-up|3|||
125938158|NCT00778700|453071133|FG001|Overall Study|Lost to Follow-up|1|||
126066574|NCT04736472|453534940|FG001|Overall Study|Protocol Violation|0|||
126066575|NCT04736472|453534941|FG002|Overall Study|Protocol Violation|6|||
126066576|NCT03861078|453534942|FG000|Overall Study|COVID-19 shut down|4|||
125938159|NCT00778700|453071134|FG002|Overall Study|Lost to Follow-up|0|||
125938160|NCT00778700|453071135|FG003|Overall Study|Lost to Follow-up|1|||
125938161|NCT00778700|453071132|FG000|Overall Study|Reason not Specified|2|||
125938162|NCT00778700|453071133|FG001|Overall Study|Reason not Specified|0|||
125938163|NCT00778700|453071134|FG002|Overall Study|Reason not Specified|1|||
125938164|NCT00778700|453071135|FG003|Overall Study|Reason not Specified|3|||
125938165|NCT00778700|453071132|FG000|Overall Study|Other|0|||
125938166|NCT00778700|453071133|FG001|Overall Study|Other|0|||
125938167|NCT00778700|453071134|FG002|Overall Study|Other|1|||
125938168|NCT00778700|453071135|FG003|Overall Study|Other|0|||
125938169|NCT04267133|453071139|FG000|Overall Study|Withdrawal by Subject|1|||
125938170|NCT04267133|453071139|FG000|Overall Study|Adverse Event|4|||
125938171|NCT00003901|453071144|FG000|Overall Study|Adverse Event|1|||
125938172|NCT00003901|453071144|FG000|Overall Study|Withdrawal by Subject|1|||
125938173|NCT00003901|453071144|FG000|Overall Study|Ineligible|6|||
125938174|NCT00003901|453071144|FG000|Overall Study|CT Scan not within protocol requirement|2|||
125938175|NCT00003901|453071144|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
125938176|NCT00003901|453071144|FG000|Overall Study|Medical problems|6|||
125938177|NCT00857220|453071148|FG000|Overall Study|Adverse Event|35|||
125938178|NCT00857220|453071148|FG000|Overall Study|Death|1|||
125938179|NCT00857220|453071148|FG000|Overall Study|Lack of Efficacy|11|||
125938180|NCT00857220|453071148|FG000|Overall Study|Lost to Follow-up|30|||
125938181|NCT00857220|453071148|FG000|Overall Study|Physician Decision|4|||
125938182|NCT00857220|453071148|FG000|Overall Study|Protocol Violation|16|||
125938183|NCT00857220|453071148|FG000|Overall Study|Withdrawal by Subject|67|||
125938184|NCT00857220|453071148|FG000|Overall Study|Clinical Hold|6|||
125938185|NCT00857220|453071148|FG000|Overall Study|Site Closed|5|||
125938186|NCT00857220|453071148|FG000|Overall Study|Miscellaneous|8|||
125938187|NCT00680745|453071149|FG000|Overall Study|Withdrawal by Subject|8|||
125938188|NCT00680745|453071150|FG001|Overall Study|Withdrawal by Subject|3|||
125938189|NCT00680745|453071151|FG002|Overall Study|Withdrawal by Subject|2|||
125938190|NCT00680745|453071152|FG003|Overall Study|Withdrawal by Subject|8|||
125938191|NCT00680745|453071149|FG000|Overall Study|Lost to Follow-up|0|||
125938192|NCT00680745|453071150|FG001|Overall Study|Lost to Follow-up|1|||
125938193|NCT00680745|453071151|FG002|Overall Study|Lost to Follow-up|1|||
125938194|NCT00680745|453071152|FG003|Overall Study|Lost to Follow-up|0|||
125938195|NCT00680745|453071149|FG000|Overall Study|Death|1|||
125938196|NCT00680745|453071150|FG001|Overall Study|Death|0|||
125938197|NCT00680745|453071151|FG002|Overall Study|Death|1|||
125938198|NCT00680745|453071152|FG003|Overall Study|Death|0|||
125938199|NCT00680745|453071149|FG000|Overall Study|Adverse Event|5|||
125938200|NCT00680745|453071150|FG001|Overall Study|Adverse Event|3|||
125938201|NCT00680745|453071151|FG002|Overall Study|Adverse Event|3|||
125938202|NCT00680745|453071152|FG003|Overall Study|Adverse Event|3|||
125938203|NCT00680745|453071149|FG000|Overall Study|Poor/Non-compliance|0|||
125938204|NCT00680745|453071150|FG001|Overall Study|Poor/Non-compliance|3|||
125938205|NCT00680745|453071151|FG002|Overall Study|Poor/Non-compliance|0|||
125938206|NCT00680745|453071152|FG003|Overall Study|Poor/Non-compliance|0|||
125938207|NCT00680745|453071149|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125938208|NCT00680745|453071150|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
125938209|NCT00680745|453071151|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
125938210|NCT00680745|453071152|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
125938211|NCT00680745|453071149|FG000|Overall Study|False Treatment|0|||
125938212|NCT00680745|453071150|FG001|Overall Study|False Treatment|1|||
125938213|NCT00680745|453071151|FG002|Overall Study|False Treatment|3|||
125938214|NCT00680745|453071152|FG003|Overall Study|False Treatment|0|||
125938215|NCT02612428|453071153|FG000|VTL-308|Death|14|||
125938216|NCT02612428|453071154|FG001|VTL-308|Death|16|||
125938217|NCT02612428|453071153|FG000|VTL-308|Withdrawal by Subject|0|||
125938218|NCT02612428|453071154|FG001|VTL-308|Withdrawal by Subject|1|||
125938219|NCT02612428|453071153|FG000|VTL-308E|Death|9|||
126066577|NCT03861078|453534942|FG000|Overall Study|Lost to Follow-up|1|||
126066578|NCT03861078|453534942|FG000|Overall Study|Protocol Violation|2|||
126066579|NCT03861078|453534942|FG000|Overall Study|lack of venous access|1|||
126066580|NCT02971683|453534943|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
125938220|NCT02612428|453071154|FG001|VTL-308E|Death|7|||
125938221|NCT02612428|453071153|FG000|VTL-308E|Lost to Follow-up|2|||
125938222|NCT02612428|453071154|FG001|VTL-308E|Lost to Follow-up|0|||
125938223|NCT00742001|453071155|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
125938224|NCT00742001|453071156|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
125938225|NCT00742001|453071157|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
125938226|NCT00137423|453071158|FG000|Overall Study|Adverse Event|7|||
125938227|NCT00137423|453071159|FG001|Overall Study|Adverse Event|9|||
125938228|NCT00137423|453071158|FG000|Overall Study|consent withdrawn|1|||
125938229|NCT00137423|453071159|FG001|Overall Study|consent withdrawn|1|||
125938230|NCT00137423|453071158|FG000|Overall Study|Lack of Efficacy|31|||
125938231|NCT00137423|453071159|FG001|Overall Study|Lack of Efficacy|33|||
125938232|NCT00137423|453071158|FG000|Overall Study|Death|0|||
125938233|NCT00137423|453071159|FG001|Overall Study|Death|1|||
125938234|NCT02617511|453071161|FG000|Overall Study|Withdrawal by Subject|1|||
125938235|NCT02617511|453071162|FG001|Overall Study|Withdrawal by Subject|0|||
125938236|NCT02141997|453071163|FG000|Overall Study|Adverse Event|0|||
125938237|NCT02141997|453071164|FG001|Overall Study|Adverse Event|2|||
125938238|NCT02141997|453071165|FG002|Overall Study|Adverse Event|0|||
125938239|NCT02141997|453071166|FG003|Overall Study|Adverse Event|1|||
125938240|NCT02141997|453071163|FG000|Overall Study|Participant noncompliance|1|||
125938241|NCT02141997|453071164|FG001|Overall Study|Participant noncompliance|0|||
125938242|NCT02141997|453071165|FG002|Overall Study|Participant noncompliance|0|||
125938243|NCT02141997|453071166|FG003|Overall Study|Participant noncompliance|0|||
125938244|NCT02141997|453071163|FG000|Overall Study|Withdrew consent|1|||
125938245|NCT02141997|453071164|FG001|Overall Study|Withdrew consent|0|||
125938246|NCT02141997|453071165|FG002|Overall Study|Withdrew consent|3|||
125938247|NCT02141997|453071166|FG003|Overall Study|Withdrew consent|0|||
125938248|NCT02141997|453071163|FG000|Overall Study|Other|1|||
125938249|NCT02141997|453071164|FG001|Overall Study|Other|4|||
125938250|NCT02141997|453071165|FG002|Overall Study|Other|0|||
125938251|NCT02141997|453071166|FG003|Overall Study|Other|0|||
125938252|NCT04105998|453071169|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
125938253|NCT04105998|453071170|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
125938254|NCT01050257|453071173|FG000|Overall Study|Adverse Event|4|||
125938255|NCT01050257|453071174|FG001|Overall Study|Adverse Event|4|||
125938256|NCT01050257|453071175|FG002|Overall Study|Adverse Event|2|||
125938257|NCT01050257|453071173|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
125938258|NCT01050257|453071174|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
125938259|NCT01050257|453071175|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
125938260|NCT01050257|453071173|FG000|Overall Study|Withdrawal by Subject|0|||
125938261|NCT01050257|453071174|FG001|Overall Study|Withdrawal by Subject|3|||
125938262|NCT01050257|453071175|FG002|Overall Study|Withdrawal by Subject|0|||
125938263|NCT01050257|453071173|FG000|Overall Study|No reason specified|0|||
125938264|NCT01050257|453071174|FG001|Overall Study|No reason specified|0|||
125938265|NCT01050257|453071175|FG002|Overall Study|No reason specified|2|||
125938266|NCT01050257|453071173|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
125938267|NCT01050257|453071174|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
125938268|NCT01050257|453071175|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
125938269|NCT01050257|453071173|FG000|Overall Study|Violation criteria|0|||
125938270|NCT01050257|453071174|FG001|Overall Study|Violation criteria|1|||
125938271|NCT01050257|453071175|FG002|Overall Study|Violation criteria|0|||
125938272|NCT01050257|453071173|FG000|Overall Study|Failure to return|0|||
125938273|NCT01050257|453071174|FG001|Overall Study|Failure to return|2|||
125938274|NCT01050257|453071175|FG002|Overall Study|Failure to return|0|||
125938275|NCT01050257|453071173|FG000|Overall Study|Death|0|||
125938276|NCT01050257|453071174|FG001|Overall Study|Death|0|||
125938277|NCT01050257|453071175|FG002|Overall Study|Death|1|||
125938278|NCT00171223|453071176|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
125938279|NCT00171223|453071177|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
125938280|NCT00171223|453071178|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
125938281|NCT00171223|453071176|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
125938282|NCT00171223|453071177|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
125938283|NCT00171223|453071178|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
125938284|NCT00171223|453071176|FG000|Overall Study|Abnormal Procedure|1|||
125938285|NCT00171223|453071177|FG001|Overall Study|Abnormal Procedure|0|||
125938286|NCT00171223|453071178|FG002|Overall Study|Abnormal Procedure|0|||
125938287|NCT00171223|453071176|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
125938288|NCT00171223|453071177|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
125938289|NCT00171223|453071178|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
125938290|NCT00171223|453071176|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
125938291|NCT00171223|453071177|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
125938292|NCT00171223|453071178|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
126066581|NCT02971683|453534944|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
126066582|NCT02971683|453534943|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
126066583|NCT02971683|453534944|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
126066584|NCT02971683|453534943|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
126066585|NCT02971683|453534944|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
125938293|NCT00171223|453071176|FG000|Overall Study|Protocol Violation|2|||
125938294|NCT00171223|453071177|FG001|Overall Study|Protocol Violation|2|||
125938295|NCT00171223|453071178|FG002|Overall Study|Protocol Violation|3|||
125938296|NCT00171223|453071176|FG000|Overall Study|Participant Withdrew Consent|12|||
125938297|NCT00171223|453071177|FG001|Overall Study|Participant Withdrew Consent|21|||
125938298|NCT00171223|453071178|FG002|Overall Study|Participant Withdrew Consent|15|||
125938299|NCT00171223|453071176|FG000|Overall Study|Lost to Follow-up|5|||
125938300|NCT00171223|453071177|FG001|Overall Study|Lost to Follow-up|2|||
125938301|NCT00171223|453071178|FG002|Overall Study|Lost to Follow-up|3|||
125938302|NCT00171223|453071176|FG000|Overall Study|Administrative Problems|4|||
125938303|NCT00171223|453071177|FG001|Overall Study|Administrative Problems|7|||
125938304|NCT00171223|453071178|FG002|Overall Study|Administrative Problems|6|||
125938305|NCT00171223|453071176|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
125938306|NCT00171223|453071177|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
125938307|NCT00171223|453071178|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
125938308|NCT00171223|453071176|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
125938309|NCT00171223|453071177|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
125938310|NCT00171223|453071178|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
125938311|NCT00278109|453071180|FG000|Overall Study|Adverse Event|3|||
125938312|NCT00278109|453071180|FG000|Overall Study|social circumstances|1|||
125938313|NCT02580357|453071181|FG000|Overall Study|Lost to Follow-up|2|||
125938314|NCT02580357|453071182|FG001|Overall Study|Lost to Follow-up|0|||
125938315|NCT02580357|453071183|FG002|Overall Study|Lost to Follow-up|0|||
125938316|NCT02580357|453071181|FG000|Overall Study|Protocol Violation|1|||
125938317|NCT02580357|453071182|FG001|Overall Study|Protocol Violation|0|||
125938318|NCT02580357|453071183|FG002|Overall Study|Protocol Violation|0|||
125938319|NCT02064166|453071184|FG000|Overall Study|Adverse Event|1|||
125938320|NCT02064166|453071185|FG001|Overall Study|Adverse Event|0|||
125938321|NCT00450333|453071186|FG000|Overall Study|Study terminated|47|||
125938322|NCT00450333|453071187|FG001|Overall Study|Study terminated|54|||
125938323|NCT00450333|453071188|FG002|Overall Study|Study terminated|16|||
125938324|NCT00450333|453071189|FG003|Overall Study|Study terminated|21|||
125938325|NCT00450333|453071186|FG000|Overall Study|Adverse Event|1|||
125938326|NCT00450333|453071187|FG001|Overall Study|Adverse Event|7|||
125938327|NCT00450333|453071188|FG002|Overall Study|Adverse Event|2|||
125938328|NCT00450333|453071189|FG003|Overall Study|Adverse Event|2|||
125938329|NCT00450333|453071186|FG000|Overall Study|Protocol Violation|1|||
125938330|NCT00450333|453071187|FG001|Overall Study|Protocol Violation|0|||
125938331|NCT00450333|453071188|FG002|Overall Study|Protocol Violation|1|||
125938332|NCT00450333|453071189|FG003|Overall Study|Protocol Violation|0|||
125938333|NCT00450333|453071186|FG000|Overall Study|Withdrawal by Subject|1|||
125938334|NCT00450333|453071187|FG001|Overall Study|Withdrawal by Subject|0|||
125938335|NCT00450333|453071188|FG002|Overall Study|Withdrawal by Subject|3|||
125938336|NCT00450333|453071189|FG003|Overall Study|Withdrawal by Subject|0|||
125938337|NCT00450333|453071186|FG000|Overall Study|Kidney transplant|1|||
125938338|NCT00450333|453071187|FG001|Overall Study|Kidney transplant|0|||
125938339|NCT00450333|453071188|FG002|Overall Study|Kidney transplant|1|||
125938340|NCT00450333|453071189|FG003|Overall Study|Kidney transplant|3|||
125938341|NCT00450333|453071186|FG000|Overall Study|Death|3|||
125938342|NCT00450333|453071187|FG001|Overall Study|Death|2|||
125938343|NCT00450333|453071188|FG002|Overall Study|Death|2|||
125938344|NCT00450333|453071189|FG003|Overall Study|Death|2|||
125938345|NCT02375113|453071192|FG000|Overall Study|Undisclosed Reason(s).|1|||
125938346|NCT02375113|453071193|FG001|Overall Study|Undisclosed Reason(s).|1|||
125938347|NCT02375113|453071192|FG000|Overall Study|Poor adherence (<70%).|1|||
125938348|NCT02375113|453071193|FG001|Overall Study|Poor adherence (<70%).|0|||
125938349|NCT02375113|453071192|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
125938350|NCT02375113|453071193|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
125938351|NCT00416078|453071206|FG000|Overall Study|Death|3|||
125938352|NCT00416078|453071207|FG001|Overall Study|Death|4|||
125938353|NCT00416078|453071206|FG000|Overall Study|Withdrawal by Subject|3|||
125938354|NCT00416078|453071207|FG001|Overall Study|Withdrawal by Subject|2|||
125938355|NCT00416078|453071206|FG000|Overall Study|Physician Decision|1|||
125938356|NCT00416078|453071207|FG001|Overall Study|Physician Decision|0|||
125938357|NCT00416078|453071206|FG000|Overall Study|Lost to Follow-up|4|||
125938358|NCT00416078|453071207|FG001|Overall Study|Lost to Follow-up|2|||
125938359|NCT01106898|453071210|FG000|Overall Study|Adverse Event|6|||
125938360|NCT01698801|453071211|FG000|Treatment Phase|Adverse Event|4|||
125938361|NCT01698801|453071211|FG000|Treatment Phase|Protocol Violation|1|||
125938362|NCT01698801|453071211|FG000|Treatment Phase|Other|4|||
125938363|NCT01698801|453071211|FG000|Treatment Phase|Withdrawal by Subject|1|||
125938364|NCT01698801|453071211|FG000|Treatment Phase|Disease progression|1|||
125938365|NCT01698801|453071211|FG000|Follow Up Phase|Withdrawal by Subject|1|||
125938366|NCT01698801|453071211|FG000|Follow Up Phase|Death|4|||
125938367|NCT02062879|453071213|FG000|Overall Study|Withdrawal by Subject|4|||
125938368|NCT02062879|453071214|FG001|Overall Study|Withdrawal by Subject|1|||
125938369|NCT00680043|453071215|FG000|Overall Study|Withdrawal by Subject|1|||
125938370|NCT00680043|453071216|FG001|Overall Study|Withdrawal by Subject|0|||
125938371|NCT00680043|453071217|FG002|Overall Study|Withdrawal by Subject|0|||
125938372|NCT00680043|453071215|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
125938373|NCT00680043|453071216|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
125938374|NCT00680043|453071217|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
125938375|NCT00680043|453071215|FG000|Overall Study|Renal Transplant|1|||
125938376|NCT00680043|453071216|FG001|Overall Study|Renal Transplant|0|||
125938377|NCT00680043|453071217|FG002|Overall Study|Renal Transplant|4|||
125938378|NCT03204305|453071221|FG000|Overall Study|Lost to Follow-up|6|||
125938379|NCT03204305|453071222|FG001|Overall Study|Lost to Follow-up|4|||
125938380|NCT03204305|453071223|FG002|Overall Study|Lost to Follow-up|0|||
125938381|NCT03204305|453071224|FG003|Overall Study|Lost to Follow-up|0|||
125938382|NCT03204305|453071221|FG000|Overall Study|Physician Decision|1|||
125938383|NCT03204305|453071222|FG001|Overall Study|Physician Decision|0|||
125938384|NCT03204305|453071223|FG002|Overall Study|Physician Decision|0|||
125938385|NCT03204305|453071224|FG003|Overall Study|Physician Decision|0|||
125938386|NCT03204305|453071221|FG000|Overall Study|failure to place arterial line|2|||
125938387|NCT03204305|453071222|FG001|Overall Study|failure to place arterial line|1|||
125938388|NCT03204305|453071223|FG002|Overall Study|failure to place arterial line|0|||
125938389|NCT03204305|453071224|FG003|Overall Study|failure to place arterial line|0|||
125938390|NCT03204305|453071221|FG000|Overall Study|Withdrawal by Subject|2|||
125938391|NCT03204305|453071222|FG001|Overall Study|Withdrawal by Subject|0|||
125938392|NCT03204305|453071223|FG002|Overall Study|Withdrawal by Subject|0|||
125938393|NCT03204305|453071224|FG003|Overall Study|Withdrawal by Subject|0|||
125938394|NCT02953314|453071225|FG000|Overall Study|Adverse Event|0|||
125938395|NCT02953314|453071226|FG001|Overall Study|Adverse Event|1|||
125938396|NCT02953314|453071225|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125938397|NCT02953314|453071226|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
125938398|NCT00535223|453071227|FG000|Overall Study|Withdrawal by Subject|4|||
125938399|NCT00535223|453071228|FG001|Overall Study|Withdrawal by Subject|1|||
125938400|NCT02335099|453071229|FG000|Treatment|Withdrawal by Subject|1|||
125938401|NCT02335099|453071230|FG001|Treatment|Withdrawal by Subject|3|||
125938402|NCT02335099|453071229|FG000|Treatment|Lost to Follow-up|2|||
125938403|NCT02335099|453071230|FG001|Treatment|Lost to Follow-up|0|||
125938404|NCT02335099|453071229|FG000|Treatment|Death|1|||
125938405|NCT02335099|453071230|FG001|Treatment|Death|0|||
125938406|NCT02335099|453071229|FG000|Treatment|Adverse Event|1|||
125938407|NCT02335099|453071230|FG001|Treatment|Adverse Event|2|||
125938408|NCT02335099|453071229|FG000|Follow-up|Death|0|||
125938409|NCT02335099|453071230|FG001|Follow-up|Death|1|||
125938410|NCT02045797|453071231|FG000|Overall Study|Adverse Event|3|||
125938411|NCT02045797|453071232|FG001|Overall Study|Adverse Event|1|||
125938412|NCT02045797|453071233|FG002|Overall Study|Adverse Event|0|||
125938413|NCT02045797|453071231|FG000|Overall Study|Lack of Efficacy|1|||
125938414|NCT02045797|453071232|FG001|Overall Study|Lack of Efficacy|0|||
125938415|NCT02045797|453071233|FG002|Overall Study|Lack of Efficacy|0|||
125938416|NCT02045797|453071231|FG000|Overall Study|Lost to Follow-up|2|||
125938417|NCT02045797|453071232|FG001|Overall Study|Lost to Follow-up|3|||
125938418|NCT02045797|453071233|FG002|Overall Study|Lost to Follow-up|1|||
125938419|NCT02045797|453071231|FG000|Overall Study|Physician Decision|0|||
125938420|NCT02045797|453071232|FG001|Overall Study|Physician Decision|1|||
125938421|NCT02045797|453071233|FG002|Overall Study|Physician Decision|0|||
125938422|NCT02045797|453071231|FG000|Overall Study|Withdrawal by Subject|1|||
125938423|NCT02045797|453071232|FG001|Overall Study|Withdrawal by Subject|2|||
125938424|NCT02045797|453071233|FG002|Overall Study|Withdrawal by Subject|0|||
125938425|NCT01765153|453071234|FG000|Training Phase 1|Format of intervention differed|1|||
125938426|NCT01765153|453071235|FG001|Training Phase 1|Format of intervention differed|0|||
125938427|NCT01765153|453071234|FG000|Training Phase 1|Poor participation in intervention|0|||
125938428|NCT01765153|453071235|FG001|Training Phase 1|Poor participation in intervention|1|||
125938429|NCT01765153|453071234|FG000|Rest Phase 1|Withdrawal by Subject|0|||
125938430|NCT01765153|453071235|FG001|Rest Phase 1|Withdrawal by Subject|1|||
125938431|NCT01765153|453071234|FG000|Training Phase 2|Withdrawal by Subject|0|||
125938432|NCT01765153|453071235|FG001|Training Phase 2|Withdrawal by Subject|1|||
125938433|NCT01765153|453071234|FG000|Rest Phase 2|Lost to Follow-up|2|||
125938434|NCT01765153|453071235|FG001|Rest Phase 2|Lost to Follow-up|1|||
125938435|NCT00415909|453073155|FG000|Overall Study|Withdrawal by Subject|2|||
125938436|NCT00415909|453073155|FG000|Overall Study|Death|1|||
125938437|NCT00312494|453073156|FG000|Overall Study|Randomized; not treated with study drug|9|||
125938438|NCT00312494|453073157|FG001|Overall Study|Randomized; not treated with study drug|10|||
125938439|NCT00312494|453073158|FG002|Overall Study|Randomized; not treated with study drug|5|||
125938440|NCT00312494|453073156|FG000|Overall Study|Adverse Event|33|||
125938441|NCT00312494|453073157|FG001|Overall Study|Adverse Event|15|||
126066586|NCT02971683|453534943|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
125938442|NCT00312494|453073158|FG002|Overall Study|Adverse Event|11|||
125938443|NCT00312494|453073156|FG000|Overall Study|Lack of Efficacy|4|||
125938444|NCT00312494|453073157|FG001|Overall Study|Lack of Efficacy|6|||
125938445|NCT00312494|453073158|FG002|Overall Study|Lack of Efficacy|8|||
125938446|NCT00312494|453073156|FG000|Overall Study|Laboratory abnormality|1|||
125938447|NCT00312494|453073157|FG001|Overall Study|Laboratory abnormality|0|||
125938448|NCT00312494|453073158|FG002|Overall Study|Laboratory abnormality|0|||
125938449|NCT00312494|453073156|FG000|Overall Study|Lost to Follow-up|8|||
125938450|NCT00312494|453073157|FG001|Overall Study|Lost to Follow-up|8|||
125938451|NCT00312494|453073158|FG002|Overall Study|Lost to Follow-up|8|||
125938452|NCT00312494|453073156|FG000|Overall Study|Withdrawal by Subject|6|||
125938453|NCT00312494|453073157|FG001|Overall Study|Withdrawal by Subject|9|||
125938454|NCT00312494|453073158|FG002|Overall Study|Withdrawal by Subject|10|||
125938455|NCT00312494|453073156|FG000|Overall Study|Other|10|||
125938456|NCT00312494|453073157|FG001|Overall Study|Other|10|||
125938457|NCT00312494|453073158|FG002|Overall Study|Other|1|||
125938458|NCT03232281|453073159|FG000|Overall Study|Adverse Event|1|||
125938459|NCT03232281|453073160|FG001|Overall Study|Adverse Event|1|||
125938460|NCT03232281|453073159|FG000|Overall Study|Withdrawal by Subject|5|||
125938461|NCT03232281|453073160|FG001|Overall Study|Withdrawal by Subject|4|||
125938462|NCT03232281|453073159|FG000|Overall Study|Protocol Deviation|1|||
125938463|NCT03232281|453073160|FG001|Overall Study|Protocol Deviation|1|||
125938464|NCT02522286|453073162|FG000|Overall Study|Withdrawal by Subject|3|||
125938465|NCT02522286|453073163|FG001|Overall Study|Withdrawal by Subject|0|||
125938466|NCT02522286|453073164|FG002|Overall Study|Withdrawal by Subject|0|||
125938467|NCT02522286|453073165|FG003|Overall Study|Withdrawal by Subject|3|||
126066587|NCT02971683|453534944|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
126066588|NCT02971683|453534943|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
125938468|NCT00174915|453073166|FG000|Overall Study|Lost to Follow-up|19|||
125938469|NCT00174915|453073167|FG001|Overall Study|Lost to Follow-up|17|||
125938470|NCT00174915|453073168|FG002|Overall Study|Lost to Follow-up|9|||
125938471|NCT00174915|453073169|FG003|Overall Study|Lost to Follow-up|17|||
125938472|NCT00174915|453073170|FG004|Overall Study|Lost to Follow-up|10|||
125938473|NCT00174915|453073166|FG000|Overall Study|Adverse Event|18|||
125938474|NCT00174915|453073167|FG001|Overall Study|Adverse Event|16|||
125938475|NCT00174915|453073168|FG002|Overall Study|Adverse Event|11|||
125938476|NCT00174915|453073169|FG003|Overall Study|Adverse Event|18|||
125938477|NCT00174915|453073170|FG004|Overall Study|Adverse Event|5|||
125938478|NCT00174915|453073166|FG000|Overall Study|Personal Reason(s)|16|||
125938479|NCT00174915|453073167|FG001|Overall Study|Personal Reason(s)|16|||
125938480|NCT00174915|453073168|FG002|Overall Study|Personal Reason(s)|9|||
125938481|NCT00174915|453073169|FG003|Overall Study|Personal Reason(s)|9|||
125938482|NCT00174915|453073170|FG004|Overall Study|Personal Reason(s)|9|||
125938483|NCT00174915|453073166|FG000|Overall Study|Other|15|||
125938484|NCT00174915|453073167|FG001|Overall Study|Other|8|||
125938485|NCT00174915|453073168|FG002|Overall Study|Other|6|||
125938486|NCT00174915|453073169|FG003|Overall Study|Other|5|||
125938487|NCT00174915|453073170|FG004|Overall Study|Other|3|||
125938488|NCT00174915|453073166|FG000|Overall Study|Gout Flare|13|||
125938489|NCT00174915|453073167|FG001|Overall Study|Gout Flare|6|||
125938490|NCT00174915|453073168|FG002|Overall Study|Gout Flare|8|||
125938491|NCT00174915|453073169|FG003|Overall Study|Gout Flare|1|||
125938492|NCT00174915|453073170|FG004|Overall Study|Gout Flare|0|||
125938493|NCT00174915|453073166|FG000|Overall Study|Protocol Violation|6|||
125938494|NCT00174915|453073167|FG001|Overall Study|Protocol Violation|3|||
125938495|NCT00174915|453073168|FG002|Overall Study|Protocol Violation|3|||
125938496|NCT00174915|453073169|FG003|Overall Study|Protocol Violation|6|||
125938497|NCT00174915|453073170|FG004|Overall Study|Protocol Violation|3|||
125938498|NCT00174915|453073166|FG000|Overall Study|Therapeutic Failure|6|||
125938499|NCT00174915|453073167|FG001|Overall Study|Therapeutic Failure|3|||
125938500|NCT00174915|453073168|FG002|Overall Study|Therapeutic Failure|2|||
125938501|NCT00174915|453073169|FG003|Overall Study|Therapeutic Failure|1|||
125938502|NCT00174915|453073170|FG004|Overall Study|Therapeutic Failure|3|||
125938503|NCT01870583|453073177|FG000|Overall Study|Protocol Violation|0|||
125938504|NCT01870583|453073178|FG001|Overall Study|Protocol Violation|5|||
125938505|NCT01870583|453073179|FG002|Overall Study|Protocol Violation|3|||
125938506|NCT01870583|453073177|FG000|Overall Study|Lost to Follow-up|11|||
125938507|NCT01870583|453073178|FG001|Overall Study|Lost to Follow-up|13|||
125938508|NCT01870583|453073179|FG002|Overall Study|Lost to Follow-up|5|||
125938509|NCT00937157|453073180|FG000|Overall Study|Pregnancy|1|||
125938510|NCT00937157|453073180|FG000|Overall Study|Lost to Follow-up|3|||
125938511|NCT00469092|453073181|FG000|Overall Study|Adverse Event|5|||
126066589|NCT02971683|453534944|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
125938512|NCT00469092|453073182|FG001|Overall Study|Adverse Event|4|||
125938513|NCT00469092|453073181|FG000|Overall Study|Lack of Efficacy|1|||
125938514|NCT00469092|453073182|FG001|Overall Study|Lack of Efficacy|0|||
125938515|NCT00469092|453073181|FG000|Overall Study|Lost to Follow-up|1|||
125938516|NCT00469092|453073182|FG001|Overall Study|Lost to Follow-up|2|||
125938517|NCT00469092|453073181|FG000|Overall Study|Protocol Violation|3|||
125938518|NCT00469092|453073182|FG001|Overall Study|Protocol Violation|3|||
125938519|NCT00469092|453073181|FG000|Overall Study|Withdrawal by Subject|4|||
125938520|NCT00469092|453073182|FG001|Overall Study|Withdrawal by Subject|4|||
125938521|NCT00469092|453073181|FG000|Overall Study|Withdrawal Criteria|3|||
125938522|NCT00469092|453073182|FG001|Overall Study|Withdrawal Criteria|4|||
126066590|NCT02971683|453534943|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
125938523|NCT00469092|453073181|FG000|Overall Study|Incorrectly Randomised|4|||
125938524|NCT00469092|453073182|FG001|Overall Study|Incorrectly Randomised|3|||
126066591|NCT02971683|453534944|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
125938525|NCT00469092|453073181|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
125938526|NCT00469092|453073182|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
125938527|NCT00469092|453073181|FG000|Overall Study|Use of lipid lowering drug|1|||
125938528|NCT00469092|453073182|FG001|Overall Study|Use of lipid lowering drug|0|||
125938529|NCT00469092|453073181|FG000|Overall Study|Hypoglycaemic Episodes|1|||
125938530|NCT00469092|453073182|FG001|Overall Study|Hypoglycaemic Episodes|1|||
125938531|NCT00469092|453073181|FG000|Overall Study|Abnormal lab value|1|||
125938532|NCT00469092|453073182|FG001|Overall Study|Abnormal lab value|0|||
125938533|NCT00469092|453073181|FG000|Overall Study|Use of Corticosteroid|1|||
125938534|NCT00469092|453073182|FG001|Overall Study|Use of Corticosteroid|0|||
125938535|NCT02024867|453073183|FG000|Overall Study|Protocol Violation|3|||
125938536|NCT02024867|453073184|FG001|Overall Study|Protocol Violation|3|||
125938537|NCT02024867|453073183|FG000|Overall Study|Lost to Follow-up|6|||
125938538|NCT02024867|453073184|FG001|Overall Study|Lost to Follow-up|4|||
125938539|NCT00413192|453073185|FG000|Overall Study|Disease progression|26|||
125938540|NCT00413192|453073186|FG001|Overall Study|Disease progression|31|||
125938541|NCT00413192|453073187|FG002|Overall Study|Disease progression|16|||
125938542|NCT00413192|453073188|FG003|Overall Study|Disease progression|25|||
125938543|NCT00413192|453073185|FG000|Overall Study|Toxicity|3|||
125938544|NCT00413192|453073186|FG001|Overall Study|Toxicity|2|||
125938545|NCT00413192|453073187|FG002|Overall Study|Toxicity|2|||
125938546|NCT00413192|453073188|FG003|Overall Study|Toxicity|2|||
125938547|NCT00413192|453073185|FG000|Overall Study|Withdrawal by Subject|3|||
125938548|NCT00413192|453073186|FG001|Overall Study|Withdrawal by Subject|5|||
125938549|NCT00413192|453073187|FG002|Overall Study|Withdrawal by Subject|0|||
125938550|NCT00413192|453073188|FG003|Overall Study|Withdrawal by Subject|1|||
125938551|NCT00413192|453073185|FG000|Overall Study|Intercurrent illness|0|||
125938552|NCT00413192|453073186|FG001|Overall Study|Intercurrent illness|0|||
125938553|NCT00413192|453073187|FG002|Overall Study|Intercurrent illness|0|||
125938554|NCT00413192|453073188|FG003|Overall Study|Intercurrent illness|1|||
125938555|NCT00413192|453073185|FG000|Overall Study|Intercurrent death|0|||
125938556|NCT00413192|453073186|FG001|Overall Study|Intercurrent death|1|||
125938557|NCT00413192|453073187|FG002|Overall Study|Intercurrent death|0|||
125938558|NCT00413192|453073188|FG003|Overall Study|Intercurrent death|0|||
125938559|NCT00413192|453073185|FG000|Overall Study|Other|5|||
125938560|NCT00413192|453073186|FG001|Overall Study|Other|1|||
125938561|NCT00413192|453073187|FG002|Overall Study|Other|1|||
125938562|NCT00413192|453073188|FG003|Overall Study|Other|2|||
125938563|NCT00413192|453073185|FG000|Overall Study|Not treated|0|||
125938564|NCT00413192|453073186|FG001|Overall Study|Not treated|0|||
125938565|NCT00413192|453073187|FG002|Overall Study|Not treated|0|||
125938566|NCT00413192|453073188|FG003|Overall Study|Not treated|1|||
125938567|NCT01998633|453073189|FG000|Overall Study|Death|1|||
125938568|NCT03992781|453073196|FG000|Overall Study|Lost to Follow-up|5|||
125938569|NCT03992781|453073196|FG000|Overall Study|Adverse Event|1|||
125938570|NCT03992781|453073196|FG000|Overall Study|Lack of Efficacy|5|||
125938571|NCT01275833|453073197|FG000|Overall Study|Study terminated|1|||
125938572|NCT01275833|453073198|FG001|Overall Study|Study terminated|1|||
125938573|NCT02268864|453073200|FG000|Overall Study|Withdrawal by Subject|2|||
125938574|NCT02268864|453073201|FG001|Overall Study|Withdrawal by Subject|0|||
125938575|NCT02268864|453073202|FG002|Overall Study|Withdrawal by Subject|0|||
125938576|NCT02268864|453073200|FG000|Overall Study|Death|0|||
125938577|NCT02268864|453073201|FG001|Overall Study|Death|1|||
125938578|NCT02268864|453073202|FG002|Overall Study|Death|0|||
125938579|NCT03311659|453073209|FG000|Overall Study|Protocol Violation|1|||
125938580|NCT04053023|453073210|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
125938581|NCT04053023|453073211|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
125938582|NCT00071760|453073212|FG000|Overall Study|Adverse Event|2|||
125938583|NCT00071760|453073213|FG001|Overall Study|Adverse Event|1|||
125938584|NCT00071760|453073212|FG000|Overall Study|Lost to Follow-up|0|||
125938585|NCT00071760|453073213|FG001|Overall Study|Lost to Follow-up|3|||
125938586|NCT00071760|453073212|FG000|Overall Study|Protocol Violation|1|||
125938587|NCT00071760|453073213|FG001|Overall Study|Protocol Violation|0|||
126114249|NCT01950247|453713757|FG001|Overall Study|Lost to Follow-up|16|||
126114250|NCT01950247|453713756|FG000|Overall Study|Physician Decision|3|||
126114251|NCT01950247|453713757|FG001|Overall Study|Physician Decision|4|||
126114252|NCT01950247|453713756|FG000|Overall Study|Adverse Event|3|||
126114253|NCT01950247|453713757|FG001|Overall Study|Adverse Event|2|||
125938588|NCT00071760|453073212|FG000|Overall Study|Withdrawal by Subject|0|||
125938589|NCT00071760|453073213|FG001|Overall Study|Withdrawal by Subject|1|||
125938590|NCT00071760|453073212|FG000|Overall Study|Insufficient Viral Load Response|1|||
125938591|NCT00071760|453073213|FG001|Overall Study|Insufficient Viral Load Response|1|||
125938592|NCT00071760|453073212|FG000|Overall Study|Lack of availability of RTV|1|||
125938593|NCT00071760|453073213|FG001|Overall Study|Lack of availability of RTV|0|||
125938594|NCT00071760|453073212|FG000|Overall Study|Physician Decision|2|||
125938595|NCT00071760|453073213|FG001|Overall Study|Physician Decision|1|||
125938596|NCT00071760|453073212|FG000|Overall Study|Relocation|0|||
125938597|NCT00071760|453073213|FG001|Overall Study|Relocation|1|||
125938598|NCT03251079|453073217|FG000|Overall Study|Withdrawal by Subject|1|||
125938599|NCT00455429|453073218|FG000|Overall Study|Study Terminated by Sponsor|0|||
125938600|NCT00455429|453073219|FG001|Overall Study|Study Terminated by Sponsor|0|||
125938601|NCT00455429|453073220|FG002|Overall Study|Study Terminated by Sponsor|0|||
125938602|NCT00455429|453073221|FG003|Overall Study|Study Terminated by Sponsor|3|||
125938603|NCT00455429|453073218|FG000|Overall Study|Lost to Follow-up|1|||
125938604|NCT00455429|453073219|FG001|Overall Study|Lost to Follow-up|0|||
125938605|NCT00455429|453073220|FG002|Overall Study|Lost to Follow-up|0|||
126114254|NCT01950247|453713756|FG000|Overall Study|Death|1|||
125938606|NCT00455429|453073221|FG003|Overall Study|Lost to Follow-up|3|||
125938607|NCT00455429|453073218|FG000|Overall Study|Withdrawal by Subject|0|||
125938608|NCT00455429|453073219|FG001|Overall Study|Withdrawal by Subject|1|||
125938609|NCT00455429|453073220|FG002|Overall Study|Withdrawal by Subject|1|||
125938610|NCT00455429|453073221|FG003|Overall Study|Withdrawal by Subject|0|||
125938611|NCT00455429|453073218|FG000|Overall Study|Lack of Efficacy|0|||
125938612|NCT00455429|453073219|FG001|Overall Study|Lack of Efficacy|1|||
125938613|NCT00455429|453073220|FG002|Overall Study|Lack of Efficacy|0|||
125938614|NCT00455429|453073221|FG003|Overall Study|Lack of Efficacy|1|||
125938615|NCT00455429|453073218|FG000|Overall Study|Adverse Event|0|||
125938616|NCT00455429|453073219|FG001|Overall Study|Adverse Event|1|||
125938617|NCT00455429|453073220|FG002|Overall Study|Adverse Event|0|||
125938618|NCT00455429|453073221|FG003|Overall Study|Adverse Event|3|||
125938619|NCT00455429|453073218|FG000|Overall Study|Randomly assigned but not treated|0|||
125938620|NCT00455429|453073219|FG001|Overall Study|Randomly assigned but not treated|0|||
125938621|NCT00455429|453073220|FG002|Overall Study|Randomly assigned but not treated|0|||
125938622|NCT00455429|453073221|FG003|Overall Study|Randomly assigned but not treated|2|||
125938623|NCT00455429|453073218|FG000|Overall Study|Personal Reason|1|||
125938624|NCT00455429|453073219|FG001|Overall Study|Personal Reason|0|||
125938625|NCT00455429|453073220|FG002|Overall Study|Personal Reason|0|||
125938626|NCT00455429|453073221|FG003|Overall Study|Personal Reason|0|||
125938627|NCT00455429|453073218|FG000|Overall Study|Non-compliance|0|||
125938628|NCT00455429|453073219|FG001|Overall Study|Non-compliance|0|||
125938629|NCT00455429|453073220|FG002|Overall Study|Non-compliance|0|||
125938630|NCT00455429|453073221|FG003|Overall Study|Non-compliance|1|||
125938631|NCT00455429|453073218|FG000|Overall Study|Other|0|||
125938632|NCT00455429|453073219|FG001|Overall Study|Other|2|||
125938633|NCT00455429|453073220|FG002|Overall Study|Other|0|||
125938634|NCT00455429|453073221|FG003|Overall Study|Other|1|||
125938635|NCT01165554|453073228|FG000|Overall Study|Withdrawal by Subject|23|||
125938636|NCT02951156|453073229|FG000|Overall Study|Death|3|||
125938637|NCT02951156|453073230|FG001|Overall Study|Death|8|||
125938638|NCT02951156|453073231|FG002|Overall Study|Death|5|||
125938639|NCT02951156|453073229|FG000|Overall Study|Progressive disease|1|||
125938640|NCT02951156|453073230|FG001|Overall Study|Progressive disease|0|||
125938641|NCT02951156|453073231|FG002|Overall Study|Progressive disease|1|||
125938642|NCT02951156|453073229|FG000|Overall Study|Withdrawal by Subject|0|||
125938643|NCT02951156|453073230|FG001|Overall Study|Withdrawal by Subject|0|||
125938644|NCT02951156|453073231|FG002|Overall Study|Withdrawal by Subject|1|||
125938645|NCT02951156|453073229|FG000|Overall Study|Study terminated by sponsor|0|||
125938646|NCT02951156|453073230|FG001|Overall Study|Study terminated by sponsor|0|||
125938647|NCT02951156|453073231|FG002|Overall Study|Study terminated by sponsor|1|||
125938648|NCT02951156|453073229|FG000|Overall Study|Other|5|||
125938649|NCT02951156|453073230|FG001|Overall Study|Other|1|||
125938650|NCT02951156|453073231|FG002|Overall Study|Other|2|||
125938651|NCT04351087|453073232|FG000|Overall Study|Lost to Follow-up|7|||
125938652|NCT04351087|453073233|FG001|Overall Study|Lost to Follow-up|3|||
125938653|NCT04351087|453073232|FG000|Overall Study|Withdrawal by Subject|3|||
125938654|NCT04351087|453073233|FG001|Overall Study|Withdrawal by Subject|4|||
125938655|NCT04351087|453073232|FG000|Overall Study|Lack of Efficacy|3|||
125938656|NCT04351087|453073233|FG001|Overall Study|Lack of Efficacy|2|||
125938657|NCT03519347|453073236|FG000|Interventional Crossover Period 1|Death|0|||
125938658|NCT03519347|453073237|FG001|Interventional Crossover Period 1|Death|0|||
125938659|NCT03519347|453073238|FG002|Interventional Crossover Period 1|Death|0|||
125938660|NCT03519347|453073239|FG003|Interventional Crossover Period 1|Death|1|||
125938661|NCT05517382|453073240|FG000|Overall Study|Lost to Follow-up|0|||
125938662|NCT05517382|453073241|FG001|Overall Study|Lost to Follow-up|1|||
125938663|NCT01641692|453073242|FG000|Treatment Period 1|Adverse Event|1|||
125938664|NCT01641692|453073243|FG001|Treatment Period 1|Adverse Event|0|||
125938665|NCT01641692|453073244|FG002|Treatment Period 1|Adverse Event|0|||
125938666|NCT01641692|453073245|FG003|Treatment Period 1|Adverse Event|0|||
125938667|NCT01641692|453073246|FG004|Treatment Period 1|Adverse Event|0|||
125938668|NCT01641692|453073247|FG005|Treatment Period 1|Adverse Event|0|||
125938669|NCT01641692|453073248|FG006|Treatment Period 1|Adverse Event|0|||
125938670|NCT01641692|453073249|FG007|Treatment Period 1|Adverse Event|0|||
125938671|NCT01641692|453073242|FG000|Treatment Period 1|Lack of Efficacy|0|||
125938672|NCT01641692|453073243|FG001|Treatment Period 1|Lack of Efficacy|0|||
125938673|NCT01641692|453073244|FG002|Treatment Period 1|Lack of Efficacy|0|||
125938674|NCT01641692|453073245|FG003|Treatment Period 1|Lack of Efficacy|0|||
125938675|NCT01641692|453073246|FG004|Treatment Period 1|Lack of Efficacy|0|||
125938676|NCT01641692|453073247|FG005|Treatment Period 1|Lack of Efficacy|0|||
125938677|NCT01641692|453073248|FG006|Treatment Period 1|Lack of Efficacy|0|||
125938678|NCT01641692|453073249|FG007|Treatment Period 1|Lack of Efficacy|1|||
125938679|NCT01641692|453073242|FG000|Treatment Period 1|Protocol Violation|1|||
125938680|NCT01641692|453073243|FG001|Treatment Period 1|Protocol Violation|0|||
125938681|NCT01641692|453073244|FG002|Treatment Period 1|Protocol Violation|0|||
125938682|NCT01641692|453073245|FG003|Treatment Period 1|Protocol Violation|0|||
125938683|NCT01641692|453073246|FG004|Treatment Period 1|Protocol Violation|2|||
125938684|NCT01641692|453073247|FG005|Treatment Period 1|Protocol Violation|0|||
125938685|NCT01641692|453073248|FG006|Treatment Period 1|Protocol Violation|0|||
125938686|NCT01641692|453073249|FG007|Treatment Period 1|Protocol Violation|0|||
125938687|NCT01641692|453073242|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125938688|NCT01641692|453073243|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125938689|NCT01641692|453073244|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125938690|NCT01641692|453073245|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125938691|NCT01641692|453073246|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
125938692|NCT01641692|453073247|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125938693|NCT01641692|453073248|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125938694|NCT01641692|453073249|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
125938695|NCT01641692|453073242|FG000|Treatment Period 1|Lost to Follow-up|0|||
125938696|NCT01641692|453073243|FG001|Treatment Period 1|Lost to Follow-up|0|||
125938697|NCT01641692|453073244|FG002|Treatment Period 1|Lost to Follow-up|1|||
125938698|NCT01641692|453073245|FG003|Treatment Period 1|Lost to Follow-up|0|||
125938699|NCT01641692|453073246|FG004|Treatment Period 1|Lost to Follow-up|0|||
125938700|NCT01641692|453073247|FG005|Treatment Period 1|Lost to Follow-up|0|||
125938701|NCT01641692|453073248|FG006|Treatment Period 1|Lost to Follow-up|0|||
125938702|NCT01641692|453073249|FG007|Treatment Period 1|Lost to Follow-up|0|||
125938703|NCT01641692|453073242|FG000|Treatment Period 1|Physician Decision|0|||
125938704|NCT01641692|453073243|FG001|Treatment Period 1|Physician Decision|0|||
125938705|NCT01641692|453073244|FG002|Treatment Period 1|Physician Decision|0|||
125938706|NCT01641692|453073245|FG003|Treatment Period 1|Physician Decision|0|||
125938707|NCT01641692|453073246|FG004|Treatment Period 1|Physician Decision|1|||
126066592|NCT02971683|453534943|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
126066593|NCT02971683|453534944|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
126066594|NCT02971683|453534943|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
126066595|NCT02971683|453534944|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
126066596|NCT02971683|453534943|FG000|Open-Label|Lost to Follow-up|1|||
126066597|NCT02971683|453534944|FG001|Open-Label|Lost to Follow-up|0|||
126066598|NCT02971683|453534943|FG000|Open-Label|Participants withdrew consent|0|||
126066599|NCT02971683|453534944|FG001|Open-Label|Participants withdrew consent|2|||
126066600|NCT02971683|453534943|FG000|Open-Label|Participant request to discontinue study treatment|1|||
126066601|NCT02971683|453534944|FG001|Open-Label|Participant request to discontinue study treatment|0|||
126066602|NCT02971683|453534943|FG000|Open-Label|Lack of Efficacy|2|||
126066603|NCT02971683|453534944|FG001|Open-Label|Lack of Efficacy|0|||
126066604|NCT02971683|453534943|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
126066605|NCT02971683|453534944|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
126066606|NCT02971683|453534943|FG000|Long-Term Open Label|Participant withdrew consent|1|||
126066607|NCT02971683|453534944|FG001|Long-Term Open Label|Participant withdrew consent|0|||
126066608|NCT02971683|453534943|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
126066609|NCT02971683|453534944|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
126066610|NCT02971683|453534943|FG000|Long-Term Open Label|Adverse Event|1|||
126066611|NCT02971683|453534944|FG001|Long-Term Open Label|Adverse Event|2|||
126066612|NCT02971683|453534943|FG000|Long-Term Open Label|Lack of Efficacy|1|||
126066613|NCT02971683|453534944|FG001|Long-Term Open Label|Lack of Efficacy|1|||
126066614|NCT02130401|453534954|FG000|Overall Study|Poor enrollment|6|||
126066615|NCT00936065|453534955|FG000|Overall Study|Adverse Event|1|||
126066616|NCT00936065|453534956|FG001|Overall Study|Adverse Event|0|||
126066617|NCT00936065|453534957|FG002|Overall Study|Adverse Event|1|||
126066618|NCT00936065|453534955|FG000|Overall Study|Lack of Efficacy|1|||
126066619|NCT00936065|453534956|FG001|Overall Study|Lack of Efficacy|0|||
126066620|NCT00936065|453534957|FG002|Overall Study|Lack of Efficacy|1|||
126066621|NCT00936065|453534955|FG000|Overall Study|Lost to Follow-up|1|||
126066622|NCT00936065|453534956|FG001|Overall Study|Lost to Follow-up|0|||
126066623|NCT00936065|453534957|FG002|Overall Study|Lost to Follow-up|0|||
126066624|NCT00936065|453534955|FG000|Overall Study|Protocol Violation|1|||
126066625|NCT00936065|453534956|FG001|Overall Study|Protocol Violation|2|||
126066626|NCT00936065|453534957|FG002|Overall Study|Protocol Violation|1|||
126066627|NCT00936065|453534955|FG000|Overall Study|Withdrawal by Subject|0|||
126066628|NCT00936065|453534956|FG001|Overall Study|Withdrawal by Subject|2|||
126066629|NCT00936065|453534957|FG002|Overall Study|Withdrawal by Subject|4|||
126066630|NCT02389894|453534958|FG000|Overall Study|Death|4|||
126066631|NCT02389894|453534959|FG001|Overall Study|Death|5|||
126066632|NCT02389894|453534960|FG002|Overall Study|Death|3|||
126066633|NCT02389894|453534958|FG000|Overall Study|Withdrawal by Subject|2|||
126066634|NCT02389894|453534959|FG001|Overall Study|Withdrawal by Subject|4|||
125938708|NCT01641692|453073247|FG005|Treatment Period 1|Physician Decision|0|||
125938709|NCT01641692|453073248|FG006|Treatment Period 1|Physician Decision|0|||
125938710|NCT01641692|453073249|FG007|Treatment Period 1|Physician Decision|0|||
125938711|NCT01641692|453073242|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126066635|NCT02389894|453534960|FG002|Overall Study|Withdrawal by Subject|5|||
126066636|NCT02389894|453534958|FG000|Overall Study|Lost to Follow-up|2|||
126066637|NCT02389894|453534959|FG001|Overall Study|Lost to Follow-up|1|||
126066638|NCT02389894|453534960|FG002|Overall Study|Lost to Follow-up|1|||
126066639|NCT00145496|453534961|FG000|Overall Study|Adverse Event|42|||
126066640|NCT00145496|453534962|FG001|Overall Study|Adverse Event|30|||
125938712|NCT01641692|453073243|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125938713|NCT01641692|453073244|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125938714|NCT01641692|453073245|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125938715|NCT01641692|453073246|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125938716|NCT01641692|453073247|FG005|Treatment Period 1|Withdrawal by Subject|2|||
125938717|NCT01641692|453073248|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125938718|NCT01641692|453073249|FG007|Treatment Period 1|Withdrawal by Subject|1|||
125938719|NCT01641692|453073242|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
125938720|NCT01641692|453073243|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125938721|NCT01641692|453073244|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125938722|NCT01641692|453073245|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125938723|NCT01641692|453073246|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125938724|NCT01641692|453073247|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125938725|NCT01641692|453073248|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125938726|NCT01641692|453073249|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125938727|NCT01641692|453073242|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125938728|NCT01641692|453073243|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125938729|NCT01641692|453073244|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125938730|NCT01641692|453073245|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125938731|NCT01641692|453073246|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125938732|NCT01641692|453073247|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125938733|NCT01641692|453073248|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
125938734|NCT01641692|453073249|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125938735|NCT01641692|453073242|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
125938736|NCT01641692|453073243|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938737|NCT01641692|453073244|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
125938738|NCT01641692|453073245|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
125938739|NCT01641692|453073246|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
125938740|NCT01641692|453073247|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938741|NCT01641692|453073248|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938742|NCT01641692|453073249|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
125938743|NCT01641692|453073242|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125938744|NCT01641692|453073243|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125938745|NCT01641692|453073244|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125938746|NCT01641692|453073245|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125938747|NCT01641692|453073246|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125938748|NCT01641692|453073247|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125938749|NCT01641692|453073248|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125938750|NCT01641692|453073249|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125938751|NCT01641692|453073242|FG000|Treatment Period 2|Lack of Efficacy|1|||
125938752|NCT01641692|453073243|FG001|Treatment Period 2|Lack of Efficacy|0|||
125938753|NCT01641692|453073244|FG002|Treatment Period 2|Lack of Efficacy|0|||
125938754|NCT01641692|453073245|FG003|Treatment Period 2|Lack of Efficacy|0|||
125938755|NCT01641692|453073246|FG004|Treatment Period 2|Lack of Efficacy|0|||
125938756|NCT01641692|453073247|FG005|Treatment Period 2|Lack of Efficacy|0|||
125938757|NCT01641692|453073248|FG006|Treatment Period 2|Lack of Efficacy|0|||
125938758|NCT01641692|453073249|FG007|Treatment Period 2|Lack of Efficacy|0|||
125938759|NCT01641692|453073242|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
125938760|NCT01641692|453073243|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125938761|NCT01641692|453073244|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125938762|NCT01641692|453073245|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125938763|NCT01641692|453073246|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125938764|NCT01641692|453073247|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125938765|NCT01641692|453073248|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125938766|NCT01641692|453073249|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125938767|NCT01641692|453073242|FG000|Treatment Period 2|Lost to Follow-up|0|||
125938768|NCT01641692|453073243|FG001|Treatment Period 2|Lost to Follow-up|0|||
125938769|NCT01641692|453073244|FG002|Treatment Period 2|Lost to Follow-up|0|||
125938770|NCT01641692|453073245|FG003|Treatment Period 2|Lost to Follow-up|0|||
125938771|NCT01641692|453073246|FG004|Treatment Period 2|Lost to Follow-up|0|||
125938772|NCT01641692|453073247|FG005|Treatment Period 2|Lost to Follow-up|1|||
125938773|NCT01641692|453073248|FG006|Treatment Period 2|Lost to Follow-up|0|||
125938774|NCT01641692|453073249|FG007|Treatment Period 2|Lost to Follow-up|0|||
125938775|NCT01641692|453073242|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125938776|NCT01641692|453073243|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125938777|NCT01641692|453073244|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125938778|NCT01641692|453073245|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125938779|NCT01641692|453073246|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125938780|NCT01641692|453073247|FG005|Treatment Period 2|Withdrawal by Subject|1|||
125938781|NCT01641692|453073248|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125938782|NCT01641692|453073249|FG007|Treatment Period 2|Withdrawal by Subject|1|||
125938783|NCT01641692|453073242|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938784|NCT01641692|453073243|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938785|NCT01641692|453073244|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938786|NCT01641692|453073245|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938787|NCT01641692|453073246|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
125938788|NCT01641692|453073247|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938789|NCT01641692|453073248|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
125938790|NCT01641692|453073249|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125938791|NCT01641692|453073242|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125938792|NCT01641692|453073243|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125938793|NCT01641692|453073244|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125938794|NCT01641692|453073245|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125938795|NCT01641692|453073246|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125938796|NCT01641692|453073247|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125938797|NCT01641692|453073248|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125938798|NCT01641692|453073249|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125938799|NCT01641692|453073242|FG000|Treatment Period 3|Adverse Event|0|||
125938800|NCT01641692|453073243|FG001|Treatment Period 3|Adverse Event|0|||
125938801|NCT01641692|453073244|FG002|Treatment Period 3|Adverse Event|0|||
125938802|NCT01641692|453073245|FG003|Treatment Period 3|Adverse Event|0|||
125938803|NCT01641692|453073246|FG004|Treatment Period 3|Adverse Event|0|||
125938804|NCT01641692|453073247|FG005|Treatment Period 3|Adverse Event|0|||
125938805|NCT01641692|453073248|FG006|Treatment Period 3|Adverse Event|1|||
125938806|NCT01641692|453073249|FG007|Treatment Period 3|Adverse Event|0|||
125938807|NCT01641692|453073242|FG000|Treatment Period 3|Protocol Violation|0|||
125938808|NCT01641692|453073243|FG001|Treatment Period 3|Protocol Violation|0|||
125938809|NCT01641692|453073244|FG002|Treatment Period 3|Protocol Violation|1|||
125938810|NCT01641692|453073245|FG003|Treatment Period 3|Protocol Violation|0|||
125938811|NCT01641692|453073246|FG004|Treatment Period 3|Protocol Violation|0|||
125938812|NCT01641692|453073247|FG005|Treatment Period 3|Protocol Violation|0|||
125938813|NCT01641692|453073248|FG006|Treatment Period 3|Protocol Violation|0|||
125938814|NCT01641692|453073249|FG007|Treatment Period 3|Protocol Violation|0|||
125938815|NCT01641692|453073242|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125938816|NCT01641692|453073243|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125938817|NCT01641692|453073244|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125938818|NCT01641692|453073245|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125938819|NCT01641692|453073246|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125938820|NCT01641692|453073247|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125938821|NCT01641692|453073248|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
125938822|NCT01641692|453073249|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125938823|NCT01641692|453073242|FG000|Treatment Period 3|Lost to Follow-up|0|||
125938824|NCT01641692|453073243|FG001|Treatment Period 3|Lost to Follow-up|1|||
125938825|NCT01641692|453073244|FG002|Treatment Period 3|Lost to Follow-up|0|||
125938826|NCT01641692|453073245|FG003|Treatment Period 3|Lost to Follow-up|0|||
125938827|NCT01641692|453073246|FG004|Treatment Period 3|Lost to Follow-up|0|||
125938828|NCT01641692|453073247|FG005|Treatment Period 3|Lost to Follow-up|0|||
125938829|NCT01641692|453073248|FG006|Treatment Period 3|Lost to Follow-up|0|||
125938830|NCT01641692|453073249|FG007|Treatment Period 3|Lost to Follow-up|0|||
125938831|NCT01641692|453073242|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
125938832|NCT01641692|453073243|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
125938833|NCT01641692|453073244|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
125938834|NCT01641692|453073245|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
125938835|NCT01641692|453073246|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
125938836|NCT01641692|453073247|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
125938837|NCT01641692|453073248|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
125938838|NCT01641692|453073249|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
125938839|NCT01641692|453073242|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125938840|NCT01641692|453073243|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
125938841|NCT01641692|453073244|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125938842|NCT01641692|453073245|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125938843|NCT01641692|453073246|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
125938844|NCT01641692|453073247|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125938845|NCT01641692|453073248|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125938846|NCT01641692|453073249|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
125938847|NCT00484939|453073256|FG000|Overall Study|Death|9|||
125938848|NCT00484939|453073257|FG001|Overall Study|Death|13|||
125938849|NCT00484939|453073256|FG000|Overall Study|Adverse Event|22|||
126066641|NCT00145496|453534961|FG000|Overall Study|Lack of Efficacy|12|||
126066642|NCT00145496|453534962|FG001|Overall Study|Lack of Efficacy|7|||
125938850|NCT00484939|453073257|FG001|Overall Study|Adverse Event|12|||
125938851|NCT00484939|453073256|FG000|Overall Study|Patient Withdrew Consent|19|||
125938852|NCT00484939|453073257|FG001|Overall Study|Patient Withdrew Consent|10|||
125938853|NCT00484939|453073256|FG000|Overall Study|Protocol Violation|3|||
125938854|NCT00484939|453073257|FG001|Overall Study|Protocol Violation|3|||
125938855|NCT00484939|453073256|FG000|Overall Study|Lost to Follow-up|0|||
125938856|NCT00484939|453073257|FG001|Overall Study|Lost to Follow-up|3|||
125938857|NCT00484939|453073256|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
125938858|NCT00484939|453073257|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
125938859|NCT00484939|453073256|FG000|Overall Study|Disease progression|67|||
125938860|NCT00484939|453073257|FG001|Overall Study|Disease progression|88|||
125938861|NCT00484939|453073256|FG000|Overall Study|Screen Failure|2|||
125938862|NCT00484939|453073257|FG001|Overall Study|Screen Failure|2|||
125938863|NCT00484939|453073256|FG000|Overall Study|Reason Not Specified|11|||
125938864|NCT00484939|453073257|FG001|Overall Study|Reason Not Specified|6|||
125938865|NCT04948450|453073258|FG000|Overall Study|Return home|1|||
125938866|NCT04948450|453073259|FG001|Overall Study|Return home|3|||
125938867|NCT00101907|453073263|FG000|Overall Study|Adverse Event|1|||
125938868|NCT00101907|453073264|FG001|Overall Study|Adverse Event|0|||
125938869|NCT00101907|453073265|FG002|Overall Study|Adverse Event|0|||
125938870|NCT00101907|453073266|FG003|Overall Study|Adverse Event|0|||
125938871|NCT00101907|453073267|FG004|Overall Study|Adverse Event|0|||
125938872|NCT00101907|453073268|FG005|Overall Study|Adverse Event|0|||
125938873|NCT00101907|453073263|FG000|Overall Study|Death|0|||
125938874|NCT00101907|453073264|FG001|Overall Study|Death|1|||
125938875|NCT00101907|453073265|FG002|Overall Study|Death|0|||
125938876|NCT00101907|453073266|FG003|Overall Study|Death|0|||
125938877|NCT00101907|453073267|FG004|Overall Study|Death|3|||
125938878|NCT00101907|453073268|FG005|Overall Study|Death|0|||
125938879|NCT00101907|453073263|FG000|Overall Study|Physician Decision|0|||
125938880|NCT00101907|453073264|FG001|Overall Study|Physician Decision|0|||
125938881|NCT00101907|453073265|FG002|Overall Study|Physician Decision|0|||
125938882|NCT00101907|453073266|FG003|Overall Study|Physician Decision|1|||
125938883|NCT00101907|453073267|FG004|Overall Study|Physician Decision|1|||
125938884|NCT00101907|453073268|FG005|Overall Study|Physician Decision|0|||
125938885|NCT00101907|453073263|FG000|Overall Study|Withdrawal by Subject|1|||
125938886|NCT00101907|453073264|FG001|Overall Study|Withdrawal by Subject|0|||
125938887|NCT00101907|453073265|FG002|Overall Study|Withdrawal by Subject|1|||
125938888|NCT00101907|453073266|FG003|Overall Study|Withdrawal by Subject|0|||
125938889|NCT00101907|453073267|FG004|Overall Study|Withdrawal by Subject|1|||
125938890|NCT00101907|453073268|FG005|Overall Study|Withdrawal by Subject|0|||
125938891|NCT01474876|453073273|FG000|Overall Study|Adverse Event|11|||
125938892|NCT01474876|453073274|FG001|Overall Study|Adverse Event|5|||
125938893|NCT01474876|453073275|FG002|Overall Study|Adverse Event|0|||
125938894|NCT01474876|453073273|FG000|Overall Study|Serious Adverse Event|2|||
125938895|NCT01474876|453073274|FG001|Overall Study|Serious Adverse Event|3|||
125938896|NCT01474876|453073275|FG002|Overall Study|Serious Adverse Event|0|||
125938897|NCT01474876|453073273|FG000|Overall Study|Lost to Follow-up|5|||
125938898|NCT01474876|453073274|FG001|Overall Study|Lost to Follow-up|4|||
125938899|NCT01474876|453073275|FG002|Overall Study|Lost to Follow-up|0|||
125938900|NCT01474876|453073273|FG000|Overall Study|Investigator's decision|28|||
125938901|NCT01474876|453073274|FG001|Overall Study|Investigator's decision|6|||
125938902|NCT01474876|453073275|FG002|Overall Study|Investigator's decision|0|||
125938903|NCT01474876|453073273|FG000|Overall Study|Patient's request|19|||
125938904|NCT01474876|453073274|FG001|Overall Study|Patient's request|5|||
125938905|NCT01474876|453073275|FG002|Overall Study|Patient's request|0|||
125938906|NCT01474876|453073273|FG000|Overall Study|Investigator's decision and pt request|1|||
125938907|NCT01474876|453073274|FG001|Overall Study|Investigator's decision and pt request|0|||
125938908|NCT01474876|453073275|FG002|Overall Study|Investigator's decision and pt request|0|||
125938909|NCT01523886|453073276|FG000|Overall Study|surgery cancelled|0|||
125938910|NCT01523886|453073277|FG001|Overall Study|surgery cancelled|1|||
125938911|NCT01367158|453073290|FG000|Overall Study|Withdrew consent|0|||
125938912|NCT01367158|453073291|FG001|Overall Study|Withdrew consent|2|||
125938913|NCT01367158|453073292|FG002|Overall Study|Withdrew consent|1|||
125938914|NCT01367158|453073293|FG003|Overall Study|Withdrew consent|0|||
125938915|NCT01367158|453073294|FG004|Overall Study|Withdrew consent|2|||
125938916|NCT01367158|453073295|FG005|Overall Study|Withdrew consent|0|||
125938917|NCT01367158|453073296|FG006|Overall Study|Withdrew consent|0|||
125938918|NCT01367158|453073297|FG007|Overall Study|Withdrew consent|1|||
125938919|NCT01367158|453073298|FG008|Overall Study|Withdrew consent|0|||
125938920|NCT01367158|453073299|FG009|Overall Study|Withdrew consent|0|||
125938921|NCT01367158|453073300|FG010|Overall Study|Withdrew consent|0|||
125938922|NCT01367158|453073290|FG000|Overall Study|Lost to Follow-up|0|||
125938923|NCT01367158|453073291|FG001|Overall Study|Lost to Follow-up|0|||
126066643|NCT00145496|453534961|FG000|Overall Study|Withdrawal by Subject|32|||
125938924|NCT01367158|453073292|FG002|Overall Study|Lost to Follow-up|0|||
125938925|NCT01367158|453073293|FG003|Overall Study|Lost to Follow-up|1|||
125938926|NCT01367158|453073294|FG004|Overall Study|Lost to Follow-up|0|||
125938927|NCT01367158|453073295|FG005|Overall Study|Lost to Follow-up|2|||
125938928|NCT01367158|453073296|FG006|Overall Study|Lost to Follow-up|0|||
125938929|NCT01367158|453073297|FG007|Overall Study|Lost to Follow-up|1|||
125938930|NCT01367158|453073298|FG008|Overall Study|Lost to Follow-up|0|||
125938931|NCT01367158|453073299|FG009|Overall Study|Lost to Follow-up|0|||
125938932|NCT01367158|453073300|FG010|Overall Study|Lost to Follow-up|1|||
125938933|NCT01367158|453073290|FG000|Overall Study|Protocol Violation|0|||
125938934|NCT01367158|453073291|FG001|Overall Study|Protocol Violation|1|||
125938935|NCT01367158|453073292|FG002|Overall Study|Protocol Violation|0|||
125938936|NCT01367158|453073293|FG003|Overall Study|Protocol Violation|0|||
125938937|NCT01367158|453073294|FG004|Overall Study|Protocol Violation|0|||
125938938|NCT01367158|453073295|FG005|Overall Study|Protocol Violation|0|||
125938939|NCT01367158|453073296|FG006|Overall Study|Protocol Violation|0|||
125938940|NCT01367158|453073297|FG007|Overall Study|Protocol Violation|0|||
125938941|NCT01367158|453073298|FG008|Overall Study|Protocol Violation|0|||
125938942|NCT01367158|453073299|FG009|Overall Study|Protocol Violation|0|||
125938943|NCT01367158|453073300|FG010|Overall Study|Protocol Violation|0|||
125938944|NCT02226003|453073302|FG000|Overall Study|Lost to Follow-up|2|||
125938945|NCT02226003|453073303|FG001|Overall Study|Lost to Follow-up|1|||
125938946|NCT02226003|453073304|FG002|Overall Study|Lost to Follow-up|3|||
125938947|NCT02226003|453073302|FG000|Overall Study|Withdrawal by Subject|0|||
125938948|NCT02226003|453073303|FG001|Overall Study|Withdrawal by Subject|0|||
125938949|NCT02226003|453073304|FG002|Overall Study|Withdrawal by Subject|3|||
125938950|NCT04219891|453073309|FG000|Overall Study|Lost to Follow-up|3|||
125938951|NCT04219891|453073309|FG000|Overall Study|Withdrawal by Subject|2|||
125938952|NCT00670800|453074661|FG000|Overall Study|2 controls were insulin resistant|0|||
125938953|NCT00670800|453074662|FG001|Overall Study|2 controls were insulin resistant|2|||
125938954|NCT01786629|453074663|FG000|Overall Study|Lack of Efficacy|0|||
125938955|NCT01786629|453074664|FG001|Overall Study|Lack of Efficacy|4|||
125938956|NCT01786629|453074663|FG000|Overall Study|Adverse Event|0|||
125938957|NCT01786629|453074664|FG001|Overall Study|Adverse Event|1|||
125938958|NCT04736199|453074665|FG000|Overall Study|Adverse Event|28|||
125938959|NCT04736199|453074666|FG001|Overall Study|Adverse Event|22|||
125938960|NCT04736199|453074665|FG000|Overall Study|Death|9|||
125938961|NCT04736199|453074666|FG001|Overall Study|Death|3|||
125938962|NCT04736199|453074665|FG000|Overall Study|Lost to Follow-up|4|||
125938963|NCT04736199|453074666|FG001|Overall Study|Lost to Follow-up|1|||
125938964|NCT04736199|453074665|FG000|Overall Study|Physician Decision|5|||
125938965|NCT04736199|453074666|FG001|Overall Study|Physician Decision|9|||
125938966|NCT04736199|453074665|FG000|Overall Study|Withdrawal by Subject|21|||
125938967|NCT04736199|453074666|FG001|Overall Study|Withdrawal by Subject|9|||
125938968|NCT04736199|453074665|FG000|Overall Study|Progressive disease|120|||
125938969|NCT04736199|453074666|FG001|Overall Study|Progressive disease|101|||
125938970|NCT04736199|453074665|FG000|Overall Study|Subject decision|13|||
125938971|NCT04736199|453074666|FG001|Overall Study|Subject decision|13|||
125938972|NCT04736199|453074665|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
125938973|NCT04736199|453074666|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
125938974|NCT04736199|453074665|FG000|Overall Study|Additional primary malignancy|1|||
125938975|NCT04736199|453074666|FG001|Overall Study|Additional primary malignancy|0|||
125938976|NCT04736199|453074665|FG000|Overall Study|Non-compliance with study drug|0|||
125938977|NCT04736199|453074666|FG001|Overall Study|Non-compliance with study drug|1|||
125938978|NCT04736199|453074665|FG000|Overall Study|Other reason|0|||
125938979|NCT04736199|453074666|FG001|Overall Study|Other reason|1|||
125938980|NCT04736199|453074665|FG000|Overall Study|Ongoing with study drug|240|||
125938981|NCT04736199|453074666|FG001|Overall Study|Ongoing with study drug|63|||
125938982|NCT04736199|453074665|FG000|Overall Study|Study drug never administered|3|||
125938983|NCT04736199|453074666|FG001|Overall Study|Study drug never administered|0|||
125938984|NCT04318080|453074667|FG000|Overall Study|Study closed by sponsor|10|||
125938985|NCT04318080|453074668|FG001|Overall Study|Study closed by sponsor|22|||
125938986|NCT04318080|453074667|FG000|Overall Study|Death|3|||
125938987|NCT04318080|453074668|FG001|Overall Study|Death|9|||
125938988|NCT04318080|453074667|FG000|Overall Study|Withdrawal by Subject|1|||
125938989|NCT04318080|453074668|FG001|Overall Study|Withdrawal by Subject|0|||
125938990|NCT04318080|453074667|FG000|Overall Study|Protocol Deviation|1|||
125938991|NCT04318080|453074668|FG001|Overall Study|Protocol Deviation|0|||
125938992|NCT00410761|453074669|FG000|Randomized Treatment Period|Adverse Event|34|||
125938993|NCT00410761|453074670|FG001|Randomized Treatment Period|Adverse Event|3|||
125938994|NCT00410761|453074669|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
125938995|NCT00410761|453074670|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
125938996|NCT00410761|453074669|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
125938997|NCT00410761|453074670|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
125938998|NCT00410761|453074669|FG000|Randomized Treatment Period|Other|69|||
125938999|NCT00410761|453074670|FG001|Randomized Treatment Period|Other|21|||
125939000|NCT00410761|453074669|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
125939001|NCT00410761|453074670|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
125939002|NCT00410761|453074669|FG000|Open-Label Treatment Period|Adverse Event|13|||
125939003|NCT00410761|453074670|FG001|Open-Label Treatment Period|Adverse Event|15|||
125939004|NCT00410761|453074669|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
125939005|NCT00410761|453074670|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
125939006|NCT00410761|453074669|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
125939007|NCT00410761|453074670|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
125939008|NCT00410761|453074669|FG000|Open-Label Treatment Period|Other|18|||
125939009|NCT00410761|453074670|FG001|Open-Label Treatment Period|Other|9|||
125939010|NCT02926924|453074671|FG000|Overall Study|withdrawal - reason unknown|0|||
125939011|NCT02926924|453074672|FG001|Overall Study|withdrawal - reason unknown|1|||
125939012|NCT03712904|453074674|FG000|Overall Study|Death|0|||
125939013|NCT03712904|453074675|FG001|Overall Study|Death|1|||
125939014|NCT03712904|453074674|FG000|Overall Study|Withdrawal by Subject|0|||
125939015|NCT03712904|453074675|FG001|Overall Study|Withdrawal by Subject|1|||
125939016|NCT03712904|453074674|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
125939017|NCT03712904|453074675|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
125939018|NCT01852942|453074677|FG000|Overall Study|Physician Decision|1|||
125939019|NCT01852942|453074678|FG001|Overall Study|Physician Decision|0|||
125939020|NCT01852942|453074677|FG000|Overall Study|Death|1|||
125939021|NCT01852942|453074678|FG001|Overall Study|Death|1|||
125939022|NCT01852942|453074677|FG000|Overall Study|Withdrawal by Subject|2|||
125939023|NCT01852942|453074678|FG001|Overall Study|Withdrawal by Subject|3|||
125939024|NCT01852942|453074677|FG000|Overall Study|Lost to Follow-up|1|||
125939025|NCT01852942|453074678|FG001|Overall Study|Lost to Follow-up|2|||
125939026|NCT01921179|453074679|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
125939027|NCT01921179|453074680|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
125939028|NCT01921179|453074679|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
125939029|NCT01921179|453074680|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
125939030|NCT04568590|453074681|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
125939031|NCT00858442|453074686|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
125939032|NCT00858442|453074687|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
125939033|NCT00202644|453074692|FG000|Overall Study|Adverse Event|12|||
125939034|NCT00202644|453074693|FG001|Overall Study|Adverse Event|13|||
125939035|NCT00202644|453074692|FG000|Overall Study|Withdrawal by Subject|8|||
125939036|NCT00202644|453074693|FG001|Overall Study|Withdrawal by Subject|6|||
125939037|NCT00202644|453074692|FG000|Overall Study|Lack of Efficacy|6|||
125939038|NCT00202644|453074693|FG001|Overall Study|Lack of Efficacy|6|||
125939039|NCT00202644|453074692|FG000|Overall Study|Lost to Follow-up|0|||
125939040|NCT00202644|453074693|FG001|Overall Study|Lost to Follow-up|1|||
125939041|NCT00202644|453074692|FG000|Overall Study|Other|9|||
125939042|NCT00202644|453074693|FG001|Overall Study|Other|1|||
125939043|NCT02750592|453074699|FG000|Overall Study|Adverse Event|3|||
125939044|NCT02750592|453074699|FG000|Overall Study|Lack of Efficacy|2|||
125939045|NCT02981342|453074702|FG000|Overall Study|Adverse Event|0|||
125939046|NCT02981342|453074703|FG001|Overall Study|Adverse Event|0|||
125939047|NCT02981342|453074704|FG002|Overall Study|Adverse Event|0|||
125939048|NCT02981342|453074705|FG003|Overall Study|Adverse Event|1|||
125939049|NCT02981342|453074702|FG000|Overall Study|Death|0|||
125939050|NCT02981342|453074703|FG001|Overall Study|Death|9|||
125939051|NCT02981342|453074704|FG002|Overall Study|Death|9|||
125939052|NCT02981342|453074705|FG003|Overall Study|Death|4|||
125939053|NCT02981342|453074702|FG000|Overall Study|Withdrawal by Subject|0|||
125939054|NCT02981342|453074703|FG001|Overall Study|Withdrawal by Subject|0|||
125939055|NCT02981342|453074704|FG002|Overall Study|Withdrawal by Subject|3|||
125939056|NCT02981342|453074705|FG003|Overall Study|Withdrawal by Subject|1|||
125939057|NCT02981342|453074702|FG000|Overall Study|Study closed by sponsor|0|||
125939058|NCT02981342|453074703|FG001|Overall Study|Study closed by sponsor|0|||
125939059|NCT02981342|453074704|FG002|Overall Study|Study closed by sponsor|1|||
125939060|NCT02981342|453074705|FG003|Overall Study|Study closed by sponsor|1|||
125939061|NCT02981342|453074702|FG000|Overall Study|Randomized, Never Treated|0|||
125939062|NCT02981342|453074703|FG001|Overall Study|Randomized, Never Treated|1|||
125939063|NCT02981342|453074704|FG002|Overall Study|Randomized, Never Treated|0|||
125939064|NCT02981342|453074705|FG003|Overall Study|Randomized, Never Treated|7|||
125939065|NCT02981342|453074702|FG000|Overall Study|Lost to Follow-up|0|||
125939066|NCT02981342|453074703|FG001|Overall Study|Lost to Follow-up|1|||
125939067|NCT02981342|453074704|FG002|Overall Study|Lost to Follow-up|0|||
125939068|NCT02981342|453074705|FG003|Overall Study|Lost to Follow-up|0|||
125939069|NCT03226392|453074706|FG000|Overall Study|Protocol Deviation|1|||
125939070|NCT03226392|453074707|FG001|Overall Study|Protocol Deviation|0|||
125939071|NCT03226392|453074706|FG000|Overall Study|Physician Decision|1|||
125939072|NCT03226392|453074707|FG001|Overall Study|Physician Decision|0|||
125939073|NCT03226392|453074706|FG000|Overall Study|Lost to Follow-up|1|||
125939074|NCT03226392|453074707|FG001|Overall Study|Lost to Follow-up|0|||
125939075|NCT03226392|453074706|FG000|Overall Study|Adverse Event|1|||
125939076|NCT03226392|453074707|FG001|Overall Study|Adverse Event|0|||
125939077|NCT03226392|453074706|FG000|Overall Study|Technical Problems|0|||
125939078|NCT03226392|453074707|FG001|Overall Study|Technical Problems|2|||
125939079|NCT03226392|453074706|FG000|Overall Study|Subject/Guardian Decision|7|||
125939080|NCT03226392|453074707|FG001|Overall Study|Subject/Guardian Decision|6|||
125939081|NCT02631850|453074709|FG000|Treatment Period|Lost to Follow-up|0|||
125939082|NCT02631850|453074710|FG001|Treatment Period|Lost to Follow-up|1|||
125939083|NCT02631850|453074711|FG002|Treatment Period|Lost to Follow-up|0|||
125939084|NCT02631850|453074712|FG003|Treatment Period|Lost to Follow-up|0|||
125939085|NCT02631850|453074709|FG000|Treatment Period|Protocol Violation|1|||
125939086|NCT02631850|453074710|FG001|Treatment Period|Protocol Violation|0|||
125939087|NCT02631850|453074711|FG002|Treatment Period|Protocol Violation|0|||
125939088|NCT02631850|453074712|FG003|Treatment Period|Protocol Violation|0|||
125939089|NCT02631850|453074709|FG000|Treatment Period|Withdrawal by Subject|0|||
125939090|NCT02631850|453074710|FG001|Treatment Period|Withdrawal by Subject|5|||
125939091|NCT02631850|453074711|FG002|Treatment Period|Withdrawal by Subject|2|||
125939092|NCT02631850|453074712|FG003|Treatment Period|Withdrawal by Subject|2|||
125939093|NCT02631850|453074709|FG000|Treatment Period|Adverse Event|1|||
125939094|NCT02631850|453074710|FG001|Treatment Period|Adverse Event|0|||
125939095|NCT02631850|453074711|FG002|Treatment Period|Adverse Event|2|||
125939096|NCT02631850|453074712|FG003|Treatment Period|Adverse Event|3|||
125939097|NCT02631850|453074709|FG000|Treatment Period|Family medical issue|1|||
125939098|NCT02631850|453074710|FG001|Treatment Period|Family medical issue|0|||
125939099|NCT02631850|453074711|FG002|Treatment Period|Family medical issue|0|||
125939100|NCT02631850|453074712|FG003|Treatment Period|Family medical issue|0|||
125939101|NCT02631850|453074709|FG000|6 Month Follow up|Lost to Follow-up|5|||
125939102|NCT02631850|453074710|FG001|6 Month Follow up|Lost to Follow-up|8|||
125939103|NCT02631850|453074711|FG002|6 Month Follow up|Lost to Follow-up|3|||
125939104|NCT02631850|453074712|FG003|6 Month Follow up|Lost to Follow-up|5|||
125939105|NCT02631850|453074709|FG000|6 Month Follow up|Withdrawal by Subject|1|||
125939106|NCT02631850|453074710|FG001|6 Month Follow up|Withdrawal by Subject|0|||
125939107|NCT02631850|453074711|FG002|6 Month Follow up|Withdrawal by Subject|0|||
125939108|NCT02631850|453074712|FG003|6 Month Follow up|Withdrawal by Subject|2|||
125939109|NCT02631850|453074709|FG000|6 Month Follow up|Adverse Event|1|||
125939110|NCT02631850|453074710|FG001|6 Month Follow up|Adverse Event|4|||
125939111|NCT02631850|453074711|FG002|6 Month Follow up|Adverse Event|1|||
125939112|NCT02631850|453074712|FG003|6 Month Follow up|Adverse Event|3|||
125939113|NCT02631850|453074709|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
125939114|NCT02631850|453074710|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
125939115|NCT02631850|453074711|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
125939116|NCT02631850|453074712|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
125939117|NCT01086540|453074714|FG000|Overall Study|Death|3|||
125939118|NCT01086540|453074715|FG001|Overall Study|Death|1|||
125939119|NCT01086540|453074714|FG000|Overall Study|Physician Decision|2|||
125939120|NCT01086540|453074715|FG001|Overall Study|Physician Decision|1|||
125939121|NCT01086540|453074714|FG000|Overall Study|Addition of new therapy for PAH|1|||
125939122|NCT01086540|453074715|FG001|Overall Study|Addition of new therapy for PAH|0|||
125939123|NCT03164928|453074716|FG000|Overall Study|Lost to Follow-up|1|||
125939124|NCT03164928|453074717|FG001|Overall Study|Lost to Follow-up|0|||
125939125|NCT01998737|453074718|FG000|Overall Study|Corrupted database|23|||
125939126|NCT01998737|453074719|FG001|Overall Study|Corrupted database|0|||
125939127|NCT00730912|453074728|FG000|Overall Study|Discontinued|0|||
125939128|NCT00730912|453074729|FG001|Overall Study|Discontinued|0|||
125939129|NCT00730912|453074730|FG002|Overall Study|Discontinued|1|||
125939130|NCT01994629|453074731|FG000|Overall Study|Withdrawal by Subject|1|||
125939131|NCT01994629|453074732|FG001|Overall Study|Withdrawal by Subject|0|||
125939132|NCT01994629|453074731|FG000|Overall Study|Lost to Follow-up|0|||
125939133|NCT01994629|453074732|FG001|Overall Study|Lost to Follow-up|3|||
125939134|NCT03424265|453074733|FG000|Overall Study|screening failure|1|||
125939135|NCT03424265|453074734|FG001|Overall Study|screening failure|0|||
125939136|NCT03424265|453074733|FG000|Overall Study|Withdrawal by Subject|0|||
125939137|NCT03424265|453074734|FG001|Overall Study|Withdrawal by Subject|2|||
125939138|NCT01558752|453074735|FG000|Overall Study|Physician Decision|2|||
125939139|NCT01558752|453074736|FG001|Overall Study|Physician Decision|0|||
125939140|NCT00894322|453074743|FG000|Overall Study|Withdrawal by Subject|1|||
125939141|NCT00894322|453074744|FG001|Overall Study|Withdrawal by Subject|0|||
125939142|NCT00894322|453074745|FG002|Overall Study|Withdrawal by Subject|0|||
125939143|NCT03338855|453074747|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
125939144|NCT03338855|453074748|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
125939145|NCT00511667|453074749|FG000|Overall Study|Adverse Event|1|||
125939146|NCT00511667|453074750|FG001|Overall Study|Adverse Event|0|||
125939147|NCT00511667|453074749|FG000|Overall Study|Protocol Violation|1|||
125939148|NCT00511667|453074750|FG001|Overall Study|Protocol Violation|1|||
125939149|NCT00511667|453074749|FG000|Overall Study|Withdrawal by Subject|2|||
125939150|NCT00511667|453074750|FG001|Overall Study|Withdrawal by Subject|0|||
125939151|NCT00511667|453074749|FG000|Overall Study|Site terminated|6|||
125939152|NCT00511667|453074750|FG001|Overall Study|Site terminated|1|||
125939153|NCT00511667|453074749|FG000|Overall Study|Other|2|||
125939154|NCT00511667|453074750|FG001|Overall Study|Other|1|||
125939155|NCT00056407|453074751|FG000|Overall Study|Adverse Event|282|||
125939156|NCT00056407|453074752|FG001|Overall Study|Adverse Event|364|||
125939157|NCT00056407|453074751|FG000|Overall Study|Withdrawal by Subject|377|||
126066644|NCT00145496|453534962|FG001|Overall Study|Withdrawal by Subject|26|||
126066645|NCT00145496|453534961|FG000|Overall Study|Lost to Follow-up|12|||
126066646|NCT00145496|453534962|FG001|Overall Study|Lost to Follow-up|5|||
126066647|NCT00145496|453534961|FG000|Overall Study|Other|25|||
126066648|NCT00145496|453534962|FG001|Overall Study|Other|13|||
126066649|NCT01052714|453534963|FG000|Overall Study|Adverse Event|6|||
126066650|NCT01052714|453534964|FG001|Overall Study|Adverse Event|3|||
126066651|NCT01052714|453534965|FG002|Overall Study|Adverse Event|0|||
126066652|NCT01052714|453534963|FG000|Overall Study|Death|1|||
126066653|NCT01052714|453534964|FG001|Overall Study|Death|2|||
126066654|NCT01052714|453534965|FG002|Overall Study|Death|0|||
126066655|NCT01052714|453534963|FG000|Overall Study|Lost to Follow-up|2|||
126066656|NCT01052714|453534964|FG001|Overall Study|Lost to Follow-up|3|||
126066657|NCT01052714|453534965|FG002|Overall Study|Lost to Follow-up|0|||
126066658|NCT01052714|453534963|FG000|Overall Study|Physician Decision|9|||
126066659|NCT01052714|453534964|FG001|Overall Study|Physician Decision|9|||
126066660|NCT01052714|453534965|FG002|Overall Study|Physician Decision|1|||
126066661|NCT01052714|453534963|FG000|Overall Study|Withdrawal by Subject|7|||
126066662|NCT01052714|453534964|FG001|Overall Study|Withdrawal by Subject|12|||
126066663|NCT01052714|453534965|FG002|Overall Study|Withdrawal by Subject|1|||
126066664|NCT00267865|453534968|FG000|Induction Treatment|Died before completing.|2|||
126066665|NCT00267865|453534968|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
126066666|NCT03686176|453534969|FG000|Overall Study|Procedure cancelled|1|||
126066667|NCT03686176|453534970|FG001|Overall Study|Procedure cancelled|0|||
126066668|NCT03686176|453534971|FG002|Overall Study|Procedure cancelled|0|||
126066669|NCT03686176|453534969|FG000|Overall Study|VR Malfunction|1|||
126066670|NCT03686176|453534970|FG001|Overall Study|VR Malfunction|0|||
126066671|NCT03686176|453534971|FG002|Overall Study|VR Malfunction|0|||
126066672|NCT01636778|453534974|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
125939158|NCT00056407|453074752|FG001|Overall Study|Withdrawal by Subject|361|||
125939159|NCT00056407|453074751|FG000|Overall Study|Lost to Follow-up|123|||
125939160|NCT00056407|453074752|FG001|Overall Study|Lost to Follow-up|113|||
125939161|NCT00056407|453074751|FG000|Overall Study|Protocol Violation|104|||
125939162|NCT00056407|453074752|FG001|Overall Study|Protocol Violation|95|||
125939163|NCT00056407|453074751|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
125939164|NCT00056407|453074752|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
125939165|NCT00056407|453074751|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
125939166|NCT00056407|453074752|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
125939167|NCT00056407|453074751|FG000|Overall Study|Missing|25|||
125939168|NCT00056407|453074752|FG001|Overall Study|Missing|34|||
125939169|NCT02738450|453074753|FG000|Overall Study|Withdrawal by Subject|0|||
125939170|NCT02738450|453074754|FG001|Overall Study|Withdrawal by Subject|2|||
125939171|NCT02738450|453074755|FG002|Overall Study|Withdrawal by Subject|0|||
125939172|NCT01173718|453074764|FG000|Overall Study|Death|17|||
125939173|NCT01173718|453074764|FG000|Overall Study|Abandonment of study graft|27|||
125939174|NCT00296374|453074770|FG000|Overall Study|Adverse Event|14|||
125939175|NCT00296374|453074771|FG001|Overall Study|Adverse Event|10|||
125939176|NCT00296374|453074772|FG002|Overall Study|Adverse Event|7|||
125939177|NCT00296374|453074770|FG000|Overall Study|Withdrawal by Subject|3|||
125939178|NCT00296374|453074771|FG001|Overall Study|Withdrawal by Subject|5|||
125939179|NCT00296374|453074772|FG002|Overall Study|Withdrawal by Subject|11|||
125939180|NCT00296374|453074770|FG000|Overall Study|Incorrect enrollment|3|||
125939181|NCT00296374|453074771|FG001|Overall Study|Incorrect enrollment|3|||
125939182|NCT00296374|453074772|FG002|Overall Study|Incorrect enrollment|4|||
125939183|NCT00296374|453074770|FG000|Overall Study|Protocol Violation|1|||
125939184|NCT00296374|453074771|FG001|Overall Study|Protocol Violation|2|||
125939185|NCT00296374|453074772|FG002|Overall Study|Protocol Violation|3|||
125939186|NCT00296374|453074770|FG000|Overall Study|Lost to Follow-up|3|||
125939187|NCT00296374|453074771|FG001|Overall Study|Lost to Follow-up|1|||
125939188|NCT00296374|453074772|FG002|Overall Study|Lost to Follow-up|1|||
125939189|NCT00296374|453074770|FG000|Overall Study|Relocated to another state|1|||
125939190|NCT00296374|453074771|FG001|Overall Study|Relocated to another state|0|||
125939191|NCT00296374|453074772|FG002|Overall Study|Relocated to another state|0|||
125939192|NCT00296374|453074770|FG000|Overall Study|Stopped drug before end of study visit|0|||
125939193|NCT00296374|453074771|FG001|Overall Study|Stopped drug before end of study visit|1|||
126066673|NCT01636778|453534975|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
126066674|NCT01636778|453534976|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
126066675|NCT01636778|453534974|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
126066676|NCT01636778|453534975|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
125939194|NCT00296374|453074772|FG002|Overall Study|Stopped drug before end of study visit|0|||
125939195|NCT00296374|453074770|FG000|Overall Study|Nephrologist introduced ACE|0|||
125939196|NCT00296374|453074771|FG001|Overall Study|Nephrologist introduced ACE|1|||
125939197|NCT00296374|453074772|FG002|Overall Study|Nephrologist introduced ACE|0|||
125939198|NCT00296374|453074770|FG000|Overall Study|Pregnancy|0|||
125939199|NCT00296374|453074771|FG001|Overall Study|Pregnancy|0|||
126066677|NCT01636778|453534976|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
126066678|NCT01636778|453534974|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
126066679|NCT01636778|453534975|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
126066680|NCT01636778|453534976|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
126066681|NCT01636778|453534974|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
125939200|NCT00296374|453074772|FG002|Overall Study|Pregnancy|2|||
125939201|NCT00296374|453074770|FG000|Overall Study|Other|0|||
125939202|NCT00296374|453074771|FG001|Overall Study|Other|0|||
125939203|NCT00296374|453074772|FG002|Overall Study|Other|1|||
125939204|NCT06308822|453076264|FG000|Overall Study|Mutation Status Not Confirmed|17|||
125939205|NCT06308822|453076264|FG000|Overall Study|Adverse Event|1|||
125939206|NCT06308822|453076264|FG000|Overall Study|Death|5|||
125939207|NCT06308822|453076264|FG000|Overall Study|Disease progression|8|||
125939208|NCT06308822|453076264|FG000|Overall Study|Withdrawal by Subject|1|||
125939209|NCT06308822|453076264|FG000|Overall Study|Physician Decision|3|||
125939210|NCT04708886|453076265|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
125939211|NCT04708886|453076265|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
125939212|NCT01372501|453076266|FG000|Overall Study|Adverse Event|4|||
125939213|NCT01372501|453076266|FG000|Overall Study|Device migration|1|||
126066682|NCT01636778|453534975|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
125939214|NCT01466348|453076267|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
125939215|NCT01466348|453076268|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
125939216|NCT03989440|453076269|FG000|Overall Study|COVID-19 travel restrictions|0|||
125939217|NCT03989440|453076270|FG001|Overall Study|COVID-19 travel restrictions|0|||
125939218|NCT03989440|453076271|FG002|Overall Study|COVID-19 travel restrictions|1|||
125939219|NCT03989440|453076272|FG003|Overall Study|COVID-19 travel restrictions|0|||
125939220|NCT03989440|453076273|FG004|Overall Study|COVID-19 travel restrictions|0|||
125939221|NCT03989440|453076274|FG005|Overall Study|COVID-19 travel restrictions|0|||
125939222|NCT03989440|453076269|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
125939223|NCT03989440|453076270|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
125939224|NCT03989440|453076271|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
125939225|NCT03989440|453076272|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
125939226|NCT03989440|453076273|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
125939227|NCT03989440|453076274|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
125939228|NCT03970733|453076277|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
125939229|NCT03970733|453076278|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
125939230|NCT03970733|453076279|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
125939231|NCT03970733|453076280|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
125939232|NCT03970733|453076281|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
125939233|NCT03970733|453076277|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
125939234|NCT03970733|453076278|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
125939235|NCT03970733|453076279|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
125939236|NCT03970733|453076280|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
125939237|NCT03970733|453076281|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
125939238|NCT03970733|453076277|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
125939239|NCT03970733|453076278|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
125939240|NCT03970733|453076279|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
125939241|NCT03970733|453076280|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
125939242|NCT03970733|453076281|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
125939243|NCT03970733|453076277|FG000|Main Study Phase (18 Months)|Other|1|||
125939244|NCT03970733|453076278|FG001|Main Study Phase (18 Months)|Other|1|||
125939245|NCT03970733|453076279|FG002|Main Study Phase (18 Months)|Other|0|||
125939246|NCT03970733|453076280|FG003|Main Study Phase (18 Months)|Other|0|||
125939247|NCT03970733|453076281|FG004|Main Study Phase (18 Months)|Other|0|||
125939248|NCT03970733|453076277|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
125939249|NCT03970733|453076278|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
125939250|NCT03970733|453076279|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
125939251|NCT03970733|453076280|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
125939252|NCT03970733|453076281|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
125939253|NCT02189473|453076285|FG000|Overall Study|Death|22|||
125939254|NCT02189473|453076286|FG001|Overall Study|Death|23|||
125939255|NCT02189473|453076285|FG000|Overall Study|Lost to Follow-up|1|||
125939256|NCT02189473|453076286|FG001|Overall Study|Lost to Follow-up|2|||
125939257|NCT01955161|453076287|FG000|Overall Study|Withdrawal before treatment|2|||
125939258|NCT01955161|453076288|FG001|Overall Study|Withdrawal before treatment|0|||
125939259|NCT01955161|453076289|FG002|Overall Study|Withdrawal before treatment|1|||
126114255|NCT01950247|453713757|FG001|Overall Study|Death|1|||
125939260|NCT01955161|453076287|FG000|Overall Study|Adverse Event|10|||
125939261|NCT01955161|453076288|FG001|Overall Study|Adverse Event|14|||
125939262|NCT01955161|453076289|FG002|Overall Study|Adverse Event|15|||
125939263|NCT01955161|453076287|FG000|Overall Study|Death|1|||
125939264|NCT01955161|453076288|FG001|Overall Study|Death|1|||
125939265|NCT01955161|453076289|FG002|Overall Study|Death|3|||
125939266|NCT01955161|453076287|FG000|Overall Study|Withdrawal by Subject|9|||
125939267|NCT01955161|453076288|FG001|Overall Study|Withdrawal by Subject|8|||
125939268|NCT01955161|453076289|FG002|Overall Study|Withdrawal by Subject|12|||
125939269|NCT01955161|453076287|FG000|Overall Study|Protocol Violation|2|||
125939270|NCT01955161|453076288|FG001|Overall Study|Protocol Violation|0|||
125939271|NCT01955161|453076289|FG002|Overall Study|Protocol Violation|0|||
125939272|NCT01955161|453076287|FG000|Overall Study|Other reason: physician decision|0|||
125939273|NCT01955161|453076288|FG001|Overall Study|Other reason: physician decision|1|||
125939274|NCT01955161|453076289|FG002|Overall Study|Other reason: physician decision|1|||
125939275|NCT01955161|453076287|FG000|Overall Study|Other reason: disallowed medication|1|||
125939276|NCT01955161|453076288|FG001|Overall Study|Other reason: disallowed medication|0|||
125939277|NCT01955161|453076289|FG002|Overall Study|Other reason: disallowed medication|1|||
125939278|NCT01955161|453076287|FG000|Overall Study|Other reason: caregiver unavailable|1|||
126066683|NCT01636778|453534976|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
126066684|NCT01636778|453534974|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
126066685|NCT01636778|453534975|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
126066686|NCT01636778|453534976|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
126066687|NCT01636778|453534974|FG000|Follow-up Period After Part 2|Other|0|||
126066688|NCT01636778|453534975|FG001|Follow-up Period After Part 2|Other|0|||
126066689|NCT01636778|453534976|FG002|Follow-up Period After Part 2|Other|1|||
126066690|NCT01636778|453534974|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
126114256|NCT01950247|453713756|FG000|Overall Study|Not Defined|4|||
126114257|NCT01950247|453713757|FG001|Overall Study|Not Defined|10|||
126114258|NCT00710879|453713760|FG000|Overall Study|Lost to Follow-up|2|||
126114259|NCT00710879|453713761|FG001|Overall Study|Lost to Follow-up|1|||
125939279|NCT01955161|453076288|FG001|Overall Study|Other reason: caregiver unavailable|0|||
125939280|NCT01955161|453076289|FG002|Overall Study|Other reason: caregiver unavailable|0|||
125939281|NCT01955161|453076287|FG000|Overall Study|Other reason: moved to nursing home|0|||
125939282|NCT01955161|453076288|FG001|Overall Study|Other reason: moved to nursing home|1|||
125939283|NCT01955161|453076289|FG002|Overall Study|Other reason: moved to nursing home|0|||
125939284|NCT01955161|453076287|FG000|Overall Study|Other reason: insufficient compliance|0|||
125939285|NCT01955161|453076288|FG001|Overall Study|Other reason: insufficient compliance|0|||
125939286|NCT01955161|453076289|FG002|Overall Study|Other reason: insufficient compliance|1|||
125939287|NCT01955161|453076287|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
125939288|NCT01955161|453076288|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
125939289|NCT01955161|453076289|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
125939290|NCT01955161|453076287|FG000|Overall Study|Other reason: patient's will|0|||
125939291|NCT01955161|453076288|FG001|Overall Study|Other reason: patient's will|0|||
125939292|NCT01955161|453076289|FG002|Overall Study|Other reason: patient's will|1|||
125939293|NCT02784821|453076292|FG000|Overall Study|Death|0|||
125939294|NCT02784821|453076293|FG001|Overall Study|Death|5|||
125939295|NCT02784821|453076294|FG002|Overall Study|Death|4|||
125939296|NCT02784821|453076295|FG003|Overall Study|Death|5|||
125939297|NCT05333900|453076296|FG000|Overall Study|Protocol Violation|0|||
125939298|NCT05333900|453076297|FG001|Overall Study|Protocol Violation|1|||
125939299|NCT05333900|453076296|FG000|Overall Study|Withdrawal by Subject|0|||
125939300|NCT05333900|453076297|FG001|Overall Study|Withdrawal by Subject|1|||
125939301|NCT05333900|453076296|FG000|Overall Study|COVID-19 Pandemic|1|||
125939302|NCT05333900|453076297|FG001|Overall Study|COVID-19 Pandemic|1|||
125939303|NCT03724812|453076300|FG000|Overall Study|Missed Visit|1|||
125939304|NCT03724812|453076300|FG000|Overall Study|Death|2|||
125939305|NCT03724812|453076300|FG000|Overall Study|Withdrawal by Subject|1|||
125939306|NCT01851720|453076301|FG000|Overall Study|Lost to Follow-up|0|||
125939307|NCT01851720|453076302|FG001|Overall Study|Lost to Follow-up|1|||
125939308|NCT01394523|453076303|FG000|Overall Study|Unable to place block|1|||
125939309|NCT01394523|453076304|FG001|Overall Study|Unable to place block|0|||
125939310|NCT01394523|453076305|FG002|Overall Study|Unable to place block|0|||
125939311|NCT03525574|453076306|FG000|Overall Study|Adverse Event|15|||
125939312|NCT03525574|453076307|FG001|Overall Study|Adverse Event|0|||
125939313|NCT03525574|453076306|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
125939314|NCT03525574|453076307|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
125939315|NCT03525574|453076306|FG000|Overall Study|Lost to Follow-up|4|||
125939316|NCT03525574|453076307|FG001|Overall Study|Lost to Follow-up|0|||
125939317|NCT03525574|453076306|FG000|Overall Study|Commercial drug is Available for participant|48|||
125939318|NCT03525574|453076307|FG001|Overall Study|Commercial drug is Available for participant|0|||
125939319|NCT03525574|453076306|FG000|Overall Study|Death|1|||
126066691|NCT01636778|453534975|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
126066692|NCT01636778|453534976|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
126066693|NCT01636778|453534974|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
125939320|NCT03525574|453076307|FG001|Overall Study|Death|0|||
125939321|NCT03525574|453076306|FG000|Overall Study|Other non-compliance|2|||
125939322|NCT03525574|453076307|FG001|Overall Study|Other non-compliance|0|||
125939323|NCT03525574|453076306|FG000|Overall Study|Physician Decision|6|||
125939324|NCT03525574|453076307|FG001|Overall Study|Physician Decision|0|||
125939325|NCT03525574|453076306|FG000|Overall Study|Other|58|||
125939326|NCT03525574|453076307|FG001|Overall Study|Other|0|||
125939327|NCT03525574|453076306|FG000|Overall Study|Enrolled but never dosed|1|||
125939328|NCT03525574|453076307|FG001|Overall Study|Enrolled but never dosed|0|||
125939329|NCT03525574|453076306|FG000|Overall Study|Not enrolled in 105 study|0|||
125939330|NCT03525574|453076307|FG001|Overall Study|Not enrolled in 105 study|3|||
125939331|NCT04741074|453076310|FG000|Overall Study|Withdrawal by Subject|1|||
125939332|NCT04741074|453076311|FG001|Overall Study|Withdrawal by Subject|1|||
125939333|NCT04741074|453076310|FG000|Overall Study|Study terminated prematurely|1|||
125939334|NCT04741074|453076311|FG001|Overall Study|Study terminated prematurely|0|||
125939335|NCT02432846|453076312|FG000|Overall Study (4 Arms/Strata)|Death|3|||
125939336|NCT02432846|453076313|FG001|Overall Study (4 Arms/Strata)|Death|2|||
125939337|NCT02432846|453076314|FG002|Overall Study (4 Arms/Strata)|Death|4|||
125939338|NCT02432846|453076315|FG003|Overall Study (4 Arms/Strata)|Death|3|||
125939339|NCT02432846|453076316|FG004|Overall Study (4 Arms/Strata)|Death|0|||
125939340|NCT02432846|453076317|FG005|Overall Study (4 Arms/Strata)|Death|0|||
125939341|NCT02432846|453076312|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
125939342|NCT02432846|453076313|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
125939343|NCT02432846|453076314|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
125939344|NCT02432846|453076315|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
125939345|NCT02432846|453076316|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
125939346|NCT02432846|453076317|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
125939347|NCT02432846|453076312|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
125939348|NCT02432846|453076313|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125939349|NCT02432846|453076314|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125939350|NCT02432846|453076315|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125939351|NCT02432846|453076316|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125939352|NCT02432846|453076317|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125939353|NCT02432846|453076312|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
125939354|NCT02432846|453076313|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
125939355|NCT02432846|453076314|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
125939356|NCT02432846|453076315|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
125939357|NCT02432846|453076316|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
125939358|NCT02432846|453076317|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
125939359|NCT02432846|453076312|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
125939360|NCT02432846|453076313|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
125939361|NCT02432846|453076314|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
125939362|NCT02432846|453076315|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
125939363|NCT02432846|453076316|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
125939364|NCT02432846|453076317|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
125939365|NCT02432846|453076312|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
125939366|NCT02432846|453076313|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
125939367|NCT02432846|453076314|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
125939368|NCT02432846|453076315|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
125939369|NCT02432846|453076316|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
125939370|NCT02432846|453076317|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
125939371|NCT02432846|453076312|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125939372|NCT02432846|453076313|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125939373|NCT02432846|453076314|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
125939374|NCT02432846|453076315|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125939375|NCT02432846|453076316|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125939376|NCT02432846|453076317|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125939377|NCT02432846|453076312|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
125939378|NCT02432846|453076313|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
125939379|NCT02432846|453076314|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
125939380|NCT02432846|453076315|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
125939381|NCT02432846|453076316|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
125939382|NCT02432846|453076317|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
126066694|NCT01636778|453534975|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
125939383|NCT02432846|453076312|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
125939384|NCT02432846|453076313|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
125939385|NCT02432846|453076314|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
125939386|NCT02432846|453076315|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
125939387|NCT02432846|453076316|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
125939388|NCT02432846|453076317|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
125939389|NCT02432846|453076312|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125939390|NCT02432846|453076313|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125939391|NCT02432846|453076314|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125939392|NCT02432846|453076315|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125939393|NCT02432846|453076316|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
125939394|NCT02432846|453076317|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125939395|NCT02432846|453076312|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
125939396|NCT02432846|453076313|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
125939397|NCT02432846|453076314|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
125939398|NCT02432846|453076315|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
125939399|NCT02432846|453076316|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
125939400|NCT02432846|453076317|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
125939401|NCT02432846|453076312|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
125939402|NCT02432846|453076313|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
125939403|NCT02432846|453076314|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
125939404|NCT02432846|453076315|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
125939405|NCT02432846|453076316|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
125939406|NCT02432846|453076317|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
125939407|NCT02432846|453076312|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
125939408|NCT02432846|453076313|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
125939409|NCT02432846|453076314|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
125939410|NCT02432846|453076315|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
125939411|NCT02432846|453076316|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
125939412|NCT02432846|453076317|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
125939413|NCT02432846|453076312|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125939414|NCT02432846|453076313|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125939415|NCT02432846|453076314|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125939416|NCT02432846|453076315|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125939417|NCT02432846|453076316|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
125939418|NCT02432846|453076317|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125939419|NCT01770379|453076318|FG000|Overall Study|Technical issues|1|||
125939420|NCT01770379|453076319|FG001|Overall Study|Technical issues|0|||
125939421|NCT01770379|453076320|FG002|Overall Study|Technical issues|0|||
125939422|NCT01770379|453076318|FG000|Overall Study|Withdrawal by Subject|7|||
125939423|NCT01770379|453076319|FG001|Overall Study|Withdrawal by Subject|10|||
125939424|NCT01770379|453076320|FG002|Overall Study|Withdrawal by Subject|7|||
125939425|NCT01770379|453076318|FG000|Overall Study|study terminated by sponsor|22|||
125939426|NCT01770379|453076319|FG001|Overall Study|study terminated by sponsor|23|||
125939427|NCT01770379|453076320|FG002|Overall Study|study terminated by sponsor|22|||
125939428|NCT01770379|453076318|FG000|Overall Study|Protocol Violation|0|||
125939429|NCT01770379|453076319|FG001|Overall Study|Protocol Violation|1|||
125939430|NCT01770379|453076320|FG002|Overall Study|Protocol Violation|1|||
125939431|NCT01770379|453076318|FG000|Overall Study|Physician Decision|0|||
125939432|NCT01770379|453076319|FG001|Overall Study|Physician Decision|1|||
125939433|NCT01770379|453076320|FG002|Overall Study|Physician Decision|2|||
125939434|NCT01770379|453076318|FG000|Overall Study|Lost to Follow-up|0|||
125939435|NCT01770379|453076319|FG001|Overall Study|Lost to Follow-up|0|||
125939436|NCT01770379|453076320|FG002|Overall Study|Lost to Follow-up|2|||
125939437|NCT01770379|453076318|FG000|Overall Study|Lack of Efficacy|8|||
125939438|NCT01770379|453076319|FG001|Overall Study|Lack of Efficacy|6|||
125939439|NCT01770379|453076320|FG002|Overall Study|Lack of Efficacy|6|||
125939440|NCT01770379|453076318|FG000|Overall Study|Adverse Event|1|||
125939441|NCT01770379|453076319|FG001|Overall Study|Adverse Event|3|||
125939442|NCT01770379|453076320|FG002|Overall Study|Adverse Event|2|||
125939443|NCT03045887|453076321|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
125939444|NCT03045887|453076322|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939445|NCT03045887|453076323|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939446|NCT03045887|453076324|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939447|NCT03045887|453076325|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939448|NCT03045887|453076326|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939449|NCT03045887|453076327|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939450|NCT03045887|453076328|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939451|NCT03045887|453076329|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939452|NCT03045887|453076330|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125939453|NCT03045887|453076321|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939454|NCT03045887|453076322|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939455|NCT03045887|453076323|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939456|NCT03045887|453076324|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
125939457|NCT03045887|453076325|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939458|NCT03045887|453076326|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939459|NCT03045887|453076327|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939460|NCT03045887|453076328|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939461|NCT03045887|453076329|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939462|NCT03045887|453076330|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125939463|NCT03045887|453076321|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
125939464|NCT03045887|453076322|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939465|NCT03045887|453076323|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939466|NCT03045887|453076324|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939467|NCT03045887|453076325|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939468|NCT03045887|453076326|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939469|NCT03045887|453076327|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939470|NCT03045887|453076328|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939471|NCT03045887|453076329|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939472|NCT03045887|453076330|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
125939473|NCT03045887|453076321|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125939474|NCT03045887|453076322|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125939475|NCT03045887|453076323|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
125939476|NCT03045887|453076324|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
125939477|NCT03045887|453076325|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125939478|NCT03045887|453076326|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125939479|NCT03045887|453076327|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125939480|NCT03045887|453076328|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125939481|NCT03045887|453076329|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125939482|NCT03045887|453076330|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125939483|NCT03045887|453076321|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939484|NCT03045887|453076322|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939485|NCT03045887|453076323|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939486|NCT03045887|453076324|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
126114260|NCT00710879|453713760|FG000|Overall Study|Protocol Violation|0|||
126114261|NCT00710879|453713761|FG001|Overall Study|Protocol Violation|3|||
126114262|NCT01809132|453713762|FG000|Overall Study|Withdrawal by Subject|0|||
126114263|NCT01809132|453713763|FG001|Overall Study|Withdrawal by Subject|0|||
126114264|NCT01809132|453713764|FG002|Overall Study|Withdrawal by Subject|1|||
126114265|NCT03349775|453713765|FG000|Overall Study|Side Effects|1|||
126114266|NCT03349775|453713766|FG001|Overall Study|Side Effects|2|||
126114267|NCT03349775|453713765|FG000|Overall Study|Withdrawal by Subject|1|||
126114268|NCT03349775|453713766|FG001|Overall Study|Withdrawal by Subject|1|||
126114269|NCT03349775|453713765|FG000|Overall Study|No primary outcome measurements|0|||
126114270|NCT03349775|453713766|FG001|Overall Study|No primary outcome measurements|1|||
126114271|NCT01516970|453713767|FG000|Overall Study|Lost to Follow-up|7|||
126114272|NCT01516970|453713768|FG001|Overall Study|Lost to Follow-up|8|||
126114273|NCT01516970|453713767|FG000|Overall Study|Adverse Event|1|||
126114274|NCT01516970|453713768|FG001|Overall Study|Adverse Event|5|||
126114275|NCT01516970|453713767|FG000|Overall Study|Withdrawal by Subject|1|||
125939487|NCT03045887|453076325|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939488|NCT03045887|453076326|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939489|NCT03045887|453076327|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939490|NCT03045887|453076328|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939491|NCT03045887|453076329|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939492|NCT03045887|453076330|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125939493|NCT01912287|453076332|FG000|Overall Study|Ineligible|1|||
125939494|NCT01912287|453076333|FG001|Overall Study|Ineligible|0|||
125939495|NCT01912287|453076334|FG002|Overall Study|Ineligible|1|||
125939496|NCT01912287|453076332|FG000|Overall Study|No-show|0|||
125939497|NCT01912287|453076333|FG001|Overall Study|No-show|0|||
125939498|NCT01912287|453076334|FG002|Overall Study|No-show|1|||
125939499|NCT01912287|453076332|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
125939500|NCT01912287|453076333|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
125939501|NCT01912287|453076334|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
125939502|NCT01912287|453076332|FG000|Overall Study|Felt treatment no longer needed|0|||
125939503|NCT01912287|453076333|FG001|Overall Study|Felt treatment no longer needed|1|||
126114276|NCT01516970|453713768|FG001|Overall Study|Withdrawal by Subject|1|||
126114277|NCT01516970|453713767|FG000|Overall Study|Other|9|||
125939504|NCT01912287|453076334|FG002|Overall Study|Felt treatment no longer needed|0|||
125939505|NCT01912287|453076332|FG000|Overall Study|Life circumstances|4|||
125939506|NCT01912287|453076333|FG001|Overall Study|Life circumstances|2|||
125939507|NCT01912287|453076334|FG002|Overall Study|Life circumstances|0|||
125939508|NCT01912287|453076332|FG000|Overall Study|Lost Interest|1|||
125939509|NCT01912287|453076333|FG001|Overall Study|Lost Interest|0|||
125939510|NCT01912287|453076334|FG002|Overall Study|Lost Interest|0|||
126114278|NCT01516970|453713768|FG001|Overall Study|Other|7|||
126114279|NCT00434421|453713769|FG000|Overall Study|Withdrawal by Subject|1|||
126114280|NCT00434421|453713769|FG000|Overall Study|Non-compliance with study treatment|1|||
126114281|NCT01756040|453713770|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
125939511|NCT01912287|453076332|FG000|Overall Study|Uknown reason - subject drop out|5|||
125939512|NCT01912287|453076333|FG001|Overall Study|Uknown reason - subject drop out|7|||
125939513|NCT01912287|453076334|FG002|Overall Study|Uknown reason - subject drop out|3|||
125939514|NCT01912287|453076332|FG000|Overall Study|Missed Assesment|1|||
125939515|NCT01912287|453076333|FG001|Overall Study|Missed Assesment|1|||
125939516|NCT01912287|453076334|FG002|Overall Study|Missed Assesment|1|||
125939517|NCT01912287|453076332|FG000|Overall Study|Scheduling/change in availability|17|||
125939518|NCT01912287|453076333|FG001|Overall Study|Scheduling/change in availability|10|||
125939519|NCT01912287|453076334|FG002|Overall Study|Scheduling/change in availability|8|||
125939520|NCT03914326|453076337|FG000|Overall Study|Withdrawal by Subject|27|||
125939521|NCT03914326|453076338|FG001|Overall Study|Withdrawal by Subject|34|||
125939522|NCT03914326|453076337|FG000|Overall Study|Lost to Follow-up|43|||
125939523|NCT03914326|453076338|FG001|Overall Study|Lost to Follow-up|51|||
125939524|NCT03914326|453076337|FG000|Overall Study|Randomised more than once|0|||
125939525|NCT03914326|453076338|FG001|Overall Study|Randomised more than once|1|||
125939526|NCT02357901|453076343|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
125939527|NCT02357901|453076344|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
125939528|NCT02357901|453076345|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
125939529|NCT02357901|453076346|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
125939530|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
125939531|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
125939532|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
125939533|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
125939534|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
125939535|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
125939536|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
125939537|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
125939538|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
125939539|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
125939540|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
125939541|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
125939542|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
125939543|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
125939544|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
125939545|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
125939546|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
125939547|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
125939548|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
125939549|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
125939550|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
125939551|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
125939552|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
126066695|NCT01636778|453534976|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
126066696|NCT03530345|453534985|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
126066697|NCT03530345|453534986|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
126066698|NCT03530345|453534985|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
126066699|NCT03530345|453534986|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
126066700|NCT03530345|453534985|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
126066701|NCT03530345|453534986|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
126066702|NCT03530345|453534985|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
126066703|NCT03530345|453534986|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
126066704|NCT02661490|453536945|FG000|Overall Study|Lost to Follow-up|0|||
126066705|NCT02661490|453536946|FG001|Overall Study|Lost to Follow-up|1|||
126066706|NCT02661490|453536947|FG002|Overall Study|Lost to Follow-up|0|||
126066707|NCT02661490|453536948|FG003|Overall Study|Lost to Follow-up|0|||
126066708|NCT02661490|453536949|FG004|Overall Study|Lost to Follow-up|2|||
126066709|NCT02661490|453536945|FG000|Overall Study|Withdrawal by Subject|2|||
126066710|NCT02661490|453536946|FG001|Overall Study|Withdrawal by Subject|0|||
125939553|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
125939554|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
125939555|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
125939556|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
125939557|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
126066711|NCT02661490|453536947|FG002|Overall Study|Withdrawal by Subject|2|||
126066712|NCT02661490|453536948|FG003|Overall Study|Withdrawal by Subject|0|||
126066713|NCT02661490|453536949|FG004|Overall Study|Withdrawal by Subject|0|||
126066714|NCT02661490|453536945|FG000|Overall Study|Death|1|||
126066715|NCT02661490|453536946|FG001|Overall Study|Death|1|||
126066716|NCT02661490|453536947|FG002|Overall Study|Death|0|||
125939558|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
125939559|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
125939560|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
125939561|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
125939562|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
125939563|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
125939564|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
125939565|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
125939566|NCT02357901|453076343|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
125939567|NCT02357901|453076344|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
125939568|NCT02357901|453076345|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
125939569|NCT02357901|453076346|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
125939570|NCT00491387|453076347|FG000|Overall Study|study terminated|20|||
125939571|NCT02278263|453076348|FG000|Overall Study|Protocol Violation|7|||
125939572|NCT02278263|453076349|FG001|Overall Study|Protocol Violation|0|||
125939573|NCT02278263|453076350|FG002|Overall Study|Protocol Violation|9|||
125939574|NCT03997383|453076351|FG000|Double-blind Treatment Period|Adverse Event|4|||
125939575|NCT03997383|453076352|FG001|Double-blind Treatment Period|Adverse Event|3|||
125939576|NCT03997383|453076351|FG000|Double-blind Treatment Period|Death|4|||
125939577|NCT03997383|453076352|FG001|Double-blind Treatment Period|Death|4|||
125939578|NCT03997383|453076351|FG000|Double-blind Treatment Period|Physician Decision|2|||
125939579|NCT03997383|453076352|FG001|Double-blind Treatment Period|Physician Decision|0|||
125939580|NCT03997383|453076351|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
125939581|NCT03997383|453076352|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
125939582|NCT03997383|453076351|FG000|Open-label Extension Period|Ongoing|148|||
125939583|NCT03997383|453076352|FG001|Open-label Extension Period|Ongoing|151|||
125939584|NCT03997383|453076351|FG000|Open-label Extension Period|Adverse Event|4|||
125939585|NCT03997383|453076352|FG001|Open-label Extension Period|Adverse Event|1|||
125939586|NCT03997383|453076351|FG000|Open-label Extension Period|Death|8|||
125939587|NCT03997383|453076352|FG001|Open-label Extension Period|Death|9|||
125939588|NCT03997383|453076351|FG000|Open-label Extension Period|Physician Decision|1|||
125939589|NCT03997383|453076352|FG001|Open-label Extension Period|Physician Decision|1|||
125939590|NCT03997383|453076351|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
125939591|NCT03997383|453076352|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
125939592|NCT03997383|453076351|FG000|Open-label Extension Period|Reason Not Specified|2|||
125939593|NCT03997383|453076352|FG001|Open-label Extension Period|Reason Not Specified|0|||
125939594|NCT03880019|453076353|FG000|Overall Study|Competing disease|1|||
125939595|NCT00326950|453076354|FG000|Overall Study|Progressive Disease|1|||
125939596|NCT05811234|453076360|FG000|Overall Study|Loss of Effectiveness|2|||
125939597|NCT05811234|453076360|FG000|Overall Study|Adverse Event|4|||
125939598|NCT05811234|453076360|FG000|Overall Study|Pregnancy|1|||
125939599|NCT05811234|453076360|FG000|Overall Study|Disease progression|1|||
125939600|NCT05811234|453076360|FG000|Overall Study|Withdrawal by Subject|4|||
125939601|NCT05811234|453076360|FG000|Overall Study|Lost to Follow-up|13|||
125939602|NCT05811234|453076360|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
125939603|NCT04499781|453076361|FG000|Overall Study|Lost to Follow-up|2|||
125939604|NCT04499781|453076362|FG001|Overall Study|Lost to Follow-up|3|||
125939605|NCT04499781|453076361|FG000|Overall Study|Withdrawal by Subject|2|||
125939606|NCT04499781|453076362|FG001|Overall Study|Withdrawal by Subject|0|||
125939607|NCT00227305|453076367|FG000|Overall Study|Adverse Event|40|||
125939608|NCT00227305|453076367|FG000|Overall Study|Withdrawal by Subject|42|||
125939609|NCT00227305|453076367|FG000|Overall Study|Lost to Follow-up|33|||
125939610|NCT00227305|453076367|FG000|Overall Study|Study specific discontinuation|13|||
125939611|NCT00227305|453076367|FG000|Overall Study|MOVED OUT OF AREA|3|||
125939612|NCT00227305|453076367|FG000|Overall Study|Lack of Efficacy|7|||
125939613|NCT00227305|453076367|FG000|Overall Study|Physician Decision|3|||
125939614|NCT00227305|453076367|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
125939615|NCT00227305|453076367|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
125939616|NCT00227305|453076367|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
125939617|NCT02118012|453076368|FG000|Overall Study|Adverse Event|0|||
125939618|NCT02118012|453076369|FG001|Overall Study|Adverse Event|1|||
125939619|NCT02118012|453076368|FG000|Overall Study|Physician Decision|0|||
125939620|NCT02118012|453076369|FG001|Overall Study|Physician Decision|1|||
125939621|NCT03698994|453076370|FG000|Overall Study|Adverse Event|2|||
125939622|NCT03698994|453076370|FG000|Overall Study|Death|1|||
125939623|NCT03698994|453076370|FG000|Overall Study|Physician Decision|1|||
125939624|NCT03698994|453076370|FG000|Overall Study|Withdrawal by Subject|3|||
125939625|NCT03698994|453076370|FG000|Overall Study|Progressive Disease|12|||
125939626|NCT04103892|453076378|FG000|Overall Study|Adverse Event|0|||
125939627|NCT04103892|453076379|FG001|Overall Study|Adverse Event|0|||
125939628|NCT04103892|453076380|FG002|Overall Study|Adverse Event|0|||
125939629|NCT04103892|453076381|FG003|Overall Study|Adverse Event|3|||
125939630|NCT04103892|453076378|FG000|Overall Study|Lost to Follow-up|0|||
125939631|NCT04103892|453076379|FG001|Overall Study|Lost to Follow-up|0|||
125939632|NCT04103892|453076380|FG002|Overall Study|Lost to Follow-up|2|||
125939633|NCT04103892|453076381|FG003|Overall Study|Lost to Follow-up|0|||
125939634|NCT04103892|453076378|FG000|Overall Study|Protocol Violation|0|||
125939635|NCT04103892|453076379|FG001|Overall Study|Protocol Violation|0|||
125939636|NCT04103892|453076380|FG002|Overall Study|Protocol Violation|1|||
125939637|NCT04103892|453076381|FG003|Overall Study|Protocol Violation|1|||
125939638|NCT04103892|453076378|FG000|Overall Study|Withdrawal by Subject|1|||
125939639|NCT04103892|453076379|FG001|Overall Study|Withdrawal by Subject|0|||
125939640|NCT04103892|453076380|FG002|Overall Study|Withdrawal by Subject|2|||
125939641|NCT04103892|453076381|FG003|Overall Study|Withdrawal by Subject|5|||
125939642|NCT04103892|453076378|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
125939643|NCT04103892|453076379|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
125939644|NCT04103892|453076380|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
125939645|NCT04103892|453076381|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
125939646|NCT03051607|453076384|FG000|Overall Study|Adverse Event|66|||
125939647|NCT01603459|453076394|FG000|Overall Study|Adverse Event|5|||
125939648|NCT01603459|453076394|FG000|Overall Study|Withdrawal by Subject|5|||
125939649|NCT01603459|453076394|FG000|Overall Study|Lost to Follow-up|3|||
125939650|NCT01603459|453076394|FG000|Overall Study|Predefined discontinuation criteria|3|||
125939651|NCT01603459|453076394|FG000|Overall Study|Non-compliance|1|||
125939652|NCT01603459|453076394|FG000|Overall Study|Administrative reason|1|||
125939653|NCT01412021|453076395|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
125939654|NCT01412021|453076395|FG000|Overall Study|Treatment Prior to Approval|3|||
125939655|NCT01412021|453076395|FG000|Overall Study|Transferred to Other Hospital|9|||
125939656|NCT03658538|453076398|FG000|Overall Study|Death|2|||
125939657|NCT03658538|453076399|FG001|Overall Study|Death|1|||
125939658|NCT03658538|453076398|FG000|Overall Study|Cancer diagnosis|1|||
125939659|NCT03658538|453076399|FG001|Overall Study|Cancer diagnosis|0|||
125939660|NCT03658538|453076398|FG000|Overall Study|Change residence|1|||
125939661|NCT03658538|453076399|FG001|Overall Study|Change residence|2|||
125939662|NCT03658538|453076398|FG000|Overall Study|Lost to Follow-up|3|||
125939663|NCT03658538|453076399|FG001|Overall Study|Lost to Follow-up|3|||
125939664|NCT03658538|453076398|FG000|Overall Study|Unblinded|2|||
125939665|NCT03658538|453076399|FG001|Overall Study|Unblinded|3|||
125939666|NCT03658538|453076398|FG000|Overall Study|Physician Decision|0|||
125939667|NCT03658538|453076399|FG001|Overall Study|Physician Decision|1|||
125939668|NCT03658538|453076398|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
125939669|NCT03658538|453076399|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
125939670|NCT03658538|453076398|FG000|Overall Study|Evicted from home|1|||
125939671|NCT03658538|453076399|FG001|Overall Study|Evicted from home|0|||
125939672|NCT01721330|453076400|FG000|Overall Study|Withdrawal by Subject|0|||
125939673|NCT01721330|453076401|FG001|Overall Study|Withdrawal by Subject|1|||
125939674|NCT05608005|453077672|FG000|Overall Study|Adverse Event|2|||
125939675|NCT05608005|453077673|FG001|Overall Study|Adverse Event|1|||
125939676|NCT05608005|453077674|FG002|Overall Study|Adverse Event|3|||
125939677|NCT05608005|453077672|FG000|Overall Study|Protocol Violation|2|||
125939678|NCT05608005|453077673|FG001|Overall Study|Protocol Violation|3|||
125939679|NCT05608005|453077674|FG002|Overall Study|Protocol Violation|0|||
125939680|NCT05608005|453077672|FG000|Overall Study|Withdrawal by Subject|10|||
125939681|NCT05608005|453077673|FG001|Overall Study|Withdrawal by Subject|12|||
125939682|NCT05608005|453077674|FG002|Overall Study|Withdrawal by Subject|4|||
125939683|NCT05608005|453077672|FG000|Overall Study|Lost to Follow-up|25|||
125939684|NCT05608005|453077673|FG001|Overall Study|Lost to Follow-up|27|||
125939685|NCT05608005|453077674|FG002|Overall Study|Lost to Follow-up|15|||
125939686|NCT05608005|453077672|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
125939687|NCT05608005|453077673|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
125939688|NCT05608005|453077674|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
125939689|NCT01277523|453077675|FG000|Overall Study|Adverse Event|1|||
125939690|NCT01277523|453077676|FG001|Overall Study|Adverse Event|0|||
125939691|NCT01277523|453077677|FG002|Overall Study|Adverse Event|0|||
125939692|NCT01277523|453077675|FG000|Overall Study|Protocol Violation|2|||
125939693|NCT01277523|453077676|FG001|Overall Study|Protocol Violation|0|||
125939694|NCT01277523|453077677|FG002|Overall Study|Protocol Violation|0|||
125939695|NCT01277523|453077675|FG000|Overall Study|Other Reason not Defined|0|||
125939696|NCT01277523|453077676|FG001|Overall Study|Other Reason not Defined|1|||
125939697|NCT01277523|453077677|FG002|Overall Study|Other Reason not Defined|0|||
125939698|NCT01030523|453077678|FG000|Initial Study (5 Years)|Death|1|||
125939699|NCT01030523|453077679|FG001|Initial Study (5 Years)|Death|0|||
125939700|NCT01030523|453077678|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
125939701|NCT01030523|453077679|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
125939702|NCT01030523|453077678|FG000|Initial Study (5 Years)|Implant failure|1|||
125939703|NCT01030523|453077679|FG001|Initial Study (5 Years)|Implant failure|0|||
125939704|NCT01030523|453077678|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
125939705|NCT01030523|453077679|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
125939706|NCT01030523|453077678|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
125939707|NCT01030523|453077679|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
125939708|NCT01030523|453077678|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
125939709|NCT01030523|453077679|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
125939710|NCT02769247|453077687|FG000|Overall Study|Withdrawal by Subject|1|||
125939711|NCT02769247|453077688|FG001|Overall Study|Withdrawal by Subject|0|||
125939712|NCT02769247|453077689|FG002|Overall Study|Withdrawal by Subject|0|||
125939713|NCT02769247|453077690|FG003|Overall Study|Withdrawal by Subject|1|||
125939714|NCT02769247|453077687|FG000|Overall Study|Protocol Violation|0|||
125939715|NCT02769247|453077688|FG001|Overall Study|Protocol Violation|0|||
125939716|NCT02769247|453077689|FG002|Overall Study|Protocol Violation|1|||
125939717|NCT02769247|453077690|FG003|Overall Study|Protocol Violation|0|||
125939718|NCT02769247|453077687|FG000|Overall Study|Physician Decision|1|||
125939719|NCT02769247|453077688|FG001|Overall Study|Physician Decision|0|||
125939720|NCT02769247|453077689|FG002|Overall Study|Physician Decision|0|||
125939721|NCT02769247|453077690|FG003|Overall Study|Physician Decision|0|||
125939722|NCT04788953|453077691|FG000|Overall Study|Adverse Event|1|||
125939723|NCT04788953|453077692|FG001|Overall Study|Adverse Event|1|||
125939724|NCT04788953|453077691|FG000|Overall Study|Withdrawal by Subject|1|||
125939725|NCT04788953|453077692|FG001|Overall Study|Withdrawal by Subject|0|||
125939726|NCT04788953|453077691|FG000|Overall Study|Protocol Violation|0|||
125939727|NCT04788953|453077692|FG001|Overall Study|Protocol Violation|1|||
125939728|NCT02150954|453077695|FG000|Overall Study|Protocol Violation|1|||
125939729|NCT02150954|453077696|FG001|Overall Study|Protocol Violation|0|||
125939730|NCT03814746|453077700|FG000|Overall Study|Participant decision|9|||
125939731|NCT03814746|453077701|FG001|Overall Study|Participant decision|6|||
125939732|NCT03814746|453077702|FG002|Overall Study|Participant decision|15|||
125939733|NCT03814746|453077700|FG000|Overall Study|Physician Decision|2|||
125939734|NCT03814746|453077701|FG001|Overall Study|Physician Decision|2|||
125939735|NCT03814746|453077702|FG002|Overall Study|Physician Decision|4|||
125939736|NCT03814746|453077700|FG000|Overall Study|Death|2|||
125939737|NCT03814746|453077701|FG001|Overall Study|Death|2|||
125939738|NCT03814746|453077702|FG002|Overall Study|Death|2|||
125939739|NCT03814746|453077700|FG000|Overall Study|Adverse Event|2|||
125939740|NCT03814746|453077701|FG001|Overall Study|Adverse Event|2|||
125939741|NCT03814746|453077702|FG002|Overall Study|Adverse Event|1|||
125939742|NCT03814746|453077700|FG000|Overall Study|Lost to Follow-up|2|||
125939743|NCT03814746|453077701|FG001|Overall Study|Lost to Follow-up|1|||
125939744|NCT03814746|453077702|FG002|Overall Study|Lost to Follow-up|2|||
125939745|NCT03814746|453077700|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125939746|NCT03814746|453077701|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125939747|NCT03814746|453077702|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125939748|NCT03814746|453077700|FG000|Overall Study|Pregnancy|0|||
125939749|NCT03814746|453077701|FG001|Overall Study|Pregnancy|1|||
125939750|NCT03814746|453077702|FG002|Overall Study|Pregnancy|1|||
125939751|NCT03814746|453077700|FG000|Overall Study|Protocol Violation|1|||
125939752|NCT03814746|453077701|FG001|Overall Study|Protocol Violation|0|||
125939753|NCT03814746|453077702|FG002|Overall Study|Protocol Violation|0|||
125939754|NCT01266460|453077711|FG000|Overall Study|Adverse Event|3|||
125939755|NCT01266460|453077711|FG000|Overall Study|Withdrawal by Subject|5|||
125939756|NCT01266460|453077711|FG000|Overall Study|Disease Progression|18|||
125939757|NCT01266460|453077711|FG000|Overall Study|Not otherwise specified|8|||
125939758|NCT01132547|453077712|FG000|Overall Study|Withdrawal by Subject|3|||
125939759|NCT01132547|453077713|FG001|Overall Study|Withdrawal by Subject|1|||
125939760|NCT01132547|453077712|FG000|Overall Study|Death|1|||
125939761|NCT01132547|453077713|FG001|Overall Study|Death|0|||
125939762|NCT00483379|453077716|FG000|Treatment Period|Adverse Event|1|||
125939763|NCT00483379|453077717|FG001|Treatment Period|Adverse Event|0|||
125939764|NCT00483379|453077716|FG000|Treatment Period|Withdrawal by Subject|1|||
125939765|NCT00483379|453077717|FG001|Treatment Period|Withdrawal by Subject|0|||
125939766|NCT02809677|453077718|FG000|Overall Study|Withdrawal by Subject|8|||
125939767|NCT04969224|453077719|FG000|Overall Study|Adverse Event|1|||
125939768|NCT04969224|453077719|FG000|Overall Study|Enrolled but never dosed|1|||
125939769|NCT03165110|453077720|FG000|Overall Study|Anroid phone software incompatibility|1|||
125939770|NCT05533632|453077721|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
125939771|NCT05533632|453077721|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
125939772|NCT05533632|453077721|FG000|Overall Study|Lost to Follow-up|1|||
125939773|NCT05533632|453077721|FG000|Overall Study|Withdrawal by Subject|4|||
125939774|NCT05533632|453077721|FG000|Overall Study|Adverse Event|4|||
125939775|NCT04327388|453077724|FG000|Overall Study|Adverse Event|17|||
125939776|NCT04327388|453077725|FG001|Overall Study|Adverse Event|18|||
125939777|NCT04327388|453077726|FG002|Overall Study|Adverse Event|9|||
125939778|NCT04327388|453077724|FG000|Overall Study|Other|1|||
125939779|NCT04327388|453077725|FG001|Overall Study|Other|2|||
125939780|NCT04327388|453077726|FG002|Overall Study|Other|0|||
125939781|NCT04327388|453077724|FG000|Overall Study|Randomized and not treated|2|||
125939782|NCT04327388|453077725|FG001|Overall Study|Randomized and not treated|0|||
125939783|NCT04327388|453077726|FG002|Overall Study|Randomized and not treated|2|||
125939784|NCT04340362|453077729|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
125939785|NCT03341533|453077734|FG000|Overall Study|Withdrawal by Subject|1|||
125939786|NCT03341533|453077735|FG001|Overall Study|Withdrawal by Subject|1|||
125939787|NCT03341533|453077734|FG000|Overall Study|Not eligible after randomization|2|||
125939788|NCT03341533|453077735|FG001|Overall Study|Not eligible after randomization|1|||
125939789|NCT00399360|453077737|FG000|Overall Study|Lost to Follow-up|2|||
125939790|NCT00399360|453077738|FG001|Overall Study|Lost to Follow-up|1|||
125939791|NCT00399360|453077739|FG002|Overall Study|Lost to Follow-up|2|||
125939792|NCT00399360|453077740|FG003|Overall Study|Lost to Follow-up|4|||
125939793|NCT00399360|453077737|FG000|Overall Study|Adverse Event|0|||
125939794|NCT00399360|453077738|FG001|Overall Study|Adverse Event|0|||
125939795|NCT00399360|453077739|FG002|Overall Study|Adverse Event|1|||
125939796|NCT00399360|453077740|FG003|Overall Study|Adverse Event|0|||
125939797|NCT00399360|453077737|FG000|Overall Study|Withdrawal by Subject|0|||
125939798|NCT00399360|453077738|FG001|Overall Study|Withdrawal by Subject|2|||
125939799|NCT00399360|453077739|FG002|Overall Study|Withdrawal by Subject|0|||
125939800|NCT00399360|453077740|FG003|Overall Study|Withdrawal by Subject|2|||
125939801|NCT01166178|453077741|FG000|Overall Study|Withdrawal by Subject|1|||
125939802|NCT01166178|453077742|FG001|Overall Study|Withdrawal by Subject|0|||
125939803|NCT01166178|453077741|FG000|Overall Study|Study was terminated|20|||
125939804|NCT01166178|453077742|FG001|Overall Study|Study was terminated|8|||
125939805|NCT00529542|453077746|FG000|Overall Study|Withdrawal by Subject|1|||
125939806|NCT00529542|453077747|FG001|Overall Study|Withdrawal by Subject|0|||
125939807|NCT00529542|453077746|FG000|Overall Study|Lost to Follow-up|0|||
125939808|NCT00529542|453077747|FG001|Overall Study|Lost to Follow-up|1|||
125939809|NCT05778786|453077748|FG000|Period 1|COVID-19 Related|3|||
125939810|NCT05778786|453077749|FG001|Period 1|COVID-19 Related|3|||
125939811|NCT05778786|453077748|FG000|Period 1|Withdrew Consent during Study|1|||
125939812|NCT05778786|453077749|FG001|Period 1|Withdrew Consent during Study|0|||
125939813|NCT05778786|453077748|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
125939814|NCT05778786|453077749|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
125939815|NCT05778786|453077748|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
125939816|NCT05778786|453077749|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
125939817|NCT03333044|453077750|FG000|Overall Study|Pregnancy|1|||
125939818|NCT03333044|453077751|FG001|Overall Study|Pregnancy|0|||
125939819|NCT03333044|453077752|FG002|Overall Study|Pregnancy|0|||
125939820|NCT03333044|453077750|FG000|Overall Study|Lost to Follow-up|0|||
125939821|NCT03333044|453077751|FG001|Overall Study|Lost to Follow-up|14|||
125939822|NCT03333044|453077752|FG002|Overall Study|Lost to Follow-up|6|||
125939823|NCT03188094|453077753|FG000|Overall Study|Screen failure|1|||
125939824|NCT03188094|453077754|FG001|Overall Study|Screen failure|0|||
125939825|NCT03188094|453077755|FG002|Overall Study|Screen failure|0|||
125939826|NCT03188094|453077753|FG000|Overall Study|Pregnancy|3|||
125939827|NCT03188094|453077754|FG001|Overall Study|Pregnancy|0|||
125939828|NCT03188094|453077755|FG002|Overall Study|Pregnancy|0|||
125939829|NCT03188094|453077753|FG000|Overall Study|Ineligible|1|||
125939830|NCT03188094|453077754|FG001|Overall Study|Ineligible|0|||
125939831|NCT03188094|453077755|FG002|Overall Study|Ineligible|0|||
125939832|NCT03188094|453077753|FG000|Overall Study|Lost to Follow-up|0|||
125939833|NCT03188094|453077754|FG001|Overall Study|Lost to Follow-up|0|||
125939834|NCT03188094|453077755|FG002|Overall Study|Lost to Follow-up|17|||
125939835|NCT04537234|453077759|FG000|Overall Study|Withdrawal by Subject|2|||
125939836|NCT04537234|453077760|FG001|Overall Study|Withdrawal by Subject|0|||
125939837|NCT02070744|453077763|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
125939838|NCT02070744|453077764|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
125939839|NCT02070744|453077765|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
125939840|NCT02070744|453077766|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
125939841|NCT02070744|453077767|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
125939842|NCT02070744|453077763|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
125939843|NCT02070744|453077764|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
125939844|NCT02070744|453077765|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
125939845|NCT02070744|453077766|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
125939846|NCT02070744|453077767|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
125939847|NCT02070744|453077763|FG000|OLE Phase (48 Weeks)|Other|0|||
125939848|NCT02070744|453077764|FG001|OLE Phase (48 Weeks)|Other|0|||
125939849|NCT02070744|453077765|FG002|OLE Phase (48 Weeks)|Other|0|||
125939850|NCT02070744|453077766|FG003|OLE Phase (48 Weeks)|Other|0|||
126066717|NCT02661490|453536948|FG003|Overall Study|Death|1|||
125939851|NCT02070744|453077767|FG004|OLE Phase (48 Weeks)|Other|1|||
125939852|NCT05478252|453077768|FG000|Overall Study|Withdrawal by Subject|2|||
125939853|NCT05478252|453077769|FG001|Overall Study|Withdrawal by Subject|3|||
125939854|NCT05478252|453077768|FG000|Overall Study|Lost to Follow-up|4|||
125939855|NCT05478252|453077769|FG001|Overall Study|Lost to Follow-up|2|||
125939856|NCT05478252|453077768|FG000|Overall Study|Physician Decision|1|||
125939857|NCT05478252|453077769|FG001|Overall Study|Physician Decision|1|||
125939858|NCT05478252|453077768|FG000|Overall Study|Death|1|||
125939859|NCT05478252|453077769|FG001|Overall Study|Death|0|||
125939860|NCT07114198|453077774|FG000|Overall Study|Protocol Violation|1|||
125939861|NCT07114198|453077775|FG001|Overall Study|Protocol Violation|1|||
125939862|NCT01859494|453079357|FG000|Overall Study|Adverse Event|1|||
125939863|NCT02389998|453079358|FG000|Overall Study|car accident|1|||
125939864|NCT02389998|453079359|FG001|Overall Study|car accident|0|||
125939865|NCT05089682|453079360|FG000|Overall Study|Withdrawal by Subject|2|||
125939866|NCT01996826|453079363|FG000|Overall Study|Lost to Follow-up|6|||
125939867|NCT01996826|453079364|FG001|Overall Study|Lost to Follow-up|2|||
125939868|NCT01996826|453079363|FG000|Overall Study|Physician Decision|1|||
125939869|NCT01996826|453079364|FG001|Overall Study|Physician Decision|1|||
125939870|NCT01514760|453079365|FG000|Overall Study|Lost to Follow-up|2|||
125939871|NCT02092662|453079366|FG000|Overall Study|Lost to Follow-up|13|||
125939872|NCT02092662|453079367|FG001|Overall Study|Lost to Follow-up|0|||
125939873|NCT03329690|453079369|FG000|Overall Study|Progressive disease per RECIST|85|||
125939874|NCT03329690|453079370|FG001|Overall Study|Progressive disease per RECIST|44|||
125939875|NCT03329690|453079371|FG002|Overall Study|Progressive disease per RECIST|6|||
125939876|NCT03329690|453079372|FG003|Overall Study|Progressive disease per RECIST|16|||
125939877|NCT03329690|453079373|FG004|Overall Study|Progressive disease per RECIST|20|||
125939878|NCT03329690|453079369|FG000|Overall Study|Clinical progression|7|||
125939879|NCT03329690|453079370|FG001|Overall Study|Clinical progression|4|||
125939880|NCT03329690|453079371|FG002|Overall Study|Clinical progression|1|||
125939881|NCT03329690|453079372|FG003|Overall Study|Clinical progression|1|||
125939882|NCT03329690|453079373|FG004|Overall Study|Clinical progression|1|||
125939883|NCT03329690|453079369|FG000|Overall Study|Adverse Event|22|||
125939884|NCT03329690|453079370|FG001|Overall Study|Adverse Event|4|||
125939885|NCT03329690|453079371|FG002|Overall Study|Adverse Event|0|||
125939886|NCT03329690|453079372|FG003|Overall Study|Adverse Event|1|||
125939887|NCT03329690|453079373|FG004|Overall Study|Adverse Event|2|||
125939888|NCT03329690|453079369|FG000|Overall Study|Death|2|||
125939889|NCT03329690|453079370|FG001|Overall Study|Death|0|||
125939890|NCT03329690|453079371|FG002|Overall Study|Death|0|||
125939891|NCT03329690|453079372|FG003|Overall Study|Death|1|||
125939892|NCT03329690|453079373|FG004|Overall Study|Death|0|||
125939893|NCT03329690|453079369|FG000|Overall Study|Withdrawal by Subject|2|||
125939894|NCT03329690|453079370|FG001|Overall Study|Withdrawal by Subject|3|||
125939895|NCT03329690|453079371|FG002|Overall Study|Withdrawal by Subject|0|||
125939896|NCT03329690|453079372|FG003|Overall Study|Withdrawal by Subject|1|||
125939897|NCT03329690|453079373|FG004|Overall Study|Withdrawal by Subject|0|||
125939898|NCT03329690|453079369|FG000|Overall Study|Physician Decision|1|||
125939899|NCT03329690|453079370|FG001|Overall Study|Physician Decision|0|||
125939900|NCT03329690|453079371|FG002|Overall Study|Physician Decision|0|||
125939901|NCT03329690|453079372|FG003|Overall Study|Physician Decision|0|||
125939902|NCT03329690|453079373|FG004|Overall Study|Physician Decision|1|||
125939903|NCT03329690|453079369|FG000|Overall Study|Miscellaneous|6|||
125939904|NCT03329690|453079370|FG001|Overall Study|Miscellaneous|0|||
125939905|NCT03329690|453079371|FG002|Overall Study|Miscellaneous|0|||
125939906|NCT03329690|453079372|FG003|Overall Study|Miscellaneous|0|||
125939907|NCT03329690|453079373|FG004|Overall Study|Miscellaneous|0|||
125939908|NCT03329690|453079369|FG000|Overall Study|Did not receive treatment|1|||
125939909|NCT03329690|453079370|FG001|Overall Study|Did not receive treatment|0|||
125939910|NCT03329690|453079371|FG002|Overall Study|Did not receive treatment|0|||
125939911|NCT03329690|453079372|FG003|Overall Study|Did not receive treatment|1|||
125939912|NCT03329690|453079373|FG004|Overall Study|Did not receive treatment|0|||
125939913|NCT02418468|453079375|FG000|Overall Study|Adverse Event|1|||
125939914|NCT02418468|453079376|FG001|Overall Study|Adverse Event|0|||
125939915|NCT02418468|453079375|FG000|Overall Study|Withdrawal of informed consent|1|||
125939916|NCT02418468|453079376|FG001|Overall Study|Withdrawal of informed consent|1|||
125939917|NCT02914769|453079377|FG000|Overall Study|Protocol Violation|3|||
125939918|NCT02914769|453079378|FG001|Overall Study|Protocol Violation|2|||
125939919|NCT02914769|453079377|FG000|Overall Study|Withdrawal by Subject|0|||
125939920|NCT02914769|453079378|FG001|Overall Study|Withdrawal by Subject|1|||
125939921|NCT02337907|453079379|FG000|Overall Study|Other than listed|1|||
125939922|NCT02337907|453079380|FG001|Overall Study|Other than listed|0|||
125939923|NCT02337907|453079381|FG002|Overall Study|Other than listed|0|||
125939924|NCT02337907|453079382|FG003|Overall Study|Other than listed|1|||
125939925|NCT02337907|453079383|FG004|Overall Study|Other than listed|1|||
125939926|NCT02337907|453079384|FG005|Overall Study|Other than listed|0|||
125939927|NCT02337907|453079379|FG000|Overall Study|Withdrawal by Subject|2|||
125939928|NCT02337907|453079380|FG001|Overall Study|Withdrawal by Subject|3|||
125939929|NCT02337907|453079381|FG002|Overall Study|Withdrawal by Subject|0|||
125939930|NCT02337907|453079382|FG003|Overall Study|Withdrawal by Subject|2|||
125939931|NCT02337907|453079383|FG004|Overall Study|Withdrawal by Subject|5|||
125939932|NCT02337907|453079384|FG005|Overall Study|Withdrawal by Subject|0|||
125939933|NCT02337907|453079379|FG000|Overall Study|Lost to Follow-up|0|||
125939934|NCT02337907|453079380|FG001|Overall Study|Lost to Follow-up|0|||
125939935|NCT02337907|453079381|FG002|Overall Study|Lost to Follow-up|0|||
125939936|NCT02337907|453079382|FG003|Overall Study|Lost to Follow-up|0|||
125939937|NCT02337907|453079383|FG004|Overall Study|Lost to Follow-up|0|||
125939938|NCT02337907|453079384|FG005|Overall Study|Lost to Follow-up|1|||
125939939|NCT02337907|453079379|FG000|Overall Study|Adverse Event|1|||
125939940|NCT02337907|453079380|FG001|Overall Study|Adverse Event|1|||
125939941|NCT02337907|453079381|FG002|Overall Study|Adverse Event|1|||
125939942|NCT02337907|453079382|FG003|Overall Study|Adverse Event|1|||
125939943|NCT02337907|453079383|FG004|Overall Study|Adverse Event|4|||
125939944|NCT02337907|453079384|FG005|Overall Study|Adverse Event|0|||
125939945|NCT01592344|453079388|FG000|Overall Study|Adverse Event|1|||
125939946|NCT01592344|453079389|FG001|Overall Study|Adverse Event|1|||
125939947|NCT01592344|453079388|FG000|Overall Study|Lack of Efficacy|1|||
125939948|NCT01592344|453079389|FG001|Overall Study|Lack of Efficacy|0|||
125939949|NCT01592344|453079388|FG000|Overall Study|not available at primary outcome visit|2|||
125939950|NCT01592344|453079389|FG001|Overall Study|not available at primary outcome visit|4|||
125939951|NCT00099437|453079391|FG000|Overall Study|Lost to Follow-up|30|||
125939952|NCT00099437|453079392|FG001|Overall Study|Lost to Follow-up|33|||
125939953|NCT00099437|453079391|FG000|Overall Study|Death|293|||
125939954|NCT00099437|453079392|FG001|Overall Study|Death|261|||
125939955|NCT00099437|453079391|FG000|Overall Study|Withdrawal by Subject|6|||
125939956|NCT00099437|453079392|FG001|Overall Study|Withdrawal by Subject|10|||
125939957|NCT00099437|453079391|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
125939958|NCT00099437|453079392|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
125939959|NCT02488681|453079395|FG000|Overall Study|Implant unsuccessful|7|||
125939960|NCT05413369|453079396|FG000|Overall Study|Adverse Event|1|||
125939961|NCT05413369|453079397|FG001|Overall Study|Adverse Event|1|||
125939962|NCT05413369|453079396|FG000|Overall Study|Withdrawal by Subject|13|||
125939963|NCT05413369|453079397|FG001|Overall Study|Withdrawal by Subject|4|||
125939964|NCT05413369|453079396|FG000|Overall Study|Non-compliance with study schedule|2|||
125939965|NCT05413369|453079397|FG001|Overall Study|Non-compliance with study schedule|1|||
125939966|NCT05413369|453079396|FG000|Overall Study|Other|1|||
125939967|NCT05413369|453079397|FG001|Overall Study|Other|1|||
125939968|NCT00720057|453079398|FG000|Overall Study|Lost to Follow-up|0|||
125939969|NCT00720057|453079399|FG001|Overall Study|Lost to Follow-up|2|||
125939970|NCT00720057|453079398|FG000|Overall Study|Protocol Violation|1|||
125939971|NCT00720057|453079399|FG001|Overall Study|Protocol Violation|0|||
125939972|NCT00720057|453079398|FG000|Overall Study|Withdrawal by Subject|0|||
125939973|NCT00720057|453079399|FG001|Overall Study|Withdrawal by Subject|1|||
125939974|NCT04120974|453079403|FG000|Overall Study|Death|1|||
125939975|NCT04120974|453079403|FG000|Overall Study|Physician Decision|1|||
125939976|NCT04120974|453079403|FG000|Overall Study|Lost to Follow-up|6|||
125939977|NCT04256785|453079404|FG000|Overall Study|Adverse Event|8|||
125939978|NCT04256785|453079405|FG001|Overall Study|Adverse Event|6|||
125939979|NCT04256785|453079404|FG000|Overall Study|Lack of Efficacy|3|||
125939980|NCT04256785|453079405|FG001|Overall Study|Lack of Efficacy|4|||
125939981|NCT04256785|453079404|FG000|Overall Study|Lost to Follow-up|7|||
125939982|NCT04256785|453079405|FG001|Overall Study|Lost to Follow-up|7|||
125939983|NCT04256785|453079404|FG000|Overall Study|Protocol Violation|1|||
125939984|NCT04256785|453079405|FG001|Overall Study|Protocol Violation|0|||
125939985|NCT04256785|453079404|FG000|Overall Study|Withdrawal by Subject|4|||
125939986|NCT04256785|453079405|FG001|Overall Study|Withdrawal by Subject|1|||
125939987|NCT04256785|453079404|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
125939988|NCT04256785|453079405|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
125939989|NCT00391274|453079406|FG000|Overall Study|Death Due to Study Disease|55|||
125939990|NCT00391274|453079407|FG001|Overall Study|Death Due to Study Disease|45|||
125939991|NCT00391274|453079406|FG000|Overall Study|Lost to Follow-up|0|||
125939992|NCT00391274|453079407|FG001|Overall Study|Lost to Follow-up|3|||
125939993|NCT00391274|453079406|FG000|Overall Study|Physician Decision|4|||
125939994|NCT00391274|453079407|FG001|Overall Study|Physician Decision|2|||
125939995|NCT00391274|453079406|FG000|Overall Study|Withdrawal by Subject|0|||
125939996|NCT00391274|453079407|FG001|Overall Study|Withdrawal by Subject|3|||
125939997|NCT00391274|453079406|FG000|Overall Study|Death Due to Adverse Event|1|||
125939998|NCT00391274|453079407|FG001|Overall Study|Death Due to Adverse Event|3|||
125939999|NCT00391274|453079406|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
126066718|NCT02661490|453536949|FG004|Overall Study|Death|0|||
125940000|NCT00391274|453079407|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
125940001|NCT00391274|453079406|FG000|Overall Study|Death Not Study Related|0|||
125940002|NCT00391274|453079407|FG001|Overall Study|Death Not Study Related|1|||
125940003|NCT03447990|453079409|FG000|Overall Study|Withdrawal by Subject|0|||
125940004|NCT03447990|453079410|FG001|Overall Study|Withdrawal by Subject|0|||
125940005|NCT03447990|453079411|FG002|Overall Study|Withdrawal by Subject|0|||
125940006|NCT03447990|453079412|FG003|Overall Study|Withdrawal by Subject|0|||
125940007|NCT03447990|453079413|FG004|Overall Study|Withdrawal by Subject|0|||
125940008|NCT03447990|453079414|FG005|Overall Study|Withdrawal by Subject|0|||
125940009|NCT03447990|453079415|FG006|Overall Study|Withdrawal by Subject|1|||
125940010|NCT03559257|453079416|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
126066719|NCT02661490|453536945|FG000|Overall Study|Reason not Specified|0|||
125940011|NCT03559257|453079417|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
125940012|NCT03559257|453079416|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125940013|NCT03559257|453079417|FG001|Double Blind Treatment Period|Protocol Violation|4|||
125940014|NCT03559257|453079416|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
125940015|NCT03559257|453079417|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
125940016|NCT03559257|453079416|FG000|Double Blind Treatment Period|Adverse Event|0|||
125940017|NCT03559257|453079417|FG001|Double Blind Treatment Period|Adverse Event|1|||
125940018|NCT03559257|453079416|FG000|Double Blind Treatment Period|Screen Failure|0|||
125940019|NCT03559257|453079417|FG001|Double Blind Treatment Period|Screen Failure|1|||
125940020|NCT03559257|453079416|FG000|Open-label Treatment Period|Adverse Event|1|||
125940021|NCT03559257|453079417|FG001|Open-label Treatment Period|Adverse Event|4|||
125940022|NCT03559257|453079416|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
125940023|NCT03559257|453079417|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
125940024|NCT03559257|453079416|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
125940025|NCT03559257|453079417|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125940026|NCT03559257|453079416|FG000|Open-label Treatment Period|Protocol Violation|2|||
125940027|NCT03559257|453079417|FG001|Open-label Treatment Period|Protocol Violation|0|||
125940028|NCT03559257|453079416|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
125940029|NCT03559257|453079417|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
125940030|NCT03559257|453079416|FG000|Open-label Treatment Period|Physician Decision|0|||
125940031|NCT03559257|453079417|FG001|Open-label Treatment Period|Physician Decision|1|||
125940032|NCT03630120|453079418|FG000|Overall Study|Disease progression|0|||
125940033|NCT03630120|453079419|FG001|Overall Study|Disease progression|1|||
125940034|NCT03630120|453079420|FG002|Overall Study|Disease progression|1|||
125940035|NCT03630120|453079421|FG003|Overall Study|Disease progression|1|||
125940036|NCT01387347|453079422|FG000|Overall Study|Lost to Follow-up|2|||
125940037|NCT01387347|453079423|FG001|Overall Study|Lost to Follow-up|1|||
125940038|NCT01519960|453079424|FG000|Overall Study|Withdrawal from the study|26|||
125940039|NCT01519960|453079425|FG001|Overall Study|Withdrawal from the study|22|||
125940040|NCT01519960|453079426|FG002|Overall Study|Withdrawal from the study|5|||
125940041|NCT00238121|453079429|FG000|Overall Study|Withdrawal by Subject|1|||
125940042|NCT00238121|453079430|FG001|Overall Study|Withdrawal by Subject|1|||
125940043|NCT00238121|453079429|FG000|Overall Study|Adverse Event|2|||
125940044|NCT00238121|453079430|FG001|Overall Study|Adverse Event|1|||
125940045|NCT01675128|453079435|FG000|Overall Study|Disease progression on study|1|||
125940046|NCT01675128|453079436|FG001|Overall Study|Disease progression on study|1|||
125940047|NCT01675128|453079437|FG002|Overall Study|Disease progression on study|1|||
125940048|NCT01675128|453079435|FG000|Overall Study|Refused further treatment|1|||
125940049|NCT01675128|453079436|FG001|Overall Study|Refused further treatment|0|||
125940050|NCT01675128|453079437|FG002|Overall Study|Refused further treatment|0|||
125940051|NCT01675128|453079435|FG000|Overall Study|Pulmonary complication; off study|0|||
125940052|NCT01675128|453079436|FG001|Overall Study|Pulmonary complication; off study|1|||
125940053|NCT01675128|453079437|FG002|Overall Study|Pulmonary complication; off study|0|||
125940054|NCT00832585|453079446|FG000|Overall Study|Withdrawal by Subject|1|||
125940055|NCT00832585|453079446|FG000|Overall Study|Lost to Follow-up|1|||
125940056|NCT01374087|453079448|FG000|Overall Study|Adverse Event|1|||
125940057|NCT01374087|453079449|FG001|Overall Study|Adverse Event|0|||
125940058|NCT01374087|453079448|FG000|Overall Study|Disease progression|2|||
125940059|NCT01374087|453079449|FG001|Overall Study|Disease progression|2|||
125940060|NCT01374087|453079448|FG000|Overall Study|Study discontinued|13|||
125940061|NCT01374087|453079449|FG001|Overall Study|Study discontinued|13|||
125940062|NCT03526458|453079450|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
125940063|NCT03526458|453079451|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
125940064|NCT03526458|453079450|FG000|Overall Study|Stone passed, surgery cancelled|2|||
125940065|NCT03526458|453079451|FG001|Overall Study|Stone passed, surgery cancelled|1|||
125940066|NCT03526458|453079450|FG000|Overall Study|Withdrawal by Subject|1|||
125940067|NCT03526458|453079451|FG001|Overall Study|Withdrawal by Subject|0|||
125940068|NCT03526458|453079450|FG000|Overall Study|Physician Decision|2|||
125940069|NCT03526458|453079451|FG001|Overall Study|Physician Decision|1|||
125940070|NCT03526458|453079450|FG000|Overall Study|Lack of equipment|1|||
125940071|NCT03526458|453079451|FG001|Overall Study|Lack of equipment|1|||
125940072|NCT04170348|453079452|FG000|Overall Study|Lost to Follow-up|2|||
126114282|NCT01756040|453713770|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
125940073|NCT04170348|453079453|FG001|Overall Study|Lost to Follow-up|2|||
125940074|NCT04170348|453079452|FG000|Overall Study|Withdrawal by Subject|1|||
125940075|NCT04170348|453079453|FG001|Overall Study|Withdrawal by Subject|5|||
125940076|NCT04170348|453079452|FG000|Overall Study|Non-adherence|1|||
125940077|NCT04170348|453079453|FG001|Overall Study|Non-adherence|1|||
125940078|NCT04170348|453079452|FG000|Overall Study|Adverse Event|1|||
125940079|NCT04170348|453079453|FG001|Overall Study|Adverse Event|0|||
125940080|NCT01082965|453079454|FG000|Overall Study|Protocol Violation|0|||
125940081|NCT01082965|453079455|FG001|Overall Study|Protocol Violation|1|||
125940082|NCT01082965|453079454|FG000|Overall Study|Other|1|||
125940083|NCT01082965|453079455|FG001|Overall Study|Other|1|||
125940084|NCT02587065|453079456|FG000|Overall Study|Adverse Event|14|||
125940085|NCT02587065|453079456|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
125940086|NCT02587065|453079456|FG000|Overall Study|Non-adherence to the Protocol|3|||
125940087|NCT02587065|453079456|FG000|Overall Study|Discontinuation of Study Medication|2|||
125940088|NCT02587065|453079456|FG000|Overall Study|Reason not Specified|3|||
125940089|NCT00445965|453079458|FG000|Overall Study|Adverse Event|2|||
125940090|NCT00445965|453079458|FG000|Overall Study|Physician Decision|1|||
125940091|NCT00445965|453079458|FG000|Overall Study|Enrolled but not treated|1|||
125940092|NCT00445965|453079458|FG000|Overall Study|Removed due to progressive disease|29|||
125940093|NCT05104567|453079459|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125940094|NCT05104567|453079460|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
125940095|NCT05104567|453079461|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125940096|NCT05104567|453079462|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125940097|NCT05104567|453079463|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125940098|NCT05104567|453079464|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125940099|NCT05104567|453079465|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125940100|NCT05104567|453079459|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
125940101|NCT05104567|453079460|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
125940102|NCT05104567|453079461|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
125940103|NCT05104567|453079462|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
125940104|NCT05104567|453079463|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
125940105|NCT05104567|453079464|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
125940106|NCT05104567|453079465|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
125940107|NCT05104567|453079459|FG000|Overall Study|Progressive disease|3|||
125940108|NCT05104567|453079460|FG001|Overall Study|Progressive disease|13|||
125940109|NCT05104567|453079461|FG002|Overall Study|Progressive disease|13|||
125940110|NCT05104567|453079462|FG003|Overall Study|Progressive disease|17|||
125940111|NCT05104567|453079463|FG004|Overall Study|Progressive disease|17|||
125940112|NCT05104567|453079464|FG005|Overall Study|Progressive disease|28|||
125940113|NCT05104567|453079465|FG006|Overall Study|Progressive disease|24|||
125940114|NCT05104567|453079459|FG000|Overall Study|Withdrawal by Subject|1|||
125940115|NCT05104567|453079460|FG001|Overall Study|Withdrawal by Subject|1|||
125940116|NCT05104567|453079461|FG002|Overall Study|Withdrawal by Subject|2|||
125940117|NCT05104567|453079462|FG003|Overall Study|Withdrawal by Subject|0|||
125940118|NCT05104567|453079463|FG004|Overall Study|Withdrawal by Subject|0|||
125940119|NCT05104567|453079464|FG005|Overall Study|Withdrawal by Subject|0|||
125940120|NCT05104567|453079465|FG006|Overall Study|Withdrawal by Subject|0|||
125940121|NCT05104567|453079459|FG000|Overall Study|Other|1|||
125940122|NCT05104567|453079460|FG001|Overall Study|Other|1|||
125940123|NCT05104567|453079461|FG002|Overall Study|Other|1|||
125940124|NCT05104567|453079462|FG003|Overall Study|Other|0|||
125940125|NCT05104567|453079463|FG004|Overall Study|Other|0|||
125940126|NCT05104567|453079464|FG005|Overall Study|Other|0|||
125940127|NCT05104567|453079465|FG006|Overall Study|Other|0|||
125940128|NCT01602380|453079478|FG000|Overall Study|Death|147|||
125940129|NCT01602380|453079479|FG001|Overall Study|Death|145|||
125940130|NCT01602380|453079478|FG000|Overall Study|Withdrawal by Subject|39|||
125940131|NCT01602380|453079479|FG001|Overall Study|Withdrawal by Subject|41|||
125940132|NCT01602380|453079478|FG000|Overall Study|Lost to Follow-up|15|||
125940133|NCT01602380|453079479|FG001|Overall Study|Lost to Follow-up|12|||
125940134|NCT01602380|453079478|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125940135|NCT01602380|453079479|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
125940136|NCT01602380|453079478|FG000|Overall Study|Other|2|||
125940137|NCT01602380|453079479|FG001|Overall Study|Other|0|||
125940138|NCT02446990|453079480|FG000|Overall Study|Death|485|||
125940139|NCT02446990|453079481|FG001|Overall Study|Death|458|||
125940140|NCT02446990|453079480|FG000|Overall Study|Lost to Follow-up|3|||
125940141|NCT02446990|453079481|FG001|Overall Study|Lost to Follow-up|1|||
125940142|NCT02446990|453079480|FG000|Overall Study|Physician Decision|1|||
125940143|NCT02446990|453079481|FG001|Overall Study|Physician Decision|0|||
125940144|NCT02446990|453079480|FG000|Overall Study|Withdrawal by Subject|231|||
125940145|NCT02446990|453079481|FG001|Overall Study|Withdrawal by Subject|199|||
125940146|NCT02921776|453079482|FG000|Overall Study|patient deterioration, fatigue|2|||
125940147|NCT02921776|453079483|FG001|Overall Study|patient deterioration, fatigue|6|||
125940148|NCT02921776|453079484|FG002|Overall Study|patient deterioration, fatigue|0|||
125940149|NCT02921776|453079485|FG003|Overall Study|patient deterioration, fatigue|0|||
125940150|NCT02921776|453079486|FG004|Overall Study|patient deterioration, fatigue|0|||
125940151|NCT02921776|453079487|FG005|Overall Study|patient deterioration, fatigue|0|||
125940152|NCT02921776|453079488|FG006|Overall Study|patient deterioration, fatigue|0|||
125940153|NCT02921776|453079489|FG007|Overall Study|patient deterioration, fatigue|0|||
125940154|NCT02921776|453079482|FG000|Overall Study|Withdrawal by Subject|0|||
125940155|NCT02921776|453079483|FG001|Overall Study|Withdrawal by Subject|2|||
125940156|NCT02921776|453079484|FG002|Overall Study|Withdrawal by Subject|0|||
125940157|NCT02921776|453079485|FG003|Overall Study|Withdrawal by Subject|1|||
125940158|NCT02921776|453079486|FG004|Overall Study|Withdrawal by Subject|1|||
125940159|NCT02921776|453079487|FG005|Overall Study|Withdrawal by Subject|0|||
125940160|NCT02921776|453079488|FG006|Overall Study|Withdrawal by Subject|8|||
125940161|NCT02921776|453079489|FG007|Overall Study|Withdrawal by Subject|1|||
125940162|NCT02921776|453079482|FG000|Overall Study|Death|0|||
125940163|NCT02921776|453079483|FG001|Overall Study|Death|0|||
125940164|NCT02921776|453079484|FG002|Overall Study|Death|0|||
125940165|NCT02921776|453079485|FG003|Overall Study|Death|2|||
125940166|NCT02921776|453079486|FG004|Overall Study|Death|0|||
125940167|NCT02921776|453079487|FG005|Overall Study|Death|0|||
125940168|NCT02921776|453079488|FG006|Overall Study|Death|0|||
125940169|NCT02921776|453079489|FG007|Overall Study|Death|0|||
125940170|NCT02921776|453079482|FG000|Overall Study|extubation or early discharge|0|||
125940171|NCT02921776|453079483|FG001|Overall Study|extubation or early discharge|0|||
125940172|NCT02921776|453079484|FG002|Overall Study|extubation or early discharge|0|||
125940173|NCT02921776|453079485|FG003|Overall Study|extubation or early discharge|5|||
125940174|NCT02921776|453079486|FG004|Overall Study|extubation or early discharge|5|||
125940175|NCT02921776|453079487|FG005|Overall Study|extubation or early discharge|0|||
125940176|NCT02921776|453079488|FG006|Overall Study|extubation or early discharge|0|||
125940177|NCT02921776|453079489|FG007|Overall Study|extubation or early discharge|0|||
125940178|NCT02921776|453079482|FG000|Overall Study|Lost to Follow-up|0|||
125940179|NCT02921776|453079483|FG001|Overall Study|Lost to Follow-up|0|||
125940180|NCT02921776|453079484|FG002|Overall Study|Lost to Follow-up|0|||
125940181|NCT02921776|453079485|FG003|Overall Study|Lost to Follow-up|0|||
125940182|NCT02921776|453079486|FG004|Overall Study|Lost to Follow-up|0|||
125940183|NCT02921776|453079487|FG005|Overall Study|Lost to Follow-up|2|||
125940184|NCT02921776|453079488|FG006|Overall Study|Lost to Follow-up|3|||
125940185|NCT02921776|453079489|FG007|Overall Study|Lost to Follow-up|6|||
125940186|NCT04199117|453079490|FG000|Overall Study|Withdrawal by Subject|3|||
125940187|NCT04199117|453079491|FG001|Overall Study|Withdrawal by Subject|0|||
125940188|NCT04199117|453079492|FG002|Overall Study|Withdrawal by Subject|0|||
125940189|NCT04199117|453079493|FG003|Overall Study|Withdrawal by Subject|1|||
125940190|NCT04199117|453079494|FG004|Overall Study|Withdrawal by Subject|1|||
125940191|NCT04199117|453079495|FG005|Overall Study|Withdrawal by Subject|0|||
125940192|NCT04199117|453079496|FG006|Overall Study|Withdrawal by Subject|0|||
125940193|NCT04199117|453079497|FG007|Overall Study|Withdrawal by Subject|2|||
125940194|NCT04199117|453079498|FG008|Overall Study|Withdrawal by Subject|0|||
125940195|NCT04199117|453079499|FG009|Overall Study|Withdrawal by Subject|0|||
125940196|NCT04199117|453079500|FG010|Overall Study|Withdrawal by Subject|1|||
125940197|NCT04199117|453079501|FG011|Overall Study|Withdrawal by Subject|1|||
125940198|NCT04199117|453079502|FG012|Overall Study|Withdrawal by Subject|2|||
125940199|NCT04199117|453079503|FG013|Overall Study|Withdrawal by Subject|1|||
125940200|NCT04199117|453079504|FG014|Overall Study|Withdrawal by Subject|1|||
125940201|NCT04199117|453079505|FG015|Overall Study|Withdrawal by Subject|1|||
125940202|NCT04199117|453079490|FG000|Overall Study|Death|1|||
125940203|NCT04199117|453079491|FG001|Overall Study|Death|1|||
125940204|NCT04199117|453079492|FG002|Overall Study|Death|0|||
125940205|NCT04199117|453079493|FG003|Overall Study|Death|0|||
125940206|NCT04199117|453079494|FG004|Overall Study|Death|0|||
125940207|NCT04199117|453079495|FG005|Overall Study|Death|0|||
125940208|NCT04199117|453079496|FG006|Overall Study|Death|0|||
125940209|NCT04199117|453079497|FG007|Overall Study|Death|0|||
125940210|NCT04199117|453079498|FG008|Overall Study|Death|0|||
125940211|NCT04199117|453079499|FG009|Overall Study|Death|0|||
125940212|NCT04199117|453079500|FG010|Overall Study|Death|0|||
125940213|NCT04199117|453079501|FG011|Overall Study|Death|1|||
125940214|NCT04199117|453079502|FG012|Overall Study|Death|0|||
125940215|NCT04199117|453079503|FG013|Overall Study|Death|1|||
125940216|NCT04199117|453079504|FG014|Overall Study|Death|0|||
125940217|NCT04199117|453079505|FG015|Overall Study|Death|0|||
125940218|NCT04199117|453079490|FG000|Overall Study|Withdrawal by PI|0|||
125940219|NCT04199117|453079491|FG001|Overall Study|Withdrawal by PI|0|||
125940220|NCT04199117|453079492|FG002|Overall Study|Withdrawal by PI|0|||
125940221|NCT04199117|453079493|FG003|Overall Study|Withdrawal by PI|0|||
125940222|NCT04199117|453079494|FG004|Overall Study|Withdrawal by PI|0|||
125940223|NCT04199117|453079495|FG005|Overall Study|Withdrawal by PI|0|||
125940224|NCT04199117|453079496|FG006|Overall Study|Withdrawal by PI|0|||
125940225|NCT04199117|453079497|FG007|Overall Study|Withdrawal by PI|0|||
125940226|NCT04199117|453079498|FG008|Overall Study|Withdrawal by PI|0|||
125940227|NCT04199117|453079499|FG009|Overall Study|Withdrawal by PI|0|||
125940228|NCT04199117|453079500|FG010|Overall Study|Withdrawal by PI|0|||
125940229|NCT04199117|453079501|FG011|Overall Study|Withdrawal by PI|0|||
125940230|NCT04199117|453079502|FG012|Overall Study|Withdrawal by PI|1|||
125940231|NCT04199117|453079503|FG013|Overall Study|Withdrawal by PI|0|||
125940232|NCT04199117|453079504|FG014|Overall Study|Withdrawal by PI|0|||
126114283|NCT01756040|453713770|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
126114284|NCT01688466|453713771|FG000|Overall Study|Withdrawal by Subject|2|||
125940233|NCT04199117|453079505|FG015|Overall Study|Withdrawal by PI|0|||
125940234|NCT01816893|453079508|FG000|Washout Period|Withdrawal by Subject|2|||
125940235|NCT01816893|453079509|FG001|Washout Period|Withdrawal by Subject|0|||
125940236|NCT00939809|453081423|FG000|Overall Study|Adverse Event|2|||
125940237|NCT00939809|453081423|FG000|Overall Study|Death|1|||
125940238|NCT00702403|453081424|FG000|From Consent to Engraftment|Progressive leukemia|6|||
125940239|NCT00702403|453081424|FG000|From Consent to Engraftment|Critically ill|2|||
125940240|NCT00702403|453081424|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
125940241|NCT00702403|453081424|FG000|From Consent to Engraftment|Myocardial infarction|1|||
125940242|NCT00702403|453081424|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
125940243|NCT00702403|453081424|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
125940244|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
125940245|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
125940246|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Non-compliance|2|||
125940247|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
125940248|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
125940249|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Suicide|1|||
125940250|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
125940251|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
125940252|NCT00702403|453081424|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
125940253|NCT00380978|453081426|FG000|Overall Study|Refused allocated intervention|0|||
125940254|NCT00380978|453081427|FG001|Overall Study|Refused allocated intervention|6|||
125940255|NCT00380978|453081426|FG000|Overall Study|Wrong study envelope|0|||
125940256|NCT00380978|453081427|FG001|Overall Study|Wrong study envelope|2|||
125940257|NCT00380978|453081426|FG000|Overall Study|Allocation prior to analgesia request|1|||
125940258|NCT00380978|453081427|FG001|Overall Study|Allocation prior to analgesia request|2|||
125940259|NCT00380978|453081426|FG000|Overall Study|Parous patient|1|||
125940260|NCT00380978|453081427|FG001|Overall Study|Parous patient|0|||
125940261|NCT04146545|453081428|FG000|Overall Study|deemed ineligible after randomization|1|||
125940262|NCT04146545|453081429|FG001|Overall Study|deemed ineligible after randomization|0|||
125940263|NCT01729754|453081430|FG000|Part 1|Adverse Event|2|||
125940264|NCT01729754|453081431|FG001|Part 1|Adverse Event|0|||
125940265|NCT01729754|453081432|FG002|Part 1|Adverse Event|0|||
125940266|NCT01729754|453081433|FG003|Part 1|Adverse Event|1|||
125940267|NCT01729754|453081434|FG004|Part 1|Adverse Event|0|||
125940268|NCT01729754|453081435|FG005|Part 1|Adverse Event|0|||
125940269|NCT01729754|453081436|FG006|Part 1|Adverse Event|2|||
125940270|NCT01729754|453081437|FG007|Part 1|Adverse Event|0|||
125940271|NCT01729754|453081438|FG008|Part 1|Adverse Event|0|||
125940272|NCT01729754|453081439|FG009|Part 1|Adverse Event|5|||
125940273|NCT01729754|453081430|FG000|Part 1|Lack of Efficacy|1|||
125940274|NCT01729754|453081431|FG001|Part 1|Lack of Efficacy|0|||
125940275|NCT01729754|453081432|FG002|Part 1|Lack of Efficacy|0|||
125940276|NCT01729754|453081433|FG003|Part 1|Lack of Efficacy|0|||
125940277|NCT01729754|453081434|FG004|Part 1|Lack of Efficacy|0|||
125940278|NCT01729754|453081435|FG005|Part 1|Lack of Efficacy|0|||
125940279|NCT01729754|453081436|FG006|Part 1|Lack of Efficacy|2|||
125940280|NCT01729754|453081437|FG007|Part 1|Lack of Efficacy|0|||
125940281|NCT01729754|453081438|FG008|Part 1|Lack of Efficacy|0|||
125940282|NCT01729754|453081439|FG009|Part 1|Lack of Efficacy|0|||
125940283|NCT01729754|453081430|FG000|Part 1|Lost to Follow-up|1|||
125940284|NCT01729754|453081431|FG001|Part 1|Lost to Follow-up|0|||
125940285|NCT01729754|453081432|FG002|Part 1|Lost to Follow-up|0|||
125940286|NCT01729754|453081433|FG003|Part 1|Lost to Follow-up|2|||
125940287|NCT01729754|453081434|FG004|Part 1|Lost to Follow-up|0|||
125940288|NCT01729754|453081435|FG005|Part 1|Lost to Follow-up|0|||
125940289|NCT01729754|453081436|FG006|Part 1|Lost to Follow-up|3|||
125940290|NCT01729754|453081437|FG007|Part 1|Lost to Follow-up|0|||
125940291|NCT01729754|453081438|FG008|Part 1|Lost to Follow-up|0|||
125940292|NCT01729754|453081439|FG009|Part 1|Lost to Follow-up|3|||
125940293|NCT01729754|453081430|FG000|Part 1|Non-compliance with Study Drug|1|||
125940294|NCT01729754|453081431|FG001|Part 1|Non-compliance with Study Drug|0|||
125940295|NCT01729754|453081432|FG002|Part 1|Non-compliance with Study Drug|0|||
126114285|NCT01688466|453713772|FG001|Overall Study|Withdrawal by Subject|1|||
125940296|NCT01729754|453081433|FG003|Part 1|Non-compliance with Study Drug|0|||
125940297|NCT01729754|453081434|FG004|Part 1|Non-compliance with Study Drug|0|||
125940298|NCT01729754|453081435|FG005|Part 1|Non-compliance with Study Drug|0|||
125940299|NCT01729754|453081436|FG006|Part 1|Non-compliance with Study Drug|0|||
125940300|NCT01729754|453081437|FG007|Part 1|Non-compliance with Study Drug|0|||
125940301|NCT01729754|453081438|FG008|Part 1|Non-compliance with Study Drug|0|||
126114286|NCT01688466|453713771|FG000|Overall Study|Death|0|||
126114287|NCT01688466|453713772|FG001|Overall Study|Death|1|||
125940302|NCT01729754|453081439|FG009|Part 1|Non-compliance with Study Drug|0|||
125940303|NCT01729754|453081430|FG000|Part 1|Physician Decision|0|||
125940304|NCT01729754|453081431|FG001|Part 1|Physician Decision|0|||
125940305|NCT01729754|453081432|FG002|Part 1|Physician Decision|0|||
125940306|NCT01729754|453081433|FG003|Part 1|Physician Decision|0|||
125940307|NCT01729754|453081434|FG004|Part 1|Physician Decision|0|||
125940308|NCT01729754|453081435|FG005|Part 1|Physician Decision|0|||
125940309|NCT01729754|453081436|FG006|Part 1|Physician Decision|0|||
125940310|NCT01729754|453081437|FG007|Part 1|Physician Decision|0|||
125940311|NCT01729754|453081438|FG008|Part 1|Physician Decision|0|||
125940312|NCT01729754|453081439|FG009|Part 1|Physician Decision|4|||
125940313|NCT01729754|453081430|FG000|Part 1|Pregnancy|0|||
125940314|NCT01729754|453081431|FG001|Part 1|Pregnancy|0|||
125940315|NCT01729754|453081432|FG002|Part 1|Pregnancy|0|||
125940316|NCT01729754|453081433|FG003|Part 1|Pregnancy|1|||
125940317|NCT01729754|453081434|FG004|Part 1|Pregnancy|0|||
125940318|NCT01729754|453081435|FG005|Part 1|Pregnancy|0|||
125940319|NCT01729754|453081436|FG006|Part 1|Pregnancy|0|||
125940320|NCT01729754|453081437|FG007|Part 1|Pregnancy|0|||
125940321|NCT01729754|453081438|FG008|Part 1|Pregnancy|0|||
126114288|NCT01688466|453713771|FG000|Overall Study|Adverse Event|0|||
126114289|NCT01688466|453713772|FG001|Overall Study|Adverse Event|4|||
126114290|NCT01688466|453713771|FG000|Overall Study|Not evaluable|0|||
126114291|NCT01688466|453713772|FG001|Overall Study|Not evaluable|1|||
126114292|NCT03631667|453713773|FG000|Overall Study|Withdrawal by Subject|3|||
126114293|NCT00892177|453713774|FG000|Phase II|Ineligible|0|||
126114294|NCT00892177|453713775|FG001|Phase II|Ineligible|0|||
126114295|NCT00892177|453713776|FG002|Phase II|Ineligible|0|||
126114296|NCT00892177|453713777|FG003|Phase II|Ineligible|0|||
126114297|NCT00892177|453713778|FG004|Phase II|Ineligible|1|||
126114298|NCT00892177|453713779|FG005|Phase II|Ineligible|1|||
126114299|NCT00892177|453713774|FG000|Phase II|Withdrawal by Subject|0|||
126114300|NCT00892177|453713775|FG001|Phase II|Withdrawal by Subject|0|||
126114301|NCT00892177|453713776|FG002|Phase II|Withdrawal by Subject|0|||
126114302|NCT00892177|453713777|FG003|Phase II|Withdrawal by Subject|0|||
126114303|NCT00892177|453713778|FG004|Phase II|Withdrawal by Subject|4|||
126114304|NCT00892177|453713779|FG005|Phase II|Withdrawal by Subject|1|||
126114305|NCT01446016|453713780|FG000|Overall Study|Lost to Follow-up|3|||
125940322|NCT01729754|453081439|FG009|Part 1|Pregnancy|1|||
125940323|NCT01729754|453081430|FG000|Part 1|Progressive Disease|0|||
125940324|NCT01729754|453081431|FG001|Part 1|Progressive Disease|0|||
125940325|NCT01729754|453081432|FG002|Part 1|Progressive Disease|0|||
125940326|NCT01729754|453081433|FG003|Part 1|Progressive Disease|0|||
125940327|NCT01729754|453081434|FG004|Part 1|Progressive Disease|0|||
126114306|NCT01446016|453713780|FG000|Overall Study|Withdrawal by Subject|1|||
126114307|NCT01446016|453713780|FG000|Overall Study|Toxicity|3|||
126114308|NCT01087957|453713790|FG000|Overall Study|Death|2|||
126114309|NCT01087957|453713791|FG001|Overall Study|Death|2|||
126114310|NCT01087957|453713790|FG000|Overall Study|Lost to Follow-up|3|||
125940328|NCT01729754|453081435|FG005|Part 1|Progressive Disease|0|||
125940329|NCT01729754|453081436|FG006|Part 1|Progressive Disease|0|||
126066720|NCT02661490|453536946|FG001|Overall Study|Reason not Specified|0|||
126066721|NCT02661490|453536947|FG002|Overall Study|Reason not Specified|0|||
126066722|NCT02661490|453536948|FG003|Overall Study|Reason not Specified|0|||
125940330|NCT01729754|453081437|FG007|Part 1|Progressive Disease|0|||
125940331|NCT01729754|453081438|FG008|Part 1|Progressive Disease|0|||
125940332|NCT01729754|453081439|FG009|Part 1|Progressive Disease|1|||
125940333|NCT01729754|453081430|FG000|Part 1|Protocol Violation|2|||
125940334|NCT01729754|453081431|FG001|Part 1|Protocol Violation|0|||
125940335|NCT01729754|453081432|FG002|Part 1|Protocol Violation|0|||
125940336|NCT01729754|453081433|FG003|Part 1|Protocol Violation|1|||
125940337|NCT01729754|453081434|FG004|Part 1|Protocol Violation|0|||
125940338|NCT01729754|453081435|FG005|Part 1|Protocol Violation|0|||
126066723|NCT02661490|453536949|FG004|Overall Study|Reason not Specified|1|||
126066724|NCT00644332|453536950|FG000|Overall Study|Adverse Event|11|||
126066725|NCT00644332|453536950|FG000|Overall Study|Withdrawal by Subject|6|||
126066726|NCT00644332|453536950|FG000|Overall Study|Completion Status Unknown|2|||
125940339|NCT01729754|453081436|FG006|Part 1|Protocol Violation|1|||
125940340|NCT01729754|453081437|FG007|Part 1|Protocol Violation|0|||
125940341|NCT01729754|453081438|FG008|Part 1|Protocol Violation|0|||
125940342|NCT01729754|453081439|FG009|Part 1|Protocol Violation|0|||
126066727|NCT00644332|453536950|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
126114311|NCT01087957|453713791|FG001|Overall Study|Lost to Follow-up|4|||
125940343|NCT01729754|453081430|FG000|Part 1|Withdrawal by Subject|5|||
125940344|NCT01729754|453081431|FG001|Part 1|Withdrawal by Subject|0|||
125940345|NCT01729754|453081432|FG002|Part 1|Withdrawal by Subject|0|||
125940346|NCT01729754|453081433|FG003|Part 1|Withdrawal by Subject|7|||
125940347|NCT01729754|453081434|FG004|Part 1|Withdrawal by Subject|0|||
126114312|NCT01087957|453713790|FG000|Overall Study|Protocol Violation|13|||
126114313|NCT01087957|453713791|FG001|Overall Study|Protocol Violation|25|||
126114314|NCT01087957|453713790|FG000|Overall Study|Withdrawal by Subject|18|||
126114315|NCT01087957|453713791|FG001|Overall Study|Withdrawal by Subject|15|||
126114316|NCT01087957|453713790|FG000|Overall Study|Physician Decision|5|||
125940348|NCT01729754|453081435|FG005|Part 1|Withdrawal by Subject|0|||
125940349|NCT01729754|453081436|FG006|Part 1|Withdrawal by Subject|5|||
125940350|NCT01729754|453081437|FG007|Part 1|Withdrawal by Subject|0|||
125940351|NCT01729754|453081438|FG008|Part 1|Withdrawal by Subject|0|||
125940352|NCT01729754|453081439|FG009|Part 1|Withdrawal by Subject|6|||
126066728|NCT00644332|453536950|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
126066729|NCT02706834|453536954|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126114317|NCT01087957|453713791|FG001|Overall Study|Physician Decision|9|||
125940353|NCT01729754|453081430|FG000|Part 1|Other Protocol Specified Criteria|2|||
125940354|NCT01729754|453081431|FG001|Part 1|Other Protocol Specified Criteria|0|||
126114318|NCT01186939|453713792|FG000|Overall Study|Death|7|||
126114319|NCT01186939|453713792|FG000|Overall Study|Withdrawal by Subject|2|||
125940355|NCT01729754|453081432|FG002|Part 1|Other Protocol Specified Criteria|0|||
125940356|NCT01729754|453081433|FG003|Part 1|Other Protocol Specified Criteria|0|||
125940357|NCT01729754|453081434|FG004|Part 1|Other Protocol Specified Criteria|0|||
125940358|NCT01729754|453081435|FG005|Part 1|Other Protocol Specified Criteria|0|||
125940359|NCT01729754|453081436|FG006|Part 1|Other Protocol Specified Criteria|1|||
125940360|NCT01729754|453081437|FG007|Part 1|Other Protocol Specified Criteria|0|||
125940361|NCT01729754|453081438|FG008|Part 1|Other Protocol Specified Criteria|0|||
125940362|NCT01729754|453081439|FG009|Part 1|Other Protocol Specified Criteria|4|||
125940363|NCT01729754|453081430|FG000|Part 2|Adverse Event|2|||
125940364|NCT01729754|453081431|FG001|Part 2|Adverse Event|0|||
125940365|NCT01729754|453081432|FG002|Part 2|Adverse Event|0|||
125940366|NCT01729754|453081433|FG003|Part 2|Adverse Event|0|||
125940367|NCT01729754|453081434|FG004|Part 2|Adverse Event|0|||
125940368|NCT01729754|453081435|FG005|Part 2|Adverse Event|0|||
125940369|NCT01729754|453081436|FG006|Part 2|Adverse Event|0|||
125940370|NCT01729754|453081437|FG007|Part 2|Adverse Event|0|||
125940371|NCT01729754|453081438|FG008|Part 2|Adverse Event|1|||
125940372|NCT01729754|453081439|FG009|Part 2|Adverse Event|2|||
125940373|NCT01729754|453081430|FG000|Part 2|Lack of Efficacy|0|||
125940374|NCT01729754|453081431|FG001|Part 2|Lack of Efficacy|0|||
125940375|NCT01729754|453081432|FG002|Part 2|Lack of Efficacy|0|||
125940376|NCT01729754|453081433|FG003|Part 2|Lack of Efficacy|0|||
125940377|NCT01729754|453081434|FG004|Part 2|Lack of Efficacy|0|||
125940378|NCT01729754|453081435|FG005|Part 2|Lack of Efficacy|0|||
125940379|NCT01729754|453081436|FG006|Part 2|Lack of Efficacy|0|||
125940380|NCT01729754|453081437|FG007|Part 2|Lack of Efficacy|0|||
125940381|NCT01729754|453081438|FG008|Part 2|Lack of Efficacy|2|||
125940382|NCT01729754|453081439|FG009|Part 2|Lack of Efficacy|2|||
125940383|NCT01729754|453081430|FG000|Part 2|Lost to Follow-up|0|||
125940384|NCT01729754|453081431|FG001|Part 2|Lost to Follow-up|0|||
125940385|NCT01729754|453081432|FG002|Part 2|Lost to Follow-up|0|||
125940386|NCT01729754|453081433|FG003|Part 2|Lost to Follow-up|2|||
125940387|NCT01729754|453081434|FG004|Part 2|Lost to Follow-up|0|||
125940388|NCT01729754|453081435|FG005|Part 2|Lost to Follow-up|0|||
125940389|NCT01729754|453081436|FG006|Part 2|Lost to Follow-up|0|||
125940390|NCT01729754|453081437|FG007|Part 2|Lost to Follow-up|1|||
125940391|NCT01729754|453081438|FG008|Part 2|Lost to Follow-up|0|||
125940392|NCT01729754|453081439|FG009|Part 2|Lost to Follow-up|2|||
125940393|NCT01729754|453081430|FG000|Part 2|Non-Compliance with Study Drug|0|||
125940394|NCT01729754|453081431|FG001|Part 2|Non-Compliance with Study Drug|0|||
125940395|NCT01729754|453081432|FG002|Part 2|Non-Compliance with Study Drug|0|||
125940396|NCT01729754|453081433|FG003|Part 2|Non-Compliance with Study Drug|0|||
125940397|NCT01729754|453081434|FG004|Part 2|Non-Compliance with Study Drug|0|||
125940398|NCT01729754|453081435|FG005|Part 2|Non-Compliance with Study Drug|0|||
125940399|NCT01729754|453081436|FG006|Part 2|Non-Compliance with Study Drug|0|||
125940400|NCT01729754|453081437|FG007|Part 2|Non-Compliance with Study Drug|0|||
125940401|NCT01729754|453081438|FG008|Part 2|Non-Compliance with Study Drug|0|||
125940402|NCT01729754|453081439|FG009|Part 2|Non-Compliance with Study Drug|1|||
125940403|NCT01729754|453081430|FG000|Part 2|Pregnancy|0|||
125940404|NCT01729754|453081431|FG001|Part 2|Pregnancy|0|||
125940405|NCT01729754|453081432|FG002|Part 2|Pregnancy|0|||
125940406|NCT01729754|453081433|FG003|Part 2|Pregnancy|1|||
125940407|NCT01729754|453081434|FG004|Part 2|Pregnancy|0|||
125940408|NCT01729754|453081435|FG005|Part 2|Pregnancy|0|||
125940409|NCT01729754|453081436|FG006|Part 2|Pregnancy|0|||
125940410|NCT01729754|453081437|FG007|Part 2|Pregnancy|0|||
125940411|NCT01729754|453081438|FG008|Part 2|Pregnancy|0|||
125940412|NCT01729754|453081439|FG009|Part 2|Pregnancy|1|||
125940413|NCT01729754|453081430|FG000|Part 2|Withdrawal by Subject|3|||
125940414|NCT01729754|453081431|FG001|Part 2|Withdrawal by Subject|0|||
125940415|NCT01729754|453081432|FG002|Part 2|Withdrawal by Subject|0|||
125940416|NCT01729754|453081433|FG003|Part 2|Withdrawal by Subject|2|||
125940417|NCT01729754|453081434|FG004|Part 2|Withdrawal by Subject|0|||
125940418|NCT01729754|453081435|FG005|Part 2|Withdrawal by Subject|0|||
125940419|NCT01729754|453081436|FG006|Part 2|Withdrawal by Subject|0|||
125940420|NCT01729754|453081437|FG007|Part 2|Withdrawal by Subject|1|||
125940421|NCT01729754|453081438|FG008|Part 2|Withdrawal by Subject|1|||
125940422|NCT01729754|453081439|FG009|Part 2|Withdrawal by Subject|4|||
125940423|NCT01729754|453081430|FG000|Part 2|Other Protocol Specified Criteria|1|||
125940424|NCT01729754|453081431|FG001|Part 2|Other Protocol Specified Criteria|0|||
125940425|NCT01729754|453081432|FG002|Part 2|Other Protocol Specified Criteria|0|||
125940426|NCT01729754|453081433|FG003|Part 2|Other Protocol Specified Criteria|0|||
125940427|NCT01729754|453081434|FG004|Part 2|Other Protocol Specified Criteria|0|||
125940428|NCT01729754|453081435|FG005|Part 2|Other Protocol Specified Criteria|0|||
125940429|NCT01729754|453081436|FG006|Part 2|Other Protocol Specified Criteria|0|||
125940430|NCT01729754|453081437|FG007|Part 2|Other Protocol Specified Criteria|1|||
125940431|NCT01729754|453081438|FG008|Part 2|Other Protocol Specified Criteria|0|||
125940432|NCT01729754|453081439|FG009|Part 2|Other Protocol Specified Criteria|0|||
125940433|NCT01729754|453081430|FG000|Part 3|Adverse Event|0|||
125940434|NCT01729754|453081431|FG001|Part 3|Adverse Event|0|||
125940435|NCT01729754|453081432|FG002|Part 3|Adverse Event|1|||
125940436|NCT01729754|453081433|FG003|Part 3|Adverse Event|0|||
125940437|NCT01729754|453081434|FG004|Part 3|Adverse Event|0|||
125940438|NCT01729754|453081435|FG005|Part 3|Adverse Event|5|||
125940439|NCT01729754|453081436|FG006|Part 3|Adverse Event|0|||
125940440|NCT01729754|453081437|FG007|Part 3|Adverse Event|0|||
125940441|NCT01729754|453081438|FG008|Part 3|Adverse Event|0|||
125940442|NCT01729754|453081439|FG009|Part 3|Adverse Event|3|||
125940443|NCT01729754|453081430|FG000|Part 3|Death|0|||
125940444|NCT01729754|453081431|FG001|Part 3|Death|0|||
125940445|NCT01729754|453081432|FG002|Part 3|Death|0|||
125940446|NCT01729754|453081433|FG003|Part 3|Death|0|||
125940447|NCT01729754|453081434|FG004|Part 3|Death|0|||
125940448|NCT01729754|453081435|FG005|Part 3|Death|2|||
125940449|NCT01729754|453081436|FG006|Part 3|Death|0|||
125940450|NCT01729754|453081437|FG007|Part 3|Death|0|||
125940451|NCT01729754|453081438|FG008|Part 3|Death|0|||
125940452|NCT01729754|453081439|FG009|Part 3|Death|0|||
125940453|NCT01729754|453081430|FG000|Part 3|Lack of Efficacy|0|||
125940454|NCT01729754|453081431|FG001|Part 3|Lack of Efficacy|0|||
125940455|NCT01729754|453081432|FG002|Part 3|Lack of Efficacy|0|||
125940456|NCT01729754|453081433|FG003|Part 3|Lack of Efficacy|0|||
125940457|NCT01729754|453081434|FG004|Part 3|Lack of Efficacy|2|||
125940458|NCT01729754|453081435|FG005|Part 3|Lack of Efficacy|0|||
125940459|NCT01729754|453081436|FG006|Part 3|Lack of Efficacy|0|||
125940460|NCT01729754|453081437|FG007|Part 3|Lack of Efficacy|0|||
125940461|NCT01729754|453081438|FG008|Part 3|Lack of Efficacy|0|||
125940462|NCT01729754|453081439|FG009|Part 3|Lack of Efficacy|4|||
125940463|NCT01729754|453081430|FG000|Part 3|Lost to Follow-up|0|||
125940464|NCT01729754|453081431|FG001|Part 3|Lost to Follow-up|1|||
125940465|NCT01729754|453081432|FG002|Part 3|Lost to Follow-up|2|||
125940466|NCT01729754|453081433|FG003|Part 3|Lost to Follow-up|0|||
125940467|NCT01729754|453081434|FG004|Part 3|Lost to Follow-up|0|||
125940468|NCT01729754|453081435|FG005|Part 3|Lost to Follow-up|3|||
125940469|NCT01729754|453081436|FG006|Part 3|Lost to Follow-up|0|||
125940470|NCT01729754|453081437|FG007|Part 3|Lost to Follow-up|0|||
125940471|NCT01729754|453081438|FG008|Part 3|Lost to Follow-up|1|||
125940472|NCT01729754|453081439|FG009|Part 3|Lost to Follow-up|0|||
125940473|NCT01729754|453081430|FG000|Part 3|Physician Decision|0|||
126066730|NCT02706834|453536955|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125940474|NCT01729754|453081431|FG001|Part 3|Physician Decision|0|||
125940475|NCT01729754|453081432|FG002|Part 3|Physician Decision|1|||
125940476|NCT01729754|453081433|FG003|Part 3|Physician Decision|0|||
125940477|NCT01729754|453081434|FG004|Part 3|Physician Decision|0|||
125940478|NCT01729754|453081435|FG005|Part 3|Physician Decision|0|||
126066731|NCT02706834|453536956|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126066732|NCT02706834|453536957|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
126066733|NCT02706834|453536958|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
126066734|NCT02706834|453536959|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
126066735|NCT02706834|453536960|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
126066736|NCT02706834|453536961|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
126066737|NCT02706834|453536962|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
126066738|NCT02706834|453536963|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
126066739|NCT02706834|453536964|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
126066740|NCT02706834|453536954|FG000|Overall Study|Lost to Follow-up|0|||
126066741|NCT02706834|453536955|FG001|Overall Study|Lost to Follow-up|0|||
126066742|NCT02706834|453536956|FG002|Overall Study|Lost to Follow-up|1|||
126066743|NCT02706834|453536957|FG003|Overall Study|Lost to Follow-up|0|||
126066744|NCT02706834|453536958|FG004|Overall Study|Lost to Follow-up|0|||
126066745|NCT02706834|453536959|FG005|Overall Study|Lost to Follow-up|0|||
126066746|NCT02706834|453536960|FG006|Overall Study|Lost to Follow-up|0|||
126066747|NCT02706834|453536961|FG007|Overall Study|Lost to Follow-up|0|||
126066748|NCT02706834|453536962|FG008|Overall Study|Lost to Follow-up|0|||
126066749|NCT02706834|453536963|FG009|Overall Study|Lost to Follow-up|0|||
126066750|NCT02706834|453536964|FG010|Overall Study|Lost to Follow-up|0|||
126066751|NCT02706834|453536954|FG000|Overall Study|Voluntary Withdrawal|1|||
126066752|NCT02706834|453536955|FG001|Overall Study|Voluntary Withdrawal|0|||
126066753|NCT02706834|453536956|FG002|Overall Study|Voluntary Withdrawal|0|||
126066754|NCT02706834|453536957|FG003|Overall Study|Voluntary Withdrawal|0|||
126066755|NCT02706834|453536958|FG004|Overall Study|Voluntary Withdrawal|0|||
126066756|NCT02706834|453536959|FG005|Overall Study|Voluntary Withdrawal|0|||
126066757|NCT02706834|453536960|FG006|Overall Study|Voluntary Withdrawal|0|||
125940479|NCT01729754|453081436|FG006|Part 3|Physician Decision|0|||
125940480|NCT01729754|453081437|FG007|Part 3|Physician Decision|0|||
125940481|NCT01729754|453081438|FG008|Part 3|Physician Decision|0|||
125940482|NCT01729754|453081439|FG009|Part 3|Physician Decision|0|||
125940483|NCT01729754|453081430|FG000|Part 3|Withdrawal by Subject|0|||
125940484|NCT01729754|453081431|FG001|Part 3|Withdrawal by Subject|4|||
125940485|NCT01729754|453081432|FG002|Part 3|Withdrawal by Subject|1|||
125940486|NCT01729754|453081433|FG003|Part 3|Withdrawal by Subject|0|||
125940487|NCT01729754|453081434|FG004|Part 3|Withdrawal by Subject|2|||
125940488|NCT01729754|453081435|FG005|Part 3|Withdrawal by Subject|1|||
125940489|NCT01729754|453081436|FG006|Part 3|Withdrawal by Subject|0|||
125940490|NCT01729754|453081437|FG007|Part 3|Withdrawal by Subject|2|||
125940491|NCT01729754|453081438|FG008|Part 3|Withdrawal by Subject|0|||
125940492|NCT01729754|453081439|FG009|Part 3|Withdrawal by Subject|0|||
125940493|NCT01729754|453081430|FG000|Part 3|Other Protocol Specified Criteria|0|||
125940494|NCT01729754|453081431|FG001|Part 3|Other Protocol Specified Criteria|0|||
125940495|NCT01729754|453081432|FG002|Part 3|Other Protocol Specified Criteria|0|||
125940496|NCT01729754|453081433|FG003|Part 3|Other Protocol Specified Criteria|0|||
125940497|NCT01729754|453081434|FG004|Part 3|Other Protocol Specified Criteria|0|||
125940498|NCT01729754|453081435|FG005|Part 3|Other Protocol Specified Criteria|2|||
125940499|NCT01729754|453081436|FG006|Part 3|Other Protocol Specified Criteria|0|||
125940500|NCT01729754|453081437|FG007|Part 3|Other Protocol Specified Criteria|1|||
125940501|NCT01729754|453081438|FG008|Part 3|Other Protocol Specified Criteria|0|||
125940502|NCT01729754|453081439|FG009|Part 3|Other Protocol Specified Criteria|0|||
125940503|NCT00773292|453081440|FG000|Treatment 48 Weeks|Adverse Event|1|||
125940504|NCT00773292|453081440|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
125940505|NCT00542919|453081441|FG000|Overall Study|Adverse Event|1|||
125940506|NCT00542919|453081442|FG001|Overall Study|Adverse Event|5|||
125940507|NCT00542919|453081443|FG002|Overall Study|Adverse Event|1|||
125940508|NCT00542919|453081441|FG000|Overall Study|Withdrawal by Subject|1|||
125940509|NCT00542919|453081442|FG001|Overall Study|Withdrawal by Subject|0|||
125940510|NCT00542919|453081443|FG002|Overall Study|Withdrawal by Subject|3|||
125940511|NCT00542919|453081441|FG000|Overall Study|Physician Decision|2|||
125940512|NCT00542919|453081442|FG001|Overall Study|Physician Decision|2|||
125940513|NCT00542919|453081443|FG002|Overall Study|Physician Decision|1|||
125940514|NCT00542919|453081441|FG000|Overall Study|Sponsor Decision|1|||
125940515|NCT00542919|453081442|FG001|Overall Study|Sponsor Decision|0|||
125940516|NCT00542919|453081443|FG002|Overall Study|Sponsor Decision|0|||
125940517|NCT00542919|453081441|FG000|Overall Study|Lost to Follow-up|2|||
125940518|NCT00542919|453081442|FG001|Overall Study|Lost to Follow-up|0|||
125940519|NCT00542919|453081443|FG002|Overall Study|Lost to Follow-up|1|||
125940520|NCT01881230|453081449|FG000|Overall Study|Death|2|||
125940521|NCT01881230|453081450|FG001|Overall Study|Death|0|||
125940522|NCT01881230|453081451|FG002|Overall Study|Death|1|||
125940523|NCT01881230|453081449|FG000|Overall Study|Adverse Event|9|||
125940524|NCT01881230|453081450|FG001|Overall Study|Adverse Event|13|||
125940525|NCT01881230|453081451|FG002|Overall Study|Adverse Event|12|||
125940526|NCT01881230|453081449|FG000|Overall Study|Progressive Disease|31|||
125940527|NCT01881230|453081450|FG001|Overall Study|Progressive Disease|35|||
125940528|NCT01881230|453081451|FG002|Overall Study|Progressive Disease|36|||
125940529|NCT01881230|453081449|FG000|Overall Study|Symptomatic Deterioration|3|||
125940530|NCT01881230|453081450|FG001|Overall Study|Symptomatic Deterioration|3|||
125940531|NCT01881230|453081451|FG002|Overall Study|Symptomatic Deterioration|1|||
125940532|NCT01881230|453081449|FG000|Overall Study|Withdrawal by Subject|6|||
125940533|NCT01881230|453081450|FG001|Overall Study|Withdrawal by Subject|4|||
125940534|NCT01881230|453081451|FG002|Overall Study|Withdrawal by Subject|6|||
125940535|NCT01881230|453081449|FG000|Overall Study|Physician Decision|4|||
125940536|NCT01881230|453081450|FG001|Overall Study|Physician Decision|3|||
125940537|NCT01881230|453081451|FG002|Overall Study|Physician Decision|6|||
125940538|NCT01881230|453081449|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125940539|NCT01881230|453081450|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125940540|NCT01881230|453081451|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125940541|NCT01881230|453081449|FG000|Overall Study|Given Commercially Available Drug|0|||
125940542|NCT01881230|453081450|FG001|Overall Study|Given Commercially Available Drug|0|||
125940543|NCT01881230|453081451|FG002|Overall Study|Given Commercially Available Drug|2|||
125940544|NCT01881230|453081449|FG000|Overall Study|Protocol Violation|1|||
125940545|NCT01881230|453081450|FG001|Overall Study|Protocol Violation|1|||
125940546|NCT01881230|453081451|FG002|Overall Study|Protocol Violation|0|||
125940547|NCT01881230|453081449|FG000|Overall Study|Miscellaneous|3|||
125940548|NCT01881230|453081450|FG001|Overall Study|Miscellaneous|3|||
125940549|NCT01881230|453081451|FG002|Overall Study|Miscellaneous|0|||
125940550|NCT01881230|453081449|FG000|Overall Study|Untreated: Other|0|||
125940551|NCT01881230|453081450|FG001|Overall Study|Untreated: Other|0|||
125940552|NCT01881230|453081451|FG002|Overall Study|Untreated: Other|1|||
125940553|NCT01881230|453081449|FG000|Overall Study|Untreated: Death|0|||
125940554|NCT01881230|453081450|FG001|Overall Study|Untreated: Death|0|||
125940555|NCT01881230|453081451|FG002|Overall Study|Untreated: Death|1|||
125940556|NCT01881230|453081449|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
125940557|NCT01881230|453081450|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
125940558|NCT01881230|453081451|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
125940559|NCT02385266|453081452|FG000|Overall Study|Withdrawal by Subject|1|||
125940560|NCT02385266|453081453|FG001|Overall Study|Withdrawal by Subject|3|||
125940561|NCT00112502|453081454|FG000|Overall Study|Withdrawal by Subject|0|||
125940562|NCT00112502|453081455|FG001|Overall Study|Withdrawal by Subject|1|||
125940563|NCT00112502|453081456|FG002|Overall Study|Withdrawal by Subject|1|||
125940564|NCT00112502|453081457|FG003|Overall Study|Withdrawal by Subject|4|||
125940565|NCT00112502|453081458|FG004|Overall Study|Withdrawal by Subject|2|||
125940566|NCT00112502|453081459|FG005|Overall Study|Withdrawal by Subject|5|||
125940567|NCT00112502|453081460|FG006|Overall Study|Withdrawal by Subject|3|||
125940568|NCT00112502|453081461|FG007|Overall Study|Withdrawal by Subject|7|||
125940569|NCT02747420|453081462|FG000|Overall Study|Lost to Follow-up|4|||
125940570|NCT02747420|453081463|FG001|Overall Study|Lost to Follow-up|2|||
125940571|NCT02747420|453081462|FG000|Overall Study|Withdrawal by Subject|3|||
125940572|NCT02747420|453081463|FG001|Overall Study|Withdrawal by Subject|2|||
125940573|NCT03662542|453081468|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
125940574|NCT03662542|453081469|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125940575|NCT03662542|453081470|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125940576|NCT03662542|453081471|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125940577|NCT03662542|453081472|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125940578|NCT03662542|453081473|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125940579|NCT03662542|453081474|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125940580|NCT03662542|453081475|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125940581|NCT03662542|453081476|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125940582|NCT03662542|453081468|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125940583|NCT03662542|453081469|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
125940584|NCT03662542|453081470|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125940585|NCT03662542|453081471|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125940586|NCT03662542|453081472|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125940587|NCT03662542|453081473|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125940588|NCT03662542|453081474|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125940589|NCT03662542|453081475|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125940590|NCT03662542|453081476|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125940591|NCT03662542|453081468|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
125940592|NCT03662542|453081469|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
125940593|NCT03662542|453081470|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
125940594|NCT03662542|453081471|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
125940595|NCT03662542|453081472|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
125940596|NCT03662542|453081473|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
125940597|NCT03662542|453081474|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
125940598|NCT03662542|453081475|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
125940599|NCT03662542|453081476|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
125940600|NCT03662542|453081468|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
125940601|NCT03662542|453081469|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125940602|NCT03662542|453081470|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125940603|NCT03662542|453081471|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125940604|NCT03662542|453081472|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125940605|NCT03662542|453081473|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125940606|NCT03662542|453081474|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125940607|NCT03662542|453081475|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125940608|NCT03662542|453081476|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125940609|NCT03662542|453081468|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125940610|NCT03662542|453081469|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125940611|NCT03662542|453081470|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125940612|NCT03662542|453081471|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125940613|NCT03662542|453081472|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125940614|NCT03662542|453081473|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
125940615|NCT03662542|453081474|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125940616|NCT03662542|453081475|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125940617|NCT03662542|453081476|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125940618|NCT03662542|453081468|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125940619|NCT03662542|453081469|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125940620|NCT03662542|453081470|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125940621|NCT03662542|453081471|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
125940622|NCT03662542|453081472|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
125940623|NCT03662542|453081473|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125940624|NCT03662542|453081474|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125940625|NCT03662542|453081475|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125940626|NCT03662542|453081476|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125940627|NCT03662542|453081468|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125940628|NCT03662542|453081469|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125940629|NCT03662542|453081470|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125940630|NCT03662542|453081471|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
125940631|NCT03662542|453081472|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
125940632|NCT03662542|453081473|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
125940633|NCT03662542|453081474|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125940634|NCT03662542|453081475|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125940635|NCT03662542|453081476|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125940636|NCT03662542|453081468|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
126114320|NCT01186939|453713792|FG000|Overall Study|No longer receiving clinical benefit|17|||
125940637|NCT03662542|453081469|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125940638|NCT03662542|453081470|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125940639|NCT03662542|453081471|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125940640|NCT03662542|453081472|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
125940641|NCT03662542|453081473|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
125940642|NCT03662542|453081474|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125940643|NCT03662542|453081475|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125940644|NCT03662542|453081476|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125940645|NCT03662542|453081468|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125940646|NCT03662542|453081469|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125940647|NCT03662542|453081470|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125940648|NCT03662542|453081471|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125940649|NCT03662542|453081472|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125940650|NCT03662542|453081473|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
125940651|NCT03662542|453081474|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125940652|NCT03662542|453081475|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125940653|NCT03662542|453081476|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125940654|NCT03662542|453081468|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
125940655|NCT03662542|453081469|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
125940656|NCT03662542|453081470|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
125940657|NCT03662542|453081471|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
125940658|NCT03662542|453081472|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
125940659|NCT03662542|453081473|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
125940660|NCT03662542|453081474|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
125940661|NCT03662542|453081475|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
125940662|NCT03662542|453081476|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
125940663|NCT03662542|453081468|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125940664|NCT03662542|453081469|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125940665|NCT03662542|453081470|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125940666|NCT03662542|453081471|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125940667|NCT03662542|453081472|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125940668|NCT03662542|453081473|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125940669|NCT03662542|453081474|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
125940670|NCT03662542|453081475|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125940671|NCT03662542|453081476|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
125940672|NCT03662542|453081468|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125940673|NCT03662542|453081469|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125940674|NCT03662542|453081470|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125940675|NCT03662542|453081471|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125940676|NCT03662542|453081472|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125940677|NCT03662542|453081473|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125940678|NCT03662542|453081474|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
125940679|NCT03662542|453081475|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125940680|NCT03662542|453081476|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
125940681|NCT03662542|453081468|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
125940682|NCT03662542|453081469|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
125940683|NCT03662542|453081470|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
125940684|NCT03662542|453081471|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
125940685|NCT03662542|453081472|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
125940686|NCT03662542|453081473|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
125940687|NCT03662542|453081474|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
125940688|NCT03662542|453081475|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
125940689|NCT03662542|453081476|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
125940690|NCT01217060|453081478|FG000|Overall Study|Withdrawal by Subject|1|||
125940691|NCT03388138|453081481|FG000|Overall Study|Protocol Violation|1|||
125940692|NCT03388138|453081482|FG001|Overall Study|Protocol Violation|0|||
125940693|NCT01528072|453081485|FG000|Overall Study|Withdrawal by Subject|5|||
125940694|NCT01528072|453081485|FG000|Overall Study|Physician Decision|1|||
125940695|NCT01528072|453081485|FG000|Overall Study|Determined not eligible by AEAC|1|||
125940696|NCT01528072|453081485|FG000|Overall Study|Missed Visit|2|||
125940697|NCT01528072|453081485|FG000|Overall Study|Lost to Follow-up|5|||
125940698|NCT01528072|453081485|FG000|Overall Study|Explanted|2|||
125940699|NCT01528072|453081485|FG000|Overall Study|Site Closure|4|||
125940700|NCT01528072|453081485|FG000|Overall Study|Death|2|||
125940701|NCT01528072|453081485|FG000|Overall Study|Early Termination of Study|52|||
125940702|NCT02063854|453081490|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
125940703|NCT02063854|453081491|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
125940704|NCT02063854|453081492|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
125940705|NCT02063854|453081493|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
125940706|NCT02063854|453081494|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
125940707|NCT02063854|453081495|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
125940708|NCT02063854|453081496|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
125940709|NCT02063854|453081490|FG000|Overall Study|Major Protocol Deviation|0|||
125940710|NCT02063854|453081491|FG001|Overall Study|Major Protocol Deviation|0|||
125940711|NCT02063854|453081492|FG002|Overall Study|Major Protocol Deviation|3|||
125940712|NCT02063854|453081493|FG003|Overall Study|Major Protocol Deviation|0|||
125940713|NCT02063854|453081494|FG004|Overall Study|Major Protocol Deviation|0|||
125940714|NCT02063854|453081495|FG005|Overall Study|Major Protocol Deviation|0|||
125940715|NCT02063854|453081496|FG006|Overall Study|Major Protocol Deviation|0|||
125940716|NCT02063854|453081490|FG000|Overall Study|Voluntary Withdrawal|2|||
125940717|NCT02063854|453081491|FG001|Overall Study|Voluntary Withdrawal|0|||
125940718|NCT02063854|453081492|FG002|Overall Study|Voluntary Withdrawal|8|||
125940719|NCT02063854|453081493|FG003|Overall Study|Voluntary Withdrawal|1|||
125940720|NCT02063854|453081494|FG004|Overall Study|Voluntary Withdrawal|3|||
125940721|NCT02063854|453081495|FG005|Overall Study|Voluntary Withdrawal|6|||
125940722|NCT02063854|453081496|FG006|Overall Study|Voluntary Withdrawal|1|||
125940723|NCT02063854|453081490|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
125940724|NCT02063854|453081491|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
125940725|NCT02063854|453081492|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
125940726|NCT02063854|453081493|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
125940727|NCT02063854|453081494|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
125940728|NCT02063854|453081495|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
125940729|NCT02063854|453081496|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
125940730|NCT02063854|453081490|FG000|Overall Study|Reason Not Specified|1|||
125940731|NCT02063854|453081491|FG001|Overall Study|Reason Not Specified|0|||
125940732|NCT02063854|453081492|FG002|Overall Study|Reason Not Specified|0|||
125940733|NCT02063854|453081493|FG003|Overall Study|Reason Not Specified|0|||
125940734|NCT02063854|453081494|FG004|Overall Study|Reason Not Specified|0|||
125940735|NCT02063854|453081495|FG005|Overall Study|Reason Not Specified|0|||
125940736|NCT02063854|453081496|FG006|Overall Study|Reason Not Specified|0|||
125940737|NCT02063854|453081490|FG000|Overall Study|Did Not Receive Study Drug|0|||
125940738|NCT02063854|453081491|FG001|Overall Study|Did Not Receive Study Drug|0|||
125940739|NCT02063854|453081492|FG002|Overall Study|Did Not Receive Study Drug|0|||
125940740|NCT02063854|453081493|FG003|Overall Study|Did Not Receive Study Drug|0|||
125940741|NCT02063854|453081494|FG004|Overall Study|Did Not Receive Study Drug|0|||
125940742|NCT02063854|453081495|FG005|Overall Study|Did Not Receive Study Drug|1|||
125940743|NCT02063854|453081496|FG006|Overall Study|Did Not Receive Study Drug|0|||
125940744|NCT01462084|453081497|FG000|Overall Study|Withdrawal by Subject|1|||
125940745|NCT01462084|453081498|FG001|Overall Study|Withdrawal by Subject|0|||
125940746|NCT01462084|453081497|FG000|Overall Study|Protocol Violation|1|||
125940747|NCT01462084|453081498|FG001|Overall Study|Protocol Violation|1|||
125940748|NCT03538158|453081499|FG000|Overall Study|Lost to Follow-up|13|||
125940749|NCT03538158|453081500|FG001|Overall Study|Lost to Follow-up|7|||
125940750|NCT03538158|453081499|FG000|Overall Study|Withdrawal by Subject|2|||
125940751|NCT03538158|453081500|FG001|Overall Study|Withdrawal by Subject|1|||
125940752|NCT00930579|453081501|FG000|Overall Study|Withdrawal by Subject|1|||
125940753|NCT00930579|453081501|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
125940754|NCT00695396|453081502|FG000|Overall Study|Study Closed Prematurely|5|||
125940755|NCT00695396|453081503|FG001|Overall Study|Study Closed Prematurely|6|||
125940756|NCT00695396|453081504|FG002|Overall Study|Study Closed Prematurely|8|||
125940757|NCT00695396|453081502|FG000|Overall Study|Withdrawal by Subject|2|||
125940758|NCT00695396|453081503|FG001|Overall Study|Withdrawal by Subject|2|||
125940759|NCT00695396|453081504|FG002|Overall Study|Withdrawal by Subject|0|||
125940760|NCT00518323|453081506|FG000|Overall Study|Lack of Efficacy|14|||
125940761|NCT00518323|453081507|FG001|Overall Study|Lack of Efficacy|2|||
125940762|NCT00518323|453081508|FG002|Overall Study|Lack of Efficacy|4|||
125940763|NCT00518323|453081509|FG003|Overall Study|Lack of Efficacy|20|||
125940764|NCT00518323|453081506|FG000|Overall Study|Withdrawal by Subject|1|||
125940765|NCT00518323|453081507|FG001|Overall Study|Withdrawal by Subject|2|||
125940766|NCT00518323|453081508|FG002|Overall Study|Withdrawal by Subject|4|||
125940767|NCT00518323|453081509|FG003|Overall Study|Withdrawal by Subject|2|||
125940768|NCT00518323|453081506|FG000|Overall Study|Lost to Follow-up|0|||
125940769|NCT00518323|453081507|FG001|Overall Study|Lost to Follow-up|2|||
125940770|NCT00518323|453081508|FG002|Overall Study|Lost to Follow-up|1|||
125940771|NCT00518323|453081509|FG003|Overall Study|Lost to Follow-up|3|||
125940772|NCT00518323|453081506|FG000|Overall Study|Adverse Event|1|||
125940773|NCT00518323|453081507|FG001|Overall Study|Adverse Event|1|||
125940774|NCT00518323|453081508|FG002|Overall Study|Adverse Event|1|||
125940775|NCT00518323|453081509|FG003|Overall Study|Adverse Event|0|||
125940776|NCT00518323|453081506|FG000|Overall Study|Prohibited medication and others|3|||
125940777|NCT00518323|453081507|FG001|Overall Study|Prohibited medication and others|1|||
125940778|NCT00518323|453081508|FG002|Overall Study|Prohibited medication and others|1|||
125940779|NCT00518323|453081509|FG003|Overall Study|Prohibited medication and others|0|||
125940780|NCT02255981|453081510|FG000|Overall Study|Lost to Follow-up|3|||
125940781|NCT02255981|453081510|FG000|Overall Study|Withdrawal by Subject|1|||
125940782|NCT02726074|453081516|FG000|Overall Study|Withdrawal by Subject|4|||
125940783|NCT02726074|453081516|FG000|Overall Study|Adverse Event|14|||
125940784|NCT02726074|453081516|FG000|Overall Study|Protocol Violation|3|||
125940785|NCT02726074|453081516|FG000|Overall Study|Lost to Follow-up|2|||
125940786|NCT02726074|453081516|FG000|Overall Study|Others|3|||
125940787|NCT00613015|453081519|FG000|Overall Study|Lost to Follow-up|0|||
125940788|NCT00613015|453081520|FG001|Overall Study|Lost to Follow-up|1|||
125940789|NCT00613015|453081521|FG002|Overall Study|Lost to Follow-up|3|||
125940790|NCT00613015|453081522|FG003|Overall Study|Lost to Follow-up|3|||
125940791|NCT00613015|453081523|FG004|Overall Study|Lost to Follow-up|2|||
125940792|NCT00613015|453081524|FG005|Overall Study|Lost to Follow-up|3|||
125940793|NCT03338062|453081525|FG000|Overall Study|Alternative Therapy|1|||
125940794|NCT03338062|453081526|FG001|Overall Study|Alternative Therapy|0|||
125940795|NCT01170091|453081527|FG000|Overall Study|Missing efficacy evaluation|3|||
125940796|NCT01170091|453081527|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
125940797|NCT02153112|453081535|FG000|Overall Study|Adverse Event|0|||
125940798|NCT02153112|453081536|FG001|Overall Study|Adverse Event|0|||
125940799|NCT02153112|453081537|FG002|Overall Study|Adverse Event|1|||
125940800|NCT02153112|453081538|FG003|Overall Study|Adverse Event|0|||
125940801|NCT02153112|453081539|FG004|Overall Study|Adverse Event|0|||
125940802|NCT02153112|453081540|FG005|Overall Study|Adverse Event|0|||
125940803|NCT02153112|453081541|FG006|Overall Study|Adverse Event|0|||
125940804|NCT02153112|453081542|FG007|Overall Study|Adverse Event|0|||
125940805|NCT02153112|453081543|FG008|Overall Study|Adverse Event|0|||
125940806|NCT02153112|453081544|FG009|Overall Study|Adverse Event|0|||
125940807|NCT02153112|453081535|FG000|Overall Study|Lost to Follow-up|1|||
125940808|NCT02153112|453081536|FG001|Overall Study|Lost to Follow-up|1|||
125940809|NCT02153112|453081537|FG002|Overall Study|Lost to Follow-up|0|||
125940810|NCT02153112|453081538|FG003|Overall Study|Lost to Follow-up|0|||
125940811|NCT02153112|453081539|FG004|Overall Study|Lost to Follow-up|2|||
125940812|NCT02153112|453081540|FG005|Overall Study|Lost to Follow-up|1|||
125940813|NCT02153112|453081541|FG006|Overall Study|Lost to Follow-up|1|||
125940814|NCT02153112|453081542|FG007|Overall Study|Lost to Follow-up|0|||
125940815|NCT02153112|453081543|FG008|Overall Study|Lost to Follow-up|1|||
125940816|NCT02153112|453081544|FG009|Overall Study|Lost to Follow-up|1|||
125940817|NCT02153112|453081535|FG000|Overall Study|Withdrawal by Subject|3|||
125940818|NCT02153112|453081536|FG001|Overall Study|Withdrawal by Subject|1|||
125940819|NCT02153112|453081537|FG002|Overall Study|Withdrawal by Subject|2|||
125940820|NCT02153112|453081538|FG003|Overall Study|Withdrawal by Subject|2|||
125940821|NCT02153112|453081539|FG004|Overall Study|Withdrawal by Subject|1|||
125940822|NCT02153112|453081540|FG005|Overall Study|Withdrawal by Subject|1|||
125940823|NCT02153112|453081541|FG006|Overall Study|Withdrawal by Subject|7|||
125940824|NCT02153112|453081542|FG007|Overall Study|Withdrawal by Subject|2|||
125940825|NCT02153112|453081543|FG008|Overall Study|Withdrawal by Subject|13|||
125940826|NCT02153112|453081544|FG009|Overall Study|Withdrawal by Subject|12|||
125940827|NCT02153112|453081535|FG000|Overall Study|Reason not Specified|0|||
125940828|NCT02153112|453081536|FG001|Overall Study|Reason not Specified|0|||
125940829|NCT02153112|453081537|FG002|Overall Study|Reason not Specified|0|||
125940830|NCT02153112|453081538|FG003|Overall Study|Reason not Specified|0|||
125940831|NCT02153112|453081539|FG004|Overall Study|Reason not Specified|0|||
125940832|NCT02153112|453081540|FG005|Overall Study|Reason not Specified|0|||
125940833|NCT02153112|453081541|FG006|Overall Study|Reason not Specified|0|||
125940834|NCT02153112|453081542|FG007|Overall Study|Reason not Specified|0|||
125940835|NCT02153112|453081543|FG008|Overall Study|Reason not Specified|1|||
125940836|NCT02153112|453081544|FG009|Overall Study|Reason not Specified|1|||
125940837|NCT00561080|453081545|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
125940838|NCT00561080|453081546|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
126066758|NCT02706834|453536961|FG007|Overall Study|Voluntary Withdrawal|0|||
126066759|NCT02706834|453536962|FG008|Overall Study|Voluntary Withdrawal|0|||
126066760|NCT02706834|453536963|FG009|Overall Study|Voluntary Withdrawal|1|||
126066761|NCT02706834|453536964|FG010|Overall Study|Voluntary Withdrawal|0|||
126066762|NCT02706834|453536954|FG000|Overall Study|Other Reason Not Specified|1|||
126066763|NCT02706834|453536955|FG001|Overall Study|Other Reason Not Specified|0|||
125940839|NCT00561080|453081547|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
125940840|NCT00561080|453081545|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
125940841|NCT00561080|453081546|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
125940842|NCT00561080|453081547|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
125940843|NCT00561080|453081545|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
125940844|NCT00561080|453081546|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
125940845|NCT00561080|453081547|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
125940846|NCT00561080|453081545|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
125940847|NCT00561080|453081546|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
125940848|NCT00561080|453081547|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
125940849|NCT00561080|453081545|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
125940850|NCT00561080|453081546|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
125940851|NCT00561080|453081547|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
125940852|NCT00561080|453081545|FG000|Vaccination Period (up to Month 4)|Other|0|||
125940853|NCT00561080|453081546|FG001|Vaccination Period (up to Month 4)|Other|2|||
125940854|NCT00561080|453081547|FG002|Vaccination Period (up to Month 4)|Other|1|||
125940855|NCT00561080|453081545|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
125940856|NCT00561080|453081546|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
125940857|NCT00561080|453081547|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
125940858|NCT00561080|453081545|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
125940859|NCT00561080|453081546|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
125940860|NCT00561080|453081547|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
125940861|NCT00561080|453081545|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
125940862|NCT00561080|453081546|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
125940863|NCT00561080|453081547|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
125940864|NCT00561080|453081545|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
125940865|NCT00561080|453081546|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
125940866|NCT00561080|453081547|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
125940867|NCT01288287|453081548|FG000|Overall Study|Lost to Follow-up|8|||
125940868|NCT01288287|453081548|FG000|Overall Study|Withdrawal by Subject|4|||
125940869|NCT01288287|453081548|FG000|Overall Study|Lack of Efficacy|13|||
125940870|NCT01288287|453081548|FG000|Overall Study|Other Reason|13|||
125940871|NCT01288287|453081548|FG000|Overall Study|Unknown Reason|1|||
125940872|NCT01288287|453081548|FG000|Overall Study|Unknown Status|7|||
125940873|NCT03255382|453081552|FG000|Overall Study|Adverse Event|3|||
125940874|NCT03255382|453081553|FG001|Overall Study|Adverse Event|0|||
125940875|NCT03255382|453081552|FG000|Overall Study|Lost to Follow-up|2|||
125940876|NCT03255382|453081553|FG001|Overall Study|Lost to Follow-up|0|||
125940877|NCT03255382|453081552|FG000|Overall Study|Withdrawal by Subject|2|||
125940878|NCT03255382|453081553|FG001|Overall Study|Withdrawal by Subject|0|||
125940879|NCT03255382|453081552|FG000|Overall Study|Other|6|||
125940880|NCT03255382|453081553|FG001|Overall Study|Other|0|||
125940881|NCT02221284|453081554|FG000|Overall Study|Case Report Forms Uncollected|56|||
125940882|NCT02221284|453081554|FG000|Overall Study|Protocol Deviation|5|||
125940883|NCT03011307|453081559|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
125940884|NCT03011307|453081560|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
125940885|NCT03011307|453081559|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
125940886|NCT03011307|453081560|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
125940887|NCT03011307|453081559|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
125940888|NCT03011307|453081560|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
125940889|NCT00271947|453081561|FG000|Overall Study|Lost to Follow-up|1|||
125940890|NCT02466555|453081562|FG000|Overall Study|Lost to Follow-up|2|||
125940891|NCT02113956|453081566|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
125940892|NCT02113956|453081567|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
125940893|NCT02113956|453081566|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
125940894|NCT02113956|453081567|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
125940895|NCT02113956|453081566|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
125940896|NCT02113956|453081567|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
125940897|NCT01498458|453081568|FG000|Overall Study|Adverse Event|4|||
125940898|NCT01498458|453081568|FG000|Overall Study|Physician Decision|3|||
125940899|NCT02406651|453081569|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
125940900|NCT00718328|453081570|FG000|Overall Study|Lost to Follow-up|1|||
125940901|NCT00718328|453081571|FG001|Overall Study|Lost to Follow-up|0|||
125940902|NCT01064401|453081575|FG000|Overall Study|Adverse Event|47|||
125940903|NCT01064401|453081576|FG001|Overall Study|Adverse Event|56|||
125940904|NCT01064401|453081575|FG000|Overall Study|Lack of Efficacy|46|||
125940905|NCT01064401|453081576|FG001|Overall Study|Lack of Efficacy|23|||
125940906|NCT01064401|453081575|FG000|Overall Study|Lost to Follow-up|12|||
125940907|NCT01064401|453081576|FG001|Overall Study|Lost to Follow-up|9|||
125940908|NCT01064401|453081575|FG000|Overall Study|Consent Withdrawn|98|||
125940909|NCT01064401|453081576|FG001|Overall Study|Consent Withdrawn|80|||
125940910|NCT01064401|453081575|FG000|Overall Study|Investigator Decision|4|||
125940911|NCT01064401|453081576|FG001|Overall Study|Investigator Decision|6|||
125940912|NCT01064401|453081575|FG000|Overall Study|Death|4|||
125940913|NCT01064401|453081576|FG001|Overall Study|Death|0|||
125940914|NCT01064401|453081575|FG000|Overall Study|Pregnancy|4|||
125940915|NCT01064401|453081576|FG001|Overall Study|Pregnancy|7|||
125940916|NCT01064401|453081575|FG000|Overall Study|Noncompliance|7|||
125940917|NCT01064401|453081576|FG001|Overall Study|Noncompliance|8|||
125940918|NCT01064401|453081575|FG000|Overall Study|Site Closure|4|||
126066764|NCT02706834|453536956|FG002|Overall Study|Other Reason Not Specified|0|||
126066765|NCT02706834|453536957|FG003|Overall Study|Other Reason Not Specified|0|||
125940919|NCT01064401|453081576|FG001|Overall Study|Site Closure|5|||
126066766|NCT02706834|453536958|FG004|Overall Study|Other Reason Not Specified|1|||
125940920|NCT01064401|453081575|FG000|Overall Study|Other|2|||
125940921|NCT01064401|453081576|FG001|Overall Study|Other|1|||
125940922|NCT03158051|453081577|FG000|Overall Study|Lost to Follow-up|41|||
126066767|NCT02706834|453536959|FG005|Overall Study|Other Reason Not Specified|0|||
126066768|NCT02706834|453536960|FG006|Overall Study|Other Reason Not Specified|0|||
126066769|NCT02706834|453536961|FG007|Overall Study|Other Reason Not Specified|0|||
126066770|NCT02706834|453536962|FG008|Overall Study|Other Reason Not Specified|0|||
126066771|NCT02706834|453536963|FG009|Overall Study|Other Reason Not Specified|0|||
126066772|NCT02706834|453536964|FG010|Overall Study|Other Reason Not Specified|0|||
126066773|NCT00627523|453536968|FG000|Overall Study|Lack of Efficacy|1|||
126066774|NCT00627523|453536969|FG001|Overall Study|Lack of Efficacy|0|||
126066775|NCT00627523|453536968|FG000|Overall Study|Withdrawal by Subject|0|||
126066776|NCT00627523|453536969|FG001|Overall Study|Withdrawal by Subject|2|||
126066777|NCT00627523|453536968|FG000|Overall Study|Other|1|||
126066778|NCT00627523|453536969|FG001|Overall Study|Other|0|||
125940923|NCT03158051|453081578|FG001|Overall Study|Lost to Follow-up|47|||
125940924|NCT03158051|453081577|FG000|Overall Study|Physician Decision|6|||
125940925|NCT03158051|453081578|FG001|Overall Study|Physician Decision|7|||
125940926|NCT03158051|453081577|FG000|Overall Study|Withdrawal by Subject|24|||
125940927|NCT03158051|453081578|FG001|Overall Study|Withdrawal by Subject|15|||
125940928|NCT03158051|453081577|FG000|Overall Study|Death|0|||
125940929|NCT03158051|453081578|FG001|Overall Study|Death|1|||
125940930|NCT02005250|453081579|FG000|Overall Study|Lost to Follow-up|15|||
125940931|NCT02005250|453081580|FG001|Overall Study|Lost to Follow-up|5|||
125940932|NCT02588833|453081581|FG000|Part 1|Withdrawal by Subject|1|||
125940933|NCT02588833|453081582|FG001|Part 1|Withdrawal by Subject|0|||
125940934|NCT02588833|453081581|FG000|Part 2A|Physician Decision|0|||
125940935|NCT02588833|453081582|FG001|Part 2A|Physician Decision|1|||
125940936|NCT02588833|453081581|FG000|Part 2A|Withdrawal by Subject|0|||
125940937|NCT02588833|453081582|FG001|Part 2A|Withdrawal by Subject|1|||
125940938|NCT02588833|453081581|FG000|Part 2B|Adverse Event|0|||
125940939|NCT02588833|453081582|FG001|Part 2B|Adverse Event|1|||
125940940|NCT02588833|453081581|FG000|Part 2C|Adverse Event|0|||
125940941|NCT02588833|453081582|FG001|Part 2C|Adverse Event|1|||
125940942|NCT02588833|453081581|FG000|Part 2C|Withdrawal by Subject|0|||
125940943|NCT02588833|453081582|FG001|Part 2C|Withdrawal by Subject|1|||
125940944|NCT02588833|453081581|FG000|Part 3 (Safety Follow-up)|Other|0|||
125940945|NCT02588833|453081582|FG001|Part 3 (Safety Follow-up)|Other|2|||
125940946|NCT02738151|453081583|FG000|Overall Study|Randomized but not treated|4|||
125940947|NCT02738151|453081584|FG001|Overall Study|Randomized but not treated|1|||
125940948|NCT02738151|453081583|FG000|Overall Study|Adverse Event|4|||
125940949|NCT02738151|453081584|FG001|Overall Study|Adverse Event|5|||
125940950|NCT02738151|453081583|FG000|Overall Study|Hypoglycemia|0|||
125940951|NCT02738151|453081584|FG001|Overall Study|Hypoglycemia|1|||
125940952|NCT02738151|453081583|FG000|Overall Study|Poor Compliance to Protocol|4|||
125940953|NCT02738151|453081584|FG001|Overall Study|Poor Compliance to Protocol|3|||
125940954|NCT02738151|453081583|FG000|Overall Study|Other than specified above|11|||
125940955|NCT02738151|453081584|FG001|Overall Study|Other than specified above|21|||
125940956|NCT03649711|453081586|FG000|Overall Study|Adverse Event|0|||
125940957|NCT03649711|453081587|FG001|Overall Study|Adverse Event|1|||
125940958|NCT03649711|453081588|FG002|Overall Study|Adverse Event|0|||
125940959|NCT03649711|453081586|FG000|Overall Study|Kidney Transplant|1|||
125940960|NCT03649711|453081587|FG001|Overall Study|Kidney Transplant|0|||
125940961|NCT03649711|453081588|FG002|Overall Study|Kidney Transplant|0|||
125940962|NCT04007094|453081593|FG000|Overall Study|Lost to Follow-up|1|||
125940963|NCT04007094|453081594|FG001|Overall Study|Lost to Follow-up|1|||
125940964|NCT02946047|453081595|FG000|Overall Study|Adverse Event|1|||
125940965|NCT02946047|453081596|FG001|Overall Study|Adverse Event|0|||
125940966|NCT02946047|453081597|FG002|Overall Study|Adverse Event|0|||
125940967|NCT02946047|453081598|FG003|Overall Study|Adverse Event|0|||
125940968|NCT01581307|453081599|FG000|Overall Study|Withdrawal by Subject|1|||
125940969|NCT04814433|453081603|FG000|Overall Study|Survey not returned|4|||
125940970|NCT04814433|453081604|FG001|Overall Study|Survey not returned|8|||
125940971|NCT04814433|453081605|FG002|Overall Study|Survey not returned|4|||
125940972|NCT04814433|453081606|FG003|Overall Study|Survey not returned|5|||
125940973|NCT02496533|453081607|FG000|Overall Study|Lack of data on outcome|3|||
125940974|NCT02496533|453081608|FG001|Overall Study|Lack of data on outcome|0|||
125940975|NCT02496533|453081607|FG000|Overall Study|Patient did not complete all measures|0|||
125940976|NCT02496533|453081608|FG001|Overall Study|Patient did not complete all measures|4|||
125940977|NCT02496533|453081607|FG000|Overall Study|Late for radiologic testing|0|||
125940978|NCT02496533|453081608|FG001|Overall Study|Late for radiologic testing|2|||
125940979|NCT02016625|453083310|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
125940980|NCT02016625|453083311|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
125940981|NCT02016625|453083310|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
125940982|NCT02016625|453083311|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
125940983|NCT02016625|453083310|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
125940984|NCT02016625|453083311|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
125940985|NCT02356783|453083312|FG000|Overall Study|Lost to Follow-up|1|||
125940986|NCT02356783|453083313|FG001|Overall Study|Lost to Follow-up|3|||
126066779|NCT03451292|453536970|FG000|Overall Study|Death|44|||
125940987|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
125940988|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
125940989|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
125940990|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
125940991|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
125940992|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
125940993|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
125940994|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
125940995|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
125940996|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
125940997|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
125940998|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
125940999|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
125941000|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
125941001|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
125941002|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
125941003|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
125941004|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
125941005|NCT00887354|453083314|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
125941006|NCT00887354|453083315|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
125941007|NCT00887354|453083314|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
125941008|NCT00887354|453083315|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
125941009|NCT00887354|453083314|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
125941010|NCT00887354|453083315|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
125941011|NCT00887354|453083314|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
125941012|NCT00887354|453083315|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
125941013|NCT00887354|453083314|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
125941014|NCT00887354|453083315|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
125941015|NCT00887354|453083314|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
125941016|NCT00887354|453083315|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
125941017|NCT00192504|453083320|FG000|Overall Study|Lost to Follow-up|1|||
125941018|NCT00192504|453083321|FG001|Overall Study|Lost to Follow-up|0|||
125941019|NCT00192504|453083322|FG002|Overall Study|Lost to Follow-up|0|||
125941020|NCT00192504|453083323|FG003|Overall Study|Lost to Follow-up|0|||
125941021|NCT00192504|453083320|FG000|Overall Study|Dosing window missed|0|||
125941022|NCT00192504|453083321|FG001|Overall Study|Dosing window missed|0|||
125941023|NCT00192504|453083322|FG002|Overall Study|Dosing window missed|1|||
125941024|NCT00192504|453083323|FG003|Overall Study|Dosing window missed|0|||
125941025|NCT01139450|453083324|FG000|Overall Study|Withdrawal by Subject|7|||
125941026|NCT01139450|453083325|FG001|Overall Study|Withdrawal by Subject|10|||
125941027|NCT01139450|453083326|FG002|Overall Study|Withdrawal by Subject|13|||
125941028|NCT01139450|453083324|FG000|Overall Study|Lack of Efficacy|3|||
125941029|NCT01139450|453083325|FG001|Overall Study|Lack of Efficacy|1|||
125941030|NCT01139450|453083326|FG002|Overall Study|Lack of Efficacy|8|||
125941031|NCT01139450|453083324|FG000|Overall Study|Protocol Violation|6|||
125941032|NCT01139450|453083325|FG001|Overall Study|Protocol Violation|5|||
125941033|NCT01139450|453083326|FG002|Overall Study|Protocol Violation|2|||
125941034|NCT01139450|453083324|FG000|Overall Study|Lost to Follow-up|9|||
125941035|NCT01139450|453083325|FG001|Overall Study|Lost to Follow-up|7|||
125941036|NCT01139450|453083326|FG002|Overall Study|Lost to Follow-up|11|||
125941037|NCT01139450|453083324|FG000|Overall Study|Administrative|0|||
125941038|NCT01139450|453083325|FG001|Overall Study|Administrative|0|||
125941039|NCT01139450|453083326|FG002|Overall Study|Administrative|1|||
125941040|NCT01139450|453083324|FG000|Overall Study|Adverse Event|2|||
125941041|NCT01139450|453083325|FG001|Overall Study|Adverse Event|2|||
125941042|NCT01139450|453083326|FG002|Overall Study|Adverse Event|3|||
125941043|NCT04608500|453083327|FG000|Overall Study|Adverse Event|2|||
125941044|NCT04608500|453083328|FG001|Overall Study|Adverse Event|0|||
125941045|NCT04608500|453083327|FG000|Overall Study|Lost to Follow-up|15|||
125941046|NCT04608500|453083328|FG001|Overall Study|Lost to Follow-up|9|||
125941047|NCT04608500|453083327|FG000|Overall Study|Participant request|11|||
125941048|NCT04608500|453083328|FG001|Overall Study|Participant request|7|||
125941049|NCT04608500|453083327|FG000|Overall Study|Protocol Violation|1|||
125941050|NCT04608500|453083328|FG001|Overall Study|Protocol Violation|0|||
125941051|NCT04608500|453083327|FG000|Overall Study|Other|6|||
125941052|NCT04608500|453083328|FG001|Overall Study|Other|2|||
125941053|NCT01327300|453083335|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
125941054|NCT01327300|453083336|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
125941055|NCT03020823|453083339|FG000|Overall Study|Physician Decision|4|||
125941056|NCT03020823|453083339|FG000|Overall Study|Lack of Efficacy|4|||
125941057|NCT03020823|453083339|FG000|Overall Study|Adverse Event|2|||
125941058|NCT03739112|453083341|FG000|Overall Study|Adverse Event|2|||
125941059|NCT03739112|453083342|FG001|Overall Study|Adverse Event|2|||
125941060|NCT03739112|453083341|FG000|Overall Study|Withdrawal by Subject|38|||
125941061|NCT03739112|453083342|FG001|Overall Study|Withdrawal by Subject|19|||
125941062|NCT03739112|453083341|FG000|Overall Study|Lost to Follow-up|31|||
125941063|NCT03739112|453083342|FG001|Overall Study|Lost to Follow-up|33|||
125941064|NCT03739112|453083341|FG000|Overall Study|Protocol Deviation|12|||
125941065|NCT03739112|453083342|FG001|Overall Study|Protocol Deviation|9|||
125941066|NCT03739112|453083341|FG000|Overall Study|Physician Decision|1|||
125941067|NCT03739112|453083342|FG001|Overall Study|Physician Decision|0|||
125941068|NCT03739112|453083341|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
125941069|NCT03739112|453083342|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
125941070|NCT03739112|453083341|FG000|Overall Study|Site went on hold|65|||
125941071|NCT03739112|453083342|FG001|Overall Study|Site went on hold|67|||
125941072|NCT03739112|453083341|FG000|Overall Study|Other than specified|8|||
125941073|NCT03739112|453083342|FG001|Overall Study|Other than specified|5|||
125941074|NCT03739112|453083341|FG000|Overall Study|Randomized but not vaccinated|31|||
125941075|NCT03739112|453083342|FG001|Overall Study|Randomized but not vaccinated|25|||
125941076|NCT04307446|453083353|FG000|Overall Study|Lost to Follow-up|2|||
125941077|NCT04307446|453083354|FG001|Overall Study|Lost to Follow-up|0|||
125941078|NCT03257631|453083357|FG000|Overall Study|Death|1|||
125941079|NCT03257631|453083358|FG001|Overall Study|Death|0|||
125941080|NCT03257631|453083359|FG002|Overall Study|Death|1|||
125941081|NCT03257631|453083360|FG003|Overall Study|Death|1|||
125941082|NCT03257631|453083357|FG000|Overall Study|Progressive Disease|10|||
125941083|NCT03257631|453083358|FG001|Overall Study|Progressive Disease|9|||
125941084|NCT03257631|453083359|FG002|Overall Study|Progressive Disease|17|||
125941085|NCT03257631|453083360|FG003|Overall Study|Progressive Disease|8|||
125941086|NCT03257631|453083357|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125941087|NCT03257631|453083358|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125941088|NCT03257631|453083359|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125941089|NCT03257631|453083360|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
125941090|NCT03257631|453083357|FG000|Overall Study|Adverse Event|0|||
125941091|NCT03257631|453083358|FG001|Overall Study|Adverse Event|0|||
125941092|NCT03257631|453083359|FG002|Overall Study|Adverse Event|2|||
125941093|NCT03257631|453083360|FG003|Overall Study|Adverse Event|0|||
125941094|NCT02529137|453083361|FG000|Overall Study|Discontinuation for different reasons|8|||
125941095|NCT01290666|453083369|FG000|Overall Study|Lost to Follow-up|11|||
125941096|NCT01290666|453083369|FG000|Overall Study|Withdrawal by Subject|23|||
125941097|NCT01290666|453083369|FG000|Overall Study|Early Termination of Study|4|||
125941098|NCT00772707|453083375|FG000|Overall Study|Withdrawn|3|||
125941099|NCT04356963|453083377|FG000|First Session|Withdrawal by Subject|1|||
125941100|NCT04356963|453083377|FG000|Second Session|Withdrawal by Subject|3|||
125941101|NCT04356963|453083377|FG000|Second Session|Lost to Follow-up|1|||
125941102|NCT04356963|453083377|FG000|Third Session|Lost to Follow-up|6|||
125941103|NCT04356963|453083377|FG000|Third Session|Withdrawal by Subject|1|||
125941104|NCT01679002|453083383|FG000|Overall Study|Adverse Event|1|||
125941105|NCT01679002|453083384|FG001|Overall Study|Adverse Event|1|||
125941106|NCT01679002|453083385|FG002|Overall Study|Adverse Event|0|||
125941107|NCT01176266|453083386|FG000|Overall Study|Death|6|||
125941108|NCT01176266|453083386|FG000|Overall Study|Withdrawal by Subject|3|||
125941109|NCT01179477|453083387|FG000|Overall Study|Death|542|||
125941110|NCT01179477|453083387|FG000|Overall Study|Unsuccessful implant|80|||
125941111|NCT01179477|453083387|FG000|Overall Study|Non-death withdrawal|438|||
125941112|NCT01179477|453083387|FG000|Overall Study|Did not complete final visit|27|||
125941113|NCT05075850|453083395|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
125941114|NCT03194321|453083396|FG000|Overall Study|Withdrawal by Subject|1|||
125941115|NCT03194321|453083396|FG000|Overall Study|Lost to Follow-up|1|||
125941116|NCT03194321|453083396|FG000|Overall Study|Travel for Follow-up|1|||
125941117|NCT01092182|453083400|FG000|Overall Study|Death|0|||
125941118|NCT01092182|453083401|FG001|Overall Study|Death|5|||
125941119|NCT01092182|453083402|FG002|Overall Study|Death|3|||
125941120|NCT01092182|453083400|FG000|Overall Study|participant safety|1|||
125941121|NCT01092182|453083401|FG001|Overall Study|participant safety|2|||
125941122|NCT01092182|453083402|FG002|Overall Study|participant safety|0|||
125941123|NCT01092182|453083400|FG000|Overall Study|Physician Decision|0|||
125941124|NCT01092182|453083401|FG001|Overall Study|Physician Decision|6|||
125941125|NCT01092182|453083402|FG002|Overall Study|Physician Decision|0|||
125941126|NCT01092182|453083400|FG000|Overall Study|Did not meet criteria|0|||
125941127|NCT01092182|453083401|FG001|Overall Study|Did not meet criteria|0|||
125941128|NCT01092182|453083402|FG002|Overall Study|Did not meet criteria|25|||
125941129|NCT01092182|453083400|FG000|Overall Study|Non-compliance|0|||
125941130|NCT01092182|453083401|FG001|Overall Study|Non-compliance|3|||
125941131|NCT01092182|453083402|FG002|Overall Study|Non-compliance|0|||
125941132|NCT01092182|453083400|FG000|Overall Study|Participant refused follow-up|0|||
125941133|NCT01092182|453083401|FG001|Overall Study|Participant refused follow-up|2|||
125941134|NCT01092182|453083402|FG002|Overall Study|Participant refused follow-up|0|||
125941135|NCT02515045|453083410|FG000|Overall Study|Adverse Event|0|||
125941136|NCT02515045|453083411|FG001|Overall Study|Adverse Event|3|||
125941137|NCT02515045|453083412|FG002|Overall Study|Adverse Event|3|||
125941138|NCT02515045|453083410|FG000|Overall Study|Lost to Follow-up|0|||
125941139|NCT02515045|453083411|FG001|Overall Study|Lost to Follow-up|1|||
125941140|NCT02515045|453083412|FG002|Overall Study|Lost to Follow-up|1|||
125941141|NCT01782664|453083415|FG000|Overall Study|Adverse Event|2|||
125941142|NCT01782664|453083416|FG001|Overall Study|Adverse Event|2|||
125941143|NCT01782664|453083417|FG002|Overall Study|Adverse Event|2|||
125941144|NCT01782664|453083418|FG003|Overall Study|Adverse Event|2|||
125941145|NCT01782664|453083419|FG004|Overall Study|Adverse Event|0|||
125941146|NCT01782664|453083420|FG005|Overall Study|Adverse Event|0|||
125941147|NCT01782664|453083415|FG000|Overall Study|Lack of Efficacy|2|||
125941148|NCT01782664|453083416|FG001|Overall Study|Lack of Efficacy|0|||
125941149|NCT01782664|453083417|FG002|Overall Study|Lack of Efficacy|2|||
125941150|NCT01782664|453083418|FG003|Overall Study|Lack of Efficacy|2|||
125941151|NCT01782664|453083419|FG004|Overall Study|Lack of Efficacy|0|||
125941152|NCT01782664|453083420|FG005|Overall Study|Lack of Efficacy|0|||
125941153|NCT01782664|453083415|FG000|Overall Study|Protocol Violation|0|||
125941154|NCT01782664|453083416|FG001|Overall Study|Protocol Violation|1|||
125941155|NCT01782664|453083417|FG002|Overall Study|Protocol Violation|0|||
125941156|NCT01782664|453083418|FG003|Overall Study|Protocol Violation|1|||
125941157|NCT01782664|453083419|FG004|Overall Study|Protocol Violation|0|||
125941158|NCT01782664|453083420|FG005|Overall Study|Protocol Violation|0|||
125941159|NCT01782664|453083415|FG000|Overall Study|Withdrawal by Subject|2|||
125941160|NCT01782664|453083416|FG001|Overall Study|Withdrawal by Subject|2|||
125941161|NCT01782664|453083417|FG002|Overall Study|Withdrawal by Subject|0|||
125941162|NCT01782664|453083418|FG003|Overall Study|Withdrawal by Subject|0|||
125941163|NCT01782664|453083419|FG004|Overall Study|Withdrawal by Subject|0|||
125941164|NCT01782664|453083420|FG005|Overall Study|Withdrawal by Subject|0|||
125941165|NCT02677987|453083421|FG000|Overall Study|Withdrawal by Subject|3|||
125941166|NCT02677987|453083422|FG001|Overall Study|Withdrawal by Subject|0|||
125941167|NCT02677987|453083421|FG000|Overall Study|Lost to Follow-up|1|||
125941168|NCT02677987|453083422|FG001|Overall Study|Lost to Follow-up|0|||
125941169|NCT00673179|453083426|FG000|Overall Study|Toxicity/Complications|3|||
125941170|NCT00673179|453083427|FG001|Overall Study|Toxicity/Complications|0|||
125941171|NCT01522365|453083428|FG000|Overall Study|Withdrawal by Subject|1|||
125941172|NCT01522365|453083429|FG001|Overall Study|Withdrawal by Subject|1|||
125941173|NCT01522365|453083428|FG000|Overall Study|Lost to Follow-up|1|||
125941174|NCT01522365|453083429|FG001|Overall Study|Lost to Follow-up|1|||
125941175|NCT00651755|453083430|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
125941176|NCT00651755|453083431|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
125941177|NCT00651755|453083430|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
125941178|NCT00651755|453083431|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
125941179|NCT00624052|453083432|FG000|Overall Study|Adverse Event|7|||
125941180|NCT00624052|453083433|FG001|Overall Study|Adverse Event|6|||
125941181|NCT00624052|453083434|FG002|Overall Study|Adverse Event|0|||
125941182|NCT00624052|453083435|FG003|Overall Study|Adverse Event|3|||
125941183|NCT00624052|453083432|FG000|Overall Study|Lack of Efficacy|1|||
125941184|NCT00624052|453083433|FG001|Overall Study|Lack of Efficacy|1|||
125941185|NCT00624052|453083434|FG002|Overall Study|Lack of Efficacy|0|||
125941186|NCT00624052|453083435|FG003|Overall Study|Lack of Efficacy|0|||
125941187|NCT00624052|453083432|FG000|Overall Study|Lost to Follow-up|2|||
125941188|NCT00624052|453083433|FG001|Overall Study|Lost to Follow-up|3|||
125941189|NCT00624052|453083434|FG002|Overall Study|Lost to Follow-up|1|||
125941190|NCT00624052|453083435|FG003|Overall Study|Lost to Follow-up|0|||
125941191|NCT00624052|453083432|FG000|Overall Study|Non compliant with the protocol|2|||
125941192|NCT00624052|453083433|FG001|Overall Study|Non compliant with the protocol|1|||
125941193|NCT00624052|453083434|FG002|Overall Study|Non compliant with the protocol|1|||
125941194|NCT00624052|453083435|FG003|Overall Study|Non compliant with the protocol|1|||
125941195|NCT00624052|453083432|FG000|Overall Study|Consent withdrawn|3|||
125941196|NCT00624052|453083433|FG001|Overall Study|Consent withdrawn|1|||
125941197|NCT00624052|453083434|FG002|Overall Study|Consent withdrawn|1|||
125941198|NCT00624052|453083435|FG003|Overall Study|Consent withdrawn|0|||
125941199|NCT00624052|453083432|FG000|Overall Study|Changed job/ran out if meds|0|||
125941200|NCT00624052|453083433|FG001|Overall Study|Changed job/ran out if meds|2|||
125941201|NCT00624052|453083434|FG002|Overall Study|Changed job/ran out if meds|0|||
125941202|NCT00624052|453083435|FG003|Overall Study|Changed job/ran out if meds|0|||
125941203|NCT00281684|453083438|FG000|Overall Study|Lost to Follow-up|0|||
125941204|NCT00281684|453083439|FG001|Overall Study|Lost to Follow-up|0|||
125941205|NCT00281684|453083440|FG002|Overall Study|Lost to Follow-up|1|||
125941206|NCT00281684|453083441|FG003|Overall Study|Lost to Follow-up|0|||
125941207|NCT00281684|453083438|FG000|Overall Study|Withdrawal by Subject|1|||
125941208|NCT00281684|453083439|FG001|Overall Study|Withdrawal by Subject|0|||
125941209|NCT00281684|453083440|FG002|Overall Study|Withdrawal by Subject|0|||
125941210|NCT00281684|453083441|FG003|Overall Study|Withdrawal by Subject|0|||
125941211|NCT01120756|453083442|FG000|Overall Study|Withdrawal by Subject|1|||
125941212|NCT01120756|453083443|FG001|Overall Study|Withdrawal by Subject|1|||
125941213|NCT03760146|453083451|FG000|Overall Study|Adverse Event|11|||
125941214|NCT03760146|453083452|FG001|Overall Study|Adverse Event|8|||
125941215|NCT03760146|453083453|FG002|Overall Study|Adverse Event|0|||
126114321|NCT01186939|453713792|FG000|Overall Study|Program closed|5|||
125941216|NCT03760146|453083454|FG003|Overall Study|Adverse Event|0|||
125941217|NCT03760146|453083455|FG004|Overall Study|Adverse Event|0|||
125941218|NCT03760146|453083456|FG005|Overall Study|Adverse Event|0|||
125941219|NCT03760146|453083451|FG000|Overall Study|Death|1|||
125941220|NCT03760146|453083452|FG001|Overall Study|Death|0|||
125941221|NCT03760146|453083453|FG002|Overall Study|Death|0|||
125941222|NCT03760146|453083454|FG003|Overall Study|Death|0|||
125941223|NCT03760146|453083455|FG004|Overall Study|Death|0|||
125941224|NCT03760146|453083456|FG005|Overall Study|Death|0|||
125941225|NCT03760146|453083451|FG000|Overall Study|Lost to Follow-up|41|||
125941226|NCT03760146|453083452|FG001|Overall Study|Lost to Follow-up|28|||
125941227|NCT03760146|453083453|FG002|Overall Study|Lost to Follow-up|9|||
125941228|NCT03760146|453083454|FG003|Overall Study|Lost to Follow-up|2|||
125941229|NCT03760146|453083455|FG004|Overall Study|Lost to Follow-up|14|||
125941230|NCT03760146|453083456|FG005|Overall Study|Lost to Follow-up|8|||
125941231|NCT03760146|453083451|FG000|Overall Study|No longer met eligibility criteria|3|||
125941232|NCT03760146|453083452|FG001|Overall Study|No longer met eligibility criteria|9|||
125941233|NCT03760146|453083453|FG002|Overall Study|No longer met eligibility criteria|0|||
125941234|NCT03760146|453083454|FG003|Overall Study|No longer met eligibility criteria|0|||
125941235|NCT03760146|453083455|FG004|Overall Study|No longer met eligibility criteria|1|||
125941236|NCT03760146|453083456|FG005|Overall Study|No longer met eligibility criteria|0|||
125941237|NCT03760146|453083451|FG000|Overall Study|Protocol Violation|21|||
125941238|NCT03760146|453083452|FG001|Overall Study|Protocol Violation|13|||
125941239|NCT03760146|453083453|FG002|Overall Study|Protocol Violation|1|||
125941240|NCT03760146|453083454|FG003|Overall Study|Protocol Violation|0|||
125941241|NCT03760146|453083455|FG004|Overall Study|Protocol Violation|1|||
125941242|NCT03760146|453083456|FG005|Overall Study|Protocol Violation|0|||
125941243|NCT03760146|453083451|FG000|Overall Study|Withdrawal by Subject|19|||
125941244|NCT03760146|453083452|FG001|Overall Study|Withdrawal by Subject|20|||
125941245|NCT03760146|453083453|FG002|Overall Study|Withdrawal by Subject|1|||
125941246|NCT03760146|453083454|FG003|Overall Study|Withdrawal by Subject|0|||
125941247|NCT03760146|453083455|FG004|Overall Study|Withdrawal by Subject|1|||
125941248|NCT03760146|453083456|FG005|Overall Study|Withdrawal by Subject|0|||
125941249|NCT00449644|453083457|FG000|Overall Study|Adverse Event|0|||
125941250|NCT00449644|453083458|FG001|Overall Study|Adverse Event|0|||
125941251|NCT00449644|453083459|FG002|Overall Study|Adverse Event|3|||
125941252|NCT00449644|453083460|FG003|Overall Study|Adverse Event|5|||
125941253|NCT00449644|453083457|FG000|Overall Study|Death|1|||
125941254|NCT00449644|453083458|FG001|Overall Study|Death|0|||
125941255|NCT00449644|453083459|FG002|Overall Study|Death|6|||
125941256|NCT00449644|453083460|FG003|Overall Study|Death|1|||
125941257|NCT00449644|453083457|FG000|Overall Study|Lost to Follow-up|1|||
125941258|NCT00449644|453083458|FG001|Overall Study|Lost to Follow-up|1|||
125941259|NCT00449644|453083459|FG002|Overall Study|Lost to Follow-up|5|||
125941260|NCT00449644|453083460|FG003|Overall Study|Lost to Follow-up|3|||
125941261|NCT00449644|453083457|FG000|Overall Study|Pregnancy|0|||
125941262|NCT00449644|453083458|FG001|Overall Study|Pregnancy|0|||
125941263|NCT00449644|453083459|FG002|Overall Study|Pregnancy|3|||
125941264|NCT00449644|453083460|FG003|Overall Study|Pregnancy|2|||
125941265|NCT00449644|453083457|FG000|Overall Study|Protocol Violation|4|||
125941266|NCT00449644|453083458|FG001|Overall Study|Protocol Violation|4|||
125941267|NCT00449644|453083459|FG002|Overall Study|Protocol Violation|3|||
125941268|NCT00449644|453083460|FG003|Overall Study|Protocol Violation|7|||
125941269|NCT00449644|453083457|FG000|Overall Study|Withdrawal by Subject|3|||
125941270|NCT00449644|453083458|FG001|Overall Study|Withdrawal by Subject|4|||
125941271|NCT00449644|453083459|FG002|Overall Study|Withdrawal by Subject|6|||
125941272|NCT00449644|453083460|FG003|Overall Study|Withdrawal by Subject|7|||
125941273|NCT00449644|453083457|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
125941274|NCT00449644|453083458|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
125941275|NCT00449644|453083459|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
125941276|NCT00449644|453083460|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
125941277|NCT00449644|453083457|FG000|Overall Study|Other|1|||
125941278|NCT00449644|453083458|FG001|Overall Study|Other|4|||
125941279|NCT00449644|453083459|FG002|Overall Study|Other|1|||
125941280|NCT00449644|453083460|FG003|Overall Study|Other|0|||
125941281|NCT00449644|453083457|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
125941282|NCT00449644|453083458|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
125941283|NCT00449644|453083459|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
125941284|NCT00449644|453083460|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
125941285|NCT03642717|453083461|FG000|Overall Study|Lost to Follow-up|2|||
126114322|NCT01186939|453713792|FG000|Overall Study|Sponsor decision|4|||
125941286|NCT03642717|453083461|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
125941287|NCT03642717|453083461|FG000|Overall Study|Taken study drug prior to contract date|3|||
125941288|NCT01559012|453083464|FG000|Overall Study|Withdrawal by Subject|0|||
125941289|NCT01559012|453083465|FG001|Overall Study|Withdrawal by Subject|1|||
125941290|NCT00946712|453083466|FG000|Overall Study|Adverse Event|118|||
125941291|NCT00946712|453083467|FG001|Overall Study|Adverse Event|124|||
125941292|NCT00946712|453083466|FG000|Overall Study|Disease progression|308|||
125941293|NCT00946712|453083467|FG001|Overall Study|Disease progression|404|||
125941294|NCT00946712|453083466|FG000|Overall Study|Death|21|||
125941295|NCT00946712|453083467|FG001|Overall Study|Death|22|||
125941296|NCT00946712|453083466|FG000|Overall Study|No treatment given|25|||
125941297|NCT00946712|453083467|FG001|Overall Study|No treatment given|29|||
125941298|NCT00946712|453083466|FG000|Overall Study|Other reasons|61|||
125941299|NCT00946712|453083467|FG001|Overall Study|Other reasons|73|||
125941300|NCT00946712|453083466|FG000|Overall Study|On Treatment|0|||
125941301|NCT00946712|453083467|FG001|Overall Study|On Treatment|4|||
125941302|NCT00946712|453083466|FG000|Overall Study|Ineligible|14|||
125941303|NCT00946712|453083467|FG001|Overall Study|Ineligible|6|||
125941304|NCT02291055|453083468|FG000|Overall Study|Death|2|||
125941305|NCT02291055|453083469|FG001|Overall Study|Death|2|||
125941306|NCT02291055|453083470|FG002|Overall Study|Death|5|||
125941307|NCT02291055|453083471|FG003|Overall Study|Death|8|||
125941308|NCT02291055|453083472|FG004|Overall Study|Death|12|||
125941309|NCT02291055|453083468|FG000|Overall Study|Lost to Follow-up|0|||
125941310|NCT02291055|453083469|FG001|Overall Study|Lost to Follow-up|0|||
125941311|NCT02291055|453083470|FG002|Overall Study|Lost to Follow-up|0|||
125941312|NCT02291055|453083471|FG003|Overall Study|Lost to Follow-up|1|||
125941313|NCT02291055|453083472|FG004|Overall Study|Lost to Follow-up|2|||
125941314|NCT02291055|453083468|FG000|Overall Study|Withdrawal by Subject|3|||
125941315|NCT02291055|453083469|FG001|Overall Study|Withdrawal by Subject|1|||
125941316|NCT02291055|453083470|FG002|Overall Study|Withdrawal by Subject|1|||
125941317|NCT02291055|453083471|FG003|Overall Study|Withdrawal by Subject|5|||
125941318|NCT02291055|453083472|FG004|Overall Study|Withdrawal by Subject|10|||
125941319|NCT02291055|453083468|FG000|Overall Study|Progressive Disease|0|||
125941320|NCT02291055|453083469|FG001|Overall Study|Progressive Disease|0|||
125941321|NCT02291055|453083470|FG002|Overall Study|Progressive Disease|1|||
125941322|NCT02291055|453083471|FG003|Overall Study|Progressive Disease|4|||
125941323|NCT02291055|453083472|FG004|Overall Study|Progressive Disease|2|||
125941324|NCT02291055|453083468|FG000|Overall Study|Study Terminated by Sponsor|0|||
125941325|NCT02291055|453083469|FG001|Overall Study|Study Terminated by Sponsor|0|||
125941326|NCT02291055|453083470|FG002|Overall Study|Study Terminated by Sponsor|0|||
125941327|NCT02291055|453083471|FG003|Overall Study|Study Terminated by Sponsor|5|||
125941328|NCT02291055|453083472|FG004|Overall Study|Study Terminated by Sponsor|1|||
125941329|NCT02291055|453083468|FG000|Overall Study|Other|0|||
125941330|NCT02291055|453083469|FG001|Overall Study|Other|2|||
125941331|NCT02291055|453083470|FG002|Overall Study|Other|1|||
125941332|NCT02291055|453083471|FG003|Overall Study|Other|4|||
125941333|NCT02291055|453083472|FG004|Overall Study|Other|0|||
125941334|NCT03839212|453083473|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
125941335|NCT00679263|453083474|FG000|Visit 2/Dose 1|Adverse Event|1|||
125941336|NCT00679263|453083475|FG001|Visit 2/Dose 1|Adverse Event|0|||
125941337|NCT00679263|453083476|FG002|Visit 2/Dose 1|Adverse Event|0|||
125941338|NCT00679263|453083474|FG000|Visit 2/Dose 1|subject not compliance|1|||
125941339|NCT00679263|453083475|FG001|Visit 2/Dose 1|subject not compliance|1|||
125941340|NCT00679263|453083476|FG002|Visit 2/Dose 1|subject not compliance|0|||
125941341|NCT01464346|453083477|FG000|Overall Study|Withdrawal by Subject|0|||
125941342|NCT01464346|453083478|FG001|Overall Study|Withdrawal by Subject|0|||
125941343|NCT01464346|453083479|FG002|Overall Study|Withdrawal by Subject|1|||
125941344|NCT00733746|453083480|FG000|Overall Study|Ineligible|5|||
125941345|NCT03999892|453083481|FG000|Overall Study|Lost to Follow-up|1|||
125941346|NCT02295995|453083482|FG000|Overall Study|Lost to Follow-up|5|||
125941347|NCT02295995|453083483|FG001|Overall Study|Lost to Follow-up|1|||
125941348|NCT02447081|453083484|FG000|Overall Study|Death|161|||
125941349|NCT02447081|453083484|FG000|Overall Study|Lost to Follow-up|36|||
125941350|NCT02447081|453083484|FG000|Overall Study|Visit not completed|17|||
125941351|NCT02447081|453083484|FG000|Overall Study|unsuccessful implant procedure|10|||
125941352|NCT00378209|453083489|FG000|Overall Study|Progressive disease|11|||
125941353|NCT00378209|453083489|FG000|Overall Study|Adverse Event|3|||
125941354|NCT00378209|453083489|FG000|Overall Study|Initiation of non-protocol therapy|3|||
125941355|NCT00378209|453083489|FG000|Overall Study|Physician Decision|3|||
125941356|NCT00378209|453083489|FG000|Overall Study|Death|1|||
125941357|NCT00378209|453083489|FG000|Overall Study|Treatment delay|1|||
125941358|NCT01536379|453085278|FG000|Overall Study|Adverse Event|1|||
125941359|NCT01536379|453085279|FG001|Overall Study|Adverse Event|2|||
125941360|NCT01536379|453085278|FG000|Overall Study|Withdrawal by Subject|1|||
125941361|NCT01536379|453085279|FG001|Overall Study|Withdrawal by Subject|1|||
125941362|NCT04439253|453085283|FG000|Overall Study|Adverse Event|1|||
125941363|NCT04439253|453085283|FG000|Overall Study|Disease progression|2|||
125941364|NCT04439253|453085283|FG000|Overall Study|Complicating disease|1|||
125941365|NCT03971695|453085284|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125941366|NCT03971695|453085285|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125941367|NCT03971695|453085286|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125941368|NCT03971695|453085287|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
125941369|NCT03971695|453085288|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
125941370|NCT03971695|453085289|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125941371|NCT03971695|453085290|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125941372|NCT03971695|453085291|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125941373|NCT03971695|453085292|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
125941374|NCT03971695|453085293|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125941375|NCT03971695|453085294|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
125941376|NCT03971695|453085295|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
125941377|NCT03971695|453085296|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
125941378|NCT04447417|453085297|FG000|Overall Study|Withdrawal by Subject|1|||
125941379|NCT04447417|453085298|FG001|Overall Study|Withdrawal by Subject|0|||
125941380|NCT04447417|453085297|FG000|Overall Study|Failure to meet inclusion criteria|1|||
125941381|NCT04447417|453085298|FG001|Overall Study|Failure to meet inclusion criteria|0|||
125941382|NCT04447417|453085297|FG000|Overall Study|Lost to Follow-up|1|||
125941383|NCT04447417|453085298|FG001|Overall Study|Lost to Follow-up|0|||
125941384|NCT02155738|453085299|FG000|Overall Study|Missing critical information|1|||
125941385|NCT02155738|453085300|FG001|Overall Study|Missing critical information|0|||
125941386|NCT02155738|453085301|FG002|Overall Study|Missing critical information|0|||
125941387|NCT02155738|453085302|FG003|Overall Study|Missing critical information|1|||
125941388|NCT01190254|453085303|FG000|Overall Study|Adverse Event|3|||
125941389|NCT01190254|453085304|FG001|Overall Study|Adverse Event|6|||
125941390|NCT01190254|453085305|FG002|Overall Study|Adverse Event|8|||
125941391|NCT01190254|453085303|FG000|Overall Study|Lack of Efficacy|7|||
125941392|NCT01190254|453085304|FG001|Overall Study|Lack of Efficacy|4|||
125941393|NCT01190254|453085305|FG002|Overall Study|Lack of Efficacy|5|||
125941394|NCT01190254|453085303|FG000|Overall Study|Lost to Follow-up|4|||
125941395|NCT01190254|453085304|FG001|Overall Study|Lost to Follow-up|2|||
125941396|NCT01190254|453085305|FG002|Overall Study|Lost to Follow-up|0|||
125941397|NCT01190254|453085303|FG000|Overall Study|Withdrawal by Subject|4|||
125941398|NCT01190254|453085304|FG001|Overall Study|Withdrawal by Subject|5|||
125941399|NCT01190254|453085305|FG002|Overall Study|Withdrawal by Subject|7|||
125941400|NCT01190254|453085303|FG000|Overall Study|Protocol Violation|2|||
125941401|NCT01190254|453085304|FG001|Overall Study|Protocol Violation|0|||
125941402|NCT01190254|453085305|FG002|Overall Study|Protocol Violation|2|||
125941403|NCT01190254|453085303|FG000|Overall Study|Did not meet protocol eligibility|1|||
125941404|NCT01190254|453085304|FG001|Overall Study|Did not meet protocol eligibility|0|||
125941405|NCT01190254|453085305|FG002|Overall Study|Did not meet protocol eligibility|0|||
125941406|NCT04729127|453085306|FG000|Overall Study|Suspended/Terminated EI Services|4|||
125941407|NCT04729127|453085307|FG001|Overall Study|Suspended/Terminated EI Services|0|||
125941408|NCT04729127|453085308|FG002|Overall Study|Suspended/Terminated EI Services|4|||
125941409|NCT04729127|453085309|FG003|Overall Study|Suspended/Terminated EI Services|6|||
125941410|NCT04729127|453085310|FG004|Overall Study|Suspended/Terminated EI Services|0|||
125941411|NCT04729127|453085311|FG005|Overall Study|Suspended/Terminated EI Services|6|||
125941412|NCT04729127|453085312|FG006|Overall Study|Suspended/Terminated EI Services|2|||
125941413|NCT04729127|453085313|FG007|Overall Study|Suspended/Terminated EI Services|0|||
125941414|NCT04729127|453085314|FG008|Overall Study|Suspended/Terminated EI Services|2|||
125941415|NCT04729127|453085306|FG000|Overall Study|Withdrawal by Subject|1|||
125941416|NCT04729127|453085307|FG001|Overall Study|Withdrawal by Subject|0|||
125941417|NCT04729127|453085308|FG002|Overall Study|Withdrawal by Subject|1|||
125941418|NCT04729127|453085309|FG003|Overall Study|Withdrawal by Subject|0|||
125941419|NCT04729127|453085310|FG004|Overall Study|Withdrawal by Subject|0|||
125941420|NCT04729127|453085311|FG005|Overall Study|Withdrawal by Subject|0|||
125941421|NCT04729127|453085312|FG006|Overall Study|Withdrawal by Subject|0|||
125941422|NCT04729127|453085313|FG007|Overall Study|Withdrawal by Subject|0|||
125941423|NCT04729127|453085314|FG008|Overall Study|Withdrawal by Subject|0|||
125941424|NCT04729127|453085306|FG000|Overall Study|Switched Agency/Setting|1|||
125941425|NCT04729127|453085307|FG001|Overall Study|Switched Agency/Setting|0|||
125941426|NCT04729127|453085308|FG002|Overall Study|Switched Agency/Setting|1|||
126066780|NCT03451292|453536971|FG001|Overall Study|Death|59|||
126066781|NCT03451292|453536970|FG000|Overall Study|Withdrawal by Subject|18|||
125941427|NCT04729127|453085309|FG003|Overall Study|Switched Agency/Setting|1|||
125941428|NCT04729127|453085310|FG004|Overall Study|Switched Agency/Setting|0|||
125941429|NCT04729127|453085311|FG005|Overall Study|Switched Agency/Setting|1|||
125941430|NCT04729127|453085312|FG006|Overall Study|Switched Agency/Setting|1|||
125941431|NCT04729127|453085313|FG007|Overall Study|Switched Agency/Setting|0|||
125941432|NCT04729127|453085314|FG008|Overall Study|Switched Agency/Setting|1|||
125941433|NCT01365507|453085315|FG000|Overall Study|Withdrawal Criteria|8|||
125941434|NCT01365507|453085316|FG001|Overall Study|Withdrawal Criteria|5|||
125941435|NCT01365507|453085315|FG000|Overall Study|Unclassified|1|||
125941436|NCT01365507|453085316|FG001|Overall Study|Unclassified|4|||
125941437|NCT02794103|453085317|FG000|Overall Study|Loss to follow up due to high sedation|3|||
125941438|NCT00914810|453085320|FG000|Overall Study|Withdrawal by Subject|1|||
126066782|NCT03451292|453536971|FG001|Overall Study|Withdrawal by Subject|13|||
125941439|NCT00914810|453085321|FG001|Overall Study|Withdrawal by Subject|0|||
125941440|NCT00914810|453085320|FG000|Overall Study|Relocated out of state|1|||
125941441|NCT00914810|453085321|FG001|Overall Study|Relocated out of state|0|||
125941442|NCT00914810|453085320|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
125941443|NCT00914810|453085321|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
125941444|NCT04782856|453085322|FG000|Overall Study|Withdrawal by Subject|0|||
125941445|NCT04782856|453085323|FG001|Overall Study|Withdrawal by Subject|1|||
125941446|NCT01465022|453085324|FG000|Overall Study|Lost to Follow-up|15|||
125941447|NCT01465022|453085325|FG001|Overall Study|Lost to Follow-up|14|||
125941448|NCT01465022|453085326|FG002|Overall Study|Lost to Follow-up|0|||
125941449|NCT01465022|453085324|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
125941450|NCT01465022|453085325|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
125941451|NCT01465022|453085326|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
125941452|NCT01465022|453085324|FG000|Overall Study|Not Randomized|0|||
125941453|NCT01465022|453085325|FG001|Overall Study|Not Randomized|0|||
125941454|NCT01465022|453085326|FG002|Overall Study|Not Randomized|70|||
125941455|NCT03446040|453085327|FG000|Overall Study|Disease progression|3|||
125941456|NCT03446040|453085328|FG001|Overall Study|Disease progression|3|||
125941457|NCT03446040|453085329|FG002|Overall Study|Disease progression|3|||
125941458|NCT03446040|453085330|FG003|Overall Study|Disease progression|4|||
125941459|NCT03446040|453085331|FG004|Overall Study|Disease progression|4|||
125941460|NCT03446040|453085332|FG005|Overall Study|Disease progression|6|||
125941461|NCT03446040|453085333|FG006|Overall Study|Disease progression|3|||
125941462|NCT03446040|453085334|FG007|Overall Study|Disease progression|4|||
125941463|NCT03446040|453085335|FG008|Overall Study|Disease progression|2|||
125941464|NCT03446040|453085336|FG009|Overall Study|Disease progression|4|||
125941465|NCT03446040|453085337|FG010|Overall Study|Disease progression|9|||
125941466|NCT03446040|453085338|FG011|Overall Study|Disease progression|3|||
125941467|NCT03446040|453085339|FG012|Overall Study|Disease progression|7|||
125941468|NCT03446040|453085340|FG013|Overall Study|Disease progression|7|||
125941469|NCT03446040|453085327|FG000|Overall Study|Study drug toxicity|0|||
125941470|NCT03446040|453085328|FG001|Overall Study|Study drug toxicity|0|||
125941471|NCT03446040|453085329|FG002|Overall Study|Study drug toxicity|0|||
125941472|NCT03446040|453085330|FG003|Overall Study|Study drug toxicity|0|||
125941473|NCT03446040|453085331|FG004|Overall Study|Study drug toxicity|0|||
125941474|NCT03446040|453085332|FG005|Overall Study|Study drug toxicity|0|||
125941475|NCT03446040|453085333|FG006|Overall Study|Study drug toxicity|0|||
125941476|NCT03446040|453085334|FG007|Overall Study|Study drug toxicity|0|||
125941477|NCT03446040|453085335|FG008|Overall Study|Study drug toxicity|1|||
125941478|NCT03446040|453085336|FG009|Overall Study|Study drug toxicity|0|||
125941479|NCT03446040|453085337|FG010|Overall Study|Study drug toxicity|0|||
125941480|NCT03446040|453085338|FG011|Overall Study|Study drug toxicity|0|||
125941481|NCT03446040|453085339|FG012|Overall Study|Study drug toxicity|0|||
125941482|NCT03446040|453085340|FG013|Overall Study|Study drug toxicity|0|||
125941483|NCT03446040|453085327|FG000|Overall Study|Adverse Event|0|||
125941484|NCT03446040|453085328|FG001|Overall Study|Adverse Event|0|||
125941485|NCT03446040|453085329|FG002|Overall Study|Adverse Event|0|||
125941486|NCT03446040|453085330|FG003|Overall Study|Adverse Event|0|||
125941487|NCT03446040|453085331|FG004|Overall Study|Adverse Event|0|||
125941488|NCT03446040|453085332|FG005|Overall Study|Adverse Event|2|||
125941489|NCT03446040|453085333|FG006|Overall Study|Adverse Event|0|||
125941490|NCT03446040|453085334|FG007|Overall Study|Adverse Event|0|||
125941491|NCT03446040|453085335|FG008|Overall Study|Adverse Event|1|||
125941492|NCT03446040|453085336|FG009|Overall Study|Adverse Event|0|||
125941493|NCT03446040|453085337|FG010|Overall Study|Adverse Event|0|||
125941494|NCT03446040|453085338|FG011|Overall Study|Adverse Event|0|||
125941495|NCT03446040|453085339|FG012|Overall Study|Adverse Event|0|||
125941496|NCT03446040|453085340|FG013|Overall Study|Adverse Event|0|||
125941497|NCT03446040|453085327|FG000|Overall Study|Death|0|||
125941498|NCT03446040|453085328|FG001|Overall Study|Death|0|||
125941499|NCT03446040|453085329|FG002|Overall Study|Death|0|||
125941500|NCT03446040|453085330|FG003|Overall Study|Death|0|||
125941501|NCT03446040|453085331|FG004|Overall Study|Death|0|||
125941502|NCT03446040|453085332|FG005|Overall Study|Death|0|||
125941503|NCT03446040|453085333|FG006|Overall Study|Death|0|||
125941504|NCT03446040|453085334|FG007|Overall Study|Death|0|||
125941505|NCT03446040|453085335|FG008|Overall Study|Death|0|||
125941506|NCT03446040|453085336|FG009|Overall Study|Death|0|||
125941507|NCT03446040|453085337|FG010|Overall Study|Death|1|||
125941508|NCT03446040|453085338|FG011|Overall Study|Death|0|||
125941509|NCT03446040|453085339|FG012|Overall Study|Death|0|||
125941510|NCT03446040|453085340|FG013|Overall Study|Death|2|||
125941511|NCT03446040|453085327|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
125941512|NCT03446040|453085328|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
125941513|NCT03446040|453085329|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
125941514|NCT03446040|453085330|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
125941515|NCT03446040|453085331|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
125941516|NCT03446040|453085332|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
125941517|NCT03446040|453085333|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
125941518|NCT03446040|453085334|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
125941519|NCT03446040|453085335|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
125941520|NCT03446040|453085336|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
125941521|NCT03446040|453085337|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
125941522|NCT03446040|453085338|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
125941523|NCT03446040|453085339|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
125941524|NCT03446040|453085340|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
125941525|NCT03446040|453085327|FG000|Overall Study|Participant withdrew consent|0|||
125941526|NCT03446040|453085328|FG001|Overall Study|Participant withdrew consent|0|||
125941527|NCT03446040|453085329|FG002|Overall Study|Participant withdrew consent|0|||
125941528|NCT03446040|453085330|FG003|Overall Study|Participant withdrew consent|0|||
125941529|NCT03446040|453085331|FG004|Overall Study|Participant withdrew consent|0|||
125941530|NCT03446040|453085332|FG005|Overall Study|Participant withdrew consent|1|||
125941531|NCT03446040|453085333|FG006|Overall Study|Participant withdrew consent|0|||
125941532|NCT03446040|453085334|FG007|Overall Study|Participant withdrew consent|1|||
125941533|NCT03446040|453085335|FG008|Overall Study|Participant withdrew consent|0|||
125941534|NCT03446040|453085336|FG009|Overall Study|Participant withdrew consent|0|||
125941535|NCT03446040|453085337|FG010|Overall Study|Participant withdrew consent|0|||
125941536|NCT03446040|453085338|FG011|Overall Study|Participant withdrew consent|0|||
125941537|NCT03446040|453085339|FG012|Overall Study|Participant withdrew consent|0|||
125941538|NCT03446040|453085340|FG013|Overall Study|Participant withdrew consent|0|||
125941539|NCT03446040|453085327|FG000|Overall Study|Not reported|0|||
125941540|NCT03446040|453085328|FG001|Overall Study|Not reported|0|||
125941541|NCT03446040|453085329|FG002|Overall Study|Not reported|1|||
125941542|NCT03446040|453085330|FG003|Overall Study|Not reported|0|||
125941543|NCT03446040|453085331|FG004|Overall Study|Not reported|0|||
125941544|NCT03446040|453085332|FG005|Overall Study|Not reported|0|||
125941545|NCT03446040|453085333|FG006|Overall Study|Not reported|0|||
125941546|NCT03446040|453085334|FG007|Overall Study|Not reported|0|||
125941547|NCT03446040|453085335|FG008|Overall Study|Not reported|0|||
125941548|NCT03446040|453085336|FG009|Overall Study|Not reported|0|||
125941549|NCT03446040|453085337|FG010|Overall Study|Not reported|0|||
125941550|NCT03446040|453085338|FG011|Overall Study|Not reported|0|||
125941551|NCT03446040|453085339|FG012|Overall Study|Not reported|0|||
125941552|NCT03446040|453085340|FG013|Overall Study|Not reported|0|||
125941553|NCT03036098|453085341|FG000|Pre-Treatment|Other Reasons|1|||
125941554|NCT03036098|453085342|FG001|Pre-Treatment|Other Reasons|2|||
125941555|NCT03036098|453085343|FG002|Pre-Treatment|Other Reasons|0|||
125941556|NCT03036098|453085344|FG003|Pre-Treatment|Other Reasons|5|||
125941557|NCT03036098|453085341|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
125941558|NCT03036098|453085342|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
125941559|NCT03036098|453085343|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
125941560|NCT03036098|453085344|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
125941561|NCT03036098|453085341|FG000|Pre-Treatment|Withdrawal by Subject|1|||
125941562|NCT03036098|453085342|FG001|Pre-Treatment|Withdrawal by Subject|14|||
125941563|NCT03036098|453085343|FG002|Pre-Treatment|Withdrawal by Subject|0|||
125941564|NCT03036098|453085344|FG003|Pre-Treatment|Withdrawal by Subject|5|||
125941565|NCT03036098|453085341|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
125941566|NCT03036098|453085342|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
125941567|NCT03036098|453085343|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
125941568|NCT03036098|453085344|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
125941569|NCT03036098|453085341|FG000|Treatment|Disease Progression|130|||
125941570|NCT03036098|453085342|FG001|Treatment|Disease Progression|77|||
125941571|NCT03036098|453085343|FG002|Treatment|Disease Progression|168|||
125941572|NCT03036098|453085344|FG003|Treatment|Disease Progression|50|||
125941573|NCT03036098|453085341|FG000|Treatment|Study Drug Toxicity|95|||
125941574|NCT03036098|453085342|FG001|Treatment|Study Drug Toxicity|45|||
125941575|NCT03036098|453085343|FG002|Treatment|Study Drug Toxicity|26|||
125941576|NCT03036098|453085344|FG003|Treatment|Study Drug Toxicity|22|||
125941577|NCT03036098|453085341|FG000|Treatment|Death|9|||
125941578|NCT03036098|453085342|FG001|Treatment|Death|3|||
125941579|NCT03036098|453085343|FG002|Treatment|Death|1|||
125941580|NCT03036098|453085344|FG003|Treatment|Death|2|||
125941581|NCT03036098|453085341|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
125941582|NCT03036098|453085342|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
125941583|NCT03036098|453085343|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
125941584|NCT03036098|453085344|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
125941585|NCT03036098|453085341|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
125941586|NCT03036098|453085342|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
125941587|NCT03036098|453085343|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
125941588|NCT03036098|453085344|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
126114323|NCT01186939|453713792|FG000|Overall Study|Started additional treatment|1|||
126114324|NCT01186939|453713792|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
125941589|NCT03036098|453085341|FG000|Treatment|Withdrawal by Subject|2|||
125941590|NCT03036098|453085342|FG001|Treatment|Withdrawal by Subject|9|||
125941591|NCT03036098|453085343|FG002|Treatment|Withdrawal by Subject|2|||
125941592|NCT03036098|453085344|FG003|Treatment|Withdrawal by Subject|4|||
125941593|NCT03036098|453085341|FG000|Treatment|Maximum Clinical Benefit|6|||
126066783|NCT03451292|453536970|FG000|Overall Study|Transplantation|18|||
126066784|NCT03451292|453536971|FG001|Overall Study|Transplantation|12|||
126066785|NCT03451292|453536970|FG000|Overall Study|Lost to Follow-up|4|||
126066786|NCT03451292|453536971|FG001|Overall Study|Lost to Follow-up|12|||
126066787|NCT03451292|453536970|FG000|Overall Study|Physician Decision|4|||
126066788|NCT03451292|453536971|FG001|Overall Study|Physician Decision|3|||
126066789|NCT03451292|453536970|FG000|Overall Study|Adverse Event|3|||
126066790|NCT03451292|453536971|FG001|Overall Study|Adverse Event|3|||
126066791|NCT03451292|453536970|FG000|Overall Study|Non-compliance with Study Drug|2|||
126066792|NCT03451292|453536971|FG001|Overall Study|Non-compliance with Study Drug|0|||
126066793|NCT00355784|453536975|FG000|Overall Study|Withdrawal by Subject|0|||
126066794|NCT00355784|453536976|FG001|Overall Study|Withdrawal by Subject|0|||
126066795|NCT00355784|453536977|FG002|Overall Study|Withdrawal by Subject|2|||
125941594|NCT03036098|453085342|FG001|Treatment|Maximum Clinical Benefit|1|||
125941595|NCT03036098|453085343|FG002|Treatment|Maximum Clinical Benefit|6|||
125941596|NCT03036098|453085344|FG003|Treatment|Maximum Clinical Benefit|10|||
125941597|NCT03036098|453085341|FG000|Treatment|Poor/Non Compliance|1|||
125941598|NCT03036098|453085342|FG001|Treatment|Poor/Non Compliance|2|||
125941599|NCT03036098|453085343|FG002|Treatment|Poor/Non Compliance|0|||
125941600|NCT03036098|453085344|FG003|Treatment|Poor/Non Compliance|1|||
125941601|NCT03036098|453085341|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
125941602|NCT03036098|453085342|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
125941603|NCT03036098|453085343|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
125941604|NCT03036098|453085344|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
125941605|NCT03036098|453085341|FG000|Treatment|Administrative Reason by Sponsor|1|||
125941606|NCT03036098|453085342|FG001|Treatment|Administrative Reason by Sponsor|0|||
125941607|NCT03036098|453085343|FG002|Treatment|Administrative Reason by Sponsor|2|||
125941608|NCT03036098|453085344|FG003|Treatment|Administrative Reason by Sponsor|1|||
125941609|NCT03036098|453085341|FG000|Treatment|Other Reasons|31|||
125941610|NCT03036098|453085342|FG001|Treatment|Other Reasons|5|||
125941611|NCT03036098|453085343|FG002|Treatment|Other Reasons|21|||
125941612|NCT03036098|453085344|FG003|Treatment|Other Reasons|8|||
125941613|NCT03036098|453085341|FG000|Treatment|Ongoing Treatment|0|||
125941614|NCT03036098|453085342|FG001|Treatment|Ongoing Treatment|0|||
125941615|NCT03036098|453085343|FG002|Treatment|Ongoing Treatment|23|||
125941616|NCT03036098|453085344|FG003|Treatment|Ongoing Treatment|0|||
125941617|NCT02672423|453085347|FG000|Period 1|Adverse Event|0|||
125941618|NCT02672423|453085348|FG001|Period 1|Adverse Event|0|||
125941619|NCT02672423|453085349|FG002|Period 1|Adverse Event|0|||
125941620|NCT02672423|453085350|FG003|Period 1|Adverse Event|0|||
125941621|NCT02672423|453085351|FG004|Period 1|Adverse Event|1|||
125941622|NCT02672423|453085352|FG005|Period 1|Adverse Event|0|||
125941623|NCT02672423|453085353|FG006|Period 1|Adverse Event|0|||
125941624|NCT02672423|453085354|FG007|Period 1|Adverse Event|0|||
125941625|NCT02672423|453085355|FG008|Period 1|Adverse Event|0|||
125941626|NCT02672423|453085356|FG009|Period 1|Adverse Event|0|||
125941627|NCT02672423|453085347|FG000|Period 2|Withdrawal by Subject|0|||
125941628|NCT02672423|453085348|FG001|Period 2|Withdrawal by Subject|0|||
125941629|NCT02672423|453085349|FG002|Period 2|Withdrawal by Subject|1|||
125941630|NCT02672423|453085350|FG003|Period 2|Withdrawal by Subject|0|||
125941631|NCT02672423|453085351|FG004|Period 2|Withdrawal by Subject|0|||
125941632|NCT02672423|453085352|FG005|Period 2|Withdrawal by Subject|0|||
125941633|NCT02672423|453085353|FG006|Period 2|Withdrawal by Subject|0|||
125941634|NCT02672423|453085354|FG007|Period 2|Withdrawal by Subject|0|||
125941635|NCT02672423|453085355|FG008|Period 2|Withdrawal by Subject|0|||
126066796|NCT03602053|453536981|FG000|Overall Study|Withdrawal by Subject|7|||
126066797|NCT03602053|453536982|FG001|Overall Study|Withdrawal by Subject|9|||
126066798|NCT03602053|453536983|FG002|Overall Study|Withdrawal by Subject|7|||
125941636|NCT02672423|453085356|FG009|Period 2|Withdrawal by Subject|0|||
125941637|NCT02672423|453085347|FG000|Period 3|Withdrawal by Subject|0|||
125941638|NCT02672423|453085348|FG001|Period 3|Withdrawal by Subject|0|||
125941639|NCT02672423|453085349|FG002|Period 3|Withdrawal by Subject|0|||
125941640|NCT02672423|453085350|FG003|Period 3|Withdrawal by Subject|0|||
125941641|NCT02672423|453085351|FG004|Period 3|Withdrawal by Subject|0|||
125941642|NCT02672423|453085352|FG005|Period 3|Withdrawal by Subject|0|||
125941643|NCT02672423|453085353|FG006|Period 3|Withdrawal by Subject|0|||
125941644|NCT02672423|453085354|FG007|Period 3|Withdrawal by Subject|1|||
125941645|NCT02672423|453085355|FG008|Period 3|Withdrawal by Subject|0|||
125941646|NCT02672423|453085356|FG009|Period 3|Withdrawal by Subject|0|||
125941647|NCT02672423|453085347|FG000|Period 3|Physician Decision|0|||
125941648|NCT02672423|453085348|FG001|Period 3|Physician Decision|0|||
126066799|NCT03602053|453536981|FG000|Overall Study|Lost to Follow-up|5|||
125941649|NCT02672423|453085349|FG002|Period 3|Physician Decision|0|||
125941650|NCT02672423|453085350|FG003|Period 3|Physician Decision|0|||
125941651|NCT02672423|453085351|FG004|Period 3|Physician Decision|0|||
125941652|NCT02672423|453085352|FG005|Period 3|Physician Decision|1|||
125941653|NCT02672423|453085353|FG006|Period 3|Physician Decision|0|||
125941654|NCT02672423|453085354|FG007|Period 3|Physician Decision|0|||
125941655|NCT02672423|453085355|FG008|Period 3|Physician Decision|0|||
125941656|NCT02672423|453085356|FG009|Period 3|Physician Decision|0|||
125941657|NCT01046682|453085360|FG000|Overall Study|Adverse Event|2|||
125941658|NCT01046682|453085361|FG001|Overall Study|Adverse Event|0|||
125941659|NCT01454570|453085364|FG000|Overall Study|Withdrawal by Subject|2|||
125941660|NCT01454570|453085364|FG000|Overall Study|Screen Failure|7|||
125941661|NCT00536107|453085365|FG000|Overall Study|Death|5|||
125941662|NCT00536107|453085366|FG001|Overall Study|Death|1|||
125941663|NCT00536107|453085365|FG000|Overall Study|Incorrect enrolment|1|||
125941664|NCT00536107|453085366|FG001|Overall Study|Incorrect enrolment|0|||
125941665|NCT00536107|453085365|FG000|Overall Study|Withdrawal by Subject|0|||
125941666|NCT00536107|453085366|FG001|Overall Study|Withdrawal by Subject|1|||
125941667|NCT00536107|453085365|FG000|Overall Study|Study Termination|2|||
125941668|NCT00536107|453085366|FG001|Overall Study|Study Termination|4|||
125941669|NCT00371254|453085367|FG000|Overall Study|Disease progression|13|||
125941670|NCT00371254|453085368|FG001|Overall Study|Disease progression|13|||
125941671|NCT00371254|453085367|FG000|Overall Study|Study drug toxicity|3|||
125941672|NCT00371254|453085368|FG001|Overall Study|Study drug toxicity|5|||
125941673|NCT00371254|453085367|FG000|Overall Study|Subject request|5|||
125941674|NCT00371254|453085368|FG001|Overall Study|Subject request|0|||
125941675|NCT00371254|453085367|FG000|Overall Study|Investigator Decision|2|||
125941676|NCT00371254|453085368|FG001|Overall Study|Investigator Decision|0|||
125941677|NCT00371254|453085367|FG000|Overall Study|Adverse event unrelated to study drug|0|||
125941678|NCT00371254|453085368|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125941679|NCT00371254|453085367|FG000|Overall Study|Lost to Follow-up|0|||
125941680|NCT00371254|453085368|FG001|Overall Study|Lost to Follow-up|1|||
125941681|NCT00371254|453085367|FG000|Overall Study|Withdrawal by Subject|0|||
125941682|NCT00371254|453085368|FG001|Overall Study|Withdrawal by Subject|1|||
125941683|NCT02246673|453085371|FG000|Overall Study|Sponsor Decision|1|||
125941684|NCT02246673|453085372|FG001|Overall Study|Sponsor Decision|0|||
125941685|NCT02246673|453085373|FG002|Overall Study|Sponsor Decision|0|||
125941686|NCT02246673|453085374|FG003|Overall Study|Sponsor Decision|0|||
125941687|NCT02246673|453085375|FG004|Overall Study|Sponsor Decision|0|||
125941688|NCT02246673|453085371|FG000|Overall Study|Withdrawal by Subject|0|||
125941689|NCT02246673|453085372|FG001|Overall Study|Withdrawal by Subject|0|||
125941690|NCT02246673|453085373|FG002|Overall Study|Withdrawal by Subject|0|||
125941691|NCT02246673|453085374|FG003|Overall Study|Withdrawal by Subject|0|||
125941692|NCT02246673|453085375|FG004|Overall Study|Withdrawal by Subject|1|||
125941693|NCT02246673|453085371|FG000|Overall Study|Lost to Follow-up|0|||
125941694|NCT02246673|453085372|FG001|Overall Study|Lost to Follow-up|0|||
125941695|NCT02246673|453085373|FG002|Overall Study|Lost to Follow-up|0|||
125941696|NCT02246673|453085374|FG003|Overall Study|Lost to Follow-up|1|||
125941697|NCT02246673|453085375|FG004|Overall Study|Lost to Follow-up|0|||
125941698|NCT02246673|453085371|FG000|Overall Study|Protocol Violation|0|||
125941699|NCT02246673|453085372|FG001|Overall Study|Protocol Violation|0|||
125941700|NCT02246673|453085373|FG002|Overall Study|Protocol Violation|0|||
125941701|NCT02246673|453085374|FG003|Overall Study|Protocol Violation|1|||
125941702|NCT02246673|453085375|FG004|Overall Study|Protocol Violation|0|||
125941703|NCT01265849|453085377|FG000|Overall Study|Randomized//Treatment not initiated|1|||
125941704|NCT01265849|453085378|FG001|Overall Study|Randomized//Treatment not initiated|4|||
125941705|NCT01265849|453085379|FG002|Overall Study|Randomized//Treatment not initiated|0|||
125941706|NCT01265849|453085377|FG000|Overall Study|Physician Decision|1|||
125941707|NCT01265849|453085378|FG001|Overall Study|Physician Decision|2|||
125941708|NCT01265849|453085379|FG002|Overall Study|Physician Decision|0|||
125941709|NCT01265849|453085377|FG000|Overall Study|Lost to Follow-up|18|||
126066800|NCT03602053|453536982|FG001|Overall Study|Lost to Follow-up|6|||
125941710|NCT01265849|453085378|FG001|Overall Study|Lost to Follow-up|15|||
126066801|NCT03602053|453536983|FG002|Overall Study|Lost to Follow-up|0|||
126066802|NCT03602053|453536981|FG000|Overall Study|Protocol Violation|3|||
126066803|NCT03602053|453536982|FG001|Overall Study|Protocol Violation|0|||
125941711|NCT01265849|453085379|FG002|Overall Study|Lost to Follow-up|5|||
125941712|NCT01265849|453085377|FG000|Overall Study|Not otherwise specified|1|||
125941713|NCT01265849|453085378|FG001|Overall Study|Not otherwise specified|6|||
125941714|NCT01265849|453085379|FG002|Overall Study|Not otherwise specified|1|||
125941715|NCT01265849|453085377|FG000|Overall Study|Withdrawal by Subject|25|||
126066804|NCT03602053|453536983|FG002|Overall Study|Protocol Violation|4|||
125941716|NCT01265849|453085378|FG001|Overall Study|Withdrawal by Subject|34|||
125941717|NCT01265849|453085379|FG002|Overall Study|Withdrawal by Subject|13|||
125941718|NCT00271609|453085381|FG000|Overall Study|Adverse Event|11|||
125941719|NCT00271609|453085382|FG001|Overall Study|Adverse Event|3|||
125941720|NCT00271609|453085381|FG000|Overall Study|Withdrawal by Subject|2|||
125941721|NCT00271609|453085382|FG001|Overall Study|Withdrawal by Subject|0|||
126066805|NCT03602053|453536981|FG000|Overall Study|Physician Decision|1|||
125941722|NCT02188589|453085383|FG000|Overall Study|Withdrawal by Subject|5|||
125941723|NCT00975481|453085386|FG000|Second Intervention Period|Adverse Event|2|||
125941724|NCT00975481|453085387|FG001|Second Intervention Period|Adverse Event|1|||
125941725|NCT00975481|453085388|FG002|Second Intervention Period|Adverse Event|0|||
125941726|NCT00975481|453085389|FG003|Second Intervention Period|Adverse Event|0|||
125941727|NCT00975481|453085390|FG004|Second Intervention Period|Adverse Event|0|||
125941728|NCT00975481|453085391|FG005|Second Intervention Period|Adverse Event|0|||
125941729|NCT00975481|453085386|FG000|Second Intervention Period|Withdrawal by Subject|0|||
125941730|NCT00975481|453085387|FG001|Second Intervention Period|Withdrawal by Subject|0|||
125941731|NCT00975481|453085388|FG002|Second Intervention Period|Withdrawal by Subject|1|||
125941732|NCT00975481|453085389|FG003|Second Intervention Period|Withdrawal by Subject|0|||
125941733|NCT00975481|453085390|FG004|Second Intervention Period|Withdrawal by Subject|0|||
125941734|NCT00975481|453085391|FG005|Second Intervention Period|Withdrawal by Subject|0|||
125941735|NCT00975481|453085386|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
125941736|NCT00975481|453085387|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
125941737|NCT00975481|453085388|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
125941738|NCT00975481|453085389|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
125941739|NCT00975481|453085390|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
125941740|NCT00975481|453085391|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
125941741|NCT00975481|453085386|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
125941742|NCT00975481|453085387|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
125941743|NCT00975481|453085388|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
125941744|NCT00975481|453085389|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
125941745|NCT00975481|453085390|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
125941746|NCT00975481|453085391|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
125941747|NCT00643682|453085392|FG000|Overall Study|did not keep appointment|522|||
125941748|NCT00643682|453085393|FG001|Overall Study|did not keep appointment|509|||
125941749|NCT03755414|453085399|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
125941750|NCT03755414|453085400|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
125941751|NCT03755414|453085401|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
125941752|NCT03755414|453085399|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
125941753|NCT03755414|453085400|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
125941754|NCT03755414|453085401|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
125941755|NCT03755414|453085399|FG000|Overall Study|Non-compliance|0|||
125941756|NCT03755414|453085400|FG001|Overall Study|Non-compliance|1|||
125941757|NCT03755414|453085401|FG002|Overall Study|Non-compliance|0|||
125941758|NCT02154581|453085409|FG000|Overall Study|Lost to Follow-up|7|||
125941759|NCT02154581|453085410|FG001|Overall Study|Lost to Follow-up|8|||
125941760|NCT00741039|453085411|FG000|Overall Study|Patient non-compliance|2|||
125941761|NCT00741039|453085412|FG001|Overall Study|Patient non-compliance|0|||
125941762|NCT00853723|453085415|FG000|Overall Study|Adverse Event|3|||
125941763|NCT00853723|453085416|FG001|Overall Study|Adverse Event|4|||
125941764|NCT00853723|453085417|FG002|Overall Study|Adverse Event|1|||
125941765|NCT00853723|453085415|FG000|Overall Study|Withdrawal by Subject|2|||
125941766|NCT00853723|453085416|FG001|Overall Study|Withdrawal by Subject|1|||
125941767|NCT00853723|453085417|FG002|Overall Study|Withdrawal by Subject|0|||
125941768|NCT00853723|453085415|FG000|Overall Study|Protocol Violation|1|||
125941769|NCT00853723|453085416|FG001|Overall Study|Protocol Violation|2|||
125941770|NCT00853723|453085417|FG002|Overall Study|Protocol Violation|1|||
125941771|NCT01531387|453085418|FG000|Overall Study|Early termination of study|11|||
125941772|NCT01531387|453085419|FG001|Overall Study|Early termination of study|11|||
125941773|NCT02642432|453085422|FG000|Overall Study|Adverse Event|2|||
125941774|NCT02642432|453085422|FG000|Overall Study|Withdrew Consent|1|||
125941775|NCT02642432|453085422|FG000|Overall Study|Lost to Follow-up|2|||
125941776|NCT02642432|453085422|FG000|Overall Study|Other|3|||
125941777|NCT01848756|453085423|FG000|Overall Study|Adverse Event|1|||
125941778|NCT01848756|453085423|FG000|Overall Study|Withdrawal by Subject|1|||
125941779|NCT01848756|453085423|FG000|Overall Study|Enrolled in Error|1|||
125941780|NCT03245008|453085424|FG000|Overall Study|Adverse Event|15|||
125941781|NCT03245008|453085425|FG001|Overall Study|Adverse Event|18|||
125941782|NCT03245008|453085426|FG002|Overall Study|Adverse Event|15|||
125941783|NCT03245008|453085427|FG003|Overall Study|Adverse Event|0|||
125941784|NCT03245008|453085428|FG004|Overall Study|Adverse Event|1|||
125941785|NCT03245008|453085424|FG000|Overall Study|Lack of Efficacy|0|||
125941786|NCT03245008|453085425|FG001|Overall Study|Lack of Efficacy|1|||
125941787|NCT03245008|453085426|FG002|Overall Study|Lack of Efficacy|0|||
125941788|NCT03245008|453085427|FG003|Overall Study|Lack of Efficacy|0|||
125941789|NCT03245008|453085428|FG004|Overall Study|Lack of Efficacy|0|||
125941790|NCT03245008|453085424|FG000|Overall Study|Lost to Follow-up|4|||
125941791|NCT03245008|453085425|FG001|Overall Study|Lost to Follow-up|1|||
125941792|NCT03245008|453085426|FG002|Overall Study|Lost to Follow-up|0|||
125941793|NCT03245008|453085427|FG003|Overall Study|Lost to Follow-up|0|||
125941794|NCT03245008|453085428|FG004|Overall Study|Lost to Follow-up|1|||
125941795|NCT03245008|453085424|FG000|Overall Study|Physician Decision|1|||
125941796|NCT03245008|453085425|FG001|Overall Study|Physician Decision|3|||
125941797|NCT03245008|453085426|FG002|Overall Study|Physician Decision|4|||
125941798|NCT03245008|453085427|FG003|Overall Study|Physician Decision|0|||
125941799|NCT03245008|453085428|FG004|Overall Study|Physician Decision|0|||
125941800|NCT03245008|453085424|FG000|Overall Study|Protocol Violation|0|||
125941801|NCT03245008|453085425|FG001|Overall Study|Protocol Violation|1|||
125941802|NCT03245008|453085426|FG002|Overall Study|Protocol Violation|0|||
125941803|NCT03245008|453085427|FG003|Overall Study|Protocol Violation|0|||
125941804|NCT03245008|453085428|FG004|Overall Study|Protocol Violation|0|||
125941805|NCT03245008|453085424|FG000|Overall Study|Withdrawal by Subject|20|||
125941806|NCT03245008|453085425|FG001|Overall Study|Withdrawal by Subject|19|||
125941807|NCT03245008|453085426|FG002|Overall Study|Withdrawal by Subject|11|||
125941808|NCT03245008|453085427|FG003|Overall Study|Withdrawal by Subject|0|||
125941809|NCT03245008|453085428|FG004|Overall Study|Withdrawal by Subject|0|||
125941810|NCT03245008|453085424|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
125941811|NCT03245008|453085425|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
125941812|NCT03245008|453085426|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
125941813|NCT03245008|453085427|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
125941814|NCT03245008|453085428|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
125941815|NCT03245008|453085424|FG000|Overall Study|Failure to meet randomization criteria|0|||
125941816|NCT03245008|453085425|FG001|Overall Study|Failure to meet randomization criteria|1|||
125941817|NCT03245008|453085426|FG002|Overall Study|Failure to meet randomization criteria|0|||
125941818|NCT03245008|453085427|FG003|Overall Study|Failure to meet randomization criteria|1|||
125941819|NCT03245008|453085428|FG004|Overall Study|Failure to meet randomization criteria|0|||
125941820|NCT02075658|453085429|FG000|Overall Study|Physician Decision|2|||
125941821|NCT02075658|453085430|FG001|Overall Study|Physician Decision|2|||
125941822|NCT01286012|453085431|FG000|Overall Study|Adverse Event|3|||
125941823|NCT01286012|453085432|FG001|Overall Study|Adverse Event|3|||
125941824|NCT01286012|453085431|FG000|Overall Study|Death|2|||
125941825|NCT01286012|453085432|FG001|Overall Study|Death|3|||
125941826|NCT01286012|453085431|FG000|Overall Study|Protocol Violation|1|||
125941827|NCT01286012|453085432|FG001|Overall Study|Protocol Violation|1|||
125941828|NCT01286012|453085431|FG000|Overall Study|Withdrawal by Subject|4|||
125941829|NCT01286012|453085432|FG001|Overall Study|Withdrawal by Subject|4|||
125941830|NCT01286012|453085431|FG000|Overall Study|Physician Decision|2|||
125941831|NCT01286012|453085432|FG001|Overall Study|Physician Decision|0|||
125941832|NCT01286012|453085431|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
125941833|NCT01286012|453085432|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
125941834|NCT02865915|453085436|FG000|Overall Study|Pregnancy|1|||
125941835|NCT02865915|453085437|FG001|Overall Study|Pregnancy|0|||
125941836|NCT02865915|453085436|FG000|Overall Study|Withdrawal by Subject|1|||
125941837|NCT02865915|453085437|FG001|Overall Study|Withdrawal by Subject|1|||
125941838|NCT02865915|453085436|FG000|Overall Study|Adverse Event|0|||
125941839|NCT02865915|453085437|FG001|Overall Study|Adverse Event|4|||
125941840|NCT02865915|453085436|FG000|Overall Study|Lost to Follow-up|0|||
125941841|NCT02865915|453085437|FG001|Overall Study|Lost to Follow-up|1|||
125941842|NCT02865915|453085436|FG000|Overall Study|Protocol Violation|0|||
125941843|NCT02865915|453085437|FG001|Overall Study|Protocol Violation|1|||
125941844|NCT02865915|453085436|FG000|Overall Study|Study terminated by sponsor|23|||
125941845|NCT02865915|453085437|FG001|Overall Study|Study terminated by sponsor|18|||
125941846|NCT02865915|453085436|FG000|Overall Study|Dosing group discontinued|0|||
125941847|NCT02865915|453085437|FG001|Overall Study|Dosing group discontinued|5|||
125941848|NCT00663052|453085438|FG000|Overall Study|Adverse Event|6|||
125941849|NCT00663052|453085439|FG001|Overall Study|Adverse Event|3|||
125941850|NCT00663052|453085438|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
125941851|NCT00663052|453085439|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125941852|NCT00663052|453085438|FG000|Overall Study|Protocol Violation|1|||
125941853|NCT00663052|453085439|FG001|Overall Study|Protocol Violation|0|||
125941854|NCT00663052|453085438|FG000|Overall Study|Withdrawal by Subject|2|||
125941855|NCT00663052|453085439|FG001|Overall Study|Withdrawal by Subject|5|||
125941856|NCT00663052|453085438|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
125941857|NCT00663052|453085439|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
126114325|NCT01186939|453713792|FG000|Overall Study|Myocardial infarction|1|||
125941858|NCT00663052|453085438|FG000|Overall Study|Other|0|||
125941859|NCT00663052|453085439|FG001|Overall Study|Other|1|||
125941860|NCT05760300|453085440|FG000|Overall Study|Adverse Event|0|||
125941861|NCT05760300|453085441|FG001|Overall Study|Adverse Event|0|||
125941862|NCT05760300|453085442|FG002|Overall Study|Adverse Event|1|||
125941863|NCT05760300|453085443|FG003|Overall Study|Adverse Event|0|||
125941864|NCT05760300|453085440|FG000|Overall Study|Participant Decision|1|||
125941865|NCT05760300|453085441|FG001|Overall Study|Participant Decision|0|||
125941866|NCT05760300|453085442|FG002|Overall Study|Participant Decision|0|||
125941867|NCT05760300|453085443|FG003|Overall Study|Participant Decision|0|||
125941868|NCT04350788|453085457|FG000|Overall Study|Lost to Follow-up|6|||
125941869|NCT04350788|453085458|FG001|Overall Study|Lost to Follow-up|2|||
125941870|NCT04350788|453085457|FG000|Overall Study|Withdrawal by Subject|2|||
125941871|NCT04350788|453085458|FG001|Overall Study|Withdrawal by Subject|4|||
125941872|NCT04350788|453085457|FG000|Overall Study|Protocol Violation|4|||
125941873|NCT04350788|453085458|FG001|Overall Study|Protocol Violation|0|||
125941874|NCT01894581|453085459|FG000|Overall Study|Withdrawal by Subject|2|||
125941875|NCT01894581|453085460|FG001|Overall Study|Withdrawal by Subject|3|||
125941876|NCT01894581|453085459|FG000|Overall Study|Screen Failure|3|||
125941877|NCT01894581|453085460|FG001|Overall Study|Screen Failure|4|||
125941878|NCT03313804|453085461|FG000|Treatment|Death|5|||
125941879|NCT03313804|453085461|FG000|Treatment|still on treatment|2|||
125941880|NCT03313804|453085461|FG000|Follow Up|still on follow up|3|||
125941881|NCT01252940|453085462|FG000|Main Study Phase|Randomized but not treated|4|||
125941882|NCT01252940|453085463|FG001|Main Study Phase|Randomized but not treated|2|||
125941883|NCT01252940|453085462|FG000|Main Study Phase|Adverse Event|3|||
125941884|NCT01252940|453085463|FG001|Main Study Phase|Adverse Event|1|||
125941885|NCT01252940|453085462|FG000|Main Study Phase|Lack of Efficacy|1|||
125941886|NCT01252940|453085463|FG001|Main Study Phase|Lack of Efficacy|0|||
125941887|NCT01252940|453085462|FG000|Main Study Phase|Lost to Follow-up|6|||
125941888|NCT01252940|453085463|FG001|Main Study Phase|Lost to Follow-up|1|||
125941889|NCT01252940|453085462|FG000|Main Study Phase|Physician Decision|1|||
125941890|NCT01252940|453085463|FG001|Main Study Phase|Physician Decision|0|||
125941891|NCT01252940|453085462|FG000|Main Study Phase|Protocol Violation|4|||
125941892|NCT01252940|453085463|FG001|Main Study Phase|Protocol Violation|2|||
125941893|NCT01252940|453085462|FG000|Main Study Phase|Withdrawal by Subject|6|||
125941894|NCT01252940|453085463|FG001|Main Study Phase|Withdrawal by Subject|5|||
125941895|NCT01252940|453085462|FG000|Main Study Phase|Subject Non-compliance|1|||
125941896|NCT01252940|453085463|FG001|Main Study Phase|Subject Non-compliance|1|||
125941897|NCT01252940|453085462|FG000|Extension Phase|Adverse Event|2|||
125941898|NCT01252940|453085463|FG001|Extension Phase|Adverse Event|1|||
125941899|NCT01252940|453085462|FG000|Extension Phase|Lack of Efficacy|1|||
125941900|NCT01252940|453085463|FG001|Extension Phase|Lack of Efficacy|0|||
125941901|NCT01252940|453085462|FG000|Extension Phase|Lost to Follow-up|5|||
125941902|NCT01252940|453085463|FG001|Extension Phase|Lost to Follow-up|0|||
125941903|NCT01252940|453085462|FG000|Extension Phase|Physician Decision|0|||
125941904|NCT01252940|453085463|FG001|Extension Phase|Physician Decision|1|||
125941905|NCT01252940|453085462|FG000|Extension Phase|Subject Non-compliance|1|||
125941906|NCT01252940|453085463|FG001|Extension Phase|Subject Non-compliance|0|||
125941907|NCT01252940|453085462|FG000|Extension Phase|Withdrawal by Subject|1|||
125941908|NCT01252940|453085463|FG001|Extension Phase|Withdrawal by Subject|1|||
125941909|NCT03759379|453086368|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
125941910|NCT03759379|453086369|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
125941911|NCT03759379|453086368|FG000|Treatment Period|Death|2|||
125941912|NCT03759379|453086369|FG001|Treatment Period|Death|3|||
125941913|NCT03759379|453086368|FG000|Treatment Period|Lost to Follow-up|1|||
125941914|NCT03759379|453086369|FG001|Treatment Period|Lost to Follow-up|0|||
125941915|NCT03759379|453086368|FG000|Treatment Period|Physician Decision|0|||
125941916|NCT03759379|453086369|FG001|Treatment Period|Physician Decision|1|||
125941917|NCT02603809|453086375|FG000|Overall Study|Withdrawal by Subject|4|||
125941918|NCT02603809|453086376|FG001|Overall Study|Withdrawal by Subject|1|||
125941919|NCT02603809|453086377|FG002|Overall Study|Withdrawal by Subject|2|||
125941920|NCT02603809|453086378|FG003|Overall Study|Withdrawal by Subject|3|||
125941921|NCT02603809|453086379|FG004|Overall Study|Withdrawal by Subject|3|||
125941922|NCT02603809|453086380|FG005|Overall Study|Withdrawal by Subject|4|||
125941923|NCT02603809|453086375|FG000|Overall Study|Lost to Follow-up|2|||
125941924|NCT02603809|453086376|FG001|Overall Study|Lost to Follow-up|3|||
125941925|NCT02603809|453086377|FG002|Overall Study|Lost to Follow-up|1|||
125941926|NCT02603809|453086378|FG003|Overall Study|Lost to Follow-up|4|||
125941927|NCT02603809|453086379|FG004|Overall Study|Lost to Follow-up|2|||
125941928|NCT02603809|453086380|FG005|Overall Study|Lost to Follow-up|2|||
125941929|NCT02603809|453086375|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
125941930|NCT02603809|453086376|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
125941931|NCT02603809|453086377|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
126066806|NCT03602053|453536982|FG001|Overall Study|Physician Decision|0|||
126066807|NCT03602053|453536983|FG002|Overall Study|Physician Decision|0|||
125941932|NCT02603809|453086378|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
125941933|NCT02603809|453086379|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
125941934|NCT02603809|453086380|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
125941935|NCT02603809|453086375|FG000|Overall Study|Physician Decision|0|||
126066808|NCT03602053|453536981|FG000|Overall Study|migration|2|||
125941936|NCT02603809|453086376|FG001|Overall Study|Physician Decision|0|||
125941937|NCT02603809|453086377|FG002|Overall Study|Physician Decision|0|||
125941938|NCT02603809|453086378|FG003|Overall Study|Physician Decision|1|||
125941939|NCT02603809|453086379|FG004|Overall Study|Physician Decision|2|||
125941940|NCT02603809|453086380|FG005|Overall Study|Physician Decision|1|||
125941941|NCT02603809|453086375|FG000|Overall Study|Adverse Event|3|||
125941942|NCT02603809|453086376|FG001|Overall Study|Adverse Event|0|||
125941943|NCT02603809|453086377|FG002|Overall Study|Adverse Event|2|||
125941944|NCT02603809|453086378|FG003|Overall Study|Adverse Event|2|||
125941945|NCT02603809|453086379|FG004|Overall Study|Adverse Event|1|||
125941946|NCT02603809|453086380|FG005|Overall Study|Adverse Event|1|||
125941947|NCT02603809|453086375|FG000|Overall Study|Lack of Efficacy|0|||
125941948|NCT02603809|453086376|FG001|Overall Study|Lack of Efficacy|1|||
125941949|NCT02603809|453086377|FG002|Overall Study|Lack of Efficacy|0|||
125941950|NCT02603809|453086378|FG003|Overall Study|Lack of Efficacy|0|||
125941951|NCT02603809|453086379|FG004|Overall Study|Lack of Efficacy|0|||
125941952|NCT02603809|453086380|FG005|Overall Study|Lack of Efficacy|1|||
125941953|NCT00156533|453086381|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
125941954|NCT00156533|453086382|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
125941955|NCT00156533|453086383|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
125941956|NCT00156533|453086384|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
125941957|NCT00156533|453086381|FG000|Overall Study|Withdrawal by Subject|1|||
125941958|NCT00156533|453086382|FG001|Overall Study|Withdrawal by Subject|0|||
125941959|NCT00156533|453086383|FG002|Overall Study|Withdrawal by Subject|0|||
125941960|NCT00156533|453086384|FG003|Overall Study|Withdrawal by Subject|1|||
125941961|NCT00156533|453086381|FG000|Overall Study|Failed Screening|1|||
125941962|NCT00156533|453086382|FG001|Overall Study|Failed Screening|0|||
125941963|NCT00156533|453086383|FG002|Overall Study|Failed Screening|1|||
125941964|NCT00156533|453086384|FG003|Overall Study|Failed Screening|1|||
125941965|NCT01254227|453086387|FG000|Overall Study|Withdrawal by Subject|6|||
125941966|NCT01254227|453086387|FG000|Overall Study|Lost to Follow-up|6|||
125941967|NCT01254227|453086387|FG000|Overall Study|Adverse Event|5|||
125941968|NCT01254227|453086387|FG000|Overall Study|Abnormal test procedure result|5|||
125941969|NCT01254227|453086387|FG000|Overall Study|Administrative problems|2|||
125941970|NCT01254227|453086387|FG000|Overall Study|Death|1|||
125941971|NCT01254227|453086387|FG000|Overall Study|Protocol deviation|1|||
125941972|NCT03265249|453086390|FG000|Overall Study|Withdrawal by Subject|0|||
125941973|NCT03265249|453086391|FG001|Overall Study|Withdrawal by Subject|1|||
125941974|NCT03873987|453086397|FG000|Overall Study|Adverse Event|1|||
125941975|NCT03873987|453086398|FG001|Overall Study|Adverse Event|0|||
125941976|NCT03873987|453086397|FG000|Overall Study|staff was unable to start a new IV line|1|||
125941977|NCT03873987|453086398|FG001|Overall Study|staff was unable to start a new IV line|0|||
125941978|NCT03873987|453086397|FG000|Overall Study|Lost to Follow-up|0|||
125941979|NCT03873987|453086398|FG001|Overall Study|Lost to Follow-up|1|||
125941980|NCT02535741|453086399|FG000|Overall Study|Adverse Event|3|||
125941981|NCT02535741|453086399|FG000|Overall Study|Withdrawal by Subject|9|||
125941982|NCT02535741|453086399|FG000|Overall Study|Lost to Follow-up|10|||
125941983|NCT02535741|453086399|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
125941984|NCT02535741|453086399|FG000|Overall Study|Missing data|6|||
125941985|NCT00798369|453086400|FG000|Overall Study|Subject withdrew consent|0|||
125941986|NCT00798369|453086401|FG001|Overall Study|Subject withdrew consent|0|||
125941987|NCT00798369|453086402|FG002|Overall Study|Subject withdrew consent|1|||
125941988|NCT00798369|453086403|FG003|Overall Study|Subject withdrew consent|1|||
125941989|NCT00798369|453086404|FG004|Overall Study|Subject withdrew consent|0|||
125941990|NCT00798369|453086405|FG005|Overall Study|Subject withdrew consent|2|||
125941991|NCT00798369|453086400|FG000|Overall Study|Lost to Follow-up|1|||
125941992|NCT00798369|453086401|FG001|Overall Study|Lost to Follow-up|1|||
125941993|NCT00798369|453086402|FG002|Overall Study|Lost to Follow-up|1|||
125941994|NCT00798369|453086403|FG003|Overall Study|Lost to Follow-up|0|||
125941995|NCT00798369|453086404|FG004|Overall Study|Lost to Follow-up|1|||
125941996|NCT00798369|453086405|FG005|Overall Study|Lost to Follow-up|0|||
125941997|NCT00798369|453086400|FG000|Overall Study|Adminstrative problems|0|||
125941998|NCT00798369|453086401|FG001|Overall Study|Adminstrative problems|0|||
125941999|NCT00798369|453086402|FG002|Overall Study|Adminstrative problems|0|||
125942000|NCT00798369|453086403|FG003|Overall Study|Adminstrative problems|0|||
125942001|NCT00798369|453086404|FG004|Overall Study|Adminstrative problems|0|||
125942002|NCT00798369|453086405|FG005|Overall Study|Adminstrative problems|1|||
125942003|NCT04475588|453086406|FG000|Overall Study|Adverse Event|2|||
125942004|NCT04475588|453086407|FG001|Overall Study|Adverse Event|0|||
125942005|NCT04014075|453086410|FG000|Overall Study|Progressive Disease|53|||
125942006|NCT04014075|453086410|FG000|Overall Study|Adverse Event|15|||
125942007|NCT04014075|453086410|FG000|Overall Study|Clinical Progression|4|||
125942008|NCT04014075|453086410|FG000|Overall Study|Death|2|||
125942009|NCT04014075|453086410|FG000|Overall Study|Withdrawal by Subject|2|||
125942010|NCT04014075|453086410|FG000|Overall Study|Miscellaneous|2|||
125942011|NCT04014075|453086410|FG000|Overall Study|Physician Decision|1|||
125942012|NCT00507442|453086413|FG000|Overall Study|Adverse Event|8|||
125942013|NCT00507442|453086414|FG001|Overall Study|Adverse Event|11|||
125942014|NCT00507442|453086415|FG002|Overall Study|Adverse Event|4|||
125942015|NCT00507442|453086416|FG003|Overall Study|Adverse Event|1|||
126066809|NCT03602053|453536982|FG001|Overall Study|migration|3|||
125942016|NCT00507442|453086413|FG000|Overall Study|Protocol Violation|0|||
125942017|NCT00507442|453086414|FG001|Overall Study|Protocol Violation|1|||
125942018|NCT00507442|453086415|FG002|Overall Study|Protocol Violation|0|||
125942019|NCT00507442|453086416|FG003|Overall Study|Protocol Violation|0|||
125942020|NCT00507442|453086413|FG000|Overall Study|Lost to Follow-up|0|||
125942021|NCT00507442|453086414|FG001|Overall Study|Lost to Follow-up|0|||
125942022|NCT00507442|453086415|FG002|Overall Study|Lost to Follow-up|1|||
125942023|NCT00507442|453086416|FG003|Overall Study|Lost to Follow-up|0|||
125942024|NCT00507442|453086413|FG000|Overall Study|Physician Decision|0|||
125942025|NCT00507442|453086414|FG001|Overall Study|Physician Decision|2|||
125942026|NCT00507442|453086415|FG002|Overall Study|Physician Decision|4|||
125942027|NCT00507442|453086416|FG003|Overall Study|Physician Decision|1|||
125942028|NCT00507442|453086413|FG000|Overall Study|Progressive Disease|2|||
125942029|NCT00507442|453086414|FG001|Overall Study|Progressive Disease|4|||
125942030|NCT00507442|453086415|FG002|Overall Study|Progressive Disease|2|||
125942031|NCT00507442|453086416|FG003|Overall Study|Progressive Disease|0|||
125942032|NCT00507442|453086413|FG000|Overall Study|Withdrawal by Subject|4|||
125942033|NCT00507442|453086414|FG001|Overall Study|Withdrawal by Subject|4|||
125942034|NCT00507442|453086415|FG002|Overall Study|Withdrawal by Subject|2|||
125942035|NCT00507442|453086416|FG003|Overall Study|Withdrawal by Subject|1|||
125942036|NCT00507442|453086413|FG000|Overall Study|Other|2|||
125942037|NCT00507442|453086414|FG001|Overall Study|Other|5|||
125942038|NCT00507442|453086415|FG002|Overall Study|Other|2|||
125942039|NCT00507442|453086416|FG003|Overall Study|Other|2|||
125942040|NCT02410954|453086421|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
125942041|NCT02410954|453086422|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
125942042|NCT02410954|453086421|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
125942043|NCT02410954|453086422|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
125942044|NCT00751348|453086423|FG000|Overall Study|Withdrawal by Subject|5|||
125942045|NCT00751348|453086424|FG001|Overall Study|Withdrawal by Subject|2|||
125942046|NCT00751348|453086423|FG000|Overall Study|Migration from study area|1|||
125942047|NCT00751348|453086424|FG001|Overall Study|Migration from study area|0|||
125942048|NCT04829318|453086425|FG000|Overall Study|Adverse Event|6|||
125942049|NCT04829318|453086425|FG000|Overall Study|Death|1|||
125942050|NCT04829318|453086425|FG000|Overall Study|Lost to Follow-up|1|||
125942051|NCT04829318|453086425|FG000|Overall Study|Physician Decision|1|||
125942052|NCT04829318|453086425|FG000|Overall Study|Withdrawal by Subject|19|||
125942053|NCT04829318|453086425|FG000|Overall Study|Site terminated by sponsor|1|||
125942054|NCT04829318|453086425|FG000|Overall Study|Sponsor decision|5|||
125942055|NCT04829318|453086425|FG000|Overall Study|Other|1|||
125942056|NCT01826487|453086428|FG000|Overall Study|Adverse Event|1|||
125942057|NCT01826487|453086429|FG001|Overall Study|Adverse Event|1|||
125942058|NCT01826487|453086428|FG000|Overall Study|Lost to Follow-up|1|||
125942059|NCT01826487|453086429|FG001|Overall Study|Lost to Follow-up|0|||
125942060|NCT01826487|453086428|FG000|Overall Study|Withdrawal by Subject|1|||
125942061|NCT01826487|453086429|FG001|Overall Study|Withdrawal by Subject|3|||
125942062|NCT01826487|453086428|FG000|Overall Study|Protocol Violation|1|||
125942063|NCT01826487|453086429|FG001|Overall Study|Protocol Violation|1|||
125942064|NCT01408030|453086430|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
125942065|NCT01408030|453086431|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
125942066|NCT01408030|453086432|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
125942067|NCT01408030|453086433|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
125942068|NCT01408030|453086430|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
125942069|NCT01408030|453086431|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
125942070|NCT01408030|453086432|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
125942071|NCT01408030|453086433|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
125942072|NCT01408030|453086430|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
125942073|NCT01408030|453086431|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
125942074|NCT01408030|453086432|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
125942075|NCT01408030|453086433|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
125942076|NCT01408030|453086430|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
125942077|NCT01408030|453086431|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
125942078|NCT01408030|453086432|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
125942079|NCT01408030|453086433|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
125942080|NCT01408030|453086430|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
125942081|NCT01408030|453086431|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
125942082|NCT01408030|453086432|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
125942083|NCT01408030|453086433|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
126066810|NCT03602053|453536983|FG002|Overall Study|migration|0|||
125942084|NCT01408030|453086430|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
126066811|NCT03602053|453536981|FG000|Overall Study|Other|1|||
126066812|NCT03602053|453536982|FG001|Overall Study|Other|0|||
125942085|NCT01408030|453086431|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
125942086|NCT01408030|453086432|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
125942087|NCT01408030|453086433|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
125942088|NCT01408030|453086430|FG000|Observation Phase (Off Drug)|Other|1|||
125942089|NCT01408030|453086431|FG001|Observation Phase (Off Drug)|Other|1|||
125942090|NCT01408030|453086432|FG002|Observation Phase (Off Drug)|Other|1|||
125942091|NCT01408030|453086433|FG003|Observation Phase (Off Drug)|Other|1|||
125942092|NCT02081079|453086435|FG000|Overall Study|Lack of Efficacy|3|||
126066813|NCT03602053|453536983|FG002|Overall Study|Other|0|||
125942093|NCT02081079|453086436|FG001|Overall Study|Lack of Efficacy|2|||
125942094|NCT02081079|453086435|FG000|Overall Study|Lost to Follow-up|1|||
125942095|NCT02081079|453086436|FG001|Overall Study|Lost to Follow-up|0|||
125942096|NCT01712854|453086437|FG000|Overall Study|Physician Decision|1|||
125942097|NCT02225743|453086438|FG000|Overall Study|Withdrawal by Subject|18|||
125942098|NCT03886220|453086439|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
125942099|NCT03886220|453086440|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
125942100|NCT03886220|453086439|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
125942101|NCT03886220|453086440|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125942102|NCT03886220|453086439|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
125942103|NCT03886220|453086440|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125942104|NCT00768300|453086441|FG000|Overall Study|Randomized but not treated|1|||
125942105|NCT00768300|453086442|FG001|Overall Study|Randomized but not treated|1|||
125942106|NCT00768300|453086441|FG000|Overall Study|Adverse Event|10|||
125942107|NCT00768300|453086442|FG001|Overall Study|Adverse Event|2|||
125942108|NCT00768300|453086441|FG000|Overall Study|Protocol Violation|6|||
125942109|NCT00768300|453086442|FG001|Overall Study|Protocol Violation|1|||
125942110|NCT00768300|453086441|FG000|Overall Study|Withdrawal by Subject|13|||
125942111|NCT00768300|453086442|FG001|Overall Study|Withdrawal by Subject|7|||
125942112|NCT00768300|453086441|FG000|Overall Study|Physician Decision|2|||
125942113|NCT00768300|453086442|FG001|Overall Study|Physician Decision|3|||
125942114|NCT00768300|453086441|FG000|Overall Study|Study discontinued by Sponsor|271|||
125942115|NCT00768300|453086442|FG001|Overall Study|Study discontinued by Sponsor|140|||
125942116|NCT00768300|453086441|FG000|Overall Study|Death|21|||
125942117|NCT00768300|453086442|FG001|Overall Study|Death|5|||
125942118|NCT00768300|453086441|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
125942119|NCT00768300|453086442|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
125942120|NCT00768300|453086441|FG000|Overall Study|Screen failure following randomization|1|||
125942121|NCT00768300|453086442|FG001|Overall Study|Screen failure following randomization|0|||
125942122|NCT00768300|453086441|FG000|Overall Study|Received lung transplant|1|||
125942123|NCT00768300|453086442|FG001|Overall Study|Received lung transplant|1|||
125942124|NCT00768300|453086441|FG000|Overall Study|Lost to Follow-up|0|||
125942125|NCT00768300|453086442|FG001|Overall Study|Lost to Follow-up|1|||
125942126|NCT00768300|453086441|FG000|Overall Study|Began prohibited concomitant medication|0|||
125942127|NCT00768300|453086442|FG001|Overall Study|Began prohibited concomitant medication|1|||
125942128|NCT00768300|453086441|FG000|Overall Study|Treated but never dosed with Study drug|1|||
125942129|NCT00768300|453086442|FG001|Overall Study|Treated but never dosed with Study drug|0|||
125942130|NCT00768300|453086441|FG000|Overall Study|Missing data|1|||
125942131|NCT00768300|453086442|FG001|Overall Study|Missing data|0|||
125942132|NCT02068222|453086447|FG000|Overall Study|Lost to Follow-up|1|||
125942133|NCT00698581|453086450|FG000|Overall Study|Lack of Efficacy|23|||
125942134|NCT00698581|453086451|FG001|Overall Study|Lack of Efficacy|11|||
125942135|NCT00698581|453086450|FG000|Overall Study|Withdrawal by Subject|6|||
125942136|NCT00698581|453086451|FG001|Overall Study|Withdrawal by Subject|0|||
125942137|NCT00698581|453086450|FG000|Overall Study|Other reason|9|||
125942138|NCT00698581|453086451|FG001|Overall Study|Other reason|1|||
125942139|NCT00698581|453086450|FG000|Overall Study|SAE, non-fatal|1|||
125942140|NCT00698581|453086451|FG001|Overall Study|SAE, non-fatal|0|||
125942141|NCT00698581|453086450|FG000|Overall Study|AE, non-serious non-fatal|4|||
125942142|NCT00698581|453086451|FG001|Overall Study|AE, non-serious non-fatal|0|||
125942143|NCT00698581|453086450|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125942144|NCT00698581|453086451|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125942145|NCT00698581|453086450|FG000|Overall Study|AE of unknown type|1|||
125942146|NCT00698581|453086451|FG001|Overall Study|AE of unknown type|0|||
125942147|NCT00302458|453086454|FG000|Overall Study|Lost to Follow-up|1|||
125942148|NCT00302458|453086454|FG000|Overall Study|Ineligible after screening|1|||
125942149|NCT00302458|453086454|FG000|Overall Study|Withdrawal by Subject|1|||
125942150|NCT03615105|453086455|FG000|Overall Study|Protocol Violation|1|||
125942151|NCT03615105|453086456|FG001|Overall Study|Protocol Violation|0|||
125942152|NCT03615105|453086457|FG002|Overall Study|Protocol Violation|0|||
125942153|NCT03615105|453086455|FG000|Overall Study|Death|0|||
125942154|NCT03615105|453086456|FG001|Overall Study|Death|2|||
125942155|NCT03615105|453086457|FG002|Overall Study|Death|0|||
125942156|NCT04383743|453086458|FG000|Overall Study|Withdrawal by Subject|1|||
125942157|NCT04383743|453086458|FG000|Overall Study|Adverse Event|1|||
125942158|NCT04837131|453086459|FG000|Overall Study|Death|1|||
125942159|NCT04837131|453086459|FG000|Overall Study|Withdrawal by Subject|1|||
125942160|NCT04837131|453086459|FG000|Overall Study|Adverse Event|1|||
125942161|NCT04837131|453086459|FG000|Overall Study|Protocol Violation|1|||
125942162|NCT03482791|453086460|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
125942163|NCT03482791|453086461|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
125942164|NCT04690751|453086463|FG000|Overall Study|Protocol Violation|0|||
125942165|NCT04690751|453086464|FG001|Overall Study|Protocol Violation|1|||
125942166|NCT04690751|453086465|FG002|Overall Study|Protocol Violation|0|||
125942167|NCT04690751|453086466|FG003|Overall Study|Protocol Violation|1|||
126066814|NCT01038128|453536984|FG000|Overall Study|Lack of Efficacy|1|||
126066815|NCT01038128|453536984|FG000|Overall Study|Lost to Follow-up|1|||
126066816|NCT01038128|453536984|FG000|Overall Study|Withdrawal by Subject|2|||
126066817|NCT01745380|453536991|FG000|Overall Study|Lost to Follow-up|1|||
126066818|NCT01745380|453536992|FG001|Overall Study|Lost to Follow-up|0|||
126066819|NCT01745380|453536991|FG000|Overall Study|Lack of Efficacy|0|||
126066820|NCT01745380|453536992|FG001|Overall Study|Lack of Efficacy|1|||
126066821|NCT01882088|453536993|FG000|Overall Study|Intolerance of esophageal manometry|1|||
126066822|NCT01882088|453536993|FG000|Overall Study|no possibility to place the catheter|1|||
126066823|NCT01882088|453536993|FG000|Overall Study|Protocol Violation|1|||
126066824|NCT01882088|453536993|FG000|Overall Study|inadequate pH-impedance tracings|2|||
126066825|NCT01193283|453536994|FG000|Overall Study|Death|1|||
126066826|NCT00168805|453536998|FG000|Overall Study|Adverse Event|7|||
126066827|NCT00168805|453536999|FG001|Overall Study|Adverse Event|11|||
126066828|NCT00168805|453537000|FG002|Overall Study|Adverse Event|16|||
126066829|NCT00168805|453536998|FG000|Overall Study|Protocol Violation|12|||
126066830|NCT00168805|453536999|FG001|Overall Study|Protocol Violation|11|||
126066831|NCT00168805|453537000|FG002|Overall Study|Protocol Violation|8|||
126066832|NCT00168805|453536998|FG000|Overall Study|Lost to Follow-up|12|||
126066833|NCT00168805|453536999|FG001|Overall Study|Lost to Follow-up|17|||
126066834|NCT00168805|453537000|FG002|Overall Study|Lost to Follow-up|11|||
126066835|NCT00168805|453536998|FG000|Overall Study|Withdrawal by Subject|16|||
125942168|NCT04690751|453086467|FG004|Overall Study|Protocol Violation|2|||
125942169|NCT04690751|453086468|FG005|Overall Study|Protocol Violation|0|||
125942170|NCT04690751|453086463|FG000|Overall Study|Adverse Event|0|||
125942171|NCT04690751|453086464|FG001|Overall Study|Adverse Event|0|||
125942172|NCT04690751|453086465|FG002|Overall Study|Adverse Event|1|||
125942173|NCT04690751|453086466|FG003|Overall Study|Adverse Event|0|||
125942174|NCT04690751|453086467|FG004|Overall Study|Adverse Event|0|||
125942175|NCT04690751|453086468|FG005|Overall Study|Adverse Event|0|||
125942176|NCT04690751|453086463|FG000|Overall Study|Positive urine drug screen test|0|||
125942177|NCT04690751|453086464|FG001|Overall Study|Positive urine drug screen test|0|||
125942178|NCT04690751|453086465|FG002|Overall Study|Positive urine drug screen test|0|||
125942179|NCT04690751|453086466|FG003|Overall Study|Positive urine drug screen test|0|||
125942180|NCT04690751|453086467|FG004|Overall Study|Positive urine drug screen test|1|||
125942181|NCT04690751|453086468|FG005|Overall Study|Positive urine drug screen test|0|||
125942182|NCT04364620|453086469|FG000|Overall Study|Disease Progression|20|||
125942183|NCT04364620|453086469|FG000|Overall Study|Adverse Event|5|||
125942184|NCT04364620|453086469|FG000|Overall Study|Physician Decision|4|||
125942185|NCT04364620|453086469|FG000|Overall Study|Death|3|||
125942186|NCT04364620|453086469|FG000|Overall Study|Other|2|||
125942187|NCT04364620|453086469|FG000|Overall Study|Withdrawal by Subject|1|||
125942188|NCT01239368|453089380|FG000|Overall Study|Principal investigator discretion|1|||
125942189|NCT01239368|453089381|FG001|Overall Study|Principal investigator discretion|0|||
125942190|NCT01239368|453089382|FG002|Overall Study|Principal investigator discretion|0|||
125942191|NCT01239368|453089383|FG003|Overall Study|Principal investigator discretion|0|||
125942192|NCT01239368|453089384|FG004|Overall Study|Principal investigator discretion|1|||
125942193|NCT01239368|453089385|FG005|Overall Study|Principal investigator discretion|2|||
125942194|NCT01239368|453089386|FG006|Overall Study|Principal investigator discretion|0|||
125942195|NCT01239368|453089387|FG007|Overall Study|Principal investigator discretion|0|||
125942196|NCT01239368|453089388|FG008|Overall Study|Principal investigator discretion|0|||
125942197|NCT01239368|453089389|FG009|Overall Study|Principal investigator discretion|1|||
125942198|NCT01239368|453089380|FG000|Overall Study|Disease progression on study|1|||
125942199|NCT01239368|453089381|FG001|Overall Study|Disease progression on study|1|||
125942200|NCT01239368|453089382|FG002|Overall Study|Disease progression on study|1|||
125942201|NCT01239368|453089383|FG003|Overall Study|Disease progression on study|1|||
125942202|NCT01239368|453089384|FG004|Overall Study|Disease progression on study|4|||
125942203|NCT01239368|453089385|FG005|Overall Study|Disease progression on study|2|||
125942204|NCT01239368|453089386|FG006|Overall Study|Disease progression on study|5|||
125942205|NCT01239368|453089387|FG007|Overall Study|Disease progression on study|0|||
125942206|NCT01239368|453089388|FG008|Overall Study|Disease progression on study|0|||
125942207|NCT01239368|453089389|FG009|Overall Study|Disease progression on study|2|||
125942208|NCT01239368|453089380|FG000|Overall Study|Refused further treatment|0|||
125942209|NCT01239368|453089381|FG001|Overall Study|Refused further treatment|0|||
125942210|NCT01239368|453089382|FG002|Overall Study|Refused further treatment|0|||
125942211|NCT01239368|453089383|FG003|Overall Study|Refused further treatment|0|||
125942212|NCT01239368|453089384|FG004|Overall Study|Refused further treatment|0|||
125942213|NCT01239368|453089385|FG005|Overall Study|Refused further treatment|0|||
125942214|NCT01239368|453089386|FG006|Overall Study|Refused further treatment|0|||
125942215|NCT01239368|453089387|FG007|Overall Study|Refused further treatment|0|||
125942216|NCT01239368|453089388|FG008|Overall Study|Refused further treatment|0|||
125942217|NCT01239368|453089389|FG009|Overall Study|Refused further treatment|1|||
126066836|NCT00168805|453536999|FG001|Overall Study|Withdrawal by Subject|18|||
126066837|NCT00168805|453537000|FG002|Overall Study|Withdrawal by Subject|21|||
126066838|NCT00168805|453536998|FG000|Overall Study|Other|24|||
126114326|NCT01186939|453713792|FG000|Overall Study|Bone marrow transplant|1|||
125942218|NCT01239368|453089380|FG000|Overall Study|Death|0|||
125942219|NCT01239368|453089381|FG001|Overall Study|Death|0|||
125942220|NCT01239368|453089382|FG002|Overall Study|Death|0|||
125942221|NCT01239368|453089383|FG003|Overall Study|Death|0|||
125942222|NCT01239368|453089384|FG004|Overall Study|Death|0|||
125942223|NCT01239368|453089385|FG005|Overall Study|Death|0|||
125942224|NCT01239368|453089386|FG006|Overall Study|Death|1|||
125942225|NCT01239368|453089387|FG007|Overall Study|Death|0|||
125942226|NCT01239368|453089388|FG008|Overall Study|Death|0|||
125942227|NCT01239368|453089389|FG009|Overall Study|Death|0|||
125942228|NCT04579380|453089390|FG000|Overall Study|Death|9|||
125942229|NCT04579380|453089391|FG001|Overall Study|Death|22|||
125942230|NCT04579380|453089392|FG002|Overall Study|Death|22|||
125942231|NCT04579380|453089393|FG003|Overall Study|Death|17|||
125942232|NCT04579380|453089394|FG004|Overall Study|Death|6|||
125942233|NCT04579380|453089395|FG005|Overall Study|Death|21|||
125942234|NCT04579380|453089396|FG006|Overall Study|Death|10|||
125942235|NCT04579380|453089397|FG007|Overall Study|Death|11|||
125942236|NCT04579380|453089398|FG008|Overall Study|Death|25|||
125942237|NCT04579380|453089390|FG000|Overall Study|Withdrawal by Subject|0|||
125942238|NCT04579380|453089391|FG001|Overall Study|Withdrawal by Subject|3|||
125942239|NCT04579380|453089392|FG002|Overall Study|Withdrawal by Subject|4|||
125942240|NCT04579380|453089393|FG003|Overall Study|Withdrawal by Subject|0|||
125942241|NCT04579380|453089394|FG004|Overall Study|Withdrawal by Subject|1|||
125942242|NCT04579380|453089395|FG005|Overall Study|Withdrawal by Subject|2|||
125942243|NCT04579380|453089396|FG006|Overall Study|Withdrawal by Subject|0|||
125942244|NCT04579380|453089397|FG007|Overall Study|Withdrawal by Subject|1|||
125942245|NCT04579380|453089398|FG008|Overall Study|Withdrawal by Subject|2|||
125942246|NCT04579380|453089390|FG000|Overall Study|Ongoing|2|||
125942247|NCT04579380|453089391|FG001|Overall Study|Ongoing|6|||
125942248|NCT04579380|453089392|FG002|Overall Study|Ongoing|4|||
125942249|NCT04579380|453089393|FG003|Overall Study|Ongoing|8|||
125942250|NCT04579380|453089394|FG004|Overall Study|Ongoing|5|||
125942251|NCT04579380|453089395|FG005|Overall Study|Ongoing|8|||
125942252|NCT04579380|453089396|FG006|Overall Study|Ongoing|3|||
125942253|NCT04579380|453089397|FG007|Overall Study|Ongoing|19|||
125942254|NCT04579380|453089398|FG008|Overall Study|Ongoing|6|||
125942255|NCT02967692|453089399|FG000|Overall Study|Progressive disease|3|||
125942256|NCT02967692|453089400|FG001|Overall Study|Progressive disease|15|||
125942257|NCT02967692|453089401|FG002|Overall Study|Progressive disease|114|||
125942258|NCT02967692|453089402|FG003|Overall Study|Progressive disease|151|||
125942259|NCT02967692|453089399|FG000|Overall Study|Subject/guardian decision|1|||
125942260|NCT02967692|453089400|FG001|Overall Study|Subject/guardian decision|1|||
125942261|NCT02967692|453089401|FG002|Overall Study|Subject/guardian decision|14|||
125942262|NCT02967692|453089402|FG003|Overall Study|Subject/guardian decision|22|||
125942263|NCT02967692|453089399|FG000|Overall Study|Death|0|||
125942264|NCT02967692|453089400|FG001|Overall Study|Death|1|||
125942265|NCT02967692|453089401|FG002|Overall Study|Death|13|||
125942266|NCT02967692|453089402|FG003|Overall Study|Death|13|||
125942267|NCT02967692|453089399|FG000|Overall Study|Protocol deviation|1|||
125942268|NCT02967692|453089400|FG001|Overall Study|Protocol deviation|0|||
125942269|NCT02967692|453089401|FG002|Overall Study|Protocol deviation|1|||
125942270|NCT02967692|453089402|FG003|Overall Study|Protocol deviation|1|||
125942271|NCT02967692|453089399|FG000|Overall Study|Lost to Follow-up|0|||
125942272|NCT02967692|453089400|FG001|Overall Study|Lost to Follow-up|0|||
125942273|NCT02967692|453089401|FG002|Overall Study|Lost to Follow-up|1|||
125942274|NCT02967692|453089402|FG003|Overall Study|Lost to Follow-up|0|||
125942275|NCT02967692|453089399|FG000|Overall Study|Physician Decision|0|||
125942276|NCT02967692|453089400|FG001|Overall Study|Physician Decision|0|||
125942277|NCT02967692|453089401|FG002|Overall Study|Physician Decision|22|||
125942278|NCT02967692|453089402|FG003|Overall Study|Physician Decision|13|||
125942279|NCT02967692|453089399|FG000|Overall Study|Adverse Event|2|||
125942280|NCT02967692|453089400|FG001|Overall Study|Adverse Event|9|||
125942281|NCT02967692|453089401|FG002|Overall Study|Adverse Event|60|||
126114327|NCT01186939|453713792|FG000|Overall Study|Transformation to AML|1|||
125942282|NCT02967692|453089402|FG003|Overall Study|Adverse Event|28|||
125942283|NCT02967692|453089399|FG000|Overall Study|Study terminated by sponsor|2|||
125942284|NCT02967692|453089400|FG001|Overall Study|Study terminated by sponsor|1|||
125942285|NCT02967692|453089401|FG002|Overall Study|Study terminated by sponsor|42|||
125942286|NCT02967692|453089402|FG003|Overall Study|Study terminated by sponsor|37|||
125942287|NCT00066066|453089405|FG000|Overall Study|Lost to Follow-up|6|||
125942288|NCT00066066|453089406|FG001|Overall Study|Lost to Follow-up|4|||
125942289|NCT00066066|453089407|FG002|Overall Study|Lost to Follow-up|7|||
125942290|NCT00066066|453089408|FG003|Overall Study|Lost to Follow-up|4|||
125942291|NCT00066066|453089409|FG004|Overall Study|Lost to Follow-up|3|||
125942292|NCT00066066|453089410|FG005|Overall Study|Lost to Follow-up|5|||
125942293|NCT02268409|453089411|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
125942294|NCT02268409|453089411|FG000|Overall Study|Death|1|||
125942295|NCT02268409|453089411|FG000|Overall Study|Lost to Follow-up|1|||
125942296|NCT02268409|453089411|FG000|Overall Study|Protocol Violation|3|||
125942297|NCT02268409|453089411|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
125942298|NCT02268409|453089411|FG000|Overall Study|Withdrawal by Subject|5|||
125942299|NCT00489853|453089416|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
125942300|NCT00489853|453089417|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
125942301|NCT00489853|453089418|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
125942302|NCT00489853|453089416|FG000|Wash-out Period 1|Adverse Event|0|||
125942303|NCT00489853|453089417|FG001|Wash-out Period 1|Adverse Event|1|||
125942304|NCT00489853|453089418|FG002|Wash-out Period 1|Adverse Event|1|||
125942305|NCT00489853|453089416|FG000|Wash-out Period 1|Protocol Violation|0|||
125942306|NCT00489853|453089417|FG001|Wash-out Period 1|Protocol Violation|1|||
125942307|NCT00489853|453089418|FG002|Wash-out Period 1|Protocol Violation|1|||
125942308|NCT00489853|453089416|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
125942309|NCT00489853|453089417|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
125942310|NCT00489853|453089418|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
125942311|NCT00489853|453089416|FG000|Wash-out Period 2|Adverse Event|1|||
125942312|NCT00489853|453089417|FG001|Wash-out Period 2|Adverse Event|1|||
125942313|NCT00489853|453089418|FG002|Wash-out Period 2|Adverse Event|0|||
125942314|NCT00489853|453089416|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
125942315|NCT00489853|453089417|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
125942316|NCT00489853|453089418|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
125942317|NCT00489853|453089416|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
125942318|NCT00489853|453089417|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
125942319|NCT00489853|453089418|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
125942320|NCT01541969|453089422|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
125942321|NCT01541969|453089423|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
125942322|NCT01541969|453089422|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
125942323|NCT01541969|453089423|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
125942324|NCT01541969|453089422|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
125942325|NCT01541969|453089423|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
125942326|NCT01541969|453089422|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
125942327|NCT01541969|453089423|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
125942328|NCT01541969|453089422|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
125942329|NCT01541969|453089423|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
125942330|NCT01541969|453089422|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
125942331|NCT01541969|453089423|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
125942332|NCT01541969|453089422|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
125942333|NCT01541969|453089423|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
125942334|NCT01541969|453089422|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
125942335|NCT01541969|453089423|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
125942336|NCT01541969|453089422|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
125942337|NCT01541969|453089423|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
125942338|NCT01541969|453089422|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
125942339|NCT01541969|453089423|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
125942340|NCT01614990|453089424|FG000|Overall Study|Protocol Violation|1|||
125942341|NCT01614990|453089425|FG001|Overall Study|Protocol Violation|1|||
125942342|NCT05129488|453089426|FG000|Overall Study|Protocol Violation|3|||
125942343|NCT02608268|453089427|FG000|Overall Study|Adverse Event|0|||
125942344|NCT02608268|453089428|FG001|Overall Study|Adverse Event|0|||
125942345|NCT02608268|453089429|FG002|Overall Study|Adverse Event|1|||
125942346|NCT02608268|453089430|FG003|Overall Study|Adverse Event|0|||
125942347|NCT02608268|453089431|FG004|Overall Study|Adverse Event|0|||
125942348|NCT02608268|453089432|FG005|Overall Study|Adverse Event|0|||
125942349|NCT02608268|453089433|FG006|Overall Study|Adverse Event|0|||
125942350|NCT02608268|453089434|FG007|Overall Study|Adverse Event|0|||
125942351|NCT02608268|453089435|FG008|Overall Study|Adverse Event|0|||
125942352|NCT02608268|453089436|FG009|Overall Study|Adverse Event|0|||
125942353|NCT02608268|453089437|FG010|Overall Study|Adverse Event|0|||
125942354|NCT02608268|453089438|FG011|Overall Study|Adverse Event|0|||
125942355|NCT02608268|453089439|FG012|Overall Study|Adverse Event|2|||
125942356|NCT02608268|453089440|FG013|Overall Study|Adverse Event|0|||
125942357|NCT02608268|453089441|FG014|Overall Study|Adverse Event|0|||
125942358|NCT02608268|453089442|FG015|Overall Study|Adverse Event|0|||
125942359|NCT02608268|453089443|FG016|Overall Study|Adverse Event|0|||
125942360|NCT02608268|453089444|FG017|Overall Study|Adverse Event|0|||
125942361|NCT02608268|453089445|FG018|Overall Study|Adverse Event|0|||
125942362|NCT02608268|453089446|FG019|Overall Study|Adverse Event|0|||
125942363|NCT02608268|453089447|FG020|Overall Study|Adverse Event|1|||
125942364|NCT02608268|453089448|FG021|Overall Study|Adverse Event|1|||
125942365|NCT02608268|453089449|FG022|Overall Study|Adverse Event|0|||
125942366|NCT02608268|453089450|FG023|Overall Study|Adverse Event|0|||
125942367|NCT02608268|453089451|FG024|Overall Study|Adverse Event|1|||
125942368|NCT02608268|453089452|FG025|Overall Study|Adverse Event|0|||
125942369|NCT02608268|453089453|FG026|Overall Study|Adverse Event|0|||
125942370|NCT02608268|453089454|FG027|Overall Study|Adverse Event|0|||
125942371|NCT02608268|453089455|FG028|Overall Study|Adverse Event|1|||
125942372|NCT02608268|453089456|FG029|Overall Study|Adverse Event|0|||
125942373|NCT02608268|453089427|FG000|Overall Study|Death|1|||
125942374|NCT02608268|453089428|FG001|Overall Study|Death|0|||
125942375|NCT02608268|453089429|FG002|Overall Study|Death|0|||
125942376|NCT02608268|453089430|FG003|Overall Study|Death|0|||
126066839|NCT00168805|453536999|FG001|Overall Study|Other|21|||
126066840|NCT00168805|453537000|FG002|Overall Study|Other|22|||
126066841|NCT00168805|453536998|FG000|Treatment|Adverse Event|25|||
126066842|NCT00168805|453536999|FG001|Treatment|Adverse Event|26|||
126066843|NCT00168805|453537000|FG002|Treatment|Adverse Event|32|||
126066844|NCT00168805|453536998|FG000|Treatment|Protocol Violation|3|||
126066845|NCT00168805|453536999|FG001|Treatment|Protocol Violation|5|||
126066846|NCT00168805|453537000|FG002|Treatment|Protocol Violation|5|||
126066847|NCT00168805|453536998|FG000|Treatment|Withdrawal by Subject|3|||
126066848|NCT00168805|453536999|FG001|Treatment|Withdrawal by Subject|7|||
126066849|NCT00168805|453537000|FG002|Treatment|Withdrawal by Subject|8|||
126066850|NCT00168805|453536998|FG000|Treatment|Other|18|||
126066851|NCT00168805|453536999|FG001|Treatment|Other|18|||
126066852|NCT00168805|453537000|FG002|Treatment|Other|17|||
126066853|NCT04879823|453537001|FG000|Overall Study|Physician Decision|3|||
126066854|NCT04879823|453537002|FG001|Overall Study|Physician Decision|1|||
126066855|NCT04879823|453537001|FG000|Overall Study|Protocol Violation|2|||
126066856|NCT04879823|453537002|FG001|Overall Study|Protocol Violation|3|||
126066857|NCT04879823|453537001|FG000|Overall Study|Lost to Follow-up|43|||
126066858|NCT04879823|453537002|FG001|Overall Study|Lost to Follow-up|35|||
126066859|NCT04468633|453537005|FG000|Overall Study|Withdrawal by Subject|4|||
126066860|NCT04468633|453537006|FG001|Overall Study|Withdrawal by Subject|0|||
126066861|NCT00460434|453537009|FG000|Overall Study|Lost to Follow-up|3|||
126066862|NCT00460434|453537010|FG001|Overall Study|Lost to Follow-up|7|||
126066863|NCT02446912|453537034|FG000|Overall Study|Adverse Event|3|||
126066864|NCT02446912|453537035|FG001|Overall Study|Adverse Event|13|||
126066865|NCT02446912|453537036|FG002|Overall Study|Adverse Event|5|||
126066866|NCT02446912|453537034|FG000|Overall Study|Condition under investigation worsened|0|||
126066867|NCT02446912|453537035|FG001|Overall Study|Condition under investigation worsened|1|||
126066868|NCT02446912|453537036|FG002|Overall Study|Condition under investigation worsened|1|||
126066869|NCT02446912|453537034|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126066870|NCT02446912|453537035|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126066871|NCT02446912|453537036|FG002|Overall Study|Study-specific withdrawal criteria|0|||
126066872|NCT02446912|453537034|FG000|Overall Study|Lack of Efficacy|1|||
126066873|NCT02446912|453537035|FG001|Overall Study|Lack of Efficacy|4|||
126066874|NCT02446912|453537036|FG002|Overall Study|Lack of Efficacy|7|||
126066875|NCT02446912|453537034|FG000|Overall Study|Lost to Follow-up|0|||
126066876|NCT02446912|453537035|FG001|Overall Study|Lost to Follow-up|0|||
126066877|NCT02446912|453537036|FG002|Overall Study|Lost to Follow-up|2|||
126114328|NCT00616434|453713793|FG000|Overall Study|Adverse Event|5|||
126114329|NCT00616434|453713794|FG001|Overall Study|Adverse Event|2|||
126114330|NCT00616434|453713793|FG000|Overall Study|Physician Decision|0|||
125942377|NCT02608268|453089431|FG004|Overall Study|Death|0|||
125942378|NCT02608268|453089432|FG005|Overall Study|Death|0|||
125942379|NCT02608268|453089433|FG006|Overall Study|Death|0|||
125942380|NCT02608268|453089434|FG007|Overall Study|Death|0|||
125942381|NCT02608268|453089435|FG008|Overall Study|Death|1|||
125942382|NCT02608268|453089436|FG009|Overall Study|Death|1|||
125942383|NCT02608268|453089437|FG010|Overall Study|Death|0|||
125942384|NCT02608268|453089438|FG011|Overall Study|Death|0|||
125942385|NCT02608268|453089439|FG012|Overall Study|Death|0|||
125942386|NCT02608268|453089440|FG013|Overall Study|Death|0|||
125942387|NCT02608268|453089441|FG014|Overall Study|Death|0|||
125942388|NCT02608268|453089442|FG015|Overall Study|Death|1|||
125942389|NCT02608268|453089443|FG016|Overall Study|Death|0|||
125942390|NCT02608268|453089444|FG017|Overall Study|Death|1|||
125942391|NCT02608268|453089445|FG018|Overall Study|Death|0|||
125942392|NCT02608268|453089446|FG019|Overall Study|Death|1|||
125942393|NCT02608268|453089447|FG020|Overall Study|Death|1|||
126066878|NCT02446912|453537034|FG000|Overall Study|Severe non-compliance to protocol|1|||
126114331|NCT00616434|453713794|FG001|Overall Study|Physician Decision|4|||
125942394|NCT02608268|453089448|FG021|Overall Study|Death|0|||
125942395|NCT02608268|453089449|FG022|Overall Study|Death|0|||
125942396|NCT02608268|453089450|FG023|Overall Study|Death|0|||
125942397|NCT02608268|453089451|FG024|Overall Study|Death|1|||
125942398|NCT02608268|453089452|FG025|Overall Study|Death|2|||
125942399|NCT02608268|453089453|FG026|Overall Study|Death|0|||
125942400|NCT02608268|453089454|FG027|Overall Study|Death|1|||
125942401|NCT02608268|453089455|FG028|Overall Study|Death|4|||
125942402|NCT02608268|453089456|FG029|Overall Study|Death|0|||
125942403|NCT02608268|453089427|FG000|Overall Study|Physician Decision|0|||
125942404|NCT02608268|453089428|FG001|Overall Study|Physician Decision|0|||
126066879|NCT02446912|453537035|FG001|Overall Study|Severe non-compliance to protocol|0|||
126066880|NCT02446912|453537036|FG002|Overall Study|Severe non-compliance to protocol|1|||
126066881|NCT02446912|453537034|FG000|Overall Study|Withdrawal by Subject|10|||
126066882|NCT02446912|453537035|FG001|Overall Study|Withdrawal by Subject|15|||
125942405|NCT02608268|453089429|FG002|Overall Study|Physician Decision|0|||
125942406|NCT02608268|453089430|FG003|Overall Study|Physician Decision|0|||
125942407|NCT02608268|453089431|FG004|Overall Study|Physician Decision|0|||
125942408|NCT02608268|453089432|FG005|Overall Study|Physician Decision|0|||
125942409|NCT02608268|453089433|FG006|Overall Study|Physician Decision|0|||
125942410|NCT02608268|453089434|FG007|Overall Study|Physician Decision|0|||
125942411|NCT02608268|453089435|FG008|Overall Study|Physician Decision|0|||
125942412|NCT02608268|453089436|FG009|Overall Study|Physician Decision|0|||
125942413|NCT02608268|453089437|FG010|Overall Study|Physician Decision|1|||
125942414|NCT02608268|453089438|FG011|Overall Study|Physician Decision|0|||
125942415|NCT02608268|453089439|FG012|Overall Study|Physician Decision|0|||
125942416|NCT02608268|453089440|FG013|Overall Study|Physician Decision|1|||
125942417|NCT02608268|453089441|FG014|Overall Study|Physician Decision|0|||
125942418|NCT02608268|453089442|FG015|Overall Study|Physician Decision|0|||
125942419|NCT02608268|453089443|FG016|Overall Study|Physician Decision|0|||
125942420|NCT02608268|453089444|FG017|Overall Study|Physician Decision|0|||
125942421|NCT02608268|453089445|FG018|Overall Study|Physician Decision|0|||
125942422|NCT02608268|453089446|FG019|Overall Study|Physician Decision|0|||
125942423|NCT02608268|453089447|FG020|Overall Study|Physician Decision|0|||
125942424|NCT02608268|453089448|FG021|Overall Study|Physician Decision|0|||
125942425|NCT02608268|453089449|FG022|Overall Study|Physician Decision|1|||
125942426|NCT02608268|453089450|FG023|Overall Study|Physician Decision|1|||
125942427|NCT02608268|453089451|FG024|Overall Study|Physician Decision|1|||
125942428|NCT02608268|453089452|FG025|Overall Study|Physician Decision|0|||
125942429|NCT02608268|453089453|FG026|Overall Study|Physician Decision|0|||
125942430|NCT02608268|453089454|FG027|Overall Study|Physician Decision|2|||
125942431|NCT02608268|453089455|FG028|Overall Study|Physician Decision|1|||
125942432|NCT02608268|453089456|FG029|Overall Study|Physician Decision|1|||
125942433|NCT02608268|453089427|FG000|Overall Study|Progressive disease|12|||
125942434|NCT02608268|453089428|FG001|Overall Study|Progressive disease|8|||
125942435|NCT02608268|453089429|FG002|Overall Study|Progressive disease|13|||
125942436|NCT02608268|453089430|FG003|Overall Study|Progressive disease|5|||
125942437|NCT02608268|453089431|FG004|Overall Study|Progressive disease|2|||
125942438|NCT02608268|453089432|FG005|Overall Study|Progressive disease|4|||
125942439|NCT02608268|453089433|FG006|Overall Study|Progressive disease|6|||
125942440|NCT02608268|453089434|FG007|Overall Study|Progressive disease|2|||
125942441|NCT02608268|453089435|FG008|Overall Study|Progressive disease|5|||
125942442|NCT02608268|453089436|FG009|Overall Study|Progressive disease|6|||
125942443|NCT02608268|453089437|FG010|Overall Study|Progressive disease|5|||
125942444|NCT02608268|453089438|FG011|Overall Study|Progressive disease|5|||
125942445|NCT02608268|453089439|FG012|Overall Study|Progressive disease|4|||
125942446|NCT02608268|453089440|FG013|Overall Study|Progressive disease|11|||
125942447|NCT02608268|453089441|FG014|Overall Study|Progressive disease|6|||
125942448|NCT02608268|453089442|FG015|Overall Study|Progressive disease|3|||
125942449|NCT02608268|453089443|FG016|Overall Study|Progressive disease|5|||
125942450|NCT02608268|453089444|FG017|Overall Study|Progressive disease|5|||
125942451|NCT02608268|453089445|FG018|Overall Study|Progressive disease|5|||
125942452|NCT02608268|453089446|FG019|Overall Study|Progressive disease|2|||
125942453|NCT02608268|453089447|FG020|Overall Study|Progressive disease|10|||
125942454|NCT02608268|453089448|FG021|Overall Study|Progressive disease|4|||
125942455|NCT02608268|453089449|FG022|Overall Study|Progressive disease|5|||
125942456|NCT02608268|453089450|FG023|Overall Study|Progressive disease|5|||
125942457|NCT02608268|453089451|FG024|Overall Study|Progressive disease|3|||
125942458|NCT02608268|453089452|FG025|Overall Study|Progressive disease|11|||
125942459|NCT02608268|453089453|FG026|Overall Study|Progressive disease|16|||
125942460|NCT02608268|453089454|FG027|Overall Study|Progressive disease|11|||
125942461|NCT02608268|453089455|FG028|Overall Study|Progressive disease|10|||
125942462|NCT02608268|453089456|FG029|Overall Study|Progressive disease|15|||
125942463|NCT02608268|453089427|FG000|Overall Study|Subject/guardian decision|1|||
125942464|NCT02608268|453089428|FG001|Overall Study|Subject/guardian decision|1|||
125942465|NCT02608268|453089429|FG002|Overall Study|Subject/guardian decision|2|||
126066883|NCT02446912|453537036|FG002|Overall Study|Withdrawal by Subject|15|||
126066884|NCT02446912|453537034|FG000|Overall Study|Miscellaneous|2|||
126066885|NCT02446912|453537035|FG001|Overall Study|Miscellaneous|2|||
125942466|NCT02608268|453089430|FG003|Overall Study|Subject/guardian decision|0|||
125942467|NCT02608268|453089431|FG004|Overall Study|Subject/guardian decision|0|||
125942468|NCT02608268|453089432|FG005|Overall Study|Subject/guardian decision|0|||
125942469|NCT02608268|453089433|FG006|Overall Study|Subject/guardian decision|0|||
125942470|NCT02608268|453089434|FG007|Overall Study|Subject/guardian decision|0|||
125942471|NCT02608268|453089435|FG008|Overall Study|Subject/guardian decision|2|||
125942472|NCT02608268|453089436|FG009|Overall Study|Subject/guardian decision|2|||
125942473|NCT02608268|453089437|FG010|Overall Study|Subject/guardian decision|0|||
125942474|NCT02608268|453089438|FG011|Overall Study|Subject/guardian decision|1|||
125942475|NCT02608268|453089439|FG012|Overall Study|Subject/guardian decision|0|||
125942476|NCT02608268|453089440|FG013|Overall Study|Subject/guardian decision|1|||
125942477|NCT02608268|453089441|FG014|Overall Study|Subject/guardian decision|0|||
125942478|NCT02608268|453089442|FG015|Overall Study|Subject/guardian decision|1|||
125942479|NCT02608268|453089443|FG016|Overall Study|Subject/guardian decision|0|||
126066886|NCT02446912|453537036|FG002|Overall Study|Miscellaneous|4|||
126066887|NCT01268488|453537037|FG000|Overall Study|Adverse Event|3|||
125942480|NCT02608268|453089444|FG017|Overall Study|Subject/guardian decision|0|||
125942481|NCT02608268|453089445|FG018|Overall Study|Subject/guardian decision|1|||
125942482|NCT02608268|453089446|FG019|Overall Study|Subject/guardian decision|0|||
125942483|NCT02608268|453089447|FG020|Overall Study|Subject/guardian decision|0|||
125942484|NCT02608268|453089448|FG021|Overall Study|Subject/guardian decision|0|||
125942485|NCT02608268|453089449|FG022|Overall Study|Subject/guardian decision|1|||
125942486|NCT02608268|453089450|FG023|Overall Study|Subject/guardian decision|0|||
125942487|NCT02608268|453089451|FG024|Overall Study|Subject/guardian decision|0|||
125942488|NCT02608268|453089452|FG025|Overall Study|Subject/guardian decision|1|||
125942489|NCT02608268|453089453|FG026|Overall Study|Subject/guardian decision|1|||
125942490|NCT02608268|453089454|FG027|Overall Study|Subject/guardian decision|1|||
125942491|NCT02608268|453089455|FG028|Overall Study|Subject/guardian decision|1|||
125942492|NCT02608268|453089456|FG029|Overall Study|Subject/guardian decision|0|||
125942493|NCT01012622|453089457|FG000|Overall Study|Withdrawal by Subject|6|||
125942494|NCT01012622|453089457|FG000|Overall Study|Lost to Follow-up|5|||
125942495|NCT01012622|453089457|FG000|Overall Study|Adverse Event|7|||
125942496|NCT01012622|453089457|FG000|Overall Study|non-compliance with the drug|9|||
125942497|NCT01012622|453089457|FG000|Overall Study|Other|1|||
125942498|NCT01012622|453089457|FG000|Overall Study|screening failure|1|||
125942499|NCT01012622|453089457|FG000|Overall Study|withdrawal of consent by a parent|2|||
125942500|NCT00588822|453089458|FG000|Overall Study|progression of disease|8|||
125942501|NCT02082210|453089460|FG000|Overall Study|Death|0|||
125942502|NCT02082210|453089461|FG001|Overall Study|Death|0|||
125942503|NCT02082210|453089462|FG002|Overall Study|Death|1|||
125942504|NCT02082210|453089463|FG003|Overall Study|Death|1|||
125942505|NCT02082210|453089464|FG004|Overall Study|Death|1|||
125942506|NCT02082210|453089465|FG005|Overall Study|Death|0|||
125942507|NCT02082210|453089460|FG000|Overall Study|Withdrawal by Subject|0|||
125942508|NCT02082210|453089461|FG001|Overall Study|Withdrawal by Subject|0|||
125942509|NCT02082210|453089462|FG002|Overall Study|Withdrawal by Subject|0|||
125942510|NCT02082210|453089463|FG003|Overall Study|Withdrawal by Subject|1|||
125942511|NCT02082210|453089464|FG004|Overall Study|Withdrawal by Subject|2|||
125942512|NCT02082210|453089465|FG005|Overall Study|Withdrawal by Subject|2|||
125942513|NCT02082210|453089460|FG000|Overall Study|Clinical Progression|0|||
125942514|NCT02082210|453089461|FG001|Overall Study|Clinical Progression|0|||
125942515|NCT02082210|453089462|FG002|Overall Study|Clinical Progression|0|||
125942516|NCT02082210|453089463|FG003|Overall Study|Clinical Progression|1|||
125942517|NCT02082210|453089464|FG004|Overall Study|Clinical Progression|0|||
125942518|NCT02082210|453089465|FG005|Overall Study|Clinical Progression|0|||
125942519|NCT02082210|453089460|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
125942520|NCT02082210|453089461|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
125942521|NCT02082210|453089462|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
125942522|NCT02082210|453089463|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
125942523|NCT02082210|453089464|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
125942524|NCT02082210|453089465|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
125942525|NCT02082210|453089460|FG000|Overall Study|Physician Decision|0|||
125942526|NCT02082210|453089461|FG001|Overall Study|Physician Decision|0|||
125942527|NCT02082210|453089462|FG002|Overall Study|Physician Decision|1|||
125942528|NCT02082210|453089463|FG003|Overall Study|Physician Decision|1|||
125942529|NCT02082210|453089464|FG004|Overall Study|Physician Decision|0|||
125942530|NCT02082210|453089465|FG005|Overall Study|Physician Decision|0|||
125942531|NCT04762680|453089466|FG000|Phase 2|Adverse Event|0|||
125942532|NCT04762680|453089467|FG001|Phase 2|Adverse Event|1|||
125942533|NCT04762680|453089468|FG002|Phase 2|Adverse Event|0|||
125942534|NCT04762680|453089469|FG003|Phase 2|Adverse Event|0|||
125942535|NCT04762680|453089470|FG004|Phase 2|Adverse Event|0|||
125942536|NCT04762680|453089471|FG005|Phase 2|Adverse Event|0|||
125942537|NCT04762680|453089472|FG006|Phase 2|Adverse Event|0|||
125942538|NCT04762680|453089473|FG007|Phase 2|Adverse Event|0|||
125942539|NCT04762680|453089474|FG008|Phase 2|Adverse Event|0|||
125942540|NCT04762680|453089475|FG009|Phase 2|Adverse Event|0|||
125942541|NCT04762680|453089476|FG010|Phase 2|Adverse Event|0|||
125942542|NCT04762680|453089477|FG011|Phase 2|Adverse Event|0|||
125942543|NCT04762680|453089478|FG012|Phase 2|Adverse Event|0|||
125942544|NCT04762680|453089479|FG013|Phase 2|Adverse Event|0|||
125942545|NCT04762680|453089480|FG014|Phase 2|Adverse Event|0|||
125942546|NCT04762680|453089481|FG015|Phase 2|Adverse Event|0|||
125942547|NCT04762680|453089482|FG016|Phase 2|Adverse Event|0|||
125942548|NCT04762680|453089483|FG017|Phase 2|Adverse Event|0|||
125942549|NCT04762680|453089484|FG018|Phase 2|Adverse Event|0|||
125942550|NCT04762680|453089485|FG019|Phase 2|Adverse Event|0|||
125942551|NCT04762680|453089486|FG020|Phase 2|Adverse Event|0|||
125942552|NCT04762680|453089487|FG021|Phase 2|Adverse Event|0|||
125942553|NCT04762680|453089466|FG000|Phase 2|Protocol Violation|5|||
125942554|NCT04762680|453089467|FG001|Phase 2|Protocol Violation|5|||
125942555|NCT04762680|453089468|FG002|Phase 2|Protocol Violation|1|||
125942556|NCT04762680|453089469|FG003|Phase 2|Protocol Violation|0|||
125942557|NCT04762680|453089470|FG004|Phase 2|Protocol Violation|0|||
125942558|NCT04762680|453089471|FG005|Phase 2|Protocol Violation|0|||
125942559|NCT04762680|453089472|FG006|Phase 2|Protocol Violation|0|||
125942560|NCT04762680|453089473|FG007|Phase 2|Protocol Violation|0|||
125942561|NCT04762680|453089474|FG008|Phase 2|Protocol Violation|0|||
125942562|NCT04762680|453089475|FG009|Phase 2|Protocol Violation|0|||
125942563|NCT04762680|453089476|FG010|Phase 2|Protocol Violation|0|||
125942564|NCT04762680|453089477|FG011|Phase 2|Protocol Violation|0|||
125942565|NCT04762680|453089478|FG012|Phase 2|Protocol Violation|0|||
125942566|NCT04762680|453089479|FG013|Phase 2|Protocol Violation|0|||
125942567|NCT04762680|453089480|FG014|Phase 2|Protocol Violation|0|||
125942568|NCT04762680|453089481|FG015|Phase 2|Protocol Violation|0|||
125942569|NCT04762680|453089482|FG016|Phase 2|Protocol Violation|0|||
125942570|NCT04762680|453089483|FG017|Phase 2|Protocol Violation|0|||
125942571|NCT04762680|453089484|FG018|Phase 2|Protocol Violation|0|||
125942572|NCT04762680|453089485|FG019|Phase 2|Protocol Violation|0|||
125942573|NCT04762680|453089486|FG020|Phase 2|Protocol Violation|0|||
125942574|NCT04762680|453089487|FG021|Phase 2|Protocol Violation|0|||
125942575|NCT04762680|453089466|FG000|Phase 2|Withdrawal by Subject|23|||
125942576|NCT04762680|453089467|FG001|Phase 2|Withdrawal by Subject|21|||
125942577|NCT04762680|453089468|FG002|Phase 2|Withdrawal by Subject|28|||
125942578|NCT04762680|453089469|FG003|Phase 2|Withdrawal by Subject|0|||
125942579|NCT04762680|453089470|FG004|Phase 2|Withdrawal by Subject|0|||
125942580|NCT04762680|453089471|FG005|Phase 2|Withdrawal by Subject|0|||
125942581|NCT04762680|453089472|FG006|Phase 2|Withdrawal by Subject|0|||
125942582|NCT04762680|453089473|FG007|Phase 2|Withdrawal by Subject|0|||
125942583|NCT04762680|453089474|FG008|Phase 2|Withdrawal by Subject|0|||
125942584|NCT04762680|453089475|FG009|Phase 2|Withdrawal by Subject|0|||
125942585|NCT04762680|453089476|FG010|Phase 2|Withdrawal by Subject|0|||
125942586|NCT04762680|453089477|FG011|Phase 2|Withdrawal by Subject|0|||
125942587|NCT04762680|453089478|FG012|Phase 2|Withdrawal by Subject|0|||
125942588|NCT04762680|453089479|FG013|Phase 2|Withdrawal by Subject|0|||
125942589|NCT04762680|453089480|FG014|Phase 2|Withdrawal by Subject|0|||
125942590|NCT04762680|453089481|FG015|Phase 2|Withdrawal by Subject|0|||
125942591|NCT04762680|453089482|FG016|Phase 2|Withdrawal by Subject|0|||
125942592|NCT04762680|453089483|FG017|Phase 2|Withdrawal by Subject|0|||
125942593|NCT04762680|453089484|FG018|Phase 2|Withdrawal by Subject|0|||
125942594|NCT04762680|453089485|FG019|Phase 2|Withdrawal by Subject|0|||
125942595|NCT04762680|453089486|FG020|Phase 2|Withdrawal by Subject|0|||
125942596|NCT04762680|453089487|FG021|Phase 2|Withdrawal by Subject|0|||
125942597|NCT04762680|453089466|FG000|Phase 2|Lost to Follow-up|14|||
125942598|NCT04762680|453089467|FG001|Phase 2|Lost to Follow-up|8|||
125942599|NCT04762680|453089468|FG002|Phase 2|Lost to Follow-up|9|||
125942600|NCT04762680|453089469|FG003|Phase 2|Lost to Follow-up|0|||
125942601|NCT04762680|453089470|FG004|Phase 2|Lost to Follow-up|0|||
125942602|NCT04762680|453089471|FG005|Phase 2|Lost to Follow-up|0|||
125942603|NCT04762680|453089472|FG006|Phase 2|Lost to Follow-up|0|||
125942604|NCT04762680|453089473|FG007|Phase 2|Lost to Follow-up|0|||
125942605|NCT04762680|453089474|FG008|Phase 2|Lost to Follow-up|0|||
125942606|NCT04762680|453089475|FG009|Phase 2|Lost to Follow-up|0|||
125942607|NCT04762680|453089476|FG010|Phase 2|Lost to Follow-up|0|||
125942608|NCT04762680|453089477|FG011|Phase 2|Lost to Follow-up|0|||
125942609|NCT04762680|453089478|FG012|Phase 2|Lost to Follow-up|0|||
125942610|NCT04762680|453089479|FG013|Phase 2|Lost to Follow-up|0|||
125942611|NCT04762680|453089480|FG014|Phase 2|Lost to Follow-up|0|||
125942612|NCT04762680|453089481|FG015|Phase 2|Lost to Follow-up|0|||
125942613|NCT04762680|453089482|FG016|Phase 2|Lost to Follow-up|0|||
125942614|NCT04762680|453089483|FG017|Phase 2|Lost to Follow-up|0|||
125942615|NCT04762680|453089484|FG018|Phase 2|Lost to Follow-up|0|||
125942616|NCT04762680|453089485|FG019|Phase 2|Lost to Follow-up|0|||
125942617|NCT04762680|453089486|FG020|Phase 2|Lost to Follow-up|0|||
125942618|NCT04762680|453089487|FG021|Phase 2|Lost to Follow-up|0|||
125942619|NCT04762680|453089466|FG000|Phase 3|Adverse Event|0|||
125942620|NCT04762680|453089467|FG001|Phase 3|Adverse Event|0|||
125942621|NCT04762680|453089468|FG002|Phase 3|Adverse Event|0|||
125942622|NCT04762680|453089469|FG003|Phase 3|Adverse Event|1|||
125942623|NCT04762680|453089470|FG004|Phase 3|Adverse Event|0|||
125942624|NCT04762680|453089471|FG005|Phase 3|Adverse Event|0|||
125942625|NCT04762680|453089472|FG006|Phase 3|Adverse Event|0|||
125942626|NCT04762680|453089473|FG007|Phase 3|Adverse Event|0|||
125942627|NCT04762680|453089474|FG008|Phase 3|Adverse Event|0|||
125942628|NCT04762680|453089475|FG009|Phase 3|Adverse Event|0|||
125942629|NCT04762680|453089476|FG010|Phase 3|Adverse Event|0|||
125942630|NCT04762680|453089477|FG011|Phase 3|Adverse Event|0|||
125942631|NCT04762680|453089478|FG012|Phase 3|Adverse Event|0|||
125942632|NCT04762680|453089479|FG013|Phase 3|Adverse Event|0|||
125942633|NCT04762680|453089480|FG014|Phase 3|Adverse Event|0|||
125942634|NCT04762680|453089481|FG015|Phase 3|Adverse Event|0|||
126066888|NCT01268488|453537037|FG000|Overall Study|Physician Decision|2|||
125942635|NCT04762680|453089482|FG016|Phase 3|Adverse Event|0|||
125942636|NCT04762680|453089483|FG017|Phase 3|Adverse Event|3|||
125942637|NCT04762680|453089484|FG018|Phase 3|Adverse Event|0|||
125942638|NCT04762680|453089485|FG019|Phase 3|Adverse Event|0|||
125942639|NCT04762680|453089486|FG020|Phase 3|Adverse Event|0|||
125942640|NCT04762680|453089487|FG021|Phase 3|Adverse Event|0|||
125942641|NCT04762680|453089466|FG000|Phase 3|Protocol Violation|0|||
125942642|NCT04762680|453089467|FG001|Phase 3|Protocol Violation|0|||
125942643|NCT04762680|453089468|FG002|Phase 3|Protocol Violation|0|||
126066889|NCT00147745|453537040|FG000|Overall Study|Withdrawal by Subject|1|||
125942644|NCT04762680|453089469|FG003|Phase 3|Protocol Violation|4|||
125942645|NCT04762680|453089470|FG004|Phase 3|Protocol Violation|1|||
125942646|NCT04762680|453089471|FG005|Phase 3|Protocol Violation|5|||
125942647|NCT04762680|453089472|FG006|Phase 3|Protocol Violation|1|||
125942648|NCT04762680|453089473|FG007|Phase 3|Protocol Violation|0|||
125942649|NCT04762680|453089474|FG008|Phase 3|Protocol Violation|0|||
125942650|NCT04762680|453089475|FG009|Phase 3|Protocol Violation|0|||
125942651|NCT04762680|453089476|FG010|Phase 3|Protocol Violation|0|||
125942652|NCT04762680|453089477|FG011|Phase 3|Protocol Violation|2|||
125942653|NCT04762680|453089478|FG012|Phase 3|Protocol Violation|3|||
125942654|NCT04762680|453089479|FG013|Phase 3|Protocol Violation|0|||
125942655|NCT04762680|453089480|FG014|Phase 3|Protocol Violation|0|||
125942656|NCT04762680|453089481|FG015|Phase 3|Protocol Violation|1|||
125942657|NCT04762680|453089482|FG016|Phase 3|Protocol Violation|0|||
125942658|NCT04762680|453089483|FG017|Phase 3|Protocol Violation|10|||
125942659|NCT04762680|453089484|FG018|Phase 3|Protocol Violation|0|||
125942660|NCT04762680|453089485|FG019|Phase 3|Protocol Violation|0|||
125942661|NCT04762680|453089486|FG020|Phase 3|Protocol Violation|0|||
125942662|NCT04762680|453089487|FG021|Phase 3|Protocol Violation|0|||
125942663|NCT04762680|453089466|FG000|Phase 3|Withdrawal by Subject|0|||
125942664|NCT04762680|453089467|FG001|Phase 3|Withdrawal by Subject|0|||
125942665|NCT04762680|453089468|FG002|Phase 3|Withdrawal by Subject|0|||
125942666|NCT04762680|453089469|FG003|Phase 3|Withdrawal by Subject|13|||
125942667|NCT04762680|453089470|FG004|Phase 3|Withdrawal by Subject|17|||
125942668|NCT04762680|453089471|FG005|Phase 3|Withdrawal by Subject|12|||
125942669|NCT04762680|453089472|FG006|Phase 3|Withdrawal by Subject|8|||
125942670|NCT04762680|453089473|FG007|Phase 3|Withdrawal by Subject|3|||
125942671|NCT04762680|453089474|FG008|Phase 3|Withdrawal by Subject|2|||
125942672|NCT04762680|453089475|FG009|Phase 3|Withdrawal by Subject|4|||
125942673|NCT04762680|453089476|FG010|Phase 3|Withdrawal by Subject|3|||
125942674|NCT04762680|453089477|FG011|Phase 3|Withdrawal by Subject|1|||
125942675|NCT04762680|453089478|FG012|Phase 3|Withdrawal by Subject|3|||
125942676|NCT04762680|453089479|FG013|Phase 3|Withdrawal by Subject|2|||
125942677|NCT04762680|453089480|FG014|Phase 3|Withdrawal by Subject|1|||
125942678|NCT04762680|453089481|FG015|Phase 3|Withdrawal by Subject|4|||
125942679|NCT04762680|453089482|FG016|Phase 3|Withdrawal by Subject|6|||
125942680|NCT04762680|453089483|FG017|Phase 3|Withdrawal by Subject|32|||
125942681|NCT04762680|453089484|FG018|Phase 3|Withdrawal by Subject|0|||
125942682|NCT04762680|453089485|FG019|Phase 3|Withdrawal by Subject|0|||
125942683|NCT04762680|453089486|FG020|Phase 3|Withdrawal by Subject|0|||
125942684|NCT04762680|453089487|FG021|Phase 3|Withdrawal by Subject|0|||
125942685|NCT04762680|453089466|FG000|Phase 3|Lost to Follow-up|0|||
125942686|NCT04762680|453089467|FG001|Phase 3|Lost to Follow-up|0|||
125942687|NCT04762680|453089468|FG002|Phase 3|Lost to Follow-up|0|||
125942688|NCT04762680|453089469|FG003|Phase 3|Lost to Follow-up|9|||
125942689|NCT04762680|453089470|FG004|Phase 3|Lost to Follow-up|22|||
125942690|NCT04762680|453089471|FG005|Phase 3|Lost to Follow-up|24|||
125942691|NCT04762680|453089472|FG006|Phase 3|Lost to Follow-up|2|||
125942692|NCT04762680|453089473|FG007|Phase 3|Lost to Follow-up|4|||
125942693|NCT04762680|453089474|FG008|Phase 3|Lost to Follow-up|6|||
125942694|NCT04762680|453089475|FG009|Phase 3|Lost to Follow-up|4|||
125942695|NCT04762680|453089476|FG010|Phase 3|Lost to Follow-up|3|||
125942696|NCT04762680|453089477|FG011|Phase 3|Lost to Follow-up|0|||
125942697|NCT04762680|453089478|FG012|Phase 3|Lost to Follow-up|5|||
125942698|NCT04762680|453089479|FG013|Phase 3|Lost to Follow-up|4|||
125942699|NCT04762680|453089480|FG014|Phase 3|Lost to Follow-up|6|||
126066890|NCT00147745|453537041|FG001|Overall Study|Withdrawal by Subject|0|||
126066891|NCT00147745|453537042|FG002|Overall Study|Withdrawal by Subject|0|||
126066892|NCT02504502|453537043|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
125942700|NCT04762680|453089481|FG015|Phase 3|Lost to Follow-up|1|||
125942701|NCT04762680|453089482|FG016|Phase 3|Lost to Follow-up|1|||
125942702|NCT04762680|453089483|FG017|Phase 3|Lost to Follow-up|66|||
125942703|NCT04762680|453089484|FG018|Phase 3|Lost to Follow-up|0|||
126066893|NCT02504502|453537044|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
126066894|NCT02504502|453537043|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
126066895|NCT02504502|453537044|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
125942704|NCT04762680|453089485|FG019|Phase 3|Lost to Follow-up|0|||
125942705|NCT04762680|453089486|FG020|Phase 3|Lost to Follow-up|0|||
125942706|NCT04762680|453089487|FG021|Phase 3|Lost to Follow-up|0|||
125942707|NCT04762680|453089466|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126066896|NCT00422162|453537048|FG000|Overall Study|Adverse Event|11|||
126066897|NCT00422162|453537049|FG001|Overall Study|Adverse Event|9|||
125942708|NCT04762680|453089467|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942709|NCT04762680|453089468|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126066898|NCT00422162|453537048|FG000|Overall Study|Lack of Efficacy|4|||
125942710|NCT04762680|453089469|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942711|NCT04762680|453089470|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942712|NCT04762680|453089471|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942713|NCT04762680|453089472|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126066899|NCT00422162|453537049|FG001|Overall Study|Lack of Efficacy|10|||
126066900|NCT00422162|453537048|FG000|Overall Study|Withdrawal by Subject|7|||
126066901|NCT00422162|453537049|FG001|Overall Study|Withdrawal by Subject|6|||
126066902|NCT00422162|453537048|FG000|Overall Study|Lost to Follow-up|1|||
126066903|NCT00422162|453537049|FG001|Overall Study|Lost to Follow-up|2|||
126066904|NCT00422162|453537048|FG000|Overall Study|Non-Compliant with Protocol|1|||
126066905|NCT00422162|453537049|FG001|Overall Study|Non-Compliant with Protocol|1|||
126066906|NCT00422162|453537048|FG000|Overall Study|Other|0|||
126066907|NCT00422162|453537049|FG001|Overall Study|Other|1|||
126066908|NCT00422162|453537048|FG000|Overall Study|Didn't Receive Treatment|0|||
126066909|NCT00422162|453537049|FG001|Overall Study|Didn't Receive Treatment|1|||
126066910|NCT05274906|453537050|FG000|Overall Study|Withdrawal by Subject|2|||
126066911|NCT05274906|453537051|FG001|Overall Study|Withdrawal by Subject|1|||
126066912|NCT03508830|453537052|FG000|Overall Study|Withdrawal by Subject|3|||
126066913|NCT03508830|453537053|FG001|Overall Study|Withdrawal by Subject|4|||
126066914|NCT03508830|453537052|FG000|Overall Study|Physician Decision|2|||
126066915|NCT03508830|453537053|FG001|Overall Study|Physician Decision|2|||
126066916|NCT02522299|453537054|FG000|Overall Study|Adverse Event|2|||
126066917|NCT02522299|453537055|FG001|Overall Study|Adverse Event|0|||
126066918|NCT02522299|453537054|FG000|Overall Study|Physician Decision|0|||
126066919|NCT02522299|453537055|FG001|Overall Study|Physician Decision|1|||
126066920|NCT02522299|453537054|FG000|Overall Study|Withdrawal by Subject|2|||
126066921|NCT02522299|453537055|FG001|Overall Study|Withdrawal by Subject|0|||
126066922|NCT04908800|453537058|FG000|Overall Study|Adverse Event|0|||
126066923|NCT04908800|453537059|FG001|Overall Study|Adverse Event|0|||
126066924|NCT04908800|453537060|FG002|Overall Study|Adverse Event|0|||
126066925|NCT04908800|453537061|FG003|Overall Study|Adverse Event|0|||
126066926|NCT04908800|453537062|FG004|Overall Study|Adverse Event|0|||
126066927|NCT04908800|453537063|FG005|Overall Study|Adverse Event|0|||
126066928|NCT04908800|453537064|FG006|Overall Study|Adverse Event|0|||
126066929|NCT04908800|453537065|FG007|Overall Study|Adverse Event|0|||
126066930|NCT04908800|453537066|FG008|Overall Study|Adverse Event|0|||
126066931|NCT04908800|453537067|FG009|Overall Study|Adverse Event|0|||
126066932|NCT04908800|453537068|FG010|Overall Study|Adverse Event|1|||
126066933|NCT04908800|453537069|FG011|Overall Study|Adverse Event|0|||
126066934|NCT04908800|453537070|FG012|Overall Study|Adverse Event|0|||
126066935|NCT02267746|453537071|FG000|Overall Study|Adverse Event|0|||
126066936|NCT02267746|453537072|FG001|Overall Study|Adverse Event|2|||
126066937|NCT02267746|453537073|FG002|Overall Study|Adverse Event|1|||
126066938|NCT02267746|453537071|FG000|Overall Study|Protocol Violation|8|||
126066939|NCT02267746|453537072|FG001|Overall Study|Protocol Violation|7|||
126066940|NCT02267746|453537073|FG002|Overall Study|Protocol Violation|3|||
126066941|NCT02267746|453537071|FG000|Overall Study|Lack of Efficacy|11|||
126066942|NCT02267746|453537072|FG001|Overall Study|Lack of Efficacy|11|||
126066943|NCT02267746|453537073|FG002|Overall Study|Lack of Efficacy|15|||
126066944|NCT02267746|453537071|FG000|Overall Study|Protocol Violation|1|||
126066945|NCT02267746|453537072|FG001|Overall Study|Protocol Violation|2|||
126066946|NCT02267746|453537073|FG002|Overall Study|Protocol Violation|1|||
126066947|NCT02267746|453537071|FG000|Overall Study|Miscellaneous|1|||
126114332|NCT00616434|453713793|FG000|Overall Study|Withdrawal by Subject|1|||
126114333|NCT00616434|453713794|FG001|Overall Study|Withdrawal by Subject|1|||
125942714|NCT04762680|453089473|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942715|NCT04762680|453089474|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942716|NCT04762680|453089475|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942717|NCT04762680|453089476|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942718|NCT04762680|453089477|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942719|NCT04762680|453089478|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942720|NCT04762680|453089479|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942721|NCT04762680|453089480|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942722|NCT04762680|453089481|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942723|NCT04762680|453089482|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942724|NCT04762680|453089483|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942725|NCT04762680|453089484|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942726|NCT04762680|453089485|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125942727|NCT04762680|453089486|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126114334|NCT00616434|453713793|FG000|Overall Study|Protocol deviation|0|||
126066948|NCT02267746|453537072|FG001|Overall Study|Miscellaneous|0|||
126066949|NCT02267746|453537073|FG002|Overall Study|Miscellaneous|1|||
126066950|NCT00728884|453537078|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
126066951|NCT00728884|453537078|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
126066952|NCT02116582|453537082|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
126066953|NCT02116582|453537082|FG000|Overall Study|Adverse Event|22|||
126066954|NCT02116582|453537082|FG000|Overall Study|Death|9|||
126066955|NCT02116582|453537082|FG000|Overall Study|Progressive Disease|148|||
126066956|NCT02116582|453537082|FG000|Overall Study|Protocol Violation|3|||
126066957|NCT02116582|453537082|FG000|Overall Study|Withdrawal by Subject|8|||
126066958|NCT02116582|453537082|FG000|Overall Study|Other: Miscellaneous|11|||
126066959|NCT02116582|453537082|FG000|Overall Study|Lost to Follow-up|1|||
125942728|NCT04762680|453089487|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
125942729|NCT04762680|453089466|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942730|NCT04762680|453089467|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942731|NCT04762680|453089468|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942732|NCT04762680|453089469|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942733|NCT04762680|453089470|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942734|NCT04762680|453089471|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942735|NCT04762680|453089472|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942736|NCT04762680|453089473|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942737|NCT04762680|453089474|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942738|NCT04762680|453089475|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942739|NCT04762680|453089476|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942740|NCT04762680|453089477|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942741|NCT04762680|453089478|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942742|NCT04762680|453089479|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942743|NCT04762680|453089480|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942744|NCT04762680|453089481|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942745|NCT04762680|453089482|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942746|NCT04762680|453089483|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942747|NCT04762680|453089484|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942748|NCT04762680|453089485|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
125942749|NCT04762680|453089486|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942750|NCT04762680|453089487|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
125942751|NCT02520011|453089488|FG000|Overall Study|Adverse Event|0|||
125942752|NCT02520011|453089489|FG001|Overall Study|Adverse Event|1|||
125942753|NCT02520011|453089490|FG002|Overall Study|Adverse Event|2|||
125942754|NCT02520011|453089488|FG000|Overall Study|Death|0|||
125942755|NCT02520011|453089489|FG001|Overall Study|Death|8|||
125942756|NCT02520011|453089490|FG002|Overall Study|Death|1|||
125942757|NCT02520011|453089488|FG000|Overall Study|Lack of Efficacy|4|||
125942758|NCT02520011|453089489|FG001|Overall Study|Lack of Efficacy|26|||
125942759|NCT02520011|453089490|FG002|Overall Study|Lack of Efficacy|4|||
125942760|NCT02520011|453089488|FG000|Overall Study|Physician Decision|0|||
125942761|NCT02520011|453089489|FG001|Overall Study|Physician Decision|2|||
125942762|NCT02520011|453089490|FG002|Overall Study|Physician Decision|0|||
125942763|NCT02520011|453089488|FG000|Overall Study|Withdrawal by Subject|1|||
125942764|NCT02520011|453089489|FG001|Overall Study|Withdrawal by Subject|3|||
125942765|NCT02520011|453089490|FG002|Overall Study|Withdrawal by Subject|0|||
125942766|NCT02520011|453089488|FG000|Overall Study|Protocol Deviation|0|||
125942767|NCT02520011|453089489|FG001|Overall Study|Protocol Deviation|1|||
125942768|NCT02520011|453089490|FG002|Overall Study|Protocol Deviation|0|||
125942769|NCT02520011|453089488|FG000|Overall Study|Patient went to hospice|0|||
125942770|NCT02520011|453089489|FG001|Overall Study|Patient went to hospice|1|||
125942771|NCT02520011|453089490|FG002|Overall Study|Patient went to hospice|0|||
125942772|NCT02520011|453089488|FG000|Overall Study|Progressive disease following response|0|||
125942773|NCT02520011|453089489|FG001|Overall Study|Progressive disease following response|4|||
125942774|NCT02520011|453089490|FG002|Overall Study|Progressive disease following response|2|||
125942775|NCT01063764|453089494|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
125942776|NCT01063764|453089494|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
125942777|NCT01063764|453089494|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
125942778|NCT01063764|453089494|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
125942779|NCT01063764|453089494|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
125942780|NCT01063764|453089494|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
125942781|NCT01063764|453089494|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
125942782|NCT02436759|453089495|FG000|Overall Study|Adverse Event|3|||
125942783|NCT02436759|453089496|FG001|Overall Study|Adverse Event|0|||
125942784|NCT02436759|453089495|FG000|Overall Study|Protocol Violation|1|||
125942785|NCT02436759|453089496|FG001|Overall Study|Protocol Violation|0|||
125942786|NCT02436759|453089495|FG000|Overall Study|Withdrawal by Subject|0|||
125942787|NCT02436759|453089496|FG001|Overall Study|Withdrawal by Subject|1|||
125942788|NCT01727141|453089497|FG000|Overall Study|Physician Decision|0|||
125942789|NCT01727141|453089498|FG001|Overall Study|Physician Decision|1|||
125942790|NCT01727141|453089499|FG002|Overall Study|Physician Decision|0|||
125942791|NCT01727141|453089500|FG003|Overall Study|Physician Decision|2|||
125942792|NCT01727141|453089497|FG000|Overall Study|Lost to Follow-up|0|||
125942793|NCT01727141|453089498|FG001|Overall Study|Lost to Follow-up|2|||
125942794|NCT01727141|453089499|FG002|Overall Study|Lost to Follow-up|0|||
125942795|NCT01727141|453089500|FG003|Overall Study|Lost to Follow-up|0|||
125942796|NCT01727141|453089497|FG000|Overall Study|Death|0|||
125942797|NCT01727141|453089498|FG001|Overall Study|Death|1|||
125942798|NCT01727141|453089499|FG002|Overall Study|Death|1|||
125942799|NCT01727141|453089500|FG003|Overall Study|Death|1|||
125942800|NCT01727141|453089497|FG000|Overall Study|Protocol deviation|1|||
125942801|NCT01727141|453089498|FG001|Overall Study|Protocol deviation|1|||
125942802|NCT01727141|453089499|FG002|Overall Study|Protocol deviation|0|||
125942803|NCT01727141|453089500|FG003|Overall Study|Protocol deviation|1|||
125942804|NCT01727141|453089497|FG000|Overall Study|Withdrawal by Subject|4|||
126066960|NCT02116582|453537082|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
126066961|NCT02268526|453537083|FG000|Overall Study|Adverse Event|0|||
126066962|NCT02268526|453537084|FG001|Overall Study|Adverse Event|2|||
126066963|NCT02268526|453537085|FG002|Overall Study|Adverse Event|1|||
126066964|NCT02268526|453537083|FG000|Overall Study|Death|1|||
126066965|NCT02268526|453537084|FG001|Overall Study|Death|11|||
126066966|NCT02268526|453537085|FG002|Overall Study|Death|0|||
126114335|NCT00616434|453713794|FG001|Overall Study|Protocol deviation|1|||
126114336|NCT00874770|453713798|FG000|Overall Study|Lack of Efficacy|2|||
126114337|NCT00874770|453713799|FG001|Overall Study|Lack of Efficacy|0|||
126114338|NCT00874770|453713800|FG002|Overall Study|Lack of Efficacy|0|||
126114339|NCT00874770|453713801|FG003|Overall Study|Lack of Efficacy|2|||
126114340|NCT00874770|453713798|FG000|Overall Study|Adverse Event|1|||
126114341|NCT00874770|453713799|FG001|Overall Study|Adverse Event|1|||
126114342|NCT00874770|453713800|FG002|Overall Study|Adverse Event|4|||
126114343|NCT00874770|453713801|FG003|Overall Study|Adverse Event|2|||
126114344|NCT00874770|453713798|FG000|Overall Study|Lost to Follow-up|1|||
126114345|NCT00874770|453713799|FG001|Overall Study|Lost to Follow-up|0|||
126114346|NCT00874770|453713800|FG002|Overall Study|Lost to Follow-up|0|||
126114347|NCT00874770|453713801|FG003|Overall Study|Lost to Follow-up|1|||
125942805|NCT01727141|453089498|FG001|Overall Study|Withdrawal by Subject|4|||
125942806|NCT01727141|453089499|FG002|Overall Study|Withdrawal by Subject|2|||
125942807|NCT01727141|453089500|FG003|Overall Study|Withdrawal by Subject|11|||
125942808|NCT02603432|453089501|FG000|Overall Study|Adverse Event|1|||
125942809|NCT02603432|453089502|FG001|Overall Study|Adverse Event|0|||
125942810|NCT02603432|453089501|FG000|Overall Study|Death|221|||
125942811|NCT02603432|453089502|FG001|Overall Study|Death|242|||
125942812|NCT02603432|453089501|FG000|Overall Study|Lost to Follow-up|3|||
125942813|NCT02603432|453089502|FG001|Overall Study|Lost to Follow-up|9|||
125942814|NCT02603432|453089501|FG000|Overall Study|Progressive Disease|7|||
125942815|NCT02603432|453089502|FG001|Overall Study|Progressive Disease|5|||
125942816|NCT02603432|453089501|FG000|Overall Study|Withdrawal by Subject|12|||
125942817|NCT02603432|453089502|FG001|Overall Study|Withdrawal by Subject|18|||
125942818|NCT02603432|453089501|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
125942819|NCT02603432|453089502|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125942820|NCT02603432|453089501|FG000|Overall Study|Study terminated by sponsor|74|||
125942821|NCT02603432|453089502|FG001|Overall Study|Study terminated by sponsor|75|||
125942822|NCT02603432|453089501|FG000|Overall Study|Other|13|||
125942823|NCT02603432|453089502|FG001|Overall Study|Other|0|||
125942824|NCT01957462|453089506|FG000|Test Period 1|Withdrawal by Subject|1|||
125942825|NCT01957462|453089507|FG001|Test Period 1|Withdrawal by Subject|0|||
125942826|NCT01957462|453089506|FG000|Test Period 1|Adverse Event|1|||
125942827|NCT01957462|453089507|FG001|Test Period 1|Adverse Event|0|||
125942828|NCT05954052|453089508|FG000|Overall Study|Adverse Event|1|||
125942829|NCT03616912|453089509|FG000|Overall Study|Adverse Event|17|||
125942830|NCT03616912|453089510|FG001|Overall Study|Adverse Event|21|||
125942831|NCT03616912|453089511|FG002|Overall Study|Adverse Event|9|||
125942832|NCT03616912|453089512|FG003|Overall Study|Adverse Event|0|||
125942833|NCT03616912|453089513|FG004|Overall Study|Adverse Event|0|||
125942834|NCT03616912|453089514|FG005|Overall Study|Adverse Event|0|||
125942835|NCT03616912|453089509|FG000|Overall Study|Death|1|||
125942836|NCT03616912|453089510|FG001|Overall Study|Death|1|||
125942837|NCT03616912|453089511|FG002|Overall Study|Death|0|||
125942838|NCT03616912|453089512|FG003|Overall Study|Death|0|||
125942839|NCT03616912|453089513|FG004|Overall Study|Death|0|||
125942840|NCT03616912|453089514|FG005|Overall Study|Death|0|||
125942841|NCT03616912|453089509|FG000|Overall Study|Lack of Efficacy|13|||
125942842|NCT03616912|453089510|FG001|Overall Study|Lack of Efficacy|6|||
125942843|NCT03616912|453089511|FG002|Overall Study|Lack of Efficacy|8|||
126114348|NCT00874770|453713798|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
126114349|NCT00874770|453713799|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
125942844|NCT03616912|453089512|FG003|Overall Study|Lack of Efficacy|4|||
126114350|NCT00874770|453713800|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
126066967|NCT02268526|453537083|FG000|Overall Study|protocol deviation|0|||
126066968|NCT02268526|453537084|FG001|Overall Study|protocol deviation|1|||
126114351|NCT00874770|453713801|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
126114352|NCT05395104|453713802|FG000|Overall Study|Met Liver Stopping Criteria|1|||
126114353|NCT05395104|453713802|FG000|Overall Study|Withdrawal by Subject|1|||
126114354|NCT03933397|453713803|FG000|Overall Study|No emergency department visit|65|||
125942845|NCT03616912|453089513|FG004|Overall Study|Lack of Efficacy|5|||
125942846|NCT03616912|453089514|FG005|Overall Study|Lack of Efficacy|1|||
125942847|NCT03616912|453089509|FG000|Overall Study|Lost to Follow-up|1|||
125942848|NCT03616912|453089510|FG001|Overall Study|Lost to Follow-up|2|||
125942849|NCT03616912|453089511|FG002|Overall Study|Lost to Follow-up|3|||
125942850|NCT03616912|453089512|FG003|Overall Study|Lost to Follow-up|0|||
125942851|NCT03616912|453089513|FG004|Overall Study|Lost to Follow-up|0|||
125942852|NCT03616912|453089514|FG005|Overall Study|Lost to Follow-up|0|||
126066969|NCT02268526|453537085|FG002|Overall Study|protocol deviation|0|||
126066970|NCT02268526|453537083|FG000|Overall Study|Physician Decision|0|||
126066971|NCT02268526|453537084|FG001|Overall Study|Physician Decision|0|||
125942853|NCT03616912|453089509|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
125942854|NCT03616912|453089510|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
125942855|NCT03616912|453089511|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
125942856|NCT03616912|453089512|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
125942857|NCT03616912|453089513|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
125942858|NCT03616912|453089514|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
125942859|NCT03616912|453089509|FG000|Overall Study|Withdrawal by Subject|12|||
125942860|NCT03616912|453089510|FG001|Overall Study|Withdrawal by Subject|12|||
125942861|NCT03616912|453089511|FG002|Overall Study|Withdrawal by Subject|15|||
125942862|NCT03616912|453089512|FG003|Overall Study|Withdrawal by Subject|2|||
125942863|NCT03616912|453089513|FG004|Overall Study|Withdrawal by Subject|0|||
125942864|NCT03616912|453089514|FG005|Overall Study|Withdrawal by Subject|2|||
125942865|NCT03616912|453089509|FG000|Overall Study|Study Terminated by Sponsor|0|||
125942866|NCT03616912|453089510|FG001|Overall Study|Study Terminated by Sponsor|0|||
125942867|NCT03616912|453089511|FG002|Overall Study|Study Terminated by Sponsor|0|||
125942868|NCT03616912|453089512|FG003|Overall Study|Study Terminated by Sponsor|10|||
125942869|NCT03616912|453089513|FG004|Overall Study|Study Terminated by Sponsor|9|||
125942870|NCT03616912|453089514|FG005|Overall Study|Study Terminated by Sponsor|11|||
125942871|NCT03616912|453089509|FG000|Overall Study|Protocol Deviation|1|||
125942872|NCT03616912|453089510|FG001|Overall Study|Protocol Deviation|1|||
125942873|NCT03616912|453089511|FG002|Overall Study|Protocol Deviation|0|||
125942874|NCT03616912|453089512|FG003|Overall Study|Protocol Deviation|0|||
125942875|NCT03616912|453089513|FG004|Overall Study|Protocol Deviation|0|||
125942876|NCT03616912|453089514|FG005|Overall Study|Protocol Deviation|0|||
125942877|NCT03616912|453089509|FG000|Overall Study|Pregnancy|1|||
125942878|NCT03616912|453089510|FG001|Overall Study|Pregnancy|0|||
125942879|NCT03616912|453089511|FG002|Overall Study|Pregnancy|4|||
125942880|NCT03616912|453089512|FG003|Overall Study|Pregnancy|0|||
125942881|NCT03616912|453089513|FG004|Overall Study|Pregnancy|0|||
125942882|NCT03616912|453089514|FG005|Overall Study|Pregnancy|0|||
125942883|NCT03616912|453089509|FG000|Overall Study|Protocol Violation|1|||
125942884|NCT03616912|453089510|FG001|Overall Study|Protocol Violation|0|||
125942885|NCT03616912|453089511|FG002|Overall Study|Protocol Violation|2|||
125942886|NCT03616912|453089512|FG003|Overall Study|Protocol Violation|0|||
125942887|NCT03616912|453089513|FG004|Overall Study|Protocol Violation|0|||
125942888|NCT03616912|453089514|FG005|Overall Study|Protocol Violation|0|||
125942889|NCT03616912|453089509|FG000|Overall Study|Physician Decision|2|||
125942890|NCT03616912|453089510|FG001|Overall Study|Physician Decision|0|||
125942891|NCT03616912|453089511|FG002|Overall Study|Physician Decision|0|||
125942892|NCT03616912|453089512|FG003|Overall Study|Physician Decision|0|||
125942893|NCT03616912|453089513|FG004|Overall Study|Physician Decision|1|||
125942894|NCT03616912|453089514|FG005|Overall Study|Physician Decision|0|||
125942895|NCT03616912|453089509|FG000|Overall Study|Randomized But Never Treated|0|||
125942896|NCT03616912|453089510|FG001|Overall Study|Randomized But Never Treated|2|||
125942897|NCT03616912|453089511|FG002|Overall Study|Randomized But Never Treated|0|||
125942898|NCT03616912|453089512|FG003|Overall Study|Randomized But Never Treated|0|||
125942899|NCT03616912|453089513|FG004|Overall Study|Randomized But Never Treated|0|||
125942900|NCT03616912|453089514|FG005|Overall Study|Randomized But Never Treated|0|||
125942901|NCT01856790|453089515|FG000|Closed Loop Control|Withdrawal by Subject|2|||
125942902|NCT01856790|453089515|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
125942903|NCT01124604|453089516|FG000|Overall Study|Adverse Event|10|||
125942904|NCT01124604|453089517|FG001|Overall Study|Adverse Event|1|||
125942905|NCT01124604|453089516|FG000|Overall Study|Lack of Efficacy|1|||
125942906|NCT01124604|453089517|FG001|Overall Study|Lack of Efficacy|0|||
125942907|NCT01124604|453089516|FG000|Overall Study|Withdrawal by Subject|4|||
125942908|NCT01124604|453089517|FG001|Overall Study|Withdrawal by Subject|0|||
125942909|NCT01124604|453089516|FG000|Overall Study|Disease Progression|0|||
125942910|NCT01124604|453089517|FG001|Overall Study|Disease Progression|1|||
125942911|NCT02584504|453089518|FG000|Double-blind Treatment|Participant withdrew consent|0|||
125942912|NCT02584504|453089519|FG001|Double-blind Treatment|Participant withdrew consent|0|||
125942913|NCT02584504|453089520|FG002|Double-blind Treatment|Participant withdrew consent|1|||
125942914|NCT02584504|453089518|FG000|Double-blind Treatment|Adverse Event|0|||
125942915|NCT02584504|453089519|FG001|Double-blind Treatment|Adverse Event|1|||
126066972|NCT02268526|453537085|FG002|Overall Study|Physician Decision|1|||
126066973|NCT02268526|453537083|FG000|Overall Study|Subject/guardian decision|0|||
126066974|NCT02268526|453537084|FG001|Overall Study|Subject/guardian decision|7|||
125942916|NCT02584504|453089520|FG002|Double-blind Treatment|Adverse Event|0|||
125942917|NCT02584504|453089518|FG000|Double-blind Treatment|Family Matter|0|||
125942918|NCT02584504|453089519|FG001|Double-blind Treatment|Family Matter|1|||
125942919|NCT02584504|453089520|FG002|Double-blind Treatment|Family Matter|0|||
125942920|NCT02584504|453089518|FG000|Open-label Treatment|Participant withdrew consent|0|||
125942921|NCT02584504|453089519|FG001|Open-label Treatment|Participant withdrew consent|0|||
125942922|NCT02584504|453089520|FG002|Open-label Treatment|Participant withdrew consent|4|||
125942923|NCT02584504|453089518|FG000|Open-label Treatment|Adverse Event|2|||
125942924|NCT02584504|453089519|FG001|Open-label Treatment|Adverse Event|2|||
126066975|NCT02268526|453537085|FG002|Overall Study|Subject/guardian decision|3|||
126066976|NCT00596960|453537086|FG000|Overall Study|Death|1|||
125942925|NCT02584504|453089520|FG002|Open-label Treatment|Adverse Event|3|||
125942926|NCT02584504|453089518|FG000|Open-label Treatment|Physician Decision|0|||
125942927|NCT02584504|453089519|FG001|Open-label Treatment|Physician Decision|1|||
125942928|NCT02584504|453089520|FG002|Open-label Treatment|Physician Decision|0|||
125942929|NCT02584504|453089518|FG000|Open-label Treatment|Entered but not treated|0|||
125942930|NCT02584504|453089519|FG001|Open-label Treatment|Entered but not treated|1|||
125942931|NCT02584504|453089520|FG002|Open-label Treatment|Entered but not treated|1|||
125942932|NCT04091646|453089521|FG000|Overall Study|Adverse Event|2|||
125942933|NCT04091646|453089522|FG001|Overall Study|Adverse Event|1|||
125942934|NCT04091646|453089521|FG000|Overall Study|Lost to Follow-up|6|||
125942935|NCT04091646|453089522|FG001|Overall Study|Lost to Follow-up|2|||
125942936|NCT04091646|453089521|FG000|Overall Study|Protocol Violation|0|||
125942937|NCT04091646|453089522|FG001|Overall Study|Protocol Violation|1|||
125942938|NCT04091646|453089521|FG000|Overall Study|Withdrawal by Subject|4|||
125942939|NCT04091646|453089522|FG001|Overall Study|Withdrawal by Subject|1|||
125942940|NCT04091646|453089521|FG000|Overall Study|Participant Incarcerated|1|||
125942941|NCT04091646|453089522|FG001|Overall Study|Participant Incarcerated|0|||
125942942|NCT03102918|453089523|FG000|Overall Study|Protocol Violation|1|||
125942943|NCT03102918|453089524|FG001|Overall Study|Protocol Violation|0|||
125942944|NCT01316276|453089529|FG000|Overall Study|Death|1|||
125942945|NCT01316276|453089529|FG000|Overall Study|Adverse Event|19|||
125942946|NCT01316276|453089529|FG000|Overall Study|Withdrawal of consent|24|||
125942947|NCT01316276|453089529|FG000|Overall Study|Lost to Follow-up|1|||
125942948|NCT01316276|453089529|FG000|Overall Study|Other|22|||
125942949|NCT01652664|453089530|FG000|Overall Study|Treatment Failure|5|||
125942950|NCT01652664|453089531|FG001|Overall Study|Treatment Failure|1|||
125942951|NCT01652664|453089530|FG000|Overall Study|Inadequate IOP control|1|||
125942952|NCT01652664|453089531|FG001|Overall Study|Inadequate IOP control|0|||
125942953|NCT00464568|453089537|FG000|Overall Study|Adverse Event|2|||
125942954|NCT03425331|453089540|FG000|Overall Study|Withdrawal by Subject|1|||
125942955|NCT03425331|453089540|FG000|Overall Study|Death|1|||
125942956|NCT03425331|453089540|FG000|Overall Study|Adverse Event|1|||
125942957|NCT03425331|453089540|FG000|Overall Study|Disease Progression|2|||
125942958|NCT02864251|453089542|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
125942959|NCT02864251|453089543|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
125942960|NCT02864251|453089544|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
125942961|NCT02864251|453089542|FG000|Pre-Treatment|Withdrawal by Participant|0|||
125942962|NCT02864251|453089543|FG001|Pre-Treatment|Withdrawal by Participant|0|||
125942963|NCT02864251|453089544|FG002|Pre-Treatment|Withdrawal by Participant|4|||
125942964|NCT02864251|453089542|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
125942965|NCT02864251|453089543|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
125942966|NCT02864251|453089544|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
125942967|NCT02864251|453089542|FG000|Pre-Treatment|Other Reasons|0|||
125942968|NCT02864251|453089543|FG001|Pre-Treatment|Other Reasons|1|||
125942969|NCT02864251|453089544|FG002|Pre-Treatment|Other Reasons|1|||
125942970|NCT02864251|453089542|FG000|Treatment|Disease Progression|109|||
125942971|NCT02864251|453089543|FG001|Treatment|Disease Progression|52|||
125942972|NCT02864251|453089544|FG002|Treatment|Disease Progression|101|||
125942973|NCT02864251|453089542|FG000|Treatment|Study Drug Toxicity|9|||
125942974|NCT02864251|453089543|FG001|Treatment|Study Drug Toxicity|4|||
125942975|NCT02864251|453089544|FG002|Treatment|Study Drug Toxicity|10|||
125942976|NCT02864251|453089542|FG000|Treatment|Death|0|||
125942977|NCT02864251|453089543|FG001|Treatment|Death|2|||
125942978|NCT02864251|453089544|FG002|Treatment|Death|3|||
125942979|NCT02864251|453089542|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
125942980|NCT02864251|453089543|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
125942981|NCT02864251|453089544|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
125942982|NCT02864251|453089542|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
125942983|NCT02864251|453089543|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
125942984|NCT02864251|453089544|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
125942985|NCT02864251|453089542|FG000|Treatment|Withdrawal by Participant|8|||
125942986|NCT02864251|453089543|FG001|Treatment|Withdrawal by Participant|5|||
125942987|NCT02864251|453089544|FG002|Treatment|Withdrawal by Participant|13|||
126066977|NCT00596960|453537087|FG001|Overall Study|Death|2|||
125942988|NCT02864251|453089542|FG000|Treatment|Maximum Clinical Benefit|1|||
125942989|NCT02864251|453089543|FG001|Treatment|Maximum Clinical Benefit|0|||
125942990|NCT02864251|453089544|FG002|Treatment|Maximum Clinical Benefit|1|||
125942991|NCT02864251|453089542|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
125942992|NCT02864251|453089543|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
125942993|NCT02864251|453089544|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
125942994|NCT02864251|453089542|FG000|Treatment|Other Reasons|1|||
125942995|NCT02864251|453089543|FG001|Treatment|Other Reasons|1|||
125942996|NCT02864251|453089544|FG002|Treatment|Other Reasons|4|||
125942997|NCT02864251|453089542|FG000|Treatment|Administrative Reason by Sponsor|1|||
125942998|NCT02864251|453089543|FG001|Treatment|Administrative Reason by Sponsor|0|||
126066978|NCT00596960|453537086|FG000|Overall Study|Lost to Follow-up|6|||
125942999|NCT02864251|453089544|FG002|Treatment|Administrative Reason by Sponsor|0|||
125943000|NCT00885755|453089545|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
125943001|NCT00885755|453089546|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
125943002|NCT00885755|453089547|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
125943003|NCT00885755|453089545|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
125943004|NCT00885755|453089546|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
125943005|NCT00885755|453089547|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
125943006|NCT00885755|453089545|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
125943007|NCT00885755|453089546|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
125943008|NCT00885755|453089547|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
125943009|NCT00885755|453089545|FG000|Part I: Trastuzumab+Taxane|Death|0|||
125943010|NCT00885755|453089546|FG001|Part I: Trastuzumab+Taxane|Death|0|||
125943011|NCT00885755|453089547|FG002|Part I: Trastuzumab+Taxane|Death|1|||
125943012|NCT00885755|453089545|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
125943013|NCT00885755|453089546|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
125943014|NCT00885755|453089547|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
125943015|NCT04343521|453089548|FG000|Overall Study|Adverse Event|0|||
125943016|NCT04343521|453089549|FG001|Overall Study|Adverse Event|2|||
125943017|NCT04343521|453089548|FG000|Overall Study|Death|1|||
125943018|NCT04343521|453089549|FG001|Overall Study|Death|2|||
125943019|NCT04343521|453089548|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
125943020|NCT04343521|453089549|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
125943021|NCT04343521|453089548|FG000|Overall Study|Withdrawal by Subject|70|||
125943022|NCT04343521|453089549|FG001|Overall Study|Withdrawal by Subject|95|||
125943023|NCT04343521|453089548|FG000|Overall Study|Withdrawal by study team|6|||
125943024|NCT04343521|453089549|FG001|Overall Study|Withdrawal by study team|12|||
125943025|NCT00107198|453089550|FG000|Overall Study|Lack of Efficacy|28|||
125943026|NCT00107198|453089550|FG000|Overall Study|Lost to Follow-up|12|||
125943027|NCT00107198|453089550|FG000|Overall Study|Protocol Violation|1|||
125943028|NCT00107198|453089550|FG000|Overall Study|Withdrawal by Subject|6|||
125943029|NCT00107198|453089550|FG000|Overall Study|Ineligible|5|||
125943030|NCT05442554|453089551|FG000|Overall Study|Adverse Event|1|||
125943031|NCT04191382|453089556|FG000|Overall Study|Withdrawal by Subject|1|||
125943032|NCT04191382|453089557|FG001|Overall Study|Withdrawal by Subject|0|||
125943033|NCT04191382|453089558|FG002|Overall Study|Withdrawal by Subject|0|||
125943034|NCT05237206|453089559|FG000|Overall Study|screen failure-did not receive treatment|8|||
125943035|NCT05237206|453089559|FG000|Overall Study|did not receive treatment|3|||
125943036|NCT05172544|453089560|FG000|Overall Study|Withdrawal by Subject|1|||
125943037|NCT05172544|453089561|FG001|Overall Study|Withdrawal by Subject|0|||
125943038|NCT05172544|453089562|FG002|Overall Study|Withdrawal by Subject|0|||
125943039|NCT05172544|453089560|FG000|Overall Study|Physician Decision|0|||
125943040|NCT05172544|453089561|FG001|Overall Study|Physician Decision|0|||
125943041|NCT05172544|453089562|FG002|Overall Study|Physician Decision|1|||
125943042|NCT03803774|453089563|FG000|Dose Escalation|Withdrawal by Subject|0|||
125943043|NCT03803774|453089564|FG001|Dose Escalation|Withdrawal by Subject|0|||
125943044|NCT03803774|453089565|FG002|Dose Escalation|Withdrawal by Subject|0|||
125943045|NCT03803774|453089566|FG003|Dose Escalation|Withdrawal by Subject|1|||
125943046|NCT03803774|453089567|FG004|Dose Escalation|Withdrawal by Subject|0|||
125943047|NCT00003641|453089568|FG000|Overall Study|Withdrawal by Subject|0|||
125943048|NCT00003641|453089569|FG001|Overall Study|Withdrawal by Subject|100|||
125943049|NCT00003641|453089568|FG000|Overall Study|Adverse Event|0|||
125943050|NCT00003641|453089569|FG001|Overall Study|Adverse Event|38|||
125943051|NCT00003641|453089568|FG000|Overall Study|Disease progression|0|||
125943052|NCT00003641|453089569|FG001|Overall Study|Disease progression|2|||
125943053|NCT00003641|453089568|FG000|Overall Study|Unknown/missing|0|||
125943054|NCT00003641|453089569|FG001|Overall Study|Unknown/missing|22|||
125943055|NCT00003641|453089568|FG000|Overall Study|Should not receive interferon therapy|2|||
125943056|NCT00003641|453089569|FG001|Overall Study|Should not receive interferon therapy|0|||
125943057|NCT00003641|453089568|FG000|Overall Study|Never started interferon|567|||
125943058|NCT00003641|453089569|FG001|Overall Study|Never started interferon|12|||
125943059|NCT03659916|453089570|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
125943060|NCT03659916|453089571|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
125943061|NCT03659916|453089572|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
125943062|NCT03659916|453089570|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
125943063|NCT03659916|453089571|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
125943064|NCT03659916|453089572|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
125943065|NCT03659916|453089570|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
125943066|NCT03659916|453089571|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
125943067|NCT03659916|453089572|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
125943068|NCT03659916|453089570|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
125943069|NCT03659916|453089571|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
125943070|NCT03659916|453089572|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
125943071|NCT03659916|453089570|FG000|Treatment Period (72 Weeks)|Other|1|||
125943072|NCT03659916|453089571|FG001|Treatment Period (72 Weeks)|Other|3|||
125943073|NCT03659916|453089572|FG002|Treatment Period (72 Weeks)|Other|9|||
125943074|NCT03659916|453089570|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
125943075|NCT03659916|453089571|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
125943076|NCT03659916|453089572|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
125943077|NCT03659916|453089570|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
125943078|NCT03659916|453089571|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
125943079|NCT03659916|453089572|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
125943080|NCT03659916|453089570|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
125943081|NCT03659916|453089571|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
125943082|NCT03659916|453089572|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
125943083|NCT03659916|453089570|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
125943084|NCT03659916|453089571|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
125943085|NCT03659916|453089572|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
125943086|NCT03659916|453089570|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
125943087|NCT03659916|453089571|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
125943088|NCT03659916|453089572|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
125943089|NCT03659916|453089570|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
125943090|NCT03659916|453089571|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
125943091|NCT03659916|453089572|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
125943092|NCT00878709|453089573|FG000|Overall Study|Withdrawal by Subject|197|||
125943093|NCT00878709|453089574|FG001|Overall Study|Withdrawal by Subject|120|||
125943094|NCT00878709|453089573|FG000|Overall Study|Lost to Follow-up|35|||
125943095|NCT00878709|453089574|FG001|Overall Study|Lost to Follow-up|33|||
125943096|NCT00878709|453089573|FG000|Overall Study|Other Reasons|93|||
125943097|NCT00878709|453089574|FG001|Overall Study|Other Reasons|84|||
125943098|NCT00322842|453089575|FG000|Overall Study|Withdrawal by Subject|0|||
125943099|NCT00322842|453089576|FG001|Overall Study|Withdrawal by Subject|1|||
125943100|NCT00322842|453089575|FG000|Overall Study|Lost to Follow-up|0|||
125943101|NCT00322842|453089576|FG001|Overall Study|Lost to Follow-up|1|||
125943102|NCT00322842|453089575|FG000|Overall Study|Refused transplant|1|||
125943103|NCT00322842|453089576|FG001|Overall Study|Refused transplant|0|||
125943104|NCT00322842|453089575|FG000|Overall Study|Death|1|||
125943105|NCT00322842|453089576|FG001|Overall Study|Death|0|||
125943106|NCT02867709|453089580|FG000|Treatment Period|Adverse Event|1|||
125943107|NCT02867709|453089581|FG001|Treatment Period|Adverse Event|1|||
125943108|NCT02867709|453089582|FG002|Treatment Period|Adverse Event|2|||
126066979|NCT00596960|453537087|FG001|Overall Study|Lost to Follow-up|5|||
126066980|NCT00596960|453537086|FG000|Overall Study|Withdrawal by Subject|1|||
126066981|NCT00596960|453537087|FG001|Overall Study|Withdrawal by Subject|0|||
126066982|NCT00596960|453537086|FG000|Overall Study|Incarcerated|2|||
126066983|NCT00596960|453537087|FG001|Overall Study|Incarcerated|0|||
126066984|NCT00596960|453537086|FG000|Overall Study|Physician Decision|1|||
126066985|NCT00596960|453537087|FG001|Overall Study|Physician Decision|0|||
126066986|NCT00596960|453537086|FG000|Overall Study|Protocol Violation|0|||
126066987|NCT00596960|453537087|FG001|Overall Study|Protocol Violation|1|||
126066988|NCT00596960|453537086|FG000|Overall Study|No alcohol use data|0|||
126066989|NCT00596960|453537087|FG001|Overall Study|No alcohol use data|1|||
126066990|NCT02374476|453537089|FG000|VT Induced Ablation|Screening Failures|36|||
126066991|NCT02374476|453537090|FG001|VT Induced Ablation|Screening Failures|0|||
126066992|NCT02374476|453537091|FG002|VT Induced Ablation|Screening Failures|0|||
126066993|NCT02374476|453537089|FG000|Arm Assignment|Withdrawal by Subject|0|||
126066994|NCT02374476|453537090|FG001|Arm Assignment|Withdrawal by Subject|0|||
126066995|NCT02374476|453537091|FG002|Arm Assignment|Withdrawal by Subject|1|||
126066996|NCT03305458|453537092|FG000|Overall Study|Withdrawal by Subject|50|||
126066997|NCT03305458|453537093|FG001|Overall Study|Withdrawal by Subject|46|||
126066998|NCT03305458|453537094|FG002|Overall Study|Withdrawal by Subject|93|||
126066999|NCT03305458|453537092|FG000|Overall Study|Lost to Follow-up|85|||
126067000|NCT03305458|453537093|FG001|Overall Study|Lost to Follow-up|85|||
126067001|NCT03305458|453537094|FG002|Overall Study|Lost to Follow-up|35|||
126114355|NCT03933397|453713804|FG001|Overall Study|No emergency department visit|71|||
125943109|NCT02867709|453089580|FG000|Treatment Period|Withdrawal of Consent|7|||
125943110|NCT02867709|453089581|FG001|Treatment Period|Withdrawal of Consent|9|||
125943111|NCT02867709|453089582|FG002|Treatment Period|Withdrawal of Consent|8|||
125943112|NCT02867709|453089580|FG000|Treatment Period|Lost to Follow-up|17|||
125943113|NCT02867709|453089581|FG001|Treatment Period|Lost to Follow-up|20|||
125943114|NCT02867709|453089582|FG002|Treatment Period|Lost to Follow-up|20|||
125943115|NCT02867709|453089580|FG000|Treatment Period|Lack of Qualifying Event|42|||
126067002|NCT05431543|453537095|FG000|Overall Study|Medical History|1|||
126067003|NCT05431543|453537096|FG001|Overall Study|Medical History|0|||
126067004|NCT05431543|453537097|FG002|Overall Study|Medical History|0|||
126067005|NCT00440037|453537098|FG000|Overall Study|Withdrawal by Subject|6|||
126067006|NCT00440037|453537098|FG000|Overall Study|Administrative decision|3|||
126067007|NCT00498797|453537099|FG000|Overall Study|Withdrawal by Subject|4|||
126067008|NCT00498797|453537100|FG001|Overall Study|Withdrawal by Subject|2|||
125943116|NCT02867709|453089581|FG001|Treatment Period|Lack of Qualifying Event|55|||
125943117|NCT02867709|453089582|FG002|Treatment Period|Lack of Qualifying Event|42|||
125943118|NCT02867709|453089580|FG000|Treatment Period|Protocol Violation|3|||
125943119|NCT02867709|453089581|FG001|Treatment Period|Protocol Violation|2|||
125943120|NCT02867709|453089582|FG002|Treatment Period|Protocol Violation|3|||
125943121|NCT02867709|453089580|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
125943122|NCT02867709|453089581|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
125943123|NCT02867709|453089582|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
125943124|NCT02867709|453089580|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
125943125|NCT02867709|453089581|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
125943126|NCT02867709|453089582|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
125943127|NCT02867709|453089580|FG000|Safety Follow-up Period|Pregnancy|0|||
125943128|NCT02867709|453089581|FG001|Safety Follow-up Period|Pregnancy|1|||
125943129|NCT02867709|453089582|FG002|Safety Follow-up Period|Pregnancy|0|||
125943130|NCT02867709|453089580|FG000|Safety Follow-up Period|Protocol Violation|0|||
125943131|NCT02867709|453089581|FG001|Safety Follow-up Period|Protocol Violation|1|||
125943132|NCT02867709|453089582|FG002|Safety Follow-up Period|Protocol Violation|1|||
125943133|NCT05214768|453089589|FG000|Induction Period|Withdrawal by Subject|1|||
125943134|NCT05214768|453089590|FG001|Induction Period|Withdrawal by Subject|0|||
125943135|NCT05214768|453089591|FG002|Induction Period|Withdrawal by Subject|0|||
125943136|NCT05214768|453089592|FG003|Induction Period|Withdrawal by Subject|0|||
125943137|NCT05214768|453089593|FG004|Induction Period|Withdrawal by Subject|0|||
125943138|NCT05214768|453089594|FG005|Induction Period|Withdrawal by Subject|0|||
125943139|NCT05214768|453089589|FG000|Induction Period|Physician Decision|1|||
125943140|NCT05214768|453089590|FG001|Induction Period|Physician Decision|0|||
125943141|NCT05214768|453089591|FG002|Induction Period|Physician Decision|0|||
125943142|NCT05214768|453089592|FG003|Induction Period|Physician Decision|0|||
125943143|NCT05214768|453089593|FG004|Induction Period|Physician Decision|0|||
125943144|NCT05214768|453089594|FG005|Induction Period|Physician Decision|0|||
125943145|NCT05214768|453089589|FG000|Maintenance Period|Other Reasons|0|||
125943146|NCT05214768|453089590|FG001|Maintenance Period|Other Reasons|0|||
125943147|NCT05214768|453089591|FG002|Maintenance Period|Other Reasons|1|||
125943148|NCT05214768|453089592|FG003|Maintenance Period|Other Reasons|1|||
125943149|NCT05214768|453089593|FG004|Maintenance Period|Other Reasons|0|||
125943150|NCT05214768|453089594|FG005|Maintenance Period|Other Reasons|0|||
125943151|NCT05214768|453089589|FG000|Maintenance Period|Withdrawal by Subject|0|||
125943152|NCT05214768|453089590|FG001|Maintenance Period|Withdrawal by Subject|0|||
125943153|NCT05214768|453089591|FG002|Maintenance Period|Withdrawal by Subject|0|||
125943154|NCT05214768|453089592|FG003|Maintenance Period|Withdrawal by Subject|1|||
125943155|NCT05214768|453089593|FG004|Maintenance Period|Withdrawal by Subject|0|||
125943156|NCT05214768|453089594|FG005|Maintenance Period|Withdrawal by Subject|0|||
125943157|NCT05214768|453089589|FG000|Maintenance Period|Lack of Efficacy|0|||
125943158|NCT05214768|453089590|FG001|Maintenance Period|Lack of Efficacy|0|||
125943159|NCT05214768|453089591|FG002|Maintenance Period|Lack of Efficacy|1|||
125943160|NCT05214768|453089592|FG003|Maintenance Period|Lack of Efficacy|0|||
125943161|NCT05214768|453089593|FG004|Maintenance Period|Lack of Efficacy|1|||
125943162|NCT05214768|453089594|FG005|Maintenance Period|Lack of Efficacy|0|||
125943163|NCT05214768|453089589|FG000|Open Label Extension Period|Physician Decision|0|||
125943164|NCT05214768|453089590|FG001|Open Label Extension Period|Physician Decision|0|||
125943165|NCT05214768|453089591|FG002|Open Label Extension Period|Physician Decision|0|||
125943166|NCT05214768|453089592|FG003|Open Label Extension Period|Physician Decision|0|||
125943167|NCT05214768|453089593|FG004|Open Label Extension Period|Physician Decision|0|||
125943168|NCT05214768|453089594|FG005|Open Label Extension Period|Physician Decision|1|||
125943169|NCT05214768|453089589|FG000|Open Label Extension Period|Lack of Efficacy|0|||
125943170|NCT05214768|453089590|FG001|Open Label Extension Period|Lack of Efficacy|0|||
125943171|NCT05214768|453089591|FG002|Open Label Extension Period|Lack of Efficacy|0|||
125943172|NCT05214768|453089592|FG003|Open Label Extension Period|Lack of Efficacy|0|||
125943173|NCT05214768|453089593|FG004|Open Label Extension Period|Lack of Efficacy|0|||
125943174|NCT05214768|453089594|FG005|Open Label Extension Period|Lack of Efficacy|1|||
125943175|NCT05214768|453089589|FG000|Open Label Extension Period|Ongoing Study|0|||
125943176|NCT05214768|453089590|FG001|Open Label Extension Period|Ongoing Study|0|||
125943177|NCT05214768|453089591|FG002|Open Label Extension Period|Ongoing Study|0|||
125943178|NCT05214768|453089592|FG003|Open Label Extension Period|Ongoing Study|0|||
125943179|NCT05214768|453089593|FG004|Open Label Extension Period|Ongoing Study|0|||
125943180|NCT05214768|453089594|FG005|Open Label Extension Period|Ongoing Study|42|||
125943181|NCT05041322|453089595|FG000|Baseline|Withdrawal by Subject|1|||
125943182|NCT05041322|453089596|FG001|Baseline|Withdrawal by Subject|0|||
125943183|NCT05041322|453089595|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
125943184|NCT05041322|453089596|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
125943185|NCT05041322|453089595|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
125943186|NCT05041322|453089596|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
125943187|NCT03795298|453089597|FG000|Overall Study|Death|34|||
125943188|NCT03795298|453089598|FG001|Overall Study|Death|29|||
125943189|NCT03795298|453089597|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
126067009|NCT00498797|453537099|FG000|Overall Study|Adverse Event|12|||
125943190|NCT03795298|453089598|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
125943191|NCT03795298|453089597|FG000|Overall Study|Lost to Follow-up|28|||
125943192|NCT03795298|453089598|FG001|Overall Study|Lost to Follow-up|17|||
125943193|NCT03795298|453089597|FG000|Overall Study|Physician Decision|5|||
125943194|NCT03795298|453089598|FG001|Overall Study|Physician Decision|4|||
125943195|NCT03795298|453089597|FG000|Overall Study|Withdrawal by Subject|43|||
125943196|NCT03795298|453089598|FG001|Overall Study|Withdrawal by Subject|28|||
125943197|NCT03795298|453089597|FG000|Overall Study|Reason not reported|7|||
125943198|NCT03795298|453089598|FG001|Overall Study|Reason not reported|9|||
125943199|NCT04303780|453089599|FG000|Overall Study|Death|104|||
125943200|NCT04303780|453089600|FG001|Overall Study|Death|85|||
125943201|NCT04303780|453089599|FG000|Overall Study|Lost to Follow-up|5|||
125943202|NCT04303780|453089600|FG001|Overall Study|Lost to Follow-up|2|||
125943203|NCT04303780|453089599|FG000|Overall Study|Withdrawal by Subject|12|||
125943204|NCT04303780|453089600|FG001|Overall Study|Withdrawal by Subject|39|||
125943205|NCT04303780|453089599|FG000|Overall Study|Ongoing in study|50|||
125943206|NCT04303780|453089600|FG001|Overall Study|Ongoing in study|45|||
125943207|NCT00697515|453090903|FG000|Dose Optimization Period|Adverse Event|4|||
125943208|NCT00697515|453090904|FG001|Dose Optimization Period|Adverse Event|0|||
125943209|NCT00697515|453090903|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
125943210|NCT00697515|453090904|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
125943211|NCT00697515|453090903|FG000|Dose Optimization Period|Lost to Follow-up|2|||
125943212|NCT00697515|453090904|FG001|Dose Optimization Period|Lost to Follow-up|0|||
125943213|NCT00697515|453090903|FG000|Dose Optimization Period|sponsor request|2|||
125943214|NCT00697515|453090904|FG001|Dose Optimization Period|sponsor request|0|||
125943215|NCT00697515|453090903|FG000|Dose Optimization Period|called to active duty|1|||
125943216|NCT00697515|453090904|FG001|Dose Optimization Period|called to active duty|0|||
125943217|NCT00697515|453090903|FG000|Dose Optimization Period|elevated QTc|1|||
125943218|NCT00697515|453090904|FG001|Dose Optimization Period|elevated QTc|0|||
125943219|NCT00697515|453090903|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
125943220|NCT00697515|453090904|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
125943221|NCT00697515|453090903|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
125943222|NCT00697515|453090904|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
125943223|NCT00697515|453090903|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
125943224|NCT00697515|453090904|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
125943225|NCT00697515|453090903|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
125943226|NCT00697515|453090904|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
125943227|NCT04765358|453090905|FG000|Overall Study|Withdrawal by Subject|1|||
125943228|NCT02731729|453090906|FG000|Overall Study|Death|2|||
125943229|NCT02731729|453090907|FG001|Overall Study|Death|2|||
125943230|NCT02731729|453090906|FG000|Overall Study|Study terminated by Sponsor|6|||
125943231|NCT02731729|453090907|FG001|Overall Study|Study terminated by Sponsor|6|||
125943232|NCT02731729|453090906|FG000|Overall Study|Withdrawal by Subject|1|||
125943233|NCT02731729|453090907|FG001|Overall Study|Withdrawal by Subject|0|||
125943234|NCT02066467|453090908|FG000|Overall Study|Did not undergo implant procedure|24|||
125943235|NCT02066467|453090908|FG000|Overall Study|Attempted to implant withoput success|43|||
125943236|NCT02066467|453090908|FG000|Overall Study|Consent ineligible|1|||
125943237|NCT02066467|453090908|FG000|Overall Study|Death|54|||
125943238|NCT02066467|453090908|FG000|Overall Study|Lost to Follow-up|51|||
125943239|NCT02066467|453090908|FG000|Overall Study|Adverse Event|20|||
125943240|NCT02066467|453090908|FG000|Overall Study|Withdrawal by Subject|16|||
125943241|NCT02066467|453090908|FG000|Overall Study|Physician Decision|2|||
125943242|NCT02066467|453090908|FG000|Overall Study|Not defined|4|||
125943243|NCT00456521|453090909|FG000|Overall Study|Adverse Event|150|||
125943244|NCT00456521|453090910|FG001|Overall Study|Adverse Event|25|||
125943245|NCT00456521|453090909|FG000|Overall Study|Withdrawal by Subject|43|||
125943246|NCT00456521|453090910|FG001|Overall Study|Withdrawal by Subject|24|||
125943247|NCT00456521|453090909|FG000|Overall Study|Lost to Follow-up|22|||
125943248|NCT00456521|453090910|FG001|Overall Study|Lost to Follow-up|17|||
125943249|NCT00456521|453090909|FG000|Overall Study|Lack of Efficacy|3|||
125943250|NCT00456521|453090910|FG001|Overall Study|Lack of Efficacy|6|||
125943251|NCT00456521|453090909|FG000|Overall Study|Protocol Violation|4|||
125943252|NCT00456521|453090910|FG001|Overall Study|Protocol Violation|0|||
125943253|NCT00456521|453090909|FG000|Overall Study|Pregnancy|1|||
125943254|NCT00456521|453090910|FG001|Overall Study|Pregnancy|1|||
125943255|NCT00456521|453090909|FG000|Overall Study|Drug non-compliance, moved, other|26|||
126067010|NCT00498797|453537100|FG001|Overall Study|Adverse Event|5|||
126067011|NCT00498797|453537099|FG000|Overall Study|Condition under investigation worsened|19|||
125943256|NCT00456521|453090910|FG001|Overall Study|Drug non-compliance, moved, other|11|||
125943257|NCT00605475|453090911|FG000|Overall Study|Abnormal Laboratory Values|0|||
125943258|NCT00605475|453090912|FG001|Overall Study|Abnormal Laboratory Values|0|||
125943259|NCT00605475|453090913|FG002|Overall Study|Abnormal Laboratory Values|0|||
125943260|NCT00605475|453090914|FG003|Overall Study|Abnormal Laboratory Values|0|||
125943261|NCT00605475|453090915|FG004|Overall Study|Abnormal Laboratory Values|0|||
125943262|NCT00605475|453090916|FG005|Overall Study|Abnormal Laboratory Values|0|||
125943263|NCT00605475|453090917|FG006|Overall Study|Abnormal Laboratory Values|0|||
125943264|NCT00605475|453090918|FG007|Overall Study|Abnormal Laboratory Values|0|||
125943265|NCT00605475|453090919|FG008|Overall Study|Abnormal Laboratory Values|1|||
125943266|NCT00605475|453090920|FG009|Overall Study|Abnormal Laboratory Values|0|||
125943267|NCT00605475|453090911|FG000|Overall Study|Administrative problems|0|||
125943268|NCT00605475|453090912|FG001|Overall Study|Administrative problems|0|||
125943269|NCT00605475|453090913|FG002|Overall Study|Administrative problems|0|||
125943270|NCT00605475|453090914|FG003|Overall Study|Administrative problems|0|||
125943271|NCT00605475|453090915|FG004|Overall Study|Administrative problems|0|||
125943272|NCT00605475|453090916|FG005|Overall Study|Administrative problems|0|||
125943273|NCT00605475|453090917|FG006|Overall Study|Administrative problems|1|||
125943274|NCT00605475|453090918|FG007|Overall Study|Administrative problems|0|||
125943275|NCT00605475|453090919|FG008|Overall Study|Administrative problems|0|||
125943276|NCT00605475|453090920|FG009|Overall Study|Administrative problems|0|||
125943277|NCT00605475|453090911|FG000|Overall Study|Lost to Follow-up|0|||
125943278|NCT00605475|453090912|FG001|Overall Study|Lost to Follow-up|0|||
125943279|NCT00605475|453090913|FG002|Overall Study|Lost to Follow-up|0|||
125943280|NCT00605475|453090914|FG003|Overall Study|Lost to Follow-up|0|||
125943281|NCT00605475|453090915|FG004|Overall Study|Lost to Follow-up|0|||
125943282|NCT00605475|453090916|FG005|Overall Study|Lost to Follow-up|0|||
125943283|NCT00605475|453090917|FG006|Overall Study|Lost to Follow-up|0|||
125943284|NCT00605475|453090918|FG007|Overall Study|Lost to Follow-up|0|||
125943285|NCT00605475|453090919|FG008|Overall Study|Lost to Follow-up|1|||
125943286|NCT00605475|453090920|FG009|Overall Study|Lost to Follow-up|1|||
125943287|NCT00605475|453090911|FG000|Overall Study|Protocol Violation|0|||
125943288|NCT00605475|453090912|FG001|Overall Study|Protocol Violation|0|||
125943289|NCT00605475|453090913|FG002|Overall Study|Protocol Violation|0|||
125943290|NCT00605475|453090914|FG003|Overall Study|Protocol Violation|0|||
125943291|NCT00605475|453090915|FG004|Overall Study|Protocol Violation|1|||
125943292|NCT00605475|453090916|FG005|Overall Study|Protocol Violation|0|||
125943293|NCT00605475|453090917|FG006|Overall Study|Protocol Violation|0|||
125943294|NCT00605475|453090918|FG007|Overall Study|Protocol Violation|0|||
125943295|NCT00605475|453090919|FG008|Overall Study|Protocol Violation|0|||
125943296|NCT00605475|453090920|FG009|Overall Study|Protocol Violation|0|||
125943297|NCT00605475|453090911|FG000|Overall Study|Withdrawal by Subject|0|||
125943298|NCT00605475|453090912|FG001|Overall Study|Withdrawal by Subject|0|||
125943299|NCT00605475|453090913|FG002|Overall Study|Withdrawal by Subject|0|||
125943300|NCT00605475|453090914|FG003|Overall Study|Withdrawal by Subject|0|||
125943301|NCT00605475|453090915|FG004|Overall Study|Withdrawal by Subject|0|||
125943302|NCT00605475|453090916|FG005|Overall Study|Withdrawal by Subject|2|||
125943303|NCT00605475|453090917|FG006|Overall Study|Withdrawal by Subject|0|||
125943304|NCT00605475|453090918|FG007|Overall Study|Withdrawal by Subject|0|||
125943305|NCT00605475|453090919|FG008|Overall Study|Withdrawal by Subject|0|||
125943306|NCT00605475|453090920|FG009|Overall Study|Withdrawal by Subject|1|||
125943307|NCT02596854|453090923|FG000|Overall Study|Withdrawn|8|||
125943308|NCT03615326|453090932|FG000|Overall Study|Death|266|||
125943309|NCT03615326|453090933|FG001|Overall Study|Death|286|||
125943310|NCT03615326|453090934|FG002|Overall Study|Death|14|||
125943311|NCT03615326|453090935|FG003|Overall Study|Death|17|||
125943312|NCT03615326|453090932|FG000|Overall Study|Lost to Follow-up|0|||
125943313|NCT03615326|453090933|FG001|Overall Study|Lost to Follow-up|1|||
125943314|NCT03615326|453090934|FG002|Overall Study|Lost to Follow-up|0|||
125943315|NCT03615326|453090935|FG003|Overall Study|Lost to Follow-up|0|||
125943316|NCT03615326|453090932|FG000|Overall Study|Withdrawal by Subject|1|||
125943317|NCT03615326|453090933|FG001|Overall Study|Withdrawal by Subject|3|||
125943318|NCT03615326|453090934|FG002|Overall Study|Withdrawal by Subject|0|||
125943319|NCT03615326|453090935|FG003|Overall Study|Withdrawal by Subject|0|||
125943320|NCT03615326|453090932|FG000|Overall Study|Participants Ongoing|83|||
125943321|NCT03615326|453090933|FG001|Overall Study|Participants Ongoing|58|||
125943322|NCT03615326|453090934|FG002|Overall Study|Participants Ongoing|6|||
125943323|NCT03615326|453090935|FG003|Overall Study|Participants Ongoing|3|||
125943324|NCT00405587|453090938|FG000|Overall Study|Death|0|||
125943325|NCT00405587|453090939|FG001|Overall Study|Death|0|||
125943326|NCT00405587|453090940|FG002|Overall Study|Death|0|||
125943327|NCT00405587|453090941|FG003|Overall Study|Death|1|||
125943328|NCT00405587|453090938|FG000|Overall Study|Disease Progression|22|||
125943329|NCT00405587|453090939|FG001|Overall Study|Disease Progression|23|||
125943330|NCT00405587|453090940|FG002|Overall Study|Disease Progression|21|||
125943331|NCT00405587|453090941|FG003|Overall Study|Disease Progression|17|||
125943332|NCT00405587|453090938|FG000|Overall Study|Physician Decision|3|||
125943333|NCT00405587|453090939|FG001|Overall Study|Physician Decision|2|||
125943334|NCT00405587|453090940|FG002|Overall Study|Physician Decision|0|||
125943335|NCT00405587|453090941|FG003|Overall Study|Physician Decision|0|||
125943336|NCT00405587|453090938|FG000|Overall Study|Adverse Event|1|||
125943337|NCT00405587|453090939|FG001|Overall Study|Adverse Event|0|||
125943338|NCT00405587|453090940|FG002|Overall Study|Adverse Event|0|||
125943339|NCT00405587|453090941|FG003|Overall Study|Adverse Event|0|||
125943340|NCT00405587|453090938|FG000|Overall Study|Lost to Follow-up|0|||
125943341|NCT00405587|453090939|FG001|Overall Study|Lost to Follow-up|1|||
125943342|NCT00405587|453090940|FG002|Overall Study|Lost to Follow-up|1|||
125943343|NCT00405587|453090941|FG003|Overall Study|Lost to Follow-up|0|||
125943344|NCT00405587|453090938|FG000|Overall Study|Radiation induced necrosis|0|||
125943345|NCT00405587|453090939|FG001|Overall Study|Radiation induced necrosis|1|||
125943346|NCT00405587|453090940|FG002|Overall Study|Radiation induced necrosis|0|||
125943347|NCT00405587|453090941|FG003|Overall Study|Radiation induced necrosis|0|||
125943348|NCT00405587|453090938|FG000|Overall Study|Withdrawal by Subject|0|||
125943349|NCT00405587|453090939|FG001|Overall Study|Withdrawal by Subject|0|||
125943350|NCT00405587|453090940|FG002|Overall Study|Withdrawal by Subject|0|||
125943351|NCT00405587|453090941|FG003|Overall Study|Withdrawal by Subject|2|||
125943352|NCT00405587|453090938|FG000|Overall Study|Participant not dosed|0|||
125943353|NCT00405587|453090939|FG001|Overall Study|Participant not dosed|1|||
125943354|NCT00405587|453090940|FG002|Overall Study|Participant not dosed|0|||
125943355|NCT00405587|453090941|FG003|Overall Study|Participant not dosed|0|||
125943356|NCT06027866|453090942|FG000|Overall Study|Withdrawal by Subject|2|||
125943357|NCT03506373|453090945|FG000|Overall Study|Adverse Event|6|||
125943358|NCT03506373|453090945|FG000|Overall Study|Withdrawal by Subject|2|||
125943359|NCT03506373|453090945|FG000|Overall Study|Disease progression|5|||
125943360|NCT03506373|453090945|FG000|Overall Study|Other|3|||
125943361|NCT01852812|453090947|FG000|Overall Study|Adverse Event|0|||
125943362|NCT01852812|453090948|FG001|Overall Study|Adverse Event|0|||
125943363|NCT01852812|453090949|FG002|Overall Study|Adverse Event|1|||
125943364|NCT01852812|453090947|FG000|Overall Study|Non-compliance With Study Drug|0|||
125943365|NCT01852812|453090948|FG001|Overall Study|Non-compliance With Study Drug|1|||
125943366|NCT01852812|453090949|FG002|Overall Study|Non-compliance With Study Drug|0|||
125943367|NCT02250443|453090950|FG000|Overall Study|Administrative problems|7|||
125943368|NCT02250443|453090950|FG000|Overall Study|Adverse Event|3|||
125943369|NCT01549964|453090951|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
125943370|NCT01549964|453090952|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
125943371|NCT01549964|453090953|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
125943372|NCT01549964|453090954|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
125943373|NCT01549964|453090951|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
125943374|NCT01549964|453090952|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
125943375|NCT01549964|453090953|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
125943376|NCT01549964|453090954|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
125943377|NCT01549964|453090951|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
125943378|NCT01549964|453090952|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
125943379|NCT01549964|453090953|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
125943380|NCT01549964|453090954|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
125943381|NCT01549964|453090951|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
125943382|NCT01549964|453090952|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
125943383|NCT01549964|453090953|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
125943384|NCT01549964|453090954|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
125943385|NCT01549964|453090951|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
125943386|NCT01549964|453090952|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
125943387|NCT01549964|453090953|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
125943388|NCT01549964|453090954|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
125943389|NCT01549964|453090951|FG000|24-Week Treatment Period|Other|1|||
125943390|NCT01549964|453090952|FG001|24-Week Treatment Period|Other|0|||
125943391|NCT01549964|453090953|FG002|24-Week Treatment Period|Other|1|||
125943392|NCT01549964|453090954|FG003|24-Week Treatment Period|Other|0|||
125943393|NCT01549964|453090951|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
125943394|NCT01549964|453090952|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
125943395|NCT01549964|453090953|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
125943396|NCT01549964|453090954|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
125943397|NCT01549964|453090951|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
125943398|NCT01549964|453090952|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
125943399|NCT01549964|453090953|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
125943400|NCT01549964|453090954|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
125943401|NCT01549964|453090951|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
125943402|NCT01549964|453090952|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
125943403|NCT01549964|453090953|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
125943404|NCT01549964|453090954|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
125943405|NCT01549964|453090951|FG000|80-Week Extension Period|Pregnancy|0|||
125943406|NCT01549964|453090952|FG001|80-Week Extension Period|Pregnancy|0|||
125943407|NCT01549964|453090953|FG002|80-Week Extension Period|Pregnancy|1|||
125943408|NCT01549964|453090954|FG003|80-Week Extension Period|Pregnancy|0|||
125943409|NCT01549964|453090951|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
125943410|NCT01549964|453090952|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
125943411|NCT01549964|453090953|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
125943412|NCT01549964|453090954|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
125943413|NCT01549964|453090951|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
125943414|NCT01549964|453090952|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
125943415|NCT01549964|453090953|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
125943416|NCT01549964|453090954|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
126067012|NCT00498797|453537100|FG001|Overall Study|Condition under investigation worsened|21|||
126067013|NCT00498797|453537099|FG000|Overall Study|Other|3|||
126067014|NCT00498797|453537100|FG001|Overall Study|Other|1|||
126067015|NCT01855399|453537101|FG000|6 Month|Lost to Follow-up|12|||
126067016|NCT01855399|453537102|FG001|6 Month|Lost to Follow-up|9|||
126067017|NCT01855399|453537101|FG000|6 Month|Withdrawal by Subject|8|||
126067018|NCT01855399|453537102|FG001|6 Month|Withdrawal by Subject|6|||
126067019|NCT01855399|453537101|FG000|12 Month|Lost to Follow-up|7|||
126067020|NCT01855399|453537102|FG001|12 Month|Lost to Follow-up|11|||
126067021|NCT03953079|453537103|FG000|Core Study|Withdrawal by Subject|1|||
126067022|NCT03953079|453537104|FG001|Core Study|Withdrawal by Subject|2|||
126067023|NCT03953079|453537105|FG002|Core Study|Withdrawal by Subject|1|||
126067024|NCT03953079|453537103|FG000|Core Study|COVID-19|0|||
126067025|NCT03953079|453537104|FG001|Core Study|COVID-19|1|||
126067026|NCT03953079|453537105|FG002|Core Study|COVID-19|0|||
126067027|NCT03953079|453537103|FG000|Core Study|Difficulties leaving the house|0|||
126067028|NCT03953079|453537104|FG001|Core Study|Difficulties leaving the house|1|||
126067029|NCT03953079|453537105|FG002|Core Study|Difficulties leaving the house|0|||
126067030|NCT03953079|453537103|FG000|Extension Study|Withdrawal by Subject|1|||
126067031|NCT03953079|453537104|FG001|Extension Study|Withdrawal by Subject|0|||
126067032|NCT03953079|453537105|FG002|Extension Study|Withdrawal by Subject|0|||
126067033|NCT03953079|453537103|FG000|Extension Study|Received Rescue Treatment|5|||
126067034|NCT03953079|453537104|FG001|Extension Study|Received Rescue Treatment|6|||
126067035|NCT03953079|453537105|FG002|Extension Study|Received Rescue Treatment|5|||
126067036|NCT04394624|453537106|FG000|Overall Study|Adverse Event|6|||
126067037|NCT04394624|453537107|FG001|Overall Study|Adverse Event|0|||
126067038|NCT04394624|453537106|FG000|Overall Study|Progressive disease|24|||
126067039|NCT04394624|453537107|FG001|Overall Study|Progressive disease|0|||
126067040|NCT04394624|453537106|FG000|Overall Study|Not related to COVID-19|1|||
126067041|NCT04394624|453537107|FG001|Overall Study|Not related to COVID-19|0|||
126067042|NCT00448344|453537113|FG000|Overall Study|Lost to Follow-up|20|||
126067043|NCT00448344|453537114|FG001|Overall Study|Lost to Follow-up|22|||
125943417|NCT01549964|453090951|FG000|80-Week Extension Period|Lost to Follow-up|1|||
125943418|NCT01549964|453090952|FG001|80-Week Extension Period|Lost to Follow-up|0|||
125943419|NCT01549964|453090953|FG002|80-Week Extension Period|Lost to Follow-up|2|||
125943420|NCT01549964|453090954|FG003|80-Week Extension Period|Lost to Follow-up|1|||
125943421|NCT01549964|453090951|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
125943422|NCT01549964|453090952|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
125943423|NCT01549964|453090953|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
125943424|NCT01549964|453090954|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
125943425|NCT02290821|453090955|FG000|Overall Study|Withdrawal by Subject|1|||
125943426|NCT02290821|453090956|FG001|Overall Study|Withdrawal by Subject|1|||
125943427|NCT02290821|453090955|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
125943428|NCT02290821|453090956|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
125943429|NCT02290821|453090955|FG000|Overall Study|Lost to Follow-up|3|||
125943430|NCT02290821|453090956|FG001|Overall Study|Lost to Follow-up|2|||
125943431|NCT02438722|453090957|FG000|Overall Study|Adverse Event|12|||
125943432|NCT02438722|453090958|FG001|Overall Study|Adverse Event|9|||
125943433|NCT02438722|453090957|FG000|Overall Study|Refusal unrelated to AE|2|||
125943434|NCT02438722|453090958|FG001|Overall Study|Refusal unrelated to AE|5|||
125943435|NCT02438722|453090957|FG000|Overall Study|Disease progression/relapse|46|||
125943436|NCT02438722|453090958|FG001|Overall Study|Disease progression/relapse|51|||
125943437|NCT02438722|453090957|FG000|Overall Study|Death|0|||
125943438|NCT02438722|453090958|FG001|Overall Study|Death|3|||
125943439|NCT02438722|453090957|FG000|Overall Study|Physician Decision|2|||
125943440|NCT02438722|453090958|FG001|Overall Study|Physician Decision|2|||
125943441|NCT02438722|453090957|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
125943442|NCT02438722|453090958|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
125943443|NCT02438722|453090957|FG000|Overall Study|Withdrawal by Subject|0|||
125943444|NCT02438722|453090958|FG001|Overall Study|Withdrawal by Subject|1|||
125943445|NCT02438722|453090957|FG000|Overall Study|On protocol treatment|15|||
125943446|NCT02438722|453090958|FG001|Overall Study|On protocol treatment|14|||
126067044|NCT00448344|453537113|FG000|Overall Study|Withdrawal by Subject|6|||
126067045|NCT00448344|453537114|FG001|Overall Study|Withdrawal by Subject|8|||
126067046|NCT00448344|453537113|FG000|Overall Study|Death|3|||
126067047|NCT00448344|453537114|FG001|Overall Study|Death|4|||
126067048|NCT00448344|453537113|FG000|Overall Study|Physician Decision|1|||
126067049|NCT00448344|453537114|FG001|Overall Study|Physician Decision|2|||
126067050|NCT00141271|453537117|FG000|Overall Study|Adverse Event|31|||
126067051|NCT00141271|453537118|FG001|Overall Study|Adverse Event|19|||
126067052|NCT00141271|453537119|FG002|Overall Study|Adverse Event|17|||
126067053|NCT00141271|453537117|FG000|Overall Study|Laboratory Abnormality|2|||
125943447|NCT02438722|453090957|FG000|Overall Study|Did not receive protocol treatment|5|||
125943448|NCT02438722|453090958|FG001|Overall Study|Did not receive protocol treatment|0|||
125943449|NCT00909779|453090959|FG000|Overall Study|Adverse Event|53|||
125943450|NCT00909779|453090960|FG001|Overall Study|Adverse Event|55|||
125943451|NCT00909779|453090959|FG000|Overall Study|Lack of Efficacy|7|||
125943452|NCT00909779|453090960|FG001|Overall Study|Lack of Efficacy|4|||
125943453|NCT00909779|453090959|FG000|Overall Study|Lost to Follow-up|19|||
125943454|NCT00909779|453090960|FG001|Overall Study|Lost to Follow-up|15|||
125943455|NCT00909779|453090959|FG000|Overall Study|Physician Decision|8|||
125943456|NCT00909779|453090960|FG001|Overall Study|Physician Decision|2|||
125943457|NCT00909779|453090959|FG000|Overall Study|Protocol Violation|2|||
125943458|NCT00909779|453090960|FG001|Overall Study|Protocol Violation|5|||
125943459|NCT00909779|453090959|FG000|Overall Study|Withdrawal by Subject|116|||
125943460|NCT00909779|453090960|FG001|Overall Study|Withdrawal by Subject|80|||
125943461|NCT00909779|453090959|FG000|Overall Study|Site Ceasing Operation|2|||
125943462|NCT00909779|453090960|FG001|Overall Study|Site Ceasing Operation|2|||
125943463|NCT00909779|453090959|FG000|Overall Study|Medical Monitor Decision|1|||
125943464|NCT00909779|453090960|FG001|Overall Study|Medical Monitor Decision|0|||
125943465|NCT00909779|453090959|FG000|Overall Study|Noncompliance|1|||
125943466|NCT00909779|453090960|FG001|Overall Study|Noncompliance|1|||
125943467|NCT00909779|453090959|FG000|Overall Study|Randomized in error|1|||
125943468|NCT00909779|453090960|FG001|Overall Study|Randomized in error|1|||
125943469|NCT00728130|453090961|FG000|Overall Study|Withdrawal by Subject|1|||
125943470|NCT00728130|453090961|FG000|Overall Study|Paperwork not completed in time|1|||
125943471|NCT00728130|453090961|FG000|Overall Study|Physician Decision|1|||
125943472|NCT01737047|453090962|FG000|Overall Study|Death|10|||
125943473|NCT01737047|453090963|FG001|Overall Study|Death|0|||
125943474|NCT01737047|453090964|FG002|Overall Study|Death|1|||
125943475|NCT01737047|453090962|FG000|Overall Study|Withdrawal by Subject|17|||
125943476|NCT01737047|453090963|FG001|Overall Study|Withdrawal by Subject|11|||
125943477|NCT01737047|453090964|FG002|Overall Study|Withdrawal by Subject|4|||
125943478|NCT01154218|453090965|FG000|Third Intervention Period|Adverse Event|0|||
125943479|NCT01154218|453090966|FG001|Third Intervention Period|Adverse Event|1|||
125943480|NCT01154218|453090967|FG002|Third Intervention Period|Adverse Event|0|||
125943481|NCT01154218|453090968|FG003|Third Intervention Period|Adverse Event|0|||
125943482|NCT01154218|453090965|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125943483|NCT01154218|453090966|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126067054|NCT00141271|453537118|FG001|Overall Study|Laboratory Abnormality|1|||
126067055|NCT00141271|453537119|FG002|Overall Study|Laboratory Abnormality|1|||
126067056|NCT00141271|453537117|FG000|Overall Study|Lack of Efficacy|7|||
126067057|NCT00141271|453537118|FG001|Overall Study|Lack of Efficacy|7|||
126067058|NCT00141271|453537119|FG002|Overall Study|Lack of Efficacy|3|||
126067059|NCT00141271|453537117|FG000|Overall Study|Lost to Follow-up|15|||
126067060|NCT00141271|453537118|FG001|Overall Study|Lost to Follow-up|15|||
126067061|NCT00141271|453537119|FG002|Overall Study|Lost to Follow-up|21|||
126067062|NCT00141271|453537117|FG000|Overall Study|Withdrawal by Subject|14|||
126067063|NCT00141271|453537118|FG001|Overall Study|Withdrawal by Subject|9|||
126067064|NCT00141271|453537119|FG002|Overall Study|Withdrawal by Subject|10|||
126067065|NCT00141271|453537117|FG000|Overall Study|Other|11|||
126067066|NCT00141271|453537118|FG001|Overall Study|Other|12|||
126067067|NCT00141271|453537119|FG002|Overall Study|Other|5|||
126067068|NCT00990314|453537123|FG000|Overall Study|Death|2|||
126067069|NCT00990314|453537123|FG000|Overall Study|Adverse Event|2|||
126067070|NCT00990314|453537123|FG000|Overall Study|Withdrawal by Subject|3|||
126067071|NCT00990314|453537123|FG000|Overall Study|Non-Compliance|1|||
126067072|NCT00990314|453537123|FG000|Overall Study|Physician Decision|3|||
126067073|NCT00990314|453537123|FG000|Overall Study|Lack of Efficacy|1|||
126067074|NCT04853394|453537131|FG000|Follow-up Interviews|Lost to Follow-up|22|||
125943484|NCT01154218|453090967|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125943485|NCT01154218|453090968|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
125943486|NCT01154218|453090965|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
125943487|NCT01154218|453090966|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
125943488|NCT01154218|453090967|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
125943489|NCT01154218|453090968|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
125943490|NCT00362115|453090971|FG000|Overall Study|Adverse Event|0|||
125943491|NCT00362115|453090972|FG001|Overall Study|Adverse Event|1|||
125943492|NCT00362115|453090973|FG002|Overall Study|Adverse Event|1|||
125943493|NCT00362115|453090974|FG003|Overall Study|Adverse Event|1|||
125943494|NCT00362115|453090975|FG004|Overall Study|Adverse Event|2|||
125943495|NCT00362115|453090976|FG005|Overall Study|Adverse Event|2|||
125943496|NCT00362115|453090977|FG006|Overall Study|Adverse Event|1|||
125943497|NCT00362115|453090971|FG000|Overall Study|Protocol Violation|0|||
126067075|NCT04853394|453537132|FG001|Follow-up Interviews|Lost to Follow-up|15|||
126067076|NCT04212299|453537133|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
126067077|NCT00705614|453539051|FG000|Initial Intervention|Adverse Event|40|||
126067078|NCT00705614|453539052|FG001|Initial Intervention|Adverse Event|21|||
126067079|NCT00705614|453539051|FG000|Initial Intervention|Lost to Follow-up|310|||
125943498|NCT00362115|453090972|FG001|Overall Study|Protocol Violation|0|||
125943499|NCT00362115|453090973|FG002|Overall Study|Protocol Violation|0|||
125943500|NCT00362115|453090974|FG003|Overall Study|Protocol Violation|0|||
125943501|NCT00362115|453090975|FG004|Overall Study|Protocol Violation|0|||
125943502|NCT00362115|453090976|FG005|Overall Study|Protocol Violation|1|||
125943503|NCT00362115|453090977|FG006|Overall Study|Protocol Violation|0|||
125943504|NCT00362115|453090971|FG000|Overall Study|Lost to Follow-up|0|||
125943505|NCT00362115|453090972|FG001|Overall Study|Lost to Follow-up|1|||
125943506|NCT00362115|453090973|FG002|Overall Study|Lost to Follow-up|0|||
125943507|NCT00362115|453090974|FG003|Overall Study|Lost to Follow-up|0|||
125943508|NCT00362115|453090975|FG004|Overall Study|Lost to Follow-up|2|||
125943509|NCT00362115|453090976|FG005|Overall Study|Lost to Follow-up|0|||
125943510|NCT00362115|453090977|FG006|Overall Study|Lost to Follow-up|1|||
125943511|NCT00362115|453090971|FG000|Overall Study|Withdrawal by Subject|1|||
125943512|NCT00362115|453090972|FG001|Overall Study|Withdrawal by Subject|3|||
125943513|NCT00362115|453090973|FG002|Overall Study|Withdrawal by Subject|1|||
125943514|NCT00362115|453090974|FG003|Overall Study|Withdrawal by Subject|0|||
125943515|NCT00362115|453090975|FG004|Overall Study|Withdrawal by Subject|1|||
125943516|NCT00362115|453090976|FG005|Overall Study|Withdrawal by Subject|3|||
125943517|NCT00362115|453090977|FG006|Overall Study|Withdrawal by Subject|4|||
125943518|NCT00362115|453090971|FG000|Overall Study|Lack of Efficacy|1|||
125943519|NCT00362115|453090972|FG001|Overall Study|Lack of Efficacy|0|||
125943520|NCT00362115|453090973|FG002|Overall Study|Lack of Efficacy|5|||
125943521|NCT00362115|453090974|FG003|Overall Study|Lack of Efficacy|2|||
125943522|NCT00362115|453090975|FG004|Overall Study|Lack of Efficacy|2|||
125943523|NCT00362115|453090976|FG005|Overall Study|Lack of Efficacy|0|||
125943524|NCT00362115|453090977|FG006|Overall Study|Lack of Efficacy|3|||
125943525|NCT00362115|453090971|FG000|Overall Study|Physician Decision|0|||
125943526|NCT00362115|453090972|FG001|Overall Study|Physician Decision|0|||
125943527|NCT00362115|453090973|FG002|Overall Study|Physician Decision|0|||
125943528|NCT00362115|453090974|FG003|Overall Study|Physician Decision|0|||
125943529|NCT00362115|453090975|FG004|Overall Study|Physician Decision|0|||
125943530|NCT00362115|453090976|FG005|Overall Study|Physician Decision|0|||
125943531|NCT00362115|453090977|FG006|Overall Study|Physician Decision|3|||
125943532|NCT00362115|453090971|FG000|Overall Study|Other|0|||
125943533|NCT00362115|453090972|FG001|Overall Study|Other|1|||
125943534|NCT00362115|453090973|FG002|Overall Study|Other|0|||
125943535|NCT00362115|453090974|FG003|Overall Study|Other|1|||
125943536|NCT00362115|453090975|FG004|Overall Study|Other|0|||
125943537|NCT00362115|453090976|FG005|Overall Study|Other|1|||
125943538|NCT00362115|453090977|FG006|Overall Study|Other|0|||
125943539|NCT03965962|453090978|FG000|Overall Study|Adverse Event|1|||
125943540|NCT03965962|453090979|FG001|Overall Study|Adverse Event|0|||
125943541|NCT03965962|453090980|FG002|Overall Study|Adverse Event|0|||
125943542|NCT03965962|453090981|FG003|Overall Study|Adverse Event|0|||
125943543|NCT03965962|453090978|FG000|Overall Study|Protocol Violation|21|||
125943544|NCT03965962|453090979|FG001|Overall Study|Protocol Violation|4|||
125943545|NCT03965962|453090980|FG002|Overall Study|Protocol Violation|10|||
125943546|NCT03965962|453090981|FG003|Overall Study|Protocol Violation|5|||
125943547|NCT03965962|453090978|FG000|Overall Study|Lost to Follow-up|0|||
125943548|NCT03965962|453090979|FG001|Overall Study|Lost to Follow-up|1|||
125943549|NCT03965962|453090980|FG002|Overall Study|Lost to Follow-up|0|||
126067080|NCT00705614|453539052|FG001|Initial Intervention|Lost to Follow-up|191|||
125943550|NCT03965962|453090981|FG003|Overall Study|Lost to Follow-up|0|||
125943551|NCT03965962|453090978|FG000|Overall Study|Withdrawal by Subject|3|||
125943552|NCT03965962|453090979|FG001|Overall Study|Withdrawal by Subject|0|||
125943553|NCT03965962|453090980|FG002|Overall Study|Withdrawal by Subject|0|||
125943554|NCT03965962|453090981|FG003|Overall Study|Withdrawal by Subject|1|||
125943555|NCT00729183|453090982|FG000|Overall Study|Adverse Event|11|||
125943556|NCT00729183|453090983|FG001|Overall Study|Adverse Event|5|||
125943557|NCT00729183|453090982|FG000|Overall Study|Lack of Efficacy|0|||
125943558|NCT00729183|453090983|FG001|Overall Study|Lack of Efficacy|1|||
125943559|NCT00729183|453090982|FG000|Overall Study|Lost to Follow-up|3|||
125943560|NCT00729183|453090983|FG001|Overall Study|Lost to Follow-up|1|||
125943561|NCT00729183|453090982|FG000|Overall Study|Physician Decision|1|||
125943562|NCT00729183|453090983|FG001|Overall Study|Physician Decision|1|||
125943563|NCT00729183|453090982|FG000|Overall Study|Protocol Violation|1|||
125943564|NCT00729183|453090983|FG001|Overall Study|Protocol Violation|0|||
125943565|NCT00729183|453090982|FG000|Overall Study|Withdrawal by Subject|9|||
125943566|NCT00729183|453090983|FG001|Overall Study|Withdrawal by Subject|7|||
125943567|NCT05497284|453090986|FG000|Overall Study|Adverse Event|1|||
125943568|NCT05497284|453090987|FG001|Overall Study|Adverse Event|0|||
125943569|NCT05497284|453090986|FG000|Overall Study|Physician Decision|0|||
125943570|NCT05497284|453090987|FG001|Overall Study|Physician Decision|1|||
125943571|NCT05497284|453090986|FG000|Overall Study|Study terminated by sponsor|7|||
125943572|NCT05497284|453090987|FG001|Overall Study|Study terminated by sponsor|4|||
125943573|NCT05497284|453090986|FG000|Overall Study|Subject Decision|0|||
125943574|NCT05497284|453090987|FG001|Overall Study|Subject Decision|1|||
125943575|NCT03878446|453090988|FG000|Overall Study|Withdrawn by parent or guardian|1|||
126067081|NCT00705614|453539051|FG000|Initial Intervention|Withdrawal by Subject|114|||
125943576|NCT03878446|453090989|FG001|Overall Study|Withdrawn by parent or guardian|0|||
125943577|NCT03878446|453090990|FG002|Overall Study|Withdrawn by parent or guardian|0|||
125943578|NCT03878446|453090991|FG003|Overall Study|Withdrawn by parent or guardian|0|||
125943579|NCT03878446|453090992|FG004|Overall Study|Withdrawn by parent or guardian|0|||
125943580|NCT01502423|453090993|FG000|Overall Study|Withdrawal by Subject|0|||
125943581|NCT01502423|453090994|FG001|Overall Study|Withdrawal by Subject|1|||
125943582|NCT01344161|453090995|FG000|Overall Study|Lost to Follow-up|4|||
125943583|NCT01344161|453090996|FG001|Overall Study|Lost to Follow-up|1|||
125943584|NCT01344161|453090995|FG000|Overall Study|Pregnancy|0|||
125943585|NCT01344161|453090996|FG001|Overall Study|Pregnancy|1|||
125943586|NCT01344161|453090995|FG000|Overall Study|Protocol Violation|1|||
125943587|NCT01344161|453090996|FG001|Overall Study|Protocol Violation|1|||
125943588|NCT02255500|453092984|FG000|Overall Study|Withdrawal by Subject|1|||
125943589|NCT02255500|453092985|FG001|Overall Study|Withdrawal by Subject|0|||
125943590|NCT00644969|453092991|FG000|Treatment Phase|Randomized, not treated|1|||
125943591|NCT00644969|453092992|FG001|Treatment Phase|Randomized, not treated|0|||
125943592|NCT00644969|453092991|FG000|Treatment Phase|Adverse Event|3|||
125943593|NCT00644969|453092992|FG001|Treatment Phase|Adverse Event|0|||
125943594|NCT00644969|453092991|FG000|Treatment Phase|Withdrawal by Subject|4|||
125943595|NCT00644969|453092992|FG001|Treatment Phase|Withdrawal by Subject|0|||
125943596|NCT00644969|453092991|FG000|Treatment Phase|Lost to Follow-up|2|||
125943597|NCT00644969|453092992|FG001|Treatment Phase|Lost to Follow-up|2|||
125943598|NCT00644969|453092991|FG000|Treatment Phase|Other|4|||
125943599|NCT00644969|453092992|FG001|Treatment Phase|Other|1|||
125943600|NCT00644969|453092991|FG000|Post Treatment Phase|Death|1|||
125943601|NCT00644969|453092992|FG001|Post Treatment Phase|Death|0|||
125943602|NCT00644969|453092991|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
125943603|NCT00644969|453092992|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
125943604|NCT00644969|453092991|FG000|Post Treatment Phase|Lost to Follow-up|4|||
125943605|NCT00644969|453092992|FG001|Post Treatment Phase|Lost to Follow-up|1|||
125943606|NCT00644969|453092991|FG000|Post Treatment Phase|Other|1|||
125943607|NCT00644969|453092992|FG001|Post Treatment Phase|Other|0|||
125943608|NCT02515942|453092993|FG000|Overall Study|Adverse Event|5|||
125943609|NCT02515942|453092994|FG001|Overall Study|Adverse Event|0|||
125943610|NCT02515942|453092995|FG002|Overall Study|Adverse Event|0|||
125943611|NCT02515942|453092993|FG000|Overall Study|Death|0|||
125943612|NCT02515942|453092994|FG001|Overall Study|Death|0|||
125943613|NCT02515942|453092995|FG002|Overall Study|Death|1|||
125943614|NCT02515942|453092993|FG000|Overall Study|Lack of Efficacy|0|||
125943615|NCT02515942|453092994|FG001|Overall Study|Lack of Efficacy|0|||
125943616|NCT02515942|453092995|FG002|Overall Study|Lack of Efficacy|1|||
125943617|NCT02515942|453092993|FG000|Overall Study|Lost to Follow-up|2|||
125943618|NCT02515942|453092994|FG001|Overall Study|Lost to Follow-up|0|||
125943619|NCT02515942|453092995|FG002|Overall Study|Lost to Follow-up|0|||
125943620|NCT02515942|453092993|FG000|Overall Study|Withdrawal by Subject|0|||
125943621|NCT02515942|453092994|FG001|Overall Study|Withdrawal by Subject|3|||
125943622|NCT02515942|453092995|FG002|Overall Study|Withdrawal by Subject|2|||
125943623|NCT00902564|453092997|FG000|Overall Study|Withdrawal by Subject|2|||
125943624|NCT02658890|453093001|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943625|NCT02658890|453093002|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943626|NCT02658890|453093003|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943627|NCT02658890|453093004|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943628|NCT02658890|453093005|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943629|NCT02658890|453093006|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943630|NCT02658890|453093007|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943631|NCT02658890|453093008|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943632|NCT02658890|453093009|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125943633|NCT02658890|453093010|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943634|NCT02658890|453093011|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943635|NCT02658890|453093012|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943636|NCT02658890|453093013|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943637|NCT02658890|453093014|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943638|NCT02658890|453093015|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943639|NCT02658890|453093016|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943640|NCT02658890|453093017|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943641|NCT02658890|453093018|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943642|NCT02658890|453093019|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943643|NCT02658890|453093020|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943644|NCT02658890|453093021|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943645|NCT02658890|453093022|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943646|NCT02658890|453093023|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943647|NCT02658890|453093024|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943648|NCT02658890|453093025|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943649|NCT02658890|453093026|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943650|NCT02658890|453093027|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943651|NCT02658890|453093001|FG000|Treatment Phase|Adverse Event|0|||
125943652|NCT02658890|453093002|FG001|Treatment Phase|Adverse Event|1|||
125943653|NCT02658890|453093003|FG002|Treatment Phase|Adverse Event|2|||
125943654|NCT02658890|453093004|FG003|Treatment Phase|Adverse Event|2|||
125943655|NCT02658890|453093005|FG004|Treatment Phase|Adverse Event|1|||
125943656|NCT02658890|453093006|FG005|Treatment Phase|Adverse Event|0|||
125943657|NCT02658890|453093007|FG006|Treatment Phase|Adverse Event|0|||
125943658|NCT02658890|453093008|FG007|Treatment Phase|Adverse Event|2|||
125943659|NCT02658890|453093009|FG008|Treatment Phase|Adverse Event|1|||
125943660|NCT02658890|453093010|FG009|Treatment Phase|Adverse Event|2|||
125943661|NCT02658890|453093011|FG010|Treatment Phase|Adverse Event|3|||
125943662|NCT02658890|453093012|FG011|Treatment Phase|Adverse Event|0|||
125943663|NCT02658890|453093013|FG012|Treatment Phase|Adverse Event|1|||
125943664|NCT02658890|453093014|FG013|Treatment Phase|Adverse Event|4|||
125943665|NCT02658890|453093015|FG014|Treatment Phase|Adverse Event|0|||
125943666|NCT02658890|453093016|FG015|Treatment Phase|Adverse Event|0|||
125943667|NCT02658890|453093017|FG016|Treatment Phase|Adverse Event|0|||
125943668|NCT02658890|453093018|FG017|Treatment Phase|Adverse Event|0|||
125943669|NCT02658890|453093019|FG018|Treatment Phase|Adverse Event|5|||
125943670|NCT02658890|453093020|FG019|Treatment Phase|Adverse Event|1|||
125943671|NCT02658890|453093021|FG020|Treatment Phase|Adverse Event|3|||
125943672|NCT02658890|453093022|FG021|Treatment Phase|Adverse Event|0|||
125943673|NCT02658890|453093023|FG022|Treatment Phase|Adverse Event|5|||
125943674|NCT02658890|453093024|FG023|Treatment Phase|Adverse Event|0|||
125943675|NCT02658890|453093025|FG024|Treatment Phase|Adverse Event|0|||
125943676|NCT02658890|453093026|FG025|Treatment Phase|Adverse Event|2|||
125943677|NCT02658890|453093027|FG026|Treatment Phase|Adverse Event|1|||
125943678|NCT02658890|453093001|FG000|Treatment Phase|Death|0|||
125943679|NCT02658890|453093002|FG001|Treatment Phase|Death|0|||
125943680|NCT02658890|453093003|FG002|Treatment Phase|Death|0|||
125943681|NCT02658890|453093004|FG003|Treatment Phase|Death|0|||
125943682|NCT02658890|453093005|FG004|Treatment Phase|Death|0|||
125943683|NCT02658890|453093006|FG005|Treatment Phase|Death|0|||
125943684|NCT02658890|453093007|FG006|Treatment Phase|Death|0|||
125943685|NCT02658890|453093008|FG007|Treatment Phase|Death|0|||
125943686|NCT02658890|453093009|FG008|Treatment Phase|Death|0|||
125943687|NCT02658890|453093010|FG009|Treatment Phase|Death|0|||
125943688|NCT02658890|453093011|FG010|Treatment Phase|Death|0|||
125943689|NCT02658890|453093012|FG011|Treatment Phase|Death|0|||
125943690|NCT02658890|453093013|FG012|Treatment Phase|Death|0|||
125943691|NCT02658890|453093014|FG013|Treatment Phase|Death|0|||
125943692|NCT02658890|453093015|FG014|Treatment Phase|Death|0|||
125943693|NCT02658890|453093016|FG015|Treatment Phase|Death|0|||
125943694|NCT02658890|453093017|FG016|Treatment Phase|Death|0|||
125943695|NCT02658890|453093018|FG017|Treatment Phase|Death|0|||
125943696|NCT02658890|453093019|FG018|Treatment Phase|Death|1|||
125943697|NCT02658890|453093020|FG019|Treatment Phase|Death|0|||
125943698|NCT02658890|453093021|FG020|Treatment Phase|Death|0|||
125943699|NCT02658890|453093022|FG021|Treatment Phase|Death|0|||
125943700|NCT02658890|453093023|FG022|Treatment Phase|Death|0|||
125943701|NCT02658890|453093024|FG023|Treatment Phase|Death|0|||
125943702|NCT02658890|453093025|FG024|Treatment Phase|Death|0|||
125943703|NCT02658890|453093026|FG025|Treatment Phase|Death|0|||
125943704|NCT02658890|453093027|FG026|Treatment Phase|Death|0|||
125943705|NCT02658890|453093001|FG000|Treatment Phase|Lost to Follow-up|0|||
125943706|NCT02658890|453093002|FG001|Treatment Phase|Lost to Follow-up|0|||
125943707|NCT02658890|453093003|FG002|Treatment Phase|Lost to Follow-up|0|||
125943708|NCT02658890|453093004|FG003|Treatment Phase|Lost to Follow-up|0|||
125943709|NCT02658890|453093005|FG004|Treatment Phase|Lost to Follow-up|0|||
125943710|NCT02658890|453093006|FG005|Treatment Phase|Lost to Follow-up|0|||
125943711|NCT02658890|453093007|FG006|Treatment Phase|Lost to Follow-up|1|||
125943712|NCT02658890|453093008|FG007|Treatment Phase|Lost to Follow-up|0|||
125943713|NCT02658890|453093009|FG008|Treatment Phase|Lost to Follow-up|0|||
125943714|NCT02658890|453093010|FG009|Treatment Phase|Lost to Follow-up|0|||
125943715|NCT02658890|453093011|FG010|Treatment Phase|Lost to Follow-up|0|||
125943716|NCT02658890|453093012|FG011|Treatment Phase|Lost to Follow-up|0|||
125943717|NCT02658890|453093013|FG012|Treatment Phase|Lost to Follow-up|0|||
125943718|NCT02658890|453093014|FG013|Treatment Phase|Lost to Follow-up|0|||
125943719|NCT02658890|453093015|FG014|Treatment Phase|Lost to Follow-up|0|||
125943720|NCT02658890|453093016|FG015|Treatment Phase|Lost to Follow-up|0|||
125943721|NCT02658890|453093017|FG016|Treatment Phase|Lost to Follow-up|0|||
125943722|NCT02658890|453093018|FG017|Treatment Phase|Lost to Follow-up|0|||
125943723|NCT02658890|453093019|FG018|Treatment Phase|Lost to Follow-up|0|||
125943724|NCT02658890|453093020|FG019|Treatment Phase|Lost to Follow-up|0|||
125943725|NCT02658890|453093021|FG020|Treatment Phase|Lost to Follow-up|0|||
125943726|NCT02658890|453093022|FG021|Treatment Phase|Lost to Follow-up|0|||
125943727|NCT02658890|453093023|FG022|Treatment Phase|Lost to Follow-up|0|||
125943728|NCT02658890|453093024|FG023|Treatment Phase|Lost to Follow-up|0|||
125943729|NCT02658890|453093025|FG024|Treatment Phase|Lost to Follow-up|0|||
125943730|NCT02658890|453093026|FG025|Treatment Phase|Lost to Follow-up|0|||
125943731|NCT02658890|453093027|FG026|Treatment Phase|Lost to Follow-up|0|||
125943732|NCT02658890|453093001|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
125943733|NCT02658890|453093002|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
125943734|NCT02658890|453093003|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
125943735|NCT02658890|453093004|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
125943736|NCT02658890|453093005|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
125943737|NCT02658890|453093006|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
125943738|NCT02658890|453093007|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
125943739|NCT02658890|453093008|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
125943740|NCT02658890|453093009|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
125943741|NCT02658890|453093010|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
125943742|NCT02658890|453093011|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
125943743|NCT02658890|453093012|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
125943744|NCT02658890|453093013|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
125943745|NCT02658890|453093014|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
125943746|NCT02658890|453093015|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
125943747|NCT02658890|453093016|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
125943748|NCT02658890|453093017|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
125943749|NCT02658890|453093018|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
125943750|NCT02658890|453093019|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
125943751|NCT02658890|453093020|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
125943752|NCT02658890|453093021|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
125943753|NCT02658890|453093022|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
125943754|NCT02658890|453093023|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
125943755|NCT02658890|453093024|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
125943756|NCT02658890|453093025|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
125943757|NCT02658890|453093026|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
125943758|NCT02658890|453093027|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
125943759|NCT02658890|453093001|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
125943760|NCT02658890|453093002|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
125943761|NCT02658890|453093003|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
125943762|NCT02658890|453093004|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
125943763|NCT02658890|453093005|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
125943764|NCT02658890|453093006|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
125943765|NCT02658890|453093007|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
125943766|NCT02658890|453093008|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
125943767|NCT02658890|453093009|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
125943768|NCT02658890|453093010|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
125943769|NCT02658890|453093011|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
125943770|NCT02658890|453093012|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
125943771|NCT02658890|453093013|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
125943772|NCT02658890|453093014|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
125943773|NCT02658890|453093015|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
125943774|NCT02658890|453093016|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
125943775|NCT02658890|453093017|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
125943776|NCT02658890|453093018|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
125943777|NCT02658890|453093019|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
125943778|NCT02658890|453093020|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
125943779|NCT02658890|453093021|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
125943780|NCT02658890|453093022|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
125943781|NCT02658890|453093023|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
126067082|NCT00705614|453539052|FG001|Initial Intervention|Withdrawal by Subject|71|||
126067083|NCT00705614|453539051|FG000|Initial Intervention|Administrative Reason|51|||
126067084|NCT00705614|453539052|FG001|Initial Intervention|Administrative Reason|38|||
126067085|NCT00705614|453539051|FG000|Initial Intervention|Status completion unknown|3|||
126067086|NCT00705614|453539052|FG001|Initial Intervention|Status completion unknown|0|||
126067087|NCT00705614|453539051|FG000|Switch to Remicade|Adverse Event|0|||
126067088|NCT00705614|453539052|FG001|Switch to Remicade|Adverse Event|5|||
126114356|NCT03933397|453713803|FG000|Overall Study|Missed emergency department visit|25|||
125943782|NCT02658890|453093024|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
125943783|NCT02658890|453093025|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
125943784|NCT02658890|453093026|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
125943785|NCT02658890|453093027|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
125943786|NCT02658890|453093001|FG000|Treatment Phase|Other Reasons|0|||
125943787|NCT02658890|453093002|FG001|Treatment Phase|Other Reasons|0|||
125943788|NCT02658890|453093003|FG002|Treatment Phase|Other Reasons|0|||
125943789|NCT02658890|453093004|FG003|Treatment Phase|Other Reasons|0|||
125943790|NCT02658890|453093005|FG004|Treatment Phase|Other Reasons|0|||
125943791|NCT02658890|453093006|FG005|Treatment Phase|Other Reasons|0|||
125943792|NCT02658890|453093007|FG006|Treatment Phase|Other Reasons|1|||
126067089|NCT00705614|453539051|FG000|Switch to Remicade|Lost to Follow-up|0|||
126067090|NCT00705614|453539052|FG001|Switch to Remicade|Lost to Follow-up|23|||
125943793|NCT02658890|453093008|FG007|Treatment Phase|Other Reasons|0|||
125943794|NCT02658890|453093009|FG008|Treatment Phase|Other Reasons|1|||
125943795|NCT02658890|453093010|FG009|Treatment Phase|Other Reasons|0|||
125943796|NCT02658890|453093011|FG010|Treatment Phase|Other Reasons|0|||
125943797|NCT02658890|453093012|FG011|Treatment Phase|Other Reasons|0|||
125943798|NCT02658890|453093013|FG012|Treatment Phase|Other Reasons|0|||
125943799|NCT02658890|453093014|FG013|Treatment Phase|Other Reasons|2|||
125943800|NCT02658890|453093015|FG014|Treatment Phase|Other Reasons|0|||
125943801|NCT02658890|453093016|FG015|Treatment Phase|Other Reasons|0|||
125943802|NCT02658890|453093017|FG016|Treatment Phase|Other Reasons|0|||
125943803|NCT02658890|453093018|FG017|Treatment Phase|Other Reasons|0|||
125943804|NCT02658890|453093019|FG018|Treatment Phase|Other Reasons|1|||
125943805|NCT02658890|453093020|FG019|Treatment Phase|Other Reasons|0|||
125943806|NCT02658890|453093021|FG020|Treatment Phase|Other Reasons|0|||
125943807|NCT02658890|453093022|FG021|Treatment Phase|Other Reasons|0|||
125943808|NCT02658890|453093023|FG022|Treatment Phase|Other Reasons|0|||
125943809|NCT02658890|453093024|FG023|Treatment Phase|Other Reasons|0|||
125943810|NCT02658890|453093025|FG024|Treatment Phase|Other Reasons|1|||
125943811|NCT02658890|453093026|FG025|Treatment Phase|Other Reasons|0|||
125943812|NCT02658890|453093027|FG026|Treatment Phase|Other Reasons|1|||
125943813|NCT02658890|453093001|FG000|Treatment Phase|Progressive Disease|6|||
125943814|NCT02658890|453093002|FG001|Treatment Phase|Progressive Disease|7|||
125943815|NCT02658890|453093003|FG002|Treatment Phase|Progressive Disease|6|||
125943816|NCT02658890|453093004|FG003|Treatment Phase|Progressive Disease|12|||
125943817|NCT02658890|453093005|FG004|Treatment Phase|Progressive Disease|6|||
125943818|NCT02658890|453093006|FG005|Treatment Phase|Progressive Disease|18|||
125943819|NCT02658890|453093007|FG006|Treatment Phase|Progressive Disease|12|||
125943820|NCT02658890|453093008|FG007|Treatment Phase|Progressive Disease|19|||
125943821|NCT02658890|453093009|FG008|Treatment Phase|Progressive Disease|26|||
125943822|NCT02658890|453093010|FG009|Treatment Phase|Progressive Disease|8|||
125943823|NCT02658890|453093011|FG010|Treatment Phase|Progressive Disease|7|||
125943824|NCT02658890|453093012|FG011|Treatment Phase|Progressive Disease|9|||
125943825|NCT02658890|453093013|FG012|Treatment Phase|Progressive Disease|8|||
125943826|NCT02658890|453093014|FG013|Treatment Phase|Progressive Disease|29|||
125943827|NCT02658890|453093015|FG014|Treatment Phase|Progressive Disease|6|||
125943828|NCT02658890|453093016|FG015|Treatment Phase|Progressive Disease|2|||
125943829|NCT02658890|453093017|FG016|Treatment Phase|Progressive Disease|32|||
125943830|NCT02658890|453093018|FG017|Treatment Phase|Progressive Disease|14|||
125943831|NCT02658890|453093019|FG018|Treatment Phase|Progressive Disease|40|||
125943832|NCT02658890|453093020|FG019|Treatment Phase|Progressive Disease|32|||
125943833|NCT02658890|453093021|FG020|Treatment Phase|Progressive Disease|19|||
125943834|NCT02658890|453093022|FG021|Treatment Phase|Progressive Disease|30|||
125943835|NCT02658890|453093023|FG022|Treatment Phase|Progressive Disease|15|||
125943836|NCT02658890|453093024|FG023|Treatment Phase|Progressive Disease|0|||
125943837|NCT02658890|453093025|FG024|Treatment Phase|Progressive Disease|0|||
125943838|NCT02658890|453093026|FG025|Treatment Phase|Progressive Disease|14|||
125943839|NCT02658890|453093027|FG026|Treatment Phase|Progressive Disease|11|||
125943840|NCT02658890|453093001|FG000|Treatment Phase|Study Drug Toxicity|0|||
125943841|NCT02658890|453093002|FG001|Treatment Phase|Study Drug Toxicity|0|||
125943842|NCT02658890|453093003|FG002|Treatment Phase|Study Drug Toxicity|2|||
125943843|NCT02658890|453093004|FG003|Treatment Phase|Study Drug Toxicity|0|||
125943844|NCT02658890|453093005|FG004|Treatment Phase|Study Drug Toxicity|0|||
125943845|NCT02658890|453093006|FG005|Treatment Phase|Study Drug Toxicity|0|||
125943846|NCT02658890|453093007|FG006|Treatment Phase|Study Drug Toxicity|0|||
125943847|NCT02658890|453093008|FG007|Treatment Phase|Study Drug Toxicity|0|||
125943848|NCT02658890|453093009|FG008|Treatment Phase|Study Drug Toxicity|3|||
125943849|NCT02658890|453093010|FG009|Treatment Phase|Study Drug Toxicity|0|||
125943850|NCT02658890|453093011|FG010|Treatment Phase|Study Drug Toxicity|1|||
125943851|NCT02658890|453093012|FG011|Treatment Phase|Study Drug Toxicity|1|||
125943852|NCT02658890|453093013|FG012|Treatment Phase|Study Drug Toxicity|2|||
125943853|NCT02658890|453093014|FG013|Treatment Phase|Study Drug Toxicity|9|||
125943854|NCT02658890|453093015|FG014|Treatment Phase|Study Drug Toxicity|0|||
125943855|NCT02658890|453093016|FG015|Treatment Phase|Study Drug Toxicity|1|||
125943856|NCT02658890|453093017|FG016|Treatment Phase|Study Drug Toxicity|1|||
125943857|NCT02658890|453093018|FG017|Treatment Phase|Study Drug Toxicity|0|||
125943858|NCT02658890|453093019|FG018|Treatment Phase|Study Drug Toxicity|8|||
126067091|NCT00705614|453539051|FG000|Switch to Remicade|Withdrawal by Subject|0|||
126067092|NCT00705614|453539052|FG001|Switch to Remicade|Withdrawal by Subject|12|||
126067093|NCT00705614|453539051|FG000|Switch to Remicade|Administrative Reason|0|||
125943859|NCT02658890|453093020|FG019|Treatment Phase|Study Drug Toxicity|3|||
125943860|NCT02658890|453093021|FG020|Treatment Phase|Study Drug Toxicity|2|||
125943861|NCT02658890|453093022|FG021|Treatment Phase|Study Drug Toxicity|0|||
125943862|NCT02658890|453093023|FG022|Treatment Phase|Study Drug Toxicity|8|||
125943863|NCT02658890|453093024|FG023|Treatment Phase|Study Drug Toxicity|0|||
125943864|NCT02658890|453093025|FG024|Treatment Phase|Study Drug Toxicity|0|||
125943865|NCT02658890|453093026|FG025|Treatment Phase|Study Drug Toxicity|2|||
126067094|NCT00705614|453539052|FG001|Switch to Remicade|Administrative Reason|9|||
125943866|NCT02658890|453093027|FG026|Treatment Phase|Study Drug Toxicity|0|||
125943867|NCT02658890|453093001|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943868|NCT02658890|453093002|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943869|NCT02658890|453093003|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943870|NCT02658890|453093004|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125943871|NCT02658890|453093005|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943872|NCT02658890|453093006|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943873|NCT02658890|453093007|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943874|NCT02658890|453093008|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943875|NCT02658890|453093009|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943876|NCT02658890|453093010|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125943877|NCT02658890|453093011|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943878|NCT02658890|453093012|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943879|NCT02658890|453093013|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943880|NCT02658890|453093014|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943881|NCT02658890|453093015|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943882|NCT02658890|453093016|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943883|NCT02658890|453093017|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943884|NCT02658890|453093018|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943885|NCT02658890|453093019|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125943886|NCT02658890|453093020|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943887|NCT02658890|453093021|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943888|NCT02658890|453093022|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943889|NCT02658890|453093023|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125943890|NCT02658890|453093024|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943891|NCT02658890|453093025|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943892|NCT02658890|453093026|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943893|NCT02658890|453093027|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125943894|NCT02658890|453093001|FG000|Treatment Phase|Withdrawal by Subject|0|||
125943895|NCT02658890|453093002|FG001|Treatment Phase|Withdrawal by Subject|1|||
125943896|NCT02658890|453093003|FG002|Treatment Phase|Withdrawal by Subject|0|||
125943897|NCT02658890|453093004|FG003|Treatment Phase|Withdrawal by Subject|0|||
125943898|NCT02658890|453093005|FG004|Treatment Phase|Withdrawal by Subject|0|||
125943899|NCT02658890|453093006|FG005|Treatment Phase|Withdrawal by Subject|0|||
125943900|NCT02658890|453093007|FG006|Treatment Phase|Withdrawal by Subject|1|||
125943901|NCT02658890|453093008|FG007|Treatment Phase|Withdrawal by Subject|0|||
125943902|NCT02658890|453093009|FG008|Treatment Phase|Withdrawal by Subject|0|||
125943903|NCT02658890|453093010|FG009|Treatment Phase|Withdrawal by Subject|1|||
125943904|NCT02658890|453093011|FG010|Treatment Phase|Withdrawal by Subject|0|||
125943905|NCT02658890|453093012|FG011|Treatment Phase|Withdrawal by Subject|0|||
125943906|NCT02658890|453093013|FG012|Treatment Phase|Withdrawal by Subject|1|||
125943907|NCT02658890|453093014|FG013|Treatment Phase|Withdrawal by Subject|3|||
125943908|NCT02658890|453093015|FG014|Treatment Phase|Withdrawal by Subject|0|||
125943909|NCT02658890|453093016|FG015|Treatment Phase|Withdrawal by Subject|0|||
125943910|NCT02658890|453093017|FG016|Treatment Phase|Withdrawal by Subject|1|||
125943911|NCT02658890|453093018|FG017|Treatment Phase|Withdrawal by Subject|0|||
125943912|NCT02658890|453093019|FG018|Treatment Phase|Withdrawal by Subject|4|||
125943913|NCT02658890|453093020|FG019|Treatment Phase|Withdrawal by Subject|3|||
125943914|NCT02658890|453093021|FG020|Treatment Phase|Withdrawal by Subject|0|||
125943915|NCT02658890|453093022|FG021|Treatment Phase|Withdrawal by Subject|4|||
125943916|NCT02658890|453093023|FG022|Treatment Phase|Withdrawal by Subject|1|||
125943917|NCT02658890|453093024|FG023|Treatment Phase|Withdrawal by Subject|1|||
125943918|NCT02658890|453093025|FG024|Treatment Phase|Withdrawal by Subject|0|||
125943919|NCT02658890|453093026|FG025|Treatment Phase|Withdrawal by Subject|0|||
125943920|NCT02658890|453093027|FG026|Treatment Phase|Withdrawal by Subject|0|||
125943921|NCT02474199|453093028|FG000|Overall Study|Lost to Follow-up|1|||
125943922|NCT02474199|453093029|FG001|Overall Study|Lost to Follow-up|0|||
125943923|NCT02474199|453093030|FG002|Overall Study|Lost to Follow-up|0|||
125943924|NCT02474199|453093031|FG003|Overall Study|Lost to Follow-up|0|||
125943925|NCT02474199|453093028|FG000|Overall Study|Withdrawal by Subject|1|||
126067095|NCT00676195|453539055|FG000|Overall Study|Lost to Follow-up|1|||
125943926|NCT02474199|453093029|FG001|Overall Study|Withdrawal by Subject|2|||
125943927|NCT02474199|453093030|FG002|Overall Study|Withdrawal by Subject|0|||
125943928|NCT02474199|453093031|FG003|Overall Study|Withdrawal by Subject|1|||
125943929|NCT02474199|453093028|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
125943930|NCT02474199|453093029|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
125943931|NCT02474199|453093030|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
126067096|NCT00676195|453539055|FG000|Overall Study|Adverse Event|1|||
126067097|NCT00676195|453539055|FG000|Overall Study|Physician Decision|1|||
126067098|NCT02878590|453539056|FG000|Overall Study|Withdrawal by Subject|2|||
126067099|NCT03034772|453539070|FG000|Overall Study|Adverse Event|0|||
126067100|NCT03034772|453539071|FG001|Overall Study|Adverse Event|1|||
126067101|NCT03034772|453539070|FG000|Overall Study|Withdrawal by Subject|0|||
126067102|NCT03034772|453539071|FG001|Overall Study|Withdrawal by Subject|1|||
126067103|NCT00116584|453539074|FG000|Overall Study|Withdrawal by Subject|1|||
126067104|NCT00116584|453539075|FG001|Overall Study|Withdrawal by Subject|0|||
126067105|NCT00116584|453539074|FG000|Overall Study|Protocol Violation|1|||
126067106|NCT00116584|453539075|FG001|Overall Study|Protocol Violation|1|||
126067107|NCT02660034|453539076|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
126067108|NCT02660034|453539077|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
126067109|NCT02660034|453539078|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
126067110|NCT02660034|453539079|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
126067111|NCT02660034|453539080|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
126067112|NCT02660034|453539081|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
126067113|NCT02660034|453539082|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
126067114|NCT02660034|453539083|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
126067115|NCT02660034|453539084|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
126067116|NCT02660034|453539085|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
126067117|NCT02660034|453539086|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
126067118|NCT02660034|453539087|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
126067119|NCT02660034|453539088|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
126067120|NCT02660034|453539089|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
126067121|NCT02660034|453539076|FG000|Overall Study|Progressive Disease (Clinical)|7|||
126067122|NCT02660034|453539077|FG001|Overall Study|Progressive Disease (Clinical)|8|||
126067123|NCT02660034|453539078|FG002|Overall Study|Progressive Disease (Clinical)|3|||
126067124|NCT02660034|453539079|FG003|Overall Study|Progressive Disease (Clinical)|9|||
126067125|NCT02660034|453539080|FG004|Overall Study|Progressive Disease (Clinical)|3|||
126067126|NCT02660034|453539081|FG005|Overall Study|Progressive Disease (Clinical)|0|||
126067127|NCT02660034|453539082|FG006|Overall Study|Progressive Disease (Clinical)|0|||
126067128|NCT02660034|453539083|FG007|Overall Study|Progressive Disease (Clinical)|0|||
126067129|NCT02660034|453539084|FG008|Overall Study|Progressive Disease (Clinical)|0|||
126067130|NCT02660034|453539085|FG009|Overall Study|Progressive Disease (Clinical)|0|||
126067131|NCT02660034|453539086|FG010|Overall Study|Progressive Disease (Clinical)|0|||
126067132|NCT02660034|453539087|FG011|Overall Study|Progressive Disease (Clinical)|0|||
126067133|NCT02660034|453539088|FG012|Overall Study|Progressive Disease (Clinical)|0|||
126067134|NCT02660034|453539089|FG013|Overall Study|Progressive Disease (Clinical)|0|||
126067135|NCT02660034|453539076|FG000|Overall Study|Lost to Follow-up|0|||
126067136|NCT02660034|453539077|FG001|Overall Study|Lost to Follow-up|0|||
126067137|NCT02660034|453539078|FG002|Overall Study|Lost to Follow-up|1|||
126067138|NCT02660034|453539079|FG003|Overall Study|Lost to Follow-up|1|||
126067139|NCT02660034|453539080|FG004|Overall Study|Lost to Follow-up|0|||
126067140|NCT02660034|453539081|FG005|Overall Study|Lost to Follow-up|0|||
126067141|NCT02660034|453539082|FG006|Overall Study|Lost to Follow-up|0|||
126067142|NCT02660034|453539083|FG007|Overall Study|Lost to Follow-up|0|||
126067143|NCT02660034|453539084|FG008|Overall Study|Lost to Follow-up|0|||
126067144|NCT02660034|453539085|FG009|Overall Study|Lost to Follow-up|1|||
126067145|NCT02660034|453539086|FG010|Overall Study|Lost to Follow-up|1|||
126067146|NCT02660034|453539087|FG011|Overall Study|Lost to Follow-up|1|||
126067147|NCT02660034|453539088|FG012|Overall Study|Lost to Follow-up|0|||
126067148|NCT02660034|453539089|FG013|Overall Study|Lost to Follow-up|0|||
126067149|NCT02660034|453539076|FG000|Overall Study|Participant moved into special access scheme|1|||
126067150|NCT02660034|453539077|FG001|Overall Study|Participant moved into special access scheme|2|||
126067151|NCT02660034|453539078|FG002|Overall Study|Participant moved into special access scheme|0|||
126067152|NCT02660034|453539079|FG003|Overall Study|Participant moved into special access scheme|0|||
126067153|NCT02660034|453539080|FG004|Overall Study|Participant moved into special access scheme|0|||
126067154|NCT02660034|453539081|FG005|Overall Study|Participant moved into special access scheme|0|||
126067155|NCT02660034|453539082|FG006|Overall Study|Participant moved into special access scheme|0|||
126067156|NCT02660034|453539083|FG007|Overall Study|Participant moved into special access scheme|0|||
126067157|NCT02660034|453539084|FG008|Overall Study|Participant moved into special access scheme|0|||
126067158|NCT02660034|453539085|FG009|Overall Study|Participant moved into special access scheme|0|||
126067159|NCT02660034|453539086|FG010|Overall Study|Participant moved into special access scheme|0|||
126067160|NCT02660034|453539087|FG011|Overall Study|Participant moved into special access scheme|0|||
126067161|NCT02660034|453539088|FG012|Overall Study|Participant moved into special access scheme|0|||
126114357|NCT03933397|453713804|FG001|Overall Study|Missed emergency department visit|30|||
126067162|NCT02660034|453539089|FG013|Overall Study|Participant moved into special access scheme|0|||
126067163|NCT02660034|453539076|FG000|Overall Study|Adverse Event|1|||
126067164|NCT02660034|453539077|FG001|Overall Study|Adverse Event|0|||
126067165|NCT02660034|453539078|FG002|Overall Study|Adverse Event|0|||
126067166|NCT02660034|453539079|FG003|Overall Study|Adverse Event|0|||
126067167|NCT02660034|453539080|FG004|Overall Study|Adverse Event|0|||
126067168|NCT02660034|453539081|FG005|Overall Study|Adverse Event|0|||
126067169|NCT02660034|453539082|FG006|Overall Study|Adverse Event|0|||
126067170|NCT02660034|453539083|FG007|Overall Study|Adverse Event|0|||
126067171|NCT02660034|453539084|FG008|Overall Study|Adverse Event|0|||
126067172|NCT02660034|453539085|FG009|Overall Study|Adverse Event|0|||
126067173|NCT02660034|453539086|FG010|Overall Study|Adverse Event|0|||
126067174|NCT02660034|453539087|FG011|Overall Study|Adverse Event|0|||
126067175|NCT02660034|453539088|FG012|Overall Study|Adverse Event|0|||
126067176|NCT02660034|453539089|FG013|Overall Study|Adverse Event|0|||
126067177|NCT02660034|453539076|FG000|Overall Study|Sponsor Decision|0|||
126067178|NCT02660034|453539077|FG001|Overall Study|Sponsor Decision|1|||
126067179|NCT02660034|453539078|FG002|Overall Study|Sponsor Decision|2|||
126067180|NCT02660034|453539079|FG003|Overall Study|Sponsor Decision|2|||
126067181|NCT02660034|453539080|FG004|Overall Study|Sponsor Decision|3|||
126067182|NCT02660034|453539081|FG005|Overall Study|Sponsor Decision|0|||
126067183|NCT02660034|453539082|FG006|Overall Study|Sponsor Decision|0|||
126067184|NCT02660034|453539083|FG007|Overall Study|Sponsor Decision|0|||
126067185|NCT02660034|453539084|FG008|Overall Study|Sponsor Decision|0|||
126067186|NCT02660034|453539085|FG009|Overall Study|Sponsor Decision|0|||
126067187|NCT02660034|453539086|FG010|Overall Study|Sponsor Decision|0|||
126067188|NCT02660034|453539087|FG011|Overall Study|Sponsor Decision|0|||
126067189|NCT02660034|453539088|FG012|Overall Study|Sponsor Decision|0|||
126067190|NCT02660034|453539089|FG013|Overall Study|Sponsor Decision|1|||
126067191|NCT02660034|453539076|FG000|Overall Study|Withdrawal by Subject|0|||
126067192|NCT02660034|453539077|FG001|Overall Study|Withdrawal by Subject|0|||
126067193|NCT02660034|453539078|FG002|Overall Study|Withdrawal by Subject|0|||
126067194|NCT02660034|453539079|FG003|Overall Study|Withdrawal by Subject|0|||
126067195|NCT02660034|453539080|FG004|Overall Study|Withdrawal by Subject|0|||
126067196|NCT02660034|453539081|FG005|Overall Study|Withdrawal by Subject|0|||
126067197|NCT02660034|453539082|FG006|Overall Study|Withdrawal by Subject|1|||
126067198|NCT02660034|453539083|FG007|Overall Study|Withdrawal by Subject|1|||
126067199|NCT02660034|453539084|FG008|Overall Study|Withdrawal by Subject|1|||
126067200|NCT02660034|453539085|FG009|Overall Study|Withdrawal by Subject|0|||
126067201|NCT02660034|453539086|FG010|Overall Study|Withdrawal by Subject|0|||
126067202|NCT02660034|453539087|FG011|Overall Study|Withdrawal by Subject|1|||
126067203|NCT02660034|453539088|FG012|Overall Study|Withdrawal by Subject|2|||
126067204|NCT02660034|453539089|FG013|Overall Study|Withdrawal by Subject|0|||
126067205|NCT02660034|453539076|FG000|Overall Study|Death|0|||
126067206|NCT02660034|453539077|FG001|Overall Study|Death|0|||
126067207|NCT02660034|453539078|FG002|Overall Study|Death|0|||
126067208|NCT02660034|453539079|FG003|Overall Study|Death|0|||
126067209|NCT02660034|453539080|FG004|Overall Study|Death|0|||
126067210|NCT02660034|453539081|FG005|Overall Study|Death|13|||
126067211|NCT02660034|453539082|FG006|Overall Study|Death|14|||
126067212|NCT02660034|453539083|FG007|Overall Study|Death|10|||
126067213|NCT02660034|453539084|FG008|Overall Study|Death|9|||
126067214|NCT02660034|453539085|FG009|Overall Study|Death|21|||
126067215|NCT02660034|453539086|FG010|Overall Study|Death|17|||
126067216|NCT02660034|453539087|FG011|Overall Study|Death|15|||
126067217|NCT02660034|453539088|FG012|Overall Study|Death|18|||
126067218|NCT02660034|453539089|FG013|Overall Study|Death|7|||
126067219|NCT02660034|453539076|FG000|Overall Study|Physician Decision|0|||
126067220|NCT02660034|453539077|FG001|Overall Study|Physician Decision|0|||
126067221|NCT02660034|453539078|FG002|Overall Study|Physician Decision|0|||
126067222|NCT02660034|453539079|FG003|Overall Study|Physician Decision|0|||
126067223|NCT02660034|453539080|FG004|Overall Study|Physician Decision|0|||
126067224|NCT02660034|453539081|FG005|Overall Study|Physician Decision|0|||
126067225|NCT02660034|453539082|FG006|Overall Study|Physician Decision|0|||
126067226|NCT02660034|453539083|FG007|Overall Study|Physician Decision|0|||
126067227|NCT02660034|453539084|FG008|Overall Study|Physician Decision|0|||
126067228|NCT02660034|453539085|FG009|Overall Study|Physician Decision|0|||
126114358|NCT03933397|453713803|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
126114359|NCT03933397|453713804|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
126114360|NCT03933397|453713803|FG000|Overall Study|Withdrawal by Subject|1|||
126067229|NCT02660034|453539086|FG010|Overall Study|Physician Decision|0|||
126114361|NCT03933397|453713804|FG001|Overall Study|Withdrawal by Subject|0|||
126114362|NCT03933397|453713803|FG000|Overall Study|Physician Decision|1|||
126067230|NCT02660034|453539087|FG011|Overall Study|Physician Decision|0|||
126067231|NCT02660034|453539088|FG012|Overall Study|Physician Decision|0|||
126067232|NCT02660034|453539089|FG013|Overall Study|Physician Decision|1|||
126067233|NCT02660034|453539076|FG000|Overall Study|Participants transferred to LTE|0|||
126067234|NCT02660034|453539077|FG001|Overall Study|Participants transferred to LTE|0|||
126114363|NCT03933397|453713804|FG001|Overall Study|Physician Decision|1|||
126067235|NCT02660034|453539078|FG002|Overall Study|Participants transferred to LTE|0|||
126067236|NCT02660034|453539079|FG003|Overall Study|Participants transferred to LTE|0|||
126067237|NCT02660034|453539080|FG004|Overall Study|Participants transferred to LTE|0|||
126067238|NCT02660034|453539081|FG005|Overall Study|Participants transferred to LTE|10|||
126067239|NCT02660034|453539082|FG006|Overall Study|Participants transferred to LTE|8|||
126067240|NCT02660034|453539083|FG007|Overall Study|Participants transferred to LTE|8|||
126067241|NCT02660034|453539084|FG008|Overall Study|Participants transferred to LTE|10|||
126067242|NCT02660034|453539085|FG009|Overall Study|Participants transferred to LTE|1|||
126067243|NCT02660034|453539086|FG010|Overall Study|Participants transferred to LTE|2|||
126067244|NCT02660034|453539087|FG011|Overall Study|Participants transferred to LTE|4|||
126067245|NCT02660034|453539088|FG012|Overall Study|Participants transferred to LTE|1|||
126067246|NCT02660034|453539089|FG013|Overall Study|Participants transferred to LTE|1|||
126067247|NCT01797705|453539093|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
126067248|NCT01797705|453539093|FG000|Overall Study|Withdrawal by Subject|1|||
126067249|NCT01838447|453539094|FG000|Overall Study|Change in surgical plan|1|||
126067250|NCT01838447|453539095|FG001|Overall Study|Change in surgical plan|2|||
126067251|NCT01838447|453539094|FG000|Overall Study|Withdrawal by Subject|1|||
126067252|NCT01838447|453539095|FG001|Overall Study|Withdrawal by Subject|1|||
126067253|NCT01533181|453539098|FG000|Overall Study|Disease progression pre-active treatment|0|||
126067254|NCT01533181|453539099|FG001|Overall Study|Disease progression pre-active treatment|1|||
126067255|NCT01533181|453539098|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
126067256|NCT01533181|453539099|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
126067257|NCT02030847|453539100|FG000|Overall Study|Death|10|||
126067258|NCT02030847|453539100|FG000|Overall Study|Disease Progression|15|||
126067259|NCT02030847|453539100|FG000|Overall Study|New Cancer Therapy|8|||
126067260|NCT02030847|453539100|FG000|Overall Study|Physician Decision|3|||
126067261|NCT02030847|453539100|FG000|Overall Study|Withdrawal by Subject|1|||
126067262|NCT01837719|453539103|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
126067263|NCT01837719|453539103|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
126067264|NCT01703988|453539104|FG000|Overall Study|Investigator Judgment|0|||
126067265|NCT01703988|453539105|FG001|Overall Study|Investigator Judgment|0|||
126067266|NCT01703988|453539106|FG002|Overall Study|Investigator Judgment|0|||
126067267|NCT01703988|453539107|FG003|Overall Study|Investigator Judgment|1|||
126067268|NCT06247488|453539108|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
126067269|NCT06247488|453539109|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126067270|NCT06247488|453539110|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126067271|NCT06247488|453539111|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126067272|NCT06247488|453539112|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126067273|NCT06247488|453539113|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126067274|NCT06247488|453539108|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126067275|NCT06247488|453539109|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126067276|NCT06247488|453539110|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126067277|NCT06247488|453539111|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
126067278|NCT06247488|453539112|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126067279|NCT06247488|453539113|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126067280|NCT06247488|453539108|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
126067281|NCT06247488|453539109|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126067282|NCT06247488|453539110|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126067283|NCT06247488|453539111|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126067284|NCT06247488|453539112|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126067285|NCT06247488|453539113|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126067286|NCT06247488|453539108|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126067287|NCT06247488|453539109|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126067288|NCT06247488|453539110|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126067289|NCT06247488|453539111|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
126067290|NCT06247488|453539112|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126067291|NCT06247488|453539113|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126067292|NCT06247488|453539108|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126067293|NCT06247488|453539109|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126067294|NCT06247488|453539110|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126067295|NCT06247488|453539111|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126114364|NCT03933397|453713803|FG000|Overall Study|missing pain score|1|||
125971455|NCT01358526|453182850|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
125971456|NCT01358526|453182851|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
125971457|NCT01358526|453182852|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
125971458|NCT01358526|453182850|FG000|Double-blind Phase|Administrative|0|||
125971459|NCT01358526|453182851|FG001|Double-blind Phase|Administrative|6|||
125971460|NCT01358526|453182852|FG002|Double-blind Phase|Administrative|10|||
125971461|NCT03277313|453182863|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
125971462|NCT03277313|453182864|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
125971463|NCT03277313|453182863|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
125971464|NCT03277313|453182864|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
125971465|NCT03277313|453182863|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
125971466|NCT03277313|453182864|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
125971467|NCT03277313|453182863|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
126067296|NCT06247488|453539112|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126067297|NCT06247488|453539113|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
126067298|NCT06247488|453539108|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
126067299|NCT06247488|453539109|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
126067300|NCT06247488|453539110|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
126067301|NCT06247488|453539111|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
126067302|NCT06247488|453539112|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
126067303|NCT06247488|453539113|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
126067304|NCT06247488|453539108|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126067305|NCT06247488|453539109|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126067306|NCT06247488|453539110|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126067307|NCT06247488|453539111|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126067308|NCT06247488|453539112|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126067309|NCT06247488|453539113|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
126067310|NCT02995733|453539114|FG000|Overall Study|Study site closed|9|||
126067311|NCT02995733|453539115|FG001|Overall Study|Study site closed|10|||
126067312|NCT02995733|453539114|FG000|Overall Study|Death|3|||
126067313|NCT02995733|453539115|FG001|Overall Study|Death|4|||
126067314|NCT02995733|453539114|FG000|Overall Study|Withdrawal by Subject|6|||
126067315|NCT02995733|453539115|FG001|Overall Study|Withdrawal by Subject|2|||
126067316|NCT02995733|453539114|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
126067317|NCT02995733|453539115|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
126067318|NCT02995733|453539114|FG000|Overall Study|Lost to Follow-up|48|||
126067319|NCT02995733|453539115|FG001|Overall Study|Lost to Follow-up|37|||
126067320|NCT02995733|453539114|FG000|Overall Study|Other|0|||
126067321|NCT02995733|453539115|FG001|Overall Study|Other|1|||
126067322|NCT03785210|453539121|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
126067323|NCT03785210|453539122|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
126067324|NCT02720198|453539123|FG000|Overall Study|Withdrawal by Subject|0|||
126067325|NCT02720198|453539124|FG001|Overall Study|Withdrawal by Subject|1|||
126067326|NCT02465866|453539127|FG000|Period 3|Withdrawal by Subject|0|||
126067327|NCT02465866|453539128|FG001|Period 3|Withdrawal by Subject|1|||
126067328|NCT02465866|453539129|FG002|Period 3|Withdrawal by Subject|0|||
126067329|NCT02465866|453539130|FG003|Period 3|Withdrawal by Subject|0|||
126067330|NCT02023099|453539131|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
126067331|NCT02023099|453539132|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
126067332|NCT02023099|453539133|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
126067333|NCT02023099|453539131|FG000|Overall Study|Withdrawn Consent|3|||
126067334|NCT02023099|453539132|FG001|Overall Study|Withdrawn Consent|0|||
126067335|NCT02023099|453539133|FG002|Overall Study|Withdrawn Consent|1|||
126067336|NCT02023099|453539131|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
126067337|NCT02023099|453539132|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
126067338|NCT02023099|453539133|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
126067339|NCT00203502|453539134|FG000|Overall Study|Death|1|||
126067340|NCT02592434|453539135|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
126067341|NCT02592434|453539136|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
126067342|NCT02592434|453539137|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
126067343|NCT02592434|453539135|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
126067344|NCT02592434|453539136|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
126067345|NCT02592434|453539137|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
126067346|NCT02592434|453539135|FG000|Open-Label Phase (18 Weeks)|Other|3|||
126067347|NCT02592434|453539136|FG001|Open-Label Phase (18 Weeks)|Other|0|||
126067348|NCT02592434|453539137|FG002|Open-Label Phase (18 Weeks)|Other|0|||
126067349|NCT02592434|453539135|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
126067350|NCT02592434|453539136|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
126067351|NCT02592434|453539137|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
126067352|NCT02592434|453539135|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
126067353|NCT02592434|453539136|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
126067354|NCT02592434|453539137|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
126067355|NCT02592434|453539135|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
126067356|NCT02592434|453539136|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
126067357|NCT02592434|453539137|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
126067358|NCT02592434|453539135|FG000|Double Blind Phase (26 Weeks)|Other|0|||
126067359|NCT02592434|453539136|FG001|Double Blind Phase (26 Weeks)|Other|1|||
126067360|NCT02592434|453539137|FG002|Double Blind Phase (26 Weeks)|Other|0|||
126067361|NCT02592434|453539135|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
126067362|NCT02592434|453539136|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
126067363|NCT02592434|453539137|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
126067364|NCT02592434|453539135|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
125943932|NCT02474199|453093031|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
126067365|NCT02592434|453539136|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
126067366|NCT02592434|453539137|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
126067367|NCT02592434|453539135|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
126067368|NCT02592434|453539136|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
126067369|NCT02592434|453539137|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
126067370|NCT01469819|453539138|FG000|Overall Study|Withdrawal by Subject|1|||
126067371|NCT01469819|453539138|FG000|Overall Study|Did not meet inclusionary criteria|2|||
126067372|NCT01469819|453539138|FG000|Overall Study|Could not swallow SmartPill|2|||
126067373|NCT01469819|453539138|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
126067374|NCT01103141|453539139|FG000|Overall Study|Death|0|||
126067375|NCT01103141|453539140|FG001|Overall Study|Death|1|||
126067376|NCT01103141|453539139|FG000|Overall Study|Lost to Follow-up|2|||
126067377|NCT01103141|453539140|FG001|Overall Study|Lost to Follow-up|1|||
126067378|NCT01403805|453539141|FG000|Overall Study|Withdrawal by Subject|0|||
126067379|NCT01403805|453539142|FG001|Overall Study|Withdrawal by Subject|4|||
126067380|NCT01403805|453539141|FG000|Overall Study|Lost to Follow-up|0|||
126067381|NCT01403805|453539142|FG001|Overall Study|Lost to Follow-up|2|||
126067382|NCT01403805|453539141|FG000|Overall Study|Death|0|||
126067383|NCT01403805|453539142|FG001|Overall Study|Death|1|||
126067384|NCT01695993|453539145|FG000|Overall Study|Lost to Follow-up|2|||
126067385|NCT01695993|453539146|FG001|Overall Study|Lost to Follow-up|1|||
126067386|NCT01695993|453539147|FG002|Overall Study|Lost to Follow-up|3|||
126067387|NCT01695993|453539145|FG000|Overall Study|Withdrawal by Subject|2|||
126067388|NCT01695993|453539146|FG001|Overall Study|Withdrawal by Subject|2|||
126067389|NCT01695993|453539147|FG002|Overall Study|Withdrawal by Subject|2|||
126067390|NCT01695993|453539145|FG000|Overall Study|To ill to continue|1|||
126067391|NCT01695993|453539146|FG001|Overall Study|To ill to continue|2|||
126067392|NCT01695993|453539147|FG002|Overall Study|To ill to continue|0|||
126067393|NCT01695993|453539145|FG000|Overall Study|Changed Medical Facility|0|||
126067394|NCT01695993|453539146|FG001|Overall Study|Changed Medical Facility|0|||
126067395|NCT01695993|453539147|FG002|Overall Study|Changed Medical Facility|1|||
126067396|NCT04057937|453539148|FG000|Placebo-controlled Phase|Adverse Event|3|||
126067397|NCT04057937|453539149|FG001|Placebo-controlled Phase|Adverse Event|0|||
126067398|NCT04057937|453539148|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
126067399|NCT04057937|453539149|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
126067400|NCT04057937|453539148|FG000|Active-treatment Phase|Pregnancy|0|||
126067401|NCT04057937|453539149|FG001|Active-treatment Phase|Pregnancy|1|||
126067402|NCT04057937|453539148|FG000|Active-treatment Phase|Physician Decision|0|||
126067403|NCT04057937|453539149|FG001|Active-treatment Phase|Physician Decision|1|||
126067404|NCT02029521|453539151|FG000|Overall Study|Protocol Violation|1|||
126067405|NCT02029521|453539152|FG001|Overall Study|Protocol Violation|0|||
126067406|NCT02029521|453539151|FG000|Overall Study|Withdrawal by Subject|1|||
126067407|NCT02029521|453539152|FG001|Overall Study|Withdrawal by Subject|1|||
126067408|NCT00428441|453539155|FG000|Overall Study|Lost to Follow-up|1|||
126067409|NCT00510783|453539162|FG000|Overall Study|Lost to Follow-up|29|||
126067410|NCT00510783|453539163|FG001|Overall Study|Lost to Follow-up|25|||
126067411|NCT00510783|453539162|FG000|Overall Study|Withdrawal by Subject|2|||
126067412|NCT00510783|453539163|FG001|Overall Study|Withdrawal by Subject|3|||
126067413|NCT00510783|453539162|FG000|Overall Study|Protocol Violation|0|||
126067414|NCT00510783|453539163|FG001|Overall Study|Protocol Violation|1|||
126067415|NCT01047306|453539173|FG000|Overall Study|Withdrawal by Subject|2|||
126067416|NCT01047306|453539174|FG001|Overall Study|Withdrawal by Subject|0|||
126067417|NCT01047306|453539173|FG000|Overall Study|Lost to Follow-up|1|||
126067418|NCT01047306|453539174|FG001|Overall Study|Lost to Follow-up|0|||
126067419|NCT00274846|453539177|FG000|Overall Study|Did not receive adequate NK cells|1|||
126067420|NCT01648699|453539180|FG000|Overall Study|Death|1|||
126067421|NCT01648699|453539180|FG000|Overall Study|Lost to Follow-up|2|||
126067422|NCT01648699|453539180|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
126067423|NCT02038803|453539181|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
126067424|NCT02038803|453539181|FG000|Overall Study|Lost to Follow-up|1|||
126067425|NCT00348283|453539182|FG000|Induction|Adverse Event|0|||
126114365|NCT03933397|453713804|FG001|Overall Study|missing pain score|1|||
126114366|NCT03933397|453713803|FG000|Overall Study|Confirmed COVID-19|1|||
126114367|NCT03933397|453713804|FG001|Overall Study|Confirmed COVID-19|2|||
126114368|NCT04029116|453713805|FG000|Overall Study|Adverse Event|0|||
126114369|NCT04029116|453713806|FG001|Overall Study|Adverse Event|2|||
126114370|NCT04029116|453713805|FG000|Overall Study|Lost to Follow-up|3|||
125943933|NCT02474199|453093028|FG000|Overall Study|Did not meet eligibility criteria|0|||
125943934|NCT02474199|453093029|FG001|Overall Study|Did not meet eligibility criteria|0|||
126067426|NCT00348283|453539183|FG001|Induction|Adverse Event|2|||
126114371|NCT04029116|453713806|FG001|Overall Study|Lost to Follow-up|5|||
126114372|NCT04029116|453713805|FG000|Overall Study|Physician Decision|2|||
126114373|NCT04029116|453713806|FG001|Overall Study|Physician Decision|0|||
126067427|NCT00348283|453539182|FG000|Induction|Protocol Violation|0|||
126067428|NCT00348283|453539183|FG001|Induction|Protocol Violation|4|||
126067429|NCT00348283|453539182|FG000|Double Blind|Adverse Event|2|||
126067430|NCT00348283|453539183|FG001|Double Blind|Adverse Event|5|||
126114374|NCT04029116|453713805|FG000|Overall Study|Pregnancy|1|||
126067431|NCT00348283|453539182|FG000|Double Blind|Withdrawal by Subject|1|||
126067432|NCT00348283|453539183|FG001|Double Blind|Withdrawal by Subject|1|||
126067433|NCT00348283|453539182|FG000|Double Blind|Protocol Violation|0|||
126067434|NCT00348283|453539183|FG001|Double Blind|Protocol Violation|1|||
126067435|NCT00348283|453539182|FG000|Double Blind|Lack of Efficacy|2|||
126067436|NCT00348283|453539183|FG001|Double Blind|Lack of Efficacy|2|||
126067437|NCT00348283|453539182|FG000|Double Blind|Pregnancy|0|||
126067438|NCT00348283|453539183|FG001|Double Blind|Pregnancy|1|||
126067439|NCT00348283|453539182|FG000|Open Label|Adverse Event|0|||
126067440|NCT00348283|453539183|FG001|Open Label|Adverse Event|8|||
126067441|NCT00348283|453539182|FG000|Open Label|Withdrawal by Subject|0|||
126067442|NCT00348283|453539183|FG001|Open Label|Withdrawal by Subject|4|||
126067443|NCT00348283|453539182|FG000|Open Label|Lost to Follow-up|0|||
126067444|NCT00348283|453539183|FG001|Open Label|Lost to Follow-up|1|||
126067445|NCT00348283|453539182|FG000|Open Label|Lack of Efficacy|0|||
126067446|NCT00348283|453539183|FG001|Open Label|Lack of Efficacy|13|||
126067447|NCT00348283|453539182|FG000|Open Label|Administrative reasons|0|||
126067448|NCT00348283|453539183|FG001|Open Label|Administrative reasons|5|||
126067449|NCT00348283|453539182|FG000|Open Label|Subject moved to the United States|0|||
126067450|NCT00348283|453539183|FG001|Open Label|Subject moved to the United States|1|||
126067451|NCT00348283|453539182|FG000|Open Label|Pregnancy|0|||
126067452|NCT00348283|453539183|FG001|Open Label|Pregnancy|1|||
126067453|NCT00348283|453539182|FG000|Open Label|Sponsor decision|0|||
126067454|NCT00348283|453539183|FG001|Open Label|Sponsor decision|1|||
126067455|NCT02588027|453539184|FG000|Overall Study|Withdrawal by Subject|1|||
126067456|NCT02588027|453539185|FG001|Overall Study|Withdrawal by Subject|3|||
126067457|NCT02588027|453539184|FG000|Overall Study|Protocol Violation|4|||
126067458|NCT02588027|453539185|FG001|Overall Study|Protocol Violation|1|||
126067459|NCT04372186|453539186|FG000|Overall Study|Death|24|||
126067460|NCT04372186|453539187|FG001|Overall Study|Death|11|||
126067461|NCT04372186|453539186|FG000|Overall Study|Transferred to a different facility for care|0|||
126067462|NCT04372186|453539187|FG001|Overall Study|Transferred to a different facility for care|2|||
126067463|NCT03219216|453539188|FG000|Overall Study|Lost to Follow-up|0|||
126067464|NCT03219216|453539189|FG001|Overall Study|Lost to Follow-up|1|||
126067465|NCT02332824|453539190|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
126067466|NCT02332824|453539191|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
126067467|NCT02332824|453539192|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
126067468|NCT02332824|453539193|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
126067469|NCT02332824|453539194|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
126067470|NCT02332824|453539195|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
126067471|NCT02332824|453539190|FG000|Overall Study|Voluntary Withdrawal|1|||
126067472|NCT02332824|453539191|FG001|Overall Study|Voluntary Withdrawal|0|||
126067473|NCT02332824|453539192|FG002|Overall Study|Voluntary Withdrawal|0|||
126067474|NCT02332824|453539193|FG003|Overall Study|Voluntary Withdrawal|0|||
126067475|NCT02332824|453539194|FG004|Overall Study|Voluntary Withdrawal|0|||
126067476|NCT02332824|453539195|FG005|Overall Study|Voluntary Withdrawal|0|||
126067477|NCT02332824|453539190|FG000|Overall Study|Inconvenient schedule|1|||
126067478|NCT02332824|453539191|FG001|Overall Study|Inconvenient schedule|1|||
126067479|NCT02332824|453539192|FG002|Overall Study|Inconvenient schedule|0|||
126067480|NCT02332824|453539193|FG003|Overall Study|Inconvenient schedule|0|||
126067481|NCT02332824|453539194|FG004|Overall Study|Inconvenient schedule|0|||
126067482|NCT02332824|453539195|FG005|Overall Study|Inconvenient schedule|0|||
126067483|NCT02332824|453539190|FG000|Overall Study|Transfer|0|||
126067484|NCT02332824|453539191|FG001|Overall Study|Transfer|0|||
126067485|NCT02332824|453539192|FG002|Overall Study|Transfer|1|||
126067486|NCT02332824|453539193|FG003|Overall Study|Transfer|1|||
126067487|NCT02332824|453539194|FG004|Overall Study|Transfer|0|||
126114375|NCT04029116|453713806|FG001|Overall Study|Pregnancy|2|||
125943935|NCT02474199|453093030|FG002|Overall Study|Did not meet eligibility criteria|2|||
125943936|NCT02474199|453093031|FG003|Overall Study|Did not meet eligibility criteria|2|||
125943937|NCT00159588|453093032|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
125943938|NCT00159588|453093033|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
125943939|NCT00159588|453093034|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
125943940|NCT00297037|453093036|FG000|Overall Study|Withdrawal by Subject|2|||
125943941|NCT00297037|453093037|FG001|Overall Study|Withdrawal by Subject|0|||
125943942|NCT00076011|453093038|FG000|Overall Study|Death|1|||
125943943|NCT00076011|453093038|FG000|Overall Study|Adverse Event|10|||
126067488|NCT02332824|453539195|FG005|Overall Study|Transfer|0|||
126067489|NCT00914732|453539196|FG000|Overall Study|Lost to Follow-up|6|||
126114376|NCT04029116|453713805|FG000|Overall Study|Withdrawal by Subject|4|||
126067490|NCT00914732|453539197|FG001|Overall Study|Lost to Follow-up|7|||
126067491|NCT00914732|453539198|FG002|Overall Study|Lost to Follow-up|9|||
126067492|NCT00914732|453539196|FG000|Overall Study|Withdrawal by Subject|3|||
126067493|NCT00914732|453539197|FG001|Overall Study|Withdrawal by Subject|0|||
126067494|NCT00914732|453539198|FG002|Overall Study|Withdrawal by Subject|2|||
126067495|NCT00914732|453539196|FG000|Overall Study|Adverse Event|1|||
126067496|NCT00914732|453539197|FG001|Overall Study|Adverse Event|0|||
126067497|NCT00914732|453539198|FG002|Overall Study|Adverse Event|0|||
125943944|NCT00076011|453093038|FG000|Overall Study|Lack of Efficacy|25|||
125943945|NCT00076011|453093038|FG000|Overall Study|Withdrawal by Subject|1|||
125943946|NCT00076011|453093038|FG000|Overall Study|Study terminated by sponsor|3|||
125943947|NCT00076011|453093038|FG000|Overall Study|Other|11|||
125943948|NCT00076011|453093038|FG000|Overall Study|Ongoing|1|||
125943949|NCT00581776|453093039|FG000|Overall Study|Disease progression or no response|3|||
125943950|NCT03056755|453093040|FG000|Treatment- Core Phase|Progressive disease|89|||
125943951|NCT03056755|453093041|FG001|Treatment- Core Phase|Progressive disease|88|||
125943952|NCT03056755|453093042|FG002|Treatment- Core Phase|Progressive disease|90|||
125943953|NCT03056755|453093040|FG000|Treatment- Core Phase|Adverse Event|20|||
125943954|NCT03056755|453093041|FG001|Treatment- Core Phase|Adverse Event|14|||
125943955|NCT03056755|453093042|FG002|Treatment- Core Phase|Adverse Event|13|||
125943956|NCT03056755|453093040|FG000|Treatment- Core Phase|Physician Decision|7|||
125943957|NCT03056755|453093041|FG001|Treatment- Core Phase|Physician Decision|13|||
125943958|NCT03056755|453093042|FG002|Treatment- Core Phase|Physician Decision|5|||
125943959|NCT03056755|453093040|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
125943960|NCT03056755|453093041|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
125943961|NCT03056755|453093042|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
125943962|NCT03056755|453093040|FG000|Treatment- Core Phase|Death|3|||
125943963|NCT03056755|453093041|FG001|Treatment- Core Phase|Death|2|||
125943964|NCT03056755|453093042|FG002|Treatment- Core Phase|Death|4|||
125943965|NCT03056755|453093040|FG000|Treatment- Core Phase|Protocol deviation|1|||
125943966|NCT03056755|453093041|FG001|Treatment- Core Phase|Protocol deviation|1|||
125943967|NCT03056755|453093042|FG002|Treatment- Core Phase|Protocol deviation|0|||
125943968|NCT03056755|453093040|FG000|Treatment- Core Phase|Technical problems|1|||
125943969|NCT03056755|453093041|FG001|Treatment- Core Phase|Technical problems|0|||
125943970|NCT03056755|453093042|FG002|Treatment- Core Phase|Technical problems|0|||
125943971|NCT03056755|453093040|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
125943972|NCT03056755|453093041|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
125943973|NCT03056755|453093042|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
125943974|NCT03056755|453093040|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
125943975|NCT03056755|453093041|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
125943976|NCT03056755|453093042|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
125943977|NCT03056755|453093040|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
125943978|NCT03056755|453093041|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
125943979|NCT03056755|453093042|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
125943980|NCT03056755|453093040|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
125943981|NCT03056755|453093041|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
125943982|NCT03056755|453093042|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
125943983|NCT04461015|453093045|FG000|Overall Study|IV access lost during the study|0|||
125943984|NCT04461015|453093046|FG001|Overall Study|IV access lost during the study|1|||
125943985|NCT04461015|453093045|FG000|Overall Study|Withdrawal by Subject|0|||
125943986|NCT04461015|453093046|FG001|Overall Study|Withdrawal by Subject|1|||
125943987|NCT02419742|453093054|FG000|Overall Study|Adverse Event|2|||
125943988|NCT02419742|453093055|FG001|Overall Study|Adverse Event|0|||
125943989|NCT02419742|453093054|FG000|Overall Study|Disease Progression|0|||
125943990|NCT02419742|453093055|FG001|Overall Study|Disease Progression|1|||
125943991|NCT02419742|453093054|FG000|Overall Study|Withdrew Consent|2|||
125943992|NCT02419742|453093055|FG001|Overall Study|Withdrew Consent|1|||
125943993|NCT02419742|453093054|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
125943994|NCT02419742|453093055|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
125943995|NCT02211131|453093061|FG000|Overall Study|Death|26|||
125943996|NCT02211131|453093062|FG001|Overall Study|Death|16|||
125943997|NCT02211131|453093061|FG000|Overall Study|Lost to Follow-up|4|||
125943998|NCT02211131|453093062|FG001|Overall Study|Lost to Follow-up|3|||
125943999|NCT02211131|453093061|FG000|Overall Study|Decision by Sponsor|1|||
125944000|NCT02211131|453093062|FG001|Overall Study|Decision by Sponsor|1|||
125944001|NCT02211131|453093061|FG000|Overall Study|Withdrawal by Subject|3|||
125944002|NCT02211131|453093062|FG001|Overall Study|Withdrawal by Subject|8|||
125944003|NCT03340025|453093064|FG000|Overall Study|Lost to Follow-up|2|||
125944004|NCT03340025|453093065|FG001|Overall Study|Lost to Follow-up|2|||
125944005|NCT03897179|453093068|FG000|Overall Study|Withdrawal by Subject|1|||
125944006|NCT02120950|453093069|FG000|Overall Study|Adverse Event|5|||
125944007|NCT02120950|453093070|FG001|Overall Study|Adverse Event|4|||
125944008|NCT02120950|453093071|FG002|Overall Study|Adverse Event|3|||
125944009|NCT02120950|453093069|FG000|Overall Study|Death|3|||
125944010|NCT02120950|453093070|FG001|Overall Study|Death|0|||
125944011|NCT02120950|453093071|FG002|Overall Study|Death|1|||
125944012|NCT02120950|453093069|FG000|Overall Study|Withdrawal by Subject|6|||
125944013|NCT02120950|453093070|FG001|Overall Study|Withdrawal by Subject|3|||
125944014|NCT02120950|453093071|FG002|Overall Study|Withdrawal by Subject|2|||
125944015|NCT02120950|453093069|FG000|Overall Study|Protocol Violation|1|||
125944016|NCT02120950|453093070|FG001|Overall Study|Protocol Violation|1|||
126067498|NCT03840148|453539201|FG000|Study Drug Disposition|Adverse Event|13|||
126067499|NCT03840148|453539202|FG001|Study Drug Disposition|Adverse Event|2|||
126067500|NCT03840148|453539201|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
126067501|NCT03840148|453539202|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
126067502|NCT03840148|453539201|FG000|Study Drug Disposition|Lack of Efficacy|3|||
126067503|NCT03840148|453539202|FG001|Study Drug Disposition|Lack of Efficacy|0|||
126067504|NCT03840148|453539201|FG000|Study Drug Disposition|Physician Decision|2|||
126067505|NCT03840148|453539202|FG001|Study Drug Disposition|Physician Decision|0|||
126067506|NCT03840148|453539201|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
126067507|NCT03840148|453539202|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
126067508|NCT03840148|453539201|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
126067509|NCT03840148|453539202|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
126067510|NCT03840148|453539201|FG000|Study Completion Disposition|Physician Decision|2|||
126067511|NCT03840148|453539202|FG001|Study Completion Disposition|Physician Decision|0|||
126067512|NCT03840148|453539201|FG000|Study Completion Disposition|Covid-19 related|2|||
126067513|NCT03840148|453539202|FG001|Study Completion Disposition|Covid-19 related|0|||
126067514|NCT03840148|453539201|FG000|Study Completion Disposition|Lost to Follow-up|1|||
126067515|NCT03840148|453539202|FG001|Study Completion Disposition|Lost to Follow-up|1|||
126067516|NCT03840148|453539201|FG000|Study Completion Disposition|Death|1|||
126067517|NCT03840148|453539202|FG001|Study Completion Disposition|Death|0|||
126067518|NCT03840148|453539201|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
126067519|NCT03840148|453539202|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
126067520|NCT03615404|453539203|FG000|Overall Study|Death|1|||
126067521|NCT03615404|453539203|FG000|Overall Study|vaccine did not pass quality assurance|1|||
126067522|NCT02577315|453539205|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126067523|NCT02577315|453539206|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
126067524|NCT01945086|453539207|FG000|Overall Study|Withdrawal by Subject|1|||
126067525|NCT01945086|453539208|FG001|Overall Study|Withdrawal by Subject|0|||
126067526|NCT01945086|453539209|FG002|Overall Study|Withdrawal by Subject|1|||
126067527|NCT01945086|453539207|FG000|Overall Study|Adverse Event|0|||
126067528|NCT01945086|453539208|FG001|Overall Study|Adverse Event|0|||
126067529|NCT01945086|453539209|FG002|Overall Study|Adverse Event|1|||
126067530|NCT04413149|453540470|FG000|Overall Study|Death|10|||
126067531|NCT04413149|453540471|FG001|Overall Study|Death|5|||
126067532|NCT04413149|453540470|FG000|Overall Study|Lung transplantation|1|||
126067533|NCT04413149|453540471|FG001|Overall Study|Lung transplantation|0|||
126067534|NCT05335005|453540475|FG000|Overall Study|Lost to Follow-up|1|||
126067535|NCT04050722|453540476|FG000|Overall Study|Withdrawal by Subject|1|||
126067536|NCT04050722|453540477|FG001|Overall Study|Withdrawal by Subject|0|||
126067537|NCT02339506|453540484|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
126067538|NCT02339506|453540485|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
126067539|NCT02339506|453540484|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
126067540|NCT02339506|453540485|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
126067541|NCT01572493|453540486|FG000|Overall Study|Physician Decision|1|||
126067542|NCT01572493|453540487|FG001|Overall Study|Physician Decision|0|||
126067543|NCT01572493|453540488|FG002|Overall Study|Physician Decision|0|||
126067544|NCT01572493|453540489|FG003|Overall Study|Physician Decision|0|||
126067545|NCT01572493|453540490|FG004|Overall Study|Physician Decision|0|||
126067546|NCT01572493|453540491|FG005|Overall Study|Physician Decision|0|||
126067547|NCT01572493|453540492|FG006|Overall Study|Physician Decision|0|||
126067548|NCT01572493|453540493|FG007|Overall Study|Physician Decision|0|||
126067549|NCT01572493|453540494|FG008|Overall Study|Physician Decision|0|||
126067550|NCT01572493|453540486|FG000|Overall Study|Switched to alternative treatment|0|||
126067551|NCT01572493|453540487|FG001|Overall Study|Switched to alternative treatment|1|||
126067552|NCT01572493|453540488|FG002|Overall Study|Switched to alternative treatment|2|||
126067553|NCT01572493|453540489|FG003|Overall Study|Switched to alternative treatment|1|||
126114377|NCT04029116|453713806|FG001|Overall Study|Withdrawal by Subject|6|||
126114378|NCT04029116|453713805|FG000|Overall Study|Other|2|||
126114379|NCT04029116|453713806|FG001|Overall Study|Other|1|||
126114380|NCT00307333|453713807|FG000|Overall Study|Lost to Follow-up|11|||
126114381|NCT00307333|453713808|FG001|Overall Study|Lost to Follow-up|3|||
126114382|NCT04513665|453713809|FG000|Overall Study|Adverse Event|2|||
126114383|NCT04513665|453713810|FG001|Overall Study|Adverse Event|0|||
126114384|NCT04513665|453713809|FG000|Overall Study|Lack of Efficacy|14|||
125944017|NCT02120950|453093071|FG002|Overall Study|Protocol Violation|7|||
125944018|NCT02120950|453093069|FG000|Overall Study|Other reasons|5|||
125944019|NCT02120950|453093070|FG001|Overall Study|Other reasons|4|||
126067554|NCT01572493|453540490|FG004|Overall Study|Switched to alternative treatment|2|||
126067555|NCT01572493|453540491|FG005|Overall Study|Switched to alternative treatment|0|||
126067556|NCT01572493|453540492|FG006|Overall Study|Switched to alternative treatment|2|||
126067557|NCT01572493|453540493|FG007|Overall Study|Switched to alternative treatment|0|||
126067558|NCT01572493|453540494|FG008|Overall Study|Switched to alternative treatment|2|||
126067559|NCT01572493|453540486|FG000|Overall Study|Death|0|||
126067560|NCT01572493|453540487|FG001|Overall Study|Death|0|||
126067561|NCT01572493|453540488|FG002|Overall Study|Death|0|||
126067562|NCT01572493|453540489|FG003|Overall Study|Death|1|||
126067563|NCT01572493|453540490|FG004|Overall Study|Death|0|||
126067564|NCT01572493|453540491|FG005|Overall Study|Death|1|||
126067565|NCT01572493|453540492|FG006|Overall Study|Death|0|||
126067566|NCT01572493|453540493|FG007|Overall Study|Death|0|||
126067567|NCT01572493|453540494|FG008|Overall Study|Death|0|||
126067568|NCT01572493|453540486|FG000|Overall Study|Adverse Event|0|||
126067569|NCT01572493|453540487|FG001|Overall Study|Adverse Event|0|||
126067570|NCT01572493|453540488|FG002|Overall Study|Adverse Event|0|||
126067571|NCT01572493|453540489|FG003|Overall Study|Adverse Event|0|||
126067572|NCT01572493|453540490|FG004|Overall Study|Adverse Event|0|||
126067573|NCT01572493|453540491|FG005|Overall Study|Adverse Event|0|||
126067574|NCT01572493|453540492|FG006|Overall Study|Adverse Event|1|||
126067575|NCT01572493|453540493|FG007|Overall Study|Adverse Event|0|||
126067576|NCT01572493|453540494|FG008|Overall Study|Adverse Event|0|||
126067577|NCT00609245|453540495|FG000|Overall Study|Adverse Event|1|||
126067578|NCT01234675|453540496|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
126067579|NCT01234675|453540497|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
126067580|NCT01234675|453540496|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126067581|NCT01234675|453540497|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
126067582|NCT00331799|453540498|FG000|Overall Study|Withdrawal by Subject|2|||
126067583|NCT00331799|453540498|FG000|Overall Study|Sedation|1|||
126067584|NCT02889809|453540499|FG000|Overall Study|Withdrawal by Subject|30|||
126067585|NCT02889809|453540500|FG001|Overall Study|Withdrawal by Subject|21|||
126067586|NCT02889809|453540499|FG000|Overall Study|Lost to Follow-up|1|||
126067587|NCT02889809|453540500|FG001|Overall Study|Lost to Follow-up|1|||
126067588|NCT02889809|453540499|FG000|Overall Study|Site Closed|12|||
126067589|NCT02889809|453540500|FG001|Overall Study|Site Closed|11|||
126067590|NCT01090076|453540503|FG000|Overall Study|Death|1|||
126067591|NCT01090076|453540504|FG001|Overall Study|Death|1|||
126067592|NCT01090076|453540503|FG000|Overall Study|Withdrawal by Subject|0|||
126067593|NCT01090076|453540504|FG001|Overall Study|Withdrawal by Subject|1|||
126067594|NCT01116440|453540506|FG000|Treatment|Withdrawal by Subject|2|||
126067595|NCT01116440|453540507|FG001|Treatment|Withdrawal by Subject|2|||
126067596|NCT01116440|453540506|FG000|Treatment|Lost to Follow-up|1|||
126067597|NCT01116440|453540507|FG001|Treatment|Lost to Follow-up|1|||
126067598|NCT01116440|453540506|FG000|Treatment|Protocol Violation|0|||
126067599|NCT01116440|453540507|FG001|Treatment|Protocol Violation|2|||
126067600|NCT01116440|453540506|FG000|Treatment|Lack of Efficacy|0|||
126067601|NCT01116440|453540507|FG001|Treatment|Lack of Efficacy|1|||
126067602|NCT01116440|453540506|FG000|Treatment|Adverse Event|0|||
126067603|NCT01116440|453540507|FG001|Treatment|Adverse Event|1|||
126067604|NCT01116440|453540506|FG000|Withdrawal|Withdrawal by Subject|0|||
126067605|NCT01116440|453540507|FG001|Withdrawal|Withdrawal by Subject|1|||
126067606|NCT01116440|453540506|FG000|Withdrawal|Lost to Follow-up|0|||
126067607|NCT01116440|453540507|FG001|Withdrawal|Lost to Follow-up|1|||
126067608|NCT01116440|453540506|FG000|Follow-up|Lost to Follow-up|0|||
126067609|NCT01116440|453540507|FG001|Follow-up|Lost to Follow-up|1|||
126067610|NCT01116440|453540506|FG000|Follow-up|Withdrawal by Subject|0|||
126067611|NCT01116440|453540507|FG001|Follow-up|Withdrawal by Subject|1|||
126067612|NCT01870999|453540513|FG000|Overall Study|Adverse Event|0|||
126067613|NCT01870999|453540514|FG001|Overall Study|Adverse Event|4|||
126067614|NCT01870999|453540515|FG002|Overall Study|Adverse Event|1|||
126067615|NCT01870999|453540513|FG000|Overall Study|Subject met withdrawal criteria|3|||
126067616|NCT01870999|453540514|FG001|Overall Study|Subject met withdrawal criteria|2|||
126067617|NCT01870999|453540515|FG002|Overall Study|Subject met withdrawal criteria|0|||
126067618|NCT01870999|453540513|FG000|Overall Study|Subject withdrawn by Investigator|1|||
126067619|NCT01870999|453540514|FG001|Overall Study|Subject withdrawn by Investigator|0|||
126067620|NCT01870999|453540515|FG002|Overall Study|Subject withdrawn by Investigator|0|||
126114385|NCT04513665|453713810|FG001|Overall Study|Lack of Efficacy|0|||
125944020|NCT02120950|453093071|FG002|Overall Study|Other reasons|1|||
125944021|NCT02120950|453093069|FG000|Overall Study|Lost to Follow-up|0|||
126067621|NCT01870999|453540513|FG000|Overall Study|Withdrawal by Subject|0|||
126067622|NCT01870999|453540514|FG001|Overall Study|Withdrawal by Subject|2|||
126067623|NCT01870999|453540515|FG002|Overall Study|Withdrawal by Subject|5|||
126067624|NCT01870999|453540513|FG000|Overall Study|Protocol Violation|0|||
126067625|NCT01870999|453540514|FG001|Overall Study|Protocol Violation|0|||
126067626|NCT01870999|453540515|FG002|Overall Study|Protocol Violation|1|||
126067627|NCT01636258|453540516|FG000|Overall Study|Lost to Follow-up|1|||
126067628|NCT01636258|453540517|FG001|Overall Study|Lost to Follow-up|0|||
126067629|NCT02798861|453540520|FG000|Overall Study|Lost to Follow-up|22|||
126067630|NCT02798861|453540520|FG000|Overall Study|Withdrawal by Subject|1|||
126067631|NCT02186015|453540521|FG000|Overall Study|Physician Decision|1|||
126067632|NCT02186015|453540522|FG001|Overall Study|Physician Decision|0|||
126067633|NCT00907517|453540523|FG000|Overall Study|Progressive Disease|3|||
126067634|NCT00907517|453540524|FG001|Overall Study|Progressive Disease|3|||
126067635|NCT00907517|453540525|FG002|Overall Study|Progressive Disease|4|||
126067636|NCT00907517|453540526|FG003|Overall Study|Progressive Disease|4|||
126067637|NCT00907517|453540527|FG004|Overall Study|Progressive Disease|4|||
126067638|NCT00907517|453540523|FG000|Overall Study|Symptomatic Deterioration|0|||
126067639|NCT00907517|453540524|FG001|Overall Study|Symptomatic Deterioration|0|||
126067640|NCT00907517|453540525|FG002|Overall Study|Symptomatic Deterioration|0|||
126067641|NCT00907517|453540526|FG003|Overall Study|Symptomatic Deterioration|0|||
126067642|NCT00907517|453540527|FG004|Overall Study|Symptomatic Deterioration|1|||
126067643|NCT02744898|453540528|FG000|Overall Study|Progressive Disease|2|||
126067644|NCT02744898|453540528|FG000|Overall Study|Physician Decision|1|||
126067645|NCT02744898|453540528|FG000|Overall Study|Toxicity|1|||
126067646|NCT01348763|453540531|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
126067647|NCT01348763|453540531|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
126067648|NCT01078571|453540532|FG000|Overall Study|Adverse Event|36|||
126067649|NCT01078571|453540532|FG000|Overall Study|Lack of effectiveness|36|||
126067650|NCT01078571|453540532|FG000|Overall Study|Reason not reported|21|||
126067651|NCT01078571|453540532|FG000|Overall Study|Withdrawal by Subject|12|||
126067652|NCT01078571|453540532|FG000|Overall Study|Lost to Follow-up|8|||
126067653|NCT01078571|453540532|FG000|Overall Study|Protocol Violation|2|||
126067654|NCT03647709|453540534|FG000|Overall Study|Lost to Follow-up|5|||
126067655|NCT03647709|453540534|FG000|Overall Study|Physician Decision|6|||
126067656|NCT03647709|453540534|FG000|Overall Study|Withdrawal by Subject|3|||
126067657|NCT03802513|453540545|FG000|Overall Study|Lost to Follow-up|1|||
126067658|NCT03045302|453540552|FG000|Overall Study|Pre-treatment adverse event|1|||
126067659|NCT05287178|453540553|FG000|Overall Study|Lost to Follow-up|2|||
126067660|NCT01774929|453540554|FG000|Overall Study|Adverse Event|3|||
126067661|NCT00603278|453540555|FG000|Overall Study|Lack of Efficacy|35|||
126067662|NCT00603278|453540556|FG001|Overall Study|Lack of Efficacy|10|||
126067663|NCT00603278|453540557|FG002|Overall Study|Lack of Efficacy|11|||
126067664|NCT00603278|453540558|FG003|Overall Study|Lack of Efficacy|8|||
126067665|NCT00603278|453540559|FG004|Overall Study|Lack of Efficacy|7|||
126067666|NCT00603278|453540560|FG005|Overall Study|Lack of Efficacy|14|||
126067667|NCT00603278|453540555|FG000|Overall Study|Adverse Event|0|||
126067668|NCT00603278|453540556|FG001|Overall Study|Adverse Event|3|||
126067669|NCT00603278|453540557|FG002|Overall Study|Adverse Event|1|||
126067670|NCT00603278|453540558|FG003|Overall Study|Adverse Event|0|||
126067671|NCT00603278|453540559|FG004|Overall Study|Adverse Event|2|||
126067672|NCT00603278|453540560|FG005|Overall Study|Adverse Event|1|||
126067673|NCT00603278|453540555|FG000|Overall Study|Withdrawal by Subject|2|||
126067674|NCT00603278|453540556|FG001|Overall Study|Withdrawal by Subject|3|||
126067675|NCT00603278|453540557|FG002|Overall Study|Withdrawal by Subject|1|||
126067676|NCT00603278|453540558|FG003|Overall Study|Withdrawal by Subject|2|||
126067677|NCT00603278|453540559|FG004|Overall Study|Withdrawal by Subject|1|||
126067678|NCT00603278|453540560|FG005|Overall Study|Withdrawal by Subject|2|||
126067679|NCT00603278|453540555|FG000|Overall Study|Protocol Violation|3|||
126067680|NCT00603278|453540556|FG001|Overall Study|Protocol Violation|0|||
126067681|NCT00603278|453540557|FG002|Overall Study|Protocol Violation|1|||
126067682|NCT00603278|453540558|FG003|Overall Study|Protocol Violation|1|||
126067683|NCT00603278|453540559|FG004|Overall Study|Protocol Violation|0|||
126067684|NCT00603278|453540560|FG005|Overall Study|Protocol Violation|1|||
126067685|NCT00603278|453540555|FG000|Overall Study|Physician Decision|0|||
126067686|NCT00603278|453540556|FG001|Overall Study|Physician Decision|1|||
126067687|NCT00603278|453540557|FG002|Overall Study|Physician Decision|0|||
126067688|NCT00603278|453540558|FG003|Overall Study|Physician Decision|0|||
126067689|NCT00603278|453540559|FG004|Overall Study|Physician Decision|2|||
126067690|NCT00603278|453540560|FG005|Overall Study|Physician Decision|1|||
126067691|NCT00603278|453540555|FG000|Overall Study|Lost to Follow-up|1|||
126067692|NCT00603278|453540556|FG001|Overall Study|Lost to Follow-up|0|||
126067693|NCT00603278|453540557|FG002|Overall Study|Lost to Follow-up|0|||
126067694|NCT00603278|453540558|FG003|Overall Study|Lost to Follow-up|0|||
126067695|NCT00603278|453540559|FG004|Overall Study|Lost to Follow-up|1|||
126067696|NCT00603278|453540560|FG005|Overall Study|Lost to Follow-up|0|||
126067697|NCT04374253|453540564|FG000|Overall Study|Adverse Event|0|||
126067698|NCT04374253|453540565|FG001|Overall Study|Adverse Event|26|||
125944022|NCT02120950|453093070|FG001|Overall Study|Lost to Follow-up|2|||
125944023|NCT02120950|453093071|FG002|Overall Study|Lost to Follow-up|1|||
125944024|NCT02424383|453093072|FG000|Overall Study|Withdrawal by Subject|32|||
126067699|NCT04374253|453540566|FG002|Overall Study|Adverse Event|2|||
126067700|NCT04374253|453540567|FG003|Overall Study|Adverse Event|12|||
126067701|NCT04374253|453540564|FG000|Overall Study|Study terminated by sponsor|13|||
126067702|NCT04374253|453540565|FG001|Overall Study|Study terminated by sponsor|593|||
126067703|NCT04374253|453540566|FG002|Overall Study|Study terminated by sponsor|21|||
126067704|NCT04374253|453540567|FG003|Overall Study|Study terminated by sponsor|567|||
126067705|NCT04374253|453540564|FG000|Overall Study|Withdrawal by Subject|0|||
126067706|NCT04374253|453540565|FG001|Overall Study|Withdrawal by Subject|55|||
126067707|NCT04374253|453540566|FG002|Overall Study|Withdrawal by Subject|3|||
126067708|NCT04374253|453540567|FG003|Overall Study|Withdrawal by Subject|40|||
126067709|NCT04374253|453540564|FG000|Overall Study|Physician Decision|1|||
126067710|NCT04374253|453540565|FG001|Overall Study|Physician Decision|10|||
126067711|NCT04374253|453540566|FG002|Overall Study|Physician Decision|1|||
126067712|NCT04374253|453540567|FG003|Overall Study|Physician Decision|10|||
126067713|NCT04374253|453540564|FG000|Overall Study|Protocol Violation|0|||
126067714|NCT04374253|453540565|FG001|Overall Study|Protocol Violation|0|||
126067715|NCT04374253|453540566|FG002|Overall Study|Protocol Violation|0|||
126067716|NCT04374253|453540567|FG003|Overall Study|Protocol Violation|2|||
126067717|NCT04374253|453540564|FG000|Overall Study|Death|0|||
126067718|NCT04374253|453540565|FG001|Overall Study|Death|3|||
126067719|NCT04374253|453540566|FG002|Overall Study|Death|1|||
126067720|NCT04374253|453540567|FG003|Overall Study|Death|1|||
126067721|NCT04374253|453540564|FG000|Overall Study|Lack of Efficacy|0|||
126067722|NCT04374253|453540565|FG001|Overall Study|Lack of Efficacy|0|||
126067723|NCT04374253|453540566|FG002|Overall Study|Lack of Efficacy|0|||
126067724|NCT04374253|453540567|FG003|Overall Study|Lack of Efficacy|1|||
126067725|NCT04374253|453540564|FG000|Overall Study|Lost to Follow-up|1|||
126067726|NCT04374253|453540565|FG001|Overall Study|Lost to Follow-up|1|||
126067727|NCT04374253|453540566|FG002|Overall Study|Lost to Follow-up|0|||
126067728|NCT04374253|453540567|FG003|Overall Study|Lost to Follow-up|2|||
126067729|NCT04374253|453540564|FG000|Overall Study|Reason Not Specified|0|||
126067730|NCT04374253|453540565|FG001|Overall Study|Reason Not Specified|8|||
126067731|NCT04374253|453540566|FG002|Overall Study|Reason Not Specified|0|||
126067732|NCT04374253|453540567|FG003|Overall Study|Reason Not Specified|8|||
126067733|NCT01207453|453540568|FG000|First Intervention|Adverse Event|2|||
126067734|NCT01207453|453540569|FG001|First Intervention|Adverse Event|1|||
126067735|NCT01207453|453540568|FG000|Washout|Adverse Event|1|||
126067736|NCT01207453|453540569|FG001|Washout|Adverse Event|0|||
126067737|NCT01207453|453540568|FG000|Washout|Lost to Follow-up|1|||
126067738|NCT01207453|453540569|FG001|Washout|Lost to Follow-up|0|||
126067739|NCT01207453|453540568|FG000|2nd Intervention|Adverse Event|1|||
126067740|NCT01207453|453540569|FG001|2nd Intervention|Adverse Event|2|||
126067741|NCT01207453|453540568|FG000|2nd Intervention|Lost to Follow-up|1|||
126067742|NCT01207453|453540569|FG001|2nd Intervention|Lost to Follow-up|0|||
126067743|NCT00990821|453540572|FG000|Overall Study|Withdrawal by Subject|0|||
126067744|NCT00990821|453540573|FG001|Overall Study|Withdrawal by Subject|2|||
126067745|NCT00990821|453540574|FG002|Overall Study|Withdrawal by Subject|0|||
126067746|NCT00990821|453540575|FG003|Overall Study|Withdrawal by Subject|0|||
126067747|NCT00990821|453540576|FG004|Overall Study|Withdrawal by Subject|3|||
126067748|NCT00990821|453540577|FG005|Overall Study|Withdrawal by Subject|3|||
126067749|NCT00990821|453540578|FG006|Overall Study|Withdrawal by Subject|1|||
126067750|NCT00990821|453540579|FG007|Overall Study|Withdrawal by Subject|0|||
126067751|NCT00990821|453540580|FG008|Overall Study|Withdrawal by Subject|0|||
126067752|NCT00990821|453540581|FG009|Overall Study|Withdrawal by Subject|1|||
126067753|NCT00990821|453540582|FG010|Overall Study|Withdrawal by Subject|3|||
126067754|NCT00990821|453540583|FG011|Overall Study|Withdrawal by Subject|5|||
126067755|NCT00990821|453540584|FG012|Overall Study|Withdrawal by Subject|2|||
126067756|NCT00990821|453540585|FG013|Overall Study|Withdrawal by Subject|1|||
126067757|NCT04150250|453540586|FG000|Overall Study|Lost to Follow-up|0|||
126067758|NCT04150250|453540587|FG001|Overall Study|Lost to Follow-up|2|||
126067759|NCT01786551|453540588|FG000|Overall Study|Participant withdrew consent|2|||
126067760|NCT00308113|453540590|FG000|Overall Study|Protocol closure|0|||
126067761|NCT00308113|453540591|FG001|Overall Study|Protocol closure|0|||
126067762|NCT00308113|453540592|FG002|Overall Study|Protocol closure|0|||
126067763|NCT00308113|453540593|FG003|Overall Study|Protocol closure|1|||
126067764|NCT00170950|453540594|FG000|Overall Study|Death|236|||
126067765|NCT00170950|453540595|FG001|Overall Study|Death|274|||
126067766|NCT00170950|453540594|FG000|Overall Study|Withdrawal by Subject|496|||
126067767|NCT00170950|453540595|FG001|Overall Study|Withdrawal by Subject|498|||
126067768|NCT00170950|453540594|FG000|Overall Study|Lost to Follow-up|134|||
126067769|NCT00170950|453540595|FG001|Overall Study|Lost to Follow-up|115|||
126067770|NCT00170950|453540594|FG000|Overall Study|Missing|2|||
126067771|NCT00170950|453540595|FG001|Overall Study|Missing|1|||
126067772|NCT00170950|453540594|FG000|Overall Study|Termination Data Not Recorded|17|||
126067773|NCT00170950|453540595|FG001|Overall Study|Termination Data Not Recorded|22|||
126067774|NCT00748098|453540596|FG000|First Treatment Intervention Period|Adverse Event|1|||
126067775|NCT00748098|453540597|FG001|First Treatment Intervention Period|Adverse Event|1|||
126067776|NCT00748098|453540596|FG000|First Treatment Intervention Period|Protocol Violation|1|||
126067777|NCT00748098|453540597|FG001|First Treatment Intervention Period|Protocol Violation|0|||
126067778|NCT00748098|453540596|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
126067779|NCT00748098|453540597|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
126067780|NCT00748098|453540596|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
126067781|NCT00748098|453540597|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
126067782|NCT00748098|453540596|FG000|First Taper Period|Protocol Violation|1|||
126067783|NCT00748098|453540597|FG001|First Taper Period|Protocol Violation|0|||
126067784|NCT00748098|453540596|FG000|First Taper Period|Withdrawal by Subject|2|||
126067785|NCT00748098|453540597|FG001|First Taper Period|Withdrawal by Subject|0|||
126067786|NCT00748098|453540596|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
126067787|NCT00748098|453540597|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
126067788|NCT00748098|453540596|FG000|1-Week Washout Period|Adverse Event|0|||
126067789|NCT00748098|453540597|FG001|1-Week Washout Period|Adverse Event|1|||
126067790|NCT00748098|453540596|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
126067791|NCT00748098|453540597|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
126067792|NCT00748098|453540596|FG000|Second Treatment Intervention Period|Adverse Event|4|||
126067793|NCT00748098|453540597|FG001|Second Treatment Intervention Period|Adverse Event|1|||
126067794|NCT00748098|453540596|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
126067795|NCT00748098|453540597|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
126067796|NCT00748098|453540596|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
126067797|NCT00748098|453540597|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
126067798|NCT02442622|453540598|FG000|Overall Study|Withdrawal by Subject|3|||
126067799|NCT02442622|453540599|FG001|Overall Study|Withdrawal by Subject|1|||
126067800|NCT01123642|453542260|FG000|Overall Study|Lost to Follow-up|23|||
126067801|NCT01123642|453542260|FG000|Overall Study|Withdrawal by Subject|9|||
126067802|NCT01123642|453542260|FG000|Overall Study|ineligible at baseline assessment|36|||
126067803|NCT03322514|453542261|FG000|Overall Study|Withdrawal by Subject|1|||
126067804|NCT03322514|453542262|FG001|Overall Study|Withdrawal by Subject|1|||
126067805|NCT01184859|453542263|FG000|Period 1: Single Dose|Insufficient urine production|0|||
126067806|NCT01184859|453542264|FG001|Period 1: Single Dose|Insufficient urine production|1|||
126067807|NCT01184859|453542265|FG002|Period 1: Single Dose|Insufficient urine production|0|||
126067808|NCT01184859|453542266|FG003|Period 1: Single Dose|Insufficient urine production|0|||
126067809|NCT01184859|453542267|FG004|Period 1: Single Dose|Insufficient urine production|0|||
126067810|NCT01184859|453542263|FG000|Period 1: Single Dose|Protocol Violation|0|||
126067811|NCT01184859|453542264|FG001|Period 1: Single Dose|Protocol Violation|1|||
126067812|NCT01184859|453542265|FG002|Period 1: Single Dose|Protocol Violation|0|||
126067813|NCT01184859|453542266|FG003|Period 1: Single Dose|Protocol Violation|0|||
126067814|NCT01184859|453542267|FG004|Period 1: Single Dose|Protocol Violation|0|||
126067815|NCT01184859|453542263|FG000|Period 1: Single Dose|Adverse Event|0|||
126067816|NCT01184859|453542264|FG001|Period 1: Single Dose|Adverse Event|0|||
126067817|NCT01184859|453542265|FG002|Period 1: Single Dose|Adverse Event|0|||
126067818|NCT01184859|453542266|FG003|Period 1: Single Dose|Adverse Event|0|||
126067819|NCT01184859|453542267|FG004|Period 1: Single Dose|Adverse Event|1|||
126067820|NCT01184859|453542263|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
126067821|NCT01184859|453542264|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
126067822|NCT01184859|453542265|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
126067823|NCT01184859|453542266|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
126067824|NCT01184859|453542267|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
126067825|NCT01184859|453542263|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
126067826|NCT01184859|453542264|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
126067827|NCT01184859|453542265|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
126067828|NCT01184859|453542266|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
126067829|NCT01184859|453542267|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
126067830|NCT00961298|453542268|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
126067831|NCT00961298|453542268|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
126067832|NCT00961298|453542268|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
126067833|NCT01904019|453542270|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
126067834|NCT01904019|453542270|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
126067835|NCT01904019|453542270|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
126067836|NCT01904019|453542270|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
126067837|NCT01904019|453542270|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
126067838|NCT01904019|453542270|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
126067839|NCT01537120|453542271|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
126067840|NCT01537120|453542271|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
126067841|NCT01503515|453542276|FG000|Overall Study|Adverse Event|4|||
126067842|NCT01503515|453542277|FG001|Overall Study|Adverse Event|5|||
126067843|NCT01503515|453542276|FG000|Overall Study|Death|0|||
126067844|NCT01503515|453542277|FG001|Overall Study|Death|1|||
126067845|NCT01503515|453542276|FG000|Overall Study|Physician Decision|14|||
126067846|NCT01503515|453542277|FG001|Overall Study|Physician Decision|23|||
126067847|NCT01503515|453542276|FG000|Overall Study|Withdrawal by Subject|0|||
126067848|NCT01503515|453542277|FG001|Overall Study|Withdrawal by Subject|1|||
126067849|NCT01503515|453542276|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
126067850|NCT01503515|453542277|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
126067851|NCT01503515|453542276|FG000|Overall Study|Ineligible|1|||
126067852|NCT01503515|453542277|FG001|Overall Study|Ineligible|1|||
126067853|NCT03087851|453542282|FG000|Overall Study|Withdraw on medical grounds|0|||
126067854|NCT03087851|453542283|FG001|Overall Study|Withdraw on medical grounds|1|||
126067855|NCT03087851|453542284|FG002|Overall Study|Withdraw on medical grounds|2|||
126067856|NCT02123797|453542287|FG000|Baseline Intervention|Death|9|||
126067857|NCT02123797|453542288|FG001|Baseline Intervention|Death|16|||
126067858|NCT02123797|453542289|FG002|Baseline Intervention|Death|0|||
126067859|NCT02123797|453542290|FG003|Baseline Intervention|Death|0|||
126067860|NCT02123797|453542291|FG004|Baseline Intervention|Death|0|||
126067861|NCT02123797|453542287|FG000|Baseline Intervention|Withdrawal by Subject|2|||
126067862|NCT02123797|453542288|FG001|Baseline Intervention|Withdrawal by Subject|8|||
126067863|NCT02123797|453542289|FG002|Baseline Intervention|Withdrawal by Subject|0|||
126067864|NCT02123797|453542290|FG003|Baseline Intervention|Withdrawal by Subject|0|||
126067865|NCT02123797|453542291|FG004|Baseline Intervention|Withdrawal by Subject|0|||
126067866|NCT02123797|453542287|FG000|Baseline Intervention|Relocation|2|||
126067867|NCT02123797|453542288|FG001|Baseline Intervention|Relocation|0|||
126067868|NCT02123797|453542289|FG002|Baseline Intervention|Relocation|0|||
126067869|NCT02123797|453542290|FG003|Baseline Intervention|Relocation|0|||
126067870|NCT02123797|453542291|FG004|Baseline Intervention|Relocation|0|||
126067871|NCT02123797|453542287|FG000|Baseline Intervention|Out of window for initial survey|6|||
126067872|NCT02123797|453542288|FG001|Baseline Intervention|Out of window for initial survey|13|||
126067873|NCT02123797|453542289|FG002|Baseline Intervention|Out of window for initial survey|0|||
126067874|NCT02123797|453542290|FG003|Baseline Intervention|Out of window for initial survey|0|||
126067875|NCT02123797|453542291|FG004|Baseline Intervention|Out of window for initial survey|0|||
126067876|NCT02123797|453542287|FG000|Baseline Intervention|Lost to Follow-up|0|||
126067877|NCT02123797|453542288|FG001|Baseline Intervention|Lost to Follow-up|5|||
126067878|NCT02123797|453542289|FG002|Baseline Intervention|Lost to Follow-up|0|||
126067879|NCT02123797|453542290|FG003|Baseline Intervention|Lost to Follow-up|0|||
126067880|NCT02123797|453542291|FG004|Baseline Intervention|Lost to Follow-up|0|||
126067881|NCT02123797|453542287|FG000|Baseline Intervention|Other Disease|3|||
126067882|NCT02123797|453542288|FG001|Baseline Intervention|Other Disease|0|||
126067883|NCT02123797|453542289|FG002|Baseline Intervention|Other Disease|0|||
126067884|NCT02123797|453542290|FG003|Baseline Intervention|Other Disease|0|||
126067885|NCT02123797|453542291|FG004|Baseline Intervention|Other Disease|0|||
126067886|NCT02123797|453542287|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
126067887|NCT02123797|453542288|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
126067888|NCT02123797|453542289|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
126067889|NCT02123797|453542290|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
126067890|NCT02123797|453542291|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
126067891|NCT02123797|453542287|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
126067892|NCT02123797|453542288|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
126067893|NCT02123797|453542289|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
126067894|NCT02123797|453542290|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
126067895|NCT02123797|453542291|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
126067896|NCT02123797|453542287|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
126067897|NCT02123797|453542288|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
126067898|NCT02123797|453542289|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126067899|NCT02123797|453542290|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126067900|NCT02123797|453542291|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126067901|NCT02123797|453542287|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
126067902|NCT02123797|453542288|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
126067903|NCT02123797|453542289|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
126067904|NCT02123797|453542290|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
126067905|NCT02123797|453542291|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
126067906|NCT02123797|453542287|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
126067907|NCT02123797|453542288|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
126067908|NCT02123797|453542289|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
126067909|NCT02123797|453542290|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
126067910|NCT02123797|453542291|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
126067911|NCT02123797|453542287|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
126067912|NCT02123797|453542288|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
126067913|NCT02123797|453542289|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
126067914|NCT02123797|453542290|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
126067915|NCT02123797|453542291|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
126067916|NCT02123797|453542287|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
126067917|NCT02123797|453542288|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
126067918|NCT02123797|453542289|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
125944025|NCT02424383|453093072|FG000|Overall Study|Death|170|||
126067919|NCT02123797|453542290|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
126067920|NCT02123797|453542291|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
126067921|NCT02123797|453542287|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
126067922|NCT02123797|453542288|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
126067923|NCT02123797|453542289|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126067924|NCT02123797|453542290|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126067925|NCT02123797|453542291|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126067926|NCT02123797|453542287|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
126067927|NCT02123797|453542288|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
126067928|NCT02123797|453542289|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
126067929|NCT02123797|453542290|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
126067930|NCT02123797|453542291|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
126067931|NCT00443755|453542292|FG000|Overall Study|Withdrawal by Subject|2|||
126067932|NCT00443755|453542293|FG001|Overall Study|Withdrawal by Subject|1|||
126067933|NCT00678899|453542296|FG000|Overall Study|Adverse Event|1|||
126067934|NCT03997409|453542302|FG000|Overall Study|Protocol Violation|1|||
126067935|NCT03997409|453542303|FG001|Overall Study|Protocol Violation|1|||
126067936|NCT03997409|453542304|FG002|Overall Study|Protocol Violation|0|||
126067937|NCT03997409|453542302|FG000|Overall Study|Withdrawal by Subject|3|||
126067938|NCT03997409|453542303|FG001|Overall Study|Withdrawal by Subject|0|||
126067939|NCT03997409|453542304|FG002|Overall Study|Withdrawal by Subject|0|||
126067940|NCT03997409|453542302|FG000|Overall Study|Lost to Follow-up|0|||
126067941|NCT03997409|453542303|FG001|Overall Study|Lost to Follow-up|0|||
126067942|NCT03997409|453542304|FG002|Overall Study|Lost to Follow-up|1|||
126067943|NCT01753323|453542305|FG000|Overall Study|Lack of Efficacy|0|||
126067944|NCT01753323|453542306|FG001|Overall Study|Lack of Efficacy|0|||
126067945|NCT01753323|453542307|FG002|Overall Study|Lack of Efficacy|8|||
126067946|NCT01753323|453542305|FG000|Overall Study|Protocol deviation|1|||
126067947|NCT01753323|453542306|FG001|Overall Study|Protocol deviation|0|||
126067948|NCT01753323|453542307|FG002|Overall Study|Protocol deviation|0|||
126067949|NCT01753323|453542305|FG000|Overall Study|Adverse Event|0|||
126067950|NCT01753323|453542306|FG001|Overall Study|Adverse Event|0|||
126067951|NCT01753323|453542307|FG002|Overall Study|Adverse Event|1|||
126067952|NCT01498445|453542309|FG000|Overall Study|Lack of Efficacy|0|||
126067953|NCT01498445|453542310|FG001|Overall Study|Lack of Efficacy|0|||
126067954|NCT01498445|453542311|FG002|Overall Study|Lack of Efficacy|1|||
126067955|NCT01498445|453542312|FG003|Overall Study|Lack of Efficacy|2|||
126067956|NCT01498445|453542313|FG004|Overall Study|Lack of Efficacy|0|||
126067957|NCT01498445|453542314|FG005|Overall Study|Lack of Efficacy|0|||
126067958|NCT01498445|453542309|FG000|Overall Study|Screen Failure|0|||
126067959|NCT01498445|453542310|FG001|Overall Study|Screen Failure|0|||
126067960|NCT01498445|453542311|FG002|Overall Study|Screen Failure|0|||
126067961|NCT01498445|453542312|FG003|Overall Study|Screen Failure|0|||
126067962|NCT01498445|453542313|FG004|Overall Study|Screen Failure|1|||
126067963|NCT01498445|453542314|FG005|Overall Study|Screen Failure|1|||
126067964|NCT00561678|453542315|FG000|Overall Study|Withdrawal by Subject|4|||
126067965|NCT00561678|453542316|FG001|Overall Study|Withdrawal by Subject|3|||
126067966|NCT00561678|453542315|FG000|Overall Study|surgery cancelled|1|||
126067967|NCT00561678|453542316|FG001|Overall Study|surgery cancelled|1|||
126067968|NCT00561678|453542315|FG000|Overall Study|surgery rescheduled to different site|2|||
126067969|NCT00561678|453542316|FG001|Overall Study|surgery rescheduled to different site|2|||
126067970|NCT00561678|453542315|FG000|Overall Study|anesthesia provider refusal|1|||
126067971|NCT00561678|453542316|FG001|Overall Study|anesthesia provider refusal|0|||
126067972|NCT01072396|453542317|FG000|Period One|Adverse Event|1|||
126067973|NCT01072396|453542318|FG001|Period One|Adverse Event|1|||
126067974|NCT01072396|453542317|FG000|Period One|Protocol Violation|2|||
126067975|NCT01072396|453542318|FG001|Period One|Protocol Violation|1|||
126067976|NCT01072396|453542317|FG000|Period One|Withdrawal by Subject|2|||
126067977|NCT01072396|453542318|FG001|Period One|Withdrawal by Subject|0|||
126067978|NCT01072396|453542317|FG000|Washout Period|Missing termination information|0|||
126067979|NCT01072396|453542318|FG001|Washout Period|Missing termination information|1|||
126067980|NCT01072396|453542317|FG000|Period Two|Adverse Event|0|||
126067981|NCT01072396|453542318|FG001|Period Two|Adverse Event|3|||
126067982|NCT01072396|453542317|FG000|Period Two|Lost to Follow-up|1|||
126067983|NCT01072396|453542318|FG001|Period Two|Lost to Follow-up|0|||
125944026|NCT02424383|453093072|FG000|Overall Study|Sponsor's decision|3|||
125944027|NCT02424383|453093072|FG000|Overall Study|Investigator's decision|44|||
125944028|NCT02424383|453093072|FG000|Overall Study|Lost to Follow-up|81|||
125944029|NCT02424383|453093072|FG000|Overall Study|Other|7|||
126067984|NCT00005908|453542319|FG000|Overall Study|Withdrawal by Subject|1|||
126067985|NCT00005908|453542320|FG001|Overall Study|Withdrawal by Subject|0|||
126067986|NCT01106586|453542321|FG000|Overall Study|Adverse Event|9|||
126067987|NCT01106586|453542322|FG001|Overall Study|Adverse Event|15|||
126067988|NCT01106586|453542321|FG000|Overall Study|Death|1|||
126067989|NCT01106586|453542322|FG001|Overall Study|Death|3|||
126067990|NCT01106586|453542321|FG000|Overall Study|Pregnancy|2|||
126067991|NCT01106586|453542322|FG001|Overall Study|Pregnancy|2|||
126067992|NCT01106586|453542321|FG000|Overall Study|Lack of Efficacy|1|||
126067993|NCT01106586|453542322|FG001|Overall Study|Lack of Efficacy|0|||
126067994|NCT01106586|453542321|FG000|Overall Study|Investigator's Discretion|5|||
126067995|NCT01106586|453542322|FG001|Overall Study|Investigator's Discretion|8|||
126067996|NCT01106586|453542321|FG000|Overall Study|Withdrew Consent|18|||
126067997|NCT01106586|453542322|FG001|Overall Study|Withdrew Consent|30|||
126067998|NCT01106586|453542321|FG000|Overall Study|Lost to Follow-up|24|||
126067999|NCT01106586|453542322|FG001|Overall Study|Lost to Follow-up|20|||
126068000|NCT01106586|453542321|FG000|Overall Study|Participant Noncompliance|12|||
126068001|NCT01106586|453542322|FG001|Overall Study|Participant Noncompliance|10|||
126068002|NCT01106586|453542321|FG000|Overall Study|Protocol Violation|1|||
126068003|NCT01106586|453542322|FG001|Overall Study|Protocol Violation|0|||
126114386|NCT02608879|453713827|FG000|Overall Study|Lost to Follow-up|1|||
126068004|NCT01106586|453542321|FG000|Overall Study|Participant Transferred to Another Study|212|||
126068005|NCT01106586|453542322|FG001|Overall Study|Participant Transferred to Another Study|197|||
126068006|NCT01379521|453542323|FG000|Overall Study -Treatment Period|Adverse Event|3|||
126068007|NCT01379521|453542324|FG001|Overall Study -Treatment Period|Adverse Event|0|||
126068008|NCT01379521|453542323|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
126068009|NCT01379521|453542324|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
126068010|NCT01379521|453542323|FG000|Overall Study -Treatment Period|Disease Progression|23|||
126068011|NCT01379521|453542324|FG001|Overall Study -Treatment Period|Disease Progression|22|||
126068012|NCT01379521|453542323|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
126068013|NCT01379521|453542324|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
126068014|NCT01379521|453542323|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
126068015|NCT01379521|453542324|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
126068016|NCT01379521|453542323|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
126068017|NCT01379521|453542324|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
126068018|NCT01379521|453542323|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
126068019|NCT01379521|453542324|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
126068020|NCT01379521|453542323|FG000|Overall Study -Treatment Period|Death|2|||
126068021|NCT01379521|453542324|FG001|Overall Study -Treatment Period|Death|1|||
126068022|NCT01379521|453542323|FG000|Post-Treatment Evaluations|Disease Progression|22|||
126068023|NCT01379521|453542324|FG001|Post-Treatment Evaluations|Disease Progression|20|||
126068024|NCT01379521|453542323|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
126068025|NCT01379521|453542324|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
126068026|NCT01379521|453542323|FG000|Post-Treatment Evaluations|Death|1|||
126068027|NCT01379521|453542324|FG001|Post-Treatment Evaluations|Death|0|||
126068028|NCT00938041|453542325|FG000|Overall Study|Lost to Follow-up|6|||
126068029|NCT00938041|453542325|FG000|Overall Study|Received Alternative Therapy|1|||
126068030|NCT00938041|453542325|FG000|Overall Study|Progressive Disease|5|||
126068031|NCT00938041|453542325|FG000|Overall Study|Death|12|||
126068032|NCT00938041|453542325|FG000|Overall Study|Adrenal Insufficiency|3|||
126068033|NCT01026103|453542326|FG000|Overall Study|Physician Decision|1|||
126068034|NCT01026103|453542326|FG000|Overall Study|did not receive study device bc of error|1|||
126068035|NCT00105521|453542327|FG000|Overall Study|Other|1|||
126068036|NCT00105521|453542328|FG001|Overall Study|Other|1|||
126068037|NCT00105521|453542329|FG002|Overall Study|Other|2|||
126068038|NCT00105521|453542330|FG003|Overall Study|Other|0|||
126068039|NCT00105521|453542327|FG000|Overall Study|Adverse Event|10|||
126068040|NCT00105521|453542328|FG001|Overall Study|Adverse Event|4|||
126068041|NCT00105521|453542329|FG002|Overall Study|Adverse Event|10|||
126068042|NCT00105521|453542330|FG003|Overall Study|Adverse Event|8|||
126068043|NCT00105521|453542327|FG000|Overall Study|Withdrawal by Subject|1|||
126068044|NCT00105521|453542328|FG001|Overall Study|Withdrawal by Subject|0|||
126068045|NCT00105521|453542329|FG002|Overall Study|Withdrawal by Subject|1|||
126068046|NCT00105521|453542330|FG003|Overall Study|Withdrawal by Subject|4|||
126068047|NCT00105521|453542327|FG000|Overall Study|Lack of Efficacy|0|||
126068048|NCT00105521|453542328|FG001|Overall Study|Lack of Efficacy|0|||
126068049|NCT00105521|453542329|FG002|Overall Study|Lack of Efficacy|0|||
126068050|NCT00105521|453542330|FG003|Overall Study|Lack of Efficacy|1|||
126068051|NCT00105521|453542327|FG000|Overall Study|Protocol Violation|3|||
126068052|NCT00105521|453542328|FG001|Overall Study|Protocol Violation|5|||
126068053|NCT00105521|453542329|FG002|Overall Study|Protocol Violation|4|||
126068054|NCT00105521|453542330|FG003|Overall Study|Protocol Violation|4|||
126068055|NCT00105521|453542327|FG000|Overall Study|Lost to Follow-up|0|||
126068056|NCT00105521|453542328|FG001|Overall Study|Lost to Follow-up|1|||
126068057|NCT00105521|453542329|FG002|Overall Study|Lost to Follow-up|0|||
126068058|NCT00105521|453542330|FG003|Overall Study|Lost to Follow-up|0|||
126068059|NCT02475733|453542331|FG000|Overall Study|Withdrawal by Subject|1|||
126068060|NCT02475733|453542332|FG001|Overall Study|Withdrawal by Subject|0|||
126068061|NCT02475733|453542331|FG000|Overall Study|Physician Decision|1|||
126068062|NCT02475733|453542332|FG001|Overall Study|Physician Decision|0|||
126068063|NCT00404547|453542335|FG000|Overall Study|Adverse Event|39|||
126068064|NCT00404547|453542336|FG001|Overall Study|Adverse Event|6|||
126068065|NCT00404547|453542335|FG000|Overall Study|Withdrawal by Subject|19|||
126068066|NCT00404547|453542336|FG001|Overall Study|Withdrawal by Subject|2|||
126068067|NCT00404547|453542335|FG000|Overall Study|Protocol Violation|0|||
126068068|NCT00404547|453542336|FG001|Overall Study|Protocol Violation|1|||
126068069|NCT00404547|453542335|FG000|Overall Study|Lost to Follow-up|20|||
126068070|NCT00404547|453542336|FG001|Overall Study|Lost to Follow-up|9|||
126068071|NCT00404547|453542335|FG000|Overall Study|Lack of compliance|5|||
126068072|NCT00404547|453542336|FG001|Overall Study|Lack of compliance|1|||
126068073|NCT00404547|453542335|FG000|Overall Study|Other|4|||
126068074|NCT00404547|453542336|FG001|Overall Study|Other|0|||
126068075|NCT00404547|453542335|FG000|Overall Study|Reason not stated|3|||
126068076|NCT00404547|453542336|FG001|Overall Study|Reason not stated|6|||
126068077|NCT02131155|453542337|FG000|Overall Study|Adverse Event|1|||
126068078|NCT02131155|453542338|FG001|Overall Study|Adverse Event|0|||
126068079|NCT02131155|453542337|FG000|Overall Study|Treatment completed|1|||
126068080|NCT02131155|453542338|FG001|Overall Study|Treatment completed|0|||
126068081|NCT02131155|453542337|FG000|Overall Study|Primary tumour recurrence|2|||
126068082|NCT02131155|453542338|FG001|Overall Study|Primary tumour recurrence|1|||
126068083|NCT02131155|453542337|FG000|Overall Study|Refused to continue study medication|1|||
126068084|NCT02131155|453542338|FG001|Overall Study|Refused to continue study medication|0|||
126068085|NCT02131155|453542337|FG000|Overall Study|Study early termination|20|||
126068086|NCT02131155|453542338|FG001|Overall Study|Study early termination|10|||
126068087|NCT02350127|453542342|FG000|4-Month Assessment|Withdrawal by Subject|10|||
126068088|NCT02350127|453542343|FG001|4-Month Assessment|Withdrawal by Subject|9|||
126068089|NCT02350127|453542342|FG000|4-Month Assessment|Death|1|||
126068090|NCT02350127|453542343|FG001|4-Month Assessment|Death|0|||
126068091|NCT02350127|453542342|FG000|8-Month Assessment|Death|1|||
126068092|NCT02350127|453542343|FG001|8-Month Assessment|Death|1|||
126068093|NCT02350127|453542342|FG000|8-Month Assessment|Withdrawal by Subject|5|||
126068094|NCT02350127|453542343|FG001|8-Month Assessment|Withdrawal by Subject|8|||
126068095|NCT03906240|453542344|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
126068096|NCT03906240|453542345|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
126068097|NCT03906240|453542344|FG000|Overall Study|Lost to Follow-up|1|||
126068098|NCT03906240|453542345|FG001|Overall Study|Lost to Follow-up|0|||
126068099|NCT03906240|453542344|FG000|Overall Study|Withdrawal by Subject|0|||
126068100|NCT03906240|453542345|FG001|Overall Study|Withdrawal by Subject|1|||
126068101|NCT01446042|453542346|FG000|Overall Study|Withdrawal by Subject|12|||
126068102|NCT01446042|453542347|FG001|Overall Study|Withdrawal by Subject|2|||
126068103|NCT01446042|453542348|FG002|Overall Study|Withdrawal by Subject|4|||
126068104|NCT01446042|453542346|FG000|Overall Study|Adverse Event|1|||
126068105|NCT01446042|453542347|FG001|Overall Study|Adverse Event|0|||
126068106|NCT01446042|453542348|FG002|Overall Study|Adverse Event|4|||
126068107|NCT01446042|453542346|FG000|Overall Study|Lost to Follow-up|5|||
126068108|NCT01446042|453542347|FG001|Overall Study|Lost to Follow-up|0|||
126068109|NCT01446042|453542348|FG002|Overall Study|Lost to Follow-up|0|||
126068110|NCT01446042|453542346|FG000|Overall Study|Other reasons|2|||
126068111|NCT01446042|453542347|FG001|Overall Study|Other reasons|1|||
126068112|NCT01446042|453542348|FG002|Overall Study|Other reasons|1|||
126068113|NCT03751280|453542358|FG000|Overall Study|Adverse Event|0|||
126068114|NCT03751280|453542359|FG001|Overall Study|Adverse Event|1|||
126068115|NCT03751280|453542358|FG000|Overall Study|Lost to Follow-up|3|||
126068116|NCT03751280|453542359|FG001|Overall Study|Lost to Follow-up|5|||
126068117|NCT03751280|453542358|FG000|Overall Study|Physician Decision|0|||
126068118|NCT03751280|453542359|FG001|Overall Study|Physician Decision|2|||
126068119|NCT03751280|453542358|FG000|Overall Study|Protocol Violation|0|||
126068120|NCT03751280|453542359|FG001|Overall Study|Protocol Violation|2|||
126068121|NCT03751280|453542358|FG000|Overall Study|Withdrawal by Subject|5|||
126068122|NCT03751280|453542359|FG001|Overall Study|Withdrawal by Subject|2|||
126068123|NCT00296504|453542360|FG000|Interim Analysis|Withdrawal by Subject|8|||
126068124|NCT00296504|453542361|FG001|Interim Analysis|Withdrawal by Subject|0|||
126068125|NCT00296504|453542362|FG002|Interim Analysis|Withdrawal by Subject|12|||
126068126|NCT00296504|453542363|FG003|Interim Analysis|Withdrawal by Subject|0|||
126068127|NCT00296504|453542364|FG004|Interim Analysis|Withdrawal by Subject|5|||
126068128|NCT00296504|453542365|FG005|Interim Analysis|Withdrawal by Subject|5|||
126068129|NCT00296504|453542366|FG006|Interim Analysis|Withdrawal by Subject|9|||
126068130|NCT00296504|453542367|FG007|Interim Analysis|Withdrawal by Subject|3|||
126068131|NCT00296504|453542368|FG008|Interim Analysis|Withdrawal by Subject|0|||
126068132|NCT00296504|453542360|FG000|Interim Analysis|Lost to Follow-up|13|||
126068133|NCT00296504|453542361|FG001|Interim Analysis|Lost to Follow-up|3|||
126068134|NCT00296504|453542362|FG002|Interim Analysis|Lost to Follow-up|26|||
126068135|NCT00296504|453542363|FG003|Interim Analysis|Lost to Follow-up|8|||
126068136|NCT00296504|453542364|FG004|Interim Analysis|Lost to Follow-up|14|||
126068137|NCT00296504|453542365|FG005|Interim Analysis|Lost to Follow-up|4|||
126068138|NCT00296504|453542366|FG006|Interim Analysis|Lost to Follow-up|11|||
126068139|NCT00296504|453542367|FG007|Interim Analysis|Lost to Follow-up|4|||
126068140|NCT00296504|453542368|FG008|Interim Analysis|Lost to Follow-up|0|||
126068141|NCT00296504|453542360|FG000|Interim Analysis|Clinical Progression|1|||
126068142|NCT00296504|453542361|FG001|Interim Analysis|Clinical Progression|0|||
126068143|NCT00296504|453542362|FG002|Interim Analysis|Clinical Progression|1|||
126068144|NCT00296504|453542363|FG003|Interim Analysis|Clinical Progression|1|||
126068145|NCT00296504|453542364|FG004|Interim Analysis|Clinical Progression|0|||
126068146|NCT00296504|453542365|FG005|Interim Analysis|Clinical Progression|2|||
126068147|NCT00296504|453542366|FG006|Interim Analysis|Clinical Progression|1|||
126068148|NCT00296504|453542367|FG007|Interim Analysis|Clinical Progression|2|||
126068149|NCT00296504|453542368|FG008|Interim Analysis|Clinical Progression|0|||
126068150|NCT00296504|453542360|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
126068151|NCT00296504|453542361|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
126068152|NCT00296504|453542362|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
126068153|NCT00296504|453542363|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
126068154|NCT00296504|453542364|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
125944030|NCT02424383|453093072|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
125944031|NCT02016482|453093075|FG000|Period A|Adverse Event|3|||
125944032|NCT02016482|453093076|FG001|Period A|Adverse Event|5|||
125944033|NCT02016482|453093075|FG000|Period A|Withdrawal by Subject|3|||
125944034|NCT02016482|453093076|FG001|Period A|Withdrawal by Subject|4|||
125944035|NCT02016482|453093075|FG000|Period A|Lost to Follow-up|3|||
125944036|NCT02016482|453093076|FG001|Period A|Lost to Follow-up|3|||
125944037|NCT02016482|453093075|FG000|Period A|Lack of Efficacy|2|||
125944038|NCT02016482|453093076|FG001|Period A|Lack of Efficacy|1|||
125944039|NCT02016482|453093075|FG000|Period A|Other|3|||
125944040|NCT02016482|453093076|FG001|Period A|Other|0|||
125944041|NCT02016482|453093075|FG000|Period A|Protocol Violation|0|||
125944042|NCT02016482|453093076|FG001|Period A|Protocol Violation|1|||
125944043|NCT02016482|453093075|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
125944044|NCT02016482|453093076|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
125944045|NCT02016482|453093075|FG000|Period B|Withdrawal by Subject|1|||
125944046|NCT02016482|453093076|FG001|Period B|Withdrawal by Subject|1|||
125944047|NCT02016482|453093075|FG000|Period B|Lost to Follow-up|2|||
125944048|NCT02016482|453093076|FG001|Period B|Lost to Follow-up|0|||
125944049|NCT02016482|453093075|FG000|Period B|Lack of Efficacy|6|||
125944050|NCT02016482|453093076|FG001|Period B|Lack of Efficacy|4|||
125944051|NCT02016482|453093075|FG000|Period B|Other|4|||
125944052|NCT02016482|453093076|FG001|Period B|Other|0|||
125944053|NCT02016482|453093075|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
125944054|NCT02016482|453093076|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
125944055|NCT02738333|453093078|FG000|Overall Study|Death|1|||
125944056|NCT02738333|453093079|FG001|Overall Study|Death|0|||
125944057|NCT02738333|453093080|FG002|Overall Study|Death|0|||
125944058|NCT02738333|453093078|FG000|Overall Study|Lost to Follow-up|1|||
125944059|NCT02738333|453093079|FG001|Overall Study|Lost to Follow-up|0|||
125944060|NCT02738333|453093080|FG002|Overall Study|Lost to Follow-up|0|||
125944061|NCT00949325|453093081|FG000|Overall Study|Adverse Event|0|||
125944062|NCT00949325|453093082|FG001|Overall Study|Adverse Event|2|||
125944063|NCT00949325|453093083|FG002|Overall Study|Adverse Event|0|||
125944064|NCT00791518|453093084|FG000|Overall Study|Protocol Violation|93|||
125944065|NCT01520363|453093085|FG000|Overall Study|Withdrawal by Subject|2|||
125944066|NCT01520363|453093086|FG001|Overall Study|Withdrawal by Subject|0|||
125944067|NCT01251380|453093090|FG000|Overall Study|Other (Not otherwise specified)|12|||
125944068|NCT01251380|453093090|FG000|Overall Study|Withdrawal by Subject|6|||
125944069|NCT01251380|453093090|FG000|Overall Study|Lack of Efficacy|1|||
125944070|NCT01251380|453093090|FG000|Overall Study|Adverse Event|1|||
125944071|NCT01251380|453093090|FG000|Overall Study|Lost to Follow-up|2|||
125944072|NCT01498952|453093091|FG000|Overall Study|Death|2|||
125944073|NCT01498952|453093092|FG001|Overall Study|Death|2|||
125944074|NCT01498952|453093093|FG002|Overall Study|Death|0|||
125944075|NCT01498952|453093094|FG003|Overall Study|Death|0|||
125944076|NCT01498952|453093095|FG004|Overall Study|Death|0|||
125944077|NCT00579826|453093096|FG000|Overall Study|Withdrawal by Subject|5|||
125944078|NCT00579826|453093097|FG001|Overall Study|Withdrawal by Subject|3|||
125944079|NCT02205333|453093103|FG000|Overall Study|Death|5|||
125944080|NCT02205333|453093104|FG001|Overall Study|Death|6|||
125944081|NCT02205333|453093105|FG002|Overall Study|Death|2|||
125944082|NCT02205333|453093106|FG003|Overall Study|Death|6|||
125944083|NCT02205333|453093107|FG004|Overall Study|Death|5|||
125944084|NCT02205333|453093108|FG005|Overall Study|Death|3|||
125944085|NCT02205333|453093109|FG006|Overall Study|Death|3|||
125944086|NCT02205333|453093110|FG007|Overall Study|Death|2|||
125944087|NCT02205333|453093111|FG008|Overall Study|Death|0|||
125944088|NCT02205333|453093103|FG000|Overall Study|Withdrawal by Subject|1|||
125944089|NCT02205333|453093104|FG001|Overall Study|Withdrawal by Subject|0|||
125944090|NCT02205333|453093105|FG002|Overall Study|Withdrawal by Subject|0|||
125944091|NCT02205333|453093106|FG003|Overall Study|Withdrawal by Subject|1|||
125944092|NCT02205333|453093107|FG004|Overall Study|Withdrawal by Subject|0|||
125944093|NCT02205333|453093108|FG005|Overall Study|Withdrawal by Subject|0|||
125944094|NCT02205333|453093109|FG006|Overall Study|Withdrawal by Subject|2|||
125944095|NCT02205333|453093110|FG007|Overall Study|Withdrawal by Subject|0|||
125944096|NCT02205333|453093111|FG008|Overall Study|Withdrawal by Subject|0|||
126068155|NCT00296504|453542365|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
126068156|NCT00296504|453542366|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
126068157|NCT00296504|453542367|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
125944097|NCT00454987|453093112|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
125944098|NCT00454987|453093113|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
125944099|NCT00454987|453093114|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
125944100|NCT00454987|453093112|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
125944101|NCT00454987|453093113|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
125944102|NCT00454987|453093114|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
125944103|NCT00454987|453093112|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
125944104|NCT00454987|453093113|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
125944105|NCT00454987|453093114|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
126068158|NCT00296504|453542368|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
126068159|NCT00296504|453542360|FG000|Interim Analysis|Adverse Event|0|||
126068160|NCT00296504|453542361|FG001|Interim Analysis|Adverse Event|0|||
126068161|NCT00296504|453542362|FG002|Interim Analysis|Adverse Event|13|||
126068162|NCT00296504|453542363|FG003|Interim Analysis|Adverse Event|4|||
126068163|NCT00296504|453542364|FG004|Interim Analysis|Adverse Event|6|||
126068164|NCT00296504|453542365|FG005|Interim Analysis|Adverse Event|3|||
126068165|NCT00296504|453542366|FG006|Interim Analysis|Adverse Event|4|||
126068166|NCT00296504|453542367|FG007|Interim Analysis|Adverse Event|5|||
126068167|NCT00296504|453542368|FG008|Interim Analysis|Adverse Event|0|||
126068168|NCT00296504|453542360|FG000|Interim Analysis|Protocol Violation|0|||
126068169|NCT00296504|453542361|FG001|Interim Analysis|Protocol Violation|0|||
126068170|NCT00296504|453542362|FG002|Interim Analysis|Protocol Violation|2|||
126068171|NCT00296504|453542363|FG003|Interim Analysis|Protocol Violation|0|||
126068172|NCT00296504|453542364|FG004|Interim Analysis|Protocol Violation|1|||
126068173|NCT00296504|453542365|FG005|Interim Analysis|Protocol Violation|0|||
126068174|NCT00296504|453542366|FG006|Interim Analysis|Protocol Violation|0|||
126068175|NCT00296504|453542367|FG007|Interim Analysis|Protocol Violation|1|||
126068176|NCT00296504|453542368|FG008|Interim Analysis|Protocol Violation|0|||
126068177|NCT00296504|453542360|FG000|Interim Analysis|Insufficient CD4 Response|0|||
126068178|NCT00296504|453542361|FG001|Interim Analysis|Insufficient CD4 Response|0|||
126068179|NCT00296504|453542362|FG002|Interim Analysis|Insufficient CD4 Response|0|||
126068180|NCT00296504|453542363|FG003|Interim Analysis|Insufficient CD4 Response|0|||
126068181|NCT00296504|453542364|FG004|Interim Analysis|Insufficient CD4 Response|1|||
126068182|NCT00296504|453542365|FG005|Interim Analysis|Insufficient CD4 Response|1|||
126068183|NCT00296504|453542366|FG006|Interim Analysis|Insufficient CD4 Response|0|||
126068184|NCT00296504|453542367|FG007|Interim Analysis|Insufficient CD4 Response|0|||
126068185|NCT00296504|453542368|FG008|Interim Analysis|Insufficient CD4 Response|0|||
126068186|NCT00296504|453542360|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
126068187|NCT00296504|453542361|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
126068188|NCT00296504|453542362|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
126068189|NCT00296504|453542363|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
126068190|NCT00296504|453542364|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
126068191|NCT00296504|453542365|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
126068192|NCT00296504|453542366|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
126068193|NCT00296504|453542367|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
126068194|NCT00296504|453542368|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
126068195|NCT00296504|453542360|FG000|Interim Analysis|Pregnancy|4|||
126068196|NCT00296504|453542361|FG001|Interim Analysis|Pregnancy|1|||
126068197|NCT00296504|453542362|FG002|Interim Analysis|Pregnancy|4|||
126068198|NCT00296504|453542363|FG003|Interim Analysis|Pregnancy|2|||
126068199|NCT00296504|453542364|FG004|Interim Analysis|Pregnancy|0|||
126068200|NCT00296504|453542365|FG005|Interim Analysis|Pregnancy|1|||
126068201|NCT00296504|453542366|FG006|Interim Analysis|Pregnancy|1|||
126068202|NCT00296504|453542367|FG007|Interim Analysis|Pregnancy|1|||
126068203|NCT00296504|453542368|FG008|Interim Analysis|Pregnancy|0|||
126068204|NCT00296504|453542360|FG000|Interim Analysis|Death|1|||
126068205|NCT00296504|453542361|FG001|Interim Analysis|Death|0|||
126068206|NCT00296504|453542362|FG002|Interim Analysis|Death|3|||
126068207|NCT00296504|453542363|FG003|Interim Analysis|Death|0|||
126068208|NCT00296504|453542364|FG004|Interim Analysis|Death|0|||
126068209|NCT00296504|453542365|FG005|Interim Analysis|Death|0|||
126068210|NCT00296504|453542366|FG006|Interim Analysis|Death|0|||
126068211|NCT00296504|453542367|FG007|Interim Analysis|Death|0|||
126068212|NCT00296504|453542368|FG008|Interim Analysis|Death|0|||
126068213|NCT00296504|453542360|FG000|Interim Analysis|Participant Non-compliant|0|||
126068214|NCT00296504|453542361|FG001|Interim Analysis|Participant Non-compliant|1|||
126114387|NCT02608879|453713828|FG001|Overall Study|Lost to Follow-up|0|||
126114388|NCT02608879|453713829|FG002|Overall Study|Lost to Follow-up|0|||
126114389|NCT02608879|453713827|FG000|Overall Study|Did not meet continuation criteria|0|||
125944106|NCT01476696|453093115|FG000|Overall Study|Sponsor decision|2|||
126068215|NCT00296504|453542362|FG002|Interim Analysis|Participant Non-compliant|2|||
126068216|NCT00296504|453542363|FG003|Interim Analysis|Participant Non-compliant|1|||
126068217|NCT00296504|453542364|FG004|Interim Analysis|Participant Non-compliant|1|||
126068218|NCT00296504|453542365|FG005|Interim Analysis|Participant Non-compliant|3|||
126068219|NCT00296504|453542366|FG006|Interim Analysis|Participant Non-compliant|6|||
126068220|NCT00296504|453542367|FG007|Interim Analysis|Participant Non-compliant|2|||
126068221|NCT00296504|453542368|FG008|Interim Analysis|Participant Non-compliant|0|||
126068222|NCT00296504|453542360|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126068223|NCT00296504|453542361|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126068224|NCT00296504|453542362|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
126068225|NCT00296504|453542363|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126068226|NCT00296504|453542364|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126068227|NCT00296504|453542365|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
126068228|NCT00296504|453542366|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126068229|NCT00296504|453542367|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126068230|NCT00296504|453542368|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126068231|NCT00296504|453542360|FG000|Interim Analysis|To Simplify Treatment|0|||
126068232|NCT00296504|453542361|FG001|Interim Analysis|To Simplify Treatment|0|||
126068233|NCT00296504|453542362|FG002|Interim Analysis|To Simplify Treatment|1|||
126068234|NCT00296504|453542363|FG003|Interim Analysis|To Simplify Treatment|0|||
126068235|NCT00296504|453542364|FG004|Interim Analysis|To Simplify Treatment|0|||
126068236|NCT00296504|453542365|FG005|Interim Analysis|To Simplify Treatment|0|||
126068237|NCT00296504|453542366|FG006|Interim Analysis|To Simplify Treatment|2|||
126068238|NCT00296504|453542367|FG007|Interim Analysis|To Simplify Treatment|0|||
126068239|NCT00296504|453542368|FG008|Interim Analysis|To Simplify Treatment|0|||
126068240|NCT00296504|453542360|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
126068241|NCT00296504|453542361|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
126068242|NCT00296504|453542362|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
126068243|NCT00296504|453542363|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
126068244|NCT00296504|453542364|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
126068245|NCT00296504|453542365|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
126068246|NCT00296504|453542366|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
126068247|NCT00296504|453542367|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
126068248|NCT00296504|453542368|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
126068249|NCT00296504|453542360|FG000|Interim Analysis|Participant Moved|1|||
126068250|NCT00296504|453542361|FG001|Interim Analysis|Participant Moved|0|||
126068251|NCT00296504|453542362|FG002|Interim Analysis|Participant Moved|1|||
126068252|NCT00296504|453542363|FG003|Interim Analysis|Participant Moved|0|||
126068253|NCT00296504|453542364|FG004|Interim Analysis|Participant Moved|0|||
126068254|NCT00296504|453542365|FG005|Interim Analysis|Participant Moved|1|||
126068255|NCT00296504|453542366|FG006|Interim Analysis|Participant Moved|1|||
126068256|NCT00296504|453542367|FG007|Interim Analysis|Participant Moved|0|||
126068257|NCT00296504|453542368|FG008|Interim Analysis|Participant Moved|0|||
126068258|NCT00296504|453542360|FG000|Interim Analysis|Participant Was Incarcerated|2|||
126068259|NCT00296504|453542361|FG001|Interim Analysis|Participant Was Incarcerated|0|||
126068260|NCT00296504|453542362|FG002|Interim Analysis|Participant Was Incarcerated|1|||
126068261|NCT00296504|453542363|FG003|Interim Analysis|Participant Was Incarcerated|0|||
126068262|NCT00296504|453542364|FG004|Interim Analysis|Participant Was Incarcerated|0|||
126068263|NCT00296504|453542365|FG005|Interim Analysis|Participant Was Incarcerated|0|||
126068264|NCT00296504|453542366|FG006|Interim Analysis|Participant Was Incarcerated|0|||
126068265|NCT00296504|453542367|FG007|Interim Analysis|Participant Was Incarcerated|0|||
126068266|NCT00296504|453542368|FG008|Interim Analysis|Participant Was Incarcerated|0|||
126068267|NCT00296504|453542360|FG000|Interim Analysis|Resistance to FPV|0|||
126068268|NCT00296504|453542361|FG001|Interim Analysis|Resistance to FPV|0|||
126068269|NCT00296504|453542362|FG002|Interim Analysis|Resistance to FPV|1|||
126068270|NCT00296504|453542363|FG003|Interim Analysis|Resistance to FPV|0|||
126068271|NCT00296504|453542364|FG004|Interim Analysis|Resistance to FPV|0|||
126068272|NCT00296504|453542365|FG005|Interim Analysis|Resistance to FPV|0|||
126068273|NCT00296504|453542366|FG006|Interim Analysis|Resistance to FPV|0|||
126068274|NCT00296504|453542367|FG007|Interim Analysis|Resistance to FPV|0|||
126068275|NCT00296504|453542368|FG008|Interim Analysis|Resistance to FPV|0|||
126068276|NCT00296504|453542360|FG000|Interim Analysis|Physician Decision|0|||
126068277|NCT00296504|453542361|FG001|Interim Analysis|Physician Decision|0|||
126068278|NCT00296504|453542362|FG002|Interim Analysis|Physician Decision|1|||
126068279|NCT00296504|453542363|FG003|Interim Analysis|Physician Decision|0|||
126068280|NCT00296504|453542364|FG004|Interim Analysis|Physician Decision|0|||
126068281|NCT00296504|453542365|FG005|Interim Analysis|Physician Decision|0|||
126068282|NCT00296504|453542366|FG006|Interim Analysis|Physician Decision|0|||
126068283|NCT00296504|453542367|FG007|Interim Analysis|Physician Decision|0|||
126068284|NCT00296504|453542368|FG008|Interim Analysis|Physician Decision|0|||
126068285|NCT00296504|453542360|FG000|Interim Analysis|Principle Investigator Discretion|2|||
126068286|NCT00296504|453542361|FG001|Interim Analysis|Principle Investigator Discretion|0|||
126068287|NCT00296504|453542362|FG002|Interim Analysis|Principle Investigator Discretion|1|||
126068288|NCT00296504|453542363|FG003|Interim Analysis|Principle Investigator Discretion|1|||
126068289|NCT00296504|453542364|FG004|Interim Analysis|Principle Investigator Discretion|0|||
126068290|NCT00296504|453542365|FG005|Interim Analysis|Principle Investigator Discretion|0|||
126068291|NCT00296504|453542366|FG006|Interim Analysis|Principle Investigator Discretion|0|||
126068292|NCT00296504|453542367|FG007|Interim Analysis|Principle Investigator Discretion|0|||
126114390|NCT02608879|453713828|FG001|Overall Study|Did not meet continuation criteria|0|||
126114391|NCT02608879|453713829|FG002|Overall Study|Did not meet continuation criteria|3|||
126068293|NCT00296504|453542368|FG008|Interim Analysis|Principle Investigator Discretion|0|||
126068294|NCT00296504|453542360|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
126068295|NCT00296504|453542361|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
126114392|NCT00760669|453713830|FG000|Overall Study|Not assessed for overall improvement|18|||
126068296|NCT00296504|453542362|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
126068297|NCT00296504|453542363|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
126068298|NCT00296504|453542364|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
126068299|NCT00296504|453542365|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
126068300|NCT00296504|453542366|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
126068301|NCT00296504|453542367|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
126068302|NCT00296504|453542368|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
126068303|NCT00296504|453542360|FG000|Interim Analysis|Non-adherence|2|||
126068304|NCT00296504|453542361|FG001|Interim Analysis|Non-adherence|0|||
126068305|NCT00296504|453542362|FG002|Interim Analysis|Non-adherence|0|||
126068306|NCT00296504|453542363|FG003|Interim Analysis|Non-adherence|0|||
126068307|NCT00296504|453542364|FG004|Interim Analysis|Non-adherence|1|||
126068308|NCT00296504|453542365|FG005|Interim Analysis|Non-adherence|0|||
126068309|NCT00296504|453542366|FG006|Interim Analysis|Non-adherence|0|||
126068310|NCT00296504|453542367|FG007|Interim Analysis|Non-adherence|1|||
126068311|NCT00296504|453542368|FG008|Interim Analysis|Non-adherence|0|||
126068312|NCT00296504|453542360|FG000|Interim Analysis|Site Closing|1|||
126068313|NCT00296504|453542361|FG001|Interim Analysis|Site Closing|0|||
126068314|NCT00296504|453542362|FG002|Interim Analysis|Site Closing|0|||
126068315|NCT00296504|453542363|FG003|Interim Analysis|Site Closing|0|||
126068316|NCT00296504|453542364|FG004|Interim Analysis|Site Closing|0|||
126068317|NCT00296504|453542365|FG005|Interim Analysis|Site Closing|1|||
126068318|NCT00296504|453542366|FG006|Interim Analysis|Site Closing|2|||
126068319|NCT00296504|453542367|FG007|Interim Analysis|Site Closing|0|||
126068320|NCT00296504|453542368|FG008|Interim Analysis|Site Closing|0|||
126068321|NCT00296504|453542360|FG000|Interim Analysis|Lack of Personnel at Site|1|||
126068322|NCT00296504|453542361|FG001|Interim Analysis|Lack of Personnel at Site|0|||
126068323|NCT00296504|453542362|FG002|Interim Analysis|Lack of Personnel at Site|0|||
126068324|NCT00296504|453542363|FG003|Interim Analysis|Lack of Personnel at Site|0|||
126068325|NCT00296504|453542364|FG004|Interim Analysis|Lack of Personnel at Site|0|||
126068326|NCT00296504|453542365|FG005|Interim Analysis|Lack of Personnel at Site|0|||
126068327|NCT00296504|453542366|FG006|Interim Analysis|Lack of Personnel at Site|0|||
126068328|NCT00296504|453542367|FG007|Interim Analysis|Lack of Personnel at Site|0|||
126068329|NCT00296504|453542368|FG008|Interim Analysis|Lack of Personnel at Site|0|||
126068330|NCT00296504|453542360|FG000|Interim Analysis|Missed Schedule Date|1|||
126068331|NCT00296504|453542361|FG001|Interim Analysis|Missed Schedule Date|0|||
126068332|NCT00296504|453542362|FG002|Interim Analysis|Missed Schedule Date|0|||
126068333|NCT00296504|453542363|FG003|Interim Analysis|Missed Schedule Date|0|||
126068334|NCT00296504|453542364|FG004|Interim Analysis|Missed Schedule Date|0|||
126068335|NCT00296504|453542365|FG005|Interim Analysis|Missed Schedule Date|0|||
126068336|NCT00296504|453542366|FG006|Interim Analysis|Missed Schedule Date|0|||
126068337|NCT00296504|453542367|FG007|Interim Analysis|Missed Schedule Date|0|||
126068338|NCT00296504|453542368|FG008|Interim Analysis|Missed Schedule Date|0|||
126068339|NCT00296504|453542360|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
126068340|NCT00296504|453542361|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
126068341|NCT00296504|453542362|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
126068342|NCT00296504|453542363|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
126068343|NCT00296504|453542364|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
126068344|NCT00296504|453542365|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
126068345|NCT00296504|453542366|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
126068346|NCT00296504|453542367|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
126068347|NCT00296504|453542368|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
126068348|NCT00296504|453542360|FG000|Interim Analysis|Participant Stopped|0|||
126068349|NCT00296504|453542361|FG001|Interim Analysis|Participant Stopped|0|||
126068350|NCT00296504|453542362|FG002|Interim Analysis|Participant Stopped|0|||
126068351|NCT00296504|453542363|FG003|Interim Analysis|Participant Stopped|0|||
126068352|NCT00296504|453542364|FG004|Interim Analysis|Participant Stopped|1|||
126068353|NCT00296504|453542365|FG005|Interim Analysis|Participant Stopped|0|||
126068354|NCT00296504|453542366|FG006|Interim Analysis|Participant Stopped|0|||
126068355|NCT00296504|453542367|FG007|Interim Analysis|Participant Stopped|0|||
126068356|NCT00296504|453542368|FG008|Interim Analysis|Participant Stopped|0|||
126068357|NCT00296504|453542360|FG000|Interim Analysis|Physician and Participant Decision|0|||
126068358|NCT00296504|453542361|FG001|Interim Analysis|Physician and Participant Decision|0|||
126068359|NCT00296504|453542362|FG002|Interim Analysis|Physician and Participant Decision|0|||
126068360|NCT00296504|453542363|FG003|Interim Analysis|Physician and Participant Decision|0|||
126068361|NCT00296504|453542364|FG004|Interim Analysis|Physician and Participant Decision|0|||
126068362|NCT00296504|453542365|FG005|Interim Analysis|Physician and Participant Decision|1|||
126068363|NCT00296504|453542366|FG006|Interim Analysis|Physician and Participant Decision|0|||
126068364|NCT00296504|453542367|FG007|Interim Analysis|Physician and Participant Decision|0|||
126068365|NCT00296504|453542368|FG008|Interim Analysis|Physician and Participant Decision|0|||
126068366|NCT00296504|453542360|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
126068367|NCT00296504|453542361|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
126068368|NCT00296504|453542362|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
126068369|NCT00296504|453542363|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
126068370|NCT00296504|453542364|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
126068371|NCT00296504|453542365|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
126068372|NCT00296504|453542366|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
126068373|NCT00296504|453542367|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
126068374|NCT00296504|453542368|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
126068375|NCT00296504|453542360|FG000|Interim Analysis|Study Ended|0|||
126068376|NCT00296504|453542361|FG001|Interim Analysis|Study Ended|0|||
126068377|NCT00296504|453542362|FG002|Interim Analysis|Study Ended|0|||
126068378|NCT00296504|453542363|FG003|Interim Analysis|Study Ended|0|||
126068379|NCT00296504|453542364|FG004|Interim Analysis|Study Ended|0|||
126068380|NCT00296504|453542365|FG005|Interim Analysis|Study Ended|0|||
126068381|NCT00296504|453542366|FG006|Interim Analysis|Study Ended|1|||
126068382|NCT00296504|453542367|FG007|Interim Analysis|Study Ended|0|||
126068383|NCT00296504|453542368|FG008|Interim Analysis|Study Ended|0|||
126068384|NCT00296504|453542360|FG000|Interim Analysis|Participant Needed Interferon|0|||
126068385|NCT00296504|453542361|FG001|Interim Analysis|Participant Needed Interferon|0|||
126068386|NCT00296504|453542362|FG002|Interim Analysis|Participant Needed Interferon|0|||
126068387|NCT00296504|453542363|FG003|Interim Analysis|Participant Needed Interferon|0|||
126068388|NCT00296504|453542364|FG004|Interim Analysis|Participant Needed Interferon|0|||
126068389|NCT00296504|453542365|FG005|Interim Analysis|Participant Needed Interferon|0|||
126068390|NCT00296504|453542366|FG006|Interim Analysis|Participant Needed Interferon|0|||
126068391|NCT00296504|453542367|FG007|Interim Analysis|Participant Needed Interferon|1|||
126068392|NCT00296504|453542368|FG008|Interim Analysis|Participant Needed Interferon|0|||
126068393|NCT00296504|453542360|FG000|Interim Analysis|Ongoing|32|||
126068394|NCT00296504|453542361|FG001|Interim Analysis|Ongoing|12|||
126068395|NCT00296504|453542362|FG002|Interim Analysis|Ongoing|16|||
126068396|NCT00296504|453542363|FG003|Interim Analysis|Ongoing|22|||
126068397|NCT00296504|453542364|FG004|Interim Analysis|Ongoing|0|||
126068398|NCT00296504|453542365|FG005|Interim Analysis|Ongoing|0|||
126068399|NCT00296504|453542366|FG006|Interim Analysis|Ongoing|30|||
126068400|NCT00296504|453542367|FG007|Interim Analysis|Ongoing|1|||
126068401|NCT00296504|453542368|FG008|Interim Analysis|Ongoing|0|||
126068402|NCT00296504|453542360|FG000|Final Analysis|Withdrawal by Subject|0|||
126068403|NCT00296504|453542361|FG001|Final Analysis|Withdrawal by Subject|0|||
126068404|NCT00296504|453542362|FG002|Final Analysis|Withdrawal by Subject|0|||
126068405|NCT00296504|453542363|FG003|Final Analysis|Withdrawal by Subject|0|||
126068406|NCT00296504|453542364|FG004|Final Analysis|Withdrawal by Subject|0|||
126068407|NCT00296504|453542365|FG005|Final Analysis|Withdrawal by Subject|0|||
126068408|NCT00296504|453542366|FG006|Final Analysis|Withdrawal by Subject|0|||
126068409|NCT00296504|453542367|FG007|Final Analysis|Withdrawal by Subject|0|||
126068410|NCT00296504|453542368|FG008|Final Analysis|Withdrawal by Subject|1|||
126068411|NCT00296504|453542360|FG000|Final Analysis|Lost to Follow-up|0|||
126068412|NCT00296504|453542361|FG001|Final Analysis|Lost to Follow-up|0|||
126068413|NCT00296504|453542362|FG002|Final Analysis|Lost to Follow-up|0|||
126068414|NCT00296504|453542363|FG003|Final Analysis|Lost to Follow-up|0|||
126068415|NCT00296504|453542364|FG004|Final Analysis|Lost to Follow-up|0|||
126068416|NCT00296504|453542365|FG005|Final Analysis|Lost to Follow-up|0|||
126068417|NCT00296504|453542366|FG006|Final Analysis|Lost to Follow-up|0|||
126068418|NCT00296504|453542367|FG007|Final Analysis|Lost to Follow-up|0|||
126068419|NCT00296504|453542368|FG008|Final Analysis|Lost to Follow-up|5|||
126068420|NCT00296504|453542360|FG000|Final Analysis|Insufficient Viral Load Response|0|||
126068421|NCT00296504|453542361|FG001|Final Analysis|Insufficient Viral Load Response|0|||
126068422|NCT00296504|453542362|FG002|Final Analysis|Insufficient Viral Load Response|0|||
126068423|NCT00296504|453542363|FG003|Final Analysis|Insufficient Viral Load Response|0|||
126068424|NCT00296504|453542364|FG004|Final Analysis|Insufficient Viral Load Response|0|||
126068425|NCT00296504|453542365|FG005|Final Analysis|Insufficient Viral Load Response|0|||
126068426|NCT00296504|453542366|FG006|Final Analysis|Insufficient Viral Load Response|0|||
126068427|NCT00296504|453542367|FG007|Final Analysis|Insufficient Viral Load Response|0|||
126068428|NCT00296504|453542368|FG008|Final Analysis|Insufficient Viral Load Response|6|||
126068429|NCT00296504|453542360|FG000|Final Analysis|Adverse Event|0|||
126068430|NCT00296504|453542361|FG001|Final Analysis|Adverse Event|0|||
126068431|NCT00296504|453542362|FG002|Final Analysis|Adverse Event|0|||
126068432|NCT00296504|453542363|FG003|Final Analysis|Adverse Event|0|||
126068433|NCT00296504|453542364|FG004|Final Analysis|Adverse Event|0|||
126068434|NCT00296504|453542365|FG005|Final Analysis|Adverse Event|0|||
126068435|NCT00296504|453542366|FG006|Final Analysis|Adverse Event|0|||
126068436|NCT00296504|453542367|FG007|Final Analysis|Adverse Event|0|||
126068437|NCT00296504|453542368|FG008|Final Analysis|Adverse Event|2|||
126068438|NCT00296504|453542360|FG000|Final Analysis|Pregnancy|0|||
126068439|NCT00296504|453542361|FG001|Final Analysis|Pregnancy|0|||
126068440|NCT00296504|453542362|FG002|Final Analysis|Pregnancy|0|||
126068441|NCT00296504|453542363|FG003|Final Analysis|Pregnancy|0|||
126068442|NCT00296504|453542364|FG004|Final Analysis|Pregnancy|0|||
126068443|NCT00296504|453542365|FG005|Final Analysis|Pregnancy|0|||
126068444|NCT00296504|453542366|FG006|Final Analysis|Pregnancy|0|||
126068445|NCT00296504|453542367|FG007|Final Analysis|Pregnancy|0|||
126068446|NCT00296504|453542368|FG008|Final Analysis|Pregnancy|4|||
126068447|NCT00296504|453542360|FG000|Final Analysis|Tuberculosis|0|||
126068448|NCT00296504|453542361|FG001|Final Analysis|Tuberculosis|0|||
126068449|NCT00296504|453542362|FG002|Final Analysis|Tuberculosis|0|||
126068450|NCT00296504|453542363|FG003|Final Analysis|Tuberculosis|0|||
126068451|NCT00296504|453542364|FG004|Final Analysis|Tuberculosis|0|||
126068452|NCT00296504|453542365|FG005|Final Analysis|Tuberculosis|0|||
126068453|NCT00296504|453542366|FG006|Final Analysis|Tuberculosis|0|||
126068454|NCT00296504|453542367|FG007|Final Analysis|Tuberculosis|0|||
126068455|NCT00296504|453542368|FG008|Final Analysis|Tuberculosis|1|||
126068456|NCT00296504|453542360|FG000|Final Analysis|Participant Moved to Another Country|0|||
126068457|NCT00296504|453542361|FG001|Final Analysis|Participant Moved to Another Country|0|||
126068458|NCT00296504|453542362|FG002|Final Analysis|Participant Moved to Another Country|0|||
126068459|NCT00296504|453542363|FG003|Final Analysis|Participant Moved to Another Country|0|||
126068460|NCT00296504|453542364|FG004|Final Analysis|Participant Moved to Another Country|0|||
126068461|NCT00296504|453542365|FG005|Final Analysis|Participant Moved to Another Country|0|||
126068462|NCT00296504|453542366|FG006|Final Analysis|Participant Moved to Another Country|0|||
126068463|NCT00296504|453542367|FG007|Final Analysis|Participant Moved to Another Country|0|||
126068464|NCT00296504|453542368|FG008|Final Analysis|Participant Moved to Another Country|1|||
126068465|NCT00296504|453542360|FG000|Final Analysis|Poor Adherence|0|||
126068466|NCT00296504|453542361|FG001|Final Analysis|Poor Adherence|0|||
126068467|NCT00296504|453542362|FG002|Final Analysis|Poor Adherence|0|||
126068468|NCT00296504|453542363|FG003|Final Analysis|Poor Adherence|0|||
126068469|NCT00296504|453542364|FG004|Final Analysis|Poor Adherence|0|||
126068470|NCT00296504|453542365|FG005|Final Analysis|Poor Adherence|0|||
126068471|NCT00296504|453542366|FG006|Final Analysis|Poor Adherence|0|||
126068472|NCT00296504|453542367|FG007|Final Analysis|Poor Adherence|0|||
126068473|NCT00296504|453542368|FG008|Final Analysis|Poor Adherence|1|||
126068474|NCT02162771|453542375|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
126068475|NCT02162771|453542376|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
126068476|NCT02162771|453542375|FG000|Core Study Period (Part 2)|Adverse Event|4|||
126068477|NCT02162771|453542376|FG001|Core Study Period (Part 2)|Adverse Event|1|||
126068478|NCT02162771|453542375|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
126068479|NCT02162771|453542376|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
126068480|NCT02162771|453542375|FG000|Core Study Period (Part 2)|Physician Decision|0|||
126068481|NCT02162771|453542376|FG001|Core Study Period (Part 2)|Physician Decision|2|||
126068482|NCT02162771|453542375|FG000|Core Study Period (Part 2)|Death|1|||
126068483|NCT02162771|453542376|FG001|Core Study Period (Part 2)|Death|0|||
126068484|NCT02162771|453542375|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
126068485|NCT02162771|453542376|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
126068486|NCT02162771|453542375|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
126068487|NCT02162771|453542376|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
126068488|NCT02162771|453542375|FG000|Maintenance Study Period (Part 2)|Death|2|||
126068489|NCT02162771|453542376|FG001|Maintenance Study Period (Part 2)|Death|1|||
126068490|NCT02162771|453542375|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
126068491|NCT02162771|453542376|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
126068492|NCT02162771|453542375|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
126068493|NCT02162771|453542376|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
126068494|NCT02162771|453542375|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
126068495|NCT02162771|453542376|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
126068496|NCT00449033|453542395|FG000|Treatment Period|Adverse Event|117|||
126068497|NCT00449033|453542396|FG001|Treatment Period|Adverse Event|83|||
126068498|NCT00449033|453542395|FG000|Treatment Period|Death|21|||
126068499|NCT00449033|453542396|FG001|Treatment Period|Death|12|||
126068500|NCT00449033|453542395|FG000|Treatment Period|Lost to Follow-up|0|||
126068501|NCT00449033|453542396|FG001|Treatment Period|Lost to Follow-up|2|||
126068502|NCT00449033|453542395|FG000|Treatment Period|Physician Decision|4|||
126068503|NCT00449033|453542396|FG001|Treatment Period|Physician Decision|5|||
126068504|NCT00449033|453542395|FG000|Treatment Period|Protocol Violation|8|||
126068505|NCT00449033|453542396|FG001|Treatment Period|Protocol Violation|7|||
126068506|NCT00449033|453542395|FG000|Treatment Period|Disease Progression|231|||
126068507|NCT00449033|453542396|FG001|Treatment Period|Disease Progression|288|||
126068508|NCT00449033|453542395|FG000|Treatment Period|Consent Withdrawn|36|||
126068509|NCT00449033|453542396|FG001|Treatment Period|Consent Withdrawn|20|||
126068510|NCT00449033|453542395|FG000|Treatment Period|Amended Protocol Criteria|22|||
126068511|NCT00449033|453542396|FG001|Treatment Period|Amended Protocol Criteria|18|||
126068512|NCT00449033|453542395|FG000|Treatment Period|Non-compliance|7|||
126114393|NCT00760669|453713830|FG000|Overall Study|Participants missing efficacy assessment|6|||
126068513|NCT00449033|453542396|FG001|Treatment Period|Non-compliance|8|||
126068514|NCT00449033|453542395|FG000|Treatment Period|Second Malignancy|0|||
126114394|NCT00760669|453713830|FG000|Overall Study|Participants with overlapping cases|1|||
125944107|NCT01476696|453093116|FG001|Overall Study|Sponsor decision|1|||
126068515|NCT00449033|453542396|FG001|Treatment Period|Second Malignancy|1|||
125944108|NCT01476696|453093117|FG002|Overall Study|Sponsor decision|0|||
125944109|NCT01476696|453093115|FG000|Overall Study|Withdrawal by Subject|1|||
125944110|NCT01476696|453093116|FG001|Overall Study|Withdrawal by Subject|0|||
125944111|NCT01476696|453093117|FG002|Overall Study|Withdrawal by Subject|0|||
125944112|NCT02009046|453093118|FG000|Overall Study|Lost to Follow-up|256|||
125944113|NCT02009046|453093119|FG001|Overall Study|Lost to Follow-up|206|||
125944114|NCT02073279|453093127|FG000|Double-blind Period|Adverse Event|1|||
125944115|NCT02073279|453093128|FG001|Double-blind Period|Adverse Event|1|||
125944116|NCT02073279|453093127|FG000|Double-blind Period|Switched to another treatment|1|||
125944117|NCT02073279|453093128|FG001|Double-blind Period|Switched to another treatment|2|||
125944118|NCT02073279|453093127|FG000|Double-blind Period|Protocol Violation|0|||
125944119|NCT02073279|453093128|FG001|Double-blind Period|Protocol Violation|1|||
125944120|NCT02073279|453093127|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
125944121|NCT02073279|453093128|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
125944122|NCT02073279|453093127|FG000|Double-blind Period|Withdrawal by Subject|2|||
125944123|NCT02073279|453093128|FG001|Double-blind Period|Withdrawal by Subject|2|||
125944124|NCT02073279|453093127|FG000|Open-label Extension Period|Adverse Event|1|||
125944125|NCT02073279|453093128|FG001|Open-label Extension Period|Adverse Event|0|||
125944126|NCT02073279|453093127|FG000|Open-label Extension Period|Lack of Efficacy|1|||
125944127|NCT02073279|453093128|FG001|Open-label Extension Period|Lack of Efficacy|0|||
125944128|NCT02073279|453093127|FG000|Open-label Extension Period|Lost to Follow-up|0|||
125944129|NCT02073279|453093128|FG001|Open-label Extension Period|Lost to Follow-up|4|||
125944130|NCT02073279|453093127|FG000|Open-label Extension Period|Switched to another treatment|1|||
125944131|NCT02073279|453093128|FG001|Open-label Extension Period|Switched to another treatment|4|||
125944132|NCT02073279|453093127|FG000|Open-label Extension Period|Protocol Violation|0|||
125944133|NCT02073279|453093128|FG001|Open-label Extension Period|Protocol Violation|1|||
125944134|NCT02073279|453093127|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
125944135|NCT02073279|453093128|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
125944136|NCT02073279|453093127|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
125944137|NCT02073279|453093128|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
125944138|NCT00304356|453093129|FG000|Nitazoxanide|Physician Decision|5|||
125944139|NCT00304356|453093129|FG000|Nitazoxanide|Physician Decision|1|||
125944140|NCT00304356|453093129|FG000|Nitazoxanide|number is 0|1|||
125944141|NCT00304356|453093129|FG000|Nitazoxanide|Physician Decision|1|||
125944142|NCT00304356|453093129|FG000|Nitazoxanide|Physician Decision|1|||
125944143|NCT00304356|453093129|FG000|Nitazoxanide|Physician Decision|1|||
125944144|NCT00335972|453093130|FG000|Overall Study|not given treatments|0|||
125944145|NCT00335972|453093131|FG001|Overall Study|not given treatments|3|||
125944146|NCT02136576|453093132|FG000|Overall Study|Lost to Follow-up|2|||
125944147|NCT02136576|453093133|FG001|Overall Study|Lost to Follow-up|0|||
125944148|NCT02136576|453093134|FG002|Overall Study|Lost to Follow-up|0|||
125944149|NCT00549562|453093136|FG000|Overall Study|Adverse Event|1|||
125944150|NCT00549562|453093136|FG000|Overall Study|Lack of Efficacy|1|||
125944151|NCT00323115|453093139|FG000|Vaccine Administration|Adverse Event|1|||
125944152|NCT00323115|453093139|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
125944153|NCT04365556|453093140|FG000|Overall Study|No longer eligible due to treatment plan|1|||
125944154|NCT04365556|453093141|FG001|Overall Study|No longer eligible due to treatment plan|0|||
125944155|NCT04365556|453093140|FG000|Overall Study|Lost to Follow-up|3|||
125944156|NCT04365556|453093141|FG001|Overall Study|Lost to Follow-up|2|||
125944157|NCT00567892|453093143|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125944158|NCT00567892|453093144|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125944159|NCT00567892|453093145|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
125944160|NCT00567892|453093146|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
125944161|NCT00567892|453093143|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125944162|NCT00567892|453093144|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125944163|NCT00567892|453093145|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125944164|NCT00567892|453093146|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
125944165|NCT04709575|453094774|FG000|Overall Study|Withdrawal by Subject|6|||
125944166|NCT04709575|453094775|FG001|Overall Study|Withdrawal by Subject|2|||
125944167|NCT04709575|453094774|FG000|Overall Study|Lost to Follow-up|2|||
125944168|NCT04709575|453094775|FG001|Overall Study|Lost to Follow-up|2|||
125944169|NCT04709575|453094774|FG000|Overall Study|Adverse Event|1|||
125944170|NCT04709575|453094775|FG001|Overall Study|Adverse Event|0|||
125944171|NCT04709575|453094774|FG000|Overall Study|Protocol Violation|1|||
126068516|NCT00449033|453542395|FG000|Treatment Period|Reason Missing|0|||
126068517|NCT00449033|453542396|FG001|Treatment Period|Reason Missing|4|||
126068518|NCT00449033|453542395|FG000|Treatment Period|Treatment Ongoing|6|||
126068519|NCT00449033|453542396|FG001|Treatment Period|Treatment Ongoing|4|||
126068520|NCT00449033|453542395|FG000|Follow-up Period|Death|299|||
126068521|NCT00449033|453542396|FG001|Follow-up Period|Death|311|||
125944172|NCT04709575|453094775|FG001|Overall Study|Protocol Violation|1|||
126068522|NCT00449033|453542395|FG000|Follow-up Period|Lost to Follow-up|6|||
125944173|NCT03181399|453094776|FG000|6 Months on Treatment|Protocol non-compliance|7|||
125944174|NCT03181399|453094776|FG000|6 Months on Treatment|Adverse Event|4|||
126068523|NCT00449033|453542396|FG001|Follow-up Period|Lost to Follow-up|10|||
126068524|NCT00449033|453542395|FG000|Follow-up Period|Reason Missing|120|||
126068525|NCT00449033|453542396|FG001|Follow-up Period|Reason Missing|113|||
126068526|NCT01257698|453542397|FG000|Overall Study|Protocol Violation|4|||
126068527|NCT01257698|453542398|FG001|Overall Study|Protocol Violation|0|||
126068528|NCT04393779|453542399|FG000|Overall Study|Death|1|||
126068529|NCT04393779|453542399|FG000|Overall Study|Device reintervention or explant|4|||
126068530|NCT01190228|453542400|FG000|Overall Study|Protocol Violation|4|||
126068531|NCT01190228|453542401|FG001|Overall Study|Protocol Violation|0|||
126068532|NCT01190228|453542402|FG002|Overall Study|Protocol Violation|0|||
126068533|NCT01190228|453542400|FG000|Overall Study|Withdrawal by Subject|1|||
126068534|NCT01190228|453542401|FG001|Overall Study|Withdrawal by Subject|0|||
126068535|NCT01190228|453542402|FG002|Overall Study|Withdrawal by Subject|0|||
126068536|NCT03023878|453542405|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
126068537|NCT03023878|453542405|FG000|Pre-Study Run-In Period|Death|1|||
126068538|NCT03023878|453542405|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
126068539|NCT03023878|453542405|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
126068540|NCT03023878|453542405|FG000|Treatment Period|Disease Progression|1|||
126068541|NCT03023878|453542405|FG000|Treatment Period|Withdrawal by Subject|1|||
126068542|NCT03023878|453542405|FG000|Treatment Period|Adverse Event|1|||
126068543|NCT03023878|453542405|FG000|Long Term Follow-Up Period|Death|2|||
126068544|NCT01247922|453542407|FG000|Overall Study|Disease progression|4|||
126068545|NCT01876823|453542410|FG000|Overall Study|Withdrawal by Subject|5|||
126068546|NCT01876823|453542410|FG000|Overall Study|Physician Decision|2|||
126068547|NCT01876823|453542410|FG000|Overall Study|Patients moved|2|||
126068548|NCT01770509|453542411|FG000|Overall Study|Injury|0|||
126068549|NCT01770509|453542412|FG001|Overall Study|Injury|1|||
126068550|NCT01770509|453542411|FG000|Overall Study|Lost to Follow-up|1|||
126068551|NCT01770509|453542412|FG001|Overall Study|Lost to Follow-up|2|||
126068552|NCT00390806|453542419|FG000|Overall Study|Lost to Follow-up|7|||
126068553|NCT00390806|453542420|FG001|Overall Study|Lost to Follow-up|6|||
126068554|NCT00390806|453542419|FG000|Overall Study|Protocol Violation|2|||
126068555|NCT00390806|453542420|FG001|Overall Study|Protocol Violation|2|||
126068556|NCT00390806|453542419|FG000|Overall Study|Withdrawal by Subject|12|||
126068557|NCT00390806|453542420|FG001|Overall Study|Withdrawal by Subject|15|||
126068558|NCT00390806|453542419|FG000|Overall Study|Investigator Decision|4|||
126068559|NCT00390806|453542420|FG001|Overall Study|Investigator Decision|6|||
126114395|NCT00760669|453713830|FG000|Overall Study|Took drug before entering in contract|5|||
126068560|NCT00390806|453542419|FG000|Overall Study|Death|1|||
126068561|NCT00390806|453542420|FG001|Overall Study|Death|0|||
126068562|NCT00390806|453542419|FG000|Overall Study|Physician Decision|0|||
126068563|NCT00390806|453542420|FG001|Overall Study|Physician Decision|1|||
126068564|NCT00390806|453542419|FG000|Overall Study|Ongoing|4|||
126068565|NCT00390806|453542420|FG001|Overall Study|Ongoing|2|||
126068566|NCT00925288|453544235|FG000|Overall Study|Lost to Follow-up|9|||
126068567|NCT00925288|453544236|FG001|Overall Study|Lost to Follow-up|7|||
126068568|NCT01232569|453544237|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
126068569|NCT01232569|453544238|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126068570|NCT01232569|453544239|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126068571|NCT01232569|453544240|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
126068572|NCT01232569|453544237|FG000|Double-blind Treatment Period|Escape|2|||
126068573|NCT01232569|453544238|FG001|Double-blind Treatment Period|Escape|2|||
126068574|NCT01232569|453544239|FG002|Double-blind Treatment Period|Escape|0|||
126068575|NCT01232569|453544240|FG003|Double-blind Treatment Period|Escape|0|||
126068576|NCT01232569|453544237|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
126068577|NCT01232569|453544238|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126068578|NCT01232569|453544239|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126068579|NCT01232569|453544240|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126068580|NCT01232569|453544237|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
126068581|NCT01232569|453544238|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
126068582|NCT01232569|453544239|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
126068583|NCT01232569|453544240|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
126068584|NCT01232569|453544237|FG000|Double-blind Treatment Period|Physician Decision|1|||
126068585|NCT01232569|453544238|FG001|Double-blind Treatment Period|Physician Decision|0|||
126068586|NCT01232569|453544239|FG002|Double-blind Treatment Period|Physician Decision|0|||
126068587|NCT01232569|453544240|FG003|Double-blind Treatment Period|Physician Decision|0|||
126068588|NCT01232569|453544237|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
125944175|NCT03181399|453094776|FG000|6 Months on Treatment|Tried alternative treatment|2|||
125944176|NCT03181399|453094776|FG000|6 Months on Treatment|Lost to Follow-up|2|||
126068589|NCT01232569|453544238|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
126068590|NCT01232569|453544239|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
126068591|NCT01232569|453544240|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
126068592|NCT01232569|453544237|FG000|Double-blind Treatment Period|Death|2|||
126068593|NCT01232569|453544238|FG001|Double-blind Treatment Period|Death|0|||
126068594|NCT01232569|453544239|FG002|Double-blind Treatment Period|Death|0|||
126068595|NCT01232569|453544240|FG003|Double-blind Treatment Period|Death|0|||
126068596|NCT04044352|453544241|FG000|Overall Study|Lost to Follow-up|9|||
126068597|NCT04044352|453544241|FG000|Overall Study|Withdrawal by Subject|2|||
126068598|NCT00651937|453544242|FG000|Overall Study|Withdrawal by Subject|4|||
126068599|NCT00651937|453544243|FG001|Overall Study|Withdrawal by Subject|1|||
126068600|NCT00814632|453544244|FG000|Overall Study|Lack of Efficacy|2|||
126068601|NCT00635570|453544246|FG000|Overall Study|Lost to Follow-up|8|||
126068602|NCT00635570|453544247|FG001|Overall Study|Lost to Follow-up|8|||
126068603|NCT00635570|453544246|FG000|Overall Study|Withdrawal by Subject|1|||
126068604|NCT00635570|453544247|FG001|Overall Study|Withdrawal by Subject|1|||
126068605|NCT00635570|453544246|FG000|Overall Study|Adverse Event|2|||
126068606|NCT00635570|453544247|FG001|Overall Study|Adverse Event|0|||
126068607|NCT00635570|453544246|FG000|Overall Study|Physician Decision|1|||
126068608|NCT00635570|453544247|FG001|Overall Study|Physician Decision|0|||
126068609|NCT00635570|453544246|FG000|Overall Study|Did not complete survey|2|||
126068610|NCT00635570|453544247|FG001|Overall Study|Did not complete survey|1|||
126068611|NCT00635570|453544246|FG000|Overall Study|Early termination(No sexual activity)|1|||
126068612|NCT00635570|453544247|FG001|Overall Study|Early termination(No sexual activity)|1|||
126068613|NCT02514577|453544258|FG000|Overall Study|Lost to Follow-up|6|||
126068614|NCT02514577|453544259|FG001|Overall Study|Lost to Follow-up|6|||
126068615|NCT02514577|453544258|FG000|Overall Study|Protocol Violation|1|||
126068616|NCT02514577|453544259|FG001|Overall Study|Protocol Violation|0|||
126068617|NCT02514577|453544258|FG000|Overall Study|Withdrawal by Subject|6|||
126068618|NCT02514577|453544259|FG001|Overall Study|Withdrawal by Subject|6|||
126068619|NCT02514577|453544258|FG000|Overall Study|Adverse Event|1|||
126068620|NCT02514577|453544259|FG001|Overall Study|Adverse Event|1|||
126068621|NCT04816708|453544262|FG000|Overall Study|Lost to Follow-up|10|||
126068622|NCT04816708|453544263|FG001|Overall Study|Lost to Follow-up|4|||
126068623|NCT02388932|453544264|FG000|Overall Study|Death|1|||
126068624|NCT03568708|453544267|FG000|Overall Study|Withdrawal by Subject|1|||
126068625|NCT03568708|453544268|FG001|Overall Study|Withdrawal by Subject|1|||
126068626|NCT03568708|453544267|FG000|Overall Study|Lost to Follow-up|0|||
126068627|NCT03568708|453544268|FG001|Overall Study|Lost to Follow-up|1|||
126068628|NCT00511147|453544269|FG000|Overall Study|Withdrawal by Subject|1|||
126068629|NCT00511147|453544269|FG000|Overall Study|Disease progression|5|||
126068630|NCT00511147|453544269|FG000|Overall Study|Required platelet transfusion|1|||
126068631|NCT00809783|453544270|FG000|Overall Study|Death|1|||
126068632|NCT00809783|453544271|FG001|Overall Study|Death|0|||
126068633|NCT00809783|453544272|FG002|Overall Study|Death|0|||
126068634|NCT00809783|453544270|FG000|Overall Study|Adverse Event|34|||
126068635|NCT00809783|453544271|FG001|Overall Study|Adverse Event|52|||
126068636|NCT00809783|453544272|FG002|Overall Study|Adverse Event|71|||
126068637|NCT00809783|453544270|FG000|Overall Study|Lack of Efficacy|39|||
126068638|NCT00809783|453544271|FG001|Overall Study|Lack of Efficacy|52|||
126068639|NCT00809783|453544272|FG002|Overall Study|Lack of Efficacy|63|||
126068640|NCT00809783|453544270|FG000|Overall Study|Lost to Follow-up|0|||
126068641|NCT00809783|453544271|FG001|Overall Study|Lost to Follow-up|3|||
126068642|NCT00809783|453544272|FG002|Overall Study|Lost to Follow-up|4|||
126068643|NCT00809783|453544270|FG000|Overall Study|Withdrawal by Subject|47|||
126068644|NCT00809783|453544271|FG001|Overall Study|Withdrawal by Subject|72|||
126068645|NCT00809783|453544272|FG002|Overall Study|Withdrawal by Subject|64|||
126068646|NCT00809783|453544270|FG000|Overall Study|Protocol Violation|2|||
126068647|NCT00809783|453544271|FG001|Overall Study|Protocol Violation|6|||
126068648|NCT00809783|453544272|FG002|Overall Study|Protocol Violation|5|||
126068649|NCT00809783|453544270|FG000|Overall Study|Randomized, but not treated|3|||
126068650|NCT00809783|453544271|FG001|Overall Study|Randomized, but not treated|0|||
126068651|NCT00809783|453544272|FG002|Overall Study|Randomized, but not treated|2|||
126068652|NCT00809783|453544270|FG000|Overall Study|Study Terminated by Sponsor|378|||
126068653|NCT00809783|453544271|FG001|Overall Study|Study Terminated by Sponsor|626|||
126068654|NCT00809783|453544272|FG002|Overall Study|Study Terminated by Sponsor|565|||
126068655|NCT00809783|453544270|FG000|Overall Study|Other|21|||
126068656|NCT00809783|453544271|FG001|Overall Study|Other|21|||
126068657|NCT00809783|453544272|FG002|Overall Study|Other|16|||
126068658|NCT00126555|453544273|FG000|Overall Study|Withdrawal by Subject|1|||
126068659|NCT00126555|453544273|FG000|Overall Study|Adverse Event|2|||
126068660|NCT00126555|453544273|FG000|Overall Study|Progressive Disease|3|||
126068661|NCT00396097|453544277|FG000|Overall Study|Withdrawal by Subject|17|||
126068662|NCT00396097|453544278|FG001|Overall Study|Withdrawal by Subject|17|||
126068663|NCT00396097|453544277|FG000|Overall Study|Lost to Follow-up|4|||
126068664|NCT00396097|453544278|FG001|Overall Study|Lost to Follow-up|9|||
126068665|NCT00396097|453544277|FG000|Overall Study|Other|3|||
126068666|NCT00396097|453544278|FG001|Overall Study|Other|5|||
126068667|NCT00396097|453544277|FG000|Overall Study|Protocol Violation|0|||
126068668|NCT00396097|453544278|FG001|Overall Study|Protocol Violation|6|||
126068669|NCT00396097|453544277|FG000|Overall Study|Adverse Event|1|||
126068670|NCT00396097|453544278|FG001|Overall Study|Adverse Event|5|||
126068671|NCT00396097|453544277|FG000|Overall Study|Insufficient Clinical Response|1|||
126068672|NCT00396097|453544278|FG001|Overall Study|Insufficient Clinical Response|4|||
126068673|NCT03461211|453544279|FG000|Overall Study|Adverse Event|1|||
125944177|NCT03181399|453094776|FG000|6 Months on Treatment|Personal reasons|1|||
125944178|NCT03181399|453094776|FG000|3 Months Off-treatment|Parent unable to travel|1|||
125944179|NCT05123222|453094777|FG000|Overall Study|Lost to Follow-up|2|||
125944180|NCT05123222|453094778|FG001|Overall Study|Lost to Follow-up|0|||
125944181|NCT05123222|453094779|FG002|Overall Study|Lost to Follow-up|0|||
125944182|NCT05123222|453094780|FG003|Overall Study|Lost to Follow-up|0|||
125944183|NCT05123222|453094777|FG000|Overall Study|Protocol Violation|0|||
125944184|NCT05123222|453094778|FG001|Overall Study|Protocol Violation|0|||
125944185|NCT05123222|453094779|FG002|Overall Study|Protocol Violation|1|||
125944186|NCT05123222|453094780|FG003|Overall Study|Protocol Violation|0|||
125944187|NCT00265343|453094781|FG000|Overall Study|Adverse Event|10|||
125944188|NCT00265343|453094782|FG001|Overall Study|Adverse Event|7|||
125944189|NCT00265343|453094781|FG000|Overall Study|Withdrawal by Subject|3|||
125944190|NCT00265343|453094782|FG001|Overall Study|Withdrawal by Subject|9|||
125944191|NCT00265343|453094781|FG000|Overall Study|Other|8|||
125944192|NCT00265343|453094782|FG001|Overall Study|Other|3|||
125944193|NCT04865354|453094783|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
125944194|NCT04865354|453094784|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
125944195|NCT04865354|453094783|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
125944196|NCT04865354|453094784|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
125944197|NCT04865354|453094783|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
125944198|NCT04865354|453094784|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
125944199|NCT00706641|453094785|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
125944200|NCT00706641|453094785|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
125944201|NCT00706641|453094785|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
125944202|NCT00004888|453094786|FG000|Overall Study|Adverse Event|5|||
125944203|NCT00004888|453094787|FG001|Overall Study|Adverse Event|10|||
125944204|NCT00004888|453094786|FG000|Overall Study|Withdrawal by Subject|0|||
125944205|NCT00004888|453094787|FG001|Overall Study|Withdrawal by Subject|3|||
125944206|NCT00004888|453094786|FG000|Overall Study|Physician Decision|1|||
125944207|NCT00004888|453094787|FG001|Overall Study|Physician Decision|1|||
125944208|NCT00004888|453094786|FG000|Overall Study|Progressive Disease|4|||
125944209|NCT00004888|453094787|FG001|Overall Study|Progressive Disease|9|||
125944210|NCT00004888|453094786|FG000|Overall Study|Death without progressive disease|0|||
125944211|NCT00004888|453094787|FG001|Overall Study|Death without progressive disease|1|||
125944212|NCT00004888|453094786|FG000|Overall Study|Toxic death|1|||
125944213|NCT00004888|453094787|FG001|Overall Study|Toxic death|0|||
125944214|NCT02579265|453094788|FG000|Overall Study|Weaned off earlier than 28 days|44|||
125944215|NCT02579265|453094789|FG001|Overall Study|Weaned off earlier than 28 days|43|||
125944216|NCT02579265|453094788|FG000|Overall Study|Adverse Event|2|||
125944217|NCT02579265|453094789|FG001|Overall Study|Adverse Event|0|||
125944218|NCT02579265|453094788|FG000|Overall Study|Any other reason not specified|0|||
125944219|NCT02579265|453094789|FG001|Overall Study|Any other reason not specified|2|||
125944220|NCT02579265|453094788|FG000|Overall Study|Withdrawal by Subject|2|||
125944221|NCT02579265|453094789|FG001|Overall Study|Withdrawal by Subject|0|||
125944222|NCT02579265|453094788|FG000|Overall Study|Physician Decision|1|||
125944223|NCT02579265|453094789|FG001|Overall Study|Physician Decision|0|||
125944224|NCT02579265|453094788|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
125944225|NCT02579265|453094789|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
125944226|NCT02174848|453094793|FG000|Overall Study|Adverse Event|2|||
125944227|NCT02174848|453094794|FG001|Overall Study|Adverse Event|1|||
125944228|NCT02174848|453094793|FG000|Overall Study|Withdrawal by Subject|3|||
125944229|NCT02174848|453094794|FG001|Overall Study|Withdrawal by Subject|3|||
125944230|NCT02174848|453094793|FG000|Overall Study|Lost to Follow-up|0|||
125944231|NCT02174848|453094794|FG001|Overall Study|Lost to Follow-up|1|||
125944232|NCT02174848|453094793|FG000|Overall Study|Worsening of disease|1|||
125944233|NCT02174848|453094794|FG001|Overall Study|Worsening of disease|1|||
125944234|NCT02174848|453094793|FG000|Overall Study|Unable to comply with study requirements|1|||
125944235|NCT02174848|453094794|FG001|Overall Study|Unable to comply with study requirements|0|||
125944236|NCT00922766|453094795|FG000|Overall Study|Death|3|||
125944237|NCT00922766|453094795|FG000|Overall Study|Withdrawal by Subject|2|||
125944238|NCT00922766|453094795|FG000|Overall Study|Other|1|||
125944239|NCT00922766|453094795|FG000|Overall Study|Adverse Event|1|||
125944240|NCT00666757|453094798|FG000|Overall Study|Lost to Follow-up|39|||
125944241|NCT00666757|453094799|FG001|Overall Study|Lost to Follow-up|35|||
125944242|NCT00666757|453094798|FG000|Overall Study|Protocol Violation|23|||
125944243|NCT00666757|453094799|FG001|Overall Study|Protocol Violation|24|||
125944244|NCT00666757|453094798|FG000|Overall Study|Adverse Event|22|||
125944245|NCT00666757|453094799|FG001|Overall Study|Adverse Event|12|||
125944246|NCT00666757|453094798|FG000|Overall Study|Withdrawal by Subject|13|||
125944247|NCT00666757|453094799|FG001|Overall Study|Withdrawal by Subject|17|||
126068674|NCT03461211|453544280|FG001|Overall Study|Adverse Event|1|||
125944248|NCT00666757|453094798|FG000|Overall Study|Lack of Efficacy|3|||
126068675|NCT03461211|453544279|FG000|Overall Study|Lack of Efficacy|0|||
125944249|NCT00666757|453094799|FG001|Overall Study|Lack of Efficacy|6|||
125944250|NCT00666757|453094798|FG000|Overall Study|Physician Decision|0|||
125944251|NCT00666757|453094799|FG001|Overall Study|Physician Decision|2|||
125944252|NCT00666757|453094798|FG000|Overall Study|Sponsor decision|0|||
125944253|NCT00666757|453094799|FG001|Overall Study|Sponsor decision|1|||
125944254|NCT01231581|453094800|FG000|Overall Study|Lost to Follow-up|2|||
125944255|NCT01231581|453094801|FG001|Overall Study|Lost to Follow-up|2|||
125944256|NCT01231581|453094800|FG000|Overall Study|Withdrawal by Subject|6|||
125944257|NCT01231581|453094801|FG001|Overall Study|Withdrawal by Subject|9|||
125944258|NCT01231581|453094800|FG000|Overall Study|Study Closed/Terminated|6|||
125944259|NCT01231581|453094801|FG001|Overall Study|Study Closed/Terminated|5|||
125944260|NCT01231581|453094800|FG000|Overall Study|Death|65|||
125944261|NCT01231581|453094801|FG001|Overall Study|Death|64|||
125944262|NCT01231581|453094800|FG000|Overall Study|Ongoing|1|||
125944263|NCT01231581|453094801|FG001|Overall Study|Ongoing|0|||
125944264|NCT02510794|453094802|FG000|Overall Study|Adverse Event|0|||
125944265|NCT02510794|453094803|FG001|Overall Study|Adverse Event|1|||
125944266|NCT02510794|453094804|FG002|Overall Study|Adverse Event|0|||
125944267|NCT02510794|453094805|FG003|Overall Study|Adverse Event|0|||
125944268|NCT02510794|453094802|FG000|Overall Study|Death|1|||
125944269|NCT02510794|453094803|FG001|Overall Study|Death|2|||
125944270|NCT02510794|453094804|FG002|Overall Study|Death|1|||
125944271|NCT02510794|453094805|FG003|Overall Study|Death|1|||
125944272|NCT02510794|453094802|FG000|Overall Study|Lack of Efficacy|3|||
125944273|NCT02510794|453094803|FG001|Overall Study|Lack of Efficacy|1|||
125944274|NCT02510794|453094804|FG002|Overall Study|Lack of Efficacy|1|||
125944275|NCT02510794|453094805|FG003|Overall Study|Lack of Efficacy|0|||
125944276|NCT02510794|453094802|FG000|Overall Study|Participant moved out of the area|0|||
125944277|NCT02510794|453094803|FG001|Overall Study|Participant moved out of the area|0|||
125944278|NCT02510794|453094804|FG002|Overall Study|Participant moved out of the area|0|||
125944279|NCT02510794|453094805|FG003|Overall Study|Participant moved out of the area|1|||
125944280|NCT02510794|453094802|FG000|Overall Study|Physician Decision|3|||
125944281|NCT02510794|453094803|FG001|Overall Study|Physician Decision|0|||
125944282|NCT02510794|453094804|FG002|Overall Study|Physician Decision|0|||
125944283|NCT02510794|453094805|FG003|Overall Study|Physician Decision|0|||
125944284|NCT02510794|453094802|FG000|Overall Study|Protocol Violation|0|||
125944285|NCT02510794|453094803|FG001|Overall Study|Protocol Violation|0|||
125944286|NCT02510794|453094804|FG002|Overall Study|Protocol Violation|1|||
125944287|NCT02510794|453094805|FG003|Overall Study|Protocol Violation|0|||
125944288|NCT02510794|453094802|FG000|Overall Study|Withdrawal by Subject|1|||
125944289|NCT02510794|453094803|FG001|Overall Study|Withdrawal by Subject|2|||
125944290|NCT02510794|453094804|FG002|Overall Study|Withdrawal by Subject|4|||
125944291|NCT02510794|453094805|FG003|Overall Study|Withdrawal by Subject|3|||
125944292|NCT01649375|453094806|FG000|Up to Week 16|Adverse Event|2|||
125944293|NCT01649375|453094807|FG001|Up to Week 16|Adverse Event|5|||
125944294|NCT01649375|453094808|FG002|Up to Week 16|Adverse Event|4|||
125944295|NCT01649375|453094809|FG003|Up to Week 16|Adverse Event|0|||
125944296|NCT01649375|453094810|FG004|Up to Week 16|Adverse Event|0|||
125944297|NCT01649375|453094806|FG000|Up to Week 16|Lack of Efficacy|0|||
125944298|NCT01649375|453094807|FG001|Up to Week 16|Lack of Efficacy|0|||
125944299|NCT01649375|453094808|FG002|Up to Week 16|Lack of Efficacy|1|||
125944300|NCT01649375|453094809|FG003|Up to Week 16|Lack of Efficacy|0|||
125944301|NCT01649375|453094810|FG004|Up to Week 16|Lack of Efficacy|0|||
125944302|NCT01649375|453094806|FG000|Up to Week 16|Physician Decision|0|||
125944303|NCT01649375|453094807|FG001|Up to Week 16|Physician Decision|0|||
125944304|NCT01649375|453094808|FG002|Up to Week 16|Physician Decision|1|||
125944305|NCT01649375|453094809|FG003|Up to Week 16|Physician Decision|0|||
125944306|NCT01649375|453094810|FG004|Up to Week 16|Physician Decision|0|||
125944307|NCT01649375|453094806|FG000|Up to Week 16|Withdrawal by Subject|2|||
125944308|NCT01649375|453094807|FG001|Up to Week 16|Withdrawal by Subject|1|||
125944309|NCT01649375|453094808|FG002|Up to Week 16|Withdrawal by Subject|2|||
125944310|NCT01649375|453094809|FG003|Up to Week 16|Withdrawal by Subject|0|||
125944311|NCT01649375|453094810|FG004|Up to Week 16|Withdrawal by Subject|0|||
125944312|NCT01649375|453094806|FG000|Up to Week 16|Death|1|||
125944313|NCT01649375|453094807|FG001|Up to Week 16|Death|0|||
125944314|NCT01649375|453094808|FG002|Up to Week 16|Death|0|||
125944315|NCT01649375|453094809|FG003|Up to Week 16|Death|0|||
125944316|NCT01649375|453094810|FG004|Up to Week 16|Death|0|||
125944317|NCT01649375|453094806|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
125944318|NCT01649375|453094807|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
125944319|NCT01649375|453094808|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
125944320|NCT01649375|453094809|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
125944321|NCT01649375|453094810|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
125944322|NCT01649375|453094806|FG000|Week 16 up to Week 260|Non-compliance|0|||
125944323|NCT01649375|453094807|FG001|Week 16 up to Week 260|Non-compliance|1|||
125944324|NCT01649375|453094808|FG002|Week 16 up to Week 260|Non-compliance|0|||
125944325|NCT01649375|453094809|FG003|Week 16 up to Week 260|Non-compliance|1|||
125944326|NCT01649375|453094810|FG004|Week 16 up to Week 260|Non-compliance|0|||
125944327|NCT01649375|453094806|FG000|Week 16 up to Week 260|Physician Decision|0|||
125944328|NCT01649375|453094807|FG001|Week 16 up to Week 260|Physician Decision|2|||
125944329|NCT01649375|453094808|FG002|Week 16 up to Week 260|Physician Decision|0|||
126068676|NCT03461211|453544280|FG001|Overall Study|Lack of Efficacy|1|||
126068677|NCT00730925|453544283|FG000|Overall Study|Progressive Disease|21|||
126068678|NCT00730925|453544283|FG000|Overall Study|Dose reducing Event|2|||
126068679|NCT00730925|453544283|FG000|Overall Study|Other Averse Event|7|||
126068680|NCT00730925|453544283|FG000|Overall Study|Protocol Violation|1|||
126068681|NCT00730925|453544283|FG000|Overall Study|Withdrawal by Subject|1|||
126068682|NCT00730925|453544283|FG000|Overall Study|Switch to combination therapy|8|||
126068683|NCT00730925|453544283|FG000|Overall Study|Other|1|||
126068684|NCT01732627|453544284|FG000|Overall Study|Withdrawal by Subject|1|||
126068685|NCT01732627|453544285|FG001|Overall Study|Withdrawal by Subject|0|||
126068686|NCT04736602|453544294|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
126068687|NCT04736602|453544294|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
126068688|NCT01887418|453544296|FG000|Overall Study|Travelling difficulties|0|||
126068689|NCT01887418|453544297|FG001|Overall Study|Travelling difficulties|0|||
126068690|NCT01887418|453544298|FG002|Overall Study|Travelling difficulties|1|||
126068691|NCT00475735|453544299|FG000|Treatment Period 1|Adverse Event|2|||
126068692|NCT00475735|453544300|FG001|Treatment Period 1|Adverse Event|0|||
126068693|NCT00475735|453544301|FG002|Treatment Period 1|Adverse Event|0|||
126068694|NCT00475735|453544302|FG003|Treatment Period 1|Adverse Event|0|||
126068695|NCT00475735|453544303|FG004|Treatment Period 1|Adverse Event|0|||
126068696|NCT00475735|453544304|FG005|Treatment Period 1|Adverse Event|0|||
126068697|NCT00475735|453544299|FG000|Treatment Period 1|Lack of Efficacy|1|||
126068698|NCT00475735|453544300|FG001|Treatment Period 1|Lack of Efficacy|0|||
126068699|NCT00475735|453544301|FG002|Treatment Period 1|Lack of Efficacy|0|||
126068700|NCT00475735|453544302|FG003|Treatment Period 1|Lack of Efficacy|0|||
126068701|NCT00475735|453544303|FG004|Treatment Period 1|Lack of Efficacy|0|||
126068702|NCT00475735|453544304|FG005|Treatment Period 1|Lack of Efficacy|0|||
126068703|NCT00475735|453544299|FG000|Treatment Period 1|Lost to Follow-up|0|||
126068704|NCT00475735|453544300|FG001|Treatment Period 1|Lost to Follow-up|0|||
126068705|NCT00475735|453544301|FG002|Treatment Period 1|Lost to Follow-up|0|||
126068706|NCT00475735|453544302|FG003|Treatment Period 1|Lost to Follow-up|0|||
126068707|NCT00475735|453544303|FG004|Treatment Period 1|Lost to Follow-up|0|||
126068708|NCT00475735|453544304|FG005|Treatment Period 1|Lost to Follow-up|1|||
126068709|NCT00475735|453544299|FG000|Treatment Period 1|Protocol Violation|0|||
126068710|NCT00475735|453544300|FG001|Treatment Period 1|Protocol Violation|0|||
126068711|NCT00475735|453544301|FG002|Treatment Period 1|Protocol Violation|0|||
126068712|NCT00475735|453544302|FG003|Treatment Period 1|Protocol Violation|1|||
126068713|NCT00475735|453544303|FG004|Treatment Period 1|Protocol Violation|0|||
126068714|NCT00475735|453544304|FG005|Treatment Period 1|Protocol Violation|0|||
126068715|NCT00475735|453544299|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126068716|NCT00475735|453544300|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126068717|NCT00475735|453544301|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126068718|NCT00475735|453544302|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126068719|NCT00475735|453544303|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126068720|NCT00475735|453544304|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126068721|NCT00475735|453544299|FG000|Treatment Period 1|DC due to AE but continuing|0|||
126068722|NCT00475735|453544300|FG001|Treatment Period 1|DC due to AE but continuing|0|||
126068723|NCT00475735|453544301|FG002|Treatment Period 1|DC due to AE but continuing|0|||
126068724|NCT00475735|453544302|FG003|Treatment Period 1|DC due to AE but continuing|1|||
126068725|NCT00475735|453544303|FG004|Treatment Period 1|DC due to AE but continuing|2|||
126068726|NCT00475735|453544304|FG005|Treatment Period 1|DC due to AE but continuing|2|||
126068727|NCT00475735|453544299|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126068728|NCT00475735|453544300|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
126068729|NCT00475735|453544301|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126068730|NCT00475735|453544302|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126068731|NCT00475735|453544303|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126068732|NCT00475735|453544304|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126068733|NCT00475735|453544299|FG000|Treatment Washout|Lost to Follow-up|0|||
126068734|NCT00475735|453544300|FG001|Treatment Washout|Lost to Follow-up|1|||
126068735|NCT00475735|453544301|FG002|Treatment Washout|Lost to Follow-up|0|||
126068736|NCT00475735|453544302|FG003|Treatment Washout|Lost to Follow-up|0|||
126068737|NCT00475735|453544303|FG004|Treatment Washout|Lost to Follow-up|0|||
126068738|NCT00475735|453544304|FG005|Treatment Washout|Lost to Follow-up|0|||
126068739|NCT00475735|453544299|FG000|Treatment Washout|Protocol Violation|0|||
126068740|NCT00475735|453544300|FG001|Treatment Washout|Protocol Violation|1|||
126068741|NCT00475735|453544301|FG002|Treatment Washout|Protocol Violation|0|||
126068742|NCT00475735|453544302|FG003|Treatment Washout|Protocol Violation|0|||
126068743|NCT00475735|453544303|FG004|Treatment Washout|Protocol Violation|0|||
126068744|NCT00475735|453544304|FG005|Treatment Washout|Protocol Violation|0|||
126068745|NCT00475735|453544299|FG000|Treatment Period 2|Adverse Event|0|||
126068746|NCT00475735|453544300|FG001|Treatment Period 2|Adverse Event|1|||
126068747|NCT00475735|453544301|FG002|Treatment Period 2|Adverse Event|0|||
126068748|NCT00475735|453544302|FG003|Treatment Period 2|Adverse Event|2|||
126068749|NCT00475735|453544303|FG004|Treatment Period 2|Adverse Event|0|||
126068750|NCT00475735|453544304|FG005|Treatment Period 2|Adverse Event|0|||
126068751|NCT00475735|453544299|FG000|Treatment Period 2|Lack of Efficacy|0|||
125944330|NCT01649375|453094809|FG003|Week 16 up to Week 260|Physician Decision|0|||
125944331|NCT01649375|453094810|FG004|Week 16 up to Week 260|Physician Decision|0|||
125944332|NCT01649375|453094806|FG000|Week 16 up to Week 260|Technical issues|0|||
125944333|NCT01649375|453094807|FG001|Week 16 up to Week 260|Technical issues|1|||
125944334|NCT01649375|453094808|FG002|Week 16 up to Week 260|Technical issues|0|||
125944335|NCT01649375|453094809|FG003|Week 16 up to Week 260|Technical issues|1|||
125944336|NCT01649375|453094810|FG004|Week 16 up to Week 260|Technical issues|0|||
125944337|NCT01649375|453094806|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
125944338|NCT01649375|453094807|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
125944339|NCT01649375|453094808|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
125944340|NCT01649375|453094809|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
125944341|NCT01649375|453094810|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
125944342|NCT01649375|453094806|FG000|Week 16 up to Week 260|Death|1|||
125944343|NCT01649375|453094807|FG001|Week 16 up to Week 260|Death|1|||
125944344|NCT01649375|453094808|FG002|Week 16 up to Week 260|Death|0|||
125944345|NCT01649375|453094809|FG003|Week 16 up to Week 260|Death|0|||
125944346|NCT01649375|453094810|FG004|Week 16 up to Week 260|Death|0|||
125944347|NCT01649375|453094806|FG000|Week 16 up to Week 260|Adverse Event|5|||
125944348|NCT01649375|453094807|FG001|Week 16 up to Week 260|Adverse Event|2|||
125944349|NCT01649375|453094808|FG002|Week 16 up to Week 260|Adverse Event|0|||
125944350|NCT01649375|453094809|FG003|Week 16 up to Week 260|Adverse Event|3|||
125944351|NCT01649375|453094810|FG004|Week 16 up to Week 260|Adverse Event|2|||
125944352|NCT01762943|453094813|FG000|Overall Study|Physician Decision|1|||
125944353|NCT01762943|453094814|FG001|Overall Study|Physician Decision|1|||
125944354|NCT01762943|453094813|FG000|Overall Study|Protocol Violation|1|||
125944355|NCT01762943|453094814|FG001|Overall Study|Protocol Violation|0|||
125944356|NCT01762943|453094813|FG000|Overall Study|Withdrawal by Subject|2|||
125944357|NCT01762943|453094814|FG001|Overall Study|Withdrawal by Subject|1|||
125944358|NCT00539838|453094815|FG000|Overall Study|Fail to return|2|||
125944359|NCT00539838|453094816|FG001|Overall Study|Fail to return|0|||
125944360|NCT00539838|453094817|FG002|Overall Study|Fail to return|0|||
125944361|NCT00539838|453094815|FG000|Overall Study|Withdrawal by Subject|0|||
125944362|NCT00539838|453094816|FG001|Overall Study|Withdrawal by Subject|4|||
125944363|NCT00539838|453094817|FG002|Overall Study|Withdrawal by Subject|0|||
125944364|NCT00539838|453094815|FG000|Overall Study|Death|0|||
125944365|NCT00539838|453094816|FG001|Overall Study|Death|2|||
125944366|NCT00539838|453094817|FG002|Overall Study|Death|0|||
125944367|NCT00539838|453094815|FG000|Overall Study|Did not cooperate|1|||
125944368|NCT00539838|453094816|FG001|Overall Study|Did not cooperate|0|||
125944369|NCT00539838|453094817|FG002|Overall Study|Did not cooperate|1|||
125944370|NCT00539838|453094815|FG000|Overall Study|Administrative|4|||
125944371|NCT00539838|453094816|FG001|Overall Study|Administrative|0|||
125944372|NCT00539838|453094817|FG002|Overall Study|Administrative|8|||
125944373|NCT03090100|453094818|FG000|Overall Study|Adverse Event|9|||
125944374|NCT03090100|453094819|FG001|Overall Study|Adverse Event|11|||
125944375|NCT03090100|453094818|FG000|Overall Study|Pregnancy|1|||
125944376|NCT03090100|453094819|FG001|Overall Study|Pregnancy|1|||
125944377|NCT03090100|453094818|FG000|Overall Study|Lack of Efficacy|2|||
125944378|NCT03090100|453094819|FG001|Overall Study|Lack of Efficacy|7|||
125944379|NCT03090100|453094818|FG000|Overall Study|Lost to Follow-up|2|||
125944380|NCT03090100|453094819|FG001|Overall Study|Lost to Follow-up|2|||
125944381|NCT03090100|453094818|FG000|Overall Study|Withdrawal by Subject|7|||
125944382|NCT03090100|453094819|FG001|Overall Study|Withdrawal by Subject|19|||
125944383|NCT03090100|453094818|FG000|Overall Study|Protocol Violation|2|||
125944384|NCT03090100|453094819|FG001|Overall Study|Protocol Violation|6|||
125944385|NCT03090100|453094818|FG000|Overall Study|Non-compliance|2|||
125944386|NCT03090100|453094819|FG001|Overall Study|Non-compliance|0|||
125944387|NCT03090100|453094818|FG000|Overall Study|Other|2|||
125944388|NCT03090100|453094819|FG001|Overall Study|Other|2|||
125944389|NCT01660711|453094820|FG000|Overall Study|Adverse Event|7|||
125944390|NCT01660711|453094820|FG000|Overall Study|Withdrawal by Subject|1|||
125944391|NCT00952341|453094821|FG000|Cycle 1|Adverse Event|4|||
125944392|NCT00952341|453094822|FG001|Cycle 1|Adverse Event|1|||
126114396|NCT01572675|453713831|FG000|Overall Study|End of prescribed treatment|140|||
126114397|NCT01572675|453713832|FG001|Overall Study|End of prescribed treatment|118|||
126114398|NCT01572675|453713831|FG000|Overall Study|Recovery|16|||
125944393|NCT00952341|453094821|FG000|Cycle 1|Withdrawal by Subject|3|||
125944394|NCT00952341|453094822|FG001|Cycle 1|Withdrawal by Subject|8|||
125944395|NCT00952341|453094821|FG000|Cycle 1|Protocol Violation|2|||
126114399|NCT01572675|453713832|FG001|Overall Study|Recovery|23|||
126114400|NCT01572675|453713831|FG000|Overall Study|Lack of Efficacy|31|||
126114401|NCT01572675|453713832|FG001|Overall Study|Lack of Efficacy|31|||
126114402|NCT01572675|453713831|FG000|Overall Study|Intolerance|6|||
126114403|NCT01572675|453713832|FG001|Overall Study|Intolerance|5|||
125944396|NCT00952341|453094822|FG001|Cycle 1|Protocol Violation|1|||
125944397|NCT00952341|453094821|FG000|Cycle 1|Lost to Follow-up|11|||
125944398|NCT00952341|453094822|FG001|Cycle 1|Lost to Follow-up|2|||
125944399|NCT00952341|453094821|FG000|Cycle 1|Physician Decision|0|||
125944400|NCT00952341|453094822|FG001|Cycle 1|Physician Decision|1|||
126114404|NCT01572675|453713831|FG000|Overall Study|Improved symptoms|8|||
126068752|NCT00475735|453544300|FG001|Treatment Period 2|Lack of Efficacy|0|||
126068753|NCT00475735|453544301|FG002|Treatment Period 2|Lack of Efficacy|0|||
126068754|NCT00475735|453544302|FG003|Treatment Period 2|Lack of Efficacy|0|||
126068755|NCT00475735|453544303|FG004|Treatment Period 2|Lack of Efficacy|0|||
126068756|NCT00475735|453544304|FG005|Treatment Period 2|Lack of Efficacy|1|||
126068757|NCT00475735|453544299|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126068758|NCT00475735|453544300|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126068759|NCT00475735|453544301|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126068760|NCT00475735|453544302|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126068761|NCT00475735|453544303|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126068762|NCT00475735|453544304|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126068763|NCT03132753|453544305|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
126068764|NCT03132753|453544306|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
126068765|NCT03132753|453544305|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
126068766|NCT03132753|453544306|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
126068767|NCT00125853|453544307|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
126068768|NCT00125853|453544308|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
126068769|NCT03575572|453544309|FG000|Overall Study|Withdrawal by Subject|2|||
126068770|NCT03575572|453544309|FG000|Overall Study|Physician Decision|2|||
126068771|NCT00157209|453544312|FG000|Overall Study|Ongoing at data cut-off|10|||
126068772|NCT00157209|453544313|FG001|Overall Study|Ongoing at data cut-off|0|||
126068773|NCT00577096|453544325|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
126068774|NCT00577096|453544326|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
126068775|NCT00577096|453544325|FG000|Short Term Participation|Withdrawal by Subject|3|||
126068776|NCT00577096|453544326|FG001|Short Term Participation|Withdrawal by Subject|5|||
126068777|NCT00577096|453544325|FG000|Short Term Participation|Death|1|||
126068778|NCT00577096|453544326|FG001|Short Term Participation|Death|1|||
126068779|NCT00794573|453544331|FG000|Overall Study|Death|3|||
126068780|NCT00794573|453544332|FG001|Overall Study|Death|0|||
126068781|NCT00794573|453544331|FG000|Overall Study|Withdrawal by Subject|9|||
126068782|NCT00794573|453544332|FG001|Overall Study|Withdrawal by Subject|12|||
126068783|NCT00794573|453544331|FG000|Overall Study|Lost to Follow-up|26|||
126068784|NCT00794573|453544332|FG001|Overall Study|Lost to Follow-up|33|||
126068785|NCT03928821|453544333|FG000|Overall Study|Death|0|||
126068786|NCT03928821|453544334|FG001|Overall Study|Death|1|||
126068787|NCT03928821|453544335|FG002|Overall Study|Death|0|||
126068788|NCT03928821|453544336|FG003|Overall Study|Death|0|||
126068789|NCT03928821|453544333|FG000|Overall Study|Lost to Follow-up|0|||
126068790|NCT03928821|453544334|FG001|Overall Study|Lost to Follow-up|2|||
126068791|NCT03928821|453544335|FG002|Overall Study|Lost to Follow-up|3|||
126068792|NCT03928821|453544336|FG003|Overall Study|Lost to Follow-up|0|||
126068793|NCT03928821|453544333|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
126068794|NCT03928821|453544334|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
126068795|NCT03928821|453544335|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
126068796|NCT03928821|453544336|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
126068797|NCT02784535|453544337|FG000|Overall Study|Adverse Event|1|||
126068798|NCT02784535|453544338|FG001|Overall Study|Adverse Event|0|||
126068799|NCT02784535|453544337|FG000|Overall Study|Withdrawal by Subject|0|||
126068800|NCT02784535|453544338|FG001|Overall Study|Withdrawal by Subject|1|||
126068801|NCT02784535|453544337|FG000|Overall Study|Physician Decision|0|||
126068802|NCT02784535|453544338|FG001|Overall Study|Physician Decision|1|||
126068803|NCT00985621|453544340|FG000|Overall Study|Adverse Event|2|||
126068804|NCT00985621|453544341|FG001|Overall Study|Adverse Event|3|||
126068805|NCT00985621|453544342|FG002|Overall Study|Adverse Event|4|||
126068806|NCT00985621|453544343|FG003|Overall Study|Adverse Event|16|||
126068807|NCT00985621|453544340|FG000|Overall Study|Lack of Efficacy|10|||
126068808|NCT00985621|453544341|FG001|Overall Study|Lack of Efficacy|6|||
126068809|NCT00985621|453544342|FG002|Overall Study|Lack of Efficacy|5|||
126068810|NCT00985621|453544343|FG003|Overall Study|Lack of Efficacy|12|||
126068811|NCT00985621|453544340|FG000|Overall Study|Lost to Follow-up|2|||
126068812|NCT00985621|453544341|FG001|Overall Study|Lost to Follow-up|3|||
126068813|NCT00985621|453544342|FG002|Overall Study|Lost to Follow-up|4|||
126068814|NCT00985621|453544343|FG003|Overall Study|Lost to Follow-up|4|||
126068815|NCT00985621|453544340|FG000|Overall Study|Study Terminated by Sponsor|89|||
126068816|NCT00985621|453544341|FG001|Overall Study|Study Terminated by Sponsor|108|||
126068817|NCT00985621|453544342|FG002|Overall Study|Study Terminated by Sponsor|99|||
126068818|NCT00985621|453544343|FG003|Overall Study|Study Terminated by Sponsor|92|||
126068819|NCT00985621|453544340|FG000|Overall Study|Protocol Violation|1|||
126068820|NCT00985621|453544341|FG001|Overall Study|Protocol Violation|1|||
126068821|NCT00985621|453544342|FG002|Overall Study|Protocol Violation|1|||
126068822|NCT00985621|453544343|FG003|Overall Study|Protocol Violation|0|||
126068823|NCT00985621|453544340|FG000|Overall Study|Withdrawal by Subject|8|||
126068824|NCT00985621|453544341|FG001|Overall Study|Withdrawal by Subject|10|||
126068825|NCT00985621|453544342|FG002|Overall Study|Withdrawal by Subject|8|||
126114405|NCT01572675|453713832|FG001|Overall Study|Improved symptoms|2|||
126068826|NCT00985621|453544343|FG003|Overall Study|Withdrawal by Subject|12|||
125944401|NCT00952341|453094821|FG000|Cycle 2|Withdrawal by Subject|1|||
125944402|NCT00952341|453094822|FG001|Cycle 2|Withdrawal by Subject|1|||
125944403|NCT00952341|453094821|FG000|Cycle 2|Protocol Violation|1|||
125944404|NCT00952341|453094822|FG001|Cycle 2|Protocol Violation|0|||
125944405|NCT00952341|453094821|FG000|Cycle 2|Lost to Follow-up|6|||
125944406|NCT00952341|453094822|FG001|Cycle 2|Lost to Follow-up|9|||
125944407|NCT00952341|453094821|FG000|Cycle 2|Physician Decision|1|||
125944408|NCT00952341|453094822|FG001|Cycle 2|Physician Decision|1|||
125944409|NCT00952341|453094821|FG000|Cycle 2|Progressive Disease|0|||
125944410|NCT00952341|453094822|FG001|Cycle 2|Progressive Disease|1|||
125944411|NCT03253848|453094825|FG000|Overall Study|Adverse Event|7|||
125944412|NCT03253848|453094825|FG000|Overall Study|Death|5|||
125944413|NCT03253848|453094825|FG000|Overall Study|initiation of other treatments|3|||
125944414|NCT03253848|453094825|FG000|Overall Study|Other complicating disease|1|||
125944415|NCT03253848|453094825|FG000|Overall Study|Withdrawal by Subject|1|||
125944416|NCT03253848|453094825|FG000|Overall Study|Declining health|1|||
125944417|NCT05352815|453094826|FG000|Overall Study|Withdrawal by Subject|28|||
125944418|NCT05352815|453094827|FG001|Overall Study|Withdrawal by Subject|24|||
125944419|NCT05352815|453094826|FG000|Overall Study|Lost to Follow-up|4|||
125944420|NCT05352815|453094827|FG001|Overall Study|Lost to Follow-up|7|||
125944421|NCT05352815|453094826|FG000|Overall Study|Death|2|||
125944422|NCT05352815|453094827|FG001|Overall Study|Death|3|||
125944423|NCT05352815|453094826|FG000|Overall Study|Site closure|1|||
125944424|NCT05352815|453094827|FG001|Overall Study|Site closure|0|||
125944425|NCT02759120|453094828|FG000|Overall Study|Death|34|||
125944426|NCT02759120|453094829|FG001|Overall Study|Death|36|||
125944427|NCT02759120|453094828|FG000|Overall Study|Lost to Follow-up|4|||
125944428|NCT02759120|453094829|FG001|Overall Study|Lost to Follow-up|7|||
125944429|NCT02759120|453094828|FG000|Overall Study|Physician Decision|3|||
125944430|NCT02759120|453094829|FG001|Overall Study|Physician Decision|0|||
125944431|NCT02759120|453094828|FG000|Overall Study|Withdrawal by Subject|28|||
125944432|NCT02759120|453094829|FG001|Overall Study|Withdrawal by Subject|15|||
125944433|NCT02759120|453094828|FG000|Overall Study|Moved out of area|3|||
125944434|NCT02759120|453094829|FG001|Overall Study|Moved out of area|4|||
125944435|NCT02759120|453094828|FG000|Overall Study|Lung transplant|3|||
125944436|NCT02759120|453094829|FG001|Overall Study|Lung transplant|5|||
125944437|NCT02759120|453094828|FG000|Overall Study|Other reason not completed|10|||
125944438|NCT02759120|453094829|FG001|Overall Study|Other reason not completed|12|||
125944439|NCT05071183|453094834|FG000|Overall Study|Death|1|||
125944440|NCT05071183|453094835|FG001|Overall Study|Death|2|||
125944441|NCT05071183|453094836|FG002|Overall Study|Death|0|||
125944442|NCT05071183|453094834|FG000|Overall Study|Other Reasons|1|||
125944443|NCT05071183|453094835|FG001|Overall Study|Other Reasons|3|||
125944444|NCT05071183|453094836|FG002|Overall Study|Other Reasons|2|||
125944445|NCT00704535|453094846|FG000|Overall Study|Adverse Event|2|||
125944446|NCT00704535|453094846|FG000|Overall Study|Death|2|||
125944447|NCT00704535|453094846|FG000|Overall Study|Lost to Follow-up|8|||
125944448|NCT00704535|453094846|FG000|Overall Study|Protocol Violation|10|||
125944449|NCT00704535|453094846|FG000|Overall Study|Completed status not on Case Report Form|124|||
125944450|NCT01480076|453094847|FG000|Overall Study|Run-in Failure|52|||
125944451|NCT01480076|453094847|FG000|Overall Study|Adverse Event|39|||
125944452|NCT01480076|453094847|FG000|Overall Study|Death|2|||
125944453|NCT01480076|453094847|FG000|Overall Study|Disease Progression|5|||
125944454|NCT01480076|453094847|FG000|Overall Study|Non-compliance With Study Protocol|15|||
125944455|NCT01480076|453094847|FG000|Overall Study|Withdrawal by Subject|105|||
125944456|NCT01480076|453094847|FG000|Overall Study|Lost to Follow-up|7|||
125944457|NCT01480076|453094847|FG000|Overall Study|Investigator Decision|13|||
125944458|NCT01480076|453094847|FG000|Overall Study|Other|52|||
125944459|NCT02503332|453094848|FG000|Overall Study|Adverse Event|17|||
125944460|NCT02503332|453094849|FG001|Overall Study|Adverse Event|5|||
125944461|NCT02503332|453094850|FG002|Overall Study|Adverse Event|3|||
125944462|NCT02503332|453094851|FG003|Overall Study|Adverse Event|1|||
125944463|NCT02503332|453094848|FG000|Overall Study|Investigator's Decision|5|||
125944464|NCT02503332|453094849|FG001|Overall Study|Investigator's Decision|1|||
125944465|NCT02503332|453094850|FG002|Overall Study|Investigator's Decision|0|||
125944466|NCT02503332|453094851|FG003|Overall Study|Investigator's Decision|0|||
125944467|NCT02503332|453094848|FG000|Overall Study|Sponsor's Decision|1|||
125944468|NCT02503332|453094849|FG001|Overall Study|Sponsor's Decision|0|||
125944469|NCT02503332|453094850|FG002|Overall Study|Sponsor's Decision|0|||
125944470|NCT02503332|453094851|FG003|Overall Study|Sponsor's Decision|1|||
125944471|NCT02503332|453094848|FG000|Overall Study|Subject Request|6|||
125944472|NCT02503332|453094849|FG001|Overall Study|Subject Request|5|||
126068827|NCT00985621|453544340|FG000|Overall Study|Other|1|||
126068828|NCT00985621|453544341|FG001|Overall Study|Other|0|||
126068829|NCT00985621|453544342|FG002|Overall Study|Other|0|||
125944473|NCT02503332|453094850|FG002|Overall Study|Subject Request|2|||
125944474|NCT02503332|453094851|FG003|Overall Study|Subject Request|1|||
125944475|NCT02503332|453094848|FG000|Overall Study|Death|0|||
125944476|NCT02503332|453094849|FG001|Overall Study|Death|2|||
125944477|NCT02503332|453094850|FG002|Overall Study|Death|2|||
125944478|NCT02503332|453094851|FG003|Overall Study|Death|0|||
125944479|NCT02503332|453094848|FG000|Overall Study|Other|5|||
125944480|NCT02503332|453094849|FG001|Overall Study|Other|6|||
125944481|NCT02503332|453094850|FG002|Overall Study|Other|1|||
125944482|NCT02503332|453094851|FG003|Overall Study|Other|1|||
125944483|NCT01413360|453094852|FG000|Overall Study|Lost to Follow-up|2|||
125944484|NCT01413360|453094852|FG000|Overall Study|Adverse Event|1|||
125944485|NCT00325754|453094856|FG000|Overall Study|Adverse Event|4|||
125944486|NCT00325754|453094857|FG001|Overall Study|Adverse Event|1|||
125944487|NCT02625090|453094869|FG000|Overall Study|Participant wants to be pregnant|2|||
125944488|NCT02625090|453094869|FG000|Overall Study|For the Promoter|1|||
125944489|NCT02625090|453094869|FG000|Overall Study|Sponsor's Decision|9|||
125944490|NCT02625090|453094869|FG000|Overall Study|Somnolence|1|||
125944491|NCT02625090|453094869|FG000|Overall Study|Study terminated by Sponsor|7|||
125944492|NCT02625090|453094869|FG000|Overall Study|Negative Benefit/Risk|1|||
125944493|NCT02625090|453094869|FG000|Overall Study|Protocol Deviation|2|||
125944494|NCT02625090|453094869|FG000|Overall Study|Lack of Efficacy|16|||
125944495|NCT02625090|453094869|FG000|Overall Study|Adverse Event|3|||
125944496|NCT02439320|453094874|FG000|Overall Study|Adverse Event|0|||
125944497|NCT02439320|453094875|FG001|Overall Study|Adverse Event|2|||
125944498|NCT02439320|453094876|FG002|Overall Study|Adverse Event|0|||
125944499|NCT02439320|453094874|FG000|Overall Study|Lost to Follow-up|37|||
125944500|NCT02439320|453094875|FG001|Overall Study|Lost to Follow-up|34|||
125944501|NCT02439320|453094876|FG002|Overall Study|Lost to Follow-up|42|||
125944502|NCT02439320|453094874|FG000|Overall Study|Death|0|||
125944503|NCT02439320|453094875|FG001|Overall Study|Death|1|||
125944504|NCT02439320|453094876|FG002|Overall Study|Death|0|||
125944505|NCT02439320|453094874|FG000|Overall Study|Noncompliance with Protocol|10|||
125944506|NCT02439320|453094875|FG001|Overall Study|Noncompliance with Protocol|11|||
125944507|NCT02439320|453094876|FG002|Overall Study|Noncompliance with Protocol|7|||
125944508|NCT02439320|453094874|FG000|Overall Study|Pregnancy|0|||
125944509|NCT02439320|453094875|FG001|Overall Study|Pregnancy|1|||
125944510|NCT02439320|453094876|FG002|Overall Study|Pregnancy|1|||
125944511|NCT02439320|453094874|FG000|Overall Study|Withdrawal by Subject|12|||
125944512|NCT02439320|453094875|FG001|Overall Study|Withdrawal by Subject|16|||
125944513|NCT02439320|453094876|FG002|Overall Study|Withdrawal by Subject|14|||
125944514|NCT02439320|453094874|FG000|Overall Study|Physician Decision|2|||
125944515|NCT02439320|453094875|FG001|Overall Study|Physician Decision|1|||
125944516|NCT02439320|453094876|FG002|Overall Study|Physician Decision|0|||
125944517|NCT02439320|453094874|FG000|Overall Study|Sponsor Request|0|||
125944518|NCT02439320|453094875|FG001|Overall Study|Sponsor Request|2|||
125944519|NCT02439320|453094876|FG002|Overall Study|Sponsor Request|1|||
125944520|NCT02439320|453094874|FG000|Overall Study|Randomization Failure|35|||
125944521|NCT02439320|453094875|FG001|Overall Study|Randomization Failure|46|||
125944522|NCT02439320|453094876|FG002|Overall Study|Randomization Failure|34|||
125944523|NCT01488097|453094880|FG000|Overall Study|Lost to Follow-up|1|||
125944524|NCT00973479|453094893|FG000|Overall Study|Lost to Follow-up|0|||
125944525|NCT00973479|453094894|FG001|Overall Study|Lost to Follow-up|3|||
125944526|NCT00973479|453094893|FG000|Overall Study|Death|2|||
125944527|NCT00973479|453094894|FG001|Overall Study|Death|2|||
125944528|NCT00973479|453094893|FG000|Overall Study|Withdrawal by Subject|15|||
125944529|NCT00973479|453094894|FG001|Overall Study|Withdrawal by Subject|16|||
125944530|NCT00973479|453094893|FG000|Overall Study|Lack of Efficacy|5|||
125944531|NCT00973479|453094894|FG001|Overall Study|Lack of Efficacy|7|||
125944532|NCT00973479|453094893|FG000|Overall Study|Adverse Event|12|||
125944533|NCT00973479|453094894|FG001|Overall Study|Adverse Event|32|||
125944534|NCT00973479|453094893|FG000|Overall Study|Protocol Violation|2|||
125944535|NCT00973479|453094894|FG001|Overall Study|Protocol Violation|2|||
125944536|NCT00973479|453094893|FG000|Overall Study|Other|1|||
125944537|NCT00973479|453094894|FG001|Overall Study|Other|7|||
125944538|NCT02882854|453094897|FG000|Overall Study|Lost to Follow-up|1|||
125944539|NCT02882854|453094898|FG001|Overall Study|Lost to Follow-up|2|||
125944540|NCT02882854|453094897|FG000|Overall Study|Physician Decision|0|||
125944541|NCT02882854|453094898|FG001|Overall Study|Physician Decision|1|||
125944542|NCT02039674|453094902|FG000|Overall Study|Adverse Event|0|||
125944543|NCT02039674|453094903|FG001|Overall Study|Adverse Event|0|||
125944544|NCT02039674|453094904|FG002|Overall Study|Adverse Event|0|||
125944545|NCT02039674|453094905|FG003|Overall Study|Adverse Event|1|||
125944546|NCT02039674|453094906|FG004|Overall Study|Adverse Event|0|||
125944547|NCT02039674|453094907|FG005|Overall Study|Adverse Event|0|||
125944548|NCT02039674|453094908|FG006|Overall Study|Adverse Event|0|||
125944549|NCT02039674|453094909|FG007|Overall Study|Adverse Event|0|||
125944550|NCT02039674|453094910|FG008|Overall Study|Adverse Event|2|||
125944551|NCT02039674|453094911|FG009|Overall Study|Adverse Event|1|||
125944552|NCT02039674|453094912|FG010|Overall Study|Adverse Event|0|||
125944553|NCT02039674|453094913|FG011|Overall Study|Adverse Event|2|||
125944554|NCT02039674|453094914|FG012|Overall Study|Adverse Event|3|||
125944555|NCT02039674|453094915|FG013|Overall Study|Adverse Event|1|||
125944556|NCT02039674|453094902|FG000|Overall Study|Death|2|||
125944557|NCT02039674|453094903|FG001|Overall Study|Death|0|||
125944558|NCT02039674|453094904|FG002|Overall Study|Death|2|||
125944559|NCT02039674|453094905|FG003|Overall Study|Death|3|||
125944560|NCT02039674|453094906|FG004|Overall Study|Death|0|||
126068830|NCT00985621|453544343|FG003|Overall Study|Other|0|||
126068831|NCT00985621|453544340|FG000|Overall Study|Randomized but not Treated|1|||
126068832|NCT00985621|453544341|FG001|Overall Study|Randomized but not Treated|0|||
126068833|NCT00985621|453544342|FG002|Overall Study|Randomized but not Treated|2|||
126068834|NCT00985621|453544343|FG003|Overall Study|Randomized but not Treated|1|||
126068835|NCT01911819|453544344|FG000|Overall Study|Adverse Event|0|||
126068836|NCT01911819|453544345|FG001|Overall Study|Adverse Event|1|||
126068837|NCT01911819|453544346|FG002|Overall Study|Adverse Event|0|||
126068838|NCT01911819|453544344|FG000|Overall Study|Withdrawal by Subject|1|||
126068839|NCT01911819|453544345|FG001|Overall Study|Withdrawal by Subject|1|||
126068840|NCT01911819|453544346|FG002|Overall Study|Withdrawal by Subject|0|||
126068841|NCT00905255|453544350|FG000|Overall Study|Adverse Event|7|||
126068842|NCT00905255|453544351|FG001|Overall Study|Adverse Event|5|||
126068843|NCT00905255|453544350|FG000|Overall Study|Withdrawal by Subject|5|||
126068844|NCT00905255|453544351|FG001|Overall Study|Withdrawal by Subject|4|||
126068845|NCT00905255|453544350|FG000|Overall Study|Familial and Personal Reasons|1|||
126068846|NCT00905255|453544351|FG001|Overall Study|Familial and Personal Reasons|0|||
126068847|NCT03849300|453544352|FG000|Overall Study|move out to different area|1|||
126068848|NCT03849300|453544353|FG001|Overall Study|move out to different area|3|||
126068849|NCT03849300|453544354|FG002|Overall Study|move out to different area|1|||
126068850|NCT03849300|453544355|FG003|Overall Study|move out to different area|4|||
126068851|NCT03849300|453544352|FG000|Overall Study|scheduling/transportation conflict|4|||
126068852|NCT03849300|453544353|FG001|Overall Study|scheduling/transportation conflict|4|||
126068853|NCT03849300|453544354|FG002|Overall Study|scheduling/transportation conflict|3|||
126068854|NCT03849300|453544355|FG003|Overall Study|scheduling/transportation conflict|2|||
126068855|NCT00464737|453544358|FG000|Overall Study|Adverse Event|12|||
126068856|NCT00464737|453544359|FG001|Overall Study|Adverse Event|17|||
126068857|NCT00464737|453544360|FG002|Overall Study|Adverse Event|33|||
126068858|NCT00464737|453544358|FG000|Overall Study|Lack of Efficacy|7|||
126068859|NCT00464737|453544359|FG001|Overall Study|Lack of Efficacy|7|||
126068860|NCT00464737|453544360|FG002|Overall Study|Lack of Efficacy|4|||
126068861|NCT00464737|453544358|FG000|Overall Study|Withdrawal by Subject|5|||
126068862|NCT00464737|453544359|FG001|Overall Study|Withdrawal by Subject|3|||
126068863|NCT00464737|453544360|FG002|Overall Study|Withdrawal by Subject|5|||
126068864|NCT00464737|453544358|FG000|Overall Study|Protocol Violation|1|||
126068865|NCT00464737|453544359|FG001|Overall Study|Protocol Violation|1|||
126068866|NCT00464737|453544360|FG002|Overall Study|Protocol Violation|5|||
126068867|NCT00464737|453544358|FG000|Overall Study|Non-compliance|0|||
126068868|NCT00464737|453544359|FG001|Overall Study|Non-compliance|1|||
126068869|NCT00464737|453544360|FG002|Overall Study|Non-compliance|1|||
126068870|NCT00464737|453544358|FG000|Overall Study|Lost to Follow-up|5|||
126068871|NCT00464737|453544359|FG001|Overall Study|Lost to Follow-up|2|||
126068872|NCT00464737|453544360|FG002|Overall Study|Lost to Follow-up|5|||
126068873|NCT00464737|453544358|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
126068874|NCT00464737|453544359|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
126068875|NCT00464737|453544360|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
126068876|NCT00464737|453544358|FG000|Overall Study|Other: Subject left town; family illness|1|||
126068877|NCT00464737|453544359|FG001|Overall Study|Other: Subject left town; family illness|0|||
126068878|NCT00464737|453544360|FG002|Overall Study|Other: Subject left town; family illness|0|||
126068879|NCT00464737|453544358|FG000|Overall Study|Other: Study demands too great|0|||
126068880|NCT00464737|453544359|FG001|Overall Study|Other: Study demands too great|1|||
126068881|NCT00464737|453544360|FG002|Overall Study|Other: Study demands too great|0|||
126068882|NCT00464737|453544358|FG000|Overall Study|Other: Personal family reasons|0|||
126068883|NCT00464737|453544359|FG001|Overall Study|Other: Personal family reasons|0|||
126068884|NCT00464737|453544360|FG002|Overall Study|Other: Personal family reasons|1|||
126068885|NCT00464737|453544358|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
126068886|NCT00464737|453544359|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
126068887|NCT00464737|453544360|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
126068888|NCT00676663|453544363|FG000|Overall Study|Death|43|||
126068889|NCT00676663|453544364|FG001|Overall Study|Death|27|||
126068890|NCT00676663|453544363|FG000|Overall Study|Withdrew Consent|1|||
126068891|NCT00676663|453544364|FG001|Overall Study|Withdrew Consent|8|||
126068892|NCT00676663|453544363|FG000|Overall Study|Lost to Follow-up|1|||
126068893|NCT00676663|453544364|FG001|Overall Study|Lost to Follow-up|3|||
126068894|NCT00580047|453544365|FG000|Overall Study|Lost to Follow-up|1|||
126068895|NCT00580047|453544366|FG001|Overall Study|Lost to Follow-up|1|||
126068896|NCT00580047|453544367|FG002|Overall Study|Lost to Follow-up|0|||
126068897|NCT00580047|453544365|FG000|Overall Study|Withdrawal by Subject|1|||
126068898|NCT00580047|453544366|FG001|Overall Study|Withdrawal by Subject|1|||
126068899|NCT00580047|453544367|FG002|Overall Study|Withdrawal by Subject|2|||
126068900|NCT00580047|453544365|FG000|Overall Study|Withdrawal by Subject|1|||
126068901|NCT00580047|453544366|FG001|Overall Study|Withdrawal by Subject|0|||
126068902|NCT00580047|453544367|FG002|Overall Study|Withdrawal by Subject|0|||
126068903|NCT04382053|453544373|FG000|Overall Study|Death|6|||
126068904|NCT04382053|453544374|FG001|Overall Study|Death|8|||
126068905|NCT04382053|453544373|FG000|Overall Study|Lost to Follow-up|0|||
126068906|NCT04382053|453544374|FG001|Overall Study|Lost to Follow-up|2|||
126068907|NCT04382053|453544373|FG000|Overall Study|Protocol Deviation|1|||
126068908|NCT04382053|453544374|FG001|Overall Study|Protocol Deviation|2|||
126068909|NCT04382053|453544373|FG000|Overall Study|Withdrawal by Subject|2|||
126068910|NCT04382053|453544374|FG001|Overall Study|Withdrawal by Subject|1|||
126068911|NCT00417989|453544380|FG000|Overall Study|Withdrawal by Subject|13|||
126068912|NCT00417989|453544381|FG001|Overall Study|Withdrawal by Subject|13|||
126068913|NCT00417989|453544380|FG000|Overall Study|Lost to Follow-up|1|||
126068914|NCT00417989|453544381|FG001|Overall Study|Lost to Follow-up|6|||
126068915|NCT00417989|453544380|FG000|Overall Study|Protocol Violation|1|||
126068916|NCT00417989|453544381|FG001|Overall Study|Protocol Violation|0|||
126068917|NCT00417989|453544380|FG000|Overall Study|Death|0|||
126068918|NCT00417989|453544381|FG001|Overall Study|Death|1|||
126068919|NCT00417989|453544380|FG000|Overall Study|Physician Decision|5|||
126068920|NCT00417989|453544381|FG001|Overall Study|Physician Decision|2|||
126068921|NCT01902381|453545792|FG000|Overall Study|Withdrawal by Subject|1|||
126068922|NCT00755716|453545793|FG000|Overall Study|Adverse Event|1|||
126068923|NCT00755716|453545794|FG001|Overall Study|Adverse Event|4|||
126068924|NCT00755716|453545795|FG002|Overall Study|Adverse Event|1|||
126068925|NCT00755716|453545793|FG000|Overall Study|Lack of Efficacy|2|||
126068926|NCT00755716|453545794|FG001|Overall Study|Lack of Efficacy|0|||
126068927|NCT00755716|453545795|FG002|Overall Study|Lack of Efficacy|0|||
126068928|NCT00755716|453545793|FG000|Overall Study|Lost to Follow-up|5|||
126068929|NCT00755716|453545794|FG001|Overall Study|Lost to Follow-up|3|||
126068930|NCT00755716|453545795|FG002|Overall Study|Lost to Follow-up|1|||
126068931|NCT00755716|453545793|FG000|Overall Study|work schedule issues|0|||
126068932|NCT00755716|453545794|FG001|Overall Study|work schedule issues|1|||
126068933|NCT00755716|453545795|FG002|Overall Study|work schedule issues|1|||
126068934|NCT01284634|453545805|FG000|Overall Study|Adverse Event|1|||
126068935|NCT01284634|453545806|FG001|Overall Study|Adverse Event|0|||
126068936|NCT01284634|453545807|FG002|Overall Study|Adverse Event|2|||
126068937|NCT01284634|453545808|FG003|Overall Study|Adverse Event|1|||
126068938|NCT01059526|453545809|FG000|Overall Study|Patient enrolled but not treated|20|||
126068939|NCT01059526|453545810|FG001|Overall Study|Patient enrolled but not treated|17|||
126068940|NCT01059526|453545809|FG000|Overall Study|Adverse Event|2|||
126068941|NCT01059526|453545810|FG001|Overall Study|Adverse Event|2|||
126068942|NCT01059526|453545809|FG000|Overall Study|Protocol Violation|0|||
126068943|NCT01059526|453545810|FG001|Overall Study|Protocol Violation|1|||
126068944|NCT01059526|453545809|FG000|Overall Study|Withdrawal by Subject|3|||
126068945|NCT01059526|453545810|FG001|Overall Study|Withdrawal by Subject|1|||
126068946|NCT01059526|453545809|FG000|Overall Study|Lost to Follow-up|4|||
126068947|NCT01059526|453545810|FG001|Overall Study|Lost to Follow-up|1|||
126068948|NCT01059526|453545809|FG000|Overall Study|Patient found to be dermatographic|1|||
126068949|NCT01059526|453545810|FG001|Overall Study|Patient found to be dermatographic|0|||
126068950|NCT01732588|453545811|FG000|First Intervention (7 Days)|Adverse Event|0|||
126068951|NCT01732588|453545812|FG001|First Intervention (7 Days)|Adverse Event|1|||
126068952|NCT01732588|453545813|FG002|First Intervention (7 Days)|Adverse Event|0|||
126068953|NCT02720081|453545814|FG000|Overall Study|Adverse Event|0|||
126068954|NCT02720081|453545815|FG001|Overall Study|Adverse Event|3|||
126068955|NCT02720081|453545814|FG000|Overall Study|Protocol Violation|4|||
126068956|NCT02720081|453545815|FG001|Overall Study|Protocol Violation|1|||
126068957|NCT05012397|453545819|FG000|Overall Study|Death|10|||
126068958|NCT05012397|453545819|FG000|Overall Study|Physician Decision|9|||
126068959|NCT05012397|453545819|FG000|Overall Study|Withdrawal by Subject|5|||
126068960|NCT05012397|453545819|FG000|Overall Study|Lost to Follow-up|2|||
126068961|NCT03334747|453545820|FG000|Treatment Phase|Technical problems|0|||
126068962|NCT03334747|453545821|FG001|Treatment Phase|Technical problems|0|||
126068963|NCT03334747|453545822|FG002|Treatment Phase|Technical problems|0|||
126068964|NCT03334747|453545823|FG003|Treatment Phase|Technical problems|0|||
126068965|NCT03334747|453545824|FG004|Treatment Phase|Technical problems|1|||
126068966|NCT03334747|453545825|FG005|Treatment Phase|Technical problems|0|||
126068967|NCT03334747|453545826|FG006|Treatment Phase|Technical problems|0|||
126068968|NCT03334747|453545827|FG007|Treatment Phase|Technical problems|0|||
126068969|NCT03334747|453545828|FG008|Treatment Phase|Technical problems|0|||
126068970|NCT03334747|453545820|FG000|Treatment Phase|Subject/guardian decision|1|||
126068971|NCT03334747|453545821|FG001|Treatment Phase|Subject/guardian decision|0|||
126068972|NCT03334747|453545822|FG002|Treatment Phase|Subject/guardian decision|0|||
126068973|NCT03334747|453545823|FG003|Treatment Phase|Subject/guardian decision|0|||
126068974|NCT03334747|453545824|FG004|Treatment Phase|Subject/guardian decision|0|||
126068975|NCT03334747|453545825|FG005|Treatment Phase|Subject/guardian decision|1|||
126068976|NCT03334747|453545826|FG006|Treatment Phase|Subject/guardian decision|0|||
126068977|NCT03334747|453545827|FG007|Treatment Phase|Subject/guardian decision|0|||
126068978|NCT03334747|453545828|FG008|Treatment Phase|Subject/guardian decision|0|||
126068979|NCT03334747|453545820|FG000|Follow-Up Phase|Subject/guardian decision|0|||
126068980|NCT03334747|453545821|FG001|Follow-Up Phase|Subject/guardian decision|0|||
126068981|NCT03334747|453545822|FG002|Follow-Up Phase|Subject/guardian decision|0|||
126068982|NCT03334747|453545823|FG003|Follow-Up Phase|Subject/guardian decision|0|||
126068983|NCT03334747|453545824|FG004|Follow-Up Phase|Subject/guardian decision|0|||
126068984|NCT03334747|453545825|FG005|Follow-Up Phase|Subject/guardian decision|0|||
126068985|NCT03334747|453545826|FG006|Follow-Up Phase|Subject/guardian decision|1|||
126068986|NCT03334747|453545827|FG007|Follow-Up Phase|Subject/guardian decision|0|||
126068987|NCT03334747|453545828|FG008|Follow-Up Phase|Subject/guardian decision|1|||
126068988|NCT02567227|453545829|FG000|9 Weeks|Adverse Event|5|||
126068989|NCT02567227|453545830|FG001|9 Weeks|Adverse Event|5|||
126068990|NCT02567227|453545829|FG000|9 Weeks|Withdrawal by Subject|18|||
126068991|NCT02567227|453545830|FG001|9 Weeks|Withdrawal by Subject|8|||
126068992|NCT02567227|453545829|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
126068993|NCT02567227|453545830|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
126068994|NCT02567227|453545829|FG000|6 Month|Death|2|||
126068995|NCT02567227|453545830|FG001|6 Month|Death|0|||
126068996|NCT02567227|453545829|FG000|6 Month|Lost to Follow-up|43|||
126068997|NCT02567227|453545830|FG001|6 Month|Lost to Follow-up|40|||
126068998|NCT02567227|453545829|FG000|12 Months|Lost to Follow-up|31|||
126068999|NCT02567227|453545830|FG001|12 Months|Lost to Follow-up|32|||
126114406|NCT01572675|453713831|FG000|Overall Study|Surgical intervention|3|||
126114407|NCT01572675|453713832|FG001|Overall Study|Surgical intervention|6|||
126114408|NCT01572675|453713831|FG000|Overall Study|Withdrawal by Subject|5|||
126114409|NCT01572675|453713832|FG001|Overall Study|Withdrawal by Subject|1|||
126114410|NCT01572675|453713831|FG000|Overall Study|Physician Decision|2|||
126114411|NCT01572675|453713832|FG001|Overall Study|Physician Decision|2|||
126114412|NCT01572675|453713831|FG000|Overall Study|Death unrelated to coxibs|1|||
126114413|NCT01572675|453713832|FG001|Overall Study|Death unrelated to coxibs|1|||
126114414|NCT01572675|453713831|FG000|Overall Study|Other disease detected|1|||
126114415|NCT01572675|453713832|FG001|Overall Study|Other disease detected|1|||
126114416|NCT01572675|453713831|FG000|Overall Study|Unknown reason|1|||
126114417|NCT01572675|453713832|FG001|Overall Study|Unknown reason|1|||
126114418|NCT01572675|453713831|FG000|Overall Study|Rheumatologist new evaluation|0|||
126114419|NCT01572675|453713832|FG001|Overall Study|Rheumatologist new evaluation|1|||
126114420|NCT01572675|453713831|FG000|Overall Study|Missing data|1|||
126114421|NCT01572675|453713832|FG001|Overall Study|Missing data|4|||
126114422|NCT01572675|453713831|FG000|Overall Study|Lost to Follow-up|22|||
126114423|NCT01572675|453713832|FG001|Overall Study|Lost to Follow-up|27|||
126114424|NCT03346057|453713834|FG000|Overall Study|Death|1|||
126114425|NCT03346057|453713835|FG001|Overall Study|Death|2|||
126114426|NCT03346057|453713836|FG002|Overall Study|Death|0|||
126114427|NCT03346057|453713837|FG003|Overall Study|Death|0|||
126114428|NCT03346057|453713834|FG000|Overall Study|Lost to Follow-up|0|||
126114429|NCT03346057|453713835|FG001|Overall Study|Lost to Follow-up|2|||
125944561|NCT02039674|453094907|FG005|Overall Study|Death|0|||
125944562|NCT02039674|453094908|FG006|Overall Study|Death|1|||
125944563|NCT02039674|453094909|FG007|Overall Study|Death|0|||
125944564|NCT02039674|453094910|FG008|Overall Study|Death|2|||
125944565|NCT02039674|453094911|FG009|Overall Study|Death|0|||
125944566|NCT02039674|453094912|FG010|Overall Study|Death|1|||
125944567|NCT02039674|453094913|FG011|Overall Study|Death|3|||
125944568|NCT02039674|453094914|FG012|Overall Study|Death|2|||
125944569|NCT02039674|453094915|FG013|Overall Study|Death|8|||
125944570|NCT02039674|453094902|FG000|Overall Study|Excluded Medication|1|||
125944571|NCT02039674|453094903|FG001|Overall Study|Excluded Medication|1|||
125944572|NCT02039674|453094904|FG002|Overall Study|Excluded Medication|0|||
126114430|NCT03346057|453713836|FG002|Overall Study|Lost to Follow-up|1|||
126114431|NCT03346057|453713837|FG003|Overall Study|Lost to Follow-up|0|||
126114432|NCT03346057|453713834|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
126114433|NCT03346057|453713835|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
126114434|NCT03346057|453713836|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
126114435|NCT03346057|453713837|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
126114436|NCT03346057|453713834|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
126114437|NCT03346057|453713835|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
126114438|NCT03346057|453713836|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
126114439|NCT03346057|453713837|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
126114440|NCT03346057|453713834|FG000|Overall Study|Physician Decision|3|||
126114441|NCT03346057|453713835|FG001|Overall Study|Physician Decision|2|||
126114442|NCT03346057|453713836|FG002|Overall Study|Physician Decision|0|||
126114443|NCT03346057|453713837|FG003|Overall Study|Physician Decision|2|||
126114444|NCT03346057|453713834|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
126114445|NCT03346057|453713835|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
126114446|NCT03346057|453713836|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
126114447|NCT03346057|453713837|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
126114448|NCT03346057|453713834|FG000|Overall Study|Withdrawal by Subject|1|||
126114449|NCT03346057|453713835|FG001|Overall Study|Withdrawal by Subject|0|||
125944573|NCT02039674|453094905|FG003|Overall Study|Excluded Medication|1|||
125944574|NCT02039674|453094906|FG004|Overall Study|Excluded Medication|0|||
125944575|NCT02039674|453094907|FG005|Overall Study|Excluded Medication|1|||
125944576|NCT02039674|453094908|FG006|Overall Study|Excluded Medication|0|||
126069000|NCT02567227|453545829|FG000|12 Months|Death|0|||
126069001|NCT02567227|453545830|FG001|12 Months|Death|2|||
126069002|NCT04748445|453545831|FG000|Overall Study|No longer met eligibility criteria|12|||
125944577|NCT02039674|453094909|FG007|Overall Study|Excluded Medication|0|||
125944578|NCT02039674|453094910|FG008|Overall Study|Excluded Medication|2|||
125944579|NCT02039674|453094911|FG009|Overall Study|Excluded Medication|3|||
125944580|NCT02039674|453094912|FG010|Overall Study|Excluded Medication|5|||
125944581|NCT02039674|453094913|FG011|Overall Study|Excluded Medication|6|||
125944582|NCT02039674|453094914|FG012|Overall Study|Excluded Medication|8|||
125944583|NCT02039674|453094915|FG013|Overall Study|Excluded Medication|3|||
125944584|NCT02039674|453094902|FG000|Overall Study|Lost to Follow-up|0|||
125944585|NCT02039674|453094903|FG001|Overall Study|Lost to Follow-up|0|||
125944586|NCT02039674|453094904|FG002|Overall Study|Lost to Follow-up|0|||
125944587|NCT02039674|453094905|FG003|Overall Study|Lost to Follow-up|0|||
125944588|NCT02039674|453094906|FG004|Overall Study|Lost to Follow-up|1|||
125944589|NCT02039674|453094907|FG005|Overall Study|Lost to Follow-up|1|||
125944590|NCT02039674|453094908|FG006|Overall Study|Lost to Follow-up|0|||
125944591|NCT02039674|453094909|FG007|Overall Study|Lost to Follow-up|0|||
125944592|NCT02039674|453094910|FG008|Overall Study|Lost to Follow-up|0|||
125944593|NCT02039674|453094911|FG009|Overall Study|Lost to Follow-up|0|||
125944594|NCT02039674|453094912|FG010|Overall Study|Lost to Follow-up|0|||
125944595|NCT02039674|453094913|FG011|Overall Study|Lost to Follow-up|2|||
125944596|NCT02039674|453094914|FG012|Overall Study|Lost to Follow-up|2|||
125944597|NCT02039674|453094915|FG013|Overall Study|Lost to Follow-up|1|||
125944598|NCT02039674|453094902|FG000|Overall Study|Physician Decision|0|||
125944599|NCT02039674|453094903|FG001|Overall Study|Physician Decision|0|||
125944600|NCT02039674|453094904|FG002|Overall Study|Physician Decision|0|||
125944601|NCT02039674|453094905|FG003|Overall Study|Physician Decision|0|||
125944602|NCT02039674|453094906|FG004|Overall Study|Physician Decision|0|||
125944603|NCT02039674|453094907|FG005|Overall Study|Physician Decision|0|||
125944604|NCT02039674|453094908|FG006|Overall Study|Physician Decision|0|||
125944605|NCT02039674|453094909|FG007|Overall Study|Physician Decision|0|||
125944606|NCT02039674|453094910|FG008|Overall Study|Physician Decision|0|||
125944607|NCT02039674|453094911|FG009|Overall Study|Physician Decision|0|||
125944608|NCT02039674|453094912|FG010|Overall Study|Physician Decision|0|||
125944609|NCT02039674|453094913|FG011|Overall Study|Physician Decision|1|||
125944610|NCT02039674|453094914|FG012|Overall Study|Physician Decision|1|||
125944611|NCT02039674|453094915|FG013|Overall Study|Physician Decision|0|||
125944612|NCT02039674|453094902|FG000|Overall Study|Progressive Disease|8|||
125944613|NCT02039674|453094903|FG001|Overall Study|Progressive Disease|8|||
125944614|NCT02039674|453094904|FG002|Overall Study|Progressive Disease|6|||
125944615|NCT02039674|453094905|FG003|Overall Study|Progressive Disease|7|||
125944616|NCT02039674|453094906|FG004|Overall Study|Progressive Disease|9|||
125944617|NCT02039674|453094907|FG005|Overall Study|Progressive Disease|10|||
125944618|NCT02039674|453094908|FG006|Overall Study|Progressive Disease|1|||
125944619|NCT02039674|453094909|FG007|Overall Study|Progressive Disease|3|||
125944620|NCT02039674|453094910|FG008|Overall Study|Progressive Disease|6|||
125944621|NCT02039674|453094911|FG009|Overall Study|Progressive Disease|4|||
125944622|NCT02039674|453094912|FG010|Overall Study|Progressive Disease|0|||
125944623|NCT02039674|453094913|FG011|Overall Study|Progressive Disease|34|||
125944624|NCT02039674|453094914|FG012|Overall Study|Progressive Disease|34|||
125944625|NCT02039674|453094915|FG013|Overall Study|Progressive Disease|18|||
125944626|NCT02039674|453094902|FG000|Overall Study|Withdrawal by Subject|1|||
125944627|NCT02039674|453094903|FG001|Overall Study|Withdrawal by Subject|2|||
125944628|NCT02039674|453094904|FG002|Overall Study|Withdrawal by Subject|3|||
125944629|NCT02039674|453094905|FG003|Overall Study|Withdrawal by Subject|0|||
125944630|NCT02039674|453094906|FG004|Overall Study|Withdrawal by Subject|1|||
125944631|NCT02039674|453094907|FG005|Overall Study|Withdrawal by Subject|0|||
125944632|NCT02039674|453094908|FG006|Overall Study|Withdrawal by Subject|0|||
125944633|NCT02039674|453094909|FG007|Overall Study|Withdrawal by Subject|0|||
125944634|NCT02039674|453094910|FG008|Overall Study|Withdrawal by Subject|0|||
125944635|NCT02039674|453094911|FG009|Overall Study|Withdrawal by Subject|1|||
125944636|NCT02039674|453094912|FG010|Overall Study|Withdrawal by Subject|1|||
125944637|NCT02039674|453094913|FG011|Overall Study|Withdrawal by Subject|4|||
125944638|NCT02039674|453094914|FG012|Overall Study|Withdrawal by Subject|6|||
125944639|NCT02039674|453094915|FG013|Overall Study|Withdrawal by Subject|2|||
125944640|NCT02039674|453094902|FG000|Overall Study|Clinical Progression|0|||
125944641|NCT02039674|453094903|FG001|Overall Study|Clinical Progression|0|||
125944642|NCT02039674|453094904|FG002|Overall Study|Clinical Progression|0|||
125944643|NCT02039674|453094905|FG003|Overall Study|Clinical Progression|0|||
125944644|NCT02039674|453094906|FG004|Overall Study|Clinical Progression|0|||
125944645|NCT02039674|453094907|FG005|Overall Study|Clinical Progression|0|||
125944646|NCT02039674|453094908|FG006|Overall Study|Clinical Progression|1|||
125944647|NCT02039674|453094909|FG007|Overall Study|Clinical Progression|0|||
125944648|NCT02039674|453094910|FG008|Overall Study|Clinical Progression|0|||
125944649|NCT02039674|453094911|FG009|Overall Study|Clinical Progression|0|||
125944650|NCT02039674|453094912|FG010|Overall Study|Clinical Progression|0|||
125944651|NCT02039674|453094913|FG011|Overall Study|Clinical Progression|0|||
125944652|NCT02039674|453094914|FG012|Overall Study|Clinical Progression|1|||
125944653|NCT02039674|453094915|FG013|Overall Study|Clinical Progression|0|||
125944654|NCT02039674|453094902|FG000|Overall Study|Sponsor Decision|1|||
125944655|NCT02039674|453094903|FG001|Overall Study|Sponsor Decision|1|||
126069003|NCT04748445|453545831|FG000|Overall Study|Other|36|||
126069004|NCT04748445|453545831|FG000|Overall Study|Withdrawal by Subject|553|||
126069005|NCT04748445|453545831|FG000|Overall Study|Lost to Follow-up|30|||
126069006|NCT02498418|453545835|FG000|Overall Study|Lack of Efficacy|0|||
126069007|NCT02498418|453545836|FG001|Overall Study|Lack of Efficacy|0|||
126069008|NCT02498418|453545837|FG002|Overall Study|Lack of Efficacy|1|||
126069009|NCT02498418|453545835|FG000|Overall Study|Withdrawal by Subject|2|||
126069010|NCT02498418|453545836|FG001|Overall Study|Withdrawal by Subject|0|||
126069011|NCT02498418|453545837|FG002|Overall Study|Withdrawal by Subject|3|||
126069012|NCT02498418|453545835|FG000|Overall Study|Lost to Follow-up|0|||
126069013|NCT02498418|453545836|FG001|Overall Study|Lost to Follow-up|1|||
126069014|NCT02498418|453545837|FG002|Overall Study|Lost to Follow-up|1|||
126069015|NCT02498418|453545835|FG000|Overall Study|Participant taken prohibited medication|0|||
126069016|NCT02498418|453545836|FG001|Overall Study|Participant taken prohibited medication|1|||
126069017|NCT02498418|453545837|FG002|Overall Study|Participant taken prohibited medication|1|||
126069018|NCT00762502|453545838|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
126069019|NCT00762502|453545839|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
126069020|NCT00762502|453545840|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
126069021|NCT00762502|453545838|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
126069022|NCT00762502|453545839|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
126069023|NCT00762502|453545840|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
126069024|NCT00762502|453545838|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
126069025|NCT00762502|453545839|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
126069026|NCT00762502|453545840|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
126069027|NCT03042559|453545841|FG000|Overall Study|drop out|1|||
126069028|NCT03042559|453545842|FG001|Overall Study|drop out|1|||
126069029|NCT01536535|453545845|FG000|Overall Study|Withdrawal by Subject|10|||
126069030|NCT01536535|453545846|FG001|Overall Study|Withdrawal by Subject|5|||
126069031|NCT01536535|453545845|FG000|Overall Study|Lost to Follow-up|4|||
126069032|NCT01536535|453545846|FG001|Overall Study|Lost to Follow-up|6|||
126069033|NCT01536535|453545845|FG000|Overall Study|Physician Decision|1|||
126069034|NCT01536535|453545846|FG001|Overall Study|Physician Decision|1|||
126069035|NCT01536535|453545845|FG000|Overall Study|Participant moved|0|||
126069036|NCT01536535|453545846|FG001|Overall Study|Participant moved|1|||
126069037|NCT00385697|453545849|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
126069038|NCT00385697|453545850|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
126069039|NCT00385697|453545851|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
126069040|NCT00385697|453545852|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
126069041|NCT00385697|453545853|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
126069042|NCT00385697|453545849|FG000|Open-label Segment 1|Lost to Follow-up|1|||
125944656|NCT02039674|453094904|FG002|Overall Study|Sponsor Decision|1|||
125944657|NCT02039674|453094905|FG003|Overall Study|Sponsor Decision|1|||
125944658|NCT02039674|453094906|FG004|Overall Study|Sponsor Decision|1|||
125944659|NCT02039674|453094907|FG005|Overall Study|Sponsor Decision|0|||
125944660|NCT02039674|453094908|FG006|Overall Study|Sponsor Decision|0|||
125944661|NCT02039674|453094909|FG007|Overall Study|Sponsor Decision|0|||
125944662|NCT02039674|453094910|FG008|Overall Study|Sponsor Decision|0|||
125944663|NCT02039674|453094911|FG009|Overall Study|Sponsor Decision|3|||
125944664|NCT02039674|453094912|FG010|Overall Study|Sponsor Decision|0|||
125944665|NCT02039674|453094913|FG011|Overall Study|Sponsor Decision|8|||
125944666|NCT02039674|453094914|FG012|Overall Study|Sponsor Decision|5|||
125944667|NCT02039674|453094915|FG013|Overall Study|Sponsor Decision|0|||
125944668|NCT02039674|453094902|FG000|Overall Study|Other|0|||
125944669|NCT02039674|453094903|FG001|Overall Study|Other|0|||
125944670|NCT02039674|453094904|FG002|Overall Study|Other|0|||
125944671|NCT02039674|453094905|FG003|Overall Study|Other|0|||
125944672|NCT02039674|453094906|FG004|Overall Study|Other|0|||
125944673|NCT02039674|453094907|FG005|Overall Study|Other|0|||
125944674|NCT02039674|453094908|FG006|Overall Study|Other|0|||
125944675|NCT02039674|453094909|FG007|Overall Study|Other|0|||
125944676|NCT02039674|453094910|FG008|Overall Study|Other|0|||
125944677|NCT02039674|453094911|FG009|Overall Study|Other|0|||
125944678|NCT02039674|453094912|FG010|Overall Study|Other|0|||
125944679|NCT02039674|453094913|FG011|Overall Study|Other|0|||
125944680|NCT02039674|453094914|FG012|Overall Study|Other|1|||
126069043|NCT00385697|453545850|FG001|Open-label Segment 1|Lost to Follow-up|0|||
125944681|NCT02039674|453094915|FG013|Overall Study|Other|0|||
126069044|NCT00385697|453545851|FG002|Open-label Segment 1|Lost to Follow-up|0|||
125944682|NCT01358357|453094916|FG000|Open Label Phase|Adverse Event|0|||
125944683|NCT01358357|453094917|FG001|Open Label Phase|Adverse Event|0|||
125944684|NCT01358357|453094918|FG002|Open Label Phase|Adverse Event|59|||
125944685|NCT01358357|453094916|FG000|Open Label Phase|Lack of Efficacy|0|||
125944686|NCT01358357|453094917|FG001|Open Label Phase|Lack of Efficacy|0|||
125944687|NCT01358357|453094918|FG002|Open Label Phase|Lack of Efficacy|107|||
125944688|NCT01358357|453094916|FG000|Open Label Phase|Lost to Follow-up|0|||
126069045|NCT00385697|453545852|FG003|Open-label Segment 1|Lost to Follow-up|0|||
126069046|NCT00385697|453545853|FG004|Open-label Segment 1|Lost to Follow-up|0|||
126069047|NCT00385697|453545849|FG000|Double-blind Segment 2|Adverse Event|0|||
126069048|NCT00385697|453545850|FG001|Double-blind Segment 2|Adverse Event|3|||
126114450|NCT03346057|453713836|FG002|Overall Study|Withdrawal by Subject|0|||
126114451|NCT03346057|453713837|FG003|Overall Study|Withdrawal by Subject|0|||
126114452|NCT01159912|453713838|FG000|Overall Study|Adverse Event|2|||
126114453|NCT01159912|453713839|FG001|Overall Study|Adverse Event|2|||
126114454|NCT01159912|453713840|FG002|Overall Study|Adverse Event|3|||
126114455|NCT01159912|453713838|FG000|Overall Study|Lack of Efficacy|23|||
126114456|NCT01159912|453713839|FG001|Overall Study|Lack of Efficacy|15|||
126114457|NCT01159912|453713840|FG002|Overall Study|Lack of Efficacy|14|||
126069049|NCT00385697|453545851|FG002|Double-blind Segment 2|Adverse Event|1|||
126069050|NCT00385697|453545852|FG003|Double-blind Segment 2|Adverse Event|0|||
126069051|NCT00385697|453545853|FG004|Double-blind Segment 2|Adverse Event|0|||
126069052|NCT00385697|453545849|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
126069053|NCT00385697|453545850|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
126069054|NCT00385697|453545851|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
126069055|NCT00385697|453545852|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
126069056|NCT00385697|453545853|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
126069057|NCT00385697|453545849|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
126069058|NCT00385697|453545850|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
126069059|NCT00385697|453545851|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
126069060|NCT00385697|453545852|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
126069061|NCT00385697|453545853|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
126069062|NCT00385697|453545849|FG000|Double-blind Segment 2|Other|0|||
126069063|NCT00385697|453545850|FG001|Double-blind Segment 2|Other|2|||
126069064|NCT00385697|453545851|FG002|Double-blind Segment 2|Other|0|||
126069065|NCT00385697|453545852|FG003|Double-blind Segment 2|Other|0|||
126069066|NCT00385697|453545853|FG004|Double-blind Segment 2|Other|0|||
126069067|NCT01485991|453545854|FG000|Overall Study|Adverse Event|0|||
126069068|NCT01485991|453545855|FG001|Overall Study|Adverse Event|4|||
126069069|NCT01485991|453545854|FG000|Overall Study|Lost to Follow-up|13|||
126069070|NCT01485991|453545855|FG001|Overall Study|Lost to Follow-up|10|||
126069071|NCT01485991|453545854|FG000|Overall Study|Withdrawal by Subject|13|||
126069072|NCT01485991|453545855|FG001|Overall Study|Withdrawal by Subject|20|||
126069073|NCT01485991|453545854|FG000|Overall Study|randomized but not treated|6|||
126069074|NCT01485991|453545855|FG001|Overall Study|randomized but not treated|2|||
126069075|NCT01475370|453545857|FG000|Overall Study|Exacerbation of primary disease|2|||
126069076|NCT01475370|453545858|FG001|Overall Study|Exacerbation of primary disease|2|||
126069077|NCT01475370|453545859|FG002|Overall Study|Exacerbation of primary disease|2|||
126069078|NCT01475370|453545857|FG000|Overall Study|Study drug administration difficult|0|||
126069079|NCT01475370|453545858|FG001|Overall Study|Study drug administration difficult|1|||
126069080|NCT01475370|453545859|FG002|Overall Study|Study drug administration difficult|1|||
126069081|NCT01475370|453545857|FG000|Overall Study|Other than specified|1|||
126069082|NCT01475370|453545858|FG001|Overall Study|Other than specified|0|||
126069083|NCT01475370|453545859|FG002|Overall Study|Other than specified|0|||
126069084|NCT02538471|453545860|FG000|Overall Study|Progression of disease|2|||
126069085|NCT01675050|453545863|FG000|Period One Treatment|Withdrawal by Subject|1|||
126069086|NCT01675050|453545864|FG001|Period One Treatment|Withdrawal by Subject|0|||
126069087|NCT00084747|453545865|FG000|Overall Study|Relapsed|8|||
126069088|NCT00084747|453545865|FG000|Overall Study|Death|3|||
126069089|NCT00084747|453545865|FG000|Overall Study|Withdrawal by Subject|2|||
126069090|NCT02382406|453545870|FG000|Study Treatment|Disease Progression|8|||
126069091|NCT02382406|453545871|FG001|Study Treatment|Disease Progression|0|||
126069092|NCT02382406|453545872|FG002|Study Treatment|Disease Progression|20|||
126069093|NCT02382406|453545870|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
126069094|NCT02382406|453545871|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
126069095|NCT02382406|453545872|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
126114458|NCT01159912|453713838|FG000|Overall Study|Protocol Violation|1|||
126114459|NCT01159912|453713839|FG001|Overall Study|Protocol Violation|2|||
126114460|NCT01159912|453713840|FG002|Overall Study|Protocol Violation|3|||
126069096|NCT02382406|453545870|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
126069097|NCT02382406|453545871|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
126069098|NCT02382406|453545872|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
126069099|NCT02382406|453545870|FG000|Study Treatment|symptomatic deterioration|1|||
126069100|NCT02382406|453545871|FG001|Study Treatment|symptomatic deterioration|0|||
126069101|NCT02382406|453545872|FG002|Study Treatment|symptomatic deterioration|1|||
126069102|NCT02382406|453545870|FG000|Study Treatment|Death|0|||
126069103|NCT02382406|453545871|FG001|Study Treatment|Death|0|||
126069104|NCT02382406|453545872|FG002|Study Treatment|Death|2|||
126069105|NCT02382406|453545870|FG000|Follow up|Death|11|||
126069106|NCT02382406|453545871|FG001|Follow up|Death|0|||
126069107|NCT02382406|453545872|FG002|Follow up|Death|19|||
126069108|NCT02382406|453545870|FG000|Follow up|Symptomatic deterioration|1|||
126069109|NCT02382406|453545871|FG001|Follow up|Symptomatic deterioration|0|||
126069110|NCT02382406|453545872|FG002|Follow up|Symptomatic deterioration|1|||
126069111|NCT02382406|453545870|FG000|Follow up|Patient Refused Follow-up|1|||
126069112|NCT02382406|453545871|FG001|Follow up|Patient Refused Follow-up|0|||
126114461|NCT01159912|453713838|FG000|Overall Study|Lost to Follow-up|4|||
126069113|NCT02382406|453545872|FG002|Follow up|Patient Refused Follow-up|0|||
126069114|NCT02382406|453545870|FG000|Follow up|Study Terminated|1|||
126069115|NCT02382406|453545871|FG001|Follow up|Study Terminated|0|||
126069116|NCT02382406|453545872|FG002|Follow up|Study Terminated|8|||
126069117|NCT02382406|453545870|FG000|Follow up|Withdrawal by Subject|0|||
126069118|NCT02382406|453545871|FG001|Follow up|Withdrawal by Subject|0|||
126069119|NCT02382406|453545872|FG002|Follow up|Withdrawal by Subject|2|||
126069120|NCT03794609|453545875|FG000|Overall Study|Other|10|||
126069121|NCT03794609|453545875|FG000|Overall Study|Withdrawal by Subject|66|||
126069122|NCT03794609|453545875|FG000|Overall Study|The child is enrolled in an interventional study|70|||
126069123|NCT03794609|453545875|FG000|Overall Study|Inclusion/exclusion criteria|8|||
126069124|NCT03794609|453545875|FG000|Overall Study|At sponsor's request|151|||
126069125|NCT03794609|453545875|FG000|Overall Study|Physician Decision|1|||
126069126|NCT03794609|453545875|FG000|Overall Study|Lost to Follow-up|5|||
126069127|NCT04543942|453545876|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
126069128|NCT04543942|453545877|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
126069129|NCT04543942|453545876|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
126069130|NCT04543942|453545877|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
126069131|NCT02097056|453545882|FG000|Overall Study|Protocol Violation|2|||
126069132|NCT02097056|453545882|FG000|Overall Study|Withdrawal by Subject|15|||
126069133|NCT02097056|453545882|FG000|Overall Study|Lost to Follow-up|2|||
126069134|NCT02097056|453545882|FG000|Overall Study|Adverse Event|37|||
126069135|NCT02097056|453545882|FG000|Overall Study|Other|2|||
126069136|NCT02335242|453545894|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
126069137|NCT02335242|453545895|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
126069138|NCT02335242|453545894|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
126069139|NCT02335242|453545895|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126069140|NCT02335242|453545894|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
126069141|NCT02335242|453545895|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
126069142|NCT00257556|453545898|FG000|Overall Study|Adverse Event|1|||
126069143|NCT00257556|453545899|FG001|Overall Study|Adverse Event|4|||
126069144|NCT00257556|453545898|FG000|Overall Study|Physician Decision|6|||
126069145|NCT00257556|453545899|FG001|Overall Study|Physician Decision|0|||
126069146|NCT00257556|453545898|FG000|Overall Study|Did not meet hCG criterion|3|||
126069147|NCT00257556|453545899|FG001|Overall Study|Did not meet hCG criterion|0|||
126069148|NCT00257556|453545898|FG000|Overall Study|other reason|4|||
126069149|NCT00257556|453545899|FG001|Overall Study|other reason|6|||
126069150|NCT04839289|453545900|FG000|Overall Study|Withdrawal by Subject|1|||
126069151|NCT04839289|453545901|FG001|Overall Study|Withdrawal by Subject|0|||
126069152|NCT02418819|453545903|FG000|Overall Study|Adverse Event|0|||
126069153|NCT02418819|453545904|FG001|Overall Study|Adverse Event|0|||
126069154|NCT02418819|453545905|FG002|Overall Study|Adverse Event|1|||
126069155|NCT02418819|453545906|FG003|Overall Study|Adverse Event|0|||
126069156|NCT02418819|453545903|FG000|Overall Study|Lost to Follow-up|1|||
126069157|NCT02418819|453545904|FG001|Overall Study|Lost to Follow-up|0|||
126069158|NCT02418819|453545905|FG002|Overall Study|Lost to Follow-up|0|||
126069159|NCT02418819|453545906|FG003|Overall Study|Lost to Follow-up|0|||
126069160|NCT02418819|453545903|FG000|Overall Study|No longer meets eligibility criteria|0|||
126069161|NCT02418819|453545904|FG001|Overall Study|No longer meets eligibility criteria|0|||
126069162|NCT02418819|453545905|FG002|Overall Study|No longer meets eligibility criteria|1|||
126069163|NCT02418819|453545906|FG003|Overall Study|No longer meets eligibility criteria|0|||
126069164|NCT02418819|453545903|FG000|Overall Study|No longer willing to participate|0|||
125944689|NCT01358357|453094917|FG001|Open Label Phase|Lost to Follow-up|0|||
125944690|NCT01358357|453094918|FG002|Open Label Phase|Lost to Follow-up|76|||
126069165|NCT02418819|453545904|FG001|Overall Study|No longer willing to participate|0|||
126069166|NCT02418819|453545905|FG002|Overall Study|No longer willing to participate|2|||
126069167|NCT02418819|453545906|FG003|Overall Study|No longer willing to participate|1|||
126069168|NCT04743999|453545907|FG000|3-month Questionnaire|Death|1|||
126069169|NCT04743999|453545907|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
126069170|NCT04743999|453545907|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
126069171|NCT04743999|453545907|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
126069172|NCT01721759|453545908|FG000|Treatment Period|Disease Progression|85|||
126069173|NCT01721759|453545908|FG000|Treatment Period|Study drug toxicity|14|||
126069174|NCT01721759|453545908|FG000|Treatment Period|Death|1|||
126069175|NCT01721759|453545908|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
126069176|NCT01721759|453545908|FG000|Treatment Period|Participant request to withdraw|3|||
126069177|NCT01721759|453545908|FG000|Treatment Period|Other Reasons|3|||
126069178|NCT01721759|453545908|FG000|End of Study Period|Participant Withdrew Consent|5|||
126069179|NCT01721759|453545908|FG000|End of Study Period|Death|101|||
126069180|NCT01721759|453545908|FG000|End of Study Period|Lost to Follow-up|1|||
126069181|NCT01721759|453545908|FG000|End of Study Period|Other Reasons|10|||
126069182|NCT01399905|453545909|FG000|Overall Study|Withdrawal by Subject|1|||
126069183|NCT01399905|453545910|FG001|Overall Study|Withdrawal by Subject|1|||
126069184|NCT01804140|453545916|FG000|Overall Study|No sampling or biopsy procedures done|114|||
126069185|NCT02785900|453545917|FG000|Overall Study|Study Termination by Sponsor|64|||
125944691|NCT01358357|453094916|FG000|Open Label Phase|Protocol Violation|0|||
125944692|NCT01358357|453094917|FG001|Open Label Phase|Protocol Violation|0|||
125944693|NCT01358357|453094918|FG002|Open Label Phase|Protocol Violation|45|||
125944694|NCT01358357|453094916|FG000|Open Label Phase|Withdrawal by Subject|0|||
125944695|NCT01358357|453094917|FG001|Open Label Phase|Withdrawal by Subject|0|||
125944696|NCT01358357|453094918|FG002|Open Label Phase|Withdrawal by Subject|112|||
125944697|NCT01358357|453094916|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
125944698|NCT01358357|453094917|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
125944699|NCT01358357|453094918|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
125944700|NCT01358357|453094916|FG000|Open Label Phase|Terminated at study completion|0|||
125944701|NCT01358357|453094917|FG001|Open Label Phase|Terminated at study completion|0|||
125944702|NCT01358357|453094918|FG002|Open Label Phase|Terminated at study completion|5|||
125944703|NCT01358357|453094916|FG000|Open Label Phase|Mood episode|0|||
125944704|NCT01358357|453094917|FG001|Open Label Phase|Mood episode|0|||
125944705|NCT01358357|453094918|FG002|Open Label Phase|Mood episode|42|||
125944706|NCT01358357|453094916|FG000|Double-Blind Phase|Adverse Event|8|||
125944707|NCT01358357|453094917|FG001|Double-Blind Phase|Adverse Event|5|||
125944708|NCT01358357|453094918|FG002|Double-Blind Phase|Adverse Event|0|||
125944709|NCT01358357|453094916|FG000|Double-Blind Phase|Lost to Follow-up|5|||
125944710|NCT01358357|453094917|FG001|Double-Blind Phase|Lost to Follow-up|7|||
125944711|NCT01358357|453094918|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125944712|NCT01358357|453094916|FG000|Double-Blind Phase|Protocol Violation|1|||
125944713|NCT01358357|453094917|FG001|Double-Blind Phase|Protocol Violation|11|||
125944714|NCT01358357|453094918|FG002|Double-Blind Phase|Protocol Violation|0|||
125944715|NCT01358357|453094916|FG000|Double-Blind Phase|Protocol Violation|16|||
125944716|NCT01358357|453094917|FG001|Double-Blind Phase|Protocol Violation|12|||
125944717|NCT01358357|453094918|FG002|Double-Blind Phase|Protocol Violation|0|||
125944718|NCT01358357|453094916|FG000|Double-Blind Phase|Terminated at study completion|2|||
125944719|NCT01358357|453094917|FG001|Double-Blind Phase|Terminated at study completion|0|||
125944720|NCT01358357|453094918|FG002|Double-Blind Phase|Terminated at study completion|0|||
125944721|NCT01358357|453094916|FG000|Double-Blind Phase|Recurrence of mood event|48|||
125944722|NCT01358357|453094917|FG001|Double-Blind Phase|Recurrence of mood event|64|||
125944723|NCT01358357|453094918|FG002|Double-Blind Phase|Recurrence of mood event|0|||
125944724|NCT01358357|453094916|FG000|Double-Blind Phase|Administrative|0|||
125944725|NCT01358357|453094917|FG001|Double-Blind Phase|Administrative|1|||
125944726|NCT01358357|453094918|FG002|Double-Blind Phase|Administrative|0|||
125944727|NCT00537381|453094919|FG000|Overall Study|Adverse Event|13|||
125944728|NCT00537381|453094920|FG001|Overall Study|Adverse Event|9|||
125944729|NCT00537381|453094919|FG000|Overall Study|Death|3|||
125944730|NCT00537381|453094920|FG001|Overall Study|Death|3|||
125944731|NCT00537381|453094919|FG000|Overall Study|Withdrawal by Subject|5|||
125944732|NCT00537381|453094920|FG001|Overall Study|Withdrawal by Subject|14|||
125944733|NCT00537381|453094919|FG000|Overall Study|Physician Decision|7|||
125944734|NCT00537381|453094920|FG001|Overall Study|Physician Decision|6|||
125944735|NCT00537381|453094919|FG000|Overall Study|Disease Progression|9|||
125944736|NCT00537381|453094920|FG001|Overall Study|Disease Progression|18|||
125944737|NCT00537381|453094919|FG000|Overall Study|Sponsor decision|14|||
125944738|NCT00537381|453094920|FG001|Overall Study|Sponsor decision|9|||
125944739|NCT00537381|453094919|FG000|Overall Study|Other|5|||
125944740|NCT00537381|453094920|FG001|Overall Study|Other|3|||
125944741|NCT03082599|453094927|FG000|Overall Study|Lost to Follow-up|1|||
125944742|NCT03082599|453094928|FG001|Overall Study|Lost to Follow-up|0|||
125944743|NCT02347189|453094929|FG000|Overall Study|No implant attempted of study device|9|||
125944744|NCT02347189|453094929|FG000|Overall Study|No primary outcome data available|2|||
125944745|NCT00735878|453094930|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
125944746|NCT00735878|453094931|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
125944747|NCT00735878|453094932|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
125944748|NCT00994240|453094933|FG000|Overall Study|Lost to Follow-up|3|||
125944749|NCT00994240|453094934|FG001|Overall Study|Lost to Follow-up|2|||
125944750|NCT00994240|453094933|FG000|Overall Study|Withdrawal by Subject|1|||
126069186|NCT02785900|453545918|FG001|Overall Study|Study Termination by Sponsor|81|||
126069187|NCT02785900|453545917|FG000|Overall Study|Death|46|||
126069188|NCT02785900|453545918|FG001|Overall Study|Death|32|||
126069189|NCT02785900|453545917|FG000|Overall Study|Withdrawal by Subject|4|||
126069190|NCT02785900|453545918|FG001|Overall Study|Withdrawal by Subject|8|||
125944751|NCT00994240|453094934|FG001|Overall Study|Withdrawal by Subject|0|||
125944752|NCT00994240|453094933|FG000|Overall Study|study termination|2|||
125944753|NCT00994240|453094934|FG001|Overall Study|study termination|3|||
125944754|NCT00352846|453094935|FG000|Overall Study|Disease progression|0|||
125944755|NCT00352846|453094936|FG001|Overall Study|Disease progression|2|||
126069191|NCT02785900|453545917|FG000|Overall Study|Physician Decision|3|||
125944756|NCT00352846|453094935|FG000|Overall Study|Withdrawal by Subject|3|||
125944757|NCT00352846|453094936|FG001|Overall Study|Withdrawal by Subject|8|||
125944758|NCT00352846|453094935|FG000|Overall Study|Ineligible|3|||
125944759|NCT00352846|453094936|FG001|Overall Study|Ineligible|2|||
126069192|NCT02785900|453545918|FG001|Overall Study|Physician Decision|2|||
126069193|NCT01808144|453545919|FG000|Overall Study|Death|1|||
126069194|NCT01808144|453545920|FG001|Overall Study|Death|0|||
126069195|NCT01808144|453545919|FG000|Overall Study|Withdrawal by Subject|16|||
126069196|NCT01808144|453545920|FG001|Overall Study|Withdrawal by Subject|23|||
126069197|NCT01808144|453545919|FG000|Overall Study|Lost to Follow-up|6|||
126069198|NCT01808144|453545920|FG001|Overall Study|Lost to Follow-up|3|||
126069199|NCT01808144|453545919|FG000|Overall Study|Protocol Violation|6|||
126069200|NCT01808144|453545920|FG001|Overall Study|Protocol Violation|6|||
126069201|NCT01808144|453545919|FG000|Overall Study|Gout flare|0|||
126069202|NCT01808144|453545920|FG001|Overall Study|Gout flare|1|||
126069203|NCT01808144|453545919|FG000|Overall Study|Adverse Event|11|||
126069204|NCT01808144|453545920|FG001|Overall Study|Adverse Event|15|||
126069205|NCT00383500|453545921|FG000|Overall Study|Withdrawal by Subject|8|||
126069206|NCT00383500|453545922|FG001|Overall Study|Withdrawal by Subject|3|||
126069207|NCT00383500|453545923|FG002|Overall Study|Withdrawal by Subject|0|||
126069208|NCT00383500|453545921|FG000|Overall Study|Lost to Follow-up|0|||
126069209|NCT00383500|453545922|FG001|Overall Study|Lost to Follow-up|0|||
126069210|NCT00383500|453545923|FG002|Overall Study|Lost to Follow-up|2|||
126069211|NCT04341584|453545927|FG000|Overall Study|Withdrew consent|0|||
126069212|NCT04341584|453545928|FG001|Overall Study|Withdrew consent|2|||
126069213|NCT04341584|453545929|FG002|Overall Study|Withdrew consent|2|||
126069214|NCT04341584|453545930|FG003|Overall Study|Withdrew consent|1|||
126069215|NCT00497198|453545932|FG000|Overall Study|Adverse Event|4|||
126069216|NCT00497198|453545933|FG001|Overall Study|Adverse Event|2|||
126069217|NCT00497198|453545932|FG000|Overall Study|Physician Decision|1|||
126069218|NCT00497198|453545933|FG001|Overall Study|Physician Decision|2|||
126069219|NCT00497198|453545932|FG000|Overall Study|Withdrawal by Subject|0|||
126069220|NCT00497198|453545933|FG001|Overall Study|Withdrawal by Subject|1|||
126069221|NCT02799745|453545934|FG000|Overall Study|Participant moved out of state|1|||
126069222|NCT02799745|453545935|FG001|Overall Study|Participant moved out of state|0|||
126069223|NCT02799745|453545934|FG000|Overall Study|Discontinued due to planned surgery|1|||
126069224|NCT02799745|453545935|FG001|Overall Study|Discontinued due to planned surgery|0|||
126069225|NCT02799745|453545934|FG000|Overall Study|Withdrawal by Subject|16|||
126069226|NCT02799745|453545935|FG001|Overall Study|Withdrawal by Subject|25|||
126069227|NCT02799745|453545934|FG000|Overall Study|Protocol Deviation|4|||
126069228|NCT02799745|453545935|FG001|Overall Study|Protocol Deviation|5|||
126069229|NCT02799745|453545934|FG000|Overall Study|Progressive Disease|28|||
126069230|NCT02799745|453545935|FG001|Overall Study|Progressive Disease|38|||
126069231|NCT02799745|453545934|FG000|Overall Study|Lost to Follow-up|3|||
126069232|NCT02799745|453545935|FG001|Overall Study|Lost to Follow-up|2|||
126069233|NCT02799745|453545934|FG000|Overall Study|Death|3|||
126069234|NCT02799745|453545935|FG001|Overall Study|Death|0|||
126069235|NCT02799745|453545934|FG000|Overall Study|Adverse Event|0|||
126069236|NCT02799745|453545935|FG001|Overall Study|Adverse Event|1|||
126069237|NCT04853238|453545936|FG000|Overall Study|Death|4|||
126069238|NCT04853238|453545937|FG001|Overall Study|Death|0|||
126069239|NCT04853238|453545938|FG002|Overall Study|Death|2|||
126069240|NCT04853238|453545936|FG000|Overall Study|Lost to Follow-up|16|||
126069241|NCT04853238|453545937|FG001|Overall Study|Lost to Follow-up|2|||
126069242|NCT04853238|453545938|FG002|Overall Study|Lost to Follow-up|37|||
126069243|NCT04853238|453545936|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
126069244|NCT04853238|453545937|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
126069245|NCT04853238|453545938|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
126069246|NCT04853238|453545936|FG000|Overall Study|Withdrawal by Subject|6|||
126069247|NCT04853238|453545937|FG001|Overall Study|Withdrawal by Subject|0|||
126069248|NCT04853238|453545938|FG002|Overall Study|Withdrawal by Subject|21|||
126069249|NCT04853238|453545936|FG000|Overall Study|Physician Decision|0|||
126069250|NCT04853238|453545937|FG001|Overall Study|Physician Decision|0|||
126069251|NCT04853238|453545938|FG002|Overall Study|Physician Decision|2|||
126069252|NCT04853238|453545936|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
126069253|NCT04853238|453545937|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
126069254|NCT04853238|453545938|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
126069255|NCT02176356|453547369|FG000|Overall Study|Screen Failure|14|||
126069256|NCT02176356|453547369|FG000|Overall Study|Lost to Follow-up|4|||
126069257|NCT02176356|453547369|FG000|Overall Study|Personal Reasons|3|||
126069258|NCT02176356|453547369|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126069259|NCT00792259|453547370|FG000|Overall Study|Poor Quality Scans|1|||
126069260|NCT00792259|453547371|FG001|Overall Study|Poor Quality Scans|0|||
126069261|NCT00792259|453547372|FG002|Overall Study|Poor Quality Scans|0|||
126114462|NCT01159912|453713839|FG001|Overall Study|Lost to Follow-up|0|||
126069262|NCT00332488|453547373|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
126069263|NCT00332488|453547374|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
126069264|NCT00332488|453547375|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
126069265|NCT00332488|453547373|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
126069266|NCT00332488|453547374|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
126069267|NCT00332488|453547375|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
126069268|NCT00332488|453547373|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
126114463|NCT01159912|453713840|FG002|Overall Study|Lost to Follow-up|0|||
125944760|NCT00352846|453094935|FG000|Overall Study|Non-compliance|2|||
125944761|NCT00352846|453094936|FG001|Overall Study|Non-compliance|0|||
125944762|NCT00352846|453094935|FG000|Overall Study|Death|0|||
125944763|NCT00352846|453094936|FG001|Overall Study|Death|1|||
125944764|NCT01527682|453094937|FG000|Overall Study|Protocol Violation|8|||
125944765|NCT04254978|453096336|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
125944766|NCT04254978|453096336|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
125944767|NCT04254978|453096336|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
125944768|NCT04254978|453096336|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
125944769|NCT04254978|453096336|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
125944770|NCT04254978|453096336|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
125944771|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
125944772|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
125944773|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
125944774|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
125944775|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
125944776|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
125944777|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
125944778|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
125944779|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
125944780|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
125944781|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
125944782|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
125944783|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
125944784|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
125944785|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
125944786|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
125944787|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
125944788|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
125944789|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
125944790|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
125944791|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
125944792|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
125944793|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
125944794|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
125944795|NCT00277212|453096337|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
125944796|NCT00277212|453096338|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
125944797|NCT00277212|453096339|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
125944798|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
125944799|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
125944800|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
125944801|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
125944802|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
125944803|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
125944804|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
125944805|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
125944806|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
125944807|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
125944808|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
125944809|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
125944810|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
125944811|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
125944812|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
125944813|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
125944814|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
125944815|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
125944816|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
125944817|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
125944818|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
125944819|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
125944820|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
125944821|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
126114464|NCT01159912|453713838|FG000|Overall Study|Physician Decision|0|||
125944822|NCT00277212|453096337|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
125944823|NCT00277212|453096338|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
125944824|NCT00277212|453096339|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
126069269|NCT00332488|453547374|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
126069270|NCT00332488|453547375|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
126069271|NCT00332488|453547373|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
126069272|NCT00332488|453547374|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
126069273|NCT00332488|453547375|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
126069274|NCT00332488|453547373|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
126069275|NCT00332488|453547374|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
126069276|NCT00332488|453547375|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
126069277|NCT00332488|453547373|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
126069278|NCT00332488|453547374|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
126069279|NCT00332488|453547375|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
126069280|NCT00332488|453547373|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
126069281|NCT00332488|453547374|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
126069282|NCT00332488|453547375|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
126069283|NCT00332488|453547373|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
126069284|NCT00332488|453547374|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
126069285|NCT00332488|453547375|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
126069286|NCT00332488|453547373|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
126069287|NCT00332488|453547374|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
126069288|NCT00332488|453547375|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
126069289|NCT00332488|453547373|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
126069290|NCT00332488|453547374|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
126069291|NCT00332488|453547375|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
126069292|NCT00332488|453547373|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
126069293|NCT00332488|453547374|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
126069294|NCT00332488|453547375|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
126069295|NCT00332488|453547373|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
126069296|NCT00332488|453547374|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
126069297|NCT00332488|453547375|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
126069298|NCT00371462|453547376|FG000|Overall Study|Withdrawal by Subject|1|||
126069299|NCT00371462|453547377|FG001|Overall Study|Withdrawal by Subject|0|||
126069300|NCT00371462|453547376|FG000|Overall Study|Other|7|||
126069301|NCT00371462|453547377|FG001|Overall Study|Other|8|||
126069302|NCT03721978|453547379|FG000|Overall Study|Withdrawal by Subject|6|||
126069303|NCT03721978|453547380|FG001|Overall Study|Withdrawal by Subject|1|||
126069304|NCT03721978|453547379|FG000|Overall Study|Adverse Event|1|||
126069305|NCT03721978|453547380|FG001|Overall Study|Adverse Event|1|||
126069306|NCT03721978|453547379|FG000|Overall Study|Progressive Disease|1|||
126069307|NCT03721978|453547380|FG001|Overall Study|Progressive Disease|0|||
126069308|NCT03721978|453547379|FG000|Overall Study|Lost to Follow-up|5|||
126069309|NCT03721978|453547380|FG001|Overall Study|Lost to Follow-up|1|||
126069310|NCT03721978|453547379|FG000|Overall Study|Reason not Specified|0|||
126069311|NCT03721978|453547380|FG001|Overall Study|Reason not Specified|2|||
126069312|NCT05244226|453547381|FG000|Overall Study|Adverse Event|1|||
126069313|NCT05244226|453547382|FG001|Overall Study|Adverse Event|0|||
126069314|NCT05244226|453547383|FG002|Overall Study|Adverse Event|0|||
126069315|NCT05244226|453547381|FG000|Overall Study|Lost to Follow-up|0|||
126069316|NCT05244226|453547382|FG001|Overall Study|Lost to Follow-up|0|||
126069317|NCT05244226|453547383|FG002|Overall Study|Lost to Follow-up|1|||
126069318|NCT05244226|453547381|FG000|Overall Study|Protocol Violation|0|||
126069319|NCT05244226|453547382|FG001|Overall Study|Protocol Violation|2|||
126114465|NCT01159912|453713839|FG001|Overall Study|Physician Decision|0|||
126114466|NCT01159912|453713840|FG002|Overall Study|Physician Decision|3|||
126114467|NCT01159912|453713838|FG000|Overall Study|Withdrawal by Subject|10|||
126114468|NCT01159912|453713839|FG001|Overall Study|Withdrawal by Subject|3|||
126114469|NCT01159912|453713840|FG002|Overall Study|Withdrawal by Subject|3|||
126114470|NCT02456662|453713842|FG000|Overall Study|Lost to Follow-up|2|||
126114471|NCT02456662|453713843|FG001|Overall Study|Lost to Follow-up|1|||
126114472|NCT00805025|453713845|FG000|Overall Study|Screened but not enrolled/treated|42|||
126069320|NCT05244226|453547383|FG002|Overall Study|Protocol Violation|2|||
126069321|NCT00733226|453547384|FG000|Overall Study|Withdrawal by Subject|1|||
126069322|NCT00733226|453547385|FG001|Overall Study|Withdrawal by Subject|0|||
126069323|NCT00733226|453547384|FG000|Overall Study|Lost to Follow-up|2|||
126069324|NCT00733226|453547385|FG001|Overall Study|Lost to Follow-up|0|||
126069325|NCT00733226|453547384|FG000|Overall Study|moved to another place|2|||
126069326|NCT00733226|453547385|FG001|Overall Study|moved to another place|0|||
126069327|NCT03722485|453547386|FG000|Overall Study|Withdrawal by Subject|1|||
126069328|NCT03722485|453547387|FG001|Overall Study|Withdrawal by Subject|0|||
126069329|NCT03722485|453547386|FG000|Overall Study|Adverse Event|0|||
126069330|NCT03722485|453547387|FG001|Overall Study|Adverse Event|2|||
126069331|NCT03722485|453547386|FG000|Overall Study|subject discharged prior to study completion|1|||
126069332|NCT03722485|453547387|FG001|Overall Study|subject discharged prior to study completion|5|||
126069333|NCT03722485|453547386|FG000|Overall Study|eligibility criteria not met|2|||
126069334|NCT03722485|453547387|FG001|Overall Study|eligibility criteria not met|0|||
126069335|NCT00349622|453547388|FG000|Overall Study|Death|168|||
126069336|NCT00349622|453547389|FG001|Overall Study|Death|86|||
126069337|NCT00349622|453547388|FG000|Overall Study|Lost to Follow-up|5|||
126069338|NCT00349622|453547389|FG001|Overall Study|Lost to Follow-up|1|||
126069339|NCT00349622|453547388|FG000|Overall Study|Withdrawal by Subject|5|||
126069340|NCT00349622|453547389|FG001|Overall Study|Withdrawal by Subject|9|||
126069341|NCT02762500|453547390|FG000|Overall Study|Lack of Efficacy|1|||
126069342|NCT02762500|453547391|FG001|Overall Study|Lack of Efficacy|0|||
126069343|NCT02762500|453547390|FG000|Overall Study|Withdrawal by Subject|1|||
126069344|NCT02762500|453547391|FG001|Overall Study|Withdrawal by Subject|1|||
126069345|NCT02762500|453547390|FG000|Overall Study|Adverse Event|0|||
126069346|NCT02762500|453547391|FG001|Overall Study|Adverse Event|2|||
126069347|NCT02229396|453547392|FG000|Overall Study|Adverse Event|6|||
126069348|NCT02229396|453547393|FG001|Overall Study|Adverse Event|12|||
126069349|NCT02229396|453547394|FG002|Overall Study|Adverse Event|12|||
126069350|NCT02229396|453547392|FG000|Overall Study|Death|2|||
126069351|NCT02229396|453547393|FG001|Overall Study|Death|3|||
126069352|NCT02229396|453547394|FG002|Overall Study|Death|1|||
126069353|NCT02229396|453547392|FG000|Overall Study|Lost to Follow-up|14|||
126069354|NCT02229396|453547393|FG001|Overall Study|Lost to Follow-up|14|||
126069355|NCT02229396|453547394|FG002|Overall Study|Lost to Follow-up|21|||
126069356|NCT02229396|453547392|FG000|Overall Study|Protocol Violation|2|||
126069357|NCT02229396|453547393|FG001|Overall Study|Protocol Violation|1|||
126069358|NCT02229396|453547394|FG002|Overall Study|Protocol Violation|0|||
126069359|NCT02229396|453547392|FG000|Overall Study|Patient Incorrectly Randomized|0|||
126069360|NCT02229396|453547393|FG001|Overall Study|Patient Incorrectly Randomized|0|||
126069361|NCT02229396|453547394|FG002|Overall Study|Patient Incorrectly Randomized|1|||
126069362|NCT02229396|453547392|FG000|Overall Study|Other|10|||
126069363|NCT02229396|453547393|FG001|Overall Study|Other|18|||
126069364|NCT02229396|453547394|FG002|Overall Study|Other|15|||
126069365|NCT02229396|453547392|FG000|Overall Study|Withdrawal by Subject|42|||
126069366|NCT02229396|453547393|FG001|Overall Study|Withdrawal by Subject|28|||
126069367|NCT02229396|453547394|FG002|Overall Study|Withdrawal by Subject|41|||
126069368|NCT02229396|453547392|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
126069369|NCT02229396|453547393|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
126069370|NCT02229396|453547394|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
126069371|NCT02229396|453547392|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
126069372|NCT02229396|453547393|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
126069373|NCT02229396|453547394|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
126069374|NCT00377312|453547397|FG000|Overall Study|Adverse Event|1|||
126069375|NCT00377312|453547398|FG001|Overall Study|Adverse Event|1|||
126069376|NCT02775214|453547399|FG000|Overall Study|Withdrawal by Subject|2|||
126069377|NCT02775214|453547400|FG001|Overall Study|Withdrawal by Subject|0|||
126069378|NCT01145417|453547401|FG000|Overall Study|Death|1|||
126069379|NCT01145417|453547402|FG001|Overall Study|Death|0|||
126069380|NCT01145417|453547401|FG000|Overall Study|Lost to Follow-up|2|||
126069381|NCT01145417|453547402|FG001|Overall Study|Lost to Follow-up|1|||
126069382|NCT01145417|453547401|FG000|Overall Study|Withdrawal by Subject|1|||
126069383|NCT01145417|453547402|FG001|Overall Study|Withdrawal by Subject|2|||
126069384|NCT01145417|453547401|FG000|Overall Study|Pregnancy|1|||
126114473|NCT00805025|453713845|FG000|Overall Study|Adverse Event|4|||
126114474|NCT00805025|453713845|FG000|Overall Study|Withdrawal by Subject|2|||
126114475|NCT00805025|453713845|FG000|Overall Study|Physician Decision|1|||
126069385|NCT01145417|453547402|FG001|Overall Study|Pregnancy|0|||
126069386|NCT01145417|453547401|FG000|Overall Study|Adverse Event|0|||
126069387|NCT01145417|453547402|FG001|Overall Study|Adverse Event|1|||
126069388|NCT01145417|453547401|FG000|Overall Study|Study terminated by sponsor|35|||
126069389|NCT01145417|453547402|FG001|Overall Study|Study terminated by sponsor|43|||
126069390|NCT01145417|453547401|FG000|Overall Study|Other|1|||
126069391|NCT01145417|453547402|FG001|Overall Study|Other|0|||
126069392|NCT01191697|453547403|FG000|Overall Study|Death|1|||
126069393|NCT01191697|453547403|FG000|Overall Study|Physician Decision|2|||
126069394|NCT01191697|453547403|FG000|Overall Study|Pursue chemoradiation|2|||
126069395|NCT01191697|453547403|FG000|Overall Study|Break from chemotherapy|2|||
126069396|NCT01191697|453547403|FG000|Overall Study|Withdrawal by Subject|1|||
126069397|NCT01191697|453547403|FG000|Overall Study|Surveillance|1|||
126069398|NCT01191697|453547403|FG000|Overall Study|Adverse Event|2|||
126069399|NCT01191697|453547403|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
126069400|NCT01191697|453547403|FG000|Overall Study|Not completed but analyzed|25|||
126069401|NCT01066897|453547407|FG000|Overall Study|Withdrawal by Subject|1|||
126069402|NCT01066897|453547408|FG001|Overall Study|Withdrawal by Subject|0|||
126069403|NCT01066897|453547407|FG000|Overall Study|stopped study after developing the flu.|1|||
126069404|NCT01066897|453547408|FG001|Overall Study|stopped study after developing the flu.|0|||
126069405|NCT05372913|453547415|FG000|Overall Study|Withdrawal by Subject|0|||
126069406|NCT05372913|453547416|FG001|Overall Study|Withdrawal by Subject|2|||
126069407|NCT05372913|453547415|FG000|Overall Study|Protocol Violation|2|||
125944825|NCT03336216|453096345|FG000|Randomization|Not reported|2|||
125944826|NCT03336216|453096346|FG001|Randomization|Not reported|0|||
125944827|NCT03336216|453096347|FG002|Randomization|Not reported|1|||
125944828|NCT03336216|453096348|FG003|Randomization|Not reported|0|||
125944829|NCT03336216|453096345|FG000|Randomization|Other reasons|1|||
125944830|NCT03336216|453096346|FG001|Randomization|Other reasons|1|||
125944831|NCT03336216|453096347|FG002|Randomization|Other reasons|1|||
125944832|NCT03336216|453096348|FG003|Randomization|Other reasons|0|||
125944833|NCT03336216|453096345|FG000|Randomization|Participant no longer meets study criteria|0|||
125944834|NCT03336216|453096346|FG001|Randomization|Participant no longer meets study criteria|2|||
125944835|NCT03336216|453096347|FG002|Randomization|Participant no longer meets study criteria|4|||
125944836|NCT03336216|453096348|FG003|Randomization|Participant no longer meets study criteria|1|||
125944837|NCT03336216|453096345|FG000|Randomization|Lost to Follow-up|1|||
125944838|NCT03336216|453096346|FG001|Randomization|Lost to Follow-up|0|||
125944839|NCT03336216|453096347|FG002|Randomization|Lost to Follow-up|0|||
125944840|NCT03336216|453096348|FG003|Randomization|Lost to Follow-up|0|||
125944841|NCT03336216|453096345|FG000|Randomization|Participant withdrew consent|9|||
125944842|NCT03336216|453096346|FG001|Randomization|Participant withdrew consent|1|||
125944843|NCT03336216|453096347|FG002|Randomization|Participant withdrew consent|0|||
125944844|NCT03336216|453096348|FG003|Randomization|Participant withdrew consent|0|||
125944845|NCT03336216|453096345|FG000|Randomization|Adverse Event|1|||
125944846|NCT03336216|453096346|FG001|Randomization|Adverse Event|1|||
125944847|NCT03336216|453096347|FG002|Randomization|Adverse Event|0|||
125944848|NCT03336216|453096348|FG003|Randomization|Adverse Event|0|||
125944849|NCT03336216|453096345|FG000|Treatment|Adverse Event|2|||
125944850|NCT03336216|453096346|FG001|Treatment|Adverse Event|3|||
125944851|NCT03336216|453096347|FG002|Treatment|Adverse Event|4|||
125944852|NCT03336216|453096348|FG003|Treatment|Adverse Event|4|||
125944853|NCT03336216|453096345|FG000|Treatment|Participant request to discontinue treatment|2|||
125944854|NCT03336216|453096346|FG001|Treatment|Participant request to discontinue treatment|1|||
125944855|NCT03336216|453096347|FG002|Treatment|Participant request to discontinue treatment|2|||
125944856|NCT03336216|453096348|FG003|Treatment|Participant request to discontinue treatment|2|||
125944857|NCT03336216|453096345|FG000|Treatment|Participant withdrew consent|7|||
125944858|NCT03336216|453096346|FG001|Treatment|Participant withdrew consent|2|||
125944859|NCT03336216|453096347|FG002|Treatment|Participant withdrew consent|3|||
125944860|NCT03336216|453096348|FG003|Treatment|Participant withdrew consent|2|||
125944861|NCT03336216|453096345|FG000|Treatment|Death|2|||
125944862|NCT03336216|453096346|FG001|Treatment|Death|3|||
125944863|NCT03336216|453096347|FG002|Treatment|Death|3|||
125944864|NCT03336216|453096348|FG003|Treatment|Death|4|||
125944865|NCT03336216|453096345|FG000|Treatment|Participant no longer meets study criteria|0|||
125944866|NCT03336216|453096346|FG001|Treatment|Participant no longer meets study criteria|1|||
125944867|NCT03336216|453096347|FG002|Treatment|Participant no longer meets study criteria|0|||
125944868|NCT03336216|453096348|FG003|Treatment|Participant no longer meets study criteria|0|||
125944869|NCT03336216|453096345|FG000|Treatment|Other reasons|2|||
125944870|NCT03336216|453096346|FG001|Treatment|Other reasons|0|||
125944871|NCT03336216|453096347|FG002|Treatment|Other reasons|0|||
125944872|NCT03336216|453096348|FG003|Treatment|Other reasons|3|||
125944873|NCT03336216|453096345|FG000|Treatment|Disease progression|23|||
125944874|NCT03336216|453096346|FG001|Treatment|Disease progression|34|||
125944875|NCT03336216|453096347|FG002|Treatment|Disease progression|33|||
125944876|NCT03336216|453096348|FG003|Treatment|Disease progression|26|||
125944877|NCT03336216|453096345|FG000|Treatment|Study drug toxicity|0|||
125944878|NCT03336216|453096346|FG001|Treatment|Study drug toxicity|3|||
125944879|NCT03336216|453096347|FG002|Treatment|Study drug toxicity|2|||
125944880|NCT03336216|453096348|FG003|Treatment|Study drug toxicity|0|||
125944881|NCT03336216|453096345|FG000|Treatment|Adverse Event unrelated to study drug|1|||
125944882|NCT03336216|453096346|FG001|Treatment|Adverse Event unrelated to study drug|1|||
126069408|NCT05372913|453547416|FG001|Overall Study|Protocol Violation|2|||
125944883|NCT03336216|453096347|FG002|Treatment|Adverse Event unrelated to study drug|1|||
125944884|NCT03336216|453096348|FG003|Treatment|Adverse Event unrelated to study drug|0|||
125944885|NCT03336216|453096345|FG000|Treatment|Disease Recurrence|1|||
125944886|NCT03336216|453096346|FG001|Treatment|Disease Recurrence|0|||
125944887|NCT03336216|453096347|FG002|Treatment|Disease Recurrence|0|||
125944888|NCT03336216|453096348|FG003|Treatment|Disease Recurrence|0|||
125944889|NCT03239470|453096349|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
125944890|NCT03239470|453096350|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
125944891|NCT01023581|453096353|FG000|Overall Study|Adverse Event|4|||
125944892|NCT01023581|453096354|FG001|Overall Study|Adverse Event|4|||
126069409|NCT05372913|453547415|FG000|Overall Study|Adverse Event|0|||
125944893|NCT01023581|453096355|FG002|Overall Study|Adverse Event|7|||
125944894|NCT01023581|453096356|FG003|Overall Study|Adverse Event|3|||
125944895|NCT01023581|453096357|FG004|Overall Study|Adverse Event|2|||
125944896|NCT01023581|453096358|FG005|Overall Study|Adverse Event|5|||
125944897|NCT01023581|453096359|FG006|Overall Study|Adverse Event|11|||
125944898|NCT01023581|453096353|FG000|Overall Study|Major protocol deviation|2|||
125944899|NCT01023581|453096354|FG001|Overall Study|Major protocol deviation|0|||
125944900|NCT01023581|453096355|FG002|Overall Study|Major protocol deviation|3|||
125944901|NCT01023581|453096356|FG003|Overall Study|Major protocol deviation|0|||
125944902|NCT01023581|453096357|FG004|Overall Study|Major protocol deviation|0|||
125944903|NCT01023581|453096358|FG005|Overall Study|Major protocol deviation|0|||
125944904|NCT01023581|453096359|FG006|Overall Study|Major protocol deviation|0|||
125944905|NCT01023581|453096353|FG000|Overall Study|Lost to Follow-up|4|||
125944906|NCT01023581|453096354|FG001|Overall Study|Lost to Follow-up|8|||
125944907|NCT01023581|453096355|FG002|Overall Study|Lost to Follow-up|7|||
125944908|NCT01023581|453096356|FG003|Overall Study|Lost to Follow-up|2|||
125944909|NCT01023581|453096357|FG004|Overall Study|Lost to Follow-up|5|||
125944910|NCT01023581|453096358|FG005|Overall Study|Lost to Follow-up|2|||
125944911|NCT01023581|453096359|FG006|Overall Study|Lost to Follow-up|2|||
125944912|NCT01023581|453096353|FG000|Overall Study|Withdrawal by Subject|13|||
125944913|NCT01023581|453096354|FG001|Overall Study|Withdrawal by Subject|8|||
125944914|NCT01023581|453096355|FG002|Overall Study|Withdrawal by Subject|16|||
125944915|NCT01023581|453096356|FG003|Overall Study|Withdrawal by Subject|10|||
125944916|NCT01023581|453096357|FG004|Overall Study|Withdrawal by Subject|6|||
125944917|NCT01023581|453096358|FG005|Overall Study|Withdrawal by Subject|8|||
125944918|NCT01023581|453096359|FG006|Overall Study|Withdrawal by Subject|5|||
125944919|NCT01023581|453096353|FG000|Overall Study|Pregnancy|0|||
125944920|NCT01023581|453096354|FG001|Overall Study|Pregnancy|0|||
125944921|NCT01023581|453096355|FG002|Overall Study|Pregnancy|0|||
125944922|NCT01023581|453096356|FG003|Overall Study|Pregnancy|2|||
125944923|NCT01023581|453096357|FG004|Overall Study|Pregnancy|0|||
125944924|NCT01023581|453096358|FG005|Overall Study|Pregnancy|1|||
125944925|NCT01023581|453096359|FG006|Overall Study|Pregnancy|0|||
125944926|NCT01023581|453096353|FG000|Overall Study|Lack of Efficacy|9|||
125944927|NCT01023581|453096354|FG001|Overall Study|Lack of Efficacy|3|||
125944928|NCT01023581|453096355|FG002|Overall Study|Lack of Efficacy|6|||
125944929|NCT01023581|453096356|FG003|Overall Study|Lack of Efficacy|2|||
125944930|NCT01023581|453096357|FG004|Overall Study|Lack of Efficacy|1|||
125944931|NCT01023581|453096358|FG005|Overall Study|Lack of Efficacy|2|||
125944932|NCT01023581|453096359|FG006|Overall Study|Lack of Efficacy|1|||
125944933|NCT01023581|453096353|FG000|Overall Study|Physician Decision|2|||
125944934|NCT01023581|453096354|FG001|Overall Study|Physician Decision|0|||
125944935|NCT01023581|453096355|FG002|Overall Study|Physician Decision|2|||
125944936|NCT01023581|453096356|FG003|Overall Study|Physician Decision|1|||
125944937|NCT01023581|453096357|FG004|Overall Study|Physician Decision|1|||
125944938|NCT01023581|453096358|FG005|Overall Study|Physician Decision|1|||
125944939|NCT01023581|453096359|FG006|Overall Study|Physician Decision|1|||
125944940|NCT01023581|453096353|FG000|Overall Study|Other|1|||
125944941|NCT01023581|453096354|FG001|Overall Study|Other|0|||
125944942|NCT01023581|453096355|FG002|Overall Study|Other|1|||
125944943|NCT01023581|453096356|FG003|Overall Study|Other|0|||
125944944|NCT01023581|453096357|FG004|Overall Study|Other|1|||
125944945|NCT01023581|453096358|FG005|Overall Study|Other|0|||
125944946|NCT01023581|453096359|FG006|Overall Study|Other|0|||
125944947|NCT02532647|453096365|FG000|Overall Study|Did not receive trial medication|1|||
125944948|NCT02532647|453096366|FG001|Overall Study|Did not receive trial medication|0|||
125944949|NCT02532647|453096367|FG002|Overall Study|Did not receive trial medication|1|||
125944950|NCT05664490|453096373|FG000|Overall Study|Withdrawal by Subject|0|||
125944951|NCT05664490|453096374|FG001|Overall Study|Withdrawal by Subject|1|||
125944952|NCT05664490|453096373|FG000|Overall Study|Lost to Follow-up|14|||
125944953|NCT05664490|453096374|FG001|Overall Study|Lost to Follow-up|22|||
125944954|NCT02939560|453096375|FG000|Overall Study|Withdrawal by Subject|2|||
125944955|NCT02939560|453096375|FG000|Overall Study|Protocol Violation|1|||
125944956|NCT02420691|453096378|FG000|Overall Study|Adverse Event|3|||
125944957|NCT02420691|453096378|FG000|Overall Study|Withdrawal by Subject|3|||
125944958|NCT05694546|453096386|FG000|Overall Study|Lost to Follow-up|11|||
125944959|NCT01589445|453096387|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
125944960|NCT01589445|453096387|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
125944961|NCT01589445|453096387|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
125944962|NCT01589445|453096387|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
125944963|NCT01589445|453096387|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
125944964|NCT01589445|453096387|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
125944965|NCT01589445|453096387|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
125944966|NCT01589445|453096387|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
125944967|NCT01589445|453096387|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
125944968|NCT01589445|453096387|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
125944969|NCT02972632|453096388|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
125944970|NCT02972632|453096388|FG000|Overall Study|Lost to Follow-up|4|||
125944971|NCT02972632|453096388|FG000|Overall Study|Voluntary Withdrawal|10|||
125944972|NCT03054870|453096405|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
125944973|NCT03054870|453096405|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
125944974|NCT01324388|453096406|FG000|Part 1 of Study|Adverse Event|2|||
125944975|NCT01324388|453096407|FG001|Part 1 of Study|Adverse Event|0|||
125944976|NCT01324388|453096408|FG002|Part 1 of Study|Adverse Event|0|||
125944977|NCT01324388|453096409|FG003|Part 1 of Study|Adverse Event|0|||
125944978|NCT01324388|453096406|FG000|Part 1 of Study|Protocol Violation|1|||
125944979|NCT01324388|453096407|FG001|Part 1 of Study|Protocol Violation|2|||
125944980|NCT01324388|453096408|FG002|Part 1 of Study|Protocol Violation|0|||
125944981|NCT01324388|453096409|FG003|Part 1 of Study|Protocol Violation|0|||
125944982|NCT01324388|453096406|FG000|Part 1 of Study|Physician Decision|1|||
125944983|NCT01324388|453096407|FG001|Part 1 of Study|Physician Decision|0|||
125944984|NCT01324388|453096408|FG002|Part 1 of Study|Physician Decision|0|||
125944985|NCT01324388|453096409|FG003|Part 1 of Study|Physician Decision|0|||
125944986|NCT01324388|453096406|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
125944987|NCT01324388|453096407|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
125944988|NCT01324388|453096408|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
125944989|NCT01324388|453096409|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
125944990|NCT01324388|453096406|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
125944991|NCT01324388|453096407|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
125944992|NCT01324388|453096408|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
125944993|NCT01324388|453096409|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
125944994|NCT00129129|453096412|FG000|Primary Phase|Adverse Event|2|||
125944995|NCT00129129|453096413|FG001|Primary Phase|Adverse Event|1|||
125944996|NCT00129129|453096414|FG002|Primary Phase|Adverse Event|0|||
125944997|NCT00129129|453096415|FG003|Primary Phase|Adverse Event|0|||
125944998|NCT00129129|453096416|FG004|Primary Phase|Adverse Event|0|||
125944999|NCT00129129|453096412|FG000|Primary Phase|Withdrawal by Subject|12|||
125945000|NCT00129129|453096413|FG001|Primary Phase|Withdrawal by Subject|10|||
125945001|NCT00129129|453096414|FG002|Primary Phase|Withdrawal by Subject|0|||
125945002|NCT00129129|453096415|FG003|Primary Phase|Withdrawal by Subject|0|||
125945003|NCT00129129|453096416|FG004|Primary Phase|Withdrawal by Subject|0|||
125945004|NCT00129129|453096412|FG000|Primary Phase|Migration from study area|1|||
125945005|NCT00129129|453096413|FG001|Primary Phase|Migration from study area|3|||
125945006|NCT00129129|453096414|FG002|Primary Phase|Migration from study area|0|||
125945007|NCT00129129|453096415|FG003|Primary Phase|Migration from study area|0|||
125945008|NCT00129129|453096416|FG004|Primary Phase|Migration from study area|0|||
125945009|NCT00129129|453096412|FG000|Primary Phase|Lost to Follow-up|8|||
125945010|NCT00129129|453096413|FG001|Primary Phase|Lost to Follow-up|6|||
125945011|NCT00129129|453096414|FG002|Primary Phase|Lost to Follow-up|0|||
125945012|NCT00129129|453096415|FG003|Primary Phase|Lost to Follow-up|0|||
125945013|NCT00129129|453096416|FG004|Primary Phase|Lost to Follow-up|0|||
125945014|NCT00129129|453096412|FG000|Primary Phase|Other|2|||
125945015|NCT00129129|453096413|FG001|Primary Phase|Other|5|||
125945016|NCT00129129|453096414|FG002|Primary Phase|Other|0|||
125945017|NCT00129129|453096415|FG003|Primary Phase|Other|0|||
125945018|NCT00129129|453096416|FG004|Primary Phase|Other|0|||
125945019|NCT00129129|453096412|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
125945020|NCT00129129|453096413|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
125945021|NCT00129129|453096414|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
125945022|NCT00129129|453096415|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
125945023|NCT00129129|453096416|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
125945024|NCT00129129|453096412|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
125945025|NCT00129129|453096413|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
125945026|NCT00129129|453096414|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
125945027|NCT00129129|453096415|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
125945028|NCT00129129|453096416|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
125945029|NCT00129129|453096412|FG000|Fourth Dose Phase|Migration from study area|0|||
125945030|NCT00129129|453096413|FG001|Fourth Dose Phase|Migration from study area|0|||
125945031|NCT00129129|453096414|FG002|Fourth Dose Phase|Migration from study area|0|||
125945032|NCT00129129|453096415|FG003|Fourth Dose Phase|Migration from study area|0|||
125945033|NCT00129129|453096416|FG004|Fourth Dose Phase|Migration from study area|2|||
125945034|NCT00129129|453096412|FG000|Fourth Dose Phase|Other|0|||
125945035|NCT00129129|453096413|FG001|Fourth Dose Phase|Other|0|||
125945036|NCT00129129|453096414|FG002|Fourth Dose Phase|Other|0|||
125945037|NCT00129129|453096415|FG003|Fourth Dose Phase|Other|1|||
125945038|NCT00129129|453096416|FG004|Fourth Dose Phase|Other|1|||
125945039|NCT00129129|453096412|FG000|Fourth Dose Phase|Protocol Violation|0|||
125945040|NCT00129129|453096413|FG001|Fourth Dose Phase|Protocol Violation|0|||
125945041|NCT00129129|453096414|FG002|Fourth Dose Phase|Protocol Violation|0|||
125945042|NCT00129129|453096415|FG003|Fourth Dose Phase|Protocol Violation|1|||
125945043|NCT00129129|453096416|FG004|Fourth Dose Phase|Protocol Violation|0|||
125945044|NCT03089606|453096417|FG000|Overall Study|Progression after Cycle 1|1|||
125945045|NCT02140567|453096419|FG000|Overall Study|Problems with recording equipment|6|||
125945046|NCT01709695|453096421|FG000|Overall Study|Withdrawal by Subject|1|||
125945047|NCT01709695|453096422|FG001|Overall Study|Withdrawal by Subject|1|||
125945048|NCT02802592|453096423|FG000|Overall Study|Study terminated due to loss of funding|4|||
125945049|NCT02590939|453096424|FG000|Overall Study|Withdrawal by Subject|3|||
125945050|NCT02590939|453096425|FG001|Overall Study|Withdrawal by Subject|1|||
125945051|NCT02590939|453096424|FG000|Overall Study|Failed the nociceptive test|2|||
126069410|NCT05372913|453547416|FG001|Overall Study|Adverse Event|1|||
126069411|NCT03275402|453547417|FG000|Overall Study|Death|17|||
126069412|NCT03275402|453547417|FG000|Overall Study|Study terminated by sponsor|21|||
126069413|NCT03275402|453547417|FG000|Overall Study|Withdrawal by Subject|1|||
126069414|NCT05135156|453547418|FG000|Overall Study|Lost to Follow-up|0|||
126069415|NCT05135156|453547419|FG001|Overall Study|Lost to Follow-up|0|||
126069416|NCT05135156|453547420|FG002|Overall Study|Lost to Follow-up|2|||
126069417|NCT02986659|453547424|FG000|First Intervention Period|Adverse Event|3|||
126069418|NCT02986659|453547425|FG001|First Intervention Period|Adverse Event|1|||
126069419|NCT02986659|453547424|FG000|First Intervention Period|Lost to Follow-up|1|||
126069420|NCT02986659|453547425|FG001|First Intervention Period|Lost to Follow-up|0|||
126069421|NCT02986659|453547424|FG000|First Intervention Period|Withdrawal by Subject|0|||
126069422|NCT02986659|453547425|FG001|First Intervention Period|Withdrawal by Subject|1|||
126069423|NCT02986659|453547424|FG000|Second Intervention Period|Adverse Event|0|||
126069424|NCT02986659|453547425|FG001|Second Intervention Period|Adverse Event|6|||
126069425|NCT02402465|453547431|FG000|Overall Study|Withdrawal by Subject|0|||
126069426|NCT02402465|453547432|FG001|Overall Study|Withdrawal by Subject|0|||
126069427|NCT02402465|453547433|FG002|Overall Study|Withdrawal by Subject|0|||
126069428|NCT02402465|453547434|FG003|Overall Study|Withdrawal by Subject|0|||
126069429|NCT02402465|453547435|FG004|Overall Study|Withdrawal by Subject|0|||
126069430|NCT02402465|453547436|FG005|Overall Study|Withdrawal by Subject|1|||
126069431|NCT02402465|453547431|FG000|Overall Study|Lost to Follow-up|0|||
126069432|NCT02402465|453547432|FG001|Overall Study|Lost to Follow-up|1|||
126069433|NCT02402465|453547433|FG002|Overall Study|Lost to Follow-up|0|||
126069434|NCT02402465|453547434|FG003|Overall Study|Lost to Follow-up|0|||
126069435|NCT02402465|453547435|FG004|Overall Study|Lost to Follow-up|1|||
126069436|NCT02402465|453547436|FG005|Overall Study|Lost to Follow-up|0|||
126069437|NCT03807700|453547437|FG000|Overall Study|Withdrawal by Subject|2|||
126069438|NCT03807700|453547438|FG001|Overall Study|Withdrawal by Subject|1|||
126069439|NCT02005029|453547439|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
126069440|NCT02005029|453547440|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
126069441|NCT01370018|453547441|FG000|Overall Study|Did not meet criteria for analysis|1|||
126069442|NCT03772041|453547442|FG000|Overall Study|Adverse Event|8|||
126069443|NCT03772041|453547443|FG001|Overall Study|Adverse Event|3|||
126069444|NCT03772041|453547442|FG000|Overall Study|Withdrawal by Subject|0|||
126069445|NCT03772041|453547443|FG001|Overall Study|Withdrawal by Subject|2|||
126069446|NCT03772041|453547442|FG000|Overall Study|Protocol Violation|4|||
126069447|NCT03772041|453547443|FG001|Overall Study|Protocol Violation|2|||
126069448|NCT03772041|453547442|FG000|Overall Study|Physician Decision|2|||
126069449|NCT03772041|453547443|FG001|Overall Study|Physician Decision|3|||
126069450|NCT01525641|453547444|FG000|Overall Study|Case report form not collected|25|||
126069451|NCT01525641|453547444|FG000|Overall Study|No visit since the first visit|16|||
126069452|NCT01525641|453547444|FG000|Overall Study|Adverse Event|73|||
126069453|NCT01525641|453547444|FG000|Overall Study|Lack of Efficacy|24|||
126069454|NCT01525641|453547444|FG000|Overall Study|Improvement|5|||
126069455|NCT01525641|453547444|FG000|Overall Study|Lost to follow-up (relocation)|1|||
126069456|NCT01525641|453547444|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
126069457|NCT01525641|453547444|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
126069458|NCT01525641|453547444|FG000|Overall Study|Other than stated above|7|||
126069459|NCT00191984|453547460|FG000|Overall Study|Disease Progression|21|||
126069460|NCT00191984|453547460|FG000|Overall Study|Adverse Event|4|||
126069461|NCT00191984|453547460|FG000|Overall Study|Death|2|||
126069462|NCT00191984|453547460|FG000|Overall Study|Entry Criteria Exclusion|1|||
126069463|NCT00191984|453547460|FG000|Overall Study|Withdrawal by Subject|7|||
126069464|NCT00191984|453547460|FG000|Overall Study|Physician Decision|4|||
126069465|NCT02137239|453547461|FG000|Overall Study|Discontinued Study Treatment|0|||
126069466|NCT02137239|453547462|FG001|Overall Study|Discontinued Study Treatment|3|||
126069467|NCT02137239|453547461|FG000|Overall Study|Withdrew Consent|1|||
126069468|NCT02137239|453547462|FG001|Overall Study|Withdrew Consent|1|||
126069469|NCT02137239|453547461|FG000|Overall Study|Adverse Event|2|||
126069470|NCT02137239|453547462|FG001|Overall Study|Adverse Event|2|||
126069471|NCT04474691|453547464|FG000|Overall Study|Withdrawal by Subject|9|||
126069472|NCT01323309|453547465|FG000|Overall Study|Death|9|||
126069473|NCT01323309|453547466|FG001|Overall Study|Death|15|||
126069474|NCT01323309|453547467|FG002|Overall Study|Death|5|||
126069475|NCT01323309|453547465|FG000|Overall Study|Lost to Follow-up|11|||
126069476|NCT01323309|453547466|FG001|Overall Study|Lost to Follow-up|14|||
126069477|NCT01323309|453547467|FG002|Overall Study|Lost to Follow-up|24|||
126069478|NCT01323309|453547465|FG000|Overall Study|Withdrawal by Subject|14|||
126069479|NCT01323309|453547466|FG001|Overall Study|Withdrawal by Subject|14|||
126069480|NCT01323309|453547467|FG002|Overall Study|Withdrawal by Subject|18|||
126069481|NCT01323309|453547465|FG000|Overall Study|Disease progression|5|||
126069482|NCT01323309|453547466|FG001|Overall Study|Disease progression|11|||
126069483|NCT01323309|453547467|FG002|Overall Study|Disease progression|4|||
126069484|NCT03048058|453547469|FG000|Overall Study|Lost to Follow-up|4|||
126069485|NCT03048058|453547470|FG001|Overall Study|Lost to Follow-up|0|||
126069486|NCT03048058|453547469|FG000|Overall Study|Withdrawal by Subject|0|||
125945052|NCT02590939|453096425|FG001|Overall Study|Failed the nociceptive test|1|||
125945053|NCT03774433|453096426|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
125945054|NCT00108160|453096427|FG000|Overall Study|Lost to Follow-up|25|||
125945055|NCT00108160|453096428|FG001|Overall Study|Lost to Follow-up|12|||
125945056|NCT00108160|453096427|FG000|Overall Study|Death|1|||
125945057|NCT00108160|453096428|FG001|Overall Study|Death|2|||
125945058|NCT00108160|453096427|FG000|Overall Study|Withdrawal by Subject|4|||
125945059|NCT00108160|453096428|FG001|Overall Study|Withdrawal by Subject|2|||
125945060|NCT00108160|453096427|FG000|Overall Study|Protocol Violation|9|||
125945061|NCT00108160|453096428|FG001|Overall Study|Protocol Violation|5|||
125945062|NCT02968979|453096432|FG000|Overall Study|Protocol Violation|7|||
125945063|NCT02968979|453096432|FG000|Overall Study|Withdrawal by Subject|1|||
125945064|NCT04404855|453096434|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
125945065|NCT04404855|453096435|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
125945066|NCT03320564|453096436|FG000|Overall Study|Protocol Violation|1|||
125945067|NCT00788827|453096437|FG000|Overall Study|Lack of Efficacy|2|||
125945068|NCT03979638|453096445|FG000|Period 1|Physician Decision|1|||
125945069|NCT03979638|453096446|FG001|Period 1|Physician Decision|1|||
125945070|NCT03979638|453096445|FG000|Period 1|Withdrawal by Subject|4|||
125945071|NCT03979638|453096446|FG001|Period 1|Withdrawal by Subject|3|||
125945072|NCT03979638|453096445|FG000|Period 1|Study terminated by Sponsor|1|||
125945073|NCT03979638|453096446|FG001|Period 1|Study terminated by Sponsor|3|||
125945074|NCT03979638|453096445|FG000|Period 1|Protocol Violation|1|||
125945075|NCT03979638|453096446|FG001|Period 1|Protocol Violation|0|||
125945076|NCT03979638|453096445|FG000|Period 2|Study terminated by Sponsor|1|||
125945077|NCT03979638|453096446|FG001|Period 2|Study terminated by Sponsor|1|||
125945078|NCT04248933|453096447|FG000|Overall Study|Lost to Follow-up|9|||
125945079|NCT04248933|453096447|FG000|Overall Study|Withdrawal by Subject|2|||
125945080|NCT00578942|453096450|FG000|Overall Study|Lost to Follow-up|1|||
125945081|NCT00600938|453096459|FG000|Core Study|Abnormal test procedure result(s)|3|||
125945082|NCT00600938|453096460|FG001|Core Study|Abnormal test procedure result(s)|2|||
125945083|NCT00600938|453096461|FG002|Core Study|Abnormal test procedure result(s)|0|||
125945084|NCT00600938|453096462|FG003|Core Study|Abnormal test procedure result(s)|0|||
125945085|NCT00600938|453096459|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
125945086|NCT00600938|453096460|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
125945087|NCT00600938|453096461|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
125945088|NCT00600938|453096462|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
125945089|NCT00600938|453096459|FG000|Core Study|Patient withdrew consent|7|||
125945090|NCT00600938|453096460|FG001|Core Study|Patient withdrew consent|12|||
125945091|NCT00600938|453096461|FG002|Core Study|Patient withdrew consent|0|||
125945092|NCT00600938|453096462|FG003|Core Study|Patient withdrew consent|0|||
125945093|NCT00600938|453096459|FG000|Core Study|Lost to Follow-up|3|||
125945094|NCT00600938|453096460|FG001|Core Study|Lost to Follow-up|2|||
125945095|NCT00600938|453096461|FG002|Core Study|Lost to Follow-up|0|||
125945096|NCT00600938|453096462|FG003|Core Study|Lost to Follow-up|0|||
125945097|NCT00600938|453096459|FG000|Core Study|Death|1|||
125945098|NCT00600938|453096460|FG001|Core Study|Death|1|||
125945099|NCT00600938|453096461|FG002|Core Study|Death|0|||
125945100|NCT00600938|453096462|FG003|Core Study|Death|0|||
125945101|NCT00600938|453096459|FG000|Core Study|Protocol Violation|1|||
125945102|NCT00600938|453096460|FG001|Core Study|Protocol Violation|2|||
125945103|NCT00600938|453096461|FG002|Core Study|Protocol Violation|0|||
125945104|NCT00600938|453096462|FG003|Core Study|Protocol Violation|0|||
125945105|NCT00600938|453096459|FG000|Extension Study|Adverse Event|1|||
125945106|NCT00600938|453096460|FG001|Extension Study|Adverse Event|0|||
125945107|NCT00600938|453096461|FG002|Extension Study|Adverse Event|2|||
125945108|NCT00600938|453096462|FG003|Extension Study|Adverse Event|0|||
125945109|NCT00600938|453096459|FG000|Extension Study|Abnormal test procedure results|0|||
125945110|NCT00600938|453096460|FG001|Extension Study|Abnormal test procedure results|1|||
125945111|NCT00600938|453096461|FG002|Extension Study|Abnormal test procedure results|1|||
125945112|NCT00600938|453096462|FG003|Extension Study|Abnormal test procedure results|1|||
125945113|NCT00600938|453096459|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
125945114|NCT00600938|453096460|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
125945115|NCT00600938|453096461|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
125945116|NCT00600938|453096462|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
125945117|NCT00600938|453096459|FG000|Extension Study|Withdrawal by Subject|2|||
125945118|NCT00600938|453096460|FG001|Extension Study|Withdrawal by Subject|2|||
125945119|NCT00600938|453096461|FG002|Extension Study|Withdrawal by Subject|3|||
125945120|NCT00600938|453096462|FG003|Extension Study|Withdrawal by Subject|0|||
125945121|NCT00600938|453096459|FG000|Extension Study|Lost to Follow-up|1|||
125945122|NCT00600938|453096460|FG001|Extension Study|Lost to Follow-up|1|||
125945123|NCT00600938|453096461|FG002|Extension Study|Lost to Follow-up|2|||
125945124|NCT00600938|453096462|FG003|Extension Study|Lost to Follow-up|0|||
125945125|NCT00600938|453096459|FG000|Extension Study|Death|1|||
125945126|NCT00600938|453096460|FG001|Extension Study|Death|0|||
125945127|NCT00600938|453096461|FG002|Extension Study|Death|0|||
126069487|NCT03048058|453547470|FG001|Overall Study|Withdrawal by Subject|4|||
126069488|NCT02625922|453547471|FG000|Overall Study|Non-availability of IMP|1|||
126069489|NCT02625922|453547472|FG001|Overall Study|Non-availability of IMP|1|||
126069490|NCT02625922|453547471|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
126069491|NCT02625922|453547472|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
126069492|NCT02359552|453547473|FG000|Overall Study|Lost to Follow-up|3|||
126069493|NCT02359552|453547474|FG001|Overall Study|Lost to Follow-up|4|||
126069494|NCT02391116|453547475|FG000|Treatment|Withdrawal by Subject|1|||
126069495|NCT02391116|453547475|FG000|Treatment|Protocol Violation|1|||
126069496|NCT02391116|453547475|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
126069497|NCT02391116|453547475|FG000|Treatment|AE with Clinical PD|3|||
126069498|NCT02391116|453547475|FG000|Safety Follow-up|Adverse Event|1|||
126069499|NCT02391116|453547475|FG000|Safety Follow-up|Withdrawal by Subject|4|||
126069500|NCT02391116|453547475|FG000|Safety Follow-up|Switching to Other Therapy|4|||
126069501|NCT02391116|453547475|FG000|Safety Follow-up|No Follow Up|1|||
126069502|NCT02391116|453547475|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
126069503|NCT02391116|453547475|FG000|Active Follow-up|Withdrawal by Subject|1|||
126069504|NCT02391116|453547475|FG000|Active Follow-up|Switching to Other Therapy|2|||
126069505|NCT02391116|453547475|FG000|Survival Follow-up|Withdrawal by Subject|3|||
126069506|NCT02391116|453547475|FG000|Survival Follow-up|Switching to Other Therapy|1|||
126069507|NCT01261793|453547479|FG000|Overall Study|Lack of Efficacy|44|||
126069508|NCT01261793|453547480|FG001|Overall Study|Lack of Efficacy|37|||
126069509|NCT01261793|453547481|FG002|Overall Study|Lack of Efficacy|32|||
126069510|NCT01261793|453547479|FG000|Overall Study|Protocol Violation|3|||
126069511|NCT01261793|453547480|FG001|Overall Study|Protocol Violation|5|||
126069512|NCT01261793|453547481|FG002|Overall Study|Protocol Violation|6|||
126069513|NCT01261793|453547479|FG000|Overall Study|Lost to Follow-up|10|||
126069514|NCT01261793|453547480|FG001|Overall Study|Lost to Follow-up|3|||
126069515|NCT01261793|453547481|FG002|Overall Study|Lost to Follow-up|7|||
126069516|NCT01261793|453547479|FG000|Overall Study|Withdrawal by Subject|12|||
126069517|NCT01261793|453547480|FG001|Overall Study|Withdrawal by Subject|14|||
126069518|NCT01261793|453547481|FG002|Overall Study|Withdrawal by Subject|14|||
126069519|NCT01261793|453547479|FG000|Overall Study|Death|3|||
126069520|NCT01261793|453547480|FG001|Overall Study|Death|1|||
126069521|NCT01261793|453547481|FG002|Overall Study|Death|0|||
126069522|NCT01261793|453547479|FG000|Overall Study|Adverse Event|9|||
126069523|NCT01261793|453547480|FG001|Overall Study|Adverse Event|24|||
125945128|NCT00600938|453096462|FG003|Extension Study|Death|0|||
125945129|NCT04220411|453096463|FG000|Overall Study|Adverse Event|0|||
125945130|NCT04220411|453096464|FG001|Overall Study|Adverse Event|0|||
125945131|NCT04220411|453096465|FG002|Overall Study|Adverse Event|0|||
125945132|NCT04220411|453096466|FG003|Overall Study|Adverse Event|1|||
125945133|NCT02680639|453096467|FG000|Screening Period|Screen Failure|7|||
125945134|NCT02680639|453096468|FG001|Screening Period|Screen Failure|0|||
125945135|NCT02680639|453096469|FG002|Screening Period|Screen Failure|0|||
125945136|NCT02678676|453096470|FG000|Overall Study|Death|619|||
125945137|NCT02678676|453096471|FG001|Overall Study|Death|649|||
125945138|NCT02678676|453096470|FG000|Overall Study|Withdrawal by Subject|13|||
125945139|NCT02678676|453096471|FG001|Overall Study|Withdrawal by Subject|5|||
125945140|NCT02678676|453096470|FG000|Overall Study|Lost to Follow-up|171|||
125945141|NCT02678676|453096471|FG001|Overall Study|Lost to Follow-up|151|||
125945142|NCT02678676|453096470|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
125945143|NCT02678676|453096471|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
125945144|NCT00747435|453096472|FG000|Overall Study|Lost to Follow-up|2|||
125945145|NCT00747435|453096472|FG000|Overall Study|Withdrawal by Subject|3|||
125945146|NCT00747435|453096472|FG000|Overall Study|Still undergoing follow up|1|||
125945147|NCT04059146|453096473|FG000|Overall Study|Withdrawal by Subject|0|||
125945148|NCT04059146|453096474|FG001|Overall Study|Withdrawal by Subject|1|||
125945149|NCT04439318|453096475|FG000|Overall Study|Ineligible|1|||
125945150|NCT04439318|453096475|FG000|Overall Study|Never Started Treatment|3|||
125945151|NCT04439318|453096475|FG000|Overall Study|Adverse Event|10|||
125945152|NCT04439318|453096475|FG000|Overall Study|Death|2|||
125945153|NCT04439318|453096475|FG000|Overall Study|Disease Progression|25|||
126069524|NCT01261793|453547481|FG002|Overall Study|Adverse Event|19|||
126069525|NCT01261793|453547479|FG000|Overall Study|Patient non-availability|1|||
126069526|NCT01261793|453547480|FG001|Overall Study|Patient non-availability|1|||
126069527|NCT01261793|453547481|FG002|Overall Study|Patient non-availability|1|||
126069528|NCT01261793|453547479|FG000|Overall Study|Suspected pregnancy|1|||
126069529|NCT01261793|453547480|FG001|Overall Study|Suspected pregnancy|1|||
125945154|NCT04439318|453096475|FG000|Overall Study|Other Complicating Disease|2|||
125945155|NCT04439318|453096475|FG000|Overall Study|Withdrawal by Subject|4|||
125945156|NCT04439318|453096475|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
125945157|NCT04439318|453096475|FG000|Overall Study|Non-Compliance|1|||
125945158|NCT04439318|453096475|FG000|Overall Study|Still on Treatment|1|||
126069530|NCT01261793|453547481|FG002|Overall Study|Suspected pregnancy|0|||
126069531|NCT01261793|453547479|FG000|Overall Study|Patient non-compliance|1|||
126069532|NCT01261793|453547480|FG001|Overall Study|Patient non-compliance|0|||
126069533|NCT01261793|453547481|FG002|Overall Study|Patient non-compliance|1|||
126069534|NCT01261793|453547479|FG000|Overall Study|Patient pregnant|1|||
126069535|NCT01261793|453547480|FG001|Overall Study|Patient pregnant|0|||
126069536|NCT01261793|453547481|FG002|Overall Study|Patient pregnant|0|||
126069537|NCT01261793|453547479|FG000|Overall Study|Outside the study area|0|||
126069538|NCT01261793|453547480|FG001|Overall Study|Outside the study area|2|||
126069539|NCT01261793|453547481|FG002|Overall Study|Outside the study area|1|||
126069540|NCT01261793|453547479|FG000|Overall Study|Lack of efficacy & patient not available|0|||
126069541|NCT01261793|453547480|FG001|Overall Study|Lack of efficacy & patient not available|1|||
126069542|NCT01261793|453547481|FG002|Overall Study|Lack of efficacy & patient not available|0|||
126069543|NCT01261793|453547479|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
126069544|NCT01261793|453547480|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
126069545|NCT01261793|453547481|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
126069546|NCT01261793|453547479|FG000|Overall Study|Randomization error|0|||
126069547|NCT01261793|453547480|FG001|Overall Study|Randomization error|1|||
126069548|NCT01261793|453547481|FG002|Overall Study|Randomization error|0|||
126069549|NCT01261793|453547479|FG000|Overall Study|Patient unable to start IV line|0|||
126069550|NCT01261793|453547480|FG001|Overall Study|Patient unable to start IV line|0|||
126069551|NCT01261793|453547481|FG002|Overall Study|Patient unable to start IV line|1|||
126069552|NCT00832650|453547485|FG000|Overall Study|Randomized but not treated|0|||
126069553|NCT00832650|453547486|FG001|Overall Study|Randomized but not treated|0|||
126069554|NCT00832650|453547487|FG002|Overall Study|Randomized but not treated|1|||
126069555|NCT02133131|453547488|FG000|Overall Study|Adverse Event|0|||
126069556|NCT02133131|453547489|FG001|Overall Study|Adverse Event|0|||
126069557|NCT02133131|453547490|FG002|Overall Study|Adverse Event|0|||
126069558|NCT02133131|453547491|FG003|Overall Study|Adverse Event|1|||
126069559|NCT02133131|453547492|FG004|Overall Study|Adverse Event|0|||
126069560|NCT02133131|453547493|FG005|Overall Study|Adverse Event|0|||
126069561|NCT02133131|453547494|FG006|Overall Study|Adverse Event|0|||
126069562|NCT02133131|453547488|FG000|Overall Study|Lost to Follow-up|1|||
126069563|NCT02133131|453547489|FG001|Overall Study|Lost to Follow-up|0|||
126069564|NCT02133131|453547490|FG002|Overall Study|Lost to Follow-up|0|||
126069565|NCT02133131|453547491|FG003|Overall Study|Lost to Follow-up|1|||
126069566|NCT02133131|453547492|FG004|Overall Study|Lost to Follow-up|0|||
126069567|NCT02133131|453547493|FG005|Overall Study|Lost to Follow-up|0|||
126069568|NCT02133131|453547494|FG006|Overall Study|Lost to Follow-up|0|||
126069569|NCT02133131|453547488|FG000|Overall Study|Status not recorded|4|||
126069570|NCT02133131|453547489|FG001|Overall Study|Status not recorded|5|||
126069571|NCT02133131|453547490|FG002|Overall Study|Status not recorded|1|||
126069572|NCT02133131|453547491|FG003|Overall Study|Status not recorded|4|||
126069573|NCT02133131|453547492|FG004|Overall Study|Status not recorded|0|||
126069574|NCT02133131|453547493|FG005|Overall Study|Status not recorded|0|||
126069575|NCT02133131|453547494|FG006|Overall Study|Status not recorded|0|||
126069576|NCT02133131|453547488|FG000|Overall Study|Ongoing in study|0|||
126069577|NCT02133131|453547489|FG001|Overall Study|Ongoing in study|0|||
126069578|NCT02133131|453547490|FG002|Overall Study|Ongoing in study|0|||
126069579|NCT02133131|453547491|FG003|Overall Study|Ongoing in study|0|||
126069580|NCT02133131|453547492|FG004|Overall Study|Ongoing in study|15|||
126069581|NCT02133131|453547493|FG005|Overall Study|Ongoing in study|14|||
126069582|NCT02133131|453547494|FG006|Overall Study|Ongoing in study|11|||
126069583|NCT02133131|453547488|FG000|Overall Study|Protocol Violation|0|||
126069584|NCT02133131|453547489|FG001|Overall Study|Protocol Violation|0|||
126069585|NCT02133131|453547490|FG002|Overall Study|Protocol Violation|0|||
126069586|NCT02133131|453547491|FG003|Overall Study|Protocol Violation|0|||
126069587|NCT02133131|453547492|FG004|Overall Study|Protocol Violation|0|||
126069588|NCT02133131|453547493|FG005|Overall Study|Protocol Violation|0|||
126069589|NCT02133131|453547494|FG006|Overall Study|Protocol Violation|1|||
126069590|NCT01544153|453547495|FG000|Overall Study|Under 18|0|||
126069591|NCT01544153|453547496|FG001|Overall Study|Under 18|1|||
126069592|NCT01544153|453547497|FG002|Overall Study|Under 18|0|||
126069593|NCT01544153|453547498|FG003|Overall Study|Under 18|0|||
126069594|NCT01544153|453547495|FG000|Overall Study|Non-smoker|0|||
126069595|NCT01544153|453547496|FG001|Overall Study|Non-smoker|0|||
126069596|NCT01544153|453547497|FG002|Overall Study|Non-smoker|1|||
126069597|NCT01544153|453547498|FG003|Overall Study|Non-smoker|0|||
126069598|NCT00884793|453547503|FG000|Overall Study|Withdrawal by Subject|1|||
126069599|NCT01032200|453547504|FG000|Overall Study|Death|1|||
126069600|NCT01032200|453547505|FG001|Overall Study|Death|1|||
126069601|NCT01032200|453547504|FG000|Overall Study|Withdrawal by Subject|1|||
126069602|NCT01032200|453547505|FG001|Overall Study|Withdrawal by Subject|3|||
126069603|NCT01032200|453547504|FG000|Overall Study|Toxicity|0|||
126069604|NCT01032200|453547505|FG001|Overall Study|Toxicity|2|||
126069605|NCT01032200|453547504|FG000|Overall Study|Progression|1|||
126069606|NCT01032200|453547505|FG001|Overall Study|Progression|0|||
126069607|NCT01032200|453547504|FG000|Overall Study|Multiple|1|||
126069608|NCT01032200|453547505|FG001|Overall Study|Multiple|1|||
126069609|NCT00714688|453547509|FG000|Overall Study|Lack of Efficacy|14|||
126069610|NCT00714688|453547510|FG001|Overall Study|Lack of Efficacy|1|||
126069611|NCT00714688|453547511|FG002|Overall Study|Lack of Efficacy|4|||
126069612|NCT00714688|453547509|FG000|Overall Study|Withdrawal by Subject|4|||
126069613|NCT00714688|453547510|FG001|Overall Study|Withdrawal by Subject|3|||
126069614|NCT00714688|453547511|FG002|Overall Study|Withdrawal by Subject|3|||
126069615|NCT00714688|453547509|FG000|Overall Study|Lost to Follow-up|5|||
126069616|NCT00714688|453547510|FG001|Overall Study|Lost to Follow-up|2|||
126069617|NCT00714688|453547511|FG002|Overall Study|Lost to Follow-up|0|||
126069618|NCT00714688|453547509|FG000|Overall Study|Adverse Event|2|||
126069619|NCT00714688|453547510|FG001|Overall Study|Adverse Event|15|||
126069620|NCT00714688|453547511|FG002|Overall Study|Adverse Event|19|||
126069621|NCT00714688|453547509|FG000|Overall Study|Subject Non-compliant|3|||
126069622|NCT00714688|453547510|FG001|Overall Study|Subject Non-compliant|5|||
126069623|NCT00714688|453547511|FG002|Overall Study|Subject Non-compliant|5|||
126069624|NCT00714688|453547509|FG000|Overall Study|Ineligible to Continue the Study|0|||
126069625|NCT00714688|453547510|FG001|Overall Study|Ineligible to Continue the Study|1|||
126069626|NCT00714688|453547511|FG002|Overall Study|Ineligible to Continue the Study|1|||
126069627|NCT00714688|453547509|FG000|Overall Study|Sponsor's Decision|0|||
126069628|NCT00714688|453547510|FG001|Overall Study|Sponsor's Decision|2|||
126069629|NCT00714688|453547511|FG002|Overall Study|Sponsor's Decision|0|||
126069630|NCT00714688|453547509|FG000|Overall Study|Other|1|||
126069631|NCT00714688|453547510|FG001|Overall Study|Other|6|||
126069632|NCT00714688|453547511|FG002|Overall Study|Other|5|||
126069633|NCT02316171|453547513|FG000|Overall Study|difficulties with urinary catheter|1|||
126069634|NCT02316171|453547514|FG001|Overall Study|difficulties with urinary catheter|0|||
126069635|NCT02316171|453547515|FG002|Overall Study|difficulties with urinary catheter|0|||
126069636|NCT02316171|453547516|FG003|Overall Study|difficulties with urinary catheter|0|||
126069637|NCT01524887|453547517|FG000|Overall Study|Withdrawal by Subject|6|||
126069638|NCT01524887|453547518|FG001|Overall Study|Withdrawal by Subject|2|||
126069639|NCT01524887|453547519|FG002|Overall Study|Withdrawal by Subject|3|||
126069640|NCT01524887|453547517|FG000|Overall Study|Adverse Event|5|||
126069641|NCT01524887|453547518|FG001|Overall Study|Adverse Event|1|||
126069642|NCT01524887|453547519|FG002|Overall Study|Adverse Event|1|||
126069643|NCT01524887|453547517|FG000|Overall Study|Protocol Violation|0|||
126069644|NCT01524887|453547518|FG001|Overall Study|Protocol Violation|0|||
126069645|NCT01524887|453547519|FG002|Overall Study|Protocol Violation|1|||
126069646|NCT01524887|453547517|FG000|Overall Study|Study termination|73|||
126069647|NCT01524887|453547518|FG001|Overall Study|Study termination|87|||
126069648|NCT01524887|453547519|FG002|Overall Study|Study termination|79|||
126069649|NCT01524887|453547517|FG000|Overall Study|Withdrawal by Caregiver|0|||
126069650|NCT01524887|453547518|FG001|Overall Study|Withdrawal by Caregiver|0|||
126069651|NCT01524887|453547519|FG002|Overall Study|Withdrawal by Caregiver|2|||
126069652|NCT01524887|453547517|FG000|Overall Study|Use of prohibited medication|1|||
126069653|NCT01524887|453547518|FG001|Overall Study|Use of prohibited medication|0|||
126069654|NCT01524887|453547519|FG002|Overall Study|Use of prohibited medication|0|||
126069655|NCT00547300|453547520|FG000|Overall Study|Study was Administratively Terminated|25|||
126069656|NCT00547300|453547521|FG001|Overall Study|Study was Administratively Terminated|24|||
126069657|NCT00547300|453547520|FG000|Overall Study|Did not Meet Entry Criteria|0|||
126069658|NCT00547300|453547521|FG001|Overall Study|Did not Meet Entry Criteria|2|||
126069659|NCT04380688|453547522|FG000|Overall Study|Death|2|||
126069660|NCT04380688|453547523|FG001|Overall Study|Death|2|||
126069661|NCT04380688|453547522|FG000|Overall Study|Lost to Follow-up|2|||
126069662|NCT04380688|453547523|FG001|Overall Study|Lost to Follow-up|4|||
126069663|NCT04380688|453547522|FG000|Overall Study|Withdrawal by Subject|3|||
126069664|NCT04380688|453547523|FG001|Overall Study|Withdrawal by Subject|3|||
126069665|NCT03993054|453547524|FG000|Overall Study|PI Decision|1|||
126069666|NCT04267393|453547527|FG000|Randomization|Adverse Event|1|||
126069667|NCT04267393|453547528|FG001|Randomization|Adverse Event|0|||
126069668|NCT04267393|453547529|FG002|Randomization|Adverse Event|0|||
126069669|NCT04267393|453547527|FG000|Randomization|Administrative Reasons by Sponsor|0|||
126069670|NCT04267393|453547528|FG001|Randomization|Administrative Reasons by Sponsor|1|||
126069671|NCT04267393|453547529|FG002|Randomization|Administrative Reasons by Sponsor|0|||
126069672|NCT04267393|453547527|FG000|Treatment Period|Adverse Event|0|||
126069673|NCT04267393|453547528|FG001|Treatment Period|Adverse Event|2|||
126069674|NCT04267393|453547529|FG002|Treatment Period|Adverse Event|3|||
126069675|NCT04267393|453547527|FG000|Treatment Period|Participant Withdrew Consent|0|||
126069676|NCT04267393|453547528|FG001|Treatment Period|Participant Withdrew Consent|0|||
126069677|NCT04267393|453547529|FG002|Treatment Period|Participant Withdrew Consent|1|||
126069678|NCT04267393|453547527|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
126069679|NCT04267393|453547528|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
126069680|NCT04267393|453547529|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
126069681|NCT01002547|453549330|FG000|Overall Study|Withdrawal by Subject|4|||
126069682|NCT01002547|453549331|FG001|Overall Study|Withdrawal by Subject|0|||
126069683|NCT01002547|453549332|FG002|Overall Study|Withdrawal by Subject|5|||
126069684|NCT01002547|453549330|FG000|Overall Study|Lost to Follow-up|2|||
126069685|NCT01002547|453549331|FG001|Overall Study|Lost to Follow-up|1|||
126069686|NCT01002547|453549332|FG002|Overall Study|Lost to Follow-up|1|||
126069687|NCT01002547|453549330|FG000|Overall Study|Physician Decision|1|||
126069688|NCT01002547|453549331|FG001|Overall Study|Physician Decision|0|||
126069689|NCT01002547|453549332|FG002|Overall Study|Physician Decision|0|||
126069690|NCT01002547|453549330|FG000|Overall Study|Death|0|||
126069691|NCT01002547|453549331|FG001|Overall Study|Death|2|||
126069692|NCT01002547|453549332|FG002|Overall Study|Death|2|||
126069693|NCT01002547|453549330|FG000|Overall Study|Adverse Event|1|||
126069694|NCT01002547|453549331|FG001|Overall Study|Adverse Event|0|||
126069695|NCT01002547|453549332|FG002|Overall Study|Adverse Event|0|||
126069696|NCT02093897|453549337|FG000|Overall Study|Physician Decision|1|||
126069697|NCT02093897|453549337|FG000|Overall Study|Planned age group closure - no's reached|17|||
126069698|NCT02093897|453549337|FG000|Overall Study|Adverse event, non-fatal|1|||
126069699|NCT00088452|453549338|FG000|Overall Study|Did not receive intervention|1|||
126069700|NCT00088452|453549339|FG001|Overall Study|Did not receive intervention|0|||
125945159|NCT04920123|453098013|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
125945160|NCT04920123|453098014|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125945161|NCT04920123|453098015|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
125945162|NCT00278954|453098016|FG000|Overall Study|Adverse Event|3|||
125945163|NCT00278954|453098016|FG000|Overall Study|Lost to Follow-up|1|||
125945164|NCT00278954|453098016|FG000|Overall Study|Withdrawal by Subject|1|||
125945165|NCT03406858|453098017|FG000|Overall Study|Failure to receive treatment drug.|1|||
125945166|NCT03406858|453098017|FG000|Overall Study|ineligible|1|||
125945167|NCT01817725|453098022|FG000|Overall Study|Withdrawal by Subject|1|||
125945168|NCT03412084|453098023|FG000|Overall Study|Withdrawal by Subject|2|||
125945169|NCT03412084|453098024|FG001|Overall Study|Withdrawal by Subject|0|||
125945170|NCT03412084|453098023|FG000|Overall Study|Participant moved|1|||
125945171|NCT03412084|453098024|FG001|Overall Study|Participant moved|0|||
125945172|NCT03412084|453098023|FG000|Overall Study|Lost to Follow-up|1|||
125945173|NCT03412084|453098024|FG001|Overall Study|Lost to Follow-up|1|||
125945174|NCT04064294|453098031|FG000|Overall Study|Adverse Event|1|||
125945175|NCT04064294|453098032|FG001|Overall Study|Adverse Event|0|||
125945176|NCT04064294|453098033|FG002|Overall Study|Adverse Event|0|||
125945177|NCT03450707|453098034|FG000|Overall Study|Outside enrollment window|4|||
125945178|NCT03450707|453098035|FG001|Overall Study|Outside enrollment window|1|||
125945179|NCT03450707|453098034|FG000|Overall Study|Death|1|||
125945180|NCT03450707|453098035|FG001|Overall Study|Death|0|||
125945181|NCT03450707|453098034|FG000|Overall Study|Indication for thiamine|1|||
125945182|NCT03450707|453098035|FG001|Overall Study|Indication for thiamine|1|||
125945183|NCT03450707|453098034|FG000|Overall Study|Evidence of traumatic brain injury|1|||
125945184|NCT03450707|453098035|FG001|Overall Study|Evidence of traumatic brain injury|0|||
125945185|NCT03450707|453098034|FG000|Overall Study|Following commands|0|||
125945186|NCT03450707|453098035|FG001|Overall Study|Following commands|3|||
125945187|NCT03450707|453098034|FG000|Overall Study|Lactate < 3.5|0|||
125945188|NCT03450707|453098035|FG001|Overall Study|Lactate < 3.5|2|||
125945189|NCT03450707|453098034|FG000|Overall Study|Rearrest with ECMO|0|||
125945190|NCT03450707|453098035|FG001|Overall Study|Rearrest with ECMO|1|||
125945191|NCT03450707|453098034|FG000|Overall Study|Indication for thiamine + head CT results|0|||
125945192|NCT03450707|453098035|FG001|Overall Study|Indication for thiamine + head CT results|1|||
125945193|NCT03450707|453098034|FG000|Overall Study|Family/patient goals of care|0|||
125945194|NCT03450707|453098035|FG001|Overall Study|Family/patient goals of care|1|||
125945195|NCT00481195|453098036|FG000|Overall Study|Adverse Event|16|||
125945196|NCT00481195|453098037|FG001|Overall Study|Adverse Event|11|||
125945197|NCT00481195|453098036|FG000|Overall Study|Lack of Efficacy|1|||
125945198|NCT00481195|453098037|FG001|Overall Study|Lack of Efficacy|3|||
125945199|NCT00481195|453098036|FG000|Overall Study|Lost to Follow-up|4|||
125945200|NCT00481195|453098037|FG001|Overall Study|Lost to Follow-up|6|||
125945201|NCT00481195|453098036|FG000|Overall Study|Physician Decision|3|||
125945202|NCT00481195|453098037|FG001|Overall Study|Physician Decision|1|||
125945203|NCT00481195|453098036|FG000|Overall Study|Protocol Violation|10|||
125945204|NCT00481195|453098037|FG001|Overall Study|Protocol Violation|7|||
125945205|NCT00481195|453098036|FG000|Overall Study|Withdrawal by Subject|3|||
125945206|NCT00481195|453098037|FG001|Overall Study|Withdrawal by Subject|9|||
125945207|NCT00481195|453098036|FG000|Overall Study|Miscellaneous|2|||
125945208|NCT00481195|453098037|FG001|Overall Study|Miscellaneous|2|||
125945209|NCT03343483|453098038|FG000|Overall Study|Death|0|||
125945210|NCT03343483|453098039|FG001|Overall Study|Death|3|||
125945211|NCT03343483|453098038|FG000|Overall Study|Lost to Follow-up|9|||
126069701|NCT00088452|453549340|FG002|Overall Study|Did not receive intervention|1|||
126069702|NCT02081196|453549342|FG000|Overall Study|Lost to Follow-up|1|||
125945212|NCT03343483|453098039|FG001|Overall Study|Lost to Follow-up|13|||
125945213|NCT03343483|453098038|FG000|Overall Study|Withdrawal by Subject|8|||
125945214|NCT03343483|453098039|FG001|Overall Study|Withdrawal by Subject|17|||
125945215|NCT01505608|453098040|FG000|Phase I|Lack of Efficacy|0|||
125945216|NCT01505608|453098041|FG001|Phase I|Lack of Efficacy|4|||
125945217|NCT01505608|453098040|FG000|Phase I|Adverse Event|0|||
125945218|NCT01505608|453098041|FG001|Phase I|Adverse Event|1|||
125945219|NCT01505608|453098040|FG000|Phase I|Withdrawal by Subject|0|||
125945220|NCT01505608|453098041|FG001|Phase I|Withdrawal by Subject|1|||
125945221|NCT01505608|453098040|FG000|Phase II|Lack of Efficacy|2|||
125945222|NCT01505608|453098041|FG001|Phase II|Lack of Efficacy|1|||
125945223|NCT01505608|453098040|FG000|Phase II|Protocol Violation|0|||
126069703|NCT03098797|453549345|FG000|Part 2 Open Label Extension|Adverse Event|2|||
126069704|NCT03098797|453549346|FG001|Part 2 Open Label Extension|Adverse Event|0|||
126069705|NCT00434577|453549349|FG000|Months 0-3|Serious Adverse Event|0|||
126069706|NCT00434577|453549350|FG001|Months 0-3|Serious Adverse Event|0|||
126069707|NCT00434577|453549351|FG002|Months 0-3|Serious Adverse Event|1|||
126069708|NCT00434577|453549352|FG003|Months 0-3|Serious Adverse Event|0|||
126069709|NCT00434577|453549353|FG004|Months 0-3|Serious Adverse Event|0|||
126069710|NCT00434577|453549349|FG000|Months 0-3|Adverse Event|0|||
126069711|NCT00434577|453549350|FG001|Months 0-3|Adverse Event|1|||
126069712|NCT00434577|453549351|FG002|Months 0-3|Adverse Event|1|||
126069713|NCT00434577|453549352|FG003|Months 0-3|Adverse Event|0|||
126069714|NCT00434577|453549353|FG004|Months 0-3|Adverse Event|0|||
126069715|NCT00434577|453549349|FG000|Months 0-3|Lost to Follow-up|0|||
126069716|NCT00434577|453549350|FG001|Months 0-3|Lost to Follow-up|0|||
126069717|NCT00434577|453549351|FG002|Months 0-3|Lost to Follow-up|0|||
126069718|NCT00434577|453549352|FG003|Months 0-3|Lost to Follow-up|0|||
126069719|NCT00434577|453549353|FG004|Months 0-3|Lost to Follow-up|2|||
126069720|NCT00434577|453549349|FG000|Months 0-3|Protocol Violation|1|||
126069721|NCT00434577|453549350|FG001|Months 0-3|Protocol Violation|0|||
126069722|NCT00434577|453549351|FG002|Months 0-3|Protocol Violation|1|||
126069723|NCT00434577|453549352|FG003|Months 0-3|Protocol Violation|0|||
126069724|NCT00434577|453549353|FG004|Months 0-3|Protocol Violation|0|||
126069725|NCT00434577|453549349|FG000|Months 0-3|Withdrawal by Subject|2|||
126069726|NCT00434577|453549350|FG001|Months 0-3|Withdrawal by Subject|1|||
126069727|NCT00434577|453549351|FG002|Months 0-3|Withdrawal by Subject|1|||
126069728|NCT00434577|453549352|FG003|Months 0-3|Withdrawal by Subject|1|||
126069729|NCT00434577|453549353|FG004|Months 0-3|Withdrawal by Subject|1|||
126069730|NCT02329223|453549354|FG000|Overall Study|Withdrawal by Subject|1|||
126069731|NCT02329223|453549355|FG001|Overall Study|Withdrawal by Subject|2|||
126069732|NCT02329223|453549356|FG002|Overall Study|Withdrawal by Subject|5|||
126069733|NCT02329223|453549354|FG000|Overall Study|Physician Decision|0|||
126069734|NCT02329223|453549355|FG001|Overall Study|Physician Decision|0|||
126069735|NCT02329223|453549356|FG002|Overall Study|Physician Decision|1|||
126069736|NCT02329223|453549354|FG000|Overall Study|Adverse Event|0|||
126069737|NCT02329223|453549355|FG001|Overall Study|Adverse Event|1|||
126069738|NCT02329223|453549356|FG002|Overall Study|Adverse Event|0|||
126069739|NCT00381888|453549364|FG000|Overall Study|Death|1|||
126069740|NCT00381888|453549364|FG000|Overall Study|Withdrawal by Subject|1|||
126069741|NCT00381888|453549364|FG000|Overall Study|Physician Decision|1|||
126069742|NCT00381888|453549364|FG000|Overall Study|Protocol Violation|9|||
126069743|NCT00381888|453549364|FG000|Overall Study|Had laparoscopic surgery|2|||
126069744|NCT00381888|453549364|FG000|Overall Study|Surgery was cancelled|2|||
126069745|NCT00381888|453549364|FG000|Overall Study|Adverse Event|1|||
126069746|NCT01231464|453549365|FG000|Overall Study|Adverse Event|0|||
126069747|NCT01231464|453549366|FG001|Overall Study|Adverse Event|1|||
126069748|NCT01231464|453549365|FG000|Overall Study|Protocol Violation|1|||
126069749|NCT01231464|453549366|FG001|Overall Study|Protocol Violation|2|||
126069750|NCT01231464|453549365|FG000|Overall Study|Lost to Follow-up|1|||
126069751|NCT01231464|453549366|FG001|Overall Study|Lost to Follow-up|2|||
126069752|NCT01231464|453549365|FG000|Overall Study|Withdrawal by Subject|3|||
126069753|NCT01231464|453549366|FG001|Overall Study|Withdrawal by Subject|2|||
126069754|NCT01589523|453549375|FG000|Overall Study|Withdrawal by Subject|1|||
126069755|NCT00961896|453549376|FG000|Overall Study|Abnormal laboratory value|0|||
126069756|NCT00961896|453549377|FG001|Overall Study|Abnormal laboratory value|0|||
126069757|NCT00961896|453549378|FG002|Overall Study|Abnormal laboratory value|1|||
126069758|NCT00506922|453549379|FG000|Overall Study|Physician Decision|0|||
126069759|NCT00506922|453549380|FG001|Overall Study|Physician Decision|0|||
126069760|NCT00506922|453549381|FG002|Overall Study|Physician Decision|0|||
126069761|NCT00506922|453549382|FG003|Overall Study|Physician Decision|2|||
126069762|NCT00506922|453549383|FG004|Overall Study|Physician Decision|0|||
126069763|NCT00506922|453549379|FG000|Overall Study|Withdrawal by Subject|0|||
126069764|NCT00506922|453549380|FG001|Overall Study|Withdrawal by Subject|0|||
126069765|NCT00506922|453549381|FG002|Overall Study|Withdrawal by Subject|0|||
126069766|NCT00506922|453549382|FG003|Overall Study|Withdrawal by Subject|0|||
126069767|NCT00506922|453549383|FG004|Overall Study|Withdrawal by Subject|1|||
126069768|NCT02507687|453549391|FG000|Overall Study|Adverse Event|3|||
126069769|NCT02507687|453549392|FG001|Overall Study|Adverse Event|2|||
126069770|NCT02507687|453549393|FG002|Overall Study|Adverse Event|2|||
126069771|NCT02507687|453549394|FG003|Overall Study|Adverse Event|2|||
126069772|NCT02507687|453549391|FG000|Overall Study|Withdrawal by Subject|1|||
126069773|NCT02507687|453549392|FG001|Overall Study|Withdrawal by Subject|4|||
126069774|NCT02507687|453549393|FG002|Overall Study|Withdrawal by Subject|6|||
126069775|NCT02507687|453549394|FG003|Overall Study|Withdrawal by Subject|6|||
126069776|NCT02507687|453549391|FG000|Overall Study|Protocol Violation|1|||
126069777|NCT02507687|453549392|FG001|Overall Study|Protocol Violation|0|||
126069778|NCT02507687|453549393|FG002|Overall Study|Protocol Violation|2|||
126069779|NCT02507687|453549394|FG003|Overall Study|Protocol Violation|0|||
126069780|NCT02507687|453549391|FG000|Overall Study|Lost to Follow-up|0|||
126069781|NCT02507687|453549392|FG001|Overall Study|Lost to Follow-up|0|||
126069782|NCT02507687|453549393|FG002|Overall Study|Lost to Follow-up|2|||
126069783|NCT02507687|453549394|FG003|Overall Study|Lost to Follow-up|1|||
126069784|NCT02507687|453549391|FG000|Overall Study|Screen Failure|0|||
126069785|NCT02507687|453549392|FG001|Overall Study|Screen Failure|0|||
126069786|NCT02507687|453549393|FG002|Overall Study|Screen Failure|1|||
126069787|NCT02507687|453549394|FG003|Overall Study|Screen Failure|0|||
126069788|NCT02507687|453549391|FG000|Overall Study|Other, Not Specified|0|||
126069789|NCT02507687|453549392|FG001|Overall Study|Other, Not Specified|0|||
126069790|NCT02507687|453549393|FG002|Overall Study|Other, Not Specified|2|||
126069791|NCT02507687|453549394|FG003|Overall Study|Other, Not Specified|4|||
126069792|NCT02675998|453549395|FG000|8-Week Treatment Period|Adverse Event|6|||
126069793|NCT02675998|453549396|FG001|8-Week Treatment Period|Adverse Event|5|||
126069794|NCT02675998|453549397|FG002|8-Week Treatment Period|Adverse Event|6|||
126069795|NCT02675998|453549398|FG003|8-Week Treatment Period|Adverse Event|0|||
126069796|NCT02675998|453549395|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
126069797|NCT02675998|453549396|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
126069798|NCT02675998|453549397|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
126069799|NCT02675998|453549398|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
126069800|NCT02675998|453549395|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
126069801|NCT02675998|453549396|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
126069802|NCT02675998|453549397|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
125945224|NCT01505608|453098041|FG001|Phase II|Protocol Violation|1|||
125945225|NCT00337103|453098042|FG000|Overall Study|Progressive Disease|414|||
125945226|NCT00337103|453098043|FG001|Overall Study|Progressive Disease|410|||
125945227|NCT00337103|453098042|FG000|Overall Study|Adverse Event|45|||
125945228|NCT00337103|453098043|FG001|Overall Study|Adverse Event|59|||
125945229|NCT00337103|453098042|FG000|Overall Study|Subject Choice|34|||
125945230|NCT00337103|453098043|FG001|Overall Study|Subject Choice|27|||
125945231|NCT00337103|453098042|FG000|Overall Study|Clinical Progression|27|||
125945232|NCT00337103|453098043|FG001|Overall Study|Clinical Progression|24|||
125945233|NCT00337103|453098042|FG000|Overall Study|Physician Decision|15|||
125945234|NCT00337103|453098043|FG001|Overall Study|Physician Decision|14|||
125945235|NCT00337103|453098042|FG000|Overall Study|Withdrawal by Subject|8|||
125945236|NCT00337103|453098043|FG001|Overall Study|Withdrawal by Subject|5|||
125945237|NCT00337103|453098042|FG000|Overall Study|Other|5|||
125945238|NCT00337103|453098043|FG001|Overall Study|Other|6|||
125945239|NCT00337103|453098042|FG000|Overall Study|Entry Criteria Not Met|4|||
125945240|NCT00337103|453098043|FG001|Overall Study|Entry Criteria Not Met|1|||
125945241|NCT00337103|453098042|FG000|Overall Study|Lost to Follow-up|1|||
125945242|NCT00337103|453098043|FG001|Overall Study|Lost to Follow-up|2|||
125945243|NCT00337103|453098042|FG000|Overall Study|Death|1|||
125945244|NCT00337103|453098043|FG001|Overall Study|Death|0|||
125945245|NCT03792672|453098046|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
125945246|NCT03792672|453098047|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
125945247|NCT03792672|453098048|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
125945248|NCT03792672|453098049|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
125945249|NCT03792672|453098050|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
125945250|NCT03792672|453098051|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
125945251|NCT03792672|453098046|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
125945252|NCT03792672|453098047|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
125945253|NCT03792672|453098048|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
125945254|NCT03792672|453098049|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
125945255|NCT03792672|453098050|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
125945256|NCT03792672|453098051|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
125945257|NCT03792672|453098046|FG000|Treatment Period 4 (2 Days)|Other|1|||
125945258|NCT03792672|453098047|FG001|Treatment Period 4 (2 Days)|Other|0|||
125945259|NCT03792672|453098048|FG002|Treatment Period 4 (2 Days)|Other|0|||
125945260|NCT03792672|453098049|FG003|Treatment Period 4 (2 Days)|Other|0|||
125945261|NCT03792672|453098050|FG004|Treatment Period 4 (2 Days)|Other|0|||
125945262|NCT03792672|453098051|FG005|Treatment Period 4 (2 Days)|Other|0|||
126069803|NCT02675998|453549398|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
126069804|NCT02675998|453549395|FG000|8-Week Treatment Period|Physician Decision|1|||
126069805|NCT02675998|453549396|FG001|8-Week Treatment Period|Physician Decision|0|||
126069806|NCT02675998|453549397|FG002|8-Week Treatment Period|Physician Decision|2|||
125945263|NCT02319031|453098057|FG000|Treatment Period|Death|1|||
125945264|NCT02319031|453098058|FG001|Treatment Period|Death|0|||
125945265|NCT01085097|453098061|FG000|Overall Study|Adverse Event|0|||
125945266|NCT01085097|453098062|FG001|Overall Study|Adverse Event|0|||
125945267|NCT01085097|453098063|FG002|Overall Study|Adverse Event|2|||
125945268|NCT01085097|453098061|FG000|Overall Study|Treatment failure|2|||
125945269|NCT01085097|453098062|FG001|Overall Study|Treatment failure|0|||
125945270|NCT01085097|453098063|FG002|Overall Study|Treatment failure|0|||
125945271|NCT03519971|453098064|FG000|Overall Study|Death|142|||
126069807|NCT02675998|453549398|FG003|8-Week Treatment Period|Physician Decision|0|||
126069808|NCT02675998|453549395|FG000|8-Week Treatment Period|GI side Effects|1|||
126069809|NCT02675998|453549396|FG001|8-Week Treatment Period|GI side Effects|4|||
126069810|NCT02675998|453549397|FG002|8-Week Treatment Period|GI side Effects|2|||
126069811|NCT02675998|453549398|FG003|8-Week Treatment Period|GI side Effects|0|||
125945272|NCT03519971|453098065|FG001|Overall Study|Death|69|||
126069812|NCT02675998|453549395|FG000|8-Week Treatment Period|Protocol Violation|1|||
126069813|NCT02675998|453549396|FG001|8-Week Treatment Period|Protocol Violation|1|||
126069814|NCT02675998|453549397|FG002|8-Week Treatment Period|Protocol Violation|1|||
126069815|NCT02675998|453549398|FG003|8-Week Treatment Period|Protocol Violation|0|||
126069816|NCT02675998|453549395|FG000|8-Week Treatment Period|Other|3|||
126069817|NCT02675998|453549396|FG001|8-Week Treatment Period|Other|1|||
126069818|NCT02675998|453549397|FG002|8-Week Treatment Period|Other|2|||
126069819|NCT02675998|453549398|FG003|8-Week Treatment Period|Other|0|||
126069820|NCT02675998|453549395|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
126069821|NCT02675998|453549396|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
126069822|NCT02675998|453549397|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
126069823|NCT02675998|453549398|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
126069824|NCT02675998|453549395|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
126069825|NCT02675998|453549396|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
126069826|NCT02675998|453549397|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
126069827|NCT02675998|453549398|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
126069828|NCT02675998|453549395|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
126069829|NCT02675998|453549396|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
126069830|NCT02675998|453549397|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
126069831|NCT02675998|453549398|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
126069832|NCT02675998|453549395|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
126069833|NCT02675998|453549396|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
126069834|NCT02675998|453549397|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
126069835|NCT02675998|453549398|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
126069836|NCT02675998|453549395|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
126069837|NCT02675998|453549396|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
126069838|NCT02675998|453549397|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
126069839|NCT02675998|453549398|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
126069840|NCT04357964|453549399|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
126069841|NCT04357964|453549400|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
126069842|NCT04357964|453549399|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
126069843|NCT04357964|453549400|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
126069844|NCT04357964|453549399|FG000|Overall Study|Adipose sample was insufficient quality|0|||
126069845|NCT04357964|453549400|FG001|Overall Study|Adipose sample was insufficient quality|1|||
126069846|NCT00848393|453549401|FG000|Overall Study|Protocol Violation|0|||
126069847|NCT00848393|453549402|FG001|Overall Study|Protocol Violation|0|||
126069848|NCT00848393|453549403|FG002|Overall Study|Protocol Violation|1|||
126069849|NCT00848393|453549401|FG000|Overall Study|surgical complications unrelated to stud|0|||
126069850|NCT00848393|453549402|FG001|Overall Study|surgical complications unrelated to stud|0|||
126069851|NCT00848393|453549403|FG002|Overall Study|surgical complications unrelated to stud|2|||
126069852|NCT01194271|453549404|FG000|Overall Study|Withdrawal by Subject|1|||
126069853|NCT01194271|453549404|FG000|Overall Study|Ineligible, Screen Failure|1|||
126069854|NCT01194271|453549404|FG000|Overall Study|Death|1|||
126069855|NCT00381797|453549407|FG000|Overall Study|Withdrawal by Subject|1|||
126069856|NCT00381797|453549408|FG001|Overall Study|Withdrawal by Subject|1|||
126069857|NCT00381797|453549409|FG002|Overall Study|Withdrawal by Subject|0|||
126069858|NCT00381797|453549410|FG003|Overall Study|Withdrawal by Subject|0|||
126069859|NCT00381797|453549411|FG004|Overall Study|Withdrawal by Subject|2|||
126069860|NCT00381797|453549407|FG000|Overall Study|Ineligible|0|||
126069861|NCT00381797|453549408|FG001|Overall Study|Ineligible|0|||
126069862|NCT00381797|453549409|FG002|Overall Study|Ineligible|0|||
126069863|NCT00381797|453549410|FG003|Overall Study|Ineligible|1|||
126069864|NCT00381797|453549411|FG004|Overall Study|Ineligible|0|||
126069865|NCT00043186|453549414|FG000|Overall Study|Physician Decision|0|||
126069866|NCT00043186|453549415|FG001|Overall Study|Physician Decision|0|||
126069867|NCT00043186|453549416|FG002|Overall Study|Physician Decision|3|||
126069868|NCT00043186|453549417|FG003|Overall Study|Physician Decision|0|||
126069869|NCT00043186|453549418|FG004|Overall Study|Physician Decision|1|||
126069870|NCT00043186|453549419|FG005|Overall Study|Physician Decision|0|||
126069871|NCT00043186|453549420|FG006|Overall Study|Physician Decision|0|||
126069872|NCT00043186|453549421|FG007|Overall Study|Physician Decision|1|||
126069873|NCT00043186|453549422|FG008|Overall Study|Physician Decision|1|||
126069874|NCT00043186|453549414|FG000|Overall Study|Adverse Event|2|||
126069875|NCT00043186|453549415|FG001|Overall Study|Adverse Event|2|||
126114476|NCT00375219|453713848|FG000|Overall Study|Failure to achieve a response|16|||
126069876|NCT00043186|453549416|FG002|Overall Study|Adverse Event|2|||
126069877|NCT00043186|453549417|FG003|Overall Study|Adverse Event|3|||
126069878|NCT00043186|453549418|FG004|Overall Study|Adverse Event|2|||
126114477|NCT00375219|453713849|FG001|Overall Study|Failure to achieve a response|2|||
126069879|NCT00043186|453549419|FG005|Overall Study|Adverse Event|1|||
126069880|NCT00043186|453549420|FG006|Overall Study|Adverse Event|2|||
125945273|NCT03519971|453098064|FG000|Overall Study|Lost to Follow-up|0|||
126069881|NCT00043186|453549421|FG007|Overall Study|Adverse Event|1|||
126069882|NCT00043186|453549422|FG008|Overall Study|Adverse Event|3|||
126069883|NCT00043186|453549414|FG000|Overall Study|Withdrawal by Subject|11|||
126069884|NCT00043186|453549415|FG001|Overall Study|Withdrawal by Subject|8|||
126069885|NCT00043186|453549416|FG002|Overall Study|Withdrawal by Subject|11|||
126069886|NCT00043186|453549417|FG003|Overall Study|Withdrawal by Subject|13|||
126069887|NCT00043186|453549418|FG004|Overall Study|Withdrawal by Subject|14|||
126069888|NCT00043186|453549419|FG005|Overall Study|Withdrawal by Subject|6|||
126069889|NCT00043186|453549420|FG006|Overall Study|Withdrawal by Subject|12|||
126069890|NCT00043186|453549421|FG007|Overall Study|Withdrawal by Subject|9|||
126069891|NCT00043186|453549422|FG008|Overall Study|Withdrawal by Subject|10|||
126069892|NCT00043186|453549414|FG000|Overall Study|Death|0|||
126069893|NCT00043186|453549415|FG001|Overall Study|Death|0|||
126069894|NCT00043186|453549416|FG002|Overall Study|Death|1|||
126069895|NCT00043186|453549417|FG003|Overall Study|Death|0|||
126069896|NCT00043186|453549418|FG004|Overall Study|Death|0|||
126069897|NCT00043186|453549419|FG005|Overall Study|Death|0|||
126069898|NCT00043186|453549420|FG006|Overall Study|Death|2|||
126069899|NCT00043186|453549421|FG007|Overall Study|Death|0|||
126069900|NCT00043186|453549422|FG008|Overall Study|Death|0|||
126069901|NCT00043186|453549414|FG000|Overall Study|Disease progression|1|||
126069902|NCT00043186|453549415|FG001|Overall Study|Disease progression|0|||
126069903|NCT00043186|453549416|FG002|Overall Study|Disease progression|0|||
126069904|NCT00043186|453549417|FG003|Overall Study|Disease progression|3|||
126069905|NCT00043186|453549418|FG004|Overall Study|Disease progression|0|||
126069906|NCT00043186|453549419|FG005|Overall Study|Disease progression|0|||
126069907|NCT00043186|453549420|FG006|Overall Study|Disease progression|0|||
126069908|NCT00043186|453549421|FG007|Overall Study|Disease progression|4|||
126069909|NCT00043186|453549422|FG008|Overall Study|Disease progression|0|||
126069910|NCT00043186|453549414|FG000|Overall Study|Ineligibility determined|0|||
125945274|NCT03519971|453098065|FG001|Overall Study|Lost to Follow-up|1|||
125945275|NCT03519971|453098064|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
125945276|NCT03519971|453098065|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
125945277|NCT03519971|453098064|FG000|Overall Study|Withdrawal by Subject|3|||
125945278|NCT03519971|453098065|FG001|Overall Study|Withdrawal by Subject|2|||
125945279|NCT03519971|453098064|FG000|Overall Study|Other|1|||
125945280|NCT03519971|453098065|FG001|Overall Study|Other|0|||
125945281|NCT01524692|453098070|FG000|Overall Study|Withdrawal by Subject|3|||
125945282|NCT02268812|453098078|FG000|Overall Study|Adverse Event|8|||
125945283|NCT02268812|453098079|FG001|Overall Study|Adverse Event|26|||
125945284|NCT02268812|453098080|FG002|Overall Study|Adverse Event|7|||
125945285|NCT02268812|453098081|FG003|Overall Study|Adverse Event|10|||
125945286|NCT02268812|453098078|FG000|Overall Study|Protocol deviation|0|||
125945287|NCT02268812|453098079|FG001|Overall Study|Protocol deviation|0|||
125945288|NCT02268812|453098080|FG002|Overall Study|Protocol deviation|1|||
125945289|NCT02268812|453098081|FG003|Overall Study|Protocol deviation|0|||
125945290|NCT02268812|453098078|FG000|Overall Study|Withdrawal by Subject|0|||
125945291|NCT02268812|453098079|FG001|Overall Study|Withdrawal by Subject|1|||
125945292|NCT02268812|453098080|FG002|Overall Study|Withdrawal by Subject|0|||
125945293|NCT02268812|453098081|FG003|Overall Study|Withdrawal by Subject|0|||
125945294|NCT02268812|453098078|FG000|Overall Study|Physician Decision|3|||
125945295|NCT02268812|453098079|FG001|Overall Study|Physician Decision|1|||
125945296|NCT02268812|453098080|FG002|Overall Study|Physician Decision|0|||
125945297|NCT02268812|453098081|FG003|Overall Study|Physician Decision|1|||
125945298|NCT02268812|453098078|FG000|Overall Study|Other|5|||
125945299|NCT02268812|453098079|FG001|Overall Study|Other|4|||
125945300|NCT02268812|453098080|FG002|Overall Study|Other|1|||
125945301|NCT02268812|453098081|FG003|Overall Study|Other|3|||
125945302|NCT00075582|453098082|FG000|Overall Study|Adverse Event|3|||
125945303|NCT00075582|453098083|FG001|Overall Study|Adverse Event|1|||
125945304|NCT00075582|453098082|FG000|Overall Study|Lack of Efficacy|4|||
125945305|NCT00075582|453098083|FG001|Overall Study|Lack of Efficacy|8|||
125945306|NCT00075582|453098082|FG000|Overall Study|Physician Decision|5|||
125945307|NCT00075582|453098083|FG001|Overall Study|Physician Decision|8|||
125945308|NCT00075582|453098082|FG000|Overall Study|Withdrawal by Subject|2|||
125945309|NCT00075582|453098083|FG001|Overall Study|Withdrawal by Subject|2|||
125945310|NCT00075582|453098082|FG000|Overall Study|Ineligible for study|36|||
125945311|NCT00075582|453098083|FG001|Overall Study|Ineligible for study|16|||
125945312|NCT05045144|453098084|FG000|Overall Study|Lost to Follow-up|3|||
125945313|NCT05045144|453098085|FG001|Overall Study|Lost to Follow-up|2|||
125945314|NCT05045144|453098086|FG002|Overall Study|Lost to Follow-up|3|||
125945315|NCT05045144|453098087|FG003|Overall Study|Lost to Follow-up|5|||
126069911|NCT00043186|453549415|FG001|Overall Study|Ineligibility determined|0|||
126069912|NCT00043186|453549416|FG002|Overall Study|Ineligibility determined|0|||
126069913|NCT00043186|453549417|FG003|Overall Study|Ineligibility determined|0|||
126069914|NCT00043186|453549418|FG004|Overall Study|Ineligibility determined|0|||
125945316|NCT05045144|453098088|FG004|Overall Study|Lost to Follow-up|13|||
125945317|NCT05045144|453098084|FG000|Overall Study|Withdrawal by Subject|0|||
126069915|NCT00043186|453549419|FG005|Overall Study|Ineligibility determined|0|||
126069916|NCT00043186|453549420|FG006|Overall Study|Ineligibility determined|0|||
126069917|NCT00043186|453549421|FG007|Overall Study|Ineligibility determined|0|||
126069918|NCT00043186|453549422|FG008|Overall Study|Ineligibility determined|1|||
126069919|NCT00043186|453549414|FG000|Overall Study|Lost to Follow-up|3|||
126069920|NCT00043186|453549415|FG001|Overall Study|Lost to Follow-up|5|||
126069921|NCT00043186|453549416|FG002|Overall Study|Lost to Follow-up|1|||
126069922|NCT00043186|453549417|FG003|Overall Study|Lost to Follow-up|1|||
126069923|NCT00043186|453549418|FG004|Overall Study|Lost to Follow-up|1|||
126069924|NCT00043186|453549419|FG005|Overall Study|Lost to Follow-up|1|||
126069925|NCT00043186|453549420|FG006|Overall Study|Lost to Follow-up|1|||
126069926|NCT00043186|453549421|FG007|Overall Study|Lost to Follow-up|1|||
126069927|NCT00043186|453549422|FG008|Overall Study|Lost to Follow-up|2|||
125945318|NCT05045144|453098085|FG001|Overall Study|Withdrawal by Subject|1|||
125945319|NCT05045144|453098086|FG002|Overall Study|Withdrawal by Subject|0|||
125945320|NCT05045144|453098087|FG003|Overall Study|Withdrawal by Subject|0|||
125945321|NCT05045144|453098088|FG004|Overall Study|Withdrawal by Subject|0|||
125945322|NCT05045144|453098084|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125945323|NCT05045144|453098085|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125945324|NCT05045144|453098086|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125945325|NCT05045144|453098087|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125945326|NCT05045144|453098088|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125945327|NCT01150123|453098089|FG000|Overall Study|Withdrawal by Subject|1|||
125945328|NCT01150123|453098090|FG001|Overall Study|Withdrawal by Subject|1|||
125945329|NCT01150123|453098091|FG002|Overall Study|Withdrawal by Subject|2|||
125945330|NCT01150123|453098092|FG003|Overall Study|Withdrawal by Subject|1|||
125945331|NCT01150123|453098093|FG004|Overall Study|Withdrawal by Subject|1|||
125945332|NCT01150123|453098094|FG005|Overall Study|Withdrawal by Subject|1|||
125945333|NCT01150123|453098095|FG006|Overall Study|Withdrawal by Subject|0|||
125945334|NCT01150123|453098096|FG007|Overall Study|Withdrawal by Subject|3|||
125945335|NCT01150123|453098097|FG008|Overall Study|Withdrawal by Subject|2|||
125945336|NCT01150123|453098098|FG009|Overall Study|Withdrawal by Subject|0|||
125945337|NCT01150123|453098099|FG010|Overall Study|Withdrawal by Subject|1|||
125945338|NCT01150123|453098100|FG011|Overall Study|Withdrawal by Subject|0|||
125945339|NCT01150123|453098101|FG012|Overall Study|Withdrawal by Subject|1|||
125945340|NCT01150123|453098102|FG013|Overall Study|Withdrawal by Subject|0|||
125945341|NCT01150123|453098103|FG014|Overall Study|Withdrawal by Subject|0|||
125945342|NCT01150123|453098104|FG015|Overall Study|Withdrawal by Subject|1|||
125945343|NCT01150123|453098105|FG016|Overall Study|Withdrawal by Subject|0|||
125945344|NCT01150123|453098106|FG017|Overall Study|Withdrawal by Subject|1|||
125945345|NCT01150123|453098089|FG000|Overall Study|Lost to Follow-up|2|||
125945346|NCT01150123|453098090|FG001|Overall Study|Lost to Follow-up|1|||
125945347|NCT01150123|453098091|FG002|Overall Study|Lost to Follow-up|2|||
125945348|NCT01150123|453098092|FG003|Overall Study|Lost to Follow-up|2|||
125945349|NCT01150123|453098093|FG004|Overall Study|Lost to Follow-up|2|||
125945350|NCT01150123|453098094|FG005|Overall Study|Lost to Follow-up|5|||
125945351|NCT01150123|453098095|FG006|Overall Study|Lost to Follow-up|0|||
125945352|NCT01150123|453098096|FG007|Overall Study|Lost to Follow-up|0|||
125945353|NCT01150123|453098097|FG008|Overall Study|Lost to Follow-up|3|||
125945354|NCT01150123|453098098|FG009|Overall Study|Lost to Follow-up|1|||
125945355|NCT01150123|453098099|FG010|Overall Study|Lost to Follow-up|1|||
125945356|NCT01150123|453098100|FG011|Overall Study|Lost to Follow-up|1|||
125945357|NCT01150123|453098101|FG012|Overall Study|Lost to Follow-up|2|||
125945358|NCT01150123|453098102|FG013|Overall Study|Lost to Follow-up|0|||
125945359|NCT01150123|453098103|FG014|Overall Study|Lost to Follow-up|0|||
125945360|NCT01150123|453098104|FG015|Overall Study|Lost to Follow-up|0|||
125945361|NCT01150123|453098105|FG016|Overall Study|Lost to Follow-up|0|||
125945362|NCT01150123|453098106|FG017|Overall Study|Lost to Follow-up|0|||
125945363|NCT02486042|453098111|FG000|Overall Study|Physician Decision|1|||
125945364|NCT02486042|453098112|FG001|Overall Study|Physician Decision|7|||
125945365|NCT02486042|453098111|FG000|Overall Study|Hospital transfer|2|||
125945366|NCT02486042|453098112|FG001|Overall Study|Hospital transfer|2|||
125945367|NCT02486042|453098111|FG000|Overall Study|Withdrawal by Subject|0|||
125945368|NCT02486042|453098112|FG001|Overall Study|Withdrawal by Subject|2|||
125945369|NCT01466387|453098113|FG000|Overall Study|Adverse Event|0|||
125945370|NCT01466387|453098114|FG001|Overall Study|Adverse Event|0|||
125945371|NCT01466387|453098115|FG002|Overall Study|Adverse Event|1|||
125945372|NCT01466387|453098116|FG003|Overall Study|Adverse Event|1|||
125945373|NCT01466387|453098117|FG004|Overall Study|Adverse Event|0|||
125945374|NCT01466387|453098118|FG005|Overall Study|Adverse Event|0|||
125945375|NCT01466387|453098113|FG000|Overall Study|Lost to Follow-up|0|||
125945376|NCT01466387|453098114|FG001|Overall Study|Lost to Follow-up|0|||
125945377|NCT01466387|453098115|FG002|Overall Study|Lost to Follow-up|0|||
125945378|NCT01466387|453098116|FG003|Overall Study|Lost to Follow-up|0|||
125945379|NCT01466387|453098117|FG004|Overall Study|Lost to Follow-up|0|||
125945380|NCT01466387|453098118|FG005|Overall Study|Lost to Follow-up|1|||
125945381|NCT01466387|453098113|FG000|Overall Study|Protocol Violation|1|||
126069928|NCT00043186|453549414|FG000|Overall Study|Noncompliance|0|||
126069929|NCT00043186|453549415|FG001|Overall Study|Noncompliance|0|||
126069930|NCT00043186|453549416|FG002|Overall Study|Noncompliance|1|||
126069931|NCT00043186|453549417|FG003|Overall Study|Noncompliance|1|||
126069932|NCT00043186|453549418|FG004|Overall Study|Noncompliance|0|||
126069933|NCT00043186|453549419|FG005|Overall Study|Noncompliance|0|||
126069934|NCT00043186|453549420|FG006|Overall Study|Noncompliance|0|||
126069935|NCT00043186|453549421|FG007|Overall Study|Noncompliance|0|||
126069936|NCT00043186|453549422|FG008|Overall Study|Noncompliance|0|||
126069937|NCT00043186|453549414|FG000|Overall Study|Other|0|||
126069938|NCT00043186|453549415|FG001|Overall Study|Other|0|||
126069939|NCT00043186|453549416|FG002|Overall Study|Other|1|||
126069940|NCT00043186|453549417|FG003|Overall Study|Other|1|||
126069941|NCT00043186|453549418|FG004|Overall Study|Other|0|||
126069942|NCT00043186|453549419|FG005|Overall Study|Other|0|||
126069943|NCT00043186|453549420|FG006|Overall Study|Other|0|||
126069944|NCT00043186|453549421|FG007|Overall Study|Other|0|||
126069945|NCT00043186|453549422|FG008|Overall Study|Other|0|||
126069946|NCT00958711|453549423|FG000|Overall Study|Withdrawal by Subject|0|||
126069947|NCT00958711|453549424|FG001|Overall Study|Withdrawal by Subject|4|||
126069948|NCT00958711|453549423|FG000|Overall Study|Physician Decision|5|||
126069949|NCT00958711|453549424|FG001|Overall Study|Physician Decision|7|||
126069950|NCT00958711|453549423|FG000|Overall Study|Lost to Follow-up|4|||
126069951|NCT00958711|453549424|FG001|Overall Study|Lost to Follow-up|1|||
126069952|NCT00958711|453549423|FG000|Overall Study|Other|2|||
126069953|NCT00958711|453549424|FG001|Overall Study|Other|5|||
126069954|NCT00958711|453549423|FG000|Overall Study|Death|1|||
126069955|NCT00958711|453549424|FG001|Overall Study|Death|2|||
126069956|NCT00958711|453549423|FG000|Overall Study|Adverse Event|1|||
126069957|NCT00958711|453549424|FG001|Overall Study|Adverse Event|2|||
126069958|NCT00550771|453549430|FG000|Overall Study|Adverse Event|11|||
126069959|NCT00550771|453549431|FG001|Overall Study|Adverse Event|3|||
126069960|NCT00550771|453549430|FG000|Overall Study|Discontinued for study-related reasons|0|||
126069961|NCT00550771|453549431|FG001|Overall Study|Discontinued for study-related reasons|1|||
126069962|NCT00550771|453549430|FG000|Overall Study|Physician Decision|2|||
126069963|NCT00550771|453549431|FG001|Overall Study|Physician Decision|0|||
126069964|NCT00550771|453549430|FG000|Overall Study|Withdrawal by Subject|0|||
126069965|NCT00550771|453549431|FG001|Overall Study|Withdrawal by Subject|1|||
126069966|NCT00550771|453549430|FG000|Overall Study|Protocol Violation|4|||
126069967|NCT00550771|453549431|FG001|Overall Study|Protocol Violation|5|||
126069968|NCT00730847|453549433|FG000|Overall Study|Adverse Event|1|||
126069969|NCT00730847|453549433|FG000|Overall Study|Protocol Violation|2|||
126069970|NCT00730847|453549433|FG000|Overall Study|Withdrawal by Subject|16|||
126069971|NCT00730847|453549433|FG000|Overall Study|Lost to Follow-up|67|||
126069972|NCT00730847|453549433|FG000|Overall Study|Unknown completion status|21|||
126069973|NCT00730847|453549433|FG000|Overall Study|Other|24|||
126069974|NCT03022578|453549434|FG000|Overall Study|Adverse Event|1|||
126069975|NCT03022578|453549434|FG000|Overall Study|Lack of Efficacy|2|||
126069976|NCT03022578|453549434|FG000|Overall Study|Withdrawal by Subject|1|||
126069977|NCT03681353|453549440|FG000|Overall Study|Lost to Follow-up|2|||
126069978|NCT03681353|453549440|FG000|Overall Study|Withdrawal by Subject|3|||
126069979|NCT03681353|453549440|FG000|Overall Study|withdrawn by PI|2|||
126069980|NCT00726388|453549446|FG000|Overall Study|Withdrawal by Subject|5|||
126069981|NCT00726388|453549446|FG000|Overall Study|Adverse Event|3|||
126069982|NCT00726388|453549446|FG000|Overall Study|Lost to Follow-up|10|||
126069983|NCT00726388|453549446|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
126069984|NCT00726388|453549446|FG000|Overall Study|Other|5|||
126069985|NCT00726388|453549446|FG000|Overall Study|Enrolled, Not Treated|79|||
126069986|NCT00111839|453549447|FG000|Overall Study|Disease Progression|30|||
126069987|NCT00111839|453549448|FG001|Overall Study|Disease Progression|33|||
126069988|NCT00111839|453549449|FG002|Overall Study|Disease Progression|33|||
126069989|NCT00111839|453549447|FG000|Overall Study|Adverse Event|5|||
126069990|NCT00111839|453549448|FG001|Overall Study|Adverse Event|3|||
126069991|NCT00111839|453549449|FG002|Overall Study|Adverse Event|1|||
126069992|NCT00111839|453549447|FG000|Overall Study|Protocol Violation|2|||
126069993|NCT00111839|453549448|FG001|Overall Study|Protocol Violation|4|||
126114478|NCT00375219|453713850|FG002|Overall Study|Failure to achieve a response|0|||
126114479|NCT00375219|453713848|FG000|Overall Study|Adverse Event|8|||
126069994|NCT00111839|453549449|FG002|Overall Study|Protocol Violation|2|||
126069995|NCT00111839|453549447|FG000|Overall Study|Death|1|||
126069996|NCT00111839|453549448|FG001|Overall Study|Death|1|||
126069997|NCT00111839|453549449|FG002|Overall Study|Death|6|||
126114480|NCT00375219|453713849|FG001|Overall Study|Adverse Event|2|||
126069998|NCT00111839|453549447|FG000|Overall Study|Withdrawal by Subject|2|||
126069999|NCT00111839|453549448|FG001|Overall Study|Withdrawal by Subject|2|||
126114481|NCT00375219|453713850|FG002|Overall Study|Adverse Event|1|||
126070000|NCT00111839|453549449|FG002|Overall Study|Withdrawal by Subject|2|||
126070001|NCT00111839|453549447|FG000|Overall Study|Lost to Follow-up|1|||
126070002|NCT00111839|453549448|FG001|Overall Study|Lost to Follow-up|0|||
126070003|NCT00111839|453549449|FG002|Overall Study|Lost to Follow-up|0|||
126070004|NCT00111839|453549447|FG000|Overall Study|Logistical Constraint|1|||
126070005|NCT00111839|453549448|FG001|Overall Study|Logistical Constraint|0|||
126070006|NCT00111839|453549449|FG002|Overall Study|Logistical Constraint|0|||
126070007|NCT00111839|453549447|FG000|Overall Study|Other|6|||
126070008|NCT00111839|453549448|FG001|Overall Study|Other|3|||
126070009|NCT00111839|453549449|FG002|Overall Study|Other|3|||
126070010|NCT00111839|453549447|FG000|Overall Study|Randomized but Not Treated|0|||
126070011|NCT00111839|453549448|FG001|Overall Study|Randomized but Not Treated|0|||
126070012|NCT00111839|453549449|FG002|Overall Study|Randomized but Not Treated|2|||
126070013|NCT00762723|453549450|FG000|Overall Study|Study Terminated slow enrollement|5|||
126070014|NCT00762723|453549451|FG001|Overall Study|Study Terminated slow enrollement|5|||
126070015|NCT00762723|453549452|FG002|Overall Study|Study Terminated slow enrollement|3|||
126070016|NCT00382408|453549453|FG000|Overall Study|Did not meet protocol requirement|3|||
126070017|NCT00382408|453549454|FG001|Overall Study|Did not meet protocol requirement|3|||
125945382|NCT01466387|453098114|FG001|Overall Study|Protocol Violation|0|||
125945383|NCT01466387|453098115|FG002|Overall Study|Protocol Violation|0|||
125945384|NCT01466387|453098116|FG003|Overall Study|Protocol Violation|1|||
125945385|NCT01466387|453098117|FG004|Overall Study|Protocol Violation|0|||
125945386|NCT01466387|453098118|FG005|Overall Study|Protocol Violation|0|||
125945387|NCT03745144|453098119|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
125945388|NCT03745144|453098120|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
125945389|NCT03745144|453098121|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
125945390|NCT03745144|453098119|FG000|Period 1|Other|0|||
125945391|NCT03745144|453098120|FG001|Period 1|Other|0|||
125945392|NCT03745144|453098121|FG002|Period 1|Other|1|||
125945393|NCT00896337|453098122|FG000|Overall Study|Death|7|||
125945394|NCT00896337|453098122|FG000|Overall Study|Withdrawal by Subject|7|||
125945395|NCT00896337|453098122|FG000|Overall Study|Lost to Follow-up|11|||
125945396|NCT01586819|453098123|FG000|Overall Study|Withdrawal by Subject|1|||
125945397|NCT01586819|453098124|FG001|Overall Study|Withdrawal by Subject|0|||
125945398|NCT01359254|453098125|FG000|Overall Study|Death|1|||
125945399|NCT01359254|453098126|FG001|Overall Study|Death|0|||
125945400|NCT04668950|453098127|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
125945401|NCT04668950|453098128|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
125945402|NCT04668950|453098127|FG000|Overall Study|Could not confirm started study medication|15|||
125945403|NCT04668950|453098128|FG001|Overall Study|Could not confirm started study medication|15|||
125945404|NCT04668950|453098127|FG000|Overall Study|Could not confirm baseline status|6|||
125945405|NCT04668950|453098128|FG001|Overall Study|Could not confirm baseline status|2|||
125945406|NCT04668950|453098127|FG000|Overall Study|Drop out and did not start medication|15|||
125945407|NCT04668950|453098128|FG001|Overall Study|Drop out and did not start medication|17|||
125945408|NCT04668950|453098127|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
125945409|NCT04668950|453098128|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
125945410|NCT04668950|453098127|FG000|Overall Study|Other|2|||
125945411|NCT04668950|453098128|FG001|Overall Study|Other|4|||
125945412|NCT01124643|453098134|FG000|Overall Study|Death|1|||
125945413|NCT02910167|453098135|FG000|Overall Study|Adverse Event|1|||
125945414|NCT02910167|453098135|FG000|Overall Study|Lost to Follow-up|18|||
125945415|NCT02028988|453098136|FG000|Overall Study|Withdrawal by Subject|2|||
125945416|NCT01063595|453098139|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
125945417|NCT01063595|453098140|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
125945418|NCT01063595|453098139|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
125945419|NCT01063595|453098140|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
125945420|NCT01063595|453098139|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
125945421|NCT01063595|453098140|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
125945422|NCT01063595|453098139|FG000|First Intervention|Adverse Event|1|||
125945423|NCT01063595|453098140|FG001|First Intervention|Adverse Event|4|||
125945424|NCT01063595|453098139|FG000|First Intervention|Withdrawal by Subject|1|||
125945425|NCT01063595|453098140|FG001|First Intervention|Withdrawal by Subject|0|||
125945426|NCT01063595|453098139|FG000|First Intervention|Reason not Specified|0|||
125945427|NCT01063595|453098140|FG001|First Intervention|Reason not Specified|1|||
125945428|NCT00851799|453098141|FG000|Overall Study|Death|1|||
125945429|NCT00851799|453098142|FG001|Overall Study|Death|0|||
125945430|NCT00851799|453098143|FG002|Overall Study|Death|1|||
125945431|NCT00851799|453098141|FG000|Overall Study|Lost to Follow-up|5|||
125945432|NCT00851799|453098142|FG001|Overall Study|Lost to Follow-up|3|||
126070018|NCT00382408|453549453|FG000|Overall Study|Protocol Violation|2|||
126114482|NCT00375219|453713848|FG000|Overall Study|Protocol Violation|1|||
125945433|NCT00851799|453098143|FG002|Overall Study|Lost to Follow-up|10|||
125945434|NCT00851799|453098141|FG000|Overall Study|Not able to get to clinic|8|||
125945435|NCT00851799|453098142|FG001|Overall Study|Not able to get to clinic|5|||
125945436|NCT00851799|453098143|FG002|Overall Study|Not able to get to clinic|9|||
125945437|NCT00851799|453098141|FG000|Overall Study|Not willing to adhere to requirements|1|||
125945438|NCT00851799|453098142|FG001|Overall Study|Not willing to adhere to requirements|2|||
125945439|NCT00851799|453098143|FG002|Overall Study|Not willing to adhere to requirements|2|||
125945440|NCT00851799|453098141|FG000|Overall Study|Withdrew consent prior study completion|1|||
126070019|NCT00382408|453549454|FG001|Overall Study|Protocol Violation|2|||
126070020|NCT00382408|453549453|FG000|Overall Study|Physician Decision|1|||
126070021|NCT00382408|453549454|FG001|Overall Study|Physician Decision|0|||
125945441|NCT00851799|453098142|FG001|Overall Study|Withdrew consent prior study completion|2|||
125945442|NCT00851799|453098143|FG002|Overall Study|Withdrew consent prior study completion|1|||
125945443|NCT00851799|453098141|FG000|Overall Study|Severe Debilitation|0|||
125945444|NCT00851799|453098142|FG001|Overall Study|Severe Debilitation|1|||
125945445|NCT00851799|453098143|FG002|Overall Study|Severe Debilitation|0|||
125945446|NCT00851799|453098141|FG000|Overall Study|Completed protocol due to pregnancy|0|||
125945447|NCT00851799|453098142|FG001|Overall Study|Completed protocol due to pregnancy|0|||
125945448|NCT00851799|453098143|FG002|Overall Study|Completed protocol due to pregnancy|1|||
125945449|NCT04056195|453098146|FG000|Overall Study|Adverse Event|1|||
125945450|NCT04056195|453098147|FG001|Overall Study|Adverse Event|0|||
125945451|NCT04056195|453098148|FG002|Overall Study|Adverse Event|0|||
125945452|NCT04056195|453098146|FG000|Overall Study|Withdrawal by Subject|0|||
125945453|NCT04056195|453098147|FG001|Overall Study|Withdrawal by Subject|1|||
125945454|NCT04056195|453098148|FG002|Overall Study|Withdrawal by Subject|1|||
125945455|NCT04056195|453098146|FG000|Overall Study|Physician Decision|1|||
125945456|NCT04056195|453098147|FG001|Overall Study|Physician Decision|1|||
125945457|NCT04056195|453098148|FG002|Overall Study|Physician Decision|1|||
125945458|NCT01796197|453098165|FG000|Overall Study|Lost to Follow-up|1|||
125945459|NCT01796197|453098165|FG000|Overall Study|Lack of Efficacy|1|||
125945460|NCT01380184|453098166|FG000|Part 1 (19 Days)|Adverse Event|1|||
125945461|NCT01380184|453098166|FG000|Part 2|Adverse Event|5|||
125945462|NCT01380184|453098166|FG000|Part 2|Disease Progression|8|||
125945463|NCT01380184|453098166|FG000|Part 2|Lost to Follow-up|1|||
125945464|NCT04243538|453098167|FG000|Overall Study|Withdrawal by Subject|0|||
125945465|NCT04243538|453098168|FG001|Overall Study|Withdrawal by Subject|2|||
125945466|NCT04243538|453098167|FG000|Overall Study|Lost to Follow-up|0|||
125945467|NCT04243538|453098168|FG001|Overall Study|Lost to Follow-up|3|||
125945468|NCT03532295|453098169|FG000|Overall Study|Did not start treatment|0|||
125945469|NCT03532295|453098170|FG001|Overall Study|Did not start treatment|2|||
125945470|NCT02776917|453098171|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
125945471|NCT00699972|453099750|FG000|Overall Study|Adverse Event|7|||
125945472|NCT00699972|453099751|FG001|Overall Study|Adverse Event|9|||
125945473|NCT00699972|453099752|FG002|Overall Study|Adverse Event|24|||
125945474|NCT00699972|453099750|FG000|Overall Study|Lost to Follow-up|0|||
125945475|NCT00699972|453099751|FG001|Overall Study|Lost to Follow-up|2|||
125945476|NCT00699972|453099752|FG002|Overall Study|Lost to Follow-up|0|||
125945477|NCT00699972|453099750|FG000|Overall Study|Withdrawal by Subject|3|||
125945478|NCT00699972|453099751|FG001|Overall Study|Withdrawal by Subject|7|||
125945479|NCT00699972|453099752|FG002|Overall Study|Withdrawal by Subject|4|||
125945480|NCT00699972|453099750|FG000|Overall Study|Lack of Efficacy|2|||
125945481|NCT00699972|453099751|FG001|Overall Study|Lack of Efficacy|0|||
125945482|NCT00699972|453099752|FG002|Overall Study|Lack of Efficacy|2|||
125945483|NCT00699972|453099750|FG000|Overall Study|Administrative/Other|3|||
125945484|NCT00699972|453099751|FG001|Overall Study|Administrative/Other|1|||
125945485|NCT00699972|453099752|FG002|Overall Study|Administrative/Other|4|||
125945486|NCT00699972|453099750|FG000|Overall Study|Randomized, Not Treated|1|||
125945487|NCT00699972|453099751|FG001|Overall Study|Randomized, Not Treated|0|||
125945488|NCT00699972|453099752|FG002|Overall Study|Randomized, Not Treated|1|||
125945489|NCT03509675|453099756|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
125945490|NCT03509675|453099757|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
125945491|NCT03509675|453099756|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
125945492|NCT03509675|453099757|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
125945493|NCT03509675|453099756|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
125945494|NCT03509675|453099757|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
125945495|NCT03509675|453099756|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
125945496|NCT03509675|453099757|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
125945497|NCT05620576|453099760|FG000|Overall Study|Adverse Event|1|||
125945498|NCT05620576|453099761|FG001|Overall Study|Adverse Event|1|||
125945499|NCT05620576|453099760|FG000|Overall Study|Lost to Follow-up|3|||
125945500|NCT05620576|453099761|FG001|Overall Study|Lost to Follow-up|1|||
125945501|NCT05620576|453099760|FG000|Overall Study|Physician Decision|0|||
125945502|NCT05620576|453099761|FG001|Overall Study|Physician Decision|1|||
125945503|NCT05620576|453099760|FG000|Overall Study|Protocol Deviation|1|||
125945504|NCT05620576|453099761|FG001|Overall Study|Protocol Deviation|1|||
125945505|NCT05620576|453099760|FG000|Overall Study|Withdrawal by Subject|2|||
125945506|NCT05620576|453099761|FG001|Overall Study|Withdrawal by Subject|3|||
125945507|NCT02622828|453099762|FG000|Overall Study|participant withdrew|3|||
125945508|NCT04214288|453099767|FG000|Overall Study|Ongoing in the study|41|||
125945509|NCT04214288|453099768|FG001|Overall Study|Ongoing in the study|51|||
125945510|NCT04214288|453099769|FG002|Overall Study|Ongoing in the study|12|||
125945511|NCT04214288|453099770|FG003|Overall Study|Ongoing in the study|39|||
125945512|NCT04214288|453099767|FG000|Overall Study|Adverse Event|1|||
125945513|NCT04214288|453099768|FG001|Overall Study|Adverse Event|0|||
125945514|NCT04214288|453099769|FG002|Overall Study|Adverse Event|0|||
125945515|NCT04214288|453099770|FG003|Overall Study|Adverse Event|0|||
125945516|NCT04214288|453099767|FG000|Overall Study|Death|22|||
125945517|NCT04214288|453099768|FG001|Overall Study|Death|13|||
125945518|NCT04214288|453099769|FG002|Overall Study|Death|7|||
125945519|NCT04214288|453099770|FG003|Overall Study|Death|19|||
125945520|NCT04214288|453099767|FG000|Overall Study|Lost to Follow-up|1|||
125945521|NCT04214288|453099768|FG001|Overall Study|Lost to Follow-up|2|||
125945522|NCT04214288|453099769|FG002|Overall Study|Lost to Follow-up|1|||
125945523|NCT04214288|453099770|FG003|Overall Study|Lost to Follow-up|0|||
125945524|NCT04214288|453099767|FG000|Overall Study|Other|1|||
125945525|NCT04214288|453099768|FG001|Overall Study|Other|2|||
125945526|NCT04214288|453099769|FG002|Overall Study|Other|0|||
125945527|NCT04214288|453099770|FG003|Overall Study|Other|6|||
125945528|NCT04214288|453099767|FG000|Overall Study|Protocol Violation|0|||
125945529|NCT04214288|453099768|FG001|Overall Study|Protocol Violation|1|||
125945530|NCT04214288|453099769|FG002|Overall Study|Protocol Violation|0|||
125945531|NCT04214288|453099770|FG003|Overall Study|Protocol Violation|0|||
125945532|NCT04214288|453099767|FG000|Overall Study|Withdrawal by Subject|8|||
125945533|NCT04214288|453099768|FG001|Overall Study|Withdrawal by Subject|4|||
125945534|NCT04214288|453099769|FG002|Overall Study|Withdrawal by Subject|0|||
125945535|NCT04214288|453099770|FG003|Overall Study|Withdrawal by Subject|9|||
125945536|NCT01203072|453099780|FG000|Overall Study|Adverse Event|5|||
125945537|NCT01203072|453099781|FG001|Overall Study|Adverse Event|3|||
125945538|NCT01203072|453099782|FG002|Overall Study|Adverse Event|2|||
126070022|NCT00382408|453549453|FG000|Overall Study|Withdrawal by Subject|17|||
126070023|NCT00382408|453549454|FG001|Overall Study|Withdrawal by Subject|6|||
126070024|NCT00382408|453549453|FG000|Overall Study|Pregnancy|2|||
126070025|NCT00382408|453549454|FG001|Overall Study|Pregnancy|0|||
126070026|NCT00382408|453549453|FG000|Overall Study|Lost to Follow-up|19|||
126070027|NCT00382408|453549454|FG001|Overall Study|Lost to Follow-up|8|||
126070028|NCT00382408|453549453|FG000|Overall Study|Other|100|||
126070029|NCT00382408|453549454|FG001|Overall Study|Other|35|||
126070030|NCT02435381|453549455|FG000|Overall Study|Lost to Follow-up|2|||
126070031|NCT02435381|453549456|FG001|Overall Study|Lost to Follow-up|1|||
126070032|NCT02316847|453549458|FG000|Overall Study|Adverse Event|0|||
126070033|NCT02316847|453549459|FG001|Overall Study|Adverse Event|3|||
126070034|NCT02316847|453549458|FG000|Overall Study|Lost to Follow-up|0|||
126070035|NCT02316847|453549459|FG001|Overall Study|Lost to Follow-up|2|||
126070036|NCT02316847|453549458|FG000|Overall Study|Physician Decision|0|||
126070037|NCT02316847|453549459|FG001|Overall Study|Physician Decision|1|||
126070038|NCT02316847|453549458|FG000|Overall Study|Pregnancy|0|||
126070039|NCT02316847|453549459|FG001|Overall Study|Pregnancy|1|||
126070040|NCT02316847|453549458|FG000|Overall Study|Withdrawal by Subject|2|||
126070041|NCT02316847|453549459|FG001|Overall Study|Withdrawal by Subject|9|||
126070042|NCT02316847|453549458|FG000|Overall Study|Noncompliance with study drug|0|||
126070043|NCT02316847|453549459|FG001|Overall Study|Noncompliance with study drug|3|||
126070044|NCT02316847|453549458|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
126070045|NCT02316847|453549459|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
126070046|NCT00139659|453549460|FG000|Overall Study|Adverse Event|12|||
126070047|NCT00139659|453549461|FG001|Overall Study|Adverse Event|1|||
126070048|NCT00139659|453549460|FG000|Overall Study|Lack of Efficacy|1|||
126070049|NCT00139659|453549461|FG001|Overall Study|Lack of Efficacy|1|||
126070050|NCT00139659|453549460|FG000|Overall Study|Lost to Follow-up|7|||
126070051|NCT00139659|453549461|FG001|Overall Study|Lost to Follow-up|3|||
126070052|NCT00139659|453549460|FG000|Overall Study|Reason not Specified|6|||
126070053|NCT00139659|453549461|FG001|Overall Study|Reason not Specified|3|||
126070054|NCT00139659|453549460|FG000|Overall Study|Withdrawal by Subject|14|||
126070055|NCT00139659|453549461|FG001|Overall Study|Withdrawal by Subject|10|||
126070056|NCT02282917|453549462|FG000|Overall Study|Withdrawal by Subject|1|||
126070057|NCT02282917|453549462|FG000|Overall Study|Screen Failure/Not Eligible|1|||
126070058|NCT01747629|453549463|FG000|Overall Study|Adverse Event|1|||
126070059|NCT01747629|453549464|FG001|Overall Study|Adverse Event|2|||
126070060|NCT01747629|453549463|FG000|Overall Study|Withdrawal by Subject|2|||
126070061|NCT01747629|453549464|FG001|Overall Study|Withdrawal by Subject|2|||
126070062|NCT01747629|453549463|FG000|Overall Study|Noncompliance|1|||
126070063|NCT01747629|453549464|FG001|Overall Study|Noncompliance|1|||
126070064|NCT01747629|453549463|FG000|Overall Study|Inclusion criteria not met|1|||
125945539|NCT01203072|453099783|FG003|Overall Study|Adverse Event|4|||
125945540|NCT01203072|453099784|FG004|Overall Study|Adverse Event|2|||
125945541|NCT01203072|453099780|FG000|Overall Study|Lack of Efficacy|1|||
126070065|NCT01747629|453549464|FG001|Overall Study|Inclusion criteria not met|0|||
126070066|NCT01747629|453549463|FG000|Overall Study|Not treated|1|||
126070067|NCT01747629|453549464|FG001|Overall Study|Not treated|0|||
126070068|NCT01747629|453549463|FG000|Overall Study|Other|2|||
126070069|NCT01747629|453549464|FG001|Overall Study|Other|1|||
125945542|NCT01203072|453099781|FG001|Overall Study|Lack of Efficacy|0|||
125945543|NCT01203072|453099782|FG002|Overall Study|Lack of Efficacy|0|||
126070070|NCT01395914|453549465|FG000|Overall Study|Unrelated to study drug AE|6|||
126070071|NCT01395914|453549466|FG001|Overall Study|Unrelated to study drug AE|1|||
126070072|NCT01395914|453549465|FG000|Overall Study|Death|23|||
125945544|NCT01203072|453099783|FG003|Overall Study|Lack of Efficacy|0|||
126070073|NCT01395914|453549466|FG001|Overall Study|Death|17|||
125945545|NCT01203072|453099784|FG004|Overall Study|Lack of Efficacy|0|||
126070074|NCT01395914|453549465|FG000|Overall Study|Other|9|||
126070075|NCT01395914|453549466|FG001|Overall Study|Other|3|||
126070076|NCT01395914|453549465|FG000|Overall Study|Withdrawal by patient|27|||
126070077|NCT01395914|453549466|FG001|Overall Study|Withdrawal by patient|14|||
126070078|NCT01395914|453549465|FG000|Overall Study|Study drug-related AE|1|||
126070079|NCT01395914|453549466|FG001|Overall Study|Study drug-related AE|0|||
126070080|NCT01395914|453549465|FG000|Overall Study|Lost to Follow-up|6|||
126070081|NCT01395914|453549466|FG001|Overall Study|Lost to Follow-up|2|||
126070082|NCT04414397|453549467|FG000|Control Period|Withdrawal by Subject|2|||
126070083|NCT04414397|453549468|FG001|Control Period|Withdrawal by Subject|2|||
126070084|NCT04414397|453549467|FG000|Control Period|Lost to Follow-up|0|||
126070085|NCT04414397|453549468|FG001|Control Period|Lost to Follow-up|4|||
126070086|NCT04414397|453549467|FG000|Control Period|Protocol deviation|0|||
126070087|NCT04414397|453549468|FG001|Control Period|Protocol deviation|1|||
126070088|NCT04414397|453549467|FG000|Post-Control Period|Withdrawal by Subject|3|||
126070089|NCT04414397|453549468|FG001|Post-Control Period|Withdrawal by Subject|6|||
126070090|NCT04414397|453549467|FG000|Post-Control Period|Lost to Follow-up|4|||
126070091|NCT04414397|453549468|FG001|Post-Control Period|Lost to Follow-up|9|||
126070092|NCT04414397|453549467|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
126070093|NCT04414397|453549468|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
126070094|NCT04414397|453549467|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
126070095|NCT04414397|453549468|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
126070096|NCT01920178|453549473|FG000|Overall Study|Lost to Follow-up|2|||
126070097|NCT01920178|453549474|FG001|Overall Study|Lost to Follow-up|1|||
126070098|NCT02391545|453549475|FG000|Overall Study|Death|0|||
126070099|NCT02391545|453549476|FG001|Overall Study|Death|2|||
126070100|NCT02391545|453549475|FG000|Overall Study|Lost to Follow-up|0|||
126070101|NCT02391545|453549476|FG001|Overall Study|Lost to Follow-up|1|||
126070102|NCT02391545|453549475|FG000|Overall Study|Termination of study by sponsor|20|||
126070103|NCT02391545|453549476|FG001|Overall Study|Termination of study by sponsor|20|||
126070104|NCT02391545|453549475|FG000|Overall Study|Withdrawal by Subject|0|||
126070105|NCT02391545|453549476|FG001|Overall Study|Withdrawal by Subject|1|||
126070106|NCT02391545|453549475|FG000|Overall Study|Other Reasons|6|||
126070107|NCT02391545|453549476|FG001|Overall Study|Other Reasons|4|||
126070108|NCT04754594|453549480|FG000|Blinded Period|Withdrawal by Subject|4|||
126070109|NCT04754594|453549481|FG001|Blinded Period|Withdrawal by Subject|9|||
126070110|NCT04754594|453549482|FG002|Blinded Period|Withdrawal by Subject|0|||
126070111|NCT04754594|453549483|FG003|Blinded Period|Withdrawal by Subject|0|||
126070112|NCT04754594|453549480|FG000|Blinded Period|Protocol Violation|2|||
126070113|NCT04754594|453549481|FG001|Blinded Period|Protocol Violation|2|||
126070114|NCT04754594|453549482|FG002|Blinded Period|Protocol Violation|0|||
126070115|NCT04754594|453549483|FG003|Blinded Period|Protocol Violation|0|||
126070116|NCT04754594|453549480|FG000|Blinded Period|Lost to Follow-up|1|||
126070117|NCT04754594|453549481|FG001|Blinded Period|Lost to Follow-up|1|||
126070118|NCT04754594|453549482|FG002|Blinded Period|Lost to Follow-up|0|||
126070119|NCT04754594|453549483|FG003|Blinded Period|Lost to Follow-up|0|||
126070120|NCT04754594|453549480|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
126070121|NCT04754594|453549481|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
126070122|NCT04754594|453549482|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
126070123|NCT04754594|453549483|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
126070124|NCT04754594|453549480|FG000|Unblinded Period|Withdrawal by Subject|6|||
126070125|NCT04754594|453549481|FG001|Unblinded Period|Withdrawal by Subject|8|||
126070126|NCT04754594|453549482|FG002|Unblinded Period|Withdrawal by Subject|0|||
126070127|NCT04754594|453549483|FG003|Unblinded Period|Withdrawal by Subject|0|||
126070128|NCT04754594|453549480|FG000|Unblinded Period|Lost to Follow-up|5|||
126070129|NCT04754594|453549481|FG001|Unblinded Period|Lost to Follow-up|3|||
126070130|NCT04754594|453549482|FG002|Unblinded Period|Lost to Follow-up|0|||
126070131|NCT04754594|453549483|FG003|Unblinded Period|Lost to Follow-up|0|||
126070132|NCT04754594|453549480|FG000|Unblinded Period|Protocol Violation|2|||
126070133|NCT04754594|453549481|FG001|Unblinded Period|Protocol Violation|4|||
126070134|NCT04754594|453549482|FG002|Unblinded Period|Protocol Violation|0|||
126070135|NCT04754594|453549483|FG003|Unblinded Period|Protocol Violation|0|||
125945546|NCT01203072|453099780|FG000|Overall Study|Lost to Follow-up|0|||
126114483|NCT00375219|453713849|FG001|Overall Study|Protocol Violation|0|||
126114484|NCT00375219|453713850|FG002|Overall Study|Protocol Violation|1|||
126070136|NCT04754594|453549480|FG000|Unblinded Period|Other|3|||
126070137|NCT04754594|453549481|FG001|Unblinded Period|Other|0|||
126070138|NCT04754594|453549482|FG002|Unblinded Period|Other|0|||
126070139|NCT04754594|453549483|FG003|Unblinded Period|Other|0|||
126070140|NCT04754594|453549480|FG000|Infant Participants|Withdrawal by Subject|0|||
126070141|NCT04754594|453549481|FG001|Infant Participants|Withdrawal by Subject|0|||
126070142|NCT04754594|453549482|FG002|Infant Participants|Withdrawal by Subject|9|||
126070143|NCT04754594|453549483|FG003|Infant Participants|Withdrawal by Subject|17|||
126070144|NCT04754594|453549480|FG000|Infant Participants|Lost to Follow-up|0|||
126070145|NCT04754594|453549481|FG001|Infant Participants|Lost to Follow-up|0|||
126070146|NCT04754594|453549482|FG002|Infant Participants|Lost to Follow-up|4|||
126070147|NCT04754594|453549483|FG003|Infant Participants|Lost to Follow-up|10|||
126070148|NCT04754594|453549480|FG000|Infant Participants|Death|0|||
126070149|NCT04754594|453549481|FG001|Infant Participants|Death|0|||
126070150|NCT04754594|453549482|FG002|Infant Participants|Death|1|||
126070151|NCT04754594|453549483|FG003|Infant Participants|Death|1|||
126070152|NCT04754594|453549480|FG000|Infant Participants|Other|0|||
126070153|NCT04754594|453549481|FG001|Infant Participants|Other|0|||
126070154|NCT04754594|453549482|FG002|Infant Participants|Other|1|||
126070155|NCT04754594|453549483|FG003|Infant Participants|Other|1|||
126070156|NCT03340766|453549486|FG000|Overall Study|Withdrawal by Subject|2|||
126070157|NCT03340766|453549487|FG001|Overall Study|Withdrawal by Subject|1|||
126070158|NCT03340766|453549488|FG002|Overall Study|Withdrawal by Subject|3|||
126070159|NCT03340766|453549486|FG000|Overall Study|Lost to Follow-up|0|||
126070160|NCT03340766|453549487|FG001|Overall Study|Lost to Follow-up|0|||
126070161|NCT03340766|453549488|FG002|Overall Study|Lost to Follow-up|1|||
126070162|NCT03340766|453549486|FG000|Overall Study|Death|6|||
126070163|NCT03340766|453549487|FG001|Overall Study|Death|7|||
126070164|NCT03340766|453549488|FG002|Overall Study|Death|4|||
126070165|NCT02849509|453549491|FG000|Overall Study|Worsening of disease under study|1|||
126070166|NCT02849509|453549492|FG001|Overall Study|Worsening of disease under study|1|||
126070167|NCT02849509|453549493|FG002|Overall Study|Worsening of disease under study|1|||
126070168|NCT02849509|453549491|FG000|Overall Study|Worsening of other pre-existing disease|0|||
126070169|NCT02849509|453549492|FG001|Overall Study|Worsening of other pre-existing disease|1|||
126070170|NCT02849509|453549493|FG002|Overall Study|Worsening of other pre-existing disease|2|||
126070171|NCT02849509|453549491|FG000|Overall Study|Other adverse event|36|||
126070172|NCT02849509|453549492|FG001|Overall Study|Other adverse event|41|||
126070173|NCT02849509|453549493|FG002|Overall Study|Other adverse event|8|||
126070174|NCT02849509|453549491|FG000|Overall Study|Withdrawal by Subject|6|||
126070175|NCT02849509|453549492|FG001|Overall Study|Withdrawal by Subject|17|||
126070176|NCT02849509|453549493|FG002|Overall Study|Withdrawal by Subject|12|||
126070177|NCT02849509|453549491|FG000|Overall Study|Lost to Follow-up|27|||
126070178|NCT02849509|453549492|FG001|Overall Study|Lost to Follow-up|67|||
126070179|NCT02849509|453549493|FG002|Overall Study|Lost to Follow-up|36|||
126070180|NCT02849509|453549491|FG000|Overall Study|Other, reason not specified|14|||
126070181|NCT02849509|453549492|FG001|Overall Study|Other, reason not specified|29|||
126070182|NCT02849509|453549493|FG002|Overall Study|Other, reason not specified|25|||
126070183|NCT02849509|453549491|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
126070184|NCT02849509|453549492|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
126070185|NCT02849509|453549493|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
126070186|NCT02256488|453549494|FG000|Overall Study|Lost to Follow-up|6|||
126070187|NCT02256488|453549495|FG001|Overall Study|Lost to Follow-up|6|||
126070188|NCT02256488|453549496|FG002|Overall Study|Lost to Follow-up|9|||
126070189|NCT02256488|453549497|FG003|Overall Study|Lost to Follow-up|3|||
126070190|NCT02256488|453549494|FG000|Overall Study|OTHER|1|||
126070191|NCT02256488|453549495|FG001|Overall Study|OTHER|0|||
126070192|NCT02256488|453549496|FG002|Overall Study|OTHER|1|||
126070193|NCT02256488|453549497|FG003|Overall Study|OTHER|1|||
126070194|NCT02256488|453549494|FG000|Overall Study|Withdrawal by Subject|1|||
126070195|NCT02256488|453549495|FG001|Overall Study|Withdrawal by Subject|0|||
126070196|NCT02256488|453549496|FG002|Overall Study|Withdrawal by Subject|0|||
126070197|NCT02256488|453549497|FG003|Overall Study|Withdrawal by Subject|2|||
126070198|NCT03169530|453549498|FG000|Overall Study|Study ended by NIH|15|||
126070199|NCT03169530|453549499|FG001|Overall Study|Study ended by NIH|17|||
126070200|NCT00500539|453549500|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
126070201|NCT00500539|453549500|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
126070202|NCT00500539|453549500|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
126070203|NCT00500539|453549500|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
126070204|NCT00500539|453549500|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
126070205|NCT00500539|453549500|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
126070206|NCT00500539|453549500|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
126070207|NCT00500539|453549500|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
126070208|NCT00500539|453549500|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
126070209|NCT00500539|453549500|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
126070210|NCT00500539|453549500|FG000|Follow-up Period (16 Weeks)|Death|1|||
126070211|NCT00500539|453549500|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
126070212|NCT00500539|453549500|FG000|Follow-up Period (16 Weeks)|Missing|3|||
126070213|NCT01967719|453551875|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
126070214|NCT01967719|453551876|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
126070215|NCT01967719|453551877|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126070216|NCT01967719|453551878|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
126070217|NCT01967719|453551875|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
126070218|NCT01967719|453551876|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
126070219|NCT01967719|453551877|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
125945547|NCT01203072|453099781|FG001|Overall Study|Lost to Follow-up|1|||
126070220|NCT01967719|453551878|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
126070221|NCT02916706|453551883|FG000|Overall Study|Adverse Event|0|||
126070222|NCT02916706|453551884|FG001|Overall Study|Adverse Event|1|||
126070223|NCT02916706|453551883|FG000|Overall Study|Lost to Follow-up|0|||
126070224|NCT02916706|453551884|FG001|Overall Study|Lost to Follow-up|1|||
126070225|NCT02916706|453551883|FG000|Overall Study|Physician Decision|1|||
126070226|NCT02916706|453551884|FG001|Overall Study|Physician Decision|0|||
126070227|NCT02916706|453551883|FG000|Overall Study|Protocol Violation|3|||
126070228|NCT02916706|453551884|FG001|Overall Study|Protocol Violation|1|||
126070229|NCT02916706|453551883|FG000|Overall Study|Withdrawal by Subject|6|||
126070230|NCT02916706|453551884|FG001|Overall Study|Withdrawal by Subject|9|||
126070231|NCT02916706|453551883|FG000|Overall Study|Other|5|||
126070232|NCT02916706|453551884|FG001|Overall Study|Other|19|||
126070233|NCT00443898|453551891|FG000|Overall Study|Adverse Event|0|||
126070234|NCT00443898|453551892|FG001|Overall Study|Adverse Event|0|||
126070235|NCT00443898|453551893|FG002|Overall Study|Adverse Event|1|||
126070236|NCT00443898|453551894|FG003|Overall Study|Adverse Event|1|||
126070237|NCT00443898|453551891|FG000|Overall Study|Lack of Efficacy|2|||
126070238|NCT00443898|453551892|FG001|Overall Study|Lack of Efficacy|3|||
126070239|NCT00443898|453551893|FG002|Overall Study|Lack of Efficacy|3|||
126070240|NCT00443898|453551894|FG003|Overall Study|Lack of Efficacy|1|||
126070241|NCT00443898|453551891|FG000|Overall Study|Protocol Violation|1|||
126070242|NCT00443898|453551892|FG001|Overall Study|Protocol Violation|1|||
126070243|NCT00443898|453551893|FG002|Overall Study|Protocol Violation|1|||
126070244|NCT00443898|453551894|FG003|Overall Study|Protocol Violation|0|||
126070245|NCT00443898|453551891|FG000|Overall Study|Withdrawal by Subject|11|||
126070246|NCT00443898|453551892|FG001|Overall Study|Withdrawal by Subject|10|||
126070247|NCT00443898|453551893|FG002|Overall Study|Withdrawal by Subject|10|||
126070248|NCT00443898|453551894|FG003|Overall Study|Withdrawal by Subject|6|||
126070249|NCT00443898|453551891|FG000|Overall Study|Lost to Follow-up|10|||
126070250|NCT00443898|453551892|FG001|Overall Study|Lost to Follow-up|10|||
126070251|NCT00443898|453551893|FG002|Overall Study|Lost to Follow-up|14|||
126070252|NCT00443898|453551894|FG003|Overall Study|Lost to Follow-up|10|||
126070253|NCT00443898|453551891|FG000|Overall Study|Death|0|||
126070254|NCT00443898|453551892|FG001|Overall Study|Death|1|||
126070255|NCT00443898|453551893|FG002|Overall Study|Death|0|||
126070256|NCT00443898|453551894|FG003|Overall Study|Death|0|||
126070257|NCT01011049|453551895|FG000|Overall Study|Protocol Violation|0|||
126070258|NCT01011049|453551896|FG001|Overall Study|Protocol Violation|0|||
126070259|NCT01011049|453551897|FG002|Overall Study|Protocol Violation|2|||
126070260|NCT01011049|453551898|FG003|Overall Study|Protocol Violation|0|||
126070261|NCT01011049|453551895|FG000|Overall Study|Lost to Follow-up|1|||
126070262|NCT01011049|453551896|FG001|Overall Study|Lost to Follow-up|2|||
126070263|NCT01011049|453551897|FG002|Overall Study|Lost to Follow-up|1|||
126070264|NCT01011049|453551898|FG003|Overall Study|Lost to Follow-up|0|||
126070265|NCT01011049|453551895|FG000|Overall Study|Withdrawal by Subject|0|||
126070266|NCT01011049|453551896|FG001|Overall Study|Withdrawal by Subject|0|||
126070267|NCT01011049|453551897|FG002|Overall Study|Withdrawal by Subject|1|||
126070268|NCT01011049|453551898|FG003|Overall Study|Withdrawal by Subject|0|||
126070269|NCT00352053|453551904|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
126070270|NCT00352053|453551905|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
126070271|NCT00352053|453551904|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
126070272|NCT00352053|453551905|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
126070273|NCT00352053|453551904|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
126070274|NCT00352053|453551905|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
126070275|NCT00352053|453551904|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
126070276|NCT00352053|453551905|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
126070277|NCT00352053|453551904|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
126070278|NCT00352053|453551905|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
126070279|NCT00352053|453551904|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
126070280|NCT00352053|453551905|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
126070281|NCT00352053|453551904|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
126070282|NCT00352053|453551905|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
126070283|NCT00352053|453551904|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
126070284|NCT00352053|453551905|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
126070285|NCT00352053|453551904|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
126070286|NCT00352053|453551905|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
126070287|NCT00352053|453551904|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
126070288|NCT00352053|453551905|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
126070289|NCT00352053|453551904|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
126070290|NCT00352053|453551905|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
126070291|NCT00352053|453551904|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
126070292|NCT00352053|453551905|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
126070293|NCT00352053|453551904|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
126070294|NCT00352053|453551905|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
126070295|NCT00520403|453551906|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
126070296|NCT00520403|453551906|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
126070297|NCT00520403|453551906|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
126070298|NCT00520403|453551906|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
126070299|NCT00520403|453551906|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
126070300|NCT00520403|453551906|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
126070301|NCT00520403|453551906|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
126070302|NCT00520403|453551906|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
126070303|NCT00405912|453551909|FG000|Overall Study|Withdrawal by Subject|12|||
126070304|NCT00405912|453551910|FG001|Overall Study|Withdrawal by Subject|11|||
126070305|NCT00405912|453551911|FG002|Overall Study|Withdrawal by Subject|12|||
126070306|NCT00405912|453551909|FG000|Overall Study|Lost to Follow-up|4|||
126070307|NCT00405912|453551910|FG001|Overall Study|Lost to Follow-up|8|||
126070308|NCT00405912|453551911|FG002|Overall Study|Lost to Follow-up|4|||
126070309|NCT03730662|453551912|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
126070310|NCT03730662|453551913|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
126070311|NCT03730662|453551914|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
126070312|NCT03730662|453551915|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
126070313|NCT03730662|453551912|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
126070314|NCT03730662|453551913|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
126070315|NCT03730662|453551914|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
126070316|NCT03730662|453551915|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
126070317|NCT03730662|453551912|FG000|Treatment Period (52 Weeks)|Death|6|||
126070318|NCT03730662|453551913|FG001|Treatment Period (52 Weeks)|Death|2|||
126070319|NCT03730662|453551914|FG002|Treatment Period (52 Weeks)|Death|2|||
126070320|NCT03730662|453551915|FG003|Treatment Period (52 Weeks)|Death|9|||
126070321|NCT03730662|453551912|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
126070322|NCT03730662|453551913|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
126070323|NCT03730662|453551914|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
126070324|NCT03730662|453551915|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
126070325|NCT03730662|453551912|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
126070326|NCT03730662|453551913|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
126070327|NCT03730662|453551914|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
126070328|NCT03730662|453551915|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
126070329|NCT03730662|453551912|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
126070330|NCT03730662|453551913|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
126070331|NCT03730662|453551914|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
126070332|NCT03730662|453551915|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
126070333|NCT03730662|453551912|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
126070334|NCT03730662|453551913|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
126070335|NCT03730662|453551914|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
126070336|NCT03730662|453551915|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
126070337|NCT03730662|453551912|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
126070338|NCT03730662|453551913|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
126070339|NCT03730662|453551914|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
126070340|NCT03730662|453551915|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
126070341|NCT03730662|453551912|FG000|Variable Treatment Period|Adverse Event|1|||
126070342|NCT03730662|453551913|FG001|Variable Treatment Period|Adverse Event|2|||
126070343|NCT03730662|453551914|FG002|Variable Treatment Period|Adverse Event|0|||
126070344|NCT03730662|453551915|FG003|Variable Treatment Period|Adverse Event|7|||
126070345|NCT03730662|453551912|FG000|Variable Treatment Period|Death|9|||
126070346|NCT03730662|453551913|FG001|Variable Treatment Period|Death|0|||
126070347|NCT03730662|453551914|FG002|Variable Treatment Period|Death|6|||
126070348|NCT03730662|453551915|FG003|Variable Treatment Period|Death|26|||
126070349|NCT03730662|453551912|FG000|Variable Treatment Period|Lost to Follow-up|2|||
126070350|NCT03730662|453551913|FG001|Variable Treatment Period|Lost to Follow-up|1|||
126114485|NCT00375219|453713848|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
126114486|NCT00375219|453713849|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
126114487|NCT00375219|453713850|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
126114488|NCT00375219|453713848|FG000|Overall Study|Lost to Follow-up|1|||
126114489|NCT00375219|453713849|FG001|Overall Study|Lost to Follow-up|1|||
126114490|NCT00375219|453713850|FG002|Overall Study|Lost to Follow-up|0|||
126070351|NCT03730662|453551914|FG002|Variable Treatment Period|Lost to Follow-up|4|||
126070352|NCT03730662|453551915|FG003|Variable Treatment Period|Lost to Follow-up|11|||
126070353|NCT03730662|453551912|FG000|Variable Treatment Period|Personal Reason|0|||
126070354|NCT03730662|453551913|FG001|Variable Treatment Period|Personal Reason|2|||
126070355|NCT03730662|453551914|FG002|Variable Treatment Period|Personal Reason|1|||
126070356|NCT03730662|453551915|FG003|Variable Treatment Period|Personal Reason|6|||
126070357|NCT03730662|453551912|FG000|Variable Treatment Period|Physician Decision|0|||
126070358|NCT03730662|453551913|FG001|Variable Treatment Period|Physician Decision|0|||
126070359|NCT03730662|453551914|FG002|Variable Treatment Period|Physician Decision|0|||
126070360|NCT03730662|453551915|FG003|Variable Treatment Period|Physician Decision|3|||
126114491|NCT00375219|453713848|FG000|Overall Study|Disease progression|18|||
126070361|NCT03730662|453551912|FG000|Variable Treatment Period|Protocol Violation|0|||
126070362|NCT03730662|453551913|FG001|Variable Treatment Period|Protocol Violation|1|||
126070363|NCT03730662|453551914|FG002|Variable Treatment Period|Protocol Violation|1|||
126070364|NCT03730662|453551915|FG003|Variable Treatment Period|Protocol Violation|1|||
126070365|NCT03730662|453551912|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
126070366|NCT03730662|453551913|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
126070367|NCT03730662|453551914|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
126070368|NCT03730662|453551915|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
126070369|NCT01797562|453551916|FG000|Overall Study|Protocol Violation|5|||
126070370|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
126070371|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
126070372|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
126070373|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
126070374|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Death|0|||
126070375|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Death|1|||
126070376|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
126070377|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
126070378|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
126070379|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
126070380|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
126070381|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
126070382|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
126070383|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
126070384|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
126070385|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
126070386|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
126070387|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
126070388|NCT01309243|453551917|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
126070389|NCT01309243|453551918|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
126070390|NCT01309243|453551917|FG000|Extension Phase|Lost to Follow-up|6|||
126070391|NCT01309243|453551918|FG001|Extension Phase|Lost to Follow-up|0|||
126070392|NCT00632931|453551921|FG000|Part 1, Period 1|Protocol Violation|1|||
126070393|NCT00632931|453551922|FG001|Part 1, Period 1|Protocol Violation|0|||
126070394|NCT00632931|453551923|FG002|Part 1, Period 1|Protocol Violation|0|||
126070395|NCT00632931|453551921|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
126070396|NCT00632931|453551922|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
126070397|NCT00632931|453551923|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
126070398|NCT00632931|453551921|FG000|Part 2|Adverse Event|0|||
126070399|NCT00632931|453551922|FG001|Part 2|Adverse Event|0|||
126070400|NCT00632931|453551923|FG002|Part 2|Adverse Event|3|||
126070401|NCT00632931|453551921|FG000|Part 2|Death|0|||
126070402|NCT00632931|453551922|FG001|Part 2|Death|0|||
126070403|NCT00632931|453551923|FG002|Part 2|Death|1|||
126070404|NCT00632931|453551921|FG000|Part 2|Lack of Efficacy|0|||
126070405|NCT00632931|453551922|FG001|Part 2|Lack of Efficacy|0|||
126070406|NCT00632931|453551923|FG002|Part 2|Lack of Efficacy|17|||
126070407|NCT00632931|453551921|FG000|Part 2|Withdrawal by Subject|0|||
126070408|NCT00632931|453551922|FG001|Part 2|Withdrawal by Subject|0|||
126070409|NCT00632931|453551923|FG002|Part 2|Withdrawal by Subject|3|||
126070410|NCT01441583|453551926|FG000|Overall Study|Withdrawal by Subject|1|||
126070411|NCT01441583|453551927|FG001|Overall Study|Withdrawal by Subject|1|||
126070412|NCT01441583|453551928|FG002|Overall Study|Withdrawal by Subject|1|||
126070413|NCT01441583|453551926|FG000|Overall Study|Death|1|||
126070414|NCT01441583|453551927|FG001|Overall Study|Death|0|||
126070415|NCT01441583|453551928|FG002|Overall Study|Death|4|||
126070416|NCT01441583|453551926|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
126070417|NCT01441583|453551927|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
126070418|NCT01441583|453551928|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
126070419|NCT03341312|453551929|FG000|Period 1|Withdrawal by Subject|0|||
126070420|NCT03341312|453551930|FG001|Period 1|Withdrawal by Subject|1|||
126070421|NCT03341312|453551931|FG002|Period 1|Withdrawal by Subject|0|||
126070422|NCT03341312|453551932|FG003|Period 1|Withdrawal by Subject|0|||
126070423|NCT00839306|453551933|FG000|Overall Study|Adverse Event|3|||
126070424|NCT00839306|453551934|FG001|Overall Study|Adverse Event|5|||
126070425|NCT00839306|453551933|FG000|Overall Study|Lost to Follow-up|6|||
126070426|NCT00839306|453551934|FG001|Overall Study|Lost to Follow-up|9|||
126070427|NCT00839306|453551933|FG000|Overall Study|Withdrawal by Subject|5|||
126070428|NCT00839306|453551934|FG001|Overall Study|Withdrawal by Subject|7|||
126070429|NCT00839306|453551933|FG000|Overall Study|Lack of Efficacy|5|||
126114492|NCT00375219|453713849|FG001|Overall Study|Disease progression|9|||
126114493|NCT00375219|453713850|FG002|Overall Study|Disease progression|12|||
125945548|NCT01203072|453099782|FG002|Overall Study|Lost to Follow-up|0|||
126070430|NCT00839306|453551934|FG001|Overall Study|Lack of Efficacy|4|||
126070431|NCT00839306|453551933|FG000|Overall Study|Other|6|||
126070432|NCT00839306|453551934|FG001|Overall Study|Other|18|||
126114494|NCT00375219|453713848|FG000|Overall Study|Death|4|||
126070433|NCT01812707|453551935|FG000|Overall Study|Adverse Event|0|||
126070434|NCT01812707|453551936|FG001|Overall Study|Adverse Event|0|||
126070435|NCT01812707|453551937|FG002|Overall Study|Adverse Event|0|||
126070436|NCT01812707|453551938|FG003|Overall Study|Adverse Event|2|||
126070437|NCT01812707|453551935|FG000|Overall Study|Poor compliance to protocol|1|||
126070438|NCT01812707|453551936|FG001|Overall Study|Poor compliance to protocol|0|||
126070439|NCT01812707|453551937|FG002|Overall Study|Poor compliance to protocol|0|||
126070440|NCT01812707|453551938|FG003|Overall Study|Poor compliance to protocol|0|||
126070441|NCT01812707|453551935|FG000|Overall Study|Consent withdrawn by participant|1|||
126070442|NCT01812707|453551936|FG001|Overall Study|Consent withdrawn by participant|0|||
126070443|NCT01812707|453551937|FG002|Overall Study|Consent withdrawn by participant|0|||
126070444|NCT01812707|453551938|FG003|Overall Study|Consent withdrawn by participant|0|||
126070445|NCT05060237|453551939|FG000|Overall Study|Withdrawal by Subject|4|||
126070446|NCT05060237|453551939|FG000|Overall Study|Screening failure|8|||
126070447|NCT01697592|453551940|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
126070448|NCT01697592|453551941|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070449|NCT01697592|453551942|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070450|NCT01697592|453551943|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070451|NCT01697592|453551944|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070452|NCT01697592|453551945|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070453|NCT01697592|453551946|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070454|NCT01697592|453551947|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070455|NCT01697592|453551948|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070456|NCT01697592|453551949|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126070457|NCT01697592|453551940|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070458|NCT01697592|453551941|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070459|NCT01697592|453551942|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070460|NCT01697592|453551943|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070461|NCT01697592|453551944|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070462|NCT01697592|453551945|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
126070463|NCT01697592|453551946|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070464|NCT01697592|453551947|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070465|NCT01697592|453551948|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070466|NCT01697592|453551949|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126070467|NCT01697592|453551940|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
126070468|NCT01697592|453551941|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070469|NCT01697592|453551942|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070470|NCT01697592|453551943|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070471|NCT01697592|453551944|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070472|NCT01697592|453551945|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070473|NCT01697592|453551946|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070474|NCT01697592|453551947|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070475|NCT01697592|453551948|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070476|NCT01697592|453551949|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126070477|NCT01697592|453551940|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126070478|NCT01697592|453551941|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126070479|NCT01697592|453551942|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126070480|NCT01697592|453551943|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126070481|NCT01697592|453551944|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126070482|NCT01697592|453551945|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126070483|NCT01697592|453551946|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126070484|NCT01697592|453551947|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126070485|NCT01697592|453551948|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126070486|NCT01697592|453551949|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126070487|NCT01697592|453551940|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126070488|NCT01697592|453551941|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
126070489|NCT01697592|453551942|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
126070490|NCT01697592|453551943|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
126070491|NCT01697592|453551944|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126070492|NCT01697592|453551945|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126070493|NCT01697592|453551946|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
126070494|NCT01697592|453551947|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126070495|NCT01697592|453551948|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126070496|NCT01697592|453551949|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
126070497|NCT01697592|453551940|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
126114495|NCT00375219|453713849|FG001|Overall Study|Death|3|||
126070498|NCT01697592|453551941|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126070499|NCT01697592|453551942|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126070500|NCT01697592|453551943|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
126070501|NCT01697592|453551944|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126070502|NCT01697592|453551945|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126070503|NCT01697592|453551946|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126070504|NCT01697592|453551947|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126070505|NCT01697592|453551948|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126070506|NCT01697592|453551949|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126070507|NCT01697592|453551940|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
126070508|NCT01697592|453551941|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126070509|NCT01697592|453551942|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126070510|NCT01697592|453551943|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126070511|NCT01697592|453551944|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126070512|NCT01697592|453551945|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
126070513|NCT01697592|453551946|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126070514|NCT01697592|453551947|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
126070515|NCT01697592|453551948|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126070516|NCT01697592|453551949|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126070517|NCT01697592|453551940|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
126070518|NCT01697592|453551941|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
126070519|NCT01697592|453551942|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
126070520|NCT01697592|453551943|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
126070521|NCT01697592|453551944|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
126070522|NCT01697592|453551945|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
126070523|NCT01697592|453551946|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
126070524|NCT01697592|453551947|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
126070525|NCT01697592|453551948|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
126070526|NCT01697592|453551949|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
126070527|NCT02396758|453551950|FG000|Overall Study|Withdrawal by Subject|2|||
126070528|NCT02396758|453551951|FG001|Overall Study|Withdrawal by Subject|0|||
126070529|NCT02396758|453551952|FG002|Overall Study|Withdrawal by Subject|0|||
126070530|NCT02396758|453551953|FG003|Overall Study|Withdrawal by Subject|1|||
126070531|NCT02396758|453551950|FG000|Overall Study|Lost to Follow-up|8|||
126070532|NCT02396758|453551951|FG001|Overall Study|Lost to Follow-up|5|||
126070533|NCT02396758|453551952|FG002|Overall Study|Lost to Follow-up|3|||
126070534|NCT02396758|453551953|FG003|Overall Study|Lost to Follow-up|3|||
126070535|NCT02396758|453551950|FG000|Overall Study|Death|1|||
126070536|NCT02396758|453551951|FG001|Overall Study|Death|1|||
126070537|NCT02396758|453551952|FG002|Overall Study|Death|0|||
126070538|NCT02396758|453551953|FG003|Overall Study|Death|1|||
126070539|NCT02396758|453551950|FG000|Overall Study|Randomized but not treated|1|||
126070540|NCT02396758|453551951|FG001|Overall Study|Randomized but not treated|0|||
126070541|NCT02396758|453551952|FG002|Overall Study|Randomized but not treated|1|||
126070542|NCT02396758|453551953|FG003|Overall Study|Randomized but not treated|0|||
126070543|NCT00265096|453551954|FG000|Overall Study|Adverse Event|14|||
126070544|NCT00265096|453551955|FG001|Overall Study|Adverse Event|18|||
126070545|NCT00265096|453551956|FG002|Overall Study|Adverse Event|18|||
126070546|NCT00265096|453551954|FG000|Overall Study|Lost to Follow-up|2|||
126070547|NCT00265096|453551955|FG001|Overall Study|Lost to Follow-up|5|||
126070548|NCT00265096|453551956|FG002|Overall Study|Lost to Follow-up|3|||
126070549|NCT00265096|453551954|FG000|Overall Study|Death|0|||
126070550|NCT00265096|453551955|FG001|Overall Study|Death|1|||
126070551|NCT00265096|453551956|FG002|Overall Study|Death|2|||
126070552|NCT00265096|453551954|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
126070553|NCT00265096|453551955|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126070554|NCT00265096|453551956|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
126070555|NCT00265096|453551954|FG000|Overall Study|Other|11|||
126070556|NCT00265096|453551955|FG001|Overall Study|Other|19|||
126070557|NCT00265096|453551956|FG002|Overall Study|Other|10|||
126070558|NCT00774306|453551957|FG000|Overall Study|Adverse Event|3|||
126070559|NCT00774306|453551958|FG001|Overall Study|Adverse Event|0|||
126070560|NCT00774306|453551959|FG002|Overall Study|Adverse Event|0|||
126070561|NCT00774306|453551960|FG003|Overall Study|Adverse Event|0|||
126070562|NCT00774306|453551957|FG000|Overall Study|Protocol Violation|2|||
126070563|NCT00774306|453551958|FG001|Overall Study|Protocol Violation|0|||
126070564|NCT00774306|453551959|FG002|Overall Study|Protocol Violation|3|||
126070565|NCT00774306|453551960|FG003|Overall Study|Protocol Violation|0|||
126070566|NCT00774306|453551957|FG000|Overall Study|Withdrawal by Subject|6|||
126070567|NCT00774306|453551958|FG001|Overall Study|Withdrawal by Subject|1|||
126070568|NCT00774306|453551959|FG002|Overall Study|Withdrawal by Subject|1|||
126070569|NCT00774306|453551960|FG003|Overall Study|Withdrawal by Subject|0|||
126070570|NCT00774306|453551957|FG000|Overall Study|Lost to Follow-up|6|||
126070571|NCT00774306|453551958|FG001|Overall Study|Lost to Follow-up|0|||
126070572|NCT00774306|453551959|FG002|Overall Study|Lost to Follow-up|4|||
126070573|NCT00774306|453551960|FG003|Overall Study|Lost to Follow-up|5|||
126114496|NCT00375219|453713850|FG002|Overall Study|Death|7|||
126114497|NCT00375219|453713848|FG000|Overall Study|Hematologic resistance|1|||
126114498|NCT00375219|453713849|FG001|Overall Study|Hematologic resistance|0|||
126070574|NCT00774306|453551957|FG000|Overall Study|Death|1|||
126070575|NCT00774306|453551958|FG001|Overall Study|Death|1|||
126070576|NCT00774306|453551959|FG002|Overall Study|Death|0|||
125945549|NCT01203072|453099783|FG003|Overall Study|Lost to Follow-up|0|||
125945550|NCT01203072|453099784|FG004|Overall Study|Lost to Follow-up|0|||
125945551|NCT01203072|453099780|FG000|Overall Study|Protocol Violation|2|||
125945552|NCT01203072|453099781|FG001|Overall Study|Protocol Violation|0|||
125945553|NCT01203072|453099782|FG002|Overall Study|Protocol Violation|0|||
125945554|NCT01203072|453099783|FG003|Overall Study|Protocol Violation|0|||
125945555|NCT01203072|453099784|FG004|Overall Study|Protocol Violation|1|||
125945556|NCT01203072|453099780|FG000|Overall Study|Withdrawal by Subject|2|||
125945557|NCT01203072|453099781|FG001|Overall Study|Withdrawal by Subject|2|||
125945558|NCT01203072|453099782|FG002|Overall Study|Withdrawal by Subject|1|||
125945559|NCT01203072|453099783|FG003|Overall Study|Withdrawal by Subject|2|||
125945560|NCT01203072|453099784|FG004|Overall Study|Withdrawal by Subject|3|||
125945561|NCT02286193|453099790|FG000|Overall Study|Referred: CRS unable to make contact|62|||
125945562|NCT02286193|453099790|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
125945563|NCT02286193|453099790|FG000|Overall Study|Referred: Declined service|38|||
125945564|NCT02023151|453099791|FG000|Overall Study|Lost to Follow-up|4|||
125945565|NCT02932904|453099792|FG000|Overall Study|Reason not Specified|1|||
125945566|NCT02932904|453099793|FG001|Overall Study|Reason not Specified|0|||
125945567|NCT02932904|453099794|FG002|Overall Study|Reason not Specified|2|||
125945568|NCT02932904|453099795|FG003|Overall Study|Reason not Specified|2|||
125945569|NCT02932904|453099792|FG000|Overall Study|Noncompliance with Study Drug|2|||
125945570|NCT02932904|453099793|FG001|Overall Study|Noncompliance with Study Drug|3|||
125945571|NCT02932904|453099794|FG002|Overall Study|Noncompliance with Study Drug|3|||
125945572|NCT02932904|453099795|FG003|Overall Study|Noncompliance with Study Drug|4|||
125945573|NCT02932904|453099792|FG000|Overall Study|Pregnancy|0|||
125945574|NCT02932904|453099793|FG001|Overall Study|Pregnancy|1|||
125945575|NCT02932904|453099794|FG002|Overall Study|Pregnancy|1|||
125945576|NCT02932904|453099795|FG003|Overall Study|Pregnancy|0|||
125945577|NCT02932904|453099792|FG000|Overall Study|Study Termination|0|||
125945578|NCT02932904|453099793|FG001|Overall Study|Study Termination|1|||
125945579|NCT02932904|453099794|FG002|Overall Study|Study Termination|0|||
125945580|NCT02932904|453099795|FG003|Overall Study|Study Termination|0|||
125945581|NCT02932904|453099792|FG000|Overall Study|Voluntary Withdrawal|2|||
125945582|NCT02932904|453099793|FG001|Overall Study|Voluntary Withdrawal|1|||
125945583|NCT02932904|453099794|FG002|Overall Study|Voluntary Withdrawal|4|||
125945584|NCT02932904|453099795|FG003|Overall Study|Voluntary Withdrawal|2|||
125945585|NCT02932904|453099792|FG000|Overall Study|Lost to Follow-up|5|||
125945586|NCT02932904|453099793|FG001|Overall Study|Lost to Follow-up|3|||
125945587|NCT02932904|453099794|FG002|Overall Study|Lost to Follow-up|6|||
125945588|NCT02932904|453099795|FG003|Overall Study|Lost to Follow-up|0|||
125945589|NCT02932904|453099792|FG000|Overall Study|Significant Protocol Deviation|2|||
125945590|NCT02932904|453099793|FG001|Overall Study|Significant Protocol Deviation|3|||
125945591|NCT02932904|453099794|FG002|Overall Study|Significant Protocol Deviation|6|||
125945592|NCT02932904|453099795|FG003|Overall Study|Significant Protocol Deviation|1|||
125945593|NCT02932904|453099792|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
125945594|NCT02932904|453099793|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
125945595|NCT02932904|453099794|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
125945596|NCT02932904|453099795|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
125945597|NCT02932904|453099792|FG000|Overall Study|Randomized But Not Treated|1|||
125945598|NCT02932904|453099793|FG001|Overall Study|Randomized But Not Treated|1|||
125945599|NCT02932904|453099794|FG002|Overall Study|Randomized But Not Treated|0|||
125945600|NCT02932904|453099795|FG003|Overall Study|Randomized But Not Treated|2|||
125945601|NCT01577758|453099796|FG000|Dose Escalation Phase|Adverse Event|0|||
125945602|NCT01577758|453099797|FG001|Dose Escalation Phase|Adverse Event|0|||
125945603|NCT01577758|453099798|FG002|Dose Escalation Phase|Adverse Event|0|||
125945604|NCT01577758|453099799|FG003|Dose Escalation Phase|Adverse Event|0|||
125945605|NCT01577758|453099800|FG004|Dose Escalation Phase|Adverse Event|0|||
125945606|NCT01577758|453099801|FG005|Dose Escalation Phase|Adverse Event|2|||
125945607|NCT01577758|453099802|FG006|Dose Escalation Phase|Adverse Event|1|||
125945608|NCT01577758|453099803|FG007|Dose Escalation Phase|Adverse Event|0|||
125945609|NCT01577758|453099796|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
125945610|NCT01577758|453099797|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
125945611|NCT01577758|453099798|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
125945612|NCT01577758|453099799|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
125945613|NCT01577758|453099800|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
125945614|NCT01577758|453099801|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
125945615|NCT01577758|453099802|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
125945616|NCT01577758|453099803|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
125945617|NCT01577758|453099796|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125945618|NCT01577758|453099797|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125945619|NCT01577758|453099798|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125945620|NCT01577758|453099799|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125945621|NCT01577758|453099800|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
126070577|NCT00774306|453551960|FG003|Overall Study|Death|0|||
126070578|NCT00666835|453551961|FG000|Overall Study|Withdrawal by Subject|5|||
126070579|NCT00666835|453551962|FG001|Overall Study|Withdrawal by Subject|2|||
126070580|NCT00666835|453551961|FG000|Overall Study|Lack of Efficacy|0|||
126070581|NCT00666835|453551962|FG001|Overall Study|Lack of Efficacy|1|||
126070582|NCT00666835|453551961|FG000|Overall Study|Incl./excl. not fulfilled|7|||
126070583|NCT00666835|453551962|FG001|Overall Study|Incl./excl. not fulfilled|2|||
126070584|NCT00666835|453551961|FG000|Overall Study|Adverse Event|7|||
126070585|NCT00666835|453551962|FG001|Overall Study|Adverse Event|6|||
126070586|NCT00666835|453551961|FG000|Overall Study|Protocol Violation|2|||
126070587|NCT00666835|453551962|FG001|Overall Study|Protocol Violation|0|||
126070588|NCT00666835|453551961|FG000|Overall Study|Death|15|||
126070589|NCT00666835|453551962|FG001|Overall Study|Death|4|||
126070590|NCT00666835|453551961|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
126070591|NCT00666835|453551962|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
126070592|NCT00666835|453551961|FG000|Overall Study|Hemoglobulin concentration|4|||
126070593|NCT00666835|453551962|FG001|Overall Study|Hemoglobulin concentration|3|||
126070594|NCT00666835|453551961|FG000|Overall Study|Planned operation|2|||
126070595|NCT00666835|453551962|FG001|Overall Study|Planned operation|0|||
126070596|NCT00666835|453551961|FG000|Overall Study|Physician Decision|1|||
126070597|NCT00666835|453551962|FG001|Overall Study|Physician Decision|2|||
126070598|NCT01126879|453551963|FG000|Overall Study|Progressive Disease|3|||
126070599|NCT01126879|453551964|FG001|Overall Study|Progressive Disease|1|||
126070600|NCT01126879|453551963|FG000|Overall Study|Withdrawal by Subject|1|||
126070601|NCT01126879|453551964|FG001|Overall Study|Withdrawal by Subject|0|||
126070602|NCT01126879|453551963|FG000|Overall Study|Adverse Event|0|||
126070603|NCT01126879|453551964|FG001|Overall Study|Adverse Event|1|||
126070604|NCT01126879|453551963|FG000|Overall Study|Physician Decision|1|||
126070605|NCT01126879|453551964|FG001|Overall Study|Physician Decision|0|||
126070606|NCT03319719|453551967|FG000|Overall Study|Lost to Follow-up|1|||
126070607|NCT03193216|453551971|FG000|Overall Study|Lost to Follow-up|1|||
126070608|NCT03193216|453551972|FG001|Overall Study|Lost to Follow-up|0|||
126070609|NCT03193216|453551971|FG000|Overall Study|Withdrawal by Subject|5|||
126070610|NCT03193216|453551972|FG001|Overall Study|Withdrawal by Subject|0|||
126070611|NCT03193216|453551971|FG000|Overall Study|Physician Decision|4|||
126070612|NCT03193216|453551972|FG001|Overall Study|Physician Decision|0|||
126070613|NCT02236598|453551976|FG000|Overall Study|Adverse Event|0|||
126070614|NCT02236598|453551977|FG001|Overall Study|Adverse Event|1|||
126070615|NCT02236598|453551976|FG000|Overall Study|Withdrawal by Subject|0|||
126070616|NCT02236598|453551977|FG001|Overall Study|Withdrawal by Subject|1|||
126070617|NCT01264887|453551979|FG000|Overall Study|Adverse Event|5|||
126070618|NCT01264887|453551979|FG000|Overall Study|Death|7|||
126070619|NCT01264887|453551979|FG000|Overall Study|Lack of Efficacy|5|||
126070620|NCT01264887|453551979|FG000|Overall Study|Physician Decision|4|||
126070621|NCT01264887|453551979|FG000|Overall Study|Withdrawal by Subject|6|||
126070622|NCT01264887|453551979|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
126070623|NCT01264887|453551979|FG000|Overall Study|Other|2|||
126070624|NCT02959177|453551980|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
126070625|NCT02959177|453551981|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
126070626|NCT02959177|453551982|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
126070627|NCT02959177|453551980|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
126070628|NCT02959177|453551981|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
126070629|NCT02959177|453551982|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
126070630|NCT02959177|453551980|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
126070631|NCT02959177|453551981|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
126070632|NCT02959177|453551982|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
126070633|NCT02959177|453551980|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
126070634|NCT02959177|453551981|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126070635|NCT02959177|453551982|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
126070636|NCT02959177|453551980|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
126070637|NCT02959177|453551981|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
126070638|NCT02959177|453551982|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
126070639|NCT02959177|453551980|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
126070640|NCT02959177|453551981|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
126070641|NCT02959177|453551982|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
126070642|NCT02959177|453551980|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
126114499|NCT00375219|453713850|FG002|Overall Study|Hematologic resistance|0|||
126114500|NCT00375219|453713848|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
126070643|NCT02959177|453551981|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
126070644|NCT02959177|453551982|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
126070645|NCT01061775|453551985|FG000|Overall Study|Physician Decision|2|||
126070646|NCT01061775|453551985|FG000|Overall Study|Lost to Follow-up|1|||
126070647|NCT01313299|453551990|FG000|Overall Study|Adverse Event|3|||
126114501|NCT00375219|453713849|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
126070648|NCT01313299|453551991|FG001|Overall Study|Adverse Event|1|||
126070649|NCT01313299|453551992|FG002|Overall Study|Adverse Event|1|||
126070650|NCT01313299|453551990|FG000|Overall Study|Lost to Follow-up|1|||
126070651|NCT01313299|453551991|FG001|Overall Study|Lost to Follow-up|0|||
126070652|NCT01313299|453551992|FG002|Overall Study|Lost to Follow-up|0|||
126070653|NCT01313299|453551990|FG000|Overall Study|Protocol Violation|2|||
126070654|NCT01313299|453551991|FG001|Overall Study|Protocol Violation|0|||
126070655|NCT01313299|453551992|FG002|Overall Study|Protocol Violation|0|||
126070656|NCT01313299|453551990|FG000|Overall Study|Withdrawal by Subject|1|||
126070657|NCT01313299|453551991|FG001|Overall Study|Withdrawal by Subject|0|||
126070658|NCT01313299|453551992|FG002|Overall Study|Withdrawal by Subject|2|||
126070659|NCT01313299|453551990|FG000|Overall Study|Family reason and moved out of state|0|||
126070660|NCT01313299|453551991|FG001|Overall Study|Family reason and moved out of state|2|||
126070661|NCT01313299|453551992|FG002|Overall Study|Family reason and moved out of state|0|||
126070662|NCT01313299|453551990|FG000|Overall Study|Lack of subject compliance|0|||
126070663|NCT01313299|453551991|FG001|Overall Study|Lack of subject compliance|0|||
126070664|NCT01313299|453551992|FG002|Overall Study|Lack of subject compliance|1|||
126070665|NCT04089332|453551996|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
126070666|NCT04089332|453551996|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
126070667|NCT04089332|453551996|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
126070668|NCT00050167|453551997|FG000|Overall Study|not eligible not invasive|1|||
126070669|NCT00050167|453551998|FG001|Overall Study|not eligible not invasive|1|||
126070670|NCT00975130|453552002|FG000|Study Part 1|Adverse Event|150|||
126070671|NCT00975130|453552003|FG001|Study Part 1|Adverse Event|0|||
126070672|NCT00975130|453552004|FG002|Study Part 1|Adverse Event|0|||
126070673|NCT00975130|453552002|FG000|Study Part 1|Lost to Follow-up|19|||
126070674|NCT00975130|453552003|FG001|Study Part 1|Lost to Follow-up|0|||
126070675|NCT00975130|453552004|FG002|Study Part 1|Lost to Follow-up|0|||
126070676|NCT00975130|453552002|FG000|Study Part 1|Withdrawal by Subject|61|||
126070677|NCT00975130|453552003|FG001|Study Part 1|Withdrawal by Subject|0|||
126070678|NCT00975130|453552004|FG002|Study Part 1|Withdrawal by Subject|0|||
126070679|NCT00975130|453552002|FG000|Study Part 1|Protocol Violation|13|||
126070680|NCT00975130|453552003|FG001|Study Part 1|Protocol Violation|0|||
126070681|NCT00975130|453552004|FG002|Study Part 1|Protocol Violation|0|||
126070682|NCT00975130|453552002|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
126070683|NCT00975130|453552003|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
126070684|NCT00975130|453552004|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
126070685|NCT00975130|453552002|FG000|Study Part 1|Administrative|4|||
126070686|NCT00975130|453552003|FG001|Study Part 1|Administrative|0|||
126070687|NCT00975130|453552004|FG002|Study Part 1|Administrative|0|||
126070688|NCT00975130|453552002|FG000|Study Part 1|Withdrew Consent|24|||
126070689|NCT00975130|453552003|FG001|Study Part 1|Withdrew Consent|0|||
126070690|NCT00975130|453552004|FG002|Study Part 1|Withdrew Consent|0|||
126070691|NCT00975130|453552002|FG000|Study Part 2|Adverse Event|0|||
126070692|NCT00975130|453552003|FG001|Study Part 2|Adverse Event|14|||
126070693|NCT00975130|453552004|FG002|Study Part 2|Adverse Event|7|||
126070694|NCT00975130|453552002|FG000|Study Part 2|Lost to Follow-up|0|||
126070695|NCT00975130|453552003|FG001|Study Part 2|Lost to Follow-up|0|||
126070696|NCT00975130|453552004|FG002|Study Part 2|Lost to Follow-up|1|||
126070697|NCT00975130|453552002|FG000|Study Part 2|Withdrawal by Subject|0|||
126070698|NCT00975130|453552003|FG001|Study Part 2|Withdrawal by Subject|13|||
126070699|NCT00975130|453552004|FG002|Study Part 2|Withdrawal by Subject|5|||
126070700|NCT00975130|453552002|FG000|Study Part 2|Withdrew Consent|0|||
126070701|NCT00975130|453552003|FG001|Study Part 2|Withdrew Consent|6|||
126070702|NCT00975130|453552004|FG002|Study Part 2|Withdrew Consent|2|||
126070703|NCT00975130|453552002|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
126070704|NCT00975130|453552003|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
126070705|NCT00975130|453552004|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
126070706|NCT00975130|453552002|FG000|Study Part 2|Administrative|0|||
126070707|NCT00975130|453552003|FG001|Study Part 2|Administrative|1|||
126070708|NCT00975130|453552004|FG002|Study Part 2|Administrative|0|||
126070709|NCT00975130|453552002|FG000|Study Part 2|Protocol Violation|0|||
126070710|NCT00975130|453552003|FG001|Study Part 2|Protocol Violation|0|||
126070711|NCT00975130|453552004|FG002|Study Part 2|Protocol Violation|1|||
126070712|NCT00240097|453552005|FG000|Part I|Adverse Event|1|||
126070713|NCT00240097|453552005|FG000|Part I|Death|1|||
126070714|NCT00240097|453552005|FG000|Part I|histology|1|||
126070715|NCT00240097|453552005|FG000|Part I|unevaluable|1|||
126070716|NCT00240097|453552005|FG000|Part II|did not continue from Part I|23|||
126070717|NCT00734851|453552006|FG000|Overall Study|Withdrawal by Subject|2|||
126070718|NCT00734851|453552006|FG000|Overall Study|Lost to Follow-up|1|||
126070719|NCT00734851|453552006|FG000|Overall Study|Physician Decision|18|||
126070720|NCT00818519|453552007|FG000|Overall Study|Adverse Event|2|||
126070721|NCT00818519|453552008|FG001|Overall Study|Adverse Event|2|||
126070722|NCT00818519|453552007|FG000|Overall Study|Lost to Follow-up|4|||
126114502|NCT00375219|453713850|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
126070723|NCT00818519|453552008|FG001|Overall Study|Lost to Follow-up|6|||
126070724|NCT00818519|453552007|FG000|Overall Study|Protocol Violation|2|||
126070725|NCT00818519|453552008|FG001|Overall Study|Protocol Violation|1|||
126070726|NCT00818519|453552007|FG000|Overall Study|Pregnancy|0|||
126070727|NCT00818519|453552008|FG001|Overall Study|Pregnancy|1|||
126070728|NCT00818519|453552007|FG000|Overall Study|Withdrawal by Subject|4|||
126070729|NCT00818519|453552008|FG001|Overall Study|Withdrawal by Subject|9|||
126070730|NCT00818519|453552007|FG000|Overall Study|participant recovered completely|1|||
126070731|NCT00818519|453552008|FG001|Overall Study|participant recovered completely|0|||
126070732|NCT00818519|453552007|FG000|Overall Study|participant will leave for long tme|1|||
126070733|NCT00818519|453552008|FG001|Overall Study|participant will leave for long tme|0|||
126070734|NCT03562117|453552009|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
126070735|NCT03562117|453552010|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
126070736|NCT03562117|453552011|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
126070737|NCT01294358|453552012|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
126070738|NCT01294358|453552013|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
126070739|NCT01294358|453552014|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
126070740|NCT01294358|453552015|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
126070741|NCT01294358|453552016|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
126070742|NCT01294358|453552012|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
126070743|NCT01294358|453552013|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
126070744|NCT01294358|453552014|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
126070745|NCT01294358|453552015|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
126070746|NCT01294358|453552016|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
126070747|NCT01294358|453552012|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
126070748|NCT01294358|453552013|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
126070749|NCT01294358|453552014|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
126070750|NCT01294358|453552015|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
126070751|NCT01294358|453552016|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
126070752|NCT01294358|453552012|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
126070753|NCT01294358|453552013|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
126070754|NCT01294358|453552014|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
126070755|NCT01294358|453552015|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
126070756|NCT01294358|453552016|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
126070757|NCT03613454|453552017|FG000|Overall Study|Protocol Violation|1|||
126070758|NCT03613454|453552018|FG001|Overall Study|Protocol Violation|0|||
126070759|NCT03613454|453552017|FG000|Overall Study|Protocol Violation|0|||
126070760|NCT03613454|453552018|FG001|Overall Study|Protocol Violation|1|||
126070761|NCT03356145|453552019|FG000|Overall Study|Withdrawal by Subject|2|||
126070762|NCT03356145|453552020|FG001|Overall Study|Withdrawal by Subject|1|||
126070763|NCT03356145|453552019|FG000|Overall Study|Did not meet inclusion criteria|1|||
126070764|NCT03356145|453552020|FG001|Overall Study|Did not meet inclusion criteria|0|||
126070765|NCT02963922|453552021|FG000|Overall Study|Adverse Event|15|||
126070766|NCT02963922|453552022|FG001|Overall Study|Adverse Event|6|||
126070767|NCT02963922|453552021|FG000|Overall Study|Protocol deviation|6|||
126070768|NCT02963922|453552022|FG001|Overall Study|Protocol deviation|6|||
126070769|NCT02963922|453552021|FG000|Overall Study|Lack of Efficacy|1|||
126070770|NCT02963922|453552022|FG001|Overall Study|Lack of Efficacy|1|||
126070771|NCT02963922|453552021|FG000|Overall Study|Lost to Follow-up|2|||
126070772|NCT02963922|453552022|FG001|Overall Study|Lost to Follow-up|3|||
126070773|NCT02963922|453552021|FG000|Overall Study|Other|8|||
126070774|NCT02963922|453552022|FG001|Overall Study|Other|14|||
126070775|NCT00655668|453552036|FG000|Overall Study|Adverse Event|6|||
126070776|NCT00655668|453552036|FG000|Overall Study|Death|5|||
126070777|NCT00655668|453552036|FG000|Overall Study|Disease Progression|27|||
126070778|NCT00655668|453552036|FG000|Overall Study|Study Terminated|9|||
126070779|NCT00655668|453552036|FG000|Overall Study|Other|1|||
126070780|NCT00655668|453552036|FG000|Overall Study|New Lymphoma Treatment Started|4|||
126070781|NCT00655668|453552036|FG000|Overall Study|Withdrawal by Subject|2|||
126070782|NCT03740919|453552037|FG000|Lead-in Period|Lost to Follow-up|1|||
126070783|NCT03740919|453552038|FG001|Lead-in Period|Lost to Follow-up|0|||
126070784|NCT03740919|453552039|FG002|Lead-in Period|Lost to Follow-up|0|||
126070785|NCT03740919|453552040|FG003|Lead-in Period|Lost to Follow-up|0|||
126070786|NCT03740919|453552037|FG000|Lead-in Period|Physician Decision|2|||
126070787|NCT03740919|453552038|FG001|Lead-in Period|Physician Decision|0|||
126070788|NCT03740919|453552039|FG002|Lead-in Period|Physician Decision|0|||
126070789|NCT03740919|453552040|FG003|Lead-in Period|Physician Decision|0|||
126070790|NCT03740919|453552037|FG000|Lead-in Period|Protocol Violation|1|||
126070791|NCT03740919|453552038|FG001|Lead-in Period|Protocol Violation|0|||
126070792|NCT03740919|453552039|FG002|Lead-in Period|Protocol Violation|0|||
126070793|NCT03740919|453552040|FG003|Lead-in Period|Protocol Violation|0|||
126070794|NCT03740919|453552037|FG000|Lead-in Period|Withdrawal by Subject|10|||
126070795|NCT03740919|453552038|FG001|Lead-in Period|Withdrawal by Subject|0|||
126070796|NCT03740919|453552039|FG002|Lead-in Period|Withdrawal by Subject|0|||
126070797|NCT03740919|453552040|FG003|Lead-in Period|Withdrawal by Subject|0|||
126070798|NCT03740919|453552037|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
126070799|NCT03740919|453552038|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
126070800|NCT03740919|453552039|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
126070801|NCT03740919|453552040|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
126070802|NCT03740919|453552037|FG000|Lead-in Period|Study Task Too Burdensome|1|||
126070803|NCT03740919|453552038|FG001|Lead-in Period|Study Task Too Burdensome|0|||
126070804|NCT03740919|453552039|FG002|Lead-in Period|Study Task Too Burdensome|0|||
126070805|NCT03740919|453552040|FG003|Lead-in Period|Study Task Too Burdensome|0|||
126070806|NCT03740919|453552037|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
126070807|NCT03740919|453552038|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
126070808|NCT03740919|453552039|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
126070809|NCT03740919|453552040|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
126070810|NCT03740919|453552037|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
126070811|NCT03740919|453552038|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
126070812|NCT03740919|453552039|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
126070813|NCT03740919|453552040|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
126070814|NCT03740919|453552037|FG000|Treatment Period|Adverse Event|0|||
126070815|NCT03740919|453552038|FG001|Treatment Period|Adverse Event|0|||
126070816|NCT03740919|453552039|FG002|Treatment Period|Adverse Event|2|||
126070817|NCT03740919|453552040|FG003|Treatment Period|Adverse Event|0|||
126070818|NCT03740919|453552037|FG000|Treatment Period|Protocol Violation|0|||
126070819|NCT03740919|453552038|FG001|Treatment Period|Protocol Violation|1|||
126070820|NCT03740919|453552039|FG002|Treatment Period|Protocol Violation|0|||
126070821|NCT03740919|453552040|FG003|Treatment Period|Protocol Violation|0|||
126070822|NCT03740919|453552037|FG000|Treatment Period|Withdrawal by Subject|0|||
126070823|NCT03740919|453552038|FG001|Treatment Period|Withdrawal by Subject|7|||
126070824|NCT03740919|453552039|FG002|Treatment Period|Withdrawal by Subject|6|||
126070825|NCT03740919|453552040|FG003|Treatment Period|Withdrawal by Subject|2|||
126070826|NCT03740919|453552037|FG000|Treatment Period|Terminated by Sponsor|0|||
126070827|NCT03740919|453552038|FG001|Treatment Period|Terminated by Sponsor|1|||
126070828|NCT03740919|453552039|FG002|Treatment Period|Terminated by Sponsor|0|||
126070829|NCT03740919|453552040|FG003|Treatment Period|Terminated by Sponsor|0|||
126070830|NCT03740919|453552037|FG000|Treatment Period|Issue with Insulin Pump|0|||
126070831|NCT03740919|453552038|FG001|Treatment Period|Issue with Insulin Pump|1|||
126070832|NCT03740919|453552039|FG002|Treatment Period|Issue with Insulin Pump|0|||
126070833|NCT03740919|453552040|FG003|Treatment Period|Issue with Insulin Pump|0|||
126070834|NCT03740919|453552037|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
126070835|NCT03740919|453552038|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
126070836|NCT03740919|453552039|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
126070837|NCT03740919|453552040|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
126070838|NCT03740919|453552037|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
126070839|NCT03740919|453552038|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
126070840|NCT03740919|453552039|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
126070841|NCT03740919|453552040|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
126070842|NCT03740919|453552037|FG000|Treatment Period|Not Completing Diary|0|||
126070843|NCT03740919|453552038|FG001|Treatment Period|Not Completing Diary|0|||
126070844|NCT03740919|453552039|FG002|Treatment Period|Not Completing Diary|1|||
126070845|NCT03740919|453552040|FG003|Treatment Period|Not Completing Diary|0|||
126070846|NCT03740919|453552037|FG000|Treatment Period|Insulin Painful to Participant|0|||
126070847|NCT03740919|453552038|FG001|Treatment Period|Insulin Painful to Participant|0|||
126070848|NCT03740919|453552039|FG002|Treatment Period|Insulin Painful to Participant|1|||
126070849|NCT03740919|453552040|FG003|Treatment Period|Insulin Painful to Participant|0|||
126070850|NCT03873038|453552044|FG000|Part 2|Withdrawal by Subject|0|||
126070851|NCT03873038|453552045|FG001|Part 2|Withdrawal by Subject|0|||
126070852|NCT03873038|453552046|FG002|Part 2|Withdrawal by Subject|0|||
126070853|NCT03873038|453552047|FG003|Part 2|Withdrawal by Subject|0|||
126070854|NCT03873038|453552048|FG004|Part 2|Withdrawal by Subject|0|||
126070855|NCT03873038|453552049|FG005|Part 2|Withdrawal by Subject|1|||
126070856|NCT03873038|453552044|FG000|Part 2|Unknon|0|||
126070857|NCT03873038|453552045|FG001|Part 2|Unknon|0|||
126070858|NCT03873038|453552046|FG002|Part 2|Unknon|0|||
126070859|NCT03873038|453552047|FG003|Part 2|Unknon|0|||
126070860|NCT03873038|453552048|FG004|Part 2|Unknon|1|||
126070861|NCT03873038|453552049|FG005|Part 2|Unknon|0|||
126070862|NCT04222088|453552050|FG000|Overall Study|Lost to Follow-up|5|||
126070863|NCT04222088|453552051|FG001|Overall Study|Lost to Follow-up|1|||
126070864|NCT04222088|453552050|FG000|Overall Study|Withdrawal by Subject|4|||
126070865|NCT04222088|453552051|FG001|Overall Study|Withdrawal by Subject|0|||
126070866|NCT00595764|453552052|FG000|Overall Study|Protocol Violation|24|||
126070867|NCT00595764|453552053|FG001|Overall Study|Protocol Violation|19|||
126070868|NCT00595764|453552052|FG000|Overall Study|Missed Medication >1 week|10|||
126070869|NCT00595764|453552053|FG001|Overall Study|Missed Medication >1 week|17|||
126070870|NCT00595764|453552052|FG000|Overall Study|Missed 3 PM visits|1|||
126070871|NCT00595764|453552053|FG001|Overall Study|Missed 3 PM visits|7|||
126070872|NCT00595764|453552052|FG000|Overall Study|Withdrawal by Subject|4|||
126070873|NCT00595764|453552053|FG001|Overall Study|Withdrawal by Subject|0|||
126070874|NCT01071317|453552054|FG000|Overall Study|Lost to Follow-up|2|||
126070875|NCT01071317|453552055|FG001|Overall Study|Lost to Follow-up|2|||
126070876|NCT01332318|453552056|FG000|Overall Study|Adverse Event|0|||
126070877|NCT01332318|453552057|FG001|Overall Study|Adverse Event|3|||
125945622|NCT01577758|453099801|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
125945623|NCT01577758|453099802|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
125945624|NCT01577758|453099803|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
125945625|NCT01577758|453099796|FG000|Dose Escalation Phase|Progression Disease|2|||
125945626|NCT01577758|453099797|FG001|Dose Escalation Phase|Progression Disease|2|||
125945627|NCT01577758|453099798|FG002|Dose Escalation Phase|Progression Disease|1|||
125945628|NCT01577758|453099799|FG003|Dose Escalation Phase|Progression Disease|2|||
125945629|NCT01577758|453099800|FG004|Dose Escalation Phase|Progression Disease|5|||
125945630|NCT01577758|453099801|FG005|Dose Escalation Phase|Progression Disease|0|||
125945631|NCT01577758|453099802|FG006|Dose Escalation Phase|Progression Disease|0|||
125945632|NCT01577758|453099803|FG007|Dose Escalation Phase|Progression Disease|0|||
125945633|NCT01577758|453099796|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125945634|NCT01577758|453099797|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125945635|NCT01577758|453099798|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125945636|NCT01577758|453099799|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125945637|NCT01577758|453099800|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125945638|NCT01577758|453099801|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125945639|NCT01577758|453099802|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125945640|NCT01577758|453099803|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
125945641|NCT01577758|453099796|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
125945642|NCT01577758|453099797|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
125945643|NCT01577758|453099798|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
125945644|NCT01577758|453099799|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
125945645|NCT01577758|453099800|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
125945646|NCT01577758|453099801|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
125945647|NCT01577758|453099802|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
125945648|NCT01577758|453099803|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
125945649|NCT01577758|453099796|FG000|mCRC Expansion Phase|Progression Disease|0|||
125945650|NCT01577758|453099797|FG001|mCRC Expansion Phase|Progression Disease|0|||
125945651|NCT01577758|453099798|FG002|mCRC Expansion Phase|Progression Disease|0|||
125945652|NCT01577758|453099799|FG003|mCRC Expansion Phase|Progression Disease|0|||
125945653|NCT01577758|453099800|FG004|mCRC Expansion Phase|Progression Disease|0|||
125945654|NCT01577758|453099801|FG005|mCRC Expansion Phase|Progression Disease|0|||
125945655|NCT01577758|453099802|FG006|mCRC Expansion Phase|Progression Disease|0|||
125945656|NCT01577758|453099803|FG007|mCRC Expansion Phase|Progression Disease|19|||
125945657|NCT03387813|453099806|FG000|Overall Study|Death|40|||
125945658|NCT03387813|453099807|FG001|Overall Study|Death|37|||
125945659|NCT03387813|453099808|FG002|Overall Study|Death|190|||
125945660|NCT03387813|453099806|FG000|Overall Study|Withdrawal by Subject|9|||
125945661|NCT03387813|453099807|FG001|Overall Study|Withdrawal by Subject|19|||
125945662|NCT03387813|453099808|FG002|Overall Study|Withdrawal by Subject|32|||
125945663|NCT03387813|453099806|FG000|Overall Study|Lost to Follow-up|3|||
125945664|NCT03387813|453099807|FG001|Overall Study|Lost to Follow-up|9|||
125945665|NCT03387813|453099808|FG002|Overall Study|Lost to Follow-up|15|||
125945666|NCT03387813|453099806|FG000|Overall Study|Non-Compliance|6|||
125945667|NCT03387813|453099807|FG001|Overall Study|Non-Compliance|6|||
125945668|NCT03387813|453099808|FG002|Overall Study|Non-Compliance|31|||
125945669|NCT03387813|453099806|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
125945670|NCT03387813|453099807|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
125945671|NCT03387813|453099808|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
125945672|NCT01289847|453099809|FG000|Overall Study|Patient could not comply with visits|1|||
125945673|NCT03975647|453099812|FG000|Overall Study|Death|71|||
125945674|NCT03975647|453099813|FG001|Overall Study|Death|63|||
125945675|NCT03975647|453099812|FG000|Overall Study|Lost to Follow-up|2|||
125945676|NCT03975647|453099813|FG001|Overall Study|Lost to Follow-up|2|||
125945677|NCT03975647|453099812|FG000|Overall Study|Subject withdrawal of consent|7|||
125945678|NCT03975647|453099813|FG001|Overall Study|Subject withdrawal of consent|11|||
125945679|NCT02872116|453099814|FG000|Pre-Treatment|Disease Progression|0|||
125945680|NCT02872116|453099815|FG001|Pre-Treatment|Disease Progression|1|||
125945681|NCT02872116|453099816|FG002|Pre-Treatment|Disease Progression|0|||
125945682|NCT02872116|453099814|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
125945683|NCT02872116|453099815|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
125945684|NCT02872116|453099816|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
125945685|NCT02872116|453099814|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
125945686|NCT02872116|453099815|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
125945687|NCT02872116|453099816|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
125945688|NCT02872116|453099814|FG000|Pre-Treatment|Participant withdrew consent|2|||
125945689|NCT02872116|453099815|FG001|Pre-Treatment|Participant withdrew consent|20|||
125945690|NCT02872116|453099816|FG002|Pre-Treatment|Participant withdrew consent|3|||
125945691|NCT02872116|453099814|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
125945692|NCT02872116|453099815|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
125945693|NCT02872116|453099816|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
126070878|NCT01332318|453552058|FG002|Overall Study|Adverse Event|0|||
126070879|NCT01332318|453552059|FG003|Overall Study|Adverse Event|0|||
126070880|NCT01332318|453552056|FG000|Overall Study|Withdrawal by Subject|1|||
126070881|NCT01332318|453552057|FG001|Overall Study|Withdrawal by Subject|1|||
126070882|NCT01332318|453552058|FG002|Overall Study|Withdrawal by Subject|0|||
126070883|NCT01332318|453552059|FG003|Overall Study|Withdrawal by Subject|1|||
126070884|NCT01332318|453552056|FG000|Overall Study|Protocol Violation|1|||
126070885|NCT01332318|453552057|FG001|Overall Study|Protocol Violation|0|||
126070886|NCT01332318|453552058|FG002|Overall Study|Protocol Violation|1|||
126070887|NCT01332318|453552059|FG003|Overall Study|Protocol Violation|1|||
126070888|NCT02820298|453552064|FG000|Overall Study|Withdrawal by Subject|0|||
126070889|NCT02820298|453552065|FG001|Overall Study|Withdrawal by Subject|1|||
126070890|NCT02820298|453552064|FG000|Overall Study|Physician Decision|1|||
126070891|NCT02820298|453552065|FG001|Overall Study|Physician Decision|0|||
126070892|NCT02820298|453552064|FG000|Overall Study|Protocol Violation|0|||
126070893|NCT02820298|453552065|FG001|Overall Study|Protocol Violation|1|||
126070894|NCT01894256|453552066|FG000|Part A|Adverse Event|0|||
126070895|NCT01894256|453552067|FG001|Part A|Adverse Event|1|||
126070896|NCT01894256|453552068|FG002|Part A|Adverse Event|0|||
126070897|NCT01894256|453552066|FG000|Part B|Death|0|||
126070898|NCT01894256|453552067|FG001|Part B|Death|1|||
126070899|NCT01894256|453552068|FG002|Part B|Death|1|||
126070900|NCT01894256|453552066|FG000|Part B|Withdrawal by Subject|0|||
126070901|NCT01894256|453552067|FG001|Part B|Withdrawal by Subject|1|||
126070902|NCT01894256|453552068|FG002|Part B|Withdrawal by Subject|0|||
126070903|NCT01894256|453552066|FG000|Part B|Lack of Efficacy|15|||
126070904|NCT01894256|453552067|FG001|Part B|Lack of Efficacy|12|||
126070905|NCT01894256|453552068|FG002|Part B|Lack of Efficacy|13|||
126070906|NCT01780584|453552069|FG000|Overall Study|Death|1|||
126070907|NCT01780584|453552070|FG001|Overall Study|Death|0|||
126070908|NCT01780584|453552071|FG002|Overall Study|Death|1|||
126070909|NCT01780584|453552069|FG000|Overall Study|Adverse Event|0|||
126070910|NCT01780584|453552070|FG001|Overall Study|Adverse Event|1|||
126070911|NCT01780584|453552071|FG002|Overall Study|Adverse Event|0|||
126070912|NCT01780584|453552069|FG000|Overall Study|Protocol Violation|0|||
126070913|NCT01780584|453552070|FG001|Overall Study|Protocol Violation|0|||
126070914|NCT01780584|453552071|FG002|Overall Study|Protocol Violation|1|||
126070915|NCT01679613|453552077|FG000|Overall Study|other than stated above|0|||
126070916|NCT01679613|453552078|FG001|Overall Study|other than stated above|1|||
126070917|NCT01679613|453552079|FG002|Overall Study|other than stated above|2|||
126070918|NCT01679613|453552080|FG003|Overall Study|other than stated above|2|||
126070919|NCT04783519|453552081|FG000|Overall Study|Withdrawal by Subject|2|||
126070920|NCT04783519|453552082|FG001|Overall Study|Withdrawal by Subject|7|||
126070921|NCT04783519|453552083|FG002|Overall Study|Withdrawal by Subject|3|||
126070922|NCT04783519|453552081|FG000|Overall Study|Lost to Follow-up|9|||
126070923|NCT04783519|453552082|FG001|Overall Study|Lost to Follow-up|7|||
126070924|NCT04783519|453552083|FG002|Overall Study|Lost to Follow-up|6|||
126070925|NCT00727259|453552084|FG000|Overall Study|Not all questionnaires completed|1055|||
126070926|NCT01021683|453552085|FG000|Overall Study|Lack of Efficacy|12|||
126070927|NCT01021683|453552085|FG000|Overall Study|Recovery of neutrophil count|51|||
126070928|NCT01021683|453552085|FG000|Overall Study|Other|8|||
126070929|NCT00645099|453552086|FG000|Overall Study|Lack of Efficacy|15|||
126070930|NCT00645099|453552087|FG001|Overall Study|Lack of Efficacy|6|||
126070931|NCT00645099|453552086|FG000|Overall Study|Withdrawal by Subject|30|||
126070932|NCT00645099|453552087|FG001|Overall Study|Withdrawal by Subject|22|||
126070933|NCT00645099|453552086|FG000|Overall Study|Lost to Follow-up|6|||
126070934|NCT00645099|453552087|FG001|Overall Study|Lost to Follow-up|4|||
126070935|NCT00645099|453552086|FG000|Overall Study|Adverse Event|11|||
126070936|NCT00645099|453552087|FG001|Overall Study|Adverse Event|5|||
126070937|NCT00645099|453552086|FG000|Overall Study|Other|9|||
126070938|NCT00645099|453552087|FG001|Overall Study|Other|5|||
126070939|NCT01201915|453552088|FG000|Overall Study|Adverse Event|2|||
126070940|NCT01201915|453552089|FG001|Overall Study|Adverse Event|1|||
126070941|NCT01201915|453552090|FG002|Overall Study|Adverse Event|1|||
126114503|NCT00375219|453713848|FG000|Overall Study|Allograft|2|||
126114504|NCT00375219|453713849|FG001|Overall Study|Allograft|0|||
126114505|NCT00375219|453713850|FG002|Overall Study|Allograft|0|||
126114506|NCT00375219|453713848|FG000|Overall Study|Cord blood transplantation|1|||
126114507|NCT00375219|453713849|FG001|Overall Study|Cord blood transplantation|0|||
126114508|NCT00375219|453713850|FG002|Overall Study|Cord blood transplantation|0|||
126114509|NCT00375219|453713848|FG000|Overall Study|Withdrawal by Subject|1|||
126070942|NCT01201915|453552088|FG000|Overall Study|Lost to Follow-up|0|||
126070943|NCT01201915|453552089|FG001|Overall Study|Lost to Follow-up|4|||
126070944|NCT01201915|453552090|FG002|Overall Study|Lost to Follow-up|0|||
126070945|NCT01201915|453552088|FG000|Overall Study|Physician Decision|3|||
126070946|NCT01201915|453552089|FG001|Overall Study|Physician Decision|0|||
126070947|NCT01201915|453552090|FG002|Overall Study|Physician Decision|0|||
126070948|NCT01201915|453552088|FG000|Overall Study|Subject Decision|3|||
126070949|NCT01201915|453552089|FG001|Overall Study|Subject Decision|3|||
126070950|NCT01201915|453552090|FG002|Overall Study|Subject Decision|5|||
126070951|NCT01201915|453552088|FG000|Overall Study|Target Lesion Progression|0|||
126070952|NCT01201915|453552089|FG001|Overall Study|Target Lesion Progression|3|||
126070953|NCT01201915|453552090|FG002|Overall Study|Target Lesion Progression|0|||
126070954|NCT00796614|453553420|FG000|Overall Study|Adverse Event|1|||
126070955|NCT00796614|453553421|FG001|Overall Study|Adverse Event|2|||
126070956|NCT00796614|453553422|FG002|Overall Study|Adverse Event|0|||
126070957|NCT00796614|453553423|FG003|Overall Study|Adverse Event|0|||
126070958|NCT00796614|453553420|FG000|Overall Study|Protocol Violation|0|||
126070959|NCT00796614|453553421|FG001|Overall Study|Protocol Violation|0|||
126070960|NCT00796614|453553422|FG002|Overall Study|Protocol Violation|2|||
126070961|NCT00796614|453553423|FG003|Overall Study|Protocol Violation|0|||
126070962|NCT00796614|453553420|FG000|Overall Study|Lost to Follow-up|2|||
126070963|NCT00796614|453553421|FG001|Overall Study|Lost to Follow-up|2|||
126070964|NCT00796614|453553422|FG002|Overall Study|Lost to Follow-up|1|||
126070965|NCT00796614|453553423|FG003|Overall Study|Lost to Follow-up|0|||
126070966|NCT00796614|453553420|FG000|Overall Study|Withdrawal by Subject|1|||
126070967|NCT00796614|453553421|FG001|Overall Study|Withdrawal by Subject|0|||
126070968|NCT00796614|453553422|FG002|Overall Study|Withdrawal by Subject|0|||
126070969|NCT00796614|453553423|FG003|Overall Study|Withdrawal by Subject|1|||
126070970|NCT00796614|453553420|FG000|Overall Study|Other than stated|1|||
126070971|NCT00796614|453553421|FG001|Overall Study|Other than stated|0|||
126070972|NCT00796614|453553422|FG002|Overall Study|Other than stated|0|||
126070973|NCT00796614|453553423|FG003|Overall Study|Other than stated|0|||
126070974|NCT00509821|453553424|FG000|Study Period 1 (Induction)|Death|0|||
126070975|NCT00509821|453553425|FG001|Study Period 1 (Induction)|Death|1|||
126070976|NCT00509821|453553424|FG000|Study Period 1 (Induction)|Adverse Event|0|||
126070977|NCT00509821|453553425|FG001|Study Period 1 (Induction)|Adverse Event|2|||
126070978|NCT00509821|453553424|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
126070979|NCT00509821|453553425|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
126070980|NCT01816685|453553426|FG000|Overall Study|Lost to Follow-up|7|||
126070981|NCT01816685|453553427|FG001|Overall Study|Lost to Follow-up|9|||
126070982|NCT01816685|453553426|FG000|Overall Study|Surgery Cancelled|3|||
126070983|NCT01816685|453553427|FG001|Overall Study|Surgery Cancelled|2|||
126070984|NCT03449134|453553428|FG000|52-Week Treatment Period|Death|2|||
126070985|NCT03449134|453553429|FG001|52-Week Treatment Period|Death|1|||
126070986|NCT03449134|453553430|FG002|52-Week Treatment Period|Death|0|||
126070987|NCT03449134|453553428|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
126070988|NCT03449134|453553429|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
126070989|NCT03449134|453553430|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
126070990|NCT03449134|453553428|FG000|52-Week Treatment Period|Physician Decision|2|||
126070991|NCT03449134|453553429|FG001|52-Week Treatment Period|Physician Decision|3|||
126070992|NCT03449134|453553430|FG002|52-Week Treatment Period|Physician Decision|3|||
125945694|NCT02872116|453099814|FG000|Pre-Treatment|Other reasons|1|||
125945695|NCT02872116|453099815|FG001|Pre-Treatment|Other reasons|2|||
125945696|NCT02872116|453099816|FG002|Pre-Treatment|Other reasons|2|||
125945697|NCT02872116|453099814|FG000|Treatment|Death|121|||
125945698|NCT02872116|453099815|FG001|Treatment|Death|94|||
125945699|NCT02872116|453099816|FG002|Treatment|Death|68|||
125945700|NCT02872116|453099814|FG000|Treatment|Lost to Follow-up|5|||
125945701|NCT02872116|453099815|FG001|Treatment|Lost to Follow-up|7|||
125945702|NCT02872116|453099816|FG002|Treatment|Lost to Follow-up|3|||
125945703|NCT02872116|453099814|FG000|Treatment|Participant withdrew consent|20|||
125945704|NCT02872116|453099815|FG001|Treatment|Participant withdrew consent|40|||
125945705|NCT02872116|453099816|FG002|Treatment|Participant withdrew consent|8|||
125945706|NCT02872116|453099814|FG000|Treatment|Other reasons|13|||
125945707|NCT02872116|453099815|FG001|Treatment|Other reasons|12|||
125945708|NCT02872116|453099816|FG002|Treatment|Other reasons|5|||
125945709|NCT03161483|453099825|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
125945710|NCT03161483|453099826|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
125945711|NCT03161483|453099827|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
125945712|NCT03161483|453099828|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
125945713|NCT03161483|453099825|FG000|Treatment Period|Death|1|||
126070993|NCT03449134|453553428|FG000|52-Week Treatment Period|Screen Failure|1|||
126070994|NCT03449134|453553429|FG001|52-Week Treatment Period|Screen Failure|0|||
126070995|NCT03449134|453553430|FG002|52-Week Treatment Period|Screen Failure|1|||
126070996|NCT03449134|453553428|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
125945714|NCT03161483|453099826|FG001|Treatment Period|Death|0|||
125945715|NCT03161483|453099827|FG002|Treatment Period|Death|0|||
125945716|NCT03161483|453099828|FG003|Treatment Period|Death|0|||
125945717|NCT03161483|453099825|FG000|Treatment Period|Adverse Event|5|||
125945718|NCT03161483|453099826|FG001|Treatment Period|Adverse Event|2|||
125945719|NCT03161483|453099827|FG002|Treatment Period|Adverse Event|1|||
126070997|NCT03449134|453553429|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
126070998|NCT03449134|453553430|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
126070999|NCT03449134|453553428|FG000|52-Week Treatment Period|Site Closure|1|||
125945720|NCT03161483|453099828|FG003|Treatment Period|Adverse Event|11|||
125945721|NCT03161483|453099825|FG000|Treatment Period|Pregnancy|1|||
125945722|NCT03161483|453099826|FG001|Treatment Period|Pregnancy|0|||
126071000|NCT03449134|453553429|FG001|52-Week Treatment Period|Site Closure|0|||
126071001|NCT03449134|453553430|FG002|52-Week Treatment Period|Site Closure|0|||
126071002|NCT00957996|453553431|FG000|Overall Study|Death|4|||
126071003|NCT00957996|453553432|FG001|Overall Study|Death|10|||
126071004|NCT00957996|453553431|FG000|Overall Study|Lost to Follow-up|4|||
126071005|NCT00957996|453553432|FG001|Overall Study|Lost to Follow-up|7|||
126071006|NCT00957996|453553431|FG000|Overall Study|Withdrawal by Subject|9|||
126071007|NCT00957996|453553432|FG001|Overall Study|Withdrawal by Subject|2|||
126071008|NCT00957996|453553431|FG000|Overall Study|Adverse Event|2|||
126071009|NCT00957996|453553432|FG001|Overall Study|Adverse Event|1|||
126071010|NCT00957996|453553431|FG000|Overall Study|Physician Decision|1|||
126071011|NCT00957996|453553432|FG001|Overall Study|Physician Decision|1|||
126071012|NCT00957996|453553431|FG000|Overall Study|Influenza-related complication|0|||
126071013|NCT00957996|453553432|FG001|Overall Study|Influenza-related complication|1|||
126071014|NCT00957996|453553431|FG000|Overall Study|Missing|1|||
126071015|NCT00957996|453553432|FG001|Overall Study|Missing|0|||
126071016|NCT00957996|453553431|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
126071017|NCT00957996|453553432|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
126071018|NCT01960348|453553435|FG000|Overall Study|Adverse event, not serious|2|||
126071019|NCT01960348|453553436|FG001|Overall Study|Adverse event, not serious|2|||
126071020|NCT01960348|453553435|FG000|Overall Study|Adverse event, serious fatal|6|||
126071021|NCT01960348|453553436|FG001|Overall Study|Adverse event, serious fatal|5|||
126071022|NCT01960348|453553435|FG000|Overall Study|Adverse event, serious non-fatal|0|||
126071023|NCT01960348|453553436|FG001|Overall Study|Adverse event, serious non-fatal|3|||
126071024|NCT01960348|453553435|FG000|Overall Study|Withdrawal by Subject|1|||
126071025|NCT01960348|453553436|FG001|Overall Study|Withdrawal by Subject|11|||
126071026|NCT01960348|453553435|FG000|Overall Study|Physician Decision|0|||
126071027|NCT01960348|453553436|FG001|Overall Study|Physician Decision|1|||
126071028|NCT01960348|453553435|FG000|Overall Study|Protocol Violation|1|||
126071029|NCT01960348|453553436|FG001|Overall Study|Protocol Violation|0|||
126071030|NCT01580995|453553437|FG000|Overall Study|Lost to Follow-up|2|||
126071031|NCT01580995|453553438|FG001|Overall Study|Lost to Follow-up|2|||
126071032|NCT02561078|453553439|FG000|Overall Study|Adverse Event|5|||
126071033|NCT02561078|453553440|FG001|Overall Study|Adverse Event|2|||
126071034|NCT02561078|453553439|FG000|Overall Study|Death|2|||
126071035|NCT02561078|453553440|FG001|Overall Study|Death|1|||
126071036|NCT02561078|453553439|FG000|Overall Study|Lost to Follow-up|2|||
126071037|NCT02561078|453553440|FG001|Overall Study|Lost to Follow-up|6|||
126071038|NCT02561078|453553439|FG000|Overall Study|Non-Compliance with Study Drug|6|||
126071039|NCT02561078|453553440|FG001|Overall Study|Non-Compliance with Study Drug|3|||
126071040|NCT02561078|453553439|FG000|Overall Study|Physician Decision|2|||
126071041|NCT02561078|453553440|FG001|Overall Study|Physician Decision|3|||
126071042|NCT02561078|453553439|FG000|Overall Study|Withdrawal by Subject|13|||
126071043|NCT02561078|453553440|FG001|Overall Study|Withdrawal by Subject|10|||
126071044|NCT00719212|453553441|FG000|Overall Study|Death|41|||
126071045|NCT00719212|453553441|FG000|Overall Study|Lost to Follow-up|2|||
126071046|NCT00719212|453553441|FG000|Overall Study|Withdrawal by Subject|1|||
126071047|NCT00508274|453553442|FG000|Overall Study|Adverse Event|5|||
126071048|NCT00508274|453553442|FG000|Overall Study|Death|7|||
126071049|NCT00508274|453553442|FG000|Overall Study|Disease progression|32|||
126071050|NCT00508274|453553442|FG000|Overall Study|Withdrawal by Subject|1|||
126071051|NCT00508274|453553442|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
126071052|NCT00508274|453553442|FG000|Overall Study|Missing|3|||
126071053|NCT03924947|453553447|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126071054|NCT03924947|453553448|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126071055|NCT03924947|453553449|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
126071056|NCT03924947|453553450|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126071057|NCT03924947|453553451|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126071058|NCT03924947|453553452|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126071059|NCT01631825|453553453|FG000|Overall Study|Adverse Event|42|||
126071060|NCT01631825|453553453|FG000|Overall Study|Lack of Efficacy|7|||
126071061|NCT01631825|453553453|FG000|Overall Study|Withdrawal by Subject|9|||
126071062|NCT01631825|453553453|FG000|Overall Study|Protocol Violation|4|||
126071063|NCT01631825|453553453|FG000|Overall Study|Discontinuation criteria|1|||
126071064|NCT01631825|453553453|FG000|Overall Study|Physician Decision|2|||
126071065|NCT02499835|453553454|FG000|Overall Study|Withdrawal by Subject|1|||
126071066|NCT02499835|453553455|FG001|Overall Study|Withdrawal by Subject|0|||
126071067|NCT02499835|453553456|FG002|Overall Study|Withdrawal by Subject|0|||
126071068|NCT02499835|453553457|FG003|Overall Study|Withdrawal by Subject|1|||
126114510|NCT00375219|453713849|FG001|Overall Study|Withdrawal by Subject|0|||
126114511|NCT00375219|453713850|FG002|Overall Study|Withdrawal by Subject|0|||
126071069|NCT02499835|453553454|FG000|Overall Study|Physician Decision|0|||
126071070|NCT02499835|453553455|FG001|Overall Study|Physician Decision|3|||
126071071|NCT02499835|453553456|FG002|Overall Study|Physician Decision|18|||
126071072|NCT02499835|453553457|FG003|Overall Study|Physician Decision|7|||
126071073|NCT02499835|453553454|FG000|Overall Study|Adverse Event|0|||
126071074|NCT02499835|453553455|FG001|Overall Study|Adverse Event|0|||
126071075|NCT02499835|453553456|FG002|Overall Study|Adverse Event|0|||
126071076|NCT02499835|453553457|FG003|Overall Study|Adverse Event|1|||
126071077|NCT02499835|453553454|FG000|Overall Study|Disease progression|2|||
126071078|NCT02499835|453553455|FG001|Overall Study|Disease progression|1|||
126071079|NCT02499835|453553456|FG002|Overall Study|Disease progression|0|||
126071080|NCT02499835|453553457|FG003|Overall Study|Disease progression|7|||
126071081|NCT05109117|453553458|FG000|Overall Study|Lost to Follow-up|1|||
126071082|NCT05109117|453553458|FG000|Overall Study|Discontinued for non-compliance|1|||
126071083|NCT03226353|453553459|FG000|Overall Study|Withdrawal by Subject|1|||
126071084|NCT03226353|453553459|FG000|Overall Study|Screen Failure|5|||
126071085|NCT00498433|453553461|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
126071086|NCT00498433|453553462|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
126071087|NCT00498433|453553463|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
126071088|NCT00498433|453553461|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
126071089|NCT00498433|453553462|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
126071090|NCT00498433|453553463|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
126071091|NCT00498433|453553461|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
126071092|NCT00498433|453553462|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
126071093|NCT00498433|453553463|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
126071094|NCT00498433|453553461|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
126071095|NCT00498433|453553462|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
126071096|NCT00498433|453553463|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
126071097|NCT00744796|453553465|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
126071098|NCT01514864|453553466|FG000|Overall Study|Disease progression|7|||
126071099|NCT01514864|453553467|FG001|Overall Study|Disease progression|5|||
126071100|NCT01514864|453553466|FG000|Overall Study|Study drug toxicity|2|||
126071101|NCT01514864|453553467|FG001|Overall Study|Study drug toxicity|0|||
126071102|NCT02253147|453553468|FG000|Overall Study|Protocol Violation|30|||
126071103|NCT02253147|453553468|FG000|Overall Study|Did not consent to study extension|9|||
126071104|NCT02253147|453553468|FG000|Overall Study|Conditional re-treatment at W52|5|||
126071105|NCT02253147|453553468|FG000|Overall Study|Lost to Follow-up|2|||
126071106|NCT02253147|453553468|FG000|Overall Study|Withdrawal by Subject|1|||
126071107|NCT02254681|453553470|FG000|Overall Study|Lack of Efficacy|6|||
126071108|NCT00797511|453553471|FG000|Overall Study|Withdrawal by Subject|1|||
126071109|NCT00843115|453553472|FG000|Overall Study|Death|4|||
126071110|NCT00843115|453553472|FG000|Overall Study|Adverse Event|30|||
126071111|NCT00843115|453553472|FG000|Overall Study|Lost to Follow-up|4|||
126071112|NCT00843115|453553472|FG000|Overall Study|Withdrawal by Subject|17|||
126071113|NCT00843115|453553472|FG000|Overall Study|Family wanted meds stopped|1|||
126071114|NCT00843115|453553472|FG000|Overall Study|Family does not want continuation|1|||
126071115|NCT00843115|453553472|FG000|Overall Study|Patient forgot to take meds|1|||
126071116|NCT00843115|453553472|FG000|Overall Study|Does not meet entrance criteria|1|||
126071117|NCT00843115|453553472|FG000|Overall Study|Physician Decision|1|||
126071118|NCT00843115|453553472|FG000|Overall Study|Family discontinued meds|1|||
126071119|NCT00843115|453553472|FG000|Overall Study|patient took for 2 days then stopped|1|||
126071120|NCT00843115|453553472|FG000|Overall Study|patient never took the medication|1|||
126071121|NCT00843115|453553472|FG000|Overall Study|hospitalized due to deterioration|1|||
126071122|NCT00843115|453553472|FG000|Overall Study|week 12 not done|1|||
126071123|NCT00843115|453553472|FG000|Overall Study|Syndrome De Glissement|1|||
126071124|NCT02621047|453553473|FG000|Overall Study|Adverse Event|0|||
126071125|NCT02621047|453553474|FG001|Overall Study|Adverse Event|0|||
126071126|NCT02621047|453553475|FG002|Overall Study|Adverse Event|1|||
126071127|NCT01951261|453553476|FG000|Overall Study|Death|1|||
126071128|NCT01951261|453553477|FG001|Overall Study|Death|0|||
126071129|NCT01951261|453553476|FG000|Overall Study|Lost to Follow-up|4|||
126071130|NCT01951261|453553477|FG001|Overall Study|Lost to Follow-up|3|||
126071131|NCT01951261|453553476|FG000|Overall Study|Protocol Violation|4|||
126071132|NCT01951261|453553477|FG001|Overall Study|Protocol Violation|3|||
126071133|NCT01924806|453553478|FG000|Overall Study|Physician Decision|2|||
126071134|NCT01924806|453553479|FG001|Overall Study|Physician Decision|1|||
126071135|NCT01954771|453553480|FG000|Overall Study|Missing HbA1c of end-point|1|||
126071136|NCT01954771|453553481|FG001|Overall Study|Missing HbA1c of end-point|1|||
126071137|NCT01954771|453553482|FG002|Overall Study|Missing HbA1c of end-point|0|||
126071138|NCT01954771|453553480|FG000|Overall Study|Missing CGMS of end-point|1|||
126071139|NCT01954771|453553481|FG001|Overall Study|Missing CGMS of end-point|1|||
126071140|NCT01954771|453553482|FG002|Overall Study|Missing CGMS of end-point|0|||
126071141|NCT01954771|453553480|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
126071142|NCT01954771|453553481|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
126071143|NCT01954771|453553482|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
126071144|NCT03635775|453553485|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
126071145|NCT03635775|453553486|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
126071146|NCT03635775|453553487|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
126071147|NCT03635775|453553488|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
126071148|NCT00495612|453553491|FG000|Overall Study|Lost to Follow-up|1|||
126071149|NCT00495612|453553492|FG001|Overall Study|Lost to Follow-up|0|||
126071150|NCT00495612|453553491|FG000|Overall Study|Subject's Decision to Withdraw|3|||
126071151|NCT00495612|453553492|FG001|Overall Study|Subject's Decision to Withdraw|0|||
126071152|NCT02864147|453553495|FG000|Overall Study|Withdrawal by Subject|3|||
126071153|NCT02864147|453553496|FG001|Overall Study|Withdrawal by Subject|2|||
126071154|NCT02864147|453553497|FG002|Overall Study|Withdrawal by Subject|1|||
126071155|NCT02864147|453553495|FG000|Overall Study|Lost to Follow-up|0|||
126071156|NCT02864147|453553496|FG001|Overall Study|Lost to Follow-up|4|||
126071157|NCT02864147|453553497|FG002|Overall Study|Lost to Follow-up|0|||
126071158|NCT02864147|453553495|FG000|Overall Study|Adverse Event|0|||
126071159|NCT02864147|453553496|FG001|Overall Study|Adverse Event|1|||
126071160|NCT02864147|453553497|FG002|Overall Study|Adverse Event|0|||
126071161|NCT02864147|453553495|FG000|Overall Study|Pregnancy|4|||
126071162|NCT02864147|453553496|FG001|Overall Study|Pregnancy|0|||
126071163|NCT02864147|453553497|FG002|Overall Study|Pregnancy|0|||
126071164|NCT02864147|453553495|FG000|Overall Study|Physician Decision|0|||
126071165|NCT02864147|453553496|FG001|Overall Study|Physician Decision|0|||
126071166|NCT02864147|453553497|FG002|Overall Study|Physician Decision|1|||
126071167|NCT02864147|453553495|FG000|Overall Study|Opted for excisional procedures|0|||
126071168|NCT02864147|453553496|FG001|Overall Study|Opted for excisional procedures|0|||
126071169|NCT02864147|453553497|FG002|Overall Study|Opted for excisional procedures|3|||
126071170|NCT02383927|453553498|FG000|Overall Study|Disease Progression|8|||
126071171|NCT02383927|453553499|FG001|Overall Study|Disease Progression|8|||
126071172|NCT02383927|453553500|FG002|Overall Study|Disease Progression|15|||
126071173|NCT02383927|453553501|FG003|Overall Study|Disease Progression|4|||
126071174|NCT02383927|453553498|FG000|Overall Study|Physician Decision|0|||
126071175|NCT02383927|453553499|FG001|Overall Study|Physician Decision|0|||
126071176|NCT02383927|453553500|FG002|Overall Study|Physician Decision|2|||
126071177|NCT02383927|453553501|FG003|Overall Study|Physician Decision|0|||
126071178|NCT02383927|453553498|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
126071179|NCT02383927|453553499|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
126071180|NCT02383927|453553500|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
126071181|NCT02383927|453553501|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
126071182|NCT02383927|453553498|FG000|Overall Study|Adverse Event|4|||
126071183|NCT02383927|453553499|FG001|Overall Study|Adverse Event|1|||
126071184|NCT02383927|453553500|FG002|Overall Study|Adverse Event|3|||
126071185|NCT02383927|453553501|FG003|Overall Study|Adverse Event|5|||
126071186|NCT02383927|453553498|FG000|Overall Study|Miscellaneous|1|||
126071187|NCT02383927|453553499|FG001|Overall Study|Miscellaneous|0|||
126071188|NCT02383927|453553500|FG002|Overall Study|Miscellaneous|0|||
126071189|NCT02383927|453553501|FG003|Overall Study|Miscellaneous|1|||
126071190|NCT02383927|453553498|FG000|Overall Study|Withdrawal by Subject|0|||
126071191|NCT02383927|453553499|FG001|Overall Study|Withdrawal by Subject|1|||
126071192|NCT02383927|453553500|FG002|Overall Study|Withdrawal by Subject|4|||
126071193|NCT02383927|453553501|FG003|Overall Study|Withdrawal by Subject|0|||
126071194|NCT02040532|453553505|FG000|Overall Study|Lost to Follow-up|1|||
126071195|NCT02040532|453553505|FG000|Overall Study|Physician Decision|4|||
126071196|NCT02040532|453553505|FG000|Overall Study|Adverse Event|4|||
126071197|NCT02040532|453553505|FG000|Overall Study|Withdrawal by Subject|3|||
126071198|NCT03640754|453553506|FG000|Overall Study|Withdrawal by Subject|1|||
126071199|NCT03640754|453553507|FG001|Overall Study|Withdrawal by Subject|0|||
126071200|NCT03640754|453553506|FG000|Overall Study|Lost to Follow-up|0|||
126071201|NCT03640754|453553507|FG001|Overall Study|Lost to Follow-up|1|||
126071202|NCT02154516|453553508|FG000|Overall Study|Withdrawal by Subject|0|||
126071203|NCT02154516|453553509|FG001|Overall Study|Withdrawal by Subject|1|||
126071204|NCT02154516|453553508|FG000|Overall Study|Lost to Follow-up|1|||
126071205|NCT02154516|453553509|FG001|Overall Study|Lost to Follow-up|0|||
126071206|NCT02154516|453553508|FG000|Overall Study|Removal/revision of device|1|||
126071207|NCT02154516|453553509|FG001|Overall Study|Removal/revision of device|0|||
126071208|NCT02154516|453553508|FG000|Overall Study|Death|2|||
126071209|NCT02154516|453553509|FG001|Overall Study|Death|1|||
126071210|NCT03406507|453553510|FG000|Extension Period|Lack of Efficacy|0|||
126071211|NCT03406507|453553511|FG001|Extension Period|Lack of Efficacy|1|||
125945723|NCT03161483|453099827|FG002|Treatment Period|Pregnancy|0|||
126071212|NCT00663923|453553512|FG000|Overall Study|Lost to Follow-up|2|||
126071213|NCT02965599|453553513|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
126114512|NCT00482703|453713851|FG000|Overall Study|Poor compliance|1|||
126114513|NCT00482703|453713852|FG001|Overall Study|Poor compliance|0|||
126114514|NCT03007979|453713853|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
126071214|NCT02965599|453553514|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
126071215|NCT00230971|453553515|FG000|Randomization|No study drug administered|3|||
126071216|NCT00230971|453553516|FG001|Randomization|No study drug administered|3|||
126071217|NCT00230971|453553515|FG000|Baseline Participants|Lost to Follow-up|5|||
126071218|NCT00230971|453553516|FG001|Baseline Participants|Lost to Follow-up|12|||
126071219|NCT00230971|453553515|FG000|Baseline Participants|Death|6|||
126071220|NCT00230971|453553516|FG001|Baseline Participants|Death|5|||
126071221|NCT00230971|453553515|FG000|Baseline Participants|Withdrawal by Subject|7|||
126071222|NCT00230971|453553516|FG001|Baseline Participants|Withdrawal by Subject|1|||
126071223|NCT00230971|453553515|FG000|Baseline Participants|Adverse Event|1|||
126071224|NCT00230971|453553516|FG001|Baseline Participants|Adverse Event|0|||
126071225|NCT00230971|453553515|FG000|Baseline Participants|No bacteria observed|1|||
126071226|NCT00230971|453553516|FG001|Baseline Participants|No bacteria observed|0|||
126071227|NCT00230971|453553515|FG000|Baseline Participants|Failure to return|1|||
126071228|NCT00230971|453553516|FG001|Baseline Participants|Failure to return|1|||
126071229|NCT00230971|453553515|FG000|Baseline Participants|Reintervention|1|||
126071230|NCT00230971|453553516|FG001|Baseline Participants|Reintervention|0|||
126071231|NCT01772147|453555052|FG000|Overall Study|Adverse Event|13|||
126071232|NCT01772147|453555053|FG001|Overall Study|Adverse Event|10|||
126071233|NCT01772147|453555054|FG002|Overall Study|Adverse Event|6|||
126071234|NCT01772147|453555052|FG000|Overall Study|Withdrew Consent|7|||
126071235|NCT01772147|453555053|FG001|Overall Study|Withdrew Consent|8|||
126071236|NCT01772147|453555054|FG002|Overall Study|Withdrew Consent|4|||
126071237|NCT01772147|453555052|FG000|Overall Study|Lost to Follow-up|1|||
126071238|NCT01772147|453555053|FG001|Overall Study|Lost to Follow-up|0|||
126071239|NCT01772147|453555054|FG002|Overall Study|Lost to Follow-up|1|||
126071240|NCT01772147|453555052|FG000|Overall Study|Protocol Deviation|2|||
126071241|NCT01772147|453555053|FG001|Overall Study|Protocol Deviation|1|||
126071242|NCT01772147|453555054|FG002|Overall Study|Protocol Deviation|1|||
126071243|NCT01772147|453555052|FG000|Overall Study|Lack of Efficacy|8|||
126071244|NCT01772147|453555053|FG001|Overall Study|Lack of Efficacy|6|||
126071245|NCT01772147|453555054|FG002|Overall Study|Lack of Efficacy|6|||
126071246|NCT00275301|453555055|FG000|Overall Study|Adverse Event|5|||
126071247|NCT00598871|453555060|FG000|Overall Study|Adverse Event|0|||
126071248|NCT00598871|453555061|FG001|Overall Study|Adverse Event|1|||
126071249|NCT01983462|453555062|FG000|Overall Study|Adverse Event|1|||
126071250|NCT01983462|453555063|FG001|Overall Study|Adverse Event|0|||
126071251|NCT01983462|453555064|FG002|Overall Study|Adverse Event|0|||
126071252|NCT00684203|453555065|FG000|Overall Study|Adverse Event|6|||
126071253|NCT00684203|453555066|FG001|Overall Study|Adverse Event|4|||
126071254|NCT00684203|453555067|FG002|Overall Study|Adverse Event|8|||
126071255|NCT00684203|453555068|FG003|Overall Study|Adverse Event|0|||
126071256|NCT00684203|453555069|FG004|Overall Study|Adverse Event|0|||
126071257|NCT00684203|453555070|FG005|Overall Study|Adverse Event|0|||
126071258|NCT00684203|453555065|FG000|Overall Study|Protocol-defined clinical event|3|||
126071259|NCT00684203|453555066|FG001|Overall Study|Protocol-defined clinical event|1|||
126071260|NCT00684203|453555067|FG002|Overall Study|Protocol-defined clinical event|0|||
126071261|NCT00684203|453555068|FG003|Overall Study|Protocol-defined clinical event|0|||
126071262|NCT00684203|453555069|FG004|Overall Study|Protocol-defined clinical event|0|||
126071263|NCT00684203|453555070|FG005|Overall Study|Protocol-defined clinical event|0|||
126071264|NCT00684203|453555065|FG000|Overall Study|Withdrawal by Subject|0|||
126071265|NCT00684203|453555066|FG001|Overall Study|Withdrawal by Subject|2|||
126071266|NCT00684203|453555067|FG002|Overall Study|Withdrawal by Subject|1|||
126071267|NCT00684203|453555068|FG003|Overall Study|Withdrawal by Subject|0|||
126071268|NCT00684203|453555069|FG004|Overall Study|Withdrawal by Subject|0|||
126071269|NCT00684203|453555070|FG005|Overall Study|Withdrawal by Subject|0|||
126071270|NCT00684203|453555065|FG000|Overall Study|Did not meet protocol eligibility|0|||
126071271|NCT00684203|453555066|FG001|Overall Study|Did not meet protocol eligibility|1|||
126071272|NCT00684203|453555067|FG002|Overall Study|Did not meet protocol eligibility|0|||
126071273|NCT00684203|453555068|FG003|Overall Study|Did not meet protocol eligibility|0|||
126071274|NCT00684203|453555069|FG004|Overall Study|Did not meet protocol eligibility|0|||
126071275|NCT00684203|453555070|FG005|Overall Study|Did not meet protocol eligibility|0|||
126071276|NCT02151643|453555075|FG000|Overall Study|Adverse Event|2|||
126071277|NCT02151643|453555076|FG001|Overall Study|Adverse Event|0|||
126071278|NCT02151643|453555077|FG002|Overall Study|Adverse Event|1|||
126071279|NCT02151643|453555078|FG003|Overall Study|Adverse Event|4|||
126071280|NCT02151643|453555079|FG004|Overall Study|Adverse Event|0|||
126071281|NCT02151643|453555075|FG000|Overall Study|Withdrawal by Subject|0|||
126071282|NCT02151643|453555076|FG001|Overall Study|Withdrawal by Subject|1|||
126071283|NCT02151643|453555077|FG002|Overall Study|Withdrawal by Subject|1|||
126071284|NCT02151643|453555078|FG003|Overall Study|Withdrawal by Subject|1|||
126071285|NCT02151643|453555079|FG004|Overall Study|Withdrawal by Subject|1|||
126071286|NCT02151643|453555075|FG000|Overall Study|Hyperphosphataemia|1|||
126071287|NCT02151643|453555076|FG001|Overall Study|Hyperphosphataemia|0|||
126071288|NCT02151643|453555077|FG002|Overall Study|Hyperphosphataemia|0|||
126071289|NCT02151643|453555078|FG003|Overall Study|Hyperphosphataemia|0|||
126071290|NCT02151643|453555079|FG004|Overall Study|Hyperphosphataemia|1|||
126071291|NCT02151643|453555075|FG000|Overall Study|High Ferritin levels|3|||
126071292|NCT02151643|453555076|FG001|Overall Study|High Ferritin levels|3|||
126071293|NCT02151643|453555077|FG002|Overall Study|High Ferritin levels|2|||
126071294|NCT02151643|453555078|FG003|Overall Study|High Ferritin levels|2|||
126071295|NCT02151643|453555079|FG004|Overall Study|High Ferritin levels|1|||
126071296|NCT03296566|453555082|FG000|Overall Study|Lost to Follow-up|19|||
126071297|NCT03296566|453555083|FG001|Overall Study|Lost to Follow-up|46|||
126071298|NCT03296566|453555082|FG000|Overall Study|Withdrawal by Subject|0|||
126071299|NCT03296566|453555083|FG001|Overall Study|Withdrawal by Subject|3|||
126071300|NCT01084239|453555086|FG000|28-Day Follow-up|Lost to Follow-up|4|||
126071301|NCT01084239|453555087|FG001|28-Day Follow-up|Lost to Follow-up|9|||
126071302|NCT02396953|453555088|FG000|Overall Study|Withdrawal by Subject|0|||
126071303|NCT02396953|453555089|FG001|Overall Study|Withdrawal by Subject|0|||
126071304|NCT02396953|453555090|FG002|Overall Study|Withdrawal by Subject|1|||
126071305|NCT02396953|453555088|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
126071306|NCT02396953|453555089|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
126071307|NCT02396953|453555090|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
126071308|NCT02396953|453555088|FG000|Overall Study|Personal Reasons|1|||
126071309|NCT02396953|453555089|FG001|Overall Study|Personal Reasons|1|||
126071310|NCT02396953|453555090|FG002|Overall Study|Personal Reasons|0|||
126071311|NCT04491006|453555091|FG000|Overall Study|Adverse Event|0|||
126071312|NCT04491006|453555092|FG001|Overall Study|Adverse Event|3|||
126071313|NCT04491006|453555093|FG002|Overall Study|Adverse Event|5|||
126071314|NCT04491006|453555091|FG000|Overall Study|Withdrawal by Subject|1|||
126071315|NCT04491006|453555092|FG001|Overall Study|Withdrawal by Subject|0|||
126071316|NCT04491006|453555093|FG002|Overall Study|Withdrawal by Subject|2|||
126071317|NCT02581189|453555098|FG000|Overall Study|Failure to return|36|||
126071318|NCT02581189|453555098|FG000|Overall Study|Withdrew consent|5|||
126071319|NCT02581189|453555098|FG000|Overall Study|Death|3|||
126071320|NCT02581189|453555098|FG000|Overall Study|Insufficient virological response|2|||
126071321|NCT02581189|453555098|FG000|Overall Study|Other, not specified|7|||
126071322|NCT03371485|453555104|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
126071323|NCT03371485|453555104|FG000|2-year Follow-up|Death|5|||
126071324|NCT02204319|453555109|FG000|Overall Study|Pregnancy|1|||
126071325|NCT02204319|453555109|FG000|Overall Study|Withdrawal by Subject|2|||
126071326|NCT04531813|453555114|FG000|Overall Study|Protocol Violation|1|||
126071327|NCT04531813|453555114|FG000|Overall Study|Withdrawal by Subject|1|||
126071328|NCT02171130|453555115|FG000|Overall Study|Death|1|||
126071329|NCT02171130|453555115|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
126071330|NCT02171130|453555115|FG000|Overall Study|Discontinued; Site Termination|5|||
126071331|NCT02171130|453555115|FG000|Overall Study|Withdrawal by Subject|3|||
126071332|NCT02171130|453555115|FG000|Overall Study|Physician Decision|1|||
126071333|NCT02171130|453555115|FG000|Overall Study|Lost to Follow-up|1|||
126071334|NCT02171130|453555115|FG000|Overall Study|Met Exclusion Criteria|1|||
126071335|NCT02853305|453555118|FG000|Overall Study|Death|287|||
126071336|NCT02853305|453555119|FG001|Overall Study|Death|249|||
126071337|NCT02853305|453555120|FG002|Overall Study|Death|300|||
126071338|NCT02853305|453555118|FG000|Overall Study|Withdrawal by Subject|2|||
126071339|NCT02853305|453555119|FG001|Overall Study|Withdrawal by Subject|8|||
126071340|NCT02853305|453555120|FG002|Overall Study|Withdrawal by Subject|3|||
126071341|NCT02853305|453555118|FG000|Overall Study|Transferred to Extension Study|46|||
126071342|NCT02853305|453555119|FG001|Overall Study|Transferred to Extension Study|30|||
126071343|NCT02853305|453555120|FG002|Overall Study|Transferred to Extension Study|25|||
126071344|NCT02853305|453555118|FG000|Overall Study|Did Not Continue on Extension Study|16|||
126071345|NCT02853305|453555119|FG001|Overall Study|Did Not Continue on Extension Study|20|||
126071346|NCT02853305|453555120|FG002|Overall Study|Did Not Continue on Extension Study|24|||
126071347|NCT02381652|453555123|FG000|Overall Study|Withdrawal by Subject|0|||
126071348|NCT02381652|453555124|FG001|Overall Study|Withdrawal by Subject|0|||
126071349|NCT02381652|453555125|FG002|Overall Study|Withdrawal by Subject|1|||
126071350|NCT01340300|453555126|FG000|Overall Study|Lost to Follow-up|3|||
126071351|NCT01340300|453555127|FG001|Overall Study|Lost to Follow-up|0|||
126071352|NCT01340300|453555128|FG002|Overall Study|Lost to Follow-up|5|||
126071353|NCT01340300|453555129|FG003|Overall Study|Lost to Follow-up|10|||
126071354|NCT01340300|453555126|FG000|Overall Study|Withdrawal by Subject|5|||
126071355|NCT01340300|453555127|FG001|Overall Study|Withdrawal by Subject|6|||
126071356|NCT01340300|453555128|FG002|Overall Study|Withdrawal by Subject|6|||
126071357|NCT01340300|453555129|FG003|Overall Study|Withdrawal by Subject|3|||
126071358|NCT01340300|453555126|FG000|Overall Study|Adverse Event|1|||
126071359|NCT01340300|453555127|FG001|Overall Study|Adverse Event|0|||
126071360|NCT01340300|453555128|FG002|Overall Study|Adverse Event|4|||
126071361|NCT01340300|453555129|FG003|Overall Study|Adverse Event|0|||
126071362|NCT01340300|453555126|FG000|Overall Study|Physician Decision|0|||
126071363|NCT01340300|453555127|FG001|Overall Study|Physician Decision|1|||
126071364|NCT01340300|453555128|FG002|Overall Study|Physician Decision|0|||
126071365|NCT01340300|453555129|FG003|Overall Study|Physician Decision|0|||
126071366|NCT01340300|453555126|FG000|Overall Study|Unrelated sickness|0|||
126071367|NCT01340300|453555127|FG001|Overall Study|Unrelated sickness|2|||
126071368|NCT01340300|453555128|FG002|Overall Study|Unrelated sickness|0|||
126071369|NCT01340300|453555129|FG003|Overall Study|Unrelated sickness|1|||
126071370|NCT03544229|453555130|FG000|Overall Study|Adverse Event|1|||
126071371|NCT03544229|453555131|FG001|Overall Study|Adverse Event|0|||
126071372|NCT03544229|453555132|FG002|Overall Study|Adverse Event|1|||
126071373|NCT03544229|453555133|FG003|Overall Study|Adverse Event|0|||
126071374|NCT03544229|453555130|FG000|Overall Study|Protocol Deviation|0|||
126071375|NCT03544229|453555131|FG001|Overall Study|Protocol Deviation|0|||
126071376|NCT03544229|453555132|FG002|Overall Study|Protocol Deviation|1|||
126071377|NCT03544229|453555133|FG003|Overall Study|Protocol Deviation|0|||
126071378|NCT03544229|453555130|FG000|Overall Study|Lost to Follow-up|3|||
126071379|NCT03544229|453555131|FG001|Overall Study|Lost to Follow-up|0|||
126071380|NCT03544229|453555132|FG002|Overall Study|Lost to Follow-up|0|||
126071381|NCT03544229|453555133|FG003|Overall Study|Lost to Follow-up|2|||
126071382|NCT03544229|453555130|FG000|Overall Study|Voluntary Withdrawal|2|||
126071383|NCT03544229|453555131|FG001|Overall Study|Voluntary Withdrawal|1|||
126071384|NCT03544229|453555132|FG002|Overall Study|Voluntary Withdrawal|3|||
126071385|NCT03544229|453555133|FG003|Overall Study|Voluntary Withdrawal|0|||
126071386|NCT03544229|453555130|FG000|Overall Study|Lack of Efficacy|0|||
126071387|NCT03544229|453555131|FG001|Overall Study|Lack of Efficacy|1|||
126071388|NCT03544229|453555132|FG002|Overall Study|Lack of Efficacy|0|||
126071389|NCT03544229|453555133|FG003|Overall Study|Lack of Efficacy|0|||
126071390|NCT04772313|453555134|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
126071391|NCT04772313|453555134|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
126071392|NCT01836198|453555136|FG000|Part A, Period 2|Protocol Violation|0|||
126071393|NCT01836198|453555137|FG001|Part A, Period 2|Protocol Violation|1|||
126071394|NCT01836198|453555138|FG002|Part A, Period 2|Protocol Violation|0|||
126071395|NCT03187353|453555139|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
126071396|NCT03187353|453555140|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
126071397|NCT03187353|453555139|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
126071398|NCT03187353|453555140|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126071399|NCT03187353|453555139|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
126071400|NCT03187353|453555140|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
126071401|NCT03187353|453555139|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
126071402|NCT03187353|453555140|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
126071403|NCT03187353|453555139|FG000|Washout (2 Weeks)|Adverse Event|2|||
126071404|NCT03187353|453555140|FG001|Washout (2 Weeks)|Adverse Event|0|||
126071405|NCT03187353|453555139|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
126071406|NCT03187353|453555140|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
126071407|NCT02215954|453555141|FG000|Overall Study|Adverse Event|0|||
126071408|NCT02215954|453555142|FG001|Overall Study|Adverse Event|0|||
126071409|NCT02215954|453555143|FG002|Overall Study|Adverse Event|1|||
126071410|NCT02215954|453555141|FG000|Overall Study|Withdrawal by Subject|0|||
126071411|NCT02215954|453555142|FG001|Overall Study|Withdrawal by Subject|0|||
126071412|NCT02215954|453555143|FG002|Overall Study|Withdrawal by Subject|2|||
126071413|NCT02215954|453555141|FG000|Overall Study|Not exposed|1|||
126071414|NCT02215954|453555142|FG001|Overall Study|Not exposed|1|||
126071415|NCT02215954|453555143|FG002|Overall Study|Not exposed|3|||
126071416|NCT02460562|453555145|FG000|Overall Study|Lost to Follow-up|15|||
126071417|NCT02460562|453555146|FG001|Overall Study|Lost to Follow-up|16|||
126071418|NCT03303521|453555147|FG000|Overall Study|Withdrawal by Subject|2|||
126071419|NCT03303521|453555148|FG001|Overall Study|Withdrawal by Subject|0|||
126071420|NCT03303521|453555147|FG000|Overall Study|Death|1|||
126071421|NCT03303521|453555148|FG001|Overall Study|Death|0|||
126071422|NCT03303521|453555147|FG000|Overall Study|Kidney transplantation|0|||
126071423|NCT03303521|453555148|FG001|Overall Study|Kidney transplantation|1|||
126071424|NCT03303521|453555147|FG000|Overall Study|Investigational product discontinuation|0|||
126071425|NCT03303521|453555148|FG001|Overall Study|Investigational product discontinuation|1|||
126071426|NCT03303521|453555147|FG000|Overall Study|Transferred to non-study dialysis center|1|||
126071427|NCT03303521|453555148|FG001|Overall Study|Transferred to non-study dialysis center|0|||
126071428|NCT03303521|453555147|FG000|Overall Study|Non-comliance to study protocol|0|||
126071429|NCT03303521|453555148|FG001|Overall Study|Non-comliance to study protocol|1|||
126071430|NCT03303521|453555147|FG000|Overall Study|Adverse Event|1|||
126071431|NCT03303521|453555148|FG001|Overall Study|Adverse Event|0|||
126071432|NCT01654289|453555149|FG000|Overall Study|Withdrawal by Subject|10|||
126071433|NCT01654289|453555150|FG001|Overall Study|Withdrawal by Subject|8|||
126071434|NCT01654289|453555151|FG002|Overall Study|Withdrawal by Subject|5|||
126071435|NCT01654289|453555149|FG000|Overall Study|Withdrew from intervention only|17|||
126071436|NCT01654289|453555150|FG001|Overall Study|Withdrew from intervention only|20|||
126114515|NCT01428661|453713860|FG000|Double-Masked Phase|Protocol Violation|9|||
126071437|NCT01654289|453555151|FG002|Overall Study|Withdrew from intervention only|0|||
126071438|NCT04194541|453555152|FG000|Day 1 Through 13|Lost to Follow-up|3|||
126071439|NCT04194541|453555152|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
126071440|NCT04194541|453555152|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
126071441|NCT02642159|453555153|FG000|Overall Study|Randomized but not treated|1|||
126071442|NCT02642159|453555154|FG001|Overall Study|Randomized but not treated|0|||
126071443|NCT02642159|453555153|FG000|Overall Study|Adverse Event|10|||
126071444|NCT02642159|453555154|FG001|Overall Study|Adverse Event|4|||
126071445|NCT02642159|453555153|FG000|Overall Study|Withdrawal by Subject|9|||
126071446|NCT02642159|453555154|FG001|Overall Study|Withdrawal by Subject|1|||
126071447|NCT02642159|453555153|FG000|Overall Study|Poor compliance to study protocol|1|||
126071448|NCT02642159|453555154|FG001|Overall Study|Poor compliance to study protocol|0|||
126071449|NCT02642159|453555153|FG000|Overall Study|Other than specified above|10|||
126071450|NCT02642159|453555154|FG001|Overall Study|Other than specified above|3|||
125945724|NCT03161483|453099828|FG003|Treatment Period|Pregnancy|0|||
125945725|NCT03161483|453099825|FG000|Treatment Period|Lack of Efficacy|0|||
125945726|NCT03161483|453099826|FG001|Treatment Period|Lack of Efficacy|0|||
125945727|NCT03161483|453099827|FG002|Treatment Period|Lack of Efficacy|0|||
125945728|NCT03161483|453099828|FG003|Treatment Period|Lack of Efficacy|1|||
125945729|NCT03161483|453099825|FG000|Treatment Period|Withdrawal by Subject|2|||
125945730|NCT03161483|453099826|FG001|Treatment Period|Withdrawal by Subject|5|||
125945731|NCT03161483|453099827|FG002|Treatment Period|Withdrawal by Subject|2|||
125945732|NCT03161483|453099828|FG003|Treatment Period|Withdrawal by Subject|6|||
125945733|NCT03161483|453099825|FG000|Treatment Period|Lost to Follow-up|0|||
125945734|NCT03161483|453099826|FG001|Treatment Period|Lost to Follow-up|0|||
125945735|NCT03161483|453099827|FG002|Treatment Period|Lost to Follow-up|0|||
125945736|NCT03161483|453099828|FG003|Treatment Period|Lost to Follow-up|1|||
125945737|NCT03161483|453099825|FG000|Treatment Period|Protocol Violation|0|||
125945738|NCT03161483|453099826|FG001|Treatment Period|Protocol Violation|0|||
125945739|NCT03161483|453099827|FG002|Treatment Period|Protocol Violation|0|||
125945740|NCT03161483|453099828|FG003|Treatment Period|Protocol Violation|1|||
125945741|NCT03161483|453099825|FG000|Treatment Period|Other reasons|1|||
125945742|NCT03161483|453099826|FG001|Treatment Period|Other reasons|1|||
125945743|NCT03161483|453099827|FG002|Treatment Period|Other reasons|0|||
125945744|NCT03161483|453099828|FG003|Treatment Period|Other reasons|0|||
125945745|NCT02404350|453099837|FG000|Overall Study|Adverse Event|2|||
125945746|NCT02404350|453099838|FG001|Overall Study|Adverse Event|2|||
125945747|NCT02404350|453099839|FG002|Overall Study|Adverse Event|3|||
125945748|NCT02404350|453099840|FG003|Overall Study|Adverse Event|9|||
125945749|NCT02404350|453099837|FG000|Overall Study|Lack of Efficacy|3|||
125945750|NCT02404350|453099838|FG001|Overall Study|Lack of Efficacy|1|||
125945751|NCT02404350|453099839|FG002|Overall Study|Lack of Efficacy|0|||
125945752|NCT02404350|453099840|FG003|Overall Study|Lack of Efficacy|3|||
125945753|NCT02404350|453099837|FG000|Overall Study|Lost to Follow-up|2|||
125945754|NCT02404350|453099838|FG001|Overall Study|Lost to Follow-up|0|||
125945755|NCT02404350|453099839|FG002|Overall Study|Lost to Follow-up|0|||
125945756|NCT02404350|453099840|FG003|Overall Study|Lost to Follow-up|1|||
125945757|NCT02404350|453099837|FG000|Overall Study|Physician Decision|1|||
125945758|NCT02404350|453099838|FG001|Overall Study|Physician Decision|0|||
125945759|NCT02404350|453099839|FG002|Overall Study|Physician Decision|0|||
125945760|NCT02404350|453099840|FG003|Overall Study|Physician Decision|2|||
125945761|NCT02404350|453099837|FG000|Overall Study|Pregnancy|0|||
125945762|NCT02404350|453099838|FG001|Overall Study|Pregnancy|0|||
125945763|NCT02404350|453099839|FG002|Overall Study|Pregnancy|0|||
125945764|NCT02404350|453099840|FG003|Overall Study|Pregnancy|1|||
125945765|NCT02404350|453099837|FG000|Overall Study|Withdrawal by Subject|7|||
125945766|NCT02404350|453099838|FG001|Overall Study|Withdrawal by Subject|3|||
125945767|NCT02404350|453099839|FG002|Overall Study|Withdrawal by Subject|3|||
125945768|NCT02404350|453099840|FG003|Overall Study|Withdrawal by Subject|19|||
125945769|NCT02404350|453099837|FG000|Overall Study|Due to Non-compliance with treatment|0|||
125945770|NCT02404350|453099838|FG001|Overall Study|Due to Non-compliance with treatment|0|||
125945771|NCT02404350|453099839|FG002|Overall Study|Due to Non-compliance with treatment|0|||
125945772|NCT02404350|453099840|FG003|Overall Study|Due to Non-compliance with treatment|1|||
125945773|NCT02404350|453099837|FG000|Overall Study|Due to Technical problems|0|||
125945774|NCT02404350|453099838|FG001|Overall Study|Due to Technical problems|0|||
125945775|NCT02404350|453099839|FG002|Overall Study|Due to Technical problems|0|||
125945776|NCT02404350|453099840|FG003|Overall Study|Due to Technical problems|1|||
125945777|NCT04238728|453099841|FG000|Overall Study|Withdrawal by Subject|1|||
125945778|NCT04238728|453099841|FG000|Overall Study|Lost to Follow-up|2|||
125945779|NCT05389657|453099843|FG000|Overall Study|Lost to Follow-up|7|||
125945780|NCT05389657|453099844|FG001|Overall Study|Lost to Follow-up|8|||
125945781|NCT01907828|453099845|FG000|Overall Study|Exclusion criteria not met|0|||
125945782|NCT01907828|453099846|FG001|Overall Study|Exclusion criteria not met|1|||
125945783|NCT01907828|453099845|FG000|Overall Study|Withdrawal by Subject|3|||
125945784|NCT01907828|453099846|FG001|Overall Study|Withdrawal by Subject|4|||
125945785|NCT01907828|453099845|FG000|Overall Study|Lost to Follow-up|3|||
125945786|NCT01907828|453099846|FG001|Overall Study|Lost to Follow-up|0|||
125945787|NCT01907828|453099845|FG000|Overall Study|Participant refused 24-month follow-up|1|||
125945788|NCT01907828|453099846|FG001|Overall Study|Participant refused 24-month follow-up|0|||
125945789|NCT01907828|453099845|FG000|Overall Study|Participant met exclusion criteria|0|||
125945790|NCT01907828|453099846|FG001|Overall Study|Participant met exclusion criteria|1|||
125945791|NCT01256593|453099848|FG000|Overall Study|Protocol Violation|26|||
125945792|NCT01256593|453099848|FG000|Overall Study|No Drug Administration Information|2|||
125945793|NCT01256593|453099848|FG000|Overall Study|No Visit After Treatment|186|||
125945794|NCT04414553|453099849|FG000|Overall Study|Lost to Follow-up|20|||
125945795|NCT01498640|453099852|FG000|Overall Study|Lost to Follow-up|1|||
125945796|NCT01498640|453099852|FG000|Overall Study|Death|1|||
125945797|NCT01498640|453099852|FG000|Overall Study|Other|3|||
125945798|NCT04007523|453099854|FG000|Overall Study|Withdrawal by Subject|0|||
125945799|NCT04007523|453099855|FG001|Overall Study|Withdrawal by Subject|1|||
125945800|NCT04007523|453099856|FG002|Overall Study|Withdrawal by Subject|1|||
126071451|NCT03746483|453555155|FG000|Overall Study|Adverse Event|0|||
126071452|NCT03746483|453555156|FG001|Overall Study|Adverse Event|1|||
126071453|NCT03746483|453555155|FG000|Overall Study|Lack of Efficacy|3|||
126071454|NCT03746483|453555156|FG001|Overall Study|Lack of Efficacy|2|||
126071455|NCT03746483|453555155|FG000|Overall Study|Lost to Follow-up|1|||
126071456|NCT03746483|453555156|FG001|Overall Study|Lost to Follow-up|0|||
126071457|NCT03746483|453555155|FG000|Overall Study|Protocol Violation|2|||
126071458|NCT03746483|453555156|FG001|Overall Study|Protocol Violation|0|||
126071459|NCT00187135|453555157|FG000|Visit One|Withdrawal by Subject|1|||
126071460|NCT00187135|453555158|FG001|Visit One|Withdrawal by Subject|0|||
126071461|NCT00187135|453555159|FG002|Visit One|Withdrawal by Subject|0|||
126071462|NCT00187135|453555160|FG003|Visit One|Withdrawal by Subject|0|||
126071463|NCT00187135|453555161|FG004|Visit One|Withdrawal by Subject|0|||
126071464|NCT00187135|453555162|FG005|Visit One|Withdrawal by Subject|1|||
126071465|NCT00187135|453555157|FG000|Visit One|Physician Decision|3|||
126071466|NCT00187135|453555158|FG001|Visit One|Physician Decision|1|||
126071467|NCT00187135|453555159|FG002|Visit One|Physician Decision|0|||
126071468|NCT00187135|453555160|FG003|Visit One|Physician Decision|0|||
126071469|NCT00187135|453555161|FG004|Visit One|Physician Decision|0|||
126071470|NCT00187135|453555162|FG005|Visit One|Physician Decision|1|||
126071471|NCT00187135|453555157|FG000|Visit Two|Death|0|||
126071472|NCT00187135|453555158|FG001|Visit Two|Death|0|||
126071473|NCT00187135|453555159|FG002|Visit Two|Death|0|||
126071474|NCT00187135|453555160|FG003|Visit Two|Death|1|||
126071475|NCT00187135|453555161|FG004|Visit Two|Death|0|||
126071476|NCT00187135|453555162|FG005|Visit Two|Death|1|||
126071477|NCT00187135|453555157|FG000|Visit Two|Physician Decision|1|||
126071478|NCT00187135|453555158|FG001|Visit Two|Physician Decision|0|||
126071479|NCT00187135|453555159|FG002|Visit Two|Physician Decision|0|||
126071480|NCT00187135|453555160|FG003|Visit Two|Physician Decision|0|||
126071481|NCT00187135|453555161|FG004|Visit Two|Physician Decision|0|||
126071482|NCT00187135|453555162|FG005|Visit Two|Physician Decision|0|||
126071483|NCT00187135|453555157|FG000|Visit Two|Withdrawal by Subject|1|||
126071484|NCT00187135|453555158|FG001|Visit Two|Withdrawal by Subject|1|||
126071485|NCT00187135|453555159|FG002|Visit Two|Withdrawal by Subject|1|||
126071486|NCT00187135|453555160|FG003|Visit Two|Withdrawal by Subject|0|||
126071487|NCT00187135|453555161|FG004|Visit Two|Withdrawal by Subject|1|||
126071488|NCT00187135|453555162|FG005|Visit Two|Withdrawal by Subject|1|||
126071489|NCT00187135|453555157|FG000|Visit Two|Study Discontinued|3|||
126071490|NCT00187135|453555158|FG001|Visit Two|Study Discontinued|2|||
126071491|NCT00187135|453555159|FG002|Visit Two|Study Discontinued|1|||
126071492|NCT00187135|453555160|FG003|Visit Two|Study Discontinued|7|||
126071493|NCT00187135|453555161|FG004|Visit Two|Study Discontinued|5|||
126071494|NCT00187135|453555162|FG005|Visit Two|Study Discontinued|6|||
126071495|NCT00187135|453555157|FG000|Visit Three|Death|0|||
126071496|NCT00187135|453555158|FG001|Visit Three|Death|0|||
126071497|NCT00187135|453555159|FG002|Visit Three|Death|1|||
126071498|NCT00187135|453555160|FG003|Visit Three|Death|0|||
126071499|NCT00187135|453555161|FG004|Visit Three|Death|1|||
126071500|NCT00187135|453555162|FG005|Visit Three|Death|0|||
126071501|NCT00187135|453555157|FG000|Visit Three|Withdrawal by Subject|0|||
126071502|NCT00187135|453555158|FG001|Visit Three|Withdrawal by Subject|1|||
126071503|NCT00187135|453555159|FG002|Visit Three|Withdrawal by Subject|1|||
126071504|NCT00187135|453555160|FG003|Visit Three|Withdrawal by Subject|2|||
126071505|NCT00187135|453555161|FG004|Visit Three|Withdrawal by Subject|0|||
126071506|NCT00187135|453555162|FG005|Visit Three|Withdrawal by Subject|0|||
126071507|NCT00187135|453555157|FG000|Visit Three|Study Discontinued|7|||
126071508|NCT00187135|453555158|FG001|Visit Three|Study Discontinued|6|||
126071509|NCT00187135|453555159|FG002|Visit Three|Study Discontinued|7|||
126071510|NCT00187135|453555160|FG003|Visit Three|Study Discontinued|7|||
126071511|NCT00187135|453555161|FG004|Visit Three|Study Discontinued|7|||
126071512|NCT00187135|453555162|FG005|Visit Three|Study Discontinued|6|||
126071513|NCT00297778|453555163|FG000|Overall Study|Adverse Event|16|||
126071514|NCT00297778|453555164|FG001|Overall Study|Adverse Event|10|||
126071515|NCT00297778|453555163|FG000|Overall Study|Withdrawal by Subject|1|||
126071516|NCT00297778|453555164|FG001|Overall Study|Withdrawal by Subject|5|||
126071517|NCT00297778|453555163|FG000|Overall Study|Lack of Efficacy|2|||
126071518|NCT00297778|453555164|FG001|Overall Study|Lack of Efficacy|1|||
126071519|NCT00297778|453555163|FG000|Overall Study|Non-compliant with trial protocol|0|||
126071520|NCT00297778|453555164|FG001|Overall Study|Non-compliant with trial protocol|3|||
126071521|NCT00297778|453555163|FG000|Overall Study|Other|0|||
126071522|NCT00297778|453555164|FG001|Overall Study|Other|1|||
126071523|NCT00679549|453555165|FG000|Overall Study|dropout|2|||
126071524|NCT00679549|453555166|FG001|Overall Study|dropout|4|||
126071525|NCT00679549|453555165|FG000|Overall Study|missing outcome echocardiograms|4|||
126071526|NCT00679549|453555166|FG001|Overall Study|missing outcome echocardiograms|5|||
126071527|NCT03280108|453555167|FG000|Overall Study|Lost to Follow-up|2|||
126071528|NCT03280108|453555168|FG001|Overall Study|Lost to Follow-up|0|||
126071529|NCT02996097|453555169|FG000|Overall Study|Lost to Follow-up|11|||
126071530|NCT02996097|453555170|FG001|Overall Study|Lost to Follow-up|11|||
126071531|NCT02201771|453555171|FG000|Overall Study|Death|3|||
126071532|NCT02201771|453555172|FG001|Overall Study|Death|2|||
126071533|NCT02201771|453555173|FG002|Overall Study|Death|0|||
126071534|NCT02201771|453555171|FG000|Overall Study|Protocol Violation|10|||
126071535|NCT02201771|453555172|FG001|Overall Study|Protocol Violation|8|||
126071536|NCT02201771|453555173|FG002|Overall Study|Protocol Violation|10|||
126071537|NCT01820637|453555174|FG000|Overall Study|Death|2|||
126071538|NCT01820637|453555174|FG000|Overall Study|Withdrawal by Subject|1|||
126071539|NCT00264498|453555175|FG000|Randomized Treatment|Death|0|||
126071540|NCT00264498|453555176|FG001|Randomized Treatment|Death|3|||
126071541|NCT00264498|453555175|FG000|Randomized Treatment|Withdrawal by Subject|0|||
126071542|NCT00264498|453555176|FG001|Randomized Treatment|Withdrawal by Subject|1|||
126071543|NCT00264498|453555175|FG000|Randomized Treatment|Objective disease Progression|13|||
126071544|NCT00264498|453555176|FG001|Randomized Treatment|Objective disease Progression|14|||
126071545|NCT00264498|453555175|FG000|Randomized Treatment|Physician Decision|1|||
126071546|NCT00264498|453555176|FG001|Randomized Treatment|Physician Decision|0|||
126071547|NCT00264498|453555175|FG000|Randomized Treatment|Incorrectly randomized|1|||
126071548|NCT00264498|453555176|FG001|Randomized Treatment|Incorrectly randomized|0|||
126071549|NCT00264498|453555175|FG000|Randomized Treatment|Study Closure|1|||
126071550|NCT00264498|453555176|FG001|Randomized Treatment|Study Closure|0|||
126071551|NCT00264498|453555175|FG000|Randomized Treatment|Protocol Violation|1|||
126071552|NCT00264498|453555176|FG001|Randomized Treatment|Protocol Violation|0|||
126071553|NCT00264498|453555175|FG000|Crossover Treatment|Death|1|||
126071554|NCT00264498|453555176|FG001|Crossover Treatment|Death|3|||
126071555|NCT00264498|453555175|FG000|Crossover Treatment|Objective disease progression|4|||
126071556|NCT00264498|453555176|FG001|Crossover Treatment|Objective disease progression|5|||
126071557|NCT00264498|453555175|FG000|Crossover Treatment|Study closure|0|||
126071558|NCT00264498|453555176|FG001|Crossover Treatment|Study closure|1|||
126071559|NCT00264498|453555175|FG000|Crossover Treatment|Withdrawal by Subject|1|||
126071560|NCT00264498|453555176|FG001|Crossover Treatment|Withdrawal by Subject|0|||
126071561|NCT00583115|453555177|FG000|Overall Study|Death|1|||
126071562|NCT02205476|453555178|FG000|Overall Study|Study termination by Sponsor|7|||
126071563|NCT02205476|453555179|FG001|Overall Study|Study termination by Sponsor|3|||
126071564|NCT02109107|453555180|FG000|Overall Study|Lost to Follow-up|2|||
126071565|NCT00607789|453555186|FG000|Overall Study|Adverse Event|3|||
126071566|NCT00607789|453555187|FG001|Overall Study|Adverse Event|0|||
126071567|NCT00607789|453555186|FG000|Overall Study|Lack of Efficacy|0|||
126071568|NCT00607789|453555187|FG001|Overall Study|Lack of Efficacy|1|||
126071569|NCT00607789|453555186|FG000|Overall Study|Inadequate adherence|3|||
126071570|NCT00607789|453555187|FG001|Overall Study|Inadequate adherence|0|||
126071571|NCT00607789|453555186|FG000|Overall Study|Lost to Follow-up|0|||
126071572|NCT00607789|453555187|FG001|Overall Study|Lost to Follow-up|5|||
126071573|NCT00607789|453555186|FG000|Overall Study|Withdrawal by Subject|1|||
126071574|NCT00607789|453555187|FG001|Overall Study|Withdrawal by Subject|0|||
126071575|NCT01919398|453555188|FG000|Overall Study|Progressive Disease|0|||
126071576|NCT01919398|453555189|FG001|Overall Study|Progressive Disease|0|||
126071577|NCT01919398|453555190|FG002|Overall Study|Progressive Disease|4|||
126071578|NCT02016690|453555191|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
126071579|NCT02016690|453555191|FG000|Overall Study|Excluded from SAS: Duplication|2|||
126071580|NCT02016690|453555191|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
126071581|NCT02016690|453555191|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
126071582|NCT02016690|453555191|FG000|Overall Study|Did not meet inclusion criteria|13|||
126071583|NCT02016690|453555191|FG000|Overall Study|Hospitalized for RSV at study start|3|||
126071584|NCT06016127|453555196|FG000|Overall Study|Withdrawal by Subject|4|||
126071585|NCT06016127|453555197|FG001|Overall Study|Withdrawal by Subject|3|||
126071586|NCT03915951|453555200|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
126071587|NCT03915951|453555201|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
126071588|NCT03915951|453555200|FG000|Overall Study|Adverse Event|12|||
126071589|NCT03915951|453555201|FG001|Overall Study|Adverse Event|6|||
126071590|NCT03915951|453555200|FG000|Overall Study|Disease progression (radiological)|17|||
126071591|NCT03915951|453555201|FG001|Overall Study|Disease progression (radiological)|15|||
126071592|NCT03915951|453555200|FG000|Overall Study|Disease progression (clinical)|4|||
126071593|NCT03915951|453555201|FG001|Overall Study|Disease progression (clinical)|1|||
126071594|NCT03915951|453555200|FG000|Overall Study|Patient decision|0|||
126071595|NCT03915951|453555201|FG001|Overall Study|Patient decision|4|||
126071596|NCT03915951|453555200|FG000|Overall Study|Investigator decision|0|||
126071597|NCT03915951|453555201|FG001|Overall Study|Investigator decision|1|||
126071598|NCT03915951|453555200|FG000|Overall Study|Consent withdrawn|1|||
126071599|NCT03915951|453555201|FG001|Overall Study|Consent withdrawn|1|||
126071600|NCT03915951|453555200|FG000|Overall Study|Death|0|||
126071601|NCT03915951|453555201|FG001|Overall Study|Death|3|||
126071602|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
126071603|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
126071604|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
126071605|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
126071606|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
126071607|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
125945801|NCT04007523|453099857|FG003|Overall Study|Withdrawal by Subject|0|||
125945802|NCT04007523|453099854|FG000|Overall Study|ICU Transfer|0|||
125945803|NCT04007523|453099855|FG001|Overall Study|ICU Transfer|1|||
125945804|NCT04007523|453099856|FG002|Overall Study|ICU Transfer|0|||
126071608|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
126071609|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
126071610|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
126071611|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
126071612|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
126071613|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
126071614|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
126071615|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
126071616|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
126071617|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
126071618|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
126071619|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
126071620|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
126071621|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
126071622|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
126071623|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
126071624|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
126071625|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
126071626|NCT02269917|453555203|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
126071627|NCT02269917|453555204|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
126071628|NCT02269917|453555205|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
126071629|NCT02269917|453555203|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
126071630|NCT02269917|453555204|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
126071631|NCT02269917|453555205|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
126071632|NCT02269917|453555203|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
126071633|NCT02269917|453555204|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
126071634|NCT02269917|453555205|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
126071635|NCT02269917|453555203|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
126071636|NCT02269917|453555204|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
126071637|NCT02269917|453555205|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
126071638|NCT02269917|453555203|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
126071639|NCT02269917|453555204|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
126071640|NCT02269917|453555205|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
126071641|NCT02269917|453555203|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
126071642|NCT02269917|453555204|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
126071643|NCT02269917|453555205|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
126071644|NCT02269917|453555203|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
126071645|NCT02269917|453555204|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
126071646|NCT02269917|453555205|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
126071647|NCT02269917|453555203|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
126071648|NCT02269917|453555204|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
126071649|NCT02269917|453555205|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
126071650|NCT02865135|453555209|FG000|Overall Study|Death|0|||
126071651|NCT02865135|453555210|FG001|Overall Study|Death|1|||
126071652|NCT02865135|453555211|FG002|Overall Study|Death|0|||
126071653|NCT02865135|453555209|FG000|Overall Study|Progression|6|||
126071654|NCT02865135|453555210|FG001|Overall Study|Progression|2|||
126071655|NCT02865135|453555211|FG002|Overall Study|Progression|2|||
126071656|NCT01121185|453555215|FG000|Overall Study|Not infused|0|||
126071657|NCT01121185|453555216|FG001|Overall Study|Not infused|1|||
126071658|NCT01121185|453555215|FG000|Overall Study|Not transplanted|1|||
126071659|NCT01121185|453555216|FG001|Overall Study|Not transplanted|0|||
126071660|NCT01196741|453555219|FG000|Overall Study|Disease progression|34|||
126071661|NCT01196741|453555220|FG001|Overall Study|Disease progression|14|||
126071662|NCT01196741|453555219|FG000|Overall Study|Adverse Event|10|||
126071663|NCT01196741|453555220|FG001|Overall Study|Adverse Event|6|||
126071664|NCT01196741|453555219|FG000|Overall Study|Serious Adverse Event|3|||
126071665|NCT01196741|453555220|FG001|Overall Study|Serious Adverse Event|1|||
126071666|NCT01196741|453555219|FG000|Overall Study|Dose limiting Adverse Event|2|||
126071667|NCT01196741|453555220|FG001|Overall Study|Dose limiting Adverse Event|1|||
126071668|NCT01196741|453555219|FG000|Overall Study|Withdrawal by Subject|3|||
126071669|NCT01196741|453555220|FG001|Overall Study|Withdrawal by Subject|0|||
126071670|NCT01196741|453555219|FG000|Overall Study|Other reason|3|||
126071671|NCT01196741|453555220|FG001|Overall Study|Other reason|3|||
126071672|NCT01196741|453555219|FG000|Overall Study|Other|3|||
126071673|NCT01196741|453555220|FG001|Overall Study|Other|2|||
125945805|NCT04007523|453099857|FG003|Overall Study|ICU Transfer|0|||
126114516|NCT01428661|453713861|FG001|Double-Masked Phase|Protocol Violation|4|||
126114517|NCT01428661|453713862|FG002|Double-Masked Phase|Protocol Violation|0|||
126114518|NCT01428661|453713860|FG000|Double-Masked Phase|Adverse Event|13|||
126114519|NCT01428661|453713861|FG001|Double-Masked Phase|Adverse Event|4|||
126114520|NCT01428661|453713862|FG002|Double-Masked Phase|Adverse Event|0|||
126114521|NCT01428661|453713860|FG000|Double-Masked Phase|Lost to Follow-up|14|||
126114522|NCT01428661|453713861|FG001|Double-Masked Phase|Lost to Follow-up|14|||
126114523|NCT01428661|453713862|FG002|Double-Masked Phase|Lost to Follow-up|0|||
126114524|NCT01428661|453713860|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
126114525|NCT01428661|453713861|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
126114526|NCT01428661|453713862|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
126114527|NCT01428661|453713860|FG000|Double-Masked Phase|Lack of Efficacy|2|||
126114528|NCT01428661|453713861|FG001|Double-Masked Phase|Lack of Efficacy|1|||
126114529|NCT01428661|453713862|FG002|Double-Masked Phase|Lack of Efficacy|0|||
126114530|NCT01428661|453713860|FG000|Double-Masked Phase|*Various|1|||
126114531|NCT01428661|453713861|FG001|Double-Masked Phase|*Various|6|||
126071674|NCT01196741|453555219|FG000|Overall Study|Protocol Violation|2|||
126071675|NCT01196741|453555220|FG001|Overall Study|Protocol Violation|1|||
126071676|NCT02273180|453555221|FG000|Overall Study|Adverse Event|2|||
126071677|NCT02273180|453555222|FG001|Overall Study|Adverse Event|2|||
126071678|NCT02273180|453555221|FG000|Overall Study|Lack of Efficacy|1|||
126071679|NCT02273180|453555222|FG001|Overall Study|Lack of Efficacy|0|||
126071680|NCT02273180|453555221|FG000|Overall Study|Protocol Violation|1|||
126071681|NCT02273180|453555222|FG001|Overall Study|Protocol Violation|7|||
126071682|NCT02273180|453555221|FG000|Overall Study|Randomized but not treated|1|||
126071683|NCT02273180|453555222|FG001|Overall Study|Randomized but not treated|0|||
126071684|NCT02273180|453555221|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
126071685|NCT02273180|453555222|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
126071686|NCT02273180|453555221|FG000|Overall Study|Other than specified above|21|||
126071687|NCT02273180|453555222|FG001|Overall Study|Other than specified above|10|||
126071688|NCT00509925|453555223|FG000|Overall Study|Personal reasons|0|||
126071689|NCT00509925|453555224|FG001|Overall Study|Personal reasons|1|||
126071690|NCT03302559|453555227|FG000|Overall Study|Adverse Event|2|||
126071691|NCT03302559|453555227|FG000|Overall Study|Lost to Follow-up|1|||
126071692|NCT03302559|453555227|FG000|Overall Study|Withdrew Consent|3|||
126071693|NCT02972242|453557356|FG000|Overall Study|Withdrawal by Subject|1|||
126071694|NCT02972242|453557357|FG001|Overall Study|Withdrawal by Subject|0|||
126071695|NCT04572997|453557358|FG000|Overall Study|Adverse Event|1|||
126071696|NCT02956278|453557359|FG000|Overall Study|Withdrawal by Subject|6|||
126071697|NCT02956278|453557360|FG001|Overall Study|Withdrawal by Subject|2|||
126071698|NCT02956278|453557361|FG002|Overall Study|Withdrawal by Subject|0|||
126071699|NCT00740597|453557370|FG000|Overall Study|insurance would not cover treatment|1|||
126071700|NCT00552513|453557374|FG000|Overall Study|Lost to Follow-up|5|||
126071701|NCT00552513|453557375|FG001|Overall Study|Lost to Follow-up|1|||
126071702|NCT02720185|453557376|FG000|Overall Study|Lost to Follow-up|1|||
126071703|NCT01157351|453557377|FG000|Overall Study|Adverse Event|5|||
126071704|NCT01157351|453557378|FG001|Overall Study|Adverse Event|4|||
126071705|NCT01157351|453557377|FG000|Overall Study|Death|1|||
126071706|NCT01157351|453557378|FG001|Overall Study|Death|0|||
126071707|NCT01157351|453557377|FG000|Overall Study|Lost to Follow-up|53|||
126071708|NCT01157351|453557378|FG001|Overall Study|Lost to Follow-up|55|||
126071709|NCT01157351|453557377|FG000|Overall Study|Withdrawal by Subject|37|||
126071710|NCT01157351|453557378|FG001|Overall Study|Withdrawal by Subject|27|||
126071711|NCT01157351|453557377|FG000|Overall Study|Physician Decision|5|||
126071712|NCT01157351|453557378|FG001|Overall Study|Physician Decision|4|||
126071713|NCT01157351|453557377|FG000|Overall Study|Protocol Violation|0|||
126071714|NCT01157351|453557378|FG001|Overall Study|Protocol Violation|1|||
126114532|NCT01428661|453713862|FG002|Double-Masked Phase|*Various|0|||
126114533|NCT01428661|453713860|FG000|Open Label Extension|Protocol Violation|0|||
126114534|NCT01428661|453713861|FG001|Open Label Extension|Protocol Violation|0|||
126114535|NCT01428661|453713862|FG002|Open Label Extension|Protocol Violation|9|||
126114536|NCT01428661|453713860|FG000|Open Label Extension|Adverse Event|0|||
126114537|NCT01428661|453713861|FG001|Open Label Extension|Adverse Event|0|||
126071715|NCT01157351|453557377|FG000|Overall Study|Other|32|||
126071716|NCT01157351|453557378|FG001|Overall Study|Other|36|||
126071717|NCT01157351|453557377|FG000|Overall Study|Noncompliance with Study Drug|0|||
126071718|NCT01157351|453557378|FG001|Overall Study|Noncompliance with Study Drug|3|||
126071719|NCT01157351|453557377|FG000|Overall Study|Randomized but not Treated|4|||
126071720|NCT01157351|453557378|FG001|Overall Study|Randomized but not Treated|2|||
126071721|NCT03418493|453557379|FG000|Overall Study|Adverse Event|1|||
126114538|NCT01428661|453713862|FG002|Open Label Extension|Adverse Event|15|||
126071722|NCT03418493|453557380|FG001|Overall Study|Adverse Event|0|||
126071723|NCT03418493|453557381|FG002|Overall Study|Adverse Event|0|||
126071724|NCT03418493|453557382|FG003|Overall Study|Adverse Event|0|||
126071725|NCT03418493|453557383|FG004|Overall Study|Adverse Event|0|||
126071726|NCT03418493|453557384|FG005|Overall Study|Adverse Event|0|||
126114539|NCT01428661|453713860|FG000|Open Label Extension|Lost to Follow-up|0|||
126114540|NCT01428661|453713861|FG001|Open Label Extension|Lost to Follow-up|0|||
126071727|NCT03418493|453557385|FG006|Overall Study|Adverse Event|0|||
126071728|NCT03418493|453557386|FG007|Overall Study|Adverse Event|0|||
126071729|NCT03418493|453557387|FG008|Overall Study|Adverse Event|0|||
126071730|NCT03418493|453557388|FG009|Overall Study|Adverse Event|0|||
126071731|NCT03418493|453557389|FG010|Overall Study|Adverse Event|0|||
126071732|NCT03418493|453557379|FG000|Overall Study|Protocol Violation|0|||
126071733|NCT03418493|453557380|FG001|Overall Study|Protocol Violation|0|||
126071734|NCT03418493|453557381|FG002|Overall Study|Protocol Violation|0|||
126071735|NCT03418493|453557382|FG003|Overall Study|Protocol Violation|0|||
126071736|NCT03418493|453557383|FG004|Overall Study|Protocol Violation|0|||
126071737|NCT03418493|453557384|FG005|Overall Study|Protocol Violation|0|||
126071738|NCT03418493|453557385|FG006|Overall Study|Protocol Violation|0|||
126071739|NCT03418493|453557386|FG007|Overall Study|Protocol Violation|0|||
126071740|NCT03418493|453557387|FG008|Overall Study|Protocol Violation|0|||
126071741|NCT03418493|453557388|FG009|Overall Study|Protocol Violation|1|||
126071742|NCT03418493|453557389|FG010|Overall Study|Protocol Violation|0|||
126071743|NCT05446714|453557390|FG000|Overall Study|Lost to Follow-up|1|||
126071744|NCT05446714|453557391|FG001|Overall Study|Lost to Follow-up|3|||
126071745|NCT05446714|453557392|FG002|Overall Study|Lost to Follow-up|2|||
126071746|NCT05446714|453557390|FG000|Overall Study|Protocol Violation|2|||
126071747|NCT05446714|453557391|FG001|Overall Study|Protocol Violation|0|||
126071748|NCT05446714|453557392|FG002|Overall Study|Protocol Violation|0|||
126071749|NCT00197106|453557395|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
126071750|NCT00197106|453557396|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
126071751|NCT00197106|453557397|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
126071752|NCT00197106|453557395|FG000|Overall Treatment Period|Lack of Efficacy|0|||
126071753|NCT00197106|453557396|FG001|Overall Treatment Period|Lack of Efficacy|1|||
126071754|NCT00197106|453557397|FG002|Overall Treatment Period|Lack of Efficacy|0|||
126071755|NCT00197106|453557395|FG000|Overall Treatment Period|Lost to Follow-up|0|||
126071756|NCT00197106|453557396|FG001|Overall Treatment Period|Lost to Follow-up|0|||
126071757|NCT00197106|453557397|FG002|Overall Treatment Period|Lost to Follow-up|2|||
126071758|NCT00197106|453557395|FG000|Overall Treatment Period|Protocol Violation|0|||
126071759|NCT00197106|453557396|FG001|Overall Treatment Period|Protocol Violation|0|||
126071760|NCT00197106|453557397|FG002|Overall Treatment Period|Protocol Violation|2|||
126071761|NCT00197106|453557395|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
126071762|NCT00197106|453557396|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
126071763|NCT00197106|453557397|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
126071764|NCT00329550|453557400|FG000|Overall Study|Adverse Event|3|||
126071765|NCT00329550|453557401|FG001|Overall Study|Adverse Event|4|||
126071766|NCT00329550|453557402|FG002|Overall Study|Adverse Event|2|||
126071767|NCT00329550|453557400|FG000|Overall Study|Withdrawal of Consent|1|||
126071768|NCT00329550|453557401|FG001|Overall Study|Withdrawal of Consent|0|||
126071769|NCT00329550|453557402|FG002|Overall Study|Withdrawal of Consent|1|||
126071770|NCT00329550|453557400|FG000|Overall Study|Due to Relocation|0|||
126071771|NCT00329550|453557401|FG001|Overall Study|Due to Relocation|0|||
126071772|NCT00329550|453557402|FG002|Overall Study|Due to Relocation|1|||
126071773|NCT02679079|453557403|FG000|Overall Study|Adverse Event|2|||
126071774|NCT02679079|453557404|FG001|Overall Study|Adverse Event|0|||
126071775|NCT02679079|453557405|FG002|Overall Study|Adverse Event|2|||
126071776|NCT02679079|453557403|FG000|Overall Study|Protocol Violation|0|||
126071777|NCT02679079|453557404|FG001|Overall Study|Protocol Violation|1|||
126071778|NCT02679079|453557405|FG002|Overall Study|Protocol Violation|0|||
126071779|NCT02679079|453557403|FG000|Overall Study|Withdrawal by Subject|2|||
126071780|NCT02679079|453557404|FG001|Overall Study|Withdrawal by Subject|1|||
126071781|NCT02679079|453557405|FG002|Overall Study|Withdrawal by Subject|0|||
126071782|NCT04150341|453557406|FG000|Overall Study|Physician Decision|0|||
126071783|NCT04150341|453557407|FG001|Overall Study|Physician Decision|0|||
126071784|NCT04150341|453557408|FG002|Overall Study|Physician Decision|1|||
126071785|NCT04150341|453557409|FG003|Overall Study|Physician Decision|0|||
126071786|NCT04150341|453557410|FG004|Overall Study|Physician Decision|0|||
126071787|NCT04150341|453557411|FG005|Overall Study|Physician Decision|0|||
126071788|NCT04150341|453557406|FG000|Overall Study|Adverse Event|0|||
126071789|NCT04150341|453557407|FG001|Overall Study|Adverse Event|0|||
126071790|NCT04150341|453557408|FG002|Overall Study|Adverse Event|0|||
126071791|NCT04150341|453557409|FG003|Overall Study|Adverse Event|0|||
126071792|NCT04150341|453557410|FG004|Overall Study|Adverse Event|1|||
126071793|NCT04150341|453557411|FG005|Overall Study|Adverse Event|0|||
126071794|NCT00833898|453557418|FG000|Overall Study|Withdrawal by Subject|33|||
126071795|NCT00833898|453557419|FG001|Overall Study|Withdrawal by Subject|27|||
126071796|NCT00833898|453557418|FG000|Overall Study|Lost to Follow-up|7|||
126071797|NCT00833898|453557419|FG001|Overall Study|Lost to Follow-up|7|||
126071798|NCT00833898|453557418|FG000|Overall Study|Patient did not receive transplant|0|||
126071799|NCT00833898|453557419|FG001|Overall Study|Patient did not receive transplant|2|||
126071800|NCT00805285|453557420|FG000|Overall Study|Lack of Efficacy|1|||
126071801|NCT00917462|453557421|FG000|Overall Study|Clinical Deterioration|1|||
126071802|NCT01402063|453557422|FG000|Overall Study|Withdrawal by Subject|3|||
126071803|NCT01402063|453557423|FG001|Overall Study|Withdrawal by Subject|3|||
126071804|NCT02110225|453557427|FG000|Overall Study|Lost to Follow-up|0|||
126114541|NCT01428661|453713862|FG002|Open Label Extension|Lost to Follow-up|38|||
126114542|NCT01428661|453713860|FG000|Open Label Extension|Withdrawal by Subject|0|||
126114543|NCT01428661|453713861|FG001|Open Label Extension|Withdrawal by Subject|0|||
126114544|NCT01428661|453713862|FG002|Open Label Extension|Withdrawal by Subject|49|||
126114545|NCT01428661|453713860|FG000|Open Label Extension|Lack of Efficacy|0|||
126114546|NCT01428661|453713861|FG001|Open Label Extension|Lack of Efficacy|0|||
126114547|NCT01428661|453713862|FG002|Open Label Extension|Lack of Efficacy|24|||
126114548|NCT01428661|453713860|FG000|Open Label Extension|**Various|0|||
126114549|NCT01428661|453713861|FG001|Open Label Extension|**Various|0|||
126114550|NCT01428661|453713862|FG002|Open Label Extension|**Various|185|||
126114551|NCT00972777|453713863|FG000|Overall Study|Adverse Event|3|||
126114552|NCT00972777|453713864|FG001|Overall Study|Adverse Event|2|||
126114553|NCT00972777|453713863|FG000|Overall Study|Lost to Follow-up|0|||
126114554|NCT00972777|453713864|FG001|Overall Study|Lost to Follow-up|4|||
126114555|NCT00972777|453713863|FG000|Overall Study|Withdrawal by Subject|4|||
126114556|NCT00972777|453713864|FG001|Overall Study|Withdrawal by Subject|5|||
126114557|NCT00972777|453713863|FG000|Overall Study|Physician Decision|4|||
126114558|NCT00972777|453713864|FG001|Overall Study|Physician Decision|0|||
126114559|NCT00972777|453713863|FG000|Overall Study|Protocol Violation|0|||
126114560|NCT00972777|453713864|FG001|Overall Study|Protocol Violation|2|||
126114561|NCT00972777|453713863|FG000|Overall Study|Screening Failure|2|||
126114562|NCT00972777|453713864|FG001|Overall Study|Screening Failure|1|||
126114563|NCT00972777|453713863|FG000|Overall Study|Missed visit|1|||
126114564|NCT00972777|453713864|FG001|Overall Study|Missed visit|0|||
126114565|NCT00729378|453715680|FG000|Baseline|Did not complete study measurements|72|||
126114566|NCT00729378|453715681|FG001|Baseline|Did not complete study measurements|33|||
126114567|NCT00729378|453715680|FG000|Baseline|Withdrawal by Subject|66|||
126114568|NCT00729378|453715681|FG001|Baseline|Withdrawal by Subject|59|||
126114569|NCT00729378|453715680|FG000|12-months|Lost to Follow-up|100|||
126114570|NCT00729378|453715681|FG001|12-months|Lost to Follow-up|65|||
126114571|NCT00729378|453715680|FG000|24-months|Lost to Follow-up|72|||
126114572|NCT00729378|453715681|FG001|24-months|Lost to Follow-up|51|||
126114573|NCT00729378|453715680|FG000|36-months|Lost to Follow-up|15|||
126114574|NCT00729378|453715681|FG001|36-months|Lost to Follow-up|6|||
126114575|NCT02246582|453715684|FG000|Overall Study|Withdrawal by Subject|3|||
126114576|NCT02246582|453715685|FG001|Overall Study|Withdrawal by Subject|4|||
126114577|NCT03441334|453715687|FG000|Overall Study|Withdrawal by Subject|1|||
126114578|NCT03441334|453715688|FG001|Overall Study|Withdrawal by Subject|0|||
126114579|NCT00395863|453715689|FG000|Overall Study|Patients did not complete both exams|2|||
126114580|NCT00395863|453715690|FG001|Overall Study|Patients did not complete both exams|3|||
126114581|NCT02592551|453715693|FG000|Overall Study|Not evaluable|1|||
126114582|NCT02592551|453715694|FG001|Overall Study|Not evaluable|3|||
126114583|NCT02592551|453715695|FG002|Overall Study|Not evaluable|0|||
126114584|NCT01876251|453715696|FG000|Overall Study|Clinical progression|1|||
125945806|NCT04007523|453099854|FG000|Overall Study|COVID hospital closure|0|||
125945807|NCT04007523|453099855|FG001|Overall Study|COVID hospital closure|0|||
125945808|NCT04007523|453099856|FG002|Overall Study|COVID hospital closure|1|||
125945809|NCT04007523|453099857|FG003|Overall Study|COVID hospital closure|2|||
125945810|NCT04007523|453099854|FG000|Overall Study|Surgery cancelled|0|||
125945811|NCT04007523|453099855|FG001|Overall Study|Surgery cancelled|0|||
125945812|NCT04007523|453099856|FG002|Overall Study|Surgery cancelled|1|||
125945813|NCT04007523|453099857|FG003|Overall Study|Surgery cancelled|1|||
125945814|NCT02197806|453099858|FG000|Overall Study|Adverse Event|0|||
125945815|NCT02197806|453099859|FG001|Overall Study|Adverse Event|1|||
125945816|NCT02197806|453099860|FG002|Overall Study|Adverse Event|0|||
125945817|NCT02197806|453099861|FG003|Overall Study|Adverse Event|1|||
125945818|NCT01894152|453099862|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
125945819|NCT01708174|453099863|FG000|Treatment Period|Withdrawal by Subject|1|||
125945820|NCT01708174|453099864|FG001|Treatment Period|Withdrawal by Subject|0|||
125945821|NCT01708174|453099865|FG002|Treatment Period|Withdrawal by Subject|0|||
125945822|NCT01708174|453099863|FG000|Treatment Period|Progressive disease|0|||
125945823|NCT01708174|453099864|FG001|Treatment Period|Progressive disease|1|||
126114585|NCT01876251|453715697|FG001|Overall Study|Clinical progression|0|||
126114586|NCT01876251|453715698|FG002|Overall Study|Clinical progression|0|||
126114587|NCT01876251|453715696|FG000|Overall Study|Death|2|||
125945824|NCT01708174|453099865|FG002|Treatment Period|Progressive disease|0|||
125945825|NCT01708174|453099863|FG000|Treatment Period|Death|0|||
125945826|NCT01708174|453099864|FG001|Treatment Period|Death|0|||
125945827|NCT01708174|453099865|FG002|Treatment Period|Death|1|||
125945828|NCT01708174|453099863|FG000|Treatment Period|Adverse Event|0|||
125945829|NCT01708174|453099864|FG001|Treatment Period|Adverse Event|1|||
126114588|NCT01876251|453715697|FG001|Overall Study|Death|0|||
126114589|NCT01876251|453715698|FG002|Overall Study|Death|1|||
126114590|NCT01876251|453715696|FG000|Overall Study|Participant started new treatment|1|||
126114591|NCT01876251|453715697|FG001|Overall Study|Participant started new treatment|0|||
126114592|NCT01876251|453715698|FG002|Overall Study|Participant started new treatment|1|||
126114593|NCT01876251|453715696|FG000|Overall Study|Participant refused further follow-up|0|||
125945830|NCT01708174|453099865|FG002|Treatment Period|Adverse Event|0|||
125945831|NCT01774786|453099866|FG000|Overall Study|Death|300|||
125945832|NCT01774786|453099867|FG001|Overall Study|Death|319|||
125945833|NCT01774786|453099866|FG000|Overall Study|Lost to Follow-up|6|||
125945834|NCT01774786|453099867|FG001|Overall Study|Lost to Follow-up|7|||
125945835|NCT01774786|453099866|FG000|Overall Study|Withdrawal by Subject|18|||
125945836|NCT01774786|453099867|FG001|Overall Study|Withdrawal by Subject|14|||
125945837|NCT01774786|453099866|FG000|Overall Study|Physician Decision|2|||
125945838|NCT01774786|453099867|FG001|Overall Study|Physician Decision|0|||
125945839|NCT01774786|453099866|FG000|Overall Study|Non-compliance|0|||
125945840|NCT01774786|453099867|FG001|Overall Study|Non-compliance|1|||
125945841|NCT01774786|453099866|FG000|Overall Study|Reason Not Specified|2|||
125945842|NCT01774786|453099867|FG001|Overall Study|Reason Not Specified|5|||
125945843|NCT02385084|453099868|FG000|Period 2|Protocol Violation|0|||
125945844|NCT02385084|453099869|FG001|Period 2|Protocol Violation|0|||
126071805|NCT02110225|453557428|FG001|Overall Study|Lost to Follow-up|1|||
126071806|NCT02110225|453557429|FG002|Overall Study|Lost to Follow-up|0|||
126071807|NCT02176018|453557430|FG000|Overall Study|Adverse Event|0|||
126071808|NCT02176018|453557431|FG001|Overall Study|Adverse Event|2|||
126071809|NCT02176018|453557430|FG000|Overall Study|Lost to Follow-up|3|||
126071810|NCT02176018|453557431|FG001|Overall Study|Lost to Follow-up|1|||
126071811|NCT02176018|453557430|FG000|Overall Study|Protocol Violation|1|||
126071812|NCT02176018|453557431|FG001|Overall Study|Protocol Violation|1|||
126071813|NCT02176018|453557430|FG000|Overall Study|Withdrawal by Subject|1|||
126071814|NCT02176018|453557431|FG001|Overall Study|Withdrawal by Subject|2|||
126071815|NCT03022045|453557432|FG000|Overall Study|Adverse Event|0|||
126071816|NCT03022045|453557433|FG001|Overall Study|Adverse Event|1|||
126071817|NCT03022045|453557432|FG000|Overall Study|Withdrawal by Subject|1|||
126071818|NCT03022045|453557433|FG001|Overall Study|Withdrawal by Subject|1|||
126071819|NCT03972137|453557440|FG000|Overall Study|Lost to Follow-up|2|||
126071820|NCT03972137|453557440|FG000|Overall Study|Withdrawal by Subject|4|||
126071821|NCT00899379|453557441|FG000|Overall Study|Adverse Event|2|||
126071822|NCT00899379|453557442|FG001|Overall Study|Adverse Event|2|||
126071823|NCT00899379|453557443|FG002|Overall Study|Adverse Event|1|||
126071824|NCT00899379|453557444|FG003|Overall Study|Adverse Event|1|||
126071825|NCT00899379|453557445|FG004|Overall Study|Adverse Event|2|||
126071826|NCT00899379|453557441|FG000|Overall Study|Lack of Efficacy|0|||
126071827|NCT00899379|453557442|FG001|Overall Study|Lack of Efficacy|4|||
126071828|NCT00899379|453557443|FG002|Overall Study|Lack of Efficacy|3|||
126071829|NCT00899379|453557444|FG003|Overall Study|Lack of Efficacy|0|||
126071830|NCT00899379|453557445|FG004|Overall Study|Lack of Efficacy|1|||
126071831|NCT00899379|453557441|FG000|Overall Study|Lost to Follow-up|9|||
126071832|NCT00899379|453557442|FG001|Overall Study|Lost to Follow-up|3|||
126071833|NCT00899379|453557443|FG002|Overall Study|Lost to Follow-up|0|||
126071834|NCT00899379|453557444|FG003|Overall Study|Lost to Follow-up|6|||
126071835|NCT00899379|453557445|FG004|Overall Study|Lost to Follow-up|2|||
126071836|NCT00899379|453557441|FG000|Overall Study|Protocol Violation|0|||
126071837|NCT00899379|453557442|FG001|Overall Study|Protocol Violation|0|||
126071838|NCT00899379|453557443|FG002|Overall Study|Protocol Violation|1|||
126071839|NCT00899379|453557444|FG003|Overall Study|Protocol Violation|1|||
126071840|NCT00899379|453557445|FG004|Overall Study|Protocol Violation|0|||
126071841|NCT00899379|453557441|FG000|Overall Study|Withdrawal by Subject|2|||
126071842|NCT00899379|453557442|FG001|Overall Study|Withdrawal by Subject|4|||
126071843|NCT00899379|453557443|FG002|Overall Study|Withdrawal by Subject|2|||
126071844|NCT00899379|453557444|FG003|Overall Study|Withdrawal by Subject|3|||
126071845|NCT00899379|453557445|FG004|Overall Study|Withdrawal by Subject|6|||
126071846|NCT00899379|453557441|FG000|Overall Study|Pregnancy|0|||
126071847|NCT00899379|453557442|FG001|Overall Study|Pregnancy|0|||
126071848|NCT00899379|453557443|FG002|Overall Study|Pregnancy|1|||
126071849|NCT00899379|453557444|FG003|Overall Study|Pregnancy|0|||
126071850|NCT00899379|453557445|FG004|Overall Study|Pregnancy|1|||
126071851|NCT00899379|453557441|FG000|Overall Study|Patient Uncooperative|0|||
126071852|NCT00899379|453557442|FG001|Overall Study|Patient Uncooperative|1|||
126071853|NCT00899379|453557443|FG002|Overall Study|Patient Uncooperative|0|||
126071854|NCT00899379|453557444|FG003|Overall Study|Patient Uncooperative|1|||
126071855|NCT00899379|453557445|FG004|Overall Study|Patient Uncooperative|2|||
126071856|NCT00899379|453557441|FG000|Overall Study|Abnormal Baseline ECG|0|||
126071857|NCT00899379|453557442|FG001|Overall Study|Abnormal Baseline ECG|0|||
126071858|NCT00899379|453557443|FG002|Overall Study|Abnormal Baseline ECG|0|||
125945845|NCT02385084|453099870|FG002|Period 2|Protocol Violation|1|||
125945846|NCT02385084|453099871|FG003|Period 2|Protocol Violation|0|||
125945847|NCT02385084|453099872|FG004|Period 2|Protocol Violation|0|||
125945848|NCT02385084|453099873|FG005|Period 2|Protocol Violation|0|||
126071859|NCT00899379|453557444|FG003|Overall Study|Abnormal Baseline ECG|1|||
126071860|NCT00899379|453557445|FG004|Overall Study|Abnormal Baseline ECG|0|||
126071861|NCT00899379|453557441|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126071862|NCT00899379|453557442|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126071863|NCT00899379|453557443|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126071864|NCT00899379|453557444|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126114594|NCT01876251|453715697|FG001|Overall Study|Participant refused further follow-up|0|||
125945849|NCT02965703|453099879|FG000|Overall Study|Withdrawal by Subject|6|||
125945850|NCT02965703|453099880|FG001|Overall Study|Withdrawal by Subject|3|||
125945851|NCT02965703|453099881|FG002|Overall Study|Withdrawal by Subject|1|||
125945852|NCT02965703|453099879|FG000|Overall Study|Protocol Violation|1|||
125945853|NCT02965703|453099880|FG001|Overall Study|Protocol Violation|0|||
125945854|NCT02965703|453099881|FG002|Overall Study|Protocol Violation|0|||
125945855|NCT02965703|453099879|FG000|Overall Study|Adverse Event|1|||
125945856|NCT02965703|453099880|FG001|Overall Study|Adverse Event|1|||
125945857|NCT02965703|453099881|FG002|Overall Study|Adverse Event|0|||
125945858|NCT02965703|453099879|FG000|Overall Study|Lost to Follow-up|2|||
125945859|NCT02965703|453099880|FG001|Overall Study|Lost to Follow-up|1|||
125945860|NCT02965703|453099881|FG002|Overall Study|Lost to Follow-up|1|||
125945861|NCT00768144|453099882|FG000|Overall Study|Adverse Event|13|||
125945862|NCT00768144|453099882|FG000|Overall Study|Progressive Disease|21|||
125945863|NCT00768144|453099882|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
125945864|NCT00768144|453099882|FG000|Overall Study|Pt Withdrew Consent|1|||
125945865|NCT04251221|453099883|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
125945866|NCT04251221|453099884|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
125945867|NCT01319877|453099887|FG000|Overall Study|Lost to Follow-up|100|||
125945868|NCT01319877|453099888|FG001|Overall Study|Lost to Follow-up|37|||
125945869|NCT01319877|453099887|FG000|Overall Study|Physician Decision|2|||
125945870|NCT01319877|453099888|FG001|Overall Study|Physician Decision|0|||
125945871|NCT01319877|453099887|FG000|Overall Study|Disease Progression|2|||
125945872|NCT01319877|453099888|FG001|Overall Study|Disease Progression|2|||
125945873|NCT01319877|453099887|FG000|Overall Study|Withdrawal by Subject|0|||
125945874|NCT01319877|453099888|FG001|Overall Study|Withdrawal by Subject|1|||
125945875|NCT01319877|453099887|FG000|Overall Study|Reason Not Specified|4|||
125945876|NCT01319877|453099888|FG001|Overall Study|Reason Not Specified|5|||
125945877|NCT01342510|453099891|FG000|Overall Study|Protocol Violation|12|||
125945878|NCT01342510|453099892|FG001|Overall Study|Protocol Violation|6|||
125945879|NCT01342510|453099893|FG002|Overall Study|Protocol Violation|13|||
125945880|NCT01342510|453099894|FG003|Overall Study|Protocol Violation|11|||
125945881|NCT01400516|453099896|FG000|Primary Trial|Withdrawal by Subject|0|||
125945882|NCT01400516|453099897|FG001|Primary Trial|Withdrawal by Subject|2|||
125945883|NCT03026257|453101379|FG000|Overall Study|Adverse Event|3|||
125945884|NCT03026257|453101380|FG001|Overall Study|Adverse Event|0|||
125945885|NCT03026257|453101381|FG002|Overall Study|Adverse Event|0|||
125945886|NCT03026257|453101382|FG003|Overall Study|Adverse Event|0|||
125945887|NCT03026257|453101383|FG004|Overall Study|Adverse Event|0|||
125945888|NCT03026257|453101384|FG005|Overall Study|Adverse Event|0|||
125945889|NCT03026257|453101379|FG000|Overall Study|Lost to Follow-up|1|||
125945890|NCT03026257|453101380|FG001|Overall Study|Lost to Follow-up|0|||
125945891|NCT03026257|453101381|FG002|Overall Study|Lost to Follow-up|0|||
125945892|NCT03026257|453101382|FG003|Overall Study|Lost to Follow-up|0|||
125945893|NCT03026257|453101383|FG004|Overall Study|Lost to Follow-up|0|||
125945894|NCT03026257|453101384|FG005|Overall Study|Lost to Follow-up|0|||
125945895|NCT03026257|453101379|FG000|Overall Study|Protocol Violation|1|||
125945896|NCT03026257|453101380|FG001|Overall Study|Protocol Violation|0|||
125945897|NCT03026257|453101381|FG002|Overall Study|Protocol Violation|0|||
125945898|NCT03026257|453101382|FG003|Overall Study|Protocol Violation|1|||
125945899|NCT03026257|453101383|FG004|Overall Study|Protocol Violation|1|||
125945900|NCT03026257|453101384|FG005|Overall Study|Protocol Violation|0|||
125945901|NCT03026257|453101379|FG000|Overall Study|Withdrawal by Subject|1|||
125945902|NCT03026257|453101380|FG001|Overall Study|Withdrawal by Subject|1|||
125945903|NCT03026257|453101381|FG002|Overall Study|Withdrawal by Subject|0|||
125945904|NCT03026257|453101382|FG003|Overall Study|Withdrawal by Subject|0|||
125945905|NCT03026257|453101383|FG004|Overall Study|Withdrawal by Subject|0|||
125945906|NCT03026257|453101384|FG005|Overall Study|Withdrawal by Subject|0|||
125945907|NCT04380857|453101385|FG000|Overall Study|Lost to Follow-up|3|||
125945908|NCT04380857|453101386|FG001|Overall Study|Lost to Follow-up|3|||
125945909|NCT02558790|453101387|FG000|Overall Study|Lost to Follow-up|2|||
125945910|NCT02558790|453101387|FG000|Overall Study|Physician Decision|1|||
125945911|NCT02558790|453101387|FG000|Overall Study|Withdrawal by Subject|1|||
125945912|NCT02558790|453101387|FG000|Overall Study|Screen Fail|3|||
125945913|NCT00838201|453101388|FG000|Overall Study|Investigator decision, or other reasons|2|||
125945914|NCT00838201|453101389|FG001|Overall Study|Investigator decision, or other reasons|3|||
125945915|NCT00838201|453101388|FG000|Overall Study|Noncompliance|0|||
125945916|NCT00838201|453101389|FG001|Overall Study|Noncompliance|1|||
125945917|NCT00838201|453101388|FG000|Overall Study|Administrative decision|1|||
125945918|NCT00838201|453101389|FG001|Overall Study|Administrative decision|2|||
125945919|NCT00838201|453101388|FG000|Overall Study|Disease progression|3|||
125945920|NCT00838201|453101389|FG001|Overall Study|Disease progression|3|||
125945921|NCT00838201|453101388|FG000|Overall Study|Consent withdrawn|16|||
125945922|NCT00838201|453101389|FG001|Overall Study|Consent withdrawn|19|||
125945923|NCT00838201|453101388|FG000|Overall Study|Lost to Follow-up|4|||
125945924|NCT00838201|453101389|FG001|Overall Study|Lost to Follow-up|3|||
125945925|NCT00838201|453101388|FG000|Overall Study|Adverse Event|5|||
125945926|NCT00838201|453101389|FG001|Overall Study|Adverse Event|9|||
125945927|NCT00838201|453101388|FG000|Overall Study|Death|11|||
125945928|NCT00838201|453101389|FG001|Overall Study|Death|13|||
125945929|NCT02053753|453101396|FG000|Overall Study|Withdrawal by Subject|2|||
125945930|NCT02053753|453101397|FG001|Overall Study|Withdrawal by Subject|4|||
125945931|NCT02053753|453101396|FG000|Overall Study|Decision by Sponsor|1|||
125945932|NCT02053753|453101397|FG001|Overall Study|Decision by Sponsor|1|||
125945933|NCT02053753|453101396|FG000|Overall Study|Lost to Follow-up|4|||
125945934|NCT02053753|453101397|FG001|Overall Study|Lost to Follow-up|3|||
125945935|NCT00634088|453101402|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
125945936|NCT00634088|453101403|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
125945937|NCT00634088|453101404|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
125945938|NCT00634088|453101405|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
125945939|NCT00634088|453101402|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
125945940|NCT00634088|453101403|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
125945941|NCT00634088|453101404|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
125945942|NCT00634088|453101405|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
125945943|NCT00634088|453101402|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
125945944|NCT00634088|453101403|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
125945945|NCT00634088|453101404|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
125945946|NCT00634088|453101405|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
125945947|NCT00634088|453101402|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
125945948|NCT00634088|453101403|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
125945949|NCT00634088|453101404|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
125945950|NCT00634088|453101405|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
125945951|NCT00634088|453101402|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
125945952|NCT00634088|453101403|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
125945953|NCT00634088|453101404|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
125945954|NCT00634088|453101405|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
125945955|NCT00634088|453101402|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
125945956|NCT00634088|453101403|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
125945957|NCT00634088|453101404|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
125945958|NCT00634088|453101405|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
125945959|NCT04327999|453101410|FG000|Overall Study|Protocol Violation|1|||
125945960|NCT03735667|453101413|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
125945961|NCT03735667|453101414|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
125945962|NCT03735667|453101415|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
125945963|NCT03735667|453101413|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
125945964|NCT03735667|453101414|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
125945965|NCT03735667|453101415|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
125945966|NCT03735667|453101413|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
125945967|NCT03735667|453101414|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
125945968|NCT03735667|453101415|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
125945969|NCT03735667|453101413|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
125945970|NCT03735667|453101414|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
125945971|NCT03735667|453101415|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
125945972|NCT03735667|453101413|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
125945973|NCT03735667|453101414|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
125945974|NCT03735667|453101415|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
125945975|NCT03735667|453101413|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
125945976|NCT03735667|453101414|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
125945977|NCT03735667|453101415|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
125945978|NCT03735667|453101413|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
125945979|NCT03735667|453101414|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
125945980|NCT03735667|453101415|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
125945981|NCT03735667|453101413|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
125945982|NCT03735667|453101414|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
125945983|NCT03735667|453101415|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
125945984|NCT03735667|453101413|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
125945985|NCT03735667|453101414|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
125945986|NCT03735667|453101415|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
125945987|NCT03735667|453101413|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
125945988|NCT03735667|453101414|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
125945989|NCT03735667|453101415|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
125945990|NCT03735667|453101413|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
125945991|NCT03735667|453101414|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
125945992|NCT03735667|453101415|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
125945993|NCT03735667|453101413|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
125945994|NCT03735667|453101414|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
125945995|NCT03735667|453101415|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
125945996|NCT00006478|453101416|FG000|Overall Study|Vaccine could not be produced|1|||
125945997|NCT00006478|453101416|FG000|Overall Study|Physician Decision|6|||
125945998|NCT01987427|453101419|FG000|Overall Study|Adverse Event|4|||
125945999|NCT01987427|453101420|FG001|Overall Study|Adverse Event|2|||
125946000|NCT01987427|453101421|FG002|Overall Study|Adverse Event|8|||
125946001|NCT01987427|453101419|FG000|Overall Study|Lost to Follow-up|6|||
125946002|NCT01987427|453101420|FG001|Overall Study|Lost to Follow-up|6|||
125946003|NCT01987427|453101421|FG002|Overall Study|Lost to Follow-up|9|||
125946004|NCT01987427|453101419|FG000|Overall Study|Withdrawal by Subject|2|||
125946005|NCT01987427|453101420|FG001|Overall Study|Withdrawal by Subject|1|||
125946006|NCT01987427|453101421|FG002|Overall Study|Withdrawal by Subject|3|||
125946007|NCT01987427|453101419|FG000|Overall Study|Lack of Efficacy|1|||
125946008|NCT01987427|453101420|FG001|Overall Study|Lack of Efficacy|0|||
125946009|NCT01987427|453101421|FG002|Overall Study|Lack of Efficacy|0|||
125946010|NCT01987427|453101419|FG000|Overall Study|Other|1|||
125946011|NCT01987427|453101420|FG001|Overall Study|Other|1|||
125946012|NCT01987427|453101421|FG002|Overall Study|Other|0|||
125946013|NCT01073865|453101422|FG000|Overall Study|Reasons other than below|19|||
125946014|NCT01073865|453101423|FG001|Overall Study|Reasons other than below|31|||
125946015|NCT01073865|453101422|FG000|Overall Study|Lost to Follow-up|1|||
125946016|NCT01073865|453101423|FG001|Overall Study|Lost to Follow-up|1|||
125946017|NCT01073865|453101422|FG000|Overall Study|Death|3|||
125946018|NCT01073865|453101423|FG001|Overall Study|Death|2|||
125946019|NCT01073865|453101422|FG000|Overall Study|Withdrawal by Subject|5|||
125946020|NCT01073865|453101423|FG001|Overall Study|Withdrawal by Subject|5|||
125946021|NCT00805766|453101424|FG000|Screening Period|Adverse Event|1|||
125946022|NCT00805766|453101424|FG000|Screening Period|Lack of Efficacy|2|||
125946023|NCT00805766|453101424|FG000|Screening Period|Pregnancy|1|||
125946024|NCT00805766|453101424|FG000|Screening Period|Responder|2|||
125946025|NCT00805766|453101424|FG000|Increased Dose Period|Adverse Event|4|||
125946026|NCT00805766|453101424|FG000|Increased Dose Period|Lack of Efficacy|7|||
125946027|NCT00805766|453101424|FG000|Increased Dose Period|Pregnancy|1|||
125946028|NCT00805766|453101424|FG000|Increased Dose Period|Withdrawal by Subject|1|||
125946029|NCT00600756|453101425|FG000|Analysis After 6 Months|Adverse Event|43|||
125946030|NCT00600756|453101426|FG001|Analysis After 6 Months|Adverse Event|33|||
125946031|NCT00600756|453101425|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
125946032|NCT00600756|453101426|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
125946033|NCT00600756|453101425|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
125946034|NCT00600756|453101426|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
125946035|NCT00600756|453101425|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
125946036|NCT00600756|453101426|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
125946037|NCT00600756|453101425|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
125946038|NCT00600756|453101426|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
125946039|NCT00600756|453101425|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
125946040|NCT00600756|453101426|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
125946041|NCT00600756|453101425|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
125946042|NCT00600756|453101426|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
125946043|NCT00600756|453101425|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
125946044|NCT00600756|453101426|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
125946045|NCT00600756|453101425|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
125946046|NCT00600756|453101426|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
125946047|NCT00600756|453101425|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
125946048|NCT00600756|453101426|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
125946049|NCT00600756|453101425|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
125946050|NCT00600756|453101426|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
125946051|NCT00600756|453101425|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
125946052|NCT00600756|453101426|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
125946053|NCT00600756|453101425|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
125946054|NCT00600756|453101426|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
125946055|NCT00600756|453101425|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
125946056|NCT00600756|453101426|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
125946057|NCT03065244|453101436|FG000|Overall Study|Lost to Follow-up|1|||
125946058|NCT03065244|453101437|FG001|Overall Study|Lost to Follow-up|1|||
126114595|NCT01876251|453715698|FG002|Overall Study|Participant refused further follow-up|1|||
125946059|NCT03065244|453101436|FG000|Overall Study|Diagnosed with a different disease|1|||
125946060|NCT03065244|453101437|FG001|Overall Study|Diagnosed with a different disease|1|||
125946061|NCT03065244|453101436|FG000|Overall Study|Protocol Violation|0|||
125946062|NCT03065244|453101437|FG001|Overall Study|Protocol Violation|1|||
125946063|NCT03065244|453101436|FG000|Overall Study|Withdrawal by Subject|1|||
125946064|NCT03065244|453101437|FG001|Overall Study|Withdrawal by Subject|1|||
125946065|NCT03717480|453101438|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
126114596|NCT01876251|453715696|FG000|Overall Study|Study terminated|1|||
125946066|NCT00744627|453101439|FG000|Overall Study|Adverse Event|6|||
125946067|NCT00744627|453101440|FG001|Overall Study|Adverse Event|9|||
125946068|NCT00744627|453101439|FG000|Overall Study|Lack of Efficacy|7|||
125946069|NCT00744627|453101440|FG001|Overall Study|Lack of Efficacy|3|||
125946070|NCT00744627|453101439|FG000|Overall Study|Noncompliance|0|||
125946071|NCT00744627|453101440|FG001|Overall Study|Noncompliance|1|||
125946072|NCT00744627|453101439|FG000|Overall Study|Protocol Deviations|0|||
125946073|NCT00744627|453101440|FG001|Overall Study|Protocol Deviations|2|||
125946074|NCT00744627|453101439|FG000|Overall Study|Voluntary Withdrawal|9|||
125946075|NCT00744627|453101440|FG001|Overall Study|Voluntary Withdrawal|6|||
125946076|NCT00744627|453101439|FG000|Overall Study|Lost to Follow-up|2|||
125946077|NCT00744627|453101440|FG001|Overall Study|Lost to Follow-up|1|||
125946078|NCT00744627|453101439|FG000|Overall Study|Other|1|||
125946079|NCT00744627|453101440|FG001|Overall Study|Other|0|||
125946080|NCT02268786|453101441|FG000|Overall Study|No Euploid Embryos available|42|||
125946081|NCT02268786|453101442|FG001|Overall Study|No Euploid Embryos available|0|||
125946082|NCT02268786|453101441|FG000|Overall Study|Withdrawal by Subject|7|||
125946083|NCT02268786|453101442|FG001|Overall Study|Withdrawal by Subject|14|||
125946084|NCT02268786|453101441|FG000|Overall Study|Thaw Failure|6|||
125946085|NCT02268786|453101442|FG001|Overall Study|Thaw Failure|4|||
125946086|NCT02268786|453101441|FG000|Overall Study|Protocol Violation|1|||
125946087|NCT02268786|453101442|FG001|Overall Study|Protocol Violation|0|||
126114597|NCT01876251|453715697|FG001|Overall Study|Study terminated|0|||
126114598|NCT01876251|453715698|FG002|Overall Study|Study terminated|0|||
126114599|NCT01876251|453715696|FG000|Overall Study|Objective progression or relapse|10|||
126114600|NCT01876251|453715697|FG001|Overall Study|Objective progression or relapse|3|||
126114601|NCT01876251|453715698|FG002|Overall Study|Objective progression or relapse|8|||
126114602|NCT00268437|453715699|FG000|Overall Study|Ineligible|1|||
126114603|NCT01628107|453715703|FG000|Overall Study|Withdrawal by Subject|17|||
126114604|NCT01628107|453715703|FG000|Overall Study|Lost to Follow-up|4|||
126114605|NCT01628107|453715703|FG000|Overall Study|Adverse Event|33|||
126114606|NCT01628107|453715703|FG000|Overall Study|Physician Decision|2|||
126114607|NCT01628107|453715703|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
126114608|NCT01628107|453715703|FG000|Overall Study|Non-compliant with Study Procedures|10|||
126114609|NCT01628107|453715703|FG000|Overall Study|Not Treated|8|||
126114610|NCT01628107|453715703|FG000|Overall Study|Sponsor Decision|11|||
126114611|NCT01628107|453715703|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
126114612|NCT01628107|453715703|FG000|Overall Study|Relocated|8|||
125946088|NCT02171260|453101443|FG000|Overall Study|Death|0|||
125946089|NCT02171260|453101444|FG001|Overall Study|Death|0|||
125946090|NCT02171260|453101445|FG002|Overall Study|Death|0|||
125946091|NCT02171260|453101446|FG003|Overall Study|Death|1|||
125946092|NCT02171260|453101443|FG000|Overall Study|Physician Decision|1|||
125946093|NCT02171260|453101444|FG001|Overall Study|Physician Decision|0|||
126071865|NCT00899379|453557445|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126071866|NCT00899379|453557441|FG000|Overall Study|Not Completed/Entered Extn|5|||
126071867|NCT00899379|453557442|FG001|Overall Study|Not Completed/Entered Extn|1|||
126071868|NCT00899379|453557443|FG002|Overall Study|Not Completed/Entered Extn|6|||
126071869|NCT00899379|453557444|FG003|Overall Study|Not Completed/Entered Extn|4|||
126071870|NCT00899379|453557445|FG004|Overall Study|Not Completed/Entered Extn|3|||
126071871|NCT00899379|453557441|FG000|Overall Study|Study Terminated|3|||
126071872|NCT00899379|453557442|FG001|Overall Study|Study Terminated|0|||
126071873|NCT00899379|453557443|FG002|Overall Study|Study Terminated|3|||
126071874|NCT00899379|453557444|FG003|Overall Study|Study Terminated|3|||
126071875|NCT00899379|453557445|FG004|Overall Study|Study Terminated|1|||
126071876|NCT00899379|453557441|FG000|Overall Study|Lost to Follow-up|3|||
126071877|NCT00899379|453557442|FG001|Overall Study|Lost to Follow-up|1|||
126071878|NCT00899379|453557443|FG002|Overall Study|Lost to Follow-up|0|||
126071879|NCT00899379|453557444|FG003|Overall Study|Lost to Follow-up|2|||
126071880|NCT00899379|453557445|FG004|Overall Study|Lost to Follow-up|5|||
126071881|NCT00899379|453557441|FG000|Overall Study|Withdrawal by Subject|4|||
126071882|NCT00899379|453557442|FG001|Overall Study|Withdrawal by Subject|7|||
126114613|NCT01628107|453715703|FG000|Overall Study|Kidney Transplant|9|||
126114614|NCT01628107|453715703|FG000|Overall Study|Use of Standard of Care|9|||
126114615|NCT01086410|453715704|FG000|Overall Study|Adverse Event|1|||
126114616|NCT01086410|453715705|FG001|Overall Study|Adverse Event|0|||
126114617|NCT01086410|453715706|FG002|Overall Study|Adverse Event|0|||
126114618|NCT01086410|453715707|FG003|Overall Study|Adverse Event|2|||
126114619|NCT01086410|453715704|FG000|Overall Study|Lack of Efficacy|1|||
126114620|NCT01086410|453715705|FG001|Overall Study|Lack of Efficacy|1|||
125946094|NCT02171260|453101445|FG002|Overall Study|Physician Decision|1|||
125946095|NCT02171260|453101446|FG003|Overall Study|Physician Decision|0|||
125946096|NCT02171260|453101443|FG000|Overall Study|Withdrawal by Subject|1|||
125946097|NCT02171260|453101444|FG001|Overall Study|Withdrawal by Subject|0|||
125946098|NCT02171260|453101445|FG002|Overall Study|Withdrawal by Subject|0|||
125946099|NCT02171260|453101446|FG003|Overall Study|Withdrawal by Subject|0|||
125946100|NCT02171260|453101443|FG000|Overall Study|Evidence of progressive disease|4|||
125946101|NCT02171260|453101444|FG001|Overall Study|Evidence of progressive disease|6|||
126071883|NCT00899379|453557443|FG002|Overall Study|Withdrawal by Subject|4|||
126071884|NCT00899379|453557444|FG003|Overall Study|Withdrawal by Subject|7|||
126071885|NCT00899379|453557445|FG004|Overall Study|Withdrawal by Subject|2|||
126071886|NCT00899379|453557441|FG000|Overall Study|Pregnancy|1|||
126071887|NCT00899379|453557442|FG001|Overall Study|Pregnancy|0|||
126071888|NCT00899379|453557443|FG002|Overall Study|Pregnancy|0|||
126071889|NCT00899379|453557444|FG003|Overall Study|Pregnancy|0|||
126071890|NCT00899379|453557445|FG004|Overall Study|Pregnancy|0|||
126071891|NCT00899379|453557441|FG000|Overall Study|Patient Uncooperative|0|||
126071892|NCT00899379|453557442|FG001|Overall Study|Patient Uncooperative|0|||
126071893|NCT00899379|453557443|FG002|Overall Study|Patient Uncooperative|0|||
126071894|NCT00899379|453557444|FG003|Overall Study|Patient Uncooperative|1|||
126071895|NCT00899379|453557445|FG004|Overall Study|Patient Uncooperative|0|||
126071896|NCT00899379|453557441|FG000|Overall Study|Abnormal Prestudy Labs|0|||
126071897|NCT00899379|453557442|FG001|Overall Study|Abnormal Prestudy Labs|0|||
126071898|NCT00899379|453557443|FG002|Overall Study|Abnormal Prestudy Labs|0|||
126071899|NCT00899379|453557444|FG003|Overall Study|Abnormal Prestudy Labs|0|||
126071900|NCT00899379|453557445|FG004|Overall Study|Abnormal Prestudy Labs|2|||
126071901|NCT00899379|453557441|FG000|Overall Study|Abnormal Baseline ECG|0|||
126071902|NCT00899379|453557442|FG001|Overall Study|Abnormal Baseline ECG|0|||
126071903|NCT00899379|453557443|FG002|Overall Study|Abnormal Baseline ECG|1|||
126071904|NCT00899379|453557444|FG003|Overall Study|Abnormal Baseline ECG|1|||
126071905|NCT00899379|453557445|FG004|Overall Study|Abnormal Baseline ECG|0|||
126071906|NCT00899379|453557441|FG000|Overall Study|No Attack Pretreatment|3|||
126071907|NCT00899379|453557442|FG001|Overall Study|No Attack Pretreatment|5|||
126071908|NCT00899379|453557443|FG002|Overall Study|No Attack Pretreatment|5|||
126071909|NCT00899379|453557444|FG003|Overall Study|No Attack Pretreatment|6|||
126071910|NCT00899379|453557445|FG004|Overall Study|No Attack Pretreatment|4|||
126114621|NCT01086410|453715706|FG002|Overall Study|Lack of Efficacy|0|||
126114622|NCT01086410|453715707|FG003|Overall Study|Lack of Efficacy|0|||
126114623|NCT01086410|453715704|FG000|Overall Study|Protocol Violation|1|||
126114624|NCT01086410|453715705|FG001|Overall Study|Protocol Violation|1|||
126114625|NCT01086410|453715706|FG002|Overall Study|Protocol Violation|0|||
126114626|NCT01086410|453715707|FG003|Overall Study|Protocol Violation|0|||
126114627|NCT01086410|453715704|FG000|Overall Study|Lost to Follow-up|0|||
126114628|NCT01086410|453715705|FG001|Overall Study|Lost to Follow-up|0|||
126114629|NCT01086410|453715706|FG002|Overall Study|Lost to Follow-up|1|||
126114630|NCT01086410|453715707|FG003|Overall Study|Lost to Follow-up|0|||
126114631|NCT02953639|453715708|FG000|Overall Study|Adverse Event|2|||
126114632|NCT02953639|453715709|FG001|Overall Study|Adverse Event|0|||
126114633|NCT02953639|453715710|FG002|Overall Study|Adverse Event|1|||
126114634|NCT02953639|453715708|FG000|Overall Study|Lost to Follow-up|8|||
126114635|NCT02953639|453715709|FG001|Overall Study|Lost to Follow-up|4|||
126114636|NCT02953639|453715710|FG002|Overall Study|Lost to Follow-up|3|||
126114637|NCT02953639|453715708|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126114638|NCT02953639|453715709|FG001|Overall Study|Non-Compliance With Study Drug|2|||
126114639|NCT02953639|453715710|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126114640|NCT02953639|453715708|FG000|Overall Study|Multiple Reasons|1|||
126114641|NCT02953639|453715709|FG001|Overall Study|Multiple Reasons|0|||
126114642|NCT02953639|453715710|FG002|Overall Study|Multiple Reasons|1|||
126114643|NCT02953639|453715708|FG000|Overall Study|Physician Decision|1|||
126114644|NCT02953639|453715709|FG001|Overall Study|Physician Decision|0|||
126114645|NCT02953639|453715710|FG002|Overall Study|Physician Decision|0|||
126114646|NCT02953639|453715708|FG000|Overall Study|Withdrawal by Subject|7|||
126114647|NCT02953639|453715709|FG001|Overall Study|Withdrawal by Subject|8|||
126114648|NCT02953639|453715710|FG002|Overall Study|Withdrawal by Subject|10|||
126114649|NCT02953639|453715708|FG000|Overall Study|Completed or Discontinued information is missing|1|||
126114650|NCT02953639|453715709|FG001|Overall Study|Completed or Discontinued information is missing|0|||
126114651|NCT02953639|453715710|FG002|Overall Study|Completed or Discontinued information is missing|0|||
126114652|NCT04196803|453715711|FG000|Overall Study|Withdrawal by Subject|1|||
126114653|NCT04196803|453715712|FG001|Overall Study|Withdrawal by Subject|3|||
126114654|NCT04196803|453715711|FG000|Overall Study|Adverse Event|4|||
126114655|NCT04196803|453715712|FG001|Overall Study|Adverse Event|2|||
126114656|NCT04196803|453715711|FG000|Overall Study|Lost to Follow-up|0|||
126071911|NCT00899379|453557441|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126114657|NCT04196803|453715712|FG001|Overall Study|Lost to Follow-up|1|||
126114658|NCT01022996|453715713|FG000|Overall Study|Adverse Event|14|||
126071912|NCT00899379|453557442|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126071913|NCT00899379|453557443|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126071914|NCT00899379|453557444|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126114659|NCT01022996|453715713|FG000|Overall Study|Withdrawal by Subject|3|||
126114660|NCT01022996|453715713|FG000|Overall Study|Lost to Follow-up|1|||
126114661|NCT01022996|453715713|FG000|Overall Study|Administrative problems|6|||
126114662|NCT01022996|453715713|FG000|Overall Study|Disease Progression|32|||
126114663|NCT01022996|453715713|FG000|Overall Study|Protocol Violation|1|||
126071915|NCT00899379|453557445|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126071916|NCT00899379|453557441|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
126071917|NCT00899379|453557442|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
126071918|NCT00899379|453557443|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
126071919|NCT00899379|453557444|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
126071920|NCT00899379|453557445|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
126071921|NCT03220776|453557450|FG000|Overall Study|Claustrophobia|0|||
126071922|NCT03220776|453557451|FG001|Overall Study|Claustrophobia|1|||
126071923|NCT03220776|453557452|FG002|Overall Study|Claustrophobia|1|||
126071924|NCT03220776|453557453|FG003|Overall Study|Claustrophobia|0|||
126071925|NCT03220776|453557454|FG004|Overall Study|Claustrophobia|1|||
126071926|NCT03220776|453557455|FG005|Overall Study|Claustrophobia|0|||
126071927|NCT03220776|453557450|FG000|Overall Study|MRI Equipment Failure|1|||
126071928|NCT03220776|453557451|FG001|Overall Study|MRI Equipment Failure|0|||
126071929|NCT03220776|453557452|FG002|Overall Study|MRI Equipment Failure|0|||
126071930|NCT03220776|453557453|FG003|Overall Study|MRI Equipment Failure|0|||
126071931|NCT03220776|453557454|FG004|Overall Study|MRI Equipment Failure|0|||
126071932|NCT03220776|453557455|FG005|Overall Study|MRI Equipment Failure|0|||
126071933|NCT03220776|453557450|FG000|Overall Study|Inclimate Weather|0|||
126071934|NCT03220776|453557451|FG001|Overall Study|Inclimate Weather|0|||
126071935|NCT03220776|453557452|FG002|Overall Study|Inclimate Weather|0|||
126071936|NCT03220776|453557453|FG003|Overall Study|Inclimate Weather|0|||
126071937|NCT03220776|453557454|FG004|Overall Study|Inclimate Weather|0|||
126071938|NCT03220776|453557455|FG005|Overall Study|Inclimate Weather|1|||
126071939|NCT03220776|453557450|FG000|Overall Study|Physician Decision|0|||
126071940|NCT03220776|453557451|FG001|Overall Study|Physician Decision|0|||
126071941|NCT03220776|453557452|FG002|Overall Study|Physician Decision|0|||
126071942|NCT03220776|453557453|FG003|Overall Study|Physician Decision|1|||
126071943|NCT03220776|453557454|FG004|Overall Study|Physician Decision|0|||
126071944|NCT03220776|453557455|FG005|Overall Study|Physician Decision|0|||
126071945|NCT03220776|453557450|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126071946|NCT03220776|453557451|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126071947|NCT03220776|453557452|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126071948|NCT03220776|453557453|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
126071949|NCT03220776|453557454|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126071950|NCT03220776|453557455|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126071951|NCT03220776|453557450|FG000|Overall Study|Protocol Violation|0|||
126071952|NCT03220776|453557451|FG001|Overall Study|Protocol Violation|0|||
126071953|NCT03220776|453557452|FG002|Overall Study|Protocol Violation|0|||
126071954|NCT03220776|453557453|FG003|Overall Study|Protocol Violation|2|||
126071955|NCT03220776|453557454|FG004|Overall Study|Protocol Violation|0|||
126071956|NCT03220776|453557455|FG005|Overall Study|Protocol Violation|1|||
126071957|NCT03220776|453557450|FG000|Overall Study|Withdrawal by Subject|1|||
126071958|NCT03220776|453557451|FG001|Overall Study|Withdrawal by Subject|0|||
126071959|NCT03220776|453557452|FG002|Overall Study|Withdrawal by Subject|0|||
126071960|NCT03220776|453557453|FG003|Overall Study|Withdrawal by Subject|0|||
126071961|NCT03220776|453557454|FG004|Overall Study|Withdrawal by Subject|0|||
126071962|NCT03220776|453557455|FG005|Overall Study|Withdrawal by Subject|0|||
126071963|NCT03441789|453557456|FG000|Overall Study|Withdrawal by Subject|1|||
126071964|NCT03441789|453557457|FG001|Overall Study|Withdrawal by Subject|1|||
126071965|NCT03441789|453557456|FG000|Overall Study|Adverse Event|0|||
126071966|NCT03441789|453557457|FG001|Overall Study|Adverse Event|1|||
126071967|NCT03441789|453557456|FG000|Overall Study|Protocol Violation|0|||
126071968|NCT03441789|453557457|FG001|Overall Study|Protocol Violation|1|||
126071969|NCT03441789|453557456|FG000|Overall Study|Lost to Follow-up|0|||
126071970|NCT03441789|453557457|FG001|Overall Study|Lost to Follow-up|1|||
126071971|NCT01780545|453557458|FG000|Overall Study|Withdrawal by Subject|3|||
126071972|NCT01780545|453557459|FG001|Overall Study|Withdrawal by Subject|1|||
126071973|NCT01780545|453557458|FG000|Overall Study|Lost to Follow-up|1|||
126071974|NCT01780545|453557459|FG001|Overall Study|Lost to Follow-up|1|||
126071975|NCT03168425|453557462|FG000|Overall Study|Lost to Follow-up|5|||
126071976|NCT03168425|453557463|FG001|Overall Study|Lost to Follow-up|8|||
126071977|NCT03168425|453557462|FG000|Overall Study|unable to confirm post op opioids|2|||
126071978|NCT03168425|453557463|FG001|Overall Study|unable to confirm post op opioids|3|||
126071979|NCT03029234|453557464|FG000|Overall Study|Sponsor Decision|1|||
126071980|NCT03029234|453557464|FG000|Overall Study|Withdrawal by Subject|5|||
126071981|NCT03029234|453557464|FG000|Overall Study|Death|91|||
126071982|NCT03029234|453557464|FG000|Overall Study|Lost to Follow-up|2|||
126071983|NCT02166047|453557468|FG000|Overall Study|Withdrawal by Participant|0|||
126071984|NCT02166047|453557469|FG001|Overall Study|Withdrawal by Participant|1|||
126071985|NCT02166047|453557470|FG002|Overall Study|Withdrawal by Participant|2|||
126071986|NCT02166047|453557471|FG003|Overall Study|Withdrawal by Participant|0|||
126071987|NCT02166047|453557472|FG004|Overall Study|Withdrawal by Participant|0|||
126071988|NCT02166047|453557473|FG005|Overall Study|Withdrawal by Participant|0|||
126071989|NCT02166047|453557474|FG006|Overall Study|Withdrawal by Participant|1|||
126071990|NCT02166047|453557475|FG007|Overall Study|Withdrawal by Participant|0|||
126071991|NCT02166047|453557476|FG008|Overall Study|Withdrawal by Participant|0|||
126071992|NCT02166047|453557477|FG009|Overall Study|Withdrawal by Participant|0|||
126071993|NCT02166047|453557478|FG010|Overall Study|Withdrawal by Participant|0|||
126071994|NCT02166047|453557479|FG011|Overall Study|Withdrawal by Participant|0|||
126071995|NCT02166047|453557468|FG000|Overall Study|Adverse Event|0|||
126071996|NCT02166047|453557469|FG001|Overall Study|Adverse Event|0|||
126071997|NCT02166047|453557470|FG002|Overall Study|Adverse Event|0|||
126071998|NCT02166047|453557471|FG003|Overall Study|Adverse Event|0|||
126071999|NCT02166047|453557472|FG004|Overall Study|Adverse Event|1|||
126072000|NCT02166047|453557473|FG005|Overall Study|Adverse Event|0|||
126072001|NCT02166047|453557474|FG006|Overall Study|Adverse Event|1|||
126072002|NCT02166047|453557475|FG007|Overall Study|Adverse Event|0|||
126072003|NCT02166047|453557476|FG008|Overall Study|Adverse Event|0|||
126072004|NCT02166047|453557477|FG009|Overall Study|Adverse Event|0|||
126072005|NCT02166047|453557478|FG010|Overall Study|Adverse Event|2|||
126072006|NCT02166047|453557479|FG011|Overall Study|Adverse Event|0|||
126072007|NCT01960114|453557480|FG000|Overall Study|Adverse Event|1|||
126072008|NCT01960114|453557481|FG001|Overall Study|Adverse Event|0|||
126072009|NCT01960114|453557480|FG000|Overall Study|Could not swallow study medication|0|||
126072010|NCT01960114|453557481|FG001|Overall Study|Could not swallow study medication|1|||
126072011|NCT02469077|453557482|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
126072012|NCT02469077|453557483|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
126072013|NCT02469077|453557482|FG000|Post Randomization/Intervention Period|Relocated|1|||
126072014|NCT02469077|453557483|FG001|Post Randomization/Intervention Period|Relocated|1|||
126072015|NCT02469077|453557482|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
126072016|NCT02469077|453557483|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
126072017|NCT02469077|453557482|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
126072018|NCT02469077|453557483|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
126072019|NCT00053352|453557489|FG000|Overall Study|Lost to Follow-up|0|||
126072020|NCT00053352|453557490|FG001|Overall Study|Lost to Follow-up|1|||
126072021|NCT00053352|453557489|FG000|Overall Study|Physician Decision|11|||
126072022|NCT00053352|453557490|FG001|Overall Study|Physician Decision|1|||
126072023|NCT00053352|453557489|FG000|Overall Study|Withdrawal by Subject|1|||
126072024|NCT00053352|453557490|FG001|Overall Study|Withdrawal by Subject|0|||
126072025|NCT00053352|453557489|FG000|Overall Study|Ineligible|8|||
126072026|NCT00053352|453557490|FG001|Overall Study|Ineligible|8|||
126072027|NCT00053352|453557489|FG000|Overall Study|Disease at new site|1|||
126072028|NCT00053352|453557490|FG001|Overall Study|Disease at new site|0|||
126072029|NCT00439647|453557491|FG000|Overall Study|Withdrawal by Subject|25|||
126072030|NCT00439647|453557492|FG001|Overall Study|Withdrawal by Subject|22|||
126072031|NCT00439647|453557491|FG000|Overall Study|Death|15|||
126072032|NCT00439647|453557492|FG001|Overall Study|Death|18|||
126072033|NCT00439647|453557491|FG000|Overall Study|Adverse Event|11|||
126072034|NCT00439647|453557492|FG001|Overall Study|Adverse Event|11|||
126072035|NCT00439647|453557491|FG000|Overall Study|Lost to Follow-up|4|||
126072036|NCT00439647|453557492|FG001|Overall Study|Lost to Follow-up|12|||
126072037|NCT00439647|453557491|FG000|Overall Study|Protocol Violation|3|||
126072038|NCT00439647|453557492|FG001|Overall Study|Protocol Violation|4|||
126072039|NCT00439647|453557491|FG000|Overall Study|Lack of Efficacy|0|||
126072040|NCT00439647|453557492|FG001|Overall Study|Lack of Efficacy|4|||
126072041|NCT02845375|453557493|FG000|Overall Study|upper airway obstruction|1|||
126072042|NCT02845375|453557494|FG001|Overall Study|upper airway obstruction|2|||
126072043|NCT02845375|453557495|FG002|Overall Study|upper airway obstruction|1|||
126072044|NCT01177137|453557499|FG000|Overall Study|Withdrawal by Subject|10|||
126072045|NCT01177137|453557500|FG001|Overall Study|Withdrawal by Subject|10|||
126072046|NCT01177137|453557501|FG002|Overall Study|Withdrawal by Subject|2|||
126072047|NCT01287416|453557502|FG000|Pre-post Training|Withdrawal by Subject|17|||
126072048|NCT01287416|453557503|FG001|Pre-post Training|Withdrawal by Subject|24|||
126072049|NCT01287416|453557502|FG000|Pre-post Training|Lost to Follow-up|5|||
126072050|NCT01287416|453557503|FG001|Pre-post Training|Lost to Follow-up|1|||
126072051|NCT01287416|453557502|FG000|6 Month Follow-up|Lost to Follow-up|3|||
126072052|NCT01287416|453557503|FG001|6 Month Follow-up|Lost to Follow-up|2|||
126072053|NCT02506881|453557505|FG000|First Intervention (Day 1)|Protocol Violation|0|||
126072054|NCT02506881|453557506|FG001|First Intervention (Day 1)|Protocol Violation|0|||
126072055|NCT02506881|453557507|FG002|First Intervention (Day 1)|Protocol Violation|1|||
126072056|NCT02506881|453557508|FG003|First Intervention (Day 1)|Protocol Violation|0|||
126072057|NCT02506881|453557505|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
126072058|NCT02506881|453557506|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
126072059|NCT02506881|453557507|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126072060|NCT02506881|453557508|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
126072061|NCT02506881|453557505|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
126072062|NCT02506881|453557506|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
126072063|NCT02506881|453557507|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
126072064|NCT02506881|453557508|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
126072065|NCT01363297|453557513|FG000|Overall Study|Other|0|||
126072066|NCT01363297|453557514|FG001|Overall Study|Other|0|||
126072067|NCT01363297|453557515|FG002|Overall Study|Other|0|||
126072068|NCT01363297|453557516|FG003|Overall Study|Other|0|||
126072069|NCT01363297|453557517|FG004|Overall Study|Other|1|||
125946102|NCT02171260|453101445|FG002|Overall Study|Evidence of progressive disease|4|||
125946103|NCT02171260|453101446|FG003|Overall Study|Evidence of progressive disease|4|||
125946104|NCT00323492|453101447|FG000|Study Phase 1|Adverse Event|2|||
125946105|NCT00323492|453101448|FG001|Study Phase 1|Adverse Event|0|||
125946106|NCT00323492|453101449|FG002|Study Phase 1|Adverse Event|0|||
125946107|NCT00323492|453101447|FG000|Study Phase 2|Adverse Event|1|||
125946108|NCT00323492|453101448|FG001|Study Phase 2|Adverse Event|0|||
125946109|NCT00323492|453101449|FG002|Study Phase 2|Adverse Event|0|||
125946110|NCT00323492|453101447|FG000|Study Phase 2|Physician Decision|1|||
125946111|NCT00323492|453101448|FG001|Study Phase 2|Physician Decision|0|||
125946112|NCT00323492|453101449|FG002|Study Phase 2|Physician Decision|0|||
125946113|NCT00323492|453101447|FG000|Study Phase 2|Lost to Follow-up|1|||
125946114|NCT00323492|453101448|FG001|Study Phase 2|Lost to Follow-up|0|||
125946115|NCT00323492|453101449|FG002|Study Phase 2|Lost to Follow-up|0|||
125946116|NCT00323492|453101447|FG000|Study Phase 2|Withdrawal by Subject|0|||
125946117|NCT00323492|453101448|FG001|Study Phase 2|Withdrawal by Subject|1|||
125946118|NCT00323492|453101449|FG002|Study Phase 2|Withdrawal by Subject|0|||
125946119|NCT00323492|453101447|FG000|Study Phase 2|Noncompliance with study schedule|0|||
125946120|NCT00323492|453101448|FG001|Study Phase 2|Noncompliance with study schedule|0|||
125946121|NCT00323492|453101449|FG002|Study Phase 2|Noncompliance with study schedule|1|||
125946122|NCT00323492|453101447|FG000|Study Phase 2|Protocol Violation|1|||
125946123|NCT00323492|453101448|FG001|Study Phase 2|Protocol Violation|0|||
125946124|NCT00323492|453101449|FG002|Study Phase 2|Protocol Violation|0|||
125946125|NCT03560531|453101450|FG000|Overall Study|Death|4|||
125946126|NCT03560531|453101451|FG001|Overall Study|Death|1|||
125946127|NCT03560531|453101452|FG002|Overall Study|Death|1|||
125946128|NCT03560531|453101453|FG003|Overall Study|Death|2|||
125946129|NCT03560531|453101454|FG004|Overall Study|Death|6|||
125946130|NCT03560531|453101455|FG005|Overall Study|Death|1|||
125946131|NCT03560531|453101456|FG006|Overall Study|Death|4|||
125946132|NCT03560531|453101457|FG007|Overall Study|Death|8|||
125946133|NCT03560531|453101458|FG008|Overall Study|Death|1|||
125946134|NCT03560531|453101459|FG009|Overall Study|Death|3|||
125946135|NCT03560531|453101460|FG010|Overall Study|Death|2|||
125946136|NCT03560531|453101461|FG011|Overall Study|Death|0|||
125946137|NCT03560531|453101462|FG012|Overall Study|Death|4|||
125946138|NCT03560531|453101463|FG013|Overall Study|Death|1|||
125946139|NCT03560531|453101450|FG000|Overall Study|Lost to Follow-up|1|||
125946140|NCT03560531|453101451|FG001|Overall Study|Lost to Follow-up|1|||
125946141|NCT03560531|453101452|FG002|Overall Study|Lost to Follow-up|0|||
125946142|NCT03560531|453101453|FG003|Overall Study|Lost to Follow-up|0|||
125946143|NCT03560531|453101454|FG004|Overall Study|Lost to Follow-up|0|||
125946144|NCT03560531|453101455|FG005|Overall Study|Lost to Follow-up|0|||
125946145|NCT03560531|453101456|FG006|Overall Study|Lost to Follow-up|1|||
125946146|NCT03560531|453101457|FG007|Overall Study|Lost to Follow-up|0|||
125946147|NCT03560531|453101458|FG008|Overall Study|Lost to Follow-up|0|||
125946148|NCT03560531|453101459|FG009|Overall Study|Lost to Follow-up|0|||
125946149|NCT03560531|453101460|FG010|Overall Study|Lost to Follow-up|0|||
125946150|NCT03560531|453101461|FG011|Overall Study|Lost to Follow-up|0|||
125946151|NCT03560531|453101462|FG012|Overall Study|Lost to Follow-up|0|||
125946152|NCT03560531|453101463|FG013|Overall Study|Lost to Follow-up|0|||
125946153|NCT03560531|453101450|FG000|Overall Study|Withdrawal by Subject|1|||
125946154|NCT03560531|453101451|FG001|Overall Study|Withdrawal by Subject|0|||
125946155|NCT03560531|453101452|FG002|Overall Study|Withdrawal by Subject|0|||
125946156|NCT03560531|453101453|FG003|Overall Study|Withdrawal by Subject|0|||
125946157|NCT03560531|453101454|FG004|Overall Study|Withdrawal by Subject|0|||
125946158|NCT03560531|453101455|FG005|Overall Study|Withdrawal by Subject|0|||
125946159|NCT03560531|453101456|FG006|Overall Study|Withdrawal by Subject|0|||
125946160|NCT03560531|453101457|FG007|Overall Study|Withdrawal by Subject|3|||
125946161|NCT03560531|453101458|FG008|Overall Study|Withdrawal by Subject|2|||
125946162|NCT03560531|453101459|FG009|Overall Study|Withdrawal by Subject|0|||
125946163|NCT03560531|453101460|FG010|Overall Study|Withdrawal by Subject|0|||
125946164|NCT03560531|453101461|FG011|Overall Study|Withdrawal by Subject|0|||
125946165|NCT03560531|453101462|FG012|Overall Study|Withdrawal by Subject|2|||
125946166|NCT03560531|453101463|FG013|Overall Study|Withdrawal by Subject|0|||
126072070|NCT01363297|453557513|FG000|Overall Study|Death|3|||
125946167|NCT03560531|453101450|FG000|Overall Study|Study end per-protocol|1|||
125946168|NCT03560531|453101451|FG001|Overall Study|Study end per-protocol|1|||
125946169|NCT03560531|453101452|FG002|Overall Study|Study end per-protocol|2|||
125946170|NCT03560531|453101453|FG003|Overall Study|Study end per-protocol|0|||
125946171|NCT03560531|453101454|FG004|Overall Study|Study end per-protocol|1|||
125946172|NCT03560531|453101455|FG005|Overall Study|Study end per-protocol|0|||
125946173|NCT03560531|453101456|FG006|Overall Study|Study end per-protocol|0|||
125946174|NCT03560531|453101457|FG007|Overall Study|Study end per-protocol|0|||
125946175|NCT03560531|453101458|FG008|Overall Study|Study end per-protocol|0|||
125946176|NCT03560531|453101459|FG009|Overall Study|Study end per-protocol|0|||
125946177|NCT03560531|453101460|FG010|Overall Study|Study end per-protocol|0|||
125946178|NCT03560531|453101461|FG011|Overall Study|Study end per-protocol|0|||
125946179|NCT03560531|453101462|FG012|Overall Study|Study end per-protocol|0|||
126072071|NCT01363297|453557514|FG001|Overall Study|Death|6|||
126072072|NCT01363297|453557515|FG002|Overall Study|Death|6|||
126072073|NCT01363297|453557516|FG003|Overall Study|Death|10|||
126072074|NCT01363297|453557517|FG004|Overall Study|Death|30|||
126072075|NCT02515097|453557518|FG000|Overall Study|Lost to Follow-up|4|||
126072076|NCT02515097|453557519|FG001|Overall Study|Lost to Follow-up|2|||
126072077|NCT02515097|453557518|FG000|Overall Study|Withdrawal by Subject|1|||
126072078|NCT02515097|453557519|FG001|Overall Study|Withdrawal by Subject|3|||
126072079|NCT02515097|453557518|FG000|Overall Study|Adverse Event|2|||
126072080|NCT02515097|453557519|FG001|Overall Study|Adverse Event|1|||
126072081|NCT03015181|453557520|FG000|Overall Study|Enrolled, but product never administered|1|||
126072082|NCT03015181|453557521|FG001|Overall Study|Enrolled, but product never administered|0|||
126072083|NCT03015181|453557522|FG002|Overall Study|Enrolled, but product never administered|0|||
126072084|NCT03015181|453557523|FG003|Overall Study|Enrolled, but product never administered|0|||
126072085|NCT03015181|453557524|FG004|Overall Study|Enrolled, but product never administered|0|||
126072086|NCT03015181|453557525|FG005|Overall Study|Enrolled, but product never administered|0|||
126072087|NCT03015181|453557526|FG006|Overall Study|Enrolled, but product never administered|0|||
126072088|NCT03015181|453557520|FG000|Overall Study|Withdrawal by Subject|0|||
126072089|NCT03015181|453557521|FG001|Overall Study|Withdrawal by Subject|0|||
126072090|NCT03015181|453557522|FG002|Overall Study|Withdrawal by Subject|0|||
126072091|NCT03015181|453557523|FG003|Overall Study|Withdrawal by Subject|0|||
126072092|NCT03015181|453557524|FG004|Overall Study|Withdrawal by Subject|0|||
126072093|NCT03015181|453557525|FG005|Overall Study|Withdrawal by Subject|1|||
126072094|NCT03015181|453557526|FG006|Overall Study|Withdrawal by Subject|0|||
126072095|NCT03015181|453557520|FG000|Overall Study|Physician Decision|0|||
126072096|NCT03015181|453557521|FG001|Overall Study|Physician Decision|0|||
126072097|NCT03015181|453557522|FG002|Overall Study|Physician Decision|0|||
126072098|NCT03015181|453557523|FG003|Overall Study|Physician Decision|0|||
126072099|NCT03015181|453557524|FG004|Overall Study|Physician Decision|0|||
126072100|NCT03015181|453557525|FG005|Overall Study|Physician Decision|0|||
126072101|NCT03015181|453557526|FG006|Overall Study|Physician Decision|1|||
126072102|NCT01064856|453557530|FG000|Double-blind (DB) Period|Adverse Event|1|||
126072103|NCT01064856|453557531|FG001|Double-blind (DB) Period|Adverse Event|0|||
126072104|NCT01064856|453557532|FG002|Double-blind (DB) Period|Adverse Event|0|||
126072105|NCT01064856|453557533|FG003|Double-blind (DB) Period|Adverse Event|0|||
126072106|NCT01064856|453557530|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
126072107|NCT01064856|453557531|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
126072108|NCT01064856|453557532|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
126072109|NCT01064856|453557533|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
126072110|NCT01064856|453557530|FG000|Open-label (OL) Period|Adverse Event|0|||
126072111|NCT01064856|453557531|FG001|Open-label (OL) Period|Adverse Event|0|||
126072112|NCT01064856|453557532|FG002|Open-label (OL) Period|Adverse Event|12|||
126072113|NCT01064856|453557533|FG003|Open-label (OL) Period|Adverse Event|6|||
126072114|NCT01064856|453557530|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
126072115|NCT01064856|453557531|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
126072116|NCT01064856|453557532|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
126072117|NCT01064856|453557533|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
126072118|NCT01064856|453557530|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
126072119|NCT01064856|453557531|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
126072120|NCT01064856|453557532|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
126072121|NCT01064856|453557533|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
126072122|NCT01064856|453557530|FG000|Open-label (OL) Period|Other|0|||
126072123|NCT01064856|453557531|FG001|Open-label (OL) Period|Other|0|||
126072124|NCT01064856|453557532|FG002|Open-label (OL) Period|Other|7|||
126072125|NCT01064856|453557533|FG003|Open-label (OL) Period|Other|7|||
126072126|NCT01204775|453557536|FG000|Overall Study|Poor/non-compliance|0|||
126114664|NCT01069120|453715714|FG000|Overall Study|Study prematurely terminated|27|||
126072127|NCT01204775|453557537|FG001|Overall Study|Poor/non-compliance|1|||
126072128|NCT01204775|453557536|FG000|Overall Study|Withdrawal by Subject|1|||
126072129|NCT01204775|453557537|FG001|Overall Study|Withdrawal by Subject|0|||
126072130|NCT03749616|453557540|FG000|Overall Study|Lost to Follow-up|4|||
126072131|NCT03749616|453557541|FG001|Overall Study|Lost to Follow-up|7|||
126072132|NCT03749616|453557540|FG000|Overall Study|Screen Failure|1|||
126072133|NCT03749616|453557541|FG001|Overall Study|Screen Failure|1|||
126072134|NCT03749616|453557540|FG000|Overall Study|Withdrawal by Subject|2|||
126072135|NCT03749616|453557541|FG001|Overall Study|Withdrawal by Subject|0|||
126072136|NCT04435522|453557542|FG000|Overall Study|Withdrawal by Subject|2|||
126072137|NCT00951171|453557543|FG000|Overall Study|Adverse Event|2|||
126072138|NCT00951171|453557544|FG001|Overall Study|Adverse Event|0|||
126072139|NCT00919061|453557545|FG000|Overall Study|Adverse Event|1|||
126072140|NCT00919061|453557545|FG000|Overall Study|Withdrawal by Subject|1|||
126072141|NCT05294328|453557554|FG000|Overall Study|Adverse Event|1|||
126072142|NCT05294328|453557555|FG001|Overall Study|Adverse Event|0|||
126114665|NCT01205438|453715715|FG000|Overall Study|Adverse Event|19|||
126072143|NCT05294328|453557556|FG002|Overall Study|Adverse Event|0|||
126072144|NCT05294328|453557554|FG000|Overall Study|Physician Decision|1|||
125946180|NCT03560531|453101463|FG013|Overall Study|Study end per-protocol|0|||
125946181|NCT03560531|453101450|FG000|Overall Study|Early study termination by sponsor|9|||
125946182|NCT03560531|453101451|FG001|Overall Study|Early study termination by sponsor|0|||
125946183|NCT03560531|453101452|FG002|Overall Study|Early study termination by sponsor|0|||
125946184|NCT03560531|453101453|FG003|Overall Study|Early study termination by sponsor|4|||
125946185|NCT03560531|453101454|FG004|Overall Study|Early study termination by sponsor|8|||
125946186|NCT03560531|453101455|FG005|Overall Study|Early study termination by sponsor|2|||
125946187|NCT03560531|453101456|FG006|Overall Study|Early study termination by sponsor|5|||
125946188|NCT03560531|453101457|FG007|Overall Study|Early study termination by sponsor|64|||
125946189|NCT03560531|453101458|FG008|Overall Study|Early study termination by sponsor|7|||
125946190|NCT03560531|453101459|FG009|Overall Study|Early study termination by sponsor|2|||
125946191|NCT03560531|453101460|FG010|Overall Study|Early study termination by sponsor|16|||
125946192|NCT03560531|453101461|FG011|Overall Study|Early study termination by sponsor|2|||
125946193|NCT03560531|453101462|FG012|Overall Study|Early study termination by sponsor|6|||
125946194|NCT03560531|453101463|FG013|Overall Study|Early study termination by sponsor|2|||
125946195|NCT01200797|453101466|FG000|Overall Study|symptomatic deterioration|2|||
125946196|NCT01200797|453101466|FG000|Overall Study|Adverse Event|4|||
125946197|NCT01200797|453101466|FG000|Overall Study|Disease Progression|13|||
125946198|NCT00642668|453101471|FG000|Overall Study|Lost to Follow-up|1|||
125946199|NCT00642668|453101471|FG000|Overall Study|Adverse Event|2|||
125946200|NCT00642668|453101471|FG000|Overall Study|Death|2|||
125946201|NCT00642668|453101471|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125946202|NCT00642668|453101471|FG000|Overall Study|Failure to Return|1|||
125946203|NCT00642668|453101471|FG000|Overall Study|Dialysis Initiation|5|||
125946204|NCT00642668|453101471|FG000|Overall Study|Blood Transfusion|2|||
125946205|NCT03608774|453101472|FG000|Overall Study|Lost to Follow-up|5|||
125946206|NCT03608774|453101473|FG001|Overall Study|Lost to Follow-up|5|||
125946207|NCT03608774|453101472|FG000|Overall Study|Withdrawal by Subject|1|||
125946208|NCT03608774|453101473|FG001|Overall Study|Withdrawal by Subject|0|||
125946209|NCT03608774|453101472|FG000|Overall Study|Protocol Violation|1|||
125946210|NCT03608774|453101473|FG001|Overall Study|Protocol Violation|0|||
125946211|NCT03608774|453101472|FG000|Overall Study|Not eligible at enrollment|0|||
125946212|NCT03608774|453101473|FG001|Overall Study|Not eligible at enrollment|1|||
125946213|NCT03608774|453101472|FG000|Overall Study|Health related event|0|||
125946214|NCT03608774|453101473|FG001|Overall Study|Health related event|1|||
125946215|NCT01177540|453101474|FG000|Overall Study|Adverse Event|1|||
125946216|NCT01177540|453101475|FG001|Overall Study|Adverse Event|0|||
125946217|NCT01623596|453101479|FG000|Overall Study|Abnormal laboratory values|2|||
125946218|NCT01623596|453101480|FG001|Overall Study|Abnormal laboratory values|0|||
125946219|NCT01623596|453101479|FG000|Overall Study|Administrative problems|9|||
125946220|NCT01623596|453101480|FG001|Overall Study|Administrative problems|13|||
125946221|NCT01623596|453101479|FG000|Overall Study|Adverse Event|20|||
125946222|NCT01623596|453101480|FG001|Overall Study|Adverse Event|29|||
125946223|NCT01623596|453101479|FG000|Overall Study|Death|0|||
125946224|NCT01623596|453101480|FG001|Overall Study|Death|2|||
125946225|NCT01623596|453101479|FG000|Overall Study|Lost to Follow-up|12|||
125946226|NCT01623596|453101480|FG001|Overall Study|Lost to Follow-up|16|||
125946227|NCT01623596|453101479|FG000|Overall Study|Withdrawal by Subject|13|||
125946228|NCT01623596|453101480|FG001|Overall Study|Withdrawal by Subject|31|||
125946229|NCT01623596|453101479|FG000|Overall Study|Patient no longer requires study drug|1|||
125946230|NCT01623596|453101480|FG001|Overall Study|Patient no longer requires study drug|0|||
125946231|NCT01623596|453101479|FG000|Overall Study|Protocol Violation|0|||
125946232|NCT01623596|453101480|FG001|Overall Study|Protocol Violation|6|||
125946233|NCT01623596|453101479|FG000|Overall Study|Lack of Efficacy|5|||
125946234|NCT01623596|453101480|FG001|Overall Study|Lack of Efficacy|3|||
125946235|NCT01070316|453101481|FG000|Extension Phase|Lack of Efficacy|3|||
125946236|NCT01070316|453101481|FG000|Extension Phase|Withdrawal by Subject|1|||
125946237|NCT03200899|453101484|FG000|Overall Study|Lost to Follow-up|10|||
125946238|NCT03200899|453101485|FG001|Overall Study|Lost to Follow-up|23|||
125946239|NCT01449526|453101486|FG000|Overall Study|Lost to Follow-up|1|||
125946240|NCT01449526|453101487|FG001|Overall Study|Lost to Follow-up|2|||
125946241|NCT01449526|453101486|FG000|Overall Study|Withdrawal by Subject|1|||
125946242|NCT01449526|453101487|FG001|Overall Study|Withdrawal by Subject|1|||
125946243|NCT01449526|453101486|FG000|Overall Study|Symptoms/complaints|0|||
125946244|NCT01449526|453101487|FG001|Overall Study|Symptoms/complaints|1|||
126072145|NCT05294328|453557555|FG001|Overall Study|Physician Decision|1|||
125946245|NCT01449526|453101486|FG000|Overall Study|Lack of Motivation|0|||
125946246|NCT01449526|453101487|FG001|Overall Study|Lack of Motivation|1|||
125946247|NCT01449526|453101486|FG000|Overall Study|Cannot maintain visits|0|||
125946248|NCT01449526|453101487|FG001|Overall Study|Cannot maintain visits|1|||
125946249|NCT01132495|453101491|FG000|Overall Study|Various reasons|40|||
125946250|NCT01132495|453101492|FG001|Overall Study|Various reasons|38|||
125946251|NCT01132495|453101493|FG002|Overall Study|Various reasons|20|||
125946252|NCT01132495|453101494|FG003|Overall Study|Various reasons|12|||
125946253|NCT00082433|453101495|FG000|Overall Study|Adverse Event|12|||
125946254|NCT00082433|453101496|FG001|Overall Study|Adverse Event|17|||
125946255|NCT00082433|453101495|FG000|Overall Study|Death|8|||
126114666|NCT01205438|453715716|FG001|Overall Study|Adverse Event|17|||
126114667|NCT01205438|453715717|FG002|Overall Study|Adverse Event|24|||
126114668|NCT01205438|453715715|FG000|Overall Study|Death|1|||
126114669|NCT01205438|453715716|FG001|Overall Study|Death|1|||
126114670|NCT01205438|453715717|FG002|Overall Study|Death|3|||
126114671|NCT01205438|453715715|FG000|Overall Study|Entry Criteria Not Met|16|||
126114672|NCT01205438|453715716|FG001|Overall Study|Entry Criteria Not Met|15|||
126114673|NCT01205438|453715717|FG002|Overall Study|Entry Criteria Not Met|13|||
126114674|NCT01205438|453715715|FG000|Overall Study|Lack of Efficacy|14|||
126114675|NCT01205438|453715716|FG001|Overall Study|Lack of Efficacy|11|||
126114676|NCT01205438|453715717|FG002|Overall Study|Lack of Efficacy|14|||
126114677|NCT01205438|453715715|FG000|Overall Study|Lost to Follow-up|6|||
126114678|NCT01205438|453715716|FG001|Overall Study|Lost to Follow-up|7|||
126114679|NCT01205438|453715717|FG002|Overall Study|Lost to Follow-up|8|||
126114680|NCT01205438|453715715|FG000|Overall Study|Withdrawal by Subject|19|||
126114681|NCT01205438|453715716|FG001|Overall Study|Withdrawal by Subject|25|||
126114682|NCT01205438|453715717|FG002|Overall Study|Withdrawal by Subject|19|||
126114683|NCT01205438|453715715|FG000|Overall Study|Physician Decision|0|||
126114684|NCT01205438|453715716|FG001|Overall Study|Physician Decision|3|||
126114685|NCT01205438|453715717|FG002|Overall Study|Physician Decision|2|||
126114686|NCT01205438|453715715|FG000|Overall Study|Protocol Violation|2|||
126114687|NCT01205438|453715716|FG001|Overall Study|Protocol Violation|7|||
126114688|NCT01205438|453715717|FG002|Overall Study|Protocol Violation|4|||
126114689|NCT01205438|453715715|FG000|Overall Study|Sponsor Decision|0|||
125946256|NCT00082433|453101496|FG001|Overall Study|Death|18|||
125946257|NCT00082433|453101495|FG000|Overall Study|Disease Progression/Relapse|270|||
126072146|NCT05294328|453557556|FG002|Overall Study|Physician Decision|0|||
126072147|NCT05294328|453557554|FG000|Overall Study|Withdrawal by Subject|0|||
126072148|NCT05294328|453557555|FG001|Overall Study|Withdrawal by Subject|2|||
126072149|NCT05294328|453557556|FG002|Overall Study|Withdrawal by Subject|1|||
126072150|NCT05294328|453557554|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
126072151|NCT05294328|453557555|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
126072152|NCT05294328|453557556|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
126072153|NCT02056873|453557557|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
126072154|NCT01990313|453559448|FG000|Overall Study|Lost to Follow-up|1|||
126072155|NCT03511378|453559449|FG000|Overall Study|Withdrawal by Subject|2|||
126072156|NCT03511378|453559450|FG001|Overall Study|Withdrawal by Subject|2|||
126072157|NCT03511378|453559449|FG000|Overall Study|Patient not coming or schedule visit|1|||
126072158|NCT03511378|453559450|FG001|Overall Study|Patient not coming or schedule visit|0|||
126072159|NCT00837096|453559451|FG000|Overall Study|Physician Decision|1|||
126072160|NCT00837096|453559452|FG001|Overall Study|Physician Decision|1|||
126114690|NCT01205438|453715716|FG001|Overall Study|Sponsor Decision|1|||
125946258|NCT00082433|453101496|FG001|Overall Study|Disease Progression/Relapse|388|||
125946259|NCT00082433|453101495|FG000|Overall Study|Physician Decision|50|||
125946260|NCT00082433|453101496|FG001|Overall Study|Physician Decision|61|||
125946261|NCT00082433|453101495|FG000|Overall Study|Lost to Follow-up|1|||
125946262|NCT00082433|453101496|FG001|Overall Study|Lost to Follow-up|2|||
125946263|NCT00082433|453101495|FG000|Overall Study|Study Drug Toxicity|179|||
125946264|NCT00082433|453101496|FG001|Overall Study|Study Drug Toxicity|66|||
125946265|NCT00082433|453101495|FG000|Overall Study|Withdrawal by Subject|55|||
125946266|NCT00082433|453101496|FG001|Overall Study|Withdrawal by Subject|30|||
125946267|NCT00082433|453101495|FG000|Overall Study|Still On Treatment|2|||
125946268|NCT00082433|453101496|FG001|Overall Study|Still On Treatment|1|||
125946269|NCT00082433|453101495|FG000|Overall Study|Not Treated|12|||
125946270|NCT00082433|453101496|FG001|Overall Study|Not Treated|11|||
125946271|NCT00082433|453101495|FG000|Overall Study|Ineligible|2|||
125946272|NCT00082433|453101496|FG001|Overall Study|Ineligible|1|||
125946273|NCT00082433|453101495|FG000|Overall Study|Noncompliance|2|||
125946274|NCT00082433|453101496|FG001|Overall Study|Noncompliance|1|||
125946275|NCT00082433|453101495|FG000|Overall Study|New primary cancer|1|||
125946276|NCT00082433|453101496|FG001|Overall Study|New primary cancer|0|||
125946277|NCT00082433|453101495|FG000|Overall Study|Impending surgery|0|||
125946278|NCT00082433|453101496|FG001|Overall Study|Impending surgery|1|||
125946279|NCT04097821|453101497|FG000|Overall Study|Subject Decision|0|||
126072161|NCT00837096|453559451|FG000|Overall Study|Not reported|9|||
126072162|NCT00837096|453559452|FG001|Overall Study|Not reported|8|||
126072163|NCT00280683|453559453|FG000|Overall Study|Withdrawal by Subject|1|||
126072164|NCT00280683|453559454|FG001|Overall Study|Withdrawal by Subject|2|||
126072165|NCT00280683|453559453|FG000|Overall Study|Adverse Event|1|||
126114691|NCT01205438|453715717|FG002|Overall Study|Sponsor Decision|1|||
126114692|NCT00884325|453715734|FG000|Overall Study|Lost to Follow-up|1|||
125946280|NCT04097821|453101498|FG001|Overall Study|Subject Decision|0|||
125946281|NCT04097821|453101499|FG002|Overall Study|Subject Decision|0|||
125946282|NCT04097821|453101500|FG003|Overall Study|Subject Decision|1|||
125946283|NCT04097821|453101501|FG004|Overall Study|Subject Decision|2|||
125946284|NCT04097821|453101502|FG005|Overall Study|Subject Decision|2|||
125946285|NCT04097821|453101503|FG006|Overall Study|Subject Decision|0|||
126114693|NCT00884325|453715735|FG001|Overall Study|Lost to Follow-up|2|||
126114694|NCT00884325|453715734|FG000|Overall Study|Lack of Efficacy|0|||
126072166|NCT00280683|453559454|FG001|Overall Study|Adverse Event|1|||
126072167|NCT00510198|453559457|FG000|Overall Study|Withdrawal by Subject|5|||
126072168|NCT00510198|453559458|FG001|Overall Study|Withdrawal by Subject|4|||
126072169|NCT01649557|453559466|FG000|Overall Study|Lost to Follow-up|5|||
126072170|NCT01649557|453559467|FG001|Overall Study|Lost to Follow-up|0|||
126072171|NCT01649557|453559468|FG002|Overall Study|Lost to Follow-up|3|||
126072172|NCT01649557|453559466|FG000|Overall Study|Adverse Event|7|||
126072173|NCT01649557|453559467|FG001|Overall Study|Adverse Event|5|||
126072174|NCT01649557|453559468|FG002|Overall Study|Adverse Event|1|||
126072175|NCT01649557|453559466|FG000|Overall Study|Met withdrawal criteria|4|||
126072176|NCT01649557|453559467|FG001|Overall Study|Met withdrawal criteria|0|||
126072177|NCT01649557|453559468|FG002|Overall Study|Met withdrawal criteria|0|||
126072178|NCT01649557|453559466|FG000|Overall Study|Physician Decision|8|||
126072179|NCT01649557|453559467|FG001|Overall Study|Physician Decision|2|||
126072180|NCT01649557|453559468|FG002|Overall Study|Physician Decision|1|||
126072181|NCT01649557|453559466|FG000|Overall Study|Withdrawal by Subject|15|||
126072182|NCT01649557|453559467|FG001|Overall Study|Withdrawal by Subject|5|||
126072183|NCT01649557|453559468|FG002|Overall Study|Withdrawal by Subject|4|||
126072184|NCT01649557|453559466|FG000|Overall Study|Protocol deviation|0|||
126072185|NCT01649557|453559467|FG001|Overall Study|Protocol deviation|2|||
126072186|NCT01649557|453559468|FG002|Overall Study|Protocol deviation|0|||
126072187|NCT01649557|453559466|FG000|Overall Study|Lack of Efficacy|5|||
126072188|NCT01649557|453559467|FG001|Overall Study|Lack of Efficacy|0|||
126072189|NCT01649557|453559468|FG002|Overall Study|Lack of Efficacy|0|||
126072190|NCT00666198|453559475|FG000|Overall Study|Protocol Violation|10|||
126072191|NCT00666198|453559475|FG000|Overall Study|No Visit After First Day of Treatment|13|||
126072192|NCT00666198|453559475|FG000|Overall Study|Safety Not Assessable|6|||
126072193|NCT00666198|453559475|FG000|Overall Study|No Drug Administration|4|||
126072194|NCT05153499|453559476|FG000|Overall Study|Withdrawal by Subject|1|||
126072195|NCT05153499|453559477|FG001|Overall Study|Withdrawal by Subject|0|||
126072196|NCT05153499|453559476|FG000|Overall Study|Clinical Hold|1|||
126072197|NCT05153499|453559477|FG001|Overall Study|Clinical Hold|0|||
126072198|NCT05153499|453559476|FG000|Overall Study|Study Termination|6|||
126072199|NCT05153499|453559477|FG001|Overall Study|Study Termination|5|||
126072200|NCT01649297|453559479|FG000|Overall Study|Adverse Event|5|||
126072201|NCT01649297|453559480|FG001|Overall Study|Adverse Event|5|||
126072202|NCT01649297|453559481|FG002|Overall Study|Adverse Event|4|||
126072203|NCT01649297|453559482|FG003|Overall Study|Adverse Event|13|||
126072204|NCT01649297|453559483|FG004|Overall Study|Adverse Event|1|||
126072205|NCT01649297|453559479|FG000|Overall Study|Lack of Efficacy|0|||
126072206|NCT01649297|453559480|FG001|Overall Study|Lack of Efficacy|0|||
126072207|NCT01649297|453559481|FG002|Overall Study|Lack of Efficacy|0|||
126072208|NCT01649297|453559482|FG003|Overall Study|Lack of Efficacy|0|||
126072209|NCT01649297|453559483|FG004|Overall Study|Lack of Efficacy|1|||
126072210|NCT01649297|453559479|FG000|Overall Study|Non compliant with Protocol|1|||
126072211|NCT01649297|453559480|FG001|Overall Study|Non compliant with Protocol|0|||
126072212|NCT01649297|453559481|FG002|Overall Study|Non compliant with Protocol|3|||
126072213|NCT01649297|453559482|FG003|Overall Study|Non compliant with Protocol|2|||
126072214|NCT01649297|453559483|FG004|Overall Study|Non compliant with Protocol|1|||
126072215|NCT01649297|453559479|FG000|Overall Study|Lost to Follow-up|1|||
126072216|NCT01649297|453559480|FG001|Overall Study|Lost to Follow-up|1|||
126072217|NCT01649297|453559481|FG002|Overall Study|Lost to Follow-up|4|||
126072218|NCT01649297|453559482|FG003|Overall Study|Lost to Follow-up|3|||
126072219|NCT01649297|453559483|FG004|Overall Study|Lost to Follow-up|0|||
126072220|NCT01649297|453559479|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
126072221|NCT01649297|453559480|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
126072222|NCT01649297|453559481|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
126072223|NCT01649297|453559482|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
126072224|NCT01649297|453559483|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
126072225|NCT01649297|453559479|FG000|Overall Study|For other reason|4|||
126072226|NCT01649297|453559480|FG001|Overall Study|For other reason|1|||
126072227|NCT01649297|453559481|FG002|Overall Study|For other reason|2|||
126072228|NCT01649297|453559482|FG003|Overall Study|For other reason|0|||
126072229|NCT01649297|453559483|FG004|Overall Study|For other reason|0|||
126072230|NCT01685047|453559484|FG000|Overall Study|Withdrawal by Subject|20|||
126072231|NCT01685047|453559484|FG000|Overall Study|Death|26|||
126072232|NCT01685047|453559484|FG000|Overall Study|Lost to Follow-up|8|||
126072233|NCT01685047|453559484|FG000|Overall Study|Physician Decision|25|||
126072234|NCT01685047|453559484|FG000|Overall Study|Adverse Event|5|||
126072235|NCT01685047|453559484|FG000|Overall Study|patient withdrawn by sponsor|1|||
126072236|NCT00922441|453559488|FG000|Overall Study|Protocol Violation|0|||
126072237|NCT00922441|453559489|FG001|Overall Study|Protocol Violation|0|||
126072238|NCT00922441|453559490|FG002|Overall Study|Protocol Violation|2|||
126072239|NCT00922441|453559488|FG000|Overall Study|Withdrawal by Subject|0|||
126072240|NCT00922441|453559489|FG001|Overall Study|Withdrawal by Subject|0|||
126072241|NCT00922441|453559490|FG002|Overall Study|Withdrawal by Subject|1|||
126072242|NCT01040403|453559493|FG000|Overall Study|Adverse Event|10|||
126072243|NCT01040403|453559493|FG000|Overall Study|Protocol Violation|2|||
126072244|NCT01040403|453559493|FG000|Overall Study|Lost to Follow-up|1|||
126072245|NCT01040403|453559493|FG000|Overall Study|Not treated|1|||
126072246|NCT01040403|453559493|FG000|Overall Study|Other reason not defined above|6|||
126072247|NCT02973477|453559494|FG000|First Intervention|Lost to Follow-up|0|||
126072248|NCT02973477|453559495|FG001|First Intervention|Lost to Follow-up|2|||
126072249|NCT02973477|453559494|FG000|Washout|Withdrawal by Subject|1|||
126072250|NCT02973477|453559495|FG001|Washout|Withdrawal by Subject|0|||
126072251|NCT02973477|453559494|FG000|Second Intervention|Lost to Follow-up|1|||
126072252|NCT02973477|453559495|FG001|Second Intervention|Lost to Follow-up|0|||
126072253|NCT01885936|453559496|FG000|Overall Study|Withdrawal by Subject|1|||
126072254|NCT01885936|453559497|FG001|Overall Study|Withdrawal by Subject|0|||
126072255|NCT03036150|453559498|FG000|Overall Study|Withdrawal by Subject|8|||
126072256|NCT03036150|453559499|FG001|Overall Study|Withdrawal by Subject|3|||
126072257|NCT03036150|453559498|FG000|Overall Study|Lost to Follow-up|2|||
126072258|NCT03036150|453559499|FG001|Overall Study|Lost to Follow-up|2|||
126072259|NCT00317603|453559500|FG000|Overall Study|Progressive Disease|3|||
126072260|NCT00523549|453559501|FG000|Overall Study|Adverse Event|6|||
126072261|NCT00523549|453559502|FG001|Overall Study|Adverse Event|3|||
126072262|NCT00523549|453559501|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126072263|NCT00523549|453559502|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126072264|NCT00523549|453559501|FG000|Overall Study|Protocol Deviation|3|||
126072265|NCT00523549|453559502|FG001|Overall Study|Protocol Deviation|1|||
126072266|NCT00523549|453559501|FG000|Overall Study|Patient withdrew consent|7|||
126072267|NCT00523549|453559502|FG001|Overall Study|Patient withdrew consent|6|||
126072268|NCT00523549|453559501|FG000|Overall Study|Lost to Follow-up|3|||
126072269|NCT00523549|453559502|FG001|Overall Study|Lost to Follow-up|5|||
126072270|NCT00427778|453559507|FG000|First Intervention (4 Weeks)|no longer interested|1|||
126072271|NCT00427778|453559508|FG001|First Intervention (4 Weeks)|no longer interested|0|||
126072272|NCT00427778|453559507|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
126072273|NCT00427778|453559508|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
126072274|NCT00427778|453559507|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
126072275|NCT00427778|453559508|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
126072276|NCT00427778|453559507|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
126072277|NCT00427778|453559508|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
126072278|NCT01388478|453559509|FG000|Overall Study|Adverse Event|4|||
126072279|NCT01388478|453559509|FG000|Overall Study|Withdrawal by Subject|1|||
126072280|NCT01037413|453559510|FG000|Part A: Skin Testing|Adverse Event|1|||
126072281|NCT01037413|453559511|FG001|Part A: Skin Testing|Adverse Event|0|||
126072282|NCT01037413|453559510|FG000|Part A: Skin Testing|Protocol Violation|1|||
126072283|NCT01037413|453559511|FG001|Part A: Skin Testing|Protocol Violation|0|||
126072284|NCT01037413|453559510|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
126072285|NCT01037413|453559511|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
126072286|NCT01037413|453559510|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
126072287|NCT01037413|453559511|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
126072288|NCT01990664|453559512|FG000|Overall Study|Lost to Follow-up|2|||
126072289|NCT01990664|453559513|FG001|Overall Study|Lost to Follow-up|6|||
126072290|NCT01990664|453559512|FG000|Overall Study|Withdrawal by Subject|2|||
126072291|NCT01990664|453559513|FG001|Overall Study|Withdrawal by Subject|3|||
126072292|NCT01990664|453559512|FG000|Overall Study|Protocol Violation|1|||
126072293|NCT01990664|453559513|FG001|Overall Study|Protocol Violation|0|||
126072294|NCT01990664|453559512|FG000|Overall Study|Lens Discomfort|1|||
126072295|NCT01990664|453559513|FG001|Overall Study|Lens Discomfort|1|||
126072296|NCT01990664|453559512|FG000|Overall Study|Lens Handling Difficulties|1|||
126072297|NCT01990664|453559513|FG001|Overall Study|Lens Handling Difficulties|0|||
126072298|NCT01990664|453559512|FG000|Overall Study|Unsatisfactory Visual Response|0|||
126072299|NCT01990664|453559513|FG001|Overall Study|Unsatisfactory Visual Response|1|||
126072300|NCT00619983|453559514|FG000|Test Drug Alone|Withdrawal by Subject|1|||
126072301|NCT00619983|453559515|FG001|Test Drug Alone|Withdrawal by Subject|0|||
126072302|NCT00619983|453559516|FG002|Test Drug Alone|Withdrawal by Subject|0|||
126072303|NCT00619983|453559517|FG003|Test Drug Alone|Withdrawal by Subject|1|||
126072304|NCT00619983|453559514|FG000|Test Drug Alone|Failure of daily diary device|1|||
126072305|NCT00619983|453559515|FG001|Test Drug Alone|Failure of daily diary device|1|||
126072306|NCT00619983|453559516|FG002|Test Drug Alone|Failure of daily diary device|2|||
126072307|NCT00619983|453559517|FG003|Test Drug Alone|Failure of daily diary device|2|||
126072308|NCT00931918|453559518|FG000|Overall Study|Adverse Event|4|||
126072309|NCT00931918|453559519|FG001|Overall Study|Adverse Event|6|||
126072310|NCT00931918|453559518|FG000|Overall Study|Progressive Disease|2|||
126072311|NCT00931918|453559519|FG001|Overall Study|Progressive Disease|1|||
126072312|NCT00931918|453559518|FG000|Overall Study|Symptomatic Deterioration|1|||
126072313|NCT00931918|453559519|FG001|Overall Study|Symptomatic Deterioration|0|||
126072314|NCT00931918|453559518|FG000|Overall Study|Withdrawal by Patient|3|||
126072315|NCT00931918|453559519|FG001|Overall Study|Withdrawal by Patient|4|||
126072316|NCT00931918|453559518|FG000|Overall Study|Other Reason not Specified|4|||
126072317|NCT00931918|453559519|FG001|Overall Study|Other Reason not Specified|4|||
125946286|NCT04097821|453101504|FG007|Overall Study|Subject Decision|1|||
126072318|NCT00931918|453559518|FG000|Overall Study|Did not receive study drug|3|||
126072319|NCT00931918|453559519|FG001|Overall Study|Did not receive study drug|2|||
126072320|NCT00570921|453559520|FG000|Overall Study|Protocol Violation|1|||
126072321|NCT00570921|453559520|FG000|Overall Study|Physician Decision|1|||
126072322|NCT00784277|453559522|FG000|IR Treatment|Adverse Event|4|||
126072323|NCT00784277|453559523|FG001|IR Treatment|Adverse Event|8|||
126072324|NCT00784277|453559524|FG002|IR Treatment|Adverse Event|19|||
126072325|NCT00784277|453559525|FG003|IR Treatment|Adverse Event|35|||
126072326|NCT00784277|453559526|FG004|IR Treatment|Adverse Event|0|||
126072327|NCT00784277|453559527|FG005|IR Treatment|Adverse Event|0|||
126072328|NCT00784277|453559528|FG006|IR Treatment|Adverse Event|0|||
126072329|NCT00784277|453559522|FG000|IR Treatment|Lack of Efficacy|4|||
126072330|NCT00784277|453559523|FG001|IR Treatment|Lack of Efficacy|4|||
126072331|NCT00784277|453559524|FG002|IR Treatment|Lack of Efficacy|1|||
126072332|NCT00784277|453559525|FG003|IR Treatment|Lack of Efficacy|0|||
126072333|NCT00784277|453559526|FG004|IR Treatment|Lack of Efficacy|0|||
126072334|NCT00784277|453559527|FG005|IR Treatment|Lack of Efficacy|0|||
126072335|NCT00784277|453559528|FG006|IR Treatment|Lack of Efficacy|0|||
126072336|NCT00784277|453559522|FG000|IR Treatment|Lost to Follow-up|1|||
126072337|NCT00784277|453559523|FG001|IR Treatment|Lost to Follow-up|0|||
126072338|NCT00784277|453559524|FG002|IR Treatment|Lost to Follow-up|1|||
126072339|NCT00784277|453559525|FG003|IR Treatment|Lost to Follow-up|0|||
126072340|NCT00784277|453559526|FG004|IR Treatment|Lost to Follow-up|0|||
126072341|NCT00784277|453559527|FG005|IR Treatment|Lost to Follow-up|0|||
126072342|NCT00784277|453559528|FG006|IR Treatment|Lost to Follow-up|0|||
126072343|NCT00784277|453559522|FG000|IR Treatment|Withdrawal by Subject|5|||
126072344|NCT00784277|453559523|FG001|IR Treatment|Withdrawal by Subject|1|||
126072345|NCT00784277|453559524|FG002|IR Treatment|Withdrawal by Subject|4|||
126072346|NCT00784277|453559525|FG003|IR Treatment|Withdrawal by Subject|6|||
126072347|NCT00784277|453559526|FG004|IR Treatment|Withdrawal by Subject|0|||
126072348|NCT00784277|453559527|FG005|IR Treatment|Withdrawal by Subject|0|||
126072349|NCT00784277|453559528|FG006|IR Treatment|Withdrawal by Subject|0|||
126072350|NCT00784277|453559522|FG000|IR Treatment|Resolution Of Pain|0|||
126072351|NCT00784277|453559523|FG001|IR Treatment|Resolution Of Pain|1|||
126072352|NCT00784277|453559524|FG002|IR Treatment|Resolution Of Pain|0|||
126072353|NCT00784277|453559525|FG003|IR Treatment|Resolution Of Pain|0|||
126072354|NCT00784277|453559526|FG004|IR Treatment|Resolution Of Pain|0|||
126114695|NCT00884325|453715735|FG001|Overall Study|Lack of Efficacy|1|||
125946287|NCT04097821|453101497|FG000|Overall Study|Death|0|||
125946288|NCT04097821|453101498|FG001|Overall Study|Death|0|||
125946289|NCT04097821|453101499|FG002|Overall Study|Death|3|||
125946290|NCT04097821|453101500|FG003|Overall Study|Death|1|||
125946291|NCT04097821|453101501|FG004|Overall Study|Death|0|||
125946292|NCT04097821|453101502|FG005|Overall Study|Death|0|||
125946293|NCT04097821|453101503|FG006|Overall Study|Death|0|||
125946294|NCT04097821|453101504|FG007|Overall Study|Death|0|||
125946295|NCT04097821|453101497|FG000|Overall Study|Physician Decision|1|||
125946296|NCT04097821|453101498|FG001|Overall Study|Physician Decision|2|||
125946297|NCT04097821|453101499|FG002|Overall Study|Physician Decision|0|||
125946298|NCT04097821|453101500|FG003|Overall Study|Physician Decision|0|||
125946299|NCT04097821|453101501|FG004|Overall Study|Physician Decision|0|||
125946300|NCT04097821|453101502|FG005|Overall Study|Physician Decision|0|||
125946301|NCT04097821|453101503|FG006|Overall Study|Physician Decision|0|||
125946302|NCT04097821|453101504|FG007|Overall Study|Physician Decision|0|||
125946303|NCT04097821|453101497|FG000|Overall Study|Adverse Event|0|||
125946304|NCT04097821|453101498|FG001|Overall Study|Adverse Event|0|||
125946305|NCT04097821|453101499|FG002|Overall Study|Adverse Event|1|||
125946306|NCT04097821|453101500|FG003|Overall Study|Adverse Event|1|||
125946307|NCT04097821|453101501|FG004|Overall Study|Adverse Event|0|||
125946308|NCT04097821|453101502|FG005|Overall Study|Adverse Event|0|||
125946309|NCT04097821|453101503|FG006|Overall Study|Adverse Event|0|||
125946310|NCT04097821|453101504|FG007|Overall Study|Adverse Event|0|||
125946311|NCT04097821|453101497|FG000|Overall Study|New Therapy For Study Indication|0|||
126072355|NCT00784277|453559527|FG005|IR Treatment|Resolution Of Pain|0|||
126072356|NCT00784277|453559528|FG006|IR Treatment|Resolution Of Pain|0|||
126072357|NCT00784277|453559522|FG000|IR Treatment|Other|2|||
126072358|NCT00784277|453559523|FG001|IR Treatment|Other|3|||
126114696|NCT00884325|453715734|FG000|Overall Study|Withdrawal by Subject|1|||
126072359|NCT00784277|453559524|FG002|IR Treatment|Other|3|||
126072360|NCT00784277|453559525|FG003|IR Treatment|Other|2|||
126114697|NCT00884325|453715735|FG001|Overall Study|Withdrawal by Subject|1|||
126114698|NCT00884325|453715734|FG000|Overall Study|Not provided|1|||
125946312|NCT04097821|453101498|FG001|Overall Study|New Therapy For Study Indication|0|||
125946313|NCT04097821|453101499|FG002|Overall Study|New Therapy For Study Indication|0|||
125946314|NCT04097821|453101500|FG003|Overall Study|New Therapy For Study Indication|0|||
125946315|NCT04097821|453101501|FG004|Overall Study|New Therapy For Study Indication|0|||
125946316|NCT04097821|453101502|FG005|Overall Study|New Therapy For Study Indication|0|||
126072361|NCT00784277|453559526|FG004|IR Treatment|Other|0|||
126072362|NCT00784277|453559527|FG005|IR Treatment|Other|0|||
126072363|NCT00784277|453559528|FG006|IR Treatment|Other|0|||
126114699|NCT00884325|453715735|FG001|Overall Study|Not provided|0|||
125946317|NCT04097821|453101503|FG006|Overall Study|New Therapy For Study Indication|1|||
125946318|NCT04097821|453101504|FG007|Overall Study|New Therapy For Study Indication|0|||
125946319|NCT04477304|453101505|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
125946320|NCT04477304|453101506|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
125946321|NCT05756790|453101509|FG000|Overall Study|Withdrawal by Subject|1|||
125946322|NCT05756790|453101510|FG001|Overall Study|Withdrawal by Subject|1|||
125946323|NCT05756790|453101511|FG002|Overall Study|Withdrawal by Subject|1|||
125946324|NCT05756790|453101512|FG003|Overall Study|Withdrawal by Subject|1|||
125946325|NCT05756790|453101513|FG004|Overall Study|Withdrawal by Subject|0|||
125946326|NCT05756790|453101514|FG005|Overall Study|Withdrawal by Subject|0|||
125946327|NCT05756790|453101509|FG000|Overall Study|Protocol Violation|0|||
125946328|NCT05756790|453101510|FG001|Overall Study|Protocol Violation|0|||
125946329|NCT05756790|453101511|FG002|Overall Study|Protocol Violation|1|||
125946330|NCT05756790|453101512|FG003|Overall Study|Protocol Violation|1|||
125946331|NCT05756790|453101513|FG004|Overall Study|Protocol Violation|0|||
125946332|NCT05756790|453101514|FG005|Overall Study|Protocol Violation|0|||
125946333|NCT05756790|453101509|FG000|Overall Study|Ineligible|0|||
125946334|NCT05756790|453101510|FG001|Overall Study|Ineligible|0|||
125946335|NCT05756790|453101511|FG002|Overall Study|Ineligible|0|||
125946336|NCT05756790|453101512|FG003|Overall Study|Ineligible|0|||
125946337|NCT05756790|453101513|FG004|Overall Study|Ineligible|2|||
125946338|NCT05756790|453101514|FG005|Overall Study|Ineligible|2|||
125946339|NCT00502697|453102972|FG000|Overall Study|Withdrawal by Subject|3|||
125946340|NCT00502697|453102973|FG001|Overall Study|Withdrawal by Subject|1|||
125946341|NCT00502697|453102972|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
125946342|NCT00502697|453102973|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
125946343|NCT00502697|453102972|FG000|Overall Study|found not to meet eligibility criteria|3|||
125946344|NCT00502697|453102973|FG001|Overall Study|found not to meet eligibility criteria|4|||
125946345|NCT00502697|453102972|FG000|Overall Study|did not meet assignment criteria|4|||
125946346|NCT00502697|453102973|FG001|Overall Study|did not meet assignment criteria|2|||
125946347|NCT01545817|453102974|FG000|Pazopanib|Disease progression|51|||
125946348|NCT01545817|453102975|FG001|Pazopanib|Disease progression|0|||
125946349|NCT01545817|453102974|FG000|Pazopanib|Adverse Event|19|||
125946350|NCT01545817|453102975|FG001|Pazopanib|Adverse Event|0|||
125946351|NCT01545817|453102974|FG000|Pazopanib|Other reason|4|||
125946352|NCT01545817|453102975|FG001|Pazopanib|Other reason|0|||
125946353|NCT01545817|453102974|FG000|Everolimus|Other reason|0|||
125946354|NCT01545817|453102975|FG001|Everolimus|Other reason|7|||
125946355|NCT01545817|453102974|FG000|Everolimus|Disease progression|0|||
125946356|NCT01545817|453102975|FG001|Everolimus|Disease progression|25|||
125946357|NCT01545817|453102974|FG000|Everolimus|Adverse Event|0|||
125946358|NCT01545817|453102975|FG001|Everolimus|Adverse Event|6|||
126072364|NCT00784277|453559522|FG000|ER Treatment|Adverse Event|0|||
126072365|NCT00784277|453559523|FG001|ER Treatment|Adverse Event|0|||
126072366|NCT00784277|453559524|FG002|ER Treatment|Adverse Event|0|||
126072367|NCT00784277|453559525|FG003|ER Treatment|Adverse Event|0|||
126072368|NCT00784277|453559526|FG004|ER Treatment|Adverse Event|1|||
126072369|NCT00784277|453559527|FG005|ER Treatment|Adverse Event|7|||
126072370|NCT00784277|453559528|FG006|ER Treatment|Adverse Event|7|||
125946359|NCT00589108|453102979|FG000|Overall Study|Lost to Follow-up|1|||
125946360|NCT00589108|453102980|FG001|Overall Study|Lost to Follow-up|1|||
125946361|NCT00589108|453102981|FG002|Overall Study|Lost to Follow-up|1|||
125946362|NCT00589108|453102979|FG000|Overall Study|Death|3|||
125946363|NCT00589108|453102980|FG001|Overall Study|Death|3|||
125946364|NCT00589108|453102981|FG002|Overall Study|Death|4|||
125946365|NCT05228470|453102985|FG000|Overall Study|Death|6|||
125946366|NCT05228470|453102986|FG001|Overall Study|Death|11|||
125946367|NCT05228470|453102985|FG000|Overall Study|Withdrawal by Subject|1|||
125946368|NCT05228470|453102986|FG001|Overall Study|Withdrawal by Subject|8|||
125946369|NCT05228470|453102985|FG000|Overall Study|Ongoing|1|||
126072371|NCT00784277|453559522|FG000|ER Treatment|Lack of Efficacy|0|||
125946370|NCT05228470|453102986|FG001|Overall Study|Ongoing|11|||
125946371|NCT00136084|453102987|FG000|Overall Study|Death|12|||
125946372|NCT00136084|453102988|FG001|Overall Study|Death|5|||
125946373|NCT00136084|453102987|FG000|Overall Study|Unacceptable toxicity|8|||
125946374|NCT00136084|453102988|FG001|Overall Study|Unacceptable toxicity|11|||
126072372|NCT00784277|453559523|FG001|ER Treatment|Lack of Efficacy|0|||
126072373|NCT00784277|453559524|FG002|ER Treatment|Lack of Efficacy|0|||
126072374|NCT00784277|453559525|FG003|ER Treatment|Lack of Efficacy|0|||
125946375|NCT00136084|453102987|FG000|Overall Study|Relapse|20|||
125946376|NCT00136084|453102988|FG001|Overall Study|Relapse|23|||
125946377|NCT00136084|453102987|FG000|Overall Study|Lost to Follow-up|2|||
125946378|NCT00136084|453102988|FG001|Overall Study|Lost to Follow-up|0|||
125946379|NCT00136084|453102987|FG000|Overall Study|No Response|1|||
125946380|NCT00136084|453102988|FG001|Overall Study|No Response|2|||
125946381|NCT00136084|453102987|FG000|Overall Study|Withdrawal by Subject|5|||
125946382|NCT00136084|453102988|FG001|Overall Study|Withdrawal by Subject|1|||
125946383|NCT02449239|453102989|FG000|Induction Phase|Lack of Efficacy|64|||
125946384|NCT02449239|453102989|FG000|Induction Phase|Adverse Event|1|||
125946385|NCT02449239|453102989|FG000|Induction Phase|Lost to Follow-up|1|||
126114700|NCT03945591|453715743|FG000|Overall Study|Participant not transplanted|1|||
126114701|NCT03945591|453715743|FG000|Overall Study|Change in treatment plan|3|||
126114702|NCT03945591|453715743|FG000|Overall Study|Adverse Event|1|||
126114703|NCT03083847|453715744|FG000|Main|Physician Decision|0|||
126114704|NCT03083847|453715745|FG001|Main|Physician Decision|0|||
126114705|NCT03083847|453715746|FG002|Main|Physician Decision|0|||
125946386|NCT02449239|453102989|FG000|Induction Phase|Protocol Violation|1|||
125946387|NCT02449239|453102989|FG000|Induction Phase|Physician Decision|1|||
125946388|NCT02449239|453102989|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
125946389|NCT02449239|453102989|FG000|Induction Phase|Withdrawal by Subject|1|||
125946390|NCT02449239|453102989|FG000|Maintenance Month 3|Lack of Efficacy|14|||
125946391|NCT02449239|453102989|FG000|Maintenance Month 6|Lack of Efficacy|10|||
125946392|NCT02449239|453102989|FG000|Maintenance Month 6|Adverse Event|2|||
125946393|NCT02449239|453102989|FG000|Maintenance Month 6|Physician Decision|1|||
125946394|NCT02449239|453102989|FG000|Maintenance Month 9|Lack of Efficacy|2|||
125946395|NCT02449239|453102989|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
125946396|NCT02449239|453102989|FG000|Maintenance Month 12|Lack of Efficacy|5|||
125946397|NCT02449239|453102989|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
125946398|NCT02449239|453102989|FG000|Maintenance Month 12|Subject moved from area|1|||
125946399|NCT02449239|453102989|FG000|Maintenance Month 15|Lack of Efficacy|1|||
125946400|NCT02449239|453102989|FG000|Maintenance Month 21|Lack of Efficacy|1|||
125946401|NCT02449239|453102989|FG000|Maintenance Month 21|Sponsor decision|1|||
125946402|NCT02476968|453102991|FG000|Overall Study|Other|0|||
125946403|NCT02476968|453102992|FG001|Overall Study|Other|2|||
125946404|NCT02476968|453102993|FG002|Overall Study|Other|0|||
125946405|NCT02476968|453102991|FG000|Overall Study|Lost to Follow-up|10|||
125946406|NCT02476968|453102992|FG001|Overall Study|Lost to Follow-up|0|||
125946407|NCT02476968|453102993|FG002|Overall Study|Lost to Follow-up|1|||
125946408|NCT02476968|453102991|FG000|Overall Study|Death|48|||
125946409|NCT02476968|453102992|FG001|Overall Study|Death|8|||
125946410|NCT02476968|453102993|FG002|Overall Study|Death|1|||
125946411|NCT02476968|453102991|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125946412|NCT02476968|453102992|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125946413|NCT02476968|453102993|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125946414|NCT02476968|453102991|FG000|Overall Study|Patient decision|37|||
125946415|NCT02476968|453102992|FG001|Overall Study|Patient decision|8|||
125946416|NCT02476968|453102993|FG002|Overall Study|Patient decision|0|||
125946417|NCT01723163|453102994|FG000|Treatment Phase|Withdrawal by Subject|14|||
125946418|NCT01723163|453102995|FG001|Treatment Phase|Withdrawal by Subject|6|||
125946419|NCT01723163|453102994|FG000|Treatment Phase|Withdrawal by PI|5|||
125946420|NCT01723163|453102995|FG001|Treatment Phase|Withdrawal by PI|1|||
125946421|NCT01723163|453102994|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
125946422|NCT01723163|453102995|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
125946423|NCT01723163|453102994|FG000|3-Month Follow-up|Unable to Contact|12|||
125946424|NCT01723163|453102995|FG001|3-Month Follow-up|Unable to Contact|19|||
125946425|NCT01723163|453102994|FG000|6-Month Follow-up|Death|1|||
125946426|NCT01723163|453102995|FG001|6-Month Follow-up|Death|0|||
125946427|NCT01723163|453102994|FG000|6-Month Follow-up|Unable to Contact|17|||
125946428|NCT01723163|453102995|FG001|6-Month Follow-up|Unable to Contact|15|||
125946429|NCT01723163|453102994|FG000|12-Month Follow-up|Death|1|||
125946430|NCT01723163|453102995|FG001|12-Month Follow-up|Death|0|||
125946431|NCT01723163|453102994|FG000|12-Month Follow-up|Unable to Contact|23|||
125946432|NCT01723163|453102995|FG001|12-Month Follow-up|Unable to Contact|28|||
125946433|NCT03314584|453103014|FG000|Overall Study|Withdrawal by Subject|3|||
125946434|NCT03314584|453103015|FG001|Overall Study|Withdrawal by Subject|3|||
125946435|NCT03314584|453103014|FG000|Overall Study|Lost to Follow-up|4|||
125946436|NCT03314584|453103015|FG001|Overall Study|Lost to Follow-up|0|||
125946437|NCT06134817|453103016|FG000|Overall Study|Physician Departure - termination of study|1|||
125946438|NCT01990495|453103018|FG000|Overall Study|Physician Decision|5|||
125946439|NCT01990495|453103019|FG001|Overall Study|Physician Decision|4|||
125946440|NCT01928862|453103020|FG000|Overall Study|Lost to Follow-up|1|||
125946441|NCT01928862|453103021|FG001|Overall Study|Lost to Follow-up|0|||
125946442|NCT01928862|453103022|FG002|Overall Study|Lost to Follow-up|0|||
125946443|NCT01928862|453103023|FG003|Overall Study|Lost to Follow-up|0|||
125946444|NCT01928862|453103024|FG004|Overall Study|Lost to Follow-up|1|||
125946445|NCT01478321|453103025|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
125946446|NCT01478321|453103025|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
125946447|NCT01478321|453103025|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
125946448|NCT01478321|453103025|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
125946449|NCT01478321|453103025|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
125946450|NCT01478321|453103025|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
125946451|NCT01478321|453103025|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
125946452|NCT01478321|453103025|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
125946453|NCT04649164|453103026|FG000|Overall Study|Withdrawal by Subject|1|||
125946454|NCT04649164|453103027|FG001|Overall Study|Withdrawal by Subject|1|||
126114706|NCT03083847|453715747|FG003|Main|Physician Decision|0|||
126114707|NCT03083847|453715748|FG004|Main|Physician Decision|0|||
125946455|NCT04649164|453103028|FG002|Overall Study|Withdrawal by Subject|2|||
125946456|NCT04649164|453103026|FG000|Overall Study|Participant's care recipient expired|0|||
125946457|NCT04649164|453103027|FG001|Overall Study|Participant's care recipient expired|0|||
125946458|NCT04649164|453103028|FG002|Overall Study|Participant's care recipient expired|2|||
125946459|NCT03168464|453103029|FG000|Overall Study|Death|9|||
125946460|NCT03168464|453103029|FG000|Overall Study|Progression of disease|6|||
125946461|NCT03261947|453103041|FG000|Overall Study|Death|10|||
125946462|NCT03261947|453103042|FG001|Overall Study|Death|13|||
125946463|NCT03261947|453103043|FG002|Overall Study|Death|17|||
125946464|NCT03261947|453103044|FG003|Overall Study|Death|12|||
125946465|NCT03261947|453103045|FG004|Overall Study|Death|8|||
125946466|NCT03261947|453103041|FG000|Overall Study|Lost to Follow-up|0|||
125946467|NCT03261947|453103042|FG001|Overall Study|Lost to Follow-up|0|||
125946468|NCT03261947|453103043|FG002|Overall Study|Lost to Follow-up|2|||
125946469|NCT03261947|453103044|FG003|Overall Study|Lost to Follow-up|1|||
125946470|NCT03261947|453103045|FG004|Overall Study|Lost to Follow-up|0|||
125946471|NCT03261947|453103041|FG000|Overall Study|Withdrawal by Subject|0|||
125946472|NCT03261947|453103042|FG001|Overall Study|Withdrawal by Subject|0|||
125946473|NCT03261947|453103043|FG002|Overall Study|Withdrawal by Subject|3|||
125946474|NCT03261947|453103044|FG003|Overall Study|Withdrawal by Subject|0|||
125946475|NCT03261947|453103045|FG004|Overall Study|Withdrawal by Subject|1|||
125946476|NCT03261947|453103041|FG000|Overall Study|Site Terminated by Sponsor|0|||
125946477|NCT03261947|453103042|FG001|Overall Study|Site Terminated by Sponsor|0|||
125946478|NCT03261947|453103043|FG002|Overall Study|Site Terminated by Sponsor|4|||
125946479|NCT03261947|453103044|FG003|Overall Study|Site Terminated by Sponsor|7|||
125946480|NCT03261947|453103045|FG004|Overall Study|Site Terminated by Sponsor|5|||
125946481|NCT03261947|453103041|FG000|Overall Study|Reason not Specified|2|||
125946482|NCT03261947|453103042|FG001|Overall Study|Reason not Specified|0|||
125946483|NCT03261947|453103043|FG002|Overall Study|Reason not Specified|4|||
125946484|NCT03261947|453103044|FG003|Overall Study|Reason not Specified|1|||
125946485|NCT03261947|453103045|FG004|Overall Study|Reason not Specified|3|||
125946486|NCT03969992|453103046|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
125946487|NCT03969992|453103047|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
125946488|NCT03969992|453103048|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
125946489|NCT03969992|453103046|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
125946490|NCT03969992|453103047|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
125946491|NCT03969992|453103048|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
125946492|NCT03969992|453103046|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
125946493|NCT03969992|453103047|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
125946494|NCT03969992|453103048|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
125946495|NCT03969992|453103046|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
125946496|NCT03969992|453103047|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
125946497|NCT03969992|453103048|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
125946498|NCT03969992|453103046|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
125946499|NCT03969992|453103047|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
125946500|NCT03969992|453103048|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
125946501|NCT02063737|453103053|FG000|Overall Study|Lost to Follow-up|11|||
125946502|NCT02063737|453103054|FG001|Overall Study|Lost to Follow-up|4|||
125946503|NCT02689258|453103057|FG000|Overall Study|Subject Non-Compliance|0|||
125946504|NCT02689258|453103058|FG001|Overall Study|Subject Non-Compliance|1|||
125946505|NCT02689258|453103059|FG002|Overall Study|Subject Non-Compliance|0|||
125946506|NCT02689258|453103060|FG003|Overall Study|Subject Non-Compliance|0|||
125946507|NCT02689258|453103061|FG004|Overall Study|Subject Non-Compliance|0|||
125946508|NCT02689258|453103062|FG005|Overall Study|Subject Non-Compliance|0|||
125946509|NCT02689258|453103063|FG006|Overall Study|Subject Non-Compliance|0|||
125946510|NCT02689258|453103064|FG007|Overall Study|Subject Non-Compliance|0|||
125946511|NCT02689258|453103065|FG008|Overall Study|Subject Non-Compliance|0|||
125946512|NCT02689258|453103066|FG009|Overall Study|Subject Non-Compliance|0|||
125946513|NCT02689258|453103067|FG010|Overall Study|Subject Non-Compliance|0|||
125946514|NCT02689258|453103068|FG011|Overall Study|Subject Non-Compliance|0|||
125946515|NCT02689258|453103057|FG000|Overall Study|Subject Refusal to Continue|0|||
125946516|NCT02689258|453103058|FG001|Overall Study|Subject Refusal to Continue|1|||
125946517|NCT02689258|453103059|FG002|Overall Study|Subject Refusal to Continue|0|||
125946518|NCT02689258|453103060|FG003|Overall Study|Subject Refusal to Continue|0|||
125946519|NCT02689258|453103061|FG004|Overall Study|Subject Refusal to Continue|0|||
125946520|NCT02689258|453103062|FG005|Overall Study|Subject Refusal to Continue|0|||
125946521|NCT02689258|453103063|FG006|Overall Study|Subject Refusal to Continue|0|||
125946522|NCT02689258|453103064|FG007|Overall Study|Subject Refusal to Continue|0|||
125946523|NCT02689258|453103065|FG008|Overall Study|Subject Refusal to Continue|1|||
125946524|NCT02689258|453103066|FG009|Overall Study|Subject Refusal to Continue|0|||
125946525|NCT02689258|453103067|FG010|Overall Study|Subject Refusal to Continue|0|||
125946526|NCT02689258|453103068|FG011|Overall Study|Subject Refusal to Continue|1|||
125946527|NCT02689258|453103057|FG000|Overall Study|Other|0|||
125946528|NCT02689258|453103058|FG001|Overall Study|Other|2|||
125946529|NCT02689258|453103059|FG002|Overall Study|Other|0|||
125946530|NCT02689258|453103060|FG003|Overall Study|Other|0|||
125946531|NCT02689258|453103061|FG004|Overall Study|Other|1|||
125946532|NCT02689258|453103062|FG005|Overall Study|Other|0|||
125946533|NCT02689258|453103063|FG006|Overall Study|Other|0|||
125946534|NCT02689258|453103064|FG007|Overall Study|Other|0|||
125946535|NCT02689258|453103065|FG008|Overall Study|Other|1|||
126072375|NCT00784277|453559526|FG004|ER Treatment|Lack of Efficacy|3|||
126072376|NCT00784277|453559527|FG005|ER Treatment|Lack of Efficacy|4|||
126072377|NCT00784277|453559528|FG006|ER Treatment|Lack of Efficacy|0|||
126072378|NCT00784277|453559522|FG000|ER Treatment|Lost to Follow-up|0|||
126072379|NCT00784277|453559523|FG001|ER Treatment|Lost to Follow-up|0|||
126072380|NCT00784277|453559524|FG002|ER Treatment|Lost to Follow-up|0|||
126072381|NCT00784277|453559525|FG003|ER Treatment|Lost to Follow-up|0|||
126072382|NCT00784277|453559526|FG004|ER Treatment|Lost to Follow-up|0|||
126072383|NCT00784277|453559527|FG005|ER Treatment|Lost to Follow-up|2|||
126072384|NCT00784277|453559528|FG006|ER Treatment|Lost to Follow-up|0|||
126072385|NCT00784277|453559522|FG000|ER Treatment|Withdrawal by Subject|0|||
126072386|NCT00784277|453559523|FG001|ER Treatment|Withdrawal by Subject|0|||
126072387|NCT00784277|453559524|FG002|ER Treatment|Withdrawal by Subject|0|||
126072388|NCT00784277|453559525|FG003|ER Treatment|Withdrawal by Subject|0|||
126072389|NCT00784277|453559526|FG004|ER Treatment|Withdrawal by Subject|2|||
126072390|NCT00784277|453559527|FG005|ER Treatment|Withdrawal by Subject|5|||
126072391|NCT00784277|453559528|FG006|ER Treatment|Withdrawal by Subject|3|||
126072392|NCT00784277|453559522|FG000|ER Treatment|Study Medication Non-Compliant|0|||
126072393|NCT00784277|453559523|FG001|ER Treatment|Study Medication Non-Compliant|0|||
126072394|NCT00784277|453559524|FG002|ER Treatment|Study Medication Non-Compliant|0|||
126072395|NCT00784277|453559525|FG003|ER Treatment|Study Medication Non-Compliant|0|||
126072396|NCT00784277|453559526|FG004|ER Treatment|Study Medication Non-Compliant|2|||
126072397|NCT00784277|453559527|FG005|ER Treatment|Study Medication Non-Compliant|3|||
126072398|NCT00784277|453559528|FG006|ER Treatment|Study Medication Non-Compliant|3|||
126072399|NCT00784277|453559522|FG000|ER Treatment|Other|0|||
126072400|NCT00784277|453559523|FG001|ER Treatment|Other|0|||
126072401|NCT00784277|453559524|FG002|ER Treatment|Other|0|||
126072402|NCT00784277|453559525|FG003|ER Treatment|Other|0|||
126072403|NCT00784277|453559526|FG004|ER Treatment|Other|1|||
126072404|NCT00784277|453559527|FG005|ER Treatment|Other|3|||
126072405|NCT00784277|453559528|FG006|ER Treatment|Other|2|||
126072406|NCT02025985|453559537|FG000|Overall Study|Consent withdrawn|0|||
126072407|NCT02025985|453559538|FG001|Overall Study|Consent withdrawn|0|||
126072408|NCT02025985|453559539|FG002|Overall Study|Consent withdrawn|1|||
126072409|NCT02025985|453559540|FG003|Overall Study|Consent withdrawn|0|||
126072410|NCT02025985|453559541|FG004|Overall Study|Consent withdrawn|0|||
126072411|NCT02025985|453559537|FG000|Overall Study|Termination of study by Sponsor|4|||
126072412|NCT02025985|453559538|FG001|Overall Study|Termination of study by Sponsor|3|||
126072413|NCT02025985|453559539|FG002|Overall Study|Termination of study by Sponsor|1|||
126072414|NCT02025985|453559540|FG003|Overall Study|Termination of study by Sponsor|1|||
126072415|NCT02025985|453559541|FG004|Overall Study|Termination of study by Sponsor|3|||
126072416|NCT02025985|453559537|FG000|Overall Study|Death|21|||
126072417|NCT02025985|453559538|FG001|Overall Study|Death|20|||
126072418|NCT02025985|453559539|FG002|Overall Study|Death|23|||
126072419|NCT02025985|453559540|FG003|Overall Study|Death|20|||
126072420|NCT02025985|453559541|FG004|Overall Study|Death|17|||
126072421|NCT03041701|453559542|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
126072422|NCT03041701|453559543|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
126072423|NCT03041701|453559544|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
126072424|NCT03041701|453559542|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
126072425|NCT03041701|453559543|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
126072426|NCT03041701|453559544|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
126072427|NCT00745121|453559545|FG000|Overall Study|Death|3|||
126072428|NCT00745121|453559546|FG001|Overall Study|Death|0|||
126072429|NCT00745121|453559545|FG000|Overall Study|Adverse Event|1|||
126072430|NCT00745121|453559546|FG001|Overall Study|Adverse Event|0|||
126072431|NCT00745121|453559545|FG000|Overall Study|Lost to Follow-up|1|||
126072432|NCT00745121|453559546|FG001|Overall Study|Lost to Follow-up|0|||
126072433|NCT00745121|453559545|FG000|Overall Study|Withdrawal by Subject|4|||
126072434|NCT00745121|453559546|FG001|Overall Study|Withdrawal by Subject|2|||
126072435|NCT01713998|453559547|FG000|Overall Study|Lost to Follow-up|2|||
126072436|NCT01713998|453559548|FG001|Overall Study|Lost to Follow-up|0|||
125946536|NCT02689258|453103066|FG009|Overall Study|Other|0|||
125946537|NCT02689258|453103067|FG010|Overall Study|Other|0|||
126072437|NCT01713998|453559549|FG002|Overall Study|Lost to Follow-up|2|||
126072438|NCT01713998|453559547|FG000|Overall Study|Withdrawal by Subject|1|||
126072439|NCT01713998|453559548|FG001|Overall Study|Withdrawal by Subject|0|||
126072440|NCT01713998|453559549|FG002|Overall Study|Withdrawal by Subject|0|||
126114708|NCT03083847|453715749|FG005|Main|Physician Decision|1|||
125946538|NCT02689258|453103068|FG011|Overall Study|Other|0|||
125946539|NCT03373383|453103069|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
126072441|NCT02101268|453559550|FG000|Randomized Treatment Phase|Subject Decision|8|||
126072442|NCT02101268|453559551|FG001|Randomized Treatment Phase|Subject Decision|4|||
126072443|NCT02101268|453559552|FG002|Randomized Treatment Phase|Subject Decision|0|||
126072444|NCT02101268|453559553|FG003|Randomized Treatment Phase|Subject Decision|0|||
126072445|NCT02101268|453559550|FG000|Randomized Treatment Phase|Physician Decision|4|||
126072446|NCT02101268|453559551|FG001|Randomized Treatment Phase|Physician Decision|1|||
126072447|NCT02101268|453559552|FG002|Randomized Treatment Phase|Physician Decision|0|||
126072448|NCT02101268|453559553|FG003|Randomized Treatment Phase|Physician Decision|0|||
126072449|NCT02101268|453559550|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
126072450|NCT02101268|453559551|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
126072451|NCT02101268|453559552|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
126072452|NCT02101268|453559553|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
126072453|NCT02101268|453559550|FG000|Randomized Treatment Phase|Adverse Event|6|||
126072454|NCT02101268|453559551|FG001|Randomized Treatment Phase|Adverse Event|0|||
126072455|NCT02101268|453559552|FG002|Randomized Treatment Phase|Adverse Event|0|||
126072456|NCT02101268|453559553|FG003|Randomized Treatment Phase|Adverse Event|0|||
126072457|NCT02101268|453559550|FG000|Randomized Treatment Phase|Death|5|||
126072458|NCT02101268|453559551|FG001|Randomized Treatment Phase|Death|4|||
126072459|NCT02101268|453559552|FG002|Randomized Treatment Phase|Death|0|||
126072460|NCT02101268|453559553|FG003|Randomized Treatment Phase|Death|0|||
126072461|NCT02101268|453559550|FG000|Randomized Treatment Phase|Disease Progression|4|||
126072462|NCT02101268|453559551|FG001|Randomized Treatment Phase|Disease Progression|1|||
126072463|NCT02101268|453559552|FG002|Randomized Treatment Phase|Disease Progression|0|||
126072464|NCT02101268|453559553|FG003|Randomized Treatment Phase|Disease Progression|0|||
126072465|NCT02101268|453559550|FG000|Extended Treatment Phase|Subject Decision|0|||
126072466|NCT02101268|453559551|FG001|Extended Treatment Phase|Subject Decision|0|||
126072467|NCT02101268|453559552|FG002|Extended Treatment Phase|Subject Decision|3|||
126072468|NCT02101268|453559553|FG003|Extended Treatment Phase|Subject Decision|2|||
126072469|NCT02101268|453559550|FG000|Extended Treatment Phase|Physician Decision|0|||
126072470|NCT02101268|453559551|FG001|Extended Treatment Phase|Physician Decision|0|||
126072471|NCT02101268|453559552|FG002|Extended Treatment Phase|Physician Decision|5|||
126072472|NCT02101268|453559553|FG003|Extended Treatment Phase|Physician Decision|2|||
126072473|NCT02101268|453559550|FG000|Extended Treatment Phase|Adverse Event|0|||
126072474|NCT02101268|453559551|FG001|Extended Treatment Phase|Adverse Event|0|||
126072475|NCT02101268|453559552|FG002|Extended Treatment Phase|Adverse Event|14|||
126072476|NCT02101268|453559553|FG003|Extended Treatment Phase|Adverse Event|18|||
126072477|NCT02101268|453559550|FG000|Extended Treatment Phase|Death|0|||
126072478|NCT02101268|453559551|FG001|Extended Treatment Phase|Death|0|||
126072479|NCT02101268|453559552|FG002|Extended Treatment Phase|Death|5|||
126072480|NCT02101268|453559553|FG003|Extended Treatment Phase|Death|1|||
126072481|NCT02101268|453559550|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
126072482|NCT02101268|453559551|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
126072483|NCT02101268|453559552|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
126072484|NCT02101268|453559553|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
126072485|NCT02101268|453559550|FG000|Extended Treatment Phase|Disease Progression|0|||
126072486|NCT02101268|453559551|FG001|Extended Treatment Phase|Disease Progression|0|||
126072487|NCT02101268|453559552|FG002|Extended Treatment Phase|Disease Progression|13|||
126072488|NCT02101268|453559553|FG003|Extended Treatment Phase|Disease Progression|6|||
126072489|NCT02101268|453559550|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
126072490|NCT02101268|453559551|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
126072491|NCT02101268|453559552|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
126072492|NCT02101268|453559553|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
126072493|NCT00740870|453559554|FG000|Overall Study|Not Catheterized|4|||
126072494|NCT00740870|453559554|FG000|Overall Study|Further testing contraindicated implant|17|||
126072495|NCT00839332|453559556|FG000|Phase 1|Disease Progression|38|||
126072496|NCT00839332|453559557|FG001|Phase 1|Disease Progression|0|||
126072497|NCT00839332|453559558|FG002|Phase 1|Disease Progression|0|||
126072498|NCT00839332|453559556|FG000|Phase 1|Adverse Event|6|||
126072499|NCT00839332|453559557|FG001|Phase 1|Adverse Event|0|||
126072500|NCT00839332|453559558|FG002|Phase 1|Adverse Event|0|||
126072501|NCT00839332|453559556|FG000|Phase 1|Withdrawal by Subject|4|||
126072502|NCT00839332|453559557|FG001|Phase 1|Withdrawal by Subject|0|||
125946540|NCT03373383|453103070|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
126072503|NCT00839332|453559558|FG002|Phase 1|Withdrawal by Subject|0|||
126072504|NCT00839332|453559556|FG000|Phase 1|Physician Decision|2|||
126072505|NCT00839332|453559557|FG001|Phase 1|Physician Decision|0|||
126072506|NCT00839332|453559558|FG002|Phase 1|Physician Decision|0|||
126072507|NCT00839332|453559556|FG000|Phase 2|Protocol Violation|0|||
126072508|NCT00839332|453559557|FG001|Phase 2|Protocol Violation|1|||
126072509|NCT00839332|453559558|FG002|Phase 2|Protocol Violation|0|||
126072510|NCT00839332|453559556|FG000|Phase 2|Disease Progression|0|||
126072511|NCT00839332|453559557|FG001|Phase 2|Disease Progression|46|||
126072512|NCT00839332|453559558|FG002|Phase 2|Disease Progression|21|||
126072513|NCT00839332|453559556|FG000|Phase 2|Adverse Event|0|||
126072514|NCT00839332|453559557|FG001|Phase 2|Adverse Event|8|||
126072515|NCT00839332|453559558|FG002|Phase 2|Adverse Event|6|||
126072516|NCT00839332|453559556|FG000|Phase 2|Death|0|||
126072517|NCT00839332|453559557|FG001|Phase 2|Death|4|||
126072518|NCT00839332|453559558|FG002|Phase 2|Death|2|||
126072519|NCT00839332|453559556|FG000|Phase 2|Withdrawal by Subject|0|||
126072520|NCT00839332|453559557|FG001|Phase 2|Withdrawal by Subject|5|||
126072521|NCT00839332|453559558|FG002|Phase 2|Withdrawal by Subject|8|||
126072522|NCT00839332|453559556|FG000|Phase 2|Physician Decision|0|||
126072523|NCT00839332|453559557|FG001|Phase 2|Physician Decision|4|||
126072524|NCT00839332|453559558|FG002|Phase 2|Physician Decision|1|||
126072525|NCT00839332|453559556|FG000|Phase 2|Lost to Follow-up|0|||
126072526|NCT00839332|453559557|FG001|Phase 2|Lost to Follow-up|0|||
126072527|NCT00839332|453559558|FG002|Phase 2|Lost to Follow-up|1|||
126072528|NCT01200485|453559559|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
126072529|NCT01200485|453559560|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
126072530|NCT01200485|453559561|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
126072531|NCT01200485|453559559|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
126072532|NCT01200485|453559560|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
126072533|NCT01200485|453559561|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
126072534|NCT06080438|453559562|FG000|Overall Study|Lost to Follow-up|2|||
126072535|NCT03569475|453559563|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
126072536|NCT03569475|453559564|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
126072537|NCT03569475|453559565|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
126072538|NCT03569475|453559563|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
126072539|NCT03569475|453559564|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
126072540|NCT03569475|453559565|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
126072541|NCT03569475|453559563|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
126072542|NCT03569475|453559564|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
126072543|NCT03569475|453559565|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
126072544|NCT03569475|453559563|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
126072545|NCT03569475|453559564|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
126072546|NCT03569475|453559565|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
126072547|NCT03569475|453559563|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
126114709|NCT03083847|453715750|FG006|Main|Physician Decision|0|||
126114710|NCT03083847|453715751|FG007|Main|Physician Decision|0|||
126114711|NCT03083847|453715752|FG008|Main|Physician Decision|0|||
126114712|NCT03083847|453715753|FG009|Main|Physician Decision|0|||
126114713|NCT03083847|453715744|FG000|Main|Pregnancy|0|||
126114714|NCT03083847|453715745|FG001|Main|Pregnancy|0|||
126114715|NCT03083847|453715746|FG002|Main|Pregnancy|0|||
126114716|NCT03083847|453715747|FG003|Main|Pregnancy|0|||
126114717|NCT03083847|453715748|FG004|Main|Pregnancy|0|||
126114718|NCT03083847|453715749|FG005|Main|Pregnancy|0|||
126114719|NCT03083847|453715750|FG006|Main|Pregnancy|0|||
126114720|NCT03083847|453715751|FG007|Main|Pregnancy|1|||
126114721|NCT03083847|453715752|FG008|Main|Pregnancy|0|||
126114722|NCT03083847|453715753|FG009|Main|Pregnancy|0|||
126114723|NCT03083847|453715744|FG000|Main|Adverse Event|0|||
126114724|NCT03083847|453715745|FG001|Main|Adverse Event|0|||
126114725|NCT03083847|453715746|FG002|Main|Adverse Event|0|||
126114726|NCT03083847|453715747|FG003|Main|Adverse Event|0|||
126114727|NCT03083847|453715748|FG004|Main|Adverse Event|0|||
126114728|NCT03083847|453715749|FG005|Main|Adverse Event|0|||
126114729|NCT03083847|453715750|FG006|Main|Adverse Event|0|||
126114730|NCT03083847|453715751|FG007|Main|Adverse Event|2|||
126114731|NCT03083847|453715752|FG008|Main|Adverse Event|0|||
126114732|NCT03083847|453715753|FG009|Main|Adverse Event|0|||
126114733|NCT03083847|453715744|FG000|Main|Withdrawal by Subject|0|||
126114734|NCT03083847|453715745|FG001|Main|Withdrawal by Subject|0|||
126114735|NCT03083847|453715746|FG002|Main|Withdrawal by Subject|0|||
126114736|NCT03083847|453715747|FG003|Main|Withdrawal by Subject|0|||
126114737|NCT03083847|453715748|FG004|Main|Withdrawal by Subject|0|||
126114738|NCT03083847|453715749|FG005|Main|Withdrawal by Subject|0|||
126114739|NCT03083847|453715750|FG006|Main|Withdrawal by Subject|1|||
126072548|NCT03569475|453559564|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
126072549|NCT03569475|453559565|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
126072550|NCT03569475|453559563|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
126072551|NCT03569475|453559564|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
126114740|NCT03083847|453715751|FG007|Main|Withdrawal by Subject|1|||
126114741|NCT03083847|453715752|FG008|Main|Withdrawal by Subject|0|||
126114742|NCT03083847|453715753|FG009|Main|Withdrawal by Subject|0|||
126114743|NCT00058552|453715755|FG000|Overall Study|Died prior to receiving treatment|4|||
126114744|NCT00058552|453715756|FG001|Overall Study|Died prior to receiving treatment|2|||
126114745|NCT00058552|453715755|FG000|Overall Study|Disease progression|52|||
126114746|NCT00058552|453715756|FG001|Overall Study|Disease progression|44|||
126114747|NCT00058552|453715755|FG000|Overall Study|Adverse Event|4|||
126114748|NCT00058552|453715756|FG001|Overall Study|Adverse Event|2|||
126114749|NCT00058552|453715755|FG000|Overall Study|Withdrawal by Subject|3|||
126072552|NCT03569475|453559565|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
126072553|NCT03569475|453559563|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
126072554|NCT03569475|453559564|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
126072555|NCT03569475|453559565|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
126072556|NCT03569475|453559563|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
126072557|NCT03569475|453559564|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
126072558|NCT03569475|453559565|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
126072559|NCT03569475|453559563|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
126072560|NCT03569475|453559564|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
126072561|NCT03569475|453559565|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
126072562|NCT03638258|453559567|FG000|Overall Study|Adverse Event|1|||
126072563|NCT03638258|453559568|FG001|Overall Study|Adverse Event|0|||
126072564|NCT03638258|453559569|FG002|Overall Study|Adverse Event|2|||
126072565|NCT03638258|453559567|FG000|Overall Study|Lost to Follow-up|2|||
126072566|NCT03638258|453559568|FG001|Overall Study|Lost to Follow-up|4|||
126072567|NCT03638258|453559569|FG002|Overall Study|Lost to Follow-up|5|||
126072568|NCT03638258|453559567|FG000|Overall Study|Pregnancy|0|||
126072569|NCT03638258|453559568|FG001|Overall Study|Pregnancy|0|||
126072570|NCT03638258|453559569|FG002|Overall Study|Pregnancy|1|||
126072571|NCT03638258|453559567|FG000|Overall Study|Protocol Violation|0|||
126072572|NCT03638258|453559568|FG001|Overall Study|Protocol Violation|0|||
126072573|NCT03638258|453559569|FG002|Overall Study|Protocol Violation|1|||
126072574|NCT03638258|453559567|FG000|Overall Study|Withdrawal by Subject|4|||
126072575|NCT03638258|453559568|FG001|Overall Study|Withdrawal by Subject|5|||
126072576|NCT03638258|453559569|FG002|Overall Study|Withdrawal by Subject|12|||
126072577|NCT03638258|453559567|FG000|Overall Study|Lack of Efficacy|0|||
126072578|NCT03638258|453559568|FG001|Overall Study|Lack of Efficacy|0|||
126072579|NCT03638258|453559569|FG002|Overall Study|Lack of Efficacy|2|||
126072580|NCT02630706|453559570|FG000|Overall Study|Adverse Event|2|||
126072581|NCT02630706|453559571|FG001|Overall Study|Adverse Event|1|||
126072582|NCT02630706|453559572|FG002|Overall Study|Adverse Event|1|||
126072583|NCT02630706|453559570|FG000|Overall Study|Lost to Follow-up|0|||
126072584|NCT02630706|453559571|FG001|Overall Study|Lost to Follow-up|1|||
126072585|NCT02630706|453559572|FG002|Overall Study|Lost to Follow-up|2|||
126072586|NCT02630706|453559570|FG000|Overall Study|Physician Decision|1|||
126072587|NCT02630706|453559571|FG001|Overall Study|Physician Decision|1|||
126072588|NCT02630706|453559572|FG002|Overall Study|Physician Decision|0|||
126072589|NCT02630706|453559570|FG000|Overall Study|Pregnancy|0|||
126072590|NCT02630706|453559571|FG001|Overall Study|Pregnancy|1|||
126072591|NCT02630706|453559572|FG002|Overall Study|Pregnancy|0|||
126072592|NCT02630706|453559570|FG000|Overall Study|Withdrawal by Subject|4|||
126072593|NCT02630706|453559571|FG001|Overall Study|Withdrawal by Subject|5|||
126072594|NCT02630706|453559572|FG002|Overall Study|Withdrawal by Subject|7|||
126072595|NCT01678898|453559573|FG000|PB-102-F01|Adverse Event|0|||
126072596|NCT01678898|453559574|FG001|PB-102-F01|Adverse Event|1|||
126072597|NCT01678898|453559575|FG002|PB-102-F01|Adverse Event|0|||
126072598|NCT01678898|453559573|FG000|PB-102-F01|Physician Decision|0|||
125946541|NCT03373383|453103071|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
125946542|NCT03373383|453103072|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
125946543|NCT03373383|453103073|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
125946544|NCT03373383|453103069|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
125946545|NCT03373383|453103070|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
125946546|NCT03373383|453103071|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125946547|NCT03373383|453103072|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125946548|NCT03373383|453103073|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125946549|NCT03373383|453103069|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
125946550|NCT03373383|453103070|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
125946551|NCT03373383|453103071|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
125946552|NCT03373383|453103072|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
125946553|NCT03373383|453103073|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
125946554|NCT03373383|453103069|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
125946555|NCT03373383|453103070|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
125946556|NCT03373383|453103071|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
125946557|NCT03373383|453103072|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
125946558|NCT03373383|453103073|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
125946559|NCT03373383|453103069|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
126072599|NCT01678898|453559574|FG001|PB-102-F01|Physician Decision|1|||
126072600|NCT01678898|453559575|FG002|PB-102-F01|Physician Decision|0|||
126072601|NCT01527500|453559578|FG000|Part A|Administrative|11|||
126072602|NCT01527500|453559579|FG001|Part A|Administrative|7|||
125946560|NCT03373383|453103070|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
125946561|NCT03373383|453103071|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
126072603|NCT01527500|453559578|FG000|Part A|Adverse Event|4|||
126072604|NCT01527500|453559579|FG001|Part A|Adverse Event|2|||
126072605|NCT01527500|453559578|FG000|Part A|Death|4|||
126072606|NCT01527500|453559579|FG001|Part A|Death|1|||
126072607|NCT01527500|453559578|FG000|Part A|Lost to Follow-up|0|||
126072608|NCT01527500|453559579|FG001|Part A|Lost to Follow-up|1|||
126072609|NCT01527500|453559578|FG000|Part A|Protocol Deviation|9|||
126072610|NCT01527500|453559579|FG001|Part A|Protocol Deviation|2|||
126072611|NCT01527500|453559578|FG000|Part A|Withdrawal by Subject|2|||
126072612|NCT01527500|453559579|FG001|Part A|Withdrawal by Subject|0|||
126072613|NCT01527500|453559578|FG000|Part B|Adverse Event|1|||
126072614|NCT01527500|453559579|FG001|Part B|Adverse Event|0|||
126072615|NCT03078751|453559587|FG000|Overall Study|Adverse Event|4|||
126072616|NCT03078751|453559588|FG001|Overall Study|Adverse Event|0|||
126072617|NCT03078751|453559587|FG000|Overall Study|Physician Decision|1|||
126072618|NCT03078751|453559588|FG001|Overall Study|Physician Decision|0|||
126072619|NCT03078751|453559587|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
126072620|NCT03078751|453559588|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
126072621|NCT03078751|453559587|FG000|Overall Study|Subject/guardian decision|8|||
126072622|NCT03078751|453559588|FG001|Overall Study|Subject/guardian decision|1|||
126072623|NCT03078751|453559587|FG000|Overall Study|Untreated|0|||
126072624|NCT03078751|453559588|FG001|Overall Study|Untreated|4|||
126072625|NCT01209286|453559589|FG000|Overall Study|Adverse Event|4|||
126072626|NCT01209286|453559590|FG001|Overall Study|Adverse Event|3|||
126072627|NCT01209286|453559591|FG002|Overall Study|Adverse Event|1|||
126072628|NCT01209286|453559589|FG000|Overall Study|Hematological Relapse After Remission|0|||
126072629|NCT01209286|453559590|FG001|Overall Study|Hematological Relapse After Remission|1|||
126072630|NCT01209286|453559591|FG002|Overall Study|Hematological Relapse After Remission|1|||
126072631|NCT01209286|453559589|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
126072632|NCT01209286|453559590|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
126072633|NCT01209286|453559591|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
126072634|NCT01209286|453559589|FG000|Overall Study|Physician Decision|0|||
126072635|NCT01209286|453559590|FG001|Overall Study|Physician Decision|2|||
126072636|NCT01209286|453559591|FG002|Overall Study|Physician Decision|0|||
126072637|NCT01209286|453559589|FG000|Overall Study|Other|0|||
126072638|NCT01209286|453559590|FG001|Overall Study|Other|1|||
126072639|NCT01209286|453559591|FG002|Overall Study|Other|0|||
126072640|NCT00981578|453559592|FG000|Overall Study|Death|1|||
126072641|NCT00981578|453559592|FG000|Overall Study|Withdrawal by Subject|2|||
126072642|NCT01180790|453559593|FG000|Overall Study|Adverse Event|1|||
126072643|NCT01180790|453559594|FG001|Overall Study|Adverse Event|1|||
126072644|NCT01180790|453559595|FG002|Overall Study|Adverse Event|2|||
126072645|NCT01180790|453559596|FG003|Overall Study|Adverse Event|0|||
126072646|NCT01180790|453559597|FG004|Overall Study|Adverse Event|1|||
126072647|NCT01180790|453559598|FG005|Overall Study|Adverse Event|3|||
126072648|NCT01180790|453559599|FG006|Overall Study|Adverse Event|0|||
126072649|NCT01180790|453559593|FG000|Overall Study|Withdrawal by Subject|3|||
126072650|NCT01180790|453559594|FG001|Overall Study|Withdrawal by Subject|0|||
126072651|NCT01180790|453559595|FG002|Overall Study|Withdrawal by Subject|5|||
126072652|NCT01180790|453559596|FG003|Overall Study|Withdrawal by Subject|0|||
126072653|NCT01180790|453559597|FG004|Overall Study|Withdrawal by Subject|2|||
126072654|NCT01180790|453559598|FG005|Overall Study|Withdrawal by Subject|1|||
126072655|NCT01180790|453559599|FG006|Overall Study|Withdrawal by Subject|0|||
126072656|NCT01180790|453559593|FG000|Overall Study|Lost to Follow-up|3|||
126072657|NCT01180790|453559594|FG001|Overall Study|Lost to Follow-up|1|||
126072658|NCT01180790|453559595|FG002|Overall Study|Lost to Follow-up|0|||
126072659|NCT01180790|453559596|FG003|Overall Study|Lost to Follow-up|2|||
126072660|NCT01180790|453559597|FG004|Overall Study|Lost to Follow-up|1|||
126072661|NCT01180790|453559598|FG005|Overall Study|Lost to Follow-up|0|||
126072662|NCT01180790|453559599|FG006|Overall Study|Lost to Follow-up|1|||
126072663|NCT01180790|453559593|FG000|Overall Study|Physician Decision|1|||
126072664|NCT01180790|453559594|FG001|Overall Study|Physician Decision|0|||
126072665|NCT01180790|453559595|FG002|Overall Study|Physician Decision|0|||
126072666|NCT01180790|453559596|FG003|Overall Study|Physician Decision|1|||
126072667|NCT01180790|453559597|FG004|Overall Study|Physician Decision|0|||
126072668|NCT01180790|453559598|FG005|Overall Study|Physician Decision|0|||
126072669|NCT01180790|453559599|FG006|Overall Study|Physician Decision|0|||
126072670|NCT01180790|453559593|FG000|Overall Study|Lack of Efficacy|1|||
126072671|NCT01180790|453559594|FG001|Overall Study|Lack of Efficacy|2|||
126072672|NCT01180790|453559595|FG002|Overall Study|Lack of Efficacy|5|||
126072673|NCT01180790|453559596|FG003|Overall Study|Lack of Efficacy|6|||
126072674|NCT01180790|453559597|FG004|Overall Study|Lack of Efficacy|1|||
126072675|NCT01180790|453559598|FG005|Overall Study|Lack of Efficacy|3|||
126072676|NCT01180790|453559599|FG006|Overall Study|Lack of Efficacy|0|||
126072677|NCT01180790|453559593|FG000|Overall Study|compliance|0|||
126072678|NCT01180790|453559594|FG001|Overall Study|compliance|1|||
126072679|NCT01180790|453559595|FG002|Overall Study|compliance|0|||
126072680|NCT01180790|453559596|FG003|Overall Study|compliance|0|||
126072681|NCT01180790|453559597|FG004|Overall Study|compliance|0|||
126072682|NCT01180790|453559598|FG005|Overall Study|compliance|0|||
126072683|NCT01180790|453559599|FG006|Overall Study|compliance|0|||
126072684|NCT01180790|453559593|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
126072685|NCT01180790|453559594|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
126072686|NCT01180790|453559595|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
126072687|NCT01180790|453559596|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
126072688|NCT01180790|453559597|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
126072689|NCT01180790|453559598|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
126072690|NCT01180790|453559599|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
126072691|NCT04582864|453559600|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
126072692|NCT04582864|453559600|FG000|Overall Study|Death|1|||
126072693|NCT01482819|453559601|FG000|Overall Study|Lost to Follow-up|2|||
126072694|NCT00702520|453559605|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
126072695|NCT00702520|453559606|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
126072696|NCT00702520|453559607|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
126072697|NCT00702520|453559608|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
126072698|NCT00702520|453559605|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
126072699|NCT00702520|453559606|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
126072700|NCT00702520|453559607|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
126072701|NCT00702520|453559608|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
126072702|NCT00702520|453559605|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
126072703|NCT00702520|453559606|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
126072704|NCT00702520|453559607|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
126072705|NCT00702520|453559608|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
126072706|NCT02481934|453559609|FG000|Overall Study|Death|2|||
126072707|NCT01374971|453559610|FG000|Overall Study|Withdrawal by Subject|1|||
126072708|NCT04130061|453559618|FG000|Overall Study|OR team forgot to request membrane|1|||
126072709|NCT04130061|453559619|FG001|Overall Study|OR team forgot to request membrane|0|||
126072710|NCT01568112|453559620|FG000|Overall Study|Randomized But Not Treated|0|||
126072711|NCT01568112|453559621|FG001|Overall Study|Randomized But Not Treated|1|||
126072712|NCT01568112|453559622|FG002|Overall Study|Randomized But Not Treated|0|||
126072713|NCT01568112|453559623|FG003|Overall Study|Randomized But Not Treated|0|||
126072714|NCT01568112|453559620|FG000|Overall Study|Withdrew due to Adverse Event|2|||
126072715|NCT01568112|453559621|FG001|Overall Study|Withdrew due to Adverse Event|4|||
126072716|NCT01568112|453559622|FG002|Overall Study|Withdrew due to Adverse Event|6|||
126072717|NCT01568112|453559623|FG003|Overall Study|Withdrew due to Adverse Event|3|||
126072718|NCT01568112|453559620|FG000|Overall Study|Lost to Follow-up|0|||
126072719|NCT01568112|453559621|FG001|Overall Study|Lost to Follow-up|0|||
126072720|NCT01568112|453559622|FG002|Overall Study|Lost to Follow-up|0|||
126072721|NCT01568112|453559623|FG003|Overall Study|Lost to Follow-up|1|||
126072722|NCT01568112|453559620|FG000|Overall Study|Withdrawal by Subject|2|||
126072723|NCT01568112|453559621|FG001|Overall Study|Withdrawal by Subject|3|||
126072724|NCT01568112|453559622|FG002|Overall Study|Withdrawal by Subject|0|||
126072725|NCT01568112|453559623|FG003|Overall Study|Withdrawal by Subject|7|||
126072726|NCT01568112|453559620|FG000|Overall Study|Withdrawal by Physician|1|||
126072727|NCT01568112|453559621|FG001|Overall Study|Withdrawal by Physician|0|||
126072728|NCT01568112|453559622|FG002|Overall Study|Withdrawal by Physician|1|||
126072729|NCT01568112|453559623|FG003|Overall Study|Withdrawal by Physician|1|||
126072730|NCT00746785|453561191|FG000|Overall Study|Lost to Follow-up|29|||
126072731|NCT00746785|453561192|FG001|Overall Study|Lost to Follow-up|25|||
126072732|NCT00746785|453561193|FG002|Overall Study|Lost to Follow-up|27|||
126072733|NCT00113269|453561194|FG000|Overall Study|Not transplanted, donor issues|4|||
126072734|NCT00113269|453561195|FG001|Overall Study|Not transplanted, donor issues|0|||
126072735|NCT00113269|453561196|FG002|Overall Study|Not transplanted, donor issues|2|||
126072736|NCT00113269|453561197|FG003|Overall Study|Not transplanted, donor issues|2|||
126072737|NCT00113269|453561194|FG000|Overall Study|Not transplanted, recipient issues|2|||
126072738|NCT00113269|453561195|FG001|Overall Study|Not transplanted, recipient issues|1|||
126072739|NCT00113269|453561196|FG002|Overall Study|Not transplanted, recipient issues|7|||
126072740|NCT00113269|453561197|FG003|Overall Study|Not transplanted, recipient issues|4|||
126072741|NCT00113269|453561194|FG000|Overall Study|Early graft loss, technical|0|||
126072742|NCT00113269|453561195|FG001|Overall Study|Early graft loss, technical|0|||
126072743|NCT00113269|453561196|FG002|Overall Study|Early graft loss, technical|2|||
126072744|NCT00113269|453561197|FG003|Overall Study|Early graft loss, technical|0|||
126072745|NCT00113269|453561194|FG000|Overall Study|Death in operating room|0|||
126072746|NCT00113269|453561195|FG001|Overall Study|Death in operating room|0|||
126114750|NCT00058552|453715756|FG001|Overall Study|Withdrawal by Subject|5|||
126072747|NCT00113269|453561196|FG002|Overall Study|Death in operating room|0|||
126072748|NCT00113269|453561197|FG003|Overall Study|Death in operating room|1|||
126072749|NCT00113269|453561194|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
126072750|NCT00113269|453561195|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
126072751|NCT00113269|453561196|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
126072752|NCT00113269|453561197|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
126072753|NCT00113269|453561194|FG000|Overall Study|Adverse Event|2|||
126114751|NCT00058552|453715755|FG000|Overall Study|Physician Decision|2|||
126114752|NCT00058552|453715756|FG001|Overall Study|Physician Decision|5|||
126072754|NCT00113269|453561195|FG001|Overall Study|Adverse Event|7|||
126072755|NCT00113269|453561196|FG002|Overall Study|Adverse Event|11|||
126072756|NCT00113269|453561197|FG003|Overall Study|Adverse Event|7|||
126072757|NCT00113269|453561194|FG000|Overall Study|Withdrawal by Subject|4|||
126072758|NCT00113269|453561195|FG001|Overall Study|Withdrawal by Subject|3|||
126072759|NCT00113269|453561196|FG002|Overall Study|Withdrawal by Subject|4|||
126072760|NCT00113269|453561197|FG003|Overall Study|Withdrawal by Subject|2|||
126072761|NCT00113269|453561194|FG000|Overall Study|Graft loss|6|||
126072762|NCT00113269|453561195|FG001|Overall Study|Graft loss|6|||
126072763|NCT00113269|453561196|FG002|Overall Study|Graft loss|4|||
126072764|NCT00113269|453561197|FG003|Overall Study|Graft loss|9|||
126072765|NCT00113269|453561194|FG000|Overall Study|Protocol Violation|1|||
126072766|NCT00113269|453561195|FG001|Overall Study|Protocol Violation|0|||
126072767|NCT00113269|453561196|FG002|Overall Study|Protocol Violation|4|||
126072768|NCT00113269|453561197|FG003|Overall Study|Protocol Violation|2|||
126072769|NCT00113269|453561194|FG000|Overall Study|Lost to Follow-up|2|||
126072770|NCT00113269|453561195|FG001|Overall Study|Lost to Follow-up|3|||
126072771|NCT00113269|453561196|FG002|Overall Study|Lost to Follow-up|6|||
126072772|NCT00113269|453561197|FG003|Overall Study|Lost to Follow-up|3|||
126072773|NCT00113269|453561194|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
126072774|NCT00113269|453561195|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
126072775|NCT00113269|453561196|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
126072776|NCT00113269|453561197|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
126072777|NCT00113269|453561194|FG000|Overall Study|Discontinued due to rejection|0|||
126072778|NCT00113269|453561195|FG001|Overall Study|Discontinued due to rejection|0|||
126072779|NCT00113269|453561196|FG002|Overall Study|Discontinued due to rejection|1|||
126072780|NCT00113269|453561197|FG003|Overall Study|Discontinued due to rejection|0|||
126072781|NCT00113269|453561194|FG000|Overall Study|Moved|0|||
126072782|NCT00113269|453561195|FG001|Overall Study|Moved|1|||
126072783|NCT00113269|453561196|FG002|Overall Study|Moved|0|||
126072784|NCT00113269|453561197|FG003|Overall Study|Moved|3|||
126072785|NCT00113269|453561194|FG000|Overall Study|Received pancreas transplant|0|||
126072786|NCT00113269|453561195|FG001|Overall Study|Received pancreas transplant|0|||
126072787|NCT00113269|453561196|FG002|Overall Study|Received pancreas transplant|0|||
126072788|NCT00113269|453561197|FG003|Overall Study|Received pancreas transplant|2|||
126072789|NCT00113269|453561194|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
126072790|NCT00113269|453561195|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
126072791|NCT00113269|453561196|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
126072792|NCT00113269|453561197|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
126072793|NCT00113269|453561194|FG000|Overall Study|Did not meet eligibility criteria|1|||
126072794|NCT00113269|453561195|FG001|Overall Study|Did not meet eligibility criteria|0|||
126072795|NCT00113269|453561196|FG002|Overall Study|Did not meet eligibility criteria|0|||
126072796|NCT00113269|453561197|FG003|Overall Study|Did not meet eligibility criteria|1|||
126072797|NCT00113269|453561194|FG000|Overall Study|Unable to return for follow up|2|||
126072798|NCT00113269|453561195|FG001|Overall Study|Unable to return for follow up|1|||
126072799|NCT00113269|453561196|FG002|Overall Study|Unable to return for follow up|0|||
126072800|NCT00113269|453561197|FG003|Overall Study|Unable to return for follow up|0|||
126072801|NCT00966979|453561199|FG000|Overall Study|Death|1|||
126072802|NCT00966979|453561199|FG000|Overall Study|Lost to Follow-up|6|||
126072803|NCT00966979|453561199|FG000|Overall Study|Withdrawal by Subject|14|||
126072804|NCT00966979|453561199|FG000|Overall Study|Adverse Event|5|||
126072805|NCT00966979|453561199|FG000|Overall Study|Sponsor terminated early|49|||
126072806|NCT00966979|453561199|FG000|Overall Study|Censored because surgery not done|2|||
126072807|NCT00966979|453561199|FG000|Overall Study|Censored because study device was not implanted|14|||
126072808|NCT00966979|453561199|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
126072809|NCT04140266|453561200|FG000|Overall Study|Physician Decision|2|||
126072810|NCT04140266|453561201|FG001|Overall Study|Physician Decision|0|||
126072811|NCT04140266|453561200|FG000|Overall Study|Withdrawal by Subject|4|||
126072812|NCT04140266|453561201|FG001|Overall Study|Withdrawal by Subject|2|||
126072813|NCT03119688|453561205|FG000|Overall Study|Adverse Event|4|||
126072814|NCT03226106|453561206|FG000|Overall Study|Withdrawal by Subject|2|||
126072815|NCT03226106|453561207|FG001|Overall Study|Withdrawal by Subject|0|||
126072816|NCT03226106|453561206|FG000|Overall Study|Adverse Event|1|||
126072817|NCT03226106|453561207|FG001|Overall Study|Adverse Event|0|||
126072818|NCT03226106|453561206|FG000|Overall Study|Lost to Follow-up|2|||
126072819|NCT03226106|453561207|FG001|Overall Study|Lost to Follow-up|0|||
126072820|NCT00721214|453561208|FG000|Overall Study|Chose another center for transplant|1|||
126072821|NCT00721214|453561208|FG000|Overall Study|Death|3|||
126072822|NCT05006417|453561209|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
126072823|NCT01243411|453561210|FG000|Overall Study|Withdrawal by Subject|18|||
126072824|NCT01243411|453561210|FG000|Overall Study|Lost to Follow-up|10|||
126072825|NCT01243411|453561210|FG000|Overall Study|Adverse Event|5|||
126072826|NCT01243411|453561210|FG000|Overall Study|Other|8|||
126072827|NCT00488319|453561213|FG000|Overall Study|Adverse Event|1|||
126072828|NCT00488319|453561214|FG001|Overall Study|Adverse Event|2|||
126072829|NCT00488319|453561215|FG002|Overall Study|Adverse Event|23|||
126072830|NCT00488319|453561213|FG000|Overall Study|Lack of Efficacy|6|||
126072831|NCT00488319|453561214|FG001|Overall Study|Lack of Efficacy|12|||
126072832|NCT00488319|453561215|FG002|Overall Study|Lack of Efficacy|27|||
126072833|NCT00488319|453561213|FG000|Overall Study|Lost to Follow-up|3|||
126072834|NCT00488319|453561214|FG001|Overall Study|Lost to Follow-up|5|||
126072835|NCT00488319|453561215|FG002|Overall Study|Lost to Follow-up|16|||
126072836|NCT00488319|453561213|FG000|Overall Study|Withdrawal by Subject|5|||
126072837|NCT00488319|453561214|FG001|Overall Study|Withdrawal by Subject|20|||
126072838|NCT00488319|453561215|FG002|Overall Study|Withdrawal by Subject|44|||
126072839|NCT00488319|453561213|FG000|Overall Study|Other reasons for withdrawal|0|||
126072840|NCT00488319|453561214|FG001|Overall Study|Other reasons for withdrawal|4|||
126072841|NCT00488319|453561215|FG002|Overall Study|Other reasons for withdrawal|12|||
126072842|NCT02158247|453561216|FG000|Overall Study|Invisible vocal cords|5|||
126072843|NCT00875615|453561223|FG000|Overall Study|Withdrawal by Subject|1|||
126072844|NCT01772823|453561224|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
126072845|NCT01772823|453561225|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
126072846|NCT01772823|453561224|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
126072847|NCT01772823|453561225|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
126072848|NCT01772823|453561224|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
126072849|NCT01772823|453561225|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
126072850|NCT01772823|453561224|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
126072851|NCT01772823|453561225|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
126072852|NCT01772823|453561224|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
126072853|NCT01772823|453561225|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
126072854|NCT01772823|453561224|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
126072855|NCT01772823|453561225|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
126072856|NCT01772823|453561224|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
126072857|NCT01772823|453561225|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
126072858|NCT01772823|453561224|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
126072859|NCT01772823|453561225|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
126072860|NCT01772823|453561224|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
126072861|NCT01772823|453561225|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
126072862|NCT01772823|453561224|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
126072863|NCT01772823|453561225|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
126072864|NCT01772823|453561224|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
126072865|NCT01772823|453561225|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
126072866|NCT01772823|453561224|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
126072867|NCT01772823|453561225|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
126072868|NCT01772823|453561224|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
126072869|NCT01772823|453561225|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
126072870|NCT01772823|453561224|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
126072871|NCT01772823|453561225|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
126072872|NCT01772823|453561224|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
126072873|NCT01772823|453561225|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
126072874|NCT01772823|453561224|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
126072875|NCT01772823|453561225|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
126072876|NCT03712449|453561228|FG000|Overall Study|Withdraw Consent|0|||
126072877|NCT03712449|453561229|FG001|Overall Study|Withdraw Consent|1|||
126072878|NCT02490878|453561234|FG000|Overall Study|deemed ineligible|0|||
126072879|NCT02490878|453561235|FG001|Overall Study|deemed ineligible|1|||
126072880|NCT02490878|453561234|FG000|Overall Study|progression prior to treatment|0|||
126072881|NCT02490878|453561235|FG001|Overall Study|progression prior to treatment|1|||
126072882|NCT02490878|453561234|FG000|Overall Study|only submitted baseline QOL|0|||
126072883|NCT02490878|453561235|FG001|Overall Study|only submitted baseline QOL|1|||
126072884|NCT02544113|453561237|FG000|Overall Study|Death|3|||
126072885|NCT02544113|453561238|FG001|Overall Study|Death|4|||
126072886|NCT00451555|453561239|FG000|Overall Study|Protocol Violation|2|||
126072887|NCT00451555|453561240|FG001|Overall Study|Protocol Violation|2|||
126072888|NCT00451555|453561239|FG000|Overall Study|Adverse Event|3|||
126072889|NCT00451555|453561240|FG001|Overall Study|Adverse Event|1|||
126072890|NCT00451555|453561239|FG000|Overall Study|Withdrawal by Subject|6|||
126072891|NCT00451555|453561240|FG001|Overall Study|Withdrawal by Subject|0|||
126072892|NCT00451555|453561239|FG000|Overall Study|Physician Decision|2|||
126072893|NCT00451555|453561240|FG001|Overall Study|Physician Decision|1|||
126072894|NCT02847637|453561241|FG000|Overall Study|Withdrawal by Subject|0|||
126072895|NCT02847637|453561242|FG001|Overall Study|Withdrawal by Subject|1|||
126072896|NCT02847637|453561243|FG002|Overall Study|Withdrawal by Subject|1|||
126072897|NCT02847637|453561244|FG003|Overall Study|Withdrawal by Subject|0|||
126072898|NCT02847637|453561241|FG000|Overall Study|Lost to Follow-up|1|||
126072899|NCT02847637|453561242|FG001|Overall Study|Lost to Follow-up|1|||
126072900|NCT02847637|453561243|FG002|Overall Study|Lost to Follow-up|0|||
126072901|NCT02847637|453561244|FG003|Overall Study|Lost to Follow-up|0|||
126072902|NCT00588341|453561252|FG000|Overall Study|Withdrawal by Subject|3|||
126072903|NCT00588341|453561252|FG000|Overall Study|Not treated due to metastatic disease|1|||
126072904|NCT00588341|453561252|FG000|Overall Study|Patient ineligible|1|||
126072905|NCT01670188|453561253|FG000|Overall Study|Death|0|||
126072906|NCT01670188|453561254|FG001|Overall Study|Death|1|||
126072907|NCT01281917|453561262|FG000|Overall Study|Withdrawal by Subject|1|||
126072908|NCT01187407|453561264|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
126072909|NCT01187407|453561265|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126072910|NCT01187407|453561266|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126072911|NCT01187407|453561267|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126072912|NCT01187407|453561268|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126072913|NCT01187407|453561264|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
126072914|NCT01187407|453561265|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126072915|NCT01187407|453561266|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126072916|NCT01187407|453561267|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126072917|NCT01187407|453561268|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126072918|NCT01187407|453561264|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
126072919|NCT01187407|453561265|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126072920|NCT01187407|453561266|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126072921|NCT01187407|453561267|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126072922|NCT01187407|453561268|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126072923|NCT01187407|453561264|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
126072924|NCT01187407|453561265|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126072925|NCT01187407|453561266|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126072926|NCT01187407|453561267|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126072927|NCT01187407|453561268|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126072928|NCT01187407|453561264|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
126072929|NCT01187407|453561265|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126072930|NCT01187407|453561266|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126072931|NCT01187407|453561267|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126072932|NCT01187407|453561268|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126072933|NCT01187407|453561264|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
126072934|NCT01187407|453561265|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126072935|NCT01187407|453561266|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126072936|NCT01187407|453561267|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126072937|NCT01187407|453561268|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126072938|NCT01187407|453561264|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
126072939|NCT01187407|453561265|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126072940|NCT01187407|453561266|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126072941|NCT01187407|453561267|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126072942|NCT01187407|453561268|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126072943|NCT01187407|453561264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
126072944|NCT01187407|453561265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
126072945|NCT01187407|453561266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
126072946|NCT01187407|453561267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
126072947|NCT01187407|453561268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
126072948|NCT01187407|453561264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
126072949|NCT01187407|453561265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
126072950|NCT01187407|453561266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
126072951|NCT01187407|453561267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
126072952|NCT01187407|453561268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
126072953|NCT01187407|453561264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
126072954|NCT01187407|453561265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
126072955|NCT01187407|453561266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
126072956|NCT01187407|453561267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
126072957|NCT01187407|453561268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
126072958|NCT01187407|453561264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126072959|NCT01187407|453561265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126072960|NCT01187407|453561266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126072961|NCT01187407|453561267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
126072962|NCT01187407|453561268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
125946562|NCT03373383|453103072|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
125946563|NCT03373383|453103073|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
126072963|NCT01187407|453561264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
126072964|NCT01187407|453561265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
126072965|NCT01187407|453561266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126072966|NCT01187407|453561267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
126072967|NCT01187407|453561268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
126072968|NCT01187407|453561264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
126072969|NCT01187407|453561265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
126072970|NCT01187407|453561266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
126072971|NCT01187407|453561267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
126072972|NCT01187407|453561268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
126072973|NCT01187407|453561264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126072974|NCT01187407|453561265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
126072975|NCT01187407|453561266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
126072976|NCT01187407|453561267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
126072977|NCT01187407|453561268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
126072978|NCT00776984|453561271|FG000|Overall Study|Adverse Event|8|||
126072979|NCT00776984|453561272|FG001|Overall Study|Adverse Event|2|||
126072980|NCT00776984|453561271|FG000|Overall Study|Protocol Violation|4|||
126072981|NCT00776984|453561272|FG001|Overall Study|Protocol Violation|2|||
126072982|NCT00776984|453561271|FG000|Overall Study|Lost to Follow-up|2|||
126072983|NCT00776984|453561272|FG001|Overall Study|Lost to Follow-up|0|||
126072984|NCT00776984|453561271|FG000|Overall Study|Withdrawal by Subject|12|||
126072985|NCT00776984|453561272|FG001|Overall Study|Withdrawal by Subject|7|||
126072986|NCT00776984|453561271|FG000|Overall Study|Lack of Efficacy|0|||
126072987|NCT00776984|453561272|FG001|Overall Study|Lack of Efficacy|1|||
126072988|NCT00776984|453561271|FG000|Overall Study|Other|5|||
126072989|NCT00776984|453561272|FG001|Overall Study|Other|9|||
126072990|NCT02573883|453561280|FG000|Six Month Follow Up|Lost to Follow-up|1|||
126072991|NCT02573883|453561281|FG001|Six Month Follow Up|Lost to Follow-up|0|||
126072992|NCT02573883|453561282|FG002|Six Month Follow Up|Lost to Follow-up|0|||
126072993|NCT02573883|453561283|FG003|Six Month Follow Up|Lost to Follow-up|0|||
126072994|NCT02573883|453561280|FG000|One Year Follow Up|Lost to Follow-up|2|||
126072995|NCT02573883|453561281|FG001|One Year Follow Up|Lost to Follow-up|1|||
126072996|NCT02573883|453561282|FG002|One Year Follow Up|Lost to Follow-up|0|||
126072997|NCT02573883|453561283|FG003|One Year Follow Up|Lost to Follow-up|0|||
126072998|NCT01544309|453561284|FG000|Overall Study|Withdrawal by Subject|12|||
126072999|NCT01544309|453561285|FG001|Overall Study|Withdrawal by Subject|7|||
126073000|NCT01544309|453561284|FG000|Overall Study|Protocol Violation|2|||
126073001|NCT01544309|453561285|FG001|Overall Study|Protocol Violation|1|||
126073002|NCT01544309|453561284|FG000|Overall Study|Physician Decision|4|||
126073003|NCT01544309|453561285|FG001|Overall Study|Physician Decision|1|||
126073004|NCT01544309|453561284|FG000|Overall Study|Not performed pre-dose examination|1|||
126073005|NCT01544309|453561285|FG001|Overall Study|Not performed pre-dose examination|2|||
126073006|NCT01544309|453561284|FG000|Overall Study|Administered prohibit prior medication|1|||
126073007|NCT01544309|453561285|FG001|Overall Study|Administered prohibit prior medication|0|||
126073008|NCT00118703|453561286|FG000|Overall Study|Protocol Violation|1|||
126114753|NCT00058552|453715755|FG000|Overall Study|Clinical disease progression|0|||
126114754|NCT00058552|453715756|FG001|Overall Study|Clinical disease progression|4|||
125946564|NCT03373383|453103069|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
125946565|NCT03373383|453103070|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
125946566|NCT03373383|453103071|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
125946567|NCT03373383|453103072|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
126073009|NCT00118703|453561287|FG001|Overall Study|Protocol Violation|0|||
126073010|NCT00118703|453561286|FG000|Overall Study|Adverse Event|1|||
126073011|NCT00118703|453561287|FG001|Overall Study|Adverse Event|1|||
126073012|NCT00118703|453561286|FG000|Overall Study|Participant took two different treatment|0|||
126073013|NCT00118703|453561287|FG001|Overall Study|Participant took two different treatment|1|||
126073014|NCT00118703|453561286|FG000|Overall Study|Withdrawal by Subject|2|||
126073015|NCT00118703|453561287|FG001|Overall Study|Withdrawal by Subject|5|||
126073016|NCT00118703|453561286|FG000|Overall Study|Lost to Follow-up|1|||
126073017|NCT00118703|453561287|FG001|Overall Study|Lost to Follow-up|2|||
126073018|NCT03796208|453561292|FG000|Overall Study|Withdrawal by Subject|3|||
126073019|NCT03796208|453561293|FG001|Overall Study|Withdrawal by Subject|0|||
126073020|NCT03796208|453561292|FG000|Overall Study|Loss of pregnancy|1|||
126073021|NCT03796208|453561293|FG001|Overall Study|Loss of pregnancy|1|||
126073022|NCT03796208|453561292|FG000|Overall Study|Changed prenatal clinics|0|||
126073023|NCT03796208|453561293|FG001|Overall Study|Changed prenatal clinics|5|||
126073024|NCT03796208|453561292|FG000|Overall Study|Lost to Follow-up|20|||
126114755|NCT02319668|453715757|FG000|Overall Study|Other (Not specified)|0|||
126114756|NCT02319668|453715758|FG001|Overall Study|Other (Not specified)|2|||
126073025|NCT03796208|453561293|FG001|Overall Study|Lost to Follow-up|16|||
126073026|NCT02725008|453561294|FG000|Overall Study|Lost to Follow-up|7|||
126073027|NCT02725008|453561295|FG001|Overall Study|Lost to Follow-up|9|||
125946568|NCT03373383|453103073|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
125946569|NCT03373383|453103069|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
125946570|NCT03373383|453103070|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
125946571|NCT03373383|453103071|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
125946572|NCT03373383|453103072|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
126114757|NCT02316340|453715761|FG000|First Progression|Clinical progression|2|||
126114758|NCT02316340|453715762|FG001|First Progression|Clinical progression|1|||
126114759|NCT02316340|453715761|FG000|First Progression|Withdrawal by Subject|1|||
125946573|NCT03373383|453103073|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
125946574|NCT03373383|453103069|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
125946575|NCT03373383|453103070|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
125946576|NCT03373383|453103071|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
125946577|NCT03373383|453103072|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
125946578|NCT03373383|453103073|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
125946579|NCT03373383|453103069|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
125946580|NCT03373383|453103070|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
125946581|NCT03373383|453103071|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
125946582|NCT03373383|453103072|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
125946583|NCT03373383|453103073|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
125946584|NCT04753164|453103077|FG000|Overall Study|Adverse Event|0|||
125946585|NCT04753164|453103078|FG001|Overall Study|Adverse Event|2|||
125946586|NCT04753164|453103077|FG000|Overall Study|Withdrawal by Subject|9|||
125946587|NCT04753164|453103078|FG001|Overall Study|Withdrawal by Subject|7|||
125946588|NCT04753164|453103077|FG000|Overall Study|Lost to Follow-up|6|||
125946589|NCT04753164|453103078|FG001|Overall Study|Lost to Follow-up|6|||
125946590|NCT04753164|453103077|FG000|Overall Study|Other|12|||
125946591|NCT04753164|453103078|FG001|Overall Study|Other|5|||
125946592|NCT00694369|453103079|FG000|Overall Study|Adverse Event|0|||
125946593|NCT00694369|453103080|FG001|Overall Study|Adverse Event|1|||
125946594|NCT00694369|453103081|FG002|Overall Study|Adverse Event|0|||
125946595|NCT00694369|453103082|FG003|Overall Study|Adverse Event|1|||
125946596|NCT00694369|453103083|FG004|Overall Study|Adverse Event|3|||
125946597|NCT00694369|453103079|FG000|Overall Study|Lost to Follow-up|0|||
125946598|NCT00694369|453103080|FG001|Overall Study|Lost to Follow-up|0|||
125946599|NCT00694369|453103081|FG002|Overall Study|Lost to Follow-up|1|||
125946600|NCT00694369|453103082|FG003|Overall Study|Lost to Follow-up|1|||
125946601|NCT00694369|453103083|FG004|Overall Study|Lost to Follow-up|0|||
125946602|NCT00694369|453103079|FG000|Overall Study|Physician Decision|0|||
125946603|NCT00694369|453103080|FG001|Overall Study|Physician Decision|0|||
125946604|NCT00694369|453103081|FG002|Overall Study|Physician Decision|0|||
125946605|NCT00694369|453103082|FG003|Overall Study|Physician Decision|0|||
125946606|NCT00694369|453103083|FG004|Overall Study|Physician Decision|1|||
125946607|NCT00694369|453103079|FG000|Overall Study|Protocol Violation|0|||
125946608|NCT00694369|453103080|FG001|Overall Study|Protocol Violation|1|||
125946609|NCT00694369|453103081|FG002|Overall Study|Protocol Violation|0|||
125946610|NCT00694369|453103082|FG003|Overall Study|Protocol Violation|0|||
125946611|NCT00694369|453103083|FG004|Overall Study|Protocol Violation|0|||
125946612|NCT00694369|453103079|FG000|Overall Study|Withdrawal by Subject|1|||
125946613|NCT00694369|453103080|FG001|Overall Study|Withdrawal by Subject|1|||
125946614|NCT00694369|453103081|FG002|Overall Study|Withdrawal by Subject|1|||
125946615|NCT00694369|453103082|FG003|Overall Study|Withdrawal by Subject|1|||
125946616|NCT00694369|453103083|FG004|Overall Study|Withdrawal by Subject|2|||
125946617|NCT00907374|453103090|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
125946618|NCT00907374|453103091|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
125946619|NCT02871739|453103092|FG000|Overall Study|Lost to Follow-up|3|||
125946620|NCT02871739|453103093|FG001|Overall Study|Lost to Follow-up|2|||
125946621|NCT02871739|453103094|FG002|Overall Study|Lost to Follow-up|0|||
125946622|NCT02871739|453103095|FG003|Overall Study|Lost to Follow-up|2|||
125946623|NCT00439556|453103096|FG000|Overall Study|Patient was taken off study for non-comp|0|||
125946624|NCT00439556|453103097|FG001|Overall Study|Patient was taken off study for non-comp|1|||
125946625|NCT00439556|453103098|FG002|Overall Study|Patient was taken off study for non-comp|0|||
125946626|NCT03818516|453103099|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
125946627|NCT04372602|453103102|FG000|Overall Study|Withdrawal by Subject|1|||
125946628|NCT04372602|453103103|FG001|Overall Study|Withdrawal by Subject|1|||
125946629|NCT04372602|453103102|FG000|Overall Study|Adverse Event|0|||
125946630|NCT04372602|453103103|FG001|Overall Study|Adverse Event|1|||
125946631|NCT04372602|453103102|FG000|Overall Study|Transitioned to comfort care|0|||
125946632|NCT04372602|453103103|FG001|Overall Study|Transitioned to comfort care|1|||
125946633|NCT04371380|453103110|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
125946634|NCT04371380|453103111|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
125946635|NCT04371380|453103112|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
125946636|NCT00680901|453103119|FG000|Overall Study|Ongoing: On Study Treatment|1|||
125946637|NCT00680901|453103120|FG001|Overall Study|Ongoing: On Study Treatment|0|||
126114760|NCT02316340|453715762|FG001|First Progression|Withdrawal by Subject|0|||
125946638|NCT00680901|453103119|FG000|Overall Study|Ongoing: In Follow Up|1|||
125946639|NCT00680901|453103120|FG001|Overall Study|Ongoing: In Follow Up|0|||
125946640|NCT00680901|453103119|FG000|Overall Study|Adverse Event|1|||
125946641|NCT00680901|453103120|FG001|Overall Study|Adverse Event|1|||
125946642|NCT00680901|453103119|FG000|Overall Study|Lost to Follow-up|3|||
125946643|NCT00680901|453103120|FG001|Overall Study|Lost to Follow-up|5|||
125946644|NCT00680901|453103119|FG000|Overall Study|Subject decided to withdraw from the study|4|||
125946645|NCT00680901|453103120|FG001|Overall Study|Subject decided to withdraw from the study|15|||
125946646|NCT00680901|453103119|FG000|Overall Study|Sponsor decision|1|||
125946647|NCT00680901|453103120|FG001|Overall Study|Sponsor decision|0|||
125946648|NCT00680901|453103119|FG000|Overall Study|Physician Decision|0|||
125946649|NCT00680901|453103120|FG001|Overall Study|Physician Decision|2|||
125946650|NCT00680901|453103119|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
125946651|NCT00680901|453103120|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
125946652|NCT00680901|453103119|FG000|Overall Study|Other protocol defined stopping criteria|17|||
125946653|NCT00680901|453103120|FG001|Overall Study|Other protocol defined stopping criteria|17|||
125946654|NCT04544293|453103121|FG000|Double-blind|Adverse Event|2|||
125946655|NCT04544293|453103122|FG001|Double-blind|Adverse Event|1|||
125946656|NCT04544293|453103121|FG000|Double-blind|Pregnancy|0|||
125946657|NCT04544293|453103122|FG001|Double-blind|Pregnancy|1|||
125946658|NCT04544293|453103121|FG000|Double-blind|Lost to Follow-up|0|||
125946659|NCT04544293|453103122|FG001|Double-blind|Lost to Follow-up|1|||
125946660|NCT04544293|453103121|FG000|Open-Label Extension|Study ongoing|79|||
125946661|NCT04544293|453103122|FG001|Open-Label Extension|Study ongoing|81|||
125946662|NCT01951157|453103123|FG000|Overall Study|Progressive Disease|12|||
125946663|NCT01951157|453103124|FG001|Overall Study|Progressive Disease|13|||
125946664|NCT01951157|453103125|FG002|Overall Study|Progressive Disease|10|||
125946665|NCT01951157|453103123|FG000|Overall Study|Treatment-unrelated AE|1|||
125946666|NCT01951157|453103124|FG001|Overall Study|Treatment-unrelated AE|0|||
125946667|NCT01951157|453103125|FG002|Overall Study|Treatment-unrelated AE|3|||
125946668|NCT01951157|453103123|FG000|Overall Study|Study Termination|0|||
125946669|NCT01951157|453103124|FG001|Overall Study|Study Termination|0|||
125946670|NCT01951157|453103125|FG002|Overall Study|Study Termination|1|||
125946671|NCT01951157|453103123|FG000|Overall Study|Physician Decision|5|||
125946672|NCT01951157|453103124|FG001|Overall Study|Physician Decision|3|||
125946673|NCT01951157|453103125|FG002|Overall Study|Physician Decision|2|||
125946674|NCT01951157|453103123|FG000|Overall Study|Non-treatmentrelated death|2|||
125946675|NCT01951157|453103124|FG001|Overall Study|Non-treatmentrelated death|2|||
125946676|NCT01951157|453103125|FG002|Overall Study|Non-treatmentrelated death|2|||
125946677|NCT01951157|453103123|FG000|Overall Study|No treated|0|||
125946678|NCT01951157|453103124|FG001|Overall Study|No treated|1|||
125946679|NCT01951157|453103125|FG002|Overall Study|No treated|0|||
125946680|NCT01951157|453103123|FG000|Overall Study|Treatment-related AE|2|||
125946681|NCT01951157|453103124|FG001|Overall Study|Treatment-related AE|0|||
125946682|NCT01951157|453103125|FG002|Overall Study|Treatment-related AE|4|||
125946683|NCT01951157|453103123|FG000|Overall Study|Consent withdrawn by subject|0|||
125946684|NCT01951157|453103124|FG001|Overall Study|Consent withdrawn by subject|1|||
125946685|NCT01951157|453103125|FG002|Overall Study|Consent withdrawn by subject|3|||
125946686|NCT01951157|453103123|FG000|Overall Study|Treatment-related death|0|||
125946687|NCT01951157|453103124|FG001|Overall Study|Treatment-related death|2|||
125946688|NCT01951157|453103125|FG002|Overall Study|Treatment-related death|0|||
125946689|NCT04809220|453103126|FG000|Overall Study|Adverse Event|4|||
125946690|NCT04809220|453103127|FG001|Overall Study|Adverse Event|0|||
125946691|NCT04809220|453103126|FG000|Overall Study|Death|1|||
125946692|NCT04809220|453103127|FG001|Overall Study|Death|0|||
125946693|NCT04809220|453103126|FG000|Overall Study|Lost to Follow-up|3|||
125946694|NCT04809220|453103127|FG001|Overall Study|Lost to Follow-up|0|||
125946695|NCT04809220|453103126|FG000|Overall Study|Physician Decision|0|||
125946696|NCT04809220|453103127|FG001|Overall Study|Physician Decision|1|||
125946697|NCT04809220|453103126|FG000|Overall Study|Withdrawal by Subject|9|||
125946698|NCT04809220|453103127|FG001|Overall Study|Withdrawal by Subject|5|||
125946699|NCT04809220|453103126|FG000|Overall Study|Due to long-term overseas business trips|1|||
125946700|NCT04809220|453103127|FG001|Overall Study|Due to long-term overseas business trips|0|||
125946701|NCT01062555|453103133|FG000|Phase 1|Death|10|||
125946702|NCT01062555|453103134|FG001|Phase 1|Death|17|||
125946703|NCT01062555|453103135|FG002|Phase 1|Death|0|||
125946704|NCT01062555|453103136|FG003|Phase 1|Death|0|||
125946705|NCT01062555|453103133|FG000|Phase 1|Graft Failure|12|||
125946706|NCT01062555|453103134|FG001|Phase 1|Graft Failure|8|||
125946707|NCT01062555|453103135|FG002|Phase 1|Graft Failure|0|||
125946708|NCT01062555|453103136|FG003|Phase 1|Graft Failure|0|||
125946709|NCT01062555|453103133|FG000|Phase 1|Withdrawal by Subject|1|||
125946710|NCT01062555|453103134|FG001|Phase 1|Withdrawal by Subject|1|||
125946711|NCT01062555|453103135|FG002|Phase 1|Withdrawal by Subject|0|||
125946712|NCT01062555|453103136|FG003|Phase 1|Withdrawal by Subject|0|||
125946713|NCT01062555|453103133|FG000|Phase 2|Death|0|||
125946714|NCT01062555|453103134|FG001|Phase 2|Death|0|||
125946715|NCT01062555|453103135|FG002|Phase 2|Death|8|||
125946716|NCT01062555|453103136|FG003|Phase 2|Death|3|||
126073028|NCT02725008|453561294|FG000|Overall Study|Withdrawal by Subject|2|||
126073029|NCT02725008|453561295|FG001|Overall Study|Withdrawal by Subject|2|||
126073030|NCT02725008|453561294|FG000|Overall Study|Admitted to hospital|0|||
126073031|NCT02725008|453561295|FG001|Overall Study|Admitted to hospital|1|||
126073032|NCT01560585|453561296|FG000|Overall Study|Physician Decision|3|||
126073033|NCT02175745|453561301|FG000|Overall Study|Not Eligible|1|||
126073034|NCT04688086|453561302|FG000|Overall Study|Lost to Follow-up|164|||
126073035|NCT04688086|453561302|FG000|Overall Study|Imaging error;|64|||
126073036|NCT04206384|453561305|FG000|Overall Study|Withdrawal by Subject|8|||
126073037|NCT04206384|453561305|FG000|Overall Study|Adverse Event|2|||
126073038|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
126073039|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
126073040|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
126073041|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Other|1|||
126073042|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Other|0|||
126073043|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Other|0|||
126073044|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Physician Decision|3|||
126073045|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Physician Decision|0|||
126073046|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Physician Decision|0|||
126073047|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
126073048|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
126073049|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
126073050|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
126073051|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
126073052|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
126073053|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Adverse Event|18|||
126073054|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Adverse Event|0|||
126073055|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Adverse Event|0|||
126073056|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
126073057|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
126073058|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
126073059|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
126073060|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
126073061|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
126073062|NCT03030599|453561306|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
126073063|NCT03030599|453561307|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
126073064|NCT03030599|453561308|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
126073065|NCT03030599|453561306|FG000|Stable Dose|Protocol deviation|3|||
126073066|NCT03030599|453561307|FG001|Stable Dose|Protocol deviation|0|||
126073067|NCT03030599|453561308|FG002|Stable Dose|Protocol deviation|0|||
126073068|NCT03030599|453561306|FG000|Stable Dose|Adverse Event|1|||
126073069|NCT03030599|453561307|FG001|Stable Dose|Adverse Event|0|||
126073070|NCT03030599|453561308|FG002|Stable Dose|Adverse Event|0|||
126073071|NCT03030599|453561306|FG000|Stable Dose|Lost to Follow-up|1|||
126073072|NCT03030599|453561307|FG001|Stable Dose|Lost to Follow-up|0|||
125946717|NCT01062555|453103133|FG000|Phase 2|Graft failure|0|||
125946718|NCT01062555|453103134|FG001|Phase 2|Graft failure|0|||
125946719|NCT01062555|453103135|FG002|Phase 2|Graft failure|7|||
125946720|NCT01062555|453103136|FG003|Phase 2|Graft failure|4|||
125946721|NCT01062555|453103133|FG000|Phase 2|Withdrawal by Subject|0|||
125946722|NCT01062555|453103134|FG001|Phase 2|Withdrawal by Subject|0|||
125946723|NCT01062555|453103135|FG002|Phase 2|Withdrawal by Subject|0|||
125946724|NCT01062555|453103136|FG003|Phase 2|Withdrawal by Subject|7|||
125946725|NCT01062555|453103133|FG000|Phase 2|Protocol Violation|0|||
125946726|NCT01062555|453103134|FG001|Phase 2|Protocol Violation|0|||
125946727|NCT01062555|453103135|FG002|Phase 2|Protocol Violation|0|||
125946728|NCT01062555|453103136|FG003|Phase 2|Protocol Violation|3|||
126073073|NCT03030599|453561308|FG002|Stable Dose|Lost to Follow-up|0|||
126073074|NCT03030599|453561306|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
126073075|NCT03030599|453561307|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
126073076|NCT03030599|453561308|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
126073077|NCT03030599|453561306|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
126073078|NCT03030599|453561307|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
126073079|NCT03030599|453561308|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
126073080|NCT03030599|453561306|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
126073081|NCT03030599|453561307|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
126073082|NCT03030599|453561308|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
126073083|NCT03030599|453561306|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
126073084|NCT03030599|453561307|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
126073085|NCT03030599|453561308|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
125946729|NCT01062555|453103133|FG000|Phase 2|Physician Decision|0|||
125946730|NCT01062555|453103134|FG001|Phase 2|Physician Decision|0|||
125946731|NCT01062555|453103135|FG002|Phase 2|Physician Decision|0|||
125946732|NCT01062555|453103136|FG003|Phase 2|Physician Decision|17|||
125946733|NCT00329407|453103139|FG000|Overall Study|Withdrawal by Subject|1|||
125946734|NCT00978068|453103140|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
125946735|NCT00978068|453103141|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
125946736|NCT00978068|453103140|FG000|Overall Study|Death|1|||
125946737|NCT00978068|453103141|FG001|Overall Study|Death|2|||
125946738|NCT00978068|453103140|FG000|Overall Study|Lost to Follow-up|1|||
125946739|NCT00978068|453103141|FG001|Overall Study|Lost to Follow-up|2|||
125946740|NCT00978068|453103140|FG000|Overall Study|Physician Decision|0|||
125946741|NCT00978068|453103141|FG001|Overall Study|Physician Decision|1|||
125946742|NCT00978068|453103140|FG000|Overall Study|Unable to Comply with Study|0|||
125946743|NCT00978068|453103141|FG001|Overall Study|Unable to Comply with Study|2|||
125946744|NCT04964128|453103142|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
125946745|NCT04964128|453103142|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
125946746|NCT01471379|453103143|FG000|Overall Study|Adverse Event|1|||
125946747|NCT01471379|453103144|FG001|Overall Study|Adverse Event|0|||
125946748|NCT01471379|453103145|FG002|Overall Study|Adverse Event|0|||
125946749|NCT01471379|453103143|FG000|Overall Study|Study terminated|0|||
125946750|NCT01471379|453103144|FG001|Overall Study|Study terminated|1|||
125946751|NCT01471379|453103145|FG002|Overall Study|Study terminated|0|||
126073086|NCT03030599|453561306|FG000|Open-label Extension|Adverse Event|3|||
126073087|NCT03030599|453561307|FG001|Open-label Extension|Adverse Event|0|||
126073088|NCT03030599|453561308|FG002|Open-label Extension|Adverse Event|0|||
126073089|NCT03030599|453561306|FG000|Open-label Extension|Lost to Follow-up|2|||
126073090|NCT03030599|453561307|FG001|Open-label Extension|Lost to Follow-up|0|||
126073091|NCT03030599|453561308|FG002|Open-label Extension|Lost to Follow-up|0|||
126073092|NCT03030599|453561306|FG000|Open-label Extension|Lack of Efficacy|1|||
126073093|NCT03030599|453561307|FG001|Open-label Extension|Lack of Efficacy|0|||
126073094|NCT03030599|453561308|FG002|Open-label Extension|Lack of Efficacy|0|||
126073095|NCT03030599|453561306|FG000|Open-label Extension|Other Reason|1|||
126073096|NCT03030599|453561307|FG001|Open-label Extension|Other Reason|0|||
126073097|NCT03030599|453561308|FG002|Open-label Extension|Other Reason|0|||
126073098|NCT00006436|453561309|FG000|Overall Study|Refused further treatment|2|||
126073099|NCT00006436|453561309|FG000|Overall Study|Declined to participate (before treatment started)|1|||
126073100|NCT00316589|453561310|FG000|Overall Study|Withdrawal by Subject|0|||
126073101|NCT00316589|453561311|FG001|Overall Study|Withdrawal by Subject|5|||
126073102|NCT00316589|453561312|FG002|Overall Study|Withdrawal by Subject|0|||
126073103|NCT00316589|453561313|FG003|Overall Study|Withdrawal by Subject|1|||
126073104|NCT00316589|453561310|FG000|Overall Study|Subject unwilling/unable to comply|0|||
126073105|NCT00316589|453561311|FG001|Overall Study|Subject unwilling/unable to comply|6|||
126073106|NCT00316589|453561312|FG002|Overall Study|Subject unwilling/unable to comply|0|||
126073107|NCT00316589|453561313|FG003|Overall Study|Subject unwilling/unable to comply|2|||
126073108|NCT00316589|453561310|FG000|Overall Study|Adverse Event|1|||
126073109|NCT00316589|453561311|FG001|Overall Study|Adverse Event|0|||
126073110|NCT00316589|453561312|FG002|Overall Study|Adverse Event|0|||
126073111|NCT00316589|453561313|FG003|Overall Study|Adverse Event|1|||
126073112|NCT00316589|453561310|FG000|Overall Study|Physician Decision|0|||
126073113|NCT00316589|453561311|FG001|Overall Study|Physician Decision|1|||
126073114|NCT00316589|453561312|FG002|Overall Study|Physician Decision|0|||
126073115|NCT00316589|453561313|FG003|Overall Study|Physician Decision|0|||
126073116|NCT00316589|453561310|FG000|Overall Study|Other reason|0|||
126073117|NCT00316589|453561311|FG001|Overall Study|Other reason|12|||
126073118|NCT00316589|453561312|FG002|Overall Study|Other reason|1|||
126073119|NCT00316589|453561313|FG003|Overall Study|Other reason|1|||
126073120|NCT00562484|453561316|FG000|Overall Study|Adverse Event|6|||
126073121|NCT00562484|453561317|FG001|Overall Study|Adverse Event|1|||
126073122|NCT00562484|453561316|FG000|Overall Study|Protocol Violation|11|||
126073123|NCT00562484|453561317|FG001|Overall Study|Protocol Violation|2|||
126073124|NCT00562484|453561316|FG000|Overall Study|Withdrawal by Subject|12|||
126073125|NCT00562484|453561317|FG001|Overall Study|Withdrawal by Subject|9|||
126073126|NCT00562484|453561316|FG000|Overall Study|Moved away from the study area|20|||
126073127|NCT00562484|453561317|FG001|Overall Study|Moved away from the study area|9|||
126114761|NCT01986920|453715763|FG000|A- 101 25%|Withdrawal by Subject|1|||
126114762|NCT01986920|453715764|FG001|A- 101 25%|Withdrawal by Subject|0|||
125946752|NCT02120794|453103146|FG000|Overall Study|Withdrawal by Subject|43|||
125946753|NCT02120794|453103146|FG000|Overall Study|Adverse Event|10|||
125946754|NCT02120794|453103146|FG000|Overall Study|Physician Decision|4|||
126073128|NCT00562484|453561316|FG000|Overall Study|Lost to Follow-up|132|||
126073129|NCT00562484|453561317|FG001|Overall Study|Lost to Follow-up|71|||
126073130|NCT00562484|453561316|FG000|Overall Study|Reason not provided or not specified|25|||
126073131|NCT00562484|453561317|FG001|Overall Study|Reason not provided or not specified|12|||
125946755|NCT02120794|453103146|FG000|Overall Study|Due to insurance coverage|1|||
125946756|NCT01712256|453103165|FG000|Overall Study|Lost to Follow-up|1|||
125946757|NCT00748215|453103168|FG000|Overall Study|Withdrawal by Subject|7|||
125946758|NCT00748215|453103169|FG001|Overall Study|Withdrawal by Subject|7|||
125946759|NCT00748215|453103168|FG000|Overall Study|Treatment change|2|||
126073132|NCT00942188|453561318|FG000|Overall Study|Adverse Event|0|||
126073133|NCT00942188|453561319|FG001|Overall Study|Adverse Event|3|||
126073134|NCT00942188|453561320|FG002|Overall Study|Adverse Event|2|||
126073135|NCT00942188|453561321|FG003|Overall Study|Adverse Event|0|||
126073136|NCT00942188|453561318|FG000|Overall Study|Lack of Efficacy|0|||
126073137|NCT00942188|453561319|FG001|Overall Study|Lack of Efficacy|0|||
126073138|NCT00942188|453561320|FG002|Overall Study|Lack of Efficacy|0|||
126073139|NCT00942188|453561321|FG003|Overall Study|Lack of Efficacy|1|||
126073140|NCT00942188|453561318|FG000|Overall Study|Protocol Violation|1|||
126073141|NCT00942188|453561319|FG001|Overall Study|Protocol Violation|1|||
126073142|NCT00942188|453561320|FG002|Overall Study|Protocol Violation|0|||
126073143|NCT00942188|453561321|FG003|Overall Study|Protocol Violation|0|||
126073144|NCT00942188|453561318|FG000|Overall Study|Lost to Follow-up|2|||
126073145|NCT00942188|453561319|FG001|Overall Study|Lost to Follow-up|1|||
126073146|NCT00942188|453561320|FG002|Overall Study|Lost to Follow-up|2|||
126073147|NCT00942188|453561321|FG003|Overall Study|Lost to Follow-up|0|||
126073148|NCT00942188|453561318|FG000|Overall Study|Withdrawal by Subject|1|||
126073149|NCT00942188|453561319|FG001|Overall Study|Withdrawal by Subject|3|||
126073150|NCT00942188|453561320|FG002|Overall Study|Withdrawal by Subject|4|||
126073151|NCT00942188|453561321|FG003|Overall Study|Withdrawal by Subject|2|||
126073152|NCT00942188|453561318|FG000|Overall Study|Physician Decision|0|||
126073153|NCT00942188|453561319|FG001|Overall Study|Physician Decision|0|||
125946760|NCT00748215|453103169|FG001|Overall Study|Treatment change|1|||
125946761|NCT00748215|453103168|FG000|Overall Study|Change in patient condition|0|||
125946762|NCT00748215|453103169|FG001|Overall Study|Change in patient condition|3|||
125946763|NCT00748215|453103168|FG000|Overall Study|Non-compliant|0|||
125946764|NCT00748215|453103169|FG001|Overall Study|Non-compliant|2|||
125946765|NCT00748215|453103168|FG000|Overall Study|Adverse Event|0|||
125946766|NCT00748215|453103169|FG001|Overall Study|Adverse Event|5|||
125946767|NCT00026793|453103173|FG000|Overall Study|Death on study due to underlying disease|4|||
125946768|NCT00026793|453103173|FG000|Overall Study|Physician Decision|2|||
125946769|NCT00026793|453103173|FG000|Overall Study|Off study|2|||
125946770|NCT04151290|453103174|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
125946771|NCT03256552|453105056|FG000|Overall Study|Protocol Violation|1|||
125946772|NCT03256552|453105056|FG000|Overall Study|Physician Decision|1|||
125946773|NCT03256552|453105056|FG000|Overall Study|Adverse Event|1|||
125946774|NCT03256552|453105056|FG000|Overall Study|Withdrawal by Subject|2|||
125946775|NCT05083442|453105062|FG000|Overall Study|Lost to Follow-up|1|||
125946776|NCT05083442|453105063|FG001|Overall Study|Lost to Follow-up|0|||
125946777|NCT05083442|453105062|FG000|Overall Study|Lack of Efficacy|0|||
125946778|NCT05083442|453105063|FG001|Overall Study|Lack of Efficacy|1|||
125946779|NCT05083442|453105062|FG000|Overall Study|Withdrawal by Subject|1|||
125946780|NCT05083442|453105063|FG001|Overall Study|Withdrawal by Subject|3|||
125946781|NCT05083442|453105062|FG000|Overall Study|scheduling difficulties|1|||
125946782|NCT05083442|453105063|FG001|Overall Study|scheduling difficulties|2|||
125946783|NCT03711162|453105066|FG000|Overall Study|Adverse Event|5|||
125946784|NCT03711162|453105067|FG001|Overall Study|Adverse Event|2|||
125946785|NCT03711162|453105068|FG002|Overall Study|Adverse Event|4|||
125946786|NCT03711162|453105066|FG000|Overall Study|Death|11|||
125946787|NCT03711162|453105067|FG001|Overall Study|Death|7|||
125946788|NCT03711162|453105068|FG002|Overall Study|Death|8|||
125946789|NCT03711162|453105066|FG000|Overall Study|Lost to Follow-up|1|||
125946790|NCT03711162|453105067|FG001|Overall Study|Lost to Follow-up|0|||
125946791|NCT03711162|453105068|FG002|Overall Study|Lost to Follow-up|1|||
125946792|NCT03711162|453105066|FG000|Overall Study|Study Terminated by Sponsor|139|||
125946793|NCT03711162|453105067|FG001|Overall Study|Study Terminated by Sponsor|152|||
125946794|NCT03711162|453105068|FG002|Overall Study|Study Terminated by Sponsor|146|||
125946795|NCT03711162|453105066|FG000|Overall Study|Withdrawal by Subject|17|||
125946796|NCT03711162|453105067|FG001|Overall Study|Withdrawal by Subject|10|||
125946797|NCT03711162|453105068|FG002|Overall Study|Withdrawal by Subject|10|||
125946798|NCT03711162|453105066|FG000|Overall Study|Miscellaneous|1|||
125946799|NCT03711162|453105067|FG001|Overall Study|Miscellaneous|2|||
125946800|NCT03711162|453105068|FG002|Overall Study|Miscellaneous|2|||
125946801|NCT03711162|453105066|FG000|Overall Study|Not Treated|1|||
125946802|NCT03711162|453105067|FG001|Overall Study|Not Treated|0|||
125946803|NCT03711162|453105068|FG002|Overall Study|Not Treated|1|||
125946804|NCT03711162|453105066|FG000|Overall Study|Physician Decision|0|||
125946805|NCT03711162|453105067|FG001|Overall Study|Physician Decision|2|||
125946806|NCT03711162|453105068|FG002|Overall Study|Physician Decision|0|||
125946807|NCT03711162|453105066|FG000|Overall Study|Lack of Efficacy|0|||
125946808|NCT03711162|453105067|FG001|Overall Study|Lack of Efficacy|0|||
125946809|NCT03711162|453105068|FG002|Overall Study|Lack of Efficacy|2|||
125946810|NCT03711162|453105066|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
125946811|NCT03711162|453105067|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
125946812|NCT03711162|453105068|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
125946813|NCT03034954|453105069|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
125946814|NCT03034954|453105070|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
125946815|NCT00394212|453105073|FG000|Overall Study|Lost to Follow-up|3|||
125946816|NCT00394212|453105074|FG001|Overall Study|Lost to Follow-up|0|||
126073154|NCT00942188|453561320|FG002|Overall Study|Physician Decision|1|||
126073155|NCT00942188|453561321|FG003|Overall Study|Physician Decision|0|||
126073156|NCT00942188|453561318|FG000|Overall Study|Sponsor Decision|0|||
126073157|NCT00942188|453561319|FG001|Overall Study|Sponsor Decision|2|||
126073158|NCT00942188|453561320|FG002|Overall Study|Sponsor Decision|0|||
126073159|NCT00942188|453561321|FG003|Overall Study|Sponsor Decision|1|||
126073160|NCT00276016|453561322|FG000|Intervention 1|Withdrawal by Subject|0|||
126073161|NCT00276016|453561323|FG001|Intervention 1|Withdrawal by Subject|1|||
126073162|NCT00276016|453561324|FG002|Intervention 1|Withdrawal by Subject|0|||
126073163|NCT00276016|453561325|FG003|Intervention 1|Withdrawal by Subject|0|||
126073164|NCT00276016|453561326|FG004|Intervention 1|Withdrawal by Subject|0|||
126073165|NCT00276016|453561327|FG005|Intervention 1|Withdrawal by Subject|0|||
126073166|NCT05041439|453561328|FG000|Overall Study|Withdrawal by Subject|1|||
126073167|NCT05041439|453561329|FG001|Overall Study|Withdrawal by Subject|1|||
126073168|NCT05041439|453561328|FG000|Overall Study|Death|1|||
126073169|NCT05041439|453561329|FG001|Overall Study|Death|0|||
126073170|NCT00560313|453562490|FG000|Overall Study|Adverse Events or Death|2|||
126073171|NCT00560313|453562490|FG000|Overall Study|Withdrawal by Subject|2|||
126073172|NCT00560313|453562490|FG000|Overall Study|Lost to Follow-up|1|||
126073173|NCT00560313|453562490|FG000|Overall Study|Protocol Violation|1|||
126073174|NCT01821729|453562491|FG000|Overall Study|Withdrawal by Subject|1|||
126073175|NCT02517528|453562492|FG000|Overall Study|Withdrawal by Subject|1|||
126073176|NCT02262364|453562496|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
126073177|NCT02741713|453562501|FG000|Overall Study|Surgery type changed intra-operatively|2|||
126073178|NCT02741713|453562502|FG001|Overall Study|Surgery type changed intra-operatively|1|||
126073179|NCT03503162|453562503|FG000|Overall Study|did not meet eligibility|1|||
126073180|NCT02246218|453562504|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126073181|NCT02246218|453562505|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126073182|NCT02246218|453562504|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
126073183|NCT02246218|453562505|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
126073184|NCT02246218|453562504|FG000|Overall Study|Adverse Event|1|||
126073185|NCT02246218|453562505|FG001|Overall Study|Adverse Event|1|||
126073186|NCT02246218|453562504|FG000|Overall Study|Lost to Follow-up|1|||
126073187|NCT02246218|453562505|FG001|Overall Study|Lost to Follow-up|0|||
126073188|NCT03891641|453562508|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
126073189|NCT03891641|453562509|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
126073190|NCT01093222|453562510|FG000|Overall Study|Ineligible|6|||
126073191|NCT01093222|453562510|FG000|Overall Study|Adverse Event|7|||
126073192|NCT01093222|453562510|FG000|Overall Study|Progression/relapse|24|||
126073193|NCT01093222|453562510|FG000|Overall Study|Death|2|||
126073194|NCT01093222|453562510|FG000|Overall Study|Not protocol specified|1|||
126073195|NCT02212301|453562511|FG000|Period 1|Lost to Follow-up|0|||
126073196|NCT02212301|453562512|FG001|Period 1|Lost to Follow-up|1|||
126073197|NCT00866918|453562517|FG000|Overall Study|Death|1|||
126073198|NCT00866918|453562518|FG001|Overall Study|Death|5|||
126073199|NCT00866918|453562517|FG000|Overall Study|Lack of Efficacy|1|||
126073200|NCT00866918|453562518|FG001|Overall Study|Lack of Efficacy|1|||
126073201|NCT00866918|453562517|FG000|Overall Study|Physician Decision|10|||
126073202|NCT00866918|453562518|FG001|Overall Study|Physician Decision|2|||
126073203|NCT00866918|453562517|FG000|Overall Study|Ineligible|2|||
126073204|NCT00866918|453562518|FG001|Overall Study|Ineligible|4|||
126073205|NCT00866918|453562517|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
126073206|NCT00866918|453562518|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
125946817|NCT00394212|453105073|FG000|Overall Study|Withdrawal by Subject|4|||
126073207|NCT00866918|453562517|FG000|Overall Study|Secondary malignancy|1|||
126073208|NCT00866918|453562518|FG001|Overall Study|Secondary malignancy|0|||
126073209|NCT00527514|453562519|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
126073210|NCT00527514|453562519|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
126073211|NCT00527514|453562519|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
126073212|NCT00527514|453562519|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
126073213|NCT00527514|453562519|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
126073214|NCT00527514|453562519|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
126073215|NCT00527514|453562519|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
126073216|NCT00920699|453562522|FG000|Overall Study|Withdrawal by Subject|2|||
126073217|NCT00920699|453562523|FG001|Overall Study|Withdrawal by Subject|0|||
126073218|NCT00920699|453562524|FG002|Overall Study|Withdrawal by Subject|2|||
126073219|NCT00920699|453562522|FG000|Overall Study|no longer met eligibility|0|||
126073220|NCT00920699|453562523|FG001|Overall Study|no longer met eligibility|1|||
126073221|NCT00920699|453562524|FG002|Overall Study|no longer met eligibility|0|||
126073222|NCT00920699|453562522|FG000|Overall Study|Lost to Follow-up|0|||
126073223|NCT00920699|453562523|FG001|Overall Study|Lost to Follow-up|0|||
126073224|NCT00920699|453562524|FG002|Overall Study|Lost to Follow-up|2|||
126073225|NCT03723915|453562527|FG000|Screening|Failed to meet screening requirements.|2|||
126073226|NCT03723915|453562527|FG000|On Treatment|Failed to meet treatment requirements|2|||
126073227|NCT01978236|453562531|FG000|Overall Study|Discontinued due to study close|2|||
126073228|NCT00634920|453562533|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
126073229|NCT00634920|453562534|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
126073230|NCT00634920|453562535|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
126073231|NCT00634920|453562533|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
126073232|NCT00634920|453562534|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
126073233|NCT00634920|453562535|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
126073234|NCT00634920|453562533|FG000|Period 1 - Pre-Randomization|Rejections|0|||
126073235|NCT00634920|453562534|FG001|Period 1 - Pre-Randomization|Rejections|0|||
126073236|NCT00634920|453562535|FG002|Period 1 - Pre-Randomization|Rejections|55|||
126073237|NCT00634920|453562533|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
126073238|NCT00634920|453562534|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
126073239|NCT00634920|453562535|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
126073240|NCT00634920|453562533|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
126073241|NCT00634920|453562534|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
126073242|NCT00634920|453562535|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
126073243|NCT00634920|453562533|FG000|Period 1 - Pre-Randomization|Other issues|0|||
126073244|NCT00634920|453562534|FG001|Period 1 - Pre-Randomization|Other issues|0|||
126073245|NCT00634920|453562535|FG002|Period 1 - Pre-Randomization|Other issues|6|||
126073246|NCT00634920|453562533|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
126073247|NCT00634920|453562534|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
126073248|NCT00634920|453562535|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
126073249|NCT00634920|453562533|FG000|Period 2 - Post-Randomization|Rejection|11|||
126073250|NCT00634920|453562534|FG001|Period 2 - Post-Randomization|Rejection|5|||
126073251|NCT00634920|453562535|FG002|Period 2 - Post-Randomization|Rejection|0|||
126073252|NCT00634920|453562533|FG000|Period 2 - Post-Randomization|Death|2|||
126073253|NCT00634920|453562534|FG001|Period 2 - Post-Randomization|Death|5|||
126073254|NCT00634920|453562535|FG002|Period 2 - Post-Randomization|Death|0|||
126073255|NCT00634920|453562533|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
126073256|NCT00634920|453562534|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
126073257|NCT00634920|453562535|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
126073258|NCT00634920|453562533|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
126073259|NCT00634920|453562534|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
126073260|NCT00634920|453562535|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
126073261|NCT00819013|453562536|FG000|Overall Study|Not meeting continuing study eligibility|2|||
126073262|NCT00819013|453562537|FG001|Overall Study|Not meeting continuing study eligibility|1|||
126073263|NCT00819013|453562538|FG002|Overall Study|Not meeting continuing study eligibility|2|||
126073264|NCT00819013|453562539|FG003|Overall Study|Not meeting continuing study eligibility|1|||
126073265|NCT00819013|453562536|FG000|Overall Study|Adverse Event|0|||
126073266|NCT00819013|453562537|FG001|Overall Study|Adverse Event|0|||
126073267|NCT00819013|453562538|FG002|Overall Study|Adverse Event|1|||
126073268|NCT00819013|453562539|FG003|Overall Study|Adverse Event|0|||
126073269|NCT00819013|453562536|FG000|Overall Study|Withdrawal by Subject|1|||
126073270|NCT00819013|453562537|FG001|Overall Study|Withdrawal by Subject|0|||
126073271|NCT00819013|453562538|FG002|Overall Study|Withdrawal by Subject|1|||
126073272|NCT00819013|453562539|FG003|Overall Study|Withdrawal by Subject|0|||
126073273|NCT00819013|453562536|FG000|Overall Study|Lost to Follow-up|0|||
126073274|NCT00819013|453562537|FG001|Overall Study|Lost to Follow-up|0|||
126073275|NCT00819013|453562538|FG002|Overall Study|Lost to Follow-up|1|||
126073276|NCT00819013|453562539|FG003|Overall Study|Lost to Follow-up|2|||
126073277|NCT00819013|453562536|FG000|Overall Study|Death|0|||
126073278|NCT00819013|453562537|FG001|Overall Study|Death|0|||
126073279|NCT00819013|453562538|FG002|Overall Study|Death|0|||
126073280|NCT00819013|453562539|FG003|Overall Study|Death|1|||
126073281|NCT00363649|453562540|FG000|Overall Study|Withdrawal by Subject|1|||
126073282|NCT00363649|453562541|FG001|Overall Study|Withdrawal by Subject|1|||
126073283|NCT00363649|453562540|FG000|Overall Study|Adverse Event|6|||
126073284|NCT00363649|453562541|FG001|Overall Study|Adverse Event|0|||
126073285|NCT00607997|453562544|FG000|Overall Study|Lack of Efficacy|6|||
126073286|NCT00607997|453562545|FG001|Overall Study|Lack of Efficacy|20|||
126073287|NCT00607997|453562546|FG002|Overall Study|Lack of Efficacy|14|||
126073288|NCT00607997|453562547|FG003|Overall Study|Lack of Efficacy|10|||
126073289|NCT00607997|453562544|FG000|Overall Study|Death|8|||
126073290|NCT00607997|453562545|FG001|Overall Study|Death|5|||
126073291|NCT00607997|453562546|FG002|Overall Study|Death|2|||
126073292|NCT00607997|453562547|FG003|Overall Study|Death|5|||
126073293|NCT00607997|453562544|FG000|Overall Study|Adverse Event|3|||
126073294|NCT00607997|453562545|FG001|Overall Study|Adverse Event|1|||
126073295|NCT00607997|453562546|FG002|Overall Study|Adverse Event|2|||
126073296|NCT00607997|453562547|FG003|Overall Study|Adverse Event|0|||
126073297|NCT00607997|453562544|FG000|Overall Study|Physician Decision|4|||
126073298|NCT00607997|453562545|FG001|Overall Study|Physician Decision|1|||
126073299|NCT00607997|453562546|FG002|Overall Study|Physician Decision|0|||
126073300|NCT00607997|453562547|FG003|Overall Study|Physician Decision|0|||
126073301|NCT00607997|453562544|FG000|Overall Study|Relapse, recurrent illness|4|||
126114763|NCT01986920|453715765|FG002|A- 101 25%|Withdrawal by Subject|0|||
126073302|NCT00607997|453562545|FG001|Overall Study|Relapse, recurrent illness|0|||
126073303|NCT00607997|453562546|FG002|Overall Study|Relapse, recurrent illness|2|||
126073304|NCT00607997|453562547|FG003|Overall Study|Relapse, recurrent illness|0|||
126073305|NCT00607997|453562544|FG000|Overall Study|Other without explanation|2|||
126073306|NCT00607997|453562545|FG001|Overall Study|Other without explanation|0|||
126073307|NCT00607997|453562546|FG002|Overall Study|Other without explanation|4|||
125946818|NCT00394212|453105074|FG001|Overall Study|Withdrawal by Subject|1|||
125946819|NCT00588445|453105075|FG000|Overall Study|Protocol Violation|1|||
125946820|NCT00588445|453105075|FG000|Overall Study|Withdrawal by Subject|3|||
125946821|NCT00588445|453105075|FG000|Overall Study|Disease Progression|1|||
125946822|NCT00588445|453105075|FG000|Overall Study|Not Treated|10|||
125946823|NCT03240133|453105076|FG000|Overall Study|Withdrawal by Subject|0|||
125946824|NCT03240133|453105077|FG001|Overall Study|Withdrawal by Subject|1|||
125946825|NCT03240133|453105078|FG002|Overall Study|Withdrawal by Subject|0|||
125946826|NCT03240133|453105076|FG000|Overall Study|Adverse Event|1|||
125946827|NCT03240133|453105077|FG001|Overall Study|Adverse Event|1|||
125946828|NCT03240133|453105078|FG002|Overall Study|Adverse Event|0|||
125946829|NCT03240133|453105076|FG000|Overall Study|Rash|1|||
125946830|NCT03240133|453105077|FG001|Overall Study|Rash|0|||
125946831|NCT03240133|453105078|FG002|Overall Study|Rash|0|||
125946832|NCT03240133|453105076|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
125946833|NCT03240133|453105077|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
125946834|NCT03240133|453105078|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
125946835|NCT03240133|453105076|FG000|Overall Study|Intercurrent illness.|0|||
125946836|NCT03240133|453105077|FG001|Overall Study|Intercurrent illness.|1|||
125946837|NCT03240133|453105078|FG002|Overall Study|Intercurrent illness.|0|||
125946838|NCT03240133|453105076|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
125946839|NCT03240133|453105077|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
125946840|NCT03240133|453105078|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
125946841|NCT01176292|453105079|FG000|Overall Study|Lost to Follow-up|2|||
125946842|NCT01176292|453105080|FG001|Overall Study|Lost to Follow-up|4|||
125946843|NCT01176292|453105079|FG000|Overall Study|Adverse Event|1|||
125946844|NCT01176292|453105080|FG001|Overall Study|Adverse Event|1|||
125946845|NCT01176292|453105079|FG000|Overall Study|Physician Decision|0|||
125946846|NCT01176292|453105080|FG001|Overall Study|Physician Decision|2|||
125946847|NCT01176292|453105079|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
125946848|NCT01176292|453105080|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
125946849|NCT00997503|453105081|FG000|Overall Study|Death|53|||
125946850|NCT00997503|453105081|FG000|Overall Study|Withdrawal by Subject|76|||
125946851|NCT00997503|453105081|FG000|Overall Study|Lost to Follow-up|33|||
125946852|NCT00997503|453105081|FG000|Overall Study|Adverse Event|3|||
125946853|NCT00997503|453105081|FG000|Overall Study|Physician Decision|10|||
125946854|NCT00997503|453105081|FG000|Overall Study|Missed 12-month follow-up|85|||
125946855|NCT00997503|453105081|FG000|Overall Study|Other reason|13|||
125946856|NCT00116831|453105082|FG000|Overall Study|Adverse Event|14|||
125946857|NCT00116831|453105083|FG001|Overall Study|Adverse Event|16|||
125946858|NCT00116831|453105082|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
125946859|NCT00116831|453105083|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
125946860|NCT00116831|453105082|FG000|Overall Study|Lost to Follow-up|8|||
125946861|NCT00116831|453105083|FG001|Overall Study|Lost to Follow-up|6|||
125946862|NCT00116831|453105082|FG000|Overall Study|Protocol Violation|3|||
125946863|NCT00116831|453105083|FG001|Overall Study|Protocol Violation|6|||
125946864|NCT00116831|453105082|FG000|Overall Study|Hypoglycaemic events|1|||
125946865|NCT00116831|453105083|FG001|Overall Study|Hypoglycaemic events|0|||
125946866|NCT00116831|453105082|FG000|Overall Study|Low haemoglobin on screening|1|||
125946867|NCT00116831|453105083|FG001|Overall Study|Low haemoglobin on screening|0|||
125946868|NCT00116831|453105082|FG000|Overall Study|Withdrawn investigational product|1|||
125946869|NCT00116831|453105083|FG001|Overall Study|Withdrawn investigational product|0|||
125946870|NCT00116831|453105082|FG000|Overall Study|Withdrawal by Subject|32|||
125946871|NCT00116831|453105083|FG001|Overall Study|Withdrawal by Subject|32|||
125946872|NCT00116831|453105082|FG000|Overall Study|Insufficient therapeutic effect|0|||
125946873|NCT00116831|453105083|FG001|Overall Study|Insufficient therapeutic effect|1|||
125946874|NCT00116831|453105082|FG000|Overall Study|Missing data for participant|1|||
125946875|NCT00116831|453105083|FG001|Overall Study|Missing data for participant|0|||
125946876|NCT00380393|453105084|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
125946877|NCT00380393|453105085|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
125946878|NCT00380393|453105084|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
125946879|NCT00380393|453105085|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
125946880|NCT00380393|453105084|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
125946881|NCT00380393|453105085|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
125946882|NCT00380393|453105084|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
125946883|NCT00380393|453105085|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
125946884|NCT00380393|453105084|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
125946885|NCT00380393|453105085|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
126073308|NCT00607997|453562547|FG003|Overall Study|Other without explanation|1|||
126073309|NCT00576823|453562548|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
126073310|NCT00576823|453562549|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
126073311|NCT00576823|453562550|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
126073312|NCT00576823|453562548|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
126073313|NCT00576823|453562549|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
126073314|NCT00576823|453562550|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
126073315|NCT00510146|453562556|FG000|Double-Blind Treatment|Adverse Event|30|||
126073316|NCT00510146|453562557|FG001|Double-Blind Treatment|Adverse Event|13|||
126073317|NCT00510146|453562556|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
126073318|NCT00510146|453562557|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
126073319|NCT00510146|453562556|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
126073320|NCT00510146|453562557|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
126073321|NCT00510146|453562556|FG000|Double-Blind Treatment|Physician Decision|6|||
126073322|NCT00510146|453562557|FG001|Double-Blind Treatment|Physician Decision|0|||
126073323|NCT00510146|453562556|FG000|Double-Blind Treatment|Protocol Violation|1|||
126073324|NCT00510146|453562557|FG001|Double-Blind Treatment|Protocol Violation|2|||
126073325|NCT00510146|453562556|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
126073326|NCT00510146|453562557|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
126073327|NCT00510146|453562556|FG000|Double-Blind Treatment|Clinical Relapse|0|||
126073328|NCT00510146|453562557|FG001|Double-Blind Treatment|Clinical Relapse|1|||
126073329|NCT00510146|453562556|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
126073330|NCT00510146|453562557|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
126073331|NCT00510146|453562556|FG000|Open-Label Treatment|Adverse Event|22|||
126073332|NCT00510146|453562557|FG001|Open-Label Treatment|Adverse Event|8|||
126073333|NCT00510146|453562556|FG000|Open-Label Treatment|Death|1|||
126073334|NCT00510146|453562557|FG001|Open-Label Treatment|Death|1|||
126073335|NCT00510146|453562556|FG000|Open-Label Treatment|Lack of Efficacy|4|||
126073336|NCT00510146|453562557|FG001|Open-Label Treatment|Lack of Efficacy|0|||
126073337|NCT00510146|453562556|FG000|Open-Label Treatment|Lost to Follow-up|10|||
126073338|NCT00510146|453562557|FG001|Open-Label Treatment|Lost to Follow-up|1|||
126073339|NCT00510146|453562556|FG000|Open-Label Treatment|Physician Decision|3|||
126073340|NCT00510146|453562557|FG001|Open-Label Treatment|Physician Decision|1|||
126073341|NCT00510146|453562556|FG000|Open-Label Treatment|Protocol Violation|4|||
126073342|NCT00510146|453562557|FG001|Open-Label Treatment|Protocol Violation|2|||
126073343|NCT00510146|453562556|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
126073344|NCT00510146|453562557|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
126073345|NCT00510146|453562556|FG000|Open-Label Treatment|Clinical Relapse|1|||
126073346|NCT00510146|453562557|FG001|Open-Label Treatment|Clinical Relapse|1|||
126073347|NCT00510146|453562556|FG000|Open-Label Treatment|Sponsor Decision|2|||
126073348|NCT00510146|453562557|FG001|Open-Label Treatment|Sponsor Decision|0|||
126073349|NCT01930214|453562559|FG000|Overall Study|Death|4|||
126073350|NCT01930214|453562560|FG001|Overall Study|Death|4|||
126073351|NCT01930214|453562561|FG002|Overall Study|Death|11|||
126073352|NCT01930214|453562559|FG000|Overall Study|Lost to Follow-up|12|||
126073353|NCT01930214|453562560|FG001|Overall Study|Lost to Follow-up|13|||
126073354|NCT01930214|453562561|FG002|Overall Study|Lost to Follow-up|12|||
126073355|NCT01930214|453562559|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
126073356|NCT01930214|453562560|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
126073357|NCT01930214|453562561|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
126073358|NCT01930214|453562559|FG000|Overall Study|Physician Decision|2|||
126073359|NCT01930214|453562560|FG001|Overall Study|Physician Decision|0|||
126073360|NCT01930214|453562561|FG002|Overall Study|Physician Decision|0|||
126073361|NCT02132117|453562562|FG000|Overall Study|Adverse Event|6|||
126073362|NCT02132117|453562563|FG001|Overall Study|Adverse Event|1|||
126073363|NCT02132117|453562562|FG000|Overall Study|Lost to Follow-up|2|||
126073364|NCT02132117|453562563|FG001|Overall Study|Lost to Follow-up|2|||
126073365|NCT02132117|453562562|FG000|Overall Study|Personal Reasons|1|||
126073366|NCT02132117|453562563|FG001|Overall Study|Personal Reasons|2|||
126073367|NCT02132117|453562562|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126073368|NCT02132117|453562563|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126073369|NCT03589300|453562564|FG000|Overall Study|Adverse Event|2|||
126073370|NCT03589300|453562564|FG000|Overall Study|Death|4|||
126073371|NCT03589300|453562564|FG000|Overall Study|Lost to Follow-up|12|||
126073372|NCT03589300|453562564|FG000|Overall Study|Withdrawal by Subject|5|||
126114764|NCT01986920|453715766|FG003|A- 101 25%|Withdrawal by Subject|0|||
126073373|NCT00640042|453562570|FG000|Enrollment|Did not receive study drug|83|||
126073374|NCT02864342|453562571|FG000|Overall Study|Eligibility Criteria Deviation|2|||
126073375|NCT02864342|453562572|FG001|Overall Study|Eligibility Criteria Deviation|3|||
126073376|NCT02864342|453562571|FG000|Overall Study|Withdrawal by Subject|4|||
126073377|NCT02864342|453562572|FG001|Overall Study|Withdrawal by Subject|2|||
126114765|NCT01986920|453715763|FG000|A-101 32.5%|Withdrawal by Subject|0|||
126073378|NCT02864342|453562571|FG000|Overall Study|Device Technology Issue|6|||
126073379|NCT02864342|453562572|FG001|Overall Study|Device Technology Issue|7|||
126073380|NCT02864342|453562571|FG000|Overall Study|Death|0|||
126073381|NCT02864342|453562572|FG001|Overall Study|Death|1|||
126073382|NCT02864342|453562571|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
126073383|NCT02864342|453562572|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
126073384|NCT02864342|453562571|FG000|Overall Study|Lost to Follow-up|1|||
126073385|NCT02864342|453562572|FG001|Overall Study|Lost to Follow-up|5|||
126073386|NCT02864342|453562571|FG000|Overall Study|Lost Device|1|||
126073387|NCT02864342|453562572|FG001|Overall Study|Lost Device|0|||
126073388|NCT02864342|453562571|FG000|Overall Study|Adverse Event|1|||
126073389|NCT02864342|453562572|FG001|Overall Study|Adverse Event|0|||
126073390|NCT00519285|453562577|FG000|Overall Study|Adverse Event|127|||
126073391|NCT00519285|453562578|FG001|Overall Study|Adverse Event|266|||
126073392|NCT00519285|453562577|FG000|Overall Study|Disease progression|334|||
126073393|NCT00519285|453562578|FG001|Overall Study|Disease progression|186|||
126073394|NCT00519285|453562577|FG000|Overall Study|Physician Decision|75|||
126073395|NCT00519285|453562578|FG001|Overall Study|Physician Decision|47|||
126073396|NCT00519285|453562577|FG000|Overall Study|Participant's request|53|||
126073397|NCT00519285|453562578|FG001|Overall Study|Participant's request|84|||
126073398|NCT00519285|453562577|FG000|Overall Study|Consent withdrawn|4|||
126073399|NCT00519285|453562578|FG001|Overall Study|Consent withdrawn|5|||
126073400|NCT00519285|453562577|FG000|Overall Study|Poor compliance to protocol|5|||
126073401|NCT00519285|453562578|FG001|Overall Study|Poor compliance to protocol|7|||
126073402|NCT00519285|453562577|FG000|Overall Study|Reason unspecified|5|||
126073403|NCT00519285|453562578|FG001|Overall Study|Reason unspecified|8|||
126073404|NCT00519285|453562577|FG000|Overall Study|Not treated|8|||
126073405|NCT00519285|453562578|FG001|Overall Study|Not treated|7|||
126073406|NCT00519285|453562577|FG000|Overall Study|Treatment ongoing|1|||
126073407|NCT00519285|453562578|FG001|Overall Study|Treatment ongoing|2|||
126073408|NCT00853021|453562579|FG000|Overall Study|Adverse Event|2|||
126073409|NCT00853021|453562579|FG000|Overall Study|Withdrawal by Subject|2|||
126073410|NCT00853021|453562579|FG000|Overall Study|Death|1|||
126073411|NCT01329419|453562580|FG000|Overall Study|Protocol Violation|235|||
126073412|NCT02212197|453562586|FG000|Overall Study|Need for radiotherapy|1|||
126073413|NCT02212197|453562587|FG001|Overall Study|Need for radiotherapy|0|||
126073414|NCT02212197|453562588|FG002|Overall Study|Need for radiotherapy|0|||
126073415|NCT02551692|453562590|FG000|Overall Study|Lost to Follow-up|0|||
126073416|NCT02551692|453562591|FG001|Overall Study|Lost to Follow-up|1|||
126073417|NCT02551692|453562592|FG002|Overall Study|Lost to Follow-up|4|||
126073418|NCT02551692|453562590|FG000|Overall Study|Withdrawal by Subject|1|||
126073419|NCT02551692|453562591|FG001|Overall Study|Withdrawal by Subject|0|||
126073420|NCT02551692|453562592|FG002|Overall Study|Withdrawal by Subject|1|||
126073421|NCT01091519|453562593|FG000|Overall Study|Adverse Event|12|||
126073422|NCT01091519|453562594|FG001|Overall Study|Adverse Event|16|||
126073423|NCT01091519|453562593|FG000|Overall Study|Death|1|||
126073424|NCT01091519|453562594|FG001|Overall Study|Death|0|||
126073425|NCT01091519|453562593|FG000|Overall Study|Lack of Efficacy|16|||
126073426|NCT01091519|453562594|FG001|Overall Study|Lack of Efficacy|19|||
126073427|NCT01091519|453562593|FG000|Overall Study|Lost to Follow-up|14|||
126073428|NCT01091519|453562594|FG001|Overall Study|Lost to Follow-up|24|||
126073429|NCT01091519|453562593|FG000|Overall Study|Withdrawal by Subject|2|||
126073430|NCT01091519|453562594|FG001|Overall Study|Withdrawal by Subject|2|||
126073431|NCT01091519|453562593|FG000|Overall Study|Other|6|||
126073432|NCT01091519|453562594|FG001|Overall Study|Other|8|||
126073433|NCT01091519|453562593|FG000|Overall Study|Randomized not treated|4|||
126073434|NCT01091519|453562594|FG001|Overall Study|Randomized not treated|4|||
126073435|NCT01177228|453562597|FG000|Overall Study|Positive tuberculosis test|0|||
126073436|NCT01177228|453562598|FG001|Overall Study|Positive tuberculosis test|1|||
126073437|NCT01177228|453562599|FG002|Overall Study|Positive tuberculosis test|0|||
126073438|NCT01177228|453562600|FG003|Overall Study|Positive tuberculosis test|0|||
126073439|NCT01177228|453562597|FG000|Overall Study|Worsening disease activity|1|||
126073440|NCT01177228|453562598|FG001|Overall Study|Worsening disease activity|0|||
126073441|NCT01177228|453562599|FG002|Overall Study|Worsening disease activity|0|||
126073442|NCT01177228|453562600|FG003|Overall Study|Worsening disease activity|0|||
126073443|NCT01177228|453562597|FG000|Overall Study|Withdrawal by Subject|0|||
126073444|NCT01177228|453562598|FG001|Overall Study|Withdrawal by Subject|1|||
126073445|NCT01177228|453562599|FG002|Overall Study|Withdrawal by Subject|0|||
126073446|NCT01177228|453562600|FG003|Overall Study|Withdrawal by Subject|0|||
126073447|NCT01171183|453564677|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
126073448|NCT01171183|453564678|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
126073449|NCT01171183|453564677|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
126073450|NCT01171183|453564678|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
126073451|NCT01171183|453564677|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
126073452|NCT01171183|453564678|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
126073453|NCT01171183|453564677|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
126073454|NCT01171183|453564678|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
126073455|NCT01171183|453564677|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
126073456|NCT01171183|453564678|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
126073457|NCT01171183|453564677|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
126073458|NCT01171183|453564678|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
126073459|NCT01904136|453564682|FG000|Overall Study|Physician Decision|0|||
126073460|NCT01904136|453564683|FG001|Overall Study|Physician Decision|0|||
126073461|NCT01904136|453564684|FG002|Overall Study|Physician Decision|0|||
126073462|NCT01904136|453564685|FG003|Overall Study|Physician Decision|0|||
126073463|NCT01904136|453564686|FG004|Overall Study|Physician Decision|0|||
126073464|NCT01904136|453564687|FG005|Overall Study|Physician Decision|1|||
126073465|NCT01904136|453564688|FG006|Overall Study|Physician Decision|0|||
126073466|NCT01904136|453564689|FG007|Overall Study|Physician Decision|0|||
126073467|NCT01904136|453564690|FG008|Overall Study|Physician Decision|0|||
126073468|NCT00853372|453564691|FG000|Overall Study|Death|30|||
126073469|NCT00853372|453564692|FG001|Overall Study|Death|26|||
126073470|NCT00853372|453564691|FG000|Overall Study|Lost to Follow-up|1|||
126073471|NCT00853372|453564692|FG001|Overall Study|Lost to Follow-up|2|||
126073472|NCT00853372|453564691|FG000|Overall Study|Full Consent Withdrawn|1|||
126073473|NCT00853372|453564692|FG001|Overall Study|Full Consent Withdrawn|1|||
126073474|NCT01093599|453564700|FG000|Overall Study|Lost to Follow-up|32|||
126073475|NCT01093599|453564701|FG001|Overall Study|Lost to Follow-up|46|||
126073476|NCT01703845|453564702|FG000|Overall Study|Adverse Event|1|||
126073477|NCT01703845|453564703|FG001|Overall Study|Adverse Event|0|||
126073478|NCT01703845|453564702|FG000|Overall Study|Protocol Violation|1|||
126073479|NCT01703845|453564703|FG001|Overall Study|Protocol Violation|0|||
126073480|NCT01703845|453564702|FG000|Overall Study|other than stated above|1|||
126073481|NCT01703845|453564703|FG001|Overall Study|other than stated above|0|||
126073482|NCT01644188|453564704|FG000|Overall Study|Adverse Event|44|||
126073483|NCT01644188|453564705|FG001|Overall Study|Adverse Event|20|||
126073484|NCT01644188|453564704|FG000|Overall Study|Poor compliance to protocol|26|||
126073485|NCT01644188|453564705|FG001|Overall Study|Poor compliance to protocol|14|||
126073486|NCT01644188|453564704|FG000|Overall Study|Physician Decision|1|||
126073487|NCT01644188|453564705|FG001|Overall Study|Physician Decision|3|||
126073488|NCT01644188|453564704|FG000|Overall Study|Participant moved|7|||
126073489|NCT01644188|453564705|FG001|Overall Study|Participant moved|2|||
126073490|NCT01644188|453564704|FG000|Overall Study|Related to auto-injector administration|2|||
126073491|NCT01644188|453564705|FG001|Overall Study|Related to auto-injector administration|2|||
126073492|NCT01644188|453564704|FG000|Overall Study|Consent withdrawn by participant|14|||
126073493|NCT01644188|453564705|FG001|Overall Study|Consent withdrawn by participant|7|||
126073494|NCT01644188|453564704|FG000|Overall Study|Selection criteria finally not met|2|||
126073495|NCT01644188|453564705|FG001|Overall Study|Selection criteria finally not met|0|||
126073496|NCT01644188|453564704|FG000|Overall Study|Lost to Follow-up|1|||
126073497|NCT01644188|453564705|FG001|Overall Study|Lost to Follow-up|0|||
126073498|NCT01644188|453564704|FG000|Overall Study|Death|4|||
126073499|NCT01644188|453564705|FG001|Overall Study|Death|3|||
126073500|NCT01644188|453564704|FG000|Overall Study|Last visit outside protocol visit window|14|||
126073501|NCT01644188|453564705|FG001|Overall Study|Last visit outside protocol visit window|16|||
126073502|NCT01644188|453564704|FG000|Overall Study|Site closure|1|||
126073503|NCT01644188|453564705|FG001|Overall Study|Site closure|1|||
126073504|NCT01644188|453564704|FG000|Overall Study|Other than specified above|6|||
126073505|NCT01644188|453564705|FG001|Overall Study|Other than specified above|7|||
126073506|NCT03713281|453564709|FG000|Overall Study|Lens handling difficuluties|2|||
126073507|NCT03713281|453564709|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
126073508|NCT00320398|453564710|FG000|Overall Study|Adverse Event|1|||
126073509|NCT00320398|453564711|FG001|Overall Study|Adverse Event|4|||
126073510|NCT00320398|453564710|FG000|Overall Study|Other|1|||
126073511|NCT00320398|453564711|FG001|Overall Study|Other|0|||
126073512|NCT01114139|453564714|FG000|Overall Study|Adverse Event|3|||
126073513|NCT01114139|453564715|FG001|Overall Study|Adverse Event|2|||
126073514|NCT01114139|453564714|FG000|Overall Study|Lost to Follow-up|15|||
126073515|NCT01114139|453564715|FG001|Overall Study|Lost to Follow-up|3|||
126073516|NCT01114139|453564714|FG000|Overall Study|Withdrawal by Subject|17|||
126073517|NCT01114139|453564715|FG001|Overall Study|Withdrawal by Subject|6|||
126073518|NCT01114139|453564714|FG000|Overall Study|Other-Missed 1 visit|1|||
126073519|NCT01114139|453564715|FG001|Overall Study|Other-Missed 1 visit|0|||
126073520|NCT01114139|453564714|FG000|Overall Study|Other-Protocol Violation|1|||
126073521|NCT01114139|453564715|FG001|Overall Study|Other-Protocol Violation|0|||
126073522|NCT01114139|453564714|FG000|Overall Study|Other-Out of window for study drug dose|1|||
125946886|NCT00380393|453105084|FG000|Month 14|Withdrawal by Subject|9|||
126073523|NCT01114139|453564715|FG001|Overall Study|Other-Out of window for study drug dose|0|||
126073524|NCT01114139|453564714|FG000|Overall Study|Other-Participant falsified records|0|||
126073525|NCT01114139|453564715|FG001|Overall Study|Other-Participant falsified records|1|||
126073526|NCT01114139|453564714|FG000|Overall Study|Other-Participant went on hospice|0|||
126073527|NCT01114139|453564715|FG001|Overall Study|Other-Participant went on hospice|1|||
126073528|NCT01114139|453564714|FG000|Overall Study|Other-Physician changed treatment|1|||
126073529|NCT01114139|453564715|FG001|Overall Study|Other-Physician changed treatment|0|||
126073530|NCT01114139|453564714|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
126073531|NCT01114139|453564715|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
125946887|NCT00380393|453105085|FG001|Month 14|Withdrawal by Subject|7|||
125946888|NCT00380393|453105084|FG000|Month 14|Death|1|||
125946889|NCT00380393|453105085|FG001|Month 14|Death|0|||
126073532|NCT02705625|453564716|FG000|Overall Study|Protocol Violation|1|||
126073533|NCT02705625|453564717|FG001|Overall Study|Protocol Violation|0|||
126073534|NCT02705625|453564718|FG002|Overall Study|Protocol Violation|0|||
126073535|NCT02705625|453564716|FG000|Overall Study|Adverse Event|6|||
126073536|NCT02705625|453564717|FG001|Overall Study|Adverse Event|5|||
126073537|NCT02705625|453564718|FG002|Overall Study|Adverse Event|2|||
126073538|NCT02705625|453564716|FG000|Overall Study|Death|0|||
126073539|NCT02705625|453564717|FG001|Overall Study|Death|0|||
126073540|NCT02705625|453564718|FG002|Overall Study|Death|1|||
126073541|NCT02705625|453564716|FG000|Overall Study|Withdrawal by Subject|1|||
126073542|NCT02705625|453564717|FG001|Overall Study|Withdrawal by Subject|4|||
126073543|NCT02705625|453564718|FG002|Overall Study|Withdrawal by Subject|5|||
126073544|NCT02705625|453564716|FG000|Overall Study|Lost to Follow-up|0|||
126073545|NCT02705625|453564717|FG001|Overall Study|Lost to Follow-up|0|||
126073546|NCT02705625|453564718|FG002|Overall Study|Lost to Follow-up|1|||
126073547|NCT02705625|453564716|FG000|Overall Study|Non-compliance|0|||
126073548|NCT02705625|453564717|FG001|Overall Study|Non-compliance|1|||
126073549|NCT02705625|453564718|FG002|Overall Study|Non-compliance|1|||
126073550|NCT02705625|453564716|FG000|Overall Study|Overdosing|0|||
126073551|NCT02705625|453564717|FG001|Overall Study|Overdosing|0|||
126073552|NCT02705625|453564718|FG002|Overall Study|Overdosing|1|||
126073553|NCT00494026|453564719|FG000|Overall Study|Sponsor Decision|4|||
126073554|NCT01057251|453564721|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
126073555|NCT01057251|453564722|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
126073556|NCT01057251|453564721|FG000|Overall Study|Adverse Event|4|||
126073557|NCT01057251|453564722|FG001|Overall Study|Adverse Event|2|||
126073558|NCT01057251|453564721|FG000|Overall Study|Lack of Efficacy|2|||
126073559|NCT01057251|453564722|FG001|Overall Study|Lack of Efficacy|11|||
126073560|NCT01057251|453564721|FG000|Overall Study|Protocol Violation|6|||
126073561|NCT01057251|453564722|FG001|Overall Study|Protocol Violation|2|||
126073562|NCT01057251|453564721|FG000|Overall Study|Withdrawal by Subject|4|||
126073563|NCT01057251|453564722|FG001|Overall Study|Withdrawal by Subject|5|||
125946890|NCT00380393|453105084|FG000|Month 14|Lost to Follow-up|0|||
125946891|NCT00380393|453105085|FG001|Month 14|Lost to Follow-up|1|||
126073564|NCT01057251|453564721|FG000|Overall Study|Lost to Follow-up|7|||
126073565|NCT01057251|453564722|FG001|Overall Study|Lost to Follow-up|6|||
126073566|NCT01057251|453564721|FG000|Overall Study|Other Reason|1|||
126073567|NCT01057251|453564722|FG001|Overall Study|Other Reason|1|||
126073568|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
126073569|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
126073570|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
126073571|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
126073572|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
126073573|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
126073574|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
126073575|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
126073576|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
126073577|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
126073578|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
126073579|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
126073580|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
126073581|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
126073582|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
126073583|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
126073584|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
126073585|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
126073586|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
126073587|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
126073588|NCT02637856|453564723|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
126073589|NCT02637856|453564724|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
125946892|NCT00380393|453105084|FG000|Month 14|Migrated/moved from study area|39|||
126073590|NCT02637856|453564723|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
126073591|NCT02637856|453564724|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
126073592|NCT02637856|453564723|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
126073593|NCT02637856|453564724|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
126114766|NCT01986920|453715764|FG001|A-101 32.5%|Withdrawal by Subject|1|||
125946893|NCT00380393|453105085|FG001|Month 14|Migrated/moved from study area|42|||
125946894|NCT00380393|453105084|FG000|Month 14|Protocol Violation|2|||
126073594|NCT00784147|453564725|FG000|Overall Study|Lost to Follow-up|2|||
126073595|NCT00784147|453564726|FG001|Overall Study|Lost to Follow-up|4|||
125946895|NCT00380393|453105085|FG001|Month 14|Protocol Violation|0|||
125946896|NCT00380393|453105084|FG000|Month 14|Others|6|||
126073596|NCT00784147|453564725|FG000|Overall Study|Withdrawal by Subject|1|||
126073597|NCT00784147|453564726|FG001|Overall Study|Withdrawal by Subject|3|||
126073598|NCT00784147|453564725|FG000|Overall Study|Physician Decision|2|||
126073599|NCT00784147|453564726|FG001|Overall Study|Physician Decision|1|||
126073600|NCT00784147|453564725|FG000|Overall Study|Protocol Violation|1|||
126073601|NCT00784147|453564726|FG001|Overall Study|Protocol Violation|1|||
126073602|NCT00784147|453564725|FG000|Overall Study|Death|2|||
126073603|NCT00784147|453564726|FG001|Overall Study|Death|0|||
126073604|NCT04544865|453564730|FG000|Overall Study|Death|0|||
126073605|NCT04544865|453564731|FG001|Overall Study|Death|2|||
126073606|NCT04544865|453564730|FG000|Overall Study|Lost to Follow-up|11|||
126073607|NCT04544865|453564731|FG001|Overall Study|Lost to Follow-up|7|||
126073608|NCT04544865|453564730|FG000|Overall Study|Withdrawal by Subject|0|||
126073609|NCT04544865|453564731|FG001|Overall Study|Withdrawal by Subject|1|||
126073610|NCT04544865|453564730|FG000|Overall Study|Other|0|||
126073611|NCT04544865|453564731|FG001|Overall Study|Other|1|||
126073612|NCT02815735|453564732|FG000|First Intervention (4 Weeks)|Discomfort|1|||
126073613|NCT02815735|453564733|FG001|First Intervention (4 Weeks)|Discomfort|0|||
126073614|NCT02815735|453564732|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
126073615|NCT02815735|453564733|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
126073616|NCT02815735|453564732|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
126073617|NCT02815735|453564733|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
126073618|NCT02815735|453564732|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
126073619|NCT02815735|453564733|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
126073620|NCT01732926|453564736|FG000|Overall Study|Study Terminated by Sponsor|168|||
126073621|NCT01732926|453564737|FG001|Overall Study|Study Terminated by Sponsor|80|||
126073622|NCT01732926|453564736|FG000|Overall Study|Withdrawal by Subject|46|||
126073623|NCT01732926|453564737|FG001|Overall Study|Withdrawal by Subject|8|||
126073624|NCT01732926|453564736|FG000|Overall Study|Physician Decision|24|||
126073625|NCT01732926|453564737|FG001|Overall Study|Physician Decision|11|||
126073626|NCT01732926|453564736|FG000|Overall Study|Other Reason|21|||
126073627|NCT01732926|453564737|FG001|Overall Study|Other Reason|4|||
126073628|NCT01732926|453564736|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
126073629|NCT01732926|453564737|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
126073630|NCT01732926|453564736|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
126073631|NCT01732926|453564737|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
126073632|NCT01049984|453564741|FG000|Overall Study|Withdrawal by Subject|1|||
126073633|NCT01049984|453564742|FG001|Overall Study|Withdrawal by Subject|5|||
126073634|NCT01049984|453564741|FG000|Overall Study|Protocol Violation|3|||
126073635|NCT01049984|453564742|FG001|Overall Study|Protocol Violation|4|||
126073636|NCT01049984|453564741|FG000|Overall Study|Lost to Follow-up|2|||
126073637|NCT01049984|453564742|FG001|Overall Study|Lost to Follow-up|1|||
126073638|NCT01049984|453564741|FG000|Overall Study|Adverse Event|13|||
126073639|NCT01049984|453564742|FG001|Overall Study|Adverse Event|7|||
126073640|NCT01049984|453564741|FG000|Overall Study|Treatment failure|0|||
126073641|NCT01049984|453564742|FG001|Overall Study|Treatment failure|2|||
126073642|NCT01746108|453564745|FG000|Overall Study|Migrated /moved from study area|0|||
126073643|NCT01746108|453564746|FG001|Overall Study|Migrated /moved from study area|1|||
126073644|NCT01746108|453564747|FG002|Overall Study|Migrated /moved from study area|0|||
126073645|NCT01746108|453564745|FG000|Overall Study|Adverse event, non-fatal|0|||
126073646|NCT01746108|453564746|FG001|Overall Study|Adverse event, non-fatal|1|||
126073647|NCT01746108|453564747|FG002|Overall Study|Adverse event, non-fatal|0|||
126073648|NCT01746108|453564745|FG000|Overall Study|Withdrawal by Subject|0|||
126073649|NCT01746108|453564746|FG001|Overall Study|Withdrawal by Subject|1|||
126073650|NCT01746108|453564747|FG002|Overall Study|Withdrawal by Subject|0|||
126073651|NCT01746108|453564745|FG000|Overall Study|Lost to Follow-up|0|||
126073652|NCT01746108|453564746|FG001|Overall Study|Lost to Follow-up|1|||
126073653|NCT01746108|453564747|FG002|Overall Study|Lost to Follow-up|0|||
126073654|NCT00468858|453564749|FG000|Overall Study|Adverse Event|0|||
126073655|NCT00468858|453564750|FG001|Overall Study|Adverse Event|1|||
126073656|NCT00468858|453564751|FG002|Overall Study|Adverse Event|0|||
126073657|NCT00468858|453564749|FG000|Overall Study|Withdrawal by Subject|7|||
126073658|NCT00468858|453564750|FG001|Overall Study|Withdrawal by Subject|4|||
126073659|NCT00468858|453564751|FG002|Overall Study|Withdrawal by Subject|5|||
126073660|NCT00468858|453564749|FG000|Overall Study|Relocation|1|||
126073661|NCT00468858|453564750|FG001|Overall Study|Relocation|3|||
126073662|NCT00468858|453564751|FG002|Overall Study|Relocation|3|||
126073663|NCT00468858|453564749|FG000|Overall Study|Lost to Follow-up|1|||
126073664|NCT00468858|453564750|FG001|Overall Study|Lost to Follow-up|2|||
126073665|NCT00468858|453564751|FG002|Overall Study|Lost to Follow-up|5|||
126073666|NCT00468858|453564749|FG000|Overall Study|Other|0|||
126073667|NCT00468858|453564750|FG001|Overall Study|Other|0|||
126073668|NCT00468858|453564751|FG002|Overall Study|Other|1|||
126073669|NCT00809341|453564754|FG000|Overall Study|Physician Decision|0|||
126073670|NCT00809341|453564755|FG001|Overall Study|Physician Decision|1|||
126073671|NCT00225277|453564763|FG000|Overall Study|Adverse Event|30|||
126073672|NCT00225277|453564764|FG001|Overall Study|Adverse Event|34|||
126073673|NCT00225277|453564763|FG000|Overall Study|Lack of Efficacy|4|||
126073674|NCT00225277|453564764|FG001|Overall Study|Lack of Efficacy|1|||
126073675|NCT00225277|453564763|FG000|Overall Study|Lost to Follow-up|4|||
126073676|NCT00225277|453564764|FG001|Overall Study|Lost to Follow-up|6|||
126073677|NCT00225277|453564763|FG000|Overall Study|Physician Decision|6|||
126073678|NCT00225277|453564764|FG001|Overall Study|Physician Decision|8|||
126073679|NCT00225277|453564763|FG000|Overall Study|Protocol Violation|6|||
126073680|NCT00225277|453564764|FG001|Overall Study|Protocol Violation|3|||
126073681|NCT00225277|453564763|FG000|Overall Study|Withdrawal by Subject|40|||
126073682|NCT00225277|453564764|FG001|Overall Study|Withdrawal by Subject|34|||
126073683|NCT00225277|453564763|FG000|Overall Study|Other|7|||
126073684|NCT00225277|453564764|FG001|Overall Study|Other|9|||
126073685|NCT04582669|453564771|FG000|Overall Study|Subject missed appointment(s).|1|||
126073686|NCT04582669|453564772|FG001|Overall Study|Subject missed appointment(s).|0|||
126073687|NCT04582669|453564773|FG002|Overall Study|Subject missed appointment(s).|1|||
126073688|NCT04582669|453564774|FG003|Overall Study|Subject missed appointment(s).|2|||
126073689|NCT04582669|453564771|FG000|Overall Study|Protocol Violation|0|||
126073690|NCT04582669|453564772|FG001|Overall Study|Protocol Violation|1|||
126073691|NCT04582669|453564773|FG002|Overall Study|Protocol Violation|1|||
126073692|NCT04582669|453564774|FG003|Overall Study|Protocol Violation|0|||
126073693|NCT00591409|453564775|FG000|Overall Study|Not Treated|0|||
126073694|NCT00591409|453564776|FG001|Overall Study|Not Treated|0|||
126073695|NCT00591409|453564777|FG002|Overall Study|Not Treated|0|||
126073696|NCT00591409|453564778|FG003|Overall Study|Not Treated|0|||
126073697|NCT00591409|453564779|FG004|Overall Study|Not Treated|1|||
126073698|NCT00591409|453564780|FG005|Overall Study|Not Treated|0|||
126073699|NCT00591409|453564781|FG006|Overall Study|Not Treated|0|||
126073700|NCT00591409|453564782|FG007|Overall Study|Not Treated|0|||
126073701|NCT00591409|453564783|FG008|Overall Study|Not Treated|0|||
126073702|NCT00591409|453564784|FG009|Overall Study|Not Treated|1|||
126073703|NCT00677092|453564785|FG000|Overall Study|Adverse Event|1|||
126073704|NCT00677092|453564785|FG000|Overall Study|Lost to Follow-up|1|||
126073705|NCT00677092|453564785|FG000|Overall Study|Withdrawal by Subject|3|||
126073706|NCT00677092|453564785|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
126073707|NCT00550446|453564786|FG000|Up To Week 12|Adverse Event|2|||
126073708|NCT00550446|453564787|FG001|Up To Week 12|Adverse Event|2|||
126073709|NCT00550446|453564788|FG002|Up To Week 12|Adverse Event|0|||
126073710|NCT00550446|453564789|FG003|Up To Week 12|Adverse Event|0|||
126073711|NCT00550446|453564790|FG004|Up To Week 12|Adverse Event|2|||
126073712|NCT00550446|453564791|FG005|Up To Week 12|Adverse Event|2|||
126073713|NCT00550446|453564792|FG006|Up To Week 12|Adverse Event|1|||
126073714|NCT00550446|453564793|FG007|Up To Week 12|Adverse Event|0|||
126073715|NCT00550446|453564794|FG008|Up To Week 12|Adverse Event|0|||
126073716|NCT00550446|453564795|FG009|Up To Week 12|Adverse Event|0|||
126073717|NCT00550446|453564796|FG010|Up To Week 12|Adverse Event|0|||
126073718|NCT00550446|453564786|FG000|Up To Week 12|Lack of Efficacy|3|||
126073719|NCT00550446|453564787|FG001|Up To Week 12|Lack of Efficacy|1|||
126073720|NCT00550446|453564788|FG002|Up To Week 12|Lack of Efficacy|0|||
126073721|NCT00550446|453564789|FG003|Up To Week 12|Lack of Efficacy|1|||
126073722|NCT00550446|453564790|FG004|Up To Week 12|Lack of Efficacy|0|||
126073723|NCT00550446|453564791|FG005|Up To Week 12|Lack of Efficacy|3|||
126073724|NCT00550446|453564792|FG006|Up To Week 12|Lack of Efficacy|3|||
126073725|NCT00550446|453564793|FG007|Up To Week 12|Lack of Efficacy|0|||
126073726|NCT00550446|453564794|FG008|Up To Week 12|Lack of Efficacy|0|||
126073727|NCT00550446|453564795|FG009|Up To Week 12|Lack of Efficacy|0|||
126073728|NCT00550446|453564796|FG010|Up To Week 12|Lack of Efficacy|0|||
126073729|NCT00550446|453564786|FG000|Up To Week 12|Lost to Follow-up|0|||
126073730|NCT00550446|453564787|FG001|Up To Week 12|Lost to Follow-up|1|||
126073731|NCT00550446|453564788|FG002|Up To Week 12|Lost to Follow-up|0|||
126073732|NCT00550446|453564789|FG003|Up To Week 12|Lost to Follow-up|0|||
126073733|NCT00550446|453564790|FG004|Up To Week 12|Lost to Follow-up|1|||
126073734|NCT00550446|453564791|FG005|Up To Week 12|Lost to Follow-up|1|||
126073735|NCT00550446|453564792|FG006|Up To Week 12|Lost to Follow-up|2|||
125946897|NCT00380393|453105085|FG001|Month 14|Others|6|||
126073736|NCT00550446|453564793|FG007|Up To Week 12|Lost to Follow-up|0|||
126073737|NCT00550446|453564794|FG008|Up To Week 12|Lost to Follow-up|0|||
126073738|NCT00550446|453564795|FG009|Up To Week 12|Lost to Follow-up|0|||
126073739|NCT00550446|453564796|FG010|Up To Week 12|Lost to Follow-up|0|||
126073740|NCT00550446|453564786|FG000|Up To Week 12|Withdrawal by Subject|2|||
126073741|NCT00550446|453564787|FG001|Up To Week 12|Withdrawal by Subject|0|||
126073742|NCT00550446|453564788|FG002|Up To Week 12|Withdrawal by Subject|3|||
126073743|NCT00550446|453564789|FG003|Up To Week 12|Withdrawal by Subject|2|||
126073744|NCT00550446|453564790|FG004|Up To Week 12|Withdrawal by Subject|0|||
126073745|NCT00550446|453564791|FG005|Up To Week 12|Withdrawal by Subject|1|||
126073746|NCT00550446|453564792|FG006|Up To Week 12|Withdrawal by Subject|3|||
126073747|NCT00550446|453564793|FG007|Up To Week 12|Withdrawal by Subject|0|||
126073748|NCT00550446|453564794|FG008|Up To Week 12|Withdrawal by Subject|0|||
126073749|NCT00550446|453564795|FG009|Up To Week 12|Withdrawal by Subject|0|||
126073750|NCT00550446|453564796|FG010|Up To Week 12|Withdrawal by Subject|0|||
126073751|NCT00550446|453564786|FG000|Up To Week 12|Other|3|||
126073752|NCT00550446|453564787|FG001|Up To Week 12|Other|0|||
126073753|NCT00550446|453564788|FG002|Up To Week 12|Other|0|||
126073754|NCT00550446|453564789|FG003|Up To Week 12|Other|0|||
126073755|NCT00550446|453564790|FG004|Up To Week 12|Other|0|||
126073756|NCT00550446|453564791|FG005|Up To Week 12|Other|1|||
126073757|NCT00550446|453564792|FG006|Up To Week 12|Other|4|||
126073758|NCT00550446|453564793|FG007|Up To Week 12|Other|0|||
126073759|NCT00550446|453564794|FG008|Up To Week 12|Other|0|||
126073760|NCT00550446|453564795|FG009|Up To Week 12|Other|0|||
126073761|NCT00550446|453564796|FG010|Up To Week 12|Other|0|||
126073762|NCT00550446|453564786|FG000|Up To Week 12|Randomized not treated|0|||
126073763|NCT00550446|453564787|FG001|Up To Week 12|Randomized not treated|1|||
126073764|NCT00550446|453564788|FG002|Up To Week 12|Randomized not treated|1|||
126073765|NCT00550446|453564789|FG003|Up To Week 12|Randomized not treated|0|||
126073766|NCT00550446|453564790|FG004|Up To Week 12|Randomized not treated|0|||
126073767|NCT00550446|453564791|FG005|Up To Week 12|Randomized not treated|0|||
126073768|NCT00550446|453564792|FG006|Up To Week 12|Randomized not treated|0|||
126073769|NCT00550446|453564793|FG007|Up To Week 12|Randomized not treated|0|||
126073770|NCT00550446|453564794|FG008|Up To Week 12|Randomized not treated|0|||
126073771|NCT00550446|453564795|FG009|Up To Week 12|Randomized not treated|0|||
126073772|NCT00550446|453564796|FG010|Up To Week 12|Randomized not treated|0|||
126073773|NCT00550446|453564786|FG000|Post Week 12|Adverse Event|2|||
126073774|NCT00550446|453564787|FG001|Post Week 12|Adverse Event|1|||
126073775|NCT00550446|453564788|FG002|Post Week 12|Adverse Event|1|||
126073776|NCT00550446|453564789|FG003|Post Week 12|Adverse Event|1|||
126073777|NCT00550446|453564790|FG004|Post Week 12|Adverse Event|1|||
126073778|NCT00550446|453564791|FG005|Post Week 12|Adverse Event|1|||
126073779|NCT00550446|453564792|FG006|Post Week 12|Adverse Event|0|||
126073780|NCT00550446|453564793|FG007|Post Week 12|Adverse Event|0|||
126073781|NCT00550446|453564794|FG008|Post Week 12|Adverse Event|0|||
126073782|NCT00550446|453564795|FG009|Post Week 12|Adverse Event|4|||
126073783|NCT00550446|453564796|FG010|Post Week 12|Adverse Event|0|||
126073784|NCT00550446|453564786|FG000|Post Week 12|Lack of Efficacy|0|||
126073785|NCT00550446|453564787|FG001|Post Week 12|Lack of Efficacy|0|||
126073786|NCT00550446|453564788|FG002|Post Week 12|Lack of Efficacy|1|||
126073787|NCT00550446|453564789|FG003|Post Week 12|Lack of Efficacy|0|||
126073788|NCT00550446|453564790|FG004|Post Week 12|Lack of Efficacy|0|||
126073789|NCT00550446|453564791|FG005|Post Week 12|Lack of Efficacy|0|||
126073790|NCT00550446|453564792|FG006|Post Week 12|Lack of Efficacy|0|||
126073791|NCT00550446|453564793|FG007|Post Week 12|Lack of Efficacy|1|||
126073792|NCT00550446|453564794|FG008|Post Week 12|Lack of Efficacy|1|||
126073793|NCT00550446|453564795|FG009|Post Week 12|Lack of Efficacy|2|||
126073794|NCT00550446|453564796|FG010|Post Week 12|Lack of Efficacy|1|||
126073795|NCT00550446|453564786|FG000|Post Week 12|Lost to Follow-up|0|||
126073796|NCT00550446|453564787|FG001|Post Week 12|Lost to Follow-up|0|||
126073797|NCT00550446|453564788|FG002|Post Week 12|Lost to Follow-up|1|||
126073798|NCT00550446|453564789|FG003|Post Week 12|Lost to Follow-up|1|||
126073799|NCT00550446|453564790|FG004|Post Week 12|Lost to Follow-up|0|||
126073800|NCT00550446|453564791|FG005|Post Week 12|Lost to Follow-up|0|||
126073801|NCT00550446|453564792|FG006|Post Week 12|Lost to Follow-up|1|||
126073802|NCT00550446|453564793|FG007|Post Week 12|Lost to Follow-up|0|||
126073803|NCT00550446|453564794|FG008|Post Week 12|Lost to Follow-up|0|||
126073804|NCT00550446|453564795|FG009|Post Week 12|Lost to Follow-up|0|||
126073805|NCT00550446|453564796|FG010|Post Week 12|Lost to Follow-up|0|||
126073806|NCT00550446|453564786|FG000|Post Week 12|Withdrawal by Subject|0|||
126073807|NCT00550446|453564787|FG001|Post Week 12|Withdrawal by Subject|0|||
126073808|NCT00550446|453564788|FG002|Post Week 12|Withdrawal by Subject|0|||
126073809|NCT00550446|453564789|FG003|Post Week 12|Withdrawal by Subject|0|||
126073810|NCT00550446|453564790|FG004|Post Week 12|Withdrawal by Subject|1|||
126073811|NCT00550446|453564791|FG005|Post Week 12|Withdrawal by Subject|0|||
126073812|NCT00550446|453564792|FG006|Post Week 12|Withdrawal by Subject|0|||
126073813|NCT00550446|453564793|FG007|Post Week 12|Withdrawal by Subject|0|||
126073814|NCT00550446|453564794|FG008|Post Week 12|Withdrawal by Subject|0|||
126073815|NCT00550446|453564795|FG009|Post Week 12|Withdrawal by Subject|0|||
126073816|NCT00550446|453564796|FG010|Post Week 12|Withdrawal by Subject|0|||
126073817|NCT00550446|453564786|FG000|Post Week 12|Other|1|||
126073818|NCT00550446|453564787|FG001|Post Week 12|Other|1|||
126073819|NCT00550446|453564788|FG002|Post Week 12|Other|0|||
126073820|NCT00550446|453564789|FG003|Post Week 12|Other|1|||
126073821|NCT00550446|453564790|FG004|Post Week 12|Other|0|||
126073822|NCT00550446|453564791|FG005|Post Week 12|Other|0|||
126073823|NCT00550446|453564792|FG006|Post Week 12|Other|1|||
126073824|NCT00550446|453564793|FG007|Post Week 12|Other|0|||
126073825|NCT00550446|453564794|FG008|Post Week 12|Other|1|||
126114767|NCT01986920|453715765|FG002|A-101 32.5%|Withdrawal by Subject|0|||
126114768|NCT01986920|453715766|FG003|A-101 32.5%|Withdrawal by Subject|0|||
126073826|NCT00550446|453564795|FG009|Post Week 12|Other|1|||
126073827|NCT00550446|453564796|FG010|Post Week 12|Other|0|||
126073828|NCT02716298|453564797|FG000|First Intervention (1 Month)|Lens discomfort|1|||
126073829|NCT02716298|453564798|FG001|First Intervention (1 Month)|Lens discomfort|1|||
126114769|NCT01986920|453715763|FG000|A-101 40%|Withdrawal by Subject|0|||
126073830|NCT04952701|453564799|FG000|Control Lens|Physician Decision|4|||
126073831|NCT04952701|453564799|FG000|Test Lens|Physician Decision|1|||
126073832|NCT03927222|453564800|FG000|Overall Study|Progression|3|||
126073833|NCT03927222|453564800|FG000|Overall Study|CMV testing results inconclusive|1|||
126073834|NCT03927222|453564800|FG000|Overall Study|Unable to generate enough vaccines|1|||
126073835|NCT03927222|453564800|FG000|Overall Study|Early study termination|1|||
126073836|NCT00578318|453564801|FG000|Overall Study|Lost to Follow-up|2|||
126073837|NCT00578318|453564802|FG001|Overall Study|Lost to Follow-up|0|||
126073838|NCT00578318|453564801|FG000|Overall Study|Physician Decision|1|||
126073839|NCT00578318|453564802|FG001|Overall Study|Physician Decision|0|||
126073840|NCT00001941|453564817|FG000|Overall Study|not treated- rapidly progressing disease|0|||
126073841|NCT00001941|453564818|FG001|Overall Study|not treated- rapidly progressing disease|0|||
126073842|NCT00001941|453564819|FG002|Overall Study|not treated- rapidly progressing disease|0|||
126073843|NCT00001941|453564820|FG003|Overall Study|not treated- rapidly progressing disease|0|||
126073844|NCT00001941|453564821|FG004|Overall Study|not treated- rapidly progressing disease|1|||
126073845|NCT01020747|453564827|FG000|Overall Study|Withdrawal by Subject|1|||
126073846|NCT01222078|453564828|FG000|Overall Study|Early termination of the study|1|||
126073847|NCT02970305|453564829|FG000|Overall Study|Adverse Event|10|||
126073848|NCT02970305|453564830|FG001|Overall Study|Adverse Event|6|||
126073849|NCT02970305|453564829|FG000|Overall Study|Lack of Efficacy|1|||
126073850|NCT02970305|453564830|FG001|Overall Study|Lack of Efficacy|1|||
126073851|NCT02970305|453564829|FG000|Overall Study|Noncompliance with study drug|2|||
126073852|NCT02970305|453564830|FG001|Overall Study|Noncompliance with study drug|4|||
126073853|NCT02970305|453564829|FG000|Overall Study|Protocol Violation|2|||
126073854|NCT02970305|453564830|FG001|Overall Study|Protocol Violation|2|||
126073855|NCT02970305|453564829|FG000|Overall Study|Withdrawal by Subject|12|||
126073856|NCT02970305|453564830|FG001|Overall Study|Withdrawal by Subject|11|||
126073857|NCT02970305|453564829|FG000|Overall Study|Not further specified|1|||
126073858|NCT02970305|453564830|FG001|Overall Study|Not further specified|2|||
126073859|NCT02970305|453564829|FG000|Overall Study|Lost to Follow-up|1|||
126073860|NCT02970305|453564830|FG001|Overall Study|Lost to Follow-up|2|||
126073861|NCT00983892|453564831|FG000|Overall Study|Withdrawal by Subject|10|||
126073862|NCT00983892|453564832|FG001|Overall Study|Withdrawal by Subject|12|||
126073863|NCT00808899|453564834|FG000|Overall Study|Death|1|||
126073864|NCT00808899|453564834|FG000|Overall Study|Physician Decision|3|||
126073865|NCT03120949|453564839|FG000|Overall Study|randomized in error|1|||
126073866|NCT03120949|453564840|FG001|Overall Study|randomized in error|0|||
126073867|NCT03120949|453564839|FG000|Overall Study|Death|13|||
126073868|NCT03120949|453564840|FG001|Overall Study|Death|13|||
126073869|NCT03120949|453564839|FG000|Overall Study|Lost to Follow-up|23|||
126073870|NCT03120949|453564840|FG001|Overall Study|Lost to Follow-up|13|||
126073871|NCT03120949|453564839|FG000|Overall Study|Withdrawal by Subject|139|||
126073872|NCT03120949|453564840|FG001|Overall Study|Withdrawal by Subject|124|||
126073873|NCT03120949|453564839|FG000|Overall Study|Covid-19|43|||
126073874|NCT03120949|453564840|FG001|Overall Study|Covid-19|34|||
126073875|NCT03120949|453564839|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
126073876|NCT03120949|453564840|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
126073877|NCT03120949|453564839|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
126073878|NCT03120949|453564840|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
126073879|NCT03120949|453564839|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
126073880|NCT03120949|453564840|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
126073881|NCT03120949|453564839|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
126073882|NCT03120949|453564840|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
126073883|NCT03120949|453564839|FG000|Overall Study|Site was closed|2|||
126073884|NCT03120949|453564840|FG001|Overall Study|Site was closed|3|||
126073885|NCT03120949|453564839|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
126073886|NCT03120949|453564840|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
126073887|NCT03120949|453564839|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
126073888|NCT03120949|453564840|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
126073889|NCT03120949|453564839|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
126073890|NCT03120949|453564840|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
126073891|NCT03120949|453564839|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
126073892|NCT03120949|453564840|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
126073893|NCT03120949|453564839|FG000|Overall Study|Other: Adverse Event|0|||
126073894|NCT03120949|453564840|FG001|Overall Study|Other: Adverse Event|1|||
126073895|NCT03120949|453564839|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
126114770|NCT01986920|453715764|FG001|A-101 40%|Withdrawal by Subject|0|||
126114771|NCT01986920|453715765|FG002|A-101 40%|Withdrawal by Subject|1|||
125946898|NCT00110812|453105086|FG000|Main Study|Death|0|||
125946899|NCT00110812|453105087|FG001|Main Study|Death|0|||
126114772|NCT01986920|453715766|FG003|A-101 40%|Withdrawal by Subject|0|||
126114773|NCT01986920|453715763|FG000|Placebo|Withdrawal by Subject|0|||
126114774|NCT01986920|453715764|FG001|Placebo|Withdrawal by Subject|0|||
126114775|NCT01986920|453715765|FG002|Placebo|Withdrawal by Subject|0|||
126114776|NCT01986920|453715766|FG003|Placebo|Withdrawal by Subject|1|||
126114777|NCT03781323|453715767|FG000|Overall Study|Withdrawal by Subject|1|||
126114778|NCT01338415|453715768|FG000|Core + Extension|Adverse Event|8|||
126114779|NCT01338415|453715769|FG001|Core + Extension|Adverse Event|6|||
126114780|NCT01338415|453715770|FG002|Core + Extension|Adverse Event|0|||
126114781|NCT01338415|453715768|FG000|Core + Extension|Withdrawal by Subject|1|||
126114782|NCT01338415|453715769|FG001|Core + Extension|Withdrawal by Subject|1|||
126114783|NCT01338415|453715770|FG002|Core + Extension|Withdrawal by Subject|0|||
126114784|NCT01338415|453715768|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
126114785|NCT01338415|453715769|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
126114786|NCT01338415|453715770|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
126114787|NCT01338415|453715768|FG000|Core + Extension|Other (administrative reason)|1|||
126114788|NCT01338415|453715769|FG001|Core + Extension|Other (administrative reason)|0|||
126114789|NCT01338415|453715770|FG002|Core + Extension|Other (administrative reason)|0|||
126114790|NCT01338415|453715768|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
125946900|NCT00110812|453105088|FG002|Main Study|Death|2|||
125946901|NCT00110812|453105086|FG000|Main Study|Withdrawal by Subject|0|||
125946902|NCT00110812|453105087|FG001|Main Study|Withdrawal by Subject|0|||
125946903|NCT00110812|453105088|FG002|Main Study|Withdrawal by Subject|1|||
125946904|NCT00110812|453105086|FG000|Main Study|Lost to Follow-up|8|||
125946905|NCT00110812|453105087|FG001|Main Study|Lost to Follow-up|11|||
125946906|NCT00110812|453105088|FG002|Main Study|Lost to Follow-up|10|||
125946907|NCT00110812|453105086|FG000|Extended Follow-up|Death|1|||
125946908|NCT00110812|453105087|FG001|Extended Follow-up|Death|0|||
125946909|NCT00110812|453105088|FG002|Extended Follow-up|Death|3|||
125946910|NCT00110812|453105086|FG000|Extended Follow-up|Withdrawal by Subject|0|||
125946911|NCT00110812|453105087|FG001|Extended Follow-up|Withdrawal by Subject|1|||
125946912|NCT00110812|453105088|FG002|Extended Follow-up|Withdrawal by Subject|0|||
125946913|NCT00110812|453105086|FG000|Extended Follow-up|Lost to Follow-up|1|||
125946914|NCT00110812|453105087|FG001|Extended Follow-up|Lost to Follow-up|3|||
125946915|NCT00110812|453105088|FG002|Extended Follow-up|Lost to Follow-up|1|||
125946916|NCT01933048|453105089|FG000|Overall Study|Lost to Follow-up|15|||
125946917|NCT01933048|453105090|FG001|Overall Study|Lost to Follow-up|18|||
125946918|NCT01933048|453105089|FG000|Overall Study|personal reasons|1|||
125946919|NCT01933048|453105090|FG001|Overall Study|personal reasons|1|||
125946920|NCT01933048|453105089|FG000|Overall Study|Protocol Violation|7|||
125946921|NCT01933048|453105090|FG001|Overall Study|Protocol Violation|8|||
125946922|NCT01933048|453105089|FG000|Overall Study|Physician Decision|1|||
125946923|NCT01933048|453105090|FG001|Overall Study|Physician Decision|0|||
125946924|NCT01933048|453105089|FG000|Overall Study|unknown reasons|1|||
125946925|NCT01933048|453105090|FG001|Overall Study|unknown reasons|1|||
125946926|NCT02780804|453105093|FG000|Overall Study|Death|1|||
125946927|NCT02780804|453105094|FG001|Overall Study|Death|0|||
125946928|NCT02780804|453105095|FG002|Overall Study|Death|0|||
125946929|NCT02780804|453105093|FG000|Overall Study|Lack of Efficacy|5|||
125946930|NCT02780804|453105094|FG001|Overall Study|Lack of Efficacy|8|||
125946931|NCT02780804|453105095|FG002|Overall Study|Lack of Efficacy|4|||
125946932|NCT02780804|453105093|FG000|Overall Study|Physician Decision|0|||
125946933|NCT02780804|453105094|FG001|Overall Study|Physician Decision|0|||
125946934|NCT02780804|453105095|FG002|Overall Study|Physician Decision|2|||
125946935|NCT02780804|453105093|FG000|Overall Study|Withdrawal by Subject|0|||
125946936|NCT02780804|453105094|FG001|Overall Study|Withdrawal by Subject|1|||
125946937|NCT02780804|453105095|FG002|Overall Study|Withdrawal by Subject|0|||
125946938|NCT01859507|453105096|FG000|Overall Study|left the country|4|||
125946939|NCT01921829|453105097|FG000|Overall Study|Withdrawal by Subject|0|||
125946940|NCT01921829|453105098|FG001|Overall Study|Withdrawal by Subject|1|||
125946941|NCT04476030|453105099|FG000|Overall Study|Withdrawal by Subject|20|||
125946942|NCT04476030|453105100|FG001|Overall Study|Withdrawal by Subject|16|||
125946943|NCT04476030|453105099|FG000|Overall Study|Adverse Event|10|||
125946944|NCT04476030|453105100|FG001|Overall Study|Adverse Event|11|||
126114791|NCT01338415|453715769|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
125946945|NCT04476030|453105099|FG000|Overall Study|Lost to Follow-up|7|||
125946946|NCT04476030|453105100|FG001|Overall Study|Lost to Follow-up|4|||
125946947|NCT04476030|453105099|FG000|Overall Study|Physician Decision|1|||
125946948|NCT04476030|453105100|FG001|Overall Study|Physician Decision|1|||
125946949|NCT04476030|453105099|FG000|Overall Study|Protocol Deviation|2|||
125946950|NCT04476030|453105100|FG001|Overall Study|Protocol Deviation|0|||
125946951|NCT04476030|453105099|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
126114792|NCT01338415|453715770|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
125946952|NCT04476030|453105100|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
125946953|NCT04476030|453105099|FG000|Overall Study|Randomized but not Dosed|2|||
125946954|NCT04476030|453105100|FG001|Overall Study|Randomized but not Dosed|8|||
125946955|NCT02404311|453105101|FG000|Part A: Month 0-18|Death|2|||
126073896|NCT03120949|453564840|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
126073897|NCT03120949|453564839|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
126073898|NCT03120949|453564840|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
126073899|NCT03120949|453564839|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
126073900|NCT03120949|453564840|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
126073901|NCT03120949|453564839|FG000|Overall Study|Personal Reasons|0|||
126073902|NCT03120949|453564840|FG001|Overall Study|Personal Reasons|1|||
126073903|NCT03120949|453564839|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
126073904|NCT03120949|453564840|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
126073905|NCT03120949|453564839|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
126073906|NCT03120949|453564840|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
126073907|NCT03120949|453564839|FG000|Overall Study|Compliance With Medication|0|||
126073908|NCT03120949|453564840|FG001|Overall Study|Compliance With Medication|1|||
126073909|NCT03120949|453564839|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
126073910|NCT03120949|453564840|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
126073911|NCT03120949|453564839|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
126073912|NCT03120949|453564840|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
126073913|NCT03120949|453564839|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
126073914|NCT03120949|453564840|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
126073915|NCT00988117|453564841|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
126073916|NCT00988117|453564841|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
126073917|NCT04522778|453564844|FG000|Overall Study|Patient did not want to wear the device|1|||
126073918|NCT04522778|453564845|FG001|Overall Study|Patient did not want to wear the device|0|||
126073919|NCT04522778|453564844|FG000|Overall Study|Lost to Follow-up|0|||
126073920|NCT04522778|453564845|FG001|Overall Study|Lost to Follow-up|1|||
126073921|NCT01225159|453564846|FG000|Overall Study|Change operation|1|||
126073922|NCT01225159|453564847|FG001|Overall Study|Change operation|0|||
126073923|NCT00312845|453564848|FG000|Overall Study|Adverse Event|19|||
126073924|NCT00312845|453564849|FG001|Overall Study|Adverse Event|5|||
126073925|NCT00312845|453564848|FG000|Overall Study|Death|2|||
126073926|NCT00312845|453564849|FG001|Overall Study|Death|2|||
126073927|NCT00312845|453564848|FG000|Overall Study|Withdrawal by Subject|14|||
126073928|NCT00312845|453564849|FG001|Overall Study|Withdrawal by Subject|6|||
126073929|NCT00312845|453564848|FG000|Overall Study|Disease Progression|56|||
126073930|NCT00312845|453564849|FG001|Overall Study|Disease Progression|77|||
126073931|NCT00312845|453564848|FG000|Overall Study|Lost to Follow-up|2|||
126073932|NCT00312845|453564849|FG001|Overall Study|Lost to Follow-up|0|||
126073933|NCT00312845|453564848|FG000|Overall Study|Other|6|||
126073934|NCT00312845|453564849|FG001|Overall Study|Other|5|||
126073935|NCT01220856|453564850|FG000|Overall Study|graft loss|3|||
126073936|NCT01220856|453564851|FG001|Overall Study|graft loss|3|||
126073937|NCT01220856|453564850|FG000|Overall Study|Lost to Follow-up|1|||
126073938|NCT01220856|453564851|FG001|Overall Study|Lost to Follow-up|0|||
126073939|NCT04088500|453564852|FG000|Overall Study|Reason unknown|1|||
126073940|NCT04088500|453564852|FG000|Overall Study|Participant withdrew consent|1|||
126073941|NCT04088500|453564852|FG000|Overall Study|Disease progression|3|||
126073942|NCT01592383|453564853|FG000|Overall Study|Adverse Event|1|||
126073943|NCT04159805|453564854|FG000|Overall Study|Withdrawal by Subject|0|||
126073944|NCT04159805|453564855|FG001|Overall Study|Withdrawal by Subject|2|||
126073945|NCT04159805|453564856|FG002|Overall Study|Withdrawal by Subject|2|||
126073946|NCT04167085|453564857|FG000|Baseline|Withdrawal by Subject|2|||
126073947|NCT04167085|453564858|FG001|Baseline|Withdrawal by Subject|1|||
126073948|NCT04167085|453564857|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
126073949|NCT04167085|453564858|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
126073950|NCT01268098|453566556|FG000|Overall Study|Adverse Event|1|||
126073951|NCT01268098|453566557|FG001|Overall Study|Adverse Event|0|||
126073952|NCT01929876|453566559|FG000|Period 2|Non-Compliance|1|||
126073953|NCT01845649|453566560|FG000|Overall Study|Adverse Event|7|||
126073954|NCT01845649|453566561|FG001|Overall Study|Adverse Event|10|||
126073955|NCT01845649|453566560|FG000|Overall Study|Lack of Efficacy|1|||
126114793|NCT01338415|453715768|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
125946956|NCT02404311|453105102|FG001|Part A: Month 0-18|Death|0|||
125946957|NCT02404311|453105103|FG002|Part A: Month 0-18|Death|0|||
126073956|NCT01845649|453566561|FG001|Overall Study|Lack of Efficacy|1|||
126073957|NCT01845649|453566560|FG000|Overall Study|Lost to Follow-up|2|||
126073958|NCT01845649|453566561|FG001|Overall Study|Lost to Follow-up|2|||
126073959|NCT01845649|453566560|FG000|Overall Study|Withdrew Consent|12|||
126073960|NCT01845649|453566561|FG001|Overall Study|Withdrew Consent|4|||
126073961|NCT01845649|453566560|FG000|Overall Study|Protocol Deviation|7|||
126073962|NCT01845649|453566561|FG001|Overall Study|Protocol Deviation|4|||
126073963|NCT01845649|453566560|FG000|Overall Study|Reason not Specified|2|||
126073964|NCT01845649|453566561|FG001|Overall Study|Reason not Specified|1|||
126073965|NCT03991988|453566562|FG000|Overall Study|Withdrawal by Subject|2|||
125946958|NCT02404311|453105104|FG003|Part A: Month 0-18|Death|0|||
125946959|NCT02404311|453105105|FG004|Part A: Month 0-18|Death|0|||
125946960|NCT02404311|453105101|FG000|Part A: Month 0-18|Physician Decision|1|||
125946961|NCT02404311|453105102|FG001|Part A: Month 0-18|Physician Decision|0|||
125946962|NCT02404311|453105103|FG002|Part A: Month 0-18|Physician Decision|0|||
125946963|NCT02404311|453105104|FG003|Part A: Month 0-18|Physician Decision|0|||
125946964|NCT02404311|453105105|FG004|Part A: Month 0-18|Physician Decision|0|||
125946965|NCT02404311|453105101|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
125946966|NCT02404311|453105102|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
125946967|NCT02404311|453105103|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
125946968|NCT02404311|453105104|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
125946969|NCT02404311|453105105|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
125946970|NCT02404311|453105101|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
125946971|NCT02404311|453105102|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
125946972|NCT02404311|453105103|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
125946973|NCT02404311|453105104|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
125946974|NCT02404311|453105105|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
125946975|NCT02404311|453105101|FG000|Part A: Month 0-18|HIV Infection|6|||
125946976|NCT02404311|453105102|FG001|Part A: Month 0-18|HIV Infection|2|||
125946977|NCT02404311|453105103|FG002|Part A: Month 0-18|HIV Infection|0|||
125946978|NCT02404311|453105104|FG003|Part A: Month 0-18|HIV Infection|0|||
125946979|NCT02404311|453105105|FG004|Part A: Month 0-18|HIV Infection|0|||
125946980|NCT02404311|453105101|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
125946981|NCT02404311|453105102|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
125946982|NCT02404311|453105103|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
125946983|NCT02404311|453105104|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
125946984|NCT02404311|453105105|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
125946985|NCT02256891|453105106|FG000|Overall Study|Death|0|||
125946986|NCT02256891|453105107|FG001|Overall Study|Death|2|||
125946987|NCT02256891|453105106|FG000|Overall Study|Lost to Follow-up|0|||
125946988|NCT02256891|453105107|FG001|Overall Study|Lost to Follow-up|3|||
125946989|NCT02256891|453105106|FG000|Overall Study|Physician Decision|7|||
125946990|NCT02256891|453105107|FG001|Overall Study|Physician Decision|3|||
125946991|NCT02256891|453105106|FG000|Overall Study|Screen Fail|5|||
125946992|NCT02256891|453105107|FG001|Overall Study|Screen Fail|4|||
125946993|NCT02256891|453105106|FG000|Overall Study|Equipment Malfunction|0|||
125946994|NCT02256891|453105107|FG001|Overall Study|Equipment Malfunction|1|||
125946995|NCT01344447|453105108|FG000|Overall Study|Adverse Event|1|||
125946996|NCT01344447|453105108|FG000|Overall Study|Protocol Violation|1|||
125946997|NCT01344447|453105108|FG000|Overall Study|Withdrawal by Subject|1|||
125946998|NCT01344447|453105108|FG000|Overall Study|The contrast was not seen|1|||
125946999|NCT01344447|453105108|FG000|Overall Study|Physician Decision|1|||
125947000|NCT01344447|453105108|FG000|Overall Study|MRA unsuccessful|1|||
125947001|NCT01344447|453105108|FG000|Overall Study|Bolus tracking failed|1|||
125947002|NCT01344447|453105108|FG000|Overall Study|Error of power injector|1|||
125947003|NCT00218296|453105109|FG000|Overall Study|Lost to Follow-up|9|||
125947004|NCT00218296|453105110|FG001|Overall Study|Lost to Follow-up|7|||
125947005|NCT00218296|453105109|FG000|Overall Study|Withdrawal by Subject|36|||
125947006|NCT00218296|453105110|FG001|Overall Study|Withdrawal by Subject|47|||
125947007|NCT00218296|453105109|FG000|Overall Study|Randomized but did not enter treatment|66|||
125947008|NCT00218296|453105110|FG001|Overall Study|Randomized but did not enter treatment|67|||
125947009|NCT01293240|453105111|FG000|Overall Study|Noncompliance|2|||
125947010|NCT00594464|453105122|FG000|Overall Study|Withdrawal by Subject|1|||
125947011|NCT00594464|453105122|FG000|Overall Study|Delay in operation|2|||
125947012|NCT00775437|453105126|FG000|Overall Study|Loss of efficacy|2|||
125947013|NCT00775437|453105126|FG000|Overall Study|Withdrawal by Subject|3|||
125947014|NCT00775437|453105126|FG000|Overall Study|Lost to Follow-up|1|||
125947015|NCT01183975|453105127|FG000|Overall Study|Lost to Follow-up|73|||
125947016|NCT02907359|453105129|FG000|Overall Study|Death|234|||
125947017|NCT02907359|453105130|FG001|Overall Study|Death|117|||
125947018|NCT02907359|453105129|FG000|Overall Study|Withdrawal by Subject|6|||
125947019|NCT02907359|453105130|FG001|Overall Study|Withdrawal by Subject|11|||
125947020|NCT02907359|453105129|FG000|Overall Study|Lost to Follow-up|1|||
125947021|NCT02907359|453105130|FG001|Overall Study|Lost to Follow-up|0|||
125947022|NCT01405963|453105131|FG000|Overall Study|Moved Away|2|||
125947023|NCT01405963|453105132|FG001|Overall Study|Moved Away|0|||
125947024|NCT01405963|453105131|FG000|Overall Study|Adverse Event|0|||
125947025|NCT01405963|453105132|FG001|Overall Study|Adverse Event|1|||
125947026|NCT01405963|453105131|FG000|Overall Study|Lost to Follow-up|0|||
125947027|NCT01405963|453105132|FG001|Overall Study|Lost to Follow-up|1|||
125947028|NCT00746941|453105135|FG000|Overall Study|Death|2|||
125947029|NCT00746941|453105136|FG001|Overall Study|Death|0|||
125947030|NCT00746941|453105137|FG002|Overall Study|Death|0|||
125947031|NCT00746941|453105138|FG003|Overall Study|Death|6|||
125947032|NCT00746941|453105135|FG000|Overall Study|Physician Decision|0|||
125947033|NCT00746941|453105136|FG001|Overall Study|Physician Decision|0|||
125947034|NCT00746941|453105137|FG002|Overall Study|Physician Decision|2|||
125947035|NCT00746941|453105138|FG003|Overall Study|Physician Decision|0|||
125947036|NCT00746941|453105135|FG000|Overall Study|Withdrawal by Subject|3|||
126073966|NCT03991988|453566563|FG001|Overall Study|Withdrawal by Subject|2|||
126073967|NCT01222533|453566565|FG000|Overall Study|Adverse Event|5|||
126073968|NCT01222533|453566565|FG000|Overall Study|Withdrawal by Subject|5|||
126073969|NCT01222533|453566565|FG000|Overall Study|Other|4|||
126073970|NCT01947517|453566566|FG000|Overall Study|Withdrawal by Subject|1|||
126073971|NCT01947517|453566567|FG001|Overall Study|Withdrawal by Subject|1|||
126073972|NCT02418845|453566571|FG000|Overall Study|Lost to Follow-up|7|||
126073973|NCT02418845|453566572|FG001|Overall Study|Lost to Follow-up|2|||
126073974|NCT02418845|453566571|FG000|Overall Study|Lack of Efficacy|0|||
126073975|NCT02418845|453566572|FG001|Overall Study|Lack of Efficacy|3|||
126073976|NCT02418845|453566571|FG000|Overall Study|Physician Decision|5|||
126073977|NCT02418845|453566572|FG001|Overall Study|Physician Decision|5|||
126073978|NCT02418845|453566571|FG000|Overall Study|Protocol Violation|1|||
126073979|NCT02418845|453566572|FG001|Overall Study|Protocol Violation|0|||
126073980|NCT02418845|453566571|FG000|Overall Study|Withdrawal by Subject|3|||
126073981|NCT02418845|453566572|FG001|Overall Study|Withdrawal by Subject|2|||
126073982|NCT00526097|453566573|FG000|Overall Study|Adverse Event|6|||
126073983|NCT00526097|453566574|FG001|Overall Study|Adverse Event|44|||
126073984|NCT00526097|453566573|FG000|Overall Study|Protocol Violation|4|||
126073985|NCT00526097|453566574|FG001|Overall Study|Protocol Violation|10|||
126073986|NCT00526097|453566573|FG000|Overall Study|Withdrawal by Subject|3|||
126073987|NCT00526097|453566574|FG001|Overall Study|Withdrawal by Subject|1|||
126114794|NCT01338415|453715769|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
126114795|NCT01338415|453715770|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
126114796|NCT01338415|453715768|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
126114797|NCT01338415|453715769|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
126114798|NCT01338415|453715770|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
126114799|NCT01338415|453715768|FG000|Exceptional Use Treatment Period|Death|0|||
126114800|NCT01338415|453715769|FG001|Exceptional Use Treatment Period|Death|0|||
126114801|NCT01338415|453715770|FG002|Exceptional Use Treatment Period|Death|1|||
126114802|NCT04880447|453715776|FG000|Overall Study|No vaccination information|1|||
125947037|NCT00746941|453105136|FG001|Overall Study|Withdrawal by Subject|0|||
125947038|NCT00746941|453105137|FG002|Overall Study|Withdrawal by Subject|0|||
126114803|NCT04880447|453715776|FG000|Overall Study|No adverse event information (missing information)|1|||
126114804|NCT04880447|453715776|FG000|Overall Study|Disease not covered in this study|35|||
126114805|NCT01970488|453715777|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
126114806|NCT01970488|453715778|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
126114807|NCT01970488|453715779|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
126114808|NCT01970488|453715780|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
126114809|NCT01970488|453715781|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
126114810|NCT01970488|453715777|FG000|Part 1: Through Week 16|Protocol Violation|1|||
126114811|NCT01970488|453715778|FG001|Part 1: Through Week 16|Protocol Violation|2|||
126114812|NCT01970488|453715779|FG002|Part 1: Through Week 16|Protocol Violation|0|||
126114813|NCT01970488|453715780|FG003|Part 1: Through Week 16|Protocol Violation|0|||
126114814|NCT01970488|453715781|FG004|Part 1: Through Week 16|Protocol Violation|0|||
126114815|NCT01970488|453715777|FG000|Part 1: Through Week 16|Adverse Event|6|||
125947039|NCT00746941|453105138|FG003|Overall Study|Withdrawal by Subject|2|||
125947040|NCT00746941|453105135|FG000|Overall Study|Other, reason not provided|2|||
125947041|NCT00746941|453105136|FG001|Overall Study|Other, reason not provided|4|||
125947042|NCT00746941|453105137|FG002|Overall Study|Other, reason not provided|0|||
125947043|NCT00746941|453105138|FG003|Overall Study|Other, reason not provided|4|||
125947044|NCT00746941|453105135|FG000|Overall Study|Adverse Event|0|||
125947045|NCT00746941|453105136|FG001|Overall Study|Adverse Event|0|||
125947046|NCT00746941|453105137|FG002|Overall Study|Adverse Event|0|||
125947047|NCT00746941|453105138|FG003|Overall Study|Adverse Event|1|||
125947048|NCT03316885|453105143|FG000|Overall Study|Adverse Event|1|||
125947049|NCT03316885|453105143|FG000|Overall Study|Death|10|||
125947050|NCT03316885|453105143|FG000|Overall Study|Lost to Follow-up|4|||
125947051|NCT03316885|453105143|FG000|Overall Study|Withdrawal by Subject|9|||
125947052|NCT03316885|453105143|FG000|Overall Study|COVID related|8|||
125947053|NCT03216850|453105150|FG000|Overall Study|Pre-analytical error|6|||
125947054|NCT00405548|453105151|FG000|Overall Study|Cognitive Memory problems on study day|1|||
126073988|NCT00526097|453566573|FG000|Overall Study|Other|2|||
126073989|NCT00526097|453566574|FG001|Overall Study|Other|1|||
126073990|NCT00460564|453566575|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
126073991|NCT00460564|453566576|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
126073992|NCT00460564|453566577|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126073993|NCT00460564|453566578|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126073994|NCT00460564|453566579|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126114816|NCT01970488|453715778|FG001|Part 1: Through Week 16|Adverse Event|5|||
125947055|NCT00405548|453105152|FG001|Overall Study|Cognitive Memory problems on study day|0|||
125947056|NCT00405548|453105151|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
125947057|NCT00405548|453105152|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
125947058|NCT00405548|453105151|FG000|Overall Study|Unable to self-administer shots|1|||
125947059|NCT00405548|453105152|FG001|Overall Study|Unable to self-administer shots|0|||
125947060|NCT00405548|453105151|FG000|Overall Study|Venous access failed during study day|1|||
125947061|NCT00405548|453105152|FG001|Overall Study|Venous access failed during study day|0|||
125947062|NCT00405548|453105151|FG000|Overall Study|Withdrawal by Subject|1|||
125947063|NCT00405548|453105152|FG001|Overall Study|Withdrawal by Subject|0|||
125947064|NCT00923559|453105153|FG000|Overall Study|Lost to Follow-up|2|||
125947065|NCT00923559|453105154|FG001|Overall Study|Lost to Follow-up|3|||
125947066|NCT01148511|453105158|FG000|Exposed to Study Drug|Protocol Violation|2|||
126114817|NCT01970488|453715779|FG002|Part 1: Through Week 16|Adverse Event|0|||
126114818|NCT01970488|453715780|FG003|Part 1: Through Week 16|Adverse Event|0|||
126114819|NCT01970488|453715781|FG004|Part 1: Through Week 16|Adverse Event|0|||
126114820|NCT01970488|453715777|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
126114821|NCT01970488|453715778|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
126114822|NCT01970488|453715779|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
126114823|NCT01970488|453715780|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
126114824|NCT01970488|453715781|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
126114825|NCT01970488|453715777|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
125947067|NCT01148511|453105159|FG001|Exposed to Study Drug|Protocol Violation|0|||
125947068|NCT01148511|453105160|FG002|Exposed to Study Drug|Protocol Violation|0|||
125947069|NCT01148511|453105158|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
125947070|NCT01148511|453105159|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
125947071|NCT01148511|453105160|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
125947072|NCT01148511|453105158|FG000|Randomized|Adverse Event|0|||
125947073|NCT01148511|453105159|FG001|Randomized|Adverse Event|1|||
125947074|NCT01148511|453105160|FG002|Randomized|Adverse Event|0|||
125947075|NCT01148511|453105158|FG000|Randomized|Protocol Violation|0|||
125947076|NCT01148511|453105159|FG001|Randomized|Protocol Violation|2|||
125947077|NCT01148511|453105160|FG002|Randomized|Protocol Violation|1|||
125947078|NCT01148511|453105158|FG000|Randomized|Lost to Follow-up|0|||
125947079|NCT01148511|453105159|FG001|Randomized|Lost to Follow-up|1|||
125947080|NCT01148511|453105160|FG002|Randomized|Lost to Follow-up|1|||
125947081|NCT01148511|453105158|FG000|Randomized|Consent withdrawal|0|||
125947082|NCT01148511|453105159|FG001|Randomized|Consent withdrawal|5|||
125947083|NCT01148511|453105160|FG002|Randomized|Consent withdrawal|3|||
125947084|NCT01148511|453105158|FG000|Randomized|Other|0|||
125947085|NCT01148511|453105159|FG001|Randomized|Other|1|||
125947086|NCT01148511|453105160|FG002|Randomized|Other|1|||
125947087|NCT04258605|453105163|FG000|Overall Study|Death|1|||
125947088|NCT04258605|453105164|FG001|Overall Study|Death|0|||
125947089|NCT04258605|453105163|FG000|Overall Study|Early study termination|21|||
125947090|NCT04258605|453105164|FG001|Overall Study|Early study termination|2|||
125947091|NCT02818777|453105172|FG000|Overall Study|Adverse Event|3|||
125947092|NCT01324349|453105182|FG000|Overall Study|Death|1|||
125947093|NCT01324349|453105183|FG001|Overall Study|Death|1|||
126073995|NCT00460564|453566580|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126073996|NCT00460564|453566581|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126073997|NCT00460564|453566582|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126073998|NCT00460564|453566575|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
126073999|NCT00460564|453566576|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126074000|NCT00460564|453566577|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126074001|NCT00460564|453566578|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125947094|NCT01324349|453105182|FG000|Overall Study|Withdrawal by Subject|0|||
125947095|NCT01324349|453105183|FG001|Overall Study|Withdrawal by Subject|1|||
125947096|NCT02013167|453105186|FG000|Overall Study|Withdrawal by Subject|15|||
125947097|NCT02013167|453105187|FG001|Overall Study|Withdrawal by Subject|14|||
125947098|NCT02013167|453105186|FG000|Overall Study|Sponsor Decision|1|||
125947099|NCT02013167|453105187|FG001|Overall Study|Sponsor Decision|3|||
126074002|NCT00460564|453566579|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126114826|NCT01970488|453715778|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
125947100|NCT02013167|453105186|FG000|Overall Study|Lost to Follow-up|0|||
125947101|NCT02013167|453105187|FG001|Overall Study|Lost to Follow-up|1|||
125947102|NCT02013167|453105186|FG000|Overall Study|Death|85|||
125947103|NCT02013167|453105187|FG001|Overall Study|Death|160|||
125947104|NCT01113879|453105188|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
125947105|NCT01113879|453105189|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
125947106|NCT03913091|453105190|FG000|Overall Study|Lost to Follow-up|18|||
125947107|NCT03913091|453105191|FG001|Overall Study|Lost to Follow-up|11|||
125947108|NCT03913091|453105190|FG000|Overall Study|Required additional meds/surgery|1|||
126074003|NCT00460564|453566580|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126114827|NCT01970488|453715779|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
126114828|NCT01970488|453715780|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
125947109|NCT03913091|453105191|FG001|Overall Study|Required additional meds/surgery|2|||
125947110|NCT03913091|453105190|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
125947111|NCT03913091|453105191|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
125947112|NCT00969553|453105192|FG000|Overall Study|Progressive disease (PD)|2|||
125947113|NCT00969553|453105193|FG001|Overall Study|Progressive disease (PD)|2|||
126074004|NCT00460564|453566581|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126074005|NCT00460564|453566582|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126074006|NCT00460564|453566575|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126074007|NCT00460564|453566576|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126074008|NCT00460564|453566577|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126074009|NCT00460564|453566578|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126074010|NCT00460564|453566579|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
126074011|NCT00460564|453566580|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
126074012|NCT00460564|453566581|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
126074013|NCT00460564|453566582|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126074014|NCT00460564|453566575|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126074015|NCT00460564|453566576|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126074016|NCT00460564|453566577|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126074017|NCT00460564|453566578|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126074018|NCT00460564|453566579|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
126074019|NCT00460564|453566580|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
126074020|NCT00460564|453566581|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126074021|NCT00460564|453566582|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126074022|NCT00460564|453566575|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126074023|NCT00460564|453566576|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126074024|NCT00460564|453566577|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126074025|NCT00460564|453566578|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126074026|NCT00460564|453566579|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
126074027|NCT00460564|453566580|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126074028|NCT00460564|453566581|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126074029|NCT00460564|453566582|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126074030|NCT00511836|453566583|FG000|Double-blind Period|Lost to Follow-up|1|||
126074031|NCT00511836|453566584|FG001|Double-blind Period|Lost to Follow-up|0|||
126074032|NCT00943618|453566588|FG000|Overall Study|Lost to Follow-up|38|||
126074033|NCT00943618|453566589|FG001|Overall Study|Lost to Follow-up|48|||
126074034|NCT00943618|453566590|FG002|Overall Study|Lost to Follow-up|20|||
126074035|NCT00943618|453566588|FG000|Overall Study|Discontinued Medication|17|||
126074036|NCT00943618|453566589|FG001|Overall Study|Discontinued Medication|29|||
126074037|NCT00943618|453566590|FG002|Overall Study|Discontinued Medication|11|||
126074038|NCT02412111|453566605|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
126074039|NCT02412111|453566606|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
126074040|NCT02412111|453566607|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
126074041|NCT02412111|453566605|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
126074042|NCT02412111|453566606|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
126074043|NCT02412111|453566607|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
126074044|NCT02412111|453566605|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
126074045|NCT02412111|453566606|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
126074046|NCT02412111|453566607|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
126074047|NCT02412111|453566605|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
126074048|NCT02412111|453566606|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
126074049|NCT02412111|453566607|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
126074050|NCT02412111|453566605|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
126074051|NCT02412111|453566606|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
126074052|NCT02412111|453566607|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
126074053|NCT02412111|453566605|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
126074054|NCT02412111|453566606|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
126074055|NCT02412111|453566607|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
126074056|NCT02412111|453566605|FG000|Active Comparator Period (8 Weeks)|Other|0|||
126074057|NCT02412111|453566606|FG001|Active Comparator Period (8 Weeks)|Other|0|||
126074058|NCT02412111|453566607|FG002|Active Comparator Period (8 Weeks)|Other|2|||
126074059|NCT00487552|453566608|FG000|Overall Study|Unsuccessful magnet placements|3|||
126074060|NCT00487552|453566608|FG000|Overall Study|Death due to progressive malignancy|2|||
126074061|NCT00487552|453566608|FG000|Overall Study|Stent not placed|1|||
126074062|NCT00630552|453566609|FG000|Overall Study|Adverse Event|0|||
126074063|NCT00630552|453566610|FG001|Overall Study|Adverse Event|1|||
126074064|NCT00630552|453566611|FG002|Overall Study|Adverse Event|5|||
126074065|NCT00630552|453566612|FG003|Overall Study|Adverse Event|4|||
126074066|NCT00630552|453566613|FG004|Overall Study|Adverse Event|2|||
126074067|NCT00630552|453566609|FG000|Overall Study|Disease progression|5|||
126074068|NCT00630552|453566610|FG001|Overall Study|Disease progression|6|||
126074069|NCT00630552|453566611|FG002|Overall Study|Disease progression|27|||
126074070|NCT00630552|453566612|FG003|Overall Study|Disease progression|22|||
126074071|NCT00630552|453566613|FG004|Overall Study|Disease progression|31|||
126074072|NCT00630552|453566609|FG000|Overall Study|Never received IP|0|||
126074073|NCT00630552|453566610|FG001|Overall Study|Never received IP|0|||
125947114|NCT00969553|453105194|FG002|Overall Study|Progressive disease (PD)|6|||
125947115|NCT00969553|453105195|FG003|Overall Study|Progressive disease (PD)|9|||
125947116|NCT00969553|453105196|FG004|Overall Study|Progressive disease (PD)|2|||
125947117|NCT00969553|453105197|FG005|Overall Study|Progressive disease (PD)|4|||
125947118|NCT00969553|453105198|FG006|Overall Study|Progressive disease (PD)|2|||
125947119|NCT00969553|453105199|FG007|Overall Study|Progressive disease (PD)|12|||
125947120|NCT00969553|453105200|FG008|Overall Study|Progressive disease (PD)|3|||
125947121|NCT00969553|453105192|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
125947122|NCT00969553|453105193|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
125947123|NCT00969553|453105194|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
125947124|NCT00969553|453105195|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
125947125|NCT00969553|453105196|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
125947126|NCT00969553|453105197|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
125947127|NCT00969553|453105198|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
125947128|NCT00969553|453105199|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
125947129|NCT00969553|453105200|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
125947130|NCT00969553|453105192|FG000|Overall Study|Other Adverse Event|0|||
125947131|NCT00969553|453105193|FG001|Overall Study|Other Adverse Event|0|||
125947132|NCT00969553|453105194|FG002|Overall Study|Other Adverse Event|0|||
125947133|NCT00969553|453105195|FG003|Overall Study|Other Adverse Event|1|||
125947134|NCT00969553|453105196|FG004|Overall Study|Other Adverse Event|0|||
125947135|NCT00969553|453105197|FG005|Overall Study|Other Adverse Event|0|||
125947136|NCT00969553|453105198|FG006|Overall Study|Other Adverse Event|1|||
125947137|NCT00969553|453105199|FG007|Overall Study|Other Adverse Event|0|||
125947138|NCT00969553|453105200|FG008|Overall Study|Other Adverse Event|0|||
125947139|NCT00969553|453105192|FG000|Overall Study|Refused cont. medication|1|||
125947140|NCT00969553|453105193|FG001|Overall Study|Refused cont. medication|1|||
125947141|NCT00969553|453105194|FG002|Overall Study|Refused cont. medication|0|||
125947142|NCT00969553|453105195|FG003|Overall Study|Refused cont. medication|2|||
125947143|NCT00969553|453105196|FG004|Overall Study|Refused cont. medication|0|||
125947144|NCT00969553|453105197|FG005|Overall Study|Refused cont. medication|0|||
125947145|NCT00969553|453105198|FG006|Overall Study|Refused cont. medication|0|||
125947146|NCT00969553|453105199|FG007|Overall Study|Refused cont. medication|1|||
125947147|NCT00969553|453105200|FG008|Overall Study|Refused cont. medication|0|||
125947148|NCT00969553|453105192|FG000|Overall Study|Not specified above|0|||
125947149|NCT00969553|453105193|FG001|Overall Study|Not specified above|0|||
125947150|NCT00969553|453105194|FG002|Overall Study|Not specified above|0|||
125947151|NCT00969553|453105195|FG003|Overall Study|Not specified above|4|||
125947152|NCT00969553|453105196|FG004|Overall Study|Not specified above|0|||
125947153|NCT00969553|453105197|FG005|Overall Study|Not specified above|0|||
125947154|NCT00969553|453105198|FG006|Overall Study|Not specified above|1|||
125947155|NCT00969553|453105199|FG007|Overall Study|Not specified above|1|||
125947156|NCT00969553|453105200|FG008|Overall Study|Not specified above|0|||
125947157|NCT02196324|453105202|FG000|Overall Study|Withdrawal by Subject|8|||
125947158|NCT02196324|453105203|FG001|Overall Study|Withdrawal by Subject|4|||
125947159|NCT02196324|453105202|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
125947160|NCT02196324|453105203|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
125947161|NCT02196324|453105202|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
125947162|NCT02196324|453105203|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
125947163|NCT02196324|453105202|FG000|Overall Study|Other|1|||
125947164|NCT02196324|453105203|FG001|Overall Study|Other|0|||
125947165|NCT00692770|453105204|FG000|Overall Study|Protocol Violation|2|||
125947166|NCT00692770|453105205|FG001|Overall Study|Protocol Violation|7|||
125947167|NCT00692770|453105204|FG000|Overall Study|Withdrawal by Subject|97|||
125947168|NCT00692770|453105205|FG001|Overall Study|Withdrawal by Subject|36|||
125947169|NCT00692770|453105204|FG000|Overall Study|Adverse Event|136|||
125947170|NCT00692770|453105205|FG001|Overall Study|Adverse Event|41|||
126074074|NCT00630552|453566611|FG002|Overall Study|Never received IP|0|||
126074075|NCT00630552|453566612|FG003|Overall Study|Never received IP|2|||
126074076|NCT00630552|453566613|FG004|Overall Study|Never received IP|2|||
126074077|NCT00630552|453566609|FG000|Overall Study|Ineligibility determined|0|||
126074078|NCT00630552|453566610|FG001|Overall Study|Ineligibility determined|0|||
126074079|NCT00630552|453566611|FG002|Overall Study|Ineligibility determined|0|||
126074080|NCT00630552|453566612|FG003|Overall Study|Ineligibility determined|0|||
126074081|NCT00630552|453566613|FG004|Overall Study|Ineligibility determined|1|||
126074082|NCT00630552|453566609|FG000|Overall Study|Protocol Violation|0|||
126074083|NCT00630552|453566610|FG001|Overall Study|Protocol Violation|0|||
125947171|NCT00692770|453105204|FG000|Overall Study|Death|10|||
125947172|NCT00692770|453105205|FG001|Overall Study|Death|5|||
125947173|NCT00692770|453105204|FG000|Overall Study|Lost to Follow-up|7|||
125947174|NCT00692770|453105205|FG001|Overall Study|Lost to Follow-up|3|||
125947175|NCT00692770|453105204|FG000|Overall Study|Non-compliant with study medication|11|||
125947176|NCT00692770|453105205|FG001|Overall Study|Non-compliant with study medication|5|||
125947177|NCT00692770|453105204|FG000|Overall Study|Progression by clinical judgment|2|||
125947178|NCT00692770|453105205|FG001|Overall Study|Progression by clinical judgment|3|||
125947179|NCT00692770|453105204|FG000|Overall Study|Physician decision not protocol driven|10|||
126074084|NCT00630552|453566611|FG002|Overall Study|Protocol Violation|0|||
126074085|NCT00630552|453566612|FG003|Overall Study|Protocol Violation|1|||
126074086|NCT00630552|453566613|FG004|Overall Study|Protocol Violation|0|||
126074087|NCT00630552|453566609|FG000|Overall Study|Physician Decision|0|||
126074088|NCT00630552|453566610|FG001|Overall Study|Physician Decision|0|||
126074089|NCT00630552|453566611|FG002|Overall Study|Physician Decision|0|||
126074090|NCT00630552|453566612|FG003|Overall Study|Physician Decision|0|||
126074091|NCT00630552|453566613|FG004|Overall Study|Physician Decision|1|||
126074092|NCT00630552|453566609|FG000|Overall Study|Death|0|||
126074093|NCT00630552|453566610|FG001|Overall Study|Death|0|||
126074094|NCT00630552|453566611|FG002|Overall Study|Death|1|||
126074095|NCT00630552|453566612|FG003|Overall Study|Death|2|||
126074096|NCT00630552|453566613|FG004|Overall Study|Death|2|||
126074097|NCT00630552|453566609|FG000|Overall Study|Withdrawal by Subject|0|||
126074098|NCT00630552|453566610|FG001|Overall Study|Withdrawal by Subject|0|||
126074099|NCT00630552|453566611|FG002|Overall Study|Withdrawal by Subject|0|||
126074100|NCT00630552|453566612|FG003|Overall Study|Withdrawal by Subject|1|||
126074101|NCT00630552|453566613|FG004|Overall Study|Withdrawal by Subject|0|||
126074102|NCT00630552|453566609|FG000|Overall Study|Other|0|||
125947180|NCT00692770|453105205|FG001|Overall Study|Physician decision not protocol driven|14|||
126074103|NCT00630552|453566610|FG001|Overall Study|Other|0|||
126074104|NCT00630552|453566611|FG002|Overall Study|Other|4|||
126074105|NCT00630552|453566612|FG003|Overall Study|Other|2|||
126074106|NCT00630552|453566613|FG004|Overall Study|Other|0|||
126074107|NCT04349644|453566614|FG000|Allocation/Pretest|Lost to pretest|0|||
126074108|NCT04349644|453566615|FG001|Allocation/Pretest|Lost to pretest|3|||
126074109|NCT04349644|453566614|FG000|Posttest|Lost to posttest|0|||
126074110|NCT04349644|453566615|FG001|Posttest|Lost to posttest|8|||
126074111|NCT04349644|453566614|FG000|Posttest|Discontinued intervention|6|||
126074112|NCT04349644|453566615|FG001|Posttest|Discontinued intervention|0|||
126074113|NCT04349644|453566614|FG000|Follow-up|Lost to Follow-up|0|||
126074114|NCT04349644|453566615|FG001|Follow-up|Lost to Follow-up|2|||
126074115|NCT00983905|453566616|FG000|Theophylline Alone|Adverse Event|1|||
126074116|NCT00983905|453566616|FG000|Colchicine Alone|Adverse Event|2|||
126074117|NCT01169636|453566617|FG000|Overall Study|Adverse Event|0|||
126074118|NCT01169636|453566618|FG001|Overall Study|Adverse Event|0|||
126074119|NCT01169636|453566619|FG002|Overall Study|Adverse Event|1|||
126074120|NCT01169636|453566620|FG003|Overall Study|Adverse Event|1|||
126074121|NCT01169636|453566621|FG004|Overall Study|Adverse Event|0|||
126074122|NCT01169636|453566617|FG000|Overall Study|Screen failure|0|||
126074123|NCT01169636|453566618|FG001|Overall Study|Screen failure|0|||
126074124|NCT01169636|453566619|FG002|Overall Study|Screen failure|2|||
126074125|NCT01169636|453566620|FG003|Overall Study|Screen failure|0|||
126074126|NCT01169636|453566621|FG004|Overall Study|Screen failure|0|||
126074127|NCT01169636|453566617|FG000|Overall Study|Withdrawal by Subject|0|||
126074128|NCT01169636|453566618|FG001|Overall Study|Withdrawal by Subject|0|||
126074129|NCT01169636|453566619|FG002|Overall Study|Withdrawal by Subject|0|||
126074130|NCT01169636|453566620|FG003|Overall Study|Withdrawal by Subject|0|||
126074131|NCT01169636|453566621|FG004|Overall Study|Withdrawal by Subject|3|||
126074132|NCT02287883|453566622|FG000|Overall Study|Death|8|||
126074133|NCT02287883|453566623|FG001|Overall Study|Death|7|||
126074134|NCT02287883|453566622|FG000|Overall Study|No longer eligible|222|||
126074135|NCT02287883|453566623|FG001|Overall Study|No longer eligible|182|||
126074136|NCT02287883|453566622|FG000|Overall Study|Non-response to survey|229|||
126074137|NCT02287883|453566623|FG001|Overall Study|Non-response to survey|237|||
126074138|NCT00802438|453566624|FG000|Overall Study|Screen Failure|20|||
126074139|NCT00802438|453566624|FG000|Overall Study|Withdrawal by Subject|7|||
126074140|NCT00802438|453566624|FG000|Overall Study|Physician Decision|1|||
126074141|NCT04016805|453566625|FG000|Overall Study|Sponsor's Discretion|30|||
126074142|NCT04016805|453566626|FG001|Overall Study|Sponsor's Discretion|6|||
126074143|NCT04016805|453566627|FG002|Overall Study|Sponsor's Discretion|5|||
126074144|NCT03175198|453566628|FG000|Overall Study|Adverse Event|480|||
126074145|NCT03175198|453566628|FG000|Overall Study|No actual visit|120|||
126074146|NCT03175198|453566628|FG000|Overall Study|Registration rule not followed|4|||
126074147|NCT03175198|453566628|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
126074148|NCT03175198|453566628|FG000|Overall Study|Other personal reason|509|||
126074149|NCT03175198|453566628|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
126074150|NCT03175198|453566628|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
126074151|NCT03175198|453566628|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
126074152|NCT03175198|453566628|FG000|Overall Study|To conduct invasive treatment of operation|53|||
126074153|NCT03175198|453566628|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
126114829|NCT01970488|453715781|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
126114830|NCT01970488|453715777|FG000|Part 2: Post Week 16|Physician Decision|0|||
126114831|NCT01970488|453715778|FG001|Part 2: Post Week 16|Physician Decision|0|||
126074154|NCT03811834|453566630|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
126074155|NCT03188536|453566631|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
126074156|NCT03188536|453566631|FG000|Overall Study|Not participated/met inclusion criteria|1|||
126074157|NCT04947436|453566634|FG000|Overall Study|Lost to Follow-up|3|||
125947181|NCT00692770|453105204|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
125947182|NCT00692770|453105205|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
125947183|NCT00692770|453105204|FG000|Overall Study|Protocol driven decision point|3|||
125947184|NCT00692770|453105205|FG001|Overall Study|Protocol driven decision point|7|||
125947185|NCT00692770|453105204|FG000|Overall Study|Completed all planned assessments|79|||
125947186|NCT00692770|453105205|FG001|Overall Study|Completed all planned assessments|101|||
125947187|NCT00692770|453105204|FG000|Overall Study|Radiological and clinical progression|8|||
125947188|NCT00692770|453105205|FG001|Overall Study|Radiological and clinical progression|8|||
125947189|NCT00692770|453105204|FG000|Overall Study|Clinical endpoint reached|16|||
125947190|NCT00692770|453105205|FG001|Overall Study|Clinical endpoint reached|43|||
125947191|NCT00692770|453105204|FG000|Overall Study|Study terminated by sponsor|2|||
125947192|NCT00692770|453105205|FG001|Overall Study|Study terminated by sponsor|2|||
125947193|NCT00692770|453105204|FG000|Overall Study|Randomized but not treated|3|||
125947194|NCT00692770|453105205|FG001|Overall Study|Randomized but not treated|4|||
125947195|NCT04248816|453105206|FG000|Overall Study|Ineligible post-randomization|7|||
125947196|NCT04248816|453105207|FG001|Overall Study|Ineligible post-randomization|21|||
125947197|NCT04248816|453105208|FG002|Overall Study|Ineligible post-randomization|25|||
125947198|NCT04327986|453105209|FG000|Overall Study|Physician Decision|2|||
125947199|NCT04327986|453105210|FG001|Overall Study|Physician Decision|0|||
125947200|NCT04327986|453105211|FG002|Overall Study|Physician Decision|0|||
125947201|NCT04327986|453105209|FG000|Overall Study|Death|1|||
125947202|NCT04327986|453105210|FG001|Overall Study|Death|0|||
125947203|NCT04327986|453105211|FG002|Overall Study|Death|0|||
125947204|NCT01714310|453106749|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
125947205|NCT01714310|453106750|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
125947206|NCT01714310|453106751|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
125947207|NCT01714310|453106749|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
125947208|NCT01714310|453106750|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
125947209|NCT01714310|453106751|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
125947210|NCT01714310|453106749|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
125947211|NCT01714310|453106750|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
125947212|NCT01714310|453106751|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
125947213|NCT01714310|453106749|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
125947214|NCT01714310|453106750|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
125947215|NCT01714310|453106751|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
125947216|NCT00654381|453106756|FG000|1st Stage|Adverse Event|3|||
125947217|NCT00654381|453106757|FG001|1st Stage|Adverse Event|3|||
125947218|NCT00654381|453106758|FG002|1st Stage|Adverse Event|3|||
125947219|NCT00654381|453106759|FG003|1st Stage|Adverse Event|3|||
125947220|NCT00654381|453106760|FG004|1st Stage|Adverse Event|2|||
125947221|NCT00654381|453106761|FG005|1st Stage|Adverse Event|1|||
125947222|NCT00654381|453106756|FG000|1st Stage|Withdrawal by Subject|0|||
125947223|NCT00654381|453106757|FG001|1st Stage|Withdrawal by Subject|0|||
125947224|NCT00654381|453106758|FG002|1st Stage|Withdrawal by Subject|0|||
125947225|NCT00654381|453106759|FG003|1st Stage|Withdrawal by Subject|1|||
125947226|NCT00654381|453106760|FG004|1st Stage|Withdrawal by Subject|0|||
125947227|NCT00654381|453106761|FG005|1st Stage|Withdrawal by Subject|1|||
125947228|NCT00654381|453106756|FG000|1st Stage|Investigator's decision|0|||
125947229|NCT00654381|453106757|FG001|1st Stage|Investigator's decision|0|||
125947230|NCT00654381|453106758|FG002|1st Stage|Investigator's decision|0|||
125947231|NCT00654381|453106759|FG003|1st Stage|Investigator's decision|1|||
125947232|NCT00654381|453106760|FG004|1st Stage|Investigator's decision|0|||
125947233|NCT00654381|453106761|FG005|1st Stage|Investigator's decision|0|||
125947234|NCT00654381|453106756|FG000|2nd Stage|Adverse Event|2|||
125947235|NCT00654381|453106757|FG001|2nd Stage|Adverse Event|0|||
125947236|NCT00654381|453106758|FG002|2nd Stage|Adverse Event|2|||
125947237|NCT00654381|453106759|FG003|2nd Stage|Adverse Event|3|||
125947238|NCT00654381|453106760|FG004|2nd Stage|Adverse Event|7|||
125947239|NCT00654381|453106761|FG005|2nd Stage|Adverse Event|2|||
125947240|NCT00654381|453106756|FG000|2nd Stage|Withdrawal by Subject|0|||
125947241|NCT00654381|453106757|FG001|2nd Stage|Withdrawal by Subject|0|||
125947242|NCT00654381|453106758|FG002|2nd Stage|Withdrawal by Subject|0|||
125947243|NCT00654381|453106759|FG003|2nd Stage|Withdrawal by Subject|0|||
125947244|NCT00654381|453106760|FG004|2nd Stage|Withdrawal by Subject|1|||
125947245|NCT00654381|453106761|FG005|2nd Stage|Withdrawal by Subject|1|||
125947246|NCT00654381|453106756|FG000|2nd Stage|Investigator's decision|0|||
125947247|NCT00654381|453106757|FG001|2nd Stage|Investigator's decision|0|||
126114832|NCT01970488|453715779|FG002|Part 2: Post Week 16|Physician Decision|0|||
125947248|NCT00654381|453106758|FG002|2nd Stage|Investigator's decision|1|||
125947249|NCT00654381|453106759|FG003|2nd Stage|Investigator's decision|1|||
125947250|NCT00654381|453106760|FG004|2nd Stage|Investigator's decision|0|||
125947251|NCT00654381|453106761|FG005|2nd Stage|Investigator's decision|0|||
125947252|NCT00654381|453106756|FG000|Extension Stage|Adverse Event|1|||
125947253|NCT00654381|453106757|FG001|Extension Stage|Adverse Event|2|||
126114833|NCT01970488|453715780|FG003|Part 2: Post Week 16|Physician Decision|0|||
125947254|NCT00654381|453106758|FG002|Extension Stage|Adverse Event|9|||
125947255|NCT00654381|453106759|FG003|Extension Stage|Adverse Event|7|||
126074158|NCT04947436|453566635|FG001|Overall Study|Lost to Follow-up|7|||
126074159|NCT04947436|453566636|FG002|Overall Study|Lost to Follow-up|5|||
126074160|NCT04947436|453566634|FG000|Overall Study|Death|1|||
126074161|NCT04947436|453566635|FG001|Overall Study|Death|1|||
126074162|NCT04947436|453566636|FG002|Overall Study|Death|1|||
126074163|NCT02161185|453566640|FG000|Treatment Phase|Administrative/Other|7|||
126074164|NCT00372255|453566641|FG000|Overall Study|Withdrawn for other reasons|2|||
126074165|NCT00372255|453566642|FG001|Overall Study|Withdrawn for other reasons|1|||
126074166|NCT01215032|453566648|FG000|Overall Study|Adverse Event|3|||
126074167|NCT01215032|453566648|FG000|Overall Study|Lack of Efficacy|17|||
126074168|NCT00361842|453566653|FG000|Overall Study|Withdrawal by Subject|2|||
126074169|NCT00361842|453566654|FG001|Overall Study|Withdrawal by Subject|3|||
126074170|NCT00361842|453566653|FG000|Overall Study|Death|2|||
126074171|NCT00361842|453566654|FG001|Overall Study|Death|1|||
126074172|NCT00361842|453566653|FG000|Overall Study|Disease progression|19|||
126074173|NCT00361842|453566654|FG001|Overall Study|Disease progression|20|||
126074174|NCT00361842|453566653|FG000|Overall Study|Adverse Event|2|||
126074175|NCT00361842|453566654|FG001|Overall Study|Adverse Event|3|||
126074176|NCT00361842|453566653|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
126074177|NCT00361842|453566654|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
126074178|NCT00361842|453566653|FG000|Overall Study|Other|1|||
126074179|NCT00361842|453566654|FG001|Overall Study|Other|0|||
126074180|NCT00361842|453566653|FG000|Overall Study|Other|0|||
126074181|NCT00361842|453566654|FG001|Overall Study|Other|2|||
126074182|NCT04814992|453566655|FG000|Overall Study|Withdrawal by Subject|6|||
126074183|NCT04814992|453566656|FG001|Overall Study|Withdrawal by Subject|3|||
126074184|NCT04814992|453566655|FG000|Overall Study|Lost to Follow-up|1|||
126074185|NCT04814992|453566656|FG001|Overall Study|Lost to Follow-up|4|||
126074186|NCT01078584|453566657|FG000|Overall Study|Final Status Unknown|1073|||
126074187|NCT01078584|453566657|FG000|Overall Study|Lost to Follow-up|670|||
126074188|NCT01078584|453566657|FG000|Overall Study|Non-serious Adverse Event|577|||
126074189|NCT01078584|453566657|FG000|Overall Study|Withdrawal of Consent|244|||
126074190|NCT01078584|453566657|FG000|Overall Study|Physician Withdrew from Study|90|||
126074191|NCT01078584|453566657|FG000|Overall Study|Non-compliance|67|||
126074192|NCT01078584|453566657|FG000|Overall Study|Blood Pressure Controlled|49|||
126074193|NCT01078584|453566657|FG000|Overall Study|Physician Switched Medication|26|||
126074194|NCT01078584|453566657|FG000|Overall Study|Physician Discontinued Patient|12|||
126074195|NCT01078584|453566657|FG000|Overall Study|Lack of Efficacy|98|||
126074196|NCT01078584|453566657|FG000|Overall Study|Protocol Violation|75|||
126074197|NCT01078584|453566657|FG000|Overall Study|Serious Adverse Event|27|||
126074198|NCT01078584|453566657|FG000|Overall Study|Multiple Reasons|2|||
126074199|NCT01208870|453566660|FG000|Overall Study|Lost to Follow-up|2|||
126074200|NCT01208870|453566661|FG001|Overall Study|Lost to Follow-up|8|||
126074201|NCT01260142|453566662|FG000|Treatment Period 1|Study on hold|1|||
126074202|NCT01260142|453566663|FG001|Treatment Period 1|Study on hold|1|||
126074203|NCT01260142|453566664|FG002|Treatment Period 1|Study on hold|0|||
126074204|NCT01260142|453566665|FG003|Treatment Period 1|Study on hold|0|||
126074205|NCT01260142|453566666|FG004|Treatment Period 1|Study on hold|1|||
126074206|NCT01260142|453566667|FG005|Treatment Period 1|Study on hold|2|||
126074207|NCT01260142|453566662|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
126074208|NCT01260142|453566663|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
126074209|NCT01260142|453566664|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
126074210|NCT01260142|453566665|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
126074211|NCT01260142|453566666|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
126074212|NCT01260142|453566667|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
126074213|NCT01260142|453566662|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126074214|NCT01260142|453566663|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126074215|NCT01260142|453566664|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126074216|NCT01260142|453566665|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126074217|NCT01260142|453566666|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126074218|NCT01260142|453566667|FG005|Treatment Period 1|Withdrawal by Subject|1|||
126074219|NCT00424177|453566668|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
126074220|NCT00424177|453566668|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
126074221|NCT00424177|453566668|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
126074222|NCT00424177|453566668|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
126074223|NCT00424177|453566668|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
126074224|NCT00424177|453566668|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
126074225|NCT00424177|453566668|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
126074226|NCT00424177|453566668|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
126074227|NCT00424177|453566668|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
126074228|NCT00424177|453566668|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
126074229|NCT00691678|453566673|FG000|Overall Study|Adverse Event|5|||
125947256|NCT00654381|453106760|FG004|Extension Stage|Adverse Event|1|||
126074230|NCT00691678|453566673|FG000|Overall Study|life events, pain|11|||
126074231|NCT00496834|453566674|FG000|Overall Study|Withdrawal by Subject|4|||
126074232|NCT00496834|453566675|FG001|Overall Study|Withdrawal by Subject|6|||
126074233|NCT00496834|453566674|FG000|Overall Study|Contraindicated medication administered|0|||
126074234|NCT00496834|453566675|FG001|Overall Study|Contraindicated medication administered|1|||
126074235|NCT00496834|453566674|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
126074236|NCT00496834|453566675|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
126074237|NCT00496834|453566674|FG000|Overall Study|Adverse Event|5|||
126074238|NCT00496834|453566675|FG001|Overall Study|Adverse Event|3|||
126074239|NCT00496834|453566674|FG000|Overall Study|IP administration violation|2|||
126074240|NCT00496834|453566675|FG001|Overall Study|IP administration violation|0|||
126074241|NCT00496834|453566674|FG000|Overall Study|Lost to Follow-up|2|||
126074242|NCT00496834|453566675|FG001|Overall Study|Lost to Follow-up|0|||
126074243|NCT00496834|453566674|FG000|Overall Study|Blood Pressure control failure|2|||
126074244|NCT00496834|453566675|FG001|Overall Study|Blood Pressure control failure|1|||
126074245|NCT01227928|453566676|FG000|Overall Study|Lost to Follow-up|4|||
126074246|NCT01227928|453566677|FG001|Overall Study|Lost to Follow-up|2|||
126074247|NCT01227928|453566676|FG000|Overall Study|Withdrawal by Subject|4|||
126074248|NCT01227928|453566677|FG001|Overall Study|Withdrawal by Subject|3|||
126074249|NCT01227928|453566676|FG000|Overall Study|Death|14|||
126074250|NCT01227928|453566677|FG001|Overall Study|Death|12|||
126074251|NCT01494298|453566678|FG000|Overall Study|Protocol Violation|2|||
126074252|NCT01494298|453566679|FG001|Overall Study|Protocol Violation|8|||
126074253|NCT02930837|453566680|FG000|Overall Study|Adverse Event|6|||
126074254|NCT02930837|453566680|FG000|Overall Study|Lost to Follow-up|5|||
126074255|NCT02930837|453566680|FG000|Overall Study|Withdrawal by Subject|1|||
126074256|NCT01393613|453566681|FG000|Overall Study|Adverse Event|11|||
126074257|NCT01393613|453566682|FG001|Overall Study|Adverse Event|11|||
126074258|NCT01393613|453566683|FG002|Overall Study|Adverse Event|13|||
126074259|NCT01393613|453566684|FG003|Overall Study|Adverse Event|22|||
126074260|NCT01393613|453566681|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
126074261|NCT01393613|453566682|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
126074262|NCT01393613|453566683|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
126074263|NCT01393613|453566684|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
126074264|NCT01393613|453566681|FG000|Overall Study|Physician Decision|2|||
126074265|NCT01393613|453566682|FG001|Overall Study|Physician Decision|0|||
126074266|NCT01393613|453566683|FG002|Overall Study|Physician Decision|0|||
126074267|NCT01393613|453566684|FG003|Overall Study|Physician Decision|1|||
126074268|NCT01393613|453566681|FG000|Overall Study|Withdrawal by Subject|15|||
126074269|NCT01393613|453566682|FG001|Overall Study|Withdrawal by Subject|25|||
126074270|NCT01393613|453566683|FG002|Overall Study|Withdrawal by Subject|23|||
126074271|NCT01393613|453566684|FG003|Overall Study|Withdrawal by Subject|21|||
126074272|NCT01393613|453566681|FG000|Overall Study|Protocol Deviation|2|||
126074273|NCT01393613|453566682|FG001|Overall Study|Protocol Deviation|1|||
126074274|NCT01393613|453566683|FG002|Overall Study|Protocol Deviation|0|||
126074275|NCT01393613|453566684|FG003|Overall Study|Protocol Deviation|0|||
126074276|NCT01393613|453566681|FG000|Overall Study|Lack of Efficacy|9|||
126074277|NCT01393613|453566682|FG001|Overall Study|Lack of Efficacy|20|||
126074278|NCT01393613|453566683|FG002|Overall Study|Lack of Efficacy|16|||
126074279|NCT01393613|453566684|FG003|Overall Study|Lack of Efficacy|21|||
126074280|NCT03821064|453566685|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
126074281|NCT02598934|453566694|FG000|Overall Study|Adverse Event|11|||
126074282|NCT02598934|453566695|FG001|Overall Study|Adverse Event|13|||
126074283|NCT02598934|453566694|FG000|Overall Study|Failure to Return|3|||
126074284|NCT02598934|453566695|FG001|Overall Study|Failure to Return|3|||
126074285|NCT02598934|453566694|FG000|Overall Study|Withdrawal by Subject|2|||
126074286|NCT02598934|453566695|FG001|Overall Study|Withdrawal by Subject|3|||
126074287|NCT02598934|453566694|FG000|Overall Study|Administrative|2|||
126074288|NCT02598934|453566695|FG001|Overall Study|Administrative|1|||
126074289|NCT02598934|453566694|FG000|Overall Study|Protocol Violation|1|||
126074290|NCT02598934|453566695|FG001|Overall Study|Protocol Violation|2|||
126074291|NCT03325608|453566698|FG000|Overall Study|Lost to Follow-up|23|||
125947257|NCT00654381|453106761|FG005|Extension Stage|Adverse Event|1|||
125947258|NCT00654381|453106756|FG000|Extension Stage|Protocol Violation|0|||
125947259|NCT00654381|453106757|FG001|Extension Stage|Protocol Violation|0|||
125947260|NCT00654381|453106758|FG002|Extension Stage|Protocol Violation|0|||
125947261|NCT00654381|453106759|FG003|Extension Stage|Protocol Violation|1|||
125947262|NCT00654381|453106760|FG004|Extension Stage|Protocol Violation|0|||
126074292|NCT03325608|453566699|FG001|Overall Study|Lost to Follow-up|23|||
126074293|NCT03325608|453566700|FG002|Overall Study|Lost to Follow-up|30|||
126074294|NCT03325608|453566701|FG003|Overall Study|Lost to Follow-up|30|||
126074295|NCT03325608|453566698|FG000|Overall Study|Death of Caregiver|0|||
126074296|NCT03325608|453566699|FG001|Overall Study|Death of Caregiver|0|||
126114834|NCT01970488|453715781|FG004|Part 2: Post Week 16|Physician Decision|1|||
126074297|NCT03325608|453566700|FG002|Overall Study|Death of Caregiver|2|||
126114835|NCT01970488|453715777|FG000|Part 2: Post Week 16|Non-compliance|0|||
125947263|NCT00654381|453106761|FG005|Extension Stage|Protocol Violation|0|||
126114836|NCT01970488|453715778|FG001|Part 2: Post Week 16|Non-compliance|0|||
126114837|NCT01970488|453715779|FG002|Part 2: Post Week 16|Non-compliance|1|||
125947264|NCT00654381|453106756|FG000|Extension Stage|Lack of Efficacy|0|||
126074298|NCT03325608|453566701|FG003|Overall Study|Death of Caregiver|2|||
126074299|NCT03325608|453566698|FG000|Overall Study|Death of Care Recipient|34|||
126074300|NCT03325608|453566699|FG001|Overall Study|Death of Care Recipient|34|||
126074301|NCT03325608|453566700|FG002|Overall Study|Death of Care Recipient|28|||
126074302|NCT03325608|453566701|FG003|Overall Study|Death of Care Recipient|28|||
126074303|NCT03325608|453566698|FG000|Overall Study|Withdrawal by Subject|49|||
126074304|NCT03325608|453566699|FG001|Overall Study|Withdrawal by Subject|49|||
126074305|NCT03325608|453566700|FG002|Overall Study|Withdrawal by Subject|35|||
126074306|NCT03325608|453566701|FG003|Overall Study|Withdrawal by Subject|35|||
126074307|NCT03325608|453566698|FG000|Overall Study|Ineligible|7|||
126074308|NCT03325608|453566699|FG001|Overall Study|Ineligible|7|||
126074309|NCT03325608|453566700|FG002|Overall Study|Ineligible|5|||
126074310|NCT03325608|453566701|FG003|Overall Study|Ineligible|5|||
126074311|NCT02188784|453566702|FG000|Overall Study|Death|3|||
126074312|NCT02188784|453566703|FG001|Overall Study|Death|1|||
126074313|NCT02188784|453566702|FG000|Overall Study|Lost to Follow-up|1|||
126074314|NCT02188784|453566703|FG001|Overall Study|Lost to Follow-up|0|||
126074315|NCT02188784|453566702|FG000|Overall Study|Withdrawal by Subject|3|||
126074316|NCT02188784|453566703|FG001|Overall Study|Withdrawal by Subject|9|||
126074317|NCT02188784|453566702|FG000|Overall Study|Physician Decision|2|||
126074318|NCT02188784|453566703|FG001|Overall Study|Physician Decision|3|||
126074319|NCT01190449|453566706|FG000|Overall Study|Ineligible|0|||
126074320|NCT01190449|453566707|FG001|Overall Study|Ineligible|4|||
126074321|NCT04944784|453566708|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
126074322|NCT04944784|453566709|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
126074323|NCT04944784|453566710|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
126074324|NCT04944784|453566711|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
126074325|NCT04944784|453566708|FG000|Double-blind Period|Adverse Event|20|||
126074326|NCT04944784|453566709|FG001|Double-blind Period|Adverse Event|4|||
126074327|NCT04944784|453566710|FG002|Double-blind Period|Adverse Event|0|||
126074328|NCT04944784|453566711|FG003|Double-blind Period|Adverse Event|0|||
126074329|NCT04944784|453566708|FG000|Double-blind Period|Withdrawal by Subject|15|||
126074330|NCT04944784|453566709|FG001|Double-blind Period|Withdrawal by Subject|4|||
126074331|NCT04944784|453566710|FG002|Double-blind Period|Withdrawal by Subject|0|||
126074332|NCT04944784|453566711|FG003|Double-blind Period|Withdrawal by Subject|0|||
126074333|NCT04944784|453566708|FG000|Double-blind Period|Death|7|||
126074334|NCT04944784|453566709|FG001|Double-blind Period|Death|2|||
126074335|NCT04944784|453566710|FG002|Double-blind Period|Death|0|||
126074336|NCT04944784|453566711|FG003|Double-blind Period|Death|0|||
126074337|NCT04944784|453566708|FG000|Double-blind Period|Physician Decision|2|||
126074338|NCT04944784|453566709|FG001|Double-blind Period|Physician Decision|1|||
126074339|NCT04944784|453566710|FG002|Double-blind Period|Physician Decision|0|||
126074340|NCT04944784|453566711|FG003|Double-blind Period|Physician Decision|0|||
126074341|NCT04944784|453566708|FG000|Double-blind Period|Lack of Efficacy|0|||
126074342|NCT04944784|453566709|FG001|Double-blind Period|Lack of Efficacy|1|||
126074343|NCT04944784|453566710|FG002|Double-blind Period|Lack of Efficacy|0|||
126074344|NCT04944784|453566711|FG003|Double-blind Period|Lack of Efficacy|0|||
126074345|NCT04944784|453566708|FG000|Double-blind Period|Sponsor Request|2|||
126074346|NCT04944784|453566709|FG001|Double-blind Period|Sponsor Request|1|||
126074347|NCT04944784|453566710|FG002|Double-blind Period|Sponsor Request|0|||
126074348|NCT04944784|453566711|FG003|Double-blind Period|Sponsor Request|0|||
126074349|NCT04944784|453566708|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
126074350|NCT04944784|453566709|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
126074351|NCT04944784|453566710|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
126074352|NCT04944784|453566711|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
126074353|NCT04944784|453566708|FG000|Double-blind Period|Participant Choice|1|||
126074354|NCT04944784|453566709|FG001|Double-blind Period|Participant Choice|1|||
126074355|NCT04944784|453566710|FG002|Double-blind Period|Participant Choice|0|||
126074356|NCT04944784|453566711|FG003|Double-blind Period|Participant Choice|0|||
126074357|NCT04944784|453566708|FG000|Double-blind Period|Progressive Disease|2|||
126074358|NCT04944784|453566709|FG001|Double-blind Period|Progressive Disease|2|||
125947265|NCT00654381|453106757|FG001|Extension Stage|Lack of Efficacy|0|||
125947266|NCT00654381|453106758|FG002|Extension Stage|Lack of Efficacy|1|||
126074359|NCT04944784|453566710|FG002|Double-blind Period|Progressive Disease|0|||
126074360|NCT04944784|453566711|FG003|Double-blind Period|Progressive Disease|0|||
126074361|NCT04944784|453566708|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
126074362|NCT04944784|453566709|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
126074363|NCT04944784|453566710|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
126074364|NCT04944784|453566711|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
126074365|NCT04944784|453566708|FG000|Active Drug Period|Adverse Event|0|||
126074366|NCT04944784|453566709|FG001|Active Drug Period|Adverse Event|0|||
126074367|NCT04944784|453566710|FG002|Active Drug Period|Adverse Event|3|||
126074368|NCT04944784|453566711|FG003|Active Drug Period|Adverse Event|6|||
126074369|NCT04944784|453566708|FG000|Active Drug Period|Withdrawal by Subject|0|||
126074370|NCT04944784|453566709|FG001|Active Drug Period|Withdrawal by Subject|0|||
126074371|NCT04944784|453566710|FG002|Active Drug Period|Withdrawal by Subject|4|||
125947267|NCT00654381|453106759|FG003|Extension Stage|Lack of Efficacy|0|||
125947268|NCT00654381|453106760|FG004|Extension Stage|Lack of Efficacy|0|||
125947269|NCT00654381|453106761|FG005|Extension Stage|Lack of Efficacy|0|||
125947270|NCT00654381|453106756|FG000|Extension Stage|Withdrawal by Subject|0|||
126074372|NCT04944784|453566711|FG003|Active Drug Period|Withdrawal by Subject|7|||
126074373|NCT04944784|453566708|FG000|Active Drug Period|Death|0|||
126074374|NCT04944784|453566709|FG001|Active Drug Period|Death|0|||
126074375|NCT04944784|453566710|FG002|Active Drug Period|Death|3|||
126074376|NCT04944784|453566711|FG003|Active Drug Period|Death|4|||
126074377|NCT04944784|453566708|FG000|Active Drug Period|Lack of Efficacy|0|||
126074378|NCT04944784|453566709|FG001|Active Drug Period|Lack of Efficacy|0|||
126074379|NCT04944784|453566710|FG002|Active Drug Period|Lack of Efficacy|2|||
126074380|NCT04944784|453566711|FG003|Active Drug Period|Lack of Efficacy|2|||
126074381|NCT04944784|453566708|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
126074382|NCT04944784|453566709|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
126074383|NCT04944784|453566710|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
126074384|NCT04944784|453566711|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
126074385|NCT04944784|453566708|FG000|Active Drug Period|Participant Choice|0|||
126074386|NCT04944784|453566709|FG001|Active Drug Period|Participant Choice|0|||
126074387|NCT04944784|453566710|FG002|Active Drug Period|Participant Choice|0|||
126074388|NCT04944784|453566711|FG003|Active Drug Period|Participant Choice|1|||
126074389|NCT04944784|453566708|FG000|Active Drug Period|Progressive Disease|0|||
126074390|NCT04944784|453566709|FG001|Active Drug Period|Progressive Disease|0|||
126074391|NCT04944784|453566710|FG002|Active Drug Period|Progressive Disease|4|||
126074392|NCT04944784|453566711|FG003|Active Drug Period|Progressive Disease|4|||
126074393|NCT04944784|453566708|FG000|Active Drug Period|Lost to Follow-up|0|||
126074394|NCT04944784|453566709|FG001|Active Drug Period|Lost to Follow-up|0|||
126074395|NCT04944784|453566710|FG002|Active Drug Period|Lost to Follow-up|0|||
126074396|NCT04944784|453566711|FG003|Active Drug Period|Lost to Follow-up|1|||
126074397|NCT02210208|453568540|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
126074398|NCT02210208|453568540|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
126074399|NCT02210208|453568540|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
126074400|NCT01066936|453568541|FG000|Overall Study|Death|2|||
126074401|NCT01066936|453568541|FG000|Overall Study|Device revised/removed|1|||
126074402|NCT01066936|453568541|FG000|Overall Study|Lost to Follow-up|3|||
126074403|NCT01066936|453568541|FG000|Overall Study|Withdrawal by Subject|4|||
126074404|NCT04984239|453568544|FG000|Overall Study|Lost to Follow-up|1|||
126074405|NCT04190225|453568545|FG000|Overall Study|Lost to Follow-up|2|||
126074406|NCT04190225|453568546|FG001|Overall Study|Lost to Follow-up|3|||
126074407|NCT04190225|453568545|FG000|Overall Study|Withdrawal by Subject|3|||
126074408|NCT04190225|453568546|FG001|Overall Study|Withdrawal by Subject|2|||
126074409|NCT04190225|453568545|FG000|Overall Study|Unrelated health condition|2|||
126074410|NCT04190225|453568546|FG001|Overall Study|Unrelated health condition|0|||
126074411|NCT02994784|453568547|FG000|6 Months Follow-up|Lost to Follow-up|3|||
126074412|NCT02466243|453568549|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
126074413|NCT02466243|453568550|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
126074414|NCT02466243|453568549|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
126074415|NCT02466243|453568550|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
126074416|NCT02466243|453568549|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
126074417|NCT02466243|453568550|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
126074418|NCT02466243|453568549|FG000|Part B Open-label Treatment Period|Missing|2|||
126074419|NCT02466243|453568550|FG001|Part B Open-label Treatment Period|Missing|2|||
126074420|NCT00477464|453568551|FG000|Overall Study|Lost to Follow-up|1|||
126074421|NCT00477464|453568551|FG000|Overall Study|Death|36|||
126074422|NCT00477464|453568551|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
126074423|NCT00639769|453568552|FG000|Overall Study|Death|2|||
126074424|NCT00639769|453568552|FG000|Overall Study|Adverse Event|7|||
126114838|NCT01970488|453715780|FG003|Part 2: Post Week 16|Non-compliance|0|||
125947271|NCT00654381|453106757|FG001|Extension Stage|Withdrawal by Subject|0|||
125947272|NCT00654381|453106758|FG002|Extension Stage|Withdrawal by Subject|1|||
125947273|NCT00654381|453106759|FG003|Extension Stage|Withdrawal by Subject|1|||
126074425|NCT00639769|453568552|FG000|Overall Study|Lack of Efficacy|1|||
126074426|NCT00639769|453568552|FG000|Overall Study|Disease progression|26|||
126074427|NCT00639769|453568552|FG000|Overall Study|Withdrawal by Subject|4|||
126074428|NCT00863798|453568553|FG000|Overall Study|Adverse Event|5|||
126074429|NCT00863798|453568554|FG001|Overall Study|Adverse Event|2|||
126074430|NCT00863798|453568555|FG002|Overall Study|Adverse Event|4|||
126074431|NCT00863798|453568553|FG000|Overall Study|Participant failed to return|2|||
126074432|NCT00863798|453568554|FG001|Overall Study|Participant failed to return|1|||
126074433|NCT00863798|453568555|FG002|Overall Study|Participant failed to return|0|||
126074434|NCT00863798|453568553|FG000|Overall Study|Investigator request|1|||
125947274|NCT00654381|453106760|FG004|Extension Stage|Withdrawal by Subject|1|||
126074435|NCT00863798|453568554|FG001|Overall Study|Investigator request|2|||
126074436|NCT00863798|453568555|FG002|Overall Study|Investigator request|1|||
126074437|NCT00863798|453568553|FG000|Overall Study|Lack of Efficacy|4|||
126074438|NCT00863798|453568554|FG001|Overall Study|Lack of Efficacy|3|||
126114839|NCT01970488|453715781|FG004|Part 2: Post Week 16|Non-compliance|0|||
126114840|NCT01970488|453715777|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
126114841|NCT01970488|453715778|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
126114842|NCT01970488|453715779|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
126114843|NCT01970488|453715780|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
126114844|NCT01970488|453715781|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
126114845|NCT01970488|453715777|FG000|Part 2: Post Week 16|Adverse Event|0|||
126114846|NCT01970488|453715778|FG001|Part 2: Post Week 16|Adverse Event|0|||
125947275|NCT00654381|453106761|FG005|Extension Stage|Withdrawal by Subject|1|||
125947276|NCT00654381|453106756|FG000|Extension Stage|Closure of the trial site|0|||
125947277|NCT00654381|453106757|FG001|Extension Stage|Closure of the trial site|0|||
125947278|NCT00654381|453106758|FG002|Extension Stage|Closure of the trial site|0|||
125947279|NCT00654381|453106759|FG003|Extension Stage|Closure of the trial site|0|||
125947280|NCT00654381|453106760|FG004|Extension Stage|Closure of the trial site|1|||
125947281|NCT00654381|453106761|FG005|Extension Stage|Closure of the trial site|1|||
125947282|NCT04164901|453106766|FG000|Overall Study|Withdrawal by Subject|4|||
125947283|NCT04164901|453106767|FG001|Overall Study|Withdrawal by Subject|4|||
125947284|NCT00097721|453106768|FG000|Overall Study|Adverse Event|8|||
125947285|NCT00097721|453106769|FG001|Overall Study|Adverse Event|1|||
125947286|NCT00097721|453106768|FG000|Overall Study|Withdrawal by Subject|6|||
125947287|NCT00097721|453106769|FG001|Overall Study|Withdrawal by Subject|1|||
125947288|NCT00097721|453106768|FG000|Overall Study|Progressive Disease|55|||
125947289|NCT00097721|453106769|FG001|Overall Study|Progressive Disease|27|||
125947290|NCT00097721|453106768|FG000|Overall Study|Physician Decision|1|||
125947291|NCT00097721|453106769|FG001|Overall Study|Physician Decision|3|||
125947292|NCT00097721|453106768|FG000|Overall Study|Reason not given|1|||
125947293|NCT00097721|453106769|FG001|Overall Study|Reason not given|1|||
125947294|NCT01752855|453106773|FG000|Overall Study|Adverse Event|1|||
125947295|NCT01752855|453106774|FG001|Overall Study|Adverse Event|0|||
125947296|NCT01752855|453106773|FG000|Overall Study|Withdrew Consent|0|||
125947297|NCT01752855|453106774|FG001|Overall Study|Withdrew Consent|2|||
125947298|NCT01752855|453106773|FG000|Overall Study|Lack of Efficacy|0|||
125947299|NCT01752855|453106774|FG001|Overall Study|Lack of Efficacy|2|||
125947300|NCT01364428|453106785|FG000|Overall Study|Adverse Event|1|||
125947301|NCT01364428|453106786|FG001|Overall Study|Adverse Event|2|||
125947302|NCT01364428|453106785|FG000|Overall Study|Protocol Violation|2|||
125947303|NCT01364428|453106786|FG001|Overall Study|Protocol Violation|0|||
125947304|NCT01364428|453106785|FG000|Overall Study|Withdrawal Criteria|14|||
125947305|NCT01364428|453106786|FG001|Overall Study|Withdrawal Criteria|10|||
125947306|NCT01364428|453106785|FG000|Overall Study|Other|3|||
125947307|NCT01364428|453106786|FG001|Overall Study|Other|3|||
125947308|NCT00743652|453106787|FG000|Overall Study|Parent/Legal Guardian Request|3|||
125947309|NCT00743652|453106788|FG001|Overall Study|Parent/Legal Guardian Request|2|||
125947310|NCT00743652|453106789|FG002|Overall Study|Parent/Legal Guardian Request|2|||
125947311|NCT00743652|453106790|FG003|Overall Study|Parent/Legal Guardian Request|2|||
125947312|NCT00743652|453106791|FG004|Overall Study|Parent/Legal Guardian Request|0|||
125947313|NCT00743652|453106787|FG000|Overall Study|Adverse Event|3|||
125947314|NCT00743652|453106788|FG001|Overall Study|Adverse Event|0|||
125947315|NCT00743652|453106789|FG002|Overall Study|Adverse Event|0|||
125947316|NCT00743652|453106790|FG003|Overall Study|Adverse Event|0|||
125947317|NCT00743652|453106791|FG004|Overall Study|Adverse Event|0|||
125947318|NCT00743652|453106787|FG000|Overall Study|Death|2|||
125947319|NCT00743652|453106788|FG001|Overall Study|Death|0|||
125947320|NCT00743652|453106789|FG002|Overall Study|Death|0|||
125947321|NCT00743652|453106790|FG003|Overall Study|Death|0|||
125947322|NCT00743652|453106791|FG004|Overall Study|Death|0|||
125947323|NCT00743652|453106787|FG000|Overall Study|Investigator Request|0|||
125947324|NCT00743652|453106788|FG001|Overall Study|Investigator Request|0|||
125947325|NCT00743652|453106789|FG002|Overall Study|Investigator Request|0|||
125947326|NCT00743652|453106790|FG003|Overall Study|Investigator Request|2|||
125947327|NCT00743652|453106791|FG004|Overall Study|Investigator Request|0|||
125947328|NCT00743652|453106787|FG000|Overall Study|Other|1|||
125947329|NCT00743652|453106788|FG001|Overall Study|Other|1|||
125947330|NCT00743652|453106789|FG002|Overall Study|Other|0|||
125947331|NCT00743652|453106790|FG003|Overall Study|Other|0|||
126114847|NCT01970488|453715779|FG002|Part 2: Post Week 16|Adverse Event|5|||
126114848|NCT01970488|453715780|FG003|Part 2: Post Week 16|Adverse Event|1|||
125947332|NCT00743652|453106791|FG004|Overall Study|Other|0|||
125947333|NCT00743652|453106787|FG000|Overall Study|Lost to Follow-up|1|||
125947334|NCT00743652|453106788|FG001|Overall Study|Lost to Follow-up|0|||
125947335|NCT00743652|453106789|FG002|Overall Study|Lost to Follow-up|0|||
125947336|NCT00743652|453106790|FG003|Overall Study|Lost to Follow-up|0|||
125947337|NCT00743652|453106791|FG004|Overall Study|Lost to Follow-up|0|||
125947338|NCT02547129|453106795|FG000|Overall Study|Difficulty with ongoing infection|1|||
125947339|NCT02547129|453106796|FG001|Overall Study|Difficulty with ongoing infection|0|||
125947340|NCT03925324|453106797|FG000|Overall Study|Death|1|||
125947341|NCT03925324|453106798|FG001|Overall Study|Death|1|||
125947342|NCT00228917|453106799|FG000|Overall Study|Migrated/moved from study area|0|||
125947343|NCT00228917|453106800|FG001|Overall Study|Migrated/moved from study area|0|||
126074439|NCT00863798|453568555|FG002|Overall Study|Lack of Efficacy|6|||
126074440|NCT00863798|453568553|FG000|Overall Study|Lost to Follow-up|6|||
126074441|NCT00863798|453568554|FG001|Overall Study|Lost to Follow-up|9|||
126074442|NCT00863798|453568555|FG002|Overall Study|Lost to Follow-up|5|||
126074443|NCT00863798|453568553|FG000|Overall Study|Other|2|||
126074444|NCT00863798|453568554|FG001|Overall Study|Other|3|||
126074445|NCT00863798|453568555|FG002|Overall Study|Other|1|||
126074446|NCT00863798|453568553|FG000|Overall Study|Protocol Violation|0|||
126074447|NCT00863798|453568554|FG001|Overall Study|Protocol Violation|1|||
126074448|NCT00863798|453568555|FG002|Overall Study|Protocol Violation|1|||
126074449|NCT00863798|453568553|FG000|Overall Study|Withdrawal by Subject|8|||
126074450|NCT00863798|453568554|FG001|Overall Study|Withdrawal by Subject|7|||
126074451|NCT00863798|453568555|FG002|Overall Study|Withdrawal by Subject|4|||
126074452|NCT00863798|453568553|FG000|Overall Study|Randomized not treated|4|||
126074453|NCT00863798|453568554|FG001|Overall Study|Randomized not treated|2|||
126074454|NCT00863798|453568555|FG002|Overall Study|Randomized not treated|3|||
126074455|NCT04238520|453568556|FG000|Overall Study|Withdrawal by Subject|1|||
126074456|NCT04238520|453568557|FG001|Overall Study|Withdrawal by Subject|1|||
126074457|NCT04238520|453568556|FG000|Overall Study|Lost to Follow-up|1|||
126074458|NCT04238520|453568557|FG001|Overall Study|Lost to Follow-up|2|||
126074459|NCT04238520|453568556|FG000|Overall Study|Death|0|||
126074460|NCT04238520|453568557|FG001|Overall Study|Death|2|||
126074461|NCT04238520|453568556|FG000|Overall Study|Unsafe home environment for research staff|0|||
126074462|NCT04238520|453568557|FG001|Overall Study|Unsafe home environment for research staff|1|||
126074463|NCT01470599|453568558|FG000|Overall Study|Did not meet entrance criteria|1|||
126074464|NCT01470599|453568559|FG001|Overall Study|Did not meet entrance criteria|0|||
126074465|NCT01470599|453568558|FG000|Overall Study|Lost to Follow-up|2|||
126074466|NCT01470599|453568559|FG001|Overall Study|Lost to Follow-up|1|||
126074467|NCT01470599|453568558|FG000|Overall Study|Withdrawal by Subject|3|||
126074468|NCT01470599|453568559|FG001|Overall Study|Withdrawal by Subject|4|||
126074469|NCT01470599|453568558|FG000|Overall Study|Other|1|||
126074470|NCT01470599|453568559|FG001|Overall Study|Other|0|||
126074471|NCT01470599|453568558|FG000|Overall Study|Protocol Violation|3|||
126074472|NCT01470599|453568559|FG001|Overall Study|Protocol Violation|1|||
126074473|NCT01470599|453568558|FG000|Overall Study|Adverse event related to study drug|2|||
126074474|NCT01470599|453568559|FG001|Overall Study|Adverse event related to study drug|5|||
126074475|NCT01470599|453568558|FG000|Overall Study|Insufficient clinical response|6|||
126074476|NCT01470599|453568559|FG001|Overall Study|Insufficient clinical response|27|||
126074477|NCT01470599|453568558|FG000|Overall Study|Adverse event not related to study drug|1|||
126074478|NCT01470599|453568559|FG001|Overall Study|Adverse event not related to study drug|5|||
126074479|NCT00195442|453568560|FG000|Overall Study|Less than expected therapeutic effect|38|||
126074480|NCT00195442|453568560|FG000|Overall Study|Lost to Follow-up|27|||
126074481|NCT00195442|453568560|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
126074482|NCT00195442|453568560|FG000|Overall Study|Intermittent product shortage|21|||
126074483|NCT00195442|453568560|FG000|Overall Study|Death|7|||
126074484|NCT00195442|453568560|FG000|Overall Study|No reason specified|4|||
126074485|NCT00195442|453568560|FG000|Overall Study|Poor cooperation|2|||
126074486|NCT00195442|453568560|FG000|Overall Study|Other|14|||
126074487|NCT01917006|453568561|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
126074488|NCT01917006|453568562|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
126074489|NCT01917006|453568563|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
125947344|NCT00228917|453106801|FG002|Overall Study|Migrated/moved from study area|0|||
126074490|NCT01917006|453568564|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
126074491|NCT01917006|453568565|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
126074492|NCT01917006|453568566|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
126074493|NCT01917006|453568567|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
126074494|NCT01917006|453568568|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
126074495|NCT01917006|453568561|FG000|Randomized-treatment Period|Personal Reasons|0|||
126074496|NCT01917006|453568562|FG001|Randomized-treatment Period|Personal Reasons|0|||
126074497|NCT01917006|453568563|FG002|Randomized-treatment Period|Personal Reasons|0|||
126074498|NCT01917006|453568564|FG003|Randomized-treatment Period|Personal Reasons|0|||
126074499|NCT01917006|453568565|FG004|Randomized-treatment Period|Personal Reasons|0|||
126074500|NCT01917006|453568566|FG005|Randomized-treatment Period|Personal Reasons|1|||
126074501|NCT01917006|453568567|FG006|Randomized-treatment Period|Personal Reasons|0|||
126074502|NCT01917006|453568568|FG007|Randomized-treatment Period|Personal Reasons|0|||
126074503|NCT01917006|453568561|FG000|Randomized-treatment Period|Protocol Violation|1|||
126074504|NCT01917006|453568562|FG001|Randomized-treatment Period|Protocol Violation|0|||
126074505|NCT01917006|453568563|FG002|Randomized-treatment Period|Protocol Violation|0|||
126074506|NCT01917006|453568564|FG003|Randomized-treatment Period|Protocol Violation|0|||
126074507|NCT01917006|453568565|FG004|Randomized-treatment Period|Protocol Violation|0|||
126074508|NCT01917006|453568566|FG005|Randomized-treatment Period|Protocol Violation|0|||
126074509|NCT01917006|453568567|FG006|Randomized-treatment Period|Protocol Violation|0|||
126074510|NCT01917006|453568568|FG007|Randomized-treatment Period|Protocol Violation|0|||
126074511|NCT01917006|453568561|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126074512|NCT01917006|453568562|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126074513|NCT01917006|453568563|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126074514|NCT01917006|453568564|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126074515|NCT01917006|453568565|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126074516|NCT01917006|453568566|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126074517|NCT01917006|453568567|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
126074518|NCT01917006|453568568|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126074519|NCT01917006|453568561|FG000|Open-label Period|Adverse Event|0|||
126074520|NCT01917006|453568562|FG001|Open-label Period|Adverse Event|0|||
126074521|NCT01917006|453568563|FG002|Open-label Period|Adverse Event|0|||
126074522|NCT01917006|453568564|FG003|Open-label Period|Adverse Event|0|||
126074523|NCT01917006|453568565|FG004|Open-label Period|Adverse Event|0|||
126074524|NCT01917006|453568566|FG005|Open-label Period|Adverse Event|0|||
126074525|NCT01917006|453568567|FG006|Open-label Period|Adverse Event|0|||
126074526|NCT01917006|453568568|FG007|Open-label Period|Adverse Event|1|||
126074527|NCT01917006|453568561|FG000|Open-label Period|Lost to Follow-up|0|||
126074528|NCT01917006|453568562|FG001|Open-label Period|Lost to Follow-up|0|||
126074529|NCT01917006|453568563|FG002|Open-label Period|Lost to Follow-up|0|||
126074530|NCT01917006|453568564|FG003|Open-label Period|Lost to Follow-up|0|||
126074531|NCT01917006|453568565|FG004|Open-label Period|Lost to Follow-up|0|||
126074532|NCT01917006|453568566|FG005|Open-label Period|Lost to Follow-up|0|||
126074533|NCT01917006|453568567|FG006|Open-label Period|Lost to Follow-up|0|||
126074534|NCT01917006|453568568|FG007|Open-label Period|Lost to Follow-up|1|||
126074535|NCT00847132|453568571|FG000|Overall Study|Death|1|||
126074536|NCT00847132|453568572|FG001|Overall Study|Death|1|||
126074537|NCT03357471|453568578|FG000|Overall Study|Adverse Event|1|||
126074538|NCT03357471|453568579|FG001|Overall Study|Adverse Event|0|||
126074539|NCT03357471|453568578|FG000|Overall Study|Lost to Follow-up|1|||
126074540|NCT03357471|453568579|FG001|Overall Study|Lost to Follow-up|0|||
126074541|NCT02973802|453568580|FG000|Overall Study|Lost to Follow-up|1|||
126074542|NCT02973802|453568580|FG000|Overall Study|Withdrawal by Subject|1|||
126074543|NCT00706914|453568581|FG000|Overall Study|Lack of Efficacy|0|||
126074544|NCT00706914|453568582|FG001|Overall Study|Lack of Efficacy|1|||
126074545|NCT00706914|453568583|FG002|Overall Study|Lack of Efficacy|0|||
126074546|NCT00706914|453568581|FG000|Overall Study|Lost to Follow-up|1|||
126074547|NCT00706914|453568582|FG001|Overall Study|Lost to Follow-up|0|||
126074548|NCT00706914|453568583|FG002|Overall Study|Lost to Follow-up|0|||
126074549|NCT00706914|453568581|FG000|Overall Study|Adverse Event|2|||
126074550|NCT00706914|453568582|FG001|Overall Study|Adverse Event|2|||
126074551|NCT00706914|453568583|FG002|Overall Study|Adverse Event|0|||
126074552|NCT00706914|453568581|FG000|Overall Study|Protocol Violation|3|||
126074553|NCT00706914|453568582|FG001|Overall Study|Protocol Violation|1|||
126074554|NCT00706914|453568583|FG002|Overall Study|Protocol Violation|1|||
126074555|NCT01850823|453568585|FG000|Overall Study|Early Visit Window|0|||
126074556|NCT01850823|453568586|FG001|Overall Study|Early Visit Window|1|||
126074557|NCT01850823|453568587|FG002|Overall Study|Early Visit Window|4|||
126074558|NCT01850823|453568585|FG000|Overall Study|Enrolled in Error|0|||
126074559|NCT01850823|453568586|FG001|Overall Study|Enrolled in Error|1|||
126074560|NCT01850823|453568587|FG002|Overall Study|Enrolled in Error|2|||
126074561|NCT01850823|453568585|FG000|Overall Study|Lack of Efficacy|1|||
126074562|NCT01850823|453568586|FG001|Overall Study|Lack of Efficacy|0|||
126074563|NCT01850823|453568587|FG002|Overall Study|Lack of Efficacy|0|||
126074564|NCT01850823|453568585|FG000|Overall Study|Lost to Follow-up|0|||
126074565|NCT01850823|453568586|FG001|Overall Study|Lost to Follow-up|0|||
126074566|NCT01850823|453568587|FG002|Overall Study|Lost to Follow-up|1|||
126074567|NCT01850823|453568585|FG000|Overall Study|Restricted Medication|0|||
126074568|NCT01850823|453568586|FG001|Overall Study|Restricted Medication|0|||
126074569|NCT01850823|453568587|FG002|Overall Study|Restricted Medication|2|||
126074570|NCT01850823|453568585|FG000|Overall Study|Significant worstening of SAR|0|||
126074571|NCT01850823|453568586|FG001|Overall Study|Significant worstening of SAR|1|||
126074572|NCT01850823|453568587|FG002|Overall Study|Significant worstening of SAR|0|||
126074573|NCT01850823|453568585|FG000|Overall Study|Withdrawal by Subject|2|||
126074574|NCT01850823|453568586|FG001|Overall Study|Withdrawal by Subject|0|||
126074575|NCT01850823|453568587|FG002|Overall Study|Withdrawal by Subject|1|||
126074576|NCT01751165|453568588|FG000|Overall Study|Adverse event, serious fatal|1|||
126074577|NCT01751165|453568589|FG001|Overall Study|Adverse event, serious fatal|0|||
126074578|NCT01751165|453568590|FG002|Overall Study|Adverse event, serious fatal|1|||
126074579|NCT01751165|453568588|FG000|Overall Study|Withdrawal by Subject|0|||
126074580|NCT01751165|453568589|FG001|Overall Study|Withdrawal by Subject|0|||
126074581|NCT01751165|453568590|FG002|Overall Study|Withdrawal by Subject|1|||
126074582|NCT01751165|453568588|FG000|Overall Study|Serious adverse event|0|||
126074583|NCT01751165|453568589|FG001|Overall Study|Serious adverse event|2|||
126074584|NCT01751165|453568590|FG002|Overall Study|Serious adverse event|0|||
126074585|NCT01751165|453568588|FG000|Overall Study|Lost to Follow-up|1|||
126074586|NCT01751165|453568589|FG001|Overall Study|Lost to Follow-up|1|||
126074587|NCT01751165|453568590|FG002|Overall Study|Lost to Follow-up|1|||
126074588|NCT00988533|453568595|FG000|Overall Study|Lost to Follow-up|3|||
125947345|NCT00228917|453106802|FG003|Overall Study|Migrated/moved from study area|0|||
125947346|NCT00228917|453106803|FG004|Overall Study|Migrated/moved from study area|0|||
125947347|NCT00228917|453106804|FG005|Overall Study|Migrated/moved from study area|2|||
125947348|NCT00228917|453106805|FG006|Overall Study|Migrated/moved from study area|0|||
125947349|NCT00228917|453106806|FG007|Overall Study|Migrated/moved from study area|0|||
125947350|NCT00409617|453106807|FG000|Overall Study|Adverse Event|57|||
125947351|NCT00409617|453106807|FG000|Overall Study|Lack of Efficacy|54|||
125947352|NCT00409617|453106807|FG000|Overall Study|Lost to Follow-up|2|||
125947353|NCT00409617|453106807|FG000|Overall Study|Protocol Violation|24|||
125947354|NCT00409617|453106807|FG000|Overall Study|Withdrawal by Subject|8|||
125947355|NCT00409617|453106807|FG000|Overall Study|Administrative reasons|1|||
125947356|NCT00409617|453106807|FG000|Overall Study|Not described|14|||
125947357|NCT02159521|453106808|FG000|Overall Study|Enrolled but not treated|3|||
126114849|NCT01970488|453715781|FG004|Part 2: Post Week 16|Adverse Event|1|||
126114850|NCT01970488|453715777|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
125947358|NCT02159521|453106808|FG000|Overall Study|Withdrawal by Subject|7|||
125947359|NCT02159521|453106808|FG000|Overall Study|Lost to Follow-up|6|||
125947360|NCT02159521|453106808|FG000|Overall Study|Death|1|||
125947361|NCT02159521|453106808|FG000|Overall Study|Other than specified|1|||
125947362|NCT03131440|453106809|FG000|Overall Study|Withdrawal by Subject|1|||
125947363|NCT03131440|453106810|FG001|Overall Study|Withdrawal by Subject|3|||
125947364|NCT03131440|453106811|FG002|Overall Study|Withdrawal by Subject|0|||
125947365|NCT03131440|453106812|FG003|Overall Study|Withdrawal by Subject|0|||
125947366|NCT03131440|453106813|FG004|Overall Study|Withdrawal by Subject|1|||
125947367|NCT03131440|453106814|FG005|Overall Study|Withdrawal by Subject|0|||
125947368|NCT03131440|453106815|FG006|Overall Study|Withdrawal by Subject|0|||
125947369|NCT03131440|453106816|FG007|Overall Study|Withdrawal by Subject|1|||
125947370|NCT03131440|453106817|FG008|Overall Study|Withdrawal by Subject|1|||
125947371|NCT03131440|453106818|FG009|Overall Study|Withdrawal by Subject|1|||
125947372|NCT03131440|453106819|FG010|Overall Study|Withdrawal by Subject|0|||
125947373|NCT03131440|453106820|FG011|Overall Study|Withdrawal by Subject|1|||
125947374|NCT03131440|453106821|FG012|Overall Study|Withdrawal by Subject|1|||
125947375|NCT03131440|453106822|FG013|Overall Study|Withdrawal by Subject|0|||
125947376|NCT03131440|453106823|FG014|Overall Study|Withdrawal by Subject|1|||
125947377|NCT03131440|453106824|FG015|Overall Study|Withdrawal by Subject|0|||
126114851|NCT01970488|453715778|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
126114852|NCT01970488|453715779|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
126114853|NCT01970488|453715780|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
126114854|NCT01970488|453715781|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
126114855|NCT01970488|453715777|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
126114856|NCT01970488|453715778|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
126114857|NCT01970488|453715779|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
126114858|NCT01970488|453715780|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
126114859|NCT01970488|453715781|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
126114860|NCT04060563|453715782|FG000|Overall Study|Lost to Follow-up|1|||
126114861|NCT04060563|453715783|FG001|Overall Study|Lost to Follow-up|1|||
126114862|NCT04060563|453715782|FG000|Overall Study|Physician Decision|0|||
126114863|NCT04060563|453715783|FG001|Overall Study|Physician Decision|1|||
125947378|NCT03131440|453106825|FG016|Overall Study|Withdrawal by Subject|0|||
125947379|NCT03131440|453106826|FG017|Overall Study|Withdrawal by Subject|0|||
125947380|NCT03131440|453106827|FG018|Overall Study|Withdrawal by Subject|1|||
125947381|NCT03131440|453106828|FG019|Overall Study|Withdrawal by Subject|0|||
125947382|NCT03131440|453106829|FG020|Overall Study|Withdrawal by Subject|1|||
125947383|NCT03131440|453106830|FG021|Overall Study|Withdrawal by Subject|1|||
125947384|NCT03131440|453106831|FG022|Overall Study|Withdrawal by Subject|1|||
125947385|NCT03131440|453106832|FG023|Overall Study|Withdrawal by Subject|0|||
125947386|NCT03131440|453106833|FG024|Overall Study|Withdrawal by Subject|0|||
125947387|NCT03131440|453106834|FG025|Overall Study|Withdrawal by Subject|0|||
125947388|NCT03131440|453106835|FG026|Overall Study|Withdrawal by Subject|0|||
125947389|NCT03131440|453106836|FG027|Overall Study|Withdrawal by Subject|0|||
125947390|NCT03131440|453106837|FG028|Overall Study|Withdrawal by Subject|0|||
125947391|NCT03131440|453106838|FG029|Overall Study|Withdrawal by Subject|0|||
125947392|NCT03131440|453106839|FG030|Overall Study|Withdrawal by Subject|1|||
125947393|NCT03131440|453106840|FG031|Overall Study|Withdrawal by Subject|0|||
125947394|NCT03131440|453106809|FG000|Overall Study|Lost to Follow-up|0|||
125947395|NCT03131440|453106810|FG001|Overall Study|Lost to Follow-up|0|||
125947396|NCT03131440|453106811|FG002|Overall Study|Lost to Follow-up|0|||
125947397|NCT03131440|453106812|FG003|Overall Study|Lost to Follow-up|0|||
125947398|NCT03131440|453106813|FG004|Overall Study|Lost to Follow-up|0|||
125947399|NCT03131440|453106814|FG005|Overall Study|Lost to Follow-up|1|||
125947400|NCT03131440|453106815|FG006|Overall Study|Lost to Follow-up|0|||
125947401|NCT03131440|453106816|FG007|Overall Study|Lost to Follow-up|0|||
125947402|NCT03131440|453106817|FG008|Overall Study|Lost to Follow-up|0|||
125947403|NCT03131440|453106818|FG009|Overall Study|Lost to Follow-up|0|||
125947404|NCT03131440|453106819|FG010|Overall Study|Lost to Follow-up|0|||
125947405|NCT03131440|453106820|FG011|Overall Study|Lost to Follow-up|0|||
126074589|NCT00943722|453568598|FG000|Base Study|Adverse Event|0|||
126074590|NCT00943722|453568599|FG001|Base Study|Adverse Event|0|||
126074591|NCT00943722|453568600|FG002|Base Study|Adverse Event|0|||
126074592|NCT00943722|453568601|FG003|Base Study|Adverse Event|1|||
126074593|NCT00943722|453568602|FG004|Base Study|Adverse Event|0|||
126074594|NCT00943722|453568603|FG005|Base Study|Adverse Event|0|||
126074595|NCT00943722|453568604|FG006|Base Study|Adverse Event|0|||
126074596|NCT00943722|453568598|FG000|Base Study|Lost to Follow-up|12|||
126074597|NCT00943722|453568599|FG001|Base Study|Lost to Follow-up|8|||
126074598|NCT00943722|453568600|FG002|Base Study|Lost to Follow-up|10|||
126074599|NCT00943722|453568601|FG003|Base Study|Lost to Follow-up|8|||
126074600|NCT00943722|453568602|FG004|Base Study|Lost to Follow-up|11|||
126074601|NCT00943722|453568603|FG005|Base Study|Lost to Follow-up|0|||
126074602|NCT00943722|453568604|FG006|Base Study|Lost to Follow-up|0|||
126074603|NCT00943722|453568598|FG000|Base Study|Physician Decision|1|||
126074604|NCT00943722|453568599|FG001|Base Study|Physician Decision|0|||
126074605|NCT00943722|453568600|FG002|Base Study|Physician Decision|0|||
126074606|NCT00943722|453568601|FG003|Base Study|Physician Decision|0|||
126074607|NCT00943722|453568602|FG004|Base Study|Physician Decision|1|||
126074608|NCT00943722|453568603|FG005|Base Study|Physician Decision|0|||
126074609|NCT00943722|453568604|FG006|Base Study|Physician Decision|0|||
126074610|NCT00943722|453568598|FG000|Base Study|Pregnancy|0|||
126074611|NCT00943722|453568599|FG001|Base Study|Pregnancy|0|||
126074612|NCT00943722|453568600|FG002|Base Study|Pregnancy|1|||
126074613|NCT00943722|453568601|FG003|Base Study|Pregnancy|0|||
126074614|NCT00943722|453568602|FG004|Base Study|Pregnancy|2|||
126074615|NCT00943722|453568603|FG005|Base Study|Pregnancy|0|||
126074616|NCT00943722|453568604|FG006|Base Study|Pregnancy|0|||
126074617|NCT00943722|453568598|FG000|Base Study|Protocol Violation|0|||
126074618|NCT00943722|453568599|FG001|Base Study|Protocol Violation|1|||
126074619|NCT00943722|453568600|FG002|Base Study|Protocol Violation|0|||
126074620|NCT00943722|453568601|FG003|Base Study|Protocol Violation|0|||
126074621|NCT00943722|453568602|FG004|Base Study|Protocol Violation|2|||
126114864|NCT02613884|453715792|FG000|Overall Study|Death|1|||
126114865|NCT02613884|453715792|FG000|Overall Study|Lost to Follow-up|1|||
125947406|NCT03131440|453106821|FG012|Overall Study|Lost to Follow-up|0|||
125947407|NCT03131440|453106822|FG013|Overall Study|Lost to Follow-up|0|||
125947408|NCT03131440|453106823|FG014|Overall Study|Lost to Follow-up|0|||
125947409|NCT03131440|453106824|FG015|Overall Study|Lost to Follow-up|0|||
125947410|NCT03131440|453106825|FG016|Overall Study|Lost to Follow-up|0|||
125947411|NCT03131440|453106826|FG017|Overall Study|Lost to Follow-up|0|||
125947412|NCT03131440|453106827|FG018|Overall Study|Lost to Follow-up|0|||
125947413|NCT03131440|453106828|FG019|Overall Study|Lost to Follow-up|2|||
125947414|NCT03131440|453106829|FG020|Overall Study|Lost to Follow-up|1|||
125947415|NCT03131440|453106830|FG021|Overall Study|Lost to Follow-up|0|||
125947416|NCT03131440|453106831|FG022|Overall Study|Lost to Follow-up|1|||
125947417|NCT03131440|453106832|FG023|Overall Study|Lost to Follow-up|0|||
125947418|NCT03131440|453106833|FG024|Overall Study|Lost to Follow-up|1|||
125947419|NCT03131440|453106834|FG025|Overall Study|Lost to Follow-up|0|||
125947420|NCT03131440|453106835|FG026|Overall Study|Lost to Follow-up|0|||
125947421|NCT03131440|453106836|FG027|Overall Study|Lost to Follow-up|2|||
125947422|NCT03131440|453106837|FG028|Overall Study|Lost to Follow-up|0|||
125947423|NCT03131440|453106838|FG029|Overall Study|Lost to Follow-up|2|||
125947424|NCT03131440|453106839|FG030|Overall Study|Lost to Follow-up|0|||
125947425|NCT03131440|453106840|FG031|Overall Study|Lost to Follow-up|0|||
125947426|NCT03131440|453106809|FG000|Overall Study|Death|0|||
125947427|NCT03131440|453106810|FG001|Overall Study|Death|0|||
125947428|NCT03131440|453106811|FG002|Overall Study|Death|0|||
125947429|NCT03131440|453106812|FG003|Overall Study|Death|0|||
125947430|NCT03131440|453106813|FG004|Overall Study|Death|0|||
125947431|NCT03131440|453106814|FG005|Overall Study|Death|0|||
126074622|NCT00943722|453568603|FG005|Base Study|Protocol Violation|0|||
126074623|NCT00943722|453568604|FG006|Base Study|Protocol Violation|0|||
126074624|NCT00943722|453568598|FG000|Base Study|Withdrawal by Subject|12|||
126074625|NCT00943722|453568599|FG001|Base Study|Withdrawal by Subject|13|||
126074626|NCT00943722|453568600|FG002|Base Study|Withdrawal by Subject|2|||
126074627|NCT00943722|453568601|FG003|Base Study|Withdrawal by Subject|13|||
126074628|NCT00943722|453568602|FG004|Base Study|Withdrawal by Subject|8|||
126074629|NCT00943722|453568603|FG005|Base Study|Withdrawal by Subject|0|||
126074630|NCT00943722|453568604|FG006|Base Study|Withdrawal by Subject|0|||
126074631|NCT00943722|453568598|FG000|Base Study|Month 12 visit not completed|0|||
126074632|NCT00943722|453568599|FG001|Base Study|Month 12 visit not completed|0|||
126114866|NCT00433914|453715796|FG000|Overall Study|Withdrawal by Subject|0|||
125947432|NCT03131440|453106815|FG006|Overall Study|Death|0|||
125947433|NCT03131440|453106816|FG007|Overall Study|Death|0|||
125947434|NCT03131440|453106817|FG008|Overall Study|Death|0|||
125947435|NCT03131440|453106818|FG009|Overall Study|Death|0|||
125947436|NCT03131440|453106819|FG010|Overall Study|Death|0|||
125947437|NCT03131440|453106820|FG011|Overall Study|Death|0|||
125947438|NCT03131440|453106821|FG012|Overall Study|Death|0|||
125947439|NCT03131440|453106822|FG013|Overall Study|Death|0|||
125947440|NCT03131440|453106823|FG014|Overall Study|Death|0|||
126074633|NCT00943722|453568600|FG002|Base Study|Month 12 visit not completed|0|||
125947441|NCT03131440|453106824|FG015|Overall Study|Death|0|||
125947442|NCT03131440|453106825|FG016|Overall Study|Death|0|||
125947443|NCT03131440|453106826|FG017|Overall Study|Death|0|||
125947444|NCT03131440|453106827|FG018|Overall Study|Death|0|||
125947445|NCT03131440|453106828|FG019|Overall Study|Death|0|||
125947446|NCT03131440|453106829|FG020|Overall Study|Death|0|||
125947447|NCT03131440|453106830|FG021|Overall Study|Death|0|||
125947448|NCT03131440|453106831|FG022|Overall Study|Death|0|||
125947449|NCT03131440|453106832|FG023|Overall Study|Death|0|||
125947450|NCT03131440|453106833|FG024|Overall Study|Death|0|||
125947451|NCT03131440|453106834|FG025|Overall Study|Death|1|||
125947452|NCT03131440|453106835|FG026|Overall Study|Death|0|||
125947453|NCT03131440|453106836|FG027|Overall Study|Death|0|||
125947454|NCT03131440|453106837|FG028|Overall Study|Death|0|||
125947455|NCT03131440|453106838|FG029|Overall Study|Death|0|||
125947456|NCT03131440|453106839|FG030|Overall Study|Death|0|||
126074634|NCT00943722|453568601|FG003|Base Study|Month 12 visit not completed|0|||
126074635|NCT00943722|453568602|FG004|Base Study|Month 12 visit not completed|2|||
126074636|NCT00943722|453568603|FG005|Base Study|Month 12 visit not completed|0|||
126074637|NCT00943722|453568604|FG006|Base Study|Month 12 visit not completed|0|||
126074638|NCT00943722|453568598|FG000|First Extension Study: EXT 1|Adverse Event|0|||
126074639|NCT00943722|453568599|FG001|First Extension Study: EXT 1|Adverse Event|0|||
126074640|NCT00943722|453568600|FG002|First Extension Study: EXT 1|Adverse Event|0|||
126074641|NCT00943722|453568601|FG003|First Extension Study: EXT 1|Adverse Event|0|||
126074642|NCT00943722|453568602|FG004|First Extension Study: EXT 1|Adverse Event|0|||
126074643|NCT00943722|453568603|FG005|First Extension Study: EXT 1|Adverse Event|1|||
126074644|NCT00943722|453568604|FG006|First Extension Study: EXT 1|Adverse Event|0|||
126074645|NCT00943722|453568598|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
126074646|NCT00943722|453568599|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
126074647|NCT00943722|453568600|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
126074648|NCT00943722|453568601|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
126074649|NCT00943722|453568602|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
126074650|NCT00943722|453568603|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
126074651|NCT00943722|453568604|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
126074652|NCT00943722|453568598|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126074653|NCT00943722|453568599|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126074654|NCT00943722|453568600|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126074655|NCT00943722|453568601|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126074656|NCT00943722|453568602|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126074657|NCT00943722|453568603|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
126074658|NCT00943722|453568604|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
126074659|NCT00943722|453568598|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
126074660|NCT00943722|453568599|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
126074661|NCT00943722|453568600|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
126074662|NCT00943722|453568601|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
126074663|NCT00943722|453568602|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
126074664|NCT00943722|453568603|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
126074665|NCT00943722|453568604|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
126074666|NCT00943722|453568598|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
126074667|NCT00943722|453568599|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
126074668|NCT00943722|453568600|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
126074669|NCT00943722|453568601|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
126074670|NCT00943722|453568602|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
126074671|NCT00943722|453568603|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
126074672|NCT00943722|453568604|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
126074673|NCT00943722|453568598|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126074674|NCT00943722|453568599|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126074675|NCT00943722|453568600|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126074676|NCT00943722|453568601|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126074677|NCT00943722|453568602|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126074678|NCT00943722|453568603|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
126074679|NCT00943722|453568604|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
126074680|NCT00943722|453568598|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
126074681|NCT00943722|453568599|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
126074682|NCT00943722|453568600|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
126074683|NCT00943722|453568601|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
126074684|NCT00943722|453568602|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
126114867|NCT00433914|453715797|FG001|Overall Study|Withdrawal by Subject|2|||
126114868|NCT00433914|453715796|FG000|Overall Study|Lost to Follow-up|0|||
125947457|NCT03131440|453106840|FG031|Overall Study|Death|0|||
125947458|NCT03190889|453106842|FG000|Overall Study|Lost to Follow-up|7|||
125947459|NCT03190889|453106843|FG001|Overall Study|Lost to Follow-up|7|||
125947460|NCT03190889|453106844|FG002|Overall Study|Lost to Follow-up|3|||
125947461|NCT03190889|453106842|FG000|Overall Study|Withdrawal by Subject|1|||
126074685|NCT00943722|453568603|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
126074686|NCT00943722|453568604|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
126074687|NCT00943722|453568598|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
126074688|NCT00943722|453568599|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
126074689|NCT00943722|453568600|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
126074690|NCT00943722|453568601|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
126074691|NCT00943722|453568602|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
126074692|NCT00943722|453568603|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
126074693|NCT00943722|453568604|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
126074694|NCT00943722|453568598|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126074695|NCT00943722|453568599|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126074696|NCT00943722|453568600|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126074697|NCT00943722|453568601|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126074698|NCT00943722|453568602|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126074699|NCT00943722|453568603|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
126074700|NCT00943722|453568604|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
126074701|NCT01036165|453568605|FG000|Overall Study|Adverse Event|6|||
126074702|NCT01036165|453568605|FG000|Overall Study|Lost to Follow-up|2|||
126074703|NCT01036165|453568605|FG000|Overall Study|Withdrawal by Subject|3|||
126074704|NCT01036165|453568605|FG000|Overall Study|Device Related Issues|3|||
126074705|NCT01036165|453568605|FG000|Overall Study|Problems finding proper area to inject|1|||
126074706|NCT00913523|453568611|FG000|Overall Study|Withdrawal by Subject|3|||
126074707|NCT00913523|453568612|FG001|Overall Study|Withdrawal by Subject|2|||
126074708|NCT00913523|453568613|FG002|Overall Study|Withdrawal by Subject|2|||
126074709|NCT00913523|453568611|FG000|Overall Study|Lost to Follow-up|1|||
126074710|NCT00913523|453568612|FG001|Overall Study|Lost to Follow-up|1|||
126074711|NCT00913523|453568613|FG002|Overall Study|Lost to Follow-up|1|||
126074712|NCT00913523|453568611|FG000|Overall Study|Adverse Event|1|||
126074713|NCT00913523|453568612|FG001|Overall Study|Adverse Event|0|||
126074714|NCT00913523|453568613|FG002|Overall Study|Adverse Event|0|||
126074715|NCT00913523|453568611|FG000|Overall Study|Protocol Violation|5|||
126074716|NCT00913523|453568612|FG001|Overall Study|Protocol Violation|8|||
126074717|NCT00913523|453568613|FG002|Overall Study|Protocol Violation|8|||
126074718|NCT00913523|453568611|FG000|Overall Study|Pregnancy|1|||
126074719|NCT00913523|453568612|FG001|Overall Study|Pregnancy|3|||
126074720|NCT00913523|453568613|FG002|Overall Study|Pregnancy|0|||
126074721|NCT00913523|453568611|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
126074722|NCT00913523|453568612|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
126074723|NCT00913523|453568613|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
126074724|NCT02895360|453568614|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
126074725|NCT02895360|453568615|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126074726|NCT02895360|453568616|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126074727|NCT02895360|453568617|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126074728|NCT02895360|453568618|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126074729|NCT02895360|453568619|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126074730|NCT02895360|453568614|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126074731|NCT02895360|453568615|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
126074732|NCT02895360|453568616|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126074733|NCT02895360|453568617|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126074734|NCT02895360|453568618|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126074735|NCT02895360|453568619|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126074736|NCT02895360|453568614|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126074737|NCT02895360|453568615|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126074738|NCT02895360|453568616|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
126074739|NCT02895360|453568617|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126074740|NCT02895360|453568618|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126074741|NCT02895360|453568619|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126074742|NCT02895360|453568614|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126074743|NCT02895360|453568615|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126074744|NCT02895360|453568616|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
126074745|NCT02895360|453568617|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126074746|NCT02895360|453568618|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126074747|NCT02895360|453568619|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126074748|NCT02895360|453568614|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126074749|NCT02895360|453568615|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126074750|NCT02895360|453568616|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126074751|NCT02895360|453568617|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
126074752|NCT02895360|453568618|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126074753|NCT02895360|453568619|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126074754|NCT02895360|453568614|FG000|Phase 2a|Adverse Event|0|||
126074755|NCT02895360|453568615|FG001|Phase 2a|Adverse Event|0|||
126074756|NCT02895360|453568616|FG002|Phase 2a|Adverse Event|0|||
126074757|NCT02895360|453568617|FG003|Phase 2a|Adverse Event|0|||
126074758|NCT02895360|453568618|FG004|Phase 2a|Adverse Event|0|||
126074759|NCT02895360|453568619|FG005|Phase 2a|Adverse Event|1|||
126074760|NCT02895360|453568614|FG000|Phase 2a|Progressive disease|0|||
126074761|NCT02895360|453568615|FG001|Phase 2a|Progressive disease|0|||
126074762|NCT02895360|453568616|FG002|Phase 2a|Progressive disease|0|||
126074763|NCT02895360|453568617|FG003|Phase 2a|Progressive disease|0|||
126074764|NCT02895360|453568618|FG004|Phase 2a|Progressive disease|11|||
126074765|NCT02895360|453568619|FG005|Phase 2a|Progressive disease|11|||
126074766|NCT00916305|453568620|FG000|Overall Study|Lost to Follow-up|21|||
126074767|NCT00916305|453568621|FG001|Overall Study|Lost to Follow-up|27|||
126074768|NCT00916305|453568620|FG000|Overall Study|Withdrawal by Subject|0|||
126074769|NCT00916305|453568621|FG001|Overall Study|Withdrawal by Subject|1|||
126074770|NCT01844726|453568622|FG000|Overall Study|Withdrawal by Subject|0|||
126074771|NCT01844726|453568623|FG001|Overall Study|Withdrawal by Subject|1|||
126074772|NCT01844726|453568622|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
126074773|NCT01844726|453568623|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
126074774|NCT00307164|453568626|FG000|Overall Study|Death|1|||
126074775|NCT00307164|453568627|FG001|Overall Study|Death|0|||
126074776|NCT00307164|453568626|FG000|Overall Study|Severe debilitation, unable to continue|1|||
126074777|NCT00307164|453568627|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126074778|NCT00307164|453568626|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
126074779|NCT00307164|453568627|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
126074780|NCT00307164|453568626|FG000|Overall Study|Withdrawal by Subject|1|||
126074781|NCT00307164|453568627|FG001|Overall Study|Withdrawal by Subject|8|||
126074782|NCT00307164|453568626|FG000|Overall Study|Not compliant with requirements|4|||
126074783|NCT00307164|453568627|FG001|Overall Study|Not compliant with requirements|4|||
126074784|NCT00307164|453568626|FG000|Overall Study|Lost to Follow-up|6|||
126074785|NCT00307164|453568627|FG001|Overall Study|Lost to Follow-up|1|||
126074786|NCT04191148|453568633|FG000|Overall Study|Withdrawal by Subject|1|||
126074787|NCT04191148|453568634|FG001|Overall Study|Withdrawal by Subject|0|||
126074788|NCT04191148|453568633|FG000|Overall Study|Adverse Event|1|||
126074789|NCT04191148|453568634|FG001|Overall Study|Adverse Event|0|||
126074790|NCT01274559|453568637|FG000|Overall Study|Adverse Event|57|||
126074791|NCT01274559|453568638|FG001|Overall Study|Adverse Event|13|||
126074792|NCT01274559|453568637|FG000|Overall Study|Death|1|||
126074793|NCT01274559|453568638|FG001|Overall Study|Death|1|||
126074794|NCT01274559|453568637|FG000|Overall Study|Lost to Follow-up|3|||
126074795|NCT01274559|453568638|FG001|Overall Study|Lost to Follow-up|3|||
126074796|NCT01274559|453568637|FG000|Overall Study|Non-compliance with Study Drug|2|||
126074797|NCT01274559|453568638|FG001|Overall Study|Non-compliance with Study Drug|4|||
126074798|NCT01274559|453568637|FG000|Overall Study|Physician Decision|2|||
126074799|NCT01274559|453568638|FG001|Overall Study|Physician Decision|1|||
126074800|NCT01274559|453568637|FG000|Overall Study|Protocol Violation|28|||
126074801|NCT01274559|453568638|FG001|Overall Study|Protocol Violation|23|||
126074802|NCT01274559|453568637|FG000|Overall Study|Study Terminated by Sponsor|79|||
126074803|NCT01274559|453568638|FG001|Overall Study|Study Terminated by Sponsor|87|||
126074804|NCT01274559|453568637|FG000|Overall Study|Withdrawal by Subject|25|||
126074805|NCT01274559|453568638|FG001|Overall Study|Withdrawal by Subject|13|||
126074806|NCT02971228|453568639|FG000|Overall Study|Withdrawal by Subject|1|||
126074807|NCT02971228|453568640|FG001|Overall Study|Withdrawal by Subject|1|||
126074808|NCT02971228|453568641|FG002|Overall Study|Withdrawal by Subject|0|||
126074809|NCT02971228|453568642|FG003|Overall Study|Withdrawal by Subject|0|||
126074810|NCT02971228|453568643|FG004|Overall Study|Withdrawal by Subject|0|||
126074811|NCT02971228|453568639|FG000|Overall Study|Logistical challenges|0|||
126074812|NCT02971228|453568640|FG001|Overall Study|Logistical challenges|1|||
126074813|NCT02971228|453568641|FG002|Overall Study|Logistical challenges|0|||
126074814|NCT02971228|453568642|FG003|Overall Study|Logistical challenges|0|||
126074815|NCT02971228|453568643|FG004|Overall Study|Logistical challenges|0|||
126074816|NCT01167192|453568644|FG000|Overall Study|Adverse Event|1|||
126074817|NCT01167192|453568644|FG000|Overall Study|Death|1|||
126074818|NCT01167192|453568644|FG000|Overall Study|Withdrawal by Subject|1|||
126074819|NCT01167192|453568644|FG000|Overall Study|Insurance denial|1|||
126074820|NCT02560389|453568645|FG000|Overall Study|Lost to Follow-up|1|||
126074821|NCT02560389|453568646|FG001|Overall Study|Lost to Follow-up|2|||
126074822|NCT02560389|453568647|FG002|Overall Study|Lost to Follow-up|2|||
126074823|NCT02560389|453568645|FG000|Overall Study|Tested positive for illicit substance|0|||
126074824|NCT02560389|453568646|FG001|Overall Study|Tested positive for illicit substance|1|||
126074825|NCT02560389|453568647|FG002|Overall Study|Tested positive for illicit substance|0|||
126074826|NCT03409731|453568658|FG000|Overall Study|Withdrawal by Subject|17|||
126074827|NCT03409731|453568658|FG000|Overall Study|Death|4|||
126074828|NCT00827775|453568664|FG000|Overall Study|Withdrawal by Subject|0|||
126074829|NCT00827775|453568665|FG001|Overall Study|Withdrawal by Subject|5|||
126074830|NCT01193218|453568668|FG000|0-12 Weeks|Adverse Event|6|||
126074831|NCT01193218|453568669|FG001|0-12 Weeks|Adverse Event|0|||
126074832|NCT01193218|453568670|FG002|0-12 Weeks|Adverse Event|1|||
126074833|NCT01193218|453568671|FG003|0-12 Weeks|Adverse Event|0|||
126074834|NCT01193218|453568672|FG004|0-12 Weeks|Adverse Event|0|||
126074835|NCT01193218|453568673|FG005|0-12 Weeks|Adverse Event|2|||
126074836|NCT01193218|453568674|FG006|0-12 Weeks|Adverse Event|2|||
126074837|NCT01193218|453568675|FG007|0-12 Weeks|Adverse Event|0|||
126074838|NCT01193218|453568668|FG000|0-12 Weeks|Protocol Violation|0|||
126074839|NCT01193218|453568669|FG001|0-12 Weeks|Protocol Violation|0|||
126074840|NCT01193218|453568670|FG002|0-12 Weeks|Protocol Violation|0|||
126074841|NCT01193218|453568671|FG003|0-12 Weeks|Protocol Violation|0|||
126074842|NCT01193218|453568672|FG004|0-12 Weeks|Protocol Violation|1|||
126074843|NCT01193218|453568673|FG005|0-12 Weeks|Protocol Violation|1|||
126074844|NCT01193218|453568674|FG006|0-12 Weeks|Protocol Violation|0|||
126074845|NCT01193218|453568675|FG007|0-12 Weeks|Protocol Violation|0|||
126074846|NCT01193218|453568668|FG000|0-12 Weeks|Withdrawal by Subject|3|||
126074847|NCT01193218|453568669|FG001|0-12 Weeks|Withdrawal by Subject|0|||
126074848|NCT01193218|453568670|FG002|0-12 Weeks|Withdrawal by Subject|2|||
126074849|NCT01193218|453568671|FG003|0-12 Weeks|Withdrawal by Subject|0|||
126074850|NCT01193218|453568672|FG004|0-12 Weeks|Withdrawal by Subject|0|||
126074851|NCT01193218|453568673|FG005|0-12 Weeks|Withdrawal by Subject|0|||
126074852|NCT01193218|453568674|FG006|0-12 Weeks|Withdrawal by Subject|1|||
126074853|NCT01193218|453568675|FG007|0-12 Weeks|Withdrawal by Subject|0|||
126074854|NCT01193218|453568668|FG000|12-52 Weeks|Adverse Event|1|||
126074855|NCT01193218|453568669|FG001|12-52 Weeks|Adverse Event|0|||
126074856|NCT01193218|453568670|FG002|12-52 Weeks|Adverse Event|1|||
126074857|NCT01193218|453568671|FG003|12-52 Weeks|Adverse Event|2|||
126074858|NCT01193218|453568672|FG004|12-52 Weeks|Adverse Event|3|||
126074859|NCT01193218|453568673|FG005|12-52 Weeks|Adverse Event|3|||
126074860|NCT01193218|453568674|FG006|12-52 Weeks|Adverse Event|1|||
126074861|NCT01193218|453568675|FG007|12-52 Weeks|Adverse Event|2|||
126074862|NCT01193218|453568668|FG000|12-52 Weeks|Lack of Efficacy|0|||
126074863|NCT01193218|453568669|FG001|12-52 Weeks|Lack of Efficacy|0|||
126074864|NCT01193218|453568670|FG002|12-52 Weeks|Lack of Efficacy|0|||
126074865|NCT01193218|453568671|FG003|12-52 Weeks|Lack of Efficacy|0|||
126074866|NCT01193218|453568672|FG004|12-52 Weeks|Lack of Efficacy|0|||
126074867|NCT01193218|453568673|FG005|12-52 Weeks|Lack of Efficacy|0|||
126074868|NCT01193218|453568674|FG006|12-52 Weeks|Lack of Efficacy|1|||
126074869|NCT01193218|453568675|FG007|12-52 Weeks|Lack of Efficacy|0|||
126074870|NCT01193218|453568668|FG000|12-52 Weeks|Withdrawal by Subject|3|||
126074871|NCT01193218|453568669|FG001|12-52 Weeks|Withdrawal by Subject|0|||
125947462|NCT03190889|453106843|FG001|Overall Study|Withdrawal by Subject|1|||
125947463|NCT03190889|453106844|FG002|Overall Study|Withdrawal by Subject|2|||
125947464|NCT03190889|453106842|FG000|Overall Study|Did not complete protocol|4|||
125947465|NCT03190889|453106843|FG001|Overall Study|Did not complete protocol|9|||
125947466|NCT03190889|453106844|FG002|Overall Study|Did not complete protocol|0|||
125947467|NCT03190889|453106842|FG000|Overall Study|COVID-19|1|||
125947468|NCT03190889|453106843|FG001|Overall Study|COVID-19|0|||
125947469|NCT03190889|453106844|FG002|Overall Study|COVID-19|2|||
125947470|NCT03554291|453106845|FG000|Overall Study|Death|2|||
125947471|NCT03554291|453106846|FG001|Overall Study|Death|1|||
125947472|NCT03554291|453106845|FG000|Overall Study|Lost to Follow-up|1|||
125947473|NCT03554291|453106846|FG001|Overall Study|Lost to Follow-up|0|||
125947474|NCT03554291|453106845|FG000|Overall Study|Withdrawal by Subject|1|||
125947475|NCT03554291|453106846|FG001|Overall Study|Withdrawal by Subject|0|||
125947476|NCT03554291|453106845|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
125947477|NCT03554291|453106846|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
125947478|NCT02741700|453106847|FG000|Overall Study|Lost to Follow-up|17|||
125947479|NCT02741700|453106848|FG001|Overall Study|Lost to Follow-up|8|||
125947480|NCT02741700|453106847|FG000|Overall Study|Withdrawal by Subject|2|||
126074872|NCT01193218|453568670|FG002|12-52 Weeks|Withdrawal by Subject|3|||
126074873|NCT01193218|453568671|FG003|12-52 Weeks|Withdrawal by Subject|0|||
126074874|NCT01193218|453568672|FG004|12-52 Weeks|Withdrawal by Subject|0|||
126074875|NCT01193218|453568673|FG005|12-52 Weeks|Withdrawal by Subject|2|||
125947481|NCT02741700|453106848|FG001|Overall Study|Withdrawal by Subject|5|||
125947482|NCT02741700|453106847|FG000|Overall Study|Physician Decision|3|||
125947483|NCT02741700|453106848|FG001|Overall Study|Physician Decision|0|||
125947484|NCT02741700|453106847|FG000|Overall Study|Moved out of State|0|||
125947485|NCT02741700|453106848|FG001|Overall Study|Moved out of State|1|||
125947486|NCT02741700|453106847|FG000|Overall Study|Death|4|||
125947487|NCT02741700|453106848|FG001|Overall Study|Death|5|||
125947488|NCT00811577|453106849|FG000|Overall Study|Lost to Follow-up|7|||
125947489|NCT00811577|453106850|FG001|Overall Study|Lost to Follow-up|1|||
125947490|NCT00811577|453106849|FG000|Overall Study|Withdrawal by Subject|3|||
125947491|NCT00811577|453106850|FG001|Overall Study|Withdrawal by Subject|0|||
126074876|NCT01193218|453568674|FG006|12-52 Weeks|Withdrawal by Subject|1|||
126074877|NCT01193218|453568675|FG007|12-52 Weeks|Withdrawal by Subject|2|||
126074878|NCT01193218|453568668|FG000|12-52 Weeks|Other reason than above|1|||
126074879|NCT01193218|453568669|FG001|12-52 Weeks|Other reason than above|0|||
126074880|NCT01193218|453568670|FG002|12-52 Weeks|Other reason than above|0|||
126074881|NCT01193218|453568671|FG003|12-52 Weeks|Other reason than above|1|||
126074882|NCT01193218|453568672|FG004|12-52 Weeks|Other reason than above|1|||
126074883|NCT01193218|453568673|FG005|12-52 Weeks|Other reason than above|0|||
126074884|NCT01193218|453568674|FG006|12-52 Weeks|Other reason than above|0|||
126074885|NCT01193218|453568675|FG007|12-52 Weeks|Other reason than above|0|||
125947492|NCT01165138|453106851|FG000|Overall Study|Adverse Event|0|||
126074886|NCT01242371|453568676|FG000|Overall Study|Withdrawal by Subject|2|||
126074887|NCT01242371|453568677|FG001|Overall Study|Withdrawal by Subject|2|||
126074888|NCT01242371|453568676|FG000|Overall Study|Protocol Violation|0|||
126074889|NCT01242371|453568677|FG001|Overall Study|Protocol Violation|3|||
126074890|NCT01424189|453568678|FG000|Overall Study|Adverse Event|1|||
126074891|NCT01424189|453568679|FG001|Overall Study|Adverse Event|0|||
126074892|NCT01424189|453568678|FG000|Overall Study|Lost to Follow-up|4|||
126074893|NCT01424189|453568679|FG001|Overall Study|Lost to Follow-up|1|||
126074894|NCT01424189|453568678|FG000|Overall Study|Withdrawal by Subject|4|||
126074895|NCT01424189|453568679|FG001|Overall Study|Withdrawal by Subject|4|||
126074896|NCT01424189|453568678|FG000|Overall Study|Subject moved|1|||
126074897|NCT01424189|453568679|FG001|Overall Study|Subject moved|0|||
126074898|NCT01424189|453568678|FG000|Overall Study|Death|3|||
126074899|NCT01424189|453568679|FG001|Overall Study|Death|1|||
126074900|NCT01203956|453568681|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
126074901|NCT01203956|453568682|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
126074902|NCT00069277|453568683|FG000|Overall Study|Adverse Event|3|||
126074903|NCT00069277|453568683|FG000|Overall Study|Withdrawal by Subject|1|||
126074904|NCT00069277|453568683|FG000|Overall Study|Progressive Disease|15|||
126074905|NCT00069277|453568683|FG000|Overall Study|Physician Decision|2|||
126074906|NCT02230306|453568684|FG000|Overall Study|Did not receive study treatment|1|||
126074907|NCT03512288|453568689|FG000|Overall Study|Adverse Event|1|||
126074908|NCT03512288|453568690|FG001|Overall Study|Adverse Event|0|||
126074909|NCT03512288|453568689|FG000|Overall Study|Lost to Follow-up|12|||
126074910|NCT03512288|453568690|FG001|Overall Study|Lost to Follow-up|15|||
126074911|NCT03512288|453568689|FG000|Overall Study|Physician Decision|0|||
126074912|NCT03512288|453568690|FG001|Overall Study|Physician Decision|2|||
126074913|NCT03512288|453568689|FG000|Overall Study|Protocol Violation|6|||
126074914|NCT03512288|453568690|FG001|Overall Study|Protocol Violation|4|||
126074915|NCT03512288|453568689|FG000|Overall Study|Medication error without associated adverse event|1|||
126074916|NCT03512288|453568690|FG001|Overall Study|Medication error without associated adverse event|0|||
126074917|NCT03512288|453568689|FG000|Overall Study|No longer met eligibility criteria|5|||
126074918|NCT03512288|453568690|FG001|Overall Study|No longer met eligibility criteria|2|||
126074919|NCT03512288|453568689|FG000|Overall Study|Withdrawal by parent/guardian|14|||
126074920|NCT03512288|453568690|FG001|Overall Study|Withdrawal by parent/guardian|18|||
126074921|NCT03512288|453568689|FG000|Overall Study|Other|1|||
126074922|NCT03512288|453568690|FG001|Overall Study|Other|1|||
126074923|NCT03512288|453568689|FG000|Overall Study|Randomized but not treated|1|||
126074924|NCT03512288|453568690|FG001|Overall Study|Randomized but not treated|1|||
126074925|NCT01077622|453568691|FG000|Overall Study|Physician Decision|2|||
126074926|NCT01077622|453568691|FG000|Overall Study|Withdrawal by Subject|1|||
126074927|NCT01831726|453568695|FG000|Overall Study|Adverse Event|16|||
126074928|NCT01831726|453568695|FG000|Overall Study|Death|7|||
126074929|NCT01831726|453568695|FG000|Overall Study|Disease Progression|49|||
126074930|NCT01831726|453568695|FG000|Overall Study|Physician Decision|1|||
126074931|NCT01831726|453568695|FG000|Overall Study|Subject/guardian decision|7|||
126074932|NCT01283971|453568702|FG000|Overall Study|Adverse Event|3|||
126074933|NCT01283971|453568703|FG001|Overall Study|Adverse Event|5|||
126074934|NCT01283971|453568702|FG000|Overall Study|Insufficient therapeutic responses|3|||
126074935|NCT01283971|453568703|FG001|Overall Study|Insufficient therapeutic responses|3|||
126074936|NCT01283971|453568702|FG000|Overall Study|Protocol Violation|5|||
126074937|NCT01283971|453568703|FG001|Overall Study|Protocol Violation|1|||
126074938|NCT01283971|453568702|FG000|Overall Study|Refused treatment|3|||
126074939|NCT01283971|453568703|FG001|Overall Study|Refused treatment|1|||
126074940|NCT01283971|453568702|FG000|Overall Study|Failure to return|0|||
126074941|NCT01283971|453568703|FG001|Overall Study|Failure to return|1|||
126074942|NCT01283971|453568702|FG000|Overall Study|Administrative reasons|1|||
126074943|NCT01283971|453568703|FG001|Overall Study|Administrative reasons|1|||
126074944|NCT01502371|453568704|FG000|Overall Study|Withdrawal by Subject|1|||
126074945|NCT01502371|453568705|FG001|Overall Study|Withdrawal by Subject|2|||
126074946|NCT01502371|453568706|FG002|Overall Study|Withdrawal by Subject|1|||
126074947|NCT01502371|453568707|FG003|Overall Study|Withdrawal by Subject|1|||
126114869|NCT00433914|453715797|FG001|Overall Study|Lost to Follow-up|1|||
125947493|NCT01165138|453106852|FG001|Overall Study|Adverse Event|1|||
125947494|NCT01165138|453106853|FG002|Overall Study|Adverse Event|0|||
125947495|NCT01165138|453106854|FG003|Overall Study|Adverse Event|2|||
125947496|NCT01165138|453106851|FG000|Overall Study|Lack of Efficacy|0|||
126074948|NCT01502371|453568708|FG004|Overall Study|Withdrawal by Subject|1|||
126074949|NCT01502371|453568704|FG000|Overall Study|Adverse Event|2|||
126074950|NCT01502371|453568705|FG001|Overall Study|Adverse Event|1|||
126074951|NCT01502371|453568706|FG002|Overall Study|Adverse Event|0|||
126074952|NCT01502371|453568707|FG003|Overall Study|Adverse Event|4|||
126074953|NCT01502371|453568708|FG004|Overall Study|Adverse Event|3|||
126074954|NCT01502371|453568704|FG000|Overall Study|Treatment Failure|22|||
126074955|NCT01502371|453568705|FG001|Overall Study|Treatment Failure|20|||
126074956|NCT01502371|453568706|FG002|Overall Study|Treatment Failure|12|||
126074957|NCT01502371|453568707|FG003|Overall Study|Treatment Failure|19|||
126114870|NCT02486653|453715798|FG000|Overall Study|Withdrawal by Subject|1|||
126114871|NCT02486653|453715799|FG001|Overall Study|Withdrawal by Subject|3|||
126114872|NCT02486653|453715798|FG000|Overall Study|Protocol Violation|1|||
126114873|NCT02486653|453715799|FG001|Overall Study|Protocol Violation|0|||
126114874|NCT02486653|453715798|FG000|Overall Study|surgery cancelled|4|||
126114875|NCT02486653|453715799|FG001|Overall Study|surgery cancelled|1|||
126114876|NCT01848353|453715800|FG000|Phase 1|Withdrawal by Subject|3|||
126114877|NCT01848353|453715801|FG001|Phase 1|Withdrawal by Subject|1|||
126114878|NCT01848353|453715802|FG002|Phase 1|Withdrawal by Subject|0|||
126114879|NCT01848353|453715803|FG003|Phase 1|Withdrawal by Subject|0|||
126114880|NCT01848353|453715800|FG000|Phase 2|Withdrawal by Subject|3|||
126114881|NCT01848353|453715801|FG001|Phase 2|Withdrawal by Subject|2|||
126114882|NCT01848353|453715802|FG002|Phase 2|Withdrawal by Subject|0|||
126114883|NCT01848353|453715803|FG003|Phase 2|Withdrawal by Subject|0|||
126114884|NCT01848353|453715800|FG000|Phase 3|Withdrawal by Subject|1|||
126114885|NCT01848353|453715801|FG001|Phase 3|Withdrawal by Subject|1|||
126114886|NCT01848353|453715802|FG002|Phase 3|Withdrawal by Subject|0|||
126114887|NCT01848353|453715803|FG003|Phase 3|Withdrawal by Subject|0|||
126114888|NCT01514136|453715807|FG000|Test Period 1; Test A|Protocol Violation|1|||
126114889|NCT01514136|453715808|FG001|Test Period 1; Test A|Protocol Violation|0|||
126114890|NCT01514136|453715809|FG002|Test Period 1; Test A|Protocol Violation|0|||
126114891|NCT01514136|453715810|FG003|Test Period 1; Test A|Protocol Violation|0|||
126114892|NCT01514136|453715811|FG004|Test Period 1; Test A|Protocol Violation|0|||
126114893|NCT01514136|453715812|FG005|Test Period 1; Test A|Protocol Violation|0|||
126114894|NCT01514136|453715813|FG006|Test Period 1; Test A|Protocol Violation|0|||
126114895|NCT01514136|453715814|FG007|Test Period 1; Test A|Protocol Violation|0|||
125947497|NCT01165138|453106852|FG001|Overall Study|Lack of Efficacy|32|||
125947498|NCT01165138|453106853|FG002|Overall Study|Lack of Efficacy|6|||
125947499|NCT01165138|453106854|FG003|Overall Study|Lack of Efficacy|7|||
125947500|NCT01165138|453106851|FG000|Overall Study|Protocol Violation|0|||
126074958|NCT01502371|453568708|FG004|Overall Study|Treatment Failure|30|||
126074959|NCT01502371|453568704|FG000|Overall Study|Lack of Efficacy|3|||
126074960|NCT01502371|453568705|FG001|Overall Study|Lack of Efficacy|3|||
126074961|NCT01502371|453568706|FG002|Overall Study|Lack of Efficacy|2|||
126074962|NCT01502371|453568707|FG003|Overall Study|Lack of Efficacy|2|||
126074963|NCT01502371|453568708|FG004|Overall Study|Lack of Efficacy|4|||
126074964|NCT01502371|453568704|FG000|Overall Study|Physician Decision|3|||
126074965|NCT01502371|453568705|FG001|Overall Study|Physician Decision|0|||
126074966|NCT01502371|453568706|FG002|Overall Study|Physician Decision|0|||
126074967|NCT01502371|453568707|FG003|Overall Study|Physician Decision|0|||
126074968|NCT01502371|453568708|FG004|Overall Study|Physician Decision|1|||
126074969|NCT01502371|453568704|FG000|Overall Study|Noncompliance with Study Drug|0|||
126074970|NCT01502371|453568705|FG001|Overall Study|Noncompliance with Study Drug|0|||
126074971|NCT01502371|453568706|FG002|Overall Study|Noncompliance with Study Drug|1|||
126074972|NCT01502371|453568707|FG003|Overall Study|Noncompliance with Study Drug|2|||
126074973|NCT01502371|453568708|FG004|Overall Study|Noncompliance with Study Drug|1|||
126074974|NCT01502371|453568704|FG000|Overall Study|Technical Problems|1|||
126074975|NCT01502371|453568705|FG001|Overall Study|Technical Problems|0|||
126074976|NCT01502371|453568706|FG002|Overall Study|Technical Problems|2|||
126074977|NCT01502371|453568707|FG003|Overall Study|Technical Problems|4|||
126074978|NCT01502371|453568708|FG004|Overall Study|Technical Problems|1|||
126074979|NCT01502371|453568704|FG000|Overall Study|Protocol Violation|9|||
126074980|NCT01502371|453568705|FG001|Overall Study|Protocol Violation|5|||
126074981|NCT01502371|453568706|FG002|Overall Study|Protocol Violation|6|||
126074982|NCT01502371|453568707|FG003|Overall Study|Protocol Violation|5|||
126074983|NCT01502371|453568708|FG004|Overall Study|Protocol Violation|10|||
126074984|NCT01502371|453568704|FG000|Overall Study|Excluded Medication|0|||
126074985|NCT01502371|453568705|FG001|Overall Study|Excluded Medication|1|||
126074986|NCT01502371|453568706|FG002|Overall Study|Excluded Medication|1|||
126074987|NCT01502371|453568707|FG003|Overall Study|Excluded Medication|0|||
125947501|NCT01165138|453106852|FG001|Overall Study|Protocol Violation|7|||
126074988|NCT01502371|453568708|FG004|Overall Study|Excluded Medication|1|||
126074989|NCT03049306|453568709|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
126114896|NCT01514136|453715807|FG000|Test Period 1; Test A|Break from study holiday|2|||
126114897|NCT01514136|453715808|FG001|Test Period 1; Test A|Break from study holiday|0|||
125947502|NCT01165138|453106853|FG002|Overall Study|Protocol Violation|0|||
126074990|NCT03049306|453568710|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
125947503|NCT01165138|453106854|FG003|Overall Study|Protocol Violation|2|||
126114898|NCT01514136|453715809|FG002|Test Period 1; Test A|Break from study holiday|0|||
126114899|NCT01514136|453715810|FG003|Test Period 1; Test A|Break from study holiday|0|||
126074991|NCT02154347|453568711|FG000|Double-blind Period|Adverse Event|1|||
126074992|NCT02154347|453568712|FG001|Double-blind Period|Adverse Event|2|||
126114900|NCT01514136|453715811|FG004|Test Period 1; Test A|Break from study holiday|0|||
125947504|NCT01165138|453106851|FG000|Overall Study|Lost to Follow-up|0|||
125947505|NCT01165138|453106852|FG001|Overall Study|Lost to Follow-up|0|||
126074993|NCT02154347|453568711|FG000|Double-blind Period|Lack of Efficacy|1|||
126074994|NCT02154347|453568712|FG001|Double-blind Period|Lack of Efficacy|0|||
126074995|NCT02154347|453568711|FG000|Double-blind Period|Physician Decision|0|||
126074996|NCT02154347|453568712|FG001|Double-blind Period|Physician Decision|1|||
126074997|NCT02154347|453568711|FG000|Double-blind Period|Withdrawal by Subject|1|||
126074998|NCT02154347|453568712|FG001|Double-blind Period|Withdrawal by Subject|1|||
126074999|NCT02154347|453568711|FG000|Open-label Period|Adverse Event|3|||
126075000|NCT02154347|453568712|FG001|Open-label Period|Adverse Event|4|||
126075001|NCT02154347|453568711|FG000|Open-label Period|Lack of Efficacy|4|||
126075002|NCT02154347|453568712|FG001|Open-label Period|Lack of Efficacy|19|||
126075003|NCT02154347|453568711|FG000|Open-label Period|Protocol Violation|0|||
126075004|NCT02154347|453568712|FG001|Open-label Period|Protocol Violation|1|||
126075005|NCT02154347|453568711|FG000|Open-label Period|Withdrawal by Subject|0|||
126075006|NCT02154347|453568712|FG001|Open-label Period|Withdrawal by Subject|1|||
126075007|NCT02473913|453568714|FG000|Overall Study|Lost to Follow-up|3|||
126075008|NCT02473913|453568715|FG001|Overall Study|Lost to Follow-up|3|||
126075009|NCT00605566|453570341|FG000|Overall Study|Adverse Event|1|||
126075010|NCT00605566|453570341|FG000|Overall Study|Clinical deterioration|1|||
126075011|NCT00605566|453570341|FG000|Overall Study|Poor compliance in run-in period|1|||
126075012|NCT04156399|453570342|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
126075013|NCT04156399|453570342|FG000|Overall Study|study suspension due to COVID pandemic|3|||
126075014|NCT03440047|453570343|FG000|Overall Study|Withdrawal by Subject|2|||
126075015|NCT01181609|453570344|FG000|Overall Study|Adverse Event|1|||
126075016|NCT01181609|453570344|FG000|Overall Study|Withdrawal by Subject|1|||
126075017|NCT01181609|453570344|FG000|Overall Study|Lost to Follow-up|1|||
126075018|NCT01181609|453570344|FG000|Overall Study|Death|50|||
126075019|NCT01333111|453570345|FG000|Overall Study|patient undergoing major surgery|0|||
126075020|NCT01333111|453570346|FG001|Overall Study|patient undergoing major surgery|2|||
126075021|NCT01333111|453570347|FG002|Overall Study|patient undergoing major surgery|0|||
126075022|NCT01333111|453570345|FG000|Overall Study|personal reasons|0|||
126075023|NCT01333111|453570346|FG001|Overall Study|personal reasons|0|||
126075024|NCT01333111|453570347|FG002|Overall Study|personal reasons|1|||
126075025|NCT01333111|453570345|FG000|Overall Study|unclassified|1|||
126075026|NCT01333111|453570346|FG001|Overall Study|unclassified|0|||
126075027|NCT01333111|453570347|FG002|Overall Study|unclassified|0|||
126075028|NCT01333111|453570345|FG000|Overall Study|withdrawal criteria|0|||
126075029|NCT01333111|453570346|FG001|Overall Study|withdrawal criteria|1|||
126075030|NCT01333111|453570347|FG002|Overall Study|withdrawal criteria|0|||
126075031|NCT01333111|453570345|FG000|Overall Study|Non-compliance|1|||
126075032|NCT01333111|453570346|FG001|Overall Study|Non-compliance|0|||
126075033|NCT01333111|453570347|FG002|Overall Study|Non-compliance|0|||
126075034|NCT01333111|453570345|FG000|Overall Study|Ineffective therapy|0|||
126075035|NCT01333111|453570346|FG001|Overall Study|Ineffective therapy|0|||
126075036|NCT01333111|453570347|FG002|Overall Study|Ineffective therapy|1|||
126075037|NCT04732871|453570348|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
126075038|NCT04732871|453570349|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
126075039|NCT04732871|453570350|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
126075040|NCT04732871|453570348|FG000|Overall Study|Lost to Follow-up|7|||
126075041|NCT04732871|453570349|FG001|Overall Study|Lost to Follow-up|4|||
126075042|NCT04732871|453570350|FG002|Overall Study|Lost to Follow-up|3|||
126075043|NCT04732871|453570348|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
126075044|NCT04732871|453570349|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
126075045|NCT04732871|453570350|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
126075046|NCT04732871|453570348|FG000|Overall Study|Migrated / moved from the study area|5|||
126075047|NCT04732871|453570349|FG001|Overall Study|Migrated / moved from the study area|0|||
126075048|NCT04732871|453570350|FG002|Overall Study|Migrated / moved from the study area|0|||
126075049|NCT04732871|453570348|FG000|Overall Study|Other|1|||
126075050|NCT04732871|453570349|FG001|Overall Study|Other|0|||
126075051|NCT04732871|453570350|FG002|Overall Study|Other|1|||
126075052|NCT04732871|453570348|FG000|Overall Study|Ongoing|6|||
126075053|NCT04732871|453570349|FG001|Overall Study|Ongoing|0|||
126075054|NCT04732871|453570350|FG002|Overall Study|Ongoing|1|||
126075055|NCT04732871|453570348|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
126075056|NCT04732871|453570349|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
126075057|NCT04732871|453570350|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
126075058|NCT00478647|453570355|FG000|Overall Study|Adverse Event|1|||
126075059|NCT00478647|453570355|FG000|Overall Study|Withdrawal by Subject|1|||
126075060|NCT03596242|453570360|FG000|Overall Study|Lost to Follow-up|2|||
126075061|NCT03596242|453570361|FG001|Overall Study|Lost to Follow-up|2|||
126075062|NCT02509312|453570362|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
126075063|NCT02509312|453570363|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
125947506|NCT01165138|453106853|FG002|Overall Study|Lost to Follow-up|1|||
125947507|NCT01165138|453106854|FG003|Overall Study|Lost to Follow-up|2|||
126075064|NCT02509312|453570362|FG000|Overall Study|Obstetrician refusal|0|||
126075065|NCT02509312|453570363|FG001|Overall Study|Obstetrician refusal|1|||
126075066|NCT02509312|453570362|FG000|Overall Study|Patient elected for TOLAC|1|||
126075067|NCT02509312|453570363|FG001|Overall Study|Patient elected for TOLAC|0|||
126075068|NCT02509312|453570362|FG000|Overall Study|Cesarean deemed stat|1|||
126075069|NCT02509312|453570363|FG001|Overall Study|Cesarean deemed stat|0|||
126075070|NCT02509312|453570362|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
126075071|NCT02509312|453570363|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
126075072|NCT03294941|453570364|FG000|Overall Study|Withdrawal by Subject|0|||
126075073|NCT03294941|453570365|FG001|Overall Study|Withdrawal by Subject|2|||
126075074|NCT00702650|453570366|FG000|Overall Study|Withdrawal by Subject|9|||
126075075|NCT00702650|453570366|FG000|Overall Study|Non-Compliance of Study Drug|3|||
126075076|NCT00702650|453570366|FG000|Overall Study|Lost to Follow-up|2|||
126075077|NCT00702650|453570366|FG000|Overall Study|Non-Compliance with Site Directives|1|||
126075078|NCT00702650|453570366|FG000|Overall Study|Sponsor Request|1|||
126075079|NCT00702650|453570366|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
126075080|NCT00702650|453570366|FG000|Overall Study|Adverse Event|3|||
126075081|NCT03927690|453570370|FG000|Overall Study|Withdrawal by Subject|3|||
126075082|NCT03927690|453570371|FG001|Overall Study|Withdrawal by Subject|1|||
126075083|NCT03927690|453570372|FG002|Overall Study|Withdrawal by Subject|1|||
126075084|NCT03927690|453570370|FG000|Overall Study|Adverse Event|1|||
126075085|NCT03927690|453570371|FG001|Overall Study|Adverse Event|0|||
126075086|NCT03927690|453570372|FG002|Overall Study|Adverse Event|0|||
126075087|NCT03927690|453570370|FG000|Overall Study|Death|1|||
126075088|NCT03927690|453570371|FG001|Overall Study|Death|0|||
126075089|NCT03927690|453570372|FG002|Overall Study|Death|0|||
126075090|NCT03927690|453570370|FG000|Overall Study|Lost to Follow-up|2|||
126075091|NCT03927690|453570371|FG001|Overall Study|Lost to Follow-up|2|||
126075092|NCT03927690|453570372|FG002|Overall Study|Lost to Follow-up|1|||
126075093|NCT01475461|453570381|FG000|Run-in Period|Not meet eligibility criteria|16|||
126075094|NCT01475461|453570382|FG001|Run-in Period|Not meet eligibility criteria|0|||
126075095|NCT01475461|453570383|FG002|Run-in Period|Not meet eligibility criteria|0|||
126075096|NCT01475461|453570384|FG003|Run-in Period|Not meet eligibility criteria|0|||
126075097|NCT01475461|453570385|FG004|Run-in Period|Not meet eligibility criteria|0|||
126075098|NCT01475461|453570386|FG005|Run-in Period|Not meet eligibility criteria|0|||
126075099|NCT01475461|453570387|FG006|Run-in Period|Not meet eligibility criteria|0|||
126075100|NCT01475461|453570381|FG000|Run-in Period|Lost to Follow-up|7|||
126075101|NCT01475461|453570382|FG001|Run-in Period|Lost to Follow-up|0|||
126075102|NCT01475461|453570383|FG002|Run-in Period|Lost to Follow-up|0|||
126075103|NCT01475461|453570384|FG003|Run-in Period|Lost to Follow-up|0|||
126075104|NCT01475461|453570385|FG004|Run-in Period|Lost to Follow-up|0|||
126075105|NCT01475461|453570386|FG005|Run-in Period|Lost to Follow-up|0|||
126075106|NCT01475461|453570387|FG006|Run-in Period|Lost to Follow-up|0|||
126075107|NCT01475461|453570381|FG000|Run-in Period|Withdrawal by Subject|11|||
126075108|NCT01475461|453570382|FG001|Run-in Period|Withdrawal by Subject|0|||
126075109|NCT01475461|453570383|FG002|Run-in Period|Withdrawal by Subject|0|||
126075110|NCT01475461|453570384|FG003|Run-in Period|Withdrawal by Subject|0|||
126075111|NCT01475461|453570385|FG004|Run-in Period|Withdrawal by Subject|0|||
126075112|NCT01475461|453570386|FG005|Run-in Period|Withdrawal by Subject|0|||
126075113|NCT01475461|453570387|FG006|Run-in Period|Withdrawal by Subject|0|||
126075114|NCT01475461|453570381|FG000|Run-in Period|Other|3|||
126075115|NCT01475461|453570382|FG001|Run-in Period|Other|0|||
126075116|NCT01475461|453570383|FG002|Run-in Period|Other|0|||
126075117|NCT01475461|453570384|FG003|Run-in Period|Other|0|||
126075118|NCT01475461|453570385|FG004|Run-in Period|Other|0|||
126075119|NCT01475461|453570386|FG005|Run-in Period|Other|0|||
126075120|NCT01475461|453570387|FG006|Run-in Period|Other|0|||
126075121|NCT01475461|453570381|FG000|Run-in Period|Protocol Violation|4|||
126075122|NCT01475461|453570382|FG001|Run-in Period|Protocol Violation|0|||
126075123|NCT01475461|453570383|FG002|Run-in Period|Protocol Violation|0|||
126075124|NCT01475461|453570384|FG003|Run-in Period|Protocol Violation|0|||
126075125|NCT01475461|453570385|FG004|Run-in Period|Protocol Violation|0|||
126075126|NCT01475461|453570386|FG005|Run-in Period|Protocol Violation|0|||
126075127|NCT01475461|453570387|FG006|Run-in Period|Protocol Violation|0|||
126075128|NCT01475461|453570381|FG000|Treatment Period|Death|0|||
126075129|NCT01475461|453570382|FG001|Treatment Period|Death|0|||
126075130|NCT01475461|453570383|FG002|Treatment Period|Death|0|||
126114901|NCT01514136|453715812|FG005|Test Period 1; Test A|Break from study holiday|0|||
126114902|NCT01514136|453715813|FG006|Test Period 1; Test A|Break from study holiday|0|||
125947508|NCT01165138|453106851|FG000|Overall Study|Physician Decision|0|||
126075131|NCT01475461|453570384|FG003|Treatment Period|Death|1|||
126075132|NCT01475461|453570385|FG004|Treatment Period|Death|0|||
126075133|NCT01475461|453570386|FG005|Treatment Period|Death|0|||
126075134|NCT01475461|453570387|FG006|Treatment Period|Death|0|||
126075135|NCT01475461|453570381|FG000|Treatment Period|Lost to Follow-up|0|||
126075136|NCT01475461|453570382|FG001|Treatment Period|Lost to Follow-up|3|||
126075137|NCT01475461|453570383|FG002|Treatment Period|Lost to Follow-up|2|||
126075138|NCT01475461|453570384|FG003|Treatment Period|Lost to Follow-up|3|||
126075139|NCT01475461|453570385|FG004|Treatment Period|Lost to Follow-up|1|||
126075140|NCT01475461|453570386|FG005|Treatment Period|Lost to Follow-up|2|||
126075141|NCT01475461|453570387|FG006|Treatment Period|Lost to Follow-up|1|||
126075142|NCT01475461|453570381|FG000|Treatment Period|Withdrawal by Subject|0|||
126075143|NCT01475461|453570382|FG001|Treatment Period|Withdrawal by Subject|2|||
126075144|NCT01475461|453570383|FG002|Treatment Period|Withdrawal by Subject|2|||
126075145|NCT01475461|453570384|FG003|Treatment Period|Withdrawal by Subject|0|||
126075146|NCT01475461|453570385|FG004|Treatment Period|Withdrawal by Subject|2|||
126075147|NCT01475461|453570386|FG005|Treatment Period|Withdrawal by Subject|2|||
126075148|NCT01475461|453570387|FG006|Treatment Period|Withdrawal by Subject|0|||
126075149|NCT01475461|453570381|FG000|Treatment Period|Other|0|||
126075150|NCT01475461|453570382|FG001|Treatment Period|Other|1|||
126075151|NCT01475461|453570383|FG002|Treatment Period|Other|0|||
126075152|NCT01475461|453570384|FG003|Treatment Period|Other|0|||
126075153|NCT01475461|453570385|FG004|Treatment Period|Other|0|||
126075154|NCT01475461|453570386|FG005|Treatment Period|Other|0|||
126075155|NCT01475461|453570387|FG006|Treatment Period|Other|0|||
126075156|NCT01475461|453570381|FG000|Treatment Period|Protocol Violation|0|||
126075157|NCT01475461|453570382|FG001|Treatment Period|Protocol Violation|1|||
126075158|NCT01475461|453570383|FG002|Treatment Period|Protocol Violation|0|||
126075159|NCT01475461|453570384|FG003|Treatment Period|Protocol Violation|0|||
126075160|NCT01475461|453570385|FG004|Treatment Period|Protocol Violation|0|||
126075161|NCT01475461|453570386|FG005|Treatment Period|Protocol Violation|0|||
126075162|NCT01475461|453570387|FG006|Treatment Period|Protocol Violation|1|||
126075163|NCT01475461|453570381|FG000|Treatment Period|Lack of Efficacy|0|||
126075164|NCT01475461|453570382|FG001|Treatment Period|Lack of Efficacy|2|||
126075165|NCT01475461|453570383|FG002|Treatment Period|Lack of Efficacy|0|||
126075166|NCT01475461|453570384|FG003|Treatment Period|Lack of Efficacy|2|||
126075167|NCT01475461|453570385|FG004|Treatment Period|Lack of Efficacy|1|||
126075168|NCT01475461|453570386|FG005|Treatment Period|Lack of Efficacy|1|||
126075169|NCT01475461|453570387|FG006|Treatment Period|Lack of Efficacy|0|||
126075170|NCT01475461|453570381|FG000|Treatment Period|Medication Error|0|||
126075171|NCT01475461|453570382|FG001|Treatment Period|Medication Error|0|||
126075172|NCT01475461|453570383|FG002|Treatment Period|Medication Error|0|||
126075173|NCT01475461|453570384|FG003|Treatment Period|Medication Error|1|||
126075174|NCT01475461|453570385|FG004|Treatment Period|Medication Error|0|||
126075175|NCT01475461|453570386|FG005|Treatment Period|Medication Error|0|||
126075176|NCT01475461|453570387|FG006|Treatment Period|Medication Error|0|||
126075177|NCT01475461|453570381|FG000|Treatment Period|Adverse Event|0|||
126075178|NCT01475461|453570382|FG001|Treatment Period|Adverse Event|0|||
126075179|NCT01475461|453570383|FG002|Treatment Period|Adverse Event|0|||
126075180|NCT01475461|453570384|FG003|Treatment Period|Adverse Event|1|||
126075181|NCT01475461|453570385|FG004|Treatment Period|Adverse Event|0|||
126075182|NCT01475461|453570386|FG005|Treatment Period|Adverse Event|0|||
126075183|NCT01475461|453570387|FG006|Treatment Period|Adverse Event|0|||
126075184|NCT02512861|453570390|FG000|Overall Study|Protocol Violation|3|||
126075185|NCT02512861|453570391|FG001|Overall Study|Protocol Violation|7|||
126075186|NCT02512861|453570390|FG000|Overall Study|Physician Decision|3|||
126075187|NCT02512861|453570391|FG001|Overall Study|Physician Decision|1|||
126075188|NCT02512861|453570390|FG000|Overall Study|Withdrawal by Subject|0|||
126075189|NCT02512861|453570391|FG001|Overall Study|Withdrawal by Subject|1|||
126075190|NCT01774019|453570392|FG000|Overall Study|No longer meets protocol criteria|2|||
126075191|NCT01774019|453570393|FG001|Overall Study|No longer meets protocol criteria|0|||
126075192|NCT01774019|453570392|FG000|Overall Study|Withdrawal by Subject|1|||
126075193|NCT01774019|453570393|FG001|Overall Study|Withdrawal by Subject|0|||
126075194|NCT01774019|453570392|FG000|Overall Study|Surgery delayed > 120 days|1|||
126075195|NCT01774019|453570393|FG001|Overall Study|Surgery delayed > 120 days|0|||
126075196|NCT01774019|453570392|FG000|Overall Study|Patient refused surgery|1|||
126075197|NCT01774019|453570393|FG001|Overall Study|Patient refused surgery|1|||
126075198|NCT01774019|453570392|FG000|Overall Study|Unable to implant study device|1|||
126075199|NCT01774019|453570393|FG001|Overall Study|Unable to implant study device|0|||
126075200|NCT01774019|453570392|FG000|Overall Study|Lost to Follow-up|0|||
126075201|NCT01774019|453570393|FG001|Overall Study|Lost to Follow-up|3|||
126075202|NCT03214250|453570396|FG000|Overall Study|Death|5|||
126075203|NCT03214250|453570397|FG001|Overall Study|Death|5|||
126075204|NCT03214250|453570398|FG002|Overall Study|Death|7|||
126075205|NCT03214250|453570399|FG003|Overall Study|Death|4|||
126075206|NCT03214250|453570400|FG004|Overall Study|Death|23|||
125947509|NCT01165138|453106852|FG001|Overall Study|Physician Decision|6|||
126075207|NCT03214250|453570401|FG005|Overall Study|Death|23|||
126075208|NCT03214250|453570402|FG006|Overall Study|Death|24|||
125947510|NCT01165138|453106853|FG002|Overall Study|Physician Decision|7|||
125947511|NCT01165138|453106854|FG003|Overall Study|Physician Decision|6|||
126075209|NCT03214250|453570396|FG000|Overall Study|Lost to Follow-up|0|||
126075210|NCT03214250|453570397|FG001|Overall Study|Lost to Follow-up|0|||
126075211|NCT03214250|453570398|FG002|Overall Study|Lost to Follow-up|0|||
126075212|NCT03214250|453570399|FG003|Overall Study|Lost to Follow-up|1|||
126075213|NCT03214250|453570400|FG004|Overall Study|Lost to Follow-up|1|||
126075214|NCT03214250|453570401|FG005|Overall Study|Lost to Follow-up|2|||
126075215|NCT03214250|453570402|FG006|Overall Study|Lost to Follow-up|0|||
126075216|NCT03214250|453570396|FG000|Overall Study|Other|0|||
126075217|NCT03214250|453570397|FG001|Overall Study|Other|0|||
126075218|NCT03214250|453570398|FG002|Overall Study|Other|0|||
126075219|NCT03214250|453570399|FG003|Overall Study|Other|0|||
126075220|NCT03214250|453570400|FG004|Overall Study|Other|1|||
126075221|NCT03214250|453570401|FG005|Overall Study|Other|1|||
126075222|NCT03214250|453570402|FG006|Overall Study|Other|2|||
126075223|NCT03214250|453570396|FG000|Overall Study|Remains on Study|2|||
126075224|NCT03214250|453570397|FG001|Overall Study|Remains on Study|2|||
126075225|NCT03214250|453570398|FG002|Overall Study|Remains on Study|0|||
126075226|NCT03214250|453570399|FG003|Overall Study|Remains on Study|1|||
126075227|NCT03214250|453570400|FG004|Overall Study|Remains on Study|7|||
126075228|NCT03214250|453570401|FG005|Overall Study|Remains on Study|5|||
126075229|NCT03214250|453570402|FG006|Overall Study|Remains on Study|3|||
126075230|NCT03214250|453570396|FG000|Overall Study|Withdrawal by Subject|0|||
126075231|NCT03214250|453570397|FG001|Overall Study|Withdrawal by Subject|0|||
126075232|NCT03214250|453570398|FG002|Overall Study|Withdrawal by Subject|1|||
126075233|NCT03214250|453570399|FG003|Overall Study|Withdrawal by Subject|2|||
126075234|NCT03214250|453570400|FG004|Overall Study|Withdrawal by Subject|5|||
126075235|NCT03214250|453570401|FG005|Overall Study|Withdrawal by Subject|0|||
126075236|NCT03214250|453570402|FG006|Overall Study|Withdrawal by Subject|2|||
126075237|NCT00292981|453570406|FG000|Overall Study|Adverse Event|1|||
126075238|NCT00292981|453570406|FG000|Overall Study|Lost to Follow-up|13|||
126075239|NCT00292981|453570406|FG000|Overall Study|Withdrawal by Subject|22|||
126075240|NCT00292981|453570406|FG000|Overall Study|Other|3|||
126075241|NCT00594178|453570407|FG000|Overall Study|Physician Decision|5|||
126075242|NCT02172950|453570408|FG000|Overall Study|Physician Decision|3|||
126075243|NCT02172950|453570409|FG001|Overall Study|Physician Decision|3|||
126075244|NCT02172950|453570408|FG000|Overall Study|Lack of Efficacy|1|||
126075245|NCT02172950|453570409|FG001|Overall Study|Lack of Efficacy|0|||
126075246|NCT02172950|453570408|FG000|Overall Study|Adverse Event|4|||
126075247|NCT02172950|453570409|FG001|Overall Study|Adverse Event|1|||
126075248|NCT02172950|453570408|FG000|Overall Study|Withdrawal by Subject|10|||
126075249|NCT02172950|453570409|FG001|Overall Study|Withdrawal by Subject|0|||
126075250|NCT02172950|453570408|FG000|Overall Study|Protocol Violation|1|||
126075251|NCT02172950|453570409|FG001|Overall Study|Protocol Violation|0|||
126075252|NCT02172950|453570408|FG000|Overall Study|Lost to Follow-up|1|||
126075253|NCT02172950|453570409|FG001|Overall Study|Lost to Follow-up|0|||
126075254|NCT02172950|453570408|FG000|Overall Study|Death|1|||
126075255|NCT02172950|453570409|FG001|Overall Study|Death|0|||
126075256|NCT02172950|453570408|FG000|Overall Study|Patient traveling|1|||
126075257|NCT02172950|453570409|FG001|Overall Study|Patient traveling|0|||
126075258|NCT02172950|453570408|FG000|Overall Study|Patient went to other country|1|||
126075259|NCT02172950|453570409|FG001|Overall Study|Patient went to other country|0|||
126075260|NCT02172950|453570408|FG000|Overall Study|Patient relocated overseas|1|||
126075261|NCT02172950|453570409|FG001|Overall Study|Patient relocated overseas|1|||
126075262|NCT02172950|453570408|FG000|Overall Study|Patient moving|1|||
126075263|NCT02172950|453570409|FG001|Overall Study|Patient moving|0|||
126075264|NCT00496626|453570410|FG000|Overall Study|Lost to Follow-up|0|||
126075265|NCT00496626|453570411|FG001|Overall Study|Lost to Follow-up|1|||
126075266|NCT00496626|453570410|FG000|Overall Study|Protocol Violation|1|||
126075267|NCT00496626|453570411|FG001|Overall Study|Protocol Violation|0|||
126075268|NCT00496626|453570410|FG000|Overall Study|Withdrawal by Subject|5|||
126075269|NCT00496626|453570411|FG001|Overall Study|Withdrawal by Subject|4|||
126075270|NCT00496626|453570410|FG000|Overall Study|Relocated|0|||
126075271|NCT00496626|453570411|FG001|Overall Study|Relocated|1|||
126075272|NCT00611715|453570412|FG000|Overall Study|Disease Progression|24|||
126075273|NCT00611715|453570413|FG001|Overall Study|Disease Progression|4|||
126075274|NCT00611715|453570412|FG000|Overall Study|Withdrawal by Subject|5|||
126075275|NCT00611715|453570413|FG001|Overall Study|Withdrawal by Subject|1|||
126075276|NCT00611715|453570412|FG000|Overall Study|Adverse Event|9|||
126075277|NCT00611715|453570413|FG001|Overall Study|Adverse Event|1|||
126075278|NCT00611715|453570412|FG000|Overall Study|Death|1|||
126075279|NCT00611715|453570413|FG001|Overall Study|Death|0|||
126075280|NCT00611715|453570412|FG000|Overall Study|two patients are still on treatment|2|||
126075281|NCT00611715|453570413|FG001|Overall Study|two patients are still on treatment|0|||
126075282|NCT00107978|453570414|FG000|Overall Study|Adverse Event|1|||
126075283|NCT00107978|453570415|FG001|Overall Study|Adverse Event|5|||
126075284|NCT00107978|453570414|FG000|Overall Study|Death|3|||
126075285|NCT00107978|453570415|FG001|Overall Study|Death|3|||
126075286|NCT00107978|453570414|FG000|Overall Study|Lost to Follow-up|20|||
125947512|NCT01165138|453106851|FG000|Overall Study|Withdrawal by Subject|0|||
125947513|NCT01165138|453106852|FG001|Overall Study|Withdrawal by Subject|6|||
125947514|NCT01165138|453106853|FG002|Overall Study|Withdrawal by Subject|6|||
125947515|NCT01165138|453106854|FG003|Overall Study|Withdrawal by Subject|3|||
126075287|NCT00107978|453570415|FG001|Overall Study|Lost to Follow-up|28|||
126075288|NCT00107978|453570414|FG000|Overall Study|Withdrawal by Subject|4|||
126075289|NCT00107978|453570415|FG001|Overall Study|Withdrawal by Subject|9|||
126075290|NCT00107978|453570414|FG000|Overall Study|Protocol Violation|0|||
126075291|NCT00107978|453570415|FG001|Overall Study|Protocol Violation|1|||
126075292|NCT00107978|453570414|FG000|Overall Study|Other|5|||
126075293|NCT00107978|453570415|FG001|Overall Study|Other|4|||
125947516|NCT02641379|453106855|FG000|Overall Study|Exclusion criterion during screening|1|||
126075294|NCT00727415|453570416|FG000|Phase I|Dose Limiting Toxicity|2|||
126075295|NCT01664923|453570420|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
126075296|NCT01664923|453570421|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
126075297|NCT01664923|453570420|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
126075298|NCT01664923|453570421|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
126075299|NCT01664923|453570420|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
126075300|NCT01664923|453570421|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
126075301|NCT01664923|453570420|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
126075302|NCT01664923|453570421|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
126075303|NCT01664923|453570420|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
126075304|NCT01664923|453570421|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
126075305|NCT01664923|453570420|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
126075306|NCT01664923|453570421|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
126075307|NCT01664923|453570420|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
126075308|NCT01664923|453570421|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
126075309|NCT01664923|453570420|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
126075310|NCT01664923|453570421|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
126075311|NCT01664923|453570420|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
126075312|NCT01664923|453570421|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
126075313|NCT01664923|453570420|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
126075314|NCT01664923|453570421|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
126075315|NCT01664923|453570420|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
126075316|NCT01664923|453570421|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
126075317|NCT01664923|453570420|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
126075318|NCT01664923|453570421|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
126075319|NCT01664923|453570420|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
126075320|NCT01664923|453570421|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
126075321|NCT01664923|453570420|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
126075322|NCT01664923|453570421|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
126075323|NCT02427958|453570422|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
126075324|NCT02427958|453570422|FG000|Overall Study|Lost to Follow-up|6|||
126075325|NCT02427958|453570422|FG000|Overall Study|Withdrawal by Subject|14|||
126075326|NCT02427958|453570422|FG000|Overall Study|Lack of Efficacy|1|||
126075327|NCT03974100|453570423|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
126075328|NCT03974100|453570424|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
126075329|NCT03974100|453570425|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
126075330|NCT03974100|453570426|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
126075331|NCT03974100|453570427|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
126075332|NCT03974100|453570423|FG000|TP1 - Day 1 to Week 52|Death|1|||
126075333|NCT03974100|453570424|FG001|TP1 - Day 1 to Week 52|Death|0|||
126075334|NCT03974100|453570425|FG002|TP1 - Day 1 to Week 52|Death|0|||
126075335|NCT03974100|453570426|FG003|TP1 - Day 1 to Week 52|Death|0|||
126075336|NCT03974100|453570427|FG004|TP1 - Day 1 to Week 52|Death|0|||
126075337|NCT03974100|453570423|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
126075338|NCT03974100|453570424|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
126075339|NCT03974100|453570425|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
126075340|NCT03974100|453570426|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
126075341|NCT03974100|453570427|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
126075342|NCT03974100|453570423|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
126075343|NCT03974100|453570424|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
126075344|NCT03974100|453570425|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
126075345|NCT03974100|453570426|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
126075346|NCT03974100|453570427|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
126075347|NCT03974100|453570423|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
126075348|NCT03974100|453570424|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
126075349|NCT03974100|453570425|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
126075350|NCT03974100|453570426|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
126075351|NCT03974100|453570427|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
125947517|NCT02641379|453106856|FG001|Overall Study|Exclusion criterion during screening|0|||
125947518|NCT02641379|453106857|FG002|Overall Study|Exclusion criterion during screening|0|||
126075352|NCT03974100|453570423|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
126075353|NCT03974100|453570424|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
126075354|NCT03974100|453570425|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
126075355|NCT03974100|453570426|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
125947519|NCT02641379|453106858|FG003|Overall Study|Exclusion criterion during screening|1|||
126075356|NCT03974100|453570427|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
126075357|NCT03974100|453570423|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
126075358|NCT03974100|453570424|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
126075359|NCT03974100|453570425|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
126075360|NCT03974100|453570426|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
126075361|NCT03974100|453570427|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
126075362|NCT03410108|453570428|FG000|Overall Study|Ongoing|41|||
126075363|NCT03410108|453570428|FG000|Overall Study|Adverse Event|4|||
126075364|NCT03410108|453570428|FG000|Overall Study|Progressive Disease|58|||
126075365|NCT03410108|453570428|FG000|Overall Study|Withdrawal by Subject|1|||
126075366|NCT00545571|453570431|FG000|Overall Study|Administrative Reasons|1|||
126075367|NCT00545571|453570431|FG000|Overall Study|Adverse Event|2|||
126075368|NCT00545571|453570431|FG000|Overall Study|Death|5|||
126075369|NCT00545571|453570431|FG000|Overall Study|Lack of Efficacy|1|||
126075370|NCT00545571|453570431|FG000|Overall Study|Protocol Violation|2|||
126075371|NCT00545571|453570431|FG000|Overall Study|Refused Treatment|1|||
126075372|NCT00545571|453570431|FG000|Overall Study|Screen Failure|16|||
126075373|NCT00545571|453570431|FG000|Overall Study|Transfusion|12|||
126075374|NCT00545571|453570431|FG000|Overall Study|Early Termination of Study|24|||
126075375|NCT00545571|453570431|FG000|Overall Study|Kidney Transplantation|3|||
126075376|NCT03269695|453570432|FG000|Overall Study|Adverse Event|2|||
126075377|NCT03269695|453570433|FG001|Overall Study|Adverse Event|1|||
126075378|NCT03269695|453570432|FG000|Overall Study|Lack of Efficacy|0|||
126075379|NCT03269695|453570433|FG001|Overall Study|Lack of Efficacy|1|||
126075380|NCT03269695|453570432|FG000|Overall Study|Withdrawal by Subject|0|||
126075381|NCT03269695|453570433|FG001|Overall Study|Withdrawal by Subject|1|||
126075382|NCT01013740|453570434|FG000|Overall Study|Lost to Follow-up|3|||
126075383|NCT01013740|453570435|FG001|Overall Study|Lost to Follow-up|5|||
126075384|NCT01013740|453570434|FG000|Overall Study|Physician Decision|2|||
126075385|NCT01013740|453570435|FG001|Overall Study|Physician Decision|0|||
126075386|NCT01013740|453570434|FG000|Overall Study|Withdrawal by Subject|2|||
126075387|NCT01013740|453570435|FG001|Overall Study|Withdrawal by Subject|10|||
125947520|NCT02641379|453106859|FG004|Overall Study|Exclusion criterion during screening|2|||
125947521|NCT02641379|453106860|FG005|Overall Study|Exclusion criterion during screening|0|||
125947522|NCT02641379|453106861|FG006|Overall Study|Exclusion criterion during screening|0|||
125947523|NCT02641379|453106862|FG007|Overall Study|Exclusion criterion during screening|0|||
125947524|NCT02641379|453106863|FG008|Overall Study|Exclusion criterion during screening|0|||
125947525|NCT02641379|453106864|FG009|Overall Study|Exclusion criterion during screening|0|||
125947526|NCT02641379|453106865|FG010|Overall Study|Exclusion criterion during screening|0|||
125947527|NCT02641379|453106855|FG000|Overall Study|Withdrawal of informed consent|0|||
125947528|NCT02641379|453106856|FG001|Overall Study|Withdrawal of informed consent|1|||
125947529|NCT02641379|453106857|FG002|Overall Study|Withdrawal of informed consent|0|||
125947530|NCT02641379|453106858|FG003|Overall Study|Withdrawal of informed consent|0|||
125947531|NCT02641379|453106859|FG004|Overall Study|Withdrawal of informed consent|0|||
125947532|NCT02641379|453106860|FG005|Overall Study|Withdrawal of informed consent|0|||
125947533|NCT02641379|453106861|FG006|Overall Study|Withdrawal of informed consent|0|||
125947534|NCT02641379|453106862|FG007|Overall Study|Withdrawal of informed consent|1|||
125947535|NCT02641379|453106863|FG008|Overall Study|Withdrawal of informed consent|0|||
125947536|NCT02641379|453106864|FG009|Overall Study|Withdrawal of informed consent|0|||
125947537|NCT02641379|453106865|FG010|Overall Study|Withdrawal of informed consent|0|||
125947538|NCT02641379|453106855|FG000|Overall Study|Adverse Event|7|||
125947539|NCT02641379|453106856|FG001|Overall Study|Adverse Event|8|||
125947540|NCT02641379|453106857|FG002|Overall Study|Adverse Event|2|||
125947541|NCT02641379|453106858|FG003|Overall Study|Adverse Event|2|||
125947542|NCT02641379|453106859|FG004|Overall Study|Adverse Event|5|||
125947543|NCT02641379|453106860|FG005|Overall Study|Adverse Event|1|||
125947544|NCT02641379|453106861|FG006|Overall Study|Adverse Event|5|||
125947545|NCT02641379|453106862|FG007|Overall Study|Adverse Event|0|||
125947546|NCT02641379|453106863|FG008|Overall Study|Adverse Event|1|||
125947547|NCT02641379|453106864|FG009|Overall Study|Adverse Event|1|||
125947548|NCT02641379|453106865|FG010|Overall Study|Adverse Event|5|||
125947549|NCT02641379|453106855|FG000|Overall Study|Lack of Efficacy|0|||
125947550|NCT02641379|453106856|FG001|Overall Study|Lack of Efficacy|0|||
125947551|NCT02641379|453106857|FG002|Overall Study|Lack of Efficacy|2|||
125947552|NCT02641379|453106858|FG003|Overall Study|Lack of Efficacy|0|||
125947553|NCT02641379|453106859|FG004|Overall Study|Lack of Efficacy|0|||
125947554|NCT02641379|453106860|FG005|Overall Study|Lack of Efficacy|2|||
125947555|NCT02641379|453106861|FG006|Overall Study|Lack of Efficacy|0|||
125947556|NCT02641379|453106862|FG007|Overall Study|Lack of Efficacy|5|||
125947557|NCT02641379|453106863|FG008|Overall Study|Lack of Efficacy|0|||
125947558|NCT02641379|453106864|FG009|Overall Study|Lack of Efficacy|0|||
125947559|NCT02641379|453106865|FG010|Overall Study|Lack of Efficacy|0|||
125947560|NCT02641379|453106855|FG000|Overall Study|Participant unable to attend study visit|4|||
125947561|NCT02641379|453106856|FG001|Overall Study|Participant unable to attend study visit|10|||
125947562|NCT02641379|453106857|FG002|Overall Study|Participant unable to attend study visit|1|||
125947563|NCT02641379|453106858|FG003|Overall Study|Participant unable to attend study visit|2|||
126075388|NCT01013740|453570434|FG000|Overall Study|study close / terminated : done in error|2|||
126075389|NCT01013740|453570435|FG001|Overall Study|study close / terminated : done in error|1|||
126075390|NCT01013740|453570434|FG000|Overall Study|Missing|2|||
126075391|NCT01013740|453570435|FG001|Overall Study|Missing|1|||
126075392|NCT01013740|453570434|FG000|Overall Study|Ongoing: Study records not completed|0|||
126075393|NCT01013740|453570435|FG001|Overall Study|Ongoing: Study records not completed|2|||
126075394|NCT00338949|453570436|FG000|Subject Screening|Screen failures|11|||
126075395|NCT00338949|453570437|FG001|Subject Screening|Screen failures|11|||
126075396|NCT00338949|453570436|FG000|Randomization|Withdrawal by Subject|1|||
126075397|NCT00338949|453570437|FG001|Randomization|Withdrawal by Subject|0|||
126075398|NCT00338949|453570436|FG000|Randomization|Adverse Event|0|||
126075399|NCT00338949|453570437|FG001|Randomization|Adverse Event|5|||
126075400|NCT00025662|453570438|FG000|Overall Study|Withdrawal by Subject|2|||
126075401|NCT00025662|453570438|FG000|Overall Study|Technical failure of manipulation|1|||
126075402|NCT00582114|453570439|FG000|Overall Study|Death|4|||
126075403|NCT00582114|453570440|FG001|Overall Study|Death|4|||
126075404|NCT00582114|453570439|FG000|Overall Study|Kidney Transplant|3|||
126075405|NCT00582114|453570440|FG001|Overall Study|Kidney Transplant|1|||
126075406|NCT00582114|453570439|FG000|Overall Study|Lost to Follow-up|7|||
126075407|NCT00582114|453570440|FG001|Overall Study|Lost to Follow-up|6|||
126075408|NCT00582114|453570439|FG000|Overall Study|Withdrawal by Subject|8|||
126075409|NCT00582114|453570440|FG001|Overall Study|Withdrawal by Subject|16|||
126075410|NCT00582114|453570439|FG000|Overall Study|Adverse Event|1|||
126075411|NCT00582114|453570440|FG001|Overall Study|Adverse Event|1|||
126075412|NCT00582114|453570439|FG000|Overall Study|Physician Decision|0|||
126075413|NCT00582114|453570440|FG001|Overall Study|Physician Decision|6|||
126075414|NCT00582114|453570439|FG000|Overall Study|Stopped by data safety monitoring board|19|||
126075415|NCT00582114|453570440|FG001|Overall Study|Stopped by data safety monitoring board|20|||
126075416|NCT02604342|453570441|FG000|Overall Study|Death|32|||
126075417|NCT02604342|453570442|FG001|Overall Study|Death|16|||
126075418|NCT02604342|453570441|FG000|Overall Study|Progression of disease|1|||
126075419|NCT02604342|453570442|FG001|Overall Study|Progression of disease|0|||
126075420|NCT02604342|453570441|FG000|Overall Study|Withdrawal by Subject|5|||
126075421|NCT02604342|453570442|FG001|Overall Study|Withdrawal by Subject|6|||
126075422|NCT02604342|453570441|FG000|Overall Study|Other|1|||
126075423|NCT02604342|453570442|FG001|Overall Study|Other|0|||
126075424|NCT02604342|453570441|FG000|Overall Study|Study Termination by Sponsor|1|||
126075425|NCT02604342|453570442|FG001|Overall Study|Study Termination by Sponsor|0|||
126075426|NCT02604342|453570441|FG000|Overall Study|Lost to Follow-up|1|||
126075427|NCT02604342|453570442|FG001|Overall Study|Lost to Follow-up|1|||
126075428|NCT02604342|453570441|FG000|Overall Study|Physician Decision|2|||
126075429|NCT02604342|453570442|FG001|Overall Study|Physician Decision|0|||
126075430|NCT02024750|453570443|FG000|Overall Study|Withdrawal by Subject|2|||
126075431|NCT02024750|453570444|FG001|Overall Study|Withdrawal by Subject|1|||
126075432|NCT00130728|453570445|FG000|Overall Study|Death|258|||
126075433|NCT00130728|453570446|FG001|Overall Study|Death|258|||
126075434|NCT00130728|453570445|FG000|Overall Study|Lost to Follow-up|4|||
126075435|NCT00130728|453570446|FG001|Overall Study|Lost to Follow-up|0|||
126075436|NCT00130728|453570445|FG000|Overall Study|Withdrawal by Subject|0|||
126075437|NCT00130728|453570446|FG001|Overall Study|Withdrawal by Subject|2|||
126075438|NCT01349036|453570447|FG000|Overall Study|Disease progression|13|||
126075439|NCT01349036|453570448|FG001|Overall Study|Disease progression|22|||
126075440|NCT01349036|453570447|FG000|Overall Study|Other|1|||
126075441|NCT01349036|453570448|FG001|Overall Study|Other|0|||
126075442|NCT01349036|453570447|FG000|Overall Study|Withdrawal by Subject|0|||
126075443|NCT01349036|453570448|FG001|Overall Study|Withdrawal by Subject|2|||
126075444|NCT00746356|453570449|FG000|Overall Study|Withdrawal by Subject|2|||
126075445|NCT00746356|453570450|FG001|Overall Study|Withdrawal by Subject|3|||
126075446|NCT00746356|453570449|FG000|Overall Study|Death|7|||
126075447|NCT00746356|453570450|FG001|Overall Study|Death|3|||
126075448|NCT00746356|453570449|FG000|Overall Study|Lost to Follow-up|1|||
126075449|NCT00746356|453570450|FG001|Overall Study|Lost to Follow-up|0|||
126075450|NCT00746356|453570449|FG000|Overall Study|Removal of Device|0|||
126075451|NCT00746356|453570450|FG001|Overall Study|Removal of Device|1|||
126075452|NCT00746356|453570449|FG000|Overall Study|Patient relocated|1|||
126075453|NCT00746356|453570450|FG001|Overall Study|Patient relocated|0|||
126075454|NCT01125566|453570455|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
126075455|NCT01125566|453570456|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
126075456|NCT01125566|453570457|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
126075457|NCT01125566|453570455|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
126075458|NCT01125566|453570456|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
126075459|NCT01125566|453570457|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
126075460|NCT01125566|453570455|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
126075461|NCT01125566|453570456|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
126075462|NCT01125566|453570457|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
126075463|NCT01125566|453570455|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
126075464|NCT01125566|453570456|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
126075465|NCT01125566|453570457|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
126075466|NCT01125566|453570455|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
126075467|NCT01125566|453570456|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
126075468|NCT01125566|453570457|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
126075469|NCT01125566|453570455|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
126075470|NCT01125566|453570456|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
126075471|NCT01125566|453570457|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
126075472|NCT01125566|453570455|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
126075473|NCT01125566|453570456|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
126075474|NCT01125566|453570457|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
126075475|NCT01125566|453570455|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
126075476|NCT01125566|453570456|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
126075477|NCT01125566|453570457|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
126075478|NCT01125566|453570455|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
126075479|NCT01125566|453570456|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
126075480|NCT01125566|453570457|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
126075481|NCT01125566|453570455|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
126075482|NCT01125566|453570456|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
126075483|NCT01125566|453570457|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
126075484|NCT01125566|453570455|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
126075485|NCT01125566|453570456|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
126075486|NCT01125566|453570457|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
126075487|NCT01125566|453570455|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
126075488|NCT01125566|453570456|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
126075489|NCT01125566|453570457|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
126075490|NCT02881047|453570458|FG000|Overall Study|Adverse Event|1|||
126075491|NCT02881047|453570458|FG000|Overall Study|Withdrawal by Subject|1|||
126075492|NCT03028012|453570459|FG000|Overall Study|Lost to Follow-up|2|||
126075493|NCT03028012|453570460|FG001|Overall Study|Lost to Follow-up|3|||
126075494|NCT03028012|453570461|FG002|Overall Study|Lost to Follow-up|3|||
126075495|NCT02484547|453570470|FG000|Placebo-Controlled Period|Adverse Event|10|||
126075496|NCT02484547|453570471|FG001|Placebo-Controlled Period|Adverse Event|13|||
126075497|NCT02484547|453570472|FG002|Placebo-Controlled Period|Adverse Event|20|||
126075498|NCT02484547|453570473|FG003|Placebo-Controlled Period|Adverse Event|0|||
126075499|NCT02484547|453570474|FG004|Placebo-Controlled Period|Adverse Event|0|||
126075500|NCT02484547|453570475|FG005|Placebo-Controlled Period|Adverse Event|0|||
126075501|NCT02484547|453570476|FG006|Placebo-Controlled Period|Adverse Event|0|||
126075502|NCT02484547|453570470|FG000|Placebo-Controlled Period|Change of Treatment|0|||
126075503|NCT02484547|453570471|FG001|Placebo-Controlled Period|Change of Treatment|0|||
126075504|NCT02484547|453570472|FG002|Placebo-Controlled Period|Change of Treatment|1|||
126075505|NCT02484547|453570473|FG003|Placebo-Controlled Period|Change of Treatment|0|||
126075506|NCT02484547|453570474|FG004|Placebo-Controlled Period|Change of Treatment|0|||
126075507|NCT02484547|453570475|FG005|Placebo-Controlled Period|Change of Treatment|0|||
126075508|NCT02484547|453570476|FG006|Placebo-Controlled Period|Change of Treatment|0|||
126075509|NCT02484547|453570470|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
126075510|NCT02484547|453570471|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
126075511|NCT02484547|453570472|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
126075512|NCT02484547|453570473|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
126075513|NCT02484547|453570474|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
126075514|NCT02484547|453570475|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
126075515|NCT02484547|453570476|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
126075516|NCT02484547|453570470|FG000|Placebo-Controlled Period|Death|5|||
126075517|NCT02484547|453570471|FG001|Placebo-Controlled Period|Death|0|||
126075518|NCT02484547|453570472|FG002|Placebo-Controlled Period|Death|6|||
126075519|NCT02484547|453570473|FG003|Placebo-Controlled Period|Death|0|||
126075520|NCT02484547|453570474|FG004|Placebo-Controlled Period|Death|0|||
126075521|NCT02484547|453570475|FG005|Placebo-Controlled Period|Death|0|||
126075522|NCT02484547|453570476|FG006|Placebo-Controlled Period|Death|0|||
126075523|NCT02484547|453570470|FG000|Placebo-Controlled Period|Disease Progression|2|||
126075524|NCT02484547|453570471|FG001|Placebo-Controlled Period|Disease Progression|0|||
126075525|NCT02484547|453570472|FG002|Placebo-Controlled Period|Disease Progression|1|||
126075526|NCT02484547|453570473|FG003|Placebo-Controlled Period|Disease Progression|0|||
126075527|NCT02484547|453570474|FG004|Placebo-Controlled Period|Disease Progression|0|||
126075528|NCT02484547|453570475|FG005|Placebo-Controlled Period|Disease Progression|0|||
126075529|NCT02484547|453570476|FG006|Placebo-Controlled Period|Disease Progression|0|||
126075530|NCT02484547|453570470|FG000|Placebo-Controlled Period|Investigator Decision|2|||
126075531|NCT02484547|453570471|FG001|Placebo-Controlled Period|Investigator Decision|2|||
126075532|NCT02484547|453570472|FG002|Placebo-Controlled Period|Investigator Decision|5|||
126075533|NCT02484547|453570473|FG003|Placebo-Controlled Period|Investigator Decision|0|||
126114903|NCT01514136|453715814|FG007|Test Period 1; Test A|Break from study holiday|0|||
126075534|NCT02484547|453570474|FG004|Placebo-Controlled Period|Investigator Decision|0|||
126075535|NCT02484547|453570475|FG005|Placebo-Controlled Period|Investigator Decision|0|||
125947564|NCT02641379|453106859|FG004|Overall Study|Participant unable to attend study visit|5|||
125947565|NCT02641379|453106860|FG005|Overall Study|Participant unable to attend study visit|1|||
125947566|NCT02641379|453106861|FG006|Overall Study|Participant unable to attend study visit|1|||
125947567|NCT02641379|453106862|FG007|Overall Study|Participant unable to attend study visit|1|||
125947568|NCT02641379|453106863|FG008|Overall Study|Participant unable to attend study visit|0|||
125947569|NCT02641379|453106864|FG009|Overall Study|Participant unable to attend study visit|2|||
125947570|NCT02641379|453106865|FG010|Overall Study|Participant unable to attend study visit|0|||
125947571|NCT02641379|453106855|FG000|Overall Study|Participant's compliance|0|||
125947572|NCT02641379|453106856|FG001|Overall Study|Participant's compliance|1|||
125947573|NCT02641379|453106857|FG002|Overall Study|Participant's compliance|0|||
125947574|NCT02641379|453106858|FG003|Overall Study|Participant's compliance|1|||
126075536|NCT02484547|453570476|FG006|Placebo-Controlled Period|Investigator Decision|0|||
126075537|NCT02484547|453570470|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
126075538|NCT02484547|453570471|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
125947575|NCT02641379|453106859|FG004|Overall Study|Participant's compliance|0|||
125947576|NCT02641379|453106860|FG005|Overall Study|Participant's compliance|2|||
125947577|NCT02641379|453106861|FG006|Overall Study|Participant's compliance|0|||
125947578|NCT02641379|453106862|FG007|Overall Study|Participant's compliance|0|||
125947579|NCT02641379|453106863|FG008|Overall Study|Participant's compliance|1|||
125947580|NCT02641379|453106864|FG009|Overall Study|Participant's compliance|1|||
125947581|NCT02641379|453106865|FG010|Overall Study|Participant's compliance|1|||
125947582|NCT02641379|453106855|FG000|Overall Study|Participant cannot be reached|4|||
125947583|NCT02641379|453106856|FG001|Overall Study|Participant cannot be reached|4|||
125947584|NCT02641379|453106857|FG002|Overall Study|Participant cannot be reached|0|||
125947585|NCT02641379|453106858|FG003|Overall Study|Participant cannot be reached|8|||
125947586|NCT02641379|453106859|FG004|Overall Study|Participant cannot be reached|2|||
125947587|NCT02641379|453106860|FG005|Overall Study|Participant cannot be reached|1|||
125947588|NCT02641379|453106861|FG006|Overall Study|Participant cannot be reached|0|||
125947589|NCT02641379|453106862|FG007|Overall Study|Participant cannot be reached|1|||
125947590|NCT02641379|453106863|FG008|Overall Study|Participant cannot be reached|0|||
126075539|NCT02484547|453570472|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
126075540|NCT02484547|453570473|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
126075541|NCT02484547|453570474|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
126075542|NCT02484547|453570475|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
126075543|NCT02484547|453570476|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
126075544|NCT02484547|453570470|FG000|Placebo-Controlled Period|Relocation|1|||
126075545|NCT02484547|453570471|FG001|Placebo-Controlled Period|Relocation|1|||
126075546|NCT02484547|453570472|FG002|Placebo-Controlled Period|Relocation|1|||
126075547|NCT02484547|453570473|FG003|Placebo-Controlled Period|Relocation|0|||
126075548|NCT02484547|453570474|FG004|Placebo-Controlled Period|Relocation|0|||
126075549|NCT02484547|453570475|FG005|Placebo-Controlled Period|Relocation|0|||
126075550|NCT02484547|453570476|FG006|Placebo-Controlled Period|Relocation|0|||
126075551|NCT02484547|453570470|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
126075552|NCT02484547|453570471|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
126075553|NCT02484547|453570472|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
126075554|NCT02484547|453570473|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
126075555|NCT02484547|453570474|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
126075556|NCT02484547|453570475|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
126075557|NCT02484547|453570476|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
126075558|NCT02484547|453570470|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
126075559|NCT02484547|453570471|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
126075560|NCT02484547|453570472|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
126075561|NCT02484547|453570473|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126075562|NCT02484547|453570474|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126075563|NCT02484547|453570475|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126075564|NCT02484547|453570476|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126075565|NCT02484547|453570470|FG000|Placebo-Controlled Period|Reason not Specified|216|||
126075566|NCT02484547|453570471|FG001|Placebo-Controlled Period|Reason not Specified|194|||
126075567|NCT02484547|453570472|FG002|Placebo-Controlled Period|Reason not Specified|183|||
126075568|NCT02484547|453570473|FG003|Placebo-Controlled Period|Reason not Specified|0|||
126075569|NCT02484547|453570474|FG004|Placebo-Controlled Period|Reason not Specified|0|||
126075570|NCT02484547|453570475|FG005|Placebo-Controlled Period|Reason not Specified|0|||
126075571|NCT02484547|453570476|FG006|Placebo-Controlled Period|Reason not Specified|0|||
125947591|NCT02641379|453106864|FG009|Overall Study|Participant cannot be reached|2|||
125947592|NCT02641379|453106865|FG010|Overall Study|Participant cannot be reached|1|||
125947593|NCT02641379|453106855|FG000|Overall Study|PCR positive at Week 24|15|||
125947594|NCT02641379|453106856|FG001|Overall Study|PCR positive at Week 24|21|||
125947595|NCT02641379|453106857|FG002|Overall Study|PCR positive at Week 24|62|||
126075572|NCT02484547|453570470|FG000|Long-Term Extension Period|Adverse Event|0|||
126075573|NCT02484547|453570471|FG001|Long-Term Extension Period|Adverse Event|0|||
126075574|NCT02484547|453570472|FG002|Long-Term Extension Period|Adverse Event|0|||
126075575|NCT02484547|453570473|FG003|Long-Term Extension Period|Adverse Event|0|||
126075576|NCT02484547|453570474|FG004|Long-Term Extension Period|Adverse Event|1|||
126075577|NCT02484547|453570475|FG005|Long-Term Extension Period|Adverse Event|3|||
126075578|NCT02484547|453570476|FG006|Long-Term Extension Period|Adverse Event|2|||
126075579|NCT02484547|453570470|FG000|Long-Term Extension Period|Death|0|||
126075580|NCT02484547|453570471|FG001|Long-Term Extension Period|Death|0|||
126075581|NCT02484547|453570472|FG002|Long-Term Extension Period|Death|0|||
126075582|NCT02484547|453570473|FG003|Long-Term Extension Period|Death|0|||
126075583|NCT02484547|453570474|FG004|Long-Term Extension Period|Death|0|||
126075584|NCT02484547|453570475|FG005|Long-Term Extension Period|Death|3|||
126075585|NCT02484547|453570476|FG006|Long-Term Extension Period|Death|0|||
126075586|NCT02484547|453570470|FG000|Long-Term Extension Period|Disease Progression|0|||
126075587|NCT02484547|453570471|FG001|Long-Term Extension Period|Disease Progression|0|||
126075588|NCT02484547|453570472|FG002|Long-Term Extension Period|Disease Progression|0|||
126075589|NCT02484547|453570473|FG003|Long-Term Extension Period|Disease Progression|0|||
126075590|NCT02484547|453570474|FG004|Long-Term Extension Period|Disease Progression|2|||
126075591|NCT02484547|453570475|FG005|Long-Term Extension Period|Disease Progression|4|||
126075592|NCT02484547|453570476|FG006|Long-Term Extension Period|Disease Progression|0|||
126075593|NCT02484547|453570470|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
126075594|NCT02484547|453570471|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
126075595|NCT02484547|453570472|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
126075596|NCT02484547|453570473|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
126075597|NCT02484547|453570474|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
126075598|NCT02484547|453570475|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
126075599|NCT02484547|453570476|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
126075600|NCT02484547|453570470|FG000|Long-Term Extension Period|Loss of Capacity|0|||
126075601|NCT02484547|453570471|FG001|Long-Term Extension Period|Loss of Capacity|0|||
126075602|NCT02484547|453570472|FG002|Long-Term Extension Period|Loss of Capacity|0|||
126075603|NCT02484547|453570473|FG003|Long-Term Extension Period|Loss of Capacity|0|||
126075604|NCT02484547|453570474|FG004|Long-Term Extension Period|Loss of Capacity|1|||
126075605|NCT02484547|453570475|FG005|Long-Term Extension Period|Loss of Capacity|0|||
126075606|NCT02484547|453570476|FG006|Long-Term Extension Period|Loss of Capacity|0|||
126075607|NCT02484547|453570470|FG000|Long-Term Extension Period|Change of Treatment|0|||
126075608|NCT02484547|453570471|FG001|Long-Term Extension Period|Change of Treatment|0|||
126075609|NCT02484547|453570472|FG002|Long-Term Extension Period|Change of Treatment|0|||
126075610|NCT02484547|453570473|FG003|Long-Term Extension Period|Change of Treatment|0|||
126075611|NCT02484547|453570474|FG004|Long-Term Extension Period|Change of Treatment|0|||
126075612|NCT02484547|453570475|FG005|Long-Term Extension Period|Change of Treatment|0|||
126075613|NCT02484547|453570476|FG006|Long-Term Extension Period|Change of Treatment|1|||
126075614|NCT02484547|453570470|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
126075615|NCT02484547|453570471|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
126075616|NCT02484547|453570472|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
126075617|NCT02484547|453570473|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
126075618|NCT02484547|453570474|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
126075619|NCT02484547|453570475|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
126075620|NCT02484547|453570476|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
126075621|NCT02484547|453570470|FG000|Long-Term Extension Period|Investigator Decision|0|||
126075622|NCT02484547|453570471|FG001|Long-Term Extension Period|Investigator Decision|0|||
126075623|NCT02484547|453570472|FG002|Long-Term Extension Period|Investigator Decision|0|||
126075624|NCT02484547|453570473|FG003|Long-Term Extension Period|Investigator Decision|2|||
126075625|NCT02484547|453570474|FG004|Long-Term Extension Period|Investigator Decision|1|||
126075626|NCT02484547|453570475|FG005|Long-Term Extension Period|Investigator Decision|0|||
126075627|NCT02484547|453570476|FG006|Long-Term Extension Period|Investigator Decision|1|||
126075628|NCT02484547|453570470|FG000|Long-Term Extension Period|Relocation|0|||
126075629|NCT02484547|453570471|FG001|Long-Term Extension Period|Relocation|0|||
126075630|NCT02484547|453570472|FG002|Long-Term Extension Period|Relocation|0|||
126075631|NCT02484547|453570473|FG003|Long-Term Extension Period|Relocation|1|||
126075632|NCT02484547|453570474|FG004|Long-Term Extension Period|Relocation|1|||
126075633|NCT02484547|453570475|FG005|Long-Term Extension Period|Relocation|0|||
126075634|NCT02484547|453570476|FG006|Long-Term Extension Period|Relocation|0|||
126075635|NCT02484547|453570470|FG000|Long-Term Extension Period|Study Visit Burden|0|||
126075636|NCT02484547|453570471|FG001|Long-Term Extension Period|Study Visit Burden|0|||
126075637|NCT02484547|453570472|FG002|Long-Term Extension Period|Study Visit Burden|0|||
126075638|NCT02484547|453570473|FG003|Long-Term Extension Period|Study Visit Burden|2|||
126075639|NCT02484547|453570474|FG004|Long-Term Extension Period|Study Visit Burden|0|||
126075640|NCT02484547|453570475|FG005|Long-Term Extension Period|Study Visit Burden|0|||
126075641|NCT02484547|453570476|FG006|Long-Term Extension Period|Study Visit Burden|3|||
126075642|NCT02484547|453570470|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
126075643|NCT02484547|453570471|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
126075644|NCT02484547|453570472|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
126075645|NCT02484547|453570473|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
125947596|NCT02641379|453106858|FG003|Overall Study|PCR positive at Week 24|0|||
125947597|NCT02641379|453106859|FG004|Overall Study|PCR positive at Week 24|0|||
125947598|NCT02641379|453106860|FG005|Overall Study|PCR positive at Week 24|6|||
125947599|NCT02641379|453106861|FG006|Overall Study|PCR positive at Week 24|3|||
125947600|NCT02641379|453106862|FG007|Overall Study|PCR positive at Week 24|8|||
125947601|NCT02641379|453106863|FG008|Overall Study|PCR positive at Week 24|0|||
125947602|NCT02641379|453106864|FG009|Overall Study|PCR positive at Week 24|1|||
125947603|NCT02641379|453106865|FG010|Overall Study|PCR positive at Week 24|0|||
125947604|NCT02641379|453106855|FG000|Overall Study|PCR positive at follow up 2|1|||
125947605|NCT02641379|453106856|FG001|Overall Study|PCR positive at follow up 2|0|||
125947606|NCT02641379|453106857|FG002|Overall Study|PCR positive at follow up 2|0|||
125947607|NCT02641379|453106858|FG003|Overall Study|PCR positive at follow up 2|0|||
125947608|NCT02641379|453106859|FG004|Overall Study|PCR positive at follow up 2|0|||
125947609|NCT02641379|453106860|FG005|Overall Study|PCR positive at follow up 2|0|||
125947610|NCT02641379|453106861|FG006|Overall Study|PCR positive at follow up 2|0|||
125947611|NCT02641379|453106862|FG007|Overall Study|PCR positive at follow up 2|0|||
125947612|NCT02641379|453106863|FG008|Overall Study|PCR positive at follow up 2|0|||
125947613|NCT02641379|453106864|FG009|Overall Study|PCR positive at follow up 2|0|||
125947614|NCT02641379|453106865|FG010|Overall Study|PCR positive at follow up 2|0|||
125947615|NCT02641379|453106855|FG000|Overall Study|Participant showed relapse|1|||
125947616|NCT02641379|453106856|FG001|Overall Study|Participant showed relapse|0|||
125947617|NCT02641379|453106857|FG002|Overall Study|Participant showed relapse|0|||
125947618|NCT02641379|453106858|FG003|Overall Study|Participant showed relapse|0|||
125947619|NCT02641379|453106859|FG004|Overall Study|Participant showed relapse|0|||
125947620|NCT02641379|453106860|FG005|Overall Study|Participant showed relapse|0|||
125947621|NCT02641379|453106861|FG006|Overall Study|Participant showed relapse|1|||
125947622|NCT02641379|453106862|FG007|Overall Study|Participant showed relapse|0|||
125947623|NCT02641379|453106863|FG008|Overall Study|Participant showed relapse|0|||
125947624|NCT02641379|453106864|FG009|Overall Study|Participant showed relapse|0|||
125947625|NCT02641379|453106865|FG010|Overall Study|Participant showed relapse|0|||
125947626|NCT02641379|453106855|FG000|Overall Study|Participant stopped study/treatment|1|||
125947627|NCT02641379|453106856|FG001|Overall Study|Participant stopped study/treatment|3|||
125947628|NCT02641379|453106857|FG002|Overall Study|Participant stopped study/treatment|1|||
125947629|NCT02641379|453106858|FG003|Overall Study|Participant stopped study/treatment|0|||
125947630|NCT02641379|453106859|FG004|Overall Study|Participant stopped study/treatment|0|||
125947631|NCT02641379|453106860|FG005|Overall Study|Participant stopped study/treatment|1|||
125947632|NCT02641379|453106861|FG006|Overall Study|Participant stopped study/treatment|2|||
125947633|NCT02641379|453106862|FG007|Overall Study|Participant stopped study/treatment|0|||
125947634|NCT02641379|453106863|FG008|Overall Study|Participant stopped study/treatment|1|||
125947635|NCT02641379|453106864|FG009|Overall Study|Participant stopped study/treatment|0|||
125947636|NCT02641379|453106865|FG010|Overall Study|Participant stopped study/treatment|0|||
125947637|NCT02641379|453106855|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
125947638|NCT02641379|453106856|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
125947639|NCT02641379|453106857|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
125947640|NCT02641379|453106858|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
125947641|NCT02641379|453106859|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
125947642|NCT02641379|453106860|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
125947643|NCT02641379|453106861|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
125947644|NCT02641379|453106862|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
125947645|NCT02641379|453106863|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
125947646|NCT02641379|453106864|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
125947647|NCT02641379|453106865|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
125947648|NCT02641379|453106855|FG000|Overall Study|Financial problems|0|||
125947649|NCT02641379|453106856|FG001|Overall Study|Financial problems|1|||
125947650|NCT02641379|453106857|FG002|Overall Study|Financial problems|0|||
125947651|NCT02641379|453106858|FG003|Overall Study|Financial problems|0|||
125947652|NCT02641379|453106859|FG004|Overall Study|Financial problems|0|||
125947653|NCT02641379|453106860|FG005|Overall Study|Financial problems|0|||
125947654|NCT02641379|453106861|FG006|Overall Study|Financial problems|0|||
125947655|NCT02641379|453106862|FG007|Overall Study|Financial problems|0|||
125947656|NCT02641379|453106863|FG008|Overall Study|Financial problems|0|||
125947657|NCT02641379|453106864|FG009|Overall Study|Financial problems|0|||
125947658|NCT02641379|453106865|FG010|Overall Study|Financial problems|0|||
125947659|NCT02641379|453106855|FG000|Overall Study|PCR positive at Week 68|0|||
125947660|NCT02641379|453106856|FG001|Overall Study|PCR positive at Week 68|1|||
125947661|NCT02641379|453106857|FG002|Overall Study|PCR positive at Week 68|0|||
125947662|NCT02641379|453106858|FG003|Overall Study|PCR positive at Week 68|0|||
125947663|NCT02641379|453106859|FG004|Overall Study|PCR positive at Week 68|0|||
125947664|NCT02641379|453106860|FG005|Overall Study|PCR positive at Week 68|0|||
125947665|NCT02641379|453106861|FG006|Overall Study|PCR positive at Week 68|0|||
125947666|NCT02641379|453106862|FG007|Overall Study|PCR positive at Week 68|0|||
125947667|NCT02641379|453106863|FG008|Overall Study|PCR positive at Week 68|0|||
125947668|NCT02641379|453106864|FG009|Overall Study|PCR positive at Week 68|0|||
125947669|NCT02641379|453106865|FG010|Overall Study|PCR positive at Week 68|0|||
126075646|NCT02484547|453570474|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
126075647|NCT02484547|453570475|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
126075648|NCT02484547|453570476|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
126075649|NCT02484547|453570470|FG000|Long-Term Extension Period|Reason not Specified|0|||
126075650|NCT02484547|453570471|FG001|Long-Term Extension Period|Reason not Specified|0|||
126075651|NCT02484547|453570472|FG002|Long-Term Extension Period|Reason not Specified|0|||
126075652|NCT02484547|453570473|FG003|Long-Term Extension Period|Reason not Specified|119|||
126075653|NCT02484547|453570474|FG004|Long-Term Extension Period|Reason not Specified|117|||
126075654|NCT02484547|453570475|FG005|Long-Term Extension Period|Reason not Specified|223|||
126075655|NCT02484547|453570476|FG006|Long-Term Extension Period|Reason not Specified|231|||
126075656|NCT01813305|453570477|FG000|Overall Study|Withdrawal by Subject|12|||
126075657|NCT01813305|453570478|FG001|Overall Study|Withdrawal by Subject|5|||
126075658|NCT01813305|453570477|FG000|Overall Study|Safety Concern|4|||
126075659|NCT01813305|453570478|FG001|Overall Study|Safety Concern|0|||
126075660|NCT01813305|453570477|FG000|Overall Study|Ulcer became worse|4|||
126075661|NCT01813305|453570478|FG001|Overall Study|Ulcer became worse|0|||
126075662|NCT01813305|453570477|FG000|Overall Study|Physician Decision|4|||
126075663|NCT01813305|453570478|FG001|Overall Study|Physician Decision|0|||
126075664|NCT01813305|453570477|FG000|Overall Study|Lost to Follow-up|3|||
126075665|NCT01813305|453570478|FG001|Overall Study|Lost to Follow-up|1|||
126075666|NCT01813305|453570477|FG000|Overall Study|Protocol Violation|1|||
126075667|NCT01813305|453570478|FG001|Overall Study|Protocol Violation|0|||
126075668|NCT01813305|453570477|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
126075669|NCT01813305|453570478|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
126075670|NCT01665599|453570482|FG000|Overall Study|Adverse Event|1|||
126075671|NCT01665599|453570482|FG000|Overall Study|Consent Withdrawn|1|||
126075672|NCT01665599|453570482|FG000|Overall Study|Investigator/Sponsor decision|1|||
126075673|NCT01665599|453570482|FG000|Overall Study|Death|1|||
126075674|NCT01665599|453570482|FG000|Overall Study|Lost to Follow-up|2|||
126075675|NCT01665599|453570482|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
126075676|NCT01665599|453570482|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
126075677|NCT01705145|453570483|FG000|Part B|Adverse Event|1|||
126075678|NCT01503164|453570487|FG000|Overall Study|Withdrawal by Subject|2|||
126075679|NCT01503164|453570488|FG001|Overall Study|Withdrawal by Subject|1|||
126075680|NCT00934700|453570489|FG000|Overall Study|missing scan|5|||
126075681|NCT00934700|453570490|FG001|Overall Study|missing scan|9|||
126075682|NCT00934700|453570489|FG000|Overall Study|Death|8|||
126075683|NCT00934700|453570490|FG001|Overall Study|Death|3|||
126075684|NCT03151551|453570493|FG000|Open-Label Treatment Period|Adverse Event|0|||
126075685|NCT03151551|453570494|FG001|Open-Label Treatment Period|Adverse Event|2|||
126075686|NCT03151551|453570493|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
126075687|NCT03151551|453570494|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
126075688|NCT03151551|453570493|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
126075689|NCT03151551|453570494|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
126075690|NCT03151551|453570493|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
126075691|NCT03151551|453570494|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
126075692|NCT03151551|453570493|FG000|Open-Label Treatment Period|Physician Decision|3|||
126075693|NCT03151551|453570494|FG001|Open-Label Treatment Period|Physician Decision|0|||
126075694|NCT03151551|453570493|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
126075695|NCT03151551|453570494|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
126075696|NCT03151551|453570493|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
126075697|NCT03151551|453570494|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
126075698|NCT03151551|453570493|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
126075699|NCT03151551|453570494|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
126075700|NCT03151551|453570493|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
126075701|NCT03151551|453570494|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
126075702|NCT03151551|453570493|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
126075703|NCT03151551|453570494|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
126075704|NCT03282799|453570501|FG000|Overall Study|Pregnancy|1|||
126075705|NCT03282799|453570502|FG001|Overall Study|Pregnancy|0|||
126075706|NCT03282799|453570501|FG000|Overall Study|Physician Decision|1|||
126075707|NCT03282799|453570502|FG001|Overall Study|Physician Decision|0|||
126075708|NCT00143598|453570507|FG000|Overall Study|Lost to Follow-up|23|||
126075709|NCT00143598|453570508|FG001|Overall Study|Lost to Follow-up|21|||
126075710|NCT00143598|453570507|FG000|Overall Study|Withdrawal by Subject|33|||
126075711|NCT00143598|453570508|FG001|Overall Study|Withdrawal by Subject|37|||
125947670|NCT02641379|453106855|FG000|Overall Study|PCR positive at Week 48|0|||
125947671|NCT02641379|453106856|FG001|Overall Study|PCR positive at Week 48|1|||
126075712|NCT00143598|453570507|FG000|Overall Study|Death|36|||
126075713|NCT00143598|453570508|FG001|Overall Study|Death|36|||
126075714|NCT03900715|453570511|FG000|Overall Study|Protocol Deviation|1|||
126075715|NCT03900715|453570511|FG000|Overall Study|Lack of Efficacy|1|||
126075716|NCT03900715|453570511|FG000|Overall Study|Progressive Disease|6|||
126075717|NCT03900715|453570511|FG000|Overall Study|Adverse Event|2|||
126075718|NCT03900715|453570511|FG000|Overall Study|Other reasons|11|||
126075719|NCT01878383|453571977|FG000|Overall Study|Lost to Follow-up|0|||
126075720|NCT01878383|453571978|FG001|Overall Study|Lost to Follow-up|1499|||
126075721|NCT03464383|453571979|FG000|Overall Study|Lost to Follow-up|1|||
126075722|NCT03464383|453571980|FG001|Overall Study|Lost to Follow-up|0|||
126075723|NCT03464383|453571981|FG002|Overall Study|Lost to Follow-up|0|||
126075724|NCT03464383|453571979|FG000|Overall Study|Withdrawal by Subject|0|||
126075725|NCT03464383|453571980|FG001|Overall Study|Withdrawal by Subject|1|||
126075726|NCT03464383|453571981|FG002|Overall Study|Withdrawal by Subject|0|||
126075727|NCT00695136|453571986|FG000|Overall Study|Withdrawal by Subject|1|||
126075728|NCT00695136|453571986|FG000|Overall Study|unrelated adverse event|1|||
126075729|NCT01726049|453571988|FG000|Overall Study|Death|1|||
126075730|NCT01726049|453571989|FG001|Overall Study|Death|1|||
126075731|NCT01726049|453571988|FG000|Overall Study|Adverse Event|4|||
126075732|NCT01726049|453571989|FG001|Overall Study|Adverse Event|1|||
126075733|NCT01726049|453571988|FG000|Overall Study|refused second HC|0|||
125947672|NCT02641379|453106857|FG002|Overall Study|PCR positive at Week 48|0|||
125947673|NCT02641379|453106858|FG003|Overall Study|PCR positive at Week 48|0|||
125947674|NCT02641379|453106859|FG004|Overall Study|PCR positive at Week 48|0|||
125947675|NCT02641379|453106860|FG005|Overall Study|PCR positive at Week 48|0|||
125947676|NCT02641379|453106861|FG006|Overall Study|PCR positive at Week 48|0|||
125947677|NCT02641379|453106862|FG007|Overall Study|PCR positive at Week 48|0|||
125947678|NCT02641379|453106863|FG008|Overall Study|PCR positive at Week 48|0|||
125947679|NCT02641379|453106864|FG009|Overall Study|PCR positive at Week 48|0|||
125947680|NCT02641379|453106865|FG010|Overall Study|PCR positive at Week 48|0|||
125947681|NCT02641379|453106855|FG000|Overall Study|PCR not performed at Week 12|0|||
125947682|NCT02641379|453106856|FG001|Overall Study|PCR not performed at Week 12|0|||
125947683|NCT02641379|453106857|FG002|Overall Study|PCR not performed at Week 12|1|||
125947684|NCT02641379|453106858|FG003|Overall Study|PCR not performed at Week 12|0|||
125947685|NCT02641379|453106859|FG004|Overall Study|PCR not performed at Week 12|0|||
125947686|NCT02641379|453106860|FG005|Overall Study|PCR not performed at Week 12|0|||
125947687|NCT02641379|453106861|FG006|Overall Study|PCR not performed at Week 12|0|||
125947688|NCT02641379|453106862|FG007|Overall Study|PCR not performed at Week 12|0|||
125947689|NCT02641379|453106863|FG008|Overall Study|PCR not performed at Week 12|0|||
125947690|NCT02641379|453106864|FG009|Overall Study|PCR not performed at Week 12|0|||
125947691|NCT02641379|453106865|FG010|Overall Study|PCR not performed at Week 12|0|||
125947692|NCT02641379|453106855|FG000|Overall Study|No PCR at baseline|0|||
125947693|NCT02641379|453106856|FG001|Overall Study|No PCR at baseline|0|||
125947694|NCT02641379|453106857|FG002|Overall Study|No PCR at baseline|1|||
125947695|NCT02641379|453106858|FG003|Overall Study|No PCR at baseline|0|||
125947696|NCT02641379|453106859|FG004|Overall Study|No PCR at baseline|0|||
125947697|NCT02641379|453106860|FG005|Overall Study|No PCR at baseline|0|||
125947698|NCT02641379|453106861|FG006|Overall Study|No PCR at baseline|0|||
125947699|NCT02641379|453106862|FG007|Overall Study|No PCR at baseline|0|||
125947700|NCT02641379|453106863|FG008|Overall Study|No PCR at baseline|0|||
125947701|NCT02641379|453106864|FG009|Overall Study|No PCR at baseline|0|||
125947702|NCT02641379|453106865|FG010|Overall Study|No PCR at baseline|0|||
125947703|NCT02641379|453106855|FG000|Overall Study|PCR positive at Week 28|0|||
125947704|NCT02641379|453106856|FG001|Overall Study|PCR positive at Week 28|0|||
125947705|NCT02641379|453106857|FG002|Overall Study|PCR positive at Week 28|1|||
125947706|NCT02641379|453106858|FG003|Overall Study|PCR positive at Week 28|0|||
125947707|NCT02641379|453106859|FG004|Overall Study|PCR positive at Week 28|0|||
125947708|NCT02641379|453106860|FG005|Overall Study|PCR positive at Week 28|0|||
125947709|NCT02641379|453106861|FG006|Overall Study|PCR positive at Week 28|0|||
125947710|NCT02641379|453106862|FG007|Overall Study|PCR positive at Week 28|0|||
125947711|NCT02641379|453106863|FG008|Overall Study|PCR positive at Week 28|0|||
125947712|NCT02641379|453106864|FG009|Overall Study|PCR positive at Week 28|0|||
125947713|NCT02641379|453106865|FG010|Overall Study|PCR positive at Week 28|0|||
125947714|NCT02641379|453106855|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
125947715|NCT02641379|453106856|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
125947716|NCT02641379|453106857|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
125947717|NCT02641379|453106858|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
125947718|NCT02641379|453106859|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
125947719|NCT02641379|453106860|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
125947720|NCT02641379|453106861|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
125947721|NCT02641379|453106862|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
125947722|NCT02641379|453106863|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
125947723|NCT02641379|453106864|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
125947724|NCT02641379|453106865|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
126075734|NCT01726049|453571989|FG001|Overall Study|refused second HC|2|||
126075735|NCT02806505|453571991|FG000|Overall Study|Adverse event/intercurrent illness|1|||
126075736|NCT02806505|453571992|FG001|Overall Study|Adverse event/intercurrent illness|3|||
125947725|NCT02641379|453106855|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
125947726|NCT02641379|453106856|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
125947727|NCT02641379|453106857|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
126075737|NCT02806505|453571991|FG000|Overall Study|Death|4|||
126075738|NCT02806505|453571992|FG001|Overall Study|Death|0|||
126075739|NCT02806505|453571991|FG000|Overall Study|Did not cooperate/refused treatment|3|||
126075740|NCT02806505|453571992|FG001|Overall Study|Did not cooperate/refused treatment|3|||
126075741|NCT02806505|453571991|FG000|Overall Study|Failure to return|0|||
126075742|NCT02806505|453571992|FG001|Overall Study|Failure to return|1|||
126075743|NCT02806505|453571991|FG000|Overall Study|Insufficient therapeutic response|2|||
126075744|NCT02806505|453571992|FG001|Overall Study|Insufficient therapeutic response|4|||
126075745|NCT01722045|453571999|FG000|Overall Study|Adverse Event|8|||
126075746|NCT01722045|453571999|FG000|Overall Study|Death|3|||
126075747|NCT01722045|453571999|FG000|Overall Study|Withdrawal by Subject|8|||
126075748|NCT01722045|453571999|FG000|Overall Study|Lost to Follow-up|4|||
126075749|NCT01722045|453571999|FG000|Overall Study|Protocol Deviation|1|||
126075750|NCT01722045|453571999|FG000|Overall Study|Physician Decision|3|||
126075751|NCT01722045|453571999|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
126075752|NCT00263211|453572004|FG000|Overall Study|Death|1|||
126075753|NCT00263211|453572005|FG001|Overall Study|Death|0|||
126075754|NCT00263211|453572004|FG000|Overall Study|Withdrawal by Subject|3|||
126075755|NCT00263211|453572005|FG001|Overall Study|Withdrawal by Subject|0|||
126075756|NCT00263211|453572004|FG000|Overall Study|Protocol Violation|1|||
126075757|NCT00263211|453572005|FG001|Overall Study|Protocol Violation|0|||
126075758|NCT00263211|453572004|FG000|Overall Study|Disease Progression|0|||
126075759|NCT00263211|453572005|FG001|Overall Study|Disease Progression|1|||
126075760|NCT03834623|453572011|FG000|Overall Study|Progression|0|||
126075761|NCT03834623|453572012|FG001|Overall Study|Progression|1|||
126075762|NCT01755546|453572013|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
126075763|NCT01755546|453572013|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
126075764|NCT01755546|453572013|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
126075765|NCT01755546|453572013|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
126075766|NCT01755546|453572013|FG000|Titration Phase|Adverse Event|11|||
126075767|NCT01755546|453572013|FG000|Titration Phase|Lack of Efficacy|18|||
126075768|NCT01755546|453572013|FG000|Titration Phase|Protocol Violation|9|||
126075769|NCT01755546|453572013|FG000|Titration Phase|Lost to Follow-up|2|||
126075770|NCT01755546|453572013|FG000|Titration Phase|Other and Continuing|22|||
126075771|NCT01755546|453572013|FG000|Titration Phase|Withdrawal by Subject|8|||
126075772|NCT01755546|453572013|FG000|Long Term Treatment|Adverse Event|12|||
126075773|NCT01755546|453572013|FG000|Long Term Treatment|Lack of Efficacy|6|||
126075774|NCT01755546|453572013|FG000|Long Term Treatment|Protocol Violation|10|||
126075775|NCT01755546|453572013|FG000|Long Term Treatment|Withdrawal by Subject|35|||
126075776|NCT01755546|453572013|FG000|Long Term Treatment|Lost to Follow-up|17|||
126075777|NCT01755546|453572013|FG000|Long Term Treatment|other and ongoing|41|||
126075778|NCT04606199|453572014|FG000|Overall Study|Withdrawal by Subject|2|||
126075779|NCT04051242|453572021|FG000|Overall Study|Withdrawal by Subject|1|||
126075780|NCT04051242|453572021|FG000|Overall Study|Physician Decision|1|||
126075781|NCT03463577|453572024|FG000|Overall Study|Lost to Follow-up|238|||
126075782|NCT03463577|453572025|FG001|Overall Study|Lost to Follow-up|435|||
126075783|NCT03463577|453572026|FG002|Overall Study|Lost to Follow-up|0|||
126075784|NCT03463577|453572027|FG003|Overall Study|Lost to Follow-up|0|||
126075785|NCT03463577|453572028|FG004|Overall Study|Lost to Follow-up|0|||
126075786|NCT03463577|453572029|FG005|Overall Study|Lost to Follow-up|0|||
126075787|NCT03463577|453572024|FG000|Overall Study|With unknown pregnancy outcome|0|||
126075788|NCT03463577|453572025|FG001|Overall Study|With unknown pregnancy outcome|5|||
126075789|NCT03463577|453572026|FG002|Overall Study|With unknown pregnancy outcome|0|||
126075790|NCT03463577|453572027|FG003|Overall Study|With unknown pregnancy outcome|0|||
126075791|NCT03463577|453572028|FG004|Overall Study|With unknown pregnancy outcome|0|||
126075792|NCT03463577|453572029|FG005|Overall Study|With unknown pregnancy outcome|0|||
126075793|NCT03463577|453572024|FG000|Overall Study|Maternal death|2|||
126075794|NCT03463577|453572025|FG001|Overall Study|Maternal death|0|||
126075795|NCT03463577|453572026|FG002|Overall Study|Maternal death|0|||
126075796|NCT03463577|453572027|FG003|Overall Study|Maternal death|0|||
126075797|NCT03463577|453572028|FG004|Overall Study|Maternal death|0|||
126075798|NCT03463577|453572029|FG005|Overall Study|Maternal death|0|||
126075799|NCT03463577|453572024|FG000|Overall Study|Neonatal death|0|||
126075800|NCT03463577|453572025|FG001|Overall Study|Neonatal death|0|||
126075801|NCT03463577|453572026|FG002|Overall Study|Neonatal death|0|||
126075802|NCT03463577|453572027|FG003|Overall Study|Neonatal death|15|||
126075803|NCT03463577|453572028|FG004|Overall Study|Neonatal death|17|||
126075804|NCT03463577|453572029|FG005|Overall Study|Neonatal death|0|||
126075805|NCT00704171|453572031|FG000|Overall Study|Withdrawal by Subject|1|||
126075806|NCT00704171|453572032|FG001|Overall Study|Withdrawal by Subject|0|||
125947728|NCT02641379|453106858|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
126075807|NCT01874665|453572033|FG000|Overall Study|Adverse Event|6|||
126075808|NCT01874665|453572034|FG001|Overall Study|Adverse Event|2|||
126075809|NCT01874665|453572033|FG000|Overall Study|Withdrawal by Subject|4|||
126075810|NCT01874665|453572034|FG001|Overall Study|Withdrawal by Subject|1|||
126075811|NCT01874665|453572033|FG000|Overall Study|Physician Decision|3|||
126075812|NCT01874665|453572034|FG001|Overall Study|Physician Decision|0|||
126075813|NCT01874665|453572033|FG000|Overall Study|Clinical Progressive Disease|4|||
126075814|NCT01874665|453572034|FG001|Overall Study|Clinical Progressive Disease|3|||
126075815|NCT01874665|453572033|FG000|Overall Study|Study Terminated by Sponsor|0|||
126075816|NCT01874665|453572034|FG001|Overall Study|Study Terminated by Sponsor|2|||
126075817|NCT01874665|453572033|FG000|Overall Study|Documented Progressive Disease|11|||
126075818|NCT01874665|453572034|FG001|Overall Study|Documented Progressive Disease|7|||
126075819|NCT01874665|453572033|FG000|Overall Study|Other|2|||
126075820|NCT01874665|453572034|FG001|Overall Study|Other|0|||
126075821|NCT04962698|453572039|FG000|Motor Imagery|Technical difficulty|1|||
126075822|NCT04962698|453572040|FG001|Motor Imagery|Technical difficulty|0|||
126075823|NCT04962698|453572039|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
126075824|NCT04962698|453572040|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
126075825|NCT04962698|453572039|FG000|Kinesthetic MI|Technical difficulty|1|||
126075826|NCT04962698|453572040|FG001|Kinesthetic MI|Technical difficulty|0|||
126075827|NCT04962698|453572039|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
126075828|NCT04962698|453572040|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
126075829|NCT04962698|453572039|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
126075830|NCT04962698|453572040|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
126075831|NCT04962698|453572039|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
126075832|NCT04962698|453572040|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
126075833|NCT04962698|453572039|FG000|Virtual-hand Interaction|Technical difficulty|1|||
126075834|NCT04962698|453572040|FG001|Virtual-hand Interaction|Technical difficulty|0|||
126075835|NCT04962698|453572039|FG000|Robotic Action Observation|Technical difficulty|1|||
126075836|NCT04962698|453572040|FG001|Robotic Action Observation|Technical difficulty|0|||
126075837|NCT04962698|453572039|FG000|Rest|Technical difficulty|1|||
126075838|NCT04962698|453572040|FG001|Rest|Technical difficulty|0|||
126075839|NCT04962698|453572039|FG000|Rest|Exclusion criteria met after enrollment|0|||
126075840|NCT04962698|453572040|FG001|Rest|Exclusion criteria met after enrollment|2|||
126075841|NCT00853229|453572041|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
126075842|NCT00853229|453572042|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
126075843|NCT03201900|453572043|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
126075844|NCT03201900|453572043|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
126075845|NCT03201900|453572043|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
126075846|NCT03201900|453572043|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
126075847|NCT03201900|453572043|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
126075848|NCT03201900|453572043|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
126075849|NCT03201900|453572043|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
126075850|NCT03201900|453572043|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
126075851|NCT03201900|453572043|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
126075852|NCT03201900|453572043|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
126075853|NCT03201900|453572043|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
126075854|NCT03201900|453572043|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
126075855|NCT03201900|453572043|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
126075856|NCT00776659|453572065|FG000|Overall Study|Lost to Follow-up|15|||
126075857|NCT00776659|453572065|FG000|Overall Study|Withdrawal by Subject|10|||
126075858|NCT00776659|453572065|FG000|Overall Study|Study Terminated by Sponsor|1|||
126075859|NCT01233999|453572066|FG000|Overall Study|Withdrawal by Subject|1|||
126075860|NCT01233999|453572066|FG000|Overall Study|Lost to Follow-up|1|||
126075861|NCT00129649|453572073|FG000|Overall Study|Withdrawal by Subject|76|||
126075862|NCT00129649|453572074|FG001|Overall Study|Withdrawal by Subject|65|||
126075863|NCT02835092|453572078|FG000|Overall Study|Withdrawal by Subject|3|||
126075864|NCT02835092|453572079|FG001|Overall Study|Withdrawal by Subject|6|||
126075865|NCT02835092|453572080|FG002|Overall Study|Withdrawal by Subject|3|||
126075866|NCT02835092|453572078|FG000|Overall Study|Lost to Follow-up|0|||
126075867|NCT02835092|453572079|FG001|Overall Study|Lost to Follow-up|2|||
126075868|NCT02835092|453572080|FG002|Overall Study|Lost to Follow-up|0|||
126075869|NCT01321723|453572082|FG000|Overall Study|Adverse Event|3|||
126075870|NCT01321723|453572083|FG001|Overall Study|Adverse Event|5|||
126075871|NCT01321723|453572084|FG002|Overall Study|Adverse Event|2|||
126075872|NCT01321723|453572082|FG000|Overall Study|Withdrawal by Subject|2|||
126075873|NCT01321723|453572083|FG001|Overall Study|Withdrawal by Subject|0|||
126075874|NCT01321723|453572084|FG002|Overall Study|Withdrawal by Subject|2|||
126075875|NCT00025506|453572085|FG000|Overall Study|Ineligible: clerical error|1|||
126075876|NCT00025506|453572085|FG000|Overall Study|Ineligible: wrong cell type|5|||
126075877|NCT00025506|453572085|FG000|Overall Study|Ineligible: inadequate pathology|2|||
126075878|NCT00025506|453572085|FG000|Overall Study|Never Treated|2|||
126075879|NCT00713206|453572086|FG000|Overall Study|Lost to Follow-up|4|||
126075880|NCT00713206|453572087|FG001|Overall Study|Lost to Follow-up|4|||
126075881|NCT00713206|453572086|FG000|Overall Study|Death|1|||
126075882|NCT00713206|453572087|FG001|Overall Study|Death|0|||
126075883|NCT02561806|453572088|FG000|Induction Period|Adverse Event|0|||
126075884|NCT02561806|453572089|FG001|Induction Period|Adverse Event|2|||
126075885|NCT02561806|453572088|FG000|Induction Period|Lack of Efficacy|1|||
126075886|NCT02561806|453572089|FG001|Induction Period|Lack of Efficacy|0|||
126075887|NCT02561806|453572088|FG000|Induction Period|Withdrawal by Subject|0|||
126075888|NCT02561806|453572089|FG001|Induction Period|Withdrawal by Subject|2|||
126075889|NCT02561806|453572088|FG000|Induction Period|Site staff became unblinded|1|||
126075890|NCT02561806|453572089|FG001|Induction Period|Site staff became unblinded|0|||
126075891|NCT02561806|453572088|FG000|Induction Period|Randomized but not treated|0|||
126075892|NCT02561806|453572089|FG001|Induction Period|Randomized but not treated|1|||
126075893|NCT02561806|453572088|FG000|Maintenance Period|Adverse Event|2|||
126075894|NCT02561806|453572089|FG001|Maintenance Period|Adverse Event|1|||
126075895|NCT02561806|453572088|FG000|Maintenance Period|Lack of Efficacy|3|||
126075896|NCT02561806|453572089|FG001|Maintenance Period|Lack of Efficacy|1|||
126075897|NCT02561806|453572088|FG000|Maintenance Period|Lost to Follow-up|2|||
126075898|NCT02561806|453572089|FG001|Maintenance Period|Lost to Follow-up|2|||
126075899|NCT02561806|453572088|FG000|Maintenance Period|Protocol Violation|1|||
126075900|NCT02561806|453572089|FG001|Maintenance Period|Protocol Violation|0|||
126075901|NCT02561806|453572088|FG000|Maintenance Period|Withdrawal by Subject|5|||
126075902|NCT02561806|453572089|FG001|Maintenance Period|Withdrawal by Subject|3|||
126075903|NCT02561806|453572088|FG000|Maintenance Period|Site staff became unblinded|0|||
126075904|NCT02561806|453572089|FG001|Maintenance Period|Site staff became unblinded|1|||
126075905|NCT02561806|453572088|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
126075906|NCT02561806|453572089|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
126075907|NCT02561806|453572088|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
126075908|NCT02561806|453572089|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
126075909|NCT02547441|453572090|FG000|Double-Blind Study Period|Adverse Event|4|||
126075910|NCT02547441|453572091|FG001|Double-Blind Study Period|Adverse Event|9|||
126075911|NCT02547441|453572090|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
126075912|NCT02547441|453572091|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
126075913|NCT02547441|453572090|FG000|Double-Blind Study Period|Physician Decision|1|||
126075914|NCT02547441|453572091|FG001|Double-Blind Study Period|Physician Decision|0|||
126075915|NCT02547441|453572090|FG000|Double-Blind Study Period|Protocol Violation|1|||
126075916|NCT02547441|453572091|FG001|Double-Blind Study Period|Protocol Violation|2|||
126075917|NCT02547441|453572090|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
126075918|NCT02547441|453572091|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
126075919|NCT02547441|453572090|FG000|Double-Blind Study Period|Sponsor Decision|1|||
126075920|NCT02547441|453572091|FG001|Double-Blind Study Period|Sponsor Decision|0|||
126075921|NCT02547441|453572090|FG000|Open-Label Study Period|Adverse Event|10|||
126075922|NCT02547441|453572091|FG001|Open-Label Study Period|Adverse Event|11|||
126075923|NCT02547441|453572090|FG000|Open-Label Study Period|Lack of Efficacy|3|||
126075924|NCT02547441|453572091|FG001|Open-Label Study Period|Lack of Efficacy|2|||
126075925|NCT02547441|453572090|FG000|Open-Label Study Period|Lost to Follow-up|7|||
126075926|NCT02547441|453572091|FG001|Open-Label Study Period|Lost to Follow-up|8|||
126075927|NCT02547441|453572090|FG000|Open-Label Study Period|Physician Decision|1|||
126075928|NCT02547441|453572091|FG001|Open-Label Study Period|Physician Decision|0|||
126075929|NCT02547441|453572090|FG000|Open-Label Study Period|Protocol Violation|2|||
126075930|NCT02547441|453572091|FG001|Open-Label Study Period|Protocol Violation|0|||
126075931|NCT02547441|453572090|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
126075932|NCT02547441|453572091|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
125947729|NCT02641379|453106859|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
125947730|NCT02641379|453106860|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
126075933|NCT02547441|453572090|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
126075934|NCT02547441|453572091|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
126075935|NCT01322009|453572093|FG000|Overall Study|Death|0|||
126075936|NCT01322009|453572094|FG001|Overall Study|Death|1|||
126075937|NCT01322009|453572093|FG000|Overall Study|Adverse Event|0|||
126075938|NCT01322009|453572094|FG001|Overall Study|Adverse Event|1|||
126075939|NCT01322009|453572093|FG000|Overall Study|ng tube discontinued|0|||
126075940|NCT01322009|453572094|FG001|Overall Study|ng tube discontinued|1|||
126075941|NCT00905034|453572095|FG000|Overall Study|Withdrawal by Subject|1|||
126075942|NCT00394589|453572096|FG000|Overall Study|Adverse Event|2|||
126075943|NCT00394589|453572097|FG001|Overall Study|Adverse Event|1|||
126075944|NCT00394589|453572098|FG002|Overall Study|Adverse Event|2|||
126075945|NCT00394589|453572096|FG000|Overall Study|Lack of Efficacy|2|||
126075946|NCT00394589|453572097|FG001|Overall Study|Lack of Efficacy|2|||
126075947|NCT00394589|453572098|FG002|Overall Study|Lack of Efficacy|3|||
126075948|NCT00394589|453572096|FG000|Overall Study|Protocol Violation|4|||
126075949|NCT00394589|453572097|FG001|Overall Study|Protocol Violation|0|||
126075950|NCT00394589|453572098|FG002|Overall Study|Protocol Violation|2|||
126075951|NCT04081389|453572099|FG000|Overall Study|Withdrawal by Subject|0|||
126075952|NCT04081389|453572100|FG001|Overall Study|Withdrawal by Subject|0|||
126075953|NCT04081389|453572101|FG002|Overall Study|Withdrawal by Subject|1|||
126075954|NCT04081389|453572102|FG003|Overall Study|Withdrawal by Subject|0|||
126075955|NCT01710800|453572103|FG000|Overall Study|Withdrawal by Subject|21|||
126075956|NCT01710800|453572103|FG000|Overall Study|Protocol Violation|1|||
126075957|NCT00511797|453572107|FG000|Overall Study|Adverse Event|1|||
125947731|NCT02641379|453106861|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
125947732|NCT02641379|453106862|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
125947733|NCT02641379|453106863|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
125947734|NCT02641379|453106864|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
125947735|NCT02641379|453106865|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
125947736|NCT02641379|453106855|FG000|Overall Study|Baseline viral load unavailable|0|||
125947737|NCT02641379|453106856|FG001|Overall Study|Baseline viral load unavailable|0|||
125947738|NCT02641379|453106857|FG002|Overall Study|Baseline viral load unavailable|0|||
125947739|NCT02641379|453106858|FG003|Overall Study|Baseline viral load unavailable|1|||
125947740|NCT02641379|453106859|FG004|Overall Study|Baseline viral load unavailable|0|||
125947741|NCT02641379|453106860|FG005|Overall Study|Baseline viral load unavailable|0|||
125947742|NCT02641379|453106861|FG006|Overall Study|Baseline viral load unavailable|0|||
125947743|NCT02641379|453106862|FG007|Overall Study|Baseline viral load unavailable|0|||
125947744|NCT02641379|453106863|FG008|Overall Study|Baseline viral load unavailable|0|||
125947745|NCT02641379|453106864|FG009|Overall Study|Baseline viral load unavailable|0|||
125947746|NCT02641379|453106865|FG010|Overall Study|Baseline viral load unavailable|0|||
125947747|NCT02641379|453106855|FG000|Overall Study|Blood could not be drawn|0|||
125947748|NCT02641379|453106856|FG001|Overall Study|Blood could not be drawn|0|||
125947749|NCT02641379|453106857|FG002|Overall Study|Blood could not be drawn|0|||
125947750|NCT02641379|453106858|FG003|Overall Study|Blood could not be drawn|0|||
125947751|NCT02641379|453106859|FG004|Overall Study|Blood could not be drawn|1|||
125947752|NCT02641379|453106860|FG005|Overall Study|Blood could not be drawn|0|||
125947753|NCT02641379|453106861|FG006|Overall Study|Blood could not be drawn|0|||
125947754|NCT02641379|453106862|FG007|Overall Study|Blood could not be drawn|0|||
125947755|NCT02641379|453106863|FG008|Overall Study|Blood could not be drawn|0|||
125947756|NCT02641379|453106864|FG009|Overall Study|Blood could not be drawn|0|||
125947757|NCT02641379|453106865|FG010|Overall Study|Blood could not be drawn|0|||
125947758|NCT02641379|453106855|FG000|Overall Study|Protocol Violation|0|||
125947759|NCT02641379|453106856|FG001|Overall Study|Protocol Violation|0|||
125947760|NCT02641379|453106857|FG002|Overall Study|Protocol Violation|0|||
125947761|NCT02641379|453106858|FG003|Overall Study|Protocol Violation|0|||
125947762|NCT02641379|453106859|FG004|Overall Study|Protocol Violation|2|||
125947763|NCT02641379|453106860|FG005|Overall Study|Protocol Violation|0|||
125947764|NCT02641379|453106861|FG006|Overall Study|Protocol Violation|0|||
125947765|NCT02641379|453106862|FG007|Overall Study|Protocol Violation|0|||
125947766|NCT02641379|453106863|FG008|Overall Study|Protocol Violation|1|||
125947767|NCT02641379|453106864|FG009|Overall Study|Protocol Violation|0|||
125947768|NCT02641379|453106865|FG010|Overall Study|Protocol Violation|0|||
125947769|NCT02641379|453106855|FG000|Overall Study|Participation in sili rescue study|0|||
125947770|NCT02641379|453106856|FG001|Overall Study|Participation in sili rescue study|0|||
125947771|NCT02641379|453106857|FG002|Overall Study|Participation in sili rescue study|0|||
125947772|NCT02641379|453106858|FG003|Overall Study|Participation in sili rescue study|0|||
125947773|NCT02641379|453106859|FG004|Overall Study|Participation in sili rescue study|0|||
125947774|NCT02641379|453106860|FG005|Overall Study|Participation in sili rescue study|1|||
125947775|NCT02641379|453106861|FG006|Overall Study|Participation in sili rescue study|0|||
125947776|NCT02641379|453106862|FG007|Overall Study|Participation in sili rescue study|0|||
125947777|NCT02641379|453106863|FG008|Overall Study|Participation in sili rescue study|0|||
125947778|NCT02641379|453106864|FG009|Overall Study|Participation in sili rescue study|0|||
125947779|NCT02641379|453106865|FG010|Overall Study|Participation in sili rescue study|0|||
125947780|NCT02641379|453106855|FG000|Overall Study|Lost to Follow-up|0|||
125947781|NCT02641379|453106856|FG001|Overall Study|Lost to Follow-up|0|||
125947782|NCT02641379|453106857|FG002|Overall Study|Lost to Follow-up|0|||
125947783|NCT02641379|453106858|FG003|Overall Study|Lost to Follow-up|0|||
125947784|NCT02641379|453106859|FG004|Overall Study|Lost to Follow-up|0|||
125947785|NCT02641379|453106860|FG005|Overall Study|Lost to Follow-up|0|||
125947786|NCT02641379|453106861|FG006|Overall Study|Lost to Follow-up|0|||
125947787|NCT02641379|453106862|FG007|Overall Study|Lost to Follow-up|0|||
125947788|NCT02641379|453106863|FG008|Overall Study|Lost to Follow-up|1|||
125947789|NCT02641379|453106864|FG009|Overall Study|Lost to Follow-up|0|||
125947790|NCT02641379|453106865|FG010|Overall Study|Lost to Follow-up|0|||
125947791|NCT02641379|453106855|FG000|Overall Study|Source data not found|0|||
125947792|NCT02641379|453106856|FG001|Overall Study|Source data not found|0|||
125947793|NCT02641379|453106857|FG002|Overall Study|Source data not found|0|||
125947794|NCT02641379|453106858|FG003|Overall Study|Source data not found|0|||
125947795|NCT02641379|453106859|FG004|Overall Study|Source data not found|0|||
125947796|NCT02641379|453106860|FG005|Overall Study|Source data not found|1|||
125947797|NCT02641379|453106861|FG006|Overall Study|Source data not found|0|||
125947798|NCT02641379|453106862|FG007|Overall Study|Source data not found|0|||
125947799|NCT02641379|453106863|FG008|Overall Study|Source data not found|0|||
125947800|NCT02641379|453106864|FG009|Overall Study|Source data not found|0|||
125947801|NCT02641379|453106865|FG010|Overall Study|Source data not found|0|||
125947802|NCT02641379|453106855|FG000|Overall Study|Participant showed weight reduction|0|||
125947803|NCT02641379|453106856|FG001|Overall Study|Participant showed weight reduction|0|||
125947804|NCT02641379|453106857|FG002|Overall Study|Participant showed weight reduction|0|||
126075958|NCT00511797|453572108|FG001|Overall Study|Adverse Event|2|||
126075959|NCT00511797|453572109|FG002|Overall Study|Adverse Event|2|||
126075960|NCT00511797|453572110|FG003|Overall Study|Adverse Event|2|||
126075961|NCT00511797|453572107|FG000|Overall Study|Lost to Follow-up|1|||
126075962|NCT00511797|453572108|FG001|Overall Study|Lost to Follow-up|0|||
126075963|NCT00511797|453572109|FG002|Overall Study|Lost to Follow-up|0|||
126075964|NCT00511797|453572110|FG003|Overall Study|Lost to Follow-up|1|||
126075965|NCT00511797|453572107|FG000|Overall Study|Pregnancy|0|||
126075966|NCT00511797|453572108|FG001|Overall Study|Pregnancy|0|||
126075967|NCT00511797|453572109|FG002|Overall Study|Pregnancy|0|||
126075968|NCT00511797|453572110|FG003|Overall Study|Pregnancy|1|||
126075969|NCT00511797|453572107|FG000|Overall Study|Protocol Violation|0|||
126075970|NCT00511797|453572108|FG001|Overall Study|Protocol Violation|2|||
126075971|NCT00511797|453572109|FG002|Overall Study|Protocol Violation|2|||
126075972|NCT00511797|453572110|FG003|Overall Study|Protocol Violation|3|||
126075973|NCT00511797|453572107|FG000|Overall Study|Withdrawal by Subject|3|||
126075974|NCT00511797|453572108|FG001|Overall Study|Withdrawal by Subject|3|||
126075975|NCT00511797|453572109|FG002|Overall Study|Withdrawal by Subject|4|||
126075976|NCT00511797|453572110|FG003|Overall Study|Withdrawal by Subject|2|||
126075977|NCT00511797|453572107|FG000|Overall Study|Never dispensed|1|||
126075978|NCT00511797|453572108|FG001|Overall Study|Never dispensed|0|||
126075979|NCT00511797|453572109|FG002|Overall Study|Never dispensed|1|||
126075980|NCT00511797|453572110|FG003|Overall Study|Never dispensed|3|||
126075981|NCT00511797|453572107|FG000|Overall Study|Study drug not taken|0|||
126075982|NCT00511797|453572108|FG001|Overall Study|Study drug not taken|1|||
126075983|NCT00511797|453572109|FG002|Overall Study|Study drug not taken|0|||
126075984|NCT00511797|453572110|FG003|Overall Study|Study drug not taken|1|||
126075985|NCT00511797|453572107|FG000|Overall Study|Partially missing diary|0|||
126075986|NCT00511797|453572108|FG001|Overall Study|Partially missing diary|0|||
126075987|NCT00511797|453572109|FG002|Overall Study|Partially missing diary|1|||
126075988|NCT00511797|453572110|FG003|Overall Study|Partially missing diary|0|||
126075989|NCT00511797|453572107|FG000|Overall Study|Other (moving etc)|1|||
126075990|NCT00511797|453572108|FG001|Overall Study|Other (moving etc)|0|||
126075991|NCT00511797|453572109|FG002|Overall Study|Other (moving etc)|1|||
126075992|NCT00511797|453572110|FG003|Overall Study|Other (moving etc)|2|||
126075993|NCT02019641|453572111|FG000|10-Week Follow up|Withdrawal by investigator|2|||
126075994|NCT02019641|453572112|FG001|10-Week Follow up|Withdrawal by investigator|0|||
126075995|NCT02019641|453572113|FG002|10-Week Follow up|Withdrawal by investigator|0|||
126075996|NCT02019641|453572111|FG000|10-Week Follow up|Withdrawal by Subject|1|||
126075997|NCT02019641|453572112|FG001|10-Week Follow up|Withdrawal by Subject|1|||
126075998|NCT02019641|453572113|FG002|10-Week Follow up|Withdrawal by Subject|0|||
126075999|NCT02019641|453572111|FG000|20-Week Follow up|Withdrawal by investigator|0|||
126076000|NCT02019641|453572112|FG001|20-Week Follow up|Withdrawal by investigator|0|||
126076001|NCT02019641|453572113|FG002|20-Week Follow up|Withdrawal by investigator|1|||
126076002|NCT01560871|453572116|FG000|Overall Study|transportation issues|2|||
126076003|NCT01560871|453572117|FG001|Overall Study|transportation issues|1|||
126076004|NCT01560871|453572116|FG000|Overall Study|relocation|1|||
126076005|NCT01560871|453572117|FG001|Overall Study|relocation|0|||
126076006|NCT01560871|453572116|FG000|Overall Study|readmission to a hospital|2|||
126076007|NCT01560871|453572117|FG001|Overall Study|readmission to a hospital|1|||
126076008|NCT01560871|453572116|FG000|Overall Study|Lost to Follow-up|1|||
126076009|NCT01560871|453572117|FG001|Overall Study|Lost to Follow-up|0|||
126076010|NCT00591591|453572120|FG000|Overall Study|Withdrawal by Subject|1|||
126076011|NCT00591591|453572121|FG001|Overall Study|Withdrawal by Subject|37|||
126076012|NCT00591591|453572120|FG000|Overall Study|Lack of Efficacy|10|||
126076013|NCT00591591|453572121|FG001|Overall Study|Lack of Efficacy|2|||
126076014|NCT00461123|453572125|FG000|Overall Study|Adverse Event|1|||
126076015|NCT00461123|453572126|FG001|Overall Study|Adverse Event|0|||
126076016|NCT00461123|453572125|FG000|Overall Study|Lost to Follow-up|1|||
126076017|NCT00461123|453572126|FG001|Overall Study|Lost to Follow-up|1|||
126076018|NCT00461123|453572125|FG000|Overall Study|Protocol Violation|3|||
126076019|NCT00461123|453572126|FG001|Overall Study|Protocol Violation|2|||
126076020|NCT00461123|453572125|FG000|Overall Study|Withdrawal by Subject|1|||
126076021|NCT00461123|453572126|FG001|Overall Study|Withdrawal by Subject|3|||
126076022|NCT03605368|453572127|FG000|Overall Study|Lost to Follow-up|2|||
126076023|NCT03605368|453572128|FG001|Overall Study|Lost to Follow-up|1|||
126076024|NCT03605368|453572129|FG002|Overall Study|Lost to Follow-up|3|||
126076025|NCT03605368|453572130|FG003|Overall Study|Lost to Follow-up|2|||
126076026|NCT03605368|453572127|FG000|Overall Study|Withdrawal by Subject|0|||
126076027|NCT03605368|453572128|FG001|Overall Study|Withdrawal by Subject|0|||
126076028|NCT03605368|453572129|FG002|Overall Study|Withdrawal by Subject|4|||
126076029|NCT03605368|453572130|FG003|Overall Study|Withdrawal by Subject|3|||
126076030|NCT01837797|453572133|FG000|Period 1|Adverse Event|9|||
126076031|NCT01837797|453572134|FG001|Period 1|Adverse Event|0|||
126076032|NCT01837797|453572135|FG002|Period 1|Adverse Event|0|||
126076033|NCT01837797|453572136|FG003|Period 1|Adverse Event|0|||
126076034|NCT01837797|453572137|FG004|Period 1|Adverse Event|0|||
126076035|NCT01837797|453572133|FG000|Period 1|Withdrawal by Subject|6|||
126076036|NCT01837797|453572134|FG001|Period 1|Withdrawal by Subject|0|||
126076037|NCT01837797|453572135|FG002|Period 1|Withdrawal by Subject|0|||
126076038|NCT01837797|453572136|FG003|Period 1|Withdrawal by Subject|0|||
126076039|NCT01837797|453572137|FG004|Period 1|Withdrawal by Subject|0|||
126076040|NCT01837797|453572133|FG000|Period 1|Administrative reasons|76|||
126076041|NCT01837797|453572134|FG001|Period 1|Administrative reasons|0|||
126076042|NCT01837797|453572135|FG002|Period 1|Administrative reasons|0|||
126076043|NCT01837797|453572136|FG003|Period 1|Administrative reasons|0|||
126076044|NCT01837797|453572137|FG004|Period 1|Administrative reasons|0|||
126076045|NCT01837797|453572133|FG000|Period 1|Withdrawal of consent before treatment|1|||
126076046|NCT01837797|453572134|FG001|Period 1|Withdrawal of consent before treatment|0|||
126076047|NCT01837797|453572135|FG002|Period 1|Withdrawal of consent before treatment|0|||
126076048|NCT01837797|453572136|FG003|Period 1|Withdrawal of consent before treatment|0|||
126076049|NCT01837797|453572137|FG004|Period 1|Withdrawal of consent before treatment|0|||
126076050|NCT01837797|453572133|FG000|Period 1|Other|10|||
126076051|NCT01837797|453572134|FG001|Period 1|Other|0|||
126076052|NCT01837797|453572135|FG002|Period 1|Other|0|||
126076053|NCT01837797|453572136|FG003|Period 1|Other|0|||
126076054|NCT01837797|453572137|FG004|Period 1|Other|0|||
126076055|NCT01837797|453572133|FG000|Period 2|Administrative or other reasons|0|||
126076056|NCT01837797|453572134|FG001|Period 2|Administrative or other reasons|5|||
126076057|NCT01837797|453572135|FG002|Period 2|Administrative or other reasons|2|||
126076058|NCT01837797|453572136|FG003|Period 2|Administrative or other reasons|4|||
126076059|NCT01837797|453572137|FG004|Period 2|Administrative or other reasons|0|||
126076060|NCT01837797|453572133|FG000|Period 2|Adverse Event|0|||
126076061|NCT01837797|453572134|FG001|Period 2|Adverse Event|0|||
126076062|NCT01837797|453572135|FG002|Period 2|Adverse Event|0|||
126076063|NCT01837797|453572136|FG003|Period 2|Adverse Event|1|||
126076064|NCT01837797|453572137|FG004|Period 2|Adverse Event|0|||
126076065|NCT01837797|453572133|FG000|Period 3|Adverse Event|0|||
126076066|NCT01837797|453572134|FG001|Period 3|Adverse Event|0|||
126076067|NCT01837797|453572135|FG002|Period 3|Adverse Event|0|||
126076068|NCT01837797|453572136|FG003|Period 3|Adverse Event|0|||
126076069|NCT01837797|453572137|FG004|Period 3|Adverse Event|1|||
126076070|NCT01837797|453572133|FG000|Period 3|Administrative reasons|0|||
126076071|NCT01837797|453572134|FG001|Period 3|Administrative reasons|0|||
126076072|NCT01837797|453572135|FG002|Period 3|Administrative reasons|0|||
126076073|NCT01837797|453572136|FG003|Period 3|Administrative reasons|0|||
126076074|NCT01837797|453572137|FG004|Period 3|Administrative reasons|20|||
126076075|NCT01837797|453572133|FG000|Period 3|Other|0|||
126076076|NCT01837797|453572134|FG001|Period 3|Other|0|||
126076077|NCT01837797|453572135|FG002|Period 3|Other|0|||
126076078|NCT01837797|453572136|FG003|Period 3|Other|0|||
126076079|NCT01837797|453572137|FG004|Period 3|Other|2|||
126076080|NCT04088136|453572143|FG000|Overall Study|Withdrawal by Subject|5|||
126076081|NCT04088136|453572144|FG001|Overall Study|Withdrawal by Subject|0|||
126076082|NCT04088136|453572143|FG000|Overall Study|Lack of Efficacy|0|||
126076083|NCT04088136|453572144|FG001|Overall Study|Lack of Efficacy|1|||
126076084|NCT00514813|453572145|FG000|Overall Study|Study terminated|14|||
126076085|NCT00514813|453572146|FG001|Overall Study|Study terminated|74|||
126076086|NCT00514813|453572147|FG002|Overall Study|Study terminated|40|||
126076087|NCT00514813|453572148|FG003|Overall Study|Study terminated|2|||
126076088|NCT00514813|453572145|FG000|Overall Study|Adverse Event|0|||
126076089|NCT00514813|453572146|FG001|Overall Study|Adverse Event|2|||
126076090|NCT00514813|453572147|FG002|Overall Study|Adverse Event|2|||
126076091|NCT00514813|453572148|FG003|Overall Study|Adverse Event|0|||
126076092|NCT00514813|453572145|FG000|Overall Study|Protocol Violation|1|||
126076093|NCT00514813|453572146|FG001|Overall Study|Protocol Violation|0|||
126076094|NCT00514813|453572147|FG002|Overall Study|Protocol Violation|0|||
126076095|NCT00514813|453572148|FG003|Overall Study|Protocol Violation|0|||
126076096|NCT00514813|453572145|FG000|Overall Study|Withdrawal by Subject|0|||
126076097|NCT00514813|453572146|FG001|Overall Study|Withdrawal by Subject|1|||
126076098|NCT00514813|453572147|FG002|Overall Study|Withdrawal by Subject|0|||
126076099|NCT00514813|453572148|FG003|Overall Study|Withdrawal by Subject|0|||
126076100|NCT00514813|453572145|FG000|Overall Study|Lack of Efficacy|0|||
126076101|NCT00514813|453572146|FG001|Overall Study|Lack of Efficacy|1|||
126076102|NCT00514813|453572147|FG002|Overall Study|Lack of Efficacy|0|||
126076103|NCT00514813|453572148|FG003|Overall Study|Lack of Efficacy|0|||
126076104|NCT00514813|453572145|FG000|Overall Study|Kidney transplant|0|||
126076105|NCT00514813|453572146|FG001|Overall Study|Kidney transplant|6|||
126076106|NCT00514813|453572147|FG002|Overall Study|Kidney transplant|2|||
126076107|NCT00514813|453572148|FG003|Overall Study|Kidney transplant|0|||
126076108|NCT00514813|453572145|FG000|Overall Study|Death|0|||
126076109|NCT00514813|453572146|FG001|Overall Study|Death|2|||
126076110|NCT00514813|453572147|FG002|Overall Study|Death|3|||
126076111|NCT00514813|453572148|FG003|Overall Study|Death|2|||
126076112|NCT02979613|453572149|FG000|Double-Blind Phase|Withdrew Consent|2|||
126076113|NCT02979613|453572150|FG001|Double-Blind Phase|Withdrew Consent|4|||
126076114|NCT02979613|453572149|FG000|Double-Blind Phase|Pregnancy|2|||
126076115|NCT02979613|453572150|FG001|Double-Blind Phase|Pregnancy|2|||
126076116|NCT02979613|453572149|FG000|Double-Blind Phase|Adverse Event|2|||
126076117|NCT02979613|453572150|FG001|Double-Blind Phase|Adverse Event|0|||
126076118|NCT02979613|453572149|FG000|Double-Blind Phase|Lost to Follow-up|1|||
126076119|NCT02979613|453572150|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125947805|NCT02641379|453106858|FG003|Overall Study|Participant showed weight reduction|0|||
125947806|NCT02641379|453106859|FG004|Overall Study|Participant showed weight reduction|0|||
125947807|NCT02641379|453106860|FG005|Overall Study|Participant showed weight reduction|0|||
125947808|NCT02641379|453106861|FG006|Overall Study|Participant showed weight reduction|0|||
125947809|NCT02641379|453106862|FG007|Overall Study|Participant showed weight reduction|1|||
125947810|NCT02641379|453106863|FG008|Overall Study|Participant showed weight reduction|0|||
125947811|NCT02641379|453106864|FG009|Overall Study|Participant showed weight reduction|0|||
125947812|NCT02641379|453106865|FG010|Overall Study|Participant showed weight reduction|0|||
125947813|NCT02641379|453106855|FG000|Overall Study|Non-response Week 12|0|||
125947814|NCT02641379|453106856|FG001|Overall Study|Non-response Week 12|0|||
125947815|NCT02641379|453106857|FG002|Overall Study|Non-response Week 12|0|||
125947816|NCT02641379|453106858|FG003|Overall Study|Non-response Week 12|0|||
125947817|NCT02641379|453106859|FG004|Overall Study|Non-response Week 12|0|||
125947818|NCT02641379|453106860|FG005|Overall Study|Non-response Week 12|0|||
125947819|NCT02641379|453106861|FG006|Overall Study|Non-response Week 12|0|||
125947820|NCT02641379|453106862|FG007|Overall Study|Non-response Week 12|1|||
125947821|NCT02641379|453106863|FG008|Overall Study|Non-response Week 12|0|||
125947822|NCT02641379|453106864|FG009|Overall Study|Non-response Week 12|0|||
125947823|NCT02641379|453106865|FG010|Overall Study|Non-response Week 12|0|||
125947824|NCT02641379|453106855|FG000|Overall Study|No 2 Log drop at Week 12|0|||
125947825|NCT02641379|453106856|FG001|Overall Study|No 2 Log drop at Week 12|0|||
125947826|NCT02641379|453106857|FG002|Overall Study|No 2 Log drop at Week 12|0|||
125947827|NCT02641379|453106858|FG003|Overall Study|No 2 Log drop at Week 12|0|||
126114904|NCT01514136|453715807|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
126114905|NCT01514136|453715808|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
126114906|NCT01514136|453715809|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
126114907|NCT01514136|453715810|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
126114908|NCT01514136|453715811|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
126076120|NCT02979613|453572149|FG000|Double-Blind Phase|Protocol Violation|1|||
126076121|NCT02979613|453572150|FG001|Double-Blind Phase|Protocol Violation|1|||
126076122|NCT02979613|453572149|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
126076123|NCT02979613|453572150|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
126076124|NCT02979613|453572149|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
126076125|NCT02979613|453572150|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
126076126|NCT02979613|453572149|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
126076127|NCT02979613|453572150|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
126076128|NCT02979613|453572149|FG000|Open-Label Extension (OLE) Phase|Death|0|||
126076129|NCT02979613|453572150|FG001|Open-Label Extension (OLE) Phase|Death|1|||
126076130|NCT02979613|453572149|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
126076131|NCT02979613|453572150|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
126076132|NCT01075100|453572151|FG000|Overall Study|Adverse Event|15|||
126076133|NCT01075100|453572152|FG001|Overall Study|Adverse Event|18|||
126076134|NCT01075100|453572151|FG000|Overall Study|Patient Request|4|||
126076135|NCT01075100|453572152|FG001|Overall Study|Patient Request|4|||
126076136|NCT01075100|453572151|FG000|Overall Study|Investigator Request|2|||
126076137|NCT01075100|453572152|FG001|Overall Study|Investigator Request|1|||
126076138|NCT01075100|453572151|FG000|Overall Study|Disease Progression|25|||
126076139|NCT01075100|453572152|FG001|Overall Study|Disease Progression|29|||
126076140|NCT01075100|453572151|FG000|Overall Study|Other|3|||
126076141|NCT01075100|453572152|FG001|Overall Study|Other|1|||
126076142|NCT02250183|453572153|FG000|Overall Study|Withdrawal by Subject|2|||
126076143|NCT02250183|453572153|FG000|Overall Study|Adverse Event|5|||
126114909|NCT01514136|453715812|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
126114910|NCT01514136|453715813|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
125947828|NCT02641379|453106859|FG004|Overall Study|No 2 Log drop at Week 12|0|||
125947829|NCT02641379|453106860|FG005|Overall Study|No 2 Log drop at Week 12|0|||
125947830|NCT02641379|453106861|FG006|Overall Study|No 2 Log drop at Week 12|0|||
125947831|NCT02641379|453106862|FG007|Overall Study|No 2 Log drop at Week 12|0|||
126076144|NCT02250183|453572153|FG000|Overall Study|Lost to Follow-up|1|||
126076145|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
126076146|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
126076147|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
126076148|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
126076149|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
126076150|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
126114911|NCT01514136|453715814|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
125947832|NCT02641379|453106863|FG008|Overall Study|No 2 Log drop at Week 12|0|||
125947833|NCT02641379|453106864|FG009|Overall Study|No 2 Log drop at Week 12|0|||
125947834|NCT02641379|453106865|FG010|Overall Study|No 2 Log drop at Week 12|1|||
126076151|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
126076152|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
126076153|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
126076154|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
126076155|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
126076156|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
126076157|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
126076158|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
126076159|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
126076160|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
126076161|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
126076162|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
126076163|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
125947835|NCT02641379|453106855|FG000|Overall Study|Negative PCR result|0|||
125947836|NCT02641379|453106856|FG001|Overall Study|Negative PCR result|0|||
126076164|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
126076165|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
126076166|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
126076167|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
126076168|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
126076169|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
126076170|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
126076171|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
126076172|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
126076173|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
125947837|NCT02641379|453106857|FG002|Overall Study|Negative PCR result|0|||
125947838|NCT02641379|453106858|FG003|Overall Study|Negative PCR result|0|||
125947839|NCT02641379|453106859|FG004|Overall Study|Negative PCR result|0|||
125947840|NCT02641379|453106860|FG005|Overall Study|Negative PCR result|0|||
125947841|NCT02641379|453106861|FG006|Overall Study|Negative PCR result|0|||
125947842|NCT02641379|453106862|FG007|Overall Study|Negative PCR result|0|||
125947843|NCT02641379|453106863|FG008|Overall Study|Negative PCR result|0|||
125947844|NCT02641379|453106864|FG009|Overall Study|Negative PCR result|1|||
125947845|NCT02641379|453106865|FG010|Overall Study|Negative PCR result|0|||
125947846|NCT02641379|453106855|FG000|Overall Study|Participant's PCR high|0|||
125947847|NCT02641379|453106856|FG001|Overall Study|Participant's PCR high|0|||
125947848|NCT02641379|453106857|FG002|Overall Study|Participant's PCR high|0|||
125947849|NCT02641379|453106858|FG003|Overall Study|Participant's PCR high|0|||
125947850|NCT02641379|453106859|FG004|Overall Study|Participant's PCR high|0|||
125947851|NCT02641379|453106860|FG005|Overall Study|Participant's PCR high|0|||
125947852|NCT02641379|453106861|FG006|Overall Study|Participant's PCR high|0|||
125947853|NCT02641379|453106862|FG007|Overall Study|Participant's PCR high|1|||
125947854|NCT02641379|453106863|FG008|Overall Study|Participant's PCR high|0|||
125947855|NCT02641379|453106864|FG009|Overall Study|Participant's PCR high|0|||
125947856|NCT02641379|453106865|FG010|Overall Study|Participant's PCR high|0|||
125947857|NCT02641379|453106855|FG000|Overall Study|Participant treated after Week 24|0|||
125947858|NCT02641379|453106856|FG001|Overall Study|Participant treated after Week 24|0|||
125947859|NCT02641379|453106857|FG002|Overall Study|Participant treated after Week 24|0|||
125947860|NCT02641379|453106858|FG003|Overall Study|Participant treated after Week 24|0|||
125947861|NCT02641379|453106859|FG004|Overall Study|Participant treated after Week 24|0|||
125947862|NCT02641379|453106860|FG005|Overall Study|Participant treated after Week 24|0|||
125947863|NCT02641379|453106861|FG006|Overall Study|Participant treated after Week 24|0|||
125947864|NCT02641379|453106862|FG007|Overall Study|Participant treated after Week 24|0|||
125947865|NCT02641379|453106863|FG008|Overall Study|Participant treated after Week 24|1|||
125947866|NCT02641379|453106864|FG009|Overall Study|Participant treated after Week 24|0|||
125947867|NCT02641379|453106865|FG010|Overall Study|Participant treated after Week 24|0|||
125947868|NCT02641379|453106855|FG000|Overall Study|Missing PCR result at Week 8|0|||
125947869|NCT02641379|453106856|FG001|Overall Study|Missing PCR result at Week 8|0|||
125947870|NCT02641379|453106857|FG002|Overall Study|Missing PCR result at Week 8|0|||
125947871|NCT02641379|453106858|FG003|Overall Study|Missing PCR result at Week 8|0|||
125947872|NCT02641379|453106859|FG004|Overall Study|Missing PCR result at Week 8|0|||
125947873|NCT02641379|453106860|FG005|Overall Study|Missing PCR result at Week 8|0|||
125947874|NCT02641379|453106861|FG006|Overall Study|Missing PCR result at Week 8|0|||
125947875|NCT02641379|453106862|FG007|Overall Study|Missing PCR result at Week 8|0|||
125947876|NCT02641379|453106863|FG008|Overall Study|Missing PCR result at Week 8|0|||
125947877|NCT02641379|453106864|FG009|Overall Study|Missing PCR result at Week 8|1|||
125947878|NCT02641379|453106865|FG010|Overall Study|Missing PCR result at Week 8|0|||
125947879|NCT02641379|453106855|FG000|Overall Study|PCR positive|0|||
125947880|NCT02641379|453106856|FG001|Overall Study|PCR positive|0|||
126076174|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
126076175|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
126076176|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
126076177|NCT00092521|453573878|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
126076178|NCT00092521|453573879|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
126076179|NCT00092521|453573880|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
126076180|NCT00092521|453573881|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
126076181|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
126076182|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
126076183|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
126076184|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
126076185|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
126076186|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
126076187|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
126076188|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
126076189|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
126076190|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
126076191|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
126076192|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
126076193|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Death|2|||
126076194|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Death|0|||
126076195|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Death|1|||
126076196|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Death|0|||
126076197|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
126076198|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
126076199|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
126076200|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
126076201|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
126076202|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
126076203|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
126076204|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
126076205|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
126076206|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
126076207|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
126076208|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
126076209|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Moved|32|||
126076210|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Moved|2|||
126076211|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Moved|28|||
126076212|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Moved|0|||
126076213|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
126076214|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
126076215|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
126076216|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
126076217|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Travel|2|||
126076218|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Travel|0|||
126076219|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Travel|0|||
126076220|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Travel|0|||
126076221|NCT00092521|453573878|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
126076222|NCT00092521|453573879|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
126076223|NCT00092521|453573880|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
126076224|NCT00092521|453573881|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
126076225|NCT00092521|453573878|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
126076226|NCT00092521|453573879|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
126076227|NCT00092521|453573880|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
126076228|NCT00092521|453573881|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
126076229|NCT00092521|453573878|FG000|Extension Study (Group 4)|Adverse Event|0|||
126076230|NCT00092521|453573879|FG001|Extension Study (Group 4)|Adverse Event|0|||
126076231|NCT00092521|453573880|FG002|Extension Study (Group 4)|Adverse Event|0|||
126076232|NCT00092521|453573881|FG003|Extension Study (Group 4)|Adverse Event|2|||
126076233|NCT00092521|453573878|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
126076234|NCT00092521|453573879|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
126076235|NCT00092521|453573880|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
126076236|NCT00092521|453573881|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
126076237|NCT00092521|453573878|FG000|Extension Study (Group 4)|Pregnancy|0|||
126076238|NCT00092521|453573879|FG001|Extension Study (Group 4)|Pregnancy|0|||
126076239|NCT00092521|453573880|FG002|Extension Study (Group 4)|Pregnancy|0|||
126076240|NCT00092521|453573881|FG003|Extension Study (Group 4)|Pregnancy|4|||
126076241|NCT00092521|453573878|FG000|Extension Study (Group 4)|Protocol Violation|0|||
126076242|NCT00092521|453573879|FG001|Extension Study (Group 4)|Protocol Violation|0|||
126076243|NCT00092521|453573880|FG002|Extension Study (Group 4)|Protocol Violation|0|||
126076244|NCT00092521|453573881|FG003|Extension Study (Group 4)|Protocol Violation|2|||
126076245|NCT00092521|453573878|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
126076246|NCT00092521|453573879|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
125947881|NCT02641379|453106857|FG002|Overall Study|PCR positive|0|||
125947882|NCT02641379|453106858|FG003|Overall Study|PCR positive|0|||
126076247|NCT00092521|453573880|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
126076248|NCT00092521|453573881|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
126076249|NCT00092521|453573878|FG000|Extension Study (Group 4)|Moved|0|||
126076250|NCT00092521|453573879|FG001|Extension Study (Group 4)|Moved|0|||
126076251|NCT00092521|453573880|FG002|Extension Study (Group 4)|Moved|0|||
126076252|NCT00092521|453573881|FG003|Extension Study (Group 4)|Moved|16|||
126076253|NCT00092521|453573878|FG000|Extension Study (Group 4)|Site Terminated|0|||
126076254|NCT00092521|453573879|FG001|Extension Study (Group 4)|Site Terminated|0|||
126076255|NCT00092521|453573880|FG002|Extension Study (Group 4)|Site Terminated|0|||
126076256|NCT00092521|453573881|FG003|Extension Study (Group 4)|Site Terminated|4|||
126076257|NCT00092521|453573878|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
126076258|NCT00092521|453573879|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
126076259|NCT00092521|453573880|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
126076260|NCT00092521|453573881|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
126076261|NCT03475056|453573882|FG000|Overall Study|Lost to Follow-up|0|||
126076262|NCT03475056|453573883|FG001|Overall Study|Lost to Follow-up|1|||
126076263|NCT03475056|453573882|FG000|Overall Study|Moved from Area|0|||
126076264|NCT03475056|453573883|FG001|Overall Study|Moved from Area|2|||
126076265|NCT01932762|453573884|FG000|Overall Study|Withdrawal by Subject|1|||
126076266|NCT01932762|453573885|FG001|Overall Study|Withdrawal by Subject|2|||
126076267|NCT01932762|453573886|FG002|Overall Study|Withdrawal by Subject|0|||
126076268|NCT01932762|453573887|FG003|Overall Study|Withdrawal by Subject|0|||
126076269|NCT01932762|453573884|FG000|Overall Study|Lost to Follow-up|4|||
126076270|NCT01932762|453573885|FG001|Overall Study|Lost to Follow-up|0|||
126076271|NCT01932762|453573886|FG002|Overall Study|Lost to Follow-up|0|||
126076272|NCT01932762|453573887|FG003|Overall Study|Lost to Follow-up|1|||
126076273|NCT01932762|453573884|FG000|Overall Study|Physician Decision|1|||
126076274|NCT01932762|453573885|FG001|Overall Study|Physician Decision|0|||
126076275|NCT01932762|453573886|FG002|Overall Study|Physician Decision|0|||
126076276|NCT01932762|453573887|FG003|Overall Study|Physician Decision|0|||
126076277|NCT01101334|453573891|FG000|Overall Study|Adverse Event|9|||
126076278|NCT01101334|453573892|FG001|Overall Study|Adverse Event|4|||
126076279|NCT01101334|453573891|FG000|Overall Study|Death|7|||
126076280|NCT01101334|453573892|FG001|Overall Study|Death|1|||
126076281|NCT01101334|453573891|FG000|Overall Study|Withdrawal by Subject|4|||
126076282|NCT01101334|453573892|FG001|Overall Study|Withdrawal by Subject|3|||
126076283|NCT01101334|453573891|FG000|Overall Study|Withdrawal by Sponsor|1|||
126076284|NCT01101334|453573892|FG001|Overall Study|Withdrawal by Sponsor|1|||
126076285|NCT01101334|453573891|FG000|Overall Study|Progressive Disease|22|||
126076286|NCT01101334|453573892|FG001|Overall Study|Progressive Disease|35|||
126076287|NCT01101334|453573891|FG000|Overall Study|Other|2|||
126076288|NCT01101334|453573892|FG001|Overall Study|Other|1|||
126076289|NCT03864341|453573895|FG000|Overall Study|Withdrawal by Subject|1|||
126076290|NCT02826798|453573897|FG000|Overall Study|Withdrawal by Subject|0|||
126076291|NCT02826798|453573898|FG001|Overall Study|Withdrawal by Subject|1|||
126076292|NCT02826798|453573899|FG002|Overall Study|Withdrawal by Subject|0|||
126076293|NCT02826798|453573900|FG003|Overall Study|Withdrawal by Subject|1|||
126076294|NCT02826798|453573901|FG004|Overall Study|Withdrawal by Subject|0|||
126076295|NCT02161406|453573904|FG000|Overall Study|Death|2|||
126076296|NCT02161406|453573905|FG001|Overall Study|Death|1|||
126076297|NCT02161406|453573904|FG000|Overall Study|Lost to Follow-up|2|||
126076298|NCT02161406|453573905|FG001|Overall Study|Lost to Follow-up|1|||
126076299|NCT02161406|453573904|FG000|Overall Study|Withdrawal by Subject|2|||
126076300|NCT02161406|453573905|FG001|Overall Study|Withdrawal by Subject|4|||
126076301|NCT02161406|453573904|FG000|Overall Study|investigator withdrew subject|3|||
126076302|NCT02161406|453573905|FG001|Overall Study|investigator withdrew subject|1|||
126076303|NCT02161406|453573904|FG000|Overall Study|Lack of Efficacy|1|||
126076304|NCT02161406|453573905|FG001|Overall Study|Lack of Efficacy|1|||
126076305|NCT02161406|453573904|FG000|Overall Study|relocation|0|||
126076306|NCT02161406|453573905|FG001|Overall Study|relocation|1|||
126076307|NCT00760513|453573906|FG000|Overall Study|Withdrawal by Subject|5|||
126076308|NCT00760513|453573907|FG001|Overall Study|Withdrawal by Subject|7|||
126076309|NCT03458728|453573909|FG000|Overall Study|Adverse Event|1|||
126076310|NCT03458728|453573910|FG001|Overall Study|Adverse Event|0|||
126076311|NCT03458728|453573909|FG000|Overall Study|Physician Decision|1|||
126076312|NCT03458728|453573910|FG001|Overall Study|Physician Decision|0|||
126076313|NCT03458728|453573909|FG000|Overall Study|Progressive disease - clinical assessment|1|||
126076314|NCT03458728|453573910|FG001|Overall Study|Progressive disease - clinical assessment|0|||
126076315|NCT03458728|453573909|FG000|Overall Study|Progressive disease - radiological progression|21|||
126076316|NCT03458728|453573910|FG001|Overall Study|Progressive disease - radiological progression|6|||
126076317|NCT03458728|453573909|FG000|Overall Study|Withdrawal by Subject|0|||
126076318|NCT03458728|453573910|FG001|Overall Study|Withdrawal by Subject|1|||
126076319|NCT00908349|453573911|FG000|Overall Study|Adverse Event|10|||
126076320|NCT00908349|453573911|FG000|Overall Study|Withdrawal by Subject|9|||
126076321|NCT00908349|453573911|FG000|Overall Study|Physician Decision|5|||
126076322|NCT00908349|453573911|FG000|Overall Study|Lost to Follow-up|5|||
126076323|NCT00908349|453573911|FG000|Overall Study|Various|6|||
126076324|NCT00362375|453573912|FG000|Overall Study|Lost to Follow-up|40|||
126076325|NCT00362375|453573913|FG001|Overall Study|Lost to Follow-up|35|||
126076326|NCT01951378|453573914|FG000|Overall Study|Study Terminated-Not completed|23|||
126076327|NCT01951378|453573915|FG001|Overall Study|Study Terminated-Not completed|17|||
126076328|NCT02624869|453573916|FG000|Overall Study|Lost to Follow-up|0|||
126076329|NCT02624869|453573917|FG001|Overall Study|Lost to Follow-up|0|||
126076330|NCT02624869|453573918|FG002|Overall Study|Lost to Follow-up|1|||
126076331|NCT02624869|453573916|FG000|Overall Study|Withdrawal by Subject|1|||
126076332|NCT02624869|453573917|FG001|Overall Study|Withdrawal by Subject|3|||
126076333|NCT02624869|453573918|FG002|Overall Study|Withdrawal by Subject|1|||
126076334|NCT01660256|453573920|FG000|Overall Study|Adverse Event|4|||
126076335|NCT01660256|453573921|FG001|Overall Study|Adverse Event|0|||
126076336|NCT01660256|453573922|FG002|Overall Study|Adverse Event|2|||
126076337|NCT01660256|453573920|FG000|Overall Study|Withdrawal by Subject|1|||
126076338|NCT01660256|453573921|FG001|Overall Study|Withdrawal by Subject|0|||
126076339|NCT01660256|453573922|FG002|Overall Study|Withdrawal by Subject|2|||
126076340|NCT03491215|453573923|FG000|Overall Study|Death|6|||
126076341|NCT03491215|453573924|FG001|Overall Study|Death|2|||
126076342|NCT03491215|453573925|FG002|Overall Study|Death|1|||
126076343|NCT03491215|453573926|FG003|Overall Study|Death|0|||
126076344|NCT03491215|453573923|FG000|Overall Study|Physician Decision|1|||
126076345|NCT03491215|453573924|FG001|Overall Study|Physician Decision|0|||
126076346|NCT03491215|453573925|FG002|Overall Study|Physician Decision|0|||
126076347|NCT03491215|453573926|FG003|Overall Study|Physician Decision|0|||
126076348|NCT00551135|453573932|FG000|Overall Study|Adverse Event|1|||
126076349|NCT00551135|453573933|FG001|Overall Study|Adverse Event|0|||
126076350|NCT00551135|453573934|FG002|Overall Study|Adverse Event|1|||
126076351|NCT00551135|453573935|FG003|Overall Study|Adverse Event|1|||
126076352|NCT00551135|453573932|FG000|Overall Study|Lost to Follow-up|0|||
126076353|NCT00551135|453573933|FG001|Overall Study|Lost to Follow-up|0|||
126076354|NCT00551135|453573934|FG002|Overall Study|Lost to Follow-up|0|||
126076355|NCT00551135|453573935|FG003|Overall Study|Lost to Follow-up|1|||
126076356|NCT00551135|453573932|FG000|Overall Study|Other|3|||
126076357|NCT00551135|453573933|FG001|Overall Study|Other|2|||
126076358|NCT00551135|453573934|FG002|Overall Study|Other|1|||
126076359|NCT00551135|453573935|FG003|Overall Study|Other|2|||
126076360|NCT00551135|453573932|FG000|Overall Study|Withdrawal by Subject|1|||
126076361|NCT00551135|453573933|FG001|Overall Study|Withdrawal by Subject|0|||
126076362|NCT00551135|453573934|FG002|Overall Study|Withdrawal by Subject|3|||
126076363|NCT00551135|453573935|FG003|Overall Study|Withdrawal by Subject|1|||
126076364|NCT01202409|453573936|FG000|Overall Study|Adverse Event|1|||
126076365|NCT01202409|453573936|FG000|Overall Study|Ineligible - KRAS mutants|7|||
126076366|NCT00858247|453573937|FG000|Baseline Assessment|Withdrawal by Subject|1|||
126076367|NCT00858247|453573938|FG001|Baseline Assessment|Withdrawal by Subject|1|||
126076368|NCT00858247|453573937|FG000|Baseline Assessment|Poor IV access|1|||
126076369|NCT00858247|453573938|FG001|Baseline Assessment|Poor IV access|0|||
126076370|NCT00858247|453573937|FG000|Baseline Assessment|Protocol Violation|0|||
126076371|NCT00858247|453573938|FG001|Baseline Assessment|Protocol Violation|1|||
126076372|NCT00858247|453573937|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
126076373|NCT00858247|453573938|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
126076374|NCT00337285|453573939|FG000|Overall Study|Withdrawal by Subject|42|||
126076375|NCT00337285|453573939|FG000|Overall Study|Lost to Follow-up|41|||
126076376|NCT00337285|453573939|FG000|Overall Study|Adverse Event|28|||
126076377|NCT00337285|453573939|FG000|Overall Study|Protocol Violation|27|||
126076378|NCT00337285|453573939|FG000|Overall Study|Lack of Efficacy|11|||
126076379|NCT00337285|453573939|FG000|Overall Study|Death|1|||
126076380|NCT00337285|453573939|FG000|Overall Study|Physician Decision|1|||
126076381|NCT00337285|453573939|FG000|Overall Study|Lack of protocol compliance|7|||
126114912|NCT01514136|453715807|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
126076382|NCT00553605|453573940|FG000|Overall Study|Did not meet entrance criteria|1|||
126076383|NCT00553605|453573941|FG001|Overall Study|Did not meet entrance criteria|3|||
126076384|NCT00553605|453573940|FG000|Overall Study|Did not receive full dose|1|||
126076385|NCT00553605|453573941|FG001|Overall Study|Did not receive full dose|0|||
126076386|NCT00553605|453573940|FG000|Overall Study|Randomized but not treated|2|||
126076387|NCT00553605|453573941|FG001|Overall Study|Randomized but not treated|0|||
126076388|NCT01004185|453573942|FG000|Overall Study|Adverse Event|1|||
126114913|NCT01514136|453715808|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
126076389|NCT01004185|453573943|FG001|Overall Study|Adverse Event|1|||
126076390|NCT01004185|453573942|FG000|Overall Study|Lost to Follow-up|0|||
126076391|NCT01004185|453573943|FG001|Overall Study|Lost to Follow-up|1|||
126076392|NCT01004185|453573942|FG000|Overall Study|Lack of Efficacy|2|||
126076393|NCT01004185|453573943|FG001|Overall Study|Lack of Efficacy|1|||
126076394|NCT01004185|453573942|FG000|Overall Study|Sponsor Terminated Study|4|||
126076395|NCT01004185|453573943|FG001|Overall Study|Sponsor Terminated Study|5|||
126076396|NCT01004185|453573942|FG000|Overall Study|Withdrawal by Subject|2|||
126076397|NCT01004185|453573943|FG001|Overall Study|Withdrawal by Subject|1|||
126076398|NCT03481556|453573946|FG000|Overall Study|Adverse Event|1|||
126076399|NCT03481556|453573947|FG001|Overall Study|Adverse Event|0|||
126076400|NCT03481556|453573948|FG002|Overall Study|Adverse Event|0|||
126076401|NCT03481556|453573949|FG003|Overall Study|Adverse Event|0|||
126076402|NCT03481556|453573946|FG000|Overall Study|Death|4|||
126076403|NCT03481556|453573947|FG001|Overall Study|Death|2|||
126076404|NCT03481556|453573948|FG002|Overall Study|Death|3|||
126076405|NCT03481556|453573949|FG003|Overall Study|Death|16|||
126076406|NCT03481556|453573946|FG000|Overall Study|Study Terminated by Sponsor|10|||
126076407|NCT03481556|453573947|FG001|Overall Study|Study Terminated by Sponsor|5|||
126076408|NCT03481556|453573948|FG002|Overall Study|Study Terminated by Sponsor|2|||
126076409|NCT03481556|453573949|FG003|Overall Study|Study Terminated by Sponsor|9|||
126076410|NCT01085812|453573950|FG000|Open-Label Period|Adverse Event|0|||
126076411|NCT01085812|453573951|FG001|Open-Label Period|Adverse Event|80|||
126076412|NCT01085812|453573950|FG000|Open-Label Period|Lack of Efficacy|0|||
126076413|NCT01085812|453573951|FG001|Open-Label Period|Lack of Efficacy|26|||
126076414|NCT01085812|453573950|FG000|Open-Label Period|Protocol Violation|0|||
126076415|NCT01085812|453573951|FG001|Open-Label Period|Protocol Violation|39|||
126076416|NCT01085812|453573950|FG000|Open-Label Period|Withdrawal by Subject|0|||
126076417|NCT01085812|453573951|FG001|Open-Label Period|Withdrawal by Subject|53|||
126076418|NCT01085812|453573950|FG000|Open-Label Period|Lost to Follow-up|0|||
126076419|NCT01085812|453573951|FG001|Open-Label Period|Lost to Follow-up|42|||
126076420|NCT01085812|453573950|FG000|Double-Blind Period|Adverse Event|3|||
126076421|NCT01085812|453573951|FG001|Double-Blind Period|Adverse Event|8|||
126076422|NCT01085812|453573950|FG000|Double-Blind Period|Protocol Violation|2|||
126076423|NCT01085812|453573951|FG001|Double-Blind Period|Protocol Violation|7|||
126076424|NCT01085812|453573950|FG000|Double-Blind Period|Withdrawal by Subject|11|||
126076425|NCT01085812|453573951|FG001|Double-Blind Period|Withdrawal by Subject|24|||
126076426|NCT01085812|453573950|FG000|Double-Blind Period|Lost to Follow-up|5|||
126076427|NCT01085812|453573951|FG001|Double-Blind Period|Lost to Follow-up|17|||
126076428|NCT01085812|453573950|FG000|Double-Blind Period|Other Reasons|0|||
126076429|NCT01085812|453573951|FG001|Double-Blind Period|Other Reasons|2|||
126076430|NCT01085812|453573950|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
126076431|NCT01085812|453573951|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
126076432|NCT01085812|453573950|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
126076433|NCT01085812|453573951|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
126076434|NCT01085812|453573950|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
126076435|NCT01085812|453573951|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
126076436|NCT01085812|453573950|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
126076437|NCT01085812|453573951|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
126076438|NCT01085812|453573950|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
126076439|NCT01085812|453573951|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
126076440|NCT01101997|453573952|FG000|Overall Study|Withdrawal by Subject|2|||
126076441|NCT01172639|453573955|FG000|Overall Study|Death|1|||
126076442|NCT01172639|453573956|FG001|Overall Study|Death|1|||
126076443|NCT01172639|453573957|FG002|Overall Study|Death|0|||
126076444|NCT01172639|453573958|FG003|Overall Study|Death|0|||
126076445|NCT01172639|453573959|FG004|Overall Study|Death|0|||
126076446|NCT01172639|453573955|FG000|Overall Study|Lost to Follow-up|9|||
126076447|NCT01172639|453573956|FG001|Overall Study|Lost to Follow-up|7|||
126076448|NCT01172639|453573957|FG002|Overall Study|Lost to Follow-up|11|||
126076449|NCT01172639|453573958|FG003|Overall Study|Lost to Follow-up|6|||
126076450|NCT01172639|453573959|FG004|Overall Study|Lost to Follow-up|6|||
126076451|NCT01172639|453573955|FG000|Overall Study|Withdrawal by Subject|3|||
126076452|NCT01172639|453573956|FG001|Overall Study|Withdrawal by Subject|3|||
126076453|NCT01172639|453573957|FG002|Overall Study|Withdrawal by Subject|5|||
126076454|NCT01172639|453573958|FG003|Overall Study|Withdrawal by Subject|5|||
126076455|NCT01172639|453573959|FG004|Overall Study|Withdrawal by Subject|0|||
126076456|NCT00469456|453573960|FG000|Overall Study|Adverse Event|4|||
126076457|NCT00469456|453573961|FG001|Overall Study|Adverse Event|3|||
126076458|NCT00469456|453573960|FG000|Overall Study|Protocol Violation|1|||
126076459|NCT00469456|453573961|FG001|Overall Study|Protocol Violation|0|||
126076460|NCT00469456|453573960|FG000|Overall Study|Withdrawal by Subject|4|||
126076461|NCT00469456|453573961|FG001|Overall Study|Withdrawal by Subject|1|||
126076462|NCT00350298|453573964|FG000|Overall Study|Death|7|||
126076463|NCT00350298|453573965|FG001|Overall Study|Death|8|||
126076464|NCT00350298|453573964|FG000|Overall Study|Lost to Follow-up|1|||
126076465|NCT00350298|453573965|FG001|Overall Study|Lost to Follow-up|2|||
126114914|NCT01514136|453715809|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
125947883|NCT02641379|453106859|FG004|Overall Study|PCR positive|0|||
126076466|NCT00350298|453573964|FG000|Overall Study|Withdrawal by Subject|1|||
126076467|NCT00350298|453573965|FG001|Overall Study|Withdrawal by Subject|3|||
126076468|NCT03634839|453573966|FG000|First Intervention (2 Hours)|Adverse Event|0|||
126076469|NCT03634839|453573967|FG001|First Intervention (2 Hours)|Adverse Event|2|||
126076470|NCT02447432|453573968|FG000|Epoch 001|Adverse Event|1|||
126076471|NCT02447432|453573969|FG001|Epoch 001|Adverse Event|1|||
126076472|NCT02447432|453573968|FG000|Epoch 001|Withdrawal by Subject|0|||
126076473|NCT02447432|453573969|FG001|Epoch 001|Withdrawal by Subject|4|||
126076474|NCT02447432|453573968|FG000|Epoch 001|Migrated/moved from study area|3|||
126076475|NCT02447432|453573969|FG001|Epoch 001|Migrated/moved from study area|5|||
126076476|NCT02447432|453573968|FG000|Epoch 001|Lost to Follow-up|1|||
126076477|NCT02447432|453573969|FG001|Epoch 001|Lost to Follow-up|3|||
126076478|NCT00233389|453573972|FG000|Overall Study|Adverse Event|5|||
126076479|NCT00233389|453573973|FG001|Overall Study|Adverse Event|5|||
126076480|NCT00233389|453573972|FG000|Overall Study|Lack of Efficacy|11|||
126076481|NCT00233389|453573973|FG001|Overall Study|Lack of Efficacy|8|||
126076482|NCT00233389|453573972|FG000|Overall Study|Lost to Follow-up|1|||
126076483|NCT00233389|453573973|FG001|Overall Study|Lost to Follow-up|1|||
126076484|NCT00233389|453573972|FG000|Overall Study|Physician Decision|1|||
126076485|NCT00233389|453573973|FG001|Overall Study|Physician Decision|0|||
126076486|NCT00233389|453573972|FG000|Overall Study|Protocol Violation|0|||
126076487|NCT00233389|453573973|FG001|Overall Study|Protocol Violation|1|||
126076488|NCT00233389|453573972|FG000|Overall Study|Withdrawal by Subject|0|||
126076489|NCT00233389|453573973|FG001|Overall Study|Withdrawal by Subject|1|||
126076490|NCT00302159|453573976|FG000|Overall Study|pt declined before treatment started|1|||
126076491|NCT00302159|453573976|FG000|Overall Study|pt started Avastin|1|||
126076492|NCT01657877|453573981|FG000|Overall Study|Withdrawal by Subject|4|||
126076493|NCT01657877|453573981|FG000|Overall Study|Protocol Violation|6|||
126076494|NCT01657877|453573981|FG000|Overall Study|Adverse Event|2|||
126076495|NCT01657877|453573981|FG000|Overall Study|Other Reason|2|||
126076496|NCT01114672|453573983|FG000|Overall Study|Death|0|||
126076497|NCT01114672|453573984|FG001|Overall Study|Death|1|||
126076498|NCT01114672|453573983|FG000|Overall Study|Withdrawal by Subject|2|||
126076499|NCT01114672|453573984|FG001|Overall Study|Withdrawal by Subject|1|||
126076500|NCT01114672|453573983|FG000|Overall Study|Lost to Follow-up|1|||
126076501|NCT01114672|453573984|FG001|Overall Study|Lost to Follow-up|0|||
126076502|NCT01114672|453573983|FG000|Overall Study|transplanted|1|||
126076503|NCT01114672|453573984|FG001|Overall Study|transplanted|0|||
126076504|NCT02586415|453573987|FG000|Overall Study|Death|13|||
126076505|NCT02586415|453573988|FG001|Overall Study|Death|23|||
125947884|NCT02641379|453106860|FG005|Overall Study|PCR positive|0|||
125947885|NCT02641379|453106861|FG006|Overall Study|PCR positive|1|||
125947886|NCT02641379|453106862|FG007|Overall Study|PCR positive|0|||
125947887|NCT02641379|453106863|FG008|Overall Study|PCR positive|0|||
125947888|NCT02641379|453106864|FG009|Overall Study|PCR positive|0|||
125947889|NCT02641379|453106865|FG010|Overall Study|PCR positive|0|||
125947890|NCT04982250|453106866|FG000|Overall Study|Lost to Follow-up|0|||
125947891|NCT04982250|453106867|FG001|Overall Study|Lost to Follow-up|26|||
125947892|NCT04982250|453106868|FG002|Overall Study|Lost to Follow-up|0|||
125947893|NCT04982250|453106869|FG003|Overall Study|Lost to Follow-up|0|||
125947894|NCT04982250|453106870|FG004|Overall Study|Lost to Follow-up|72|||
125947895|NCT04982250|453106871|FG005|Overall Study|Lost to Follow-up|69|||
125947896|NCT04982250|453106866|FG000|Overall Study|Not Eligible to Enroll|0|||
125947897|NCT04982250|453106867|FG001|Overall Study|Not Eligible to Enroll|0|||
125947898|NCT04982250|453106868|FG002|Overall Study|Not Eligible to Enroll|0|||
125947899|NCT04982250|453106869|FG003|Overall Study|Not Eligible to Enroll|0|||
125947900|NCT04982250|453106870|FG004|Overall Study|Not Eligible to Enroll|10|||
125947901|NCT04982250|453106871|FG005|Overall Study|Not Eligible to Enroll|7|||
125947902|NCT01644175|453106872|FG000|Overall Study|Randomized But Not Treated|0|||
125947903|NCT01644175|453106873|FG001|Overall Study|Randomized But Not Treated|2|||
125947904|NCT01644175|453106872|FG000|Overall Study|Adverse Event|8|||
125947905|NCT01644175|453106873|FG001|Overall Study|Adverse Event|13|||
125947906|NCT01644175|453106872|FG000|Overall Study|Death|1|||
125947907|NCT01644175|453106873|FG001|Overall Study|Death|2|||
125947908|NCT01644175|453106872|FG000|Overall Study|Poor compliance to protocol|9|||
125947909|NCT01644175|453106873|FG001|Overall Study|Poor compliance to protocol|10|||
125947910|NCT01644175|453106872|FG000|Overall Study|Physician Decision|1|||
125947911|NCT01644175|453106873|FG001|Overall Study|Physician Decision|2|||
125947912|NCT01644175|453106872|FG000|Overall Study|Participant Moved|1|||
125947913|NCT01644175|453106873|FG001|Overall Study|Participant Moved|2|||
125947914|NCT01644175|453106872|FG000|Overall Study|Consent withdrawn by participant|3|||
125947915|NCT01644175|453106873|FG001|Overall Study|Consent withdrawn by participant|4|||
125947916|NCT01644175|453106872|FG000|Overall Study|Related to Autoinjector Administration|2|||
125947917|NCT01644175|453106873|FG001|Overall Study|Related to Autoinjector Administration|1|||
125947918|NCT01644175|453106872|FG000|Overall Study|Last visit outside protocol visit window|4|||
125947919|NCT01644175|453106873|FG001|Overall Study|Last visit outside protocol visit window|11|||
125947920|NCT01644175|453106872|FG000|Overall Study|Selection criteria finally not met|0|||
125947921|NCT01644175|453106873|FG001|Overall Study|Selection criteria finally not met|1|||
125947922|NCT01644175|453106872|FG000|Overall Study|Site closure|2|||
125947923|NCT01644175|453106873|FG001|Overall Study|Site closure|2|||
125947924|NCT01644175|453106872|FG000|Overall Study|Lost to Follow-up|1|||
125947925|NCT01644175|453106873|FG001|Overall Study|Lost to Follow-up|0|||
125947926|NCT01644175|453106872|FG000|Overall Study|Other than specified above|0|||
125947927|NCT01644175|453106873|FG001|Overall Study|Other than specified above|3|||
126076506|NCT02586415|453573987|FG000|Overall Study|Lost to Follow-up|1|||
126076507|NCT02586415|453573988|FG001|Overall Study|Lost to Follow-up|2|||
125947928|NCT01418937|453106876|FG000|Overall Study|Lost to Follow-up|5|||
125947929|NCT01418937|453106876|FG000|Overall Study|Protocol Violation|1|||
125947930|NCT01418937|453106876|FG000|Overall Study|Pregnancy|1|||
126076508|NCT02872311|453573989|FG000|Overall Study|Death|2|||
126076509|NCT02872311|453573990|FG001|Overall Study|Death|0|||
126076510|NCT02872311|453573991|FG002|Overall Study|Death|0|||
126076511|NCT02872311|453573992|FG003|Overall Study|Death|0|||
126076512|NCT02872311|453573993|FG004|Overall Study|Death|0|||
126076513|NCT02872311|453573989|FG000|Overall Study|Lost to Follow-up|2|||
126076514|NCT02872311|453573990|FG001|Overall Study|Lost to Follow-up|0|||
126076515|NCT02872311|453573991|FG002|Overall Study|Lost to Follow-up|0|||
126076516|NCT02872311|453573992|FG003|Overall Study|Lost to Follow-up|0|||
126076517|NCT02872311|453573993|FG004|Overall Study|Lost to Follow-up|0|||
126076518|NCT02872311|453573989|FG000|Overall Study|Protocol Violation|0|||
126076519|NCT02872311|453573990|FG001|Overall Study|Protocol Violation|2|||
126076520|NCT02872311|453573991|FG002|Overall Study|Protocol Violation|1|||
126076521|NCT02872311|453573992|FG003|Overall Study|Protocol Violation|0|||
126076522|NCT02872311|453573993|FG004|Overall Study|Protocol Violation|0|||
126076523|NCT01585298|453573994|FG000|Overall Study|Study completion was not documented.|1|||
126076524|NCT01585298|453573994|FG000|Overall Study|Protocol deviation|1|||
126076525|NCT01585298|453573994|FG000|Overall Study|Administrative problems|4|||
126076526|NCT01585298|453573994|FG000|Overall Study|Lost to Follow-up|2|||
126076527|NCT01585298|453573994|FG000|Overall Study|Withdrawal by Subject|4|||
126076528|NCT01585298|453573994|FG000|Overall Study|Abnormal test procedure results|1|||
126076529|NCT01585298|453573994|FG000|Overall Study|Adverse Event|24|||
126076530|NCT04545476|453573995|FG000|Overall Study|Lost to Follow-up|1|||
126076531|NCT04545476|453573996|FG001|Overall Study|Lost to Follow-up|1|||
126076532|NCT04545476|453573997|FG002|Overall Study|Lost to Follow-up|0|||
126076533|NCT04545476|453573998|FG003|Overall Study|Lost to Follow-up|0|||
126076534|NCT03318783|453574001|FG000|Overall Study|Withdrawal by Subject|0|||
126076535|NCT03318783|453574002|FG001|Overall Study|Withdrawal by Subject|1|||
126076536|NCT03318783|453574001|FG000|Overall Study|Death|0|||
126076537|NCT03318783|453574002|FG001|Overall Study|Death|1|||
126076538|NCT04035577|453574005|FG000|Overall Study|Lost to Follow-up|1|||
126076539|NCT04035577|453574005|FG000|Overall Study|Withdrawal by Subject|1|||
126076540|NCT01313624|453574007|FG000|Double-Blind Phase|Adverse Event|27|||
126076541|NCT01313624|453574008|FG001|Double-Blind Phase|Adverse Event|4|||
126076542|NCT01313624|453574007|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
126076543|NCT01313624|453574008|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
126076544|NCT01313624|453574007|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126076545|NCT01313624|453574008|FG001|Double-Blind Phase|Lost to Follow-up|2|||
126076546|NCT01313624|453574007|FG000|Double-Blind Phase|Physician Decision|1|||
126076547|NCT01313624|453574008|FG001|Double-Blind Phase|Physician Decision|0|||
126076548|NCT01313624|453574007|FG000|Double-Blind Phase|Lack of Efficacy|1|||
126076549|NCT01313624|453574008|FG001|Double-Blind Phase|Lack of Efficacy|0|||
126076550|NCT01313624|453574007|FG000|Open-Label Phase|Adverse Event|1|||
126076551|NCT01313624|453574008|FG001|Open-Label Phase|Adverse Event|10|||
126076552|NCT01313624|453574007|FG000|Open-Label Phase|Withdrawal by Subject|2|||
126076553|NCT01313624|453574008|FG001|Open-Label Phase|Withdrawal by Subject|2|||
126076554|NCT01313624|453574007|FG000|Open-Label Phase|Lost to Follow-up|1|||
126076555|NCT01313624|453574008|FG001|Open-Label Phase|Lost to Follow-up|1|||
126076556|NCT00104637|453574009|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
126076557|NCT00104637|453574010|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
126076558|NCT00505414|453574011|FG000|Titration Phase|Adverse Event|0|||
126076559|NCT00505414|453574012|FG001|Titration Phase|Adverse Event|0|||
126076560|NCT00505414|453574013|FG002|Titration Phase|Adverse Event|0|||
126076561|NCT00505414|453574014|FG003|Titration Phase|Adverse Event|8|||
126076562|NCT00505414|453574015|FG004|Titration Phase|Adverse Event|3|||
126076563|NCT00505414|453574011|FG000|Titration Phase|Death|0|||
126076564|NCT00505414|453574012|FG001|Titration Phase|Death|0|||
126076565|NCT00505414|453574013|FG002|Titration Phase|Death|0|||
126076566|NCT00505414|453574014|FG003|Titration Phase|Death|2|||
126076567|NCT00505414|453574015|FG004|Titration Phase|Death|0|||
126076568|NCT00505414|453574011|FG000|Titration Phase|Lack of Efficacy|0|||
126076569|NCT00505414|453574012|FG001|Titration Phase|Lack of Efficacy|0|||
126076570|NCT00505414|453574013|FG002|Titration Phase|Lack of Efficacy|0|||
126076571|NCT00505414|453574014|FG003|Titration Phase|Lack of Efficacy|10|||
126076572|NCT00505414|453574015|FG004|Titration Phase|Lack of Efficacy|1|||
126076573|NCT00505414|453574011|FG000|Titration Phase|Protocol Violation|0|||
126076574|NCT00505414|453574012|FG001|Titration Phase|Protocol Violation|0|||
126076575|NCT00505414|453574013|FG002|Titration Phase|Protocol Violation|0|||
126076576|NCT00505414|453574014|FG003|Titration Phase|Protocol Violation|0|||
126076577|NCT00505414|453574015|FG004|Titration Phase|Protocol Violation|1|||
126076578|NCT00505414|453574011|FG000|Titration Phase|Withdrawal by Subject|0|||
126076579|NCT00505414|453574012|FG001|Titration Phase|Withdrawal by Subject|0|||
126076580|NCT00505414|453574013|FG002|Titration Phase|Withdrawal by Subject|0|||
126076581|NCT00505414|453574014|FG003|Titration Phase|Withdrawal by Subject|3|||
126076582|NCT00505414|453574015|FG004|Titration Phase|Withdrawal by Subject|4|||
126076583|NCT00505414|453574011|FG000|Titration Phase|Underlying disease and therapy required|0|||
126076584|NCT00505414|453574012|FG001|Titration Phase|Underlying disease and therapy required|0|||
126076585|NCT00505414|453574013|FG002|Titration Phase|Underlying disease and therapy required|0|||
126076586|NCT00505414|453574014|FG003|Titration Phase|Underlying disease and therapy required|7|||
126076587|NCT00505414|453574015|FG004|Titration Phase|Underlying disease and therapy required|3|||
126076588|NCT00505414|453574011|FG000|Maintenance Phase|Adverse Event|2|||
126076589|NCT00505414|453574012|FG001|Maintenance Phase|Adverse Event|2|||
126076590|NCT00505414|453574013|FG002|Maintenance Phase|Adverse Event|3|||
126076591|NCT00505414|453574014|FG003|Maintenance Phase|Adverse Event|0|||
126076592|NCT00505414|453574015|FG004|Maintenance Phase|Adverse Event|0|||
126076593|NCT00505414|453574011|FG000|Maintenance Phase|Death|2|||
126076594|NCT00505414|453574012|FG001|Maintenance Phase|Death|0|||
126076595|NCT00505414|453574013|FG002|Maintenance Phase|Death|1|||
126076596|NCT00505414|453574014|FG003|Maintenance Phase|Death|0|||
126076597|NCT00505414|453574015|FG004|Maintenance Phase|Death|0|||
126076598|NCT00505414|453574011|FG000|Maintenance Phase|Lack of Efficacy|2|||
126076599|NCT00505414|453574012|FG001|Maintenance Phase|Lack of Efficacy|1|||
126076600|NCT00505414|453574013|FG002|Maintenance Phase|Lack of Efficacy|1|||
126076601|NCT00505414|453574014|FG003|Maintenance Phase|Lack of Efficacy|0|||
126076602|NCT00505414|453574015|FG004|Maintenance Phase|Lack of Efficacy|0|||
126076603|NCT00505414|453574011|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126076604|NCT00505414|453574012|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126076605|NCT00505414|453574013|FG002|Maintenance Phase|Withdrawal by Subject|1|||
126076606|NCT00505414|453574014|FG003|Maintenance Phase|Withdrawal by Subject|0|||
126076607|NCT00505414|453574015|FG004|Maintenance Phase|Withdrawal by Subject|0|||
126076608|NCT00505414|453574011|FG000|Maintenance Phase|underlying disease and therapy required|0|||
126076609|NCT00505414|453574012|FG001|Maintenance Phase|underlying disease and therapy required|2|||
126076610|NCT00505414|453574013|FG002|Maintenance Phase|underlying disease and therapy required|2|||
126076611|NCT00505414|453574014|FG003|Maintenance Phase|underlying disease and therapy required|0|||
126076612|NCT00505414|453574015|FG004|Maintenance Phase|underlying disease and therapy required|0|||
126076613|NCT00644878|453574016|FG000|Overall Study|Adverse Event|2|||
126076614|NCT00644878|453574016|FG000|Overall Study|Abnormal laboratory value|3|||
126076615|NCT00644878|453574016|FG000|Overall Study|Protocol deviation|2|||
126076616|NCT00644878|453574016|FG000|Overall Study|Treatment duration completed as per protocol|11|||
126076617|NCT01841112|453574019|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
126076618|NCT01841112|453574020|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
126076619|NCT01841112|453574021|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
126076620|NCT01841112|453574022|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
126076621|NCT01841112|453574023|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
126076622|NCT00878553|453574024|FG000|Sleep Study|Withdrawal by Subject|2|||
126076623|NCT00878553|453574025|FG001|Sleep Study|Withdrawal by Subject|0|||
126076624|NCT00878553|453574026|FG002|Sleep Study|Withdrawal by Subject|0|||
126076625|NCT00878553|453574027|FG003|Sleep Study|Withdrawal by Subject|0|||
126076626|NCT00878553|453574028|FG004|Sleep Study|Withdrawal by Subject|0|||
126076627|NCT00878553|453574024|FG000|Sleep Study|Lost to Follow-up|1|||
126076628|NCT00878553|453574025|FG001|Sleep Study|Lost to Follow-up|0|||
126076629|NCT00878553|453574026|FG002|Sleep Study|Lost to Follow-up|0|||
126076630|NCT00878553|453574027|FG003|Sleep Study|Lost to Follow-up|0|||
126076631|NCT00878553|453574028|FG004|Sleep Study|Lost to Follow-up|0|||
126076632|NCT00878553|453574024|FG000|Sleep Study|car accident|1|||
126076633|NCT00878553|453574025|FG001|Sleep Study|car accident|0|||
126076634|NCT00878553|453574026|FG002|Sleep Study|car accident|0|||
126076635|NCT00878553|453574027|FG003|Sleep Study|car accident|0|||
126076636|NCT00878553|453574028|FG004|Sleep Study|car accident|0|||
126076637|NCT00878553|453574024|FG000|Sleep Study|family emergency|1|||
126076638|NCT00878553|453574025|FG001|Sleep Study|family emergency|0|||
126076639|NCT00878553|453574026|FG002|Sleep Study|family emergency|0|||
126076640|NCT00878553|453574027|FG003|Sleep Study|family emergency|0|||
126076641|NCT00878553|453574028|FG004|Sleep Study|family emergency|0|||
126076642|NCT00878553|453574024|FG000|PK Study|Withdrawal by Subject|0|||
126076643|NCT00878553|453574025|FG001|PK Study|Withdrawal by Subject|0|||
126076644|NCT00878553|453574026|FG002|PK Study|Withdrawal by Subject|0|||
126076645|NCT00878553|453574027|FG003|PK Study|Withdrawal by Subject|1|||
126076646|NCT00878553|453574028|FG004|PK Study|Withdrawal by Subject|0|||
126076647|NCT05896696|453574031|FG000|Overall Study|Screening Failure|7|||
126076648|NCT05896696|453574031|FG000|Overall Study|Withdrawal by Subject|2|||
126076649|NCT02080403|453576280|FG000|Overall Study|Adverse Event|5|||
126076650|NCT02080403|453576281|FG001|Overall Study|Adverse Event|1|||
126076651|NCT02080403|453576280|FG000|Overall Study|Death|0|||
126114915|NCT01514136|453715810|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
125947931|NCT01418937|453106876|FG000|Overall Study|Withdrawal by Subject|1|||
125947932|NCT00856908|453106877|FG000|Overall Study|Lost to Follow-up|1|||
126076652|NCT02080403|453576281|FG001|Overall Study|Death|2|||
126076653|NCT02080403|453576280|FG000|Overall Study|Lost to Follow-up|2|||
126076654|NCT02080403|453576281|FG001|Overall Study|Lost to Follow-up|0|||
126076655|NCT02080403|453576280|FG000|Overall Study|Pregnancy|0|||
126076656|NCT02080403|453576281|FG001|Overall Study|Pregnancy|1|||
126076657|NCT02080403|453576280|FG000|Overall Study|Protocol Violation|3|||
126076658|NCT02080403|453576281|FG001|Overall Study|Protocol Violation|7|||
126076659|NCT02080403|453576280|FG000|Overall Study|Withdrawal by Subject|5|||
126076660|NCT02080403|453576281|FG001|Overall Study|Withdrawal by Subject|1|||
126076661|NCT01999972|453576282|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
126076662|NCT01999972|453576283|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
125947933|NCT00856908|453106878|FG001|Overall Study|Lost to Follow-up|0|||
125947934|NCT00962104|453106880|FG000|Overall Study|Adverse Event|10|||
125947935|NCT00962104|453106881|FG001|Overall Study|Adverse Event|3|||
125947936|NCT00962104|453106880|FG000|Overall Study|Entry Criteria Not Met|1|||
125947937|NCT00962104|453106881|FG001|Overall Study|Entry Criteria Not Met|2|||
125947938|NCT00962104|453106880|FG000|Overall Study|Lack of Efficacy|0|||
125947939|NCT00962104|453106881|FG001|Overall Study|Lack of Efficacy|1|||
125947940|NCT00962104|453106880|FG000|Overall Study|Lost to Follow-up|10|||
125947941|NCT00962104|453106881|FG001|Overall Study|Lost to Follow-up|4|||
125947942|NCT00962104|453106880|FG000|Overall Study|Physician Decision|1|||
125947943|NCT00962104|453106881|FG001|Overall Study|Physician Decision|0|||
125947944|NCT00962104|453106880|FG000|Overall Study|Protocol Violation|6|||
125947945|NCT00962104|453106881|FG001|Overall Study|Protocol Violation|8|||
125947946|NCT00962104|453106880|FG000|Overall Study|Sponsor Decision|0|||
125947947|NCT00962104|453106881|FG001|Overall Study|Sponsor Decision|1|||
125947948|NCT00962104|453106880|FG000|Overall Study|Withdrawal by Subject|10|||
125947949|NCT00962104|453106881|FG001|Overall Study|Withdrawal by Subject|6|||
125947950|NCT00962104|453106880|FG000|Overall Study|Other|2|||
125947951|NCT00962104|453106881|FG001|Overall Study|Other|0|||
125947952|NCT03274986|453106882|FG000|Overall Study|Withdrawal by Subject|0|||
125947953|NCT03274986|453106883|FG001|Overall Study|Withdrawal by Subject|1|||
125947954|NCT03274986|453106882|FG000|Overall Study|Lost to Follow-up|0|||
125947955|NCT03274986|453106883|FG001|Overall Study|Lost to Follow-up|1|||
125947956|NCT00842348|453106884|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
125947957|NCT00842348|453106885|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
125947958|NCT00842348|453106884|FG000|Study 729|Disease progression/death|19|||
125947959|NCT00842348|453106885|FG001|Study 729|Disease progression/death|30|||
125947960|NCT00842348|453106884|FG000|Study 729|Adverse Event|1|||
125947961|NCT00842348|453106885|FG001|Study 729|Adverse Event|1|||
125947962|NCT00842348|453106884|FG000|Study 729|Protocol Violation|1|||
125947963|NCT00842348|453106885|FG001|Study 729|Protocol Violation|1|||
125947964|NCT00842348|453106884|FG000|Study 729|Withdrawal by Subject|2|||
125947965|NCT00842348|453106885|FG001|Study 729|Withdrawal by Subject|4|||
125947966|NCT00842348|453106884|FG000|Study 729|Due to Sponsor stopping the study|1|||
125947967|NCT00842348|453106885|FG001|Study 729|Due to Sponsor stopping the study|1|||
125947968|NCT00842348|453106884|FG000|Study 729|Due to non-availability of IP|0|||
125947969|NCT00842348|453106885|FG001|Study 729|Due to non-availability of IP|1|||
125947970|NCT00842348|453106884|FG000|Study 729|Sponsor's decision|1|||
125947971|NCT00842348|453106885|FG001|Study 729|Sponsor's decision|0|||
125947972|NCT00842348|453106884|FG000|Study 729|Surgical resection|1|||
125947973|NCT00842348|453106885|FG001|Study 729|Surgical resection|0|||
125947974|NCT00615056|453106888|FG000|Overall Study|Death|31|||
125947975|NCT00615056|453106889|FG001|Overall Study|Death|31|||
125947976|NCT00615056|453106890|FG002|Overall Study|Death|21|||
125947977|NCT00615056|453106891|FG003|Overall Study|Death|23|||
125947978|NCT00615056|453106888|FG000|Overall Study|Lost to Follow-up|1|||
125947979|NCT00615056|453106889|FG001|Overall Study|Lost to Follow-up|2|||
125947980|NCT00615056|453106890|FG002|Overall Study|Lost to Follow-up|4|||
125947981|NCT00615056|453106891|FG003|Overall Study|Lost to Follow-up|5|||
125947982|NCT00615056|453106888|FG000|Overall Study|Other|13|||
125947983|NCT00615056|453106889|FG001|Overall Study|Other|15|||
125947984|NCT00615056|453106890|FG002|Overall Study|Other|10|||
125947985|NCT00615056|453106891|FG003|Overall Study|Other|7|||
125947986|NCT00615056|453106888|FG000|Overall Study|Objective progression or relapse|0|||
125947987|NCT00615056|453106889|FG001|Overall Study|Objective progression or relapse|2|||
125947988|NCT00615056|453106890|FG002|Overall Study|Objective progression or relapse|0|||
125947989|NCT00615056|453106891|FG003|Overall Study|Objective progression or relapse|0|||
125947990|NCT00615056|453106888|FG000|Overall Study|Withdrawal by Subject|0|||
125947991|NCT00615056|453106889|FG001|Overall Study|Withdrawal by Subject|1|||
125947992|NCT00615056|453106890|FG002|Overall Study|Withdrawal by Subject|1|||
125947993|NCT00615056|453106891|FG003|Overall Study|Withdrawal by Subject|0|||
125947994|NCT00615056|453106888|FG000|Overall Study|Discontinued by Sponsor|1|||
125947995|NCT00615056|453106889|FG001|Overall Study|Discontinued by Sponsor|0|||
125947996|NCT00615056|453106890|FG002|Overall Study|Discontinued by Sponsor|0|||
125947997|NCT00615056|453106891|FG003|Overall Study|Discontinued by Sponsor|0|||
125947998|NCT00615056|453106888|FG000|Overall Study|Randomized but not treated|3|||
125947999|NCT00615056|453106889|FG001|Overall Study|Randomized but not treated|0|||
125948000|NCT00615056|453106890|FG002|Overall Study|Randomized but not treated|0|||
125948001|NCT00615056|453106891|FG003|Overall Study|Randomized but not treated|0|||
125948002|NCT02276612|453106892|FG000|Overall Study|Death|1|||
125948003|NCT02276612|453106893|FG001|Overall Study|Death|0|||
125948004|NCT02276612|453106892|FG000|Overall Study|Pregnancy|1|||
125948005|NCT02276612|453106893|FG001|Overall Study|Pregnancy|0|||
125948006|NCT02276612|453106892|FG000|Overall Study|Withdrew Consent|1|||
125948007|NCT02276612|453106893|FG001|Overall Study|Withdrew Consent|0|||
125948008|NCT02276612|453106892|FG000|Overall Study|Lost to Follow-up|1|||
125948009|NCT02276612|453106893|FG001|Overall Study|Lost to Follow-up|0|||
125948010|NCT00262067|453106894|FG000|Overall Study|Death|190|||
125948011|NCT00262067|453106895|FG001|Overall Study|Death|89|||
125948012|NCT00262067|453106896|FG002|Overall Study|Death|186|||
126076663|NCT01999972|453576284|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
126076664|NCT01999972|453576285|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
126076665|NCT01999972|453576286|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
126076666|NCT01999972|453576287|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
126076667|NCT01999972|453576282|FG000|Dose Escalation Part|Death|0|||
126076668|NCT01999972|453576283|FG001|Dose Escalation Part|Death|1|||
126076669|NCT01999972|453576284|FG002|Dose Escalation Part|Death|0|||
126076670|NCT01999972|453576285|FG003|Dose Escalation Part|Death|0|||
126076671|NCT01999972|453576286|FG004|Dose Escalation Part|Death|0|||
126076672|NCT01999972|453576287|FG005|Dose Escalation Part|Death|0|||
126076673|NCT01999972|453576282|FG000|Dose Escalation Part|Enrolled but not treated|0|||
126076674|NCT01999972|453576283|FG001|Dose Escalation Part|Enrolled but not treated|0|||
126076675|NCT01999972|453576284|FG002|Dose Escalation Part|Enrolled but not treated|1|||
126076676|NCT01999972|453576285|FG003|Dose Escalation Part|Enrolled but not treated|1|||
126076677|NCT01999972|453576286|FG004|Dose Escalation Part|Enrolled but not treated|0|||
126076678|NCT01999972|453576287|FG005|Dose Escalation Part|Enrolled but not treated|0|||
126076679|NCT01999972|453576282|FG000|Dose Escalation Part|Disease progression|3|||
126076680|NCT01999972|453576283|FG001|Dose Escalation Part|Disease progression|2|||
126076681|NCT01999972|453576284|FG002|Dose Escalation Part|Disease progression|3|||
126076682|NCT01999972|453576285|FG003|Dose Escalation Part|Disease progression|6|||
126076683|NCT01999972|453576286|FG004|Dose Escalation Part|Disease progression|0|||
126076684|NCT01999972|453576287|FG005|Dose Escalation Part|Disease progression|0|||
126076685|NCT01999972|453576282|FG000|Dose Escalation Part|Adverse Event|0|||
126076686|NCT01999972|453576283|FG001|Dose Escalation Part|Adverse Event|0|||
126076687|NCT01999972|453576284|FG002|Dose Escalation Part|Adverse Event|0|||
126076688|NCT01999972|453576285|FG003|Dose Escalation Part|Adverse Event|2|||
126076689|NCT01999972|453576286|FG004|Dose Escalation Part|Adverse Event|0|||
126076690|NCT01999972|453576287|FG005|Dose Escalation Part|Adverse Event|0|||
126076691|NCT01999972|453576282|FG000|Dose Escalation Part|Global deterioration of health status|1|||
126076692|NCT01999972|453576283|FG001|Dose Escalation Part|Global deterioration of health status|0|||
126076693|NCT01999972|453576284|FG002|Dose Escalation Part|Global deterioration of health status|0|||
126076694|NCT01999972|453576285|FG003|Dose Escalation Part|Global deterioration of health status|1|||
126076695|NCT01999972|453576286|FG004|Dose Escalation Part|Global deterioration of health status|0|||
126076696|NCT01999972|453576287|FG005|Dose Escalation Part|Global deterioration of health status|0|||
126076697|NCT01999972|453576282|FG000|Dose Expansion Part|Death|0|||
126076698|NCT01999972|453576283|FG001|Dose Expansion Part|Death|0|||
126076699|NCT01999972|453576284|FG002|Dose Expansion Part|Death|0|||
126076700|NCT01999972|453576285|FG003|Dose Expansion Part|Death|0|||
126076701|NCT01999972|453576286|FG004|Dose Expansion Part|Death|2|||
126076702|NCT01999972|453576287|FG005|Dose Expansion Part|Death|1|||
126076703|NCT01999972|453576282|FG000|Dose Expansion Part|Disease progression|0|||
126076704|NCT01999972|453576283|FG001|Dose Expansion Part|Disease progression|0|||
126076705|NCT01999972|453576284|FG002|Dose Expansion Part|Disease progression|0|||
126076706|NCT01999972|453576285|FG003|Dose Expansion Part|Disease progression|0|||
126076707|NCT01999972|453576286|FG004|Dose Expansion Part|Disease progression|9|||
126076708|NCT01999972|453576287|FG005|Dose Expansion Part|Disease progression|3|||
126076709|NCT01999972|453576282|FG000|Dose Expansion Part|Sponsor decision|0|||
126076710|NCT01999972|453576283|FG001|Dose Expansion Part|Sponsor decision|0|||
126076711|NCT01999972|453576284|FG002|Dose Expansion Part|Sponsor decision|0|||
126076712|NCT01999972|453576285|FG003|Dose Expansion Part|Sponsor decision|0|||
126076713|NCT01999972|453576286|FG004|Dose Expansion Part|Sponsor decision|1|||
126076714|NCT01999972|453576287|FG005|Dose Expansion Part|Sponsor decision|0|||
126076715|NCT01999972|453576282|FG000|Dose Expansion Part|Adverse Event|0|||
126076716|NCT01999972|453576283|FG001|Dose Expansion Part|Adverse Event|0|||
126076717|NCT01999972|453576284|FG002|Dose Expansion Part|Adverse Event|0|||
126076718|NCT01999972|453576285|FG003|Dose Expansion Part|Adverse Event|0|||
126076719|NCT01999972|453576286|FG004|Dose Expansion Part|Adverse Event|4|||
126076720|NCT01999972|453576287|FG005|Dose Expansion Part|Adverse Event|2|||
126076721|NCT01999972|453576282|FG000|Dose Expansion Part|Participant's non-compliance|0|||
126076722|NCT01999972|453576283|FG001|Dose Expansion Part|Participant's non-compliance|0|||
126076723|NCT01999972|453576284|FG002|Dose Expansion Part|Participant's non-compliance|0|||
126076724|NCT01999972|453576285|FG003|Dose Expansion Part|Participant's non-compliance|0|||
126076725|NCT01999972|453576286|FG004|Dose Expansion Part|Participant's non-compliance|0|||
125948013|NCT00262067|453106897|FG003|Overall Study|Death|99|||
126076726|NCT01999972|453576287|FG005|Dose Expansion Part|Participant's non-compliance|1|||
126076727|NCT01999972|453576282|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
126076728|NCT01999972|453576283|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
126076729|NCT01999972|453576284|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
126076730|NCT01999972|453576285|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
126076731|NCT01999972|453576286|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
126076732|NCT01999972|453576287|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
125948014|NCT00262067|453106894|FG000|Overall Study|Lost to Follow-up|5|||
125948015|NCT00262067|453106895|FG001|Overall Study|Lost to Follow-up|4|||
126076733|NCT01999972|453576282|FG000|Dose Expansion Part|Changed to standard of care|0|||
126076734|NCT01999972|453576283|FG001|Dose Expansion Part|Changed to standard of care|0|||
126076735|NCT01999972|453576284|FG002|Dose Expansion Part|Changed to standard of care|0|||
126076736|NCT01999972|453576285|FG003|Dose Expansion Part|Changed to standard of care|0|||
126076737|NCT01999972|453576286|FG004|Dose Expansion Part|Changed to standard of care|1|||
126076738|NCT01999972|453576287|FG005|Dose Expansion Part|Changed to standard of care|0|||
126076739|NCT02202109|453576288|FG000|Overall Study|Lost to Follow-up|88|||
126076740|NCT02202109|453576289|FG001|Overall Study|Lost to Follow-up|87|||
126076741|NCT02202109|453576288|FG000|Overall Study|Withdrawal by Subject|2|||
126076742|NCT02202109|453576289|FG001|Overall Study|Withdrawal by Subject|0|||
126076743|NCT00612352|453576291|FG000|Overall Study|Adverse Event|1|||
126076744|NCT00612352|453576292|FG001|Overall Study|Adverse Event|0|||
126076745|NCT00612352|453576291|FG000|Overall Study|Withdrawal by Subject|3|||
126076746|NCT00612352|453576292|FG001|Overall Study|Withdrawal by Subject|5|||
126076747|NCT00612352|453576291|FG000|Overall Study|moved out of state|1|||
126076748|NCT00612352|453576292|FG001|Overall Study|moved out of state|0|||
126076749|NCT00612352|453576291|FG000|Overall Study|didn't return calls/show up on test date|4|||
126076750|NCT00612352|453576292|FG001|Overall Study|didn't return calls/show up on test date|1|||
126076751|NCT01986114|453576293|FG000|Overall Study|Adverse Event|59|||
126076752|NCT01986114|453576293|FG000|Overall Study|Lack of Efficacy|23|||
126076753|NCT01986114|453576293|FG000|Overall Study|Withdrawal by Subject|58|||
126076754|NCT01986114|453576293|FG000|Overall Study|Noncompliance|3|||
126076755|NCT01986114|453576293|FG000|Overall Study|Protocol Violation|1|||
126076756|NCT01986114|453576293|FG000|Overall Study|Lost to Follow-up|5|||
126076757|NCT01986114|453576293|FG000|Overall Study|Other reason|7|||
126076758|NCT00664105|453576294|FG000|Overall Study|Death|3|||
126076759|NCT00664105|453576294|FG000|Overall Study|Withdrawal by Subject|5|||
126076760|NCT00664105|453576294|FG000|Overall Study|Adverse Event|9|||
126076761|NCT00664105|453576294|FG000|Overall Study|Disease progression|7|||
126076762|NCT02034162|453576295|FG000|Double-blind|Lost to Follow-up|3|||
126076763|NCT02034162|453576296|FG001|Double-blind|Lost to Follow-up|0|||
126076764|NCT02034162|453576297|FG002|Double-blind|Lost to Follow-up|0|||
126076765|NCT02034162|453576295|FG000|Double-blind|Physician Decision|1|||
126076766|NCT02034162|453576296|FG001|Double-blind|Physician Decision|0|||
126076767|NCT02034162|453576297|FG002|Double-blind|Physician Decision|0|||
126076768|NCT02034162|453576295|FG000|Double-blind|Protocol Violation|0|||
126076769|NCT02034162|453576296|FG001|Double-blind|Protocol Violation|1|||
126076770|NCT02034162|453576297|FG002|Double-blind|Protocol Violation|0|||
126076771|NCT02034162|453576295|FG000|Double-blind|Withdrawal by Subject|5|||
126076772|NCT02034162|453576296|FG001|Double-blind|Withdrawal by Subject|7|||
126076773|NCT02034162|453576297|FG002|Double-blind|Withdrawal by Subject|0|||
126076774|NCT01468077|453576301|FG000|Overall Study|Adverse Event|2|||
126076775|NCT01468077|453576302|FG001|Overall Study|Adverse Event|2|||
126076776|NCT01468077|453576301|FG000|Overall Study|Lack of Efficacy|1|||
126076777|NCT01468077|453576302|FG001|Overall Study|Lack of Efficacy|1|||
126076778|NCT01468077|453576301|FG000|Overall Study|Physician Decision|1|||
126076779|NCT01468077|453576302|FG001|Overall Study|Physician Decision|0|||
126076780|NCT00761956|453576303|FG000|Overall Study|Lost to Follow-up|6|||
126076781|NCT00761956|453576304|FG001|Overall Study|Lost to Follow-up|11|||
126076782|NCT00761956|453576303|FG000|Overall Study|Withdrawal by Subject|3|||
126076783|NCT00761956|453576304|FG001|Overall Study|Withdrawal by Subject|8|||
126076784|NCT00761956|453576303|FG000|Overall Study|Death|0|||
126076785|NCT00761956|453576304|FG001|Overall Study|Death|1|||
126076786|NCT00761956|453576303|FG000|Overall Study|Adverse Event|26|||
126076787|NCT00761956|453576304|FG001|Overall Study|Adverse Event|34|||
126076788|NCT03024996|453576305|FG000|Overall Study|Death|57|||
126076789|NCT03024996|453576306|FG001|Overall Study|Death|55|||
126076790|NCT03024996|453576305|FG000|Overall Study|Disease relapse|1|||
126076791|NCT03024996|453576306|FG001|Overall Study|Disease relapse|0|||
126076792|NCT03024996|453576305|FG000|Overall Study|Lost to Follow-up|5|||
126076793|NCT03024996|453576306|FG001|Overall Study|Lost to Follow-up|10|||
126076794|NCT03024996|453576305|FG000|Overall Study|Other|3|||
126076795|NCT03024996|453576306|FG001|Overall Study|Other|3|||
126076796|NCT03024996|453576305|FG000|Overall Study|Physician Decision|0|||
126076797|NCT03024996|453576306|FG001|Overall Study|Physician Decision|1|||
126076798|NCT03024996|453576305|FG000|Overall Study|Study terminated by sponsor|303|||
126076799|NCT03024996|453576306|FG001|Overall Study|Study terminated by sponsor|283|||
126076800|NCT03024996|453576305|FG000|Overall Study|Withdrawal by Subject|21|||
126076801|NCT03024996|453576306|FG001|Overall Study|Withdrawal by Subject|36|||
126076802|NCT02106195|453576311|FG000|Overall Study|Adverse Event|2|||
126076803|NCT02106195|453576311|FG000|Overall Study|Protocol Violation|1|||
126076804|NCT04702893|453576312|FG000|Overall Study|Other reasons than listed|11|||
126076805|NCT04702893|453576312|FG000|Overall Study|Withdrawal by Subject|3|||
126076806|NCT04702893|453576312|FG000|Overall Study|Lost to Follow-up|7|||
126076807|NCT04702893|453576312|FG000|Overall Study|Death|10|||
126076808|NCT04702893|453576312|FG000|Overall Study|Not treated|6|||
126076809|NCT04469465|453576313|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
125948016|NCT00262067|453106896|FG002|Overall Study|Lost to Follow-up|7|||
126076810|NCT04469465|453576314|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
126076811|NCT04469465|453576313|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
126076812|NCT04469465|453576314|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
126076813|NCT04469465|453576313|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
126076814|NCT04469465|453576314|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
126076815|NCT04469465|453576313|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
126076816|NCT04469465|453576314|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
126076817|NCT04469465|453576313|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
126076818|NCT04469465|453576314|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
126076819|NCT04469465|453576313|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
126076820|NCT04469465|453576314|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
126076821|NCT04469465|453576313|FG000|Long-Term Extension (LTE)|Death|0|||
126076822|NCT04469465|453576314|FG001|Long-Term Extension (LTE)|Death|1|||
126076823|NCT04469465|453576313|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
126076824|NCT04469465|453576314|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
126076825|NCT02669407|453576319|FG000|Overall Study|Physician Decision|3|||
126076826|NCT02647788|453576325|FG000|Overall Study|Lost to Follow-up|13|||
126076827|NCT02647788|453576326|FG001|Overall Study|Lost to Follow-up|11|||
126076828|NCT02647788|453576325|FG000|Overall Study|Did not want opiate|0|||
126076829|NCT02647788|453576326|FG001|Overall Study|Did not want opiate|1|||
126076830|NCT02647788|453576325|FG000|Overall Study|Withdrawal by Subject|1|||
126076831|NCT02647788|453576326|FG001|Overall Study|Withdrawal by Subject|0|||
126076832|NCT02647788|453576325|FG000|Overall Study|Felt itchy with assigned medication|1|||
126076833|NCT02647788|453576326|FG001|Overall Study|Felt itchy with assigned medication|0|||
126076834|NCT02647788|453576325|FG000|Overall Study|Felt nauseous with assigned medication|1|||
126076835|NCT02647788|453576326|FG001|Overall Study|Felt nauseous with assigned medication|1|||
126076836|NCT00719043|453576332|FG000|Overall Study|Adverse Event|5|||
126076837|NCT00719043|453576333|FG001|Overall Study|Adverse Event|1|||
126076838|NCT00719043|453576334|FG002|Overall Study|Adverse Event|2|||
126076839|NCT00719043|453576335|FG003|Overall Study|Adverse Event|2|||
126076840|NCT00719043|453576336|FG004|Overall Study|Adverse Event|1|||
126076841|NCT00719043|453576337|FG005|Overall Study|Adverse Event|4|||
126076842|NCT00719043|453576338|FG006|Overall Study|Adverse Event|4|||
126076843|NCT00719043|453576332|FG000|Overall Study|Lost to Follow-up|14|||
126076844|NCT00719043|453576333|FG001|Overall Study|Lost to Follow-up|10|||
126076845|NCT00719043|453576334|FG002|Overall Study|Lost to Follow-up|8|||
126076846|NCT00719043|453576335|FG003|Overall Study|Lost to Follow-up|9|||
126076847|NCT00719043|453576336|FG004|Overall Study|Lost to Follow-up|10|||
126076848|NCT00719043|453576337|FG005|Overall Study|Lost to Follow-up|9|||
126076849|NCT00719043|453576338|FG006|Overall Study|Lost to Follow-up|9|||
126076850|NCT00719043|453576332|FG000|Overall Study|Protocol Violation|0|||
126076851|NCT00719043|453576333|FG001|Overall Study|Protocol Violation|0|||
126076852|NCT00719043|453576334|FG002|Overall Study|Protocol Violation|0|||
126076853|NCT00719043|453576335|FG003|Overall Study|Protocol Violation|0|||
126076854|NCT00719043|453576336|FG004|Overall Study|Protocol Violation|0|||
126076855|NCT00719043|453576337|FG005|Overall Study|Protocol Violation|1|||
126076856|NCT00719043|453576338|FG006|Overall Study|Protocol Violation|0|||
126076857|NCT00719043|453576332|FG000|Overall Study|Other|1|||
126076858|NCT00719043|453576333|FG001|Overall Study|Other|0|||
126076859|NCT00719043|453576334|FG002|Overall Study|Other|1|||
126076860|NCT00719043|453576335|FG003|Overall Study|Other|2|||
126076861|NCT00719043|453576336|FG004|Overall Study|Other|0|||
126076862|NCT00719043|453576337|FG005|Overall Study|Other|2|||
126076863|NCT00719043|453576338|FG006|Overall Study|Other|1|||
126076864|NCT00719043|453576332|FG000|Overall Study|Withdrawal by Subject|12|||
126076865|NCT00719043|453576333|FG001|Overall Study|Withdrawal by Subject|14|||
126076866|NCT00719043|453576334|FG002|Overall Study|Withdrawal by Subject|9|||
126076867|NCT00719043|453576335|FG003|Overall Study|Withdrawal by Subject|10|||
126076868|NCT00719043|453576336|FG004|Overall Study|Withdrawal by Subject|16|||
126076869|NCT00719043|453576337|FG005|Overall Study|Withdrawal by Subject|18|||
126076870|NCT00719043|453576338|FG006|Overall Study|Withdrawal by Subject|14|||
126076871|NCT01588366|453576339|FG000|Overall Study|Adverse Event|0|||
126076872|NCT01588366|453576340|FG001|Overall Study|Adverse Event|1|||
125948017|NCT00262067|453106897|FG003|Overall Study|Lost to Follow-up|5|||
126076873|NCT01588366|453576341|FG002|Overall Study|Adverse Event|0|||
126076874|NCT01588366|453576342|FG003|Overall Study|Adverse Event|1|||
126076875|NCT01588366|453576343|FG004|Overall Study|Adverse Event|0|||
126076876|NCT01588366|453576344|FG005|Overall Study|Adverse Event|2|||
126076877|NCT03245619|453576345|FG000|Part A (Up to Day 22)|Physician Decision|4|||
126076878|NCT03245619|453576346|FG001|Part A (Up to Day 22)|Physician Decision|6|||
126076879|NCT03245619|453576347|FG002|Part A (Up to Day 22)|Physician Decision|6|||
126076880|NCT03245619|453576348|FG003|Part A (Up to Day 22)|Physician Decision|0|||
126076881|NCT03245619|453576349|FG004|Part A (Up to Day 22)|Physician Decision|0|||
126076882|NCT03245619|453576350|FG005|Part A (Up to Day 22)|Physician Decision|0|||
126076883|NCT03245619|453576351|FG006|Part A (Up to Day 22)|Physician Decision|0|||
126076884|NCT03245619|453576352|FG007|Part A (Up to Day 22)|Physician Decision|0|||
126076885|NCT03245619|453576353|FG008|Part A (Up to Day 22)|Physician Decision|0|||
126076886|NCT03245619|453576354|FG009|Part A (Up to Day 22)|Physician Decision|0|||
126076887|NCT03245619|453576355|FG010|Part A (Up to Day 22)|Physician Decision|0|||
126076888|NCT03245619|453576356|FG011|Part A (Up to Day 22)|Physician Decision|0|||
126076889|NCT03245619|453576357|FG012|Part A (Up to Day 22)|Physician Decision|0|||
126076890|NCT03245619|453576358|FG013|Part A (Up to Day 22)|Physician Decision|0|||
126076891|NCT03245619|453576359|FG014|Part A (Up to Day 22)|Physician Decision|0|||
126076892|NCT03245619|453576360|FG015|Part A (Up to Day 22)|Physician Decision|0|||
126076893|NCT03245619|453576361|FG016|Part A (Up to Day 22)|Physician Decision|0|||
126076894|NCT01704547|453576362|FG000|Overall Study|Physician Decision|4|||
126076895|NCT01704547|453576362|FG000|Overall Study|Withdrawal by Subject|1|||
126076896|NCT00690378|453576363|FG000|Overall Study|Adverse Event|1|||
126076897|NCT00690378|453576364|FG001|Overall Study|Adverse Event|0|||
126076898|NCT00690378|453576363|FG000|Overall Study|Withdrawal by Subject|2|||
126076899|NCT00690378|453576364|FG001|Overall Study|Withdrawal by Subject|0|||
126076900|NCT00690378|453576363|FG000|Overall Study|Protocol Violation|1|||
126076901|NCT00690378|453576364|FG001|Overall Study|Protocol Violation|0|||
126076902|NCT00690378|453576363|FG000|Overall Study|Lost to Follow-up|2|||
126076903|NCT00690378|453576364|FG001|Overall Study|Lost to Follow-up|3|||
126076904|NCT00690378|453576363|FG000|Overall Study|Did not meet inc/exc criteria|13|||
126076905|NCT00690378|453576364|FG001|Overall Study|Did not meet inc/exc criteria|11|||
126076906|NCT00690378|453576363|FG000|Overall Study|Social problem|1|||
126076907|NCT00690378|453576364|FG001|Overall Study|Social problem|0|||
126076908|NCT00846768|453576372|FG000|Overall Study|Adverse Event|0|||
126076909|NCT00846768|453576373|FG001|Overall Study|Adverse Event|1|||
126076910|NCT00846768|453576374|FG002|Overall Study|Adverse Event|0|||
126076911|NCT00846768|453576375|FG003|Overall Study|Adverse Event|0|||
126076912|NCT00912223|453576380|FG000|Overall Study|Withdrawal by Subject|1|||
126076913|NCT00912223|453576380|FG000|Overall Study|Not transplanted|1|||
126076914|NCT00912223|453576380|FG000|Overall Study|Transformed disease|1|||
126076915|NCT01099579|453576381|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
126076916|NCT01099579|453576382|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
126076917|NCT01099579|453576383|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
126076918|NCT01099579|453576381|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
126076919|NCT01099579|453576382|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
126076920|NCT01099579|453576383|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
126076921|NCT01099579|453576381|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
126076922|NCT01099579|453576382|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
126076923|NCT01099579|453576383|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
126076924|NCT01099579|453576381|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
126076925|NCT01099579|453576382|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
126076926|NCT01099579|453576383|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
126076927|NCT01099579|453576381|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
126076928|NCT01099579|453576382|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
126076929|NCT01099579|453576383|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
126076930|NCT01099579|453576381|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
126076931|NCT01099579|453576382|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
126076932|NCT01099579|453576383|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
126076933|NCT01099579|453576381|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
126076934|NCT01099579|453576382|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
126076935|NCT01099579|453576383|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
126076936|NCT01099579|453576381|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
126076937|NCT01099579|453576382|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
126076938|NCT01099579|453576383|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
126076939|NCT01099579|453576381|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
126076940|NCT01099579|453576382|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
126076941|NCT01099579|453576383|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
126076942|NCT01099579|453576381|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
126076943|NCT01099579|453576382|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
126076944|NCT01099579|453576383|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
126076945|NCT00909532|453576384|FG000|Overall Study|Adverse Event|4|||
126076946|NCT00909532|453576385|FG001|Overall Study|Adverse Event|1|||
126076947|NCT00909532|453576384|FG000|Overall Study|Pregnancy|0|||
126076948|NCT00909532|453576385|FG001|Overall Study|Pregnancy|1|||
126076949|NCT00909532|453576384|FG000|Overall Study|Prohibited Medication|2|||
126076950|NCT00909532|453576385|FG001|Overall Study|Prohibited Medication|1|||
126076951|NCT00909532|453576384|FG000|Overall Study|Withdrawal of Consent|1|||
126076952|NCT00909532|453576385|FG001|Overall Study|Withdrawal of Consent|1|||
126076953|NCT00909532|453576384|FG000|Overall Study|Noncompliance with Study Requirements|0|||
126076954|NCT00909532|453576385|FG001|Overall Study|Noncompliance with Study Requirements|2|||
126076955|NCT00909532|453576384|FG000|Overall Study|Physician Decision|1|||
126076956|NCT00909532|453576385|FG001|Overall Study|Physician Decision|0|||
126076957|NCT00909532|453576384|FG000|Overall Study|Wrong Genotype|1|||
126076958|NCT00909532|453576385|FG001|Overall Study|Wrong Genotype|0|||
126076959|NCT00909532|453576384|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
126076960|NCT00909532|453576385|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
125948018|NCT00262067|453106894|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
125948019|NCT00262067|453106895|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
126076961|NCT01157377|453576388|FG000|Overall Study|Lost to Follow-up|0|||
126076962|NCT01157377|453576389|FG001|Overall Study|Lost to Follow-up|0|||
126076963|NCT01157377|453576390|FG002|Overall Study|Lost to Follow-up|1|||
126076964|NCT01157377|453576391|FG003|Overall Study|Lost to Follow-up|0|||
126076965|NCT01157377|453576392|FG004|Overall Study|Lost to Follow-up|1|||
126076966|NCT01157377|453576393|FG005|Overall Study|Lost to Follow-up|1|||
126076967|NCT01157377|453576394|FG006|Overall Study|Lost to Follow-up|0|||
126076968|NCT01157377|453576388|FG000|Overall Study|Personal Reasons|2|||
126076969|NCT01157377|453576389|FG001|Overall Study|Personal Reasons|1|||
126076970|NCT01157377|453576390|FG002|Overall Study|Personal Reasons|0|||
126076971|NCT01157377|453576391|FG003|Overall Study|Personal Reasons|1|||
126076972|NCT01157377|453576392|FG004|Overall Study|Personal Reasons|0|||
126076973|NCT01157377|453576393|FG005|Overall Study|Personal Reasons|0|||
126076974|NCT01157377|453576394|FG006|Overall Study|Personal Reasons|0|||
126076975|NCT01157377|453576388|FG000|Overall Study|Protocol Violation|0|||
126076976|NCT01157377|453576389|FG001|Overall Study|Protocol Violation|0|||
126076977|NCT01157377|453576390|FG002|Overall Study|Protocol Violation|0|||
126076978|NCT01157377|453576391|FG003|Overall Study|Protocol Violation|0|||
126076979|NCT01157377|453576392|FG004|Overall Study|Protocol Violation|0|||
126076980|NCT01157377|453576393|FG005|Overall Study|Protocol Violation|1|||
126076981|NCT01157377|453576394|FG006|Overall Study|Protocol Violation|0|||
126076982|NCT01157377|453576388|FG000|Overall Study|Lack of Efficacy|0|||
126076983|NCT01157377|453576389|FG001|Overall Study|Lack of Efficacy|0|||
126076984|NCT01157377|453576390|FG002|Overall Study|Lack of Efficacy|0|||
126076985|NCT01157377|453576391|FG003|Overall Study|Lack of Efficacy|0|||
126076986|NCT01157377|453576392|FG004|Overall Study|Lack of Efficacy|0|||
126076987|NCT01157377|453576393|FG005|Overall Study|Lack of Efficacy|0|||
126076988|NCT01157377|453576394|FG006|Overall Study|Lack of Efficacy|1|||
126076989|NCT01157377|453576388|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126076990|NCT01157377|453576389|FG001|Overall Study|Other Miscellaneous Reasons|2|||
126076991|NCT01157377|453576390|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126076992|NCT01157377|453576391|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126076993|NCT01157377|453576392|FG004|Overall Study|Other Miscellaneous Reasons|1|||
126076994|NCT01157377|453576393|FG005|Overall Study|Other Miscellaneous Reasons|1|||
126076995|NCT01157377|453576394|FG006|Overall Study|Other Miscellaneous Reasons|1|||
126076996|NCT00927901|453576395|FG000|Treatment Period 1|Subject withdrew consent|0|||
126076997|NCT00927901|453576396|FG001|Treatment Period 1|Subject withdrew consent|0|||
126076998|NCT00927901|453576397|FG002|Treatment Period 1|Subject withdrew consent|1|||
126076999|NCT00927901|453576398|FG003|Treatment Period 1|Subject withdrew consent|0|||
126077000|NCT00927901|453576395|FG000|Treatment Period 4|Adverse Event|0|||
125948020|NCT00262067|453106896|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
125948021|NCT00262067|453106897|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
125948022|NCT00262067|453106894|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
125948023|NCT00262067|453106895|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
125948024|NCT00262067|453106896|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
125948025|NCT00262067|453106897|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
125948026|NCT00655564|453106898|FG000|Overall Study|Adverse Event|1|||
125948027|NCT00655564|453106898|FG000|Overall Study|Lost to Follow-up|1|||
125948028|NCT00655564|453106898|FG000|Overall Study|Desired Alternate Therapy|1|||
125948029|NCT01077804|453106899|FG000|Overall Study|Unreachable|102|||
126077001|NCT00927901|453576396|FG001|Treatment Period 4|Adverse Event|0|||
126077002|NCT00927901|453576397|FG002|Treatment Period 4|Adverse Event|0|||
126077003|NCT00927901|453576398|FG003|Treatment Period 4|Adverse Event|1|||
126077004|NCT00927901|453576395|FG000|Treatment Period 4|Subject withdrew consent|0|||
126077005|NCT00927901|453576396|FG001|Treatment Period 4|Subject withdrew consent|0|||
125948030|NCT01077804|453106899|FG000|Overall Study|Refused to continue|79|||
125948031|NCT01077804|453106899|FG000|Overall Study|Other|18|||
125948032|NCT02620046|453106900|FG000|Overall Study|Adverse Event|22|||
126077006|NCT00927901|453576397|FG002|Treatment Period 4|Subject withdrew consent|1|||
126077007|NCT00927901|453576398|FG003|Treatment Period 4|Subject withdrew consent|0|||
126077008|NCT01263925|453576403|FG000|Overall Study|Protocol Violation|1|||
125948033|NCT02620046|453106901|FG001|Overall Study|Adverse Event|42|||
125948034|NCT02620046|453106900|FG000|Overall Study|Lost to Follow-up|4|||
126077009|NCT01263925|453576404|FG001|Overall Study|Protocol Violation|0|||
126077010|NCT01263925|453576403|FG000|Overall Study|Lack of Efficacy|0|||
126077011|NCT01263925|453576404|FG001|Overall Study|Lack of Efficacy|1|||
126114916|NCT01514136|453715811|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
126077012|NCT01263925|453576403|FG000|Overall Study|Adverse Event|23|||
125948035|NCT02620046|453106901|FG001|Overall Study|Lost to Follow-up|10|||
125948036|NCT02620046|453106900|FG000|Overall Study|Withdrawal by Subject|36|||
125948037|NCT02620046|453106901|FG001|Overall Study|Withdrawal by Subject|66|||
125948038|NCT02620046|453106900|FG000|Overall Study|Site Termination|3|||
126077013|NCT01263925|453576404|FG001|Overall Study|Adverse Event|22|||
126077014|NCT01263925|453576403|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
126077015|NCT01263925|453576404|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
126077016|NCT01263925|453576403|FG000|Overall Study|Withdrawal by Subject|6|||
126077017|NCT01263925|453576404|FG001|Overall Study|Withdrawal by Subject|8|||
126077018|NCT01263925|453576403|FG000|Overall Study|Other|4|||
126077019|NCT01263925|453576404|FG001|Overall Study|Other|4|||
126077020|NCT01263925|453576403|FG000|Overall Study|Lost to Follow-up|3|||
126077021|NCT01263925|453576404|FG001|Overall Study|Lost to Follow-up|1|||
126077022|NCT01263925|453576403|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
126077023|NCT01263925|453576404|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
126077024|NCT01263925|453576403|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
126077025|NCT01263925|453576404|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
126077026|NCT01263925|453576403|FG000|Overall Study|AE/ Withdrawal|1|||
126077027|NCT01263925|453576404|FG001|Overall Study|AE/ Withdrawal|4|||
126077028|NCT01263925|453576403|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
126077029|NCT01263925|453576404|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
126077030|NCT01263925|453576403|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
126077031|NCT01263925|453576404|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
126077032|NCT01263925|453576403|FG000|Overall Study|Withdrawal/ Not specified|0|||
126077033|NCT01263925|453576404|FG001|Overall Study|Withdrawal/ Not specified|1|||
126077034|NCT03029819|453576405|FG000|Overall Study|Lost to Follow-up|3|||
126077035|NCT03029819|453576406|FG001|Overall Study|Lost to Follow-up|5|||
126077036|NCT03029819|453576405|FG000|Overall Study|Removed due to disruptive behavior|0|||
126077037|NCT03029819|453576406|FG001|Overall Study|Removed due to disruptive behavior|1|||
126077038|NCT02650466|453576413|FG000|Overall Study|Physician Decision|1|||
126077039|NCT02650466|453576413|FG000|Overall Study|Withdrawal by Subject|5|||
126077040|NCT02650466|453576413|FG000|Overall Study|Lost to Follow-up|1|||
126077041|NCT01726517|453576414|FG000|Overall Study|Withdrawal by Subject|0|||
126077042|NCT01726517|453576415|FG001|Overall Study|Withdrawal by Subject|0|||
126077043|NCT01726517|453576416|FG002|Overall Study|Withdrawal by Subject|1|||
126077044|NCT01726517|453576417|FG003|Overall Study|Withdrawal by Subject|0|||
126077045|NCT01726517|453576418|FG004|Overall Study|Withdrawal by Subject|0|||
126077046|NCT00573651|453576419|FG000|Overall Study|Lost to Follow-up|3|||
126077047|NCT00573651|453576419|FG000|Overall Study|Withdrawal by Subject|1|||
126077048|NCT03765164|453576420|FG000|Pre-intervention|Withdrawal by Subject|5|||
126077049|NCT03765164|453576421|FG001|Pre-intervention|Withdrawal by Subject|6|||
126077050|NCT03797989|453576443|FG000|VAC069A|Withdrawal by Subject|0|||
126077051|NCT03797989|453576444|FG001|VAC069A|Withdrawal by Subject|0|||
126077052|NCT03797989|453576445|FG002|VAC069A|Withdrawal by Subject|1|||
126077053|NCT03797989|453576446|FG003|VAC069A|Withdrawal by Subject|0|||
126077054|NCT03797989|453576447|FG004|VAC069A|Withdrawal by Subject|0|||
126077055|NCT03797989|453576448|FG005|VAC069A|Withdrawal by Subject|0|||
126077056|NCT03797989|453576449|FG006|VAC069A|Withdrawal by Subject|0|||
126077057|NCT03797989|453576450|FG007|VAC069A|Withdrawal by Subject|0|||
126077058|NCT03797989|453576451|FG008|VAC069A|Withdrawal by Subject|0|||
126077059|NCT03797989|453576452|FG009|VAC069A|Withdrawal by Subject|0|||
126077060|NCT03797989|453576453|FG010|VAC069A|Withdrawal by Subject|0|||
126077061|NCT03797989|453576454|FG011|VAC069A|Withdrawal by Subject|0|||
126077062|NCT04052997|453576455|FG000|Overall Study|Withdrawal by Subject|17|||
126077063|NCT04052997|453576455|FG000|Overall Study|Physician Decision|50|||
126077064|NCT04052997|453576455|FG000|Overall Study|Death|43|||
126077065|NCT04052997|453576455|FG000|Overall Study|Lost to Follow-up|5|||
126077066|NCT04052997|453576455|FG000|Overall Study|Progression of Disease|1|||
126077067|NCT01024036|453576456|FG000|Blinded Treatment|Adverse Event|1|||
126077068|NCT01024036|453576457|FG001|Blinded Treatment|Adverse Event|1|||
126077069|NCT01024036|453576456|FG000|Blinded Treatment|Lack of Efficacy|16|||
126077070|NCT01024036|453576457|FG001|Blinded Treatment|Lack of Efficacy|14|||
126077071|NCT01024036|453576456|FG000|Blinded Treatment|Physician Decision|1|||
126077072|NCT01024036|453576457|FG001|Blinded Treatment|Physician Decision|0|||
126077073|NCT01024036|453576456|FG000|Blinded Treatment|Death|0|||
126077074|NCT01024036|453576457|FG001|Blinded Treatment|Death|2|||
126077075|NCT01024036|453576456|FG000|Blinded Treatment|Withdrawal by Subject|4|||
126077076|NCT01024036|453576457|FG001|Blinded Treatment|Withdrawal by Subject|3|||
126077077|NCT01024036|453576456|FG000|Unblinded Treatment|Adverse Event|0|||
126077078|NCT01024036|453576457|FG001|Unblinded Treatment|Adverse Event|1|||
126077079|NCT01024036|453576456|FG000|Unblinded Treatment|Lack of Efficacy|0|||
126077080|NCT01024036|453576457|FG001|Unblinded Treatment|Lack of Efficacy|2|||
126077081|NCT01024036|453576456|FG000|Follow-Up Period|Lost to Follow-up|1|||
126077082|NCT01024036|453576457|FG001|Follow-Up Period|Lost to Follow-up|1|||
126077083|NCT01024036|453576456|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126077084|NCT01024036|453576457|FG001|Follow-Up Period|Withdrawal by Subject|1|||
126077085|NCT01024036|453576456|FG000|Follow-Up Period|Adverse Event|4|||
126077086|NCT01024036|453576457|FG001|Follow-Up Period|Adverse Event|1|||
126077087|NCT00604188|453576462|FG000|Overall Study|Adverse Event|1|||
126077088|NCT00604188|453576463|FG001|Overall Study|Adverse Event|4|||
126114917|NCT01514136|453715812|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
126077089|NCT00604188|453576462|FG000|Overall Study|Lost to Follow-up|17|||
126077090|NCT00604188|453576463|FG001|Overall Study|Lost to Follow-up|15|||
126077091|NCT00604188|453576462|FG000|Overall Study|Withdrawal by Subject|5|||
126077092|NCT00604188|453576463|FG001|Overall Study|Withdrawal by Subject|1|||
126077093|NCT00604188|453576462|FG000|Overall Study|Non-compliance with protocol|4|||
126077094|NCT00604188|453576463|FG001|Overall Study|Non-compliance with protocol|4|||
126077095|NCT00604188|453576462|FG000|Overall Study|Did not receive study drug|0|||
126077096|NCT00604188|453576463|FG001|Overall Study|Did not receive study drug|1|||
126077097|NCT00356759|453576466|FG000|Overall Study|Death|5|||
126077098|NCT00356759|453576467|FG001|Overall Study|Death|2|||
126077099|NCT00356759|453576466|FG000|Overall Study|Withdrawal by Subject|2|||
126077100|NCT00356759|453576467|FG001|Overall Study|Withdrawal by Subject|2|||
126077101|NCT00356759|453576466|FG000|Overall Study|Adverse Event|1|||
126077102|NCT00356759|453576467|FG001|Overall Study|Adverse Event|3|||
126077103|NCT00356759|453576466|FG000|Overall Study|Lost to Follow-up|1|||
126077104|NCT00356759|453576467|FG001|Overall Study|Lost to Follow-up|1|||
126077105|NCT00356759|453576466|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
126077106|NCT00356759|453576467|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
126077107|NCT00474383|453576469|FG000|Main Study|Adverse Event|11|||
126077108|NCT00474383|453576470|FG001|Main Study|Adverse Event|0|||
126077109|NCT00474383|453576469|FG000|Main Study|Symptomatic Deterioration|1|||
126077110|NCT00474383|453576470|FG001|Main Study|Symptomatic Deterioration|0|||
126077111|NCT00474383|453576469|FG000|Main Study|Progressive Disease|23|||
126077112|NCT00474383|453576470|FG001|Main Study|Progressive Disease|0|||
126077113|NCT00474383|453576469|FG000|Main Study|Other|1|||
126077114|NCT00474383|453576470|FG001|Main Study|Other|0|||
126077115|NCT00474383|453576469|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
126077116|NCT00474383|453576470|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
126077117|NCT00474383|453576469|FG000|Extension|Progressive Disease|0|||
126077118|NCT00474383|453576470|FG001|Extension|Progressive Disease|5|||
126077119|NCT02998918|453576471|FG000|Overall Study|Withdrawal by Subject|1|||
126077120|NCT02998918|453576472|FG001|Overall Study|Withdrawal by Subject|0|||
126077121|NCT00443599|453576480|FG000|Overall Study|Physician Decision|2|||
126077122|NCT00443599|453576481|FG001|Overall Study|Physician Decision|1|||
126077123|NCT00443599|453576480|FG000|Overall Study|Death|1|||
126077124|NCT00443599|453576481|FG001|Overall Study|Death|1|||
126077125|NCT00443599|453576480|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
126077126|NCT00443599|453576481|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
126077127|NCT01256671|453578365|FG000|Overall Study|Adverse Event|29|||
126077128|NCT01256671|453578365|FG000|Overall Study|Lost to Follow-up|16|||
126077129|NCT01256671|453578365|FG000|Overall Study|Withdrawal by Subject|31|||
126077130|NCT01256671|453578365|FG000|Overall Study|Physician Decision|3|||
126077131|NCT01256671|453578365|FG000|Overall Study|Lack of Efficacy|4|||
126077132|NCT01256671|453578365|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
126077133|NCT00030823|453578369|FG000|Overall Study|Withdrawal by Subject|1|||
125948039|NCT02620046|453106901|FG001|Overall Study|Site Termination|3|||
125948040|NCT02620046|453106900|FG000|Overall Study|Pregnancy|3|||
125948041|NCT02620046|453106901|FG001|Overall Study|Pregnancy|7|||
125948042|NCT02620046|453106900|FG000|Overall Study|Lack of Efficacy|81|||
126077134|NCT04333147|453578371|FG000|Overall Study|Adverse Event|43|||
126077135|NCT04333147|453578372|FG001|Overall Study|Adverse Event|40|||
126077136|NCT04333147|453578371|FG000|Overall Study|Lack of Efficacy|49|||
126077137|NCT04333147|453578372|FG001|Overall Study|Lack of Efficacy|48|||
126077138|NCT04333147|453578371|FG000|Overall Study|Lost to Follow-up|19|||
126077139|NCT04333147|453578372|FG001|Overall Study|Lost to Follow-up|16|||
126077140|NCT04333147|453578371|FG000|Overall Study|Physician Decision|17|||
126077141|NCT04333147|453578372|FG001|Overall Study|Physician Decision|20|||
126077142|NCT04333147|453578371|FG000|Overall Study|Withdrawal by Subject|65|||
126077143|NCT04333147|453578372|FG001|Overall Study|Withdrawal by Subject|68|||
126077144|NCT04333147|453578371|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
126077145|NCT04333147|453578372|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
126077146|NCT04333147|453578371|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
126077147|NCT04333147|453578372|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
126077148|NCT04333147|453578371|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
126077149|NCT04333147|453578372|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
126077150|NCT00408928|453578373|FG000|Overall Study|Withdrawal by Subject|1|||
126114918|NCT01514136|453715813|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
126114919|NCT01514136|453715814|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
125948043|NCT02620046|453106901|FG001|Overall Study|Lack of Efficacy|146|||
126077151|NCT00408928|453578373|FG000|Overall Study|Death|1|||
126077152|NCT00408928|453578373|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
126077153|NCT03305809|453578376|FG000|Overall Study|Adverse Event|2|||
126077154|NCT03305809|453578377|FG001|Overall Study|Adverse Event|2|||
126077155|NCT03305809|453578378|FG002|Overall Study|Adverse Event|6|||
126077156|NCT03305809|453578379|FG003|Overall Study|Adverse Event|6|||
126077157|NCT03305809|453578376|FG000|Overall Study|Death|0|||
126077158|NCT03305809|453578377|FG001|Overall Study|Death|0|||
126077159|NCT03305809|453578378|FG002|Overall Study|Death|1|||
126077160|NCT03305809|453578379|FG003|Overall Study|Death|1|||
126077161|NCT03305809|453578376|FG000|Overall Study|Lost to Follow-up|1|||
126077162|NCT03305809|453578377|FG001|Overall Study|Lost to Follow-up|2|||
126077163|NCT03305809|453578378|FG002|Overall Study|Lost to Follow-up|0|||
126077164|NCT03305809|453578379|FG003|Overall Study|Lost to Follow-up|0|||
126077165|NCT03305809|453578376|FG000|Overall Study|Sponsor Decision|1|||
126077166|NCT03305809|453578377|FG001|Overall Study|Sponsor Decision|0|||
126077167|NCT03305809|453578378|FG002|Overall Study|Sponsor Decision|1|||
126077168|NCT03305809|453578379|FG003|Overall Study|Sponsor Decision|8|||
126077169|NCT03305809|453578376|FG000|Overall Study|Physician Decision|0|||
126077170|NCT03305809|453578377|FG001|Overall Study|Physician Decision|0|||
126077171|NCT03305809|453578378|FG002|Overall Study|Physician Decision|2|||
126077172|NCT03305809|453578379|FG003|Overall Study|Physician Decision|4|||
126077173|NCT03305809|453578376|FG000|Overall Study|Progressive Disease|0|||
126077174|NCT03305809|453578377|FG001|Overall Study|Progressive Disease|0|||
126077175|NCT03305809|453578378|FG002|Overall Study|Progressive Disease|1|||
126077176|NCT03305809|453578379|FG003|Overall Study|Progressive Disease|0|||
126077177|NCT03305809|453578376|FG000|Overall Study|Protocol Violation|1|||
126077178|NCT03305809|453578377|FG001|Overall Study|Protocol Violation|0|||
126077179|NCT03305809|453578378|FG002|Overall Study|Protocol Violation|2|||
126077180|NCT03305809|453578379|FG003|Overall Study|Protocol Violation|3|||
126077181|NCT03305809|453578376|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
126077182|NCT03305809|453578377|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
126077183|NCT03305809|453578378|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
126077184|NCT03305809|453578379|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
126077185|NCT03305809|453578376|FG000|Overall Study|Withdrawal by Subject|2|||
126077186|NCT03305809|453578377|FG001|Overall Study|Withdrawal by Subject|4|||
126077187|NCT03305809|453578378|FG002|Overall Study|Withdrawal by Subject|5|||
126077188|NCT03305809|453578379|FG003|Overall Study|Withdrawal by Subject|2|||
126077189|NCT03305809|453578376|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
126077190|NCT03305809|453578377|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
126077191|NCT03305809|453578378|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
126077192|NCT03305809|453578379|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
126077193|NCT00816556|453578380|FG000|Overall Study|Adverse Event|1|||
126077194|NCT00816556|453578381|FG001|Overall Study|Adverse Event|1|||
126077195|NCT00816556|453578382|FG002|Overall Study|Adverse Event|1|||
126077196|NCT00816556|453578380|FG000|Overall Study|Withdrawal by Subject|1|||
125948044|NCT02620046|453106900|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
125948045|NCT02620046|453106901|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
126114920|NCT01514136|453715807|FG000|Test Period 2; Test A*|Adverse Event|0|||
126114921|NCT01514136|453715808|FG001|Test Period 2; Test A*|Adverse Event|0|||
126114922|NCT01514136|453715809|FG002|Test Period 2; Test A*|Adverse Event|0|||
126114923|NCT01514136|453715810|FG003|Test Period 2; Test A*|Adverse Event|0|||
126114924|NCT01514136|453715811|FG004|Test Period 2; Test A*|Adverse Event|1|||
126114925|NCT01514136|453715812|FG005|Test Period 2; Test A*|Adverse Event|0|||
126114926|NCT01514136|453715813|FG006|Test Period 2; Test A*|Adverse Event|0|||
126114927|NCT01514136|453715814|FG007|Test Period 2; Test A*|Adverse Event|0|||
126114928|NCT01514136|453715807|FG000|Test Period 2; Test A*|Holiday|0|||
126114929|NCT01514136|453715808|FG001|Test Period 2; Test A*|Holiday|0|||
126114930|NCT01514136|453715809|FG002|Test Period 2; Test A*|Holiday|0|||
126114931|NCT01514136|453715810|FG003|Test Period 2; Test A*|Holiday|0|||
125948046|NCT02620046|453106900|FG000|Overall Study|Reason Not Specified|13|||
125948047|NCT02620046|453106901|FG001|Overall Study|Reason Not Specified|21|||
125948048|NCT02620046|453106900|FG000|Overall Study|Significant Protocol Deviation|0|||
125948049|NCT02620046|453106901|FG001|Overall Study|Significant Protocol Deviation|1|||
125948050|NCT03962543|453106903|FG000|Treatment Phase|Death|0|||
125948051|NCT03962543|453106904|FG001|Treatment Phase|Death|1|||
125948052|NCT03962543|453106903|FG000|Treatment Phase|Withdrawal by Subject|3|||
125948053|NCT03962543|453106904|FG001|Treatment Phase|Withdrawal by Subject|0|||
125948054|NCT03962543|453106903|FG000|Treatment Phase|Adverse Event|3|||
125948055|NCT03962543|453106904|FG001|Treatment Phase|Adverse Event|12|||
125948056|NCT03962543|453106903|FG000|Treatment Phase|Lost to Follow-up|1|||
125948057|NCT03962543|453106904|FG001|Treatment Phase|Lost to Follow-up|2|||
125948058|NCT03962543|453106903|FG000|Treatment Phase|Radiographic PD|9|||
125948059|NCT03962543|453106904|FG001|Treatment Phase|Radiographic PD|3|||
125948060|NCT03962543|453106903|FG000|Treatment Phase|Participant Decision|3|||
125948061|NCT03962543|453106904|FG001|Treatment Phase|Participant Decision|8|||
126077197|NCT00816556|453578381|FG001|Overall Study|Withdrawal by Subject|1|||
126114932|NCT01514136|453715811|FG004|Test Period 2; Test A*|Holiday|1|||
126114933|NCT01514136|453715812|FG005|Test Period 2; Test A*|Holiday|0|||
125948062|NCT03962543|453106903|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
126077198|NCT00816556|453578382|FG002|Overall Study|Withdrawal by Subject|1|||
126077199|NCT00816556|453578380|FG000|Overall Study|Lost to Follow-up|0|||
126077200|NCT00816556|453578381|FG001|Overall Study|Lost to Follow-up|0|||
126114934|NCT01514136|453715813|FG006|Test Period 2; Test A*|Holiday|0|||
125948063|NCT03962543|453106904|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
126077201|NCT00816556|453578382|FG002|Overall Study|Lost to Follow-up|1|||
126077202|NCT03546816|453578383|FG000|Overall Study|Adverse Event|5|||
126077203|NCT03546816|453578384|FG001|Overall Study|Adverse Event|3|||
126077204|NCT03546816|453578383|FG000|Overall Study|Lack of Efficacy|2|||
126077205|NCT03546816|453578384|FG001|Overall Study|Lack of Efficacy|4|||
126077206|NCT03546816|453578383|FG000|Overall Study|Pregnancy|1|||
126077207|NCT03546816|453578384|FG001|Overall Study|Pregnancy|0|||
126077208|NCT03546816|453578383|FG000|Overall Study|Physician Decision|2|||
126077209|NCT03546816|453578384|FG001|Overall Study|Physician Decision|0|||
126077210|NCT03546816|453578383|FG000|Overall Study|Withdrawal by Subject|8|||
126077211|NCT03546816|453578384|FG001|Overall Study|Withdrawal by Subject|10|||
126077212|NCT03546816|453578383|FG000|Overall Study|Lost to Follow-up|3|||
126077213|NCT03546816|453578384|FG001|Overall Study|Lost to Follow-up|2|||
126077214|NCT02438371|453578385|FG000|Overall Study|Lost to Follow-up|3|||
126077215|NCT02438371|453578386|FG001|Overall Study|Lost to Follow-up|2|||
126077216|NCT02438371|453578385|FG000|Overall Study|Withdrawal by Subject|1|||
126077217|NCT02438371|453578386|FG001|Overall Study|Withdrawal by Subject|1|||
126077218|NCT01161446|453578387|FG000|Overall Study|Lost to Follow-up|18|||
126077219|NCT01161446|453578388|FG001|Overall Study|Lost to Follow-up|14|||
126077220|NCT01161446|453578387|FG000|Overall Study|Withdrawal by Subject|0|||
126077221|NCT01161446|453578388|FG001|Overall Study|Withdrawal by Subject|1|||
126077222|NCT03065933|453578389|FG000|Overall Study|study terminated|5|||
126077223|NCT02330562|453578390|FG000|Overall Study|Adverse Event|0|||
126077224|NCT02330562|453578391|FG001|Overall Study|Adverse Event|0|||
126077225|NCT02330562|453578392|FG002|Overall Study|Adverse Event|3|||
126077226|NCT02330562|453578393|FG003|Overall Study|Adverse Event|0|||
126077227|NCT02330562|453578394|FG004|Overall Study|Adverse Event|3|||
126077228|NCT02330562|453578395|FG005|Overall Study|Adverse Event|1|||
126077229|NCT02330562|453578396|FG006|Overall Study|Adverse Event|0|||
126077230|NCT02330562|453578397|FG007|Overall Study|Adverse Event|0|||
126077231|NCT02330562|453578398|FG008|Overall Study|Adverse Event|0|||
126077232|NCT02330562|453578399|FG009|Overall Study|Adverse Event|1|||
126077233|NCT02330562|453578400|FG010|Overall Study|Adverse Event|1|||
126077234|NCT02330562|453578390|FG000|Overall Study|Participant decision|1|||
126077235|NCT02330562|453578391|FG001|Overall Study|Participant decision|0|||
126077236|NCT02330562|453578392|FG002|Overall Study|Participant decision|4|||
126077237|NCT02330562|453578393|FG003|Overall Study|Participant decision|1|||
126077238|NCT02330562|453578394|FG004|Overall Study|Participant decision|5|||
125948064|NCT03962543|453106903|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
125948065|NCT03962543|453106904|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
125948066|NCT03962543|453106903|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
125948067|NCT03962543|453106904|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
125948068|NCT03962543|453106903|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
125948069|NCT03962543|453106904|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
125948070|NCT03962543|453106903|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
125948071|NCT03962543|453106904|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
126077239|NCT02330562|453578395|FG005|Overall Study|Participant decision|2|||
126077240|NCT02330562|453578396|FG006|Overall Study|Participant decision|0|||
126077241|NCT02330562|453578397|FG007|Overall Study|Participant decision|0|||
126077242|NCT02330562|453578398|FG008|Overall Study|Participant decision|0|||
126077243|NCT02330562|453578399|FG009|Overall Study|Participant decision|3|||
126077244|NCT02330562|453578400|FG010|Overall Study|Participant decision|0|||
126077245|NCT02330562|453578390|FG000|Overall Study|Disease progression|5|||
126077246|NCT02330562|453578391|FG001|Overall Study|Disease progression|3|||
126077247|NCT02330562|453578392|FG002|Overall Study|Disease progression|20|||
126077248|NCT02330562|453578393|FG003|Overall Study|Disease progression|28|||
126077249|NCT02330562|453578394|FG004|Overall Study|Disease progression|23|||
126077250|NCT02330562|453578395|FG005|Overall Study|Disease progression|7|||
126077251|NCT02330562|453578396|FG006|Overall Study|Disease progression|1|||
126077252|NCT02330562|453578397|FG007|Overall Study|Disease progression|1|||
126077253|NCT02330562|453578398|FG008|Overall Study|Disease progression|1|||
126077254|NCT02330562|453578399|FG009|Overall Study|Disease progression|0|||
126077255|NCT02330562|453578400|FG010|Overall Study|Disease progression|5|||
126077256|NCT02330562|453578390|FG000|Overall Study|Other reasons|0|||
126077257|NCT02330562|453578391|FG001|Overall Study|Other reasons|0|||
125948072|NCT03962543|453106903|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
126077258|NCT02330562|453578392|FG002|Overall Study|Other reasons|0|||
126077259|NCT02330562|453578393|FG003|Overall Study|Other reasons|1|||
125948073|NCT03962543|453106904|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
125948074|NCT03962543|453106903|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
126077260|NCT02330562|453578394|FG004|Overall Study|Other reasons|0|||
126077261|NCT02330562|453578395|FG005|Overall Study|Other reasons|0|||
126077262|NCT02330562|453578396|FG006|Overall Study|Other reasons|0|||
126077263|NCT02330562|453578397|FG007|Overall Study|Other reasons|0|||
126077264|NCT02330562|453578398|FG008|Overall Study|Other reasons|0|||
126077265|NCT02330562|453578399|FG009|Overall Study|Other reasons|0|||
126077266|NCT02330562|453578400|FG010|Overall Study|Other reasons|0|||
126077267|NCT02330562|453578390|FG000|Overall Study|Withdrawal by Subject|0|||
126077268|NCT02330562|453578391|FG001|Overall Study|Withdrawal by Subject|0|||
126077269|NCT02330562|453578392|FG002|Overall Study|Withdrawal by Subject|0|||
126077270|NCT02330562|453578393|FG003|Overall Study|Withdrawal by Subject|0|||
126077271|NCT02330562|453578394|FG004|Overall Study|Withdrawal by Subject|0|||
126077272|NCT02330562|453578395|FG005|Overall Study|Withdrawal by Subject|0|||
126077273|NCT02330562|453578396|FG006|Overall Study|Withdrawal by Subject|0|||
126077274|NCT02330562|453578397|FG007|Overall Study|Withdrawal by Subject|0|||
126077275|NCT02330562|453578398|FG008|Overall Study|Withdrawal by Subject|0|||
126077276|NCT02330562|453578399|FG009|Overall Study|Withdrawal by Subject|1|||
126077277|NCT02330562|453578400|FG010|Overall Study|Withdrawal by Subject|0|||
126077278|NCT01162135|453578403|FG000|Overall Study|Withdrawal by Subject|1|||
126077279|NCT01162135|453578403|FG000|Overall Study|Severe back pain|1|||
126077280|NCT01162135|453578403|FG000|Overall Study|Ineligible|1|||
126077281|NCT01379703|453578404|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
126077282|NCT01379703|453578405|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
126077283|NCT01379703|453578406|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
126077284|NCT01379703|453578404|FG000|Study Start Through 9 Months|Adverse Event|0|||
126077285|NCT01379703|453578405|FG001|Study Start Through 9 Months|Adverse Event|14|||
126077286|NCT01379703|453578406|FG002|Study Start Through 9 Months|Adverse Event|10|||
126077287|NCT01379703|453578404|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
126077288|NCT01379703|453578405|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
126077289|NCT01379703|453578406|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
126077290|NCT01379703|453578404|FG000|Study Start Through 9 Months|Treatment Failure|0|||
126077291|NCT01379703|453578405|FG001|Study Start Through 9 Months|Treatment Failure|2|||
126077292|NCT01379703|453578406|FG002|Study Start Through 9 Months|Treatment Failure|2|||
126077293|NCT01379703|453578404|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
126077294|NCT01379703|453578405|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
126077295|NCT01379703|453578406|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
126077296|NCT01379703|453578404|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
126077297|NCT01379703|453578405|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
126077298|NCT01379703|453578406|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
126077299|NCT01379703|453578404|FG000|Study Start Through 9 Months|Medication not available|0|||
126077300|NCT01379703|453578405|FG001|Study Start Through 9 Months|Medication not available|2|||
126077301|NCT01379703|453578406|FG002|Study Start Through 9 Months|Medication not available|1|||
126077302|NCT01379703|453578404|FG000|Study Start Through 9 Months|Poor general condition|0|||
126077303|NCT01379703|453578405|FG001|Study Start Through 9 Months|Poor general condition|1|||
126077304|NCT01379703|453578406|FG002|Study Start Through 9 Months|Poor general condition|0|||
126077305|NCT01379703|453578404|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
126077306|NCT01379703|453578405|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
126077307|NCT01379703|453578406|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
126077308|NCT01379703|453578404|FG000|Study Start Through 9 Months|Reason unknown|2|||
126077309|NCT01379703|453578405|FG001|Study Start Through 9 Months|Reason unknown|31|||
126077310|NCT01379703|453578406|FG002|Study Start Through 9 Months|Reason unknown|24|||
126077311|NCT01379703|453578404|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
126077312|NCT01379703|453578405|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
126077313|NCT01379703|453578406|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
126077314|NCT01379703|453578404|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
126077315|NCT01379703|453578405|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
126077316|NCT01379703|453578406|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
126077317|NCT01379703|453578404|FG000|9 Months Through 18 Months|Adverse Event|0|||
126077318|NCT01379703|453578405|FG001|9 Months Through 18 Months|Adverse Event|6|||
126077319|NCT01379703|453578406|FG002|9 Months Through 18 Months|Adverse Event|0|||
126077320|NCT01379703|453578404|FG000|9 Months Through 18 Months|Treatment failure|0|||
126077321|NCT01379703|453578405|FG001|9 Months Through 18 Months|Treatment failure|5|||
126077322|NCT01379703|453578406|FG002|9 Months Through 18 Months|Treatment failure|0|||
126077323|NCT01379703|453578404|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
126077324|NCT01379703|453578405|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
126077325|NCT01379703|453578406|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
126077326|NCT01379703|453578404|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
126077327|NCT01379703|453578405|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
126077328|NCT01379703|453578406|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
126077329|NCT01379703|453578404|FG000|9 Months Through 18 Months|Fatigue|0|||
126077330|NCT01379703|453578405|FG001|9 Months Through 18 Months|Fatigue|1|||
126077331|NCT01379703|453578406|FG002|9 Months Through 18 Months|Fatigue|0|||
126077332|NCT01379703|453578404|FG000|9 Months Through 18 Months|Reason Unknown|0|||
126077333|NCT01379703|453578405|FG001|9 Months Through 18 Months|Reason Unknown|23|||
126077334|NCT01379703|453578406|FG002|9 Months Through 18 Months|Reason Unknown|0|||
126077335|NCT01316887|453578407|FG000|Overall Study|Adverse Event|13|||
126077336|NCT01316887|453578408|FG001|Overall Study|Adverse Event|21|||
126077337|NCT01316887|453578409|FG002|Overall Study|Adverse Event|17|||
126077338|NCT01316887|453578407|FG000|Overall Study|Lack of Efficacy|9|||
126077339|NCT01316887|453578408|FG001|Overall Study|Lack of Efficacy|3|||
126077340|NCT01316887|453578409|FG002|Overall Study|Lack of Efficacy|1|||
126114935|NCT01514136|453715814|FG007|Test Period 2; Test A*|Holiday|0|||
125948075|NCT03962543|453106904|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
126077341|NCT01316887|453578407|FG000|Overall Study|Protocol Violation|2|||
126077342|NCT01316887|453578408|FG001|Overall Study|Protocol Violation|6|||
126077343|NCT01316887|453578409|FG002|Overall Study|Protocol Violation|6|||
126077344|NCT01316887|453578407|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
126077345|NCT01316887|453578408|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
126077346|NCT01316887|453578409|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
126077347|NCT01316887|453578407|FG000|Overall Study|Study Closed/Terminated|2|||
126077348|NCT01316887|453578408|FG001|Overall Study|Study Closed/Terminated|4|||
126077349|NCT01316887|453578409|FG002|Overall Study|Study Closed/Terminated|3|||
126077350|NCT01316887|453578407|FG000|Overall Study|Lost to Follow-up|1|||
126077351|NCT01316887|453578408|FG001|Overall Study|Lost to Follow-up|7|||
126077352|NCT01316887|453578409|FG002|Overall Study|Lost to Follow-up|5|||
126077353|NCT01316887|453578407|FG000|Overall Study|Withdrawal by Subject|8|||
126077354|NCT01316887|453578408|FG001|Overall Study|Withdrawal by Subject|16|||
126077355|NCT01316887|453578409|FG002|Overall Study|Withdrawal by Subject|15|||
126077356|NCT03470545|453578412|FG000|Overall Study|Death|0|||
126077357|NCT03470545|453578413|FG001|Overall Study|Death|1|||
126077358|NCT03470545|453578412|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
126077359|NCT03470545|453578413|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
126077360|NCT03470545|453578412|FG000|Overall Study|Adverse Event|2|||
126077361|NCT03470545|453578413|FG001|Overall Study|Adverse Event|0|||
126077362|NCT03470545|453578412|FG000|Overall Study|Withdrawal by Subject|1|||
126077363|NCT03470545|453578413|FG001|Overall Study|Withdrawal by Subject|1|||
126077364|NCT03470545|453578412|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
126077365|NCT03470545|453578413|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
126077366|NCT02312206|453578414|FG000|Overall Study|Adverse Event|3|||
126077367|NCT02312206|453578415|FG001|Overall Study|Adverse Event|6|||
126077368|NCT02312206|453578414|FG000|Overall Study|Withdrawal by Subject|6|||
126077369|NCT02312206|453578415|FG001|Overall Study|Withdrawal by Subject|6|||
126077370|NCT02312206|453578414|FG000|Overall Study|Physician Decision|7|||
126077371|NCT02312206|453578415|FG001|Overall Study|Physician Decision|6|||
126077372|NCT02312206|453578414|FG000|Overall Study|Death|31|||
126077373|NCT02312206|453578415|FG001|Overall Study|Death|36|||
126077374|NCT02312206|453578414|FG000|Overall Study|Study Terminated by Sponsor|81|||
126077375|NCT02312206|453578415|FG001|Overall Study|Study Terminated by Sponsor|74|||
126077376|NCT02312206|453578414|FG000|Overall Study|Patient transferred to hospice|0|||
126077377|NCT02312206|453578415|FG001|Overall Study|Patient transferred to hospice|1|||
126077378|NCT02312206|453578414|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
126077379|NCT02312206|453578415|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
126077380|NCT02312206|453578414|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
126077381|NCT02312206|453578415|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
126077382|NCT02312206|453578414|FG000|Overall Study|Disease Progression|1|||
126077383|NCT02312206|453578415|FG001|Overall Study|Disease Progression|0|||
126077384|NCT00585975|453578416|FG000|Overall Study|Withdrawal by Subject|3|||
126077385|NCT00585975|453578417|FG001|Overall Study|Withdrawal by Subject|3|||
126077386|NCT00585975|453578416|FG000|Overall Study|Lost to Follow-up|2|||
126077387|NCT00585975|453578417|FG001|Overall Study|Lost to Follow-up|1|||
126077388|NCT00585975|453578416|FG000|Overall Study|Enrollment met/over-enrolled|10|||
126077389|NCT00585975|453578417|FG001|Overall Study|Enrollment met/over-enrolled|9|||
126077390|NCT03082612|453578418|FG000|Overall Study|Lost to Follow-up|2|||
126077391|NCT03082612|453578419|FG001|Overall Study|Lost to Follow-up|0|||
126077392|NCT01336205|453578420|FG000|Overall Study|Other|22|||
126077393|NCT01336205|453578421|FG001|Overall Study|Other|9|||
126077394|NCT01336205|453578420|FG000|Overall Study|Lost to Follow-up|40|||
126077395|NCT01336205|453578421|FG001|Overall Study|Lost to Follow-up|20|||
126077396|NCT01336205|453578420|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
126077397|NCT01336205|453578421|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
126077398|NCT01336205|453578420|FG000|Overall Study|Lack of Efficacy|4|||
126077399|NCT01336205|453578421|FG001|Overall Study|Lack of Efficacy|0|||
126077400|NCT01336205|453578420|FG000|Overall Study|Severe noncompliance with protocol|9|||
126077401|NCT01336205|453578421|FG001|Overall Study|Severe noncompliance with protocol|2|||
126077402|NCT01336205|453578420|FG000|Overall Study|Adverse Event|56|||
126077403|NCT01336205|453578421|FG001|Overall Study|Adverse Event|6|||
125948076|NCT03962543|453106903|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
125948077|NCT03962543|453106904|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
125948078|NCT03962543|453106903|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
126077404|NCT01336205|453578420|FG000|Overall Study|Death|1|||
126077405|NCT01336205|453578421|FG001|Overall Study|Death|1|||
126077406|NCT01336205|453578420|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
126077407|NCT01336205|453578421|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
126077408|NCT01336205|453578420|FG000|Overall Study|Withdrawal by Subject|72|||
126077409|NCT01336205|453578421|FG001|Overall Study|Withdrawal by Subject|38|||
126077410|NCT01336205|453578420|FG000|Overall Study|Did not receive treatment|4|||
126077411|NCT01336205|453578421|FG001|Overall Study|Did not receive treatment|0|||
126077412|NCT01006616|453578422|FG000|Period 1 (6 Months)|Adverse Event|10|||
126077413|NCT01006616|453578423|FG001|Period 1 (6 Months)|Adverse Event|31|||
126077414|NCT01006616|453578424|FG002|Period 1 (6 Months)|Adverse Event|37|||
126077415|NCT01006616|453578425|FG003|Period 1 (6 Months)|Adverse Event|9|||
126077416|NCT01006616|453578422|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
126077417|NCT01006616|453578423|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
126077418|NCT01006616|453578424|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
126077419|NCT01006616|453578425|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
126077420|NCT01006616|453578422|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
126077421|NCT01006616|453578423|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
126077422|NCT01006616|453578424|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
126077423|NCT01006616|453578425|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
126077424|NCT01006616|453578422|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
126077425|NCT01006616|453578423|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
126077426|NCT01006616|453578424|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
126077427|NCT01006616|453578425|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
126077428|NCT01006616|453578422|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
126077429|NCT01006616|453578423|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
126077430|NCT01006616|453578424|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
126077431|NCT01006616|453578425|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
126077432|NCT01006616|453578422|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
126077433|NCT01006616|453578423|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
126077434|NCT01006616|453578424|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
126077435|NCT01006616|453578425|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
126077436|NCT01006616|453578422|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
126077437|NCT01006616|453578423|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
126077438|NCT01006616|453578424|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
126077439|NCT01006616|453578425|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
126077440|NCT01006616|453578422|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
126077441|NCT01006616|453578423|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
126077442|NCT01006616|453578424|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
126077443|NCT01006616|453578425|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
126077444|NCT01006616|453578422|FG000|Period 1 (6 Months)|Not Treated|0|||
126077445|NCT01006616|453578423|FG001|Period 1 (6 Months)|Not Treated|0|||
126077446|NCT01006616|453578424|FG002|Period 1 (6 Months)|Not Treated|1|||
126077447|NCT01006616|453578425|FG003|Period 1 (6 Months)|Not Treated|1|||
126077448|NCT01006616|453578422|FG000|Period 2 (18 Months)|Adverse Event|6|||
126077449|NCT01006616|453578423|FG001|Period 2 (18 Months)|Adverse Event|6|||
126077450|NCT01006616|453578424|FG002|Period 2 (18 Months)|Adverse Event|6|||
126077451|NCT01006616|453578425|FG003|Period 2 (18 Months)|Adverse Event|4|||
126077452|NCT01006616|453578422|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
126077453|NCT01006616|453578423|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
126077454|NCT01006616|453578424|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
126077455|NCT01006616|453578425|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
126077456|NCT01006616|453578422|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
126077457|NCT01006616|453578423|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
126077458|NCT01006616|453578424|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
126077459|NCT01006616|453578425|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
126077460|NCT01006616|453578422|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
126077461|NCT01006616|453578423|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
126077462|NCT01006616|453578424|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
126077463|NCT01006616|453578425|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
126077464|NCT01006616|453578422|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
126077465|NCT01006616|453578423|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
126077466|NCT01006616|453578424|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
126077467|NCT01006616|453578425|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
126077468|NCT01006616|453578422|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
126077469|NCT01006616|453578423|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
126077470|NCT01006616|453578424|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
126077471|NCT01006616|453578425|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
126077472|NCT01006616|453578422|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
126114936|NCT01514136|453715807|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
126077473|NCT01006616|453578423|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
126077474|NCT01006616|453578424|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
126077475|NCT01006616|453578425|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
126077476|NCT01006616|453578422|FG000|Period 2 (18 Months)|Study Terminated|63|||
126077477|NCT01006616|453578423|FG001|Period 2 (18 Months)|Study Terminated|46|||
126077478|NCT01006616|453578424|FG002|Period 2 (18 Months)|Study Terminated|44|||
126077479|NCT01006616|453578425|FG003|Period 2 (18 Months)|Study Terminated|70|||
126077480|NCT03672175|453578428|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
126077481|NCT03672175|453578429|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
126077482|NCT03672175|453578430|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
126077483|NCT03672175|453578428|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
126077484|NCT03672175|453578429|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
126077485|NCT03672175|453578430|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
126077486|NCT03672175|453578428|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
126077487|NCT03672175|453578429|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
126077488|NCT03672175|453578430|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
126077489|NCT03672175|453578428|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
126077490|NCT03672175|453578429|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
126077491|NCT03672175|453578430|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
126077492|NCT03672175|453578428|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
125948079|NCT03962543|453106904|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
125948080|NCT03962543|453106903|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
125948081|NCT03962543|453106904|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
125948082|NCT00560950|453106905|FG000|Overall Study|Lost to Follow-up|1|||
125948083|NCT00560950|453106906|FG001|Overall Study|Lost to Follow-up|0|||
125948084|NCT03264404|453108655|FG000|Overall Study|Death|2|||
125948085|NCT03264404|453108655|FG000|Overall Study|Physician Decision|1|||
125948086|NCT03264404|453108655|FG000|Overall Study|Disease Progression|28|||
125948087|NCT03264404|453108655|FG000|Overall Study|Adverse Event|1|||
125948088|NCT03264404|453108655|FG000|Overall Study|Off study prior to treatment|2|||
125948089|NCT01940120|453108656|FG000|Overall Study|Death|40|||
125948090|NCT01940120|453108656|FG000|Overall Study|Withdrawal by Subject|8|||
125948091|NCT01888497|453108657|FG000|Washout Period 1|Withdrawal by Subject|0|||
125948092|NCT01888497|453108658|FG001|Washout Period 1|Withdrawal by Subject|0|||
125948093|NCT01888497|453108659|FG002|Washout Period 1|Withdrawal by Subject|1|||
125948094|NCT01888497|453108660|FG003|Washout Period 1|Withdrawal by Subject|1|||
125948095|NCT01888497|453108657|FG000|Washout Period 2|Adverse Event|0|||
125948096|NCT01888497|453108658|FG001|Washout Period 2|Adverse Event|0|||
125948097|NCT01888497|453108659|FG002|Washout Period 2|Adverse Event|0|||
125948098|NCT01888497|453108660|FG003|Washout Period 2|Adverse Event|1|||
125948099|NCT01888497|453108657|FG000|Washout Period 2|Withdrawal by Subject|0|||
125948100|NCT01888497|453108658|FG001|Washout Period 2|Withdrawal by Subject|0|||
125948101|NCT01888497|453108659|FG002|Washout Period 2|Withdrawal by Subject|0|||
125948102|NCT01888497|453108660|FG003|Washout Period 2|Withdrawal by Subject|1|||
125948103|NCT04152447|453108661|FG000|Overall Study|Lost to Follow-up|1|||
125948104|NCT04152447|453108662|FG001|Overall Study|Lost to Follow-up|0|||
125948105|NCT04152447|453108661|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
125948106|NCT04152447|453108662|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
125948107|NCT04152447|453108661|FG000|Overall Study|Withdrawal by Subject|0|||
126077493|NCT03672175|453578429|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
126077494|NCT03672175|453578430|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
126077495|NCT03672175|453578428|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
126077496|NCT03672175|453578429|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
126077497|NCT03672175|453578430|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
126077498|NCT03672175|453578428|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
126077499|NCT03672175|453578429|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
126077500|NCT03672175|453578430|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
126077501|NCT03672175|453578428|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
126077502|NCT03672175|453578429|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
126077503|NCT03672175|453578430|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
126077504|NCT03672175|453578428|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
126077505|NCT03672175|453578429|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
126077506|NCT03672175|453578430|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
126077507|NCT03672175|453578428|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
126077508|NCT03672175|453578429|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
126077509|NCT03672175|453578430|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
126077510|NCT03672175|453578428|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
126077511|NCT03672175|453578429|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
126077512|NCT03672175|453578430|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
126077513|NCT03672175|453578428|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
126077514|NCT03672175|453578429|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
126077515|NCT03672175|453578430|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
126077516|NCT02482935|453578431|FG000|Period 1|Withdrawal by Subject|1|||
126077517|NCT02482935|453578432|FG001|Period 1|Withdrawal by Subject|0|||
125948108|NCT04152447|453108662|FG001|Overall Study|Withdrawal by Subject|1|||
125948109|NCT04152447|453108661|FG000|Overall Study|Found ineligible after enrolling|1|||
126077518|NCT03414047|453578433|FG000|Overall Study|Adverse Event|0|||
126077519|NCT03414047|453578434|FG001|Overall Study|Adverse Event|0|||
126077520|NCT03414047|453578435|FG002|Overall Study|Adverse Event|1|||
126077521|NCT03414047|453578436|FG003|Overall Study|Adverse Event|1|||
126077522|NCT03414047|453578433|FG000|Overall Study|Physician Decision|1|||
126077523|NCT03414047|453578434|FG001|Overall Study|Physician Decision|0|||
126077524|NCT03414047|453578435|FG002|Overall Study|Physician Decision|0|||
126077525|NCT03414047|453578436|FG003|Overall Study|Physician Decision|1|||
126077526|NCT03414047|453578433|FG000|Overall Study|Withdrawal by Subject|1|||
126077527|NCT03414047|453578434|FG001|Overall Study|Withdrawal by Subject|0|||
126077528|NCT03414047|453578435|FG002|Overall Study|Withdrawal by Subject|2|||
126077529|NCT03414047|453578436|FG003|Overall Study|Withdrawal by Subject|0|||
126077530|NCT00217022|453578444|FG000|Overall Study|Withdrawal by Subject|1|||
126077531|NCT00217022|453578445|FG001|Overall Study|Withdrawal by Subject|1|||
126077532|NCT02777242|453578449|FG000|Overall Study|Other|2|||
126077533|NCT02777242|453578449|FG000|Overall Study|Lost to Follow-up|1|||
126077534|NCT02777242|453578449|FG000|Overall Study|Multiple|1|||
126077535|NCT02777242|453578449|FG000|Overall Study|Sponsor's request|1|||
126077536|NCT02777242|453578449|FG000|Overall Study|Withdrawal by Subject|1|||
126077537|NCT01898442|453578450|FG000|Overall Study|Hemolysis/technical problems|1|||
126077538|NCT01898442|453578451|FG001|Overall Study|Hemolysis/technical problems|2|||
126077539|NCT01898442|453578452|FG002|Overall Study|Hemolysis/technical problems|2|||
126077540|NCT01898442|453578450|FG000|Overall Study|Patient vomited pills|0|||
126077541|NCT01898442|453578451|FG001|Overall Study|Patient vomited pills|0|||
126077542|NCT01898442|453578452|FG002|Overall Study|Patient vomited pills|1|||
126077543|NCT05178979|453578453|FG000|Overall Study|Death|0|||
126077544|NCT05178979|453578454|FG001|Overall Study|Death|5|||
126077545|NCT05178979|453578455|FG002|Overall Study|Death|0|||
126077546|NCT05178979|453578456|FG003|Overall Study|Death|3|||
126077547|NCT05178979|453578453|FG000|Overall Study|Adverse Event|0|||
126077548|NCT05178979|453578454|FG001|Overall Study|Adverse Event|1|||
126077549|NCT05178979|453578455|FG002|Overall Study|Adverse Event|0|||
126077550|NCT05178979|453578456|FG003|Overall Study|Adverse Event|0|||
126077551|NCT05178979|453578453|FG000|Overall Study|Lost to Follow-up|1|||
126077552|NCT05178979|453578454|FG001|Overall Study|Lost to Follow-up|8|||
126077553|NCT05178979|453578455|FG002|Overall Study|Lost to Follow-up|3|||
126077554|NCT05178979|453578456|FG003|Overall Study|Lost to Follow-up|8|||
126077555|NCT01747837|453578458|FG000|Overall Study|Lost to Follow-up|5|||
126077556|NCT01747837|453578459|FG001|Overall Study|Lost to Follow-up|2|||
126077557|NCT01747837|453578458|FG000|Overall Study|Death|4|||
126077558|NCT01747837|453578459|FG001|Overall Study|Death|4|||
126077559|NCT01435798|453578460|FG000|Overall Study|Withdrawal by Subject|1|||
126077560|NCT01253447|453578461|FG000|Overall Study|Adverse Event|2|||
126077561|NCT02299427|453578462|FG000|Overall Study|Withdrawal by Subject|1|||
126077562|NCT02299427|453578463|FG001|Overall Study|Withdrawal by Subject|0|||
126077563|NCT02299427|453578462|FG000|Overall Study|Lost to Follow-up|1|||
126077564|NCT02299427|453578463|FG001|Overall Study|Lost to Follow-up|3|||
126077565|NCT02299427|453578462|FG000|Overall Study|not adherent to dog website use|21|||
126077566|NCT02299427|453578463|FG001|Overall Study|not adherent to dog website use|0|||
126077567|NCT00937521|453578472|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126077568|NCT00937521|453578473|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126077569|NCT00937521|453578474|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
126077570|NCT00937521|453578475|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126077571|NCT00937521|453578476|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126077572|NCT00937521|453578477|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126077573|NCT00937521|453578478|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
126077574|NCT00937521|453578479|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126077575|NCT00937521|453578472|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
126077576|NCT00937521|453578473|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
126077577|NCT00937521|453578474|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
126077578|NCT00937521|453578475|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
126077579|NCT00937521|453578476|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
126077580|NCT00937521|453578477|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
126077581|NCT00937521|453578478|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
126077582|NCT00937521|453578479|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
126077583|NCT00937521|453578472|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126077584|NCT00937521|453578473|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126077585|NCT00937521|453578474|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
126077586|NCT00937521|453578475|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
126077587|NCT00937521|453578476|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126077588|NCT00937521|453578477|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126077589|NCT00937521|453578478|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126077590|NCT00937521|453578479|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126077591|NCT00937521|453578472|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
126077592|NCT00937521|453578473|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
126077593|NCT00937521|453578474|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
126077594|NCT00937521|453578475|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
126077595|NCT00937521|453578476|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
126077596|NCT00937521|453578477|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
126077597|NCT00937521|453578478|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
126077598|NCT00937521|453578479|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
126077599|NCT00937521|453578472|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
126077600|NCT00937521|453578473|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126077601|NCT00937521|453578474|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126077602|NCT00937521|453578475|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126077603|NCT00937521|453578476|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126077604|NCT00937521|453578477|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126077605|NCT00937521|453578478|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
126077606|NCT00937521|453578479|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126077607|NCT00937521|453578472|FG000|Booster Phase|Adverse Event|0|||
126077608|NCT00937521|453578473|FG001|Booster Phase|Adverse Event|0|||
126077609|NCT00937521|453578474|FG002|Booster Phase|Adverse Event|0|||
126077610|NCT00937521|453578475|FG003|Booster Phase|Adverse Event|0|||
126077611|NCT00937521|453578476|FG004|Booster Phase|Adverse Event|0|||
126077612|NCT00937521|453578477|FG005|Booster Phase|Adverse Event|0|||
126077613|NCT00937521|453578478|FG006|Booster Phase|Adverse Event|1|||
126077614|NCT00937521|453578479|FG007|Booster Phase|Adverse Event|0|||
126077615|NCT00937521|453578472|FG000|Booster Phase|Withdrawal by Subject|1|||
126077616|NCT00937521|453578473|FG001|Booster Phase|Withdrawal by Subject|0|||
126077617|NCT00937521|453578474|FG002|Booster Phase|Withdrawal by Subject|0|||
126077618|NCT00937521|453578475|FG003|Booster Phase|Withdrawal by Subject|1|||
126077619|NCT00937521|453578476|FG004|Booster Phase|Withdrawal by Subject|0|||
126077620|NCT00937521|453578477|FG005|Booster Phase|Withdrawal by Subject|0|||
126077621|NCT00937521|453578478|FG006|Booster Phase|Withdrawal by Subject|0|||
126077622|NCT00937521|453578479|FG007|Booster Phase|Withdrawal by Subject|2|||
126077623|NCT00937521|453578472|FG000|Booster Phase|Lost to Follow-up|2|||
126077624|NCT00937521|453578473|FG001|Booster Phase|Lost to Follow-up|2|||
126077625|NCT00937521|453578474|FG002|Booster Phase|Lost to Follow-up|4|||
126077626|NCT00937521|453578475|FG003|Booster Phase|Lost to Follow-up|2|||
126077627|NCT00937521|453578476|FG004|Booster Phase|Lost to Follow-up|4|||
126077628|NCT00937521|453578477|FG005|Booster Phase|Lost to Follow-up|4|||
126077629|NCT00937521|453578478|FG006|Booster Phase|Lost to Follow-up|3|||
126077630|NCT00937521|453578479|FG007|Booster Phase|Lost to Follow-up|0|||
126077631|NCT00937521|453578472|FG000|Booster Phase|Administrative Reason|0|||
126077632|NCT00937521|453578473|FG001|Booster Phase|Administrative Reason|0|||
126077633|NCT00937521|453578474|FG002|Booster Phase|Administrative Reason|1|||
126077634|NCT00937521|453578475|FG003|Booster Phase|Administrative Reason|0|||
126077635|NCT00937521|453578476|FG004|Booster Phase|Administrative Reason|1|||
126077636|NCT00937521|453578477|FG005|Booster Phase|Administrative Reason|1|||
126077637|NCT00937521|453578478|FG006|Booster Phase|Administrative Reason|0|||
126077638|NCT00937521|453578479|FG007|Booster Phase|Administrative Reason|0|||
126077639|NCT00937521|453578472|FG000|Booster Phase|Protocol Deviation|0|||
126077640|NCT00937521|453578473|FG001|Booster Phase|Protocol Deviation|0|||
126077641|NCT00937521|453578474|FG002|Booster Phase|Protocol Deviation|0|||
126077642|NCT00937521|453578475|FG003|Booster Phase|Protocol Deviation|0|||
126077643|NCT00937521|453578476|FG004|Booster Phase|Protocol Deviation|0|||
126077644|NCT00937521|453578477|FG005|Booster Phase|Protocol Deviation|0|||
126077645|NCT00937521|453578478|FG006|Booster Phase|Protocol Deviation|1|||
126077646|NCT00937521|453578479|FG007|Booster Phase|Protocol Deviation|0|||
126077647|NCT01721746|453578480|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
126077648|NCT01721746|453578481|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
126077649|NCT01721746|453578480|FG000|Pre-Treatment|Withdrawal by Subject|1|||
126077650|NCT01721746|453578481|FG001|Pre-Treatment|Withdrawal by Subject|16|||
126077651|NCT01721746|453578480|FG000|Pre-Treatment|Poor/Non-compliance|1|||
126077652|NCT01721746|453578481|FG001|Pre-Treatment|Poor/Non-compliance|0|||
126077653|NCT01721746|453578480|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
126077654|NCT01721746|453578481|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
126077655|NCT01721746|453578480|FG000|Treatment|Disease Progression|192|||
126077656|NCT01721746|453578481|FG001|Treatment|Disease Progression|74|||
126077657|NCT01721746|453578480|FG000|Treatment|Study Drug Toxicity|19|||
126077658|NCT01721746|453578481|FG001|Treatment|Study Drug Toxicity|11|||
126077659|NCT01721746|453578480|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
126077660|NCT01721746|453578481|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
126077661|NCT01721746|453578480|FG000|Treatment|Participant request to discontinue Study treatment|26|||
126077662|NCT01721746|453578481|FG001|Treatment|Participant request to discontinue Study treatment|7|||
126077663|NCT01721746|453578480|FG000|Treatment|Participant withdrew consent|4|||
126077664|NCT01721746|453578481|FG001|Treatment|Participant withdrew consent|2|||
126077665|NCT01721746|453578480|FG000|Treatment|Maximum Clinical Benefit|9|||
126077666|NCT01721746|453578481|FG001|Treatment|Maximum Clinical Benefit|3|||
126077667|NCT01721746|453578480|FG000|Treatment|Poor/Non-compliance|2|||
126077668|NCT01721746|453578481|FG001|Treatment|Poor/Non-compliance|0|||
126077669|NCT01721746|453578480|FG000|Treatment|Participant no longer met Study criteria|4|||
126077670|NCT01721746|453578481|FG001|Treatment|Participant no longer met Study criteria|0|||
126077671|NCT01721746|453578480|FG000|Treatment|Other reasons|6|||
126077672|NCT01721746|453578481|FG001|Treatment|Other reasons|2|||
126077673|NCT04358068|453578482|FG000|Overall Study|Did not initiate study treatment|2|||
126077674|NCT04358068|453578483|FG001|Overall Study|Did not initiate study treatment|2|||
126077675|NCT02447718|453578484|FG000|Overall Study|Lost to Follow-up|8|||
126077676|NCT02447718|453578485|FG001|Overall Study|Lost to Follow-up|0|||
126077677|NCT02447718|453578484|FG000|Overall Study|Withdrawal by Subject|3|||
126077678|NCT02447718|453578485|FG001|Overall Study|Withdrawal by Subject|0|||
126077679|NCT02447718|453578484|FG000|Overall Study|Screen Failure|1|||
126077680|NCT02447718|453578485|FG001|Overall Study|Screen Failure|0|||
126077681|NCT00239681|453578486|FG000|Overall Study|Adverse Event|100|||
126077682|NCT00239681|453578487|FG001|Overall Study|Adverse Event|99|||
126077683|NCT00239681|453578486|FG000|Overall Study|Withdrawal by Subject|458|||
126077684|NCT00239681|453578487|FG001|Overall Study|Withdrawal by Subject|489|||
126077685|NCT00239681|453578486|FG000|Overall Study|Lost to Follow-up|28|||
126077686|NCT00239681|453578487|FG001|Overall Study|Lost to Follow-up|22|||
126077687|NCT00239681|453578486|FG000|Overall Study|Protocol Violation|4|||
126077688|NCT00239681|453578487|FG001|Overall Study|Protocol Violation|4|||
126077689|NCT00239681|453578486|FG000|Overall Study|Physician Decision|13|||
126077690|NCT00239681|453578487|FG001|Overall Study|Physician Decision|17|||
126077691|NCT00239681|453578486|FG000|Overall Study|No information chacked on CaseReportForm|90|||
126077692|NCT00239681|453578487|FG001|Overall Study|No information chacked on CaseReportForm|84|||
126077693|NCT03599622|453578488|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
126077694|NCT03599622|453578489|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
126077695|NCT03599622|453578490|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
126077696|NCT03599622|453578491|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
126077697|NCT03599622|453578488|FG000|Pre-Treatment Period|Other reasons|1|||
126077698|NCT03599622|453578489|FG001|Pre-Treatment Period|Other reasons|1|||
126077699|NCT03599622|453578490|FG002|Pre-Treatment Period|Other reasons|1|||
126077700|NCT03599622|453578491|FG003|Pre-Treatment Period|Other reasons|0|||
126077701|NCT03599622|453578488|FG000|Treatment Period|Adverse Event|11|||
126077702|NCT03599622|453578489|FG001|Treatment Period|Adverse Event|20|||
126077703|NCT03599622|453578490|FG002|Treatment Period|Adverse Event|18|||
126077704|NCT03599622|453578491|FG003|Treatment Period|Adverse Event|2|||
126077705|NCT03599622|453578488|FG000|Treatment Period|Lack of Efficacy|18|||
126077706|NCT03599622|453578489|FG001|Treatment Period|Lack of Efficacy|12|||
126077707|NCT03599622|453578490|FG002|Treatment Period|Lack of Efficacy|13|||
126077708|NCT03599622|453578491|FG003|Treatment Period|Lack of Efficacy|2|||
126077709|NCT03599622|453578488|FG000|Treatment Period|Withdrawal by Subject|5|||
126077710|NCT03599622|453578489|FG001|Treatment Period|Withdrawal by Subject|11|||
126077711|NCT03599622|453578490|FG002|Treatment Period|Withdrawal by Subject|16|||
126077712|NCT03599622|453578491|FG003|Treatment Period|Withdrawal by Subject|1|||
126077713|NCT03599622|453578488|FG000|Treatment Period|Other reasons|4|||
126077714|NCT03599622|453578489|FG001|Treatment Period|Other reasons|6|||
126077715|NCT03599622|453578490|FG002|Treatment Period|Other reasons|7|||
126077716|NCT03599622|453578491|FG003|Treatment Period|Other reasons|0|||
126077717|NCT03599622|453578488|FG000|Treatment Period|Lost to Follow-up|1|||
126077718|NCT03599622|453578489|FG001|Treatment Period|Lost to Follow-up|0|||
126077719|NCT03599622|453578490|FG002|Treatment Period|Lost to Follow-up|0|||
126077720|NCT03599622|453578491|FG003|Treatment Period|Lost to Follow-up|0|||
126077721|NCT03599622|453578488|FG000|Treatment Period|Study terminated by sponsor|7|||
126077722|NCT03599622|453578489|FG001|Treatment Period|Study terminated by sponsor|20|||
126077723|NCT03599622|453578490|FG002|Treatment Period|Study terminated by sponsor|15|||
126077724|NCT03599622|453578491|FG003|Treatment Period|Study terminated by sponsor|0|||
126077725|NCT03599622|453578488|FG000|Treatment Period|Site terminated by sponsor|0|||
126077726|NCT03599622|453578489|FG001|Treatment Period|Site terminated by sponsor|1|||
126077727|NCT03599622|453578490|FG002|Treatment Period|Site terminated by sponsor|0|||
126077728|NCT03599622|453578491|FG003|Treatment Period|Site terminated by sponsor|0|||
126077729|NCT00770588|453578492|FG000|Overall Study|Adverse Event|9|||
126077730|NCT00770588|453578493|FG001|Overall Study|Adverse Event|2|||
126077731|NCT00770588|453578492|FG000|Overall Study|Death caused by progression of disease|70|||
126077732|NCT00770588|453578493|FG001|Overall Study|Death caused by progression of disease|91|||
126077733|NCT00770588|453578492|FG000|Overall Study|Lost to Follow-up|1|||
126077734|NCT00770588|453578493|FG001|Overall Study|Lost to Follow-up|1|||
126077735|NCT00770588|453578492|FG000|Overall Study|Withdrawal by Subject|1|||
126077736|NCT00770588|453578493|FG001|Overall Study|Withdrawal by Subject|1|||
126077737|NCT00468130|453578495|FG000|Overall Study|Adverse Event|2|||
126077738|NCT00468130|453578496|FG001|Overall Study|Adverse Event|1|||
126077739|NCT00468130|453578495|FG000|Overall Study|Withdrawal by Subject|0|||
126077740|NCT00468130|453578496|FG001|Overall Study|Withdrawal by Subject|1|||
126077741|NCT00436956|453578497|FG000|Overall Study|Not evaluable|1|||
126077742|NCT00436956|453578498|FG001|Overall Study|Not evaluable|0|||
126077743|NCT01006889|453578499|FG000|Overall Study|Withdrawal by Subject|3|||
125948110|NCT04152447|453108662|FG001|Overall Study|Found ineligible after enrolling|1|||
125948111|NCT04152447|453108661|FG000|Overall Study|Did not receive VR headset in time.|0|||
125948112|NCT04152447|453108662|FG001|Overall Study|Did not receive VR headset in time.|2|||
126077744|NCT02143063|453578502|FG000|Overall Study|Lost to Follow-up|16|||
126077745|NCT02143063|453578503|FG001|Overall Study|Lost to Follow-up|28|||
126077746|NCT02143063|453578504|FG002|Overall Study|Lost to Follow-up|29|||
126077747|NCT02143063|453578502|FG000|Overall Study|Withdrawal by Subject|0|||
126077748|NCT02143063|453578503|FG001|Overall Study|Withdrawal by Subject|1|||
126077749|NCT02143063|453578504|FG002|Overall Study|Withdrawal by Subject|0|||
126077750|NCT02143063|453578502|FG000|Overall Study|Death|0|||
126077751|NCT02143063|453578503|FG001|Overall Study|Death|1|||
126077752|NCT02143063|453578504|FG002|Overall Study|Death|1|||
126077753|NCT00623363|453578505|FG000|Overall Study|Adverse Event|2|||
126077754|NCT00623363|453578506|FG001|Overall Study|Adverse Event|2|||
126077755|NCT01130168|453578508|FG000|Period 1|Withdrawal by Subject|0|||
126077756|NCT01130168|453578509|FG001|Period 1|Withdrawal by Subject|1|||
126077757|NCT01130168|453578510|FG002|Period 1|Withdrawal by Subject|0|||
126077758|NCT01130168|453578511|FG003|Period 1|Withdrawal by Subject|1|||
126077759|NCT01130168|453578512|FG004|Period 1|Withdrawal by Subject|0|||
126077760|NCT01130168|453578513|FG005|Period 1|Withdrawal by Subject|0|||
126077761|NCT01130168|453578508|FG000|Period 1|Discontinued For Other Reason|0|||
126077762|NCT01130168|453578509|FG001|Period 1|Discontinued For Other Reason|0|||
126077763|NCT01130168|453578510|FG002|Period 1|Discontinued For Other Reason|1|||
126077764|NCT01130168|453578511|FG003|Period 1|Discontinued For Other Reason|1|||
126077765|NCT01130168|453578512|FG004|Period 1|Discontinued For Other Reason|0|||
126077766|NCT01130168|453578513|FG005|Period 1|Discontinued For Other Reason|0|||
126077767|NCT01130168|453578508|FG000|Period 1|Adverse Event|0|||
126077768|NCT01130168|453578509|FG001|Period 1|Adverse Event|0|||
126077769|NCT01130168|453578510|FG002|Period 1|Adverse Event|0|||
126077770|NCT01130168|453578511|FG003|Period 1|Adverse Event|1|||
126077771|NCT01130168|453578512|FG004|Period 1|Adverse Event|0|||
126077772|NCT01130168|453578513|FG005|Period 1|Adverse Event|0|||
126077773|NCT01702519|453578514|FG000|Washout Period|Lost to Follow-up|1|||
126077774|NCT01702519|453578515|FG001|Washout Period|Lost to Follow-up|0|||
126077775|NCT01702519|453578514|FG000|Washout Period|Withdrawal by Subject|0|||
126077776|NCT01702519|453578515|FG001|Washout Period|Withdrawal by Subject|2|||
126077777|NCT03738397|453578518|FG000|Overall Study|Adverse Event|3|||
126077778|NCT03738397|453578519|FG001|Overall Study|Adverse Event|7|||
126077779|NCT03738397|453578518|FG000|Overall Study|Withdrawal by Subject|8|||
126077780|NCT03738397|453578519|FG001|Overall Study|Withdrawal by Subject|11|||
126077781|NCT03738397|453578518|FG000|Overall Study|Lost to Follow-up|7|||
126077782|NCT03738397|453578519|FG001|Overall Study|Lost to Follow-up|5|||
126077783|NCT03738397|453578518|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
126077784|NCT03738397|453578519|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
126077785|NCT03738397|453578518|FG000|Overall Study|Other|4|||
126077786|NCT03738397|453578519|FG001|Overall Study|Other|6|||
126077787|NCT00904722|453578520|FG000|Overall Study|Physician Decision|1|||
126077788|NCT01891890|453578521|FG000|Overall Study|Lost to Follow-up|0|||
126077789|NCT01891890|453578522|FG001|Overall Study|Lost to Follow-up|0|||
126077790|NCT01891890|453578523|FG002|Overall Study|Lost to Follow-up|1|||
126077791|NCT01891890|453578521|FG000|Overall Study|Study ended before endpoint reached|7|||
126077792|NCT01891890|453578522|FG001|Overall Study|Study ended before endpoint reached|3|||
126077793|NCT01891890|453578523|FG002|Overall Study|Study ended before endpoint reached|6|||
126077794|NCT03448536|453578530|FG000|Overall Study|Protocol Violation|2|||
126077795|NCT03448536|453578531|FG001|Overall Study|Protocol Violation|0|||
126077796|NCT03448536|453578530|FG000|Overall Study|Pregnancy|1|||
126077797|NCT03448536|453578531|FG001|Overall Study|Pregnancy|0|||
126077798|NCT03448536|453578530|FG000|Overall Study|Withdrawal by Subject|1|||
126077799|NCT03448536|453578531|FG001|Overall Study|Withdrawal by Subject|2|||
125948113|NCT04013191|453108663|FG000|Overall Study|Adverse Event|1|||
126114937|NCT01514136|453715808|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
126114938|NCT01514136|453715809|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
126114939|NCT01514136|453715810|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
126077800|NCT03448536|453578530|FG000|Overall Study|Lost to Follow-up|3|||
126077801|NCT03448536|453578531|FG001|Overall Study|Lost to Follow-up|2|||
126077802|NCT03448536|453578530|FG000|Overall Study|Inadequate pain reporter|1|||
126077803|NCT03448536|453578531|FG001|Overall Study|Inadequate pain reporter|0|||
126077804|NCT03448536|453578530|FG000|Overall Study|Other|3|||
126077805|NCT03448536|453578531|FG001|Overall Study|Other|0|||
126077806|NCT03448536|453578530|FG000|Overall Study|Physician Decision|1|||
126077807|NCT03448536|453578531|FG001|Overall Study|Physician Decision|0|||
126077808|NCT04811339|453578538|FG000|Overall Study|lack of transportation not wanting to return|4|||
126077809|NCT04811339|453578539|FG001|Overall Study|lack of transportation not wanting to return|8|||
126077810|NCT04811339|453578540|FG002|Overall Study|lack of transportation not wanting to return|0|||
126077811|NCT04811339|453578538|FG000|Overall Study|Adverse Event|3|||
126077812|NCT04811339|453578539|FG001|Overall Study|Adverse Event|0|||
126077813|NCT04811339|453578540|FG002|Overall Study|Adverse Event|0|||
126077814|NCT04811339|453578538|FG000|Overall Study|Lost to Follow-up|1|||
126077815|NCT04811339|453578539|FG001|Overall Study|Lost to Follow-up|0|||
126077816|NCT04811339|453578540|FG002|Overall Study|Lost to Follow-up|0|||
126077817|NCT04811339|453578538|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
126077818|NCT04811339|453578539|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
126077819|NCT04811339|453578540|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
126077820|NCT04811339|453578538|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
126077821|NCT04811339|453578539|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
126077822|NCT04811339|453578540|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
126077823|NCT04811339|453578538|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
126077824|NCT04811339|453578539|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
126077825|NCT04811339|453578540|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
126077826|NCT04811339|453578538|FG000|Overall Study|Withdrawal by Subject|0|||
126077827|NCT04811339|453578539|FG001|Overall Study|Withdrawal by Subject|3|||
126077828|NCT04811339|453578540|FG002|Overall Study|Withdrawal by Subject|0|||
126077829|NCT04811339|453578538|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
126077830|NCT04811339|453578539|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
126077831|NCT04811339|453578540|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
126077832|NCT04811339|453578538|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
126077833|NCT04811339|453578539|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
126077834|NCT04811339|453578540|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
126077835|NCT00497874|453580264|FG000|Overall Study|Withdrawal by Subject|48|||
126077836|NCT00497874|453580265|FG001|Overall Study|Withdrawal by Subject|17|||
126077837|NCT00497874|453580264|FG000|Overall Study|Illness|8|||
126077838|NCT00497874|453580265|FG001|Overall Study|Illness|4|||
126077839|NCT00497874|453580264|FG000|Overall Study|Death|2|||
126077840|NCT00497874|453580265|FG001|Overall Study|Death|4|||
126077841|NCT00497874|453580264|FG000|Overall Study|Unable to contact|52|||
126077842|NCT00497874|453580265|FG001|Overall Study|Unable to contact|67|||
126077843|NCT00497874|453580264|FG000|Overall Study|Unable to schedule|37|||
126077844|NCT00497874|453580265|FG001|Overall Study|Unable to schedule|24|||
126077845|NCT04843579|453580269|FG000|Overall Study|Adverse Event|1|||
126077846|NCT04843579|453580269|FG000|Overall Study|Disease Progression|1|||
126077847|NCT04009629|453580270|FG000|Overall Study|Withdrawal by Subject|2|||
126077848|NCT04009629|453580271|FG001|Overall Study|Withdrawal by Subject|0|||
126077849|NCT02808975|453580273|FG000|Overall Study|Adverse Event|3|||
126077850|NCT02808975|453580274|FG001|Overall Study|Adverse Event|4|||
126077851|NCT02808975|453580273|FG000|Overall Study|Withdrew consent|9|||
126077852|NCT02808975|453580274|FG001|Overall Study|Withdrew consent|8|||
126077853|NCT02808975|453580273|FG000|Overall Study|Lost to Follow-up|4|||
126077854|NCT02808975|453580274|FG001|Overall Study|Lost to Follow-up|6|||
126077855|NCT02808975|453580273|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
126077856|NCT02808975|453580274|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
126077857|NCT02808975|453580273|FG000|Overall Study|Other, not specified|5|||
126077858|NCT02808975|453580274|FG001|Overall Study|Other, not specified|1|||
126077859|NCT03602586|453580275|FG000|Overall Study|Withdrawal by Subject|3|||
126077860|NCT03062449|453580276|FG000|Overall Study|Withdrawal by Subject|7|||
126077861|NCT03062449|453580277|FG001|Overall Study|Withdrawal by Subject|1|||
126077862|NCT03568812|453580279|FG000|Overall Study|Physician Decision|0|||
126077863|NCT03568812|453580280|FG001|Overall Study|Physician Decision|1|||
126077864|NCT03194867|453580281|FG000|Overall Study|Incorrect completion of end of study form|0|||
126077865|NCT03194867|453580282|FG001|Overall Study|Incorrect completion of end of study form|0|||
126077866|NCT03194867|453580283|FG002|Overall Study|Incorrect completion of end of study form|1|||
126077867|NCT03194867|453580284|FG003|Overall Study|Incorrect completion of end of study form|0|||
126077868|NCT00464945|453580285|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
126077869|NCT00464945|453580286|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
126077870|NCT00464945|453580285|FG000|Infant Series|Protocol Violation|1|||
126077871|NCT00464945|453580286|FG001|Infant Series|Protocol Violation|0|||
126077872|NCT00464945|453580285|FG000|Infant Series|Lost to Follow-up|1|||
125948114|NCT04013191|453108664|FG001|Overall Study|Adverse Event|0|||
126077873|NCT00464945|453580286|FG001|Infant Series|Lost to Follow-up|0|||
126077874|NCT00464945|453580285|FG000|After Infant Series|Withdrawal by Subject|0|||
126077875|NCT00464945|453580286|FG001|After Infant Series|Withdrawal by Subject|2|||
126077876|NCT00464945|453580285|FG000|Toddler Dose|Lost to Follow-up|0|||
126077877|NCT00464945|453580286|FG001|Toddler Dose|Lost to Follow-up|1|||
125948115|NCT01275066|453108675|FG000|Overall Study|Withdrawal by Subject|0|||
126077878|NCT04014790|453580287|FG000|Overall Study|Death|4|||
126077879|NCT04014790|453580287|FG000|Overall Study|Adverse Event|1|||
126077880|NCT04014790|453580287|FG000|Overall Study|Withdrawal by Subject|1|||
126077881|NCT02536742|453580288|FG000|Overall Study|Did not start protocol therapy|1|||
125948116|NCT01275066|453108676|FG001|Overall Study|Withdrawal by Subject|0|||
126077882|NCT02536742|453580288|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
125948117|NCT01275066|453108677|FG002|Overall Study|Withdrawal by Subject|1|||
125948118|NCT01275066|453108675|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
125948119|NCT01275066|453108676|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
125948120|NCT01275066|453108677|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
125948121|NCT04200248|453108680|FG000|Overall Study|Personal reasons|0|||
125948122|NCT04200248|453108681|FG001|Overall Study|Personal reasons|0|||
125948123|NCT04200248|453108682|FG002|Overall Study|Personal reasons|1|||
125948124|NCT04200248|453108680|FG000|Overall Study|Discontinued prior to treatment|3|||
125948125|NCT04200248|453108681|FG001|Overall Study|Discontinued prior to treatment|3|||
125948126|NCT04200248|453108682|FG002|Overall Study|Discontinued prior to treatment|2|||
125948127|NCT00934544|453108686|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
125948128|NCT00934544|453108687|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
125948129|NCT00934544|453108688|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
125948130|NCT00934544|453108686|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
125948131|NCT00934544|453108687|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
125948132|NCT00934544|453108688|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
125948133|NCT00934544|453108686|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
125948134|NCT00934544|453108687|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
125948135|NCT00934544|453108688|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
125948136|NCT00934544|453108686|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
125948137|NCT00934544|453108687|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
125948138|NCT00934544|453108688|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
125948139|NCT00934544|453108686|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
125948140|NCT00934544|453108687|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
125948141|NCT00934544|453108688|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
125948142|NCT00934544|453108686|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
125948143|NCT00934544|453108687|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
125948144|NCT00934544|453108688|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
125948145|NCT00934544|453108686|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
125948146|NCT00934544|453108687|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
125948147|NCT00934544|453108688|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
125948148|NCT00934544|453108686|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
125948149|NCT00934544|453108687|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
125948150|NCT00934544|453108688|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
125948151|NCT00934544|453108686|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
125948152|NCT00934544|453108687|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
125948153|NCT00934544|453108688|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
125948154|NCT00934544|453108686|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
125948155|NCT00934544|453108687|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
125948156|NCT00934544|453108688|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
125948157|NCT00934544|453108686|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
125948158|NCT00934544|453108687|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
125948159|NCT00934544|453108688|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
125948160|NCT00934544|453108686|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
125948161|NCT00934544|453108687|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
125948162|NCT00934544|453108688|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
125948163|NCT00934544|453108686|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
125948164|NCT00934544|453108687|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
125948165|NCT00934544|453108688|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
125948166|NCT00934544|453108686|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
125948167|NCT00934544|453108687|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
125948168|NCT00934544|453108688|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
125948169|NCT00934544|453108686|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
125948170|NCT00934544|453108687|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
125948171|NCT00934544|453108688|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
125948172|NCT00934544|453108686|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
125948173|NCT00934544|453108687|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
125948174|NCT00934544|453108688|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
125948175|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
125948176|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
125948177|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
125948178|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
125948179|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
125948180|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
126077883|NCT04629443|453580289|FG000|Overall Study|Adverse Event|2|||
126077884|NCT04629443|453580290|FG001|Overall Study|Adverse Event|1|||
126077885|NCT04629443|453580291|FG002|Overall Study|Adverse Event|2|||
126077886|NCT04629443|453580289|FG000|Overall Study|Progressive Disease|2|||
126077887|NCT04629443|453580290|FG001|Overall Study|Progressive Disease|3|||
126077888|NCT04629443|453580291|FG002|Overall Study|Progressive Disease|3|||
126077889|NCT04629443|453580289|FG000|Overall Study|Physician Decision|1|||
126077890|NCT04629443|453580290|FG001|Overall Study|Physician Decision|3|||
126077891|NCT04629443|453580291|FG002|Overall Study|Physician Decision|0|||
126077892|NCT01547117|453580292|FG000|Overall Study|Physician Decision|0|||
126077893|NCT01547117|453580293|FG001|Overall Study|Physician Decision|1|||
126077894|NCT01547117|453580294|FG002|Overall Study|Physician Decision|1|||
126077895|NCT01547117|453580295|FG003|Overall Study|Physician Decision|3|||
126077896|NCT01547117|453580292|FG000|Overall Study|Withdrawal by Subject|1|||
126077897|NCT01547117|453580293|FG001|Overall Study|Withdrawal by Subject|2|||
126077898|NCT01547117|453580294|FG002|Overall Study|Withdrawal by Subject|1|||
126077899|NCT01547117|453580295|FG003|Overall Study|Withdrawal by Subject|2|||
126077900|NCT03021551|453580297|FG000|Overall Study|Equipment Issues|2|||
126077901|NCT03021551|453580297|FG000|Overall Study|Protocol Violation|1|||
126077902|NCT02088554|453580301|FG000|Overall Study|Exited before procedure|130|||
126077903|NCT02088554|453580301|FG000|Overall Study|Attempted but not implanted|31|||
126077904|NCT02088554|453580301|FG000|Overall Study|Implant not attempted|19|||
126077905|NCT02088554|453580301|FG000|Overall Study|Pending next visit|532|||
126077906|NCT02088554|453580301|FG000|Overall Study|Death|170|||
126077907|NCT02088554|453580301|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
126077908|NCT02088554|453580301|FG000|Overall Study|Lost to Follow-up|23|||
126077909|NCT02088554|453580301|FG000|Overall Study|Explanted|32|||
126077910|NCT02088554|453580301|FG000|Overall Study|Any other reason not covered by previous categories|11|||
126077911|NCT03898960|453580304|FG000|Overall Study|Death|10|||
126077912|NCT00548847|453580305|FG000|Overall Study|Disease progression|7|||
126077913|NCT00813098|453580306|FG000|Overall Study|Adverse Event|2|||
126077914|NCT00813098|453580307|FG001|Overall Study|Adverse Event|4|||
126077915|NCT00813098|453580308|FG002|Overall Study|Adverse Event|1|||
126077916|NCT00813098|453580306|FG000|Overall Study|Withdrawal by Subject|0|||
126077917|NCT00813098|453580307|FG001|Overall Study|Withdrawal by Subject|1|||
126077918|NCT00813098|453580308|FG002|Overall Study|Withdrawal by Subject|0|||
126077919|NCT00813098|453580306|FG000|Overall Study|Inability to complete study procedures|1|||
126077920|NCT00813098|453580307|FG001|Overall Study|Inability to complete study procedures|0|||
126077921|NCT00813098|453580308|FG002|Overall Study|Inability to complete study procedures|0|||
126077922|NCT00813098|453580306|FG000|Overall Study|Lost to Follow-up|0|||
126077923|NCT00813098|453580307|FG001|Overall Study|Lost to Follow-up|1|||
126077924|NCT00813098|453580308|FG002|Overall Study|Lost to Follow-up|0|||
126077925|NCT00813098|453580306|FG000|Overall Study|Protocol Violation|0|||
126077926|NCT00813098|453580307|FG001|Overall Study|Protocol Violation|0|||
126077927|NCT00813098|453580308|FG002|Overall Study|Protocol Violation|1|||
126077928|NCT00813098|453580306|FG000|Overall Study|Principal Investigator decision|0|||
126077929|NCT00813098|453580307|FG001|Overall Study|Principal Investigator decision|1|||
126077930|NCT00813098|453580308|FG002|Overall Study|Principal Investigator decision|0|||
126077931|NCT00813098|453580306|FG000|Overall Study|Withdrew Consent|0|||
126077932|NCT00813098|453580307|FG001|Overall Study|Withdrew Consent|1|||
126077933|NCT00813098|453580308|FG002|Overall Study|Withdrew Consent|0|||
126077934|NCT01086384|453580311|FG000|2-week Run-in Period|Adverse Event|1|||
126077935|NCT01086384|453580312|FG001|2-week Run-in Period|Adverse Event|0|||
126077936|NCT01086384|453580313|FG002|2-week Run-in Period|Adverse Event|0|||
126077937|NCT01086384|453580311|FG000|2-week Run-in Period|Protocol Violation|1|||
126077938|NCT01086384|453580312|FG001|2-week Run-in Period|Protocol Violation|0|||
126077939|NCT01086384|453580313|FG002|2-week Run-in Period|Protocol Violation|0|||
126077940|NCT01086384|453580311|FG000|2-week Run-in Period|Lost to Follow-up|1|||
126077941|NCT01086384|453580312|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126077942|NCT01086384|453580313|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126077943|NCT01086384|453580311|FG000|2-week Run-in Period|Physician Decision|6|||
126077944|NCT01086384|453580312|FG001|2-week Run-in Period|Physician Decision|0|||
126077945|NCT01086384|453580313|FG002|2-week Run-in Period|Physician Decision|0|||
126077946|NCT01086384|453580311|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
126077947|NCT01086384|453580312|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126077948|NCT01086384|453580313|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126077949|NCT01086384|453580311|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
126077950|NCT01086384|453580312|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
126077951|NCT01086384|453580313|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
126077952|NCT01086384|453580311|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
126077953|NCT01086384|453580312|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
126077954|NCT01086384|453580313|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
126077955|NCT01086384|453580311|FG000|2-week Run-in Period|Randomized in Error|1|||
126077956|NCT01086384|453580312|FG001|2-week Run-in Period|Randomized in Error|0|||
126077957|NCT01086384|453580313|FG002|2-week Run-in Period|Randomized in Error|0|||
126077958|NCT01086384|453580311|FG000|Treatment Period|Withdrawal by Subject|0|||
126077959|NCT01086384|453580312|FG001|Treatment Period|Withdrawal by Subject|53|||
126077960|NCT01086384|453580313|FG002|Treatment Period|Withdrawal by Subject|55|||
126077961|NCT01086384|453580311|FG000|Treatment Period|Protocol Violation|0|||
126077962|NCT01086384|453580312|FG001|Treatment Period|Protocol Violation|26|||
126077963|NCT01086384|453580313|FG002|Treatment Period|Protocol Violation|17|||
126077964|NCT01086384|453580311|FG000|Treatment Period|Lack of Efficacy|0|||
126077965|NCT01086384|453580312|FG001|Treatment Period|Lack of Efficacy|22|||
126077966|NCT01086384|453580313|FG002|Treatment Period|Lack of Efficacy|13|||
126077967|NCT01086384|453580311|FG000|Treatment Period|Adverse Event|0|||
126077968|NCT01086384|453580312|FG001|Treatment Period|Adverse Event|19|||
126077969|NCT01086384|453580313|FG002|Treatment Period|Adverse Event|15|||
126077970|NCT01086384|453580311|FG000|Treatment Period|Lost to Follow-up|0|||
126077971|NCT01086384|453580312|FG001|Treatment Period|Lost to Follow-up|11|||
126077972|NCT01086384|453580313|FG002|Treatment Period|Lost to Follow-up|9|||
126077973|NCT01086384|453580311|FG000|Treatment Period|Physician Decision|0|||
126077974|NCT01086384|453580312|FG001|Treatment Period|Physician Decision|9|||
126077975|NCT01086384|453580313|FG002|Treatment Period|Physician Decision|6|||
126077976|NCT01086384|453580311|FG000|Treatment Period|Study Closed/Terminated|0|||
126077977|NCT01086384|453580312|FG001|Treatment Period|Study Closed/Terminated|7|||
126077978|NCT01086384|453580313|FG002|Treatment Period|Study Closed/Terminated|8|||
126077979|NCT01086384|453580311|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
126077980|NCT01086384|453580312|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
126077981|NCT01086384|453580313|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
126077982|NCT01086384|453580311|FG000|Treatment Period|Received Treatment in Error|0|||
126077983|NCT01086384|453580312|FG001|Treatment Period|Received Treatment in Error|1|||
126077984|NCT01086384|453580313|FG002|Treatment Period|Received Treatment in Error|0|||
126077985|NCT00992992|453580314|FG000|Overall Study|Lost to Follow-up|3|||
126077986|NCT00992992|453580314|FG000|Overall Study|Death|16|||
126077987|NCT00992992|453580314|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
126077988|NCT00992992|453580314|FG000|Overall Study|Sponsor Closed the Study|4|||
126077989|NCT02250534|453580315|FG000|Overall Study|Lost to Follow-up|18|||
126077990|NCT02250534|453580316|FG001|Overall Study|Lost to Follow-up|28|||
126077991|NCT02250534|453580317|FG002|Overall Study|Lost to Follow-up|33|||
126077992|NCT02250534|453580315|FG000|Overall Study|Personal reasons|7|||
126077993|NCT02250534|453580316|FG001|Overall Study|Personal reasons|8|||
126077994|NCT02250534|453580317|FG002|Overall Study|Personal reasons|14|||
126077995|NCT02250534|453580315|FG000|Overall Study|Adverse Event|6|||
126077996|NCT02250534|453580316|FG001|Overall Study|Adverse Event|3|||
126077997|NCT02250534|453580317|FG002|Overall Study|Adverse Event|8|||
126077998|NCT02250534|453580315|FG000|Overall Study|incarcerated|2|||
126077999|NCT02250534|453580316|FG001|Overall Study|incarcerated|1|||
126078000|NCT02250534|453580317|FG002|Overall Study|incarcerated|2|||
126078001|NCT02250534|453580315|FG000|Overall Study|Withdrawal by Subject|0|||
126078002|NCT02250534|453580316|FG001|Overall Study|Withdrawal by Subject|1|||
126078003|NCT02250534|453580317|FG002|Overall Study|Withdrawal by Subject|2|||
126078004|NCT02250534|453580315|FG000|Overall Study|Death|0|||
126078005|NCT02250534|453580316|FG001|Overall Study|Death|1|||
126078006|NCT02250534|453580317|FG002|Overall Study|Death|1|||
126078007|NCT02250534|453580315|FG000|Overall Study|Physician Decision|1|||
126078008|NCT02250534|453580316|FG001|Overall Study|Physician Decision|3|||
126078009|NCT02250534|453580317|FG002|Overall Study|Physician Decision|1|||
126078010|NCT02250534|453580315|FG000|Overall Study|Protocol Violation|1|||
126078011|NCT02250534|453580316|FG001|Overall Study|Protocol Violation|0|||
126078012|NCT02250534|453580317|FG002|Overall Study|Protocol Violation|1|||
126078013|NCT02250534|453580315|FG000|Overall Study|Reason unknown|1|||
126078014|NCT02250534|453580316|FG001|Overall Study|Reason unknown|0|||
126078015|NCT02250534|453580317|FG002|Overall Study|Reason unknown|0|||
126078016|NCT02725567|453580319|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
126078017|NCT02725567|453580320|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
126078018|NCT02725567|453580319|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
126078019|NCT02725567|453580320|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
126078020|NCT02725567|453580319|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
126078021|NCT02725567|453580320|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
126078022|NCT00255944|453580321|FG000|Overall Study|Lost to Follow-up|797|||
126078023|NCT00255944|453580322|FG001|Overall Study|Lost to Follow-up|834|||
126078024|NCT01129115|453580323|FG000|Overall Study|Adverse Event|1|||
126078025|NCT01129115|453580324|FG001|Overall Study|Adverse Event|2|||
126078026|NCT01129115|453580325|FG002|Overall Study|Adverse Event|3|||
126078027|NCT01129115|453580326|FG003|Overall Study|Adverse Event|3|||
126078028|NCT01129115|453580323|FG000|Overall Study|Withdrawal by Subject|1|||
126078029|NCT01129115|453580324|FG001|Overall Study|Withdrawal by Subject|3|||
126078030|NCT01129115|453580325|FG002|Overall Study|Withdrawal by Subject|1|||
126078031|NCT01129115|453580326|FG003|Overall Study|Withdrawal by Subject|4|||
126078032|NCT01129115|453580323|FG000|Overall Study|Protocol Violation|0|||
126078033|NCT01129115|453580324|FG001|Overall Study|Protocol Violation|2|||
126078034|NCT01129115|453580325|FG002|Overall Study|Protocol Violation|2|||
126078035|NCT01129115|453580326|FG003|Overall Study|Protocol Violation|2|||
126078036|NCT00817336|453580329|FG000|Overall Study|Withdrawal by Subject|1|||
126078037|NCT00817336|453580330|FG001|Overall Study|Withdrawal by Subject|1|||
126078038|NCT02108652|453580331|FG000|Overall Study|Death|253|||
126078039|NCT02108652|453580331|FG000|Overall Study|Lost to Follow-up|2|||
126078040|NCT02108652|453580331|FG000|Overall Study|Withdrawal by Subject|16|||
126078041|NCT02108652|453580331|FG000|Overall Study|Study Terminated By Sponsor|31|||
126078042|NCT02108652|453580331|FG000|Overall Study|Non-Compliance|1|||
126078043|NCT02108652|453580331|FG000|Overall Study|Physician Decision|6|||
126078044|NCT02108652|453580331|FG000|Overall Study|Progression Of Disease|1|||
126078045|NCT01182181|453580332|FG000|First Intervention|Adverse Event|1|||
126078046|NCT01182181|453580333|FG001|First Intervention|Adverse Event|0|||
126078047|NCT01182181|453580332|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
126078048|NCT01182181|453580333|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
126078049|NCT01121913|453580334|FG000|First Intervention Period|Adverse Event|0|||
126078050|NCT01121913|453580335|FG001|First Intervention Period|Adverse Event|0|||
126078051|NCT01121913|453580336|FG002|First Intervention Period|Adverse Event|1|||
126078052|NCT01121913|453580337|FG003|First Intervention Period|Adverse Event|0|||
126078053|NCT01121913|453580334|FG000|First Washout Period|Withdrawal by Subject|1|||
126078054|NCT01121913|453580335|FG001|First Washout Period|Withdrawal by Subject|0|||
126078055|NCT01121913|453580336|FG002|First Washout Period|Withdrawal by Subject|0|||
126078056|NCT01121913|453580337|FG003|First Washout Period|Withdrawal by Subject|0|||
126078057|NCT01121913|453580334|FG000|Second Intervention Period|Adverse Event|0|||
126078058|NCT01121913|453580335|FG001|Second Intervention Period|Adverse Event|0|||
126078059|NCT01121913|453580336|FG002|Second Intervention Period|Adverse Event|1|||
126078060|NCT01121913|453580337|FG003|Second Intervention Period|Adverse Event|0|||
126078061|NCT01121913|453580334|FG000|Second Washout Period|Withdrawal by Subject|0|||
126078062|NCT01121913|453580335|FG001|Second Washout Period|Withdrawal by Subject|0|||
126078063|NCT01121913|453580336|FG002|Second Washout Period|Withdrawal by Subject|1|||
126078064|NCT01121913|453580337|FG003|Second Washout Period|Withdrawal by Subject|0|||
126078065|NCT01121913|453580334|FG000|Third Washout Period|Adverse Event|1|||
126078066|NCT01121913|453580335|FG001|Third Washout Period|Adverse Event|0|||
126078067|NCT01121913|453580336|FG002|Third Washout Period|Adverse Event|0|||
126078068|NCT01121913|453580337|FG003|Third Washout Period|Adverse Event|0|||
126078069|NCT02564718|453580340|FG000|Overall Study|Withdrew from treatment|0|||
126078070|NCT02564718|453580341|FG001|Overall Study|Withdrew from treatment|1|||
126078071|NCT01017263|453580342|FG000|Overall Study|not eligible|12|||
126078072|NCT02980705|453580343|FG000|Overall Study|Adverse Event|0|||
126078073|NCT02980705|453580344|FG001|Overall Study|Adverse Event|1|||
126078074|NCT02980705|453580343|FG000|Overall Study|Withdrawal by Subject|6|||
126078075|NCT02980705|453580344|FG001|Overall Study|Withdrawal by Subject|9|||
126078076|NCT02980705|453580343|FG000|Overall Study|withdrew participation|0|||
126078077|NCT02980705|453580344|FG001|Overall Study|withdrew participation|1|||
126078078|NCT02980705|453580343|FG000|Overall Study|Lost to Follow-up|2|||
126078079|NCT02980705|453580344|FG001|Overall Study|Lost to Follow-up|0|||
126078080|NCT04353817|453580345|FG000|Overall Study|Adverse Event|0|||
126078081|NCT04353817|453580346|FG001|Overall Study|Adverse Event|1|||
126078082|NCT00002597|453580347|FG000|Overall Study|Protocol Violation|19|||
126078083|NCT00002597|453580348|FG001|Overall Study|Protocol Violation|17|||
126078084|NCT00002597|453580347|FG000|Overall Study|Withdrawal by Subject|7|||
126078085|NCT00002597|453580348|FG001|Overall Study|Withdrawal by Subject|6|||
126078086|NCT02654132|453580349|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
126078087|NCT02654132|453580350|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
126078088|NCT02654132|453580349|FG000|Treatment Period|Disease progression|43|||
126078089|NCT02654132|453580350|FG001|Treatment Period|Disease progression|38|||
126078090|NCT02654132|453580349|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
125948181|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
125948182|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
125948183|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
125948184|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
125948185|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
125948186|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
125948187|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
125948188|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
125948189|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
126078091|NCT02654132|453580350|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
126078092|NCT02654132|453580349|FG000|Treatment Period|Other reasons|4|||
126078093|NCT02654132|453580350|FG001|Treatment Period|Other reasons|2|||
126078094|NCT02654132|453580349|FG000|Treatment Period|Study drug toxicity|2|||
126078095|NCT02654132|453580350|FG001|Treatment Period|Study drug toxicity|2|||
126078096|NCT02654132|453580349|FG000|Treatment Period|Withdrawal by Subject|2|||
126078097|NCT02654132|453580350|FG001|Treatment Period|Withdrawal by Subject|1|||
126078098|NCT02654132|453580349|FG000|Treatment Period|Maximum Clinical Benefit|0|||
126078099|NCT02654132|453580350|FG001|Treatment Period|Maximum Clinical Benefit|2|||
126078100|NCT02654132|453580349|FG000|Treatment Period|Participant request to discontinue|2|||
126078101|NCT02654132|453580350|FG001|Treatment Period|Participant request to discontinue|0|||
126078102|NCT02654132|453580349|FG000|Treatment Period|Administrative reasons by sponsor|0|||
126078103|NCT02654132|453580350|FG001|Treatment Period|Administrative reasons by sponsor|1|||
126078104|NCT02654132|453580349|FG000|Treatment Period|Death|1|||
126078105|NCT02654132|453580350|FG001|Treatment Period|Death|0|||
126078106|NCT02485899|453580352|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
126078107|NCT02485899|453580353|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126078108|NCT02485899|453580352|FG000|Overall Study|Withdrawal by Subject|1|||
126078109|NCT02485899|453580353|FG001|Overall Study|Withdrawal by Subject|0|||
126078110|NCT02485899|453580352|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
126078111|NCT02485899|453580353|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
126078112|NCT01918371|453580354|FG000|Overall Study|Missing Data|1|||
126078113|NCT01918371|453580355|FG001|Overall Study|Missing Data|1|||
126078114|NCT00823836|453580356|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
126078115|NCT00823836|453580357|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
126078116|NCT00823836|453580356|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
126078117|NCT00823836|453580357|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
126078118|NCT00823836|453580356|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
126078119|NCT00823836|453580357|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
126078120|NCT00823836|453580356|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
126078121|NCT00823836|453580357|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
126078122|NCT00823836|453580356|FG000|Long-term Phase|Adverse Event|3|||
126078123|NCT00823836|453580357|FG001|Long-term Phase|Adverse Event|2|||
126078124|NCT00823836|453580356|FG000|Long-term Phase|Physician Decision|1|||
126078125|NCT00823836|453580357|FG001|Long-term Phase|Physician Decision|2|||
126078126|NCT00823836|453580356|FG000|Long-term Phase|Withdrawal by Subject|1|||
126078127|NCT00823836|453580357|FG001|Long-term Phase|Withdrawal by Subject|1|||
126078128|NCT03713320|453580358|FG000|Randomized Period|Adverse Event|1|||
126078129|NCT03713320|453580359|FG001|Randomized Period|Adverse Event|5|||
126078130|NCT03713320|453580360|FG002|Randomized Period|Adverse Event|0|||
126078131|NCT03713320|453580358|FG000|Randomized Period|Physician Decision|1|||
126078132|NCT03713320|453580359|FG001|Randomized Period|Physician Decision|1|||
126078133|NCT03713320|453580360|FG002|Randomized Period|Physician Decision|0|||
126078134|NCT03713320|453580358|FG000|Randomized Period|Withdrawal by Subject|4|||
126078135|NCT03713320|453580359|FG001|Randomized Period|Withdrawal by Subject|0|||
126078136|NCT03713320|453580360|FG002|Randomized Period|Withdrawal by Subject|0|||
126078137|NCT03713320|453580358|FG000|Randomized Period|Participant decision|3|||
126078138|NCT03713320|453580359|FG001|Randomized Period|Participant decision|1|||
126078139|NCT03713320|453580360|FG002|Randomized Period|Participant decision|0|||
126078140|NCT03713320|453580358|FG000|Randomized Period|Study terminated by sponsor|6|||
126078141|NCT03713320|453580359|FG001|Randomized Period|Study terminated by sponsor|3|||
126078142|NCT03713320|453580360|FG002|Randomized Period|Study terminated by sponsor|0|||
126078143|NCT03713320|453580358|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
126078144|NCT03713320|453580359|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
126078145|NCT03713320|453580360|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
126078146|NCT03713320|453580358|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
126078147|NCT03713320|453580359|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
126078148|NCT03713320|453580360|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
126078149|NCT01880437|453580361|FG000|Overall Study|Death|12|||
126078150|NCT01880437|453580362|FG001|Overall Study|Death|4|||
126078151|NCT01880437|453580363|FG002|Overall Study|Death|17|||
126078152|NCT01880437|453580361|FG000|Overall Study|Study terminated by Sponsor|3|||
126078153|NCT01880437|453580362|FG001|Overall Study|Study terminated by Sponsor|0|||
126078154|NCT01880437|453580363|FG002|Overall Study|Study terminated by Sponsor|2|||
126078155|NCT04354168|453580368|FG000|Overall Study|Lost to Follow-up|22|||
126078156|NCT01438840|453580371|FG000|Core Study|Adverse Event|0|||
126078157|NCT01438840|453580372|FG001|Core Study|Adverse Event|3|||
125948190|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
125948191|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
125948192|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
125948193|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
126078158|NCT01438840|453580373|FG002|Core Study|Adverse Event|0|||
126078159|NCT01438840|453580371|FG000|Core Study|Lack of Efficacy|15|||
126078160|NCT01438840|453580372|FG001|Core Study|Lack of Efficacy|7|||
126078161|NCT01438840|453580373|FG002|Core Study|Lack of Efficacy|0|||
126078162|NCT01438840|453580371|FG000|Core Study|Withdrawal of consent|1|||
126078163|NCT01438840|453580372|FG001|Core Study|Withdrawal of consent|0|||
126078164|NCT01438840|453580373|FG002|Core Study|Withdrawal of consent|0|||
126078165|NCT01438840|453580371|FG000|Extension Phase|Adverse Event|0|||
126078166|NCT01438840|453580372|FG001|Extension Phase|Adverse Event|0|||
126078167|NCT01438840|453580373|FG002|Extension Phase|Adverse Event|3|||
126078168|NCT01438840|453580371|FG000|Extension Phase|Lost to Follow-up|0|||
126078169|NCT01438840|453580372|FG001|Extension Phase|Lost to Follow-up|0|||
126078170|NCT01438840|453580373|FG002|Extension Phase|Lost to Follow-up|1|||
126078171|NCT01438840|453580371|FG000|Extension Phase|Withdrawal by Subject|0|||
126078172|NCT01438840|453580372|FG001|Extension Phase|Withdrawal by Subject|0|||
126078173|NCT01438840|453580373|FG002|Extension Phase|Withdrawal by Subject|3|||
126078174|NCT01438840|453580371|FG000|Extension Phase|Lack of Efficacy|0|||
126078175|NCT01438840|453580372|FG001|Extension Phase|Lack of Efficacy|0|||
126078176|NCT01438840|453580373|FG002|Extension Phase|Lack of Efficacy|2|||
126078177|NCT01438840|453580371|FG000|Extension Phase|Other|0|||
126078178|NCT01438840|453580372|FG001|Extension Phase|Other|0|||
126078179|NCT01438840|453580373|FG002|Extension Phase|Other|1|||
126078180|NCT02062645|453580376|FG000|Overall Study|Adverse Event|2|||
126078181|NCT02062645|453580376|FG000|Overall Study|Protocol Violation|8|||
126078182|NCT02062645|453580376|FG000|Overall Study|Lost to Follow-up|5|||
126078183|NCT02804399|453580377|FG000|Period 2|Adverse Event|0|||
126078184|NCT02804399|453580378|FG001|Period 2|Adverse Event|1|||
126078185|NCT01774305|453580379|FG000|Overall Study|Physician Decision|1|||
126078186|NCT01774305|453580380|FG001|Overall Study|Physician Decision|0|||
126078187|NCT04211389|453580381|FG000|Overall Study|Adverse Event|1|||
126078188|NCT04211389|453580382|FG001|Overall Study|Adverse Event|2|||
126078189|NCT04211389|453580381|FG000|Overall Study|Lost to Follow-up|15|||
126078190|NCT04211389|453580382|FG001|Overall Study|Lost to Follow-up|7|||
126078191|NCT04211389|453580381|FG000|Overall Study|Protocol Violation|0|||
126078192|NCT04211389|453580382|FG001|Overall Study|Protocol Violation|1|||
126078193|NCT04211389|453580381|FG000|Overall Study|Withdrawal by Subject|10|||
126078194|NCT04211389|453580382|FG001|Overall Study|Withdrawal by Subject|11|||
126078195|NCT01062971|453580388|FG000|Overall Study|Protocol Violation|1|||
126078196|NCT01062971|453580389|FG001|Overall Study|Protocol Violation|3|||
126078197|NCT01062971|453580388|FG000|Overall Study|Lost to Follow-up|3|||
126078198|NCT01062971|453580389|FG001|Overall Study|Lost to Follow-up|4|||
126078199|NCT01530087|453580390|FG000|Overall Study|Physician Decision|2|||
126078200|NCT05523219|453580391|FG000|Overall Study|Wrong inclusion|1|||
126078201|NCT05523219|453580391|FG000|Overall Study|Lost to Follow-up|7|||
126078202|NCT02760485|453580392|FG000|Phase 1|Death|3|||
126078203|NCT02760485|453580393|FG001|Phase 1|Death|6|||
126078204|NCT02760485|453580394|FG002|Phase 1|Death|0|||
126078205|NCT02760485|453580392|FG000|Phase 1|Withdrawal by Subject|2|||
126078206|NCT02760485|453580393|FG001|Phase 1|Withdrawal by Subject|0|||
126078207|NCT02760485|453580394|FG002|Phase 1|Withdrawal by Subject|0|||
126078208|NCT02760485|453580392|FG000|Phase 1|Progressive Disease|1|||
126078209|NCT02760485|453580393|FG001|Phase 1|Progressive Disease|0|||
126078210|NCT02760485|453580394|FG002|Phase 1|Progressive Disease|0|||
126078211|NCT02760485|453580392|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
126078212|NCT02760485|453580393|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
126078213|NCT02760485|453580394|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
126078214|NCT02760485|453580392|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
126078215|NCT02760485|453580393|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
126078216|NCT02760485|453580394|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
126078217|NCT02760485|453580392|FG000|Phase 2|Death|0|||
126078218|NCT02760485|453580393|FG001|Phase 2|Death|0|||
126078219|NCT02760485|453580394|FG002|Phase 2|Death|12|||
126078220|NCT02760485|453580392|FG000|Phase 2|Withdrawal by Subject|0|||
126078221|NCT02760485|453580393|FG001|Phase 2|Withdrawal by Subject|0|||
126078222|NCT02760485|453580394|FG002|Phase 2|Withdrawal by Subject|3|||
126078223|NCT02760485|453580392|FG000|Phase 2|Progressive Disease|0|||
126078224|NCT02760485|453580393|FG001|Phase 2|Progressive Disease|0|||
126078225|NCT02760485|453580394|FG002|Phase 2|Progressive Disease|1|||
126078226|NCT02760485|453580392|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
126078227|NCT02760485|453580393|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
126078228|NCT02760485|453580394|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
126078229|NCT02261285|453580395|FG000|Overall Study|Disease progression|0|||
126078230|NCT02261285|453580396|FG001|Overall Study|Disease progression|0|||
126078231|NCT02261285|453580397|FG002|Overall Study|Disease progression|1|||
126078232|NCT01182207|453580398|FG000|First Intervention|Positive Hepatitis Results|0|||
126078233|NCT01182207|453580399|FG001|First Intervention|Positive Hepatitis Results|1|||
126078234|NCT01182207|453580398|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
126078235|NCT01182207|453580399|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
126078236|NCT01087814|453580400|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
126078237|NCT01087814|453580401|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
126078238|NCT01087814|453580400|FG000|Second Intervention (5 Days)|Physician Decision|1|||
126078239|NCT01087814|453580401|FG001|Second Intervention (5 Days)|Physician Decision|0|||
126078240|NCT00661713|453580402|FG000|Overall Study|Death|1|||
126078241|NCT00661713|453580403|FG001|Overall Study|Death|0|||
126078242|NCT00661713|453580404|FG002|Overall Study|Death|0|||
126078243|NCT00661713|453580405|FG003|Overall Study|Death|0|||
126078244|NCT00661713|453580406|FG004|Overall Study|Death|1|||
126078245|NCT00661713|453580407|FG005|Overall Study|Death|0|||
126078246|NCT00661713|453580408|FG006|Overall Study|Death|0|||
126078247|NCT00661713|453580409|FG007|Overall Study|Death|0|||
126078248|NCT00661713|453580402|FG000|Overall Study|Unable to Classify|1|||
126078249|NCT00661713|453580403|FG001|Overall Study|Unable to Classify|0|||
126078250|NCT00661713|453580404|FG002|Overall Study|Unable to Classify|0|||
126078251|NCT00661713|453580405|FG003|Overall Study|Unable to Classify|0|||
126078252|NCT00661713|453580406|FG004|Overall Study|Unable to Classify|0|||
126078253|NCT00661713|453580407|FG005|Overall Study|Unable to Classify|0|||
126078254|NCT00661713|453580408|FG006|Overall Study|Unable to Classify|0|||
126078255|NCT00661713|453580409|FG007|Overall Study|Unable to Classify|0|||
126078256|NCT00661713|453580402|FG000|Overall Study|Protocol Violation|1|||
126078257|NCT00661713|453580403|FG001|Overall Study|Protocol Violation|6|||
126078258|NCT00661713|453580404|FG002|Overall Study|Protocol Violation|3|||
126078259|NCT00661713|453580405|FG003|Overall Study|Protocol Violation|3|||
126078260|NCT00661713|453580406|FG004|Overall Study|Protocol Violation|0|||
126078261|NCT00661713|453580407|FG005|Overall Study|Protocol Violation|2|||
126078262|NCT00661713|453580408|FG006|Overall Study|Protocol Violation|2|||
126078263|NCT00661713|453580409|FG007|Overall Study|Protocol Violation|1|||
126078264|NCT00661713|453580402|FG000|Overall Study|Withdrawal by Subject|11|||
126078265|NCT00661713|453580403|FG001|Overall Study|Withdrawal by Subject|25|||
126078266|NCT00661713|453580404|FG002|Overall Study|Withdrawal by Subject|12|||
126078267|NCT00661713|453580405|FG003|Overall Study|Withdrawal by Subject|21|||
126078268|NCT00661713|453580406|FG004|Overall Study|Withdrawal by Subject|12|||
126078269|NCT00661713|453580407|FG005|Overall Study|Withdrawal by Subject|26|||
126078270|NCT00661713|453580408|FG006|Overall Study|Withdrawal by Subject|45|||
126078271|NCT00661713|453580409|FG007|Overall Study|Withdrawal by Subject|9|||
126078272|NCT00661713|453580402|FG000|Overall Study|Lost to Follow-up|2|||
126078273|NCT00661713|453580403|FG001|Overall Study|Lost to Follow-up|7|||
126078274|NCT00661713|453580404|FG002|Overall Study|Lost to Follow-up|2|||
126078275|NCT00661713|453580405|FG003|Overall Study|Lost to Follow-up|2|||
126078276|NCT00661713|453580406|FG004|Overall Study|Lost to Follow-up|5|||
126078277|NCT00661713|453580407|FG005|Overall Study|Lost to Follow-up|7|||
126078278|NCT00661713|453580408|FG006|Overall Study|Lost to Follow-up|14|||
126078279|NCT00661713|453580409|FG007|Overall Study|Lost to Follow-up|1|||
126078280|NCT00661713|453580402|FG000|Overall Study|Administrative Reason|0|||
126078281|NCT00661713|453580403|FG001|Overall Study|Administrative Reason|1|||
126078282|NCT00661713|453580404|FG002|Overall Study|Administrative Reason|0|||
126078283|NCT00661713|453580405|FG003|Overall Study|Administrative Reason|2|||
126078284|NCT00661713|453580406|FG004|Overall Study|Administrative Reason|2|||
126078285|NCT00661713|453580407|FG005|Overall Study|Administrative Reason|2|||
126078286|NCT00661713|453580408|FG006|Overall Study|Administrative Reason|1|||
126078287|NCT00661713|453580409|FG007|Overall Study|Administrative Reason|0|||
126078288|NCT00661713|453580402|FG000|Overall Study|Adverse Event|0|||
126078289|NCT00661713|453580403|FG001|Overall Study|Adverse Event|0|||
126078290|NCT00661713|453580404|FG002|Overall Study|Adverse Event|0|||
126078291|NCT00661713|453580405|FG003|Overall Study|Adverse Event|0|||
126078292|NCT00661713|453580406|FG004|Overall Study|Adverse Event|0|||
126078293|NCT00661713|453580407|FG005|Overall Study|Adverse Event|0|||
126078294|NCT00661713|453580408|FG006|Overall Study|Adverse Event|1|||
126078295|NCT00661713|453580409|FG007|Overall Study|Adverse Event|0|||
126078296|NCT00661713|453580402|FG000|Overall Study|Inappropriate Enrollment|0|||
126078297|NCT00661713|453580403|FG001|Overall Study|Inappropriate Enrollment|0|||
126078298|NCT00661713|453580404|FG002|Overall Study|Inappropriate Enrollment|0|||
126078299|NCT00661713|453580405|FG003|Overall Study|Inappropriate Enrollment|0|||
126078300|NCT00661713|453580406|FG004|Overall Study|Inappropriate Enrollment|0|||
126078301|NCT00661713|453580407|FG005|Overall Study|Inappropriate Enrollment|0|||
126078302|NCT00661713|453580408|FG006|Overall Study|Inappropriate Enrollment|1|||
125948194|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
125948195|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
125948196|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
125948197|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
125948198|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
126078303|NCT00661713|453580409|FG007|Overall Study|Inappropriate Enrollment|0|||
126078304|NCT01161628|453580410|FG000|Overall Study|Death|6|||
126078305|NCT01161628|453580410|FG000|Overall Study|Lack of Efficacy|2|||
126078306|NCT01482429|453580411|FG000|Care Usual|Protocol Violation|0|||
126078307|NCT01482429|453580412|FG001|Care Usual|Protocol Violation|172|||
126078308|NCT01482429|453580411|FG000|Care Usual|Lost to Follow-up|0|||
126078309|NCT01482429|453580412|FG001|Care Usual|Lost to Follow-up|1|||
126078310|NCT01482429|453580411|FG000|Protocol|Protocol Violation|275|||
126078311|NCT01482429|453580412|FG001|Protocol|Protocol Violation|0|||
126078312|NCT04680637|453580413|FG000|Overall Study|Lost to Follow-up|0|||
126078313|NCT04680637|453580414|FG001|Overall Study|Lost to Follow-up|1|||
126078314|NCT04680637|453580415|FG002|Overall Study|Lost to Follow-up|0|||
126078315|NCT04680637|453580416|FG003|Overall Study|Lost to Follow-up|1|||
126078316|NCT04680637|453580413|FG000|Overall Study|Death|1|||
126078317|NCT04680637|453580414|FG001|Overall Study|Death|0|||
126078318|NCT04680637|453580415|FG002|Overall Study|Death|0|||
126078319|NCT04680637|453580416|FG003|Overall Study|Death|0|||
126078320|NCT04680637|453580413|FG000|Overall Study|Withdrawal by Subject|7|||
126078321|NCT04680637|453580414|FG001|Overall Study|Withdrawal by Subject|10|||
125948199|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
125948200|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
125948201|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
125948202|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
125948203|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
125948204|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
125948205|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
125948206|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
125948207|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
125948208|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
125948209|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
125948210|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
125948211|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
125948212|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
126078322|NCT04680637|453580415|FG002|Overall Study|Withdrawal by Subject|17|||
126078323|NCT04680637|453580416|FG003|Overall Study|Withdrawal by Subject|15|||
126078324|NCT04680637|453580413|FG000|Overall Study|Decision by Sponsor|21|||
126078325|NCT04680637|453580414|FG001|Overall Study|Decision by Sponsor|15|||
126078326|NCT04680637|453580415|FG002|Overall Study|Decision by Sponsor|7|||
126078327|NCT04680637|453580416|FG003|Overall Study|Decision by Sponsor|32|||
126078328|NCT02037256|453580417|FG000|Overall Study|Protocol Violation|0|||
126078329|NCT02037256|453580418|FG001|Overall Study|Protocol Violation|1|||
126078330|NCT02037256|453580417|FG000|Overall Study|Withdrawn prior to Velcade|0|||
126078331|NCT02037256|453580418|FG001|Overall Study|Withdrawn prior to Velcade|2|||
126078332|NCT04398368|453582008|FG000|Overall Study|Withdrawal by Subject|2|||
126078333|NCT00891046|453582013|FG000|Overall Study|Protocol Violation|1|||
126078334|NCT00891046|453582014|FG001|Overall Study|Protocol Violation|1|||
126078335|NCT00891046|453582015|FG002|Overall Study|Protocol Violation|0|||
126078336|NCT00891046|453582016|FG003|Overall Study|Protocol Violation|0|||
126078337|NCT00891046|453582017|FG004|Overall Study|Protocol Violation|1|||
126078338|NCT00891046|453582013|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126078339|NCT00891046|453582014|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126078340|NCT00891046|453582015|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
126078341|NCT00891046|453582016|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
126078342|NCT00891046|453582017|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
126078343|NCT00891046|453582013|FG000|Overall Study|Administrative problems|0|||
126078344|NCT00891046|453582014|FG001|Overall Study|Administrative problems|0|||
126078345|NCT00891046|453582015|FG002|Overall Study|Administrative problems|0|||
126078346|NCT00891046|453582016|FG003|Overall Study|Administrative problems|0|||
126078347|NCT00891046|453582017|FG004|Overall Study|Administrative problems|1|||
126078348|NCT00891046|453582013|FG000|Overall Study|Participant no longer required drug|0|||
126078349|NCT00891046|453582014|FG001|Overall Study|Participant no longer required drug|2|||
126078350|NCT00891046|453582015|FG002|Overall Study|Participant no longer required drug|0|||
126078351|NCT00891046|453582016|FG003|Overall Study|Participant no longer required drug|0|||
126078352|NCT00891046|453582017|FG004|Overall Study|Participant no longer required drug|1|||
126078353|NCT00891046|453582013|FG000|Overall Study|Adverse Event|4|||
126078354|NCT00891046|453582014|FG001|Overall Study|Adverse Event|3|||
126078355|NCT00891046|453582015|FG002|Overall Study|Adverse Event|2|||
126078356|NCT00891046|453582016|FG003|Overall Study|Adverse Event|0|||
126078357|NCT00891046|453582017|FG004|Overall Study|Adverse Event|14|||
126078358|NCT00891046|453582013|FG000|Overall Study|Withdrawal by Subject|2|||
126078359|NCT00891046|453582014|FG001|Overall Study|Withdrawal by Subject|1|||
125948213|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
125948214|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
125948215|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
125948216|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
125948217|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
126078360|NCT00891046|453582015|FG002|Overall Study|Withdrawal by Subject|2|||
126078361|NCT00891046|453582016|FG003|Overall Study|Withdrawal by Subject|1|||
126078362|NCT00891046|453582017|FG004|Overall Study|Withdrawal by Subject|1|||
126078363|NCT00891046|453582013|FG000|Overall Study|Lost to Follow-up|0|||
126078364|NCT00891046|453582014|FG001|Overall Study|Lost to Follow-up|0|||
126078365|NCT00891046|453582015|FG002|Overall Study|Lost to Follow-up|0|||
126078366|NCT00891046|453582016|FG003|Overall Study|Lost to Follow-up|0|||
126078367|NCT00891046|453582017|FG004|Overall Study|Lost to Follow-up|1|||
126078368|NCT04523207|453582020|FG000|Overall Study|Adverse Event|5|||
126078369|NCT04523207|453582021|FG001|Overall Study|Adverse Event|1|||
126078370|NCT04523207|453582020|FG000|Overall Study|Lost to Follow-up|2|||
126078371|NCT04523207|453582021|FG001|Overall Study|Lost to Follow-up|0|||
126078372|NCT04523207|453582020|FG000|Overall Study|Withdrawal by Subject|2|||
126078373|NCT04523207|453582021|FG001|Overall Study|Withdrawal by Subject|0|||
126078374|NCT04523207|453582020|FG000|Overall Study|Progressive Disease|2|||
126078375|NCT04523207|453582021|FG001|Overall Study|Progressive Disease|1|||
125948218|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
125948219|NCT01218516|453108689|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
125948220|NCT01218516|453108690|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
125948221|NCT01218516|453108691|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
125948222|NCT01218516|453108692|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
125948223|NCT04033003|453108694|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
125948224|NCT04033003|453108695|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
125948225|NCT04033003|453108694|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
125948226|NCT04033003|453108695|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
125948227|NCT04033003|453108694|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
125948228|NCT04033003|453108695|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
125948229|NCT04033003|453108694|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
125948230|NCT04033003|453108695|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
125948231|NCT04033003|453108694|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
125948232|NCT04033003|453108695|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
126114940|NCT01514136|453715811|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
126114941|NCT01514136|453715812|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
126114942|NCT01514136|453715813|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
126114943|NCT01514136|453715814|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
126114944|NCT01514136|453715807|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
125948233|NCT04033003|453108694|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
125948234|NCT04033003|453108695|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
125948235|NCT04033003|453108694|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
125948236|NCT04033003|453108695|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
125948237|NCT04033003|453108694|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
125948238|NCT04033003|453108695|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
125948239|NCT04033003|453108694|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
125948240|NCT04033003|453108695|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
125948241|NCT04033003|453108694|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
125948242|NCT04033003|453108695|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
125948243|NCT04033003|453108694|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
125948244|NCT04033003|453108695|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
125948245|NCT04033003|453108694|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
125948246|NCT04033003|453108695|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
125948247|NCT04033003|453108694|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
125948248|NCT04033003|453108695|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
125948249|NCT00706966|453108696|FG000|Overall Study|Adverse Event|1|||
125948250|NCT02046148|453108709|FG000|Overall Study|Lost to Follow-up|1|||
125948251|NCT02046148|453108710|FG001|Overall Study|Lost to Follow-up|1|||
125948252|NCT02046148|453108709|FG000|Overall Study|Withdrawal by Subject|0|||
125948253|NCT02046148|453108710|FG001|Overall Study|Withdrawal by Subject|2|||
125948254|NCT00235872|453108720|FG000|Overall Study|Adverse Event|34|||
125948255|NCT00235872|453108720|FG000|Overall Study|Death|1|||
125948256|NCT00235872|453108720|FG000|Overall Study|Lost to Follow-up|1|||
125948257|NCT00235872|453108720|FG000|Overall Study|Withdrawal by Subject|50|||
125948258|NCT00235872|453108720|FG000|Overall Study|Administrative reason|61|||
125948259|NCT01446965|453108721|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
125948260|NCT01446965|453108722|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
125948261|NCT01446965|453108721|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
125948262|NCT01446965|453108722|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
125948263|NCT02852265|453108723|FG000|3-month Follow-up|Lost to Follow-up|1|||
125948264|NCT02852265|453108724|FG001|3-month Follow-up|Lost to Follow-up|1|||
125948265|NCT01232296|453108725|FG000|Overall Study|Adverse Event|24|||
125948266|NCT01232296|453108726|FG001|Overall Study|Adverse Event|12|||
125948267|NCT01232296|453108725|FG000|Overall Study|Physician Decision|1|||
125948268|NCT01232296|453108726|FG001|Overall Study|Physician Decision|1|||
125948269|NCT01232296|453108725|FG000|Overall Study|Progressive disease|43|||
125948270|NCT01232296|453108726|FG001|Overall Study|Progressive disease|61|||
125948271|NCT01232296|453108725|FG000|Overall Study|Study terminated by sponsor|0|||
125948272|NCT01232296|453108726|FG001|Overall Study|Study terminated by sponsor|1|||
125948273|NCT01232296|453108725|FG000|Overall Study|Technical problems|3|||
125948274|NCT01232296|453108726|FG001|Overall Study|Technical problems|0|||
125948275|NCT01232296|453108725|FG000|Overall Study|Subject/guardian decision|10|||
125948276|NCT01232296|453108726|FG001|Overall Study|Subject/guardian decision|2|||
125948277|NCT01232296|453108725|FG000|Overall Study|Death|1|||
125948278|NCT01232296|453108726|FG001|Overall Study|Death|6|||
126114945|NCT01514136|453715808|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
125948279|NCT02871375|453108727|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
125948280|NCT02871375|453108728|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
125948281|NCT03144180|453108729|FG000|Overall Study|STAT Delivery|1|||
126078376|NCT04523207|453582020|FG000|Overall Study|Other|7|||
126078377|NCT04523207|453582021|FG001|Overall Study|Other|1|||
126078378|NCT03113383|453582022|FG000|Overall Study|Death|4|||
126078379|NCT03113383|453582023|FG001|Overall Study|Death|0|||
126078380|NCT02053610|453582025|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
126078381|NCT02053610|453582026|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
126078382|NCT02053610|453582025|FG000|Overall Study|Withdrew Consent|2|||
126078383|NCT02053610|453582026|FG001|Overall Study|Withdrew Consent|9|||
126078384|NCT02053610|453582025|FG000|Overall Study|Death|5|||
126078385|NCT02053610|453582026|FG001|Overall Study|Death|5|||
126078386|NCT02053610|453582025|FG000|Overall Study|Administrative/Other|1|||
126078387|NCT02053610|453582026|FG001|Overall Study|Administrative/Other|1|||
126078388|NCT02053610|453582025|FG000|Overall Study|Disease Progression|2|||
126078389|NCT02053610|453582026|FG001|Overall Study|Disease Progression|3|||
126078390|NCT02053610|453582025|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
126078391|NCT02053610|453582026|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
126078392|NCT02053610|453582025|FG000|Overall Study|Did not Receive Treatment|4|||
126078393|NCT02053610|453582026|FG001|Overall Study|Did not Receive Treatment|2|||
126078394|NCT02053610|453582025|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126078395|NCT02053610|453582026|FG001|Overall Study|Insufficient Therapeutic Response|1|||
126078396|NCT02053610|453582025|FG000|Overall Study|Violation of Selection Criteria|1|||
126078397|NCT02053610|453582026|FG001|Overall Study|Violation of Selection Criteria|0|||
126078398|NCT00543062|453582030|FG000|Overall Study|Withdrawal by Subject|1|||
126078399|NCT00543062|453582031|FG001|Overall Study|Withdrawal by Subject|0|||
126078400|NCT00543062|453582032|FG002|Overall Study|Withdrawal by Subject|2|||
126078401|NCT00543062|453582033|FG003|Overall Study|Withdrawal by Subject|0|||
126078402|NCT00543062|453582030|FG000|Overall Study|Adverse Event|0|||
126078403|NCT00543062|453582031|FG001|Overall Study|Adverse Event|1|||
126078404|NCT00543062|453582032|FG002|Overall Study|Adverse Event|1|||
126078405|NCT00543062|453582033|FG003|Overall Study|Adverse Event|1|||
126078406|NCT00543062|453582030|FG000|Overall Study|Protocol Violation|1|||
126078407|NCT00543062|453582031|FG001|Overall Study|Protocol Violation|0|||
126078408|NCT00543062|453582032|FG002|Overall Study|Protocol Violation|0|||
126078409|NCT00543062|453582033|FG003|Overall Study|Protocol Violation|0|||
125948282|NCT03144180|453108730|FG001|Overall Study|STAT Delivery|1|||
125948283|NCT03144180|453108729|FG000|Overall Study|Provider forgot to fill out forms|1|||
125948284|NCT03144180|453108730|FG001|Overall Study|Provider forgot to fill out forms|3|||
125948285|NCT03144180|453108729|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
125948286|NCT03144180|453108730|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
125948287|NCT03144180|453108729|FG000|Overall Study|Scrub tech removed tube cap|0|||
125948288|NCT03144180|453108730|FG001|Overall Study|Scrub tech removed tube cap|1|||
125948289|NCT00606892|453108735|FG000|First Intervention|Protocol Violation|1|||
125948290|NCT00606892|453108736|FG001|First Intervention|Protocol Violation|4|||
125948291|NCT00794196|453108740|FG000|Overall Study|Lost to Follow-up|5|||
125948292|NCT00794196|453108741|FG001|Overall Study|Lost to Follow-up|23|||
125948293|NCT02129803|453108742|FG000|Overall Study|Protocol Violation|4|||
125948294|NCT02129803|453108743|FG001|Overall Study|Protocol Violation|0|||
125948295|NCT02129803|453108742|FG000|Overall Study|Physician Decision|0|||
125948296|NCT02129803|453108743|FG001|Overall Study|Physician Decision|1|||
125948297|NCT02129803|453108742|FG000|Overall Study|Difficulty sleeping|1|||
125948298|NCT02129803|453108743|FG001|Overall Study|Difficulty sleeping|0|||
125948299|NCT02129803|453108742|FG000|Overall Study|Morning headache|0|||
125948300|NCT02129803|453108743|FG001|Overall Study|Morning headache|1|||
125948301|NCT02129803|453108742|FG000|Overall Study|Withdrawal by Subject|1|||
125948302|NCT02129803|453108743|FG001|Overall Study|Withdrawal by Subject|1|||
125948303|NCT00149747|453108745|FG000|Overall Study|Death|1|||
125948304|NCT00149747|453108746|FG001|Overall Study|Death|0|||
125948305|NCT00149747|453108745|FG000|Overall Study|Withdrawal by Subject|3|||
125948306|NCT00149747|453108746|FG001|Overall Study|Withdrawal by Subject|3|||
125948307|NCT06049043|453108747|FG000|Overall Study|Lost to Follow-up|11|||
125948308|NCT06049043|453108748|FG001|Overall Study|Lost to Follow-up|9|||
125948309|NCT02739269|453108752|FG000|Overall Study|Protocol Violation|5|||
125948310|NCT02739269|453108753|FG001|Overall Study|Protocol Violation|0|||
125948311|NCT02739269|453108752|FG000|Overall Study|Cycle cancellation|2|||
125948312|NCT02739269|453108753|FG001|Overall Study|Cycle cancellation|2|||
126078410|NCT01010204|453582036|FG000|Overall Study|Lost to Follow-up|2|||
126078411|NCT01010204|453582037|FG001|Overall Study|Lost to Follow-up|2|||
126078412|NCT01010204|453582036|FG000|Overall Study|Adverse Event|1|||
125948313|NCT02739269|453108752|FG000|Overall Study|Withdrawal by Subject|0|||
125948314|NCT02739269|453108753|FG001|Overall Study|Withdrawal by Subject|2|||
125948315|NCT01354496|453108754|FG000|Period 1|Adverse Event|0|||
125948316|NCT01354496|453108755|FG001|Period 1|Adverse Event|0|||
126078413|NCT01010204|453582037|FG001|Overall Study|Adverse Event|3|||
126078414|NCT01010204|453582036|FG000|Overall Study|Withdrawal by Subject|2|||
125948317|NCT01354496|453108756|FG002|Period 1|Adverse Event|1|||
125948318|NCT01354496|453108757|FG003|Period 1|Adverse Event|0|||
126078415|NCT01010204|453582037|FG001|Overall Study|Withdrawal by Subject|3|||
126078416|NCT01010204|453582036|FG000|Overall Study|psychiatric hospitalization|2|||
126078417|NCT01010204|453582037|FG001|Overall Study|psychiatric hospitalization|1|||
126078418|NCT01513330|453582038|FG000|SenSura Mio First,|Adverse Event|2|||
125948319|NCT01354496|453108758|FG004|Period 1|Adverse Event|0|||
125948320|NCT01354496|453108759|FG005|Period 1|Adverse Event|0|||
125948321|NCT01354496|453108754|FG000|Period 1|Physician Decision|0|||
125948322|NCT01354496|453108755|FG001|Period 1|Physician Decision|0|||
125948323|NCT01354496|453108756|FG002|Period 1|Physician Decision|1|||
125948324|NCT01354496|453108757|FG003|Period 1|Physician Decision|0|||
126078419|NCT01513330|453582039|FG001|SenSura Mio First,|Adverse Event|0|||
126078420|NCT01513330|453582038|FG000|SenSura Mio First,|Lack of Efficacy|0|||
126078421|NCT01513330|453582039|FG001|SenSura Mio First,|Lack of Efficacy|1|||
126078422|NCT01513330|453582038|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
126078423|NCT01513330|453582039|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
126078424|NCT01513330|453582038|FG000|SenSura Mio First,|Other|1|||
126078425|NCT01513330|453582039|FG001|SenSura Mio First,|Other|0|||
126078426|NCT01513330|453582038|FG000|Standard Care First,|Lack of Efficacy|2|||
126078427|NCT01513330|453582039|FG001|Standard Care First,|Lack of Efficacy|2|||
126078428|NCT01513330|453582038|FG000|Standard Care First,|Withdrawal by Subject|1|||
126078429|NCT01513330|453582039|FG001|Standard Care First,|Withdrawal by Subject|2|||
126078430|NCT01513330|453582038|FG000|Standard Care First,|Other|1|||
126078431|NCT01513330|453582039|FG001|Standard Care First,|Other|0|||
126078432|NCT01519778|453582040|FG000|Overall Study|Withdrawal by Subject|3|||
126078433|NCT01519778|453582040|FG000|Overall Study|Lost to Follow-up|10|||
126078434|NCT01519778|453582040|FG000|Overall Study|Physician Decision|1|||
126078435|NCT04486313|453582041|FG000|Overall Study|Lost to Follow-up|7|||
126078436|NCT04486313|453582042|FG001|Overall Study|Lost to Follow-up|9|||
126078437|NCT04486313|453582041|FG000|Overall Study|Withdrawal by Subject|8|||
126078438|NCT04486313|453582042|FG001|Overall Study|Withdrawal by Subject|6|||
126078439|NCT04486313|453582041|FG000|Overall Study|Physician Decision|1|||
126078440|NCT04486313|453582042|FG001|Overall Study|Physician Decision|1|||
126078441|NCT04486313|453582041|FG000|Overall Study|Death|2|||
126078442|NCT04486313|453582042|FG001|Overall Study|Death|0|||
126078443|NCT04486313|453582041|FG000|Overall Study|Protocol Violation|1|||
126078444|NCT04486313|453582042|FG001|Overall Study|Protocol Violation|1|||
126078445|NCT01657799|453582043|FG000|Overall Study|Adverse Event Related to progression|6|||
126078446|NCT01657799|453582044|FG001|Overall Study|Adverse Event Related to progression|8|||
126078447|NCT01657799|453582045|FG002|Overall Study|Adverse Event Related to progression|12|||
126078448|NCT01657799|453582043|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
126078449|NCT01657799|453582044|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
126078450|NCT01657799|453582045|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
126078451|NCT01657799|453582043|FG000|Overall Study|Withdrawal by Subject|13|||
126078452|NCT01657799|453582044|FG001|Overall Study|Withdrawal by Subject|10|||
126078453|NCT01657799|453582045|FG002|Overall Study|Withdrawal by Subject|10|||
126078454|NCT01657799|453582043|FG000|Overall Study|Lost to Follow-up|1|||
126078455|NCT01657799|453582044|FG001|Overall Study|Lost to Follow-up|0|||
126078456|NCT01657799|453582045|FG002|Overall Study|Lost to Follow-up|1|||
126078457|NCT01657799|453582043|FG000|Overall Study|Disease Progression|2|||
126078458|NCT01657799|453582044|FG001|Overall Study|Disease Progression|4|||
126078459|NCT01657799|453582045|FG002|Overall Study|Disease Progression|4|||
126078460|NCT01657799|453582043|FG000|Overall Study|Progressive Disease Clinical|7|||
126078461|NCT01657799|453582044|FG001|Overall Study|Progressive Disease Clinical|4|||
126078462|NCT01657799|453582045|FG002|Overall Study|Progressive Disease Clinical|7|||
126078463|NCT01657799|453582043|FG000|Overall Study|Radiographic & Clinical Progression|16|||
126078464|NCT01657799|453582044|FG001|Overall Study|Radiographic & Clinical Progression|11|||
126078465|NCT01657799|453582045|FG002|Overall Study|Radiographic & Clinical Progression|15|||
126078466|NCT01657799|453582043|FG000|Overall Study|Other|52|||
126078467|NCT01657799|453582044|FG001|Overall Study|Other|62|||
126078468|NCT01657799|453582045|FG002|Overall Study|Other|49|||
126078469|NCT00412880|453582046|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
126078470|NCT00412880|453582046|FG000|Overall Study|Consent withdrawn|1|||
126078471|NCT00412880|453582046|FG000|Overall Study|Adverse Event|1|||
126078472|NCT00412880|453582046|FG000|Overall Study|Progressive disease|20|||
126078473|NCT01843777|453582048|FG000|Overall Study|Withdrawal by Subject|1|||
126078474|NCT01843777|453582049|FG001|Overall Study|Withdrawal by Subject|0|||
125948325|NCT01354496|453108758|FG004|Period 1|Physician Decision|0|||
125948326|NCT01354496|453108759|FG005|Period 1|Physician Decision|0|||
125948327|NCT01354496|453108754|FG000|Period 2|Adverse Event|0|||
126078475|NCT04599855|453582060|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
126078476|NCT04599855|453582061|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
126078477|NCT04599855|453582062|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
126078478|NCT04599855|453582060|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
126078479|NCT04599855|453582061|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
125948328|NCT01354496|453108755|FG001|Period 2|Adverse Event|0|||
126078480|NCT04599855|453582062|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
126078481|NCT04599855|453582060|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
125948329|NCT01354496|453108756|FG002|Period 2|Adverse Event|0|||
126114946|NCT01514136|453715809|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
126114947|NCT01514136|453715810|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
126114948|NCT01514136|453715811|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
126114949|NCT01514136|453715812|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
125948330|NCT01354496|453108757|FG003|Period 2|Adverse Event|1|||
125948331|NCT01354496|453108758|FG004|Period 2|Adverse Event|0|||
125948332|NCT01354496|453108759|FG005|Period 2|Adverse Event|0|||
125948333|NCT01354496|453108754|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
125948334|NCT01354496|453108755|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
125948335|NCT01354496|453108756|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
125948336|NCT01354496|453108757|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
125948337|NCT01354496|453108758|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
125948338|NCT01354496|453108759|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
125948339|NCT01228747|453108760|FG000|Overall Study|Adverse Event|8|||
125948340|NCT01228747|453108761|FG001|Overall Study|Adverse Event|4|||
125948341|NCT01228747|453108760|FG000|Overall Study|Lack of Efficacy|40|||
125948342|NCT01228747|453108761|FG001|Overall Study|Lack of Efficacy|27|||
125948343|NCT01228747|453108760|FG000|Overall Study|Protocol Violation|6|||
125948344|NCT01228747|453108761|FG001|Overall Study|Protocol Violation|5|||
125948345|NCT01228747|453108760|FG000|Overall Study|Lost to Follow-up|4|||
125948346|NCT01228747|453108761|FG001|Overall Study|Lost to Follow-up|3|||
125948347|NCT01228747|453108760|FG000|Overall Study|Withdrawal by Subject|5|||
125948348|NCT01228747|453108761|FG001|Overall Study|Withdrawal by Subject|1|||
125948349|NCT01228747|453108760|FG000|Overall Study|Other Reason|2|||
125948350|NCT01228747|453108761|FG001|Overall Study|Other Reason|5|||
125948351|NCT02036502|453108762|FG000|Part 1:Dose Determination/Escalation|Death|3|||
125948352|NCT02036502|453108763|FG001|Part 1:Dose Determination/Escalation|Death|2|||
125948353|NCT02036502|453108764|FG002|Part 1:Dose Determination/Escalation|Death|0|||
125948354|NCT02036502|453108765|FG003|Part 1:Dose Determination/Escalation|Death|0|||
125948355|NCT02036502|453108766|FG004|Part 1:Dose Determination/Escalation|Death|0|||
125948356|NCT02036502|453108767|FG005|Part 1:Dose Determination/Escalation|Death|0|||
125948357|NCT02036502|453108768|FG006|Part 1:Dose Determination/Escalation|Death|0|||
125948358|NCT02036502|453108769|FG007|Part 1:Dose Determination/Escalation|Death|0|||
125948359|NCT02036502|453108762|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
125948360|NCT02036502|453108763|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125948361|NCT02036502|453108764|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125948362|NCT02036502|453108765|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125948363|NCT02036502|453108766|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125948364|NCT02036502|453108767|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125948365|NCT02036502|453108768|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125948366|NCT02036502|453108769|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125948367|NCT02036502|453108762|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125948368|NCT02036502|453108763|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
125948369|NCT02036502|453108764|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125948370|NCT02036502|453108765|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125948371|NCT02036502|453108766|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125948372|NCT02036502|453108767|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125948373|NCT02036502|453108768|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125948374|NCT02036502|453108769|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125948375|NCT02036502|453108762|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
125948376|NCT02036502|453108763|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
125948377|NCT02036502|453108764|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
125948378|NCT02036502|453108765|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
125948379|NCT02036502|453108766|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
125948380|NCT02036502|453108767|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
125948381|NCT02036502|453108768|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
125948382|NCT02036502|453108769|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
125948383|NCT02036502|453108762|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125948384|NCT02036502|453108763|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125948385|NCT02036502|453108764|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
125948386|NCT02036502|453108765|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
125948387|NCT02036502|453108766|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
125948388|NCT02036502|453108767|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125948389|NCT02036502|453108768|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
126114950|NCT01514136|453715813|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
126114951|NCT01514136|453715814|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
126114952|NCT01514136|453715807|FG000|Test Period 2; Test C*|holiday|0|||
125948390|NCT02036502|453108769|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125948391|NCT02036502|453108762|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125948392|NCT02036502|453108763|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126078482|NCT04599855|453582061|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
126078483|NCT04599855|453582062|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
126078484|NCT04599855|453582060|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
126078485|NCT04599855|453582061|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
126078486|NCT04599855|453582062|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
126078487|NCT04599855|453582060|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
126078488|NCT04599855|453582061|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
126078489|NCT04599855|453582062|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
126078490|NCT04599855|453582060|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
126078491|NCT04599855|453582061|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
126078492|NCT04599855|453582062|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
126078493|NCT04599855|453582060|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
126078494|NCT04599855|453582061|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
126078495|NCT04599855|453582062|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
126078496|NCT04599855|453582060|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
126078497|NCT04599855|453582061|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
126078498|NCT04599855|453582062|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
126078499|NCT04599855|453582060|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
126078500|NCT04599855|453582061|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
126078501|NCT04599855|453582062|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
126078502|NCT04599855|453582060|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
126078503|NCT04599855|453582061|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
126078504|NCT04599855|453582062|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
126078505|NCT04599855|453582060|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
126078506|NCT04599855|453582061|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
126078507|NCT04599855|453582062|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
126078508|NCT04599855|453582060|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
126078509|NCT04599855|453582061|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
126078510|NCT04599855|453582062|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
126078511|NCT04599855|453582060|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
126078512|NCT04599855|453582061|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
126078513|NCT04599855|453582062|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
126078514|NCT04599855|453582060|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
126078515|NCT04599855|453582061|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
126078516|NCT04599855|453582062|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
126078517|NCT02165397|453582063|FG000|Overall Study|Death|7|||
126078518|NCT02165397|453582064|FG001|Overall Study|Death|10|||
126078519|NCT02165397|453582065|FG002|Overall Study|Death|8|||
126078520|NCT02165397|453582063|FG000|Overall Study|Lost to Follow-up|1|||
126078521|NCT02165397|453582064|FG001|Overall Study|Lost to Follow-up|3|||
126078522|NCT02165397|453582065|FG002|Overall Study|Lost to Follow-up|0|||
126078523|NCT02165397|453582063|FG000|Overall Study|Withdrawal by Subject|6|||
126078524|NCT02165397|453582064|FG001|Overall Study|Withdrawal by Subject|6|||
126078525|NCT02165397|453582065|FG002|Overall Study|Withdrawal by Subject|1|||
126078526|NCT02165397|453582063|FG000|Overall Study|Other, Not Specified|0|||
126078527|NCT02165397|453582064|FG001|Overall Study|Other, Not Specified|0|||
126078528|NCT02165397|453582065|FG002|Overall Study|Other, Not Specified|1|||
126078529|NCT03297398|453582066|FG000|Overall Study|Sponsor's decision|6|||
126078530|NCT03297398|453582067|FG001|Overall Study|Sponsor's decision|9|||
126078531|NCT03297398|453582068|FG002|Overall Study|Sponsor's decision|7|||
126078532|NCT03297398|453582066|FG000|Overall Study|Adverse Event|1|||
126078533|NCT03297398|453582067|FG001|Overall Study|Adverse Event|4|||
126078534|NCT03297398|453582068|FG002|Overall Study|Adverse Event|4|||
126078535|NCT03297398|453582066|FG000|Overall Study|Withdrawal by Subject|1|||
126078536|NCT03297398|453582067|FG001|Overall Study|Withdrawal by Subject|2|||
126078537|NCT03297398|453582068|FG002|Overall Study|Withdrawal by Subject|2|||
126078538|NCT03297398|453582066|FG000|Overall Study|Protocol Violation|0|||
126078539|NCT03297398|453582067|FG001|Overall Study|Protocol Violation|2|||
126078540|NCT03297398|453582068|FG002|Overall Study|Protocol Violation|0|||
126078541|NCT03297398|453582066|FG000|Overall Study|Physician Decision|0|||
126078542|NCT03297398|453582067|FG001|Overall Study|Physician Decision|0|||
126078543|NCT03297398|453582068|FG002|Overall Study|Physician Decision|1|||
126078544|NCT03297398|453582066|FG000|Overall Study|Lost to Follow-up|0|||
126078545|NCT03297398|453582067|FG001|Overall Study|Lost to Follow-up|0|||
126078546|NCT03297398|453582068|FG002|Overall Study|Lost to Follow-up|1|||
126078547|NCT00236184|453582073|FG000|Overall Study|Adverse Event|5|||
126078548|NCT00236184|453582074|FG001|Overall Study|Adverse Event|2|||
126078549|NCT00236184|453582073|FG000|Overall Study|Lack of Efficacy|0|||
126078550|NCT00236184|453582074|FG001|Overall Study|Lack of Efficacy|1|||
126078551|NCT00236184|453582073|FG000|Overall Study|Lost to Follow-up|3|||
126078552|NCT00236184|453582074|FG001|Overall Study|Lost to Follow-up|4|||
126078553|NCT00236184|453582073|FG000|Overall Study|Physician Decision|1|||
126078554|NCT00236184|453582074|FG001|Overall Study|Physician Decision|1|||
126078555|NCT00236184|453582073|FG000|Overall Study|Withdrawal by Subject|3|||
126078556|NCT00236184|453582074|FG001|Overall Study|Withdrawal by Subject|0|||
126078557|NCT00236184|453582073|FG000|Overall Study|Protocol Violation|3|||
126078558|NCT00236184|453582074|FG001|Overall Study|Protocol Violation|0|||
126078559|NCT00236184|453582073|FG000|Overall Study|non-compliance with study drug|2|||
126078560|NCT00236184|453582074|FG001|Overall Study|non-compliance with study drug|1|||
126078561|NCT00236184|453582073|FG000|Overall Study|other|1|||
126078562|NCT00236184|453582074|FG001|Overall Study|other|2|||
126078563|NCT01772563|453582075|FG000|Cycle 1|Dose limiting toxicity|2|||
126078564|NCT01772563|453582075|FG000|Cycle 1|Progressive disease|2|||
126078565|NCT01772563|453582075|FG000|Cycle 2 and Beyond|Progressive disease|17|||
126078566|NCT01772563|453582075|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
126078567|NCT01772563|453582075|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
126078568|NCT01192776|453582077|FG000|Overall Study|Death|8|||
126078569|NCT01192776|453582078|FG001|Overall Study|Death|15|||
126078570|NCT01192776|453582079|FG002|Overall Study|Death|18|||
126078571|NCT01192776|453582080|FG003|Overall Study|Death|15|||
126078572|NCT01192776|453582077|FG000|Overall Study|Lost to Follow-up|3|||
126078573|NCT01192776|453582078|FG001|Overall Study|Lost to Follow-up|6|||
126078574|NCT01192776|453582079|FG002|Overall Study|Lost to Follow-up|3|||
126078575|NCT01192776|453582080|FG003|Overall Study|Lost to Follow-up|5|||
126078576|NCT03732820|453582088|FG000|Overall Study|Death|168|||
126078577|NCT03732820|453582089|FG001|Overall Study|Death|203|||
126078578|NCT03732820|453582088|FG000|Overall Study|Other|2|||
126078579|NCT03732820|453582089|FG001|Overall Study|Other|2|||
126078580|NCT03732820|453582088|FG000|Overall Study|Failure to meet randomisation criteria|1|||
126078581|NCT03732820|453582089|FG001|Overall Study|Failure to meet randomisation criteria|1|||
126078582|NCT03732820|453582088|FG000|Overall Study|Patient decision|14|||
126078583|NCT03732820|453582089|FG001|Overall Study|Patient decision|10|||
126078584|NCT03732820|453582088|FG000|Overall Study|Screen failure|0|||
126078585|NCT03732820|453582089|FG001|Overall Study|Screen failure|1|||
126078586|NCT03732820|453582088|FG000|Overall Study|Patients ongoing study at data cut off|210|||
126078587|NCT03732820|453582089|FG001|Overall Study|Patients ongoing study at data cut off|178|||
126078588|NCT03732820|453582088|FG000|Overall Study|Lost to Follow-up|4|||
126078589|NCT03732820|453582089|FG001|Overall Study|Lost to Follow-up|2|||
126078590|NCT00832000|453582090|FG000|Overall Study|Adverse Event|2|||
126078591|NCT00832000|453582091|FG001|Overall Study|Adverse Event|0|||
126078592|NCT00832000|453582090|FG000|Overall Study|Withdrawal by Subject|1|||
126078593|NCT00832000|453582091|FG001|Overall Study|Withdrawal by Subject|0|||
126078594|NCT00832000|453582090|FG000|Overall Study|No calls to IVR in either period|1|||
126078595|NCT00832000|453582091|FG001|Overall Study|No calls to IVR in either period|1|||
126078596|NCT00832000|453582090|FG000|Overall Study|No calls to IVR in period 2|2|||
126078597|NCT00832000|453582091|FG001|Overall Study|No calls to IVR in period 2|0|||
126078598|NCT03845075|453582092|FG000|Part 1 - DB|Withdrawal by Subject|1|||
126078599|NCT03845075|453582093|FG001|Part 1 - DB|Withdrawal by Subject|1|||
126078600|NCT03845075|453582094|FG002|Part 1 - DB|Withdrawal by Subject|0|||
126078601|NCT03845075|453582095|FG003|Part 1 - DB|Withdrawal by Subject|0|||
126078602|NCT03845075|453582092|FG000|Part 1 - DB|Adverse Event|0|||
126078603|NCT03845075|453582093|FG001|Part 1 - DB|Adverse Event|1|||
126078604|NCT03845075|453582094|FG002|Part 1 - DB|Adverse Event|0|||
126078605|NCT03845075|453582095|FG003|Part 1 - DB|Adverse Event|0|||
126078606|NCT03845075|453582092|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
126078607|NCT03845075|453582093|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
126078608|NCT03845075|453582094|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
126078609|NCT03845075|453582095|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
126078610|NCT00935259|453582096|FG000|Period 1|Administrative (scheduling conflict)|1|||
126078611|NCT00935259|453582097|FG001|Period 1|Administrative (scheduling conflict)|1|||
126078612|NCT03856047|453582098|FG000|Overall Study|Withdrawal by Subject|0|||
126078613|NCT03856047|453582099|FG001|Overall Study|Withdrawal by Subject|1|||
126078614|NCT03856047|453582100|FG002|Overall Study|Withdrawal by Subject|1|||
126078615|NCT03856047|453582101|FG003|Overall Study|Withdrawal by Subject|0|||
126078616|NCT03856047|453582102|FG004|Overall Study|Withdrawal by Subject|3|||
126078617|NCT03856047|453582103|FG005|Overall Study|Withdrawal by Subject|0|||
126078618|NCT03856047|453582104|FG006|Overall Study|Withdrawal by Subject|2|||
126078619|NCT03856047|453582098|FG000|Overall Study|Lost to Follow-up|4|||
126078620|NCT03856047|453582099|FG001|Overall Study|Lost to Follow-up|2|||
126078621|NCT03856047|453582100|FG002|Overall Study|Lost to Follow-up|3|||
126078622|NCT03856047|453582101|FG003|Overall Study|Lost to Follow-up|1|||
126078623|NCT03856047|453582102|FG004|Overall Study|Lost to Follow-up|4|||
126078624|NCT03856047|453582103|FG005|Overall Study|Lost to Follow-up|4|||
126078625|NCT03856047|453582104|FG006|Overall Study|Lost to Follow-up|4|||
126078626|NCT00874497|453582108|FG000|Overall Study|Lost to Follow-up|2|||
126078627|NCT00874497|453582109|FG001|Overall Study|Lost to Follow-up|4|||
126078628|NCT00874497|453582108|FG000|Overall Study|Adverse Event|9|||
126078629|NCT00874497|453582109|FG001|Overall Study|Adverse Event|4|||
126078630|NCT00874497|453582108|FG000|Overall Study|Sponsor Discontinued Trial|7|||
126078631|NCT00874497|453582109|FG001|Overall Study|Sponsor Discontinued Trial|3|||
126078632|NCT00874497|453582108|FG000|Overall Study|Met Withdrawal Criteria|4|||
126078633|NCT00874497|453582109|FG001|Overall Study|Met Withdrawal Criteria|2|||
126078634|NCT00874497|453582108|FG000|Overall Study|Physician Decision|1|||
126078635|NCT00874497|453582109|FG001|Overall Study|Physician Decision|1|||
126078636|NCT00874497|453582108|FG000|Overall Study|Withdrawal by Subject|5|||
126078637|NCT00874497|453582109|FG001|Overall Study|Withdrawal by Subject|4|||
126078638|NCT00665223|453582114|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
126078639|NCT00665223|453582115|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
126078640|NCT00665223|453582116|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
126078641|NCT00665223|453582114|FG000|Randomized Phase (26 Weeks)|Death|0|||
126078642|NCT00665223|453582115|FG001|Randomized Phase (26 Weeks)|Death|0|||
126078643|NCT00665223|453582116|FG002|Randomized Phase (26 Weeks)|Death|1|||
126078644|NCT00665223|453582114|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
126078645|NCT00665223|453582115|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
126078646|NCT00665223|453582116|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
126078647|NCT00665223|453582114|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
126078648|NCT00665223|453582115|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
126078649|NCT00665223|453582116|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
126078650|NCT00665223|453582114|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
126078651|NCT00665223|453582115|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
126078652|NCT00665223|453582116|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
126078653|NCT00665223|453582114|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
126078654|NCT00665223|453582115|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
126078655|NCT00665223|453582116|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
126078656|NCT00665223|453582114|FG000|Open-Label Period (26 Weeks)|Death|0|||
126078657|NCT00665223|453582115|FG001|Open-Label Period (26 Weeks)|Death|1|||
126078658|NCT00665223|453582116|FG002|Open-Label Period (26 Weeks)|Death|0|||
126078659|NCT00665223|453582114|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
126078660|NCT00665223|453582115|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
126078661|NCT00665223|453582116|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
126078662|NCT00665223|453582114|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
126078663|NCT00665223|453582115|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
126078664|NCT00665223|453582116|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
126078665|NCT00665223|453582114|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
126078666|NCT00665223|453582115|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
126078667|NCT00665223|453582116|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
126078668|NCT00665223|453582114|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
126078669|NCT00665223|453582115|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
126078670|NCT00665223|453582116|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
126078671|NCT01278615|453582117|FG000|Overall Study|Withdrawal by Subject|2|||
126078672|NCT00905359|453582118|FG000|Overall Study|Lost to Follow-up|17|||
126078673|NCT00905359|453582119|FG001|Overall Study|Lost to Follow-up|10|||
126078674|NCT00905359|453582118|FG000|Overall Study|Death|2|||
126078675|NCT00905359|453582119|FG001|Overall Study|Death|0|||
126078676|NCT00905359|453582118|FG000|Overall Study|Withdrawal consent|5|||
126078677|NCT00905359|453582119|FG001|Overall Study|Withdrawal consent|6|||
126078678|NCT00243022|453582120|FG000|Overall Study|Withdrawal by Subject|1|||
126078679|NCT00243022|453582121|FG001|Overall Study|Withdrawal by Subject|0|||
126078680|NCT00243022|453582120|FG000|Overall Study|Death|1|||
126078681|NCT00243022|453582121|FG001|Overall Study|Death|0|||
126078682|NCT00243022|453582120|FG000|Overall Study|Difficult Travel Distance|0|||
126078683|NCT00243022|453582121|FG001|Overall Study|Difficult Travel Distance|1|||
126078684|NCT03517111|453582122|FG000|Enrolled|Withdrawal by Subject|0|||
126078685|NCT03517111|453582123|FG001|Enrolled|Withdrawal by Subject|1|||
126078686|NCT03517111|453582124|FG002|Enrolled|Withdrawal by Subject|0|||
126078687|NCT03517111|453582122|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
126078688|NCT03517111|453582123|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
126078689|NCT03517111|453582124|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
126078690|NCT03517111|453582122|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
126078691|NCT03517111|453582123|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
126078692|NCT03517111|453582124|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
126078693|NCT03517111|453582122|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
126078694|NCT03517111|453582123|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
126078695|NCT03517111|453582124|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
126078696|NCT03517111|453582122|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
126078697|NCT03517111|453582123|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
126078698|NCT03517111|453582124|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
126078699|NCT00621192|453582125|FG000|Overall Study|Withdrawal by Subject|0|||
126078700|NCT00621192|453582126|FG001|Overall Study|Withdrawal by Subject|0|||
126078701|NCT00621192|453582127|FG002|Overall Study|Withdrawal by Subject|2|||
126078702|NCT00621192|453582128|FG003|Overall Study|Withdrawal by Subject|0|||
126078703|NCT00621192|453582125|FG000|Overall Study|Physician Decision|1|||
126078704|NCT00621192|453582126|FG001|Overall Study|Physician Decision|3|||
126078705|NCT00621192|453582127|FG002|Overall Study|Physician Decision|0|||
126078706|NCT00621192|453582128|FG003|Overall Study|Physician Decision|0|||
126078707|NCT00621192|453582125|FG000|Overall Study|Protocol Violation|1|||
126078708|NCT00621192|453582126|FG001|Overall Study|Protocol Violation|0|||
126078709|NCT00621192|453582127|FG002|Overall Study|Protocol Violation|0|||
126078710|NCT00621192|453582128|FG003|Overall Study|Protocol Violation|1|||
126078711|NCT00621192|453582125|FG000|Overall Study|Adverse Event|0|||
126078712|NCT00621192|453582126|FG001|Overall Study|Adverse Event|1|||
126078713|NCT00621192|453582127|FG002|Overall Study|Adverse Event|0|||
126078714|NCT00621192|453582128|FG003|Overall Study|Adverse Event|1|||
126078715|NCT00621192|453582125|FG000|Overall Study|Death|2|||
126078716|NCT00621192|453582126|FG001|Overall Study|Death|5|||
126078717|NCT00621192|453582127|FG002|Overall Study|Death|0|||
126078718|NCT00621192|453582128|FG003|Overall Study|Death|0|||
126078719|NCT00621192|453582125|FG000|Overall Study|Final Assessments not Completed|0|||
126078720|NCT00621192|453582126|FG001|Overall Study|Final Assessments not Completed|0|||
126078721|NCT00621192|453582127|FG002|Overall Study|Final Assessments not Completed|3|||
126078722|NCT00621192|453582128|FG003|Overall Study|Final Assessments not Completed|1|||
126078723|NCT04706793|453582129|FG000|Treatment|Disease worsening|10|||
126078724|NCT04706793|453582130|FG001|Treatment|Disease worsening|10|||
126078725|NCT04706793|453582129|FG000|Follow-up|Lack of Efficacy|1|||
126078726|NCT04706793|453582130|FG001|Follow-up|Lack of Efficacy|0|||
126078727|NCT04706793|453582129|FG000|Follow-up|Disease worsening|8|||
126078728|NCT04706793|453582130|FG001|Follow-up|Disease worsening|10|||
126078729|NCT04706793|453582129|FG000|Follow-up|Adverse Event|1|||
126078730|NCT04706793|453582130|FG001|Follow-up|Adverse Event|0|||
126078731|NCT01781832|453582134|FG000|Overall Study|Withdrawal by Subject|1|||
126078732|NCT02601209|453582135|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
126078733|NCT02601209|453582136|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
126078734|NCT02601209|453582137|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
126078735|NCT02601209|453582138|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126078736|NCT02601209|453582139|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126078737|NCT02601209|453582140|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126078738|NCT02601209|453582141|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126078739|NCT02601209|453582142|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126078740|NCT02601209|453582143|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126078741|NCT02601209|453582135|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126078742|NCT02601209|453582136|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126078743|NCT02601209|453582137|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126078744|NCT02601209|453582138|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126078745|NCT02601209|453582139|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
126078746|NCT02601209|453582140|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
126078747|NCT02601209|453582141|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
126078748|NCT02601209|453582142|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126078749|NCT02601209|453582143|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126078750|NCT03636373|453582144|FG000|Overall Study|Study closure due to Covid-19|1|||
126078751|NCT03636373|453582145|FG001|Overall Study|Study closure due to Covid-19|0|||
126078752|NCT00572533|453582146|FG000|Overall Study|Death|4|||
126078753|NCT00572533|453582147|FG001|Overall Study|Death|1|||
126078754|NCT00572533|453582146|FG000|Overall Study|Received Kidney Transplant|2|||
126078755|NCT00572533|453582147|FG001|Overall Study|Received Kidney Transplant|1|||
126078756|NCT00572533|453582146|FG000|Overall Study|Social Issues|1|||
126078757|NCT00572533|453582147|FG001|Overall Study|Social Issues|0|||
126078758|NCT00572533|453582146|FG000|Overall Study|Transfer out of Facility|0|||
126078759|NCT00572533|453582147|FG001|Overall Study|Transfer out of Facility|1|||
126078760|NCT00798304|453582151|FG000|Overall Study|Adverse Event|0|||
126078761|NCT00798304|453582152|FG001|Overall Study|Adverse Event|1|||
126078762|NCT00798304|453582153|FG002|Overall Study|Adverse Event|1|||
126078763|NCT00798304|453582151|FG000|Overall Study|Discontinuation by Sponsor|14|||
126078764|NCT00798304|453582152|FG001|Overall Study|Discontinuation by Sponsor|21|||
126078765|NCT00798304|453582153|FG002|Overall Study|Discontinuation by Sponsor|9|||
126078766|NCT00087555|453582154|FG000|Overall Study|Adverse Event|3|||
126078767|NCT00087555|453582155|FG001|Overall Study|Adverse Event|6|||
126078768|NCT00087555|453582156|FG002|Overall Study|Adverse Event|14|||
126078769|NCT00087555|453582154|FG000|Overall Study|Lost to Follow-up|0|||
126078770|NCT00087555|453582155|FG001|Overall Study|Lost to Follow-up|1|||
126078771|NCT00087555|453582156|FG002|Overall Study|Lost to Follow-up|1|||
126078772|NCT00087555|453582154|FG000|Overall Study|Non - Compliance|1|||
126078773|NCT00087555|453582155|FG001|Overall Study|Non - Compliance|0|||
126078774|NCT00087555|453582156|FG002|Overall Study|Non - Compliance|0|||
126078775|NCT00087555|453582154|FG000|Overall Study|Protocol Violation|0|||
126078776|NCT00087555|453582155|FG001|Overall Study|Protocol Violation|0|||
126078777|NCT00087555|453582156|FG002|Overall Study|Protocol Violation|2|||
126078778|NCT00087555|453582154|FG000|Overall Study|Screen Failure|1|||
126078779|NCT00087555|453582155|FG001|Overall Study|Screen Failure|1|||
126078780|NCT00087555|453582156|FG002|Overall Study|Screen Failure|0|||
126078781|NCT00087555|453582154|FG000|Overall Study|Pregnancy|0|||
126078782|NCT00087555|453582155|FG001|Overall Study|Pregnancy|1|||
126078783|NCT00087555|453582156|FG002|Overall Study|Pregnancy|1|||
126078784|NCT00087555|453582154|FG000|Overall Study|Withdrawal by Subject|3|||
126078785|NCT00087555|453582155|FG001|Overall Study|Withdrawal by Subject|2|||
126078786|NCT00087555|453582156|FG002|Overall Study|Withdrawal by Subject|1|||
126078787|NCT00087555|453582154|FG000|Overall Study|Lack of Efficacy|2|||
126078788|NCT00087555|453582155|FG001|Overall Study|Lack of Efficacy|0|||
126078789|NCT00087555|453582156|FG002|Overall Study|Lack of Efficacy|1|||
126078790|NCT00087555|453582154|FG000|Overall Study|Non Compliance|0|||
126078791|NCT00087555|453582155|FG001|Overall Study|Non Compliance|0|||
126078792|NCT00087555|453582156|FG002|Overall Study|Non Compliance|1|||
126078793|NCT00087555|453582154|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
126078794|NCT00087555|453582155|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
126078795|NCT00087555|453582156|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
126078796|NCT00087555|453582154|FG000|Overall Study|Patient wanted to go back on Med|1|||
126078797|NCT00087555|453582155|FG001|Overall Study|Patient wanted to go back on Med|0|||
126078798|NCT00087555|453582156|FG002|Overall Study|Patient wanted to go back on Med|0|||
126078799|NCT02344173|453582161|FG000|Procedure|Ablation Procedure Not Performed|7|||
126078800|NCT02344173|453582161|FG000|12-month Visit|Death|8|||
126078801|NCT02344173|453582161|FG000|12-month Visit|Withdrawal by Subject|30|||
126078802|NCT02344173|453582161|FG000|12-month Visit|Lost to Follow-up|58|||
126078803|NCT00715117|453582162|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
126078804|NCT00715117|453582163|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
126078805|NCT00416598|453584269|FG000|Induction & Intensification|Adverse Event|38|||
126078806|NCT00416598|453584269|FG000|Induction & Intensification|Death|32|||
126078807|NCT00416598|453584269|FG000|Induction & Intensification|Withdrawal by Subject|46|||
126078808|NCT00416598|453584269|FG000|Induction & Intensification|Alternative Treatment|135|||
126078809|NCT00416598|453584269|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
126078810|NCT00416598|453584269|FG000|Induction & Intensification|Relapse/progression|29|||
126078811|NCT00416598|453584269|FG000|Induction & Intensification|Failed induction|87|||
126078812|NCT00416598|453584269|FG000|Decitabine Maintenance|Adverse Event|5|||
126078813|NCT00416598|453584269|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
126078814|NCT00416598|453584269|FG000|Decitabine Maintenance|Progression/relapse|38|||
126078815|NCT00416598|453584269|FG000|Decitabine Maintenance|Alternative treatment|2|||
126078816|NCT00416598|453584269|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
126078817|NCT02166476|453584270|FG000|Overall Study|Withdrawal by Subject|5|||
126078818|NCT02166476|453584271|FG001|Overall Study|Withdrawal by Subject|7|||
126078819|NCT02166476|453584270|FG000|Overall Study|Adverse Event|3|||
126078820|NCT02166476|453584271|FG001|Overall Study|Adverse Event|3|||
126078821|NCT02166476|453584270|FG000|Overall Study|Lost to Follow-up|5|||
126078822|NCT02166476|453584271|FG001|Overall Study|Lost to Follow-up|10|||
126078823|NCT02166476|453584270|FG000|Overall Study|Physician Decision|1|||
126078824|NCT02166476|453584271|FG001|Overall Study|Physician Decision|0|||
126078825|NCT02166476|453584270|FG000|Overall Study|Unable to Come for Visit|0|||
126078826|NCT02166476|453584271|FG001|Overall Study|Unable to Come for Visit|3|||
126078827|NCT00328562|453584279|FG000|Overall Study|Disease progression|1|||
126078828|NCT00810342|453584280|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
126078829|NCT00810342|453584281|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
126078830|NCT00810342|453584280|FG000|Month 1 Follow-up|Pregnancy|1|||
126078831|NCT00810342|453584281|FG001|Month 1 Follow-up|Pregnancy|0|||
126078832|NCT00810342|453584280|FG000|6-month Follow-up|Lost to Follow-up|18|||
126078833|NCT00810342|453584281|FG001|6-month Follow-up|Lost to Follow-up|6|||
126078834|NCT00810342|453584280|FG000|6-month Follow-up|Pregnancy|6|||
126078835|NCT00810342|453584281|FG001|6-month Follow-up|Pregnancy|2|||
126078836|NCT00810342|453584280|FG000|12-month Followup|Pregnancy|9|||
126078837|NCT00810342|453584281|FG001|12-month Followup|Pregnancy|10|||
126078838|NCT00810342|453584280|FG000|12-month Followup|Lost to Follow-up|3|||
126078839|NCT00810342|453584281|FG001|12-month Followup|Lost to Follow-up|1|||
126078840|NCT04504630|453584282|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
126078841|NCT04504630|453584283|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
126078842|NCT04504630|453584282|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
126114953|NCT01514136|453715808|FG001|Test Period 2; Test C*|holiday|0|||
126078843|NCT04504630|453584283|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
126078844|NCT01496365|453584284|FG000|Overall Study|Adverse Event|2|||
126078845|NCT01496365|453584285|FG001|Overall Study|Adverse Event|3|||
126078846|NCT01496365|453584286|FG002|Overall Study|Adverse Event|3|||
126078847|NCT01496365|453584287|FG003|Overall Study|Adverse Event|2|||
126078848|NCT01496365|453584288|FG004|Overall Study|Adverse Event|5|||
126078849|NCT01496365|453584289|FG005|Overall Study|Adverse Event|6|||
126078850|NCT01496365|453584290|FG006|Overall Study|Adverse Event|4|||
126078851|NCT01496365|453584284|FG000|Overall Study|Withdrawal by Subject|6|||
125948393|NCT02036502|453108764|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
126078852|NCT01496365|453584285|FG001|Overall Study|Withdrawal by Subject|6|||
126078853|NCT01496365|453584286|FG002|Overall Study|Withdrawal by Subject|0|||
126078854|NCT01496365|453584287|FG003|Overall Study|Withdrawal by Subject|1|||
126078855|NCT01496365|453584288|FG004|Overall Study|Withdrawal by Subject|3|||
126078856|NCT01496365|453584289|FG005|Overall Study|Withdrawal by Subject|2|||
126078857|NCT01496365|453584290|FG006|Overall Study|Withdrawal by Subject|1|||
126078858|NCT01496365|453584284|FG000|Overall Study|Protocol Violation|2|||
126078859|NCT01496365|453584285|FG001|Overall Study|Protocol Violation|1|||
126078860|NCT01496365|453584286|FG002|Overall Study|Protocol Violation|1|||
126078861|NCT01496365|453584287|FG003|Overall Study|Protocol Violation|0|||
126078862|NCT01496365|453584288|FG004|Overall Study|Protocol Violation|0|||
126078863|NCT01496365|453584289|FG005|Overall Study|Protocol Violation|1|||
126078864|NCT01496365|453584290|FG006|Overall Study|Protocol Violation|0|||
126078865|NCT01496365|453584284|FG000|Overall Study|Lack of Efficacy|1|||
126078866|NCT01496365|453584285|FG001|Overall Study|Lack of Efficacy|0|||
126078867|NCT01496365|453584286|FG002|Overall Study|Lack of Efficacy|0|||
126078868|NCT01496365|453584287|FG003|Overall Study|Lack of Efficacy|0|||
126078869|NCT01496365|453584288|FG004|Overall Study|Lack of Efficacy|0|||
126078870|NCT01496365|453584289|FG005|Overall Study|Lack of Efficacy|1|||
126078871|NCT01496365|453584290|FG006|Overall Study|Lack of Efficacy|0|||
126078872|NCT01496365|453584284|FG000|Overall Study|Lost to Follow-up|0|||
126078873|NCT01496365|453584285|FG001|Overall Study|Lost to Follow-up|1|||
126078874|NCT01496365|453584286|FG002|Overall Study|Lost to Follow-up|0|||
126078875|NCT01496365|453584287|FG003|Overall Study|Lost to Follow-up|0|||
126078876|NCT01496365|453584288|FG004|Overall Study|Lost to Follow-up|2|||
126078877|NCT01496365|453584289|FG005|Overall Study|Lost to Follow-up|0|||
126078878|NCT01496365|453584290|FG006|Overall Study|Lost to Follow-up|0|||
126078879|NCT01496365|453584284|FG000|Overall Study|Other|4|||
126078880|NCT01496365|453584285|FG001|Overall Study|Other|4|||
126078881|NCT01496365|453584286|FG002|Overall Study|Other|2|||
126078882|NCT01496365|453584287|FG003|Overall Study|Other|1|||
126078883|NCT01496365|453584288|FG004|Overall Study|Other|3|||
126078884|NCT01496365|453584289|FG005|Overall Study|Other|0|||
126078885|NCT01496365|453584290|FG006|Overall Study|Other|1|||
126078886|NCT02706951|453584291|FG000|Period 1|Adverse Event|1|||
126078887|NCT02706951|453584292|FG001|Period 1|Adverse Event|5|||
126078888|NCT02706951|453584293|FG002|Period 1|Adverse Event|3|||
126078889|NCT02706951|453584294|FG003|Period 1|Adverse Event|0|||
126078890|NCT02706951|453584295|FG004|Period 1|Adverse Event|0|||
126078891|NCT02706951|453584291|FG000|Period 1|Withdrawal by Subject|10|||
126078892|NCT02706951|453584292|FG001|Period 1|Withdrawal by Subject|6|||
126078893|NCT02706951|453584293|FG002|Period 1|Withdrawal by Subject|6|||
126078894|NCT02706951|453584294|FG003|Period 1|Withdrawal by Subject|0|||
126078895|NCT02706951|453584295|FG004|Period 1|Withdrawal by Subject|0|||
126078896|NCT02706951|453584291|FG000|Period 1|Lost to Follow-up|0|||
126078897|NCT02706951|453584292|FG001|Period 1|Lost to Follow-up|4|||
126078898|NCT02706951|453584293|FG002|Period 1|Lost to Follow-up|1|||
126078899|NCT02706951|453584294|FG003|Period 1|Lost to Follow-up|0|||
126078900|NCT02706951|453584295|FG004|Period 1|Lost to Follow-up|0|||
126078901|NCT02706951|453584291|FG000|Period 1|Other|2|||
126078902|NCT02706951|453584292|FG001|Period 1|Other|1|||
126078903|NCT02706951|453584293|FG002|Period 1|Other|0|||
126078904|NCT02706951|453584294|FG003|Period 1|Other|0|||
126078905|NCT02706951|453584295|FG004|Period 1|Other|0|||
126078906|NCT02706951|453584291|FG000|Period 2|Adverse Event|0|||
126078907|NCT02706951|453584292|FG001|Period 2|Adverse Event|0|||
126078908|NCT02706951|453584293|FG002|Period 2|Adverse Event|0|||
126078909|NCT02706951|453584294|FG003|Period 2|Adverse Event|25|||
126078910|NCT02706951|453584295|FG004|Period 2|Adverse Event|34|||
126078911|NCT02706951|453584291|FG000|Period 2|Withdrawal by Subject|0|||
126078912|NCT02706951|453584292|FG001|Period 2|Withdrawal by Subject|0|||
126078913|NCT02706951|453584293|FG002|Period 2|Withdrawal by Subject|0|||
126078914|NCT02706951|453584294|FG003|Period 2|Withdrawal by Subject|38|||
126078915|NCT02706951|453584295|FG004|Period 2|Withdrawal by Subject|44|||
126078916|NCT02706951|453584291|FG000|Period 2|Lost to Follow-up|0|||
125948394|NCT02036502|453108765|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125948395|NCT02036502|453108766|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125948396|NCT02036502|453108767|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126114954|NCT01514136|453715809|FG002|Test Period 2; Test C*|holiday|0|||
126114955|NCT01514136|453715810|FG003|Test Period 2; Test C*|holiday|0|||
126078917|NCT02706951|453584292|FG001|Period 2|Lost to Follow-up|0|||
126078918|NCT02706951|453584293|FG002|Period 2|Lost to Follow-up|0|||
126078919|NCT02706951|453584294|FG003|Period 2|Lost to Follow-up|17|||
126078920|NCT02706951|453584295|FG004|Period 2|Lost to Follow-up|9|||
126078921|NCT02706951|453584291|FG000|Period 2|COVID-19 Related|0|||
126078922|NCT02706951|453584292|FG001|Period 2|COVID-19 Related|0|||
126078923|NCT02706951|453584293|FG002|Period 2|COVID-19 Related|0|||
126078924|NCT02706951|453584294|FG003|Period 2|COVID-19 Related|1|||
126078925|NCT02706951|453584295|FG004|Period 2|COVID-19 Related|2|||
126078926|NCT02706951|453584291|FG000|Period 2|Other|0|||
126078927|NCT02706951|453584292|FG001|Period 2|Other|0|||
126078928|NCT02706951|453584293|FG002|Period 2|Other|0|||
126078929|NCT02706951|453584294|FG003|Period 2|Other|37|||
126078930|NCT02706951|453584295|FG004|Period 2|Other|31|||
126078931|NCT01777334|453584296|FG000|Overall Study|Adverse Event|18|||
126078932|NCT01777334|453584297|FG001|Overall Study|Adverse Event|14|||
126078933|NCT01777334|453584296|FG000|Overall Study|Lack of Efficacy|15|||
126078934|NCT01777334|453584297|FG001|Overall Study|Lack of Efficacy|29|||
126078935|NCT01777334|453584296|FG000|Overall Study|Protocol Violation|3|||
126078936|NCT01777334|453584297|FG001|Overall Study|Protocol Violation|7|||
126078937|NCT01777334|453584296|FG000|Overall Study|Lost to Follow-up|3|||
126078938|NCT01777334|453584297|FG001|Overall Study|Lost to Follow-up|2|||
126078939|NCT01777334|453584296|FG000|Overall Study|Withdrawal by Subject|14|||
126078940|NCT01777334|453584297|FG001|Overall Study|Withdrawal by Subject|11|||
126078941|NCT04294667|453584298|FG000|Overall Study|Lack of Efficacy|4|||
126078942|NCT04294667|453584299|FG001|Overall Study|Lack of Efficacy|4|||
126078943|NCT04294667|453584298|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
126078944|NCT04294667|453584299|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
126078945|NCT04294667|453584298|FG000|Overall Study|Patient has a Renal Flare|1|||
126078946|NCT04294667|453584299|FG001|Overall Study|Patient has a Renal Flare|0|||
126078947|NCT04294667|453584298|FG000|Overall Study|SLE Worsening|0|||
126078948|NCT04294667|453584299|FG001|Overall Study|SLE Worsening|1|||
126078949|NCT04294667|453584298|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
126078950|NCT04294667|453584299|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
126078951|NCT04294667|453584298|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
126078952|NCT04294667|453584299|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
126078953|NCT04294667|453584298|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
126078954|NCT04294667|453584299|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
126078955|NCT04294667|453584298|FG000|Overall Study|Subject Moved to Another State|0|||
126078956|NCT04294667|453584299|FG001|Overall Study|Subject Moved to Another State|1|||
126078957|NCT04294667|453584298|FG000|Overall Study|Adverse event, serious fatal|0|||
126078958|NCT04294667|453584299|FG001|Overall Study|Adverse event, serious fatal|1|||
126078959|NCT04294667|453584298|FG000|Overall Study|Adverse event, non-fatal|3|||
126078960|NCT04294667|453584299|FG001|Overall Study|Adverse event, non-fatal|4|||
126078961|NCT04799418|453584300|FG000|Overall Study|Death|1|||
126078962|NCT04799418|453584301|FG001|Overall Study|Death|1|||
126078963|NCT04799418|453584300|FG000|Overall Study|Lack of Efficacy|14|||
126078964|NCT04799418|453584301|FG001|Overall Study|Lack of Efficacy|14|||
126078965|NCT04799418|453584300|FG000|Overall Study|Withdrawal by Subject|10|||
126078966|NCT04799418|453584301|FG001|Overall Study|Withdrawal by Subject|7|||
126078967|NCT04799418|453584300|FG000|Overall Study|Adverse Event|3|||
126078968|NCT04799418|453584301|FG001|Overall Study|Adverse Event|2|||
126078969|NCT02599688|453584302|FG000|Overall Study|Lack of Efficacy|1|||
126078970|NCT02599688|453584302|FG000|Overall Study|Withdrawal by Subject|1|||
126078971|NCT02599688|453584302|FG000|Overall Study|Termination by Sponsor|2|||
126078972|NCT01841697|453584303|FG000|Overall Study|Death|0|||
126078973|NCT01841697|453584304|FG001|Overall Study|Death|1|||
126078974|NCT01841697|453584303|FG000|Overall Study|Lost to Follow-up|4|||
126078975|NCT01841697|453584304|FG001|Overall Study|Lost to Follow-up|1|||
126078976|NCT01841697|453584303|FG000|Overall Study|Withdrawal by Subject|16|||
126078977|NCT01841697|453584304|FG001|Overall Study|Withdrawal by Subject|16|||
126078978|NCT00756457|453584305|FG000|Overall Study|Lost to Follow-up|1|||
126078979|NCT00756457|453584306|FG001|Overall Study|Lost to Follow-up|2|||
126078980|NCT00632021|453584317|FG000|Overall Study|Withdrawal/death|4|||
126078981|NCT00632021|453584318|FG001|Overall Study|Withdrawal/death|7|||
126078982|NCT00952848|453584321|FG000|Overall Study|Withdrawal by Subject|4|||
126078983|NCT00458393|453584322|FG000|Overall Study|Withdrawal by Subject|67|||
126078984|NCT00458393|453584323|FG001|Overall Study|Withdrawal by Subject|80|||
126078985|NCT00458393|453584322|FG000|Overall Study|Physician Decision|31|||
126078986|NCT00458393|453584323|FG001|Overall Study|Physician Decision|22|||
126078987|NCT00458393|453584322|FG000|Overall Study|Relocated|77|||
126078988|NCT00458393|453584323|FG001|Overall Study|Relocated|81|||
126078989|NCT00458393|453584322|FG000|Overall Study|Lost to Follow-up|115|||
126078990|NCT00458393|453584323|FG001|Overall Study|Lost to Follow-up|92|||
126078991|NCT00458393|453584322|FG000|Overall Study|Sites marked other on the form.|19|||
126078992|NCT00458393|453584323|FG001|Overall Study|Sites marked other on the form.|20|||
126078993|NCT00857233|453584326|FG000|Overall Study|Adverse Event|24|||
126078994|NCT00857233|453584326|FG000|Overall Study|Lack of Efficacy|1|||
126078995|NCT00857233|453584326|FG000|Overall Study|Non-compliance|1|||
126078996|NCT00857233|453584326|FG000|Overall Study|Withdrawal of Consent|9|||
126078997|NCT00857233|453584326|FG000|Overall Study|Lost to Follow-up|4|||
126078998|NCT00857233|453584326|FG000|Overall Study|Nursing Home Placement|14|||
126078999|NCT00857233|453584326|FG000|Overall Study|Other Reasons|2|||
126079000|NCT05043883|453584327|FG000|Overall Study|Minimum required measurements could not be taken|4|||
126079001|NCT01587118|453584328|FG000|Overall Study|Adverse Event|3|||
126079002|NCT01587118|453584328|FG000|Overall Study|Lost to Follow-up|2|||
126079003|NCT01587118|453584328|FG000|Overall Study|Relocation|1|||
126079004|NCT01587118|453584328|FG000|Overall Study|nonresponse|1|||
126079005|NCT00263575|453584329|FG000|Titration Period|Adverse Event|14|||
126079006|NCT00263575|453584329|FG000|Titration Period|Withdrawal by Subject|10|||
125948397|NCT02036502|453108768|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125948398|NCT02036502|453108769|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125948399|NCT02036502|453108762|FG000|Part 2:Dose Confirmation|Death|0|||
125948400|NCT02036502|453108763|FG001|Part 2:Dose Confirmation|Death|0|||
125948401|NCT02036502|453108764|FG002|Part 2:Dose Confirmation|Death|1|||
125948402|NCT02036502|453108765|FG003|Part 2:Dose Confirmation|Death|0|||
125948403|NCT02036502|453108766|FG004|Part 2:Dose Confirmation|Death|0|||
126079007|NCT00263575|453584329|FG000|Titration Period|Protocol Violation|9|||
126079008|NCT00263575|453584329|FG000|Titration Period|Sponsor Decision|2|||
126079009|NCT00263575|453584329|FG000|Titration Period|Other|2|||
126079010|NCT00263575|453584329|FG000|Titration Period|Lack of Efficacy|6|||
126079011|NCT00263575|453584329|FG000|Maintence Period|Adverse Event|23|||
126079012|NCT00263575|453584329|FG000|Maintence Period|Withdrawal by Subject|8|||
126079013|NCT00263575|453584329|FG000|Maintence Period|Protocol Violation|4|||
126079014|NCT00263575|453584329|FG000|Maintence Period|Lack of Efficacy|4|||
126079015|NCT00263575|453584329|FG000|Maintence Period|Physician Decision|6|||
126079016|NCT00263575|453584329|FG000|Maintence Period|Lost to Follow-up|1|||
126079017|NCT00263575|453584329|FG000|Maintence Period|Sponsor Decision|24|||
126079018|NCT00263575|453584329|FG000|Maintence Period|Other|7|||
126079019|NCT00537329|453584330|FG000|Overall Study|Death|10|||
126079020|NCT00537329|453584330|FG000|Overall Study|Adverse Event|3|||
126079021|NCT00537329|453584330|FG000|Overall Study|Lack of Efficacy|2|||
126079022|NCT00537329|453584330|FG000|Overall Study|Lost to Follow-up|6|||
126079023|NCT00537329|453584330|FG000|Overall Study|Withdrawal by Subject|4|||
126079024|NCT00537329|453584330|FG000|Overall Study|Other|1|||
126079025|NCT02049515|453584331|FG000|Overall Study|Adverse Event|46|||
126079026|NCT02049515|453584332|FG001|Overall Study|Adverse Event|2|||
126079027|NCT02049515|453584331|FG000|Overall Study|Protocol-specified Disease Progression|23|||
126079028|NCT02049515|453584332|FG001|Overall Study|Protocol-specified Disease Progression|2|||
126079029|NCT02049515|453584331|FG000|Overall Study|Death|6|||
126079030|NCT02049515|453584332|FG001|Overall Study|Death|0|||
126079031|NCT02049515|453584331|FG000|Overall Study|Physician Decision|5|||
126079032|NCT02049515|453584332|FG001|Overall Study|Physician Decision|1|||
126079033|NCT02049515|453584331|FG000|Overall Study|Withdrawal by Subject|3|||
126079034|NCT02049515|453584332|FG001|Overall Study|Withdrawal by Subject|0|||
126079035|NCT02049515|453584331|FG000|Overall Study|Termination of the Study by Sponsor|2|||
126079036|NCT02049515|453584332|FG001|Overall Study|Termination of the Study by Sponsor|0|||
126079037|NCT02049515|453584331|FG000|Overall Study|Protocol Violation|1|||
126079038|NCT02049515|453584332|FG001|Overall Study|Protocol Violation|1|||
126079039|NCT02049515|453584331|FG000|Overall Study|Clinical Deterioration|1|||
126079040|NCT02049515|453584332|FG001|Overall Study|Clinical Deterioration|0|||
125948404|NCT02036502|453108767|FG005|Part 2:Dose Confirmation|Death|0|||
125948405|NCT02036502|453108768|FG006|Part 2:Dose Confirmation|Death|0|||
125948406|NCT02036502|453108769|FG007|Part 2:Dose Confirmation|Death|0|||
125948407|NCT02036502|453108762|FG000|Part 2:Dose Confirmation|Not treated|0|||
125948408|NCT02036502|453108763|FG001|Part 2:Dose Confirmation|Not treated|0|||
125948409|NCT02036502|453108764|FG002|Part 2:Dose Confirmation|Not treated|0|||
125948410|NCT02036502|453108765|FG003|Part 2:Dose Confirmation|Not treated|1|||
125948411|NCT02036502|453108766|FG004|Part 2:Dose Confirmation|Not treated|0|||
125948412|NCT02036502|453108767|FG005|Part 2:Dose Confirmation|Not treated|0|||
125948413|NCT02036502|453108768|FG006|Part 2:Dose Confirmation|Not treated|0|||
125948414|NCT02036502|453108769|FG007|Part 2:Dose Confirmation|Not treated|0|||
125948415|NCT02036502|453108762|FG000|Part 3:Dose Expansion|Adverse Event|0|||
125948416|NCT02036502|453108763|FG001|Part 3:Dose Expansion|Adverse Event|0|||
125948417|NCT02036502|453108764|FG002|Part 3:Dose Expansion|Adverse Event|0|||
125948418|NCT02036502|453108765|FG003|Part 3:Dose Expansion|Adverse Event|0|||
125948419|NCT02036502|453108766|FG004|Part 3:Dose Expansion|Adverse Event|0|||
125948420|NCT02036502|453108767|FG005|Part 3:Dose Expansion|Adverse Event|4|||
125948421|NCT02036502|453108768|FG006|Part 3:Dose Expansion|Adverse Event|0|||
125948422|NCT02036502|453108769|FG007|Part 3:Dose Expansion|Adverse Event|2|||
125948423|NCT02036502|453108762|FG000|Part 3:Dose Expansion|Death|0|||
125948424|NCT02036502|453108763|FG001|Part 3:Dose Expansion|Death|0|||
125948425|NCT02036502|453108764|FG002|Part 3:Dose Expansion|Death|0|||
125948426|NCT02036502|453108765|FG003|Part 3:Dose Expansion|Death|0|||
125948427|NCT02036502|453108766|FG004|Part 3:Dose Expansion|Death|0|||
125948428|NCT02036502|453108767|FG005|Part 3:Dose Expansion|Death|24|||
125948429|NCT02036502|453108768|FG006|Part 3:Dose Expansion|Death|0|||
125948430|NCT02036502|453108769|FG007|Part 3:Dose Expansion|Death|3|||
125948431|NCT02036502|453108762|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
126079041|NCT02049515|453584331|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
126079042|NCT02049515|453584332|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
126079043|NCT02049515|453584331|FG000|Overall Study|Treatment Interruption >42 Days|1|||
126079044|NCT02049515|453584332|FG001|Overall Study|Treatment Interruption >42 Days|0|||
126079045|NCT02049515|453584331|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
126079046|NCT02049515|453584332|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
126079047|NCT02138253|453584337|FG000|Overall Study|Adverse Event|3|||
125948432|NCT02036502|453108763|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
126079048|NCT02138253|453584338|FG001|Overall Study|Adverse Event|3|||
126079049|NCT02138253|453584337|FG000|Overall Study|Lost to Follow-up|2|||
126079050|NCT02138253|453584338|FG001|Overall Study|Lost to Follow-up|1|||
126079051|NCT02138253|453584337|FG000|Overall Study|Physician Decision|2|||
126079052|NCT02138253|453584338|FG001|Overall Study|Physician Decision|0|||
126079053|NCT02138253|453584337|FG000|Overall Study|Non compliance|1|||
126079054|NCT02138253|453584338|FG001|Overall Study|Non compliance|0|||
126079055|NCT02138253|453584337|FG000|Overall Study|Withdrawal by Subject|1|||
126079056|NCT02138253|453584338|FG001|Overall Study|Withdrawal by Subject|0|||
126079057|NCT01426113|453584339|FG000|Overall Study|Study Discontinued|1|||
126079058|NCT01426113|453584340|FG001|Overall Study|Study Discontinued|1|||
126079059|NCT01426113|453584339|FG000|Overall Study|Adverse Event|0|||
126079060|NCT01426113|453584340|FG001|Overall Study|Adverse Event|1|||
126079061|NCT02872012|453584341|FG000|Overall Study|Withdrawal by Subject|1|||
126079062|NCT02872012|453584342|FG001|Overall Study|Withdrawal by Subject|0|||
126079063|NCT02872012|453584343|FG002|Overall Study|Withdrawal by Subject|0|||
126079064|NCT02872012|453584344|FG003|Overall Study|Withdrawal by Subject|0|||
126079065|NCT02872012|453584345|FG004|Overall Study|Withdrawal by Subject|0|||
126079066|NCT01728623|453584346|FG000|Overall Study|Disease progression|26|||
126079067|NCT01728623|453584346|FG000|Overall Study|Adverse Event|1|||
126079068|NCT01728623|453584346|FG000|Overall Study|Withdrawal by Subject|1|||
126079069|NCT01390441|453584347|FG000|Treatment Period|Protocol Violation|0|||
126079070|NCT01390441|453584348|FG001|Treatment Period|Protocol Violation|1|||
126079071|NCT01390441|453584349|FG002|Treatment Period|Protocol Violation|0|||
126079072|NCT01390441|453584350|FG003|Treatment Period|Protocol Violation|0|||
126079073|NCT01390441|453584351|FG004|Treatment Period|Protocol Violation|0|||
126079074|NCT01390441|453584347|FG000|Treatment Period|Physician Decision|0|||
126079075|NCT01390441|453584348|FG001|Treatment Period|Physician Decision|0|||
126079076|NCT01390441|453584349|FG002|Treatment Period|Physician Decision|0|||
126079077|NCT01390441|453584350|FG003|Treatment Period|Physician Decision|1|||
126079078|NCT01390441|453584351|FG004|Treatment Period|Physician Decision|0|||
126079079|NCT01390441|453584347|FG000|Treatment Period|Lack of Efficacy|0|||
126079080|NCT01390441|453584348|FG001|Treatment Period|Lack of Efficacy|0|||
126079081|NCT01390441|453584349|FG002|Treatment Period|Lack of Efficacy|0|||
126079082|NCT01390441|453584350|FG003|Treatment Period|Lack of Efficacy|0|||
126079083|NCT01390441|453584351|FG004|Treatment Period|Lack of Efficacy|1|||
126079084|NCT01390441|453584347|FG000|Treatment Period|Unknown due to early stopping of study|0|||
126079085|NCT01390441|453584348|FG001|Treatment Period|Unknown due to early stopping of study|0|||
126079086|NCT01390441|453584349|FG002|Treatment Period|Unknown due to early stopping of study|8|||
126079087|NCT01390441|453584350|FG003|Treatment Period|Unknown due to early stopping of study|11|||
126079088|NCT01390441|453584351|FG004|Treatment Period|Unknown due to early stopping of study|7|||
126079089|NCT01390441|453584347|FG000|Treatment Period|Adverse Event|0|||
126079090|NCT01390441|453584348|FG001|Treatment Period|Adverse Event|0|||
126079091|NCT01390441|453584349|FG002|Treatment Period|Adverse Event|1|||
126079092|NCT01390441|453584350|FG003|Treatment Period|Adverse Event|1|||
126079093|NCT01390441|453584351|FG004|Treatment Period|Adverse Event|2|||
126079094|NCT01390441|453584347|FG000|Treatment Period|Withdrawal by Subject|0|||
126079095|NCT01390441|453584348|FG001|Treatment Period|Withdrawal by Subject|0|||
126079096|NCT01390441|453584349|FG002|Treatment Period|Withdrawal by Subject|1|||
126079097|NCT01390441|453584350|FG003|Treatment Period|Withdrawal by Subject|0|||
126079098|NCT01390441|453584351|FG004|Treatment Period|Withdrawal by Subject|1|||
126079099|NCT01390441|453584347|FG000|Treatment Period|Lost to Follow-up|1|||
126079100|NCT01390441|453584348|FG001|Treatment Period|Lost to Follow-up|0|||
126079101|NCT01390441|453584349|FG002|Treatment Period|Lost to Follow-up|0|||
126079102|NCT01390441|453584350|FG003|Treatment Period|Lost to Follow-up|0|||
126079103|NCT01390441|453584351|FG004|Treatment Period|Lost to Follow-up|0|||
126079104|NCT01390441|453584347|FG000|Extension Period|Protocol Violation|3|||
126079105|NCT01390441|453584348|FG001|Extension Period|Protocol Violation|1|||
126079106|NCT01390441|453584349|FG002|Extension Period|Protocol Violation|0|||
126079107|NCT01390441|453584350|FG003|Extension Period|Protocol Violation|1|||
126079108|NCT01390441|453584351|FG004|Extension Period|Protocol Violation|0|||
126079109|NCT02725528|453584353|FG000|Overall Study|Lost to Follow-up|1|||
126079110|NCT02725528|453584354|FG001|Overall Study|Lost to Follow-up|4|||
126079111|NCT02725528|453584353|FG000|Overall Study|Withdrawal by Subject|0|||
126079112|NCT02725528|453584354|FG001|Overall Study|Withdrawal by Subject|1|||
126079113|NCT02569957|453584356|FG000|Overall Study|Withdrawal by Subject|0|||
126079114|NCT02569957|453584357|FG001|Overall Study|Withdrawal by Subject|1|||
126079115|NCT02635386|453584358|FG000|Overall Study|Pregnancy|2|||
126079116|NCT02635386|453584359|FG001|Overall Study|Pregnancy|0|||
126079117|NCT02635386|453584360|FG002|Overall Study|Pregnancy|0|||
126079118|NCT02635386|453584361|FG003|Overall Study|Pregnancy|0|||
126079119|NCT02635386|453584362|FG004|Overall Study|Pregnancy|2|||
126079120|NCT02635386|453584358|FG000|Overall Study|Withdrawal by Subject|1|||
126079121|NCT02635386|453584359|FG001|Overall Study|Withdrawal by Subject|1|||
126079122|NCT02635386|453584360|FG002|Overall Study|Withdrawal by Subject|0|||
126079123|NCT02635386|453584361|FG003|Overall Study|Withdrawal by Subject|1|||
126079124|NCT02635386|453584362|FG004|Overall Study|Withdrawal by Subject|0|||
126079125|NCT02635386|453584358|FG000|Overall Study|Physician Decision|0|||
126079126|NCT02635386|453584359|FG001|Overall Study|Physician Decision|1|||
126079127|NCT02635386|453584360|FG002|Overall Study|Physician Decision|0|||
126079128|NCT02635386|453584361|FG003|Overall Study|Physician Decision|0|||
126079129|NCT02635386|453584362|FG004|Overall Study|Physician Decision|0|||
126079130|NCT02635386|453584358|FG000|Overall Study|Moved Out of State|0|||
126079131|NCT02635386|453584359|FG001|Overall Study|Moved Out of State|1|||
126079132|NCT02635386|453584360|FG002|Overall Study|Moved Out of State|0|||
126079133|NCT02635386|453584361|FG003|Overall Study|Moved Out of State|0|||
126079134|NCT02635386|453584362|FG004|Overall Study|Moved Out of State|0|||
126079135|NCT02635386|453584358|FG000|Overall Study|Noncompliant|0|||
126079136|NCT02635386|453584359|FG001|Overall Study|Noncompliant|2|||
126079137|NCT02635386|453584360|FG002|Overall Study|Noncompliant|1|||
126079138|NCT02635386|453584361|FG003|Overall Study|Noncompliant|1|||
126079139|NCT02635386|453584362|FG004|Overall Study|Noncompliant|1|||
126079140|NCT02635386|453584358|FG000|Overall Study|side effects|0|||
126079141|NCT02635386|453584359|FG001|Overall Study|side effects|0|||
126079142|NCT02635386|453584360|FG002|Overall Study|side effects|1|||
126079143|NCT02635386|453584361|FG003|Overall Study|side effects|4|||
126079144|NCT02635386|453584362|FG004|Overall Study|side effects|6|||
126079145|NCT02635386|453584358|FG000|Overall Study|needed other major surgery|0|||
126079146|NCT02635386|453584359|FG001|Overall Study|needed other major surgery|1|||
126079147|NCT02635386|453584360|FG002|Overall Study|needed other major surgery|0|||
126079148|NCT02635386|453584361|FG003|Overall Study|needed other major surgery|0|||
126079149|NCT02635386|453584362|FG004|Overall Study|needed other major surgery|0|||
126079150|NCT02635386|453584358|FG000|Overall Study|Other medical problems not drug related|0|||
126079151|NCT02635386|453584359|FG001|Overall Study|Other medical problems not drug related|0|||
126079152|NCT02635386|453584360|FG002|Overall Study|Other medical problems not drug related|0|||
126079153|NCT02635386|453584361|FG003|Overall Study|Other medical problems not drug related|1|||
126079154|NCT02635386|453584362|FG004|Overall Study|Other medical problems not drug related|0|||
126079155|NCT01209598|453584363|FG000|Overall Study|Withdrawal by Subject|1|||
126079156|NCT01209598|453584364|FG001|Overall Study|Withdrawal by Subject|0|||
126079157|NCT02719743|453584365|FG000|Overall Study|Consent withdrawal|0|||
126079158|NCT02719743|453584366|FG001|Overall Study|Consent withdrawal|2|||
126079159|NCT02719743|453584367|FG002|Overall Study|Consent withdrawal|0|||
126079160|NCT02719743|453584368|FG003|Overall Study|Consent withdrawal|1|||
126079161|NCT02719743|453584369|FG004|Overall Study|Consent withdrawal|0|||
126079162|NCT02719743|453584365|FG000|Overall Study|Migrated/moved from study area|0|||
126079163|NCT02719743|453584366|FG001|Overall Study|Migrated/moved from study area|0|||
126079164|NCT02719743|453584367|FG002|Overall Study|Migrated/moved from study area|0|||
126079165|NCT02719743|453584368|FG003|Overall Study|Migrated/moved from study area|0|||
126079166|NCT02719743|453584369|FG004|Overall Study|Migrated/moved from study area|2|||
126079167|NCT02719743|453584365|FG000|Overall Study|Lost to Follow-up|1|||
126079168|NCT02719743|453584366|FG001|Overall Study|Lost to Follow-up|1|||
126079169|NCT02719743|453584367|FG002|Overall Study|Lost to Follow-up|0|||
126079170|NCT02719743|453584368|FG003|Overall Study|Lost to Follow-up|0|||
126079171|NCT02719743|453584369|FG004|Overall Study|Lost to Follow-up|0|||
126079172|NCT02287233|453584370|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
126079173|NCT02287233|453584371|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
126079174|NCT02287233|453584372|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
126079175|NCT02287233|453584370|FG000|Overall Study|Adverse Event Related to Progression|0|||
126079176|NCT02287233|453584371|FG001|Overall Study|Adverse Event Related to Progression|2|||
126079177|NCT02287233|453584372|FG002|Overall Study|Adverse Event Related to Progression|8|||
126079178|NCT02287233|453584370|FG000|Overall Study|Physician Decision|1|||
126079179|NCT02287233|453584371|FG001|Overall Study|Physician Decision|2|||
126079180|NCT02287233|453584372|FG002|Overall Study|Physician Decision|4|||
126079181|NCT02287233|453584370|FG000|Overall Study|Progressive Disease with Death|0|||
126079182|NCT02287233|453584371|FG001|Overall Study|Progressive Disease with Death|0|||
126079183|NCT02287233|453584372|FG002|Overall Study|Progressive Disease with Death|10|||
126079184|NCT02287233|453584370|FG000|Overall Study|Progressive Disease Without Death|2|||
126079185|NCT02287233|453584371|FG001|Overall Study|Progressive Disease Without Death|3|||
126079186|NCT02287233|453584372|FG002|Overall Study|Progressive Disease Without Death|20|||
126079187|NCT02287233|453584370|FG000|Overall Study|Withdrawal by Subject|1|||
126079188|NCT02287233|453584371|FG001|Overall Study|Withdrawal by Subject|1|||
126079189|NCT02287233|453584372|FG002|Overall Study|Withdrawal by Subject|7|||
126079190|NCT02287233|453584370|FG000|Overall Study|Other|3|||
126079191|NCT02287233|453584371|FG001|Overall Study|Other|0|||
126079192|NCT02287233|453584372|FG002|Overall Study|Other|15|||
126079193|NCT02287233|453584370|FG000|Overall Study|Did Not Receive Treatment|0|||
126079194|NCT02287233|453584371|FG001|Overall Study|Did Not Receive Treatment|0|||
126079195|NCT02287233|453584372|FG002|Overall Study|Did Not Receive Treatment|2|||
126079196|NCT01163474|453584373|FG000|Overall Study|Withdrawal by Subject|1|||
126079197|NCT01163474|453584373|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
126079198|NCT01163474|453584373|FG000|Overall Study|Lost to Follow-up|3|||
126079199|NCT03432390|453584376|FG000|Apnea Period|Protocol Violation|2|||
126079200|NCT03432390|453584377|FG001|Apnea Period|Protocol Violation|2|||
126079201|NCT02689453|453584390|FG000|Overall Study|Progressive disease|0|||
126079202|NCT02689453|453584391|FG001|Overall Study|Progressive disease|1|||
126079203|NCT02689453|453584392|FG002|Overall Study|Progressive disease|1|||
126079204|NCT04206085|453584393|FG000|Overall Study|Lost to Follow-up|0|||
126079205|NCT04206085|453584394|FG001|Overall Study|Lost to Follow-up|1|||
126079206|NCT04206085|453584395|FG002|Overall Study|Lost to Follow-up|0|||
126079207|NCT04206085|453584393|FG000|Overall Study|Lost to Follow-up|0|||
126079208|NCT04206085|453584394|FG001|Overall Study|Lost to Follow-up|0|||
126079209|NCT04206085|453584395|FG002|Overall Study|Lost to Follow-up|1|||
126079210|NCT00763451|453584396|FG000|Overall Study|Adverse Event|4|||
126079211|NCT00763451|453584397|FG001|Overall Study|Adverse Event|6|||
126079212|NCT00763451|453584398|FG002|Overall Study|Adverse Event|19|||
126079213|NCT00763451|453584399|FG003|Overall Study|Adverse Event|14|||
126079214|NCT00763451|453584396|FG000|Overall Study|Lack of Efficacy|1|||
126079215|NCT00763451|453584397|FG001|Overall Study|Lack of Efficacy|4|||
126079216|NCT00763451|453584398|FG002|Overall Study|Lack of Efficacy|3|||
126079217|NCT00763451|453584399|FG003|Overall Study|Lack of Efficacy|2|||
126079218|NCT00763451|453584396|FG000|Overall Study|Withdrawal by Subject|1|||
126079219|NCT00763451|453584397|FG001|Overall Study|Withdrawal by Subject|6|||
126079220|NCT00763451|453584398|FG002|Overall Study|Withdrawal by Subject|9|||
126079221|NCT00763451|453584399|FG003|Overall Study|Withdrawal by Subject|7|||
126079222|NCT00763451|453584396|FG000|Overall Study|Protocol Violation|0|||
126079223|NCT00763451|453584397|FG001|Overall Study|Protocol Violation|0|||
126079224|NCT00763451|453584398|FG002|Overall Study|Protocol Violation|1|||
126079225|NCT00763451|453584399|FG003|Overall Study|Protocol Violation|0|||
126079226|NCT00763451|453584396|FG000|Overall Study|Poor Compliance to Protocol|1|||
126079227|NCT00763451|453584397|FG001|Overall Study|Poor Compliance to Protocol|1|||
126079228|NCT00763451|453584398|FG002|Overall Study|Poor Compliance to Protocol|2|||
126079229|NCT00763451|453584399|FG003|Overall Study|Poor Compliance to Protocol|2|||
126079230|NCT00763451|453584396|FG000|Overall Study|Familial and Personal Reasons|5|||
126079231|NCT00763451|453584397|FG001|Overall Study|Familial and Personal Reasons|3|||
126079232|NCT00763451|453584398|FG002|Overall Study|Familial and Personal Reasons|5|||
126079233|NCT00763451|453584399|FG003|Overall Study|Familial and Personal Reasons|4|||
126079234|NCT00763451|453584396|FG000|Overall Study|Randomized but not Treated|1|||
126079235|NCT00763451|453584397|FG001|Overall Study|Randomized but not Treated|1|||
126079236|NCT00763451|453584398|FG002|Overall Study|Randomized but not Treated|0|||
126079237|NCT00763451|453584399|FG003|Overall Study|Randomized but not Treated|0|||
126079238|NCT00763451|453584396|FG000|Overall Study|Study Site Reason|0|||
126079239|NCT00763451|453584397|FG001|Overall Study|Study Site Reason|1|||
126079240|NCT00763451|453584398|FG002|Overall Study|Study Site Reason|1|||
126079241|NCT00763451|453584399|FG003|Overall Study|Study Site Reason|1|||
126079242|NCT00725543|453584403|FG000|Overall Study|Adverse Event|10|||
126079243|NCT00725543|453584403|FG000|Overall Study|Lack of Efficacy|3|||
126079244|NCT00725543|453584403|FG000|Overall Study|Withdrawal by Subject|10|||
126079245|NCT00725543|453584403|FG000|Overall Study|Physician Decision|5|||
126079246|NCT00725543|453584403|FG000|Overall Study|Lost to Follow-up|4|||
126079247|NCT00725543|453584403|FG000|Overall Study|Non-compliance|2|||
126079248|NCT00725543|453584403|FG000|Overall Study|Other|119|||
126079249|NCT05594589|453584404|FG000|Overall Study|Other|0|||
126079250|NCT05594589|453584405|FG001|Overall Study|Other|1|||
126079251|NCT05594589|453584406|FG002|Overall Study|Other|0|||
126079252|NCT02168478|453584413|FG000|Overall Study|Withdrawal by Subject|1|||
126079253|NCT02168478|453584413|FG000|Overall Study|Did Not Consent to Participation|2|||
126079254|NCT02168478|453584413|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
126079255|NCT03845023|453584418|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
125948433|NCT02036502|453108764|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
125948434|NCT02036502|453108765|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
126114956|NCT01514136|453715811|FG004|Test Period 2; Test C*|holiday|0|||
126114957|NCT01514136|453715812|FG005|Test Period 2; Test C*|holiday|0|||
126079256|NCT03845023|453584419|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
126079257|NCT03845023|453584420|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
126079258|NCT03845023|453584421|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
125948435|NCT02036502|453108766|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
126079259|NCT03845023|453584418|FG000|Follow-Up (14 Days)|Adverse Event|0|||
126079260|NCT03845023|453584419|FG001|Follow-Up (14 Days)|Adverse Event|0|||
126114958|NCT01514136|453715813|FG006|Test Period 2; Test C*|holiday|1|||
125948436|NCT02036502|453108767|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
126079261|NCT03845023|453584420|FG002|Follow-Up (14 Days)|Adverse Event|1|||
126079262|NCT03845023|453584421|FG003|Follow-Up (14 Days)|Adverse Event|1|||
126079263|NCT03772613|453584422|FG000|Overall Study|Lost to Follow-up|0|||
126079264|NCT03772613|453584423|FG001|Overall Study|Lost to Follow-up|1|||
126079265|NCT03772613|453584424|FG002|Overall Study|Lost to Follow-up|1|||
126079266|NCT02554383|453584428|FG000|Overall Study|Ineligible|3|||
126079267|NCT02554383|453584429|FG001|Overall Study|Ineligible|2|||
126079268|NCT02554383|453584428|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
126079269|NCT02554383|453584429|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
126079270|NCT02554383|453584428|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
126114959|NCT01514136|453715814|FG007|Test Period 2; Test C*|holiday|0|||
126079271|NCT02554383|453584429|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
126079272|NCT02554383|453584428|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
126079273|NCT02554383|453584429|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
126079274|NCT01801982|453584432|FG000|Overall Study|Lost to Follow-up|1|||
126079275|NCT02918292|453584433|FG000|Study Enrollment Prior to Transplant|Death|1|||
126079276|NCT02918292|453584433|FG000|Study Follow up After Transplant|Death|6|||
126079277|NCT01185171|453584434|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
126079278|NCT01185171|453584434|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
126079279|NCT01185171|453584434|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
126079280|NCT01185171|453584434|FG000|Maintenance|Elevated liver transaminases|3|||
126079281|NCT01185171|453584434|FG000|Maintenance|Rush|2|||
126079282|NCT01185171|453584434|FG000|Maintenance|Diarrhea|1|||
126079283|NCT01185171|453584434|FG000|Maintenance|Xerostomia|1|||
126079284|NCT01185171|453584434|FG000|Maintenance|Nausea|1|||
126079285|NCT01185171|453584434|FG000|Maintenance|Comorbid Illness|2|||
126079286|NCT01185171|453584434|FG000|Maintenance|Withdrawal by Subject|1|||
126079287|NCT01185171|453584434|FG000|Maintenance|Disease Recurrence|1|||
126079288|NCT00727506|453584435|FG000|Overall Study|Adverse Event|0|||
126079289|NCT00727506|453584436|FG001|Overall Study|Adverse Event|0|||
126079290|NCT00727506|453584437|FG002|Overall Study|Adverse Event|4|||
126079291|NCT00727506|453584438|FG003|Overall Study|Adverse Event|4|||
126079292|NCT00727506|453584439|FG004|Overall Study|Adverse Event|1|||
126079293|NCT00727506|453584440|FG005|Overall Study|Adverse Event|8|||
126079294|NCT00727506|453584435|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126079295|NCT00727506|453584436|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126079296|NCT00727506|453584437|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126079297|NCT00727506|453584438|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126079298|NCT00727506|453584439|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126079299|NCT00727506|453584440|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126079300|NCT00727506|453584435|FG000|Overall Study|Progressive disease|4|||
126079301|NCT00727506|453584436|FG001|Overall Study|Progressive disease|7|||
126079302|NCT00727506|453584437|FG002|Overall Study|Progressive disease|9|||
126079303|NCT00727506|453584438|FG003|Overall Study|Progressive disease|28|||
126079304|NCT00727506|453584439|FG004|Overall Study|Progressive disease|38|||
126079305|NCT00727506|453584440|FG005|Overall Study|Progressive disease|28|||
126079306|NCT00727506|453584435|FG000|Overall Study|Refused to continue medication|0|||
126079307|NCT00727506|453584436|FG001|Overall Study|Refused to continue medication|1|||
126079308|NCT00727506|453584437|FG002|Overall Study|Refused to continue medication|2|||
126079309|NCT00727506|453584438|FG003|Overall Study|Refused to continue medication|3|||
126079310|NCT00727506|453584439|FG004|Overall Study|Refused to continue medication|1|||
126079311|NCT00727506|453584440|FG005|Overall Study|Refused to continue medication|2|||
126079312|NCT00727506|453584435|FG000|Overall Study|Other reason not described above|0|||
126079313|NCT00727506|453584436|FG001|Overall Study|Other reason not described above|0|||
126079314|NCT00727506|453584437|FG002|Overall Study|Other reason not described above|1|||
126079315|NCT00727506|453584438|FG003|Overall Study|Other reason not described above|4|||
126079316|NCT00727506|453584439|FG004|Overall Study|Other reason not described above|1|||
126079317|NCT00727506|453584440|FG005|Overall Study|Other reason not described above|1|||
126079318|NCT03561597|453584441|FG000|Overall Study|Lost to Follow-up|20|||
126079319|NCT03783689|453584445|FG000|Overall Study|Adverse Event|2|||
126079320|NCT03783689|453584446|FG001|Overall Study|Adverse Event|0|||
126079321|NCT03783689|453584445|FG000|Overall Study|Lost to Follow-up|2|||
126079322|NCT03783689|453584446|FG001|Overall Study|Lost to Follow-up|1|||
126079323|NCT03783689|453584445|FG000|Overall Study|Physician Decision|2|||
126079324|NCT03783689|453584446|FG001|Overall Study|Physician Decision|1|||
126079325|NCT03783689|453584445|FG000|Overall Study|Withdrawal by Subject|3|||
126079326|NCT03783689|453584446|FG001|Overall Study|Withdrawal by Subject|3|||
126079327|NCT03783871|453584452|FG000|Overall Study|Withdrawal by Subject|15|||
126079328|NCT03783871|453584452|FG000|Overall Study|Death|13|||
126079329|NCT03783871|453584452|FG000|Overall Study|Lost to Follow-up|2|||
126079330|NCT04594733|453584454|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126079331|NCT04594733|453584455|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126079332|NCT04594733|453584454|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
126079333|NCT04594733|453584455|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
126079334|NCT04594733|453584454|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
126079335|NCT04594733|453584455|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
126079336|NCT02647645|453584458|FG000|Overall Study|Lost to Follow-up|2|||
126079337|NCT02647645|453584459|FG001|Overall Study|Lost to Follow-up|1|||
126079338|NCT00356811|453584460|FG000|Overall Study|Death|35|||
126079339|NCT00356811|453584460|FG000|Overall Study|Lost to Follow-up|2|||
126079340|NCT00356811|453584460|FG000|Overall Study|Withdrawal by Subject|6|||
126079341|NCT00356811|453584460|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
126079342|NCT00356811|453584460|FG000|Overall Study|Study Is Terminating|3|||
126079343|NCT00356811|453584460|FG000|Overall Study|Site Closed during Follow-up|2|||
126079344|NCT02386839|453584461|FG000|Overall Study|Death|1|||
126079345|NCT02386839|453584462|FG001|Overall Study|Death|0|||
126079346|NCT02386839|453584461|FG000|Overall Study|Withdrawal by Subject|9|||
126079347|NCT02386839|453584462|FG001|Overall Study|Withdrawal by Subject|10|||
126079348|NCT02386839|453584461|FG000|Overall Study|Lost to Follow-up|4|||
126079349|NCT02386839|453584462|FG001|Overall Study|Lost to Follow-up|4|||
126079350|NCT02386839|453584461|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
126079351|NCT02386839|453584462|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
126079352|NCT02386839|453584461|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
126079353|NCT02386839|453584462|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
126079354|NCT02386839|453584461|FG000|Overall Study|Other (unspecified)|1|||
126079355|NCT02386839|453584462|FG001|Overall Study|Other (unspecified)|0|||
126079356|NCT02101983|453584463|FG000|Overall Study|Physician Decision|1|||
125948437|NCT02036502|453108768|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
125948438|NCT02036502|453108769|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
125948439|NCT02036502|453108762|FG000|Part 3:Dose Expansion|Physician Decision|0|||
125948440|NCT02036502|453108763|FG001|Part 3:Dose Expansion|Physician Decision|0|||
125948441|NCT02036502|453108764|FG002|Part 3:Dose Expansion|Physician Decision|0|||
125948442|NCT02036502|453108765|FG003|Part 3:Dose Expansion|Physician Decision|0|||
125948443|NCT02036502|453108766|FG004|Part 3:Dose Expansion|Physician Decision|0|||
125948444|NCT02036502|453108767|FG005|Part 3:Dose Expansion|Physician Decision|1|||
125948445|NCT02036502|453108768|FG006|Part 3:Dose Expansion|Physician Decision|0|||
125948446|NCT02036502|453108769|FG007|Part 3:Dose Expansion|Physician Decision|0|||
125948447|NCT02036502|453108762|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
125948448|NCT02036502|453108763|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
125948449|NCT02036502|453108764|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
125948450|NCT02036502|453108765|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
125948451|NCT02036502|453108766|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
125948452|NCT02036502|453108767|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
125948453|NCT02036502|453108768|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
125948454|NCT02036502|453108769|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
125948455|NCT02036502|453108762|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125948456|NCT02036502|453108763|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125948457|NCT02036502|453108764|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125948458|NCT02036502|453108765|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125948459|NCT02036502|453108766|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125948460|NCT02036502|453108767|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
125948461|NCT02036502|453108768|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125948462|NCT02036502|453108769|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
125948463|NCT02036502|453108762|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125948464|NCT02036502|453108763|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125948465|NCT02036502|453108764|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125948466|NCT02036502|453108765|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125948467|NCT02036502|453108766|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125948468|NCT02036502|453108767|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
125948469|NCT02036502|453108768|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
125948470|NCT02036502|453108769|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
125948471|NCT02036502|453108762|FG000|Part 3:Dose Expansion|Not Treated|0|||
125948472|NCT02036502|453108763|FG001|Part 3:Dose Expansion|Not Treated|0|||
125948473|NCT02036502|453108764|FG002|Part 3:Dose Expansion|Not Treated|0|||
125948474|NCT02036502|453108765|FG003|Part 3:Dose Expansion|Not Treated|0|||
125948475|NCT02036502|453108766|FG004|Part 3:Dose Expansion|Not Treated|0|||
125948476|NCT02036502|453108767|FG005|Part 3:Dose Expansion|Not Treated|2|||
125948477|NCT02036502|453108768|FG006|Part 3:Dose Expansion|Not Treated|0|||
125948478|NCT02036502|453108769|FG007|Part 3:Dose Expansion|Not Treated|0|||
125948479|NCT00500292|453108773|FG000|Overall Study|Adverse Event|3|||
125948480|NCT00500292|453108774|FG001|Overall Study|Adverse Event|6|||
125948481|NCT00500292|453108775|FG002|Overall Study|Adverse Event|4|||
125948482|NCT00500292|453108773|FG000|Overall Study|Condition under investigation worsened|21|||
125948483|NCT00500292|453108774|FG001|Overall Study|Condition under investigation worsened|23|||
125948484|NCT00500292|453108775|FG002|Overall Study|Condition under investigation worsened|19|||
125948485|NCT00500292|453108773|FG000|Overall Study|Withdrawal by Subject|0|||
125948486|NCT00500292|453108774|FG001|Overall Study|Withdrawal by Subject|1|||
125948487|NCT00500292|453108775|FG002|Overall Study|Withdrawal by Subject|0|||
125948488|NCT00500292|453108773|FG000|Overall Study|Other|1|||
125948489|NCT00500292|453108774|FG001|Overall Study|Other|1|||
125948490|NCT00500292|453108775|FG002|Overall Study|Other|4|||
125948491|NCT01068509|453108776|FG000|Overall Study|Death|0|||
125948492|NCT01068509|453108777|FG001|Overall Study|Death|0|||
125948493|NCT01068509|453108778|FG002|Overall Study|Death|1|||
125948494|NCT01068509|453108776|FG000|Overall Study|Disease Progression|5|||
126079357|NCT02101983|453584464|FG001|Overall Study|Physician Decision|0|||
125948495|NCT01068509|453108777|FG001|Overall Study|Disease Progression|20|||
125948496|NCT01068509|453108778|FG002|Overall Study|Disease Progression|18|||
125948497|NCT01068509|453108776|FG000|Overall Study|Lost to Follow-up|1|||
126079358|NCT00826228|453585794|FG000|Overall Study|Withdrawal by Subject|1|||
126079359|NCT00903760|453585795|FG000|Overall Study|Disease Progression/Death|8|||
126079360|NCT00903760|453585796|FG001|Overall Study|Disease Progression/Death|6|||
126079361|NCT00903760|453585795|FG000|Overall Study|Stem Cell Transplant|8|||
126079362|NCT00903760|453585796|FG001|Overall Study|Stem Cell Transplant|4|||
126079363|NCT00903760|453585795|FG000|Overall Study|Physician Decision|1|||
126079364|NCT00903760|453585796|FG001|Overall Study|Physician Decision|2|||
126079365|NCT00903760|453585795|FG000|Overall Study|Death|0|||
126079366|NCT00903760|453585796|FG001|Overall Study|Death|1|||
126079367|NCT00903760|453585795|FG000|Overall Study|Lost to Follow-up|1|||
126079368|NCT00903760|453585796|FG001|Overall Study|Lost to Follow-up|0|||
126079369|NCT00903760|453585795|FG000|Overall Study|Withdrawal by Subject|1|||
126079370|NCT00903760|453585796|FG001|Overall Study|Withdrawal by Subject|2|||
126079371|NCT00903760|453585795|FG000|Overall Study|Off treatment for long period|0|||
126079372|NCT00903760|453585796|FG001|Overall Study|Off treatment for long period|1|||
126079373|NCT01845805|453585798|FG000|Overall Study|Withdrawal by Subject|1|||
126079374|NCT01845805|453585799|FG001|Overall Study|Withdrawal by Subject|2|||
126079375|NCT01845805|453585798|FG000|Overall Study|Disease Progression|13|||
126079376|NCT01845805|453585799|FG001|Overall Study|Disease Progression|14|||
126079377|NCT01845805|453585798|FG000|Overall Study|Drug-related Toxicity|4|||
126079378|NCT01845805|453585799|FG001|Overall Study|Drug-related Toxicity|0|||
125948498|NCT01068509|453108777|FG001|Overall Study|Lost to Follow-up|0|||
125948499|NCT01068509|453108778|FG002|Overall Study|Lost to Follow-up|0|||
125948500|NCT01068509|453108776|FG000|Overall Study|Withdrew Consent|0|||
125948501|NCT01068509|453108777|FG001|Overall Study|Withdrew Consent|1|||
125948502|NCT01068509|453108778|FG002|Overall Study|Withdrew Consent|2|||
125948503|NCT01068509|453108776|FG000|Overall Study|Reason Not Specified|0|||
125948504|NCT01068509|453108777|FG001|Overall Study|Reason Not Specified|1|||
125948505|NCT01068509|453108778|FG002|Overall Study|Reason Not Specified|0|||
125948506|NCT02442778|453108779|FG000|Overall Study|Adverse Event|2|||
125948507|NCT02442778|453108780|FG001|Overall Study|Adverse Event|6|||
125948508|NCT02442778|453108781|FG002|Overall Study|Adverse Event|6|||
125948509|NCT02442778|453108779|FG000|Overall Study|Death|0|||
125948510|NCT02442778|453108780|FG001|Overall Study|Death|2|||
125948511|NCT02442778|453108781|FG002|Overall Study|Death|0|||
125948512|NCT02442778|453108779|FG000|Overall Study|Lack of Efficacy|1|||
125948513|NCT02442778|453108780|FG001|Overall Study|Lack of Efficacy|0|||
125948514|NCT02442778|453108781|FG002|Overall Study|Lack of Efficacy|0|||
125948515|NCT02442778|453108779|FG000|Overall Study|Lost to Follow-up|1|||
125948516|NCT02442778|453108780|FG001|Overall Study|Lost to Follow-up|1|||
125948517|NCT02442778|453108781|FG002|Overall Study|Lost to Follow-up|1|||
125948518|NCT02442778|453108779|FG000|Overall Study|Non-compliance with study drug|2|||
125948519|NCT02442778|453108780|FG001|Overall Study|Non-compliance with study drug|0|||
125948520|NCT02442778|453108781|FG002|Overall Study|Non-compliance with study drug|1|||
125948521|NCT02442778|453108779|FG000|Overall Study|Physician Decision|1|||
125948522|NCT02442778|453108780|FG001|Overall Study|Physician Decision|1|||
125948523|NCT02442778|453108781|FG002|Overall Study|Physician Decision|1|||
125948524|NCT02442778|453108779|FG000|Overall Study|Protocol Deviation|3|||
125948525|NCT02442778|453108780|FG001|Overall Study|Protocol Deviation|0|||
125948526|NCT02442778|453108781|FG002|Overall Study|Protocol Deviation|1|||
125948527|NCT02442778|453108779|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
125948528|NCT02442778|453108780|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
125948529|NCT02442778|453108781|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
125948530|NCT02442778|453108779|FG000|Overall Study|Withdrawal by Subject|4|||
125948531|NCT02442778|453108780|FG001|Overall Study|Withdrawal by Subject|4|||
125948532|NCT02442778|453108781|FG002|Overall Study|Withdrawal by Subject|3|||
125948533|NCT02442778|453108779|FG000|Overall Study|Reason not specified|1|||
125948534|NCT02442778|453108780|FG001|Overall Study|Reason not specified|4|||
125948535|NCT02442778|453108781|FG002|Overall Study|Reason not specified|0|||
125948536|NCT00603746|453108789|FG000|Overall Study|Adverse Event|2|||
125948537|NCT00603746|453108790|FG001|Overall Study|Adverse Event|3|||
125948538|NCT00603746|453108791|FG002|Overall Study|Adverse Event|0|||
125948539|NCT00603746|453108792|FG003|Overall Study|Adverse Event|1|||
125948540|NCT00603746|453108793|FG004|Overall Study|Adverse Event|0|||
125948541|NCT00603746|453108794|FG005|Overall Study|Adverse Event|4|||
125948542|NCT00603746|453108789|FG000|Overall Study|Lack of Efficacy|34|||
125948543|NCT00603746|453108790|FG001|Overall Study|Lack of Efficacy|11|||
126079379|NCT04795336|453585800|FG000|Overall Study|Withdrawal by Subject|3|||
126079380|NCT04795336|453585801|FG001|Overall Study|Withdrawal by Subject|4|||
126079381|NCT04795336|453585802|FG002|Overall Study|Withdrawal by Subject|3|||
126079382|NCT04795336|453585803|FG003|Overall Study|Withdrawal by Subject|12|||
125948544|NCT00603746|453108791|FG002|Overall Study|Lack of Efficacy|6|||
125948545|NCT00603746|453108792|FG003|Overall Study|Lack of Efficacy|11|||
125948546|NCT00603746|453108793|FG004|Overall Study|Lack of Efficacy|12|||
125948547|NCT00603746|453108794|FG005|Overall Study|Lack of Efficacy|8|||
125948548|NCT00603746|453108789|FG000|Overall Study|Protocol Violation|0|||
125948549|NCT00603746|453108790|FG001|Overall Study|Protocol Violation|3|||
125948550|NCT00603746|453108791|FG002|Overall Study|Protocol Violation|1|||
125948551|NCT00603746|453108792|FG003|Overall Study|Protocol Violation|0|||
125948552|NCT00603746|453108793|FG004|Overall Study|Protocol Violation|1|||
125948553|NCT00603746|453108794|FG005|Overall Study|Protocol Violation|0|||
126079383|NCT04795336|453585800|FG000|Overall Study|Lost study logs|0|||
126079384|NCT04795336|453585801|FG001|Overall Study|Lost study logs|1|||
126079385|NCT04795336|453585802|FG002|Overall Study|Lost study logs|0|||
126079386|NCT04795336|453585803|FG003|Overall Study|Lost study logs|2|||
126079387|NCT04795336|453585800|FG000|Overall Study|Did not take study medication|2|||
126079388|NCT04795336|453585801|FG001|Overall Study|Did not take study medication|0|||
126079389|NCT04795336|453585802|FG002|Overall Study|Did not take study medication|0|||
126079390|NCT04795336|453585803|FG003|Overall Study|Did not take study medication|0|||
126079391|NCT03898700|453585804|FG000|Overall Study|Withdrawal by Subject|2|||
126079392|NCT00589303|453585811|FG000|Overall Study|Withdrawal by Subject|2|||
126079393|NCT00589303|453585812|FG001|Overall Study|Withdrawal by Subject|1|||
126079394|NCT04367480|453585813|FG000|Overall Study|Adverse Event|1|||
126079395|NCT04367480|453585814|FG001|Overall Study|Adverse Event|1|||
126079396|NCT04367480|453585813|FG000|Overall Study|Death|1|||
126079397|NCT04367480|453585814|FG001|Overall Study|Death|0|||
126079398|NCT04367480|453585813|FG000|Overall Study|Lost to Follow-up|1|||
126079399|NCT04367480|453585814|FG001|Overall Study|Lost to Follow-up|1|||
126079400|NCT04367480|453585813|FG000|Overall Study|Withdrawal by Subject|0|||
126079401|NCT04367480|453585814|FG001|Overall Study|Withdrawal by Subject|3|||
126079402|NCT04367480|453585813|FG000|Overall Study|App glitch during the study|1|||
126079403|NCT04367480|453585814|FG001|Overall Study|App glitch during the study|0|||
126079404|NCT04367480|453585813|FG000|Overall Study|Device Distribution Error|0|||
126079405|NCT04367480|453585814|FG001|Overall Study|Device Distribution Error|2|||
126079406|NCT04367480|453585813|FG000|Overall Study|Ineligible after Randomization|0|||
126079407|NCT04367480|453585814|FG001|Overall Study|Ineligible after Randomization|1|||
126079408|NCT04367480|453585813|FG000|Overall Study|Other Medical Reasons|0|||
126079409|NCT04367480|453585814|FG001|Overall Study|Other Medical Reasons|2|||
126079410|NCT04120376|453585815|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
126079411|NCT04120376|453585816|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
126079412|NCT00634842|453585817|FG000|Overall Study|Adverse Event|2|||
126079413|NCT00634842|453585818|FG001|Overall Study|Adverse Event|3|||
126079414|NCT00634842|453585817|FG000|Overall Study|Protocol Violation|8|||
126079415|NCT00634842|453585818|FG001|Overall Study|Protocol Violation|4|||
126079416|NCT00634842|453585817|FG000|Overall Study|Move to another state|1|||
126079417|NCT00634842|453585818|FG001|Overall Study|Move to another state|0|||
126079418|NCT00634842|453585817|FG000|Overall Study|Inclusion criteria were not met|1|||
126079419|NCT00634842|453585818|FG001|Overall Study|Inclusion criteria were not met|0|||
126079420|NCT00634842|453585817|FG000|Overall Study|Lost to Follow-up|1|||
126079421|NCT00634842|453585818|FG001|Overall Study|Lost to Follow-up|2|||
126079422|NCT00634842|453585817|FG000|Overall Study|Physician Decision|1|||
126079423|NCT00634842|453585818|FG001|Overall Study|Physician Decision|0|||
126079424|NCT00634842|453585817|FG000|Overall Study|Withdrawal by Subject|1|||
126079425|NCT00634842|453585818|FG001|Overall Study|Withdrawal by Subject|3|||
126079426|NCT00634842|453585817|FG000|Overall Study|Lack of time and intolerance to drug|0|||
126079427|NCT00634842|453585818|FG001|Overall Study|Lack of time and intolerance to drug|1|||
126079428|NCT00634842|453585817|FG000|Overall Study|Discontinued due to injection|0|||
126079429|NCT00634842|453585818|FG001|Overall Study|Discontinued due to injection|2|||
126079430|NCT00634842|453585817|FG000|Overall Study|No need of study drug to treat diabetes|0|||
126079431|NCT00634842|453585818|FG001|Overall Study|No need of study drug to treat diabetes|1|||
126079432|NCT00634842|453585817|FG000|Overall Study|No wish to keep taking Avandia|0|||
126079433|NCT00634842|453585818|FG001|Overall Study|No wish to keep taking Avandia|1|||
126079434|NCT00634842|453585817|FG000|Overall Study|Subject off study drug for too long|0|||
126079435|NCT00634842|453585818|FG001|Overall Study|Subject off study drug for too long|1|||
126079436|NCT02229578|453585842|FG000|Overall Study|Withdrawal by Subject|1|||
126079437|NCT02229578|453585843|FG001|Overall Study|Withdrawal by Subject|3|||
126079438|NCT02229578|453585842|FG000|Overall Study|Protocol Violation|2|||
126079439|NCT02229578|453585843|FG001|Overall Study|Protocol Violation|0|||
126079440|NCT00943787|453585844|FG000|Overall Study|Physician Decision|4|||
126079441|NCT00943787|453585844|FG000|Overall Study|Withdrawal by Subject|3|||
126079442|NCT01288209|453585846|FG000|Overall Study|Withdrawal by Subject|1|||
126079443|NCT01288209|453585847|FG001|Overall Study|Withdrawal by Subject|3|||
126079444|NCT01288209|453585846|FG000|Overall Study|Other|1|||
126079445|NCT01288209|453585847|FG001|Overall Study|Other|0|||
126079446|NCT01015677|453585848|FG000|Overall Study|Adverse Event|0|||
126079447|NCT01015677|453585849|FG001|Overall Study|Adverse Event|1|||
126079448|NCT01015677|453585850|FG002|Overall Study|Adverse Event|0|||
126079449|NCT01015677|453585848|FG000|Overall Study|Lack of Efficacy|0|||
126079450|NCT01015677|453585849|FG001|Overall Study|Lack of Efficacy|1|||
126079451|NCT01015677|453585850|FG002|Overall Study|Lack of Efficacy|0|||
126079452|NCT01015677|453585848|FG000|Overall Study|Protocol Violation|0|||
126079453|NCT01015677|453585849|FG001|Overall Study|Protocol Violation|1|||
126079454|NCT01015677|453585850|FG002|Overall Study|Protocol Violation|0|||
126079455|NCT01015677|453585848|FG000|Overall Study|Withdrawal by Subject|1|||
126079456|NCT01015677|453585849|FG001|Overall Study|Withdrawal by Subject|1|||
126079457|NCT01015677|453585850|FG002|Overall Study|Withdrawal by Subject|0|||
126079458|NCT02232399|453585851|FG000|Overall Study|Adverse Event|1|||
126079459|NCT02232399|453585852|FG001|Overall Study|Adverse Event|0|||
126079460|NCT02232399|453585851|FG000|Overall Study|Withdrawal by Subject|0|||
126079461|NCT02232399|453585852|FG001|Overall Study|Withdrawal by Subject|1|||
126079462|NCT01646385|453585855|FG000|Overall Study|Death|202|||
126079463|NCT01646385|453585856|FG001|Overall Study|Death|222|||
126079464|NCT01646385|453585855|FG000|Overall Study|Switched to alternate biologic|636|||
126079465|NCT01646385|453585856|FG001|Overall Study|Switched to alternate biologic|649|||
126079466|NCT01216072|453585857|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
125948554|NCT00603746|453108789|FG000|Overall Study|Lost to Follow-up|0|||
125948555|NCT00603746|453108790|FG001|Overall Study|Lost to Follow-up|1|||
125948556|NCT00603746|453108791|FG002|Overall Study|Lost to Follow-up|1|||
125948557|NCT00603746|453108792|FG003|Overall Study|Lost to Follow-up|0|||
125948558|NCT00603746|453108793|FG004|Overall Study|Lost to Follow-up|0|||
125948559|NCT00603746|453108794|FG005|Overall Study|Lost to Follow-up|0|||
125948560|NCT00603746|453108789|FG000|Overall Study|Physician Decision|1|||
125948561|NCT00603746|453108790|FG001|Overall Study|Physician Decision|0|||
125948562|NCT00603746|453108791|FG002|Overall Study|Physician Decision|0|||
125948563|NCT00603746|453108792|FG003|Overall Study|Physician Decision|0|||
125948564|NCT00603746|453108793|FG004|Overall Study|Physician Decision|1|||
125948565|NCT00603746|453108794|FG005|Overall Study|Physician Decision|0|||
125948566|NCT00603746|453108789|FG000|Overall Study|Withdrawal by Subject|1|||
125948567|NCT00603746|453108790|FG001|Overall Study|Withdrawal by Subject|0|||
125948568|NCT00603746|453108791|FG002|Overall Study|Withdrawal by Subject|0|||
125948569|NCT00603746|453108792|FG003|Overall Study|Withdrawal by Subject|1|||
125948570|NCT00603746|453108793|FG004|Overall Study|Withdrawal by Subject|3|||
125948571|NCT00603746|453108794|FG005|Overall Study|Withdrawal by Subject|1|||
125948572|NCT01524627|453108798|FG000|Overall Study|Physician Decision|0|||
125948573|NCT01524627|453108799|FG001|Overall Study|Physician Decision|1|||
125948574|NCT01524627|453108798|FG000|Overall Study|Lost to Follow-up|1|||
125948575|NCT01524627|453108799|FG001|Overall Study|Lost to Follow-up|1|||
125948576|NCT03323658|453108800|FG000|Overall Study|Adverse Event|0|||
125948577|NCT03323658|453108801|FG001|Overall Study|Adverse Event|1|||
125948578|NCT03323658|453108802|FG002|Overall Study|Adverse Event|0|||
125948579|NCT04536727|453108808|FG000|Overall Study|Lost to Follow-up|1|||
125948580|NCT04536727|453108809|FG001|Overall Study|Lost to Follow-up|1|||
125948581|NCT04536727|453108808|FG000|Overall Study|Death|0|||
125948582|NCT04536727|453108809|FG001|Overall Study|Death|1|||
125948583|NCT02849548|453108810|FG000|Overall Study|Lost to Follow-up|1|||
125948584|NCT02849548|453108811|FG001|Overall Study|Lost to Follow-up|2|||
125948585|NCT02849548|453108810|FG000|Overall Study|Protocol Violation|1|||
125948586|NCT02849548|453108811|FG001|Overall Study|Protocol Violation|0|||
125948587|NCT02357147|453108813|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
125948588|NCT02357147|453108814|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
125948589|NCT02357147|453108813|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
125948590|NCT02357147|453108814|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
125948591|NCT02357147|453108813|FG000|Combination Treatment Phase|Investigator Discretion|1|||
125948592|NCT02357147|453108814|FG001|Combination Treatment Phase|Investigator Discretion|1|||
125948593|NCT02357147|453108813|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
125948594|NCT02357147|453108814|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
125948595|NCT02357147|453108813|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
125948596|NCT02357147|453108814|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
125948597|NCT02357147|453108813|FG000|Combination Treatment Phase|Adverse Event|12|||
125948598|NCT02357147|453108814|FG001|Combination Treatment Phase|Adverse Event|4|||
125948599|NCT02357147|453108813|FG000|Combination Treatment Phase|Death|1|||
125948600|NCT02357147|453108814|FG001|Combination Treatment Phase|Death|1|||
125948601|NCT02357147|453108813|FG000|Combination Treatment Phase|Sponsor Decision|0|||
125948602|NCT02357147|453108814|FG001|Combination Treatment Phase|Sponsor Decision|12|||
125948603|NCT02357147|453108813|FG000|Combination Treatment Phase|Other|1|||
126079467|NCT01216072|453585858|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
126114960|NCT01514136|453715807|FG000|Test Period 2; Test C*|Protocol Violation|0|||
126114961|NCT01514136|453715808|FG001|Test Period 2; Test C*|Protocol Violation|0|||
125948604|NCT02357147|453108814|FG001|Combination Treatment Phase|Other|0|||
125948605|NCT02357147|453108813|FG000|Combination Treatment Phase|Not treated|0|||
125948606|NCT02357147|453108814|FG001|Combination Treatment Phase|Not treated|2|||
125948607|NCT02357147|453108813|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
125948608|NCT02357147|453108814|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
126079468|NCT01216072|453585857|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
126079469|NCT01216072|453585858|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
125948609|NCT02357147|453108813|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125948610|NCT02357147|453108814|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
125948611|NCT02357147|453108813|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
125948612|NCT02357147|453108814|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
126114962|NCT01514136|453715809|FG002|Test Period 2; Test C*|Protocol Violation|0|||
125948613|NCT02357147|453108813|FG000|Maintenance Treatment Phase|Adverse Event|0|||
125948614|NCT02357147|453108814|FG001|Maintenance Treatment Phase|Adverse Event|3|||
125948615|NCT02357147|453108813|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
125948616|NCT02357147|453108814|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
125948617|NCT02357147|453108813|FG000|Maintenance Treatment Phase|Not Treated|1|||
125948618|NCT02357147|453108814|FG001|Maintenance Treatment Phase|Not Treated|0|||
125948619|NCT00256698|453108815|FG000|Overall Study|Withdrawal by Subject|7|||
125948620|NCT00256698|453108816|FG001|Overall Study|Withdrawal by Subject|7|||
125948621|NCT00256698|453108815|FG000|Overall Study|Adverse Event|13|||
125948622|NCT00256698|453108816|FG001|Overall Study|Adverse Event|6|||
125948623|NCT00256698|453108815|FG000|Overall Study|Protocol Violation|6|||
125948624|NCT00256698|453108816|FG001|Overall Study|Protocol Violation|5|||
125948625|NCT00256698|453108815|FG000|Overall Study|Lost to Follow-up|1|||
125948626|NCT00256698|453108816|FG001|Overall Study|Lost to Follow-up|3|||
125948627|NCT00256698|453108815|FG000|Overall Study|disease progression|97|||
125948628|NCT00256698|453108816|FG001|Overall Study|disease progression|105|||
125948629|NCT00256698|453108815|FG000|Overall Study|still ongoing at data cut-off|41|||
125948630|NCT00256698|453108816|FG001|Overall Study|still ongoing at data cut-off|46|||
125948631|NCT00256698|453108815|FG000|Overall Study|withdrawn due to osteoporosis|1|||
125948632|NCT00256698|453108816|FG001|Overall Study|withdrawn due to osteoporosis|0|||
125948633|NCT00256698|453108815|FG000|Overall Study|Prematurely Discontinued|1|||
125948634|NCT00256698|453108816|FG001|Overall Study|Prematurely Discontinued|0|||
125948635|NCT03036566|453110492|FG000|Overall Study|Lost to Follow-up|3|||
125948636|NCT01914666|453110496|FG000|Treatment Period|Lack of Efficacy|0|||
125948637|NCT01914666|453110497|FG001|Treatment Period|Lack of Efficacy|0|||
125948638|NCT01914666|453110498|FG002|Treatment Period|Lack of Efficacy|2|||
126079470|NCT01216072|453585857|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
126079471|NCT01216072|453585858|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
126079472|NCT01216072|453585857|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
126079473|NCT01216072|453585858|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
126079474|NCT01216072|453585857|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
126079475|NCT01216072|453585858|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
126079476|NCT01216072|453585857|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
126079477|NCT01216072|453585858|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
126079478|NCT01216072|453585857|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
126079479|NCT01216072|453585858|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
126079480|NCT01216072|453585857|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
126079481|NCT01216072|453585858|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
126079482|NCT01216072|453585857|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
126079483|NCT01216072|453585858|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
126079484|NCT01216072|453585857|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
126079485|NCT01216072|453585858|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
126079486|NCT01777490|453585862|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
126079487|NCT01777490|453585863|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
126079488|NCT01777490|453585864|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
126079489|NCT01777490|453585865|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
126079490|NCT00822770|453585866|FG000|Overall Study|Not treated|1|||
126079491|NCT00822770|453585867|FG001|Overall Study|Not treated|0|||
126079492|NCT00822770|453585866|FG000|Overall Study|Complication/Incomplete treatment|1|||
126079493|NCT00822770|453585867|FG001|Overall Study|Complication/Incomplete treatment|0|||
126079494|NCT00822770|453585866|FG000|Overall Study|Death|1|||
126079495|NCT00822770|453585867|FG001|Overall Study|Death|1|||
126079496|NCT02818998|453585868|FG000|Overall Study|Adverse Event|3|||
126079497|NCT02818998|453585869|FG001|Overall Study|Adverse Event|2|||
126079498|NCT02818998|453585870|FG002|Overall Study|Adverse Event|1|||
126079499|NCT02818998|453585868|FG000|Overall Study|Lost to Follow-up|4|||
126079500|NCT02818998|453585869|FG001|Overall Study|Lost to Follow-up|1|||
126079501|NCT02818998|453585870|FG002|Overall Study|Lost to Follow-up|2|||
126079502|NCT02818998|453585868|FG000|Overall Study|Withdrawal by sponsor|0|||
126079503|NCT02818998|453585869|FG001|Overall Study|Withdrawal by sponsor|1|||
126079504|NCT02818998|453585870|FG002|Overall Study|Withdrawal by sponsor|1|||
125948639|NCT01914666|453110496|FG000|Treatment Period|Adverse Event|10|||
125948640|NCT01914666|453110497|FG001|Treatment Period|Adverse Event|4|||
125948641|NCT01914666|453110498|FG002|Treatment Period|Adverse Event|2|||
125948642|NCT01914666|453110496|FG000|Treatment Period|Withdrawal by Subject|3|||
125948643|NCT01914666|453110497|FG001|Treatment Period|Withdrawal by Subject|2|||
125948644|NCT01914666|453110498|FG002|Treatment Period|Withdrawal by Subject|2|||
126079505|NCT02818998|453585868|FG000|Overall Study|Death|3|||
126079506|NCT02818998|453585869|FG001|Overall Study|Death|6|||
126079507|NCT02818998|453585870|FG002|Overall Study|Death|8|||
126079508|NCT02818998|453585868|FG000|Overall Study|Withdrawal by Subject|7|||
126079509|NCT02818998|453585869|FG001|Overall Study|Withdrawal by Subject|6|||
126079510|NCT02818998|453585870|FG002|Overall Study|Withdrawal by Subject|6|||
126079511|NCT02818998|453585868|FG000|Overall Study|Physician Decision|1|||
125948645|NCT01914666|453110496|FG000|Treatment Period|Physician Decision|0|||
125948646|NCT01914666|453110497|FG001|Treatment Period|Physician Decision|0|||
125948647|NCT01914666|453110498|FG002|Treatment Period|Physician Decision|2|||
125948648|NCT03252522|453110499|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
125948649|NCT03252522|453110500|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
125948650|NCT03252522|453110501|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
125948651|NCT03252522|453110499|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
125948652|NCT03252522|453110500|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
125948653|NCT03252522|453110501|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
125948654|NCT03252522|453110499|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
125948655|NCT03252522|453110500|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
125948656|NCT03252522|453110501|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
125948657|NCT03252522|453110499|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
125948658|NCT03252522|453110500|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
125948659|NCT03252522|453110501|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
125948660|NCT03252522|453110499|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
125948661|NCT03252522|453110500|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
125948662|NCT03252522|453110501|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
125948663|NCT03252522|453110499|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
125948664|NCT03252522|453110500|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
125948665|NCT03252522|453110501|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
125948666|NCT03252522|453110499|FG000|Phase 2: Open Label|Adverse Event|0|||
125948667|NCT03252522|453110500|FG001|Phase 2: Open Label|Adverse Event|0|||
125948668|NCT03252522|453110501|FG002|Phase 2: Open Label|Adverse Event|2|||
125948669|NCT03252522|453110499|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
125948670|NCT03252522|453110500|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
125948671|NCT03252522|453110501|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
125948672|NCT02181556|453110503|FG000|Overall Study|Withdrawal by Subject|1|||
125948673|NCT00427635|453110504|FG000|Treatment Phase|Withdrawal by Subject|1|||
125948674|NCT00427635|453110505|FG001|Treatment Phase|Withdrawal by Subject|0|||
125948675|NCT00427635|453110504|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
125948676|NCT00427635|453110505|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
125948677|NCT03277846|453110506|FG000|Overall Study|Inpatient stay too brief|12|||
125948678|NCT03277846|453110507|FG001|Overall Study|Inpatient stay too brief|11|||
125948679|NCT01572038|453110509|FG000|Overall Study|Death|648|||
125948680|NCT01572038|453110509|FG000|Overall Study|Withdrawal by Subject|204|||
125948681|NCT01572038|453110509|FG000|Overall Study|Lost to Follow-up|81|||
125948682|NCT01572038|453110509|FG000|Overall Study|Physician Decision|20|||
125948683|NCT01572038|453110509|FG000|Overall Study|Patient Decision|14|||
125948684|NCT01572038|453110509|FG000|Overall Study|Progressive Disease|8|||
125948685|NCT01572038|453110509|FG000|Overall Study|Site Closed Before Completing Form|6|||
125948686|NCT01572038|453110509|FG000|Overall Study|Enrolled into Another Trial|3|||
125948687|NCT01572038|453110509|FG000|Overall Study|Participated in Another Trial|3|||
125948688|NCT01572038|453110509|FG000|Overall Study|Termination by Sponsor|2|||
125948689|NCT01572038|453110509|FG000|Overall Study|Patient Deterioration|1|||
125948690|NCT01572038|453110509|FG000|Overall Study|Sponsor Decision|1|||
125948691|NCT00913744|453110517|FG000|Overall Study|Adverse Event|2|||
125948692|NCT00913744|453110518|FG001|Overall Study|Adverse Event|0|||
125948693|NCT00913744|453110517|FG000|Overall Study|Withdrawal by Subject|2|||
125948694|NCT00913744|453110518|FG001|Overall Study|Withdrawal by Subject|1|||
125948695|NCT00913744|453110517|FG000|Overall Study|Death|1|||
125948696|NCT00913744|453110518|FG001|Overall Study|Death|0|||
125948697|NCT00805935|453110519|FG000|Overall Study|Stimulation Failure|1|||
125948698|NCT00805935|453110520|FG001|Overall Study|Stimulation Failure|5|||
125948699|NCT00805935|453110521|FG002|Overall Study|Stimulation Failure|2|||
125948700|NCT00805935|453110522|FG003|Overall Study|Stimulation Failure|2|||
125948701|NCT00805935|453110519|FG000|Overall Study|Cycle cancelled|0|||
125948702|NCT00805935|453110520|FG001|Overall Study|Cycle cancelled|0|||
125948703|NCT00805935|453110521|FG002|Overall Study|Cycle cancelled|2|||
125948704|NCT00805935|453110522|FG003|Overall Study|Cycle cancelled|0|||
125948705|NCT00805935|453110519|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
125948706|NCT00805935|453110520|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
125948707|NCT00805935|453110521|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
125948708|NCT00805935|453110522|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
125948709|NCT00805935|453110519|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
125948710|NCT00805935|453110520|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
125948711|NCT00805935|453110521|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
125948712|NCT00805935|453110522|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
125948713|NCT00805935|453110519|FG000|Overall Study|Lost to Follow-up|1|||
126079512|NCT02818998|453585869|FG001|Overall Study|Physician Decision|0|||
126079513|NCT02818998|453585870|FG002|Overall Study|Physician Decision|0|||
125948714|NCT00805935|453110520|FG001|Overall Study|Lost to Follow-up|0|||
126079514|NCT01101061|453585871|FG000|Overall Study|Adverse Event|0|||
126079515|NCT01101061|453585872|FG001|Overall Study|Adverse Event|0|||
125948715|NCT00805935|453110521|FG002|Overall Study|Lost to Follow-up|0|||
125948716|NCT00805935|453110522|FG003|Overall Study|Lost to Follow-up|0|||
125948717|NCT00805935|453110519|FG000|Overall Study|No positive serum pregnancy|8|||
125948718|NCT00805935|453110520|FG001|Overall Study|No positive serum pregnancy|7|||
125948719|NCT00805935|453110521|FG002|Overall Study|No positive serum pregnancy|6|||
125948720|NCT00805935|453110522|FG003|Overall Study|No positive serum pregnancy|5|||
125948721|NCT00805935|453110519|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125948722|NCT00805935|453110520|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125948723|NCT00805935|453110521|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125948724|NCT00805935|453110522|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
125948725|NCT00805935|453110519|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
125948726|NCT00805935|453110520|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
125948727|NCT00805935|453110521|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
125948728|NCT00805935|453110522|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
125948729|NCT00805935|453110519|FG000|Overall Study|Biochemical pregnancy|0|||
125948730|NCT00805935|453110520|FG001|Overall Study|Biochemical pregnancy|1|||
125948731|NCT00805935|453110521|FG002|Overall Study|Biochemical pregnancy|0|||
125948732|NCT00805935|453110522|FG003|Overall Study|Biochemical pregnancy|0|||
125948733|NCT00805935|453110519|FG000|Overall Study|Chemical pregnancy|0|||
125948734|NCT00805935|453110520|FG001|Overall Study|Chemical pregnancy|5|||
125948735|NCT00805935|453110521|FG002|Overall Study|Chemical pregnancy|3|||
125948736|NCT00805935|453110522|FG003|Overall Study|Chemical pregnancy|2|||
125948737|NCT00805935|453110519|FG000|Overall Study|Ectopic pregnancy|0|||
125948738|NCT00805935|453110520|FG001|Overall Study|Ectopic pregnancy|0|||
125948739|NCT00805935|453110521|FG002|Overall Study|Ectopic pregnancy|1|||
125948740|NCT00805935|453110522|FG003|Overall Study|Ectopic pregnancy|0|||
125948741|NCT00805935|453110519|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
125948742|NCT00805935|453110520|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
125948743|NCT00805935|453110521|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
125948744|NCT00805935|453110522|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
125948745|NCT02945410|453110523|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125948746|NCT02945410|453110524|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
125948747|NCT02945410|453110525|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125948748|NCT02945410|453110526|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125948749|NCT02945410|453110527|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125948750|NCT02945410|453110528|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125948751|NCT02945410|453110523|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
125948752|NCT02945410|453110524|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
125948753|NCT02945410|453110525|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
125948754|NCT02945410|453110526|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
125948755|NCT02945410|453110527|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
125948756|NCT02945410|453110528|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
125948757|NCT02945410|453110523|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
125948758|NCT02945410|453110524|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
125948759|NCT02945410|453110525|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
125948760|NCT02945410|453110526|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
125948761|NCT02945410|453110527|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
125948762|NCT02945410|453110528|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
125948763|NCT01344369|453110529|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
125948764|NCT01344369|453110530|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
125948765|NCT01344369|453110529|FG000|Washout of 28 Days|Physician Decision|0|||
125948766|NCT01344369|453110530|FG001|Washout of 28 Days|Physician Decision|1|||
125948767|NCT01344369|453110529|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
125948768|NCT01344369|453110530|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
125948769|NCT03848845|453110531|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
125948770|NCT03848845|453110532|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
125948771|NCT03848845|453110533|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
125948772|NCT03848845|453110534|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
125948773|NCT03848845|453110531|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
125948774|NCT03848845|453110532|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
125948775|NCT03848845|453110533|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
125948776|NCT03848845|453110534|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
125948777|NCT03848845|453110531|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
125948778|NCT03848845|453110532|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
125948779|NCT03848845|453110533|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
126079516|NCT01101061|453585873|FG002|Overall Study|Adverse Event|1|||
126079517|NCT01101061|453585874|FG003|Overall Study|Adverse Event|0|||
126079518|NCT01101061|453585875|FG004|Overall Study|Adverse Event|0|||
126079519|NCT01101061|453585876|FG005|Overall Study|Adverse Event|0|||
126079520|NCT00224029|453585877|FG000|Overall Study|Lost to Follow-up|1|||
125948780|NCT03848845|453110534|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
125948781|NCT03848845|453110531|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
125948782|NCT03848845|453110532|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
125948783|NCT03848845|453110533|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
125948784|NCT03848845|453110534|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
125948785|NCT01454726|453110535|FG000|Overall Study|Withdrawal by Subject|0|||
125948786|NCT01454726|453110536|FG001|Overall Study|Withdrawal by Subject|1|||
125948787|NCT00302003|453110539|FG000|Overall Study|Lack of Efficacy|62|||
125948788|NCT00302003|453110539|FG000|Overall Study|Lost to Follow-up|1|||
125948789|NCT00302003|453110539|FG000|Overall Study|Physician Decision|2|||
125948790|NCT00302003|453110539|FG000|Overall Study|Withdrawal by Subject|5|||
125948791|NCT00302003|453110539|FG000|Overall Study|Ineligible|9|||
125948792|NCT00302003|453110539|FG000|Overall Study|Protocol Violation|1|||
125948793|NCT02042924|453110540|FG000|Overall Study|Early Death|1|||
125948794|NCT00283439|453110541|FG000|Overall Study|Adverse Event|0|||
125948795|NCT00283439|453110542|FG001|Overall Study|Adverse Event|0|||
125948796|NCT00283439|453110543|FG002|Overall Study|Adverse Event|0|||
125948797|NCT00283439|453110544|FG003|Overall Study|Adverse Event|1|||
125948798|NCT00283439|453110541|FG000|Overall Study|Death|0|||
125948799|NCT00283439|453110542|FG001|Overall Study|Death|0|||
125948800|NCT00283439|453110543|FG002|Overall Study|Death|1|||
125948801|NCT00283439|453110544|FG003|Overall Study|Death|0|||
125948802|NCT00283439|453110541|FG000|Overall Study|Disease progression|0|||
125948803|NCT00283439|453110542|FG001|Overall Study|Disease progression|1|||
125948804|NCT00283439|453110543|FG002|Overall Study|Disease progression|0|||
125948805|NCT00283439|453110544|FG003|Overall Study|Disease progression|0|||
125948806|NCT00283439|453110541|FG000|Overall Study|Requirement for alternative therapy|1|||
125948807|NCT00283439|453110542|FG001|Overall Study|Requirement for alternative therapy|2|||
125948808|NCT00283439|453110543|FG002|Overall Study|Requirement for alternative therapy|5|||
125948809|NCT00283439|453110544|FG003|Overall Study|Requirement for alternative therapy|2|||
125948810|NCT00283439|453110541|FG000|Overall Study|Stem cell transplant|6|||
125948811|NCT00283439|453110542|FG001|Overall Study|Stem cell transplant|6|||
125948812|NCT00283439|453110543|FG002|Overall Study|Stem cell transplant|4|||
125948813|NCT00283439|453110544|FG003|Overall Study|Stem cell transplant|3|||
125948814|NCT00283439|453110541|FG000|Overall Study|Treatment discontinued|0|||
125948815|NCT00283439|453110542|FG001|Overall Study|Treatment discontinued|2|||
125948816|NCT00283439|453110543|FG002|Overall Study|Treatment discontinued|1|||
125948817|NCT00283439|453110544|FG003|Overall Study|Treatment discontinued|3|||
125948818|NCT00283439|453110541|FG000|Overall Study|Other|1|||
125948819|NCT00283439|453110542|FG001|Overall Study|Other|0|||
125948820|NCT00283439|453110543|FG002|Overall Study|Other|0|||
125948821|NCT00283439|453110544|FG003|Overall Study|Other|0|||
125948822|NCT00430092|453110545|FG000|Overall Study|Adverse Event|0|||
125948823|NCT00430092|453110546|FG001|Overall Study|Adverse Event|0|||
125948824|NCT00430092|453110547|FG002|Overall Study|Adverse Event|1|||
125948825|NCT00430092|453110545|FG000|Overall Study|Lack of Efficacy|5|||
125948826|NCT00430092|453110546|FG001|Overall Study|Lack of Efficacy|2|||
125948827|NCT00430092|453110547|FG002|Overall Study|Lack of Efficacy|54|||
125948828|NCT00430092|453110545|FG000|Overall Study|Lost to Follow-up|1|||
125948829|NCT00430092|453110546|FG001|Overall Study|Lost to Follow-up|0|||
125948830|NCT00430092|453110547|FG002|Overall Study|Lost to Follow-up|0|||
125948831|NCT00430092|453110545|FG000|Overall Study|Protocol Violation|0|||
125948832|NCT00430092|453110546|FG001|Overall Study|Protocol Violation|1|||
125948833|NCT00430092|453110547|FG002|Overall Study|Protocol Violation|1|||
125948834|NCT00430092|453110545|FG000|Overall Study|Withdrawal by Subject|0|||
125948835|NCT00430092|453110546|FG001|Overall Study|Withdrawal by Subject|1|||
125948836|NCT00430092|453110547|FG002|Overall Study|Withdrawal by Subject|1|||
125948837|NCT02884089|453110549|FG000|Period 1|Dosing error|2|||
125948838|NCT02884089|453110550|FG001|Period 1|Dosing error|2|||
125948839|NCT02884089|453110551|FG002|Period 1|Dosing error|0|||
125948840|NCT02884089|453110552|FG003|Period 1|Dosing error|0|||
125948841|NCT02884089|453110549|FG000|Washout Period 1|Lost to Follow-up|0|||
125948842|NCT02884089|453110550|FG001|Washout Period 1|Lost to Follow-up|1|||
125948843|NCT02884089|453110551|FG002|Washout Period 1|Lost to Follow-up|0|||
125948844|NCT02884089|453110552|FG003|Washout Period 1|Lost to Follow-up|1|||
125948845|NCT02884089|453110549|FG000|Washout Period 1|Withdrawal by Subject|0|||
125948846|NCT02884089|453110550|FG001|Washout Period 1|Withdrawal by Subject|1|||
125948847|NCT02884089|453110551|FG002|Washout Period 1|Withdrawal by Subject|0|||
125948848|NCT02884089|453110552|FG003|Washout Period 1|Withdrawal by Subject|0|||
125948849|NCT02884089|453110549|FG000|Period 2|Adverse Event|1|||
125948850|NCT02884089|453110550|FG001|Period 2|Adverse Event|0|||
125948851|NCT02884089|453110551|FG002|Period 2|Adverse Event|0|||
125948852|NCT02884089|453110552|FG003|Period 2|Adverse Event|0|||
125948853|NCT02884089|453110549|FG000|Period 3|Withdrawal by Subject|0|||
125948854|NCT02884089|453110550|FG001|Period 3|Withdrawal by Subject|0|||
125948855|NCT02884089|453110551|FG002|Period 3|Withdrawal by Subject|1|||
125948856|NCT02884089|453110552|FG003|Period 3|Withdrawal by Subject|0|||
125948857|NCT02884089|453110549|FG000|Washout Period 3|Withdrawal by Subject|0|||
125948858|NCT02884089|453110550|FG001|Washout Period 3|Withdrawal by Subject|0|||
125948859|NCT02884089|453110551|FG002|Washout Period 3|Withdrawal by Subject|1|||
125948860|NCT02884089|453110552|FG003|Washout Period 3|Withdrawal by Subject|0|||
126114963|NCT01514136|453715810|FG003|Test Period 2; Test C*|Protocol Violation|0|||
125948861|NCT02884089|453110549|FG000|Washout Period 3|Lost to Follow-up|0|||
125948862|NCT02884089|453110550|FG001|Washout Period 3|Lost to Follow-up|0|||
125948863|NCT02884089|453110551|FG002|Washout Period 3|Lost to Follow-up|0|||
125948864|NCT02884089|453110552|FG003|Washout Period 3|Lost to Follow-up|1|||
125948865|NCT02884089|453110549|FG000|Period 4|Withdrawal by Subject|0|||
125948866|NCT02884089|453110550|FG001|Period 4|Withdrawal by Subject|1|||
125948867|NCT02884089|453110551|FG002|Period 4|Withdrawal by Subject|0|||
125948868|NCT02884089|453110552|FG003|Period 4|Withdrawal by Subject|0|||
125948869|NCT02884089|453110549|FG000|Period 4|Lost to Follow-up|1|||
125948870|NCT02884089|453110550|FG001|Period 4|Lost to Follow-up|0|||
125948871|NCT02884089|453110551|FG002|Period 4|Lost to Follow-up|0|||
125948872|NCT02884089|453110552|FG003|Period 4|Lost to Follow-up|0|||
125948873|NCT02884089|453110549|FG000|Follow-up Visit|Withdrawal by Subject|1|||
125948874|NCT02884089|453110550|FG001|Follow-up Visit|Withdrawal by Subject|0|||
125948875|NCT02884089|453110551|FG002|Follow-up Visit|Withdrawal by Subject|0|||
125948876|NCT02884089|453110552|FG003|Follow-up Visit|Withdrawal by Subject|1|||
125948877|NCT01631474|453110553|FG000|Overall Study|Lost to Follow-up|8|||
125948878|NCT01631474|453110554|FG001|Overall Study|Lost to Follow-up|5|||
125948879|NCT01631474|453110555|FG002|Overall Study|Lost to Follow-up|7|||
125948880|NCT01631474|453110556|FG003|Overall Study|Lost to Follow-up|5|||
125948881|NCT01631474|453110557|FG004|Overall Study|Lost to Follow-up|5|||
125948882|NCT01631474|453110553|FG000|Overall Study|Withdrawal by Subject|4|||
125948883|NCT01631474|453110554|FG001|Overall Study|Withdrawal by Subject|4|||
125948884|NCT01631474|453110555|FG002|Overall Study|Withdrawal by Subject|2|||
125948885|NCT01631474|453110556|FG003|Overall Study|Withdrawal by Subject|6|||
125948886|NCT01631474|453110557|FG004|Overall Study|Withdrawal by Subject|5|||
125948887|NCT01631474|453110553|FG000|Overall Study|Lack of Efficacy|2|||
125948888|NCT01631474|453110554|FG001|Overall Study|Lack of Efficacy|2|||
125948889|NCT01631474|453110555|FG002|Overall Study|Lack of Efficacy|0|||
125948890|NCT01631474|453110556|FG003|Overall Study|Lack of Efficacy|0|||
125948891|NCT01631474|453110557|FG004|Overall Study|Lack of Efficacy|2|||
125948892|NCT01631474|453110553|FG000|Overall Study|Noncompliance with Study Drug|0|||
125948893|NCT01631474|453110554|FG001|Overall Study|Noncompliance with Study Drug|0|||
125948894|NCT01631474|453110555|FG002|Overall Study|Noncompliance with Study Drug|0|||
125948895|NCT01631474|453110556|FG003|Overall Study|Noncompliance with Study Drug|0|||
125948896|NCT01631474|453110557|FG004|Overall Study|Noncompliance with Study Drug|1|||
125948897|NCT01631474|453110553|FG000|Overall Study|Adverse Event|0|||
125948898|NCT01631474|453110554|FG001|Overall Study|Adverse Event|1|||
125948899|NCT01631474|453110555|FG002|Overall Study|Adverse Event|0|||
125948900|NCT01631474|453110556|FG003|Overall Study|Adverse Event|0|||
125948901|NCT01631474|453110557|FG004|Overall Study|Adverse Event|0|||
125948902|NCT02624284|453110558|FG000|Overall Study|Withdrawal by Subject|3|||
125948903|NCT02624284|453110559|FG001|Overall Study|Withdrawal by Subject|6|||
125948904|NCT02624284|453110560|FG002|Overall Study|Withdrawal by Subject|3|||
125948905|NCT02624284|453110558|FG000|Overall Study|Protocol Violation|9|||
125948906|NCT02624284|453110559|FG001|Overall Study|Protocol Violation|10|||
125948907|NCT02624284|453110560|FG002|Overall Study|Protocol Violation|7|||
125948908|NCT02624284|453110558|FG000|Overall Study|Revealed exclusionary condition|2|||
125948909|NCT02624284|453110559|FG001|Overall Study|Revealed exclusionary condition|2|||
125948910|NCT02624284|453110560|FG002|Overall Study|Revealed exclusionary condition|0|||
125948911|NCT02624284|453110558|FG000|Overall Study|Adverse Event|0|||
125948912|NCT02624284|453110559|FG001|Overall Study|Adverse Event|0|||
125948913|NCT02624284|453110560|FG002|Overall Study|Adverse Event|1|||
125948914|NCT02487394|453110561|FG000|Phase 1|Withdrawal by Subject|0|||
125948915|NCT02487394|453110562|FG001|Phase 1|Withdrawal by Subject|1|||
125948916|NCT01641367|453110566|FG000|Cohorts|Death|18|||
125948917|NCT01641367|453110567|FG001|Cohorts|Death|1|||
125948918|NCT01641367|453110568|FG002|Cohorts|Death|2|||
125948919|NCT01641367|453110569|FG003|Cohorts|Death|0|||
125948920|NCT01641367|453110570|FG004|Cohorts|Death|1|||
125948921|NCT01641367|453110571|FG005|Cohorts|Death|1|||
126114964|NCT01514136|453715811|FG004|Test Period 2; Test C*|Protocol Violation|0|||
126114965|NCT01514136|453715812|FG005|Test Period 2; Test C*|Protocol Violation|0|||
125948922|NCT01641367|453110572|FG006|Cohorts|Death|0|||
125948923|NCT01641367|453110573|FG007|Cohorts|Death|0|||
126114966|NCT01514136|453715813|FG006|Test Period 2; Test C*|Protocol Violation|1|||
126114967|NCT01514136|453715814|FG007|Test Period 2; Test C*|Protocol Violation|0|||
126114968|NCT02941926|453715815|FG000|Core Phase|Progressive disease|1109|||
125948924|NCT01641367|453110566|FG000|Cohorts|Lost to Follow-up|16|||
125948925|NCT01641367|453110567|FG001|Cohorts|Lost to Follow-up|0|||
125948926|NCT01641367|453110568|FG002|Cohorts|Lost to Follow-up|2|||
125948927|NCT01641367|453110569|FG003|Cohorts|Lost to Follow-up|0|||
125948928|NCT01641367|453110570|FG004|Cohorts|Lost to Follow-up|2|||
125948929|NCT01641367|453110571|FG005|Cohorts|Lost to Follow-up|0|||
125948930|NCT01641367|453110572|FG006|Cohorts|Lost to Follow-up|0|||
125948931|NCT01641367|453110573|FG007|Cohorts|Lost to Follow-up|0|||
125948932|NCT01641367|453110566|FG000|Randomized Adherence Intervention|Death|0|||
125948933|NCT01641367|453110567|FG001|Randomized Adherence Intervention|Death|0|||
125948934|NCT01641367|453110568|FG002|Randomized Adherence Intervention|Death|0|||
125948935|NCT01641367|453110569|FG003|Randomized Adherence Intervention|Death|0|||
125948936|NCT01641367|453110570|FG004|Randomized Adherence Intervention|Death|0|||
125948937|NCT01641367|453110571|FG005|Randomized Adherence Intervention|Death|0|||
125948938|NCT01641367|453110572|FG006|Randomized Adherence Intervention|Death|11|||
125948939|NCT01641367|453110573|FG007|Randomized Adherence Intervention|Death|12|||
125948940|NCT01641367|453110566|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
125948941|NCT01641367|453110567|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
125948942|NCT01641367|453110568|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
125948943|NCT01641367|453110569|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
125948944|NCT01641367|453110570|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
125948945|NCT01641367|453110571|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
125948946|NCT01641367|453110572|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
125948947|NCT01641367|453110573|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
125948948|NCT01604343|453110581|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
125948949|NCT01604343|453110582|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
125948950|NCT01604343|453110583|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
125948951|NCT01604343|453110584|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
125948952|NCT01604343|453110585|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
125948953|NCT01604343|453110581|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
125948954|NCT01604343|453110582|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
125948955|NCT01604343|453110583|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
125948956|NCT01604343|453110584|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
125948957|NCT01604343|453110585|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
125948958|NCT01604343|453110581|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
125948959|NCT01604343|453110582|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
125948960|NCT01604343|453110583|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
125948961|NCT01604343|453110584|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
125948962|NCT01604343|453110585|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
125948963|NCT01604343|453110581|FG000|Prior to W52 Administration(Through W52)|Death|5|||
125948964|NCT01604343|453110582|FG001|Prior to W52 Administration(Through W52)|Death|0|||
125948965|NCT01604343|453110583|FG002|Prior to W52 Administration(Through W52)|Death|2|||
125948966|NCT01604343|453110584|FG003|Prior to W52 Administration(Through W52)|Death|0|||
125948967|NCT01604343|453110585|FG004|Prior to W52 Administration(Through W52)|Death|4|||
125948968|NCT01604343|453110581|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
125948969|NCT01604343|453110582|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
125948970|NCT01604343|453110583|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
125948971|NCT01604343|453110584|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
126079521|NCT00224029|453585877|FG000|Overall Study|Withdrawal by Subject|4|||
126079522|NCT00224029|453585877|FG000|Overall Study|Other|1|||
126079523|NCT00085566|453585885|FG000|Overall Study|Adverse Event|0|||
126079524|NCT00085566|453585886|FG001|Overall Study|Adverse Event|0|||
126079525|NCT00085566|453585887|FG002|Overall Study|Adverse Event|10|||
126079526|NCT00085566|453585885|FG000|Overall Study|Patient Not treated|0|||
126079527|NCT00085566|453585886|FG001|Overall Study|Patient Not treated|0|||
126079528|NCT00085566|453585887|FG002|Overall Study|Patient Not treated|3|||
126079529|NCT00085566|453585885|FG000|Overall Study|Clinical progression|0|||
126079530|NCT00085566|453585886|FG001|Overall Study|Clinical progression|0|||
126079531|NCT00085566|453585887|FG002|Overall Study|Clinical progression|1|||
126079532|NCT03174782|453585888|FG000|Overall Study|Protocol Violation|1|||
126079533|NCT03174782|453585889|FG001|Overall Study|Protocol Violation|0|||
126079534|NCT03174782|453585888|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
126079535|NCT03174782|453585889|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
126079536|NCT00778921|453585890|FG000|Overall Study|Adverse Event|9|||
126079537|NCT00778921|453585891|FG001|Overall Study|Adverse Event|10|||
126079538|NCT00778921|453585892|FG002|Overall Study|Adverse Event|14|||
126079539|NCT00778921|453585890|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
126079540|NCT00778921|453585891|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
126079541|NCT00778921|453585892|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
126079542|NCT00778921|453585890|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
126079543|NCT00778921|453585891|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126079544|NCT00778921|453585892|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
126079545|NCT00778921|453585890|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
126079546|NCT00778921|453585891|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
126079547|NCT00778921|453585892|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
126079548|NCT00778921|453585890|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
126079549|NCT00778921|453585891|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
126079550|NCT00778921|453585892|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
126079551|NCT00778921|453585890|FG000|Overall Study|Patient withdrew request|3|||
126079552|NCT00778921|453585891|FG001|Overall Study|Patient withdrew request|1|||
126114969|NCT02941926|453715815|FG000|Core Phase|Adverse Event|504|||
125948972|NCT01604343|453110585|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
125948973|NCT01604343|453110581|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
125948974|NCT01604343|453110582|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
125948975|NCT01604343|453110583|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
125948976|NCT01604343|453110584|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
125948977|NCT01604343|453110585|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
125948978|NCT01604343|453110581|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
126114970|NCT02941926|453715815|FG000|Core Phase|Subject/guardian decision|127|||
125948979|NCT01604343|453110582|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
125948980|NCT01604343|453110583|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
125948981|NCT01604343|453110584|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
125948982|NCT01604343|453110585|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
125948983|NCT01604343|453110581|FG000|Prior to W52 Administration(Through W52)|Other|15|||
125948984|NCT01604343|453110582|FG001|Prior to W52 Administration(Through W52)|Other|0|||
125948985|NCT01604343|453110583|FG002|Prior to W52 Administration(Through W52)|Other|10|||
125948986|NCT01604343|453110584|FG003|Prior to W52 Administration(Through W52)|Other|0|||
125948987|NCT01604343|453110585|FG004|Prior to W52 Administration(Through W52)|Other|6|||
125948988|NCT01604343|453110581|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
125948989|NCT01604343|453110582|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
125948990|NCT01604343|453110583|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
125948991|NCT01604343|453110584|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
125948992|NCT01604343|453110585|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
125948993|NCT01604343|453110581|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
125948994|NCT01604343|453110582|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
125948995|NCT01604343|453110583|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
125948996|NCT01604343|453110584|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
125948997|NCT01604343|453110585|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
125948998|NCT01604343|453110581|FG000|Week 52 to Week 104|Adverse Event|0|||
125948999|NCT01604343|453110582|FG001|Week 52 to Week 104|Adverse Event|12|||
125949000|NCT01604343|453110583|FG002|Week 52 to Week 104|Adverse Event|26|||
125949001|NCT01604343|453110584|FG003|Week 52 to Week 104|Adverse Event|21|||
125949002|NCT01604343|453110585|FG004|Week 52 to Week 104|Adverse Event|27|||
125949003|NCT01604343|453110581|FG000|Week 52 to Week 104|Death|0|||
125949004|NCT01604343|453110582|FG001|Week 52 to Week 104|Death|4|||
125949005|NCT01604343|453110583|FG002|Week 52 to Week 104|Death|2|||
126114971|NCT02941926|453715815|FG000|Core Phase|Physician Decision|112|||
126114972|NCT02941926|453715815|FG000|Core Phase|Death|46|||
126114973|NCT02941926|453715815|FG000|Core Phase|Protocol deviation|34|||
126114974|NCT02941926|453715815|FG000|Core Phase|Lost to Follow-up|8|||
126114975|NCT02941926|453715815|FG000|Core Phase|Technical problems|5|||
126114976|NCT02941926|453715815|FG000|Extension Phase|Physician Decision|155|||
126114977|NCT02941926|453715815|FG000|Extension Phase|Progressive disease|115|||
126114978|NCT02941926|453715815|FG000|Extension Phase|Adverse Event|13|||
126114979|NCT02941926|453715815|FG000|Extension Phase|Subject/Guardian decision|12|||
125949006|NCT01604343|453110584|FG003|Week 52 to Week 104|Death|5|||
125949007|NCT01604343|453110585|FG004|Week 52 to Week 104|Death|0|||
125949008|NCT01604343|453110581|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
125949009|NCT01604343|453110582|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
125949010|NCT01604343|453110583|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
125949011|NCT01604343|453110584|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
125949012|NCT01604343|453110585|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
125949013|NCT01604343|453110581|FG000|Week 52 to Week 104|Physician Decision|0|||
125949014|NCT01604343|453110582|FG001|Week 52 to Week 104|Physician Decision|1|||
125949015|NCT01604343|453110583|FG002|Week 52 to Week 104|Physician Decision|0|||
125949016|NCT01604343|453110584|FG003|Week 52 to Week 104|Physician Decision|0|||
125949017|NCT01604343|453110585|FG004|Week 52 to Week 104|Physician Decision|2|||
126079553|NCT00778921|453585892|FG002|Overall Study|Patient withdrew request|6|||
126079554|NCT00778921|453585890|FG000|Overall Study|Lost to Follow-up|0|||
126079555|NCT00778921|453585891|FG001|Overall Study|Lost to Follow-up|2|||
126079556|NCT00778921|453585892|FG002|Overall Study|Lost to Follow-up|1|||
126079557|NCT00778921|453585890|FG000|Overall Study|Administrative Problems|1|||
126079558|NCT00778921|453585891|FG001|Overall Study|Administrative Problems|2|||
126079559|NCT00778921|453585892|FG002|Overall Study|Administrative Problems|0|||
126114980|NCT02941926|453715815|FG000|Extension Phase|Death|6|||
125949018|NCT01604343|453110581|FG000|Week 52 to Week 104|Pregnancy|0|||
126114981|NCT02729740|453715816|FG000|Overall Study|Early Termination|130|||
125949019|NCT01604343|453110582|FG001|Week 52 to Week 104|Pregnancy|0|||
125949020|NCT01604343|453110583|FG002|Week 52 to Week 104|Pregnancy|1|||
125949021|NCT01604343|453110584|FG003|Week 52 to Week 104|Pregnancy|2|||
125949022|NCT01604343|453110585|FG004|Week 52 to Week 104|Pregnancy|1|||
126079560|NCT00778921|453585890|FG000|Overall Study|Protocol Violation|3|||
126079561|NCT00778921|453585891|FG001|Overall Study|Protocol Violation|0|||
126079562|NCT00778921|453585892|FG002|Overall Study|Protocol Violation|2|||
126079563|NCT00778921|453585890|FG000|Overall Study|Not treated|0|||
126114982|NCT02729740|453715816|FG000|Overall Study|Other|1|||
126114983|NCT00601705|453715820|FG000|Overall Study|Withdrawal by Subject|1|||
125949023|NCT01604343|453110581|FG000|Week 52 to Week 104|Other|0|||
125949024|NCT01604343|453110582|FG001|Week 52 to Week 104|Other|11|||
125949025|NCT01604343|453110583|FG002|Week 52 to Week 104|Other|11|||
125949026|NCT01604343|453110584|FG003|Week 52 to Week 104|Other|6|||
125949027|NCT01604343|453110585|FG004|Week 52 to Week 104|Other|3|||
125949028|NCT01604343|453110581|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
125949029|NCT01604343|453110582|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
125949030|NCT01604343|453110583|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
125949031|NCT01604343|453110584|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
125949032|NCT01604343|453110585|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
125949033|NCT01604343|453110581|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
125949034|NCT01604343|453110582|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
125949035|NCT01604343|453110583|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
125949036|NCT01604343|453110584|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
125949037|NCT01604343|453110585|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
125949038|NCT01604343|453110581|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
125949039|NCT01604343|453110582|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
125949040|NCT01604343|453110583|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
125949041|NCT01604343|453110584|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
125949042|NCT01604343|453110585|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
125949043|NCT00850200|453110589|FG000|Overall Study|Physician Decision|2|||
125949044|NCT00850200|453110589|FG000|Overall Study|Did not recieve treatment|2|||
125949045|NCT00850200|453110589|FG000|Overall Study|Withdrawal by Subject|1|||
125949046|NCT02711800|453110590|FG000|Overall Study|Lost to Follow-up|1|||
125949047|NCT02711800|453110590|FG000|Overall Study|Withdrawal by Subject|1|||
125949048|NCT05040152|453110593|FG000|Overall Study|Withdrawal by Subject|5|||
125949049|NCT05040152|453110594|FG001|Overall Study|Withdrawal by Subject|0|||
125949050|NCT05040152|453110593|FG000|Overall Study|Lost to Follow-up|0|||
125949051|NCT05040152|453110594|FG001|Overall Study|Lost to Follow-up|2|||
125949052|NCT00314574|453110602|FG000|Overall Study|Death|3|||
125949053|NCT00314574|453110603|FG001|Overall Study|Death|0|||
125949054|NCT00314574|453110602|FG000|Overall Study|Adverse Event|11|||
125949055|NCT00314574|453110603|FG001|Overall Study|Adverse Event|16|||
125949056|NCT00314574|453110602|FG000|Overall Study|Lost to Follow-up|19|||
125949057|NCT00314574|453110603|FG001|Overall Study|Lost to Follow-up|25|||
125949058|NCT00314574|453110602|FG000|Overall Study|Withdrawal by Subject|33|||
125949059|NCT00314574|453110603|FG001|Overall Study|Withdrawal by Subject|22|||
125949060|NCT00314574|453110602|FG000|Overall Study|Physician Decision|22|||
125949061|NCT00314574|453110603|FG001|Overall Study|Physician Decision|15|||
125949062|NCT00314574|453110602|FG000|Overall Study|Pregnancy|6|||
125949063|NCT00314574|453110603|FG001|Overall Study|Pregnancy|4|||
125949064|NCT00314574|453110602|FG000|Overall Study|Data unknown at database lock|0|||
125949065|NCT00314574|453110603|FG001|Overall Study|Data unknown at database lock|1|||
125949066|NCT00449956|453110604|FG000|Overall Study|Adverse Event|7|||
125949067|NCT00449956|453110605|FG001|Overall Study|Adverse Event|1|||
125949068|NCT00449956|453110606|FG002|Overall Study|Adverse Event|6|||
125949069|NCT00449956|453110604|FG000|Overall Study|Lack of Efficacy|0|||
125949070|NCT00449956|453110605|FG001|Overall Study|Lack of Efficacy|0|||
125949071|NCT00449956|453110606|FG002|Overall Study|Lack of Efficacy|1|||
125949072|NCT00449956|453110604|FG000|Overall Study|Protocol Violation|1|||
125949073|NCT00449956|453110605|FG001|Overall Study|Protocol Violation|1|||
125949074|NCT00449956|453110606|FG002|Overall Study|Protocol Violation|1|||
125949075|NCT00449956|453110604|FG000|Overall Study|Withdrawal by Subject|0|||
125949076|NCT00449956|453110605|FG001|Overall Study|Withdrawal by Subject|1|||
125949077|NCT00449956|453110606|FG002|Overall Study|Withdrawal by Subject|0|||
125949078|NCT00449956|453110604|FG000|Overall Study|Physician Decision|2|||
125949079|NCT00449956|453110605|FG001|Overall Study|Physician Decision|1|||
125949080|NCT00449956|453110606|FG002|Overall Study|Physician Decision|1|||
125949081|NCT01828034|453110609|FG000|Overall Study|Withdrawal by Subject|0|||
125949082|NCT01828034|453110610|FG001|Overall Study|Withdrawal by Subject|0|||
125949083|NCT01828034|453110611|FG002|Overall Study|Withdrawal by Subject|0|||
125949084|NCT01828034|453110612|FG003|Overall Study|Withdrawal by Subject|1|||
125949085|NCT01988571|453110613|FG000|Overall Study|Death|3|||
125949086|NCT01988571|453110614|FG001|Overall Study|Death|1|||
125949087|NCT01988571|453110613|FG000|Overall Study|Physician Decision|2|||
125949088|NCT01988571|453110614|FG001|Overall Study|Physician Decision|1|||
125949089|NCT01988571|453110613|FG000|Overall Study|Lost to Follow-up|3|||
125949090|NCT01988571|453110614|FG001|Overall Study|Lost to Follow-up|0|||
125949091|NCT01988571|453110613|FG000|Overall Study|Withdrawal by Subject|31|||
125949092|NCT01988571|453110614|FG001|Overall Study|Withdrawal by Subject|33|||
125949093|NCT00004412|453110615|FG000|Randomized Period|Moved to Crossover Period|3|||
125949094|NCT00004412|453110616|FG001|Randomized Period|Moved to Crossover Period|0|||
125949095|NCT00004412|453110617|FG002|Randomized Period|Moved to Crossover Period|0|||
125949096|NCT02346136|453110619|FG000|Overall Study|Withdrawal by Subject|7|||
125949097|NCT02346136|453110620|FG001|Overall Study|Withdrawal by Subject|5|||
125949098|NCT02346136|453110619|FG000|Overall Study|Death|1|||
125949099|NCT02346136|453110620|FG001|Overall Study|Death|0|||
125949100|NCT02346136|453110619|FG000|Overall Study|Study termination|14|||
125949101|NCT02346136|453110620|FG001|Overall Study|Study termination|18|||
125949102|NCT02308735|453110623|FG000|Overall Study|Physician Decision|2|||
125949103|NCT02308735|453110624|FG001|Overall Study|Physician Decision|0|||
125949104|NCT02308735|453110625|FG002|Overall Study|Physician Decision|0|||
125949105|NCT02308735|453110626|FG003|Overall Study|Physician Decision|2|||
125949106|NCT00453999|453110627|FG000|Overall Study|Adverse Event|1|||
125949107|NCT00453999|453110628|FG001|Overall Study|Adverse Event|2|||
125949108|NCT00453999|453110629|FG002|Overall Study|Adverse Event|1|||
125949109|NCT00453999|453110627|FG000|Overall Study|Lost to Follow-up|0|||
125949110|NCT00453999|453110628|FG001|Overall Study|Lost to Follow-up|1|||
125949111|NCT00453999|453110629|FG002|Overall Study|Lost to Follow-up|1|||
125949112|NCT00453999|453110627|FG000|Overall Study|Withdrawal by Subject|2|||
125949113|NCT00453999|453110628|FG001|Overall Study|Withdrawal by Subject|1|||
125949114|NCT00453999|453110629|FG002|Overall Study|Withdrawal by Subject|1|||
125949115|NCT00453999|453110627|FG000|Overall Study|Subject Request|2|||
125949116|NCT00453999|453110628|FG001|Overall Study|Subject Request|1|||
125949117|NCT00453999|453110629|FG002|Overall Study|Subject Request|0|||
125949118|NCT00696137|453110637|FG000|Overall Study|Withdrawal by Subject|2|||
125949119|NCT03742141|453110648|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
125949120|NCT00850395|453110649|FG000|Overall Study|Death|1|||
125949121|NCT00850395|453110649|FG000|Overall Study|Adverse Event|1|||
125949122|NCT00850395|453110649|FG000|Overall Study|Insufficient clinical response|3|||
125949123|NCT00850395|453110649|FG000|Overall Study|Other|5|||
125949124|NCT02376166|453110650|FG000|Overall Study|Adverse Event|1|||
125949125|NCT02376166|453110650|FG000|Overall Study|Discontinued metformin early|2|||
125949126|NCT04180020|453110651|FG000|Overall Study|missed visit|18|||
125949127|NCT04180020|453110652|FG001|Overall Study|missed visit|16|||
125949128|NCT04180020|453110651|FG000|Overall Study|Death|2|||
125949129|NCT04180020|453110652|FG001|Overall Study|Death|3|||
125949130|NCT04180020|453110651|FG000|Overall Study|Withdrawal by Subject|1|||
125949131|NCT04180020|453110652|FG001|Overall Study|Withdrawal by Subject|5|||
125949132|NCT04180020|453110651|FG000|Overall Study|incarcerated|1|||
125949133|NCT04180020|453110652|FG001|Overall Study|incarcerated|1|||
125949134|NCT04180020|453110651|FG000|Overall Study|Physician Decision|0|||
125949135|NCT04180020|453110652|FG001|Overall Study|Physician Decision|2|||
125949136|NCT02917031|453110658|FG000|Overall Study|Reason not specified|7|||
125949137|NCT02917031|453110659|FG001|Overall Study|Reason not specified|5|||
125949138|NCT02917031|453110660|FG002|Overall Study|Reason not specified|6|||
125949139|NCT02917031|453110658|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
125949140|NCT02917031|453110659|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
125949141|NCT02917031|453110660|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
125949142|NCT02917031|453110658|FG000|Overall Study|Withdrawal by Subject|3|||
125949143|NCT02917031|453110659|FG001|Overall Study|Withdrawal by Subject|3|||
125949144|NCT02917031|453110660|FG002|Overall Study|Withdrawal by Subject|0|||
125949145|NCT02917031|453110658|FG000|Overall Study|Physician Decision|1|||
125949146|NCT02917031|453110659|FG001|Overall Study|Physician Decision|0|||
125949147|NCT02917031|453110660|FG002|Overall Study|Physician Decision|0|||
125949148|NCT02917031|453110658|FG000|Overall Study|Adverse Event|4|||
125949149|NCT02917031|453110659|FG001|Overall Study|Adverse Event|1|||
125949150|NCT02917031|453110660|FG002|Overall Study|Adverse Event|5|||
125949151|NCT02917031|453110658|FG000|Overall Study|Death|2|||
125949152|NCT02917031|453110659|FG001|Overall Study|Death|3|||
125949153|NCT02917031|453110660|FG002|Overall Study|Death|4|||
125949154|NCT00403273|453112319|FG000|Overall Study|Lost to Follow-up|3|||
125949155|NCT00403273|453112320|FG001|Overall Study|Lost to Follow-up|2|||
125949156|NCT00403273|453112319|FG000|Overall Study|Physician Decision|0|||
125949157|NCT00403273|453112320|FG001|Overall Study|Physician Decision|1|||
125949158|NCT00403273|453112319|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
125949159|NCT00403273|453112320|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
125949160|NCT01852292|453112329|FG000|Overall Study|Untreated - did not receive study drug|3|||
125949161|NCT01852292|453112330|FG001|Overall Study|Untreated - did not receive study drug|1|||
125949162|NCT01852292|453112329|FG000|Overall Study|Death|9|||
125949163|NCT01852292|453112330|FG001|Overall Study|Death|8|||
125949164|NCT01852292|453112329|FG000|Overall Study|Patient/guardian decision|8|||
125949165|NCT01852292|453112330|FG001|Overall Study|Patient/guardian decision|4|||
125949166|NCT01852292|453112329|FG000|Overall Study|Adverse Event|8|||
125949167|NCT01852292|453112330|FG001|Overall Study|Adverse Event|11|||
125949168|NCT01852292|453112329|FG000|Overall Study|Physician Decision|6|||
125949169|NCT01852292|453112330|FG001|Overall Study|Physician Decision|2|||
125949170|NCT01852292|453112329|FG000|Overall Study|Protocol Violation|2|||
125949171|NCT01852292|453112330|FG001|Overall Study|Protocol Violation|0|||
125949172|NCT01852292|453112329|FG000|Overall Study|Non-compliance with study treatment|1|||
125949173|NCT01852292|453112330|FG001|Overall Study|Non-compliance with study treatment|0|||
125949174|NCT01852292|453112329|FG000|Overall Study|Study terminated by Sponsor|0|||
125949175|NCT01852292|453112330|FG001|Overall Study|Study terminated by Sponsor|1|||
125949176|NCT01852292|453112329|FG000|Overall Study|Progressive disease|42|||
125949177|NCT01852292|453112330|FG001|Overall Study|Progressive disease|52|||
125949178|NCT02586012|453112331|FG000|Overall Study|Withdrawal by Subject|1|||
125949179|NCT02586012|453112332|FG001|Overall Study|Withdrawal by Subject|1|||
125949180|NCT02586012|453112333|FG002|Overall Study|Withdrawal by Subject|0|||
125949181|NCT02586012|453112334|FG003|Overall Study|Withdrawal by Subject|1|||
125949182|NCT02586012|453112335|FG004|Overall Study|Withdrawal by Subject|0|||
125949183|NCT02586012|453112336|FG005|Overall Study|Withdrawal by Subject|2|||
125949184|NCT02586012|453112331|FG000|Overall Study|Protocol Violation|0|||
125949185|NCT02586012|453112332|FG001|Overall Study|Protocol Violation|0|||
125949186|NCT02586012|453112333|FG002|Overall Study|Protocol Violation|0|||
125949187|NCT02586012|453112334|FG003|Overall Study|Protocol Violation|0|||
125949188|NCT02586012|453112335|FG004|Overall Study|Protocol Violation|0|||
125949189|NCT02586012|453112336|FG005|Overall Study|Protocol Violation|1|||
125949190|NCT02586012|453112331|FG000|Overall Study|study terminated|0|||
125949191|NCT02586012|453112332|FG001|Overall Study|study terminated|2|||
125949192|NCT02586012|453112333|FG002|Overall Study|study terminated|1|||
125949193|NCT02586012|453112334|FG003|Overall Study|study terminated|1|||
125949194|NCT02586012|453112335|FG004|Overall Study|study terminated|1|||
125949195|NCT02586012|453112336|FG005|Overall Study|study terminated|0|||
125949196|NCT02388737|453112338|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
125949197|NCT02388737|453112339|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
125949198|NCT02388737|453112340|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
125949199|NCT02388737|453112338|FG000|Overall Study|Major Protocol Deviation|18|||
125949200|NCT02388737|453112339|FG001|Overall Study|Major Protocol Deviation|25|||
125949201|NCT02388737|453112340|FG002|Overall Study|Major Protocol Deviation|22|||
125949202|NCT02388737|453112338|FG000|Overall Study|Lost to Follow-up|5|||
125949203|NCT02388737|453112339|FG001|Overall Study|Lost to Follow-up|1|||
125949204|NCT02388737|453112340|FG002|Overall Study|Lost to Follow-up|4|||
125949205|NCT02388737|453112338|FG000|Overall Study|Voluntary Withdrawal|10|||
125949206|NCT02388737|453112339|FG001|Overall Study|Voluntary Withdrawal|18|||
125949207|NCT02388737|453112340|FG002|Overall Study|Voluntary Withdrawal|17|||
125949208|NCT02388737|453112338|FG000|Overall Study|Lack of Efficacy|3|||
125949209|NCT02388737|453112339|FG001|Overall Study|Lack of Efficacy|0|||
125949210|NCT02388737|453112340|FG002|Overall Study|Lack of Efficacy|3|||
125949211|NCT02388737|453112338|FG000|Overall Study|Reason Not Specified|5|||
125949212|NCT02388737|453112339|FG001|Overall Study|Reason Not Specified|5|||
125949213|NCT02388737|453112340|FG002|Overall Study|Reason Not Specified|4|||
125949214|NCT03299842|453112341|FG000|Overall Study|Caregiver withdrew consent|2|||
125949215|NCT03299842|453112341|FG000|Overall Study|Child would not keep the watch on|3|||
125949216|NCT01816139|453112344|FG000|Overall Study|Adverse Event|6|||
125949217|NCT01816139|453112345|FG001|Overall Study|Adverse Event|8|||
125949218|NCT01816139|453112344|FG000|Overall Study|Lack of Efficacy|1|||
125949219|NCT01816139|453112345|FG001|Overall Study|Lack of Efficacy|2|||
125949220|NCT01816139|453112344|FG000|Overall Study|Lost to Follow-up|5|||
125949221|NCT01816139|453112345|FG001|Overall Study|Lost to Follow-up|3|||
125949222|NCT01816139|453112344|FG000|Overall Study|Withdrew Consent|6|||
125949223|NCT01816139|453112345|FG001|Overall Study|Withdrew Consent|4|||
125949224|NCT01816139|453112344|FG000|Overall Study|Protocol Violation|6|||
125949225|NCT01816139|453112345|FG001|Overall Study|Protocol Violation|3|||
125949226|NCT01816139|453112344|FG000|Overall Study|Reason not Specified|4|||
125949227|NCT01816139|453112345|FG001|Overall Study|Reason not Specified|2|||
125949228|NCT03240575|453112346|FG000|Overall Study|Adverse Event|0|||
125949229|NCT03240575|453112347|FG001|Overall Study|Adverse Event|2|||
125949230|NCT03240575|453112348|FG002|Overall Study|Adverse Event|0|||
125949231|NCT03240575|453112349|FG003|Overall Study|Adverse Event|1|||
125949232|NCT03240575|453112346|FG000|Overall Study|Withdrawal by Subject|2|||
125949233|NCT03240575|453112347|FG001|Overall Study|Withdrawal by Subject|11|||
125949234|NCT03240575|453112348|FG002|Overall Study|Withdrawal by Subject|0|||
125949235|NCT03240575|453112349|FG003|Overall Study|Withdrawal by Subject|1|||
125949236|NCT03240575|453112346|FG000|Overall Study|Other|0|||
125949237|NCT03240575|453112347|FG001|Overall Study|Other|1|||
125949238|NCT03240575|453112348|FG002|Overall Study|Other|0|||
125949239|NCT03240575|453112349|FG003|Overall Study|Other|0|||
125949240|NCT02342704|453112352|FG000|Overall Study|Physician Decision|0|||
125949241|NCT02342704|453112353|FG001|Overall Study|Physician Decision|3|||
125949242|NCT02342704|453112352|FG000|Overall Study|Sponsor Termination|49|||
125949243|NCT02342704|453112353|FG001|Overall Study|Sponsor Termination|43|||
125949244|NCT02342704|453112352|FG000|Overall Study|Other|0|||
125949245|NCT02342704|453112353|FG001|Overall Study|Other|1|||
125949246|NCT02342704|453112352|FG000|Overall Study|Withdrawal by Subject|1|||
125949247|NCT02342704|453112353|FG001|Overall Study|Withdrawal by Subject|0|||
125949248|NCT02342704|453112352|FG000|Overall Study|Lost to Follow-up|2|||
125949249|NCT02342704|453112353|FG001|Overall Study|Lost to Follow-up|1|||
125949250|NCT02342704|453112352|FG000|Overall Study|Adverse Event|1|||
125949251|NCT02342704|453112353|FG001|Overall Study|Adverse Event|3|||
125949252|NCT02347527|453112354|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
125949253|NCT02347527|453112355|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
125949254|NCT02347527|453112356|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
125949255|NCT02347527|453112357|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
125949256|NCT02347527|453112354|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
125949257|NCT02347527|453112355|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
125949258|NCT02347527|453112356|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
125949259|NCT02347527|453112357|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
125949260|NCT02347527|453112354|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
125949261|NCT02347527|453112355|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
125949262|NCT02347527|453112356|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
126079564|NCT00778921|453585891|FG001|Overall Study|Not treated|2|||
126079565|NCT00778921|453585892|FG002|Overall Study|Not treated|2|||
126079566|NCT03178045|453585893|FG000|Overall Study|Withdrawal by Subject|5|||
126079567|NCT03178045|453585894|FG001|Overall Study|Withdrawal by Subject|7|||
126079568|NCT03178045|453585893|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
126079569|NCT03178045|453585894|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
126079570|NCT03178045|453585893|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
126079571|NCT03178045|453585894|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
126079572|NCT01078922|453585895|FG000|Overall Study|Adverse Event|1|||
126079573|NCT02706847|453585896|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
126079574|NCT02706847|453585897|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
126079575|NCT02706847|453585898|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
126079576|NCT02706847|453585899|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
126079577|NCT02706847|453585896|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
126079578|NCT02706847|453585897|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
126079579|NCT02706847|453585898|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
126079580|NCT02706847|453585899|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
126079581|NCT02706847|453585896|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
126079582|NCT02706847|453585897|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
126114984|NCT03044249|453715821|FG000|Overall Study|Adverse Event|4|||
126114985|NCT03044249|453715822|FG001|Overall Study|Adverse Event|9|||
125949263|NCT02347527|453112357|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
125949264|NCT02347527|453112354|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
125949265|NCT02347527|453112355|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
125949266|NCT02347527|453112356|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
125949267|NCT02347527|453112357|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
125949268|NCT02347527|453112354|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
125949269|NCT02347527|453112355|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
125949270|NCT02347527|453112356|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
125949271|NCT02347527|453112357|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
125949272|NCT01632891|453112359|FG000|Overall Study|Lost to Follow-up|0|||
125949273|NCT01632891|453112360|FG001|Overall Study|Lost to Follow-up|1|||
125949274|NCT01632891|453112359|FG000|Overall Study|Withdrawal by Subject|1|||
125949275|NCT01632891|453112360|FG001|Overall Study|Withdrawal by Subject|0|||
125949276|NCT02919670|453112361|FG000|Overall Study|Only 17 participants met compliance|43|||
125949277|NCT02919670|453112362|FG001|Overall Study|Only 17 participants met compliance|39|||
125949278|NCT01466270|453112363|FG000|Overall Study|Withdrawal by Subject|4|||
125949279|NCT01466270|453112364|FG001|Overall Study|Withdrawal by Subject|1|||
125949280|NCT01466270|453112363|FG000|Overall Study|Physician Decision|1|||
125949281|NCT01466270|453112364|FG001|Overall Study|Physician Decision|0|||
125949282|NCT01466270|453112363|FG000|Overall Study|Lost to Follow-up|1|||
125949283|NCT01466270|453112364|FG001|Overall Study|Lost to Follow-up|3|||
125949284|NCT01466270|453112363|FG000|Overall Study|Progression|1|||
125949285|NCT01466270|453112364|FG001|Overall Study|Progression|0|||
125949286|NCT01466270|453112363|FG000|Overall Study|Toxicity|4|||
125949287|NCT01466270|453112364|FG001|Overall Study|Toxicity|1|||
125949288|NCT01466270|453112363|FG000|Overall Study|Multiple|1|||
125949289|NCT01466270|453112364|FG001|Overall Study|Multiple|1|||
125949290|NCT01454934|453112371|FG000|Overall Study|Clinical progression|28|||
125949291|NCT01454934|453112372|FG001|Overall Study|Clinical progression|25|||
125949292|NCT01454934|453112371|FG000|Overall Study|Other|6|||
125949293|NCT01454934|453112372|FG001|Overall Study|Other|17|||
125949294|NCT01454934|453112371|FG000|Overall Study|Adverse Event|28|||
126079583|NCT02706847|453585898|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
126079584|NCT02706847|453585899|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
126079585|NCT02706847|453585896|FG000|Period 1: Day 1 to Week 12|Other|4|||
126079586|NCT02706847|453585897|FG001|Period 1: Day 1 to Week 12|Other|4|||
125949295|NCT01454934|453112372|FG001|Overall Study|Adverse Event|24|||
125949296|NCT01454934|453112371|FG000|Overall Study|Withdrawn consent|2|||
125949297|NCT01454934|453112372|FG001|Overall Study|Withdrawn consent|5|||
125949298|NCT01454934|453112371|FG000|Overall Study|Withdrawal by Subject|11|||
126079587|NCT02706847|453585898|FG002|Period 1: Day 1 to Week 12|Other|2|||
126079588|NCT02706847|453585899|FG003|Period 1: Day 1 to Week 12|Other|2|||
125949299|NCT01454934|453112372|FG001|Overall Study|Withdrawal by Subject|15|||
125949300|NCT01454934|453112371|FG000|Overall Study|Disease progression|194|||
125949301|NCT01454934|453112372|FG001|Overall Study|Disease progression|181|||
125949302|NCT01454934|453112371|FG000|Overall Study|Lost to Follow-up|0|||
125949303|NCT01454934|453112372|FG001|Overall Study|Lost to Follow-up|1|||
125949304|NCT01454934|453112371|FG000|Overall Study|Not treated|1|||
125949305|NCT01454934|453112372|FG001|Overall Study|Not treated|2|||
125949306|NCT02118428|453112373|FG000|Overall Study|Physician Decision|0|||
125949307|NCT02118428|453112374|FG001|Overall Study|Physician Decision|1|||
125949308|NCT02118428|453112375|FG002|Overall Study|Physician Decision|0|||
125949309|NCT02118428|453112373|FG000|Overall Study|Withdrawal by Subject|2|||
125949310|NCT02118428|453112374|FG001|Overall Study|Withdrawal by Subject|2|||
125949311|NCT02118428|453112375|FG002|Overall Study|Withdrawal by Subject|0|||
125949312|NCT02118428|453112373|FG000|Overall Study|Death|7|||
125949313|NCT02118428|453112374|FG001|Overall Study|Death|5|||
125949314|NCT02118428|453112375|FG002|Overall Study|Death|0|||
125949315|NCT02118428|453112373|FG000|Overall Study|Lost to Follow-up|3|||
125949316|NCT02118428|453112374|FG001|Overall Study|Lost to Follow-up|1|||
125949317|NCT02118428|453112375|FG002|Overall Study|Lost to Follow-up|0|||
125949318|NCT02118428|453112373|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
125949319|NCT02118428|453112374|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
125949320|NCT02118428|453112375|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
125949321|NCT04171414|453112379|FG000|Overall Study|Death|1|||
125949322|NCT04171414|453112379|FG000|Overall Study|Withdrawal by Subject|1|||
125949323|NCT03100825|453112391|FG000|Overall Study|Participant/Guardian Decision|7|||
125949324|NCT03100825|453112391|FG000|Overall Study|Physician Decision|1|||
125949325|NCT00826267|453112392|FG000|Overall Study|Other Adverse Event|1|||
125949326|NCT00826267|453112393|FG001|Overall Study|Other Adverse Event|0|||
125949327|NCT00826267|453112394|FG002|Overall Study|Other Adverse Event|0|||
125949328|NCT02586493|453112403|FG000|Overall Study|Adverse Event|4|||
125949329|NCT02586493|453112403|FG000|Overall Study|Protocol Violation|6|||
125949330|NCT02586493|453112403|FG000|Overall Study|Lost to Follow-up|1|||
125949331|NCT02586493|453112403|FG000|Overall Study|Withdrawal by Subject|1|||
125949332|NCT01675882|453112414|FG000|Overall Study|Adverse Event|0|||
125949333|NCT01675882|453112415|FG001|Overall Study|Adverse Event|2|||
125949334|NCT01675882|453112416|FG002|Overall Study|Adverse Event|1|||
125949335|NCT01675882|453112417|FG003|Overall Study|Adverse Event|0|||
125949336|NCT01675882|453112414|FG000|Overall Study|Participant unwilling to continue|2|||
125949337|NCT01675882|453112415|FG001|Overall Study|Participant unwilling to continue|4|||
125949338|NCT01675882|453112416|FG002|Overall Study|Participant unwilling to continue|2|||
125949339|NCT01675882|453112417|FG003|Overall Study|Participant unwilling to continue|1|||
125949340|NCT01675882|453112414|FG000|Overall Study|Lost to Follow-up|0|||
125949341|NCT01675882|453112415|FG001|Overall Study|Lost to Follow-up|1|||
125949342|NCT01675882|453112416|FG002|Overall Study|Lost to Follow-up|0|||
125949343|NCT01675882|453112417|FG003|Overall Study|Lost to Follow-up|0|||
125949344|NCT01675882|453112414|FG000|Overall Study|Non-compliance|0|||
125949345|NCT01675882|453112415|FG001|Overall Study|Non-compliance|0|||
125949346|NCT01675882|453112416|FG002|Overall Study|Non-compliance|0|||
125949347|NCT01675882|453112417|FG003|Overall Study|Non-compliance|1|||
125949348|NCT00735371|453112418|FG000|Overall Study|Adverse Event|3|||
125949349|NCT00735371|453112419|FG001|Overall Study|Adverse Event|3|||
125949350|NCT00735371|453112420|FG002|Overall Study|Adverse Event|4|||
125949351|NCT00735371|453112421|FG003|Overall Study|Adverse Event|1|||
125949352|NCT00735371|453112418|FG000|Overall Study|Protocol Violation|2|||
125949353|NCT00735371|453112419|FG001|Overall Study|Protocol Violation|2|||
125949354|NCT00735371|453112420|FG002|Overall Study|Protocol Violation|0|||
125949355|NCT00735371|453112421|FG003|Overall Study|Protocol Violation|3|||
125949356|NCT00735371|453112418|FG000|Overall Study|Withdrawal by Subject|0|||
125949357|NCT00735371|453112419|FG001|Overall Study|Withdrawal by Subject|2|||
125949358|NCT00735371|453112420|FG002|Overall Study|Withdrawal by Subject|2|||
125949359|NCT00735371|453112421|FG003|Overall Study|Withdrawal by Subject|0|||
125949360|NCT00735371|453112418|FG000|Overall Study|Lost to Follow-up|1|||
125949361|NCT00735371|453112419|FG001|Overall Study|Lost to Follow-up|1|||
125949362|NCT00735371|453112420|FG002|Overall Study|Lost to Follow-up|3|||
125949363|NCT00735371|453112421|FG003|Overall Study|Lost to Follow-up|1|||
125949364|NCT00735371|453112418|FG000|Overall Study|Lack of Efficacy|4|||
125949365|NCT00735371|453112419|FG001|Overall Study|Lack of Efficacy|2|||
125949366|NCT00735371|453112420|FG002|Overall Study|Lack of Efficacy|0|||
125949367|NCT00735371|453112421|FG003|Overall Study|Lack of Efficacy|4|||
125949368|NCT00735371|453112418|FG000|Overall Study|Sponsor Decision|3|||
125949369|NCT00735371|453112419|FG001|Overall Study|Sponsor Decision|1|||
125949370|NCT00735371|453112420|FG002|Overall Study|Sponsor Decision|0|||
125949371|NCT00735371|453112421|FG003|Overall Study|Sponsor Decision|1|||
125949372|NCT00735371|453112418|FG000|Overall Study|Protocol Violation|0|||
125949373|NCT00735371|453112419|FG001|Overall Study|Protocol Violation|1|||
125949374|NCT00735371|453112420|FG002|Overall Study|Protocol Violation|2|||
125949375|NCT00735371|453112421|FG003|Overall Study|Protocol Violation|0|||
125949376|NCT00735371|453112418|FG000|Overall Study|Prior Vyvanse Exposure|1|||
125949377|NCT00735371|453112419|FG001|Overall Study|Prior Vyvanse Exposure|1|||
125949378|NCT00735371|453112420|FG002|Overall Study|Prior Vyvanse Exposure|0|||
125949379|NCT00735371|453112421|FG003|Overall Study|Prior Vyvanse Exposure|0|||
125949380|NCT00735371|453112418|FG000|Overall Study|Exclusion criteria|1|||
125949381|NCT00735371|453112419|FG001|Overall Study|Exclusion criteria|0|||
125949382|NCT00735371|453112420|FG002|Overall Study|Exclusion criteria|0|||
125949383|NCT00735371|453112421|FG003|Overall Study|Exclusion criteria|0|||
125949384|NCT00994448|453112422|FG000|Overall Study|Adverse Event|1|||
125949385|NCT00994448|453112423|FG001|Overall Study|Adverse Event|0|||
125949386|NCT00994448|453112422|FG000|Overall Study|Lost to Follow-up|5|||
125949387|NCT00994448|453112423|FG001|Overall Study|Lost to Follow-up|1|||
125949388|NCT00994448|453112422|FG000|Overall Study|Withdrawal by Subject|1|||
125949389|NCT00994448|453112423|FG001|Overall Study|Withdrawal by Subject|1|||
125949390|NCT00994448|453112422|FG000|Overall Study|Physician Decision|1|||
125949391|NCT00994448|453112423|FG001|Overall Study|Physician Decision|0|||
125949392|NCT00436748|453112426|FG000|Overall Study|Ineligibility Determined|1|||
125949393|NCT00436748|453112427|FG001|Overall Study|Ineligibility Determined|1|||
125949394|NCT00436748|453112426|FG000|Overall Study|Adverse Event|0|||
125949395|NCT00436748|453112427|FG001|Overall Study|Adverse Event|2|||
125949396|NCT00436748|453112426|FG000|Overall Study|Consent Withdrawn|1|||
125949397|NCT00436748|453112427|FG001|Overall Study|Consent Withdrawn|4|||
125949398|NCT00436748|453112426|FG000|Overall Study|Administrative Decision|1|||
125949399|NCT00436748|453112427|FG001|Overall Study|Administrative Decision|0|||
125949400|NCT00436748|453112426|FG000|Overall Study|Lost to Follow-up|0|||
125949401|NCT00436748|453112427|FG001|Overall Study|Lost to Follow-up|1|||
125949402|NCT00436748|453112426|FG000|Overall Study|Protocol-specified Criteria|5|||
125949403|NCT00436748|453112427|FG001|Overall Study|Protocol-specified Criteria|4|||
125949404|NCT00436748|453112426|FG000|Overall Study|Other|3|||
125949405|NCT00436748|453112427|FG001|Overall Study|Other|0|||
125949406|NCT01610791|453112428|FG000|Overall Study|Lost to Follow-up|7|||
125949407|NCT01610791|453112428|FG000|Overall Study|Adverse Event|6|||
125949408|NCT01610791|453112428|FG000|Overall Study|Physician Decision|1|||
125949409|NCT01610791|453112428|FG000|Overall Study|Adverse event and Investigator decision|1|||
125949410|NCT01610791|453112428|FG000|Overall Study|Death|1|||
125949411|NCT01610791|453112428|FG000|Overall Study|Not determined|5|||
125949412|NCT02086110|453112431|FG000|Overall Study|Withdrawal by Subject|1|||
125949413|NCT02086110|453112432|FG001|Overall Study|Withdrawal by Subject|1|||
125949414|NCT01869192|453112433|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
125949415|NCT01869192|453112434|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
125949416|NCT01869192|453112433|FG000|Postoperative Chemotherapy|Physician Decision|0|||
125949417|NCT01869192|453112434|FG001|Postoperative Chemotherapy|Physician Decision|2|||
125949418|NCT00423891|453112438|FG000|Enrolled|Withdrawal by Subject|0|||
125949419|NCT00423891|453112439|FG001|Enrolled|Withdrawal by Subject|0|||
125949420|NCT00423891|453112440|FG002|Enrolled|Withdrawal by Subject|1|||
125949421|NCT00423891|453112438|FG000|Enrolled|Lost to Follow-up|0|||
125949422|NCT00423891|453112439|FG001|Enrolled|Lost to Follow-up|0|||
125949423|NCT00423891|453112440|FG002|Enrolled|Lost to Follow-up|1|||
125949424|NCT00423891|453112438|FG000|Enrolled|No longer met criteria|11|||
125949425|NCT00423891|453112439|FG001|Enrolled|No longer met criteria|2|||
125949426|NCT00423891|453112440|FG002|Enrolled|No longer met criteria|1|||
125949427|NCT00423891|453112438|FG000|Treatment|Withdrawal by Subject|1|||
125949428|NCT00423891|453112439|FG001|Treatment|Withdrawal by Subject|0|||
125949429|NCT00423891|453112440|FG002|Treatment|Withdrawal by Subject|0|||
125949430|NCT00423891|453112438|FG000|Treatment|Lost to Follow-up|1|||
125949431|NCT00423891|453112439|FG001|Treatment|Lost to Follow-up|0|||
125949432|NCT00423891|453112440|FG002|Treatment|Lost to Follow-up|0|||
125949433|NCT00423891|453112438|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
125949434|NCT00423891|453112439|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
125949435|NCT00423891|453112440|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
125949436|NCT00423891|453112438|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
125949437|NCT00423891|453112439|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
125949438|NCT00423891|453112440|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
125949439|NCT00414661|453112441|FG000|Overall Study|Death|2|||
125949440|NCT00414661|453112442|FG001|Overall Study|Death|5|||
125949441|NCT00414661|453112443|FG002|Overall Study|Death|0|||
125949442|NCT00414661|453112444|FG003|Overall Study|Death|0|||
125949443|NCT00414661|453112441|FG000|Overall Study|Lost to Follow-up|1|||
125949444|NCT00414661|453112442|FG001|Overall Study|Lost to Follow-up|4|||
125949445|NCT00414661|453112443|FG002|Overall Study|Lost to Follow-up|0|||
125949446|NCT00414661|453112444|FG003|Overall Study|Lost to Follow-up|1|||
125949447|NCT00414661|453112441|FG000|Overall Study|Withdrawal by Subject|5|||
125949448|NCT00414661|453112442|FG001|Overall Study|Withdrawal by Subject|2|||
125949449|NCT00414661|453112443|FG002|Overall Study|Withdrawal by Subject|2|||
125949450|NCT00414661|453112444|FG003|Overall Study|Withdrawal by Subject|2|||
125949451|NCT00414661|453112441|FG000|Overall Study|Other|6|||
125949452|NCT00414661|453112442|FG001|Overall Study|Other|3|||
125949453|NCT00414661|453112443|FG002|Overall Study|Other|0|||
125949454|NCT00414661|453112444|FG003|Overall Study|Other|0|||
125949455|NCT00357370|453112445|FG000|Cohort 2|Lack of Efficacy|0|||
125949456|NCT00357370|453112446|FG001|Cohort 2|Lack of Efficacy|2|||
125949457|NCT00357370|453112447|FG002|Cohort 2|Lack of Efficacy|1|||
125949458|NCT00357370|453112445|FG000|Cohort 2|Adverse Event|1|||
125949459|NCT00357370|453112446|FG001|Cohort 2|Adverse Event|1|||
125949460|NCT00357370|453112447|FG002|Cohort 2|Adverse Event|1|||
125949461|NCT00357370|453112445|FG000|Cohort 2|Lost to Follow-up|0|||
125949462|NCT00357370|453112446|FG001|Cohort 2|Lost to Follow-up|1|||
125949463|NCT00357370|453112447|FG002|Cohort 2|Lost to Follow-up|0|||
125949464|NCT00357370|453112445|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
125949465|NCT00357370|453112446|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
125949466|NCT00357370|453112447|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
125949467|NCT00357370|453112445|FG000|Cohort 2|Withdrawal by Subject|0|||
125949468|NCT00357370|453112446|FG001|Cohort 2|Withdrawal by Subject|2|||
125949469|NCT00357370|453112447|FG002|Cohort 2|Withdrawal by Subject|0|||
125949470|NCT00937547|453112451|FG000|Overall Study|misdiagnosis|1|||
125949471|NCT00937547|453112452|FG001|Overall Study|misdiagnosis|6|||
125949472|NCT00937547|453112453|FG002|Overall Study|misdiagnosis|7|||
125949473|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
125949474|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
125949475|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
125949476|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
125949477|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
125949478|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
125949479|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
125949480|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
125949481|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
125949482|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
125949483|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
125949484|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
125949485|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
125949486|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
125949487|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
125949488|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
125949489|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
125949490|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
125949491|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Death|0|||
125949492|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Death|0|||
125949493|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Death|1|||
125949494|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Death|0|||
125949495|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Death|0|||
125949496|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Death|0|||
125949497|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Death|0|||
125949498|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Death|0|||
125949499|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Death|0|||
125949500|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
125949501|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
125949502|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
125949503|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125949504|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125949505|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125949506|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125949507|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125949508|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125949509|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
125949510|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
125949511|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
125949512|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125949513|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125949514|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125949515|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125949516|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125949517|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
126079589|NCT02706847|453585896|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
126079590|NCT02706847|453585897|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
125949518|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
125949519|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
125949520|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
125949521|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
125949522|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
125949523|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
125949524|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
125949525|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
125949526|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
125949527|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
125949528|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
125949529|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
125949530|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
125949531|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
125949532|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
125949533|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
125949534|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
125949535|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
125949536|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
125949537|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
125949538|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
125949539|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125949540|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125949541|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125949542|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125949543|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125949544|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125949545|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125949546|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
125949547|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125949548|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125949549|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125949550|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125949551|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125949552|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125949553|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125949554|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
125949555|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
125949556|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
125949557|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
125949558|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
125949559|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
125949560|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
125949561|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
125949562|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
125949563|NCT00404352|453112455|FG000|Double Blind (up to 24 Month)|Other|0|||
125949564|NCT00404352|453112456|FG001|Double Blind (up to 24 Month)|Other|1|||
125949565|NCT00404352|453112457|FG002|Double Blind (up to 24 Month)|Other|0|||
125949566|NCT00404352|453112458|FG003|Double Blind (up to 24 Month)|Other|0|||
125949567|NCT00404352|453112459|FG004|Double Blind (up to 24 Month)|Other|0|||
125949568|NCT00404352|453112460|FG005|Double Blind (up to 24 Month)|Other|0|||
125949569|NCT00404352|453112461|FG006|Double Blind (up to 24 Month)|Other|0|||
125949570|NCT00404352|453112462|FG007|Double Blind (up to 24 Month)|Other|0|||
125949571|NCT00404352|453112463|FG008|Double Blind (up to 24 Month)|Other|0|||
125949572|NCT00404352|453112455|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
125949573|NCT00404352|453112456|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
125949574|NCT00404352|453112457|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
125949575|NCT00404352|453112458|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
125949576|NCT00404352|453112459|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
125949577|NCT00404352|453112460|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
125949578|NCT00404352|453112461|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
125949579|NCT00404352|453112462|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
125949580|NCT00404352|453112463|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
125949581|NCT00404352|453112455|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
125949582|NCT00404352|453112456|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
125949583|NCT00404352|453112457|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
125949584|NCT00404352|453112458|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
125949585|NCT00404352|453112459|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
125949586|NCT00404352|453112460|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
125949587|NCT00404352|453112461|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
125949588|NCT00404352|453112462|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
125949589|NCT00404352|453112463|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
125949590|NCT00404352|453112455|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125949591|NCT00404352|453112456|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125949592|NCT00404352|453112457|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125949593|NCT00404352|453112458|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125949594|NCT00404352|453112459|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
125949595|NCT00404352|453112460|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125949596|NCT00404352|453112461|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125949597|NCT00404352|453112462|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126114986|NCT03044249|453715821|FG000|Overall Study|Lost to Follow-up|1|||
126114987|NCT03044249|453715822|FG001|Overall Study|Lost to Follow-up|0|||
126114988|NCT03044249|453715821|FG000|Overall Study|Non-compliance with Study Drug|1|||
126114989|NCT03044249|453715822|FG001|Overall Study|Non-compliance with Study Drug|0|||
126114990|NCT03044249|453715821|FG000|Overall Study|Study Terminated by Sponsor|2|||
126114991|NCT03044249|453715822|FG001|Overall Study|Study Terminated by Sponsor|0|||
126114992|NCT03044249|453715821|FG000|Overall Study|Withdrawal by Subject|2|||
126114993|NCT03044249|453715822|FG001|Overall Study|Withdrawal by Subject|5|||
126114994|NCT02101021|453715823|FG000|Overall Study|Death|4|||
126114995|NCT02101021|453715824|FG001|Overall Study|Death|3|||
126114996|NCT02101021|453715825|FG002|Overall Study|Death|6|||
126114997|NCT02101021|453715826|FG003|Overall Study|Death|0|||
126114998|NCT02101021|453715827|FG004|Overall Study|Death|3|||
126114999|NCT02101021|453715823|FG000|Overall Study|Withdrew Consent from study|1|||
126115000|NCT02101021|453715824|FG001|Overall Study|Withdrew Consent from study|1|||
126115001|NCT02101021|453715825|FG002|Overall Study|Withdrew Consent from study|0|||
126115002|NCT02101021|453715826|FG003|Overall Study|Withdrew Consent from study|2|||
126115003|NCT02101021|453715827|FG004|Overall Study|Withdrew Consent from study|0|||
126115004|NCT02101021|453715823|FG000|Overall Study|Lost to Follow-up|1|||
126115005|NCT02101021|453715824|FG001|Overall Study|Lost to Follow-up|0|||
126115006|NCT02101021|453715825|FG002|Overall Study|Lost to Follow-up|0|||
126115007|NCT02101021|453715826|FG003|Overall Study|Lost to Follow-up|0|||
126115008|NCT02101021|453715827|FG004|Overall Study|Lost to Follow-up|0|||
126115009|NCT02101021|453715823|FG000|Overall Study|Study Terminated by Sponsor|1|||
125949598|NCT00404352|453112463|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125949599|NCT00404352|453112455|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125949600|NCT00404352|453112456|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125949601|NCT00404352|453112457|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125949602|NCT00404352|453112458|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125949603|NCT00404352|453112459|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125949604|NCT00404352|453112460|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
125949605|NCT00404352|453112461|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125949606|NCT00404352|453112462|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125949607|NCT00404352|453112463|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125949608|NCT00404352|453112455|FG000|Open Label (up to 24 Month)|Disease progression|0|||
125949609|NCT00404352|453112456|FG001|Open Label (up to 24 Month)|Disease progression|0|||
125949610|NCT00404352|453112457|FG002|Open Label (up to 24 Month)|Disease progression|0|||
125949611|NCT00404352|453112458|FG003|Open Label (up to 24 Month)|Disease progression|1|||
125949612|NCT00404352|453112459|FG004|Open Label (up to 24 Month)|Disease progression|0|||
125949613|NCT00404352|453112460|FG005|Open Label (up to 24 Month)|Disease progression|0|||
125949614|NCT00404352|453112461|FG006|Open Label (up to 24 Month)|Disease progression|0|||
125949615|NCT00404352|453112462|FG007|Open Label (up to 24 Month)|Disease progression|0|||
125949616|NCT00404352|453112463|FG008|Open Label (up to 24 Month)|Disease progression|0|||
125949617|NCT00404352|453112455|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125949618|NCT00404352|453112456|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125949619|NCT00404352|453112457|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125949620|NCT00404352|453112458|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125949621|NCT00404352|453112459|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125949622|NCT00404352|453112460|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125949623|NCT00404352|453112461|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
125949624|NCT00404352|453112462|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
125949625|NCT00404352|453112463|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125949626|NCT00404352|453112455|FG000|Open Label Extension (up to 36 Months)|Other|0|||
125949627|NCT00404352|453112456|FG001|Open Label Extension (up to 36 Months)|Other|0|||
125949628|NCT00404352|453112457|FG002|Open Label Extension (up to 36 Months)|Other|0|||
125949629|NCT00404352|453112458|FG003|Open Label Extension (up to 36 Months)|Other|0|||
125949630|NCT00404352|453112459|FG004|Open Label Extension (up to 36 Months)|Other|0|||
126115010|NCT02101021|453715824|FG001|Overall Study|Study Terminated by Sponsor|0|||
126115011|NCT02101021|453715825|FG002|Overall Study|Study Terminated by Sponsor|1|||
126115012|NCT02101021|453715826|FG003|Overall Study|Study Terminated by Sponsor|1|||
126115013|NCT02101021|453715827|FG004|Overall Study|Study Terminated by Sponsor|1|||
126115014|NCT01621542|453715828|FG000|Overall Study|Adverse Event|0|||
126115015|NCT01621542|453715829|FG001|Overall Study|Adverse Event|0|||
126115016|NCT01621542|453715830|FG002|Overall Study|Adverse Event|1|||
126115017|NCT01621542|453715831|FG003|Overall Study|Adverse Event|3|||
126115018|NCT01621542|453715832|FG004|Overall Study|Adverse Event|0|||
126115019|NCT01621542|453715833|FG005|Overall Study|Adverse Event|0|||
125949631|NCT00404352|453112460|FG005|Open Label Extension (up to 36 Months)|Other|0|||
126115020|NCT01621542|453715828|FG000|Overall Study|Death|0|||
125949632|NCT00404352|453112461|FG006|Open Label Extension (up to 36 Months)|Other|0|||
126115021|NCT01621542|453715829|FG001|Overall Study|Death|1|||
126115022|NCT01621542|453715830|FG002|Overall Study|Death|0|||
126115023|NCT01621542|453715831|FG003|Overall Study|Death|0|||
126115024|NCT01621542|453715832|FG004|Overall Study|Death|0|||
126115025|NCT01621542|453715833|FG005|Overall Study|Death|0|||
126115026|NCT01621542|453715828|FG000|Overall Study|Physician Decision|1|||
126115027|NCT01621542|453715829|FG001|Overall Study|Physician Decision|0|||
126115028|NCT01621542|453715830|FG002|Overall Study|Physician Decision|1|||
126115029|NCT01621542|453715831|FG003|Overall Study|Physician Decision|13|||
126115030|NCT01621542|453715832|FG004|Overall Study|Physician Decision|3|||
126115031|NCT01621542|453715833|FG005|Overall Study|Physician Decision|1|||
126115032|NCT01621542|453715828|FG000|Overall Study|Withdrawal by Subject|2|||
125949633|NCT00404352|453112462|FG007|Open Label Extension (up to 36 Months)|Other|0|||
125949634|NCT00404352|453112463|FG008|Open Label Extension (up to 36 Months)|Other|2|||
125949635|NCT01116232|453112473|FG000|Overall Study|Progressive diease|4|||
125949636|NCT02357940|453112474|FG000|Overall Study|Adverse Event|0|||
125949637|NCT02357940|453112475|FG001|Overall Study|Adverse Event|1|||
125949638|NCT02357940|453112474|FG000|Overall Study|Investigator's judgement|0|||
125949639|NCT02357940|453112475|FG001|Overall Study|Investigator's judgement|1|||
125949640|NCT02275481|453112476|FG000|Overall Study|Death|2|||
125949641|NCT02275481|453112477|FG001|Overall Study|Death|1|||
125949642|NCT02275481|453112476|FG000|Overall Study|Lost to Follow-up|2|||
125949643|NCT02275481|453112477|FG001|Overall Study|Lost to Follow-up|0|||
125949644|NCT02275481|453112476|FG000|Overall Study|Withdrawal by Subject|3|||
125949645|NCT02275481|453112477|FG001|Overall Study|Withdrawal by Subject|0|||
125949646|NCT02275481|453112476|FG000|Overall Study|all other reasons combined|2|||
125949647|NCT02275481|453112477|FG001|Overall Study|all other reasons combined|1|||
125949648|NCT02275481|453112476|FG000|Overall Study|Physician Decision|0|||
125949649|NCT02275481|453112477|FG001|Overall Study|Physician Decision|1|||
125949650|NCT00717769|453112481|FG000|Overall Study|Adverse Event|9|||
125949651|NCT00717769|453112482|FG001|Overall Study|Adverse Event|6|||
125949652|NCT00717769|453112483|FG002|Overall Study|Adverse Event|1|||
125949653|NCT00717769|453112481|FG000|Overall Study|Lack of compliance|0|||
125949654|NCT00717769|453112482|FG001|Overall Study|Lack of compliance|2|||
125949655|NCT00717769|453112483|FG002|Overall Study|Lack of compliance|0|||
125949656|NCT00717769|453112481|FG000|Overall Study|Lost to Follow-up|3|||
125949657|NCT00717769|453112482|FG001|Overall Study|Lost to Follow-up|4|||
125949658|NCT00717769|453112483|FG002|Overall Study|Lost to Follow-up|0|||
125949659|NCT00717769|453112481|FG000|Overall Study|Lack of Efficacy|1|||
125949660|NCT00717769|453112482|FG001|Overall Study|Lack of Efficacy|2|||
125949661|NCT00717769|453112483|FG002|Overall Study|Lack of Efficacy|0|||
125949662|NCT00717769|453112481|FG000|Overall Study|Protocol Violation|0|||
125949663|NCT00717769|453112482|FG001|Overall Study|Protocol Violation|2|||
125949664|NCT00717769|453112483|FG002|Overall Study|Protocol Violation|0|||
125949665|NCT00717769|453112481|FG000|Overall Study|Sponsor decision|1|||
125949666|NCT00717769|453112482|FG001|Overall Study|Sponsor decision|0|||
125949667|NCT00717769|453112483|FG002|Overall Study|Sponsor decision|10|||
125949668|NCT00717769|453112481|FG000|Overall Study|Withdrew consent|2|||
125949669|NCT00717769|453112482|FG001|Overall Study|Withdrew consent|2|||
125949670|NCT00717769|453112483|FG002|Overall Study|Withdrew consent|0|||
125949671|NCT03350503|453112487|FG000|Overall Study|Adverse Event|5|||
125949672|NCT03350503|453112487|FG000|Overall Study|Withdrawal by Subject|5|||
125949673|NCT03350503|453112487|FG000|Overall Study|Continuation impossible due to move|4|||
125949674|NCT03350503|453112487|FG000|Overall Study|Physician Decision|3|||
125949675|NCT01399593|453112490|FG000|Overall Study|Physician Decision|1|||
125949676|NCT01399593|453112491|FG001|Overall Study|Physician Decision|0|||
125949677|NCT01399593|453112490|FG000|Overall Study|Adverse Event|1|||
125949678|NCT01399593|453112491|FG001|Overall Study|Adverse Event|0|||
125949679|NCT01399593|453112490|FG000|Overall Study|Death|1|||
125949680|NCT01399593|453112491|FG001|Overall Study|Death|1|||
125949681|NCT01399593|453112490|FG000|Overall Study|Transplantectomy|0|||
125949682|NCT01399593|453112491|FG001|Overall Study|Transplantectomy|1|||
125949683|NCT00344773|453112495|FG000|Overall Study|Adverse Event|2|||
125949684|NCT00344773|453112495|FG000|Overall Study|Objective Disease Progression|16|||
125949685|NCT00344773|453112495|FG000|Overall Study|Withdrawal by Subject|1|||
125949686|NCT00344773|453112495|FG000|Overall Study|Not Eligible for the study|2|||
126115033|NCT01621542|453715829|FG001|Overall Study|Withdrawal by Subject|0|||
126115034|NCT01621542|453715830|FG002|Overall Study|Withdrawal by Subject|1|||
126115035|NCT01621542|453715831|FG003|Overall Study|Withdrawal by Subject|3|||
126115036|NCT01621542|453715832|FG004|Overall Study|Withdrawal by Subject|3|||
126115037|NCT01621542|453715833|FG005|Overall Study|Withdrawal by Subject|3|||
126115038|NCT01621542|453715828|FG000|Overall Study|progression/treatment failure|2|||
125949687|NCT02141074|453112497|FG000|Pre-prophylaxis|Adverse Event|3|||
125949688|NCT02141074|453112498|FG001|Pre-prophylaxis|Adverse Event|0|||
125949689|NCT02141074|453112497|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
125949690|NCT02141074|453112498|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
125949691|NCT02141074|453112497|FG000|Prophylaxis|Adverse Event|0|||
125949692|NCT02141074|453112498|FG001|Prophylaxis|Adverse Event|4|||
125949693|NCT02141074|453112497|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
125949694|NCT02141074|453112498|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
126115039|NCT01621542|453715829|FG001|Overall Study|progression/treatment failure|4|||
125949695|NCT02141074|453112497|FG000|Prophylaxis|Withdrawal by Subject|0|||
125949696|NCT02141074|453112498|FG001|Prophylaxis|Withdrawal by Subject|1|||
125949697|NCT06023394|453112500|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
125949698|NCT06023394|453112501|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
125949699|NCT06023394|453112500|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
125949700|NCT06023394|453112501|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
125949701|NCT06023394|453112500|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
125949702|NCT06023394|453112501|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
125949703|NCT06023394|453112500|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
125949704|NCT06023394|453112501|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
125949705|NCT02283788|453112503|FG000|Overall Study|Adverse Event|1|||
125949706|NCT02283788|453112504|FG001|Overall Study|Adverse Event|3|||
125949707|NCT02283788|453112505|FG002|Overall Study|Adverse Event|5|||
125949708|NCT02283788|453112506|FG003|Overall Study|Adverse Event|1|||
125949709|NCT02283788|453112503|FG000|Overall Study|Withdrawal by Subject|0|||
125949710|NCT02283788|453112504|FG001|Overall Study|Withdrawal by Subject|1|||
125949711|NCT02283788|453112505|FG002|Overall Study|Withdrawal by Subject|0|||
125949712|NCT02283788|453112506|FG003|Overall Study|Withdrawal by Subject|1|||
125949713|NCT02970968|453114075|FG000|Overall Study|Withdrawal by Subject|3|||
125949714|NCT02970968|453114076|FG001|Overall Study|Withdrawal by Subject|3|||
125949715|NCT02970968|453114075|FG000|Overall Study|Adverse Event|1|||
125949716|NCT02970968|453114076|FG001|Overall Study|Adverse Event|2|||
125949717|NCT02970968|453114075|FG000|Overall Study|Lost to Follow-up|1|||
125949718|NCT02970968|453114076|FG001|Overall Study|Lost to Follow-up|1|||
125949719|NCT02970968|453114075|FG000|Overall Study|Non-Compliance|0|||
125949720|NCT02970968|453114076|FG001|Overall Study|Non-Compliance|1|||
125949721|NCT01332149|453114077|FG000|Overall Study|Adverse Event|11|||
125949722|NCT01332149|453114078|FG001|Overall Study|Adverse Event|9|||
125949723|NCT01332149|453114077|FG000|Overall Study|Other unspecified|5|||
125949724|NCT01332149|453114078|FG001|Overall Study|Other unspecified|7|||
125949725|NCT01332149|453114077|FG000|Overall Study|Protocol Violation|1|||
125949726|NCT01332149|453114078|FG001|Overall Study|Protocol Violation|3|||
125949727|NCT01332149|453114077|FG000|Overall Study|Withdrawal by Subject|4|||
125949728|NCT01332149|453114078|FG001|Overall Study|Withdrawal by Subject|5|||
125949729|NCT01332149|453114077|FG000|Overall Study|Lost to Follow-up|1|||
125949730|NCT01332149|453114078|FG001|Overall Study|Lost to Follow-up|1|||
125949731|NCT01332149|453114077|FG000|Overall Study|Insufficient clinical response|4|||
125949732|NCT01332149|453114078|FG001|Overall Study|Insufficient clinical response|7|||
125949733|NCT01332149|453114077|FG000|Overall Study|Did not meet entrance criteria|3|||
125949734|NCT01332149|453114078|FG001|Overall Study|Did not meet entrance criteria|4|||
125949735|NCT01332149|453114077|FG000|Overall Study|Randomized but not treated|1|||
125949736|NCT01332149|453114078|FG001|Overall Study|Randomized but not treated|2|||
125949737|NCT02565381|453114079|FG000|Overall Study|Lost to Follow-up|1|||
125949738|NCT02565381|453114080|FG001|Overall Study|Lost to Follow-up|0|||
125949739|NCT02565381|453114081|FG002|Overall Study|Lost to Follow-up|1|||
125949740|NCT04615949|453114082|FG000|Overall Study|Withdrawal by Subject|2|||
125949741|NCT04615949|453114083|FG001|Overall Study|Withdrawal by Subject|4|||
125949742|NCT04615949|453114082|FG000|Overall Study|Lost to Follow-up|2|||
125949743|NCT04615949|453114083|FG001|Overall Study|Lost to Follow-up|2|||
125949744|NCT04615949|453114082|FG000|Overall Study|Death|0|||
125949745|NCT04615949|453114083|FG001|Overall Study|Death|2|||
125949746|NCT02554656|453114084|FG000|Overall Study|Protocol Violation|3|||
125949747|NCT00749463|453114089|FG000|Overall Study|Adverse Event|0|||
125949748|NCT00749463|453114090|FG001|Overall Study|Adverse Event|4|||
125949749|NCT00749463|453114091|FG002|Overall Study|Adverse Event|1|||
125949750|NCT00749463|453114089|FG000|Overall Study|Withdrawal by Subject|1|||
125949751|NCT00749463|453114090|FG001|Overall Study|Withdrawal by Subject|0|||
125949752|NCT00749463|453114091|FG002|Overall Study|Withdrawal by Subject|0|||
125949753|NCT03643562|453114098|FG000|Overall Study|Adverse Event|1|||
125949754|NCT03643562|453114099|FG001|Overall Study|Adverse Event|0|||
125949755|NCT03643562|453114098|FG000|Overall Study|Lack of Efficacy|0|||
125949756|NCT03643562|453114099|FG001|Overall Study|Lack of Efficacy|1|||
125949757|NCT03643562|453114098|FG000|Overall Study|Physician Decision|0|||
125949758|NCT03643562|453114099|FG001|Overall Study|Physician Decision|1|||
125949759|NCT03643562|453114098|FG000|Overall Study|Study Terminated by Sponsor|2|||
125949760|NCT03643562|453114099|FG001|Overall Study|Study Terminated by Sponsor|10|||
125949761|NCT03643562|453114098|FG000|Overall Study|Withdrawal by Subject|2|||
125949762|NCT03643562|453114099|FG001|Overall Study|Withdrawal by Subject|2|||
125949763|NCT03643562|453114098|FG000|Overall Study|Other than specified|3|||
125949764|NCT03643562|453114099|FG001|Overall Study|Other than specified|2|||
125949765|NCT01982253|453114100|FG000|Overall Study|Withdrawal by Subject|1|||
125949766|NCT01982253|453114101|FG001|Overall Study|Withdrawal by Subject|0|||
125949767|NCT01982253|453114102|FG002|Overall Study|Withdrawal by Subject|0|||
125949768|NCT01982253|453114100|FG000|Overall Study|Study terminated by sponsor|1|||
125949769|NCT01982253|453114101|FG001|Overall Study|Study terminated by sponsor|4|||
125949770|NCT01982253|453114102|FG002|Overall Study|Study terminated by sponsor|4|||
125949771|NCT01886833|453114104|FG000|Overall Study|IgA not available from both periods|204|||
125949772|NCT02223767|453114112|FG000|Overall Study|Withdrawal by Subject|4|||
125949773|NCT02223767|453114113|FG001|Overall Study|Withdrawal by Subject|4|||
125949774|NCT04206293|453114114|FG000|Overall Study|Consent withdrawal|1|||
125949775|NCT00782210|453114120|FG000|Overall Study|Adverse Event|21|||
125949776|NCT00782210|453114121|FG001|Overall Study|Adverse Event|17|||
125949777|NCT00782210|453114122|FG002|Overall Study|Adverse Event|16|||
125949778|NCT00782210|453114120|FG000|Overall Study|Lost to Follow-up|2|||
125949779|NCT00782210|453114121|FG001|Overall Study|Lost to Follow-up|1|||
125949780|NCT00782210|453114122|FG002|Overall Study|Lost to Follow-up|2|||
125949781|NCT00782210|453114120|FG000|Overall Study|Withdrawal by Subject|11|||
125949782|NCT00782210|453114121|FG001|Overall Study|Withdrawal by Subject|8|||
125949783|NCT00782210|453114122|FG002|Overall Study|Withdrawal by Subject|11|||
125949784|NCT00782210|453114120|FG000|Overall Study|Non compliance with protocol|0|||
125949785|NCT00782210|453114121|FG001|Overall Study|Non compliance with protocol|3|||
125949786|NCT00782210|453114122|FG002|Overall Study|Non compliance with protocol|2|||
125949787|NCT00782210|453114120|FG000|Overall Study|Lack of Efficacy|13|||
125949788|NCT00782210|453114121|FG001|Overall Study|Lack of Efficacy|4|||
125949789|NCT00782210|453114122|FG002|Overall Study|Lack of Efficacy|1|||
125949790|NCT00782210|453114120|FG000|Overall Study|Other reason not described above|3|||
125949791|NCT00782210|453114121|FG001|Overall Study|Other reason not described above|2|||
125949792|NCT00782210|453114122|FG002|Overall Study|Other reason not described above|3|||
125949793|NCT02272413|453114125|FG000|Randomized Through Treatment Start|Not treated|3|||
125949794|NCT02272413|453114126|FG001|Randomized Through Treatment Start|Not treated|5|||
125949795|NCT02272413|453114125|FG000|Pre-switch Period|Adverse Event|38|||
125949796|NCT02272413|453114126|FG001|Pre-switch Period|Adverse Event|37|||
125949797|NCT02272413|453114125|FG000|Pre-switch Period|Death|26|||
125949798|NCT02272413|453114126|FG001|Pre-switch Period|Death|26|||
125949799|NCT02272413|453114125|FG000|Pre-switch Period|Withdrawal by Subject|27|||
125949800|NCT02272413|453114126|FG001|Pre-switch Period|Withdrawal by Subject|15|||
125949801|NCT02272413|453114125|FG000|Pre-switch Period|Physician Decision|6|||
125949802|NCT02272413|453114126|FG001|Pre-switch Period|Physician Decision|18|||
125949803|NCT02272413|453114125|FG000|Pre-switch Period|Progressive disease|185|||
125949804|NCT02272413|453114126|FG001|Pre-switch Period|Progressive disease|173|||
125949805|NCT02272413|453114125|FG000|Pre-switch Period|Lost to Follow-up|0|||
125949806|NCT02272413|453114126|FG001|Pre-switch Period|Lost to Follow-up|2|||
125949807|NCT02272413|453114125|FG000|Pre-switch Period|Protocol Violation|1|||
125949808|NCT02272413|453114126|FG001|Pre-switch Period|Protocol Violation|0|||
125949809|NCT02272413|453114125|FG000|Pre-switch Period|Other than listed|10|||
125949810|NCT02272413|453114126|FG001|Pre-switch Period|Other than listed|11|||
125949811|NCT02272413|453114125|FG000|Post-switch Period|Adverse Event|4|||
125949812|NCT02272413|453114126|FG001|Post-switch Period|Adverse Event|4|||
125949813|NCT02272413|453114125|FG000|Post-switch Period|Death|3|||
125949814|NCT02272413|453114126|FG001|Post-switch Period|Death|2|||
125949815|NCT02272413|453114125|FG000|Post-switch Period|Withdrawal by Subject|1|||
125949816|NCT02272413|453114126|FG001|Post-switch Period|Withdrawal by Subject|2|||
125949817|NCT02272413|453114125|FG000|Post-switch Period|Physician Decision|1|||
125949818|NCT02272413|453114126|FG001|Post-switch Period|Physician Decision|1|||
125949819|NCT02272413|453114125|FG000|Post-switch Period|Progressive disease|21|||
125949820|NCT02272413|453114126|FG001|Post-switch Period|Progressive disease|21|||
125949821|NCT02272413|453114125|FG000|Post-switch Period|Study terminated by sponsor|8|||
125949822|NCT02272413|453114126|FG001|Post-switch Period|Study terminated by sponsor|11|||
125949823|NCT02272413|453114125|FG000|Post-switch Period|Other than listed|4|||
125949824|NCT02272413|453114126|FG001|Post-switch Period|Other than listed|5|||
125949825|NCT02126969|453114127|FG000|Overall Study|Withdrawal by Subject|1|||
125949826|NCT02126969|453114128|FG001|Overall Study|Withdrawal by Subject|2|||
125949827|NCT01533246|453114129|FG000|Overall Study|Adverse Event|1|||
125949828|NCT01533246|453114129|FG000|Overall Study|Withdrawal by Subject|1|||
125949829|NCT01143090|453114130|FG000|Overall Study|Lack of Efficacy|2|||
125949830|NCT01143090|453114130|FG000|Overall Study|Adverse Event|17|||
125949831|NCT01143090|453114130|FG000|Overall Study|Lost to Follow-up|9|||
125949832|NCT01143090|453114130|FG000|Overall Study|Protocol Violation|2|||
125949833|NCT01143090|453114130|FG000|Overall Study|Withdrawal by Subject|18|||
125949834|NCT01143090|453114130|FG000|Overall Study|Non-compliance with study drug|1|||
125949835|NCT01143090|453114130|FG000|Overall Study|Failure to meet eligibility criteria|1|||
125949836|NCT01143090|453114130|FG000|Overall Study|Administrative|1|||
125949837|NCT01461096|453114133|FG000|Overall Study|Death|3|||
125949838|NCT01461096|453114134|FG001|Overall Study|Death|6|||
125949839|NCT01461096|453114133|FG000|Overall Study|Severe debilitation, unable to continue|1|||
125949840|NCT01461096|453114134|FG001|Overall Study|Severe debilitation, unable to continue|1|||
125949841|NCT01461096|453114133|FG000|Overall Study|Subj not able to get to clinic|15|||
125949842|NCT01461096|453114134|FG001|Overall Study|Subj not able to get to clinic|13|||
125949843|NCT01461096|453114133|FG000|Overall Study|Site is closing|27|||
125949844|NCT01461096|453114134|FG001|Overall Study|Site is closing|30|||
125949845|NCT01461096|453114133|FG000|Overall Study|Withdrawal by Subject|5|||
125949846|NCT01461096|453114134|FG001|Overall Study|Withdrawal by Subject|3|||
125949847|NCT01461096|453114133|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
125949848|NCT01461096|453114134|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
125949849|NCT01461096|453114133|FG000|Overall Study|Lost to Follow-up|8|||
125949850|NCT01461096|453114134|FG001|Overall Study|Lost to Follow-up|4|||
125949851|NCT04370691|453114137|FG000|Overall Study|Pending visit|48|||
125949852|NCT04370691|453114137|FG000|Overall Study|Have Not Reached Lower Window|15|||
125949853|NCT04370691|453114137|FG000|Overall Study|Termination|14|||
125949854|NCT04370691|453114137|FG000|Overall Study|Missed or Overdue|10|||
125949855|NCT00855309|453114144|FG000|Overall Study|patient never recieved drug|1|||
125949856|NCT00855309|453114145|FG001|Overall Study|patient never recieved drug|0|||
125949857|NCT00829296|453114146|FG000|Overall Study|Adverse Event|5|||
125949858|NCT00829296|453114147|FG001|Overall Study|Adverse Event|4|||
125949859|NCT04960228|453114148|FG000|Overall Study|Withdrawal by Subject|216|||
125949860|NCT04960228|453114149|FG001|Overall Study|Withdrawal by Subject|35|||
125949861|NCT04960228|453114148|FG000|Overall Study|Failed attention check|69|||
125949862|NCT04960228|453114149|FG001|Overall Study|Failed attention check|148|||
125949863|NCT04960228|453114148|FG000|Overall Study|Flagged for response quality by Dynata|3|||
125949864|NCT04960228|453114149|FG001|Overall Study|Flagged for response quality by Dynata|3|||
125949865|NCT00582933|453114153|FG000|Overall Study|Physician Decision|3|||
125949866|NCT01077960|453114154|FG000|Overall Study|Adverse Event|6|||
125949867|NCT01077960|453114154|FG000|Overall Study|Protocol Violation|3|||
125949868|NCT01077960|453114154|FG000|Overall Study|Lost to Follow-up|5|||
125949869|NCT01077960|453114154|FG000|Overall Study|Subject decision|1|||
125949870|NCT01077960|453114154|FG000|Overall Study|Reason unspecified|1|||
125949871|NCT03837899|453114155|FG000|Overall Study|Death|6|||
125949872|NCT03837899|453114156|FG001|Overall Study|Death|8|||
125949873|NCT03837899|453114157|FG002|Overall Study|Death|3|||
125949874|NCT03837899|453114158|FG003|Overall Study|Death|7|||
125949875|NCT03837899|453114159|FG004|Overall Study|Death|8|||
125949876|NCT03837899|453114160|FG005|Overall Study|Death|7|||
125949877|NCT03837899|453114155|FG000|Overall Study|Moved to post-trial access program|0|||
125949878|NCT03837899|453114156|FG001|Overall Study|Moved to post-trial access program|1|||
125949879|NCT03837899|453114157|FG002|Overall Study|Moved to post-trial access program|0|||
125949880|NCT03837899|453114158|FG003|Overall Study|Moved to post-trial access program|0|||
125949881|NCT03837899|453114159|FG004|Overall Study|Moved to post-trial access program|0|||
125949882|NCT03837899|453114160|FG005|Overall Study|Moved to post-trial access program|0|||
125949883|NCT03837899|453114155|FG000|Overall Study|Other|0|||
125949884|NCT03837899|453114156|FG001|Overall Study|Other|0|||
125949885|NCT03837899|453114157|FG002|Overall Study|Other|0|||
125949886|NCT03837899|453114158|FG003|Overall Study|Other|0|||
125949887|NCT03837899|453114159|FG004|Overall Study|Other|0|||
125949888|NCT03837899|453114160|FG005|Overall Study|Other|2|||
125949889|NCT03837899|453114155|FG000|Overall Study|Lost to Follow-up|0|||
125949890|NCT03837899|453114156|FG001|Overall Study|Lost to Follow-up|1|||
125949891|NCT03837899|453114157|FG002|Overall Study|Lost to Follow-up|0|||
125949892|NCT03837899|453114158|FG003|Overall Study|Lost to Follow-up|0|||
125949893|NCT03837899|453114159|FG004|Overall Study|Lost to Follow-up|0|||
125949894|NCT03837899|453114160|FG005|Overall Study|Lost to Follow-up|0|||
125949895|NCT03837899|453114155|FG000|Overall Study|Withdrawal by Subject|0|||
125949896|NCT03837899|453114156|FG001|Overall Study|Withdrawal by Subject|0|||
125949897|NCT03837899|453114157|FG002|Overall Study|Withdrawal by Subject|0|||
125949898|NCT03837899|453114158|FG003|Overall Study|Withdrawal by Subject|1|||
125949899|NCT03837899|453114159|FG004|Overall Study|Withdrawal by Subject|0|||
125949900|NCT03837899|453114160|FG005|Overall Study|Withdrawal by Subject|0|||
125949901|NCT03837899|453114155|FG000|Overall Study|Study specific discontinuation criteria|0|||
125949902|NCT03837899|453114156|FG001|Overall Study|Study specific discontinuation criteria|1|||
125949903|NCT03837899|453114157|FG002|Overall Study|Study specific discontinuation criteria|0|||
125949904|NCT03837899|453114158|FG003|Overall Study|Study specific discontinuation criteria|0|||
125949905|NCT03837899|453114159|FG004|Overall Study|Study specific discontinuation criteria|3|||
125949906|NCT03837899|453114160|FG005|Overall Study|Study specific discontinuation criteria|1|||
125949907|NCT01371656|453114161|FG000|Overall Study|Death|7|||
125949908|NCT01371656|453114162|FG001|Overall Study|Death|4|||
125949909|NCT01371656|453114161|FG000|Overall Study|Physician Decision|46|||
125949910|NCT01371656|453114162|FG001|Overall Study|Physician Decision|7|||
125949911|NCT01371656|453114161|FG000|Overall Study|Withdrawal by Subject|7|||
125949912|NCT01371656|453114162|FG001|Overall Study|Withdrawal by Subject|0|||
125949913|NCT01371656|453114161|FG000|Overall Study|Ineligible|4|||
125949914|NCT01371656|453114162|FG001|Overall Study|Ineligible|3|||
125949915|NCT01465464|453114163|FG000|Overall Study|Adverse Event|96|||
125949916|NCT01465464|453114164|FG001|Overall Study|Adverse Event|49|||
125949917|NCT01465464|453114163|FG000|Overall Study|Lack of Efficacy|139|||
125949918|NCT01465464|453114164|FG001|Overall Study|Lack of Efficacy|190|||
125949919|NCT01465464|453114163|FG000|Overall Study|Physician Decision|13|||
125949920|NCT01465464|453114164|FG001|Overall Study|Physician Decision|5|||
125949921|NCT01465464|453114163|FG000|Overall Study|Protocol Violation|1|||
125949922|NCT01465464|453114164|FG001|Overall Study|Protocol Violation|1|||
125949923|NCT01465464|453114163|FG000|Overall Study|Withdrawal by Subject|46|||
125949924|NCT01465464|453114164|FG001|Overall Study|Withdrawal by Subject|30|||
125949925|NCT01465464|453114163|FG000|Overall Study|Other|9|||
125949926|NCT01465464|453114164|FG001|Overall Study|Other|3|||
125949927|NCT01465464|453114163|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
125949928|NCT01465464|453114164|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
125949929|NCT00785486|453114165|FG000|Midazolam Alone|Withdrawal by Subject|1|||
125949930|NCT01554618|453114166|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
125949931|NCT01554618|453114167|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
125949932|NCT01554618|453114166|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
125949933|NCT01554618|453114167|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
125949934|NCT01554618|453114166|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
125949935|NCT01554618|453114167|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
125949936|NCT01554618|453114166|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
125949937|NCT01554618|453114167|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
125949938|NCT01554618|453114166|FG000|Open-Label Extension Period|Physician Decision|0|||
125949939|NCT01554618|453114167|FG001|Open-Label Extension Period|Physician Decision|1|||
125949940|NCT01554618|453114166|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
125949941|NCT01554618|453114167|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
125949942|NCT01393405|453114171|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
125949943|NCT01393405|453114172|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
125949944|NCT01393405|453114173|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
125949945|NCT01393405|453114171|FG000|Induction Period (week1-16)|Adverse Event|16|||
125949946|NCT01393405|453114172|FG001|Induction Period (week1-16)|Adverse Event|0|||
125949947|NCT01393405|453114173|FG002|Induction Period (week1-16)|Adverse Event|0|||
125949948|NCT01393405|453114171|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
125949949|NCT01393405|453114172|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
125949950|NCT01393405|453114173|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
125949951|NCT01393405|453114171|FG000|Maintenance Period Week|Lack of Efficacy|0|||
125949952|NCT01393405|453114172|FG001|Maintenance Period Week|Lack of Efficacy|22|||
125949953|NCT01393405|453114173|FG002|Maintenance Period Week|Lack of Efficacy|22|||
125949954|NCT01393405|453114171|FG000|Maintenance Period Week|Adverse Event|0|||
125949955|NCT01393405|453114172|FG001|Maintenance Period Week|Adverse Event|5|||
125949956|NCT01393405|453114173|FG002|Maintenance Period Week|Adverse Event|2|||
125949957|NCT01393405|453114171|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
125949958|NCT01393405|453114172|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
125949959|NCT01393405|453114173|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
125949960|NCT01393405|453114171|FG000|Maintenance Period Week|Lost to Follow-up|0|||
125949961|NCT01393405|453114172|FG001|Maintenance Period Week|Lost to Follow-up|1|||
125949962|NCT01393405|453114173|FG002|Maintenance Period Week|Lost to Follow-up|0|||
125949963|NCT02540954|453114176|FG000|Overall Study|Physician Decision|3|||
125949964|NCT02540954|453114177|FG001|Overall Study|Physician Decision|1|||
125949965|NCT02540954|453114176|FG000|Overall Study|Withdrawal by Subject|6|||
125949966|NCT02540954|453114177|FG001|Overall Study|Withdrawal by Subject|5|||
125949967|NCT02540954|453114176|FG000|Overall Study|Lost to Follow-up|1|||
125949968|NCT02540954|453114177|FG001|Overall Study|Lost to Follow-up|1|||
125949969|NCT02540954|453114176|FG000|Overall Study|Adverse Event|4|||
125949970|NCT02540954|453114177|FG001|Overall Study|Adverse Event|2|||
125949971|NCT02540954|453114176|FG000|Overall Study|Death|0|||
125949972|NCT02540954|453114177|FG001|Overall Study|Death|3|||
125949973|NCT02540954|453114176|FG000|Overall Study|Treatment failure|1|||
125949974|NCT02540954|453114177|FG001|Overall Study|Treatment failure|0|||
125949975|NCT02540954|453114176|FG000|Overall Study|Other reason|4|||
125949976|NCT02540954|453114177|FG001|Overall Study|Other reason|2|||
125949977|NCT01393743|453114178|FG000|Core Study|Adverse Event|5|||
125949978|NCT01393743|453114179|FG001|Core Study|Adverse Event|9|||
125949979|NCT01393743|453114180|FG002|Core Study|Adverse Event|0|||
125949980|NCT01393743|453114178|FG000|Core Study|Lost to Follow-up|1|||
125949981|NCT01393743|453114179|FG001|Core Study|Lost to Follow-up|1|||
125949982|NCT01393743|453114180|FG002|Core Study|Lost to Follow-up|0|||
125949983|NCT01393743|453114178|FG000|Core Study|Participant's Choice|2|||
125949984|NCT01393743|453114179|FG001|Core Study|Participant's Choice|3|||
125949985|NCT01393743|453114180|FG002|Core Study|Participant's Choice|0|||
125949986|NCT01393743|453114178|FG000|Core Study|Inadequate therapeutic effect|2|||
125949987|NCT01393743|453114179|FG001|Core Study|Inadequate therapeutic effect|0|||
125949988|NCT01393743|453114180|FG002|Core Study|Inadequate therapeutic effect|0|||
125949989|NCT01393743|453114178|FG000|Extension Phase|Adverse Event|0|||
125949990|NCT01393743|453114179|FG001|Extension Phase|Adverse Event|0|||
125949991|NCT01393743|453114180|FG002|Extension Phase|Adverse Event|12|||
125949992|NCT01393743|453114178|FG000|Extension Phase|Lost to Follow-up|0|||
125949993|NCT01393743|453114179|FG001|Extension Phase|Lost to Follow-up|0|||
125949994|NCT01393743|453114180|FG002|Extension Phase|Lost to Follow-up|2|||
125949995|NCT01393743|453114178|FG000|Extension Phase|Participant choice|0|||
125949996|NCT01393743|453114179|FG001|Extension Phase|Participant choice|0|||
125949997|NCT01393743|453114180|FG002|Extension Phase|Participant choice|16|||
125949998|NCT01393743|453114178|FG000|Extension Phase|Inadequate therapeutic effect|0|||
125949999|NCT01393743|453114179|FG001|Extension Phase|Inadequate therapeutic effect|0|||
125950000|NCT01393743|453114180|FG002|Extension Phase|Inadequate therapeutic effect|7|||
125950001|NCT01393743|453114178|FG000|Extension Phase|Withdrawal by Subject|0|||
125950002|NCT01393743|453114179|FG001|Extension Phase|Withdrawal by Subject|0|||
125950003|NCT01393743|453114180|FG002|Extension Phase|Withdrawal by Subject|8|||
125950004|NCT01393743|453114178|FG000|Extension Phase|Pregnancy|0|||
125950005|NCT01393743|453114179|FG001|Extension Phase|Pregnancy|0|||
125950006|NCT01393743|453114180|FG002|Extension Phase|Pregnancy|1|||
125950007|NCT01393743|453114178|FG000|Extension Phase|Other|0|||
125950008|NCT01393743|453114179|FG001|Extension Phase|Other|0|||
125950009|NCT01393743|453114180|FG002|Extension Phase|Other|14|||
125950010|NCT02321462|453114181|FG000|Overall Study|Withdrawal by Subject|5|||
125950011|NCT02321462|453114182|FG001|Overall Study|Withdrawal by Subject|2|||
125950012|NCT02321462|453114181|FG000|Overall Study|Subject withdrawn before any treatment|1|||
125950013|NCT02321462|453114182|FG001|Overall Study|Subject withdrawn before any treatment|1|||
125950014|NCT03829046|453114195|FG000|Overall Study|Withdrawal by Subject|1|||
125950015|NCT03829046|453114196|FG001|Overall Study|Withdrawal by Subject|0|||
125950016|NCT00989833|453114201|FG000|Overall Study|Lost to Follow-up|0|||
125950017|NCT00989833|453114202|FG001|Overall Study|Lost to Follow-up|1|||
125950018|NCT00989833|453114203|FG002|Overall Study|Lost to Follow-up|0|||
125950019|NCT00989833|453114201|FG000|Overall Study|Protocol Violation|1|||
125950020|NCT00989833|453114202|FG001|Overall Study|Protocol Violation|2|||
125950021|NCT00989833|453114203|FG002|Overall Study|Protocol Violation|1|||
125950022|NCT00989833|453114201|FG000|Overall Study|Withdrawal by Subject|0|||
125950023|NCT00989833|453114202|FG001|Overall Study|Withdrawal by Subject|0|||
125950024|NCT00989833|453114203|FG002|Overall Study|Withdrawal by Subject|1|||
125950025|NCT00989833|453114201|FG000|Overall Study|Incorrectly randomized|1|||
125950026|NCT00989833|453114202|FG001|Overall Study|Incorrectly randomized|0|||
125950027|NCT00989833|453114203|FG002|Overall Study|Incorrectly randomized|0|||
125950028|NCT00244712|453114206|FG000|Overall Study|Adverse Event|20|||
125950029|NCT00244712|453114207|FG001|Overall Study|Adverse Event|21|||
125950030|NCT00244712|453114206|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
125950031|NCT00244712|453114207|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
125950032|NCT00244712|453114206|FG000|Overall Study|Lack of Compliance|10|||
125950033|NCT00244712|453114207|FG001|Overall Study|Lack of Compliance|11|||
125950034|NCT00244712|453114206|FG000|Overall Study|Lost to Follow-up|45|||
125950035|NCT00244712|453114207|FG001|Overall Study|Lost to Follow-up|52|||
125950036|NCT00244712|453114206|FG000|Overall Study|Withdrawal by Subject|13|||
125950037|NCT00244712|453114207|FG001|Overall Study|Withdrawal by Subject|23|||
125950038|NCT00244712|453114206|FG000|Overall Study|Protocol Violation, disease progression|13|||
125950039|NCT00244712|453114207|FG001|Overall Study|Protocol Violation, disease progression|11|||
125950040|NCT00500370|453114208|FG000|Overall Study|Adverse Event|9|||
125950041|NCT00500370|453114209|FG001|Overall Study|Adverse Event|3|||
125950042|NCT00500370|453114208|FG000|Overall Study|Lost to Follow-up|10|||
125950043|NCT00500370|453114209|FG001|Overall Study|Lost to Follow-up|10|||
125950044|NCT00500370|453114208|FG000|Overall Study|Protocol Violation|2|||
125950045|NCT00500370|453114209|FG001|Overall Study|Protocol Violation|4|||
125950046|NCT00500370|453114208|FG000|Overall Study|Sponsor Decision|2|||
125950047|NCT00500370|453114209|FG001|Overall Study|Sponsor Decision|0|||
125950048|NCT00500370|453114208|FG000|Overall Study|Subject Decision|10|||
125950049|NCT00500370|453114209|FG001|Overall Study|Subject Decision|17|||
125950050|NCT00714259|453114210|FG000|Overall Study|Death|2|||
125950051|NCT05627518|453114211|FG000|Treatment Period 1|Adverse Event|0|||
125950052|NCT05627518|453114212|FG001|Treatment Period 1|Adverse Event|0|||
125950053|NCT05627518|453114213|FG002|Treatment Period 1|Adverse Event|1|||
125950054|NCT05627518|453114214|FG003|Treatment Period 1|Adverse Event|0|||
125950055|NCT05627518|453114215|FG004|Treatment Period 1|Adverse Event|0|||
125950056|NCT05627518|453114216|FG005|Treatment Period 1|Adverse Event|0|||
125950057|NCT05627518|453114217|FG006|Treatment Period 1|Adverse Event|0|||
125950058|NCT05627518|453114218|FG007|Treatment Period 1|Adverse Event|1|||
125950059|NCT05627518|453114211|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125950060|NCT05627518|453114212|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125950061|NCT05627518|453114213|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125950062|NCT05627518|453114214|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125950063|NCT05627518|453114215|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125950064|NCT05627518|453114216|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125950065|NCT05627518|453114217|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125950066|NCT05627518|453114218|FG007|Treatment Period 1|Withdrawal by Subject|0|||
125950067|NCT05627518|453114211|FG000|Treatment Period 1|Protocol Violation|0|||
125950068|NCT05627518|453114212|FG001|Treatment Period 1|Protocol Violation|0|||
125950069|NCT05627518|453114213|FG002|Treatment Period 1|Protocol Violation|0|||
125950070|NCT05627518|453114214|FG003|Treatment Period 1|Protocol Violation|0|||
125950071|NCT05627518|453114215|FG004|Treatment Period 1|Protocol Violation|0|||
125950072|NCT05627518|453114216|FG005|Treatment Period 1|Protocol Violation|0|||
125950073|NCT05627518|453114217|FG006|Treatment Period 1|Protocol Violation|6|||
125950074|NCT05627518|453114218|FG007|Treatment Period 1|Protocol Violation|6|||
125950075|NCT05627518|453114211|FG000|Treatment Period 2|Adverse Event|1|||
125950076|NCT05627518|453114212|FG001|Treatment Period 2|Adverse Event|0|||
125950077|NCT05627518|453114213|FG002|Treatment Period 2|Adverse Event|0|||
125950078|NCT05627518|453114214|FG003|Treatment Period 2|Adverse Event|0|||
125950079|NCT05627518|453114215|FG004|Treatment Period 2|Adverse Event|0|||
125950080|NCT05627518|453114216|FG005|Treatment Period 2|Adverse Event|0|||
125950081|NCT05627518|453114217|FG006|Treatment Period 2|Adverse Event|0|||
125950082|NCT05627518|453114218|FG007|Treatment Period 2|Adverse Event|0|||
125950083|NCT05627518|453114211|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125950084|NCT05627518|453114212|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125950085|NCT05627518|453114213|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125950086|NCT05627518|453114214|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125950087|NCT05627518|453114215|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125950088|NCT05627518|453114216|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125950089|NCT05627518|453114217|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125950090|NCT05627518|453114218|FG007|Treatment Period 2|Withdrawal by Subject|0|||
125950091|NCT00574405|453115950|FG000|Overall Study|Withdrawal by Subject|3|||
125950092|NCT00574405|453115951|FG001|Overall Study|Withdrawal by Subject|2|||
125950093|NCT01336738|453115952|FG000|Overall Study|Adverse Event|0|||
125950094|NCT01336738|453115953|FG001|Overall Study|Adverse Event|3|||
125950095|NCT01336738|453115954|FG002|Overall Study|Adverse Event|2|||
125950096|NCT01336738|453115955|FG003|Overall Study|Adverse Event|1|||
125950097|NCT01336738|453115956|FG004|Overall Study|Adverse Event|3|||
125950098|NCT01336738|453115952|FG000|Overall Study|Lost to Follow-up|2|||
125950099|NCT01336738|453115953|FG001|Overall Study|Lost to Follow-up|1|||
125950100|NCT01336738|453115954|FG002|Overall Study|Lost to Follow-up|2|||
125950101|NCT01336738|453115955|FG003|Overall Study|Lost to Follow-up|2|||
125950102|NCT01336738|453115956|FG004|Overall Study|Lost to Follow-up|2|||
125950103|NCT01336738|453115952|FG000|Overall Study|Did not meet entrance criteria|0|||
125950104|NCT01336738|453115953|FG001|Overall Study|Did not meet entrance criteria|1|||
125950105|NCT01336738|453115954|FG002|Overall Study|Did not meet entrance criteria|0|||
125950106|NCT01336738|453115955|FG003|Overall Study|Did not meet entrance criteria|0|||
125950107|NCT01336738|453115956|FG004|Overall Study|Did not meet entrance criteria|0|||
125950108|NCT01336738|453115952|FG000|Overall Study|Protocol Violation|0|||
125950109|NCT01336738|453115953|FG001|Overall Study|Protocol Violation|1|||
125950110|NCT01336738|453115954|FG002|Overall Study|Protocol Violation|0|||
125950111|NCT01336738|453115955|FG003|Overall Study|Protocol Violation|0|||
125950112|NCT01336738|453115956|FG004|Overall Study|Protocol Violation|0|||
125950113|NCT01336738|453115952|FG000|Overall Study|Withdrawal by Subject|2|||
125950114|NCT01336738|453115953|FG001|Overall Study|Withdrawal by Subject|0|||
125950115|NCT01336738|453115954|FG002|Overall Study|Withdrawal by Subject|2|||
125950116|NCT01336738|453115955|FG003|Overall Study|Withdrawal by Subject|1|||
125950117|NCT01336738|453115956|FG004|Overall Study|Withdrawal by Subject|1|||
125950118|NCT01336738|453115952|FG000|Overall Study|Other|3|||
125950119|NCT01336738|453115953|FG001|Overall Study|Other|3|||
125950120|NCT01336738|453115954|FG002|Overall Study|Other|2|||
125950121|NCT01336738|453115955|FG003|Overall Study|Other|3|||
125950122|NCT01336738|453115956|FG004|Overall Study|Other|4|||
125950123|NCT03003520|453115958|FG000|Overall Study|Adverse Event|9|||
125950124|NCT03003520|453115959|FG001|Overall Study|Adverse Event|0|||
125950125|NCT03003520|453115958|FG000|Overall Study|Death|1|||
125950126|NCT03003520|453115959|FG001|Overall Study|Death|0|||
125950127|NCT03003520|453115958|FG000|Overall Study|Other reasons|4|||
125950128|NCT03003520|453115959|FG001|Overall Study|Other reasons|0|||
125950129|NCT03003520|453115958|FG000|Overall Study|Withdrawal by Subject|6|||
125950130|NCT03003520|453115959|FG001|Overall Study|Withdrawal by Subject|0|||
125950131|NCT03003520|453115958|FG000|Overall Study|Progressive disease|9|||
125950132|NCT03003520|453115959|FG001|Overall Study|Progressive disease|1|||
125950133|NCT05084053|453115962|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
125950134|NCT05084053|453115963|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
125950135|NCT05084053|453115964|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
125950136|NCT05084053|453115965|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
125950137|NCT05084053|453115962|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
125950138|NCT05084053|453115963|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
125950139|NCT05084053|453115964|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
125950140|NCT05084053|453115965|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
125950141|NCT05084053|453115962|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
125950142|NCT05084053|453115963|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
125950143|NCT05084053|453115964|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
125950144|NCT05084053|453115965|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
125950145|NCT01920932|453115966|FG000|Overall Study|Death|1|||
125950146|NCT01920932|453115966|FG000|Overall Study|Withdrawal of consent|1|||
125950147|NCT00071812|453115967|FG000|24-Week Double-Blind Period|Adverse Event|2|||
125950148|NCT00071812|453115968|FG001|24-Week Double-Blind Period|Adverse Event|3|||
125950149|NCT00071812|453115969|FG002|24-Week Double-Blind Period|Adverse Event|4|||
125950150|NCT00071812|453115970|FG003|24-Week Double-Blind Period|Adverse Event|4|||
125950151|NCT00071812|453115967|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
125950152|NCT00071812|453115968|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
125950153|NCT00071812|453115969|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
125950154|NCT00071812|453115970|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
125950155|NCT00071812|453115967|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
125950156|NCT00071812|453115968|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
125950157|NCT00071812|453115969|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
125950158|NCT00071812|453115970|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
125950159|NCT00071812|453115967|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
125950160|NCT00071812|453115968|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
125950161|NCT00071812|453115969|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
125950162|NCT00071812|453115970|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
125950163|NCT00071812|453115967|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
125950164|NCT00071812|453115968|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
125950165|NCT00071812|453115969|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
125950166|NCT00071812|453115970|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
125950167|NCT00071812|453115967|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
125950168|NCT00071812|453115968|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
125950169|NCT00071812|453115969|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
125950170|NCT00071812|453115970|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
125950171|NCT00071812|453115967|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125950172|NCT00071812|453115968|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125950173|NCT00071812|453115969|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125950174|NCT00071812|453115970|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
125950175|NCT00071812|453115967|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125950176|NCT00071812|453115968|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125950177|NCT00071812|453115969|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125950178|NCT00071812|453115970|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
125950179|NCT00071812|453115967|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125950180|NCT00071812|453115968|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125950181|NCT00071812|453115969|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125950182|NCT00071812|453115970|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
125950183|NCT00071812|453115967|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125950184|NCT00071812|453115968|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125950185|NCT00071812|453115969|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
125950186|NCT00071812|453115970|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
125950187|NCT00697346|453115971|FG000|Overall Study|Adverse Event|4|||
125950188|NCT00697346|453115972|FG001|Overall Study|Adverse Event|5|||
125950189|NCT00697346|453115973|FG002|Overall Study|Adverse Event|0|||
125950190|NCT00697346|453115971|FG000|Overall Study|Progressive Disease|19|||
125950191|NCT00697346|453115972|FG001|Overall Study|Progressive Disease|18|||
125950192|NCT00697346|453115973|FG002|Overall Study|Progressive Disease|0|||
125950193|NCT00697346|453115971|FG000|Overall Study|Symptomatic Deterioration|0|||
125950194|NCT00697346|453115972|FG001|Overall Study|Symptomatic Deterioration|1|||
125950195|NCT00697346|453115973|FG002|Overall Study|Symptomatic Deterioration|0|||
125950196|NCT00697346|453115971|FG000|Overall Study|Withdrawal by Subject|2|||
125950197|NCT00697346|453115972|FG001|Overall Study|Withdrawal by Subject|2|||
125950198|NCT00697346|453115973|FG002|Overall Study|Withdrawal by Subject|0|||
125950199|NCT00697346|453115971|FG000|Overall Study|Reason not Specified|3|||
125950200|NCT00697346|453115972|FG001|Overall Study|Reason not Specified|0|||
125950201|NCT00697346|453115973|FG002|Overall Study|Reason not Specified|1|||
125950202|NCT00348556|453115978|FG000|Overall Study|Adverse Event|1|||
125950203|NCT00333229|453115981|FG000|Overall Study|Lack of Efficacy|0|||
125950204|NCT00333229|453115982|FG001|Overall Study|Lack of Efficacy|1|||
125950205|NCT00240071|453115983|FG000|Overall Study|Withdrawal by Subject|3|||
125950206|NCT01944059|453115984|FG000|Overall Study|Lost to Follow-up|1|||
125950207|NCT01944059|453115984|FG000|Overall Study|Physician Decision|3|||
125950208|NCT01944059|453115984|FG000|Overall Study|Withdrawal by Subject|1|||
125950209|NCT01944059|453115984|FG000|Overall Study|Adverse Event|2|||
125950210|NCT00463060|453115995|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
125950211|NCT00463060|453115995|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
125950212|NCT01802775|453115998|FG000|Overall Study|Death|0|||
125950213|NCT01802775|453115999|FG001|Overall Study|Death|3|||
125950214|NCT01802775|453115998|FG000|Overall Study|Reason not provided|0|||
125950215|NCT01802775|453115999|FG001|Overall Study|Reason not provided|1|||
125950216|NCT01802775|453115998|FG000|Overall Study|Physician Decision|1|||
125950217|NCT01802775|453115999|FG001|Overall Study|Physician Decision|0|||
125950218|NCT01802775|453115998|FG000|Overall Study|Adverse Event|1|||
125950219|NCT01802775|453115999|FG001|Overall Study|Adverse Event|1|||
125950220|NCT01802775|453115998|FG000|Overall Study|Withdrawal by Subject|3|||
125950221|NCT01802775|453115999|FG001|Overall Study|Withdrawal by Subject|5|||
125950222|NCT01802775|453115998|FG000|Overall Study|Lost to Follow-up|1|||
125950223|NCT01802775|453115999|FG001|Overall Study|Lost to Follow-up|2|||
125950224|NCT00048542|453116005|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125950225|NCT00048542|453116006|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
125950226|NCT00048542|453116007|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125950227|NCT00048542|453116008|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126115040|NCT01621542|453715830|FG002|Overall Study|progression/treatment failure|3|||
126115041|NCT01621542|453715831|FG003|Overall Study|progression/treatment failure|7|||
126115042|NCT01621542|453715832|FG004|Overall Study|progression/treatment failure|3|||
126115043|NCT01621542|453715833|FG005|Overall Study|progression/treatment failure|5|||
126115044|NCT01621542|453715828|FG000|Overall Study|Protocol Violation|0|||
126115045|NCT01621542|453715829|FG001|Overall Study|Protocol Violation|0|||
126115046|NCT01621542|453715830|FG002|Overall Study|Protocol Violation|0|||
126115047|NCT01621542|453715831|FG003|Overall Study|Protocol Violation|1|||
126115048|NCT01621542|453715832|FG004|Overall Study|Protocol Violation|0|||
126115049|NCT01621542|453715833|FG005|Overall Study|Protocol Violation|0|||
126115050|NCT01621542|453715828|FG000|Overall Study|study stopped by sponsor|0|||
126115051|NCT01621542|453715829|FG001|Overall Study|study stopped by sponsor|0|||
125950228|NCT00048542|453116009|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125950229|NCT00048542|453116010|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
125950230|NCT00048542|453116011|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
125950231|NCT00048542|453116012|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
125950232|NCT00048542|453116005|FG000|Double-Blind Phase|Protocol Violation|0|||
125950233|NCT00048542|453116006|FG001|Double-Blind Phase|Protocol Violation|0|||
126115052|NCT01621542|453715830|FG002|Overall Study|study stopped by sponsor|0|||
126115053|NCT01621542|453715831|FG003|Overall Study|study stopped by sponsor|1|||
126115054|NCT01621542|453715832|FG004|Overall Study|study stopped by sponsor|0|||
126115055|NCT01621542|453715833|FG005|Overall Study|study stopped by sponsor|0|||
126115056|NCT01368042|453715834|FG000|Overall Study|Death|14|||
125950234|NCT00048542|453116007|FG002|Double-Blind Phase|Protocol Violation|1|||
125950235|NCT00048542|453116008|FG003|Double-Blind Phase|Protocol Violation|0|||
125950236|NCT00048542|453116009|FG004|Double-Blind Phase|Protocol Violation|0|||
125950237|NCT00048542|453116010|FG005|Double-Blind Phase|Protocol Violation|0|||
125950238|NCT00048542|453116011|FG006|Double-Blind Phase|Protocol Violation|0|||
125950239|NCT00048542|453116012|FG007|Double-Blind Phase|Protocol Violation|0|||
125950240|NCT00048542|453116005|FG000|Double-Blind Phase|Sponsor request or decision|2|||
125950241|NCT00048542|453116006|FG001|Double-Blind Phase|Sponsor request or decision|0|||
125950242|NCT00048542|453116007|FG002|Double-Blind Phase|Sponsor request or decision|0|||
125950243|NCT00048542|453116008|FG003|Double-Blind Phase|Sponsor request or decision|0|||
125950244|NCT00048542|453116009|FG004|Double-Blind Phase|Sponsor request or decision|0|||
125950245|NCT00048542|453116010|FG005|Double-Blind Phase|Sponsor request or decision|0|||
125950246|NCT00048542|453116011|FG006|Double-Blind Phase|Sponsor request or decision|0|||
125950247|NCT00048542|453116012|FG007|Double-Blind Phase|Sponsor request or decision|0|||
125950248|NCT00048542|453116005|FG000|Double-Blind Phase|Randomized in error|1|||
125950249|NCT00048542|453116006|FG001|Double-Blind Phase|Randomized in error|0|||
125950250|NCT00048542|453116007|FG002|Double-Blind Phase|Randomized in error|0|||
126079591|NCT02706847|453585898|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
126079592|NCT02706847|453585899|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
126079593|NCT02706847|453585896|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
126079594|NCT02706847|453585897|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
126079595|NCT02706847|453585898|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
126079596|NCT02706847|453585899|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
126079597|NCT02706847|453585896|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
126079598|NCT02706847|453585897|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
126079599|NCT02706847|453585898|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
126079600|NCT02706847|453585899|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
126079601|NCT02706847|453585896|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
126079602|NCT02706847|453585897|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
126079603|NCT02706847|453585898|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
126079604|NCT02706847|453585899|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
126079605|NCT02706847|453585896|FG000|Period 1: Week 12 to Week 24|Other|1|||
126079606|NCT02706847|453585897|FG001|Period 1: Week 12 to Week 24|Other|0|||
126079607|NCT02706847|453585898|FG002|Period 1: Week 12 to Week 24|Other|1|||
126079608|NCT02706847|453585899|FG003|Period 1: Week 12 to Week 24|Other|4|||
126079609|NCT02706847|453585896|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
126079610|NCT02706847|453585897|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
126079611|NCT02706847|453585898|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
126079612|NCT02706847|453585899|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
126079613|NCT02706847|453585896|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
125950251|NCT00048542|453116008|FG003|Double-Blind Phase|Randomized in error|0|||
126079614|NCT02706847|453585897|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
126079615|NCT02706847|453585898|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
126079616|NCT02706847|453585899|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
126079617|NCT02706847|453585896|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
126079618|NCT02706847|453585897|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
126079619|NCT02706847|453585898|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
125950252|NCT00048542|453116009|FG004|Double-Blind Phase|Randomized in error|0|||
125950253|NCT00048542|453116010|FG005|Double-Blind Phase|Randomized in error|0|||
125950254|NCT00048542|453116011|FG006|Double-Blind Phase|Randomized in error|0|||
125950255|NCT00048542|453116012|FG007|Double-Blind Phase|Randomized in error|0|||
125950256|NCT00048542|453116005|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125950257|NCT00048542|453116006|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125950258|NCT00048542|453116007|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125950259|NCT00048542|453116008|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125950260|NCT00048542|453116009|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
125950261|NCT00048542|453116010|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
125950262|NCT00048542|453116011|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125950263|NCT00048542|453116012|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125950264|NCT00048542|453116005|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
125950265|NCT00048542|453116006|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
125950266|NCT00048542|453116007|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
125950267|NCT00048542|453116008|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
125950268|NCT00048542|453116009|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
125950269|NCT00048542|453116010|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
125950270|NCT00048542|453116011|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
125950271|NCT00048542|453116012|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
125950272|NCT00048542|453116005|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125950273|NCT00048542|453116006|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125950274|NCT00048542|453116007|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125950275|NCT00048542|453116008|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125950276|NCT00048542|453116009|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
125950277|NCT00048542|453116010|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
125950278|NCT00048542|453116011|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125950279|NCT00048542|453116012|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125950280|NCT00048542|453116005|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
125950281|NCT00048542|453116006|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
125950282|NCT00048542|453116007|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
125950283|NCT00048542|453116008|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
125950284|NCT00048542|453116009|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
125950285|NCT00048542|453116010|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
125950286|NCT00048542|453116011|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
125950287|NCT00048542|453116012|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
125950288|NCT00048542|453116005|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125950289|NCT00048542|453116006|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125950290|NCT00048542|453116007|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125950291|NCT00048542|453116008|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125950292|NCT00048542|453116009|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
125950293|NCT00048542|453116010|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
125950294|NCT00048542|453116011|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125950295|NCT00048542|453116012|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125950296|NCT00048542|453116005|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125950297|NCT00048542|453116006|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125950298|NCT00048542|453116007|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125950299|NCT00048542|453116008|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125950300|NCT00048542|453116009|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125950301|NCT00048542|453116010|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125950302|NCT00048542|453116011|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
125950303|NCT00048542|453116012|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
125950304|NCT00048542|453116005|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125950305|NCT00048542|453116006|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125950306|NCT00048542|453116007|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125950307|NCT00048542|453116008|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125950308|NCT00048542|453116009|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125950309|NCT00048542|453116010|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125950310|NCT00048542|453116011|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
125950311|NCT00048542|453116012|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
125950312|NCT00048542|453116005|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125950313|NCT00048542|453116006|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125950314|NCT00048542|453116007|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125950315|NCT00048542|453116008|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125950316|NCT00048542|453116009|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125950317|NCT00048542|453116010|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125950318|NCT00048542|453116011|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
125950319|NCT00048542|453116012|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
125950320|NCT00048542|453116005|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125950321|NCT00048542|453116006|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125950322|NCT00048542|453116007|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125950323|NCT00048542|453116008|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125950324|NCT00048542|453116009|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125950325|NCT00048542|453116010|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125950326|NCT00048542|453116011|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
125950327|NCT00048542|453116012|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
125950328|NCT00048542|453116005|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125950329|NCT00048542|453116006|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125950330|NCT00048542|453116007|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125950331|NCT00048542|453116008|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125950332|NCT00048542|453116009|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125950333|NCT00048542|453116010|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125950334|NCT00048542|453116011|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
125950335|NCT00048542|453116012|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
125950336|NCT00048542|453116005|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125950337|NCT00048542|453116006|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125950338|NCT00048542|453116007|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125950339|NCT00048542|453116008|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125950340|NCT00048542|453116009|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125950341|NCT00048542|453116010|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125950342|NCT00048542|453116011|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
125950343|NCT00048542|453116012|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
125950344|NCT00578175|453116013|FG000|Overall Study|Adverse Event|0|||
125950345|NCT00578175|453116014|FG001|Overall Study|Adverse Event|1|||
125950346|NCT00578175|453116015|FG002|Overall Study|Adverse Event|1|||
125950347|NCT00578175|453116013|FG000|Overall Study|Other reasons|70|||
125950348|NCT00578175|453116014|FG001|Overall Study|Other reasons|42|||
125950349|NCT00578175|453116015|FG002|Overall Study|Other reasons|23|||
125950350|NCT00486265|453116020|FG000|Overall Study|Adverse Event|1|||
125950351|NCT00486265|453116020|FG000|Overall Study|Lack of Efficacy|8|||
125950352|NCT01452412|453116021|FG000|Overall Study|Withdrawal by Subject|15|||
125950353|NCT01452412|453116022|FG001|Overall Study|Withdrawal by Subject|11|||
125950354|NCT01452412|453116021|FG000|Overall Study|Adverse Event|4|||
125950355|NCT01452412|453116022|FG001|Overall Study|Adverse Event|3|||
125950356|NCT01452412|453116021|FG000|Overall Study|Lost to Follow-up|5|||
125950357|NCT01452412|453116022|FG001|Overall Study|Lost to Follow-up|3|||
125950358|NCT01452412|453116021|FG000|Overall Study|Death|1|||
125950359|NCT01452412|453116022|FG001|Overall Study|Death|0|||
125950360|NCT01452412|453116021|FG000|Overall Study|Initiated dialysis|1|||
125950361|NCT01452412|453116022|FG001|Overall Study|Initiated dialysis|0|||
125950362|NCT01452412|453116021|FG000|Overall Study|Other|2|||
125950363|NCT01452412|453116022|FG001|Overall Study|Other|0|||
125950364|NCT03013543|453116025|FG000|Overall Study|Withdrawal by Subject|0|||
125950365|NCT03013543|453116026|FG001|Overall Study|Withdrawal by Subject|2|||
125950366|NCT03013543|453116027|FG002|Overall Study|Withdrawal by Subject|0|||
125950367|NCT03013543|453116028|FG003|Overall Study|Withdrawal by Subject|5|||
125950368|NCT03013543|453116029|FG004|Overall Study|Withdrawal by Subject|6|||
125950369|NCT03013543|453116030|FG005|Overall Study|Withdrawal by Subject|2|||
125950370|NCT03013543|453116031|FG006|Overall Study|Withdrawal by Subject|3|||
125950371|NCT03013543|453116032|FG007|Overall Study|Withdrawal by Subject|1|||
125950372|NCT03013543|453116033|FG008|Overall Study|Withdrawal by Subject|0|||
125950373|NCT03013543|453116034|FG009|Overall Study|Withdrawal by Subject|4|||
125950374|NCT03013543|453116025|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125950375|NCT03013543|453116026|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
125950376|NCT03013543|453116027|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
125950377|NCT03013543|453116028|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
125950378|NCT03013543|453116029|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
125950379|NCT03013543|453116030|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
125950380|NCT03013543|453116031|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
126115057|NCT01368042|453715834|FG000|Overall Study|Protocol Violation|11|||
125950381|NCT03013543|453116032|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
125950382|NCT03013543|453116033|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
125950383|NCT03013543|453116034|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
125950384|NCT03013543|453116025|FG000|Overall Study|Other|0|||
125950385|NCT03013543|453116026|FG001|Overall Study|Other|0|||
125950386|NCT03013543|453116027|FG002|Overall Study|Other|2|||
125950387|NCT03013543|453116028|FG003|Overall Study|Other|0|||
126115058|NCT01368042|453715834|FG000|Overall Study|Lost to Follow-up|4|||
126115059|NCT01368042|453715834|FG000|Overall Study|Transplanted|1|||
125950388|NCT03013543|453116029|FG004|Overall Study|Other|2|||
125950389|NCT03013543|453116030|FG005|Overall Study|Other|0|||
125950390|NCT03013543|453116031|FG006|Overall Study|Other|0|||
126115060|NCT00955279|453715835|FG000|Overall Study|Other|0|||
126115061|NCT00955279|453715836|FG001|Overall Study|Other|0|||
126115062|NCT00955279|453715837|FG002|Overall Study|Other|3|||
125950391|NCT03013543|453116032|FG007|Overall Study|Other|0|||
125950392|NCT03013543|453116033|FG008|Overall Study|Other|1|||
125950393|NCT03013543|453116034|FG009|Overall Study|Other|0|||
125950394|NCT03013543|453116025|FG000|Overall Study|Adverse Event|0|||
125950395|NCT03013543|453116026|FG001|Overall Study|Adverse Event|0|||
125950396|NCT03013543|453116027|FG002|Overall Study|Adverse Event|0|||
125950397|NCT03013543|453116028|FG003|Overall Study|Adverse Event|3|||
125950398|NCT03013543|453116029|FG004|Overall Study|Adverse Event|2|||
126115063|NCT00955279|453715835|FG000|Overall Study|Death|1|||
126115064|NCT00955279|453715836|FG001|Overall Study|Death|1|||
126115065|NCT00955279|453715837|FG002|Overall Study|Death|1|||
126115066|NCT00955279|453715835|FG000|Overall Study|Lost to Follow-up|0|||
126115067|NCT00955279|453715836|FG001|Overall Study|Lost to Follow-up|3|||
126115068|NCT00955279|453715837|FG002|Overall Study|Lost to Follow-up|1|||
126115069|NCT00955279|453715835|FG000|Overall Study|Withdrawal by Subject|2|||
126115070|NCT00955279|453715836|FG001|Overall Study|Withdrawal by Subject|0|||
126115071|NCT00955279|453715837|FG002|Overall Study|Withdrawal by Subject|3|||
126115072|NCT02632721|453715839|FG000|Overall Study|Adverse Event|0|||
125950399|NCT03013543|453116030|FG005|Overall Study|Adverse Event|1|||
125950400|NCT03013543|453116031|FG006|Overall Study|Adverse Event|3|||
125950401|NCT03013543|453116032|FG007|Overall Study|Adverse Event|8|||
125950402|NCT03013543|453116033|FG008|Overall Study|Adverse Event|0|||
125950403|NCT03013543|453116034|FG009|Overall Study|Adverse Event|2|||
125950404|NCT03013543|453116025|FG000|Overall Study|Death|0|||
125950405|NCT03013543|453116026|FG001|Overall Study|Death|0|||
125950406|NCT03013543|453116027|FG002|Overall Study|Death|0|||
125950407|NCT03013543|453116028|FG003|Overall Study|Death|1|||
125950408|NCT03013543|453116029|FG004|Overall Study|Death|0|||
125950409|NCT03013543|453116030|FG005|Overall Study|Death|0|||
125950410|NCT03013543|453116031|FG006|Overall Study|Death|0|||
125950411|NCT03013543|453116032|FG007|Overall Study|Death|0|||
126115073|NCT02632721|453715840|FG001|Overall Study|Adverse Event|0|||
126115074|NCT02632721|453715841|FG002|Overall Study|Adverse Event|2|||
126115075|NCT02632721|453715842|FG003|Overall Study|Adverse Event|5|||
126115076|NCT02632721|453715843|FG004|Overall Study|Adverse Event|3|||
126115077|NCT02632721|453715839|FG000|Overall Study|Dose limiting toxicity|0|||
126115078|NCT02632721|453715840|FG001|Overall Study|Dose limiting toxicity|0|||
126115079|NCT02632721|453715841|FG002|Overall Study|Dose limiting toxicity|0|||
126115080|NCT02632721|453715842|FG003|Overall Study|Dose limiting toxicity|1|||
126115081|NCT02632721|453715843|FG004|Overall Study|Dose limiting toxicity|0|||
125950412|NCT03013543|453116033|FG008|Overall Study|Death|0|||
125950413|NCT03013543|453116034|FG009|Overall Study|Death|0|||
125950414|NCT03013543|453116025|FG000|Overall Study|Lack of Efficacy|0|||
126115082|NCT02632721|453715839|FG000|Overall Study|Progressive disease|3|||
126115083|NCT02632721|453715840|FG001|Overall Study|Progressive disease|0|||
126115084|NCT02632721|453715841|FG002|Overall Study|Progressive disease|4|||
126115085|NCT02632721|453715842|FG003|Overall Study|Progressive disease|6|||
126115086|NCT02632721|453715843|FG004|Overall Study|Progressive disease|5|||
126115087|NCT02632721|453715839|FG000|Overall Study|Refused to continue taking trial medication|0|||
126115088|NCT02632721|453715840|FG001|Overall Study|Refused to continue taking trial medication|1|||
126115089|NCT02632721|453715841|FG002|Overall Study|Refused to continue taking trial medication|1|||
126115090|NCT02632721|453715842|FG003|Overall Study|Refused to continue taking trial medication|1|||
126115091|NCT02632721|453715843|FG004|Overall Study|Refused to continue taking trial medication|2|||
126115092|NCT02632721|453715839|FG000|Overall Study|Inadequate clinical condition|0|||
126115093|NCT02632721|453715840|FG001|Overall Study|Inadequate clinical condition|0|||
126115094|NCT02632721|453715841|FG002|Overall Study|Inadequate clinical condition|0|||
126115095|NCT02632721|453715842|FG003|Overall Study|Inadequate clinical condition|0|||
126115096|NCT02632721|453715843|FG004|Overall Study|Inadequate clinical condition|1|||
126115097|NCT02632721|453715839|FG000|Overall Study|No meet eligibility|0|||
126115098|NCT02632721|453715840|FG001|Overall Study|No meet eligibility|0|||
126115099|NCT02632721|453715841|FG002|Overall Study|No meet eligibility|0|||
126115100|NCT02632721|453715842|FG003|Overall Study|No meet eligibility|0|||
126115101|NCT02632721|453715843|FG004|Overall Study|No meet eligibility|1|||
126115102|NCT02632721|453715839|FG000|Overall Study|Allergic reaction|0|||
126115103|NCT02632721|453715840|FG001|Overall Study|Allergic reaction|0|||
126115104|NCT02632721|453715841|FG002|Overall Study|Allergic reaction|0|||
126115105|NCT02632721|453715842|FG003|Overall Study|Allergic reaction|1|||
126115106|NCT02632721|453715843|FG004|Overall Study|Allergic reaction|0|||
126115107|NCT02632721|453715839|FG000|Overall Study|Receiving Decitabine locally|0|||
125950415|NCT03013543|453116026|FG001|Overall Study|Lack of Efficacy|0|||
125950416|NCT03013543|453116027|FG002|Overall Study|Lack of Efficacy|0|||
125950417|NCT03013543|453116028|FG003|Overall Study|Lack of Efficacy|1|||
125950418|NCT03013543|453116029|FG004|Overall Study|Lack of Efficacy|0|||
125950419|NCT03013543|453116030|FG005|Overall Study|Lack of Efficacy|0|||
125950420|NCT03013543|453116031|FG006|Overall Study|Lack of Efficacy|0|||
125950421|NCT03013543|453116032|FG007|Overall Study|Lack of Efficacy|0|||
126115108|NCT02632721|453715840|FG001|Overall Study|Receiving Decitabine locally|0|||
126115109|NCT02632721|453715841|FG002|Overall Study|Receiving Decitabine locally|1|||
126115110|NCT02632721|453715842|FG003|Overall Study|Receiving Decitabine locally|0|||
126115111|NCT02632721|453715843|FG004|Overall Study|Receiving Decitabine locally|0|||
126115112|NCT02632721|453715839|FG000|Overall Study|No benefit from study treatment|1|||
125950422|NCT03013543|453116033|FG008|Overall Study|Lack of Efficacy|0|||
125950423|NCT03013543|453116034|FG009|Overall Study|Lack of Efficacy|0|||
125950424|NCT03013543|453116025|FG000|Overall Study|Lost to Follow-up|0|||
125950425|NCT03013543|453116026|FG001|Overall Study|Lost to Follow-up|0|||
125950426|NCT03013543|453116027|FG002|Overall Study|Lost to Follow-up|0|||
125950427|NCT03013543|453116028|FG003|Overall Study|Lost to Follow-up|1|||
125950428|NCT03013543|453116029|FG004|Overall Study|Lost to Follow-up|0|||
125950429|NCT03013543|453116030|FG005|Overall Study|Lost to Follow-up|0|||
125950430|NCT03013543|453116031|FG006|Overall Study|Lost to Follow-up|1|||
125950431|NCT03013543|453116032|FG007|Overall Study|Lost to Follow-up|0|||
125950432|NCT03013543|453116033|FG008|Overall Study|Lost to Follow-up|0|||
125950433|NCT03013543|453116034|FG009|Overall Study|Lost to Follow-up|2|||
125950434|NCT03013543|453116025|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125950435|NCT03013543|453116026|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125950436|NCT03013543|453116027|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125950437|NCT03013543|453116028|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125950438|NCT03013543|453116029|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125950439|NCT03013543|453116030|FG005|Overall Study|Non-Compliance With Study Drug|0|||
125950440|NCT03013543|453116031|FG006|Overall Study|Non-Compliance With Study Drug|0|||
125950441|NCT03013543|453116032|FG007|Overall Study|Non-Compliance With Study Drug|0|||
125950442|NCT03013543|453116033|FG008|Overall Study|Non-Compliance With Study Drug|1|||
125950443|NCT03013543|453116034|FG009|Overall Study|Non-Compliance With Study Drug|0|||
125950444|NCT03013543|453116025|FG000|Overall Study|Physician Decision|0|||
125950445|NCT03013543|453116026|FG001|Overall Study|Physician Decision|0|||
125950446|NCT03013543|453116027|FG002|Overall Study|Physician Decision|0|||
125950447|NCT03013543|453116028|FG003|Overall Study|Physician Decision|0|||
125950448|NCT03013543|453116029|FG004|Overall Study|Physician Decision|1|||
125950449|NCT03013543|453116030|FG005|Overall Study|Physician Decision|0|||
125950450|NCT03013543|453116031|FG006|Overall Study|Physician Decision|0|||
125950451|NCT03013543|453116032|FG007|Overall Study|Physician Decision|0|||
125950452|NCT03013543|453116033|FG008|Overall Study|Physician Decision|0|||
125950453|NCT03013543|453116034|FG009|Overall Study|Physician Decision|0|||
125950454|NCT03013543|453116025|FG000|Overall Study|Protocol Violation|0|||
125950455|NCT03013543|453116026|FG001|Overall Study|Protocol Violation|0|||
125950456|NCT03013543|453116027|FG002|Overall Study|Protocol Violation|0|||
125950457|NCT03013543|453116028|FG003|Overall Study|Protocol Violation|0|||
125950458|NCT03013543|453116029|FG004|Overall Study|Protocol Violation|0|||
125950459|NCT03013543|453116030|FG005|Overall Study|Protocol Violation|0|||
125950460|NCT03013543|453116031|FG006|Overall Study|Protocol Violation|0|||
125950461|NCT03013543|453116032|FG007|Overall Study|Protocol Violation|0|||
125950462|NCT03013543|453116033|FG008|Overall Study|Protocol Violation|0|||
125950463|NCT03013543|453116034|FG009|Overall Study|Protocol Violation|1|||
125950464|NCT04225923|453116035|FG000|Overall Study|Protocol Violation|1|||
125950465|NCT04225923|453116036|FG001|Overall Study|Protocol Violation|0|||
125950466|NCT04225923|453116037|FG002|Overall Study|Protocol Violation|1|||
125950467|NCT04225923|453116035|FG000|Overall Study|Withdrawal by Subject|4|||
125950468|NCT04225923|453116036|FG001|Overall Study|Withdrawal by Subject|1|||
125950469|NCT04225923|453116037|FG002|Overall Study|Withdrawal by Subject|3|||
125950470|NCT04225923|453116035|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
125950471|NCT04225923|453116036|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
125950472|NCT04225923|453116037|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
125950473|NCT01417481|453116038|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
125950474|NCT01417481|453116039|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125950475|NCT03029624|453116040|FG000|Overall Study|Adverse Event|1|||
125950476|NCT03029624|453116040|FG000|Overall Study|Withdrawal by Subject|1|||
125950477|NCT03029624|453116040|FG000|Overall Study|Lack of Efficacy|1|||
125950478|NCT03029624|453116040|FG000|Overall Study|MRI need|2|||
126115113|NCT02632721|453715840|FG001|Overall Study|No benefit from study treatment|1|||
126115114|NCT02632721|453715841|FG002|Overall Study|No benefit from study treatment|0|||
125950479|NCT04116710|453116041|FG000|Overall Study|Death|4|||
125950480|NCT04116710|453116042|FG001|Overall Study|Death|6|||
125950481|NCT04116710|453116043|FG002|Overall Study|Death|3|||
125950482|NCT04116710|453116044|FG003|Overall Study|Death|1|||
125950483|NCT04116710|453116041|FG000|Overall Study|Withdrawal by Subject|0|||
125950484|NCT04116710|453116042|FG001|Overall Study|Withdrawal by Subject|0|||
125950485|NCT04116710|453116043|FG002|Overall Study|Withdrawal by Subject|0|||
125950486|NCT04116710|453116044|FG003|Overall Study|Withdrawal by Subject|1|||
125950487|NCT01537783|453116049|FG000|Overall Study|Lost to Follow-up|11|||
125950488|NCT01537783|453116050|FG001|Overall Study|Lost to Follow-up|2|||
125950489|NCT01640366|453116051|FG000|Overall Study|Withdrawal by Subject|1|||
125950490|NCT01640366|453116051|FG000|Overall Study|Protocol Violation|16|||
125950491|NCT01640366|453116051|FG000|Overall Study|Lost to Follow-up|5|||
125950492|NCT00291668|453116058|FG000|Overall Study|Lack of Efficacy|1|||
125950493|NCT00291668|453116059|FG001|Overall Study|Lack of Efficacy|0|||
125950494|NCT00291668|453116060|FG002|Overall Study|Lack of Efficacy|0|||
125950495|NCT00291668|453116058|FG000|Overall Study|SAE, non-fatal|1|||
125950496|NCT00291668|453116059|FG001|Overall Study|SAE, non-fatal|1|||
125950497|NCT00291668|453116060|FG002|Overall Study|SAE, non-fatal|1|||
125950498|NCT00291668|453116058|FG000|Overall Study|AE, non-serious non-fatal|1|||
125950499|NCT00291668|453116059|FG001|Overall Study|AE, non-serious non-fatal|0|||
125950500|NCT00291668|453116060|FG002|Overall Study|AE, non-serious non-fatal|0|||
125950501|NCT00291668|453116058|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125950502|NCT00291668|453116059|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125950503|NCT00291668|453116060|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125950504|NCT00313612|453116061|FG000|Overall Study|Patient never received treatment|0|||
125950505|NCT00313612|453116062|FG001|Overall Study|Patient never received treatment|1|||
125950506|NCT00451035|453116063|FG000|Overall Study|Disease progression|11|||
125950507|NCT00451035|453116063|FG000|Overall Study|Death|3|||
125950508|NCT00451035|453116063|FG000|Overall Study|New anti-neoplastic therapy|3|||
125950509|NCT04656132|453116068|FG000|Overall Study|Lost to Follow-up|4|||
125950510|NCT04656132|453116068|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
125950511|NCT00677807|453116069|FG000|Overall Study|Adverse Event|4|||
125950512|NCT00677807|453116070|FG001|Overall Study|Adverse Event|1|||
125950513|NCT00677807|453116071|FG002|Overall Study|Adverse Event|6|||
125950514|NCT00677807|453116069|FG000|Overall Study|Lack of Efficacy|0|||
125950515|NCT00677807|453116070|FG001|Overall Study|Lack of Efficacy|0|||
125950516|NCT00677807|453116071|FG002|Overall Study|Lack of Efficacy|2|||
125950517|NCT00677807|453116069|FG000|Overall Study|Participant no longer needs study drug|0|||
125950518|NCT00677807|453116070|FG001|Overall Study|Participant no longer needs study drug|0|||
125950519|NCT00677807|453116071|FG002|Overall Study|Participant no longer needs study drug|1|||
125950520|NCT00677807|453116069|FG000|Overall Study|Withdrawal by Subject|10|||
125950521|NCT00677807|453116070|FG001|Overall Study|Withdrawal by Subject|3|||
125950522|NCT00677807|453116071|FG002|Overall Study|Withdrawal by Subject|6|||
125950523|NCT00677807|453116069|FG000|Overall Study|Lost to Follow-up|2|||
125950524|NCT00677807|453116070|FG001|Overall Study|Lost to Follow-up|2|||
125950525|NCT00677807|453116071|FG002|Overall Study|Lost to Follow-up|2|||
125950526|NCT00677807|453116069|FG000|Overall Study|Administrative problems|1|||
125950527|NCT00677807|453116070|FG001|Overall Study|Administrative problems|1|||
125950528|NCT00677807|453116071|FG002|Overall Study|Administrative problems|2|||
125950529|NCT00677807|453116069|FG000|Overall Study|Death|0|||
125950530|NCT00677807|453116070|FG001|Overall Study|Death|1|||
125950531|NCT00677807|453116071|FG002|Overall Study|Death|1|||
125950532|NCT00677807|453116069|FG000|Overall Study|Protocol Deviation|1|||
125950533|NCT00677807|453116070|FG001|Overall Study|Protocol Deviation|3|||
125950534|NCT00677807|453116071|FG002|Overall Study|Protocol Deviation|0|||
125950535|NCT04365699|453116072|FG000|Overall Study|Death|2|||
125950536|NCT04365699|453116073|FG001|Overall Study|Death|5|||
125950537|NCT04365699|453116074|FG002|Overall Study|Death|15|||
125950538|NCT04019041|453116075|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
125950539|NCT04019041|453116076|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
125950540|NCT04019041|453116077|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
125950541|NCT04019041|453116078|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125950542|NCT04019041|453116079|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125950543|NCT04019041|453116080|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125950544|NCT04019041|453116075|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125950545|NCT04019041|453116076|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125950546|NCT04019041|453116077|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
126079620|NCT02706847|453585899|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
126079621|NCT02706847|453585896|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
126079622|NCT02706847|453585897|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
126079623|NCT02706847|453585898|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
126079624|NCT02706847|453585899|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
126079625|NCT02706847|453585896|FG000|Period 2: Week 24 to Week 260|Other|8|||
126079626|NCT02706847|453585897|FG001|Period 2: Week 24 to Week 260|Other|5|||
125950547|NCT04019041|453116078|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125950548|NCT04019041|453116079|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125950549|NCT04019041|453116080|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125950550|NCT04019041|453116075|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
125950551|NCT04019041|453116076|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
125950552|NCT04019041|453116077|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
125950553|NCT04019041|453116078|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125950554|NCT04019041|453116079|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125950555|NCT04019041|453116080|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125950556|NCT04019041|453116075|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
126079627|NCT02706847|453585898|FG002|Period 2: Week 24 to Week 260|Other|15|||
125950557|NCT04019041|453116076|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
125950558|NCT04019041|453116077|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
125950559|NCT04019041|453116078|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
125950560|NCT04019041|453116079|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
126115115|NCT02632721|453715842|FG003|Overall Study|No benefit from study treatment|0|||
126115116|NCT02632721|453715843|FG004|Overall Study|No benefit from study treatment|1|||
126115117|NCT02632721|453715839|FG000|Overall Study|Patient wish for other treatment|0|||
126115118|NCT02632721|453715840|FG001|Overall Study|Patient wish for other treatment|1|||
126115119|NCT02632721|453715841|FG002|Overall Study|Patient wish for other treatment|0|||
126115120|NCT02632721|453715842|FG003|Overall Study|Patient wish for other treatment|0|||
126115121|NCT02632721|453715843|FG004|Overall Study|Patient wish for other treatment|0|||
126115122|NCT02632721|453715839|FG000|Overall Study|Relapsed Pneumonia|0|||
126115123|NCT02632721|453715840|FG001|Overall Study|Relapsed Pneumonia|0|||
126115124|NCT02632721|453715841|FG002|Overall Study|Relapsed Pneumonia|0|||
126115125|NCT02632721|453715842|FG003|Overall Study|Relapsed Pneumonia|0|||
126115126|NCT02632721|453715843|FG004|Overall Study|Relapsed Pneumonia|1|||
126115127|NCT02632721|453715839|FG000|Overall Study|Therapy refractory AML|0|||
126115128|NCT02632721|453715840|FG001|Overall Study|Therapy refractory AML|0|||
126115129|NCT02632721|453715841|FG002|Overall Study|Therapy refractory AML|0|||
126115130|NCT02632721|453715842|FG003|Overall Study|Therapy refractory AML|0|||
126115131|NCT02632721|453715843|FG004|Overall Study|Therapy refractory AML|1|||
126115132|NCT02632721|453715839|FG000|Overall Study|Increase of white blood cell count|0|||
126115133|NCT02632721|453715840|FG001|Overall Study|Increase of white blood cell count|0|||
126115134|NCT02632721|453715841|FG002|Overall Study|Increase of white blood cell count|0|||
126115135|NCT02632721|453715842|FG003|Overall Study|Increase of white blood cell count|0|||
126115136|NCT02632721|453715843|FG004|Overall Study|Increase of white blood cell count|1|||
125950561|NCT04019041|453116080|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
125950562|NCT04019041|453116075|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125950563|NCT04019041|453116076|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125950564|NCT04019041|453116077|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125950565|NCT04019041|453116078|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
125950566|NCT04019041|453116079|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
125950567|NCT04019041|453116080|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
125950568|NCT04019041|453116075|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125950569|NCT04019041|453116076|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125950570|NCT04019041|453116077|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125950571|NCT04019041|453116078|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
125950572|NCT04019041|453116079|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125950573|NCT04019041|453116080|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125950574|NCT04019041|453116075|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125950575|NCT04019041|453116076|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125950576|NCT04019041|453116077|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125950577|NCT04019041|453116078|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125950578|NCT04019041|453116079|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
125950579|NCT04019041|453116080|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125950580|NCT04019041|453116075|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125950581|NCT04019041|453116076|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125950582|NCT04019041|453116077|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125950583|NCT04019041|453116078|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
125950584|NCT04019041|453116079|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
125950585|NCT04019041|453116080|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
125950586|NCT04019041|453116075|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125950587|NCT04019041|453116076|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125950588|NCT04019041|453116077|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125950589|NCT04019041|453116078|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125950590|NCT04019041|453116079|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
125950591|NCT04019041|453116080|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
125950592|NCT00314366|453116081|FG000|Overall Study|not treated due to patient medical condi|1|||
125950593|NCT00314366|453116082|FG001|Overall Study|not treated due to patient medical condi|0|||
125950594|NCT00834912|453116087|FG000|Treatment Period 1|Adverse Event|0|||
126115137|NCT02632721|453715839|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
126115138|NCT02632721|453715840|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
126115139|NCT02632721|453715841|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
126115140|NCT02632721|453715842|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
126115141|NCT02632721|453715843|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125950595|NCT00834912|453116088|FG001|Treatment Period 1|Adverse Event|1|||
126115142|NCT00544648|453715849|FG000|Overall Study|Withdrawal by Subject|1|||
125950596|NCT00834912|453116089|FG002|Treatment Period 1|Adverse Event|0|||
125950597|NCT00834912|453116090|FG003|Treatment Period 1|Adverse Event|1|||
125950598|NCT00834912|453116091|FG004|Treatment Period 1|Adverse Event|0|||
125950599|NCT00834912|453116092|FG005|Treatment Period 1|Adverse Event|0|||
125950600|NCT00834912|453116087|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125950601|NCT00834912|453116088|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125950602|NCT00834912|453116089|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125950603|NCT00834912|453116090|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125950604|NCT00834912|453116091|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125950605|NCT00834912|453116092|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125950606|NCT03044197|453116093|FG000|Overall Study|Withdrawal by Subject|3|||
125950607|NCT03044197|453116094|FG001|Overall Study|Withdrawal by Subject|1|||
125950608|NCT01282424|453116105|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
125950609|NCT01282424|453116105|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
125950610|NCT01282424|453116105|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
125950611|NCT01282424|453116105|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
125950612|NCT01282424|453116105|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
125950613|NCT01282424|453116105|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
125950614|NCT01282424|453116105|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
125950615|NCT01282424|453116105|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
125950616|NCT04804813|453116106|FG000|Overall Study|Protocol Violation|2|||
125950617|NCT04804813|453116107|FG001|Overall Study|Protocol Violation|0|||
125950618|NCT04804813|453116106|FG000|Overall Study|Withdrawal by Subject|1|||
125950619|NCT04804813|453116107|FG001|Overall Study|Withdrawal by Subject|0|||
125950620|NCT02777125|453116114|FG000|Overall Study|Consent form violation|14|||
125950621|NCT02777125|453116115|FG001|Overall Study|Consent form violation|12|||
125950622|NCT02777125|453116114|FG000|Overall Study|Assent form violation|21|||
125950623|NCT02777125|453116115|FG001|Overall Study|Assent form violation|23|||
125950624|NCT02777125|453116114|FG000|Overall Study|Protocol Violation|8|||
125950625|NCT02777125|453116115|FG001|Overall Study|Protocol Violation|12|||
125971468|NCT03277313|453182864|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
125971469|NCT03277313|453182863|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
125971470|NCT03277313|453182864|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
125971471|NCT02132611|453182865|FG000|Overall Study|Death|2|||
125971472|NCT02194621|453182874|FG000|Overall Study|6 withdrew prior to randomization|2|||
125971473|NCT02194621|453182875|FG001|Overall Study|6 withdrew prior to randomization|2|||
125971474|NCT02194621|453182876|FG002|Overall Study|6 withdrew prior to randomization|2|||
125971475|NCT02194621|453182874|FG000|Overall Study|Withdrawal by Subject|4|||
125971476|NCT02194621|453182875|FG001|Overall Study|Withdrawal by Subject|4|||
125971477|NCT02194621|453182876|FG002|Overall Study|Withdrawal by Subject|7|||
125971478|NCT02763384|453182877|FG000|Overall Study|Physician Decision|1|||
125971479|NCT02763384|453182877|FG000|Overall Study|Rapid decline - went on hospice|1|||
125971480|NCT02493127|453182878|FG000|Overall Study|Lost to Follow-up|1|||
125971481|NCT02493127|453182879|FG001|Overall Study|Lost to Follow-up|1|||
125971482|NCT02096900|453182881|FG000|Overall Study|Did not receive medication|3|||
125971483|NCT02096900|453182882|FG001|Overall Study|Did not receive medication|1|||
125971484|NCT02096900|453182881|FG000|Overall Study|Surgery cancelled- medication received|1|||
125971485|NCT02096900|453182882|FG001|Overall Study|Surgery cancelled- medication received|1|||
125971486|NCT03034577|453182885|FG000|Overall Study|Withdrawal by Subject|6|||
125971487|NCT03034577|453182886|FG001|Overall Study|Withdrawal by Subject|9|||
125971488|NCT03034577|453182885|FG000|Overall Study|Lost to Follow-up|25|||
125971489|NCT03034577|453182886|FG001|Overall Study|Lost to Follow-up|26|||
125971490|NCT04177758|453182887|FG000|Overall Study|Lost to Follow-up|19|||
125971491|NCT04177758|453182888|FG001|Overall Study|Lost to Follow-up|11|||
125971492|NCT03156023|453182899|FG000|Overall Study|Withdrawal by Subject|1|||
125971493|NCT03156023|453182900|FG001|Overall Study|Withdrawal by Subject|0|||
125971494|NCT03156023|453182901|FG002|Overall Study|Withdrawal by Subject|2|||
125971495|NCT03156023|453182902|FG003|Overall Study|Withdrawal by Subject|1|||
125971496|NCT03156023|453182903|FG004|Overall Study|Withdrawal by Subject|1|||
125971497|NCT03156023|453182899|FG000|Overall Study|Lost to Follow-up|0|||
125971498|NCT03156023|453182900|FG001|Overall Study|Lost to Follow-up|0|||
125971499|NCT03156023|453182901|FG002|Overall Study|Lost to Follow-up|0|||
125971500|NCT03156023|453182902|FG003|Overall Study|Lost to Follow-up|0|||
125971501|NCT03156023|453182903|FG004|Overall Study|Lost to Follow-up|1|||
125971502|NCT00726752|453182904|FG000|Overall Study|Lack of Efficacy|6|||
125971503|NCT00791765|453184716|FG000|Weeks 1 to 12|Adverse Event|0|||
125971504|NCT00791765|453184717|FG001|Weeks 1 to 12|Adverse Event|1|||
125971505|NCT00791765|453184716|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
125971506|NCT00791765|453184717|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
125971507|NCT00791765|453184716|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
125971508|NCT00791765|453184717|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
125971509|NCT00791765|453184716|FG000|Weeks 1 to 12|Physician Decision|1|||
125971510|NCT00791765|453184717|FG001|Weeks 1 to 12|Physician Decision|0|||
125971511|NCT00791765|453184716|FG000|Weeks 1 to 12|Disease progression|3|||
125971512|NCT00791765|453184717|FG001|Weeks 1 to 12|Disease progression|0|||
125950626|NCT05458856|453117333|FG000|Overall Study|Withdrawal by Subject|5|||
125950627|NCT05458856|453117333|FG000|Overall Study|Death|4|||
125950628|NCT05458856|453117333|FG000|Overall Study|Protocol Deviation|3|||
125950629|NCT05458856|453117333|FG000|Overall Study|Physician Decision|1|||
125950630|NCT01589822|453117334|FG000|Overall Study|Withdrawal by Subject|1|||
125950631|NCT01589822|453117335|FG001|Overall Study|Withdrawal by Subject|2|||
125950632|NCT01589822|453117336|FG002|Overall Study|Withdrawal by Subject|0|||
125950633|NCT01589822|453117334|FG000|Overall Study|Death|1|||
125950634|NCT01589822|453117335|FG001|Overall Study|Death|0|||
125950635|NCT01589822|453117336|FG002|Overall Study|Death|0|||
125950636|NCT01589822|453117334|FG000|Overall Study|Missed 90 day visit|2|||
125950637|NCT01589822|453117335|FG001|Overall Study|Missed 90 day visit|1|||
125950638|NCT01589822|453117336|FG002|Overall Study|Missed 90 day visit|1|||
125950639|NCT05168475|453117337|FG000|Period 1|Protocol Violation|1|||
125950640|NCT05168475|453117337|FG000|Period 1|IMP shortage|2|||
125950641|NCT05168475|453117337|FG000|Period 1|Not randomised|2|||
125950642|NCT05168475|453117337|FG000|Period 2|IMP shortage|1|||
125950643|NCT01140477|453117338|FG000|Overall Study|Lost to Follow-up|4|||
125950644|NCT01140477|453117339|FG001|Overall Study|Lost to Follow-up|0|||
125950645|NCT01140477|453117338|FG000|Overall Study|Withdrawal by Subject|1|||
125950646|NCT01140477|453117339|FG001|Overall Study|Withdrawal by Subject|4|||
125950647|NCT01140477|453117338|FG000|Overall Study|Surgical complication preventing implant|2|||
125950648|NCT01140477|453117339|FG001|Overall Study|Surgical complication preventing implant|0|||
125950649|NCT01140477|453117338|FG000|Overall Study|Death|1|||
125950650|NCT01140477|453117339|FG001|Overall Study|Death|1|||
125950651|NCT01140477|453117338|FG000|Overall Study|Subject explanted|0|||
125950652|NCT01140477|453117339|FG001|Overall Study|Subject explanted|1|||
125950653|NCT01945489|453117346|FG000|Cycle 1|Adverse Event|2|||
125950654|NCT01945489|453117347|FG001|Cycle 1|Adverse Event|0|||
125950655|NCT01945489|453117346|FG000|Cycle 1|Lost to Follow-up|4|||
125950656|NCT01945489|453117347|FG001|Cycle 1|Lost to Follow-up|0|||
125950657|NCT01945489|453117346|FG000|Cycle 1|Personal Reasons|4|||
125950658|NCT01945489|453117347|FG001|Cycle 1|Personal Reasons|2|||
125950659|NCT01945489|453117346|FG000|Cycle 1|Protocol Violation|0|||
125950660|NCT01945489|453117347|FG001|Cycle 1|Protocol Violation|1|||
125950661|NCT01945489|453117346|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
125950662|NCT01945489|453117347|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
125950663|NCT01945489|453117346|FG000|Cycle 2|Adverse Event|1|||
125950664|NCT01945489|453117347|FG001|Cycle 2|Adverse Event|0|||
125950665|NCT01945489|453117346|FG000|Cycle 2|Lost to Follow-up|0|||
125950666|NCT01945489|453117347|FG001|Cycle 2|Lost to Follow-up|1|||
125950667|NCT03569371|453117348|FG000|Overall Study|Lack of Efficacy|1|||
125950668|NCT03569371|453117348|FG000|Overall Study|Lost to Follow-up|1|||
125950669|NCT03569371|453117348|FG000|Overall Study|Adverse Event|1|||
125950670|NCT01236755|453117349|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
125950671|NCT01236755|453117349|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
125950672|NCT01236755|453117349|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
125950673|NCT01236755|453117349|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
125950674|NCT04904185|453117350|FG000|Overall Study|Expansion failure|1|||
125950675|NCT04904185|453117351|FG001|Overall Study|Expansion failure|0|||
125950676|NCT04904185|453117350|FG000|Overall Study|Late response on prior treatment|1|||
125950677|NCT04904185|453117351|FG001|Overall Study|Late response on prior treatment|0|||
125950678|NCT02433834|453117355|FG000|Overall Study|Protocol-specified criteria|7|||
125950679|NCT02433834|453117355|FG000|Overall Study|Protocol Violation|3|||
125950680|NCT02433834|453117355|FG000|Overall Study|Lost to Follow-up|6|||
125950681|NCT02433834|453117355|FG000|Overall Study|Withdrawal by Subject|14|||
125950682|NCT02433834|453117355|FG000|Overall Study|Adverse Event|6|||
125950683|NCT02433834|453117355|FG000|Overall Study|Physician Decision|1|||
125950684|NCT01539226|453117356|FG000|Overall Study|Withdrawal by Subject|24|||
125950685|NCT01539226|453117357|FG001|Overall Study|Withdrawal by Subject|54|||
125950686|NCT01539226|453117356|FG000|Overall Study|Lost to Follow-up|20|||
125950687|NCT01539226|453117357|FG001|Overall Study|Lost to Follow-up|54|||
125950688|NCT01539226|453117356|FG000|Overall Study|Death|1|||
125950689|NCT01539226|453117357|FG001|Overall Study|Death|2|||
125950690|NCT01539226|453117356|FG000|Overall Study|Adverse Event|2|||
125950691|NCT01539226|453117357|FG001|Overall Study|Adverse Event|0|||
126079628|NCT02706847|453585899|FG003|Period 2: Week 24 to Week 260|Other|15|||
125950692|NCT01539226|453117356|FG000|Overall Study|Pregnancy|13|||
125950693|NCT01539226|453117357|FG001|Overall Study|Pregnancy|29|||
126079629|NCT01427738|453585902|FG000|Overall Study|Death|12|||
125950694|NCT01539226|453117356|FG000|Overall Study|inappropriate enrollment|0|||
125950695|NCT01539226|453117357|FG001|Overall Study|inappropriate enrollment|1|||
125950696|NCT01539226|453117356|FG000|Overall Study|Multiple Reasons|3|||
125950697|NCT01539226|453117357|FG001|Overall Study|Multiple Reasons|1|||
125950698|NCT01539226|453117356|FG000|Overall Study|not HIV seroconversion-related|93|||
125950699|NCT01539226|453117357|FG001|Overall Study|not HIV seroconversion-related|176|||
125950700|NCT01539226|453117356|FG000|Overall Study|HIV seroconversion-related|55|||
125950701|NCT01539226|453117357|FG001|Overall Study|HIV seroconversion-related|80|||
125950702|NCT01539226|453117356|FG000|Overall Study|Non-compliance|6|||
125950703|NCT01539226|453117357|FG001|Overall Study|Non-compliance|8|||
125950704|NCT02643251|453117358|FG000|Overall Study|Adverse Event|3|||
125950705|NCT02643251|453117359|FG001|Overall Study|Adverse Event|1|||
125950706|NCT02643251|453117358|FG000|Overall Study|Withdrawal by Subject|2|||
125950707|NCT02643251|453117359|FG001|Overall Study|Withdrawal by Subject|0|||
125950708|NCT02643251|453117358|FG000|Overall Study|Lost to Follow-up|4|||
125950709|NCT02643251|453117359|FG001|Overall Study|Lost to Follow-up|1|||
125950710|NCT02643251|453117358|FG000|Overall Study|Protocol Violation|1|||
125950711|NCT02643251|453117359|FG001|Overall Study|Protocol Violation|0|||
125950712|NCT02643251|453117358|FG000|Overall Study|PI Decision to terminate patient|1|||
125950713|NCT02643251|453117359|FG001|Overall Study|PI Decision to terminate patient|0|||
125950714|NCT02365636|453117360|FG000|Overall Study|Adverse Event|3|||
125950715|NCT02365636|453117361|FG001|Overall Study|Adverse Event|3|||
125950716|NCT02365636|453117362|FG002|Overall Study|Adverse Event|2|||
125950717|NCT02365636|453117360|FG000|Overall Study|Protocol Violation|1|||
125950718|NCT02365636|453117361|FG001|Overall Study|Protocol Violation|4|||
125950719|NCT02365636|453117362|FG002|Overall Study|Protocol Violation|0|||
125950720|NCT02365636|453117360|FG000|Overall Study|Lost to Follow-up|0|||
125950721|NCT02365636|453117361|FG001|Overall Study|Lost to Follow-up|0|||
125950722|NCT02365636|453117362|FG002|Overall Study|Lost to Follow-up|1|||
125950723|NCT02365636|453117360|FG000|Overall Study|Other|2|||
125950724|NCT02365636|453117361|FG001|Overall Study|Other|0|||
125950725|NCT02365636|453117362|FG002|Overall Study|Other|0|||
125950726|NCT01956110|453117370|FG000|Overall Study|Protocol Violation|25|||
125950727|NCT01956110|453117371|FG001|Overall Study|Protocol Violation|11|||
125950728|NCT01956110|453117370|FG000|Overall Study|Adverse Event|9|||
125950729|NCT01956110|453117371|FG001|Overall Study|Adverse Event|10|||
125950730|NCT01956110|453117370|FG000|Overall Study|Personal reasons|1|||
125950731|NCT01956110|453117371|FG001|Overall Study|Personal reasons|1|||
125950732|NCT01782313|453117376|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
125950733|NCT01782313|453117376|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
125950734|NCT01782313|453117376|FG000|Treated Cycle 3|Progressive Disease|21|||
125950735|NCT01782313|453117376|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
125950736|NCT01782313|453117376|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
125950737|NCT01782313|453117376|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
125950738|NCT01782313|453117376|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
125950739|NCT01782313|453117376|FG000|Survival Follow up|Lost to Follow-up|1|||
125950740|NCT02506816|453117377|FG000|Overall Study|Adverse Event|3|||
125950741|NCT01067352|453117382|FG000|Overall Study|Withdrawal by Subject|1|||
125950742|NCT01067352|453117383|FG001|Overall Study|Withdrawal by Subject|2|||
125950743|NCT01067352|453117384|FG002|Overall Study|Withdrawal by Subject|1|||
125950744|NCT01067352|453117382|FG000|Overall Study|Physician Decision|0|||
125950745|NCT01067352|453117383|FG001|Overall Study|Physician Decision|1|||
125950746|NCT01067352|453117384|FG002|Overall Study|Physician Decision|0|||
125950747|NCT01096784|453117385|FG000|Overall Study|Withdrawal by Subject|2|||
125950748|NCT01096784|453117386|FG001|Overall Study|Withdrawal by Subject|1|||
125950749|NCT01096784|453117385|FG000|Overall Study|Adverse Event|11|||
125950750|NCT01096784|453117386|FG001|Overall Study|Adverse Event|9|||
125950751|NCT01096784|453117385|FG000|Overall Study|Protocol Deviation|2|||
125950752|NCT01096784|453117386|FG001|Overall Study|Protocol Deviation|2|||
125950753|NCT01096784|453117385|FG000|Overall Study|Administrative Decision|0|||
125950754|NCT01096784|453117386|FG001|Overall Study|Administrative Decision|1|||
125950755|NCT01096784|453117385|FG000|Overall Study|Other Unspecified|0|||
125950756|NCT01096784|453117386|FG001|Overall Study|Other Unspecified|1|||
125950757|NCT03761628|453117387|FG000|Overall Study|Withdrawal by Subject|3|||
125950758|NCT03761628|453117387|FG000|Overall Study|Physician Decision|1|||
125950759|NCT03761628|453117387|FG000|Overall Study|Pregnancy|1|||
125950760|NCT03761628|453117387|FG000|Overall Study|Lost to Follow-up|1|||
125950761|NCT05923229|453117388|FG000|Overall Study|Withdrawal by Subject|3|||
125950762|NCT05923229|453117389|FG001|Overall Study|Withdrawal by Subject|0|||
125950763|NCT05923229|453117388|FG000|Overall Study|Health related|2|||
125950764|NCT05923229|453117389|FG001|Overall Study|Health related|1|||
125950765|NCT03064126|453117390|FG000|Overall Study|Death|40|||
125950766|NCT03064126|453117391|FG001|Overall Study|Death|16|||
125950767|NCT03064126|453117392|FG002|Overall Study|Death|4|||
125950768|NCT03064126|453117393|FG003|Overall Study|Death|2|||
125950769|NCT03064126|453117390|FG000|Overall Study|Withdrawal by Subject|17|||
125950770|NCT03064126|453117391|FG001|Overall Study|Withdrawal by Subject|9|||
125950771|NCT03064126|453117392|FG002|Overall Study|Withdrawal by Subject|0|||
125950772|NCT03064126|453117393|FG003|Overall Study|Withdrawal by Subject|2|||
125950773|NCT03064126|453117390|FG000|Overall Study|Lost to Follow-up|7|||
125950774|NCT03064126|453117391|FG001|Overall Study|Lost to Follow-up|3|||
125950775|NCT03064126|453117392|FG002|Overall Study|Lost to Follow-up|0|||
125950776|NCT03064126|453117393|FG003|Overall Study|Lost to Follow-up|0|||
125950777|NCT03064126|453117390|FG000|Overall Study|Adverse Event|2|||
125950778|NCT03064126|453117391|FG001|Overall Study|Adverse Event|0|||
125950779|NCT03064126|453117392|FG002|Overall Study|Adverse Event|0|||
125950780|NCT03064126|453117393|FG003|Overall Study|Adverse Event|0|||
125950781|NCT03064126|453117390|FG000|Overall Study|Physician Decision|3|||
125950782|NCT03064126|453117391|FG001|Overall Study|Physician Decision|0|||
125950783|NCT03064126|453117392|FG002|Overall Study|Physician Decision|0|||
125950784|NCT03064126|453117393|FG003|Overall Study|Physician Decision|0|||
125950785|NCT03064126|453117390|FG000|Overall Study|Other reason for early termination|3|||
125950786|NCT03064126|453117391|FG001|Overall Study|Other reason for early termination|2|||
125950787|NCT03064126|453117392|FG002|Overall Study|Other reason for early termination|0|||
125950788|NCT03064126|453117393|FG003|Overall Study|Other reason for early termination|0|||
125950789|NCT03064126|453117390|FG000|Overall Study|Missed Visit|3|||
125950790|NCT03064126|453117391|FG001|Overall Study|Missed Visit|1|||
125950791|NCT03064126|453117392|FG002|Overall Study|Missed Visit|0|||
125950792|NCT03064126|453117393|FG003|Overall Study|Missed Visit|0|||
125950793|NCT05288556|453117397|FG000|Overall Study|Protocol Violation|1|||
126115143|NCT00544648|453715850|FG001|Overall Study|Withdrawal by Subject|0|||
126115144|NCT00544648|453715849|FG000|Overall Study|Adverse Event|1|||
126115145|NCT00544648|453715850|FG001|Overall Study|Adverse Event|1|||
126115146|NCT00544648|453715849|FG000|Overall Study|progression of disease|1|||
126115147|NCT00544648|453715850|FG001|Overall Study|progression of disease|0|||
125950794|NCT05288556|453117397|FG000|Overall Study|Withdrawal by Subject|1|||
125950795|NCT02775344|453117399|FG000|Overall Study|No ovarian cyst identified|3|||
125950796|NCT02775344|453117400|FG001|Overall Study|No ovarian cyst identified|2|||
125950797|NCT04627064|453117412|FG000|Overall Study|Progressive disease|8|||
125950798|NCT04627064|453117413|FG001|Overall Study|Progressive disease|0|||
125950799|NCT04627064|453117412|FG000|Overall Study|Withdrawal by Subject|2|||
125950800|NCT04627064|453117413|FG001|Overall Study|Withdrawal by Subject|0|||
125950801|NCT04627064|453117412|FG000|Overall Study|Physician Decision|1|||
125950802|NCT04627064|453117413|FG001|Overall Study|Physician Decision|0|||
125950803|NCT02018458|453117414|FG000|Overall Study|Death|4|||
125950804|NCT03491150|453117417|FG000|Overall Study|Adverse Event|1|||
125950805|NCT03491150|453117418|FG001|Overall Study|Adverse Event|0|||
125950806|NCT03491150|453117417|FG000|Overall Study|Study Terminated by Sponsor|74|||
125950807|NCT03491150|453117418|FG001|Overall Study|Study Terminated by Sponsor|70|||
125950808|NCT03491150|453117417|FG000|Overall Study|Other|0|||
125950809|NCT03491150|453117418|FG001|Overall Study|Other|1|||
125950810|NCT03491150|453117417|FG000|Overall Study|Withdrawal by Subject|1|||
125950811|NCT03491150|453117418|FG001|Overall Study|Withdrawal by Subject|2|||
125950812|NCT01800916|453117419|FG000|Test Period 1 (1 Week)|Convex product user|0|||
125950813|NCT01800916|453117420|FG001|Test Period 1 (1 Week)|Convex product user|0|||
125950814|NCT01800916|453117421|FG002|Test Period 1 (1 Week)|Convex product user|0|||
125950815|NCT01800916|453117422|FG003|Test Period 1 (1 Week)|Convex product user|1|||
125950816|NCT01800916|453117423|FG004|Test Period 1 (1 Week)|Convex product user|0|||
125950817|NCT01800916|453117424|FG005|Test Period 1 (1 Week)|Convex product user|0|||
125950818|NCT01800916|453117425|FG006|Test Period 1 (1 Week)|Convex product user|0|||
125950819|NCT01800916|453117426|FG007|Test Period 1 (1 Week)|Convex product user|0|||
125950820|NCT01800916|453117427|FG008|Test Period 1 (1 Week)|Convex product user|0|||
125950821|NCT01800916|453117419|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
125950822|NCT01800916|453117420|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
125950823|NCT01800916|453117421|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
125950824|NCT01800916|453117422|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
125950825|NCT01800916|453117423|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
125950826|NCT01800916|453117424|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
125950827|NCT01800916|453117425|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
125950828|NCT01800916|453117426|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
125950829|NCT01800916|453117427|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
125950830|NCT00727714|453117428|FG000|Overall Study|Lost to Follow-up|2|||
125950831|NCT00325234|453117429|FG000|Overall Study|Adverse Event|10|||
125950832|NCT00325234|453117430|FG001|Overall Study|Adverse Event|7|||
125950833|NCT00325234|453117429|FG000|Overall Study|Death due to Study Disease|1|||
125950834|NCT00325234|453117430|FG001|Overall Study|Death due to Study Disease|0|||
125950835|NCT00325234|453117429|FG000|Overall Study|Entry Criteria Not Met|1|||
125950836|NCT00325234|453117430|FG001|Overall Study|Entry Criteria Not Met|2|||
125950837|NCT00325234|453117429|FG000|Overall Study|Subject Decision|6|||
125950838|NCT00325234|453117430|FG001|Overall Study|Subject Decision|8|||
125950839|NCT00325234|453117429|FG000|Overall Study|Physician Decision|17|||
125950840|NCT00325234|453117430|FG001|Overall Study|Physician Decision|12|||
125950841|NCT00325234|453117429|FG000|Overall Study|Progressive Disease|34|||
126115148|NCT02663271|453715851|FG000|Overall Study|Withdrawal by Subject|5|||
125950842|NCT00325234|453117430|FG001|Overall Study|Progressive Disease|37|||
125950843|NCT01234467|453117431|FG000|Overall Study|Adverse Event|3|||
125950844|NCT01234467|453117431|FG000|Overall Study|Death|2|||
125950845|NCT01234467|453117431|FG000|Overall Study|Withdrawal by Subject|2|||
126115149|NCT02663271|453715851|FG000|Overall Study|Lack of Efficacy|1|||
125950846|NCT01234467|453117431|FG000|Overall Study|Disease Progression|2|||
125950847|NCT01234467|453117431|FG000|Overall Study|Clinical deterioration|1|||
125950848|NCT01234467|453117431|FG000|Overall Study|Physician Decision|1|||
125950849|NCT01234467|453117431|FG000|Overall Study|Other complicating disease (stroke)|1|||
126115150|NCT01235793|453715852|FG000|Overall Study|Death|6|||
125950850|NCT01479621|453117432|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
125950851|NCT01479621|453117433|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125950852|NCT01479621|453117434|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125950853|NCT01479621|453117435|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125950854|NCT01479621|453117436|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125950855|NCT01479621|453117437|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125950856|NCT01479621|453117438|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125950857|NCT01479621|453117432|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
125950858|NCT01479621|453117433|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125950859|NCT01479621|453117434|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125950860|NCT01479621|453117435|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125950861|NCT01479621|453117436|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125950862|NCT01479621|453117437|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125950863|NCT01479621|453117438|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125950864|NCT01479621|453117432|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
125950865|NCT01479621|453117433|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125950866|NCT01479621|453117434|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125950867|NCT01479621|453117435|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125950868|NCT01479621|453117436|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125950869|NCT01479621|453117437|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125950870|NCT01479621|453117438|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125950871|NCT01479621|453117432|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
125950872|NCT01479621|453117433|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125950873|NCT01479621|453117434|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125950874|NCT01479621|453117435|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125950875|NCT01479621|453117436|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125950876|NCT01479621|453117437|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125950877|NCT01479621|453117438|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125950878|NCT01479621|453117432|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
125950879|NCT01479621|453117433|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125950880|NCT01479621|453117434|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125950881|NCT01479621|453117435|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125950882|NCT01479621|453117436|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125950883|NCT01479621|453117437|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125950884|NCT01479621|453117438|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125950885|NCT01479621|453117432|FG000|Treatment Period|Adverse Event|0|||
125950886|NCT01479621|453117433|FG001|Treatment Period|Adverse Event|0|||
125950887|NCT01479621|453117434|FG002|Treatment Period|Adverse Event|0|||
125950888|NCT01479621|453117435|FG003|Treatment Period|Adverse Event|0|||
125950889|NCT01479621|453117436|FG004|Treatment Period|Adverse Event|1|||
125950890|NCT01479621|453117437|FG005|Treatment Period|Adverse Event|2|||
125950891|NCT01479621|453117438|FG006|Treatment Period|Adverse Event|2|||
125950892|NCT01479621|453117432|FG000|Treatment Period|Withdrawal by Subject|0|||
125950893|NCT01479621|453117433|FG001|Treatment Period|Withdrawal by Subject|4|||
125950894|NCT01479621|453117434|FG002|Treatment Period|Withdrawal by Subject|2|||
125950895|NCT01479621|453117435|FG003|Treatment Period|Withdrawal by Subject|2|||
125950896|NCT01479621|453117436|FG004|Treatment Period|Withdrawal by Subject|5|||
125950897|NCT01479621|453117437|FG005|Treatment Period|Withdrawal by Subject|5|||
125950898|NCT01479621|453117438|FG006|Treatment Period|Withdrawal by Subject|1|||
125950899|NCT01479621|453117432|FG000|Treatment Period|Physician Decision|0|||
125950900|NCT01479621|453117433|FG001|Treatment Period|Physician Decision|0|||
125950901|NCT01479621|453117434|FG002|Treatment Period|Physician Decision|0|||
125950902|NCT01479621|453117435|FG003|Treatment Period|Physician Decision|0|||
125950903|NCT01479621|453117436|FG004|Treatment Period|Physician Decision|1|||
125950904|NCT01479621|453117437|FG005|Treatment Period|Physician Decision|1|||
125950905|NCT01479621|453117438|FG006|Treatment Period|Physician Decision|0|||
125950906|NCT01479621|453117432|FG000|Treatment Period|Non-compliance to study drug|0|||
125950907|NCT01479621|453117433|FG001|Treatment Period|Non-compliance to study drug|1|||
125950908|NCT01479621|453117434|FG002|Treatment Period|Non-compliance to study drug|0|||
125950909|NCT01479621|453117435|FG003|Treatment Period|Non-compliance to study drug|0|||
125950910|NCT01479621|453117436|FG004|Treatment Period|Non-compliance to study drug|0|||
125950911|NCT01479621|453117437|FG005|Treatment Period|Non-compliance to study drug|0|||
125950912|NCT01479621|453117438|FG006|Treatment Period|Non-compliance to study drug|1|||
125950913|NCT01479621|453117432|FG000|Treatment Period|Protocol Violation|0|||
125950914|NCT01479621|453117433|FG001|Treatment Period|Protocol Violation|9|||
125950915|NCT01479621|453117434|FG002|Treatment Period|Protocol Violation|6|||
125950916|NCT01479621|453117435|FG003|Treatment Period|Protocol Violation|5|||
125950917|NCT01479621|453117436|FG004|Treatment Period|Protocol Violation|2|||
125950918|NCT01479621|453117437|FG005|Treatment Period|Protocol Violation|10|||
125950919|NCT01479621|453117438|FG006|Treatment Period|Protocol Violation|6|||
125950920|NCT01479621|453117432|FG000|Treatment Period|Pregnancy|0|||
125950921|NCT01479621|453117433|FG001|Treatment Period|Pregnancy|0|||
125950922|NCT01479621|453117434|FG002|Treatment Period|Pregnancy|2|||
125950923|NCT01479621|453117435|FG003|Treatment Period|Pregnancy|0|||
125950924|NCT01479621|453117436|FG004|Treatment Period|Pregnancy|0|||
125950925|NCT01479621|453117437|FG005|Treatment Period|Pregnancy|0|||
125950926|NCT01479621|453117438|FG006|Treatment Period|Pregnancy|0|||
125950927|NCT01479621|453117432|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
125950928|NCT01479621|453117433|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
125950929|NCT01479621|453117434|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
125950930|NCT01479621|453117435|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
125950931|NCT01479621|453117436|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
126115151|NCT03519867|453715853|FG000|Overall Study|Adverse Event|1|||
126115152|NCT03519867|453715854|FG001|Overall Study|Adverse Event|1|||
126115153|NCT03519867|453715855|FG002|Overall Study|Adverse Event|0|||
126115154|NCT03519867|453715856|FG003|Overall Study|Adverse Event|0|||
125950932|NCT01479621|453117437|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
125950933|NCT01479621|453117438|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
125950934|NCT01479621|453117432|FG000|Treatment Period|Lost to Follow-up|0|||
125950935|NCT01479621|453117433|FG001|Treatment Period|Lost to Follow-up|0|||
125950936|NCT01479621|453117434|FG002|Treatment Period|Lost to Follow-up|1|||
125950937|NCT01479621|453117435|FG003|Treatment Period|Lost to Follow-up|0|||
125950938|NCT01479621|453117436|FG004|Treatment Period|Lost to Follow-up|2|||
125950939|NCT01479621|453117437|FG005|Treatment Period|Lost to Follow-up|2|||
125950940|NCT01479621|453117438|FG006|Treatment Period|Lost to Follow-up|1|||
125950941|NCT01479621|453117432|FG000|Treatment Period|Met stopping criteria|0|||
125950942|NCT01479621|453117433|FG001|Treatment Period|Met stopping criteria|8|||
125950943|NCT01479621|453117434|FG002|Treatment Period|Met stopping criteria|7|||
125950944|NCT01479621|453117435|FG003|Treatment Period|Met stopping criteria|4|||
125950945|NCT01479621|453117436|FG004|Treatment Period|Met stopping criteria|9|||
125950946|NCT01479621|453117437|FG005|Treatment Period|Met stopping criteria|20|||
125950947|NCT01479621|453117438|FG006|Treatment Period|Met stopping criteria|6|||
125950948|NCT02722928|453117439|FG000|Overall Study|Standard CT was not as required per prot|5|||
125950949|NCT02722928|453117440|FG001|Overall Study|Standard CT was not as required per prot|13|||
125950950|NCT02722928|453117439|FG000|Overall Study|Required Intraoperative MRI|5|||
125950951|NCT02722928|453117440|FG001|Overall Study|Required Intraoperative MRI|7|||
125950952|NCT01838642|453117441|FG000|Overall Study|Died on study|1|||
125950953|NCT01398956|453117442|FG000|Overall Study|Withdrawal by Subject|4|||
125950954|NCT01398956|453117442|FG000|Overall Study|AE, non-serious non-fatal|4|||
125950955|NCT01398956|453117442|FG000|Overall Study|Withdrawal Criteria No.3|1|||
125950956|NCT01398956|453117442|FG000|Overall Study|Subject moved a long distance|1|||
125950957|NCT01557400|453117443|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
125950958|NCT01557400|453117443|FG000|Overall Study|Adverse Event|3|||
125950959|NCT01557400|453117443|FG000|Overall Study|Lost to Follow-up|5|||
125950960|NCT01557400|453117443|FG000|Overall Study|Withdrawal by Subject|9|||
125950961|NCT02281552|453117446|FG000|Overall Study|Medication error|1|||
125950962|NCT02281552|453117447|FG001|Overall Study|Medication error|0|||
125950963|NCT02281552|453117446|FG000|Overall Study|Insufficient clinical response|0|||
125950964|NCT02281552|453117447|FG001|Overall Study|Insufficient clinical response|1|||
125950965|NCT02281552|453117446|FG000|Overall Study|Adverse Event|3|||
125950966|NCT02281552|453117447|FG001|Overall Study|Adverse Event|9|||
125950967|NCT01224639|453117448|FG000|Overall Study|Withdrawal by Subject|0|||
125950968|NCT01224639|453117449|FG001|Overall Study|Withdrawal by Subject|0|||
125950969|NCT01224639|453117450|FG002|Overall Study|Withdrawal by Subject|0|||
125950970|NCT01224639|453117451|FG003|Overall Study|Withdrawal by Subject|0|||
125950971|NCT01224639|453117452|FG004|Overall Study|Withdrawal by Subject|2|||
125950972|NCT01224639|453117453|FG005|Overall Study|Withdrawal by Subject|0|||
125950973|NCT01224639|453117454|FG006|Overall Study|Withdrawal by Subject|1|||
125950974|NCT01224639|453117455|FG007|Overall Study|Withdrawal by Subject|1|||
125950975|NCT01224639|453117448|FG000|Overall Study|Adverse Event|0|||
125950976|NCT01224639|453117449|FG001|Overall Study|Adverse Event|0|||
125950977|NCT01224639|453117450|FG002|Overall Study|Adverse Event|0|||
125950978|NCT01224639|453117451|FG003|Overall Study|Adverse Event|0|||
125950979|NCT01224639|453117452|FG004|Overall Study|Adverse Event|0|||
125950980|NCT01224639|453117453|FG005|Overall Study|Adverse Event|0|||
125950981|NCT01224639|453117454|FG006|Overall Study|Adverse Event|0|||
125950982|NCT01224639|453117455|FG007|Overall Study|Adverse Event|1|||
125950983|NCT03465878|453117456|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
125950984|NCT03465878|453117457|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
125950985|NCT03465878|453117458|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
125950986|NCT03465878|453117459|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
126115155|NCT03519867|453715857|FG004|Overall Study|Adverse Event|0|||
125950987|NCT03465878|453117456|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
125950988|NCT03465878|453117457|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
125950989|NCT03465878|453117458|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
125950990|NCT03465878|453117459|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
125950991|NCT03465878|453117456|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
125950992|NCT03465878|453117457|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
125950993|NCT03465878|453117458|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
125950994|NCT03465878|453117459|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
125950995|NCT01083433|453119551|FG000|Overall Study|Lost to Follow-up|2|||
125950996|NCT01083433|453119552|FG001|Overall Study|Lost to Follow-up|1|||
125950997|NCT01083433|453119553|FG002|Overall Study|Lost to Follow-up|1|||
125950998|NCT01083433|453119551|FG000|Overall Study|Withdrawal by Subject|0|||
125950999|NCT01083433|453119552|FG001|Overall Study|Withdrawal by Subject|5|||
125951000|NCT01083433|453119553|FG002|Overall Study|Withdrawal by Subject|3|||
125951001|NCT01083433|453119551|FG000|Overall Study|Pregnancy|0|||
125951002|NCT01083433|453119552|FG001|Overall Study|Pregnancy|0|||
125951003|NCT01083433|453119553|FG002|Overall Study|Pregnancy|1|||
125951004|NCT01581593|453119554|FG000|Overall Study|Withdrawal by Subject|1|||
125951005|NCT04982029|453119555|FG000|Overall Study|Lost to Follow-up|2|||
125951006|NCT04982029|453119556|FG001|Overall Study|Lost to Follow-up|3|||
125951007|NCT00773175|453119559|FG000|Overall Study|Adverse Event|2|||
125951008|NCT00773175|453119560|FG001|Overall Study|Adverse Event|0|||
125951009|NCT00773175|453119559|FG000|Overall Study|Consent Withdrawn|0|||
125951010|NCT00773175|453119560|FG001|Overall Study|Consent Withdrawn|2|||
125951011|NCT04127786|453119563|FG000|Primary Series|Adverse Event|1|||
125951012|NCT04127786|453119564|FG001|Primary Series|Adverse Event|0|||
125951013|NCT04127786|453119565|FG002|Primary Series|Adverse Event|0|||
125951014|NCT04127786|453119566|FG003|Primary Series|Adverse Event|1|||
125951015|NCT04127786|453119567|FG004|Primary Series|Adverse Event|0|||
125951016|NCT04127786|453119568|FG005|Primary Series|Adverse Event|1|||
125951017|NCT04127786|453119563|FG000|Primary Series|Protocol Violation|5|||
125951018|NCT04127786|453119564|FG001|Primary Series|Protocol Violation|3|||
125951019|NCT04127786|453119565|FG002|Primary Series|Protocol Violation|4|||
125951020|NCT04127786|453119566|FG003|Primary Series|Protocol Violation|3|||
125951021|NCT04127786|453119567|FG004|Primary Series|Protocol Violation|2|||
125951022|NCT04127786|453119568|FG005|Primary Series|Protocol Violation|0|||
125951023|NCT04127786|453119563|FG000|Primary Series|Withdrawal by Subject|0|||
125951024|NCT04127786|453119564|FG001|Primary Series|Withdrawal by Subject|0|||
125951025|NCT04127786|453119565|FG002|Primary Series|Withdrawal by Subject|0|||
125951026|NCT04127786|453119566|FG003|Primary Series|Withdrawal by Subject|1|||
125951027|NCT04127786|453119567|FG004|Primary Series|Withdrawal by Subject|0|||
125951028|NCT04127786|453119568|FG005|Primary Series|Withdrawal by Subject|0|||
125951029|NCT04127786|453119563|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
125951030|NCT04127786|453119564|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
125951031|NCT04127786|453119565|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
125951032|NCT04127786|453119566|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
125951033|NCT04127786|453119567|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
125951034|NCT04127786|453119568|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
125951035|NCT04127786|453119563|FG000|Booster Phase|Withdrawal by Subject|2|||
125951036|NCT04127786|453119564|FG001|Booster Phase|Withdrawal by Subject|0|||
125951037|NCT04127786|453119565|FG002|Booster Phase|Withdrawal by Subject|0|||
125951038|NCT04127786|453119566|FG003|Booster Phase|Withdrawal by Subject|0|||
125951039|NCT04127786|453119567|FG004|Booster Phase|Withdrawal by Subject|0|||
125951040|NCT04127786|453119568|FG005|Booster Phase|Withdrawal by Subject|0|||
125951041|NCT01904604|453119569|FG000|Overall Study|Withdrew before receiving dosing|0|||
125951042|NCT01904604|453119570|FG001|Overall Study|Withdrew before receiving dosing|1|||
125951043|NCT01904604|453119571|FG002|Overall Study|Withdrew before receiving dosing|0|||
125951044|NCT01904604|453119569|FG000|Overall Study|Non-compliance|1|||
125951045|NCT01904604|453119570|FG001|Overall Study|Non-compliance|0|||
125951046|NCT01904604|453119571|FG002|Overall Study|Non-compliance|0|||
125951047|NCT01904604|453119569|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
125951048|NCT01904604|453119570|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
125951049|NCT01904604|453119571|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
125951050|NCT01904604|453119569|FG000|Overall Study|Patch site reactions|1|||
126115156|NCT03519867|453715858|FG005|Overall Study|Adverse Event|0|||
126115157|NCT03519867|453715859|FG006|Overall Study|Adverse Event|0|||
126115158|NCT03519867|453715860|FG007|Overall Study|Adverse Event|0|||
125951051|NCT01904604|453119570|FG001|Overall Study|Patch site reactions|1|||
125951052|NCT01904604|453119571|FG002|Overall Study|Patch site reactions|0|||
125951053|NCT01904604|453119569|FG000|Overall Study|Increased syncope|0|||
125951054|NCT01904604|453119570|FG001|Overall Study|Increased syncope|1|||
126115159|NCT03519867|453715861|FG008|Overall Study|Adverse Event|0|||
126115160|NCT03519867|453715862|FG009|Overall Study|Adverse Event|0|||
126115161|NCT03519867|453715853|FG000|Overall Study|Protocol Violation|0|||
125951055|NCT01904604|453119571|FG002|Overall Study|Increased syncope|0|||
125951056|NCT01904604|453119569|FG000|Overall Study|Unrelated illness|0|||
125951057|NCT01904604|453119570|FG001|Overall Study|Unrelated illness|1|||
126115162|NCT03519867|453715854|FG001|Overall Study|Protocol Violation|0|||
126115163|NCT03519867|453715855|FG002|Overall Study|Protocol Violation|0|||
125951058|NCT01904604|453119571|FG002|Overall Study|Unrelated illness|0|||
125951059|NCT01904604|453119569|FG000|Overall Study|Passed Week 52 OFC|1|||
125951060|NCT01904604|453119570|FG001|Overall Study|Passed Week 52 OFC|0|||
126115164|NCT03519867|453715856|FG003|Overall Study|Protocol Violation|0|||
126115165|NCT03519867|453715857|FG004|Overall Study|Protocol Violation|0|||
126115166|NCT03519867|453715858|FG005|Overall Study|Protocol Violation|1|||
126115167|NCT03519867|453715859|FG006|Overall Study|Protocol Violation|0|||
126115168|NCT03519867|453715860|FG007|Overall Study|Protocol Violation|0|||
126115169|NCT03519867|453715861|FG008|Overall Study|Protocol Violation|0|||
126115170|NCT03519867|453715862|FG009|Overall Study|Protocol Violation|0|||
126115171|NCT03519867|453715853|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115172|NCT03519867|453715854|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115173|NCT03519867|453715855|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115174|NCT03519867|453715856|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115175|NCT03519867|453715857|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115176|NCT03519867|453715858|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115177|NCT03519867|453715859|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
125951061|NCT01904604|453119571|FG002|Overall Study|Passed Week 52 OFC|0|||
125951062|NCT01904604|453119569|FG000|Overall Study|Withdrawal by Subject|1|||
125951063|NCT01904604|453119570|FG001|Overall Study|Withdrawal by Subject|2|||
125951064|NCT01904604|453119571|FG002|Overall Study|Withdrawal by Subject|0|||
125951065|NCT01904604|453119569|FG000|Overall Study|Participant Relocated|1|||
125951066|NCT01904604|453119570|FG001|Overall Study|Participant Relocated|1|||
125951067|NCT01904604|453119571|FG002|Overall Study|Participant Relocated|1|||
125951068|NCT01904604|453119569|FG000|Overall Study|Lost to Follow-up|0|||
125951069|NCT01904604|453119570|FG001|Overall Study|Lost to Follow-up|0|||
125951070|NCT01904604|453119571|FG002|Overall Study|Lost to Follow-up|1|||
125951071|NCT03568942|453119574|FG000|Overall Study|Family emergency|1|||
125951072|NCT03568942|453119574|FG000|Overall Study|Lost to Follow-up|1|||
125951073|NCT00358527|453119576|FG000|Overall Study|Adverse Event|4|||
125951074|NCT00358527|453119577|FG001|Overall Study|Adverse Event|0|||
125951075|NCT00358527|453119576|FG000|Overall Study|Withdrawal by Subject|1|||
125951076|NCT00358527|453119577|FG001|Overall Study|Withdrawal by Subject|1|||
125951077|NCT00358527|453119576|FG000|Overall Study|Non-compliance with protocol|6|||
125951078|NCT00358527|453119577|FG001|Overall Study|Non-compliance with protocol|1|||
125951079|NCT00358527|453119576|FG000|Overall Study|Administrative|2|||
125951080|NCT00358527|453119577|FG001|Overall Study|Administrative|1|||
125951081|NCT04144166|453119578|FG000|Overall Study|Discharged before study start|1|||
125951082|NCT04144166|453119578|FG000|Overall Study|Pregnancy|1|||
125951083|NCT04144166|453119578|FG000|Overall Study|Nail polish could not be removed from finger|1|||
125951084|NCT04145895|453119580|FG000|Overall Study|Physician Decision|2|||
125951085|NCT04145895|453119581|FG001|Overall Study|Physician Decision|0|||
125951086|NCT04145895|453119580|FG000|Overall Study|Withdrawal by Subject|0|||
125951087|NCT04145895|453119581|FG001|Overall Study|Withdrawal by Subject|2|||
125951088|NCT01481116|453119582|FG000|Overall Study|Adverse Event|26|||
125951089|NCT01481116|453119583|FG001|Overall Study|Adverse Event|26|||
125951090|NCT01481116|453119584|FG002|Overall Study|Adverse Event|42|||
125951091|NCT01481116|453119582|FG000|Overall Study|Major Protocol Deviation|3|||
125951092|NCT01481116|453119583|FG001|Overall Study|Major Protocol Deviation|7|||
125951093|NCT01481116|453119584|FG002|Overall Study|Major Protocol Deviation|1|||
125951094|NCT01481116|453119582|FG000|Overall Study|Lost to Follow-up|8|||
125951095|NCT01481116|453119583|FG001|Overall Study|Lost to Follow-up|12|||
125951096|NCT01481116|453119584|FG002|Overall Study|Lost to Follow-up|11|||
125951097|NCT01481116|453119582|FG000|Overall Study|Withdrawal by Subject|37|||
125951098|NCT01481116|453119583|FG001|Overall Study|Withdrawal by Subject|33|||
126115178|NCT03519867|453715860|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115179|NCT03519867|453715861|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115180|NCT03519867|453715862|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126115181|NCT03519867|453715853|FG000|Overall Study|Admin. of other reversal agent|1|||
126115182|NCT03519867|453715854|FG001|Overall Study|Admin. of other reversal agent|1|||
125951099|NCT01481116|453119584|FG002|Overall Study|Withdrawal by Subject|37|||
125951100|NCT01481116|453119582|FG000|Overall Study|Study Termination|730|||
125951101|NCT01481116|453119583|FG001|Overall Study|Study Termination|729|||
125951102|NCT01481116|453119584|FG002|Overall Study|Study Termination|713|||
125951103|NCT01481116|453119582|FG000|Overall Study|Pregnancy|0|||
126115183|NCT03519867|453715855|FG002|Overall Study|Admin. of other reversal agent|0|||
125951104|NCT01481116|453119583|FG001|Overall Study|Pregnancy|0|||
125951105|NCT01481116|453119584|FG002|Overall Study|Pregnancy|1|||
125951106|NCT01481116|453119582|FG000|Overall Study|Lack of Efficacy|3|||
125951107|NCT01481116|453119583|FG001|Overall Study|Lack of Efficacy|3|||
125951108|NCT01481116|453119584|FG002|Overall Study|Lack of Efficacy|1|||
125951109|NCT01481116|453119582|FG000|Overall Study|Contraindications|1|||
125951110|NCT01481116|453119583|FG001|Overall Study|Contraindications|1|||
126115184|NCT03519867|453715856|FG003|Overall Study|Admin. of other reversal agent|0|||
125951111|NCT01481116|453119584|FG002|Overall Study|Contraindications|0|||
125951112|NCT01481116|453119582|FG000|Overall Study|Other|1|||
125951113|NCT01481116|453119583|FG001|Overall Study|Other|1|||
125951114|NCT01481116|453119584|FG002|Overall Study|Other|0|||
125951115|NCT01481116|453119582|FG000|Overall Study|Participant Started Taking Glipizide|1|||
125951116|NCT01481116|453119583|FG001|Overall Study|Participant Started Taking Glipizide|0|||
125951117|NCT01481116|453119584|FG002|Overall Study|Participant Started Taking Glipizide|0|||
125951118|NCT01481116|453119582|FG000|Overall Study|Participant Moved Out of Area|2|||
125951119|NCT01481116|453119583|FG001|Overall Study|Participant Moved Out of Area|0|||
125951120|NCT01481116|453119584|FG002|Overall Study|Participant Moved Out of Area|1|||
125951121|NCT01481116|453119582|FG000|Overall Study|Participant Moved Out of Country|1|||
125951122|NCT01481116|453119583|FG001|Overall Study|Participant Moved Out of Country|0|||
125951123|NCT01481116|453119584|FG002|Overall Study|Participant Moved Out of Country|1|||
125951124|NCT01481116|453119582|FG000|Overall Study|Investigator Decision|3|||
125951125|NCT01481116|453119583|FG001|Overall Study|Investigator Decision|2|||
125951126|NCT01481116|453119584|FG002|Overall Study|Investigator Decision|1|||
125951127|NCT01481116|453119582|FG000|Overall Study|Sponsor Decision|0|||
125951128|NCT01481116|453119583|FG001|Overall Study|Sponsor Decision|1|||
125951129|NCT01481116|453119584|FG002|Overall Study|Sponsor Decision|3|||
125951130|NCT01481116|453119582|FG000|Overall Study|Non-Compliant With Study Drug|0|||
125951131|NCT01481116|453119583|FG001|Overall Study|Non-Compliant With Study Drug|1|||
125951132|NCT01481116|453119584|FG002|Overall Study|Non-Compliant With Study Drug|1|||
125951133|NCT01481116|453119582|FG000|Overall Study|Investigator's Discretion|2|||
125951134|NCT01481116|453119583|FG001|Overall Study|Investigator's Discretion|0|||
125951135|NCT01481116|453119584|FG002|Overall Study|Investigator's Discretion|0|||
125951136|NCT01481116|453119582|FG000|Overall Study|Death|2|||
125951137|NCT01481116|453119583|FG001|Overall Study|Death|1|||
125951138|NCT01481116|453119584|FG002|Overall Study|Death|0|||
125951139|NCT01481116|453119582|FG000|Overall Study|Hypoglycemic Event|4|||
125951140|NCT01481116|453119583|FG001|Overall Study|Hypoglycemic Event|0|||
125951141|NCT01481116|453119584|FG002|Overall Study|Hypoglycemic Event|0|||
125951142|NCT00640510|453119585|FG000|Overall Study|Lack of Efficacy|0|||
125951143|NCT00640510|453119586|FG001|Overall Study|Lack of Efficacy|1|||
125951144|NCT00640510|453119585|FG000|Overall Study|Protocol Violation|1|||
125951145|NCT00640510|453119586|FG001|Overall Study|Protocol Violation|0|||
125951146|NCT00640510|453119585|FG000|Overall Study|Physician Decision|0|||
125951147|NCT00640510|453119586|FG001|Overall Study|Physician Decision|1|||
125951148|NCT00910715|453119592|FG000|Overall Study|Lost to Follow-up|22|||
125951149|NCT00910715|453119593|FG001|Overall Study|Lost to Follow-up|26|||
125951150|NCT00910715|453119594|FG002|Overall Study|Lost to Follow-up|0|||
125951151|NCT01467076|453119595|FG000|Overall Study|Lost to Follow-up|1|||
125951152|NCT01467076|453119596|FG001|Overall Study|Lost to Follow-up|0|||
125951153|NCT01467076|453119597|FG002|Overall Study|Lost to Follow-up|0|||
125951154|NCT00418691|453119599|FG000|Overall Study|Lost to Follow-up|1|||
125951155|NCT00418691|453119600|FG001|Overall Study|Lost to Follow-up|2|||
125951156|NCT00418691|453119601|FG002|Overall Study|Lost to Follow-up|3|||
125951157|NCT00418691|453119599|FG000|Overall Study|Started new medication voiding entry|0|||
125951158|NCT00418691|453119600|FG001|Overall Study|Started new medication voiding entry|0|||
125951159|NCT00418691|453119601|FG002|Overall Study|Started new medication voiding entry|1|||
125951160|NCT00418691|453119599|FG000|Overall Study|Progressive Disease|1|||
125951161|NCT00418691|453119600|FG001|Overall Study|Progressive Disease|0|||
125951162|NCT00418691|453119601|FG002|Overall Study|Progressive Disease|1|||
125951163|NCT02465528|453119602|FG000|Overall Study|Progressive disease|0|||
125951164|NCT02465528|453119603|FG001|Overall Study|Progressive disease|2|||
125951165|NCT02465528|453119604|FG002|Overall Study|Progressive disease|9|||
125951166|NCT02465528|453119605|FG003|Overall Study|Progressive disease|4|||
125951167|NCT02465528|453119602|FG000|Overall Study|Study terminated by sponsor|1|||
125951168|NCT02465528|453119603|FG001|Overall Study|Study terminated by sponsor|2|||
125951169|NCT02465528|453119604|FG002|Overall Study|Study terminated by sponsor|0|||
125951170|NCT02465528|453119605|FG003|Overall Study|Study terminated by sponsor|0|||
125951171|NCT02465528|453119602|FG000|Overall Study|Withdrawal by Subject|0|||
125951172|NCT02465528|453119603|FG001|Overall Study|Withdrawal by Subject|0|||
125951173|NCT02465528|453119604|FG002|Overall Study|Withdrawal by Subject|2|||
125951174|NCT02465528|453119605|FG003|Overall Study|Withdrawal by Subject|0|||
125951175|NCT02465528|453119602|FG000|Overall Study|Adverse Event|0|||
125951176|NCT02465528|453119603|FG001|Overall Study|Adverse Event|0|||
125951177|NCT02465528|453119604|FG002|Overall Study|Adverse Event|0|||
125951178|NCT02465528|453119605|FG003|Overall Study|Adverse Event|1|||
125951179|NCT02465528|453119602|FG000|Overall Study|Physician Decision|0|||
125951180|NCT02465528|453119603|FG001|Overall Study|Physician Decision|0|||
125951181|NCT02465528|453119604|FG002|Overall Study|Physician Decision|1|||
125951182|NCT02465528|453119605|FG003|Overall Study|Physician Decision|0|||
125951183|NCT03907683|453119608|FG000|Overall Study|Pregnancy|1|||
125951184|NCT03907683|453119608|FG000|Overall Study|Withdrawal by Subject|1|||
125951185|NCT03400332|453119610|FG000|Pre-Treatment|Other reasons|0|||
125951186|NCT03400332|453119611|FG001|Pre-Treatment|Other reasons|0|||
125951187|NCT03400332|453119612|FG002|Pre-Treatment|Other reasons|0|||
125951188|NCT03400332|453119613|FG003|Pre-Treatment|Other reasons|0|||
125951189|NCT03400332|453119614|FG004|Pre-Treatment|Other reasons|0|||
125951190|NCT03400332|453119615|FG005|Pre-Treatment|Other reasons|0|||
125951191|NCT03400332|453119616|FG006|Pre-Treatment|Other reasons|0|||
125951192|NCT03400332|453119617|FG007|Pre-Treatment|Other reasons|0|||
125951193|NCT03400332|453119618|FG008|Pre-Treatment|Other reasons|1|||
125951194|NCT03400332|453119610|FG000|Pre-Treatment|No longer met study criteria|0|||
125951195|NCT03400332|453119611|FG001|Pre-Treatment|No longer met study criteria|0|||
125951196|NCT03400332|453119612|FG002|Pre-Treatment|No longer met study criteria|0|||
125951197|NCT03400332|453119613|FG003|Pre-Treatment|No longer met study criteria|0|||
125951198|NCT03400332|453119614|FG004|Pre-Treatment|No longer met study criteria|0|||
125951199|NCT03400332|453119615|FG005|Pre-Treatment|No longer met study criteria|0|||
125951200|NCT03400332|453119616|FG006|Pre-Treatment|No longer met study criteria|0|||
125951201|NCT03400332|453119617|FG007|Pre-Treatment|No longer met study criteria|0|||
125951202|NCT03400332|453119618|FG008|Pre-Treatment|No longer met study criteria|1|||
125951203|NCT03400332|453119610|FG000|Pre-Treatment|Withdrawal by Subject|0|||
125951204|NCT03400332|453119611|FG001|Pre-Treatment|Withdrawal by Subject|0|||
125951205|NCT03400332|453119612|FG002|Pre-Treatment|Withdrawal by Subject|0|||
125951206|NCT03400332|453119613|FG003|Pre-Treatment|Withdrawal by Subject|0|||
125951207|NCT03400332|453119614|FG004|Pre-Treatment|Withdrawal by Subject|0|||
125951208|NCT03400332|453119615|FG005|Pre-Treatment|Withdrawal by Subject|0|||
125951209|NCT03400332|453119616|FG006|Pre-Treatment|Withdrawal by Subject|0|||
125951210|NCT03400332|453119617|FG007|Pre-Treatment|Withdrawal by Subject|0|||
125951211|NCT03400332|453119618|FG008|Pre-Treatment|Withdrawal by Subject|1|||
125951212|NCT03400332|453119610|FG000|Treatment|Participant withdrew consent|2|||
125951213|NCT03400332|453119611|FG001|Treatment|Participant withdrew consent|2|||
125951214|NCT03400332|453119612|FG002|Treatment|Participant withdrew consent|0|||
125951215|NCT03400332|453119613|FG003|Treatment|Participant withdrew consent|0|||
125951216|NCT03400332|453119614|FG004|Treatment|Participant withdrew consent|3|||
125951217|NCT03400332|453119615|FG005|Treatment|Participant withdrew consent|3|||
125951218|NCT03400332|453119616|FG006|Treatment|Participant withdrew consent|1|||
125951219|NCT03400332|453119617|FG007|Treatment|Participant withdrew consent|1|||
125951220|NCT03400332|453119618|FG008|Treatment|Participant withdrew consent|1|||
125951221|NCT03400332|453119610|FG000|Treatment|Other reasons|0|||
125951222|NCT03400332|453119611|FG001|Treatment|Other reasons|1|||
125951223|NCT03400332|453119612|FG002|Treatment|Other reasons|1|||
125951224|NCT03400332|453119613|FG003|Treatment|Other reasons|0|||
125951225|NCT03400332|453119614|FG004|Treatment|Other reasons|3|||
125951226|NCT03400332|453119615|FG005|Treatment|Other reasons|1|||
125951227|NCT03400332|453119616|FG006|Treatment|Other reasons|2|||
125951228|NCT03400332|453119617|FG007|Treatment|Other reasons|0|||
125951229|NCT03400332|453119618|FG008|Treatment|Other reasons|1|||
125951230|NCT03400332|453119610|FG000|Treatment|Lost to Follow-up|0|||
125951231|NCT03400332|453119611|FG001|Treatment|Lost to Follow-up|1|||
125951232|NCT03400332|453119612|FG002|Treatment|Lost to Follow-up|0|||
125951233|NCT03400332|453119613|FG003|Treatment|Lost to Follow-up|0|||
125951234|NCT03400332|453119614|FG004|Treatment|Lost to Follow-up|0|||
125951235|NCT03400332|453119615|FG005|Treatment|Lost to Follow-up|0|||
125951236|NCT03400332|453119616|FG006|Treatment|Lost to Follow-up|0|||
125951237|NCT03400332|453119617|FG007|Treatment|Lost to Follow-up|0|||
125951238|NCT03400332|453119618|FG008|Treatment|Lost to Follow-up|0|||
125951239|NCT03400332|453119610|FG000|Treatment|Death|3|||
125951240|NCT03400332|453119611|FG001|Treatment|Death|1|||
125951241|NCT03400332|453119612|FG002|Treatment|Death|2|||
126115185|NCT03519867|453715857|FG004|Overall Study|Admin. of other reversal agent|0|||
125951242|NCT03400332|453119613|FG003|Treatment|Death|3|||
125951243|NCT03400332|453119614|FG004|Treatment|Death|6|||
125951244|NCT03400332|453119615|FG005|Treatment|Death|2|||
125951245|NCT03400332|453119616|FG006|Treatment|Death|1|||
125951246|NCT03400332|453119617|FG007|Treatment|Death|3|||
125951247|NCT03400332|453119618|FG008|Treatment|Death|6|||
125951248|NCT04476017|453119621|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
125951249|NCT04476017|453119622|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
125951250|NCT02704364|453119623|FG000|Overall Study|Adverse Event|1|||
125951251|NCT02704364|453119624|FG001|Overall Study|Adverse Event|1|||
125951252|NCT02704364|453119625|FG002|Overall Study|Adverse Event|0|||
125951253|NCT02704364|453119623|FG000|Overall Study|Noncompliance with study drug|1|||
125951254|NCT02704364|453119624|FG001|Overall Study|Noncompliance with study drug|1|||
125951255|NCT02704364|453119625|FG002|Overall Study|Noncompliance with study drug|0|||
125951256|NCT02704364|453119623|FG000|Overall Study|Other|0|||
125951257|NCT02704364|453119624|FG001|Overall Study|Other|1|||
125951258|NCT02704364|453119625|FG002|Overall Study|Other|1|||
125951259|NCT02975934|453119626|FG000|Treatment Phase|Never initiated study drug|0|||
125951260|NCT02975934|453119627|FG001|Treatment Phase|Never initiated study drug|5|||
125951261|NCT02975934|453119628|FG002|Treatment Phase|Never initiated study drug|0|||
125951262|NCT02075840|453119629|FG000|Overall Study|Withdrawal by Subject|13|||
125951263|NCT02075840|453119630|FG001|Overall Study|Withdrawal by Subject|22|||
125951264|NCT02075840|453119629|FG000|Overall Study|Reason not specified|1|||
125951265|NCT02075840|453119630|FG001|Overall Study|Reason not specified|0|||
125951266|NCT02075840|453119629|FG000|Overall Study|Adverse Event|0|||
125951267|NCT02075840|453119630|FG001|Overall Study|Adverse Event|2|||
125951268|NCT02075840|453119629|FG000|Overall Study|Death|35|||
125951269|NCT02075840|453119630|FG001|Overall Study|Death|40|||
125951270|NCT02075840|453119629|FG000|Overall Study|Lost to Follow-up|3|||
125951271|NCT02075840|453119630|FG001|Overall Study|Lost to Follow-up|2|||
125951272|NCT02075840|453119629|FG000|Overall Study|Physician Decision|1|||
125951273|NCT02075840|453119630|FG001|Overall Study|Physician Decision|3|||
125951274|NCT02075840|453119629|FG000|Overall Study|Ongoing at CCOD|99|||
125951275|NCT02075840|453119630|FG001|Overall Study|Ongoing at CCOD|82|||
125951276|NCT00846742|453119631|FG000|Overall Study|Withdrawal by Subject|1|||
125951277|NCT03909165|453119632|FG000|Overall Study|Physician Decision|0|||
125951278|NCT03909165|453119633|FG001|Overall Study|Physician Decision|1|||
125951279|NCT03909165|453119634|FG002|Overall Study|Physician Decision|0|||
125951280|NCT03909165|453119635|FG003|Overall Study|Physician Decision|0|||
125951281|NCT03909165|453119636|FG004|Overall Study|Physician Decision|0|||
125951282|NCT03909165|453119632|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125951283|NCT03909165|453119633|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125951284|NCT03909165|453119634|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125951285|NCT03909165|453119635|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125951286|NCT03909165|453119636|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125951287|NCT03909165|453119632|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125951288|NCT03909165|453119633|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
125951289|NCT03909165|453119634|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
125951290|NCT03909165|453119635|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
125951291|NCT03909165|453119636|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
125951292|NCT03909165|453119632|FG000|Overall Study|Previous Drug Exposure|0|||
125951293|NCT03909165|453119633|FG001|Overall Study|Previous Drug Exposure|0|||
125951294|NCT03909165|453119634|FG002|Overall Study|Previous Drug Exposure|1|||
125951295|NCT03909165|453119635|FG003|Overall Study|Previous Drug Exposure|0|||
125951296|NCT03909165|453119636|FG004|Overall Study|Previous Drug Exposure|0|||
125951297|NCT03909165|453119632|FG000|Overall Study|Early Discharge|1|||
125951298|NCT03909165|453119633|FG001|Overall Study|Early Discharge|0|||
125951299|NCT03909165|453119634|FG002|Overall Study|Early Discharge|0|||
125951300|NCT03909165|453119635|FG003|Overall Study|Early Discharge|0|||
125951301|NCT03909165|453119636|FG004|Overall Study|Early Discharge|0|||
125951302|NCT04033159|453119637|FG000|Washout Period|Physician Decision|0|||
125951303|NCT04033159|453119638|FG001|Washout Period|Physician Decision|1|||
125951304|NCT04033159|453119639|FG002|Washout Period|Physician Decision|0|||
125951305|NCT04033159|453119637|FG000|Washout Period|Study terminated by Sponsor|0|||
125951306|NCT04033159|453119638|FG001|Washout Period|Study terminated by Sponsor|7|||
125951307|NCT04033159|453119639|FG002|Washout Period|Study terminated by Sponsor|0|||
125951308|NCT04033159|453119637|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
125951309|NCT04033159|453119638|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
125951310|NCT04033159|453119639|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
125951311|NCT00354172|453119644|FG000|Overall Study|Did not receive transplant|1|||
125951312|NCT02287896|453119660|FG000|Second Injection Visit|Withdrawal by Subject|0|||
125951313|NCT02287896|453119661|FG001|Second Injection Visit|Withdrawal by Subject|1|||
125951314|NCT00559962|453119662|FG000|Overall Study|Adverse Event|1|||
125951315|NCT00559962|453119663|FG001|Overall Study|Adverse Event|7|||
125951316|NCT00559962|453119664|FG002|Overall Study|Adverse Event|8|||
125951317|NCT00559962|453119665|FG003|Overall Study|Adverse Event|5|||
125951318|NCT00559962|453119666|FG004|Overall Study|Adverse Event|11|||
125951319|NCT00559962|453119667|FG005|Overall Study|Adverse Event|4|||
125951320|NCT00559962|453119668|FG006|Overall Study|Adverse Event|4|||
125951321|NCT00559962|453119669|FG007|Overall Study|Adverse Event|2|||
125951322|NCT00559962|453119662|FG000|Overall Study|Lost to Follow-up|0|||
125951323|NCT00559962|453119663|FG001|Overall Study|Lost to Follow-up|1|||
125951324|NCT00559962|453119664|FG002|Overall Study|Lost to Follow-up|0|||
125951325|NCT00559962|453119665|FG003|Overall Study|Lost to Follow-up|0|||
125951326|NCT00559962|453119666|FG004|Overall Study|Lost to Follow-up|0|||
125951327|NCT00559962|453119667|FG005|Overall Study|Lost to Follow-up|0|||
125951328|NCT00559962|453119668|FG006|Overall Study|Lost to Follow-up|0|||
125951329|NCT00559962|453119669|FG007|Overall Study|Lost to Follow-up|0|||
125951330|NCT00559962|453119662|FG000|Overall Study|Withdrawal by Subject|1|||
126115186|NCT03519867|453715858|FG005|Overall Study|Admin. of other reversal agent|1|||
125951331|NCT00559962|453119663|FG001|Overall Study|Withdrawal by Subject|1|||
125951332|NCT00559962|453119664|FG002|Overall Study|Withdrawal by Subject|2|||
125951333|NCT00559962|453119665|FG003|Overall Study|Withdrawal by Subject|0|||
125951334|NCT00559962|453119666|FG004|Overall Study|Withdrawal by Subject|3|||
125951335|NCT00559962|453119667|FG005|Overall Study|Withdrawal by Subject|1|||
125951336|NCT00559962|453119668|FG006|Overall Study|Withdrawal by Subject|0|||
125951337|NCT00559962|453119669|FG007|Overall Study|Withdrawal by Subject|2|||
125951338|NCT00559962|453119662|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
126115187|NCT03519867|453715859|FG006|Overall Study|Admin. of other reversal agent|0|||
125951339|NCT00559962|453119663|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
126115188|NCT03519867|453715860|FG007|Overall Study|Admin. of other reversal agent|0|||
126115189|NCT03519867|453715861|FG008|Overall Study|Admin. of other reversal agent|0|||
126115190|NCT03519867|453715862|FG009|Overall Study|Admin. of other reversal agent|0|||
126115191|NCT03519867|453715853|FG000|Overall Study|Reason not provided|1|||
126115192|NCT03519867|453715854|FG001|Overall Study|Reason not provided|1|||
126115193|NCT03519867|453715855|FG002|Overall Study|Reason not provided|1|||
126115194|NCT03519867|453715856|FG003|Overall Study|Reason not provided|1|||
126115195|NCT03519867|453715857|FG004|Overall Study|Reason not provided|0|||
126115196|NCT03519867|453715858|FG005|Overall Study|Reason not provided|1|||
126115197|NCT03519867|453715859|FG006|Overall Study|Reason not provided|0|||
126115198|NCT03519867|453715860|FG007|Overall Study|Reason not provided|1|||
126115199|NCT03519867|453715861|FG008|Overall Study|Reason not provided|1|||
126115200|NCT03519867|453715862|FG009|Overall Study|Reason not provided|0|||
126115201|NCT04223791|453715863|FG000|Overall Study|Lost to Follow-up|0|||
126115202|NCT04223791|453715864|FG001|Overall Study|Lost to Follow-up|4|||
126115203|NCT04223791|453715863|FG000|Overall Study|Physician Decision|5|||
126115204|NCT04223791|453715864|FG001|Overall Study|Physician Decision|1|||
126115205|NCT04223791|453715863|FG000|Overall Study|Protocol Violation|1|||
126115206|NCT04223791|453715864|FG001|Overall Study|Protocol Violation|1|||
126115207|NCT04223791|453715863|FG000|Overall Study|Withdrawal by Subject|10|||
126115208|NCT04223791|453715864|FG001|Overall Study|Withdrawal by Subject|12|||
126115209|NCT04223791|453715863|FG000|Overall Study|Pregnancy|1|||
126115210|NCT04223791|453715864|FG001|Overall Study|Pregnancy|1|||
126115211|NCT04223791|453715863|FG000|Overall Study|Ongoing in Study|305|||
126115212|NCT04223791|453715864|FG001|Overall Study|Ongoing in Study|302|||
126115213|NCT05097716|453717996|FG000|Period 1|Adverse Event|1|||
126115214|NCT05097716|453717996|FG000|Period 1|Close contact with highly-transmissible infection|1|||
126115215|NCT01372150|453717999|FG000|Overall Study|Lack of Efficacy|3|||
126115216|NCT01372150|453718000|FG001|Overall Study|Lack of Efficacy|0|||
126115217|NCT01372150|453718001|FG002|Overall Study|Lack of Efficacy|1|||
126115218|NCT01372150|453717999|FG000|Overall Study|Lost to Follow-up|4|||
126115219|NCT01372150|453718000|FG001|Overall Study|Lost to Follow-up|5|||
126115220|NCT01372150|453718001|FG002|Overall Study|Lost to Follow-up|6|||
126115221|NCT01372150|453717999|FG000|Overall Study|Protocol Violation|1|||
126115222|NCT01372150|453718000|FG001|Overall Study|Protocol Violation|0|||
126115223|NCT01372150|453718001|FG002|Overall Study|Protocol Violation|3|||
126115224|NCT01372150|453717999|FG000|Overall Study|Withdrawal by Subject|2|||
126115225|NCT01372150|453718000|FG001|Overall Study|Withdrawal by Subject|7|||
126115226|NCT01372150|453718001|FG002|Overall Study|Withdrawal by Subject|2|||
126115227|NCT01372150|453717999|FG000|Overall Study|Other|1|||
126115228|NCT01372150|453718000|FG001|Overall Study|Other|0|||
126115229|NCT01372150|453718001|FG002|Overall Study|Other|2|||
126115230|NCT01372150|453717999|FG000|Overall Study|Adverse Event|2|||
126115231|NCT01372150|453718000|FG001|Overall Study|Adverse Event|1|||
126115232|NCT01372150|453718001|FG002|Overall Study|Adverse Event|2|||
126115233|NCT01372150|453717999|FG000|Overall Study|Randomized but not treated|0|||
126115234|NCT01372150|453718000|FG001|Overall Study|Randomized but not treated|1|||
126115235|NCT01372150|453718001|FG002|Overall Study|Randomized but not treated|0|||
126115236|NCT01526551|453718002|FG000|Overall Study|Lack of returned parental consent form|424|||
126115237|NCT05215262|453718003|FG000|Overall Study|Lost to Follow-up|12|||
126115238|NCT05215262|453718004|FG001|Overall Study|Lost to Follow-up|0|||
126115239|NCT00718549|453718009|FG000|Induction Phase|Disease Progression|1|||
126115240|NCT00718549|453718010|FG001|Induction Phase|Disease Progression|0|||
126115241|NCT00718549|453718011|FG002|Induction Phase|Disease Progression|0|||
126115242|NCT00718549|453718009|FG000|Induction Phase|Eligibility Criteria Violation|2|||
126115243|NCT00718549|453718010|FG001|Induction Phase|Eligibility Criteria Violation|0|||
126115244|NCT00718549|453718011|FG002|Induction Phase|Eligibility Criteria Violation|0|||
126115245|NCT00718549|453718009|FG000|Induction Phase|Early Termination - No Additional Info|59|||
126115246|NCT00718549|453718010|FG001|Induction Phase|Early Termination - No Additional Info|0|||
126115247|NCT00718549|453718011|FG002|Induction Phase|Early Termination - No Additional Info|0|||
126115248|NCT00718549|453718009|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
126115249|NCT00718549|453718010|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
126115250|NCT00718549|453718011|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
126115251|NCT00718549|453718009|FG000|Maintenance/ Observation Phase|Death|0|||
126115252|NCT00718549|453718010|FG001|Maintenance/ Observation Phase|Death|1|||
126115253|NCT00718549|453718011|FG002|Maintenance/ Observation Phase|Death|2|||
126115254|NCT00718549|453718009|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
126115255|NCT00718549|453718010|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
126115256|NCT00718549|453718011|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
126115257|NCT00718549|453718009|FG000|Maintenance/ Observation Phase|Progression|0|||
126115258|NCT00718549|453718010|FG001|Maintenance/ Observation Phase|Progression|5|||
126115259|NCT00718549|453718011|FG002|Maintenance/ Observation Phase|Progression|14|||
125951340|NCT00559962|453119664|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
126115260|NCT00718549|453718009|FG000|Maintenance/ Observation Phase|Relapse|0|||
126115261|NCT00718549|453718010|FG001|Maintenance/ Observation Phase|Relapse|3|||
126115262|NCT00718549|453718011|FG002|Maintenance/ Observation Phase|Relapse|2|||
125951341|NCT00559962|453119665|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
125951342|NCT00559962|453119666|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
125951343|NCT00559962|453119667|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
125951344|NCT00559962|453119668|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
125951345|NCT00559962|453119669|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
125951346|NCT01639040|453119670|FG000|Overall Study|Adverse Event|1|||
125951347|NCT01639040|453119671|FG001|Overall Study|Adverse Event|0|||
125951348|NCT03047135|453119675|FG000|Overall Study|Still being treated|3|||
125951349|NCT01585766|453119676|FG000|Overall Study|Withdrawal by Subject|0|||
125951350|NCT01585766|453119677|FG001|Overall Study|Withdrawal by Subject|1|||
125951351|NCT01585766|453119678|FG002|Overall Study|Withdrawal by Subject|1|||
125951352|NCT01585766|453119679|FG003|Overall Study|Withdrawal by Subject|0|||
125951353|NCT01585766|453119680|FG004|Overall Study|Withdrawal by Subject|0|||
125951354|NCT01585766|453119681|FG005|Overall Study|Withdrawal by Subject|0|||
125951355|NCT01585766|453119676|FG000|Overall Study|Death|0|||
125951356|NCT01585766|453119677|FG001|Overall Study|Death|1|||
125951357|NCT01585766|453119678|FG002|Overall Study|Death|0|||
125951358|NCT01585766|453119679|FG003|Overall Study|Death|0|||
125951359|NCT01585766|453119680|FG004|Overall Study|Death|0|||
125951360|NCT01585766|453119681|FG005|Overall Study|Death|0|||
125951361|NCT01585766|453119676|FG000|Overall Study|Physician Decision|0|||
125951362|NCT01585766|453119677|FG001|Overall Study|Physician Decision|0|||
125951363|NCT01585766|453119678|FG002|Overall Study|Physician Decision|1|||
125951364|NCT01585766|453119679|FG003|Overall Study|Physician Decision|0|||
125951365|NCT01585766|453119680|FG004|Overall Study|Physician Decision|0|||
125951366|NCT01585766|453119681|FG005|Overall Study|Physician Decision|0|||
125951367|NCT02385799|453119682|FG000|Overall Study|Lost to Follow-up|1|||
125951368|NCT02385799|453119683|FG001|Overall Study|Lost to Follow-up|2|||
125951369|NCT02385799|453119682|FG000|Overall Study|Adverse Event|4|||
125951370|NCT02385799|453119683|FG001|Overall Study|Adverse Event|2|||
125951371|NCT02385799|453119682|FG000|Overall Study|Withdrawal by Subject|0|||
126079630|NCT01427738|453585903|FG001|Overall Study|Death|9|||
126079631|NCT01427738|453585902|FG000|Overall Study|Severe debilitation, unable to continue|0|||
126079632|NCT01427738|453585903|FG001|Overall Study|Severe debilitation, unable to continue|1|||
126079633|NCT01427738|453585902|FG000|Overall Study|Subject unable to get to clinic|5|||
126079634|NCT01427738|453585903|FG001|Overall Study|Subject unable to get to clinic|2|||
126079635|NCT01427738|453585902|FG000|Overall Study|Withdrawal by Subject|0|||
126079636|NCT01427738|453585903|FG001|Overall Study|Withdrawal by Subject|2|||
126079637|NCT01427738|453585902|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
126079638|NCT01427738|453585903|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
126079639|NCT01427738|453585902|FG000|Overall Study|Lost to Follow-up|1|||
126079640|NCT01427738|453585903|FG001|Overall Study|Lost to Follow-up|5|||
126079641|NCT05314374|453585904|FG000|Overall Study|Adverse Event|2|||
126079642|NCT05314374|453585905|FG001|Overall Study|Adverse Event|2|||
126079643|NCT02658175|453585906|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
126079644|NCT02658175|453585907|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
126079645|NCT02658175|453585908|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
126079646|NCT02658175|453585906|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
126079647|NCT02658175|453585907|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
126079648|NCT02658175|453585908|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
126079649|NCT02658175|453585906|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
126079650|NCT02658175|453585907|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
126079651|NCT02658175|453585908|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
126079652|NCT02658175|453585906|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
126079653|NCT02658175|453585907|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
126079654|NCT02658175|453585908|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
126079655|NCT02658175|453585906|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
126079656|NCT02658175|453585907|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
126079657|NCT02658175|453585908|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
126079658|NCT02658175|453585906|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
126079659|NCT02658175|453585907|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
126079660|NCT02658175|453585908|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
126079661|NCT02658175|453585906|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
125951372|NCT02385799|453119683|FG001|Overall Study|Withdrawal by Subject|4|||
125951373|NCT02130765|453119685|FG000|Overall Study|Did not receive treatment|4|||
126079662|NCT02658175|453585907|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
126079663|NCT02658175|453585908|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
125951374|NCT02130765|453119686|FG001|Overall Study|Did not receive treatment|0|||
125951375|NCT02130765|453119687|FG002|Overall Study|Did not receive treatment|0|||
125951376|NCT02130765|453119688|FG003|Overall Study|Did not receive treatment|0|||
125951377|NCT00058825|453119695|FG000|Overall Study|Relapse|9|||
126115263|NCT01353508|453718012|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
126115264|NCT01353508|453718013|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
126115265|NCT01353508|453718014|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
126115266|NCT01353508|453718015|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
126115267|NCT01353508|453718012|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
126115268|NCT01353508|453718013|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
126115269|NCT01353508|453718014|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
126115270|NCT01353508|453718015|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
126115271|NCT02448225|453718018|FG000|Overall Study|Withdrawal by Subject|1|||
126115272|NCT02448225|453718018|FG000|Overall Study|Did not get FSPG scan|18|||
126115273|NCT02448225|453718018|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
126115274|NCT00851682|453718019|FG000|Overall Study|screen failure|5|||
126115275|NCT00851682|453718020|FG001|Overall Study|screen failure|0|||
125951378|NCT00058825|453119695|FG000|Overall Study|Progressive Disease|5|||
125951379|NCT00058825|453119695|FG000|Overall Study|Graft Failure|5|||
125951380|NCT00058825|453119695|FG000|Overall Study|Death|3|||
125951381|NCT04399161|453119696|FG000|Overall Study|Withdrawal by Subject|1|||
125951382|NCT04399161|453119697|FG001|Overall Study|Withdrawal by Subject|0|||
125951383|NCT04399161|453119698|FG002|Overall Study|Withdrawal by Subject|2|||
125951384|NCT04399161|453119696|FG000|Overall Study|Protocol Violation|1|||
125951385|NCT04399161|453119697|FG001|Overall Study|Protocol Violation|2|||
125951386|NCT04399161|453119698|FG002|Overall Study|Protocol Violation|0|||
125951387|NCT00477672|453119699|FG000|Overall Study|Adverse Event|3|||
125951388|NCT00477672|453119700|FG001|Overall Study|Adverse Event|5|||
125951389|NCT00477672|453119701|FG002|Overall Study|Adverse Event|6|||
125951390|NCT00477672|453119699|FG000|Overall Study|Death|0|||
125951391|NCT00477672|453119700|FG001|Overall Study|Death|1|||
125951392|NCT00477672|453119701|FG002|Overall Study|Death|0|||
125951393|NCT00477672|453119699|FG000|Overall Study|Disease progression|0|||
125951394|NCT00477672|453119700|FG001|Overall Study|Disease progression|1|||
125951395|NCT00477672|453119701|FG002|Overall Study|Disease progression|0|||
125951396|NCT00477672|453119699|FG000|Overall Study|Physician Decision|1|||
125951397|NCT00477672|453119700|FG001|Overall Study|Physician Decision|0|||
125951398|NCT00477672|453119701|FG002|Overall Study|Physician Decision|0|||
125951399|NCT00477672|453119699|FG000|Overall Study|Protocol noncompliance|0|||
125951400|NCT00477672|453119700|FG001|Overall Study|Protocol noncompliance|2|||
125951401|NCT00477672|453119701|FG002|Overall Study|Protocol noncompliance|0|||
125951402|NCT00477672|453119699|FG000|Overall Study|Consent withdrawn|2|||
125951403|NCT00477672|453119700|FG001|Overall Study|Consent withdrawn|5|||
125951404|NCT00477672|453119701|FG002|Overall Study|Consent withdrawn|10|||
125951405|NCT00477672|453119699|FG000|Overall Study|Discretion of Sponsor|1|||
125951406|NCT00477672|453119700|FG001|Overall Study|Discretion of Sponsor|2|||
125951407|NCT00477672|453119701|FG002|Overall Study|Discretion of Sponsor|0|||
125951408|NCT02244580|453119704|FG000|Overall Study|No cancer tissues available|241|||
125951409|NCT00838565|453119705|FG000|Overall Study|Withdrawal by Subject|0|||
125951410|NCT00838565|453119706|FG001|Overall Study|Withdrawal by Subject|0|||
125951411|NCT00838565|453119707|FG002|Overall Study|Withdrawal by Subject|1|||
125951412|NCT00838565|453119708|FG003|Overall Study|Withdrawal by Subject|0|||
125951413|NCT00838565|453119709|FG004|Overall Study|Withdrawal by Subject|0|||
125951414|NCT00838565|453119710|FG005|Overall Study|Withdrawal by Subject|2|||
125951415|NCT00838565|453119705|FG000|Overall Study|Other|0|||
125951416|NCT00838565|453119706|FG001|Overall Study|Other|2|||
125951417|NCT00838565|453119707|FG002|Overall Study|Other|0|||
125951418|NCT00838565|453119708|FG003|Overall Study|Other|0|||
125951419|NCT00838565|453119709|FG004|Overall Study|Other|0|||
125951420|NCT00838565|453119710|FG005|Overall Study|Other|0|||
125951421|NCT00838565|453119705|FG000|Overall Study|Randomized but not Treated|0|||
125951422|NCT00838565|453119706|FG001|Overall Study|Randomized but not Treated|1|||
125951423|NCT00838565|453119707|FG002|Overall Study|Randomized but not Treated|0|||
125951424|NCT00838565|453119708|FG003|Overall Study|Randomized but not Treated|0|||
125951425|NCT00838565|453119709|FG004|Overall Study|Randomized but not Treated|0|||
126115276|NCT02678416|453718031|FG000|Part 1|Withdrawal by Subject|1|||
126115277|NCT02678416|453718031|FG000|Part 2|Adverse Event|2|||
125951426|NCT00838565|453119710|FG005|Overall Study|Randomized but not Treated|0|||
126115278|NCT02678416|453718031|FG000|Part 2|Withdrawal by Subject|1|||
126115279|NCT00935272|453718032|FG000|Overall Study|Lost to Follow-up|10|||
125951427|NCT03571516|453119711|FG000|Overall Study|Severe diarrhea|1|||
125951428|NCT03571516|453119712|FG001|Overall Study|Severe diarrhea|0|||
125951429|NCT03571516|453119711|FG000|Overall Study|Withdrawal by Subject|0|||
125951430|NCT03571516|453119712|FG001|Overall Study|Withdrawal by Subject|1|||
125951431|NCT04011410|453119717|FG000|Overall Study|Withdrawal by Subject|1|||
125951432|NCT01455012|453119718|FG000|Overall Study|Adverse Event|0|||
125951433|NCT01455012|453119719|FG001|Overall Study|Adverse Event|2|||
125951434|NCT01455012|453119718|FG000|Overall Study|Lack of Efficacy|6|||
125951435|NCT01455012|453119719|FG001|Overall Study|Lack of Efficacy|1|||
125951436|NCT01455012|453119718|FG000|Overall Study|Withdrawal by Subject|3|||
126115280|NCT00935272|453718033|FG001|Overall Study|Lost to Follow-up|3|||
125951437|NCT01455012|453119719|FG001|Overall Study|Withdrawal by Subject|1|||
125951438|NCT01455012|453119718|FG000|Overall Study|Unknown reason|2|||
125951439|NCT01455012|453119719|FG001|Overall Study|Unknown reason|0|||
125951440|NCT01215227|453119721|FG000|Overall Study|Adverse Event|11|||
125951441|NCT01215227|453119722|FG001|Overall Study|Adverse Event|11|||
125951442|NCT01215227|453119723|FG002|Overall Study|Adverse Event|4|||
125951443|NCT01215227|453119724|FG003|Overall Study|Adverse Event|8|||
125951444|NCT01215227|453119725|FG004|Overall Study|Adverse Event|7|||
125951445|NCT01215227|453119726|FG005|Overall Study|Adverse Event|6|||
125951446|NCT01215227|453119721|FG000|Overall Study|Treatment Failure|8|||
125951447|NCT01215227|453119722|FG001|Overall Study|Treatment Failure|4|||
125951448|NCT01215227|453119723|FG002|Overall Study|Treatment Failure|1|||
125951449|NCT01215227|453119724|FG003|Overall Study|Treatment Failure|5|||
125951450|NCT01215227|453119725|FG004|Overall Study|Treatment Failure|1|||
125951451|NCT01215227|453119726|FG005|Overall Study|Treatment Failure|1|||
125951452|NCT01215227|453119721|FG000|Overall Study|Lost to Follow-up|1|||
125951453|NCT01215227|453119722|FG001|Overall Study|Lost to Follow-up|4|||
125951454|NCT01215227|453119723|FG002|Overall Study|Lost to Follow-up|1|||
125951455|NCT01215227|453119724|FG003|Overall Study|Lost to Follow-up|1|||
125951456|NCT01215227|453119725|FG004|Overall Study|Lost to Follow-up|1|||
125951457|NCT01215227|453119726|FG005|Overall Study|Lost to Follow-up|2|||
125951458|NCT01215227|453119721|FG000|Overall Study|Subject Withdrew Consent|16|||
126079664|NCT02658175|453585906|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
126079665|NCT02658175|453585907|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
126079666|NCT02658175|453585908|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
126079667|NCT02658175|453585906|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
126079668|NCT02658175|453585907|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
126079669|NCT02658175|453585908|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
126079670|NCT02658175|453585906|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
126079671|NCT02658175|453585907|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
126079672|NCT02658175|453585908|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
126079673|NCT01214421|453585909|FG000|Overall Study|Lost to Follow-up|7|||
126079674|NCT01214421|453585910|FG001|Overall Study|Lost to Follow-up|3|||
126079675|NCT01214421|453585911|FG002|Overall Study|Lost to Follow-up|7|||
126079676|NCT01214421|453585912|FG003|Overall Study|Lost to Follow-up|3|||
126079677|NCT01214421|453585909|FG000|Overall Study|Adverse Event|16|||
126079678|NCT01214421|453585910|FG001|Overall Study|Adverse Event|35|||
126079679|NCT01214421|453585911|FG002|Overall Study|Adverse Event|14|||
126079680|NCT01214421|453585912|FG003|Overall Study|Adverse Event|3|||
126079681|NCT01214421|453585909|FG000|Overall Study|Sponsor Discontinued Site|1|||
126079682|NCT01214421|453585910|FG001|Overall Study|Sponsor Discontinued Site|2|||
126079683|NCT01214421|453585911|FG002|Overall Study|Sponsor Discontinued Site|0|||
126079684|NCT01214421|453585912|FG003|Overall Study|Sponsor Discontinued Site|0|||
126079685|NCT01214421|453585909|FG000|Overall Study|Withdrawal Criteria Met|3|||
126079686|NCT01214421|453585910|FG001|Overall Study|Withdrawal Criteria Met|0|||
126079687|NCT01214421|453585911|FG002|Overall Study|Withdrawal Criteria Met|2|||
126079688|NCT01214421|453585912|FG003|Overall Study|Withdrawal Criteria Met|1|||
126079689|NCT01214421|453585909|FG000|Overall Study|Physician Decision|2|||
126079690|NCT01214421|453585910|FG001|Overall Study|Physician Decision|0|||
126079691|NCT01214421|453585911|FG002|Overall Study|Physician Decision|4|||
126079692|NCT01214421|453585912|FG003|Overall Study|Physician Decision|0|||
126079693|NCT01214421|453585909|FG000|Overall Study|Withdrawal by Subject|21|||
126079694|NCT01214421|453585910|FG001|Overall Study|Withdrawal by Subject|18|||
126079695|NCT01214421|453585911|FG002|Overall Study|Withdrawal by Subject|11|||
126079696|NCT01214421|453585912|FG003|Overall Study|Withdrawal by Subject|2|||
126079697|NCT02581059|453585915|FG000|Study Treatment|Disease Progression|1|||
126079698|NCT02581059|453585916|FG001|Study Treatment|Disease Progression|1|||
126079699|NCT02581059|453585915|FG000|Study Treatment|Adverse Event|2|||
126079700|NCT02581059|453585916|FG001|Study Treatment|Adverse Event|1|||
126079701|NCT02581059|453585915|FG000|Study Treatment|Death|1|||
126079702|NCT02581059|453585916|FG001|Study Treatment|Death|1|||
126079703|NCT02581059|453585915|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
126079704|NCT02581059|453585916|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
126079705|NCT02581059|453585915|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
126079706|NCT02581059|453585916|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
125951459|NCT01215227|453119722|FG001|Overall Study|Subject Withdrew Consent|20|||
125951460|NCT01215227|453119723|FG002|Overall Study|Subject Withdrew Consent|7|||
126079707|NCT02581059|453585915|FG000|Follow up|Death|1|||
126079708|NCT02581059|453585916|FG001|Follow up|Death|3|||
126079709|NCT02581059|453585915|FG000|Follow up|study terminated|1|||
126079710|NCT02581059|453585916|FG001|Follow up|study terminated|1|||
126079711|NCT02581059|453585915|FG000|Follow up|screen failure|0|||
126079712|NCT02581059|453585916|FG001|Follow up|screen failure|1|||
126079713|NCT02581059|453585915|FG000|Follow up|Patient started new clinical trial|1|||
125951461|NCT01215227|453119724|FG003|Overall Study|Subject Withdrew Consent|10|||
125951462|NCT01215227|453119725|FG004|Overall Study|Subject Withdrew Consent|11|||
125951463|NCT01215227|453119726|FG005|Overall Study|Subject Withdrew Consent|8|||
125951464|NCT01215227|453119721|FG000|Overall Study|Non-Compliance With Protocol|2|||
126079714|NCT02581059|453585916|FG001|Follow up|Patient started new clinical trial|0|||
126079715|NCT02392104|453585917|FG000|Overall Study|discontinuation of warfarin|3|||
126079716|NCT02392104|453585917|FG000|Overall Study|bleeding event|1|||
126079717|NCT02392104|453585917|FG000|Overall Study|transferred care to another doctor|2|||
125951465|NCT01215227|453119722|FG001|Overall Study|Non-Compliance With Protocol|6|||
125951466|NCT01215227|453119723|FG002|Overall Study|Non-Compliance With Protocol|1|||
125951467|NCT01215227|453119724|FG003|Overall Study|Non-Compliance With Protocol|0|||
125951468|NCT01215227|453119725|FG004|Overall Study|Non-Compliance With Protocol|0|||
125951469|NCT01215227|453119726|FG005|Overall Study|Non-Compliance With Protocol|0|||
125951470|NCT01215227|453119721|FG000|Overall Study|Administrative|83|||
125951471|NCT01215227|453119722|FG001|Overall Study|Administrative|73|||
125951472|NCT01215227|453119723|FG002|Overall Study|Administrative|42|||
125951473|NCT01215227|453119724|FG003|Overall Study|Administrative|24|||
125951474|NCT01215227|453119725|FG004|Overall Study|Administrative|28|||
125951475|NCT01215227|453119726|FG005|Overall Study|Administrative|40|||
125951476|NCT01215227|453119721|FG000|Overall Study|Missing Status|0|||
125951477|NCT01215227|453119722|FG001|Overall Study|Missing Status|1|||
125951478|NCT01215227|453119723|FG002|Overall Study|Missing Status|0|||
125951479|NCT01215227|453119724|FG003|Overall Study|Missing Status|0|||
125951480|NCT01215227|453119725|FG004|Overall Study|Missing Status|0|||
125951481|NCT01215227|453119726|FG005|Overall Study|Missing Status|0|||
125951482|NCT01215227|453119721|FG000|Overall Study|Randomized but not treated|0|||
125951483|NCT01215227|453119722|FG001|Overall Study|Randomized but not treated|0|||
125951484|NCT01215227|453119723|FG002|Overall Study|Randomized but not treated|1|||
125951485|NCT01215227|453119724|FG003|Overall Study|Randomized but not treated|1|||
125951486|NCT01215227|453119725|FG004|Overall Study|Randomized but not treated|0|||
125951487|NCT01215227|453119726|FG005|Overall Study|Randomized but not treated|1|||
125951488|NCT02253810|453119727|FG000|Overall Study|Withdrawal by Subject|2|||
125951489|NCT02253810|453119728|FG001|Overall Study|Withdrawal by Subject|1|||
125951490|NCT02253810|453119727|FG000|Overall Study|Unknown concomitant procedure|3|||
125951491|NCT02253810|453119728|FG001|Overall Study|Unknown concomitant procedure|2|||
125951492|NCT01434290|453119736|FG000|Overall Study|Protocol Violation|6|||
125951493|NCT01434290|453119737|FG001|Overall Study|Protocol Violation|3|||
125951494|NCT01434290|453119736|FG000|Overall Study|No protocol treatment|2|||
125951495|NCT01434290|453119737|FG001|Overall Study|No protocol treatment|4|||
125951496|NCT03925727|453119739|FG000|Overall Study|Adverse Event|4|||
125951497|NCT03925727|453119740|FG001|Overall Study|Adverse Event|0|||
125951498|NCT03925727|453119741|FG002|Overall Study|Adverse Event|3|||
125951499|NCT03925727|453119739|FG000|Overall Study|Protocol Violation|1|||
125951500|NCT03925727|453119740|FG001|Overall Study|Protocol Violation|2|||
125951501|NCT03925727|453119741|FG002|Overall Study|Protocol Violation|2|||
125951502|NCT03925727|453119739|FG000|Overall Study|Withdrawal by Subject|3|||
125951503|NCT03925727|453119740|FG001|Overall Study|Withdrawal by Subject|2|||
125951504|NCT03925727|453119741|FG002|Overall Study|Withdrawal by Subject|4|||
125951505|NCT03925727|453119739|FG000|Overall Study|Administrative Reasons|3|||
125951506|NCT03925727|453119740|FG001|Overall Study|Administrative Reasons|1|||
125951507|NCT03925727|453119741|FG002|Overall Study|Administrative Reasons|2|||
125951508|NCT03925727|453119739|FG000|Overall Study|Randomized in error or Disqualified|8|||
125951509|NCT03925727|453119740|FG001|Overall Study|Randomized in error or Disqualified|1|||
125951510|NCT03925727|453119741|FG002|Overall Study|Randomized in error or Disqualified|7|||
125951511|NCT00213148|453119742|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
125951512|NCT00213148|453119743|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
125951513|NCT00213148|453119744|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
125951514|NCT00213148|453119745|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
125951515|NCT00213148|453119746|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
125951516|NCT00213148|453119742|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
125951517|NCT00213148|453119743|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
125951518|NCT00213148|453119744|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
126079718|NCT02392104|453585917|FG000|Overall Study|INR goal range changed|1|||
126079719|NCT02392104|453585917|FG000|Overall Study|admitted to skilled nursing facility|3|||
125951519|NCT00213148|453119745|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
125951520|NCT00213148|453119746|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
125951521|NCT00213148|453119742|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
125951522|NCT00213148|453119743|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
125951523|NCT00213148|453119744|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
125951524|NCT00213148|453119745|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
125951525|NCT00213148|453119746|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
125951526|NCT00213148|453119742|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
125951527|NCT00213148|453119743|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
125951528|NCT00213148|453119744|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
126079720|NCT02392104|453585917|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
125951529|NCT00213148|453119745|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
125951530|NCT00213148|453119746|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
125951531|NCT00213148|453119742|FG000|Cycle 1 (1 Month)|Other|3|||
125951532|NCT00213148|453119743|FG001|Cycle 1 (1 Month)|Other|0|||
125951533|NCT00213148|453119744|FG002|Cycle 1 (1 Month)|Other|2|||
125951534|NCT00213148|453119745|FG003|Cycle 1 (1 Month)|Other|2|||
125951535|NCT00213148|453119746|FG004|Cycle 1 (1 Month)|Other|7|||
125951536|NCT00213148|453119742|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125951537|NCT00213148|453119743|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125951538|NCT00213148|453119744|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125951539|NCT00213148|453119745|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
125951540|NCT00213148|453119746|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125951541|NCT00213148|453119742|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
125951542|NCT00213148|453119743|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
125951543|NCT00213148|453119744|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
125951544|NCT00213148|453119745|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
125951545|NCT00213148|453119746|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
125951546|NCT00213148|453119742|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
125951547|NCT00213148|453119743|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
125951548|NCT00213148|453119744|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
125951549|NCT00213148|453119745|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
125951550|NCT00213148|453119746|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
125951551|NCT00213148|453119742|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
125951552|NCT00213148|453119743|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
125951553|NCT00213148|453119744|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
125951554|NCT00213148|453119745|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
125951555|NCT00213148|453119746|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
125951556|NCT00213148|453119742|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
125951557|NCT00213148|453119743|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
125951558|NCT00213148|453119744|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
125951559|NCT00213148|453119745|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
125951560|NCT00213148|453119746|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
125951561|NCT00213148|453119742|FG000|Cycle 2 (1 Month)|Other|2|||
125951562|NCT00213148|453119743|FG001|Cycle 2 (1 Month)|Other|1|||
125951563|NCT00213148|453119744|FG002|Cycle 2 (1 Month)|Other|2|||
125951564|NCT00213148|453119745|FG003|Cycle 2 (1 Month)|Other|8|||
125951565|NCT00213148|453119746|FG004|Cycle 2 (1 Month)|Other|7|||
125951566|NCT00213148|453119742|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125951567|NCT00213148|453119743|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
125951568|NCT00213148|453119744|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125951569|NCT00213148|453119745|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125951570|NCT00213148|453119746|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125951571|NCT00213148|453119742|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
125951572|NCT00213148|453119743|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
125951573|NCT00213148|453119744|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
125951574|NCT00213148|453119745|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
125951575|NCT00213148|453119746|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
125951576|NCT00213148|453119742|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
125951577|NCT00213148|453119743|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
125951578|NCT00213148|453119744|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
125951579|NCT00213148|453119745|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
125951580|NCT00213148|453119746|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
125951581|NCT00213148|453119742|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
125951582|NCT00213148|453119743|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
125951583|NCT00213148|453119744|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
125951584|NCT00213148|453119745|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
125951585|NCT00213148|453119746|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
125951586|NCT00213148|453119742|FG000|Cycle 3 (1 Month)|Other|0|||
125951587|NCT00213148|453119743|FG001|Cycle 3 (1 Month)|Other|0|||
125951588|NCT00213148|453119744|FG002|Cycle 3 (1 Month)|Other|1|||
125951589|NCT00213148|453119745|FG003|Cycle 3 (1 Month)|Other|1|||
125951590|NCT00213148|453119746|FG004|Cycle 3 (1 Month)|Other|0|||
125951591|NCT01806896|453119747|FG000|Overall Study|Adverse Event|2|||
125951592|NCT01806896|453119748|FG001|Overall Study|Adverse Event|0|||
125951593|NCT01806896|453119747|FG000|Overall Study|Other|1|||
125951594|NCT01806896|453119748|FG001|Overall Study|Other|0|||
125951595|NCT05308901|453121776|FG000|Overall Study|Death|6|||
125951596|NCT00978731|453121777|FG000|Overall Study|Death|4|||
125951597|NCT00978731|453121778|FG001|Overall Study|Death|1|||
125951598|NCT00978731|453121779|FG002|Overall Study|Death|1|||
125951599|NCT00978731|453121780|FG003|Overall Study|Death|0|||
125951600|NCT00978731|453121777|FG000|Overall Study|Lost to Follow-up|0|||
125951601|NCT00978731|453121778|FG001|Overall Study|Lost to Follow-up|0|||
125951602|NCT00978731|453121779|FG002|Overall Study|Lost to Follow-up|0|||
125951603|NCT00978731|453121780|FG003|Overall Study|Lost to Follow-up|1|||
125951604|NCT00978731|453121777|FG000|Overall Study|Adverse Event|5|||
125951605|NCT00978731|453121778|FG001|Overall Study|Adverse Event|2|||
125951606|NCT00978731|453121779|FG002|Overall Study|Adverse Event|0|||
125951607|NCT00978731|453121780|FG003|Overall Study|Adverse Event|0|||
125951608|NCT00978731|453121777|FG000|Overall Study|Participant's request|1|||
125951609|NCT00978731|453121778|FG001|Overall Study|Participant's request|0|||
125951610|NCT00978731|453121779|FG002|Overall Study|Participant's request|0|||
125951611|NCT00978731|453121780|FG003|Overall Study|Participant's request|0|||
125951612|NCT00978731|453121777|FG000|Overall Study|Administrative reason|3|||
125951613|NCT00978731|453121778|FG001|Overall Study|Administrative reason|3|||
125951614|NCT00978731|453121779|FG002|Overall Study|Administrative reason|1|||
125951615|NCT00978731|453121780|FG003|Overall Study|Administrative reason|0|||
125951616|NCT00978731|453121777|FG000|Overall Study|Deterioration without progression|0|||
125951617|NCT00978731|453121778|FG001|Overall Study|Deterioration without progression|1|||
125951618|NCT00978731|453121779|FG002|Overall Study|Deterioration without progression|0|||
125951619|NCT00978731|453121780|FG003|Overall Study|Deterioration without progression|0|||
125951620|NCT00978731|453121777|FG000|Overall Study|Disease progression/relapse|5|||
125951621|NCT00978731|453121778|FG001|Overall Study|Disease progression/relapse|4|||
125951622|NCT00978731|453121779|FG002|Overall Study|Disease progression/relapse|2|||
125951623|NCT00978731|453121780|FG003|Overall Study|Disease progression/relapse|2|||
125951624|NCT00978731|453121777|FG000|Overall Study|Study closure|3|||
125951625|NCT00978731|453121778|FG001|Overall Study|Study closure|4|||
125951626|NCT00978731|453121779|FG002|Overall Study|Study closure|1|||
125951627|NCT00978731|453121780|FG003|Overall Study|Study closure|1|||
125951628|NCT00978731|453121777|FG000|Overall Study|No response|1|||
125951629|NCT00978731|453121778|FG001|Overall Study|No response|0|||
125951630|NCT00978731|453121779|FG002|Overall Study|No response|0|||
125951631|NCT00978731|453121780|FG003|Overall Study|No response|0|||
125951632|NCT01896895|453121781|FG000|Double-blind MP|Physician Decision|0|||
125951633|NCT01896895|453121782|FG001|Double-blind MP|Physician Decision|0|||
125951634|NCT01896895|453121783|FG002|Double-blind MP|Physician Decision|1|||
125951635|NCT01896895|453121784|FG003|Double-blind MP|Physician Decision|0|||
125951636|NCT01896895|453121781|FG000|Double-blind MP|Withdrawal by Subject|0|||
125951637|NCT01896895|453121782|FG001|Double-blind MP|Withdrawal by Subject|2|||
125951638|NCT01896895|453121783|FG002|Double-blind MP|Withdrawal by Subject|1|||
125951639|NCT01896895|453121784|FG003|Double-blind MP|Withdrawal by Subject|0|||
125951640|NCT01896895|453121781|FG000|Double-blind MP|Lost to Follow-up|1|||
125951641|NCT01896895|453121782|FG001|Double-blind MP|Lost to Follow-up|0|||
125951642|NCT01896895|453121783|FG002|Double-blind MP|Lost to Follow-up|1|||
125951643|NCT01896895|453121784|FG003|Double-blind MP|Lost to Follow-up|0|||
125951644|NCT01302964|453121785|FG000|Overall Study|Adverse Event|1|||
125951645|NCT01302964|453121786|FG001|Overall Study|Adverse Event|0|||
125951646|NCT00145509|453121790|FG000|Overall Study|Adverse Event|10|||
125951647|NCT00145509|453121791|FG001|Overall Study|Adverse Event|3|||
125951648|NCT00145509|453121790|FG000|Overall Study|Lack of Efficacy|3|||
125951649|NCT00145509|453121791|FG001|Overall Study|Lack of Efficacy|1|||
125951650|NCT00145509|453121790|FG000|Overall Study|Lost to Follow-up|5|||
125951651|NCT00145509|453121791|FG001|Overall Study|Lost to Follow-up|9|||
125951652|NCT00145509|453121790|FG000|Overall Study|Withdrew Consent|2|||
125951653|NCT00145509|453121791|FG001|Overall Study|Withdrew Consent|7|||
125951654|NCT00145509|453121790|FG000|Overall Study|Reason not provided|2|||
125951655|NCT00145509|453121791|FG001|Overall Study|Reason not provided|1|||
125951656|NCT02789176|453121794|FG000|Overall Study|Death|0|||
125951657|NCT02789176|453121795|FG001|Overall Study|Death|0|||
125951658|NCT02789176|453121796|FG002|Overall Study|Death|3|||
125951659|NCT02789176|453121797|FG003|Overall Study|Death|0|||
125951660|NCT02789176|453121794|FG000|Overall Study|Withdrawal by Subject|0|||
125951661|NCT02789176|453121795|FG001|Overall Study|Withdrawal by Subject|0|||
125951662|NCT02789176|453121796|FG002|Overall Study|Withdrawal by Subject|1|||
125951663|NCT02789176|453121797|FG003|Overall Study|Withdrawal by Subject|0|||
125951664|NCT02789176|453121794|FG000|Overall Study|Lost to Follow-up|8|||
125951665|NCT02789176|453121795|FG001|Overall Study|Lost to Follow-up|2|||
125951666|NCT02789176|453121796|FG002|Overall Study|Lost to Follow-up|6|||
125951667|NCT02789176|453121797|FG003|Overall Study|Lost to Follow-up|1|||
125951668|NCT00596011|453121798|FG000|Overall Study|Withdrawal by Subject|2|||
125951669|NCT00596011|453121799|FG001|Overall Study|Withdrawal by Subject|3|||
125951670|NCT00596011|453121798|FG000|Overall Study|Adverse Event|11|||
125951671|NCT00596011|453121799|FG001|Overall Study|Adverse Event|7|||
125951672|NCT00192075|453121800|FG000|Overall Study|Disease Progression|23|||
125951673|NCT00192075|453121801|FG001|Overall Study|Disease Progression|6|||
126079721|NCT04887506|453585920|FG000|Overall Study|Death|1|||
126079722|NCT04887506|453585921|FG001|Overall Study|Death|1|||
126079723|NCT04887506|453585920|FG000|Overall Study|Withdrawal by Subject|0|||
125951674|NCT00192075|453121800|FG000|Overall Study|Adverse Event|1|||
125951675|NCT00192075|453121801|FG001|Overall Study|Adverse Event|3|||
125951676|NCT00192075|453121800|FG000|Overall Study|Death|0|||
125951677|NCT00192075|453121801|FG001|Overall Study|Death|1|||
125951678|NCT00192075|453121800|FG000|Overall Study|Lack of Efficacy|0|||
125951679|NCT00192075|453121801|FG001|Overall Study|Lack of Efficacy|0|||
125951680|NCT00192075|453121800|FG000|Overall Study|Physician Decision|3|||
125951681|NCT00192075|453121801|FG001|Overall Study|Physician Decision|0|||
125951682|NCT00192075|453121800|FG000|Overall Study|Withdrawal by Subject|5|||
125951683|NCT00192075|453121801|FG001|Overall Study|Withdrawal by Subject|5|||
125951684|NCT00192075|453121800|FG000|Overall Study|Patient Non-Compliance|0|||
125951685|NCT00192075|453121801|FG001|Overall Study|Patient Non-Compliance|1|||
125951686|NCT00192075|453121800|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
125951687|NCT00192075|453121801|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
125951688|NCT00192075|453121800|FG000|Overall Study|Other|5|||
125951689|NCT00192075|453121801|FG001|Overall Study|Other|2|||
125951690|NCT00779675|453121802|FG000|Treatment Period|Adverse Event|87|||
125951691|NCT00779675|453121802|FG000|Treatment Period|Treatment Failure|80|||
125951692|NCT00779675|453121802|FG000|Treatment Period|Transferred to Another Study|38|||
125951693|NCT00779675|453121802|FG000|Treatment Period|Lost to Follow-up|23|||
125951694|NCT00779675|453121802|FG000|Treatment Period|Withdrawal by Subject|46|||
125951695|NCT00779675|453121802|FG000|Treatment Period|Protocol Violation|54|||
125951696|NCT00779675|453121802|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
125951697|NCT00779675|453121802|FG000|Treatment Period|Administrative|3|||
125951698|NCT00779675|453121802|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
125951699|NCT00779675|453121802|FG000|Extended Treatment Period|Protocol Violation|13|||
125951700|NCT00779675|453121802|FG000|Extended Treatment Period|Adverse Event|6|||
125951701|NCT00779675|453121802|FG000|Extended Treatment Period|Treatment Failure|11|||
125951702|NCT00779675|453121802|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
125951703|NCT00779675|453121802|FG000|Extended Treatment Period|Lost to Follow-up|6|||
125951704|NCT02821962|453121805|FG000|Overall Study|Lost to Follow-up|2|||
125951705|NCT02821962|453121806|FG001|Overall Study|Lost to Follow-up|0|||
125951706|NCT00355238|453121809|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125951707|NCT00355238|453121810|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125951708|NCT00355238|453121811|FG002|Overall Study|Adverse event unrelated to study drug|0|||
125951709|NCT00355238|453121812|FG003|Overall Study|Adverse event unrelated to study drug|1|||
125951710|NCT00355238|453121809|FG000|Overall Study|Death|1|||
125951711|NCT00355238|453121810|FG001|Overall Study|Death|0|||
125951712|NCT00355238|453121811|FG002|Overall Study|Death|0|||
125951713|NCT00355238|453121812|FG003|Overall Study|Death|0|||
125951714|NCT00355238|453121809|FG000|Overall Study|Disease progression|37|||
125951715|NCT00355238|453121810|FG001|Overall Study|Disease progression|36|||
125951716|NCT00355238|453121811|FG002|Overall Study|Disease progression|16|||
125951717|NCT00355238|453121812|FG003|Overall Study|Disease progression|11|||
125951718|NCT00355238|453121809|FG000|Overall Study|Study drug toxicity|11|||
125951719|NCT00355238|453121810|FG001|Overall Study|Study drug toxicity|7|||
125951720|NCT00355238|453121811|FG002|Overall Study|Study drug toxicity|5|||
125951721|NCT00355238|453121812|FG003|Overall Study|Study drug toxicity|2|||
125951722|NCT00355238|453121809|FG000|Overall Study|Participant withdrew consent|3|||
125951723|NCT00355238|453121810|FG001|Overall Study|Participant withdrew consent|1|||
125951724|NCT00355238|453121811|FG002|Overall Study|Participant withdrew consent|0|||
125951725|NCT00355238|453121812|FG003|Overall Study|Participant withdrew consent|0|||
125951726|NCT00355238|453121809|FG000|Overall Study|Participant request to discontinue study treatment|1|||
125951727|NCT00355238|453121810|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125951728|NCT00355238|453121811|FG002|Overall Study|Participant request to discontinue study treatment|1|||
125951729|NCT00355238|453121812|FG003|Overall Study|Participant request to discontinue study treatment|0|||
125951730|NCT04649151|453121821|FG000|Overall Study|Pregnancy|0|||
125951731|NCT04649151|453121822|FG001|Overall Study|Pregnancy|0|||
125951732|NCT04649151|453121823|FG002|Overall Study|Pregnancy|0|||
125951733|NCT04649151|453121824|FG003|Overall Study|Pregnancy|0|||
125951734|NCT04649151|453121825|FG004|Overall Study|Pregnancy|3|||
125951735|NCT04649151|453121821|FG000|Overall Study|Physician Decision|10|||
125951736|NCT04649151|453121822|FG001|Overall Study|Physician Decision|0|||
125951737|NCT04649151|453121823|FG002|Overall Study|Physician Decision|0|||
125951738|NCT04649151|453121824|FG003|Overall Study|Physician Decision|1|||
125951739|NCT04649151|453121825|FG004|Overall Study|Physician Decision|1|||
125951740|NCT04649151|453121821|FG000|Overall Study|Protocol Deviation|25|||
125951741|NCT04649151|453121822|FG001|Overall Study|Protocol Deviation|3|||
125951742|NCT04649151|453121823|FG002|Overall Study|Protocol Deviation|0|||
125951743|NCT04649151|453121824|FG003|Overall Study|Protocol Deviation|0|||
125951744|NCT04649151|453121825|FG004|Overall Study|Protocol Deviation|0|||
125951745|NCT04649151|453121821|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
125951746|NCT04649151|453121822|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
125951747|NCT04649151|453121823|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
125951748|NCT04649151|453121824|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
125951749|NCT04649151|453121825|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
125951750|NCT04649151|453121821|FG000|Overall Study|Withdrawal by Subject|370|||
125951751|NCT04649151|453121822|FG001|Overall Study|Withdrawal by Subject|113|||
125951752|NCT04649151|453121823|FG002|Overall Study|Withdrawal by Subject|2|||
125951753|NCT04649151|453121824|FG003|Overall Study|Withdrawal by Subject|7|||
125951754|NCT04649151|453121825|FG004|Overall Study|Withdrawal by Subject|15|||
125951755|NCT04649151|453121821|FG000|Overall Study|Adverse Event|1|||
125951756|NCT04649151|453121822|FG001|Overall Study|Adverse Event|0|||
125951757|NCT04649151|453121823|FG002|Overall Study|Adverse Event|0|||
125951758|NCT04649151|453121824|FG003|Overall Study|Adverse Event|0|||
125951759|NCT04649151|453121825|FG004|Overall Study|Adverse Event|0|||
125951760|NCT04649151|453121821|FG000|Overall Study|Lost to Follow-up|256|||
125951761|NCT04649151|453121822|FG001|Overall Study|Lost to Follow-up|29|||
125951762|NCT04649151|453121823|FG002|Overall Study|Lost to Follow-up|10|||
125951763|NCT04649151|453121824|FG003|Overall Study|Lost to Follow-up|3|||
125951764|NCT04649151|453121825|FG004|Overall Study|Lost to Follow-up|6|||
125951765|NCT04649151|453121821|FG000|Overall Study|Other than specified|59|||
125951766|NCT04649151|453121822|FG001|Overall Study|Other than specified|294|||
125951767|NCT04649151|453121823|FG002|Overall Study|Other than specified|0|||
125951768|NCT04649151|453121824|FG003|Overall Study|Other than specified|0|||
125951769|NCT04649151|453121825|FG004|Overall Study|Other than specified|4|||
125951770|NCT04649151|453121821|FG000|Overall Study|Death|0|||
125951771|NCT04649151|453121822|FG001|Overall Study|Death|0|||
125951772|NCT04649151|453121823|FG002|Overall Study|Death|0|||
125951773|NCT04649151|453121824|FG003|Overall Study|Death|0|||
125951774|NCT04649151|453121825|FG004|Overall Study|Death|1|||
125951775|NCT03752619|453121826|FG000|Overall Study|Lost to Follow-up|2|||
125951776|NCT03752619|453121827|FG001|Overall Study|Lost to Follow-up|1|||
125951777|NCT03752619|453121826|FG000|Overall Study|Withdrawal by Subject|1|||
125951778|NCT03752619|453121827|FG001|Overall Study|Withdrawal by Subject|1|||
125951779|NCT03752619|453121826|FG000|Overall Study|Adverse Event|0|||
125951780|NCT03752619|453121827|FG001|Overall Study|Adverse Event|1|||
125951781|NCT03362502|453121830|FG000|Overall Study|Death|0|||
125951782|NCT03362502|453121831|FG001|Overall Study|Death|0|||
125951783|NCT03362502|453121832|FG002|Overall Study|Death|1|||
125951784|NCT03795610|453121833|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
125951785|NCT03795610|453121833|FG000|Overall Study|Withdrawal by Subject|1|||
125951786|NCT03795610|453121833|FG000|Overall Study|Screen Failure (Unknown)|1|||
125951787|NCT04098458|453121857|FG000|Overall Study|Death|1|||
125951788|NCT04098458|453121857|FG000|Overall Study|did not meet study inclusion criteria|3|||
125951789|NCT00006489|453121858|FG000|Overall Study|Adverse Event|3|||
125951790|NCT00006489|453121859|FG001|Overall Study|Adverse Event|2|||
125951791|NCT00006489|453121860|FG002|Overall Study|Adverse Event|4|||
125951792|NCT00006489|453121861|FG003|Overall Study|Adverse Event|3|||
125951793|NCT00006489|453121858|FG000|Overall Study|Withdrawal by Subject|10|||
125951794|NCT00006489|453121859|FG001|Overall Study|Withdrawal by Subject|9|||
125951795|NCT00006489|453121860|FG002|Overall Study|Withdrawal by Subject|9|||
125951796|NCT00006489|453121861|FG003|Overall Study|Withdrawal by Subject|6|||
125951797|NCT00006489|453121858|FG000|Overall Study|Scheduling Conflict|0|||
125951798|NCT00006489|453121859|FG001|Overall Study|Scheduling Conflict|3|||
125951799|NCT00006489|453121860|FG002|Overall Study|Scheduling Conflict|2|||
125951800|NCT00006489|453121861|FG003|Overall Study|Scheduling Conflict|1|||
125951801|NCT00006489|453121858|FG000|Overall Study|Death|0|||
125951802|NCT00006489|453121859|FG001|Overall Study|Death|0|||
125951803|NCT00006489|453121860|FG002|Overall Study|Death|0|||
125951804|NCT00006489|453121861|FG003|Overall Study|Death|1|||
125951805|NCT03762083|453121862|FG000|Overall Study|Withdrawal by Subject|2|||
125951806|NCT03762083|453121862|FG000|Overall Study|Physician Decision|1|||
125951807|NCT00116558|453121863|FG000|Overall Study|Death|11|||
125951808|NCT00116558|453121864|FG001|Overall Study|Death|5|||
125951809|NCT00116558|453121865|FG002|Overall Study|Death|3|||
125951810|NCT00116558|453121863|FG000|Overall Study|Withdrawal by Subject|17|||
125951811|NCT00116558|453121864|FG001|Overall Study|Withdrawal by Subject|3|||
125951812|NCT00116558|453121865|FG002|Overall Study|Withdrawal by Subject|12|||
125951813|NCT00116558|453121863|FG000|Overall Study|disease progression|3|||
125951814|NCT00116558|453121864|FG001|Overall Study|disease progression|7|||
125951815|NCT00116558|453121865|FG002|Overall Study|disease progression|18|||
125951816|NCT02027844|453121866|FG000|Overall Study|Withdrawal by Subject|3|||
125951817|NCT02027844|453121867|FG001|Overall Study|Withdrawal by Subject|2|||
125951818|NCT02027844|453121868|FG002|Overall Study|Withdrawal by Subject|1|||
125951819|NCT02027844|453121866|FG000|Overall Study|Lost to Follow-up|0|||
125951820|NCT02027844|453121867|FG001|Overall Study|Lost to Follow-up|2|||
125951821|NCT02027844|453121868|FG002|Overall Study|Lost to Follow-up|1|||
125951822|NCT02027844|453121866|FG000|Overall Study|Protocol Violation|0|||
125951823|NCT02027844|453121867|FG001|Overall Study|Protocol Violation|2|||
125951824|NCT02027844|453121868|FG002|Overall Study|Protocol Violation|0|||
125951825|NCT02027844|453121866|FG000|Overall Study|Incomlete data|2|||
125951826|NCT02027844|453121867|FG001|Overall Study|Incomlete data|0|||
125951827|NCT02027844|453121868|FG002|Overall Study|Incomlete data|0|||
125951828|NCT00378014|453121869|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
125951829|NCT00378014|453121870|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
125951830|NCT00378014|453121869|FG000|Core (Randomization to Month 11)|Graft loss|1|||
125951831|NCT00378014|453121870|FG001|Core (Randomization to Month 11)|Graft loss|2|||
125951832|NCT00378014|453121869|FG000|Core (Randomization to Month 11)|Death|5|||
125951833|NCT00378014|453121870|FG001|Core (Randomization to Month 11)|Death|3|||
125951834|NCT00378014|453121869|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
125951835|NCT00378014|453121870|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
125951836|NCT00378014|453121869|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
125951837|NCT00378014|453121870|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
125951838|NCT00378014|453121869|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
125951839|NCT00378014|453121870|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
125951840|NCT00378014|453121869|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
125951841|NCT00378014|453121870|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
125951842|NCT00378014|453121869|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
125951843|NCT00378014|453121870|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
125951844|NCT00378014|453121869|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
125951845|NCT00378014|453121870|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
125951846|NCT00378014|453121869|FG000|Extension (Month 12 to Month 59)|Death|1|||
125951847|NCT00378014|453121870|FG001|Extension (Month 12 to Month 59)|Death|2|||
125951848|NCT00378014|453121869|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
125951849|NCT00378014|453121870|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
125951850|NCT00378014|453121869|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
125951851|NCT00378014|453121870|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
125951852|NCT00378014|453121869|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
125951853|NCT00378014|453121870|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
125951854|NCT00378014|453121869|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
125951855|NCT00378014|453121870|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
125951856|NCT04889625|453121873|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
125951857|NCT04889625|453121874|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
125951858|NCT04889625|453121873|FG000|Period 1|Subject out of window|0|||
125951859|NCT04889625|453121874|FG001|Period 1|Subject out of window|1|||
125951860|NCT04889625|453121873|FG000|Period 1|Wrong add power dispensed|0|||
125951861|NCT04889625|453121874|FG001|Period 1|Wrong add power dispensed|1|||
125951862|NCT04889625|453121873|FG000|Period 1|Discontinued due to fitting guide error|1|||
125951863|NCT04889625|453121874|FG001|Period 1|Discontinued due to fitting guide error|1|||
125951864|NCT04889625|453121873|FG000|Period 2|Test article no longer available|1|||
125951865|NCT04889625|453121874|FG001|Period 2|Test article no longer available|0|||
125951866|NCT04889625|453121873|FG000|Period 2|Incorrect lens dispensed|1|||
125951867|NCT04889625|453121874|FG001|Period 2|Incorrect lens dispensed|0|||
125951868|NCT04889625|453121873|FG000|Period 2|Wrong add power dispensed|0|||
125951869|NCT04889625|453121874|FG001|Period 2|Wrong add power dispensed|1|||
125951870|NCT03746522|453121884|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
125951871|NCT03746522|453121885|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
125951872|NCT03746522|453121886|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
125951873|NCT03746522|453121884|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
125951874|NCT03746522|453121885|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
125951875|NCT03746522|453121886|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
125951876|NCT03746522|453121884|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
125951877|NCT03746522|453121885|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
125951878|NCT03746522|453121886|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
125951879|NCT03746522|453121884|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
125951880|NCT03746522|453121885|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
125951881|NCT03746522|453121886|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
125951882|NCT03746522|453121884|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
125951883|NCT03746522|453121885|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
125951884|NCT03746522|453121886|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
125951885|NCT00323414|453121889|FG000|Overall Study|Withdrawal by Subject|0|||
125951886|NCT00323414|453121890|FG001|Overall Study|Withdrawal by Subject|1|||
125951887|NCT02552316|453121892|FG000|Overall Study|Withdrawal by Subject|1|||
125951888|NCT02552316|453121892|FG000|Overall Study|Withdrawal due to non-compliance|1|||
125951889|NCT02659020|453121893|FG000|Overall Study|Adverse Event|0|||
125951890|NCT02659020|453121894|FG001|Overall Study|Adverse Event|0|||
125951891|NCT02659020|453121895|FG002|Overall Study|Adverse Event|0|||
125951892|NCT02659020|453121896|FG003|Overall Study|Adverse Event|2|||
125951893|NCT02659020|453121897|FG004|Overall Study|Adverse Event|0|||
125951894|NCT02659020|453121898|FG005|Overall Study|Adverse Event|0|||
125951895|NCT02659020|453121899|FG006|Overall Study|Adverse Event|2|||
125951896|NCT02659020|453121893|FG000|Overall Study|Lost to Follow-up|1|||
125951897|NCT02659020|453121894|FG001|Overall Study|Lost to Follow-up|2|||
125951898|NCT02659020|453121895|FG002|Overall Study|Lost to Follow-up|1|||
125951899|NCT02659020|453121896|FG003|Overall Study|Lost to Follow-up|6|||
125951900|NCT02659020|453121897|FG004|Overall Study|Lost to Follow-up|1|||
125951901|NCT02659020|453121898|FG005|Overall Study|Lost to Follow-up|5|||
125951902|NCT02659020|453121899|FG006|Overall Study|Lost to Follow-up|0|||
125951903|NCT02659020|453121893|FG000|Overall Study|Physician Decision|0|||
125951904|NCT02659020|453121894|FG001|Overall Study|Physician Decision|0|||
125951905|NCT02659020|453121895|FG002|Overall Study|Physician Decision|0|||
125951906|NCT02659020|453121896|FG003|Overall Study|Physician Decision|1|||
125951907|NCT02659020|453121897|FG004|Overall Study|Physician Decision|1|||
125951908|NCT02659020|453121898|FG005|Overall Study|Physician Decision|0|||
125951909|NCT02659020|453121899|FG006|Overall Study|Physician Decision|1|||
125951910|NCT02659020|453121893|FG000|Overall Study|Withdrawal by Subject|2|||
125951911|NCT02659020|453121894|FG001|Overall Study|Withdrawal by Subject|1|||
125951912|NCT02659020|453121895|FG002|Overall Study|Withdrawal by Subject|0|||
125951913|NCT02659020|453121896|FG003|Overall Study|Withdrawal by Subject|3|||
125951914|NCT02659020|453121897|FG004|Overall Study|Withdrawal by Subject|3|||
125951915|NCT02659020|453121898|FG005|Overall Study|Withdrawal by Subject|6|||
125951916|NCT02659020|453121899|FG006|Overall Study|Withdrawal by Subject|3|||
125951917|NCT02659020|453121893|FG000|Overall Study|Progressive Disease|0|||
125951918|NCT02659020|453121894|FG001|Overall Study|Progressive Disease|0|||
125951919|NCT02659020|453121895|FG002|Overall Study|Progressive Disease|0|||
125951920|NCT02659020|453121896|FG003|Overall Study|Progressive Disease|4|||
125951921|NCT02659020|453121897|FG004|Overall Study|Progressive Disease|1|||
125951922|NCT02659020|453121898|FG005|Overall Study|Progressive Disease|0|||
125951923|NCT02659020|453121899|FG006|Overall Study|Progressive Disease|2|||
125951924|NCT04382911|453121900|FG000|Overall Study|unable to be imaged prior to surgery|2|||
125951925|NCT01120210|453121901|FG000|MAIN INFUSION|Adverse Event|1|||
125951926|NCT01120210|453121902|FG001|MAIN INFUSION|Adverse Event|0|||
125951927|NCT01120210|453121901|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
125951928|NCT01120210|453121902|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
125951929|NCT02043015|453121913|FG000|Overall Study|Lost to Follow-up|4|||
125951930|NCT02043015|453121913|FG000|Overall Study|Withdrawal by Subject|4|||
125951931|NCT02043015|453121913|FG000|Overall Study|Removed once target enrollment reached|15|||
125951932|NCT02043015|453121913|FG000|Overall Study|Participant moved away from study city|4|||
125951933|NCT02043015|453121913|FG000|Overall Study|Incarceration|1|||
125951934|NCT01526889|453121915|FG000|Treatment Period|Adverse Event|2|||
125951935|NCT01526889|453121916|FG001|Treatment Period|Adverse Event|0|||
125951936|NCT01526889|453121915|FG000|Treatment Extension Period|Administrative problems|1|||
125951937|NCT01526889|453121916|FG001|Treatment Extension Period|Administrative problems|0|||
125951938|NCT00974571|453121919|FG000|Overall Study|Adverse Event|31|||
125951939|NCT00974571|453121920|FG001|Overall Study|Adverse Event|4|||
125951940|NCT00974571|453121921|FG002|Overall Study|Adverse Event|27|||
125951941|NCT00974571|453121919|FG000|Overall Study|Lack of Efficacy|3|||
125951942|NCT00974571|453121920|FG001|Overall Study|Lack of Efficacy|2|||
125951943|NCT00974571|453121921|FG002|Overall Study|Lack of Efficacy|9|||
125951944|NCT00974571|453121919|FG000|Overall Study|Lost to Follow-up|2|||
125951945|NCT00974571|453121920|FG001|Overall Study|Lost to Follow-up|1|||
125951946|NCT00974571|453121921|FG002|Overall Study|Lost to Follow-up|2|||
125951947|NCT00974571|453121919|FG000|Overall Study|Protocol Violation|13|||
125951948|NCT00974571|453121920|FG001|Overall Study|Protocol Violation|4|||
125951949|NCT00974571|453121921|FG002|Overall Study|Protocol Violation|18|||
125951950|NCT00974571|453121919|FG000|Overall Study|Withdrawal by Subject|14|||
125951951|NCT00974571|453121920|FG001|Overall Study|Withdrawal by Subject|5|||
125951952|NCT00974571|453121921|FG002|Overall Study|Withdrawal by Subject|16|||
125951953|NCT00974571|453121919|FG000|Overall Study|Patient Moved|1|||
125951954|NCT00974571|453121920|FG001|Overall Study|Patient Moved|0|||
125951955|NCT00974571|453121921|FG002|Overall Study|Patient Moved|1|||
125951956|NCT00974571|453121919|FG000|Overall Study|Other|4|||
125951957|NCT00974571|453121920|FG001|Overall Study|Other|0|||
125951958|NCT00974571|453121921|FG002|Overall Study|Other|10|||
125951959|NCT01494610|453121933|FG000|Period 1|Withdrawal by Subject|1|||
125951960|NCT01494610|453121934|FG001|Period 1|Withdrawal by Subject|1|||
125951961|NCT01494610|453121933|FG000|Period 3|Adverse Event|1|||
125951962|NCT01494610|453121934|FG001|Period 3|Adverse Event|0|||
125951963|NCT01494610|453121933|FG000|Period 3|Withdrawal by Subject|1|||
125951964|NCT01494610|453121934|FG001|Period 3|Withdrawal by Subject|0|||
125951965|NCT01494610|453121933|FG000|Period 4|Protocol Violation|1|||
125951966|NCT01494610|453121934|FG001|Period 4|Protocol Violation|0|||
125951967|NCT00547703|453121937|FG000|Overall Study|Lost to Follow-up|1|||
125951968|NCT00547703|453121938|FG001|Overall Study|Lost to Follow-up|0|||
125951969|NCT04108208|453121939|FG000|Overall Study|Withdrawal by Subject|2|||
125951970|NCT04108208|453121940|FG001|Overall Study|Withdrawal by Subject|6|||
125951971|NCT04108208|453121939|FG000|Overall Study|other-ongoing|20|||
125951972|NCT04108208|453121940|FG001|Overall Study|other-ongoing|40|||
125951973|NCT04108208|453121939|FG000|Overall Study|Death|1|||
125951974|NCT04108208|453121940|FG001|Overall Study|Death|4|||
125951975|NCT04108208|453121939|FG000|Overall Study|Lost to Follow-up|2|||
125951976|NCT04108208|453121940|FG001|Overall Study|Lost to Follow-up|0|||
125951977|NCT00376168|453121943|FG000|Overall Study|Adverse Event|1|||
125951978|NCT00376168|453121944|FG001|Overall Study|Adverse Event|1|||
125951979|NCT00376168|453121943|FG000|Overall Study|Pregnancy|1|||
125951980|NCT00376168|453121944|FG001|Overall Study|Pregnancy|0|||
125951981|NCT02350309|453121945|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
125951982|NCT02350309|453121946|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
125951983|NCT02350309|453121947|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
125951984|NCT02350309|453121948|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
125951985|NCT02350309|453121949|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
125951986|NCT02350309|453121950|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
125951987|NCT02350309|453121945|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
125951988|NCT02350309|453121946|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
125951989|NCT02350309|453121947|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
125951990|NCT02350309|453121948|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
125951991|NCT02350309|453121949|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
125951992|NCT02350309|453121950|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
125951993|NCT01736696|453121951|FG000|Overall Study|Withdrawal by Subject|0|||
125951994|NCT01736696|453121952|FG001|Overall Study|Withdrawal by Subject|0|||
125951995|NCT01736696|453121953|FG002|Overall Study|Withdrawal by Subject|1|||
125951996|NCT01736696|453121954|FG003|Overall Study|Withdrawal by Subject|0|||
125951997|NCT01736696|453121955|FG004|Overall Study|Withdrawal by Subject|0|||
125951998|NCT01736696|453121956|FG005|Overall Study|Withdrawal by Subject|0|||
125951999|NCT01736696|453121957|FG006|Overall Study|Withdrawal by Subject|0|||
125952000|NCT02114879|453121958|FG000|Overall Study|Withdrawal by Subject|9|||
125952001|NCT02114879|453121959|FG001|Overall Study|Withdrawal by Subject|5|||
125952002|NCT02114879|453121958|FG000|Overall Study|Death|6|||
125952003|NCT02114879|453121959|FG001|Overall Study|Death|11|||
125952004|NCT02114879|453121958|FG000|Overall Study|Lost to Follow-up|4|||
125952005|NCT02114879|453121959|FG001|Overall Study|Lost to Follow-up|6|||
125952006|NCT02114879|453121958|FG000|Overall Study|Physician Decision|0|||
125952007|NCT02114879|453121959|FG001|Overall Study|Physician Decision|2|||
125952008|NCT00558103|453121960|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
125952009|NCT00558103|453121961|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
125952010|NCT00558103|453121962|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
125952011|NCT00558103|453121963|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
125952012|NCT00558103|453121964|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
125952013|NCT00558103|453121965|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
125952014|NCT00558103|453121960|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
125952015|NCT00558103|453121961|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
125952016|NCT00558103|453121962|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
125952017|NCT00558103|453121963|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
125952018|NCT00558103|453121964|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
125952019|NCT00558103|453121965|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
125952020|NCT00558103|453121960|FG000|Randomized Treatment Phase|Disease Progression|1|||
125952021|NCT00558103|453121961|FG001|Randomized Treatment Phase|Disease Progression|0|||
125952022|NCT00558103|453121962|FG002|Randomized Treatment Phase|Disease Progression|1|||
125952023|NCT00558103|453121963|FG003|Randomized Treatment Phase|Disease Progression|0|||
125952024|NCT00558103|453121964|FG004|Randomized Treatment Phase|Disease Progression|0|||
125952025|NCT00558103|453121965|FG005|Randomized Treatment Phase|Disease Progression|0|||
125952026|NCT00558103|453121960|FG000|Randomized Treatment Phase|Adverse Event|0|||
125952027|NCT00558103|453121961|FG001|Randomized Treatment Phase|Adverse Event|0|||
125952028|NCT00558103|453121962|FG002|Randomized Treatment Phase|Adverse Event|0|||
125952029|NCT00558103|453121963|FG003|Randomized Treatment Phase|Adverse Event|1|||
125952030|NCT00558103|453121964|FG004|Randomized Treatment Phase|Adverse Event|1|||
125952031|NCT00558103|453121965|FG005|Randomized Treatment Phase|Adverse Event|0|||
125952032|NCT00558103|453121960|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
125952033|NCT00558103|453121961|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
125952034|NCT00558103|453121962|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
125952035|NCT00558103|453121963|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
125952036|NCT00558103|453121964|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
125952037|NCT00558103|453121965|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
125952038|NCT00558103|453121960|FG000|Monotherapy Extension Phase|Disease Progression|0|||
125952039|NCT00558103|453121961|FG001|Monotherapy Extension Phase|Disease Progression|0|||
125952040|NCT00558103|453121962|FG002|Monotherapy Extension Phase|Disease Progression|0|||
125952041|NCT00558103|453121963|FG003|Monotherapy Extension Phase|Disease Progression|0|||
125952042|NCT00558103|453121964|FG004|Monotherapy Extension Phase|Disease Progression|0|||
125952043|NCT00558103|453121965|FG005|Monotherapy Extension Phase|Disease Progression|8|||
125952044|NCT02469610|453121968|FG000|Overall Study|Death|1|||
125952045|NCT02469610|453121969|FG001|Overall Study|Death|0|||
125952046|NCT02469610|453121968|FG000|Overall Study|Lost to Follow-up|1|||
125952047|NCT02469610|453121969|FG001|Overall Study|Lost to Follow-up|0|||
125952048|NCT02469610|453121968|FG000|Overall Study|exclusion criteria|2|||
125952049|NCT02469610|453121969|FG001|Overall Study|exclusion criteria|1|||
126115281|NCT00935272|453718032|FG000|Overall Study|Withdrawal by Subject|8|||
125952050|NCT02434770|453121970|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
125952051|NCT02434770|453121971|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
125952052|NCT02434770|453121972|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
125952053|NCT02434770|453121970|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
125952054|NCT02434770|453121971|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
125952055|NCT02434770|453121972|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
125952056|NCT02434770|453121970|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
125952057|NCT02434770|453121971|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
126115282|NCT00935272|453718033|FG001|Overall Study|Withdrawal by Subject|2|||
125952058|NCT02434770|453121972|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
125952059|NCT02434770|453121970|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
125952060|NCT02434770|453121971|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
125952061|NCT02434770|453121972|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
125952062|NCT02434770|453121970|FG000|Week 1 to Week 18|Death|1|||
125952063|NCT02434770|453121971|FG001|Week 1 to Week 18|Death|0|||
125952064|NCT02434770|453121972|FG002|Week 1 to Week 18|Death|0|||
125952065|NCT02434770|453121970|FG000|Week 18 to Week|Lost to Follow-up|2|||
125952066|NCT02434770|453121971|FG001|Week 18 to Week|Lost to Follow-up|2|||
125952067|NCT02434770|453121972|FG002|Week 18 to Week|Lost to Follow-up|1|||
125952068|NCT02434770|453121970|FG000|Week 18 to Week|Withdrawal by Subject|0|||
125952069|NCT02434770|453121971|FG001|Week 18 to Week|Withdrawal by Subject|0|||
125952070|NCT02434770|453121972|FG002|Week 18 to Week|Withdrawal by Subject|2|||
125952071|NCT02434770|453121970|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
125952072|NCT02434770|453121971|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
125952073|NCT02434770|453121972|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
125952074|NCT00245765|453121973|FG000|Overall Study|Adverse Event|1|||
125952075|NCT00245765|453121974|FG001|Overall Study|Adverse Event|1|||
125952076|NCT00245765|453121975|FG002|Overall Study|Adverse Event|0|||
125952077|NCT00245765|453121973|FG000|Overall Study|Lack of Efficacy|14|||
125952078|NCT00245765|453121974|FG001|Overall Study|Lack of Efficacy|7|||
125952079|NCT00245765|453121975|FG002|Overall Study|Lack of Efficacy|0|||
125952080|NCT00245765|453121973|FG000|Overall Study|Lost to Follow-up|1|||
125952081|NCT00245765|453121974|FG001|Overall Study|Lost to Follow-up|2|||
125952082|NCT00245765|453121975|FG002|Overall Study|Lost to Follow-up|0|||
125952083|NCT00245765|453121973|FG000|Overall Study|Withdrawal by Subject|1|||
125952084|NCT00245765|453121974|FG001|Overall Study|Withdrawal by Subject|0|||
125952085|NCT00245765|453121975|FG002|Overall Study|Withdrawal by Subject|3|||
125952086|NCT00245765|453121973|FG000|Overall Study|Other reason|2|||
125952087|NCT00245765|453121974|FG001|Overall Study|Other reason|0|||
125952088|NCT00245765|453121975|FG002|Overall Study|Other reason|1|||
125952089|NCT00245765|453121973|FG000|Overall Study|Other|13|||
125952090|NCT00245765|453121974|FG001|Overall Study|Other|4|||
125952091|NCT00245765|453121975|FG002|Overall Study|Other|4|||
125952092|NCT01574352|453121976|FG000|Overall Study|Withdrawal by Subject|6|||
125952093|NCT01574352|453121977|FG001|Overall Study|Withdrawal by Subject|13|||
125952094|NCT01574352|453121976|FG000|Overall Study|Injury in non-camp related sport|1|||
125952095|NCT01574352|453121977|FG001|Overall Study|Injury in non-camp related sport|0|||
125952096|NCT00660348|453121978|FG000|Overall Study|Withdrawal by Subject|1|||
125952097|NCT00660348|453121979|FG001|Overall Study|Withdrawal by Subject|0|||
125952098|NCT03316872|453121983|FG000|Overall Study|Death|1|||
125952099|NCT04074317|453121986|FG000|Third Period|Withdrawal by Subject|0|||
125952100|NCT04074317|453121987|FG001|Third Period|Withdrawal by Subject|0|||
125952101|NCT04074317|453121988|FG002|Third Period|Withdrawal by Subject|0|||
125952102|NCT04074317|453121989|FG003|Third Period|Withdrawal by Subject|1|||
125952103|NCT04074317|453121990|FG004|Third Period|Withdrawal by Subject|0|||
125952104|NCT04074317|453121991|FG005|Third Period|Withdrawal by Subject|0|||
125952105|NCT03548584|453123843|FG000|Overall Study|Lost to Follow-up|0|||
125952106|NCT03548584|453123844|FG001|Overall Study|Lost to Follow-up|0|||
125952107|NCT03548584|453123845|FG002|Overall Study|Lost to Follow-up|1|||
125952108|NCT03548584|453123843|FG000|Overall Study|Adverse Event|1|||
125952109|NCT03548584|453123844|FG001|Overall Study|Adverse Event|11|||
125952110|NCT03548584|453123845|FG002|Overall Study|Adverse Event|5|||
125952111|NCT03548584|453123843|FG000|Overall Study|Site Terminated by Sponsor|1|||
125952112|NCT03548584|453123844|FG001|Overall Study|Site Terminated by Sponsor|3|||
125952113|NCT03548584|453123845|FG002|Overall Study|Site Terminated by Sponsor|2|||
125952114|NCT03548584|453123843|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
126079724|NCT04887506|453585921|FG001|Overall Study|Withdrawal by Subject|3|||
126079725|NCT04887506|453585920|FG000|Overall Study|Adverse Event|4|||
126079726|NCT04887506|453585921|FG001|Overall Study|Adverse Event|3|||
126079727|NCT04887506|453585920|FG000|Overall Study|Other - Not Reported|1|||
126079728|NCT04887506|453585921|FG001|Overall Study|Other - Not Reported|1|||
126079729|NCT02394665|453585924|FG000|Overall Study|Physician Decision|1|||
125952115|NCT03548584|453123844|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
125952116|NCT03548584|453123845|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
125952117|NCT03548584|453123843|FG000|Overall Study|Lack of Efficacy|0|||
125952118|NCT03548584|453123844|FG001|Overall Study|Lack of Efficacy|1|||
125952119|NCT03548584|453123845|FG002|Overall Study|Lack of Efficacy|0|||
125952120|NCT03548584|453123843|FG000|Overall Study|Non-compliance with Study Drug|0|||
125952121|NCT03548584|453123844|FG001|Overall Study|Non-compliance with Study Drug|1|||
125952122|NCT03548584|453123845|FG002|Overall Study|Non-compliance with Study Drug|0|||
125952123|NCT03548584|453123843|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
125952124|NCT03548584|453123844|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
126079730|NCT02394665|453585925|FG001|Overall Study|Physician Decision|0|||
126079731|NCT02394665|453585926|FG002|Overall Study|Physician Decision|0|||
126079732|NCT02636608|453585927|FG000|Overall Study|Failure to Return|4|||
125952125|NCT03548584|453123845|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
125952126|NCT00653224|453123848|FG000|Overall Study|Adverse Event|2|||
125952127|NCT00653224|453123849|FG001|Overall Study|Adverse Event|1|||
125952128|NCT00653224|453123848|FG000|Overall Study|Lack of Efficacy|1|||
125952129|NCT00653224|453123849|FG001|Overall Study|Lack of Efficacy|2|||
125952130|NCT00653224|453123848|FG000|Overall Study|Loss of efficacy|1|||
125952131|NCT00653224|453123849|FG001|Overall Study|Loss of efficacy|0|||
125952132|NCT00653224|453123848|FG000|Overall Study|Lost to Follow-up|1|||
125952133|NCT00653224|453123849|FG001|Overall Study|Lost to Follow-up|0|||
125952134|NCT00653224|453123848|FG000|Overall Study|Other|2|||
125952135|NCT00653224|453123849|FG001|Overall Study|Other|4|||
125952136|NCT00293384|453123850|FG000|Overall Study|Non-compliance|2|||
125952137|NCT00293384|453123850|FG000|Overall Study|Missed dosage/study drug|1|||
125952138|NCT00293384|453123850|FG000|Overall Study|Ineligible|2|||
125952139|NCT04482179|453123851|FG000|Overall Study|Death|1|||
125952140|NCT04482179|453123852|FG001|Overall Study|Death|0|||
125952141|NCT04482179|453123851|FG000|Overall Study|Withdrawal by Subject|1|||
125952142|NCT04482179|453123852|FG001|Overall Study|Withdrawal by Subject|0|||
125952143|NCT04709237|453123853|FG000|Overall Study|Lost to Follow-up|1|||
125952144|NCT04709237|453123854|FG001|Overall Study|Lost to Follow-up|0|||
125952145|NCT04709237|453123855|FG002|Overall Study|Lost to Follow-up|0|||
125952146|NCT04300296|453123857|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
125952147|NCT04300296|453123858|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125952148|NCT04300296|453123859|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125952149|NCT04300296|453123860|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125952150|NCT04300296|453123861|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125952151|NCT04300296|453123862|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125952152|NCT04300296|453123857|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125952153|NCT04300296|453123858|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125952154|NCT04300296|453123859|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125952155|NCT04300296|453123860|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125952156|NCT04300296|453123861|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
125952157|NCT04300296|453123862|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125952158|NCT04300296|453123857|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
125952159|NCT04300296|453123858|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
125952160|NCT04300296|453123859|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
125952161|NCT04300296|453123860|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
125952162|NCT04300296|453123861|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
125952163|NCT04300296|453123862|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
125952164|NCT04300296|453123857|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
125952165|NCT04300296|453123858|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
125952166|NCT04300296|453123859|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
125952167|NCT04300296|453123860|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
125952168|NCT04300296|453123861|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
125952169|NCT04300296|453123862|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
125952170|NCT04300296|453123857|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
125952171|NCT04300296|453123858|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
125952172|NCT04300296|453123859|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
125952173|NCT04300296|453123860|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
125952174|NCT04300296|453123861|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
125952175|NCT04300296|453123862|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
125952176|NCT04300296|453123857|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125952177|NCT04300296|453123858|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
125952178|NCT04300296|453123859|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125952179|NCT04300296|453123860|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125952180|NCT04300296|453123861|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125952181|NCT04300296|453123862|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125952182|NCT04300296|453123857|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
125952183|NCT04300296|453123858|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
125952184|NCT04300296|453123859|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
125952185|NCT04300296|453123860|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
125952186|NCT04300296|453123861|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
125952187|NCT04300296|453123862|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
125952188|NCT03325166|453123863|FG000|Overall Study|Adverse Event|1|||
125952189|NCT01633944|453123864|FG000|Open-label Titration Phase|Adverse Event|109|||
125952190|NCT01633944|453123865|FG001|Open-label Titration Phase|Adverse Event|0|||
126079733|NCT02636608|453585927|FG000|Overall Study|Insufficient Virological Response|1|||
126079734|NCT02636608|453585927|FG000|Overall Study|Death|3|||
126079735|NCT02636608|453585927|FG000|Overall Study|Other|2|||
125952191|NCT01633944|453123866|FG002|Open-label Titration Phase|Adverse Event|0|||
125952192|NCT01633944|453123864|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
125952193|NCT01633944|453123865|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
125952194|NCT01633944|453123866|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
125952195|NCT01633944|453123864|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
125952196|NCT01633944|453123865|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
125952197|NCT01633944|453123866|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
125952198|NCT01633944|453123864|FG000|Open-label Titration Phase|Protocol Violation|24|||
125952199|NCT01633944|453123865|FG001|Open-label Titration Phase|Protocol Violation|0|||
125952200|NCT01633944|453123866|FG002|Open-label Titration Phase|Protocol Violation|0|||
125952201|NCT01633944|453123864|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
125952202|NCT01633944|453123865|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
125952203|NCT01633944|453123866|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
125952204|NCT01633944|453123864|FG000|Open-label Titration Phase|Other|68|||
125952205|NCT01633944|453123865|FG001|Open-label Titration Phase|Other|0|||
125952206|NCT01633944|453123866|FG002|Open-label Titration Phase|Other|0|||
125952207|NCT01633944|453123864|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125952208|NCT01633944|453123865|FG001|Double-blind Treatment Phase|Adverse Event|13|||
125952209|NCT01633944|453123866|FG002|Double-blind Treatment Phase|Adverse Event|7|||
125952210|NCT01633944|453123864|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
125952211|NCT01633944|453123865|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
125952212|NCT01633944|453123866|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
125952213|NCT01633944|453123864|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125952214|NCT01633944|453123865|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
125952215|NCT01633944|453123866|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
125952216|NCT01633944|453123864|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
125952217|NCT01633944|453123865|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
125952218|NCT01633944|453123866|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
125952219|NCT01633944|453123864|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125952220|NCT01633944|453123865|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
125952221|NCT01633944|453123866|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
125952222|NCT01633944|453123864|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
125952223|NCT01633944|453123865|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
125952224|NCT01633944|453123866|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
125952225|NCT01633944|453123864|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
125952226|NCT01633944|453123865|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
125952227|NCT01633944|453123866|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
125952228|NCT01633944|453123864|FG000|Double-blind Treatment Phase|Other|0|||
125952229|NCT01633944|453123865|FG001|Double-blind Treatment Phase|Other|7|||
125952230|NCT01633944|453123866|FG002|Double-blind Treatment Phase|Other|0|||
125952231|NCT00701129|453123868|FG000|Overall Study|Death|2|||
125952232|NCT02412631|453123871|FG000|Overall Study|Adverse Event|1|||
125952233|NCT02412631|453123872|FG001|Overall Study|Adverse Event|2|||
125952234|NCT02412631|453123871|FG000|Overall Study|Lost to Follow-up|5|||
125952235|NCT02412631|453123872|FG001|Overall Study|Lost to Follow-up|9|||
125952236|NCT02412631|453123871|FG000|Overall Study|Withdrawal by Subject|9|||
125952237|NCT02412631|453123872|FG001|Overall Study|Withdrawal by Subject|3|||
125952238|NCT02412631|453123871|FG000|Overall Study|Early stop by FDA|5|||
125952239|NCT02412631|453123872|FG001|Overall Study|Early stop by FDA|2|||
125952240|NCT02412631|453123871|FG000|Overall Study|Unspecified reason|6|||
125952241|NCT02412631|453123872|FG001|Overall Study|Unspecified reason|8|||
125952242|NCT00958776|453123873|FG000|Overall Study|Adverse Event|0|||
125952243|NCT00958776|453123874|FG001|Overall Study|Adverse Event|1|||
125952244|NCT00958776|453123873|FG000|Overall Study|Physician Decision|1|||
125952245|NCT00958776|453123874|FG001|Overall Study|Physician Decision|0|||
125952246|NCT00958776|453123873|FG000|Overall Study|Lost to Follow-up|2|||
125952247|NCT00958776|453123874|FG001|Overall Study|Lost to Follow-up|6|||
125952248|NCT00958776|453123873|FG000|Overall Study|Withdrawal by Subject|7|||
125952249|NCT00958776|453123874|FG001|Overall Study|Withdrawal by Subject|16|||
125952250|NCT00958776|453123873|FG000|Overall Study|Protocol Violation|1|||
125952251|NCT00958776|453123874|FG001|Overall Study|Protocol Violation|1|||
125952252|NCT00958776|453123873|FG000|Overall Study|Death|2|||
125952253|NCT00958776|453123874|FG001|Overall Study|Death|1|||
125952254|NCT00958776|453123873|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
125952255|NCT00958776|453123874|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
125952256|NCT00958776|453123873|FG000|Overall Study|Missing|1|||
125952257|NCT00958776|453123874|FG001|Overall Study|Missing|1|||
125952258|NCT00976898|453123882|FG000|Overall Study|Protocol Violation|1|||
125952259|NCT00976898|453123882|FG000|Overall Study|Adverse Event|1|||
125952260|NCT00976898|453123882|FG000|Overall Study|Physician Decision|1|||
125952261|NCT00976898|453123882|FG000|Overall Study|Liver Transplant|1|||
125952262|NCT00976898|453123882|FG000|Overall Study|Progressive Disease|1|||
125952263|NCT05107128|453123883|FG000|Overall Study|Adverse Event|2|||
125952264|NCT05107128|453123884|FG001|Overall Study|Adverse Event|0|||
125952265|NCT05107128|453123883|FG000|Overall Study|Withdrawal by Subject|3|||
125952266|NCT05107128|453123884|FG001|Overall Study|Withdrawal by Subject|3|||
125952267|NCT05107128|453123883|FG000|Overall Study|Withdrawal of Consent|0|||
125952268|NCT05107128|453123884|FG001|Overall Study|Withdrawal of Consent|1|||
125952269|NCT05107128|453123883|FG000|Overall Study|Reason Not Specified|2|||
125952270|NCT05107128|453123884|FG001|Overall Study|Reason Not Specified|0|||
125952271|NCT01470469|453123885|FG000|Overall Study|Withdrawal by Subject|4|||
125952272|NCT01470469|453123886|FG001|Overall Study|Withdrawal by Subject|6|||
125952273|NCT01470469|453123885|FG000|Overall Study|Lack of Efficacy|1|||
125952274|NCT01470469|453123886|FG001|Overall Study|Lack of Efficacy|7|||
125952275|NCT01470469|453123885|FG000|Overall Study|Adverse Event|0|||
125952276|NCT01470469|453123886|FG001|Overall Study|Adverse Event|7|||
125952277|NCT01470469|453123885|FG000|Overall Study|Lost to Follow-up|2|||
125952278|NCT01470469|453123886|FG001|Overall Study|Lost to Follow-up|2|||
125952279|NCT01470469|453123885|FG000|Overall Study|Protocol Violation|1|||
125952280|NCT01470469|453123886|FG001|Overall Study|Protocol Violation|1|||
125952281|NCT01470469|453123885|FG000|Overall Study|Other|2|||
125952282|NCT01470469|453123886|FG001|Overall Study|Other|1|||
125952283|NCT04988295|453123887|FG000|Overall Study|Withdrawal by Subject|9|||
125952284|NCT04988295|453123888|FG001|Overall Study|Withdrawal by Subject|29|||
125952285|NCT04988295|453123889|FG002|Overall Study|Withdrawal by Subject|6|||
125952286|NCT04988295|453123890|FG003|Overall Study|Withdrawal by Subject|0|||
125952287|NCT04988295|453123887|FG000|Overall Study|Lost to Follow-up|1|||
125952288|NCT04988295|453123888|FG001|Overall Study|Lost to Follow-up|0|||
125952289|NCT04988295|453123889|FG002|Overall Study|Lost to Follow-up|0|||
125952290|NCT04988295|453123890|FG003|Overall Study|Lost to Follow-up|0|||
125952291|NCT04988295|453123887|FG000|Overall Study|Study participation ongoing|186|||
125952292|NCT04988295|453123888|FG001|Overall Study|Study participation ongoing|169|||
125952293|NCT04988295|453123889|FG002|Overall Study|Study participation ongoing|99|||
125952294|NCT04988295|453123890|FG003|Overall Study|Study participation ongoing|119|||
125952295|NCT04083976|453123891|FG000|Overall Study|Lost to Follow-up|3|||
125952296|NCT04083976|453123892|FG001|Overall Study|Lost to Follow-up|0|||
125952297|NCT04083976|453123893|FG002|Overall Study|Lost to Follow-up|0|||
125952298|NCT04083976|453123894|FG003|Overall Study|Lost to Follow-up|1|||
125952299|NCT04083976|453123891|FG000|Overall Study|Withdrawal by Subject|16|||
125952300|NCT04083976|453123892|FG001|Overall Study|Withdrawal by Subject|1|||
125952301|NCT04083976|453123893|FG002|Overall Study|Withdrawal by Subject|9|||
125952302|NCT04083976|453123894|FG003|Overall Study|Withdrawal by Subject|0|||
125952303|NCT04083976|453123891|FG000|Overall Study|Sponsor Decision|14|||
125952304|NCT04083976|453123892|FG001|Overall Study|Sponsor Decision|0|||
125952305|NCT04083976|453123893|FG002|Overall Study|Sponsor Decision|0|||
125952306|NCT04083976|453123894|FG003|Overall Study|Sponsor Decision|7|||
125952307|NCT04083976|453123891|FG000|Overall Study|Other|1|||
125952308|NCT04083976|453123892|FG001|Overall Study|Other|0|||
125952309|NCT04083976|453123893|FG002|Overall Study|Other|1|||
125952310|NCT04083976|453123894|FG003|Overall Study|Other|0|||
125952311|NCT05358821|453123895|FG000|Overall Study|Withdrawal by Subject|0|||
125952312|NCT05358821|453123896|FG001|Overall Study|Withdrawal by Subject|1|||
125952313|NCT05358821|453123897|FG002|Overall Study|Withdrawal by Subject|0|||
125952314|NCT05358821|453123895|FG000|Overall Study|Withdrawal of Consent|0|||
125952315|NCT05358821|453123896|FG001|Overall Study|Withdrawal of Consent|0|||
125952316|NCT05358821|453123897|FG002|Overall Study|Withdrawal of Consent|1|||
125952317|NCT02504372|453123898|FG000|Overall Study|Death|136|||
125952318|NCT02504372|453123899|FG001|Overall Study|Death|154|||
125952319|NCT02504372|453123898|FG000|Overall Study|Lost to Follow-up|0|||
125952320|NCT02504372|453123899|FG001|Overall Study|Lost to Follow-up|2|||
125952321|NCT02504372|453123898|FG000|Overall Study|Withdrawal of consent|25|||
125952322|NCT02504372|453123899|FG001|Overall Study|Withdrawal of consent|16|||
125952323|NCT02504372|453123898|FG000|Overall Study|Participants ongoing|429|||
125952324|NCT02504372|453123899|FG001|Overall Study|Participants ongoing|415|||
125952325|NCT03901963|453123900|FG000|Overall Study|Lost to Follow-up|1|||
125952326|NCT03901963|453123901|FG001|Overall Study|Lost to Follow-up|1|||
125952327|NCT03901963|453123900|FG000|Overall Study|Physician Decision|1|||
125952328|NCT03901963|453123901|FG001|Overall Study|Physician Decision|2|||
125952329|NCT03901963|453123900|FG000|Overall Study|Protocol Violation|1|||
125952330|NCT03901963|453123901|FG001|Overall Study|Protocol Violation|1|||
125952331|NCT03901963|453123900|FG000|Overall Study|Withdrawal by Subject|4|||
125952332|NCT03901963|453123901|FG001|Overall Study|Withdrawal by Subject|11|||
125952333|NCT03901963|453123900|FG000|Overall Study|Ongoing|84|||
125952334|NCT03901963|453123901|FG001|Overall Study|Ongoing|73|||
125952335|NCT03901963|453123900|FG000|Overall Study|Randomized but not treated|3|||
125952336|NCT03901963|453123901|FG001|Overall Study|Randomized but not treated|3|||
125952337|NCT00433654|453123907|FG000|Overall Study|Death|4|||
125952338|NCT00433654|453123908|FG001|Overall Study|Death|0|||
125952339|NCT00433654|453123907|FG000|Overall Study|Missed visit|6|||
125952340|NCT00433654|453123908|FG001|Overall Study|Missed visit|3|||
125952341|NCT00433654|453123907|FG000|Overall Study|Subject not yet due for visit|4|||
125952342|NCT00433654|453123908|FG001|Overall Study|Subject not yet due for visit|0|||
125952343|NCT00433654|453123907|FG000|Overall Study|Withdrawal by Subject|1|||
125952344|NCT00433654|453123908|FG001|Overall Study|Withdrawal by Subject|2|||
125952345|NCT01428193|453123909|FG000|Overall Study|Physician Decision|1|||
125952346|NCT01428193|453123909|FG000|Overall Study|Elevated screening liver enzymes|1|||
125952347|NCT04049760|453123910|FG000|Overall Study|Withdrawal by Subject|1|||
125952348|NCT02457598|453123911|FG000|Overall Study|Progressive Disease|2|||
125952349|NCT02457598|453123912|FG001|Overall Study|Progressive Disease|2|||
125952350|NCT02457598|453123913|FG002|Overall Study|Progressive Disease|1|||
125952351|NCT02457598|453123914|FG003|Overall Study|Progressive Disease|11|||
125952352|NCT02457598|453123915|FG004|Overall Study|Progressive Disease|7|||
125952353|NCT02457598|453123916|FG005|Overall Study|Progressive Disease|3|||
125952354|NCT02457598|453123917|FG006|Overall Study|Progressive Disease|2|||
125952355|NCT02457598|453123918|FG007|Overall Study|Progressive Disease|1|||
125952356|NCT02457598|453123919|FG008|Overall Study|Progressive Disease|1|||
125952357|NCT02457598|453123920|FG009|Overall Study|Progressive Disease|2|||
125952358|NCT02457598|453123921|FG010|Overall Study|Progressive Disease|45|||
125952359|NCT02457598|453123922|FG011|Overall Study|Progressive Disease|6|||
125952360|NCT02457598|453123923|FG012|Overall Study|Progressive Disease|2|||
125952361|NCT02457598|453123924|FG013|Overall Study|Progressive Disease|2|||
125952362|NCT02457598|453123925|FG014|Overall Study|Progressive Disease|10|||
125952363|NCT02457598|453123926|FG015|Overall Study|Progressive Disease|1|||
125952364|NCT02457598|453123927|FG016|Overall Study|Progressive Disease|1|||
125952365|NCT02457598|453123911|FG000|Overall Study|Investigator's Discretion|0|||
125952366|NCT02457598|453123912|FG001|Overall Study|Investigator's Discretion|2|||
125952367|NCT02457598|453123913|FG002|Overall Study|Investigator's Discretion|2|||
125952368|NCT02457598|453123914|FG003|Overall Study|Investigator's Discretion|2|||
125952369|NCT02457598|453123915|FG004|Overall Study|Investigator's Discretion|0|||
125952370|NCT02457598|453123916|FG005|Overall Study|Investigator's Discretion|0|||
125952371|NCT02457598|453123917|FG006|Overall Study|Investigator's Discretion|0|||
125952372|NCT02457598|453123918|FG007|Overall Study|Investigator's Discretion|1|||
125952373|NCT02457598|453123919|FG008|Overall Study|Investigator's Discretion|2|||
125952374|NCT02457598|453123920|FG009|Overall Study|Investigator's Discretion|0|||
125952375|NCT02457598|453123921|FG010|Overall Study|Investigator's Discretion|10|||
125952376|NCT02457598|453123922|FG011|Overall Study|Investigator's Discretion|2|||
125952377|NCT02457598|453123923|FG012|Overall Study|Investigator's Discretion|2|||
125952378|NCT02457598|453123924|FG013|Overall Study|Investigator's Discretion|1|||
125952379|NCT02457598|453123925|FG014|Overall Study|Investigator's Discretion|5|||
125952380|NCT02457598|453123926|FG015|Overall Study|Investigator's Discretion|0|||
125952381|NCT02457598|453123927|FG016|Overall Study|Investigator's Discretion|0|||
125952382|NCT02457598|453123911|FG000|Overall Study|Study Terminated by Sponsor|0|||
125952383|NCT02457598|453123912|FG001|Overall Study|Study Terminated by Sponsor|1|||
125952384|NCT02457598|453123913|FG002|Overall Study|Study Terminated by Sponsor|0|||
125952385|NCT02457598|453123914|FG003|Overall Study|Study Terminated by Sponsor|4|||
125952386|NCT02457598|453123915|FG004|Overall Study|Study Terminated by Sponsor|1|||
125952387|NCT02457598|453123916|FG005|Overall Study|Study Terminated by Sponsor|0|||
125952388|NCT02457598|453123917|FG006|Overall Study|Study Terminated by Sponsor|1|||
125952389|NCT02457598|453123918|FG007|Overall Study|Study Terminated by Sponsor|0|||
125952390|NCT02457598|453123919|FG008|Overall Study|Study Terminated by Sponsor|0|||
125952391|NCT02457598|453123920|FG009|Overall Study|Study Terminated by Sponsor|0|||
125952392|NCT02457598|453123921|FG010|Overall Study|Study Terminated by Sponsor|4|||
125952393|NCT02457598|453123922|FG011|Overall Study|Study Terminated by Sponsor|0|||
125952394|NCT02457598|453123923|FG012|Overall Study|Study Terminated by Sponsor|1|||
125952395|NCT02457598|453123924|FG013|Overall Study|Study Terminated by Sponsor|0|||
125952396|NCT02457598|453123925|FG014|Overall Study|Study Terminated by Sponsor|8|||
125952397|NCT02457598|453123926|FG015|Overall Study|Study Terminated by Sponsor|1|||
125952398|NCT02457598|453123927|FG016|Overall Study|Study Terminated by Sponsor|0|||
125952399|NCT02457598|453123911|FG000|Overall Study|Adverse Event|0|||
125952400|NCT02457598|453123912|FG001|Overall Study|Adverse Event|1|||
125952401|NCT02457598|453123913|FG002|Overall Study|Adverse Event|1|||
125952402|NCT02457598|453123914|FG003|Overall Study|Adverse Event|4|||
125952403|NCT02457598|453123915|FG004|Overall Study|Adverse Event|1|||
125952404|NCT02457598|453123916|FG005|Overall Study|Adverse Event|0|||
125952405|NCT02457598|453123917|FG006|Overall Study|Adverse Event|0|||
125952406|NCT02457598|453123918|FG007|Overall Study|Adverse Event|1|||
125952407|NCT02457598|453123919|FG008|Overall Study|Adverse Event|0|||
125952408|NCT02457598|453123920|FG009|Overall Study|Adverse Event|1|||
125952409|NCT02457598|453123921|FG010|Overall Study|Adverse Event|6|||
125952410|NCT02457598|453123922|FG011|Overall Study|Adverse Event|0|||
125952411|NCT02457598|453123923|FG012|Overall Study|Adverse Event|0|||
125952412|NCT02457598|453123924|FG013|Overall Study|Adverse Event|1|||
125952413|NCT02457598|453123925|FG014|Overall Study|Adverse Event|2|||
125952414|NCT02457598|453123926|FG015|Overall Study|Adverse Event|0|||
125952415|NCT02457598|453123927|FG016|Overall Study|Adverse Event|0|||
125952416|NCT02457598|453123911|FG000|Overall Study|Death|0|||
125952417|NCT02457598|453123912|FG001|Overall Study|Death|0|||
125952418|NCT02457598|453123913|FG002|Overall Study|Death|0|||
125952419|NCT02457598|453123914|FG003|Overall Study|Death|3|||
125952420|NCT02457598|453123915|FG004|Overall Study|Death|0|||
125952421|NCT02457598|453123916|FG005|Overall Study|Death|1|||
125952422|NCT02457598|453123917|FG006|Overall Study|Death|0|||
126115283|NCT00935272|453718032|FG000|Overall Study|Physician Decision|1|||
126115284|NCT00935272|453718033|FG001|Overall Study|Physician Decision|0|||
126115285|NCT00935272|453718032|FG000|Overall Study|Protocol Violation|0|||
126115286|NCT00935272|453718033|FG001|Overall Study|Protocol Violation|1|||
126115287|NCT01478360|453718045|FG000|Overall Study|Lost to Follow-up|1|||
126115288|NCT01478360|453718046|FG001|Overall Study|Lost to Follow-up|0|||
126115289|NCT01478360|453718045|FG000|Overall Study|Adverse Event|0|||
126115290|NCT01478360|453718046|FG001|Overall Study|Adverse Event|1|||
126115291|NCT01478360|453718045|FG000|Overall Study|Administrative problems|1|||
126115292|NCT01478360|453718046|FG001|Overall Study|Administrative problems|2|||
126115293|NCT02289352|453718047|FG000|Overall Study|Withdrawal by Subject|1|||
126115294|NCT02289352|453718048|FG001|Overall Study|Withdrawal by Subject|1|||
126115295|NCT02289352|453718049|FG002|Overall Study|Withdrawal by Subject|0|||
126115296|NCT01177384|453718050|FG000|Overall Study|Adverse Event|6|||
126115297|NCT01177384|453718051|FG001|Overall Study|Adverse Event|4|||
126115298|NCT01177384|453718050|FG000|Overall Study|Lack of Efficacy|0|||
126115299|NCT01177384|453718051|FG001|Overall Study|Lack of Efficacy|1|||
126115300|NCT01177384|453718050|FG000|Overall Study|Lost to Follow-up|3|||
126115301|NCT01177384|453718051|FG001|Overall Study|Lost to Follow-up|4|||
126115302|NCT01177384|453718050|FG000|Overall Study|Physician Decision|0|||
126115303|NCT01177384|453718051|FG001|Overall Study|Physician Decision|3|||
126115304|NCT01177384|453718050|FG000|Overall Study|Protocol Violation|0|||
126115305|NCT01177384|453718051|FG001|Overall Study|Protocol Violation|2|||
126115306|NCT01177384|453718050|FG000|Overall Study|Withdrawal by Subject|5|||
126115307|NCT01177384|453718051|FG001|Overall Study|Withdrawal by Subject|12|||
126115308|NCT01849497|453718052|FG000|Overall Study|Withdrawal by Subject|1|||
125952423|NCT02457598|453123918|FG007|Overall Study|Death|0|||
125952424|NCT02457598|453123919|FG008|Overall Study|Death|0|||
125952425|NCT02457598|453123920|FG009|Overall Study|Death|0|||
126079736|NCT02636608|453585927|FG000|Overall Study|Did Not Receive Treatment|1|||
126079737|NCT01255761|453585928|FG000|Overall Study|Adverse Event|29|||
126079738|NCT01255761|453585929|FG001|Overall Study|Adverse Event|43|||
126079739|NCT01255761|453585928|FG000|Overall Study|Lack of Efficacy|86|||
126079740|NCT01255761|453585929|FG001|Overall Study|Lack of Efficacy|74|||
126079741|NCT01255761|453585928|FG000|Overall Study|Protocol Violation|9|||
126079742|NCT01255761|453585929|FG001|Overall Study|Protocol Violation|5|||
126079743|NCT01255761|453585928|FG000|Overall Study|Lost to Follow-up|10|||
126079744|NCT01255761|453585929|FG001|Overall Study|Lost to Follow-up|8|||
126079745|NCT01255761|453585928|FG000|Overall Study|Withdrawal by Subject|11|||
126079746|NCT01255761|453585929|FG001|Overall Study|Withdrawal by Subject|27|||
126079747|NCT01255761|453585928|FG000|Overall Study|Other Reasons|37|||
126079748|NCT01255761|453585929|FG001|Overall Study|Other Reasons|18|||
126079749|NCT05613088|453585932|FG000|Treatment|Ongoing Study Treatment|9|||
126079750|NCT05613088|453585933|FG001|Treatment|Ongoing Study Treatment|2|||
126079751|NCT05613088|453585932|FG000|Treatment|Adverse Event|3|||
126079752|NCT05613088|453585933|FG001|Treatment|Adverse Event|1|||
126079753|NCT05613088|453585932|FG000|Treatment|Other Reasons|0|||
126079754|NCT05613088|453585933|FG001|Treatment|Other Reasons|1|||
126079755|NCT05613088|453585932|FG000|Treatment|Progressive Disease|58|||
126079756|NCT05613088|453585933|FG001|Treatment|Progressive Disease|26|||
126079757|NCT05613088|453585932|FG000|Treatment|Withdrawal by Subject|0|||
126079758|NCT05613088|453585933|FG001|Treatment|Withdrawal by Subject|4|||
126079759|NCT03912532|453585934|FG000|Overall Study|Adverse Event|3|||
126079760|NCT03912532|453585935|FG001|Overall Study|Adverse Event|3|||
126079761|NCT03912532|453585936|FG002|Overall Study|Adverse Event|2|||
126079762|NCT03912532|453585937|FG003|Overall Study|Adverse Event|2|||
126079763|NCT03912532|453585934|FG000|Overall Study|Lost to Follow-up|3|||
126079764|NCT03912532|453585935|FG001|Overall Study|Lost to Follow-up|2|||
126079765|NCT03912532|453585936|FG002|Overall Study|Lost to Follow-up|1|||
126079766|NCT03912532|453585937|FG003|Overall Study|Lost to Follow-up|2|||
126079767|NCT03912532|453585934|FG000|Overall Study|Withdrawal by Subject|1|||
126079768|NCT03912532|453585935|FG001|Overall Study|Withdrawal by Subject|1|||
126079769|NCT03912532|453585936|FG002|Overall Study|Withdrawal by Subject|2|||
126115309|NCT01849497|453718053|FG001|Overall Study|Withdrawal by Subject|2|||
126115310|NCT01849497|453718052|FG000|Overall Study|Sponsor Decision|0|||
126115311|NCT01849497|453718053|FG001|Overall Study|Sponsor Decision|1|||
126115312|NCT01849497|453718052|FG000|Overall Study|Lost to Follow-up|0|||
126115313|NCT01849497|453718053|FG001|Overall Study|Lost to Follow-up|1|||
126115314|NCT00911625|453718079|FG000|Overall Study|Lost to Follow-up|7|||
126115315|NCT00911625|453718080|FG001|Overall Study|Lost to Follow-up|0|||
125952426|NCT02457598|453123921|FG010|Overall Study|Death|3|||
125952427|NCT02457598|453123922|FG011|Overall Study|Death|0|||
126079770|NCT03912532|453585937|FG003|Overall Study|Withdrawal by Subject|0|||
126079771|NCT03912532|453585934|FG000|Overall Study|Physician Decision|1|||
126079772|NCT03912532|453585935|FG001|Overall Study|Physician Decision|0|||
126079773|NCT03912532|453585936|FG002|Overall Study|Physician Decision|0|||
126079774|NCT03912532|453585937|FG003|Overall Study|Physician Decision|3|||
126079775|NCT03912532|453585934|FG000|Overall Study|Other|0|||
126079776|NCT03912532|453585935|FG001|Overall Study|Other|1|||
126079777|NCT03912532|453585936|FG002|Overall Study|Other|1|||
126115316|NCT00529451|453718081|FG000|Overall Study|Subject withdrew consent|16|||
126079778|NCT03912532|453585937|FG003|Overall Study|Other|0|||
126079779|NCT03569891|453585938|FG000|Lead-in|Ineligible during lead-in|8|||
126079780|NCT03569891|453585938|FG000|Lead-in|Withdrawal by Subject|3|||
126079781|NCT03569891|453585938|FG000|Lead-in|Risks related to COVID-19|2|||
126079782|NCT03569891|453585938|FG000|AMT-061|Adverse Event|1|||
126079783|NCT03614676|453587952|FG000|Overall Study|Delivery before planned visit|2|||
126079784|NCT03614676|453587953|FG001|Overall Study|Delivery before planned visit|0|||
126079785|NCT03614676|453587952|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
126079786|NCT03614676|453587953|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
126079787|NCT03614676|453587952|FG000|Overall Study|Migrated / moved from the study area|30|||
126079788|NCT03614676|453587953|FG001|Overall Study|Migrated / moved from the study area|22|||
126079789|NCT03614676|453587952|FG000|Overall Study|Lost to Follow-up|17|||
126079790|NCT03614676|453587953|FG001|Overall Study|Lost to Follow-up|42|||
126079791|NCT03614676|453587952|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
126115317|NCT00529451|453718082|FG001|Overall Study|Subject withdrew consent|21|||
125952428|NCT02457598|453123923|FG012|Overall Study|Death|0|||
125952429|NCT02457598|453123924|FG013|Overall Study|Death|1|||
125952430|NCT02457598|453123925|FG014|Overall Study|Death|2|||
125952431|NCT02457598|453123926|FG015|Overall Study|Death|0|||
125952432|NCT02457598|453123927|FG016|Overall Study|Death|1|||
125952433|NCT02457598|453123911|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952434|NCT02457598|453123912|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
125952435|NCT02457598|453123913|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952436|NCT02457598|453123914|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
125952437|NCT02457598|453123915|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952438|NCT02457598|453123916|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952439|NCT02457598|453123917|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952440|NCT02457598|453123918|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
125952441|NCT02457598|453123919|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952442|NCT02457598|453123920|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952443|NCT02457598|453123921|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
125952444|NCT02457598|453123922|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952445|NCT02457598|453123923|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952446|NCT02457598|453123924|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
125952447|NCT02457598|453123925|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
125952448|NCT02457598|453123926|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
125952449|NCT02457598|453123927|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
125952450|NCT02457598|453123911|FG000|Overall Study|Withdrew Consent|0|||
125952451|NCT02457598|453123912|FG001|Overall Study|Withdrew Consent|0|||
125952452|NCT02457598|453123913|FG002|Overall Study|Withdrew Consent|0|||
125952453|NCT02457598|453123914|FG003|Overall Study|Withdrew Consent|0|||
125952454|NCT02457598|453123915|FG004|Overall Study|Withdrew Consent|0|||
125952455|NCT02457598|453123916|FG005|Overall Study|Withdrew Consent|0|||
125952456|NCT02457598|453123917|FG006|Overall Study|Withdrew Consent|0|||
125952457|NCT02457598|453123918|FG007|Overall Study|Withdrew Consent|2|||
125952458|NCT02457598|453123919|FG008|Overall Study|Withdrew Consent|0|||
125952459|NCT02457598|453123920|FG009|Overall Study|Withdrew Consent|0|||
125952460|NCT02457598|453123921|FG010|Overall Study|Withdrew Consent|3|||
125952461|NCT02457598|453123922|FG011|Overall Study|Withdrew Consent|0|||
125952462|NCT02457598|453123923|FG012|Overall Study|Withdrew Consent|0|||
125952463|NCT02457598|453123924|FG013|Overall Study|Withdrew Consent|1|||
125952464|NCT02457598|453123925|FG014|Overall Study|Withdrew Consent|0|||
125952465|NCT02457598|453123926|FG015|Overall Study|Withdrew Consent|0|||
125952466|NCT02457598|453123927|FG016|Overall Study|Withdrew Consent|0|||
125952467|NCT02457598|453123911|FG000|Overall Study|Unacceptable Toxicity|0|||
125952468|NCT02457598|453123912|FG001|Overall Study|Unacceptable Toxicity|0|||
125952469|NCT02457598|453123913|FG002|Overall Study|Unacceptable Toxicity|0|||
125952470|NCT02457598|453123914|FG003|Overall Study|Unacceptable Toxicity|0|||
125952471|NCT02457598|453123915|FG004|Overall Study|Unacceptable Toxicity|0|||
125952472|NCT02457598|453123916|FG005|Overall Study|Unacceptable Toxicity|0|||
125952473|NCT02457598|453123917|FG006|Overall Study|Unacceptable Toxicity|0|||
125952474|NCT02457598|453123918|FG007|Overall Study|Unacceptable Toxicity|0|||
125952475|NCT02457598|453123919|FG008|Overall Study|Unacceptable Toxicity|0|||
125952476|NCT02457598|453123920|FG009|Overall Study|Unacceptable Toxicity|0|||
125952477|NCT02457598|453123921|FG010|Overall Study|Unacceptable Toxicity|1|||
126115318|NCT00529451|453718083|FG002|Overall Study|Subject withdrew consent|13|||
126115319|NCT00529451|453718084|FG003|Overall Study|Subject withdrew consent|12|||
125952478|NCT02457598|453123922|FG011|Overall Study|Unacceptable Toxicity|0|||
125952479|NCT02457598|453123923|FG012|Overall Study|Unacceptable Toxicity|1|||
125952480|NCT02457598|453123924|FG013|Overall Study|Unacceptable Toxicity|1|||
125952481|NCT02457598|453123925|FG014|Overall Study|Unacceptable Toxicity|1|||
125952482|NCT02457598|453123926|FG015|Overall Study|Unacceptable Toxicity|0|||
125952483|NCT02457598|453123927|FG016|Overall Study|Unacceptable Toxicity|0|||
126079792|NCT03614676|453587953|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
126079793|NCT03614676|453587952|FG000|Overall Study|Other|16|||
126079794|NCT03614676|453587953|FG001|Overall Study|Other|47|||
126079795|NCT03614676|453587952|FG000|Overall Study|Protocol Violation|0|||
126079796|NCT03614676|453587953|FG001|Overall Study|Protocol Violation|2|||
126079797|NCT03614676|453587952|FG000|Overall Study|Neonatal event of interest|0|||
126079798|NCT03614676|453587953|FG001|Overall Study|Neonatal event of interest|6|||
126079799|NCT03614676|453587952|FG000|Overall Study|Death in infant greater than 28 days old|0|||
126079800|NCT03614676|453587953|FG001|Overall Study|Death in infant greater than 28 days old|12|||
126079801|NCT03614676|453587952|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
126079802|NCT03614676|453587953|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
126079803|NCT02388347|453587954|FG000|Overall Study|Withdrawal by Subject|0|||
126079804|NCT02388347|453587955|FG001|Overall Study|Withdrawal by Subject|0|||
126079805|NCT02388347|453587956|FG002|Overall Study|Withdrawal by Subject|1|||
126079806|NCT02388347|453587957|FG003|Overall Study|Withdrawal by Subject|0|||
126079807|NCT02388347|453587958|FG004|Overall Study|Withdrawal by Subject|0|||
126079808|NCT02825251|453587960|FG000|Overall Study|Adverse Event|0|||
125952484|NCT02457598|453123911|FG000|Overall Study|Intercurrent Illness|0|||
125952485|NCT02457598|453123912|FG001|Overall Study|Intercurrent Illness|0|||
125952486|NCT02457598|453123913|FG002|Overall Study|Intercurrent Illness|0|||
125952487|NCT02457598|453123914|FG003|Overall Study|Intercurrent Illness|0|||
125952488|NCT02457598|453123915|FG004|Overall Study|Intercurrent Illness|0|||
125952489|NCT02457598|453123916|FG005|Overall Study|Intercurrent Illness|0|||
125952490|NCT02457598|453123917|FG006|Overall Study|Intercurrent Illness|0|||
125952491|NCT02457598|453123918|FG007|Overall Study|Intercurrent Illness|0|||
125952492|NCT02457598|453123919|FG008|Overall Study|Intercurrent Illness|0|||
125952493|NCT02457598|453123920|FG009|Overall Study|Intercurrent Illness|0|||
125952494|NCT02457598|453123921|FG010|Overall Study|Intercurrent Illness|1|||
125952495|NCT02457598|453123922|FG011|Overall Study|Intercurrent Illness|0|||
125952496|NCT02457598|453123923|FG012|Overall Study|Intercurrent Illness|0|||
125952497|NCT02457598|453123924|FG013|Overall Study|Intercurrent Illness|0|||
125952498|NCT02457598|453123925|FG014|Overall Study|Intercurrent Illness|0|||
125952499|NCT02457598|453123926|FG015|Overall Study|Intercurrent Illness|0|||
125952500|NCT02457598|453123927|FG016|Overall Study|Intercurrent Illness|0|||
125952501|NCT02457598|453123911|FG000|Overall Study|Protocol Violation|0|||
125952502|NCT02457598|453123912|FG001|Overall Study|Protocol Violation|0|||
125952503|NCT02457598|453123913|FG002|Overall Study|Protocol Violation|0|||
125952504|NCT02457598|453123914|FG003|Overall Study|Protocol Violation|0|||
125952505|NCT02457598|453123915|FG004|Overall Study|Protocol Violation|0|||
125952506|NCT02457598|453123916|FG005|Overall Study|Protocol Violation|0|||
125952507|NCT02457598|453123917|FG006|Overall Study|Protocol Violation|0|||
125952508|NCT02457598|453123918|FG007|Overall Study|Protocol Violation|0|||
125952509|NCT02457598|453123919|FG008|Overall Study|Protocol Violation|0|||
125952510|NCT02457598|453123920|FG009|Overall Study|Protocol Violation|0|||
125952511|NCT02457598|453123921|FG010|Overall Study|Protocol Violation|1|||
125952512|NCT02457598|453123922|FG011|Overall Study|Protocol Violation|0|||
125952513|NCT02457598|453123923|FG012|Overall Study|Protocol Violation|0|||
125952514|NCT02457598|453123924|FG013|Overall Study|Protocol Violation|0|||
125952515|NCT02457598|453123925|FG014|Overall Study|Protocol Violation|0|||
125952516|NCT02457598|453123926|FG015|Overall Study|Protocol Violation|0|||
125952517|NCT02457598|453123927|FG016|Overall Study|Protocol Violation|0|||
125952518|NCT01403974|453123928|FG000|Overall Study|Progressive disease according to RECIST|3|||
125952519|NCT01403974|453123929|FG001|Overall Study|Progressive disease according to RECIST|3|||
125952520|NCT01403974|453123930|FG002|Overall Study|Progressive disease according to RECIST|2|||
125952521|NCT01403974|453123931|FG003|Overall Study|Progressive disease according to RECIST|3|||
125952522|NCT01403974|453123932|FG004|Overall Study|Progressive disease according to RECIST|3|||
125952523|NCT01403974|453123933|FG005|Overall Study|Progressive disease according to RECIST|2|||
125952524|NCT01403974|453123934|FG006|Overall Study|Progressive disease according to RECIST|3|||
125952525|NCT01403974|453123935|FG007|Overall Study|Progressive disease according to RECIST|2|||
125952526|NCT01403974|453123936|FG008|Overall Study|Progressive disease according to RECIST|6|||
125952527|NCT01403974|453123937|FG009|Overall Study|Progressive disease according to RECIST|2|||
125952528|NCT01403974|453123938|FG010|Overall Study|Progressive disease according to RECIST|3|||
125952529|NCT01403974|453123939|FG011|Overall Study|Progressive disease according to RECIST|2|||
125952530|NCT01403974|453123940|FG012|Overall Study|Progressive disease according to RECIST|2|||
125952531|NCT01403974|453123941|FG013|Overall Study|Progressive disease according to RECIST|3|||
125952532|NCT01403974|453123942|FG014|Overall Study|Progressive disease according to RECIST|1|||
125952533|NCT01403974|453123943|FG015|Overall Study|Progressive disease according to RECIST|8|||
125952534|NCT01403974|453123928|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
125952535|NCT01403974|453123929|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
125952536|NCT01403974|453123930|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
125952537|NCT01403974|453123931|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
126079809|NCT02825251|453587961|FG001|Overall Study|Adverse Event|1|||
126079810|NCT02825251|453587960|FG000|Overall Study|Lost to Follow-up|0|||
125952538|NCT01403974|453123932|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
125952539|NCT01403974|453123933|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
125952540|NCT01403974|453123934|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
125952541|NCT01403974|453123935|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
125952542|NCT01403974|453123936|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
125952543|NCT01403974|453123937|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
125952544|NCT01403974|453123938|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
125952545|NCT01403974|453123939|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
125952546|NCT01403974|453123940|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
125952547|NCT01403974|453123941|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
125952548|NCT01403974|453123942|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
125952549|NCT01403974|453123943|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
125952550|NCT01403974|453123928|FG000|Overall Study|Refused to continue study medication|0|||
125952551|NCT01403974|453123929|FG001|Overall Study|Refused to continue study medication|0|||
125952552|NCT01403974|453123930|FG002|Overall Study|Refused to continue study medication|0|||
125952553|NCT01403974|453123931|FG003|Overall Study|Refused to continue study medication|0|||
125952554|NCT01403974|453123932|FG004|Overall Study|Refused to continue study medication|0|||
125952555|NCT01403974|453123933|FG005|Overall Study|Refused to continue study medication|1|||
125952556|NCT01403974|453123934|FG006|Overall Study|Refused to continue study medication|0|||
125952557|NCT01403974|453123935|FG007|Overall Study|Refused to continue study medication|0|||
125952558|NCT01403974|453123936|FG008|Overall Study|Refused to continue study medication|1|||
125952559|NCT01403974|453123937|FG009|Overall Study|Refused to continue study medication|0|||
125952560|NCT01403974|453123938|FG010|Overall Study|Refused to continue study medication|1|||
125952561|NCT01403974|453123939|FG011|Overall Study|Refused to continue study medication|0|||
125952562|NCT01403974|453123940|FG012|Overall Study|Refused to continue study medication|0|||
125952563|NCT01403974|453123941|FG013|Overall Study|Refused to continue study medication|0|||
125952564|NCT01403974|453123942|FG014|Overall Study|Refused to continue study medication|0|||
125952565|NCT01403974|453123943|FG015|Overall Study|Refused to continue study medication|4|||
125952566|NCT01403974|453123928|FG000|Overall Study|Adverse Event|0|||
125952567|NCT01403974|453123929|FG001|Overall Study|Adverse Event|0|||
125952568|NCT01403974|453123930|FG002|Overall Study|Adverse Event|1|||
125952569|NCT01403974|453123931|FG003|Overall Study|Adverse Event|0|||
125952570|NCT01403974|453123932|FG004|Overall Study|Adverse Event|0|||
125952571|NCT01403974|453123933|FG005|Overall Study|Adverse Event|0|||
125952572|NCT01403974|453123934|FG006|Overall Study|Adverse Event|0|||
125952573|NCT01403974|453123935|FG007|Overall Study|Adverse Event|1|||
125952574|NCT01403974|453123936|FG008|Overall Study|Adverse Event|0|||
125952575|NCT01403974|453123937|FG009|Overall Study|Adverse Event|0|||
125952576|NCT01403974|453123938|FG010|Overall Study|Adverse Event|0|||
125952577|NCT01403974|453123939|FG011|Overall Study|Adverse Event|0|||
125952578|NCT01403974|453123940|FG012|Overall Study|Adverse Event|1|||
125952579|NCT01403974|453123941|FG013|Overall Study|Adverse Event|0|||
125952580|NCT01403974|453123942|FG014|Overall Study|Adverse Event|0|||
125952581|NCT01403974|453123943|FG015|Overall Study|Adverse Event|0|||
125952582|NCT01403974|453123928|FG000|Overall Study|Other than specified|0|||
125952583|NCT01403974|453123929|FG001|Overall Study|Other than specified|0|||
125952584|NCT01403974|453123930|FG002|Overall Study|Other than specified|0|||
125952585|NCT01403974|453123931|FG003|Overall Study|Other than specified|0|||
125952586|NCT01403974|453123932|FG004|Overall Study|Other than specified|0|||
125952587|NCT01403974|453123933|FG005|Overall Study|Other than specified|0|||
125952588|NCT01403974|453123934|FG006|Overall Study|Other than specified|0|||
125952589|NCT01403974|453123935|FG007|Overall Study|Other than specified|0|||
125952590|NCT01403974|453123936|FG008|Overall Study|Other than specified|0|||
125952591|NCT01403974|453123937|FG009|Overall Study|Other than specified|1|||
125952592|NCT01403974|453123938|FG010|Overall Study|Other than specified|0|||
125952593|NCT01403974|453123939|FG011|Overall Study|Other than specified|1|||
125952594|NCT01403974|453123940|FG012|Overall Study|Other than specified|0|||
125952595|NCT01403974|453123941|FG013|Overall Study|Other than specified|0|||
125952596|NCT01403974|453123942|FG014|Overall Study|Other than specified|0|||
125952597|NCT01403974|453123943|FG015|Overall Study|Other than specified|0|||
125952598|NCT04334460|453123950|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
125952599|NCT04334460|453123951|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
125952600|NCT04334460|453123950|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
125952601|NCT04334460|453123951|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
125952602|NCT03995953|453123954|FG000|Overall Study|Death|3|||
125952603|NCT03995953|453123955|FG001|Overall Study|Death|0|||
125952604|NCT03995953|453123956|FG002|Overall Study|Death|3|||
125952605|NCT03995953|453123957|FG003|Overall Study|Death|0|||
125952606|NCT03995953|453123958|FG004|Overall Study|Death|3|||
125952607|NCT03995953|453123959|FG005|Overall Study|Death|0|||
125952608|NCT03995953|453123960|FG006|Overall Study|Death|0|||
125952609|NCT03995953|453123961|FG007|Overall Study|Death|0|||
126079811|NCT02825251|453587961|FG001|Overall Study|Lost to Follow-up|1|||
126079812|NCT02825251|453587960|FG000|Overall Study|Withdrawal by Subject|1|||
126079813|NCT02825251|453587961|FG001|Overall Study|Withdrawal by Subject|4|||
126079814|NCT02825251|453587960|FG000|Overall Study|Unclassified|2|||
126079815|NCT02825251|453587961|FG001|Overall Study|Unclassified|0|||
126079816|NCT00487825|453587962|FG000|Overall Study|Adverse Event|2|||
126079817|NCT00487825|453587963|FG001|Overall Study|Adverse Event|2|||
126079818|NCT00487825|453587962|FG000|Overall Study|Lack of Efficacy|1|||
126079819|NCT00487825|453587963|FG001|Overall Study|Lack of Efficacy|1|||
126079820|NCT00487825|453587962|FG000|Overall Study|Other|3|||
126079821|NCT00487825|453587963|FG001|Overall Study|Other|2|||
126079822|NCT01639742|453587966|FG000|Overall Study|Study Ongoing|17|||
126079823|NCT01639742|453587966|FG000|Overall Study|Lost to Follow-up|1|||
126079824|NCT01190644|453587968|FG000|Overall Study|Death|2|||
126079825|NCT01190644|453587968|FG000|Overall Study|Disease progression|1|||
126079826|NCT02366143|453587969|FG000|Overall Study|Death|307|||
126079827|NCT02366143|453587970|FG001|Overall Study|Death|278|||
126079828|NCT02366143|453587971|FG002|Overall Study|Death|280|||
126079829|NCT02366143|453587969|FG000|Overall Study|Lost to Follow-up|2|||
126079830|NCT02366143|453587970|FG001|Overall Study|Lost to Follow-up|4|||
126079831|NCT02366143|453587971|FG002|Overall Study|Lost to Follow-up|2|||
126079832|NCT02366143|453587969|FG000|Overall Study|Physician Decision|1|||
126079833|NCT02366143|453587970|FG001|Overall Study|Physician Decision|2|||
126079834|NCT02366143|453587971|FG002|Overall Study|Physician Decision|1|||
126079835|NCT02366143|453587969|FG000|Overall Study|Protocol Violation|0|||
126079836|NCT02366143|453587970|FG001|Overall Study|Protocol Violation|0|||
126079837|NCT02366143|453587971|FG002|Overall Study|Protocol Violation|2|||
126079838|NCT02366143|453587969|FG000|Overall Study|Withdrawal by Subject|16|||
126079839|NCT02366143|453587970|FG001|Overall Study|Withdrawal by Subject|17|||
126079840|NCT02366143|453587971|FG002|Overall Study|Withdrawal by Subject|22|||
126079841|NCT02366143|453587969|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
126079842|NCT02366143|453587970|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
126079843|NCT02366143|453587971|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
126079844|NCT02366143|453587969|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
126079845|NCT02366143|453587970|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
126079846|NCT02366143|453587971|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
126079847|NCT02366143|453587969|FG000|Overall Study|Randomization Error|1|||
126079848|NCT02366143|453587970|FG001|Overall Study|Randomization Error|0|||
126079849|NCT02366143|453587971|FG002|Overall Study|Randomization Error|0|||
126079850|NCT02366143|453587969|FG000|Overall Study|PI Move and Site Closure|1|||
126079851|NCT02366143|453587970|FG001|Overall Study|PI Move and Site Closure|0|||
126079852|NCT02366143|453587971|FG002|Overall Study|PI Move and Site Closure|1|||
126079853|NCT02366143|453587969|FG000|Overall Study|Study Terminated By Sponsor|0|||
126079854|NCT02366143|453587970|FG001|Overall Study|Study Terminated By Sponsor|0|||
126079855|NCT02366143|453587971|FG002|Overall Study|Study Terminated By Sponsor|2|||
126079856|NCT02366143|453587969|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
126079857|NCT02366143|453587970|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
126079858|NCT02366143|453587971|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
126079859|NCT02366143|453587969|FG000|Overall Study|Patient moved to roll-over study|1|||
126079860|NCT02366143|453587970|FG001|Overall Study|Patient moved to roll-over study|19|||
126079861|NCT02366143|453587971|FG002|Overall Study|Patient moved to roll-over study|28|||
126079862|NCT02366143|453587969|FG000|Overall Study|Patient moved to commercial stock|0|||
126079863|NCT02366143|453587970|FG001|Overall Study|Patient moved to commercial stock|0|||
126079864|NCT02366143|453587971|FG002|Overall Study|Patient moved to commercial stock|1|||
126079865|NCT02366143|453587969|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
126079866|NCT02366143|453587970|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
126115320|NCT00529451|453718081|FG000|Overall Study|Adverse Event|9|||
126115321|NCT00529451|453718082|FG001|Overall Study|Adverse Event|16|||
126115322|NCT00529451|453718083|FG002|Overall Study|Adverse Event|14|||
126115323|NCT00529451|453718084|FG003|Overall Study|Adverse Event|8|||
126115324|NCT00529451|453718081|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
126115325|NCT00529451|453718082|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
126115326|NCT00529451|453718083|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
126079867|NCT02366143|453587971|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
126079868|NCT02366143|453587969|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
126079869|NCT02366143|453587970|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
126079870|NCT02366143|453587971|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
126079871|NCT02366143|453587969|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
126079872|NCT02366143|453587970|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
126079873|NCT02366143|453587971|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
126079874|NCT02366143|453587969|FG000|Overall Study|Requester's instructions|1|||
126079875|NCT02366143|453587970|FG001|Overall Study|Requester's instructions|1|||
126079876|NCT02366143|453587971|FG002|Overall Study|Requester's instructions|1|||
126079877|NCT02366143|453587969|FG000|Overall Study|Uneligible|0|||
126079878|NCT02366143|453587970|FG001|Overall Study|Uneligible|1|||
126079879|NCT02366143|453587971|FG002|Overall Study|Uneligible|0|||
126079880|NCT02366143|453587969|FG000|Overall Study|Post Trial Migration|0|||
126079881|NCT02366143|453587970|FG001|Overall Study|Post Trial Migration|1|||
126079882|NCT02366143|453587971|FG002|Overall Study|Post Trial Migration|0|||
126079883|NCT02366143|453587969|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
126079884|NCT02366143|453587970|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
126079885|NCT02366143|453587971|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
126079886|NCT02366143|453587969|FG000|Overall Study|Patient switched to PTAP|0|||
126079887|NCT02366143|453587970|FG001|Overall Study|Patient switched to PTAP|1|||
126079888|NCT02366143|453587971|FG002|Overall Study|Patient switched to PTAP|0|||
126079889|NCT02366143|453587969|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
126079890|NCT02366143|453587970|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
126079891|NCT02366143|453587971|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
126079892|NCT04411186|453587972|FG000|Overall Study|Withdrawn due to protocol violation|0|||
126079893|NCT04411186|453587973|FG001|Overall Study|Withdrawn due to protocol violation|1|||
126079894|NCT02820597|453587974|FG000|Overall Study|Lost to Follow-up|12|||
126079895|NCT00575042|453587975|FG000|Overall Study|Adverse Event|2|||
126079896|NCT00575042|453587975|FG000|Overall Study|Lost to Follow-up|1|||
126079897|NCT01053247|453587976|FG000|Overall Study|Withdrawal by Subject|9|||
126079898|NCT01053247|453587977|FG001|Overall Study|Withdrawal by Subject|4|||
126079899|NCT01053247|453587978|FG002|Overall Study|Withdrawal by Subject|15|||
126079900|NCT01053247|453587976|FG000|Overall Study|Lack of Efficacy|1|||
126079901|NCT01053247|453587977|FG001|Overall Study|Lack of Efficacy|0|||
126079902|NCT01053247|453587978|FG002|Overall Study|Lack of Efficacy|1|||
126079903|NCT01053247|453587976|FG000|Overall Study|Protocol Violation|2|||
126079904|NCT01053247|453587977|FG001|Overall Study|Protocol Violation|1|||
126079905|NCT01053247|453587978|FG002|Overall Study|Protocol Violation|2|||
126079906|NCT01053247|453587976|FG000|Overall Study|Lost to Follow-up|8|||
126079907|NCT01053247|453587977|FG001|Overall Study|Lost to Follow-up|5|||
126079908|NCT01053247|453587978|FG002|Overall Study|Lost to Follow-up|7|||
126079909|NCT01053247|453587976|FG000|Overall Study|Adverse Event|0|||
126079910|NCT01053247|453587977|FG001|Overall Study|Adverse Event|9|||
126079911|NCT01053247|453587978|FG002|Overall Study|Adverse Event|3|||
126079912|NCT00701909|453587981|FG000|Overall Study|Withdrawal by Subject|0|||
126079913|NCT00701909|453587982|FG001|Overall Study|Withdrawal by Subject|1|||
126079914|NCT03023722|453587987|FG000|Overall Study|No follow-up assessment|4|||
126079915|NCT03616964|453587988|FG000|Overall Study|Adverse Event|15|||
126079916|NCT03616964|453587989|FG001|Overall Study|Adverse Event|10|||
126079917|NCT03616964|453587990|FG002|Overall Study|Adverse Event|16|||
126079918|NCT03616964|453587988|FG000|Overall Study|Death|3|||
126079919|NCT03616964|453587989|FG001|Overall Study|Death|0|||
126079920|NCT03616964|453587990|FG002|Overall Study|Death|4|||
126079921|NCT03616964|453587988|FG000|Overall Study|Lack of Efficacy|4|||
126079922|NCT03616964|453587989|FG001|Overall Study|Lack of Efficacy|8|||
126079923|NCT03616964|453587990|FG002|Overall Study|Lack of Efficacy|8|||
126079924|NCT03616964|453587988|FG000|Overall Study|Lost to Follow-up|2|||
126079925|NCT03616964|453587989|FG001|Overall Study|Lost to Follow-up|1|||
126079926|NCT03616964|453587990|FG002|Overall Study|Lost to Follow-up|3|||
126079927|NCT03616964|453587988|FG000|Overall Study|Withdrawal by Subject|18|||
126079928|NCT03616964|453587989|FG001|Overall Study|Withdrawal by Subject|14|||
126079929|NCT03616964|453587990|FG002|Overall Study|Withdrawal by Subject|21|||
126079930|NCT03616964|453587988|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
126079931|NCT03616964|453587989|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
126079932|NCT03616964|453587990|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
126079933|NCT03616964|453587988|FG000|Overall Study|Sponsor's Decision|1|||
126079934|NCT03616964|453587989|FG001|Overall Study|Sponsor's Decision|0|||
126079935|NCT03616964|453587990|FG002|Overall Study|Sponsor's Decision|0|||
126079936|NCT03616964|453587988|FG000|Overall Study|Physician Decision|0|||
126079937|NCT03616964|453587989|FG001|Overall Study|Physician Decision|2|||
126079938|NCT03616964|453587990|FG002|Overall Study|Physician Decision|0|||
126079939|NCT03616964|453587988|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
126079940|NCT03616964|453587989|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
126079941|NCT03616964|453587990|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
126079942|NCT03616964|453587988|FG000|Overall Study|Protocol Violation|0|||
126079943|NCT03616964|453587989|FG001|Overall Study|Protocol Violation|1|||
126079944|NCT03616964|453587990|FG002|Overall Study|Protocol Violation|0|||
126079945|NCT03616964|453587988|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
126079946|NCT03616964|453587989|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
126079947|NCT03616964|453587990|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
126079948|NCT03616964|453587988|FG000|Overall Study|Randomized but Never Treated|1|||
126079949|NCT03616964|453587989|FG001|Overall Study|Randomized but Never Treated|1|||
125952610|NCT03995953|453123962|FG008|Overall Study|Death|1|||
125952611|NCT03995953|453123963|FG009|Overall Study|Death|0|||
125952612|NCT03995953|453123964|FG010|Overall Study|Death|0|||
125952613|NCT03995953|453123965|FG011|Overall Study|Death|0|||
125952614|NCT03995953|453123954|FG000|Overall Study|Lost to Follow-up|6|||
125952615|NCT03995953|453123955|FG001|Overall Study|Lost to Follow-up|54|||
125952616|NCT03995953|453123956|FG002|Overall Study|Lost to Follow-up|3|||
125952617|NCT03995953|453123957|FG003|Overall Study|Lost to Follow-up|32|||
125952618|NCT03995953|453123958|FG004|Overall Study|Lost to Follow-up|5|||
125952619|NCT03995953|453123959|FG005|Overall Study|Lost to Follow-up|44|||
125952620|NCT03995953|453123960|FG006|Overall Study|Lost to Follow-up|0|||
125952621|NCT03995953|453123961|FG007|Overall Study|Lost to Follow-up|31|||
125952622|NCT03995953|453123962|FG008|Overall Study|Lost to Follow-up|8|||
125952623|NCT03995953|453123963|FG009|Overall Study|Lost to Follow-up|36|||
125952624|NCT03995953|453123964|FG010|Overall Study|Lost to Follow-up|5|||
125952625|NCT03995953|453123965|FG011|Overall Study|Lost to Follow-up|41|||
125952626|NCT03995953|453123954|FG000|Overall Study|Withdrawal by Subject|4|||
125952627|NCT03995953|453123955|FG001|Overall Study|Withdrawal by Subject|0|||
125952628|NCT03995953|453123956|FG002|Overall Study|Withdrawal by Subject|1|||
125952629|NCT03995953|453123957|FG003|Overall Study|Withdrawal by Subject|0|||
125952630|NCT03995953|453123958|FG004|Overall Study|Withdrawal by Subject|1|||
125952631|NCT03995953|453123959|FG005|Overall Study|Withdrawal by Subject|0|||
125952632|NCT03995953|453123960|FG006|Overall Study|Withdrawal by Subject|1|||
125952633|NCT03995953|453123961|FG007|Overall Study|Withdrawal by Subject|0|||
125952634|NCT03995953|453123962|FG008|Overall Study|Withdrawal by Subject|3|||
125952635|NCT03995953|453123963|FG009|Overall Study|Withdrawal by Subject|0|||
125952636|NCT03995953|453123964|FG010|Overall Study|Withdrawal by Subject|3|||
125952637|NCT03995953|453123965|FG011|Overall Study|Withdrawal by Subject|0|||
125952638|NCT03995953|453123954|FG000|Overall Study|Health Issues|0|||
125952639|NCT03995953|453123955|FG001|Overall Study|Health Issues|0|||
125952640|NCT03995953|453123956|FG002|Overall Study|Health Issues|0|||
125952641|NCT03995953|453123957|FG003|Overall Study|Health Issues|0|||
125952642|NCT03995953|453123958|FG004|Overall Study|Health Issues|1|||
125952643|NCT03995953|453123959|FG005|Overall Study|Health Issues|0|||
125952644|NCT03995953|453123960|FG006|Overall Study|Health Issues|0|||
125952645|NCT03995953|453123961|FG007|Overall Study|Health Issues|0|||
125952646|NCT03995953|453123962|FG008|Overall Study|Health Issues|4|||
125952647|NCT03995953|453123963|FG009|Overall Study|Health Issues|0|||
125952648|NCT03995953|453123964|FG010|Overall Study|Health Issues|0|||
125952649|NCT03995953|453123965|FG011|Overall Study|Health Issues|0|||
125952650|NCT03995953|453123954|FG000|Overall Study|Relocated|11|||
125952651|NCT03995953|453123955|FG001|Overall Study|Relocated|0|||
125952652|NCT03995953|453123956|FG002|Overall Study|Relocated|16|||
125952653|NCT03995953|453123957|FG003|Overall Study|Relocated|0|||
125952654|NCT03995953|453123958|FG004|Overall Study|Relocated|14|||
125952655|NCT03995953|453123959|FG005|Overall Study|Relocated|0|||
125952656|NCT03995953|453123960|FG006|Overall Study|Relocated|16|||
125952657|NCT03995953|453123961|FG007|Overall Study|Relocated|0|||
125952658|NCT03995953|453123962|FG008|Overall Study|Relocated|14|||
125952659|NCT03995953|453123963|FG009|Overall Study|Relocated|0|||
125952660|NCT03995953|453123964|FG010|Overall Study|Relocated|15|||
125952661|NCT03995953|453123965|FG011|Overall Study|Relocated|0|||
125952662|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
125952663|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
125952664|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
125952665|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
125952666|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
125952667|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
125952668|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
125952669|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
125952670|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
125952671|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
125952672|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
125952673|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
125952674|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
125952675|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
125952676|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
125952677|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
125952678|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
125952679|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
125952680|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
126115327|NCT00529451|453718084|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
125952681|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
125952682|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
125952683|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
125952684|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
125952685|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
125952686|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
125952687|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
125952688|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
125952689|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
125952690|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
125952691|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
125952692|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
125952693|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
125952694|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
125952695|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
125952696|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
125952697|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
125952698|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
125952699|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
125952700|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
125952701|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
125952702|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
125952703|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
125952704|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
125952705|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
125952706|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
125952707|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
125952708|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
125952709|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
125952710|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
125952711|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
125952712|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
125952713|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
125952714|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
125952715|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
125952716|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
125952717|NCT04951622|453123975|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
125952718|NCT04951622|453123976|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
125952719|NCT04951622|453123977|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
125952720|NCT04951622|453123978|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
125952721|NCT04951622|453123979|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
125952722|NCT04951622|453123975|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
125952723|NCT04951622|453123976|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
125952724|NCT04951622|453123977|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
125952725|NCT04951622|453123978|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
125952726|NCT04951622|453123979|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
125952727|NCT04951622|453123975|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
125952728|NCT04951622|453123976|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
125952729|NCT04951622|453123977|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
125952730|NCT04951622|453123978|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
125952731|NCT04951622|453123979|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
125952732|NCT04951622|453123975|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
125952733|NCT04951622|453123976|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
125952734|NCT04951622|453123977|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
125952735|NCT04951622|453123978|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
125952736|NCT04951622|453123979|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
125952737|NCT04951622|453123975|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
125952738|NCT04951622|453123976|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
125952739|NCT04951622|453123977|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
125952740|NCT04951622|453123978|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
125952741|NCT04951622|453123979|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
125952742|NCT04951622|453123975|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
125952743|NCT04951622|453123976|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
125952744|NCT04951622|453123977|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
125952745|NCT04951622|453123978|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
125952746|NCT04951622|453123979|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
125952747|NCT04951622|453123975|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
126079950|NCT03616964|453587990|FG002|Overall Study|Randomized but Never Treated|1|||
126079951|NCT01266018|453587998|FG000|Overall Study|Physician Decision|1|||
125952748|NCT04951622|453123976|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
126079952|NCT01266018|453587999|FG001|Overall Study|Physician Decision|0|||
126079953|NCT01266018|453587998|FG000|Overall Study|Progressive disease|0|||
126079954|NCT01266018|453587999|FG001|Overall Study|Progressive disease|1|||
126079955|NCT03167151|453588000|FG000|Overall Study|Withdrawal by Subject|1|||
126079956|NCT03167151|453588001|FG001|Overall Study|Withdrawal by Subject|0|||
126079957|NCT03167151|453588002|FG002|Overall Study|Withdrawal by Subject|0|||
126079958|NCT03167151|453588000|FG000|Overall Study|No evidence of tumour at surgery|0|||
126079959|NCT03167151|453588001|FG001|Overall Study|No evidence of tumour at surgery|1|||
126079960|NCT03167151|453588002|FG002|Overall Study|No evidence of tumour at surgery|1|||
126079961|NCT00730015|453588004|FG000|Overall Study|Adverse Event|11|||
126079962|NCT00730015|453588005|FG001|Overall Study|Adverse Event|10|||
126079963|NCT00730015|453588006|FG002|Overall Study|Adverse Event|8|||
126079964|NCT00730015|453588004|FG000|Overall Study|Protocol Violation|2|||
126079965|NCT00730015|453588005|FG001|Overall Study|Protocol Violation|6|||
126079966|NCT00730015|453588006|FG002|Overall Study|Protocol Violation|4|||
126079967|NCT00730015|453588004|FG000|Overall Study|Withdrawal by Subject|12|||
126079968|NCT00730015|453588005|FG001|Overall Study|Withdrawal by Subject|12|||
126079969|NCT00730015|453588006|FG002|Overall Study|Withdrawal by Subject|8|||
126079970|NCT00730015|453588004|FG000|Overall Study|Lost to Follow-up|4|||
126079971|NCT00730015|453588005|FG001|Overall Study|Lost to Follow-up|10|||
126079972|NCT00730015|453588006|FG002|Overall Study|Lost to Follow-up|3|||
126079973|NCT00730015|453588004|FG000|Overall Study|Lack of Efficacy|1|||
126079974|NCT00730015|453588005|FG001|Overall Study|Lack of Efficacy|2|||
126079975|NCT00730015|453588006|FG002|Overall Study|Lack of Efficacy|8|||
126079976|NCT00730015|453588004|FG000|Overall Study|Other Reason|1|||
126079977|NCT00730015|453588005|FG001|Overall Study|Other Reason|0|||
126079978|NCT00730015|453588006|FG002|Overall Study|Other Reason|1|||
126079979|NCT02641587|453588007|FG000|Confinement Period|Adverse Event|1|||
126079980|NCT02641587|453588008|FG001|Confinement Period|Adverse Event|0|||
126079981|NCT02641587|453588007|FG000|Confinement Period|Withdrawal by Subject|2|||
126079982|NCT02641587|453588008|FG001|Confinement Period|Withdrawal by Subject|1|||
126079983|NCT02641587|453588007|FG000|Ambulatory Period|Withdrawal by Subject|1|||
126079984|NCT02641587|453588008|FG001|Ambulatory Period|Withdrawal by Subject|0|||
126079985|NCT01165177|453588009|FG000|Overall Study|Serious Adverse Event|227|||
126079986|NCT01165177|453588010|FG001|Overall Study|Serious Adverse Event|235|||
126079987|NCT01165177|453588009|FG000|Overall Study|Withdrawal by Subject|368|||
126079988|NCT01165177|453588010|FG001|Overall Study|Withdrawal by Subject|354|||
126079989|NCT01165177|453588009|FG000|Overall Study|Protocol Violation|19|||
126079990|NCT01165177|453588010|FG001|Overall Study|Protocol Violation|21|||
126079991|NCT01165177|453588009|FG000|Overall Study|Non-serious adverse event|30|||
126079992|NCT01165177|453588010|FG001|Overall Study|Non-serious adverse event|18|||
126079993|NCT01165177|453588009|FG000|Overall Study|Other unspecified reasons|47|||
126079994|NCT01165177|453588010|FG001|Overall Study|Other unspecified reasons|35|||
126079995|NCT01165177|453588009|FG000|Overall Study|Suspected HZ episode|0|||
126079996|NCT01165177|453588010|FG001|Overall Study|Suspected HZ episode|2|||
126079997|NCT01165177|453588009|FG000|Overall Study|Lost to Follow-up|183|||
126079998|NCT01165177|453588010|FG001|Overall Study|Lost to Follow-up|194|||
126079999|NCT01165177|453588009|FG000|Overall Study|Migrated/ moved from study area|48|||
126080000|NCT01165177|453588010|FG001|Overall Study|Migrated/ moved from study area|43|||
126080001|NCT01663506|453588011|FG000|Overall Study|Lack of Efficacy|3|||
126080002|NCT01663506|453588011|FG000|Overall Study|Consent Withdrawal by Subject|1|||
126080003|NCT01663506|453588011|FG000|Overall Study|Lost to Follow-up|1|||
126080004|NCT01663506|453588011|FG000|Overall Study|Adverse Event|1|||
126080005|NCT01663506|453588011|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
126080006|NCT03210519|453588015|FG000|Overall Study|Adverse Event|2|||
126080007|NCT03210519|453588016|FG001|Overall Study|Adverse Event|0|||
126080008|NCT04351269|453588017|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
126080009|NCT04351269|453588018|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
126080010|NCT04351269|453588019|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
126080011|NCT04351269|453588017|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
126080012|NCT04351269|453588018|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
126080013|NCT04351269|453588019|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
126080014|NCT04351269|453588017|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
126080015|NCT04351269|453588018|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
126080016|NCT04351269|453588019|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
126080017|NCT04351269|453588017|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
126080018|NCT04351269|453588018|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
126080019|NCT04351269|453588019|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
126080020|NCT04351269|453588017|FG000|Overall Study|Lost to Follow-up|1|||
126080021|NCT04351269|453588018|FG001|Overall Study|Lost to Follow-up|3|||
126080022|NCT04351269|453588019|FG002|Overall Study|Lost to Follow-up|0|||
126080023|NCT01407276|453588024|FG000|Overall Study|Withdrawal by Subject|0|||
126080024|NCT01407276|453588025|FG001|Overall Study|Withdrawal by Subject|0|||
126080025|NCT01407276|453588026|FG002|Overall Study|Withdrawal by Subject|0|||
126080026|NCT01407276|453588027|FG003|Overall Study|Withdrawal by Subject|0|||
126080027|NCT01407276|453588028|FG004|Overall Study|Withdrawal by Subject|0|||
126080028|NCT01407276|453588029|FG005|Overall Study|Withdrawal by Subject|0|||
126080029|NCT01407276|453588030|FG006|Overall Study|Withdrawal by Subject|0|||
126080030|NCT01407276|453588031|FG007|Overall Study|Withdrawal by Subject|1|||
126080031|NCT00745498|453588032|FG000|Overall Study|Lost to Follow-up|1|||
126080032|NCT00745498|453588033|FG001|Overall Study|Lost to Follow-up|1|||
126080033|NCT00745498|453588034|FG002|Overall Study|Lost to Follow-up|3|||
126080034|NCT00745498|453588032|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
126080035|NCT00745498|453588033|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
126080036|NCT00745498|453588034|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
126080037|NCT00745498|453588032|FG000|Overall Study|Non-PDR related VH|0|||
126080038|NCT00745498|453588033|FG001|Overall Study|Non-PDR related VH|1|||
126115328|NCT00529451|453718081|FG000|Overall Study|Lost to Follow-up|4|||
126115329|NCT00529451|453718082|FG001|Overall Study|Lost to Follow-up|7|||
125952749|NCT04951622|453123977|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
125952750|NCT04951622|453123978|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
125952751|NCT04951622|453123979|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
125952752|NCT04951622|453123975|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
125952753|NCT04951622|453123976|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
125952754|NCT04951622|453123977|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
125952755|NCT04951622|453123978|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
125952756|NCT04951622|453123979|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
125952757|NCT04951622|453123975|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
125952758|NCT04951622|453123976|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
125952759|NCT04951622|453123977|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
125952760|NCT04951622|453123978|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
125952761|NCT04951622|453123979|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
125952762|NCT02948842|453123980|FG000|Overall Study|Withdrawal by Subject|4|||
125952763|NCT02681302|453123984|FG000|Overall Study|Withdrawal by Subject|1|||
125952764|NCT02681302|453123985|FG001|Overall Study|Withdrawal by Subject|1|||
125952765|NCT02681302|453123986|FG002|Overall Study|Withdrawal by Subject|0|||
125952766|NCT02681302|453123987|FG003|Overall Study|Withdrawal by Subject|0|||
125952767|NCT02681302|453123988|FG004|Overall Study|Withdrawal by Subject|1|||
125952768|NCT02681302|453123989|FG005|Overall Study|Withdrawal by Subject|0|||
125952769|NCT02681302|453123984|FG000|Overall Study|Screen Failure|2|||
125952770|NCT02681302|453123985|FG001|Overall Study|Screen Failure|4|||
125952771|NCT02681302|453123986|FG002|Overall Study|Screen Failure|2|||
125952772|NCT02681302|453123987|FG003|Overall Study|Screen Failure|0|||
125952773|NCT02681302|453123988|FG004|Overall Study|Screen Failure|1|||
125952774|NCT02681302|453123989|FG005|Overall Study|Screen Failure|1|||
125952775|NCT02681302|453123984|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125952776|NCT02681302|453123985|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125952777|NCT02681302|453123986|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125952778|NCT02681302|453123987|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125952779|NCT02681302|453123988|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125952780|NCT02681302|453123989|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
125952781|NCT05059600|453123990|FG000|Overall Study|Enrolled but not Treated|10|||
125952782|NCT02152995|453123991|FG000|Overall Study|Withdrawal by Subject|1|||
125952783|NCT02152995|453123992|FG001|Overall Study|Withdrawal by Subject|0|||
125952784|NCT04552587|453123994|FG000|Overall Study|Lost to Follow-up|4|||
125952785|NCT00613509|453123996|FG000|Cycle 1|Adverse Event|2|||
125952786|NCT00613509|453123997|FG001|Cycle 1|Adverse Event|1|||
125952787|NCT00613509|453123996|FG000|Cycle 1|Disease Progression|2|||
125952788|NCT00613509|453123997|FG001|Cycle 1|Disease Progression|6|||
125952789|NCT00613509|453123996|FG000|Cycle 1|Unacceptable Toxicity|1|||
125952790|NCT00613509|453123997|FG001|Cycle 1|Unacceptable Toxicity|0|||
125952791|NCT00613509|453123996|FG000|Cycle 1|Other administrative reason|0|||
125952792|NCT00613509|453123997|FG001|Cycle 1|Other administrative reason|1|||
125952793|NCT03400033|453124007|FG000|Overall Study|Withdrawal by Subject|1|||
125952794|NCT03400033|453124008|FG001|Overall Study|Withdrawal by Subject|2|||
125952795|NCT02741115|453124014|FG000|Overall Study|Adverse Event|1|||
125952796|NCT02741115|453124015|FG001|Overall Study|Adverse Event|0|||
125952797|NCT02741115|453124014|FG000|Overall Study|Lost to Follow-up|7|||
125952798|NCT02741115|453124015|FG001|Overall Study|Lost to Follow-up|4|||
126115330|NCT00529451|453718083|FG002|Overall Study|Lost to Follow-up|4|||
125952799|NCT02741115|453124014|FG000|Overall Study|Withdrawal by Subject|4|||
126080039|NCT00745498|453588034|FG002|Overall Study|Non-PDR related VH|1|||
126080040|NCT00745498|453588032|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
126080041|NCT00745498|453588033|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
126080042|NCT00745498|453588034|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
126080043|NCT04805073|453588035|FG000|Overall Study|study personnel not available|2|||
126080044|NCT04805073|453588036|FG001|Overall Study|study personnel not available|0|||
126080045|NCT04805073|453588035|FG000|Overall Study|spinal anesthesia failure|0|||
126080046|NCT04805073|453588036|FG001|Overall Study|spinal anesthesia failure|1|||
126080047|NCT04805073|453588035|FG000|Overall Study|Lost to Follow-up|0|||
126080048|NCT04805073|453588036|FG001|Overall Study|Lost to Follow-up|2|||
126080049|NCT01174264|453588044|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
126080050|NCT01174264|453588045|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
126080051|NCT01174264|453588046|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
126115331|NCT00529451|453718084|FG003|Overall Study|Lost to Follow-up|4|||
126115332|NCT00529451|453718081|FG000|Overall Study|Protocol deviation|1|||
126115333|NCT00529451|453718082|FG001|Overall Study|Protocol deviation|1|||
126115334|NCT00529451|453718083|FG002|Overall Study|Protocol deviation|4|||
126115335|NCT00529451|453718084|FG003|Overall Study|Protocol deviation|1|||
126115336|NCT00529451|453718081|FG000|Overall Study|Administrative problems|1|||
126115337|NCT00529451|453718082|FG001|Overall Study|Administrative problems|1|||
126115338|NCT00529451|453718083|FG002|Overall Study|Administrative problems|0|||
126115339|NCT00529451|453718084|FG003|Overall Study|Administrative problems|2|||
126115340|NCT01010633|453718092|FG000|Overall Study|Adverse Event|1|||
126115341|NCT01010633|453718093|FG001|Overall Study|Adverse Event|1|||
126115342|NCT01010633|453718092|FG000|Overall Study|Protocol Violation|1|||
126115343|NCT01010633|453718093|FG001|Overall Study|Protocol Violation|2|||
126115344|NCT01010633|453718092|FG000|Overall Study|Withdrawal by Subject|2|||
126115345|NCT01010633|453718093|FG001|Overall Study|Withdrawal by Subject|1|||
126115346|NCT01010633|453718092|FG000|Overall Study|Investigator decision|0|||
126115347|NCT01010633|453718093|FG001|Overall Study|Investigator decision|1|||
126115348|NCT00097773|453718095|FG000|Overall Study|Lost to Follow-up|2|||
126115349|NCT00097773|453718096|FG001|Overall Study|Lost to Follow-up|2|||
126115350|NCT00097773|453718097|FG002|Overall Study|Lost to Follow-up|0|||
126115351|NCT00097773|453718098|FG003|Overall Study|Lost to Follow-up|1|||
126115352|NCT00097773|453718095|FG000|Overall Study|Physician Decision|2|||
126115353|NCT00097773|453718096|FG001|Overall Study|Physician Decision|2|||
126115354|NCT00097773|453718097|FG002|Overall Study|Physician Decision|3|||
126115355|NCT00097773|453718098|FG003|Overall Study|Physician Decision|1|||
126115356|NCT00097773|453718095|FG000|Overall Study|Withdrawal by Subject|3|||
126115357|NCT00097773|453718096|FG001|Overall Study|Withdrawal by Subject|3|||
126115358|NCT00097773|453718097|FG002|Overall Study|Withdrawal by Subject|3|||
126115359|NCT00097773|453718098|FG003|Overall Study|Withdrawal by Subject|1|||
126115360|NCT00097773|453718095|FG000|Overall Study|Adverse Event|0|||
126115361|NCT00097773|453718096|FG001|Overall Study|Adverse Event|1|||
126115362|NCT00097773|453718097|FG002|Overall Study|Adverse Event|0|||
126115363|NCT00097773|453718098|FG003|Overall Study|Adverse Event|0|||
126115364|NCT00097773|453718095|FG000|Overall Study|Other|1|||
126115365|NCT00097773|453718096|FG001|Overall Study|Other|0|||
126115366|NCT00097773|453718097|FG002|Overall Study|Other|2|||
126115367|NCT00097773|453718098|FG003|Overall Study|Other|0|||
126115368|NCT00003702|453718099|FG000|Overall Study|Ineligible cell types|2|||
126115369|NCT00003702|453718100|FG001|Overall Study|Ineligible cell types|2|||
126115370|NCT00003702|453718099|FG000|Overall Study|Did not meet criteria for persistence|8|||
126115371|NCT00003702|453718100|FG001|Overall Study|Did not meet criteria for persistence|5|||
126115372|NCT00003702|453718099|FG000|Overall Study|WHO score > 6|2|||
126115373|NCT00003702|453718100|FG001|Overall Study|WHO score > 6|1|||
126115374|NCT00003702|453718099|FG000|Overall Study|Inadequate documentation of disease|1|||
126115375|NCT00003702|453718100|FG001|Overall Study|Inadequate documentation of disease|3|||
126115376|NCT01494350|453718101|FG000|Overall Study|Worsening of lesion|1|||
126115377|NCT00698932|453718102|FG000|Overall Study|Adverse Event|0|||
126115378|NCT00698932|453718103|FG001|Overall Study|Adverse Event|2|||
126115379|NCT00698932|453718102|FG000|Overall Study|Incorrect enrollment|0|||
126115380|NCT00698932|453718103|FG001|Overall Study|Incorrect enrollment|2|||
126115381|NCT00698932|453718102|FG000|Overall Study|Study specific discontinuation criteria|3|||
126115382|NCT00698932|453718103|FG001|Overall Study|Study specific discontinuation criteria|4|||
126115383|NCT00698932|453718102|FG000|Overall Study|Withdrawal by Subject|11|||
125952800|NCT02741115|453124015|FG001|Overall Study|Withdrawal by Subject|2|||
126080052|NCT01174264|453588044|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
126115384|NCT00698932|453718103|FG001|Overall Study|Withdrawal by Subject|23|||
126115385|NCT00698932|453718102|FG000|Overall Study|Lost to Follow-up|6|||
126115386|NCT00698932|453718103|FG001|Overall Study|Lost to Follow-up|1|||
126115387|NCT00698932|453718102|FG000|Overall Study|Severe non-compliance to protocol|1|||
126115388|NCT00698932|453718103|FG001|Overall Study|Severe non-compliance to protocol|2|||
126115389|NCT00698932|453718102|FG000|Overall Study|Safety reasons|0|||
126080053|NCT01174264|453588045|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
126115390|NCT00698932|453718103|FG001|Overall Study|Safety reasons|2|||
126115391|NCT00698932|453718102|FG000|Overall Study|Death|1|||
126115392|NCT00698932|453718103|FG001|Overall Study|Death|0|||
126115393|NCT01245387|453718104|FG000|Overall Study|Lost to Follow-up|106|||
126115394|NCT01245387|453718104|FG000|Overall Study|Lack of Efficacy|195|||
126080054|NCT01174264|453588046|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
126080055|NCT01174264|453588044|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
126080056|NCT01174264|453588045|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
126080057|NCT01174264|453588046|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
126080058|NCT02058836|453588048|FG000|Overall Study|Withdrawal by Subject|1|||
126080059|NCT02058836|453588049|FG001|Overall Study|Withdrawal by Subject|1|||
126080060|NCT00267098|453588050|FG000|Overall Study|Death|0|||
126080061|NCT00267098|453588051|FG001|Overall Study|Death|0|||
126080062|NCT00267098|453588052|FG002|Overall Study|Death|57|||
126080063|NCT00267098|453588053|FG003|Overall Study|Death|66|||
126080064|NCT00267098|453588054|FG004|Overall Study|Death|14|||
126080065|NCT00267098|453588055|FG005|Overall Study|Death|23|||
126080066|NCT00267098|453588056|FG006|Overall Study|Death|28|||
126080067|NCT00267098|453588057|FG007|Overall Study|Death|9|||
126080068|NCT00267098|453588050|FG000|Overall Study|Lost to Follow-up|0|||
126080069|NCT00267098|453588051|FG001|Overall Study|Lost to Follow-up|0|||
126080070|NCT00267098|453588052|FG002|Overall Study|Lost to Follow-up|6|||
126080071|NCT00267098|453588053|FG003|Overall Study|Lost to Follow-up|5|||
126080072|NCT00267098|453588054|FG004|Overall Study|Lost to Follow-up|2|||
126080073|NCT00267098|453588055|FG005|Overall Study|Lost to Follow-up|3|||
126080074|NCT00267098|453588056|FG006|Overall Study|Lost to Follow-up|1|||
126080075|NCT00267098|453588057|FG007|Overall Study|Lost to Follow-up|1|||
126080076|NCT00267098|453588050|FG000|Overall Study|Withdrawal by Subject|8|||
126080077|NCT00267098|453588051|FG001|Overall Study|Withdrawal by Subject|0|||
126080078|NCT00267098|453588052|FG002|Overall Study|Withdrawal by Subject|24|||
126080079|NCT00267098|453588053|FG003|Overall Study|Withdrawal by Subject|21|||
126080080|NCT00267098|453588054|FG004|Overall Study|Withdrawal by Subject|12|||
126080081|NCT00267098|453588055|FG005|Overall Study|Withdrawal by Subject|9|||
126080082|NCT00267098|453588056|FG006|Overall Study|Withdrawal by Subject|12|||
126080083|NCT00267098|453588057|FG007|Overall Study|Withdrawal by Subject|5|||
126080084|NCT00267098|453588050|FG000|Overall Study|Physician Decision|5|||
126080085|NCT00267098|453588051|FG001|Overall Study|Physician Decision|0|||
126080086|NCT00267098|453588052|FG002|Overall Study|Physician Decision|7|||
126080087|NCT00267098|453588053|FG003|Overall Study|Physician Decision|11|||
126080088|NCT00267098|453588054|FG004|Overall Study|Physician Decision|5|||
126080089|NCT00267098|453588055|FG005|Overall Study|Physician Decision|4|||
126080090|NCT00267098|453588056|FG006|Overall Study|Physician Decision|3|||
126080091|NCT00267098|453588057|FG007|Overall Study|Physician Decision|0|||
126080092|NCT00267098|453588050|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
126080093|NCT00267098|453588051|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126080094|NCT00267098|453588052|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126080095|NCT00267098|453588053|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126080096|NCT00267098|453588054|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
126080097|NCT00267098|453588055|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126080098|NCT00267098|453588056|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126080099|NCT00267098|453588057|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126080100|NCT00267098|453588050|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126080101|NCT00267098|453588051|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
126080102|NCT00267098|453588052|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126080103|NCT00267098|453588053|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126080104|NCT00267098|453588054|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126080105|NCT00267098|453588055|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126080106|NCT00267098|453588056|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126080107|NCT00267098|453588057|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126080108|NCT00267098|453588050|FG000|Overall Study|Site closure|0|||
126080109|NCT00267098|453588051|FG001|Overall Study|Site closure|0|||
126080110|NCT00267098|453588052|FG002|Overall Study|Site closure|0|||
126080111|NCT00267098|453588053|FG003|Overall Study|Site closure|1|||
126080112|NCT00267098|453588054|FG004|Overall Study|Site closure|0|||
126080113|NCT00267098|453588055|FG005|Overall Study|Site closure|1|||
126080114|NCT00267098|453588056|FG006|Overall Study|Site closure|1|||
126080115|NCT00267098|453588057|FG007|Overall Study|Site closure|0|||
126080116|NCT00267098|453588050|FG000|Overall Study|Explanted Medtronic device|0|||
126080117|NCT00267098|453588051|FG001|Overall Study|Explanted Medtronic device|0|||
126080118|NCT00267098|453588052|FG002|Overall Study|Explanted Medtronic device|0|||
126080119|NCT00267098|453588053|FG003|Overall Study|Explanted Medtronic device|1|||
126080120|NCT00267098|453588054|FG004|Overall Study|Explanted Medtronic device|0|||
126080121|NCT00267098|453588055|FG005|Overall Study|Explanted Medtronic device|0|||
126080122|NCT00267098|453588056|FG006|Overall Study|Explanted Medtronic device|0|||
126080123|NCT00267098|453588057|FG007|Overall Study|Explanted Medtronic device|0|||
126080124|NCT00267098|453588050|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126080125|NCT00267098|453588051|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126080126|NCT00267098|453588052|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126080127|NCT00267098|453588053|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126115395|NCT01245387|453718104|FG000|Overall Study|Adverse Event|9|||
126080128|NCT00267098|453588054|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
126080129|NCT00267098|453588055|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126080130|NCT00267098|453588056|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126080131|NCT00267098|453588057|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126080132|NCT00267098|453588050|FG000|Overall Study|Subject listed for heart transplant|0|||
126080133|NCT00267098|453588051|FG001|Overall Study|Subject listed for heart transplant|0|||
126080134|NCT00267098|453588052|FG002|Overall Study|Subject listed for heart transplant|0|||
126080135|NCT00267098|453588053|FG003|Overall Study|Subject listed for heart transplant|0|||
126080136|NCT00267098|453588054|FG004|Overall Study|Subject listed for heart transplant|0|||
126080137|NCT00267098|453588055|FG005|Overall Study|Subject listed for heart transplant|0|||
126080138|NCT00267098|453588056|FG006|Overall Study|Subject listed for heart transplant|1|||
126080139|NCT00267098|453588057|FG007|Overall Study|Subject listed for heart transplant|0|||
126080140|NCT00267098|453588050|FG000|Overall Study|Sponsor withdrew subject|0|||
126080141|NCT00267098|453588051|FG001|Overall Study|Sponsor withdrew subject|0|||
126080142|NCT00267098|453588052|FG002|Overall Study|Sponsor withdrew subject|0|||
126080143|NCT00267098|453588053|FG003|Overall Study|Sponsor withdrew subject|1|||
126080144|NCT00267098|453588054|FG004|Overall Study|Sponsor withdrew subject|0|||
126080145|NCT00267098|453588055|FG005|Overall Study|Sponsor withdrew subject|0|||
126080146|NCT00267098|453588056|FG006|Overall Study|Sponsor withdrew subject|0|||
126080147|NCT00267098|453588057|FG007|Overall Study|Sponsor withdrew subject|0|||
126080148|NCT00547534|453588058|FG000|Overall Study|Adverse Event|7|||
126080149|NCT00547534|453588058|FG000|Overall Study|Disease Progression|4|||
126080150|NCT02688530|453588060|FG000|Overall Study|Withdrawal by Subject|0|||
126080151|NCT02688530|453588061|FG001|Overall Study|Withdrawal by Subject|1|||
126080152|NCT02688530|453588062|FG002|Overall Study|Withdrawal by Subject|0|||
126080153|NCT02688530|453588063|FG003|Overall Study|Withdrawal by Subject|0|||
126080154|NCT02688530|453588060|FG000|Overall Study|Lost to Follow-up|0|||
126080155|NCT02688530|453588061|FG001|Overall Study|Lost to Follow-up|0|||
126080156|NCT02688530|453588062|FG002|Overall Study|Lost to Follow-up|2|||
126080157|NCT02688530|453588063|FG003|Overall Study|Lost to Follow-up|0|||
126080158|NCT01658020|453588064|FG000|Overall Study|Adverse Event|3|||
126080159|NCT01658020|453588065|FG001|Overall Study|Adverse Event|3|||
126080160|NCT01658020|453588064|FG000|Overall Study|Lost to Follow-up|1|||
126080161|NCT01658020|453588065|FG001|Overall Study|Lost to Follow-up|0|||
126080162|NCT01658020|453588064|FG000|Overall Study|Withdrawal by Subject|4|||
126080163|NCT01658020|453588065|FG001|Overall Study|Withdrawal by Subject|5|||
126080164|NCT01658020|453588064|FG000|Overall Study|Protocol Violation|0|||
126080165|NCT01658020|453588065|FG001|Overall Study|Protocol Violation|1|||
126080166|NCT02353871|453588066|FG000|Overall Study|Protocol deviation|0|||
126080167|NCT02353871|453588067|FG001|Overall Study|Protocol deviation|1|||
126080168|NCT02353871|453588066|FG000|Overall Study|Consent withdrawn|1|||
126080169|NCT02353871|453588067|FG001|Overall Study|Consent withdrawn|8|||
126080170|NCT02353871|453588066|FG000|Overall Study|Lost to Follow-up|2|||
126080171|NCT02353871|453588067|FG001|Overall Study|Lost to Follow-up|0|||
126080172|NCT00115336|453588068|FG000|Overall Study|Hospital discharge before study drug|0|||
126080173|NCT00115336|453588069|FG001|Overall Study|Hospital discharge before study drug|1|||
126080174|NCT04199052|453588074|FG000|Overall Study|Lost to Follow-up|11|||
126080175|NCT04199052|453588075|FG001|Overall Study|Lost to Follow-up|18|||
126080176|NCT00815919|453588076|FG000|Overall Study|Unrelated Fungal Infection|1|||
126080177|NCT00815919|453588076|FG000|Overall Study|AML Relapse|1|||
126080178|NCT00815919|453588076|FG000|Overall Study|Lack of Efficacy|2|||
126080179|NCT04599907|453588081|FG000|Overall Study|Withdrawal by Subject|1|||
126080180|NCT04599907|453588082|FG001|Overall Study|Withdrawal by Subject|7|||
126080181|NCT04599907|453588083|FG002|Overall Study|Withdrawal by Subject|6|||
126080182|NCT04599907|453588081|FG000|Overall Study|Lost to Follow-up|0|||
126080183|NCT04599907|453588082|FG001|Overall Study|Lost to Follow-up|1|||
126080184|NCT04599907|453588083|FG002|Overall Study|Lost to Follow-up|0|||
126080185|NCT01466790|453588087|FG000|Overall Study|Adverse Event|1|||
126080186|NCT01466790|453588088|FG001|Overall Study|Adverse Event|0|||
126080187|NCT01466790|453588089|FG002|Overall Study|Adverse Event|0|||
126080188|NCT01466790|453588090|FG003|Overall Study|Adverse Event|0|||
125952801|NCT01101841|453125927|FG000|Overall Study|Adverse Event|15|||
125952802|NCT01101841|453125928|FG001|Overall Study|Adverse Event|15|||
125952803|NCT01101841|453125927|FG000|Overall Study|Lost to Follow-up|9|||
125952804|NCT01101841|453125928|FG001|Overall Study|Lost to Follow-up|3|||
125952805|NCT01101841|453125927|FG000|Overall Study|Withdrawal by Subject|21|||
125952806|NCT01101841|453125928|FG001|Overall Study|Withdrawal by Subject|40|||
125952807|NCT01101841|453125927|FG000|Overall Study|Protocol Violation|1|||
125952808|NCT01101841|453125928|FG001|Overall Study|Protocol Violation|1|||
125952809|NCT01101841|453125927|FG000|Overall Study|Physician Decision|0|||
125952810|NCT01101841|453125928|FG001|Overall Study|Physician Decision|2|||
125952811|NCT01101841|453125927|FG000|Overall Study|Lack of Efficacy|0|||
125952812|NCT01101841|453125928|FG001|Overall Study|Lack of Efficacy|2|||
126080189|NCT01466790|453588091|FG004|Overall Study|Adverse Event|2|||
126080190|NCT01466790|453588092|FG005|Overall Study|Adverse Event|0|||
126080191|NCT01466790|453588093|FG006|Overall Study|Adverse Event|0|||
126115396|NCT01245387|453718104|FG000|Overall Study|Death|3|||
126080192|NCT01466790|453588094|FG007|Overall Study|Adverse Event|0|||
126080193|NCT01466790|453588087|FG000|Overall Study|Lost to Follow-up|2|||
126080194|NCT01466790|453588088|FG001|Overall Study|Lost to Follow-up|0|||
126080195|NCT01466790|453588089|FG002|Overall Study|Lost to Follow-up|0|||
126080196|NCT01466790|453588090|FG003|Overall Study|Lost to Follow-up|0|||
126080197|NCT01466790|453588091|FG004|Overall Study|Lost to Follow-up|0|||
126080198|NCT01466790|453588092|FG005|Overall Study|Lost to Follow-up|0|||
126080199|NCT01466790|453588093|FG006|Overall Study|Lost to Follow-up|0|||
126080200|NCT01466790|453588094|FG007|Overall Study|Lost to Follow-up|0|||
126080201|NCT01466790|453588087|FG000|Overall Study|Withdrawal by Subject|1|||
126080202|NCT01466790|453588088|FG001|Overall Study|Withdrawal by Subject|1|||
126080203|NCT01466790|453588089|FG002|Overall Study|Withdrawal by Subject|0|||
126080204|NCT01466790|453588090|FG003|Overall Study|Withdrawal by Subject|0|||
126080205|NCT01466790|453588091|FG004|Overall Study|Withdrawal by Subject|1|||
126080206|NCT01466790|453588092|FG005|Overall Study|Withdrawal by Subject|0|||
126080207|NCT01466790|453588093|FG006|Overall Study|Withdrawal by Subject|1|||
126080208|NCT01466790|453588094|FG007|Overall Study|Withdrawal by Subject|1|||
126080209|NCT02242643|453588095|FG000|Overall Study|Protocol Violation|1|||
126080210|NCT02242643|453588096|FG001|Overall Study|Protocol Violation|2|||
126080211|NCT02242643|453588095|FG000|Overall Study|Withdrawal by Subject|15|||
126080212|NCT02242643|453588096|FG001|Overall Study|Withdrawal by Subject|10|||
126080213|NCT02242643|453588095|FG000|Overall Study|Migrated/moved from study area|1|||
126080214|NCT02242643|453588096|FG001|Overall Study|Migrated/moved from study area|3|||
126080215|NCT02242643|453588095|FG000|Overall Study|Lost to Follow-up|54|||
126080216|NCT02242643|453588096|FG001|Overall Study|Lost to Follow-up|61|||
126080217|NCT02242643|453588095|FG000|Overall Study|Child placed in foster care by family|0|||
126080218|NCT02242643|453588096|FG001|Overall Study|Child placed in foster care by family|1|||
126080219|NCT02242643|453588095|FG000|Overall Study|Non-compliance|1|||
126080220|NCT02242643|453588096|FG001|Overall Study|Non-compliance|0|||
126080221|NCT02242643|453588095|FG000|Overall Study|Consent withdrawal by parent|1|||
126080222|NCT02242643|453588096|FG001|Overall Study|Consent withdrawal by parent|0|||
126080223|NCT02242643|453588095|FG000|Overall Study|Protocol requirements not followed|1|||
126080224|NCT02242643|453588096|FG001|Overall Study|Protocol requirements not followed|0|||
126080225|NCT02242643|453588095|FG000|Overall Study|Language barrier|1|||
126080226|NCT02242643|453588096|FG001|Overall Study|Language barrier|0|||
126080227|NCT02242643|453588095|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
126080228|NCT02242643|453588096|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
126080229|NCT01251887|453588097|FG000|Overall Study|Scheduling conflict|1|||
126080230|NCT01251887|453588098|FG001|Overall Study|Scheduling conflict|2|||
126080231|NCT01251887|453588099|FG002|Overall Study|Scheduling conflict|2|||
126080232|NCT01251887|453588097|FG000|Overall Study|Physician Decision|0|||
126080233|NCT01251887|453588098|FG001|Overall Study|Physician Decision|1|||
126080234|NCT01251887|453588099|FG002|Overall Study|Physician Decision|0|||
126080235|NCT02633397|453588100|FG000|Overall Study|Adverse Event|8|||
126080236|NCT02633397|453588101|FG001|Overall Study|Adverse Event|8|||
126080237|NCT02633397|453588100|FG000|Overall Study|Study Burden|4|||
126080238|NCT02633397|453588101|FG001|Overall Study|Study Burden|1|||
126080239|NCT02633397|453588100|FG000|Overall Study|Treatment interruption|2|||
126080240|NCT02633397|453588101|FG001|Overall Study|Treatment interruption|5|||
126080241|NCT02633397|453588100|FG000|Overall Study|Death|2|||
126080242|NCT02633397|453588101|FG001|Overall Study|Death|2|||
126080243|NCT02633397|453588100|FG000|Overall Study|Physician Decision|0|||
126080244|NCT02633397|453588101|FG001|Overall Study|Physician Decision|1|||
126080245|NCT03595878|453588102|FG000|Overall Study|Death|2|||
126080246|NCT03595878|453588103|FG001|Overall Study|Death|1|||
126080247|NCT03595878|453588104|FG002|Overall Study|Death|0|||
126080248|NCT03595878|453588102|FG000|Overall Study|Disease progression|2|||
126080249|NCT03595878|453588103|FG001|Overall Study|Disease progression|1|||
126080250|NCT03595878|453588104|FG002|Overall Study|Disease progression|2|||
126080251|NCT03668223|453588105|FG000|Overall Study|Death|10|||
126080252|NCT03668223|453588106|FG001|Overall Study|Death|5|||
126080253|NCT03668223|453588105|FG000|Overall Study|Lost to Follow-up|12|||
126080254|NCT03668223|453588106|FG001|Overall Study|Lost to Follow-up|12|||
126080255|NCT03668223|453588105|FG000|Overall Study|Withdrawal by Subject|8|||
126080256|NCT03668223|453588106|FG001|Overall Study|Withdrawal by Subject|3|||
126080257|NCT01103232|453588107|FG000|Overall Study|Withdrawal by Subject|1|||
126080258|NCT01103232|453588108|FG001|Overall Study|Withdrawal by Subject|1|||
126080259|NCT01103232|453588107|FG000|Overall Study|Protocol Violation|0|||
126080260|NCT01103232|453588108|FG001|Overall Study|Protocol Violation|1|||
126080261|NCT05093504|453588109|FG000|Overall Study|Death|0|||
126080262|NCT05093504|453588110|FG001|Overall Study|Death|1|||
126080263|NCT02394925|453588111|FG000|Overall Study|Adverse Event|1|||
126080264|NCT02394925|453588111|FG000|Overall Study|Lens Discomfort|3|||
126080265|NCT02394925|453588111|FG000|Overall Study|Lens handling difficulities|5|||
126080266|NCT02394925|453588111|FG000|Overall Study|Lost to Follow-up|9|||
126080267|NCT02394925|453588111|FG000|Overall Study|Protocol Violation|5|||
126080268|NCT02394925|453588111|FG000|Overall Study|No longer meet eligibility criteria|1|||
126080269|NCT02394925|453588111|FG000|Overall Study|Unsatisfactory Visual Response|5|||
126080270|NCT05347485|453588117|FG000|Overall Study|Death|14|||
126080271|NCT05347485|453588117|FG000|Overall Study|Lost to Follow-up|2|||
126080272|NCT05347485|453588117|FG000|Overall Study|Withdrawal by Subject|13|||
126080273|NCT05347485|453588117|FG000|Overall Study|Progressive Disease|1|||
126080274|NCT05347485|453588117|FG000|Overall Study|Study Terminated by Sponsor|49|||
126080275|NCT05347485|453588117|FG000|Overall Study|Other|1|||
126080276|NCT05347485|453588117|FG000|Overall Study|Enrolled (consented) but not treated|4|||
126080277|NCT05347485|453588117|FG000|Overall Study|Disease Relapse|2|||
126080278|NCT04886518|453588118|FG000|Overall Study|Noncompliance with study drug|1|||
126080279|NCT04886518|453588119|FG001|Overall Study|Noncompliance with study drug|0|||
126080280|NCT04886518|453588120|FG002|Overall Study|Noncompliance with study drug|0|||
126080281|NCT04886518|453588118|FG000|Overall Study|Adverse Event|0|||
126080282|NCT04886518|453588119|FG001|Overall Study|Adverse Event|1|||
126080283|NCT04886518|453588120|FG002|Overall Study|Adverse Event|0|||
126080284|NCT04886518|453588118|FG000|Overall Study|Withdrawal by Subject|1|||
126080285|NCT04886518|453588119|FG001|Overall Study|Withdrawal by Subject|0|||
126080286|NCT04886518|453588120|FG002|Overall Study|Withdrawal by Subject|0|||
126080287|NCT03733899|453588121|FG000|Period 1|Protocol Violation|0|||
126080288|NCT03733899|453588122|FG001|Period 1|Protocol Violation|0|||
126080289|NCT03733899|453588123|FG002|Period 1|Protocol Violation|0|||
126080290|NCT03733899|453588124|FG003|Period 1|Protocol Violation|0|||
126080291|NCT03733899|453588125|FG004|Period 1|Protocol Violation|0|||
126080292|NCT03733899|453588126|FG005|Period 1|Protocol Violation|1|||
126080293|NCT03733899|453588121|FG000|Period 2|Unscuccessful Treatment|0|||
126080294|NCT03733899|453588122|FG001|Period 2|Unscuccessful Treatment|1|||
126080295|NCT03733899|453588123|FG002|Period 2|Unscuccessful Treatment|0|||
126080296|NCT03733899|453588124|FG003|Period 2|Unscuccessful Treatment|0|||
126080297|NCT03733899|453588125|FG004|Period 2|Unscuccessful Treatment|0|||
126080298|NCT03733899|453588126|FG005|Period 2|Unscuccessful Treatment|0|||
126080299|NCT03733899|453588121|FG000|Period 3|Withdrawal by Subject|1|||
126080300|NCT03733899|453588122|FG001|Period 3|Withdrawal by Subject|0|||
126080301|NCT03733899|453588123|FG002|Period 3|Withdrawal by Subject|0|||
126080302|NCT03733899|453588124|FG003|Period 3|Withdrawal by Subject|0|||
126080303|NCT03733899|453588125|FG004|Period 3|Withdrawal by Subject|0|||
126080304|NCT03733899|453588126|FG005|Period 3|Withdrawal by Subject|0|||
126080305|NCT04650698|453590043|FG000|Overall Study|Protocol Violation|2|||
126080306|NCT04650698|453590044|FG001|Overall Study|Protocol Violation|1|||
126080307|NCT04650698|453590043|FG000|Overall Study|Withdrawal by Subject|0|||
126080308|NCT04650698|453590044|FG001|Overall Study|Withdrawal by Subject|1|||
126080309|NCT01090011|453590045|FG000|Overall Study|Progressive disease|128|||
126080310|NCT01090011|453590045|FG000|Overall Study|Adverse Event|32|||
126080311|NCT01090011|453590045|FG000|Overall Study|Protocol Violation|1|||
126080312|NCT01090011|453590045|FG000|Overall Study|Refusal to start/continue medication|5|||
126080313|NCT01090011|453590045|FG000|Overall Study|Other reason not defined above|5|||
126080314|NCT00307047|453590046|FG000|Overall Study|Lost to Follow-up|35|||
126080315|NCT00307047|453590047|FG001|Overall Study|Lost to Follow-up|24|||
126080316|NCT00307047|453590046|FG000|Overall Study|Withdrawal by Subject|6|||
126080317|NCT00307047|453590047|FG001|Overall Study|Withdrawal by Subject|6|||
126080318|NCT00307047|453590046|FG000|Overall Study|Physician Decision|1|||
126080319|NCT00307047|453590047|FG001|Overall Study|Physician Decision|2|||
126080320|NCT00307047|453590046|FG000|Overall Study|Lost to follow-up for other reasons|0|||
126080321|NCT00307047|453590047|FG001|Overall Study|Lost to follow-up for other reasons|1|||
126080322|NCT00307047|453590046|FG000|Overall Study|All death, all MI, all Revascularization|27|||
126080323|NCT00307047|453590047|FG001|Overall Study|All death, all MI, all Revascularization|16|||
126080324|NCT00379769|453590048|FG000|Main Study|Death|57|||
126080325|NCT00379769|453590049|FG001|Main Study|Death|67|||
126080326|NCT00379769|453590050|FG002|Main Study|Death|54|||
126080327|NCT00379769|453590051|FG003|Main Study|Death|72|||
126080328|NCT00379769|453590052|FG004|Main Study|Death|0|||
126080329|NCT00379769|453590053|FG005|Main Study|Death|0|||
126080330|NCT00379769|453590048|FG000|Main Study|Adverse Event|5|||
126080331|NCT00379769|453590049|FG001|Main Study|Adverse Event|8|||
126080332|NCT00379769|453590050|FG002|Main Study|Adverse Event|10|||
126080333|NCT00379769|453590051|FG003|Main Study|Adverse Event|11|||
126080334|NCT00379769|453590052|FG004|Main Study|Adverse Event|0|||
126080335|NCT00379769|453590053|FG005|Main Study|Adverse Event|0|||
126080336|NCT00379769|453590048|FG000|Main Study|Lost to Follow-up|29|||
126080337|NCT00379769|453590049|FG001|Main Study|Lost to Follow-up|29|||
126080338|NCT00379769|453590050|FG002|Main Study|Lost to Follow-up|25|||
126080339|NCT00379769|453590051|FG003|Main Study|Lost to Follow-up|26|||
126080340|NCT00379769|453590052|FG004|Main Study|Lost to Follow-up|0|||
126080341|NCT00379769|453590053|FG005|Main Study|Lost to Follow-up|0|||
126080342|NCT00379769|453590048|FG000|Main Study|Withdrawal by Subject|46|||
126080343|NCT00379769|453590049|FG001|Main Study|Withdrawal by Subject|56|||
126080344|NCT00379769|453590050|FG002|Main Study|Withdrawal by Subject|72|||
126080345|NCT00379769|453590051|FG003|Main Study|Withdrawal by Subject|70|||
126080346|NCT00379769|453590052|FG004|Main Study|Withdrawal by Subject|0|||
126080347|NCT00379769|453590053|FG005|Main Study|Withdrawal by Subject|0|||
126080348|NCT00379769|453590048|FG000|Main Study|Moved to survival status follow-up only|27|||
126080349|NCT00379769|453590049|FG001|Main Study|Moved to survival status follow-up only|25|||
126115397|NCT01245387|453718104|FG000|Overall Study|Other|131|||
126080350|NCT00379769|453590050|FG002|Main Study|Moved to survival status follow-up only|32|||
126080351|NCT00379769|453590051|FG003|Main Study|Moved to survival status follow-up only|36|||
126080352|NCT00379769|453590052|FG004|Main Study|Moved to survival status follow-up only|0|||
126080353|NCT00379769|453590053|FG005|Main Study|Moved to survival status follow-up only|0|||
126080354|NCT00379769|453590048|FG000|Main Study|Participant moved|3|||
126080355|NCT00379769|453590049|FG001|Main Study|Participant moved|2|||
126080356|NCT00379769|453590050|FG002|Main Study|Participant moved|3|||
126080357|NCT00379769|453590051|FG003|Main Study|Participant moved|3|||
126080358|NCT00379769|453590052|FG004|Main Study|Participant moved|0|||
126080359|NCT00379769|453590053|FG005|Main Study|Participant moved|0|||
126080360|NCT00379769|453590048|FG000|Main Study|Poor compliance|3|||
126080361|NCT00379769|453590049|FG001|Main Study|Poor compliance|2|||
126080362|NCT00379769|453590050|FG002|Main Study|Poor compliance|2|||
126080363|NCT00379769|453590051|FG003|Main Study|Poor compliance|1|||
126080364|NCT00379769|453590052|FG004|Main Study|Poor compliance|0|||
126080365|NCT00379769|453590053|FG005|Main Study|Poor compliance|0|||
126080366|NCT00379769|453590048|FG000|Main Study|Prohibited glucose lowering medication|0|||
126080367|NCT00379769|453590049|FG001|Main Study|Prohibited glucose lowering medication|3|||
126080368|NCT00379769|453590050|FG002|Main Study|Prohibited glucose lowering medication|0|||
126080369|NCT00379769|453590051|FG003|Main Study|Prohibited glucose lowering medication|1|||
126080370|NCT00379769|453590052|FG004|Main Study|Prohibited glucose lowering medication|0|||
126080371|NCT00379769|453590053|FG005|Main Study|Prohibited glucose lowering medication|0|||
126080372|NCT00379769|453590048|FG000|Main Study|Site closed|4|||
126080373|NCT00379769|453590049|FG001|Main Study|Site closed|4|||
126080374|NCT00379769|453590050|FG002|Main Study|Site closed|4|||
126080375|NCT00379769|453590051|FG003|Main Study|Site closed|8|||
126080376|NCT00379769|453590052|FG004|Main Study|Site closed|0|||
126080377|NCT00379769|453590053|FG005|Main Study|Site closed|0|||
126080378|NCT00379769|453590048|FG000|Main Study|Entry criteria violation|0|||
126080379|NCT00379769|453590049|FG001|Main Study|Entry criteria violation|0|||
126080380|NCT00379769|453590050|FG002|Main Study|Entry criteria violation|1|||
126080381|NCT00379769|453590051|FG003|Main Study|Entry criteria violation|1|||
126080382|NCT00379769|453590052|FG004|Main Study|Entry criteria violation|0|||
126080383|NCT00379769|453590053|FG005|Main Study|Entry criteria violation|0|||
126080384|NCT00379769|453590048|FG000|Main Study|Participant did not take study drug|0|||
126080385|NCT00379769|453590049|FG001|Main Study|Participant did not take study drug|0|||
126080386|NCT00379769|453590050|FG002|Main Study|Participant did not take study drug|1|||
126080387|NCT00379769|453590051|FG003|Main Study|Participant did not take study drug|0|||
126080388|NCT00379769|453590052|FG004|Main Study|Participant did not take study drug|0|||
126080389|NCT00379769|453590053|FG005|Main Study|Participant did not take study drug|0|||
126080390|NCT00379769|453590048|FG000|Main Study|Physician Decision|2|||
126080391|NCT00379769|453590049|FG001|Main Study|Physician Decision|2|||
126080392|NCT00379769|453590050|FG002|Main Study|Physician Decision|1|||
126080393|NCT00379769|453590051|FG003|Main Study|Physician Decision|1|||
126080394|NCT00379769|453590052|FG004|Main Study|Physician Decision|0|||
126080395|NCT00379769|453590053|FG005|Main Study|Physician Decision|0|||
126080396|NCT00379769|453590048|FG000|Main Study|Participant completed study at visit 27|1|||
126080397|NCT00379769|453590049|FG001|Main Study|Participant completed study at visit 27|0|||
126080398|NCT00379769|453590050|FG002|Main Study|Participant completed study at visit 27|0|||
126080399|NCT00379769|453590051|FG003|Main Study|Participant completed study at visit 27|0|||
126080400|NCT00379769|453590052|FG004|Main Study|Participant completed study at visit 27|0|||
126080401|NCT00379769|453590053|FG005|Main Study|Participant completed study at visit 27|0|||
126080402|NCT00379769|453590048|FG000|Main Study|Personal reasons|1|||
126080403|NCT00379769|453590049|FG001|Main Study|Personal reasons|0|||
126080404|NCT00379769|453590050|FG002|Main Study|Personal reasons|0|||
126080405|NCT00379769|453590051|FG003|Main Study|Personal reasons|0|||
126080406|NCT00379769|453590052|FG004|Main Study|Personal reasons|0|||
126080407|NCT00379769|453590053|FG005|Main Study|Personal reasons|0|||
126080408|NCT00379769|453590048|FG000|Main Study|Risk of heart failure|0|||
126080409|NCT00379769|453590049|FG001|Main Study|Risk of heart failure|1|||
126080410|NCT00379769|453590050|FG002|Main Study|Risk of heart failure|0|||
126080411|NCT00379769|453590051|FG003|Main Study|Risk of heart failure|0|||
126080412|NCT00379769|453590052|FG004|Main Study|Risk of heart failure|0|||
126080413|NCT00379769|453590053|FG005|Main Study|Risk of heart failure|0|||
126080414|NCT00379769|453590048|FG000|Main Study|Investigator refused to log temperature|0|||
126080415|NCT00379769|453590049|FG001|Main Study|Investigator refused to log temperature|0|||
126080416|NCT00379769|453590050|FG002|Main Study|Investigator refused to log temperature|1|||
126080417|NCT00379769|453590051|FG003|Main Study|Investigator refused to log temperature|0|||
126080418|NCT00379769|453590052|FG004|Main Study|Investigator refused to log temperature|0|||
125952813|NCT01101841|453125927|FG000|Overall Study|Other|0|||
125952814|NCT01101841|453125928|FG001|Overall Study|Other|1|||
125952815|NCT01101841|453125927|FG000|Overall Study|Suicidality Tracking Scale|3|||
126080419|NCT00379769|453590053|FG005|Main Study|Investigator refused to log temperature|0|||
126080420|NCT00379769|453590048|FG000|Main Study|Reason unspecified|0|||
126080421|NCT00379769|453590049|FG001|Main Study|Reason unspecified|0|||
126080422|NCT00379769|453590050|FG002|Main Study|Reason unspecified|1|||
126080423|NCT00379769|453590051|FG003|Main Study|Reason unspecified|0|||
126080424|NCT00379769|453590052|FG004|Main Study|Reason unspecified|0|||
126080425|NCT00379769|453590053|FG005|Main Study|Reason unspecified|0|||
126080426|NCT00379769|453590048|FG000|Observational Follow-up|Death|0|||
126080427|NCT00379769|453590049|FG001|Observational Follow-up|Death|0|||
126080428|NCT00379769|453590050|FG002|Observational Follow-up|Death|0|||
126080429|NCT00379769|453590051|FG003|Observational Follow-up|Death|0|||
126080430|NCT00379769|453590052|FG004|Observational Follow-up|Death|78|||
126080431|NCT00379769|453590053|FG005|Observational Follow-up|Death|70|||
126080432|NCT00379769|453590048|FG000|Observational Follow-up|Adverse Event|0|||
126080433|NCT00379769|453590049|FG001|Observational Follow-up|Adverse Event|0|||
126080434|NCT00379769|453590050|FG002|Observational Follow-up|Adverse Event|0|||
126080435|NCT00379769|453590051|FG003|Observational Follow-up|Adverse Event|0|||
126080436|NCT00379769|453590052|FG004|Observational Follow-up|Adverse Event|1|||
126080437|NCT00379769|453590053|FG005|Observational Follow-up|Adverse Event|0|||
126080438|NCT00379769|453590048|FG000|Observational Follow-up|Lost to Follow-up|0|||
126080439|NCT00379769|453590049|FG001|Observational Follow-up|Lost to Follow-up|0|||
126080440|NCT00379769|453590050|FG002|Observational Follow-up|Lost to Follow-up|0|||
126080441|NCT00379769|453590051|FG003|Observational Follow-up|Lost to Follow-up|0|||
126080442|NCT00379769|453590052|FG004|Observational Follow-up|Lost to Follow-up|25|||
126080443|NCT00379769|453590053|FG005|Observational Follow-up|Lost to Follow-up|27|||
126080444|NCT00379769|453590048|FG000|Observational Follow-up|Withdrawal by Subject|0|||
126080445|NCT00379769|453590049|FG001|Observational Follow-up|Withdrawal by Subject|0|||
126080446|NCT00379769|453590050|FG002|Observational Follow-up|Withdrawal by Subject|0|||
126080447|NCT00379769|453590051|FG003|Observational Follow-up|Withdrawal by Subject|0|||
126080448|NCT00379769|453590052|FG004|Observational Follow-up|Withdrawal by Subject|12|||
126080449|NCT00379769|453590053|FG005|Observational Follow-up|Withdrawal by Subject|12|||
126080450|NCT00379769|453590048|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
126080451|NCT00379769|453590049|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
126080452|NCT00379769|453590050|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
126080453|NCT00379769|453590051|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
126080454|NCT00379769|453590052|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
126080455|NCT00379769|453590053|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
126080456|NCT00379769|453590048|FG000|Observational Follow-up|Physician Decision|0|||
126080457|NCT00379769|453590049|FG001|Observational Follow-up|Physician Decision|0|||
126080458|NCT00379769|453590050|FG002|Observational Follow-up|Physician Decision|0|||
126080459|NCT00379769|453590051|FG003|Observational Follow-up|Physician Decision|0|||
126080460|NCT00379769|453590052|FG004|Observational Follow-up|Physician Decision|8|||
126080461|NCT00379769|453590053|FG005|Observational Follow-up|Physician Decision|8|||
126080462|NCT00379769|453590048|FG000|Observational Follow-up|Site Closed Early|0|||
126080463|NCT00379769|453590049|FG001|Observational Follow-up|Site Closed Early|0|||
126080464|NCT00379769|453590050|FG002|Observational Follow-up|Site Closed Early|0|||
126080465|NCT00379769|453590051|FG003|Observational Follow-up|Site Closed Early|0|||
126080466|NCT00379769|453590052|FG004|Observational Follow-up|Site Closed Early|6|||
126080467|NCT00379769|453590053|FG005|Observational Follow-up|Site Closed Early|7|||
126080468|NCT00379769|453590048|FG000|Observational Follow-up|Participant Moved|0|||
126080469|NCT00379769|453590049|FG001|Observational Follow-up|Participant Moved|0|||
126080470|NCT00379769|453590050|FG002|Observational Follow-up|Participant Moved|0|||
126080471|NCT00379769|453590051|FG003|Observational Follow-up|Participant Moved|0|||
126080472|NCT00379769|453590052|FG004|Observational Follow-up|Participant Moved|0|||
126080473|NCT00379769|453590053|FG005|Observational Follow-up|Participant Moved|1|||
126080474|NCT00379769|453590048|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
126080475|NCT00379769|453590049|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
126080476|NCT00379769|453590050|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
126080477|NCT00379769|453590051|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
126080478|NCT00379769|453590052|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
126080479|NCT00379769|453590053|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
126080480|NCT03778294|453590054|FG000|Overall Study|Death|1|||
126080481|NCT03778294|453590054|FG000|Overall Study|Issues with insurance|1|||
126080482|NCT03778294|453590054|FG000|Overall Study|disease progression before treatment|2|||
126080483|NCT02666664|453590057|FG000|Overall Study|Physician Decision|0|||
125952816|NCT01101841|453125928|FG001|Overall Study|Suicidality Tracking Scale|1|||
125952817|NCT01101841|453125927|FG000|Overall Study|Eligibility Criteria|1|||
126080484|NCT02666664|453590058|FG001|Overall Study|Physician Decision|1|||
126080485|NCT02666664|453590057|FG000|Overall Study|Protocol Violation|0|||
126080486|NCT02666664|453590058|FG001|Overall Study|Protocol Violation|2|||
126080487|NCT02666664|453590057|FG000|Overall Study|Other|0|||
126080488|NCT02666664|453590058|FG001|Overall Study|Other|1|||
126080489|NCT02666664|453590057|FG000|Overall Study|Adverse Event|12|||
126080490|NCT02666664|453590058|FG001|Overall Study|Adverse Event|37|||
126080491|NCT02666664|453590057|FG000|Overall Study|Withdrawal by participant|23|||
126080492|NCT02666664|453590058|FG001|Overall Study|Withdrawal by participant|40|||
126080493|NCT02666664|453590057|FG000|Overall Study|Sponsor decision|0|||
126115398|NCT01245387|453718104|FG000|Overall Study|Missing discontinuation status|369|||
125952818|NCT01101841|453125928|FG001|Overall Study|Eligibility Criteria|2|||
125952819|NCT03633396|453125931|FG000|Overall Study|Withdrawal by Subject|4|||
125952820|NCT03633396|453125932|FG001|Overall Study|Withdrawal by Subject|4|||
125952821|NCT03633396|453125931|FG000|Overall Study|Adverse Event|1|||
125952822|NCT03633396|453125932|FG001|Overall Study|Adverse Event|1|||
125952823|NCT03633396|453125931|FG000|Overall Study|Lack of Efficacy|1|||
125952824|NCT03633396|453125932|FG001|Overall Study|Lack of Efficacy|0|||
125952825|NCT03633396|453125931|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
125952826|NCT03633396|453125932|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
125952827|NCT01012817|453125933|FG000|Overall Study|Withdrawal by Subject|0|||
125952828|NCT01012817|453125934|FG001|Overall Study|Withdrawal by Subject|0|||
125952829|NCT01012817|453125935|FG002|Overall Study|Withdrawal by Subject|0|||
125952830|NCT01012817|453125936|FG003|Overall Study|Withdrawal by Subject|1|||
125952831|NCT01012817|453125937|FG004|Overall Study|Withdrawal by Subject|0|||
125952832|NCT01012817|453125938|FG005|Overall Study|Withdrawal by Subject|0|||
125952833|NCT01012817|453125939|FG006|Overall Study|Withdrawal by Subject|0|||
125952834|NCT01012817|453125940|FG007|Overall Study|Withdrawal by Subject|1|||
125952835|NCT01012817|453125941|FG008|Overall Study|Withdrawal by Subject|0|||
125952836|NCT01012817|453125942|FG009|Overall Study|Withdrawal by Subject|0|||
125952837|NCT01012817|453125943|FG010|Overall Study|Withdrawal by Subject|1|||
125952838|NCT01012817|453125944|FG011|Overall Study|Withdrawal by Subject|1|||
125952839|NCT01012817|453125945|FG012|Overall Study|Withdrawal by Subject|0|||
125952840|NCT01012817|453125946|FG013|Overall Study|Withdrawal by Subject|1|||
125952841|NCT01012817|453125933|FG000|Overall Study|Adverse Event|0|||
125952842|NCT01012817|453125934|FG001|Overall Study|Adverse Event|0|||
125952843|NCT01012817|453125935|FG002|Overall Study|Adverse Event|0|||
125952844|NCT01012817|453125936|FG003|Overall Study|Adverse Event|0|||
125952845|NCT01012817|453125937|FG004|Overall Study|Adverse Event|0|||
125952846|NCT01012817|453125938|FG005|Overall Study|Adverse Event|1|||
125952847|NCT01012817|453125939|FG006|Overall Study|Adverse Event|0|||
125952848|NCT01012817|453125940|FG007|Overall Study|Adverse Event|0|||
125952849|NCT01012817|453125941|FG008|Overall Study|Adverse Event|0|||
125952850|NCT01012817|453125942|FG009|Overall Study|Adverse Event|0|||
125952851|NCT01012817|453125943|FG010|Overall Study|Adverse Event|1|||
125952852|NCT01012817|453125944|FG011|Overall Study|Adverse Event|0|||
125952853|NCT01012817|453125945|FG012|Overall Study|Adverse Event|0|||
125952854|NCT01012817|453125946|FG013|Overall Study|Adverse Event|1|||
125952855|NCT03756558|453125947|FG000|Overall Study|Death|1|||
125952856|NCT03756558|453125947|FG000|Overall Study|Lost to Follow-up|2|||
125952857|NCT03756558|453125947|FG000|Overall Study|Withdrawal by Subject|2|||
125952858|NCT01433263|453125954|FG000|Overall Study|Adverse Event|3|||
125952859|NCT01433263|453125955|FG001|Overall Study|Adverse Event|1|||
125952860|NCT01433263|453125954|FG000|Overall Study|Death|5|||
125952861|NCT01433263|453125955|FG001|Overall Study|Death|3|||
125952862|NCT01433263|453125954|FG000|Overall Study|Lost to Follow-up|0|||
125952863|NCT01433263|453125955|FG001|Overall Study|Lost to Follow-up|1|||
125952864|NCT01433263|453125954|FG000|Overall Study|Protocol Deviation|1|||
125952865|NCT01433263|453125955|FG001|Overall Study|Protocol Deviation|0|||
125952866|NCT01433263|453125954|FG000|Overall Study|Withdrawal by Subject|10|||
125952867|NCT01433263|453125955|FG001|Overall Study|Withdrawal by Subject|7|||
125952868|NCT03107988|453125956|FG000|Overall Study|Adverse Event|0|||
125952869|NCT03107988|453125957|FG001|Overall Study|Adverse Event|0|||
125952870|NCT03107988|453125958|FG002|Overall Study|Adverse Event|0|||
125952871|NCT03107988|453125959|FG003|Overall Study|Adverse Event|1|||
125952872|NCT03107988|453125960|FG004|Overall Study|Adverse Event|0|||
125952873|NCT03107988|453125961|FG005|Overall Study|Adverse Event|1|||
125952874|NCT03107988|453125962|FG006|Overall Study|Adverse Event|0|||
125952875|NCT03107988|453125963|FG007|Overall Study|Adverse Event|1|||
125952876|NCT03107988|453125964|FG008|Overall Study|Adverse Event|0|||
125952877|NCT03107988|453125965|FG009|Overall Study|Adverse Event|0|||
125952878|NCT03107988|453125966|FG010|Overall Study|Adverse Event|0|||
125952879|NCT03107988|453125967|FG011|Overall Study|Adverse Event|0|||
125952880|NCT03107988|453125968|FG012|Overall Study|Adverse Event|0|||
125952881|NCT03107988|453125956|FG000|Overall Study|Disease Progression or Relapse|1|||
125952882|NCT03107988|453125957|FG001|Overall Study|Disease Progression or Relapse|2|||
125952883|NCT03107988|453125958|FG002|Overall Study|Disease Progression or Relapse|2|||
125952884|NCT03107988|453125959|FG003|Overall Study|Disease Progression or Relapse|5|||
125952885|NCT03107988|453125960|FG004|Overall Study|Disease Progression or Relapse|1|||
125952886|NCT03107988|453125961|FG005|Overall Study|Disease Progression or Relapse|1|||
125952887|NCT03107988|453125962|FG006|Overall Study|Disease Progression or Relapse|0|||
125952888|NCT03107988|453125963|FG007|Overall Study|Disease Progression or Relapse|0|||
125952889|NCT03107988|453125964|FG008|Overall Study|Disease Progression or Relapse|0|||
125952890|NCT03107988|453125965|FG009|Overall Study|Disease Progression or Relapse|1|||
125952891|NCT03107988|453125966|FG010|Overall Study|Disease Progression or Relapse|4|||
125952892|NCT03107988|453125967|FG011|Overall Study|Disease Progression or Relapse|0|||
125952893|NCT03107988|453125968|FG012|Overall Study|Disease Progression or Relapse|0|||
125952894|NCT03107988|453125956|FG000|Overall Study|Ineligible|0|||
125952895|NCT03107988|453125957|FG001|Overall Study|Ineligible|0|||
125952896|NCT03107988|453125958|FG002|Overall Study|Ineligible|0|||
125952897|NCT03107988|453125959|FG003|Overall Study|Ineligible|0|||
125952898|NCT03107988|453125960|FG004|Overall Study|Ineligible|0|||
125952899|NCT03107988|453125961|FG005|Overall Study|Ineligible|0|||
125952900|NCT03107988|453125962|FG006|Overall Study|Ineligible|0|||
125952901|NCT03107988|453125963|FG007|Overall Study|Ineligible|0|||
125952902|NCT03107988|453125964|FG008|Overall Study|Ineligible|1|||
125952903|NCT03107988|453125965|FG009|Overall Study|Ineligible|0|||
125952904|NCT03107988|453125966|FG010|Overall Study|Ineligible|0|||
125952905|NCT03107988|453125967|FG011|Overall Study|Ineligible|0|||
125952906|NCT03107988|453125968|FG012|Overall Study|Ineligible|0|||
125952907|NCT02489318|453125969|FG000|Randomized|Withdrawal by Subject|0|||
125952908|NCT02489318|453125970|FG001|Randomized|Withdrawal by Subject|1|||
125952909|NCT02489318|453125969|FG000|Treated|Adverse Event|19|||
125952910|NCT02489318|453125970|FG001|Treated|Adverse Event|62|||
125952911|NCT02489318|453125969|FG000|Treated|Death|13|||
125952912|NCT02489318|453125970|FG001|Treated|Death|11|||
125952913|NCT02489318|453125969|FG000|Treated|Physician Decision|4|||
125952914|NCT02489318|453125970|FG001|Treated|Physician Decision|6|||
125952915|NCT02489318|453125969|FG000|Treated|Protocol Violation|1|||
125952916|NCT02489318|453125970|FG001|Treated|Protocol Violation|2|||
125952917|NCT02489318|453125969|FG000|Treated|Withdrawal by Subject|37|||
125952918|NCT02489318|453125970|FG001|Treated|Withdrawal by Subject|36|||
125952919|NCT02489318|453125969|FG000|Treated|Other: Progressive Disease|245|||
125952920|NCT02489318|453125970|FG001|Treated|Other: Progressive Disease|138|||
125952921|NCT02489318|453125969|FG000|Treated|Other|0|||
125952922|NCT02489318|453125970|FG001|Treated|Other|2|||
125952923|NCT02489318|453125969|FG000|Treated|Ongoing|0|||
125952924|NCT02489318|453125970|FG001|Treated|Ongoing|267|||
125952925|NCT05723770|453125971|FG000|Overall Study|Lost to Follow-up|4|||
125952926|NCT05723770|453125971|FG000|Overall Study|Withdrawal by Subject|2|||
125952927|NCT01171898|453125972|FG000|Overall Study|Death|0|||
125952928|NCT01171898|453125973|FG001|Overall Study|Death|0|||
125952929|NCT01171898|453125974|FG002|Overall Study|Death|2|||
125952930|NCT01171898|453125975|FG003|Overall Study|Death|0|||
125952931|NCT01171898|453125972|FG000|Overall Study|Lost to Follow-up|0|||
125952932|NCT01171898|453125973|FG001|Overall Study|Lost to Follow-up|1|||
125952933|NCT01171898|453125974|FG002|Overall Study|Lost to Follow-up|1|||
125952934|NCT01171898|453125975|FG003|Overall Study|Lost to Follow-up|1|||
125952935|NCT01171898|453125972|FG000|Overall Study|Withdrawal by Subject|1|||
125952936|NCT01171898|453125973|FG001|Overall Study|Withdrawal by Subject|4|||
125952937|NCT01171898|453125974|FG002|Overall Study|Withdrawal by Subject|6|||
125952938|NCT01171898|453125975|FG003|Overall Study|Withdrawal by Subject|3|||
125952939|NCT01171898|453125972|FG000|Overall Study|Terminated by Sponsor|1|||
125952940|NCT01171898|453125973|FG001|Overall Study|Terminated by Sponsor|0|||
125952941|NCT01171898|453125974|FG002|Overall Study|Terminated by Sponsor|0|||
125952942|NCT01171898|453125975|FG003|Overall Study|Terminated by Sponsor|0|||
125952943|NCT01171898|453125972|FG000|Overall Study|Ongoing|1|||
125952944|NCT01171898|453125973|FG001|Overall Study|Ongoing|9|||
125952945|NCT01171898|453125974|FG002|Overall Study|Ongoing|3|||
125952946|NCT01171898|453125975|FG003|Overall Study|Ongoing|0|||
125952947|NCT01171898|453125972|FG000|Overall Study|Other|1|||
125952948|NCT01171898|453125973|FG001|Overall Study|Other|5|||
125952949|NCT01171898|453125974|FG002|Overall Study|Other|0|||
125952950|NCT01171898|453125975|FG003|Overall Study|Other|2|||
125952951|NCT01359592|453125976|FG000|Initial Registration|Adverse Event|1|||
125952952|NCT01359592|453125977|FG001|Initial Registration|Adverse Event|0|||
125952953|NCT01359592|453125978|FG002|Initial Registration|Adverse Event|0|||
125952954|NCT01359592|453125979|FG003|Initial Registration|Adverse Event|0|||
125952955|NCT01359592|453125976|FG000|Initial Registration|Death|1|||
125952956|NCT01359592|453125977|FG001|Initial Registration|Death|0|||
125952957|NCT01359592|453125978|FG002|Initial Registration|Death|0|||
125952958|NCT01359592|453125979|FG003|Initial Registration|Death|0|||
125952959|NCT01359592|453125976|FG000|Initial Registration|Other reason not protocol specified|1|||
125952960|NCT01359592|453125977|FG001|Initial Registration|Other reason not protocol specified|0|||
125952961|NCT01359592|453125978|FG002|Initial Registration|Other reason not protocol specified|0|||
125952962|NCT01359592|453125979|FG003|Initial Registration|Other reason not protocol specified|0|||
125952963|NCT01359592|453125976|FG000|Initial Registration|Ineligible|26|||
125952964|NCT01359592|453125977|FG001|Initial Registration|Ineligible|0|||
125952965|NCT01359592|453125978|FG002|Initial Registration|Ineligible|0|||
125952966|NCT01359592|453125979|FG003|Initial Registration|Ineligible|0|||
125952967|NCT01359592|453125976|FG000|PET-Directed Therapy|Adverse Event|0|||
125952968|NCT01359592|453125977|FG001|PET-Directed Therapy|Adverse Event|0|||
125952969|NCT01359592|453125978|FG002|PET-Directed Therapy|Adverse Event|1|||
125952970|NCT01359592|453125979|FG003|PET-Directed Therapy|Adverse Event|0|||
125952971|NCT01359592|453125976|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
125952972|NCT01359592|453125977|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
125952973|NCT01359592|453125978|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
125952974|NCT01359592|453125979|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
126080494|NCT02666664|453590058|FG001|Overall Study|Sponsor decision|1|||
126080495|NCT02666664|453590057|FG000|Overall Study|Lost to Follow-up|1|||
126080496|NCT02666664|453590058|FG001|Overall Study|Lost to Follow-up|2|||
126080497|NCT00971997|453590059|FG000|Overall Study|Adverse Event|2|||
126080498|NCT00971997|453590059|FG000|Overall Study|Death|1|||
126080499|NCT00971997|453590059|FG000|Overall Study|Protocol Violation|4|||
126080500|NCT00971997|453590059|FG000|Overall Study|Withdrawal by Subject|5|||
126080501|NCT00971997|453590059|FG000|Overall Study|Physician Decision|7|||
126080502|NCT01385748|453590060|FG000|Overall Study|Withdrawal by Subject|7|||
126080503|NCT01385748|453590061|FG001|Overall Study|Withdrawal by Subject|4|||
126080504|NCT01385748|453590062|FG002|Overall Study|Withdrawal by Subject|5|||
126080505|NCT01385748|453590060|FG000|Overall Study|Noncompliance|3|||
126080506|NCT01385748|453590061|FG001|Overall Study|Noncompliance|1|||
126080507|NCT01385748|453590062|FG002|Overall Study|Noncompliance|6|||
126080508|NCT01385748|453590060|FG000|Overall Study|Other|1|||
126080509|NCT01385748|453590061|FG001|Overall Study|Other|7|||
126080510|NCT01385748|453590062|FG002|Overall Study|Other|1|||
126080511|NCT01385748|453590060|FG000|Overall Study|Adverse Event|4|||
126080512|NCT01385748|453590061|FG001|Overall Study|Adverse Event|2|||
126080513|NCT01385748|453590062|FG002|Overall Study|Adverse Event|1|||
126080514|NCT01458522|453590063|FG000|Overall Study|Withdrawal by Subject|2|||
126080515|NCT01458522|453590064|FG001|Overall Study|Withdrawal by Subject|2|||
126080516|NCT01458522|453590063|FG000|Overall Study|Physician Decision|1|||
126080517|NCT01458522|453590064|FG001|Overall Study|Physician Decision|9|||
126080518|NCT02684123|453590065|FG000|Phase 1|Lack of Efficacy|5|||
126080519|NCT02684123|453590066|FG001|Phase 1|Lack of Efficacy|0|||
126080520|NCT02684123|453590065|FG000|Phase 1|Adverse Event|3|||
126080521|NCT02684123|453590066|FG001|Phase 1|Adverse Event|0|||
126080522|NCT02684123|453590065|FG000|Phase 1|Lost to Follow-up|0|||
126080523|NCT02684123|453590066|FG001|Phase 1|Lost to Follow-up|1|||
126080524|NCT02684123|453590065|FG000|Phase 2|Lack of Efficacy|1|||
126080525|NCT02684123|453590066|FG001|Phase 2|Lack of Efficacy|8|||
126080526|NCT00516139|453590067|FG000|Overall Study|Adverse Event|27|||
126080527|NCT00516139|453590067|FG000|Overall Study|Lost to Follow-up|1|||
126080528|NCT00516139|453590067|FG000|Overall Study|Protocol Violation|1|||
126080529|NCT00516139|453590067|FG000|Overall Study|Withdrawal by Subject|8|||
126080530|NCT00516139|453590067|FG000|Overall Study|Lack of Efficacy|1|||
126080531|NCT03382561|453590072|FG000|Overall Study|Disease progression|47|||
126080532|NCT03382561|453590073|FG001|Overall Study|Disease progression|6|||
126080533|NCT03382561|453590072|FG000|Overall Study|Adverse Event|10|||
126080534|NCT03382561|453590073|FG001|Overall Study|Adverse Event|2|||
126080535|NCT03382561|453590072|FG000|Overall Study|Death|8|||
126080536|NCT03382561|453590073|FG001|Overall Study|Death|3|||
126080537|NCT03382561|453590072|FG000|Overall Study|Withdrawal by Subject|6|||
126080538|NCT03382561|453590073|FG001|Overall Study|Withdrawal by Subject|5|||
126080539|NCT03382561|453590072|FG000|Overall Study|Alternative therapy|2|||
126080540|NCT03382561|453590073|FG001|Overall Study|Alternative therapy|8|||
126080541|NCT03382561|453590072|FG000|Overall Study|Never started treatment|3|||
126080542|NCT03382561|453590073|FG001|Overall Study|Never started treatment|6|||
126080543|NCT03382561|453590072|FG000|Overall Study|Lack of Efficacy|0|||
126080544|NCT03382561|453590073|FG001|Overall Study|Lack of Efficacy|1|||
126080545|NCT03382561|453590072|FG000|Overall Study|Physician Decision|0|||
126080546|NCT03382561|453590073|FG001|Overall Study|Physician Decision|1|||
126080547|NCT03382561|453590072|FG000|Overall Study|Other complicating disease|0|||
126080548|NCT03382561|453590073|FG001|Overall Study|Other complicating disease|1|||
126080549|NCT02370251|453590076|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
126080550|NCT02370251|453590076|FG000|Overall Study|Death|4|||
125952975|NCT01359592|453125976|FG000|PET-Directed Therapy|Ineligible|0|||
126080551|NCT02270671|453590079|FG000|Overall Study|Withdrawal by Subject|1|||
126080552|NCT02270671|453590080|FG001|Overall Study|Withdrawal by Subject|1|||
126080553|NCT02270671|453590079|FG000|Overall Study|Protocol Violation|0|||
126080554|NCT02270671|453590080|FG001|Overall Study|Protocol Violation|1|||
126080555|NCT02270671|453590079|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
126080556|NCT02270671|453590080|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
126080557|NCT02270671|453590079|FG000|Overall Study|Lost to Follow-up|2|||
125952976|NCT01359592|453125977|FG001|PET-Directed Therapy|Ineligible|0|||
126080558|NCT02270671|453590080|FG001|Overall Study|Lost to Follow-up|1|||
126080559|NCT02367352|453590090|FG000|Overall Study|Progressive disease|7|||
126080560|NCT02367352|453590091|FG001|Overall Study|Progressive disease|0|||
126080561|NCT02367352|453590092|FG002|Overall Study|Progressive disease|0|||
126080562|NCT02367352|453590090|FG000|Overall Study|Participant Received Alternative Therapy|1|||
126080563|NCT02367352|453590091|FG001|Overall Study|Participant Received Alternative Therapy|0|||
126080564|NCT02367352|453590092|FG002|Overall Study|Participant Received Alternative Therapy|0|||
126080565|NCT02367352|453590090|FG000|Overall Study|Adverse Event|1|||
126080566|NCT02367352|453590091|FG001|Overall Study|Adverse Event|0|||
126080567|NCT02367352|453590092|FG002|Overall Study|Adverse Event|0|||
126080568|NCT00174447|453590093|FG000|Overall Study|Adverse Event|19|||
126080569|NCT00174447|453590093|FG000|Overall Study|Withdrawal by Subject|15|||
126080570|NCT00174447|453590093|FG000|Overall Study|Protocol Violation|1|||
126080571|NCT00174447|453590093|FG000|Overall Study|Lack of Efficacy|1|||
126080572|NCT00174447|453590093|FG000|Overall Study|Administrative reason/Other|2|||
126080573|NCT01437423|453590094|FG000|Overall Study|Lost to Follow-up|12|||
126080574|NCT01437423|453590094|FG000|Overall Study|Off label usage|3|||
126080575|NCT05878873|453590095|FG000|Overall Study|Lost to Follow-up|2|||
126080576|NCT05878873|453590096|FG001|Overall Study|Lost to Follow-up|0|||
126080577|NCT00633945|453590098|FG000|Overall Study|Physician Decision|2|||
126080578|NCT01271504|453590099|FG000|Overall Study|Death|7|||
126080579|NCT01271504|453590100|FG001|Overall Study|Death|6|||
126080580|NCT01271504|453590101|FG002|Overall Study|Death|32|||
126080581|NCT01271504|453590102|FG003|Overall Study|Death|32|||
126080582|NCT01271504|453590099|FG000|Overall Study|Lost to Follow-up|0|||
126080583|NCT01271504|453590100|FG001|Overall Study|Lost to Follow-up|1|||
126080584|NCT01271504|453590101|FG002|Overall Study|Lost to Follow-up|3|||
126080585|NCT01271504|453590102|FG003|Overall Study|Lost to Follow-up|1|||
126080586|NCT01271504|453590099|FG000|Overall Study|Protocol Violation|0|||
126080587|NCT01271504|453590100|FG001|Overall Study|Protocol Violation|0|||
126080588|NCT01271504|453590101|FG002|Overall Study|Protocol Violation|0|||
126080589|NCT01271504|453590102|FG003|Overall Study|Protocol Violation|2|||
126080590|NCT01271504|453590099|FG000|Overall Study|Administrative Reasons|0|||
126080591|NCT01271504|453590100|FG001|Overall Study|Administrative Reasons|0|||
126080592|NCT01271504|453590101|FG002|Overall Study|Administrative Reasons|6|||
126080593|NCT01271504|453590102|FG003|Overall Study|Administrative Reasons|5|||
126080594|NCT01271504|453590099|FG000|Overall Study|Withdrawal by Subject|0|||
126080595|NCT01271504|453590100|FG001|Overall Study|Withdrawal by Subject|0|||
126080596|NCT01271504|453590101|FG002|Overall Study|Withdrawal by Subject|1|||
126080597|NCT01271504|453590102|FG003|Overall Study|Withdrawal by Subject|3|||
126080598|NCT01271504|453590099|FG000|Overall Study|Other|0|||
126080599|NCT01271504|453590100|FG001|Overall Study|Other|1|||
126080600|NCT01271504|453590101|FG002|Overall Study|Other|2|||
126080601|NCT01271504|453590102|FG003|Overall Study|Other|0|||
126080602|NCT00882115|453590103|FG000|Overall Study|Withdrawal by Subject|3|||
126080603|NCT00882115|453590103|FG000|Overall Study|did not respond to DEP challe|6|||
126080604|NCT03865953|453590104|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
126080605|NCT03865953|453590105|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
126080606|NCT03865953|453590104|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
126080607|NCT03865953|453590105|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
126080608|NCT03865953|453590104|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
126080609|NCT03865953|453590105|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
126080610|NCT02552147|453590106|FG000|First Intervention (7 Days)|Protocol Violation|1|||
126080611|NCT02552147|453590107|FG001|First Intervention (7 Days)|Protocol Violation|0|||
126080612|NCT02552147|453590106|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
126080613|NCT02552147|453590107|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
126080614|NCT02375347|453590108|FG000|Overall Study|Protocol Violation|1|||
126080615|NCT02472145|453590109|FG000|Overall Study|Death|10|||
126080616|NCT02472145|453590110|FG001|Overall Study|Death|101|||
126080617|NCT02472145|453590111|FG002|Overall Study|Death|99|||
126080618|NCT02472145|453590109|FG000|Overall Study|Lost to Follow-up|0|||
126080619|NCT02472145|453590110|FG001|Overall Study|Lost to Follow-up|1|||
126080620|NCT02472145|453590111|FG002|Overall Study|Lost to Follow-up|0|||
126080621|NCT02472145|453590109|FG000|Overall Study|Withdrawal by Subject|0|||
126080622|NCT02472145|453590110|FG001|Overall Study|Withdrawal by Subject|9|||
126080623|NCT02472145|453590111|FG002|Overall Study|Withdrawal by Subject|13|||
126080624|NCT02472145|453590109|FG000|Overall Study|Sponsor decision|0|||
126080625|NCT02472145|453590110|FG001|Overall Study|Sponsor decision|3|||
126080626|NCT02472145|453590111|FG002|Overall Study|Sponsor decision|2|||
126080627|NCT02472145|453590109|FG000|Overall Study|Other|0|||
126080628|NCT02472145|453590110|FG001|Overall Study|Other|45|||
126080629|NCT02472145|453590111|FG002|Overall Study|Other|43|||
126080630|NCT01080326|453590112|FG000|Overall Study|Patient deterioration prior to procedure|3|||
126080631|NCT01080326|453590112|FG000|Overall Study|Surgeon decision|1|||
126080632|NCT01296555|453590113|FG000|Overall Study|Adverse Event|0|||
126080633|NCT01296555|453590114|FG001|Overall Study|Adverse Event|0|||
126080634|NCT01296555|453590115|FG002|Overall Study|Adverse Event|1|||
125952977|NCT01359592|453125978|FG002|PET-Directed Therapy|Ineligible|24|||
125952978|NCT01359592|453125979|FG003|PET-Directed Therapy|Ineligible|0|||
126080635|NCT01296555|453590116|FG003|Overall Study|Adverse Event|1|||
126080636|NCT01296555|453590117|FG004|Overall Study|Adverse Event|2|||
126080637|NCT01296555|453590118|FG005|Overall Study|Adverse Event|4|||
126080638|NCT01296555|453590119|FG006|Overall Study|Adverse Event|1|||
126080639|NCT01296555|453590120|FG007|Overall Study|Adverse Event|4|||
126080640|NCT01296555|453590121|FG008|Overall Study|Adverse Event|3|||
126080641|NCT01296555|453590122|FG009|Overall Study|Adverse Event|1|||
126080642|NCT01296555|453590123|FG010|Overall Study|Adverse Event|0|||
126080643|NCT01296555|453590124|FG011|Overall Study|Adverse Event|4|||
126080644|NCT01296555|453590125|FG012|Overall Study|Adverse Event|1|||
126080645|NCT01296555|453590126|FG013|Overall Study|Adverse Event|4|||
126080646|NCT01296555|453590127|FG014|Overall Study|Adverse Event|0|||
126080647|NCT01296555|453590128|FG015|Overall Study|Adverse Event|0|||
126080648|NCT01296555|453590129|FG016|Overall Study|Adverse Event|0|||
126080649|NCT01296555|453590130|FG017|Overall Study|Adverse Event|0|||
126080650|NCT01296555|453590131|FG018|Overall Study|Adverse Event|0|||
126080651|NCT01296555|453590132|FG019|Overall Study|Adverse Event|1|||
126080652|NCT01296555|453590133|FG020|Overall Study|Adverse Event|0|||
126080653|NCT01296555|453590134|FG021|Overall Study|Adverse Event|0|||
126080654|NCT01296555|453590135|FG022|Overall Study|Adverse Event|0|||
126080655|NCT01296555|453590136|FG023|Overall Study|Adverse Event|0|||
126080656|NCT01296555|453590137|FG024|Overall Study|Adverse Event|0|||
126080657|NCT01296555|453590138|FG025|Overall Study|Adverse Event|0|||
126080658|NCT01296555|453590139|FG026|Overall Study|Adverse Event|0|||
126080659|NCT01296555|453590140|FG027|Overall Study|Adverse Event|0|||
126080660|NCT01296555|453590141|FG028|Overall Study|Adverse Event|0|||
126080661|NCT01296555|453590113|FG000|Overall Study|Reason Not Specified|0|||
126080662|NCT01296555|453590114|FG001|Overall Study|Reason Not Specified|0|||
126080663|NCT01296555|453590115|FG002|Overall Study|Reason Not Specified|0|||
126080664|NCT01296555|453590116|FG003|Overall Study|Reason Not Specified|0|||
126080665|NCT01296555|453590117|FG004|Overall Study|Reason Not Specified|0|||
126080666|NCT01296555|453590118|FG005|Overall Study|Reason Not Specified|0|||
126080667|NCT01296555|453590119|FG006|Overall Study|Reason Not Specified|0|||
126080668|NCT01296555|453590120|FG007|Overall Study|Reason Not Specified|0|||
126080669|NCT01296555|453590121|FG008|Overall Study|Reason Not Specified|0|||
126080670|NCT01296555|453590122|FG009|Overall Study|Reason Not Specified|0|||
126080671|NCT01296555|453590123|FG010|Overall Study|Reason Not Specified|0|||
126080672|NCT01296555|453590124|FG011|Overall Study|Reason Not Specified|0|||
126080673|NCT01296555|453590125|FG012|Overall Study|Reason Not Specified|0|||
126080674|NCT01296555|453590126|FG013|Overall Study|Reason Not Specified|1|||
126080675|NCT01296555|453590127|FG014|Overall Study|Reason Not Specified|2|||
126080676|NCT01296555|453590128|FG015|Overall Study|Reason Not Specified|3|||
126080677|NCT01296555|453590129|FG016|Overall Study|Reason Not Specified|7|||
126080678|NCT01296555|453590130|FG017|Overall Study|Reason Not Specified|4|||
126080679|NCT01296555|453590131|FG018|Overall Study|Reason Not Specified|3|||
126080680|NCT01296555|453590132|FG019|Overall Study|Reason Not Specified|7|||
126080681|NCT01296555|453590133|FG020|Overall Study|Reason Not Specified|11|||
126080682|NCT01296555|453590134|FG021|Overall Study|Reason Not Specified|5|||
126080683|NCT01296555|453590135|FG022|Overall Study|Reason Not Specified|5|||
126080684|NCT01296555|453590136|FG023|Overall Study|Reason Not Specified|7|||
126080685|NCT01296555|453590137|FG024|Overall Study|Reason Not Specified|2|||
126080686|NCT01296555|453590138|FG025|Overall Study|Reason Not Specified|2|||
126080687|NCT01296555|453590139|FG026|Overall Study|Reason Not Specified|19|||
126080688|NCT01296555|453590140|FG027|Overall Study|Reason Not Specified|11|||
126080689|NCT01296555|453590141|FG028|Overall Study|Reason Not Specified|9|||
126080690|NCT01296555|453590113|FG000|Overall Study|Physician Decision|0|||
126080691|NCT01296555|453590114|FG001|Overall Study|Physician Decision|0|||
126080692|NCT01296555|453590115|FG002|Overall Study|Physician Decision|0|||
126080693|NCT01296555|453590116|FG003|Overall Study|Physician Decision|0|||
126080694|NCT01296555|453590117|FG004|Overall Study|Physician Decision|1|||
126080695|NCT01296555|453590118|FG005|Overall Study|Physician Decision|0|||
126080696|NCT01296555|453590119|FG006|Overall Study|Physician Decision|0|||
126080697|NCT01296555|453590120|FG007|Overall Study|Physician Decision|0|||
126080698|NCT01296555|453590121|FG008|Overall Study|Physician Decision|0|||
126080699|NCT01296555|453590122|FG009|Overall Study|Physician Decision|0|||
126080700|NCT01296555|453590123|FG010|Overall Study|Physician Decision|0|||
126080701|NCT01296555|453590124|FG011|Overall Study|Physician Decision|0|||
126080702|NCT01296555|453590125|FG012|Overall Study|Physician Decision|0|||
126080703|NCT01296555|453590126|FG013|Overall Study|Physician Decision|1|||
126080704|NCT01296555|453590127|FG014|Overall Study|Physician Decision|0|||
126080705|NCT01296555|453590128|FG015|Overall Study|Physician Decision|0|||
126080706|NCT01296555|453590129|FG016|Overall Study|Physician Decision|0|||
126080707|NCT01296555|453590130|FG017|Overall Study|Physician Decision|0|||
126080708|NCT01296555|453590131|FG018|Overall Study|Physician Decision|0|||
126080709|NCT01296555|453590132|FG019|Overall Study|Physician Decision|1|||
126080710|NCT01296555|453590133|FG020|Overall Study|Physician Decision|0|||
126080711|NCT01296555|453590134|FG021|Overall Study|Physician Decision|0|||
126080712|NCT01296555|453590135|FG022|Overall Study|Physician Decision|0|||
126080713|NCT01296555|453590136|FG023|Overall Study|Physician Decision|0|||
126080714|NCT01296555|453590137|FG024|Overall Study|Physician Decision|0|||
126080715|NCT01296555|453590138|FG025|Overall Study|Physician Decision|0|||
126080716|NCT01296555|453590139|FG026|Overall Study|Physician Decision|0|||
126080717|NCT01296555|453590140|FG027|Overall Study|Physician Decision|0|||
126080718|NCT01296555|453590141|FG028|Overall Study|Physician Decision|0|||
125952979|NCT00326612|453125980|FG000|Overall Study|They did not have a seizure requiring tx|129|||
125952980|NCT00326612|453125981|FG001|Overall Study|They did not have a seizure requiring tx|137|||
126080719|NCT01296555|453590113|FG000|Overall Study|Progressive Disease|6|||
125952981|NCT00419562|453125982|FG000|Overall Study|Lost to Follow-up|12|||
126080720|NCT01296555|453590114|FG001|Overall Study|Progressive Disease|3|||
126080721|NCT01296555|453590115|FG002|Overall Study|Progressive Disease|3|||
126080722|NCT01296555|453590116|FG003|Overall Study|Progressive Disease|7|||
126080723|NCT01296555|453590117|FG004|Overall Study|Progressive Disease|6|||
126080724|NCT01296555|453590118|FG005|Overall Study|Progressive Disease|16|||
126080725|NCT01296555|453590119|FG006|Overall Study|Progressive Disease|16|||
126080726|NCT01296555|453590120|FG007|Overall Study|Progressive Disease|8|||
126080727|NCT01296555|453590121|FG008|Overall Study|Progressive Disease|7|||
126080728|NCT01296555|453590122|FG009|Overall Study|Progressive Disease|18|||
126080729|NCT01296555|453590123|FG010|Overall Study|Progressive Disease|7|||
126080730|NCT01296555|453590124|FG011|Overall Study|Progressive Disease|14|||
126080731|NCT01296555|453590125|FG012|Overall Study|Progressive Disease|5|||
126080732|NCT01296555|453590126|FG013|Overall Study|Progressive Disease|12|||
126080733|NCT01296555|453590127|FG014|Overall Study|Progressive Disease|1|||
126080734|NCT01296555|453590128|FG015|Overall Study|Progressive Disease|1|||
126080735|NCT01296555|453590129|FG016|Overall Study|Progressive Disease|0|||
126080736|NCT01296555|453590130|FG017|Overall Study|Progressive Disease|0|||
126080737|NCT01296555|453590131|FG018|Overall Study|Progressive Disease|0|||
126080738|NCT01296555|453590132|FG019|Overall Study|Progressive Disease|1|||
126080739|NCT01296555|453590133|FG020|Overall Study|Progressive Disease|0|||
126080740|NCT01296555|453590134|FG021|Overall Study|Progressive Disease|0|||
126080741|NCT01296555|453590135|FG022|Overall Study|Progressive Disease|0|||
126080742|NCT01296555|453590136|FG023|Overall Study|Progressive Disease|0|||
126080743|NCT01296555|453590137|FG024|Overall Study|Progressive Disease|1|||
126080744|NCT01296555|453590138|FG025|Overall Study|Progressive Disease|0|||
126080745|NCT01296555|453590139|FG026|Overall Study|Progressive Disease|5|||
126080746|NCT01296555|453590140|FG027|Overall Study|Progressive Disease|1|||
126080747|NCT01296555|453590141|FG028|Overall Study|Progressive Disease|0|||
126080748|NCT01296555|453590113|FG000|Overall Study|Protocol Violation|0|||
126080749|NCT01296555|453590114|FG001|Overall Study|Protocol Violation|0|||
126080750|NCT01296555|453590115|FG002|Overall Study|Protocol Violation|0|||
126080751|NCT01296555|453590116|FG003|Overall Study|Protocol Violation|0|||
126080752|NCT01296555|453590117|FG004|Overall Study|Protocol Violation|0|||
126080753|NCT01296555|453590118|FG005|Overall Study|Protocol Violation|0|||
126080754|NCT01296555|453590119|FG006|Overall Study|Protocol Violation|0|||
126080755|NCT01296555|453590120|FG007|Overall Study|Protocol Violation|0|||
126080756|NCT01296555|453590121|FG008|Overall Study|Protocol Violation|0|||
126080757|NCT01296555|453590122|FG009|Overall Study|Protocol Violation|0|||
126080758|NCT01296555|453590123|FG010|Overall Study|Protocol Violation|0|||
126080759|NCT01296555|453590124|FG011|Overall Study|Protocol Violation|0|||
126080760|NCT01296555|453590125|FG012|Overall Study|Protocol Violation|0|||
126080761|NCT01296555|453590126|FG013|Overall Study|Protocol Violation|1|||
126080762|NCT01296555|453590127|FG014|Overall Study|Protocol Violation|0|||
126080763|NCT01296555|453590128|FG015|Overall Study|Protocol Violation|0|||
126080764|NCT01296555|453590129|FG016|Overall Study|Protocol Violation|0|||
126080765|NCT01296555|453590130|FG017|Overall Study|Protocol Violation|0|||
126080766|NCT01296555|453590131|FG018|Overall Study|Protocol Violation|0|||
126080767|NCT01296555|453590132|FG019|Overall Study|Protocol Violation|0|||
126080768|NCT01296555|453590133|FG020|Overall Study|Protocol Violation|0|||
126080769|NCT01296555|453590134|FG021|Overall Study|Protocol Violation|0|||
126080770|NCT01296555|453590135|FG022|Overall Study|Protocol Violation|0|||
126080771|NCT01296555|453590136|FG023|Overall Study|Protocol Violation|0|||
126080772|NCT01296555|453590137|FG024|Overall Study|Protocol Violation|0|||
126080773|NCT01296555|453590138|FG025|Overall Study|Protocol Violation|0|||
126080774|NCT01296555|453590139|FG026|Overall Study|Protocol Violation|0|||
126080775|NCT01296555|453590140|FG027|Overall Study|Protocol Violation|0|||
126080776|NCT01296555|453590141|FG028|Overall Study|Protocol Violation|0|||
126080777|NCT01296555|453590113|FG000|Overall Study|Study Terminated By Sponsor|0|||
126080778|NCT01296555|453590114|FG001|Overall Study|Study Terminated By Sponsor|0|||
126080779|NCT01296555|453590115|FG002|Overall Study|Study Terminated By Sponsor|0|||
126080780|NCT01296555|453590116|FG003|Overall Study|Study Terminated By Sponsor|0|||
126080781|NCT01296555|453590117|FG004|Overall Study|Study Terminated By Sponsor|0|||
126080782|NCT01296555|453590118|FG005|Overall Study|Study Terminated By Sponsor|0|||
126080783|NCT01296555|453590119|FG006|Overall Study|Study Terminated By Sponsor|0|||
126080784|NCT01296555|453590120|FG007|Overall Study|Study Terminated By Sponsor|0|||
126080785|NCT01296555|453590121|FG008|Overall Study|Study Terminated By Sponsor|0|||
126080786|NCT01296555|453590122|FG009|Overall Study|Study Terminated By Sponsor|0|||
125952982|NCT00419562|453125983|FG001|Overall Study|Lost to Follow-up|13|||
125952983|NCT00419562|453125982|FG000|Overall Study|Withdrawal by Subject|20|||
126080787|NCT01296555|453590123|FG010|Overall Study|Study Terminated By Sponsor|0|||
126080788|NCT01296555|453590124|FG011|Overall Study|Study Terminated By Sponsor|0|||
126080789|NCT01296555|453590125|FG012|Overall Study|Study Terminated By Sponsor|0|||
125952984|NCT00419562|453125983|FG001|Overall Study|Withdrawal by Subject|18|||
125952985|NCT00419562|453125982|FG000|Overall Study|Participant Institutionalized|1|||
126080790|NCT01296555|453590126|FG013|Overall Study|Study Terminated By Sponsor|0|||
125952986|NCT00419562|453125983|FG001|Overall Study|Participant Institutionalized|0|||
125952987|NCT00548808|453125992|FG000|Overall Study|Lost to Follow-up|9|||
125952988|NCT00548808|453125993|FG001|Overall Study|Lost to Follow-up|3|||
126080791|NCT01296555|453590127|FG014|Overall Study|Study Terminated By Sponsor|0|||
126080792|NCT01296555|453590128|FG015|Overall Study|Study Terminated By Sponsor|0|||
126080793|NCT01296555|453590129|FG016|Overall Study|Study Terminated By Sponsor|0|||
126080794|NCT01296555|453590130|FG017|Overall Study|Study Terminated By Sponsor|0|||
126080795|NCT01296555|453590131|FG018|Overall Study|Study Terminated By Sponsor|0|||
125952989|NCT00548808|453125992|FG000|Overall Study|Protocol Violation|8|||
125952990|NCT00548808|453125993|FG001|Overall Study|Protocol Violation|8|||
125952991|NCT00548808|453125992|FG000|Overall Study|Withdrawal by Subject|8|||
125952992|NCT00548808|453125993|FG001|Overall Study|Withdrawal by Subject|4|||
125952993|NCT00548808|453125992|FG000|Overall Study|Physician Decision|6|||
125952994|NCT00548808|453125993|FG001|Overall Study|Physician Decision|3|||
125952995|NCT00548808|453125992|FG000|Overall Study|Adverse Event|4|||
125952996|NCT00548808|453125993|FG001|Overall Study|Adverse Event|5|||
125952997|NCT00548808|453125992|FG000|Overall Study|Death|2|||
125952998|NCT00548808|453125993|FG001|Overall Study|Death|0|||
125952999|NCT00548808|453125992|FG000|Overall Study|Entry Criteria Not Met|2|||
125953000|NCT00548808|453125993|FG001|Overall Study|Entry Criteria Not Met|2|||
125953001|NCT00548808|453125992|FG000|Overall Study|Lack of Efficacy|2|||
125953002|NCT00548808|453125993|FG001|Overall Study|Lack of Efficacy|0|||
125953003|NCT00548808|453125992|FG000|Overall Study|Sponsor Decision|1|||
125953004|NCT00548808|453125993|FG001|Overall Study|Sponsor Decision|1|||
125953005|NCT00749775|453125994|FG000|Overall Study|Protocol Violation|24|||
125953006|NCT00749775|453125994|FG000|Overall Study|Lost to Follow-up|36|||
125953007|NCT00749775|453125994|FG000|Overall Study|No visit after first day of treatment|44|||
125953008|NCT00749775|453125994|FG000|Overall Study|No drug administration|3|||
125953009|NCT01400841|453125995|FG000|Initial Study Phase (6 Months)|Death|1|||
125953010|NCT01400841|453125995|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
125953011|NCT00770120|453125996|FG000|Overall Study|Progression|31|||
125953012|NCT00770120|453125996|FG000|Overall Study|Adverse Event|11|||
125953013|NCT00770120|453125996|FG000|Overall Study|Not Protocol Specified|11|||
125953014|NCT00770120|453125996|FG000|Overall Study|Death|3|||
125953015|NCT00770120|453125996|FG000|Overall Study|Withdrawal by Subject|2|||
125953016|NCT00770120|453125996|FG000|Overall Study|Ineligible|1|||
125953017|NCT00770120|453125996|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
125953018|NCT00770120|453125996|FG000|Overall Study|Reason under Review|1|||
125953019|NCT00480636|453125997|FG000|Overall Study|Death|12|||
125953020|NCT00480636|453125997|FG000|Overall Study|Lost to Follow-up|4|||
125953021|NCT00480636|453125997|FG000|Overall Study|Other|2|||
125953022|NCT00480636|453125997|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
125953023|NCT02583256|453125998|FG000|Overall Study|Withdrawal by Subject|0|||
125953024|NCT02583256|453125999|FG001|Overall Study|Withdrawal by Subject|1|||
125953025|NCT02583256|453126000|FG002|Overall Study|Withdrawal by Subject|1|||
125953026|NCT02583256|453126001|FG003|Overall Study|Withdrawal by Subject|0|||
125953027|NCT02583256|453125998|FG000|Overall Study|Lost to Follow-up|1|||
125953028|NCT02583256|453125999|FG001|Overall Study|Lost to Follow-up|1|||
125953029|NCT02583256|453126000|FG002|Overall Study|Lost to Follow-up|0|||
125953030|NCT02583256|453126001|FG003|Overall Study|Lost to Follow-up|1|||
125953031|NCT02583256|453125998|FG000|Overall Study|Administrative/Other|2|||
125953032|NCT02583256|453125999|FG001|Overall Study|Administrative/Other|0|||
125953033|NCT02583256|453126000|FG002|Overall Study|Administrative/Other|1|||
125953034|NCT02583256|453126001|FG003|Overall Study|Administrative/Other|2|||
125953035|NCT00326911|453126002|FG000|Overall Study|Hospitalization prior to treatment|0|||
125953036|NCT00326911|453126003|FG001|Overall Study|Hospitalization prior to treatment|1|||
125953037|NCT00326911|453126002|FG000|Overall Study|Physician decision prior to treatment|1|||
125953038|NCT00326911|453126003|FG001|Overall Study|Physician decision prior to treatment|0|||
125953039|NCT00326911|453126002|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
125953040|NCT00326911|453126003|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
125953041|NCT04537806|453126010|FG000|Overall Study|Randomized but not treated|1|||
125953042|NCT04537806|453126011|FG001|Overall Study|Randomized but not treated|0|||
125953043|NCT04537806|453126010|FG000|Overall Study|Adverse Event|1|||
125953044|NCT04537806|453126011|FG001|Overall Study|Adverse Event|1|||
125953045|NCT03019627|453126012|FG000|Overall Study|Adverse Event|8|||
125953046|NCT03019627|453126013|FG001|Overall Study|Adverse Event|0|||
125953047|NCT03019627|453126012|FG000|Overall Study|Unrelated to adverse event|1|||
125953048|NCT03019627|453126013|FG001|Overall Study|Unrelated to adverse event|3|||
125953049|NCT03019627|453126012|FG000|Overall Study|Lost to Follow-up|2|||
125953050|NCT03019627|453126013|FG001|Overall Study|Lost to Follow-up|1|||
125953051|NCT03019627|453126012|FG000|Overall Study|not compliance|2|||
125953052|NCT03019627|453126013|FG001|Overall Study|not compliance|2|||
125953053|NCT03019627|453126012|FG000|Overall Study|Other|2|||
125953054|NCT03019627|453126013|FG001|Overall Study|Other|2|||
125953055|NCT03364049|453126014|FG000|Overall Study|Death|6|||
125953056|NCT03364049|453126015|FG001|Overall Study|Death|4|||
125953057|NCT03364049|453126016|FG002|Overall Study|Death|5|||
125953058|NCT03364049|453126017|FG003|Overall Study|Death|14|||
125953059|NCT03364049|453126014|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
125953060|NCT03364049|453126015|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
125953061|NCT03364049|453126016|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
125953062|NCT03364049|453126017|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
125953063|NCT03364049|453126014|FG000|Overall Study|Withdrawal by Subject|0|||
126080796|NCT01296555|453590132|FG019|Overall Study|Study Terminated By Sponsor|0|||
126080797|NCT01296555|453590133|FG020|Overall Study|Study Terminated By Sponsor|0|||
126080798|NCT01296555|453590134|FG021|Overall Study|Study Terminated By Sponsor|0|||
126080799|NCT01296555|453590135|FG022|Overall Study|Study Terminated By Sponsor|0|||
126080800|NCT01296555|453590136|FG023|Overall Study|Study Terminated By Sponsor|0|||
126080801|NCT01296555|453590137|FG024|Overall Study|Study Terminated By Sponsor|0|||
126080802|NCT01296555|453590138|FG025|Overall Study|Study Terminated By Sponsor|1|||
126080803|NCT01296555|453590139|FG026|Overall Study|Study Terminated By Sponsor|0|||
126080804|NCT01296555|453590140|FG027|Overall Study|Study Terminated By Sponsor|0|||
126080805|NCT01296555|453590141|FG028|Overall Study|Study Terminated By Sponsor|0|||
126080806|NCT01296555|453590113|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080807|NCT01296555|453590114|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080808|NCT01296555|453590115|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080809|NCT01296555|453590116|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080810|NCT01296555|453590117|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080811|NCT01296555|453590118|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080812|NCT01296555|453590119|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080813|NCT01296555|453590120|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080814|NCT01296555|453590121|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080815|NCT01296555|453590122|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080816|NCT01296555|453590123|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080817|NCT01296555|453590124|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080818|NCT01296555|453590125|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080819|NCT01296555|453590126|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080820|NCT01296555|453590127|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080821|NCT01296555|453590128|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080822|NCT01296555|453590129|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080823|NCT01296555|453590130|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080824|NCT01296555|453590131|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080825|NCT01296555|453590132|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
126080826|NCT01296555|453590133|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080827|NCT01296555|453590134|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080828|NCT01296555|453590135|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080829|NCT01296555|453590136|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125953064|NCT03364049|453126015|FG001|Overall Study|Withdrawal by Subject|1|||
125953065|NCT03364049|453126016|FG002|Overall Study|Withdrawal by Subject|1|||
125953066|NCT03364049|453126017|FG003|Overall Study|Withdrawal by Subject|1|||
125953067|NCT02953821|453126018|FG000|Overall Study|Adverse Event|0|||
125953068|NCT02953821|453126019|FG001|Overall Study|Adverse Event|4|||
125953069|NCT02953821|453126018|FG000|Overall Study|Death|1|||
125953070|NCT02953821|453126019|FG001|Overall Study|Death|0|||
125953071|NCT02953821|453126018|FG000|Overall Study|Progressive Disease|5|||
125953072|NCT02953821|453126019|FG001|Overall Study|Progressive Disease|1|||
125953073|NCT02953821|453126018|FG000|Overall Study|Lost to Follow-up|2|||
125953074|NCT02953821|453126019|FG001|Overall Study|Lost to Follow-up|0|||
125953075|NCT02953821|453126018|FG000|Overall Study|Physician Decision|1|||
125953076|NCT02953821|453126019|FG001|Overall Study|Physician Decision|1|||
125953077|NCT02953821|453126018|FG000|Overall Study|Withdrawal by Subject|3|||
125953078|NCT02953821|453126019|FG001|Overall Study|Withdrawal by Subject|3|||
125953079|NCT02953821|453126018|FG000|Overall Study|Change of address|0|||
125953080|NCT02953821|453126019|FG001|Overall Study|Change of address|1|||
125953081|NCT02953821|453126018|FG000|Overall Study|Lack of Efficacy|1|||
125953082|NCT02953821|453126019|FG001|Overall Study|Lack of Efficacy|0|||
125953083|NCT02953821|453126018|FG000|Overall Study|Out of state for indeterminate time|0|||
125953084|NCT02953821|453126019|FG001|Overall Study|Out of state for indeterminate time|1|||
125953085|NCT02953821|453126018|FG000|Overall Study|No improvement|0|||
125953086|NCT02953821|453126019|FG001|Overall Study|No improvement|1|||
125953087|NCT02953821|453126018|FG000|Overall Study|Refused follow-up visit|2|||
125953088|NCT02953821|453126019|FG001|Overall Study|Refused follow-up visit|1|||
125953089|NCT02103478|453126020|FG000|Overall Study|Adverse Event|0|||
125953090|NCT02103478|453126021|FG001|Overall Study|Adverse Event|0|||
125953091|NCT02103478|453126022|FG002|Overall Study|Adverse Event|1|||
125953092|NCT02103478|453126023|FG003|Overall Study|Adverse Event|1|||
125953093|NCT02103478|453126024|FG004|Overall Study|Adverse Event|2|||
125953094|NCT02103478|453126025|FG005|Overall Study|Adverse Event|1|||
125953095|NCT02103478|453126026|FG006|Overall Study|Adverse Event|0|||
125953096|NCT02103478|453126027|FG007|Overall Study|Adverse Event|0|||
125953097|NCT02103478|453126028|FG008|Overall Study|Adverse Event|0|||
125953098|NCT02103478|453126020|FG000|Overall Study|Death|2|||
125953099|NCT02103478|453126021|FG001|Overall Study|Death|2|||
126080830|NCT01296555|453590137|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080831|NCT01296555|453590138|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080832|NCT01296555|453590139|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125953100|NCT02103478|453126022|FG002|Overall Study|Death|1|||
125953101|NCT02103478|453126023|FG003|Overall Study|Death|1|||
125953102|NCT02103478|453126024|FG004|Overall Study|Death|5|||
126080833|NCT01296555|453590140|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080834|NCT01296555|453590141|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126080835|NCT01296555|453590113|FG000|Overall Study|Death|0|||
126080836|NCT01296555|453590114|FG001|Overall Study|Death|0|||
126080837|NCT01296555|453590115|FG002|Overall Study|Death|0|||
126080838|NCT01296555|453590116|FG003|Overall Study|Death|2|||
126080839|NCT01296555|453590117|FG004|Overall Study|Death|1|||
126080840|NCT01296555|453590118|FG005|Overall Study|Death|0|||
126080841|NCT01296555|453590119|FG006|Overall Study|Death|2|||
126080842|NCT01296555|453590120|FG007|Overall Study|Death|0|||
126080843|NCT01296555|453590121|FG008|Overall Study|Death|0|||
126080844|NCT01296555|453590122|FG009|Overall Study|Death|1|||
126080845|NCT01296555|453590123|FG010|Overall Study|Death|0|||
126080846|NCT01296555|453590124|FG011|Overall Study|Death|1|||
126080847|NCT01296555|453590125|FG012|Overall Study|Death|0|||
126080848|NCT01296555|453590126|FG013|Overall Study|Death|2|||
126080849|NCT01296555|453590127|FG014|Overall Study|Death|27|||
126080850|NCT01296555|453590128|FG015|Overall Study|Death|15|||
126080851|NCT01296555|453590129|FG016|Overall Study|Death|11|||
126080852|NCT01296555|453590130|FG017|Overall Study|Death|11|||
126080853|NCT01296555|453590131|FG018|Overall Study|Death|17|||
126080854|NCT01296555|453590132|FG019|Overall Study|Death|12|||
126080855|NCT01296555|453590133|FG020|Overall Study|Death|13|||
126080856|NCT01296555|453590134|FG021|Overall Study|Death|12|||
126080857|NCT01296555|453590135|FG022|Overall Study|Death|12|||
126080858|NCT01296555|453590136|FG023|Overall Study|Death|13|||
126080859|NCT01296555|453590137|FG024|Overall Study|Death|7|||
126080860|NCT01296555|453590138|FG025|Overall Study|Death|7|||
126080861|NCT01296555|453590139|FG026|Overall Study|Death|35|||
126080862|NCT01296555|453590140|FG027|Overall Study|Death|92|||
126080863|NCT01296555|453590141|FG028|Overall Study|Death|44|||
126080864|NCT01296555|453590113|FG000|Overall Study|Lost to Follow-up|0|||
126080865|NCT01296555|453590114|FG001|Overall Study|Lost to Follow-up|0|||
126080866|NCT01296555|453590115|FG002|Overall Study|Lost to Follow-up|0|||
126080867|NCT01296555|453590116|FG003|Overall Study|Lost to Follow-up|0|||
126080868|NCT01296555|453590117|FG004|Overall Study|Lost to Follow-up|0|||
126080869|NCT01296555|453590118|FG005|Overall Study|Lost to Follow-up|0|||
126080870|NCT01296555|453590119|FG006|Overall Study|Lost to Follow-up|0|||
126080871|NCT01296555|453590120|FG007|Overall Study|Lost to Follow-up|0|||
126080872|NCT01296555|453590121|FG008|Overall Study|Lost to Follow-up|0|||
126080873|NCT01296555|453590122|FG009|Overall Study|Lost to Follow-up|0|||
126080874|NCT01296555|453590123|FG010|Overall Study|Lost to Follow-up|0|||
126080875|NCT01296555|453590124|FG011|Overall Study|Lost to Follow-up|0|||
126080876|NCT01296555|453590125|FG012|Overall Study|Lost to Follow-up|0|||
126080877|NCT01296555|453590126|FG013|Overall Study|Lost to Follow-up|0|||
126080878|NCT01296555|453590127|FG014|Overall Study|Lost to Follow-up|2|||
126080879|NCT01296555|453590128|FG015|Overall Study|Lost to Follow-up|1|||
126080880|NCT01296555|453590129|FG016|Overall Study|Lost to Follow-up|0|||
126080881|NCT01296555|453590130|FG017|Overall Study|Lost to Follow-up|2|||
126080882|NCT01296555|453590131|FG018|Overall Study|Lost to Follow-up|0|||
126080883|NCT01296555|453590132|FG019|Overall Study|Lost to Follow-up|2|||
126080884|NCT01296555|453590133|FG020|Overall Study|Lost to Follow-up|3|||
126080885|NCT01296555|453590134|FG021|Overall Study|Lost to Follow-up|2|||
126080886|NCT01296555|453590135|FG022|Overall Study|Lost to Follow-up|0|||
126080887|NCT01296555|453590136|FG023|Overall Study|Lost to Follow-up|0|||
126080888|NCT01296555|453590137|FG024|Overall Study|Lost to Follow-up|0|||
126080889|NCT01296555|453590138|FG025|Overall Study|Lost to Follow-up|0|||
126080890|NCT01296555|453590139|FG026|Overall Study|Lost to Follow-up|3|||
126080891|NCT01296555|453590140|FG027|Overall Study|Lost to Follow-up|13|||
126080892|NCT01296555|453590141|FG028|Overall Study|Lost to Follow-up|5|||
126080893|NCT01296555|453590113|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126080894|NCT01296555|453590114|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126080895|NCT01296555|453590115|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126115399|NCT00757003|453718105|FG000|Overall Study|Death|33|||
126115400|NCT00757003|453718105|FG000|Overall Study|Lost to Follow-up|9|||
125953103|NCT02103478|453126025|FG005|Overall Study|Death|15|||
125953104|NCT02103478|453126026|FG006|Overall Study|Death|14|||
125953105|NCT02103478|453126027|FG007|Overall Study|Death|10|||
125953106|NCT02103478|453126028|FG008|Overall Study|Death|11|||
125953107|NCT02103478|453126020|FG000|Overall Study|Progressive Disease|2|||
125953108|NCT02103478|453126021|FG001|Overall Study|Progressive Disease|1|||
125953109|NCT02103478|453126022|FG002|Overall Study|Progressive Disease|2|||
126080896|NCT01296555|453590116|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126115401|NCT00757003|453718105|FG000|Overall Study|Withdrawal by Subject|4|||
126115402|NCT00757003|453718105|FG000|Overall Study|Surgically explanted|2|||
126115403|NCT00757003|453718105|FG000|Overall Study|Not implanted|1|||
125953110|NCT02103478|453126023|FG003|Overall Study|Progressive Disease|0|||
125953111|NCT02103478|453126024|FG004|Overall Study|Progressive Disease|9|||
126080897|NCT01296555|453590117|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126080898|NCT01296555|453590118|FG005|Overall Study|Non-Compliance With Study Drug|0|||
126080899|NCT01296555|453590119|FG006|Overall Study|Non-Compliance With Study Drug|0|||
126080900|NCT01296555|453590120|FG007|Overall Study|Non-Compliance With Study Drug|1|||
126080901|NCT01296555|453590121|FG008|Overall Study|Non-Compliance With Study Drug|0|||
126080902|NCT01296555|453590122|FG009|Overall Study|Non-Compliance With Study Drug|0|||
126080903|NCT01296555|453590123|FG010|Overall Study|Non-Compliance With Study Drug|0|||
126080904|NCT01296555|453590124|FG011|Overall Study|Non-Compliance With Study Drug|0|||
126080905|NCT01296555|453590125|FG012|Overall Study|Non-Compliance With Study Drug|0|||
126080906|NCT01296555|453590126|FG013|Overall Study|Non-Compliance With Study Drug|0|||
126080907|NCT01296555|453590127|FG014|Overall Study|Non-Compliance With Study Drug|0|||
126080908|NCT01296555|453590128|FG015|Overall Study|Non-Compliance With Study Drug|0|||
126080909|NCT01296555|453590129|FG016|Overall Study|Non-Compliance With Study Drug|0|||
126080910|NCT01296555|453590130|FG017|Overall Study|Non-Compliance With Study Drug|0|||
126080911|NCT01296555|453590131|FG018|Overall Study|Non-Compliance With Study Drug|0|||
126080912|NCT01296555|453590132|FG019|Overall Study|Non-Compliance With Study Drug|0|||
126080913|NCT01296555|453590133|FG020|Overall Study|Non-Compliance With Study Drug|0|||
126080914|NCT01296555|453590134|FG021|Overall Study|Non-Compliance With Study Drug|0|||
126080915|NCT01296555|453590135|FG022|Overall Study|Non-Compliance With Study Drug|0|||
126080916|NCT01296555|453590136|FG023|Overall Study|Non-Compliance With Study Drug|0|||
126080917|NCT01296555|453590137|FG024|Overall Study|Non-Compliance With Study Drug|0|||
126080918|NCT01296555|453590138|FG025|Overall Study|Non-Compliance With Study Drug|0|||
126080919|NCT01296555|453590139|FG026|Overall Study|Non-Compliance With Study Drug|0|||
126080920|NCT01296555|453590140|FG027|Overall Study|Non-Compliance With Study Drug|0|||
126080921|NCT01296555|453590141|FG028|Overall Study|Non-Compliance With Study Drug|0|||
126080922|NCT01296555|453590113|FG000|Overall Study|Withdrawal by Subject|0|||
126080923|NCT01296555|453590114|FG001|Overall Study|Withdrawal by Subject|0|||
126080924|NCT01296555|453590115|FG002|Overall Study|Withdrawal by Subject|0|||
126080925|NCT01296555|453590116|FG003|Overall Study|Withdrawal by Subject|0|||
126080926|NCT01296555|453590117|FG004|Overall Study|Withdrawal by Subject|1|||
126080927|NCT01296555|453590118|FG005|Overall Study|Withdrawal by Subject|0|||
126080928|NCT01296555|453590119|FG006|Overall Study|Withdrawal by Subject|1|||
126080929|NCT01296555|453590120|FG007|Overall Study|Withdrawal by Subject|0|||
126080930|NCT01296555|453590121|FG008|Overall Study|Withdrawal by Subject|0|||
126080931|NCT01296555|453590122|FG009|Overall Study|Withdrawal by Subject|0|||
126080932|NCT01296555|453590123|FG010|Overall Study|Withdrawal by Subject|1|||
126080933|NCT01296555|453590124|FG011|Overall Study|Withdrawal by Subject|1|||
126080934|NCT01296555|453590125|FG012|Overall Study|Withdrawal by Subject|0|||
126080935|NCT01296555|453590126|FG013|Overall Study|Withdrawal by Subject|0|||
126080936|NCT01296555|453590127|FG014|Overall Study|Withdrawal by Subject|3|||
126080937|NCT01296555|453590128|FG015|Overall Study|Withdrawal by Subject|0|||
126080938|NCT01296555|453590129|FG016|Overall Study|Withdrawal by Subject|2|||
126080939|NCT01296555|453590130|FG017|Overall Study|Withdrawal by Subject|1|||
126080940|NCT01296555|453590131|FG018|Overall Study|Withdrawal by Subject|0|||
126080941|NCT01296555|453590132|FG019|Overall Study|Withdrawal by Subject|1|||
126080942|NCT01296555|453590133|FG020|Overall Study|Withdrawal by Subject|1|||
126080943|NCT01296555|453590134|FG021|Overall Study|Withdrawal by Subject|1|||
126080944|NCT01296555|453590135|FG022|Overall Study|Withdrawal by Subject|3|||
126080945|NCT01296555|453590136|FG023|Overall Study|Withdrawal by Subject|0|||
126080946|NCT01296555|453590137|FG024|Overall Study|Withdrawal by Subject|0|||
126080947|NCT01296555|453590138|FG025|Overall Study|Withdrawal by Subject|0|||
126080948|NCT01296555|453590139|FG026|Overall Study|Withdrawal by Subject|8|||
126080949|NCT01296555|453590140|FG027|Overall Study|Withdrawal by Subject|4|||
126080950|NCT01296555|453590141|FG028|Overall Study|Withdrawal by Subject|2|||
126080951|NCT00409409|453590142|FG000|Overall Study|Adverse Event|7|||
126080952|NCT00409409|453590143|FG001|Overall Study|Adverse Event|2|||
126080953|NCT00409409|453590142|FG000|Overall Study|Withdrawal by Subject|1|||
126080954|NCT00409409|453590143|FG001|Overall Study|Withdrawal by Subject|1|||
126080955|NCT00409409|453590142|FG000|Overall Study|Any other reason not above-mentioned|0|||
126080956|NCT00409409|453590143|FG001|Overall Study|Any other reason not above-mentioned|1|||
126080957|NCT03000348|453590145|FG000|Overall Study|Adverse Event|1|||
126080958|NCT03000348|453590146|FG001|Overall Study|Adverse Event|1|||
126080959|NCT03000348|453590147|FG002|Overall Study|Adverse Event|1|||
126080960|NCT03000348|453590148|FG003|Overall Study|Adverse Event|1|||
126080961|NCT03000348|453590149|FG004|Overall Study|Adverse Event|1|||
126080962|NCT03000348|453590150|FG005|Overall Study|Adverse Event|1|||
126080963|NCT03000348|453590145|FG000|Overall Study|Lost to Follow-up|0|||
126080964|NCT03000348|453590146|FG001|Overall Study|Lost to Follow-up|0|||
126080965|NCT03000348|453590147|FG002|Overall Study|Lost to Follow-up|1|||
126080966|NCT03000348|453590148|FG003|Overall Study|Lost to Follow-up|0|||
126080967|NCT03000348|453590149|FG004|Overall Study|Lost to Follow-up|0|||
126080968|NCT03000348|453590150|FG005|Overall Study|Lost to Follow-up|0|||
126080969|NCT03000348|453590145|FG000|Overall Study|Withdrawal by Subject|0|||
126080970|NCT03000348|453590146|FG001|Overall Study|Withdrawal by Subject|1|||
126080971|NCT03000348|453590147|FG002|Overall Study|Withdrawal by Subject|0|||
126080972|NCT03000348|453590148|FG003|Overall Study|Withdrawal by Subject|0|||
126080973|NCT03000348|453590149|FG004|Overall Study|Withdrawal by Subject|0|||
126080974|NCT03000348|453590150|FG005|Overall Study|Withdrawal by Subject|0|||
125953112|NCT02103478|453126025|FG005|Overall Study|Progressive Disease|1|||
125953113|NCT02103478|453126026|FG006|Overall Study|Progressive Disease|2|||
125953114|NCT02103478|453126027|FG007|Overall Study|Progressive Disease|0|||
125953115|NCT02103478|453126028|FG008|Overall Study|Progressive Disease|1|||
125953116|NCT02103478|453126020|FG000|Overall Study|Withdrawal by Subject|2|||
125953117|NCT02103478|453126021|FG001|Overall Study|Withdrawal by Subject|0|||
125953118|NCT02103478|453126022|FG002|Overall Study|Withdrawal by Subject|0|||
125953119|NCT02103478|453126023|FG003|Overall Study|Withdrawal by Subject|4|||
125953120|NCT02103478|453126024|FG004|Overall Study|Withdrawal by Subject|0|||
125953121|NCT02103478|453126025|FG005|Overall Study|Withdrawal by Subject|0|||
125953122|NCT02103478|453126026|FG006|Overall Study|Withdrawal by Subject|1|||
125953123|NCT02103478|453126027|FG007|Overall Study|Withdrawal by Subject|1|||
125953124|NCT02103478|453126028|FG008|Overall Study|Withdrawal by Subject|0|||
125953125|NCT02103478|453126020|FG000|Overall Study|Lost to Follow-up|0|||
125953126|NCT02103478|453126021|FG001|Overall Study|Lost to Follow-up|0|||
125953127|NCT02103478|453126022|FG002|Overall Study|Lost to Follow-up|0|||
125953128|NCT02103478|453126023|FG003|Overall Study|Lost to Follow-up|0|||
125953129|NCT02103478|453126024|FG004|Overall Study|Lost to Follow-up|0|||
125953130|NCT02103478|453126025|FG005|Overall Study|Lost to Follow-up|0|||
125953131|NCT02103478|453126026|FG006|Overall Study|Lost to Follow-up|0|||
125953132|NCT02103478|453126027|FG007|Overall Study|Lost to Follow-up|1|||
125953133|NCT02103478|453126028|FG008|Overall Study|Lost to Follow-up|0|||
125953134|NCT02103478|453126020|FG000|Overall Study|Other|1|||
125953135|NCT02103478|453126021|FG001|Overall Study|Other|3|||
125953136|NCT02103478|453126022|FG002|Overall Study|Other|2|||
125953137|NCT02103478|453126023|FG003|Overall Study|Other|0|||
125953138|NCT02103478|453126024|FG004|Overall Study|Other|3|||
125953139|NCT02103478|453126025|FG005|Overall Study|Other|8|||
125953140|NCT02103478|453126026|FG006|Overall Study|Other|8|||
125953141|NCT02103478|453126027|FG007|Overall Study|Other|4|||
125953142|NCT02103478|453126028|FG008|Overall Study|Other|2|||
125953143|NCT03219333|453126029|FG000|Overall Study|Withdrawal by Subject|9|||
125953144|NCT03219333|453126030|FG001|Overall Study|Withdrawal by Subject|4|||
125953145|NCT03219333|453126029|FG000|Overall Study|Lost to Follow-up|1|||
125953146|NCT03219333|453126030|FG001|Overall Study|Lost to Follow-up|1|||
125953147|NCT03219333|453126029|FG000|Overall Study|Death|104|||
125953148|NCT03219333|453126030|FG001|Overall Study|Death|72|||
125953149|NCT03219333|453126029|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
125953150|NCT03219333|453126030|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
125953151|NCT03219333|453126029|FG000|Overall Study|Other|2|||
125953152|NCT03219333|453126030|FG001|Overall Study|Other|2|||
125953153|NCT05459129|453126031|FG000|Overall Study|Death|1|||
125953154|NCT05459129|453126032|FG001|Overall Study|Death|0|||
125953155|NCT05459129|453126031|FG000|Overall Study|Study Terminated By Sponsor|5|||
125953156|NCT05459129|453126032|FG001|Overall Study|Study Terminated By Sponsor|6|||
125953157|NCT04182100|453126033|FG000|Overall Study|Adverse Event|1|||
125953158|NCT04182100|453126033|FG000|Overall Study|Withdrawal by Subject|1|||
125953159|NCT03748641|453126036|FG000|Overall Study|Ongoing|155|||
125953160|NCT03748641|453126037|FG001|Overall Study|Ongoing|148|||
125953161|NCT03748641|453126038|FG002|Overall Study|Ongoing|66|||
125953162|NCT03748641|453126039|FG003|Overall Study|Ongoing|79|||
125953163|NCT03748641|453126040|FG004|Overall Study|Ongoing|84|||
125953164|NCT03748641|453126036|FG000|Overall Study|Death|54|||
125953165|NCT03748641|453126037|FG001|Overall Study|Death|59|||
125953166|NCT03748641|453126038|FG002|Overall Study|Death|51|||
125953167|NCT03748641|453126039|FG003|Overall Study|Death|42|||
125953168|NCT03748641|453126040|FG004|Overall Study|Death|9|||
125953169|NCT03748641|453126036|FG000|Overall Study|Lost to Follow-up|0|||
125953170|NCT03748641|453126037|FG001|Overall Study|Lost to Follow-up|2|||
125953171|NCT03748641|453126038|FG002|Overall Study|Lost to Follow-up|1|||
125953172|NCT03748641|453126039|FG003|Overall Study|Lost to Follow-up|0|||
125953173|NCT03748641|453126040|FG004|Overall Study|Lost to Follow-up|0|||
125953174|NCT03748641|453126036|FG000|Overall Study|Withdrawal by Subject|3|||
125953175|NCT03748641|453126037|FG001|Overall Study|Withdrawal by Subject|2|||
125953176|NCT03748641|453126038|FG002|Overall Study|Withdrawal by Subject|5|||
125953177|NCT03748641|453126039|FG003|Overall Study|Withdrawal by Subject|3|||
125953178|NCT03748641|453126040|FG004|Overall Study|Withdrawal by Subject|2|||
125953179|NCT05179421|453126041|FG000|First Infusion Day|Adverse Event|1|||
125953180|NCT05179421|453126042|FG001|First Infusion Day|Adverse Event|0|||
125953181|NCT05132127|453126044|FG000|Overall Study|Adverse Event|1|||
125953182|NCT03473743|453126045|FG000|Overall Study|Withdrawal by Subject|0|||
125953183|NCT03473743|453126046|FG001|Overall Study|Withdrawal by Subject|0|||
125953184|NCT03473743|453126047|FG002|Overall Study|Withdrawal by Subject|0|||
125953185|NCT03473743|453126048|FG003|Overall Study|Withdrawal by Subject|0|||
125953186|NCT03473743|453126049|FG004|Overall Study|Withdrawal by Subject|0|||
125953187|NCT03473743|453126050|FG005|Overall Study|Withdrawal by Subject|0|||
125953188|NCT03473743|453126051|FG006|Overall Study|Withdrawal by Subject|0|||
125953189|NCT03473743|453126052|FG007|Overall Study|Withdrawal by Subject|3|||
125953190|NCT03473743|453126045|FG000|Overall Study|Other|0|||
126080975|NCT03000348|453590145|FG000|Overall Study|Consent|0|||
126080976|NCT03000348|453590146|FG001|Overall Study|Consent|0|||
126080977|NCT03000348|453590147|FG002|Overall Study|Consent|0|||
126080978|NCT03000348|453590148|FG003|Overall Study|Consent|0|||
126080979|NCT03000348|453590149|FG004|Overall Study|Consent|1|||
126080980|NCT03000348|453590150|FG005|Overall Study|Consent|0|||
126080981|NCT03000348|453590145|FG000|Overall Study|Failure to expectorate sputum|1|||
126080982|NCT03000348|453590146|FG001|Overall Study|Failure to expectorate sputum|0|||
126080983|NCT03000348|453590147|FG002|Overall Study|Failure to expectorate sputum|1|||
126080984|NCT03000348|453590148|FG003|Overall Study|Failure to expectorate sputum|0|||
126080985|NCT03000348|453590149|FG004|Overall Study|Failure to expectorate sputum|1|||
126080986|NCT03000348|453590150|FG005|Overall Study|Failure to expectorate sputum|0|||
126080987|NCT03000348|453590145|FG000|Overall Study|No gram negative|1|||
126080988|NCT03000348|453590146|FG001|Overall Study|No gram negative|2|||
126080989|NCT03000348|453590147|FG002|Overall Study|No gram negative|1|||
126080990|NCT03000348|453590148|FG003|Overall Study|No gram negative|1|||
126080991|NCT03000348|453590149|FG004|Overall Study|No gram negative|1|||
126080992|NCT03000348|453590150|FG005|Overall Study|No gram negative|1|||
126080993|NCT03000348|453590145|FG000|Overall Study|Patient had no transport|0|||
126080994|NCT03000348|453590146|FG001|Overall Study|Patient had no transport|0|||
126080995|NCT03000348|453590147|FG002|Overall Study|Patient had no transport|0|||
126080996|NCT03000348|453590148|FG003|Overall Study|Patient had no transport|1|||
126080997|NCT03000348|453590149|FG004|Overall Study|Patient had no transport|0|||
126080998|NCT03000348|453590150|FG005|Overall Study|Patient had no transport|0|||
126080999|NCT03000348|453590145|FG000|Overall Study|Dosing|0|||
126081000|NCT03000348|453590146|FG001|Overall Study|Dosing|0|||
126081001|NCT03000348|453590147|FG002|Overall Study|Dosing|0|||
126081002|NCT03000348|453590148|FG003|Overall Study|Dosing|0|||
126081003|NCT03000348|453590149|FG004|Overall Study|Dosing|1|||
126081004|NCT03000348|453590150|FG005|Overall Study|Dosing|0|||
126081005|NCT04042077|453590151|FG000|Overall Study|Adverse Event|0|||
126081006|NCT04042077|453590152|FG001|Overall Study|Adverse Event|1|||
126081007|NCT04042077|453590151|FG000|Overall Study|Death|2|||
126081008|NCT04042077|453590152|FG001|Overall Study|Death|1|||
126081009|NCT04042077|453590151|FG000|Overall Study|Physician Decision|2|||
126081010|NCT04042077|453590152|FG001|Overall Study|Physician Decision|0|||
126081011|NCT04042077|453590151|FG000|Overall Study|Withdrawal by Subject|3|||
126081012|NCT04042077|453590152|FG001|Overall Study|Withdrawal by Subject|2|||
126081013|NCT04042077|453590151|FG000|Overall Study|Lack of Efficacy|0|||
126081014|NCT04042077|453590152|FG001|Overall Study|Lack of Efficacy|1|||
126081015|NCT01236352|453590157|FG000|Overall Study|Death|0|||
126081016|NCT01236352|453590158|FG001|Overall Study|Death|0|||
126081017|NCT01236352|453590159|FG002|Overall Study|Death|0|||
126081018|NCT01236352|453590160|FG003|Overall Study|Death|0|||
126081019|NCT01236352|453590161|FG004|Overall Study|Death|0|||
126081020|NCT01236352|453590162|FG005|Overall Study|Death|0|||
126081021|NCT01236352|453590163|FG006|Overall Study|Death|0|||
126081022|NCT01236352|453590164|FG007|Overall Study|Death|1|||
126081023|NCT01236352|453590165|FG008|Overall Study|Death|0|||
126081024|NCT01236352|453590166|FG009|Overall Study|Death|0|||
126081025|NCT01236352|453590167|FG010|Overall Study|Death|0|||
126081026|NCT01236352|453590157|FG000|Overall Study|Withdrawal by Subject|0|||
126081027|NCT01236352|453590158|FG001|Overall Study|Withdrawal by Subject|0|||
126081028|NCT01236352|453590159|FG002|Overall Study|Withdrawal by Subject|0|||
126081029|NCT01236352|453590160|FG003|Overall Study|Withdrawal by Subject|0|||
126081030|NCT01236352|453590161|FG004|Overall Study|Withdrawal by Subject|0|||
126081031|NCT01236352|453590162|FG005|Overall Study|Withdrawal by Subject|0|||
126081032|NCT01236352|453590163|FG006|Overall Study|Withdrawal by Subject|0|||
126081033|NCT01236352|453590164|FG007|Overall Study|Withdrawal by Subject|0|||
126081034|NCT01236352|453590165|FG008|Overall Study|Withdrawal by Subject|0|||
126081035|NCT01236352|453590166|FG009|Overall Study|Withdrawal by Subject|2|||
126081036|NCT01236352|453590167|FG010|Overall Study|Withdrawal by Subject|1|||
126081037|NCT01236352|453590157|FG000|Overall Study|Adverse Event|0|||
126081038|NCT01236352|453590158|FG001|Overall Study|Adverse Event|0|||
126081039|NCT01236352|453590159|FG002|Overall Study|Adverse Event|0|||
126081040|NCT01236352|453590160|FG003|Overall Study|Adverse Event|0|||
126081041|NCT01236352|453590161|FG004|Overall Study|Adverse Event|0|||
126081042|NCT01236352|453590162|FG005|Overall Study|Adverse Event|0|||
126081043|NCT01236352|453590163|FG006|Overall Study|Adverse Event|2|||
126081044|NCT01236352|453590164|FG007|Overall Study|Adverse Event|0|||
126081045|NCT01236352|453590165|FG008|Overall Study|Adverse Event|0|||
126081046|NCT01236352|453590166|FG009|Overall Study|Adverse Event|4|||
126081047|NCT01236352|453590167|FG010|Overall Study|Adverse Event|1|||
126081048|NCT01236352|453590157|FG000|Overall Study|Study drug toxicity|0|||
126081049|NCT01236352|453590158|FG001|Overall Study|Study drug toxicity|0|||
126081050|NCT01236352|453590159|FG002|Overall Study|Study drug toxicity|0|||
126081051|NCT01236352|453590160|FG003|Overall Study|Study drug toxicity|0|||
126081052|NCT01236352|453590161|FG004|Overall Study|Study drug toxicity|0|||
126081053|NCT01236352|453590162|FG005|Overall Study|Study drug toxicity|1|||
126081054|NCT01236352|453590163|FG006|Overall Study|Study drug toxicity|1|||
126081055|NCT01236352|453590164|FG007|Overall Study|Study drug toxicity|0|||
126081056|NCT01236352|453590165|FG008|Overall Study|Study drug toxicity|0|||
126081057|NCT01236352|453590166|FG009|Overall Study|Study drug toxicity|2|||
126081058|NCT01236352|453590167|FG010|Overall Study|Study drug toxicity|2|||
126081059|NCT01236352|453590157|FG000|Overall Study|Disease progression|1|||
126081060|NCT01236352|453590158|FG001|Overall Study|Disease progression|2|||
126081061|NCT01236352|453590159|FG002|Overall Study|Disease progression|1|||
126081062|NCT01236352|453590160|FG003|Overall Study|Disease progression|2|||
126081063|NCT01236352|453590161|FG004|Overall Study|Disease progression|2|||
126081064|NCT01236352|453590162|FG005|Overall Study|Disease progression|2|||
126081065|NCT01236352|453590163|FG006|Overall Study|Disease progression|1|||
126081066|NCT01236352|453590164|FG007|Overall Study|Disease progression|3|||
126081067|NCT01236352|453590165|FG008|Overall Study|Disease progression|2|||
126081068|NCT01236352|453590166|FG009|Overall Study|Disease progression|2|||
126081069|NCT01236352|453590167|FG010|Overall Study|Disease progression|2|||
126081070|NCT01236352|453590157|FG000|Overall Study|Poor/Non-compliance|1|||
126081071|NCT01236352|453590158|FG001|Overall Study|Poor/Non-compliance|0|||
126081072|NCT01236352|453590159|FG002|Overall Study|Poor/Non-compliance|0|||
126081073|NCT01236352|453590160|FG003|Overall Study|Poor/Non-compliance|0|||
126081074|NCT01236352|453590161|FG004|Overall Study|Poor/Non-compliance|0|||
126081075|NCT01236352|453590162|FG005|Overall Study|Poor/Non-compliance|0|||
126081076|NCT01236352|453590163|FG006|Overall Study|Poor/Non-compliance|0|||
126081077|NCT01236352|453590164|FG007|Overall Study|Poor/Non-compliance|0|||
126081078|NCT01236352|453590165|FG008|Overall Study|Poor/Non-compliance|0|||
126081079|NCT01236352|453590166|FG009|Overall Study|Poor/Non-compliance|0|||
126081080|NCT01236352|453590167|FG010|Overall Study|Poor/Non-compliance|0|||
126081081|NCT01236352|453590157|FG000|Overall Study|Maximum clinical benefit|1|||
126081082|NCT01236352|453590158|FG001|Overall Study|Maximum clinical benefit|1|||
126081083|NCT01236352|453590159|FG002|Overall Study|Maximum clinical benefit|1|||
126081084|NCT01236352|453590160|FG003|Overall Study|Maximum clinical benefit|0|||
126081085|NCT01236352|453590161|FG004|Overall Study|Maximum clinical benefit|2|||
126081086|NCT01236352|453590162|FG005|Overall Study|Maximum clinical benefit|0|||
126081087|NCT01236352|453590163|FG006|Overall Study|Maximum clinical benefit|3|||
126081088|NCT01236352|453590164|FG007|Overall Study|Maximum clinical benefit|1|||
126081089|NCT01236352|453590165|FG008|Overall Study|Maximum clinical benefit|1|||
126081090|NCT01236352|453590166|FG009|Overall Study|Maximum clinical benefit|4|||
126081091|NCT01236352|453590167|FG010|Overall Study|Maximum clinical benefit|2|||
126081092|NCT01236352|453590157|FG000|Overall Study|Subject request to discontinue treatment|0|||
126081093|NCT01236352|453590158|FG001|Overall Study|Subject request to discontinue treatment|0|||
126081094|NCT01236352|453590159|FG002|Overall Study|Subject request to discontinue treatment|1|||
126081095|NCT01236352|453590160|FG003|Overall Study|Subject request to discontinue treatment|1|||
126081096|NCT01236352|453590161|FG004|Overall Study|Subject request to discontinue treatment|0|||
126081097|NCT01236352|453590162|FG005|Overall Study|Subject request to discontinue treatment|1|||
126081098|NCT01236352|453590163|FG006|Overall Study|Subject request to discontinue treatment|0|||
126081099|NCT01236352|453590164|FG007|Overall Study|Subject request to discontinue treatment|0|||
125953191|NCT03473743|453126046|FG001|Overall Study|Other|0|||
125953192|NCT03473743|453126047|FG002|Overall Study|Other|0|||
125953193|NCT03473743|453126048|FG003|Overall Study|Other|1|||
125953194|NCT03473743|453126049|FG004|Overall Study|Other|0|||
125953195|NCT03473743|453126050|FG005|Overall Study|Other|0|||
125953196|NCT03473743|453126051|FG006|Overall Study|Other|0|||
125953197|NCT03473743|453126052|FG007|Overall Study|Other|0|||
125953198|NCT03473743|453126045|FG000|Overall Study|Ongoing|0|||
125953199|NCT03473743|453126046|FG001|Overall Study|Ongoing|0|||
125953200|NCT03473743|453126047|FG002|Overall Study|Ongoing|6|||
125953201|NCT03473743|453126048|FG003|Overall Study|Ongoing|8|||
125953202|NCT03473743|453126049|FG004|Overall Study|Ongoing|1|||
125953203|NCT03473743|453126050|FG005|Overall Study|Ongoing|1|||
125953204|NCT03473743|453126051|FG006|Overall Study|Ongoing|22|||
125953205|NCT03473743|453126052|FG007|Overall Study|Ongoing|24|||
125953206|NCT03473743|453126045|FG000|Overall Study|Randomized but not treated|0|||
125953207|NCT03473743|453126046|FG001|Overall Study|Randomized but not treated|0|||
125953208|NCT03473743|453126047|FG002|Overall Study|Randomized but not treated|0|||
125953209|NCT03473743|453126048|FG003|Overall Study|Randomized but not treated|0|||
126081100|NCT01236352|453590165|FG008|Overall Study|Subject request to discontinue treatment|0|||
126081101|NCT01236352|453590166|FG009|Overall Study|Subject request to discontinue treatment|1|||
126081102|NCT01236352|453590167|FG010|Overall Study|Subject request to discontinue treatment|4|||
126081103|NCT01236352|453590157|FG000|Overall Study|Subject to receive drug via EAP|1|||
126081104|NCT01236352|453590158|FG001|Overall Study|Subject to receive drug via EAP|1|||
126081105|NCT01236352|453590159|FG002|Overall Study|Subject to receive drug via EAP|1|||
126081106|NCT01236352|453590160|FG003|Overall Study|Subject to receive drug via EAP|0|||
126081107|NCT01236352|453590161|FG004|Overall Study|Subject to receive drug via EAP|0|||
126081108|NCT01236352|453590162|FG005|Overall Study|Subject to receive drug via EAP|0|||
126081109|NCT01236352|453590163|FG006|Overall Study|Subject to receive drug via EAP|0|||
126081110|NCT01236352|453590164|FG007|Overall Study|Subject to receive drug via EAP|2|||
126081111|NCT01236352|453590165|FG008|Overall Study|Subject to receive drug via EAP|0|||
126081112|NCT01236352|453590166|FG009|Overall Study|Subject to receive drug via EAP|4|||
126081113|NCT01236352|453590167|FG010|Overall Study|Subject to receive drug via EAP|0|||
126081114|NCT01236352|453590157|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
126081115|NCT01236352|453590158|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
126081116|NCT01236352|453590159|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
126081117|NCT01236352|453590160|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
126081118|NCT01236352|453590161|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
126081119|NCT01236352|453590162|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
126081120|NCT01236352|453590163|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
126081121|NCT01236352|453590164|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
126081122|NCT01236352|453590165|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
126081123|NCT01236352|453590166|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
126081124|NCT01236352|453590167|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
126081125|NCT01236352|453590157|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081126|NCT01236352|453590158|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081127|NCT01236352|453590159|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081128|NCT01236352|453590160|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081129|NCT01236352|453590161|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081130|NCT01236352|453590162|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081131|NCT01236352|453590163|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081132|NCT01236352|453590164|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081133|NCT01236352|453590165|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081134|NCT01236352|453590166|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126081135|NCT01236352|453590167|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
126081136|NCT01236352|453590157|FG000|Overall Study|Lack of response to drug|0|||
126081137|NCT01236352|453590158|FG001|Overall Study|Lack of response to drug|0|||
126081138|NCT01236352|453590159|FG002|Overall Study|Lack of response to drug|0|||
126081139|NCT01236352|453590160|FG003|Overall Study|Lack of response to drug|0|||
126081140|NCT01236352|453590161|FG004|Overall Study|Lack of response to drug|0|||
126081141|NCT01236352|453590162|FG005|Overall Study|Lack of response to drug|0|||
126081142|NCT01236352|453590163|FG006|Overall Study|Lack of response to drug|0|||
126081143|NCT01236352|453590164|FG007|Overall Study|Lack of response to drug|0|||
126081144|NCT01236352|453590165|FG008|Overall Study|Lack of response to drug|0|||
126081145|NCT01236352|453590166|FG009|Overall Study|Lack of response to drug|1|||
126081146|NCT01236352|453590167|FG010|Overall Study|Lack of response to drug|1|||
126081147|NCT01236352|453590157|FG000|Overall Study|Patient transferred to IST|0|||
126081148|NCT01236352|453590158|FG001|Overall Study|Patient transferred to IST|0|||
126081149|NCT01236352|453590159|FG002|Overall Study|Patient transferred to IST|0|||
126081150|NCT01236352|453590160|FG003|Overall Study|Patient transferred to IST|0|||
126081151|NCT01236352|453590161|FG004|Overall Study|Patient transferred to IST|0|||
126081152|NCT01236352|453590162|FG005|Overall Study|Patient transferred to IST|0|||
126081153|NCT01236352|453590163|FG006|Overall Study|Patient transferred to IST|0|||
126081154|NCT01236352|453590164|FG007|Overall Study|Patient transferred to IST|0|||
126081155|NCT01236352|453590165|FG008|Overall Study|Patient transferred to IST|0|||
126081156|NCT01236352|453590166|FG009|Overall Study|Patient transferred to IST|2|||
126081157|NCT01236352|453590167|FG010|Overall Study|Patient transferred to IST|6|||
126081158|NCT02031536|453590168|FG000|Overall Study|ineligible|1|||
126081159|NCT02031536|453590169|FG001|Overall Study|ineligible|0|||
126081160|NCT01191008|453590182|FG000|Overall Study|Protocol Violation|7|||
126081161|NCT01191008|453590182|FG000|Overall Study|Lost to Follow-up|8|||
126081162|NCT04905849|453590185|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
126081163|NCT04905849|453590186|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
126081164|NCT00838929|453590191|FG000|Overall Study|Protocol Violation|0|||
126081165|NCT00838929|453590192|FG001|Overall Study|Protocol Violation|1|||
126081166|NCT00838929|453590193|FG002|Overall Study|Protocol Violation|0|||
126081167|NCT00838929|453590191|FG000|Overall Study|Disease progression|0|||
126081168|NCT00838929|453590192|FG001|Overall Study|Disease progression|2|||
126081169|NCT00838929|453590193|FG002|Overall Study|Disease progression|1|||
126081170|NCT04913948|453590199|FG000|Overall Study|Withdrawal by Subject|2|||
126081171|NCT04913948|453590199|FG000|Overall Study|Sample processing issues|1|||
126081172|NCT04913948|453590199|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
126081173|NCT01068210|453590202|FG000|Overall Study|Lost to Follow-up|1|||
126081174|NCT01068210|453590203|FG001|Overall Study|Lost to Follow-up|2|||
126081175|NCT01068210|453590204|FG002|Overall Study|Lost to Follow-up|2|||
126081176|NCT01068210|453590205|FG003|Overall Study|Lost to Follow-up|1|||
126081177|NCT01068210|453590202|FG000|Overall Study|Second cancer|0|||
126081178|NCT01068210|453590203|FG001|Overall Study|Second cancer|1|||
126081179|NCT01068210|453590204|FG002|Overall Study|Second cancer|0|||
126081180|NCT01068210|453590205|FG003|Overall Study|Second cancer|0|||
126081181|NCT01068210|453590202|FG000|Overall Study|Disease progression|0|||
126081182|NCT01068210|453590203|FG001|Overall Study|Disease progression|0|||
126081183|NCT01068210|453590204|FG002|Overall Study|Disease progression|0|||
126081184|NCT01068210|453590205|FG003|Overall Study|Disease progression|2|||
126081185|NCT03522389|453590206|FG000|Overall Study|Lost to Follow-up|1|||
126081186|NCT03522389|453590207|FG001|Overall Study|Lost to Follow-up|1|||
126081187|NCT03522389|453590208|FG002|Overall Study|Lost to Follow-up|2|||
126081188|NCT03522389|453590206|FG000|Overall Study|had herniated nucleus pulposus|0|||
126081189|NCT03522389|453590207|FG001|Overall Study|had herniated nucleus pulposus|1|||
126081190|NCT03522389|453590208|FG002|Overall Study|had herniated nucleus pulposus|0|||
126081191|NCT03522389|453590206|FG000|Overall Study|go to work in other province|1|||
126081192|NCT03522389|453590207|FG001|Overall Study|go to work in other province|0|||
126081193|NCT03522389|453590208|FG002|Overall Study|go to work in other province|0|||
126081194|NCT02257918|453590209|FG000|Overall Study|Lost to Follow-up|4|||
126081195|NCT02257918|453590210|FG001|Overall Study|Lost to Follow-up|1|||
126081196|NCT02257918|453590211|FG002|Overall Study|Lost to Follow-up|0|||
126081197|NCT02257918|453590209|FG000|Overall Study|Withdrawal by Subject|0|||
126081198|NCT02257918|453590210|FG001|Overall Study|Withdrawal by Subject|0|||
126081199|NCT02257918|453590211|FG002|Overall Study|Withdrawal by Subject|1|||
126081200|NCT02257918|453590209|FG000|Overall Study|Pregnancy|0|||
126081201|NCT02257918|453590210|FG001|Overall Study|Pregnancy|0|||
126081202|NCT02257918|453590211|FG002|Overall Study|Pregnancy|1|||
126081203|NCT01263054|453590216|FG000|Overall Study|Death|1|||
126081204|NCT01263054|453590217|FG001|Overall Study|Death|0|||
126081205|NCT01263054|453590216|FG000|Overall Study|Lost to Follow-up|2|||
126081206|NCT01263054|453590217|FG001|Overall Study|Lost to Follow-up|2|||
126081207|NCT01263054|453590216|FG000|Overall Study|Withdrawal by Subject|1|||
126081208|NCT01263054|453590217|FG001|Overall Study|Withdrawal by Subject|3|||
126081209|NCT01263054|453590216|FG000|Overall Study|Qualification Violation|1|||
126081210|NCT01263054|453590217|FG001|Overall Study|Qualification Violation|0|||
126081211|NCT01263054|453590216|FG000|Overall Study|Other|0|||
126081212|NCT01263054|453590217|FG001|Overall Study|Other|1|||
126081213|NCT03494985|453590225|FG000|Overall Study|Adverse Event|3|||
126081214|NCT03494985|453590226|FG001|Overall Study|Adverse Event|2|||
126081215|NCT03494985|453590227|FG002|Overall Study|Adverse Event|3|||
126081216|NCT03494985|453590228|FG003|Overall Study|Adverse Event|0|||
126081217|NCT03494985|453590225|FG000|Overall Study|Other (Withdrawal of consent)|2|||
126081218|NCT03494985|453590226|FG001|Overall Study|Other (Withdrawal of consent)|3|||
126081219|NCT03494985|453590227|FG002|Overall Study|Other (Withdrawal of consent)|2|||
126081220|NCT03494985|453590228|FG003|Overall Study|Other (Withdrawal of consent)|5|||
126081221|NCT03494985|453590225|FG000|Overall Study|Other (Not specified)|0|||
126081222|NCT03494985|453590226|FG001|Overall Study|Other (Not specified)|1|||
126081223|NCT03494985|453590227|FG002|Overall Study|Other (Not specified)|1|||
126081224|NCT03494985|453590228|FG003|Overall Study|Other (Not specified)|0|||
126081225|NCT03036124|453590229|FG000|Overall Study|Lost to Follow-up|0|||
126081226|NCT03036124|453590230|FG001|Overall Study|Lost to Follow-up|2|||
126081227|NCT03036124|453590229|FG000|Overall Study|Withdrawal by Subject|5|||
126081228|NCT03036124|453590230|FG001|Overall Study|Withdrawal by Subject|4|||
126081229|NCT02282059|453590231|FG000|Overall Study|Other|15|||
126081230|NCT02282059|453590232|FG001|Overall Study|Other|3|||
126081231|NCT02282059|453590231|FG000|Overall Study|Participant refused further follow-up|8|||
126081232|NCT02282059|453590232|FG001|Overall Study|Participant refused further follow-up|4|||
126081233|NCT02282059|453590231|FG000|Overall Study|Lost to Follow-up|19|||
126081234|NCT02282059|453590232|FG001|Overall Study|Lost to Follow-up|3|||
126081235|NCT02282059|453590231|FG000|Overall Study|Death|40|||
126081236|NCT02282059|453590232|FG001|Overall Study|Death|8|||
126081237|NCT01689363|453592052|FG000|Overall Study|Protocol Violation|0|||
126081238|NCT01689363|453592053|FG001|Overall Study|Protocol Violation|1|||
126081239|NCT01689363|453592054|FG002|Overall Study|Protocol Violation|0|||
126081240|NCT01689363|453592055|FG003|Overall Study|Protocol Violation|0|||
126081241|NCT01689363|453592056|FG004|Overall Study|Protocol Violation|0|||
126081242|NCT01689363|453592057|FG005|Overall Study|Protocol Violation|0|||
126081243|NCT01689363|453592058|FG006|Overall Study|Protocol Violation|0|||
126081244|NCT01689363|453592059|FG007|Overall Study|Protocol Violation|0|||
126081245|NCT02104505|453592060|FG000|First Intervention (14 Days)|Adverse Event|2|||
126081246|NCT02104505|453592061|FG001|First Intervention (14 Days)|Adverse Event|0|||
126081247|NCT02104505|453592060|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
126081248|NCT02104505|453592061|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
126081249|NCT02104505|453592060|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
126081250|NCT02104505|453592061|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
126081251|NCT02104505|453592060|FG000|First Intervention (14 Days)|exclusionary condition|0|||
126081252|NCT02104505|453592061|FG001|First Intervention (14 Days)|exclusionary condition|1|||
126081253|NCT02104505|453592060|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
126081254|NCT02104505|453592061|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
126081255|NCT02104505|453592060|FG000|Second Intervention (14 Days)|Adverse Event|2|||
126081256|NCT02104505|453592061|FG001|Second Intervention (14 Days)|Adverse Event|0|||
126081257|NCT02859064|453592062|FG000|Overall Study|Progressive Disease|3|||
126081258|NCT02859064|453592062|FG000|Overall Study|Physician Decision|1|||
126081259|NCT02859064|453592062|FG000|Overall Study|Withdrawal by Subject|1|||
126081260|NCT02859064|453592062|FG000|Overall Study|Death|1|||
126081261|NCT00321685|453592063|FG000|Overall Study|Adverse Event|18|||
126081262|NCT00321685|453592063|FG000|Overall Study|Death|2|||
126081263|NCT00321685|453592063|FG000|Overall Study|Withdrawal by Subject|8|||
126081264|NCT00321685|453592063|FG000|Overall Study|Alternative therapy|1|||
126081265|NCT00321685|453592063|FG000|Overall Study|Complicating disese|1|||
126081266|NCT00321685|453592063|FG000|Overall Study|Other|5|||
126081267|NCT00321685|453592063|FG000|Overall Study|Not start protocol therapy|2|||
126081268|NCT00321685|453592063|FG000|Overall Study|Ineligible|2|||
126081269|NCT00127842|453592064|FG000|Overall Study|Adverse Event|15|||
126081270|NCT00127842|453592064|FG000|Overall Study|Withdrawal by Subject|3|||
126081271|NCT00127842|453592064|FG000|Overall Study|Lost to Follow-up|1|||
126081272|NCT00127842|453592064|FG000|Overall Study|Lack of Efficacy|12|||
126081273|NCT00127842|453592064|FG000|Overall Study|Noncompliance|2|||
126081274|NCT00127842|453592064|FG000|Overall Study|Protocol Violation|1|||
126081275|NCT00127842|453592064|FG000|Overall Study|Other|5|||
126081276|NCT01638390|453592067|FG000|Overall Study|screening failures|21|||
126081277|NCT01377389|453592070|FG000|Overall Study|Withdrawal by Subject|1|||
126081278|NCT01377389|453592070|FG000|Overall Study|Screen failure|2|||
126081279|NCT01439867|453592071|FG000|Overall Study|Non-compliance|0|||
126081280|NCT01439867|453592072|FG001|Overall Study|Non-compliance|1|||
126081281|NCT01439867|453592071|FG000|Overall Study|Withdrawal by Subject|1|||
126081282|NCT01439867|453592072|FG001|Overall Study|Withdrawal by Subject|2|||
126081283|NCT01439867|453592071|FG000|Overall Study|Administrative Decision|4|||
126081284|NCT01439867|453592072|FG001|Overall Study|Administrative Decision|5|||
126081285|NCT01439867|453592071|FG000|Overall Study|Protocol-specified Criteria|1|||
126081286|NCT01439867|453592072|FG001|Overall Study|Protocol-specified Criteria|0|||
126081287|NCT01131104|453592073|FG000|Overall Study|Withdrawal by Subject|3|||
126081288|NCT01131104|453592073|FG000|Overall Study|Physician Decision|4|||
126081289|NCT01131104|453592073|FG000|Overall Study|Information Not Available|5|||
126081290|NCT01131104|453592073|FG000|Overall Study|No Information on Index Date of Onset|1|||
126081291|NCT00334542|453592074|FG000|Overall Study|Adverse Event|3|||
126081292|NCT00334542|453592074|FG000|Overall Study|Withdrawal by Subject|1|||
126081293|NCT00334542|453592074|FG000|Overall Study|New cancer diagnosis|1|||
126081294|NCT04698915|453592078|FG000|Overall Study|Adverse Event|2|||
126081295|NCT04698915|453592079|FG001|Overall Study|Adverse Event|0|||
126081296|NCT04698915|453592078|FG000|Overall Study|Death|23|||
126081297|NCT04698915|453592079|FG001|Overall Study|Death|20|||
126081298|NCT04698915|453592078|FG000|Overall Study|Physician Decision|1|||
126081299|NCT04698915|453592079|FG001|Overall Study|Physician Decision|1|||
126081300|NCT04698915|453592078|FG000|Overall Study|Lost to Follow-up|1|||
126081301|NCT04698915|453592079|FG001|Overall Study|Lost to Follow-up|0|||
126081302|NCT04698915|453592078|FG000|Overall Study|Study Terminated by Sponsor|55|||
126081303|NCT04698915|453592079|FG001|Overall Study|Study Terminated by Sponsor|60|||
126081304|NCT04698915|453592078|FG000|Overall Study|Withdrawal by Subject|2|||
126081305|NCT04698915|453592079|FG001|Overall Study|Withdrawal by Subject|3|||
126081306|NCT00013611|453592080|FG000|Overall Study|Lost to Follow-up|91|||
126081307|NCT00013611|453592081|FG001|Overall Study|Lost to Follow-up|100|||
126081308|NCT01150045|453592082|FG000|Overall Study|Protocol Violation|0|||
126081309|NCT01150045|453592083|FG001|Overall Study|Protocol Violation|1|||
126081310|NCT01150045|453592084|FG002|Overall Study|Protocol Violation|0|||
126081311|NCT01150045|453592085|FG003|Overall Study|Protocol Violation|1|||
126081312|NCT02094898|453592092|FG000|Overall Study|Clinical Worsening|2|||
126081313|NCT02094898|453592092|FG000|Overall Study|Adverse Event|2|||
126081314|NCT02094898|453592092|FG000|Overall Study|Lack of Efficacy|1|||
126081315|NCT03520075|453592093|FG000|Phase 1 (Dose Escalation)|Death|2|||
126081316|NCT03520075|453592094|FG001|Phase 1 (Dose Escalation)|Death|2|||
126081317|NCT03520075|453592095|FG002|Phase 1 (Dose Escalation)|Death|3|||
126081318|NCT03520075|453592096|FG003|Phase 1 (Dose Escalation)|Death|2|||
126081319|NCT03520075|453592097|FG004|Phase 1 (Dose Escalation)|Death|6|||
126081320|NCT03520075|453592098|FG005|Phase 1 (Dose Escalation)|Death|5|||
126081321|NCT03520075|453592099|FG006|Phase 1 (Dose Escalation)|Death|3|||
126081322|NCT03520075|453592100|FG007|Phase 1 (Dose Escalation)|Death|2|||
126081323|NCT03520075|453592101|FG008|Phase 1 (Dose Escalation)|Death|3|||
126081324|NCT03520075|453592102|FG009|Phase 1 (Dose Escalation)|Death|1|||
126081325|NCT03520075|453592103|FG010|Phase 1 (Dose Escalation)|Death|5|||
126081326|NCT03520075|453592104|FG011|Phase 1 (Dose Escalation)|Death|7|||
126081327|NCT03520075|453592105|FG012|Phase 1 (Dose Escalation)|Death|11|||
126081328|NCT03520075|453592106|FG013|Phase 1 (Dose Escalation)|Death|0|||
126081329|NCT03520075|453592107|FG014|Phase 1 (Dose Escalation)|Death|0|||
126081330|NCT03520075|453592108|FG015|Phase 1 (Dose Escalation)|Death|0|||
126081331|NCT03520075|453592109|FG016|Phase 1 (Dose Escalation)|Death|0|||
126081332|NCT03520075|453592110|FG017|Phase 1 (Dose Escalation)|Death|0|||
126081333|NCT03520075|453592111|FG018|Phase 1 (Dose Escalation)|Death|0|||
126081334|NCT03520075|453592093|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
126081335|NCT03520075|453592094|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081336|NCT03520075|453592095|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081337|NCT03520075|453592096|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
126081338|NCT03520075|453592097|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
126081339|NCT03520075|453592098|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
126081340|NCT03520075|453592099|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125953210|NCT03473743|453126049|FG004|Overall Study|Randomized but not treated|0|||
125953211|NCT03473743|453126050|FG005|Overall Study|Randomized but not treated|0|||
125953212|NCT03473743|453126051|FG006|Overall Study|Randomized but not treated|1|||
125953213|NCT03473743|453126052|FG007|Overall Study|Randomized but not treated|1|||
125953214|NCT02052739|453126058|FG000|Overall Study|Withdrew due to Adverse Event|3|||
125953215|NCT02052739|453126059|FG001|Overall Study|Withdrew due to Adverse Event|0|||
125953216|NCT02052739|453126058|FG000|Overall Study|Participant Died|2|||
125953217|NCT02052739|453126059|FG001|Overall Study|Participant Died|1|||
125953218|NCT05619692|453126060|FG000|Overall Study|Adverse Event|2|||
125953219|NCT05619692|453126061|FG001|Overall Study|Adverse Event|2|||
125953220|NCT05619692|453126060|FG000|Overall Study|Withdrawal by Participant|3|||
125953221|NCT05619692|453126061|FG001|Overall Study|Withdrawal by Participant|4|||
125953222|NCT05619692|453126060|FG000|Overall Study|Lost to Follow-up|2|||
125953223|NCT05619692|453126061|FG001|Overall Study|Lost to Follow-up|1|||
125953224|NCT05619692|453126060|FG000|Overall Study|Randomized but not treated|1|||
125953225|NCT05619692|453126061|FG001|Overall Study|Randomized but not treated|3|||
125953226|NCT05267054|453126062|FG000|Overall Study|Death|13|||
125953227|NCT05267054|453126063|FG001|Overall Study|Death|14|||
125953228|NCT05267054|453126062|FG000|Overall Study|Study Ended by Sponsor|9|||
125953229|NCT05267054|453126063|FG001|Overall Study|Study Ended by Sponsor|13|||
125953230|NCT05267054|453126062|FG000|Overall Study|Lost to Follow-up|1|||
125953231|NCT05267054|453126063|FG001|Overall Study|Lost to Follow-up|1|||
125953232|NCT05267054|453126062|FG000|Overall Study|Withdrawal by Subject|1|||
125953233|NCT05267054|453126063|FG001|Overall Study|Withdrawal by Subject|1|||
125953234|NCT03604692|453126064|FG000|Overall Study|Investigator's Decision|0|||
125953235|NCT03604692|453126065|FG001|Overall Study|Investigator's Decision|0|||
125953236|NCT03604692|453126066|FG002|Overall Study|Investigator's Decision|0|||
125953237|NCT03604692|453126067|FG003|Overall Study|Investigator's Decision|1|||
125953238|NCT03604692|453126068|FG004|Overall Study|Investigator's Decision|0|||
125953239|NCT03604692|453126069|FG005|Overall Study|Investigator's Decision|7|||
125953240|NCT03604692|453126064|FG000|Overall Study|Withdrawal by Subject|0|||
125953241|NCT03604692|453126065|FG001|Overall Study|Withdrawal by Subject|0|||
125953242|NCT03604692|453126066|FG002|Overall Study|Withdrawal by Subject|0|||
125953243|NCT03604692|453126067|FG003|Overall Study|Withdrawal by Subject|0|||
125953244|NCT03604692|453126068|FG004|Overall Study|Withdrawal by Subject|0|||
125953245|NCT03604692|453126069|FG005|Overall Study|Withdrawal by Subject|2|||
125953246|NCT03604692|453126064|FG000|Overall Study|Progressive Disease|1|||
125953247|NCT03604692|453126065|FG001|Overall Study|Progressive Disease|0|||
125953248|NCT03604692|453126066|FG002|Overall Study|Progressive Disease|1|||
125953249|NCT03604692|453126067|FG003|Overall Study|Progressive Disease|0|||
125953250|NCT03604692|453126068|FG004|Overall Study|Progressive Disease|3|||
125953251|NCT03604692|453126069|FG005|Overall Study|Progressive Disease|4|||
125953252|NCT03604692|453126064|FG000|Overall Study|Difficulty Coming into Site|0|||
125953253|NCT03604692|453126065|FG001|Overall Study|Difficulty Coming into Site|0|||
125953254|NCT03604692|453126066|FG002|Overall Study|Difficulty Coming into Site|0|||
125953255|NCT03604692|453126067|FG003|Overall Study|Difficulty Coming into Site|0|||
125953256|NCT03604692|453126068|FG004|Overall Study|Difficulty Coming into Site|0|||
125953257|NCT03604692|453126069|FG005|Overall Study|Difficulty Coming into Site|1|||
125953258|NCT03604692|453126064|FG000|Overall Study|Death|0|||
125953259|NCT03604692|453126065|FG001|Overall Study|Death|0|||
125953260|NCT03604692|453126066|FG002|Overall Study|Death|1|||
125953261|NCT03604692|453126067|FG003|Overall Study|Death|0|||
125953262|NCT03604692|453126068|FG004|Overall Study|Death|0|||
125953263|NCT03604692|453126069|FG005|Overall Study|Death|0|||
125953264|NCT03604692|453126064|FG000|Overall Study|Drug Intolerance|0|||
125953265|NCT03604692|453126065|FG001|Overall Study|Drug Intolerance|0|||
125953266|NCT03604692|453126066|FG002|Overall Study|Drug Intolerance|0|||
125953267|NCT03604692|453126067|FG003|Overall Study|Drug Intolerance|1|||
125953268|NCT03604692|453126068|FG004|Overall Study|Drug Intolerance|0|||
125953269|NCT03604692|453126069|FG005|Overall Study|Drug Intolerance|0|||
125953270|NCT03604692|453126064|FG000|Overall Study|Noncompliance with follow-up visit|0|||
125953271|NCT03604692|453126065|FG001|Overall Study|Noncompliance with follow-up visit|0|||
125953272|NCT03604692|453126066|FG002|Overall Study|Noncompliance with follow-up visit|0|||
125953273|NCT03604692|453126067|FG003|Overall Study|Noncompliance with follow-up visit|1|||
125953274|NCT03604692|453126068|FG004|Overall Study|Noncompliance with follow-up visit|0|||
125953275|NCT03604692|453126069|FG005|Overall Study|Noncompliance with follow-up visit|0|||
125953276|NCT03604692|453126064|FG000|Overall Study|Not Treated|0|||
125953277|NCT03604692|453126065|FG001|Overall Study|Not Treated|0|||
125953278|NCT03604692|453126066|FG002|Overall Study|Not Treated|0|||
125953279|NCT03604692|453126067|FG003|Overall Study|Not Treated|0|||
125953280|NCT03604692|453126068|FG004|Overall Study|Not Treated|1|||
125953281|NCT03604692|453126069|FG005|Overall Study|Not Treated|0|||
125953282|NCT02703636|453126070|FG000|Overall Study|Adverse Event|14|||
125953283|NCT02703636|453126070|FG000|Overall Study|Study stopped by sponsor|1|||
125953284|NCT02703636|453126070|FG000|Overall Study|Withdrawal by Subject|1|||
125953285|NCT00393939|453126071|FG000|Overall Study|Protocol Violation|1|||
125953286|NCT00393939|453126072|FG001|Overall Study|Protocol Violation|1|||
125953287|NCT00393939|453126071|FG000|Overall Study|Lost to Follow-up|2|||
126081341|NCT03520075|453592100|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
126081342|NCT03520075|453592101|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081343|NCT03520075|453592102|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
126081344|NCT03520075|453592103|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081345|NCT03520075|453592104|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081346|NCT03520075|453592105|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
126081347|NCT03520075|453592106|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081348|NCT03520075|453592107|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081349|NCT03520075|453592108|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081350|NCT03520075|453592109|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081351|NCT03520075|453592110|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081352|NCT03520075|453592111|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126081353|NCT03520075|453592093|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081354|NCT03520075|453592094|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126081355|NCT03520075|453592095|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081356|NCT03520075|453592096|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126081357|NCT03520075|453592097|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126081358|NCT03520075|453592098|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081359|NCT03520075|453592099|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081360|NCT03520075|453592100|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081361|NCT03520075|453592101|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081362|NCT03520075|453592102|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081363|NCT03520075|453592103|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126081364|NCT03520075|453592104|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081365|NCT03520075|453592105|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126081366|NCT03520075|453592106|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081367|NCT03520075|453592107|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081368|NCT03520075|453592108|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081369|NCT03520075|453592109|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081370|NCT03520075|453592110|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081371|NCT03520075|453592111|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126081372|NCT03520075|453592093|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081373|NCT03520075|453592094|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081374|NCT03520075|453592095|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081375|NCT03520075|453592096|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081376|NCT03520075|453592097|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081377|NCT03520075|453592098|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081378|NCT03520075|453592099|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081379|NCT03520075|453592100|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081380|NCT03520075|453592101|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081381|NCT03520075|453592102|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
126081382|NCT03520075|453592103|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081383|NCT03520075|453592104|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081384|NCT03520075|453592105|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
126081385|NCT03520075|453592106|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081386|NCT03520075|453592107|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081387|NCT03520075|453592108|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081388|NCT03520075|453592109|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081389|NCT03520075|453592110|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081390|NCT03520075|453592111|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126081391|NCT03520075|453592093|FG000|Phase 2 (Dose Expansion)|Death|0|||
126081392|NCT03520075|453592094|FG001|Phase 2 (Dose Expansion)|Death|0|||
126081393|NCT03520075|453592095|FG002|Phase 2 (Dose Expansion)|Death|0|||
126081394|NCT03520075|453592096|FG003|Phase 2 (Dose Expansion)|Death|0|||
126081395|NCT03520075|453592097|FG004|Phase 2 (Dose Expansion)|Death|0|||
126081396|NCT03520075|453592098|FG005|Phase 2 (Dose Expansion)|Death|0|||
126081397|NCT03520075|453592099|FG006|Phase 2 (Dose Expansion)|Death|0|||
126081398|NCT03520075|453592100|FG007|Phase 2 (Dose Expansion)|Death|0|||
126081399|NCT03520075|453592101|FG008|Phase 2 (Dose Expansion)|Death|0|||
126081400|NCT03520075|453592102|FG009|Phase 2 (Dose Expansion)|Death|0|||
126115404|NCT02146599|453718108|FG000|Overall Study|Failed to meet inclusion criteria|5|||
126081401|NCT03520075|453592103|FG010|Phase 2 (Dose Expansion)|Death|0|||
126081402|NCT03520075|453592104|FG011|Phase 2 (Dose Expansion)|Death|0|||
126081403|NCT03520075|453592105|FG012|Phase 2 (Dose Expansion)|Death|0|||
126081404|NCT03520075|453592106|FG013|Phase 2 (Dose Expansion)|Death|20|||
126081405|NCT03520075|453592107|FG014|Phase 2 (Dose Expansion)|Death|13|||
126081406|NCT03520075|453592108|FG015|Phase 2 (Dose Expansion)|Death|9|||
126115405|NCT03061175|453718114|FG000|Baseline|Participant was deemed ineligible|1|||
125953288|NCT00393939|453126072|FG001|Overall Study|Lost to Follow-up|4|||
125953289|NCT00393939|453126071|FG000|Overall Study|Death|10|||
126081407|NCT03520075|453592109|FG016|Phase 2 (Dose Expansion)|Death|5|||
126081408|NCT03520075|453592110|FG017|Phase 2 (Dose Expansion)|Death|14|||
126081409|NCT03520075|453592111|FG018|Phase 2 (Dose Expansion)|Death|12|||
126081410|NCT03520075|453592093|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081411|NCT03520075|453592094|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081412|NCT03520075|453592095|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081413|NCT03520075|453592096|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081414|NCT03520075|453592097|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081415|NCT03520075|453592098|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081416|NCT03520075|453592099|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081417|NCT03520075|453592100|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081418|NCT03520075|453592101|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081419|NCT03520075|453592102|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081420|NCT03520075|453592103|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081421|NCT03520075|453592104|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081422|NCT03520075|453592105|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081423|NCT03520075|453592106|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126081424|NCT03520075|453592107|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
126081425|NCT03520075|453592108|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
126081426|NCT03520075|453592109|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
126081427|NCT03520075|453592110|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
126081428|NCT03520075|453592111|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
126081429|NCT03520075|453592093|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081430|NCT03520075|453592094|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081431|NCT03520075|453592095|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081432|NCT03520075|453592096|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081433|NCT03520075|453592097|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081434|NCT03520075|453592098|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081435|NCT03520075|453592099|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081436|NCT03520075|453592100|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081437|NCT03520075|453592101|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081438|NCT03520075|453592102|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081439|NCT03520075|453592103|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081440|NCT03520075|453592104|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081441|NCT03520075|453592105|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081442|NCT03520075|453592106|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081443|NCT03520075|453592107|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
126081444|NCT03520075|453592108|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
126081445|NCT03520075|453592109|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081446|NCT03520075|453592110|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126081447|NCT03520075|453592111|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
126081448|NCT03520075|453592093|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081449|NCT03520075|453592094|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081450|NCT03520075|453592095|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081451|NCT03520075|453592096|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081452|NCT03520075|453592097|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081453|NCT03520075|453592098|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081454|NCT03520075|453592099|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081455|NCT03520075|453592100|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081456|NCT03520075|453592101|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081457|NCT03520075|453592102|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081458|NCT03520075|453592103|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081459|NCT03520075|453592104|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125953290|NCT00393939|453126072|FG001|Overall Study|Death|4|||
125953291|NCT00393939|453126071|FG000|Overall Study|Sponsor|5|||
125953292|NCT00393939|453126072|FG001|Overall Study|Sponsor|13|||
125953293|NCT00393939|453126071|FG000|Overall Study|Objective progression or relapse|239|||
125953294|NCT00393939|453126072|FG001|Overall Study|Objective progression or relapse|223|||
125953295|NCT00393939|453126071|FG000|Overall Study|Withdrawal by Subject|2|||
125953296|NCT00393939|453126072|FG001|Overall Study|Withdrawal by Subject|7|||
125953297|NCT00393939|453126071|FG000|Overall Study|Other|37|||
125953298|NCT00393939|453126072|FG001|Overall Study|Other|45|||
125953299|NCT00006184|453126073|FG000|Overall Study|Death|1|||
125953300|NCT00006184|453126074|FG001|Overall Study|Death|0|||
125953301|NCT02161718|453126075|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
126081460|NCT03520075|453592105|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081461|NCT03520075|453592106|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
125953302|NCT02161718|453126076|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
125953303|NCT02161718|453126077|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
125953304|NCT02161718|453126075|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
125953305|NCT02161718|453126076|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
125953306|NCT02161718|453126077|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
125953307|NCT02161718|453126075|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
126081462|NCT03520075|453592107|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081463|NCT03520075|453592108|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081464|NCT03520075|453592109|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
126081465|NCT03520075|453592110|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
126081466|NCT03520075|453592111|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126081467|NCT05382039|453592112|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
126081468|NCT05382039|453592113|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
126081469|NCT05382039|453592114|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
126081470|NCT05382039|453592112|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
126081471|NCT05382039|453592113|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
126081472|NCT05382039|453592114|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
126081473|NCT05382039|453592112|FG000|Overall Study|waiting for confirmation|0|||
126081474|NCT05382039|453592113|FG001|Overall Study|waiting for confirmation|0|||
126081475|NCT05382039|453592114|FG002|Overall Study|waiting for confirmation|1|||
126081476|NCT01432626|453592115|FG000|Overall Study|LV function recovered|2|||
126081477|NCT01432626|453592115|FG000|Overall Study|Withdrawal by Subject|2|||
126081478|NCT01432626|453592115|FG000|Overall Study|Only 1 image competed|2|||
126081479|NCT01432626|453592115|FG000|Overall Study|Imaging agent not available|1|||
126081480|NCT01234883|453592116|FG000|Overall Study|Early treatment release|8|||
126081481|NCT01234883|453592117|FG001|Overall Study|Early treatment release|10|||
126081482|NCT01234883|453592116|FG000|Overall Study|Parent/guardian withdrew consent|1|||
126081483|NCT01234883|453592117|FG001|Overall Study|Parent/guardian withdrew consent|2|||
126081484|NCT01234883|453592116|FG000|Overall Study|Technical difficulties with IV infusion|0|||
126081485|NCT01234883|453592117|FG001|Overall Study|Technical difficulties with IV infusion|1|||
126081486|NCT01234883|453592116|FG000|Overall Study|Inclusion/exclusion failure|1|||
126081487|NCT01234883|453592117|FG001|Overall Study|Inclusion/exclusion failure|0|||
126081488|NCT00126659|453592123|FG000|Overall Study|Adverse Event|0|||
126081489|NCT00126659|453592124|FG001|Overall Study|Adverse Event|0|||
126081490|NCT00126659|453592125|FG002|Overall Study|Adverse Event|2|||
126081491|NCT01013961|453592126|FG000|Overall Study|Adverse Event|2|||
126081492|NCT01013961|453592127|FG001|Overall Study|Adverse Event|2|||
126081493|NCT01013961|453592126|FG000|Overall Study|Withdrawal by Subject|1|||
126081494|NCT01013961|453592127|FG001|Overall Study|Withdrawal by Subject|0|||
126081495|NCT01013961|453592126|FG000|Overall Study|Physician Decision|0|||
126081496|NCT01013961|453592127|FG001|Overall Study|Physician Decision|1|||
126081497|NCT01375751|453592132|FG000|Overall Study|Other|0|||
126081498|NCT01375751|453592133|FG001|Overall Study|Other|1|||
126081499|NCT01375751|453592134|FG002|Overall Study|Other|0|||
126081500|NCT02980523|453592135|FG000|Overall Study|Lost to Follow-up|1|||
126081501|NCT02980523|453592136|FG001|Overall Study|Lost to Follow-up|4|||
126081502|NCT02980523|453592137|FG002|Overall Study|Lost to Follow-up|1|||
126081503|NCT02980523|453592138|FG003|Overall Study|Lost to Follow-up|2|||
126081504|NCT02980523|453592139|FG004|Overall Study|Lost to Follow-up|1|||
126081505|NCT02980523|453592135|FG000|Overall Study|Excluded from analysis|1|||
126081506|NCT02980523|453592136|FG001|Overall Study|Excluded from analysis|3|||
126081507|NCT02980523|453592137|FG002|Overall Study|Excluded from analysis|1|||
126081508|NCT02980523|453592138|FG003|Overall Study|Excluded from analysis|1|||
126081509|NCT02980523|453592139|FG004|Overall Study|Excluded from analysis|1|||
126081510|NCT02980523|453592135|FG000|Overall Study|Lack of Efficacy|1|||
126081511|NCT02980523|453592136|FG001|Overall Study|Lack of Efficacy|4|||
126081512|NCT02980523|453592137|FG002|Overall Study|Lack of Efficacy|4|||
126081513|NCT02980523|453592138|FG003|Overall Study|Lack of Efficacy|5|||
126081514|NCT02980523|453592139|FG004|Overall Study|Lack of Efficacy|8|||
126081515|NCT02980523|453592135|FG000|Overall Study|Did not receive intervention|0|||
126081516|NCT02980523|453592136|FG001|Overall Study|Did not receive intervention|0|||
126081517|NCT02980523|453592137|FG002|Overall Study|Did not receive intervention|0|||
126081518|NCT02980523|453592138|FG003|Overall Study|Did not receive intervention|1|||
126081519|NCT02980523|453592139|FG004|Overall Study|Did not receive intervention|0|||
126081520|NCT01547598|453592140|FG000|Overall Study|Withdrew consent|1|||
125953308|NCT02161718|453126076|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
125953309|NCT02161718|453126077|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
126081521|NCT01547598|453592141|FG001|Overall Study|Withdrew consent|1|||
126081522|NCT01547598|453592140|FG000|Overall Study|Lost to Follow-up|1|||
126081523|NCT01547598|453592141|FG001|Overall Study|Lost to Follow-up|1|||
126081524|NCT01547598|453592140|FG000|Overall Study|Adverse Event|1|||
126081525|NCT01547598|453592141|FG001|Overall Study|Adverse Event|1|||
126081526|NCT01547598|453592140|FG000|Overall Study|Protocol Violation|1|||
126081527|NCT01547598|453592141|FG001|Overall Study|Protocol Violation|1|||
126081528|NCT01547598|453592140|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126081529|NCT01547598|453592141|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125953310|NCT02161718|453126075|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
125953311|NCT02161718|453126076|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
125953312|NCT02161718|453126077|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
125953313|NCT02161718|453126075|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
125953314|NCT02161718|453126076|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
125953315|NCT02161718|453126077|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
125953316|NCT02161718|453126075|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
125953317|NCT02161718|453126076|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
125953318|NCT02161718|453126077|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
125953319|NCT02161718|453126075|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
125953320|NCT02161718|453126076|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
125953321|NCT02161718|453126077|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
125953322|NCT02161718|453126075|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
125953323|NCT02161718|453126076|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
125953324|NCT02161718|453126077|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
125953325|NCT02161718|453126075|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
125953326|NCT02161718|453126076|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
125953327|NCT02161718|453126077|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
125953328|NCT02161718|453126075|FG000|Post- Randomization Period|Lost to Follow-up|0|||
125953329|NCT02161718|453126076|FG001|Post- Randomization Period|Lost to Follow-up|9|||
125953330|NCT02161718|453126077|FG002|Post- Randomization Period|Lost to Follow-up|15|||
125953331|NCT02161718|453126075|FG000|Post- Randomization Period|Adverse Event|0|||
125953332|NCT02161718|453126076|FG001|Post- Randomization Period|Adverse Event|9|||
125953333|NCT02161718|453126077|FG002|Post- Randomization Period|Adverse Event|10|||
125953334|NCT02161718|453126075|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
125953335|NCT02161718|453126076|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
125953336|NCT02161718|453126077|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
125953337|NCT02161718|453126075|FG000|Post- Randomization Period|Physician Decision|0|||
125953338|NCT02161718|453126076|FG001|Post- Randomization Period|Physician Decision|2|||
125953339|NCT02161718|453126077|FG002|Post- Randomization Period|Physician Decision|4|||
125953340|NCT02161718|453126075|FG000|Post- Randomization Period|Protocol Violation|0|||
125953341|NCT02161718|453126076|FG001|Post- Randomization Period|Protocol Violation|2|||
125953342|NCT02161718|453126077|FG002|Post- Randomization Period|Protocol Violation|3|||
125953343|NCT02161718|453126075|FG000|Post- Randomization Period|Lack of Efficacy|0|||
125953344|NCT02161718|453126076|FG001|Post- Randomization Period|Lack of Efficacy|0|||
125953345|NCT02161718|453126077|FG002|Post- Randomization Period|Lack of Efficacy|1|||
125953346|NCT02161718|453126075|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
125953347|NCT02161718|453126076|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
125953348|NCT02161718|453126077|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
125953349|NCT02161718|453126075|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
125953350|NCT02161718|453126076|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
125953351|NCT02161718|453126077|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
125953352|NCT02161718|453126075|FG000|Post- Randomization Period|Relocation|0|||
125953353|NCT02161718|453126076|FG001|Post- Randomization Period|Relocation|3|||
125953354|NCT02161718|453126077|FG002|Post- Randomization Period|Relocation|0|||
125953355|NCT04181827|453126080|FG000|Overall Study|Ongoing|124|||
125953356|NCT04181827|453126081|FG001|Overall Study|Ongoing|157|||
125953357|NCT04181827|453126080|FG000|Overall Study|Death|82|||
125953358|NCT04181827|453126081|FG001|Overall Study|Death|50|||
125953359|NCT04181827|453126080|FG000|Overall Study|Lost to Follow-up|0|||
125953360|NCT04181827|453126081|FG001|Overall Study|Lost to Follow-up|1|||
125953361|NCT04181827|453126080|FG000|Overall Study|Withdrawal by Subject|5|||
125953362|NCT04181827|453126081|FG001|Overall Study|Withdrawal by Subject|0|||
125953363|NCT01857063|453126082|FG000|Period 1 (7 Days)|Adverse Event|0|||
125953364|NCT01857063|453126083|FG001|Period 1 (7 Days)|Adverse Event|1|||
125953365|NCT01857063|453126082|FG000|Period 1 (7 Days)|Physician Decision|1|||
125953366|NCT01857063|453126083|FG001|Period 1 (7 Days)|Physician Decision|0|||
125953367|NCT01857063|453126082|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
125953368|NCT01857063|453126083|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
125953369|NCT01857063|453126082|FG000|Period 2 (7 Days)|Adverse Event|2|||
125953370|NCT01857063|453126083|FG001|Period 2 (7 Days)|Adverse Event|1|||
125953371|NCT01857063|453126082|FG000|Period 2 (7 Days)|Physician Decision|1|||
125953372|NCT01857063|453126083|FG001|Period 2 (7 Days)|Physician Decision|1|||
125953373|NCT01857063|453126082|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
125953374|NCT01857063|453126083|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
125953375|NCT01256710|453126086|FG000|Overall Study|Death|449|||
126081530|NCT02229227|453592150|FG000|Overall Study|Adverse Event|14|||
125953376|NCT01256710|453126086|FG000|Overall Study|System Explant|67|||
125953377|NCT01256710|453126086|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
125953378|NCT01256710|453126086|FG000|Overall Study|Lost to Follow-up|67|||
126081531|NCT02229227|453592151|FG001|Overall Study|Adverse Event|9|||
126081532|NCT02229227|453592150|FG000|Overall Study|Lack of Efficacy|3|||
126081533|NCT02229227|453592151|FG001|Overall Study|Lack of Efficacy|3|||
126081534|NCT02229227|453592150|FG000|Overall Study|Protocol Violation|6|||
126081535|NCT02229227|453592151|FG001|Overall Study|Protocol Violation|8|||
126081536|NCT02229227|453592150|FG000|Overall Study|Protocol defined stopping criteria|1|||
126081537|NCT02229227|453592151|FG001|Overall Study|Protocol defined stopping criteria|3|||
126081538|NCT02229227|453592150|FG000|Overall Study|Lost to Follow-up|3|||
126081539|NCT02229227|453592151|FG001|Overall Study|Lost to Follow-up|3|||
126081540|NCT02229227|453592150|FG000|Overall Study|Study terminated by sponsor|11|||
126081541|NCT02229227|453592151|FG001|Overall Study|Study terminated by sponsor|11|||
126081542|NCT02229227|453592150|FG000|Overall Study|Withdrawal by Subject|8|||
126081543|NCT02229227|453592151|FG001|Overall Study|Withdrawal by Subject|12|||
126081544|NCT02229227|453592150|FG000|Overall Study|Other|0|||
126081545|NCT02229227|453592151|FG001|Overall Study|Other|1|||
126081546|NCT02229227|453592150|FG000|Overall Study|Physician Decision|5|||
126081547|NCT02229227|453592151|FG001|Overall Study|Physician Decision|12|||
126081548|NCT04071301|453592152|FG000|Overall Study|Withdrawal by Subject|6|||
126081549|NCT04071301|453592152|FG000|Overall Study|Death|1|||
126081550|NCT05186311|453592153|FG000|Part A: Serum|Withdrawal by Subject|1|||
126081551|NCT02125279|453592154|FG000|Overall Study|Lack of Efficacy|2|||
126081552|NCT02125279|453592154|FG000|Overall Study|Withdrawal by Subject|6|||
126081553|NCT02125279|453592154|FG000|Overall Study|Protocol Violation|1|||
126081554|NCT02125279|453592154|FG000|Overall Study|Lost to Follow-up|4|||
126081555|NCT01850589|453592162|FG000|Overall Study|Withdrawal by Subject|8|||
126081556|NCT01850589|453592163|FG001|Overall Study|Withdrawal by Subject|0|||
126081557|NCT04468230|453592167|FG000|Overall Study|Adverse Event|2|||
126081558|NCT01790295|453592171|FG000|Overall Study|Adverse Event|1|||
126081559|NCT01790295|453592171|FG000|Overall Study|Death|4|||
126081560|NCT01790295|453592171|FG000|Overall Study|Lack of Efficacy|2|||
126081561|NCT01790295|453592171|FG000|Overall Study|Study closure|4|||
126081562|NCT03721705|453592172|FG000|Overall Study|Adverse Event|2|||
126081563|NCT03721705|453592173|FG001|Overall Study|Adverse Event|0|||
126081564|NCT03721705|453592172|FG000|Overall Study|Withdrawal by Subject|4|||
126081565|NCT03721705|453592173|FG001|Overall Study|Withdrawal by Subject|10|||
126081566|NCT03721705|453592172|FG000|Overall Study|No Suitable Study Partner|1|||
126081567|NCT03721705|453592173|FG001|Overall Study|No Suitable Study Partner|0|||
126081568|NCT03721705|453592172|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
126081569|NCT03721705|453592173|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
126081570|NCT03721705|453592172|FG000|Overall Study|Death|0|||
126081571|NCT03721705|453592173|FG001|Overall Study|Death|1|||
126081572|NCT03721172|453592176|FG000|Placebo-controlled Phase|Adverse Event|7|||
126081573|NCT03721172|453592177|FG001|Placebo-controlled Phase|Adverse Event|7|||
126081574|NCT03721172|453592178|FG002|Placebo-controlled Phase|Adverse Event|0|||
126081575|NCT03721172|453592176|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
126081576|NCT03721172|453592177|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
126081577|NCT03721172|453592178|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
126081578|NCT03721172|453592176|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
126081579|NCT03721172|453592177|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
126081580|NCT03721172|453592178|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
126081581|NCT03721172|453592176|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
126081582|NCT03721172|453592177|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
126081583|NCT03721172|453592178|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
126081584|NCT03721172|453592176|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
126081585|NCT03721172|453592177|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
126115406|NCT03061175|453718115|FG001|Baseline|Participant was deemed ineligible|0|||
126081586|NCT03721172|453592178|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
126081587|NCT03721172|453592176|FG000|Placebo-controlled Phase|Other|3|||
126081588|NCT03721172|453592177|FG001|Placebo-controlled Phase|Other|0|||
126081589|NCT03721172|453592178|FG002|Placebo-controlled Phase|Other|0|||
126081590|NCT03721172|453592176|FG000|Apremilast Extension Phase|Adverse Event|0|||
126081591|NCT03721172|453592177|FG001|Apremilast Extension Phase|Adverse Event|0|||
126081592|NCT03721172|453592178|FG002|Apremilast Extension Phase|Adverse Event|10|||
126081593|NCT03721172|453592176|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
126081594|NCT03721172|453592177|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
126081595|NCT03721172|453592178|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
126081596|NCT03721172|453592176|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
126081597|NCT03721172|453592177|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
126081598|NCT03721172|453592178|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
126081599|NCT03721172|453592176|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
126081600|NCT03721172|453592177|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
126081601|NCT03721172|453592178|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
126081602|NCT03721172|453592176|FG000|Apremilast Extension Phase|Protocol Violation|0|||
126081603|NCT03721172|453592177|FG001|Apremilast Extension Phase|Protocol Violation|0|||
126115407|NCT03061175|453718114|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
126081604|NCT03721172|453592178|FG002|Apremilast Extension Phase|Protocol Violation|1|||
126081605|NCT03721172|453592176|FG000|Apremilast Extension Phase|Physician Decision|0|||
126081606|NCT03721172|453592177|FG001|Apremilast Extension Phase|Physician Decision|0|||
126081607|NCT03721172|453592178|FG002|Apremilast Extension Phase|Physician Decision|1|||
126081608|NCT03721172|453592176|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
126081609|NCT03721172|453592177|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
126081610|NCT03721172|453592178|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
126081611|NCT03721172|453592176|FG000|Apremilast Extension Phase|Other|0|||
126081612|NCT03721172|453592177|FG001|Apremilast Extension Phase|Other|0|||
126081613|NCT03721172|453592178|FG002|Apremilast Extension Phase|Other|3|||
126081614|NCT03721172|453592176|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
126081615|NCT03721172|453592177|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
126081616|NCT03721172|453592178|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
126081617|NCT00420784|453592179|FG000|Overall Study|Adverse Event|11|||
126081618|NCT00420784|453592180|FG001|Overall Study|Adverse Event|29|||
126081619|NCT00420784|453592181|FG002|Overall Study|Adverse Event|10|||
126081620|NCT00420784|453592182|FG003|Overall Study|Adverse Event|5|||
126081621|NCT00420784|453592179|FG000|Overall Study|Withdrawal by Subject|0|||
126081622|NCT00420784|453592180|FG001|Overall Study|Withdrawal by Subject|1|||
126081623|NCT00420784|453592181|FG002|Overall Study|Withdrawal by Subject|0|||
126081624|NCT00420784|453592182|FG003|Overall Study|Withdrawal by Subject|0|||
126081625|NCT00420784|453592179|FG000|Overall Study|Lost to Follow-up|0|||
126081626|NCT00420784|453592180|FG001|Overall Study|Lost to Follow-up|0|||
126081627|NCT00420784|453592181|FG002|Overall Study|Lost to Follow-up|2|||
126081628|NCT00420784|453592182|FG003|Overall Study|Lost to Follow-up|1|||
126081629|NCT00420784|453592179|FG000|Overall Study|Virologic Stopping Rule|17|||
126081630|NCT00420784|453592180|FG001|Overall Study|Virologic Stopping Rule|26|||
126081631|NCT00420784|453592181|FG002|Overall Study|Virologic Stopping Rule|41|||
126081632|NCT00420784|453592182|FG003|Overall Study|Virologic Stopping Rule|67|||
126081633|NCT00420784|453592179|FG000|Overall Study|Other|1|||
126081634|NCT00420784|453592180|FG001|Overall Study|Other|2|||
126081635|NCT00420784|453592181|FG002|Overall Study|Other|0|||
126081636|NCT00420784|453592182|FG003|Overall Study|Other|5|||
126081637|NCT00983853|453592189|FG000|Overall Study|Lost to Follow-up|1|||
126081638|NCT00983853|453592190|FG001|Overall Study|Lost to Follow-up|1|||
126081639|NCT00983853|453592191|FG002|Overall Study|Lost to Follow-up|2|||
126081640|NCT00983853|453592192|FG003|Overall Study|Lost to Follow-up|2|||
126081641|NCT00983853|453592193|FG004|Overall Study|Lost to Follow-up|2|||
126081642|NCT00983853|453592194|FG005|Overall Study|Lost to Follow-up|1|||
126081643|NCT00983853|453592189|FG000|Overall Study|Withdrawal by Subject|0|||
126081644|NCT00983853|453592190|FG001|Overall Study|Withdrawal by Subject|0|||
126081645|NCT00983853|453592191|FG002|Overall Study|Withdrawal by Subject|1|||
126081646|NCT00983853|453592192|FG003|Overall Study|Withdrawal by Subject|0|||
126081647|NCT00983853|453592193|FG004|Overall Study|Withdrawal by Subject|1|||
126081648|NCT00983853|453592194|FG005|Overall Study|Withdrawal by Subject|0|||
126081649|NCT00983853|453592189|FG000|Overall Study|Unable to come to study follow-up visits|0|||
126081650|NCT00983853|453592190|FG001|Overall Study|Unable to come to study follow-up visits|1|||
126081651|NCT00983853|453592191|FG002|Overall Study|Unable to come to study follow-up visits|0|||
126081652|NCT00983853|453592192|FG003|Overall Study|Unable to come to study follow-up visits|0|||
126081653|NCT00983853|453592193|FG004|Overall Study|Unable to come to study follow-up visits|0|||
126081654|NCT00983853|453592194|FG005|Overall Study|Unable to come to study follow-up visits|0|||
126081655|NCT03603639|453592195|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126081656|NCT03603639|453592196|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126081657|NCT03603639|453592197|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126081658|NCT03603639|453592198|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
126081659|NCT03603639|453592199|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126081660|NCT03603639|453592200|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126081661|NCT03603639|453592195|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
126081662|NCT03603639|453592196|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
126081663|NCT03603639|453592197|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
126081664|NCT03603639|453592198|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
126081665|NCT03603639|453592199|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
126081666|NCT03603639|453592200|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
126081667|NCT02947100|453592203|FG000|Overall Study|study terminated early|3|||
126081668|NCT02947100|453592203|FG000|Overall Study|did not meet inclusion criteria|1|||
126081669|NCT02402322|453592204|FG000|Pretreatment|Withdrawal by Subject|3|||
126081670|NCT02402322|453592205|FG001|Pretreatment|Withdrawal by Subject|1|||
126081671|NCT02402322|453592206|FG002|Pretreatment|Withdrawal by Subject|1|||
126081672|NCT02402322|453592204|FG000|Follow-up|Withdrawal by Subject|6|||
126081673|NCT02402322|453592205|FG001|Follow-up|Withdrawal by Subject|3|||
126081674|NCT02402322|453592206|FG002|Follow-up|Withdrawal by Subject|24|||
126081675|NCT00742326|453592207|FG000|Overall Study|Physician Decision|0|||
126081676|NCT00742326|453592208|FG001|Overall Study|Physician Decision|1|||
126081677|NCT01318876|453592210|FG000|Day 8 Survey|email address invalid|96|||
126081678|NCT01318876|453592210|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
126081679|NCT01318876|453592210|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
126081680|NCT03635086|453592214|FG000|Overall Study|Withdrawal of consent|0|||
126081681|NCT03635086|453592215|FG001|Overall Study|Withdrawal of consent|0|||
126081682|NCT03635086|453592216|FG002|Overall Study|Withdrawal of consent|1|||
126081683|NCT03635086|453592217|FG003|Overall Study|Withdrawal of consent|0|||
126081684|NCT03635086|453592218|FG004|Overall Study|Withdrawal of consent|0|||
126081685|NCT03635086|453592214|FG000|Overall Study|Adverse Event|0|||
126081686|NCT03635086|453592215|FG001|Overall Study|Adverse Event|1|||
126081687|NCT03635086|453592216|FG002|Overall Study|Adverse Event|0|||
126081688|NCT03635086|453592217|FG003|Overall Study|Adverse Event|0|||
126081689|NCT03635086|453592218|FG004|Overall Study|Adverse Event|0|||
126081690|NCT03635086|453592214|FG000|Overall Study|Lost to Follow-up|1|||
126081691|NCT03635086|453592215|FG001|Overall Study|Lost to Follow-up|0|||
126081692|NCT03635086|453592216|FG002|Overall Study|Lost to Follow-up|0|||
126081693|NCT03635086|453592217|FG003|Overall Study|Lost to Follow-up|0|||
126081694|NCT03635086|453592218|FG004|Overall Study|Lost to Follow-up|0|||
126081695|NCT01056263|453592231|FG000|Overall Study|Adverse Event|12|||
126081696|NCT01056263|453592231|FG000|Overall Study|Death|1|||
126081697|NCT01056263|453592231|FG000|Overall Study|Withdrawal by Subject|1|||
126081698|NCT01056263|453592231|FG000|Overall Study|Lack of Efficacy|29|||
126081699|NCT01056263|453592231|FG000|Overall Study|Progressive disease|2|||
126081700|NCT01056263|453592231|FG000|Overall Study|Neoplasm progression|1|||
126081701|NCT01056263|453592231|FG000|Overall Study|Objective progression or relapse|1|||
126081702|NCT01056263|453592231|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
126081703|NCT01262092|453592232|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
126081704|NCT01262092|453592233|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
126081705|NCT01262092|453592232|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
126081706|NCT01262092|453592233|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
126081707|NCT01262092|453592232|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
126081708|NCT01262092|453592233|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
126081709|NCT01262092|453592232|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
126081710|NCT01262092|453592233|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
126081711|NCT04147858|453592234|FG000|Overall Study|Adverse Event|6|||
126081712|NCT04147858|453592235|FG001|Overall Study|Adverse Event|6|||
126081713|NCT04147858|453592236|FG002|Overall Study|Adverse Event|6|||
126081714|NCT04147858|453592234|FG000|Overall Study|Lack of Efficacy|3|||
126081715|NCT04147858|453592235|FG001|Overall Study|Lack of Efficacy|3|||
126081716|NCT04147858|453592236|FG002|Overall Study|Lack of Efficacy|1|||
126081717|NCT04147858|453592234|FG000|Overall Study|Lost to Follow-up|1|||
126081718|NCT04147858|453592235|FG001|Overall Study|Lost to Follow-up|6|||
126081719|NCT04147858|453592236|FG002|Overall Study|Lost to Follow-up|2|||
126081720|NCT04147858|453592234|FG000|Overall Study|Withdrawal by Subject|3|||
126081721|NCT04147858|453592235|FG001|Overall Study|Withdrawal by Subject|4|||
126081722|NCT04147858|453592236|FG002|Overall Study|Withdrawal by Subject|10|||
126081723|NCT04147858|453592234|FG000|Overall Study|Subject Noncompliance, Other|4|||
126081724|NCT04147858|453592235|FG001|Overall Study|Subject Noncompliance, Other|3|||
126081725|NCT04147858|453592236|FG002|Overall Study|Subject Noncompliance, Other|1|||
126081726|NCT00699842|453592239|FG000|Overall Study|Death|0|||
126081727|NCT00699842|453592240|FG001|Overall Study|Death|1|||
126081728|NCT00699842|453592241|FG002|Overall Study|Death|0|||
126081729|NCT05990387|453592242|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
126081730|NCT05990387|453592243|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
126081731|NCT04750577|453592244|FG000|Overall Study|Adverse Event|2|||
126081732|NCT04750577|453592245|FG001|Overall Study|Adverse Event|10|||
125953379|NCT01256710|453126086|FG000|Overall Study|Withdrawal by Subject|29|||
125953380|NCT01256710|453126086|FG000|Overall Study|Physician Decision|9|||
126081733|NCT04750577|453592246|FG002|Overall Study|Adverse Event|8|||
126081734|NCT04750577|453592247|FG003|Overall Study|Adverse Event|1|||
126081735|NCT04750577|453592244|FG000|Overall Study|Change of residence|0|||
126081736|NCT04750577|453592245|FG001|Overall Study|Change of residence|0|||
126081737|NCT04750577|453592246|FG002|Overall Study|Change of residence|1|||
126081738|NCT04750577|453592247|FG003|Overall Study|Change of residence|0|||
126081739|NCT04750577|453592244|FG000|Overall Study|Burden of study procedures|0|||
126081740|NCT04750577|453592245|FG001|Overall Study|Burden of study procedures|2|||
126081741|NCT04750577|453592246|FG002|Overall Study|Burden of study procedures|2|||
126081742|NCT04750577|453592247|FG003|Overall Study|Burden of study procedures|0|||
126081743|NCT04750577|453592244|FG000|Overall Study|Prematurely discontinued|0|||
126081744|NCT04750577|453592245|FG001|Overall Study|Prematurely discontinued|0|||
126081745|NCT04750577|453592246|FG002|Overall Study|Prematurely discontinued|0|||
126081746|NCT04750577|453592247|FG003|Overall Study|Prematurely discontinued|2|||
126081747|NCT04750577|453592244|FG000|Overall Study|Protocol deviation|1|||
126081748|NCT04750577|453592245|FG001|Overall Study|Protocol deviation|1|||
126081749|NCT04750577|453592246|FG002|Overall Study|Protocol deviation|1|||
126081750|NCT04750577|453592247|FG003|Overall Study|Protocol deviation|1|||
126081751|NCT04750577|453592244|FG000|Overall Study|Other than listed|3|||
126081752|NCT04750577|453592245|FG001|Overall Study|Other than listed|2|||
126081753|NCT04750577|453592246|FG002|Overall Study|Other than listed|2|||
126081754|NCT04750577|453592247|FG003|Overall Study|Other than listed|1|||
126081755|NCT04750577|453592244|FG000|Overall Study|Not treated|0|||
126081756|NCT04750577|453592245|FG001|Overall Study|Not treated|0|||
126081757|NCT04750577|453592246|FG002|Overall Study|Not treated|0|||
126081758|NCT04750577|453592247|FG003|Overall Study|Not treated|2|||
126081759|NCT01806389|453592250|FG000|Overall Study|Withdrawal by Subject|4|||
126081760|NCT03371823|453592253|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
126081761|NCT03371823|453592254|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
126081762|NCT01310699|453592255|FG000|Overall Study|Patients did not complete tandem.|4|||
126081763|NCT01310699|453592256|FG001|Overall Study|Patients did not complete tandem.|6|||
126081764|NCT00936598|453592257|FG000|Overall Study|Withdrawal by Subject|1|||
126081765|NCT00936598|453592258|FG001|Overall Study|Withdrawal by Subject|0|||
126081766|NCT00936598|453592257|FG000|Overall Study|Ineligible after consent|1|||
126081767|NCT00936598|453592258|FG001|Overall Study|Ineligible after consent|0|||
126081768|NCT00926575|453592259|FG000|Overall Study|Adverse Event|1|||
126081769|NCT00926575|453592260|FG001|Overall Study|Adverse Event|1|||
126081770|NCT00926575|453592259|FG000|Overall Study|Death|4|||
126081771|NCT00926575|453592260|FG001|Overall Study|Death|4|||
126081772|NCT00926575|453592259|FG000|Overall Study|Lost to Follow-up|1|||
126081773|NCT00926575|453592260|FG001|Overall Study|Lost to Follow-up|1|||
126081774|NCT00926575|453592259|FG000|Overall Study|Physician Decision|1|||
126081775|NCT00926575|453592260|FG001|Overall Study|Physician Decision|2|||
126081776|NCT00926575|453592259|FG000|Overall Study|Protocol Violation|1|||
126081777|NCT00926575|453592260|FG001|Overall Study|Protocol Violation|0|||
126081778|NCT00926575|453592259|FG000|Overall Study|Withdrawal by Subject|8|||
126081779|NCT00926575|453592260|FG001|Overall Study|Withdrawal by Subject|9|||
126081780|NCT02035696|453594218|FG000|Overall Study|Lost to Follow-up|0|||
126081781|NCT02035696|453594219|FG001|Overall Study|Lost to Follow-up|3|||
126081782|NCT02035696|453594220|FG002|Overall Study|Lost to Follow-up|1|||
126081783|NCT02035696|453594221|FG003|Overall Study|Lost to Follow-up|2|||
126081784|NCT02035696|453594218|FG000|Overall Study|Withdrawal by Subject|3|||
126081785|NCT02035696|453594219|FG001|Overall Study|Withdrawal by Subject|0|||
126081786|NCT02035696|453594220|FG002|Overall Study|Withdrawal by Subject|2|||
126081787|NCT02035696|453594221|FG003|Overall Study|Withdrawal by Subject|1|||
126081788|NCT00966264|453594222|FG000|Overall Study|Lost to Follow-up|4|||
126081789|NCT00966264|453594223|FG001|Overall Study|Lost to Follow-up|3|||
126081790|NCT01246999|453594224|FG000|Overall Study|Lost to Follow-up|0|||
126081791|NCT01246999|453594225|FG001|Overall Study|Lost to Follow-up|1|||
126081792|NCT01246999|453594226|FG002|Overall Study|Lost to Follow-up|0|||
126081793|NCT01246999|453594227|FG003|Overall Study|Lost to Follow-up|0|||
126081794|NCT01246999|453594224|FG000|Overall Study|Withdrawal by Subject|0|||
126081795|NCT01246999|453594225|FG001|Overall Study|Withdrawal by Subject|0|||
126081796|NCT01246999|453594226|FG002|Overall Study|Withdrawal by Subject|0|||
126081797|NCT01246999|453594227|FG003|Overall Study|Withdrawal by Subject|2|||
126081798|NCT01867047|453594228|FG000|Overall Study|Lost to Follow-up|3|||
126081799|NCT01867047|453594229|FG001|Overall Study|Lost to Follow-up|3|||
126081800|NCT01867047|453594228|FG000|Overall Study|Withdrawal by Subject|2|||
126081801|NCT01867047|453594229|FG001|Overall Study|Withdrawal by Subject|0|||
126081802|NCT01867047|453594228|FG000|Overall Study|Physician Decision|2|||
126081803|NCT01867047|453594229|FG001|Overall Study|Physician Decision|0|||
126081804|NCT01867047|453594228|FG000|Overall Study|surgery not indicated in protocol|1|||
126081805|NCT01867047|453594229|FG001|Overall Study|surgery not indicated in protocol|2|||
126081806|NCT01536587|453594232|FG000|Overall Study|Adverse Event|2|||
126081807|NCT02354651|453594233|FG000|Overall Study|Withdrawal by Subject|2|||
126081808|NCT02354651|453594233|FG000|Overall Study|Physician Decision|1|||
126081809|NCT01245140|453594240|FG000|Overall Study|Adverse Event|1|||
126081810|NCT01245140|453594241|FG001|Overall Study|Adverse Event|3|||
126081811|NCT01245140|453594240|FG000|Overall Study|Lack of Efficacy|2|||
126115408|NCT03061175|453718115|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
126115409|NCT03061175|453718114|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
126081812|NCT01245140|453594241|FG001|Overall Study|Lack of Efficacy|4|||
126081813|NCT01245140|453594240|FG000|Overall Study|Protocol Violation|0|||
126081814|NCT01245140|453594241|FG001|Overall Study|Protocol Violation|1|||
126081815|NCT01245140|453594240|FG000|Overall Study|Withdrawal by Subject|0|||
126081816|NCT01245140|453594241|FG001|Overall Study|Withdrawal by Subject|1|||
126081817|NCT01245140|453594240|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
126081818|NCT01245140|453594241|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
126081819|NCT04836559|453594242|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126081820|NCT04836559|453594243|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
126081821|NCT04836559|453594244|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
126081822|NCT04836559|453594245|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
126081823|NCT04836559|453594246|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126081824|NCT04836559|453594247|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126081825|NCT04836559|453594248|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
125953381|NCT01256710|453126086|FG000|Overall Study|Subject Noncompliance|2|||
125953382|NCT01256710|453126086|FG000|Overall Study|Study Terminated by Sponsor|273|||
125953383|NCT04115358|453126087|FG000|Overall Study|exfoliation|0|||
125953384|NCT04115358|453126088|FG001|Overall Study|exfoliation|0|||
125953385|NCT04115358|453126089|FG002|Overall Study|exfoliation|1|||
125953386|NCT01205165|453126090|FG000|Overall Study|Lost to Follow-up|2|||
125953387|NCT02942017|453126093|FG000|Overall Study|Adverse Event|0|||
125953388|NCT02942017|453126094|FG001|Overall Study|Adverse Event|1|||
125953389|NCT02942017|453126093|FG000|Overall Study|Withdrawal by Subject|0|||
125953390|NCT02942017|453126094|FG001|Overall Study|Withdrawal by Subject|1|||
125953391|NCT02942017|453126093|FG000|Overall Study|Lost to Follow-up|1|||
125953392|NCT02942017|453126094|FG001|Overall Study|Lost to Follow-up|1|||
125953393|NCT02942017|453126093|FG000|Overall Study|Randomized but not dosed|1|||
125953394|NCT02942017|453126094|FG001|Overall Study|Randomized but not dosed|3|||
125953395|NCT02115282|453126095|FG000|Overall Study|Disease progression during treatment|216|||
125953396|NCT02115282|453126096|FG001|Overall Study|Disease progression during treatment|229|||
125953397|NCT02115282|453126095|FG000|Overall Study|Adverse Event|49|||
125953398|NCT02115282|453126096|FG001|Overall Study|Adverse Event|23|||
125953399|NCT02115282|453126095|FG000|Overall Study|Death|1|||
125953400|NCT02115282|453126096|FG001|Overall Study|Death|3|||
125953401|NCT02115282|453126095|FG000|Overall Study|Alternative therapy|1|||
125953402|NCT02115282|453126096|FG001|Overall Study|Alternative therapy|1|||
125953403|NCT02115282|453126095|FG000|Overall Study|Complicating disease|0|||
125953404|NCT02115282|453126096|FG001|Overall Study|Complicating disease|3|||
125953405|NCT02115282|453126095|FG000|Overall Study|Withdrawal by Subject|12|||
125953406|NCT02115282|453126096|FG001|Overall Study|Withdrawal by Subject|10|||
125953407|NCT02115282|453126095|FG000|Overall Study|Symptomatic progression/deterioration|7|||
125953408|NCT02115282|453126096|FG001|Overall Study|Symptomatic progression/deterioration|18|||
125953409|NCT02115282|453126095|FG000|Overall Study|Non-compliance|5|||
125953410|NCT02115282|453126096|FG001|Overall Study|Non-compliance|1|||
125953411|NCT02115282|453126095|FG000|Overall Study|Protocol Violation|2|||
125953412|NCT02115282|453126096|FG001|Overall Study|Protocol Violation|2|||
125953413|NCT02115282|453126095|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
125953414|NCT02115282|453126096|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
125953415|NCT02115282|453126095|FG000|Overall Study|Not start protocol therapy|9|||
125953416|NCT02115282|453126096|FG001|Overall Study|Not start protocol therapy|10|||
125953417|NCT00458484|453126099|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
125953418|NCT00458484|453126100|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
125953419|NCT00458484|453126101|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
125953420|NCT00458484|453126102|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
125953421|NCT00458484|453126103|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
125953422|NCT00458484|453126104|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
125953423|NCT00458484|453126105|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
125953424|NCT04538664|453126106|FG000|Overall Study|Withdrawal by Subject|5|||
125953425|NCT04538664|453126107|FG001|Overall Study|Withdrawal by Subject|9|||
125953426|NCT04538664|453126106|FG000|Overall Study|Lost to Follow-up|2|||
125953427|NCT04538664|453126107|FG001|Overall Study|Lost to Follow-up|1|||
125953428|NCT04538664|453126106|FG000|Overall Study|Ongoing|106|||
125953429|NCT04538664|453126107|FG001|Overall Study|Ongoing|115|||
125953430|NCT00480779|453126108|FG000|Overall Study|Other|2|||
125953431|NCT00480779|453126109|FG001|Overall Study|Other|0|||
125953432|NCT00480779|453126108|FG000|Overall Study|Job and Health-related|0|||
125953433|NCT00480779|453126109|FG001|Overall Study|Job and Health-related|3|||
125953434|NCT04907032|453126110|FG000|Overall Study|Withdrawal by Subject|7|||
125953435|NCT04907032|453126111|FG001|Overall Study|Withdrawal by Subject|1|||
125953436|NCT03431350|453126112|FG000|Overall Study|ONGOING|0|||
125953437|NCT03431350|453126113|FG001|Overall Study|ONGOING|0|||
125953438|NCT03431350|453126114|FG002|Overall Study|ONGOING|2|||
125953439|NCT03431350|453126115|FG003|Overall Study|ONGOING|0|||
125953440|NCT03431350|453126116|FG004|Overall Study|ONGOING|1|||
125953441|NCT03431350|453126117|FG005|Overall Study|ONGOING|3|||
125953442|NCT03431350|453126118|FG006|Overall Study|ONGOING|0|||
125953443|NCT03431350|453126119|FG007|Overall Study|ONGOING|1|||
125953444|NCT03431350|453126120|FG008|Overall Study|ONGOING|3|||
125953445|NCT03431350|453126121|FG009|Overall Study|ONGOING|4|||
125953446|NCT03431350|453126122|FG010|Overall Study|ONGOING|2|||
125953447|NCT03431350|453126123|FG011|Overall Study|ONGOING|1|||
125953448|NCT03431350|453126112|FG000|Overall Study|Death|6|||
125953449|NCT03431350|453126113|FG001|Overall Study|Death|5|||
125953450|NCT03431350|453126114|FG002|Overall Study|Death|18|||
125953451|NCT03431350|453126115|FG003|Overall Study|Death|7|||
125953452|NCT03431350|453126116|FG004|Overall Study|Death|4|||
125953453|NCT03431350|453126117|FG005|Overall Study|Death|3|||
125953454|NCT03431350|453126118|FG006|Overall Study|Death|2|||
125953455|NCT03431350|453126119|FG007|Overall Study|Death|0|||
125953456|NCT03431350|453126120|FG008|Overall Study|Death|0|||
125953457|NCT03431350|453126121|FG009|Overall Study|Death|0|||
125953458|NCT03431350|453126122|FG010|Overall Study|Death|4|||
125953459|NCT03431350|453126123|FG011|Overall Study|Death|0|||
126081826|NCT04836559|453594249|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126081827|NCT04836559|453594242|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126081828|NCT04836559|453594243|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
126081829|NCT04836559|453594244|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
126081830|NCT04836559|453594245|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
126081831|NCT04836559|453594246|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126081832|NCT04836559|453594247|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126081833|NCT04836559|453594248|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126081834|NCT04836559|453594249|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126081835|NCT04836559|453594242|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
126081836|NCT04836559|453594243|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126081837|NCT04836559|453594244|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126081838|NCT04836559|453594245|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126081839|NCT04836559|453594246|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126081840|NCT04836559|453594247|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126081841|NCT04836559|453594248|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126081842|NCT04836559|453594249|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126081843|NCT04836559|453594242|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
126081844|NCT04836559|453594243|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
126081845|NCT04836559|453594244|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
126081846|NCT04836559|453594245|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
126081847|NCT04836559|453594246|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
126081848|NCT04836559|453594247|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
126081849|NCT04836559|453594248|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
126081850|NCT04836559|453594249|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
126081851|NCT04836559|453594242|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126081852|NCT04836559|453594243|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126081853|NCT04836559|453594244|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126081854|NCT04836559|453594245|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
126081855|NCT04836559|453594246|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126081856|NCT04836559|453594247|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126081857|NCT04836559|453594248|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126081858|NCT04836559|453594249|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126081859|NCT04836559|453594242|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
126081860|NCT04836559|453594243|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
126081861|NCT04836559|453594244|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
126081862|NCT04836559|453594245|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
126081863|NCT04836559|453594246|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
126081864|NCT04836559|453594247|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
126081865|NCT04836559|453594248|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
126081866|NCT04836559|453594249|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
126081867|NCT04836559|453594242|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
126081868|NCT04836559|453594243|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
126081869|NCT04836559|453594244|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
126081870|NCT04836559|453594245|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
126081871|NCT04836559|453594246|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
126081872|NCT04836559|453594247|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
126081873|NCT04836559|453594248|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
126081874|NCT04836559|453594249|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
126081875|NCT04836559|453594242|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126081876|NCT04836559|453594243|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126081877|NCT04836559|453594244|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126081878|NCT04836559|453594245|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126081879|NCT04836559|453594246|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
126081880|NCT04836559|453594247|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
126081881|NCT04836559|453594248|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126081882|NCT04836559|453594249|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
126081883|NCT04836559|453594242|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126081884|NCT04836559|453594243|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126081885|NCT04836559|453594244|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126081886|NCT04836559|453594245|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126081887|NCT04836559|453594246|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126081888|NCT04836559|453594247|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126081889|NCT04836559|453594248|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126081890|NCT04836559|453594249|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
126081891|NCT02635360|453594250|FG000|Overall Study|Adverse Event|0|||
126081892|NCT02635360|453594251|FG001|Overall Study|Adverse Event|3|||
126081893|NCT02635360|453594250|FG000|Overall Study|Withdrawal by Subject|2|||
126081894|NCT02635360|453594251|FG001|Overall Study|Withdrawal by Subject|0|||
126081895|NCT02635360|453594250|FG000|Overall Study|Non-Compliance|3|||
126081896|NCT02635360|453594251|FG001|Overall Study|Non-Compliance|1|||
126081897|NCT02635360|453594250|FG000|Overall Study|Disease Progression|0|||
126081898|NCT02635360|453594251|FG001|Overall Study|Disease Progression|2|||
126081899|NCT02635360|453594250|FG000|Overall Study|Lost to Follow-up|1|||
126081900|NCT02635360|453594251|FG001|Overall Study|Lost to Follow-up|1|||
126081901|NCT04978350|453594252|FG000|Overall Study|Lost to Follow-up|6|||
126081902|NCT05765435|453594255|FG000|Overall Study|Lost to Follow-up|0|||
126081903|NCT05765435|453594256|FG001|Overall Study|Lost to Follow-up|1|||
126081904|NCT05765435|453594257|FG002|Overall Study|Lost to Follow-up|0|||
126081905|NCT05765435|453594255|FG000|Overall Study|Withdrawal by Subject|0|||
126081906|NCT05765435|453594256|FG001|Overall Study|Withdrawal by Subject|0|||
126081907|NCT05765435|453594257|FG002|Overall Study|Withdrawal by Subject|1|||
126081908|NCT00781937|453594263|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
126081909|NCT00781937|453594264|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
126081910|NCT00781937|453594263|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
126081911|NCT00781937|453594264|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
126081912|NCT00781937|453594263|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
126081913|NCT00781937|453594264|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
126081914|NCT00781937|453594263|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
126081915|NCT00781937|453594264|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
126081916|NCT00781937|453594263|FG000|Main Trial Period Through Week 56|Unclassified|10|||
126081917|NCT00781937|453594264|FG001|Main Trial Period Through Week 56|Unclassified|15|||
126081918|NCT00781937|453594263|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
126081919|NCT00781937|453594264|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
126081920|NCT00781937|453594263|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
126081921|NCT00781937|453594264|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
126081922|NCT02417441|453594269|FG000|Overall Study|Inconclusive due to missing data|52|||
126081923|NCT02417441|453594270|FG001|Overall Study|Inconclusive due to missing data|19|||
126081924|NCT03016598|453594276|FG000|Overall Study|Lost to Follow-up|0|||
126081925|NCT03016598|453594277|FG001|Overall Study|Lost to Follow-up|2|||
126081926|NCT04593823|453594279|FG000|Overall Study|Withdrawal by Subject|1|||
126081927|NCT04593823|453594280|FG001|Overall Study|Withdrawal by Subject|1|||
126081928|NCT04593823|453594279|FG000|Overall Study|Lost to Follow-up|0|||
126081929|NCT04593823|453594280|FG001|Overall Study|Lost to Follow-up|1|||
126081930|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
126081931|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
126081932|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
126081933|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
126081934|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
126081935|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
126081936|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
126081937|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
126081938|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
126081939|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
126081940|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
126081941|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
126081942|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
126081943|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
126081944|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
126081945|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
126081946|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
126081947|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
126081948|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Missing|2|||
126081949|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Missing|1|||
126081950|NCT00443209|453594283|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
126081951|NCT00443209|453594284|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
126081952|NCT00443209|453594283|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
126081953|NCT00443209|453594284|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
126081954|NCT00443209|453594283|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
126081955|NCT00443209|453594284|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
126081956|NCT00443209|453594283|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
126081957|NCT00443209|453594284|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
126081958|NCT00443209|453594283|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
126081959|NCT00443209|453594284|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
126081960|NCT00443209|453594283|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
126081961|NCT00443209|453594284|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
126081962|NCT00443209|453594283|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
126081963|NCT00443209|453594284|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
126081964|NCT01628692|453594285|FG000|Overall Study|Lack of Efficacy|4|||
126081965|NCT01628692|453594286|FG001|Overall Study|Lack of Efficacy|4|||
126081966|NCT01628692|453594287|FG002|Overall Study|Lack of Efficacy|5|||
126081967|NCT01628692|453594288|FG003|Overall Study|Lack of Efficacy|1|||
126081968|NCT01628692|453594289|FG004|Overall Study|Lack of Efficacy|4|||
126081969|NCT01628692|453594290|FG005|Overall Study|Lack of Efficacy|7|||
126081970|NCT01628692|453594285|FG000|Overall Study|Adverse Event|2|||
126081971|NCT01628692|453594286|FG001|Overall Study|Adverse Event|0|||
126081972|NCT01628692|453594287|FG002|Overall Study|Adverse Event|2|||
126081973|NCT01628692|453594288|FG003|Overall Study|Adverse Event|0|||
126081974|NCT01628692|453594289|FG004|Overall Study|Adverse Event|0|||
126081975|NCT01628692|453594290|FG005|Overall Study|Adverse Event|0|||
126081976|NCT01628692|453594285|FG000|Overall Study|Withdrawal by Subject|0|||
126081977|NCT01628692|453594286|FG001|Overall Study|Withdrawal by Subject|1|||
126081978|NCT01628692|453594287|FG002|Overall Study|Withdrawal by Subject|1|||
126081979|NCT01628692|453594288|FG003|Overall Study|Withdrawal by Subject|0|||
126081980|NCT01628692|453594289|FG004|Overall Study|Withdrawal by Subject|0|||
126081981|NCT01628692|453594290|FG005|Overall Study|Withdrawal by Subject|0|||
126081982|NCT01628692|453594285|FG000|Overall Study|Death|0|||
126081983|NCT01628692|453594286|FG001|Overall Study|Death|1|||
126081984|NCT01628692|453594287|FG002|Overall Study|Death|0|||
126081985|NCT01628692|453594288|FG003|Overall Study|Death|0|||
126081986|NCT01628692|453594289|FG004|Overall Study|Death|0|||
126081987|NCT01628692|453594290|FG005|Overall Study|Death|0|||
126081988|NCT01628692|453594285|FG000|Overall Study|Poor compliance/noncompliance|1|||
126081989|NCT01628692|453594286|FG001|Overall Study|Poor compliance/noncompliance|0|||
126081990|NCT01628692|453594287|FG002|Overall Study|Poor compliance/noncompliance|0|||
126081991|NCT01628692|453594288|FG003|Overall Study|Poor compliance/noncompliance|0|||
126081992|NCT01628692|453594289|FG004|Overall Study|Poor compliance/noncompliance|0|||
126081993|NCT01628692|453594290|FG005|Overall Study|Poor compliance/noncompliance|0|||
126081994|NCT01628692|453594285|FG000|Overall Study|Administrative reason by sponsor|0|||
126081995|NCT01628692|453594286|FG001|Overall Study|Administrative reason by sponsor|0|||
126081996|NCT01628692|453594287|FG002|Overall Study|Administrative reason by sponsor|0|||
126081997|NCT01628692|453594288|FG003|Overall Study|Administrative reason by sponsor|0|||
126081998|NCT01628692|453594289|FG004|Overall Study|Administrative reason by sponsor|0|||
126081999|NCT01628692|453594290|FG005|Overall Study|Administrative reason by sponsor|1|||
126082000|NCT01628692|453594285|FG000|Overall Study|Completed 12 Week only|0|||
126082001|NCT01628692|453594286|FG001|Overall Study|Completed 12 Week only|0|||
126082002|NCT01628692|453594287|FG002|Overall Study|Completed 12 Week only|0|||
126082003|NCT01628692|453594288|FG003|Overall Study|Completed 12 Week only|0|||
126082004|NCT01628692|453594289|FG004|Overall Study|Completed 12 Week only|0|||
126082005|NCT01628692|453594290|FG005|Overall Study|Completed 12 Week only|1|||
126082006|NCT02196077|453594292|FG000|Overall Study|Adverse Event|4|||
126082007|NCT02196077|453594292|FG000|Overall Study|Lack of Efficacy|1|||
126082008|NCT02196077|453594292|FG000|Overall Study|Withdrawal by Subject|14|||
126082009|NCT02196077|453594292|FG000|Overall Study|Physician Decision|1|||
126082010|NCT02196077|453594292|FG000|Overall Study|Lost to Follow-up|3|||
126082011|NCT02196077|453594292|FG000|Overall Study|Protocol Violation|24|||
126082012|NCT02638103|453594297|FG000|Overall Study|Adverse Event|13|||
126082013|NCT02638103|453594298|FG001|Overall Study|Adverse Event|12|||
126082014|NCT02638103|453594299|FG002|Overall Study|Adverse Event|19|||
126082015|NCT02638103|453594300|FG003|Overall Study|Adverse Event|12|||
126082016|NCT02638103|453594297|FG000|Overall Study|Withdrawal by Subject|43|||
126082017|NCT02638103|453594298|FG001|Overall Study|Withdrawal by Subject|53|||
126082018|NCT02638103|453594299|FG002|Overall Study|Withdrawal by Subject|30|||
126082019|NCT02638103|453594300|FG003|Overall Study|Withdrawal by Subject|61|||
126082020|NCT02638103|453594297|FG000|Overall Study|Protocol Violation|1|||
126082021|NCT02638103|453594298|FG001|Overall Study|Protocol Violation|2|||
126082022|NCT02638103|453594299|FG002|Overall Study|Protocol Violation|1|||
126082023|NCT02638103|453594300|FG003|Overall Study|Protocol Violation|4|||
126082024|NCT02638103|453594297|FG000|Overall Study|Pregnancy|2|||
126082025|NCT02638103|453594298|FG001|Overall Study|Pregnancy|3|||
126082026|NCT02638103|453594299|FG002|Overall Study|Pregnancy|0|||
126082027|NCT02638103|453594300|FG003|Overall Study|Pregnancy|1|||
126082028|NCT02638103|453594297|FG000|Overall Study|Non-compliance to Study Procedures|2|||
126082029|NCT02638103|453594298|FG001|Overall Study|Non-compliance to Study Procedures|1|||
126082030|NCT02638103|453594299|FG002|Overall Study|Non-compliance to Study Procedures|1|||
126082031|NCT02638103|453594300|FG003|Overall Study|Non-compliance to Study Procedures|1|||
126082032|NCT02638103|453594297|FG000|Overall Study|Lost to Follow-up|26|||
126082033|NCT02638103|453594298|FG001|Overall Study|Lost to Follow-up|33|||
126082034|NCT02638103|453594299|FG002|Overall Study|Lost to Follow-up|20|||
126082035|NCT02638103|453594300|FG003|Overall Study|Lost to Follow-up|37|||
126082036|NCT02638103|453594297|FG000|Overall Study|Lack of Efficacy|14|||
126082037|NCT02638103|453594298|FG001|Overall Study|Lack of Efficacy|10|||
126082038|NCT02638103|453594299|FG002|Overall Study|Lack of Efficacy|12|||
126082039|NCT02638103|453594300|FG003|Overall Study|Lack of Efficacy|22|||
126082040|NCT02638103|453594297|FG000|Overall Study|Other than specified|5|||
126082041|NCT02638103|453594298|FG001|Overall Study|Other than specified|4|||
125953460|NCT03431350|453126112|FG000|Overall Study|Lost to Follow-up|0|||
125953461|NCT03431350|453126113|FG001|Overall Study|Lost to Follow-up|1|||
125953462|NCT03431350|453126114|FG002|Overall Study|Lost to Follow-up|0|||
125953463|NCT03431350|453126115|FG003|Overall Study|Lost to Follow-up|0|||
125953464|NCT03431350|453126116|FG004|Overall Study|Lost to Follow-up|0|||
125953465|NCT03431350|453126117|FG005|Overall Study|Lost to Follow-up|0|||
125953466|NCT03431350|453126118|FG006|Overall Study|Lost to Follow-up|0|||
125953467|NCT03431350|453126119|FG007|Overall Study|Lost to Follow-up|0|||
125953468|NCT03431350|453126120|FG008|Overall Study|Lost to Follow-up|0|||
125953469|NCT03431350|453126121|FG009|Overall Study|Lost to Follow-up|0|||
125953470|NCT03431350|453126122|FG010|Overall Study|Lost to Follow-up|0|||
125953471|NCT03431350|453126123|FG011|Overall Study|Lost to Follow-up|0|||
125953472|NCT03431350|453126112|FG000|Overall Study|Withdrawal by Subject|0|||
125953473|NCT03431350|453126113|FG001|Overall Study|Withdrawal by Subject|0|||
125953474|NCT03431350|453126114|FG002|Overall Study|Withdrawal by Subject|0|||
125953475|NCT03431350|453126115|FG003|Overall Study|Withdrawal by Subject|1|||
125953476|NCT03431350|453126116|FG004|Overall Study|Withdrawal by Subject|1|||
125953477|NCT03431350|453126117|FG005|Overall Study|Withdrawal by Subject|1|||
125953478|NCT03431350|453126118|FG006|Overall Study|Withdrawal by Subject|0|||
125953479|NCT03431350|453126119|FG007|Overall Study|Withdrawal by Subject|0|||
125953480|NCT03431350|453126120|FG008|Overall Study|Withdrawal by Subject|0|||
125953481|NCT03431350|453126121|FG009|Overall Study|Withdrawal by Subject|2|||
125953482|NCT03431350|453126122|FG010|Overall Study|Withdrawal by Subject|0|||
125953483|NCT03431350|453126123|FG011|Overall Study|Withdrawal by Subject|1|||
125953484|NCT03431350|453126112|FG000|Overall Study|Other|0|||
125953485|NCT03431350|453126113|FG001|Overall Study|Other|0|||
125953486|NCT03431350|453126114|FG002|Overall Study|Other|1|||
125953487|NCT03431350|453126115|FG003|Overall Study|Other|3|||
125953488|NCT03431350|453126116|FG004|Overall Study|Other|2|||
125953489|NCT03431350|453126117|FG005|Overall Study|Other|2|||
125953490|NCT03431350|453126118|FG006|Overall Study|Other|4|||
125953491|NCT03431350|453126119|FG007|Overall Study|Other|0|||
125953492|NCT03431350|453126120|FG008|Overall Study|Other|14|||
125953493|NCT03431350|453126121|FG009|Overall Study|Other|11|||
125953494|NCT03431350|453126122|FG010|Overall Study|Other|11|||
125953495|NCT03431350|453126123|FG011|Overall Study|Other|15|||
125953496|NCT06425458|453126125|FG000|Overall Study|Removed by study team|2|||
125953497|NCT06425458|453126125|FG000|Overall Study|Lost to Follow-up|5|||
125953498|NCT00316199|453126128|FG000|Overall Study|Adverse Event|2|||
125953499|NCT00316199|453126128|FG000|Overall Study|Death|8|||
125953500|NCT00316199|453126128|FG000|Overall Study|Lost to Follow-up|2|||
125953501|NCT00590954|453126129|FG000|Overall Study|Inevaluable|2|||
125953502|NCT03890367|453126130|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125953503|NCT03890367|453126131|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125953504|NCT03890367|453126132|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125953505|NCT03890367|453126130|FG000|Overall Study|Protocol deviation|2|||
125953506|NCT03890367|453126131|FG001|Overall Study|Protocol deviation|2|||
125953507|NCT03890367|453126132|FG002|Overall Study|Protocol deviation|1|||
125953508|NCT03890367|453126130|FG000|Overall Study|Lost to Follow-up|1|||
125953509|NCT03890367|453126131|FG001|Overall Study|Lost to Follow-up|1|||
125953510|NCT03890367|453126132|FG002|Overall Study|Lost to Follow-up|0|||
125953511|NCT03370341|453127489|FG000|Overall Study|Lost to Follow-up|0|||
125953512|NCT03370341|453127490|FG001|Overall Study|Lost to Follow-up|1|||
125953513|NCT01707004|453127491|FG000|Overall Study|Physician Decision|3|||
125953514|NCT04368429|453127492|FG000|Overall Study|Adverse Event|1|||
125953515|NCT04368429|453127493|FG001|Overall Study|Adverse Event|0|||
125953516|NCT02143414|453127496|FG000|Induction|Adverse Event|1|||
125953517|NCT02143414|453127497|FG001|Induction|Adverse Event|2|||
125953518|NCT02143414|453127496|FG000|Induction|Death|1|||
125953519|NCT02143414|453127497|FG001|Induction|Death|2|||
125953520|NCT02143414|453127496|FG000|Induction|Patient refusal|1|||
126082042|NCT02638103|453594299|FG002|Overall Study|Other than specified|2|||
126082043|NCT02638103|453594300|FG003|Overall Study|Other than specified|4|||
126082044|NCT01827046|453594306|FG000|Overall Study|Lost to Follow-up|1|||
125953521|NCT02143414|453127497|FG001|Induction|Patient refusal|1|||
125953522|NCT02143414|453127496|FG000|Induction|Refractory|1|||
125953523|NCT02143414|453127497|FG001|Induction|Refractory|0|||
125953524|NCT02143414|453127496|FG000|Induction|Began alternative treatment|1|||
125953525|NCT02143414|453127497|FG001|Induction|Began alternative treatment|0|||
125953526|NCT02143414|453127496|FG000|Induction|Ineligible for postremission|5|||
125953527|NCT02143414|453127497|FG001|Induction|Ineligible for postremission|1|||
125953528|NCT02143414|453127496|FG000|Post-remission|Adverse Event|0|||
125953529|NCT02143414|453127497|FG001|Post-remission|Adverse Event|2|||
125953530|NCT02143414|453127496|FG000|Post-remission|Disease progression/relapse|5|||
126082045|NCT01827046|453594307|FG001|Overall Study|Lost to Follow-up|5|||
126082046|NCT01827046|453594306|FG000|Overall Study|Withdrawal by Subject|0|||
126082047|NCT01827046|453594307|FG001|Overall Study|Withdrawal by Subject|4|||
126082048|NCT02734004|453594308|FG000|Overall Study|Death|36|||
126082049|NCT02734004|453594309|FG001|Overall Study|Death|24|||
126082050|NCT02734004|453594310|FG002|Overall Study|Death|26|||
126082051|NCT02734004|453594311|FG003|Overall Study|Death|35|||
126082052|NCT02734004|453594312|FG004|Overall Study|Death|13|||
126082053|NCT02734004|453594313|FG005|Overall Study|Death|17|||
126082054|NCT02734004|453594314|FG006|Overall Study|Death|20|||
126082055|NCT02734004|453594308|FG000|Overall Study|Lost to Follow-up|1|||
126082056|NCT02734004|453594309|FG001|Overall Study|Lost to Follow-up|1|||
126082057|NCT02734004|453594310|FG002|Overall Study|Lost to Follow-up|0|||
126082058|NCT02734004|453594311|FG003|Overall Study|Lost to Follow-up|0|||
126082059|NCT02734004|453594312|FG004|Overall Study|Lost to Follow-up|1|||
126082060|NCT02734004|453594313|FG005|Overall Study|Lost to Follow-up|0|||
126082061|NCT02734004|453594314|FG006|Overall Study|Lost to Follow-up|0|||
126082062|NCT02734004|453594308|FG000|Overall Study|Withdrawal by Subject|3|||
126082063|NCT02734004|453594309|FG001|Overall Study|Withdrawal by Subject|1|||
126082064|NCT02734004|453594310|FG002|Overall Study|Withdrawal by Subject|1|||
126082065|NCT02734004|453594311|FG003|Overall Study|Withdrawal by Subject|1|||
126082066|NCT02734004|453594312|FG004|Overall Study|Withdrawal by Subject|3|||
126082067|NCT02734004|453594313|FG005|Overall Study|Withdrawal by Subject|0|||
126082068|NCT02734004|453594314|FG006|Overall Study|Withdrawal by Subject|2|||
126082069|NCT02734004|453594308|FG000|Overall Study|Other|0|||
126082070|NCT02734004|453594309|FG001|Overall Study|Other|8|||
126082071|NCT02734004|453594310|FG002|Overall Study|Other|7|||
126082072|NCT02734004|453594311|FG003|Overall Study|Other|4|||
126082073|NCT02734004|453594312|FG004|Overall Study|Other|34|||
126082074|NCT02734004|453594313|FG005|Overall Study|Other|14|||
126082075|NCT02734004|453594314|FG006|Overall Study|Other|10|||
126082076|NCT01294436|453594315|FG000|Overall Study|Adverse Event|10|||
126082077|NCT01294436|453594316|FG001|Overall Study|Adverse Event|17|||
126082078|NCT01294436|453594315|FG000|Overall Study|Withdrawal by Subject|11|||
126082079|NCT01294436|453594316|FG001|Overall Study|Withdrawal by Subject|28|||
126082080|NCT01294436|453594315|FG000|Overall Study|subject no longer meets study criteria|5|||
126082081|NCT01294436|453594316|FG001|Overall Study|subject no longer meets study criteria|20|||
126082082|NCT01294436|453594315|FG000|Overall Study|poor/non-compliance|2|||
126082083|NCT01294436|453594316|FG001|Overall Study|poor/non-compliance|5|||
126082084|NCT01536171|453594317|FG000|Overall Study|Withdrawal by Subject|1|||
126082085|NCT01018732|453594318|FG000|Overall Study|Lost to Follow-up|0|||
126082086|NCT01018732|453594319|FG001|Overall Study|Lost to Follow-up|0|||
126082087|NCT01018732|453594320|FG002|Overall Study|Lost to Follow-up|3|||
126082088|NCT01018732|453594318|FG000|Overall Study|Protocol Violation|1|||
126082089|NCT01018732|453594319|FG001|Overall Study|Protocol Violation|1|||
126082090|NCT01018732|453594320|FG002|Overall Study|Protocol Violation|0|||
126082091|NCT01018732|453594318|FG000|Overall Study|Inappropriate Enrollment|0|||
126082092|NCT01018732|453594319|FG001|Overall Study|Inappropriate Enrollment|1|||
126082093|NCT01018732|453594320|FG002|Overall Study|Inappropriate Enrollment|0|||
126082094|NCT01018732|453594318|FG000|Overall Study|Unable to Classify|0|||
126082095|NCT01018732|453594319|FG001|Overall Study|Unable to Classify|0|||
126082096|NCT01018732|453594320|FG002|Overall Study|Unable to Classify|1|||
126082097|NCT00585078|453594321|FG000|Overall Study|Withdrawal by Subject|4|||
126082098|NCT00585078|453594321|FG000|Overall Study|Poor performance status|1|||
126082099|NCT00585078|453594321|FG000|Overall Study|Disease Progression|24|||
126082100|NCT00585078|453594321|FG000|Overall Study|Adverse Event|10|||
126082101|NCT00585078|453594321|FG000|Overall Study|Death|1|||
126082102|NCT02781311|453594324|FG000|Overall Study|Adverse Event|2|||
126082103|NCT02781311|453594325|FG001|Overall Study|Adverse Event|6|||
126082104|NCT02781311|453594326|FG002|Overall Study|Adverse Event|1|||
126082105|NCT02781311|453594324|FG000|Overall Study|Withdrawal of Consent|11|||
125953531|NCT02143414|453127497|FG001|Post-remission|Disease progression/relapse|0|||
125953532|NCT02143414|453127496|FG000|Maintenance|Adverse Event|4|||
126082106|NCT02781311|453594325|FG001|Overall Study|Withdrawal of Consent|12|||
126082107|NCT02781311|453594326|FG002|Overall Study|Withdrawal of Consent|2|||
126082108|NCT02781311|453594324|FG000|Overall Study|Lost to Follow-up|11|||
126082109|NCT02781311|453594325|FG001|Overall Study|Lost to Follow-up|8|||
126082110|NCT02781311|453594326|FG002|Overall Study|Lost to Follow-up|1|||
126082111|NCT02781311|453594324|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126082112|NCT02781311|453594325|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126082113|NCT02781311|453594326|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125953533|NCT02143414|453127497|FG001|Maintenance|Adverse Event|6|||
126082114|NCT02165826|453594328|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
126082115|NCT02165826|453594329|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
126082116|NCT02165826|453594330|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
126082117|NCT02165826|453594328|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
125953534|NCT02143414|453127496|FG000|Maintenance|Disease progression/relapse|3|||
125953535|NCT02143414|453127497|FG001|Maintenance|Disease progression/relapse|2|||
126082118|NCT02165826|453594329|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
125953536|NCT02143414|453127496|FG000|Maintenance|Patient refusal|2|||
125953537|NCT02143414|453127497|FG001|Maintenance|Patient refusal|1|||
125953538|NCT02143414|453127496|FG000|Maintenance|Physician Decision|1|||
125953539|NCT02143414|453127497|FG001|Maintenance|Physician Decision|0|||
125953540|NCT02143414|453127496|FG000|Maintenance|Death|0|||
125953541|NCT02143414|453127497|FG001|Maintenance|Death|1|||
125953542|NCT02143414|453127496|FG000|Maintenance|On protocol treatment|0|||
125953543|NCT02143414|453127497|FG001|Maintenance|On protocol treatment|6|||
125953544|NCT00679341|453127498|FG000|Overall Study|Disease progression|42|||
125953545|NCT00679341|453127499|FG001|Overall Study|Disease progression|36|||
125953546|NCT00679341|453127498|FG000|Overall Study|Adverse Event|5|||
125953547|NCT00679341|453127499|FG001|Overall Study|Adverse Event|6|||
125953548|NCT00679341|453127498|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
125953549|NCT00679341|453127499|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
125953550|NCT00679341|453127498|FG000|Overall Study|Death|1|||
125953551|NCT00679341|453127499|FG001|Overall Study|Death|1|||
125953552|NCT00679341|453127498|FG000|Overall Study|Other|1|||
125953553|NCT00679341|453127499|FG001|Overall Study|Other|0|||
125953554|NCT00679341|453127498|FG000|Overall Study|Physician Decision|1|||
125953555|NCT00679341|453127499|FG001|Overall Study|Physician Decision|0|||
125953556|NCT00679341|453127498|FG000|Overall Study|Not treated|0|||
125953557|NCT00679341|453127499|FG001|Overall Study|Not treated|2|||
125953558|NCT00679341|453127498|FG000|Overall Study|Physician/patient decision to withdraw|0|||
125953559|NCT00679341|453127499|FG001|Overall Study|Physician/patient decision to withdraw|6|||
125953560|NCT04530552|453127502|FG000|Overall Study|Physician Decision|0|||
125953561|NCT04530552|453127503|FG001|Overall Study|Physician Decision|1|||
125953562|NCT04530552|453127502|FG000|Overall Study|Withdrawal by Subject|0|||
125953563|NCT04530552|453127503|FG001|Overall Study|Withdrawal by Subject|1|||
125953564|NCT04530552|453127502|FG000|Overall Study|Adverse Event|0|||
125953565|NCT04530552|453127503|FG001|Overall Study|Adverse Event|1|||
125953566|NCT04530552|453127502|FG000|Overall Study|No surgery|0|||
125953567|NCT04530552|453127503|FG001|Overall Study|No surgery|1|||
125953568|NCT06034496|453127504|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
125953569|NCT06034496|453127505|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
125953570|NCT06034496|453127504|FG000|Overall Study|Withdrawal by Subject|5|||
125953571|NCT06034496|453127505|FG001|Overall Study|Withdrawal by Subject|4|||
125953572|NCT04397263|453127508|FG000|Overall Study|Withdrawal by Subject|2|||
125953573|NCT03277261|453127511|FG000|Overall Study|Adverse Event|17|||
125953574|NCT03277261|453127512|FG001|Overall Study|Adverse Event|1|||
125953575|NCT03277261|453127511|FG000|Overall Study|Participant Withdrawal of Consent|6|||
125953576|NCT03277261|453127512|FG001|Overall Study|Participant Withdrawal of Consent|15|||
125953577|NCT03277261|453127511|FG000|Overall Study|Investigator / Sponsor Decision|4|||
125953578|NCT03277261|453127512|FG001|Overall Study|Investigator / Sponsor Decision|2|||
125953579|NCT03277261|453127511|FG000|Overall Study|Pregnancy|2|||
125953580|NCT03277261|453127512|FG001|Overall Study|Pregnancy|0|||
125953581|NCT03277261|453127511|FG000|Overall Study|Lost to Follow-up|2|||
125953582|NCT03277261|453127512|FG001|Overall Study|Lost to Follow-up|2|||
125953583|NCT03277261|453127511|FG000|Overall Study|Lack of Efficacy|2|||
125953584|NCT03277261|453127512|FG001|Overall Study|Lack of Efficacy|2|||
125953585|NCT03277261|453127511|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
125953586|NCT03277261|453127512|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
125953587|NCT02365597|453127516|FG000|Overall Study|Lost to Follow-up|0|||
125953588|NCT02365597|453127517|FG001|Overall Study|Lost to Follow-up|1|||
125953589|NCT02365597|453127518|FG002|Overall Study|Lost to Follow-up|0|||
125953590|NCT02365597|453127519|FG003|Overall Study|Lost to Follow-up|1|||
125953591|NCT02365597|453127516|FG000|Overall Study|Withdrawal by Subject|1|||
125953592|NCT02365597|453127517|FG001|Overall Study|Withdrawal by Subject|8|||
125953593|NCT02365597|453127518|FG002|Overall Study|Withdrawal by Subject|5|||
125953594|NCT02365597|453127519|FG003|Overall Study|Withdrawal by Subject|1|||
125953595|NCT02365597|453127516|FG000|Overall Study|Sponsor's decision|1|||
125953596|NCT02365597|453127517|FG001|Overall Study|Sponsor's decision|3|||
125953597|NCT02365597|453127518|FG002|Overall Study|Sponsor's decision|13|||
125953598|NCT02365597|453127519|FG003|Overall Study|Sponsor's decision|0|||
125953599|NCT02365597|453127516|FG000|Overall Study|Other|0|||
125953600|NCT02365597|453127517|FG001|Overall Study|Other|4|||
125953601|NCT02365597|453127518|FG002|Overall Study|Other|0|||
125953602|NCT02365597|453127519|FG003|Overall Study|Other|0|||
125953603|NCT02365597|453127516|FG000|Overall Study|Enrolled but not treated|0|||
125953604|NCT02365597|453127517|FG001|Overall Study|Enrolled but not treated|1|||
125953605|NCT02365597|453127518|FG002|Overall Study|Enrolled but not treated|1|||
125953606|NCT02365597|453127519|FG003|Overall Study|Enrolled but not treated|0|||
125953607|NCT02365597|453127516|FG000|Overall Study|Ongoing|0|||
125953608|NCT02365597|453127517|FG001|Overall Study|Ongoing|0|||
125953609|NCT02365597|453127518|FG002|Overall Study|Ongoing|0|||
125953610|NCT02365597|453127519|FG003|Overall Study|Ongoing|17|||
125953611|NCT00499603|453127520|FG000|Overall Study|Adverse Event|0|||
125953612|NCT00499603|453127521|FG001|Overall Study|Adverse Event|1|||
125953613|NCT01552226|453127522|FG000|Overall Study|Withdrawal by Subject|4|||
125953614|NCT01552226|453127523|FG001|Overall Study|Withdrawal by Subject|4|||
126082119|NCT02165826|453594330|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
126082120|NCT02165826|453594328|FG000|Main Treatment Period|Lost to Follow-up|4|||
126082121|NCT02165826|453594329|FG001|Main Treatment Period|Lost to Follow-up|2|||
126082122|NCT02165826|453594330|FG002|Main Treatment Period|Lost to Follow-up|1|||
126082123|NCT02165826|453594328|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
126082124|NCT02165826|453594329|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
126082125|NCT02165826|453594330|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
126082126|NCT02165826|453594328|FG000|Main Treatment Period|Lack of Efficacy|2|||
126082127|NCT02165826|453594329|FG001|Main Treatment Period|Lack of Efficacy|0|||
126082128|NCT02165826|453594330|FG002|Main Treatment Period|Lack of Efficacy|0|||
126082129|NCT02165826|453594328|FG000|Main Treatment Period|Reason Not Specified|8|||
126082130|NCT02165826|453594329|FG001|Main Treatment Period|Reason Not Specified|5|||
126082131|NCT02165826|453594330|FG002|Main Treatment Period|Reason Not Specified|16|||
126082132|NCT02165826|453594328|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
126082133|NCT02165826|453594329|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
126082134|NCT02165826|453594330|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
126082135|NCT02165826|453594328|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
126082136|NCT02165826|453594329|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
126082137|NCT02165826|453594330|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
126082138|NCT02165826|453594328|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
126082139|NCT02165826|453594329|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
126082140|NCT02165826|453594330|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
126082141|NCT02165826|453594328|FG000|Down-Titration Period|Reason Not Specified|1|||
126082142|NCT02165826|453594329|FG001|Down-Titration Period|Reason Not Specified|0|||
126082143|NCT02165826|453594330|FG002|Down-Titration Period|Reason Not Specified|2|||
126082144|NCT00250432|453594335|FG000|Overall Study|Adverse Event|25|||
126082145|NCT00250432|453594336|FG001|Overall Study|Adverse Event|29|||
126082146|NCT00250432|453594335|FG000|Overall Study|Lack of Efficacy|2|||
126082147|NCT00250432|453594336|FG001|Overall Study|Lack of Efficacy|1|||
126082148|NCT00250432|453594335|FG000|Overall Study|Lost to Follow-up|6|||
126082149|NCT00250432|453594336|FG001|Overall Study|Lost to Follow-up|5|||
126082150|NCT00250432|453594335|FG000|Overall Study|Patient Moved|0|||
126082151|NCT00250432|453594336|FG001|Overall Study|Patient Moved|1|||
126082152|NCT00250432|453594335|FG000|Overall Study|Protocol Violation|0|||
126082153|NCT00250432|453594336|FG001|Overall Study|Protocol Violation|3|||
126082154|NCT00250432|453594335|FG000|Overall Study|Withdrawal by Subject|6|||
126082155|NCT00250432|453594336|FG001|Overall Study|Withdrawal by Subject|2|||
126082156|NCT00250432|453594335|FG000|Overall Study|Pt died out of posttherapy report period|6|||
126082157|NCT00250432|453594336|FG001|Overall Study|Pt died out of posttherapy report period|5|||
126082158|NCT00250432|453594335|FG000|Overall Study|Pt was considered untreatable|0|||
126082159|NCT00250432|453594336|FG001|Overall Study|Pt was considered untreatable|1|||
126082160|NCT00658606|453594339|FG000|Overall Study|Adverse Event|2|||
126082161|NCT00658606|453594340|FG001|Overall Study|Adverse Event|1|||
126082162|NCT00658606|453594339|FG000|Overall Study|Lack of Efficacy|6|||
126082163|NCT00658606|453594340|FG001|Overall Study|Lack of Efficacy|3|||
126082164|NCT00658606|453594339|FG000|Overall Study|Lost to Follow-up|1|||
126082165|NCT00658606|453594340|FG001|Overall Study|Lost to Follow-up|0|||
126082166|NCT00658606|453594339|FG000|Overall Study|Withdrawal by Subject|7|||
126082167|NCT00658606|453594340|FG001|Overall Study|Withdrawal by Subject|16|||
126082168|NCT00658606|453594339|FG000|Overall Study|Lack of Compliance|0|||
126082169|NCT00658606|453594340|FG001|Overall Study|Lack of Compliance|3|||
126082170|NCT00365547|453594343|FG000|Overall Study|Insurance did not cover Avastin|1|||
126082171|NCT00365547|453594343|FG000|Overall Study|Screen failure|1|||
126082172|NCT00365547|453594343|FG000|Overall Study|Withdrawal by Subject|1|||
126082173|NCT03023423|453594344|FG000|Overall Study|Death|5|||
126082174|NCT03023423|453594345|FG001|Overall Study|Death|12|||
126082175|NCT03023423|453594346|FG002|Overall Study|Death|20|||
126082176|NCT03023423|453594344|FG000|Overall Study|Other|0|||
126082177|NCT03023423|453594345|FG001|Overall Study|Other|2|||
126082178|NCT03023423|453594346|FG002|Overall Study|Other|2|||
126082179|NCT03023423|453594344|FG000|Overall Study|Ongoing|2|||
126082180|NCT03023423|453594345|FG001|Overall Study|Ongoing|32|||
126082181|NCT03023423|453594346|FG002|Overall Study|Ongoing|24|||
126082182|NCT03512197|453594347|FG000|Overall Study|Guardian decision|1|||
126082183|NCT03512197|453594348|FG001|Overall Study|Guardian decision|1|||
126082184|NCT03512197|453594347|FG000|Overall Study|Lack of Efficacy|19|||
126082185|NCT03512197|453594348|FG001|Overall Study|Lack of Efficacy|11|||
126082186|NCT03512197|453594347|FG000|Overall Study|New Therapy for Study Indication|16|||
126082187|NCT03512197|453594348|FG001|Overall Study|New Therapy for Study Indication|16|||
126082188|NCT03512197|453594347|FG000|Overall Study|Physician Decision|60|||
126082189|NCT03512197|453594348|FG001|Overall Study|Physician Decision|60|||
126082190|NCT03512197|453594347|FG000|Overall Study|Protocol Violation|0|||
126082191|NCT03512197|453594348|FG001|Overall Study|Protocol Violation|2|||
126082192|NCT03512197|453594347|FG000|Overall Study|Terminated by Sponsored|46|||
126082193|NCT03512197|453594348|FG001|Overall Study|Terminated by Sponsored|50|||
126082194|NCT03512197|453594347|FG000|Overall Study|Subject Decision|15|||
126082195|NCT03512197|453594348|FG001|Overall Study|Subject Decision|12|||
126082196|NCT03512197|453594347|FG000|Overall Study|Withdrawal of informed consent|20|||
126082197|NCT03512197|453594348|FG001|Overall Study|Withdrawal of informed consent|14|||
126082198|NCT03512197|453594347|FG000|Overall Study|Adverse Event|30|||
126082199|NCT03512197|453594348|FG001|Overall Study|Adverse Event|34|||
126082200|NCT03512197|453594347|FG000|Overall Study|Death|14|||
126082201|NCT03512197|453594348|FG001|Overall Study|Death|9|||
126082202|NCT03512197|453594347|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
126082203|NCT03512197|453594348|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
126082204|NCT03512197|453594347|FG000|Overall Study|Missing|3|||
126082205|NCT03512197|453594348|FG001|Overall Study|Missing|13|||
126082206|NCT03842436|453594349|FG000|Overall Study|Lost to Follow-up|1|||
126082207|NCT00490698|453594353|FG000|Overall Study|Withdrawal by Subject|1|||
126082208|NCT00490698|453594353|FG000|Overall Study|Disease Progression|7|||
126082209|NCT00490698|453594353|FG000|Overall Study|Physician Decision|2|||
126082210|NCT02201901|453594356|FG000|Overall Study|Randomized but never treated|0|||
126082211|NCT02201901|453594357|FG001|Overall Study|Randomized but never treated|1|||
126082212|NCT02201901|453594358|FG002|Overall Study|Randomized but never treated|0|||
126082213|NCT02201901|453594356|FG000|Overall Study|Lack of Efficacy|7|||
126082214|NCT02201901|453594357|FG001|Overall Study|Lack of Efficacy|1|||
126082215|NCT02201901|453594358|FG002|Overall Study|Lack of Efficacy|6|||
126082216|NCT02201901|453594356|FG000|Overall Study|Death|3|||
126082217|NCT02201901|453594357|FG001|Overall Study|Death|3|||
126082218|NCT02201901|453594358|FG002|Overall Study|Death|3|||
126082219|NCT02201901|453594356|FG000|Overall Study|Lost to Follow-up|2|||
126082220|NCT02201901|453594357|FG001|Overall Study|Lost to Follow-up|3|||
126082221|NCT02201901|453594358|FG002|Overall Study|Lost to Follow-up|2|||
126082222|NCT02201901|453594356|FG000|Overall Study|Withdrew Consent|2|||
126082223|NCT02201901|453594357|FG001|Overall Study|Withdrew Consent|0|||
126082224|NCT02201901|453594358|FG002|Overall Study|Withdrew Consent|2|||
126082225|NCT02201901|453594356|FG000|Overall Study|Adverse Event|1|||
126082226|NCT02201901|453594357|FG001|Overall Study|Adverse Event|1|||
126082227|NCT02201901|453594358|FG002|Overall Study|Adverse Event|0|||
126082228|NCT04277507|453594359|FG000|Overall Study|Lost to Follow-up|17|||
126082229|NCT04277507|453594359|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
126082230|NCT04277507|453594359|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
126082231|NCT04277507|453594359|FG000|Overall Study|Withdrawal by Subject|3|||
126082232|NCT04277507|453594359|FG000|Overall Study|Death due to COVID-19|1|||
126082233|NCT04277507|453594359|FG000|Overall Study|Data missing for full evaluation|5|||
126082234|NCT03358238|453594360|FG000|Overall Study|Withdrawal by Subject|0|||
126082235|NCT03358238|453594361|FG001|Overall Study|Withdrawal by Subject|1|||
126082236|NCT01431950|453594364|FG000|Overall Study|Study Site Closed/Terminated|7|||
126082237|NCT01431950|453594365|FG001|Overall Study|Study Site Closed/Terminated|3|||
126082238|NCT01431950|453594364|FG000|Overall Study|Withdrawal by Subject|4|||
126082239|NCT01431950|453594365|FG001|Overall Study|Withdrawal by Subject|3|||
126082240|NCT01431950|453594364|FG000|Overall Study|Protocol Violation|2|||
126082241|NCT01431950|453594365|FG001|Overall Study|Protocol Violation|3|||
126082242|NCT01431950|453594364|FG000|Overall Study|Adverse Event|2|||
126082243|NCT01431950|453594365|FG001|Overall Study|Adverse Event|2|||
126082244|NCT01431950|453594364|FG000|Overall Study|Physician Decision|2|||
126082245|NCT01431950|453594365|FG001|Overall Study|Physician Decision|1|||
126082246|NCT01431950|453594364|FG000|Overall Study|Lack of Efficacy|2|||
126082247|NCT01431950|453594365|FG001|Overall Study|Lack of Efficacy|1|||
126082248|NCT01431950|453594364|FG000|Overall Study|Lost to Follow-up|0|||
126082249|NCT01431950|453594365|FG001|Overall Study|Lost to Follow-up|1|||
126082250|NCT01431950|453594364|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126082251|NCT01431950|453594365|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126082252|NCT06719986|453594366|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
126082253|NCT06719986|453594367|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
125953615|NCT04697628|453127524|FG000|Overall Study|Withdrawal by Subject|17|||
125953616|NCT04697628|453127525|FG001|Overall Study|Withdrawal by Subject|23|||
125953617|NCT04697628|453127524|FG000|Overall Study|Lost to Follow-up|0|||
126082254|NCT06719986|453594368|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
126082255|NCT06719986|453594366|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
126082256|NCT06719986|453594367|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
126082257|NCT06719986|453594368|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
126082258|NCT05992922|453594369|FG000|Overall Study|Adverse Event|6|||
126082259|NCT05992922|453594370|FG001|Overall Study|Adverse Event|0|||
126082260|NCT05992922|453594369|FG000|Overall Study|Sponsor Termination of Study|14|||
126082261|NCT05992922|453594370|FG001|Overall Study|Sponsor Termination of Study|20|||
126082262|NCT04596995|453595709|FG000|Overall Study|Lack of Efficacy|8|||
126082263|NCT04596995|453595709|FG000|Overall Study|Lost to Follow-up|3|||
126082264|NCT04596995|453595709|FG000|Overall Study|Withdrawal by Subject|12|||
126082265|NCT04596995|453595709|FG000|Overall Study|Sponsor decision|3|||
126082266|NCT04596995|453595709|FG000|Overall Study|Enrolled in managed access program|3|||
126082267|NCT00590564|453595711|FG000|Overall Study|Withdrawal by Subject|4|||
126082268|NCT00590564|453595711|FG000|Overall Study|Lost to Follow-up|6|||
126082269|NCT00590564|453595711|FG000|Overall Study|Protocol Violation|1|||
126082270|NCT00590564|453595711|FG000|Overall Study|Patient Found to be Ineligible|1|||
126082271|NCT00590564|453595711|FG000|Overall Study|Patient Non-compliance|6|||
126082272|NCT01434680|453595712|FG000|Overall Study|Withdrawal by Subject|1|||
126082273|NCT01434680|453595713|FG001|Overall Study|Withdrawal by Subject|0|||
126082274|NCT01434680|453595714|FG002|Overall Study|Withdrawal by Subject|2|||
126082275|NCT01434680|453595715|FG003|Overall Study|Withdrawal by Subject|0|||
126082276|NCT01434680|453595712|FG000|Overall Study|Lost to Follow-up|1|||
126082277|NCT01434680|453595713|FG001|Overall Study|Lost to Follow-up|1|||
126082278|NCT01434680|453595714|FG002|Overall Study|Lost to Follow-up|0|||
126082279|NCT01434680|453595715|FG003|Overall Study|Lost to Follow-up|0|||
126082280|NCT01434680|453595712|FG000|Overall Study|Protocol Violation|1|||
126082281|NCT01434680|453595713|FG001|Overall Study|Protocol Violation|1|||
126082282|NCT01434680|453595714|FG002|Overall Study|Protocol Violation|0|||
126082283|NCT01434680|453595715|FG003|Overall Study|Protocol Violation|0|||
126082284|NCT00983749|453595718|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
126082285|NCT00983749|453595719|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
126082286|NCT01952847|453595720|FG000|Overall Study|Ineligible|1|||
126082287|NCT01952847|453595721|FG001|Overall Study|Ineligible|0|||
126082288|NCT01952847|453595722|FG002|Overall Study|Ineligible|0|||
126082289|NCT01952847|453595723|FG003|Overall Study|Ineligible|0|||
126082290|NCT01952847|453595720|FG000|Overall Study|Lack of Insurance Coverage|0|||
126082291|NCT01952847|453595721|FG001|Overall Study|Lack of Insurance Coverage|1|||
126082292|NCT01952847|453595722|FG002|Overall Study|Lack of Insurance Coverage|0|||
126082293|NCT01952847|453595723|FG003|Overall Study|Lack of Insurance Coverage|0|||
126082294|NCT01952847|453595720|FG000|Overall Study|Withdrawal by Subject|1|||
126082295|NCT01952847|453595721|FG001|Overall Study|Withdrawal by Subject|1|||
126082296|NCT01952847|453595722|FG002|Overall Study|Withdrawal by Subject|0|||
126082297|NCT01952847|453595723|FG003|Overall Study|Withdrawal by Subject|1|||
126082298|NCT01907906|453595724|FG000|Overall Study|Withdrawal by Subject|1|||
126082299|NCT01907906|453595725|FG001|Overall Study|Withdrawal by Subject|0|||
126082300|NCT01907906|453595724|FG000|Overall Study|Physician Decision|3|||
126082301|NCT01907906|453595725|FG001|Overall Study|Physician Decision|1|||
126082302|NCT00490945|453595727|FG000|Overall Study|Adverse Event|0|||
126082303|NCT00490945|453595728|FG001|Overall Study|Adverse Event|1|||
126082304|NCT00490945|453595729|FG002|Overall Study|Adverse Event|0|||
126082305|NCT00490945|453595730|FG003|Overall Study|Adverse Event|0|||
126082306|NCT00490945|453595731|FG004|Overall Study|Adverse Event|0|||
126082307|NCT03334253|453595732|FG000|Overall Study|Withdrawal by Subject|1|||
126082308|NCT03334253|453595733|FG001|Overall Study|Withdrawal by Subject|0|||
126082309|NCT03334253|453595732|FG000|Overall Study|Lost to Follow-up|4|||
126082310|NCT03334253|453595733|FG001|Overall Study|Lost to Follow-up|3|||
126082311|NCT03334253|453595732|FG000|Overall Study|Moved residence|2|||
126082312|NCT03334253|453595733|FG001|Overall Study|Moved residence|2|||
126082313|NCT00203047|453595734|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
126082314|NCT00203047|453595735|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
126082315|NCT00203047|453595734|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
126082316|NCT00203047|453595735|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
126082317|NCT00203047|453595734|FG000|Overall Study|Withdrawal by Subject|13|||
126082318|NCT00203047|453595735|FG001|Overall Study|Withdrawal by Subject|47|||
126082319|NCT00203047|453595734|FG000|Overall Study|Teva requested participant withdrawal|1|||
126082320|NCT00203047|453595735|FG001|Overall Study|Teva requested participant withdrawal|1|||
126082321|NCT00203047|453595734|FG000|Overall Study|Physician Decision|8|||
126082322|NCT00203047|453595735|FG001|Overall Study|Physician Decision|7|||
126082323|NCT00203047|453595734|FG000|Overall Study|Non-compliance|4|||
126082324|NCT00203047|453595735|FG001|Overall Study|Non-compliance|8|||
126082325|NCT00203047|453595734|FG000|Overall Study|Protocol Violation|1|||
126082326|NCT00203047|453595735|FG001|Overall Study|Protocol Violation|0|||
126115410|NCT03061175|453718115|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
126115411|NCT03061175|453718114|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
126115412|NCT03061175|453718115|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
126115413|NCT02243865|453718116|FG000|Overall Study|Protocol Violation|1|||
126115414|NCT02243865|453718117|FG001|Overall Study|Protocol Violation|3|||
126115415|NCT02243865|453718116|FG000|Overall Study|Lost to Follow-up|1|||
126115416|NCT02243865|453718117|FG001|Overall Study|Lost to Follow-up|1|||
126082327|NCT00203047|453595734|FG000|Overall Study|Lost to Follow-up|11|||
126082328|NCT00203047|453595735|FG001|Overall Study|Lost to Follow-up|5|||
126082329|NCT00203047|453595734|FG000|Overall Study|Adverse Event|8|||
126082330|NCT00203047|453595735|FG001|Overall Study|Adverse Event|18|||
126082331|NCT00203047|453595734|FG000|Overall Study|Death|1|||
126082332|NCT00203047|453595735|FG001|Overall Study|Death|2|||
126082333|NCT00203047|453595734|FG000|Overall Study|Pregnancy|3|||
126082334|NCT00203047|453595735|FG001|Overall Study|Pregnancy|0|||
126115417|NCT02243865|453718116|FG000|Overall Study|Withdrawal by Subject|1|||
126082335|NCT00203047|453595734|FG000|Overall Study|Other|5|||
126082336|NCT00203047|453595735|FG001|Overall Study|Other|5|||
126082337|NCT00340704|453595738|FG000|PK Study|Adverse Event|0|||
126082338|NCT00340704|453595739|FG001|PK Study|Adverse Event|1|||
126082339|NCT00340704|453595740|FG002|PK Study|Adverse Event|0|||
126082340|NCT00340704|453595741|FG003|PK Study|Adverse Event|0|||
126082341|NCT00340704|453595742|FG004|PK Study|Adverse Event|0|||
126082342|NCT00340704|453595743|FG005|PK Study|Adverse Event|0|||
126082343|NCT00340704|453595744|FG006|PK Study|Adverse Event|0|||
126082344|NCT00340704|453595745|FG007|PK Study|Adverse Event|0|||
126082345|NCT00340704|453595746|FG008|PK Study|Adverse Event|0|||
126082346|NCT00340704|453595738|FG000|PK Study|Not treated|0|||
126082347|NCT00340704|453595739|FG001|PK Study|Not treated|0|||
126082348|NCT00340704|453595740|FG002|PK Study|Not treated|1|||
126082349|NCT00340704|453595741|FG003|PK Study|Not treated|0|||
126082350|NCT00340704|453595742|FG004|PK Study|Not treated|0|||
126082351|NCT00340704|453595743|FG005|PK Study|Not treated|0|||
126082352|NCT00340704|453595744|FG006|PK Study|Not treated|0|||
126082353|NCT00340704|453595745|FG007|PK Study|Not treated|0|||
126082354|NCT00340704|453595746|FG008|PK Study|Not treated|0|||
126082355|NCT00340704|453595738|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126082356|NCT00340704|453595739|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126082357|NCT00340704|453595740|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126082358|NCT00340704|453595741|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
126082359|NCT00340704|453595742|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
126082360|NCT00340704|453595743|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126082361|NCT00340704|453595744|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126082362|NCT00340704|453595745|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
126082363|NCT00340704|453595746|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
126082364|NCT00340704|453595738|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126082365|NCT00340704|453595739|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126082366|NCT00340704|453595740|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126082367|NCT00340704|453595741|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126082368|NCT00340704|453595742|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126082369|NCT00340704|453595743|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
126082370|NCT00340704|453595744|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126082371|NCT00340704|453595745|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126082372|NCT00340704|453595746|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126082373|NCT00340704|453595738|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126082374|NCT00340704|453595739|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126082375|NCT00340704|453595740|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126082376|NCT00340704|453595741|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126082377|NCT00340704|453595742|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
126082378|NCT00340704|453595743|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
126082379|NCT00340704|453595744|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126082380|NCT00340704|453595745|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126082381|NCT00340704|453595746|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126082382|NCT00340704|453595738|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126082383|NCT00340704|453595739|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126082384|NCT00340704|453595740|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126082385|NCT00340704|453595741|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126082386|NCT00340704|453595742|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126082387|NCT00340704|453595743|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
126082388|NCT00340704|453595744|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
126082389|NCT00340704|453595745|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
126082390|NCT00340704|453595746|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
126082391|NCT00121667|453595747|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
126082392|NCT00121667|453595748|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
126082393|NCT00121667|453595749|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
126082394|NCT00121667|453595750|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
126082395|NCT00121667|453595747|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
126082396|NCT00121667|453595748|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
126082397|NCT00121667|453595749|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
126082398|NCT00121667|453595750|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
126082399|NCT00121667|453595747|FG000|Short Term (ST) Period|Adverse Event|5|||
126082400|NCT00121667|453595748|FG001|Short Term (ST) Period|Adverse Event|6|||
126082401|NCT00121667|453595749|FG002|Short Term (ST) Period|Adverse Event|5|||
126082402|NCT00121667|453595750|FG003|Short Term (ST) Period|Adverse Event|3|||
126082403|NCT00121667|453595747|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
126082404|NCT00121667|453595748|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
126082405|NCT00121667|453595749|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
126082406|NCT00121667|453595750|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
126082407|NCT00121667|453595747|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
126082408|NCT00121667|453595748|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
126082409|NCT00121667|453595749|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
126082410|NCT00121667|453595750|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
126082411|NCT00121667|453595747|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
126082412|NCT00121667|453595748|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
126082413|NCT00121667|453595749|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
126082414|NCT00121667|453595750|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
126082415|NCT00121667|453595747|FG000|Short Term (ST) Period|Other Reason|3|||
126082416|NCT00121667|453595748|FG001|Short Term (ST) Period|Other Reason|0|||
126082417|NCT00121667|453595749|FG002|Short Term (ST) Period|Other Reason|0|||
126082418|NCT00121667|453595750|FG003|Short Term (ST) Period|Other Reason|0|||
126082419|NCT00121667|453595747|FG000|Short Term (ST) Period|Death|0|||
126082420|NCT00121667|453595748|FG001|Short Term (ST) Period|Death|0|||
126082421|NCT00121667|453595749|FG002|Short Term (ST) Period|Death|0|||
126082422|NCT00121667|453595750|FG003|Short Term (ST) Period|Death|1|||
126082423|NCT00121667|453595747|FG000|Short Term (ST) Period|Pregnancy|0|||
126082424|NCT00121667|453595748|FG001|Short Term (ST) Period|Pregnancy|0|||
126082425|NCT00121667|453595749|FG002|Short Term (ST) Period|Pregnancy|0|||
126082426|NCT00121667|453595750|FG003|Short Term (ST) Period|Pregnancy|1|||
126082427|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
126082428|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
126082429|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
126082430|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
126082431|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
126082432|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
126082433|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
126082434|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
126082435|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
126082436|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
126082437|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
126082438|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
126082439|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
126082440|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
126082441|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
126082442|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
126082443|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
126082444|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
126082445|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
126082446|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
126082447|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
126082448|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
126082449|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
126082450|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
126082451|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
126082452|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
126082453|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
126082454|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
126082455|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
126082456|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
126082457|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
126082458|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
126082459|NCT00121667|453595747|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
126082460|NCT00121667|453595748|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
126082461|NCT00121667|453595749|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
126082462|NCT00121667|453595750|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
126082463|NCT01453023|453595751|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
126082464|NCT01453023|453595752|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
126082465|NCT01453023|453595751|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
126082466|NCT01453023|453595752|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
125953618|NCT04697628|453127525|FG001|Overall Study|Lost to Follow-up|4|||
126082467|NCT01453023|453595751|FG000|Treatment Period 2|Protocol Violation|0|||
126082468|NCT01453023|453595752|FG001|Treatment Period 2|Protocol Violation|1|||
126082469|NCT02879383|453595753|FG000|First 24 Weeks|Physician Decision|0|||
126082470|NCT02879383|453595754|FG001|First 24 Weeks|Physician Decision|1|||
126082471|NCT02879383|453595755|FG002|First 24 Weeks|Physician Decision|0|||
126082472|NCT02879383|453595756|FG003|First 24 Weeks|Physician Decision|0|||
125953619|NCT04697628|453127524|FG000|Overall Study|On-going in study|122|||
126082473|NCT02413593|453595770|FG000|Overall Study|Lost to Follow-up|3|||
126082474|NCT02413593|453595770|FG000|Overall Study|Adverse Event|1|||
126082475|NCT00723125|453595771|FG000|Overall Study|Met Dx|1|||
126082476|NCT00723125|453595772|FG001|Overall Study|Met Dx|0|||
126082477|NCT00723125|453595771|FG000|Overall Study|Withdrawal by Subject|15|||
126082478|NCT00723125|453595772|FG001|Overall Study|Withdrawal by Subject|6|||
126082479|NCT00723125|453595771|FG000|Overall Study|Adverse Event|2|||
126082480|NCT00723125|453595772|FG001|Overall Study|Adverse Event|0|||
126082481|NCT01807182|453595775|FG000|Overall Study|Death|1|||
126082482|NCT01807182|453595775|FG000|Overall Study|New therapy|1|||
126082483|NCT01807182|453595775|FG000|Overall Study|Moved to hospice care|1|||
126082484|NCT01080300|453595776|FG000|Overall Study|Adverse Event|49|||
126082485|NCT01080300|453595777|FG001|Overall Study|Adverse Event|35|||
126082486|NCT01080300|453595776|FG000|Overall Study|Lack of Efficacy|12|||
126082487|NCT01080300|453595777|FG001|Overall Study|Lack of Efficacy|15|||
126082488|NCT01080300|453595776|FG000|Overall Study|Protocol Violation|7|||
126082489|NCT01080300|453595777|FG001|Overall Study|Protocol Violation|13|||
126082490|NCT01080300|453595776|FG000|Overall Study|Lost to Follow-up|10|||
126082491|NCT01080300|453595777|FG001|Overall Study|Lost to Follow-up|6|||
126082492|NCT01080300|453595776|FG000|Overall Study|Death|0|||
126082493|NCT01080300|453595777|FG001|Overall Study|Death|1|||
126082494|NCT01080300|453595776|FG000|Overall Study|Withdrawal by Subject|12|||
126082495|NCT01080300|453595777|FG001|Overall Study|Withdrawal by Subject|28|||
126082496|NCT01080300|453595776|FG000|Overall Study|Reasons not specified|4|||
126082497|NCT01080300|453595777|FG001|Overall Study|Reasons not specified|6|||
126082498|NCT00478205|453595781|FG000|Overall Study|Adverse Event|182|||
126082499|NCT00478205|453595782|FG001|Overall Study|Adverse Event|39|||
126082500|NCT00478205|453595781|FG000|Overall Study|Medication Non-compliance|9|||
126082501|NCT00478205|453595782|FG001|Overall Study|Medication Non-compliance|4|||
126082502|NCT00478205|453595781|FG000|Overall Study|Protocol Violation|15|||
126082503|NCT00478205|453595782|FG001|Overall Study|Protocol Violation|5|||
126082504|NCT00478205|453595781|FG000|Overall Study|Request of Investigator or Sponsor|4|||
126082505|NCT00478205|453595782|FG001|Overall Study|Request of Investigator or Sponsor|5|||
126082506|NCT00478205|453595781|FG000|Overall Study|Withdrawal by Subject|61|||
126082507|NCT00478205|453595782|FG001|Overall Study|Withdrawal by Subject|22|||
126082508|NCT00478205|453595781|FG000|Overall Study|Lack of Efficacy|1|||
126082509|NCT00478205|453595782|FG001|Overall Study|Lack of Efficacy|0|||
126082510|NCT00478205|453595781|FG000|Overall Study|Other|24|||
126082511|NCT00478205|453595782|FG001|Overall Study|Other|12|||
126082512|NCT03513068|453595783|FG000|Overall Study|Death|1|||
126082513|NCT03513068|453595784|FG001|Overall Study|Death|0|||
126082514|NCT03513068|453595783|FG000|Overall Study|Withdrawal by Subject|4|||
126082515|NCT03513068|453595784|FG001|Overall Study|Withdrawal by Subject|6|||
126082516|NCT00003477|453595787|FG000|Overall Study|Not evalauable|4|||
126082517|NCT01575873|453595788|FG000|Overall Study|Withdrawal by Subject|15|||
126082518|NCT01575873|453595789|FG001|Overall Study|Withdrawal by Subject|20|||
126082519|NCT01575873|453595790|FG002|Overall Study|Withdrawal by Subject|34|||
126082520|NCT01575873|453595791|FG003|Overall Study|Withdrawal by Subject|34|||
126082521|NCT01575873|453595788|FG000|Overall Study|Adverse Event|7|||
126082522|NCT01575873|453595789|FG001|Overall Study|Adverse Event|7|||
126082523|NCT01575873|453595790|FG002|Overall Study|Adverse Event|9|||
126082524|NCT01575873|453595791|FG003|Overall Study|Adverse Event|12|||
126082525|NCT01575873|453595788|FG000|Overall Study|Lost to Follow-up|1|||
126082526|NCT01575873|453595789|FG001|Overall Study|Lost to Follow-up|3|||
126082527|NCT01575873|453595790|FG002|Overall Study|Lost to Follow-up|13|||
126082528|NCT01575873|453595791|FG003|Overall Study|Lost to Follow-up|5|||
126082529|NCT01575873|453595788|FG000|Overall Study|Death|3|||
126115418|NCT02243865|453718117|FG001|Overall Study|Withdrawal by Subject|0|||
125953620|NCT04697628|453127525|FG001|Overall Study|On-going in study|91|||
126082530|NCT01575873|453595789|FG001|Overall Study|Death|2|||
126082531|NCT01575873|453595790|FG002|Overall Study|Death|8|||
126082532|NCT01575873|453595791|FG003|Overall Study|Death|9|||
126082533|NCT01575873|453595788|FG000|Overall Study|Noncompliance|1|||
126082534|NCT01575873|453595789|FG001|Overall Study|Noncompliance|2|||
126115419|NCT02243865|453718116|FG000|Overall Study|Adverse Event|1|||
126082535|NCT01575873|453595790|FG002|Overall Study|Noncompliance|4|||
126082536|NCT01575873|453595791|FG003|Overall Study|Noncompliance|3|||
126082537|NCT01575873|453595788|FG000|Overall Study|Administrative decision|1|||
126082538|NCT01575873|453595789|FG001|Overall Study|Administrative decision|1|||
126082539|NCT01575873|453595790|FG002|Overall Study|Administrative decision|1|||
126082540|NCT01575873|453595791|FG003|Overall Study|Administrative decision|0|||
126082541|NCT01575873|453595788|FG000|Overall Study|Protocol deviation|0|||
126082542|NCT01575873|453595789|FG001|Overall Study|Protocol deviation|1|||
126082543|NCT01575873|453595790|FG002|Overall Study|Protocol deviation|0|||
126082544|NCT01575873|453595791|FG003|Overall Study|Protocol deviation|1|||
126082545|NCT01575873|453595788|FG000|Overall Study|Requirement for Alternative Therapy|0|||
126082546|NCT01575873|453595789|FG001|Overall Study|Requirement for Alternative Therapy|0|||
126082547|NCT01575873|453595790|FG002|Overall Study|Requirement for Alternative Therapy|1|||
126082548|NCT01575873|453595791|FG003|Overall Study|Requirement for Alternative Therapy|1|||
126115420|NCT02243865|453718117|FG001|Overall Study|Adverse Event|1|||
126082549|NCT01575873|453595788|FG000|Overall Study|Other|0|||
126082550|NCT01575873|453595789|FG001|Overall Study|Other|0|||
126082551|NCT01575873|453595790|FG002|Overall Study|Other|4|||
126082552|NCT01575873|453595791|FG003|Overall Study|Other|2|||
126082553|NCT01850030|453595792|FG000|Overall Study|Adverse Event|64|||
126082554|NCT01850030|453595793|FG001|Overall Study|Adverse Event|82|||
126082555|NCT01850030|453595792|FG000|Overall Study|Lack of Efficacy|3|||
126082556|NCT01850030|453595793|FG001|Overall Study|Lack of Efficacy|1|||
126082557|NCT01850030|453595792|FG000|Overall Study|Lost to Follow-up|5|||
126082558|NCT01850030|453595793|FG001|Overall Study|Lost to Follow-up|5|||
126082559|NCT01850030|453595792|FG000|Overall Study|Withdrawal by Subject|3|||
126082560|NCT01850030|453595793|FG001|Overall Study|Withdrawal by Subject|4|||
126082561|NCT01850030|453595792|FG000|Overall Study|Protocol Violation|24|||
126082562|NCT01850030|453595793|FG001|Overall Study|Protocol Violation|28|||
126082563|NCT01850030|453595792|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
126082564|NCT01850030|453595793|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
126082565|NCT00762476|453595794|FG000|Overall Study|Adverse Event|7|||
126082566|NCT00762476|453595795|FG001|Overall Study|Adverse Event|1|||
126082567|NCT00762476|453595794|FG000|Overall Study|Lost to Follow-up|2|||
126082568|NCT00762476|453595795|FG001|Overall Study|Lost to Follow-up|0|||
126082569|NCT00762476|453595794|FG000|Overall Study|Protocol Violation|5|||
126082570|NCT00762476|453595795|FG001|Overall Study|Protocol Violation|6|||
126082571|NCT00762476|453595794|FG000|Overall Study|Physician Decision|2|||
126082572|NCT00762476|453595795|FG001|Overall Study|Physician Decision|14|||
126082573|NCT00762476|453595794|FG000|Overall Study|Withdrawal by Subject|6|||
126082574|NCT00762476|453595795|FG001|Overall Study|Withdrawal by Subject|12|||
126082575|NCT00762476|453595794|FG000|Overall Study|antibiotic use|0|||
126082576|NCT00762476|453595795|FG001|Overall Study|antibiotic use|1|||
126082577|NCT00762476|453595794|FG000|Overall Study|non-compliance with study visits|0|||
126082578|NCT00762476|453595795|FG001|Overall Study|non-compliance with study visits|2|||
126082579|NCT00762476|453595794|FG000|Overall Study|Seasonal allergies|1|||
126082580|NCT00762476|453595795|FG001|Overall Study|Seasonal allergies|0|||
126082581|NCT00965497|453595797|FG000|Overall Study|Physician Decision|1|||
126082582|NCT00953615|453595798|FG000|Overall Study|Adverse Event|1|||
126082583|NCT01299480|453595799|FG000|Overall Study|No longer willing to participate|19|||
126082584|NCT01299480|453595800|FG001|Overall Study|No longer willing to participate|17|||
126082585|NCT01299480|453595801|FG002|Overall Study|No longer willing to participate|14|||
126082586|NCT01299480|453595802|FG003|Overall Study|No longer willing to participate|13|||
126082587|NCT01299480|453595803|FG004|Overall Study|No longer willing to participate|10|||
126082588|NCT01299480|453595799|FG000|Overall Study|Protocol Violation|7|||
126082589|NCT01299480|453595800|FG001|Overall Study|Protocol Violation|5|||
126082590|NCT01299480|453595801|FG002|Overall Study|Protocol Violation|8|||
126082591|NCT01299480|453595802|FG003|Overall Study|Protocol Violation|1|||
126082592|NCT01299480|453595803|FG004|Overall Study|Protocol Violation|1|||
126082593|NCT01299480|453595799|FG000|Overall Study|Withdrawal by Subject|3|||
126082594|NCT01299480|453595800|FG001|Overall Study|Withdrawal by Subject|4|||
126082595|NCT01299480|453595801|FG002|Overall Study|Withdrawal by Subject|7|||
126082596|NCT01299480|453595802|FG003|Overall Study|Withdrawal by Subject|3|||
126082597|NCT01299480|453595803|FG004|Overall Study|Withdrawal by Subject|4|||
126082598|NCT01299480|453595799|FG000|Overall Study|Adverse Event|6|||
126082599|NCT01299480|453595800|FG001|Overall Study|Adverse Event|4|||
125953621|NCT01946204|453127526|FG000|Overall Study|Death|38|||
126082600|NCT01299480|453595801|FG002|Overall Study|Adverse Event|5|||
126115421|NCT04166383|453718125|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
125953622|NCT01946204|453127527|FG001|Overall Study|Death|59|||
126082601|NCT01299480|453595802|FG003|Overall Study|Adverse Event|4|||
126082602|NCT01299480|453595803|FG004|Overall Study|Adverse Event|0|||
126082603|NCT01299480|453595799|FG000|Overall Study|Withdrawal due to pregnancy|0|||
126082604|NCT01299480|453595800|FG001|Overall Study|Withdrawal due to pregnancy|1|||
126082605|NCT01299480|453595801|FG002|Overall Study|Withdrawal due to pregnancy|1|||
126082606|NCT01299480|453595802|FG003|Overall Study|Withdrawal due to pregnancy|0|||
126082607|NCT01299480|453595803|FG004|Overall Study|Withdrawal due to pregnancy|0|||
126082608|NCT01299480|453595799|FG000|Overall Study|Physician Decision|1|||
126082609|NCT01299480|453595800|FG001|Overall Study|Physician Decision|1|||
126115422|NCT04166383|453718125|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
125953623|NCT01946204|453127526|FG000|Overall Study|Withdrawal by Subject|37|||
126082610|NCT01299480|453595801|FG002|Overall Study|Physician Decision|0|||
126082611|NCT01299480|453595802|FG003|Overall Study|Physician Decision|2|||
126082612|NCT01299480|453595803|FG004|Overall Study|Physician Decision|0|||
126082613|NCT01299480|453595799|FG000|Overall Study|Lost to Follow-up|3|||
126082614|NCT01299480|453595800|FG001|Overall Study|Lost to Follow-up|1|||
125953624|NCT01946204|453127527|FG001|Overall Study|Withdrawal by Subject|50|||
125953625|NCT01946204|453127526|FG000|Overall Study|Lost to Follow-up|3|||
126082615|NCT01299480|453595801|FG002|Overall Study|Lost to Follow-up|2|||
126082616|NCT01299480|453595802|FG003|Overall Study|Lost to Follow-up|1|||
126082617|NCT01299480|453595803|FG004|Overall Study|Lost to Follow-up|2|||
126082618|NCT01299480|453595799|FG000|Overall Study|Other|3|||
126082619|NCT01299480|453595800|FG001|Overall Study|Other|2|||
126082620|NCT01299480|453595801|FG002|Overall Study|Other|3|||
126082621|NCT01299480|453595802|FG003|Overall Study|Other|0|||
126082622|NCT01299480|453595803|FG004|Overall Study|Other|3|||
126082623|NCT01299480|453595799|FG000|Overall Study|Started, but not vaccinated|0|||
126082624|NCT01299480|453595800|FG001|Overall Study|Started, but not vaccinated|0|||
126082625|NCT01299480|453595801|FG002|Overall Study|Started, but not vaccinated|1|||
126082626|NCT01299480|453595802|FG003|Overall Study|Started, but not vaccinated|1|||
126082627|NCT01299480|453595803|FG004|Overall Study|Started, but not vaccinated|0|||
126082628|NCT02296892|453595810|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
126082629|NCT02296892|453595811|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
126082630|NCT02296892|453595812|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
126082631|NCT02296892|453595810|FG000|Overall Study|Lost to Follow-up|5|||
126082632|NCT02296892|453595811|FG001|Overall Study|Lost to Follow-up|0|||
126082633|NCT02296892|453595812|FG002|Overall Study|Lost to Follow-up|1|||
126082634|NCT04547023|453595815|FG000|Overall Study|Did Not Receive Intervention|3|||
126082635|NCT04547023|453595816|FG001|Overall Study|Did Not Receive Intervention|2|||
126082636|NCT04547023|453595815|FG000|Overall Study|Lost to Follow-up|1|||
126082637|NCT04547023|453595816|FG001|Overall Study|Lost to Follow-up|1|||
126082638|NCT01011868|453595817|FG000|After Week 18 Follow-up|Adverse Event|8|||
126082639|NCT01011868|453595818|FG001|After Week 18 Follow-up|Adverse Event|6|||
126082640|NCT01011868|453595819|FG002|After Week 18 Follow-up|Adverse Event|13|||
126082641|NCT01011868|453595817|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
126082642|NCT01011868|453595818|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
126082643|NCT01011868|453595819|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
126082644|NCT01011868|453595817|FG000|After Week 18 Follow-up|Protocol Violation|1|||
125953626|NCT01946204|453127527|FG001|Overall Study|Lost to Follow-up|7|||
125953627|NCT01946204|453127526|FG000|Overall Study|Ongoing|316|||
125953628|NCT01946204|453127527|FG001|Overall Study|Ongoing|687|||
125953629|NCT01946204|453127526|FG000|Overall Study|Other|7|||
125953630|NCT01946204|453127527|FG001|Overall Study|Other|3|||
126082645|NCT01011868|453595818|FG001|After Week 18 Follow-up|Protocol Violation|1|||
126082646|NCT01011868|453595819|FG002|After Week 18 Follow-up|Protocol Violation|1|||
126082647|NCT01011868|453595817|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
126082648|NCT01011868|453595818|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
126082649|NCT01011868|453595819|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
126082650|NCT01011868|453595817|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
126082651|NCT01011868|453595818|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
126082652|NCT01011868|453595819|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
126082653|NCT01011868|453595817|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
126082654|NCT01011868|453595818|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
126082655|NCT01011868|453595819|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
126082656|NCT01011868|453595817|FG000|After Week 78 Follow-up|Adverse Event|14|||
125953631|NCT03466411|453127528|FG000|Overall Study|Lost to Follow-up|0|||
125953632|NCT03466411|453127529|FG001|Overall Study|Lost to Follow-up|1|||
125953633|NCT03466411|453127530|FG002|Overall Study|Lost to Follow-up|1|||
125953634|NCT03466411|453127531|FG003|Overall Study|Lost to Follow-up|0|||
125953635|NCT03466411|453127532|FG004|Overall Study|Lost to Follow-up|0|||
125953636|NCT03466411|453127533|FG005|Overall Study|Lost to Follow-up|0|||
125953637|NCT03466411|453127534|FG006|Overall Study|Lost to Follow-up|1|||
125953638|NCT03466411|453127535|FG007|Overall Study|Lost to Follow-up|1|||
125953639|NCT03466411|453127536|FG008|Overall Study|Lost to Follow-up|0|||
125953640|NCT03466411|453127537|FG009|Overall Study|Lost to Follow-up|1|||
125953641|NCT03466411|453127538|FG010|Overall Study|Lost to Follow-up|1|||
126082657|NCT01011868|453595818|FG001|After Week 78 Follow-up|Adverse Event|18|||
126082658|NCT01011868|453595819|FG002|After Week 78 Follow-up|Adverse Event|21|||
126082659|NCT01011868|453595817|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
126082660|NCT01011868|453595818|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
126082661|NCT01011868|453595819|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
126082662|NCT01011868|453595817|FG000|After Week 78 Follow-up|Protocol Violation|9|||
126082663|NCT01011868|453595818|FG001|After Week 78 Follow-up|Protocol Violation|1|||
126082664|NCT01011868|453595819|FG002|After Week 78 Follow-up|Protocol Violation|2|||
126082665|NCT01011868|453595817|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
126082666|NCT01011868|453595818|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
126082667|NCT01011868|453595819|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
126082668|NCT01011868|453595817|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
126082669|NCT01011868|453595818|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
126082670|NCT01011868|453595819|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
126082671|NCT01011868|453595817|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
126082672|NCT01011868|453595818|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
126082673|NCT01011868|453595819|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
126082674|NCT03784820|453595820|FG000|Overall Study|Lost to Follow-up|5|||
125953642|NCT03466411|453127539|FG011|Overall Study|Lost to Follow-up|1|||
125953643|NCT03466411|453127540|FG012|Overall Study|Lost to Follow-up|0|||
125953644|NCT03466411|453127528|FG000|Overall Study|Withdrawal by Subject|14|||
126082675|NCT03784820|453595821|FG001|Overall Study|Lost to Follow-up|5|||
126082676|NCT03784820|453595822|FG002|Overall Study|Lost to Follow-up|3|||
126082677|NCT03784820|453595823|FG003|Overall Study|Lost to Follow-up|3|||
126082678|NCT03170518|453595824|FG000|Overall Study|Lost to Follow-up|4|||
126082679|NCT03170518|453595825|FG001|Overall Study|Lost to Follow-up|1|||
126082680|NCT03170518|453595826|FG002|Overall Study|Lost to Follow-up|0|||
126082681|NCT03170518|453595824|FG000|Overall Study|Physician Decision|1|||
126082682|NCT03170518|453595825|FG001|Overall Study|Physician Decision|0|||
126082683|NCT03170518|453595826|FG002|Overall Study|Physician Decision|0|||
126082684|NCT03170518|453595824|FG000|Overall Study|Withdrawal by Subject|4|||
126082685|NCT03170518|453595825|FG001|Overall Study|Withdrawal by Subject|5|||
126082686|NCT03170518|453595826|FG002|Overall Study|Withdrawal by Subject|2|||
126082687|NCT03170518|453595824|FG000|Overall Study|Site terminated by sponsor|0|||
126082688|NCT03170518|453595825|FG001|Overall Study|Site terminated by sponsor|1|||
126082689|NCT03170518|453595826|FG002|Overall Study|Site terminated by sponsor|0|||
126082690|NCT03170518|453595824|FG000|Overall Study|Non-compliance with study drug|1|||
126082691|NCT03170518|453595825|FG001|Overall Study|Non-compliance with study drug|0|||
126082692|NCT03170518|453595826|FG002|Overall Study|Non-compliance with study drug|1|||
125953645|NCT03466411|453127529|FG001|Overall Study|Withdrawal by Subject|7|||
125953646|NCT03466411|453127530|FG002|Overall Study|Withdrawal by Subject|8|||
126082693|NCT03170518|453595824|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126082694|NCT03170518|453595825|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126082695|NCT03170518|453595826|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126082696|NCT04428476|453595827|FG000|Overall Study|Withdrawal by Subject|1|||
126082697|NCT04428476|453595827|FG000|Overall Study|Still on treatment|12|||
126082698|NCT00546078|453595828|FG000|Overall Study|Lost to Follow-up|1|||
126082699|NCT00546078|453595829|FG001|Overall Study|Lost to Follow-up|3|||
126082700|NCT00546078|453595828|FG000|Overall Study|Withdrawal by Subject|2|||
126082701|NCT00546078|453595829|FG001|Overall Study|Withdrawal by Subject|3|||
126082702|NCT00546078|453595828|FG000|Overall Study|Other reason|1|||
126082703|NCT00546078|453595829|FG001|Overall Study|Other reason|1|||
126082704|NCT02559310|453595833|FG000|Overall Study|Death|4|||
126082705|NCT02559310|453595834|FG001|Overall Study|Death|3|||
126082706|NCT02559310|453595833|FG000|Overall Study|Lost to Follow-up|5|||
126082707|NCT02559310|453595834|FG001|Overall Study|Lost to Follow-up|3|||
126082708|NCT02559310|453595833|FG000|Overall Study|Physician Decision|2|||
126082709|NCT02559310|453595834|FG001|Overall Study|Physician Decision|1|||
126082710|NCT02559310|453595833|FG000|Overall Study|Withdrawal by Subject|13|||
126082711|NCT02559310|453595834|FG001|Overall Study|Withdrawal by Subject|9|||
126082712|NCT02559310|453595833|FG000|Overall Study|Sponsor Decision|0|||
126082713|NCT02559310|453595834|FG001|Overall Study|Sponsor Decision|1|||
126082714|NCT02559310|453595833|FG000|Overall Study|Randomized but not treated|3|||
126082715|NCT02559310|453595834|FG001|Overall Study|Randomized but not treated|2|||
126082716|NCT01740154|453595835|FG000|Overall Study|Adverse Event|1|||
126082717|NCT04577573|453595838|FG000|Overall Study|Technical - invalid protocol|0|||
126082718|NCT04577573|453595839|FG001|Overall Study|Technical - invalid protocol|2|||
126082719|NCT04577573|453595840|FG002|Overall Study|Technical - invalid protocol|0|||
126082720|NCT02726945|453595843|FG000|Overall Study|Withdrawal by Subject|0|||
126082721|NCT02726945|453595844|FG001|Overall Study|Withdrawal by Subject|0|||
126082722|NCT02726945|453595845|FG002|Overall Study|Withdrawal by Subject|1|||
126082723|NCT02726945|453595843|FG000|Overall Study|Elected to have total knee replacement|0|||
126082724|NCT02726945|453595844|FG001|Overall Study|Elected to have total knee replacement|1|||
126082725|NCT02726945|453595845|FG002|Overall Study|Elected to have total knee replacement|0|||
126082726|NCT02737826|453598102|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
126082727|NCT02737826|453598103|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
126082728|NCT02737826|453598104|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
126082729|NCT00129935|453598105|FG000|Overall Study|Adverse Event|18|||
126082730|NCT00129935|453598106|FG001|Overall Study|Adverse Event|56|||
126082731|NCT00129935|453598105|FG000|Overall Study|Death|1|||
126082732|NCT00129935|453598106|FG001|Overall Study|Death|1|||
126082733|NCT00129935|453598105|FG000|Overall Study|Withdrawal by Subject|7|||
126082734|NCT00129935|453598106|FG001|Overall Study|Withdrawal by Subject|20|||
126082735|NCT00129935|453598105|FG000|Overall Study|Protocol Violation|0|||
126082736|NCT00129935|453598106|FG001|Overall Study|Protocol Violation|4|||
125953647|NCT03466411|453127531|FG003|Overall Study|Withdrawal by Subject|4|||
126082737|NCT00129935|453598105|FG000|Overall Study|Physician Decision|3|||
126082738|NCT00129935|453598106|FG001|Overall Study|Physician Decision|4|||
126082739|NCT00129935|453598105|FG000|Overall Study|Recurrence|1|||
126082740|NCT00129935|453598106|FG001|Overall Study|Recurrence|3|||
126082741|NCT00129935|453598105|FG000|Overall Study|Second primary|0|||
126082742|NCT00129935|453598106|FG001|Overall Study|Second primary|1|||
126082743|NCT00129935|453598105|FG000|Overall Study|Other|3|||
126082744|NCT00129935|453598106|FG001|Overall Study|Other|2|||
126082745|NCT00129935|453598105|FG000|Overall Study|Crossed to the other arm|2|||
126082746|NCT00129935|453598106|FG001|Overall Study|Crossed to the other arm|1|||
126082747|NCT00129935|453598105|FG000|Overall Study|Incorrect study treatment|1|||
126082748|NCT00129935|453598106|FG001|Overall Study|Incorrect study treatment|0|||
126082749|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
126082750|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
126082751|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
126082752|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Death|4|||
126082753|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Death|2|||
126082754|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Death|3|||
126082755|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
126082756|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
126115423|NCT04166383|453718125|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
126115424|NCT03044886|453718127|FG000|Overall Study|Lost to Follow-up|15|||
126115425|NCT03044886|453718128|FG001|Overall Study|Lost to Follow-up|10|||
126115426|NCT03044886|453718129|FG002|Overall Study|Lost to Follow-up|12|||
126115427|NCT02921269|453718130|FG000|Overall Study|Did not complete DLT period|1|||
126115428|NCT02054325|453718141|FG000|Overall Study|Lost to Follow-up|8|||
126115429|NCT02054325|453718142|FG001|Overall Study|Lost to Follow-up|5|||
126115430|NCT00504153|453718149|FG000|Overall Study|Withdrawal by Subject|1|||
126115431|NCT00504153|453718149|FG000|Overall Study|Adverse Event|4|||
126115432|NCT00504153|453718149|FG000|Overall Study|Death|1|||
126115433|NCT00074581|453718151|FG000|Overall Study|Death|15|||
126115434|NCT00074581|453718152|FG001|Overall Study|Death|16|||
126115435|NCT00074581|453718151|FG000|Overall Study|Withdrawal by Subject|50|||
126115436|NCT00074581|453718152|FG001|Overall Study|Withdrawal by Subject|49|||
126115437|NCT00074581|453718151|FG000|Overall Study|Unable to adhere to visit schedule|13|||
126115438|NCT00074581|453718152|FG001|Overall Study|Unable to adhere to visit schedule|14|||
126115439|NCT00074581|453718151|FG000|Overall Study|Relocated|14|||
126115440|NCT00074581|453718152|FG001|Overall Study|Relocated|9|||
126115441|NCT00074581|453718151|FG000|Overall Study|Were withdrawn by investigator|5|||
126115442|NCT00074581|453718152|FG001|Overall Study|Were withdrawn by investigator|2|||
126115443|NCT00074581|453718151|FG000|Overall Study|Lost to Follow-up|16|||
126115444|NCT00074581|453718152|FG001|Overall Study|Lost to Follow-up|11|||
126115445|NCT00074581|453718151|FG000|Overall Study|Ended relationship w. index participant|117|||
126115446|NCT00074581|453718152|FG001|Overall Study|Ended relationship w. index participant|106|||
126115447|NCT00074581|453718151|FG000|Overall Study|Other|14|||
126115448|NCT00074581|453718152|FG001|Overall Study|Other|19|||
126115449|NCT02322229|453718156|FG000|Overall Study|Physician Decision|2|||
126115450|NCT03250832|453718157|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
126115451|NCT03250832|453718158|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
126115452|NCT03250832|453718159|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
126115453|NCT03250832|453718160|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
126115454|NCT03250832|453718161|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
126115455|NCT03250832|453718162|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
126115456|NCT03250832|453718163|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
126115457|NCT03250832|453718164|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
126115458|NCT03250832|453718165|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
126115459|NCT03250832|453718166|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
126115460|NCT03250832|453718167|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
126115461|NCT03250832|453718168|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
126115462|NCT03250832|453718157|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
126115463|NCT03250832|453718158|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
126115464|NCT03250832|453718159|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
126115465|NCT03250832|453718160|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
126115466|NCT03250832|453718161|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
126115467|NCT03250832|453718162|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
126115468|NCT03250832|453718163|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
126115469|NCT03250832|453718164|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126115470|NCT03250832|453718165|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126115471|NCT03250832|453718166|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126115472|NCT03250832|453718167|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126115473|NCT03250832|453718168|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126115474|NCT03250832|453718157|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125953648|NCT03466411|453127532|FG004|Overall Study|Withdrawal by Subject|6|||
125953649|NCT03466411|453127533|FG005|Overall Study|Withdrawal by Subject|3|||
126082757|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
126115475|NCT03250832|453718158|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115476|NCT03250832|453718159|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
126115477|NCT03250832|453718160|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115478|NCT03250832|453718161|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115479|NCT03250832|453718162|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115480|NCT03250832|453718163|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115481|NCT03250832|453718164|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126082758|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
126082759|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
126082760|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
126082761|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
126082762|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
126082763|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
126082764|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
126082765|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
126082766|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
126082767|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
126082768|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
126082769|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
126082770|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
126082771|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
126082772|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
126082773|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
126082774|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
126082775|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
126082776|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
126082777|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
126082778|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
126082779|NCT02783573|453598107|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
126082780|NCT02783573|453598108|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
126082781|NCT02783573|453598109|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
126082782|NCT02783573|453598107|FG000|Delayed-Start Period|Sponsor Decision|0|||
126082783|NCT02783573|453598108|FG001|Delayed-Start Period|Sponsor Decision|17|||
126082784|NCT02783573|453598109|FG002|Delayed-Start Period|Sponsor Decision|12|||
126082785|NCT02797522|453598117|FG000|Overall Study|Study Terminated by Sponsor|0|||
126082786|NCT02797522|453598118|FG001|Overall Study|Study Terminated by Sponsor|0|||
126082787|NCT02797522|453598119|FG002|Overall Study|Study Terminated by Sponsor|0|||
126082788|NCT02797522|453598120|FG003|Overall Study|Study Terminated by Sponsor|0|||
126082789|NCT02797522|453598121|FG004|Overall Study|Study Terminated by Sponsor|0|||
126082790|NCT02797522|453598122|FG005|Overall Study|Study Terminated by Sponsor|0|||
126082791|NCT02797522|453598123|FG006|Overall Study|Study Terminated by Sponsor|0|||
126082792|NCT02797522|453598124|FG007|Overall Study|Study Terminated by Sponsor|4|||
126082793|NCT02797522|453598125|FG008|Overall Study|Study Terminated by Sponsor|2|||
126082794|NCT02797522|453598126|FG009|Overall Study|Study Terminated by Sponsor|4|||
126082795|NCT02797522|453598127|FG010|Overall Study|Study Terminated by Sponsor|1|||
126082796|NCT00725712|453598128|FG000|Overall Study|Withdrawal by Subject|2|||
126082797|NCT00725712|453598129|FG001|Overall Study|Withdrawal by Subject|1|||
126082798|NCT00725712|453598128|FG000|Overall Study|Protocol Violation|1|||
126082799|NCT00725712|453598129|FG001|Overall Study|Protocol Violation|0|||
126082800|NCT00725712|453598128|FG000|Overall Study|Progressive disease|37|||
126082801|NCT00725712|453598129|FG001|Overall Study|Progressive disease|16|||
126082802|NCT00725712|453598128|FG000|Overall Study|Clinical progression not based on RECIST|0|||
126082803|NCT00725712|453598129|FG001|Overall Study|Clinical progression not based on RECIST|3|||
126082804|NCT00725712|453598128|FG000|Overall Study|Adverse Event|5|||
126082805|NCT00725712|453598129|FG001|Overall Study|Adverse Event|5|||
126082806|NCT00725712|453598128|FG000|Overall Study|Death|2|||
126082807|NCT00725712|453598129|FG001|Overall Study|Death|0|||
126082808|NCT00725712|453598128|FG000|Overall Study|Other: Death|1|||
126082809|NCT00725712|453598129|FG001|Overall Study|Other: Death|0|||
126082810|NCT00725712|453598128|FG000|Overall Study|Hospitalized, unable to continue|0|||
126082811|NCT00725712|453598129|FG001|Overall Study|Hospitalized, unable to continue|1|||
126082812|NCT03020069|453598130|FG000|Overall Study|Lost to Follow-up|0|||
126082813|NCT03020069|453598131|FG001|Overall Study|Lost to Follow-up|1|||
126082814|NCT00132678|453598134|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
126082815|NCT00132678|453598135|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
126082816|NCT00132678|453598136|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
126082817|NCT00132678|453598134|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
126082818|NCT00132678|453598135|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
126082819|NCT00132678|453598136|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
126082820|NCT00132678|453598134|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
126082821|NCT00132678|453598135|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
126082822|NCT00132678|453598136|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
126082823|NCT00132678|453598134|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
126082824|NCT00132678|453598135|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
126082825|NCT00132678|453598136|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
126082826|NCT00132678|453598134|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
126082827|NCT00132678|453598135|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
126082828|NCT00132678|453598136|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
126082829|NCT00132678|453598134|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
126082830|NCT00132678|453598135|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
126082831|NCT00132678|453598136|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
126082832|NCT00132678|453598134|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
126082833|NCT00132678|453598135|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
126082834|NCT00132678|453598136|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
126082835|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Death|2|||
126082836|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Death|0|||
126082837|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Death|0|||
126082838|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
126082839|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
126082840|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
126082841|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
126082842|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
126082843|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
126082844|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
126082845|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
126082846|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
126082847|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
126082848|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
126082849|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
126082850|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
126082851|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
126082852|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
126082853|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
126082854|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
126082855|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
126082856|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
126082857|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
126082858|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
126082859|NCT00132678|453598134|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
126082860|NCT00132678|453598135|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
126082861|NCT00132678|453598136|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
126082862|NCT00132678|453598134|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
126082863|NCT00132678|453598135|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
126082864|NCT00132678|453598136|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
126082865|NCT00132678|453598134|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
126082866|NCT00132678|453598135|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
126082867|NCT00132678|453598136|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
126082868|NCT00132678|453598134|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
126082869|NCT00132678|453598135|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
126082870|NCT00132678|453598136|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
126082871|NCT00132678|453598134|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
126082872|NCT00132678|453598135|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
126082873|NCT00132678|453598136|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
126082874|NCT00132678|453598134|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
126082875|NCT00132678|453598135|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
126082876|NCT00132678|453598136|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
126082877|NCT00132678|453598134|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
126082878|NCT00132678|453598135|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
126082879|NCT00132678|453598136|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
126082880|NCT00132678|453598134|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
126082881|NCT00132678|453598135|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
126082882|NCT00132678|453598136|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
126082883|NCT02056626|453598137|FG000|Overall Study|patient did not follow directions|3|||
126082884|NCT02056626|453598138|FG001|Overall Study|patient did not follow directions|1|||
126082885|NCT02056626|453598139|FG002|Overall Study|patient did not follow directions|0|||
126082886|NCT02056626|453598140|FG003|Overall Study|patient did not follow directions|0|||
126082887|NCT00863512|453598141|FG000|Overall Study|Adverse Event|2|||
126082888|NCT00863512|453598142|FG001|Overall Study|Adverse Event|0|||
126082889|NCT00863512|453598141|FG000|Overall Study|Withdrawal by Subject|11|||
126082890|NCT00863512|453598142|FG001|Overall Study|Withdrawal by Subject|0|||
126082891|NCT00863512|453598141|FG000|Overall Study|Physician Decision|1|||
126082892|NCT00863512|453598142|FG001|Overall Study|Physician Decision|0|||
126115482|NCT03250832|453718165|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115483|NCT03250832|453718166|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115484|NCT03250832|453718167|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115485|NCT03250832|453718168|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126115486|NCT03250832|453718157|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115487|NCT03250832|453718158|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115488|NCT03250832|453718159|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115489|NCT03250832|453718160|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115490|NCT03250832|453718161|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115491|NCT03250832|453718162|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115492|NCT03250832|453718163|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115493|NCT03250832|453718164|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
126115494|NCT03250832|453718165|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115495|NCT03250832|453718166|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115496|NCT03250832|453718167|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115497|NCT03250832|453718168|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
126115498|NCT03250832|453718157|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115499|NCT03250832|453718158|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115500|NCT03250832|453718159|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115501|NCT03250832|453718160|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115502|NCT03250832|453718161|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115503|NCT03250832|453718162|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115504|NCT03250832|453718163|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115505|NCT03250832|453718164|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
126115506|NCT03250832|453718165|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115507|NCT03250832|453718166|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115508|NCT03250832|453718167|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115509|NCT03250832|453718168|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126115510|NCT03250832|453718157|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115511|NCT03250832|453718158|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115512|NCT03250832|453718159|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115513|NCT03250832|453718160|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115514|NCT03250832|453718161|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115515|NCT03250832|453718162|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115516|NCT03250832|453718163|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115517|NCT03250832|453718164|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
126115518|NCT03250832|453718165|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115519|NCT03250832|453718166|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115520|NCT03250832|453718167|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115521|NCT03250832|453718168|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126115522|NCT03250832|453718157|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115523|NCT03250832|453718158|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115524|NCT03250832|453718159|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115525|NCT03250832|453718160|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115526|NCT03250832|453718161|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115527|NCT03250832|453718162|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115528|NCT03250832|453718163|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115529|NCT03250832|453718164|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
126115530|NCT03250832|453718165|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115531|NCT03250832|453718166|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115532|NCT03250832|453718167|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126082893|NCT02037477|453598143|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
126082894|NCT02037477|453598144|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
126082895|NCT02037477|453598145|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
126082896|NCT02037477|453598146|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
126082897|NCT01454739|453598147|FG000|Overall Study|Protocol Violation|2|||
126082898|NCT01454739|453598148|FG001|Overall Study|Protocol Violation|3|||
126082899|NCT01454739|453598147|FG000|Overall Study|Withdrawal by Subject|2|||
126082900|NCT01454739|453598148|FG001|Overall Study|Withdrawal by Subject|6|||
126082901|NCT01454739|453598147|FG000|Overall Study|Other|3|||
126082902|NCT01454739|453598148|FG001|Overall Study|Other|5|||
126082903|NCT01454739|453598147|FG000|Overall Study|Physician Decision|0|||
126115533|NCT03250832|453718168|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126115534|NCT03250832|453718157|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
126082904|NCT01454739|453598148|FG001|Overall Study|Physician Decision|5|||
126082905|NCT01454739|453598147|FG000|Overall Study|Lost to Follow-up|0|||
126082906|NCT01454739|453598148|FG001|Overall Study|Lost to Follow-up|1|||
126082907|NCT01454739|453598147|FG000|Overall Study|Adverse Event|0|||
126082908|NCT01454739|453598148|FG001|Overall Study|Adverse Event|1|||
126082909|NCT02577003|453598151|FG000|Overall Study|Adverse Event|2|||
126082910|NCT02577003|453598152|FG001|Overall Study|Adverse Event|4|||
126082911|NCT02577003|453598151|FG000|Overall Study|Withdrawal by Subject|0|||
126082912|NCT02577003|453598152|FG001|Overall Study|Withdrawal by Subject|1|||
126082913|NCT02786004|453598153|FG000|Overall Study|Withdrawal by Subject|0|||
126082914|NCT02786004|453598154|FG001|Overall Study|Withdrawal by Subject|1|||
126082915|NCT01677299|453598155|FG000|Overall Study|Adverse Event|0|||
126082916|NCT01677299|453598156|FG001|Overall Study|Adverse Event|2|||
126082917|NCT01677299|453598157|FG002|Overall Study|Adverse Event|1|||
126082918|NCT01677299|453598158|FG003|Overall Study|Adverse Event|0|||
126082919|NCT01677299|453598155|FG000|Overall Study|Withdrawal by Subject|0|||
126082920|NCT01677299|453598156|FG001|Overall Study|Withdrawal by Subject|1|||
126082921|NCT01677299|453598157|FG002|Overall Study|Withdrawal by Subject|0|||
126082922|NCT01677299|453598158|FG003|Overall Study|Withdrawal by Subject|1|||
126082923|NCT00559377|453598160|FG000|Overall Study|Withdrawal by Subject|9|||
126082924|NCT00940875|453598161|FG000|Treatment Phase|Adverse Event|9|||
126082925|NCT00940875|453598162|FG001|Treatment Phase|Adverse Event|3|||
126082926|NCT00940875|453598161|FG000|Treatment Phase|Death|3|||
126082927|NCT00940875|453598162|FG001|Treatment Phase|Death|5|||
126082928|NCT00940875|453598161|FG000|Treatment Phase|Lack of Efficacy|1|||
126082929|NCT00940875|453598162|FG001|Treatment Phase|Lack of Efficacy|0|||
126082930|NCT00940875|453598161|FG000|Treatment Phase|Withdrawal by Subject|3|||
126082931|NCT00940875|453598162|FG001|Treatment Phase|Withdrawal by Subject|0|||
126082932|NCT00940875|453598161|FG000|Treatment Phase|Disease progression|9|||
126082933|NCT00940875|453598162|FG001|Treatment Phase|Disease progression|11|||
126082934|NCT00940875|453598161|FG000|Treatment Phase|Physician Decision|1|||
126082935|NCT00940875|453598162|FG001|Treatment Phase|Physician Decision|0|||
126082936|NCT00940875|453598161|FG000|Post-Study Treatment|Death|0|||
126082937|NCT00940875|453598162|FG001|Post-Study Treatment|Death|1|||
126082938|NCT00940875|453598161|FG000|Post-Study Treatment|Disease Progression|0|||
126082939|NCT00940875|453598162|FG001|Post-Study Treatment|Disease Progression|2|||
126082940|NCT00872001|453598163|FG000|Overall Study|Adverse Event|34|||
126082941|NCT00872001|453598164|FG001|Overall Study|Adverse Event|23|||
126082942|NCT00872001|453598163|FG000|Overall Study|Protocol Defined Clinical Event|5|||
126082943|NCT00872001|453598164|FG001|Overall Study|Protocol Defined Clinical Event|7|||
126082944|NCT00872001|453598163|FG000|Overall Study|Lost to Follow-up|13|||
126082945|NCT00872001|453598164|FG001|Overall Study|Lost to Follow-up|12|||
126082946|NCT00872001|453598163|FG000|Overall Study|Withdrawal by Subject|18|||
126082947|NCT00872001|453598164|FG001|Overall Study|Withdrawal by Subject|30|||
126082948|NCT00872001|453598163|FG000|Overall Study|Protocol Violation|5|||
126082949|NCT00872001|453598164|FG001|Overall Study|Protocol Violation|8|||
126082950|NCT00872001|453598163|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
126082951|NCT00872001|453598164|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
126082952|NCT00872001|453598163|FG000|Overall Study|Administrative|23|||
126082953|NCT00872001|453598164|FG001|Overall Study|Administrative|15|||
126082954|NCT03482752|453598170|FG000|Overall Study|Withdrawal by Subject|2|||
126082955|NCT03482752|453598170|FG000|Overall Study|Lost to Follow-up|1|||
126082956|NCT03482752|453598170|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
126082957|NCT01776008|453598171|FG000|Overall Study|ineligible|2|||
126082958|NCT02838134|453598172|FG000|Overall Study|Lost to Follow-up|1|||
126082959|NCT02838134|453598173|FG001|Overall Study|Lost to Follow-up|2|||
126082960|NCT02838134|453598172|FG000|Overall Study|logistic problems|1|||
126082961|NCT02838134|453598173|FG001|Overall Study|logistic problems|1|||
126082962|NCT04674189|453598174|FG000|Overall Study|Adverse Event|0|||
126082963|NCT04674189|453598175|FG001|Overall Study|Adverse Event|0|||
126082964|NCT04674189|453598176|FG002|Overall Study|Adverse Event|1|||
126082965|NCT04674189|453598174|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
126082966|NCT04674189|453598175|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
126082967|NCT04674189|453598176|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
126082968|NCT04674189|453598174|FG000|Overall Study|Physician Decision|1|||
126082969|NCT04674189|453598175|FG001|Overall Study|Physician Decision|0|||
126082970|NCT04674189|453598176|FG002|Overall Study|Physician Decision|0|||
126082971|NCT04674189|453598174|FG000|Overall Study|Withdrawal by Participant|83|||
126082972|NCT04674189|453598175|FG001|Overall Study|Withdrawal by Participant|71|||
126082973|NCT04674189|453598176|FG002|Overall Study|Withdrawal by Participant|142|||
126115535|NCT03250832|453718158|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115536|NCT03250832|453718159|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
126082974|NCT04674189|453598174|FG000|Overall Study|Lost to Follow-up|55|||
126082975|NCT04674189|453598175|FG001|Overall Study|Lost to Follow-up|53|||
126082976|NCT04674189|453598176|FG002|Overall Study|Lost to Follow-up|44|||
126082977|NCT04674189|453598174|FG000|Overall Study|Miscellaneous|27|||
126082978|NCT04674189|453598175|FG001|Overall Study|Miscellaneous|23|||
126082979|NCT04674189|453598176|FG002|Overall Study|Miscellaneous|207|||
126082980|NCT04674189|453598174|FG000|Overall Study|Did Not Receive Treatment|3|||
126082981|NCT04674189|453598175|FG001|Overall Study|Did Not Receive Treatment|1|||
126082982|NCT04674189|453598176|FG002|Overall Study|Did Not Receive Treatment|2|||
126082983|NCT01564277|453598180|FG000|Overall Study|Protocol Violation|0|||
126082984|NCT01564277|453598181|FG001|Overall Study|Protocol Violation|1|||
126082985|NCT01564277|453598180|FG000|Overall Study|Physician Decision|1|||
126082986|NCT01564277|453598181|FG001|Overall Study|Physician Decision|0|||
126082987|NCT01637077|453598182|FG000|Overall Study|Cancel|1|||
126082988|NCT01637077|453598183|FG001|Overall Study|Cancel|1|||
126082989|NCT01637077|453598182|FG000|Overall Study|Withdrawal by Subject|1|||
126082990|NCT01637077|453598183|FG001|Overall Study|Withdrawal by Subject|0|||
126082991|NCT01637077|453598182|FG000|Overall Study|No cycle 1 questionnaire data|2|||
126082992|NCT01637077|453598183|FG001|Overall Study|No cycle 1 questionnaire data|0|||
126082993|NCT00246090|453598184|FG000|Overall Study|Adverse Event|25|||
126082994|NCT00246090|453598184|FG000|Overall Study|Withdrawal by Subject|7|||
126082995|NCT00246090|453598184|FG000|Overall Study|Progressive Disease|212|||
126082996|NCT00246090|453598184|FG000|Overall Study|Clinical Progression|30|||
126082997|NCT00246090|453598184|FG000|Overall Study|Physician Decision|11|||
126082998|NCT00246090|453598184|FG000|Overall Study|Not Otherwise Specified|10|||
126082999|NCT02595372|453598185|FG000|Overall Study|Adverse Event|6|||
126083000|NCT02595372|453598185|FG000|Overall Study|Physician Decision|2|||
126083001|NCT02595372|453598185|FG000|Overall Study|Disease Progression|1|||
126083002|NCT00794924|453598186|FG000|Overall Study|Lost to Follow-up|6|||
126083003|NCT00794924|453598187|FG001|Overall Study|Lost to Follow-up|8|||
126083004|NCT00794924|453598186|FG000|Overall Study|Withdrawal by Subject|48|||
126083005|NCT00794924|453598187|FG001|Overall Study|Withdrawal by Subject|60|||
126083006|NCT00794924|453598186|FG000|Overall Study|Adverse Event|6|||
126083007|NCT00794924|453598187|FG001|Overall Study|Adverse Event|2|||
126083008|NCT01594970|453598188|FG000|Overall Study|Non-Adverse Event Related|4|||
126083009|NCT01594970|453598189|FG001|Overall Study|Non-Adverse Event Related|5|||
126083010|NCT01594970|453598190|FG002|Overall Study|Non-Adverse Event Related|6|||
126083011|NCT01594970|453598188|FG000|Overall Study|Adverse Event|17|||
126083012|NCT01594970|453598189|FG001|Overall Study|Adverse Event|23|||
126083013|NCT01594970|453598190|FG002|Overall Study|Adverse Event|23|||
126083014|NCT01594970|453598188|FG000|Overall Study|Lost to Follow-up|54|||
126083015|NCT01594970|453598189|FG001|Overall Study|Lost to Follow-up|54|||
126083016|NCT01594970|453598190|FG002|Overall Study|Lost to Follow-up|37|||
126083017|NCT02389764|453598191|FG000|Overall Study|Lack of Efficacy|9|||
126083018|NCT00583947|453598192|FG000|Cross-over Period|Adverse Event|2|||
126083019|NCT00583947|453598193|FG001|Cross-over Period|Adverse Event|0|||
126083020|NCT00583947|453598192|FG000|Cross-over Period|Withdrawal by Subject|2|||
126083021|NCT00583947|453598193|FG001|Cross-over Period|Withdrawal by Subject|0|||
126083022|NCT00583947|453598192|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
126083023|NCT00583947|453598193|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
126083024|NCT00583947|453598192|FG000|Cross-over Period|Other|1|||
126083025|NCT00583947|453598193|FG001|Cross-over Period|Other|1|||
126083026|NCT00738283|453598194|FG000|Overall Study|Death|1|||
126083027|NCT00738283|453598194|FG000|Overall Study|Transfer to another facility|2|||
126083028|NCT00738283|453598194|FG000|Overall Study|Discharge home prior to end of study|1|||
126083029|NCT00486252|453598197|FG000|Overall Study|Adverse Event|7|||
126083030|NCT00486252|453598197|FG000|Overall Study|Lack of Efficacy|9|||
126083031|NCT00486252|453598197|FG000|Overall Study|Lost to Follow-up|24|||
125953650|NCT03466411|453127534|FG006|Overall Study|Withdrawal by Subject|6|||
125953651|NCT03466411|453127535|FG007|Overall Study|Withdrawal by Subject|9|||
125953652|NCT03466411|453127536|FG008|Overall Study|Withdrawal by Subject|6|||
125953653|NCT03466411|453127537|FG009|Overall Study|Withdrawal by Subject|11|||
125953654|NCT03466411|453127538|FG010|Overall Study|Withdrawal by Subject|14|||
125953655|NCT03466411|453127539|FG011|Overall Study|Withdrawal by Subject|12|||
125953656|NCT03466411|453127540|FG012|Overall Study|Withdrawal by Subject|7|||
125953657|NCT03466411|453127528|FG000|Overall Study|Other|1|||
125953658|NCT03466411|453127529|FG001|Overall Study|Other|1|||
125953659|NCT03466411|453127530|FG002|Overall Study|Other|0|||
125953660|NCT03466411|453127531|FG003|Overall Study|Other|1|||
125953661|NCT03466411|453127532|FG004|Overall Study|Other|2|||
125953662|NCT03466411|453127533|FG005|Overall Study|Other|0|||
125953663|NCT03466411|453127534|FG006|Overall Study|Other|0|||
125953664|NCT03466411|453127535|FG007|Overall Study|Other|0|||
126083032|NCT00486252|453598197|FG000|Overall Study|Other|18|||
126083033|NCT01261247|453598198|FG000|Overall Study|Ineligible|2|||
126083034|NCT01210651|453598199|FG000|Overall Study|Lost to Follow-up|1|||
126083035|NCT01210651|453598200|FG001|Overall Study|Lost to Follow-up|1|||
126083036|NCT01210651|453598199|FG000|Overall Study|schedule conflicts|1|||
126083037|NCT01210651|453598200|FG001|Overall Study|schedule conflicts|5|||
126083038|NCT01210651|453598199|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
126083039|NCT01210651|453598200|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
126083040|NCT01210651|453598199|FG000|Overall Study|Withdrawal by Subject|1|||
126083041|NCT01210651|453598200|FG001|Overall Study|Withdrawal by Subject|1|||
126083042|NCT01210651|453598199|FG000|Overall Study|Injury outside study|2|||
126083043|NCT01210651|453598200|FG001|Overall Study|Injury outside study|0|||
126083044|NCT02592707|453598204|FG000|Overall Study|Consent Withdrawn|0|||
126083045|NCT02592707|453598205|FG001|Overall Study|Consent Withdrawn|1|||
125953665|NCT03466411|453127536|FG008|Overall Study|Other|0|||
125953666|NCT03466411|453127537|FG009|Overall Study|Other|1|||
125953667|NCT03466411|453127538|FG010|Overall Study|Other|2|||
125953668|NCT03466411|453127539|FG011|Overall Study|Other|0|||
125953669|NCT03466411|453127540|FG012|Overall Study|Other|0|||
125953670|NCT03466411|453127528|FG000|Overall Study|Randomized but not Treated|0|||
125953671|NCT03466411|453127529|FG001|Overall Study|Randomized but not Treated|0|||
125953672|NCT03466411|453127530|FG002|Overall Study|Randomized but not Treated|0|||
125953673|NCT03466411|453127531|FG003|Overall Study|Randomized but not Treated|0|||
125953674|NCT03466411|453127532|FG004|Overall Study|Randomized but not Treated|0|||
125953675|NCT03466411|453127533|FG005|Overall Study|Randomized but not Treated|0|||
125953676|NCT03466411|453127534|FG006|Overall Study|Randomized but not Treated|1|||
125953677|NCT03466411|453127535|FG007|Overall Study|Randomized but not Treated|0|||
125953678|NCT03466411|453127536|FG008|Overall Study|Randomized but not Treated|0|||
125953679|NCT03466411|453127537|FG009|Overall Study|Randomized but not Treated|0|||
125953680|NCT03466411|453127538|FG010|Overall Study|Randomized but not Treated|0|||
125953681|NCT03466411|453127539|FG011|Overall Study|Randomized but not Treated|0|||
125953682|NCT03466411|453127540|FG012|Overall Study|Randomized but not Treated|0|||
125953683|NCT03778931|453127541|FG000|Overall Study|Withdrawal by Subject|12|||
126083046|NCT02592707|453598206|FG002|Overall Study|Consent Withdrawn|2|||
126083047|NCT02592707|453598207|FG003|Overall Study|Consent Withdrawn|0|||
126083048|NCT02592707|453598204|FG000|Overall Study|Death|1|||
126083049|NCT02592707|453598205|FG001|Overall Study|Death|0|||
126083050|NCT02592707|453598206|FG002|Overall Study|Death|0|||
126083051|NCT02592707|453598207|FG003|Overall Study|Death|0|||
126083052|NCT02592707|453598204|FG000|Overall Study|Progressive Disease|4|||
126083053|NCT02592707|453598205|FG001|Overall Study|Progressive Disease|4|||
126083054|NCT02592707|453598206|FG002|Overall Study|Progressive Disease|3|||
126083055|NCT02592707|453598207|FG003|Overall Study|Progressive Disease|3|||
126083056|NCT02592707|453598204|FG000|Overall Study|Other|0|||
126083057|NCT02592707|453598205|FG001|Overall Study|Other|0|||
126083058|NCT02592707|453598206|FG002|Overall Study|Other|1|||
126083059|NCT02592707|453598207|FG003|Overall Study|Other|2|||
126083060|NCT02592707|453598204|FG000|Overall Study|Never entered LTFU period|1|||
126083061|NCT02592707|453598205|FG001|Overall Study|Never entered LTFU period|0|||
126083062|NCT02592707|453598206|FG002|Overall Study|Never entered LTFU period|0|||
126083063|NCT02592707|453598207|FG003|Overall Study|Never entered LTFU period|2|||
126083064|NCT00469859|453598208|FG000|Overall Study|Inevaluable|0|||
126083065|NCT00469859|453598209|FG001|Overall Study|Inevaluable|2|||
126083066|NCT04124471|453598210|FG000|Overall Study|screen failure|1|||
126083067|NCT05226130|453598211|FG000|Overall Study|Lost to Follow-up|0|||
126083068|NCT05226130|453598212|FG001|Overall Study|Lost to Follow-up|1|||
126083069|NCT05226130|453598211|FG000|Overall Study|Not treatment adherent|0|||
126083070|NCT05226130|453598212|FG001|Overall Study|Not treatment adherent|2|||
126083071|NCT04855734|453598213|FG000|Overall Study|Lost to Follow-up|2|||
126083072|NCT04855734|453598214|FG001|Overall Study|Lost to Follow-up|2|||
126083073|NCT03358472|453598215|FG000|Overall Study|Death|6|||
126083074|NCT03358472|453598216|FG001|Overall Study|Death|3|||
126083075|NCT03358472|453598217|FG002|Overall Study|Death|10|||
126083076|NCT03358472|453598215|FG000|Overall Study|Physician Decision|0|||
126083077|NCT03358472|453598216|FG001|Overall Study|Physician Decision|1|||
126083078|NCT03358472|453598217|FG002|Overall Study|Physician Decision|0|||
126083079|NCT03358472|453598215|FG000|Overall Study|Withdrawal by Subject|0|||
126083080|NCT03358472|453598216|FG001|Overall Study|Withdrawal by Subject|0|||
126083081|NCT03358472|453598217|FG002|Overall Study|Withdrawal by Subject|1|||
126083082|NCT03358472|453598215|FG000|Overall Study|On-going at clinical cut off date|9|||
126083083|NCT03358472|453598216|FG001|Overall Study|On-going at clinical cut off date|6|||
126083084|NCT03358472|453598217|FG002|Overall Study|On-going at clinical cut off date|5|||
126083085|NCT03732677|453598218|FG000|Overall Study|Terminated the study|154|||
126083086|NCT03732677|453598219|FG001|Overall Study|Terminated the study|197|||
126083087|NCT03732677|453598218|FG000|Overall Study|Continuing study off treatment|379|||
126083088|NCT03732677|453598219|FG001|Overall Study|Continuing study off treatment|333|||
126083089|NCT04013971|453598220|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
126083090|NCT04013971|453598221|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
126083091|NCT04013971|453598220|FG000|Overall Study|Missing biomechanical data|0|||
126083092|NCT04013971|453598221|FG001|Overall Study|Missing biomechanical data|1|||
126083093|NCT02520310|453598224|FG000|At 6 Months Clinical Follow-up|Death|1|||
126083094|NCT02520310|453598224|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
126083095|NCT02520310|453598224|FG000|AT 3 Year Clinical Follow-up|Death|2|||
125953684|NCT03778931|453127542|FG001|Overall Study|Withdrawal by Subject|25|||
125953685|NCT03778931|453127541|FG000|Overall Study|Physician Decision|1|||
126083096|NCT02520310|453598224|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
126083097|NCT02520310|453598224|FG000|AT 4 Year Clinical Follow-up|Death|1|||
126083098|NCT02520310|453598224|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
126083099|NCT01340014|453598225|FG000|Period 1, First 7 Days|Adverse Event|1|||
126083100|NCT01340014|453598226|FG001|Period 1, First 7 Days|Adverse Event|0|||
126083101|NCT01340014|453598225|FG000|Period 1, First 7 Days|Personal Reasons|1|||
126083102|NCT01340014|453598226|FG001|Period 1, First 7 Days|Personal Reasons|0|||
125953686|NCT03778931|453127542|FG001|Overall Study|Physician Decision|3|||
125953687|NCT03778931|453127541|FG000|Overall Study|Participant Noncompliance|1|||
125953688|NCT03778931|453127542|FG001|Overall Study|Participant Noncompliance|1|||
125953689|NCT03778931|453127541|FG000|Overall Study|Lost to Follow-up|4|||
125953690|NCT03778931|453127542|FG001|Overall Study|Lost to Follow-up|1|||
125953691|NCT03778931|453127541|FG000|Overall Study|Death|69|||
125953692|NCT03778931|453127542|FG001|Overall Study|Death|79|||
125953693|NCT03306264|453127547|FG000|Overall Study|Death|33|||
125953694|NCT03306264|453127548|FG001|Overall Study|Death|25|||
125953695|NCT03306264|453127549|FG002|Overall Study|Death|34|||
125953696|NCT03306264|453127550|FG003|Overall Study|Death|34|||
125953697|NCT03306264|453127547|FG000|Overall Study|Complete Consent Withdrawal|4|||
125953698|NCT03306264|453127548|FG001|Overall Study|Complete Consent Withdrawal|4|||
125953699|NCT03306264|453127549|FG002|Overall Study|Complete Consent Withdrawal|1|||
125953700|NCT03306264|453127550|FG003|Overall Study|Complete Consent Withdrawal|8|||
125953701|NCT03306264|453127547|FG000|Overall Study|Lost to Follow-up|1|||
125953702|NCT03306264|453127548|FG001|Overall Study|Lost to Follow-up|0|||
125953703|NCT03306264|453127549|FG002|Overall Study|Lost to Follow-up|1|||
125953704|NCT03306264|453127550|FG003|Overall Study|Lost to Follow-up|0|||
125953705|NCT03306264|453127547|FG000|Overall Study|Rollover to ASTX727-06|10|||
125953706|NCT03306264|453127548|FG001|Overall Study|Rollover to ASTX727-06|18|||
125953707|NCT03306264|453127549|FG002|Overall Study|Rollover to ASTX727-06|4|||
125953708|NCT03306264|453127550|FG003|Overall Study|Rollover to ASTX727-06|2|||
125953709|NCT03306264|453127547|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
125953710|NCT03306264|453127548|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
125953711|NCT03306264|453127549|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
125953712|NCT03306264|453127550|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
125953713|NCT02257736|453127561|FG000|Overall Study|Progressive disease|365|||
125953714|NCT02257736|453127562|FG001|Overall Study|Progressive disease|327|||
125953715|NCT02257736|453127561|FG000|Overall Study|Adverse Event|45|||
125953716|NCT02257736|453127562|FG001|Overall Study|Adverse Event|56|||
125953717|NCT02257736|453127561|FG000|Overall Study|Withdrawal by Subject|21|||
125953718|NCT02257736|453127562|FG001|Overall Study|Withdrawal by Subject|38|||
125953719|NCT02257736|453127561|FG000|Overall Study|Death|11|||
125953720|NCT02257736|453127562|FG001|Overall Study|Death|6|||
125953721|NCT02257736|453127561|FG000|Overall Study|Physician Decision|5|||
125953722|NCT02257736|453127562|FG001|Overall Study|Physician Decision|9|||
125953723|NCT02257736|453127561|FG000|Overall Study|Non-Compliance with study drug|1|||
125953724|NCT02257736|453127562|FG001|Overall Study|Non-Compliance with study drug|2|||
125953725|NCT02257736|453127561|FG000|Overall Study|Protocol Violation|1|||
125953726|NCT02257736|453127562|FG001|Overall Study|Protocol Violation|0|||
125953727|NCT02257736|453127561|FG000|Overall Study|Other|1|||
125953728|NCT02257736|453127562|FG001|Overall Study|Other|7|||
126115537|NCT03250832|453718160|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115538|NCT03250832|453718161|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115539|NCT03250832|453718162|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115540|NCT03250832|453718163|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115541|NCT03250832|453718164|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
126115542|NCT03250832|453718165|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115543|NCT03250832|453718166|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115544|NCT03250832|453718167|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115545|NCT03250832|453718168|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
126115546|NCT03250832|453718157|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115547|NCT03250832|453718158|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115548|NCT03250832|453718159|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115549|NCT03250832|453718160|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115550|NCT03250832|453718161|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115551|NCT03250832|453718162|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115552|NCT03250832|453718163|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115553|NCT03250832|453718164|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115554|NCT03250832|453718165|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
126115555|NCT03250832|453718166|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
126115556|NCT03250832|453718167|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115557|NCT03250832|453718168|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
126115558|NCT03250832|453718157|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125953729|NCT02257736|453127561|FG000|Overall Study|Randomized, not treated|1|||
125953730|NCT02257736|453127562|FG001|Overall Study|Randomized, not treated|2|||
126115559|NCT03250832|453718158|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126115560|NCT03250832|453718159|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125953731|NCT04136912|453127563|FG000|Overall Study|Operational reasons|0|||
125953732|NCT04136912|453127564|FG001|Overall Study|Operational reasons|0|||
125953733|NCT04136912|453127565|FG002|Overall Study|Operational reasons|2|||
125953734|NCT02167256|453127566|FG000|Overall Study|Adverse Event|13|||
125953735|NCT02167256|453127567|FG001|Overall Study|Adverse Event|6|||
125953736|NCT02167256|453127566|FG000|Overall Study|Withdrawal by Subject|4|||
125953737|NCT02167256|453127567|FG001|Overall Study|Withdrawal by Subject|4|||
125953738|NCT02167256|453127566|FG000|Overall Study|non-compliance|3|||
125953739|NCT02167256|453127567|FG001|Overall Study|non-compliance|0|||
125953740|NCT02167256|453127566|FG000|Overall Study|Study partner unable to participate|1|||
125953741|NCT02167256|453127567|FG001|Overall Study|Study partner unable to participate|0|||
125953742|NCT00414388|453127570|FG000|Overall Study|Adverse Event|1|||
125953743|NCT03591575|453127571|FG000|Overall Study|Adverse Event|2|||
125953744|NCT03591575|453127572|FG001|Overall Study|Adverse Event|0|||
125953745|NCT03591575|453127571|FG000|Overall Study|Withdrawal by Subject|4|||
125953746|NCT03591575|453127572|FG001|Overall Study|Withdrawal by Subject|1|||
125953747|NCT01723228|453127573|FG000|Overall Study|Adverse Event|2|||
125953748|NCT01723228|453127574|FG001|Overall Study|Adverse Event|6|||
125953749|NCT01723228|453127573|FG000|Overall Study|Withdrawal by Subject|2|||
125953750|NCT01723228|453127574|FG001|Overall Study|Withdrawal by Subject|1|||
125953751|NCT01723228|453127573|FG000|Overall Study|Protocol Violation|0|||
125953752|NCT01723228|453127574|FG001|Overall Study|Protocol Violation|2|||
125953753|NCT01723228|453127573|FG000|Overall Study|Lost to Follow-up|2|||
125953754|NCT01723228|453127574|FG001|Overall Study|Lost to Follow-up|1|||
125953755|NCT01723228|453127573|FG000|Overall Study|Other|2|||
125953756|NCT01723228|453127574|FG001|Overall Study|Other|1|||
125953757|NCT00218543|453127575|FG000|Overall Study|Lost to Follow-up|8|||
125953758|NCT00218543|453127575|FG000|Overall Study|relocated|1|||
125953759|NCT00218543|453127575|FG000|Overall Study|Withdrawal by Subject|1|||
125953760|NCT00218543|453127575|FG000|Overall Study|Physician Decision|3|||
125953761|NCT00218543|453127575|FG000|Overall Study|Adverse Event|2|||
125953762|NCT02448875|453127576|FG000|Overall Study|Adverse Event|2|||
125953763|NCT02448875|453127577|FG001|Overall Study|Adverse Event|1|||
125953764|NCT02448875|453127578|FG002|Overall Study|Adverse Event|0|||
125953765|NCT02448875|453127576|FG000|Overall Study|Lost to Follow-up|1|||
125953766|NCT02448875|453127577|FG001|Overall Study|Lost to Follow-up|0|||
125953767|NCT02448875|453127578|FG002|Overall Study|Lost to Follow-up|0|||
125953768|NCT02448875|453127576|FG000|Overall Study|Investigator Decision|3|||
125953769|NCT02448875|453127577|FG001|Overall Study|Investigator Decision|0|||
125953770|NCT02448875|453127578|FG002|Overall Study|Investigator Decision|1|||
125953771|NCT02448875|453127576|FG000|Overall Study|Withdrawal by Subject|1|||
125953772|NCT02448875|453127577|FG001|Overall Study|Withdrawal by Subject|0|||
125953773|NCT02448875|453127578|FG002|Overall Study|Withdrawal by Subject|0|||
125953774|NCT01864291|453127579|FG000|Overall Study|need for revision surgery|2|||
125953775|NCT01451424|453127581|FG000|Overall Study|Withdrawal by Subject|1|||
125953776|NCT01451424|453127582|FG001|Overall Study|Withdrawal by Subject|1|||
125953777|NCT01451424|453127583|FG002|Overall Study|Withdrawal by Subject|0|||
125953778|NCT01451424|453127584|FG003|Overall Study|Withdrawal by Subject|2|||
125953779|NCT01451424|453127581|FG000|Overall Study|Lost to Follow-up|0|||
125953780|NCT01451424|453127582|FG001|Overall Study|Lost to Follow-up|1|||
125953781|NCT01451424|453127583|FG002|Overall Study|Lost to Follow-up|0|||
125953782|NCT01451424|453127584|FG003|Overall Study|Lost to Follow-up|1|||
125953783|NCT01451424|453127581|FG000|Overall Study|Physician Decision|0|||
125953784|NCT01451424|453127582|FG001|Overall Study|Physician Decision|0|||
125953785|NCT01451424|453127583|FG002|Overall Study|Physician Decision|1|||
125953786|NCT01451424|453127584|FG003|Overall Study|Physician Decision|1|||
125953787|NCT01451424|453127581|FG000|Overall Study|Adverse Event|0|||
125953788|NCT01451424|453127582|FG001|Overall Study|Adverse Event|0|||
125953789|NCT01451424|453127583|FG002|Overall Study|Adverse Event|0|||
125953790|NCT01451424|453127584|FG003|Overall Study|Adverse Event|1|||
125953791|NCT00689481|453127585|FG000|Overall Study|Adverse Event|7|||
125953792|NCT00689481|453127586|FG001|Overall Study|Adverse Event|1|||
125953793|NCT00689481|453127585|FG000|Overall Study|Lost to Follow-up|4|||
125953794|NCT00689481|453127586|FG001|Overall Study|Lost to Follow-up|3|||
125953795|NCT00689481|453127585|FG000|Overall Study|Lack of Efficacy|4|||
125953796|NCT00689481|453127586|FG001|Overall Study|Lack of Efficacy|3|||
125953797|NCT00689481|453127585|FG000|Overall Study|Non-compliance with study treatment|1|||
125953798|NCT00689481|453127586|FG001|Overall Study|Non-compliance with study treatment|1|||
126083103|NCT01340014|453598225|FG000|Period 2, Second 7 Days|Adverse Event|0|||
126083104|NCT01340014|453598226|FG001|Period 2, Second 7 Days|Adverse Event|1|||
126083105|NCT04535544|453598229|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
126083106|NCT04535544|453598230|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
126083107|NCT04535544|453598231|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
126083108|NCT04535544|453598232|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
126083109|NCT04535544|453598229|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
126083110|NCT04535544|453598230|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
125953799|NCT00689481|453127585|FG000|Overall Study|Withdrawal by Subject|8|||
125953800|NCT00689481|453127586|FG001|Overall Study|Withdrawal by Subject|4|||
125953801|NCT00689481|453127585|FG000|Overall Study|Excluded medication started during study|0|||
125953802|NCT00689481|453127586|FG001|Overall Study|Excluded medication started during study|1|||
125953803|NCT00689481|453127585|FG000|Overall Study|Subject early term, left on vacation|0|||
125953804|NCT00689481|453127586|FG001|Overall Study|Subject early term, left on vacation|1|||
125953805|NCT04325828|453127587|FG000|Overall Study|Ongoing|26|||
126083111|NCT04535544|453598231|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
126083112|NCT04535544|453598232|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
126083113|NCT04535544|453598229|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
126083114|NCT04535544|453598230|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
126083115|NCT04535544|453598231|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
126083116|NCT04535544|453598232|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
126083117|NCT04535544|453598229|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
126083118|NCT04535544|453598230|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
126083119|NCT04535544|453598231|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
126083120|NCT04535544|453598232|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
126083121|NCT04535544|453598229|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
126083122|NCT04535544|453598230|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
126083123|NCT04535544|453598231|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
126083124|NCT04535544|453598232|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
126083125|NCT04535544|453598229|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
126083126|NCT04535544|453598230|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
126083127|NCT04535544|453598231|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
126083128|NCT04535544|453598232|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
126083129|NCT04535544|453598229|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
126083130|NCT04535544|453598230|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
126083131|NCT04535544|453598231|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
126083132|NCT04535544|453598232|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
126083133|NCT04535544|453598229|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
126083134|NCT04535544|453598230|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
126083135|NCT04535544|453598231|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
126083136|NCT04535544|453598232|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
126083137|NCT05131477|453598239|FG000|PART 1|Withdrawal by Subject|2|||
126083138|NCT05131477|453598240|FG001|PART 1|Withdrawal by Subject|9|||
126083139|NCT05131477|453598241|FG002|PART 1|Withdrawal by Subject|6|||
126083140|NCT05131477|453598242|FG003|PART 1|Withdrawal by Subject|2|||
126083141|NCT05131477|453598243|FG004|PART 1|Withdrawal by Subject|8|||
126083142|NCT05131477|453598244|FG005|PART 1|Withdrawal by Subject|0|||
126083143|NCT05131477|453598245|FG006|PART 1|Withdrawal by Subject|0|||
126083144|NCT05131477|453598246|FG007|PART 1|Withdrawal by Subject|0|||
126083145|NCT05131477|453598247|FG008|PART 1|Withdrawal by Subject|0|||
126083146|NCT05131477|453598248|FG009|PART 1|Withdrawal by Subject|0|||
126083147|NCT05131477|453598249|FG010|PART 1|Withdrawal by Subject|0|||
126083148|NCT05131477|453598250|FG011|PART 1|Withdrawal by Subject|0|||
126083149|NCT05131477|453598251|FG012|PART 1|Withdrawal by Subject|0|||
126083150|NCT05131477|453598252|FG013|PART 1|Withdrawal by Subject|0|||
126083151|NCT05131477|453598239|FG000|PART 1|Physician Decision|1|||
126083152|NCT05131477|453598240|FG001|PART 1|Physician Decision|0|||
126083153|NCT05131477|453598241|FG002|PART 1|Physician Decision|0|||
126083154|NCT05131477|453598242|FG003|PART 1|Physician Decision|0|||
126083155|NCT05131477|453598243|FG004|PART 1|Physician Decision|0|||
126083156|NCT05131477|453598244|FG005|PART 1|Physician Decision|0|||
126083157|NCT05131477|453598245|FG006|PART 1|Physician Decision|0|||
126083158|NCT05131477|453598246|FG007|PART 1|Physician Decision|0|||
126083159|NCT05131477|453598247|FG008|PART 1|Physician Decision|0|||
126083160|NCT05131477|453598248|FG009|PART 1|Physician Decision|0|||
126083161|NCT05131477|453598249|FG010|PART 1|Physician Decision|0|||
126083162|NCT05131477|453598250|FG011|PART 1|Physician Decision|0|||
126083163|NCT05131477|453598251|FG012|PART 1|Physician Decision|0|||
126083164|NCT05131477|453598252|FG013|PART 1|Physician Decision|0|||
126083165|NCT05131477|453598239|FG000|PART 1|Adverse Event|3|||
126083166|NCT05131477|453598240|FG001|PART 1|Adverse Event|5|||
126083167|NCT05131477|453598241|FG002|PART 1|Adverse Event|1|||
126083168|NCT05131477|453598242|FG003|PART 1|Adverse Event|6|||
126083169|NCT05131477|453598243|FG004|PART 1|Adverse Event|4|||
126083170|NCT05131477|453598244|FG005|PART 1|Adverse Event|0|||
126083171|NCT05131477|453598245|FG006|PART 1|Adverse Event|0|||
126083172|NCT05131477|453598246|FG007|PART 1|Adverse Event|0|||
126083173|NCT05131477|453598247|FG008|PART 1|Adverse Event|0|||
126083174|NCT05131477|453598248|FG009|PART 1|Adverse Event|0|||
126083175|NCT05131477|453598249|FG010|PART 1|Adverse Event|0|||
126083176|NCT05131477|453598250|FG011|PART 1|Adverse Event|0|||
126083177|NCT05131477|453598251|FG012|PART 1|Adverse Event|0|||
126115561|NCT03250832|453718160|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126083178|NCT05131477|453598252|FG013|PART 1|Adverse Event|0|||
126115562|NCT03250832|453718161|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126083179|NCT05131477|453598239|FG000|PART 1|unclassified|1|||
126083180|NCT05131477|453598240|FG001|PART 1|unclassified|1|||
126083181|NCT05131477|453598241|FG002|PART 1|unclassified|0|||
126083182|NCT05131477|453598242|FG003|PART 1|unclassified|0|||
126083183|NCT05131477|453598243|FG004|PART 1|unclassified|4|||
126083184|NCT05131477|453598244|FG005|PART 1|unclassified|0|||
126083185|NCT05131477|453598245|FG006|PART 1|unclassified|0|||
126083186|NCT05131477|453598246|FG007|PART 1|unclassified|0|||
126083187|NCT05131477|453598247|FG008|PART 1|unclassified|0|||
125953806|NCT04602624|453127592|FG000|Overall Study|Protocol Deviation|1|||
125953807|NCT04602624|453127592|FG000|Overall Study|Withdrawal by Participant|1|||
125953808|NCT04084769|453127593|FG000|Overall Study|Protocol Violation|1|||
125953809|NCT04084769|453127594|FG001|Overall Study|Protocol Violation|3|||
125953810|NCT04084769|453127595|FG002|Overall Study|Protocol Violation|0|||
125953811|NCT04084769|453127596|FG003|Overall Study|Protocol Violation|1|||
125953812|NCT04084769|453127593|FG000|Overall Study|Withdrawal by Subject|0|||
125953813|NCT04084769|453127594|FG001|Overall Study|Withdrawal by Subject|1|||
125953814|NCT04084769|453127595|FG002|Overall Study|Withdrawal by Subject|0|||
125953815|NCT04084769|453127596|FG003|Overall Study|Withdrawal by Subject|0|||
125953816|NCT04084769|453127593|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125953817|NCT04084769|453127594|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125953818|NCT04084769|453127595|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125953819|NCT04084769|453127596|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125953820|NCT04084769|453127593|FG000|Overall Study|Lost to Follow-up|2|||
125953821|NCT04084769|453127594|FG001|Overall Study|Lost to Follow-up|0|||
125953822|NCT04084769|453127595|FG002|Overall Study|Lost to Follow-up|0|||
125953823|NCT04084769|453127596|FG003|Overall Study|Lost to Follow-up|0|||
125953824|NCT03390504|453127597|FG000|Overall Study|Lost to Follow-up|2|||
125953825|NCT03390504|453127598|FG001|Overall Study|Lost to Follow-up|4|||
125953826|NCT03390504|453127599|FG002|Overall Study|Lost to Follow-up|0|||
125953827|NCT03390504|453127600|FG003|Overall Study|Lost to Follow-up|1|||
125953828|NCT03390504|453127597|FG000|Overall Study|Withdrawal by Subject|3|||
125953829|NCT03390504|453127598|FG001|Overall Study|Withdrawal by Subject|15|||
125953830|NCT03390504|453127599|FG002|Overall Study|Withdrawal by Subject|5|||
125953831|NCT03390504|453127600|FG003|Overall Study|Withdrawal by Subject|2|||
125953832|NCT03390504|453127597|FG000|Overall Study|Other|1|||
125953833|NCT03390504|453127598|FG001|Overall Study|Other|2|||
125953834|NCT03390504|453127599|FG002|Overall Study|Other|2|||
125953835|NCT03390504|453127600|FG003|Overall Study|Other|6|||
125953836|NCT03492177|453127601|FG000|Overall Study|Adverse Event|1|||
125953837|NCT03492177|453127602|FG001|Overall Study|Adverse Event|0|||
125953838|NCT03492177|453127603|FG002|Overall Study|Adverse Event|0|||
125953839|NCT03492177|453127601|FG000|Overall Study|Death|3|||
125953840|NCT03492177|453127602|FG001|Overall Study|Death|0|||
125953841|NCT03492177|453127603|FG002|Overall Study|Death|3|||
125953842|NCT03492177|453127601|FG000|Overall Study|Lack of Efficacy|1|||
125953843|NCT03492177|453127602|FG001|Overall Study|Lack of Efficacy|2|||
125953844|NCT03492177|453127603|FG002|Overall Study|Lack of Efficacy|0|||
125953845|NCT03492177|453127601|FG000|Overall Study|Other|1|||
125953846|NCT03492177|453127602|FG001|Overall Study|Other|0|||
125953847|NCT03492177|453127603|FG002|Overall Study|Other|0|||
125953848|NCT03492177|453127601|FG000|Overall Study|Ongoing|16|||
125953849|NCT03492177|453127602|FG001|Overall Study|Ongoing|19|||
125953850|NCT03492177|453127603|FG002|Overall Study|Ongoing|17|||
125953851|NCT03508219|453127604|FG000|Overall Study|Death|2|||
125953852|NCT03508219|453127604|FG000|Overall Study|Withdrawal by Subject|1|||
125953853|NCT03508219|453127604|FG000|Overall Study|Lost to Follow-up|4|||
125953854|NCT03508219|453127604|FG000|Overall Study|Missed visit|2|||
125953855|NCT03945981|453127607|FG000|Overall Study|Lost to Follow-up|12|||
125953856|NCT03945981|453127607|FG000|Overall Study|Physician Decision|4|||
125953857|NCT03945981|453127607|FG000|Overall Study|Withdrawal by Subject|6|||
125953858|NCT03945981|453127607|FG000|Overall Study|Protocol Violation|1|||
125953859|NCT03665038|453127608|FG000|Overall Study|Lost to Follow-up|0|||
125953860|NCT03665038|453127609|FG001|Overall Study|Lost to Follow-up|0|||
125953861|NCT03665038|453127610|FG002|Overall Study|Lost to Follow-up|1|||
125953862|NCT04466891|453127611|FG000|Overall Study|Death|60|||
125953863|NCT04466891|453127612|FG001|Overall Study|Death|6|||
125953864|NCT04466891|453127611|FG000|Overall Study|Withdrawal by Subject|8|||
125953865|NCT04466891|453127612|FG001|Overall Study|Withdrawal by Subject|1|||
125953866|NCT04466891|453127611|FG000|Overall Study|Study terminated by sponsor|5|||
126115563|NCT03250832|453718162|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125953867|NCT04466891|453127612|FG001|Overall Study|Study terminated by sponsor|0|||
125953868|NCT04466891|453127611|FG000|Overall Study|Lost to Follow-up|2|||
125953869|NCT04466891|453127612|FG001|Overall Study|Lost to Follow-up|0|||
125953870|NCT04466891|453127611|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
125953871|NCT04466891|453127612|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
125953872|NCT00445328|453127613|FG000|Overall Study|Death|0|||
125953873|NCT00445328|453127614|FG001|Overall Study|Death|1|||
125953874|NCT00445328|453127613|FG000|Overall Study|Adverse Event|0|||
125953875|NCT00445328|453127614|FG001|Overall Study|Adverse Event|3|||
125953876|NCT00445328|453127613|FG000|Overall Study|Other|0|||
125953877|NCT00445328|453127614|FG001|Overall Study|Other|2|||
125953878|NCT00445328|453127613|FG000|Overall Study|Withdrawal by Subject|2|||
125953879|NCT00445328|453127614|FG001|Overall Study|Withdrawal by Subject|0|||
125953880|NCT00445328|453127613|FG000|Overall Study|Protocol Violation|1|||
125953881|NCT00445328|453127614|FG001|Overall Study|Protocol Violation|0|||
125953882|NCT02254278|453127615|FG000|Overall Study|Protocol Violation|1|||
125953883|NCT02254278|453127616|FG001|Overall Study|Protocol Violation|1|||
126083188|NCT05131477|453598248|FG009|PART 1|unclassified|0|||
126083189|NCT05131477|453598249|FG010|PART 1|unclassified|0|||
126083190|NCT05131477|453598250|FG011|PART 1|unclassified|0|||
126083191|NCT05131477|453598251|FG012|PART 1|unclassified|0|||
126083192|NCT05131477|453598252|FG013|PART 1|unclassified|0|||
126083193|NCT05131477|453598239|FG000|PART 1|Randomized and not treated|0|||
126083194|NCT05131477|453598240|FG001|PART 1|Randomized and not treated|0|||
126083195|NCT05131477|453598241|FG002|PART 1|Randomized and not treated|0|||
126083196|NCT05131477|453598242|FG003|PART 1|Randomized and not treated|1|||
126083197|NCT05131477|453598243|FG004|PART 1|Randomized and not treated|1|||
126083198|NCT05131477|453598244|FG005|PART 1|Randomized and not treated|0|||
126083199|NCT05131477|453598245|FG006|PART 1|Randomized and not treated|0|||
126083200|NCT05131477|453598246|FG007|PART 1|Randomized and not treated|0|||
126083201|NCT05131477|453598247|FG008|PART 1|Randomized and not treated|0|||
126083202|NCT05131477|453598248|FG009|PART 1|Randomized and not treated|0|||
126083203|NCT05131477|453598249|FG010|PART 1|Randomized and not treated|0|||
126083204|NCT05131477|453598250|FG011|PART 1|Randomized and not treated|0|||
126083205|NCT05131477|453598251|FG012|PART 1|Randomized and not treated|0|||
126083206|NCT05131477|453598252|FG013|PART 1|Randomized and not treated|0|||
126083207|NCT05131477|453598239|FG000|PART 1|Protocol Violation|2|||
126083208|NCT05131477|453598240|FG001|PART 1|Protocol Violation|0|||
126083209|NCT05131477|453598241|FG002|PART 1|Protocol Violation|0|||
126083210|NCT05131477|453598242|FG003|PART 1|Protocol Violation|1|||
126083211|NCT05131477|453598243|FG004|PART 1|Protocol Violation|0|||
126083212|NCT05131477|453598244|FG005|PART 1|Protocol Violation|0|||
126083213|NCT05131477|453598245|FG006|PART 1|Protocol Violation|0|||
126083214|NCT05131477|453598246|FG007|PART 1|Protocol Violation|0|||
126083215|NCT05131477|453598247|FG008|PART 1|Protocol Violation|0|||
126083216|NCT05131477|453598248|FG009|PART 1|Protocol Violation|0|||
126083217|NCT05131477|453598249|FG010|PART 1|Protocol Violation|0|||
126083218|NCT05131477|453598250|FG011|PART 1|Protocol Violation|0|||
126083219|NCT05131477|453598251|FG012|PART 1|Protocol Violation|0|||
126083220|NCT05131477|453598252|FG013|PART 1|Protocol Violation|0|||
126083221|NCT05131477|453598239|FG000|PART 1|Lack of Efficacy|0|||
126083222|NCT05131477|453598240|FG001|PART 1|Lack of Efficacy|1|||
126083223|NCT05131477|453598241|FG002|PART 1|Lack of Efficacy|1|||
126083224|NCT05131477|453598242|FG003|PART 1|Lack of Efficacy|2|||
126083225|NCT05131477|453598243|FG004|PART 1|Lack of Efficacy|5|||
126083226|NCT05131477|453598244|FG005|PART 1|Lack of Efficacy|0|||
126083227|NCT05131477|453598245|FG006|PART 1|Lack of Efficacy|0|||
126083228|NCT05131477|453598246|FG007|PART 1|Lack of Efficacy|0|||
126083229|NCT05131477|453598247|FG008|PART 1|Lack of Efficacy|0|||
126083230|NCT05131477|453598248|FG009|PART 1|Lack of Efficacy|0|||
126083231|NCT05131477|453598249|FG010|PART 1|Lack of Efficacy|0|||
126083232|NCT05131477|453598250|FG011|PART 1|Lack of Efficacy|0|||
126083233|NCT05131477|453598251|FG012|PART 1|Lack of Efficacy|0|||
126083234|NCT05131477|453598252|FG013|PART 1|Lack of Efficacy|0|||
126083235|NCT05131477|453598239|FG000|PART 2|Withdrawal by Subject|0|||
126083236|NCT05131477|453598240|FG001|PART 2|Withdrawal by Subject|0|||
126083237|NCT05131477|453598241|FG002|PART 2|Withdrawal by Subject|0|||
126083238|NCT05131477|453598242|FG003|PART 2|Withdrawal by Subject|0|||
126083239|NCT05131477|453598243|FG004|PART 2|Withdrawal by Subject|0|||
126083240|NCT05131477|453598244|FG005|PART 2|Withdrawal by Subject|0|||
126083241|NCT05131477|453598245|FG006|PART 2|Withdrawal by Subject|2|||
126083242|NCT05131477|453598246|FG007|PART 2|Withdrawal by Subject|0|||
126083243|NCT05131477|453598247|FG008|PART 2|Withdrawal by Subject|0|||
126083244|NCT05131477|453598248|FG009|PART 2|Withdrawal by Subject|0|||
126083245|NCT05131477|453598249|FG010|PART 2|Withdrawal by Subject|2|||
126083246|NCT05131477|453598250|FG011|PART 2|Withdrawal by Subject|0|||
126083247|NCT05131477|453598251|FG012|PART 2|Withdrawal by Subject|2|||
126083248|NCT05131477|453598252|FG013|PART 2|Withdrawal by Subject|2|||
126083249|NCT05131477|453598239|FG000|PART 2|Other|0|||
126083250|NCT05131477|453598240|FG001|PART 2|Other|0|||
126083251|NCT05131477|453598241|FG002|PART 2|Other|0|||
126083252|NCT05131477|453598242|FG003|PART 2|Other|0|||
126083253|NCT05131477|453598243|FG004|PART 2|Other|0|||
126083254|NCT05131477|453598244|FG005|PART 2|Other|0|||
126083255|NCT05131477|453598245|FG006|PART 2|Other|0|||
126083256|NCT05131477|453598246|FG007|PART 2|Other|0|||
126083257|NCT05131477|453598247|FG008|PART 2|Other|1|||
126083258|NCT05131477|453598248|FG009|PART 2|Other|1|||
126083259|NCT05131477|453598249|FG010|PART 2|Other|0|||
126083260|NCT05131477|453598250|FG011|PART 2|Other|0|||
126083261|NCT05131477|453598251|FG012|PART 2|Other|1|||
126115564|NCT03250832|453718163|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126083262|NCT05131477|453598252|FG013|PART 2|Other|0|||
126083263|NCT05131477|453598239|FG000|PART 2|Lack of Efficacy|0|||
126083264|NCT05131477|453598240|FG001|PART 2|Lack of Efficacy|0|||
126083265|NCT05131477|453598241|FG002|PART 2|Lack of Efficacy|0|||
126083266|NCT05131477|453598242|FG003|PART 2|Lack of Efficacy|0|||
126083267|NCT05131477|453598243|FG004|PART 2|Lack of Efficacy|0|||
126083268|NCT05131477|453598244|FG005|PART 2|Lack of Efficacy|1|||
126083269|NCT05131477|453598245|FG006|PART 2|Lack of Efficacy|1|||
126083270|NCT05131477|453598246|FG007|PART 2|Lack of Efficacy|0|||
126083271|NCT05131477|453598247|FG008|PART 2|Lack of Efficacy|3|||
126083272|NCT05131477|453598248|FG009|PART 2|Lack of Efficacy|0|||
126083273|NCT05131477|453598249|FG010|PART 2|Lack of Efficacy|1|||
126115565|NCT03250832|453718164|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126115566|NCT03250832|453718165|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
126115567|NCT03250832|453718166|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
126115568|NCT03250832|453718167|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126115569|NCT03250832|453718168|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126115570|NCT03250832|453718157|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115571|NCT03250832|453718158|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115572|NCT03250832|453718159|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115573|NCT03250832|453718160|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115574|NCT03250832|453718161|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115575|NCT03250832|453718162|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115576|NCT03250832|453718163|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115577|NCT03250832|453718164|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115578|NCT03250832|453718165|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
126115579|NCT03250832|453718166|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
126115580|NCT03250832|453718167|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115581|NCT03250832|453718168|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126115582|NCT03250832|453718157|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115583|NCT03250832|453718158|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115584|NCT03250832|453718159|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115585|NCT03250832|453718160|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115586|NCT03250832|453718161|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115587|NCT03250832|453718162|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115588|NCT03250832|453718163|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115589|NCT03250832|453718164|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115590|NCT03250832|453718165|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115591|NCT03250832|453718166|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115592|NCT03250832|453718167|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126115593|NCT03250832|453718168|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
126115594|NCT00617604|453718169|FG000|Overall Study|Death|2|||
126115595|NCT00617604|453718170|FG001|Overall Study|Death|1|||
126115596|NCT00617604|453718169|FG000|Overall Study|Lost to Follow-up|1|||
126115597|NCT00617604|453718170|FG001|Overall Study|Lost to Follow-up|0|||
126115598|NCT00617604|453718169|FG000|Overall Study|Miscellaneous Reasons|8|||
126115599|NCT00617604|453718170|FG001|Overall Study|Miscellaneous Reasons|10|||
126115600|NCT00617604|453718169|FG000|Overall Study|Withdrawal by Subject|4|||
126115601|NCT00617604|453718170|FG001|Overall Study|Withdrawal by Subject|6|||
126115602|NCT00617604|453718169|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
126115603|NCT00617604|453718170|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
126115604|NCT02303704|453718171|FG000|Overall Study|Protocol Violation|5|||
126115605|NCT02303704|453718172|FG001|Overall Study|Protocol Violation|9|||
126115606|NCT00705432|453718175|FG000|Treatment Period|Adverse Event|45|||
126115607|NCT00705432|453718176|FG001|Treatment Period|Adverse Event|37|||
126115608|NCT00705432|453718177|FG002|Treatment Period|Adverse Event|51|||
126115609|NCT00705432|453718178|FG003|Treatment Period|Adverse Event|12|||
126115610|NCT00705432|453718179|FG004|Treatment Period|Adverse Event|8|||
126115611|NCT00705432|453718180|FG005|Treatment Period|Adverse Event|9|||
126115612|NCT00705432|453718175|FG000|Treatment Period|Treatment failure|92|||
126115613|NCT00705432|453718176|FG001|Treatment Period|Treatment failure|42|||
126115614|NCT00705432|453718177|FG002|Treatment Period|Treatment failure|33|||
125953884|NCT02782949|453127618|FG000|Overall Study|Protocol Violation|1|||
125953885|NCT02782949|453127619|FG001|Overall Study|Protocol Violation|0|||
125953886|NCT02782949|453127618|FG000|Overall Study|Withdrawal by Subject|0|||
125953887|NCT02782949|453127619|FG001|Overall Study|Withdrawal by Subject|1|||
125953888|NCT04745689|453127620|FG000|Overall Study|Death|9|||
125953889|NCT04745689|453127621|FG001|Overall Study|Death|6|||
125953890|NCT04745689|453127620|FG000|Overall Study|Lost to Follow-up|1|||
125953891|NCT04745689|453127621|FG001|Overall Study|Lost to Follow-up|0|||
125953892|NCT04745689|453127620|FG000|Overall Study|Withdrawal by Subject|2|||
125953893|NCT04745689|453127621|FG001|Overall Study|Withdrawal by Subject|0|||
125953894|NCT04745689|453127620|FG000|Overall Study|Study terminated by sponsor|10|||
125953895|NCT04745689|453127621|FG001|Overall Study|Study terminated by sponsor|3|||
125953896|NCT00634647|453128600|FG000|Overall Study|death on study|3|||
125953897|NCT00634647|453128600|FG000|Overall Study|refused further treatment|3|||
125953898|NCT00634647|453128600|FG000|Overall Study|declined to participate before treatment|1|||
125953899|NCT02984020|453128601|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
125953900|NCT02984020|453128601|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
125953901|NCT02984020|453128601|FG000|Overall Study|Other significant protocol violation|2|||
125953902|NCT01700179|453128603|FG000|Overall Study|Physician Decision|2|||
125953903|NCT00667342|453128604|FG000|Overall Study|Protocol Violation|1|||
125953904|NCT00667342|453128605|FG001|Overall Study|Protocol Violation|0|||
125953905|NCT00667342|453128606|FG002|Overall Study|Protocol Violation|0|||
125953906|NCT00667342|453128604|FG000|Overall Study|Withdrawal by Subject|1|||
125953907|NCT00667342|453128605|FG001|Overall Study|Withdrawal by Subject|0|||
125953908|NCT00667342|453128606|FG002|Overall Study|Withdrawal by Subject|0|||
125953909|NCT00667342|453128604|FG000|Overall Study|Physician Decision|3|||
125953910|NCT00667342|453128605|FG001|Overall Study|Physician Decision|0|||
125953911|NCT00667342|453128606|FG002|Overall Study|Physician Decision|0|||
125953912|NCT00667342|453128604|FG000|Overall Study|Relapse or tumor progression|9|||
125953913|NCT00667342|453128605|FG001|Overall Study|Relapse or tumor progression|0|||
125953914|NCT00667342|453128606|FG002|Overall Study|Relapse or tumor progression|7|||
125953915|NCT00667342|453128604|FG000|Overall Study|Adverse Event|0|||
125953916|NCT00667342|453128605|FG001|Overall Study|Adverse Event|0|||
125953917|NCT00667342|453128606|FG002|Overall Study|Adverse Event|1|||
125953918|NCT00667342|453128604|FG000|Overall Study|Ineligible|0|||
125953919|NCT00667342|453128605|FG001|Overall Study|Ineligible|0|||
125953920|NCT00667342|453128606|FG002|Overall Study|Ineligible|1|||
125953921|NCT05220397|453128607|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
125953922|NCT05220397|453128608|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
125953923|NCT05220397|453128609|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
125953924|NCT05220397|453128610|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
125953925|NCT05220397|453128611|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
125953926|NCT00637195|453128612|FG000|Overall Study|Lost to Follow-up|1|||
125953927|NCT00637195|453128613|FG001|Overall Study|Lost to Follow-up|0|||
125953928|NCT00637195|453128612|FG000|Overall Study|Other|2|||
125953929|NCT00637195|453128613|FG001|Overall Study|Other|0|||
125953930|NCT00637195|453128612|FG000|Overall Study|Withdrawal by Subject|0|||
125953931|NCT00637195|453128613|FG001|Overall Study|Withdrawal by Subject|1|||
125953932|NCT01110915|453128614|FG000|Overall Study|Death|2|||
125953933|NCT01110915|453128615|FG001|Overall Study|Death|1|||
125953934|NCT01110915|453128614|FG000|Overall Study|Lost to Follow-up|1|||
125953935|NCT01110915|453128615|FG001|Overall Study|Lost to Follow-up|0|||
125953936|NCT01110915|453128614|FG000|Overall Study|Withdrawal by Subject|7|||
125953937|NCT01110915|453128615|FG001|Overall Study|Withdrawal by Subject|1|||
125953938|NCT00207142|453128616|FG000|Induction Phase|Adverse Event|9|||
125953939|NCT00207142|453128617|FG001|Induction Phase|Adverse Event|0|||
125953940|NCT00207142|453128618|FG002|Induction Phase|Adverse Event|0|||
125953941|NCT00207142|453128619|FG003|Induction Phase|Adverse Event|0|||
125953942|NCT00207142|453128616|FG000|Induction Phase|Death|1|||
125953943|NCT00207142|453128617|FG001|Induction Phase|Death|0|||
125953944|NCT00207142|453128618|FG002|Induction Phase|Death|0|||
125953945|NCT00207142|453128619|FG003|Induction Phase|Death|0|||
125953946|NCT00207142|453128616|FG000|Induction Phase|Lack of Efficacy|1|||
125953947|NCT00207142|453128617|FG001|Induction Phase|Lack of Efficacy|0|||
125953948|NCT00207142|453128618|FG002|Induction Phase|Lack of Efficacy|0|||
125953949|NCT00207142|453128619|FG003|Induction Phase|Lack of Efficacy|0|||
125953950|NCT00207142|453128616|FG000|Induction Phase|Lost to Follow-up|5|||
125953951|NCT00207142|453128617|FG001|Induction Phase|Lost to Follow-up|0|||
125953952|NCT00207142|453128618|FG002|Induction Phase|Lost to Follow-up|0|||
125953953|NCT00207142|453128619|FG003|Induction Phase|Lost to Follow-up|0|||
125953954|NCT00207142|453128616|FG000|Induction Phase|Physician Decision|2|||
125953955|NCT00207142|453128617|FG001|Induction Phase|Physician Decision|0|||
125953956|NCT00207142|453128618|FG002|Induction Phase|Physician Decision|0|||
125953957|NCT00207142|453128619|FG003|Induction Phase|Physician Decision|0|||
125953958|NCT00207142|453128616|FG000|Induction Phase|Poor/noncompliance|2|||
125953959|NCT00207142|453128617|FG001|Induction Phase|Poor/noncompliance|0|||
125953960|NCT00207142|453128618|FG002|Induction Phase|Poor/noncompliance|0|||
125953961|NCT00207142|453128619|FG003|Induction Phase|Poor/noncompliance|0|||
125953962|NCT00207142|453128616|FG000|Induction Phase|Pregnancy|1|||
125953963|NCT00207142|453128617|FG001|Induction Phase|Pregnancy|0|||
125953964|NCT00207142|453128618|FG002|Induction Phase|Pregnancy|0|||
125953965|NCT00207142|453128619|FG003|Induction Phase|Pregnancy|0|||
125953966|NCT00207142|453128616|FG000|Induction Phase|Subject no longer meets study criteria|3|||
125953967|NCT00207142|453128617|FG001|Induction Phase|Subject no longer meets study criteria|0|||
125953968|NCT00207142|453128618|FG002|Induction Phase|Subject no longer meets study criteria|0|||
125953969|NCT00207142|453128619|FG003|Induction Phase|Subject no longer meets study criteria|0|||
125953970|NCT00207142|453128616|FG000|Induction Phase|Withdrawal by Subject|4|||
125953971|NCT00207142|453128617|FG001|Induction Phase|Withdrawal by Subject|0|||
125953972|NCT00207142|453128618|FG002|Induction Phase|Withdrawal by Subject|0|||
125953973|NCT00207142|453128619|FG003|Induction Phase|Withdrawal by Subject|0|||
125953974|NCT00207142|453128616|FG000|Induction Phase|Incarceration|1|||
125953975|NCT00207142|453128617|FG001|Induction Phase|Incarceration|0|||
125953976|NCT00207142|453128618|FG002|Induction Phase|Incarceration|0|||
125953977|NCT00207142|453128619|FG003|Induction Phase|Incarceration|0|||
125953978|NCT00207142|453128616|FG000|Induction Phase|Missing lab data|1|||
125953979|NCT00207142|453128617|FG001|Induction Phase|Missing lab data|0|||
125953980|NCT00207142|453128618|FG002|Induction Phase|Missing lab data|0|||
125953981|NCT00207142|453128619|FG003|Induction Phase|Missing lab data|0|||
126083274|NCT05131477|453598250|FG011|PART 2|Lack of Efficacy|0|||
126083275|NCT05131477|453598251|FG012|PART 2|Lack of Efficacy|2|||
126083276|NCT05131477|453598252|FG013|PART 2|Lack of Efficacy|0|||
126083277|NCT05131477|453598239|FG000|PART 2|Unclassified|0|||
126083278|NCT05131477|453598240|FG001|PART 2|Unclassified|0|||
126083279|NCT05131477|453598241|FG002|PART 2|Unclassified|0|||
126083280|NCT05131477|453598242|FG003|PART 2|Unclassified|0|||
126083281|NCT05131477|453598243|FG004|PART 2|Unclassified|0|||
126083282|NCT05131477|453598244|FG005|PART 2|Unclassified|0|||
126083283|NCT05131477|453598245|FG006|PART 2|Unclassified|0|||
126083284|NCT05131477|453598246|FG007|PART 2|Unclassified|0|||
126083285|NCT05131477|453598247|FG008|PART 2|Unclassified|0|||
126083286|NCT05131477|453598248|FG009|PART 2|Unclassified|0|||
126083287|NCT05131477|453598249|FG010|PART 2|Unclassified|1|||
126083288|NCT05131477|453598250|FG011|PART 2|Unclassified|0|||
126083289|NCT05131477|453598251|FG012|PART 2|Unclassified|0|||
126083290|NCT05131477|453598252|FG013|PART 2|Unclassified|0|||
126083291|NCT05131477|453598239|FG000|PART 2|Re-randomized and not treated|0|||
126083292|NCT05131477|453598240|FG001|PART 2|Re-randomized and not treated|0|||
126083293|NCT05131477|453598241|FG002|PART 2|Re-randomized and not treated|0|||
126083294|NCT05131477|453598242|FG003|PART 2|Re-randomized and not treated|0|||
126083295|NCT05131477|453598243|FG004|PART 2|Re-randomized and not treated|0|||
126083296|NCT05131477|453598244|FG005|PART 2|Re-randomized and not treated|0|||
126083297|NCT05131477|453598245|FG006|PART 2|Re-randomized and not treated|0|||
126083298|NCT05131477|453598246|FG007|PART 2|Re-randomized and not treated|1|||
126083299|NCT05131477|453598247|FG008|PART 2|Re-randomized and not treated|0|||
126083300|NCT05131477|453598248|FG009|PART 2|Re-randomized and not treated|0|||
126083301|NCT05131477|453598249|FG010|PART 2|Re-randomized and not treated|1|||
126083302|NCT05131477|453598250|FG011|PART 2|Re-randomized and not treated|0|||
126083303|NCT05131477|453598251|FG012|PART 2|Re-randomized and not treated|1|||
126083304|NCT05131477|453598252|FG013|PART 2|Re-randomized and not treated|1|||
126083305|NCT02194829|453598253|FG000|Overall Study|Adverse Event|2|||
126083306|NCT02194829|453598254|FG001|Overall Study|Adverse Event|2|||
126083307|NCT02194829|453598253|FG000|Overall Study|Death|0|||
126083308|NCT02194829|453598254|FG001|Overall Study|Death|1|||
126083309|NCT02194829|453598253|FG000|Overall Study|Disease progression|0|||
126083310|NCT02194829|453598254|FG001|Overall Study|Disease progression|1|||
126083311|NCT02194829|453598253|FG000|Overall Study|Withdrawal by Subject|0|||
126083312|NCT02194829|453598254|FG001|Overall Study|Withdrawal by Subject|1|||
126083313|NCT02194829|453598253|FG000|Overall Study|Never started protocol therapy|0|||
126083314|NCT02194829|453598254|FG001|Overall Study|Never started protocol therapy|1|||
126083315|NCT05101993|453598257|FG000|Overall Study|Withdrawal by Subject|1|||
126083316|NCT01124838|453598258|FG000|Overall Study|Miscellaneous|4|||
126083317|NCT01124838|453598259|FG001|Overall Study|Miscellaneous|2|||
126083318|NCT01124838|453598258|FG000|Overall Study|Adverse Event|7|||
126083319|NCT01124838|453598259|FG001|Overall Study|Adverse Event|11|||
126083320|NCT01124838|453598258|FG000|Overall Study|Lack of Efficacy|2|||
126083321|NCT01124838|453598259|FG001|Overall Study|Lack of Efficacy|0|||
126083322|NCT01124838|453598258|FG000|Overall Study|Withdrawal by Subject|3|||
126083323|NCT01124838|453598259|FG001|Overall Study|Withdrawal by Subject|2|||
126083324|NCT01124838|453598258|FG000|Overall Study|Lost to Follow-up|2|||
126083325|NCT01124838|453598259|FG001|Overall Study|Lost to Follow-up|0|||
126083326|NCT04297618|453598260|FG000|Overall Study|Adverse Event|1|||
126083327|NCT04297618|453598260|FG000|Overall Study|Withdrawal by Subject|1|||
126083328|NCT02600897|453598261|FG000|Overall Study|Death|1|||
126083329|NCT02600897|453598262|FG001|Overall Study|Death|2|||
126083330|NCT02600897|453598263|FG002|Overall Study|Death|1|||
126083331|NCT02600897|453598264|FG003|Overall Study|Death|2|||
126083332|NCT02600897|453598265|FG004|Overall Study|Death|3|||
126083333|NCT02600897|453598266|FG005|Overall Study|Death|2|||
126083334|NCT02600897|453598267|FG006|Overall Study|Death|10|||
126083335|NCT02600897|453598268|FG007|Overall Study|Death|7|||
126083336|NCT02600897|453598269|FG008|Overall Study|Death|20|||
126083337|NCT02600897|453598261|FG000|Overall Study|Lost to Follow-up|1|||
126083338|NCT02600897|453598262|FG001|Overall Study|Lost to Follow-up|0|||
126083339|NCT02600897|453598263|FG002|Overall Study|Lost to Follow-up|0|||
126083340|NCT02600897|453598264|FG003|Overall Study|Lost to Follow-up|0|||
126083341|NCT02600897|453598265|FG004|Overall Study|Lost to Follow-up|0|||
126083342|NCT02600897|453598266|FG005|Overall Study|Lost to Follow-up|0|||
126083343|NCT02600897|453598267|FG006|Overall Study|Lost to Follow-up|0|||
126083344|NCT02600897|453598268|FG007|Overall Study|Lost to Follow-up|1|||
126083345|NCT02600897|453598269|FG008|Overall Study|Lost to Follow-up|0|||
126083346|NCT02600897|453598261|FG000|Overall Study|Withdrawal by Subject|0|||
126083347|NCT02600897|453598262|FG001|Overall Study|Withdrawal by Subject|0|||
126083348|NCT02600897|453598263|FG002|Overall Study|Withdrawal by Subject|0|||
126083349|NCT02600897|453598264|FG003|Overall Study|Withdrawal by Subject|0|||
126083350|NCT02600897|453598265|FG004|Overall Study|Withdrawal by Subject|0|||
126083351|NCT02600897|453598266|FG005|Overall Study|Withdrawal by Subject|0|||
126083352|NCT02600897|453598267|FG006|Overall Study|Withdrawal by Subject|0|||
126083353|NCT02600897|453598268|FG007|Overall Study|Withdrawal by Subject|4|||
126083354|NCT02600897|453598269|FG008|Overall Study|Withdrawal by Subject|2|||
126083355|NCT02600897|453598261|FG000|Overall Study|Reason Not Specified|0|||
126083356|NCT02600897|453598262|FG001|Overall Study|Reason Not Specified|0|||
126083357|NCT02600897|453598263|FG002|Overall Study|Reason Not Specified|0|||
126083358|NCT02600897|453598264|FG003|Overall Study|Reason Not Specified|0|||
126083359|NCT02600897|453598265|FG004|Overall Study|Reason Not Specified|0|||
126083360|NCT02600897|453598266|FG005|Overall Study|Reason Not Specified|0|||
126083361|NCT02600897|453598267|FG006|Overall Study|Reason Not Specified|0|||
126083362|NCT02600897|453598268|FG007|Overall Study|Reason Not Specified|0|||
126083363|NCT02600897|453598269|FG008|Overall Study|Reason Not Specified|1|||
126083364|NCT06840769|453598270|FG000|Overall Study|Withdrawal by Subject|1|||
126083365|NCT06840769|453598271|FG001|Overall Study|Withdrawal by Subject|0|||
126083366|NCT06840769|453598272|FG002|Overall Study|Withdrawal by Subject|0|||
126083367|NCT06840769|453598273|FG003|Overall Study|Withdrawal by Subject|0|||
126083368|NCT06840769|453598274|FG004|Overall Study|Withdrawal by Subject|0|||
126083369|NCT02172911|453599468|FG000|Overall Study|Serious Adverse Event|0|||
126083370|NCT02172911|453599469|FG001|Overall Study|Serious Adverse Event|1|||
126083371|NCT02172911|453599468|FG000|Overall Study|Progression of Disease|0|||
126083372|NCT02172911|453599469|FG001|Overall Study|Progression of Disease|1|||
126083373|NCT02172911|453599468|FG000|Overall Study|Loss of insurance coverage|1|||
126083374|NCT02172911|453599469|FG001|Overall Study|Loss of insurance coverage|0|||
126083375|NCT01367847|453599470|FG000|Overall Study|Withdrawal by Subject|2|||
126083376|NCT01367847|453599471|FG001|Overall Study|Withdrawal by Subject|2|||
126083377|NCT00953147|453599472|FG000|Overall Study|Adverse Event|8|||
126083378|NCT00953147|453599473|FG001|Overall Study|Adverse Event|16|||
126083379|NCT00953147|453599474|FG002|Overall Study|Adverse Event|6|||
126083380|NCT00953147|453599472|FG000|Overall Study|Protocol Violation|2|||
126083381|NCT00953147|453599473|FG001|Overall Study|Protocol Violation|8|||
126083382|NCT00953147|453599474|FG002|Overall Study|Protocol Violation|4|||
126083383|NCT00953147|453599472|FG000|Overall Study|Withdrawal by Subject|13|||
126083384|NCT00953147|453599473|FG001|Overall Study|Withdrawal by Subject|15|||
126083385|NCT00953147|453599474|FG002|Overall Study|Withdrawal by Subject|12|||
126083386|NCT00953147|453599472|FG000|Overall Study|Lost to Follow-up|8|||
126083387|NCT00953147|453599473|FG001|Overall Study|Lost to Follow-up|9|||
126083388|NCT00953147|453599474|FG002|Overall Study|Lost to Follow-up|4|||
126083389|NCT00953147|453599472|FG000|Overall Study|Physician Decision|2|||
126083390|NCT00953147|453599473|FG001|Overall Study|Physician Decision|7|||
126083391|NCT00953147|453599474|FG002|Overall Study|Physician Decision|3|||
126083392|NCT00953147|453599472|FG000|Overall Study|Other|4|||
126083393|NCT00953147|453599473|FG001|Overall Study|Other|11|||
126083394|NCT00953147|453599474|FG002|Overall Study|Other|13|||
126083395|NCT00078338|453599475|FG000|Overall Study|Adverse Event|31|||
126083396|NCT00078338|453599476|FG001|Overall Study|Adverse Event|24|||
126083397|NCT00078338|453599475|FG000|Overall Study|Lost to Follow-up|17|||
126083398|NCT00078338|453599476|FG001|Overall Study|Lost to Follow-up|2|||
126083399|NCT00078338|453599475|FG000|Overall Study|Protocol Violation|2|||
126083400|NCT00078338|453599476|FG001|Overall Study|Protocol Violation|2|||
126083401|NCT00078338|453599475|FG000|Overall Study|Disease Progression|4|||
126083402|NCT00078338|453599476|FG001|Overall Study|Disease Progression|7|||
126083403|NCT00078338|453599475|FG000|Overall Study|Other|28|||
126083404|NCT00078338|453599476|FG001|Overall Study|Other|16|||
126083405|NCT00078338|453599475|FG000|Overall Study|Subjects randomized, but not treated|3|||
126083406|NCT00078338|453599476|FG001|Overall Study|Subjects randomized, but not treated|3|||
126083407|NCT03258723|453599477|FG000|Overall Study|COVID Interruption of study|54|||
126083408|NCT03258723|453599477|FG000|Overall Study|Lost to Follow-up|8|||
126083409|NCT00592293|453599481|FG000|Overall Study|Withdrawal by Subject|1|||
126083410|NCT01606319|453599482|FG000|Overall Study|Lost to Follow-up|17|||
126083411|NCT01606319|453599483|FG001|Overall Study|Lost to Follow-up|14|||
126083412|NCT01606319|453599482|FG000|Overall Study|Withdrawal by Subject|9|||
126083413|NCT01606319|453599483|FG001|Overall Study|Withdrawal by Subject|12|||
126083414|NCT01606319|453599482|FG000|Overall Study|Physician Decision|1|||
126083415|NCT01606319|453599483|FG001|Overall Study|Physician Decision|2|||
126083416|NCT01606319|453599482|FG000|Overall Study|Lack of Efficacy|6|||
126083417|NCT01606319|453599483|FG001|Overall Study|Lack of Efficacy|8|||
126083418|NCT01606319|453599482|FG000|Overall Study|Adverse Event|1|||
126083419|NCT01606319|453599483|FG001|Overall Study|Adverse Event|4|||
126115615|NCT00705432|453718178|FG003|Treatment Period|Treatment failure|25|||
126115616|NCT00705432|453718179|FG004|Treatment Period|Treatment failure|13|||
126083420|NCT01784523|453599486|FG000|Overall Study|Study closed early|7|||
126083421|NCT01784523|453599487|FG001|Overall Study|Study closed early|4|||
126083422|NCT04340947|453599488|FG000|7-day Washout Period|Lost to Follow-up|5|||
126083423|NCT04340947|453599489|FG001|7-day Washout Period|Lost to Follow-up|4|||
126083424|NCT01124097|453599494|FG000|Overall Study|Withdrawal by Subject|4|||
126083425|NCT01124097|453599495|FG001|Overall Study|Withdrawal by Subject|3|||
126083426|NCT01124097|453599496|FG002|Overall Study|Withdrawal by Subject|2|||
126083427|NCT01124097|453599497|FG003|Overall Study|Withdrawal by Subject|3|||
126083428|NCT01124097|453599494|FG000|Overall Study|Lack of Efficacy|2|||
126083429|NCT01124097|453599495|FG001|Overall Study|Lack of Efficacy|3|||
126083430|NCT01124097|453599496|FG002|Overall Study|Lack of Efficacy|1|||
126083431|NCT01124097|453599497|FG003|Overall Study|Lack of Efficacy|3|||
126083432|NCT01124097|453599494|FG000|Overall Study|Adverse Event|24|||
126083433|NCT01124097|453599495|FG001|Overall Study|Adverse Event|15|||
126083434|NCT01124097|453599496|FG002|Overall Study|Adverse Event|15|||
126083435|NCT01124097|453599497|FG003|Overall Study|Adverse Event|7|||
126083436|NCT01124097|453599494|FG000|Overall Study|Protocol Violation|2|||
126083437|NCT01124097|453599495|FG001|Overall Study|Protocol Violation|0|||
126083438|NCT01124097|453599496|FG002|Overall Study|Protocol Violation|2|||
126083439|NCT01124097|453599497|FG003|Overall Study|Protocol Violation|1|||
126083440|NCT01124097|453599494|FG000|Overall Study|Physician Decision|2|||
126083441|NCT01124097|453599495|FG001|Overall Study|Physician Decision|1|||
126083442|NCT01124097|453599496|FG002|Overall Study|Physician Decision|0|||
126083443|NCT01124097|453599497|FG003|Overall Study|Physician Decision|0|||
126083444|NCT01821937|453599498|FG000|Overall Study|Adverse Event|0|||
126083445|NCT01821937|453599499|FG001|Overall Study|Adverse Event|3|||
126083446|NCT00193479|453599500|FG000|Induction Chemotherapy|Adverse Event|2|||
126083447|NCT00193479|453599500|FG000|Induction Chemotherapy|Disease Progression|1|||
126083448|NCT00193479|453599500|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
126083449|NCT00193479|453599500|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
126083450|NCT02030002|453599501|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
126083451|NCT02030002|453599501|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
126083452|NCT02030002|453599501|FG000|Follow-up|Lost to Follow-up|2|||
126083453|NCT00609947|453599502|FG000|Overall Study|Death|1|||
126083454|NCT01304498|453599503|FG000|Overall Study|Adverse Event|1|||
126083455|NCT01304498|453599504|FG001|Overall Study|Adverse Event|1|||
126083456|NCT01304498|453599503|FG000|Overall Study|Withdrawal by Subject|2|||
126083457|NCT01304498|453599504|FG001|Overall Study|Withdrawal by Subject|3|||
126083458|NCT01304498|453599503|FG000|Overall Study|Protocol Violation|1|||
126083459|NCT01304498|453599504|FG001|Overall Study|Protocol Violation|0|||
125953982|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
125953983|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
125953984|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
125953985|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
125953986|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
125953987|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
125953988|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
125953989|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
125953990|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
125953991|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
125953992|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
125953993|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
125953994|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
125953995|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
125953996|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
125953997|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
125953998|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
125953999|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
125954000|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
125954001|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
125954002|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
125954003|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
125954004|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
125954005|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
125954006|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
125954007|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
125954008|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
125954009|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
125954010|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|Death|0|||
125954011|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|Death|0|||
125954012|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|Death|0|||
125954013|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|Death|1|||
125954014|NCT00207142|453128616|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
125954015|NCT00207142|453128617|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
125954016|NCT00207142|453128618|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
126083460|NCT01304498|453599503|FG000|Overall Study|Lost to Follow-up|2|||
126083461|NCT01304498|453599504|FG001|Overall Study|Lost to Follow-up|1|||
126083462|NCT01834586|453599506|FG000|Overall Study|Adverse Event|1|||
126083463|NCT01667549|453599507|FG000|Overall Study|Withdrawal by Subject|3|||
126083464|NCT01667549|453599508|FG001|Overall Study|Withdrawal by Subject|5|||
126083465|NCT01667549|453599509|FG002|Overall Study|Withdrawal by Subject|7|||
126083466|NCT01667549|453599510|FG003|Overall Study|Withdrawal by Subject|6|||
126083467|NCT01667549|453599511|FG004|Overall Study|Withdrawal by Subject|1|||
126083468|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
126083469|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
126083470|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
126083471|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
126083472|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
126083473|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
126083474|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
126083475|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
126083476|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
126083477|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
126083478|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
126083479|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
126083480|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
126083481|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
126083482|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
126083483|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
126083484|NCT04210843|453599512|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
126083485|NCT04210843|453599513|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
126083486|NCT04210843|453599512|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
126083487|NCT04210843|453599513|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
126083488|NCT04210843|453599512|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
126083489|NCT04210843|453599513|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
126083490|NCT04210843|453599512|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
126083491|NCT04210843|453599513|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
126083492|NCT04210843|453599512|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
126083493|NCT04210843|453599513|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
126083494|NCT04210843|453599512|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
126083495|NCT04210843|453599513|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
126083496|NCT04210843|453599512|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
126083497|NCT04210843|453599513|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
126083498|NCT04210843|453599512|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
126083499|NCT04210843|453599513|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
126083500|NCT04210843|453599512|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
126083501|NCT04210843|453599513|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
126083502|NCT04210843|453599512|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
126083503|NCT04210843|453599513|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
126083504|NCT04210843|453599512|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
126083505|NCT04210843|453599513|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
126083506|NCT04210843|453599512|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
126083507|NCT04210843|453599513|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
126083508|NCT04210843|453599512|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
126083509|NCT04210843|453599513|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
126083510|NCT04210843|453599512|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
126083511|NCT04210843|453599513|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
126083512|NCT04210843|453599512|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
126083513|NCT04210843|453599513|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
126083514|NCT04210843|453599512|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
126083515|NCT04210843|453599513|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
126083516|NCT02844777|453599514|FG000|Overall Study|Withdrawal by Subject|2|||
126083517|NCT02844777|453599515|FG001|Overall Study|Withdrawal by Subject|0|||
126083518|NCT02844777|453599516|FG002|Overall Study|Withdrawal by Subject|0|||
126083519|NCT00150618|453599517|FG000|Overall Study|Adverse Event|2|||
126083520|NCT00150618|453599518|FG001|Overall Study|Adverse Event|2|||
126083521|NCT00150618|453599519|FG002|Overall Study|Adverse Event|6|||
126083522|NCT00150618|453599520|FG003|Overall Study|Adverse Event|9|||
126083523|NCT00150618|453599521|FG004|Overall Study|Adverse Event|5|||
126083524|NCT00150618|453599517|FG000|Overall Study|Withdrawal by Subject|6|||
126083525|NCT00150618|453599518|FG001|Overall Study|Withdrawal by Subject|8|||
126083526|NCT00150618|453599519|FG002|Overall Study|Withdrawal by Subject|8|||
126083527|NCT00150618|453599520|FG003|Overall Study|Withdrawal by Subject|4|||
126083528|NCT00150618|453599521|FG004|Overall Study|Withdrawal by Subject|5|||
126083529|NCT00150618|453599517|FG000|Overall Study|Lost to Follow-up|4|||
126083530|NCT00150618|453599518|FG001|Overall Study|Lost to Follow-up|1|||
126083531|NCT00150618|453599519|FG002|Overall Study|Lost to Follow-up|5|||
126083532|NCT00150618|453599520|FG003|Overall Study|Lost to Follow-up|8|||
126115617|NCT00705432|453718180|FG005|Treatment Period|Treatment failure|14|||
126115618|NCT00705432|453718175|FG000|Treatment Period|Non medical reason|26|||
126083533|NCT00150618|453599521|FG004|Overall Study|Lost to Follow-up|4|||
126115619|NCT00705432|453718176|FG001|Treatment Period|Non medical reason|32|||
126115620|NCT00705432|453718177|FG002|Treatment Period|Non medical reason|37|||
126115621|NCT00705432|453718178|FG003|Treatment Period|Non medical reason|4|||
126115622|NCT00705432|453718179|FG004|Treatment Period|Non medical reason|7|||
126115623|NCT00705432|453718180|FG005|Treatment Period|Non medical reason|7|||
126115624|NCT00705432|453718175|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
126115625|NCT00705432|453718176|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
126115626|NCT00705432|453718177|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
126115627|NCT00705432|453718178|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
126115628|NCT00705432|453718179|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
126115629|NCT00705432|453718180|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
126115630|NCT00705432|453718175|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
126115631|NCT00705432|453718176|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
126115632|NCT00705432|453718177|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
126115633|NCT00705432|453718178|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
126115634|NCT00705432|453718179|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
126115635|NCT00705432|453718180|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
126115636|NCT04411628|453718181|FG000|Overall Study|Withdrawal by Subject|1|||
126115637|NCT04411628|453718182|FG001|Overall Study|Withdrawal by Subject|1|||
126115638|NCT04411628|453718183|FG002|Overall Study|Withdrawal by Subject|2|||
126115639|NCT04411628|453718184|FG003|Overall Study|Withdrawal by Subject|0|||
126115640|NCT04411628|453718181|FG000|Overall Study|Lost to Follow-up|0|||
126115641|NCT04411628|453718182|FG001|Overall Study|Lost to Follow-up|1|||
126115642|NCT04411628|453718183|FG002|Overall Study|Lost to Follow-up|0|||
126115643|NCT04411628|453718184|FG003|Overall Study|Lost to Follow-up|0|||
126115644|NCT00521053|453718185|FG000|Observation Phase|Disease Progression|55|||
126115645|NCT00521053|453718185|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
126115646|NCT00521053|453718185|FG000|Observation Phase|Death|2|||
126115647|NCT00521053|453718185|FG000|Observation Phase|Adverse Event|1|||
126115648|NCT00521053|453718185|FG000|Observation Phase|Other non-study melanoma treatment|1|||
126115649|NCT00521053|453718185|FG000|Observation Phase|Physician Decision|1|||
126115650|NCT00732251|453718186|FG000|Overall Study|Lost to Follow-up|3|||
126115651|NCT00732251|453718186|FG000|Overall Study|Withdrawal by Subject|3|||
126115652|NCT00732251|453718186|FG000|Overall Study|Early Term due to Site Closure|1|||
126115653|NCT01034540|453718187|FG000|Overall Study|Adverse Event|0|||
126115654|NCT01034540|453718188|FG001|Overall Study|Adverse Event|1|||
126115655|NCT01252810|453718191|FG000|Overall Study|Withdrawal by Subject|4|||
126115656|NCT01252810|453718192|FG001|Overall Study|Withdrawal by Subject|1|||
126115657|NCT01252810|453718191|FG000|Overall Study|Lost to Follow-up|0|||
126115658|NCT01252810|453718192|FG001|Overall Study|Lost to Follow-up|1|||
126115659|NCT01252810|453718191|FG000|Overall Study|Physician Decision|2|||
126115660|NCT01252810|453718192|FG001|Overall Study|Physician Decision|1|||
126115661|NCT01252810|453718191|FG000|Overall Study|Various reasons|8|||
126115662|NCT01252810|453718192|FG001|Overall Study|Various reasons|0|||
126115663|NCT05162027|453719981|FG000|Overall Study|Adverse Event|1|||
126115664|NCT05162027|453719982|FG001|Overall Study|Adverse Event|0|||
126115665|NCT02767323|453719986|FG000|Overall Study|Withdrawal by Subject|17|||
126115666|NCT02767323|453719987|FG001|Overall Study|Withdrawal by Subject|5|||
126115667|NCT02767323|453719988|FG002|Overall Study|Withdrawal by Subject|13|||
126115668|NCT02767323|453719989|FG003|Overall Study|Withdrawal by Subject|0|||
126115669|NCT02767323|453719986|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
126115670|NCT02767323|453719987|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
126115671|NCT02767323|453719988|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
126115672|NCT02767323|453719989|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
125954017|NCT00207142|453128619|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
125954018|NCT01020019|453128620|FG000|Overall Study|Lost to Follow-up|21|||
125954019|NCT01020019|453128621|FG001|Overall Study|Lost to Follow-up|18|||
125954020|NCT01020019|453128620|FG000|Overall Study|Adverse Event|1|||
125954021|NCT01020019|453128621|FG001|Overall Study|Adverse Event|5|||
126115673|NCT01641237|453719991|FG000|Period II|Withdrawal by Subject|1|||
126115674|NCT01641237|453719992|FG001|Period II|Withdrawal by Subject|0|||
126115675|NCT01641237|453719993|FG002|Period II|Withdrawal by Subject|0|||
126115676|NCT01641237|453719994|FG003|Period II|Withdrawal by Subject|0|||
126115677|NCT01641237|453719991|FG000|Period III|Lost to Follow-up|1|||
126115678|NCT01641237|453719992|FG001|Period III|Lost to Follow-up|0|||
126115679|NCT01641237|453719993|FG002|Period III|Lost to Follow-up|0|||
126115680|NCT01641237|453719994|FG003|Period III|Lost to Follow-up|0|||
126115681|NCT03593850|453719999|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
126115682|NCT03593850|453720000|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
125954022|NCT01020019|453128620|FG000|Overall Study|not interested in treatment|4|||
125954023|NCT01020019|453128621|FG001|Overall Study|not interested in treatment|4|||
125954024|NCT01020019|453128620|FG000|Overall Study|moving|0|||
125954025|NCT01020019|453128621|FG001|Overall Study|moving|2|||
126083534|NCT00150618|453599517|FG000|Overall Study|Protocol Violation|1|||
126083535|NCT00150618|453599518|FG001|Overall Study|Protocol Violation|0|||
126083536|NCT00150618|453599519|FG002|Overall Study|Protocol Violation|0|||
126083537|NCT00150618|453599520|FG003|Overall Study|Protocol Violation|0|||
126083538|NCT00150618|453599521|FG004|Overall Study|Protocol Violation|1|||
126083539|NCT00150618|453599517|FG000|Overall Study|Lack of Efficacy|1|||
126083540|NCT00150618|453599518|FG001|Overall Study|Lack of Efficacy|4|||
126083541|NCT00150618|453599519|FG002|Overall Study|Lack of Efficacy|7|||
126083542|NCT00150618|453599520|FG003|Overall Study|Lack of Efficacy|4|||
126083543|NCT00150618|453599521|FG004|Overall Study|Lack of Efficacy|6|||
126083544|NCT00150618|453599517|FG000|Overall Study|No study meds|0|||
126083545|NCT00150618|453599518|FG001|Overall Study|No study meds|0|||
126083546|NCT00150618|453599519|FG002|Overall Study|No study meds|0|||
126083547|NCT00150618|453599520|FG003|Overall Study|No study meds|0|||
126083548|NCT00150618|453599521|FG004|Overall Study|No study meds|2|||
126083549|NCT00150618|453599517|FG000|Overall Study|Physician Decision|0|||
126083550|NCT00150618|453599518|FG001|Overall Study|Physician Decision|2|||
126083551|NCT00150618|453599519|FG002|Overall Study|Physician Decision|0|||
126083552|NCT00150618|453599520|FG003|Overall Study|Physician Decision|0|||
126083553|NCT00150618|453599521|FG004|Overall Study|Physician Decision|1|||
126083554|NCT00150618|453599517|FG000|Overall Study|Lack of compliance|2|||
126083555|NCT00150618|453599518|FG001|Overall Study|Lack of compliance|1|||
126083556|NCT00150618|453599519|FG002|Overall Study|Lack of compliance|1|||
126083557|NCT00150618|453599520|FG003|Overall Study|Lack of compliance|0|||
126083558|NCT00150618|453599521|FG004|Overall Study|Lack of compliance|1|||
126083559|NCT00150618|453599517|FG000|Overall Study|Abnormal ECG|1|||
126083560|NCT00150618|453599518|FG001|Overall Study|Abnormal ECG|0|||
126083561|NCT00150618|453599519|FG002|Overall Study|Abnormal ECG|0|||
126083562|NCT00150618|453599520|FG003|Overall Study|Abnormal ECG|0|||
126083563|NCT00150618|453599521|FG004|Overall Study|Abnormal ECG|0|||
126083564|NCT00150618|453599517|FG000|Overall Study|Sponsor's decision|0|||
126083565|NCT00150618|453599518|FG001|Overall Study|Sponsor's decision|0|||
126083566|NCT00150618|453599519|FG002|Overall Study|Sponsor's decision|0|||
126083567|NCT00150618|453599520|FG003|Overall Study|Sponsor's decision|1|||
126083568|NCT00150618|453599521|FG004|Overall Study|Sponsor's decision|0|||
126083569|NCT01012947|453599522|FG000|Overall Study|Lost to Follow-up|131|||
126083570|NCT01012947|453599523|FG001|Overall Study|Lost to Follow-up|135|||
126083571|NCT01012947|453599524|FG002|Overall Study|Lost to Follow-up|130|||
126083572|NCT01012947|453599525|FG003|Overall Study|Lost to Follow-up|118|||
126083573|NCT01012947|453599526|FG004|Overall Study|Lost to Follow-up|142|||
126083574|NCT01791413|453599527|FG000|Overall Study|Lost to Follow-up|5|||
126083575|NCT01791413|453599528|FG001|Overall Study|Lost to Follow-up|1|||
126083576|NCT00825305|453599529|FG000|Overall Study|Adverse Event|1|||
126083577|NCT00825305|453599530|FG001|Overall Study|Adverse Event|1|||
126083578|NCT00825305|453599529|FG000|Overall Study|Withdrawal by Subject|6|||
126083579|NCT00825305|453599530|FG001|Overall Study|Withdrawal by Subject|12|||
126083580|NCT00825305|453599529|FG000|Overall Study|Inappropriate inclusion|1|||
126083581|NCT00825305|453599530|FG001|Overall Study|Inappropriate inclusion|0|||
126083582|NCT00825305|453599529|FG000|Overall Study|Protocol Violation|9|||
126083583|NCT00825305|453599530|FG001|Overall Study|Protocol Violation|9|||
126083584|NCT00825305|453599529|FG000|Overall Study|Can not be classified|0|||
126083585|NCT00825305|453599530|FG001|Overall Study|Can not be classified|1|||
126083586|NCT04016272|453599531|FG000|Overall Study|Withdrawal by Subject|1|||
126083587|NCT04016272|453599532|FG001|Overall Study|Withdrawal by Subject|2|||
126083588|NCT02493946|453599535|FG000|DB Period|Withdrawal by Subject|8|||
126083589|NCT02493946|453599536|FG001|DB Period|Withdrawal by Subject|5|||
126083590|NCT02493946|453599537|FG002|DB Period|Withdrawal by Subject|0|||
126083591|NCT02493946|453599535|FG000|Open Label Period|Withdrawal by Subject|0|||
126083592|NCT02493946|453599536|FG001|Open Label Period|Withdrawal by Subject|0|||
126083593|NCT02493946|453599537|FG002|Open Label Period|Withdrawal by Subject|74|||
126083594|NCT02493946|453599535|FG000|Open Label Period|Adverse Event|0|||
126083595|NCT02493946|453599536|FG001|Open Label Period|Adverse Event|0|||
126083596|NCT02493946|453599537|FG002|Open Label Period|Adverse Event|4|||
126083597|NCT02493946|453599535|FG000|Open Label Period|Lost to Follow-up|0|||
126083598|NCT02493946|453599536|FG001|Open Label Period|Lost to Follow-up|0|||
126083599|NCT02493946|453599537|FG002|Open Label Period|Lost to Follow-up|1|||
126083600|NCT02493946|453599535|FG000|Open Label Period|Investigator decision, non-compliance|0|||
126083601|NCT02493946|453599536|FG001|Open Label Period|Investigator decision, non-compliance|0|||
126083602|NCT02493946|453599537|FG002|Open Label Period|Investigator decision, non-compliance|2|||
126083603|NCT02493946|453599535|FG000|Open Label Period|Investigator decision, non-availability|0|||
126083604|NCT02493946|453599536|FG001|Open Label Period|Investigator decision, non-availability|0|||
126083605|NCT02493946|453599537|FG002|Open Label Period|Investigator decision, non-availability|1|||
126083606|NCT02493946|453599535|FG000|Open Label Period|Pregnancy|0|||
126083607|NCT02493946|453599536|FG001|Open Label Period|Pregnancy|0|||
126083608|NCT02493946|453599537|FG002|Open Label Period|Pregnancy|3|||
126083609|NCT02493946|453599535|FG000|Open Label Period|Site error|0|||
126083610|NCT02493946|453599536|FG001|Open Label Period|Site error|0|||
126083611|NCT02493946|453599537|FG002|Open Label Period|Site error|1|||
126083612|NCT01727505|453599539|FG000|First 24 Hours|Adverse Event|0|||
126083613|NCT01727505|453599540|FG001|First 24 Hours|Adverse Event|1|||
126083614|NCT01727505|453599539|FG000|Second 24 Hours|Missing data|0|||
126083615|NCT01727505|453599540|FG001|Second 24 Hours|Missing data|1|||
126083616|NCT02878603|453599541|FG000|Overall Study|Lost to Follow-up|4|||
126083617|NCT02878603|453599542|FG001|Overall Study|Lost to Follow-up|1|||
126083618|NCT02878603|453599541|FG000|Overall Study|Withdrawal by Subject|1|||
126083619|NCT02878603|453599542|FG001|Overall Study|Withdrawal by Subject|1|||
126083620|NCT02878603|453599541|FG000|Overall Study|Death|1|||
126083621|NCT02878603|453599542|FG001|Overall Study|Death|0|||
126083622|NCT02878603|453599541|FG000|Overall Study|Physician Decision|0|||
126083623|NCT02878603|453599542|FG001|Overall Study|Physician Decision|3|||
126083624|NCT03327831|453599543|FG000|Overall Study|Lost to Follow-up|2|||
126083625|NCT02498236|453599549|FG000|Overall Study|Did not show for testing|1|||
126083626|NCT02498236|453599550|FG001|Overall Study|Did not show for testing|0|||
126083627|NCT02498236|453599551|FG002|Overall Study|Did not show for testing|0|||
126083628|NCT02498236|453599552|FG003|Overall Study|Did not show for testing|0|||
126083629|NCT02498236|453599553|FG004|Overall Study|Did not show for testing|0|||
126083630|NCT02498236|453599554|FG005|Overall Study|Did not show for testing|0|||
126083631|NCT02498236|453599555|FG006|Overall Study|Did not show for testing|0|||
126083632|NCT02498236|453599556|FG007|Overall Study|Did not show for testing|1|||
126083633|NCT02498236|453599549|FG000|Overall Study|Equipment failure|0|||
126083634|NCT02498236|453599550|FG001|Overall Study|Equipment failure|0|||
126083635|NCT02498236|453599551|FG002|Overall Study|Equipment failure|0|||
126083636|NCT02498236|453599552|FG003|Overall Study|Equipment failure|0|||
126083637|NCT02498236|453599553|FG004|Overall Study|Equipment failure|0|||
126083638|NCT02498236|453599554|FG005|Overall Study|Equipment failure|0|||
126083639|NCT02498236|453599555|FG006|Overall Study|Equipment failure|1|||
126083640|NCT02498236|453599556|FG007|Overall Study|Equipment failure|0|||
126083641|NCT02498236|453599549|FG000|Overall Study|Withdrawal by Subject|0|||
126083642|NCT02498236|453599550|FG001|Overall Study|Withdrawal by Subject|0|||
126083643|NCT02498236|453599551|FG002|Overall Study|Withdrawal by Subject|0|||
126083644|NCT02498236|453599552|FG003|Overall Study|Withdrawal by Subject|0|||
126083645|NCT02498236|453599553|FG004|Overall Study|Withdrawal by Subject|1|||
126083646|NCT02498236|453599554|FG005|Overall Study|Withdrawal by Subject|0|||
126083647|NCT02498236|453599555|FG006|Overall Study|Withdrawal by Subject|0|||
126083648|NCT02498236|453599556|FG007|Overall Study|Withdrawal by Subject|0|||
126083649|NCT00383123|453599557|FG000|Overall Study|Adverse Event|1|||
126083650|NCT00383123|453599558|FG001|Overall Study|Adverse Event|0|||
126083651|NCT00383123|453599557|FG000|Overall Study|Lost to Follow-up|68|||
126083652|NCT00383123|453599558|FG001|Overall Study|Lost to Follow-up|61|||
126083653|NCT00383123|453599557|FG000|Overall Study|Protocol Violation|5|||
126083654|NCT00383123|453599558|FG001|Overall Study|Protocol Violation|1|||
126083655|NCT00383123|453599557|FG000|Overall Study|Withdrawal by Subject|27|||
126083656|NCT00383123|453599558|FG001|Overall Study|Withdrawal by Subject|18|||
126083657|NCT00383123|453599557|FG000|Overall Study|Other reason|10|||
126083658|NCT00383123|453599558|FG001|Overall Study|Other reason|6|||
126083659|NCT01814072|453599559|FG000|Overall Study|Lost to Follow-up|2|||
126083660|NCT01814072|453599560|FG001|Overall Study|Lost to Follow-up|2|||
126083661|NCT01814072|453599561|FG002|Overall Study|Lost to Follow-up|2|||
126083662|NCT01814072|453599562|FG003|Overall Study|Lost to Follow-up|0|||
126083663|NCT01814072|453599563|FG004|Overall Study|Lost to Follow-up|2|||
126083664|NCT01814072|453599564|FG005|Overall Study|Lost to Follow-up|3|||
126083665|NCT01814072|453599565|FG006|Overall Study|Lost to Follow-up|3|||
126083666|NCT01814072|453599566|FG007|Overall Study|Lost to Follow-up|1|||
126083667|NCT01814072|453599567|FG008|Overall Study|Lost to Follow-up|2|||
126083668|NCT01814072|453599568|FG009|Overall Study|Lost to Follow-up|3|||
126083669|NCT01814072|453599569|FG010|Overall Study|Lost to Follow-up|1|||
126083670|NCT01814072|453599570|FG011|Overall Study|Lost to Follow-up|2|||
126083671|NCT01814072|453599571|FG012|Overall Study|Lost to Follow-up|2|||
126083672|NCT01814072|453599572|FG013|Overall Study|Lost to Follow-up|1|||
126083673|NCT01814072|453599573|FG014|Overall Study|Lost to Follow-up|2|||
126115683|NCT01735279|453720001|FG000|Overall Study|Lost to Follow-up|11|||
126115684|NCT01735279|453720002|FG001|Overall Study|Lost to Follow-up|8|||
126115685|NCT01195090|453720008|FG000|Overall Study|Adverse Event|1|||
126115686|NCT01195090|453720009|FG001|Overall Study|Adverse Event|2|||
126083674|NCT01814072|453599574|FG015|Overall Study|Lost to Follow-up|1|||
126083675|NCT01814072|453599575|FG016|Overall Study|Lost to Follow-up|3|||
126083676|NCT01814072|453599576|FG017|Overall Study|Lost to Follow-up|1|||
126083677|NCT01814072|453599577|FG018|Overall Study|Lost to Follow-up|3|||
126083678|NCT01814072|453599578|FG019|Overall Study|Lost to Follow-up|3|||
126083679|NCT01814072|453599579|FG020|Overall Study|Lost to Follow-up|2|||
126083680|NCT01814072|453599580|FG021|Overall Study|Lost to Follow-up|1|||
126083681|NCT01814072|453599581|FG022|Overall Study|Lost to Follow-up|3|||
126083682|NCT01814072|453599582|FG023|Overall Study|Lost to Follow-up|1|||
126083683|NCT01814072|453599583|FG024|Overall Study|Lost to Follow-up|4|||
126083684|NCT01814072|453599584|FG025|Overall Study|Lost to Follow-up|1|||
126083685|NCT01814072|453599585|FG026|Overall Study|Lost to Follow-up|1|||
126083686|NCT01814072|453599586|FG027|Overall Study|Lost to Follow-up|2|||
126083687|NCT01814072|453599587|FG028|Overall Study|Lost to Follow-up|3|||
126115687|NCT01195090|453720008|FG000|Overall Study|Lost to Follow-up|2|||
125954026|NCT05091528|453128622|FG000|Overall Study|Study Termination by Sponsor|0|||
125954027|NCT05091528|453128623|FG001|Overall Study|Study Termination by Sponsor|1|||
125954028|NCT05091528|453128624|FG002|Overall Study|Study Termination by Sponsor|0|||
125954029|NCT05091528|453128625|FG003|Overall Study|Study Termination by Sponsor|1|||
125954030|NCT04958109|453128626|FG000|Overall Study|Withdrawal by Subject|0|||
125954031|NCT04958109|453128627|FG001|Overall Study|Withdrawal by Subject|1|||
125954032|NCT04958109|453128626|FG000|Overall Study|Lost to Follow-up|0|||
125954033|NCT04958109|453128627|FG001|Overall Study|Lost to Follow-up|1|||
125954034|NCT01573624|453128631|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125954035|NCT01573624|453128632|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125954036|NCT01573624|453128633|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
125954037|NCT01573624|453128634|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125954038|NCT01573624|453128635|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125954039|NCT01573624|453128636|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
125954040|NCT01573624|453128637|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125954041|NCT01573624|453128631|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
125954042|NCT01573624|453128632|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
125954043|NCT01573624|453128633|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
125954044|NCT01573624|453128634|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
125954045|NCT01573624|453128635|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
125954046|NCT01573624|453128636|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125954047|NCT01573624|453128637|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
125954048|NCT01573624|453128631|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
125954049|NCT01573624|453128632|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125954050|NCT01573624|453128633|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125954051|NCT01573624|453128634|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125954052|NCT01573624|453128635|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125954053|NCT01573624|453128636|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125954054|NCT01573624|453128637|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125954055|NCT01573624|453128631|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125954056|NCT01573624|453128632|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125954057|NCT01573624|453128633|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125954058|NCT01573624|453128634|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125954059|NCT01573624|453128635|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125954060|NCT01573624|453128636|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
125954061|NCT01573624|453128637|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125954062|NCT01573624|453128631|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
125954063|NCT01573624|453128632|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
125954064|NCT01573624|453128633|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
125954065|NCT01573624|453128634|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
125954066|NCT01573624|453128635|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
125954067|NCT01573624|453128636|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
125954068|NCT01573624|453128637|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
125954069|NCT01573624|453128631|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125954070|NCT01573624|453128632|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125954071|NCT01573624|453128633|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125954072|NCT01573624|453128634|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125954073|NCT01573624|453128635|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125954074|NCT01573624|453128636|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
125954075|NCT01573624|453128637|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125954076|NCT01573624|453128631|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
125954077|NCT01573624|453128632|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
125954078|NCT01573624|453128633|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
125954079|NCT01573624|453128634|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
125954080|NCT01573624|453128635|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
125954081|NCT01573624|453128636|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
125954082|NCT01573624|453128637|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
125954083|NCT01573624|453128631|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
125954084|NCT01573624|453128632|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125954085|NCT01573624|453128633|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
125954086|NCT01573624|453128634|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
125954087|NCT01573624|453128635|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125954088|NCT01573624|453128636|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125954089|NCT01573624|453128637|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126083688|NCT01814072|453599588|FG029|Overall Study|Lost to Follow-up|3|||
126083689|NCT01814072|453599589|FG030|Overall Study|Lost to Follow-up|2|||
126083690|NCT01814072|453599590|FG031|Overall Study|Lost to Follow-up|0|||
126083691|NCT01814072|453599559|FG000|Overall Study|Withdrawal by Subject|2|||
126083692|NCT01814072|453599560|FG001|Overall Study|Withdrawal by Subject|0|||
126083693|NCT01814072|453599561|FG002|Overall Study|Withdrawal by Subject|1|||
126083694|NCT01814072|453599562|FG003|Overall Study|Withdrawal by Subject|0|||
126083695|NCT01814072|453599563|FG004|Overall Study|Withdrawal by Subject|2|||
126083696|NCT01814072|453599564|FG005|Overall Study|Withdrawal by Subject|3|||
126083697|NCT01814072|453599565|FG006|Overall Study|Withdrawal by Subject|1|||
126083698|NCT01814072|453599566|FG007|Overall Study|Withdrawal by Subject|0|||
126083699|NCT01814072|453599567|FG008|Overall Study|Withdrawal by Subject|1|||
126083700|NCT01814072|453599568|FG009|Overall Study|Withdrawal by Subject|2|||
126083701|NCT01814072|453599569|FG010|Overall Study|Withdrawal by Subject|0|||
126083702|NCT01814072|453599570|FG011|Overall Study|Withdrawal by Subject|0|||
126083703|NCT01814072|453599571|FG012|Overall Study|Withdrawal by Subject|1|||
126083704|NCT01814072|453599572|FG013|Overall Study|Withdrawal by Subject|1|||
126083705|NCT01814072|453599573|FG014|Overall Study|Withdrawal by Subject|1|||
126083706|NCT01814072|453599574|FG015|Overall Study|Withdrawal by Subject|1|||
126083707|NCT01814072|453599575|FG016|Overall Study|Withdrawal by Subject|0|||
126083708|NCT01814072|453599576|FG017|Overall Study|Withdrawal by Subject|0|||
126083709|NCT01814072|453599577|FG018|Overall Study|Withdrawal by Subject|0|||
126083710|NCT01814072|453599578|FG019|Overall Study|Withdrawal by Subject|2|||
126083711|NCT01814072|453599579|FG020|Overall Study|Withdrawal by Subject|0|||
126083712|NCT01814072|453599580|FG021|Overall Study|Withdrawal by Subject|0|||
126083713|NCT01814072|453599581|FG022|Overall Study|Withdrawal by Subject|1|||
126083714|NCT01814072|453599582|FG023|Overall Study|Withdrawal by Subject|0|||
126083715|NCT01814072|453599583|FG024|Overall Study|Withdrawal by Subject|2|||
126083716|NCT01814072|453599584|FG025|Overall Study|Withdrawal by Subject|1|||
126083717|NCT01814072|453599585|FG026|Overall Study|Withdrawal by Subject|1|||
126083718|NCT01814072|453599586|FG027|Overall Study|Withdrawal by Subject|2|||
126083719|NCT01814072|453599587|FG028|Overall Study|Withdrawal by Subject|1|||
126083720|NCT01814072|453599588|FG029|Overall Study|Withdrawal by Subject|0|||
126083721|NCT01814072|453599589|FG030|Overall Study|Withdrawal by Subject|0|||
126083722|NCT01814072|453599590|FG031|Overall Study|Withdrawal by Subject|0|||
126083723|NCT02336425|453599591|FG000|Overall Study|Study terminated.|2|||
126083724|NCT02336425|453599592|FG001|Overall Study|Study terminated.|2|||
126083725|NCT02336425|453599593|FG002|Overall Study|Study terminated.|3|||
126083726|NCT02336425|453599594|FG003|Overall Study|Study terminated.|3|||
126083727|NCT00978562|453599595|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
126083728|NCT01782690|453599596|FG000|Overall Study|Not reported|7|||
126083729|NCT01782690|453599596|FG000|Overall Study|Toxicity of gemcitabine|1|||
126083730|NCT01782690|453599596|FG000|Overall Study|Toxicity of erlotinib|1|||
126083731|NCT01782690|453599596|FG000|Overall Study|Lost to Follow-up|31|||
126083732|NCT01782690|453599596|FG000|Overall Study|Withdrawal of informed consent|2|||
126083733|NCT01782690|453599596|FG000|Overall Study|Absent rash|9|||
126083734|NCT01782690|453599596|FG000|Overall Study|Physician Decision|13|||
126083735|NCT01782690|453599596|FG000|Overall Study|Patient's wish|21|||
126083736|NCT01782690|453599596|FG000|Overall Study|Tumor progression|74|||
126083737|NCT01782690|453599596|FG000|Overall Study|Death|133|||
126083738|NCT01782690|453599596|FG000|Overall Study|Study completion unknown|7|||
126083739|NCT04946942|453599598|FG000|Overall Study|Lost to Follow-up|6|||
126083740|NCT04946942|453599599|FG001|Overall Study|Lost to Follow-up|2|||
126083741|NCT04946942|453599600|FG002|Overall Study|Lost to Follow-up|0|||
126083742|NCT04907357|453599601|FG000|Overall Study|Death|0|||
126083743|NCT04907357|453599602|FG001|Overall Study|Death|1|||
126083744|NCT04907357|453599601|FG000|Overall Study|Lost to Follow-up|9|||
126083745|NCT04907357|453599602|FG001|Overall Study|Lost to Follow-up|18|||
126083746|NCT04907357|453599601|FG000|Overall Study|Physician Decision|1|||
126083747|NCT04907357|453599602|FG001|Overall Study|Physician Decision|0|||
126115688|NCT01195090|453720009|FG001|Overall Study|Lost to Follow-up|2|||
126115689|NCT01195090|453720008|FG000|Overall Study|Protocol Violation|3|||
126115690|NCT01195090|453720009|FG001|Overall Study|Protocol Violation|4|||
126115691|NCT05111041|453720010|FG000|Overall Study|Lost to Follow-up|6|||
126115692|NCT05111041|453720011|FG001|Overall Study|Lost to Follow-up|7|||
126115693|NCT05111041|453720010|FG000|Overall Study|Withdrawal by Subject|1|||
126115694|NCT05111041|453720011|FG001|Overall Study|Withdrawal by Subject|0|||
126083748|NCT04907357|453599601|FG000|Overall Study|Withdrawal by Subject|0|||
126083749|NCT04907357|453599602|FG001|Overall Study|Withdrawal by Subject|1|||
126083750|NCT04907357|453599601|FG000|Overall Study|Unable to attend visits|1|||
126083751|NCT04907357|453599602|FG001|Overall Study|Unable to attend visits|0|||
126083752|NCT04907357|453599601|FG000|Overall Study|Incarcerated|1|||
126083753|NCT04907357|453599602|FG001|Overall Study|Incarcerated|1|||
126083754|NCT01948076|453599603|FG000|Overall Study|Withdrawal by Subject|0|||
126083755|NCT01948076|453599604|FG001|Overall Study|Withdrawal by Subject|1|||
126083756|NCT00344032|453599613|FG000|Overall Study|Adverse Event|0|||
126083757|NCT00344032|453599614|FG001|Overall Study|Adverse Event|1|||
126083758|NCT00344032|453599613|FG000|Overall Study|Withdrawal by Subject|6|||
126083759|NCT00344032|453599614|FG001|Overall Study|Withdrawal by Subject|2|||
126083760|NCT00344032|453599613|FG000|Overall Study|Lost to Follow-up|4|||
126083761|NCT00344032|453599614|FG001|Overall Study|Lost to Follow-up|6|||
126083762|NCT00344032|453599613|FG000|Overall Study|Physician Decision|4|||
126083763|NCT00344032|453599614|FG001|Overall Study|Physician Decision|1|||
126083764|NCT02065882|453599615|FG000|Part I: PK/PD|Screening failure|5|||
126083765|NCT02065882|453599615|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
126083766|NCT02065882|453599615|FG000|Part I: PK/PD|Adverse Event|1|||
126083767|NCT02065882|453599615|FG000|Part II: Clinical Efficacy|Screening failure|7|||
126083768|NCT02065882|453599615|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
126083769|NCT02065882|453599615|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
126083770|NCT02065882|453599615|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
126083771|NCT02065882|453599615|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
126083772|NCT02065882|453599615|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
126083773|NCT03192462|453602009|FG000|Overall Study|Death|13|||
126083774|NCT03192462|453602010|FG001|Overall Study|Death|11|||
126083775|NCT03192462|453602011|FG002|Overall Study|Death|9|||
126083776|NCT03192462|453602009|FG000|Overall Study|Lost to Follow-up|0|||
126083777|NCT03192462|453602010|FG001|Overall Study|Lost to Follow-up|1|||
126083778|NCT03192462|453602011|FG002|Overall Study|Lost to Follow-up|0|||
126083779|NCT03192462|453602009|FG000|Overall Study|On follow up|0|||
126083780|NCT03192462|453602010|FG001|Overall Study|On follow up|0|||
126083781|NCT03192462|453602011|FG002|Overall Study|On follow up|3|||
126083782|NCT02419417|453602012|FG000|Overall Study|Disease progression|5|||
126083783|NCT02419417|453602013|FG001|Overall Study|Disease progression|4|||
126083784|NCT02419417|453602014|FG002|Overall Study|Disease progression|13|||
125954090|NCT01573624|453128631|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125954091|NCT01573624|453128632|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125954092|NCT01573624|453128633|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125954093|NCT01573624|453128634|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125954094|NCT01573624|453128635|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125954095|NCT01573624|453128636|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
125954096|NCT01573624|453128637|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125954097|NCT01573624|453128631|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125954098|NCT01573624|453128632|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125954099|NCT01573624|453128633|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125954100|NCT01573624|453128634|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
125954101|NCT01573624|453128635|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126083785|NCT02419417|453602015|FG003|Overall Study|Disease progression|10|||
126083786|NCT02419417|453602016|FG004|Overall Study|Disease progression|10|||
126083787|NCT02419417|453602017|FG005|Overall Study|Disease progression|3|||
126083788|NCT02419417|453602018|FG006|Overall Study|Disease progression|4|||
126083789|NCT02419417|453602019|FG007|Overall Study|Disease progression|5|||
126083790|NCT02419417|453602020|FG008|Overall Study|Disease progression|13|||
126083791|NCT02419417|453602021|FG009|Overall Study|Disease progression|9|||
126083792|NCT02419417|453602022|FG010|Overall Study|Disease progression|0|||
126083793|NCT02419417|453602012|FG000|Overall Study|Study drug toxicity|0|||
126083794|NCT02419417|453602013|FG001|Overall Study|Study drug toxicity|0|||
126083795|NCT02419417|453602014|FG002|Overall Study|Study drug toxicity|0|||
126083796|NCT02419417|453602015|FG003|Overall Study|Study drug toxicity|0|||
126083797|NCT02419417|453602016|FG004|Overall Study|Study drug toxicity|1|||
126083798|NCT02419417|453602017|FG005|Overall Study|Study drug toxicity|0|||
126083799|NCT02419417|453602018|FG006|Overall Study|Study drug toxicity|0|||
126083800|NCT02419417|453602019|FG007|Overall Study|Study drug toxicity|0|||
126083801|NCT02419417|453602020|FG008|Overall Study|Study drug toxicity|0|||
126083802|NCT02419417|453602021|FG009|Overall Study|Study drug toxicity|0|||
126083803|NCT02419417|453602022|FG010|Overall Study|Study drug toxicity|0|||
126083804|NCT02419417|453602012|FG000|Overall Study|Adverse event unrelated to study drug|0|||
126083805|NCT02419417|453602013|FG001|Overall Study|Adverse event unrelated to study drug|0|||
125954102|NCT01573624|453128636|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126083806|NCT02419417|453602014|FG002|Overall Study|Adverse event unrelated to study drug|0|||
126083807|NCT02419417|453602015|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126083808|NCT02419417|453602016|FG004|Overall Study|Adverse event unrelated to study drug|2|||
126083809|NCT02419417|453602017|FG005|Overall Study|Adverse event unrelated to study drug|1|||
126083810|NCT02419417|453602018|FG006|Overall Study|Adverse event unrelated to study drug|0|||
126083811|NCT02419417|453602019|FG007|Overall Study|Adverse event unrelated to study drug|1|||
126083812|NCT02419417|453602020|FG008|Overall Study|Adverse event unrelated to study drug|0|||
126083813|NCT02419417|453602021|FG009|Overall Study|Adverse event unrelated to study drug|0|||
126083814|NCT02419417|453602022|FG010|Overall Study|Adverse event unrelated to study drug|0|||
126083815|NCT02419417|453602012|FG000|Overall Study|Participant request to discontinue|0|||
126083816|NCT02419417|453602013|FG001|Overall Study|Participant request to discontinue|0|||
126083817|NCT02419417|453602014|FG002|Overall Study|Participant request to discontinue|0|||
126083818|NCT02419417|453602015|FG003|Overall Study|Participant request to discontinue|0|||
126083819|NCT02419417|453602016|FG004|Overall Study|Participant request to discontinue|0|||
126083820|NCT02419417|453602017|FG005|Overall Study|Participant request to discontinue|0|||
126083821|NCT02419417|453602018|FG006|Overall Study|Participant request to discontinue|0|||
126083822|NCT02419417|453602019|FG007|Overall Study|Participant request to discontinue|0|||
126083823|NCT02419417|453602020|FG008|Overall Study|Participant request to discontinue|0|||
126083824|NCT02419417|453602021|FG009|Overall Study|Participant request to discontinue|1|||
126083825|NCT02419417|453602022|FG010|Overall Study|Participant request to discontinue|0|||
126083826|NCT02419417|453602012|FG000|Overall Study|Withdrawal by Subject|0|||
126083827|NCT02419417|453602013|FG001|Overall Study|Withdrawal by Subject|0|||
126083828|NCT02419417|453602014|FG002|Overall Study|Withdrawal by Subject|0|||
126083829|NCT02419417|453602015|FG003|Overall Study|Withdrawal by Subject|0|||
126083830|NCT02419417|453602016|FG004|Overall Study|Withdrawal by Subject|0|||
126083831|NCT02419417|453602017|FG005|Overall Study|Withdrawal by Subject|0|||
126083832|NCT02419417|453602018|FG006|Overall Study|Withdrawal by Subject|0|||
126083833|NCT02419417|453602019|FG007|Overall Study|Withdrawal by Subject|0|||
126083834|NCT02419417|453602020|FG008|Overall Study|Withdrawal by Subject|0|||
126083835|NCT02419417|453602021|FG009|Overall Study|Withdrawal by Subject|0|||
126083836|NCT02419417|453602022|FG010|Overall Study|Withdrawal by Subject|1|||
126083837|NCT00078377|453602023|FG000|Overall Study|Adverse Event|2|||
126083838|NCT00078377|453602024|FG001|Overall Study|Adverse Event|5|||
126083839|NCT00078377|453602025|FG002|Overall Study|Adverse Event|1|||
126083840|NCT00078377|453602023|FG000|Overall Study|Lack of Efficacy|2|||
126083841|NCT00078377|453602024|FG001|Overall Study|Lack of Efficacy|0|||
126083842|NCT00078377|453602025|FG002|Overall Study|Lack of Efficacy|2|||
126083843|NCT00078377|453602023|FG000|Overall Study|Lost to Follow-up|0|||
126083844|NCT00078377|453602024|FG001|Overall Study|Lost to Follow-up|1|||
126083845|NCT00078377|453602025|FG002|Overall Study|Lost to Follow-up|1|||
126083846|NCT00078377|453602023|FG000|Overall Study|Physician Decision|2|||
126083847|NCT00078377|453602024|FG001|Overall Study|Physician Decision|0|||
126083848|NCT00078377|453602025|FG002|Overall Study|Physician Decision|0|||
126083849|NCT00078377|453602023|FG000|Overall Study|Withdrawal by Subject|3|||
126083850|NCT00078377|453602024|FG001|Overall Study|Withdrawal by Subject|4|||
126083851|NCT00078377|453602025|FG002|Overall Study|Withdrawal by Subject|4|||
126083852|NCT00078377|453602023|FG000|Overall Study|Miscellaneous|2|||
126083853|NCT00078377|453602024|FG001|Overall Study|Miscellaneous|6|||
126083854|NCT00078377|453602025|FG002|Overall Study|Miscellaneous|1|||
126083855|NCT00581893|453602026|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
126083856|NCT00581893|453602027|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
126083857|NCT00233480|453602028|FG000|Overall Study|Underwent status II heart transplant|0|||
126083858|NCT00233480|453602029|FG001|Overall Study|Underwent status II heart transplant|1|||
126083859|NCT00790400|453602032|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
126083860|NCT00790400|453602033|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
126083861|NCT00790400|453602032|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
126083862|NCT00790400|453602033|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
126083863|NCT00790400|453602032|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
126083864|NCT00790400|453602033|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
126083865|NCT00790400|453602032|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
126083866|NCT00790400|453602033|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
126083867|NCT00790400|453602032|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
126083868|NCT00790400|453602033|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
126083869|NCT00790400|453602032|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
126083870|NCT00790400|453602033|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
126083871|NCT00790400|453602032|FG000|Double-blind Period (Core Phase)|Death|1|||
126083872|NCT00790400|453602033|FG001|Double-blind Period (Core Phase)|Death|0|||
126083873|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
126083874|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
126083875|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
126083876|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
126083877|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
126083878|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
126083879|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
126083880|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
126083881|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
126083882|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
126083883|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|Death|1|||
126083884|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|Death|0|||
126083885|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
126083886|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
126083887|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
126083888|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
126083889|NCT00790400|453602032|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
126083890|NCT00790400|453602033|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
126083891|NCT00944229|453602036|FG000|Overall Study|Withdrawal by Subject|11|||
126083892|NCT00944229|453602036|FG000|Overall Study|Physician Decision|14|||
126083893|NCT04292470|453602037|FG000|Overall Study|Withdrawal by Subject|0|||
126083894|NCT04292470|453602038|FG001|Overall Study|Withdrawal by Subject|1|||
126083895|NCT02906020|453602039|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
126083896|NCT02906020|453602040|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
126083897|NCT02906020|453602041|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
126083898|NCT02906020|453602042|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
126083899|NCT02906020|453602043|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
126083900|NCT02906020|453602044|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
126083901|NCT02906020|453602045|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
126083902|NCT02906020|453602046|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
126083903|NCT02906020|453602047|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
126083904|NCT02906020|453602048|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
126083905|NCT02906020|453602049|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
126083906|NCT02906020|453602050|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
126083907|NCT02906020|453602051|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
126083908|NCT02906020|453602052|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
126083909|NCT02906020|453602053|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
126083910|NCT02906020|453602054|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
126083911|NCT02906020|453602039|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083912|NCT02906020|453602040|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083913|NCT02906020|453602041|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083914|NCT02906020|453602042|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083915|NCT02906020|453602043|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083916|NCT02906020|453602044|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083917|NCT02906020|453602045|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083918|NCT02906020|453602046|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083919|NCT02906020|453602047|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
126083920|NCT02906020|453602048|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
126083921|NCT02906020|453602049|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083922|NCT02906020|453602050|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083923|NCT02906020|453602051|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083924|NCT02906020|453602052|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083925|NCT02906020|453602053|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083926|NCT02906020|453602054|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126083927|NCT02906020|453602039|FG000|Part 2: Double-blind Treatment Period|Other|0|||
126083928|NCT02906020|453602040|FG001|Part 2: Double-blind Treatment Period|Other|0|||
126083929|NCT02906020|453602041|FG002|Part 2: Double-blind Treatment Period|Other|0|||
126083930|NCT02906020|453602042|FG003|Part 2: Double-blind Treatment Period|Other|0|||
126083931|NCT02906020|453602043|FG004|Part 2: Double-blind Treatment Period|Other|0|||
126083932|NCT02906020|453602044|FG005|Part 2: Double-blind Treatment Period|Other|0|||
126083933|NCT02906020|453602045|FG006|Part 2: Double-blind Treatment Period|Other|0|||
126083934|NCT02906020|453602046|FG007|Part 2: Double-blind Treatment Period|Other|0|||
126083935|NCT02906020|453602047|FG008|Part 2: Double-blind Treatment Period|Other|6|||
126083936|NCT02906020|453602048|FG009|Part 2: Double-blind Treatment Period|Other|10|||
126083937|NCT02906020|453602049|FG010|Part 2: Double-blind Treatment Period|Other|0|||
126083938|NCT02906020|453602050|FG011|Part 2: Double-blind Treatment Period|Other|0|||
126083939|NCT02906020|453602051|FG012|Part 2: Double-blind Treatment Period|Other|0|||
126083940|NCT02906020|453602052|FG013|Part 2: Double-blind Treatment Period|Other|0|||
126083941|NCT02906020|453602053|FG014|Part 2: Double-blind Treatment Period|Other|0|||
126083942|NCT02906020|453602054|FG015|Part 2: Double-blind Treatment Period|Other|0|||
126083943|NCT02906020|453602039|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083944|NCT02906020|453602040|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083945|NCT02906020|453602041|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083946|NCT02906020|453602042|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126115695|NCT01205230|453720012|FG000|Overall Study|Adverse Event|4|||
126115696|NCT01205230|453720013|FG001|Overall Study|Adverse Event|0|||
126115697|NCT01205230|453720012|FG000|Overall Study|Physician Decision|1|||
126115698|NCT01205230|453720013|FG001|Overall Study|Physician Decision|0|||
126115699|NCT00791258|453720014|FG000|Overall Study|Adverse Event|87|||
126083947|NCT02906020|453602043|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083948|NCT02906020|453602044|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083949|NCT02906020|453602045|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083950|NCT02906020|453602046|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083951|NCT02906020|453602047|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126115700|NCT00791258|453720014|FG000|Overall Study|Lost to Follow-up|18|||
126115701|NCT00791258|453720014|FG000|Overall Study|Protocol Violation|109|||
126115702|NCT00791258|453720014|FG000|Overall Study|Withdrawal by Subject|40|||
126115703|NCT00791258|453720014|FG000|Overall Study|Did not take medication for >3 days|1|||
126115704|NCT00791258|453720014|FG000|Overall Study|subject left area|2|||
126115705|NCT00791258|453720014|FG000|Overall Study|non-compliance|3|||
126115706|NCT00791258|453720014|FG000|Overall Study|Subject incarcerated|1|||
126115707|NCT00791258|453720014|FG000|Overall Study|Subject required restricted medication|1|||
126115708|NCT00791258|453720014|FG000|Overall Study|Lack of Efficacy|1|||
126115709|NCT00922480|453720015|FG000|Main Study|Protocol Violation|3|||
126115710|NCT00922480|453720016|FG001|Main Study|Protocol Violation|6|||
126115711|NCT00922480|453720015|FG000|Main Study|Adverse Event|6|||
126115712|NCT00922480|453720016|FG001|Main Study|Adverse Event|7|||
126115713|NCT00922480|453720015|FG000|Main Study|Lack of Efficacy|3|||
126115714|NCT00922480|453720016|FG001|Main Study|Lack of Efficacy|0|||
126115715|NCT00922480|453720015|FG000|Main Study|Withdrawal by Subject|20|||
126115716|NCT00922480|453720016|FG001|Main Study|Withdrawal by Subject|15|||
126115717|NCT00922480|453720015|FG000|Main Study|Lost to Follow-up|5|||
126115718|NCT00922480|453720016|FG001|Main Study|Lost to Follow-up|0|||
126115719|NCT00922480|453720015|FG000|Main Study|Physician Decision|0|||
126115720|NCT00922480|453720016|FG001|Main Study|Physician Decision|1|||
126115721|NCT00922480|453720015|FG000|Extension Study|Protocol Violation|3|||
126115722|NCT00922480|453720016|FG001|Extension Study|Protocol Violation|0|||
126115723|NCT00922480|453720015|FG000|Extension Study|Adverse Event|1|||
126115724|NCT00922480|453720016|FG001|Extension Study|Adverse Event|1|||
126115725|NCT00922480|453720015|FG000|Extension Study|Withdrawal by Subject|1|||
126115726|NCT00922480|453720016|FG001|Extension Study|Withdrawal by Subject|1|||
126115727|NCT00922480|453720015|FG000|Extension Study|Others|0|||
126115728|NCT00922480|453720016|FG001|Extension Study|Others|1|||
126115729|NCT04784897|453720017|FG000|Overall Study|Death|4|||
126115730|NCT04784897|453720018|FG001|Overall Study|Death|2|||
126115731|NCT04784897|453720019|FG002|Overall Study|Death|1|||
126115732|NCT04784897|453720017|FG000|Overall Study|Withdrawal by Subject|0|||
126115733|NCT04784897|453720018|FG001|Overall Study|Withdrawal by Subject|0|||
126115734|NCT04784897|453720019|FG002|Overall Study|Withdrawal by Subject|1|||
126115735|NCT04667377|453720020|FG000|Dose Escalation Period|Other not specified below|3|||
126115736|NCT04667377|453720021|FG001|Dose Escalation Period|Other not specified below|3|||
126115737|NCT04667377|453720022|FG002|Dose Escalation Period|Other not specified below|2|||
126115738|NCT04667377|453720023|FG003|Dose Escalation Period|Other not specified below|1|||
126115739|NCT04667377|453720024|FG004|Dose Escalation Period|Other not specified below|3|||
126115740|NCT04667377|453720020|FG000|Dose Escalation Period|Protocol Violation|2|||
126115741|NCT04667377|453720021|FG001|Dose Escalation Period|Protocol Violation|2|||
126115742|NCT04667377|453720022|FG002|Dose Escalation Period|Protocol Violation|0|||
126115743|NCT04667377|453720023|FG003|Dose Escalation Period|Protocol Violation|2|||
126115744|NCT04667377|453720024|FG004|Dose Escalation Period|Protocol Violation|1|||
126115745|NCT04667377|453720020|FG000|Dose Escalation Period|Burden of study procedures|2|||
126115746|NCT04667377|453720021|FG001|Dose Escalation Period|Burden of study procedures|1|||
126115747|NCT04667377|453720022|FG002|Dose Escalation Period|Burden of study procedures|1|||
126115748|NCT04667377|453720023|FG003|Dose Escalation Period|Burden of study procedures|1|||
126115749|NCT04667377|453720024|FG004|Dose Escalation Period|Burden of study procedures|5|||
126115750|NCT04667377|453720020|FG000|Dose Escalation Period|Change of residence|0|||
126115751|NCT04667377|453720021|FG001|Dose Escalation Period|Change of residence|0|||
126115752|NCT04667377|453720022|FG002|Dose Escalation Period|Change of residence|1|||
126115753|NCT04667377|453720023|FG003|Dose Escalation Period|Change of residence|0|||
126115754|NCT04667377|453720024|FG004|Dose Escalation Period|Change of residence|0|||
126115755|NCT04667377|453720020|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
126115756|NCT04667377|453720021|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
126115757|NCT04667377|453720022|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
126115758|NCT04667377|453720023|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
126115759|NCT04667377|453720024|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
126115760|NCT04667377|453720020|FG000|Dose Escalation Period|Adverse Event|9|||
126115761|NCT04667377|453720021|FG001|Dose Escalation Period|Adverse Event|10|||
126115762|NCT04667377|453720022|FG002|Dose Escalation Period|Adverse Event|12|||
126115763|NCT04667377|453720023|FG003|Dose Escalation Period|Adverse Event|17|||
126115764|NCT04667377|453720024|FG004|Dose Escalation Period|Adverse Event|3|||
126115765|NCT04667377|453720020|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
126115766|NCT04667377|453720021|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
126115767|NCT04667377|453720022|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
126115768|NCT04667377|453720023|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
126115769|NCT04667377|453720024|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
126115770|NCT04667377|453720020|FG000|Dose Escalation Period|Not treated|1|||
126115771|NCT04667377|453720021|FG001|Dose Escalation Period|Not treated|0|||
126115772|NCT04667377|453720022|FG002|Dose Escalation Period|Not treated|0|||
126115773|NCT04667377|453720023|FG003|Dose Escalation Period|Not treated|0|||
126115774|NCT04667377|453720024|FG004|Dose Escalation Period|Not treated|0|||
126115775|NCT04667377|453720020|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
126115776|NCT04667377|453720021|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
126083952|NCT02906020|453602048|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083953|NCT02906020|453602049|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083954|NCT02906020|453602050|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083955|NCT02906020|453602051|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
126083956|NCT02906020|453602052|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
126083957|NCT02906020|453602053|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083958|NCT02906020|453602054|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126083959|NCT02906020|453602039|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083960|NCT02906020|453602040|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083961|NCT02906020|453602041|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083962|NCT02906020|453602042|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083963|NCT02906020|453602043|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083964|NCT02906020|453602044|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083965|NCT02906020|453602045|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083966|NCT02906020|453602046|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083967|NCT02906020|453602047|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083968|NCT02906020|453602048|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083969|NCT02906020|453602049|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083970|NCT02906020|453602050|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083971|NCT02906020|453602051|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
126083972|NCT02906020|453602052|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
126083973|NCT02906020|453602053|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126083974|NCT02906020|453602054|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
126083975|NCT02906020|453602039|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083976|NCT02906020|453602040|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083977|NCT02906020|453602041|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083978|NCT02906020|453602042|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083979|NCT02906020|453602043|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083980|NCT02906020|453602044|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083981|NCT02906020|453602045|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083982|NCT02906020|453602046|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083983|NCT02906020|453602047|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083984|NCT02906020|453602048|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083985|NCT02906020|453602049|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083986|NCT02906020|453602050|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083987|NCT02906020|453602051|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
126083988|NCT02906020|453602052|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
126083989|NCT02906020|453602053|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083990|NCT02906020|453602054|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126083991|NCT02906020|453602039|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126083992|NCT02906020|453602040|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126083993|NCT02906020|453602041|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126083994|NCT02906020|453602042|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126083995|NCT02906020|453602043|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126083996|NCT02906020|453602044|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126083997|NCT02906020|453602045|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126083998|NCT02906020|453602046|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126083999|NCT02906020|453602047|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126084000|NCT02906020|453602048|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126084001|NCT02906020|453602049|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126084002|NCT02906020|453602050|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126084003|NCT02906020|453602051|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
126084004|NCT02906020|453602052|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
126084005|NCT02906020|453602053|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126084006|NCT02906020|453602054|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126084007|NCT02906020|453602039|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084008|NCT02906020|453602040|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084009|NCT02906020|453602041|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084010|NCT02906020|453602042|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084011|NCT02906020|453602043|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084012|NCT02906020|453602044|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084013|NCT02906020|453602045|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084014|NCT02906020|453602046|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126115777|NCT04667377|453720022|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
126084015|NCT02906020|453602047|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084016|NCT02906020|453602048|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084017|NCT02906020|453602049|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084018|NCT02906020|453602050|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126084019|NCT02906020|453602051|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
126084020|NCT02906020|453602052|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
126084021|NCT02906020|453602053|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
126084022|NCT02906020|453602054|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
126084023|NCT02906020|453602039|FG000|Part 2: Long-term Follow-up Period|Other|0|||
126084024|NCT02906020|453602040|FG001|Part 2: Long-term Follow-up Period|Other|0|||
126084025|NCT02906020|453602041|FG002|Part 2: Long-term Follow-up Period|Other|0|||
126084026|NCT02906020|453602042|FG003|Part 2: Long-term Follow-up Period|Other|0|||
126084027|NCT02906020|453602043|FG004|Part 2: Long-term Follow-up Period|Other|0|||
126084028|NCT02906020|453602044|FG005|Part 2: Long-term Follow-up Period|Other|0|||
126084029|NCT02906020|453602045|FG006|Part 2: Long-term Follow-up Period|Other|0|||
126084030|NCT02906020|453602046|FG007|Part 2: Long-term Follow-up Period|Other|0|||
126084031|NCT02906020|453602047|FG008|Part 2: Long-term Follow-up Period|Other|0|||
126084032|NCT02906020|453602048|FG009|Part 2: Long-term Follow-up Period|Other|0|||
126084033|NCT02906020|453602049|FG010|Part 2: Long-term Follow-up Period|Other|0|||
126084034|NCT02906020|453602050|FG011|Part 2: Long-term Follow-up Period|Other|0|||
126084035|NCT02906020|453602051|FG012|Part 2: Long-term Follow-up Period|Other|13|||
126084036|NCT02906020|453602052|FG013|Part 2: Long-term Follow-up Period|Other|8|||
126084037|NCT02906020|453602053|FG014|Part 2: Long-term Follow-up Period|Other|3|||
126084038|NCT02906020|453602054|FG015|Part 2: Long-term Follow-up Period|Other|2|||
126084039|NCT00884650|453602056|FG000|Overall Study|Did not return complete pain diaries|7|||
126084040|NCT00884650|453602057|FG001|Overall Study|Did not return complete pain diaries|7|||
126084041|NCT00884650|453602056|FG000|Overall Study|Admitted Post-Op|1|||
126084042|NCT00884650|453602057|FG001|Overall Study|Admitted Post-Op|0|||
126084043|NCT00884650|453602056|FG000|Overall Study|Femoral Stress Fracture|1|||
126084044|NCT00884650|453602057|FG001|Overall Study|Femoral Stress Fracture|0|||
126084045|NCT00884650|453602056|FG000|Overall Study|Pain Pump Complication|0|||
126084046|NCT00884650|453602057|FG001|Overall Study|Pain Pump Complication|1|||
126084047|NCT01594827|453602063|FG000|Overall Study|Adverse Event|1|||
126084048|NCT01594827|453602064|FG001|Overall Study|Adverse Event|0|||
126084049|NCT01594827|453602063|FG000|Overall Study|Physician Decision|3|||
126084050|NCT01594827|453602064|FG001|Overall Study|Physician Decision|0|||
126084051|NCT02153905|453602065|FG000|Overall Study|Death|1|||
126084052|NCT02153905|453602066|FG001|Overall Study|Death|0|||
126084053|NCT01607879|453602071|FG000|Overall Study|Death|1|||
126084054|NCT01607879|453602072|FG001|Overall Study|Death|0|||
126084055|NCT01592045|453602073|FG000|Overall Study|Disease Progression|1|||
126084056|NCT01592045|453602074|FG001|Overall Study|Disease Progression|1|||
126084057|NCT01592045|453602073|FG000|Overall Study|Adverse Event|1|||
126084058|NCT01592045|453602074|FG001|Overall Study|Adverse Event|1|||
126084059|NCT01592045|453602073|FG000|Overall Study|Withdrawal by Subject|1|||
126084060|NCT01592045|453602074|FG001|Overall Study|Withdrawal by Subject|0|||
126084061|NCT01592045|453602073|FG000|Overall Study|Moved out of country|2|||
126084062|NCT01592045|453602074|FG001|Overall Study|Moved out of country|0|||
126084063|NCT03994731|453602075|FG000|Pegloticase + IMM Period|Death|2|||
126084064|NCT03994731|453602076|FG001|Pegloticase + IMM Period|Death|0|||
126084065|NCT03994731|453602075|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
126084066|NCT03994731|453602076|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
126084067|NCT03994731|453602075|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
126084068|NCT03994731|453602076|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
126084069|NCT02406248|453602077|FG000|Overall Study|Death|7|||
126084070|NCT02406248|453602077|FG000|Overall Study|Withdrawal by Subject|2|||
126084071|NCT03812029|453602079|FG000|Overall Study|Protocol Violation|1|||
126084072|NCT03812029|453602080|FG001|Overall Study|Protocol Violation|0|||
126084073|NCT03812029|453602081|FG002|Overall Study|Protocol Violation|0|||
126084074|NCT03812029|453602082|FG003|Overall Study|Protocol Violation|1|||
126084075|NCT03812029|453602083|FG004|Overall Study|Protocol Violation|0|||
126084076|NCT03812029|453602079|FG000|Overall Study|Withdrawal by Subject|1|||
126084077|NCT03812029|453602080|FG001|Overall Study|Withdrawal by Subject|0|||
126084078|NCT03812029|453602081|FG002|Overall Study|Withdrawal by Subject|0|||
126084079|NCT03812029|453602082|FG003|Overall Study|Withdrawal by Subject|2|||
126084080|NCT03812029|453602083|FG004|Overall Study|Withdrawal by Subject|2|||
126084081|NCT03812029|453602079|FG000|Overall Study|Stopping rules|0|||
126084082|NCT03812029|453602080|FG001|Overall Study|Stopping rules|1|||
126084083|NCT03812029|453602081|FG002|Overall Study|Stopping rules|0|||
126084084|NCT03812029|453602082|FG003|Overall Study|Stopping rules|0|||
126084085|NCT03812029|453602083|FG004|Overall Study|Stopping rules|0|||
126084086|NCT03812029|453602079|FG000|Overall Study|Adverse Event|0|||
126084087|NCT03812029|453602080|FG001|Overall Study|Adverse Event|9|||
126084088|NCT03812029|453602081|FG002|Overall Study|Adverse Event|0|||
126084089|NCT03812029|453602082|FG003|Overall Study|Adverse Event|3|||
126084090|NCT03812029|453602083|FG004|Overall Study|Adverse Event|5|||
126084091|NCT03812029|453602079|FG000|Overall Study|Lost to Follow-up|0|||
126084092|NCT03812029|453602080|FG001|Overall Study|Lost to Follow-up|0|||
126084093|NCT03812029|453602081|FG002|Overall Study|Lost to Follow-up|0|||
126084094|NCT03812029|453602082|FG003|Overall Study|Lost to Follow-up|0|||
126084095|NCT03812029|453602083|FG004|Overall Study|Lost to Follow-up|3|||
126084096|NCT03149042|453602084|FG000|Overall Study|Invasive FFR not performed|21|||
126084097|NCT03149042|453602084|FG000|Overall Study|Poor CT Image Quality|1|||
126084098|NCT03149042|453602084|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
126084099|NCT00790205|453602085|FG000|Overall Study|Lost to Follow-up|61|||
126084100|NCT00790205|453602086|FG001|Overall Study|Lost to Follow-up|71|||
126084101|NCT00790205|453602085|FG000|Overall Study|Withdrawal by Subject|299|||
126084102|NCT00790205|453602086|FG001|Overall Study|Withdrawal by Subject|363|||
126084103|NCT04092452|453602102|FG000|Overall Study|Adverse Event|1|||
126084104|NCT04092452|453602103|FG001|Overall Study|Adverse Event|3|||
126084105|NCT04092452|453602104|FG002|Overall Study|Adverse Event|3|||
126084106|NCT04092452|453602105|FG003|Overall Study|Adverse Event|7|||
126084107|NCT04092452|453602102|FG000|Overall Study|Lack of Efficacy|1|||
126084108|NCT04092452|453602103|FG001|Overall Study|Lack of Efficacy|1|||
126084109|NCT04092452|453602104|FG002|Overall Study|Lack of Efficacy|1|||
126084110|NCT04092452|453602105|FG003|Overall Study|Lack of Efficacy|0|||
126084111|NCT04092452|453602102|FG000|Overall Study|Lost to Follow-up|4|||
126084112|NCT04092452|453602103|FG001|Overall Study|Lost to Follow-up|3|||
126084113|NCT04092452|453602104|FG002|Overall Study|Lost to Follow-up|5|||
126084114|NCT04092452|453602105|FG003|Overall Study|Lost to Follow-up|1|||
126084115|NCT04092452|453602102|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126084116|NCT04092452|453602103|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126084117|NCT04092452|453602104|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126084118|NCT04092452|453602105|FG003|Overall Study|Non-Compliance With Study Drug|1|||
126084119|NCT04092452|453602102|FG000|Overall Study|Physician Decision|1|||
126084120|NCT04092452|453602103|FG001|Overall Study|Physician Decision|0|||
126084121|NCT04092452|453602104|FG002|Overall Study|Physician Decision|1|||
126084122|NCT04092452|453602105|FG003|Overall Study|Physician Decision|0|||
126084123|NCT04092452|453602102|FG000|Overall Study|Pregnancy|2|||
126084124|NCT04092452|453602103|FG001|Overall Study|Pregnancy|0|||
126084125|NCT04092452|453602104|FG002|Overall Study|Pregnancy|0|||
126084126|NCT04092452|453602105|FG003|Overall Study|Pregnancy|0|||
126084127|NCT04092452|453602102|FG000|Overall Study|Protocol Deviation|1|||
126084128|NCT04092452|453602103|FG001|Overall Study|Protocol Deviation|0|||
126084129|NCT04092452|453602104|FG002|Overall Study|Protocol Deviation|0|||
126084130|NCT04092452|453602105|FG003|Overall Study|Protocol Deviation|0|||
126084131|NCT04092452|453602102|FG000|Overall Study|Withdrawal by Subject|3|||
126084132|NCT04092452|453602103|FG001|Overall Study|Withdrawal by Subject|10|||
126084133|NCT04092452|453602104|FG002|Overall Study|Withdrawal by Subject|3|||
126084134|NCT04092452|453602105|FG003|Overall Study|Withdrawal by Subject|5|||
126084135|NCT04092452|453602102|FG000|Overall Study|Other|0|||
126084136|NCT04092452|453602103|FG001|Overall Study|Other|0|||
126084137|NCT04092452|453602104|FG002|Overall Study|Other|1|||
126084138|NCT04092452|453602105|FG003|Overall Study|Other|2|||
126084139|NCT02127125|453602106|FG000|Overall Study|Lost to Follow-up|0|||
126084140|NCT02127125|453602107|FG001|Overall Study|Lost to Follow-up|0|||
126084141|NCT02127125|453602108|FG002|Overall Study|Lost to Follow-up|0|||
126084142|NCT02127125|453602109|FG003|Overall Study|Lost to Follow-up|0|||
126084143|NCT02127125|453602110|FG004|Overall Study|Lost to Follow-up|2|||
126084144|NCT02127125|453602111|FG005|Overall Study|Lost to Follow-up|1|||
126084145|NCT02127125|453602112|FG006|Overall Study|Lost to Follow-up|0|||
126084146|NCT02127125|453602113|FG007|Overall Study|Lost to Follow-up|0|||
126084147|NCT02127125|453602114|FG008|Overall Study|Lost to Follow-up|0|||
126084148|NCT02127125|453602106|FG000|Overall Study|Withdrawal by Subject|0|||
126084149|NCT02127125|453602107|FG001|Overall Study|Withdrawal by Subject|0|||
126084150|NCT02127125|453602108|FG002|Overall Study|Withdrawal by Subject|0|||
126084151|NCT02127125|453602109|FG003|Overall Study|Withdrawal by Subject|1|||
126084152|NCT02127125|453602110|FG004|Overall Study|Withdrawal by Subject|0|||
126084153|NCT02127125|453602111|FG005|Overall Study|Withdrawal by Subject|0|||
126084154|NCT02127125|453602112|FG006|Overall Study|Withdrawal by Subject|0|||
126084155|NCT02127125|453602113|FG007|Overall Study|Withdrawal by Subject|0|||
126084156|NCT02127125|453602114|FG008|Overall Study|Withdrawal by Subject|0|||
126084157|NCT02127125|453602106|FG000|Overall Study|Physician Decision|0|||
126084158|NCT02127125|453602107|FG001|Overall Study|Physician Decision|0|||
126084159|NCT02127125|453602108|FG002|Overall Study|Physician Decision|1|||
126084160|NCT02127125|453602109|FG003|Overall Study|Physician Decision|0|||
126084161|NCT02127125|453602110|FG004|Overall Study|Physician Decision|1|||
126084162|NCT02127125|453602111|FG005|Overall Study|Physician Decision|2|||
126084163|NCT02127125|453602112|FG006|Overall Study|Physician Decision|0|||
126084164|NCT02127125|453602113|FG007|Overall Study|Physician Decision|0|||
126084165|NCT02127125|453602114|FG008|Overall Study|Physician Decision|0|||
126084166|NCT02353468|453602116|FG000|Overall Study|Study terminated|3|||
126084167|NCT02344342|453602117|FG000|Overall Study|Industry partner dropped out|11|||
126084168|NCT02344342|453602118|FG001|Overall Study|Industry partner dropped out|9|||
126084169|NCT02344342|453602119|FG002|Overall Study|Industry partner dropped out|14|||
125954103|NCT01573624|453128637|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125954104|NCT01573624|453128631|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
125954105|NCT01573624|453128632|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
125954106|NCT01573624|453128633|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
125954107|NCT01573624|453128634|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
125954108|NCT01573624|453128635|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
125954109|NCT01573624|453128636|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
125954110|NCT01573624|453128637|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
125954111|NCT01573624|453128631|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
125954112|NCT01573624|453128632|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
125954113|NCT01573624|453128633|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
125954114|NCT01573624|453128634|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
125954115|NCT01573624|453128635|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
125954116|NCT01573624|453128636|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
125954117|NCT01573624|453128637|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
125954118|NCT01573624|453128631|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125954119|NCT01573624|453128632|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
125954120|NCT01573624|453128633|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125954121|NCT01573624|453128634|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125954122|NCT01573624|453128635|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125954123|NCT01573624|453128636|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
125954124|NCT01573624|453128637|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125954125|NCT01573624|453128631|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
125954126|NCT01573624|453128632|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125954127|NCT01573624|453128633|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125954128|NCT01573624|453128634|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125954129|NCT01573624|453128635|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125954130|NCT01573624|453128636|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125954131|NCT01573624|453128637|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125954132|NCT01573624|453128631|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125954133|NCT01573624|453128632|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
125954134|NCT01573624|453128633|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
125954135|NCT01573624|453128634|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125954136|NCT01573624|453128635|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125954137|NCT01573624|453128636|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
125954138|NCT01573624|453128637|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125954139|NCT01573624|453128631|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
125954140|NCT01573624|453128632|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125954141|NCT01573624|453128633|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125954142|NCT01573624|453128634|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125954143|NCT01573624|453128635|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125954144|NCT01573624|453128636|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125954145|NCT01573624|453128637|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125954146|NCT01573624|453128631|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
125954147|NCT01573624|453128632|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125954148|NCT01573624|453128633|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125954149|NCT01573624|453128634|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125954150|NCT01573624|453128635|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125954151|NCT01573624|453128636|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125954152|NCT01573624|453128637|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
125954153|NCT01573624|453128631|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
125954154|NCT01573624|453128632|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125954155|NCT01573624|453128633|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125954156|NCT01573624|453128634|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125954157|NCT01573624|453128635|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125954158|NCT01573624|453128636|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
125954159|NCT01573624|453128637|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125954160|NCT01573624|453128631|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125954161|NCT01573624|453128632|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
125954162|NCT01573624|453128633|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125954163|NCT01573624|453128634|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
126115778|NCT04667377|453720023|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
126115779|NCT04667377|453720024|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
126115780|NCT04667377|453720020|FG000|Dose Escalation Period|Lost to Follow-up|0|||
126115781|NCT04667377|453720021|FG001|Dose Escalation Period|Lost to Follow-up|1|||
126084170|NCT02344342|453602120|FG003|Overall Study|Industry partner dropped out|10|||
126084171|NCT00848484|453602122|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
126084172|NCT00848484|453602123|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
126084173|NCT00848484|453602122|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
126084174|NCT00848484|453602123|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
126084175|NCT00848484|453602122|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
126084176|NCT00848484|453602123|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
126084177|NCT00848484|453602122|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
126084178|NCT00848484|453602123|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
126084179|NCT00848484|453602122|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
126084180|NCT00848484|453602123|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
126084181|NCT03355209|453602127|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
126084182|NCT03355209|453602128|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
126084183|NCT03355209|453602129|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
126084184|NCT03355209|453602130|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
126084185|NCT03355209|453602131|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
126084186|NCT03355209|453602132|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
126084187|NCT03355209|453602127|FG000|Part 1: Double-Blind Period|Death|0|||
126084188|NCT03355209|453602128|FG001|Part 1: Double-Blind Period|Death|0|||
126084189|NCT03355209|453602129|FG002|Part 1: Double-Blind Period|Death|1|||
126084190|NCT03355209|453602130|FG003|Part 1: Double-Blind Period|Death|0|||
126084191|NCT03355209|453602131|FG004|Part 1: Double-Blind Period|Death|0|||
126084192|NCT03355209|453602132|FG005|Part 1: Double-Blind Period|Death|0|||
126084193|NCT03355209|453602127|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
126084194|NCT03355209|453602128|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
126084195|NCT03355209|453602129|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
126084196|NCT03355209|453602130|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
126084197|NCT03355209|453602131|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
126084198|NCT03355209|453602132|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
126084199|NCT03355209|453602127|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
126084200|NCT03355209|453602128|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
126084201|NCT03355209|453602129|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
126084202|NCT03355209|453602130|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126084203|NCT03355209|453602131|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126084204|NCT03355209|453602132|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126084205|NCT03355209|453602127|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
126084206|NCT03355209|453602128|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
126084207|NCT03355209|453602129|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
126084208|NCT03355209|453602130|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
126084209|NCT03355209|453602131|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
126084210|NCT03355209|453602132|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
126084211|NCT03355209|453602127|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126084212|NCT03355209|453602128|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
126084213|NCT03355209|453602129|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126084214|NCT03355209|453602130|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126084215|NCT03355209|453602131|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126084216|NCT03355209|453602132|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126084217|NCT03355209|453602127|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
126084218|NCT03355209|453602128|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
126084219|NCT03355209|453602129|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
126084220|NCT03355209|453602130|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
126084221|NCT03355209|453602131|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
126084222|NCT03355209|453602132|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
126084223|NCT03355209|453602127|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
126084224|NCT03355209|453602128|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
126115782|NCT04667377|453720022|FG002|Dose Escalation Period|Lost to Follow-up|0|||
126115783|NCT04667377|453720023|FG003|Dose Escalation Period|Lost to Follow-up|0|||
126115784|NCT04667377|453720024|FG004|Dose Escalation Period|Lost to Follow-up|0|||
125954164|NCT01573624|453128635|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125954165|NCT01573624|453128636|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125954166|NCT01573624|453128637|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
126115785|NCT04667377|453720020|FG000|Maintenance Period|Perceived lack of efficacy|0|||
126084225|NCT03355209|453602129|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
126084226|NCT03355209|453602130|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
126084227|NCT03355209|453602131|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
126084228|NCT03355209|453602132|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
126084229|NCT03355209|453602127|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
126084230|NCT03355209|453602128|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
126084231|NCT03355209|453602129|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
126084232|NCT03355209|453602130|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126084233|NCT03355209|453602131|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
126084234|NCT03355209|453602132|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126084235|NCT03355209|453602127|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
126084236|NCT03355209|453602128|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
126084237|NCT03355209|453602129|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
126084238|NCT03355209|453602130|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
126084239|NCT03355209|453602131|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
126084240|NCT03355209|453602132|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
126084241|NCT03355209|453602127|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
126084242|NCT03355209|453602128|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
126084243|NCT03355209|453602129|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
126084244|NCT03355209|453602130|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
126084245|NCT03355209|453602131|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
126084246|NCT03355209|453602132|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
126084247|NCT03017742|453602136|FG000|Overall Study|Protocol Violation|36|||
126084248|NCT03017742|453602136|FG000|Overall Study|Withdrawal by Subject|37|||
126084249|NCT02975102|453602137|FG000|Overall Study|Adverse Event|2|||
126084250|NCT02975102|453602138|FG001|Overall Study|Adverse Event|1|||
126084251|NCT01441635|453602143|FG000|Overall Study|Adverse Event|4|||
126084252|NCT01441635|453602144|FG001|Overall Study|Adverse Event|3|||
126084253|NCT01441635|453602145|FG002|Overall Study|Adverse Event|1|||
126084254|NCT01441635|453602146|FG003|Overall Study|Adverse Event|5|||
126084255|NCT01441635|453602147|FG004|Overall Study|Adverse Event|1|||
126084256|NCT01441635|453602148|FG005|Overall Study|Adverse Event|2|||
126084257|NCT01441635|453602149|FG006|Overall Study|Adverse Event|2|||
126084258|NCT01441635|453602150|FG007|Overall Study|Adverse Event|2|||
126084259|NCT01441635|453602151|FG008|Overall Study|Adverse Event|1|||
126084260|NCT01441635|453602152|FG009|Overall Study|Adverse Event|0|||
126084261|NCT01441635|453602143|FG000|Overall Study|Withdrawal by Subject|1|||
126084262|NCT01441635|453602144|FG001|Overall Study|Withdrawal by Subject|1|||
126084263|NCT01441635|453602145|FG002|Overall Study|Withdrawal by Subject|0|||
126084264|NCT01441635|453602146|FG003|Overall Study|Withdrawal by Subject|1|||
126084265|NCT01441635|453602147|FG004|Overall Study|Withdrawal by Subject|0|||
126084266|NCT01441635|453602148|FG005|Overall Study|Withdrawal by Subject|0|||
126084267|NCT01441635|453602149|FG006|Overall Study|Withdrawal by Subject|2|||
126084268|NCT01441635|453602150|FG007|Overall Study|Withdrawal by Subject|0|||
126084269|NCT01441635|453602151|FG008|Overall Study|Withdrawal by Subject|1|||
126084270|NCT01441635|453602152|FG009|Overall Study|Withdrawal by Subject|1|||
126084271|NCT01441635|453602143|FG000|Overall Study|Lost to Follow-up|0|||
126084272|NCT01441635|453602144|FG001|Overall Study|Lost to Follow-up|1|||
126084273|NCT01441635|453602145|FG002|Overall Study|Lost to Follow-up|1|||
126084274|NCT01441635|453602146|FG003|Overall Study|Lost to Follow-up|1|||
126084275|NCT01441635|453602147|FG004|Overall Study|Lost to Follow-up|1|||
126084276|NCT01441635|453602148|FG005|Overall Study|Lost to Follow-up|3|||
126084277|NCT01441635|453602149|FG006|Overall Study|Lost to Follow-up|1|||
126084278|NCT01441635|453602150|FG007|Overall Study|Lost to Follow-up|1|||
126084279|NCT01441635|453602151|FG008|Overall Study|Lost to Follow-up|0|||
126084280|NCT01441635|453602152|FG009|Overall Study|Lost to Follow-up|1|||
126084281|NCT01441635|453602143|FG000|Overall Study|Noncompliance|0|||
126084282|NCT01441635|453602144|FG001|Overall Study|Noncompliance|1|||
126084283|NCT01441635|453602145|FG002|Overall Study|Noncompliance|0|||
126084284|NCT01441635|453602146|FG003|Overall Study|Noncompliance|0|||
126084285|NCT01441635|453602147|FG004|Overall Study|Noncompliance|0|||
126084286|NCT01441635|453602148|FG005|Overall Study|Noncompliance|0|||
126084287|NCT01441635|453602149|FG006|Overall Study|Noncompliance|1|||
126084288|NCT01441635|453602150|FG007|Overall Study|Noncompliance|0|||
126084289|NCT01441635|453602151|FG008|Overall Study|Noncompliance|0|||
126084290|NCT01441635|453602152|FG009|Overall Study|Noncompliance|0|||
126084291|NCT01441635|453602143|FG000|Overall Study|Surgery or Invasive Intervention|0|||
126084292|NCT01441635|453602144|FG001|Overall Study|Surgery or Invasive Intervention|0|||
126084293|NCT01441635|453602145|FG002|Overall Study|Surgery or Invasive Intervention|1|||
126084294|NCT01441635|453602146|FG003|Overall Study|Surgery or Invasive Intervention|0|||
126084295|NCT01441635|453602147|FG004|Overall Study|Surgery or Invasive Intervention|0|||
126084296|NCT01441635|453602148|FG005|Overall Study|Surgery or Invasive Intervention|0|||
126084297|NCT01441635|453602149|FG006|Overall Study|Surgery or Invasive Intervention|0|||
126084298|NCT01441635|453602150|FG007|Overall Study|Surgery or Invasive Intervention|0|||
126115786|NCT04667377|453720021|FG001|Maintenance Period|Perceived lack of efficacy|2|||
126115787|NCT04667377|453720022|FG002|Maintenance Period|Perceived lack of efficacy|1|||
126115788|NCT04667377|453720023|FG003|Maintenance Period|Perceived lack of efficacy|0|||
126115789|NCT04667377|453720024|FG004|Maintenance Period|Perceived lack of efficacy|1|||
126115790|NCT04667377|453720020|FG000|Maintenance Period|Adverse Event|2|||
126115791|NCT04667377|453720021|FG001|Maintenance Period|Adverse Event|8|||
126115792|NCT04667377|453720022|FG002|Maintenance Period|Adverse Event|5|||
126115793|NCT04667377|453720023|FG003|Maintenance Period|Adverse Event|4|||
126115794|NCT04667377|453720024|FG004|Maintenance Period|Adverse Event|1|||
126115795|NCT04667377|453720020|FG000|Maintenance Period|Adverse event: COVID infection|0|||
126115796|NCT04667377|453720021|FG001|Maintenance Period|Adverse event: COVID infection|1|||
126115797|NCT04667377|453720022|FG002|Maintenance Period|Adverse event: COVID infection|0|||
126115798|NCT04667377|453720023|FG003|Maintenance Period|Adverse event: COVID infection|0|||
126115799|NCT04667377|453720024|FG004|Maintenance Period|Adverse event: COVID infection|0|||
126115800|NCT04667377|453720020|FG000|Maintenance Period|COVID-related|0|||
126115801|NCT04667377|453720021|FG001|Maintenance Period|COVID-related|0|||
126115802|NCT04667377|453720022|FG002|Maintenance Period|COVID-related|1|||
126115803|NCT04667377|453720023|FG003|Maintenance Period|COVID-related|1|||
126115804|NCT04667377|453720024|FG004|Maintenance Period|COVID-related|0|||
126115805|NCT04667377|453720020|FG000|Maintenance Period|Protocol Violation|1|||
126115806|NCT04667377|453720021|FG001|Maintenance Period|Protocol Violation|0|||
126115807|NCT04667377|453720022|FG002|Maintenance Period|Protocol Violation|0|||
126115808|NCT04667377|453720023|FG003|Maintenance Period|Protocol Violation|0|||
126115809|NCT04667377|453720024|FG004|Maintenance Period|Protocol Violation|1|||
126115810|NCT04667377|453720020|FG000|Maintenance Period|Burden of study procedures|1|||
126115811|NCT04667377|453720021|FG001|Maintenance Period|Burden of study procedures|2|||
126115812|NCT04667377|453720022|FG002|Maintenance Period|Burden of study procedures|0|||
126115813|NCT04667377|453720023|FG003|Maintenance Period|Burden of study procedures|1|||
126115814|NCT04667377|453720024|FG004|Maintenance Period|Burden of study procedures|0|||
126115815|NCT04667377|453720020|FG000|Maintenance Period|Change of residence|0|||
126115816|NCT04667377|453720021|FG001|Maintenance Period|Change of residence|1|||
126115817|NCT04667377|453720022|FG002|Maintenance Period|Change of residence|0|||
126115818|NCT04667377|453720023|FG003|Maintenance Period|Change of residence|0|||
126115819|NCT04667377|453720024|FG004|Maintenance Period|Change of residence|1|||
126115820|NCT04667377|453720020|FG000|Maintenance Period|Missing|1|||
126115821|NCT04667377|453720021|FG001|Maintenance Period|Missing|0|||
126115822|NCT04667377|453720022|FG002|Maintenance Period|Missing|0|||
126115823|NCT04667377|453720023|FG003|Maintenance Period|Missing|0|||
126115824|NCT04667377|453720024|FG004|Maintenance Period|Missing|0|||
126115825|NCT04667377|453720020|FG000|Maintenance Period|Other than listed above|2|||
126115826|NCT04667377|453720021|FG001|Maintenance Period|Other than listed above|0|||
126115827|NCT04667377|453720022|FG002|Maintenance Period|Other than listed above|3|||
126115828|NCT04667377|453720023|FG003|Maintenance Period|Other than listed above|2|||
126115829|NCT04667377|453720024|FG004|Maintenance Period|Other than listed above|6|||
126115830|NCT04667377|453720020|FG000|Maintenance Period|Withdrawal by Subject|0|||
126115831|NCT04667377|453720021|FG001|Maintenance Period|Withdrawal by Subject|1|||
126115832|NCT04667377|453720022|FG002|Maintenance Period|Withdrawal by Subject|0|||
126115833|NCT04667377|453720023|FG003|Maintenance Period|Withdrawal by Subject|0|||
126115834|NCT04667377|453720024|FG004|Maintenance Period|Withdrawal by Subject|0|||
126115835|NCT04667377|453720020|FG000|Maintenance Period|Lost to Follow-up|1|||
126115836|NCT04667377|453720021|FG001|Maintenance Period|Lost to Follow-up|0|||
126115837|NCT04667377|453720022|FG002|Maintenance Period|Lost to Follow-up|1|||
126115838|NCT04667377|453720023|FG003|Maintenance Period|Lost to Follow-up|0|||
126115839|NCT04667377|453720024|FG004|Maintenance Period|Lost to Follow-up|1|||
126115840|NCT01011439|453720025|FG000|Overall Study|Death|37|||
126115841|NCT01011439|453720025|FG000|Overall Study|Lost to Follow-up|4|||
126115842|NCT01011439|453720025|FG000|Overall Study|Withdrawal by Subject|1|||
126115843|NCT01011439|453720025|FG000|Overall Study|Sponsor's decision|15|||
125954167|NCT01573624|453128631|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125954168|NCT01573624|453128632|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
126115844|NCT02428855|453720026|FG000|Overall Study|Withdrawal by Subject|2|||
126115845|NCT02066311|453720027|FG000|Overall Study|Adverse Event|4|||
126115846|NCT02066311|453720027|FG000|Overall Study|Withdrawal by Subject|1|||
126115847|NCT03198520|453720032|FG000|Overall Study|Physician Decision|2|||
126115848|NCT03198520|453720032|FG000|Overall Study|Protocol Violation|2|||
126115849|NCT03198520|453720032|FG000|Overall Study|Withdrawal by Subject|1|||
126115850|NCT03198520|453720032|FG000|Overall Study|Study Ended|1|||
126115851|NCT01670539|453720033|FG000|Overall Study|Death|3|||
126115852|NCT01670539|453720034|FG001|Overall Study|Death|5|||
126115853|NCT01670539|453720033|FG000|Overall Study|Withdrawal by Subject|3|||
126115854|NCT01670539|453720034|FG001|Overall Study|Withdrawal by Subject|0|||
126115855|NCT00536809|453720035|FG000|Phase II|Adverse Event|1|||
126115856|NCT00536809|453720035|FG000|Phase II|Referred for surgical resection|1|||
126115857|NCT02606461|453720036|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126115858|NCT02606461|453720037|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125954169|NCT01573624|453128633|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125954170|NCT01573624|453128634|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125954171|NCT01573624|453128635|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125954172|NCT01573624|453128636|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125954173|NCT01573624|453128637|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125954174|NCT01573624|453128631|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125954175|NCT01573624|453128632|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125954176|NCT01573624|453128633|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125954177|NCT01573624|453128634|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125954178|NCT01573624|453128635|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125954179|NCT01573624|453128636|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125954180|NCT01573624|453128637|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125954181|NCT01573624|453128631|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
125954182|NCT01573624|453128632|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
125954183|NCT01573624|453128633|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
125954184|NCT01573624|453128634|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
125954185|NCT01573624|453128635|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
125954186|NCT01573624|453128636|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
125954187|NCT01573624|453128637|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
125954188|NCT01573624|453128631|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
125954189|NCT01573624|453128632|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125954190|NCT01573624|453128633|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125954191|NCT01573624|453128634|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125954192|NCT01573624|453128635|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
125954193|NCT01573624|453128636|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
125954194|NCT01573624|453128637|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
125954195|NCT01573624|453128631|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125954196|NCT01573624|453128632|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
125954197|NCT01573624|453128633|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125954198|NCT01573624|453128634|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125954199|NCT01573624|453128635|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125954200|NCT01573624|453128636|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
125954201|NCT01573624|453128637|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125954202|NCT01573624|453128631|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
125954203|NCT01573624|453128632|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125954204|NCT01573624|453128633|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125954205|NCT01573624|453128634|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125954206|NCT01573624|453128635|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125954207|NCT01573624|453128636|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125954208|NCT01573624|453128637|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125954209|NCT01573624|453128631|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125954210|NCT01573624|453128632|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125954211|NCT01573624|453128633|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125954212|NCT01573624|453128634|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125954213|NCT01573624|453128635|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
125954214|NCT01573624|453128636|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
125954215|NCT01573624|453128637|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125954216|NCT01573624|453128631|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
125954217|NCT01573624|453128632|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125954218|NCT01573624|453128633|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125954219|NCT01573624|453128634|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125954220|NCT01573624|453128635|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125954221|NCT01573624|453128636|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125954222|NCT01573624|453128637|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125954223|NCT03417141|453128640|FG000|Overall Study|Withdrawal by Subject|1|||
125954224|NCT03417141|453128640|FG000|Overall Study|Protocol Violation|3|||
125954225|NCT03706690|453128641|FG000|Overall Study|Withdrawal by Subject|8|||
125954226|NCT03706690|453128642|FG001|Overall Study|Withdrawal by Subject|8|||
125954227|NCT03706690|453128641|FG000|Overall Study|Death|143|||
125954228|NCT03706690|453128642|FG001|Overall Study|Death|75|||
126084299|NCT01441635|453602151|FG008|Overall Study|Surgery or Invasive Intervention|0|||
125954229|NCT03706690|453128641|FG000|Overall Study|Ongoing at DCO|121|||
125954230|NCT03706690|453128642|FG001|Overall Study|Ongoing at DCO|52|||
125954231|NCT02143843|453128643|FG000|Overall Study|Adverse Event|8|||
126084300|NCT01441635|453602152|FG009|Overall Study|Surgery or Invasive Intervention|0|||
126084301|NCT01441635|453602143|FG000|Overall Study|Received Exclusionary Medication|1|||
126084302|NCT01441635|453602144|FG001|Overall Study|Received Exclusionary Medication|0|||
126084303|NCT01441635|453602145|FG002|Overall Study|Received Exclusionary Medication|0|||
126084304|NCT01441635|453602146|FG003|Overall Study|Received Exclusionary Medication|0|||
126084305|NCT01441635|453602147|FG004|Overall Study|Received Exclusionary Medication|0|||
126084306|NCT01441635|453602148|FG005|Overall Study|Received Exclusionary Medication|0|||
126084307|NCT01441635|453602149|FG006|Overall Study|Received Exclusionary Medication|0|||
126084308|NCT01441635|453602150|FG007|Overall Study|Received Exclusionary Medication|0|||
126084309|NCT01441635|453602151|FG008|Overall Study|Received Exclusionary Medication|0|||
126084310|NCT01441635|453602152|FG009|Overall Study|Received Exclusionary Medication|0|||
126084311|NCT01441635|453602143|FG000|Overall Study|Other|0|||
126084312|NCT01441635|453602144|FG001|Overall Study|Other|0|||
126084313|NCT01441635|453602145|FG002|Overall Study|Other|0|||
126084314|NCT01441635|453602146|FG003|Overall Study|Other|0|||
126084315|NCT01441635|453602147|FG004|Overall Study|Other|0|||
126084316|NCT01441635|453602148|FG005|Overall Study|Other|0|||
126084317|NCT01441635|453602149|FG006|Overall Study|Other|0|||
126084318|NCT01441635|453602150|FG007|Overall Study|Other|1|||
126084319|NCT01441635|453602151|FG008|Overall Study|Other|0|||
126084320|NCT01441635|453602152|FG009|Overall Study|Other|0|||
126084321|NCT01825577|453602153|FG000|Overall Study|Physician Decision|2|||
126084322|NCT01825577|453602153|FG000|Overall Study|Withdrawal by Subject|1|||
126084323|NCT01825577|453602153|FG000|Overall Study|Withdrawn by family members|2|||
126084324|NCT01825577|453602153|FG000|Overall Study|Lack of Efficacy|3|||
126084325|NCT00358644|453602154|FG000|Overall Study|Progressive Disease|21|||
126084326|NCT00358644|453602154|FG000|Overall Study|Adverse Event|7|||
126084327|NCT00358644|453602154|FG000|Overall Study|Death|11|||
126084328|NCT00358644|453602154|FG000|Overall Study|Withdrawal by Subject|4|||
126084329|NCT00358644|453602154|FG000|Overall Study|Physician Decision|6|||
126084330|NCT00358644|453602154|FG000|Overall Study|Patient not eligible for study|1|||
126084331|NCT01358331|453602155|FG000|Overall Study|Lost to Follow-up|0|||
126084332|NCT01358331|453602156|FG001|Overall Study|Lost to Follow-up|0|||
126084333|NCT01358331|453602157|FG002|Overall Study|Lost to Follow-up|0|||
126084334|NCT01358331|453602158|FG003|Overall Study|Lost to Follow-up|1|||
126084335|NCT01358331|453602159|FG004|Overall Study|Lost to Follow-up|0|||
126084336|NCT01358331|453602160|FG005|Overall Study|Lost to Follow-up|0|||
126084337|NCT01358331|453602155|FG000|Overall Study|Withdrawal by Subject|0|||
126084338|NCT01358331|453602156|FG001|Overall Study|Withdrawal by Subject|0|||
126084339|NCT01358331|453602157|FG002|Overall Study|Withdrawal by Subject|0|||
126084340|NCT01358331|453602158|FG003|Overall Study|Withdrawal by Subject|1|||
126084341|NCT01358331|453602159|FG004|Overall Study|Withdrawal by Subject|1|||
126084342|NCT01358331|453602160|FG005|Overall Study|Withdrawal by Subject|1|||
126084343|NCT01358331|453602155|FG000|Overall Study|Adverse Events|1|||
126084344|NCT01358331|453602156|FG001|Overall Study|Adverse Events|1|||
126084345|NCT01358331|453602157|FG002|Overall Study|Adverse Events|1|||
126084346|NCT01358331|453602158|FG003|Overall Study|Adverse Events|0|||
126084347|NCT01358331|453602159|FG004|Overall Study|Adverse Events|1|||
126084348|NCT01358331|453602160|FG005|Overall Study|Adverse Events|5|||
126084349|NCT01358331|453602155|FG000|Overall Study|Symptomatic Deterioration|0|||
126084350|NCT01358331|453602156|FG001|Overall Study|Symptomatic Deterioration|0|||
126084351|NCT01358331|453602157|FG002|Overall Study|Symptomatic Deterioration|0|||
126084352|NCT01358331|453602158|FG003|Overall Study|Symptomatic Deterioration|0|||
126084353|NCT01358331|453602159|FG004|Overall Study|Symptomatic Deterioration|1|||
126084354|NCT01358331|453602160|FG005|Overall Study|Symptomatic Deterioration|0|||
126084355|NCT01358331|453602155|FG000|Overall Study|Participants did not wish to continue|0|||
126084356|NCT01358331|453602156|FG001|Overall Study|Participants did not wish to continue|0|||
126084357|NCT01358331|453602157|FG002|Overall Study|Participants did not wish to continue|0|||
126084358|NCT01358331|453602158|FG003|Overall Study|Participants did not wish to continue|0|||
126084359|NCT01358331|453602159|FG004|Overall Study|Participants did not wish to continue|1|||
126084360|NCT01358331|453602160|FG005|Overall Study|Participants did not wish to continue|0|||
126084361|NCT01358331|453602155|FG000|Overall Study|Progress of disease under investigation|1|||
126084362|NCT01358331|453602156|FG001|Overall Study|Progress of disease under investigation|2|||
126084363|NCT01358331|453602157|FG002|Overall Study|Progress of disease under investigation|3|||
126084364|NCT01358331|453602158|FG003|Overall Study|Progress of disease under investigation|1|||
126084365|NCT01358331|453602159|FG004|Overall Study|Progress of disease under investigation|3|||
126084366|NCT01358331|453602160|FG005|Overall Study|Progress of disease under investigation|0|||
126084367|NCT03332784|453602163|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084368|NCT03332784|453602164|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
126084369|NCT03332784|453602165|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084370|NCT03332784|453602166|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084371|NCT03332784|453602167|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084372|NCT03332784|453602168|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084373|NCT03332784|453602169|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084374|NCT03332784|453602170|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084375|NCT03332784|453602171|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126115859|NCT02606461|453720038|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
126115860|NCT02606461|453720039|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126115861|NCT02606461|453720040|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126115862|NCT02606461|453720041|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126115863|NCT02092350|453720046|FG000|Overall Study|Adverse Event|0|||
126115864|NCT02092350|453720047|FG001|Overall Study|Adverse Event|3|||
126115865|NCT02092350|453720046|FG000|Overall Study|Death|2|||
126115866|NCT02092350|453720047|FG001|Overall Study|Death|5|||
126115867|NCT02092350|453720046|FG000|Overall Study|Lost to Follow-up|3|||
126115868|NCT02092350|453720047|FG001|Overall Study|Lost to Follow-up|1|||
126115869|NCT02092350|453720046|FG000|Overall Study|Protocol Violation|1|||
126115870|NCT02092350|453720047|FG001|Overall Study|Protocol Violation|0|||
126115871|NCT02092350|453720046|FG000|Overall Study|Physician Decision|1|||
126115872|NCT02092350|453720047|FG001|Overall Study|Physician Decision|1|||
126115873|NCT02092350|453720046|FG000|Overall Study|Screen Failure|1|||
126115874|NCT02092350|453720047|FG001|Overall Study|Screen Failure|0|||
126115875|NCT02092350|453720046|FG000|Overall Study|Withdrawal by Subject|2|||
126115876|NCT02092350|453720047|FG001|Overall Study|Withdrawal by Subject|2|||
126115877|NCT00239226|453720048|FG000|Overall Study|permAF during stabilization period|0|||
126115878|NCT00239226|453720049|FG001|Overall Study|permAF during stabilization period|0|||
126115879|NCT00239226|453720050|FG002|Overall Study|permAF during stabilization period|0|||
126115880|NCT00239226|453720051|FG003|Overall Study|permAF during stabilization period|3|||
126115881|NCT00239226|453720048|FG000|Overall Study|Lost to Follow-up|1|||
126115882|NCT00239226|453720049|FG001|Overall Study|Lost to Follow-up|0|||
126115883|NCT00239226|453720050|FG002|Overall Study|Lost to Follow-up|1|||
126115884|NCT00239226|453720051|FG003|Overall Study|Lost to Follow-up|0|||
126115885|NCT00646906|453720053|FG000|Crossover Period 1|Withdrawal by Subject|1|||
126115886|NCT00646906|453720054|FG001|Crossover Period 1|Withdrawal by Subject|0|||
126115887|NCT00646906|453720055|FG002|Crossover Period 1|Withdrawal by Subject|0|||
126115888|NCT00646906|453720056|FG003|Crossover Period 1|Withdrawal by Subject|0|||
126115889|NCT00646906|453720057|FG004|Crossover Period 1|Withdrawal by Subject|0|||
126115890|NCT00646906|453720058|FG005|Crossover Period 1|Withdrawal by Subject|1|||
126115891|NCT00646906|453720059|FG006|Crossover Period 1|Withdrawal by Subject|0|||
126115892|NCT00646906|453720053|FG000|Crossover Period 2|Withdrawal by Subject|0|||
126115893|NCT00646906|453720054|FG001|Crossover Period 2|Withdrawal by Subject|1|||
126084376|NCT03332784|453602172|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084377|NCT03332784|453602173|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084378|NCT03332784|453602174|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084379|NCT03332784|453602175|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084380|NCT03332784|453602176|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084381|NCT03332784|453602177|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
126084382|NCT03332784|453602178|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084383|NCT03332784|453602179|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084384|NCT03332784|453602180|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084385|NCT03332784|453602181|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084386|NCT03332784|453602182|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126084387|NCT01969851|453602187|FG000|Overall Study|Adverse Event|0|||
126084388|NCT01969851|453602188|FG001|Overall Study|Adverse Event|0|||
126084389|NCT01969851|453602189|FG002|Overall Study|Adverse Event|3|||
126084390|NCT01969851|453602187|FG000|Overall Study|Lack of Efficacy|0|||
126084391|NCT01969851|453602188|FG001|Overall Study|Lack of Efficacy|3|||
126084392|NCT01969851|453602189|FG002|Overall Study|Lack of Efficacy|1|||
126084393|NCT01969851|453602187|FG000|Overall Study|Withdrawal by Subject|1|||
126084394|NCT01969851|453602188|FG001|Overall Study|Withdrawal by Subject|0|||
126084395|NCT01969851|453602189|FG002|Overall Study|Withdrawal by Subject|1|||
126084396|NCT01969851|453602187|FG000|Overall Study|No effective dose in Titration period|0|||
126084397|NCT01969851|453602188|FG001|Overall Study|No effective dose in Titration period|0|||
126084398|NCT01969851|453602189|FG002|Overall Study|No effective dose in Titration period|1|||
126084399|NCT01969851|453602187|FG000|Overall Study|Sponsor decision|0|||
126084400|NCT01969851|453602188|FG001|Overall Study|Sponsor decision|0|||
126084401|NCT01969851|453602189|FG002|Overall Study|Sponsor decision|1|||
126084402|NCT01430468|453602198|FG000|Overall Study|Physician Decision|2|||
126084403|NCT01430468|453602199|FG001|Overall Study|Physician Decision|1|||
126084404|NCT01430468|453602198|FG000|Overall Study|Withdrawal by Subject|5|||
126084405|NCT01430468|453602199|FG001|Overall Study|Withdrawal by Subject|5|||
126084406|NCT00617929|453602202|FG000|Overall Study|Physician Decision|1|||
126084407|NCT01426347|453602203|FG000|Overall Study|Lost to Follow-up|0|||
126115894|NCT00646906|453720055|FG002|Crossover Period 2|Withdrawal by Subject|2|||
126115895|NCT00646906|453720056|FG003|Crossover Period 2|Withdrawal by Subject|1|||
126115896|NCT00646906|453720057|FG004|Crossover Period 2|Withdrawal by Subject|0|||
126115897|NCT00646906|453720058|FG005|Crossover Period 2|Withdrawal by Subject|0|||
126084408|NCT01426347|453602204|FG001|Overall Study|Lost to Follow-up|3|||
126084409|NCT01426347|453602203|FG000|Overall Study|Protocol Violation|2|||
126084410|NCT01426347|453602204|FG001|Overall Study|Protocol Violation|0|||
126084411|NCT01426347|453602203|FG000|Overall Study|Withdrawal by Subject|5|||
126084412|NCT01426347|453602204|FG001|Overall Study|Withdrawal by Subject|0|||
126084413|NCT01151423|453602206|FG000|Overall Study|Study terminated by Sponsor|9|||
126084414|NCT01151423|453602207|FG001|Overall Study|Study terminated by Sponsor|10|||
126084415|NCT01151423|453602206|FG000|Overall Study|Protocol Violation|0|||
126084416|NCT01151423|453602207|FG001|Overall Study|Protocol Violation|1|||
126084417|NCT01151423|453602206|FG000|Overall Study|Physician Decision|1|||
126084418|NCT01151423|453602207|FG001|Overall Study|Physician Decision|1|||
126084419|NCT01151423|453602206|FG000|Overall Study|Pregnancy|0|||
126084420|NCT01151423|453602207|FG001|Overall Study|Pregnancy|1|||
126084421|NCT01151423|453602206|FG000|Overall Study|Death|0|||
126084422|NCT01151423|453602207|FG001|Overall Study|Death|1|||
126084423|NCT01151423|453602206|FG000|Overall Study|Adverse Event|3|||
126084424|NCT01151423|453602207|FG001|Overall Study|Adverse Event|0|||
126084425|NCT01151423|453602206|FG000|Overall Study|Withdrawal by Subject|1|||
126084426|NCT01151423|453602207|FG001|Overall Study|Withdrawal by Subject|3|||
126084427|NCT01151423|453602206|FG000|Overall Study|Lost to Follow-up|1|||
126084428|NCT01151423|453602207|FG001|Overall Study|Lost to Follow-up|0|||
126084429|NCT01151423|453602206|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
126084430|NCT01151423|453602207|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
126084431|NCT01151423|453602206|FG000|Overall Study|Participated in other clinical trial|1|||
126084432|NCT01151423|453602207|FG001|Overall Study|Participated in other clinical trial|0|||
126084433|NCT02763215|453604035|FG000|Overall Study|Participants withdrew from study|3|||
126084434|NCT02763215|453604035|FG000|Overall Study|Missed visit|1|||
126084435|NCT02763215|453604035|FG000|Overall Study|Visit outside visit-window|1|||
126084436|NCT02763215|453604035|FG000|Overall Study|Death|1|||
126084437|NCT02763215|453604035|FG000|Overall Study|Lost to Follow-up|1|||
126084438|NCT00475644|453604037|FG000|Overall Study|Protocol Violation|13|||
126084439|NCT01411241|453604038|FG000|Overall Study|Protocol Violation|0|||
126084440|NCT01411241|453604039|FG001|Overall Study|Protocol Violation|5|||
126084441|NCT01411241|453604038|FG000|Overall Study|Withdrawal by Subject|9|||
126084442|NCT01411241|453604039|FG001|Overall Study|Withdrawal by Subject|10|||
126084443|NCT01411241|453604038|FG000|Overall Study|Serious Adverse Event|0|||
126084444|NCT01411241|453604039|FG001|Overall Study|Serious Adverse Event|3|||
126084445|NCT01411241|453604038|FG000|Overall Study|Lost to Follow-up|2|||
126084446|NCT01411241|453604039|FG001|Overall Study|Lost to Follow-up|4|||
126084447|NCT01107899|453604043|FG000|Overall Study|Physician Decision|5|||
126084448|NCT01107899|453604044|FG001|Overall Study|Physician Decision|0|||
126084449|NCT01107899|453604045|FG002|Overall Study|Physician Decision|3|||
126084450|NCT01107899|453604043|FG000|Overall Study|Withdrawal by Subject|0|||
126084451|NCT01107899|453604044|FG001|Overall Study|Withdrawal by Subject|0|||
126084452|NCT01107899|453604045|FG002|Overall Study|Withdrawal by Subject|1|||
126084453|NCT00974259|453604046|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
126084454|NCT00974259|453604047|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
126084455|NCT01810939|453604067|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
126084456|NCT01810939|453604068|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
126084457|NCT01810939|453604069|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
126084458|NCT01810939|453604067|FG000|Part A Treatment Period|Protocol Violation|2|||
126084459|NCT01810939|453604068|FG001|Part A Treatment Period|Protocol Violation|0|||
126084460|NCT01810939|453604069|FG002|Part A Treatment Period|Protocol Violation|0|||
126084461|NCT01810939|453604067|FG000|Part A Treatment Period|Adverse Event|10|||
126084462|NCT01810939|453604068|FG001|Part A Treatment Period|Adverse Event|0|||
126084463|NCT01810939|453604069|FG002|Part A Treatment Period|Adverse Event|0|||
126084464|NCT01810939|453604067|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
126084465|NCT01810939|453604068|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
126084466|NCT01810939|453604069|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
126084467|NCT01810939|453604067|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
126084468|NCT01810939|453604068|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
126084469|NCT01810939|453604069|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
126084470|NCT01810939|453604067|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
126084471|NCT01810939|453604068|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
126084472|NCT01810939|453604069|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
126115898|NCT00646906|453720059|FG006|Crossover Period 2|Withdrawal by Subject|0|||
125954232|NCT02143843|453128643|FG000|Overall Study|Lack of Efficacy|2|||
126084473|NCT01810939|453604067|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
126084474|NCT01810939|453604068|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
126084475|NCT01810939|453604069|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
125954233|NCT02143843|453128643|FG000|Overall Study|Withdrawal by Subject|2|||
126084476|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
126084477|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
126084478|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
126084479|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
126084480|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
126084481|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
126115899|NCT00646906|453720053|FG000|Crossover Period 2|Physician Decision|0|||
126115900|NCT00646906|453720054|FG001|Crossover Period 2|Physician Decision|0|||
126115901|NCT00646906|453720055|FG002|Crossover Period 2|Physician Decision|0|||
126115902|NCT00646906|453720056|FG003|Crossover Period 2|Physician Decision|0|||
126115903|NCT00646906|453720057|FG004|Crossover Period 2|Physician Decision|0|||
126115904|NCT00646906|453720058|FG005|Crossover Period 2|Physician Decision|0|||
126115905|NCT00646906|453720059|FG006|Crossover Period 2|Physician Decision|1|||
126115906|NCT01303965|453720060|FG000|Overall Study|Adverse Event|1|||
126115907|NCT01303965|453720061|FG001|Overall Study|Adverse Event|1|||
126115908|NCT01303965|453720060|FG000|Overall Study|Death|0|||
126115909|NCT01303965|453720061|FG001|Overall Study|Death|3|||
126115910|NCT01303965|453720060|FG000|Overall Study|Withdrawal by Subject|1|||
126115911|NCT01303965|453720061|FG001|Overall Study|Withdrawal by Subject|0|||
126115912|NCT01303965|453720060|FG000|Overall Study|Disease Progression|1|||
126115913|NCT01303965|453720061|FG001|Overall Study|Disease Progression|6|||
126115914|NCT02844920|453720065|FG000|Overall Study|Lost to Follow-up|2|||
126115915|NCT00800436|453720070|FG000|Overall Study|Withdrawal by Subject|0|||
126115916|NCT00800436|453720071|FG001|Overall Study|Withdrawal by Subject|0|||
126115917|NCT00800436|453720072|FG002|Overall Study|Withdrawal by Subject|1|||
126115918|NCT00800436|453720073|FG003|Overall Study|Withdrawal by Subject|1|||
126115919|NCT00800436|453720074|FG004|Overall Study|Withdrawal by Subject|0|||
126115920|NCT00800436|453720075|FG005|Overall Study|Withdrawal by Subject|0|||
126115921|NCT00800436|453720076|FG006|Overall Study|Withdrawal by Subject|0|||
126115922|NCT00766090|453720077|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115923|NCT00766090|453720078|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115924|NCT00766090|453720079|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115925|NCT00766090|453720080|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115926|NCT00766090|453720081|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115927|NCT00766090|453720082|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115928|NCT00766090|453720083|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115929|NCT00766090|453720084|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115930|NCT00766090|453720085|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
126115931|NCT00766090|453720086|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115932|NCT00766090|453720087|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115933|NCT00766090|453720088|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126115934|NCT00766090|453720077|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
126115935|NCT00766090|453720078|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115936|NCT00766090|453720079|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115937|NCT00766090|453720080|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115938|NCT00766090|453720081|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115939|NCT00766090|453720082|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115940|NCT00766090|453720083|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115941|NCT00766090|453720084|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115942|NCT00766090|453720085|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115943|NCT00766090|453720086|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115944|NCT00766090|453720087|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126084482|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
126084483|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
126084484|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
126084485|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
126084486|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
126084487|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
126084488|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
126084489|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
126084490|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
126084491|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
126084492|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
126084493|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
126084494|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
126084495|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
126115945|NCT00766090|453720088|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126115946|NCT00766090|453720077|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126115947|NCT00766090|453720078|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126115948|NCT00766090|453720079|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126115949|NCT00766090|453720080|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126084496|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
126084497|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
126115950|NCT00766090|453720081|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126115951|NCT00766090|453720082|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126115952|NCT00766090|453720083|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125954234|NCT00308711|453128647|FG000|Overall Study|Withdrawal by Subject|1|||
125954235|NCT00308711|453128648|FG001|Overall Study|Withdrawal by Subject|0|||
125954236|NCT00308711|453128649|FG002|Overall Study|Withdrawal by Subject|1|||
125954237|NCT00308711|453128647|FG000|Overall Study|Protocol Violation|0|||
125954238|NCT00308711|453128648|FG001|Overall Study|Protocol Violation|1|||
125954239|NCT00308711|453128649|FG002|Overall Study|Protocol Violation|1|||
125954240|NCT00308711|453128647|FG000|Overall Study|Lost to Follow-up|0|||
125954241|NCT00308711|453128648|FG001|Overall Study|Lost to Follow-up|1|||
125954242|NCT00308711|453128649|FG002|Overall Study|Lost to Follow-up|0|||
125954243|NCT00308711|453128647|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
125954244|NCT00308711|453128648|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
125954245|NCT00308711|453128649|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
125954246|NCT00308711|453128647|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
125954247|NCT00308711|453128648|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
125954248|NCT00308711|453128649|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
125954249|NCT01420081|453128650|FG000|Overall Study|Death|1|||
125954250|NCT01420081|453128651|FG001|Overall Study|Death|0|||
125954251|NCT01420081|453128652|FG002|Overall Study|Death|8|||
125954252|NCT01420081|453128653|FG003|Overall Study|Death|0|||
125954253|NCT01420081|453128654|FG004|Overall Study|Death|7|||
125954254|NCT01420081|453128655|FG005|Overall Study|Death|12|||
125954255|NCT01420081|453128656|FG006|Overall Study|Death|0|||
125954256|NCT01420081|453128657|FG007|Overall Study|Death|1|||
125954257|NCT01420081|453128658|FG008|Overall Study|Death|1|||
125954258|NCT01420081|453128650|FG000|Overall Study|Lost to Follow-up|0|||
125954259|NCT01420081|453128651|FG001|Overall Study|Lost to Follow-up|0|||
125954260|NCT01420081|453128652|FG002|Overall Study|Lost to Follow-up|0|||
125954261|NCT01420081|453128653|FG003|Overall Study|Lost to Follow-up|0|||
125954262|NCT01420081|453128654|FG004|Overall Study|Lost to Follow-up|1|||
125954263|NCT01420081|453128655|FG005|Overall Study|Lost to Follow-up|1|||
125954264|NCT01420081|453128656|FG006|Overall Study|Lost to Follow-up|0|||
125954265|NCT01420081|453128657|FG007|Overall Study|Lost to Follow-up|0|||
125954266|NCT01420081|453128658|FG008|Overall Study|Lost to Follow-up|0|||
125954267|NCT01420081|453128650|FG000|Overall Study|Study Terminated by Sponsor|2|||
125954268|NCT01420081|453128651|FG001|Overall Study|Study Terminated by Sponsor|1|||
125954269|NCT01420081|453128652|FG002|Overall Study|Study Terminated by Sponsor|1|||
125954270|NCT01420081|453128653|FG003|Overall Study|Study Terminated by Sponsor|3|||
125954271|NCT01420081|453128654|FG004|Overall Study|Study Terminated by Sponsor|11|||
125954272|NCT01420081|453128655|FG005|Overall Study|Study Terminated by Sponsor|7|||
125954273|NCT01420081|453128656|FG006|Overall Study|Study Terminated by Sponsor|3|||
125954274|NCT01420081|453128657|FG007|Overall Study|Study Terminated by Sponsor|2|||
125954275|NCT01420081|453128658|FG008|Overall Study|Study Terminated by Sponsor|2|||
125954276|NCT01420081|453128650|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
125954277|NCT01420081|453128651|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
125954278|NCT01420081|453128652|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
125954279|NCT01420081|453128653|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
125954280|NCT01420081|453128654|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
125954281|NCT01420081|453128655|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
125954282|NCT01420081|453128656|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
125954283|NCT01420081|453128657|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
125954284|NCT01420081|453128658|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
125954285|NCT01420081|453128650|FG000|Overall Study|Other Reasons|0|||
125954286|NCT01420081|453128651|FG001|Overall Study|Other Reasons|0|||
125954287|NCT01420081|453128652|FG002|Overall Study|Other Reasons|1|||
125954288|NCT01420081|453128653|FG003|Overall Study|Other Reasons|0|||
125954289|NCT01420081|453128654|FG004|Overall Study|Other Reasons|0|||
125954290|NCT01420081|453128655|FG005|Overall Study|Other Reasons|0|||
125954291|NCT01420081|453128656|FG006|Overall Study|Other Reasons|0|||
125954292|NCT01420081|453128657|FG007|Overall Study|Other Reasons|0|||
125954293|NCT01420081|453128658|FG008|Overall Study|Other Reasons|0|||
125954294|NCT03467425|453128659|FG000|Overall Study|Adverse Event|9|||
125954295|NCT03467425|453128660|FG001|Overall Study|Adverse Event|9|||
125954296|NCT03467425|453128659|FG000|Overall Study|Lack of Efficacy|3|||
125954297|NCT03467425|453128660|FG001|Overall Study|Lack of Efficacy|1|||
125954298|NCT03467425|453128659|FG000|Overall Study|Protocol Violation|0|||
126084498|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
126084499|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
125954299|NCT03467425|453128660|FG001|Overall Study|Protocol Violation|1|||
125954300|NCT03467425|453128659|FG000|Overall Study|Lost to Follow-up|18|||
125954301|NCT03467425|453128660|FG001|Overall Study|Lost to Follow-up|25|||
126084500|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
125954302|NCT03467425|453128659|FG000|Overall Study|Physician Decision|2|||
125954303|NCT03467425|453128660|FG001|Overall Study|Physician Decision|1|||
125954304|NCT03467425|453128659|FG000|Overall Study|Withdrawal by Subject|15|||
125954305|NCT03467425|453128660|FG001|Overall Study|Withdrawal by Subject|17|||
125954306|NCT02318693|453128662|FG000|Overall Study|Protocol Violation|0|||
125954307|NCT02318693|453128663|FG001|Overall Study|Protocol Violation|1|||
125954308|NCT00025883|453128664|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
125954309|NCT00025883|453128664|FG000|Overall Study|no baseline data|1|||
125954310|NCT00025883|453128664|FG000|Overall Study|Death|1|||
125954311|NCT00025883|453128664|FG000|Overall Study|Adverse Event|1|||
125954312|NCT00025883|453128664|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
125954313|NCT00528528|453128670|FG000|Overall Study|Lost to Follow-up|0|||
125954314|NCT00528528|453128671|FG001|Overall Study|Lost to Follow-up|0|||
125954315|NCT00528528|453128672|FG002|Overall Study|Lost to Follow-up|1|||
125954316|NCT00528528|453128673|FG003|Overall Study|Lost to Follow-up|1|||
125954317|NCT00528528|453128670|FG000|Overall Study|Ineligible to continue the trial|0|||
125954318|NCT00528528|453128671|FG001|Overall Study|Ineligible to continue the trial|0|||
125954319|NCT00528528|453128672|FG002|Overall Study|Ineligible to continue the trial|0|||
125954320|NCT00528528|453128673|FG003|Overall Study|Ineligible to continue the trial|1|||
125954321|NCT00528528|453128670|FG000|Overall Study|Other|0|||
125954322|NCT00528528|453128671|FG001|Overall Study|Other|1|||
125954323|NCT00528528|453128672|FG002|Overall Study|Other|0|||
125954324|NCT00528528|453128673|FG003|Overall Study|Other|0|||
125954325|NCT00528528|453128670|FG000|Overall Study|Withdrawal by Subject|3|||
125954326|NCT00528528|453128671|FG001|Overall Study|Withdrawal by Subject|2|||
125954327|NCT00528528|453128672|FG002|Overall Study|Withdrawal by Subject|1|||
125954328|NCT00528528|453128673|FG003|Overall Study|Withdrawal by Subject|1|||
125954329|NCT00528528|453128670|FG000|Overall Study|Ongoing participant|0|||
125954330|NCT00528528|453128671|FG001|Overall Study|Ongoing participant|0|||
125954331|NCT00528528|453128672|FG002|Overall Study|Ongoing participant|1|||
125954332|NCT00528528|453128673|FG003|Overall Study|Ongoing participant|0|||
125954333|NCT04579679|453128674|FG000|Overall Study|New Antitumor Therapy|6|||
125954334|NCT04579679|453128675|FG001|Overall Study|New Antitumor Therapy|4|||
125954335|NCT04579679|453128676|FG002|Overall Study|New Antitumor Therapy|7|||
125954336|NCT04579679|453128677|FG003|Overall Study|New Antitumor Therapy|0|||
125954337|NCT04579679|453128674|FG000|Overall Study|Withdrawal of Consent|1|||
125954338|NCT04579679|453128675|FG001|Overall Study|Withdrawal of Consent|1|||
125954339|NCT04579679|453128676|FG002|Overall Study|Withdrawal of Consent|2|||
125954340|NCT04579679|453128677|FG003|Overall Study|Withdrawal of Consent|4|||
125954341|NCT04579679|453128674|FG000|Overall Study|Death|2|||
125954342|NCT04579679|453128675|FG001|Overall Study|Death|2|||
125954343|NCT04579679|453128676|FG002|Overall Study|Death|2|||
125954344|NCT04579679|453128677|FG003|Overall Study|Death|0|||
125954345|NCT04579679|453128674|FG000|Overall Study|Adverse Event|0|||
125954346|NCT04579679|453128675|FG001|Overall Study|Adverse Event|4|||
125954347|NCT04579679|453128676|FG002|Overall Study|Adverse Event|0|||
125954348|NCT04579679|453128677|FG003|Overall Study|Adverse Event|0|||
125954349|NCT04579679|453128674|FG000|Overall Study|Disease Progression|9|||
125954350|NCT04579679|453128675|FG001|Overall Study|Disease Progression|13|||
125954351|NCT04579679|453128676|FG002|Overall Study|Disease Progression|7|||
125954352|NCT04579679|453128677|FG003|Overall Study|Disease Progression|0|||
125954353|NCT04579679|453128674|FG000|Overall Study|Physician Decision|0|||
125954354|NCT04579679|453128675|FG001|Overall Study|Physician Decision|0|||
125954355|NCT04579679|453128676|FG002|Overall Study|Physician Decision|1|||
125954356|NCT04579679|453128677|FG003|Overall Study|Physician Decision|0|||
125954357|NCT04579679|453128674|FG000|Overall Study|Study Terminated by Sponsor|2|||
125954358|NCT04579679|453128675|FG001|Overall Study|Study Terminated by Sponsor|7|||
125954359|NCT04579679|453128676|FG002|Overall Study|Study Terminated by Sponsor|1|||
125954360|NCT04579679|453128677|FG003|Overall Study|Study Terminated by Sponsor|0|||
125954361|NCT03091192|453128678|FG000|Overall Study|Study terminated by sponsor|21|||
125954362|NCT03091192|453128679|FG001|Overall Study|Study terminated by sponsor|14|||
125954363|NCT03091192|453128678|FG000|Overall Study|Death|9|||
125954364|NCT03091192|453128679|FG001|Overall Study|Death|13|||
125954365|NCT03091192|453128678|FG000|Overall Study|Withdrawal by Subject|2|||
125954366|NCT03091192|453128679|FG001|Overall Study|Withdrawal by Subject|0|||
125954367|NCT03091192|453128678|FG000|Overall Study|Lost to Follow-up|1|||
125954368|NCT03091192|453128679|FG001|Overall Study|Lost to Follow-up|0|||
125954369|NCT04487080|453128680|FG000|Overall Study|Withdrawal by Subject|19|||
125954370|NCT04487080|453128681|FG001|Overall Study|Withdrawal by Subject|18|||
126084501|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
126084502|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
126084503|NCT01810939|453604067|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
125954371|NCT04487080|453128682|FG002|Overall Study|Withdrawal by Subject|13|||
125954372|NCT04487080|453128680|FG000|Overall Study|Lost to Follow-up|3|||
125954373|NCT04487080|453128681|FG001|Overall Study|Lost to Follow-up|1|||
125954374|NCT04487080|453128682|FG002|Overall Study|Lost to Follow-up|0|||
125954375|NCT04487080|453128680|FG000|Overall Study|Ongoing|313|||
126084504|NCT01810939|453604068|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
125954376|NCT04487080|453128681|FG001|Overall Study|Ongoing|297|||
125954377|NCT04487080|453128682|FG002|Overall Study|Ongoing|149|||
125954378|NCT05645432|453128683|FG000|Overall Study|Withdrawal by Subject|1|||
125954379|NCT03195478|453128684|FG000|Overall Study|Disease Progression|5|||
125954380|NCT03195478|453128685|FG001|Overall Study|Disease Progression|4|||
125954381|NCT03195478|453128686|FG002|Overall Study|Disease Progression|6|||
126084505|NCT01810939|453604069|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
126084506|NCT02963090|453604070|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
126084507|NCT02963090|453604071|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
126084508|NCT01375673|453604072|FG000|Overall Study|Withdrawal by Subject|0|||
126084509|NCT01375673|453604073|FG001|Overall Study|Withdrawal by Subject|1|||
126084510|NCT00979953|453604076|FG000|Overall Study|Adverse Event|5|||
126084511|NCT00979953|453604077|FG001|Overall Study|Adverse Event|2|||
126084512|NCT00979953|453604078|FG002|Overall Study|Adverse Event|17|||
126084513|NCT00979953|453604079|FG003|Overall Study|Adverse Event|4|||
126084514|NCT00979953|453604076|FG000|Overall Study|Lack of Efficacy|1|||
126084515|NCT00979953|453604077|FG001|Overall Study|Lack of Efficacy|2|||
126084516|NCT00979953|453604078|FG002|Overall Study|Lack of Efficacy|0|||
126084517|NCT00979953|453604079|FG003|Overall Study|Lack of Efficacy|0|||
126084518|NCT00979953|453604076|FG000|Overall Study|Lost to Follow-up|1|||
126084519|NCT00979953|453604077|FG001|Overall Study|Lost to Follow-up|1|||
126084520|NCT00979953|453604078|FG002|Overall Study|Lost to Follow-up|1|||
126084521|NCT00979953|453604079|FG003|Overall Study|Lost to Follow-up|0|||
126084522|NCT00979953|453604076|FG000|Overall Study|Withdrawal by Subject|0|||
126084523|NCT00979953|453604077|FG001|Overall Study|Withdrawal by Subject|0|||
126084524|NCT00979953|453604078|FG002|Overall Study|Withdrawal by Subject|2|||
126084525|NCT00979953|453604079|FG003|Overall Study|Withdrawal by Subject|1|||
126084526|NCT00979953|453604076|FG000|Overall Study|Protocol Violation|1|||
126084527|NCT00979953|453604077|FG001|Overall Study|Protocol Violation|0|||
126084528|NCT00979953|453604078|FG002|Overall Study|Protocol Violation|2|||
126084529|NCT00979953|453604079|FG003|Overall Study|Protocol Violation|2|||
126084530|NCT03054337|453604082|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
126084531|NCT03054337|453604083|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
126084532|NCT03054337|453604084|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
126084533|NCT03054337|453604085|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
126084534|NCT03054337|453604086|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
126084535|NCT03054337|453604087|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
126084536|NCT01681992|453604092|FG000|Overall Study|Adverse Event|3|||
126084537|NCT01681992|453604093|FG001|Overall Study|Adverse Event|2|||
126084538|NCT01681992|453604094|FG002|Overall Study|Adverse Event|3|||
126084539|NCT01681992|453604092|FG000|Overall Study|Lost to Follow-up|36|||
126084540|NCT01681992|453604093|FG001|Overall Study|Lost to Follow-up|38|||
126084541|NCT01681992|453604094|FG002|Overall Study|Lost to Follow-up|53|||
126084542|NCT01681992|453604092|FG000|Overall Study|As Per Sponsor Decision|0|||
126084543|NCT01681992|453604093|FG001|Overall Study|As Per Sponsor Decision|0|||
126084544|NCT01681992|453604094|FG002|Overall Study|As Per Sponsor Decision|1|||
126084545|NCT01681992|453604092|FG000|Overall Study|Protocol Violation|0|||
126084546|NCT01681992|453604093|FG001|Overall Study|Protocol Violation|0|||
126084547|NCT01681992|453604094|FG002|Overall Study|Protocol Violation|1|||
126084548|NCT01681992|453604092|FG000|Overall Study|Withdrawal by Subject|27|||
126084549|NCT01681992|453604093|FG001|Overall Study|Withdrawal by Subject|30|||
126084550|NCT01681992|453604094|FG002|Overall Study|Withdrawal by Subject|25|||
126084551|NCT01967069|453604100|FG000|Overall Study|Adverse Event|2|||
126084552|NCT01967069|453604101|FG001|Overall Study|Adverse Event|2|||
126084553|NCT01967069|453604100|FG000|Overall Study|Lost to Follow-up|5|||
126084554|NCT01967069|453604101|FG001|Overall Study|Lost to Follow-up|2|||
126084555|NCT01967069|453604100|FG000|Overall Study|Withdrawal by Subject|1|||
126084556|NCT01967069|453604101|FG001|Overall Study|Withdrawal by Subject|3|||
126084557|NCT01967069|453604100|FG000|Overall Study|Lack of Efficacy|0|||
126084558|NCT01967069|453604101|FG001|Overall Study|Lack of Efficacy|1|||
126084559|NCT02643628|453604110|FG000|Overall Study|Lost to Follow-up|1|||
126084560|NCT02643628|453604111|FG001|Overall Study|Lost to Follow-up|4|||
126084561|NCT02643628|453604110|FG000|Overall Study|Withdrawal by Subject|0|||
126084562|NCT02643628|453604111|FG001|Overall Study|Withdrawal by Subject|1|||
126084563|NCT02643628|453604110|FG000|Overall Study|Relocated out of state|0|||
126084564|NCT02643628|453604111|FG001|Overall Study|Relocated out of state|1|||
126084565|NCT04245345|453604112|FG000|Overall Study|Death|1|||
126084566|NCT04245345|453604112|FG000|Overall Study|Exited prior to implant|5|||
126084567|NCT04245345|453604112|FG000|Overall Study|Exited prior to 1-month|9|||
126084568|NCT04245345|453604112|FG000|Overall Study|Missed 1-month visit|3|||
126115953|NCT00766090|453720084|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126115954|NCT00766090|453720085|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126115955|NCT00766090|453720086|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126084569|NCT04245345|453604112|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
126084570|NCT04245345|453604112|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
126084571|NCT00706654|453604113|FG000|Conversion Phase|Lost to Follow-up|4|||
126084572|NCT00706654|453604114|FG001|Conversion Phase|Lost to Follow-up|0|||
126084573|NCT00706654|453604115|FG002|Conversion Phase|Lost to Follow-up|0|||
126084574|NCT00706654|453604116|FG003|Conversion Phase|Lost to Follow-up|0|||
126084575|NCT00706654|453604113|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
126084576|NCT00706654|453604114|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
126084577|NCT00706654|453604115|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
126084578|NCT00706654|453604116|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
126084579|NCT00706654|453604113|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
126084580|NCT00706654|453604114|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
126084581|NCT00706654|453604115|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
126084582|NCT00706654|453604116|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
126084583|NCT00706654|453604113|FG000|Conversion Phase|Withdrawn by Investigator|14|||
126084584|NCT00706654|453604114|FG001|Conversion Phase|Withdrawn by Investigator|0|||
126084585|NCT00706654|453604115|FG002|Conversion Phase|Withdrawn by Investigator|0|||
126084586|NCT00706654|453604116|FG003|Conversion Phase|Withdrawn by Investigator|0|||
126084587|NCT00706654|453604113|FG000|Conversion Phase|Withdrew Consent|38|||
126084588|NCT00706654|453604114|FG001|Conversion Phase|Withdrew Consent|0|||
126084589|NCT00706654|453604115|FG002|Conversion Phase|Withdrew Consent|0|||
126084590|NCT00706654|453604116|FG003|Conversion Phase|Withdrew Consent|0|||
126084591|NCT00706654|453604113|FG000|Conversion Phase|Adverse Event|18|||
126084592|NCT00706654|453604114|FG001|Conversion Phase|Adverse Event|0|||
126084593|NCT00706654|453604115|FG002|Conversion Phase|Adverse Event|0|||
126084594|NCT00706654|453604116|FG003|Conversion Phase|Adverse Event|0|||
126084595|NCT00706654|453604113|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
126084596|NCT00706654|453604114|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126084597|NCT00706654|453604115|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126084598|NCT00706654|453604116|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126084599|NCT00706654|453604113|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
126084600|NCT00706654|453604114|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126084601|NCT00706654|453604115|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126084602|NCT00706654|453604116|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126084603|NCT00706654|453604113|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
126084604|NCT00706654|453604114|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
126084605|NCT00706654|453604115|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
126084606|NCT00706654|453604116|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
126084607|NCT00706654|453604113|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
126084608|NCT00706654|453604114|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
126084609|NCT00706654|453604115|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
126084610|NCT00706654|453604116|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
126084611|NCT00706654|453604113|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
126084612|NCT00706654|453604114|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126084613|NCT00706654|453604115|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126084614|NCT00706654|453604116|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126084615|NCT00706654|453604113|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
126084616|NCT00706654|453604114|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126084617|NCT00706654|453604115|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126084618|NCT00706654|453604116|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126084619|NCT00706654|453604113|FG000|Oral Stabilization Phase|Withdrew consent|55|||
126084620|NCT00706654|453604114|FG001|Oral Stabilization Phase|Withdrew consent|0|||
126084621|NCT00706654|453604115|FG002|Oral Stabilization Phase|Withdrew consent|0|||
126084622|NCT00706654|453604116|FG003|Oral Stabilization Phase|Withdrew consent|0|||
126084623|NCT00706654|453604113|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
126084624|NCT00706654|453604114|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
126084625|NCT00706654|453604115|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
126084626|NCT00706654|453604116|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
126084627|NCT00706654|453604113|FG000|Oral Stabilization Phase|Adverse Event|21|||
126084628|NCT00706654|453604114|FG001|Oral Stabilization Phase|Adverse Event|0|||
126084629|NCT00706654|453604115|FG002|Oral Stabilization Phase|Adverse Event|0|||
126084630|NCT00706654|453604116|FG003|Oral Stabilization Phase|Adverse Event|0|||
126084631|NCT00706654|453604113|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
126084632|NCT00706654|453604114|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126084633|NCT00706654|453604115|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126084634|NCT00706654|453604116|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126084635|NCT00706654|453604113|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
126084636|NCT00706654|453604114|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126084637|NCT00706654|453604115|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126084638|NCT00706654|453604116|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126084639|NCT00706654|453604113|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
126084640|NCT00706654|453604114|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
126084641|NCT00706654|453604115|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
126084642|NCT00706654|453604116|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
126084643|NCT00706654|453604113|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
126084644|NCT00706654|453604114|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
126084645|NCT00706654|453604115|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
126084646|NCT00706654|453604116|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
125954382|NCT03195478|453128687|FG003|Overall Study|Disease Progression|1|||
125954383|NCT03195478|453128684|FG000|Overall Study|Study Drug Toxicity|2|||
125954384|NCT03195478|453128685|FG001|Overall Study|Study Drug Toxicity|0|||
125954385|NCT03195478|453128686|FG002|Overall Study|Study Drug Toxicity|0|||
125954386|NCT03195478|453128687|FG003|Overall Study|Study Drug Toxicity|1|||
125954387|NCT03195478|453128684|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
125954388|NCT03195478|453128685|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
125954389|NCT03195478|453128686|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
125954390|NCT03195478|453128687|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
125954391|NCT03195478|453128684|FG000|Overall Study|Participant Withdrew Consent|1|||
125954392|NCT03195478|453128685|FG001|Overall Study|Participant Withdrew Consent|0|||
125954393|NCT03195478|453128686|FG002|Overall Study|Participant Withdrew Consent|0|||
125954394|NCT03195478|453128687|FG003|Overall Study|Participant Withdrew Consent|0|||
125954395|NCT03195478|453128684|FG000|Overall Study|Maximum Clinical benefit|0|||
125954396|NCT03195478|453128685|FG001|Overall Study|Maximum Clinical benefit|0|||
125954397|NCT03195478|453128686|FG002|Overall Study|Maximum Clinical benefit|1|||
125954398|NCT03195478|453128687|FG003|Overall Study|Maximum Clinical benefit|0|||
125954399|NCT03195478|453128684|FG000|Overall Study|Other Reasons|0|||
125954400|NCT03195478|453128685|FG001|Overall Study|Other Reasons|0|||
125954401|NCT03195478|453128686|FG002|Overall Study|Other Reasons|1|||
125954402|NCT03195478|453128687|FG003|Overall Study|Other Reasons|0|||
125954403|NCT01677195|453129797|FG000|Overall Study|Lost to Follow-up|14|||
125954404|NCT01677195|453129798|FG001|Overall Study|Lost to Follow-up|22|||
125954405|NCT01677195|453129799|FG002|Overall Study|Lost to Follow-up|22|||
125954406|NCT01677195|453129797|FG000|Overall Study|Withdrawal by Subject|1|||
125954407|NCT01677195|453129798|FG001|Overall Study|Withdrawal by Subject|0|||
125954408|NCT01677195|453129799|FG002|Overall Study|Withdrawal by Subject|1|||
125954409|NCT01677195|453129797|FG000|Overall Study|Adverse Event|6|||
125954410|NCT01677195|453129798|FG001|Overall Study|Adverse Event|4|||
125954411|NCT01677195|453129799|FG002|Overall Study|Adverse Event|1|||
125954412|NCT01677195|453129797|FG000|Overall Study|Physician Decision|1|||
125954413|NCT01677195|453129798|FG001|Overall Study|Physician Decision|2|||
125954414|NCT01677195|453129799|FG002|Overall Study|Physician Decision|2|||
125954415|NCT01677195|453129797|FG000|Overall Study|Pregnancy|0|||
125954416|NCT01677195|453129798|FG001|Overall Study|Pregnancy|1|||
125954417|NCT01677195|453129799|FG002|Overall Study|Pregnancy|0|||
125954418|NCT01677195|453129797|FG000|Overall Study|Protocol Violation|7|||
125954419|NCT01677195|453129798|FG001|Overall Study|Protocol Violation|3|||
125954420|NCT01677195|453129799|FG002|Overall Study|Protocol Violation|4|||
125954421|NCT02472756|453129801|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
125954422|NCT02472756|453129801|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
125954423|NCT02472756|453129801|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
125954424|NCT02472756|453129801|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
125954425|NCT02472756|453129801|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
125954426|NCT00110266|453129805|FG000|Overall Study|Adverse Event|27|||
125954427|NCT00110266|453129805|FG000|Overall Study|Abnormal laboratory value|15|||
125954428|NCT00110266|453129805|FG000|Overall Study|Withdrawal by Subject|16|||
125954429|NCT00110266|453129805|FG000|Overall Study|Death|17|||
125954430|NCT00110266|453129805|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125954431|NCT00110266|453129805|FG000|Overall Study|Participant condition no longer requires study drug|1|||
125954432|NCT02896400|453129806|FG000|1 Month Follow-up|Lost to Follow-up|7|||
125954433|NCT02896400|453129807|FG001|1 Month Follow-up|Lost to Follow-up|7|||
125954434|NCT02896400|453129808|FG002|1 Month Follow-up|Lost to Follow-up|5|||
125954435|NCT02896400|453129809|FG003|1 Month Follow-up|Lost to Follow-up|8|||
125954436|NCT02896400|453129810|FG004|1 Month Follow-up|Lost to Follow-up|9|||
125954437|NCT02896400|453129811|FG005|1 Month Follow-up|Lost to Follow-up|6|||
125954438|NCT02896400|453129812|FG006|1 Month Follow-up|Lost to Follow-up|5|||
125954439|NCT02896400|453129813|FG007|1 Month Follow-up|Lost to Follow-up|6|||
125954440|NCT02896400|453129814|FG008|1 Month Follow-up|Lost to Follow-up|4|||
125954441|NCT02896400|453129815|FG009|1 Month Follow-up|Lost to Follow-up|7|||
125954442|NCT02896400|453129816|FG010|1 Month Follow-up|Lost to Follow-up|5|||
125954443|NCT02896400|453129817|FG011|1 Month Follow-up|Lost to Follow-up|5|||
125954444|NCT02896400|453129818|FG012|1 Month Follow-up|Lost to Follow-up|3|||
125954445|NCT02896400|453129819|FG013|1 Month Follow-up|Lost to Follow-up|4|||
126084647|NCT00706654|453604113|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
126084648|NCT00706654|453604114|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
126084649|NCT00706654|453604115|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
125954446|NCT02896400|453129820|FG014|1 Month Follow-up|Lost to Follow-up|1|||
125954447|NCT02896400|453129821|FG015|1 Month Follow-up|Lost to Follow-up|2|||
125954448|NCT02896400|453129806|FG000|1 Month Follow-up|Death|0|||
125954449|NCT02896400|453129807|FG001|1 Month Follow-up|Death|0|||
125954450|NCT02896400|453129808|FG002|1 Month Follow-up|Death|0|||
125954451|NCT02896400|453129809|FG003|1 Month Follow-up|Death|0|||
125954452|NCT02896400|453129810|FG004|1 Month Follow-up|Death|0|||
125954453|NCT02896400|453129811|FG005|1 Month Follow-up|Death|0|||
126084650|NCT00706654|453604116|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
125954454|NCT02896400|453129812|FG006|1 Month Follow-up|Death|0|||
125954455|NCT02896400|453129813|FG007|1 Month Follow-up|Death|0|||
125954456|NCT02896400|453129814|FG008|1 Month Follow-up|Death|0|||
125954457|NCT02896400|453129815|FG009|1 Month Follow-up|Death|0|||
125954458|NCT02896400|453129816|FG010|1 Month Follow-up|Death|0|||
125954459|NCT02896400|453129817|FG011|1 Month Follow-up|Death|0|||
125954460|NCT02896400|453129818|FG012|1 Month Follow-up|Death|0|||
125954461|NCT02896400|453129819|FG013|1 Month Follow-up|Death|0|||
125954462|NCT02896400|453129820|FG014|1 Month Follow-up|Death|0|||
125954463|NCT02896400|453129821|FG015|1 Month Follow-up|Death|1|||
125954464|NCT02896400|453129806|FG000|3 Month Follow-up|Lost to Follow-up|6|||
125954465|NCT02896400|453129807|FG001|3 Month Follow-up|Lost to Follow-up|3|||
125954466|NCT02896400|453129808|FG002|3 Month Follow-up|Lost to Follow-up|6|||
125954467|NCT02896400|453129809|FG003|3 Month Follow-up|Lost to Follow-up|11|||
125954468|NCT02896400|453129810|FG004|3 Month Follow-up|Lost to Follow-up|12|||
125954469|NCT02896400|453129811|FG005|3 Month Follow-up|Lost to Follow-up|6|||
125954470|NCT02896400|453129812|FG006|3 Month Follow-up|Lost to Follow-up|4|||
125954471|NCT02896400|453129813|FG007|3 Month Follow-up|Lost to Follow-up|3|||
125954472|NCT02896400|453129814|FG008|3 Month Follow-up|Lost to Follow-up|6|||
125954473|NCT02896400|453129815|FG009|3 Month Follow-up|Lost to Follow-up|5|||
125954474|NCT02896400|453129816|FG010|3 Month Follow-up|Lost to Follow-up|6|||
125954475|NCT02896400|453129817|FG011|3 Month Follow-up|Lost to Follow-up|6|||
125954476|NCT02896400|453129818|FG012|3 Month Follow-up|Lost to Follow-up|3|||
125954477|NCT02896400|453129819|FG013|3 Month Follow-up|Lost to Follow-up|5|||
125954478|NCT02896400|453129820|FG014|3 Month Follow-up|Lost to Follow-up|3|||
125954479|NCT02896400|453129821|FG015|3 Month Follow-up|Lost to Follow-up|2|||
125954480|NCT02896400|453129806|FG000|3 Month Follow-up|Death|0|||
125954481|NCT02896400|453129807|FG001|3 Month Follow-up|Death|0|||
125954482|NCT02896400|453129808|FG002|3 Month Follow-up|Death|0|||
125954483|NCT02896400|453129809|FG003|3 Month Follow-up|Death|0|||
125954484|NCT02896400|453129810|FG004|3 Month Follow-up|Death|0|||
125954485|NCT02896400|453129811|FG005|3 Month Follow-up|Death|0|||
125954486|NCT02896400|453129812|FG006|3 Month Follow-up|Death|0|||
125954487|NCT02896400|453129813|FG007|3 Month Follow-up|Death|0|||
125954488|NCT02896400|453129814|FG008|3 Month Follow-up|Death|0|||
125954489|NCT02896400|453129815|FG009|3 Month Follow-up|Death|0|||
125954490|NCT02896400|453129816|FG010|3 Month Follow-up|Death|0|||
125954491|NCT02896400|453129817|FG011|3 Month Follow-up|Death|0|||
125954492|NCT02896400|453129818|FG012|3 Month Follow-up|Death|0|||
125954493|NCT02896400|453129819|FG013|3 Month Follow-up|Death|1|||
125954494|NCT02896400|453129820|FG014|3 Month Follow-up|Death|1|||
125954495|NCT02896400|453129821|FG015|3 Month Follow-up|Death|0|||
125954496|NCT02896400|453129806|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125954497|NCT02896400|453129807|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125954498|NCT02896400|453129808|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125954499|NCT02896400|453129809|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125954500|NCT02896400|453129810|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125954501|NCT02896400|453129811|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125954502|NCT02896400|453129812|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
125954503|NCT02896400|453129813|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
125954504|NCT02896400|453129814|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125954505|NCT02896400|453129815|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125954506|NCT02896400|453129816|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125954507|NCT02896400|453129817|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125954508|NCT02896400|453129818|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125954509|NCT02896400|453129819|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125954510|NCT02896400|453129820|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
125954511|NCT02896400|453129821|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125954512|NCT02896400|453129806|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
125954513|NCT02896400|453129807|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
125954514|NCT02896400|453129808|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
125954515|NCT02896400|453129809|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
125954516|NCT02896400|453129810|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
125954517|NCT02896400|453129811|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
125954518|NCT02896400|453129812|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
125954519|NCT02896400|453129813|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
125954520|NCT02896400|453129814|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
125954521|NCT02896400|453129815|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
125954522|NCT02896400|453129816|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
125954523|NCT02896400|453129817|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
125954524|NCT02896400|453129818|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
125971513|NCT00791765|453184716|FG000|Weeks 1 to 12|Ineligibility determined|0|||
126084651|NCT00706654|453604113|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
126084652|NCT00706654|453604114|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
125954525|NCT02896400|453129819|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
125954526|NCT02896400|453129820|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
125954527|NCT02896400|453129821|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
125954528|NCT01207778|453129822|FG000|Overall Study|Lost to Follow-up|0|||
125954529|NCT01207778|453129823|FG001|Overall Study|Lost to Follow-up|3|||
125954530|NCT01207778|453129824|FG002|Overall Study|Lost to Follow-up|3|||
125954531|NCT00646204|453129825|FG000|Overall Study|Adverse Event|3|||
125954532|NCT00646204|453129826|FG001|Overall Study|Adverse Event|0|||
125954533|NCT00646204|453129825|FG000|Overall Study|Withdrawal by Subject|1|||
125954534|NCT00646204|453129826|FG001|Overall Study|Withdrawal by Subject|0|||
125954535|NCT02488629|453129830|FG000|Overall Study|Lack of Efficacy|3|||
125954536|NCT02488629|453129831|FG001|Overall Study|Lack of Efficacy|1|||
125954537|NCT02488629|453129832|FG002|Overall Study|Lack of Efficacy|0|||
125954538|NCT02488629|453129833|FG003|Overall Study|Lack of Efficacy|0|||
125954539|NCT02488629|453129830|FG000|Overall Study|Withdrawal by Subject|0|||
125954540|NCT02488629|453129831|FG001|Overall Study|Withdrawal by Subject|1|||
125954541|NCT02488629|453129832|FG002|Overall Study|Withdrawal by Subject|0|||
125954542|NCT02488629|453129833|FG003|Overall Study|Withdrawal by Subject|0|||
125954543|NCT02940691|453129834|FG000|Overall Study|Lost to Follow-up|5|||
125954544|NCT02940691|453129834|FG000|Overall Study|Incarceration|1|||
125954545|NCT03912233|453129835|FG000|Overall Study|Adverse Event|1|||
125954546|NCT03912233|453129836|FG001|Overall Study|Adverse Event|0|||
125954547|NCT03912233|453129837|FG002|Overall Study|Adverse Event|0|||
125954548|NCT03912233|453129838|FG003|Overall Study|Adverse Event|0|||
125954549|NCT03912233|453129839|FG004|Overall Study|Adverse Event|0|||
125954550|NCT03912233|453129840|FG005|Overall Study|Adverse Event|0|||
125954551|NCT03912233|453129835|FG000|Overall Study|Physician Decision|1|||
125954552|NCT03912233|453129836|FG001|Overall Study|Physician Decision|0|||
125954553|NCT03912233|453129837|FG002|Overall Study|Physician Decision|0|||
125954554|NCT03912233|453129838|FG003|Overall Study|Physician Decision|0|||
125954555|NCT03912233|453129839|FG004|Overall Study|Physician Decision|0|||
125954556|NCT03912233|453129840|FG005|Overall Study|Physician Decision|0|||
125954557|NCT03912233|453129835|FG000|Overall Study|Other|0|||
125954558|NCT03912233|453129836|FG001|Overall Study|Other|0|||
125954559|NCT03912233|453129837|FG002|Overall Study|Other|0|||
125954560|NCT03912233|453129838|FG003|Overall Study|Other|0|||
125954561|NCT03912233|453129839|FG004|Overall Study|Other|7|||
125954562|NCT03912233|453129840|FG005|Overall Study|Other|12|||
125954563|NCT02177266|453129841|FG000|Overall Study|Adverse Event|0|||
125954564|NCT02177266|453129842|FG001|Overall Study|Adverse Event|1|||
125954565|NCT02177266|453129841|FG000|Overall Study|Withdrawal by Subject|1|||
125954566|NCT02177266|453129842|FG001|Overall Study|Withdrawal by Subject|0|||
125954567|NCT00546715|453129844|FG000|Overall Study|Withdrawal by Subject|0|||
125954568|NCT00546715|453129845|FG001|Overall Study|Withdrawal by Subject|1|||
125954569|NCT00546715|453129846|FG002|Overall Study|Withdrawal by Subject|0|||
125954570|NCT00546715|453129847|FG003|Overall Study|Withdrawal by Subject|0|||
125954571|NCT00723606|453129848|FG000|Overall Study|Adverse Event|2|||
125954572|NCT00723606|453129849|FG001|Overall Study|Adverse Event|5|||
125954573|NCT00723606|453129848|FG000|Overall Study|Other|2|||
125954574|NCT00723606|453129849|FG001|Overall Study|Other|0|||
125954575|NCT00723606|453129848|FG000|Overall Study|Withdrawal by Subject|0|||
125954576|NCT00723606|453129849|FG001|Overall Study|Withdrawal by Subject|2|||
125954577|NCT01350128|453129859|FG000|Overall Study|Withdrawal by Subject|3|||
125954578|NCT01350128|453129859|FG000|Overall Study|Protocol discontinuation criteria|8|||
125954579|NCT01350128|453129859|FG000|Overall Study|Physician Decision|1|||
125954580|NCT01350128|453129859|FG000|Overall Study|Lost to Follow-up|2|||
125954581|NCT02644967|453129865|FG000|Overall Study|Death|26|||
125954582|NCT02644967|453129865|FG000|Overall Study|Physician Decision|1|||
125954583|NCT02644967|453129865|FG000|Overall Study|Withdrawal by Subject|2|||
126084653|NCT00706654|453604115|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
126084654|NCT00706654|453604116|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
126084655|NCT00706654|453604113|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
125954584|NCT02644967|453129865|FG000|Overall Study|Protocol Violation|1|||
125954585|NCT02644967|453129865|FG000|Overall Study|Progressive Disease|1|||
125954586|NCT02644967|453129865|FG000|Overall Study|Study Terminated by Sponsor|4|||
125954587|NCT03323099|453129867|FG000|Overall Study|Withdrawal by Subject|6|||
125954588|NCT03323099|453129868|FG001|Overall Study|Withdrawal by Subject|12|||
125954589|NCT03323099|453129867|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
125954590|NCT03323099|453129868|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
125954591|NCT01502644|453129873|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
125954592|NCT01502644|453129874|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
125954593|NCT01502644|453129875|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
125954594|NCT01502644|453129876|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
126084656|NCT00706654|453604114|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
125954595|NCT01502644|453129873|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
125954596|NCT01502644|453129874|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
125954597|NCT01502644|453129875|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
125954598|NCT01502644|453129876|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
125954599|NCT01502644|453129873|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
125954600|NCT01502644|453129874|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
125954601|NCT01502644|453129875|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
125954602|NCT01502644|453129876|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
125954603|NCT01502644|453129873|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
125954604|NCT01502644|453129874|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
125954605|NCT01502644|453129875|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
125954606|NCT01502644|453129876|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
125954607|NCT01502644|453129873|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
125954608|NCT01502644|453129874|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
125954609|NCT01502644|453129875|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
125954610|NCT01502644|453129876|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
125954611|NCT02388997|453129879|FG000|Overall Study|Adverse Event|1|||
125954612|NCT02388997|453129880|FG001|Overall Study|Adverse Event|2|||
125954613|NCT02388997|453129879|FG000|Overall Study|Withdrawal by Subject|2|||
125954614|NCT02388997|453129880|FG001|Overall Study|Withdrawal by Subject|1|||
125954615|NCT02388997|453129879|FG000|Overall Study|Lung function exclusion criteria|0|||
125954616|NCT02388997|453129880|FG001|Overall Study|Lung function exclusion criteria|2|||
125954617|NCT02388997|453129879|FG000|Overall Study|Tested positive for virus during run-in|0|||
125954618|NCT02388997|453129880|FG001|Overall Study|Tested positive for virus during run-in|1|||
125954619|NCT03025828|453129881|FG000|Overall Study|Lost to Follow-up|1|||
125954620|NCT02375672|453129882|FG000|Overall Study|remain on follow up|20|||
125954621|NCT01559311|453129883|FG000|Overall Study|Protocol Violation|0|||
125954622|NCT01559311|453129884|FG001|Overall Study|Protocol Violation|0|||
125954623|NCT01559311|453129885|FG002|Overall Study|Protocol Violation|2|||
125954624|NCT01559311|453129883|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
125954625|NCT01559311|453129884|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
125954626|NCT01559311|453129885|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
125954627|NCT01559311|453129883|FG000|Overall Study|Withdrawal by Subject|2|||
125954628|NCT01559311|453129884|FG001|Overall Study|Withdrawal by Subject|1|||
126084657|NCT00706654|453604115|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
126084658|NCT00706654|453604116|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
126084659|NCT00706654|453604113|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
126084660|NCT00706654|453604114|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
126084661|NCT00706654|453604115|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
126084662|NCT00706654|453604116|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
126084663|NCT00706654|453604113|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
126084664|NCT00706654|453604114|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
126084665|NCT00706654|453604115|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
126084666|NCT00706654|453604116|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
126084667|NCT00706654|453604113|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
126084668|NCT00706654|453604114|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
126084669|NCT00706654|453604115|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
126084670|NCT00706654|453604116|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
126084671|NCT01001390|453604122|FG000|Overall Study|Failure to wear AFO device|2|||
126084672|NCT01001390|453604123|FG001|Overall Study|Failure to wear AFO device|0|||
126084673|NCT03690427|453604124|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
126084674|NCT03690427|453604125|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
126084675|NCT01151215|453604126|FG000|Overall Study|Worsening of condition under study|1|||
126084676|NCT01151215|453604127|FG001|Overall Study|Worsening of condition under study|1|||
126084677|NCT01151215|453604128|FG002|Overall Study|Worsening of condition under study|1|||
126084678|NCT01151215|453604126|FG000|Overall Study|Death|16|||
126084679|NCT01151215|453604127|FG001|Overall Study|Death|20|||
126084680|NCT01151215|453604128|FG002|Overall Study|Death|11|||
126084681|NCT01151215|453604126|FG000|Overall Study|Lost to Follow-up|0|||
126084682|NCT01151215|453604127|FG001|Overall Study|Lost to Follow-up|0|||
126084683|NCT01151215|453604128|FG002|Overall Study|Lost to Follow-up|3|||
126084684|NCT01151215|453604126|FG000|Overall Study|Withdrawal by Subject|3|||
126084685|NCT01151215|453604127|FG001|Overall Study|Withdrawal by Subject|1|||
126084686|NCT01151215|453604128|FG002|Overall Study|Withdrawal by Subject|2|||
126084687|NCT01151215|453604126|FG000|Overall Study|Disease progression|0|||
126084688|NCT01151215|453604127|FG001|Overall Study|Disease progression|1|||
126084689|NCT01151215|453604128|FG002|Overall Study|Disease progression|1|||
126084690|NCT01151215|453604126|FG000|Overall Study|Safety as judged by the investigator|0|||
126084691|NCT01151215|453604127|FG001|Overall Study|Safety as judged by the investigator|0|||
126084692|NCT01151215|453604128|FG002|Overall Study|Safety as judged by the investigator|1|||
126084693|NCT01721954|453604132|FG000|Overall Study|Death|58|||
126084694|NCT01721954|453604133|FG001|Overall Study|Death|64|||
126084695|NCT01721954|453604132|FG000|Overall Study|Withdrawal by Subject|8|||
126084696|NCT01721954|453604133|FG001|Overall Study|Withdrawal by Subject|4|||
126084697|NCT01721954|453604132|FG000|Overall Study|Adverse Event|2|||
126084698|NCT01721954|453604133|FG001|Overall Study|Adverse Event|0|||
126084699|NCT01721954|453604132|FG000|Overall Study|Lost to Follow-up|2|||
126084700|NCT01721954|453604133|FG001|Overall Study|Lost to Follow-up|1|||
126084701|NCT02609672|453604137|FG000|Overall Study|Lost to Follow-up|3|||
126084702|NCT02609672|453604138|FG001|Overall Study|Lost to Follow-up|1|||
126084703|NCT03392168|453604139|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
126084704|NCT03392168|453604140|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
126084705|NCT03392168|453604141|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
126084706|NCT03392168|453604142|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
126084707|NCT03392168|453604139|FG000|Period 2: Cohort 2|Other|0|||
126084708|NCT03392168|453604140|FG001|Period 2: Cohort 2|Other|1|||
126084709|NCT03392168|453604141|FG002|Period 2: Cohort 2|Other|0|||
126084710|NCT03392168|453604142|FG003|Period 2: Cohort 2|Other|0|||
126084711|NCT02956837|453604143|FG000|Overall Study|Serious Adverse Events|0|||
126084712|NCT02956837|453604144|FG001|Overall Study|Serious Adverse Events|1|||
126084713|NCT02956837|453604145|FG002|Overall Study|Serious Adverse Events|0|||
126084714|NCT02956837|453604146|FG003|Overall Study|Serious Adverse Events|0|||
126084715|NCT02956837|453604143|FG000|Overall Study|Withdrawal by Subject|0|||
126084716|NCT02956837|453604144|FG001|Overall Study|Withdrawal by Subject|1|||
126084717|NCT02956837|453604145|FG002|Overall Study|Withdrawal by Subject|0|||
126084718|NCT02956837|453604146|FG003|Overall Study|Withdrawal by Subject|3|||
126084719|NCT02956837|453604143|FG000|Overall Study|Lost to Follow-up|0|||
126084720|NCT02956837|453604144|FG001|Overall Study|Lost to Follow-up|1|||
126084721|NCT02956837|453604145|FG002|Overall Study|Lost to Follow-up|2|||
126084722|NCT02956837|453604146|FG003|Overall Study|Lost to Follow-up|0|||
126084723|NCT02597712|453604147|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
126084724|NCT02597712|453604148|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
126084725|NCT02597712|453604147|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
126084726|NCT02597712|453604148|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
126084727|NCT02597712|453604147|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
126084728|NCT02597712|453604148|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
126084729|NCT02637323|453604149|FG000|Overall Study|Lost to Follow-up|2|||
126084730|NCT02637323|453604150|FG001|Overall Study|Lost to Follow-up|0|||
126084731|NCT02637323|453604149|FG000|Overall Study|Protocol Violation|0|||
126084732|NCT02637323|453604150|FG001|Overall Study|Protocol Violation|1|||
126084733|NCT00513708|453604151|FG000|Overall Study|Lost to Follow-up|4|||
126084734|NCT00513708|453604152|FG001|Overall Study|Lost to Follow-up|4|||
126084735|NCT00513708|453604153|FG002|Overall Study|Lost to Follow-up|4|||
126084736|NCT01162486|453604154|FG000|Overall Study|low ANC|1|||
126084737|NCT01162486|453604155|FG001|Overall Study|low ANC|0|||
126084738|NCT01162486|453604156|FG002|Overall Study|low ANC|0|||
126084739|NCT01162486|453604157|FG003|Overall Study|low ANC|0|||
126084740|NCT01162486|453604158|FG004|Overall Study|low ANC|0|||
126084741|NCT01162486|453604154|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
126084742|NCT01162486|453604155|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
126084743|NCT01162486|453604156|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
126084744|NCT01162486|453604157|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
126084745|NCT01162486|453604158|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
126084746|NCT01162486|453604154|FG000|Overall Study|elevated LFTs|0|||
126084747|NCT01162486|453604155|FG001|Overall Study|elevated LFTs|0|||
126084748|NCT01162486|453604156|FG002|Overall Study|elevated LFTs|1|||
126084749|NCT01162486|453604157|FG003|Overall Study|elevated LFTs|0|||
126084750|NCT01162486|453604158|FG004|Overall Study|elevated LFTs|0|||
126084751|NCT01162486|453604154|FG000|Overall Study|Pregnancy|0|||
126084752|NCT01162486|453604155|FG001|Overall Study|Pregnancy|0|||
126084753|NCT01162486|453604156|FG002|Overall Study|Pregnancy|0|||
126084754|NCT01162486|453604157|FG003|Overall Study|Pregnancy|1|||
126084755|NCT01162486|453604158|FG004|Overall Study|Pregnancy|0|||
126084756|NCT03274895|453604161|FG000|Overall Study|Lack of Efficacy|1|||
126084757|NCT03274895|453604162|FG001|Overall Study|Lack of Efficacy|0|||
126084758|NCT03274895|453604161|FG000|Overall Study|Adverse Event|8|||
126084759|NCT03274895|453604162|FG001|Overall Study|Adverse Event|7|||
126084760|NCT03274895|453604161|FG000|Overall Study|Lost to Follow-up|1|||
126084761|NCT03274895|453604162|FG001|Overall Study|Lost to Follow-up|0|||
126084762|NCT03274895|453604161|FG000|Overall Study|Diagnosis not confirmed|3|||
126084763|NCT03274895|453604162|FG001|Overall Study|Diagnosis not confirmed|4|||
126084764|NCT00401258|453604166|FG000|Overall Study|Adverse Event|7|||
126084765|NCT03229486|453604172|FG000|Overall Study|Protocol Violation|0|||
126084766|NCT03229486|453604173|FG001|Overall Study|Protocol Violation|1|||
126084767|NCT01461005|453604174|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
126084768|NCT00760747|453604179|FG000|Study Period II|Adverse Event|3|||
126084769|NCT00760747|453604180|FG001|Study Period II|Adverse Event|4|||
126084770|NCT00760747|453604179|FG000|Study Period II|Lack of Efficacy|0|||
126084771|NCT00760747|453604180|FG001|Study Period II|Lack of Efficacy|6|||
126084772|NCT00760747|453604179|FG000|Study Period II|Parent/Caregiver Decision|3|||
126084773|NCT00760747|453604180|FG001|Study Period II|Parent/Caregiver Decision|0|||
126084774|NCT00760747|453604179|FG000|Study Period II|Protocol Violation|6|||
126084775|NCT00760747|453604180|FG001|Study Period II|Protocol Violation|3|||
126084776|NCT00760747|453604179|FG000|Study Period II|Withdrawal by Subject|1|||
126084777|NCT00760747|453604180|FG001|Study Period II|Withdrawal by Subject|0|||
126084778|NCT00760747|453604179|FG000|Study Period II|No drug administered|0|||
126084779|NCT00760747|453604180|FG001|Study Period II|No drug administered|1|||
126084780|NCT00760747|453604179|FG000|Study Period III|Adverse Event|1|||
126084781|NCT00760747|453604180|FG001|Study Period III|Adverse Event|0|||
126084782|NCT00760747|453604179|FG000|Study Period III|Lack of Efficacy|1|||
126084783|NCT00760747|453604180|FG001|Study Period III|Lack of Efficacy|0|||
126084784|NCT00760747|453604179|FG000|Study Period III|Parent/Caregiver Decision|0|||
126084785|NCT00760747|453604180|FG001|Study Period III|Parent/Caregiver Decision|1|||
126084786|NCT00760747|453604179|FG000|Study Period III|Protocol Violation|1|||
126084787|NCT00760747|453604180|FG001|Study Period III|Protocol Violation|1|||
126084788|NCT00760747|453604179|FG000|Study Period III|Physician Decision|0|||
126084789|NCT00760747|453604180|FG001|Study Period III|Physician Decision|1|||
126084790|NCT01443923|453604181|FG000|Overall Study|Adverse Event|1|||
126084791|NCT01443923|453604182|FG001|Overall Study|Adverse Event|0|||
126084792|NCT03566979|453604185|FG000|Overall Study|Withdrawal by Subject|2|||
126084793|NCT03566979|453604186|FG001|Overall Study|Withdrawal by Subject|0|||
126084794|NCT03566979|453604187|FG002|Overall Study|Withdrawal by Subject|1|||
126084795|NCT03566979|453604188|FG003|Overall Study|Withdrawal by Subject|1|||
126084796|NCT03566979|453604185|FG000|Overall Study|Lost to Follow-up|2|||
126084797|NCT03566979|453604186|FG001|Overall Study|Lost to Follow-up|7|||
126084798|NCT03566979|453604187|FG002|Overall Study|Lost to Follow-up|9|||
126084799|NCT03566979|453604188|FG003|Overall Study|Lost to Follow-up|5|||
126084800|NCT03566979|453604185|FG000|Overall Study|Adverse Event|1|||
126084801|NCT03566979|453604186|FG001|Overall Study|Adverse Event|0|||
126084802|NCT03566979|453604187|FG002|Overall Study|Adverse Event|0|||
126084803|NCT03566979|453604188|FG003|Overall Study|Adverse Event|0|||
126084804|NCT01228175|453604193|FG000|Overall Study|Lost to Follow-up|64|||
126084805|NCT01228175|453604194|FG001|Overall Study|Lost to Follow-up|50|||
126084806|NCT01228175|453604193|FG000|Overall Study|Withdrawal by Subject|1|||
126084807|NCT01228175|453604194|FG001|Overall Study|Withdrawal by Subject|2|||
126084808|NCT01228175|453604193|FG000|Overall Study|Physician Decision|1|||
126084809|NCT01228175|453604194|FG001|Overall Study|Physician Decision|1|||
126084810|NCT01889069|453604195|FG000|Overall Study|Death|18|||
126084811|NCT01889069|453604195|FG000|Overall Study|Progression of Disease|14|||
126084812|NCT01889069|453604195|FG000|Overall Study|Lost to Follow-up|6|||
126084813|NCT01889069|453604195|FG000|Overall Study|Other|4|||
126084814|NCT01889069|453604195|FG000|Overall Study|Consent Withdrawal|3|||
126084815|NCT00108745|453604196|FG000|Overall Study|Withdrawal by Subject|19|||
126084816|NCT00108745|453604197|FG001|Overall Study|Withdrawal by Subject|12|||
126084817|NCT00108745|453604198|FG002|Overall Study|Withdrawal by Subject|12|||
126084818|NCT00108745|453604196|FG000|Overall Study|Never Treated|8|||
126084819|NCT00108745|453604197|FG001|Overall Study|Never Treated|10|||
126084820|NCT00108745|453604198|FG002|Overall Study|Never Treated|12|||
126084821|NCT00108745|453604196|FG000|Overall Study|Ineligible|7|||
126084822|NCT00108745|453604197|FG001|Overall Study|Ineligible|13|||
126084823|NCT00108745|453604198|FG002|Overall Study|Ineligible|13|||
126084824|NCT00455741|453604200|FG000|Overall Study|Physician Decision|0|||
126084825|NCT00455741|453604201|FG001|Overall Study|Physician Decision|1|||
126084826|NCT01245374|453604205|FG000|Overall Study|Protocol Violation|1|||
126084827|NCT01245374|453604205|FG000|Overall Study|Withdrawal by Subject|3|||
126084828|NCT02227992|453604206|FG000|Overall Study|Lost to Follow-up|1|||
126084829|NCT02227992|453604207|FG001|Overall Study|Lost to Follow-up|1|||
126084830|NCT00935532|453604208|FG000|Overall Study|Adverse Event|11|||
126115956|NCT00766090|453720087|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126115957|NCT00766090|453720088|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126084831|NCT00935532|453604209|FG001|Overall Study|Adverse Event|6|||
126084832|NCT00935532|453604208|FG000|Overall Study|Death|1|||
126084833|NCT00935532|453604209|FG001|Overall Study|Death|0|||
126084834|NCT00935532|453604208|FG000|Overall Study|Lost to Follow-up|1|||
126084835|NCT00935532|453604209|FG001|Overall Study|Lost to Follow-up|0|||
126115958|NCT00766090|453720077|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
125954629|NCT01559311|453129885|FG002|Overall Study|Withdrawal by Subject|0|||
126084836|NCT00935532|453604208|FG000|Overall Study|Physician Decision|1|||
126084837|NCT00935532|453604209|FG001|Overall Study|Physician Decision|2|||
126084838|NCT00935532|453604208|FG000|Overall Study|Protocol Violation|2|||
126084839|NCT00935532|453604209|FG001|Overall Study|Protocol Violation|1|||
126084840|NCT00935532|453604208|FG000|Overall Study|Subject Decision|2|||
126084841|NCT00935532|453604209|FG001|Overall Study|Subject Decision|1|||
126084842|NCT00935532|453604208|FG000|Overall Study|Sponsor Decision|0|||
126084843|NCT00935532|453604209|FG001|Overall Study|Sponsor Decision|1|||
126084844|NCT00935532|453604208|FG000|Overall Study|Loss Glucose Control|4|||
126084845|NCT00935532|453604209|FG001|Overall Study|Loss Glucose Control|0|||
126084846|NCT04954326|453604210|FG000|Overall Study|Protocol Violation|0|||
126084847|NCT04954326|453604211|FG001|Overall Study|Protocol Violation|1|||
126084848|NCT04954326|453604210|FG000|Overall Study|Death|0|||
126084849|NCT04954326|453604211|FG001|Overall Study|Death|2|||
126084850|NCT04954326|453604210|FG000|Overall Study|Physician Decision|0|||
126084851|NCT04954326|453604211|FG001|Overall Study|Physician Decision|1|||
126084852|NCT04982575|453604212|FG000|Overall Study|Withdrawal by Subject|2|||
126084853|NCT04982575|453604213|FG001|Overall Study|Withdrawal by Subject|0|||
126084854|NCT04982575|453604214|FG002|Overall Study|Withdrawal by Subject|2|||
126084855|NCT00475228|453604215|FG000|Overall Study|Lost to Follow-up|17|||
126084856|NCT00475228|453604216|FG001|Overall Study|Lost to Follow-up|17|||
126084857|NCT04949802|453606399|FG000|Overall Study|Lost to Follow-up|3|||
126084858|NCT02473965|453606400|FG000|Overall Study|Adverse Event|6|||
126084859|NCT02473965|453606401|FG001|Overall Study|Adverse Event|4|||
126084860|NCT02473965|453606400|FG000|Overall Study|MG worsening|4|||
126084861|NCT02473965|453606401|FG001|Overall Study|MG worsening|1|||
126084862|NCT02473965|453606400|FG000|Overall Study|Withdrawal by Subject|2|||
126084863|NCT02473965|453606401|FG001|Overall Study|Withdrawal by Subject|3|||
126084864|NCT02473965|453606400|FG000|Overall Study|Physician Decision|0|||
126084865|NCT02473965|453606401|FG001|Overall Study|Physician Decision|2|||
126084866|NCT01183390|453606402|FG000|First Intervention|Adverse Event|0|||
126084867|NCT01183390|453606403|FG001|First Intervention|Adverse Event|1|||
126084868|NCT03816761|453606404|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126084869|NCT03816761|453606405|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126084870|NCT03816761|453606406|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126084871|NCT03816761|453606407|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126084872|NCT03816761|453606408|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126084873|NCT03816761|453606409|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
126084874|NCT03816761|453606404|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
126084875|NCT03816761|453606405|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
126084876|NCT03816761|453606406|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
126084877|NCT03816761|453606407|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
126084878|NCT03816761|453606408|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
126084879|NCT03816761|453606409|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
126084880|NCT01240551|453606410|FG000|Overall Study|Refused further treatment|3|||
126084881|NCT01240551|453606411|FG001|Overall Study|Refused further treatment|2|||
126084882|NCT01240551|453606410|FG000|Overall Study|Lost to Follow-up|1|||
126084883|NCT01240551|453606411|FG001|Overall Study|Lost to Follow-up|1|||
126084884|NCT01730950|453606417|FG000|Overall Study|Protocol Violation|6|||
126084885|NCT01730950|453606418|FG001|Overall Study|Protocol Violation|6|||
126084886|NCT00667459|453606419|FG000|Overall Study|Death|0|||
126084887|NCT00667459|453606420|FG001|Overall Study|Death|2|||
126084888|NCT00667459|453606419|FG000|Overall Study|Lost to Follow-up|8|||
126084889|NCT00667459|453606420|FG001|Overall Study|Lost to Follow-up|43|||
126084890|NCT02568397|453606421|FG000|Period 2|Withdrawal by Subject|0|||
126084891|NCT02568397|453606422|FG001|Period 2|Withdrawal by Subject|1|||
126084892|NCT02568397|453606421|FG000|Period 2|Physician Decision|0|||
126084893|NCT02568397|453606422|FG001|Period 2|Physician Decision|1|||
126084894|NCT01200342|453606423|FG000|Overall Study|Disease Progression|1|||
126084895|NCT04546217|453606426|FG000|Overall Study|Withdrawal by Subject|2|||
126115959|NCT00766090|453720078|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
126115960|NCT00766090|453720079|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
126115961|NCT00766090|453720080|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
126115962|NCT00766090|453720081|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
126115963|NCT00766090|453720082|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
126115964|NCT00766090|453720083|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
126084896|NCT04546217|453606427|FG001|Overall Study|Withdrawal by Subject|0|||
126084897|NCT04546217|453606426|FG000|Overall Study|Uncontrolled hypertension|1|||
126084898|NCT04546217|453606427|FG001|Overall Study|Uncontrolled hypertension|0|||
126084899|NCT02550938|453606428|FG000|Overall Study|Lost to Follow-up|8|||
126084900|NCT02550938|453606429|FG001|Overall Study|Lost to Follow-up|7|||
126115965|NCT00766090|453720084|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
126084901|NCT02550938|453606430|FG002|Overall Study|Lost to Follow-up|12|||
126115966|NCT00766090|453720085|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
126084902|NCT02550938|453606431|FG003|Overall Study|Lost to Follow-up|11|||
126115967|NCT00766090|453720086|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
126115968|NCT00766090|453720087|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
126115969|NCT00766090|453720088|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
126084903|NCT01484431|453606432|FG000|Period 1: High Dose|Physician Decision|0|||
126084904|NCT01484431|453606433|FG001|Period 1: High Dose|Physician Decision|1|||
126084905|NCT01484431|453606434|FG002|Period 1: High Dose|Physician Decision|0|||
126084906|NCT01484431|453606432|FG000|Period 2|Death|0|||
126084907|NCT01484431|453606433|FG001|Period 2|Death|1|||
125954630|NCT01559311|453129883|FG000|Overall Study|Death|0|||
125954631|NCT01559311|453129884|FG001|Overall Study|Death|2|||
125954632|NCT01559311|453129885|FG002|Overall Study|Death|3|||
125954633|NCT01559311|453129883|FG000|Overall Study|Lost to Follow-up|0|||
125954634|NCT01559311|453129884|FG001|Overall Study|Lost to Follow-up|3|||
125954635|NCT01559311|453129885|FG002|Overall Study|Lost to Follow-up|2|||
125954636|NCT01559311|453129883|FG000|Overall Study|Adverse Event|0|||
125954637|NCT01559311|453129884|FG001|Overall Study|Adverse Event|0|||
125954638|NCT01559311|453129885|FG002|Overall Study|Adverse Event|1|||
125954639|NCT02346240|453129886|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954640|NCT02346240|453129887|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
125954641|NCT02346240|453129888|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
125954642|NCT02346240|453129889|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
125954643|NCT02346240|453129890|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954644|NCT02346240|453129891|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954645|NCT02346240|453129892|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954646|NCT02346240|453129893|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954647|NCT02346240|453129894|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954648|NCT02346240|453129895|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954649|NCT02346240|453129896|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954650|NCT02346240|453129897|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954651|NCT02346240|453129898|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954652|NCT02346240|453129899|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954653|NCT02346240|453129900|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954654|NCT02346240|453129901|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954655|NCT02346240|453129902|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954656|NCT02346240|453129903|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954657|NCT02346240|453129904|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954658|NCT02346240|453129905|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954659|NCT02346240|453129906|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954660|NCT02346240|453129907|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954661|NCT02346240|453129908|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954662|NCT02346240|453129909|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125954663|NCT02346240|453129886|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954664|NCT02346240|453129887|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
125954665|NCT02346240|453129888|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954666|NCT02346240|453129889|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954667|NCT02346240|453129890|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954668|NCT02346240|453129891|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954669|NCT02346240|453129892|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954670|NCT02346240|453129893|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954671|NCT02346240|453129894|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954672|NCT02346240|453129895|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954673|NCT02346240|453129896|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954674|NCT02346240|453129897|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954675|NCT02346240|453129898|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954676|NCT02346240|453129899|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954677|NCT02346240|453129900|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954678|NCT02346240|453129901|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954679|NCT02346240|453129902|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954680|NCT02346240|453129903|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954681|NCT02346240|453129904|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954682|NCT02346240|453129905|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954683|NCT02346240|453129906|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954684|NCT02346240|453129907|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954685|NCT02346240|453129908|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954686|NCT02346240|453129909|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125954687|NCT02346240|453129886|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954688|NCT02346240|453129887|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
125954689|NCT02346240|453129888|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954690|NCT02346240|453129889|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954691|NCT02346240|453129890|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954692|NCT02346240|453129891|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954693|NCT02346240|453129892|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126084908|NCT01484431|453606434|FG002|Period 2|Death|1|||
126084909|NCT01484431|453606432|FG000|Period 2|Physician Decision|0|||
126084910|NCT01484431|453606433|FG001|Period 2|Physician Decision|0|||
126084911|NCT01484431|453606434|FG002|Period 2|Physician Decision|1|||
126084912|NCT01484431|453606432|FG000|Period 2|Non-Compliance with Study Drug|1|||
126084913|NCT01484431|453606433|FG001|Period 2|Non-Compliance with Study Drug|0|||
126084914|NCT01484431|453606434|FG002|Period 2|Non-Compliance with Study Drug|0|||
126084915|NCT01888874|453606438|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
126084916|NCT01888874|453606439|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
126084917|NCT01888874|453606440|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
126084918|NCT01888874|453606441|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
126084919|NCT01888874|453606442|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
126084920|NCT01888874|453606443|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
126084921|NCT01888874|453606444|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
126084922|NCT01888874|453606438|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
126084923|NCT01888874|453606439|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
126084924|NCT01888874|453606440|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
126084925|NCT01888874|453606441|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
126084926|NCT01888874|453606442|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
126084927|NCT01888874|453606443|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
126084928|NCT01888874|453606444|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
126084929|NCT01888874|453606438|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126084930|NCT01888874|453606439|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126084931|NCT01888874|453606440|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126084932|NCT01888874|453606441|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126084933|NCT01888874|453606442|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126084934|NCT01888874|453606443|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126084935|NCT01888874|453606444|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
126084936|NCT01888874|453606438|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
126084937|NCT01888874|453606439|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
126084938|NCT01888874|453606440|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
126084939|NCT01888874|453606441|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
126084940|NCT01888874|453606442|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
126084941|NCT01888874|453606443|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
126084942|NCT01888874|453606444|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
126084943|NCT01888874|453606438|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126084944|NCT01888874|453606439|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126084945|NCT01888874|453606440|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126084946|NCT01888874|453606441|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126084947|NCT01888874|453606442|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
126084948|NCT01888874|453606443|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126084949|NCT01888874|453606444|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126084950|NCT01888874|453606438|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126084951|NCT01888874|453606439|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
126084952|NCT01888874|453606440|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126084953|NCT01888874|453606441|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126084954|NCT01888874|453606442|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126084955|NCT01888874|453606443|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126084956|NCT01888874|453606444|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126084957|NCT01888874|453606438|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126084958|NCT01888874|453606439|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
126084959|NCT01888874|453606440|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126084960|NCT01888874|453606441|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126084961|NCT01888874|453606442|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126084962|NCT01888874|453606443|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
126084963|NCT01888874|453606444|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126084964|NCT01888874|453606438|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
126084965|NCT01888874|453606439|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
126084966|NCT01888874|453606440|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
126084967|NCT01888874|453606441|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126084968|NCT01888874|453606442|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
126084969|NCT01888874|453606443|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126084970|NCT01888874|453606444|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126084971|NCT01888874|453606438|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126084972|NCT01888874|453606439|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126084973|NCT01888874|453606440|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126084974|NCT01888874|453606441|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126084975|NCT01888874|453606442|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
126084976|NCT01888874|453606443|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126084977|NCT01888874|453606444|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126084978|NCT01888874|453606438|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126084979|NCT01888874|453606439|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126084980|NCT01888874|453606440|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
126084981|NCT01888874|453606441|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126084982|NCT01888874|453606442|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126084983|NCT01888874|453606443|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
126084984|NCT01888874|453606444|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126084985|NCT01888874|453606438|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126084986|NCT01888874|453606439|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126084987|NCT01888874|453606440|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
126084988|NCT01888874|453606441|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126084989|NCT01888874|453606442|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126084990|NCT01888874|453606443|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126084991|NCT01888874|453606444|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126084992|NCT01888874|453606438|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
126084993|NCT01888874|453606439|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
126084994|NCT01888874|453606440|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
126084995|NCT01888874|453606441|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
126084996|NCT01888874|453606442|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
126084997|NCT01888874|453606443|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
126084998|NCT01888874|453606444|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
126084999|NCT01888874|453606438|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126085000|NCT01888874|453606439|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
126085001|NCT01888874|453606440|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126085002|NCT01888874|453606441|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126085003|NCT01888874|453606442|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126085004|NCT01888874|453606443|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
126085005|NCT01888874|453606444|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126085006|NCT02980042|453606447|FG000|Overall Study|Lost to Follow-up|5|||
126085007|NCT02980042|453606448|FG001|Overall Study|Lost to Follow-up|0|||
126085008|NCT02980042|453606447|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
126085009|NCT02980042|453606448|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
126085010|NCT01483144|453606456|FG000|Overall Study|Adverse Event|9|||
126085011|NCT01483144|453606457|FG001|Overall Study|Adverse Event|4|||
126085012|NCT01483144|453606458|FG002|Overall Study|Adverse Event|6|||
126085013|NCT01483144|453606456|FG000|Overall Study|Withdrawal by Subject|0|||
126085014|NCT01483144|453606457|FG001|Overall Study|Withdrawal by Subject|2|||
126085015|NCT01483144|453606458|FG002|Overall Study|Withdrawal by Subject|5|||
126085016|NCT01483144|453606456|FG000|Overall Study|Physician Decision|1|||
126085017|NCT01483144|453606457|FG001|Overall Study|Physician Decision|0|||
126085018|NCT01483144|453606458|FG002|Overall Study|Physician Decision|0|||
126085019|NCT01483144|453606456|FG000|Overall Study|Lost to Follow-up|2|||
126085020|NCT01483144|453606457|FG001|Overall Study|Lost to Follow-up|4|||
126085021|NCT01483144|453606458|FG002|Overall Study|Lost to Follow-up|1|||
126085022|NCT01483144|453606456|FG000|Overall Study|Protocol Violation|3|||
126085023|NCT01483144|453606457|FG001|Overall Study|Protocol Violation|3|||
126085024|NCT01483144|453606458|FG002|Overall Study|Protocol Violation|3|||
126085025|NCT02460575|453606459|FG000|Overall Study|Lost to Follow-up|1|||
126085026|NCT02460575|453606460|FG001|Overall Study|Lost to Follow-up|0|||
126085027|NCT02870972|453606461|FG000|Overall Study|Adverse Event|1|||
126085028|NCT02870972|453606462|FG001|Overall Study|Adverse Event|0|||
126085029|NCT02870972|453606463|FG002|Overall Study|Adverse Event|0|||
126085030|NCT02870972|453606464|FG003|Overall Study|Adverse Event|0|||
126085031|NCT02870972|453606465|FG004|Overall Study|Adverse Event|0|||
126085032|NCT02179177|453606466|FG000|Overall Study|Lost to Follow-up|1|||
126085033|NCT02179177|453606467|FG001|Overall Study|Lost to Follow-up|1|||
126085034|NCT02179177|453606466|FG000|Overall Study|Withdrawal by Subject|1|||
126085035|NCT02179177|453606467|FG001|Overall Study|Withdrawal by Subject|1|||
126085036|NCT04497389|453606468|FG000|Overall Study|Withdrawal by Subject|1|||
126085037|NCT04497389|453606469|FG001|Overall Study|Withdrawal by Subject|0|||
126085038|NCT04052425|453606470|FG000|24-Week Double-blind Period|Adverse Event|0|||
126085039|NCT04052425|453606471|FG001|24-Week Double-blind Period|Adverse Event|1|||
126085040|NCT04052425|453606472|FG002|24-Week Double-blind Period|Adverse Event|0|||
126085041|NCT04052425|453606473|FG003|24-Week Double-blind Period|Adverse Event|0|||
126085042|NCT04052425|453606470|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
126085043|NCT04052425|453606471|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
126085044|NCT04052425|453606472|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
126085045|NCT04052425|453606473|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
126085046|NCT04052425|453606470|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
126085047|NCT04052425|453606471|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
126085048|NCT04052425|453606472|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
126085049|NCT04052425|453606473|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
126085050|NCT04052425|453606470|FG000|24-Week Double-blind Period|Physician Decision|1|||
126085051|NCT04052425|453606471|FG001|24-Week Double-blind Period|Physician Decision|0|||
126085052|NCT04052425|453606472|FG002|24-Week Double-blind Period|Physician Decision|0|||
126085053|NCT04052425|453606473|FG003|24-Week Double-blind Period|Physician Decision|0|||
126085054|NCT04052425|453606470|FG000|24-Week Double-blind Period|Protocol Violation|1|||
126085055|NCT04052425|453606471|FG001|24-Week Double-blind Period|Protocol Violation|0|||
126085056|NCT04052425|453606472|FG002|24-Week Double-blind Period|Protocol Violation|0|||
126085057|NCT04052425|453606473|FG003|24-Week Double-blind Period|Protocol Violation|0|||
126085058|NCT04052425|453606470|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
126085059|NCT04052425|453606471|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
126085060|NCT04052425|453606472|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
126085061|NCT04052425|453606473|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
126085062|NCT04052425|453606470|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
126085063|NCT04052425|453606471|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
126085064|NCT04052425|453606472|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
126085065|NCT04052425|453606473|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
126085066|NCT04052425|453606470|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
126085067|NCT04052425|453606471|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
126085068|NCT04052425|453606472|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
126085069|NCT04052425|453606473|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
126085070|NCT04052425|453606470|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
126085071|NCT04052425|453606471|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
126085072|NCT04052425|453606472|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
126085073|NCT04052425|453606473|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
126085074|NCT04052425|453606470|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
126085075|NCT04052425|453606471|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
126085076|NCT04052425|453606472|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
126085077|NCT04052425|453606473|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
126085078|NCT04052425|453606470|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
126085079|NCT04052425|453606471|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
126085080|NCT04052425|453606472|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
126085081|NCT04052425|453606473|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
126085082|NCT04052425|453606470|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
126085083|NCT04052425|453606471|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
126085084|NCT04052425|453606472|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
126085085|NCT04052425|453606473|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
126085086|NCT04052425|453606470|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
126085087|NCT04052425|453606471|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
126085088|NCT04052425|453606472|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
126085089|NCT04052425|453606473|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
126085090|NCT04052425|453606470|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
126085091|NCT04052425|453606471|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
126085092|NCT04052425|453606472|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
126085093|NCT04052425|453606473|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
126085094|NCT04829747|453606476|FG000|Overall Study|Protocol Violation|1|||
126085095|NCT02615509|453606479|FG000|Overall Study|Lost to Follow-up|134|||
126085096|NCT02615509|453606479|FG000|Overall Study|Death|4|||
126085097|NCT02615509|453606479|FG000|Overall Study|Withdrawal by Subject|8|||
126085098|NCT00425607|453606480|FG000|Overall Study|Death|1|||
126085099|NCT00425607|453606480|FG000|Overall Study|Withdrawal by Subject|1|||
126085100|NCT00079339|453606481|FG000|Overall Study|Adverse Event|1|||
126085101|NCT00079339|453606482|FG001|Overall Study|Adverse Event|7|||
126085102|NCT00079339|453606483|FG002|Overall Study|Adverse Event|2|||
126085103|NCT00079339|453606481|FG000|Overall Study|Death|1|||
126085104|NCT00079339|453606482|FG001|Overall Study|Death|0|||
126085105|NCT00079339|453606483|FG002|Overall Study|Death|0|||
126085106|NCT00079339|453606481|FG000|Overall Study|Non-compliance|0|||
126085107|NCT00079339|453606482|FG001|Overall Study|Non-compliance|0|||
126085108|NCT00079339|453606483|FG002|Overall Study|Non-compliance|1|||
126085109|NCT00079339|453606481|FG000|Overall Study|Withdrawal by Subject|0|||
126085110|NCT00079339|453606482|FG001|Overall Study|Withdrawal by Subject|4|||
126085111|NCT00079339|453606483|FG002|Overall Study|Withdrawal by Subject|1|||
126085112|NCT00079339|453606481|FG000|Overall Study|Disease progression|3|||
126085113|NCT00079339|453606482|FG001|Overall Study|Disease progression|28|||
126085114|NCT00079339|453606483|FG002|Overall Study|Disease progression|2|||
126085115|NCT02563548|453606484|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
126085116|NCT02563548|453606485|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
126085117|NCT02563548|453606486|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
125954694|NCT02346240|453129893|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954695|NCT02346240|453129894|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954696|NCT02346240|453129895|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954697|NCT02346240|453129896|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954698|NCT02346240|453129897|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954699|NCT02346240|453129898|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954700|NCT02346240|453129899|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954701|NCT02346240|453129900|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954702|NCT02346240|453129901|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954703|NCT02346240|453129902|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954704|NCT02346240|453129903|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954705|NCT02346240|453129904|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954706|NCT02346240|453129905|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954707|NCT02346240|453129906|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954708|NCT02346240|453129907|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954709|NCT02346240|453129908|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954710|NCT02346240|453129909|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125954711|NCT02346240|453129886|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
125954712|NCT02346240|453129887|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
125954713|NCT02346240|453129888|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
125954714|NCT02346240|453129889|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
125954715|NCT02346240|453129890|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954716|NCT02346240|453129891|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954717|NCT02346240|453129892|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954718|NCT02346240|453129893|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954719|NCT02346240|453129894|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954720|NCT02346240|453129895|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954721|NCT02346240|453129896|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954722|NCT02346240|453129897|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954723|NCT02346240|453129898|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954724|NCT02346240|453129899|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954725|NCT02346240|453129900|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954726|NCT02346240|453129901|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954727|NCT02346240|453129902|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954728|NCT02346240|453129903|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954729|NCT02346240|453129904|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954730|NCT02346240|453129905|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954731|NCT02346240|453129906|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954732|NCT02346240|453129907|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954733|NCT02346240|453129908|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954734|NCT02346240|453129909|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125954735|NCT02346240|453129886|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
125954736|NCT02346240|453129887|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
125954737|NCT02346240|453129888|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
125954738|NCT02346240|453129889|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
125954739|NCT02346240|453129890|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954740|NCT02346240|453129891|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954741|NCT02346240|453129892|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954742|NCT02346240|453129893|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954743|NCT02346240|453129894|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954744|NCT02346240|453129895|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954745|NCT02346240|453129896|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954746|NCT02346240|453129897|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954747|NCT02346240|453129898|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954748|NCT02346240|453129899|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954749|NCT02346240|453129900|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954750|NCT02346240|453129901|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954751|NCT02346240|453129902|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954752|NCT02346240|453129903|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954753|NCT02346240|453129904|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954754|NCT02346240|453129905|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954755|NCT02346240|453129906|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954756|NCT02346240|453129907|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125954757|NCT02346240|453129908|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126085118|NCT02563548|453606487|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
126085119|NCT02563548|453606488|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
126085120|NCT02563548|453606489|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
126085121|NCT02563548|453606484|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
126085122|NCT02563548|453606485|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
126085123|NCT02563548|453606486|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
126085124|NCT02563548|453606487|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
126085125|NCT02563548|453606488|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
126085126|NCT02563548|453606489|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
126085127|NCT02563548|453606484|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126085128|NCT02563548|453606485|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126085129|NCT02563548|453606486|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
126085130|NCT02563548|453606487|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126085131|NCT02563548|453606488|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126085132|NCT02563548|453606489|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126085133|NCT02563548|453606484|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
126085134|NCT02563548|453606485|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
126085135|NCT02563548|453606486|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
126085136|NCT02563548|453606487|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
126085137|NCT02563548|453606488|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
126085138|NCT02563548|453606489|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
126085139|NCT02563548|453606484|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
126085140|NCT02563548|453606485|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
126085141|NCT02563548|453606486|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
126085142|NCT02563548|453606487|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
126085143|NCT02563548|453606488|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
126085144|NCT02563548|453606489|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
126085145|NCT02563548|453606484|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
126085146|NCT02563548|453606485|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
126085147|NCT02563548|453606486|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
126085148|NCT02563548|453606487|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
126085149|NCT02563548|453606488|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
126085150|NCT02563548|453606489|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
126085151|NCT02563548|453606484|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126085152|NCT02563548|453606485|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126085153|NCT02563548|453606486|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126085154|NCT02563548|453606487|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126115970|NCT00766090|453720077|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115971|NCT00766090|453720078|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115972|NCT00766090|453720079|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115973|NCT00766090|453720080|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115974|NCT00766090|453720081|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
126115975|NCT00766090|453720082|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115976|NCT00766090|453720083|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126085155|NCT02563548|453606488|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
126085156|NCT02563548|453606489|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126085157|NCT02563548|453606484|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
126085158|NCT02563548|453606485|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
126085159|NCT02563548|453606486|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
126085160|NCT02563548|453606487|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
126085161|NCT02563548|453606488|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
126085162|NCT02563548|453606489|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
126085163|NCT02563548|453606484|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126115977|NCT00766090|453720084|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115978|NCT00766090|453720085|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115979|NCT00766090|453720086|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126085164|NCT02563548|453606485|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126085165|NCT02563548|453606486|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126085166|NCT02563548|453606487|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126085167|NCT02563548|453606488|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126085168|NCT02563548|453606489|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
126085169|NCT02563548|453606484|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126085170|NCT02563548|453606485|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126115980|NCT00766090|453720087|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115981|NCT00766090|453720088|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126115982|NCT00766090|453720077|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126085171|NCT02563548|453606486|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126085172|NCT02563548|453606487|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126085173|NCT02563548|453606488|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126085174|NCT02563548|453606489|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
126085175|NCT02563548|453606484|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126085176|NCT02563548|453606485|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126085177|NCT02563548|453606486|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126085178|NCT02563548|453606487|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126085179|NCT02563548|453606488|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126085180|NCT02563548|453606489|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
126085181|NCT02563548|453606484|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126085182|NCT02563548|453606485|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126085183|NCT02563548|453606486|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126085184|NCT02563548|453606487|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126085185|NCT02563548|453606488|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
126085186|NCT02563548|453606489|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126085187|NCT00520845|453606490|FG000|Overall Study|Death|3|||
126085188|NCT00520845|453606490|FG000|Overall Study|Adverse Event|4|||
126085189|NCT00520845|453606490|FG000|Overall Study|Disease Progression, relapse|13|||
126085190|NCT00520845|453606490|FG000|Overall Study|Withdrawal by Subject|1|||
126085191|NCT00520845|453606490|FG000|Overall Study|Alternative Therapy|1|||
126085192|NCT03274453|453606493|FG000|Overall Study|Lost to Follow-up|2|||
126085193|NCT03274453|453606494|FG001|Overall Study|Lost to Follow-up|5|||
126085194|NCT03274453|453606495|FG002|Overall Study|Lost to Follow-up|4|||
126085195|NCT03274453|453606496|FG003|Overall Study|Lost to Follow-up|1|||
126085196|NCT03274453|453606493|FG000|Overall Study|Physician Decision|2|||
126085197|NCT03274453|453606494|FG001|Overall Study|Physician Decision|0|||
126085198|NCT03274453|453606495|FG002|Overall Study|Physician Decision|0|||
126085199|NCT03274453|453606496|FG003|Overall Study|Physician Decision|3|||
126085200|NCT03274453|453606493|FG000|Overall Study|Surgery Cancelled|0|||
126085201|NCT03274453|453606494|FG001|Overall Study|Surgery Cancelled|1|||
126085202|NCT03274453|453606495|FG002|Overall Study|Surgery Cancelled|0|||
126085203|NCT03274453|453606496|FG003|Overall Study|Surgery Cancelled|0|||
126085204|NCT01516749|453606498|FG000|Active Therapy|Lost to Follow-up|1|||
126085205|NCT01516749|453606498|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
126085206|NCT00351377|453606499|FG000|Overall Study|Adverse Event|5|||
126085207|NCT00351377|453606499|FG000|Overall Study|Death|1|||
126085208|NCT00351377|453606499|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126085209|NCT01732549|453606500|FG000|Overall Study|Adverse Event|13|||
126085210|NCT01732549|453606501|FG001|Overall Study|Adverse Event|3|||
126085211|NCT01732549|453606500|FG000|Overall Study|Consent withdrawn|13|||
126085212|NCT01732549|453606501|FG001|Overall Study|Consent withdrawn|6|||
126085213|NCT01732549|453606500|FG000|Overall Study|Disease progression|37|||
126085214|NCT01732549|453606501|FG001|Overall Study|Disease progression|50|||
126085215|NCT01732549|453606500|FG000|Overall Study|Other|8|||
126085216|NCT01732549|453606501|FG001|Overall Study|Other|14|||
126085217|NCT02493062|453606506|FG000|Overall Study|Physician Decision|12|||
126085218|NCT03845140|453606507|FG000|Overall Study|Participant travelled outside study area|0|||
126085219|NCT03845140|453606508|FG001|Overall Study|Participant travelled outside study area|1|||
126085220|NCT03845140|453606509|FG002|Overall Study|Participant travelled outside study area|0|||
126085221|NCT03845140|453606510|FG003|Overall Study|Participant travelled outside study area|0|||
126085222|NCT03845140|453606511|FG004|Overall Study|Participant travelled outside study area|0|||
126085223|NCT03845140|453606512|FG005|Overall Study|Participant travelled outside study area|0|||
126085224|NCT01327612|453606518|FG000|Overall Study|Withdrawal by Subject|0|||
126085225|NCT01327612|453606519|FG001|Overall Study|Withdrawal by Subject|0|||
126085226|NCT01327612|453606520|FG002|Overall Study|Withdrawal by Subject|0|||
126085227|NCT01327612|453606521|FG003|Overall Study|Withdrawal by Subject|0|||
126085228|NCT01327612|453606522|FG004|Overall Study|Withdrawal by Subject|0|||
126085229|NCT01327612|453606523|FG005|Overall Study|Withdrawal by Subject|1|||
126085230|NCT01327612|453606524|FG006|Overall Study|Withdrawal by Subject|0|||
126085231|NCT01327612|453606518|FG000|Overall Study|Disease Progression|1|||
126115983|NCT00766090|453720078|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125954758|NCT02346240|453129909|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126085232|NCT01327612|453606519|FG001|Overall Study|Disease Progression|1|||
126085233|NCT01327612|453606520|FG002|Overall Study|Disease Progression|1|||
126085234|NCT01327612|453606521|FG003|Overall Study|Disease Progression|0|||
126085235|NCT01327612|453606522|FG004|Overall Study|Disease Progression|1|||
126085236|NCT01327612|453606523|FG005|Overall Study|Disease Progression|2|||
126085237|NCT01327612|453606524|FG006|Overall Study|Disease Progression|2|||
126085238|NCT01327612|453606518|FG000|Overall Study|Administrative Decision|0|||
126085239|NCT01327612|453606519|FG001|Overall Study|Administrative Decision|0|||
126085240|NCT01327612|453606520|FG002|Overall Study|Administrative Decision|0|||
126085241|NCT01327612|453606521|FG003|Overall Study|Administrative Decision|1|||
126085242|NCT01327612|453606522|FG004|Overall Study|Administrative Decision|0|||
126085243|NCT01327612|453606523|FG005|Overall Study|Administrative Decision|0|||
126085244|NCT01327612|453606524|FG006|Overall Study|Administrative Decision|0|||
126085245|NCT01327612|453606518|FG000|Overall Study|Death|0|||
126085246|NCT01327612|453606519|FG001|Overall Study|Death|0|||
126085247|NCT01327612|453606520|FG002|Overall Study|Death|0|||
126085248|NCT01327612|453606521|FG003|Overall Study|Death|0|||
126085249|NCT01327612|453606522|FG004|Overall Study|Death|1|||
126085250|NCT01327612|453606523|FG005|Overall Study|Death|0|||
126085251|NCT01327612|453606524|FG006|Overall Study|Death|0|||
126085252|NCT00447590|453606525|FG000|Overall Study|Withdrawal by Subject|26|||
126085253|NCT00447590|453606525|FG000|Overall Study|Lost to Follow-up|24|||
126085254|NCT00447590|453606525|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
126085255|NCT01661205|453606527|FG000|Overall Study|Physician Decision|2|||
126085256|NCT05569421|453606531|FG000|Overall Study|Withdrawal by Subject|1|||
126085257|NCT05569421|453606532|FG001|Overall Study|Withdrawal by Subject|0|||
126085258|NCT05569421|453606533|FG002|Overall Study|Withdrawal by Subject|0|||
126085259|NCT03111095|453606534|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
126085260|NCT03111095|453606535|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
126085261|NCT03111095|453606534|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
126085262|NCT03111095|453606535|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
126085263|NCT00504075|453606536|FG000|Overall Study|Adverse Event|1|||
126085264|NCT00504075|453606536|FG000|Overall Study|Lost to Follow-up|5|||
126085265|NCT00504075|453606536|FG000|Overall Study|Withdrawal by Subject|1|||
126085266|NCT00504075|453606536|FG000|Overall Study|Required other therapeutic intervention|1|||
126085267|NCT01689857|453606538|FG000|Overall Study|Lost to Follow-up|5|||
126085268|NCT01689857|453606539|FG001|Overall Study|Lost to Follow-up|2|||
126085269|NCT05105087|453606540|FG000|Overall Study|Withdrawal by Subject|2|||
126085270|NCT05105087|453606540|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
126085271|NCT03106753|453606543|FG000|Overall Study|Withdrawal by Subject|0|||
126085272|NCT03106753|453606544|FG001|Overall Study|Withdrawal by Subject|1|||
126085273|NCT00844597|453606549|FG000|Overall Study|Adverse Event|0|||
126085274|NCT00844597|453606550|FG001|Overall Study|Adverse Event|0|||
126085275|NCT00844597|453606551|FG002|Overall Study|Adverse Event|0|||
126085276|NCT00844597|453606552|FG003|Overall Study|Adverse Event|1|||
126085277|NCT00844597|453606553|FG004|Overall Study|Adverse Event|0|||
126085278|NCT00844597|453606554|FG005|Overall Study|Adverse Event|0|||
126085279|NCT02670122|453606555|FG000|Overall Study|Lost to Follow-up|4|||
126085280|NCT02762903|453606556|FG000|Overall Study|Lost to Follow-up|0|||
126085281|NCT02762903|453606557|FG001|Overall Study|Lost to Follow-up|1|||
126085282|NCT00243074|453606558|FG000|Overall Study|Ineligible|6|||
126085283|NCT00243074|453606558|FG000|Overall Study|Adverse Event|6|||
126085284|NCT00243074|453606558|FG000|Overall Study|Withdrawal by Subject|2|||
126085285|NCT00243074|453606558|FG000|Overall Study|Lack of Efficacy|36|||
126085286|NCT00243074|453606558|FG000|Overall Study|Death|2|||
126085287|NCT00243074|453606558|FG000|Overall Study|not protocol specified|1|||
126085288|NCT00243074|453606558|FG000|Overall Study|Did not receive any treatment|1|||
126085289|NCT03041792|453606559|FG000|Overall Study|Adverse Event|4|||
126085290|NCT03041792|453606560|FG001|Overall Study|Adverse Event|0|||
126085291|NCT03041792|453606559|FG000|Overall Study|Death in the family|0|||
126085292|NCT03041792|453606560|FG001|Overall Study|Death in the family|2|||
126085293|NCT03041792|453606559|FG000|Overall Study|Randomized but not treated|0|||
126085294|NCT03041792|453606560|FG001|Overall Study|Randomized but not treated|1|||
126085295|NCT04978090|453606563|FG000|Overall Study|unable to adequately fit device|2|||
126085296|NCT00632502|453606566|FG000|Overall Study|Adverse Event|0|||
126085297|NCT00632502|453606567|FG001|Overall Study|Adverse Event|1|||
126085298|NCT00632502|453606566|FG000|Overall Study|Randomized not treated|3|||
126085299|NCT00632502|453606567|FG001|Overall Study|Randomized not treated|0|||
126085300|NCT03075527|453606568|FG000|Overall Study|Death|1|||
126085301|NCT03075527|453606568|FG000|Overall Study|Withdrawal by Subject|1|||
126085302|NCT03075527|453606568|FG000|Overall Study|Physician Decision|3|||
126085303|NCT03075527|453606568|FG000|Overall Study|Progression/Relapse|14|||
126085304|NCT00681668|453606569|FG000|Overall Study|Protocol Violation|1|||
126085305|NCT00681668|453606569|FG000|Overall Study|Withdrawal by Subject|1|||
126085306|NCT02209181|453606570|FG000|Overall Study|Adverse Event|1|||
126085307|NCT02209181|453606571|FG001|Overall Study|Adverse Event|0|||
126085308|NCT02209181|453606572|FG002|Overall Study|Adverse Event|1|||
126085309|NCT02209181|453606573|FG003|Overall Study|Adverse Event|0|||
126085310|NCT02209181|453606570|FG000|Overall Study|Withdrawal by Subject|0|||
126085311|NCT02209181|453606571|FG001|Overall Study|Withdrawal by Subject|1|||
126085312|NCT02209181|453606572|FG002|Overall Study|Withdrawal by Subject|0|||
126085313|NCT02209181|453606573|FG003|Overall Study|Withdrawal by Subject|0|||
125954759|NCT02346240|453129886|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954760|NCT02346240|453129887|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
126085314|NCT06926673|453606574|FG000|Overall Study|Lost to Follow-up|0|||
126085315|NCT06926673|453606575|FG001|Overall Study|Lost to Follow-up|0|||
126085316|NCT06926673|453606576|FG002|Overall Study|Lost to Follow-up|0|||
126085317|NCT06926673|453606577|FG003|Overall Study|Lost to Follow-up|1|||
126085318|NCT06926673|453606578|FG004|Overall Study|Lost to Follow-up|0|||
126085319|NCT06926673|453606579|FG005|Overall Study|Lost to Follow-up|0|||
126085320|NCT06926673|453606580|FG006|Overall Study|Lost to Follow-up|0|||
126085321|NCT06926673|453606574|FG000|Overall Study|Physician Decision|0|||
126085322|NCT06926673|453606575|FG001|Overall Study|Physician Decision|0|||
126085323|NCT06926673|453606576|FG002|Overall Study|Physician Decision|0|||
126085324|NCT06926673|453606577|FG003|Overall Study|Physician Decision|0|||
126085325|NCT06926673|453606578|FG004|Overall Study|Physician Decision|0|||
126085326|NCT06926673|453606579|FG005|Overall Study|Physician Decision|0|||
126085327|NCT06926673|453606580|FG006|Overall Study|Physician Decision|1|||
126085328|NCT06926673|453606574|FG000|Overall Study|Withdrawal by Subject|0|||
126085329|NCT06926673|453606575|FG001|Overall Study|Withdrawal by Subject|3|||
126085330|NCT06926673|453606576|FG002|Overall Study|Withdrawal by Subject|2|||
126085331|NCT06926673|453606577|FG003|Overall Study|Withdrawal by Subject|1|||
126085332|NCT06926673|453606578|FG004|Overall Study|Withdrawal by Subject|0|||
126085333|NCT06926673|453606579|FG005|Overall Study|Withdrawal by Subject|2|||
126085334|NCT06926673|453606580|FG006|Overall Study|Withdrawal by Subject|0|||
126085335|NCT02358668|453609296|FG000|Overall Study|Adverse Event|2|||
126085336|NCT02358668|453609297|FG001|Overall Study|Adverse Event|0|||
126085337|NCT02358668|453609298|FG002|Overall Study|Adverse Event|0|||
126085338|NCT02358668|453609296|FG000|Overall Study|Withdrawal by Subject|0|||
126085339|NCT02358668|453609297|FG001|Overall Study|Withdrawal by Subject|1|||
126085340|NCT02358668|453609298|FG002|Overall Study|Withdrawal by Subject|0|||
126085341|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Adverse Event|2|||
126085342|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Adverse Event|0|||
126085343|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Adverse Event|0|||
126085344|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Adverse Event|0|||
126085345|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
126085346|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
126085347|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
126085348|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
126085349|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
126085350|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
126085351|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
126085352|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
126085353|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Physician Decision|1|||
126085354|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Physician Decision|0|||
126085355|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Physician Decision|0|||
126085356|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Physician Decision|0|||
126085357|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Pregnancy|1|||
126085358|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Pregnancy|0|||
126085359|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Pregnancy|0|||
126085360|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Pregnancy|0|||
126085361|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
126085362|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
126085363|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
126085364|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
126085365|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
126085366|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
126085367|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
126085368|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
126085369|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
126085370|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
126085371|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
126085372|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
126085373|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
126085374|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
126085375|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
126085376|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
126085377|NCT04057573|453609299|FG000|24-Week Double-Blind Period|Not Treated|1|||
126085378|NCT04057573|453609300|FG001|24-Week Double-Blind Period|Not Treated|0|||
126085379|NCT04057573|453609301|FG002|24-Week Double-Blind Period|Not Treated|0|||
126085380|NCT04057573|453609302|FG003|24-Week Double-Blind Period|Not Treated|0|||
126085381|NCT04057573|453609299|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
126085382|NCT04057573|453609300|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
126085383|NCT04057573|453609301|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
126085384|NCT04057573|453609302|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
126085385|NCT04057573|453609299|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
126085386|NCT04057573|453609300|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
126115984|NCT00766090|453720079|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
126085387|NCT04057573|453609301|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
126085388|NCT04057573|453609302|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
126085389|NCT04057573|453609299|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
126085390|NCT04057573|453609300|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
126085391|NCT04057573|453609301|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
126085392|NCT04057573|453609302|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
126085393|NCT04057573|453609299|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
126085394|NCT04057573|453609300|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
126085395|NCT04057573|453609301|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
126085396|NCT04057573|453609302|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
126085397|NCT04057573|453609299|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
126085398|NCT04057573|453609300|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
126085399|NCT04057573|453609301|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
126085400|NCT04057573|453609302|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
126085401|NCT01317875|453609305|FG000|Overall Study|Other|0|||
126085402|NCT01317875|453609306|FG001|Overall Study|Other|0|||
126085403|NCT01317875|453609307|FG002|Overall Study|Other|1|||
126085404|NCT01317875|453609308|FG003|Overall Study|Other|0|||
126085405|NCT01317875|453609309|FG004|Overall Study|Other|0|||
126085406|NCT01317875|453609310|FG005|Overall Study|Other|0|||
126085407|NCT01317875|453609311|FG006|Overall Study|Other|0|||
126085408|NCT01317875|453609312|FG007|Overall Study|Other|0|||
126085409|NCT01317875|453609313|FG008|Overall Study|Other|0|||
126085410|NCT01317875|453609314|FG009|Overall Study|Other|0|||
126085411|NCT01317875|453609305|FG000|Overall Study|Noncompliance with study drug|0|||
126085412|NCT01317875|453609306|FG001|Overall Study|Noncompliance with study drug|0|||
126085413|NCT01317875|453609307|FG002|Overall Study|Noncompliance with study drug|1|||
126085414|NCT01317875|453609308|FG003|Overall Study|Noncompliance with study drug|0|||
126085415|NCT01317875|453609309|FG004|Overall Study|Noncompliance with study drug|0|||
126085416|NCT01317875|453609310|FG005|Overall Study|Noncompliance with study drug|0|||
126085417|NCT01317875|453609311|FG006|Overall Study|Noncompliance with study drug|0|||
126085418|NCT01317875|453609312|FG007|Overall Study|Noncompliance with study drug|0|||
126085419|NCT01317875|453609313|FG008|Overall Study|Noncompliance with study drug|0|||
126085420|NCT01317875|453609314|FG009|Overall Study|Noncompliance with study drug|0|||
126085421|NCT01317875|453609305|FG000|Overall Study|Progressive Disease|1|||
126085422|NCT01317875|453609306|FG001|Overall Study|Progressive Disease|0|||
126085423|NCT01317875|453609307|FG002|Overall Study|Progressive Disease|2|||
126085424|NCT01317875|453609308|FG003|Overall Study|Progressive Disease|0|||
126085425|NCT01317875|453609309|FG004|Overall Study|Progressive Disease|1|||
126085426|NCT01317875|453609310|FG005|Overall Study|Progressive Disease|0|||
126085427|NCT01317875|453609311|FG006|Overall Study|Progressive Disease|0|||
126085428|NCT01317875|453609312|FG007|Overall Study|Progressive Disease|1|||
126085429|NCT01317875|453609313|FG008|Overall Study|Progressive Disease|0|||
126085430|NCT01317875|453609314|FG009|Overall Study|Progressive Disease|0|||
126085431|NCT01317875|453609305|FG000|Overall Study|Withdrawal by Subject|0|||
126085432|NCT01317875|453609306|FG001|Overall Study|Withdrawal by Subject|0|||
126085433|NCT01317875|453609307|FG002|Overall Study|Withdrawal by Subject|0|||
126085434|NCT01317875|453609308|FG003|Overall Study|Withdrawal by Subject|0|||
126085435|NCT01317875|453609309|FG004|Overall Study|Withdrawal by Subject|1|||
126085436|NCT01317875|453609310|FG005|Overall Study|Withdrawal by Subject|0|||
126085437|NCT01317875|453609311|FG006|Overall Study|Withdrawal by Subject|0|||
126085438|NCT01317875|453609312|FG007|Overall Study|Withdrawal by Subject|3|||
126085439|NCT01317875|453609313|FG008|Overall Study|Withdrawal by Subject|0|||
126085440|NCT01317875|453609314|FG009|Overall Study|Withdrawal by Subject|0|||
126085441|NCT01317875|453609305|FG000|Overall Study|Physician Decision|0|||
126085442|NCT01317875|453609306|FG001|Overall Study|Physician Decision|1|||
126085443|NCT01317875|453609307|FG002|Overall Study|Physician Decision|1|||
126085444|NCT01317875|453609308|FG003|Overall Study|Physician Decision|0|||
126085445|NCT01317875|453609309|FG004|Overall Study|Physician Decision|2|||
126085446|NCT01317875|453609310|FG005|Overall Study|Physician Decision|0|||
126085447|NCT01317875|453609311|FG006|Overall Study|Physician Decision|0|||
126085448|NCT01317875|453609312|FG007|Overall Study|Physician Decision|2|||
126085449|NCT01317875|453609313|FG008|Overall Study|Physician Decision|0|||
126085450|NCT01317875|453609314|FG009|Overall Study|Physician Decision|0|||
126085451|NCT01317875|453609305|FG000|Overall Study|Death|0|||
126085452|NCT01317875|453609306|FG001|Overall Study|Death|0|||
126085453|NCT01317875|453609307|FG002|Overall Study|Death|2|||
126085454|NCT01317875|453609308|FG003|Overall Study|Death|1|||
126085455|NCT01317875|453609309|FG004|Overall Study|Death|0|||
126085456|NCT01317875|453609310|FG005|Overall Study|Death|1|||
126085457|NCT01317875|453609311|FG006|Overall Study|Death|0|||
126085458|NCT01317875|453609312|FG007|Overall Study|Death|4|||
126085459|NCT01317875|453609313|FG008|Overall Study|Death|0|||
126085460|NCT01317875|453609314|FG009|Overall Study|Death|0|||
126085461|NCT01317875|453609305|FG000|Overall Study|Adverse Event|2|||
126085462|NCT01317875|453609306|FG001|Overall Study|Adverse Event|1|||
125954761|NCT02346240|453129888|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954762|NCT02346240|453129889|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
125954763|NCT02346240|453129890|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954764|NCT02346240|453129891|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954765|NCT02346240|453129892|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954766|NCT02346240|453129893|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954767|NCT02346240|453129894|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954768|NCT02346240|453129895|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954769|NCT02346240|453129896|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954770|NCT02346240|453129897|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954771|NCT02346240|453129898|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954772|NCT02346240|453129899|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954773|NCT02346240|453129900|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954774|NCT02346240|453129901|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954775|NCT02346240|453129902|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954776|NCT02346240|453129903|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954777|NCT02346240|453129904|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954778|NCT02346240|453129905|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954779|NCT02346240|453129906|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954780|NCT02346240|453129907|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954781|NCT02346240|453129908|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954782|NCT02346240|453129909|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125954783|NCT02346240|453129886|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954784|NCT02346240|453129887|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954785|NCT02346240|453129888|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
125954786|NCT02346240|453129889|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954787|NCT02346240|453129890|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954788|NCT02346240|453129891|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954789|NCT02346240|453129892|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954790|NCT02346240|453129893|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954791|NCT02346240|453129894|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954792|NCT02346240|453129895|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954793|NCT02346240|453129896|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954794|NCT02346240|453129897|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954795|NCT02346240|453129898|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954796|NCT02346240|453129899|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954797|NCT02346240|453129900|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954798|NCT02346240|453129901|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954799|NCT02346240|453129902|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954800|NCT02346240|453129903|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954801|NCT02346240|453129904|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954802|NCT02346240|453129905|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954803|NCT02346240|453129906|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954804|NCT02346240|453129907|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954805|NCT02346240|453129908|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954806|NCT02346240|453129909|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125954807|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954808|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954809|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954810|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954811|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954812|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954813|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954814|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125954815|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
125954816|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954817|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954818|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954819|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954820|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125954821|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
125954822|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125954823|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
125954824|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126085463|NCT01317875|453609307|FG002|Overall Study|Adverse Event|2|||
126085464|NCT01317875|453609308|FG003|Overall Study|Adverse Event|1|||
126085465|NCT01317875|453609309|FG004|Overall Study|Adverse Event|5|||
126085466|NCT01317875|453609310|FG005|Overall Study|Adverse Event|1|||
126085467|NCT01317875|453609311|FG006|Overall Study|Adverse Event|2|||
126085468|NCT01317875|453609312|FG007|Overall Study|Adverse Event|5|||
126085469|NCT01317875|453609313|FG008|Overall Study|Adverse Event|0|||
126085470|NCT01317875|453609314|FG009|Overall Study|Adverse Event|0|||
126085471|NCT01381575|453609315|FG000|Overall Study|Serious Adverse Event|1|||
126085472|NCT01381575|453609316|FG001|Overall Study|Serious Adverse Event|0|||
126085473|NCT01381575|453609317|FG002|Overall Study|Serious Adverse Event|0|||
126085474|NCT01381575|453609315|FG000|Overall Study|Non-Serious Adverse Event|0|||
126085475|NCT01381575|453609316|FG001|Overall Study|Non-Serious Adverse Event|0|||
126085476|NCT01381575|453609317|FG002|Overall Study|Non-Serious Adverse Event|1|||
126085477|NCT01381575|453609315|FG000|Overall Study|Protocol Violation|0|||
126085478|NCT01381575|453609316|FG001|Overall Study|Protocol Violation|1|||
126085479|NCT01381575|453609317|FG002|Overall Study|Protocol Violation|1|||
126085480|NCT01381575|453609315|FG000|Overall Study|Withdrawal by Subject|15|||
126085481|NCT01381575|453609316|FG001|Overall Study|Withdrawal by Subject|9|||
126085482|NCT01381575|453609317|FG002|Overall Study|Withdrawal by Subject|7|||
126085483|NCT01381575|453609315|FG000|Overall Study|Migrated/moved from study area|2|||
126085484|NCT01381575|453609316|FG001|Overall Study|Migrated/moved from study area|12|||
126085485|NCT01381575|453609317|FG002|Overall Study|Migrated/moved from study area|2|||
126085486|NCT01381575|453609315|FG000|Overall Study|Lost to Follow-up|8|||
126085487|NCT01381575|453609316|FG001|Overall Study|Lost to Follow-up|17|||
126085488|NCT01381575|453609317|FG002|Overall Study|Lost to Follow-up|9|||
126085489|NCT01920477|453609318|FG000|Overall Study|Adverse Event|0|||
126085490|NCT01920477|453609319|FG001|Overall Study|Adverse Event|1|||
126085491|NCT01920477|453609318|FG000|Overall Study|Lack of Efficacy|1|||
126085492|NCT01920477|453609319|FG001|Overall Study|Lack of Efficacy|0|||
126085493|NCT01920477|453609318|FG000|Overall Study|Study closed/terminated|14|||
126085494|NCT01920477|453609319|FG001|Overall Study|Study closed/terminated|15|||
126085495|NCT01920477|453609318|FG000|Overall Study|Withdrawal by Subject|0|||
126085496|NCT01920477|453609319|FG001|Overall Study|Withdrawal by Subject|1|||
126085497|NCT01443403|453609320|FG000|Overall Study|Adverse Event|1|||
126085498|NCT01443403|453609321|FG001|Overall Study|Adverse Event|1|||
126085499|NCT01443403|453609322|FG002|Overall Study|Adverse Event|4|||
126085500|NCT01443403|453609323|FG003|Overall Study|Adverse Event|5|||
126085501|NCT01443403|453609320|FG000|Overall Study|Withdrawal by Subject|0|||
126085502|NCT01443403|453609321|FG001|Overall Study|Withdrawal by Subject|1|||
126085503|NCT01443403|453609322|FG002|Overall Study|Withdrawal by Subject|2|||
126085504|NCT01443403|453609323|FG003|Overall Study|Withdrawal by Subject|1|||
126085505|NCT01443403|453609320|FG000|Overall Study|Lost to Follow-up|0|||
126085506|NCT01443403|453609321|FG001|Overall Study|Lost to Follow-up|0|||
126085507|NCT01443403|453609322|FG002|Overall Study|Lost to Follow-up|0|||
126085508|NCT01443403|453609323|FG003|Overall Study|Lost to Follow-up|1|||
126085509|NCT01443403|453609320|FG000|Overall Study|Protocol Violation|2|||
126085510|NCT01443403|453609321|FG001|Overall Study|Protocol Violation|1|||
126085511|NCT01443403|453609322|FG002|Overall Study|Protocol Violation|1|||
126085512|NCT01443403|453609323|FG003|Overall Study|Protocol Violation|1|||
126085513|NCT01443403|453609320|FG000|Overall Study|Use of Prohibited Treatment|2|||
126085514|NCT01443403|453609321|FG001|Overall Study|Use of Prohibited Treatment|3|||
126085515|NCT01443403|453609322|FG002|Overall Study|Use of Prohibited Treatment|0|||
126085516|NCT01443403|453609323|FG003|Overall Study|Use of Prohibited Treatment|0|||
126085517|NCT01443403|453609320|FG000|Overall Study|Other - Miscellaneous|1|||
126085518|NCT01443403|453609321|FG001|Overall Study|Other - Miscellaneous|0|||
126085519|NCT01443403|453609322|FG002|Overall Study|Other - Miscellaneous|0|||
126085520|NCT01443403|453609323|FG003|Overall Study|Other - Miscellaneous|1|||
126085521|NCT01681277|453609324|FG000|Overall Study|Adverse Event|1|||
126085522|NCT01681277|453609325|FG001|Overall Study|Adverse Event|0|||
126085523|NCT01681277|453609326|FG002|Overall Study|Adverse Event|0|||
126085524|NCT01681277|453609327|FG003|Overall Study|Adverse Event|0|||
126085525|NCT01681277|453609328|FG004|Overall Study|Adverse Event|0|||
126085526|NCT00474526|453609329|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
126085527|NCT00474526|453609330|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
126085528|NCT00474526|453609331|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
126085529|NCT00474526|453609332|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
126085530|NCT00474526|453609333|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
126085531|NCT00474526|453609334|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
126085532|NCT00474526|453609335|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
126085533|NCT00474526|453609336|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
126085534|NCT00474526|453609337|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
126085535|NCT00474526|453609338|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
126085536|NCT00474526|453609339|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
126085537|NCT00474526|453609340|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
126085538|NCT00474526|453609341|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
126085539|NCT00474526|453609342|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
126085540|NCT00474526|453609343|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
126085541|NCT00474526|453609344|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
126085542|NCT00474526|453609345|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
126085543|NCT00474526|453609329|FG000|Overall Study|Adverse Event|2|||
126085544|NCT00474526|453609330|FG001|Overall Study|Adverse Event|0|||
126085545|NCT00474526|453609331|FG002|Overall Study|Adverse Event|2|||
126085546|NCT00474526|453609332|FG003|Overall Study|Adverse Event|4|||
126085547|NCT00474526|453609333|FG004|Overall Study|Adverse Event|2|||
126085548|NCT00474526|453609334|FG005|Overall Study|Adverse Event|1|||
126085549|NCT00474526|453609335|FG006|Overall Study|Adverse Event|1|||
126085550|NCT00474526|453609336|FG007|Overall Study|Adverse Event|0|||
126085551|NCT00474526|453609337|FG008|Overall Study|Adverse Event|0|||
126085552|NCT00474526|453609338|FG009|Overall Study|Adverse Event|0|||
126085553|NCT00474526|453609339|FG010|Overall Study|Adverse Event|0|||
126085554|NCT00474526|453609340|FG011|Overall Study|Adverse Event|0|||
126085555|NCT00474526|453609341|FG012|Overall Study|Adverse Event|0|||
126085556|NCT00474526|453609342|FG013|Overall Study|Adverse Event|0|||
126085557|NCT00474526|453609343|FG014|Overall Study|Adverse Event|1|||
126085558|NCT00474526|453609344|FG015|Overall Study|Adverse Event|1|||
126085559|NCT00474526|453609345|FG016|Overall Study|Adverse Event|0|||
126085560|NCT00474526|453609329|FG000|Overall Study|Death|0|||
126085561|NCT00474526|453609330|FG001|Overall Study|Death|0|||
126085562|NCT00474526|453609331|FG002|Overall Study|Death|0|||
126085563|NCT00474526|453609332|FG003|Overall Study|Death|0|||
126085564|NCT00474526|453609333|FG004|Overall Study|Death|0|||
126085565|NCT00474526|453609334|FG005|Overall Study|Death|0|||
126085566|NCT00474526|453609335|FG006|Overall Study|Death|0|||
126085567|NCT00474526|453609336|FG007|Overall Study|Death|0|||
126085568|NCT00474526|453609337|FG008|Overall Study|Death|0|||
126085569|NCT00474526|453609338|FG009|Overall Study|Death|0|||
126085570|NCT00474526|453609339|FG010|Overall Study|Death|0|||
126085571|NCT00474526|453609340|FG011|Overall Study|Death|0|||
126085572|NCT00474526|453609341|FG012|Overall Study|Death|0|||
126085573|NCT00474526|453609342|FG013|Overall Study|Death|3|||
126085574|NCT00474526|453609343|FG014|Overall Study|Death|0|||
126085575|NCT00474526|453609344|FG015|Overall Study|Death|0|||
126085576|NCT00474526|453609345|FG016|Overall Study|Death|0|||
126085577|NCT00474526|453609329|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085578|NCT00474526|453609330|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
126085579|NCT00474526|453609331|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085580|NCT00474526|453609332|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
126085581|NCT00474526|453609333|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
126085582|NCT00474526|453609334|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085583|NCT00474526|453609335|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085584|NCT00474526|453609336|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085585|NCT00474526|453609337|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085586|NCT00474526|453609338|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085587|NCT00474526|453609339|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085588|NCT00474526|453609340|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085589|NCT00474526|453609341|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085590|NCT00474526|453609342|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
126085591|NCT00474526|453609343|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
126085592|NCT00474526|453609344|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085593|NCT00474526|453609345|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126085594|NCT00474526|453609329|FG000|Overall Study|Lost to Follow-up|8|||
125954825|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126085595|NCT00474526|453609330|FG001|Overall Study|Lost to Follow-up|6|||
126085596|NCT00474526|453609331|FG002|Overall Study|Lost to Follow-up|13|||
126085597|NCT00474526|453609332|FG003|Overall Study|Lost to Follow-up|29|||
126085598|NCT00474526|453609333|FG004|Overall Study|Lost to Follow-up|11|||
126085599|NCT00474526|453609334|FG005|Overall Study|Lost to Follow-up|5|||
126085600|NCT00474526|453609335|FG006|Overall Study|Lost to Follow-up|8|||
126085601|NCT00474526|453609336|FG007|Overall Study|Lost to Follow-up|1|||
126085602|NCT00474526|453609337|FG008|Overall Study|Lost to Follow-up|0|||
125954826|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954827|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126085603|NCT00474526|453609338|FG009|Overall Study|Lost to Follow-up|6|||
126085604|NCT00474526|453609339|FG010|Overall Study|Lost to Follow-up|2|||
126085605|NCT00474526|453609340|FG011|Overall Study|Lost to Follow-up|4|||
126085606|NCT00474526|453609341|FG012|Overall Study|Lost to Follow-up|6|||
126085607|NCT00474526|453609342|FG013|Overall Study|Lost to Follow-up|74|||
126085608|NCT00474526|453609343|FG014|Overall Study|Lost to Follow-up|29|||
126085609|NCT00474526|453609344|FG015|Overall Study|Lost to Follow-up|4|||
126085610|NCT00474526|453609345|FG016|Overall Study|Lost to Follow-up|5|||
126085611|NCT00474526|453609329|FG000|Overall Study|Protocol Violation|2|||
126085612|NCT00474526|453609330|FG001|Overall Study|Protocol Violation|6|||
126085613|NCT00474526|453609331|FG002|Overall Study|Protocol Violation|4|||
126085614|NCT00474526|453609332|FG003|Overall Study|Protocol Violation|12|||
126085615|NCT00474526|453609333|FG004|Overall Study|Protocol Violation|3|||
126085616|NCT00474526|453609334|FG005|Overall Study|Protocol Violation|1|||
126085617|NCT00474526|453609335|FG006|Overall Study|Protocol Violation|3|||
126085618|NCT00474526|453609336|FG007|Overall Study|Protocol Violation|0|||
126085619|NCT00474526|453609337|FG008|Overall Study|Protocol Violation|0|||
126085620|NCT00474526|453609338|FG009|Overall Study|Protocol Violation|4|||
126085621|NCT00474526|453609339|FG010|Overall Study|Protocol Violation|2|||
126085622|NCT00474526|453609340|FG011|Overall Study|Protocol Violation|2|||
126085623|NCT00474526|453609341|FG012|Overall Study|Protocol Violation|4|||
126085624|NCT00474526|453609342|FG013|Overall Study|Protocol Violation|19|||
126085625|NCT00474526|453609343|FG014|Overall Study|Protocol Violation|9|||
126085626|NCT00474526|453609344|FG015|Overall Study|Protocol Violation|6|||
126085627|NCT00474526|453609345|FG016|Overall Study|Protocol Violation|2|||
126085628|NCT00474526|453609329|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
125954828|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954829|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954830|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125954831|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954832|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954833|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954834|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954835|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954836|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954837|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954838|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954839|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954840|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954841|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954842|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954843|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954844|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
125954845|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954846|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
125954847|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954848|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954849|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954850|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954851|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954852|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954853|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954854|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125954855|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954856|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954857|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954858|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954859|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954860|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954861|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954862|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954863|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954864|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954865|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954866|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954867|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954868|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954869|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
125954870|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954871|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954872|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954873|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954874|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954875|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954876|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954877|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954878|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125954879|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954880|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126085629|NCT00474526|453609330|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
126085630|NCT00474526|453609331|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
126085631|NCT00474526|453609332|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
126085632|NCT00474526|453609333|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
126085633|NCT00474526|453609334|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
126085634|NCT00474526|453609335|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
126085635|NCT00474526|453609336|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
126085636|NCT00474526|453609337|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
126085637|NCT00474526|453609338|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
126085638|NCT00474526|453609339|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
126085639|NCT00474526|453609340|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
126085640|NCT00474526|453609341|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
126085641|NCT00474526|453609342|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
126085642|NCT00474526|453609343|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
126085643|NCT00474526|453609344|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
126085644|NCT00474526|453609345|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
126085645|NCT00474526|453609329|FG000|Overall Study|Withdrawal by Subject|9|||
126085646|NCT00474526|453609330|FG001|Overall Study|Withdrawal by Subject|24|||
126085647|NCT00474526|453609331|FG002|Overall Study|Withdrawal by Subject|21|||
126085648|NCT00474526|453609332|FG003|Overall Study|Withdrawal by Subject|52|||
126085649|NCT00474526|453609333|FG004|Overall Study|Withdrawal by Subject|38|||
126085650|NCT00474526|453609334|FG005|Overall Study|Withdrawal by Subject|6|||
126085651|NCT00474526|453609335|FG006|Overall Study|Withdrawal by Subject|12|||
126085652|NCT00474526|453609336|FG007|Overall Study|Withdrawal by Subject|4|||
126085653|NCT00474526|453609337|FG008|Overall Study|Withdrawal by Subject|4|||
126085654|NCT00474526|453609338|FG009|Overall Study|Withdrawal by Subject|13|||
126085655|NCT00474526|453609339|FG010|Overall Study|Withdrawal by Subject|5|||
126085656|NCT00474526|453609340|FG011|Overall Study|Withdrawal by Subject|4|||
126085657|NCT00474526|453609341|FG012|Overall Study|Withdrawal by Subject|4|||
126085658|NCT00474526|453609342|FG013|Overall Study|Withdrawal by Subject|37|||
126085659|NCT00474526|453609343|FG014|Overall Study|Withdrawal by Subject|22|||
126085660|NCT00474526|453609344|FG015|Overall Study|Withdrawal by Subject|1|||
126085661|NCT00474526|453609345|FG016|Overall Study|Withdrawal by Subject|1|||
126085662|NCT01251770|453609349|FG000|Overall Study|Protocol Violation|13|||
126085663|NCT01251770|453609350|FG001|Overall Study|Protocol Violation|7|||
126085664|NCT02113124|453609351|FG000|Overall Study|Unable to retrieve blood sample|1|||
126085665|NCT02113124|453609352|FG001|Overall Study|Unable to retrieve blood sample|1|||
126085666|NCT02514239|453609353|FG000|Overall Study|Refused to continue trial medication|0|||
126085667|NCT02514239|453609354|FG001|Overall Study|Refused to continue trial medication|0|||
126085668|NCT02514239|453609355|FG002|Overall Study|Refused to continue trial medication|0|||
126085669|NCT02514239|453609356|FG003|Overall Study|Refused to continue trial medication|0|||
126085670|NCT02514239|453609357|FG004|Overall Study|Refused to continue trial medication|0|||
126085671|NCT02514239|453609358|FG005|Overall Study|Refused to continue trial medication|0|||
126085672|NCT02514239|453609359|FG006|Overall Study|Refused to continue trial medication|0|||
126085673|NCT02514239|453609360|FG007|Overall Study|Refused to continue trial medication|0|||
126085674|NCT02514239|453609361|FG008|Overall Study|Refused to continue trial medication|0|||
126085675|NCT02514239|453609362|FG009|Overall Study|Refused to continue trial medication|1|||
126085676|NCT02514239|453609353|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
126085677|NCT02514239|453609354|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
126085678|NCT02514239|453609355|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
126085679|NCT02514239|453609356|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
126085680|NCT02514239|453609357|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
126085681|NCT02514239|453609358|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
126085682|NCT02514239|453609359|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
126085683|NCT02514239|453609360|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
126085684|NCT02514239|453609361|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
126085685|NCT02514239|453609362|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
126085686|NCT02514239|453609353|FG000|Overall Study|Not treated|0|||
126085687|NCT02514239|453609354|FG001|Overall Study|Not treated|1|||
126085688|NCT02514239|453609355|FG002|Overall Study|Not treated|0|||
126085689|NCT02514239|453609356|FG003|Overall Study|Not treated|0|||
126085690|NCT02514239|453609357|FG004|Overall Study|Not treated|0|||
126085691|NCT02514239|453609358|FG005|Overall Study|Not treated|0|||
126085692|NCT02514239|453609359|FG006|Overall Study|Not treated|0|||
126085693|NCT02514239|453609360|FG007|Overall Study|Not treated|0|||
126085694|NCT02514239|453609361|FG008|Overall Study|Not treated|0|||
126085695|NCT02514239|453609362|FG009|Overall Study|Not treated|0|||
126085696|NCT02514239|453609353|FG000|Overall Study|Other Adverse Events|2|||
126085697|NCT02514239|453609354|FG001|Overall Study|Other Adverse Events|0|||
126085698|NCT02514239|453609355|FG002|Overall Study|Other Adverse Events|0|||
126085699|NCT02514239|453609356|FG003|Overall Study|Other Adverse Events|1|||
126085700|NCT02514239|453609357|FG004|Overall Study|Other Adverse Events|0|||
126085701|NCT02514239|453609358|FG005|Overall Study|Other Adverse Events|1|||
126085702|NCT02514239|453609359|FG006|Overall Study|Other Adverse Events|0|||
126085703|NCT02514239|453609360|FG007|Overall Study|Other Adverse Events|1|||
126085704|NCT02514239|453609361|FG008|Overall Study|Other Adverse Events|2|||
126085705|NCT02514239|453609362|FG009|Overall Study|Other Adverse Events|0|||
126085706|NCT02514239|453609353|FG000|Overall Study|Progressive disease|3|||
126085707|NCT02514239|453609354|FG001|Overall Study|Progressive disease|3|||
126085708|NCT02514239|453609355|FG002|Overall Study|Progressive disease|2|||
126115985|NCT00766090|453720080|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115986|NCT00766090|453720081|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115987|NCT00766090|453720082|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115988|NCT00766090|453720083|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115989|NCT00766090|453720084|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115990|NCT00766090|453720085|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115991|NCT00766090|453720086|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115992|NCT00766090|453720087|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115993|NCT00766090|453720088|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126115994|NCT00766090|453720077|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
126115995|NCT00766090|453720078|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
126115996|NCT00766090|453720079|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
126115997|NCT00766090|453720080|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
126115998|NCT00766090|453720081|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
126115999|NCT00766090|453720082|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
126116000|NCT00766090|453720083|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
126116001|NCT00766090|453720084|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
126116002|NCT00766090|453720085|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
126116003|NCT00766090|453720086|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
126116004|NCT00766090|453720087|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
126116005|NCT00766090|453720088|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
126116006|NCT00766090|453720077|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116007|NCT00766090|453720078|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116008|NCT00766090|453720079|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116009|NCT00766090|453720080|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116010|NCT00766090|453720081|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116011|NCT00766090|453720082|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
126116012|NCT00766090|453720083|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116013|NCT00766090|453720084|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116014|NCT00766090|453720085|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116015|NCT00766090|453720086|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116016|NCT00766090|453720087|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116017|NCT00766090|453720088|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126116018|NCT00766090|453720077|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126116019|NCT00766090|453720078|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
126116020|NCT00766090|453720079|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126116021|NCT00766090|453720080|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
126116022|NCT00766090|453720081|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125954881|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954882|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954883|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954884|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125954885|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125954886|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125954887|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125954888|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954889|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125954890|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
125954891|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954892|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
125954893|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
125954894|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
125954895|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125954896|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954897|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954898|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954899|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954900|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954901|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954902|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125954903|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954904|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954905|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954906|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954907|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126116023|NCT00766090|453720082|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126085709|NCT02514239|453609356|FG003|Overall Study|Progressive disease|2|||
126085710|NCT02514239|453609357|FG004|Overall Study|Progressive disease|3|||
126085711|NCT02514239|453609358|FG005|Overall Study|Progressive disease|3|||
126085712|NCT02514239|453609359|FG006|Overall Study|Progressive disease|4|||
126085713|NCT02514239|453609360|FG007|Overall Study|Progressive disease|2|||
126085714|NCT02514239|453609361|FG008|Overall Study|Progressive disease|5|||
126085715|NCT02514239|453609362|FG009|Overall Study|Progressive disease|0|||
126085716|NCT01020877|453609364|FG000|Second Intervention|Withdrawal by Subject|1|||
126085717|NCT01020877|453609365|FG001|Second Intervention|Withdrawal by Subject|0|||
126085718|NCT04307940|453609366|FG000|Overall Study|Adverse Event|1|||
126085719|NCT04307940|453609367|FG001|Overall Study|Adverse Event|0|||
126085720|NCT04307940|453609368|FG002|Overall Study|Adverse Event|0|||
126085721|NCT04307940|453609366|FG000|Overall Study|Withdrawal by Subject|2|||
126085722|NCT04307940|453609367|FG001|Overall Study|Withdrawal by Subject|3|||
126085723|NCT04307940|453609368|FG002|Overall Study|Withdrawal by Subject|1|||
126085724|NCT04307940|453609366|FG000|Overall Study|Lost to Follow-up|2|||
126085725|NCT04307940|453609367|FG001|Overall Study|Lost to Follow-up|0|||
126085726|NCT04307940|453609368|FG002|Overall Study|Lost to Follow-up|1|||
126085727|NCT04624243|453609369|FG000|Overall Study|Death|0|||
126085728|NCT04624243|453609370|FG001|Overall Study|Death|1|||
126085729|NCT04624243|453609371|FG002|Overall Study|Death|0|||
126085730|NCT04624243|453609372|FG003|Overall Study|Death|0|||
126085731|NCT04624243|453609373|FG004|Overall Study|Death|0|||
126085732|NCT04624243|453609369|FG000|Overall Study|Lost to Follow-up|2|||
126085733|NCT04624243|453609370|FG001|Overall Study|Lost to Follow-up|3|||
126085734|NCT04624243|453609371|FG002|Overall Study|Lost to Follow-up|7|||
126085735|NCT04624243|453609372|FG003|Overall Study|Lost to Follow-up|1|||
126085736|NCT04624243|453609373|FG004|Overall Study|Lost to Follow-up|3|||
126085737|NCT04624243|453609369|FG000|Overall Study|Physician Decision|3|||
126085738|NCT04624243|453609370|FG001|Overall Study|Physician Decision|8|||
126085739|NCT04624243|453609371|FG002|Overall Study|Physician Decision|15|||
126085740|NCT04624243|453609372|FG003|Overall Study|Physician Decision|2|||
126085741|NCT04624243|453609373|FG004|Overall Study|Physician Decision|11|||
126085742|NCT04624243|453609369|FG000|Overall Study|Withdrawal by Subject|19|||
126085743|NCT04624243|453609370|FG001|Overall Study|Withdrawal by Subject|44|||
126085744|NCT04624243|453609371|FG002|Overall Study|Withdrawal by Subject|40|||
126085745|NCT04624243|453609372|FG003|Overall Study|Withdrawal by Subject|21|||
126085746|NCT04624243|453609373|FG004|Overall Study|Withdrawal by Subject|39|||
126085747|NCT04624243|453609369|FG000|Overall Study|Miscellaneous|3|||
126085748|NCT04624243|453609370|FG001|Overall Study|Miscellaneous|12|||
126085749|NCT04624243|453609371|FG002|Overall Study|Miscellaneous|9|||
126085750|NCT04624243|453609372|FG003|Overall Study|Miscellaneous|4|||
126085751|NCT04624243|453609373|FG004|Overall Study|Miscellaneous|6|||
126085752|NCT05543174|453609374|FG000|Overall Study|Ongoing|7|||
126085753|NCT00953771|453609375|FG000|Overall Study|Death|1|||
126085754|NCT00953771|453609376|FG001|Overall Study|Death|0|||
126085755|NCT04896008|453609377|FG000|Overall Study|Ongoing|70|||
126085756|NCT04896008|453609378|FG001|Overall Study|Ongoing|38|||
126085757|NCT04896008|453609377|FG000|Overall Study|Adverse Event|0|||
126085758|NCT04896008|453609378|FG001|Overall Study|Adverse Event|2|||
126085759|NCT04896008|453609377|FG000|Overall Study|Death|5|||
126085760|NCT04896008|453609378|FG001|Overall Study|Death|10|||
126085761|NCT04896008|453609377|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
126085762|NCT04896008|453609378|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
126085763|NCT04896008|453609377|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
126085764|NCT04896008|453609378|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
126085765|NCT04896008|453609377|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
126085766|NCT04896008|453609378|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
126085767|NCT04896008|453609377|FG000|Overall Study|Withdrawal by Subject|1|||
126085768|NCT04896008|453609378|FG001|Overall Study|Withdrawal by Subject|4|||
126085769|NCT04896008|453609377|FG000|Overall Study|Investigator Decision|2|||
126085770|NCT04896008|453609378|FG001|Overall Study|Investigator Decision|0|||
126085771|NCT04896008|453609377|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
126085772|NCT04896008|453609378|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
126085773|NCT01270828|453609383|FG000|Pregabalin CR SB|Reason Unspecified|0|||
126085774|NCT01270828|453609384|FG001|Pregabalin CR SB|Reason Unspecified|0|||
126085775|NCT01270828|453609385|FG002|Pregabalin CR SB|Reason Unspecified|8|||
126085776|NCT01270828|453609383|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
126085777|NCT01270828|453609384|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
126085778|NCT01270828|453609385|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
126085779|NCT01270828|453609383|FG000|Pregabalin CR SB|Related adverse event|0|||
126085780|NCT01270828|453609384|FG001|Pregabalin CR SB|Related adverse event|0|||
126085781|NCT01270828|453609385|FG002|Pregabalin CR SB|Related adverse event|46|||
126085782|NCT01270828|453609383|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
126085783|NCT01270828|453609384|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
126085784|NCT01270828|453609385|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
126085785|NCT01270828|453609383|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
126085786|NCT01270828|453609384|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
126085787|NCT01270828|453609385|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
126085788|NCT01270828|453609383|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
126085789|NCT01270828|453609384|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
126085790|NCT01270828|453609385|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
126085791|NCT01270828|453609383|FG000|Pregabalin CR SB|Unrelated AE|0|||
126085792|NCT01270828|453609384|FG001|Pregabalin CR SB|Unrelated AE|0|||
126085793|NCT01270828|453609385|FG002|Pregabalin CR SB|Unrelated AE|8|||
126085794|NCT01270828|453609383|FG000|Pregabalin CR SB|Protocol Violation|0|||
126085795|NCT01270828|453609384|FG001|Pregabalin CR SB|Protocol Violation|0|||
126085796|NCT01270828|453609385|FG002|Pregabalin CR SB|Protocol Violation|8|||
126085797|NCT01270828|453609383|FG000|Double Blind Phase|Death|0|||
126085798|NCT01270828|453609384|FG001|Double Blind Phase|Death|1|||
126085799|NCT01270828|453609385|FG002|Double Blind Phase|Death|0|||
126085800|NCT01270828|453609383|FG000|Double Blind Phase|Protocol Violation|0|||
126085801|NCT01270828|453609384|FG001|Double Blind Phase|Protocol Violation|1|||
126085802|NCT01270828|453609385|FG002|Double Blind Phase|Protocol Violation|0|||
126085803|NCT01270828|453609383|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
126085804|NCT01270828|453609384|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
126085805|NCT01270828|453609385|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
126085806|NCT01270828|453609383|FG000|Double Blind Phase|Reason Unspecified|7|||
126085807|NCT01270828|453609384|FG001|Double Blind Phase|Reason Unspecified|4|||
126085808|NCT01270828|453609385|FG002|Double Blind Phase|Reason Unspecified|0|||
126085809|NCT01270828|453609383|FG000|Double Blind Phase|Withdrawal by Subject|6|||
126085810|NCT01270828|453609384|FG001|Double Blind Phase|Withdrawal by Subject|15|||
126085811|NCT01270828|453609385|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126085812|NCT01270828|453609383|FG000|Double Blind Phase|Lost to Follow-up|1|||
126085813|NCT01270828|453609384|FG001|Double Blind Phase|Lost to Follow-up|2|||
126085814|NCT01270828|453609385|FG002|Double Blind Phase|Lost to Follow-up|0|||
126085815|NCT01270828|453609383|FG000|Double Blind Phase|Lack of Efficacy|2|||
126085816|NCT01270828|453609384|FG001|Double Blind Phase|Lack of Efficacy|11|||
126085817|NCT01270828|453609385|FG002|Double Blind Phase|Lack of Efficacy|0|||
126085818|NCT01270828|453609383|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
126085819|NCT01270828|453609384|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
126085820|NCT01270828|453609385|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
126085821|NCT01270828|453609383|FG000|Double Blind Phase|Adverse event related to study drug|5|||
126085822|NCT01270828|453609384|FG001|Double Blind Phase|Adverse event related to study drug|7|||
126085823|NCT01270828|453609385|FG002|Double Blind Phase|Adverse event related to study drug|0|||
126085824|NCT00709228|453609393|FG000|Overall Study|Not treated|14|||
126085825|NCT00709228|453609393|FG000|Overall Study|Eligibility criteria not met|281|||
126085826|NCT00709228|453609393|FG000|Overall Study|Adverse events|2|||
126085827|NCT00709228|453609393|FG000|Overall Study|Discontinued treatment|14|||
126085828|NCT00709228|453609393|FG000|Overall Study|Did not enter follow-up|4|||
126085829|NCT00709228|453609393|FG000|Overall Study|Discontinued follow-up|5|||
126085830|NCT00709228|453609393|FG000|Overall Study|Disease progression|1|||
126085831|NCT00709228|453609393|FG000|Overall Study|Lost to Follow-up|6|||
126085832|NCT00709228|453609393|FG000|Overall Study|Non-compliance|5|||
126085833|NCT03322540|453609396|FG000|Overall Study|Death|21|||
126085834|NCT03322540|453609397|FG001|Overall Study|Death|28|||
126085835|NCT03322540|453609396|FG000|Overall Study|Lost to Follow-up|0|||
126085836|NCT03322540|453609397|FG001|Overall Study|Lost to Follow-up|1|||
126085837|NCT03322540|453609396|FG000|Overall Study|Physician Decision|7|||
126085838|NCT03322540|453609397|FG001|Overall Study|Physician Decision|6|||
126085839|NCT03322540|453609396|FG000|Overall Study|Withdrawal by Subject|3|||
126085840|NCT03322540|453609397|FG001|Overall Study|Withdrawal by Subject|1|||
126085841|NCT03322540|453609396|FG000|Overall Study|Study terminated by sponsor|0|||
126085842|NCT03322540|453609397|FG001|Overall Study|Study terminated by sponsor|1|||
126085843|NCT04334278|453609398|FG000|Overall Study|Lost to Follow-up|0|||
126085844|NCT04334278|453609399|FG001|Overall Study|Lost to Follow-up|3|||
126085845|NCT04334278|453609398|FG000|Overall Study|Withdrawal by Subject|4|||
126085846|NCT04334278|453609399|FG001|Overall Study|Withdrawal by Subject|2|||
126085847|NCT03445533|453609400|FG000|Overall Study|Progressive Disease|48|||
126085848|NCT03445533|453609401|FG001|Overall Study|Progressive Disease|81|||
126085849|NCT03445533|453609400|FG000|Overall Study|Adverse Event|60|||
126085850|NCT03445533|453609401|FG001|Overall Study|Adverse Event|64|||
126085851|NCT03445533|453609400|FG000|Overall Study|Death|9|||
126085852|NCT03445533|453609401|FG001|Overall Study|Death|19|||
126085853|NCT03445533|453609400|FG000|Overall Study|Miscellaneous|0|||
126085854|NCT03445533|453609401|FG001|Overall Study|Miscellaneous|16|||
126085855|NCT03445533|453609400|FG000|Overall Study|Withdrawal by Subject|3|||
126085856|NCT03445533|453609401|FG001|Overall Study|Withdrawal by Subject|4|||
126085857|NCT03445533|453609400|FG000|Overall Study|Physician Decision|1|||
126085858|NCT03445533|453609401|FG001|Overall Study|Physician Decision|3|||
126085859|NCT03445533|453609400|FG000|Overall Study|Sponsor Decision|0|||
126085860|NCT03445533|453609401|FG001|Overall Study|Sponsor Decision|1|||
126085861|NCT03445533|453609400|FG000|Overall Study|Lost to Follow-up|0|||
126085862|NCT03445533|453609401|FG001|Overall Study|Lost to Follow-up|1|||
126116024|NCT00766090|453720083|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126116025|NCT00766090|453720084|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126116026|NCT00766090|453720085|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126116027|NCT00766090|453720086|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126116028|NCT00766090|453720087|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126116029|NCT00766090|453720088|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
126116030|NCT00766090|453720077|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116031|NCT00766090|453720078|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116032|NCT00766090|453720079|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116033|NCT00766090|453720080|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116034|NCT00766090|453720081|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
126116035|NCT00766090|453720082|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116036|NCT00766090|453720083|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116037|NCT00766090|453720084|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116038|NCT00766090|453720085|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116039|NCT00766090|453720086|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116040|NCT00766090|453720087|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116041|NCT00766090|453720088|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126116042|NCT01106027|453720093|FG000|Overall Study|Lost graft early, discontinued|1|||
126116043|NCT02871778|453720094|FG000|Part A: Treatment Period 1|Adverse Event|1|||
126116044|NCT02871778|453720095|FG001|Part A: Treatment Period 1|Adverse Event|1|||
126116045|NCT02871778|453720096|FG002|Part A: Treatment Period 1|Adverse Event|1|||
126116046|NCT02871778|453720097|FG003|Part A: Treatment Period 1|Adverse Event|0|||
126116047|NCT02871778|453720098|FG004|Part A: Treatment Period 1|Adverse Event|0|||
126116048|NCT02871778|453720099|FG005|Part A: Treatment Period 1|Adverse Event|0|||
126116049|NCT02871778|453720100|FG006|Part A: Treatment Period 1|Adverse Event|0|||
126116050|NCT02871778|453720101|FG007|Part A: Treatment Period 1|Adverse Event|0|||
126116051|NCT02871778|453720094|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
126116052|NCT02871778|453720095|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
126116053|NCT02871778|453720096|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126116054|NCT02871778|453720097|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
126116055|NCT02871778|453720098|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126116056|NCT02871778|453720099|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126116057|NCT02871778|453720100|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126116058|NCT02871778|453720101|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126116059|NCT02871778|453720094|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126116060|NCT02871778|453720095|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126116061|NCT02871778|453720096|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
126116062|NCT02871778|453720097|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126116063|NCT02871778|453720098|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126116064|NCT02871778|453720099|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126116065|NCT02871778|453720100|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126116066|NCT02871778|453720101|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126116067|NCT02871778|453720094|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126116068|NCT02871778|453720095|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126116069|NCT02871778|453720096|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
126116070|NCT02871778|453720097|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126116071|NCT02871778|453720098|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126116072|NCT02871778|453720099|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126116073|NCT02871778|453720100|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126116074|NCT02871778|453720101|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126116075|NCT02871778|453720094|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
126116076|NCT02871778|453720095|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
126116077|NCT02871778|453720096|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
126116078|NCT02871778|453720097|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
126116079|NCT02871778|453720098|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
126116080|NCT02871778|453720099|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
126116081|NCT02871778|453720100|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
126116082|NCT02871778|453720101|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
126116083|NCT02871778|453720094|FG000|Part A: Treatment Period 2|Adverse Event|2|||
126116084|NCT02871778|453720095|FG001|Part A: Treatment Period 2|Adverse Event|2|||
126116085|NCT02871778|453720096|FG002|Part A: Treatment Period 2|Adverse Event|0|||
126116086|NCT02871778|453720097|FG003|Part A: Treatment Period 2|Adverse Event|0|||
126116087|NCT02871778|453720098|FG004|Part A: Treatment Period 2|Adverse Event|0|||
126116088|NCT02871778|453720099|FG005|Part A: Treatment Period 2|Adverse Event|0|||
126116089|NCT02871778|453720100|FG006|Part A: Treatment Period 2|Adverse Event|0|||
125954908|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126085863|NCT03445533|453609400|FG000|Overall Study|Never Received any Study Treatment|7|||
126085864|NCT03445533|453609401|FG001|Overall Study|Never Received any Study Treatment|4|||
126085865|NCT00968526|453609403|FG000|Overall Study|Adverse Event|2|||
126085866|NCT00968526|453609404|FG001|Overall Study|Adverse Event|0|||
126085867|NCT00968526|453609403|FG000|Overall Study|Migrated/moved from study area|1|||
126085868|NCT00968526|453609404|FG001|Overall Study|Migrated/moved from study area|0|||
126085869|NCT00945672|453609405|FG000|Overall Study|Withdrawal by Subject|0|||
126085870|NCT00945672|453609406|FG001|Overall Study|Withdrawal by Subject|0|||
126085871|NCT00945672|453609407|FG002|Overall Study|Withdrawal by Subject|0|||
126085872|NCT00945672|453609408|FG003|Overall Study|Withdrawal by Subject|1|||
126085873|NCT03926195|453609410|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
126085874|NCT03926195|453609411|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
126085875|NCT03926195|453609410|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
126085876|NCT03926195|453609411|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
126085877|NCT03926195|453609410|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
126085878|NCT03926195|453609411|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
126085879|NCT03926195|453609410|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
126085880|NCT03926195|453609411|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
126085881|NCT03926195|453609410|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
126085882|NCT03926195|453609411|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
126085883|NCT03926195|453609410|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
126085884|NCT03926195|453609411|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
126085885|NCT01736540|453609412|FG000|Overall Study|Did not complete scan within 45 days|2|||
126085886|NCT01736540|453609412|FG000|Overall Study|Death|1|||
126085887|NCT01736540|453609412|FG000|Overall Study|Abnormal test procedure|1|||
126085888|NCT01736540|453609412|FG000|Overall Study|Withdrawal by Subject|5|||
126085889|NCT01736540|453609412|FG000|Overall Study|Protocol Violation|1|||
126085890|NCT01736540|453609412|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
126085891|NCT01736540|453609412|FG000|Overall Study|No show for MRI appointment|1|||
126085892|NCT01736540|453609412|FG000|Overall Study|Unable to make MRI appointment|3|||
126085893|NCT00479882|453609413|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
126085894|NCT00479882|453609414|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
126085895|NCT00479882|453609415|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
126085896|NCT00479882|453609416|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
126085897|NCT00479882|453609413|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
126085898|NCT00479882|453609414|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
126085899|NCT00479882|453609415|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
126085900|NCT00479882|453609416|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
126085901|NCT00479882|453609413|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
126085902|NCT00479882|453609414|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
126085903|NCT00479882|453609415|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
126085904|NCT00479882|453609416|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
126085905|NCT00479882|453609413|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
126085906|NCT00479882|453609414|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
126085907|NCT00479882|453609415|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
126085908|NCT00479882|453609416|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
126085909|NCT00479882|453609413|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
126085910|NCT00479882|453609414|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
126085911|NCT00479882|453609415|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
126085912|NCT00479882|453609416|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
126085913|NCT00479882|453609413|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
126085914|NCT00479882|453609414|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
126085915|NCT00479882|453609415|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
126085916|NCT00479882|453609416|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
126085917|NCT00479882|453609413|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
126085918|NCT00479882|453609414|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
126085919|NCT00479882|453609415|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
126085920|NCT00479882|453609416|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
126085921|NCT00479882|453609413|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
126085922|NCT00479882|453609414|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
126085923|NCT00479882|453609415|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
126085924|NCT00479882|453609416|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
126085925|NCT00479882|453609413|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
126085926|NCT00479882|453609414|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
126116090|NCT02871778|453720101|FG007|Part A: Treatment Period 2|Adverse Event|0|||
126116091|NCT02871778|453720094|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
126116092|NCT02871778|453720095|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
125954909|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954910|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954911|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954912|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954913|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954914|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954915|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954916|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
125954917|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
125954918|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
125954919|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
125954920|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954921|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954922|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954923|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954924|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954925|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954926|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125954927|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954928|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954929|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954930|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954931|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954932|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954933|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
125954934|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954935|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954936|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954937|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954938|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954939|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954940|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954941|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954942|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954943|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954944|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954945|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954946|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954947|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954948|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954949|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954950|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125954951|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954952|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954953|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954954|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954955|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954956|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954957|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954958|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954959|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
125954960|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954961|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954962|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
125954963|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954964|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
125954965|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
125954966|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126085927|NCT00479882|453609415|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
126085928|NCT00479882|453609416|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
126085929|NCT00479882|453609413|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
126085930|NCT00479882|453609414|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
126085931|NCT00479882|453609415|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
126085932|NCT00479882|453609416|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
126085933|NCT00479882|453609413|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
126085934|NCT00479882|453609414|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
126085935|NCT00479882|453609415|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
126085936|NCT00479882|453609416|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
126085937|NCT00479882|453609413|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
126085938|NCT00479882|453609414|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
126085939|NCT00479882|453609415|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
126085940|NCT00479882|453609416|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
126085941|NCT00479882|453609413|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
126085942|NCT00479882|453609414|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
126085943|NCT00479882|453609415|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
126085944|NCT00479882|453609416|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
126085945|NCT00479882|453609413|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
126085946|NCT00479882|453609414|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
126085947|NCT00479882|453609415|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
126085948|NCT00479882|453609416|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
126085949|NCT03738475|453609417|FG000|Overall Study|Participant Non-Compliance|1|||
126085950|NCT03738475|453609418|FG001|Overall Study|Participant Non-Compliance|0|||
126085951|NCT00737477|453609419|FG000|Overall Study|Adverse Event|9|||
126085952|NCT00737477|453609419|FG000|Overall Study|Death|9|||
126085953|NCT00737477|453609419|FG000|Overall Study|Treatment Refusal|1|||
126085954|NCT00737477|453609419|FG000|Overall Study|Withdrawal by Subject|1|||
126085955|NCT00737477|453609419|FG000|Overall Study|Renal Transplantation|10|||
126085956|NCT00737477|453609419|FG000|Overall Study|Other|4|||
126085957|NCT01370655|453609420|FG000|Period 1|Adverse Event|2|||
126085958|NCT01370655|453609421|FG001|Period 1|Adverse Event|0|||
126085959|NCT01370655|453609422|FG002|Period 1|Adverse Event|0|||
126085960|NCT01370655|453609423|FG003|Period 1|Adverse Event|0|||
126085961|NCT01370655|453609424|FG004|Period 1|Adverse Event|0|||
126085962|NCT01370655|453609425|FG005|Period 1|Adverse Event|0|||
126085963|NCT01370655|453609426|FG006|Period 1|Adverse Event|1|||
126085964|NCT01370655|453609427|FG007|Period 1|Adverse Event|0|||
126085965|NCT01370655|453609428|FG008|Period 1|Adverse Event|0|||
126085966|NCT01370655|453609429|FG009|Period 1|Adverse Event|0|||
126085967|NCT01370655|453609430|FG010|Period 1|Adverse Event|0|||
126085968|NCT01370655|453609431|FG011|Period 1|Adverse Event|0|||
126085969|NCT01370655|453609420|FG000|Period 2|Adverse Event|0|||
126085970|NCT01370655|453609421|FG001|Period 2|Adverse Event|0|||
126085971|NCT01370655|453609422|FG002|Period 2|Adverse Event|1|||
126085972|NCT01370655|453609423|FG003|Period 2|Adverse Event|0|||
126085973|NCT01370655|453609424|FG004|Period 2|Adverse Event|1|||
126085974|NCT01370655|453609425|FG005|Period 2|Adverse Event|0|||
126085975|NCT01370655|453609426|FG006|Period 2|Adverse Event|0|||
126085976|NCT01370655|453609427|FG007|Period 2|Adverse Event|1|||
126085977|NCT01370655|453609428|FG008|Period 2|Adverse Event|0|||
126085978|NCT01370655|453609429|FG009|Period 2|Adverse Event|0|||
126085979|NCT01370655|453609430|FG010|Period 2|Adverse Event|0|||
126085980|NCT01370655|453609431|FG011|Period 2|Adverse Event|0|||
126085981|NCT01370655|453609420|FG000|Period 2|met protocol specified stopping criteria|0|||
126085982|NCT01370655|453609421|FG001|Period 2|met protocol specified stopping criteria|0|||
126085983|NCT01370655|453609422|FG002|Period 2|met protocol specified stopping criteria|1|||
126085984|NCT01370655|453609423|FG003|Period 2|met protocol specified stopping criteria|0|||
126085985|NCT01370655|453609424|FG004|Period 2|met protocol specified stopping criteria|0|||
126085986|NCT01370655|453609425|FG005|Period 2|met protocol specified stopping criteria|0|||
126085987|NCT01370655|453609426|FG006|Period 2|met protocol specified stopping criteria|1|||
126085988|NCT01370655|453609427|FG007|Period 2|met protocol specified stopping criteria|0|||
126085989|NCT01370655|453609428|FG008|Period 2|met protocol specified stopping criteria|1|||
126085990|NCT01370655|453609429|FG009|Period 2|met protocol specified stopping criteria|0|||
126085991|NCT01370655|453609430|FG010|Period 2|met protocol specified stopping criteria|1|||
126085992|NCT01370655|453609431|FG011|Period 2|met protocol specified stopping criteria|0|||
126085993|NCT01370655|453609420|FG000|Period 2|Withdrawal by Subject|0|||
126085994|NCT01370655|453609421|FG001|Period 2|Withdrawal by Subject|0|||
126085995|NCT01370655|453609422|FG002|Period 2|Withdrawal by Subject|0|||
126085996|NCT01370655|453609423|FG003|Period 2|Withdrawal by Subject|0|||
126085997|NCT01370655|453609424|FG004|Period 2|Withdrawal by Subject|0|||
126085998|NCT01370655|453609425|FG005|Period 2|Withdrawal by Subject|0|||
126085999|NCT01370655|453609426|FG006|Period 2|Withdrawal by Subject|0|||
126086000|NCT01370655|453609427|FG007|Period 2|Withdrawal by Subject|0|||
126086001|NCT01370655|453609428|FG008|Period 2|Withdrawal by Subject|1|||
126086002|NCT01370655|453609429|FG009|Period 2|Withdrawal by Subject|0|||
126086003|NCT01370655|453609430|FG010|Period 2|Withdrawal by Subject|0|||
126086004|NCT01370655|453609431|FG011|Period 2|Withdrawal by Subject|0|||
126086005|NCT00581477|453609432|FG000|Overall Study|Physician Decision|2|||
126086006|NCT02159040|453609435|FG000|Overall Study|Death|1|||
126086007|NCT02803593|453609438|FG000|Overall Study|Lost to Follow-up|17|||
126086008|NCT02803593|453609439|FG001|Overall Study|Lost to Follow-up|35|||
126086009|NCT05143138|453609440|FG000|Overall Study|Death|5|||
126086010|NCT05143138|453609441|FG001|Overall Study|Death|35|||
126086011|NCT05143138|453609442|FG002|Overall Study|Death|1|||
126086012|NCT05143138|453609440|FG000|Overall Study|Lost to Follow-up|2|||
126086013|NCT05143138|453609441|FG001|Overall Study|Lost to Follow-up|4|||
126086014|NCT05143138|453609442|FG002|Overall Study|Lost to Follow-up|0|||
126086015|NCT05143138|453609440|FG000|Overall Study|withdrawal|1|||
126086016|NCT05143138|453609441|FG001|Overall Study|withdrawal|1|||
126086017|NCT05143138|453609442|FG002|Overall Study|withdrawal|0|||
126086018|NCT03443414|453609445|FG000|Overall Study|Adverse Event|6|||
126086019|NCT03443414|453609446|FG001|Overall Study|Adverse Event|0|||
126086020|NCT03443414|453609447|FG002|Overall Study|Adverse Event|4|||
126086021|NCT03443414|453609448|FG003|Overall Study|Adverse Event|2|||
126086022|NCT03443414|453609449|FG004|Overall Study|Adverse Event|3|||
126086023|NCT03443414|453609445|FG000|Overall Study|Withdrawal by Subject|3|||
126086024|NCT03443414|453609446|FG001|Overall Study|Withdrawal by Subject|2|||
126086025|NCT03443414|453609447|FG002|Overall Study|Withdrawal by Subject|2|||
126086026|NCT03443414|453609448|FG003|Overall Study|Withdrawal by Subject|2|||
126086027|NCT03443414|453609449|FG004|Overall Study|Withdrawal by Subject|1|||
126086028|NCT03443414|453609445|FG000|Overall Study|Death|0|||
126086029|NCT03443414|453609446|FG001|Overall Study|Death|1|||
126086030|NCT03443414|453609447|FG002|Overall Study|Death|0|||
126086031|NCT03443414|453609448|FG003|Overall Study|Death|1|||
126086032|NCT03443414|453609449|FG004|Overall Study|Death|0|||
126086033|NCT03443414|453609445|FG000|Overall Study|Reason not specified|2|||
126086034|NCT03443414|453609446|FG001|Overall Study|Reason not specified|0|||
126086035|NCT03443414|453609447|FG002|Overall Study|Reason not specified|0|||
126086036|NCT03443414|453609448|FG003|Overall Study|Reason not specified|0|||
126086037|NCT03443414|453609449|FG004|Overall Study|Reason not specified|1|||
126086038|NCT00732992|453609450|FG000|Overall Study|Adverse Event|1|||
126086039|NCT00732992|453609451|FG001|Overall Study|Adverse Event|1|||
126086040|NCT00732992|453609450|FG000|Overall Study|Objective Progression or Relapse|3|||
126086041|NCT00732992|453609451|FG001|Overall Study|Objective Progression or Relapse|5|||
126086042|NCT00732992|453609450|FG000|Overall Study|Global Deterioration of Health Status|1|||
126086043|NCT00732992|453609451|FG001|Overall Study|Global Deterioration of Health Status|0|||
126086044|NCT00732992|453609450|FG000|Overall Study|Withdrawal by Subject|1|||
126086045|NCT00732992|453609451|FG001|Overall Study|Withdrawal by Subject|0|||
126086046|NCT03933462|453609454|FG000|Overall Study|Adverse Event|2|||
126086047|NCT03933462|453609455|FG001|Overall Study|Adverse Event|0|||
126086048|NCT00422734|453609461|FG000|Overall Study|Physician Decision|1|||
126086049|NCT00422734|453609462|FG001|Overall Study|Physician Decision|1|||
126086050|NCT00422734|453609461|FG000|Overall Study|Protocol Violation|1|||
126086051|NCT00422734|453609462|FG001|Overall Study|Protocol Violation|6|||
126086052|NCT00422734|453609461|FG000|Overall Study|Withdrawal by Subject|12|||
126086053|NCT00422734|453609462|FG001|Overall Study|Withdrawal by Subject|8|||
126086054|NCT00422734|453609461|FG000|Overall Study|Adverse Event|0|||
126086055|NCT00422734|453609462|FG001|Overall Study|Adverse Event|3|||
126086056|NCT00422734|453609461|FG000|Overall Study|Partner Decision|0|||
126086057|NCT00422734|453609462|FG001|Overall Study|Partner Decision|3|||
126086058|NCT00368875|453609466|FG000|Overall Study|Adverse Event|0|||
126086059|NCT00368875|453609467|FG001|Overall Study|Adverse Event|12|||
126086060|NCT00368875|453609466|FG000|Overall Study|Progressive disease|3|||
126086061|NCT00368875|453609467|FG001|Overall Study|Progressive disease|27|||
126086062|NCT00368875|453609466|FG000|Overall Study|Withdrawal by Subject|2|||
126086063|NCT00368875|453609467|FG001|Overall Study|Withdrawal by Subject|6|||
126086064|NCT00368875|453609466|FG000|Overall Study|Other Reason|0|||
126086065|NCT00368875|453609467|FG001|Overall Study|Other Reason|2|||
126086066|NCT00368875|453609466|FG000|Overall Study|Alternative Therapy|1|||
126086067|NCT00368875|453609467|FG001|Overall Study|Alternative Therapy|1|||
126086068|NCT04160988|453609473|FG000|Overall Study|poor image quality|28|||
126086069|NCT00664534|453609475|FG000|Overall Study|Adverse Event|2|||
126086070|NCT00664534|453609476|FG001|Overall Study|Adverse Event|3|||
126086071|NCT00664534|453609475|FG000|Overall Study|Lost to Follow-up|6|||
126086072|NCT00664534|453609476|FG001|Overall Study|Lost to Follow-up|10|||
126086073|NCT00664534|453609475|FG000|Overall Study|Protocol Violation|10|||
126086074|NCT00664534|453609476|FG001|Overall Study|Protocol Violation|8|||
126086075|NCT00664534|453609475|FG000|Overall Study|Withdrawal by Subject|7|||
126086076|NCT00664534|453609476|FG001|Overall Study|Withdrawal by Subject|6|||
126086077|NCT00664534|453609475|FG000|Overall Study|Physician Decision|8|||
126086078|NCT00664534|453609476|FG001|Overall Study|Physician Decision|0|||
126086079|NCT00664534|453609475|FG000|Overall Study|Sponsor decision|8|||
126086080|NCT00664534|453609476|FG001|Overall Study|Sponsor decision|6|||
126086081|NCT00996606|453609479|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
126086082|NCT00996606|453609479|FG000|Overall Study|Insufficient Therapeutic Response|2|||
126086083|NCT00996606|453609479|FG000|Overall Study|Protocol Violation|1|||
126086084|NCT00996606|453609479|FG000|Overall Study|Withdrawal by Subject|3|||
126086085|NCT02548078|453609484|FG000|Overall Study|Serious adverse event/Adverse event|1|||
126086086|NCT02548078|453609485|FG001|Overall Study|Serious adverse event/Adverse event|0|||
126086087|NCT02548078|453609484|FG000|Overall Study|Moved from study area|3|||
126086088|NCT02548078|453609485|FG001|Overall Study|Moved from study area|3|||
126086089|NCT02548078|453609484|FG000|Overall Study|Lost to Follow-up|1|||
126086090|NCT02548078|453609485|FG001|Overall Study|Lost to Follow-up|3|||
126086091|NCT03128671|453609490|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
126086092|NCT03128671|453609491|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
126086093|NCT03128671|453609490|FG000|Allocation|Death|1|||
126086094|NCT03128671|453609491|FG001|Allocation|Death|0|||
126086095|NCT03128671|453609490|FG000|Allocation|Withdrawal by Subject|4|||
126086096|NCT03128671|453609491|FG001|Allocation|Withdrawal by Subject|0|||
126086097|NCT03128671|453609490|FG000|Intervention|Withdrawal by Subject|11|||
126086098|NCT03128671|453609491|FG001|Intervention|Withdrawal by Subject|10|||
126086099|NCT03128671|453609490|FG000|Intervention|Palliative/hospice care initiated|9|||
126086100|NCT03128671|453609491|FG001|Intervention|Palliative/hospice care initiated|10|||
126086101|NCT03128671|453609490|FG000|Intervention|Death|13|||
126086102|NCT03128671|453609491|FG001|Intervention|Death|11|||
126086103|NCT03128671|453609490|FG000|Intervention|Interrupted by hurricane|1|||
126086104|NCT03128671|453609491|FG001|Intervention|Interrupted by hurricane|0|||
126086105|NCT03128671|453609490|FG000|Intervention|Physician Decision|2|||
126086106|NCT03128671|453609491|FG001|Intervention|Physician Decision|3|||
126086107|NCT04641962|453609493|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
126086108|NCT04641962|453609494|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
126086109|NCT04641962|453609495|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
126086110|NCT04641962|453609496|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
126086111|NCT04641962|453609497|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
126086112|NCT04641962|453609493|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
126086113|NCT04641962|453609494|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
126086114|NCT04641962|453609495|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
126086115|NCT04641962|453609496|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
126086116|NCT04641962|453609497|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
126086117|NCT04641962|453609493|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
126086118|NCT04641962|453609494|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
126086119|NCT04641962|453609495|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
126086120|NCT04641962|453609496|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
126086121|NCT04641962|453609497|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
126086122|NCT04641962|453609493|FG000|DBT Period: Up to 52 Weeks|Death|1|||
126086123|NCT04641962|453609494|FG001|DBT Period: Up to 52 Weeks|Death|0|||
126086124|NCT04641962|453609495|FG002|DBT Period: Up to 52 Weeks|Death|0|||
126086125|NCT04641962|453609496|FG003|DBT Period: Up to 52 Weeks|Death|0|||
126086126|NCT04641962|453609497|FG004|DBT Period: Up to 52 Weeks|Death|0|||
126086127|NCT04641962|453609493|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
126086128|NCT04641962|453609494|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
126086129|NCT04641962|453609495|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
126086130|NCT04641962|453609496|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
126086131|NCT04641962|453609497|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
126086132|NCT04641962|453609493|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
126086133|NCT04641962|453609494|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
126086134|NCT04641962|453609495|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
126086135|NCT04641962|453609496|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
126086136|NCT04641962|453609497|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
126086137|NCT04641962|453609493|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
126086138|NCT04641962|453609494|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
126086139|NCT04641962|453609495|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
126086140|NCT04641962|453609496|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
126086141|NCT04641962|453609497|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
126086142|NCT00862836|453609499|FG000|Overall Study|Withdrawal by Subject|1|||
126086143|NCT04463680|453609500|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
126086144|NCT04463680|453609500|FG000|Overall Study|Not eligible due to implant duration of use|1|||
126086145|NCT04463680|453609500|FG000|Overall Study|Withdrawal by Subject|3|||
126086146|NCT05239598|453609503|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
126086147|NCT05239598|453609504|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
126086148|NCT05239598|453609503|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
126086149|NCT05239598|453609504|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
126086150|NCT05823012|453609507|FG000|Titration Period|Adverse Event|1|||
126086151|NCT05823012|453609507|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
126086152|NCT05823012|453609507|FG000|Maintenance Period|Adverse Event|1|||
126086153|NCT05823012|453609507|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
126086154|NCT05823012|453609507|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
126086155|NCT02271984|453611198|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086156|NCT02271984|453611199|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086157|NCT02271984|453611200|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086158|NCT02271984|453611201|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086159|NCT02271984|453611202|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086160|NCT02271984|453611203|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
126086161|NCT02271984|453611204|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086162|NCT02271984|453611205|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
126086163|NCT02271984|453611206|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086164|NCT02271984|453611207|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086165|NCT02271984|453611208|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086166|NCT02271984|453611209|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126086167|NCT03104075|453611210|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
126086168|NCT03104075|453611211|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
126086169|NCT04024462|453611212|FG000|Overall Study|Withdrawal by Subject|6|||
126086170|NCT04024462|453611213|FG001|Overall Study|Withdrawal by Subject|7|||
126086171|NCT04024462|453611212|FG000|Overall Study|Progressive Disease|0|||
126086172|NCT04024462|453611213|FG001|Overall Study|Progressive Disease|1|||
126086173|NCT04024462|453611212|FG000|Overall Study|Adverse Event|0|||
126086174|NCT04024462|453611213|FG001|Overall Study|Adverse Event|1|||
126086175|NCT04024462|453611212|FG000|Overall Study|Death|0|||
126086176|NCT04024462|453611213|FG001|Overall Study|Death|1|||
126086177|NCT04024462|453611212|FG000|Overall Study|Lost to Follow-up|1|||
126086178|NCT04024462|453611213|FG001|Overall Study|Lost to Follow-up|0|||
126086179|NCT04024462|453611212|FG000|Overall Study|Ongoing in the Study|94|||
126086180|NCT04024462|453611213|FG001|Overall Study|Ongoing in the Study|89|||
126086181|NCT00789360|453611216|FG000|Overall Study|Protocol Violation|3|||
126086182|NCT00789360|453611217|FG001|Overall Study|Protocol Violation|1|||
126086183|NCT04400487|453611218|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126086184|NCT04400487|453611218|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
126086185|NCT04400487|453611218|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
126086186|NCT03559062|453611219|FG000|Overall Study|Other|0|||
126086187|NCT03559062|453611220|FG001|Overall Study|Other|1|||
126086188|NCT03559062|453611221|FG002|Overall Study|Other|0|||
126086189|NCT00022659|453611222|FG000|Overall Study|Ineligible: wrong primary|1|||
126086190|NCT00022659|453611222|FG000|Overall Study|Never treated|1|||
126086191|NCT00426127|453611224|FG000|Overall Study|Adverse Event|1|||
126086192|NCT00426127|453611224|FG000|Overall Study|Removed due to disease progression|1|||
126086193|NCT05048238|453611227|FG000|Overall Study|Withdrawal by Subject|1|||
126086194|NCT01730378|453611228|FG000|Overall Study|Lost to Follow-up|1|||
126086195|NCT01730378|453611229|FG001|Overall Study|Lost to Follow-up|0|||
126086196|NCT00955708|453611230|FG000|Overall Study|Death|269|||
126086197|NCT00955708|453611230|FG000|Overall Study|Lost to Follow-up|72|||
126086198|NCT00955708|453611230|FG000|Overall Study|Physician Decision|36|||
126086199|NCT00955708|453611230|FG000|Overall Study|Protocol Violation|134|||
126086200|NCT00955708|453611230|FG000|Overall Study|Registry Conclusion|186|||
126086201|NCT00955708|453611230|FG000|Overall Study|Product removed from service|94|||
126086202|NCT00955708|453611230|FG000|Overall Study|Patient Refused to participate further|116|||
126086203|NCT00955708|453611230|FG000|Overall Study|Closure of study location|60|||
126086204|NCT00955708|453611230|FG000|Overall Study|Patient changed care provider/moved|91|||
126086205|NCT01016262|453611231|FG000|Double-blind Phase|Adverse Event|0|||
126086206|NCT01016262|453611232|FG001|Double-blind Phase|Adverse Event|0|||
126086207|NCT01016262|453611233|FG002|Double-blind Phase|Adverse Event|1|||
126086208|NCT01016262|453611234|FG003|Double-blind Phase|Adverse Event|0|||
126086209|NCT01016262|453611235|FG004|Double-blind Phase|Adverse Event|0|||
126086210|NCT01016262|453611236|FG005|Double-blind Phase|Adverse Event|0|||
126086211|NCT01016262|453611231|FG000|Double-blind Phase|Lack of Efficacy|1|||
126086212|NCT01016262|453611232|FG001|Double-blind Phase|Lack of Efficacy|0|||
126086213|NCT01016262|453611233|FG002|Double-blind Phase|Lack of Efficacy|5|||
126086214|NCT01016262|453611234|FG003|Double-blind Phase|Lack of Efficacy|0|||
126086215|NCT01016262|453611235|FG004|Double-blind Phase|Lack of Efficacy|0|||
126086216|NCT01016262|453611236|FG005|Double-blind Phase|Lack of Efficacy|0|||
126086217|NCT01016262|453611231|FG000|Double-blind Phase|Disease Progression|0|||
126086218|NCT01016262|453611232|FG001|Double-blind Phase|Disease Progression|1|||
126086219|NCT01016262|453611233|FG002|Double-blind Phase|Disease Progression|2|||
126086220|NCT01016262|453611234|FG003|Double-blind Phase|Disease Progression|0|||
126086221|NCT01016262|453611235|FG004|Double-blind Phase|Disease Progression|0|||
126086222|NCT01016262|453611236|FG005|Double-blind Phase|Disease Progression|0|||
126086223|NCT01016262|453611231|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
126086224|NCT01016262|453611232|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
126086225|NCT01016262|453611233|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
126086226|NCT01016262|453611234|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
126086227|NCT01016262|453611235|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
126086228|NCT01016262|453611236|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
126086229|NCT01016262|453611231|FG000|Open-Label Phase|Adverse Event|0|||
126086230|NCT01016262|453611232|FG001|Open-Label Phase|Adverse Event|0|||
126086231|NCT01016262|453611233|FG002|Open-Label Phase|Adverse Event|0|||
126086232|NCT01016262|453611234|FG003|Open-Label Phase|Adverse Event|1|||
126086233|NCT01016262|453611235|FG004|Open-Label Phase|Adverse Event|0|||
126086234|NCT01016262|453611236|FG005|Open-Label Phase|Adverse Event|0|||
126086235|NCT01016262|453611231|FG000|Open-Label Phase|Lost to Follow-up|0|||
126086236|NCT01016262|453611232|FG001|Open-Label Phase|Lost to Follow-up|0|||
126086237|NCT01016262|453611233|FG002|Open-Label Phase|Lost to Follow-up|0|||
126086238|NCT01016262|453611234|FG003|Open-Label Phase|Lost to Follow-up|0|||
126086239|NCT01016262|453611235|FG004|Open-Label Phase|Lost to Follow-up|1|||
126086240|NCT01016262|453611236|FG005|Open-Label Phase|Lost to Follow-up|0|||
126086241|NCT01016262|453611231|FG000|Open-Label Phase|Lack of Efficacy|0|||
126086242|NCT01016262|453611232|FG001|Open-Label Phase|Lack of Efficacy|0|||
126086243|NCT01016262|453611233|FG002|Open-Label Phase|Lack of Efficacy|0|||
126086244|NCT01016262|453611234|FG003|Open-Label Phase|Lack of Efficacy|1|||
126086245|NCT01016262|453611235|FG004|Open-Label Phase|Lack of Efficacy|0|||
126086246|NCT01016262|453611236|FG005|Open-Label Phase|Lack of Efficacy|0|||
126086247|NCT01016262|453611231|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
126086248|NCT01016262|453611232|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
126086249|NCT01016262|453611233|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
126086250|NCT01016262|453611234|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
126086251|NCT01016262|453611235|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
126086252|NCT01016262|453611236|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
126086253|NCT02057575|453611241|FG000|Overall Study|Adverse Event|0|||
126086254|NCT02057575|453611242|FG001|Overall Study|Adverse Event|2|||
126086255|NCT02057575|453611243|FG002|Overall Study|Adverse Event|0|||
126086256|NCT02057575|453611244|FG003|Overall Study|Adverse Event|1|||
126086257|NCT02057575|453611241|FG000|Overall Study|Withdrawal by Subject|1|||
126086258|NCT02057575|453611242|FG001|Overall Study|Withdrawal by Subject|0|||
126086259|NCT02057575|453611243|FG002|Overall Study|Withdrawal by Subject|0|||
126086260|NCT02057575|453611244|FG003|Overall Study|Withdrawal by Subject|0|||
126086261|NCT02057575|453611241|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
126086262|NCT02057575|453611242|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
126086263|NCT02057575|453611243|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
126086264|NCT02057575|453611244|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
126086265|NCT02057575|453611241|FG000|Overall Study|Protocol Violation|0|||
126086266|NCT02057575|453611242|FG001|Overall Study|Protocol Violation|1|||
126086267|NCT02057575|453611243|FG002|Overall Study|Protocol Violation|0|||
126086268|NCT02057575|453611244|FG003|Overall Study|Protocol Violation|0|||
126086269|NCT00332462|453611245|FG000|Overall Study|Adverse Event|5|||
126086270|NCT00332462|453611245|FG000|Overall Study|Abnormal Lab Value|1|||
126086271|NCT00332462|453611245|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126086272|NCT00332462|453611245|FG000|Overall Study|no longer requires study drug|1|||
126086273|NCT00332462|453611245|FG000|Overall Study|Death|3|||
126086274|NCT00332462|453611245|FG000|Overall Study|Graft Loss|2|||
126086275|NCT01643044|453611246|FG000|Overall Study|Lost to Follow-up|1|||
126086276|NCT01643044|453611247|FG001|Overall Study|Lost to Follow-up|1|||
126086277|NCT01643044|453611246|FG000|Overall Study|Miscarried baby|2|||
126086278|NCT01643044|453611247|FG001|Overall Study|Miscarried baby|2|||
126086279|NCT01643044|453611246|FG000|Overall Study|Delivered outside of hospital|1|||
126086280|NCT01643044|453611247|FG001|Overall Study|Delivered outside of hospital|2|||
126086281|NCT01735175|453611251|FG000|Overall Study|Withdrawal by Subject|9|||
126086282|NCT01735175|453611252|FG001|Overall Study|Withdrawal by Subject|2|||
126086283|NCT01735175|453611251|FG000|Overall Study|Lost to Follow-up|4|||
126086284|NCT01735175|453611252|FG001|Overall Study|Lost to Follow-up|2|||
126086285|NCT01735175|453611251|FG000|Overall Study|Death|3|||
126086286|NCT01735175|453611252|FG001|Overall Study|Death|2|||
126086287|NCT01735175|453611251|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
126086288|NCT01735175|453611252|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
126086289|NCT01853475|453611253|FG000|Overall Study|Withdrawal by Subject|0|||
126086290|NCT01853475|453611254|FG001|Overall Study|Withdrawal by Subject|1|||
126086291|NCT01853475|453611255|FG002|Overall Study|Withdrawal by Subject|0|||
126086292|NCT01023958|453611258|FG000|Overall Study|Progressive disease|48|||
126086293|NCT01023958|453611258|FG000|Overall Study|Other adverse event|1|||
126086294|NCT01023958|453611258|FG000|Overall Study|Refused to continue medication|1|||
126086295|NCT03080493|453611259|FG000|Overall Study|Did not provide NRS pain results|1|||
126086296|NCT03080493|453611260|FG001|Overall Study|Did not provide NRS pain results|0|||
126086297|NCT03080493|453611259|FG000|Overall Study|Adverse Event|0|||
126086298|NCT03080493|453611260|FG001|Overall Study|Adverse Event|1|||
126086299|NCT03080493|453611259|FG000|Overall Study|Randomization error (parity group)|0|||
126086300|NCT03080493|453611260|FG001|Overall Study|Randomization error (parity group)|1|||
126086301|NCT00755417|453611261|FG000|Overall Study|Adverse Event|28|||
126086302|NCT00755417|453611262|FG001|Overall Study|Adverse Event|20|||
126086303|NCT00755417|453611263|FG002|Overall Study|Adverse Event|7|||
126086304|NCT00755417|453611261|FG000|Overall Study|Lack of Efficacy|8|||
126086305|NCT00755417|453611262|FG001|Overall Study|Lack of Efficacy|4|||
126086306|NCT00755417|453611263|FG002|Overall Study|Lack of Efficacy|9|||
126086307|NCT00755417|453611261|FG000|Overall Study|Protocol Violation|2|||
126086308|NCT00755417|453611262|FG001|Overall Study|Protocol Violation|1|||
126086309|NCT00755417|453611263|FG002|Overall Study|Protocol Violation|1|||
126086310|NCT00755417|453611261|FG000|Overall Study|Lost to Follow-up|3|||
126086311|NCT00755417|453611262|FG001|Overall Study|Lost to Follow-up|0|||
126086312|NCT00755417|453611263|FG002|Overall Study|Lost to Follow-up|1|||
126086313|NCT00755417|453611261|FG000|Overall Study|Withdrawal by Subject|12|||
126086314|NCT00755417|453611262|FG001|Overall Study|Withdrawal by Subject|12|||
126086315|NCT00755417|453611263|FG002|Overall Study|Withdrawal by Subject|12|||
126086316|NCT00755417|453611261|FG000|Overall Study|Not specified or missing data|9|||
126086317|NCT00755417|453611262|FG001|Overall Study|Not specified or missing data|18|||
126086318|NCT00755417|453611263|FG002|Overall Study|Not specified or missing data|12|||
126086319|NCT02362503|453611264|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
126086320|NCT02362503|453611265|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
126086321|NCT02362503|453611266|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
126086322|NCT02362503|453611264|FG000|Double-blind Period-Up to 8 Days|Death|1|||
126086323|NCT02362503|453611265|FG001|Double-blind Period-Up to 8 Days|Death|0|||
126086324|NCT02362503|453611266|FG002|Double-blind Period-Up to 8 Days|Death|0|||
126086325|NCT02362503|453611264|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
126086326|NCT02362503|453611265|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
126086327|NCT02362503|453611266|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
126086328|NCT02362503|453611264|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
126086329|NCT02362503|453611265|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
126086330|NCT02362503|453611266|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
126086331|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
126086332|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
126086333|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
126086334|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
126086335|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
126086336|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
126086337|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
126086338|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
126086339|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
126086340|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
126086341|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
126086342|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
126086343|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
126086344|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
126086345|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
126086346|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
126086347|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
126086348|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
126086349|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
126086350|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
126086351|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
126086352|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
126086353|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
126086354|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
126086355|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
126086356|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
126086357|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
126086358|NCT02362503|453611264|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
126086359|NCT02362503|453611265|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
126086360|NCT02362503|453611266|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
126086361|NCT02195479|453611267|FG000|Overall Study|Lost to Follow-up|18|||
126086362|NCT02195479|453611268|FG001|Overall Study|Lost to Follow-up|15|||
126086363|NCT02195479|453611267|FG000|Overall Study|Death|217|||
126086364|NCT02195479|453611268|FG001|Overall Study|Death|171|||
126086365|NCT02195479|453611267|FG000|Overall Study|Physician Decision|1|||
126116093|NCT02871778|453720096|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
125954967|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954968|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954969|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954970|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126086366|NCT02195479|453611268|FG001|Overall Study|Physician Decision|0|||
126086367|NCT02195479|453611267|FG000|Overall Study|Withdrawal by Subject|30|||
126086368|NCT02195479|453611268|FG001|Overall Study|Withdrawal by Subject|30|||
126086369|NCT02195479|453611267|FG000|Overall Study|Other|3|||
126086370|NCT02195479|453611268|FG001|Overall Study|Other|4|||
126086371|NCT02195479|453611267|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
126086372|NCT02195479|453611268|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
126086373|NCT03325777|453611273|FG000|Overall Study|Lost to Follow-up|9|||
126086374|NCT03325777|453611274|FG001|Overall Study|Lost to Follow-up|12|||
126086375|NCT03004404|453611277|FG000|Period 2|Adverse Event|0|||
126086376|NCT03004404|453611278|FG001|Period 2|Adverse Event|0|||
126086377|NCT03004404|453611279|FG002|Period 2|Adverse Event|0|||
126086378|NCT03004404|453611280|FG003|Period 2|Adverse Event|0|||
126086379|NCT03004404|453611281|FG004|Period 2|Adverse Event|0|||
126086380|NCT03004404|453611282|FG005|Period 2|Adverse Event|0|||
126086381|NCT03004404|453611283|FG006|Period 2|Adverse Event|0|||
126086382|NCT03004404|453611284|FG007|Period 2|Adverse Event|0|||
126086383|NCT03004404|453611285|FG008|Period 2|Adverse Event|1|||
126086384|NCT03004404|453611286|FG009|Period 2|Adverse Event|0|||
126086385|NCT03004404|453611287|FG010|Period 2|Adverse Event|0|||
126086386|NCT03004404|453611288|FG011|Period 2|Adverse Event|0|||
126086387|NCT03004404|453611289|FG012|Period 2|Adverse Event|0|||
126086388|NCT03004404|453611290|FG013|Period 2|Adverse Event|0|||
126086389|NCT03004404|453611291|FG014|Period 2|Adverse Event|0|||
126086390|NCT03004404|453611292|FG015|Period 2|Adverse Event|1|||
126086391|NCT02522728|453611297|FG000|Overall Study|Withdrawal by Subject|6|||
126086392|NCT02522728|453611298|FG001|Overall Study|Withdrawal by Subject|6|||
126086393|NCT02522728|453611297|FG000|Overall Study|Death|4|||
126086394|NCT02522728|453611298|FG001|Overall Study|Death|3|||
126086395|NCT02522728|453611297|FG000|Overall Study|Adverse Event|2|||
126086396|NCT02522728|453611298|FG001|Overall Study|Adverse Event|1|||
126086397|NCT02522728|453611297|FG000|Overall Study|Did not receive randomized study device|0|||
126086398|NCT02522728|453611298|FG001|Overall Study|Did not receive randomized study device|1|||
126086399|NCT01099917|453611299|FG000|Overall Study|Adverse Event|3|||
126086400|NCT01099917|453611299|FG000|Overall Study|Not Treated|24|||
126086401|NCT01266161|453611306|FG000|Overall Study|Ineligible|1|||
126086402|NCT01266161|453611307|FG001|Overall Study|Ineligible|0|||
126086403|NCT01266161|453611306|FG000|Overall Study|Lack of Efficacy|0|||
126086404|NCT01266161|453611307|FG001|Overall Study|Lack of Efficacy|1|||
126086405|NCT01266161|453611306|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
126086406|NCT01266161|453611307|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
126086407|NCT02990468|453611308|FG000|Phase 2: MTD|Change in treatment|0|||
126086408|NCT02990468|453611309|FG001|Phase 2: MTD|Change in treatment|0|||
126086409|NCT02990468|453611310|FG002|Phase 2: MTD|Change in treatment|1|||
126086410|NCT01436305|453611312|FG000|Overall Study|Death|1|||
126086411|NCT01436305|453611313|FG001|Overall Study|Death|0|||
126086412|NCT01436305|453611314|FG002|Overall Study|Death|0|||
126086413|NCT01436305|453611312|FG000|Overall Study|Lost to Follow-up|0|||
126086414|NCT01436305|453611313|FG001|Overall Study|Lost to Follow-up|1|||
126086415|NCT01436305|453611314|FG002|Overall Study|Lost to Follow-up|0|||
126086416|NCT01436305|453611312|FG000|Overall Study|Withdrawal by Subject|1|||
126086417|NCT01436305|453611313|FG001|Overall Study|Withdrawal by Subject|3|||
126086418|NCT01436305|453611314|FG002|Overall Study|Withdrawal by Subject|0|||
126086419|NCT01485120|453611317|FG000|Overall Study|Withdrawal by Subject|2|||
126086420|NCT05071053|453611318|FG000|Overall Study|Progressive disease|30|||
126086421|NCT05071053|453611318|FG000|Overall Study|Adverse Event|5|||
126086422|NCT01081886|453611319|FG000|Overall Study|Study termination|11|||
126086423|NCT01081886|453611320|FG001|Overall Study|Study termination|13|||
126086424|NCT02567708|453611321|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
126086425|NCT02567708|453611322|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
126086426|NCT02567708|453611321|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
126086427|NCT02567708|453611322|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
126086428|NCT02567708|453611321|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
126086429|NCT02567708|453611322|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
126086430|NCT02567708|453611321|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
126086431|NCT02567708|453611322|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
126086432|NCT04148651|453611327|FG000|Overall Study|Lost to Follow-up|2|||
126086433|NCT01602510|453611328|FG000|Open Label Phase|Adverse Event|46|||
126086434|NCT01602510|453611329|FG001|Open Label Phase|Adverse Event|0|||
126086435|NCT01602510|453611330|FG002|Open Label Phase|Adverse Event|0|||
126086436|NCT01602510|453611328|FG000|Open Label Phase|Lack of Efficacy|22|||
126086437|NCT01602510|453611329|FG001|Open Label Phase|Lack of Efficacy|0|||
126086438|NCT01602510|453611330|FG002|Open Label Phase|Lack of Efficacy|0|||
126086439|NCT01602510|453611328|FG000|Open Label Phase|Protocol Violation|15|||
126086440|NCT01602510|453611329|FG001|Open Label Phase|Protocol Violation|0|||
126086441|NCT01602510|453611330|FG002|Open Label Phase|Protocol Violation|0|||
126086442|NCT01602510|453611328|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
126086443|NCT01602510|453611329|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
126086444|NCT01602510|453611330|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
126086445|NCT01602510|453611328|FG000|Open Label Phase|Lost to Follow-up|22|||
126086446|NCT01602510|453611329|FG001|Open Label Phase|Lost to Follow-up|0|||
126086447|NCT01602510|453611330|FG002|Open Label Phase|Lost to Follow-up|0|||
126086448|NCT01602510|453611328|FG000|Open Label Phase|Physician Decision|19|||
126086449|NCT01602510|453611329|FG001|Open Label Phase|Physician Decision|0|||
126086450|NCT01602510|453611330|FG002|Open Label Phase|Physician Decision|0|||
126086451|NCT01602510|453611328|FG000|Open Label Phase|Withdrawal by Subject|57|||
126086452|NCT01602510|453611329|FG001|Open Label Phase|Withdrawal by Subject|0|||
126086453|NCT01602510|453611330|FG002|Open Label Phase|Withdrawal by Subject|0|||
126086454|NCT01602510|453611328|FG000|Randomized Phase|Adverse Event|0|||
126086455|NCT01602510|453611329|FG001|Randomized Phase|Adverse Event|2|||
126086456|NCT01602510|453611330|FG002|Randomized Phase|Adverse Event|6|||
126086457|NCT01602510|453611328|FG000|Randomized Phase|Lack of Efficacy|0|||
126086458|NCT01602510|453611329|FG001|Randomized Phase|Lack of Efficacy|4|||
126086459|NCT01602510|453611330|FG002|Randomized Phase|Lack of Efficacy|4|||
126086460|NCT01602510|453611328|FG000|Randomized Phase|Protocol Violation|0|||
126086461|NCT01602510|453611329|FG001|Randomized Phase|Protocol Violation|3|||
126086462|NCT01602510|453611330|FG002|Randomized Phase|Protocol Violation|3|||
126086463|NCT01602510|453611328|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
126086464|NCT01602510|453611329|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
126086465|NCT01602510|453611330|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
126086466|NCT01602510|453611328|FG000|Randomized Phase|Lost to Follow-up|0|||
126086467|NCT01602510|453611329|FG001|Randomized Phase|Lost to Follow-up|1|||
126086468|NCT01602510|453611330|FG002|Randomized Phase|Lost to Follow-up|3|||
126086469|NCT01602510|453611328|FG000|Randomized Phase|Physician Decision|0|||
126086470|NCT01602510|453611329|FG001|Randomized Phase|Physician Decision|0|||
126086471|NCT01602510|453611330|FG002|Randomized Phase|Physician Decision|2|||
126086472|NCT01602510|453611328|FG000|Randomized Phase|Withdrawal by Subject|0|||
126086473|NCT01602510|453611329|FG001|Randomized Phase|Withdrawal by Subject|6|||
126086474|NCT01602510|453611330|FG002|Randomized Phase|Withdrawal by Subject|7|||
126086475|NCT05262751|453611331|FG000|Washout Period 2|Adverse Event|1|||
126086476|NCT05262751|453611332|FG001|Washout Period 2|Adverse Event|0|||
126086477|NCT05262751|453611333|FG002|Washout Period 2|Adverse Event|0|||
126086478|NCT05262751|453611334|FG003|Washout Period 2|Adverse Event|0|||
126086479|NCT05262751|453611335|FG004|Washout Period 2|Adverse Event|0|||
126086480|NCT05262751|453611336|FG005|Washout Period 2|Adverse Event|0|||
126086481|NCT05262751|453611331|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
126086482|NCT05262751|453611332|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
126086483|NCT05262751|453611333|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
126086484|NCT05262751|453611334|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
126086485|NCT05262751|453611335|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
126086486|NCT05262751|453611336|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
126086487|NCT03519204|453611337|FG000|Overall Study|Lost to Follow-up|3|||
126086488|NCT03519204|453611338|FG001|Overall Study|Lost to Follow-up|8|||
126086489|NCT03519204|453611337|FG000|Overall Study|Withdrawal by Subject|9|||
126086490|NCT03519204|453611338|FG001|Overall Study|Withdrawal by Subject|7|||
126086491|NCT03519204|453611337|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126086492|NCT03519204|453611338|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126086493|NCT01154140|453611339|FG000|Overall Study|Death|71|||
126086494|NCT01154140|453611340|FG001|Overall Study|Death|81|||
126086495|NCT01154140|453611339|FG000|Overall Study|Lost to Follow-up|4|||
126086496|NCT01154140|453611340|FG001|Overall Study|Lost to Follow-up|5|||
126086497|NCT01154140|453611339|FG000|Overall Study|Withdrawal by Subject|12|||
126086498|NCT01154140|453611340|FG001|Overall Study|Withdrawal by Subject|13|||
126086499|NCT01154140|453611339|FG000|Overall Study|Other|3|||
126086500|NCT01154140|453611340|FG001|Overall Study|Other|1|||
126086501|NCT01154140|453611339|FG000|Overall Study|Randomized but not treated|1|||
126086502|NCT01154140|453611340|FG001|Overall Study|Randomized but not treated|2|||
126086503|NCT01818531|453611344|FG000|Overall Study|Withdrawn for case delay after block|1|||
126086504|NCT01818531|453611345|FG001|Overall Study|Withdrawn for case delay after block|0|||
126086505|NCT01818531|453611344|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
126086506|NCT01818531|453611345|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
126086507|NCT01818531|453611344|FG000|Overall Study|Withdrawn for failure to place block|0|||
126086508|NCT01818531|453611345|FG001|Overall Study|Withdrawn for failure to place block|1|||
126086509|NCT00477490|453611346|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
126086510|NCT00477490|453611347|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
126116094|NCT02871778|453720097|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
126116095|NCT02871778|453720098|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
126116096|NCT02871778|453720099|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
126086511|NCT00477490|453611348|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
126086512|NCT00477490|453611349|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
126086513|NCT00477490|453611350|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
126086514|NCT00477490|453611351|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
126086515|NCT00477490|453611352|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
126086516|NCT00477490|453611353|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
126086517|NCT00477490|453611354|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
126086518|NCT00477490|453611346|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
126086519|NCT00477490|453611347|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126086520|NCT00477490|453611348|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126116097|NCT02871778|453720100|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
126086521|NCT00477490|453611349|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
126086522|NCT00477490|453611350|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
126086523|NCT00477490|453611351|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126086524|NCT00477490|453611352|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126086525|NCT00477490|453611353|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126086526|NCT00477490|453611354|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126086527|NCT00477490|453611346|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
126086528|NCT00477490|453611347|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
126086529|NCT00477490|453611348|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
126086530|NCT00477490|453611349|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
126086531|NCT00477490|453611350|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
126086532|NCT00477490|453611351|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
126086533|NCT00477490|453611352|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
126086534|NCT00477490|453611353|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
126086535|NCT00477490|453611354|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
126086536|NCT00477490|453611346|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
126086537|NCT00477490|453611347|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
126086538|NCT00477490|453611348|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
126086539|NCT00477490|453611349|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
126086540|NCT00477490|453611350|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
126086541|NCT00477490|453611351|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
126086542|NCT00477490|453611352|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
126086543|NCT00477490|453611353|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
126086544|NCT00477490|453611354|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
126086545|NCT00477490|453611346|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
126086546|NCT00477490|453611347|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
126086547|NCT00477490|453611348|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
126086548|NCT00477490|453611349|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
126086549|NCT00477490|453611350|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
126086550|NCT00477490|453611351|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
126086551|NCT00477490|453611352|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
126086552|NCT00477490|453611353|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
126086553|NCT00477490|453611354|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
126086554|NCT00477490|453611346|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
126086555|NCT00477490|453611347|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
126086556|NCT00477490|453611348|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
126086557|NCT00477490|453611349|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
126086558|NCT00477490|453611350|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
126086559|NCT00477490|453611351|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
126086560|NCT00477490|453611352|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
126086561|NCT00477490|453611353|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
126086562|NCT00477490|453611354|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
126086563|NCT00477490|453611346|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
126086564|NCT00477490|453611347|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
126086565|NCT00477490|453611348|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
126086566|NCT00477490|453611349|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
126086567|NCT00477490|453611350|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
126086568|NCT00477490|453611351|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
126086569|NCT00477490|453611352|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
126086570|NCT00477490|453611353|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
126086571|NCT00477490|453611354|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
125954971|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954972|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126086572|NCT00477490|453611346|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
126086573|NCT00477490|453611347|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
126086574|NCT00477490|453611348|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
126086575|NCT00477490|453611349|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
126086576|NCT00477490|453611350|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
126086577|NCT00477490|453611351|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
126086578|NCT00477490|453611352|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
126086579|NCT00477490|453611353|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
126086580|NCT00477490|453611354|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
126086581|NCT00477490|453611346|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
126086582|NCT00477490|453611347|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
126086583|NCT00477490|453611348|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
126086584|NCT00477490|453611349|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126086585|NCT00477490|453611350|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126086586|NCT00477490|453611351|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126086587|NCT00477490|453611352|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126086588|NCT00477490|453611353|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126086589|NCT00477490|453611354|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
126086590|NCT00477490|453611346|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126086591|NCT00477490|453611347|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
126086592|NCT00477490|453611348|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
126086593|NCT00477490|453611349|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126086594|NCT00477490|453611350|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
126086595|NCT00477490|453611351|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126086596|NCT00477490|453611352|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
126086597|NCT00477490|453611353|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126086598|NCT00477490|453611354|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126086599|NCT00477490|453611346|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126086600|NCT00477490|453611347|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126086601|NCT00477490|453611348|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126086602|NCT00477490|453611349|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126086603|NCT00477490|453611350|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
126086604|NCT00477490|453611351|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126086605|NCT00477490|453611352|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126086606|NCT00477490|453611353|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
126086607|NCT00477490|453611354|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
126086608|NCT00477490|453611346|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126086609|NCT00477490|453611347|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
126086610|NCT00477490|453611348|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126086611|NCT00477490|453611349|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126086612|NCT00477490|453611350|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126086613|NCT00477490|453611351|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126086614|NCT00477490|453611352|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126086615|NCT00477490|453611353|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126086616|NCT00477490|453611354|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126086617|NCT00477490|453611346|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
126086618|NCT00477490|453611347|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
126116098|NCT02871778|453720101|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
126116099|NCT02871778|453720094|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
126116100|NCT02871778|453720095|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126116101|NCT02871778|453720096|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
126116102|NCT02871778|453720097|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126116103|NCT02871778|453720098|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126116104|NCT02871778|453720099|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126116105|NCT02871778|453720100|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126116106|NCT02871778|453720101|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126116107|NCT02871778|453720094|FG000|Part B: Treatment Period 3|Adverse Event|0|||
126116108|NCT02871778|453720095|FG001|Part B: Treatment Period 3|Adverse Event|0|||
126116109|NCT02871778|453720096|FG002|Part B: Treatment Period 3|Adverse Event|0|||
126116110|NCT02871778|453720097|FG003|Part B: Treatment Period 3|Adverse Event|0|||
126116111|NCT02871778|453720098|FG004|Part B: Treatment Period 3|Adverse Event|1|||
126116112|NCT02871778|453720099|FG005|Part B: Treatment Period 3|Adverse Event|1|||
126116113|NCT02871778|453720100|FG006|Part B: Treatment Period 3|Adverse Event|1|||
126116114|NCT02871778|453720101|FG007|Part B: Treatment Period 3|Adverse Event|0|||
126116115|NCT02653300|453720102|FG000|Overall Study|Withdrawal by Subject|2|||
126116116|NCT02170779|453720103|FG000|Overall Study|Withdrawal by Subject|1|||
126116117|NCT02170779|453720104|FG001|Overall Study|Withdrawal by Subject|0|||
126116118|NCT02170779|453720103|FG000|Overall Study|Lost to Follow-up|0|||
126116119|NCT02170779|453720104|FG001|Overall Study|Lost to Follow-up|1|||
125954973|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126116120|NCT00369785|453720116|FG000|Overall Study|Physician Decision|3|||
125954974|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125954975|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126086619|NCT00477490|453611348|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
126086620|NCT00477490|453611349|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
126086621|NCT00477490|453611350|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
126086622|NCT00477490|453611351|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
126086623|NCT00477490|453611352|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
126086624|NCT00477490|453611353|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
126086625|NCT00477490|453611354|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
126116121|NCT00369785|453720117|FG001|Overall Study|Physician Decision|2|||
126116122|NCT00369785|453720116|FG000|Overall Study|Death|1|||
126086626|NCT00477490|453611346|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126086627|NCT00477490|453611347|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
126086628|NCT00477490|453611348|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
126086629|NCT00477490|453611349|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126086630|NCT00477490|453611350|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
126086631|NCT00477490|453611351|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126086632|NCT00477490|453611352|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126086633|NCT00477490|453611353|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126086634|NCT00477490|453611354|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126086635|NCT01646177|453611355|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
126086636|NCT01646177|453611356|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
126086637|NCT01646177|453611357|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
126086638|NCT01646177|453611358|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
126086639|NCT01646177|453611359|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126086640|NCT01646177|453611360|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126086641|NCT01646177|453611361|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126086642|NCT01646177|453611362|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126086643|NCT01646177|453611363|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126086644|NCT01646177|453611364|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126086645|NCT01646177|453611365|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126086646|NCT01646177|453611366|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126086647|NCT01646177|453611355|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
126086648|NCT01646177|453611356|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
126086649|NCT01646177|453611357|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
126086650|NCT01646177|453611358|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
126086651|NCT01646177|453611359|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126086652|NCT01646177|453611360|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126086653|NCT01646177|453611361|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126086654|NCT01646177|453611362|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126086655|NCT01646177|453611363|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126086656|NCT01646177|453611364|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126086657|NCT01646177|453611365|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126086658|NCT01646177|453611366|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126086659|NCT01646177|453611355|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
126086660|NCT01646177|453611356|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
126086661|NCT01646177|453611357|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
126086662|NCT01646177|453611358|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
126086663|NCT01646177|453611359|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126086664|NCT01646177|453611360|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126086665|NCT01646177|453611361|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126086666|NCT01646177|453611362|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126086667|NCT01646177|453611363|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126086668|NCT01646177|453611364|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126086669|NCT01646177|453611365|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126086670|NCT01646177|453611366|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126086671|NCT01646177|453611355|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
126086672|NCT01646177|453611356|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
126086673|NCT01646177|453611357|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
126086674|NCT01646177|453611358|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
126086675|NCT01646177|453611359|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126086676|NCT01646177|453611360|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126086677|NCT01646177|453611361|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126086678|NCT01646177|453611362|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126086679|NCT01646177|453611363|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126086680|NCT01646177|453611364|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126086681|NCT01646177|453611365|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126086682|NCT01646177|453611366|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126086683|NCT01646177|453611355|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086684|NCT01646177|453611356|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126116123|NCT00369785|453720117|FG001|Overall Study|Death|2|||
126116124|NCT00369785|453720116|FG000|Overall Study|Withdrawal by Subject|7|||
126086685|NCT01646177|453611357|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
126086686|NCT01646177|453611358|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
126086687|NCT01646177|453611359|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086688|NCT01646177|453611360|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086689|NCT01646177|453611361|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086690|NCT01646177|453611362|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086691|NCT01646177|453611363|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086692|NCT01646177|453611364|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086693|NCT01646177|453611365|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086694|NCT01646177|453611366|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126086695|NCT01646177|453611355|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
126086696|NCT01646177|453611356|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
126086697|NCT01646177|453611357|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
126086698|NCT01646177|453611358|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086699|NCT01646177|453611359|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086700|NCT01646177|453611360|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086701|NCT01646177|453611361|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086702|NCT01646177|453611362|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086703|NCT01646177|453611363|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086704|NCT01646177|453611364|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086705|NCT01646177|453611365|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086706|NCT01646177|453611366|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126086707|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126086708|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126086709|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126086710|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126086711|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
126086712|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
126086713|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
126086714|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
126086715|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126086716|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126086717|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126086718|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126086719|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126086720|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126086721|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126086722|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126086723|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
126086724|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
126086725|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
126086726|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
126086727|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126086728|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126086729|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126086730|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126086731|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126086732|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126086733|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126086734|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126086735|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
126086736|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
126086737|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
126086738|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
126086739|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126086740|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126086741|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126086742|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126086743|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126086744|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126086745|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126086746|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126086747|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
126086748|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
126086749|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
126086750|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
126086751|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126086752|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125954976|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954977|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954978|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954979|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954980|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954981|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954982|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954983|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954984|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
125954985|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954986|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954987|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954988|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954989|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954990|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954991|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954992|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954993|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954994|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954995|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954996|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954997|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954998|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125954999|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955000|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955001|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955002|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955003|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955004|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955005|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955006|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955007|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955008|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955009|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
125955010|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955011|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955012|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955013|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955014|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955015|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955016|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955017|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955018|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955019|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955020|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955021|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955022|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125955023|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955024|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955025|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955026|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955027|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955028|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955029|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955030|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955031|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955032|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955033|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955034|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955035|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955036|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955037|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
125955038|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955039|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955040|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955041|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126086753|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126086754|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126086755|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126086756|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126086757|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126086758|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126086759|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
126086760|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
126086761|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
126086762|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
126086763|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126086764|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126086765|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126086766|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126086767|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086768|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086769|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086770|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086771|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
126086772|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
126086773|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086774|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
126086775|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086776|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086777|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086778|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126086779|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126086780|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126086781|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126086782|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126086783|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
126086784|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
126086785|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
126086786|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
126086787|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126086788|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126086789|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126086790|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126086791|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
126086792|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
126086793|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
126086794|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
126086795|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
126086796|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
126086797|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
126086798|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
126086799|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
126116125|NCT00369785|453720117|FG001|Overall Study|Withdrawal by Subject|6|||
126116126|NCT00369785|453720116|FG000|Overall Study|Toxicity|6|||
126116127|NCT00369785|453720117|FG001|Overall Study|Toxicity|4|||
126116128|NCT00369785|453720116|FG000|Overall Study|Never started|0|||
125955042|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955043|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125971514|NCT00791765|453184717|FG001|Weeks 1 to 12|Ineligibility determined|3|||
126116129|NCT00369785|453720117|FG001|Overall Study|Never started|2|||
126116130|NCT00369785|453720116|FG000|Overall Study|Progression|4|||
126116131|NCT00369785|453720117|FG001|Overall Study|Progression|4|||
126116132|NCT00369785|453720116|FG000|Overall Study|Multiple reasons|6|||
126116133|NCT00369785|453720117|FG001|Overall Study|Multiple reasons|5|||
126116134|NCT00800683|453720118|FG000|Overall Study|Adverse Event|11|||
126116135|NCT00800683|453720119|FG001|Overall Study|Adverse Event|8|||
126116136|NCT00800683|453720118|FG000|Overall Study|Lost to Follow-up|3|||
126116137|NCT00800683|453720119|FG001|Overall Study|Lost to Follow-up|1|||
126116138|NCT00800683|453720118|FG000|Overall Study|Withdrawal by Subject|1|||
126116139|NCT00800683|453720119|FG001|Overall Study|Withdrawal by Subject|7|||
126116140|NCT00800683|453720118|FG000|Overall Study|Lack of Efficacy|1|||
126116141|NCT00800683|453720119|FG001|Overall Study|Lack of Efficacy|1|||
126116142|NCT00800683|453720118|FG000|Overall Study|Other|1|||
126116143|NCT00800683|453720119|FG001|Overall Study|Other|2|||
126116144|NCT04556136|453720124|FG000|Overall Study|Lost to Follow-up|6|||
126116145|NCT04556136|453720125|FG001|Overall Study|Lost to Follow-up|6|||
126116146|NCT04556136|453720124|FG000|Overall Study|Physician Decision|2|||
126116147|NCT04556136|453720125|FG001|Overall Study|Physician Decision|1|||
126116148|NCT04556136|453720124|FG000|Overall Study|Withdrawal by Subject|2|||
126116149|NCT04556136|453720125|FG001|Overall Study|Withdrawal by Subject|1|||
126116150|NCT03492554|453720126|FG000|Overall Study|Protocol Violation|0|||
126116151|NCT03492554|453720127|FG001|Overall Study|Protocol Violation|14|||
126116152|NCT04340557|453720128|FG000|Overall Study|Transferred to ICU and/or death|1|||
126116153|NCT04340557|453720129|FG001|Overall Study|Transferred to ICU and/or death|2|||
126116154|NCT01289821|453720132|FG000|Treatment Period|Withdrawal by Subject|1|||
126116155|NCT01289821|453720132|FG000|Treatment Period|Physician Decision|3|||
126116156|NCT01289821|453720132|FG000|Treatment Period|Adverse Event|4|||
126116157|NCT01289821|453720132|FG000|Treatment Period|Radiological Progression|43|||
126116158|NCT01289821|453720132|FG000|Treatment Period|Clinical Progression|2|||
126116159|NCT01289821|453720132|FG000|Treatment Period|Therapeutic procedure required|1|||
126116160|NCT01289821|453720132|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
126116161|NCT01289821|453720132|FG000|Safety Follow-up Period|Protocol Violation|3|||
126116162|NCT01289821|453720132|FG000|Safety Follow-up Period|Unspecified reason|1|||
126116163|NCT01289821|453720132|FG000|Survival Follow-up Period|Protocol Violation|1|||
126116164|NCT01289821|453720132|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
126116165|NCT01289821|453720132|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
126116166|NCT00773136|453720135|FG000|Overall Study|Physician Decision|2|||
126116167|NCT02463071|453720137|FG000|Overall Study|Adverse Event|3|||
126116168|NCT02463071|453720138|FG001|Overall Study|Adverse Event|5|||
126116169|NCT02463071|453720139|FG002|Overall Study|Adverse Event|1|||
126116170|NCT02463071|453720137|FG000|Overall Study|Death|1|||
126116171|NCT02463071|453720138|FG001|Overall Study|Death|0|||
126116172|NCT02463071|453720139|FG002|Overall Study|Death|0|||
126116173|NCT02463071|453720137|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
126116174|NCT02463071|453720138|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126116175|NCT02463071|453720139|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126116176|NCT02463071|453720137|FG000|Overall Study|Reason not specified|7|||
126116177|NCT02463071|453720138|FG001|Overall Study|Reason not specified|9|||
126116178|NCT02463071|453720139|FG002|Overall Study|Reason not specified|4|||
126116179|NCT02463071|453720137|FG000|Overall Study|Protocol Violation|0|||
126116180|NCT02463071|453720138|FG001|Overall Study|Protocol Violation|2|||
126116181|NCT02463071|453720139|FG002|Overall Study|Protocol Violation|0|||
126116182|NCT02463071|453720137|FG000|Overall Study|Lost to Follow-up|0|||
126116183|NCT02463071|453720138|FG001|Overall Study|Lost to Follow-up|0|||
126116184|NCT02463071|453720139|FG002|Overall Study|Lost to Follow-up|1|||
126116185|NCT00888381|453720142|FG000|Overall Study|Lost to Follow-up|0|||
126116186|NCT00888381|453720143|FG001|Overall Study|Lost to Follow-up|1|||
126116187|NCT01009034|453720144|FG000|Overall Study|Lost to Follow-up|2|||
126116188|NCT01009034|453720144|FG000|Overall Study|Withdrawal by Subject|2|||
126116189|NCT03986866|453720145|FG000|Overall Study|Withdrawal by Subject|0|||
126116190|NCT03986866|453720146|FG001|Overall Study|Withdrawal by Subject|3|||
126116191|NCT03986866|453720145|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
126116192|NCT03986866|453720146|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
126116193|NCT05093322|453720149|FG000|Overall Study|Death|6|||
126116194|NCT05093322|453720150|FG001|Overall Study|Death|2|||
126116195|NCT05093322|453720149|FG000|Overall Study|Other|4|||
126116196|NCT05093322|453720150|FG001|Overall Study|Other|1|||
126116197|NCT00667823|453720151|FG000|Overall Study|Lost to Follow-up|5|||
126116198|NCT00667823|453720151|FG000|Overall Study|Adverse Event|7|||
126116199|NCT00667823|453720151|FG000|Overall Study|Death|182|||
126116200|NCT00667823|453720151|FG000|Overall Study|Withdrawal by Subject|12|||
126116201|NCT00667823|453720151|FG000|Overall Study|Other|8|||
126116202|NCT00667823|453720151|FG000|Overall Study|Missing (completion page missing)|2|||
126116203|NCT00583024|453720152|FG000|Overall Study|Lost to Follow-up|4|||
126116204|NCT04376827|453720158|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
126116205|NCT04376827|453720159|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
126116206|NCT04376827|453720158|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
126116207|NCT04376827|453720159|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
126116208|NCT04376827|453720158|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
126116209|NCT04376827|453720159|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
126116210|NCT04376827|453720158|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
126116211|NCT04376827|453720159|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
126116212|NCT04376827|453720158|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
126116213|NCT04376827|453720159|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
126116214|NCT00761306|453721874|FG000|Overall Study|Adverse Event|5|||
126116215|NCT00761306|453721874|FG000|Overall Study|Lack of Efficacy|4|||
126116216|NCT00761306|453721874|FG000|Overall Study|Protocol Violation|2|||
126116217|NCT00761306|453721874|FG000|Overall Study|Withdrawal of Consent|3|||
126116218|NCT00761306|453721874|FG000|Overall Study|Lost to Follow-up|1|||
126116219|NCT00761306|453721874|FG000|Overall Study|Administrative or Other Reasons|5|||
126116220|NCT04042740|453721877|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
126116221|NCT04042740|453721877|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
126116222|NCT03713034|453721878|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
126116223|NCT03713034|453721879|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
126116224|NCT02982239|453721882|FG000|Overall Study|Lost to Follow-up|3|||
126116225|NCT02982239|453721883|FG001|Overall Study|Lost to Follow-up|2|||
126116226|NCT00880555|453721890|FG000|Overall Study|Physician Decision|0|||
126116227|NCT00880555|453721891|FG001|Overall Study|Physician Decision|8|||
126086800|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
126086801|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
126086802|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
126086803|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126086804|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126086805|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126086806|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126086807|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
126086808|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
126086809|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
126086810|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
126086811|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126086812|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126086813|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126086814|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126086815|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086816|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086817|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086818|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086819|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086820|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086821|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086822|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
126086823|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086824|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086825|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086826|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126086827|NCT01646177|453611355|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086828|NCT01646177|453611356|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086829|NCT01646177|453611357|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086830|NCT01646177|453611358|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086831|NCT01646177|453611359|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086832|NCT01646177|453611360|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
126086833|NCT01646177|453611361|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
126116228|NCT00880555|453721892|FG002|Overall Study|Physician Decision|0|||
126116229|NCT00880555|453721893|FG003|Overall Study|Physician Decision|2|||
126116230|NCT00880555|453721894|FG004|Overall Study|Physician Decision|1|||
126116231|NCT00880555|453721895|FG005|Overall Study|Physician Decision|0|||
126116232|NCT00880555|453721890|FG000|Overall Study|Withdrawal by Subject|1|||
126116233|NCT00880555|453721891|FG001|Overall Study|Withdrawal by Subject|1|||
126116234|NCT00880555|453721892|FG002|Overall Study|Withdrawal by Subject|0|||
126116235|NCT00880555|453721893|FG003|Overall Study|Withdrawal by Subject|0|||
126116236|NCT00880555|453721894|FG004|Overall Study|Withdrawal by Subject|0|||
126116237|NCT00880555|453721895|FG005|Overall Study|Withdrawal by Subject|0|||
126086834|NCT01646177|453611362|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
126086835|NCT01646177|453611363|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086836|NCT01646177|453611364|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086837|NCT01646177|453611365|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086838|NCT01646177|453611366|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126086839|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126086840|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126086841|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126086842|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126086843|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126086844|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126086845|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126086846|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126086847|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
126086848|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
126086849|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
126086850|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
126086851|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126086852|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126086853|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126086854|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126086855|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126086856|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126086857|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126086858|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126086859|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
126086860|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
126086861|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
126086862|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
126086863|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126086864|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126086865|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126086866|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126086867|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126086868|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126086869|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126086870|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126086871|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
126086872|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
126086873|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
126086874|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
126086875|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126086876|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126086877|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126086878|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126086879|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126086880|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126086881|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126086882|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126086883|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
126086884|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
126086885|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
126086886|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
126086887|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126086888|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126086889|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126086890|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126086891|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126086892|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126086893|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125955044|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126086894|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126086895|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
126086896|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
125955045|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955046|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125955047|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126086897|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
126086898|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
126086899|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126086900|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126086901|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126086902|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126086903|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126086904|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126086905|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126086906|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126086907|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
126086908|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
126086909|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
126086910|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
126086911|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086912|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086913|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086914|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086915|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086916|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086917|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086918|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086919|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126086920|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
126086921|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
126086922|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
126086923|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086924|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086925|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086926|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086927|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086928|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086929|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086930|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086931|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126086932|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
126086933|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
126086934|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
126086935|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086936|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086937|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086938|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086939|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086940|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086941|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086942|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086943|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
126086944|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126086945|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
126086946|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
126086947|NCT01646177|453611355|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125955048|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955049|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955050|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955051|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955052|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955053|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955054|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955055|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955056|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955057|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955058|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126086948|NCT01646177|453611356|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086949|NCT01646177|453611357|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086950|NCT01646177|453611358|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086951|NCT01646177|453611359|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086952|NCT01646177|453611360|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086953|NCT01646177|453611361|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086954|NCT01646177|453611362|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086955|NCT01646177|453611363|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086956|NCT01646177|453611364|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126086957|NCT01646177|453611365|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
126086958|NCT01646177|453611366|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
126086959|NCT01305239|453611370|FG000|Overall Study|Adverse Event|22|||
126086960|NCT01305239|453611370|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
126086961|NCT00570908|453611383|FG000|Overall Study|Adverse Event|5|||
126086962|NCT00570908|453611383|FG000|Overall Study|Withdrawal by Subject|2|||
126086963|NCT06152224|453611389|FG000|Overall Study|Withdrawal by Subject|1|||
126086964|NCT06152224|453611390|FG001|Overall Study|Withdrawal by Subject|0|||
126086965|NCT06152224|453611389|FG000|Overall Study|Lost to Follow-up|0|||
126086966|NCT06152224|453611390|FG001|Overall Study|Lost to Follow-up|1|||
126086967|NCT06152224|453611389|FG000|Overall Study|On Follow Up|18|||
126086968|NCT06152224|453611390|FG001|Overall Study|On Follow Up|18|||
126086969|NCT00281320|453611391|FG000|Overall Study|Adverse Event|12|||
126086970|NCT00281320|453611392|FG001|Overall Study|Adverse Event|9|||
126086971|NCT00281320|453611391|FG000|Overall Study|Lack of Efficacy|4|||
126086972|NCT00281320|453611392|FG001|Overall Study|Lack of Efficacy|3|||
126086973|NCT00281320|453611391|FG000|Overall Study|Withdrawal by Subject|5|||
126086974|NCT00281320|453611392|FG001|Overall Study|Withdrawal by Subject|6|||
126086975|NCT00281320|453611391|FG000|Overall Study|Lost to Follow-up|1|||
126086976|NCT00281320|453611392|FG001|Overall Study|Lost to Follow-up|2|||
126086977|NCT00281320|453611391|FG000|Overall Study|Other|3|||
126086978|NCT00281320|453611392|FG001|Overall Study|Other|1|||
126086979|NCT01447576|453611401|FG000|Overall Study|Lost to Follow-up|52|||
126086980|NCT01447576|453611401|FG000|Overall Study|Adverse Event|127|||
126086981|NCT01447576|453611401|FG000|Overall Study|Participant met withdrawal criteria|40|||
126086982|NCT01447576|453611401|FG000|Overall Study|Withdrawal by Subject|100|||
126086983|NCT01447576|453611401|FG000|Overall Study|Protocol deviation|83|||
126086984|NCT01447576|453611401|FG000|Overall Study|Lack of Efficacy|68|||
126086985|NCT01447576|453611401|FG000|Overall Study|Physician Decision|6|||
126086986|NCT00975676|453611402|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
126086987|NCT00975676|453611403|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
126086988|NCT02579772|453611404|FG000|Overall Study|Withdrawal by Subject|0|||
126086989|NCT02579772|453611405|FG001|Overall Study|Withdrawal by Subject|1|||
126086990|NCT02579772|453611404|FG000|Overall Study|Usage of additional antioxidants|1|||
126086991|NCT02579772|453611405|FG001|Overall Study|Usage of additional antioxidants|0|||
126086992|NCT02579772|453611404|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
126086993|NCT02579772|453611405|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
126086994|NCT04991753|453612884|FG000|Overall Study|Withdrawal by Subject|0|||
126086995|NCT04991753|453612885|FG001|Overall Study|Withdrawal by Subject|1|||
126086996|NCT03299049|453612888|FG000|Overall Study|On-going|486|||
126086997|NCT03299049|453612889|FG001|Overall Study|On-going|481|||
126086998|NCT03299049|453612888|FG000|Overall Study|Withdrawal by Subject|6|||
126086999|NCT03299049|453612889|FG001|Overall Study|Withdrawal by Subject|21|||
126087000|NCT03299049|453612888|FG000|Overall Study|Physician Decision|5|||
126087001|NCT03299049|453612889|FG001|Overall Study|Physician Decision|1|||
126116238|NCT00880555|453721890|FG000|Overall Study|Lack of resources (hired rater)|9|||
126116239|NCT00880555|453721891|FG001|Overall Study|Lack of resources (hired rater)|7|||
126116240|NCT00880555|453721892|FG002|Overall Study|Lack of resources (hired rater)|5|||
126116241|NCT00880555|453721893|FG003|Overall Study|Lack of resources (hired rater)|0|||
126087002|NCT03299049|453612888|FG000|Overall Study|Lost to Follow-up|2|||
126087003|NCT03299049|453612889|FG001|Overall Study|Lost to Follow-up|0|||
126087004|NCT03299049|453612888|FG000|Overall Study|Pregnancy|1|||
126087005|NCT03299049|453612889|FG001|Overall Study|Pregnancy|3|||
126087006|NCT03299049|453612888|FG000|Overall Study|Protocol Violation|1|||
126087007|NCT03299049|453612889|FG001|Overall Study|Protocol Violation|1|||
126087008|NCT03299049|453612888|FG000|Overall Study|Lack of Efficacy|9|||
126087009|NCT03299049|453612889|FG001|Overall Study|Lack of Efficacy|3|||
126087010|NCT03299049|453612888|FG000|Overall Study|Adverse Event|12|||
126087011|NCT03299049|453612889|FG001|Overall Study|Adverse Event|13|||
126087012|NCT01901419|453612890|FG000|Overall Study|Protocol Violation|2|||
126087013|NCT01901419|453612891|FG001|Overall Study|Protocol Violation|6|||
126087014|NCT01901419|453612890|FG000|Overall Study|unavailable researchers|6|||
126087015|NCT01901419|453612891|FG001|Overall Study|unavailable researchers|3|||
126087016|NCT01667926|453612896|FG000|Overall Study|Withdrawal by Subject|1|||
126116242|NCT00880555|453721894|FG004|Overall Study|Lack of resources (hired rater)|0|||
125955059|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955060|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955061|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
125955062|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955063|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955064|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955065|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955066|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955067|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955068|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955069|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955070|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125955071|NCT02346240|453129886|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955072|NCT02346240|453129887|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955073|NCT02346240|453129888|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955074|NCT02346240|453129889|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955075|NCT02346240|453129890|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955076|NCT02346240|453129891|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955077|NCT02346240|453129892|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955078|NCT02346240|453129893|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955079|NCT02346240|453129894|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955080|NCT02346240|453129895|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955081|NCT02346240|453129896|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955082|NCT02346240|453129897|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955083|NCT02346240|453129898|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955084|NCT02346240|453129899|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955085|NCT02346240|453129900|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
125955086|NCT02346240|453129901|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955087|NCT02346240|453129902|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955088|NCT02346240|453129903|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955089|NCT02346240|453129904|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955090|NCT02346240|453129905|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955091|NCT02346240|453129906|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955092|NCT02346240|453129907|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955093|NCT02346240|453129908|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955094|NCT02346240|453129909|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125955095|NCT02346240|453129886|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955096|NCT02346240|453129887|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955097|NCT02346240|453129888|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955098|NCT02346240|453129889|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955099|NCT02346240|453129890|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955100|NCT02346240|453129891|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955101|NCT02346240|453129892|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955102|NCT02346240|453129893|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955103|NCT02346240|453129894|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955104|NCT02346240|453129895|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955105|NCT02346240|453129896|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955106|NCT02346240|453129897|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955107|NCT02346240|453129898|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955108|NCT02346240|453129899|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955109|NCT02346240|453129900|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955110|NCT02346240|453129901|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955111|NCT02346240|453129902|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125955112|NCT02346240|453129903|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
125955113|NCT02346240|453129904|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
125955114|NCT02346240|453129905|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
126087017|NCT01667926|453612897|FG001|Overall Study|Withdrawal by Subject|2|||
126087018|NCT01667926|453612898|FG002|Overall Study|Withdrawal by Subject|2|||
126087019|NCT01667926|453612896|FG000|Overall Study|Physician Decision|0|||
126087020|NCT01667926|453612897|FG001|Overall Study|Physician Decision|0|||
126087021|NCT01667926|453612898|FG002|Overall Study|Physician Decision|1|||
125955115|NCT02346240|453129906|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
125955116|NCT02346240|453129907|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
125955117|NCT02346240|453129908|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
125955118|NCT02346240|453129909|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
125955119|NCT02346240|453129886|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955120|NCT02346240|453129887|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955121|NCT02346240|453129888|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955122|NCT02346240|453129889|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955123|NCT02346240|453129890|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955124|NCT02346240|453129891|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955125|NCT02346240|453129892|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955126|NCT02346240|453129893|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955127|NCT02346240|453129894|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955128|NCT02346240|453129895|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955129|NCT02346240|453129896|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955130|NCT02346240|453129897|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955131|NCT02346240|453129898|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955132|NCT02346240|453129899|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955133|NCT02346240|453129900|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955134|NCT02346240|453129901|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955135|NCT02346240|453129902|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955136|NCT02346240|453129903|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955137|NCT02346240|453129904|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
125955138|NCT02346240|453129905|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
125955139|NCT02346240|453129906|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955140|NCT02346240|453129907|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
125955141|NCT02346240|453129908|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955142|NCT02346240|453129909|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
125955143|NCT02346240|453129886|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955144|NCT02346240|453129887|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955145|NCT02346240|453129888|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955146|NCT02346240|453129889|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955147|NCT02346240|453129890|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955148|NCT02346240|453129891|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955149|NCT02346240|453129892|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955150|NCT02346240|453129893|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955151|NCT02346240|453129894|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955152|NCT02346240|453129895|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955153|NCT02346240|453129896|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955154|NCT02346240|453129897|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955155|NCT02346240|453129898|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955156|NCT02346240|453129899|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955157|NCT02346240|453129900|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955158|NCT02346240|453129901|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955159|NCT02346240|453129902|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955160|NCT02346240|453129903|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955161|NCT02346240|453129904|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125955162|NCT02346240|453129905|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955163|NCT02346240|453129906|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955164|NCT02346240|453129907|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125955165|NCT02346240|453129908|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955166|NCT02346240|453129909|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125955167|NCT02346240|453129886|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955168|NCT02346240|453129887|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955169|NCT02346240|453129888|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955170|NCT02346240|453129889|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955171|NCT02346240|453129890|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955172|NCT02346240|453129891|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955173|NCT02346240|453129892|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955174|NCT02346240|453129893|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955175|NCT02346240|453129894|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955176|NCT02346240|453129895|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955177|NCT02346240|453129896|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955178|NCT02346240|453129897|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955179|NCT02346240|453129898|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955180|NCT02346240|453129899|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955181|NCT02346240|453129900|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955182|NCT02346240|453129901|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955183|NCT02346240|453129902|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955184|NCT02346240|453129903|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955185|NCT02346240|453129904|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955186|NCT02346240|453129905|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955187|NCT02346240|453129906|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955188|NCT02346240|453129907|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
125955189|NCT02346240|453129908|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955190|NCT02346240|453129909|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125955191|NCT02346240|453129886|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955192|NCT02346240|453129887|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955193|NCT02346240|453129888|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955194|NCT02346240|453129889|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955195|NCT02346240|453129890|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955196|NCT02346240|453129891|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955197|NCT02346240|453129892|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955198|NCT02346240|453129893|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955199|NCT02346240|453129894|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955200|NCT02346240|453129895|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955201|NCT02346240|453129896|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955202|NCT02346240|453129897|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955203|NCT02346240|453129898|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955204|NCT02346240|453129899|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955205|NCT02346240|453129900|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955206|NCT02346240|453129901|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955207|NCT02346240|453129902|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955208|NCT02346240|453129903|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
126087022|NCT01667926|453612896|FG000|Overall Study|Time committment|0|||
126087023|NCT01667926|453612897|FG001|Overall Study|Time committment|0|||
126087024|NCT01667926|453612898|FG002|Overall Study|Time committment|2|||
126087025|NCT01667926|453612896|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
126087026|NCT01667926|453612897|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
126087027|NCT01667926|453612898|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
126087028|NCT01667926|453612896|FG000|Overall Study|Lost to Follow-up|1|||
126087029|NCT01667926|453612897|FG001|Overall Study|Lost to Follow-up|2|||
126087030|NCT01667926|453612898|FG002|Overall Study|Lost to Follow-up|1|||
126087031|NCT01667926|453612896|FG000|Overall Study|Side effects|3|||
126087032|NCT01667926|453612897|FG001|Overall Study|Side effects|0|||
126087033|NCT01667926|453612898|FG002|Overall Study|Side effects|0|||
126087034|NCT01088984|453612903|FG000|Phase 1|Death|2|||
126087035|NCT01088984|453612904|FG001|Phase 1|Death|1|||
126087036|NCT01088984|453612903|FG000|Phase 1|Disease Progression|2|||
126087037|NCT01088984|453612904|FG001|Phase 1|Disease Progression|4|||
126087038|NCT01088984|453612903|FG000|Phase 1|Other|1|||
126087039|NCT01088984|453612904|FG001|Phase 1|Other|1|||
126087040|NCT01088984|453612903|FG000|Phase 2|Death|0|||
126087041|NCT01088984|453612904|FG001|Phase 2|Death|5|||
126087042|NCT01088984|453612903|FG000|Phase 2|Withdrawal by Subject|0|||
126087043|NCT01088984|453612904|FG001|Phase 2|Withdrawal by Subject|1|||
126087044|NCT01088984|453612903|FG000|Phase 2|DIsease Progression|0|||
126087045|NCT01088984|453612904|FG001|Phase 2|DIsease Progression|25|||
126087046|NCT01088984|453612903|FG000|Phase 2|Other|0|||
126087047|NCT01088984|453612904|FG001|Phase 2|Other|1|||
126087048|NCT04707664|453612905|FG000|Overall Study|Adverse Event|2|||
126087049|NCT04707664|453612906|FG001|Overall Study|Adverse Event|0|||
126087050|NCT04707664|453612905|FG000|Overall Study|Death|1|||
126087051|NCT04707664|453612906|FG001|Overall Study|Death|2|||
126087052|NCT04707664|453612905|FG000|Overall Study|Withdrawal by Subject|13|||
126087053|NCT04707664|453612906|FG001|Overall Study|Withdrawal by Subject|21|||
126087054|NCT04707664|453612905|FG000|Overall Study|Lost to Follow-up|11|||
126087055|NCT04707664|453612906|FG001|Overall Study|Lost to Follow-up|13|||
126087056|NCT04707664|453612905|FG000|Overall Study|Not treated|2|||
126087057|NCT04707664|453612906|FG001|Overall Study|Not treated|0|||
126087058|NCT00699153|453612907|FG000|Overall Study|Lost to Follow-up|1|||
126087059|NCT00699153|453612908|FG001|Overall Study|Lost to Follow-up|0|||
126087060|NCT00699153|453612907|FG000|Overall Study|Adverse Event|0|||
126087061|NCT00699153|453612908|FG001|Overall Study|Adverse Event|2|||
126087062|NCT00699153|453612907|FG000|Overall Study|Protocol Violation|1|||
126087063|NCT00699153|453612908|FG001|Overall Study|Protocol Violation|0|||
126087064|NCT00699153|453612907|FG000|Overall Study|Travel Problem|1|||
126087065|NCT00699153|453612908|FG001|Overall Study|Travel Problem|0|||
126087066|NCT02412735|453612911|FG000|Overall Study|Adverse Event|0|||
126087067|NCT02412735|453612912|FG001|Overall Study|Adverse Event|1|||
126087068|NCT02412735|453612913|FG002|Overall Study|Adverse Event|2|||
125955209|NCT02346240|453129904|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
125955210|NCT02346240|453129905|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
125955211|NCT02346240|453129906|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125955212|NCT02346240|453129907|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
125955213|NCT02346240|453129908|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
125955214|NCT02346240|453129909|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
125955215|NCT02346240|453129886|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955216|NCT02346240|453129887|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955217|NCT02346240|453129888|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955218|NCT02346240|453129889|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955219|NCT02346240|453129890|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955220|NCT02346240|453129891|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955221|NCT02346240|453129892|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955222|NCT02346240|453129893|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955223|NCT02346240|453129894|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955224|NCT02346240|453129895|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955225|NCT02346240|453129896|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955226|NCT02346240|453129897|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955227|NCT02346240|453129898|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955228|NCT02346240|453129899|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955229|NCT02346240|453129900|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955230|NCT02346240|453129901|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955231|NCT02346240|453129902|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955232|NCT02346240|453129903|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955233|NCT02346240|453129904|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
125955234|NCT02346240|453129905|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
125955235|NCT02346240|453129906|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125955236|NCT02346240|453129907|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
125955237|NCT02346240|453129908|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
125955238|NCT02346240|453129909|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
125955239|NCT02346240|453129886|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955240|NCT02346240|453129887|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955241|NCT02346240|453129888|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955242|NCT02346240|453129889|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955243|NCT02346240|453129890|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955244|NCT02346240|453129891|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955245|NCT02346240|453129892|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955246|NCT02346240|453129893|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955247|NCT02346240|453129894|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955248|NCT02346240|453129895|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955249|NCT02346240|453129896|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955250|NCT02346240|453129897|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955251|NCT02346240|453129898|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955252|NCT02346240|453129899|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955253|NCT02346240|453129900|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955254|NCT02346240|453129901|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955255|NCT02346240|453129902|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955256|NCT02346240|453129903|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955257|NCT02346240|453129904|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
125955258|NCT02346240|453129905|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955259|NCT02346240|453129906|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125955260|NCT02346240|453129907|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
125955261|NCT02346240|453129908|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
125955262|NCT02346240|453129909|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
125955263|NCT02346240|453129886|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955264|NCT02346240|453129887|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955265|NCT02346240|453129888|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955266|NCT02346240|453129889|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955267|NCT02346240|453129890|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126116243|NCT00880555|453721895|FG005|Overall Study|Lack of resources (hired rater)|0|||
126116244|NCT00880555|453721890|FG000|Overall Study|Death|0|||
126116245|NCT00880555|453721891|FG001|Overall Study|Death|0|||
125955268|NCT02346240|453129891|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955269|NCT02346240|453129892|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126116246|NCT00880555|453721892|FG002|Overall Study|Death|0|||
126116247|NCT00880555|453721893|FG003|Overall Study|Death|0|||
126116248|NCT00880555|453721894|FG004|Overall Study|Death|0|||
126116249|NCT00880555|453721895|FG005|Overall Study|Death|1|||
126116250|NCT00880555|453721890|FG000|Overall Study|Lost to Follow-up|0|||
126116251|NCT00880555|453721891|FG001|Overall Study|Lost to Follow-up|1|||
126116252|NCT00880555|453721892|FG002|Overall Study|Lost to Follow-up|0|||
126116253|NCT00880555|453721893|FG003|Overall Study|Lost to Follow-up|0|||
126116254|NCT00880555|453721894|FG004|Overall Study|Lost to Follow-up|0|||
126116255|NCT00880555|453721895|FG005|Overall Study|Lost to Follow-up|0|||
126116256|NCT02982590|453721897|FG000|Overall Study|Lost to Follow-up|0|||
126116257|NCT02982590|453721898|FG001|Overall Study|Lost to Follow-up|1|||
126116258|NCT02982590|453721897|FG000|Overall Study|Death|4|||
126116259|NCT02982590|453721898|FG001|Overall Study|Death|0|||
126116260|NCT01168973|453721899|FG000|Overall Study|Progressive Disease|341|||
126116261|NCT01168973|453721900|FG001|Overall Study|Progressive Disease|429|||
126116262|NCT01168973|453721899|FG000|Overall Study|Adverse Event|94|||
126116263|NCT01168973|453721900|FG001|Overall Study|Adverse Event|55|||
126116264|NCT01168973|453721899|FG000|Overall Study|Withdrawal by Subject|90|||
126116265|NCT01168973|453721900|FG001|Overall Study|Withdrawal by Subject|53|||
126116266|NCT01168973|453721899|FG000|Overall Study|Death|42|||
126116267|NCT01168973|453721900|FG001|Overall Study|Death|45|||
125955270|NCT02346240|453129893|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955271|NCT02346240|453129894|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955272|NCT02346240|453129895|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955273|NCT02346240|453129896|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955274|NCT02346240|453129897|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955275|NCT02346240|453129898|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955276|NCT02346240|453129899|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955277|NCT02346240|453129900|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955278|NCT02346240|453129901|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955279|NCT02346240|453129902|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955280|NCT02346240|453129903|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955281|NCT02346240|453129904|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
125955282|NCT02346240|453129905|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955283|NCT02346240|453129906|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955284|NCT02346240|453129907|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955285|NCT02346240|453129908|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955286|NCT02346240|453129909|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125955287|NCT02098109|453129913|FG000|Overall Study|Protocol Violation|3|||
125955288|NCT02098109|453129914|FG001|Overall Study|Protocol Violation|0|||
125955289|NCT01822132|453129915|FG000|Overall Study|Lost to Follow-up|4|||
125955290|NCT01822132|453129916|FG001|Overall Study|Lost to Follow-up|2|||
125955291|NCT03385239|453129922|FG000|Overall Study|Voluntary Withdrawal|2|||
125955292|NCT03385239|453129923|FG001|Overall Study|Voluntary Withdrawal|3|||
125955293|NCT03385239|453129924|FG002|Overall Study|Voluntary Withdrawal|2|||
125955294|NCT03385239|453129925|FG003|Overall Study|Voluntary Withdrawal|3|||
125955295|NCT03385239|453129926|FG004|Overall Study|Voluntary Withdrawal|0|||
125955296|NCT03385239|453129922|FG000|Overall Study|Adverse Event|0|||
125955297|NCT03385239|453129923|FG001|Overall Study|Adverse Event|0|||
125955298|NCT03385239|453129924|FG002|Overall Study|Adverse Event|1|||
125955299|NCT03385239|453129925|FG003|Overall Study|Adverse Event|0|||
125955300|NCT03385239|453129926|FG004|Overall Study|Adverse Event|0|||
126087069|NCT02412735|453612911|FG000|Overall Study|Withdrawal by Subject|23|||
126087070|NCT02412735|453612912|FG001|Overall Study|Withdrawal by Subject|27|||
126087071|NCT02412735|453612913|FG002|Overall Study|Withdrawal by Subject|22|||
126087072|NCT02412735|453612911|FG000|Overall Study|Investigator Decision|3|||
126087073|NCT02412735|453612912|FG001|Overall Study|Investigator Decision|3|||
126087074|NCT02412735|453612913|FG002|Overall Study|Investigator Decision|2|||
126087075|NCT02412735|453612911|FG000|Overall Study|Lost to Follow-up|17|||
126087076|NCT02412735|453612912|FG001|Overall Study|Lost to Follow-up|11|||
126087077|NCT02412735|453612913|FG002|Overall Study|Lost to Follow-up|18|||
126087078|NCT02412735|453612911|FG000|Overall Study|Reason not Specified|3|||
126087079|NCT02412735|453612912|FG001|Overall Study|Reason not Specified|2|||
126087080|NCT02412735|453612913|FG002|Overall Study|Reason not Specified|2|||
126087081|NCT01228318|453612914|FG000|Overall Study|Clinic no show to receive intervention|1|||
126116268|NCT01168973|453721899|FG000|Overall Study|Physician Decision|37|||
126116269|NCT01168973|453721900|FG001|Overall Study|Physician Decision|19|||
126116270|NCT01168973|453721899|FG000|Overall Study|Sponsor Decision|2|||
126116271|NCT01168973|453721900|FG001|Overall Study|Sponsor Decision|1|||
125955301|NCT03385239|453129922|FG000|Overall Study|Other|0|||
125955302|NCT03385239|453129923|FG001|Overall Study|Other|0|||
125955303|NCT03385239|453129924|FG002|Overall Study|Other|0|||
125955304|NCT03385239|453129925|FG003|Overall Study|Other|1|||
125955305|NCT03385239|453129926|FG004|Overall Study|Other|0|||
125955306|NCT01574703|453129927|FG000|Overall Study|Adverse Event|0|||
125955307|NCT01574703|453129928|FG001|Overall Study|Adverse Event|2|||
125955308|NCT01574703|453129929|FG002|Overall Study|Adverse Event|1|||
125955309|NCT01574703|453129930|FG003|Overall Study|Adverse Event|1|||
125955310|NCT01574703|453129927|FG000|Overall Study|Protocol Violation|0|||
125955311|NCT01574703|453129928|FG001|Overall Study|Protocol Violation|0|||
125955312|NCT01574703|453129929|FG002|Overall Study|Protocol Violation|0|||
125955313|NCT01574703|453129930|FG003|Overall Study|Protocol Violation|1|||
125955314|NCT01574703|453129927|FG000|Overall Study|Unspecified Reason|27|||
125955315|NCT01574703|453129928|FG001|Overall Study|Unspecified Reason|15|||
125955316|NCT01574703|453129929|FG002|Overall Study|Unspecified Reason|20|||
125955317|NCT01574703|453129930|FG003|Overall Study|Unspecified Reason|16|||
125955318|NCT01574703|453129927|FG000|Overall Study|Withdrawal by Subject|53|||
125955319|NCT01574703|453129928|FG001|Overall Study|Withdrawal by Subject|52|||
125955320|NCT01574703|453129929|FG002|Overall Study|Withdrawal by Subject|36|||
125955321|NCT01574703|453129930|FG003|Overall Study|Withdrawal by Subject|61|||
125955322|NCT01574703|453129927|FG000|Overall Study|Met Withdrawal Criteria|0|||
125955323|NCT01574703|453129928|FG001|Overall Study|Met Withdrawal Criteria|1|||
125955324|NCT01574703|453129929|FG002|Overall Study|Met Withdrawal Criteria|1|||
125955325|NCT01574703|453129930|FG003|Overall Study|Met Withdrawal Criteria|0|||
125955326|NCT01574703|453129927|FG000|Overall Study|Lost to Follow-up|43|||
125955327|NCT01574703|453129928|FG001|Overall Study|Lost to Follow-up|41|||
125955328|NCT01574703|453129929|FG002|Overall Study|Lost to Follow-up|46|||
125955329|NCT01574703|453129930|FG003|Overall Study|Lost to Follow-up|35|||
125955330|NCT01574703|453129927|FG000|Overall Study|Death|2|||
125955331|NCT01574703|453129928|FG001|Overall Study|Death|1|||
125955332|NCT01574703|453129929|FG002|Overall Study|Death|1|||
125955333|NCT01574703|453129930|FG003|Overall Study|Death|0|||
125955334|NCT01524770|453129932|FG000|First Intervention|Withdrawal by Subject|1|||
125955335|NCT01524770|453129933|FG001|First Intervention|Withdrawal by Subject|0|||
125955336|NCT01524770|453129932|FG000|First Intervention|Adverse Event|1|||
125955337|NCT01524770|453129933|FG001|First Intervention|Adverse Event|1|||
125955338|NCT01524770|453129932|FG000|First Intervention|Protocol Violation|1|||
125955339|NCT01524770|453129933|FG001|First Intervention|Protocol Violation|0|||
125955340|NCT03080961|453129934|FG000|Overall Study|Withdrawal by Subject|3|||
125955341|NCT04197713|453129935|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
125955342|NCT04197713|453129936|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
125955343|NCT05569954|453129937|FG000|Overall Study|Lost to Follow-up|3|||
125955344|NCT05569954|453129938|FG001|Overall Study|Lost to Follow-up|4|||
125955345|NCT05569954|453129937|FG000|Overall Study|Protocol Violation|1|||
125955346|NCT05569954|453129938|FG001|Overall Study|Protocol Violation|2|||
125955347|NCT05569954|453129937|FG000|Overall Study|Withdrawal by Subject|4|||
125955348|NCT05569954|453129938|FG001|Overall Study|Withdrawal by Subject|2|||
125955349|NCT02239536|453129939|FG000|Overall Study|Non-neoplastic polyp|23|||
125955350|NCT02239536|453129940|FG001|Overall Study|Non-neoplastic polyp|17|||
125955351|NCT01038778|453129943|FG000|Overall Study|Withdrawal by Subject|0|||
125955352|NCT01038778|453129944|FG001|Overall Study|Withdrawal by Subject|2|||
125955353|NCT01038778|453129945|FG002|Overall Study|Withdrawal by Subject|3|||
125955354|NCT04740034|453129946|FG000|Overall Study|Death|0|||
125955355|NCT04740034|453129947|FG001|Overall Study|Death|1|||
125955356|NCT04740034|453129948|FG002|Overall Study|Death|2|||
125955357|NCT04740034|453129949|FG003|Overall Study|Death|3|||
125955358|NCT04740034|453129950|FG004|Overall Study|Death|4|||
125955359|NCT04740034|453129951|FG005|Overall Study|Death|4|||
125955360|NCT04740034|453129952|FG006|Overall Study|Death|2|||
125955361|NCT04740034|453129953|FG007|Overall Study|Death|2|||
125955362|NCT04740034|453129954|FG008|Overall Study|Death|2|||
125955363|NCT04740034|453129955|FG009|Overall Study|Death|4|||
125955364|NCT04740034|453129956|FG010|Overall Study|Death|0|||
125955365|NCT04740034|453129946|FG000|Overall Study|Lost to Follow-up|0|||
125955366|NCT04740034|453129947|FG001|Overall Study|Lost to Follow-up|0|||
125955367|NCT04740034|453129948|FG002|Overall Study|Lost to Follow-up|0|||
125955368|NCT04740034|453129949|FG003|Overall Study|Lost to Follow-up|1|||
125955369|NCT04740034|453129950|FG004|Overall Study|Lost to Follow-up|2|||
125955370|NCT04740034|453129951|FG005|Overall Study|Lost to Follow-up|2|||
125955371|NCT04740034|453129952|FG006|Overall Study|Lost to Follow-up|0|||
125955372|NCT04740034|453129953|FG007|Overall Study|Lost to Follow-up|0|||
125955373|NCT04740034|453129954|FG008|Overall Study|Lost to Follow-up|0|||
125955374|NCT04740034|453129955|FG009|Overall Study|Lost to Follow-up|1|||
125955375|NCT04740034|453129956|FG010|Overall Study|Lost to Follow-up|0|||
125955376|NCT04740034|453129946|FG000|Overall Study|Withdrawal by Subject|1|||
125955377|NCT04740034|453129947|FG001|Overall Study|Withdrawal by Subject|0|||
125955378|NCT04740034|453129948|FG002|Overall Study|Withdrawal by Subject|0|||
125955379|NCT04740034|453129949|FG003|Overall Study|Withdrawal by Subject|0|||
125955380|NCT04740034|453129950|FG004|Overall Study|Withdrawal by Subject|0|||
125955381|NCT04740034|453129951|FG005|Overall Study|Withdrawal by Subject|0|||
125955382|NCT04740034|453129952|FG006|Overall Study|Withdrawal by Subject|0|||
125955383|NCT04740034|453129953|FG007|Overall Study|Withdrawal by Subject|1|||
125955384|NCT04740034|453129954|FG008|Overall Study|Withdrawal by Subject|0|||
125955385|NCT04740034|453129955|FG009|Overall Study|Withdrawal by Subject|1|||
125955386|NCT04740034|453129956|FG010|Overall Study|Withdrawal by Subject|0|||
125955387|NCT04740034|453129946|FG000|Overall Study|Decision by sponsor|0|||
125955388|NCT04740034|453129947|FG001|Overall Study|Decision by sponsor|0|||
125955389|NCT04740034|453129948|FG002|Overall Study|Decision by sponsor|1|||
125955390|NCT04740034|453129949|FG003|Overall Study|Decision by sponsor|0|||
125955391|NCT04740034|453129950|FG004|Overall Study|Decision by sponsor|0|||
125955392|NCT04740034|453129951|FG005|Overall Study|Decision by sponsor|0|||
125955393|NCT04740034|453129952|FG006|Overall Study|Decision by sponsor|1|||
125955394|NCT04740034|453129953|FG007|Overall Study|Decision by sponsor|2|||
125955395|NCT04740034|453129954|FG008|Overall Study|Decision by sponsor|1|||
125955396|NCT04740034|453129955|FG009|Overall Study|Decision by sponsor|1|||
125955397|NCT04740034|453129956|FG010|Overall Study|Decision by sponsor|2|||
125955398|NCT04346615|453131806|FG000|Overall Study|Lost to Follow-up|0|||
125955399|NCT04346615|453131807|FG001|Overall Study|Lost to Follow-up|2|||
125955400|NCT04346615|453131806|FG000|Overall Study|Withdrawal by Subject|1|||
125955401|NCT04346615|453131807|FG001|Overall Study|Withdrawal by Subject|0|||
125955402|NCT04346615|453131806|FG000|Overall Study|Death|5|||
125955403|NCT04346615|453131807|FG001|Overall Study|Death|1|||
125955404|NCT04346615|453131806|FG000|Overall Study|Other|0|||
125955405|NCT04346615|453131807|FG001|Overall Study|Other|2|||
125955406|NCT04346615|453131806|FG000|Overall Study|Randomized not treated|1|||
125955407|NCT04346615|453131807|FG001|Overall Study|Randomized not treated|0|||
125955408|NCT04524403|453131810|FG000|Overall Study|Withdrawal by Subject|10|||
125955409|NCT04524403|453131811|FG001|Overall Study|Withdrawal by Subject|3|||
125955410|NCT04524403|453131812|FG002|Overall Study|Withdrawal by Subject|8|||
125955411|NCT04524403|453131810|FG000|Overall Study|Lost to Follow-up|3|||
125955412|NCT04524403|453131811|FG001|Overall Study|Lost to Follow-up|4|||
125955413|NCT04524403|453131812|FG002|Overall Study|Lost to Follow-up|3|||
125955414|NCT04524403|453131810|FG000|Overall Study|Adverse Event|3|||
125955415|NCT04524403|453131811|FG001|Overall Study|Adverse Event|1|||
125955416|NCT04524403|453131812|FG002|Overall Study|Adverse Event|4|||
125955417|NCT04524403|453131810|FG000|Overall Study|Non-compliant with study drug|1|||
125955418|NCT04524403|453131811|FG001|Overall Study|Non-compliant with study drug|2|||
125955419|NCT04524403|453131812|FG002|Overall Study|Non-compliant with study drug|3|||
125955420|NCT04524403|453131810|FG000|Overall Study|Moved|0|||
125955421|NCT04524403|453131811|FG001|Overall Study|Moved|1|||
125955422|NCT04524403|453131812|FG002|Overall Study|Moved|0|||
125955423|NCT00533949|453131815|FG000|Overall Study|Protocol Violation|12|||
125955424|NCT00533949|453131816|FG001|Overall Study|Protocol Violation|12|||
125955425|NCT00533949|453131817|FG002|Overall Study|Protocol Violation|9|||
125955426|NCT00533949|453131818|FG003|Overall Study|Protocol Violation|9|||
125955427|NCT00533949|453131815|FG000|Overall Study|Withdrawal by Subject|3|||
125955428|NCT00533949|453131816|FG001|Overall Study|Withdrawal by Subject|2|||
125955429|NCT00533949|453131817|FG002|Overall Study|Withdrawal by Subject|1|||
125955430|NCT00533949|453131818|FG003|Overall Study|Withdrawal by Subject|1|||
125955431|NCT00727194|453131819|FG000|Screening Period|Low QMG scores|0|||
125955432|NCT00727194|453131820|FG001|Screening Period|Low QMG scores|0|||
125955433|NCT00727194|453131821|FG002|Screening Period|Low QMG scores|6|||
125955434|NCT00727194|453131819|FG000|Screening Period|Lacked AChR antibodies|0|||
125955435|NCT00727194|453131820|FG001|Screening Period|Lacked AChR antibodies|0|||
125955436|NCT00727194|453131821|FG002|Screening Period|Lacked AChR antibodies|5|||
126087082|NCT01228318|453612915|FG001|Overall Study|Clinic no show to receive intervention|0|||
125955437|NCT00727194|453131819|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
125955438|NCT00727194|453131820|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
125955439|NCT00727194|453131821|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
125955440|NCT00727194|453131819|FG000|Screening Period|Severe infections|0|||
125955441|NCT00727194|453131820|FG001|Screening Period|Severe infections|0|||
125955442|NCT00727194|453131821|FG002|Screening Period|Severe infections|2|||
125955443|NCT00727194|453131819|FG000|Screening Period|History of thymoma|0|||
125955444|NCT00727194|453131820|FG001|Screening Period|History of thymoma|0|||
126087083|NCT01228318|453612914|FG000|Overall Study|Unable to contact|2|||
126087084|NCT01228318|453612915|FG001|Overall Study|Unable to contact|5|||
125955445|NCT00727194|453131821|FG002|Screening Period|History of thymoma|1|||
125955446|NCT00727194|453131819|FG000|Treatment Period 2|Lack of Efficacy|0|||
125955447|NCT00727194|453131820|FG001|Treatment Period 2|Lack of Efficacy|1|||
125955448|NCT00727194|453131821|FG002|Treatment Period 2|Lack of Efficacy|0|||
125955449|NCT04269161|453131827|FG000|Overall Study|Change of modality and no longer eligible|3|||
125955450|NCT04269161|453131828|FG001|Overall Study|Change of modality and no longer eligible|3|||
125955451|NCT04269161|453131827|FG000|Overall Study|Required procedure outside of NICU|1|||
125955452|NCT04269161|453131828|FG001|Overall Study|Required procedure outside of NICU|0|||
126087085|NCT01228318|453612914|FG000|Overall Study|Moved|0|||
125955453|NCT04269161|453131827|FG000|Overall Study|Equipment issue|1|||
125955454|NCT04269161|453131828|FG001|Overall Study|Equipment issue|1|||
125955455|NCT01513317|453131829|FG000|Overall Study|Withdrawal by Subject|15|||
125955456|NCT01513317|453131830|FG001|Overall Study|Withdrawal by Subject|4|||
125955457|NCT01513317|453131829|FG000|Overall Study|Death|1|||
126087086|NCT01228318|453612915|FG001|Overall Study|Moved|2|||
126087087|NCT01228318|453612914|FG000|Overall Study|Incarcerated|1|||
126087088|NCT01228318|453612915|FG001|Overall Study|Incarcerated|0|||
125955458|NCT01513317|453131830|FG001|Overall Study|Death|1|||
125955459|NCT01513317|453131829|FG000|Overall Study|Study terminated by sponsor|18|||
125955460|NCT01513317|453131830|FG001|Overall Study|Study terminated by sponsor|18|||
125955461|NCT01513317|453131829|FG000|Overall Study|Other|0|||
125955462|NCT01513317|453131830|FG001|Overall Study|Other|1|||
125955463|NCT04108130|453131831|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
125955464|NCT04108130|453131832|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
125955465|NCT04108130|453131831|FG000|Overall Study|Consent Withdrawn|9|||
125955466|NCT04108130|453131832|FG001|Overall Study|Consent Withdrawn|6|||
125955467|NCT04108130|453131831|FG000|Overall Study|Surgery Cancelled|4|||
125955468|NCT04108130|453131832|FG001|Overall Study|Surgery Cancelled|4|||
125955469|NCT04108130|453131831|FG000|Overall Study|Found Ineligible for Study|4|||
125955470|NCT04108130|453131832|FG001|Overall Study|Found Ineligible for Study|3|||
125955471|NCT04108130|453131831|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
125955472|NCT04108130|453131832|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
125955473|NCT04108130|453131831|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
125955474|NCT04108130|453131832|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
125955475|NCT00298896|453131838|FG000|Overall Study|Death|3|||
125955476|NCT00298896|453131838|FG000|Overall Study|Physician Decision|2|||
125955477|NCT00298896|453131838|FG000|Overall Study|Intercurrent Illness|1|||
125955478|NCT00298896|453131838|FG000|Overall Study|Disease Progression|41|||
125955479|NCT00298896|453131838|FG000|Overall Study|Withdrawal by Subject|2|||
125955480|NCT00298896|453131838|FG000|Overall Study|Assigned to treatment in error|1|||
125955481|NCT02649972|453131841|FG000|Overall Study|Not treated|1|||
125955482|NCT03285646|453131851|FG000|Overall Study|Adverse Event|1|||
125955483|NCT03285646|453131852|FG001|Overall Study|Adverse Event|0|||
125955484|NCT03285646|453131851|FG000|Overall Study|Withdrawal by Subject|10|||
125955485|NCT03285646|453131852|FG001|Overall Study|Withdrawal by Subject|2|||
125955486|NCT03285646|453131851|FG000|Overall Study|Lost to Follow-up|2|||
125955487|NCT03285646|453131852|FG001|Overall Study|Lost to Follow-up|1|||
125955488|NCT03285646|453131851|FG000|Overall Study|Investigator/Sponsor Decision|0|||
125955489|NCT03285646|453131852|FG001|Overall Study|Investigator/Sponsor Decision|1|||
125955490|NCT02610192|453131854|FG000|Overall Study|Received other treatment|8|||
125955491|NCT02610192|453131854|FG000|Overall Study|Physician Decision|1|||
125955492|NCT00503841|453131855|FG000|Overall Study|All screen failures|44|||
125955493|NCT01344057|453131856|FG000|Overall Study|Premature Withdrawal|1|||
125955494|NCT00306592|453131857|FG000|Overall Study|Adverse Event|8|||
125955495|NCT00306592|453131858|FG001|Overall Study|Adverse Event|15|||
125955496|NCT00306592|453131857|FG000|Overall Study|Lost to Follow-up|1|||
125955497|NCT00306592|453131858|FG001|Overall Study|Lost to Follow-up|0|||
125955498|NCT00306592|453131857|FG000|Overall Study|Noncompliance|0|||
125955499|NCT00306592|453131858|FG001|Overall Study|Noncompliance|2|||
125955500|NCT00306592|453131857|FG000|Overall Study|Persistent Antibodies|6|||
125955501|NCT00306592|453131858|FG001|Overall Study|Persistent Antibodies|3|||
125955502|NCT00306592|453131857|FG000|Overall Study|Voluntary|10|||
125955503|NCT00306592|453131858|FG001|Overall Study|Voluntary|6|||
125955504|NCT00306592|453131857|FG000|Overall Study|Other|5|||
125955505|NCT00306592|453131858|FG001|Overall Study|Other|10|||
126087089|NCT04043143|453612916|FG000|Overall Study|Lost to Follow-up|5|||
125955506|NCT00306592|453131857|FG000|Overall Study|Other|1|||
125955507|NCT00306592|453131858|FG001|Overall Study|Other|2|||
125955508|NCT00306592|453131857|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
125955509|NCT00306592|453131858|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
125955510|NCT00279708|453131859|FG000|Overall Study|Withdrawal by Subject|2|||
125955511|NCT00279708|453131860|FG001|Overall Study|Withdrawal by Subject|3|||
125955512|NCT00279708|453131859|FG000|Overall Study|Adverse Event|1|||
125955513|NCT00279708|453131860|FG001|Overall Study|Adverse Event|1|||
125955514|NCT03354429|453131861|FG000|Overall Study|Withdrawal by Subject|8|||
125955515|NCT03354429|453131862|FG001|Overall Study|Withdrawal by Subject|7|||
125955516|NCT03354429|453131861|FG000|Overall Study|Lost to Follow-up|1|||
125955517|NCT03354429|453131862|FG001|Overall Study|Lost to Follow-up|0|||
125955518|NCT00654628|453131863|FG000|6-week Active Treatment Period|Adverse Event|9|||
125955519|NCT00654628|453131863|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
125955520|NCT00654628|453131863|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
125955521|NCT00654628|453131863|FG000|6-week Active Treatment Period|Out of window period|1|||
125955522|NCT00654628|453131863|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
125955523|NCT00654628|453131863|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
125955524|NCT00953329|453131868|FG000|Overall Study|Lack of Efficacy|1|||
125955525|NCT02477020|453131872|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
125955526|NCT02477020|453131873|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
125955527|NCT02477020|453131872|FG000|Overall Study|Voluntary Withdrawal|7|||
125955528|NCT02477020|453131873|FG001|Overall Study|Voluntary Withdrawal|16|||
125955529|NCT02477020|453131872|FG000|Overall Study|Reason not Specified|3|||
125955530|NCT02477020|453131873|FG001|Overall Study|Reason not Specified|1|||
125955531|NCT02477020|453131872|FG000|Overall Study|Lack of Efficacy|14|||
125955532|NCT02477020|453131873|FG001|Overall Study|Lack of Efficacy|5|||
125955533|NCT01465802|453131874|FG000|Overall Study|Study terminated by sponsor|1|||
125955534|NCT01465802|453131875|FG001|Overall Study|Study terminated by sponsor|0|||
125955535|NCT01465802|453131876|FG002|Overall Study|Study terminated by sponsor|0|||
125955536|NCT01465802|453131877|FG003|Overall Study|Study terminated by sponsor|1|||
125955537|NCT01465802|453131878|FG004|Overall Study|Study terminated by sponsor|7|||
125955538|NCT01465802|453131874|FG000|Overall Study|Withdrawal by Subject|7|||
125955539|NCT01465802|453131875|FG001|Overall Study|Withdrawal by Subject|7|||
125955540|NCT01465802|453131876|FG002|Overall Study|Withdrawal by Subject|0|||
125955541|NCT01465802|453131877|FG003|Overall Study|Withdrawal by Subject|8|||
125955542|NCT01465802|453131878|FG004|Overall Study|Withdrawal by Subject|1|||
125955543|NCT01465802|453131874|FG000|Overall Study|Lost to Follow-up|1|||
125955544|NCT01465802|453131875|FG001|Overall Study|Lost to Follow-up|1|||
125955545|NCT01465802|453131876|FG002|Overall Study|Lost to Follow-up|0|||
125955546|NCT01465802|453131877|FG003|Overall Study|Lost to Follow-up|0|||
125955547|NCT01465802|453131878|FG004|Overall Study|Lost to Follow-up|0|||
125955548|NCT01465802|453131874|FG000|Overall Study|Reason not specified|9|||
125955549|NCT01465802|453131875|FG001|Overall Study|Reason not specified|4|||
125955550|NCT01465802|453131876|FG002|Overall Study|Reason not specified|0|||
125955551|NCT01465802|453131877|FG003|Overall Study|Reason not specified|10|||
125955552|NCT01465802|453131878|FG004|Overall Study|Reason not specified|2|||
125955553|NCT01465802|453131874|FG000|Overall Study|Death|15|||
125955554|NCT01465802|453131875|FG001|Overall Study|Death|12|||
125955555|NCT01465802|453131876|FG002|Overall Study|Death|0|||
125955556|NCT01465802|453131877|FG003|Overall Study|Death|10|||
125955557|NCT01465802|453131878|FG004|Overall Study|Death|2|||
125955558|NCT01340976|453131879|FG000|Overall Study|Physician Decision|2|||
125955559|NCT01340976|453131880|FG001|Overall Study|Physician Decision|0|||
125955560|NCT01340976|453131881|FG002|Overall Study|Physician Decision|1|||
125955561|NCT01340976|453131882|FG003|Overall Study|Physician Decision|1|||
125955562|NCT01340976|453131883|FG004|Overall Study|Physician Decision|1|||
125955563|NCT01340976|453131884|FG005|Overall Study|Physician Decision|0|||
125955564|NCT01340976|453131879|FG000|Overall Study|Death|0|||
125955565|NCT01340976|453131880|FG001|Overall Study|Death|1|||
125955566|NCT01340976|453131881|FG002|Overall Study|Death|0|||
125955567|NCT01340976|453131882|FG003|Overall Study|Death|0|||
125955568|NCT01340976|453131883|FG004|Overall Study|Death|0|||
125955569|NCT01340976|453131884|FG005|Overall Study|Death|0|||
125955570|NCT01340976|453131879|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
125955571|NCT01340976|453131880|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125955572|NCT01340976|453131881|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125955573|NCT01340976|453131882|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125955574|NCT01340976|453131883|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125955575|NCT01340976|453131884|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125955576|NCT01340976|453131879|FG000|Overall Study|Withdrawal by Subject|0|||
125955577|NCT01340976|453131880|FG001|Overall Study|Withdrawal by Subject|0|||
125955578|NCT01340976|453131881|FG002|Overall Study|Withdrawal by Subject|0|||
125955579|NCT01340976|453131882|FG003|Overall Study|Withdrawal by Subject|1|||
125955580|NCT01340976|453131883|FG004|Overall Study|Withdrawal by Subject|1|||
125955581|NCT01340976|453131884|FG005|Overall Study|Withdrawal by Subject|0|||
125955582|NCT01340976|453131879|FG000|Overall Study|Other anemia treatment|1|||
125955583|NCT01340976|453131880|FG001|Overall Study|Other anemia treatment|0|||
125955584|NCT01340976|453131881|FG002|Overall Study|Other anemia treatment|2|||
125955585|NCT01340976|453131882|FG003|Overall Study|Other anemia treatment|1|||
125955586|NCT01340976|453131883|FG004|Overall Study|Other anemia treatment|0|||
125955587|NCT01340976|453131884|FG005|Overall Study|Other anemia treatment|1|||
125955588|NCT01340976|453131879|FG000|Overall Study|Adverse Event|0|||
125955589|NCT01340976|453131880|FG001|Overall Study|Adverse Event|1|||
126116272|NCT01168973|453721899|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
125955590|NCT01340976|453131881|FG002|Overall Study|Adverse Event|0|||
125955591|NCT01340976|453131882|FG003|Overall Study|Adverse Event|0|||
125955592|NCT01340976|453131883|FG004|Overall Study|Adverse Event|0|||
125955593|NCT01340976|453131884|FG005|Overall Study|Adverse Event|0|||
126116273|NCT01168973|453721900|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
125955594|NCT02331446|453131885|FG000|Overall Study|Lost to Follow-up|2|||
125955595|NCT02331446|453131886|FG001|Overall Study|Lost to Follow-up|1|||
125955596|NCT02331446|453131887|FG002|Overall Study|Lost to Follow-up|0|||
125955597|NCT02331446|453131888|FG003|Overall Study|Lost to Follow-up|1|||
125955598|NCT02331446|453131885|FG000|Overall Study|Personal Problem|2|||
125955599|NCT02331446|453131886|FG001|Overall Study|Personal Problem|0|||
125955600|NCT02331446|453131887|FG002|Overall Study|Personal Problem|0|||
126116274|NCT00388505|453721905|FG000|Overall Study|Adverse Event or Death|43|||
126116275|NCT00388505|453721906|FG001|Overall Study|Adverse Event or Death|17|||
126116276|NCT00388505|453721905|FG000|Overall Study|Withdrawal by Subject|24|||
126116277|NCT00388505|453721906|FG001|Overall Study|Withdrawal by Subject|9|||
126116278|NCT00388505|453721905|FG000|Overall Study|Lost to Follow-up|5|||
126116279|NCT00388505|453721906|FG001|Overall Study|Lost to Follow-up|3|||
126116280|NCT00388505|453721905|FG000|Overall Study|Inappropriate Enrollment|0|||
126116281|NCT00388505|453721906|FG001|Overall Study|Inappropriate Enrollment|1|||
126116282|NCT00388505|453721905|FG000|Overall Study|Administrative Reason|1|||
126116283|NCT00388505|453721906|FG001|Overall Study|Administrative Reason|0|||
126116284|NCT00388505|453721905|FG000|Overall Study|Protocol Violation|6|||
126116285|NCT00388505|453721906|FG001|Overall Study|Protocol Violation|5|||
126116286|NCT00388505|453721905|FG000|Overall Study|Unable to classify|4|||
126116287|NCT00388505|453721906|FG001|Overall Study|Unable to classify|3|||
126116288|NCT04479436|453721910|FG000|Overall Study|Progressive disease|26|||
126116289|NCT04479436|453721911|FG001|Overall Study|Progressive disease|1|||
126116290|NCT04479436|453721910|FG000|Overall Study|Adverse Event|6|||
126116291|NCT04479436|453721911|FG001|Overall Study|Adverse Event|0|||
126116292|NCT04479436|453721910|FG000|Overall Study|Withdrawal by Subject|5|||
126116293|NCT04479436|453721911|FG001|Overall Study|Withdrawal by Subject|0|||
126116294|NCT04479436|453721910|FG000|Overall Study|Clinical progression|1|||
126116295|NCT04479436|453721911|FG001|Overall Study|Clinical progression|0|||
126116296|NCT04479436|453721910|FG000|Overall Study|Physician Decision|1|||
126116297|NCT04479436|453721911|FG001|Overall Study|Physician Decision|0|||
126116298|NCT01480284|453721914|FG000|Overall Study|Withdrawal by Subject|2|||
126116299|NCT01480284|453721915|FG001|Overall Study|Withdrawal by Subject|0|||
126116300|NCT01480284|453721914|FG000|Overall Study|Adverse Event|1|||
126116301|NCT01480284|453721915|FG001|Overall Study|Adverse Event|0|||
126116302|NCT01480284|453721914|FG000|Overall Study|Study closed/terminated|3|||
126116303|NCT01480284|453721915|FG001|Overall Study|Study closed/terminated|0|||
126116304|NCT01480284|453721914|FG000|Overall Study|Lost to Follow-up|1|||
126116305|NCT01480284|453721915|FG001|Overall Study|Lost to Follow-up|0|||
126116306|NCT01480284|453721914|FG000|Overall Study|Physician Decision|1|||
126116307|NCT01480284|453721915|FG001|Overall Study|Physician Decision|0|||
126116308|NCT02357134|453721916|FG000|Overall Study|Lost to Follow-up|1|||
126116309|NCT02357134|453721917|FG001|Overall Study|Lost to Follow-up|0|||
126116310|NCT02357134|453721918|FG002|Overall Study|Lost to Follow-up|0|||
126116311|NCT02357134|453721919|FG003|Overall Study|Lost to Follow-up|0|||
126116312|NCT00709111|453721920|FG000|Overall Study|Withdrawal by Subject|1|||
126116313|NCT00709111|453721920|FG000|Overall Study|Unable to attend clinic visits|1|||
126116314|NCT02716675|453721921|FG000|Overall Study|Death|2|||
126116315|NCT02716675|453721922|FG001|Overall Study|Death|3|||
125955601|NCT02331446|453131888|FG003|Overall Study|Personal Problem|0|||
125955602|NCT02331446|453131885|FG000|Overall Study|Disease|0|||
125955603|NCT02331446|453131886|FG001|Overall Study|Disease|2|||
125955604|NCT02331446|453131887|FG002|Overall Study|Disease|2|||
125955605|NCT02331446|453131888|FG003|Overall Study|Disease|1|||
125955606|NCT02331446|453131885|FG000|Overall Study|Physician Decision|0|||
125955607|NCT02331446|453131886|FG001|Overall Study|Physician Decision|1|||
125955608|NCT02331446|453131887|FG002|Overall Study|Physician Decision|0|||
125955609|NCT02331446|453131888|FG003|Overall Study|Physician Decision|1|||
125955610|NCT02331446|453131885|FG000|Overall Study|Lost before baseline analysis|0|||
125955611|NCT02331446|453131886|FG001|Overall Study|Lost before baseline analysis|1|||
125955612|NCT02331446|453131887|FG002|Overall Study|Lost before baseline analysis|1|||
125955613|NCT02331446|453131888|FG003|Overall Study|Lost before baseline analysis|0|||
125955614|NCT02566759|453131895|FG000|All Parts|Withdrawal by Subject|0|||
125955615|NCT02566759|453131896|FG001|All Parts|Withdrawal by Subject|1|||
125955616|NCT02566759|453131897|FG002|All Parts|Withdrawal by Subject|0|||
125955617|NCT02566759|453131898|FG003|All Parts|Withdrawal by Subject|0|||
125955618|NCT02566759|453131899|FG004|All Parts|Withdrawal by Subject|0|||
125955619|NCT02566759|453131900|FG005|All Parts|Withdrawal by Subject|0|||
125955620|NCT02566759|453131901|FG006|All Parts|Withdrawal by Subject|0|||
125955621|NCT02566759|453131902|FG007|All Parts|Withdrawal by Subject|0|||
125955622|NCT02566759|453131903|FG008|All Parts|Withdrawal by Subject|0|||
125955623|NCT02566759|453131904|FG009|All Parts|Withdrawal by Subject|0|||
125955624|NCT02566759|453131905|FG010|All Parts|Withdrawal by Subject|0|||
125955625|NCT02566759|453131906|FG011|All Parts|Withdrawal by Subject|0|||
126116316|NCT02716675|453721923|FG002|Overall Study|Death|0|||
126116317|NCT02716675|453721921|FG000|Overall Study|Physician Decision|2|||
126116318|NCT02716675|453721922|FG001|Overall Study|Physician Decision|1|||
126116319|NCT02716675|453721923|FG002|Overall Study|Physician Decision|1|||
125955626|NCT02566759|453131907|FG012|All Parts|Withdrawal by Subject|0|||
126116320|NCT02716675|453721921|FG000|Overall Study|Lost to Follow-up|100|||
126116321|NCT02716675|453721922|FG001|Overall Study|Lost to Follow-up|87|||
126116322|NCT02716675|453721923|FG002|Overall Study|Lost to Follow-up|99|||
125955627|NCT02566759|453131908|FG013|All Parts|Withdrawal by Subject|0|||
126116323|NCT02716675|453721921|FG000|Overall Study|Withdrawal by Subject|22|||
126116324|NCT02716675|453721922|FG001|Overall Study|Withdrawal by Subject|25|||
126116325|NCT02716675|453721923|FG002|Overall Study|Withdrawal by Subject|20|||
125955628|NCT02566759|453131909|FG014|All Parts|Withdrawal by Subject|0|||
125955629|NCT02566759|453131910|FG015|All Parts|Withdrawal by Subject|0|||
125955630|NCT02566759|453131911|FG016|All Parts|Withdrawal by Subject|0|||
125955631|NCT02566759|453131895|FG000|All Parts|Adverse Event|0|||
125955632|NCT02566759|453131896|FG001|All Parts|Adverse Event|0|||
125955633|NCT02566759|453131897|FG002|All Parts|Adverse Event|0|||
125955634|NCT02566759|453131898|FG003|All Parts|Adverse Event|0|||
125955635|NCT02566759|453131899|FG004|All Parts|Adverse Event|0|||
125955636|NCT02566759|453131900|FG005|All Parts|Adverse Event|0|||
125955637|NCT02566759|453131901|FG006|All Parts|Adverse Event|0|||
125955638|NCT02566759|453131902|FG007|All Parts|Adverse Event|0|||
125955639|NCT02566759|453131903|FG008|All Parts|Adverse Event|0|||
125955640|NCT02566759|453131904|FG009|All Parts|Adverse Event|0|||
125955641|NCT02566759|453131905|FG010|All Parts|Adverse Event|0|||
125955642|NCT02566759|453131906|FG011|All Parts|Adverse Event|0|||
125955643|NCT02566759|453131907|FG012|All Parts|Adverse Event|1|||
125955644|NCT02566759|453131908|FG013|All Parts|Adverse Event|3|||
125955645|NCT02566759|453131909|FG014|All Parts|Adverse Event|0|||
125955646|NCT02566759|453131910|FG015|All Parts|Adverse Event|0|||
125955647|NCT02566759|453131911|FG016|All Parts|Adverse Event|0|||
125955648|NCT02566759|453131895|FG000|All Parts|Other|0|||
125955649|NCT02566759|453131896|FG001|All Parts|Other|0|||
125955650|NCT02566759|453131897|FG002|All Parts|Other|0|||
125955651|NCT02566759|453131898|FG003|All Parts|Other|0|||
125955652|NCT02566759|453131899|FG004|All Parts|Other|0|||
125955653|NCT02566759|453131900|FG005|All Parts|Other|0|||
125955654|NCT02566759|453131901|FG006|All Parts|Other|0|||
125955655|NCT02566759|453131902|FG007|All Parts|Other|0|||
125955656|NCT02566759|453131903|FG008|All Parts|Other|0|||
125955657|NCT02566759|453131904|FG009|All Parts|Other|0|||
125955658|NCT02566759|453131905|FG010|All Parts|Other|0|||
125955659|NCT02566759|453131906|FG011|All Parts|Other|0|||
125955660|NCT02566759|453131907|FG012|All Parts|Other|0|||
125955661|NCT02566759|453131908|FG013|All Parts|Other|2|||
125955662|NCT02566759|453131909|FG014|All Parts|Other|0|||
125955663|NCT02566759|453131910|FG015|All Parts|Other|0|||
125955664|NCT02566759|453131911|FG016|All Parts|Other|0|||
125955665|NCT02566759|453131895|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955666|NCT02566759|453131896|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955667|NCT02566759|453131897|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955668|NCT02566759|453131898|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955669|NCT02566759|453131899|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955670|NCT02566759|453131900|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955671|NCT02566759|453131901|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955672|NCT02566759|453131902|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955673|NCT02566759|453131903|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955674|NCT02566759|453131904|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955675|NCT02566759|453131905|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955676|NCT02566759|453131906|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955677|NCT02566759|453131907|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955678|NCT02566759|453131908|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955679|NCT02566759|453131909|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955680|NCT02566759|453131910|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125955681|NCT02566759|453131911|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
125955682|NCT01126541|453131912|FG000|Overall Study|Adverse Event|0|||
125955683|NCT01126541|453131913|FG001|Overall Study|Adverse Event|2|||
125955684|NCT01126541|453131914|FG002|Overall Study|Adverse Event|4|||
125955685|NCT01126541|453131912|FG000|Overall Study|Death|0|||
125955686|NCT01126541|453131913|FG001|Overall Study|Death|1|||
125955687|NCT01126541|453131914|FG002|Overall Study|Death|0|||
125955688|NCT01126541|453131912|FG000|Overall Study|Lack of Efficacy|6|||
125955689|NCT01126541|453131913|FG001|Overall Study|Lack of Efficacy|1|||
125955690|NCT01126541|453131914|FG002|Overall Study|Lack of Efficacy|11|||
125955691|NCT01126541|453131912|FG000|Overall Study|Lost to Follow-up|1|||
125955692|NCT01126541|453131913|FG001|Overall Study|Lost to Follow-up|2|||
125955693|NCT01126541|453131914|FG002|Overall Study|Lost to Follow-up|2|||
125955694|NCT01126541|453131912|FG000|Overall Study|Withdrawal by Subject|2|||
125955695|NCT01126541|453131913|FG001|Overall Study|Withdrawal by Subject|5|||
125955696|NCT01126541|453131914|FG002|Overall Study|Withdrawal by Subject|6|||
125955697|NCT01126541|453131912|FG000|Overall Study|Protocol Violation|0|||
125955698|NCT01126541|453131913|FG001|Overall Study|Protocol Violation|0|||
125955699|NCT01126541|453131914|FG002|Overall Study|Protocol Violation|1|||
125955700|NCT01126541|453131912|FG000|Overall Study|Administrative reason or other|1|||
125955701|NCT01126541|453131913|FG001|Overall Study|Administrative reason or other|1|||
125955702|NCT01126541|453131914|FG002|Overall Study|Administrative reason or other|2|||
125955703|NCT00226941|453131915|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
125955704|NCT00226941|453131916|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
125955705|NCT00226941|453131917|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
125955706|NCT00226941|453131918|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
125955707|NCT00226941|453131915|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
125955708|NCT00226941|453131916|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
125955709|NCT00226941|453131917|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
125955710|NCT00226941|453131918|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
125955711|NCT01513291|453131919|FG000|Treatment Period|Adverse Event|8|||
125955712|NCT01513291|453131920|FG001|Treatment Period|Adverse Event|4|||
125955713|NCT01513291|453131921|FG002|Treatment Period|Adverse Event|0|||
125955714|NCT01513291|453131922|FG003|Treatment Period|Adverse Event|0|||
125955715|NCT01513291|453131923|FG004|Treatment Period|Adverse Event|0|||
125955716|NCT01513291|453131919|FG000|Treatment Period|Lack of Efficacy|3|||
125955717|NCT01513291|453131920|FG001|Treatment Period|Lack of Efficacy|0|||
125955718|NCT01513291|453131921|FG002|Treatment Period|Lack of Efficacy|0|||
125955719|NCT01513291|453131922|FG003|Treatment Period|Lack of Efficacy|0|||
125955720|NCT01513291|453131923|FG004|Treatment Period|Lack of Efficacy|0|||
125955721|NCT01513291|453131919|FG000|Treatment Period|Lost to Follow-up|2|||
125955722|NCT01513291|453131920|FG001|Treatment Period|Lost to Follow-up|3|||
125955723|NCT01513291|453131921|FG002|Treatment Period|Lost to Follow-up|0|||
125955724|NCT01513291|453131922|FG003|Treatment Period|Lost to Follow-up|0|||
125955725|NCT01513291|453131923|FG004|Treatment Period|Lost to Follow-up|0|||
125955726|NCT01513291|453131919|FG000|Treatment Period|Physician Decision|1|||
125955727|NCT01513291|453131920|FG001|Treatment Period|Physician Decision|0|||
125955728|NCT01513291|453131921|FG002|Treatment Period|Physician Decision|0|||
125955729|NCT01513291|453131922|FG003|Treatment Period|Physician Decision|0|||
125955730|NCT01513291|453131923|FG004|Treatment Period|Physician Decision|0|||
125955731|NCT01513291|453131919|FG000|Treatment Period|Protocol Violation|1|||
125955732|NCT01513291|453131920|FG001|Treatment Period|Protocol Violation|2|||
125955733|NCT01513291|453131921|FG002|Treatment Period|Protocol Violation|0|||
125955734|NCT01513291|453131922|FG003|Treatment Period|Protocol Violation|0|||
125955735|NCT01513291|453131923|FG004|Treatment Period|Protocol Violation|0|||
126087090|NCT04043143|453612917|FG001|Overall Study|Lost to Follow-up|5|||
126087091|NCT04043143|453612916|FG000|Overall Study|screen failure|1|||
126087092|NCT04043143|453612917|FG001|Overall Study|screen failure|0|||
126087093|NCT02521363|453612918|FG000|Overall Study|Withdrawal by Subject|1|||
126087094|NCT02521363|453612919|FG001|Overall Study|Withdrawal by Subject|2|||
126087095|NCT03374488|453612920|FG000|Overall Study|Death|13|||
126087096|NCT03374488|453612921|FG001|Overall Study|Death|13|||
126087097|NCT03374488|453612920|FG000|Overall Study|Withdrawal by Subject|3|||
126087098|NCT03374488|453612921|FG001|Overall Study|Withdrawal by Subject|1|||
126087099|NCT03374488|453612920|FG000|Overall Study|Physician Decision|3|||
126087100|NCT03374488|453612921|FG001|Overall Study|Physician Decision|0|||
126087101|NCT01757197|453612922|FG000|Overall Study|Death|2|||
126087102|NCT01077128|453612925|FG000|Overall Study|Adverse Event|8|||
126087103|NCT01077128|453612925|FG000|Overall Study|Lack of Efficacy|1|||
126087104|NCT01077128|453612925|FG000|Overall Study|Disease exacerbation|1|||
126087105|NCT01077128|453612925|FG000|Overall Study|Adverse event and consent withdrawal|1|||
126087106|NCT01077128|453612925|FG000|Overall Study|Adverse event and disease exacerbation|1|||
126087107|NCT01077128|453612925|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
126087108|NCT01077128|453612925|FG000|Overall Study|Other|54|||
126087109|NCT01706705|453612926|FG000|Overall Study|Death|1|||
126087110|NCT01706705|453612926|FG000|Overall Study|Lack of Efficacy|13|||
126087111|NCT01706705|453612926|FG000|Overall Study|Non-clinical|6|||
126087112|NCT04703192|453612927|FG000|Overall Study|Withdrawal by Subject|2|||
126087113|NCT04703192|453612928|FG001|Overall Study|Withdrawal by Subject|0|||
126087114|NCT04703192|453612927|FG000|Overall Study|Death|3|||
126087115|NCT04703192|453612928|FG001|Overall Study|Death|1|||
126087116|NCT04703192|453612927|FG000|Overall Study|Adverse Event|13|||
126087117|NCT04703192|453612928|FG001|Overall Study|Adverse Event|2|||
126087118|NCT04703192|453612927|FG000|Overall Study|Progressive or Relapsed Disease|46|||
126087119|NCT04703192|453612928|FG001|Overall Study|Progressive or Relapsed Disease|7|||
126087120|NCT04703192|453612927|FG000|Overall Study|Clinical Progression|19|||
126087121|NCT04703192|453612928|FG001|Overall Study|Clinical Progression|8|||
126087122|NCT04703192|453612927|FG000|Overall Study|Lost to Follow-up|1|||
126087123|NCT04703192|453612928|FG001|Overall Study|Lost to Follow-up|0|||
126087124|NCT04703192|453612927|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
126087125|NCT04703192|453612928|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
125955736|NCT01513291|453131919|FG000|Treatment Period|Withdrawal by Subject|8|||
125955737|NCT01513291|453131920|FG001|Treatment Period|Withdrawal by Subject|5|||
125955738|NCT01513291|453131921|FG002|Treatment Period|Withdrawal by Subject|0|||
125955739|NCT01513291|453131922|FG003|Treatment Period|Withdrawal by Subject|0|||
125955740|NCT01513291|453131923|FG004|Treatment Period|Withdrawal by Subject|0|||
126087126|NCT04703192|453612927|FG000|Overall Study|Other|5|||
126087127|NCT04703192|453612928|FG001|Overall Study|Other|1|||
126087128|NCT02088957|453612929|FG000|Overall Study|Lack of Efficacy|1|||
126087129|NCT02088957|453612930|FG001|Overall Study|Lack of Efficacy|0|||
126087130|NCT01939353|453612931|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
125955741|NCT01513291|453131919|FG000|Treatment Period|Randomized not treated|0|||
126087131|NCT01939353|453612931|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
126087132|NCT01939353|453612931|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
125955742|NCT01513291|453131920|FG001|Treatment Period|Randomized not treated|2|||
125955743|NCT01513291|453131921|FG002|Treatment Period|Randomized not treated|0|||
125955744|NCT01513291|453131922|FG003|Treatment Period|Randomized not treated|0|||
125955745|NCT01513291|453131923|FG004|Treatment Period|Randomized not treated|0|||
125955746|NCT01513291|453131919|FG000|Run-out Period|Lost to Follow-up|0|||
125955747|NCT01513291|453131920|FG001|Run-out Period|Lost to Follow-up|0|||
125955748|NCT01513291|453131921|FG002|Run-out Period|Lost to Follow-up|0|||
125955749|NCT01513291|453131922|FG003|Run-out Period|Lost to Follow-up|1|||
125955750|NCT01513291|453131923|FG004|Run-out Period|Lost to Follow-up|0|||
125955751|NCT01513291|453131919|FG000|Run-out Period|Withdrawal by Subject|0|||
125955752|NCT01513291|453131920|FG001|Run-out Period|Withdrawal by Subject|0|||
125955753|NCT01513291|453131921|FG002|Run-out Period|Withdrawal by Subject|0|||
125955754|NCT01513291|453131922|FG003|Run-out Period|Withdrawal by Subject|1|||
125955755|NCT01513291|453131923|FG004|Run-out Period|Withdrawal by Subject|0|||
125955756|NCT03732638|453131924|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
125955757|NCT03732638|453131925|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
125955758|NCT03732638|453131924|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
125955759|NCT03732638|453131925|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
125955760|NCT03732638|453131924|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
125955761|NCT03732638|453131925|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
125955762|NCT03732638|453131924|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
125955763|NCT03732638|453131925|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
125955764|NCT03732638|453131924|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
125955765|NCT03732638|453131925|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
125955766|NCT03732638|453131924|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
125955767|NCT03732638|453131925|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
125955768|NCT03732638|453131924|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
125955769|NCT03732638|453131925|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
125955770|NCT03732638|453131924|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
125955771|NCT03732638|453131925|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
125955772|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
125955773|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
125955774|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
125955775|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
125955776|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
125955777|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
125955778|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
125955779|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
125955780|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
125955781|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
125955782|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
125955783|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
125955784|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
125955785|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
125955786|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
125955787|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
125955788|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
125955789|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
125955790|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
125955791|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
125955792|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
125955793|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
125955794|NCT03732638|453131924|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
125955795|NCT03732638|453131925|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
125955796|NCT03732638|453131924|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
125955797|NCT03732638|453131925|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
125955798|NCT03732638|453131924|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
125955799|NCT03732638|453131925|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
125955800|NCT03732638|453131924|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
125955801|NCT03732638|453131925|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
125955802|NCT03732638|453131924|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
125955803|NCT03732638|453131925|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
125955804|NCT01358981|453131926|FG000|Period 1|Withdrawal by Subject|0|||
125955805|NCT01358981|453131927|FG001|Period 1|Withdrawal by Subject|0|||
125955806|NCT01358981|453131928|FG002|Period 1|Withdrawal by Subject|0|||
125955807|NCT01358981|453131929|FG003|Period 1|Withdrawal by Subject|1|||
125955808|NCT01358981|453131930|FG004|Period 1|Withdrawal by Subject|0|||
125955809|NCT01358981|453131931|FG005|Period 1|Withdrawal by Subject|0|||
125955810|NCT01358981|453131932|FG006|Period 1|Withdrawal by Subject|0|||
125955811|NCT03728582|453131933|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
125955812|NCT03728582|453131934|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
125955813|NCT03728582|453131933|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
125955814|NCT03728582|453131934|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
125955815|NCT01034397|453131935|FG000|Overall Study|Lack of compliance|0|||
125955816|NCT01034397|453131936|FG001|Overall Study|Lack of compliance|1|||
125955817|NCT01034397|453131935|FG000|Overall Study|Lack of Efficacy|3|||
125955818|NCT01034397|453131936|FG001|Overall Study|Lack of Efficacy|0|||
125955819|NCT01034397|453131935|FG000|Overall Study|Adverse Event|4|||
125955820|NCT01034397|453131936|FG001|Overall Study|Adverse Event|0|||
125955821|NCT01034397|453131935|FG000|Overall Study|Other|0|||
125955822|NCT01034397|453131936|FG001|Overall Study|Other|1|||
125955823|NCT01018264|453131937|FG000|Overall Study|Withdrawal by Subject|1|||
125955824|NCT01018264|453131938|FG001|Overall Study|Withdrawal by Subject|0|||
126116326|NCT02716675|453721921|FG000|Overall Study|Protocol Violation|0|||
126116327|NCT02716675|453721922|FG001|Overall Study|Protocol Violation|3|||
126116328|NCT02716675|453721923|FG002|Overall Study|Protocol Violation|1|||
126116329|NCT02716675|453721921|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
126116330|NCT02716675|453721922|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
126116331|NCT02716675|453721923|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
126116332|NCT02716675|453721921|FG000|Overall Study|Other|38|||
126116333|NCT02716675|453721922|FG001|Overall Study|Other|47|||
126116334|NCT02716675|453721923|FG002|Overall Study|Other|48|||
126116335|NCT01301456|453721924|FG000|Stage 1|Withdrawal by Subject|0|||
126116336|NCT01301456|453721925|FG001|Stage 1|Withdrawal by Subject|0|||
126116337|NCT01301456|453721926|FG002|Stage 1|Withdrawal by Subject|1|||
126116338|NCT01301456|453721927|FG003|Stage 1|Withdrawal by Subject|0|||
126116339|NCT01301456|453721928|FG004|Stage 1|Withdrawal by Subject|1|||
126116340|NCT01301456|453721929|FG005|Stage 1|Withdrawal by Subject|0|||
126116341|NCT01301456|453721930|FG006|Stage 1|Withdrawal by Subject|0|||
126116342|NCT01301456|453721931|FG007|Stage 1|Withdrawal by Subject|0|||
126116343|NCT01301456|453721932|FG008|Stage 1|Withdrawal by Subject|0|||
126116344|NCT01301456|453721933|FG009|Stage 1|Withdrawal by Subject|0|||
126116345|NCT01301456|453721934|FG010|Stage 1|Withdrawal by Subject|0|||
126116346|NCT01301456|453721935|FG011|Stage 1|Withdrawal by Subject|0|||
126116347|NCT01301456|453721924|FG000|Stage 1|Randomized but not treated|0|||
126116348|NCT01301456|453721925|FG001|Stage 1|Randomized but not treated|0|||
126116349|NCT01301456|453721926|FG002|Stage 1|Randomized but not treated|0|||
126116350|NCT01301456|453721927|FG003|Stage 1|Randomized but not treated|0|||
126116351|NCT01301456|453721928|FG004|Stage 1|Randomized but not treated|0|||
126116352|NCT01301456|453721929|FG005|Stage 1|Randomized but not treated|0|||
126116353|NCT01301456|453721930|FG006|Stage 1|Randomized but not treated|1|||
126116354|NCT01301456|453721931|FG007|Stage 1|Randomized but not treated|0|||
126116355|NCT01301456|453721932|FG008|Stage 1|Randomized but not treated|0|||
126116356|NCT01301456|453721933|FG009|Stage 1|Randomized but not treated|0|||
126116357|NCT01301456|453721934|FG010|Stage 1|Randomized but not treated|0|||
126116358|NCT01301456|453721935|FG011|Stage 1|Randomized but not treated|0|||
126116359|NCT01301456|453721924|FG000|Stage 2|Adverse Event|0|||
126116360|NCT01301456|453721925|FG001|Stage 2|Adverse Event|0|||
126116361|NCT01301456|453721926|FG002|Stage 2|Adverse Event|0|||
126116362|NCT01301456|453721927|FG003|Stage 2|Adverse Event|0|||
126116363|NCT01301456|453721928|FG004|Stage 2|Adverse Event|0|||
126116364|NCT01301456|453721929|FG005|Stage 2|Adverse Event|0|||
126116365|NCT01301456|453721930|FG006|Stage 2|Adverse Event|0|||
126116366|NCT01301456|453721931|FG007|Stage 2|Adverse Event|0|||
126116367|NCT01301456|453721932|FG008|Stage 2|Adverse Event|0|||
126116368|NCT01301456|453721933|FG009|Stage 2|Adverse Event|0|||
126116369|NCT01301456|453721934|FG010|Stage 2|Adverse Event|1|||
126116370|NCT01301456|453721935|FG011|Stage 2|Adverse Event|0|||
126116371|NCT00915772|453721936|FG000|Overall Study|Adverse Event|12|||
126116372|NCT00915772|453721937|FG001|Overall Study|Adverse Event|13|||
126116373|NCT00915772|453721938|FG002|Overall Study|Adverse Event|11|||
126116374|NCT00915772|453721936|FG000|Overall Study|Protocol Violation|4|||
126116375|NCT00915772|453721937|FG001|Overall Study|Protocol Violation|1|||
126116376|NCT00915772|453721938|FG002|Overall Study|Protocol Violation|2|||
126116377|NCT00915772|453721936|FG000|Overall Study|Lost to Follow-up|1|||
126116378|NCT00915772|453721937|FG001|Overall Study|Lost to Follow-up|2|||
125955825|NCT01018264|453131937|FG000|Overall Study|Lost to Follow-up|0|||
125955826|NCT01018264|453131938|FG001|Overall Study|Lost to Follow-up|1|||
126116379|NCT00915772|453721938|FG002|Overall Study|Lost to Follow-up|2|||
126116380|NCT00915772|453721936|FG000|Overall Study|Lack of Efficacy|9|||
125955827|NCT01785524|453131939|FG000|Overall Study|Withdrawal by Subject|2|||
125955828|NCT01785524|453131940|FG001|Overall Study|Withdrawal by Subject|2|||
126116381|NCT00915772|453721937|FG001|Overall Study|Lack of Efficacy|15|||
126116382|NCT00915772|453721938|FG002|Overall Study|Lack of Efficacy|3|||
126116383|NCT00915772|453721936|FG000|Overall Study|Refused to continue trial medication|6|||
126116384|NCT00915772|453721937|FG001|Overall Study|Refused to continue trial medication|8|||
126116385|NCT00915772|453721938|FG002|Overall Study|Refused to continue trial medication|4|||
126116386|NCT00915772|453721936|FG000|Overall Study|Any other reason|4|||
125955829|NCT03217136|453131945|FG000|Overall Study|Lost to Follow-up|2|||
125955830|NCT03217136|453131946|FG001|Overall Study|Lost to Follow-up|1|||
125955831|NCT03217136|453131945|FG000|Overall Study|Site Randomized Participant in Error|0|||
126116387|NCT00915772|453721937|FG001|Overall Study|Any other reason|7|||
126116388|NCT00915772|453721938|FG002|Overall Study|Any other reason|7|||
125955832|NCT03217136|453131946|FG001|Overall Study|Site Randomized Participant in Error|1|||
125955833|NCT03217136|453131945|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
125955834|NCT03217136|453131946|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
125955835|NCT03217136|453131945|FG000|Overall Study|Dispensing Error|1|||
125955836|NCT03217136|453131946|FG001|Overall Study|Dispensing Error|0|||
125955837|NCT03217136|453131945|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125955838|NCT03217136|453131946|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125955839|NCT03670810|453131949|FG000|Main Study|Adverse Event|37|||
125955840|NCT03670810|453131950|FG001|Main Study|Adverse Event|38|||
125955841|NCT03670810|453131951|FG002|Main Study|Adverse Event|3|||
125955842|NCT03670810|453131952|FG003|Main Study|Adverse Event|4|||
125955843|NCT03670810|453131953|FG004|Main Study|Adverse Event|4|||
125955844|NCT03670810|453131954|FG005|Main Study|Adverse Event|5|||
125955845|NCT03670810|453131955|FG006|Main Study|Adverse Event|0|||
125955846|NCT03670810|453131956|FG007|Main Study|Adverse Event|0|||
125955847|NCT03670810|453131957|FG008|Main Study|Adverse Event|0|||
125955848|NCT03670810|453131949|FG000|Main Study|Lack of Efficacy|8|||
125955849|NCT03670810|453131950|FG001|Main Study|Lack of Efficacy|9|||
125955850|NCT03670810|453131951|FG002|Main Study|Lack of Efficacy|3|||
125955851|NCT03670810|453131952|FG003|Main Study|Lack of Efficacy|4|||
125955852|NCT03670810|453131953|FG004|Main Study|Lack of Efficacy|0|||
125955853|NCT03670810|453131954|FG005|Main Study|Lack of Efficacy|0|||
125955854|NCT03670810|453131955|FG006|Main Study|Lack of Efficacy|0|||
125955855|NCT03670810|453131956|FG007|Main Study|Lack of Efficacy|0|||
125955856|NCT03670810|453131957|FG008|Main Study|Lack of Efficacy|0|||
125955857|NCT03670810|453131949|FG000|Main Study|Lost to Follow-up|9|||
125955858|NCT03670810|453131950|FG001|Main Study|Lost to Follow-up|7|||
125955859|NCT03670810|453131951|FG002|Main Study|Lost to Follow-up|4|||
125955860|NCT03670810|453131952|FG003|Main Study|Lost to Follow-up|6|||
125955861|NCT03670810|453131953|FG004|Main Study|Lost to Follow-up|1|||
125955862|NCT03670810|453131954|FG005|Main Study|Lost to Follow-up|0|||
125955863|NCT03670810|453131955|FG006|Main Study|Lost to Follow-up|0|||
125955864|NCT03670810|453131956|FG007|Main Study|Lost to Follow-up|0|||
125955865|NCT03670810|453131957|FG008|Main Study|Lost to Follow-up|0|||
125955866|NCT03670810|453131949|FG000|Main Study|Non-compliance with Study Drug|0|||
125955867|NCT03670810|453131950|FG001|Main Study|Non-compliance with Study Drug|2|||
125955868|NCT03670810|453131951|FG002|Main Study|Non-compliance with Study Drug|3|||
125955869|NCT03670810|453131952|FG003|Main Study|Non-compliance with Study Drug|0|||
125955870|NCT03670810|453131953|FG004|Main Study|Non-compliance with Study Drug|0|||
125955871|NCT03670810|453131954|FG005|Main Study|Non-compliance with Study Drug|0|||
125955872|NCT03670810|453131955|FG006|Main Study|Non-compliance with Study Drug|0|||
125955873|NCT03670810|453131956|FG007|Main Study|Non-compliance with Study Drug|1|||
126116389|NCT03583450|453721939|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
126116390|NCT03583450|453721940|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
126116391|NCT03374995|453721941|FG000|Overall Study|Withdrawal by Subject|0|||
126116392|NCT03374995|453721942|FG001|Overall Study|Withdrawal by Subject|1|||
126116393|NCT01383096|453721943|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
126116394|NCT01383096|453721944|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
126116395|NCT01383096|453721945|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
126116396|NCT01383096|453721943|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
126116397|NCT01383096|453721944|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
126116398|NCT01383096|453721945|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
126116399|NCT01383096|453721943|FG000|Third Intervention (8 Days)|Elevated AST|0|||
125955874|NCT03670810|453131957|FG008|Main Study|Non-compliance with Study Drug|0|||
125955875|NCT03670810|453131949|FG000|Main Study|Physician Decision|3|||
125955876|NCT03670810|453131950|FG001|Main Study|Physician Decision|0|||
125955877|NCT03670810|453131951|FG002|Main Study|Physician Decision|1|||
125955878|NCT03670810|453131952|FG003|Main Study|Physician Decision|0|||
125955879|NCT03670810|453131953|FG004|Main Study|Physician Decision|0|||
125955880|NCT03670810|453131954|FG005|Main Study|Physician Decision|0|||
126116400|NCT01383096|453721944|FG001|Third Intervention (8 Days)|Elevated AST|1|||
126116401|NCT01383096|453721945|FG002|Third Intervention (8 Days)|Elevated AST|0|||
126116402|NCT01383096|453721943|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
125955881|NCT03670810|453131955|FG006|Main Study|Physician Decision|1|||
125955882|NCT03670810|453131956|FG007|Main Study|Physician Decision|1|||
125955883|NCT03670810|453131957|FG008|Main Study|Physician Decision|0|||
125955884|NCT03670810|453131949|FG000|Main Study|Pregnancy|1|||
125955885|NCT03670810|453131950|FG001|Main Study|Pregnancy|2|||
125955886|NCT03670810|453131951|FG002|Main Study|Pregnancy|0|||
125955887|NCT03670810|453131952|FG003|Main Study|Pregnancy|0|||
125955888|NCT03670810|453131953|FG004|Main Study|Pregnancy|0|||
125955889|NCT03670810|453131954|FG005|Main Study|Pregnancy|0|||
125955890|NCT03670810|453131955|FG006|Main Study|Pregnancy|0|||
125955891|NCT03670810|453131956|FG007|Main Study|Pregnancy|0|||
125955892|NCT03670810|453131957|FG008|Main Study|Pregnancy|0|||
125955893|NCT03670810|453131949|FG000|Main Study|Protocol Deviation|2|||
125955894|NCT03670810|453131950|FG001|Main Study|Protocol Deviation|12|||
125955895|NCT03670810|453131951|FG002|Main Study|Protocol Deviation|8|||
125955896|NCT03670810|453131952|FG003|Main Study|Protocol Deviation|4|||
125955897|NCT03670810|453131953|FG004|Main Study|Protocol Deviation|0|||
125955898|NCT03670810|453131954|FG005|Main Study|Protocol Deviation|0|||
125955899|NCT03670810|453131955|FG006|Main Study|Protocol Deviation|0|||
125955900|NCT03670810|453131956|FG007|Main Study|Protocol Deviation|0|||
125955901|NCT03670810|453131957|FG008|Main Study|Protocol Deviation|0|||
125955902|NCT03670810|453131949|FG000|Main Study|Withdrawal by Subject|21|||
125955903|NCT03670810|453131950|FG001|Main Study|Withdrawal by Subject|21|||
125955904|NCT03670810|453131951|FG002|Main Study|Withdrawal by Subject|8|||
125955905|NCT03670810|453131952|FG003|Main Study|Withdrawal by Subject|9|||
125955906|NCT03670810|453131953|FG004|Main Study|Withdrawal by Subject|5|||
125955907|NCT03670810|453131954|FG005|Main Study|Withdrawal by Subject|2|||
125955908|NCT03670810|453131955|FG006|Main Study|Withdrawal by Subject|1|||
125955909|NCT03670810|453131956|FG007|Main Study|Withdrawal by Subject|1|||
125955910|NCT03670810|453131957|FG008|Main Study|Withdrawal by Subject|0|||
125955911|NCT03670810|453131949|FG000|Main Study|Participant did not want to take the three other treatments|1|||
125955912|NCT03670810|453131950|FG001|Main Study|Participant did not want to take the three other treatments|0|||
125955913|NCT03670810|453131951|FG002|Main Study|Participant did not want to take the three other treatments|0|||
125955914|NCT03670810|453131952|FG003|Main Study|Participant did not want to take the three other treatments|0|||
125955915|NCT03670810|453131953|FG004|Main Study|Participant did not want to take the three other treatments|0|||
125955916|NCT03670810|453131954|FG005|Main Study|Participant did not want to take the three other treatments|0|||
125955917|NCT03670810|453131955|FG006|Main Study|Participant did not want to take the three other treatments|0|||
125955918|NCT03670810|453131956|FG007|Main Study|Participant did not want to take the three other treatments|0|||
125955919|NCT03670810|453131957|FG008|Main Study|Participant did not want to take the three other treatments|0|||
125955920|NCT03670810|453131949|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125955921|NCT03670810|453131950|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
125955922|NCT03670810|453131951|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125955923|NCT03670810|453131952|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125955924|NCT03670810|453131953|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125955925|NCT03670810|453131954|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125955926|NCT03670810|453131955|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125955927|NCT03670810|453131956|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125955928|NCT03670810|453131957|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125955929|NCT03670810|453131949|FG000|Main Study|Travel and Coronavirus issues|0|||
125955930|NCT03670810|453131950|FG001|Main Study|Travel and Coronavirus issues|0|||
125955931|NCT03670810|453131951|FG002|Main Study|Travel and Coronavirus issues|0|||
125955932|NCT03670810|453131952|FG003|Main Study|Travel and Coronavirus issues|1|||
125955933|NCT03670810|453131953|FG004|Main Study|Travel and Coronavirus issues|0|||
125955934|NCT03670810|453131954|FG005|Main Study|Travel and Coronavirus issues|0|||
125955935|NCT03670810|453131955|FG006|Main Study|Travel and Coronavirus issues|0|||
125955936|NCT03670810|453131956|FG007|Main Study|Travel and Coronavirus issues|0|||
125955937|NCT03670810|453131957|FG008|Main Study|Travel and Coronavirus issues|0|||
125955938|NCT03670810|453131949|FG000|Open Label Extension|Protocol Deviation|0|||
125955939|NCT03670810|453131950|FG001|Open Label Extension|Protocol Deviation|0|||
125955940|NCT03670810|453131951|FG002|Open Label Extension|Protocol Deviation|0|||
125955941|NCT03670810|453131952|FG003|Open Label Extension|Protocol Deviation|0|||
125955942|NCT03670810|453131953|FG004|Open Label Extension|Protocol Deviation|0|||
125955943|NCT03670810|453131954|FG005|Open Label Extension|Protocol Deviation|0|||
125955944|NCT03670810|453131955|FG006|Open Label Extension|Protocol Deviation|0|||
125955945|NCT03670810|453131956|FG007|Open Label Extension|Protocol Deviation|0|||
125955946|NCT03670810|453131957|FG008|Open Label Extension|Protocol Deviation|5|||
125955947|NCT03670810|453131949|FG000|Open Label Extension|Death|0|||
125955948|NCT03670810|453131950|FG001|Open Label Extension|Death|0|||
125955949|NCT03670810|453131951|FG002|Open Label Extension|Death|0|||
125955950|NCT03670810|453131952|FG003|Open Label Extension|Death|0|||
125955951|NCT03670810|453131953|FG004|Open Label Extension|Death|0|||
125955952|NCT03670810|453131954|FG005|Open Label Extension|Death|0|||
125955953|NCT03670810|453131955|FG006|Open Label Extension|Death|0|||
125955954|NCT03670810|453131956|FG007|Open Label Extension|Death|0|||
125955955|NCT03670810|453131957|FG008|Open Label Extension|Death|1|||
125955956|NCT03670810|453131949|FG000|Open Label Extension|COVID-19|0|||
125955957|NCT03670810|453131950|FG001|Open Label Extension|COVID-19|0|||
126116403|NCT01383096|453721944|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
126116404|NCT01383096|453721945|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
125955958|NCT03670810|453131951|FG002|Open Label Extension|COVID-19|0|||
125955959|NCT03670810|453131952|FG003|Open Label Extension|COVID-19|0|||
125955960|NCT03670810|453131953|FG004|Open Label Extension|COVID-19|0|||
125955961|NCT03670810|453131954|FG005|Open Label Extension|COVID-19|0|||
125955962|NCT03670810|453131955|FG006|Open Label Extension|COVID-19|0|||
125955963|NCT03670810|453131956|FG007|Open Label Extension|COVID-19|0|||
125955964|NCT03670810|453131957|FG008|Open Label Extension|COVID-19|1|||
125955965|NCT03670810|453131949|FG000|Open Label Extension|Lack of Efficacy|0|||
125955966|NCT03670810|453131950|FG001|Open Label Extension|Lack of Efficacy|0|||
125955967|NCT03670810|453131951|FG002|Open Label Extension|Lack of Efficacy|0|||
125955968|NCT03670810|453131952|FG003|Open Label Extension|Lack of Efficacy|0|||
125955969|NCT03670810|453131953|FG004|Open Label Extension|Lack of Efficacy|0|||
125955970|NCT03670810|453131954|FG005|Open Label Extension|Lack of Efficacy|0|||
125955971|NCT03670810|453131955|FG006|Open Label Extension|Lack of Efficacy|0|||
125955972|NCT03670810|453131956|FG007|Open Label Extension|Lack of Efficacy|0|||
125955973|NCT03670810|453131957|FG008|Open Label Extension|Lack of Efficacy|39|||
125955974|NCT03670810|453131949|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
125955975|NCT03670810|453131950|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
125955976|NCT03670810|453131951|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
125955977|NCT03670810|453131952|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
125955978|NCT03670810|453131953|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
125955979|NCT03670810|453131954|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
125955980|NCT03670810|453131955|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
125955981|NCT03670810|453131956|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
125955982|NCT03670810|453131957|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
125955983|NCT03670810|453131949|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125955984|NCT03670810|453131950|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125955985|NCT03670810|453131951|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125955986|NCT03670810|453131952|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125955987|NCT03670810|453131953|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125955988|NCT03670810|453131954|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125955989|NCT03670810|453131955|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125955990|NCT03670810|453131956|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125955991|NCT03670810|453131957|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
125955992|NCT03670810|453131949|FG000|Open Label Extension|Withdrawal by Subject|0|||
125955993|NCT03670810|453131950|FG001|Open Label Extension|Withdrawal by Subject|0|||
125955994|NCT03670810|453131951|FG002|Open Label Extension|Withdrawal by Subject|0|||
125955995|NCT03670810|453131952|FG003|Open Label Extension|Withdrawal by Subject|0|||
125955996|NCT03670810|453131953|FG004|Open Label Extension|Withdrawal by Subject|0|||
125955997|NCT03670810|453131954|FG005|Open Label Extension|Withdrawal by Subject|0|||
125955998|NCT03670810|453131955|FG006|Open Label Extension|Withdrawal by Subject|0|||
125955999|NCT03670810|453131956|FG007|Open Label Extension|Withdrawal by Subject|0|||
125956000|NCT03670810|453131957|FG008|Open Label Extension|Withdrawal by Subject|46|||
125956001|NCT03670810|453131949|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125956002|NCT03670810|453131950|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125956003|NCT03670810|453131951|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125956004|NCT03670810|453131952|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125956005|NCT03670810|453131953|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125956006|NCT03670810|453131954|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125956007|NCT03670810|453131955|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125956008|NCT03670810|453131956|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125956009|NCT03670810|453131957|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
125956010|NCT03670810|453131949|FG000|Open Label Extension|Physician Decision|0|||
125956011|NCT03670810|453131950|FG001|Open Label Extension|Physician Decision|0|||
125956012|NCT03670810|453131951|FG002|Open Label Extension|Physician Decision|0|||
125956013|NCT03670810|453131952|FG003|Open Label Extension|Physician Decision|0|||
125956014|NCT03670810|453131953|FG004|Open Label Extension|Physician Decision|0|||
125956015|NCT03670810|453131954|FG005|Open Label Extension|Physician Decision|0|||
125956016|NCT03670810|453131955|FG006|Open Label Extension|Physician Decision|0|||
125956017|NCT03670810|453131956|FG007|Open Label Extension|Physician Decision|0|||
125956018|NCT03670810|453131957|FG008|Open Label Extension|Physician Decision|2|||
125956019|NCT03670810|453131949|FG000|Open Label Extension|Non-compliance with study drug|0|||
125956020|NCT03670810|453131950|FG001|Open Label Extension|Non-compliance with study drug|0|||
125956021|NCT03670810|453131951|FG002|Open Label Extension|Non-compliance with study drug|0|||
125956022|NCT03670810|453131952|FG003|Open Label Extension|Non-compliance with study drug|0|||
125956023|NCT03670810|453131953|FG004|Open Label Extension|Non-compliance with study drug|0|||
125956024|NCT03670810|453131954|FG005|Open Label Extension|Non-compliance with study drug|0|||
126087133|NCT01939353|453612931|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
126087134|NCT01939353|453612931|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
126087135|NCT00874731|453612939|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
125956025|NCT03670810|453131955|FG006|Open Label Extension|Non-compliance with study drug|0|||
125956026|NCT03670810|453131956|FG007|Open Label Extension|Non-compliance with study drug|0|||
125956027|NCT03670810|453131957|FG008|Open Label Extension|Non-compliance with study drug|5|||
125956028|NCT03670810|453131949|FG000|Open Label Extension|Pregnancy|0|||
125956029|NCT03670810|453131950|FG001|Open Label Extension|Pregnancy|0|||
125956030|NCT03670810|453131951|FG002|Open Label Extension|Pregnancy|0|||
125956031|NCT03670810|453131952|FG003|Open Label Extension|Pregnancy|0|||
125956032|NCT03670810|453131953|FG004|Open Label Extension|Pregnancy|0|||
125956033|NCT03670810|453131954|FG005|Open Label Extension|Pregnancy|0|||
125956034|NCT03670810|453131955|FG006|Open Label Extension|Pregnancy|0|||
125956035|NCT03670810|453131956|FG007|Open Label Extension|Pregnancy|0|||
125956036|NCT03670810|453131957|FG008|Open Label Extension|Pregnancy|3|||
125956037|NCT03670810|453131949|FG000|Open Label Extension|Adverse Event|0|||
125956038|NCT03670810|453131950|FG001|Open Label Extension|Adverse Event|0|||
125956039|NCT03670810|453131951|FG002|Open Label Extension|Adverse Event|0|||
125956040|NCT03670810|453131952|FG003|Open Label Extension|Adverse Event|0|||
125956041|NCT03670810|453131953|FG004|Open Label Extension|Adverse Event|0|||
125956042|NCT03670810|453131954|FG005|Open Label Extension|Adverse Event|0|||
125956043|NCT03670810|453131955|FG006|Open Label Extension|Adverse Event|0|||
125956044|NCT03670810|453131956|FG007|Open Label Extension|Adverse Event|0|||
125956045|NCT03670810|453131957|FG008|Open Label Extension|Adverse Event|24|||
125956046|NCT03670810|453131949|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
125956047|NCT03670810|453131950|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
125956048|NCT03670810|453131951|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
125956049|NCT03670810|453131952|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
125956050|NCT03670810|453131953|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
125956051|NCT03670810|453131954|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
125956052|NCT03670810|453131955|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
125956053|NCT03670810|453131956|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
125956054|NCT03670810|453131957|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
125956055|NCT03670810|453131949|FG000|Open Label Extension|Lost to Follow-up|0|||
125956056|NCT03670810|453131950|FG001|Open Label Extension|Lost to Follow-up|0|||
125956057|NCT03670810|453131951|FG002|Open Label Extension|Lost to Follow-up|0|||
125956058|NCT03670810|453131952|FG003|Open Label Extension|Lost to Follow-up|0|||
125956059|NCT03670810|453131953|FG004|Open Label Extension|Lost to Follow-up|0|||
125956060|NCT03670810|453131954|FG005|Open Label Extension|Lost to Follow-up|0|||
125956061|NCT03670810|453131955|FG006|Open Label Extension|Lost to Follow-up|0|||
125956062|NCT03670810|453131956|FG007|Open Label Extension|Lost to Follow-up|0|||
125956063|NCT03670810|453131957|FG008|Open Label Extension|Lost to Follow-up|23|||
125956064|NCT00482391|453131958|FG000|Overall Study|Withdrawal by Subject|1|||
125956065|NCT00482391|453131958|FG000|Overall Study|Adverse Event|1|||
125956066|NCT00482391|453131958|FG000|Overall Study|Death|1|||
125956067|NCT06640829|453131966|FG000|Overall Study|Withdrawal by Subject|1|||
125956068|NCT06640829|453131966|FG000|Overall Study|Lost to Follow-up|1|||
125956069|NCT01365273|453131967|FG000|Overall Study|Lost to Follow-up|1|||
125956070|NCT01365273|453131968|FG001|Overall Study|Lost to Follow-up|0|||
126087136|NCT00874731|453612940|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
126087137|NCT00874731|453612941|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
126087138|NCT00874731|453612939|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
126087139|NCT00874731|453612940|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
126087140|NCT00874731|453612941|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
126087141|NCT00874731|453612939|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
126087142|NCT00874731|453612940|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
126087143|NCT00874731|453612941|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
126087144|NCT01132820|453612946|FG000|Overall Study|Ineligible: wrong cell type|1|||
126087145|NCT01132820|453612946|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
126087146|NCT01132820|453612946|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
126087147|NCT01132820|453612946|FG000|Overall Study|Never treated|1|||
126087148|NCT01132820|453612946|FG000|Overall Study|Inadequate data|1|||
126087149|NCT00667394|453612948|FG000|Overall Study|Adverse Event|3|||
126087150|NCT00667394|453612949|FG001|Overall Study|Adverse Event|0|||
126087151|NCT00667394|453612948|FG000|Overall Study|Progressive disease|1|||
126087152|NCT00667394|453612949|FG001|Overall Study|Progressive disease|0|||
126087153|NCT05000216|453612950|FG000|Stage 1|Lost to Follow-up|0|||
126087154|NCT05000216|453612951|FG001|Stage 1|Lost to Follow-up|0|||
126087155|NCT05000216|453612952|FG002|Stage 1|Lost to Follow-up|0|||
126087156|NCT05000216|453612953|FG003|Stage 1|Lost to Follow-up|0|||
125956071|NCT01365273|453131967|FG000|Overall Study|Protocol Violation|0|||
125956072|NCT01365273|453131968|FG001|Overall Study|Protocol Violation|1|||
125956073|NCT01365273|453131967|FG000|Overall Study|Physician Decision|1|||
126087157|NCT05000216|453612954|FG004|Stage 1|Lost to Follow-up|0|||
126087158|NCT05000216|453612955|FG005|Stage 1|Lost to Follow-up|0|||
126087159|NCT05000216|453612956|FG006|Stage 1|Lost to Follow-up|1|||
126087160|NCT05000216|453612957|FG007|Stage 1|Lost to Follow-up|1|||
126087161|NCT05000216|453612958|FG008|Stage 1|Lost to Follow-up|0|||
125956074|NCT01365273|453131968|FG001|Overall Study|Physician Decision|0|||
125956075|NCT02519712|453131971|FG000|Overall Study|Disease Relapse|1|||
125956076|NCT02519712|453131971|FG000|Overall Study|Disease Progression|1|||
125956077|NCT02519712|453131971|FG000|Overall Study|Accruals are donors|2|||
125956078|NCT03254134|453131972|FG000|Overall Study|Not eligible patients|599|||
125956079|NCT03254134|453131973|FG001|Overall Study|Not eligible patients|3630|||
125956080|NCT01462357|453131974|FG000|Overall Study|Death|0|||
125956081|NCT01462357|453131975|FG001|Overall Study|Death|0|||
125956082|NCT01462357|453131976|FG002|Overall Study|Death|1|||
125956083|NCT01462357|453131974|FG000|Overall Study|Withdrawal by Subject|3|||
125956084|NCT01462357|453131975|FG001|Overall Study|Withdrawal by Subject|11|||
125956085|NCT01462357|453131976|FG002|Overall Study|Withdrawal by Subject|3|||
125956086|NCT01462357|453131974|FG000|Overall Study|Migrated/moved from study area|2|||
125956087|NCT01462357|453131975|FG001|Overall Study|Migrated/moved from study area|3|||
125956088|NCT01462357|453131976|FG002|Overall Study|Migrated/moved from study area|1|||
125956089|NCT01462357|453131974|FG000|Overall Study|Lost to Follow-up|3|||
125956090|NCT01462357|453131975|FG001|Overall Study|Lost to Follow-up|5|||
125956091|NCT01462357|453131976|FG002|Overall Study|Lost to Follow-up|7|||
125956092|NCT01247090|453131977|FG000|Overall Study|Physician Decision|1|||
125956093|NCT01247090|453131978|FG001|Overall Study|Physician Decision|0|||
125956094|NCT01247090|453131979|FG002|Overall Study|Physician Decision|0|||
125956095|NCT01247090|453131977|FG000|Overall Study|Withdrawal by Subject|0|||
125956096|NCT01247090|453131978|FG001|Overall Study|Withdrawal by Subject|1|||
125956097|NCT01247090|453131979|FG002|Overall Study|Withdrawal by Subject|0|||
125956098|NCT00006916|453131980|FG000|Overall Study|Device not inserted|4|||
125956099|NCT00006916|453131980|FG000|Overall Study|Complication of device insertion|1|||
125956100|NCT02751983|453131983|FG000|Treatment|Stopped ACT, but Remained in study|2|||
125956101|NCT02751983|453131984|FG001|Treatment|Stopped ACT, but Remained in study|0|||
125956102|NCT02751983|453131983|FG000|Treatment|Discharged prior to beginning ACT|2|||
125956103|NCT02751983|453131984|FG001|Treatment|Discharged prior to beginning ACT|0|||
125956104|NCT02751983|453131983|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
125956105|NCT02751983|453131984|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
125956106|NCT02751983|453131983|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
125956107|NCT02751983|453131984|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
125956108|NCT02751983|453131983|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
125956109|NCT02751983|453131984|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
125956110|NCT00813358|453131987|FG000|Overall Study|Death|32|||
125956111|NCT00813358|453131987|FG000|Overall Study|Lost to Follow-up|12|||
125956112|NCT00813358|453131987|FG000|Overall Study|other endpoints|5|||
125956113|NCT00813358|453131987|FG000|Overall Study|Withdrawal by Subject|20|||
125956114|NCT01282216|453131988|FG000|Overall Study|Graft failure|0|||
125956115|NCT01282216|453131989|FG001|Overall Study|Graft failure|0|||
125956116|NCT01282216|453131990|FG002|Overall Study|Graft failure|3|||
125956117|NCT01282216|453131991|FG003|Overall Study|Graft failure|2|||
125956118|NCT01282216|453131988|FG000|Overall Study|Physician Decision|0|||
125956119|NCT01282216|453131989|FG001|Overall Study|Physician Decision|0|||
125956120|NCT01282216|453131990|FG002|Overall Study|Physician Decision|11|||
125956121|NCT01282216|453131991|FG003|Overall Study|Physician Decision|0|||
125956122|NCT01282216|453131988|FG000|Overall Study|Relapse|0|||
125956123|NCT01282216|453131989|FG001|Overall Study|Relapse|0|||
125956124|NCT01282216|453131990|FG002|Overall Study|Relapse|17|||
125956125|NCT01282216|453131991|FG003|Overall Study|Relapse|6|||
125956126|NCT01282216|453131988|FG000|Overall Study|Death|0|||
125956127|NCT01282216|453131989|FG001|Overall Study|Death|0|||
125956128|NCT01282216|453131990|FG002|Overall Study|Death|2|||
125956129|NCT01282216|453131991|FG003|Overall Study|Death|0|||
125956130|NCT01387607|453131992|FG000|Overall Study|Adverse Event|23|||
125956131|NCT01387607|453131993|FG001|Overall Study|Adverse Event|11|||
125956132|NCT01387607|453131992|FG000|Overall Study|Lack of Efficacy|8|||
125956133|NCT01387607|453131993|FG001|Overall Study|Lack of Efficacy|6|||
125956134|NCT01387607|453131992|FG000|Overall Study|Lost to Follow-up|2|||
125956135|NCT01387607|453131993|FG001|Overall Study|Lost to Follow-up|1|||
125956136|NCT01387607|453131992|FG000|Overall Study|No longer meets eligibility criteria|0|||
125956137|NCT01387607|453131993|FG001|Overall Study|No longer meets eligibility criteria|1|||
125956138|NCT01387607|453131992|FG000|Overall Study|Protocol Violation|1|||
125956139|NCT01387607|453131993|FG001|Overall Study|Protocol Violation|5|||
125956140|NCT01387607|453131992|FG000|Overall Study|Withdrawal by Subject|13|||
125956141|NCT01387607|453131993|FG001|Overall Study|Withdrawal by Subject|14|||
125956142|NCT01387607|453131992|FG000|Overall Study|Other|1|||
125956143|NCT01387607|453131993|FG001|Overall Study|Other|1|||
125956144|NCT01387607|453131992|FG000|Overall Study|Randomized, not treated|3|||
125956145|NCT01387607|453131993|FG001|Overall Study|Randomized, not treated|6|||
125956146|NCT03878134|453131994|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
125956147|NCT03851016|453131995|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125956148|NCT03851016|453131996|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
125956149|NCT00586469|453131998|FG000|Overall Study|Adverse Event|0|||
125956150|NCT00586469|453131999|FG001|Overall Study|Adverse Event|1|||
125956151|NCT02908529|453132000|FG000|Overall Study|Lost to Follow-up|0|||
125956152|NCT02908529|453132001|FG001|Overall Study|Lost to Follow-up|2|||
125956153|NCT03337724|453132004|FG000|Overall Study|Reason not Specified|12|||
125956154|NCT03337724|453132005|FG001|Overall Study|Reason not Specified|21|||
125956155|NCT03337724|453132006|FG002|Overall Study|Reason not Specified|9|||
125956156|NCT03337724|453132007|FG003|Overall Study|Reason not Specified|9|||
125956157|NCT03337724|453132008|FG004|Overall Study|Reason not Specified|29|||
125956158|NCT03337724|453132004|FG000|Overall Study|Withdrawal by Subject|13|||
125956159|NCT03337724|453132005|FG001|Overall Study|Withdrawal by Subject|15|||
125956160|NCT03337724|453132006|FG002|Overall Study|Withdrawal by Subject|4|||
125956161|NCT03337724|453132007|FG003|Overall Study|Withdrawal by Subject|15|||
125956162|NCT03337724|453132008|FG004|Overall Study|Withdrawal by Subject|6|||
125956163|NCT03337724|453132004|FG000|Overall Study|Protocol Deviation|0|||
125956164|NCT03337724|453132005|FG001|Overall Study|Protocol Deviation|1|||
125956165|NCT03337724|453132006|FG002|Overall Study|Protocol Deviation|1|||
125956166|NCT03337724|453132007|FG003|Overall Study|Protocol Deviation|1|||
125956167|NCT03337724|453132008|FG004|Overall Study|Protocol Deviation|0|||
125956168|NCT03337724|453132004|FG000|Overall Study|Adverse Event|1|||
125956169|NCT03337724|453132005|FG001|Overall Study|Adverse Event|1|||
125956170|NCT03337724|453132006|FG002|Overall Study|Adverse Event|0|||
125956171|NCT03337724|453132007|FG003|Overall Study|Adverse Event|1|||
125956172|NCT03337724|453132008|FG004|Overall Study|Adverse Event|0|||
125956173|NCT03337724|453132004|FG000|Overall Study|Death|40|||
125956174|NCT03337724|453132005|FG001|Overall Study|Death|89|||
125956175|NCT03337724|453132006|FG002|Overall Study|Death|43|||
125956176|NCT03337724|453132007|FG003|Overall Study|Death|76|||
125956177|NCT03337724|453132008|FG004|Overall Study|Death|50|||
125956178|NCT03337724|453132004|FG000|Overall Study|Lost to Follow-up|5|||
125956179|NCT03337724|453132005|FG001|Overall Study|Lost to Follow-up|5|||
125956180|NCT03337724|453132006|FG002|Overall Study|Lost to Follow-up|4|||
125956181|NCT03337724|453132007|FG003|Overall Study|Lost to Follow-up|7|||
125956182|NCT03337724|453132008|FG004|Overall Study|Lost to Follow-up|4|||
125956183|NCT03337724|453132004|FG000|Overall Study|Physician Decision|16|||
125956184|NCT03337724|453132005|FG001|Overall Study|Physician Decision|34|||
125956185|NCT03337724|453132006|FG002|Overall Study|Physician Decision|14|||
125956186|NCT03337724|453132007|FG003|Overall Study|Physician Decision|34|||
125956187|NCT03337724|453132008|FG004|Overall Study|Physician Decision|13|||
125956188|NCT03337724|453132004|FG000|Overall Study|Progressive Disease|0|||
125956189|NCT03337724|453132005|FG001|Overall Study|Progressive Disease|2|||
125956190|NCT03337724|453132006|FG002|Overall Study|Progressive Disease|1|||
125956191|NCT03337724|453132007|FG003|Overall Study|Progressive Disease|2|||
125956192|NCT03337724|453132008|FG004|Overall Study|Progressive Disease|0|||
125956193|NCT03337724|453132004|FG000|Overall Study|Symptomatic Deterioration|0|||
125956194|NCT03337724|453132005|FG001|Overall Study|Symptomatic Deterioration|0|||
125956195|NCT03337724|453132006|FG002|Overall Study|Symptomatic Deterioration|0|||
125956196|NCT03337724|453132007|FG003|Overall Study|Symptomatic Deterioration|1|||
125956197|NCT03337724|453132008|FG004|Overall Study|Symptomatic Deterioration|0|||
125956198|NCT01660412|453132011|FG000|Overall Study|Protocol Violation|0|||
125956199|NCT01660412|453132012|FG001|Overall Study|Protocol Violation|3|||
125956200|NCT03085927|453133639|FG000|Overall Study|Withdrawal by Subject|1|||
125956201|NCT03085927|453133640|FG001|Overall Study|Withdrawal by Subject|4|||
125956202|NCT03085927|453133639|FG000|Overall Study|Lost to Follow-up|3|||
125956203|NCT03085927|453133640|FG001|Overall Study|Lost to Follow-up|1|||
125956204|NCT03085927|453133639|FG000|Overall Study|Death|1|||
125956205|NCT03085927|453133640|FG001|Overall Study|Death|0|||
125956206|NCT03085927|453133639|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
125956207|NCT03085927|453133640|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
125956208|NCT03085927|453133639|FG000|Overall Study|Dyad Became Ineligible|0|||
125956209|NCT03085927|453133640|FG001|Overall Study|Dyad Became Ineligible|1|||
125956210|NCT02349711|453133642|FG000|Overall Study|Withdrawal by Subject|2|||
125956211|NCT02349711|453133643|FG001|Overall Study|Withdrawal by Subject|1|||
125956212|NCT02349711|453133642|FG000|Overall Study|Lost to Follow-up|1|||
125956213|NCT02349711|453133643|FG001|Overall Study|Lost to Follow-up|1|||
125956214|NCT00194012|453133644|FG000|Randomized Phase|Lack of Efficacy|8|||
125956215|NCT00194012|453133645|FG001|Randomized Phase|Lack of Efficacy|18|||
125956216|NCT00194012|453133644|FG000|Randomized Phase|Study nonadherence|2|||
125956217|NCT00194012|453133645|FG001|Randomized Phase|Study nonadherence|1|||
125956218|NCT00194012|453133644|FG000|Randomized Phase|Withdrawal by Subject|3|||
125956219|NCT00194012|453133645|FG001|Randomized Phase|Withdrawal by Subject|3|||
125956220|NCT00194012|453133644|FG000|Randomized Phase|Adverse Event|2|||
125956221|NCT00194012|453133645|FG001|Randomized Phase|Adverse Event|1|||
125956222|NCT00194012|453133644|FG000|Randomized Phase|Participant reported having a rash|1|||
125956223|NCT00194012|453133645|FG001|Randomized Phase|Participant reported having a rash|0|||
125956224|NCT00194012|453133644|FG000|Randomized Phase|Emesis and enuresis|0|||
125956225|NCT00194012|453133645|FG001|Randomized Phase|Emesis and enuresis|1|||
125956226|NCT00194012|453133644|FG000|Randomized Phase|Oral/nasal twitching|0|||
125956227|NCT00194012|453133645|FG001|Randomized Phase|Oral/nasal twitching|1|||
125956228|NCT00194012|453133644|FG000|Open Label Extension (OLE)|Weight Gain|1|||
125956229|NCT00194012|453133645|FG001|Open Label Extension (OLE)|Weight Gain|0|||
125956230|NCT00194012|453133644|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
125956231|NCT00194012|453133645|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
125956232|NCT00194012|453133644|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
125956233|NCT00194012|453133645|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
125956234|NCT00194012|453133644|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
125956235|NCT00194012|453133645|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
125956236|NCT02564198|453133651|FG000|Overall Study|Withdrawal by Subject|2|||
125956237|NCT02564198|453133652|FG001|Overall Study|Withdrawal by Subject|4|||
125956238|NCT02564198|453133653|FG002|Overall Study|Withdrawal by Subject|0|||
125956239|NCT02564198|453133651|FG000|Overall Study|Adverse Event|0|||
125956240|NCT02564198|453133652|FG001|Overall Study|Adverse Event|1|||
125956241|NCT02564198|453133653|FG002|Overall Study|Adverse Event|0|||
125956242|NCT02200042|453133654|FG000|Overall Study|Withdrawal by Subject|0|||
125956243|NCT02200042|453133655|FG001|Overall Study|Withdrawal by Subject|1|||
125956244|NCT01440322|453133660|FG000|Overall Study|Discomfort|2|||
125956245|NCT01440322|453133661|FG001|Overall Study|Discomfort|0|||
125956246|NCT01440322|453133660|FG000|Overall Study|Biomicroscopy|1|||
125956247|NCT01440322|453133661|FG001|Overall Study|Biomicroscopy|0|||
125956248|NCT01440322|453133660|FG000|Overall Study|Symptoms and Problems|1|||
125956249|NCT01440322|453133661|FG001|Overall Study|Symptoms and Problems|0|||
125956250|NCT01440322|453133660|FG000|Overall Study|Unacceptable Subjective Vision|1|||
125956251|NCT01440322|453133661|FG001|Overall Study|Unacceptable Subjective Vision|0|||
125956252|NCT01440322|453133660|FG000|Overall Study|Other Product Related|1|||
125956253|NCT01440322|453133661|FG001|Overall Study|Other Product Related|0|||
125956254|NCT01440322|453133660|FG000|Overall Study|Unrelated Medical Problem|0|||
125956255|NCT01440322|453133661|FG001|Overall Study|Unrelated Medical Problem|1|||
125956256|NCT01440322|453133660|FG000|Overall Study|Other Non-Product Related|1|||
125956257|NCT01440322|453133661|FG001|Overall Study|Other Non-Product Related|0|||
125956258|NCT05044234|453133663|FG000|Overall Study|Lost to Follow-up|2|||
125956259|NCT05044234|453133664|FG001|Overall Study|Lost to Follow-up|1|||
125956260|NCT05044234|453133665|FG002|Overall Study|Lost to Follow-up|1|||
125956261|NCT05044234|453133666|FG003|Overall Study|Lost to Follow-up|2|||
125956262|NCT05044234|453133663|FG000|Overall Study|Withdrawal by Subject|6|||
125956263|NCT05044234|453133664|FG001|Overall Study|Withdrawal by Subject|4|||
125956264|NCT05044234|453133665|FG002|Overall Study|Withdrawal by Subject|5|||
125956265|NCT05044234|453133666|FG003|Overall Study|Withdrawal by Subject|8|||
125956266|NCT05044234|453133663|FG000|Overall Study|Study terminated by Sponsor|21|||
125956267|NCT05044234|453133664|FG001|Overall Study|Study terminated by Sponsor|21|||
125956268|NCT05044234|453133665|FG002|Overall Study|Study terminated by Sponsor|20|||
125956269|NCT05044234|453133666|FG003|Overall Study|Study terminated by Sponsor|14|||
125956270|NCT05044234|453133663|FG000|Overall Study|Other, not specified|0|||
125956271|NCT05044234|453133664|FG001|Overall Study|Other, not specified|0|||
125956272|NCT05044234|453133665|FG002|Overall Study|Other, not specified|1|||
125956273|NCT05044234|453133666|FG003|Overall Study|Other, not specified|2|||
125956274|NCT05044234|453133663|FG000|Overall Study|Delayed data entry|0|||
125956275|NCT05044234|453133664|FG001|Overall Study|Delayed data entry|0|||
125956276|NCT05044234|453133665|FG002|Overall Study|Delayed data entry|0|||
125956277|NCT05044234|453133666|FG003|Overall Study|Delayed data entry|1|||
125956278|NCT02896127|453133667|FG000|COMPLETED WEEK 52|Adverse Event|9|||
125956279|NCT02896127|453133668|FG001|COMPLETED WEEK 52|Adverse Event|2|||
125956280|NCT02896127|453133667|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
125956281|NCT02896127|453133668|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
125956282|NCT02896127|453133667|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
125956283|NCT02896127|453133668|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
125956284|NCT02896127|453133667|FG000|COMPLETED WEEK 52|Physician Decision|1|||
125956285|NCT02896127|453133668|FG001|COMPLETED WEEK 52|Physician Decision|1|||
125956286|NCT02896127|453133667|FG000|COMPLETED WEEK 52|Pregnancy|2|||
125956287|NCT02896127|453133668|FG001|COMPLETED WEEK 52|Pregnancy|0|||
125956288|NCT02896127|453133667|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
125956289|NCT02896127|453133668|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
125956290|NCT02896127|453133667|FG000|COMPLETED WEEK 52|Technical problems|1|||
125956291|NCT02896127|453133668|FG001|COMPLETED WEEK 52|Technical problems|0|||
125956292|NCT02896127|453133667|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
125956293|NCT02896127|453133668|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
125956294|NCT02896127|453133667|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
125956295|NCT02896127|453133668|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
125956296|NCT02896127|453133667|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
125956297|NCT02896127|453133668|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
125956298|NCT02896127|453133667|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
125956299|NCT02896127|453133668|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
125956300|NCT02896127|453133667|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
125956301|NCT02896127|453133668|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
125956302|NCT03192150|453133669|FG000|Overall Study|Adverse Event|14|||
125956303|NCT03192150|453133670|FG001|Overall Study|Adverse Event|12|||
125956304|NCT03192150|453133669|FG000|Overall Study|Lack of Efficacy|23|||
125956305|NCT03192150|453133670|FG001|Overall Study|Lack of Efficacy|30|||
125956306|NCT03192150|453133669|FG000|Overall Study|Lost to Follow-up|1|||
125956307|NCT03192150|453133670|FG001|Overall Study|Lost to Follow-up|1|||
125956308|NCT03192150|453133669|FG000|Overall Study|Withdrawal by Subject|4|||
125956309|NCT03192150|453133670|FG001|Overall Study|Withdrawal by Subject|2|||
125956310|NCT03192150|453133669|FG000|Overall Study|Protocol Violation|5|||
125956311|NCT03192150|453133670|FG001|Overall Study|Protocol Violation|2|||
125956312|NCT03192150|453133669|FG000|Overall Study|Surgery Canceled|6|||
125956313|NCT03192150|453133670|FG001|Overall Study|Surgery Canceled|2|||
125956314|NCT03192150|453133669|FG000|Overall Study|Other-Various Administrative Reasons|2|||
125956315|NCT03192150|453133670|FG001|Overall Study|Other-Various Administrative Reasons|5|||
125956316|NCT02579616|453133671|FG000|Overall Study|Participants did not receive treatment|3|||
125956317|NCT00261716|453133677|FG000|Overall Study|Withdrawal by Subject|6|||
125956318|NCT00261716|453133678|FG001|Overall Study|Withdrawal by Subject|8|||
125956319|NCT00261716|453133677|FG000|Overall Study|Lost to Follow-up|0|||
125956320|NCT00261716|453133678|FG001|Overall Study|Lost to Follow-up|2|||
125956321|NCT02075437|453133679|FG000|Overall Study|Withdrawal by Subject|5|||
125956322|NCT02075437|453133679|FG000|Overall Study|Lost to Follow-up|1|||
125956323|NCT04439240|453133680|FG000|Overall Study|Ineligible|2|||
125956324|NCT04439240|453133680|FG000|Overall Study|Never started treatment|2|||
125956325|NCT04439240|453133680|FG000|Overall Study|Adverse Event|12|||
125956326|NCT04439240|453133680|FG000|Overall Study|Death|2|||
125956327|NCT04439240|453133680|FG000|Overall Study|Disease progression|25|||
125956328|NCT04439240|453133680|FG000|Overall Study|Other diseases|2|||
125956329|NCT04439240|453133680|FG000|Overall Study|Withdrawal by Subject|3|||
125956330|NCT04439240|453133680|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
125956331|NCT04439240|453133680|FG000|Overall Study|Symptomatic decline|1|||
125956332|NCT04439240|453133680|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
125956333|NCT04439240|453133680|FG000|Overall Study|Clinical progression|1|||
125956334|NCT00673452|453133681|FG000|Acute Double-Blind Phase|Adverse Event|41|||
125956335|NCT00673452|453133682|FG001|Acute Double-Blind Phase|Adverse Event|24|||
125956336|NCT00673452|453133681|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
125956337|NCT00673452|453133682|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
125956338|NCT00673452|453133681|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
125956339|NCT00673452|453133682|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
125956340|NCT00673452|453133681|FG000|Acute Double-Blind Phase|Physician Decision|0|||
125956341|NCT00673452|453133682|FG001|Acute Double-Blind Phase|Physician Decision|6|||
125956342|NCT00673452|453133681|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
125956343|NCT00673452|453133682|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
125956344|NCT00673452|453133681|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
125956345|NCT00673452|453133682|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
125956346|NCT00673452|453133681|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
125956347|NCT00673452|453133682|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
125956348|NCT00673452|453133681|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
125956349|NCT00673452|453133682|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
125956350|NCT00673452|453133681|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
125956351|NCT00673452|453133682|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
125956352|NCT00673452|453133681|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
125956353|NCT00673452|453133682|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
125956354|NCT00673452|453133681|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
125956355|NCT00673452|453133682|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
125956356|NCT00673452|453133681|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
125956357|NCT00673452|453133682|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
125956358|NCT00673452|453133681|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
125956359|NCT00673452|453133682|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
125956360|NCT00673452|453133681|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
125956361|NCT00673452|453133682|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
125956362|NCT00673452|453133681|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
125956363|NCT00673452|453133682|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
125956364|NCT00813124|453133683|FG000|Overall Study|Death|2|||
125956365|NCT00813124|453133683|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
125956366|NCT00813124|453133683|FG000|Overall Study|Withdrawal by Subject|1|||
125956367|NCT00767676|453133684|FG000|Overall Study|Investigator error|54|||
125956368|NCT02075320|453133685|FG000|Overall Study|Withdrawal by Subject|2|||
125956369|NCT01147653|453133687|FG000|Year 2|Withdrawal by Subject|2|||
125956370|NCT01147653|453133688|FG001|Year 2|Withdrawal by Subject|3|||
125956371|NCT00353366|453133689|FG000|Overall Study|Adverse Event|8|||
125956372|NCT00353366|453133689|FG000|Overall Study|Protocol Violation|12|||
125956373|NCT00353366|453133689|FG000|Overall Study|Withdrawal by Subject|12|||
125956374|NCT00353366|453133689|FG000|Overall Study|Lost to Follow-up|92|||
125956375|NCT00353366|453133689|FG000|Overall Study|Other|19|||
125956376|NCT00259857|453133690|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
125956377|NCT00259857|453133691|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
125956378|NCT00259857|453133690|FG000|24 Months Treatment|Lost to Follow-up|0|||
125956379|NCT00259857|453133691|FG001|24 Months Treatment|Lost to Follow-up|3|||
125956380|NCT01813019|453133694|FG000|Overall Study|Adverse Event|0|||
125956381|NCT01813019|453133695|FG001|Overall Study|Adverse Event|3|||
125956382|NCT01813019|453133694|FG000|Overall Study|Withdrawal by Subject|3|||
125956383|NCT01813019|453133695|FG001|Overall Study|Withdrawal by Subject|2|||
125956384|NCT01813019|453133694|FG000|Overall Study|administrative problems|2|||
125956385|NCT01813019|453133695|FG001|Overall Study|administrative problems|0|||
125956386|NCT01813019|453133694|FG000|Overall Study|Protocol Deviation|2|||
125956387|NCT01813019|453133695|FG001|Overall Study|Protocol Deviation|1|||
125956388|NCT02214121|453133707|FG000|Part A|Patient decision|2|||
125956389|NCT02214121|453133708|FG001|Part A|Patient decision|0|||
125956390|NCT02214121|453133709|FG002|Part A|Patient decision|0|||
125956391|NCT02214121|453133707|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
125956392|NCT02214121|453133708|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
125956393|NCT02214121|453133709|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
125956394|NCT02214121|453133707|FG000|Part A|Other|1|||
125956395|NCT02214121|453133708|FG001|Part A|Other|0|||
125956396|NCT02214121|453133709|FG002|Part A|Other|0|||
125956397|NCT02214121|453133707|FG000|Part B|Patient decision|0|||
125956398|NCT02214121|453133708|FG001|Part B|Patient decision|1|||
125956399|NCT02214121|453133709|FG002|Part B|Patient decision|0|||
125956400|NCT02214121|453133707|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
125956401|NCT02214121|453133708|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
125956402|NCT02214121|453133709|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
125956403|NCT02214121|453133707|FG000|Part B|Lost to Follow-up|0|||
125956404|NCT02214121|453133708|FG001|Part B|Lost to Follow-up|0|||
125956405|NCT02214121|453133709|FG002|Part B|Lost to Follow-up|1|||
125956406|NCT00715793|453133710|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
125956407|NCT00715793|453133711|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
125956408|NCT00715793|453133710|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
125956409|NCT00715793|453133711|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
125956410|NCT01849588|453133712|FG000|Overall Study|Lack of Efficacy|3|||
125956411|NCT00094653|453133713|FG000|Overall Study|Death|306|||
125956412|NCT00094653|453133714|FG001|Overall Study|Death|100|||
125956413|NCT00094653|453133715|FG002|Overall Study|Death|119|||
125956414|NCT00094653|453133713|FG000|Overall Study|Subject Withdrew Consent|10|||
125956415|NCT00094653|453133714|FG001|Overall Study|Subject Withdrew Consent|2|||
125956416|NCT00094653|453133715|FG002|Overall Study|Subject Withdrew Consent|3|||
125956417|NCT00094653|453133713|FG000|Overall Study|Other|2|||
125956418|NCT00094653|453133714|FG001|Overall Study|Other|2|||
125956419|NCT00094653|453133715|FG002|Overall Study|Other|2|||
125956420|NCT00094653|453133713|FG000|Overall Study|Lost to Follow-up|3|||
125956421|NCT00094653|453133714|FG001|Overall Study|Lost to Follow-up|2|||
125956422|NCT00094653|453133715|FG002|Overall Study|Lost to Follow-up|1|||
125956423|NCT00094653|453133713|FG000|Overall Study|Protocol Violation|0|||
125956424|NCT00094653|453133714|FG001|Overall Study|Protocol Violation|0|||
125956425|NCT00094653|453133715|FG002|Overall Study|Protocol Violation|1|||
125956426|NCT03921411|453133716|FG000|Overall Study|Withdrawal by Subject|1|||
125956427|NCT03921411|453133716|FG000|Overall Study|Protocol Deviation|2|||
125956428|NCT03921411|453133716|FG000|Overall Study|Enrolled, but never treated|2|||
125956429|NCT03120013|453133719|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125956430|NCT03120013|453133720|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125956431|NCT01541826|453133722|FG000|Overall Study|Lost to Follow-up|2|||
125956432|NCT01541826|453133723|FG001|Overall Study|Lost to Follow-up|3|||
125956433|NCT01541826|453133724|FG002|Overall Study|Lost to Follow-up|0|||
125956434|NCT01541826|453133722|FG000|Overall Study|Withdrawal by Subject|2|||
125956435|NCT01541826|453133723|FG001|Overall Study|Withdrawal by Subject|0|||
125956436|NCT01541826|453133724|FG002|Overall Study|Withdrawal by Subject|0|||
125956437|NCT01339390|453133729|FG000|Overall Study|Death|32|||
125956438|NCT01339390|453133730|FG001|Overall Study|Death|29|||
125956439|NCT01339390|453133729|FG000|Overall Study|Lost to Follow-up|125|||
125956440|NCT01339390|453133730|FG001|Overall Study|Lost to Follow-up|127|||
125956441|NCT04847674|453133731|FG000|Overall Study|Withdrawal by Subject|0|||
125956442|NCT04847674|453133732|FG001|Overall Study|Withdrawal by Subject|1|||
125956443|NCT04847674|453133733|FG002|Overall Study|Withdrawal by Subject|0|||
125956444|NCT04847674|453133731|FG000|Overall Study|Lost to Follow-up|0|||
125956445|NCT04847674|453133732|FG001|Overall Study|Lost to Follow-up|0|||
125956446|NCT04847674|453133733|FG002|Overall Study|Lost to Follow-up|2|||
125956447|NCT04847674|453133731|FG000|Overall Study|Other than specified|21|||
125956448|NCT04847674|453133732|FG001|Overall Study|Other than specified|20|||
125956449|NCT04847674|453133733|FG002|Overall Study|Other than specified|20|||
125956450|NCT02563028|453133735|FG000|Overall Study|Lack of equipment|1|||
125956451|NCT02563028|453133735|FG000|Overall Study|Unable to elicit VEP post induction|1|||
125956452|NCT02702401|453133736|FG000|Overall Study|Death|242|||
125956453|NCT02702401|453133737|FG001|Overall Study|Death|125|||
125956454|NCT02702401|453133736|FG000|Overall Study|Withdrawal by Subject|15|||
125956455|NCT02702401|453133737|FG001|Overall Study|Withdrawal by Subject|5|||
125956456|NCT02702401|453133736|FG000|Overall Study|Sponsor Decision|19|||
125956457|NCT02702401|453133737|FG001|Overall Study|Sponsor Decision|3|||
125956458|NCT02702401|453133736|FG000|Overall Study|Physician Decision|1|||
125956459|NCT02702401|453133737|FG001|Overall Study|Physician Decision|2|||
125956460|NCT02702401|453133736|FG000|Overall Study|Lost to Follow-up|1|||
125956461|NCT02702401|453133737|FG001|Overall Study|Lost to Follow-up|0|||
125956462|NCT04292730|453133748|FG000|Overall Study|Lost to Follow-up|8|||
125956463|NCT04292730|453133749|FG001|Overall Study|Lost to Follow-up|12|||
125956464|NCT04292730|453133750|FG002|Overall Study|Lost to Follow-up|12|||
125956465|NCT04292730|453133751|FG003|Overall Study|Lost to Follow-up|48|||
125956466|NCT04292730|453133748|FG000|Overall Study|Death|2|||
125956467|NCT04292730|453133749|FG001|Overall Study|Death|2|||
125956468|NCT04292730|453133750|FG002|Overall Study|Death|4|||
125956469|NCT04292730|453133751|FG003|Overall Study|Death|12|||
125956470|NCT04292730|453133748|FG000|Overall Study|Withdrew Consent|2|||
125956471|NCT04292730|453133749|FG001|Overall Study|Withdrew Consent|2|||
125956472|NCT04292730|453133750|FG002|Overall Study|Withdrew Consent|5|||
125956473|NCT04292730|453133751|FG003|Overall Study|Withdrew Consent|6|||
125956474|NCT04292730|453133748|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125956475|NCT04292730|453133749|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125956476|NCT04292730|453133750|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125956477|NCT04292730|453133751|FG003|Overall Study|Non-Compliance with Study Drug|0|||
125956478|NCT04292730|453133748|FG000|Overall Study|Protocol Violation|0|||
125956479|NCT04292730|453133749|FG001|Overall Study|Protocol Violation|0|||
125956480|NCT04292730|453133750|FG002|Overall Study|Protocol Violation|1|||
125956481|NCT04292730|453133751|FG003|Overall Study|Protocol Violation|0|||
125956482|NCT04292730|453133748|FG000|Overall Study|Randomized but not Treated|8|||
125956483|NCT04292730|453133749|FG001|Overall Study|Randomized but not Treated|4|||
125956484|NCT04292730|453133750|FG002|Overall Study|Randomized but not Treated|0|||
125956485|NCT04292730|453133751|FG003|Overall Study|Randomized but not Treated|14|||
125956486|NCT01527292|453133753|FG000|Overall Study|Physician Decision|0|||
125956487|NCT01527292|453133754|FG001|Overall Study|Physician Decision|3|||
125956488|NCT01482767|453133755|FG000|Overall Study|Death|1|||
125956489|NCT01482767|453133756|FG001|Overall Study|Death|1|||
125956490|NCT01482767|453133755|FG000|Overall Study|Withdrawal by Subject|7|||
125956491|NCT01482767|453133756|FG001|Overall Study|Withdrawal by Subject|5|||
125956492|NCT01482767|453133755|FG000|Overall Study|Lost to Follow-up|12|||
125956493|NCT01482767|453133756|FG001|Overall Study|Lost to Follow-up|6|||
125956494|NCT01482767|453133755|FG000|Overall Study|Adverse Event|0|||
125956495|NCT01482767|453133756|FG001|Overall Study|Adverse Event|3|||
125956496|NCT01482767|453133755|FG000|Overall Study|Site closure|22|||
125956497|NCT01482767|453133756|FG001|Overall Study|Site closure|14|||
125956498|NCT01482767|453133755|FG000|Overall Study|Non-adherence to study requirements|4|||
125956499|NCT01482767|453133756|FG001|Overall Study|Non-adherence to study requirements|7|||
125956500|NCT01482767|453133755|FG000|Overall Study|Alternate HCV treatment|7|||
125956501|NCT01482767|453133756|FG001|Overall Study|Alternate HCV treatment|8|||
125956502|NCT01482767|453133755|FG000|Overall Study|Ineligible|0|||
125956503|NCT01482767|453133756|FG001|Overall Study|Ineligible|5|||
125956504|NCT01482767|453133755|FG000|Overall Study|Nurse error|1|||
125956505|NCT01482767|453133756|FG001|Overall Study|Nurse error|0|||
125956506|NCT01856543|453133757|FG000|Overall Study|Treatment discontinued|6|||
126087162|NCT05000216|453612959|FG009|Stage 1|Lost to Follow-up|2|||
126087163|NCT05000216|453612960|FG010|Stage 1|Lost to Follow-up|3|||
126087164|NCT05000216|453612961|FG011|Stage 1|Lost to Follow-up|0|||
126087165|NCT05000216|453612962|FG012|Stage 1|Lost to Follow-up|0|||
126087166|NCT05000216|453612963|FG013|Stage 1|Lost to Follow-up|0|||
126087167|NCT05000216|453612964|FG014|Stage 1|Lost to Follow-up|0|||
126087168|NCT05000216|453612965|FG015|Stage 1|Lost to Follow-up|0|||
126087169|NCT05000216|453612966|FG016|Stage 1|Lost to Follow-up|0|||
126087170|NCT05000216|453612967|FG017|Stage 1|Lost to Follow-up|0|||
126087171|NCT05000216|453612968|FG018|Stage 1|Lost to Follow-up|0|||
126087172|NCT05000216|453612969|FG019|Stage 1|Lost to Follow-up|0|||
126087173|NCT05000216|453612970|FG020|Stage 1|Lost to Follow-up|0|||
126087174|NCT05000216|453612971|FG021|Stage 1|Lost to Follow-up|0|||
126087175|NCT05000216|453612950|FG000|Stage 1|Physician Decision|0|||
126087176|NCT05000216|453612951|FG001|Stage 1|Physician Decision|0|||
126087177|NCT05000216|453612952|FG002|Stage 1|Physician Decision|0|||
126087178|NCT05000216|453612953|FG003|Stage 1|Physician Decision|0|||
126087179|NCT05000216|453612954|FG004|Stage 1|Physician Decision|0|||
126116405|NCT01383096|453721943|FG000|Third Intervention (8 Days)|Adverse Event|1|||
125956507|NCT01856543|453133758|FG001|Overall Study|Treatment discontinued|3|||
125956508|NCT01856543|453133757|FG000|Overall Study|Withdrawn before start|7|||
125956509|NCT01856543|453133758|FG001|Overall Study|Withdrawn before start|3|||
125956510|NCT00806546|453133759|FG000|Overall Study|Enrolled, not treated|35|||
126087180|NCT05000216|453612955|FG005|Stage 1|Physician Decision|0|||
125956511|NCT00806546|453133759|FG000|Overall Study|Lost to Follow-up|32|||
125956512|NCT00806546|453133759|FG000|Overall Study|Adverse Event|74|||
125956513|NCT00806546|453133759|FG000|Overall Study|Withdrawal by Subject|75|||
125956514|NCT00806546|453133759|FG000|Overall Study|Protocol Violation|49|||
126087181|NCT05000216|453612956|FG006|Stage 1|Physician Decision|0|||
126087182|NCT05000216|453612957|FG007|Stage 1|Physician Decision|1|||
126087183|NCT05000216|453612958|FG008|Stage 1|Physician Decision|1|||
125956515|NCT00806546|453133759|FG000|Overall Study|Various|42|||
125956516|NCT00096044|453133762|FG000|Overall Study|Withdrawal by Subject|9|||
125956517|NCT00096044|453133762|FG000|Overall Study|Adverse Event|21|||
125956518|NCT00096044|453133762|FG000|Overall Study|Disease Progression|4|||
125956519|NCT00004031|453133763|FG000|Overall Study|Adverse Event|5|||
125956520|NCT00004031|453133764|FG001|Overall Study|Adverse Event|0|||
125956521|NCT00004031|453133763|FG000|Overall Study|Refusal unrelated to adverse events|2|||
125956522|NCT00004031|453133764|FG001|Overall Study|Refusal unrelated to adverse events|11|||
125956523|NCT00004031|453133763|FG000|Overall Study|Progression/relapse|9|||
125956524|NCT00004031|453133764|FG001|Overall Study|Progression/relapse|4|||
125956525|NCT00004031|453133763|FG000|Overall Study|Death|3|||
125956526|NCT00004031|453133764|FG001|Overall Study|Death|1|||
125956527|NCT00004031|453133763|FG000|Overall Study|Other- not protocol specified|3|||
125956528|NCT00004031|453133764|FG001|Overall Study|Other- not protocol specified|3|||
125956529|NCT00004031|453133763|FG000|Overall Study|Reason under review|3|||
125956530|NCT00004031|453133764|FG001|Overall Study|Reason under review|2|||
125956531|NCT02920983|453133765|FG000|Dispense 1|Unacceptable Lens Fit|0|||
125956532|NCT02920983|453133766|FG001|Dispense 1|Unacceptable Lens Fit|0|||
125956533|NCT02920983|453133767|FG002|Dispense 1|Unacceptable Lens Fit|0|||
125956534|NCT02920983|453133768|FG003|Dispense 1|Unacceptable Lens Fit|0|||
125956535|NCT02920983|453133769|FG004|Dispense 1|Unacceptable Lens Fit|1|||
125956536|NCT02920983|453133770|FG005|Dispense 1|Unacceptable Lens Fit|0|||
125956537|NCT02920983|453133765|FG000|Dispense 2|Unscceptable lens fit|1|||
125956538|NCT02920983|453133766|FG001|Dispense 2|Unscceptable lens fit|0|||
125956539|NCT02920983|453133767|FG002|Dispense 2|Unscceptable lens fit|0|||
125956540|NCT02920983|453133768|FG003|Dispense 2|Unscceptable lens fit|0|||
125956541|NCT02920983|453133769|FG004|Dispense 2|Unscceptable lens fit|1|||
125956542|NCT02920983|453133770|FG005|Dispense 2|Unscceptable lens fit|0|||
125956543|NCT02920983|453133765|FG000|Dispense 3|Unacceptable Lens Fit|1|||
125956544|NCT02920983|453133766|FG001|Dispense 3|Unacceptable Lens Fit|1|||
125956545|NCT02920983|453133767|FG002|Dispense 3|Unacceptable Lens Fit|0|||
125956546|NCT02920983|453133768|FG003|Dispense 3|Unacceptable Lens Fit|0|||
125956547|NCT02920983|453133769|FG004|Dispense 3|Unacceptable Lens Fit|1|||
125956548|NCT02920983|453133770|FG005|Dispense 3|Unacceptable Lens Fit|0|||
125956549|NCT02553421|453133775|FG000|Overall Study|Lost to Follow-up|21|||
125956550|NCT02553421|453133776|FG001|Overall Study|Lost to Follow-up|1|||
125956551|NCT02553421|453133775|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
125956552|NCT02553421|453133776|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
125956553|NCT02553421|453133775|FG000|Overall Study|Improper Device Placement|3|||
125956554|NCT02553421|453133776|FG001|Overall Study|Improper Device Placement|0|||
125956555|NCT03551210|453133778|FG000|Overall Study|Adverse Event|5|||
125956556|NCT03551210|453133779|FG001|Overall Study|Adverse Event|6|||
125956557|NCT03551210|453133778|FG000|Overall Study|Withdrawal by Subject|1|||
125956558|NCT03551210|453133779|FG001|Overall Study|Withdrawal by Subject|7|||
125956559|NCT03551210|453133778|FG000|Overall Study|Needed in other antibiotic treatment|2|||
125956560|NCT03551210|453133779|FG001|Overall Study|Needed in other antibiotic treatment|5|||
125956561|NCT03551210|453133778|FG000|Overall Study|Lost to Follow-up|1|||
125956562|NCT03551210|453133779|FG001|Overall Study|Lost to Follow-up|1|||
125956563|NCT03551210|453133778|FG000|Overall Study|Absence of visit 4 and 5|1|||
125956564|NCT03551210|453133779|FG001|Overall Study|Absence of visit 4 and 5|0|||
125956565|NCT03551210|453133778|FG000|Overall Study|No drug for dispensing|0|||
125956566|NCT03551210|453133779|FG001|Overall Study|No drug for dispensing|1|||
125956567|NCT03013491|453133780|FG000|Main Study|Death|2|||
125956568|NCT03013491|453133781|FG001|Main Study|Death|2|||
125956569|NCT03013491|453133782|FG002|Main Study|Death|5|||
125956570|NCT03013491|453133783|FG003|Main Study|Death|3|||
125956571|NCT03013491|453133784|FG004|Main Study|Death|9|||
125956572|NCT03013491|453133785|FG005|Main Study|Death|12|||
125956573|NCT03013491|453133786|FG006|Main Study|Death|3|||
125956574|NCT03013491|453133787|FG007|Main Study|Death|5|||
125956575|NCT03013491|453133788|FG008|Main Study|Death|1|||
125956576|NCT03013491|453133789|FG009|Main Study|Death|2|||
125956577|NCT03013491|453133790|FG010|Main Study|Death|4|||
125956578|NCT03013491|453133791|FG011|Main Study|Death|1|||
125956579|NCT03013491|453133792|FG012|Main Study|Death|1|||
125956580|NCT03013491|453133793|FG013|Main Study|Death|4|||
125956581|NCT03013491|453133794|FG014|Main Study|Death|0|||
125956582|NCT03013491|453133795|FG015|Main Study|Death|3|||
125956583|NCT03013491|453133796|FG016|Main Study|Death|5|||
125956584|NCT03013491|453133797|FG017|Main Study|Death|1|||
125956585|NCT03013491|453133798|FG018|Main Study|Death|47|||
125956586|NCT03013491|453133780|FG000|Main Study|Lost to Follow-up|0|||
125956587|NCT03013491|453133781|FG001|Main Study|Lost to Follow-up|0|||
125956588|NCT03013491|453133782|FG002|Main Study|Lost to Follow-up|1|||
125956589|NCT03013491|453133783|FG003|Main Study|Lost to Follow-up|0|||
125956590|NCT03013491|453133784|FG004|Main Study|Lost to Follow-up|1|||
125956591|NCT03013491|453133785|FG005|Main Study|Lost to Follow-up|0|||
125956592|NCT03013491|453133786|FG006|Main Study|Lost to Follow-up|0|||
125956593|NCT03013491|453133787|FG007|Main Study|Lost to Follow-up|0|||
125956594|NCT03013491|453133788|FG008|Main Study|Lost to Follow-up|0|||
125956595|NCT03013491|453133789|FG009|Main Study|Lost to Follow-up|0|||
125956596|NCT03013491|453133790|FG010|Main Study|Lost to Follow-up|0|||
125956597|NCT03013491|453133791|FG011|Main Study|Lost to Follow-up|0|||
125956598|NCT03013491|453133792|FG012|Main Study|Lost to Follow-up|0|||
125956599|NCT03013491|453133793|FG013|Main Study|Lost to Follow-up|0|||
125956600|NCT03013491|453133794|FG014|Main Study|Lost to Follow-up|0|||
125956601|NCT03013491|453133795|FG015|Main Study|Lost to Follow-up|0|||
125956602|NCT03013491|453133796|FG016|Main Study|Lost to Follow-up|0|||
125956603|NCT03013491|453133797|FG017|Main Study|Lost to Follow-up|0|||
125956604|NCT03013491|453133798|FG018|Main Study|Lost to Follow-up|3|||
125956605|NCT03013491|453133780|FG000|Main Study|Termination of the study by Sponsor|0|||
125956606|NCT03013491|453133781|FG001|Main Study|Termination of the study by Sponsor|0|||
125956607|NCT03013491|453133782|FG002|Main Study|Termination of the study by Sponsor|2|||
125956608|NCT03013491|453133783|FG003|Main Study|Termination of the study by Sponsor|0|||
125956609|NCT03013491|453133784|FG004|Main Study|Termination of the study by Sponsor|1|||
125956610|NCT03013491|453133785|FG005|Main Study|Termination of the study by Sponsor|2|||
125956611|NCT03013491|453133786|FG006|Main Study|Termination of the study by Sponsor|0|||
125956612|NCT03013491|453133787|FG007|Main Study|Termination of the study by Sponsor|0|||
125956613|NCT03013491|453133788|FG008|Main Study|Termination of the study by Sponsor|1|||
125956614|NCT03013491|453133789|FG009|Main Study|Termination of the study by Sponsor|1|||
125956615|NCT03013491|453133790|FG010|Main Study|Termination of the study by Sponsor|1|||
125956616|NCT03013491|453133791|FG011|Main Study|Termination of the study by Sponsor|2|||
125956617|NCT03013491|453133792|FG012|Main Study|Termination of the study by Sponsor|0|||
125956618|NCT03013491|453133793|FG013|Main Study|Termination of the study by Sponsor|0|||
125956619|NCT03013491|453133794|FG014|Main Study|Termination of the study by Sponsor|0|||
125956620|NCT03013491|453133795|FG015|Main Study|Termination of the study by Sponsor|0|||
125956621|NCT03013491|453133796|FG016|Main Study|Termination of the study by Sponsor|0|||
125956622|NCT03013491|453133797|FG017|Main Study|Termination of the study by Sponsor|1|||
125956623|NCT03013491|453133798|FG018|Main Study|Termination of the study by Sponsor|13|||
125956624|NCT03013491|453133780|FG000|Main Study|Withdrawal by Subject|0|||
125956625|NCT03013491|453133781|FG001|Main Study|Withdrawal by Subject|0|||
125956626|NCT03013491|453133782|FG002|Main Study|Withdrawal by Subject|0|||
125956627|NCT03013491|453133783|FG003|Main Study|Withdrawal by Subject|4|||
125956628|NCT03013491|453133784|FG004|Main Study|Withdrawal by Subject|2|||
125956629|NCT03013491|453133785|FG005|Main Study|Withdrawal by Subject|1|||
125956630|NCT03013491|453133786|FG006|Main Study|Withdrawal by Subject|0|||
125956631|NCT03013491|453133787|FG007|Main Study|Withdrawal by Subject|0|||
125956632|NCT03013491|453133788|FG008|Main Study|Withdrawal by Subject|0|||
125956633|NCT03013491|453133789|FG009|Main Study|Withdrawal by Subject|0|||
125956634|NCT03013491|453133790|FG010|Main Study|Withdrawal by Subject|1|||
125956635|NCT03013491|453133791|FG011|Main Study|Withdrawal by Subject|2|||
125956636|NCT03013491|453133792|FG012|Main Study|Withdrawal by Subject|0|||
125956637|NCT03013491|453133793|FG013|Main Study|Withdrawal by Subject|2|||
125956638|NCT03013491|453133794|FG014|Main Study|Withdrawal by Subject|0|||
125956639|NCT03013491|453133795|FG015|Main Study|Withdrawal by Subject|0|||
125956640|NCT03013491|453133796|FG016|Main Study|Withdrawal by Subject|0|||
125956641|NCT03013491|453133797|FG017|Main Study|Withdrawal by Subject|0|||
125956642|NCT03013491|453133798|FG018|Main Study|Withdrawal by Subject|18|||
125956643|NCT03013491|453133780|FG000|Main Study|Disease progression|0|||
125956644|NCT03013491|453133781|FG001|Main Study|Disease progression|0|||
125956645|NCT03013491|453133782|FG002|Main Study|Disease progression|0|||
125956646|NCT03013491|453133783|FG003|Main Study|Disease progression|1|||
125956647|NCT03013491|453133784|FG004|Main Study|Disease progression|0|||
125956648|NCT03013491|453133785|FG005|Main Study|Disease progression|0|||
125956649|NCT03013491|453133786|FG006|Main Study|Disease progression|0|||
125956650|NCT03013491|453133787|FG007|Main Study|Disease progression|0|||
125956651|NCT03013491|453133788|FG008|Main Study|Disease progression|1|||
125956652|NCT03013491|453133789|FG009|Main Study|Disease progression|0|||
125956653|NCT03013491|453133790|FG010|Main Study|Disease progression|1|||
125956654|NCT03013491|453133791|FG011|Main Study|Disease progression|0|||
125956655|NCT03013491|453133792|FG012|Main Study|Disease progression|0|||
125956656|NCT03013491|453133793|FG013|Main Study|Disease progression|0|||
125956657|NCT03013491|453133794|FG014|Main Study|Disease progression|0|||
125956658|NCT03013491|453133795|FG015|Main Study|Disease progression|0|||
125956659|NCT03013491|453133796|FG016|Main Study|Disease progression|0|||
125956660|NCT03013491|453133797|FG017|Main Study|Disease progression|0|||
125956661|NCT03013491|453133798|FG018|Main Study|Disease progression|4|||
125956662|NCT03013491|453133780|FG000|Main Study|Symptomatic deterioration|0|||
125956663|NCT03013491|453133781|FG001|Main Study|Symptomatic deterioration|0|||
125956664|NCT03013491|453133782|FG002|Main Study|Symptomatic deterioration|0|||
126116406|NCT01383096|453721944|FG001|Third Intervention (8 Days)|Adverse Event|0|||
125956665|NCT03013491|453133783|FG003|Main Study|Symptomatic deterioration|0|||
125956666|NCT03013491|453133784|FG004|Main Study|Symptomatic deterioration|0|||
126116407|NCT01383096|453721945|FG002|Third Intervention (8 Days)|Adverse Event|0|||
125956667|NCT03013491|453133785|FG005|Main Study|Symptomatic deterioration|1|||
125956668|NCT03013491|453133786|FG006|Main Study|Symptomatic deterioration|0|||
126116408|NCT01383096|453721943|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
125956669|NCT03013491|453133787|FG007|Main Study|Symptomatic deterioration|0|||
125956670|NCT03013491|453133788|FG008|Main Study|Symptomatic deterioration|0|||
125956671|NCT03013491|453133789|FG009|Main Study|Symptomatic deterioration|0|||
125956672|NCT03013491|453133790|FG010|Main Study|Symptomatic deterioration|0|||
125956673|NCT03013491|453133791|FG011|Main Study|Symptomatic deterioration|0|||
125956674|NCT03013491|453133792|FG012|Main Study|Symptomatic deterioration|0|||
125956675|NCT03013491|453133793|FG013|Main Study|Symptomatic deterioration|0|||
125956676|NCT03013491|453133794|FG014|Main Study|Symptomatic deterioration|0|||
125956677|NCT03013491|453133795|FG015|Main Study|Symptomatic deterioration|0|||
125956678|NCT03013491|453133796|FG016|Main Study|Symptomatic deterioration|0|||
125956679|NCT03013491|453133797|FG017|Main Study|Symptomatic deterioration|0|||
125956680|NCT03013491|453133798|FG018|Main Study|Symptomatic deterioration|0|||
125956681|NCT03013491|453133780|FG000|Main Study|Protocol version 8.0 approval|0|||
125956682|NCT03013491|453133781|FG001|Main Study|Protocol version 8.0 approval|0|||
125956683|NCT03013491|453133782|FG002|Main Study|Protocol version 8.0 approval|0|||
125956684|NCT03013491|453133783|FG003|Main Study|Protocol version 8.0 approval|0|||
125956685|NCT03013491|453133784|FG004|Main Study|Protocol version 8.0 approval|0|||
125956686|NCT03013491|453133785|FG005|Main Study|Protocol version 8.0 approval|0|||
125956687|NCT03013491|453133786|FG006|Main Study|Protocol version 8.0 approval|0|||
125956688|NCT03013491|453133787|FG007|Main Study|Protocol version 8.0 approval|0|||
125956689|NCT03013491|453133788|FG008|Main Study|Protocol version 8.0 approval|0|||
125956690|NCT03013491|453133789|FG009|Main Study|Protocol version 8.0 approval|0|||
125956691|NCT03013491|453133790|FG010|Main Study|Protocol version 8.0 approval|1|||
125956692|NCT03013491|453133791|FG011|Main Study|Protocol version 8.0 approval|0|||
125956693|NCT03013491|453133792|FG012|Main Study|Protocol version 8.0 approval|0|||
125956694|NCT03013491|453133793|FG013|Main Study|Protocol version 8.0 approval|0|||
125956695|NCT03013491|453133794|FG014|Main Study|Protocol version 8.0 approval|0|||
125956696|NCT03013491|453133795|FG015|Main Study|Protocol version 8.0 approval|0|||
125956697|NCT03013491|453133796|FG016|Main Study|Protocol version 8.0 approval|0|||
125956698|NCT03013491|453133797|FG017|Main Study|Protocol version 8.0 approval|0|||
125956699|NCT03013491|453133798|FG018|Main Study|Protocol version 8.0 approval|0|||
125956700|NCT03013491|453133780|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
125956701|NCT03013491|453133781|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
125956702|NCT03013491|453133782|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
125956703|NCT03013491|453133783|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
125956704|NCT03013491|453133784|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
125956705|NCT03013491|453133785|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
125956706|NCT03013491|453133786|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
125956707|NCT03013491|453133787|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
125956708|NCT03013491|453133788|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
125956709|NCT03013491|453133789|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
125956710|NCT03013491|453133790|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
125956711|NCT03013491|453133791|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
125956712|NCT03013491|453133792|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
125956713|NCT03013491|453133793|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
125956714|NCT03013491|453133794|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
125956715|NCT03013491|453133795|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
125956716|NCT03013491|453133796|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
125956717|NCT03013491|453133797|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
126116409|NCT01383096|453721944|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
126116410|NCT01383096|453721945|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
126116411|NCT01383096|453721943|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
126116412|NCT01383096|453721944|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
126116413|NCT01383096|453721945|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
126116414|NCT01383096|453721943|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
126116415|NCT01383096|453721944|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
126116416|NCT01383096|453721945|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
126116417|NCT01383096|453721943|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
126116418|NCT01383096|453721944|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
126116419|NCT01383096|453721945|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
126116420|NCT01383096|453721943|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
126116421|NCT01383096|453721944|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
126116422|NCT01383096|453721945|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
126116423|NCT01383096|453721943|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
126116424|NCT01383096|453721944|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
126116425|NCT01383096|453721945|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
126116426|NCT01211535|453721946|FG000|Overall Study|Adverse Event|0|||
126116427|NCT01211535|453721947|FG001|Overall Study|Adverse Event|1|||
126116428|NCT01380730|453721948|FG000|Overall Study|Death|0|||
126116429|NCT01380730|453721949|FG001|Overall Study|Death|0|||
125956718|NCT03013491|453133798|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
125956719|NCT03013491|453133780|FG000|Main Study|Start of new anticancer therapy|0|||
125956720|NCT03013491|453133781|FG001|Main Study|Start of new anticancer therapy|0|||
125956721|NCT03013491|453133782|FG002|Main Study|Start of new anticancer therapy|0|||
125956722|NCT03013491|453133783|FG003|Main Study|Start of new anticancer therapy|0|||
125956723|NCT03013491|453133784|FG004|Main Study|Start of new anticancer therapy|0|||
125956724|NCT03013491|453133785|FG005|Main Study|Start of new anticancer therapy|0|||
125956725|NCT03013491|453133786|FG006|Main Study|Start of new anticancer therapy|0|||
125956726|NCT03013491|453133787|FG007|Main Study|Start of new anticancer therapy|0|||
125956727|NCT03013491|453133788|FG008|Main Study|Start of new anticancer therapy|0|||
125956728|NCT03013491|453133789|FG009|Main Study|Start of new anticancer therapy|0|||
125956729|NCT03013491|453133790|FG010|Main Study|Start of new anticancer therapy|0|||
125956730|NCT03013491|453133791|FG011|Main Study|Start of new anticancer therapy|0|||
125956731|NCT03013491|453133792|FG012|Main Study|Start of new anticancer therapy|0|||
125956732|NCT03013491|453133793|FG013|Main Study|Start of new anticancer therapy|0|||
125956733|NCT03013491|453133794|FG014|Main Study|Start of new anticancer therapy|0|||
125956734|NCT03013491|453133795|FG015|Main Study|Start of new anticancer therapy|0|||
125956735|NCT03013491|453133796|FG016|Main Study|Start of new anticancer therapy|0|||
125956736|NCT03013491|453133797|FG017|Main Study|Start of new anticancer therapy|0|||
125956737|NCT03013491|453133798|FG018|Main Study|Start of new anticancer therapy|2|||
125956738|NCT03013491|453133780|FG000|Long-term Extension|Disease progression|0|||
125956739|NCT03013491|453133781|FG001|Long-term Extension|Disease progression|0|||
125956740|NCT03013491|453133782|FG002|Long-term Extension|Disease progression|0|||
125956741|NCT03013491|453133783|FG003|Long-term Extension|Disease progression|1|||
125956742|NCT03013491|453133784|FG004|Long-term Extension|Disease progression|0|||
125956743|NCT03013491|453133785|FG005|Long-term Extension|Disease progression|0|||
125956744|NCT03013491|453133786|FG006|Long-term Extension|Disease progression|0|||
125956745|NCT03013491|453133787|FG007|Long-term Extension|Disease progression|0|||
125956746|NCT03013491|453133788|FG008|Long-term Extension|Disease progression|0|||
125956747|NCT03013491|453133789|FG009|Long-term Extension|Disease progression|0|||
125956748|NCT03013491|453133790|FG010|Long-term Extension|Disease progression|0|||
125956749|NCT03013491|453133791|FG011|Long-term Extension|Disease progression|0|||
125956750|NCT03013491|453133792|FG012|Long-term Extension|Disease progression|0|||
125956751|NCT03013491|453133793|FG013|Long-term Extension|Disease progression|0|||
125956752|NCT03013491|453133794|FG014|Long-term Extension|Disease progression|0|||
125956753|NCT03013491|453133795|FG015|Long-term Extension|Disease progression|0|||
125956754|NCT03013491|453133796|FG016|Long-term Extension|Disease progression|0|||
125956755|NCT03013491|453133797|FG017|Long-term Extension|Disease progression|0|||
125956756|NCT03013491|453133798|FG018|Long-term Extension|Disease progression|1|||
125956757|NCT03013491|453133780|FG000|Long-term Extension|Withdrawal by Subject|0|||
125956758|NCT03013491|453133781|FG001|Long-term Extension|Withdrawal by Subject|0|||
125956759|NCT03013491|453133782|FG002|Long-term Extension|Withdrawal by Subject|0|||
125956760|NCT03013491|453133783|FG003|Long-term Extension|Withdrawal by Subject|0|||
125956761|NCT03013491|453133784|FG004|Long-term Extension|Withdrawal by Subject|0|||
125956762|NCT03013491|453133785|FG005|Long-term Extension|Withdrawal by Subject|0|||
125956763|NCT03013491|453133786|FG006|Long-term Extension|Withdrawal by Subject|0|||
125956764|NCT03013491|453133787|FG007|Long-term Extension|Withdrawal by Subject|1|||
125956765|NCT03013491|453133788|FG008|Long-term Extension|Withdrawal by Subject|0|||
125956766|NCT03013491|453133789|FG009|Long-term Extension|Withdrawal by Subject|0|||
125956767|NCT03013491|453133790|FG010|Long-term Extension|Withdrawal by Subject|0|||
125956768|NCT03013491|453133791|FG011|Long-term Extension|Withdrawal by Subject|0|||
125956769|NCT03013491|453133792|FG012|Long-term Extension|Withdrawal by Subject|0|||
125956770|NCT03013491|453133793|FG013|Long-term Extension|Withdrawal by Subject|0|||
125956771|NCT03013491|453133794|FG014|Long-term Extension|Withdrawal by Subject|0|||
125956772|NCT03013491|453133795|FG015|Long-term Extension|Withdrawal by Subject|0|||
125956773|NCT03013491|453133796|FG016|Long-term Extension|Withdrawal by Subject|0|||
125956774|NCT03013491|453133797|FG017|Long-term Extension|Withdrawal by Subject|0|||
125956775|NCT03013491|453133798|FG018|Long-term Extension|Withdrawal by Subject|0|||
125956776|NCT03013491|453133780|FG000|Long-term Extension|Adverse Event|0|||
125956777|NCT03013491|453133781|FG001|Long-term Extension|Adverse Event|0|||
125956778|NCT03013491|453133782|FG002|Long-term Extension|Adverse Event|0|||
125956779|NCT03013491|453133783|FG003|Long-term Extension|Adverse Event|0|||
125956780|NCT03013491|453133784|FG004|Long-term Extension|Adverse Event|0|||
125956781|NCT03013491|453133785|FG005|Long-term Extension|Adverse Event|0|||
125956782|NCT03013491|453133786|FG006|Long-term Extension|Adverse Event|0|||
125956783|NCT03013491|453133787|FG007|Long-term Extension|Adverse Event|0|||
125956784|NCT03013491|453133788|FG008|Long-term Extension|Adverse Event|0|||
125956785|NCT03013491|453133789|FG009|Long-term Extension|Adverse Event|0|||
125956786|NCT03013491|453133790|FG010|Long-term Extension|Adverse Event|0|||
125956787|NCT03013491|453133791|FG011|Long-term Extension|Adverse Event|0|||
125956788|NCT03013491|453133792|FG012|Long-term Extension|Adverse Event|0|||
125956789|NCT03013491|453133793|FG013|Long-term Extension|Adverse Event|0|||
125956790|NCT03013491|453133794|FG014|Long-term Extension|Adverse Event|0|||
125956791|NCT03013491|453133795|FG015|Long-term Extension|Adverse Event|0|||
125956792|NCT03013491|453133796|FG016|Long-term Extension|Adverse Event|0|||
126087184|NCT05000216|453612959|FG009|Stage 1|Physician Decision|0|||
125956793|NCT03013491|453133797|FG017|Long-term Extension|Adverse Event|0|||
125956794|NCT03013491|453133798|FG018|Long-term Extension|Adverse Event|1|||
125956795|NCT03013491|453133780|FG000|Long-term Extension|Death|0|||
125956796|NCT03013491|453133781|FG001|Long-term Extension|Death|0|||
125956797|NCT03013491|453133782|FG002|Long-term Extension|Death|0|||
125956798|NCT03013491|453133783|FG003|Long-term Extension|Death|0|||
125956799|NCT03013491|453133784|FG004|Long-term Extension|Death|0|||
125956800|NCT03013491|453133785|FG005|Long-term Extension|Death|0|||
125956801|NCT03013491|453133786|FG006|Long-term Extension|Death|0|||
125956802|NCT03013491|453133787|FG007|Long-term Extension|Death|0|||
125956803|NCT03013491|453133788|FG008|Long-term Extension|Death|0|||
125956804|NCT03013491|453133789|FG009|Long-term Extension|Death|0|||
125956805|NCT03013491|453133790|FG010|Long-term Extension|Death|0|||
125956806|NCT03013491|453133791|FG011|Long-term Extension|Death|0|||
125956807|NCT03013491|453133792|FG012|Long-term Extension|Death|0|||
125956808|NCT03013491|453133793|FG013|Long-term Extension|Death|0|||
125956809|NCT03013491|453133794|FG014|Long-term Extension|Death|0|||
125956810|NCT03013491|453133795|FG015|Long-term Extension|Death|0|||
125956811|NCT03013491|453133796|FG016|Long-term Extension|Death|0|||
125956812|NCT03013491|453133797|FG017|Long-term Extension|Death|0|||
125956813|NCT03013491|453133798|FG018|Long-term Extension|Death|1|||
125956814|NCT03265119|453133799|FG000|Overall Study|Adverse Event|2|||
125956815|NCT03265119|453133800|FG001|Overall Study|Adverse Event|1|||
125956816|NCT03265119|453133799|FG000|Overall Study|Lack of Efficacy|3|||
125956817|NCT03265119|453133800|FG001|Overall Study|Lack of Efficacy|0|||
125956818|NCT03265119|453133799|FG000|Overall Study|Protocol Violation|1|||
125956819|NCT03265119|453133800|FG001|Overall Study|Protocol Violation|2|||
125956820|NCT03265119|453133799|FG000|Overall Study|Withdrawal by Subject|2|||
125956821|NCT03265119|453133800|FG001|Overall Study|Withdrawal by Subject|4|||
125956822|NCT03265119|453133799|FG000|Overall Study|Lost to Follow-up|1|||
125956823|NCT03265119|453133800|FG001|Overall Study|Lost to Follow-up|0|||
125956824|NCT03265119|453133799|FG000|Overall Study|Lack of Compliance|1|||
125956825|NCT03265119|453133800|FG001|Overall Study|Lack of Compliance|0|||
125956826|NCT03238911|453133803|FG000|Overall Study|Withdrawal by Subject|1|||
125956827|NCT03238911|453133804|FG001|Overall Study|Withdrawal by Subject|2|||
125956828|NCT03238911|453133803|FG000|Overall Study|Lost to Follow-up|2|||
125956829|NCT03238911|453133804|FG001|Overall Study|Lost to Follow-up|1|||
125956830|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
125956831|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
125956832|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
125956833|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Death|1|||
125956834|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Death|0|||
125956835|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Death|0|||
125956836|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
125956837|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
125956838|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
125956839|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
125956840|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
125956841|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
125956842|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
125956843|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
125956844|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
125956845|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
125956846|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
125956847|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
125956848|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
125956849|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
125956850|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
125956851|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
125956852|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
125956853|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
125956854|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
125956855|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
125956856|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
125956857|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
125956858|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
125956859|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
125956860|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
125956861|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
125956862|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
125956863|NCT03655236|453133805|FG000|Subject Disposition in Part 1 Period|Other|0|||
125956864|NCT03655236|453133806|FG001|Subject Disposition in Part 1 Period|Other|2|||
125956865|NCT03655236|453133807|FG002|Subject Disposition in Part 1 Period|Other|2|||
125956866|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
125956867|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
125956868|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
125956869|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
125956870|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
125956871|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
125956872|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
125956873|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
125956874|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
125956875|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
125956876|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
125956877|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
125956878|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
125956879|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
125956880|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
125956881|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
125956882|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
125956883|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
125956884|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
125956885|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
125956886|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
125956887|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
125956888|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
125956889|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
125956890|NCT03655236|453133805|FG000|Subject Disposition in Part 2 Period|Other|1|||
125956891|NCT03655236|453133806|FG001|Subject Disposition in Part 2 Period|Other|0|||
125956892|NCT03655236|453133807|FG002|Subject Disposition in Part 2 Period|Other|0|||
125956893|NCT02097134|453135386|FG000|Overall Study|Physician Decision|4|||
125956894|NCT02097134|453135386|FG000|Overall Study|Non-Protocol Therapy|1|||
125956895|NCT02097134|453135386|FG000|Overall Study|Progressive Disease|3|||
125956896|NCT02097134|453135386|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
125956897|NCT03394391|453135387|FG000|Overall Study|Lost to Follow-up|1|||
125956898|NCT03394391|453135388|FG001|Overall Study|Lost to Follow-up|2|||
125956899|NCT01434823|453135391|FG000|Overall Study|Incomplete data in medical record|4|||
125956900|NCT01434823|453135392|FG001|Overall Study|Incomplete data in medical record|7|||
125956901|NCT00519649|453135393|FG000|Overall Study|Withdrawal by Subject|1|||
125956902|NCT04879745|453135394|FG000|Overall Study|Lost to Follow-up|4|||
125956903|NCT04879745|453135395|FG001|Overall Study|Lost to Follow-up|1|||
125956904|NCT00120042|453135396|FG000|Overall Study|all completed protocl|0|||
125956905|NCT00120042|453135397|FG001|Overall Study|all completed protocl|0|||
125956906|NCT00120042|453135398|FG002|Overall Study|all completed protocl|0|||
125956907|NCT03592641|453135401|FG000|Overall Study|Withdrawal by Subject|1|||
125956908|NCT00436280|453135402|FG000|Period 1: Induction|Adverse Event|8|||
125956909|NCT00436280|453135402|FG000|Period 1: Induction|Progressive Disease|12|||
125956910|NCT00436280|453135402|FG000|Period 1: Induction|Stable Disease|6|||
125956911|NCT00436280|453135402|FG000|Period 1: Induction|Withdrawal by Subject|1|||
125956912|NCT00436280|453135402|FG000|Period 1: Induction|Death|1|||
125956913|NCT00436280|453135402|FG000|Period 2: Consolidation|Adverse Event|1|||
125956914|NCT00436280|453135402|FG000|Period 2: Consolidation|Progressive Disease|10|||
125956915|NCT00436280|453135402|FG000|Period 2: Consolidation|Stable Disease|1|||
125956916|NCT00436280|453135402|FG000|Period 2: Consolidation|Physician Decision|2|||
125956917|NCT00436280|453135402|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
125956918|NCT00436280|453135402|FG000|Period 2: Consolidation|Death|1|||
125956919|NCT00436280|453135402|FG000|Period 3: Maintenance|Adverse Event|6|||
125956920|NCT00436280|453135402|FG000|Period 3: Maintenance|Progressive Disease|12|||
125956921|NCT01049919|453135406|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
125956922|NCT01049919|453135407|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
125956923|NCT01049919|453135406|FG000|Overall Study|Withdrawal by Subject|5|||
125956924|NCT01049919|453135407|FG001|Overall Study|Withdrawal by Subject|0|||
125956925|NCT01049919|453135406|FG000|Overall Study|Lost to Follow-up|6|||
125956926|NCT01049919|453135407|FG001|Overall Study|Lost to Follow-up|1|||
125956927|NCT01049919|453135406|FG000|Overall Study|Physician Decision|2|||
125956928|NCT01049919|453135407|FG001|Overall Study|Physician Decision|0|||
125956929|NCT01049919|453135406|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
125956930|NCT01049919|453135407|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
125956931|NCT01049919|453135406|FG000|Overall Study|Early study termination by sponsor.|2|||
125956932|NCT01049919|453135407|FG001|Overall Study|Early study termination by sponsor.|0|||
125956933|NCT01532687|453135412|FG000|Overall Study|Death|2|||
125956934|NCT01532687|453135413|FG001|Overall Study|Death|0|||
125956935|NCT01532687|453135412|FG000|Overall Study|Adverse Event|6|||
125956936|NCT01532687|453135413|FG001|Overall Study|Adverse Event|1|||
125956937|NCT01532687|453135412|FG000|Overall Study|Withdrawal by Subject|1|||
125956938|NCT01532687|453135413|FG001|Overall Study|Withdrawal by Subject|0|||
125956939|NCT01532687|453135412|FG000|Overall Study|Physician Decision|2|||
125956940|NCT01532687|453135413|FG001|Overall Study|Physician Decision|1|||
125956941|NCT01532687|453135412|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
125956942|NCT01532687|453135413|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
125956943|NCT03160703|453135414|FG000|Overall Study|Withdrawal by Subject|0|||
125956944|NCT03160703|453135415|FG001|Overall Study|Withdrawal by Subject|0|||
125956945|NCT03160703|453135416|FG002|Overall Study|Withdrawal by Subject|0|||
125956946|NCT03160703|453135417|FG003|Overall Study|Withdrawal by Subject|1|||
125956947|NCT02984995|453135418|FG000|Overall Study|Required stem cell transplant|13|||
125956948|NCT02984995|453135419|FG001|Overall Study|Required stem cell transplant|2|||
125956949|NCT02984995|453135418|FG000|Overall Study|Progressive disease|11|||
125956950|NCT02984995|453135419|FG001|Overall Study|Progressive disease|1|||
125956951|NCT02984995|453135418|FG000|Overall Study|Adverse Event|1|||
125956952|NCT02984995|453135419|FG001|Overall Study|Adverse Event|0|||
125956953|NCT01263873|453135422|FG000|Overall Study|One provider unable to complete numbers|1|||
125956954|NCT01263873|453135423|FG001|Overall Study|One provider unable to complete numbers|1|||
125956955|NCT00047463|453135424|FG000|Overall Study|Withdrawal by Subject|0|||
125956956|NCT00047463|453135425|FG001|Overall Study|Withdrawal by Subject|3|||
125956957|NCT01401530|453135427|FG000|Overall Study|Disease Progression|1|||
125956958|NCT01401530|453135428|FG001|Overall Study|Disease Progression|2|||
125956959|NCT01401530|453135429|FG002|Overall Study|Disease Progression|1|||
125956960|NCT01401530|453135427|FG000|Overall Study|Adverse Event|1|||
125956961|NCT01401530|453135428|FG001|Overall Study|Adverse Event|1|||
125956962|NCT01401530|453135429|FG002|Overall Study|Adverse Event|1|||
125956963|NCT01401530|453135427|FG000|Overall Study|Participant Choice|1|||
125956964|NCT01401530|453135428|FG001|Overall Study|Participant Choice|2|||
125956965|NCT01401530|453135429|FG002|Overall Study|Participant Choice|1|||
125956966|NCT01401530|453135427|FG000|Overall Study|Physician Decision|0|||
125956967|NCT01401530|453135428|FG001|Overall Study|Physician Decision|1|||
125956968|NCT01401530|453135429|FG002|Overall Study|Physician Decision|0|||
125956969|NCT01448850|453135430|FG000|Overall Study|Death|3|||
125956970|NCT01448850|453135431|FG001|Overall Study|Death|6|||
125956971|NCT01448850|453135430|FG000|Overall Study|Withdrawal by Subject|13|||
125956972|NCT01448850|453135431|FG001|Overall Study|Withdrawal by Subject|21|||
125956973|NCT01448850|453135430|FG000|Overall Study|Lost to Follow-up|3|||
125956974|NCT01448850|453135431|FG001|Overall Study|Lost to Follow-up|1|||
125956975|NCT01448850|453135430|FG000|Overall Study|Other|15|||
125956976|NCT01448850|453135431|FG001|Overall Study|Other|12|||
125956977|NCT02939404|453135432|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
125956978|NCT02939404|453135433|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
125956979|NCT02939404|453135432|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
125956980|NCT02939404|453135433|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
125956981|NCT01859715|453135439|FG000|Overall Study|No 2nd VAS|16|||
125956982|NCT01859715|453135440|FG001|Overall Study|No 2nd VAS|8|||
125956983|NCT01859715|453135441|FG002|Overall Study|No 2nd VAS|23|||
125956984|NCT01252290|453135442|FG000|Overall Study|Withdrawal by Subject|1|||
125956985|NCT00086580|453135443|FG000|Treatment Period|Disease progression|9|||
125956986|NCT00086580|453135444|FG001|Treatment Period|Disease progression|8|||
125956987|NCT00086580|453135443|FG000|Treatment Period|Unable to comply with protocol|3|||
125956988|NCT00086580|453135444|FG001|Treatment Period|Unable to comply with protocol|1|||
125956989|NCT00086580|453135443|FG000|Treatment Period|Withdrawal by Subject|7|||
125956990|NCT00086580|453135444|FG001|Treatment Period|Withdrawal by Subject|8|||
125956991|NCT00086580|453135443|FG000|Treatment Period|Physician Decision|13|||
125956992|NCT00086580|453135444|FG001|Treatment Period|Physician Decision|7|||
125956993|NCT00086580|453135443|FG000|Treatment Period|AE - not treatment related|7|||
125956994|NCT00086580|453135444|FG001|Treatment Period|AE - not treatment related|7|||
125956995|NCT00086580|453135443|FG000|Treatment Period|Toxicity - treatment related|15|||
125956996|NCT00086580|453135444|FG001|Treatment Period|Toxicity - treatment related|15|||
126116430|NCT01380730|453721950|FG002|Overall Study|Death|0|||
126116431|NCT01380730|453721951|FG003|Overall Study|Death|0|||
126116432|NCT01380730|453721952|FG004|Overall Study|Death|1|||
126116433|NCT01380730|453721953|FG005|Overall Study|Death|0|||
126116434|NCT01380730|453721954|FG006|Overall Study|Death|0|||
125956997|NCT00086580|453135443|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
125956998|NCT00086580|453135444|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
125956999|NCT00086580|453135443|FG000|Treatment Period|Death|5|||
125957000|NCT00086580|453135444|FG001|Treatment Period|Death|7|||
125957001|NCT00086580|453135443|FG000|Treatment Period|Other|5|||
125957002|NCT00086580|453135444|FG001|Treatment Period|Other|3|||
125957003|NCT00086580|453135443|FG000|Follow-up Period|Disease progression|72|||
125957004|NCT00086580|453135444|FG001|Follow-up Period|Disease progression|99|||
125957005|NCT00086580|453135443|FG000|Follow-up Period|Unable to comply with protocol|5|||
125957006|NCT00086580|453135444|FG001|Follow-up Period|Unable to comply with protocol|0|||
125957007|NCT00086580|453135443|FG000|Follow-up Period|Withdrawal by Subject|6|||
125957008|NCT00086580|453135444|FG001|Follow-up Period|Withdrawal by Subject|6|||
125957009|NCT00086580|453135443|FG000|Follow-up Period|Physician Decision|0|||
125957010|NCT00086580|453135444|FG001|Follow-up Period|Physician Decision|1|||
125957011|NCT00086580|453135443|FG000|Follow-up Period|AE - not related|1|||
125957012|NCT00086580|453135444|FG001|Follow-up Period|AE - not related|0|||
125957013|NCT00086580|453135443|FG000|Follow-up Period|Death|13|||
125957014|NCT00086580|453135444|FG001|Follow-up Period|Death|7|||
125957015|NCT00086580|453135443|FG000|Follow-up Period|Other|7|||
125957016|NCT00086580|453135444|FG001|Follow-up Period|Other|6|||
125957017|NCT00086580|453135443|FG000|Observation Period|Unable to comply with protocol|1|||
125957018|NCT00086580|453135444|FG001|Observation Period|Unable to comply with protocol|1|||
125957019|NCT00086580|453135443|FG000|Observation Period|Withdrawal by Subject|4|||
125957020|NCT00086580|453135444|FG001|Observation Period|Withdrawal by Subject|2|||
125957021|NCT00086580|453135443|FG000|Observation Period|Death|33|||
125957022|NCT00086580|453135444|FG001|Observation Period|Death|55|||
125957023|NCT00086580|453135443|FG000|Observation Period|Other|8|||
125957024|NCT00086580|453135444|FG001|Observation Period|Other|7|||
125957025|NCT02047110|453135445|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
125957026|NCT02047110|453135446|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
125957027|NCT02047110|453135447|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
125957028|NCT02047110|453135448|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
125957029|NCT02047110|453135445|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
125957030|NCT02047110|453135446|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
125957031|NCT02047110|453135447|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
125957032|NCT02047110|453135448|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
125957033|NCT02047110|453135445|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
125957034|NCT02047110|453135446|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
125957035|NCT02047110|453135447|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
125957036|NCT02047110|453135448|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
125957037|NCT02047110|453135445|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
125957038|NCT02047110|453135446|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
125957039|NCT02047110|453135447|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
125957040|NCT02047110|453135448|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
125957041|NCT02047110|453135445|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
125957042|NCT02047110|453135446|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
125957043|NCT02047110|453135447|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
125957044|NCT02047110|453135448|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
125957045|NCT02047110|453135445|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
125957046|NCT02047110|453135446|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
125957047|NCT02047110|453135447|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
125957048|NCT02047110|453135448|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
125957049|NCT02047110|453135445|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
125957050|NCT02047110|453135446|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
125957051|NCT02047110|453135447|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
125957052|NCT02047110|453135448|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
125957053|NCT02047110|453135445|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
125957054|NCT02047110|453135446|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
125957055|NCT02047110|453135447|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
125957056|NCT02047110|453135448|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
125957057|NCT02047110|453135445|FG000|Escape Treatment Period|Adverse Event|1|||
125957058|NCT02047110|453135446|FG001|Escape Treatment Period|Adverse Event|2|||
125957059|NCT02047110|453135447|FG002|Escape Treatment Period|Adverse Event|2|||
125957060|NCT02047110|453135448|FG003|Escape Treatment Period|Adverse Event|0|||
125957061|NCT02047110|453135445|FG000|Escape Treatment Period|Other than specified|1|||
125957062|NCT02047110|453135446|FG001|Escape Treatment Period|Other than specified|2|||
125957063|NCT02047110|453135447|FG002|Escape Treatment Period|Other than specified|0|||
125957064|NCT02047110|453135448|FG003|Escape Treatment Period|Other than specified|1|||
125957065|NCT02047110|453135445|FG000|OLE Treatment Period|Other than specified|0|||
125957066|NCT02047110|453135446|FG001|OLE Treatment Period|Other than specified|0|||
125957067|NCT02047110|453135447|FG002|OLE Treatment Period|Other than specified|1|||
125957068|NCT02047110|453135448|FG003|OLE Treatment Period|Other than specified|0|||
125957069|NCT01959581|453135449|FG000|Overall Study|Lost to Follow-up|5|||
125957070|NCT00079274|453135450|FG000|Overall Study|Withdrawal by Subject|111|||
125957071|NCT00079274|453135451|FG001|Overall Study|Withdrawal by Subject|10|||
125957072|NCT00079274|453135452|FG002|Overall Study|Withdrawal by Subject|12|||
125957073|NCT00079274|453135453|FG003|Overall Study|Withdrawal by Subject|163|||
125957074|NCT00079274|453135454|FG004|Overall Study|Withdrawal by Subject|7|||
125957075|NCT00079274|453135455|FG005|Overall Study|Withdrawal by Subject|8|||
125957076|NCT00079274|453135456|FG006|Overall Study|Withdrawal by Subject|0|||
125957077|NCT00079274|453135450|FG000|Overall Study|Adverse Event|130|||
125957078|NCT00079274|453135451|FG001|Overall Study|Adverse Event|8|||
125957079|NCT00079274|453135452|FG002|Overall Study|Adverse Event|8|||
125957080|NCT00079274|453135453|FG003|Overall Study|Adverse Event|184|||
125957081|NCT00079274|453135454|FG004|Overall Study|Adverse Event|7|||
125957082|NCT00079274|453135455|FG005|Overall Study|Adverse Event|8|||
125957083|NCT00079274|453135456|FG006|Overall Study|Adverse Event|0|||
125957084|NCT00079274|453135450|FG000|Overall Study|Recurrence|21|||
125957085|NCT00079274|453135451|FG001|Overall Study|Recurrence|0|||
125957086|NCT00079274|453135452|FG002|Overall Study|Recurrence|1|||
125957087|NCT00079274|453135453|FG003|Overall Study|Recurrence|15|||
125957088|NCT00079274|453135454|FG004|Overall Study|Recurrence|0|||
125957089|NCT00079274|453135455|FG005|Overall Study|Recurrence|2|||
125957090|NCT00079274|453135456|FG006|Overall Study|Recurrence|0|||
125957091|NCT00079274|453135450|FG000|Overall Study|Alternate Treatment|6|||
125957092|NCT00079274|453135451|FG001|Overall Study|Alternate Treatment|1|||
125957093|NCT00079274|453135452|FG002|Overall Study|Alternate Treatment|0|||
125957094|NCT00079274|453135453|FG003|Overall Study|Alternate Treatment|3|||
125957095|NCT00079274|453135454|FG004|Overall Study|Alternate Treatment|0|||
125957096|NCT00079274|453135455|FG005|Overall Study|Alternate Treatment|0|||
125957097|NCT00079274|453135456|FG006|Overall Study|Alternate Treatment|0|||
125957098|NCT00079274|453135450|FG000|Overall Study|Other Medical Problems|6|||
125957099|NCT00079274|453135451|FG001|Overall Study|Other Medical Problems|1|||
125957100|NCT00079274|453135452|FG002|Overall Study|Other Medical Problems|0|||
125957101|NCT00079274|453135453|FG003|Overall Study|Other Medical Problems|7|||
125957102|NCT00079274|453135454|FG004|Overall Study|Other Medical Problems|0|||
125957103|NCT00079274|453135455|FG005|Overall Study|Other Medical Problems|0|||
125957104|NCT00079274|453135456|FG006|Overall Study|Other Medical Problems|0|||
125957105|NCT00079274|453135450|FG000|Overall Study|Death|4|||
125957106|NCT00079274|453135451|FG001|Overall Study|Death|0|||
125957107|NCT00079274|453135452|FG002|Overall Study|Death|1|||
125957108|NCT00079274|453135453|FG003|Overall Study|Death|15|||
125957109|NCT00079274|453135454|FG004|Overall Study|Death|0|||
125957110|NCT00079274|453135455|FG005|Overall Study|Death|0|||
125957111|NCT00079274|453135456|FG006|Overall Study|Death|0|||
125957112|NCT00079274|453135450|FG000|Overall Study|Cytogenetic resistance|0|||
125957113|NCT00079274|453135451|FG001|Overall Study|Cytogenetic resistance|0|||
125957114|NCT00079274|453135452|FG002|Overall Study|Cytogenetic resistance|0|||
125957115|NCT00079274|453135453|FG003|Overall Study|Cytogenetic resistance|2|||
125957116|NCT00079274|453135454|FG004|Overall Study|Cytogenetic resistance|0|||
125957117|NCT00079274|453135455|FG005|Overall Study|Cytogenetic resistance|0|||
125957118|NCT00079274|453135456|FG006|Overall Study|Cytogenetic resistance|0|||
125957119|NCT00079274|453135450|FG000|Overall Study|Other|43|||
125957120|NCT00079274|453135451|FG001|Overall Study|Other|7|||
125957121|NCT00079274|453135452|FG002|Overall Study|Other|5|||
125957122|NCT00079274|453135453|FG003|Overall Study|Other|55|||
125957123|NCT00079274|453135454|FG004|Overall Study|Other|1|||
125957124|NCT00079274|453135455|FG005|Overall Study|Other|2|||
125957125|NCT00079274|453135456|FG006|Overall Study|Other|0|||
125957126|NCT00617240|453135457|FG000|Overall Study|Lack of Efficacy|1|||
125957127|NCT00617240|453135458|FG001|Overall Study|Lack of Efficacy|0|||
125957128|NCT01611259|453135459|FG000|Overall Study|Physician Decision|1|||
125957129|NCT01611259|453135459|FG000|Overall Study|Lack of Efficacy|2|||
125957130|NCT01611259|453135459|FG000|Overall Study|Adverse Event|4|||
125957131|NCT01611259|453135459|FG000|Overall Study|Withdrawal by Subject|7|||
125957132|NCT04936685|453135460|FG000|Overall Study|Protocol Violation|1|||
125957133|NCT04936685|453135461|FG001|Overall Study|Protocol Violation|0|||
125957134|NCT03969212|453135464|FG000|Overall Study|Adverse Event|1|||
125957135|NCT03969212|453135465|FG001|Overall Study|Adverse Event|0|||
125957136|NCT03969212|453135466|FG002|Overall Study|Adverse Event|0|||
125957137|NCT03969212|453135467|FG003|Overall Study|Adverse Event|0|||
125957138|NCT03969212|453135464|FG000|Overall Study|Lost to Follow-up|2|||
125957139|NCT03969212|453135465|FG001|Overall Study|Lost to Follow-up|2|||
125957140|NCT03969212|453135466|FG002|Overall Study|Lost to Follow-up|2|||
125957141|NCT03969212|453135467|FG003|Overall Study|Lost to Follow-up|2|||
125957142|NCT03969212|453135464|FG000|Overall Study|Protocol Violation|0|||
125957143|NCT03969212|453135465|FG001|Overall Study|Protocol Violation|0|||
125957144|NCT03969212|453135466|FG002|Overall Study|Protocol Violation|0|||
125957145|NCT03969212|453135467|FG003|Overall Study|Protocol Violation|1|||
125957146|NCT03969212|453135464|FG000|Overall Study|Withdrawal by Subject|7|||
125957147|NCT03969212|453135465|FG001|Overall Study|Withdrawal by Subject|13|||
125957148|NCT03969212|453135466|FG002|Overall Study|Withdrawal by Subject|5|||
125957149|NCT03969212|453135467|FG003|Overall Study|Withdrawal by Subject|11|||
126116435|NCT01380730|453721955|FG007|Overall Study|Death|0|||
126116436|NCT00467779|453721956|FG000|Stage 1|Adverse Event|1|||
125957150|NCT03969212|453135464|FG000|Overall Study|Physician Decision|0|||
125957151|NCT03969212|453135465|FG001|Overall Study|Physician Decision|0|||
125957152|NCT03969212|453135466|FG002|Overall Study|Physician Decision|1|||
125957153|NCT03969212|453135467|FG003|Overall Study|Physician Decision|0|||
125957154|NCT03969212|453135464|FG000|Overall Study|Reason not Specified|22|||
125957155|NCT03969212|453135465|FG001|Overall Study|Reason not Specified|23|||
125957156|NCT03969212|453135466|FG002|Overall Study|Reason not Specified|28|||
125957157|NCT03969212|453135467|FG003|Overall Study|Reason not Specified|26|||
125957158|NCT03773757|453135470|FG000|Overall Study|Withdrawal by Subject|2|||
125957159|NCT03773757|453135471|FG001|Overall Study|Withdrawal by Subject|4|||
126116437|NCT00467779|453721957|FG001|Stage 1|Adverse Event|0|||
126116438|NCT00467779|453721958|FG002|Stage 1|Adverse Event|0|||
126116439|NCT00467779|453721959|FG003|Stage 1|Adverse Event|0|||
126116440|NCT00467779|453721960|FG004|Stage 1|Adverse Event|0|||
126116441|NCT00467779|453721961|FG005|Stage 1|Adverse Event|1|||
126116442|NCT00467779|453721962|FG006|Stage 1|Adverse Event|2|||
126116443|NCT00467779|453721963|FG007|Stage 1|Adverse Event|1|||
126116444|NCT00467779|453721964|FG008|Stage 1|Adverse Event|0|||
126116445|NCT00467779|453721965|FG009|Stage 1|Adverse Event|0|||
126116446|NCT00467779|453721966|FG010|Stage 1|Adverse Event|0|||
126116447|NCT00467779|453721967|FG011|Stage 1|Adverse Event|0|||
126116448|NCT00467779|453721968|FG012|Stage 1|Adverse Event|0|||
126116449|NCT00467779|453721969|FG013|Stage 1|Adverse Event|0|||
126116450|NCT00467779|453721970|FG014|Stage 1|Adverse Event|0|||
126116451|NCT00467779|453721956|FG000|Stage 1|Disease Progression|2|||
126116452|NCT00467779|453721957|FG001|Stage 1|Disease Progression|2|||
126116453|NCT00467779|453721958|FG002|Stage 1|Disease Progression|2|||
126116454|NCT00467779|453721959|FG003|Stage 1|Disease Progression|3|||
126116455|NCT00467779|453721960|FG004|Stage 1|Disease Progression|2|||
126116456|NCT00467779|453721961|FG005|Stage 1|Disease Progression|2|||
126116457|NCT00467779|453721962|FG006|Stage 1|Disease Progression|4|||
126116458|NCT00467779|453721963|FG007|Stage 1|Disease Progression|5|||
126116459|NCT00467779|453721964|FG008|Stage 1|Disease Progression|0|||
126116460|NCT00467779|453721965|FG009|Stage 1|Disease Progression|0|||
126116461|NCT00467779|453721966|FG010|Stage 1|Disease Progression|0|||
126116462|NCT00467779|453721967|FG011|Stage 1|Disease Progression|0|||
126116463|NCT00467779|453721968|FG012|Stage 1|Disease Progression|0|||
126116464|NCT00467779|453721969|FG013|Stage 1|Disease Progression|0|||
126116465|NCT00467779|453721970|FG014|Stage 1|Disease Progression|0|||
126116466|NCT00467779|453721956|FG000|Stage 1|Unspecified Reason|1|||
126116467|NCT00467779|453721957|FG001|Stage 1|Unspecified Reason|0|||
126116468|NCT00467779|453721958|FG002|Stage 1|Unspecified Reason|1|||
126116469|NCT00467779|453721959|FG003|Stage 1|Unspecified Reason|0|||
126116470|NCT00467779|453721960|FG004|Stage 1|Unspecified Reason|1|||
126116471|NCT00467779|453721961|FG005|Stage 1|Unspecified Reason|2|||
126116472|NCT00467779|453721962|FG006|Stage 1|Unspecified Reason|0|||
126116473|NCT00467779|453721963|FG007|Stage 1|Unspecified Reason|0|||
126116474|NCT00467779|453721964|FG008|Stage 1|Unspecified Reason|0|||
126116475|NCT00467779|453721965|FG009|Stage 1|Unspecified Reason|0|||
126116476|NCT00467779|453721966|FG010|Stage 1|Unspecified Reason|0|||
126116477|NCT00467779|453721967|FG011|Stage 1|Unspecified Reason|0|||
126116478|NCT00467779|453721968|FG012|Stage 1|Unspecified Reason|0|||
126116479|NCT00467779|453721969|FG013|Stage 1|Unspecified Reason|0|||
126116480|NCT00467779|453721970|FG014|Stage 1|Unspecified Reason|0|||
126116481|NCT00467779|453721956|FG000|Stage 1|Physician Decision|0|||
126116482|NCT00467779|453721957|FG001|Stage 1|Physician Decision|1|||
126116483|NCT00467779|453721958|FG002|Stage 1|Physician Decision|0|||
126116484|NCT00467779|453721959|FG003|Stage 1|Physician Decision|0|||
126116485|NCT00467779|453721960|FG004|Stage 1|Physician Decision|0|||
126116486|NCT00467779|453721961|FG005|Stage 1|Physician Decision|0|||
126116487|NCT00467779|453721962|FG006|Stage 1|Physician Decision|0|||
126116488|NCT00467779|453721963|FG007|Stage 1|Physician Decision|0|||
126116489|NCT00467779|453721964|FG008|Stage 1|Physician Decision|0|||
126116490|NCT00467779|453721965|FG009|Stage 1|Physician Decision|0|||
126116491|NCT00467779|453721966|FG010|Stage 1|Physician Decision|0|||
126116492|NCT00467779|453721967|FG011|Stage 1|Physician Decision|0|||
126116493|NCT00467779|453721968|FG012|Stage 1|Physician Decision|0|||
126116494|NCT00467779|453721969|FG013|Stage 1|Physician Decision|0|||
126116495|NCT00467779|453721970|FG014|Stage 1|Physician Decision|0|||
126116496|NCT00467779|453721956|FG000|Stage 1|Withdrawal by Subject|0|||
126116497|NCT00467779|453721957|FG001|Stage 1|Withdrawal by Subject|0|||
126116498|NCT00467779|453721958|FG002|Stage 1|Withdrawal by Subject|0|||
126116499|NCT00467779|453721959|FG003|Stage 1|Withdrawal by Subject|0|||
126116500|NCT00467779|453721960|FG004|Stage 1|Withdrawal by Subject|0|||
126116501|NCT00467779|453721961|FG005|Stage 1|Withdrawal by Subject|0|||
126116502|NCT00467779|453721962|FG006|Stage 1|Withdrawal by Subject|1|||
126116503|NCT00467779|453721963|FG007|Stage 1|Withdrawal by Subject|1|||
126116504|NCT00467779|453721964|FG008|Stage 1|Withdrawal by Subject|0|||
126116505|NCT00467779|453721965|FG009|Stage 1|Withdrawal by Subject|0|||
126116506|NCT00467779|453721966|FG010|Stage 1|Withdrawal by Subject|0|||
126116507|NCT00467779|453721967|FG011|Stage 1|Withdrawal by Subject|0|||
126116508|NCT00467779|453721968|FG012|Stage 1|Withdrawal by Subject|0|||
126116509|NCT00467779|453721969|FG013|Stage 1|Withdrawal by Subject|0|||
126116510|NCT00467779|453721970|FG014|Stage 1|Withdrawal by Subject|0|||
126116511|NCT00467779|453721956|FG000|Stage 1A|Adverse Event|0|||
126116512|NCT00467779|453721957|FG001|Stage 1A|Adverse Event|0|||
126116513|NCT00467779|453721958|FG002|Stage 1A|Adverse Event|0|||
126116514|NCT00467779|453721959|FG003|Stage 1A|Adverse Event|0|||
126116515|NCT00467779|453721960|FG004|Stage 1A|Adverse Event|0|||
126116516|NCT00467779|453721961|FG005|Stage 1A|Adverse Event|0|||
126116517|NCT00467779|453721962|FG006|Stage 1A|Adverse Event|0|||
126116518|NCT00467779|453721963|FG007|Stage 1A|Adverse Event|0|||
126116519|NCT00467779|453721964|FG008|Stage 1A|Adverse Event|0|||
125957160|NCT00280566|453135472|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
125957161|NCT00280566|453135473|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
125957162|NCT00280566|453135474|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
125957163|NCT00280566|453135472|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
125957164|NCT00280566|453135473|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
125957165|NCT00280566|453135474|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
125957166|NCT00280566|453135472|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
125957167|NCT00280566|453135473|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
125957168|NCT00280566|453135474|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
125957169|NCT00280566|453135472|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
125957170|NCT00280566|453135473|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
125957171|NCT00280566|453135474|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
125957172|NCT00280566|453135472|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
125957173|NCT00280566|453135473|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
125957174|NCT00280566|453135474|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
125957175|NCT00280566|453135472|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
125957176|NCT00280566|453135473|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
125957177|NCT00280566|453135474|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
125957178|NCT00280566|453135472|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
125957179|NCT00280566|453135473|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
125957180|NCT00280566|453135474|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
125957181|NCT00280566|453135472|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
125957182|NCT00280566|453135473|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
125957183|NCT00280566|453135474|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
125957184|NCT00280566|453135472|FG000|Period 2 Double Blind|Adverse Event|0|||
125957185|NCT00280566|453135473|FG001|Period 2 Double Blind|Adverse Event|11|||
125957186|NCT00280566|453135474|FG002|Period 2 Double Blind|Adverse Event|15|||
125957187|NCT00280566|453135472|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
125957188|NCT00280566|453135473|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
125957189|NCT00280566|453135474|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
125957190|NCT00280566|453135472|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
125957191|NCT00280566|453135473|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
125957192|NCT00280566|453135474|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
125957193|NCT00280566|453135472|FG000|Period 2 Double Blind|miscellaneous|0|||
125957194|NCT00280566|453135473|FG001|Period 2 Double Blind|miscellaneous|10|||
125957195|NCT00280566|453135474|FG002|Period 2 Double Blind|miscellaneous|5|||
125957196|NCT01109316|453135475|FG000|Study Period 1|Adverse Event|0|||
125957197|NCT01109316|453135476|FG001|Study Period 1|Adverse Event|0|||
125957198|NCT01109316|453135477|FG002|Study Period 1|Adverse Event|1|||
125957199|NCT01109316|453135478|FG003|Study Period 1|Adverse Event|0|||
125957200|NCT01109316|453135479|FG004|Study Period 1|Adverse Event|0|||
125957201|NCT01109316|453135480|FG005|Study Period 1|Adverse Event|0|||
125957202|NCT01109316|453135475|FG000|Study Period 1|Lost to Follow-up|0|||
125957203|NCT01109316|453135476|FG001|Study Period 1|Lost to Follow-up|0|||
125957204|NCT01109316|453135477|FG002|Study Period 1|Lost to Follow-up|1|||
125957205|NCT01109316|453135478|FG003|Study Period 1|Lost to Follow-up|1|||
125957206|NCT01109316|453135479|FG004|Study Period 1|Lost to Follow-up|0|||
125957207|NCT01109316|453135480|FG005|Study Period 1|Lost to Follow-up|0|||
125957208|NCT01109316|453135475|FG000|Study Period 1|Withdrawal by Subject|0|||
125957209|NCT01109316|453135476|FG001|Study Period 1|Withdrawal by Subject|0|||
125957210|NCT01109316|453135477|FG002|Study Period 1|Withdrawal by Subject|1|||
125957211|NCT01109316|453135478|FG003|Study Period 1|Withdrawal by Subject|0|||
125957212|NCT01109316|453135479|FG004|Study Period 1|Withdrawal by Subject|2|||
125957213|NCT01109316|453135480|FG005|Study Period 1|Withdrawal by Subject|0|||
125957214|NCT01109316|453135475|FG000|Study Period 1|Sponsor Decision|0|||
125957215|NCT01109316|453135476|FG001|Study Period 1|Sponsor Decision|0|||
125957216|NCT01109316|453135477|FG002|Study Period 1|Sponsor Decision|0|||
125957217|NCT01109316|453135478|FG003|Study Period 1|Sponsor Decision|0|||
125957218|NCT01109316|453135479|FG004|Study Period 1|Sponsor Decision|0|||
125957219|NCT01109316|453135480|FG005|Study Period 1|Sponsor Decision|2|||
125957220|NCT01109316|453135475|FG000|Study Period 2|Entry Criteria Not Met|0|||
125957221|NCT01109316|453135476|FG001|Study Period 2|Entry Criteria Not Met|1|||
125957222|NCT01109316|453135477|FG002|Study Period 2|Entry Criteria Not Met|0|||
125957223|NCT01109316|453135478|FG003|Study Period 2|Entry Criteria Not Met|0|||
125957224|NCT01109316|453135479|FG004|Study Period 2|Entry Criteria Not Met|0|||
125957225|NCT01109316|453135480|FG005|Study Period 2|Entry Criteria Not Met|0|||
125957226|NCT01109316|453135475|FG000|Study Period 2|Physician Decision|0|||
125957227|NCT01109316|453135476|FG001|Study Period 2|Physician Decision|0|||
125957228|NCT01109316|453135477|FG002|Study Period 2|Physician Decision|0|||
125957229|NCT01109316|453135478|FG003|Study Period 2|Physician Decision|1|||
125957230|NCT01109316|453135479|FG004|Study Period 2|Physician Decision|0|||
125957231|NCT01109316|453135480|FG005|Study Period 2|Physician Decision|0|||
125957232|NCT01109316|453135475|FG000|Study Period 2|Protocol Violation|1|||
125957233|NCT01109316|453135476|FG001|Study Period 2|Protocol Violation|0|||
125957234|NCT01109316|453135477|FG002|Study Period 2|Protocol Violation|0|||
126116520|NCT00467779|453721965|FG009|Stage 1A|Adverse Event|0|||
126116521|NCT00467779|453721966|FG010|Stage 1A|Adverse Event|0|||
126116522|NCT00467779|453721967|FG011|Stage 1A|Adverse Event|0|||
126116523|NCT00467779|453721968|FG012|Stage 1A|Adverse Event|1|||
126116524|NCT00467779|453721969|FG013|Stage 1A|Adverse Event|0|||
126116525|NCT00467779|453721970|FG014|Stage 1A|Adverse Event|0|||
126116526|NCT00467779|453721956|FG000|Stage 1A|Death|0|||
126116527|NCT00467779|453721957|FG001|Stage 1A|Death|0|||
126116528|NCT00467779|453721958|FG002|Stage 1A|Death|0|||
126116529|NCT00467779|453721959|FG003|Stage 1A|Death|0|||
126116530|NCT00467779|453721960|FG004|Stage 1A|Death|0|||
126116531|NCT00467779|453721961|FG005|Stage 1A|Death|0|||
126116532|NCT00467779|453721962|FG006|Stage 1A|Death|0|||
126116533|NCT00467779|453721963|FG007|Stage 1A|Death|0|||
126116534|NCT00467779|453721964|FG008|Stage 1A|Death|0|||
126116535|NCT00467779|453721965|FG009|Stage 1A|Death|0|||
126116536|NCT00467779|453721966|FG010|Stage 1A|Death|0|||
126116537|NCT00467779|453721967|FG011|Stage 1A|Death|1|||
126116538|NCT00467779|453721968|FG012|Stage 1A|Death|1|||
126116539|NCT00467779|453721969|FG013|Stage 1A|Death|0|||
126116540|NCT00467779|453721970|FG014|Stage 1A|Death|0|||
126116541|NCT00467779|453721956|FG000|Stage 1A|Disease Progression|0|||
126116542|NCT00467779|453721957|FG001|Stage 1A|Disease Progression|0|||
126116543|NCT00467779|453721958|FG002|Stage 1A|Disease Progression|0|||
126116544|NCT00467779|453721959|FG003|Stage 1A|Disease Progression|0|||
126116545|NCT00467779|453721960|FG004|Stage 1A|Disease Progression|0|||
126116546|NCT00467779|453721961|FG005|Stage 1A|Disease Progression|0|||
126116547|NCT00467779|453721962|FG006|Stage 1A|Disease Progression|0|||
126116548|NCT00467779|453721963|FG007|Stage 1A|Disease Progression|0|||
126116549|NCT00467779|453721964|FG008|Stage 1A|Disease Progression|0|||
126116550|NCT00467779|453721965|FG009|Stage 1A|Disease Progression|2|||
126116551|NCT00467779|453721966|FG010|Stage 1A|Disease Progression|2|||
126116552|NCT00467779|453721967|FG011|Stage 1A|Disease Progression|5|||
126116553|NCT00467779|453721968|FG012|Stage 1A|Disease Progression|2|||
126116554|NCT00467779|453721969|FG013|Stage 1A|Disease Progression|0|||
126116555|NCT00467779|453721970|FG014|Stage 1A|Disease Progression|0|||
126116556|NCT00467779|453721956|FG000|Stage 1A|Physician Decision|0|||
126116557|NCT00467779|453721957|FG001|Stage 1A|Physician Decision|0|||
126116558|NCT00467779|453721958|FG002|Stage 1A|Physician Decision|0|||
126116559|NCT00467779|453721959|FG003|Stage 1A|Physician Decision|0|||
125957235|NCT01109316|453135478|FG003|Study Period 2|Protocol Violation|0|||
125957236|NCT01109316|453135479|FG004|Study Period 2|Protocol Violation|0|||
125957237|NCT01109316|453135480|FG005|Study Period 2|Protocol Violation|0|||
125957238|NCT01109316|453135475|FG000|Study Period 2|Withdrawal by Subject|0|||
125957239|NCT01109316|453135476|FG001|Study Period 2|Withdrawal by Subject|0|||
125957240|NCT01109316|453135477|FG002|Study Period 2|Withdrawal by Subject|1|||
125957241|NCT01109316|453135478|FG003|Study Period 2|Withdrawal by Subject|0|||
125957242|NCT01109316|453135479|FG004|Study Period 2|Withdrawal by Subject|0|||
125957243|NCT01109316|453135480|FG005|Study Period 2|Withdrawal by Subject|1|||
125957244|NCT01109316|453135475|FG000|Study Period 3|Lost to Follow-up|0|||
125957245|NCT01109316|453135476|FG001|Study Period 3|Lost to Follow-up|0|||
125957246|NCT01109316|453135477|FG002|Study Period 3|Lost to Follow-up|0|||
125957247|NCT01109316|453135478|FG003|Study Period 3|Lost to Follow-up|0|||
125957248|NCT01109316|453135479|FG004|Study Period 3|Lost to Follow-up|1|||
125957249|NCT01109316|453135480|FG005|Study Period 3|Lost to Follow-up|0|||
125957250|NCT01109316|453135475|FG000|Study Period 3|Withdrawal by Subject|1|||
125957251|NCT01109316|453135476|FG001|Study Period 3|Withdrawal by Subject|0|||
125957252|NCT01109316|453135477|FG002|Study Period 3|Withdrawal by Subject|0|||
125957253|NCT01109316|453135478|FG003|Study Period 3|Withdrawal by Subject|0|||
125957254|NCT01109316|453135479|FG004|Study Period 3|Withdrawal by Subject|1|||
125957255|NCT01109316|453135480|FG005|Study Period 3|Withdrawal by Subject|0|||
125957256|NCT01302392|453135483|FG000|Overall Study|Lost to Follow-up|1|||
125957257|NCT01302392|453135484|FG001|Overall Study|Lost to Follow-up|0|||
125957258|NCT01302392|453135483|FG000|Overall Study|Withdrawal by Subject|6|||
125957259|NCT01302392|453135484|FG001|Overall Study|Withdrawal by Subject|1|||
125957260|NCT00670228|453135485|FG000|Overall Study|Adverse Event|1|||
125957261|NCT00670228|453135486|FG001|Overall Study|Adverse Event|0|||
125957262|NCT00670228|453135485|FG000|Overall Study|Death or MACE|0|||
125957263|NCT00670228|453135486|FG001|Overall Study|Death or MACE|1|||
126116560|NCT00467779|453721960|FG004|Stage 1A|Physician Decision|0|||
126116561|NCT00467779|453721961|FG005|Stage 1A|Physician Decision|0|||
126116562|NCT00467779|453721962|FG006|Stage 1A|Physician Decision|0|||
126116563|NCT00467779|453721963|FG007|Stage 1A|Physician Decision|0|||
125957264|NCT00670228|453135485|FG000|Overall Study|Not treated|2|||
126116564|NCT00467779|453721964|FG008|Stage 1A|Physician Decision|0|||
126116565|NCT00467779|453721965|FG009|Stage 1A|Physician Decision|1|||
125957265|NCT00670228|453135486|FG001|Overall Study|Not treated|2|||
126116566|NCT00467779|453721966|FG010|Stage 1A|Physician Decision|0|||
126116567|NCT00467779|453721967|FG011|Stage 1A|Physician Decision|0|||
126116568|NCT00467779|453721968|FG012|Stage 1A|Physician Decision|0|||
126116569|NCT00467779|453721969|FG013|Stage 1A|Physician Decision|0|||
126116570|NCT00467779|453721970|FG014|Stage 1A|Physician Decision|0|||
126116571|NCT00467779|453721956|FG000|Stage 1A|Withdrawal by Subject|0|||
125957266|NCT00670228|453135485|FG000|Overall Study|Not meeting the selection criteria|2|||
125957267|NCT00670228|453135486|FG001|Overall Study|Not meeting the selection criteria|0|||
125957268|NCT03049813|453135495|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
125957269|NCT03049813|453135496|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
125957270|NCT03049813|453135497|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
125957271|NCT03049813|453135498|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
125957272|NCT03049813|453135495|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
125957273|NCT03049813|453135496|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
125957274|NCT03049813|453135497|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
125957275|NCT03049813|453135498|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
125957276|NCT03049813|453135495|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
125957277|NCT03049813|453135496|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
125957278|NCT03049813|453135497|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
125957279|NCT03049813|453135498|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
125957280|NCT03049813|453135495|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
125957281|NCT03049813|453135496|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
125957282|NCT03049813|453135497|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
125957283|NCT03049813|453135498|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
125957284|NCT00550836|453135499|FG000|Overall Study|Withdrawal by Subject|3|||
125957285|NCT00550836|453135500|FG001|Overall Study|Withdrawal by Subject|9|||
125957286|NCT00179413|453135501|FG000|Overall Study|Adverse Event|38|||
125957287|NCT00179413|453135502|FG001|Overall Study|Adverse Event|20|||
125957288|NCT00179413|453135501|FG000|Overall Study|Withdrawal by Subject|87|||
125957289|NCT00179413|453135502|FG001|Overall Study|Withdrawal by Subject|95|||
125957290|NCT03075644|453135505|FG000|Overall Study|Withdrawal by Subject|1|||
125957291|NCT03075644|453135506|FG001|Overall Study|Withdrawal by Subject|1|||
125957292|NCT01458171|453135507|FG000|Overall Study|Adverse Event|1|||
125957293|NCT01696032|453135508|FG000|Overall Study|Withdrawal by Subject|0|||
125957294|NCT01696032|453135509|FG001|Overall Study|Withdrawal by Subject|0|||
125957295|NCT01696032|453135510|FG002|Overall Study|Withdrawal by Subject|1|||
125957296|NCT01696032|453135511|FG003|Overall Study|Withdrawal by Subject|2|||
125957297|NCT01696032|453135508|FG000|Overall Study|Death|14|||
125957298|NCT01696032|453135509|FG001|Overall Study|Death|4|||
125957299|NCT01696032|453135510|FG002|Overall Study|Death|43|||
125957300|NCT01696032|453135511|FG003|Overall Study|Death|18|||
125957301|NCT01696032|453135508|FG000|Overall Study|Lost to Follow-up|0|||
125957302|NCT01696032|453135509|FG001|Overall Study|Lost to Follow-up|1|||
125957303|NCT01696032|453135510|FG002|Overall Study|Lost to Follow-up|0|||
125957304|NCT01696032|453135511|FG003|Overall Study|Lost to Follow-up|0|||
125957305|NCT01696032|453135508|FG000|Overall Study|Database lock|0|||
125957306|NCT01696032|453135509|FG001|Overall Study|Database lock|1|||
125957307|NCT01696032|453135510|FG002|Overall Study|Database lock|7|||
125957308|NCT01696032|453135511|FG003|Overall Study|Database lock|2|||
125957309|NCT01192152|453135514|FG000|Period 1|left prematurely (while on treatment B)|0|||
125957310|NCT01192152|453135515|FG001|Period 1|left prematurely (while on treatment B)|1|||
125957311|NCT01192152|453135514|FG000|Period 3|family emergency|1|||
125957312|NCT01192152|453135515|FG001|Period 3|family emergency|0|||
125957313|NCT05013905|453135516|FG000|Overall Study|Adverse Event|1|||
125957314|NCT05013905|453135516|FG000|Overall Study|Lack of Efficacy|1|||
125957315|NCT00854581|453135519|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
125957316|NCT00854581|453135519|FG000|Induction (Up to Day 21)|Death|1|||
125957317|NCT00854581|453135519|FG000|Induction (Up to Day 21)|Physician Decision|1|||
125957318|NCT00854581|453135519|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
125957319|NCT05402995|453135522|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
126116572|NCT00467779|453721957|FG001|Stage 1A|Withdrawal by Subject|0|||
126116573|NCT00467779|453721958|FG002|Stage 1A|Withdrawal by Subject|0|||
126116574|NCT00467779|453721959|FG003|Stage 1A|Withdrawal by Subject|0|||
126116575|NCT00467779|453721960|FG004|Stage 1A|Withdrawal by Subject|0|||
126116576|NCT00467779|453721961|FG005|Stage 1A|Withdrawal by Subject|0|||
126116577|NCT00467779|453721962|FG006|Stage 1A|Withdrawal by Subject|0|||
126116578|NCT00467779|453721963|FG007|Stage 1A|Withdrawal by Subject|0|||
125957320|NCT05402995|453135523|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
125957321|NCT05402995|453135524|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
125957322|NCT05402995|453135525|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
125957323|NCT02705820|453135526|FG000|Overall Study|Death|2|||
125957324|NCT02705820|453135526|FG000|Overall Study|Disease Progression|34|||
125957325|NCT02705820|453135526|FG000|Overall Study|Clinical Deterioration|3|||
125957326|NCT01009099|453135527|FG000|Overall Study|Lost to Follow-up|1|||
125957327|NCT01009099|453135528|FG001|Overall Study|Lost to Follow-up|0|||
125957328|NCT01009099|453135527|FG000|Overall Study|Physician Decision|3|||
125957329|NCT01009099|453135528|FG001|Overall Study|Physician Decision|2|||
125957330|NCT01009099|453135527|FG000|Overall Study|Withdrawal by Subject|1|||
125957331|NCT01009099|453135528|FG001|Overall Study|Withdrawal by Subject|1|||
125957332|NCT01009099|453135527|FG000|Overall Study|Death|0|||
125957333|NCT01009099|453135528|FG001|Overall Study|Death|1|||
125957334|NCT01541930|453135529|FG000|Overall Study|Withdrawal by Subject|1|||
125957335|NCT02501096|453135530|FG000|Overall Study|Lost to Follow-up|0|||
125957336|NCT02501096|453135531|FG001|Overall Study|Lost to Follow-up|0|||
125957337|NCT02501096|453135532|FG002|Overall Study|Lost to Follow-up|0|||
125957338|NCT02501096|453135533|FG003|Overall Study|Lost to Follow-up|0|||
125957339|NCT02501096|453135534|FG004|Overall Study|Lost to Follow-up|1|||
125957340|NCT02501096|453135535|FG005|Overall Study|Lost to Follow-up|1|||
125957341|NCT02501096|453135536|FG006|Overall Study|Lost to Follow-up|3|||
125957342|NCT02501096|453135537|FG007|Overall Study|Lost to Follow-up|0|||
125957343|NCT02501096|453135538|FG008|Overall Study|Lost to Follow-up|0|||
125957344|NCT02501096|453135530|FG000|Overall Study|Withdrawal by Subject|1|||
125957345|NCT02501096|453135531|FG001|Overall Study|Withdrawal by Subject|0|||
125957346|NCT02501096|453135532|FG002|Overall Study|Withdrawal by Subject|7|||
125957347|NCT02501096|453135533|FG003|Overall Study|Withdrawal by Subject|13|||
125957348|NCT02501096|453135534|FG004|Overall Study|Withdrawal by Subject|2|||
125957349|NCT02501096|453135535|FG005|Overall Study|Withdrawal by Subject|2|||
125957350|NCT02501096|453135536|FG006|Overall Study|Withdrawal by Subject|2|||
125957351|NCT02501096|453135537|FG007|Overall Study|Withdrawal by Subject|3|||
125957352|NCT02501096|453135538|FG008|Overall Study|Withdrawal by Subject|0|||
125957353|NCT02501096|453135530|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
125957354|NCT02501096|453135531|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
125957355|NCT02501096|453135532|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
125957356|NCT02501096|453135533|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
125957357|NCT02501096|453135534|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
125957358|NCT02501096|453135535|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
125957359|NCT02501096|453135536|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
125957360|NCT02501096|453135537|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
125957361|NCT02501096|453135538|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
125957362|NCT02501096|453135530|FG000|Overall Study|Death|1|||
125957363|NCT02501096|453135531|FG001|Overall Study|Death|1|||
125957364|NCT02501096|453135532|FG002|Overall Study|Death|88|||
125957365|NCT02501096|453135533|FG003|Overall Study|Death|74|||
125957366|NCT02501096|453135534|FG004|Overall Study|Death|15|||
125957367|NCT02501096|453135535|FG005|Overall Study|Death|16|||
125957368|NCT02501096|453135536|FG006|Overall Study|Death|15|||
125957369|NCT02501096|453135537|FG007|Overall Study|Death|16|||
125957370|NCT02501096|453135538|FG008|Overall Study|Death|1|||
125957371|NCT04187196|453135539|FG000|Overall Study|Screen Failure|2|||
125957372|NCT04187196|453135540|FG001|Overall Study|Screen Failure|0|||
125957373|NCT03139916|453135543|FG000|Overall Study|Withdrawal by Subject|2|||
125957374|NCT03139916|453135543|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
125957375|NCT01957475|453135544|FG000|Test Period 1|Withdrawal by Subject|1|||
125957376|NCT01957475|453135545|FG001|Test Period 1|Withdrawal by Subject|0|||
125957377|NCT01957475|453135544|FG000|Test Period 1|Other|1|||
125957378|NCT01957475|453135545|FG001|Test Period 1|Other|0|||
125957379|NCT01957475|453135544|FG000|Test Period 1|Lack of Efficacy|0|||
125957380|NCT01957475|453135545|FG001|Test Period 1|Lack of Efficacy|1|||
125957381|NCT01957475|453135544|FG000|Test Period 2|Adverse Event|1|||
125957382|NCT01957475|453135545|FG001|Test Period 2|Adverse Event|0|||
125957383|NCT04587193|453135546|FG000|Overall Study|Screen failure after consent|3|||
125957384|NCT04587193|453135547|FG001|Overall Study|Screen failure after consent|0|||
125957385|NCT04587193|453135546|FG000|Overall Study|Device broke during study|3|||
125957386|NCT04587193|453135547|FG001|Overall Study|Device broke during study|2|||
125957387|NCT01552772|453135548|FG000|Overall Study|Lost to Follow-up|2|||
125957388|NCT01552772|453135548|FG000|Overall Study|Adverse Event|1|||
125957389|NCT01552772|453135548|FG000|Overall Study|Protocol Deviation|1|||
125957390|NCT02707640|453135552|FG000|Overall Study|Adverse Event|4|||
125957391|NCT02707640|453135553|FG001|Overall Study|Adverse Event|2|||
125957392|NCT02707640|453135552|FG000|Overall Study|Death|1|||
125957393|NCT02707640|453135553|FG001|Overall Study|Death|2|||
125957394|NCT02707640|453135552|FG000|Overall Study|Physician Decision|2|||
125957395|NCT02707640|453135553|FG001|Overall Study|Physician Decision|0|||
125957396|NCT02707640|453135552|FG000|Overall Study|Withdrawal by Subject|0|||
125957397|NCT02707640|453135553|FG001|Overall Study|Withdrawal by Subject|1|||
125957398|NCT02707640|453135552|FG000|Overall Study|Participant's Personal Decision|1|||
126116579|NCT00467779|453721964|FG008|Stage 1A|Withdrawal by Subject|0|||
125957399|NCT02707640|453135553|FG001|Overall Study|Participant's Personal Decision|2|||
126116580|NCT00467779|453721965|FG009|Stage 1A|Withdrawal by Subject|0|||
125957400|NCT02707640|453135552|FG000|Overall Study|Sponsor Discretion|1|||
125957401|NCT02707640|453135553|FG001|Overall Study|Sponsor Discretion|0|||
125957402|NCT02517905|453135554|FG000|Overall Study|Lost to Follow-up|4|||
125957403|NCT02517905|453135555|FG001|Overall Study|Lost to Follow-up|0|||
125957404|NCT02517905|453135554|FG000|Overall Study|Withdrawal by Subject|4|||
125957405|NCT02517905|453135555|FG001|Overall Study|Withdrawal by Subject|0|||
125957406|NCT02517905|453135554|FG000|Overall Study|Screen failure|2|||
125957407|NCT02517905|453135555|FG001|Overall Study|Screen failure|2|||
125957408|NCT02742103|453137021|FG000|Overall Study|Protocol Violation|1|||
125957409|NCT02742103|453137022|FG001|Overall Study|Protocol Violation|0|||
125957410|NCT02742103|453137021|FG000|Overall Study|Death|2|||
125957411|NCT02742103|453137022|FG001|Overall Study|Death|2|||
125957412|NCT02742103|453137021|FG000|Overall Study|Adverse Event|1|||
125957413|NCT02742103|453137022|FG001|Overall Study|Adverse Event|0|||
125957414|NCT02742103|453137021|FG000|Overall Study|Moved to another town|0|||
125957415|NCT02742103|453137022|FG001|Overall Study|Moved to another town|1|||
125957416|NCT02742103|453137021|FG000|Overall Study|Withdrawal by Subject|5|||
125957417|NCT02742103|453137022|FG001|Overall Study|Withdrawal by Subject|2|||
125957418|NCT00991302|453137023|FG000|Overall Study|Death|0|||
125957419|NCT00991302|453137024|FG001|Overall Study|Death|1|||
125957420|NCT00991302|453137023|FG000|Overall Study|Lost to Follow-up|14|||
125957421|NCT00991302|453137024|FG001|Overall Study|Lost to Follow-up|12|||
125957422|NCT01709318|453137025|FG000|Overall Study|Adverse Event|3|||
125957423|NCT01709318|453137026|FG001|Overall Study|Adverse Event|4|||
125957424|NCT01709318|453137027|FG002|Overall Study|Adverse Event|2|||
125957425|NCT01709318|453137028|FG003|Overall Study|Adverse Event|2|||
125957426|NCT01709318|453137029|FG004|Overall Study|Adverse Event|0|||
125957427|NCT01709318|453137030|FG005|Overall Study|Adverse Event|1|||
125957428|NCT01709318|453137031|FG006|Overall Study|Adverse Event|2|||
125957429|NCT01709318|453137025|FG000|Overall Study|Lost to Follow-up|2|||
125957430|NCT01709318|453137026|FG001|Overall Study|Lost to Follow-up|0|||
125957431|NCT01709318|453137027|FG002|Overall Study|Lost to Follow-up|0|||
125957432|NCT01709318|453137028|FG003|Overall Study|Lost to Follow-up|0|||
125957433|NCT01709318|453137029|FG004|Overall Study|Lost to Follow-up|1|||
125957434|NCT01709318|453137030|FG005|Overall Study|Lost to Follow-up|1|||
125957435|NCT01709318|453137031|FG006|Overall Study|Lost to Follow-up|1|||
125957436|NCT01709318|453137025|FG000|Overall Study|Non-compliance with Study Drug|0|||
125957437|NCT01709318|453137026|FG001|Overall Study|Non-compliance with Study Drug|2|||
125957438|NCT01709318|453137027|FG002|Overall Study|Non-compliance with Study Drug|1|||
125957439|NCT01709318|453137028|FG003|Overall Study|Non-compliance with Study Drug|1|||
125957440|NCT01709318|453137029|FG004|Overall Study|Non-compliance with Study Drug|0|||
125957441|NCT01709318|453137030|FG005|Overall Study|Non-compliance with Study Drug|0|||
125957442|NCT01709318|453137031|FG006|Overall Study|Non-compliance with Study Drug|2|||
125957443|NCT01709318|453137025|FG000|Overall Study|Physician Decision|0|||
125957444|NCT01709318|453137026|FG001|Overall Study|Physician Decision|0|||
125957445|NCT01709318|453137027|FG002|Overall Study|Physician Decision|0|||
125957446|NCT01709318|453137028|FG003|Overall Study|Physician Decision|0|||
125957447|NCT01709318|453137029|FG004|Overall Study|Physician Decision|0|||
125957448|NCT01709318|453137030|FG005|Overall Study|Physician Decision|0|||
125957449|NCT01709318|453137031|FG006|Overall Study|Physician Decision|1|||
125957450|NCT01709318|453137025|FG000|Overall Study|Pregnancy|0|||
125957451|NCT01709318|453137026|FG001|Overall Study|Pregnancy|0|||
125957452|NCT01709318|453137027|FG002|Overall Study|Pregnancy|0|||
125957453|NCT01709318|453137028|FG003|Overall Study|Pregnancy|0|||
125957454|NCT01709318|453137029|FG004|Overall Study|Pregnancy|1|||
125957455|NCT01709318|453137030|FG005|Overall Study|Pregnancy|0|||
125957456|NCT01709318|453137031|FG006|Overall Study|Pregnancy|0|||
125957457|NCT01709318|453137025|FG000|Overall Study|Protocol Violation|0|||
125957458|NCT01709318|453137026|FG001|Overall Study|Protocol Violation|0|||
125957459|NCT01709318|453137027|FG002|Overall Study|Protocol Violation|0|||
125957460|NCT01709318|453137028|FG003|Overall Study|Protocol Violation|0|||
125957461|NCT01709318|453137029|FG004|Overall Study|Protocol Violation|2|||
125957462|NCT01709318|453137030|FG005|Overall Study|Protocol Violation|0|||
125957463|NCT01709318|453137031|FG006|Overall Study|Protocol Violation|1|||
125957464|NCT01709318|453137025|FG000|Overall Study|Technical Problems|1|||
125957465|NCT01709318|453137026|FG001|Overall Study|Technical Problems|0|||
125957466|NCT01709318|453137027|FG002|Overall Study|Technical Problems|0|||
125957467|NCT01709318|453137028|FG003|Overall Study|Technical Problems|0|||
125957468|NCT01709318|453137029|FG004|Overall Study|Technical Problems|0|||
125957469|NCT01709318|453137030|FG005|Overall Study|Technical Problems|0|||
125957470|NCT01709318|453137031|FG006|Overall Study|Technical Problems|0|||
125957471|NCT01709318|453137025|FG000|Overall Study|Withdrawal by Subject|3|||
125957472|NCT01709318|453137026|FG001|Overall Study|Withdrawal by Subject|0|||
125957473|NCT01709318|453137027|FG002|Overall Study|Withdrawal by Subject|3|||
125957474|NCT01709318|453137028|FG003|Overall Study|Withdrawal by Subject|3|||
125957475|NCT01709318|453137029|FG004|Overall Study|Withdrawal by Subject|0|||
125957476|NCT01709318|453137030|FG005|Overall Study|Withdrawal by Subject|2|||
126116581|NCT00467779|453721966|FG010|Stage 1A|Withdrawal by Subject|1|||
126116582|NCT00467779|453721967|FG011|Stage 1A|Withdrawal by Subject|1|||
125957477|NCT01709318|453137031|FG006|Overall Study|Withdrawal by Subject|4|||
125957478|NCT01709318|453137025|FG000|Overall Study|Other Protocol Specified Criteria|0|||
126116583|NCT00467779|453721968|FG012|Stage 1A|Withdrawal by Subject|1|||
125957479|NCT01709318|453137026|FG001|Overall Study|Other Protocol Specified Criteria|1|||
125957480|NCT01709318|453137027|FG002|Overall Study|Other Protocol Specified Criteria|0|||
125957481|NCT01709318|453137028|FG003|Overall Study|Other Protocol Specified Criteria|0|||
125957482|NCT01709318|453137029|FG004|Overall Study|Other Protocol Specified Criteria|0|||
125957483|NCT01709318|453137030|FG005|Overall Study|Other Protocol Specified Criteria|0|||
125957484|NCT01709318|453137031|FG006|Overall Study|Other Protocol Specified Criteria|0|||
125957485|NCT03042312|453137032|FG000|Overall Study|Administrative Reason|1|||
125957486|NCT03042312|453137033|FG001|Overall Study|Administrative Reason|1|||
125957487|NCT03042312|453137032|FG000|Overall Study|Adverse Event|0|||
125957488|NCT03042312|453137033|FG001|Overall Study|Adverse Event|1|||
125957489|NCT03042312|453137032|FG000|Overall Study|Lost to Follow-up|1|||
125957490|NCT03042312|453137033|FG001|Overall Study|Lost to Follow-up|3|||
125957491|NCT03042312|453137032|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
125957492|NCT03042312|453137033|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
125957493|NCT03042312|453137032|FG000|Overall Study|Withdrawal by Subject|4|||
125957494|NCT03042312|453137033|FG001|Overall Study|Withdrawal by Subject|5|||
125957495|NCT02383758|453137034|FG000|Overall Study|Withdrawal by Subject|0|||
125957496|NCT02383758|453137035|FG001|Overall Study|Withdrawal by Subject|2|||
125957497|NCT00646958|453137040|FG000|Overall Study|Lack of Efficacy|1|||
125957498|NCT00646958|453137041|FG001|Overall Study|Lack of Efficacy|0|||
125957499|NCT00646958|453137042|FG002|Overall Study|Lack of Efficacy|0|||
125957500|NCT00646958|453137040|FG000|Overall Study|Adverse Event|4|||
125957501|NCT00646958|453137041|FG001|Overall Study|Adverse Event|0|||
125957502|NCT00646958|453137042|FG002|Overall Study|Adverse Event|0|||
125957503|NCT00646958|453137040|FG000|Overall Study|Lost to Follow-up|1|||
125957504|NCT00646958|453137041|FG001|Overall Study|Lost to Follow-up|5|||
125957505|NCT00646958|453137042|FG002|Overall Study|Lost to Follow-up|7|||
125957506|NCT00646958|453137040|FG000|Overall Study|Protocol Violation|1|||
125957507|NCT00646958|453137041|FG001|Overall Study|Protocol Violation|1|||
125957508|NCT00646958|453137042|FG002|Overall Study|Protocol Violation|0|||
125957509|NCT00646958|453137040|FG000|Overall Study|Abnormal screening lab tests|1|||
125957510|NCT00646958|453137041|FG001|Overall Study|Abnormal screening lab tests|1|||
125957511|NCT00646958|453137042|FG002|Overall Study|Abnormal screening lab tests|0|||
125957512|NCT00646958|453137040|FG000|Overall Study|Withdrawal by Subject|1|||
125957513|NCT00646958|453137041|FG001|Overall Study|Withdrawal by Subject|2|||
125957514|NCT00646958|453137042|FG002|Overall Study|Withdrawal by Subject|0|||
125957515|NCT00646958|453137040|FG000|Overall Study|Did not receive study drug|2|||
125957516|NCT00646958|453137041|FG001|Overall Study|Did not receive study drug|0|||
125957517|NCT00646958|453137042|FG002|Overall Study|Did not receive study drug|2|||
125957518|NCT00600821|453137044|FG000|Overall Study|Death|45|||
125957519|NCT00600821|453137045|FG001|Overall Study|Death|46|||
125957520|NCT00600821|453137044|FG000|Overall Study|Lost to Follow-up|2|||
125957521|NCT00600821|453137045|FG001|Overall Study|Lost to Follow-up|2|||
125957522|NCT00600821|453137044|FG000|Overall Study|Withdrawal by Subject|1|||
125957523|NCT00600821|453137045|FG001|Overall Study|Withdrawal by Subject|1|||
125957524|NCT00600821|453137044|FG000|Overall Study|Terminated by sponsor|8|||
125957525|NCT00600821|453137045|FG001|Overall Study|Terminated by sponsor|6|||
125957526|NCT00600821|453137044|FG000|Overall Study|Objective progression or relapse|0|||
125957527|NCT00600821|453137045|FG001|Overall Study|Objective progression or relapse|1|||
125957528|NCT00600821|453137044|FG000|Overall Study|Randomized but not treated|0|||
125957529|NCT00600821|453137045|FG001|Overall Study|Randomized but not treated|1|||
125957530|NCT00600821|453137044|FG000|Overall Study|Other|2|||
125957531|NCT00600821|453137045|FG001|Overall Study|Other|3|||
125957532|NCT00659646|453137051|FG000|Overall Study|Protocol Violation|12|||
125957533|NCT00659646|453137052|FG001|Overall Study|Protocol Violation|8|||
125957534|NCT00659646|453137051|FG000|Overall Study|Adverse Event|1|||
125957535|NCT00659646|453137052|FG001|Overall Study|Adverse Event|0|||
125957536|NCT00659646|453137051|FG000|Overall Study|Lost to Follow-up|1|||
125957537|NCT00659646|453137052|FG001|Overall Study|Lost to Follow-up|0|||
125957538|NCT00659646|453137051|FG000|Overall Study|protocol noncompliance after randomized|1|||
125957539|NCT00659646|453137052|FG001|Overall Study|protocol noncompliance after randomized|0|||
125957540|NCT00023673|453137053|FG000|Overall Study|Ineligible / no protocol treatment|0|||
125957541|NCT00023673|453137054|FG001|Overall Study|Ineligible / no protocol treatment|0|||
125957542|NCT00023673|453137055|FG002|Overall Study|Ineligible / no protocol treatment|0|||
125957543|NCT00023673|453137056|FG003|Overall Study|Ineligible / no protocol treatment|1|||
125957544|NCT00023673|453137053|FG000|Overall Study|Patient withdrew consent|0|||
125957545|NCT00023673|453137054|FG001|Overall Study|Patient withdrew consent|0|||
125957546|NCT00023673|453137055|FG002|Overall Study|Patient withdrew consent|0|||
125957547|NCT00023673|453137056|FG003|Overall Study|Patient withdrew consent|1|||
125957548|NCT02453594|453137060|FG000|Overall Study|Protocol Violation|0|||
125957549|NCT02453594|453137061|FG001|Overall Study|Protocol Violation|0|||
125957550|NCT02453594|453137062|FG002|Overall Study|Protocol Violation|1|||
125957551|NCT02453594|453137060|FG000|Overall Study|Cohort Was Closed|17|||
125957552|NCT02453594|453137061|FG001|Overall Study|Cohort Was Closed|21|||
125957553|NCT02453594|453137062|FG002|Overall Study|Cohort Was Closed|14|||
125957554|NCT02453594|453137060|FG000|Overall Study|Death|20|||
125957555|NCT02453594|453137061|FG001|Overall Study|Death|24|||
125957556|NCT02453594|453137062|FG002|Overall Study|Death|16|||
125957557|NCT02453594|453137060|FG000|Overall Study|Lost to Follow-up|6|||
125957558|NCT02453594|453137061|FG001|Overall Study|Lost to Follow-up|14|||
125957559|NCT02453594|453137062|FG002|Overall Study|Lost to Follow-up|2|||
125957560|NCT02453594|453137060|FG000|Overall Study|Physician Decision|2|||
125957561|NCT02453594|453137061|FG001|Overall Study|Physician Decision|4|||
125957562|NCT02453594|453137062|FG002|Overall Study|Physician Decision|0|||
125957563|NCT02453594|453137060|FG000|Overall Study|Site Terminated by Sponsor|1|||
125957564|NCT02453594|453137061|FG001|Overall Study|Site Terminated by Sponsor|0|||
125957565|NCT02453594|453137062|FG002|Overall Study|Site Terminated by Sponsor|1|||
125957566|NCT02453594|453137060|FG000|Overall Study|Transitioned to Extension Study|16|||
125957567|NCT02453594|453137061|FG001|Overall Study|Transitioned to Extension Study|9|||
125957568|NCT02453594|453137062|FG002|Overall Study|Transitioned to Extension Study|16|||
125957569|NCT02453594|453137060|FG000|Overall Study|Withdrawal by Subject|7|||
125957570|NCT02453594|453137061|FG001|Overall Study|Withdrawal by Subject|9|||
125957571|NCT02453594|453137062|FG002|Overall Study|Withdrawal by Subject|11|||
125957572|NCT04101526|453137072|FG000|Overall Study|Did not complete all sleep diary entries|0|||
125957573|NCT04101526|453137073|FG001|Overall Study|Did not complete all sleep diary entries|1|||
125957574|NCT00912405|453137074|FG000|Overall Study|Lost to Follow-up|5|||
125957575|NCT02167035|453137075|FG000|Overall Study|Adverse Event|2|||
125957576|NCT02167035|453137076|FG001|Overall Study|Adverse Event|2|||
125957577|NCT02167035|453137075|FG000|Overall Study|Lost to Follow-up|3|||
125957578|NCT02167035|453137076|FG001|Overall Study|Lost to Follow-up|3|||
125957579|NCT02167035|453137075|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
125957580|NCT02167035|453137076|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
125957581|NCT02148003|453137077|FG000|Overall Study|Failed inclusion criteria|1|||
125957582|NCT02148003|453137078|FG001|Overall Study|Failed inclusion criteria|0|||
125957583|NCT02148003|453137077|FG000|Overall Study|Met exclusion criteria|0|||
125957584|NCT02148003|453137078|FG001|Overall Study|Met exclusion criteria|1|||
125957585|NCT02148003|453137077|FG000|Overall Study|Withdrawal by Subject|0|||
125957586|NCT02148003|453137078|FG001|Overall Study|Withdrawal by Subject|1|||
125957587|NCT02489981|453137079|FG000|Overall Study|Adverse Event|21|||
125957588|NCT02489981|453137079|FG000|Overall Study|Insufficient effectiveness|16|||
125957589|NCT02489981|453137079|FG000|Overall Study|Improved|31|||
125957590|NCT02489981|453137079|FG000|Overall Study|Lost to Follow-up|31|||
125957591|NCT02489981|453137079|FG000|Overall Study|Other than listed|28|||
125957592|NCT03852316|453137082|FG000|Overall Study|Protocol Violation|1|||
125957593|NCT03852316|453137082|FG000|Overall Study|Withdrawal by Subject|2|||
125957594|NCT03852316|453137082|FG000|Overall Study|Enrolled but Device not Utilized|1|||
125957595|NCT02664038|453137086|FG000|13 Week|Lost to Follow-up|7|||
125957596|NCT02664038|453137087|FG001|13 Week|Lost to Follow-up|14|||
125957597|NCT02664038|453137086|FG000|13 Week|Withdrawal by Subject|1|||
125957598|NCT02664038|453137087|FG001|13 Week|Withdrawal by Subject|0|||
125957599|NCT02664038|453137086|FG000|26 Week|Lost to Follow-up|5|||
125957600|NCT02664038|453137087|FG001|26 Week|Lost to Follow-up|4|||
125957601|NCT02606136|453137092|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
125957602|NCT02606136|453137092|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
125957603|NCT02606136|453137092|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
125957604|NCT02606136|453137092|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
125957605|NCT03296696|453137093|FG000|Overall Study|Started Other Antitumor Therapy|1|||
125957606|NCT03296696|453137094|FG001|Overall Study|Started Other Antitumor Therapy|2|||
125957607|NCT03296696|453137095|FG002|Overall Study|Started Other Antitumor Therapy|1|||
125957608|NCT03296696|453137096|FG003|Overall Study|Started Other Antitumor Therapy|2|||
125957609|NCT03296696|453137097|FG004|Overall Study|Started Other Antitumor Therapy|1|||
125957610|NCT03296696|453137098|FG005|Overall Study|Started Other Antitumor Therapy|1|||
125957611|NCT03296696|453137099|FG006|Overall Study|Started Other Antitumor Therapy|2|||
125957612|NCT03296696|453137100|FG007|Overall Study|Started Other Antitumor Therapy|3|||
125957613|NCT03296696|453137101|FG008|Overall Study|Started Other Antitumor Therapy|1|||
125957614|NCT03296696|453137102|FG009|Overall Study|Started Other Antitumor Therapy|0|||
125957615|NCT03296696|453137093|FG000|Overall Study|Death|0|||
125957616|NCT03296696|453137094|FG001|Overall Study|Death|1|||
125957617|NCT03296696|453137095|FG002|Overall Study|Death|1|||
125957618|NCT03296696|453137096|FG003|Overall Study|Death|2|||
125957619|NCT03296696|453137097|FG004|Overall Study|Death|2|||
125957620|NCT03296696|453137098|FG005|Overall Study|Death|3|||
125957621|NCT03296696|453137099|FG006|Overall Study|Death|1|||
125957622|NCT03296696|453137100|FG007|Overall Study|Death|2|||
126116584|NCT00467779|453721969|FG013|Stage 1A|Withdrawal by Subject|0|||
126116585|NCT00467779|453721970|FG014|Stage 1A|Withdrawal by Subject|0|||
125957623|NCT03296696|453137101|FG008|Overall Study|Death|0|||
125957624|NCT03296696|453137102|FG009|Overall Study|Death|0|||
125957625|NCT03296696|453137093|FG000|Overall Study|Withdrawal by Subject|0|||
125957626|NCT03296696|453137094|FG001|Overall Study|Withdrawal by Subject|0|||
125957627|NCT03296696|453137095|FG002|Overall Study|Withdrawal by Subject|1|||
125957628|NCT03296696|453137096|FG003|Overall Study|Withdrawal by Subject|0|||
125957629|NCT03296696|453137097|FG004|Overall Study|Withdrawal by Subject|1|||
125957630|NCT03296696|453137098|FG005|Overall Study|Withdrawal by Subject|0|||
125957631|NCT03296696|453137099|FG006|Overall Study|Withdrawal by Subject|0|||
125957632|NCT03296696|453137100|FG007|Overall Study|Withdrawal by Subject|0|||
125957633|NCT03296696|453137101|FG008|Overall Study|Withdrawal by Subject|0|||
125957634|NCT03296696|453137102|FG009|Overall Study|Withdrawal by Subject|1|||
125957635|NCT04694131|453137106|FG000|Overall Study|Withdrawal by Subject|7|||
125957636|NCT04694131|453137106|FG000|Overall Study|Screen Failure|1|||
125957637|NCT04694131|453137106|FG000|Overall Study|High stimulation threshold|3|||
125957638|NCT04456699|453137107|FG000|Overall Study|Death|48|||
125957639|NCT04456699|453137108|FG001|Overall Study|Death|50|||
125957640|NCT04456699|453137109|FG002|Overall Study|Death|52|||
125957641|NCT04456699|453137107|FG000|Overall Study|Physician Decision|0|||
125957642|NCT04456699|453137108|FG001|Overall Study|Physician Decision|0|||
125957643|NCT04456699|453137109|FG002|Overall Study|Physician Decision|2|||
125957644|NCT04456699|453137107|FG000|Overall Study|Sponsor Decision|55|||
125957645|NCT04456699|453137108|FG001|Overall Study|Sponsor Decision|61|||
125957646|NCT04456699|453137109|FG002|Overall Study|Sponsor Decision|50|||
125957647|NCT04456699|453137107|FG000|Overall Study|Withdrawal by Subject|8|||
125957648|NCT04456699|453137108|FG001|Overall Study|Withdrawal by Subject|4|||
125957649|NCT04456699|453137109|FG002|Overall Study|Withdrawal by Subject|5|||
125957650|NCT04112810|453137110|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
125957651|NCT02247349|453137121|FG000|Overall Study|Disease Progression|7|||
125957652|NCT02247349|453137122|FG001|Overall Study|Disease Progression|4|||
125957653|NCT02247349|453137123|FG002|Overall Study|Disease Progression|26|||
125957654|NCT02247349|453137124|FG003|Overall Study|Disease Progression|31|||
125957655|NCT02247349|453137125|FG004|Overall Study|Disease Progression|16|||
125957656|NCT02247349|453137126|FG005|Overall Study|Disease Progression|6|||
125957657|NCT02247349|453137121|FG000|Overall Study|Study drug toxicity|0|||
125957658|NCT02247349|453137122|FG001|Overall Study|Study drug toxicity|1|||
125957659|NCT02247349|453137123|FG002|Overall Study|Study drug toxicity|1|||
125957660|NCT02247349|453137124|FG003|Overall Study|Study drug toxicity|1|||
125957661|NCT02247349|453137125|FG004|Overall Study|Study drug toxicity|2|||
125957662|NCT02247349|453137126|FG005|Overall Study|Study drug toxicity|2|||
125957663|NCT02247349|453137121|FG000|Overall Study|Death|0|||
125957664|NCT02247349|453137122|FG001|Overall Study|Death|0|||
125957665|NCT02247349|453137123|FG002|Overall Study|Death|0|||
125957666|NCT02247349|453137124|FG003|Overall Study|Death|1|||
125957667|NCT02247349|453137125|FG004|Overall Study|Death|0|||
125957668|NCT02247349|453137126|FG005|Overall Study|Death|0|||
125957669|NCT02247349|453137121|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
125957670|NCT02247349|453137122|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
125957671|NCT02247349|453137123|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
125957672|NCT02247349|453137124|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
125957673|NCT02247349|453137125|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
125957674|NCT02247349|453137126|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
125957675|NCT02247349|453137121|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125957676|NCT02247349|453137122|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125957677|NCT02247349|453137123|FG002|Overall Study|Participant request to discontinue study treatment|1|||
125957678|NCT02247349|453137124|FG003|Overall Study|Participant request to discontinue study treatment|2|||
125957679|NCT02247349|453137125|FG004|Overall Study|Participant request to discontinue study treatment|1|||
125957680|NCT02247349|453137126|FG005|Overall Study|Participant request to discontinue study treatment|0|||
125957681|NCT02247349|453137121|FG000|Overall Study|Withdrawal by Subject|0|||
125957682|NCT02247349|453137122|FG001|Overall Study|Withdrawal by Subject|1|||
125957683|NCT02247349|453137123|FG002|Overall Study|Withdrawal by Subject|0|||
125957684|NCT02247349|453137124|FG003|Overall Study|Withdrawal by Subject|0|||
125957685|NCT02247349|453137125|FG004|Overall Study|Withdrawal by Subject|0|||
125957686|NCT02247349|453137126|FG005|Overall Study|Withdrawal by Subject|0|||
125957687|NCT02247349|453137121|FG000|Overall Study|Administrative reason by sponsor|0|||
125957688|NCT02247349|453137122|FG001|Overall Study|Administrative reason by sponsor|0|||
125957689|NCT02247349|453137123|FG002|Overall Study|Administrative reason by sponsor|0|||
125957690|NCT02247349|453137124|FG003|Overall Study|Administrative reason by sponsor|0|||
125957691|NCT02247349|453137125|FG004|Overall Study|Administrative reason by sponsor|1|||
125957692|NCT02247349|453137126|FG005|Overall Study|Administrative reason by sponsor|0|||
125957693|NCT02247349|453137121|FG000|Overall Study|Other reasons|0|||
125957694|NCT02247349|453137122|FG001|Overall Study|Other reasons|0|||
125957695|NCT02247349|453137123|FG002|Overall Study|Other reasons|1|||
125957696|NCT02247349|453137124|FG003|Overall Study|Other reasons|0|||
125957697|NCT02247349|453137125|FG004|Overall Study|Other reasons|0|||
125957698|NCT02247349|453137126|FG005|Overall Study|Other reasons|0|||
126116586|NCT00467779|453721956|FG000|Stage 1A|Unspecified Reason|0|||
126116587|NCT00467779|453721957|FG001|Stage 1A|Unspecified Reason|0|||
125957699|NCT04542070|453137132|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
126116588|NCT00467779|453721958|FG002|Stage 1A|Unspecified Reason|0|||
126116589|NCT00467779|453721959|FG003|Stage 1A|Unspecified Reason|0|||
126116590|NCT00467779|453721960|FG004|Stage 1A|Unspecified Reason|0|||
125957700|NCT04542070|453137133|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
125957701|NCT04542070|453137134|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
126116591|NCT00467779|453721961|FG005|Stage 1A|Unspecified Reason|0|||
125957702|NCT04542070|453137135|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
125957703|NCT04542070|453137132|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
125957704|NCT04542070|453137133|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
125957705|NCT04542070|453137134|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
125957706|NCT04542070|453137135|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
125957707|NCT04542070|453137132|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
125957708|NCT04542070|453137133|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
125957709|NCT04542070|453137134|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
125957710|NCT04542070|453137135|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
125957711|NCT04542070|453137132|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
125957712|NCT04542070|453137133|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
125957713|NCT04542070|453137134|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
125957714|NCT04542070|453137135|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
125957715|NCT04542070|453137132|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
125957716|NCT04542070|453137133|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
125957717|NCT04542070|453137134|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
125957718|NCT04542070|453137135|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
125957719|NCT04542070|453137132|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
125957720|NCT04542070|453137133|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
125957721|NCT04542070|453137134|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
125957722|NCT04542070|453137135|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
125957723|NCT04542070|453137132|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
125957724|NCT04542070|453137133|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
125957725|NCT04542070|453137134|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
125957726|NCT04542070|453137135|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
125957727|NCT04542070|453137132|FG000|Maintenance + Extension Period|Adverse Event|10|||
125957728|NCT04542070|453137133|FG001|Maintenance + Extension Period|Adverse Event|2|||
125957729|NCT04542070|453137134|FG002|Maintenance + Extension Period|Adverse Event|0|||
125957730|NCT04542070|453137135|FG003|Maintenance + Extension Period|Adverse Event|0|||
125957731|NCT04542070|453137132|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
125957732|NCT04542070|453137133|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
125957733|NCT04542070|453137134|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
125957734|NCT04542070|453137135|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
125957735|NCT04542070|453137132|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
125957736|NCT04542070|453137133|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
125957737|NCT04542070|453137134|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
125957738|NCT04542070|453137135|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
125957739|NCT04542070|453137132|FG000|Maintenance + Extension Period|Physician Decision|1|||
125957740|NCT04542070|453137133|FG001|Maintenance + Extension Period|Physician Decision|1|||
125957741|NCT04542070|453137134|FG002|Maintenance + Extension Period|Physician Decision|0|||
125957742|NCT04542070|453137135|FG003|Maintenance + Extension Period|Physician Decision|0|||
125957743|NCT04542070|453137132|FG000|Maintenance + Extension Period|Protocol Violation|2|||
125957744|NCT04542070|453137133|FG001|Maintenance + Extension Period|Protocol Violation|5|||
125957745|NCT04542070|453137134|FG002|Maintenance + Extension Period|Protocol Violation|0|||
125957746|NCT04542070|453137135|FG003|Maintenance + Extension Period|Protocol Violation|0|||
125957747|NCT04542070|453137132|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
125957748|NCT04542070|453137133|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
125957749|NCT04542070|453137134|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
125957750|NCT04542070|453137135|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
125957751|NCT04542070|453137132|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
125957752|NCT04542070|453137133|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
125957753|NCT04542070|453137134|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
125957754|NCT04542070|453137135|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
125957755|NCT04542070|453137132|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
125957756|NCT04542070|453137133|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
125957757|NCT04542070|453137134|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
125957758|NCT04542070|453137135|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
125957759|NCT04542070|453137132|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
125957760|NCT04542070|453137133|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
125957761|NCT04542070|453137134|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
125957762|NCT04542070|453137135|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
125957763|NCT04542070|453137132|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
125957764|NCT04542070|453137133|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
125957765|NCT04542070|453137134|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
125957766|NCT04542070|453137135|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
125957767|NCT04542070|453137132|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
126116592|NCT00467779|453721962|FG006|Stage 1A|Unspecified Reason|0|||
126116593|NCT00467779|453721963|FG007|Stage 1A|Unspecified Reason|0|||
126116594|NCT00467779|453721964|FG008|Stage 1A|Unspecified Reason|0|||
125957768|NCT04542070|453137133|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
125957769|NCT04542070|453137134|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
125957770|NCT04542070|453137135|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
125957771|NCT04542070|453137132|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
125957772|NCT04542070|453137133|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
125957773|NCT04542070|453137134|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
125957774|NCT04542070|453137135|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
125957775|NCT04666259|453137137|FG000|Treatment Phase|Physician Decision|9|||
125957776|NCT04666259|453137138|FG001|Treatment Phase|Physician Decision|3|||
125957777|NCT04666259|453137139|FG002|Treatment Phase|Physician Decision|3|||
125957778|NCT04666259|453137137|FG000|Treatment Phase|Adverse Event|3|||
125957779|NCT04666259|453137138|FG001|Treatment Phase|Adverse Event|1|||
125957780|NCT04666259|453137139|FG002|Treatment Phase|Adverse Event|0|||
125957781|NCT04666259|453137137|FG000|Treatment Phase|Subject decision|1|||
125957782|NCT04666259|453137138|FG001|Treatment Phase|Subject decision|2|||
125957783|NCT04666259|453137139|FG002|Treatment Phase|Subject decision|0|||
125957784|NCT04666259|453137137|FG000|Treatment Phase|Progressive disease|0|||
125957785|NCT04666259|453137138|FG001|Treatment Phase|Progressive disease|1|||
125957786|NCT04666259|453137139|FG002|Treatment Phase|Progressive disease|0|||
125957787|NCT04666259|453137137|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
125957788|NCT04666259|453137138|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
125957789|NCT04666259|453137139|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
125957790|NCT04666259|453137137|FG000|Safety Follow-up Phase|Physician Decision|2|||
125957791|NCT04666259|453137138|FG001|Safety Follow-up Phase|Physician Decision|0|||
125957792|NCT04666259|453137139|FG002|Safety Follow-up Phase|Physician Decision|0|||
125957793|NCT04666259|453137137|FG000|Safety Follow-up Phase|Subject decision|1|||
125957794|NCT04666259|453137138|FG001|Safety Follow-up Phase|Subject decision|0|||
125957795|NCT04666259|453137139|FG002|Safety Follow-up Phase|Subject decision|0|||
125957796|NCT04666259|453137137|FG000|Safety Follow-up Phase|Death|0|||
125957797|NCT04666259|453137138|FG001|Safety Follow-up Phase|Death|1|||
125957798|NCT04666259|453137139|FG002|Safety Follow-up Phase|Death|0|||
125957799|NCT00378703|453137140|FG000|Overall Study|Disease progression|59|||
125957800|NCT00378703|453137141|FG001|Overall Study|Disease progression|43|||
125957801|NCT00378703|453137142|FG002|Overall Study|Disease progression|48|||
125957802|NCT00378703|453137143|FG003|Overall Study|Disease progression|49|||
125957803|NCT00378703|453137140|FG000|Overall Study|Adverse Event|11|||
125957804|NCT00378703|453137141|FG001|Overall Study|Adverse Event|17|||
125957805|NCT00378703|453137142|FG002|Overall Study|Adverse Event|20|||
125957806|NCT00378703|453137143|FG003|Overall Study|Adverse Event|18|||
125957807|NCT00378703|453137140|FG000|Overall Study|Death|2|||
125957808|NCT00378703|453137141|FG001|Overall Study|Death|2|||
125957809|NCT00378703|453137142|FG002|Overall Study|Death|4|||
125957810|NCT00378703|453137143|FG003|Overall Study|Death|3|||
125957811|NCT00378703|453137140|FG000|Overall Study|Withdrawal by Subject|4|||
125957812|NCT00378703|453137141|FG001|Overall Study|Withdrawal by Subject|8|||
125957813|NCT00378703|453137142|FG002|Overall Study|Withdrawal by Subject|5|||
125957814|NCT00378703|453137143|FG003|Overall Study|Withdrawal by Subject|7|||
125957815|NCT00378703|453137140|FG000|Overall Study|Physician Decision|1|||
125957816|NCT00378703|453137141|FG001|Overall Study|Physician Decision|4|||
125957817|NCT00378703|453137142|FG002|Overall Study|Physician Decision|1|||
125957818|NCT00378703|453137143|FG003|Overall Study|Physician Decision|0|||
125957819|NCT00378703|453137140|FG000|Overall Study|Alternative therapy|4|||
125957820|NCT00378703|453137141|FG001|Overall Study|Alternative therapy|2|||
125957821|NCT00378703|453137142|FG002|Overall Study|Alternative therapy|0|||
125957822|NCT00378703|453137143|FG003|Overall Study|Alternative therapy|0|||
125957823|NCT00378703|453137140|FG000|Overall Study|Other complicated disease|0|||
125957824|NCT00378703|453137141|FG001|Overall Study|Other complicated disease|2|||
125957825|NCT00378703|453137142|FG002|Overall Study|Other complicated disease|2|||
125957826|NCT00378703|453137143|FG003|Overall Study|Other complicated disease|0|||
125957827|NCT00378703|453137140|FG000|Overall Study|Symptomatic deterioration|0|||
125957828|NCT00378703|453137141|FG001|Overall Study|Symptomatic deterioration|1|||
125957829|NCT00378703|453137142|FG002|Overall Study|Symptomatic deterioration|0|||
125957830|NCT00378703|453137143|FG003|Overall Study|Symptomatic deterioration|2|||
125957831|NCT00378703|453137140|FG000|Overall Study|Surgery|1|||
125957832|NCT00378703|453137141|FG001|Overall Study|Surgery|0|||
125957833|NCT00378703|453137142|FG002|Overall Study|Surgery|0|||
125957834|NCT00378703|453137143|FG003|Overall Study|Surgery|1|||
125957835|NCT00378703|453137140|FG000|Overall Study|Joint decision of physician and patient|1|||
125957836|NCT00378703|453137141|FG001|Overall Study|Joint decision of physician and patient|0|||
125957837|NCT00378703|453137142|FG002|Overall Study|Joint decision of physician and patient|0|||
125957838|NCT00378703|453137143|FG003|Overall Study|Joint decision of physician and patient|0|||
125957839|NCT00378703|453137140|FG000|Overall Study|Adverse events and progressive disease|0|||
126116595|NCT00467779|453721965|FG009|Stage 1A|Unspecified Reason|0|||
125957840|NCT00378703|453137141|FG001|Overall Study|Adverse events and progressive disease|0|||
125957841|NCT00378703|453137142|FG002|Overall Study|Adverse events and progressive disease|0|||
125957842|NCT00378703|453137143|FG003|Overall Study|Adverse events and progressive disease|1|||
125957843|NCT00378703|453137140|FG000|Overall Study|Relocation|0|||
125957844|NCT00378703|453137141|FG001|Overall Study|Relocation|0|||
125957845|NCT00378703|453137142|FG002|Overall Study|Relocation|1|||
125957846|NCT00378703|453137143|FG003|Overall Study|Relocation|0|||
125957847|NCT00378703|453137140|FG000|Overall Study|Ineligible|4|||
125957848|NCT00378703|453137141|FG001|Overall Study|Ineligible|7|||
125957849|NCT00378703|453137142|FG002|Overall Study|Ineligible|7|||
125957850|NCT00378703|453137143|FG003|Overall Study|Ineligible|7|||
125957851|NCT00378703|453137140|FG000|Overall Study|Never started treatment|1|||
125957852|NCT00378703|453137141|FG001|Overall Study|Never started treatment|4|||
125957853|NCT00378703|453137142|FG002|Overall Study|Never started treatment|0|||
125957854|NCT00378703|453137143|FG003|Overall Study|Never started treatment|0|||
125957855|NCT00378703|453137140|FG000|Overall Study|Other|1|||
125957856|NCT00378703|453137141|FG001|Overall Study|Other|1|||
125957857|NCT00378703|453137142|FG002|Overall Study|Other|2|||
125957858|NCT00378703|453137143|FG003|Overall Study|Other|3|||
125957859|NCT02188485|453137144|FG000|Overall Study|Withdrawal by Subject|2|||
125957860|NCT02188485|453137145|FG001|Overall Study|Withdrawal by Subject|1|||
125957861|NCT02188485|453137144|FG000|Overall Study|PI withdrew, lack of capacity|0|||
125957862|NCT02188485|453137145|FG001|Overall Study|PI withdrew, lack of capacity|2|||
125957863|NCT02457325|453137149|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
125957864|NCT02457325|453137150|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
125957865|NCT00773097|453137153|FG000|Overall Study|Withdrawal by Subject|1|||
125957866|NCT00773097|453137153|FG000|Overall Study|Physician Decision|6|||
125957867|NCT00424372|453138417|FG000|Overall Study|Death|1|||
125957868|NCT00424372|453138417|FG000|Overall Study|Adverse Event|18|||
125957869|NCT00424372|453138417|FG000|Overall Study|Lack of Efficacy|6|||
125957870|NCT00424372|453138417|FG000|Overall Study|Withdrawal by Subject|4|||
125957871|NCT00424372|453138417|FG000|Overall Study|Protocol Violation|1|||
125957872|NCT00424372|453138417|FG000|Overall Study|Health deterioration|1|||
125957873|NCT02932891|453138418|FG000|Overall Study|Lost to Follow-up|2|||
125957874|NCT02932891|453138418|FG000|Overall Study|HPA Suppress|2|||
125957875|NCT04622254|453138419|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125957876|NCT04622254|453138420|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
125957877|NCT04622254|453138421|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125957878|NCT04622254|453138422|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125957879|NCT04622254|453138423|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125957880|NCT04622254|453138424|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125957881|NCT04622254|453138419|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
125957882|NCT04622254|453138420|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
125957883|NCT04622254|453138421|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
125957884|NCT04622254|453138422|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125957885|NCT04622254|453138423|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125957886|NCT04622254|453138424|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125957887|NCT04622254|453138419|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
125957888|NCT04622254|453138420|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125957889|NCT04622254|453138421|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125957890|NCT04622254|453138422|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125957891|NCT04622254|453138423|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125957892|NCT04622254|453138424|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125957893|NCT04622254|453138419|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125957894|NCT04622254|453138420|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
125957895|NCT04622254|453138421|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
125957896|NCT04622254|453138422|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125957897|NCT04622254|453138423|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125957898|NCT04622254|453138424|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125957899|NCT04622254|453138419|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125957900|NCT04622254|453138420|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125957901|NCT04622254|453138421|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125957902|NCT04622254|453138422|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
125957903|NCT04622254|453138423|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125957904|NCT04622254|453138424|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126116596|NCT00467779|453721966|FG010|Stage 1A|Unspecified Reason|0|||
125957905|NCT04622254|453138419|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125957906|NCT04622254|453138420|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125957907|NCT04622254|453138421|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126116597|NCT00467779|453721967|FG011|Stage 1A|Unspecified Reason|1|||
125957908|NCT04622254|453138422|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
125957909|NCT04622254|453138423|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125957910|NCT04622254|453138424|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
126116598|NCT00467779|453721968|FG012|Stage 1A|Unspecified Reason|1|||
125957911|NCT04622254|453138419|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125957912|NCT04622254|453138420|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125957913|NCT04622254|453138421|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125957914|NCT04622254|453138422|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
125957915|NCT04622254|453138423|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125957916|NCT04622254|453138424|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125957917|NCT04622254|453138419|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125957918|NCT04622254|453138420|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125957919|NCT04622254|453138421|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125957920|NCT04622254|453138422|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
125957921|NCT04622254|453138423|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125957922|NCT04622254|453138424|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125957923|NCT04622254|453138419|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125957924|NCT04622254|453138420|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125957925|NCT04622254|453138421|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125957926|NCT04622254|453138422|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
125957927|NCT04622254|453138423|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
125957928|NCT04622254|453138424|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
125957929|NCT04622254|453138419|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125957930|NCT04622254|453138420|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125957931|NCT04622254|453138421|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125957932|NCT04622254|453138422|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
125957933|NCT04622254|453138423|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
125957934|NCT04622254|453138424|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
125957935|NCT04622254|453138419|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
125957936|NCT04622254|453138420|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
125957937|NCT04622254|453138421|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
125957938|NCT04622254|453138422|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
125957939|NCT04622254|453138423|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
125957940|NCT04622254|453138424|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
125957941|NCT02652624|453138425|FG000|Randomized Phase|Pregnancy|3|||
125957942|NCT02652624|453138426|FG001|Randomized Phase|Pregnancy|1|||
125957943|NCT02652624|453138425|FG000|Randomized Phase|Investigator's Discretion|0|||
125957944|NCT02652624|453138426|FG001|Randomized Phase|Investigator's Discretion|2|||
125957945|NCT02652624|453138425|FG000|Randomized Phase|Death|0|||
125957946|NCT02652624|453138426|FG001|Randomized Phase|Death|1|||
125957947|NCT02652624|453138425|FG000|Randomized Phase|Lost to Follow-up|0|||
125957948|NCT02652624|453138426|FG001|Randomized Phase|Lost to Follow-up|1|||
125957949|NCT02652624|453138425|FG000|Extension Phase|Lost to Follow-up|3|||
125957950|NCT02652624|453138426|FG001|Extension Phase|Lost to Follow-up|1|||
125957951|NCT02652624|453138425|FG000|Extension Phase|Pregnancy|1|||
125957952|NCT02652624|453138426|FG001|Extension Phase|Pregnancy|1|||
125957953|NCT02652624|453138425|FG000|Extension Phase|Adverse Event|0|||
125957954|NCT02652624|453138426|FG001|Extension Phase|Adverse Event|1|||
125957955|NCT02652624|453138425|FG000|Extension Phase|Withdrew Consent|0|||
125957956|NCT02652624|453138426|FG001|Extension Phase|Withdrew Consent|1|||
125957957|NCT01023659|453138427|FG000|Overall Study|Lost to Follow-up|73|||
125957958|NCT01023659|453138428|FG001|Overall Study|Lost to Follow-up|228|||
125957959|NCT01023659|453138429|FG002|Overall Study|Lost to Follow-up|99|||
125957960|NCT00501540|453138432|FG000|Overall Study|Death|5|||
125957961|NCT01797536|453138433|FG000|Overall Study|Adverse Event|0|||
125957962|NCT01797536|453138434|FG001|Overall Study|Adverse Event|1|||
125957963|NCT01797536|453138435|FG002|Overall Study|Adverse Event|0|||
125957964|NCT01797536|453138436|FG003|Overall Study|Adverse Event|0|||
125957965|NCT00098839|453138437|FG000|Overall Study|Adverse Event|5|||
126116599|NCT00467779|453721969|FG013|Stage 1A|Unspecified Reason|0|||
126116600|NCT00467779|453721970|FG014|Stage 1A|Unspecified Reason|0|||
126116601|NCT00467779|453721956|FG000|Stage 2|Adverse Event|0|||
126116602|NCT00467779|453721957|FG001|Stage 2|Adverse Event|0|||
126116603|NCT00467779|453721958|FG002|Stage 2|Adverse Event|0|||
126116604|NCT00467779|453721959|FG003|Stage 2|Adverse Event|0|||
125957966|NCT00098839|453138438|FG001|Overall Study|Adverse Event|2|||
125957967|NCT00098839|453138437|FG000|Overall Study|Death|1|||
125957968|NCT00098839|453138438|FG001|Overall Study|Death|2|||
125957969|NCT00098839|453138437|FG000|Overall Study|Physician Decision|4|||
125957970|NCT00098839|453138438|FG001|Overall Study|Physician Decision|14|||
125957971|NCT00098839|453138437|FG000|Overall Study|Withdrawal by Subject|1|||
125957972|NCT00098839|453138438|FG001|Overall Study|Withdrawal by Subject|0|||
125957973|NCT00098839|453138437|FG000|Overall Study|Refusal of further protocol therapy|3|||
125957974|NCT00098839|453138438|FG001|Overall Study|Refusal of further protocol therapy|1|||
125957975|NCT00098839|453138437|FG000|Overall Study|Relapse|6|||
125957976|NCT00098839|453138438|FG001|Overall Study|Relapse|3|||
125957977|NCT00098839|453138437|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
126116605|NCT00467779|453721960|FG004|Stage 2|Adverse Event|0|||
126116606|NCT00467779|453721961|FG005|Stage 2|Adverse Event|0|||
125957978|NCT00098839|453138438|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
125957979|NCT00098839|453138437|FG000|Overall Study|Ineligible|2|||
125957980|NCT00098839|453138438|FG001|Overall Study|Ineligible|0|||
125957981|NCT03228680|453138441|FG000|Overall Study|Adverse Event|13|||
125957982|NCT03228680|453138442|FG001|Overall Study|Adverse Event|18|||
125957983|NCT03228680|453138441|FG000|Overall Study|Randomization failure|0|||
125957984|NCT03228680|453138442|FG001|Overall Study|Randomization failure|1|||
125957985|NCT03228680|453138441|FG000|Overall Study|Withdrawal by Subject|1|||
125957986|NCT03228680|453138442|FG001|Overall Study|Withdrawal by Subject|0|||
125957987|NCT03228680|453138441|FG000|Overall Study|Other|9|||
125957988|NCT03228680|453138442|FG001|Overall Study|Other|16|||
125957989|NCT00796861|453138450|FG000|Overall Study|Withdrawal by Subject|2|||
125957990|NCT00796861|453138450|FG000|Overall Study|Death|2|||
125957991|NCT02370888|453138451|FG000|Overall Study|disease progression|2|||
125957992|NCT02370888|453138451|FG000|Overall Study|did not meet chimerism criteria|6|||
125957993|NCT02104557|453138452|FG000|Overall Study|Adverse Event|24|||
125957994|NCT02104557|453138452|FG000|Overall Study|Lost to Follow-up|34|||
125957995|NCT02104557|453138452|FG000|Overall Study|Violated the usage and dosage|14|||
125957996|NCT02104557|453138452|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
125957997|NCT02104557|453138452|FG000|Overall Study|Administered Sayana prior to the contract|1|||
125957998|NCT02104557|453138452|FG000|Overall Study|Other|17|||
125957999|NCT02104557|453138452|FG000|Overall Study|Change to other contraception methods|5|||
125958000|NCT02104557|453138452|FG000|Overall Study|Discontinuation due to no pain|1|||
125958001|NCT02104557|453138452|FG000|Overall Study|Withdrawal consent|2|||
125958002|NCT02104557|453138452|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
125958003|NCT02104557|453138452|FG000|Overall Study|Discontinuation of contraception|9|||
125958004|NCT02178475|453138454|FG000|Overall Study|Withdrawal by Subject|7|||
125958005|NCT02178475|453138454|FG000|Overall Study|Lost to Follow-up|10|||
125958006|NCT02178475|453138454|FG000|Overall Study|Death|13|||
125958007|NCT02178475|453138454|FG000|Overall Study|Protocol-specified Criteria|99|||
125958008|NCT01430585|453138455|FG000|Overall Study|Death|1|||
125958009|NCT01430585|453138455|FG000|Overall Study|Objective Progression or Relapse|3|||
125958010|NCT01430585|453138455|FG000|Overall Study|Study Terminated by Sponsor|3|||
125958011|NCT01430585|453138455|FG000|Overall Study|Other|7|||
125958012|NCT01412424|453138456|FG000|Core Treatment Period|Treatment Failure|24|||
125958013|NCT01412424|453138456|FG000|Core Treatment Period|Adverse Event|21|||
125958014|NCT01412424|453138456|FG000|Core Treatment Period|Patient Request|5|||
125958015|NCT01412424|453138456|FG000|Core Treatment Period|Lost to Follow-up|2|||
125958016|NCT01412424|453138456|FG000|Core Treatment Period|Sponsor Request|1|||
125958017|NCT01412424|453138456|FG000|Extension Treatment Period|Adverse Event|2|||
125958018|NCT01412424|453138456|FG000|Extension Treatment Period|Treatment Failure|2|||
125958019|NCT01412424|453138456|FG000|Extension Treatment Period|Patient Request|2|||
125958020|NCT04304001|453138459|FG000|Overall Study|Lost to Follow-up|13|||
125958021|NCT04304001|453138460|FG001|Overall Study|Lost to Follow-up|9|||
125958022|NCT00699699|453138463|FG000|Overall Study|Adverse Event|36|||
125958023|NCT00699699|453138463|FG000|Overall Study|Individual different reasons|21|||
125958024|NCT01000051|453138464|FG000|Overall Study|Withdrawal by Subject|1|||
125958025|NCT01000051|453138465|FG001|Overall Study|Withdrawal by Subject|1|||
125958026|NCT01000051|453138464|FG000|Overall Study|Disease Progression|1|||
125958027|NCT01000051|453138465|FG001|Overall Study|Disease Progression|0|||
125958028|NCT01000051|453138464|FG000|Overall Study|Serious noncompliance|1|||
125958029|NCT01000051|453138465|FG001|Overall Study|Serious noncompliance|0|||
125958030|NCT00414050|453138466|FG000|Overall Study|Adverse Event|1|||
125958031|NCT00414050|453138467|FG001|Overall Study|Adverse Event|1|||
125958032|NCT00414050|453138468|FG002|Overall Study|Adverse Event|1|||
125958033|NCT00414050|453138469|FG003|Overall Study|Adverse Event|1|||
125958034|NCT00414050|453138466|FG000|Overall Study|Lost to Follow-up|2|||
125958035|NCT00414050|453138467|FG001|Overall Study|Lost to Follow-up|2|||
125958036|NCT00414050|453138468|FG002|Overall Study|Lost to Follow-up|1|||
125958037|NCT00414050|453138469|FG003|Overall Study|Lost to Follow-up|1|||
125958038|NCT00414050|453138466|FG000|Overall Study|Withdrawal by Subject|5|||
125958039|NCT00414050|453138467|FG001|Overall Study|Withdrawal by Subject|3|||
125958040|NCT00414050|453138468|FG002|Overall Study|Withdrawal by Subject|2|||
125958041|NCT00414050|453138469|FG003|Overall Study|Withdrawal by Subject|4|||
125958042|NCT00414050|453138466|FG000|Overall Study|Subject discontinued for other reason|1|||
125958043|NCT00414050|453138467|FG001|Overall Study|Subject discontinued for other reason|2|||
125958044|NCT00414050|453138468|FG002|Overall Study|Subject discontinued for other reason|2|||
126116607|NCT00467779|453721962|FG006|Stage 2|Adverse Event|0|||
126116608|NCT00467779|453721963|FG007|Stage 2|Adverse Event|0|||
125958045|NCT00414050|453138469|FG003|Overall Study|Subject discontinued for other reason|1|||
125958046|NCT00414050|453138466|FG000|Overall Study|Subject Moved|0|||
125958047|NCT00414050|453138467|FG001|Overall Study|Subject Moved|0|||
125958048|NCT00414050|453138468|FG002|Overall Study|Subject Moved|0|||
125958049|NCT00414050|453138469|FG003|Overall Study|Subject Moved|1|||
125958050|NCT03495908|453138475|FG000|Overall Study|Withdrawal by Subject|3|||
125958051|NCT03495908|453138476|FG001|Overall Study|Withdrawal by Subject|1|||
126116609|NCT00467779|453721964|FG008|Stage 2|Adverse Event|1|||
125958052|NCT03495908|453138475|FG000|Overall Study|Lost to Follow-up|1|||
125958053|NCT03495908|453138476|FG001|Overall Study|Lost to Follow-up|4|||
125958054|NCT03495908|453138475|FG000|Overall Study|Adverse Event|0|||
125958055|NCT03495908|453138476|FG001|Overall Study|Adverse Event|2|||
125958056|NCT03495908|453138475|FG000|Overall Study|Death|1|||
125958057|NCT03495908|453138476|FG001|Overall Study|Death|0|||
125958058|NCT03495908|453138475|FG000|Overall Study|Physician Decision|5|||
125958059|NCT03495908|453138476|FG001|Overall Study|Physician Decision|4|||
125958060|NCT03495908|453138475|FG000|Overall Study|No documented reason|0|||
125958061|NCT03495908|453138476|FG001|Overall Study|No documented reason|2|||
125958062|NCT03304379|453138477|FG000|Overall Study|Protocol Violation|8|||
125958063|NCT03304379|453138478|FG001|Overall Study|Protocol Violation|10|||
125958064|NCT03304379|453138479|FG002|Overall Study|Protocol Violation|5|||
125958065|NCT03304379|453138480|FG003|Overall Study|Protocol Violation|0|||
125958066|NCT03304379|453138481|FG004|Overall Study|Protocol Violation|2|||
125958067|NCT03304379|453138477|FG000|Overall Study|Adverse Event|4|||
125958068|NCT03304379|453138478|FG001|Overall Study|Adverse Event|20|||
125958069|NCT03304379|453138479|FG002|Overall Study|Adverse Event|17|||
125958070|NCT03304379|453138480|FG003|Overall Study|Adverse Event|1|||
125958071|NCT03304379|453138481|FG004|Overall Study|Adverse Event|0|||
125958072|NCT03304379|453138477|FG000|Overall Study|Lack of Efficacy|17|||
125958073|NCT03304379|453138478|FG001|Overall Study|Lack of Efficacy|16|||
125958074|NCT03304379|453138479|FG002|Overall Study|Lack of Efficacy|20|||
125958075|NCT03304379|453138480|FG003|Overall Study|Lack of Efficacy|0|||
125958076|NCT03304379|453138481|FG004|Overall Study|Lack of Efficacy|0|||
125958077|NCT03304379|453138477|FG000|Overall Study|Physician Decision|6|||
125958078|NCT03304379|453138478|FG001|Overall Study|Physician Decision|10|||
125958079|NCT03304379|453138479|FG002|Overall Study|Physician Decision|6|||
125958080|NCT03304379|453138480|FG003|Overall Study|Physician Decision|9|||
125958081|NCT03304379|453138481|FG004|Overall Study|Physician Decision|10|||
125958082|NCT03304379|453138477|FG000|Overall Study|Withdrawal by Subject|26|||
125958083|NCT03304379|453138478|FG001|Overall Study|Withdrawal by Subject|58|||
125958084|NCT03304379|453138479|FG002|Overall Study|Withdrawal by Subject|66|||
125958085|NCT03304379|453138480|FG003|Overall Study|Withdrawal by Subject|3|||
125958086|NCT03304379|453138481|FG004|Overall Study|Withdrawal by Subject|5|||
125958087|NCT03304379|453138477|FG000|Overall Study|Lost to Follow-up|8|||
125958088|NCT03304379|453138478|FG001|Overall Study|Lost to Follow-up|24|||
125958089|NCT03304379|453138479|FG002|Overall Study|Lost to Follow-up|35|||
125958090|NCT03304379|453138480|FG003|Overall Study|Lost to Follow-up|4|||
125958091|NCT03304379|453138481|FG004|Overall Study|Lost to Follow-up|0|||
125958092|NCT03304379|453138477|FG000|Overall Study|Death|1|||
125958093|NCT03304379|453138478|FG001|Overall Study|Death|2|||
125958094|NCT03304379|453138479|FG002|Overall Study|Death|0|||
125958095|NCT03304379|453138480|FG003|Overall Study|Death|0|||
125958096|NCT03304379|453138481|FG004|Overall Study|Death|0|||
125958097|NCT03304379|453138477|FG000|Overall Study|Other|0|||
125958098|NCT03304379|453138478|FG001|Overall Study|Other|1|||
125958099|NCT03304379|453138479|FG002|Overall Study|Other|0|||
126116610|NCT00467779|453721965|FG009|Stage 2|Adverse Event|0|||
126116611|NCT00467779|453721966|FG010|Stage 2|Adverse Event|0|||
126116612|NCT00467779|453721967|FG011|Stage 2|Adverse Event|0|||
126116613|NCT00467779|453721968|FG012|Stage 2|Adverse Event|0|||
126116614|NCT00467779|453721969|FG013|Stage 2|Adverse Event|0|||
126116615|NCT00467779|453721970|FG014|Stage 2|Adverse Event|0|||
126116616|NCT00467779|453721956|FG000|Stage 2|Death|0|||
126116617|NCT00467779|453721957|FG001|Stage 2|Death|0|||
126116618|NCT00467779|453721958|FG002|Stage 2|Death|0|||
126116619|NCT00467779|453721959|FG003|Stage 2|Death|0|||
126116620|NCT00467779|453721960|FG004|Stage 2|Death|0|||
126116621|NCT00467779|453721961|FG005|Stage 2|Death|0|||
126116622|NCT00467779|453721962|FG006|Stage 2|Death|0|||
126116623|NCT00467779|453721963|FG007|Stage 2|Death|0|||
126116624|NCT00467779|453721964|FG008|Stage 2|Death|1|||
125958100|NCT03304379|453138480|FG003|Overall Study|Other|0|||
125958101|NCT03304379|453138481|FG004|Overall Study|Other|0|||
125958102|NCT01469065|453138495|FG000|Overall Study|Lack of Efficacy|0|||
125958103|NCT01469065|453138496|FG001|Overall Study|Lack of Efficacy|0|||
125958104|NCT01469065|453138497|FG002|Overall Study|Lack of Efficacy|0|||
125958105|NCT01469065|453138498|FG003|Overall Study|Lack of Efficacy|0|||
125958106|NCT01469065|453138499|FG004|Overall Study|Lack of Efficacy|1|||
125958107|NCT01469065|453138495|FG000|Overall Study|Other|0|||
125958108|NCT01469065|453138496|FG001|Overall Study|Other|1|||
125958109|NCT01469065|453138497|FG002|Overall Study|Other|0|||
125958110|NCT01469065|453138498|FG003|Overall Study|Other|0|||
125958111|NCT01469065|453138499|FG004|Overall Study|Other|0|||
125958112|NCT00578565|453138500|FG000|Overall Study|Adverse Event|3|||
125971515|NCT00791765|453184716|FG000|Weeks 13 to 24|Protocol deviation|2|||
126116625|NCT00467779|453721965|FG009|Stage 2|Death|0|||
126116626|NCT00467779|453721966|FG010|Stage 2|Death|0|||
126116627|NCT00467779|453721967|FG011|Stage 2|Death|0|||
126116628|NCT00467779|453721968|FG012|Stage 2|Death|0|||
126116629|NCT00467779|453721969|FG013|Stage 2|Death|0|||
126116630|NCT00467779|453721970|FG014|Stage 2|Death|0|||
126116631|NCT00467779|453721956|FG000|Stage 2|Disease Progression|0|||
126116632|NCT00467779|453721957|FG001|Stage 2|Disease Progression|0|||
125958113|NCT02203591|453138501|FG000|Overall Study|Did not meet treatment day baseline|147|||
125958114|NCT02203591|453138502|FG001|Overall Study|Did not meet treatment day baseline|141|||
125958115|NCT02203591|453138503|FG002|Overall Study|Did not meet treatment day baseline|150|||
125958116|NCT02203591|453138504|FG003|Overall Study|Did not meet treatment day baseline|45|||
125958117|NCT02203591|453138505|FG004|Overall Study|Did not meet treatment day baseline|33|||
125958118|NCT02203591|453138506|FG005|Overall Study|Did not meet treatment day baseline|35|||
125958119|NCT02203591|453138507|FG006|Overall Study|Did not meet treatment day baseline|29|||
125958120|NCT02203591|453138508|FG007|Overall Study|Did not meet treatment day baseline|12|||
125958121|NCT02203591|453138501|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
125958122|NCT02203591|453138502|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
125958123|NCT02203591|453138503|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
125958124|NCT02203591|453138504|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
125958125|NCT02203591|453138505|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
125958126|NCT02203591|453138506|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
125958127|NCT02203591|453138507|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
125958128|NCT02203591|453138508|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
125958129|NCT03286140|453138510|FG000|Overall Study|Withdrawal by Subject|10|||
125958130|NCT03286140|453138511|FG001|Overall Study|Withdrawal by Subject|5|||
125958131|NCT03286140|453138510|FG000|Overall Study|Lost to Follow-up|5|||
125958132|NCT03286140|453138511|FG001|Overall Study|Lost to Follow-up|10|||
125958133|NCT03286140|453138510|FG000|Overall Study|Failure to comply|0|||
125958134|NCT03286140|453138511|FG001|Overall Study|Failure to comply|1|||
125958135|NCT01565291|453138512|FG000|Overall Study|Withdrawal by Subject|1|||
125958136|NCT01565291|453138513|FG001|Overall Study|Withdrawal by Subject|0|||
125958137|NCT00515827|453138514|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
125958138|NCT00515827|453138515|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
125958139|NCT00515827|453138514|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
125958140|NCT00515827|453138515|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
125958141|NCT01227512|453138521|FG000|Overall Study|Physician Decision|6|||
125958142|NCT01227512|453138522|FG001|Overall Study|Physician Decision|6|||
125958143|NCT01227512|453138521|FG000|Overall Study|Adverse Event|4|||
125958144|NCT01227512|453138522|FG001|Overall Study|Adverse Event|3|||
125958145|NCT01227512|453138521|FG000|Overall Study|Withdrawal by Subject|3|||
125958146|NCT01227512|453138522|FG001|Overall Study|Withdrawal by Subject|0|||
125958147|NCT01227512|453138521|FG000|Overall Study|Participant met withdrawal criteria|0|||
125958148|NCT01227512|453138522|FG001|Overall Study|Participant met withdrawal criteria|1|||
125958149|NCT04055116|453138529|FG000|First Intervention|Physician Decision|2|||
125958150|NCT04055116|453138530|FG001|First Intervention|Physician Decision|7|||
125958151|NCT02774681|453138531|FG000|Treatment on Study|Progressive Disease|7|||
125958152|NCT02774681|453138531|FG000|Follow-Up for 3 Years|Death|11|||
125958153|NCT02774681|453138531|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
125958154|NCT04497987|453138532|FG000|Overall Study|Adverse Event|1|||
125958155|NCT04497987|453138533|FG001|Overall Study|Adverse Event|0|||
125958156|NCT04497987|453138532|FG000|Overall Study|Death|21|||
125958157|NCT04497987|453138533|FG001|Overall Study|Death|13|||
125958158|NCT04497987|453138532|FG000|Overall Study|Lost to Follow-up|19|||
125958159|NCT04497987|453138533|FG001|Overall Study|Lost to Follow-up|17|||
125958160|NCT04497987|453138532|FG000|Overall Study|Other - as reported by the investigator|22|||
125958161|NCT04497987|453138533|FG001|Overall Study|Other - as reported by the investigator|16|||
125958162|NCT04497987|453138532|FG000|Overall Study|Physician Decision|1|||
125958163|NCT04497987|453138533|FG001|Overall Study|Physician Decision|0|||
125958164|NCT04497987|453138532|FG000|Overall Study|Withdrawal by Subject|35|||
125958165|NCT04497987|453138533|FG001|Overall Study|Withdrawal by Subject|21|||
125958166|NCT00512096|453138534|FG000|Overall Study|Adverse Event|2|||
125958167|NCT00512096|453138534|FG000|Overall Study|Withdrawal by Subject|2|||
125958168|NCT00512096|453138534|FG000|Overall Study|Lack of Efficacy|3|||
125958169|NCT01069289|453138535|FG000|Overall Study|Withdrawal by Subject|15|||
125958170|NCT01069289|453138536|FG001|Overall Study|Withdrawal by Subject|26|||
125958171|NCT01069289|453138535|FG000|Overall Study|Adverse Event|21|||
125958172|NCT01069289|453138536|FG001|Overall Study|Adverse Event|28|||
125958173|NCT01069289|453138535|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125958174|NCT01069289|453138536|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125958175|NCT01069289|453138535|FG000|Overall Study|Severe non-compliance to protocol|3|||
125958176|NCT01069289|453138536|FG001|Overall Study|Severe non-compliance to protocol|2|||
125958177|NCT01069289|453138535|FG000|Overall Study|Due to deteriorating health condition|1|||
125958178|NCT01069289|453138536|FG001|Overall Study|Due to deteriorating health condition|0|||
125958179|NCT00298038|453138537|FG000|Overall Study|Lost to Follow-up|0|||
125958180|NCT00298038|453138538|FG001|Overall Study|Lost to Follow-up|1|||
125958181|NCT00298038|453138537|FG000|Overall Study|Liver Transplant|0|||
125958182|NCT00298038|453138538|FG001|Overall Study|Liver Transplant|1|||
125958183|NCT00298038|453138537|FG000|Overall Study|Protocol Violation|1|||
125958184|NCT00298038|453138538|FG001|Overall Study|Protocol Violation|3|||
126087185|NCT05000216|453612960|FG010|Stage 1|Physician Decision|0|||
125958185|NCT00298038|453138537|FG000|Overall Study|Death|6|||
125958186|NCT00298038|453138538|FG001|Overall Study|Death|3|||
125958187|NCT00298038|453138537|FG000|Overall Study|Withdrawal by Subject|6|||
125958188|NCT00298038|453138538|FG001|Overall Study|Withdrawal by Subject|9|||
125958189|NCT00298038|453138537|FG000|Overall Study|Adverse Event|8|||
125958190|NCT00298038|453138538|FG001|Overall Study|Adverse Event|7|||
125958191|NCT00298038|453138537|FG000|Overall Study|Breakthrough overt HE episode|28|||
125958192|NCT00298038|453138538|FG001|Overall Study|Breakthrough overt HE episode|69|||
125958193|NCT00298038|453138537|FG000|Overall Study|Noncompliance|1|||
125958194|NCT00298038|453138538|FG001|Overall Study|Noncompliance|0|||
125958195|NCT00298038|453138537|FG000|Overall Study|Cocaine Abuse|1|||
125958196|NCT00298038|453138538|FG001|Overall Study|Cocaine Abuse|0|||
125958197|NCT00298038|453138537|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
125958198|NCT00298038|453138538|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
125958199|NCT02696096|453138539|FG000|Overall Study|ruled out at screening|1|||
125958200|NCT02696096|453138539|FG000|Overall Study|did not attend second fMRI|1|||
125958201|NCT01755416|453138542|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
125958202|NCT01755416|453138543|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
125958203|NCT02573324|453140515|FG000|Overall Study|Withdrawal by Subject|26|||
125958204|NCT02573324|453140516|FG001|Overall Study|Withdrawal by Subject|23|||
125958205|NCT02573324|453140517|FG002|Overall Study|Withdrawal by Subject|3|||
125958206|NCT02573324|453140515|FG000|Overall Study|Lost to Follow-up|4|||
125958207|NCT02573324|453140516|FG001|Overall Study|Lost to Follow-up|5|||
125958208|NCT02573324|453140517|FG002|Overall Study|Lost to Follow-up|0|||
125958209|NCT02573324|453140515|FG000|Overall Study|Study Terminated by Sponsor|107|||
125958210|NCT02573324|453140516|FG001|Overall Study|Study Terminated by Sponsor|89|||
125958211|NCT02573324|453140517|FG002|Overall Study|Study Terminated by Sponsor|2|||
125958212|NCT02573324|453140515|FG000|Overall Study|Death|182|||
125958213|NCT02573324|453140516|FG001|Overall Study|Death|200|||
125958214|NCT02573324|453140517|FG002|Overall Study|Death|1|||
125958215|NCT02573324|453140515|FG000|Overall Study|Other, Not Specified|20|||
125958216|NCT02573324|453140516|FG001|Overall Study|Other, Not Specified|27|||
125958217|NCT02573324|453140517|FG002|Overall Study|Other, Not Specified|0|||
125958218|NCT02573324|453140515|FG000|Overall Study|Unknown Reason|2|||
125958219|NCT02573324|453140516|FG001|Overall Study|Unknown Reason|0|||
125958220|NCT02573324|453140517|FG002|Overall Study|Unknown Reason|0|||
125958221|NCT01607905|453140518|FG000|Overall Study|Withdrawal by participant|7|||
125958222|NCT01607905|453140519|FG001|Overall Study|Withdrawal by participant|2|||
125958223|NCT01607905|453140520|FG002|Overall Study|Withdrawal by participant|4|||
125958224|NCT01607905|453140521|FG003|Overall Study|Withdrawal by participant|6|||
125958225|NCT01607905|453140522|FG004|Overall Study|Withdrawal by participant|0|||
125958226|NCT01607905|453140523|FG005|Overall Study|Withdrawal by participant|4|||
125958227|NCT01607905|453140524|FG006|Overall Study|Withdrawal by participant|12|||
125958228|NCT01607905|453140518|FG000|Overall Study|Incidence or severity of AEs|5|||
125958229|NCT01607905|453140519|FG001|Overall Study|Incidence or severity of AEs|1|||
125958230|NCT01607905|453140520|FG002|Overall Study|Incidence or severity of AEs|1|||
125958231|NCT01607905|453140521|FG003|Overall Study|Incidence or severity of AEs|3|||
125958232|NCT01607905|453140522|FG004|Overall Study|Incidence or severity of AEs|0|||
125958233|NCT01607905|453140523|FG005|Overall Study|Incidence or severity of AEs|2|||
125958234|NCT01607905|453140524|FG006|Overall Study|Incidence or severity of AEs|8|||
125958235|NCT01607905|453140518|FG000|Overall Study|Disease progression|44|||
125958236|NCT01607905|453140519|FG001|Overall Study|Disease progression|16|||
125958237|NCT01607905|453140520|FG002|Overall Study|Disease progression|15|||
125958238|NCT01607905|453140521|FG003|Overall Study|Disease progression|11|||
125958239|NCT01607905|453140522|FG004|Overall Study|Disease progression|6|||
125958240|NCT01607905|453140523|FG005|Overall Study|Disease progression|7|||
125958241|NCT01607905|453140524|FG006|Overall Study|Disease progression|21|||
125958242|NCT01607905|453140518|FG000|Overall Study|Non-compliance with study procedures|0|||
125958243|NCT01607905|453140519|FG001|Overall Study|Non-compliance with study procedures|0|||
125958244|NCT01607905|453140520|FG002|Overall Study|Non-compliance with study procedures|0|||
125958245|NCT01607905|453140521|FG003|Overall Study|Non-compliance with study procedures|0|||
125958246|NCT01607905|453140522|FG004|Overall Study|Non-compliance with study procedures|0|||
125958247|NCT01607905|453140523|FG005|Overall Study|Non-compliance with study procedures|0|||
125958248|NCT01607905|453140524|FG006|Overall Study|Non-compliance with study procedures|1|||
125958249|NCT01607905|453140518|FG000|Overall Study|Death|1|||
125958250|NCT01607905|453140519|FG001|Overall Study|Death|1|||
125958251|NCT01607905|453140520|FG002|Overall Study|Death|1|||
125958252|NCT01607905|453140521|FG003|Overall Study|Death|1|||
125958253|NCT01607905|453140522|FG004|Overall Study|Death|0|||
125958254|NCT01607905|453140523|FG005|Overall Study|Death|0|||
125958255|NCT01607905|453140524|FG006|Overall Study|Death|3|||
125958256|NCT01607905|453140518|FG000|Overall Study|Other treatments become available|1|||
125958257|NCT01607905|453140519|FG001|Overall Study|Other treatments become available|0|||
125958258|NCT01607905|453140520|FG002|Overall Study|Other treatments become available|0|||
125958259|NCT01607905|453140521|FG003|Overall Study|Other treatments become available|0|||
125958260|NCT01607905|453140522|FG004|Overall Study|Other treatments become available|0|||
125958261|NCT01607905|453140523|FG005|Overall Study|Other treatments become available|0|||
125958262|NCT01607905|453140524|FG006|Overall Study|Other treatments become available|1|||
125958263|NCT01607905|453140518|FG000|Overall Study|Investigator discretion|0|||
125958264|NCT01607905|453140519|FG001|Overall Study|Investigator discretion|0|||
125958265|NCT01607905|453140520|FG002|Overall Study|Investigator discretion|0|||
125958266|NCT01607905|453140521|FG003|Overall Study|Investigator discretion|0|||
125958267|NCT01607905|453140522|FG004|Overall Study|Investigator discretion|0|||
125958268|NCT01607905|453140523|FG005|Overall Study|Investigator discretion|1|||
125958269|NCT01607905|453140524|FG006|Overall Study|Investigator discretion|0|||
125958270|NCT01607905|453140518|FG000|Overall Study|Other|1|||
125958271|NCT01607905|453140519|FG001|Overall Study|Other|0|||
125958272|NCT01607905|453140520|FG002|Overall Study|Other|0|||
125958273|NCT01607905|453140521|FG003|Overall Study|Other|0|||
125958274|NCT01607905|453140522|FG004|Overall Study|Other|0|||
125958275|NCT01607905|453140523|FG005|Overall Study|Other|0|||
125958276|NCT01607905|453140524|FG006|Overall Study|Other|1|||
125958277|NCT01607905|453140518|FG000|Overall Study|Randomized but not treated|1|||
125958278|NCT01607905|453140519|FG001|Overall Study|Randomized but not treated|0|||
125958279|NCT01607905|453140520|FG002|Overall Study|Randomized but not treated|0|||
125958280|NCT01607905|453140521|FG003|Overall Study|Randomized but not treated|0|||
125958281|NCT01607905|453140522|FG004|Overall Study|Randomized but not treated|1|||
125958282|NCT01607905|453140523|FG005|Overall Study|Randomized but not treated|1|||
125958283|NCT01607905|453140524|FG006|Overall Study|Randomized but not treated|0|||
125958284|NCT01105533|453140525|FG000|Overall Study|Death|0|||
125958285|NCT01105533|453140526|FG001|Overall Study|Death|0|||
125958286|NCT01105533|453140527|FG002|Overall Study|Death|0|||
125958287|NCT01105533|453140528|FG003|Overall Study|Death|0|||
125958288|NCT01105533|453140529|FG004|Overall Study|Death|1|||
125958289|NCT01105533|453140530|FG005|Overall Study|Death|0|||
125958290|NCT01105533|453140531|FG006|Overall Study|Death|0|||
125958291|NCT01105533|453140532|FG007|Overall Study|Death|0|||
125958292|NCT01105533|453140533|FG008|Overall Study|Death|0|||
125958293|NCT01105533|453140525|FG000|Overall Study|Lack of Efficacy|1|||
125958294|NCT01105533|453140526|FG001|Overall Study|Lack of Efficacy|1|||
125958295|NCT01105533|453140527|FG002|Overall Study|Lack of Efficacy|3|||
125958296|NCT01105533|453140528|FG003|Overall Study|Lack of Efficacy|3|||
125958297|NCT01105533|453140529|FG004|Overall Study|Lack of Efficacy|4|||
125958298|NCT01105533|453140530|FG005|Overall Study|Lack of Efficacy|5|||
125958299|NCT01105533|453140531|FG006|Overall Study|Lack of Efficacy|3|||
125958300|NCT01105533|453140532|FG007|Overall Study|Lack of Efficacy|2|||
125958301|NCT01105533|453140533|FG008|Overall Study|Lack of Efficacy|9|||
125958302|NCT01105533|453140525|FG000|Overall Study|Adverse Event|0|||
125958303|NCT01105533|453140526|FG001|Overall Study|Adverse Event|0|||
125958304|NCT01105533|453140527|FG002|Overall Study|Adverse Event|0|||
125958305|NCT01105533|453140528|FG003|Overall Study|Adverse Event|0|||
125958306|NCT01105533|453140529|FG004|Overall Study|Adverse Event|1|||
125958307|NCT01105533|453140530|FG005|Overall Study|Adverse Event|2|||
125958308|NCT01105533|453140531|FG006|Overall Study|Adverse Event|2|||
125958309|NCT01105533|453140532|FG007|Overall Study|Adverse Event|0|||
125958310|NCT01105533|453140533|FG008|Overall Study|Adverse Event|1|||
125958311|NCT01105533|453140525|FG000|Overall Study|Other|0|||
125958312|NCT01105533|453140526|FG001|Overall Study|Other|0|||
125958313|NCT01105533|453140527|FG002|Overall Study|Other|0|||
125958314|NCT01105533|453140528|FG003|Overall Study|Other|0|||
125958315|NCT01105533|453140529|FG004|Overall Study|Other|1|||
125958316|NCT01105533|453140530|FG005|Overall Study|Other|0|||
125958317|NCT01105533|453140531|FG006|Overall Study|Other|3|||
125958318|NCT01105533|453140532|FG007|Overall Study|Other|1|||
125958319|NCT01105533|453140533|FG008|Overall Study|Other|2|||
125958320|NCT01105533|453140525|FG000|Overall Study|Physician Decision|0|||
125958321|NCT01105533|453140526|FG001|Overall Study|Physician Decision|0|||
125958322|NCT01105533|453140527|FG002|Overall Study|Physician Decision|0|||
125958323|NCT01105533|453140528|FG003|Overall Study|Physician Decision|0|||
125958324|NCT01105533|453140529|FG004|Overall Study|Physician Decision|0|||
125958325|NCT01105533|453140530|FG005|Overall Study|Physician Decision|0|||
125958326|NCT01105533|453140531|FG006|Overall Study|Physician Decision|0|||
125958327|NCT01105533|453140532|FG007|Overall Study|Physician Decision|1|||
125958328|NCT01105533|453140533|FG008|Overall Study|Physician Decision|0|||
125958329|NCT02096835|453140534|FG000|Overall Study|Withdrawal by Subject|1|||
125958330|NCT02096835|453140535|FG001|Overall Study|Withdrawal by Subject|0|||
125958331|NCT02096835|453140536|FG002|Overall Study|Withdrawal by Subject|0|||
125958332|NCT02096835|453140534|FG000|Overall Study|converted to open procedures|1|||
125958333|NCT02096835|453140535|FG001|Overall Study|converted to open procedures|0|||
125958334|NCT02096835|453140536|FG002|Overall Study|converted to open procedures|0|||
125958335|NCT02096835|453140534|FG000|Overall Study|Lost to Follow-up|1|||
125958336|NCT02096835|453140535|FG001|Overall Study|Lost to Follow-up|0|||
126087186|NCT05000216|453612961|FG011|Stage 1|Physician Decision|0|||
125958337|NCT02096835|453140536|FG002|Overall Study|Lost to Follow-up|1|||
125958338|NCT03892889|453140537|FG000|Overall Study|Adverse Event|17|||
125958339|NCT03892889|453140537|FG000|Overall Study|Lack of Efficacy|1|||
125958340|NCT03892889|453140537|FG000|Overall Study|Lost to Follow-up|46|||
125958341|NCT03892889|453140537|FG000|Overall Study|Non-compliance with study drug|22|||
125958342|NCT03892889|453140537|FG000|Overall Study|Pregnancy|1|||
125958343|NCT03892889|453140537|FG000|Overall Study|Protocol Deviation|3|||
125958344|NCT03892889|453140537|FG000|Overall Study|Withdrawal by Subject|50|||
125958345|NCT03892889|453140537|FG000|Overall Study|Withdrawal by Caregiver|1|||
125958346|NCT03892889|453140537|FG000|Overall Study|Study Terminated by Sponsor|50|||
125958347|NCT03892889|453140537|FG000|Overall Study|Physician Decision|8|||
125958348|NCT03892889|453140537|FG000|Overall Study|Reason not Specified|5|||
125958349|NCT04260191|453140538|FG000|Overall Study|Decision by Sponsor|0|||
125958350|NCT04260191|453140539|FG001|Overall Study|Decision by Sponsor|1|||
125958351|NCT04260191|453140540|FG002|Overall Study|Decision by Sponsor|0|||
125958352|NCT04260191|453140538|FG000|Overall Study|Withdrawal by Subject|1|||
125958353|NCT04260191|453140539|FG001|Overall Study|Withdrawal by Subject|0|||
125958354|NCT04260191|453140540|FG002|Overall Study|Withdrawal by Subject|3|||
125958355|NCT04260191|453140538|FG000|Overall Study|Death|4|||
125958356|NCT04260191|453140539|FG001|Overall Study|Death|3|||
125958357|NCT04260191|453140540|FG002|Overall Study|Death|2|||
125958358|NCT01643473|453140541|FG000|Overall Study|Lost to Follow-up|1|||
125958359|NCT01643473|453140542|FG001|Overall Study|Lost to Follow-up|0|||
125958360|NCT01519518|453140543|FG000|Overall Study|Consent not available|7|||
125958361|NCT01519518|453140544|FG001|Overall Study|Consent not available|10|||
125958362|NCT01312909|453140546|FG000|Overall Study|Randomized but not treated|1|||
125958363|NCT01312909|453140547|FG001|Overall Study|Randomized but not treated|3|||
125958364|NCT01312909|453140548|FG002|Overall Study|Randomized but not treated|1|||
125958365|NCT01312909|453140546|FG000|Overall Study|Adverse Event|1|||
125958366|NCT01312909|453140547|FG001|Overall Study|Adverse Event|0|||
125958367|NCT01312909|453140548|FG002|Overall Study|Adverse Event|3|||
125958368|NCT01312909|453140546|FG000|Overall Study|Protocol Violation|2|||
125958369|NCT01312909|453140547|FG001|Overall Study|Protocol Violation|0|||
125958370|NCT01312909|453140548|FG002|Overall Study|Protocol Violation|2|||
125958371|NCT01312909|453140546|FG000|Overall Study|Other|9|||
126116633|NCT00467779|453721958|FG002|Stage 2|Disease Progression|0|||
126116634|NCT00467779|453721959|FG003|Stage 2|Disease Progression|0|||
126116635|NCT00467779|453721960|FG004|Stage 2|Disease Progression|0|||
126116636|NCT00467779|453721961|FG005|Stage 2|Disease Progression|0|||
126116637|NCT00467779|453721962|FG006|Stage 2|Disease Progression|0|||
126116638|NCT00467779|453721963|FG007|Stage 2|Disease Progression|0|||
126116639|NCT00467779|453721964|FG008|Stage 2|Disease Progression|16|||
126116640|NCT00467779|453721965|FG009|Stage 2|Disease Progression|0|||
126116641|NCT00467779|453721966|FG010|Stage 2|Disease Progression|0|||
126116642|NCT00467779|453721967|FG011|Stage 2|Disease Progression|0|||
126116643|NCT00467779|453721968|FG012|Stage 2|Disease Progression|0|||
126116644|NCT00467779|453721969|FG013|Stage 2|Disease Progression|0|||
126116645|NCT00467779|453721970|FG014|Stage 2|Disease Progression|0|||
126116646|NCT00467779|453721956|FG000|Stage 2|Unspecified Reason|0|||
126116647|NCT00467779|453721957|FG001|Stage 2|Unspecified Reason|0|||
126116648|NCT00467779|453721958|FG002|Stage 2|Unspecified Reason|0|||
126116649|NCT00467779|453721959|FG003|Stage 2|Unspecified Reason|0|||
126116650|NCT00467779|453721960|FG004|Stage 2|Unspecified Reason|0|||
126116651|NCT00467779|453721961|FG005|Stage 2|Unspecified Reason|0|||
126116652|NCT00467779|453721962|FG006|Stage 2|Unspecified Reason|0|||
126116653|NCT00467779|453721963|FG007|Stage 2|Unspecified Reason|0|||
126116654|NCT00467779|453721964|FG008|Stage 2|Unspecified Reason|3|||
126116655|NCT00467779|453721965|FG009|Stage 2|Unspecified Reason|0|||
126116656|NCT00467779|453721966|FG010|Stage 2|Unspecified Reason|0|||
126116657|NCT00467779|453721967|FG011|Stage 2|Unspecified Reason|0|||
126116658|NCT00467779|453721968|FG012|Stage 2|Unspecified Reason|0|||
126116659|NCT00467779|453721969|FG013|Stage 2|Unspecified Reason|0|||
126116660|NCT00467779|453721970|FG014|Stage 2|Unspecified Reason|0|||
126116661|NCT00467779|453721956|FG000|Stage 2A|Adverse Event|0|||
126116662|NCT00467779|453721957|FG001|Stage 2A|Adverse Event|0|||
126116663|NCT00467779|453721958|FG002|Stage 2A|Adverse Event|0|||
126116664|NCT00467779|453721959|FG003|Stage 2A|Adverse Event|0|||
126116665|NCT00467779|453721960|FG004|Stage 2A|Adverse Event|0|||
126116666|NCT00467779|453721961|FG005|Stage 2A|Adverse Event|0|||
126116667|NCT00467779|453721962|FG006|Stage 2A|Adverse Event|0|||
126116668|NCT00467779|453721963|FG007|Stage 2A|Adverse Event|0|||
126116669|NCT00467779|453721964|FG008|Stage 2A|Adverse Event|0|||
126116670|NCT00467779|453721965|FG009|Stage 2A|Adverse Event|0|||
126116671|NCT00467779|453721966|FG010|Stage 2A|Adverse Event|0|||
125958372|NCT01312909|453140547|FG001|Overall Study|Other|6|||
125958373|NCT01312909|453140548|FG002|Overall Study|Other|11|||
125958374|NCT01312909|453140546|FG000|Overall Study|Withdrawal by Subject|8|||
126116672|NCT00467779|453721967|FG011|Stage 2A|Adverse Event|0|||
126116673|NCT00467779|453721968|FG012|Stage 2A|Adverse Event|0|||
126116674|NCT00467779|453721969|FG013|Stage 2A|Adverse Event|2|||
126116675|NCT00467779|453721970|FG014|Stage 2A|Adverse Event|0|||
126116676|NCT00467779|453721956|FG000|Stage 2A|Death|0|||
125958375|NCT01312909|453140547|FG001|Overall Study|Withdrawal by Subject|10|||
125958376|NCT01312909|453140548|FG002|Overall Study|Withdrawal by Subject|7|||
126116677|NCT00467779|453721957|FG001|Stage 2A|Death|0|||
126116678|NCT00467779|453721958|FG002|Stage 2A|Death|0|||
125958377|NCT01312909|453140546|FG000|Overall Study|Lost to Follow-up|21|||
125958378|NCT01312909|453140547|FG001|Overall Study|Lost to Follow-up|17|||
125958379|NCT01312909|453140548|FG002|Overall Study|Lost to Follow-up|20|||
125958380|NCT01312909|453140546|FG000|Overall Study|Insufficient clinical response|0|||
125958381|NCT01312909|453140547|FG001|Overall Study|Insufficient clinical response|0|||
125958382|NCT01312909|453140548|FG002|Overall Study|Insufficient clinical response|1|||
125958383|NCT01312909|453140546|FG000|Overall Study|Entrance criteria not met|0|||
125958384|NCT01312909|453140547|FG001|Overall Study|Entrance criteria not met|0|||
125958385|NCT01312909|453140548|FG002|Overall Study|Entrance criteria not met|2|||
125958386|NCT00938431|453140553|FG000|Overall Study|Adverse Event|5|||
125958387|NCT00938431|453140554|FG001|Overall Study|Adverse Event|8|||
125958388|NCT00938431|453140555|FG002|Overall Study|Adverse Event|6|||
125958389|NCT00938431|453140553|FG000|Overall Study|Lack of Efficacy|0|||
125958390|NCT00938431|453140554|FG001|Overall Study|Lack of Efficacy|1|||
125958391|NCT00938431|453140555|FG002|Overall Study|Lack of Efficacy|0|||
125958392|NCT00938431|453140553|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
125958393|NCT00938431|453140554|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
125958394|NCT00938431|453140555|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
125958395|NCT00938431|453140553|FG000|Overall Study|Dosing compliance issue|0|||
125958396|NCT00938431|453140554|FG001|Overall Study|Dosing compliance issue|0|||
125958397|NCT00938431|453140555|FG002|Overall Study|Dosing compliance issue|1|||
125958398|NCT00938431|453140553|FG000|Overall Study|Reached maximum dose early|0|||
125958399|NCT00938431|453140554|FG001|Overall Study|Reached maximum dose early|0|||
125958400|NCT00938431|453140555|FG002|Overall Study|Reached maximum dose early|1|||
125958401|NCT02086591|453140556|FG000|Overall Study|Adverse Event|1|||
125958402|NCT02086591|453140556|FG000|Overall Study|Withdrawal by Subject|1|||
125958403|NCT02086591|453140556|FG000|Overall Study|protocol terminated|3|||
125958404|NCT01774903|453140557|FG000|Overall Study|Adverse Event|7|||
125958405|NCT01774903|453140557|FG000|Overall Study|Withdrawal by Subject|2|||
125958406|NCT01774903|453140557|FG000|Overall Study|Lack of Efficacy|1|||
125958407|NCT01774903|453140557|FG000|Overall Study|Ineligible to continue the trial|1|||
125958408|NCT02212730|453140560|FG000|Overall Study|Tumor not of the required cell histology|1|||
125958409|NCT02212730|453140561|FG001|Overall Study|Tumor not of the required cell histology|0|||
125958410|NCT02212730|453140560|FG000|Overall Study|Withdrawal by Subject|1|||
125958411|NCT02212730|453140561|FG001|Overall Study|Withdrawal by Subject|0|||
125958412|NCT02212730|453140560|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
125958413|NCT02212730|453140561|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
125958414|NCT02880371|453140562|FG000|Phase 1b|Lost to Follow-up|1|||
125958415|NCT02880371|453140563|FG001|Phase 1b|Lost to Follow-up|0|||
125958416|NCT02880371|453140564|FG002|Phase 1b|Lost to Follow-up|0|||
125958417|NCT02880371|453140565|FG003|Phase 1b|Lost to Follow-up|0|||
125958418|NCT02880371|453140566|FG004|Phase 1b|Lost to Follow-up|0|||
125958419|NCT02880371|453140567|FG005|Phase 1b|Lost to Follow-up|0|||
125958420|NCT02880371|453140568|FG006|Phase 1b|Lost to Follow-up|0|||
125958421|NCT02880371|453140569|FG007|Phase 1b|Lost to Follow-up|0|||
125958422|NCT02880371|453140562|FG000|Phase 1b|Participants terminated by Sponsor|1|||
125958423|NCT02880371|453140563|FG001|Phase 1b|Participants terminated by Sponsor|0|||
125958424|NCT02880371|453140564|FG002|Phase 1b|Participants terminated by Sponsor|0|||
125958425|NCT02880371|453140565|FG003|Phase 1b|Participants terminated by Sponsor|0|||
125958426|NCT02880371|453140566|FG004|Phase 1b|Participants terminated by Sponsor|0|||
125958427|NCT02880371|453140567|FG005|Phase 1b|Participants terminated by Sponsor|0|||
125958428|NCT02880371|453140568|FG006|Phase 1b|Participants terminated by Sponsor|0|||
125958429|NCT02880371|453140569|FG007|Phase 1b|Participants terminated by Sponsor|0|||
125958430|NCT02880371|453140562|FG000|Phase 1b|Withdrawal by Subject|0|||
125958431|NCT02880371|453140563|FG001|Phase 1b|Withdrawal by Subject|0|||
125958432|NCT02880371|453140564|FG002|Phase 1b|Withdrawal by Subject|1|||
126116679|NCT00467779|453721959|FG003|Stage 2A|Death|0|||
126116680|NCT00467779|453721960|FG004|Stage 2A|Death|0|||
126116681|NCT00467779|453721961|FG005|Stage 2A|Death|0|||
126116682|NCT00467779|453721962|FG006|Stage 2A|Death|0|||
126116683|NCT00467779|453721963|FG007|Stage 2A|Death|0|||
126116684|NCT00467779|453721964|FG008|Stage 2A|Death|0|||
126116685|NCT00467779|453721965|FG009|Stage 2A|Death|0|||
126116686|NCT00467779|453721966|FG010|Stage 2A|Death|0|||
126116687|NCT00467779|453721967|FG011|Stage 2A|Death|0|||
126116688|NCT00467779|453721968|FG012|Stage 2A|Death|0|||
126116689|NCT00467779|453721969|FG013|Stage 2A|Death|1|||
125958433|NCT02880371|453140565|FG003|Phase 1b|Withdrawal by Subject|0|||
125958434|NCT02880371|453140566|FG004|Phase 1b|Withdrawal by Subject|0|||
125958435|NCT02880371|453140567|FG005|Phase 1b|Withdrawal by Subject|0|||
125958436|NCT02880371|453140568|FG006|Phase 1b|Withdrawal by Subject|0|||
125958437|NCT02880371|453140569|FG007|Phase 1b|Withdrawal by Subject|0|||
125958438|NCT02880371|453140562|FG000|Phase 1b|Death|4|||
125958439|NCT02880371|453140563|FG001|Phase 1b|Death|6|||
125958440|NCT02880371|453140564|FG002|Phase 1b|Death|5|||
125958441|NCT02880371|453140565|FG003|Phase 1b|Death|1|||
126116690|NCT00467779|453721970|FG014|Stage 2A|Death|0|||
126116691|NCT00467779|453721956|FG000|Stage 2A|Disease Progression|0|||
126116692|NCT00467779|453721957|FG001|Stage 2A|Disease Progression|0|||
125958442|NCT02880371|453140566|FG004|Phase 1b|Death|0|||
125958443|NCT02880371|453140567|FG005|Phase 1b|Death|0|||
125958444|NCT02880371|453140568|FG006|Phase 1b|Death|0|||
125958445|NCT02880371|453140569|FG007|Phase 1b|Death|0|||
125958446|NCT02880371|453140562|FG000|Phase 1b|Enrolled but not Treated|0|||
125958447|NCT02880371|453140563|FG001|Phase 1b|Enrolled but not Treated|1|||
125958448|NCT02880371|453140564|FG002|Phase 1b|Enrolled but not Treated|0|||
125958449|NCT02880371|453140565|FG003|Phase 1b|Enrolled but not Treated|0|||
125958450|NCT02880371|453140566|FG004|Phase 1b|Enrolled but not Treated|0|||
125958451|NCT02880371|453140567|FG005|Phase 1b|Enrolled but not Treated|0|||
125958452|NCT02880371|453140568|FG006|Phase 1b|Enrolled but not Treated|0|||
125958453|NCT02880371|453140569|FG007|Phase 1b|Enrolled but not Treated|0|||
125958454|NCT02880371|453140562|FG000|Phase 2|Enrolled but not Treated|0|||
125958455|NCT02880371|453140563|FG001|Phase 2|Enrolled but not Treated|0|||
125958456|NCT02880371|453140564|FG002|Phase 2|Enrolled but not Treated|0|||
125958457|NCT02880371|453140565|FG003|Phase 2|Enrolled but not Treated|0|||
125958458|NCT02880371|453140566|FG004|Phase 2|Enrolled but not Treated|0|||
125958459|NCT02880371|453140567|FG005|Phase 2|Enrolled but not Treated|1|||
125958460|NCT02880371|453140568|FG006|Phase 2|Enrolled but not Treated|1|||
125958461|NCT02880371|453140569|FG007|Phase 2|Enrolled but not Treated|0|||
125958462|NCT02880371|453140562|FG000|Phase 2|Other|0|||
125958463|NCT02880371|453140563|FG001|Phase 2|Other|0|||
125958464|NCT02880371|453140564|FG002|Phase 2|Other|0|||
125958465|NCT02880371|453140565|FG003|Phase 2|Other|0|||
125958466|NCT02880371|453140566|FG004|Phase 2|Other|0|||
125958467|NCT02880371|453140567|FG005|Phase 2|Other|1|||
125958468|NCT02880371|453140568|FG006|Phase 2|Other|2|||
125958469|NCT02880371|453140569|FG007|Phase 2|Other|1|||
125958470|NCT02880371|453140562|FG000|Phase 2|Participants terminated by Sponsor|0|||
125958471|NCT02880371|453140563|FG001|Phase 2|Participants terminated by Sponsor|0|||
125958472|NCT02880371|453140564|FG002|Phase 2|Participants terminated by Sponsor|0|||
125958473|NCT02880371|453140565|FG003|Phase 2|Participants terminated by Sponsor|0|||
125958474|NCT02880371|453140566|FG004|Phase 2|Participants terminated by Sponsor|1|||
125958475|NCT02880371|453140567|FG005|Phase 2|Participants terminated by Sponsor|6|||
125958476|NCT02880371|453140568|FG006|Phase 2|Participants terminated by Sponsor|1|||
125958477|NCT02880371|453140569|FG007|Phase 2|Participants terminated by Sponsor|5|||
125958478|NCT02880371|453140562|FG000|Phase 2|Death|0|||
125958479|NCT02880371|453140563|FG001|Phase 2|Death|0|||
125958480|NCT02880371|453140564|FG002|Phase 2|Death|0|||
125958481|NCT02880371|453140565|FG003|Phase 2|Death|0|||
125958482|NCT02880371|453140566|FG004|Phase 2|Death|1|||
125958483|NCT02880371|453140567|FG005|Phase 2|Death|10|||
125958484|NCT02880371|453140568|FG006|Phase 2|Death|20|||
125958485|NCT02880371|453140569|FG007|Phase 2|Death|5|||
125958486|NCT02880371|453140562|FG000|Phase 2|Lost to Follow-up|0|||
125958487|NCT02880371|453140563|FG001|Phase 2|Lost to Follow-up|0|||
125958488|NCT02880371|453140564|FG002|Phase 2|Lost to Follow-up|0|||
125958489|NCT02880371|453140565|FG003|Phase 2|Lost to Follow-up|0|||
125958490|NCT02880371|453140566|FG004|Phase 2|Lost to Follow-up|0|||
125958491|NCT02880371|453140567|FG005|Phase 2|Lost to Follow-up|0|||
125958492|NCT02880371|453140568|FG006|Phase 2|Lost to Follow-up|3|||
125958493|NCT02880371|453140569|FG007|Phase 2|Lost to Follow-up|0|||
125958494|NCT02880371|453140562|FG000|Phase 2|Withdrawal by Subject|0|||
125958495|NCT02880371|453140563|FG001|Phase 2|Withdrawal by Subject|0|||
125958496|NCT02880371|453140564|FG002|Phase 2|Withdrawal by Subject|0|||
125958497|NCT02880371|453140565|FG003|Phase 2|Withdrawal by Subject|0|||
125958498|NCT02880371|453140566|FG004|Phase 2|Withdrawal by Subject|0|||
125958499|NCT02880371|453140567|FG005|Phase 2|Withdrawal by Subject|1|||
125958500|NCT02880371|453140568|FG006|Phase 2|Withdrawal by Subject|1|||
125958501|NCT02880371|453140569|FG007|Phase 2|Withdrawal by Subject|0|||
125958502|NCT02880371|453140562|FG000|Phase 2|End of Study page not completed by error|0|||
125958503|NCT02880371|453140563|FG001|Phase 2|End of Study page not completed by error|0|||
125958504|NCT02880371|453140564|FG002|Phase 2|End of Study page not completed by error|0|||
125958505|NCT02880371|453140565|FG003|Phase 2|End of Study page not completed by error|0|||
125958506|NCT02880371|453140566|FG004|Phase 2|End of Study page not completed by error|0|||
125958507|NCT02880371|453140567|FG005|Phase 2|End of Study page not completed by error|1|||
125958508|NCT02880371|453140568|FG006|Phase 2|End of Study page not completed by error|0|||
125958509|NCT02880371|453140569|FG007|Phase 2|End of Study page not completed by error|0|||
125958510|NCT01777997|453140572|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
125958511|NCT01777997|453140572|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
125958512|NCT01777997|453140572|FG000|Weeks 48 to 72/96 on ART|Death|1|||
125958513|NCT01777997|453140572|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
125958514|NCT02660359|453140573|FG000|Overall Study|Protocol Deviation|0|||
125958515|NCT02660359|453140574|FG001|Overall Study|Protocol Deviation|0|||
125958516|NCT02660359|453140575|FG002|Overall Study|Protocol Deviation|1|||
125958517|NCT02660359|453140573|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
125958518|NCT02660359|453140574|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
125958519|NCT02660359|453140575|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
125958520|NCT02660359|453140573|FG000|Overall Study|Lack of Efficacy|1|||
125958521|NCT02660359|453140574|FG001|Overall Study|Lack of Efficacy|1|||
125958522|NCT02660359|453140575|FG002|Overall Study|Lack of Efficacy|1|||
126116693|NCT00467779|453721958|FG002|Stage 2A|Disease Progression|0|||
126116694|NCT00467779|453721959|FG003|Stage 2A|Disease Progression|0|||
126116695|NCT00467779|453721960|FG004|Stage 2A|Disease Progression|0|||
126116696|NCT00467779|453721961|FG005|Stage 2A|Disease Progression|0|||
126116697|NCT00467779|453721962|FG006|Stage 2A|Disease Progression|0|||
126116698|NCT00467779|453721963|FG007|Stage 2A|Disease Progression|0|||
126116699|NCT00467779|453721964|FG008|Stage 2A|Disease Progression|0|||
126116700|NCT00467779|453721965|FG009|Stage 2A|Disease Progression|0|||
126116701|NCT00467779|453721966|FG010|Stage 2A|Disease Progression|0|||
126116702|NCT00467779|453721967|FG011|Stage 2A|Disease Progression|0|||
126116703|NCT00467779|453721968|FG012|Stage 2A|Disease Progression|0|||
126116704|NCT00467779|453721969|FG013|Stage 2A|Disease Progression|10|||
126116705|NCT00467779|453721970|FG014|Stage 2A|Disease Progression|0|||
126116706|NCT00467779|453721956|FG000|Stage 2A|Unspecified Reason|0|||
126116707|NCT00467779|453721957|FG001|Stage 2A|Unspecified Reason|0|||
126116708|NCT00467779|453721958|FG002|Stage 2A|Unspecified Reason|0|||
126116709|NCT00467779|453721959|FG003|Stage 2A|Unspecified Reason|0|||
126116710|NCT00467779|453721960|FG004|Stage 2A|Unspecified Reason|0|||
126116711|NCT00467779|453721961|FG005|Stage 2A|Unspecified Reason|0|||
126116712|NCT00467779|453721962|FG006|Stage 2A|Unspecified Reason|0|||
126116713|NCT00467779|453721963|FG007|Stage 2A|Unspecified Reason|0|||
125958523|NCT02660359|453140573|FG000|Overall Study|Adverse Event|0|||
125958524|NCT02660359|453140574|FG001|Overall Study|Adverse Event|1|||
125958525|NCT02660359|453140575|FG002|Overall Study|Adverse Event|0|||
125958526|NCT02660359|453140573|FG000|Overall Study|Other|2|||
125958527|NCT02660359|453140574|FG001|Overall Study|Other|1|||
125958528|NCT02660359|453140575|FG002|Overall Study|Other|3|||
125958529|NCT02660359|453140573|FG000|Overall Study|Withdrawal by Subject|7|||
125958530|NCT02660359|453140574|FG001|Overall Study|Withdrawal by Subject|5|||
125958531|NCT02660359|453140575|FG002|Overall Study|Withdrawal by Subject|8|||
125958532|NCT02660359|453140573|FG000|Overall Study|Lost to Follow-up|3|||
125958533|NCT02660359|453140574|FG001|Overall Study|Lost to Follow-up|3|||
125958534|NCT02660359|453140575|FG002|Overall Study|Lost to Follow-up|0|||
125958535|NCT04532112|453140580|FG000|Overall Study|Adverse Event|3|||
125958536|NCT04532112|453140581|FG001|Overall Study|Adverse Event|0|||
125958537|NCT00529386|453140582|FG000|Overall Study|Lost to Follow-up|1|||
125958538|NCT03348904|453140583|FG000|Overall Study|Administrative reason by the sponsor|0|||
125958539|NCT03348904|453140584|FG001|Overall Study|Administrative reason by the sponsor|1|||
125958540|NCT03348904|453140585|FG002|Overall Study|Administrative reason by the sponsor|0|||
125958541|NCT02039427|453140591|FG000|Overall Study|Duration of surgery > 3h|1|||
125958542|NCT02039427|453140592|FG001|Overall Study|Duration of surgery > 3h|1|||
125958543|NCT02039427|453140593|FG002|Overall Study|Duration of surgery > 3h|0|||
125958544|NCT02039427|453140594|FG003|Overall Study|Duration of surgery > 3h|0|||
125958545|NCT02039427|453140591|FG000|Overall Study|Withdrawal on concent|0|||
125958546|NCT02039427|453140592|FG001|Overall Study|Withdrawal on concent|0|||
125958547|NCT02039427|453140593|FG002|Overall Study|Withdrawal on concent|0|||
125958548|NCT02039427|453140594|FG003|Overall Study|Withdrawal on concent|1|||
125958549|NCT02039427|453140591|FG000|Overall Study|Cancellation of surgery|0|||
125958550|NCT02039427|453140592|FG001|Overall Study|Cancellation of surgery|0|||
125958551|NCT02039427|453140593|FG002|Overall Study|Cancellation of surgery|1|||
125958552|NCT02039427|453140594|FG003|Overall Study|Cancellation of surgery|0|||
125958553|NCT02039427|453140591|FG000|Overall Study|Loss of follow - up|1|||
125958554|NCT02039427|453140592|FG001|Overall Study|Loss of follow - up|0|||
125958555|NCT02039427|453140593|FG002|Overall Study|Loss of follow - up|2|||
125958556|NCT02039427|453140594|FG003|Overall Study|Loss of follow - up|4|||
125958557|NCT02039427|453140591|FG000|Overall Study|Steroid Use|1|||
125958558|NCT02039427|453140592|FG001|Overall Study|Steroid Use|0|||
125958559|NCT02039427|453140593|FG002|Overall Study|Steroid Use|0|||
125958560|NCT02039427|453140594|FG003|Overall Study|Steroid Use|0|||
125958561|NCT04354831|453140595|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
125958562|NCT04354831|453140596|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
126116714|NCT00467779|453721964|FG008|Stage 2A|Unspecified Reason|0|||
126116715|NCT00467779|453721965|FG009|Stage 2A|Unspecified Reason|0|||
126116716|NCT00467779|453721966|FG010|Stage 2A|Unspecified Reason|0|||
126116717|NCT00467779|453721967|FG011|Stage 2A|Unspecified Reason|0|||
126116718|NCT00467779|453721968|FG012|Stage 2A|Unspecified Reason|0|||
125958563|NCT02732847|453140597|FG000|Overall Study|some filled early|42|||
125958564|NCT02732847|453140598|FG001|Overall Study|some filled early|42|||
126116719|NCT00467779|453721969|FG013|Stage 2A|Unspecified Reason|7|||
126116720|NCT00467779|453721970|FG014|Stage 2A|Unspecified Reason|0|||
126116721|NCT00467779|453721956|FG000|Stage 2A|Withdrawal by Subject|0|||
125958565|NCT04027686|453140599|FG000|Overall Study|Lost to Follow-up|2|||
125958566|NCT04027686|453140600|FG001|Overall Study|Lost to Follow-up|0|||
125958567|NCT04027686|453140599|FG000|Overall Study|Withdrawal by Subject|0|||
125958568|NCT04027686|453140600|FG001|Overall Study|Withdrawal by Subject|1|||
125958569|NCT00111228|453140601|FG000|Overall Study|Withdrawal by Subject|5|||
125958570|NCT00111228|453140602|FG001|Overall Study|Withdrawal by Subject|1|||
126116722|NCT00467779|453721957|FG001|Stage 2A|Withdrawal by Subject|0|||
126116723|NCT00467779|453721958|FG002|Stage 2A|Withdrawal by Subject|0|||
126116724|NCT00467779|453721959|FG003|Stage 2A|Withdrawal by Subject|0|||
126116725|NCT00467779|453721960|FG004|Stage 2A|Withdrawal by Subject|0|||
126116726|NCT00467779|453721961|FG005|Stage 2A|Withdrawal by Subject|0|||
126116727|NCT00467779|453721962|FG006|Stage 2A|Withdrawal by Subject|0|||
126116728|NCT00467779|453721963|FG007|Stage 2A|Withdrawal by Subject|0|||
126116729|NCT00467779|453721964|FG008|Stage 2A|Withdrawal by Subject|0|||
126116730|NCT00467779|453721965|FG009|Stage 2A|Withdrawal by Subject|0|||
126116731|NCT00467779|453721966|FG010|Stage 2A|Withdrawal by Subject|0|||
126116732|NCT00467779|453721967|FG011|Stage 2A|Withdrawal by Subject|0|||
126116733|NCT00467779|453721968|FG012|Stage 2A|Withdrawal by Subject|0|||
126116734|NCT00467779|453721969|FG013|Stage 2A|Withdrawal by Subject|1|||
126116735|NCT00467779|453721970|FG014|Stage 2A|Withdrawal by Subject|0|||
126116736|NCT00467779|453721956|FG000|Stage 3|Adverse Event|0|||
126116737|NCT00467779|453721957|FG001|Stage 3|Adverse Event|0|||
126116738|NCT00467779|453721958|FG002|Stage 3|Adverse Event|0|||
126116739|NCT00467779|453721959|FG003|Stage 3|Adverse Event|0|||
126116740|NCT00467779|453721960|FG004|Stage 3|Adverse Event|0|||
126116741|NCT00467779|453721961|FG005|Stage 3|Adverse Event|0|||
126116742|NCT00467779|453721962|FG006|Stage 3|Adverse Event|0|||
126116743|NCT00467779|453721963|FG007|Stage 3|Adverse Event|0|||
126116744|NCT00467779|453721964|FG008|Stage 3|Adverse Event|0|||
126116745|NCT00467779|453721965|FG009|Stage 3|Adverse Event|0|||
126116746|NCT00467779|453721966|FG010|Stage 3|Adverse Event|0|||
126116747|NCT00467779|453721967|FG011|Stage 3|Adverse Event|0|||
126116748|NCT00467779|453721968|FG012|Stage 3|Adverse Event|0|||
126116749|NCT00467779|453721969|FG013|Stage 3|Adverse Event|0|||
126116750|NCT00467779|453721970|FG014|Stage 3|Adverse Event|2|||
126116751|NCT00467779|453721956|FG000|Stage 3|Death|0|||
126116752|NCT00467779|453721957|FG001|Stage 3|Death|0|||
126116753|NCT00467779|453721958|FG002|Stage 3|Death|0|||
126116754|NCT00467779|453721959|FG003|Stage 3|Death|0|||
126116755|NCT00467779|453721960|FG004|Stage 3|Death|0|||
126116756|NCT00467779|453721961|FG005|Stage 3|Death|0|||
126116757|NCT00467779|453721962|FG006|Stage 3|Death|0|||
126116758|NCT00467779|453721963|FG007|Stage 3|Death|0|||
126116759|NCT00467779|453721964|FG008|Stage 3|Death|0|||
126116760|NCT00467779|453721965|FG009|Stage 3|Death|0|||
126116761|NCT00467779|453721966|FG010|Stage 3|Death|0|||
126116762|NCT00467779|453721967|FG011|Stage 3|Death|0|||
126116763|NCT00467779|453721968|FG012|Stage 3|Death|0|||
126116764|NCT00467779|453721969|FG013|Stage 3|Death|0|||
126116765|NCT00467779|453721970|FG014|Stage 3|Death|1|||
126116766|NCT00467779|453721956|FG000|Stage 3|Disease Progression|0|||
126116767|NCT00467779|453721957|FG001|Stage 3|Disease Progression|0|||
126116768|NCT00467779|453721958|FG002|Stage 3|Disease Progression|0|||
126116769|NCT00467779|453721959|FG003|Stage 3|Disease Progression|0|||
126116770|NCT00467779|453721960|FG004|Stage 3|Disease Progression|0|||
126116771|NCT00467779|453721961|FG005|Stage 3|Disease Progression|0|||
126116772|NCT00467779|453721962|FG006|Stage 3|Disease Progression|0|||
126116773|NCT00467779|453721963|FG007|Stage 3|Disease Progression|0|||
126116774|NCT00467779|453721964|FG008|Stage 3|Disease Progression|0|||
126116775|NCT00467779|453721965|FG009|Stage 3|Disease Progression|0|||
126116776|NCT00467779|453721966|FG010|Stage 3|Disease Progression|0|||
126116777|NCT00467779|453721967|FG011|Stage 3|Disease Progression|0|||
126116778|NCT00467779|453721968|FG012|Stage 3|Disease Progression|0|||
126116779|NCT00467779|453721969|FG013|Stage 3|Disease Progression|0|||
126116780|NCT00467779|453721970|FG014|Stage 3|Disease Progression|9|||
126116781|NCT00467779|453721956|FG000|Stage 3|Unspecified Reason|0|||
126116782|NCT00467779|453721957|FG001|Stage 3|Unspecified Reason|0|||
126116783|NCT00467779|453721958|FG002|Stage 3|Unspecified Reason|0|||
126116784|NCT00467779|453721959|FG003|Stage 3|Unspecified Reason|0|||
126116785|NCT00467779|453721960|FG004|Stage 3|Unspecified Reason|0|||
126116786|NCT00467779|453721961|FG005|Stage 3|Unspecified Reason|0|||
126116787|NCT00467779|453721962|FG006|Stage 3|Unspecified Reason|0|||
125958571|NCT00111228|453140603|FG002|Overall Study|Withdrawal by Subject|0|||
125958572|NCT00779766|453140604|FG000|Month 24|Serious Adverse Event|2|||
126116788|NCT00467779|453721963|FG007|Stage 3|Unspecified Reason|0|||
126116789|NCT00467779|453721964|FG008|Stage 3|Unspecified Reason|0|||
126116790|NCT00467779|453721965|FG009|Stage 3|Unspecified Reason|0|||
126116791|NCT00467779|453721966|FG010|Stage 3|Unspecified Reason|0|||
126116792|NCT00467779|453721967|FG011|Stage 3|Unspecified Reason|0|||
126116793|NCT00467779|453721968|FG012|Stage 3|Unspecified Reason|0|||
126116794|NCT00467779|453721969|FG013|Stage 3|Unspecified Reason|0|||
126116795|NCT00467779|453721970|FG014|Stage 3|Unspecified Reason|5|||
126116796|NCT00041080|453721973|FG000|Overall Study|Adverse Event|21|||
126116797|NCT00041080|453721974|FG001|Overall Study|Adverse Event|1|||
126116798|NCT00041080|453721973|FG000|Overall Study|Withdrawal by Subject|6|||
126116799|NCT00041080|453721974|FG001|Overall Study|Withdrawal by Subject|6|||
126116800|NCT00041080|453721973|FG000|Overall Study|Concommitant Illness/Other|1|||
126116801|NCT00041080|453721974|FG001|Overall Study|Concommitant Illness/Other|2|||
126116802|NCT00041080|453721973|FG000|Overall Study|Did not start therapy|1|||
126116803|NCT00041080|453721974|FG001|Overall Study|Did not start therapy|1|||
126116804|NCT00041080|453721973|FG000|Overall Study|Ineligible|1|||
126116805|NCT00041080|453721974|FG001|Overall Study|Ineligible|0|||
126116806|NCT04353596|453721977|FG000|Overall Study|Protocol Violation|4|||
126116807|NCT04353596|453721978|FG001|Overall Study|Protocol Violation|4|||
126116808|NCT04353596|453721977|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
126116809|NCT04353596|453721978|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
126116810|NCT00823823|453721979|FG000|Overall Study|Lost to Follow-up|3|||
126116811|NCT00823823|453721980|FG001|Overall Study|Lost to Follow-up|1|||
126116812|NCT00823823|453721979|FG000|Overall Study|Protocol Violation|5|||
126116813|NCT00823823|453721980|FG001|Overall Study|Protocol Violation|5|||
126116814|NCT04422990|453721984|FG000|Overall Study|Withdrawal by Subject|0|||
126116815|NCT04422990|453721985|FG001|Overall Study|Withdrawal by Subject|1|||
126116816|NCT04422990|453721984|FG000|Overall Study|Travel|3|||
126116817|NCT04422990|453721985|FG001|Overall Study|Travel|0|||
126116818|NCT01490814|453721986|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
126116819|NCT01490814|453721987|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
126116820|NCT01490814|453721986|FG000|Overall Study|Physician Decision|1|||
126116821|NCT01490814|453721987|FG001|Overall Study|Physician Decision|0|||
126116822|NCT01490814|453721986|FG000|Overall Study|Withdrawal by Subject|0|||
126116823|NCT01490814|453721987|FG001|Overall Study|Withdrawal by Subject|5|||
126116824|NCT03024970|453721999|FG000|First Intervention|Adverse Event|1|||
126116825|NCT03024970|453722000|FG001|First Intervention|Adverse Event|0|||
126116826|NCT03024970|453721999|FG000|Second Intervention|Lost to Follow-up|1|||
126116827|NCT03024970|453722000|FG001|Second Intervention|Lost to Follow-up|0|||
126116828|NCT01221727|453722004|FG000|Overall Study|Physician Decision|2|||
126116829|NCT01221727|453722005|FG001|Overall Study|Physician Decision|0|||
126116830|NCT01221727|453722004|FG000|Overall Study|Withdrawal by Subject|1|||
126116831|NCT01221727|453722005|FG001|Overall Study|Withdrawal by Subject|1|||
126116832|NCT00590044|453722006|FG000|Overall Study|Withdrawal by Subject|2|||
126116833|NCT00590044|453722007|FG001|Overall Study|Withdrawal by Subject|2|||
126116834|NCT00590044|453722006|FG000|Overall Study|wrong insulin arm assigned|1|||
126116835|NCT00590044|453722007|FG001|Overall Study|wrong insulin arm assigned|0|||
126116836|NCT00590044|453722006|FG000|Overall Study|Protocol Violation|1|||
126116837|NCT00590044|453722007|FG001|Overall Study|Protocol Violation|0|||
126116838|NCT02790138|453722008|FG000|Overall Study|Adverse Event|5|||
126116839|NCT02790138|453722009|FG001|Overall Study|Adverse Event|2|||
126116840|NCT02790138|453722008|FG000|Overall Study|Significant Protocol Deviation|0|||
126116841|NCT02790138|453722009|FG001|Overall Study|Significant Protocol Deviation|1|||
126116842|NCT02790138|453722008|FG000|Overall Study|Lost to Follow-up|1|||
126116843|NCT02790138|453722009|FG001|Overall Study|Lost to Follow-up|0|||
126116844|NCT02790138|453722008|FG000|Overall Study|Voluntary Withdrawal|8|||
126116845|NCT02790138|453722009|FG001|Overall Study|Voluntary Withdrawal|9|||
126116846|NCT02790138|453722008|FG000|Overall Study|Lack of Efficacy|6|||
126116847|NCT02790138|453722009|FG001|Overall Study|Lack of Efficacy|7|||
126116848|NCT02790138|453722008|FG000|Overall Study|Reason not Specified|1|||
126116849|NCT02790138|453722009|FG001|Overall Study|Reason not Specified|0|||
126116850|NCT01786603|453722010|FG000|Overall Study|Death|5|||
126116851|NCT01786603|453722011|FG001|Overall Study|Death|1|||
126116852|NCT01786603|453722010|FG000|Overall Study|Adverse Event|6|||
126116853|NCT01786603|453722011|FG001|Overall Study|Adverse Event|2|||
126116854|NCT01786603|453722010|FG000|Overall Study|Physician decision to withdraw|6|||
125958573|NCT00779766|453140605|FG001|Month 24|Serious Adverse Event|3|||
125958574|NCT00779766|453140604|FG000|Month 24|Adverse Event|3|||
125958575|NCT00779766|453140605|FG001|Month 24|Adverse Event|3|||
125958576|NCT00779766|453140604|FG000|Month 24|Protocol Violation|3|||
125958577|NCT00779766|453140605|FG001|Month 24|Protocol Violation|1|||
125958578|NCT00779766|453140604|FG000|Month 24|Withdrawal by Subject|159|||
125958579|NCT00779766|453140605|FG001|Month 24|Withdrawal by Subject|127|||
125958580|NCT00779766|453140604|FG000|Month 24|Migrated/moved from study area|138|||
125958581|NCT00779766|453140605|FG001|Month 24|Migrated/moved from study area|162|||
125958582|NCT00779766|453140604|FG000|Month 24|Lost to Follow-up|9|||
125958583|NCT00779766|453140605|FG001|Month 24|Lost to Follow-up|9|||
125958584|NCT00779766|453140604|FG000|Month 24|Other|18|||
125958585|NCT00779766|453140605|FG001|Month 24|Other|27|||
126116855|NCT01786603|453722011|FG001|Overall Study|Physician decision to withdraw|7|||
126116856|NCT01786603|453722010|FG000|Overall Study|Lost to Follow-up|1|||
126116857|NCT01786603|453722011|FG001|Overall Study|Lost to Follow-up|2|||
126116858|NCT01226459|453722012|FG000|Overall Study|Adverse Event|2|||
126116859|NCT01226459|453722013|FG001|Overall Study|Adverse Event|8|||
126116860|NCT01226459|453722012|FG000|Overall Study|Protocol Violation|4|||
126116861|NCT01226459|453722013|FG001|Overall Study|Protocol Violation|3|||
126116862|NCT01226459|453722012|FG000|Overall Study|Withdrawal by Subject|10|||
126116863|NCT01226459|453722013|FG001|Overall Study|Withdrawal by Subject|13|||
126116864|NCT01226459|453722012|FG000|Overall Study|Lost to Follow-up|4|||
125958586|NCT00779766|453140604|FG000|Month 48|Withdrawal by Subject|68|||
125958587|NCT00779766|453140605|FG001|Month 48|Withdrawal by Subject|63|||
125958588|NCT00779766|453140604|FG000|Month 48|Migrated/moved from study area|76|||
125958589|NCT00779766|453140605|FG001|Month 48|Migrated/moved from study area|75|||
125958590|NCT00779766|453140604|FG000|Month 48|Lost to Follow-up|29|||
126116865|NCT01226459|453722013|FG001|Overall Study|Lost to Follow-up|8|||
126116866|NCT01226459|453722012|FG000|Overall Study|Pregnancy|1|||
125958591|NCT00779766|453140605|FG001|Month 48|Lost to Follow-up|30|||
125958592|NCT00779766|453140604|FG000|Month 48|Other|1|||
125958593|NCT00779766|453140605|FG001|Month 48|Other|0|||
125958594|NCT00779766|453140604|FG000|Month 72|Withdrawal by Subject|55|||
125958595|NCT00779766|453140605|FG001|Month 72|Withdrawal by Subject|71|||
125958596|NCT00779766|453140604|FG000|Month 72|Migrated/moved from study area|124|||
125958597|NCT00779766|453140605|FG001|Month 72|Migrated/moved from study area|109|||
125958598|NCT00779766|453140604|FG000|Month 72|Lost to Follow-up|6|||
125958599|NCT00779766|453140605|FG001|Month 72|Lost to Follow-up|8|||
125958600|NCT00779766|453140604|FG000|Month 72|Other|0|||
125958601|NCT00779766|453140605|FG001|Month 72|Other|1|||
125958602|NCT01274637|453140608|FG000|Overall Study|Withdrawal by Subject|0|||
125958603|NCT01274637|453140609|FG001|Overall Study|Withdrawal by Subject|1|||
125958604|NCT01274637|453140608|FG000|Overall Study|Lost to Follow-up|0|||
125958605|NCT01274637|453140609|FG001|Overall Study|Lost to Follow-up|1|||
125958606|NCT02357576|453140613|FG000|Treatment Period|Withdrawal by Subject|0|||
125958607|NCT02357576|453140614|FG001|Treatment Period|Withdrawal by Subject|1|||
125958608|NCT02357576|453140613|FG000|Treatment Period|Physician Decision|0|||
125958609|NCT02357576|453140614|FG001|Treatment Period|Physician Decision|1|||
125958610|NCT02357576|453140613|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
125958611|NCT02357576|453140614|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
125958612|NCT02357576|453140613|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
125958613|NCT02357576|453140614|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
125958614|NCT02357576|453140613|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
125958615|NCT02357576|453140614|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
125958616|NCT02357576|453140613|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
125958617|NCT02357576|453140614|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
125958618|NCT00057746|453140619|FG000|Overall Study|Withdrawal by Subject|0|||
125958619|NCT00057746|453140620|FG001|Overall Study|Withdrawal by Subject|0|||
125958620|NCT00057746|453140621|FG002|Overall Study|Withdrawal by Subject|1|||
125958621|NCT00439140|453140624|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
125958622|NCT00439140|453140625|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
125958623|NCT00439140|453140626|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
125958624|NCT00439140|453140624|FG000|Treatment Cycle 1|Personal reasons|0|||
125958625|NCT00439140|453140625|FG001|Treatment Cycle 1|Personal reasons|2|||
125958626|NCT00439140|453140626|FG002|Treatment Cycle 1|Personal reasons|0|||
125958627|NCT00439140|453140624|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
125958628|NCT00439140|453140625|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
125958629|NCT00439140|453140626|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
125958630|NCT00439140|453140624|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
125958631|NCT00439140|453140625|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
125958632|NCT00439140|453140626|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
125958633|NCT00439140|453140624|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
125958634|NCT00439140|453140625|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
125958635|NCT00439140|453140626|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
125958636|NCT01752933|453140627|FG000|Treatment|Disease Progression|3|||
125958637|NCT01752933|453140628|FG001|Treatment|Disease Progression|29|||
125958638|NCT01752933|453140627|FG000|Treatment|Withdrawal by Subject|0|||
125958639|NCT01752933|453140628|FG001|Treatment|Withdrawal by Subject|5|||
125958640|NCT01752933|453140627|FG000|Treatment|Adverse Event|1|||
125958641|NCT01752933|453140628|FG001|Treatment|Adverse Event|4|||
125958642|NCT01752933|453140627|FG000|Treatment|Physician Decision|0|||
125958643|NCT01752933|453140628|FG001|Treatment|Physician Decision|3|||
125958644|NCT01752933|453140627|FG000|Treatment|Death|0|||
125958645|NCT01752933|453140628|FG001|Treatment|Death|2|||
125958646|NCT01752933|453140627|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
126116867|NCT01226459|453722013|FG001|Overall Study|Pregnancy|0|||
126116868|NCT00474708|453722014|FG000|Overall Study|Lack of Efficacy|11|||
126116869|NCT00474708|453722015|FG001|Overall Study|Lack of Efficacy|5|||
126116870|NCT00474708|453722014|FG000|Overall Study|Suicide ideation/behavior|0|||
126116871|NCT00474708|453722015|FG001|Overall Study|Suicide ideation/behavior|1|||
126116872|NCT00474708|453722014|FG000|Overall Study|Withdrawal by Subject|7|||
125958647|NCT01752933|453140628|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
125958648|NCT01752933|453140627|FG000|Treatment|Patient noncompliant|0|||
125958649|NCT01752933|453140628|FG001|Treatment|Patient noncompliant|1|||
125958650|NCT01752933|453140627|FG000|Treatment|Patient unable to travel to appointments|0|||
125958651|NCT01752933|453140628|FG001|Treatment|Patient unable to travel to appointments|1|||
125958652|NCT01752933|453140627|FG000|Overall Study and Follow-up|Death|4|||
125958653|NCT01752933|453140628|FG001|Overall Study and Follow-up|Death|34|||
125958654|NCT01752933|453140627|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
125958655|NCT01752933|453140628|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
125958656|NCT01752933|453140627|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
126116873|NCT00474708|453722015|FG001|Overall Study|Withdrawal by Subject|0|||
125958657|NCT01752933|453140628|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
125958658|NCT01752933|453140627|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
126116874|NCT00474708|453722014|FG000|Overall Study|Lack of compliance|12|||
125958659|NCT01752933|453140628|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
125958660|NCT04154631|453140631|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
125958661|NCT04154631|453140632|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
125958662|NCT02185768|453140633|FG000|Overall Study|Patients were not treated|2|||
125958663|NCT02550652|453140634|FG000|Overall Study|Death|1|||
125958664|NCT02550652|453140635|FG001|Overall Study|Death|4|||
125958665|NCT02550652|453140634|FG000|Overall Study|Lack of Efficacy|1|||
125958666|NCT02550652|453140635|FG001|Overall Study|Lack of Efficacy|0|||
125958667|NCT02550652|453140634|FG000|Overall Study|Withdrawal by Subject|4|||
125958668|NCT02550652|453140635|FG001|Overall Study|Withdrawal by Subject|7|||
125958669|NCT02550652|453140634|FG000|Overall Study|Post Trial Access|1|||
125958670|NCT02550652|453140635|FG001|Overall Study|Post Trial Access|0|||
125958671|NCT02550652|453140634|FG000|Overall Study|Lost to Follow-up|1|||
125958672|NCT02550652|453140635|FG001|Overall Study|Lost to Follow-up|3|||
125958673|NCT02550652|453140634|FG000|Overall Study|Physician Decision|0|||
125958674|NCT02550652|453140635|FG001|Overall Study|Physician Decision|2|||
125958675|NCT02550652|453140634|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
125958676|NCT02550652|453140635|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
125958677|NCT01706250|453140636|FG000|Overall Study|Lost to Follow-up|2|||
125958678|NCT03181542|453140640|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
125958679|NCT03181542|453140641|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
125958680|NCT03149237|453140653|FG000|Overall Study|Withdrawal by Subject|4|||
125958681|NCT03149237|453140654|FG001|Overall Study|Withdrawal by Subject|5|||
125958682|NCT01466192|453140655|FG000|Overall Study|Physician Decision|1|||
125958683|NCT01466192|453140655|FG000|Overall Study|Withdrawal by Subject|3|||
125958684|NCT04568122|453140656|FG000|Overall Study|Lost to Follow-up|48|||
125958685|NCT04568122|453140657|FG001|Overall Study|Lost to Follow-up|44|||
125958686|NCT04568122|453140658|FG002|Overall Study|Lost to Follow-up|4|||
125958687|NCT04568122|453140659|FG003|Overall Study|Lost to Follow-up|0|||
125958688|NCT04568122|453140660|FG004|Overall Study|Lost to Follow-up|0|||
125958689|NCT00678561|453140663|FG000|Overall Study|Adverse Event|0|||
125958690|NCT00678561|453140664|FG001|Overall Study|Adverse Event|1|||
125958691|NCT00678561|453140665|FG002|Overall Study|Adverse Event|1|||
125958692|NCT00678561|453140666|FG003|Overall Study|Adverse Event|0|||
125958693|NCT00678561|453140667|FG004|Overall Study|Adverse Event|1|||
125958694|NCT00678561|453140668|FG005|Overall Study|Adverse Event|0|||
125958695|NCT00678561|453140669|FG006|Overall Study|Adverse Event|0|||
125958696|NCT00678561|453140670|FG007|Overall Study|Adverse Event|0|||
125958697|NCT00678561|453140663|FG000|Overall Study|Protocol Violation|0|||
125958698|NCT00678561|453140664|FG001|Overall Study|Protocol Violation|0|||
125958699|NCT00678561|453140665|FG002|Overall Study|Protocol Violation|0|||
125958700|NCT00678561|453140666|FG003|Overall Study|Protocol Violation|0|||
125958701|NCT00678561|453140667|FG004|Overall Study|Protocol Violation|1|||
125958702|NCT00678561|453140668|FG005|Overall Study|Protocol Violation|1|||
125958703|NCT00678561|453140669|FG006|Overall Study|Protocol Violation|0|||
125958704|NCT00678561|453140670|FG007|Overall Study|Protocol Violation|0|||
125958705|NCT00678561|453140663|FG000|Overall Study|Withdrawal by Subject|0|||
125958706|NCT00678561|453140664|FG001|Overall Study|Withdrawal by Subject|0|||
125958707|NCT00678561|453140665|FG002|Overall Study|Withdrawal by Subject|0|||
125958708|NCT00678561|453140666|FG003|Overall Study|Withdrawal by Subject|0|||
125958709|NCT00678561|453140667|FG004|Overall Study|Withdrawal by Subject|0|||
125958710|NCT00678561|453140668|FG005|Overall Study|Withdrawal by Subject|0|||
125958711|NCT00678561|453140669|FG006|Overall Study|Withdrawal by Subject|0|||
125958712|NCT00678561|453140670|FG007|Overall Study|Withdrawal by Subject|1|||
125958713|NCT00700011|453140671|FG000|Overall Study|Death|0|||
125958714|NCT00700011|453140672|FG001|Overall Study|Death|1|||
125958715|NCT00437034|453140673|FG000|Overall Study|Adverse Event|1|||
125958716|NCT00437034|453140673|FG000|Overall Study|Disease progression during treatment|5|||
125958717|NCT00853658|453140675|FG000|Overall Study|Death|713|||
125958718|NCT00853658|453140676|FG001|Overall Study|Death|768|||
125958719|NCT00853658|453140677|FG002|Overall Study|Death|753|||
125958720|NCT00853658|453140675|FG000|Overall Study|Lost to Follow-up|11|||
125958721|NCT00853658|453140676|FG001|Overall Study|Lost to Follow-up|6|||
125958722|NCT00853658|453140677|FG002|Overall Study|Lost to Follow-up|11|||
125958723|NCT00853658|453140675|FG000|Overall Study|H.A. Request|26|||
125958724|NCT00853658|453140676|FG001|Overall Study|H.A. Request|23|||
125958725|NCT00853658|453140677|FG002|Overall Study|H.A. Request|19|||
125958726|NCT00853658|453140675|FG000|Overall Study|IRB request|0|||
125958727|NCT00853658|453140676|FG001|Overall Study|IRB request|0|||
125958728|NCT00853658|453140677|FG002|Overall Study|IRB request|2|||
125958729|NCT00853658|453140675|FG000|Overall Study|Vital Status known (alive) at study end|2|||
125958730|NCT00853658|453140676|FG001|Overall Study|Vital Status known (alive) at study end|3|||
125958731|NCT00853658|453140677|FG002|Overall Study|Vital Status known (alive) at study end|3|||
125958732|NCT00853658|453140675|FG000|Overall Study|Vital Status unknown at study end|1|||
125958733|NCT00853658|453140676|FG001|Overall Study|Vital Status unknown at study end|1|||
125958734|NCT00853658|453140677|FG002|Overall Study|Vital Status unknown at study end|0|||
126116875|NCT00474708|453722015|FG001|Overall Study|Lack of compliance|4|||
126116876|NCT00474708|453722014|FG000|Overall Study|Lost to Follow-up|18|||
126116877|NCT00474708|453722015|FG001|Overall Study|Lost to Follow-up|9|||
126116878|NCT00474708|453722014|FG000|Overall Study|Physician Decision|9|||
126116879|NCT00474708|453722015|FG001|Overall Study|Physician Decision|6|||
126116880|NCT03700320|453722016|FG000|Overall Study|Adverse Event|5|||
126116881|NCT03700320|453722017|FG001|Overall Study|Adverse Event|31|||
126116882|NCT03700320|453722016|FG000|Overall Study|Lack of Efficacy|2|||
126116883|NCT03700320|453722017|FG001|Overall Study|Lack of Efficacy|5|||
126116884|NCT03700320|453722016|FG000|Overall Study|Withdrawal by Subject|29|||
126116885|NCT03700320|453722017|FG001|Overall Study|Withdrawal by Subject|75|||
126116886|NCT03700320|453722016|FG000|Overall Study|Lost to Follow-up|16|||
126116887|NCT03700320|453722017|FG001|Overall Study|Lost to Follow-up|23|||
126116888|NCT03700320|453722016|FG000|Overall Study|Pregnancy|2|||
126116889|NCT03700320|453722017|FG001|Overall Study|Pregnancy|4|||
126116890|NCT03700320|453722016|FG000|Overall Study|Protocol Deviation|7|||
126116891|NCT03700320|453722017|FG001|Overall Study|Protocol Deviation|31|||
126116892|NCT03700320|453722016|FG000|Overall Study|Non-compliance with Study Drug|1|||
126116893|NCT03700320|453722017|FG001|Overall Study|Non-compliance with Study Drug|3|||
126116894|NCT03700320|453722016|FG000|Overall Study|Reason not Specified|0|||
126116895|NCT03700320|453722017|FG001|Overall Study|Reason not Specified|1|||
126116896|NCT00175877|453722021|FG000|Overall Study|Adverse Event|136|||
126116897|NCT00175877|453722021|FG000|Overall Study|Withdrawal by Subject|141|||
126116898|NCT00175877|453722021|FG000|Overall Study|Lost to Follow-up|9|||
126116899|NCT00175877|453722021|FG000|Overall Study|Lack of Efficacy|26|||
126116900|NCT00175877|453722021|FG000|Overall Study|Protocol Violation|15|||
126116901|NCT00175877|453722021|FG000|Overall Study|Other Reason|20|||
126116902|NCT00175877|453722021|FG000|Overall Study|AE & Other|1|||
126116903|NCT00175877|453722021|FG000|Overall Study|Withdrawal by subject & Other|1|||
126116904|NCT01092143|453722024|FG000|Overall Study|Adverse Event|10|||
126116905|NCT01092143|453722025|FG001|Overall Study|Adverse Event|5|||
126116906|NCT01092143|453722026|FG002|Overall Study|Adverse Event|1|||
126116907|NCT01092143|453722027|FG003|Overall Study|Adverse Event|4|||
126116908|NCT01092143|453722028|FG004|Overall Study|Adverse Event|3|||
126116909|NCT01092143|453722024|FG000|Overall Study|Lost to Follow-up|1|||
126116910|NCT01092143|453722025|FG001|Overall Study|Lost to Follow-up|0|||
126116911|NCT01092143|453722026|FG002|Overall Study|Lost to Follow-up|1|||
126116912|NCT01092143|453722027|FG003|Overall Study|Lost to Follow-up|0|||
126116913|NCT01092143|453722028|FG004|Overall Study|Lost to Follow-up|0|||
126116914|NCT01092143|453722024|FG000|Overall Study|Consent withdrawn|2|||
126116915|NCT01092143|453722025|FG001|Overall Study|Consent withdrawn|1|||
126116916|NCT01092143|453722026|FG002|Overall Study|Consent withdrawn|0|||
126116917|NCT01092143|453722027|FG003|Overall Study|Consent withdrawn|1|||
126116918|NCT01092143|453722028|FG004|Overall Study|Consent withdrawn|3|||
126116919|NCT01092143|453722024|FG000|Overall Study|Not treated|0|||
126116920|NCT01092143|453722025|FG001|Overall Study|Not treated|0|||
126116921|NCT01092143|453722026|FG002|Overall Study|Not treated|1|||
126116922|NCT01092143|453722027|FG003|Overall Study|Not treated|0|||
126116923|NCT01092143|453722028|FG004|Overall Study|Not treated|0|||
126116924|NCT01092143|453722024|FG000|Overall Study|did not reversibility criteria|0|||
126116925|NCT01092143|453722025|FG001|Overall Study|did not reversibility criteria|0|||
126116926|NCT01092143|453722026|FG002|Overall Study|did not reversibility criteria|1|||
126116927|NCT01092143|453722027|FG003|Overall Study|did not reversibility criteria|0|||
126116928|NCT01092143|453722028|FG004|Overall Study|did not reversibility criteria|0|||
126116929|NCT01092143|453722024|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
126116930|NCT01092143|453722025|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
125958735|NCT00853658|453140675|FG000|Overall Study|Vital Status at study end N/A|8|||
125958736|NCT00853658|453140676|FG001|Overall Study|Vital Status at study end N/A|10|||
125958737|NCT00853658|453140677|FG002|Overall Study|Vital Status at study end N/A|10|||
125958738|NCT00853658|453140675|FG000|Overall Study|Patient's request|21|||
125958739|NCT00853658|453140676|FG001|Overall Study|Patient's request|17|||
125958740|NCT00853658|453140677|FG002|Overall Study|Patient's request|11|||
125958741|NCT00853658|453140675|FG000|Overall Study|Missing study completion information|5|||
125958742|NCT00853658|453140676|FG001|Overall Study|Missing study completion information|4|||
125958743|NCT00853658|453140677|FG002|Overall Study|Missing study completion information|6|||
125958744|NCT02047604|453140678|FG000|Overall Study|Withdrawal by Subject|0|||
125958745|NCT02047604|453140679|FG001|Overall Study|Withdrawal by Subject|0|||
125958746|NCT02047604|453140680|FG002|Overall Study|Withdrawal by Subject|0|||
125958747|NCT02047604|453140681|FG003|Overall Study|Withdrawal by Subject|0|||
125958748|NCT02047604|453140682|FG004|Overall Study|Withdrawal by Subject|1|||
125958749|NCT02047604|453140683|FG005|Overall Study|Withdrawal by Subject|1|||
125958750|NCT04035486|453140684|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
125958751|NCT04035486|453140685|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
125958752|NCT04035486|453140686|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
126116931|NCT01092143|453722026|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
126116932|NCT01092143|453722027|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
126116933|NCT01092143|453722028|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
126116934|NCT01092143|453722024|FG000|Overall Study|Ineligible patient|1|||
126116935|NCT01092143|453722025|FG001|Overall Study|Ineligible patient|0|||
126116936|NCT01092143|453722026|FG002|Overall Study|Ineligible patient|0|||
126116937|NCT01092143|453722027|FG003|Overall Study|Ineligible patient|0|||
126116938|NCT01092143|453722028|FG004|Overall Study|Ineligible patient|0|||
126116939|NCT01092143|453722024|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
126116940|NCT01092143|453722025|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
126116941|NCT01092143|453722026|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
126116942|NCT01092143|453722027|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
126116943|NCT01092143|453722028|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
126116944|NCT01092143|453722024|FG000|Overall Study|Patient travel|0|||
126116945|NCT01092143|453722025|FG001|Overall Study|Patient travel|0|||
126116946|NCT01092143|453722026|FG002|Overall Study|Patient travel|0|||
126116947|NCT01092143|453722027|FG003|Overall Study|Patient travel|0|||
126116948|NCT01092143|453722028|FG004|Overall Study|Patient travel|1|||
126116949|NCT01092143|453722024|FG000|Overall Study|Non compliance with study medication|0|||
126116950|NCT01092143|453722025|FG001|Overall Study|Non compliance with study medication|0|||
126116951|NCT01092143|453722026|FG002|Overall Study|Non compliance with study medication|0|||
126116952|NCT01092143|453722027|FG003|Overall Study|Non compliance with study medication|0|||
126116953|NCT01092143|453722028|FG004|Overall Study|Non compliance with study medication|1|||
126116954|NCT01092143|453722024|FG000|Overall Study|Randomized by mistake|0|||
126116955|NCT01092143|453722025|FG001|Overall Study|Randomized by mistake|0|||
126116956|NCT01092143|453722026|FG002|Overall Study|Randomized by mistake|0|||
126116957|NCT01092143|453722027|FG003|Overall Study|Randomized by mistake|1|||
126116958|NCT01092143|453722028|FG004|Overall Study|Randomized by mistake|0|||
126116959|NCT01092143|453722024|FG000|Overall Study|Pregnancy|0|||
126116960|NCT01092143|453722025|FG001|Overall Study|Pregnancy|0|||
125958753|NCT04035486|453140687|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
125958754|NCT04035486|453140684|FG000|Overall Study|Death|6|||
125958755|NCT04035486|453140685|FG001|Overall Study|Death|3|||
125958756|NCT04035486|453140686|FG002|Overall Study|Death|70|||
125958757|NCT04035486|453140687|FG003|Overall Study|Death|77|||
125958758|NCT04035486|453140684|FG000|Overall Study|Screen Failure|0|||
125958759|NCT04035486|453140685|FG001|Overall Study|Screen Failure|0|||
125958760|NCT04035486|453140686|FG002|Overall Study|Screen Failure|1|||
125958761|NCT04035486|453140687|FG003|Overall Study|Screen Failure|1|||
125958762|NCT04035486|453140684|FG000|Overall Study|Withdrawal by Subject|1|||
125958763|NCT04035486|453140685|FG001|Overall Study|Withdrawal by Subject|1|||
125958764|NCT04035486|453140686|FG002|Overall Study|Withdrawal by Subject|11|||
125958765|NCT04035486|453140687|FG003|Overall Study|Withdrawal by Subject|9|||
125958766|NCT01976845|453140690|FG000|Overall Study|Physician Decision|8|||
125958767|NCT01976845|453140691|FG001|Overall Study|Physician Decision|8|||
125958768|NCT01976845|453140692|FG002|Overall Study|Physician Decision|3|||
125958769|NCT06748040|453140693|FG000|Overall Study|Death|3|||
125958770|NCT06748040|453140694|FG001|Overall Study|Death|4|||
125958771|NCT06748040|453140693|FG000|Overall Study|Lost to Follow-up|134|||
125958772|NCT06748040|453140694|FG001|Overall Study|Lost to Follow-up|132|||
125958773|NCT06748040|453140693|FG000|Overall Study|Withdrawal by Subject|3|||
125958774|NCT06748040|453140694|FG001|Overall Study|Withdrawal by Subject|5|||
125958775|NCT02556710|453143382|FG000|Overall Study|Surgical treatment|3|||
125958776|NCT02556710|453143383|FG001|Overall Study|Surgical treatment|0|||
125958777|NCT02556710|453143382|FG000|Overall Study|Required proscribed pain medication|2|||
125958778|NCT02556710|453143383|FG001|Overall Study|Required proscribed pain medication|1|||
125958779|NCT02556710|453143382|FG000|Overall Study|Lack of Efficacy|1|||
125958780|NCT02556710|453143383|FG001|Overall Study|Lack of Efficacy|0|||
125958781|NCT02556710|453143382|FG000|Overall Study|Worsening osteoarthritis|1|||
125958782|NCT02556710|453143383|FG001|Overall Study|Worsening osteoarthritis|0|||
125958783|NCT02556710|453143382|FG000|Overall Study|Moved out of state|1|||
125958784|NCT02556710|453143383|FG001|Overall Study|Moved out of state|0|||
126116961|NCT01092143|453722026|FG002|Overall Study|Pregnancy|0|||
125958785|NCT02556710|453143382|FG000|Overall Study|Missing reason|3|||
125958786|NCT02556710|453143383|FG001|Overall Study|Missing reason|1|||
125958787|NCT02556710|453143382|FG000|Overall Study|Pain as lack of efficacy|0|||
125958788|NCT02556710|453143383|FG001|Overall Study|Pain as lack of efficacy|4|||
125958789|NCT04258839|453143386|FG000|Overall Study|Adverse Event|2|||
125958790|NCT04258839|453143387|FG001|Overall Study|Adverse Event|4|||
126116962|NCT01092143|453722027|FG003|Overall Study|Pregnancy|1|||
126116963|NCT01092143|453722028|FG004|Overall Study|Pregnancy|0|||
126116964|NCT00397033|453722034|FG000|Overall Study|Adverse Event|7|||
125958791|NCT04258839|453143386|FG000|Overall Study|Lack of Efficacy|0|||
125958792|NCT04258839|453143387|FG001|Overall Study|Lack of Efficacy|2|||
125958793|NCT04258839|453143386|FG000|Overall Study|Lost to Follow-up|2|||
125958794|NCT04258839|453143387|FG001|Overall Study|Lost to Follow-up|0|||
125958795|NCT04258839|453143386|FG000|Overall Study|Withdrawal by Subject|1|||
125958796|NCT04258839|453143387|FG001|Overall Study|Withdrawal by Subject|2|||
126116965|NCT00397033|453722035|FG001|Overall Study|Adverse Event|10|||
126116966|NCT00397033|453722036|FG002|Overall Study|Adverse Event|4|||
126116967|NCT00397033|453722034|FG000|Overall Study|Lack of Efficacy|22|||
126116968|NCT00397033|453722035|FG001|Overall Study|Lack of Efficacy|12|||
125958797|NCT04258839|453143386|FG000|Overall Study|Withdrawal by Caregiver|5|||
125958798|NCT04258839|453143387|FG001|Overall Study|Withdrawal by Caregiver|6|||
125958799|NCT04258839|453143386|FG000|Overall Study|Reason not Specified|0|||
125958800|NCT04258839|453143387|FG001|Overall Study|Reason not Specified|1|||
125958801|NCT02944578|453143389|FG000|Overall Study|Physician Decision|1|||
125958802|NCT02944578|453143390|FG001|Overall Study|Physician Decision|0|||
125958803|NCT02691455|453143391|FG000|Overall Study|Withdrawal by Subject|1|||
125958804|NCT02691455|453143392|FG001|Overall Study|Withdrawal by Subject|2|||
125958805|NCT02691455|453143391|FG000|Overall Study|Lost to Follow-up|15|||
125958806|NCT02691455|453143392|FG001|Overall Study|Lost to Follow-up|15|||
125958807|NCT01257204|453143393|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
125958808|NCT01257204|453143394|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
125958809|NCT01257204|453143395|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
125958810|NCT01257204|453143393|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
125958811|NCT01257204|453143394|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
125958812|NCT01257204|453143395|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
125958813|NCT01257204|453143393|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
125958814|NCT01257204|453143394|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
125958815|NCT01257204|453143395|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
125958816|NCT01257204|453143393|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
125958817|NCT01257204|453143394|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
125958818|NCT01257204|453143395|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
125958819|NCT01257204|453143393|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
125958820|NCT01257204|453143394|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
125958821|NCT01257204|453143395|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
125958822|NCT01257204|453143393|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
125958823|NCT01257204|453143394|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
125958824|NCT01257204|453143395|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
125958825|NCT01257204|453143393|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
125958826|NCT01257204|453143394|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
125958827|NCT01257204|453143395|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
125958828|NCT01257204|453143393|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
125958829|NCT01257204|453143394|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
125958830|NCT01257204|453143395|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
125958831|NCT01257204|453143393|FG000|Follow-up Period (up to Week 48)|Other|0|||
125958832|NCT01257204|453143394|FG001|Follow-up Period (up to Week 48)|Other|0|||
125958833|NCT01257204|453143395|FG002|Follow-up Period (up to Week 48)|Other|5|||
125958834|NCT00451282|453143399|FG000|Overall Study|Lost to Follow-up|6|||
125958835|NCT00451282|453143400|FG001|Overall Study|Lost to Follow-up|5|||
125958836|NCT00577122|453143401|FG000|Overall Study|Adverse Event|0|||
125958837|NCT00577122|453143402|FG001|Overall Study|Adverse Event|2|||
125958838|NCT00577122|453143401|FG000|Overall Study|Progression, relapse during active trt|6|||
125958839|NCT00577122|453143402|FG001|Overall Study|Progression, relapse during active trt|8|||
125958840|NCT00577122|453143401|FG000|Overall Study|Prog, refract disease during active trt|8|||
125958841|NCT00577122|453143402|FG001|Overall Study|Prog, refract disease during active trt|5|||
125958842|NCT00577122|453143401|FG000|Overall Study|Alternative Therapy|0|||
125958843|NCT00577122|453143402|FG001|Overall Study|Alternative Therapy|1|||
125958844|NCT01824303|453143409|FG000|Randomized Study|Withdrawal by Subject|1|||
125958845|NCT01824303|453143410|FG001|Randomized Study|Withdrawal by Subject|1|||
125958846|NCT01824303|453143409|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
125958847|NCT01824303|453143410|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
125958848|NCT01743092|453143411|FG000|Overall Study|Lost to Follow-up|14|||
125958849|NCT01743092|453143412|FG001|Overall Study|Lost to Follow-up|15|||
125958850|NCT03586869|453143413|FG000|Overall Study|Progressive Disease|3|||
125958851|NCT00403455|453143414|FG000|Overall Study|Withdrawal by Subject|1|||
125958852|NCT02809976|453143421|FG000|Overall Study|Lost to Follow-up|1|||
125958853|NCT02809976|453143421|FG000|Overall Study|Withdrawal by Subject|1|||
125958854|NCT00087568|453143422|FG000|Overall Study|Adverse Event|4|||
125958855|NCT00087568|453143423|FG001|Overall Study|Adverse Event|0|||
125958856|NCT00087568|453143422|FG000|Overall Study|Withdrawal by Subject|1|||
125958857|NCT00087568|453143423|FG001|Overall Study|Withdrawal by Subject|1|||
125958858|NCT00087568|453143422|FG000|Overall Study|Lost to Follow-up|1|||
125958859|NCT00087568|453143423|FG001|Overall Study|Lost to Follow-up|0|||
125958860|NCT00087568|453143422|FG000|Overall Study|Lack of Efficacy|24|||
125958861|NCT00087568|453143423|FG001|Overall Study|Lack of Efficacy|1|||
125958862|NCT04394351|453143424|FG000|Part A (16 Weeks)|Adverse Event|1|||
125958863|NCT04394351|453143425|FG001|Part A (16 Weeks)|Adverse Event|0|||
125958864|NCT04394351|453143426|FG002|Part A (16 Weeks)|Adverse Event|0|||
125958865|NCT04394351|453143427|FG003|Part A (16 Weeks)|Adverse Event|0|||
125958866|NCT04394351|453143428|FG004|Part A (16 Weeks)|Adverse Event|0|||
125958867|NCT04394351|453143429|FG005|Part A (16 Weeks)|Adverse Event|0|||
125958868|NCT04394351|453143430|FG006|Part A (16 Weeks)|Adverse Event|0|||
125958869|NCT04394351|453143431|FG007|Part A (16 Weeks)|Adverse Event|0|||
125958870|NCT04394351|453143424|FG000|Part A (16 Weeks)|Physician Decision|0|||
125958871|NCT04394351|453143425|FG001|Part A (16 Weeks)|Physician Decision|1|||
125958872|NCT04394351|453143426|FG002|Part A (16 Weeks)|Physician Decision|0|||
125958873|NCT04394351|453143427|FG003|Part A (16 Weeks)|Physician Decision|0|||
125958874|NCT04394351|453143428|FG004|Part A (16 Weeks)|Physician Decision|0|||
125958875|NCT04394351|453143429|FG005|Part A (16 Weeks)|Physician Decision|0|||
125958876|NCT04394351|453143430|FG006|Part A (16 Weeks)|Physician Decision|0|||
125958877|NCT04394351|453143431|FG007|Part A (16 Weeks)|Physician Decision|0|||
125958878|NCT04394351|453143424|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
125958879|NCT04394351|453143425|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
125958880|NCT04394351|453143426|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
125958881|NCT04394351|453143427|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
125958882|NCT04394351|453143428|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
125958883|NCT04394351|453143429|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
125958884|NCT04394351|453143430|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
125958885|NCT04394351|453143431|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
125958886|NCT04394351|453143424|FG000|Part B (36 Weeks)|Adverse Event|0|||
125958887|NCT04394351|453143425|FG001|Part B (36 Weeks)|Adverse Event|0|||
125958888|NCT04394351|453143426|FG002|Part B (36 Weeks)|Adverse Event|0|||
125958889|NCT04394351|453143427|FG003|Part B (36 Weeks)|Adverse Event|0|||
125958890|NCT04394351|453143428|FG004|Part B (36 Weeks)|Adverse Event|0|||
125958891|NCT04394351|453143429|FG005|Part B (36 Weeks)|Adverse Event|0|||
125958892|NCT04394351|453143430|FG006|Part B (36 Weeks)|Adverse Event|1|||
125958893|NCT04394351|453143431|FG007|Part B (36 Weeks)|Adverse Event|0|||
125958894|NCT02992899|453143436|FG000|Overall Study|Withdrawal by Subject|1|||
125958895|NCT02992899|453143437|FG001|Overall Study|Withdrawal by Subject|0|||
125958896|NCT02992899|453143436|FG000|Overall Study|Lost to Follow-up|1|||
125958897|NCT02992899|453143437|FG001|Overall Study|Lost to Follow-up|3|||
125958898|NCT02738775|453143438|FG000|Overall Study|Withdrawal by Subject|0|||
125958899|NCT02738775|453143439|FG001|Overall Study|Withdrawal by Subject|1|||
125958900|NCT02738775|453143440|FG002|Overall Study|Withdrawal by Subject|0|||
125958901|NCT02738775|453143441|FG003|Overall Study|Withdrawal by Subject|0|||
125958902|NCT02738775|453143442|FG004|Overall Study|Withdrawal by Subject|0|||
125958903|NCT02738775|453143443|FG005|Overall Study|Withdrawal by Subject|0|||
125958904|NCT02738775|453143438|FG000|Overall Study|Adverse Event|0|||
125958905|NCT02738775|453143439|FG001|Overall Study|Adverse Event|0|||
125958906|NCT02738775|453143440|FG002|Overall Study|Adverse Event|0|||
125958907|NCT02738775|453143441|FG003|Overall Study|Adverse Event|1|||
125958908|NCT02738775|453143442|FG004|Overall Study|Adverse Event|0|||
125958909|NCT02738775|453143443|FG005|Overall Study|Adverse Event|0|||
125958910|NCT02738775|453143438|FG000|Overall Study|Pregnancy|0|||
125958911|NCT02738775|453143439|FG001|Overall Study|Pregnancy|1|||
125958912|NCT02738775|453143440|FG002|Overall Study|Pregnancy|0|||
125958913|NCT02738775|453143441|FG003|Overall Study|Pregnancy|0|||
125958914|NCT02738775|453143442|FG004|Overall Study|Pregnancy|0|||
125958915|NCT02738775|453143443|FG005|Overall Study|Pregnancy|0|||
125958916|NCT02738775|453143438|FG000|Overall Study|Missing|0|||
125958917|NCT02738775|453143439|FG001|Overall Study|Missing|0|||
125958918|NCT02738775|453143440|FG002|Overall Study|Missing|0|||
125958919|NCT02738775|453143441|FG003|Overall Study|Missing|0|||
125958920|NCT02738775|453143442|FG004|Overall Study|Missing|0|||
125958921|NCT02738775|453143443|FG005|Overall Study|Missing|1|||
125958922|NCT04574362|453143444|FG000|Overall Study|Other|0|||
125958923|NCT04574362|453143445|FG001|Overall Study|Other|5|||
125958924|NCT04574362|453143444|FG000|Overall Study|COVID-19|0|||
125958925|NCT04574362|453143445|FG001|Overall Study|COVID-19|1|||
125958926|NCT04574362|453143444|FG000|Overall Study|Adverse Event|1|||
125958927|NCT04574362|453143445|FG001|Overall Study|Adverse Event|1|||
126116969|NCT00397033|453722036|FG002|Overall Study|Lack of Efficacy|9|||
126116970|NCT00397033|453722034|FG000|Overall Study|Lost to Follow-up|3|||
125958928|NCT04574362|453143444|FG000|Overall Study|Withdrawal by Subject|2|||
125958929|NCT04574362|453143445|FG001|Overall Study|Withdrawal by Subject|4|||
125958930|NCT04574362|453143444|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
125958931|NCT04574362|453143445|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
125958932|NCT04574362|453143444|FG000|Overall Study|Participant refused to come to the hospital|1|||
125958933|NCT04574362|453143445|FG001|Overall Study|Participant refused to come to the hospital|0|||
125958934|NCT04574362|453143444|FG000|Overall Study|Participant refused the visit|1|||
125958935|NCT04574362|453143445|FG001|Overall Study|Participant refused the visit|0|||
125958936|NCT04574362|453143444|FG000|Overall Study|Participant quit early because of business trip|1|||
125958937|NCT04574362|453143445|FG001|Overall Study|Participant quit early because of business trip|0|||
125958938|NCT01060384|453143446|FG000|Overall Study|Withdrawal by Subject|0|||
125958939|NCT01060384|453143447|FG001|Overall Study|Withdrawal by Subject|1|||
125958940|NCT01060384|453143448|FG002|Overall Study|Withdrawal by Subject|0|||
125958941|NCT01060384|453143449|FG003|Overall Study|Withdrawal by Subject|0|||
125958942|NCT01060384|453143450|FG004|Overall Study|Withdrawal by Subject|0|||
125958943|NCT01060384|453143446|FG000|Overall Study|Death|0|||
125958944|NCT01060384|453143447|FG001|Overall Study|Death|0|||
125958945|NCT01060384|453143448|FG002|Overall Study|Death|0|||
125958946|NCT01060384|453143449|FG003|Overall Study|Death|0|||
125958947|NCT01060384|453143450|FG004|Overall Study|Death|1|||
125958948|NCT01060384|453143446|FG000|Overall Study|Intercurrent illness|0|||
125958949|NCT01060384|453143447|FG001|Overall Study|Intercurrent illness|0|||
125958950|NCT01060384|453143448|FG002|Overall Study|Intercurrent illness|0|||
125958951|NCT01060384|453143449|FG003|Overall Study|Intercurrent illness|0|||
125958952|NCT01060384|453143450|FG004|Overall Study|Intercurrent illness|1|||
125958953|NCT00812929|453143454|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
125958954|NCT00812929|453143455|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
125958955|NCT00812929|453143456|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
125958956|NCT00812929|453143457|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
125958957|NCT00812929|453143458|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
125958958|NCT00812929|453143459|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
125958959|NCT00812929|453143460|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
125958960|NCT00812929|453143461|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
125958961|NCT00812929|453143462|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
125958962|NCT00812929|453143463|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
125958963|NCT00812929|453143454|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
125958964|NCT00812929|453143455|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
125958965|NCT00812929|453143456|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
125958966|NCT00812929|453143457|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
125958967|NCT00812929|453143458|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
125958968|NCT00812929|453143459|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
125958969|NCT00812929|453143460|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
125958970|NCT00812929|453143461|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
125958971|NCT00812929|453143462|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
125958972|NCT00812929|453143463|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
125958973|NCT00812929|453143454|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
125958974|NCT00812929|453143455|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
125958975|NCT00812929|453143456|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
125958976|NCT00812929|453143457|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
125958977|NCT00812929|453143458|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
125958978|NCT00812929|453143459|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
125958979|NCT00812929|453143460|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
125958980|NCT00812929|453143461|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
125958981|NCT00812929|453143462|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
125958982|NCT00812929|453143463|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
125958983|NCT00211081|453143464|FG000|Overall Study|Withdrawal by Subject|2|||
125958984|NCT01332305|453143465|FG000|Overall Study|Adverse Event|1|||
125958985|NCT01332305|453143466|FG001|Overall Study|Adverse Event|4|||
125958986|NCT01332305|453143467|FG002|Overall Study|Adverse Event|6|||
125958987|NCT01332305|453143468|FG003|Overall Study|Adverse Event|3|||
125958988|NCT01332305|453143469|FG004|Overall Study|Adverse Event|5|||
125958989|NCT01332305|453143465|FG000|Overall Study|Withdrawal by Subject|6|||
125958990|NCT01332305|453143466|FG001|Overall Study|Withdrawal by Subject|5|||
125958991|NCT01332305|453143467|FG002|Overall Study|Withdrawal by Subject|4|||
125958992|NCT01332305|453143468|FG003|Overall Study|Withdrawal by Subject|1|||
125958993|NCT01332305|453143469|FG004|Overall Study|Withdrawal by Subject|0|||
125958994|NCT01332305|453143465|FG000|Overall Study|Lost to Follow-up|0|||
125958995|NCT01332305|453143466|FG001|Overall Study|Lost to Follow-up|2|||
125958996|NCT01332305|453143467|FG002|Overall Study|Lost to Follow-up|3|||
125958997|NCT01332305|453143468|FG003|Overall Study|Lost to Follow-up|2|||
125958998|NCT01332305|453143469|FG004|Overall Study|Lost to Follow-up|3|||
125958999|NCT01332305|453143465|FG000|Overall Study|Protocol Violation|1|||
125959000|NCT01332305|453143466|FG001|Overall Study|Protocol Violation|2|||
125959001|NCT01332305|453143467|FG002|Overall Study|Protocol Violation|1|||
125959002|NCT01332305|453143468|FG003|Overall Study|Protocol Violation|0|||
125959003|NCT01332305|453143469|FG004|Overall Study|Protocol Violation|3|||
125959004|NCT01332305|453143465|FG000|Overall Study|Withdrawal by Sponsor|1|||
125959005|NCT01332305|453143466|FG001|Overall Study|Withdrawal by Sponsor|0|||
125959006|NCT01332305|453143467|FG002|Overall Study|Withdrawal by Sponsor|0|||
125959007|NCT01332305|453143468|FG003|Overall Study|Withdrawal by Sponsor|1|||
125959008|NCT01332305|453143469|FG004|Overall Study|Withdrawal by Sponsor|1|||
125959009|NCT01332305|453143465|FG000|Overall Study|Treatment Failure|1|||
125959010|NCT01332305|453143466|FG001|Overall Study|Treatment Failure|1|||
125959011|NCT01332305|453143467|FG002|Overall Study|Treatment Failure|0|||
125959012|NCT01332305|453143468|FG003|Overall Study|Treatment Failure|0|||
125959013|NCT01332305|453143469|FG004|Overall Study|Treatment Failure|0|||
125959014|NCT01332305|453143465|FG000|Overall Study|Physician Decision|0|||
125959015|NCT01332305|453143466|FG001|Overall Study|Physician Decision|0|||
125959016|NCT01332305|453143467|FG002|Overall Study|Physician Decision|0|||
125959017|NCT01332305|453143468|FG003|Overall Study|Physician Decision|1|||
125959018|NCT01332305|453143469|FG004|Overall Study|Physician Decision|0|||
125959019|NCT03755765|453143476|FG000|Overall Study|Withdrawal by Subject|2|||
125959020|NCT03755765|453143477|FG001|Overall Study|Withdrawal by Subject|4|||
125959021|NCT03755765|453143478|FG002|Overall Study|Withdrawal by Subject|4|||
125959022|NCT00678691|453143481|FG000|Overall Study|Adverse Event|6|||
125959023|NCT00678691|453143482|FG001|Overall Study|Adverse Event|4|||
125959024|NCT01632800|453143489|FG000|Overall Study|Subject did not fit in apparatus|1|||
125959025|NCT02170727|453143491|FG000|Overall Study|Lost to Follow-up|1|||
125959026|NCT02170727|453143492|FG001|Overall Study|Lost to Follow-up|0|||
125959027|NCT02170727|453143491|FG000|Overall Study|Withdrawal by Subject|2|||
125959028|NCT02170727|453143492|FG001|Overall Study|Withdrawal by Subject|0|||
125959029|NCT00720876|453143493|FG000|Overall Study|found to be ineligible after starting tx|2|||
125959030|NCT00684424|453143499|FG000|Overall Study|Adverse Event|1|||
125959031|NCT00684424|453143499|FG000|Overall Study|Lost to Follow-up|2|||
125959032|NCT00684424|453143499|FG000|Overall Study|Other|2|||
125959033|NCT02410811|453143500|FG000|Overall Study|Withdrawal by Subject|0|||
125959034|NCT02410811|453143501|FG001|Overall Study|Withdrawal by Subject|0|||
125959035|NCT02410811|453143502|FG002|Overall Study|Withdrawal by Subject|1|||
125959036|NCT02410811|453143503|FG003|Overall Study|Withdrawal by Subject|0|||
125959037|NCT03511560|453143509|FG000|Overall Study|Death|0|||
125959038|NCT03511560|453143510|FG001|Overall Study|Death|1|||
125959039|NCT03511560|453143509|FG000|Overall Study|Adverse Event|0|||
125959040|NCT03511560|453143510|FG001|Overall Study|Adverse Event|2|||
125959041|NCT03511560|453143509|FG000|Overall Study|Transplant cancelled|0|||
125959042|NCT03511560|453143510|FG001|Overall Study|Transplant cancelled|1|||
125959043|NCT03511560|453143509|FG000|Overall Study|Patient switched to another drug|1|||
125959044|NCT03511560|453143510|FG001|Overall Study|Patient switched to another drug|0|||
125959045|NCT02985736|453143515|FG000|Overall Study|Lost to Follow-up|3|||
125959046|NCT00382733|453143516|FG000|Overall Study|Withdrawal by Subject|0|||
125959047|NCT00382733|453143517|FG001|Overall Study|Withdrawal by Subject|1|||
125959048|NCT00382733|453143518|FG002|Overall Study|Withdrawal by Subject|0|||
125959049|NCT00382733|453143519|FG003|Overall Study|Withdrawal by Subject|0|||
125959050|NCT00382733|453143520|FG004|Overall Study|Withdrawal by Subject|0|||
125959051|NCT00799617|453143528|FG000|Main Testosterone Trial|Randomized in error|1|||
125959052|NCT00799617|453143529|FG001|Main Testosterone Trial|Randomized in error|1|||
125959053|NCT00799617|453143528|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
125959054|NCT00799617|453143529|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
125959055|NCT00799617|453143528|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
125959056|NCT00799617|453143529|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
125959057|NCT00799617|453143528|FG000|Sexual Funtion Trial|No Baseline Data|4|||
125959058|NCT00799617|453143529|FG001|Sexual Funtion Trial|No Baseline Data|7|||
125959059|NCT00799617|453143528|FG000|Physical Function Trial|Lost to Follow-up|6|||
125959060|NCT00799617|453143529|FG001|Physical Function Trial|Lost to Follow-up|11|||
125959061|NCT00799617|453143528|FG000|Vitality Trial|Lost to Follow-up|7|||
125959062|NCT00799617|453143529|FG001|Vitality Trial|Lost to Follow-up|22|||
125959063|NCT00799617|453143528|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
125959064|NCT00799617|453143529|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
125959065|NCT00799617|453143528|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
125959066|NCT00799617|453143529|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
125959067|NCT00799617|453143528|FG000|Bone Trial|Month 12 scan not available|6|||
125959068|NCT00799617|453143529|FG001|Bone Trial|Month 12 scan not available|16|||
125959069|NCT00799617|453143528|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
125959070|NCT00799617|453143529|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
125959071|NCT00799617|453143528|FG000|Anemia Trial|Withdrawal by Subject|3|||
125959072|NCT00799617|453143529|FG001|Anemia Trial|Withdrawal by Subject|3|||
125959073|NCT04545515|453143530|FG000|Overall Study|Adverse Event|1|||
125959074|NCT04545515|453143530|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
125959075|NCT04545515|453143530|FG000|Overall Study|Commercial drug is available for participant|7|||
125959076|NCT01848990|453143531|FG000|Overall Study|Adverse Event|6|||
125959077|NCT01848990|453143532|FG001|Overall Study|Adverse Event|2|||
125959078|NCT01848990|453143533|FG002|Overall Study|Adverse Event|0|||
125959079|NCT01848990|453143531|FG000|Overall Study|Lost to Follow-up|6|||
125959080|NCT01848990|453143532|FG001|Overall Study|Lost to Follow-up|2|||
125959081|NCT01848990|453143533|FG002|Overall Study|Lost to Follow-up|2|||
125959082|NCT01848990|453143531|FG000|Overall Study|Protocol Violation|1|||
125959083|NCT01848990|453143532|FG001|Overall Study|Protocol Violation|1|||
125959084|NCT01848990|453143533|FG002|Overall Study|Protocol Violation|0|||
125959085|NCT01848990|453143531|FG000|Overall Study|Withdrawal by Subject|29|||
125959086|NCT01848990|453143532|FG001|Overall Study|Withdrawal by Subject|10|||
125959087|NCT01848990|453143533|FG002|Overall Study|Withdrawal by Subject|11|||
125959088|NCT01848990|453143531|FG000|Overall Study|Physician Decision|1|||
125959089|NCT01848990|453143532|FG001|Overall Study|Physician Decision|1|||
125959090|NCT01848990|453143533|FG002|Overall Study|Physician Decision|0|||
125959091|NCT01848990|453143531|FG000|Overall Study|Non Compliance|1|||
125959092|NCT01848990|453143532|FG001|Overall Study|Non Compliance|0|||
125959093|NCT01848990|453143533|FG002|Overall Study|Non Compliance|0|||
125959094|NCT01848990|453143531|FG000|Overall Study|Death|1|||
125959095|NCT01848990|453143532|FG001|Overall Study|Death|0|||
125959096|NCT01848990|453143533|FG002|Overall Study|Death|1|||
125959097|NCT01848990|453143531|FG000|Overall Study|Other|1|||
125959098|NCT01848990|453143532|FG001|Overall Study|Other|4|||
125959099|NCT01848990|453143533|FG002|Overall Study|Other|2|||
125959100|NCT00958880|453143534|FG000|Overall Study|Lost to Follow-up|2|||
125959101|NCT00958880|453143535|FG001|Overall Study|Lost to Follow-up|2|||
125959102|NCT01712984|453143536|FG000|Overall Study|Adverse Event|0|||
125959103|NCT01712984|453143537|FG001|Overall Study|Adverse Event|0|||
125959104|NCT01712984|453143538|FG002|Overall Study|Adverse Event|1|||
125959105|NCT01712984|453143536|FG000|Overall Study|Protocol Violation|2|||
125959106|NCT01712984|453143537|FG001|Overall Study|Protocol Violation|0|||
125959107|NCT01712984|453143538|FG002|Overall Study|Protocol Violation|1|||
125959108|NCT01712984|453143536|FG000|Overall Study|Lost to Follow-up|8|||
125959109|NCT01712984|453143537|FG001|Overall Study|Lost to Follow-up|10|||
125959110|NCT01712984|453143538|FG002|Overall Study|Lost to Follow-up|1|||
125959111|NCT01712984|453143536|FG000|Overall Study|Withdrawal by Subject|6|||
125959112|NCT01712984|453143537|FG001|Overall Study|Withdrawal by Subject|6|||
125959113|NCT01712984|453143538|FG002|Overall Study|Withdrawal by Subject|7|||
125959114|NCT02755831|453143541|FG000|Overall Study|Lost to Follow-up|3|||
125959115|NCT02755831|453143542|FG001|Overall Study|Lost to Follow-up|3|||
125959116|NCT01720069|453143543|FG000|Overall Study|Could not use e-diary correctly|0|||
125959117|NCT01720069|453143544|FG001|Overall Study|Could not use e-diary correctly|1|||
125959118|NCT01720069|453143545|FG002|Overall Study|Could not use e-diary correctly|1|||
125959119|NCT01720069|453143543|FG000|Overall Study|Randomised without baseline values|0|||
125959120|NCT01720069|453143544|FG001|Overall Study|Randomised without baseline values|0|||
125959121|NCT01720069|453143545|FG002|Overall Study|Randomised without baseline values|1|||
125959122|NCT01720069|453143543|FG000|Overall Study|Adverse Event|0|||
125959123|NCT01720069|453143544|FG001|Overall Study|Adverse Event|0|||
125959124|NCT01720069|453143545|FG002|Overall Study|Adverse Event|1|||
125959125|NCT01720069|453143543|FG000|Overall Study|Lack of Efficacy|0|||
125959126|NCT01720069|453143544|FG001|Overall Study|Lack of Efficacy|4|||
125959127|NCT01720069|453143545|FG002|Overall Study|Lack of Efficacy|0|||
125959128|NCT01720069|453143543|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
125959129|NCT01720069|453143544|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
125959130|NCT01720069|453143545|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
125959131|NCT01720069|453143543|FG000|Overall Study|Withdrawal by Subject|0|||
125959132|NCT01720069|453143544|FG001|Overall Study|Withdrawal by Subject|2|||
125959133|NCT01720069|453143545|FG002|Overall Study|Withdrawal by Subject|1|||
125959134|NCT01720069|453143543|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
125959135|NCT01720069|453143544|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
125959136|NCT01720069|453143545|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
125959137|NCT01720069|453143543|FG000|Overall Study|Non-compliance on using e-diary|0|||
125959138|NCT01720069|453143544|FG001|Overall Study|Non-compliance on using e-diary|0|||
125959139|NCT01720069|453143545|FG002|Overall Study|Non-compliance on using e-diary|1|||
125959140|NCT01720069|453143543|FG000|Overall Study|Lost to Follow-up|0|||
125959141|NCT01720069|453143544|FG001|Overall Study|Lost to Follow-up|0|||
125959142|NCT01720069|453143545|FG002|Overall Study|Lost to Follow-up|1|||
125959143|NCT00508742|453143546|FG000|Period 1: Infant Series|Adverse Event|5|||
125959144|NCT00508742|453143547|FG001|Period 1: Infant Series|Adverse Event|4|||
125959145|NCT00508742|453143546|FG000|Period 1: Infant Series|Protocol Violation|1|||
125959146|NCT00508742|453143547|FG001|Period 1: Infant Series|Protocol Violation|0|||
125959147|NCT00508742|453143546|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
125959148|NCT00508742|453143547|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
125959149|NCT00508742|453143546|FG000|Period 1: Infant Series|Physician Decision|1|||
125959150|NCT00508742|453143547|FG001|Period 1: Infant Series|Physician Decision|0|||
125959151|NCT00508742|453143546|FG000|Period 1: Infant Series|Other|4|||
125959152|NCT00508742|453143547|FG001|Period 1: Infant Series|Other|1|||
125959153|NCT00508742|453143546|FG000|Period 2: After Infant Series|Adverse Event|2|||
125959154|NCT00508742|453143547|FG001|Period 2: After Infant Series|Adverse Event|6|||
125959155|NCT00508742|453143546|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
125959156|NCT00508742|453143547|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
125959157|NCT00508742|453143546|FG000|Period 2: After Infant Series|Protocol Violation|1|||
125959158|NCT00508742|453143547|FG001|Period 2: After Infant Series|Protocol Violation|0|||
125959159|NCT00508742|453143546|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
125959160|NCT00508742|453143547|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
125959161|NCT00508742|453143546|FG000|Period 2: After Infant Series|Failed to Return|1|||
125959162|NCT00508742|453143547|FG001|Period 2: After Infant Series|Failed to Return|0|||
125959163|NCT00508742|453143546|FG000|Period 2: After Infant Series|Other|2|||
125959164|NCT00508742|453143547|FG001|Period 2: After Infant Series|Other|1|||
125959165|NCT00508742|453143546|FG000|Period 3: Toddler Dose|Adverse Event|1|||
125959166|NCT00508742|453143547|FG001|Period 3: Toddler Dose|Adverse Event|0|||
125959167|NCT00508742|453143546|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
125959168|NCT00508742|453143547|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
125959169|NCT00508742|453143546|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
125959170|NCT00508742|453143547|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
125959171|NCT00508742|453143546|FG000|Period 3: Toddler Dose|Other|5|||
125959172|NCT00508742|453143547|FG001|Period 3: Toddler Dose|Other|4|||
125959173|NCT02460224|453143552|FG000|Overall Study|Adverse Event|0|||
125959174|NCT02460224|453143553|FG001|Overall Study|Adverse Event|0|||
125959175|NCT02460224|453143554|FG002|Overall Study|Adverse Event|0|||
125959176|NCT02460224|453143555|FG003|Overall Study|Adverse Event|0|||
125959177|NCT02460224|453143556|FG004|Overall Study|Adverse Event|0|||
125959178|NCT02460224|453143557|FG005|Overall Study|Adverse Event|0|||
125959179|NCT02460224|453143558|FG006|Overall Study|Adverse Event|1|||
125959180|NCT02460224|453143559|FG007|Overall Study|Adverse Event|0|||
125959181|NCT02460224|453143560|FG008|Overall Study|Adverse Event|0|||
125959182|NCT02460224|453143561|FG009|Overall Study|Adverse Event|0|||
125959183|NCT02460224|453143562|FG010|Overall Study|Adverse Event|0|||
125959184|NCT02460224|453143563|FG011|Overall Study|Adverse Event|0|||
125959185|NCT02460224|453143564|FG012|Overall Study|Adverse Event|1|||
125959186|NCT02460224|453143565|FG013|Overall Study|Adverse Event|0|||
125959187|NCT02460224|453143566|FG014|Overall Study|Adverse Event|0|||
125959188|NCT02460224|453143567|FG015|Overall Study|Adverse Event|0|||
125959189|NCT02460224|453143568|FG016|Overall Study|Adverse Event|1|||
125959190|NCT02460224|453143569|FG017|Overall Study|Adverse Event|0|||
125959191|NCT02460224|453143570|FG018|Overall Study|Adverse Event|1|||
125959192|NCT02460224|453143571|FG019|Overall Study|Adverse Event|0|||
125959193|NCT02460224|453143572|FG020|Overall Study|Adverse Event|1|||
125959194|NCT02460224|453143573|FG021|Overall Study|Adverse Event|1|||
125959195|NCT02460224|453143574|FG022|Overall Study|Adverse Event|1|||
125959196|NCT02460224|453143575|FG023|Overall Study|Adverse Event|0|||
125959197|NCT02460224|453143576|FG024|Overall Study|Adverse Event|0|||
125959198|NCT02460224|453143577|FG025|Overall Study|Adverse Event|0|||
125959199|NCT02460224|453143578|FG026|Overall Study|Adverse Event|11|||
125959200|NCT02460224|453143579|FG027|Overall Study|Adverse Event|1|||
125959201|NCT02460224|453143580|FG028|Overall Study|Adverse Event|6|||
125959202|NCT02460224|453143552|FG000|Overall Study|Death|0|||
125959203|NCT02460224|453143553|FG001|Overall Study|Death|0|||
125959204|NCT02460224|453143554|FG002|Overall Study|Death|0|||
125959205|NCT02460224|453143555|FG003|Overall Study|Death|0|||
125959206|NCT02460224|453143556|FG004|Overall Study|Death|0|||
125959207|NCT02460224|453143557|FG005|Overall Study|Death|2|||
125959208|NCT02460224|453143558|FG006|Overall Study|Death|1|||
125959209|NCT02460224|453143559|FG007|Overall Study|Death|0|||
125959210|NCT02460224|453143560|FG008|Overall Study|Death|0|||
125959211|NCT02460224|453143561|FG009|Overall Study|Death|1|||
125959212|NCT02460224|453143562|FG010|Overall Study|Death|0|||
125959213|NCT02460224|453143563|FG011|Overall Study|Death|0|||
125959214|NCT02460224|453143564|FG012|Overall Study|Death|0|||
125959215|NCT02460224|453143565|FG013|Overall Study|Death|1|||
125959216|NCT02460224|453143566|FG014|Overall Study|Death|0|||
125959217|NCT02460224|453143567|FG015|Overall Study|Death|0|||
125959218|NCT02460224|453143568|FG016|Overall Study|Death|2|||
125959219|NCT02460224|453143569|FG017|Overall Study|Death|1|||
125959220|NCT02460224|453143570|FG018|Overall Study|Death|0|||
125959221|NCT02460224|453143571|FG019|Overall Study|Death|2|||
125959222|NCT02460224|453143572|FG020|Overall Study|Death|0|||
125959223|NCT02460224|453143573|FG021|Overall Study|Death|0|||
125959224|NCT02460224|453143574|FG022|Overall Study|Death|0|||
125959225|NCT02460224|453143575|FG023|Overall Study|Death|0|||
125959226|NCT02460224|453143576|FG024|Overall Study|Death|1|||
125959227|NCT02460224|453143577|FG025|Overall Study|Death|1|||
125959228|NCT02460224|453143578|FG026|Overall Study|Death|5|||
125959229|NCT02460224|453143579|FG027|Overall Study|Death|0|||
125959230|NCT02460224|453143580|FG028|Overall Study|Death|1|||
125959231|NCT02460224|453143552|FG000|Overall Study|Lost to Follow-up|0|||
125959232|NCT02460224|453143553|FG001|Overall Study|Lost to Follow-up|0|||
125959233|NCT02460224|453143554|FG002|Overall Study|Lost to Follow-up|0|||
125959234|NCT02460224|453143555|FG003|Overall Study|Lost to Follow-up|0|||
125959235|NCT02460224|453143556|FG004|Overall Study|Lost to Follow-up|0|||
125959236|NCT02460224|453143557|FG005|Overall Study|Lost to Follow-up|0|||
125959237|NCT02460224|453143558|FG006|Overall Study|Lost to Follow-up|0|||
125959238|NCT02460224|453143559|FG007|Overall Study|Lost to Follow-up|0|||
125959239|NCT02460224|453143560|FG008|Overall Study|Lost to Follow-up|0|||
125959240|NCT02460224|453143561|FG009|Overall Study|Lost to Follow-up|0|||
125959241|NCT02460224|453143562|FG010|Overall Study|Lost to Follow-up|0|||
125959242|NCT02460224|453143563|FG011|Overall Study|Lost to Follow-up|0|||
125959243|NCT02460224|453143564|FG012|Overall Study|Lost to Follow-up|0|||
125959244|NCT02460224|453143565|FG013|Overall Study|Lost to Follow-up|0|||
125959245|NCT02460224|453143566|FG014|Overall Study|Lost to Follow-up|0|||
125959246|NCT02460224|453143567|FG015|Overall Study|Lost to Follow-up|0|||
125959247|NCT02460224|453143568|FG016|Overall Study|Lost to Follow-up|0|||
125959248|NCT02460224|453143569|FG017|Overall Study|Lost to Follow-up|0|||
125959249|NCT02460224|453143570|FG018|Overall Study|Lost to Follow-up|0|||
125959250|NCT02460224|453143571|FG019|Overall Study|Lost to Follow-up|0|||
125959251|NCT02460224|453143572|FG020|Overall Study|Lost to Follow-up|0|||
125959252|NCT02460224|453143573|FG021|Overall Study|Lost to Follow-up|0|||
125959253|NCT02460224|453143574|FG022|Overall Study|Lost to Follow-up|1|||
125959254|NCT02460224|453143575|FG023|Overall Study|Lost to Follow-up|0|||
125959255|NCT02460224|453143576|FG024|Overall Study|Lost to Follow-up|0|||
125959256|NCT02460224|453143577|FG025|Overall Study|Lost to Follow-up|0|||
125959257|NCT02460224|453143578|FG026|Overall Study|Lost to Follow-up|0|||
125959258|NCT02460224|453143579|FG027|Overall Study|Lost to Follow-up|0|||
125959259|NCT02460224|453143580|FG028|Overall Study|Lost to Follow-up|0|||
125959260|NCT02460224|453143552|FG000|Overall Study|Physician Decision|0|||
125959261|NCT02460224|453143553|FG001|Overall Study|Physician Decision|1|||
125959262|NCT02460224|453143554|FG002|Overall Study|Physician Decision|0|||
125959263|NCT02460224|453143555|FG003|Overall Study|Physician Decision|0|||
125959264|NCT02460224|453143556|FG004|Overall Study|Physician Decision|1|||
125959265|NCT02460224|453143557|FG005|Overall Study|Physician Decision|0|||
125959266|NCT02460224|453143558|FG006|Overall Study|Physician Decision|0|||
125959267|NCT02460224|453143559|FG007|Overall Study|Physician Decision|1|||
125959268|NCT02460224|453143560|FG008|Overall Study|Physician Decision|0|||
125959269|NCT02460224|453143561|FG009|Overall Study|Physician Decision|0|||
125959270|NCT02460224|453143562|FG010|Overall Study|Physician Decision|0|||
125959271|NCT02460224|453143563|FG011|Overall Study|Physician Decision|1|||
125959272|NCT02460224|453143564|FG012|Overall Study|Physician Decision|0|||
125959273|NCT02460224|453143565|FG013|Overall Study|Physician Decision|1|||
125959274|NCT02460224|453143566|FG014|Overall Study|Physician Decision|0|||
125959275|NCT02460224|453143567|FG015|Overall Study|Physician Decision|0|||
125959276|NCT02460224|453143568|FG016|Overall Study|Physician Decision|2|||
125959277|NCT02460224|453143569|FG017|Overall Study|Physician Decision|1|||
125959278|NCT02460224|453143570|FG018|Overall Study|Physician Decision|1|||
125959279|NCT02460224|453143571|FG019|Overall Study|Physician Decision|2|||
125959280|NCT02460224|453143572|FG020|Overall Study|Physician Decision|1|||
125959281|NCT02460224|453143573|FG021|Overall Study|Physician Decision|1|||
125959282|NCT02460224|453143574|FG022|Overall Study|Physician Decision|0|||
125959283|NCT02460224|453143575|FG023|Overall Study|Physician Decision|0|||
125959284|NCT02460224|453143576|FG024|Overall Study|Physician Decision|1|||
125959285|NCT02460224|453143577|FG025|Overall Study|Physician Decision|0|||
125959286|NCT02460224|453143578|FG026|Overall Study|Physician Decision|14|||
125959287|NCT02460224|453143579|FG027|Overall Study|Physician Decision|1|||
125959288|NCT02460224|453143580|FG028|Overall Study|Physician Decision|6|||
125959289|NCT02460224|453143552|FG000|Overall Study|Progressive disease|15|||
125959290|NCT02460224|453143553|FG001|Overall Study|Progressive disease|11|||
125959291|NCT02460224|453143554|FG002|Overall Study|Progressive disease|5|||
125959292|NCT02460224|453143555|FG003|Overall Study|Progressive disease|6|||
125959293|NCT02460224|453143556|FG004|Overall Study|Progressive disease|3|||
125959294|NCT02460224|453143557|FG005|Overall Study|Progressive disease|26|||
125959295|NCT02460224|453143558|FG006|Overall Study|Progressive disease|28|||
125959296|NCT02460224|453143559|FG007|Overall Study|Progressive disease|4|||
125959297|NCT02460224|453143560|FG008|Overall Study|Progressive disease|5|||
125959298|NCT02460224|453143561|FG009|Overall Study|Progressive disease|9|||
125959299|NCT02460224|453143562|FG010|Overall Study|Progressive disease|5|||
125959300|NCT02460224|453143563|FG011|Overall Study|Progressive disease|4|||
125959301|NCT02460224|453143564|FG012|Overall Study|Progressive disease|5|||
125959302|NCT02460224|453143565|FG013|Overall Study|Progressive disease|4|||
125959303|NCT02460224|453143566|FG014|Overall Study|Progressive disease|5|||
125959304|NCT02460224|453143567|FG015|Overall Study|Progressive disease|5|||
125959305|NCT02460224|453143568|FG016|Overall Study|Progressive disease|15|||
125959306|NCT02460224|453143569|FG017|Overall Study|Progressive disease|3|||
125959307|NCT02460224|453143570|FG018|Overall Study|Progressive disease|8|||
125959308|NCT02460224|453143571|FG019|Overall Study|Progressive disease|3|||
125959309|NCT02460224|453143572|FG020|Overall Study|Progressive disease|4|||
125959310|NCT02460224|453143573|FG021|Overall Study|Progressive disease|9|||
125959311|NCT02460224|453143574|FG022|Overall Study|Progressive disease|4|||
125959312|NCT02460224|453143575|FG023|Overall Study|Progressive disease|11|||
125959313|NCT02460224|453143576|FG024|Overall Study|Progressive disease|4|||
125959314|NCT02460224|453143577|FG025|Overall Study|Progressive disease|5|||
125959315|NCT02460224|453143578|FG026|Overall Study|Progressive disease|85|||
125959316|NCT02460224|453143579|FG027|Overall Study|Progressive disease|17|||
125959317|NCT02460224|453143580|FG028|Overall Study|Progressive disease|77|||
125959318|NCT02460224|453143552|FG000|Overall Study|Subject/guardian decision|2|||
125959319|NCT02460224|453143553|FG001|Overall Study|Subject/guardian decision|0|||
125959320|NCT02460224|453143554|FG002|Overall Study|Subject/guardian decision|1|||
125959321|NCT02460224|453143555|FG003|Overall Study|Subject/guardian decision|0|||
126116971|NCT00397033|453722035|FG001|Overall Study|Lost to Follow-up|3|||
125959322|NCT02460224|453143556|FG004|Overall Study|Subject/guardian decision|2|||
125959323|NCT02460224|453143557|FG005|Overall Study|Subject/guardian decision|2|||
125959324|NCT02460224|453143558|FG006|Overall Study|Subject/guardian decision|0|||
125959325|NCT02460224|453143559|FG007|Overall Study|Subject/guardian decision|0|||
125959326|NCT02460224|453143560|FG008|Overall Study|Subject/guardian decision|1|||
125959327|NCT02460224|453143561|FG009|Overall Study|Subject/guardian decision|1|||
125959328|NCT02460224|453143562|FG010|Overall Study|Subject/guardian decision|0|||
125959329|NCT02460224|453143563|FG011|Overall Study|Subject/guardian decision|1|||
125959330|NCT02460224|453143564|FG012|Overall Study|Subject/guardian decision|0|||
125959331|NCT02460224|453143565|FG013|Overall Study|Subject/guardian decision|0|||
125959332|NCT02460224|453143566|FG014|Overall Study|Subject/guardian decision|0|||
125959333|NCT02460224|453143567|FG015|Overall Study|Subject/guardian decision|1|||
125959334|NCT02460224|453143568|FG016|Overall Study|Subject/guardian decision|0|||
125959335|NCT02460224|453143569|FG017|Overall Study|Subject/guardian decision|1|||
125959336|NCT02460224|453143570|FG018|Overall Study|Subject/guardian decision|2|||
125959337|NCT02460224|453143571|FG019|Overall Study|Subject/guardian decision|0|||
125959338|NCT02460224|453143572|FG020|Overall Study|Subject/guardian decision|0|||
125959339|NCT02460224|453143573|FG021|Overall Study|Subject/guardian decision|1|||
125959340|NCT02460224|453143574|FG022|Overall Study|Subject/guardian decision|0|||
125959341|NCT02460224|453143575|FG023|Overall Study|Subject/guardian decision|0|||
125959342|NCT02460224|453143576|FG024|Overall Study|Subject/guardian decision|0|||
125959343|NCT02460224|453143577|FG025|Overall Study|Subject/guardian decision|0|||
125959344|NCT02460224|453143578|FG026|Overall Study|Subject/guardian decision|6|||
125959345|NCT02460224|453143579|FG027|Overall Study|Subject/guardian decision|2|||
125959346|NCT02460224|453143580|FG028|Overall Study|Subject/guardian decision|3|||
125959347|NCT03146650|453143582|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
125959348|NCT03146650|453143582|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
125959349|NCT03146650|453143582|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
125959350|NCT03146650|453143582|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
125959351|NCT03146650|453143582|FG000|2 Year Follow-up|Death|11|||
125959352|NCT03146650|453143582|FG000|2 Year Follow-up|Still in follow-up|7|||
125959353|NCT03146650|453143582|FG000|2 Year Follow-up|Lost to Follow-up|1|||
125959354|NCT03333486|453143585|FG000|Overall Study|Withdrawal by Subject|1|||
125959355|NCT03333486|453143585|FG000|Overall Study|Lost to Follow-up|1|||
125959356|NCT03246529|453143587|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
125959357|NCT03246529|453143588|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
125959358|NCT03246529|453143589|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
125959359|NCT03246529|453143587|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
125959360|NCT03246529|453143588|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
125959361|NCT03246529|453143589|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
125959362|NCT03246529|453143587|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
125959363|NCT03246529|453143588|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
125959364|NCT03246529|453143589|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
125959365|NCT03246529|453143587|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
125959366|NCT03246529|453143588|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
125959367|NCT03246529|453143589|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
125959368|NCT03246529|453143587|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
125959369|NCT03246529|453143588|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
125959370|NCT03246529|453143589|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
125959371|NCT03246529|453143587|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
125959372|NCT03246529|453143588|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
125959373|NCT03246529|453143589|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
125959374|NCT03246529|453143587|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
125959375|NCT03246529|453143588|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
125959376|NCT03246529|453143589|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
125959377|NCT03246529|453143587|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
125959378|NCT03246529|453143588|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
125959379|NCT03246529|453143589|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
125959380|NCT03246529|453143587|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
125959381|NCT03246529|453143588|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
125959382|NCT03246529|453143589|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
125959383|NCT01209624|453143590|FG000|Overall Study|Death|2|||
125959384|NCT01209624|453143590|FG000|Overall Study|Adverse Event|13|||
125959385|NCT01209624|453143590|FG000|Overall Study|Lack of Efficacy|17|||
125959386|NCT01209624|453143590|FG000|Overall Study|Lost to Follow-up|290|||
125959387|NCT01209624|453143590|FG000|Overall Study|Other|4|||
125959388|NCT00441337|453143595|FG000|Overall Study|Disease Progression|6|||
125959389|NCT00441337|453143596|FG001|Overall Study|Disease Progression|6|||
125959390|NCT00441337|453143597|FG002|Overall Study|Disease Progression|4|||
125959391|NCT00441337|453143598|FG003|Overall Study|Disease Progression|18|||
125959392|NCT00441337|453143595|FG000|Overall Study|Lost to Follow-up|0|||
125959393|NCT00441337|453143596|FG001|Overall Study|Lost to Follow-up|0|||
125959394|NCT00441337|453143597|FG002|Overall Study|Lost to Follow-up|0|||
125959395|NCT00441337|453143598|FG003|Overall Study|Lost to Follow-up|1|||
125959396|NCT00441337|453143595|FG000|Overall Study|Sponsor Decision|0|||
125959397|NCT00441337|453143596|FG001|Overall Study|Sponsor Decision|0|||
125959398|NCT00441337|453143597|FG002|Overall Study|Sponsor Decision|1|||
125959399|NCT00441337|453143598|FG003|Overall Study|Sponsor Decision|2|||
125959400|NCT00441337|453143595|FG000|Overall Study|Did not meet inclusion criteria|0|||
126116972|NCT00397033|453722036|FG002|Overall Study|Lost to Follow-up|3|||
126116973|NCT00397033|453722034|FG000|Overall Study|Withdrawal by Subject|12|||
125959401|NCT00441337|453143596|FG001|Overall Study|Did not meet inclusion criteria|0|||
125959402|NCT00441337|453143597|FG002|Overall Study|Did not meet inclusion criteria|1|||
126116974|NCT00397033|453722035|FG001|Overall Study|Withdrawal by Subject|7|||
126116975|NCT00397033|453722036|FG002|Overall Study|Withdrawal by Subject|5|||
125959403|NCT00441337|453143598|FG003|Overall Study|Did not meet inclusion criteria|0|||
125959404|NCT00827372|453145534|FG000|Overall Study|Adverse Event|5|||
125959405|NCT00827372|453145534|FG000|Overall Study|Lack of Efficacy|3|||
125959406|NCT02602288|453145542|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
125959407|NCT02602288|453145543|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
125959408|NCT02602288|453145542|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
125959409|NCT02602288|453145543|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
125959410|NCT02602288|453145542|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
125959411|NCT02602288|453145543|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
125959412|NCT02602288|453145542|FG000|12 Month Follow-up|Lost to Follow-up|0|||
125959413|NCT02602288|453145543|FG001|12 Month Follow-up|Lost to Follow-up|4|||
125959414|NCT02602288|453145542|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
125959415|NCT02602288|453145543|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
125959416|NCT01310413|453145544|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
125959417|NCT01310413|453145545|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
125959418|NCT01310413|453145546|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
125959419|NCT01310413|453145547|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
125959420|NCT01310413|453145548|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
125959421|NCT01310413|453145549|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
125959422|NCT01310413|453145550|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
125959423|NCT01310413|453145544|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
125959424|NCT01310413|453145545|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
125959425|NCT01310413|453145546|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
126116976|NCT00397033|453722034|FG000|Overall Study|Other|0|||
126116977|NCT00397033|453722035|FG001|Overall Study|Other|5|||
126116978|NCT00397033|453722036|FG002|Overall Study|Other|2|||
126116979|NCT01984164|453722037|FG000|Overall Study|Withdrawal by Subject|4|||
126116980|NCT01984164|453722038|FG001|Overall Study|Withdrawal by Subject|3|||
126116981|NCT01984164|453722037|FG000|Overall Study|Adverse Event|5|||
126116982|NCT01984164|453722038|FG001|Overall Study|Adverse Event|19|||
126116983|NCT01984164|453722037|FG000|Overall Study|Lost to Follow-up|1|||
126116984|NCT01984164|453722038|FG001|Overall Study|Lost to Follow-up|3|||
126116985|NCT05293743|453722039|FG000|Overall Study|Withdrawal by Subject|1|||
126116986|NCT05293743|453722040|FG001|Overall Study|Withdrawal by Subject|0|||
126116987|NCT02064920|453722041|FG000|Overall Study|Adverse Event|0|||
126116988|NCT02064920|453722042|FG001|Overall Study|Adverse Event|4|||
126116989|NCT02064920|453722041|FG000|Overall Study|Physician Decision|0|||
126116990|NCT02064920|453722042|FG001|Overall Study|Physician Decision|1|||
126116991|NCT02064920|453722041|FG000|Overall Study|Technical Problems|0|||
126116992|NCT02064920|453722042|FG001|Overall Study|Technical Problems|1|||
126116993|NCT02064920|453722041|FG000|Overall Study|Withdrawal by Subject|1|||
126116994|NCT02064920|453722042|FG001|Overall Study|Withdrawal by Subject|3|||
126116995|NCT00688155|453722043|FG000|Overall Study|Withdrawal by Subject|2|||
126116996|NCT00688155|453722044|FG001|Overall Study|Withdrawal by Subject|2|||
126116997|NCT00688155|453722045|FG002|Overall Study|Withdrawal by Subject|1|||
126116998|NCT00688155|453722046|FG003|Overall Study|Withdrawal by Subject|1|||
126116999|NCT01129921|453722051|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
126117000|NCT01129921|453722052|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
126117001|NCT01129921|453722051|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
126117002|NCT01129921|453722052|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
126117003|NCT01129921|453722051|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
126117004|NCT01129921|453722052|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
126117005|NCT01129921|453722051|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
126117006|NCT01129921|453722052|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
126117007|NCT00574145|453723710|FG000|Overall Study|Withdrawal by Subject|2|||
126117008|NCT00574145|453723711|FG001|Overall Study|Withdrawal by Subject|1|||
126117009|NCT03227471|453723712|FG000|Overall Study|Withdrawal by Subject|0|||
126117010|NCT03227471|453723713|FG001|Overall Study|Withdrawal by Subject|0|||
125959426|NCT01310413|453145547|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
125959427|NCT01310413|453145548|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
125959428|NCT01310413|453145549|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
125959429|NCT01310413|453145550|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
125959430|NCT01310413|453145544|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
125959431|NCT01310413|453145545|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
125959432|NCT01310413|453145546|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
125959433|NCT01310413|453145547|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
125959434|NCT01310413|453145548|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
125959435|NCT01310413|453145549|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
125959436|NCT01310413|453145550|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
125959437|NCT01310413|453145544|FG000|Day 0 to Day 385|Other|1|||
125959438|NCT01310413|453145545|FG001|Day 0 to Day 385|Other|0|||
125959439|NCT01310413|453145546|FG002|Day 0 to Day 385|Other|3|||
126117011|NCT03227471|453723714|FG002|Overall Study|Withdrawal by Subject|0|||
126117012|NCT03227471|453723715|FG003|Overall Study|Withdrawal by Subject|0|||
125959440|NCT01310413|453145547|FG003|Day 0 to Day 385|Other|0|||
125959441|NCT01310413|453145548|FG004|Day 0 to Day 385|Other|0|||
125959442|NCT01310413|453145549|FG005|Day 0 to Day 385|Other|0|||
125959443|NCT01310413|453145550|FG006|Day 0 to Day 385|Other|0|||
125959444|NCT01310413|453145544|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
125959445|NCT01310413|453145545|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
125959446|NCT01310413|453145546|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
125959447|NCT01310413|453145547|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
125959448|NCT01310413|453145548|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
125959449|NCT01310413|453145549|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
125959450|NCT01310413|453145550|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
125959451|NCT01310413|453145544|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
125959452|NCT01310413|453145545|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
125959453|NCT01310413|453145546|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
125959454|NCT01310413|453145547|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
125959455|NCT01310413|453145548|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
125959456|NCT01310413|453145549|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
125959457|NCT01310413|453145550|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
125959458|NCT00941733|453145551|FG000|Overall Study|Death|24|||
125959459|NCT00941733|453145552|FG001|Overall Study|Death|10|||
125959460|NCT00941733|453145551|FG000|Overall Study|Withdrawal by Subject|14|||
125959461|NCT00941733|453145552|FG001|Overall Study|Withdrawal by Subject|6|||
125959462|NCT00941733|453145551|FG000|Overall Study|Adverse Event|20|||
125959463|NCT00941733|453145552|FG001|Overall Study|Adverse Event|4|||
125959464|NCT00941733|453145551|FG000|Overall Study|Lost to Follow-up|1|||
125959465|NCT00941733|453145552|FG001|Overall Study|Lost to Follow-up|2|||
125959466|NCT00941733|453145551|FG000|Overall Study|Protocol Violation|15|||
125959467|NCT00941733|453145552|FG001|Overall Study|Protocol Violation|6|||
126117013|NCT03227471|453723716|FG004|Overall Study|Withdrawal by Subject|1|||
126117014|NCT03227471|453723717|FG005|Overall Study|Withdrawal by Subject|0|||
126117015|NCT03227471|453723718|FG006|Overall Study|Withdrawal by Subject|0|||
126117016|NCT03227471|453723719|FG007|Overall Study|Withdrawal by Subject|0|||
126117017|NCT03227471|453723720|FG008|Overall Study|Withdrawal by Subject|0|||
126117018|NCT03227471|453723721|FG009|Overall Study|Withdrawal by Subject|0|||
126117019|NCT03227471|453723722|FG010|Overall Study|Withdrawal by Subject|0|||
126117020|NCT03227471|453723723|FG011|Overall Study|Withdrawal by Subject|0|||
126117021|NCT03227471|453723724|FG012|Overall Study|Withdrawal by Subject|1|||
126117022|NCT03227471|453723725|FG013|Overall Study|Withdrawal by Subject|0|||
126117023|NCT03227471|453723726|FG014|Overall Study|Withdrawal by Subject|0|||
126117024|NCT03227471|453723712|FG000|Overall Study|Randomized, Never Dosed|0|||
126117025|NCT03227471|453723713|FG001|Overall Study|Randomized, Never Dosed|0|||
126117026|NCT03227471|453723714|FG002|Overall Study|Randomized, Never Dosed|0|||
126117027|NCT03227471|453723715|FG003|Overall Study|Randomized, Never Dosed|0|||
126117028|NCT03227471|453723716|FG004|Overall Study|Randomized, Never Dosed|0|||
126117029|NCT03227471|453723717|FG005|Overall Study|Randomized, Never Dosed|0|||
126117030|NCT03227471|453723718|FG006|Overall Study|Randomized, Never Dosed|0|||
126117031|NCT03227471|453723719|FG007|Overall Study|Randomized, Never Dosed|0|||
126117032|NCT03227471|453723720|FG008|Overall Study|Randomized, Never Dosed|0|||
126117033|NCT03227471|453723721|FG009|Overall Study|Randomized, Never Dosed|0|||
126117034|NCT03227471|453723722|FG010|Overall Study|Randomized, Never Dosed|0|||
126117035|NCT03227471|453723723|FG011|Overall Study|Randomized, Never Dosed|0|||
126117036|NCT03227471|453723724|FG012|Overall Study|Randomized, Never Dosed|0|||
126117037|NCT03227471|453723725|FG013|Overall Study|Randomized, Never Dosed|0|||
126117038|NCT03227471|453723726|FG014|Overall Study|Randomized, Never Dosed|1|||
126117039|NCT00682448|453723727|FG000|Overall Study|Adverse Event|1|||
126117040|NCT00682448|453723728|FG001|Overall Study|Adverse Event|2|||
126117041|NCT00682448|453723727|FG000|Overall Study|Lack of Efficacy|1|||
126117042|NCT00682448|453723728|FG001|Overall Study|Lack of Efficacy|0|||
126087187|NCT05000216|453612962|FG012|Stage 1|Physician Decision|0|||
126087188|NCT05000216|453612963|FG013|Stage 1|Physician Decision|0|||
126087189|NCT05000216|453612964|FG014|Stage 1|Physician Decision|0|||
126087190|NCT05000216|453612965|FG015|Stage 1|Physician Decision|0|||
126087191|NCT05000216|453612966|FG016|Stage 1|Physician Decision|0|||
126087192|NCT05000216|453612967|FG017|Stage 1|Physician Decision|0|||
126087193|NCT05000216|453612968|FG018|Stage 1|Physician Decision|0|||
126087194|NCT05000216|453612969|FG019|Stage 1|Physician Decision|0|||
126087195|NCT05000216|453612970|FG020|Stage 1|Physician Decision|0|||
126087196|NCT05000216|453612971|FG021|Stage 1|Physician Decision|0|||
125959468|NCT00612066|453145555|FG000|Overall Study|Adverse Event|1|||
125959469|NCT00630877|453145556|FG000|Overall Study|Adverse Event|11|||
126117043|NCT00682448|453723727|FG000|Overall Study|Lost to Follow-up|1|||
126117044|NCT00682448|453723728|FG001|Overall Study|Lost to Follow-up|3|||
126117045|NCT00682448|453723727|FG000|Overall Study|Pregnancy|0|||
126117046|NCT00682448|453723728|FG001|Overall Study|Pregnancy|1|||
126117047|NCT00682448|453723727|FG000|Overall Study|Withdrawal by Subject|2|||
125959470|NCT00630877|453145557|FG001|Overall Study|Adverse Event|8|||
126087197|NCT05000216|453612950|FG000|Stage 1|Withdrawal by Subject|0|||
126117048|NCT00682448|453723728|FG001|Overall Study|Withdrawal by Subject|0|||
126117049|NCT02737852|453723731|FG000|Overall Study|Withdrawal by Subject|2|||
126117050|NCT03335163|453723738|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
126117051|NCT03335163|453723738|FG000|Overall Study|Withdrawal by Subject|18|||
126117052|NCT00525044|453723739|FG000|Overall Study|Lost to Follow-up|0|||
125959471|NCT00630877|453145558|FG002|Overall Study|Adverse Event|7|||
125959472|NCT00630877|453145556|FG000|Overall Study|Withdrawal by Subject|3|||
125959473|NCT00630877|453145557|FG001|Overall Study|Withdrawal by Subject|4|||
125959474|NCT00630877|453145558|FG002|Overall Study|Withdrawal by Subject|0|||
125959475|NCT00630877|453145556|FG000|Overall Study|Lost to Follow-up|2|||
125959476|NCT00630877|453145557|FG001|Overall Study|Lost to Follow-up|0|||
125959477|NCT00630877|453145558|FG002|Overall Study|Lost to Follow-up|0|||
125959478|NCT00630877|453145556|FG000|Overall Study|Noncompliance|2|||
125959479|NCT00630877|453145557|FG001|Overall Study|Noncompliance|3|||
125959480|NCT00630877|453145558|FG002|Overall Study|Noncompliance|1|||
125959481|NCT00630877|453145556|FG000|Overall Study|Protocol violation|1|||
125959482|NCT00630877|453145557|FG001|Overall Study|Protocol violation|0|||
125959483|NCT00630877|453145558|FG002|Overall Study|Protocol violation|1|||
125959484|NCT00630877|453145556|FG000|Overall Study|Personal reasons|0|||
125959485|NCT00630877|453145557|FG001|Overall Study|Personal reasons|0|||
125959486|NCT00630877|453145558|FG002|Overall Study|Personal reasons|1|||
125959487|NCT02391948|453145561|FG000|6-month Assessment|Death|0|||
125959488|NCT02391948|453145562|FG001|6-month Assessment|Death|0|||
125959489|NCT02391948|453145563|FG002|6-month Assessment|Death|0|||
125959490|NCT02391948|453145564|FG003|6-month Assessment|Death|0|||
125959491|NCT02391948|453145565|FG004|6-month Assessment|Death|1|||
125959492|NCT02391948|453145561|FG000|6-month Assessment|Withdrawal by Subject|0|||
125959493|NCT02391948|453145562|FG001|6-month Assessment|Withdrawal by Subject|0|||
125959494|NCT02391948|453145563|FG002|6-month Assessment|Withdrawal by Subject|1|||
125959495|NCT02391948|453145564|FG003|6-month Assessment|Withdrawal by Subject|2|||
125959496|NCT02391948|453145565|FG004|6-month Assessment|Withdrawal by Subject|0|||
125959497|NCT02391948|453145561|FG000|6-month Assessment|Lost to Follow-up|4|||
125959498|NCT02391948|453145562|FG001|6-month Assessment|Lost to Follow-up|5|||
125959499|NCT02391948|453145563|FG002|6-month Assessment|Lost to Follow-up|2|||
125959500|NCT02391948|453145564|FG003|6-month Assessment|Lost to Follow-up|3|||
125959501|NCT02391948|453145565|FG004|6-month Assessment|Lost to Follow-up|1|||
125959502|NCT02391948|453145561|FG000|6-month Assessment|Medical issue/illness|1|||
125959503|NCT02391948|453145562|FG001|6-month Assessment|Medical issue/illness|1|||
125959504|NCT02391948|453145563|FG002|6-month Assessment|Medical issue/illness|0|||
125959505|NCT02391948|453145564|FG003|6-month Assessment|Medical issue/illness|0|||
125959506|NCT02391948|453145565|FG004|6-month Assessment|Medical issue/illness|0|||
125959507|NCT02391948|453145561|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
125959508|NCT02391948|453145562|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
125959509|NCT02391948|453145563|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
125959510|NCT02391948|453145564|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
125959511|NCT02391948|453145565|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
125959512|NCT02391948|453145561|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
125959513|NCT02391948|453145562|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
125959514|NCT02391948|453145563|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
125959515|NCT02391948|453145564|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
125959516|NCT02391948|453145565|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
125959517|NCT02391948|453145561|FG000|12-month Assessment|Death|0|||
125959518|NCT02391948|453145562|FG001|12-month Assessment|Death|0|||
125959519|NCT02391948|453145563|FG002|12-month Assessment|Death|0|||
125959520|NCT02391948|453145564|FG003|12-month Assessment|Death|1|||
125959521|NCT02391948|453145565|FG004|12-month Assessment|Death|0|||
125959522|NCT02391948|453145561|FG000|12-month Assessment|Withdrawal by Subject|1|||
125959523|NCT02391948|453145562|FG001|12-month Assessment|Withdrawal by Subject|0|||
125959524|NCT02391948|453145563|FG002|12-month Assessment|Withdrawal by Subject|0|||
125959525|NCT02391948|453145564|FG003|12-month Assessment|Withdrawal by Subject|1|||
125959526|NCT02391948|453145565|FG004|12-month Assessment|Withdrawal by Subject|0|||
125959527|NCT02391948|453145561|FG000|12-month Assessment|Lost to Follow-up|5|||
125959528|NCT02391948|453145562|FG001|12-month Assessment|Lost to Follow-up|4|||
125959529|NCT02391948|453145563|FG002|12-month Assessment|Lost to Follow-up|4|||
125959530|NCT02391948|453145564|FG003|12-month Assessment|Lost to Follow-up|4|||
125959531|NCT02391948|453145565|FG004|12-month Assessment|Lost to Follow-up|5|||
125959532|NCT02391948|453145561|FG000|12-month Assessment|Medical issue/illness|0|||
125959533|NCT02391948|453145562|FG001|12-month Assessment|Medical issue/illness|1|||
125959534|NCT02391948|453145563|FG002|12-month Assessment|Medical issue/illness|0|||
125959535|NCT02391948|453145564|FG003|12-month Assessment|Medical issue/illness|1|||
125959536|NCT02391948|453145565|FG004|12-month Assessment|Medical issue/illness|0|||
126117053|NCT00525044|453723740|FG001|Overall Study|Lost to Follow-up|1|||
125959537|NCT02391948|453145561|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
125959538|NCT02391948|453145562|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
125959539|NCT02391948|453145563|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
125959540|NCT02391948|453145564|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
125959541|NCT02391948|453145565|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
125959542|NCT02391948|453145561|FG000|18-month Assessment|Death|0|||
125959543|NCT02391948|453145562|FG001|18-month Assessment|Death|0|||
125959544|NCT02391948|453145563|FG002|18-month Assessment|Death|0|||
125959545|NCT02391948|453145564|FG003|18-month Assessment|Death|1|||
125959546|NCT02391948|453145565|FG004|18-month Assessment|Death|1|||
125959547|NCT02391948|453145561|FG000|18-month Assessment|Withdrawal by Subject|1|||
125959548|NCT02391948|453145562|FG001|18-month Assessment|Withdrawal by Subject|0|||
125959549|NCT02391948|453145563|FG002|18-month Assessment|Withdrawal by Subject|0|||
125959550|NCT02391948|453145564|FG003|18-month Assessment|Withdrawal by Subject|1|||
125959551|NCT02391948|453145565|FG004|18-month Assessment|Withdrawal by Subject|0|||
125959552|NCT02391948|453145561|FG000|18-month Assessment|Lost to Follow-up|2|||
125959553|NCT02391948|453145562|FG001|18-month Assessment|Lost to Follow-up|6|||
125959554|NCT02391948|453145563|FG002|18-month Assessment|Lost to Follow-up|2|||
125959555|NCT02391948|453145564|FG003|18-month Assessment|Lost to Follow-up|2|||
125959556|NCT02391948|453145565|FG004|18-month Assessment|Lost to Follow-up|3|||
125959557|NCT02391948|453145561|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
125959558|NCT02391948|453145562|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
125959559|NCT02391948|453145563|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
125959560|NCT02391948|453145564|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
125959561|NCT02391948|453145565|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
125959562|NCT02391948|453145561|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
125959563|NCT02391948|453145562|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
125959564|NCT02391948|453145563|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
125959565|NCT02391948|453145564|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
125959566|NCT02391948|453145565|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
125959567|NCT02391948|453145561|FG000|24-month Assessment|Death|0|||
125959568|NCT02391948|453145562|FG001|24-month Assessment|Death|0|||
125959569|NCT02391948|453145563|FG002|24-month Assessment|Death|0|||
125959570|NCT02391948|453145564|FG003|24-month Assessment|Death|0|||
125959571|NCT02391948|453145565|FG004|24-month Assessment|Death|1|||
125959572|NCT02391948|453145561|FG000|24-month Assessment|Withdrawal by Subject|1|||
125959573|NCT02391948|453145562|FG001|24-month Assessment|Withdrawal by Subject|1|||
125959574|NCT02391948|453145563|FG002|24-month Assessment|Withdrawal by Subject|0|||
125959575|NCT02391948|453145564|FG003|24-month Assessment|Withdrawal by Subject|0|||
125959576|NCT02391948|453145565|FG004|24-month Assessment|Withdrawal by Subject|1|||
125959577|NCT02391948|453145561|FG000|24-month Assessment|Lost to Follow-up|5|||
125959578|NCT02391948|453145562|FG001|24-month Assessment|Lost to Follow-up|4|||
125959579|NCT02391948|453145563|FG002|24-month Assessment|Lost to Follow-up|0|||
125959580|NCT02391948|453145564|FG003|24-month Assessment|Lost to Follow-up|0|||
125959581|NCT02391948|453145565|FG004|24-month Assessment|Lost to Follow-up|0|||
125959582|NCT02391948|453145561|FG000|24-month Assessment|Medical issue/illness|0|||
125959583|NCT02391948|453145562|FG001|24-month Assessment|Medical issue/illness|0|||
125959584|NCT02391948|453145563|FG002|24-month Assessment|Medical issue/illness|1|||
125959585|NCT02391948|453145564|FG003|24-month Assessment|Medical issue/illness|0|||
125959586|NCT02391948|453145565|FG004|24-month Assessment|Medical issue/illness|0|||
125959587|NCT02391948|453145561|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
125959588|NCT02391948|453145562|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
125959589|NCT02391948|453145563|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
125959590|NCT02391948|453145564|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
125959591|NCT02391948|453145565|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
125959592|NCT01529645|453145566|FG000|Overall Study|Lost to Follow-up|0|||
125959593|NCT01529645|453145567|FG001|Overall Study|Lost to Follow-up|1|||
125959594|NCT01529645|453145568|FG002|Overall Study|Lost to Follow-up|1|||
125959595|NCT01529645|453145569|FG003|Overall Study|Lost to Follow-up|1|||
125959596|NCT01529645|453145570|FG004|Overall Study|Lost to Follow-up|1|||
125959597|NCT01529645|453145571|FG005|Overall Study|Lost to Follow-up|0|||
125959598|NCT01529645|453145572|FG006|Overall Study|Lost to Follow-up|2|||
125959599|NCT01529645|453145573|FG007|Overall Study|Lost to Follow-up|0|||
125959600|NCT01529645|453145574|FG008|Overall Study|Lost to Follow-up|1|||
125959601|NCT01529645|453145575|FG009|Overall Study|Lost to Follow-up|0|||
125959602|NCT01529645|453145566|FG000|Overall Study|SAE - Premature contractions|0|||
125959603|NCT01529645|453145567|FG001|Overall Study|SAE - Premature contractions|0|||
126117054|NCT02553265|453723742|FG000|Enrollment|Death|0|||
126117055|NCT02553265|453723743|FG001|Enrollment|Death|0|||
125959604|NCT01529645|453145568|FG002|Overall Study|SAE - Premature contractions|1|||
125959605|NCT01529645|453145569|FG003|Overall Study|SAE - Premature contractions|0|||
125959606|NCT01529645|453145570|FG004|Overall Study|SAE - Premature contractions|0|||
125959607|NCT01529645|453145571|FG005|Overall Study|SAE - Premature contractions|0|||
125959608|NCT01529645|453145572|FG006|Overall Study|SAE - Premature contractions|0|||
125959609|NCT01529645|453145573|FG007|Overall Study|SAE - Premature contractions|0|||
125959610|NCT01529645|453145574|FG008|Overall Study|SAE - Premature contractions|0|||
125959611|NCT01529645|453145575|FG009|Overall Study|SAE - Premature contractions|0|||
126117056|NCT02553265|453723744|FG002|Enrollment|Death|1|||
125959612|NCT01529645|453145566|FG000|Overall Study|Withdrawal by Subject|2|||
125959613|NCT01529645|453145567|FG001|Overall Study|Withdrawal by Subject|0|||
125959614|NCT01529645|453145568|FG002|Overall Study|Withdrawal by Subject|0|||
125959615|NCT01529645|453145569|FG003|Overall Study|Withdrawal by Subject|1|||
125959616|NCT01529645|453145570|FG004|Overall Study|Withdrawal by Subject|1|||
125959617|NCT01529645|453145571|FG005|Overall Study|Withdrawal by Subject|1|||
125959618|NCT01529645|453145572|FG006|Overall Study|Withdrawal by Subject|0|||
125959619|NCT01529645|453145573|FG007|Overall Study|Withdrawal by Subject|0|||
125959620|NCT01529645|453145574|FG008|Overall Study|Withdrawal by Subject|0|||
125959621|NCT01529645|453145575|FG009|Overall Study|Withdrawal by Subject|0|||
125959622|NCT01602315|453145576|FG000|Overall Study|Protocol Violation|0|||
125959623|NCT01602315|453145577|FG001|Overall Study|Protocol Violation|0|||
125959624|NCT01602315|453145578|FG002|Overall Study|Protocol Violation|0|||
125959625|NCT01602315|453145579|FG003|Overall Study|Protocol Violation|0|||
125959626|NCT01602315|453145580|FG004|Overall Study|Protocol Violation|0|||
125959627|NCT01602315|453145581|FG005|Overall Study|Protocol Violation|1|||
125959628|NCT01602315|453145582|FG006|Overall Study|Protocol Violation|0|||
125959629|NCT01602315|453145576|FG000|Overall Study|Physician Decision|2|||
125959630|NCT01602315|453145577|FG001|Overall Study|Physician Decision|0|||
125959631|NCT01602315|453145578|FG002|Overall Study|Physician Decision|0|||
125959632|NCT01602315|453145579|FG003|Overall Study|Physician Decision|0|||
125959633|NCT01602315|453145580|FG004|Overall Study|Physician Decision|2|||
125959634|NCT01602315|453145581|FG005|Overall Study|Physician Decision|1|||
125959635|NCT01602315|453145582|FG006|Overall Study|Physician Decision|1|||
125959636|NCT01602315|453145576|FG000|Overall Study|Disease progression|6|||
125959637|NCT01602315|453145577|FG001|Overall Study|Disease progression|3|||
125959638|NCT01602315|453145578|FG002|Overall Study|Disease progression|10|||
125959639|NCT01602315|453145579|FG003|Overall Study|Disease progression|1|||
125959640|NCT01602315|453145580|FG004|Overall Study|Disease progression|41|||
125959641|NCT01602315|453145581|FG005|Overall Study|Disease progression|12|||
125959642|NCT01602315|453145582|FG006|Overall Study|Disease progression|15|||
125959643|NCT01602315|453145576|FG000|Overall Study|Death|1|||
125959644|NCT01602315|453145577|FG001|Overall Study|Death|1|||
125959645|NCT01602315|453145578|FG002|Overall Study|Death|1|||
125959646|NCT01602315|453145579|FG003|Overall Study|Death|1|||
125959647|NCT01602315|453145580|FG004|Overall Study|Death|7|||
125959648|NCT01602315|453145581|FG005|Overall Study|Death|2|||
125959649|NCT01602315|453145582|FG006|Overall Study|Death|2|||
125959650|NCT01602315|453145576|FG000|Overall Study|Withdrawal by Subject|2|||
125959651|NCT01602315|453145577|FG001|Overall Study|Withdrawal by Subject|0|||
125959652|NCT01602315|453145578|FG002|Overall Study|Withdrawal by Subject|2|||
125959653|NCT01602315|453145579|FG003|Overall Study|Withdrawal by Subject|0|||
125959654|NCT01602315|453145580|FG004|Overall Study|Withdrawal by Subject|6|||
125959655|NCT01602315|453145581|FG005|Overall Study|Withdrawal by Subject|0|||
125959656|NCT01602315|453145582|FG006|Overall Study|Withdrawal by Subject|1|||
125959657|NCT01602315|453145576|FG000|Overall Study|Adverse Event|5|||
125959658|NCT01602315|453145577|FG001|Overall Study|Adverse Event|1|||
125959659|NCT01602315|453145578|FG002|Overall Study|Adverse Event|5|||
125959660|NCT01602315|453145579|FG003|Overall Study|Adverse Event|4|||
125959661|NCT01602315|453145580|FG004|Overall Study|Adverse Event|15|||
125959662|NCT01602315|453145581|FG005|Overall Study|Adverse Event|3|||
125959663|NCT01602315|453145582|FG006|Overall Study|Adverse Event|9|||
125959664|NCT01602315|453145576|FG000|Overall Study|Subject/guardian decision|0|||
125959665|NCT01602315|453145577|FG001|Overall Study|Subject/guardian decision|0|||
125959666|NCT01602315|453145578|FG002|Overall Study|Subject/guardian decision|0|||
125959667|NCT01602315|453145579|FG003|Overall Study|Subject/guardian decision|0|||
125959668|NCT01602315|453145580|FG004|Overall Study|Subject/guardian decision|0|||
125959669|NCT01602315|453145581|FG005|Overall Study|Subject/guardian decision|0|||
125959670|NCT01602315|453145582|FG006|Overall Study|Subject/guardian decision|1|||
125959671|NCT01602315|453145576|FG000|Overall Study|Cross-over patients to combo treatment|0|||
125959672|NCT01602315|453145577|FG001|Overall Study|Cross-over patients to combo treatment|0|||
125959673|NCT01602315|453145578|FG002|Overall Study|Cross-over patients to combo treatment|0|||
125959674|NCT01602315|453145579|FG003|Overall Study|Cross-over patients to combo treatment|0|||
125959675|NCT01602315|453145580|FG004|Overall Study|Cross-over patients to combo treatment|0|||
125959676|NCT01602315|453145581|FG005|Overall Study|Cross-over patients to combo treatment|16|||
126087198|NCT05000216|453612951|FG001|Stage 1|Withdrawal by Subject|1|||
126087199|NCT05000216|453612952|FG002|Stage 1|Withdrawal by Subject|0|||
126087200|NCT05000216|453612953|FG003|Stage 1|Withdrawal by Subject|0|||
126087201|NCT05000216|453612954|FG004|Stage 1|Withdrawal by Subject|0|||
126087202|NCT05000216|453612955|FG005|Stage 1|Withdrawal by Subject|0|||
126087203|NCT05000216|453612956|FG006|Stage 1|Withdrawal by Subject|0|||
125959677|NCT01602315|453145582|FG006|Overall Study|Cross-over patients to combo treatment|0|||
125959678|NCT00440271|453145583|FG000|Overall Study|Protocol Violation|1|||
125959679|NCT00440271|453145584|FG001|Overall Study|Protocol Violation|1|||
125959680|NCT00440271|453145583|FG000|Overall Study|Adverse Event|0|||
125959681|NCT00440271|453145584|FG001|Overall Study|Adverse Event|1|||
125959682|NCT00440271|453145583|FG000|Overall Study|Lost to Follow-up|1|||
126087204|NCT05000216|453612957|FG007|Stage 1|Withdrawal by Subject|0|||
125959683|NCT00440271|453145584|FG001|Overall Study|Lost to Follow-up|0|||
125959684|NCT00440271|453145583|FG000|Overall Study|Withdrawal by Subject|0|||
125959685|NCT00440271|453145584|FG001|Overall Study|Withdrawal by Subject|2|||
125959686|NCT00440271|453145583|FG000|Overall Study|Lack of Efficacy|0|||
125959687|NCT00440271|453145584|FG001|Overall Study|Lack of Efficacy|1|||
125959688|NCT00440271|453145583|FG000|Overall Study|Due to closure of trial|8|||
125959689|NCT00440271|453145584|FG001|Overall Study|Due to closure of trial|10|||
125959690|NCT00440271|453145583|FG000|Overall Study|Other|2|||
125959691|NCT00440271|453145584|FG001|Overall Study|Other|0|||
125959692|NCT00723801|453145585|FG000|Overall Study|Lost to Follow-up|1|||
125959693|NCT00723801|453145586|FG001|Overall Study|Lost to Follow-up|2|||
125959694|NCT00723801|453145585|FG000|Overall Study|Protocol Violation|2|||
125959695|NCT00723801|453145586|FG001|Overall Study|Protocol Violation|1|||
125959696|NCT01565993|453145589|FG000|Overall Study|Physician Decision|0|||
125959697|NCT01565993|453145590|FG001|Overall Study|Physician Decision|3|||
125959698|NCT04086472|453145591|FG000|Overall Study|Lost to Follow-up|1|||
125959699|NCT04086472|453145592|FG001|Overall Study|Lost to Follow-up|0|||
125959700|NCT04086472|453145593|FG002|Overall Study|Lost to Follow-up|0|||
125959701|NCT04086472|453145594|FG003|Overall Study|Lost to Follow-up|0|||
126087205|NCT05000216|453612958|FG008|Stage 1|Withdrawal by Subject|0|||
126087206|NCT05000216|453612959|FG009|Stage 1|Withdrawal by Subject|3|||
126087207|NCT05000216|453612960|FG010|Stage 1|Withdrawal by Subject|10|||
126087208|NCT05000216|453612961|FG011|Stage 1|Withdrawal by Subject|0|||
126087209|NCT05000216|453612962|FG012|Stage 1|Withdrawal by Subject|0|||
126087210|NCT05000216|453612963|FG013|Stage 1|Withdrawal by Subject|0|||
126087211|NCT05000216|453612964|FG014|Stage 1|Withdrawal by Subject|0|||
126087212|NCT05000216|453612965|FG015|Stage 1|Withdrawal by Subject|0|||
126087213|NCT05000216|453612966|FG016|Stage 1|Withdrawal by Subject|0|||
126087214|NCT05000216|453612967|FG017|Stage 1|Withdrawal by Subject|0|||
126087215|NCT05000216|453612968|FG018|Stage 1|Withdrawal by Subject|0|||
126087216|NCT05000216|453612969|FG019|Stage 1|Withdrawal by Subject|0|||
126087217|NCT05000216|453612970|FG020|Stage 1|Withdrawal by Subject|0|||
126087218|NCT05000216|453612971|FG021|Stage 1|Withdrawal by Subject|0|||
126087219|NCT05000216|453612950|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
126087220|NCT05000216|453612951|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
126087221|NCT05000216|453612952|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
126087222|NCT05000216|453612953|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
126087223|NCT05000216|453612954|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
126087224|NCT05000216|453612955|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
126087225|NCT05000216|453612956|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
126087226|NCT05000216|453612957|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
126087227|NCT05000216|453612958|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
126087228|NCT05000216|453612959|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
126087229|NCT05000216|453612960|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
126087230|NCT05000216|453612961|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
126087231|NCT05000216|453612962|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
126087232|NCT05000216|453612963|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
126087233|NCT05000216|453612964|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
126087234|NCT05000216|453612965|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
126087235|NCT05000216|453612966|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
126087236|NCT05000216|453612967|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
126087237|NCT05000216|453612968|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
126087238|NCT05000216|453612969|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
126087239|NCT05000216|453612970|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
126087240|NCT05000216|453612971|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
126087241|NCT05000216|453612950|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087242|NCT05000216|453612951|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087243|NCT05000216|453612952|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087244|NCT05000216|453612953|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087245|NCT05000216|453612954|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087246|NCT05000216|453612955|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087247|NCT05000216|453612956|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087248|NCT05000216|453612957|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087249|NCT05000216|453612958|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
126087250|NCT05000216|453612959|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087251|NCT05000216|453612960|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126117057|NCT02553265|453723742|FG000|First Intervention (28 Days)|Adverse Event|1|||
125959702|NCT04086472|453145595|FG004|Overall Study|Lost to Follow-up|1|||
126087252|NCT05000216|453612961|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087253|NCT05000216|453612962|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087254|NCT05000216|453612963|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087255|NCT05000216|453612964|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087256|NCT05000216|453612965|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125959703|NCT04086472|453145591|FG000|Overall Study|Physician Decision|0|||
125959704|NCT04086472|453145592|FG001|Overall Study|Physician Decision|1|||
125959705|NCT04086472|453145593|FG002|Overall Study|Physician Decision|1|||
125959706|NCT04086472|453145594|FG003|Overall Study|Physician Decision|0|||
125959707|NCT04086472|453145595|FG004|Overall Study|Physician Decision|0|||
125959708|NCT04086472|453145591|FG000|Overall Study|Withdrawal by Subject|1|||
125959709|NCT04086472|453145592|FG001|Overall Study|Withdrawal by Subject|1|||
125959710|NCT04086472|453145593|FG002|Overall Study|Withdrawal by Subject|1|||
125959711|NCT04086472|453145594|FG003|Overall Study|Withdrawal by Subject|0|||
125959712|NCT04086472|453145595|FG004|Overall Study|Withdrawal by Subject|0|||
125959713|NCT04086472|453145591|FG000|Overall Study|Various reasons|2|||
125959714|NCT04086472|453145592|FG001|Overall Study|Various reasons|0|||
125959715|NCT04086472|453145593|FG002|Overall Study|Various reasons|0|||
125959716|NCT04086472|453145594|FG003|Overall Study|Various reasons|3|||
125959717|NCT04086472|453145595|FG004|Overall Study|Various reasons|1|||
125959718|NCT00048724|453145596|FG000|Overall Study|Adverse Event|53|||
125959719|NCT00048724|453145597|FG001|Overall Study|Adverse Event|12|||
125959720|NCT00048724|453145596|FG000|Overall Study|Withdrawal by Subject|34|||
125959721|NCT00048724|453145597|FG001|Overall Study|Withdrawal by Subject|54|||
125959722|NCT00048724|453145596|FG000|Overall Study|Lost to Follow-up|5|||
125959723|NCT00048724|453145597|FG001|Overall Study|Lost to Follow-up|5|||
125959724|NCT00048724|453145596|FG000|Overall Study|Protocol-defined Clinical Event|17|||
125959725|NCT00048724|453145597|FG001|Overall Study|Protocol-defined Clinical Event|32|||
125959726|NCT00048724|453145596|FG000|Overall Study|Noncompliance With Protocol|4|||
125959727|NCT00048724|453145597|FG001|Overall Study|Noncompliance With Protocol|12|||
125959728|NCT00048724|453145596|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
125959729|NCT00048724|453145597|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
125959730|NCT00048724|453145596|FG000|Overall Study|Administrative|1|||
125959731|NCT00048724|453145597|FG001|Overall Study|Administrative|1|||
125959732|NCT00844545|453145598|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
125959733|NCT00844545|453145598|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
125959734|NCT00844545|453145598|FG000|Extension Treatment Period|Adverse Event|2|||
125959735|NCT00844545|453145598|FG000|Post Treatment Period|Withdrawal by Subject|1|||
125959736|NCT01600040|453145606|FG000|Overall Study|Withdrawal by Subject|1|||
125959737|NCT04713748|453145607|FG000|Overall Study|Not enough kits allocated|35|||
125959738|NCT00113516|453145608|FG000|Part 1|Adverse Event|6|||
125959739|NCT00113516|453145609|FG001|Part 1|Adverse Event|0|||
125959740|NCT00113516|453145608|FG000|Part 1|Death|3|||
125959741|NCT00113516|453145609|FG001|Part 1|Death|0|||
125959742|NCT00113516|453145608|FG000|Part 1|Other|3|||
125959743|NCT00113516|453145609|FG001|Part 1|Other|0|||
125959744|NCT00113516|453145608|FG000|Part 1|Withdrawal by Subject|2|||
125959745|NCT00113516|453145609|FG001|Part 1|Withdrawal by Subject|0|||
125959746|NCT00113516|453145608|FG000|Part 1|Lack of Efficacy|2|||
125959747|NCT00113516|453145609|FG001|Part 1|Lack of Efficacy|0|||
125959748|NCT00113516|453145608|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
125959749|NCT00113516|453145609|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
125959750|NCT00113516|453145608|FG000|Part 1|Laboratory Abnormality|1|||
125959751|NCT00113516|453145609|FG001|Part 1|Laboratory Abnormality|0|||
125959752|NCT00113516|453145608|FG000|Part 1|Ongoing|1|||
125959753|NCT00113516|453145609|FG001|Part 1|Ongoing|0|||
125959754|NCT00113516|453145608|FG000|Part 1|Missing|65|||
125959755|NCT00113516|453145609|FG001|Part 1|Missing|0|||
125959756|NCT00113516|453145608|FG000|Part 2|Adverse Event|0|||
125959757|NCT00113516|453145609|FG001|Part 2|Adverse Event|16|||
125959758|NCT00113516|453145608|FG000|Part 2|Death|0|||
125959759|NCT00113516|453145609|FG001|Part 2|Death|5|||
125959760|NCT00113516|453145608|FG000|Part 2|Lack of Efficacy|0|||
125959761|NCT00113516|453145609|FG001|Part 2|Lack of Efficacy|37|||
125959762|NCT00113516|453145608|FG000|Part 2|Withdrawal by Subject|0|||
125959763|NCT00113516|453145609|FG001|Part 2|Withdrawal by Subject|3|||
125959764|NCT00113516|453145608|FG000|Part 2|Other|0|||
125959765|NCT00113516|453145609|FG001|Part 2|Other|3|||
125959766|NCT00113516|453145608|FG000|Part 2|Laboratory Abnormality|0|||
125959767|NCT00113516|453145609|FG001|Part 2|Laboratory Abnormality|1|||
125959768|NCT00113516|453145608|FG000|Part 2|Ongoing|0|||
125959769|NCT00113516|453145609|FG001|Part 2|Ongoing|1|||
125959770|NCT00642304|453145610|FG000|Overall Study|Adverse Event|1|||
125959771|NCT00642304|453145610|FG000|Overall Study|Death|1|||
125959772|NCT00642304|453145610|FG000|Overall Study|Blood transfusion|2|||
126087257|NCT05000216|453612966|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087258|NCT05000216|453612967|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125959773|NCT00642304|453145610|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
125959774|NCT00642304|453145610|FG000|Overall Study|Transplantation|1|||
125959775|NCT00812812|453145614|FG000|Overall Study|Adverse Event|2|||
125959776|NCT00812812|453145615|FG001|Overall Study|Adverse Event|1|||
125959777|NCT00812812|453145614|FG000|Overall Study|Lack of Efficacy|1|||
125959778|NCT00812812|453145615|FG001|Overall Study|Lack of Efficacy|0|||
125959779|NCT00812812|453145614|FG000|Overall Study|Lost to Follow-up|0|||
125959780|NCT00812812|453145615|FG001|Overall Study|Lost to Follow-up|1|||
125959781|NCT00812812|453145614|FG000|Overall Study|Withdrawal by Subject|0|||
125959782|NCT00812812|453145615|FG001|Overall Study|Withdrawal by Subject|2|||
125959783|NCT02863354|453145619|FG000|Year 1|Lost to Follow-up|1|||
125959784|NCT02863354|453145620|FG001|Year 1|Lost to Follow-up|1|||
125959785|NCT02863354|453145619|FG000|Year 1|Withdrawal by Subject|3|||
125959786|NCT02863354|453145620|FG001|Year 1|Withdrawal by Subject|0|||
125959787|NCT02863354|453145619|FG000|Year 1|Death|0|||
125959788|NCT02863354|453145620|FG001|Year 1|Death|1|||
125959789|NCT02863354|453145619|FG000|Year 2|Lost to Follow-up|2|||
125959790|NCT02863354|453145620|FG001|Year 2|Lost to Follow-up|2|||
125959791|NCT03235024|453145624|FG000|Overall Study|Adverse Event|2|||
125959792|NCT03235024|453145625|FG001|Overall Study|Adverse Event|2|||
125959793|NCT03235024|453145624|FG000|Overall Study|Death|1|||
125959794|NCT03235024|453145625|FG001|Overall Study|Death|0|||
125959795|NCT03235024|453145624|FG000|Overall Study|Lost to Follow-up|2|||
125959796|NCT03235024|453145625|FG001|Overall Study|Lost to Follow-up|5|||
125959797|NCT03235024|453145624|FG000|Overall Study|Protocol Violation|1|||
125959798|NCT03235024|453145625|FG001|Overall Study|Protocol Violation|0|||
125959799|NCT03235024|453145624|FG000|Overall Study|Withdrawal by Subject|0|||
125959800|NCT03235024|453145625|FG001|Overall Study|Withdrawal by Subject|3|||
125959801|NCT00705575|453145626|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125959802|NCT00705575|453145627|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125959803|NCT00705575|453145626|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125959804|NCT00705575|453145627|FG001|Overall Study|Abnormal test procedure result(s)|12|||
125959805|NCT00705575|453145626|FG000|Overall Study|Adverse Event|11|||
125959806|NCT00705575|453145627|FG001|Overall Study|Adverse Event|15|||
125959807|NCT00705575|453145626|FG000|Overall Study|Lost to Follow-up|3|||
125959808|NCT00705575|453145627|FG001|Overall Study|Lost to Follow-up|4|||
125959809|NCT00705575|453145626|FG000|Overall Study|Protocol Violation|2|||
125959810|NCT00705575|453145627|FG001|Overall Study|Protocol Violation|2|||
125959811|NCT00705575|453145626|FG000|Overall Study|Withdrawal by Subject|5|||
125959812|NCT00705575|453145627|FG001|Overall Study|Withdrawal by Subject|10|||
125959813|NCT01599650|453145628|FG000|Overall Study|Administrative issue|1|||
125959814|NCT01599650|453145629|FG001|Overall Study|Administrative issue|0|||
125959815|NCT01599650|453145630|FG002|Overall Study|Administrative issue|1|||
125959816|NCT01599650|453145628|FG000|Overall Study|Physician Decision|2|||
125959817|NCT01599650|453145629|FG001|Overall Study|Physician Decision|0|||
125959818|NCT01599650|453145630|FG002|Overall Study|Physician Decision|7|||
125959819|NCT01599650|453145628|FG000|Overall Study|Protocol Violation|0|||
125959820|NCT01599650|453145629|FG001|Overall Study|Protocol Violation|3|||
125959821|NCT01599650|453145630|FG002|Overall Study|Protocol Violation|0|||
125959822|NCT01599650|453145628|FG000|Overall Study|Death|2|||
125959823|NCT01599650|453145629|FG001|Overall Study|Death|1|||
125959824|NCT01599650|453145630|FG002|Overall Study|Death|2|||
125959825|NCT01599650|453145628|FG000|Overall Study|Lost to Follow-up|3|||
125959826|NCT01599650|453145629|FG001|Overall Study|Lost to Follow-up|3|||
125959827|NCT01599650|453145630|FG002|Overall Study|Lost to Follow-up|3|||
125959828|NCT01599650|453145628|FG000|Overall Study|Withdrawal by Subject|11|||
125959829|NCT01599650|453145629|FG001|Overall Study|Withdrawal by Subject|11|||
125959830|NCT01599650|453145630|FG002|Overall Study|Withdrawal by Subject|10|||
125959831|NCT01599650|453145628|FG000|Overall Study|Adverse Event|3|||
125959832|NCT01599650|453145629|FG001|Overall Study|Adverse Event|8|||
125959833|NCT01599650|453145630|FG002|Overall Study|Adverse Event|4|||
125959834|NCT02802345|453145631|FG000|Overall Study|Not Treated|0|||
125959835|NCT02802345|453145632|FG001|Overall Study|Not Treated|1|||
125959836|NCT02802345|453145631|FG000|Overall Study|Adverse Event|28|||
125959837|NCT02802345|453145632|FG001|Overall Study|Adverse Event|20|||
125959838|NCT02802345|453145631|FG000|Overall Study|Withdrawal by Subject|3|||
125959839|NCT02802345|453145632|FG001|Overall Study|Withdrawal by Subject|3|||
125959840|NCT02802345|453145631|FG000|Overall Study|Protocol Violation|0|||
125959841|NCT02802345|453145632|FG001|Overall Study|Protocol Violation|1|||
125959842|NCT02802345|453145631|FG000|Overall Study|Other than listed|1|||
125959843|NCT02802345|453145632|FG001|Overall Study|Other than listed|5|||
125959844|NCT05857527|453145635|FG000|Overall Study|Withdrawal by Subject|0|||
125959845|NCT05857527|453145636|FG001|Overall Study|Withdrawal by Subject|1|||
125959846|NCT01748994|453145641|FG000|Overall Study|Lost to Follow-up|8|||
125959847|NCT01748994|453145642|FG001|Overall Study|Lost to Follow-up|6|||
125959848|NCT02520531|453145645|FG000|Overall Study|Revision of study device components|2|||
125959849|NCT02520531|453145646|FG001|Overall Study|Revision of study device components|2|||
125959850|NCT02520531|453145645|FG000|Overall Study|Death|1|||
125959851|NCT02520531|453145646|FG001|Overall Study|Death|2|||
125959852|NCT02520531|453145645|FG000|Overall Study|Lost to Follow-up|1|||
125959853|NCT02520531|453145646|FG001|Overall Study|Lost to Follow-up|1|||
125959854|NCT02520531|453145645|FG000|Overall Study|Meet exclusion criterion|0|||
125959855|NCT02520531|453145646|FG001|Overall Study|Meet exclusion criterion|1|||
125959856|NCT02520531|453145645|FG000|Overall Study|Withdrawal by Subject|1|||
125959857|NCT02520531|453145646|FG001|Overall Study|Withdrawal by Subject|0|||
125959858|NCT02520531|453145645|FG000|Overall Study|Not study device|1|||
125959859|NCT02520531|453145646|FG001|Overall Study|Not study device|0|||
125959860|NCT01723904|453145649|FG000|Overall Study|Noncompliant|3|||
125959861|NCT01723904|453145649|FG000|Overall Study|Adverse Event|5|||
125959862|NCT01723904|453145649|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
125959863|NCT01193556|453145658|FG000|Overall Study|Study termination|26|||
125959864|NCT01193556|453145659|FG001|Overall Study|Study termination|25|||
126117058|NCT02553265|453723743|FG001|First Intervention (28 Days)|Adverse Event|0|||
126117059|NCT02553265|453723744|FG002|First Intervention (28 Days)|Adverse Event|0|||
126117060|NCT02553265|453723742|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
126117061|NCT02553265|453723743|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
126117062|NCT02553265|453723744|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
126117063|NCT02553265|453723742|FG000|Second Intervention (28 Days)|Adverse Event|1|||
126117064|NCT02553265|453723743|FG001|Second Intervention (28 Days)|Adverse Event|0|||
126117065|NCT02553265|453723744|FG002|Second Intervention (28 Days)|Adverse Event|0|||
126117066|NCT02553265|453723742|FG000|Third Intervention (28 Days)|Adverse Event|1|||
126117067|NCT02553265|453723743|FG001|Third Intervention (28 Days)|Adverse Event|0|||
126117068|NCT02553265|453723744|FG002|Third Intervention (28 Days)|Adverse Event|0|||
126117069|NCT02553265|453723742|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
126117070|NCT02553265|453723743|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
126117071|NCT02553265|453723744|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
126117072|NCT02023242|453723745|FG000|Overall Study|Lost to Follow-up|3|||
126117073|NCT02023242|453723746|FG001|Overall Study|Lost to Follow-up|1|||
126117074|NCT02023242|453723745|FG000|Overall Study|Death|0|||
126117075|NCT02023242|453723746|FG001|Overall Study|Death|1|||
126117076|NCT04854434|453723753|FG000|Overall Study|Death|1|||
126117077|NCT04854434|453723754|FG001|Overall Study|Death|3|||
126117078|NCT04854434|453723755|FG002|Overall Study|Death|4|||
126117079|NCT04854434|453723753|FG000|Overall Study|Study Terminated by Sponsor|2|||
126117080|NCT04854434|453723754|FG001|Overall Study|Study Terminated by Sponsor|0|||
126117081|NCT04854434|453723755|FG002|Overall Study|Study Terminated by Sponsor|0|||
126117082|NCT04854434|453723753|FG000|Overall Study|Other|1|||
126117083|NCT04854434|453723754|FG001|Overall Study|Other|1|||
126117084|NCT04854434|453723755|FG002|Overall Study|Other|0|||
126117085|NCT02667275|453723756|FG000|Overall Study|Protocol Violation|11|||
126117086|NCT02667275|453723757|FG001|Overall Study|Protocol Violation|7|||
126117087|NCT02667275|453723756|FG000|Overall Study|Lost to Follow-up|0|||
126117088|NCT02667275|453723757|FG001|Overall Study|Lost to Follow-up|2|||
126117089|NCT02667275|453723756|FG000|Overall Study|Withdrawal by Subject|0|||
126117090|NCT02667275|453723757|FG001|Overall Study|Withdrawal by Subject|5|||
126117091|NCT02667275|453723756|FG000|Overall Study|Discontinued early without completing|0|||
126117092|NCT02667275|453723757|FG001|Overall Study|Discontinued early without completing|1|||
126117093|NCT01274715|453723758|FG000|Overall Study|Lost to Follow-up|1|||
126117094|NCT01274715|453723758|FG000|Overall Study|After consent, met exclusion criteria.|1|||
126117095|NCT01274715|453723758|FG000|Overall Study|After consent, met exclusion criteria.|1|||
126117096|NCT01274715|453723758|FG000|Overall Study|After consent, met exclusion criteria.|1|||
126117097|NCT02285920|453723759|FG000|Overall Study|Kidney transplantation|2|||
126117098|NCT02285920|453723760|FG001|Overall Study|Kidney transplantation|2|||
126117099|NCT02285920|453723761|FG002|Overall Study|Kidney transplantation|2|||
126117100|NCT02285920|453723762|FG003|Overall Study|Kidney transplantation|0|||
126117101|NCT02285920|453723759|FG000|Overall Study|Change to peritoneal dialysis|0|||
126117102|NCT02285920|453723760|FG001|Overall Study|Change to peritoneal dialysis|0|||
126117103|NCT02285920|453723761|FG002|Overall Study|Change to peritoneal dialysis|1|||
126117104|NCT02285920|453723762|FG003|Overall Study|Change to peritoneal dialysis|0|||
126117105|NCT02285920|453723759|FG000|Overall Study|Transfer to non-participating unit|0|||
126117106|NCT02285920|453723760|FG001|Overall Study|Transfer to non-participating unit|1|||
126117107|NCT02285920|453723761|FG002|Overall Study|Transfer to non-participating unit|0|||
126117108|NCT02285920|453723762|FG003|Overall Study|Transfer to non-participating unit|0|||
126117109|NCT02285920|453723759|FG000|Overall Study|Dialysis discontinuation|0|||
126117110|NCT02285920|453723760|FG001|Overall Study|Dialysis discontinuation|1|||
126117111|NCT02285920|453723761|FG002|Overall Study|Dialysis discontinuation|0|||
126117112|NCT02285920|453723762|FG003|Overall Study|Dialysis discontinuation|0|||
126117113|NCT02285920|453723759|FG000|Overall Study|Death|2|||
126117114|NCT02285920|453723760|FG001|Overall Study|Death|0|||
126117115|NCT02285920|453723761|FG002|Overall Study|Death|2|||
126117116|NCT02285920|453723762|FG003|Overall Study|Death|1|||
126117117|NCT05418673|453723763|FG000|Overall Study|Study Terminated by Sponsor|2|||
126117118|NCT05418673|453723764|FG001|Overall Study|Study Terminated by Sponsor|4|||
126117119|NCT05418673|453723763|FG000|Overall Study|Lost to Follow-up|1|||
126117120|NCT05418673|453723764|FG001|Overall Study|Lost to Follow-up|0|||
126117121|NCT02665052|453723767|FG000|Overall Study|Lost to Follow-up|1|||
126117122|NCT02665052|453723768|FG001|Overall Study|Lost to Follow-up|0|||
126117123|NCT02665052|453723769|FG002|Overall Study|Lost to Follow-up|0|||
125959865|NCT02486406|453145662|FG000|Overall Study|Withdrew consent|1|||
125959866|NCT02486406|453145663|FG001|Overall Study|Withdrew consent|0|||
126117124|NCT02665052|453723770|FG003|Overall Study|Lost to Follow-up|0|||
126117125|NCT02665052|453723767|FG000|Overall Study|Withdrawal by Subject|1|||
126117126|NCT02665052|453723768|FG001|Overall Study|Withdrawal by Subject|1|||
126117127|NCT02665052|453723769|FG002|Overall Study|Withdrawal by Subject|0|||
126117128|NCT02665052|453723770|FG003|Overall Study|Withdrawal by Subject|5|||
126117129|NCT02665052|453723767|FG000|Overall Study|Adverse Event|1|||
126117130|NCT02665052|453723768|FG001|Overall Study|Adverse Event|1|||
126117131|NCT02665052|453723769|FG002|Overall Study|Adverse Event|0|||
125959867|NCT02486406|453145664|FG002|Overall Study|Withdrew consent|0|||
125959868|NCT02486406|453145665|FG003|Overall Study|Withdrew consent|1|||
125959869|NCT02486406|453145662|FG000|Overall Study|Lost to Follow-up|1|||
125959870|NCT02486406|453145663|FG001|Overall Study|Lost to Follow-up|3|||
125959871|NCT02486406|453145664|FG002|Overall Study|Lost to Follow-up|1|||
125959872|NCT02486406|453145665|FG003|Overall Study|Lost to Follow-up|3|||
125959873|NCT02486406|453145662|FG000|Overall Study|Other, not specified|0|||
125959874|NCT02486406|453145663|FG001|Overall Study|Other, not specified|0|||
125959875|NCT02486406|453145664|FG002|Overall Study|Other, not specified|1|||
125959876|NCT02486406|453145665|FG003|Overall Study|Other, not specified|0|||
125959877|NCT01826825|453145670|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
125959878|NCT01826825|453145671|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
125959879|NCT01858194|453145672|FG000|Overall Study|Total Artificial Heart Implant|0|||
125959880|NCT01858194|453145673|FG001|Overall Study|Total Artificial Heart Implant|1|||
125959881|NCT01858194|453145672|FG000|Overall Study|Lost to Follow-up|0|||
125959882|NCT01858194|453145673|FG001|Overall Study|Lost to Follow-up|1|||
125959883|NCT03062891|453145680|FG000|Overall Study|Withdrawal by Subject|2|||
125959884|NCT03062891|453145681|FG001|Overall Study|Withdrawal by Subject|0|||
125959885|NCT03062891|453145680|FG000|Overall Study|Lost to Follow-up|50|||
125959886|NCT03062891|453145681|FG001|Overall Study|Lost to Follow-up|38|||
125959887|NCT02127307|453145682|FG000|Overall Study|Protocol Violation|36|||
125959888|NCT02127307|453145682|FG000|Overall Study|Lost to Follow-up|2|||
125959889|NCT02127307|453145682|FG000|Overall Study|Death|101|||
125959890|NCT02127307|453145682|FG000|Overall Study|Other than specified above|169|||
125959891|NCT03509948|453145683|FG000|Overall Study|Protocol Violation|0|||
125959892|NCT03509948|453145684|FG001|Overall Study|Protocol Violation|1|||
125959893|NCT01071512|453145694|FG000|Overall Study|Adverse Event|1|||
125959894|NCT01071512|453145694|FG000|Overall Study|Development of antibodies to drug|2|||
125959895|NCT01071512|453145694|FG000|Overall Study|positive anti-JC virus antibody test|2|||
125959896|NCT01687166|453145707|FG000|Overall Study|Attempt subject|2|||
125959897|NCT01687166|453145708|FG001|Overall Study|Attempt subject|3|||
125959898|NCT01687166|453145709|FG002|Overall Study|Attempt subject|2|||
125959899|NCT01687166|453145710|FG003|Overall Study|Attempt subject|0|||
125959900|NCT01687166|453145707|FG000|Overall Study|Did not meet eligibility criteria|4|||
125959901|NCT01687166|453145708|FG001|Overall Study|Did not meet eligibility criteria|6|||
125959902|NCT01687166|453145709|FG002|Overall Study|Did not meet eligibility criteria|1|||
125959903|NCT01687166|453145710|FG003|Overall Study|Did not meet eligibility criteria|1|||
125959904|NCT01687166|453145707|FG000|Overall Study|Adverse Event|2|||
125959905|NCT01687166|453145708|FG001|Overall Study|Adverse Event|1|||
125959906|NCT01687166|453145709|FG002|Overall Study|Adverse Event|0|||
125959907|NCT01687166|453145710|FG003|Overall Study|Adverse Event|0|||
125959908|NCT01687166|453145707|FG000|Overall Study|Physician Decision|3|||
125959909|NCT01687166|453145708|FG001|Overall Study|Physician Decision|2|||
125959910|NCT01687166|453145709|FG002|Overall Study|Physician Decision|1|||
125959911|NCT01687166|453145710|FG003|Overall Study|Physician Decision|0|||
125959912|NCT01687166|453145707|FG000|Overall Study|Withdrawal by Subject|11|||
125959913|NCT01687166|453145708|FG001|Overall Study|Withdrawal by Subject|4|||
125959914|NCT01687166|453145709|FG002|Overall Study|Withdrawal by Subject|3|||
125959915|NCT01687166|453145710|FG003|Overall Study|Withdrawal by Subject|0|||
125959916|NCT01687166|453145707|FG000|Overall Study|Lost to Follow-up|2|||
125959917|NCT01687166|453145708|FG001|Overall Study|Lost to Follow-up|5|||
125959918|NCT01687166|453145709|FG002|Overall Study|Lost to Follow-up|1|||
125959919|NCT01687166|453145710|FG003|Overall Study|Lost to Follow-up|0|||
125959920|NCT01687166|453145707|FG000|Overall Study|Equipment/Device Availability|0|||
125959921|NCT01687166|453145708|FG001|Overall Study|Equipment/Device Availability|1|||
125959922|NCT01687166|453145709|FG002|Overall Study|Equipment/Device Availability|0|||
125959923|NCT01687166|453145710|FG003|Overall Study|Equipment/Device Availability|0|||
125959924|NCT01687166|453145707|FG000|Overall Study|Death|1|||
125959925|NCT01687166|453145708|FG001|Overall Study|Death|1|||
125959926|NCT01687166|453145709|FG002|Overall Study|Death|0|||
125959927|NCT01687166|453145710|FG003|Overall Study|Death|0|||
125959928|NCT01687166|453145707|FG000|Overall Study|Protocol Violation|1|||
125959929|NCT01687166|453145708|FG001|Overall Study|Protocol Violation|1|||
125959930|NCT01687166|453145709|FG002|Overall Study|Protocol Violation|1|||
125959931|NCT01687166|453145710|FG003|Overall Study|Protocol Violation|0|||
125959932|NCT01687166|453145707|FG000|Overall Study|Subject moved out of state|0|||
125959933|NCT01687166|453145708|FG001|Overall Study|Subject moved out of state|1|||
125959934|NCT01687166|453145709|FG002|Overall Study|Subject moved out of state|0|||
125959935|NCT01687166|453145710|FG003|Overall Study|Subject moved out of state|0|||
125959936|NCT01687166|453145707|FG000|Overall Study|Patient unable to be compliant|1|||
125959937|NCT01687166|453145708|FG001|Overall Study|Patient unable to be compliant|0|||
125959938|NCT01687166|453145709|FG002|Overall Study|Patient unable to be compliant|0|||
125959939|NCT01687166|453145710|FG003|Overall Study|Patient unable to be compliant|0|||
126117132|NCT02665052|453723770|FG003|Overall Study|Adverse Event|0|||
125959940|NCT01687166|453145707|FG000|Overall Study|Physician choice to use different device|1|||
125959941|NCT01687166|453145708|FG001|Overall Study|Physician choice to use different device|2|||
126117133|NCT02234284|453723771|FG000|Overall Study|Death|4|||
126117134|NCT02234284|453723772|FG001|Overall Study|Death|2|||
126117135|NCT02234284|453723771|FG000|Overall Study|Withdrawal by Subject|1|||
126117136|NCT02234284|453723772|FG001|Overall Study|Withdrawal by Subject|0|||
126117137|NCT02234284|453723771|FG000|Overall Study|Lost to Follow-up|20|||
126117138|NCT02234284|453723772|FG001|Overall Study|Lost to Follow-up|7|||
126117139|NCT00233363|453723774|FG000|Overall Study|Adverse Event|1|||
126117140|NCT00233363|453723775|FG001|Overall Study|Adverse Event|2|||
126117141|NCT00233363|453723774|FG000|Overall Study|Lack of Efficacy|0|||
126117142|NCT00233363|453723775|FG001|Overall Study|Lack of Efficacy|2|||
126117143|NCT00233363|453723774|FG000|Overall Study|Withdrawal by Subject|1|||
126117144|NCT00233363|453723775|FG001|Overall Study|Withdrawal by Subject|1|||
126117145|NCT00233363|453723774|FG000|Overall Study|Aggravation of complication|1|||
126117146|NCT00233363|453723775|FG001|Overall Study|Aggravation of complication|0|||
126117147|NCT00873366|453723779|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
125959942|NCT01687166|453145709|FG002|Overall Study|Physician choice to use different device|4|||
125959943|NCT01687166|453145710|FG003|Overall Study|Physician choice to use different device|0|||
125959944|NCT01687166|453145707|FG000|Overall Study|Insurance|0|||
125959945|NCT01687166|453145708|FG001|Overall Study|Insurance|0|||
125959946|NCT01687166|453145709|FG002|Overall Study|Insurance|1|||
125959947|NCT01687166|453145710|FG003|Overall Study|Insurance|1|||
125959948|NCT02442830|453145711|FG000|Overall Study|Technical Failure|0|||
125959949|NCT02442830|453145712|FG001|Overall Study|Technical Failure|1|||
125959950|NCT00183872|453145713|FG000|Overall Study|Death|3|||
125959951|NCT00183872|453145713|FG000|Overall Study|Adverse Event|9|||
125959952|NCT00183872|453145713|FG000|Overall Study|Withdrawal by Subject|2|||
125959953|NCT00183872|453145713|FG000|Overall Study|Drug delayed more than 28 days|2|||
125959954|NCT01516879|453145714|FG000|Overall Study|Withdrawal by Subject|9|||
126117148|NCT00873366|453723779|FG000|Overall Study|Off tamoxifen due to side effects|2|||
126117149|NCT00873366|453723779|FG000|Overall Study|Refused to continue DM-BT testing|3|||
126117150|NCT01576172|453723780|FG000|Overall Study|Ineligible|2|||
126117151|NCT01576172|453723781|FG001|Overall Study|Ineligible|1|||
126117152|NCT01576172|453723780|FG000|Overall Study|Withdrawal by Subject|2|||
126117153|NCT01576172|453723781|FG001|Overall Study|Withdrawal by Subject|0|||
126117154|NCT01576172|453723780|FG000|Overall Study|Insurance issue|1|||
126117155|NCT01576172|453723781|FG001|Overall Study|Insurance issue|0|||
126117156|NCT03199040|453723785|FG000|Overall Study|Lack of Efficacy|2|||
126117157|NCT03199040|453723786|FG001|Overall Study|Lack of Efficacy|0|||
126117158|NCT03199040|453723785|FG000|Overall Study|Withdrawal by Subject|2|||
126117159|NCT03199040|453723786|FG001|Overall Study|Withdrawal by Subject|0|||
126117160|NCT03199040|453723785|FG000|Overall Study|Adverse Event|0|||
126117161|NCT03199040|453723786|FG001|Overall Study|Adverse Event|1|||
126117162|NCT03199040|453723785|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
126117163|NCT03199040|453723786|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
126117164|NCT00199836|453723789|FG000|Overall Study|Progressive Disease|5|||
126117165|NCT00199836|453723789|FG000|Overall Study|Death|1|||
126117166|NCT01708291|453723790|FG000|Overall Study|fighting|2|||
126117167|NCT01708291|453723791|FG001|Overall Study|fighting|1|||
126117168|NCT01843972|453723792|FG000|Overall Study|Withdrawal by Subject|0|||
126117169|NCT01843972|453723793|FG001|Overall Study|Withdrawal by Subject|0|||
126117170|NCT01843972|453723794|FG002|Overall Study|Withdrawal by Subject|0|||
126117171|NCT01843972|453723795|FG003|Overall Study|Withdrawal by Subject|0|||
126117172|NCT01843972|453723796|FG004|Overall Study|Withdrawal by Subject|1|||
126117173|NCT01843972|453723797|FG005|Overall Study|Withdrawal by Subject|0|||
126117174|NCT01843972|453723798|FG006|Overall Study|Withdrawal by Subject|0|||
126117175|NCT01843972|453723799|FG007|Overall Study|Withdrawal by Subject|0|||
126117176|NCT01843972|453723800|FG008|Overall Study|Withdrawal by Subject|0|||
126117177|NCT01843972|453723801|FG009|Overall Study|Withdrawal by Subject|0|||
126117178|NCT00932425|453723805|FG000|Overall Study|Lost to Follow-up|0|||
126117179|NCT00932425|453723806|FG001|Overall Study|Lost to Follow-up|1|||
126117180|NCT00932425|453723805|FG000|Overall Study|Withdrawal by Subject|0|||
126117181|NCT00932425|453723806|FG001|Overall Study|Withdrawal by Subject|1|||
126117182|NCT01854645|453723809|FG000|Overall Study|Protocol-Specified Criteria|13|||
126117183|NCT01854645|453723810|FG001|Overall Study|Protocol-Specified Criteria|10|||
126117184|NCT01854645|453723811|FG002|Overall Study|Protocol-Specified Criteria|8|||
126117185|NCT01854645|453723812|FG003|Overall Study|Protocol-Specified Criteria|5|||
126117186|NCT01854645|453723813|FG004|Overall Study|Protocol-Specified Criteria|7|||
126117187|NCT01854645|453723809|FG000|Overall Study|Administrative Reasons / Missing|0|||
126117188|NCT01854645|453723810|FG001|Overall Study|Administrative Reasons / Missing|0|||
126117189|NCT01854645|453723811|FG002|Overall Study|Administrative Reasons / Missing|0|||
126117190|NCT01854645|453723812|FG003|Overall Study|Administrative Reasons / Missing|1|||
126117191|NCT01854645|453723813|FG004|Overall Study|Administrative Reasons / Missing|1|||
126117192|NCT01854645|453723809|FG000|Overall Study|Protocol Violation|3|||
126117193|NCT01854645|453723810|FG001|Overall Study|Protocol Violation|0|||
125959955|NCT01516879|453145715|FG001|Overall Study|Withdrawal by Subject|11|||
125959956|NCT01516879|453145714|FG000|Overall Study|Death|0|||
126117194|NCT01854645|453723811|FG002|Overall Study|Protocol Violation|5|||
126117195|NCT01854645|453723812|FG003|Overall Study|Protocol Violation|4|||
125959957|NCT01516879|453145715|FG001|Overall Study|Death|2|||
125959958|NCT01516879|453145714|FG000|Overall Study|Lost to Follow-up|2|||
125959959|NCT01516879|453145715|FG001|Overall Study|Lost to Follow-up|11|||
125959960|NCT01516879|453145714|FG000|Overall Study|Other|5|||
125959961|NCT01516879|453145715|FG001|Overall Study|Other|10|||
125959962|NCT02797262|453145716|FG000|Overall Study|Withdrawal by Subject|5|||
125959963|NCT02797262|453145717|FG001|Overall Study|Withdrawal by Subject|1|||
125959964|NCT02797262|453145716|FG000|Overall Study|Lost to Follow-up|10|||
125959965|NCT02797262|453145717|FG001|Overall Study|Lost to Follow-up|7|||
125959966|NCT02797262|453145716|FG000|Overall Study|Death|1|||
125959967|NCT02797262|453145717|FG001|Overall Study|Death|2|||
125959968|NCT02797262|453145716|FG000|Overall Study|Adverse Event|1|||
125959969|NCT02797262|453145717|FG001|Overall Study|Adverse Event|0|||
125959970|NCT02797262|453145716|FG000|Overall Study|COVID-19|2|||
125959971|NCT02797262|453145717|FG001|Overall Study|COVID-19|1|||
125959972|NCT02797262|453145716|FG000|Overall Study|Out-of-country|1|||
125959973|NCT02797262|453145717|FG001|Overall Study|Out-of-country|0|||
125959974|NCT01898793|453145718|FG000|Overall Study|Death|2|||
125959975|NCT01898793|453145719|FG001|Overall Study|Death|1|||
125959976|NCT01898793|453145720|FG002|Overall Study|Death|4|||
125959977|NCT01898793|453145721|FG003|Overall Study|Death|0|||
125959978|NCT01898793|453145722|FG004|Overall Study|Death|0|||
125959979|NCT01898793|453145723|FG005|Overall Study|Death|0|||
125959980|NCT01898793|453145724|FG006|Overall Study|Death|0|||
125959981|NCT00983814|453145725|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
125959982|NCT00983814|453145726|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
125959983|NCT00983814|453145727|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
125959984|NCT00983814|453145725|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
125959985|NCT00983814|453145726|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
125959986|NCT00983814|453145727|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
125959987|NCT00983814|453145725|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
125959988|NCT00983814|453145726|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
125959989|NCT00983814|453145727|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
125959990|NCT00983814|453145725|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
125959991|NCT00983814|453145726|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
125959992|NCT00983814|453145727|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
125959993|NCT00983814|453145725|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
125959994|NCT00983814|453145726|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
125959995|NCT00983814|453145727|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
125959996|NCT00829621|453145728|FG000|Overall Study|Death|1|||
125959997|NCT00829621|453145729|FG001|Overall Study|Death|0|||
125959998|NCT00829621|453145728|FG000|Overall Study|Lost to Follow-up|3|||
125959999|NCT00829621|453145729|FG001|Overall Study|Lost to Follow-up|4|||
125960000|NCT01818336|453147431|FG000|Overall Study|Declined retest visit|0|||
125960001|NCT01818336|453147432|FG001|Overall Study|Declined retest visit|11|||
125960002|NCT01818336|453147431|FG000|Overall Study|Lost to Follow-up|0|||
125960003|NCT01818336|453147432|FG001|Overall Study|Lost to Follow-up|1|||
125960004|NCT02293005|453147437|FG000|Overall Study|Adverse Event|2|||
125960005|NCT02293005|453147437|FG000|Overall Study|Death|4|||
125960006|NCT02293005|453147437|FG000|Overall Study|Lost to Follow-up|1|||
125960007|NCT02293005|453147437|FG000|Overall Study|Withdrawal by Subject|2|||
125960008|NCT02293005|453147437|FG000|Overall Study|Progression|17|||
125960009|NCT02139644|453147438|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
125960010|NCT02139644|453147439|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125960011|NCT02139644|453147440|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125960012|NCT02139644|453147441|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125960013|NCT02139644|453147442|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125960014|NCT02139644|453147443|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125960015|NCT02139644|453147438|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
125960016|NCT02139644|453147439|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125960017|NCT02139644|453147440|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125960018|NCT02139644|453147441|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125960019|NCT02139644|453147442|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125960020|NCT02139644|453147443|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125960021|NCT02139644|453147438|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
125960022|NCT02139644|453147439|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125960023|NCT02139644|453147440|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125960024|NCT02139644|453147441|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125960025|NCT02139644|453147442|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125960026|NCT02139644|453147443|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125960027|NCT02139644|453147438|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
125960028|NCT02139644|453147439|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125960029|NCT02139644|453147440|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125960030|NCT02139644|453147441|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125960031|NCT02139644|453147442|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126117196|NCT01854645|453723813|FG004|Overall Study|Protocol Violation|1|||
126117197|NCT01854645|453723809|FG000|Overall Study|Lost to Follow-up|10|||
126117198|NCT01854645|453723810|FG001|Overall Study|Lost to Follow-up|7|||
126117199|NCT01854645|453723811|FG002|Overall Study|Lost to Follow-up|8|||
126117200|NCT01854645|453723812|FG003|Overall Study|Lost to Follow-up|5|||
126117201|NCT01854645|453723813|FG004|Overall Study|Lost to Follow-up|0|||
126117202|NCT01854645|453723809|FG000|Overall Study|Physician Decision|1|||
126117203|NCT01854645|453723810|FG001|Overall Study|Physician Decision|5|||
126117204|NCT01854645|453723811|FG002|Overall Study|Physician Decision|3|||
126117205|NCT01854645|453723812|FG003|Overall Study|Physician Decision|3|||
126117206|NCT01854645|453723813|FG004|Overall Study|Physician Decision|7|||
126117207|NCT01854645|453723809|FG000|Overall Study|Withdrawal by Subject|31|||
126117208|NCT01854645|453723810|FG001|Overall Study|Withdrawal by Subject|41|||
126117209|NCT01854645|453723811|FG002|Overall Study|Withdrawal by Subject|30|||
126117210|NCT01854645|453723812|FG003|Overall Study|Withdrawal by Subject|21|||
126117211|NCT01854645|453723813|FG004|Overall Study|Withdrawal by Subject|24|||
126117212|NCT01854645|453723809|FG000|Overall Study|Lack of Efficacy|7|||
126117213|NCT01854645|453723810|FG001|Overall Study|Lack of Efficacy|12|||
126117214|NCT01854645|453723811|FG002|Overall Study|Lack of Efficacy|9|||
126117215|NCT01854645|453723812|FG003|Overall Study|Lack of Efficacy|3|||
126117216|NCT01854645|453723813|FG004|Overall Study|Lack of Efficacy|9|||
126117217|NCT01854645|453723809|FG000|Overall Study|Adverse Event|33|||
126117218|NCT01854645|453723810|FG001|Overall Study|Adverse Event|31|||
126117219|NCT01854645|453723811|FG002|Overall Study|Adverse Event|19|||
126117220|NCT01854645|453723812|FG003|Overall Study|Adverse Event|20|||
126117221|NCT01854645|453723813|FG004|Overall Study|Adverse Event|11|||
125960032|NCT02139644|453147443|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125960033|NCT02139644|453147438|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
125960034|NCT02139644|453147439|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125960035|NCT02139644|453147440|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125960036|NCT02139644|453147441|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125960037|NCT02139644|453147442|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125960038|NCT02139644|453147443|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125960039|NCT02139644|453147438|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
125960040|NCT02139644|453147439|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
125960041|NCT02139644|453147440|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
125960042|NCT02139644|453147441|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
125960043|NCT02139644|453147442|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
125960044|NCT02139644|453147443|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
125960045|NCT02139644|453147438|FG000|Run-In Period (Pre-assignment)|Other|6|||
125960046|NCT02139644|453147439|FG001|Run-In Period (Pre-assignment)|Other|0|||
125960047|NCT02139644|453147440|FG002|Run-In Period (Pre-assignment)|Other|0|||
125960048|NCT02139644|453147441|FG003|Run-In Period (Pre-assignment)|Other|0|||
125960049|NCT02139644|453147442|FG004|Run-In Period (Pre-assignment)|Other|0|||
125960050|NCT02139644|453147443|FG005|Run-In Period (Pre-assignment)|Other|0|||
125960051|NCT02139644|453147438|FG000|Treatment Period|Adverse Event|0|||
125960052|NCT02139644|453147439|FG001|Treatment Period|Adverse Event|0|||
125960053|NCT02139644|453147440|FG002|Treatment Period|Adverse Event|3|||
125960054|NCT02139644|453147441|FG003|Treatment Period|Adverse Event|2|||
125960055|NCT02139644|453147442|FG004|Treatment Period|Adverse Event|1|||
125960056|NCT02139644|453147443|FG005|Treatment Period|Adverse Event|6|||
125960057|NCT02139644|453147438|FG000|Treatment Period|Withdrawal by Subject|0|||
125960058|NCT02139644|453147439|FG001|Treatment Period|Withdrawal by Subject|0|||
125960059|NCT02139644|453147440|FG002|Treatment Period|Withdrawal by Subject|2|||
125960060|NCT02139644|453147441|FG003|Treatment Period|Withdrawal by Subject|2|||
125960061|NCT02139644|453147442|FG004|Treatment Period|Withdrawal by Subject|3|||
125960062|NCT02139644|453147443|FG005|Treatment Period|Withdrawal by Subject|2|||
125960063|NCT02139644|453147438|FG000|Treatment Period|Non-compliance|0|||
125960064|NCT02139644|453147439|FG001|Treatment Period|Non-compliance|0|||
125960065|NCT02139644|453147440|FG002|Treatment Period|Non-compliance|0|||
125960066|NCT02139644|453147441|FG003|Treatment Period|Non-compliance|1|||
125960067|NCT02139644|453147442|FG004|Treatment Period|Non-compliance|0|||
125960068|NCT02139644|453147443|FG005|Treatment Period|Non-compliance|0|||
125960069|NCT02139644|453147438|FG000|Treatment Period|Protocol Violation|0|||
125960070|NCT02139644|453147439|FG001|Treatment Period|Protocol Violation|0|||
125960071|NCT02139644|453147440|FG002|Treatment Period|Protocol Violation|0|||
125960072|NCT02139644|453147441|FG003|Treatment Period|Protocol Violation|1|||
125960073|NCT02139644|453147442|FG004|Treatment Period|Protocol Violation|1|||
125960074|NCT02139644|453147443|FG005|Treatment Period|Protocol Violation|1|||
125960075|NCT02139644|453147438|FG000|Treatment Period|Disease progression|0|||
125960076|NCT02139644|453147439|FG001|Treatment Period|Disease progression|0|||
125960077|NCT02139644|453147440|FG002|Treatment Period|Disease progression|0|||
126117222|NCT00430482|453723814|FG000|Completed Treatment|Insufficient Treatment|7|||
126117223|NCT00430482|453723815|FG001|Completed Treatment|Insufficient Treatment|11|||
126117224|NCT00555477|453723816|FG000|Overall Study|Adverse Event|0|||
126117225|NCT00555477|453723817|FG001|Overall Study|Adverse Event|9|||
126117226|NCT00555477|453723816|FG000|Overall Study|Withdrawal by Subject|1|||
125960078|NCT02139644|453147441|FG003|Treatment Period|Disease progression|1|||
125960079|NCT02139644|453147442|FG004|Treatment Period|Disease progression|1|||
125960080|NCT02139644|453147443|FG005|Treatment Period|Disease progression|2|||
125960081|NCT02139644|453147438|FG000|Treatment Period|Lost to Follow-up|0|||
125960082|NCT02139644|453147439|FG001|Treatment Period|Lost to Follow-up|0|||
125960083|NCT02139644|453147440|FG002|Treatment Period|Lost to Follow-up|1|||
125960084|NCT02139644|453147441|FG003|Treatment Period|Lost to Follow-up|1|||
125960085|NCT02139644|453147442|FG004|Treatment Period|Lost to Follow-up|1|||
125960086|NCT02139644|453147443|FG005|Treatment Period|Lost to Follow-up|1|||
125960087|NCT02139644|453147438|FG000|Treatment Period|Lack of Efficacy|0|||
125960088|NCT02139644|453147439|FG001|Treatment Period|Lack of Efficacy|0|||
125960089|NCT02139644|453147440|FG002|Treatment Period|Lack of Efficacy|1|||
125960090|NCT02139644|453147441|FG003|Treatment Period|Lack of Efficacy|0|||
125960091|NCT02139644|453147442|FG004|Treatment Period|Lack of Efficacy|1|||
125960092|NCT02139644|453147443|FG005|Treatment Period|Lack of Efficacy|4|||
125960093|NCT02139644|453147438|FG000|Treatment Period|Other|0|||
125960094|NCT02139644|453147439|FG001|Treatment Period|Other|3|||
125960095|NCT02139644|453147440|FG002|Treatment Period|Other|1|||
125960096|NCT02139644|453147441|FG003|Treatment Period|Other|1|||
125960097|NCT02139644|453147442|FG004|Treatment Period|Other|0|||
125960098|NCT02139644|453147443|FG005|Treatment Period|Other|1|||
125960099|NCT00608829|453147444|FG000|Overall Study|Death|6|||
125960100|NCT00608829|453147444|FG000|Overall Study|Withdrawal by Subject|4|||
125960101|NCT00608829|453147444|FG000|Overall Study|Subject refuses to follow up or return.|5|||
125960102|NCT02564471|453147445|FG000|Overall Study|Adverse Event|1|||
125960103|NCT02564471|453147446|FG001|Overall Study|Adverse Event|0|||
125960104|NCT02564471|453147447|FG002|Overall Study|Adverse Event|0|||
125960105|NCT02564471|453147448|FG003|Overall Study|Adverse Event|0|||
125960106|NCT02564471|453147445|FG000|Overall Study|Withdrawal by Subject|2|||
125960107|NCT02564471|453147446|FG001|Overall Study|Withdrawal by Subject|1|||
125960108|NCT02564471|453147447|FG002|Overall Study|Withdrawal by Subject|3|||
125960109|NCT02564471|453147448|FG003|Overall Study|Withdrawal by Subject|0|||
125960110|NCT02564471|453147445|FG000|Overall Study|Lost to Follow-up|0|||
125960111|NCT02564471|453147446|FG001|Overall Study|Lost to Follow-up|2|||
125960112|NCT02564471|453147447|FG002|Overall Study|Lost to Follow-up|0|||
125960113|NCT02564471|453147448|FG003|Overall Study|Lost to Follow-up|0|||
125960114|NCT02805257|453147449|FG000|Overall Study|Lost to Follow-up|7|||
125960115|NCT02805257|453147450|FG001|Overall Study|Lost to Follow-up|6|||
125960116|NCT02805257|453147449|FG000|Overall Study|Death|0|||
125960117|NCT02805257|453147450|FG001|Overall Study|Death|1|||
125960118|NCT02033889|453147456|FG000|Overall Study|Adverse Event|3|||
125960119|NCT02033889|453147457|FG001|Overall Study|Adverse Event|1|||
125960120|NCT02033889|453147458|FG002|Overall Study|Adverse Event|3|||
125960121|NCT02033889|453147456|FG000|Overall Study|Death|3|||
125960122|NCT02033889|453147457|FG001|Overall Study|Death|1|||
125960123|NCT02033889|453147458|FG002|Overall Study|Death|2|||
125960124|NCT02033889|453147456|FG000|Overall Study|Excluded Medication|1|||
125960125|NCT02033889|453147457|FG001|Overall Study|Excluded Medication|1|||
125960126|NCT02033889|453147458|FG002|Overall Study|Excluded Medication|0|||
125960127|NCT02033889|453147456|FG000|Overall Study|Lost to Follow-up|8|||
125960128|NCT02033889|453147457|FG001|Overall Study|Lost to Follow-up|5|||
125960129|NCT02033889|453147458|FG002|Overall Study|Lost to Follow-up|6|||
125960130|NCT02033889|453147456|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125960131|NCT02033889|453147457|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125960132|NCT02033889|453147458|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125960133|NCT02033889|453147456|FG000|Overall Study|Physician Decision|0|||
125960134|NCT02033889|453147457|FG001|Overall Study|Physician Decision|1|||
125960135|NCT02033889|453147458|FG002|Overall Study|Physician Decision|1|||
125960136|NCT02033889|453147456|FG000|Overall Study|Participant moved|0|||
125960137|NCT02033889|453147457|FG001|Overall Study|Participant moved|1|||
125960138|NCT02033889|453147458|FG002|Overall Study|Participant moved|0|||
125960139|NCT02033889|453147456|FG000|Overall Study|Withdrawal by Subject|18|||
125960140|NCT02033889|453147457|FG001|Overall Study|Withdrawal by Subject|10|||
125960141|NCT02033889|453147458|FG002|Overall Study|Withdrawal by Subject|13|||
125960142|NCT02343458|453147461|FG000|Overall Study|Adverse Event|15|||
125960143|NCT02343458|453147462|FG001|Overall Study|Adverse Event|14|||
125960144|NCT02343458|453147463|FG002|Overall Study|Adverse Event|15|||
125960145|NCT02343458|453147464|FG003|Overall Study|Adverse Event|3|||
125960146|NCT02343458|453147461|FG000|Overall Study|Lack of Efficacy|3|||
125960147|NCT02343458|453147462|FG001|Overall Study|Lack of Efficacy|8|||
125960148|NCT02343458|453147463|FG002|Overall Study|Lack of Efficacy|4|||
125960149|NCT02343458|453147464|FG003|Overall Study|Lack of Efficacy|8|||
125960150|NCT02343458|453147461|FG000|Overall Study|Withdrawal by Subject|18|||
125960151|NCT02343458|453147462|FG001|Overall Study|Withdrawal by Subject|17|||
125960152|NCT02343458|453147463|FG002|Overall Study|Withdrawal by Subject|23|||
125960153|NCT02343458|453147464|FG003|Overall Study|Withdrawal by Subject|14|||
125960154|NCT02343458|453147461|FG000|Overall Study|Physician Decision|1|||
125960155|NCT02343458|453147462|FG001|Overall Study|Physician Decision|4|||
125960156|NCT02343458|453147463|FG002|Overall Study|Physician Decision|2|||
125960157|NCT02343458|453147464|FG003|Overall Study|Physician Decision|2|||
125960158|NCT02343458|453147461|FG000|Overall Study|Lost to Follow-up|5|||
125960159|NCT02343458|453147462|FG001|Overall Study|Lost to Follow-up|5|||
125960160|NCT02343458|453147463|FG002|Overall Study|Lost to Follow-up|3|||
125960161|NCT02343458|453147464|FG003|Overall Study|Lost to Follow-up|1|||
125960162|NCT02343458|453147461|FG000|Overall Study|Protocol Violation|2|||
125960163|NCT02343458|453147462|FG001|Overall Study|Protocol Violation|5|||
125960164|NCT02343458|453147463|FG002|Overall Study|Protocol Violation|2|||
125960165|NCT02343458|453147464|FG003|Overall Study|Protocol Violation|2|||
125960166|NCT02343458|453147461|FG000|Overall Study|Protocol Specified Criteria|17|||
125960167|NCT02343458|453147462|FG001|Overall Study|Protocol Specified Criteria|13|||
125960168|NCT02343458|453147463|FG002|Overall Study|Protocol Specified Criteria|14|||
125960169|NCT02343458|453147464|FG003|Overall Study|Protocol Specified Criteria|8|||
125960170|NCT02080091|453147465|FG000|Overall Study|Study Terminated|22|||
125960171|NCT02080091|453147465|FG000|Overall Study|Death|1|||
125960172|NCT02080091|453147465|FG000|Overall Study|Withdrawal by Subject|1|||
125960173|NCT02080091|453147465|FG000|Overall Study|Other|1|||
125960174|NCT01913041|453147466|FG000|Overall Study|Protocol Violation|35|||
125960175|NCT01913041|453147466|FG000|Overall Study|Withdrawal by Subject|3|||
125960176|NCT01913041|453147466|FG000|Overall Study|Physician Decision|1|||
125960177|NCT01265953|453147468|FG000|Overall Study|Non compliance|5|||
125960178|NCT01265953|453147469|FG001|Overall Study|Non compliance|3|||
125960179|NCT01610700|453147470|FG000|Overall Study|Adverse Event|3|||
125960180|NCT01610700|453147471|FG001|Overall Study|Adverse Event|1|||
125960181|NCT01610700|453147470|FG000|Overall Study|Withdrawal by Subject|0|||
125960182|NCT01610700|453147471|FG001|Overall Study|Withdrawal by Subject|1|||
125960183|NCT01610700|453147470|FG000|Overall Study|subject took one dose of street cannabis|0|||
125960184|NCT01610700|453147471|FG001|Overall Study|subject took one dose of street cannabis|1|||
125960185|NCT02648698|453147472|FG000|Overall Study|Protocol Violation|1|||
125960186|NCT02648698|453147473|FG001|Overall Study|Protocol Violation|5|||
125960187|NCT01640301|453147474|FG000|Overall Study|Death|0|||
125960188|NCT01640301|453147475|FG001|Overall Study|Death|8|||
125960189|NCT03143829|453147476|FG000|Overall Study|Withdrawal by Subject|2|||
125960190|NCT03143829|453147477|FG001|Overall Study|Withdrawal by Subject|5|||
125960191|NCT03143829|453147476|FG000|Overall Study|Lost to Follow-up|0|||
125960192|NCT03143829|453147477|FG001|Overall Study|Lost to Follow-up|2|||
125960193|NCT03143829|453147476|FG000|Overall Study|Death|1|||
125960194|NCT03143829|453147477|FG001|Overall Study|Death|1|||
125960195|NCT03143829|453147476|FG000|Overall Study|changed treatment, no longer eligible|2|||
125960196|NCT03143829|453147477|FG001|Overall Study|changed treatment, no longer eligible|2|||
125960197|NCT00672477|453147480|FG000|Overall Study|Adverse Event|10|||
125960198|NCT00672477|453147481|FG001|Overall Study|Adverse Event|7|||
125960199|NCT00672477|453147480|FG000|Overall Study|Death|7|||
125960200|NCT00672477|453147481|FG001|Overall Study|Death|11|||
125960201|NCT00672477|453147480|FG000|Overall Study|Physician Decision|2|||
125960202|NCT00672477|453147481|FG001|Overall Study|Physician Decision|0|||
125960203|NCT00672477|453147480|FG000|Overall Study|Protocol Violation|1|||
125960204|NCT00672477|453147481|FG001|Overall Study|Protocol Violation|1|||
125960205|NCT00672477|453147480|FG000|Overall Study|Withdrawal by Subject|5|||
125960206|NCT00672477|453147481|FG001|Overall Study|Withdrawal by Subject|3|||
125960207|NCT00672477|453147480|FG000|Overall Study|Lack of Efficacy|1|||
125960208|NCT00672477|453147481|FG001|Overall Study|Lack of Efficacy|1|||
125960209|NCT00672477|453147480|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
125960210|NCT00672477|453147481|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
125960211|NCT02886572|453147485|FG000|Overall Study|Death|8|||
125960212|NCT00274716|453147490|FG000|Phase A|Other non-reported reason|4|||
125960213|NCT00274716|453147491|FG001|Phase A|Other non-reported reason|2|||
125960214|NCT00274716|453147492|FG002|Phase A|Other non-reported reason|1|||
125960215|NCT00274716|453147493|FG003|Phase A|Other non-reported reason|2|||
125960216|NCT00274716|453147494|FG004|Phase A|Other non-reported reason|0|||
125960217|NCT00274716|453147495|FG005|Phase A|Other non-reported reason|1|||
125960218|NCT00274716|453147490|FG000|Phase A|Participant moved|0|||
125960219|NCT00274716|453147491|FG001|Phase A|Participant moved|0|||
125960220|NCT00274716|453147492|FG002|Phase A|Participant moved|1|||
125960221|NCT00274716|453147493|FG003|Phase A|Participant moved|0|||
125960222|NCT00274716|453147494|FG004|Phase A|Participant moved|0|||
126087259|NCT05000216|453612968|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125960223|NCT00274716|453147495|FG005|Phase A|Participant moved|1|||
125960224|NCT00274716|453147490|FG000|Phase A|Site Terminated|0|||
125960225|NCT00274716|453147491|FG001|Phase A|Site Terminated|0|||
125960226|NCT00274716|453147492|FG002|Phase A|Site Terminated|0|||
125960227|NCT00274716|453147493|FG003|Phase A|Site Terminated|1|||
125960228|NCT00274716|453147494|FG004|Phase A|Site Terminated|0|||
125960229|NCT00274716|453147495|FG005|Phase A|Site Terminated|0|||
125960230|NCT00274716|453147490|FG000|Phase A|Protocol Violation|1|||
125960231|NCT00274716|453147491|FG001|Phase A|Protocol Violation|0|||
125960232|NCT00274716|453147492|FG002|Phase A|Protocol Violation|0|||
125960233|NCT00274716|453147493|FG003|Phase A|Protocol Violation|1|||
125960234|NCT00274716|453147494|FG004|Phase A|Protocol Violation|0|||
125960235|NCT00274716|453147495|FG005|Phase A|Protocol Violation|0|||
125960236|NCT00274716|453147490|FG000|Phase A|Met criteria for discontinuation|1|||
125960237|NCT00274716|453147491|FG001|Phase A|Met criteria for discontinuation|1|||
125960238|NCT00274716|453147492|FG002|Phase A|Met criteria for discontinuation|0|||
125960239|NCT00274716|453147493|FG003|Phase A|Met criteria for discontinuation|0|||
125960240|NCT00274716|453147494|FG004|Phase A|Met criteria for discontinuation|0|||
125960241|NCT00274716|453147495|FG005|Phase A|Met criteria for discontinuation|0|||
125960242|NCT00274716|453147490|FG000|Phase A|Withdrawal by Subject|2|||
125960243|NCT00274716|453147491|FG001|Phase A|Withdrawal by Subject|2|||
125960244|NCT00274716|453147492|FG002|Phase A|Withdrawal by Subject|1|||
125960245|NCT00274716|453147493|FG003|Phase A|Withdrawal by Subject|3|||
125960246|NCT00274716|453147494|FG004|Phase A|Withdrawal by Subject|0|||
125960247|NCT00274716|453147495|FG005|Phase A|Withdrawal by Subject|1|||
125960248|NCT00274716|453147490|FG000|Phase A|Adverse Event|2|||
125960249|NCT00274716|453147491|FG001|Phase A|Adverse Event|3|||
125960250|NCT00274716|453147492|FG002|Phase A|Adverse Event|3|||
125960251|NCT00274716|453147493|FG003|Phase A|Adverse Event|0|||
125960252|NCT00274716|453147494|FG004|Phase A|Adverse Event|2|||
125960253|NCT00274716|453147495|FG005|Phase A|Adverse Event|0|||
125960254|NCT00274716|453147490|FG000|Phase A|Completed but did not enter Phase B|1|||
125960255|NCT00274716|453147491|FG001|Phase A|Completed but did not enter Phase B|2|||
125960256|NCT00274716|453147492|FG002|Phase A|Completed but did not enter Phase B|2|||
125960257|NCT00274716|453147493|FG003|Phase A|Completed but did not enter Phase B|2|||
125960258|NCT00274716|453147494|FG004|Phase A|Completed but did not enter Phase B|1|||
125960259|NCT00274716|453147495|FG005|Phase A|Completed but did not enter Phase B|1|||
125960260|NCT00274716|453147490|FG000|Phase B|Adverse Event|0|||
125960261|NCT00274716|453147491|FG001|Phase B|Adverse Event|0|||
125960262|NCT00274716|453147492|FG002|Phase B|Adverse Event|2|||
125960263|NCT00274716|453147493|FG003|Phase B|Adverse Event|0|||
125960264|NCT00274716|453147494|FG004|Phase B|Adverse Event|0|||
125960265|NCT00274716|453147495|FG005|Phase B|Adverse Event|1|||
125960266|NCT00274716|453147490|FG000|Phase B|Protocol Violation|0|||
125960267|NCT00274716|453147491|FG001|Phase B|Protocol Violation|2|||
125960268|NCT00274716|453147492|FG002|Phase B|Protocol Violation|0|||
125960269|NCT00274716|453147493|FG003|Phase B|Protocol Violation|0|||
125960270|NCT00274716|453147494|FG004|Phase B|Protocol Violation|0|||
125960271|NCT00274716|453147495|FG005|Phase B|Protocol Violation|0|||
125960272|NCT00274716|453147490|FG000|Phase B|Withdrawal by Subject|0|||
125960273|NCT00274716|453147491|FG001|Phase B|Withdrawal by Subject|1|||
125960274|NCT00274716|453147492|FG002|Phase B|Withdrawal by Subject|0|||
125960275|NCT00274716|453147493|FG003|Phase B|Withdrawal by Subject|0|||
125960276|NCT00274716|453147494|FG004|Phase B|Withdrawal by Subject|0|||
125960277|NCT00274716|453147495|FG005|Phase B|Withdrawal by Subject|0|||
125960278|NCT00274716|453147490|FG000|Phase B|Participant moved|1|||
125960279|NCT00274716|453147491|FG001|Phase B|Participant moved|0|||
125960280|NCT00274716|453147492|FG002|Phase B|Participant moved|0|||
125960281|NCT00274716|453147493|FG003|Phase B|Participant moved|0|||
125960282|NCT00274716|453147494|FG004|Phase B|Participant moved|0|||
125960283|NCT00274716|453147495|FG005|Phase B|Participant moved|0|||
125960284|NCT00274716|453147490|FG000|Phase B|Other non-reported reason|0|||
125960285|NCT00274716|453147491|FG001|Phase B|Other non-reported reason|0|||
125960286|NCT00274716|453147492|FG002|Phase B|Other non-reported reason|1|||
125960287|NCT00274716|453147493|FG003|Phase B|Other non-reported reason|1|||
125960288|NCT00274716|453147494|FG004|Phase B|Other non-reported reason|0|||
125960289|NCT00274716|453147495|FG005|Phase B|Other non-reported reason|0|||
125960290|NCT00274716|453147490|FG000|Phase B|Lost to Follow-up|0|||
125960291|NCT00274716|453147491|FG001|Phase B|Lost to Follow-up|1|||
125960292|NCT00274716|453147492|FG002|Phase B|Lost to Follow-up|0|||
125960293|NCT00274716|453147493|FG003|Phase B|Lost to Follow-up|0|||
125960294|NCT00274716|453147494|FG004|Phase B|Lost to Follow-up|0|||
125960295|NCT00274716|453147495|FG005|Phase B|Lost to Follow-up|0|||
125960296|NCT00982319|453147498|FG000|Overall Study|Surgery date change|1|||
126087260|NCT05000216|453612969|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125960297|NCT00982319|453147499|FG001|Overall Study|Surgery date change|0|||
125960298|NCT00982319|453147498|FG000|Overall Study|Preop values out of acceptable range|1|||
125960299|NCT00982319|453147499|FG001|Overall Study|Preop values out of acceptable range|1|||
125960300|NCT00982319|453147498|FG000|Overall Study|Pregnancy|0|||
125960301|NCT00982319|453147499|FG001|Overall Study|Pregnancy|1|||
125960302|NCT00975975|453147500|FG000|Overall Study|Death|6|||
125960303|NCT00961259|453147501|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
125960304|NCT00961259|453147502|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
125960305|NCT00961259|453147503|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
125960306|NCT01252251|453147506|FG000|Overall Study|Withdrawal by Subject|1|||
125960307|NCT01324024|453147507|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
125960308|NCT01324024|453147508|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125960309|NCT01923181|453147509|FG000|Overall Study|Protocol Violation|2|||
125960310|NCT01923181|453147510|FG001|Overall Study|Protocol Violation|2|||
125960311|NCT01923181|453147511|FG002|Overall Study|Protocol Violation|0|||
125960312|NCT01923181|453147512|FG003|Overall Study|Protocol Violation|2|||
125960313|NCT01923181|453147513|FG004|Overall Study|Protocol Violation|2|||
125960314|NCT01923181|453147514|FG005|Overall Study|Protocol Violation|1|||
125960315|NCT01923181|453147515|FG006|Overall Study|Protocol Violation|1|||
125960316|NCT01923181|453147516|FG007|Overall Study|Protocol Violation|2|||
125960317|NCT01923181|453147517|FG008|Overall Study|Protocol Violation|1|||
125960318|NCT01923181|453147509|FG000|Overall Study|Withdrawal by Subject|0|||
125960319|NCT01923181|453147510|FG001|Overall Study|Withdrawal by Subject|1|||
125960320|NCT01923181|453147511|FG002|Overall Study|Withdrawal by Subject|0|||
125960321|NCT01923181|453147512|FG003|Overall Study|Withdrawal by Subject|1|||
125960322|NCT01923181|453147513|FG004|Overall Study|Withdrawal by Subject|4|||
125960323|NCT01923181|453147514|FG005|Overall Study|Withdrawal by Subject|2|||
125960324|NCT01923181|453147515|FG006|Overall Study|Withdrawal by Subject|4|||
125960325|NCT01923181|453147516|FG007|Overall Study|Withdrawal by Subject|3|||
125960326|NCT01923181|453147517|FG008|Overall Study|Withdrawal by Subject|1|||
125960327|NCT01923181|453147509|FG000|Overall Study|Other|1|||
125960328|NCT01923181|453147510|FG001|Overall Study|Other|0|||
125960329|NCT01923181|453147511|FG002|Overall Study|Other|0|||
125960330|NCT01923181|453147512|FG003|Overall Study|Other|1|||
125960331|NCT01923181|453147513|FG004|Overall Study|Other|0|||
125960332|NCT01923181|453147514|FG005|Overall Study|Other|0|||
125960333|NCT01923181|453147515|FG006|Overall Study|Other|0|||
125960334|NCT01923181|453147516|FG007|Overall Study|Other|0|||
125960335|NCT01923181|453147517|FG008|Overall Study|Other|0|||
125960336|NCT01923181|453147509|FG000|Overall Study|Lost to Follow-up|0|||
125960337|NCT01923181|453147510|FG001|Overall Study|Lost to Follow-up|3|||
125960338|NCT01923181|453147511|FG002|Overall Study|Lost to Follow-up|2|||
125960339|NCT01923181|453147512|FG003|Overall Study|Lost to Follow-up|1|||
125960340|NCT01923181|453147513|FG004|Overall Study|Lost to Follow-up|2|||
125960341|NCT01923181|453147514|FG005|Overall Study|Lost to Follow-up|1|||
125960342|NCT01923181|453147515|FG006|Overall Study|Lost to Follow-up|3|||
125960343|NCT01923181|453147516|FG007|Overall Study|Lost to Follow-up|3|||
125960344|NCT01923181|453147517|FG008|Overall Study|Lost to Follow-up|1|||
125960345|NCT03698773|453147523|FG000|Overall Study|Lost to Follow-up|2|||
125960346|NCT03698773|453147524|FG001|Overall Study|Lost to Follow-up|1|||
125960347|NCT02822794|453147525|FG000|Overall Study|Withdrew Consent|1|||
125960348|NCT02822794|453147526|FG001|Overall Study|Withdrew Consent|0|||
125960349|NCT01243944|453147532|FG000|Overall Study|Adverse Event|15|||
125960350|NCT01243944|453147533|FG001|Overall Study|Adverse Event|13|||
125960351|NCT01243944|453147532|FG000|Overall Study|Lost to Follow-up|2|||
125960352|NCT01243944|453147533|FG001|Overall Study|Lost to Follow-up|1|||
125960353|NCT01243944|453147532|FG000|Overall Study|Physician Decision|2|||
125960354|NCT01243944|453147533|FG001|Overall Study|Physician Decision|7|||
125960355|NCT01243944|453147532|FG000|Overall Study|Disease progression|12|||
125960356|NCT01243944|453147533|FG001|Overall Study|Disease progression|11|||
125960357|NCT01243944|453147532|FG000|Overall Study|Protocol deviation|1|||
125960358|NCT01243944|453147533|FG001|Overall Study|Protocol deviation|1|||
125960359|NCT01243944|453147532|FG000|Overall Study|Participant decision|10|||
125960360|NCT01243944|453147533|FG001|Overall Study|Participant decision|15|||
125960361|NCT01243944|453147532|FG000|Overall Study|Death|2|||
125960362|NCT01243944|453147533|FG001|Overall Study|Death|3|||
125960363|NCT01243944|453147532|FG000|Overall Study|Non-compliance with study treatment|1|||
125960364|NCT01243944|453147533|FG001|Overall Study|Non-compliance with study treatment|0|||
125960365|NCT01416805|453147534|FG000|Overall Study|Lost to Follow-up|4|||
125960366|NCT01416805|453147535|FG001|Overall Study|Lost to Follow-up|4|||
125960367|NCT04632940|453147536|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
125960368|NCT04632940|453147537|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
125960369|NCT04632940|453147536|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
125960370|NCT04632940|453147537|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
126117227|NCT00555477|453723817|FG001|Overall Study|Withdrawal by Subject|2|||
126117228|NCT00555477|453723816|FG000|Overall Study|Physician Decision|1|||
126117229|NCT00555477|453723817|FG001|Overall Study|Physician Decision|2|||
125960371|NCT04632940|453147536|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
126117230|NCT00545402|453723818|FG000|Overall Study|Discontinuation of treatment|17|||
126117231|NCT00545402|453723819|FG001|Overall Study|Discontinuation of treatment|9|||
126117232|NCT00545402|453723818|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
125960372|NCT04632940|453147537|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
125960373|NCT04632940|453147536|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
125960374|NCT04632940|453147537|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
125960375|NCT04632940|453147536|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
125960376|NCT04632940|453147537|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
125960377|NCT04632940|453147536|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
125960378|NCT04632940|453147537|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
126117233|NCT00545402|453723819|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
125960379|NCT04632940|453147536|FG000|OLE Period (52 Weeks)|Other than specified|0|||
125960380|NCT04632940|453147537|FG001|OLE Period (52 Weeks)|Other than specified|1|||
125960381|NCT04632940|453147536|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
125960382|NCT04632940|453147537|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
125960383|NCT02799082|453147538|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
125960384|NCT02799082|453147539|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
125960385|NCT02799082|453147538|FG000|Overall Study|Protocol Violation|0|||
125960386|NCT02799082|453147539|FG001|Overall Study|Protocol Violation|1|||
125960387|NCT03251924|453147542|FG000|Overall Study|Disease Progression|6|||
125960388|NCT03251924|453147543|FG001|Overall Study|Disease Progression|6|||
125960389|NCT03251924|453147544|FG002|Overall Study|Disease Progression|7|||
125960390|NCT03251924|453147545|FG003|Overall Study|Disease Progression|8|||
125960391|NCT03251924|453147546|FG004|Overall Study|Disease Progression|8|||
125960392|NCT03251924|453147547|FG005|Overall Study|Disease Progression|7|||
125960393|NCT03251924|453147548|FG006|Overall Study|Disease Progression|6|||
125960394|NCT03251924|453147549|FG007|Overall Study|Disease Progression|10|||
125960395|NCT03251924|453147550|FG008|Overall Study|Disease Progression|6|||
125960396|NCT03251924|453147542|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
125960397|NCT03251924|453147543|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
125960398|NCT03251924|453147544|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
125960399|NCT03251924|453147545|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
125960400|NCT03251924|453147546|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
125960401|NCT03251924|453147547|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
125960402|NCT03251924|453147548|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
125960403|NCT03251924|453147549|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
125960404|NCT03251924|453147550|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
125960405|NCT03251924|453147542|FG000|Overall Study|Death|0|||
125960406|NCT03251924|453147543|FG001|Overall Study|Death|1|||
125960407|NCT03251924|453147544|FG002|Overall Study|Death|0|||
125960408|NCT03251924|453147545|FG003|Overall Study|Death|1|||
125960409|NCT03251924|453147546|FG004|Overall Study|Death|1|||
125960410|NCT03251924|453147547|FG005|Overall Study|Death|1|||
125960411|NCT03251924|453147548|FG006|Overall Study|Death|0|||
125960412|NCT03251924|453147549|FG007|Overall Study|Death|0|||
125960413|NCT03251924|453147550|FG008|Overall Study|Death|0|||
125960414|NCT03251924|453147542|FG000|Overall Study|Study Drug Toxicity|0|||
126087261|NCT05000216|453612970|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087262|NCT05000216|453612971|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126087263|NCT05000216|453612950|FG000|Stage 1|Other|0|||
126087264|NCT05000216|453612951|FG001|Stage 1|Other|0|||
126087265|NCT05000216|453612952|FG002|Stage 1|Other|0|||
126087266|NCT05000216|453612953|FG003|Stage 1|Other|0|||
126087267|NCT05000216|453612954|FG004|Stage 1|Other|1|||
126087268|NCT05000216|453612955|FG005|Stage 1|Other|0|||
126087269|NCT05000216|453612956|FG006|Stage 1|Other|0|||
126087270|NCT05000216|453612957|FG007|Stage 1|Other|2|||
126087271|NCT05000216|453612958|FG008|Stage 1|Other|0|||
126087272|NCT05000216|453612959|FG009|Stage 1|Other|0|||
126087273|NCT05000216|453612960|FG010|Stage 1|Other|1|||
126087274|NCT05000216|453612961|FG011|Stage 1|Other|1|||
126087275|NCT05000216|453612962|FG012|Stage 1|Other|0|||
126087276|NCT05000216|453612963|FG013|Stage 1|Other|0|||
126087277|NCT05000216|453612964|FG014|Stage 1|Other|0|||
126087278|NCT05000216|453612965|FG015|Stage 1|Other|0|||
126087279|NCT05000216|453612966|FG016|Stage 1|Other|0|||
126087280|NCT05000216|453612967|FG017|Stage 1|Other|0|||
126087281|NCT05000216|453612968|FG018|Stage 1|Other|0|||
126087282|NCT05000216|453612969|FG019|Stage 1|Other|0|||
126087283|NCT05000216|453612970|FG020|Stage 1|Other|0|||
126087284|NCT05000216|453612971|FG021|Stage 1|Other|0|||
126087285|NCT05000216|453612950|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
126087286|NCT05000216|453612951|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
126087287|NCT05000216|453612952|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
126087288|NCT05000216|453612953|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
126087289|NCT05000216|453612954|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
126087290|NCT05000216|453612955|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
126087291|NCT05000216|453612956|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
126087292|NCT05000216|453612957|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
126087293|NCT05000216|453612958|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
126087294|NCT05000216|453612959|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
126087295|NCT05000216|453612960|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
126087296|NCT05000216|453612961|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
126087297|NCT05000216|453612962|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
125960415|NCT03251924|453147543|FG001|Overall Study|Study Drug Toxicity|0|||
126087298|NCT05000216|453612963|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
126087299|NCT05000216|453612964|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
125960416|NCT03251924|453147544|FG002|Overall Study|Study Drug Toxicity|0|||
125960417|NCT03251924|453147545|FG003|Overall Study|Study Drug Toxicity|1|||
125960418|NCT03251924|453147546|FG004|Overall Study|Study Drug Toxicity|0|||
125960419|NCT03251924|453147547|FG005|Overall Study|Study Drug Toxicity|0|||
125960420|NCT03251924|453147548|FG006|Overall Study|Study Drug Toxicity|0|||
125960421|NCT03251924|453147549|FG007|Overall Study|Study Drug Toxicity|0|||
125960422|NCT03251924|453147550|FG008|Overall Study|Study Drug Toxicity|1|||
126087300|NCT05000216|453612965|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
126087301|NCT05000216|453612966|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
126087302|NCT05000216|453612967|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
126087303|NCT05000216|453612968|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
125960423|NCT03251924|453147542|FG000|Overall Study|Other Reasons|0|||
125960424|NCT03251924|453147543|FG001|Overall Study|Other Reasons|0|||
125960425|NCT03251924|453147544|FG002|Overall Study|Other Reasons|0|||
125960426|NCT03251924|453147545|FG003|Overall Study|Other Reasons|0|||
125960427|NCT03251924|453147546|FG004|Overall Study|Other Reasons|0|||
125960428|NCT03251924|453147547|FG005|Overall Study|Other Reasons|0|||
125960429|NCT03251924|453147548|FG006|Overall Study|Other Reasons|0|||
125960430|NCT03251924|453147549|FG007|Overall Study|Other Reasons|0|||
125960431|NCT03251924|453147550|FG008|Overall Study|Other Reasons|1|||
125960432|NCT03251924|453147542|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125960433|NCT03251924|453147543|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125960434|NCT03251924|453147544|FG002|Overall Study|Participant request to discontinue study treatment|0|||
125960435|NCT03251924|453147545|FG003|Overall Study|Participant request to discontinue study treatment|0|||
125960436|NCT03251924|453147546|FG004|Overall Study|Participant request to discontinue study treatment|0|||
125960437|NCT03251924|453147547|FG005|Overall Study|Participant request to discontinue study treatment|0|||
125960438|NCT03251924|453147548|FG006|Overall Study|Participant request to discontinue study treatment|0|||
125960439|NCT03251924|453147549|FG007|Overall Study|Participant request to discontinue study treatment|1|||
125960440|NCT03251924|453147550|FG008|Overall Study|Participant request to discontinue study treatment|0|||
125960441|NCT02617589|453147551|FG000|Randomization|Request to Discontinue Study Treatment|1|||
125960442|NCT02617589|453147552|FG001|Randomization|Request to Discontinue Study Treatment|3|||
125960443|NCT02617589|453147551|FG000|Randomization|Participant Withdrew Consent|1|||
125960444|NCT02617589|453147552|FG001|Randomization|Participant Withdrew Consent|2|||
125960445|NCT02617589|453147551|FG000|Treatment|Other Reasons|3|||
125960446|NCT02617589|453147552|FG001|Treatment|Other Reasons|3|||
125960447|NCT02617589|453147551|FG000|Treatment|Poor/Non Compliance|1|||
125960448|NCT02617589|453147552|FG001|Treatment|Poor/Non Compliance|1|||
125960449|NCT02617589|453147551|FG000|Treatment|Maximum Clinical Benefit|0|||
125960450|NCT02617589|453147552|FG001|Treatment|Maximum Clinical Benefit|2|||
125960451|NCT02617589|453147551|FG000|Treatment|Participant Withdrew Consent|2|||
125960452|NCT02617589|453147552|FG001|Treatment|Participant Withdrew Consent|6|||
125960453|NCT02617589|453147551|FG000|Treatment|Participant Request to Discontinue|12|||
125960454|NCT02617589|453147552|FG001|Treatment|Participant Request to Discontinue|21|||
125960455|NCT02617589|453147551|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
125960456|NCT02617589|453147552|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
125960457|NCT02617589|453147551|FG000|Treatment|Death|1|||
125960458|NCT02617589|453147552|FG001|Treatment|Death|1|||
125960459|NCT02617589|453147551|FG000|Treatment|Study Drug Toxicity|27|||
125960460|NCT02617589|453147552|FG001|Treatment|Study Drug Toxicity|20|||
125960461|NCT02617589|453147551|FG000|Treatment|Disease Progression|216|||
125960462|NCT02617589|453147552|FG001|Treatment|Disease Progression|136|||
125960463|NCT01591681|453147553|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
125960464|NCT01591681|453147553|FG000|Overall Study|Failed to use system during run-in|1|||
125960465|NCT00179647|453147558|FG000|Overall Study|Adverse Event|294|||
125960466|NCT00179647|453147558|FG000|Overall Study|Lack of Efficacy|478|||
125960467|NCT00179647|453147558|FG000|Overall Study|Withdrawal by Subject|83|||
125960468|NCT00179647|453147558|FG000|Overall Study|Lost to Follow-up|4|||
125960469|NCT00179647|453147558|FG000|Overall Study|Death|94|||
125960470|NCT00179647|453147558|FG000|Overall Study|Other|960|||
125960471|NCT00835406|453147559|FG000|Period: First Intervention|Adverse Event|0|||
125960472|NCT00835406|453147560|FG001|Period: First Intervention|Adverse Event|1|||
125960473|NCT00835406|453147559|FG000|Period: First Intervention|Withdrawal by Subject|2|||
125960474|NCT00835406|453147560|FG001|Period: First Intervention|Withdrawal by Subject|0|||
125960475|NCT00835406|453147559|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
125960476|NCT00835406|453147560|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
125960477|NCT02138214|453147561|FG000|Overall Study|Withdrawal by Subject|0|||
125960478|NCT02138214|453147562|FG001|Overall Study|Withdrawal by Subject|1|||
125960479|NCT02138214|453147563|FG002|Overall Study|Withdrawal by Subject|0|||
125960480|NCT02138214|453147561|FG000|Overall Study|Lost to Follow-up|0|||
125960481|NCT02138214|453147562|FG001|Overall Study|Lost to Follow-up|2|||
125960482|NCT02138214|453147563|FG002|Overall Study|Lost to Follow-up|4|||
125960483|NCT02138214|453147561|FG000|Overall Study|Screen Failure|0|||
125960484|NCT02138214|453147562|FG001|Overall Study|Screen Failure|1|||
126087304|NCT05000216|453612969|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
126087305|NCT05000216|453612970|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
126087306|NCT05000216|453612971|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
126087307|NCT05000216|453612950|FG000|Stage 2|Lost to Follow-up|0|||
126087308|NCT05000216|453612951|FG001|Stage 2|Lost to Follow-up|0|||
126087309|NCT05000216|453612952|FG002|Stage 2|Lost to Follow-up|0|||
126087310|NCT05000216|453612953|FG003|Stage 2|Lost to Follow-up|0|||
126087311|NCT05000216|453612954|FG004|Stage 2|Lost to Follow-up|0|||
126087312|NCT05000216|453612955|FG005|Stage 2|Lost to Follow-up|0|||
125960485|NCT02138214|453147563|FG002|Overall Study|Screen Failure|0|||
125960486|NCT03027466|453147566|FG000|Overall Study|Opting out of the app|1869|||
125960487|NCT03027466|453147567|FG001|Overall Study|Opting out of the app|1819|||
125960488|NCT03027466|453147568|FG002|Overall Study|Opting out of the app|1743|||
126087313|NCT05000216|453612956|FG006|Stage 2|Lost to Follow-up|0|||
126087314|NCT05000216|453612957|FG007|Stage 2|Lost to Follow-up|0|||
126087315|NCT05000216|453612958|FG008|Stage 2|Lost to Follow-up|0|||
126087316|NCT05000216|453612959|FG009|Stage 2|Lost to Follow-up|0|||
126087317|NCT05000216|453612960|FG010|Stage 2|Lost to Follow-up|0|||
126087318|NCT05000216|453612961|FG011|Stage 2|Lost to Follow-up|0|||
126087319|NCT05000216|453612962|FG012|Stage 2|Lost to Follow-up|0|||
126087320|NCT05000216|453612963|FG013|Stage 2|Lost to Follow-up|0|||
126087321|NCT05000216|453612964|FG014|Stage 2|Lost to Follow-up|0|||
126087322|NCT05000216|453612965|FG015|Stage 2|Lost to Follow-up|0|||
126087323|NCT05000216|453612966|FG016|Stage 2|Lost to Follow-up|4|||
126087324|NCT05000216|453612967|FG017|Stage 2|Lost to Follow-up|0|||
126087325|NCT05000216|453612968|FG018|Stage 2|Lost to Follow-up|0|||
126087326|NCT05000216|453612969|FG019|Stage 2|Lost to Follow-up|0|||
126087327|NCT05000216|453612970|FG020|Stage 2|Lost to Follow-up|0|||
126087328|NCT05000216|453612971|FG021|Stage 2|Lost to Follow-up|0|||
126087329|NCT05000216|453612950|FG000|Stage 2|Physician Decision|0|||
126087330|NCT05000216|453612951|FG001|Stage 2|Physician Decision|0|||
126087331|NCT05000216|453612952|FG002|Stage 2|Physician Decision|0|||
126087332|NCT05000216|453612953|FG003|Stage 2|Physician Decision|0|||
126087333|NCT05000216|453612954|FG004|Stage 2|Physician Decision|0|||
126087334|NCT05000216|453612955|FG005|Stage 2|Physician Decision|0|||
126087335|NCT05000216|453612956|FG006|Stage 2|Physician Decision|0|||
126117234|NCT00545402|453723818|FG000|Overall Study|Death|5|||
126117235|NCT00545402|453723819|FG001|Overall Study|Death|7|||
126117236|NCT00545402|453723818|FG000|Overall Study|Graft loss|2|||
126117237|NCT00545402|453723819|FG001|Overall Study|Graft loss|4|||
126117238|NCT00545402|453723818|FG000|Overall Study|Withdrawal by Subject|0|||
126117239|NCT00545402|453723819|FG001|Overall Study|Withdrawal by Subject|1|||
126117240|NCT00545402|453723818|FG000|Overall Study|Protocol Violation|1|||
126117241|NCT00545402|453723819|FG001|Overall Study|Protocol Violation|0|||
126117242|NCT00545402|453723818|FG000|Overall Study|Reason not specified|1|||
126117243|NCT00545402|453723819|FG001|Overall Study|Reason not specified|1|||
126117244|NCT01721876|453723820|FG000|Overall Study|Not treated|1|||
126117245|NCT01721876|453723821|FG001|Overall Study|Not treated|4|||
126117246|NCT01721876|453723820|FG000|Overall Study|Disease progression / relapse|123|||
126117247|NCT01721876|453723821|FG001|Overall Study|Disease progression / relapse|156|||
126117248|NCT01721876|453723820|FG000|Overall Study|Death|6|||
126117249|NCT01721876|453723821|FG001|Overall Study|Death|13|||
126117250|NCT01721876|453723820|FG000|Overall Study|Adverse Event|41|||
126117251|NCT01721876|453723821|FG001|Overall Study|Adverse Event|165|||
126117252|NCT01721876|453723820|FG000|Overall Study|Protocol Violation|2|||
126117253|NCT01721876|453723821|FG001|Overall Study|Protocol Violation|1|||
126117254|NCT01721876|453723820|FG000|Overall Study|Withdrawal by Subject|15|||
126117255|NCT01721876|453723821|FG001|Overall Study|Withdrawal by Subject|38|||
126117256|NCT01721876|453723820|FG000|Overall Study|Reason not listed|34|||
126117257|NCT01721876|453723821|FG001|Overall Study|Reason not listed|63|||
126117258|NCT01721876|453723820|FG000|Overall Study|Sponsor terminated trial|0|||
126117259|NCT01721876|453723821|FG001|Overall Study|Sponsor terminated trial|4|||
126117260|NCT01721057|453723824|FG000|Treatment Period|Withdrawal by Subject|11|||
126117261|NCT01721057|453723825|FG001|Treatment Period|Withdrawal by Subject|5|||
126117262|NCT01721057|453723826|FG002|Treatment Period|Withdrawal by Subject|8|||
126117263|NCT01721057|453723827|FG003|Treatment Period|Withdrawal by Subject|0|||
126117264|NCT01721057|453723828|FG004|Treatment Period|Withdrawal by Subject|0|||
126117265|NCT01721057|453723829|FG005|Treatment Period|Withdrawal by Subject|0|||
126117266|NCT01721057|453723830|FG006|Treatment Period|Withdrawal by Subject|0|||
126117267|NCT01721057|453723824|FG000|Treatment Period|Adverse Event|7|||
126117268|NCT01721057|453723825|FG001|Treatment Period|Adverse Event|10|||
126117269|NCT01721057|453723826|FG002|Treatment Period|Adverse Event|12|||
126117270|NCT01721057|453723827|FG003|Treatment Period|Adverse Event|0|||
126117271|NCT01721057|453723828|FG004|Treatment Period|Adverse Event|0|||
126117272|NCT01721057|453723829|FG005|Treatment Period|Adverse Event|0|||
126117273|NCT01721057|453723830|FG006|Treatment Period|Adverse Event|0|||
126117274|NCT01721057|453723824|FG000|Treatment Period|Lack of Efficacy|7|||
126117275|NCT01721057|453723825|FG001|Treatment Period|Lack of Efficacy|3|||
126087336|NCT05000216|453612957|FG007|Stage 2|Physician Decision|0|||
126117276|NCT01721057|453723826|FG002|Treatment Period|Lack of Efficacy|0|||
126117277|NCT01721057|453723827|FG003|Treatment Period|Lack of Efficacy|0|||
126117278|NCT01721057|453723828|FG004|Treatment Period|Lack of Efficacy|0|||
126117279|NCT01721057|453723829|FG005|Treatment Period|Lack of Efficacy|0|||
126117280|NCT01721057|453723830|FG006|Treatment Period|Lack of Efficacy|0|||
126087337|NCT05000216|453612958|FG008|Stage 2|Physician Decision|0|||
126087338|NCT05000216|453612959|FG009|Stage 2|Physician Decision|0|||
126117281|NCT01721057|453723824|FG000|Treatment Period|Lost to Follow-up|1|||
126117282|NCT01721057|453723825|FG001|Treatment Period|Lost to Follow-up|0|||
126117283|NCT01721057|453723826|FG002|Treatment Period|Lost to Follow-up|0|||
126117284|NCT01721057|453723827|FG003|Treatment Period|Lost to Follow-up|0|||
126087339|NCT05000216|453612960|FG010|Stage 2|Physician Decision|0|||
126087340|NCT05000216|453612961|FG011|Stage 2|Physician Decision|0|||
126087341|NCT05000216|453612962|FG012|Stage 2|Physician Decision|1|||
126087342|NCT05000216|453612963|FG013|Stage 2|Physician Decision|0|||
126117285|NCT01721057|453723828|FG004|Treatment Period|Lost to Follow-up|0|||
126117286|NCT01721057|453723829|FG005|Treatment Period|Lost to Follow-up|0|||
126117287|NCT01721057|453723830|FG006|Treatment Period|Lost to Follow-up|0|||
126117288|NCT01721057|453723824|FG000|Treatment Period|Physician Decision|0|||
126117289|NCT01721057|453723825|FG001|Treatment Period|Physician Decision|1|||
126117290|NCT01721057|453723826|FG002|Treatment Period|Physician Decision|3|||
126117291|NCT01721057|453723827|FG003|Treatment Period|Physician Decision|0|||
126117292|NCT01721057|453723828|FG004|Treatment Period|Physician Decision|0|||
126117293|NCT01721057|453723829|FG005|Treatment Period|Physician Decision|0|||
126117294|NCT01721057|453723830|FG006|Treatment Period|Physician Decision|0|||
126117295|NCT01721057|453723824|FG000|Treatment Period|Death|2|||
126117296|NCT01721057|453723825|FG001|Treatment Period|Death|0|||
126117297|NCT01721057|453723826|FG002|Treatment Period|Death|0|||
126117298|NCT01721057|453723827|FG003|Treatment Period|Death|0|||
126117299|NCT01721057|453723828|FG004|Treatment Period|Death|0|||
126117300|NCT01721057|453723829|FG005|Treatment Period|Death|0|||
126117301|NCT01721057|453723830|FG006|Treatment Period|Death|0|||
126117302|NCT01721057|453723824|FG000|Rescue Period|Adverse Event|0|||
126117303|NCT01721057|453723825|FG001|Rescue Period|Adverse Event|0|||
126117304|NCT01721057|453723826|FG002|Rescue Period|Adverse Event|0|||
126117305|NCT01721057|453723827|FG003|Rescue Period|Adverse Event|1|||
126117306|NCT01721057|453723828|FG004|Rescue Period|Adverse Event|0|||
126117307|NCT01721057|453723829|FG005|Rescue Period|Adverse Event|0|||
126117308|NCT01721057|453723830|FG006|Rescue Period|Adverse Event|0|||
126117309|NCT01721057|453723824|FG000|Rescue Period|Lack of Efficacy|0|||
126117310|NCT01721057|453723825|FG001|Rescue Period|Lack of Efficacy|0|||
126117311|NCT01721057|453723826|FG002|Rescue Period|Lack of Efficacy|0|||
126117312|NCT01721057|453723827|FG003|Rescue Period|Lack of Efficacy|2|||
126117313|NCT01721057|453723828|FG004|Rescue Period|Lack of Efficacy|0|||
126117314|NCT01721057|453723829|FG005|Rescue Period|Lack of Efficacy|0|||
126117315|NCT01721057|453723830|FG006|Rescue Period|Lack of Efficacy|0|||
126117316|NCT01202279|453723831|FG000|Overall Study|Adverse Event|8|||
126117317|NCT01202279|453723832|FG001|Overall Study|Adverse Event|6|||
126117318|NCT01202279|453723831|FG000|Overall Study|Withdrawal by Subject|13|||
126117319|NCT01202279|453723832|FG001|Overall Study|Withdrawal by Subject|10|||
126117320|NCT01202279|453723831|FG000|Overall Study|Physician Decision|0|||
126117321|NCT01202279|453723832|FG001|Overall Study|Physician Decision|1|||
126117322|NCT01202279|453723831|FG000|Overall Study|Lost to Follow-up|10|||
125960489|NCT03027466|453147569|FG003|Overall Study|Opting out of the app|1821|||
125960490|NCT02158039|453147570|FG000|Overall Study|Withdrawal by Subject|1|||
125960491|NCT02158039|453147570|FG000|Overall Study|Screen Failure|9|||
125960492|NCT03221257|453147576|FG000|Overall Study|Lost to Follow-up|0|||
125960493|NCT03221257|453147577|FG001|Overall Study|Lost to Follow-up|1|||
125960494|NCT03221257|453147576|FG000|Overall Study|Withdrawal by Subject|1|||
125960495|NCT03221257|453147577|FG001|Overall Study|Withdrawal by Subject|1|||
125960496|NCT01334866|453147578|FG000|Overall Study|Withdrawal by Subject|10|||
125960497|NCT01334866|453147578|FG000|Overall Study|Lost to Follow-up|3|||
125960498|NCT01334866|453147578|FG000|Overall Study|Physician Decision|3|||
125960499|NCT01334866|453147578|FG000|Overall Study|medically necessary prior to procedure|2|||
125960500|NCT01334866|453147578|FG000|Overall Study|medically necessary post-procedure|1|||
125960501|NCT02296112|453147581|FG000|Overall Study|Disease progression|7|||
125960502|NCT02296112|453147581|FG000|Overall Study|Toxicity|1|||
125960503|NCT02296112|453147581|FG000|Overall Study|Began an alternate therapy|1|||
125960504|NCT01600586|453147582|FG000|Overall Study|Physician Decision|3|||
125960505|NCT01600586|453147583|FG001|Overall Study|Physician Decision|3|||
125960506|NCT00931307|453147584|FG000|Overall Study|Lack of Efficacy|12|||
125960507|NCT00931307|453147584|FG000|Overall Study|Biomicroscopy|1|||
125960508|NCT00774995|453147585|FG000|Overall Study|Protocol Violation|0|||
125960509|NCT00774995|453147586|FG001|Overall Study|Protocol Violation|0|||
125960510|NCT00774995|453147587|FG002|Overall Study|Protocol Violation|1|||
125960511|NCT00774995|453147588|FG003|Overall Study|Protocol Violation|0|||
125960512|NCT03328897|453149225|FG000|Randomized-treatment Epoch|Adverse Event|4|||
125960513|NCT03328897|453149226|FG001|Randomized-treatment Epoch|Adverse Event|1|||
126117323|NCT01202279|453723832|FG001|Overall Study|Lost to Follow-up|7|||
126117324|NCT01202279|453723831|FG000|Overall Study|Protocol Violation|1|||
125960514|NCT03328897|453149227|FG002|Randomized-treatment Epoch|Adverse Event|1|||
125960515|NCT03328897|453149225|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
125960516|NCT03328897|453149226|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
126117325|NCT01202279|453723832|FG001|Overall Study|Protocol Violation|1|||
126117326|NCT01202279|453723831|FG000|Overall Study|study compliance|5|||
126117327|NCT01202279|453723832|FG001|Overall Study|study compliance|2|||
125960517|NCT03328897|453149227|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
125960518|NCT03328897|453149225|FG000|Randomized-treatment Epoch|Pregnancy|3|||
125960519|NCT03328897|453149226|FG001|Randomized-treatment Epoch|Pregnancy|0|||
125960520|NCT03328897|453149227|FG002|Randomized-treatment Epoch|Pregnancy|0|||
125971516|NCT00791765|453184717|FG001|Weeks 13 to 24|Protocol deviation|0|||
126117328|NCT02546765|453723835|FG000|Overall Study|Withdrawal by Subject|0|||
126117329|NCT02546765|453723836|FG001|Overall Study|Withdrawal by Subject|1|||
126117330|NCT02546765|453723837|FG002|Overall Study|Withdrawal by Subject|0|||
126117331|NCT02546765|453723838|FG003|Overall Study|Withdrawal by Subject|0|||
126117332|NCT00475722|453723839|FG000|Overall Study|Withdrawal by Subject|12|||
126117333|NCT00475722|453723840|FG001|Overall Study|Withdrawal by Subject|12|||
126117334|NCT00475722|453723839|FG000|Overall Study|Protocol Violation|3|||
126117335|NCT00475722|453723840|FG001|Overall Study|Protocol Violation|0|||
126117336|NCT00916279|453723841|FG000|Overall Study|Death|2|||
126117337|NCT00916279|453723841|FG000|Overall Study|Lost to Follow-up|2|||
126117338|NCT00310804|453723842|FG000|Overall Study|Lost to Follow-up|2|||
126117339|NCT00310804|453723843|FG001|Overall Study|Lost to Follow-up|0|||
126117340|NCT00310804|453723842|FG000|Overall Study|Withdrawal by Subject|3|||
126117341|NCT00310804|453723843|FG001|Overall Study|Withdrawal by Subject|0|||
126117342|NCT02109562|453723844|FG000|Overall Study|Insufficient clinical response|2|||
126117343|NCT02109562|453723845|FG001|Overall Study|Insufficient clinical response|0|||
126117344|NCT02109562|453723846|FG002|Overall Study|Insufficient clinical response|4|||
126117345|NCT02109562|453723844|FG000|Overall Study|Adverse Event|0|||
126117346|NCT02109562|453723845|FG001|Overall Study|Adverse Event|2|||
126117347|NCT02109562|453723846|FG002|Overall Study|Adverse Event|3|||
126117348|NCT02109562|453723844|FG000|Overall Study|Lost to Follow-up|1|||
126117349|NCT02109562|453723845|FG001|Overall Study|Lost to Follow-up|0|||
126117350|NCT02109562|453723846|FG002|Overall Study|Lost to Follow-up|1|||
126117351|NCT02109562|453723844|FG000|Overall Study|Protocol Violation|0|||
126117352|NCT02109562|453723845|FG001|Overall Study|Protocol Violation|3|||
126117353|NCT02109562|453723846|FG002|Overall Study|Protocol Violation|1|||
126117354|NCT02109562|453723844|FG000|Overall Study|Withdrawal by Subject|20|||
126117355|NCT02109562|453723845|FG001|Overall Study|Withdrawal by Subject|25|||
126117356|NCT02109562|453723846|FG002|Overall Study|Withdrawal by Subject|21|||
126117357|NCT02109562|453723844|FG000|Overall Study|Physician Decision|3|||
126117358|NCT02109562|453723845|FG001|Overall Study|Physician Decision|4|||
126117359|NCT02109562|453723846|FG002|Overall Study|Physician Decision|5|||
126117360|NCT03318978|453723855|FG000|Overall Study|Withdrawal by Subject|1|||
126117361|NCT01200238|453723857|FG000|Overall Study|Adverse Event|2|||
126117362|NCT01200238|453723858|FG001|Overall Study|Adverse Event|1|||
126117363|NCT01200238|453723857|FG000|Overall Study|Progressive Disease|5|||
126117364|NCT01200238|453723858|FG001|Overall Study|Progressive Disease|8|||
126117365|NCT01200238|453723857|FG000|Overall Study|Withdrawal by Subject|0|||
126117366|NCT01200238|453723858|FG001|Overall Study|Withdrawal by Subject|1|||
126117367|NCT05050318|453725195|FG000|Overall Study|Protocol Deviation|1|||
126117368|NCT05050318|453725196|FG001|Overall Study|Protocol Deviation|0|||
126117369|NCT05050318|453725197|FG002|Overall Study|Protocol Deviation|0|||
126117370|NCT02229539|453725202|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
126117371|NCT02229539|453725203|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
126117372|NCT02229539|453725204|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
126117373|NCT02229539|453725202|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
126117374|NCT02229539|453725203|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
126117375|NCT02229539|453725204|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
126117376|NCT02229539|453725202|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
126117377|NCT02229539|453725203|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
126117378|NCT02229539|453725204|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
126117379|NCT02229539|453725202|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
126117380|NCT02229539|453725203|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
126117381|NCT02229539|453725204|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
126117382|NCT02229539|453725202|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
126117383|NCT02229539|453725203|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
126117384|NCT02229539|453725204|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
126117385|NCT02229539|453725202|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
126117386|NCT02229539|453725203|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
126117387|NCT02229539|453725204|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
125960521|NCT03328897|453149225|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
126117388|NCT00382720|453725208|FG000|Overall Study|Adverse Event|21|||
126117389|NCT00382720|453725209|FG001|Overall Study|Adverse Event|23|||
126117390|NCT00382720|453725210|FG002|Overall Study|Adverse Event|15|||
126117391|NCT00382720|453725208|FG000|Overall Study|Protocol Violation|2|||
126117392|NCT00382720|453725209|FG001|Overall Study|Protocol Violation|5|||
126117393|NCT00382720|453725210|FG002|Overall Study|Protocol Violation|1|||
126117394|NCT00382720|453725208|FG000|Overall Study|Death|0|||
126117395|NCT00382720|453725209|FG001|Overall Study|Death|1|||
126117396|NCT00382720|453725210|FG002|Overall Study|Death|2|||
126117397|NCT00382720|453725208|FG000|Overall Study|Progressive disease|37|||
126117398|NCT00382720|453725209|FG001|Overall Study|Progressive disease|28|||
126117399|NCT00382720|453725210|FG002|Overall Study|Progressive disease|38|||
126117400|NCT00382720|453725208|FG000|Overall Study|Withdrew consent|1|||
126117401|NCT00382720|453725209|FG001|Overall Study|Withdrew consent|1|||
126117402|NCT00382720|453725210|FG002|Overall Study|Withdrew consent|2|||
126117403|NCT00382720|453725208|FG000|Overall Study|Withdrawal by Subject|11|||
126117404|NCT00382720|453725209|FG001|Overall Study|Withdrawal by Subject|20|||
126117405|NCT00382720|453725210|FG002|Overall Study|Withdrawal by Subject|12|||
126117406|NCT00382720|453725208|FG000|Overall Study|Surgery|1|||
126117407|NCT00382720|453725209|FG001|Overall Study|Surgery|1|||
126117408|NCT00382720|453725210|FG002|Overall Study|Surgery|4|||
126117409|NCT00382720|453725208|FG000|Overall Study|Patient did not receive study medication|1|||
126117410|NCT00382720|453725209|FG001|Overall Study|Patient did not receive study medication|1|||
126117411|NCT00382720|453725210|FG002|Overall Study|Patient did not receive study medication|4|||
126117412|NCT00382720|453725208|FG000|Overall Study|Clinically progressive disease|0|||
126117413|NCT00382720|453725209|FG001|Overall Study|Clinically progressive disease|1|||
126117414|NCT00382720|453725210|FG002|Overall Study|Clinically progressive disease|0|||
126117415|NCT00382720|453725208|FG000|Overall Study|Good prognosis|0|||
126117416|NCT00382720|453725209|FG001|Overall Study|Good prognosis|1|||
126117417|NCT00382720|453725210|FG002|Overall Study|Good prognosis|0|||
126087343|NCT05000216|453612964|FG014|Stage 2|Physician Decision|0|||
126117418|NCT00382720|453725208|FG000|Overall Study|Investigator/Clinical decision|5|||
126117419|NCT00382720|453725209|FG001|Overall Study|Investigator/Clinical decision|6|||
126117420|NCT00382720|453725210|FG002|Overall Study|Investigator/Clinical decision|6|||
126117421|NCT00382720|453725208|FG000|Overall Study|Discontinued at end of study|0|||
126117422|NCT00382720|453725209|FG001|Overall Study|Discontinued at end of study|1|||
126117423|NCT00382720|453725210|FG002|Overall Study|Discontinued at end of study|2|||
126117424|NCT00257166|453725214|FG000|Overall Study|Adverse Event|18|||
126117425|NCT00257166|453725215|FG001|Overall Study|Adverse Event|13|||
126117426|NCT00257166|453725214|FG000|Overall Study|Laboratory abnormality|1|||
126117427|NCT00257166|453725215|FG001|Overall Study|Laboratory abnormality|0|||
126117428|NCT00257166|453725214|FG000|Overall Study|Lost to Follow-up|8|||
126117429|NCT00257166|453725215|FG001|Overall Study|Lost to Follow-up|1|||
126117430|NCT00257166|453725214|FG000|Overall Study|Withdrawal by Subject|9|||
126117431|NCT00257166|453725215|FG001|Overall Study|Withdrawal by Subject|2|||
126117432|NCT00257166|453725214|FG000|Overall Study|Other|16|||
126117433|NCT00257166|453725215|FG001|Overall Study|Other|21|||
126117434|NCT00257166|453725214|FG000|Overall Study|Randomized, but not treated|1|||
126117435|NCT00257166|453725215|FG001|Overall Study|Randomized, but not treated|0|||
126117436|NCT04050670|453725218|FG000|Period 3|Physician Decision|0|||
126117437|NCT04050670|453725219|FG001|Period 3|Physician Decision|1|||
126117438|NCT04050670|453725220|FG002|Period 3|Physician Decision|0|||
126117439|NCT02230254|453725221|FG000|Overall Study|Lost to Follow-up|3|||
126117440|NCT01942148|453725223|FG000|Overall Study|Adverse Event|4|||
126117441|NCT01942148|453725223|FG000|Overall Study|Lack of Efficacy|2|||
126117442|NCT01942148|453725223|FG000|Overall Study|Physician Decision|11|||
126117443|NCT01942148|453725223|FG000|Overall Study|Protocol Violation|1|||
126117444|NCT01942148|453725223|FG000|Overall Study|Withdrawal by Subject|8|||
126117445|NCT01942148|453725223|FG000|Overall Study|Use of the prohibition medicine|1|||
126117446|NCT00514514|453725225|FG000|Pre-phase|Death|10|||
126117447|NCT00514514|453725226|FG001|Pre-phase|Death|0|||
126117448|NCT00514514|453725227|FG002|Pre-phase|Death|0|||
126117449|NCT00514514|453725225|FG000|Pre-phase|administrative problems|2|||
126117450|NCT00514514|453725226|FG001|Pre-phase|administrative problems|0|||
126117451|NCT00514514|453725227|FG002|Pre-phase|administrative problems|0|||
126117452|NCT00514514|453725225|FG000|Pre-phase|Protocol Violation|6|||
126117453|NCT00514514|453725226|FG001|Pre-phase|Protocol Violation|0|||
126117454|NCT00514514|453725227|FG002|Pre-phase|Protocol Violation|0|||
126117455|NCT00514514|453725225|FG000|Pre-phase|condition no longer requires study drug|7|||
126117456|NCT00514514|453725226|FG001|Pre-phase|condition no longer requires study drug|0|||
126117457|NCT00514514|453725227|FG002|Pre-phase|condition no longer requires study drug|0|||
126117458|NCT00514514|453725225|FG000|Pre-phase|abnormal test procedure results|15|||
126117459|NCT00514514|453725226|FG001|Pre-phase|abnormal test procedure results|0|||
126117460|NCT00514514|453725227|FG002|Pre-phase|abnormal test procedure results|0|||
126117461|NCT00514514|453725225|FG000|Pre-phase|Lost to Follow-up|2|||
126117462|NCT00514514|453725226|FG001|Pre-phase|Lost to Follow-up|0|||
126087344|NCT05000216|453612965|FG015|Stage 2|Physician Decision|0|||
126087345|NCT05000216|453612966|FG016|Stage 2|Physician Decision|0|||
126087346|NCT05000216|453612967|FG017|Stage 2|Physician Decision|0|||
126087347|NCT05000216|453612968|FG018|Stage 2|Physician Decision|0|||
126087348|NCT05000216|453612969|FG019|Stage 2|Physician Decision|0|||
126087349|NCT05000216|453612970|FG020|Stage 2|Physician Decision|0|||
126087350|NCT05000216|453612971|FG021|Stage 2|Physician Decision|0|||
126087351|NCT05000216|453612950|FG000|Stage 2|Withdrawal by Subject|0|||
126087352|NCT05000216|453612951|FG001|Stage 2|Withdrawal by Subject|0|||
126087353|NCT05000216|453612952|FG002|Stage 2|Withdrawal by Subject|0|||
126087354|NCT05000216|453612953|FG003|Stage 2|Withdrawal by Subject|0|||
126087355|NCT05000216|453612954|FG004|Stage 2|Withdrawal by Subject|0|||
126087356|NCT05000216|453612955|FG005|Stage 2|Withdrawal by Subject|0|||
126087357|NCT05000216|453612956|FG006|Stage 2|Withdrawal by Subject|0|||
126117463|NCT00514514|453725227|FG002|Pre-phase|Lost to Follow-up|0|||
126117464|NCT00514514|453725225|FG000|Pre-phase|abnormal lab values|23|||
126087358|NCT05000216|453612957|FG007|Stage 2|Withdrawal by Subject|0|||
126087359|NCT05000216|453612958|FG008|Stage 2|Withdrawal by Subject|0|||
126087360|NCT05000216|453612959|FG009|Stage 2|Withdrawal by Subject|0|||
126117465|NCT00514514|453725226|FG001|Pre-phase|abnormal lab values|0|||
126117466|NCT00514514|453725227|FG002|Pre-phase|abnormal lab values|0|||
126117467|NCT00514514|453725225|FG000|Pre-phase|Lack of Efficacy|35|||
126117468|NCT00514514|453725226|FG001|Pre-phase|Lack of Efficacy|0|||
126117469|NCT00514514|453725227|FG002|Pre-phase|Lack of Efficacy|0|||
126117470|NCT00514514|453725225|FG000|Pre-phase|Adverse Event|137|||
126117471|NCT00514514|453725226|FG001|Pre-phase|Adverse Event|0|||
126117472|NCT00514514|453725227|FG002|Pre-phase|Adverse Event|0|||
126117473|NCT00514514|453725225|FG000|Pre-phase|Withdrawal by Subject|66|||
126117474|NCT00514514|453725226|FG001|Pre-phase|Withdrawal by Subject|0|||
125960522|NCT03328897|453149226|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
125960523|NCT03328897|453149227|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
125960524|NCT03328897|453149225|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
125960525|NCT03328897|453149226|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
125960526|NCT03328897|453149227|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
125960527|NCT03328897|453149225|FG000|Follow-up Epoch|Adverse Event|4|||
125960528|NCT03328897|453149226|FG001|Follow-up Epoch|Adverse Event|0|||
125960529|NCT03328897|453149227|FG002|Follow-up Epoch|Adverse Event|1|||
125960530|NCT03328897|453149225|FG000|Follow-up Epoch|Lack of Efficacy|1|||
125960531|NCT03328897|453149226|FG001|Follow-up Epoch|Lack of Efficacy|1|||
125960532|NCT03328897|453149227|FG002|Follow-up Epoch|Lack of Efficacy|1|||
125960533|NCT03328897|453149225|FG000|Follow-up Epoch|Lost to Follow-up|0|||
125960534|NCT03328897|453149226|FG001|Follow-up Epoch|Lost to Follow-up|1|||
125960535|NCT03328897|453149227|FG002|Follow-up Epoch|Lost to Follow-up|0|||
125960536|NCT03328897|453149225|FG000|Follow-up Epoch|Pregnancy|1|||
125960537|NCT03328897|453149226|FG001|Follow-up Epoch|Pregnancy|0|||
125960538|NCT03328897|453149227|FG002|Follow-up Epoch|Pregnancy|0|||
125960539|NCT03328897|453149225|FG000|Follow-up Epoch|Patient/guardian decision|2|||
125960540|NCT03328897|453149226|FG001|Follow-up Epoch|Patient/guardian decision|1|||
125960541|NCT03328897|453149227|FG002|Follow-up Epoch|Patient/guardian decision|0|||
125960542|NCT02766608|453149230|FG000|Overall Study|Adverse Event|27|||
125960543|NCT02766608|453149231|FG001|Overall Study|Adverse Event|22|||
125960544|NCT02766608|453149232|FG002|Overall Study|Adverse Event|17|||
125960545|NCT02766608|453149233|FG003|Overall Study|Adverse Event|13|||
125960546|NCT02766608|453149234|FG004|Overall Study|Adverse Event|12|||
125960547|NCT02766608|453149230|FG000|Overall Study|Withdrawal by Subject|21|||
126117475|NCT00514514|453725227|FG002|Pre-phase|Withdrawal by Subject|0|||
126117476|NCT00514514|453725225|FG000|Randomized - 9 Month|Death|3|||
126117477|NCT00514514|453725226|FG001|Randomized - 9 Month|Death|2|||
126117478|NCT00514514|453725227|FG002|Randomized - 9 Month|Death|2|||
126117479|NCT00514514|453725225|FG000|Randomized - 9 Month|Administrative problems|1|||
126117480|NCT00514514|453725226|FG001|Randomized - 9 Month|Administrative problems|1|||
126117481|NCT00514514|453725227|FG002|Randomized - 9 Month|Administrative problems|2|||
126117482|NCT00514514|453725225|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
126117483|NCT00514514|453725226|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
126117484|NCT00514514|453725227|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
126117485|NCT00514514|453725225|FG000|Randomized - 9 Month|Protocol Violation|1|||
126117486|NCT00514514|453725226|FG001|Randomized - 9 Month|Protocol Violation|1|||
126117487|NCT00514514|453725227|FG002|Randomized - 9 Month|Protocol Violation|0|||
126117488|NCT00514514|453725225|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
126117489|NCT00514514|453725226|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
126117490|NCT00514514|453725227|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
126117491|NCT00514514|453725225|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
126117492|NCT00514514|453725226|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
126117493|NCT00514514|453725227|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
126117494|NCT00514514|453725225|FG000|Randomized - 9 Month|Adverse Event|25|||
126117495|NCT00514514|453725226|FG001|Randomized - 9 Month|Adverse Event|44|||
126117496|NCT00514514|453725227|FG002|Randomized - 9 Month|Adverse Event|27|||
126117497|NCT00514514|453725225|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
126117498|NCT00514514|453725226|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
126117499|NCT00514514|453725227|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
126117500|NCT00514514|453725225|FG000|Extension - 4 Years|Lost to Follow-up|12|||
126117501|NCT00514514|453725226|FG001|Extension - 4 Years|Lost to Follow-up|10|||
126117502|NCT00514514|453725227|FG002|Extension - 4 Years|Lost to Follow-up|9|||
126117503|NCT00514514|453725225|FG000|Extension - 4 Years|Administrative problems|3|||
126117504|NCT00514514|453725226|FG001|Extension - 4 Years|Administrative problems|1|||
126117505|NCT00514514|453725227|FG002|Extension - 4 Years|Administrative problems|1|||
126117506|NCT00514514|453725225|FG000|Extension - 4 Years|Death|8|||
126117507|NCT00514514|453725226|FG001|Extension - 4 Years|Death|3|||
126117508|NCT00514514|453725227|FG002|Extension - 4 Years|Death|6|||
126117509|NCT00514514|453725225|FG000|Extension - 4 Years|Adverse Event|9|||
126117510|NCT00514514|453725226|FG001|Extension - 4 Years|Adverse Event|6|||
126117511|NCT00514514|453725227|FG002|Extension - 4 Years|Adverse Event|3|||
126117512|NCT01101438|453725230|FG000|Overall Study|Withdrawal by Subject|8|||
126117513|NCT01101438|453725231|FG001|Overall Study|Withdrawal by Subject|9|||
126117514|NCT02713542|453725232|FG000|Overall Study|Use of prohibited medication|14|||
125960548|NCT02766608|453149231|FG001|Overall Study|Withdrawal by Subject|20|||
126117515|NCT02713542|453725233|FG001|Overall Study|Use of prohibited medication|5|||
126117516|NCT02713542|453725232|FG000|Overall Study|Withdrawal by Subject|4|||
126117517|NCT02713542|453725233|FG001|Overall Study|Withdrawal by Subject|1|||
126117518|NCT00066742|453725234|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
126117519|NCT00066742|453725234|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
126117520|NCT00066742|453725234|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
126117521|NCT00066742|453725234|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
126117522|NCT00066742|453725234|FG000|Induction Chemoradiotherapy|Ineligible|3|||
126117523|NCT00066742|453725234|FG000|Consolidation Chemotherapy|not protocol specified|1|||
126117524|NCT00066742|453725234|FG000|Consolidation Chemotherapy|Ineligible|2|||
126117525|NCT03794583|453725236|FG000|Overall Study|Death|8|||
126117526|NCT03794583|453725236|FG000|Overall Study|Study Terminated by Sponsor|24|||
126117527|NCT03794583|453725236|FG000|Overall Study|Withdrawal by Subject|9|||
126117528|NCT01994382|453725245|FG000|Overall Study|Informed consent withdrawn|0|||
126117529|NCT01994382|453725246|FG001|Overall Study|Informed consent withdrawn|0|||
126117530|NCT01994382|453725247|FG002|Overall Study|Informed consent withdrawn|0|||
126117531|NCT01994382|453725248|FG003|Overall Study|Informed consent withdrawn|0|||
126117532|NCT01994382|453725249|FG004|Overall Study|Informed consent withdrawn|0|||
126117533|NCT01994382|453725250|FG005|Overall Study|Informed consent withdrawn|0|||
126117534|NCT01994382|453725251|FG006|Overall Study|Informed consent withdrawn|1|||
126117535|NCT01994382|453725252|FG007|Overall Study|Informed consent withdrawn|0|||
126117536|NCT01994382|453725253|FG008|Overall Study|Informed consent withdrawn|0|||
126117537|NCT01994382|453725254|FG009|Overall Study|Informed consent withdrawn|0|||
126117538|NCT01994382|453725255|FG010|Overall Study|Informed consent withdrawn|0|||
126117539|NCT01994382|453725256|FG011|Overall Study|Informed consent withdrawn|0|||
126117540|NCT01994382|453725257|FG012|Overall Study|Informed consent withdrawn|0|||
126117541|NCT01994382|453725258|FG013|Overall Study|Informed consent withdrawn|0|||
126117542|NCT01994382|453725259|FG014|Overall Study|Informed consent withdrawn|0|||
126117543|NCT01994382|453725260|FG015|Overall Study|Informed consent withdrawn|0|||
126117544|NCT01994382|453725261|FG016|Overall Study|Informed consent withdrawn|0|||
126117545|NCT01994382|453725245|FG000|Overall Study|Progressive disease|3|||
126117546|NCT01994382|453725246|FG001|Overall Study|Progressive disease|4|||
126117547|NCT01994382|453725247|FG002|Overall Study|Progressive disease|4|||
126117548|NCT01994382|453725248|FG003|Overall Study|Progressive disease|3|||
126117549|NCT01994382|453725249|FG004|Overall Study|Progressive disease|2|||
126117550|NCT01994382|453725250|FG005|Overall Study|Progressive disease|3|||
126117551|NCT01994382|453725251|FG006|Overall Study|Progressive disease|3|||
126117552|NCT01994382|453725252|FG007|Overall Study|Progressive disease|6|||
126117553|NCT01994382|453725253|FG008|Overall Study|Progressive disease|2|||
126117554|NCT01994382|453725254|FG009|Overall Study|Progressive disease|2|||
126117555|NCT01994382|453725255|FG010|Overall Study|Progressive disease|13|||
126117556|NCT01994382|453725256|FG011|Overall Study|Progressive disease|8|||
126117557|NCT01994382|453725257|FG012|Overall Study|Progressive disease|7|||
126117558|NCT01994382|453725258|FG013|Overall Study|Progressive disease|3|||
126117559|NCT01994382|453725259|FG014|Overall Study|Progressive disease|6|||
126117560|NCT01994382|453725260|FG015|Overall Study|Progressive disease|44|||
126117561|NCT01994382|453725261|FG016|Overall Study|Progressive disease|28|||
126117562|NCT01994382|453725245|FG000|Overall Study|Physician Decision|0|||
126117563|NCT01994382|453725246|FG001|Overall Study|Physician Decision|1|||
126117564|NCT01994382|453725247|FG002|Overall Study|Physician Decision|0|||
126117565|NCT01994382|453725248|FG003|Overall Study|Physician Decision|0|||
126117566|NCT01994382|453725249|FG004|Overall Study|Physician Decision|0|||
126117567|NCT01994382|453725250|FG005|Overall Study|Physician Decision|0|||
126117568|NCT01994382|453725251|FG006|Overall Study|Physician Decision|0|||
126117569|NCT01994382|453725252|FG007|Overall Study|Physician Decision|0|||
126117570|NCT01994382|453725253|FG008|Overall Study|Physician Decision|0|||
126117571|NCT01994382|453725254|FG009|Overall Study|Physician Decision|0|||
126117572|NCT01994382|453725255|FG010|Overall Study|Physician Decision|3|||
126117573|NCT01994382|453725256|FG011|Overall Study|Physician Decision|1|||
126117574|NCT01994382|453725257|FG012|Overall Study|Physician Decision|1|||
126117575|NCT01994382|453725258|FG013|Overall Study|Physician Decision|0|||
126117576|NCT01994382|453725259|FG014|Overall Study|Physician Decision|1|||
126117577|NCT01994382|453725260|FG015|Overall Study|Physician Decision|4|||
126117578|NCT01994382|453725261|FG016|Overall Study|Physician Decision|2|||
126117579|NCT01994382|453725245|FG000|Overall Study|Death|0|||
126117580|NCT01994382|453725246|FG001|Overall Study|Death|0|||
126117581|NCT01994382|453725247|FG002|Overall Study|Death|0|||
126117582|NCT01994382|453725248|FG003|Overall Study|Death|0|||
126117583|NCT01994382|453725249|FG004|Overall Study|Death|1|||
126117584|NCT01994382|453725250|FG005|Overall Study|Death|0|||
126117585|NCT01994382|453725251|FG006|Overall Study|Death|0|||
126117586|NCT01994382|453725252|FG007|Overall Study|Death|0|||
126117587|NCT01994382|453725253|FG008|Overall Study|Death|1|||
126117588|NCT01994382|453725254|FG009|Overall Study|Death|1|||
126117589|NCT01994382|453725255|FG010|Overall Study|Death|0|||
126117590|NCT01994382|453725256|FG011|Overall Study|Death|0|||
126117591|NCT01994382|453725257|FG012|Overall Study|Death|0|||
126117592|NCT01994382|453725258|FG013|Overall Study|Death|0|||
126117593|NCT01994382|453725259|FG014|Overall Study|Death|0|||
126117594|NCT01994382|453725260|FG015|Overall Study|Death|1|||
126117595|NCT01994382|453725261|FG016|Overall Study|Death|0|||
126117596|NCT01994382|453725245|FG000|Overall Study|Adverse Event|0|||
126117597|NCT01994382|453725246|FG001|Overall Study|Adverse Event|1|||
126117598|NCT01994382|453725247|FG002|Overall Study|Adverse Event|2|||
126117599|NCT01994382|453725248|FG003|Overall Study|Adverse Event|0|||
126117600|NCT01994382|453725249|FG004|Overall Study|Adverse Event|0|||
126117601|NCT01994382|453725250|FG005|Overall Study|Adverse Event|0|||
126117602|NCT01994382|453725251|FG006|Overall Study|Adverse Event|0|||
126117603|NCT01994382|453725252|FG007|Overall Study|Adverse Event|0|||
126117604|NCT01994382|453725253|FG008|Overall Study|Adverse Event|0|||
126117605|NCT01994382|453725254|FG009|Overall Study|Adverse Event|0|||
126117606|NCT01994382|453725255|FG010|Overall Study|Adverse Event|15|||
126117607|NCT01994382|453725256|FG011|Overall Study|Adverse Event|2|||
126117608|NCT01994382|453725257|FG012|Overall Study|Adverse Event|7|||
126117609|NCT01994382|453725258|FG013|Overall Study|Adverse Event|3|||
126117610|NCT01994382|453725259|FG014|Overall Study|Adverse Event|17|||
126117611|NCT01994382|453725260|FG015|Overall Study|Adverse Event|6|||
126117612|NCT01994382|453725261|FG016|Overall Study|Adverse Event|3|||
126117613|NCT01994382|453725245|FG000|Overall Study|Other than specified|0|||
126117614|NCT01994382|453725246|FG001|Overall Study|Other than specified|0|||
126117615|NCT01994382|453725247|FG002|Overall Study|Other than specified|0|||
126117616|NCT01994382|453725248|FG003|Overall Study|Other than specified|0|||
126117617|NCT01994382|453725249|FG004|Overall Study|Other than specified|0|||
126117618|NCT01994382|453725250|FG005|Overall Study|Other than specified|0|||
126117619|NCT01994382|453725251|FG006|Overall Study|Other than specified|0|||
126117620|NCT01994382|453725252|FG007|Overall Study|Other than specified|0|||
126117621|NCT01994382|453725253|FG008|Overall Study|Other than specified|0|||
126117622|NCT01994382|453725254|FG009|Overall Study|Other than specified|0|||
126117623|NCT01994382|453725255|FG010|Overall Study|Other than specified|2|||
126117624|NCT01994382|453725256|FG011|Overall Study|Other than specified|0|||
126117625|NCT01994382|453725257|FG012|Overall Study|Other than specified|2|||
126117626|NCT01994382|453725258|FG013|Overall Study|Other than specified|0|||
126117627|NCT01994382|453725259|FG014|Overall Study|Other than specified|0|||
126117628|NCT01994382|453725260|FG015|Overall Study|Other than specified|4|||
126117629|NCT01994382|453725261|FG016|Overall Study|Other than specified|4|||
126117630|NCT01994382|453725245|FG000|Overall Study|Withdrawal by Subject|0|||
126117631|NCT01994382|453725246|FG001|Overall Study|Withdrawal by Subject|0|||
126117632|NCT01994382|453725247|FG002|Overall Study|Withdrawal by Subject|0|||
126117633|NCT01994382|453725248|FG003|Overall Study|Withdrawal by Subject|0|||
126117634|NCT01994382|453725249|FG004|Overall Study|Withdrawal by Subject|0|||
126117635|NCT01994382|453725250|FG005|Overall Study|Withdrawal by Subject|0|||
126117636|NCT01994382|453725251|FG006|Overall Study|Withdrawal by Subject|0|||
126117637|NCT01994382|453725252|FG007|Overall Study|Withdrawal by Subject|0|||
126117638|NCT01994382|453725253|FG008|Overall Study|Withdrawal by Subject|0|||
126117639|NCT01994382|453725254|FG009|Overall Study|Withdrawal by Subject|0|||
126117640|NCT01994382|453725255|FG010|Overall Study|Withdrawal by Subject|6|||
126117641|NCT01994382|453725256|FG011|Overall Study|Withdrawal by Subject|0|||
126117642|NCT01994382|453725257|FG012|Overall Study|Withdrawal by Subject|2|||
126117643|NCT01994382|453725258|FG013|Overall Study|Withdrawal by Subject|0|||
126117644|NCT01994382|453725259|FG014|Overall Study|Withdrawal by Subject|4|||
126117645|NCT01994382|453725260|FG015|Overall Study|Withdrawal by Subject|3|||
126117646|NCT01994382|453725261|FG016|Overall Study|Withdrawal by Subject|0|||
126117647|NCT01994382|453725245|FG000|Overall Study|Lost to Follow-up|0|||
126117648|NCT01994382|453725246|FG001|Overall Study|Lost to Follow-up|0|||
126117649|NCT01994382|453725247|FG002|Overall Study|Lost to Follow-up|0|||
126117650|NCT01994382|453725248|FG003|Overall Study|Lost to Follow-up|0|||
126117651|NCT01994382|453725249|FG004|Overall Study|Lost to Follow-up|0|||
126117652|NCT01994382|453725250|FG005|Overall Study|Lost to Follow-up|0|||
126117653|NCT01994382|453725251|FG006|Overall Study|Lost to Follow-up|0|||
126117654|NCT01994382|453725252|FG007|Overall Study|Lost to Follow-up|0|||
125960549|NCT02766608|453149232|FG002|Overall Study|Withdrawal by Subject|24|||
125960550|NCT02766608|453149233|FG003|Overall Study|Withdrawal by Subject|13|||
126117655|NCT01994382|453725253|FG008|Overall Study|Lost to Follow-up|0|||
126117656|NCT01994382|453725254|FG009|Overall Study|Lost to Follow-up|0|||
126117657|NCT01994382|453725255|FG010|Overall Study|Lost to Follow-up|1|||
126117658|NCT01994382|453725256|FG011|Overall Study|Lost to Follow-up|0|||
126117659|NCT01994382|453725257|FG012|Overall Study|Lost to Follow-up|0|||
126117660|NCT01994382|453725258|FG013|Overall Study|Lost to Follow-up|0|||
126117661|NCT01994382|453725259|FG014|Overall Study|Lost to Follow-up|0|||
126117662|NCT01994382|453725260|FG015|Overall Study|Lost to Follow-up|0|||
126117663|NCT01994382|453725261|FG016|Overall Study|Lost to Follow-up|0|||
126117664|NCT01994382|453725245|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117665|NCT01994382|453725246|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117666|NCT01994382|453725247|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117667|NCT01994382|453725248|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117668|NCT01994382|453725249|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125960551|NCT02766608|453149234|FG004|Overall Study|Withdrawal by Subject|10|||
125960552|NCT02766608|453149230|FG000|Overall Study|Lack of Efficacy|16|||
125960553|NCT02766608|453149231|FG001|Overall Study|Lack of Efficacy|15|||
125960554|NCT02766608|453149232|FG002|Overall Study|Lack of Efficacy|32|||
125960555|NCT02766608|453149233|FG003|Overall Study|Lack of Efficacy|8|||
125960556|NCT02766608|453149234|FG004|Overall Study|Lack of Efficacy|2|||
125960557|NCT02766608|453149230|FG000|Overall Study|Lost to Follow-up|6|||
125960558|NCT02766608|453149231|FG001|Overall Study|Lost to Follow-up|3|||
125960559|NCT02766608|453149232|FG002|Overall Study|Lost to Follow-up|5|||
125960560|NCT02766608|453149233|FG003|Overall Study|Lost to Follow-up|2|||
125960561|NCT02766608|453149234|FG004|Overall Study|Lost to Follow-up|2|||
125960562|NCT02766608|453149230|FG000|Overall Study|Physician Decision|3|||
125960563|NCT02766608|453149231|FG001|Overall Study|Physician Decision|2|||
125960564|NCT02766608|453149232|FG002|Overall Study|Physician Decision|3|||
125960565|NCT02766608|453149233|FG003|Overall Study|Physician Decision|1|||
125960566|NCT02766608|453149234|FG004|Overall Study|Physician Decision|2|||
125960567|NCT02766608|453149230|FG000|Overall Study|Protocol disc criteria|3|||
125960568|NCT02766608|453149231|FG001|Overall Study|Protocol disc criteria|3|||
125960569|NCT02766608|453149232|FG002|Overall Study|Protocol disc criteria|4|||
125960570|NCT02766608|453149233|FG003|Overall Study|Protocol disc criteria|0|||
125960571|NCT02766608|453149234|FG004|Overall Study|Protocol disc criteria|0|||
125960572|NCT02766608|453149230|FG000|Overall Study|Protocol Violation|0|||
125960573|NCT02766608|453149231|FG001|Overall Study|Protocol Violation|4|||
125960574|NCT02766608|453149232|FG002|Overall Study|Protocol Violation|4|||
125960575|NCT02766608|453149233|FG003|Overall Study|Protocol Violation|0|||
125960576|NCT02766608|453149234|FG004|Overall Study|Protocol Violation|1|||
125960577|NCT02766608|453149230|FG000|Overall Study|Administrative Reasons|3|||
125960578|NCT02766608|453149231|FG001|Overall Study|Administrative Reasons|1|||
125960579|NCT02766608|453149232|FG002|Overall Study|Administrative Reasons|1|||
125960580|NCT02766608|453149233|FG003|Overall Study|Administrative Reasons|0|||
125960581|NCT02766608|453149234|FG004|Overall Study|Administrative Reasons|0|||
125960582|NCT02066298|453149235|FG000|Overall Study|Lost to Follow-up|3|||
125960583|NCT02066298|453149236|FG001|Overall Study|Lost to Follow-up|2|||
125960584|NCT02066298|453149237|FG002|Overall Study|Lost to Follow-up|3|||
125960585|NCT02066298|453149238|FG003|Overall Study|Lost to Follow-up|2|||
125960586|NCT02066298|453149239|FG004|Overall Study|Lost to Follow-up|3|||
125960587|NCT02066298|453149240|FG005|Overall Study|Lost to Follow-up|4|||
125960588|NCT02066298|453149235|FG000|Overall Study|Withdrawal by Subject|6|||
125960589|NCT02066298|453149236|FG001|Overall Study|Withdrawal by Subject|6|||
125960590|NCT02066298|453149237|FG002|Overall Study|Withdrawal by Subject|6|||
125960591|NCT02066298|453149238|FG003|Overall Study|Withdrawal by Subject|4|||
125960592|NCT02066298|453149239|FG004|Overall Study|Withdrawal by Subject|5|||
125960593|NCT02066298|453149240|FG005|Overall Study|Withdrawal by Subject|8|||
125960594|NCT02066298|453149235|FG000|Overall Study|Physician Decision|0|||
125960595|NCT02066298|453149236|FG001|Overall Study|Physician Decision|0|||
125960596|NCT02066298|453149237|FG002|Overall Study|Physician Decision|1|||
125960597|NCT02066298|453149238|FG003|Overall Study|Physician Decision|0|||
125960598|NCT02066298|453149239|FG004|Overall Study|Physician Decision|1|||
125960599|NCT02066298|453149240|FG005|Overall Study|Physician Decision|0|||
125960600|NCT02348489|453149242|FG000|Overall Study|Death|336|||
125960601|NCT02348489|453149243|FG001|Overall Study|Death|335|||
125960602|NCT02348489|453149242|FG000|Overall Study|Withdrawal by Subject|14|||
125960603|NCT02348489|453149243|FG001|Overall Study|Withdrawal by Subject|27|||
125960604|NCT02348489|453149242|FG000|Overall Study|Lost to Follow-up|3|||
125960605|NCT02348489|453149243|FG001|Overall Study|Lost to Follow-up|5|||
125960606|NCT01639001|453149244|FG000|Overall Study|Refused further follow-up|9|||
125960607|NCT01639001|453149245|FG001|Overall Study|Refused further follow-up|12|||
125960608|NCT01639001|453149244|FG000|Overall Study|Lost to Follow-up|3|||
125960609|NCT01639001|453149245|FG001|Overall Study|Lost to Follow-up|0|||
125960610|NCT01639001|453149244|FG000|Overall Study|Death|62|||
125960611|NCT01639001|453149245|FG001|Overall Study|Death|61|||
125960612|NCT01639001|453149244|FG000|Overall Study|Randomized but not treated|0|||
125960613|NCT01639001|453149245|FG001|Overall Study|Randomized but not treated|2|||
125960614|NCT01639001|453149244|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
125960615|NCT01639001|453149245|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
125960616|NCT02866682|453149246|FG000|Overall Study|Death|0|||
125960617|NCT02866682|453149247|FG001|Overall Study|Death|1|||
125960618|NCT02866682|453149246|FG000|Overall Study|Lost to Follow-up|0|||
125960619|NCT02866682|453149247|FG001|Overall Study|Lost to Follow-up|4|||
125960620|NCT02866682|453149246|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
125960621|NCT02866682|453149247|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
125960622|NCT02866682|453149246|FG000|Overall Study|Other|0|||
125960623|NCT02866682|453149247|FG001|Overall Study|Other|1|||
125960624|NCT00201006|453149248|FG000|Overall Study|Withdrawal by Subject|7|||
125960625|NCT00201006|453149249|FG001|Overall Study|Withdrawal by Subject|2|||
125960626|NCT00201006|453149250|FG002|Overall Study|Withdrawal by Subject|3|||
125960627|NCT00201006|453149248|FG000|Overall Study|Adverse Event|1|||
125960628|NCT00201006|453149249|FG001|Overall Study|Adverse Event|0|||
125960629|NCT00201006|453149250|FG002|Overall Study|Adverse Event|1|||
126117669|NCT01994382|453725250|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117670|NCT01994382|453725251|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117671|NCT01994382|453725252|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117672|NCT01994382|453725253|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117673|NCT01994382|453725254|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117674|NCT01994382|453725255|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
126117675|NCT01994382|453725256|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117676|NCT01994382|453725257|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
126117677|NCT01994382|453725258|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117678|NCT01994382|453725259|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126117679|NCT01994382|453725260|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
126117680|NCT01994382|453725261|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
126117681|NCT01994382|453725245|FG000|Overall Study|Protocol violation/noncompliance|0|||
126117682|NCT01994382|453725246|FG001|Overall Study|Protocol violation/noncompliance|0|||
126117683|NCT01994382|453725247|FG002|Overall Study|Protocol violation/noncompliance|0|||
126117684|NCT01994382|453725248|FG003|Overall Study|Protocol violation/noncompliance|0|||
126117685|NCT01994382|453725249|FG004|Overall Study|Protocol violation/noncompliance|0|||
126117686|NCT01994382|453725250|FG005|Overall Study|Protocol violation/noncompliance|0|||
126117687|NCT01994382|453725251|FG006|Overall Study|Protocol violation/noncompliance|0|||
126117688|NCT01994382|453725252|FG007|Overall Study|Protocol violation/noncompliance|0|||
126117689|NCT01994382|453725253|FG008|Overall Study|Protocol violation/noncompliance|0|||
126117690|NCT01994382|453725254|FG009|Overall Study|Protocol violation/noncompliance|0|||
126117691|NCT01994382|453725255|FG010|Overall Study|Protocol violation/noncompliance|0|||
126117692|NCT01994382|453725256|FG011|Overall Study|Protocol violation/noncompliance|1|||
126117693|NCT01994382|453725257|FG012|Overall Study|Protocol violation/noncompliance|0|||
126117694|NCT01994382|453725258|FG013|Overall Study|Protocol violation/noncompliance|0|||
126117695|NCT01994382|453725259|FG014|Overall Study|Protocol violation/noncompliance|0|||
126117696|NCT01994382|453725260|FG015|Overall Study|Protocol violation/noncompliance|0|||
126117697|NCT01994382|453725261|FG016|Overall Study|Protocol violation/noncompliance|2|||
126117698|NCT01994382|453725245|FG000|Overall Study|Rolled over to Phase 2a|0|||
126117699|NCT01994382|453725246|FG001|Overall Study|Rolled over to Phase 2a|0|||
126117700|NCT01994382|453725247|FG002|Overall Study|Rolled over to Phase 2a|1|||
126117701|NCT01994382|453725248|FG003|Overall Study|Rolled over to Phase 2a|0|||
126117702|NCT01994382|453725249|FG004|Overall Study|Rolled over to Phase 2a|0|||
126117703|NCT01994382|453725250|FG005|Overall Study|Rolled over to Phase 2a|0|||
126117704|NCT01994382|453725251|FG006|Overall Study|Rolled over to Phase 2a|0|||
126117705|NCT01994382|453725252|FG007|Overall Study|Rolled over to Phase 2a|0|||
126117706|NCT01994382|453725253|FG008|Overall Study|Rolled over to Phase 2a|0|||
126117707|NCT01994382|453725254|FG009|Overall Study|Rolled over to Phase 2a|2|||
126117708|NCT01994382|453725255|FG010|Overall Study|Rolled over to Phase 2a|0|||
126117709|NCT01994382|453725256|FG011|Overall Study|Rolled over to Phase 2a|0|||
126117710|NCT01994382|453725257|FG012|Overall Study|Rolled over to Phase 2a|0|||
126117711|NCT01994382|453725258|FG013|Overall Study|Rolled over to Phase 2a|0|||
126117712|NCT01994382|453725259|FG014|Overall Study|Rolled over to Phase 2a|0|||
126117713|NCT01994382|453725260|FG015|Overall Study|Rolled over to Phase 2a|0|||
126117714|NCT01994382|453725261|FG016|Overall Study|Rolled over to Phase 2a|0|||
126117715|NCT01537198|453725272|FG000|Overall Study|RSV infection|2|||
126117716|NCT01537198|453725272|FG000|Overall Study|Adverse Event|4|||
126117717|NCT01537198|453725272|FG000|Overall Study|No Further Visits to the Clinic|37|||
126117718|NCT01537198|453725272|FG000|Overall Study|Other|111|||
126117719|NCT01231659|453725273|FG000|Overall Study|Adverse Event|9|||
126117720|NCT01231659|453725273|FG000|Overall Study|Disease Progression|48|||
126117721|NCT01231659|453725273|FG000|Overall Study|Death|2|||
126117722|NCT01231659|453725273|FG000|Overall Study|Patient refused to complete study visit|1|||
126117723|NCT01231659|453725273|FG000|Overall Study|Other protocol defined criteria|12|||
126117724|NCT02247960|453725274|FG000|Patient Consent and Randomization|Physician Decision|2|||
126117725|NCT02247960|453725275|FG001|Patient Consent and Randomization|Physician Decision|2|||
126117726|NCT02247960|453725274|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
126117727|NCT02247960|453725275|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
126117728|NCT02247960|453725274|FG000|Catheter Removed|Lost to Follow-up|7|||
126117729|NCT02247960|453725275|FG001|Catheter Removed|Lost to Follow-up|10|||
126117730|NCT00736034|453725276|FG000|Overall Study|Adverse Event|2|||
126117731|NCT01022502|453725277|FG000|Overall Study|Adverse Event|1|||
126117732|NCT01022502|453725277|FG000|Overall Study|employment related reasons|1|||
126117733|NCT01022502|453725277|FG000|Overall Study|Withdrawal by Subject|1|||
126117734|NCT03123250|453725278|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
126117735|NCT01390272|453725279|FG000|Overall Study|Death|3|||
126117736|NCT01390272|453725280|FG001|Overall Study|Death|2|||
126117737|NCT01390272|453725279|FG000|Overall Study|Withdrawal by Subject|9|||
126117738|NCT01390272|453725280|FG001|Overall Study|Withdrawal by Subject|5|||
126117739|NCT01390272|453725279|FG000|Overall Study|Patient moved, no longer eligible|5|||
126117740|NCT01390272|453725280|FG001|Overall Study|Patient moved, no longer eligible|8|||
126117741|NCT03086057|453725283|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
126117742|NCT03086057|453725284|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
126117743|NCT03086057|453725285|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
126117744|NCT03086057|453725286|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
126117745|NCT03086057|453725283|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
126117746|NCT03086057|453725284|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
126117747|NCT03086057|453725285|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
126117748|NCT03086057|453725286|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
126117749|NCT03086057|453725283|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
126117750|NCT03086057|453725284|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
126117751|NCT03086057|453725285|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
126117752|NCT03086057|453725286|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
126117753|NCT03086057|453725283|FG000|Stage 1: PrEP Uptake|Death|1|||
126117754|NCT03086057|453725284|FG001|Stage 1: PrEP Uptake|Death|0|||
126117755|NCT03086057|453725285|FG002|Stage 1: PrEP Uptake|Death|0|||
126117756|NCT03086057|453725286|FG003|Stage 1: PrEP Uptake|Death|0|||
126117757|NCT03086057|453725283|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
126117758|NCT03086057|453725284|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
126117759|NCT03086057|453725285|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
126117760|NCT03086057|453725286|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
126117761|NCT03086057|453725283|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
126117762|NCT03086057|453725284|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
126117763|NCT03086057|453725285|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
126117764|NCT03086057|453725286|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
126117765|NCT03086057|453725283|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
126117766|NCT03086057|453725284|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
126117767|NCT03086057|453725285|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
126117768|NCT03086057|453725286|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
126117769|NCT04305275|453725289|FG000|Overall Study|Adverse Event|4|||
126117770|NCT04305275|453725290|FG001|Overall Study|Adverse Event|0|||
126117771|NCT04305275|453725289|FG000|Overall Study|Lost to Follow-up|1|||
126117772|NCT04305275|453725290|FG001|Overall Study|Lost to Follow-up|1|||
126117773|NCT04305275|453725289|FG000|Overall Study|Withdrawal by Participant|8|||
126117774|NCT04305275|453725290|FG001|Overall Study|Withdrawal by Participant|1|||
126117775|NCT00117598|453725291|FG000|Prior to Treatment Cross Over|Death|40|||
126117776|NCT00117598|453725292|FG001|Prior to Treatment Cross Over|Death|41|||
126117777|NCT00117598|453725293|FG002|Prior to Treatment Cross Over|Death|37|||
126117778|NCT00117598|453725294|FG003|Prior to Treatment Cross Over|Death|0|||
126117779|NCT00117598|453725295|FG004|Prior to Treatment Cross Over|Death|0|||
126117780|NCT00117598|453725291|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
126117781|NCT00117598|453725292|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
126117782|NCT00117598|453725293|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
126117783|NCT00117598|453725294|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
126117784|NCT00117598|453725295|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
126117785|NCT00117598|453725291|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
126117786|NCT00117598|453725292|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
126117787|NCT00117598|453725293|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
126117788|NCT00117598|453725294|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
126117789|NCT00117598|453725295|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
126117790|NCT00117598|453725291|FG000|Prior to Treatment Cross Over|Other|15|||
126117791|NCT00117598|453725292|FG001|Prior to Treatment Cross Over|Other|9|||
126117792|NCT00117598|453725293|FG002|Prior to Treatment Cross Over|Other|9|||
126117793|NCT00117598|453725294|FG003|Prior to Treatment Cross Over|Other|0|||
126117794|NCT00117598|453725295|FG004|Prior to Treatment Cross Over|Other|0|||
126117795|NCT00117598|453725291|FG000|After Treament Cross Over|Death|0|||
126117796|NCT00117598|453725292|FG001|After Treament Cross Over|Death|0|||
125960630|NCT01750268|453149251|FG000|Overall Study|Lost to Follow-up|0|||
125960631|NCT01750268|453149252|FG001|Overall Study|Lost to Follow-up|2|||
125960632|NCT01750268|453149251|FG000|Overall Study|Physician Decision|0|||
125960633|NCT01750268|453149252|FG001|Overall Study|Physician Decision|3|||
125960634|NCT01750268|453149251|FG000|Overall Study|Withdrawal by Subject|2|||
125960635|NCT01750268|453149252|FG001|Overall Study|Withdrawal by Subject|0|||
125960636|NCT01969838|453149255|FG000|Double-blind Phase|Adverse Event|10|||
125960637|NCT01969838|453149256|FG001|Double-blind Phase|Adverse Event|4|||
125960638|NCT01969838|453149257|FG002|Double-blind Phase|Adverse Event|0|||
126117797|NCT00117598|453725293|FG002|After Treament Cross Over|Death|0|||
126117798|NCT00117598|453725294|FG003|After Treament Cross Over|Death|1|||
126117799|NCT00117598|453725295|FG004|After Treament Cross Over|Death|2|||
126117800|NCT00117598|453725291|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
126117801|NCT00117598|453725292|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
126117802|NCT00117598|453725293|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
125960639|NCT01969838|453149258|FG003|Double-blind Phase|Adverse Event|0|||
125960640|NCT01969838|453149255|FG000|Double-blind Phase|Death|5|||
125960641|NCT01969838|453149256|FG001|Double-blind Phase|Death|2|||
125960642|NCT01969838|453149257|FG002|Double-blind Phase|Death|0|||
125960643|NCT01969838|453149258|FG003|Double-blind Phase|Death|0|||
125960644|NCT01969838|453149255|FG000|Double-blind Phase|Physician Decision|5|||
125960645|NCT01969838|453149256|FG001|Double-blind Phase|Physician Decision|1|||
125960646|NCT01969838|453149257|FG002|Double-blind Phase|Physician Decision|0|||
125960647|NCT01969838|453149258|FG003|Double-blind Phase|Physician Decision|0|||
125960648|NCT01969838|453149255|FG000|Double-blind Phase|Subject Decision|4|||
125960649|NCT01969838|453149256|FG001|Double-blind Phase|Subject Decision|2|||
125960650|NCT01969838|453149257|FG002|Double-blind Phase|Subject Decision|0|||
126117803|NCT00117598|453725294|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
126117804|NCT00117598|453725295|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
126117805|NCT00117598|453725291|FG000|After Treament Cross Over|Other|0|||
126117806|NCT00117598|453725292|FG001|After Treament Cross Over|Other|0|||
126117807|NCT00117598|453725293|FG002|After Treament Cross Over|Other|0|||
126117808|NCT00117598|453725294|FG003|After Treament Cross Over|Other|1|||
126117809|NCT00117598|453725295|FG004|After Treament Cross Over|Other|2|||
126117810|NCT01536951|453725296|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126117811|NCT01536951|453725297|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126117812|NCT01536951|453725298|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
126117813|NCT01536951|453725299|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126117814|NCT01536951|453725300|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126117815|NCT01536951|453725301|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126117816|NCT01536951|453725302|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126117817|NCT01536951|453725303|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126117818|NCT01536951|453725304|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126117819|NCT01536951|453725296|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
126117820|NCT01536951|453725297|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
126117821|NCT01536951|453725298|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
126117822|NCT01536951|453725299|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
126117823|NCT01536951|453725300|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
126117824|NCT01536951|453725301|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
126117825|NCT01536951|453725302|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
126117826|NCT01536951|453725303|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
126117827|NCT01536951|453725304|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
126117828|NCT03805750|453725305|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
126117829|NCT03805750|453725306|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
126117830|NCT01177683|453725307|FG000|Study Treatment|Disease Progressions during treatment|2|||
126117831|NCT01177683|453725308|FG001|Study Treatment|Disease Progressions during treatment|0|||
126117832|NCT01177683|453725309|FG002|Study Treatment|Disease Progressions during treatment|3|||
126117833|NCT01177683|453725307|FG000|Study Treatment|Adverse Event|0|||
126117834|NCT01177683|453725308|FG001|Study Treatment|Adverse Event|1|||
126117835|NCT01177683|453725309|FG002|Study Treatment|Adverse Event|12|||
126117836|NCT01177683|453725307|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
126117837|NCT01177683|453725308|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
126117838|NCT01177683|453725309|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
126117839|NCT01177683|453725307|FG000|Study Treatment|Alternative therapy|0|||
126117840|NCT01177683|453725308|FG001|Study Treatment|Alternative therapy|0|||
126117841|NCT01177683|453725309|FG002|Study Treatment|Alternative therapy|4|||
126117842|NCT01177683|453725307|FG000|Study Treatment|Physician Decision|1|||
126117843|NCT01177683|453725308|FG001|Study Treatment|Physician Decision|0|||
126117844|NCT01177683|453725309|FG002|Study Treatment|Physician Decision|1|||
126117845|NCT01177683|453725307|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
126117846|NCT01177683|453725308|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
126117847|NCT01177683|453725309|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
126117848|NCT01177683|453725307|FG000|Study Treatment|Symptomatic Deterioration|0|||
126117849|NCT01177683|453725308|FG001|Study Treatment|Symptomatic Deterioration|0|||
126117850|NCT01177683|453725309|FG002|Study Treatment|Symptomatic Deterioration|1|||
126117851|NCT01177683|453725307|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
126117852|NCT01177683|453725308|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
126117853|NCT01177683|453725309|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
126117854|NCT01177683|453725307|FG000|Follow up|Patient lost to follow up|0|||
126117855|NCT01177683|453725308|FG001|Follow up|Patient lost to follow up|0|||
126117856|NCT01177683|453725309|FG002|Follow up|Patient lost to follow up|2|||
125960651|NCT01969838|453149258|FG003|Double-blind Phase|Subject Decision|0|||
125960652|NCT01969838|453149255|FG000|Double-blind Phase|Disease Progression|2|||
125960653|NCT01969838|453149256|FG001|Double-blind Phase|Disease Progression|0|||
125960654|NCT01969838|453149257|FG002|Double-blind Phase|Disease Progression|0|||
125960655|NCT01969838|453149258|FG003|Double-blind Phase|Disease Progression|0|||
125960656|NCT01969838|453149255|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
126117857|NCT01177683|453725307|FG000|Follow up|Death|2|||
126117858|NCT01177683|453725308|FG001|Follow up|Death|1|||
126117859|NCT01177683|453725309|FG002|Follow up|Death|7|||
126117860|NCT01177683|453725307|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
126117861|NCT01177683|453725308|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
126117862|NCT01177683|453725309|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
126117863|NCT01889238|453725311|FG000|Overall Study|Death|1|||
126117864|NCT01889238|453725311|FG000|Overall Study|Withdrawal by Subject|1|||
126117865|NCT01889238|453725311|FG000|Overall Study|Adverse Event|6|||
126117866|NCT01889238|453725311|FG000|Overall Study|Disease Progression|104|||
126117867|NCT01889238|453725311|FG000|Overall Study|Other|6|||
126117868|NCT04136184|453725312|FG000|Overall Study|Lost to Follow-up|0|||
126117869|NCT04136184|453725313|FG001|Overall Study|Lost to Follow-up|3|||
126117870|NCT04136184|453725312|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
126117871|NCT04136184|453725313|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
126117872|NCT02844816|453725314|FG000|Overall Study|No protocol treatment received|5|||
126117873|NCT02844816|453725315|FG001|Overall Study|No protocol treatment received|1|||
126117874|NCT02844816|453725314|FG000|Overall Study|Ineligible|22|||
126117875|NCT02844816|453725315|FG001|Overall Study|Ineligible|15|||
126117876|NCT02844816|453725314|FG000|Overall Study|Participant refusal|5|||
126117877|NCT02844816|453725315|FG001|Overall Study|Participant refusal|5|||
126117878|NCT02844816|453725314|FG000|Overall Study|Adverse Event|5|||
126117879|NCT02844816|453725315|FG001|Overall Study|Adverse Event|4|||
126117880|NCT02844816|453725314|FG000|Overall Study|Death|0|||
126117881|NCT02844816|453725315|FG001|Overall Study|Death|1|||
126117882|NCT02844816|453725314|FG000|Overall Study|Disease progression/recurrence|50|||
126117883|NCT02844816|453725315|FG001|Overall Study|Disease progression/recurrence|24|||
126117884|NCT02844816|453725314|FG000|Overall Study|Physician Decision|1|||
126117885|NCT02844816|453725315|FG001|Overall Study|Physician Decision|1|||
126117886|NCT02717754|453725316|FG000|Overall Study|Incorrect Infusion Duration|0|||
126117887|NCT02717754|453725317|FG001|Overall Study|Incorrect Infusion Duration|0|||
126117888|NCT02717754|453725318|FG002|Overall Study|Incorrect Infusion Duration|0|||
126117889|NCT02717754|453725319|FG003|Overall Study|Incorrect Infusion Duration|10|||
126117890|NCT02717754|453725320|FG004|Overall Study|Incorrect Infusion Duration|20|||
126117891|NCT02717754|453725321|FG005|Overall Study|Incorrect Infusion Duration|20|||
126117892|NCT03734016|453725322|FG000|Overall Study|Sponsor Ended Study|225|||
126117893|NCT03734016|453725323|FG001|Overall Study|Sponsor Ended Study|200|||
126117894|NCT03734016|453725322|FG000|Overall Study|Death|69|||
126117895|NCT03734016|453725323|FG001|Overall Study|Death|83|||
126117896|NCT03734016|453725322|FG000|Overall Study|Withdrawal by Subject|21|||
126117897|NCT03734016|453725323|FG001|Overall Study|Withdrawal by Subject|27|||
126117898|NCT03734016|453725322|FG000|Overall Study|Physician Decision|1|||
126117899|NCT03734016|453725323|FG001|Overall Study|Physician Decision|12|||
126117900|NCT03734016|453725322|FG000|Overall Study|Lost to Follow-up|6|||
126117901|NCT03734016|453725323|FG001|Overall Study|Lost to Follow-up|2|||
126117902|NCT03734016|453725322|FG000|Overall Study|Miscellaneous|5|||
126117903|NCT03734016|453725323|FG001|Overall Study|Miscellaneous|1|||
126117904|NCT01979835|453725324|FG000|Primary Outcome SA Measurment|failed insertion|18|||
126117905|NCT01979835|453725324|FG000|Follow-up|Lost to Follow-up|32|||
126117906|NCT02592018|453725327|FG000|Overall Study|Adverse Event|1|||
126117907|NCT02592018|453725327|FG000|Overall Study|Lost to Follow-up|1|||
126117908|NCT02710136|453725330|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
126117909|NCT02710136|453725331|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
126117910|NCT00418665|453725332|FG000|Treatment Period|Ineligibility determined|1|||
126117911|NCT00418665|453725333|FG001|Treatment Period|Ineligibility determined|1|||
126117912|NCT00418665|453725334|FG002|Treatment Period|Ineligibility determined|0|||
126117913|NCT00418665|453725332|FG000|Treatment Period|Adverse Event|2|||
126117914|NCT00418665|453725333|FG001|Treatment Period|Adverse Event|2|||
126117915|NCT00418665|453725334|FG002|Treatment Period|Adverse Event|0|||
126117916|NCT00418665|453725332|FG000|Treatment Period|Withdrawal by Subject|0|||
126117917|NCT00418665|453725333|FG001|Treatment Period|Withdrawal by Subject|3|||
126117918|NCT00418665|453725334|FG002|Treatment Period|Withdrawal by Subject|1|||
126117919|NCT00418665|453725332|FG000|Treatment Period|Requirement for alternative therapy|1|||
126117920|NCT00418665|453725333|FG001|Treatment Period|Requirement for alternative therapy|0|||
126117921|NCT00418665|453725334|FG002|Treatment Period|Requirement for alternative therapy|0|||
126117922|NCT00418665|453725332|FG000|Treatment Period|Physician Decision|1|||
126117923|NCT00418665|453725333|FG001|Treatment Period|Physician Decision|0|||
126117924|NCT00418665|453725334|FG002|Treatment Period|Physician Decision|3|||
126117925|NCT00418665|453725332|FG000|Treatment Extension|Adverse Event|1|||
126117926|NCT00418665|453725333|FG001|Treatment Extension|Adverse Event|0|||
126117927|NCT00418665|453725334|FG002|Treatment Extension|Adverse Event|0|||
126117928|NCT00418665|453725332|FG000|Treatment Extension|Withdrawal by Subject|1|||
126117929|NCT00418665|453725333|FG001|Treatment Extension|Withdrawal by Subject|0|||
126117930|NCT00418665|453725334|FG002|Treatment Extension|Withdrawal by Subject|0|||
126117931|NCT00418665|453725332|FG000|Treatment Extension|Requirement for alternative therapy|2|||
126117932|NCT00418665|453725333|FG001|Treatment Extension|Requirement for alternative therapy|2|||
126117933|NCT00418665|453725334|FG002|Treatment Extension|Requirement for alternative therapy|0|||
126117934|NCT00418665|453725332|FG000|Treatment Extension|Physician Decision|2|||
126117935|NCT00418665|453725333|FG001|Treatment Extension|Physician Decision|2|||
126117936|NCT00418665|453725334|FG002|Treatment Extension|Physician Decision|1|||
126117937|NCT00418665|453725332|FG000|Treatment Extension|Death|0|||
126117938|NCT00418665|453725333|FG001|Treatment Extension|Death|0|||
126117939|NCT00418665|453725334|FG002|Treatment Extension|Death|1|||
126117940|NCT01133379|453725337|FG000|Overall Study|Withdrawal by Subject|0|||
126117941|NCT01133379|453725338|FG001|Overall Study|Withdrawal by Subject|1|||
126117942|NCT01133379|453725339|FG002|Overall Study|Withdrawal by Subject|1|||
126117943|NCT01133379|453725337|FG000|Overall Study|Lost to Follow-up|1|||
126117944|NCT01133379|453725338|FG001|Overall Study|Lost to Follow-up|1|||
126117945|NCT01133379|453725339|FG002|Overall Study|Lost to Follow-up|1|||
126117946|NCT00591214|453725342|FG000|Overall Study|Physician Decision|7|||
126117947|NCT00591214|453725342|FG000|Overall Study|Withdrawal by Subject|1|||
126151350|NCT00356915|453841967|FG001|Overall Study|Miscellaneous reasons|8|||
126151351|NCT00356915|453841968|FG002|Overall Study|Miscellaneous reasons|3|||
126151352|NCT00509106|453841970|FG000|Overall Study|Adverse Event|3|||
126151353|NCT00509106|453841971|FG001|Overall Study|Adverse Event|2|||
126151354|NCT00509106|453841970|FG000|Overall Study|Noncompliance|0|||
126151355|NCT00509106|453841971|FG001|Overall Study|Noncompliance|1|||
126151356|NCT00509106|453841970|FG000|Overall Study|At the request of sponsor/investigator|1|||
126151357|NCT00509106|453841971|FG001|Overall Study|At the request of sponsor/investigator|2|||
126151358|NCT00509106|453841970|FG000|Overall Study|Withdrew consent|4|||
126151359|NCT00509106|453841971|FG001|Overall Study|Withdrew consent|8|||
126151360|NCT00509106|453841970|FG000|Overall Study|Lost to Follow-up|16|||
126151361|NCT00509106|453841971|FG001|Overall Study|Lost to Follow-up|10|||
126151362|NCT00509106|453841970|FG000|Overall Study|Other|1|||
126151363|NCT00509106|453841971|FG001|Overall Study|Other|0|||
126151364|NCT00509106|453841970|FG000|Overall Study|Death|6|||
126151365|NCT00509106|453841971|FG001|Overall Study|Death|6|||
126151366|NCT02318602|453841972|FG000|Overall Study|Adverse Event|0|||
126151367|NCT02318602|453841973|FG001|Overall Study|Adverse Event|1|||
126151368|NCT02318602|453841974|FG002|Overall Study|Adverse Event|1|||
126151369|NCT02318602|453841972|FG000|Overall Study|Withdrawal by Subject|0|||
126151370|NCT02318602|453841973|FG001|Overall Study|Withdrawal by Subject|3|||
126151371|NCT02318602|453841974|FG002|Overall Study|Withdrawal by Subject|0|||
126151372|NCT02318602|453841972|FG000|Overall Study|Death|1|||
126151373|NCT02318602|453841973|FG001|Overall Study|Death|0|||
126151374|NCT02318602|453841974|FG002|Overall Study|Death|0|||
126151375|NCT02318602|453841972|FG000|Overall Study|Guardian decision to withdraw|0|||
126151376|NCT02318602|453841973|FG001|Overall Study|Guardian decision to withdraw|0|||
126151377|NCT02318602|453841974|FG002|Overall Study|Guardian decision to withdraw|1|||
126151378|NCT00693706|453841975|FG000|Overall Study|Protocol Violation|0|||
126151379|NCT00693706|453841976|FG001|Overall Study|Protocol Violation|1|||
126151380|NCT00488631|453841977|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
126151381|NCT00488631|453841978|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
126151382|NCT00488631|453841979|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
126151383|NCT00488631|453841980|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
126151384|NCT00488631|453841981|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
126151385|NCT00488631|453841982|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
126151386|NCT00488631|453841983|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
126151387|NCT00488631|453841984|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
126151388|NCT00488631|453841985|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
126151389|NCT00488631|453841986|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
126151390|NCT00488631|453841977|FG000|Double Blind Period (Week 0-54)|Death|0|||
126151391|NCT00488631|453841978|FG001|Double Blind Period (Week 0-54)|Death|0|||
126151392|NCT00488631|453841979|FG002|Double Blind Period (Week 0-54)|Death|0|||
126151393|NCT00488631|453841980|FG003|Double Blind Period (Week 0-54)|Death|0|||
126151394|NCT00488631|453841981|FG004|Double Blind Period (Week 0-54)|Death|0|||
126151395|NCT00488631|453841982|FG005|Double Blind Period (Week 0-54)|Death|1|||
126151396|NCT00488631|453841983|FG006|Double Blind Period (Week 0-54)|Death|0|||
126151397|NCT00488631|453841984|FG007|Double Blind Period (Week 0-54)|Death|0|||
126151398|NCT00488631|453841985|FG008|Double Blind Period (Week 0-54)|Death|0|||
126151399|NCT00488631|453841986|FG009|Double Blind Period (Week 0-54)|Death|0|||
126151400|NCT00488631|453841977|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
126151401|NCT00488631|453841978|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
126151402|NCT00488631|453841979|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
126151403|NCT00488631|453841980|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
126151404|NCT00488631|453841981|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
126151405|NCT00488631|453841982|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
126151406|NCT00488631|453841983|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
126151407|NCT00488631|453841984|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
126151408|NCT00488631|453841985|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
126151409|NCT00488631|453841986|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
126117948|NCT02142738|453726954|FG000|Overall Study|Adverse Event|13|||
126117949|NCT02142738|453726955|FG001|Overall Study|Adverse Event|9|||
126117950|NCT02142738|453726954|FG000|Overall Study|Death|92|||
126117951|NCT02142738|453726955|FG001|Overall Study|Death|112|||
126117952|NCT02142738|453726954|FG000|Overall Study|Lost to Follow-up|0|||
126117953|NCT02142738|453726955|FG001|Overall Study|Lost to Follow-up|3|||
126117954|NCT02142738|453726954|FG000|Overall Study|Withdrawal by Subject|6|||
126117955|NCT02142738|453726955|FG001|Overall Study|Withdrawal by Subject|7|||
126117956|NCT02142738|453726954|FG000|Overall Study|Follow up ended by sponsor|43|||
126117957|NCT02142738|453726955|FG001|Overall Study|Follow up ended by sponsor|20|||
126117958|NCT03688880|453726956|FG000|Overall Study|Withdrawal by Subject|0|||
126117959|NCT03688880|453726957|FG001|Overall Study|Withdrawal by Subject|2|||
126117960|NCT03688880|453726956|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
126117961|NCT03688880|453726957|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
126117962|NCT03688880|453726956|FG000|Overall Study|Lost to Follow-up|4|||
126117963|NCT03688880|453726957|FG001|Overall Study|Lost to Follow-up|7|||
126117964|NCT03688880|453726956|FG000|Overall Study|Adverse Event|0|||
126117965|NCT03688880|453726957|FG001|Overall Study|Adverse Event|2|||
126117966|NCT03688880|453726956|FG000|Overall Study|Device deficiencies|0|||
126117967|NCT03688880|453726957|FG001|Overall Study|Device deficiencies|2|||
126117968|NCT03688880|453726956|FG000|Overall Study|Other|10|||
126117969|NCT03688880|453726957|FG001|Overall Study|Other|16|||
126117970|NCT04490395|453726958|FG000|Overall Study|Lost to Follow-up|0|||
126117971|NCT04490395|453726959|FG001|Overall Study|Lost to Follow-up|1|||
126117972|NCT00257725|453726961|FG000|Overall Study|Adverse Event|3|||
126117973|NCT01858532|453726962|FG000|Overall Study|Adverse Event|58|||
126117974|NCT01858532|453726963|FG001|Overall Study|Adverse Event|50|||
126117975|NCT01858532|453726964|FG002|Overall Study|Adverse Event|23|||
126117976|NCT01858532|453726965|FG003|Overall Study|Adverse Event|28|||
126117977|NCT01858532|453726962|FG000|Overall Study|Withdrew consent|71|||
126117978|NCT01858532|453726963|FG001|Overall Study|Withdrew consent|93|||
126117979|NCT01858532|453726964|FG002|Overall Study|Withdrew consent|46|||
126117980|NCT01858532|453726965|FG003|Overall Study|Withdrew consent|27|||
126117981|NCT01858532|453726962|FG000|Overall Study|Lost to Follow-up|17|||
126117982|NCT01858532|453726963|FG001|Overall Study|Lost to Follow-up|26|||
126117983|NCT01858532|453726964|FG002|Overall Study|Lost to Follow-up|11|||
126117984|NCT01858532|453726965|FG003|Overall Study|Lost to Follow-up|14|||
126117985|NCT01858532|453726962|FG000|Overall Study|Deterioration of medical status|3|||
126117986|NCT01858532|453726963|FG001|Overall Study|Deterioration of medical status|4|||
126117987|NCT01858532|453726964|FG002|Overall Study|Deterioration of medical status|3|||
126117988|NCT01858532|453726965|FG003|Overall Study|Deterioration of medical status|7|||
126117989|NCT01858532|453726962|FG000|Overall Study|Investigator request|3|||
126117990|NCT01858532|453726963|FG001|Overall Study|Investigator request|4|||
126117991|NCT01858532|453726964|FG002|Overall Study|Investigator request|2|||
126117992|NCT01858532|453726965|FG003|Overall Study|Investigator request|6|||
126117993|NCT01858532|453726962|FG000|Overall Study|Other, not specified|29|||
126117994|NCT01858532|453726963|FG001|Overall Study|Other, not specified|15|||
126117995|NCT01858532|453726964|FG002|Overall Study|Other, not specified|13|||
126117996|NCT01858532|453726965|FG003|Overall Study|Other, not specified|11|||
126117997|NCT03785925|453726967|FG000|Overall Study|Withdrawal by Subject|15|||
126117998|NCT03785925|453726967|FG000|Overall Study|Lost to Follow-up|1|||
126117999|NCT00806195|453726971|FG000|Overall Study|Death|6|||
126118000|NCT00806195|453726972|FG001|Overall Study|Death|0|||
126118001|NCT00806195|453726973|FG002|Overall Study|Death|1|||
126118002|NCT00806195|453726974|FG003|Overall Study|Death|0|||
126118003|NCT00806195|453726971|FG000|Overall Study|Adverse Event|25|||
126118004|NCT00806195|453726972|FG001|Overall Study|Adverse Event|5|||
126118005|NCT00806195|453726973|FG002|Overall Study|Adverse Event|11|||
126118006|NCT00806195|453726974|FG003|Overall Study|Adverse Event|2|||
126118007|NCT00806195|453726971|FG000|Overall Study|Withdrawal by Subject|119|||
126118008|NCT00806195|453726972|FG001|Overall Study|Withdrawal by Subject|31|||
126118009|NCT00806195|453726973|FG002|Overall Study|Withdrawal by Subject|76|||
126118010|NCT00806195|453726974|FG003|Overall Study|Withdrawal by Subject|35|||
126118011|NCT00806195|453726971|FG000|Overall Study|Lost to Follow-up|217|||
126118012|NCT00806195|453726972|FG001|Overall Study|Lost to Follow-up|66|||
126118013|NCT00806195|453726973|FG002|Overall Study|Lost to Follow-up|90|||
126118014|NCT00806195|453726974|FG003|Overall Study|Lost to Follow-up|34|||
126118015|NCT00806195|453726971|FG000|Overall Study|Inappropriate Enrollment|0|||
126118016|NCT00806195|453726972|FG001|Overall Study|Inappropriate Enrollment|1|||
126118017|NCT00806195|453726973|FG002|Overall Study|Inappropriate Enrollment|0|||
126118018|NCT00806195|453726974|FG003|Overall Study|Inappropriate Enrollment|0|||
126118019|NCT00806195|453726971|FG000|Overall Study|Administrative Reason|113|||
126118020|NCT00806195|453726972|FG001|Overall Study|Administrative Reason|35|||
126118021|NCT00806195|453726973|FG002|Overall Study|Administrative Reason|66|||
126118022|NCT00806195|453726974|FG003|Overall Study|Administrative Reason|26|||
126118023|NCT00806195|453726971|FG000|Overall Study|Protocol Violation|34|||
126118024|NCT00806195|453726972|FG001|Overall Study|Protocol Violation|24|||
126118025|NCT00806195|453726973|FG002|Overall Study|Protocol Violation|26|||
126118026|NCT00806195|453726974|FG003|Overall Study|Protocol Violation|9|||
126118027|NCT02490475|453726975|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
126118028|NCT02490475|453726976|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
126118029|NCT02490475|453726977|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
126118030|NCT02490475|453726978|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
126118031|NCT02490475|453726975|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
126118032|NCT02490475|453726976|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
126118033|NCT02490475|453726977|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
126118034|NCT02490475|453726978|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
126118035|NCT02490475|453726975|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
126118036|NCT02490475|453726976|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
126118037|NCT02490475|453726977|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
126118038|NCT02490475|453726978|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
126118039|NCT02490475|453726975|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
126118040|NCT02490475|453726976|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
126118041|NCT02490475|453726977|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
126118042|NCT02490475|453726978|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
126118043|NCT02490475|453726975|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
126118044|NCT02490475|453726976|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
126118045|NCT02490475|453726977|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
126118046|NCT02490475|453726978|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
126118047|NCT02490475|453726975|FG000|Period 2: Extension Phase|Refused Treatment|0|||
126118048|NCT02490475|453726976|FG001|Period 2: Extension Phase|Refused Treatment|0|||
126118049|NCT02490475|453726977|FG002|Period 2: Extension Phase|Refused Treatment|0|||
126118050|NCT02490475|453726978|FG003|Period 2: Extension Phase|Refused Treatment|1|||
126118051|NCT02490475|453726975|FG000|Period 2: Extension Phase|Adverse Event|0|||
126118052|NCT02490475|453726976|FG001|Period 2: Extension Phase|Adverse Event|0|||
126118053|NCT02490475|453726977|FG002|Period 2: Extension Phase|Adverse Event|1|||
126118054|NCT02490475|453726978|FG003|Period 2: Extension Phase|Adverse Event|0|||
126118055|NCT00139776|453726979|FG000|Period I|Did not enter Period II|575|||
126118056|NCT00139776|453726980|FG001|Period I|Did not enter Period II|0|||
126118057|NCT00139776|453726981|FG002|Period I|Did not enter Period II|0|||
126118058|NCT00139776|453726982|FG003|Period I|Did not enter Period II|0|||
126118059|NCT00139776|453726979|FG000|Period II|Not Randomized into Period III|0|||
126118060|NCT00139776|453726980|FG001|Period II|Not Randomized into Period III|322|||
126118061|NCT00139776|453726981|FG002|Period II|Not Randomized into Period III|0|||
126118062|NCT00139776|453726982|FG003|Period II|Not Randomized into Period III|0|||
126118063|NCT00139776|453726979|FG000|Period III|Adverse Event|0|||
126118064|NCT00139776|453726980|FG001|Period III|Adverse Event|0|||
126118065|NCT00139776|453726981|FG002|Period III|Adverse Event|22|||
126118066|NCT00139776|453726982|FG003|Period III|Adverse Event|23|||
126118067|NCT00139776|453726979|FG000|Period III|Other|0|||
126118068|NCT00139776|453726980|FG001|Period III|Other|0|||
126118069|NCT00139776|453726981|FG002|Period III|Other|23|||
126118070|NCT00139776|453726982|FG003|Period III|Other|34|||
126118071|NCT00139776|453726979|FG000|Period III|Lack of Efficacy|0|||
126118072|NCT00139776|453726980|FG001|Period III|Lack of Efficacy|0|||
126118073|NCT00139776|453726981|FG002|Period III|Lack of Efficacy|10|||
126118074|NCT00139776|453726982|FG003|Period III|Lack of Efficacy|24|||
126118075|NCT00139776|453726979|FG000|Period III|Lost to Follow-up|0|||
126118076|NCT00139776|453726980|FG001|Period III|Lost to Follow-up|0|||
126118077|NCT00139776|453726981|FG002|Period III|Lost to Follow-up|5|||
126118078|NCT00139776|453726982|FG003|Period III|Lost to Follow-up|4|||
126118079|NCT00139776|453726979|FG000|Period III|Withdrawal by Subject|0|||
126118080|NCT00139776|453726980|FG001|Period III|Withdrawal by Subject|0|||
126118081|NCT00139776|453726981|FG002|Period III|Withdrawal by Subject|16|||
126118082|NCT00139776|453726982|FG003|Period III|Withdrawal by Subject|21|||
126118083|NCT01519934|453726987|FG000|Overall Study|Lost to Follow-up|3|||
126118084|NCT01368536|453726990|FG000|Overall Study|Adverse Event|5|||
126118085|NCT01368536|453726991|FG001|Overall Study|Adverse Event|6|||
126118086|NCT01368536|453726992|FG002|Overall Study|Adverse Event|8|||
126118087|NCT01368536|453726990|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126118088|NCT01368536|453726991|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126118089|NCT01368536|453726992|FG002|Overall Study|Abnormal laboratory value(s)|2|||
126118090|NCT01368536|453726990|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126118091|NCT01368536|453726991|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126118092|NCT01368536|453726992|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126118093|NCT01368536|453726990|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
126118094|NCT01368536|453726991|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126118095|NCT01368536|453726992|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126118096|NCT01368536|453726990|FG000|Overall Study|No longer required study medication|0|||
125960657|NCT01969838|453149256|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
126118097|NCT01368536|453726991|FG001|Overall Study|No longer required study medication|0|||
126118098|NCT01368536|453726992|FG002|Overall Study|No longer required study medication|1|||
125960658|NCT01969838|453149257|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
126118099|NCT01368536|453726990|FG000|Overall Study|Withdrawal by Subject|2|||
126118100|NCT01368536|453726991|FG001|Overall Study|Withdrawal by Subject|5|||
126118101|NCT01368536|453726992|FG002|Overall Study|Withdrawal by Subject|4|||
126118102|NCT01368536|453726990|FG000|Overall Study|Lost to Follow-up|3|||
126118103|NCT01368536|453726991|FG001|Overall Study|Lost to Follow-up|3|||
126118104|NCT01368536|453726992|FG002|Overall Study|Lost to Follow-up|5|||
126118105|NCT01368536|453726990|FG000|Overall Study|Administrative problems|34|||
126118106|NCT01368536|453726991|FG001|Overall Study|Administrative problems|39|||
126118107|NCT01368536|453726992|FG002|Overall Study|Administrative problems|35|||
126118108|NCT01368536|453726990|FG000|Overall Study|Protocol deviation|0|||
126118109|NCT01368536|453726991|FG001|Overall Study|Protocol deviation|3|||
126118110|NCT01368536|453726992|FG002|Overall Study|Protocol deviation|1|||
126118111|NCT00359021|453726993|FG000|Overall Study|Adverse Event|26|||
126118112|NCT00359021|453726994|FG001|Overall Study|Adverse Event|8|||
126118113|NCT00359021|453726993|FG000|Overall Study|Subject Non-Compliant|1|||
126118114|NCT00359021|453726994|FG001|Overall Study|Subject Non-Compliant|2|||
126118115|NCT00359021|453726993|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
126118116|NCT00359021|453726994|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
126118117|NCT00359021|453726993|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
126118118|NCT00359021|453726994|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
126118119|NCT00359021|453726993|FG000|Overall Study|Withdrawal by Subject|2|||
126118120|NCT00359021|453726994|FG001|Overall Study|Withdrawal by Subject|9|||
126118121|NCT00359021|453726993|FG000|Overall Study|Lost to Follow-up|1|||
126118122|NCT00359021|453726994|FG001|Overall Study|Lost to Follow-up|0|||
126118123|NCT00359021|453726993|FG000|Overall Study|Other|4|||
126118124|NCT00359021|453726994|FG001|Overall Study|Other|1|||
126118125|NCT00359021|453726993|FG000|Overall Study|Pregnancy|1|||
126118126|NCT00359021|453726994|FG001|Overall Study|Pregnancy|0|||
126118127|NCT03861936|453726995|FG000|Overall Study|Withdrawal by Subject|4|||
126118128|NCT03861936|453726996|FG001|Overall Study|Withdrawal by Subject|1|||
126118129|NCT03861936|453726997|FG002|Overall Study|Withdrawal by Subject|3|||
126118130|NCT03861936|453726995|FG000|Overall Study|Lost to Follow-up|5|||
126118131|NCT03861936|453726996|FG001|Overall Study|Lost to Follow-up|3|||
126118132|NCT03861936|453726997|FG002|Overall Study|Lost to Follow-up|3|||
126118133|NCT03861936|453726995|FG000|Overall Study|Physician Decision|0|||
126118134|NCT03861936|453726996|FG001|Overall Study|Physician Decision|1|||
126118135|NCT03861936|453726997|FG002|Overall Study|Physician Decision|0|||
126118136|NCT03861936|453726995|FG000|Overall Study|Protocol Deviation|0|||
126118137|NCT03861936|453726996|FG001|Overall Study|Protocol Deviation|0|||
126118138|NCT03861936|453726997|FG002|Overall Study|Protocol Deviation|1|||
126118139|NCT03861936|453726995|FG000|Overall Study|Reason not Specified|5|||
126118140|NCT03861936|453726996|FG001|Overall Study|Reason not Specified|5|||
126118141|NCT03861936|453726997|FG002|Overall Study|Reason not Specified|3|||
126118142|NCT01835015|453727001|FG000|Overall Study|Adverse Event|0|||
126118143|NCT01835015|453727002|FG001|Overall Study|Adverse Event|0|||
126118144|NCT01835015|453727003|FG002|Overall Study|Adverse Event|1|||
126118145|NCT01835015|453727004|FG003|Overall Study|Adverse Event|0|||
126118146|NCT01835015|453727005|FG004|Overall Study|Adverse Event|0|||
126118147|NCT04569032|453727010|FG000|Overall Study|Death|10|||
126118148|NCT04569032|453727011|FG001|Overall Study|Death|13|||
126118149|NCT04569032|453727010|FG000|Overall Study|Withdrawal by Subject|2|||
126118150|NCT04569032|453727011|FG001|Overall Study|Withdrawal by Subject|0|||
126118151|NCT04569032|453727010|FG000|Overall Study|Lost to Follow-up|0|||
126118152|NCT04569032|453727011|FG001|Overall Study|Lost to Follow-up|1|||
126118153|NCT04569032|453727010|FG000|Overall Study|In long term follow up|22|||
126118154|NCT04569032|453727011|FG001|Overall Study|In long term follow up|34|||
126118155|NCT00701090|453727013|FG000|Overall Study|Adverse Event|11|||
126118156|NCT00701090|453727014|FG001|Overall Study|Adverse Event|2|||
126118157|NCT00701090|453727013|FG000|Overall Study|Death|0|||
126118158|NCT00701090|453727014|FG001|Overall Study|Death|1|||
126118159|NCT00701090|453727013|FG000|Overall Study|Lack of Efficacy|5|||
126118160|NCT00701090|453727014|FG001|Overall Study|Lack of Efficacy|4|||
126118161|NCT00701090|453727013|FG000|Overall Study|Lost to Follow-up|9|||
126118162|NCT00701090|453727014|FG001|Overall Study|Lost to Follow-up|9|||
126118163|NCT00701090|453727013|FG000|Overall Study|Physician Decision|3|||
126118164|NCT00701090|453727014|FG001|Overall Study|Physician Decision|4|||
126118165|NCT00701090|453727013|FG000|Overall Study|Protocol Violation|2|||
126118166|NCT00701090|453727014|FG001|Overall Study|Protocol Violation|3|||
126118167|NCT00701090|453727013|FG000|Overall Study|Withdrawal by Subject|11|||
126118168|NCT00701090|453727014|FG001|Overall Study|Withdrawal by Subject|16|||
126118169|NCT00701090|453727013|FG000|Overall Study|Other|7|||
126118170|NCT00701090|453727014|FG001|Overall Study|Other|12|||
126118171|NCT04534491|453727019|FG000|Overall Study|Not completed end-of-study interview|24|||
126118172|NCT04534491|453727019|FG000|Overall Study|Non-users|70|||
126118173|NCT04534491|453727019|FG000|Overall Study|Non-verifiable users|58|||
126118174|NCT00113074|453727021|FG000|Overall Study|Lost to Follow-up|10|||
126118175|NCT00113074|453727022|FG001|Overall Study|Lost to Follow-up|10|||
126118176|NCT00113074|453727023|FG002|Overall Study|Lost to Follow-up|14|||
126118177|NCT02114268|453727024|FG000|Overall Study|Lost to Follow-up|4|||
126118178|NCT02114268|453727025|FG001|Overall Study|Lost to Follow-up|1|||
126118179|NCT02114268|453727026|FG002|Overall Study|Lost to Follow-up|1|||
126118180|NCT02114268|453727027|FG003|Overall Study|Lost to Follow-up|0|||
126118181|NCT02114268|453727028|FG004|Overall Study|Lost to Follow-up|0|||
126118182|NCT02114268|453727029|FG005|Overall Study|Lost to Follow-up|2|||
126118183|NCT02114268|453727024|FG000|Overall Study|Withdrawal by Subject|1|||
126118184|NCT02114268|453727025|FG001|Overall Study|Withdrawal by Subject|0|||
126118185|NCT02114268|453727026|FG002|Overall Study|Withdrawal by Subject|0|||
126118186|NCT02114268|453727027|FG003|Overall Study|Withdrawal by Subject|0|||
126118187|NCT02114268|453727028|FG004|Overall Study|Withdrawal by Subject|0|||
126118188|NCT02114268|453727029|FG005|Overall Study|Withdrawal by Subject|1|||
126118189|NCT02114268|453727024|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
126118190|NCT02114268|453727025|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
126118191|NCT02114268|453727026|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
126118192|NCT02114268|453727027|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
126118193|NCT02114268|453727028|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
126118194|NCT02114268|453727029|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
126118195|NCT03962738|453727030|FG000|Overall Study|Protocol Deviation|3|||
126118196|NCT03962738|453727031|FG001|Overall Study|Protocol Deviation|0|||
126118197|NCT03962738|453727032|FG002|Overall Study|Protocol Deviation|1|||
126118198|NCT03962738|453727033|FG003|Overall Study|Protocol Deviation|1|||
126118199|NCT03962738|453727030|FG000|Overall Study|Withdrawal by Subject|4|||
126118200|NCT03962738|453727031|FG001|Overall Study|Withdrawal by Subject|0|||
126118201|NCT03962738|453727032|FG002|Overall Study|Withdrawal by Subject|0|||
126118202|NCT03962738|453727033|FG003|Overall Study|Withdrawal by Subject|0|||
126118203|NCT03962738|453727030|FG000|Overall Study|Lost to Follow-up|0|||
126118204|NCT03962738|453727031|FG001|Overall Study|Lost to Follow-up|0|||
126118205|NCT03962738|453727032|FG002|Overall Study|Lost to Follow-up|1|||
126118206|NCT03962738|453727033|FG003|Overall Study|Lost to Follow-up|0|||
126118207|NCT00509067|453727034|FG000|Overall Study|Lost to Follow-up|1|||
126118208|NCT00509067|453727035|FG001|Overall Study|Lost to Follow-up|1|||
126118209|NCT00509067|453727034|FG000|Overall Study|Adverse Event|3|||
126118210|NCT00509067|453727035|FG001|Overall Study|Adverse Event|1|||
126118211|NCT00509067|453727034|FG000|Overall Study|Protocol Violation|0|||
126118212|NCT00509067|453727035|FG001|Overall Study|Protocol Violation|3|||
126118213|NCT00131469|453727036|FG000|Overall Study|Withdrawal by Subject|3|||
126118214|NCT00131469|453727037|FG001|Overall Study|Withdrawal by Subject|4|||
126118215|NCT00131469|453727036|FG000|Overall Study|Protocol Violation|3|||
126118216|NCT00131469|453727037|FG001|Overall Study|Protocol Violation|1|||
126118217|NCT00131469|453727036|FG000|Overall Study|Death|0|||
126118218|NCT00131469|453727037|FG001|Overall Study|Death|1|||
126118219|NCT00131469|453727036|FG000|Overall Study|Lost to Follow-up|0|||
126118220|NCT00131469|453727037|FG001|Overall Study|Lost to Follow-up|1|||
126118221|NCT00131469|453727036|FG000|Overall Study|scan not analyzable|3|||
126118222|NCT00131469|453727037|FG001|Overall Study|scan not analyzable|6|||
126118223|NCT00356889|453727039|FG000|Overall Study|Protocol Violation|2|||
126118224|NCT00356889|453727039|FG000|Overall Study|Adverse Event|1|||
126118225|NCT00702325|453727040|FG000|Overall Study|Adverse Event|1|||
126118226|NCT00702325|453727041|FG001|Overall Study|Adverse Event|0|||
126118227|NCT00702325|453727040|FG000|Overall Study|Withdrawal by Subject|7|||
126118228|NCT00702325|453727041|FG001|Overall Study|Withdrawal by Subject|7|||
126118229|NCT00702325|453727040|FG000|Overall Study|Lost to Follow-up|3|||
126118230|NCT00702325|453727041|FG001|Overall Study|Lost to Follow-up|4|||
126118231|NCT00702325|453727040|FG000|Overall Study|Incorrect enrollment|5|||
126118232|NCT00702325|453727041|FG001|Overall Study|Incorrect enrollment|7|||
126118233|NCT00702325|453727040|FG000|Overall Study|Developed study discontinuation criteria|18|||
126118234|NCT00702325|453727041|FG001|Overall Study|Developed study discontinuation criteria|28|||
126118235|NCT00702325|453727040|FG000|Overall Study|Severe noncompliance to protocol|3|||
126118236|NCT00702325|453727041|FG001|Overall Study|Severe noncompliance to protocol|3|||
126118237|NCT00702325|453727040|FG000|Overall Study|Termination due to lab results|1|||
126118238|NCT00702325|453727041|FG001|Overall Study|Termination due to lab results|0|||
126118239|NCT00702325|453727040|FG000|Overall Study|Didn't follow study medication dosage|0|||
126118240|NCT00702325|453727041|FG001|Overall Study|Didn't follow study medication dosage|2|||
126118241|NCT00702325|453727040|FG000|Overall Study|Withdrew consent|0|||
126118242|NCT00702325|453727041|FG001|Overall Study|Withdrew consent|1|||
126118243|NCT00702325|453727040|FG000|Overall Study|Incorrectly Discontinued|0|||
125960659|NCT01969838|453149258|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
125971517|NCT00791765|453184716|FG000|Weeks 13 to 24|Adverse Event|0|||
126118244|NCT00702325|453727041|FG001|Overall Study|Incorrectly Discontinued|1|||
126118245|NCT03716050|453727047|FG000|Overall Study|Lost to Follow-up|0|||
126118246|NCT03716050|453727048|FG001|Overall Study|Lost to Follow-up|0|||
126118247|NCT03716050|453727049|FG002|Overall Study|Lost to Follow-up|1|||
126118248|NCT03716050|453727050|FG003|Overall Study|Lost to Follow-up|0|||
126118249|NCT03716050|453727051|FG004|Overall Study|Lost to Follow-up|0|||
126118250|NCT03716050|453727052|FG005|Overall Study|Lost to Follow-up|0|||
126118251|NCT03716050|453727053|FG006|Overall Study|Lost to Follow-up|0|||
126118252|NCT03716050|453727054|FG007|Overall Study|Lost to Follow-up|0|||
126118253|NCT03716050|453727047|FG000|Overall Study|Physician Decision|0|||
126118254|NCT03716050|453727048|FG001|Overall Study|Physician Decision|0|||
126118255|NCT03716050|453727049|FG002|Overall Study|Physician Decision|0|||
126118256|NCT03716050|453727050|FG003|Overall Study|Physician Decision|1|||
126118257|NCT03716050|453727051|FG004|Overall Study|Physician Decision|0|||
126118258|NCT03716050|453727052|FG005|Overall Study|Physician Decision|0|||
126118259|NCT03716050|453727053|FG006|Overall Study|Physician Decision|0|||
126118260|NCT03716050|453727054|FG007|Overall Study|Physician Decision|0|||
126118261|NCT03716050|453727047|FG000|Overall Study|Protocol Violation|0|||
126118262|NCT03716050|453727048|FG001|Overall Study|Protocol Violation|0|||
126118263|NCT03716050|453727049|FG002|Overall Study|Protocol Violation|0|||
126118264|NCT03716050|453727050|FG003|Overall Study|Protocol Violation|1|||
126118265|NCT03716050|453727051|FG004|Overall Study|Protocol Violation|0|||
126118266|NCT03716050|453727052|FG005|Overall Study|Protocol Violation|0|||
126118267|NCT03716050|453727053|FG006|Overall Study|Protocol Violation|0|||
126118268|NCT03716050|453727054|FG007|Overall Study|Protocol Violation|2|||
126118269|NCT02566577|453727055|FG000|Overall Study|Withdrawal by Subject|1|||
126118270|NCT02566577|453727056|FG001|Overall Study|Withdrawal by Subject|1|||
126118271|NCT02566577|453727055|FG000|Overall Study|Equipment failure|1|||
126118272|NCT02566577|453727056|FG001|Overall Study|Equipment failure|1|||
126118273|NCT02566577|453727055|FG000|Overall Study|Physical limitation|1|||
126118274|NCT02566577|453727056|FG001|Overall Study|Physical limitation|0|||
126118275|NCT00073528|453727063|FG000|Overall Study|Death|488|||
126118276|NCT00073528|453727064|FG001|Overall Study|Death|473|||
126118277|NCT00073528|453727063|FG000|Overall Study|Lost to Follow-up|52|||
126118278|NCT00073528|453727064|FG001|Overall Study|Lost to Follow-up|45|||
126118279|NCT00073528|453727063|FG000|Overall Study|Withdrawal by Subject|50|||
126118280|NCT00073528|453727064|FG001|Overall Study|Withdrawal by Subject|45|||
126118281|NCT00073528|453727063|FG000|Overall Study|Study terminated by Sponsor|10|||
126118282|NCT00073528|453727064|FG001|Overall Study|Study terminated by Sponsor|29|||
126118283|NCT00073528|453727063|FG000|Overall Study|Other|18|||
126118284|NCT00073528|453727064|FG001|Overall Study|Other|19|||
126118285|NCT00073528|453727063|FG000|Overall Study|Other|9|||
126118286|NCT00073528|453727064|FG001|Overall Study|Other|12|||
126118287|NCT00073528|453727063|FG000|Overall Study|Protocol Violation|3|||
126118288|NCT00073528|453727064|FG001|Overall Study|Protocol Violation|5|||
126118289|NCT03654976|453727068|FG000|Overall Study|Withdrawal by Subject|12|||
126118290|NCT03654976|453727069|FG001|Overall Study|Withdrawal by Subject|11|||
126118291|NCT03654976|453727068|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
126118292|NCT03654976|453727069|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
126118293|NCT03654976|453727068|FG000|Overall Study|Adverse Event|5|||
126118294|NCT03654976|453727069|FG001|Overall Study|Adverse Event|0|||
126118295|NCT03654976|453727068|FG000|Overall Study|Lost to Follow-up|2|||
126118296|NCT03654976|453727069|FG001|Overall Study|Lost to Follow-up|0|||
126118297|NCT03654976|453727068|FG000|Overall Study|Lack of Efficacy|0|||
126118298|NCT03654976|453727069|FG001|Overall Study|Lack of Efficacy|1|||
126118299|NCT03098836|453727075|FG000|Overall Study|Adverse Event|1|||
126118300|NCT03098836|453727076|FG001|Overall Study|Adverse Event|3|||
126118301|NCT03098836|453727075|FG000|Overall Study|Lack of Efficacy|30|||
126118302|NCT03098836|453727076|FG001|Overall Study|Lack of Efficacy|15|||
126118303|NCT03098836|453727075|FG000|Overall Study|Physician Decision|2|||
126118304|NCT03098836|453727076|FG001|Overall Study|Physician Decision|1|||
126118305|NCT03098836|453727075|FG000|Overall Study|Withdrawal by Subject|3|||
126118306|NCT03098836|453727076|FG001|Overall Study|Withdrawal by Subject|2|||
126118307|NCT04688775|453727079|FG000|Placebo-controlled Period|Randomized, not treated|1|||
126118308|NCT04688775|453727080|FG001|Placebo-controlled Period|Randomized, not treated|1|||
126118309|NCT04688775|453727081|FG002|Placebo-controlled Period|Randomized, not treated|0|||
126118310|NCT04688775|453727082|FG003|Placebo-controlled Period|Randomized, not treated|0|||
126118311|NCT04688775|453727079|FG000|Placebo-controlled Period|Adverse Event|2|||
126118312|NCT04688775|453727080|FG001|Placebo-controlled Period|Adverse Event|0|||
126118313|NCT04688775|453727081|FG002|Placebo-controlled Period|Adverse Event|0|||
126118314|NCT04688775|453727082|FG003|Placebo-controlled Period|Adverse Event|0|||
126118315|NCT04688775|453727079|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
126118316|NCT04688775|453727080|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
126118317|NCT04688775|453727081|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
126118318|NCT04688775|453727082|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
126118319|NCT04688775|453727079|FG000|Placebo-controlled Period|Protocol Violation|0|||
126118320|NCT04688775|453727080|FG001|Placebo-controlled Period|Protocol Violation|1|||
126118321|NCT04688775|453727081|FG002|Placebo-controlled Period|Protocol Violation|0|||
126118322|NCT04688775|453727082|FG003|Placebo-controlled Period|Protocol Violation|0|||
126118323|NCT04688775|453727079|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
126118324|NCT04688775|453727080|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
126118325|NCT04688775|453727081|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
126118326|NCT04688775|453727082|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
126118327|NCT04688775|453727079|FG000|Placebo-controlled Period|Other reasons|0|||
126118328|NCT04688775|453727080|FG001|Placebo-controlled Period|Other reasons|1|||
126118329|NCT04688775|453727081|FG002|Placebo-controlled Period|Other reasons|0|||
126118330|NCT04688775|453727082|FG003|Placebo-controlled Period|Other reasons|0|||
126118331|NCT04688775|453727079|FG000|Delayed Start Period|Adverse Event|0|||
126118332|NCT04688775|453727080|FG001|Delayed Start Period|Adverse Event|0|||
126118333|NCT04688775|453727081|FG002|Delayed Start Period|Adverse Event|1|||
126118334|NCT04688775|453727082|FG003|Delayed Start Period|Adverse Event|0|||
126118335|NCT04688775|453727079|FG000|Delayed Start Period|Lack of Efficacy|0|||
126118336|NCT04688775|453727080|FG001|Delayed Start Period|Lack of Efficacy|0|||
126118337|NCT04688775|453727081|FG002|Delayed Start Period|Lack of Efficacy|0|||
126118338|NCT04688775|453727082|FG003|Delayed Start Period|Lack of Efficacy|3|||
126118339|NCT04688775|453727079|FG000|Delayed Start Period|Withdrawal by Subject|0|||
126118340|NCT04688775|453727080|FG001|Delayed Start Period|Withdrawal by Subject|0|||
126118341|NCT04688775|453727081|FG002|Delayed Start Period|Withdrawal by Subject|2|||
126118342|NCT04688775|453727082|FG003|Delayed Start Period|Withdrawal by Subject|4|||
126118343|NCT04688775|453727079|FG000|Delayed Start Period|Lost to Follow-up|0|||
126118344|NCT04688775|453727080|FG001|Delayed Start Period|Lost to Follow-up|0|||
126118345|NCT04688775|453727081|FG002|Delayed Start Period|Lost to Follow-up|2|||
126118346|NCT04688775|453727082|FG003|Delayed Start Period|Lost to Follow-up|1|||
126118347|NCT04688775|453727079|FG000|Delayed Start Period|other reasons|0|||
126118348|NCT04688775|453727080|FG001|Delayed Start Period|other reasons|0|||
126118349|NCT04688775|453727081|FG002|Delayed Start Period|other reasons|1|||
126118350|NCT04688775|453727082|FG003|Delayed Start Period|other reasons|0|||
126118351|NCT01770912|453727083|FG000|Overall Study|Lost to Follow-up|2|||
126118352|NCT01770912|453727084|FG001|Overall Study|Lost to Follow-up|0|||
126118353|NCT01817751|453727089|FG000|Overall Study|Physician Decision|1|||
126118354|NCT00382018|453727090|FG000|Overall Study|Progression|0|||
126118355|NCT00382018|453727091|FG001|Overall Study|Progression|136|||
126118356|NCT00382018|453727092|FG002|Overall Study|Progression|51|||
126118357|NCT00382018|453727093|FG003|Overall Study|Progression|43|||
126118358|NCT00382018|453727090|FG000|Overall Study|Death|0|||
126118359|NCT00382018|453727091|FG001|Overall Study|Death|9|||
126118360|NCT00382018|453727092|FG002|Overall Study|Death|7|||
126118361|NCT00382018|453727093|FG003|Overall Study|Death|11|||
126118362|NCT00382018|453727090|FG000|Overall Study|Withdrawal by Subject|0|||
126118363|NCT00382018|453727091|FG001|Overall Study|Withdrawal by Subject|4|||
126118364|NCT00382018|453727092|FG002|Overall Study|Withdrawal by Subject|3|||
126118365|NCT00382018|453727093|FG003|Overall Study|Withdrawal by Subject|4|||
126118366|NCT00382018|453727090|FG000|Overall Study|Other, not protocol specified|0|||
126118367|NCT00382018|453727091|FG001|Overall Study|Other, not protocol specified|16|||
126118368|NCT00382018|453727092|FG002|Overall Study|Other, not protocol specified|3|||
126118369|NCT00382018|453727093|FG003|Overall Study|Other, not protocol specified|1|||
126118370|NCT00789880|453727094|FG000|Overall Study|Adverse Event|0|||
126118371|NCT00789880|453727095|FG001|Overall Study|Adverse Event|0|||
126118372|NCT00789880|453727096|FG002|Overall Study|Adverse Event|0|||
126118373|NCT00789880|453727097|FG003|Overall Study|Adverse Event|0|||
126118374|NCT00789880|453727098|FG004|Overall Study|Adverse Event|1|||
126118375|NCT00789880|453727099|FG005|Overall Study|Adverse Event|0|||
126118376|NCT00789880|453727094|FG000|Overall Study|Protocol Violation|0|||
126118377|NCT00789880|453727095|FG001|Overall Study|Protocol Violation|1|||
126118378|NCT00789880|453727096|FG002|Overall Study|Protocol Violation|0|||
126118379|NCT00789880|453727097|FG003|Overall Study|Protocol Violation|1|||
126118380|NCT00789880|453727098|FG004|Overall Study|Protocol Violation|0|||
126118381|NCT00789880|453727099|FG005|Overall Study|Protocol Violation|0|||
126118382|NCT00789880|453727094|FG000|Overall Study|Withdrawal by Subject|1|||
126118383|NCT00789880|453727095|FG001|Overall Study|Withdrawal by Subject|0|||
126118384|NCT00789880|453727096|FG002|Overall Study|Withdrawal by Subject|0|||
126118385|NCT00789880|453727097|FG003|Overall Study|Withdrawal by Subject|0|||
126118386|NCT00789880|453727098|FG004|Overall Study|Withdrawal by Subject|2|||
126118387|NCT00789880|453727099|FG005|Overall Study|Withdrawal by Subject|0|||
126118388|NCT01977820|453727103|FG000|Overall Study|Sponsor terminated the study|1|||
126118389|NCT01977820|453727104|FG001|Overall Study|Sponsor terminated the study|1|||
126118390|NCT00493220|453727105|FG000|Third Intervention|Withdrawal by Subject|1|||
126118391|NCT00493220|453727106|FG001|Third Intervention|Withdrawal by Subject|0|||
126118392|NCT00493220|453727107|FG002|Third Intervention|Withdrawal by Subject|0|||
126118393|NCT00493220|453727108|FG003|Third Intervention|Withdrawal by Subject|0|||
126118394|NCT00493220|453727109|FG004|Third Intervention|Withdrawal by Subject|0|||
126118395|NCT00493220|453727110|FG005|Third Intervention|Withdrawal by Subject|0|||
126118396|NCT02568475|453727111|FG000|Overall Study|Lost to Follow-up|40|||
126118397|NCT02568475|453727112|FG001|Overall Study|Lost to Follow-up|39|||
126118398|NCT02568475|453727111|FG000|Overall Study|Withdrawal by Subject|2|||
126118399|NCT02568475|453727112|FG001|Overall Study|Withdrawal by Subject|0|||
126118400|NCT02568475|453727111|FG000|Overall Study|Discharged home|4|||
126118401|NCT02568475|453727112|FG001|Overall Study|Discharged home|4|||
126118402|NCT02568475|453727111|FG000|Overall Study|Short-term: Discharge location unknown|4|||
126118403|NCT02568475|453727112|FG001|Overall Study|Short-term: Discharge location unknown|0|||
126118404|NCT02568475|453727111|FG000|Overall Study|Transferred to another facility|1|||
126118405|NCT02568475|453727112|FG001|Overall Study|Transferred to another facility|0|||
126118406|NCT02625233|453727113|FG000|Overall Study|Adverse Event|2|||
126118407|NCT02625233|453727114|FG001|Overall Study|Adverse Event|0|||
126118408|NCT03520959|453727121|FG000|Overall Study|Study terminated by Sponsor|0|||
126118409|NCT03520959|453727122|FG001|Overall Study|Study terminated by Sponsor|1|||
126118410|NCT01449461|453727123|FG000|Overall Study|Adverse Event|0|||
126118411|NCT01449461|453727124|FG001|Overall Study|Adverse Event|3|||
126118412|NCT01449461|453727125|FG002|Overall Study|Adverse Event|2|||
126118413|NCT01449461|453727126|FG003|Overall Study|Adverse Event|3|||
126118414|NCT01449461|453727127|FG004|Overall Study|Adverse Event|4|||
126118415|NCT01449461|453727128|FG005|Overall Study|Adverse Event|4|||
126118416|NCT01449461|453727123|FG000|Overall Study|Death|0|||
126118417|NCT01449461|453727124|FG001|Overall Study|Death|2|||
126118418|NCT01449461|453727125|FG002|Overall Study|Death|0|||
126118419|NCT01449461|453727126|FG003|Overall Study|Death|0|||
126118420|NCT01449461|453727127|FG004|Overall Study|Death|7|||
126118421|NCT01449461|453727128|FG005|Overall Study|Death|1|||
126118422|NCT01449461|453727123|FG000|Overall Study|Physician Decision|0|||
126118423|NCT01449461|453727124|FG001|Overall Study|Physician Decision|1|||
126118424|NCT01449461|453727125|FG002|Overall Study|Physician Decision|0|||
126118425|NCT01449461|453727126|FG003|Overall Study|Physician Decision|4|||
126118426|NCT01449461|453727127|FG004|Overall Study|Physician Decision|1|||
126118427|NCT01449461|453727128|FG005|Overall Study|Physician Decision|0|||
126118428|NCT01449461|453727123|FG000|Overall Study|Documented Progressive Disease|4|||
126118429|NCT01449461|453727124|FG001|Overall Study|Documented Progressive Disease|7|||
126118430|NCT01449461|453727125|FG002|Overall Study|Documented Progressive Disease|14|||
126118431|NCT01449461|453727126|FG003|Overall Study|Documented Progressive Disease|15|||
126118432|NCT01449461|453727127|FG004|Overall Study|Documented Progressive Disease|24|||
126118433|NCT01449461|453727128|FG005|Overall Study|Documented Progressive Disease|5|||
126118434|NCT01449461|453727123|FG000|Overall Study|Clinical Progressive Disease|2|||
126118435|NCT01449461|453727124|FG001|Overall Study|Clinical Progressive Disease|2|||
126118436|NCT01449461|453727125|FG002|Overall Study|Clinical Progressive Disease|0|||
126118437|NCT01449461|453727126|FG003|Overall Study|Clinical Progressive Disease|3|||
126118438|NCT01449461|453727127|FG004|Overall Study|Clinical Progressive Disease|4|||
126118439|NCT01449461|453727128|FG005|Overall Study|Clinical Progressive Disease|2|||
126118440|NCT01449461|453727123|FG000|Overall Study|Protocol Violation|0|||
126118441|NCT01449461|453727124|FG001|Overall Study|Protocol Violation|0|||
126118442|NCT01449461|453727125|FG002|Overall Study|Protocol Violation|0|||
126118443|NCT01449461|453727126|FG003|Overall Study|Protocol Violation|1|||
126118444|NCT01449461|453727127|FG004|Overall Study|Protocol Violation|0|||
126118445|NCT01449461|453727128|FG005|Overall Study|Protocol Violation|0|||
126118446|NCT01449461|453727123|FG000|Overall Study|Site Terminated by Sponsor|0|||
126118447|NCT01449461|453727124|FG001|Overall Study|Site Terminated by Sponsor|1|||
126118448|NCT01449461|453727125|FG002|Overall Study|Site Terminated by Sponsor|2|||
126118449|NCT01449461|453727126|FG003|Overall Study|Site Terminated by Sponsor|3|||
126118450|NCT01449461|453727127|FG004|Overall Study|Site Terminated by Sponsor|4|||
126118451|NCT01449461|453727128|FG005|Overall Study|Site Terminated by Sponsor|1|||
126118452|NCT01449461|453727123|FG000|Overall Study|Withdrawal by Subject|0|||
126118453|NCT01449461|453727124|FG001|Overall Study|Withdrawal by Subject|1|||
126118454|NCT01449461|453727125|FG002|Overall Study|Withdrawal by Subject|0|||
126118455|NCT01449461|453727126|FG003|Overall Study|Withdrawal by Subject|0|||
126118456|NCT01449461|453727127|FG004|Overall Study|Withdrawal by Subject|2|||
126118457|NCT01449461|453727128|FG005|Overall Study|Withdrawal by Subject|1|||
126118458|NCT01449461|453727123|FG000|Overall Study|Reason not Specified|0|||
126118459|NCT01449461|453727124|FG001|Overall Study|Reason not Specified|1|||
126118460|NCT01449461|453727125|FG002|Overall Study|Reason not Specified|0|||
126118461|NCT01449461|453727126|FG003|Overall Study|Reason not Specified|3|||
126118462|NCT01449461|453727127|FG004|Overall Study|Reason not Specified|2|||
126118463|NCT01449461|453727128|FG005|Overall Study|Reason not Specified|1|||
126118464|NCT01357577|453727129|FG000|Overall Study|Lost to Follow-up|20|||
126118465|NCT01357577|453727130|FG001|Overall Study|Lost to Follow-up|16|||
126118466|NCT01357577|453727129|FG000|Overall Study|Withdrawal by Subject|16|||
126118467|NCT01357577|453727130|FG001|Overall Study|Withdrawal by Subject|8|||
126118468|NCT01357577|453727129|FG000|Overall Study|look at data in database?|1|||
126118469|NCT01357577|453727130|FG001|Overall Study|look at data in database?|2|||
126118470|NCT01704287|453728446|FG000|Initial Treatment Period|Death|139|||
126118471|NCT01704287|453728447|FG001|Initial Treatment Period|Death|129|||
126118472|NCT01704287|453728448|FG002|Initial Treatment Period|Death|71|||
126118473|NCT01704287|453728449|FG003|Initial Treatment Period|Death|0|||
126118474|NCT01704287|453728450|FG004|Initial Treatment Period|Death|0|||
126118475|NCT01704287|453728446|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
126118476|NCT01704287|453728447|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
126118477|NCT01704287|453728448|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
126118478|NCT01704287|453728449|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
126118479|NCT01704287|453728450|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
126118480|NCT01704287|453728446|FG000|Initial Treatment Period|Lost to Follow-up|5|||
126118481|NCT01704287|453728447|FG001|Initial Treatment Period|Lost to Follow-up|3|||
126118482|NCT01704287|453728448|FG002|Initial Treatment Period|Lost to Follow-up|0|||
126118483|NCT01704287|453728449|FG003|Initial Treatment Period|Lost to Follow-up|0|||
126118484|NCT01704287|453728450|FG004|Initial Treatment Period|Lost to Follow-up|0|||
126118485|NCT01704287|453728446|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
126118486|NCT01704287|453728447|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
126118487|NCT01704287|453728448|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
126118488|NCT01704287|453728449|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
126118489|NCT01704287|453728450|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
126118490|NCT01704287|453728446|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
126118491|NCT01704287|453728447|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
126118492|NCT01704287|453728448|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
126118493|NCT01704287|453728449|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
126118494|NCT01704287|453728450|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
126118495|NCT01704287|453728446|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
126118496|NCT01704287|453728447|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
126118497|NCT01704287|453728448|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
126118498|NCT01704287|453728449|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
126118499|NCT01704287|453728450|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
126118500|NCT01704287|453728446|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
126118501|NCT01704287|453728447|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
126118502|NCT01704287|453728448|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
126118503|NCT01704287|453728449|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
126118504|NCT01704287|453728450|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
126118505|NCT00938717|453728451|FG000|Overall Study|Adverse Event|10|||
126118506|NCT00938717|453728452|FG001|Overall Study|Adverse Event|41|||
126118507|NCT00938717|453728451|FG000|Overall Study|Protocol Violation|11|||
126118508|NCT00938717|453728452|FG001|Overall Study|Protocol Violation|8|||
126118509|NCT00938717|453728451|FG000|Overall Study|Withdrawal by Subject|26|||
126118510|NCT00938717|453728452|FG001|Overall Study|Withdrawal by Subject|24|||
126118511|NCT00938717|453728451|FG000|Overall Study|Lost to Follow-up|13|||
126118512|NCT00938717|453728452|FG001|Overall Study|Lost to Follow-up|18|||
126118513|NCT00938717|453728451|FG000|Overall Study|Lack of Efficacy|33|||
126118514|NCT00938717|453728452|FG001|Overall Study|Lack of Efficacy|15|||
126118515|NCT00938717|453728451|FG000|Overall Study|Other reason|5|||
126118516|NCT00938717|453728452|FG001|Overall Study|Other reason|2|||
126118517|NCT01462435|453728455|FG000|Overall Study|Lack of Efficacy|1|||
126118518|NCT01462435|453728456|FG001|Overall Study|Lack of Efficacy|0|||
126118519|NCT01462435|453728457|FG002|Overall Study|Lack of Efficacy|0|||
126118520|NCT01462435|453728458|FG003|Overall Study|Lack of Efficacy|3|||
126118521|NCT01462435|453728455|FG000|Overall Study|Physician Decision|0|||
126118522|NCT01462435|453728456|FG001|Overall Study|Physician Decision|0|||
126118523|NCT01462435|453728457|FG002|Overall Study|Physician Decision|1|||
126118524|NCT01462435|453728458|FG003|Overall Study|Physician Decision|0|||
126118525|NCT01462435|453728455|FG000|Overall Study|Withdrawal by Subject|0|||
126118526|NCT01462435|453728456|FG001|Overall Study|Withdrawal by Subject|0|||
126118527|NCT01462435|453728457|FG002|Overall Study|Withdrawal by Subject|0|||
126118528|NCT01462435|453728458|FG003|Overall Study|Withdrawal by Subject|1|||
126118529|NCT01462435|453728455|FG000|Overall Study|Lost to Follow-up|0|||
126118530|NCT01462435|453728456|FG001|Overall Study|Lost to Follow-up|0|||
126118531|NCT01462435|453728457|FG002|Overall Study|Lost to Follow-up|0|||
126118532|NCT01462435|453728458|FG003|Overall Study|Lost to Follow-up|1|||
126118533|NCT05092919|453728459|FG000|Overall Study|Lost to Follow-up|7|||
126118534|NCT05092919|453728459|FG000|Overall Study|Withdrawal by Subject|2|||
126118535|NCT02248259|453728461|FG000|Treatment Period 1|Adverse Event|0|||
126118536|NCT02248259|453728462|FG001|Treatment Period 1|Adverse Event|0|||
126118537|NCT02248259|453728463|FG002|Treatment Period 1|Adverse Event|1|||
126118538|NCT02248259|453728464|FG003|Treatment Period 1|Adverse Event|0|||
126118539|NCT02573870|453728465|FG000|Overall Study|Adverse Event|0|||
126118540|NCT02573870|453728466|FG001|Overall Study|Adverse Event|2|||
126118541|NCT02573870|453728465|FG000|Overall Study|Lack of Efficacy|0|||
126118542|NCT02573870|453728466|FG001|Overall Study|Lack of Efficacy|1|||
126118543|NCT02573870|453728465|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
125960660|NCT01969838|453149255|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
125960661|NCT01969838|453149256|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
125960662|NCT01969838|453149257|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
126118544|NCT02573870|453728466|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
126118545|NCT02573870|453728465|FG000|Overall Study|Lost to Follow-up|0|||
126118546|NCT02573870|453728466|FG001|Overall Study|Lost to Follow-up|1|||
126118547|NCT02573870|453728465|FG000|Overall Study|Other: Fail to Meet Visit|0|||
126118548|NCT02573870|453728466|FG001|Overall Study|Other: Fail to Meet Visit|2|||
126118549|NCT01848288|453728470|FG000|Overall Study|Death|1|||
126118550|NCT01848288|453728470|FG000|Overall Study|Protocol Violation|1|||
125971518|NCT00791765|453184717|FG001|Weeks 13 to 24|Adverse Event|3|||
126118551|NCT01848288|453728470|FG000|Overall Study|Withdrawal by Subject|1|||
126118552|NCT00677820|453728472|FG000|Overall Study|Lost to Follow-up|1|||
126118553|NCT00677820|453728473|FG001|Overall Study|Lost to Follow-up|0|||
126118554|NCT02865018|453728495|FG000|Overall Study|Withdrawal by Subject|1|||
126118555|NCT00290290|453728496|FG000|Overall Study|Death|3|||
126118556|NCT00290290|453728497|FG001|Overall Study|Death|4|||
126118557|NCT00290290|453728496|FG000|Overall Study|Withdrawal by Subject|2|||
126118558|NCT00290290|453728497|FG001|Overall Study|Withdrawal by Subject|2|||
126118559|NCT00290290|453728496|FG000|Overall Study|Underwent clean surgical procedure|13|||
126118560|NCT00290290|453728497|FG001|Overall Study|Underwent clean surgical procedure|12|||
126118561|NCT00549939|453728505|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
126118562|NCT00549939|453728506|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
126118563|NCT00549939|453728507|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
126118564|NCT00549939|453728505|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
126118565|NCT00549939|453728506|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
126118566|NCT00549939|453728507|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
126118567|NCT00549939|453728505|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
126118568|NCT00549939|453728506|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
126118569|NCT00549939|453728507|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
126118570|NCT00549939|453728505|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
126118571|NCT00549939|453728506|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
126118572|NCT00549939|453728507|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
126118573|NCT00549939|453728505|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
126118574|NCT00549939|453728506|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
126118575|NCT00549939|453728507|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
126118576|NCT00549939|453728505|FG000|40-week Open Label Treatment Period|Other|0|||
126118577|NCT00549939|453728506|FG001|40-week Open Label Treatment Period|Other|1|||
126118578|NCT00549939|453728507|FG002|40-week Open Label Treatment Period|Other|4|||
126118579|NCT03677596|453728508|FG000|Overall Study|Adverse Event|0|||
126118580|NCT03677596|453728509|FG001|Overall Study|Adverse Event|1|||
126118581|NCT03677596|453728508|FG000|Overall Study|Death|10|||
126118582|NCT03677596|453728509|FG001|Overall Study|Death|6|||
126118583|NCT03677596|453728508|FG000|Overall Study|Lost to Follow-up|0|||
126118584|NCT03677596|453728509|FG001|Overall Study|Lost to Follow-up|1|||
126118585|NCT03677596|453728508|FG000|Overall Study|Progressive Disease|8|||
126118586|NCT03677596|453728509|FG001|Overall Study|Progressive Disease|8|||
126118587|NCT03677596|453728508|FG000|Overall Study|Withdrawal by Subject|3|||
126118588|NCT03677596|453728509|FG001|Overall Study|Withdrawal by Subject|0|||
126118589|NCT03677596|453728508|FG000|Overall Study|Disease Relapse|2|||
126118590|NCT03677596|453728509|FG001|Overall Study|Disease Relapse|2|||
126118591|NCT03677596|453728508|FG000|Overall Study|Other|0|||
126118592|NCT03677596|453728509|FG001|Overall Study|Other|1|||
126118593|NCT00003895|453728510|FG000|Overall Study|Adverse Event|4|||
126118594|NCT00003895|453728511|FG001|Overall Study|Adverse Event|0|||
126118595|NCT00003895|453728510|FG000|Overall Study|Lack of Efficacy|1|||
126118596|NCT00003895|453728511|FG001|Overall Study|Lack of Efficacy|1|||
126118597|NCT00003895|453728510|FG000|Overall Study|Patient Vacation|2|||
126118598|NCT00003895|453728511|FG001|Overall Study|Patient Vacation|0|||
126118599|NCT00003895|453728510|FG000|Overall Study|Withdrawal by Subject|0|||
126118600|NCT00003895|453728511|FG001|Overall Study|Withdrawal by Subject|3|||
126118601|NCT04912245|453728514|FG000|Overall Study|Withdrawal by Subject|21|||
126118602|NCT04912245|453728515|FG001|Overall Study|Withdrawal by Subject|4|||
126118603|NCT04912245|453728514|FG000|Overall Study|Lost to Follow-up|5|||
126118604|NCT04912245|453728515|FG001|Overall Study|Lost to Follow-up|11|||
126118605|NCT01134614|453728516|FG000|Overall Study|Still on treatment as of March 2013|21|||
126118606|NCT01134614|453728517|FG001|Overall Study|Still on treatment as of March 2013|13|||
126118607|NCT01134614|453728516|FG000|Overall Study|Progressive disease|60|||
126118608|NCT01134614|453728517|FG001|Overall Study|Progressive disease|54|||
126118609|NCT01134614|453728516|FG000|Overall Study|Adverse Event|26|||
126118610|NCT01134614|453728517|FG001|Overall Study|Adverse Event|39|||
126118611|NCT01134614|453728516|FG000|Overall Study|Death|5|||
126118612|NCT01134614|453728517|FG001|Overall Study|Death|8|||
126118613|NCT01134614|453728516|FG000|Overall Study|Withdrawal by Subject|3|||
126118614|NCT01134614|453728517|FG001|Overall Study|Withdrawal by Subject|2|||
126118615|NCT01134614|453728516|FG000|Overall Study|Alternative therapy|2|||
126118616|NCT01134614|453728517|FG001|Overall Study|Alternative therapy|0|||
126118617|NCT01134614|453728516|FG000|Overall Study|Complicating disease|2|||
126118618|NCT01134614|453728517|FG001|Overall Study|Complicating disease|1|||
126118619|NCT01134614|453728516|FG000|Overall Study|Physician's decision|0|||
126118620|NCT01134614|453728517|FG001|Overall Study|Physician's decision|1|||
126118621|NCT01134614|453728516|FG000|Overall Study|Never started treatment|4|||
126118622|NCT01134614|453728517|FG001|Overall Study|Never started treatment|1|||
126118623|NCT01134614|453728516|FG000|Overall Study|Pt received tx not allowed on study|0|||
126118624|NCT01134614|453728517|FG001|Overall Study|Pt received tx not allowed on study|1|||
126118625|NCT01134614|453728516|FG000|Overall Study|Symptomatic deterioration|0|||
126118626|NCT01134614|453728517|FG001|Overall Study|Symptomatic deterioration|1|||
126118627|NCT01134614|453728516|FG000|Overall Study|Patient in hospice care|0|||
126118628|NCT01134614|453728517|FG001|Overall Study|Patient in hospice care|1|||
126118629|NCT02752035|453728518|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
126118630|NCT02752035|453728519|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
126118631|NCT02752035|453728520|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
126118632|NCT02752035|453728521|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
126118633|NCT02752035|453728518|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
126118634|NCT02752035|453728519|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
126118635|NCT02752035|453728520|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
126118636|NCT02752035|453728521|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
126118637|NCT02752035|453728518|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
126118638|NCT02752035|453728519|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
126118639|NCT02752035|453728520|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
126118640|NCT02752035|453728521|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
126118641|NCT02752035|453728518|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
126118642|NCT02752035|453728519|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
126118643|NCT02752035|453728520|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
126118644|NCT02752035|453728521|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
126118645|NCT02752035|453728518|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
126118646|NCT02752035|453728519|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
126118647|NCT02752035|453728520|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
126118648|NCT02752035|453728521|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
126118649|NCT02752035|453728518|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
126118650|NCT02752035|453728519|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
126118651|NCT02752035|453728520|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
126118652|NCT02752035|453728521|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
126118653|NCT02752035|453728518|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
126118654|NCT02752035|453728519|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
126118655|NCT02752035|453728520|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
126118656|NCT02752035|453728521|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
126118657|NCT02752035|453728518|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
126118658|NCT02752035|453728519|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
126118659|NCT02752035|453728520|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
126118660|NCT02752035|453728521|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
126118661|NCT02752035|453728518|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
126118662|NCT02752035|453728519|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
126118663|NCT02752035|453728520|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
126118664|NCT02752035|453728521|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
126118665|NCT02752035|453728518|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
126118666|NCT02752035|453728519|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
126118667|NCT02752035|453728520|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
126118668|NCT02752035|453728521|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
126118669|NCT02752035|453728518|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
126118670|NCT02752035|453728519|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
126118671|NCT02752035|453728520|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
126118672|NCT02752035|453728521|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
126118673|NCT02752035|453728518|FG000|Randomization: Approximately 3 Years|Death|0|||
126118674|NCT02752035|453728519|FG001|Randomization: Approximately 3 Years|Death|25|||
126118675|NCT02752035|453728520|FG002|Randomization: Approximately 3 Years|Death|13|||
126118676|NCT02752035|453728521|FG003|Randomization: Approximately 3 Years|Death|4|||
126118677|NCT02752035|453728518|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
126118678|NCT02752035|453728519|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
126118679|NCT02752035|453728520|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
126118680|NCT02752035|453728521|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
126118681|NCT02752035|453728518|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
126118682|NCT02752035|453728519|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
126118683|NCT02752035|453728520|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
126118684|NCT02752035|453728521|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
126118685|NCT02752035|453728518|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
126118686|NCT02752035|453728519|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
126118687|NCT02752035|453728520|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
126118688|NCT02752035|453728521|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
126118689|NCT02752035|453728518|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
126118690|NCT02752035|453728519|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
126118691|NCT02752035|453728520|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
126118692|NCT02752035|453728521|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
125960663|NCT01969838|453149258|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
126118693|NCT02752035|453728518|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
126118694|NCT02752035|453728519|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
126118695|NCT02752035|453728520|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
126118696|NCT02752035|453728521|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
126118697|NCT01161043|453728524|FG000|Overall Study|Withdrawal by Subject|3|||
126118698|NCT01236573|453728525|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126118699|NCT01236573|453728526|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126118700|NCT01236573|453728527|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126118701|NCT01236573|453728528|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126118702|NCT01236573|453728529|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126118703|NCT01236573|453728530|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126118704|NCT01236573|453728531|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
126118705|NCT01236573|453728532|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126118706|NCT01236573|453728533|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
126118707|NCT01236573|453728534|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
126118708|NCT01236573|453728535|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126118709|NCT01236573|453728525|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118710|NCT01236573|453728526|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118711|NCT01236573|453728527|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118712|NCT01236573|453728528|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118713|NCT01236573|453728529|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118714|NCT01236573|453728530|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118715|NCT01236573|453728531|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118716|NCT01236573|453728532|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118717|NCT01236573|453728533|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
126118718|NCT01236573|453728534|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118719|NCT01236573|453728535|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126118720|NCT01236573|453728525|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118721|NCT01236573|453728526|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118722|NCT01236573|453728527|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118723|NCT01236573|453728528|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118724|NCT01236573|453728529|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118725|NCT01236573|453728530|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118726|NCT01236573|453728531|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118727|NCT01236573|453728532|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118728|NCT01236573|453728533|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118729|NCT01236573|453728534|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126118730|NCT01236573|453728535|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
126118731|NCT02164929|453728538|FG000|Overall Study|Converted to open procedure|1|||
126118732|NCT02164929|453728539|FG001|Overall Study|Converted to open procedure|0|||
126118733|NCT02164929|453728540|FG002|Overall Study|Converted to open procedure|0|||
126118734|NCT02164929|453728541|FG003|Overall Study|Converted to open procedure|2|||
126118735|NCT02164929|453728538|FG000|Overall Study|Failed regional block|0|||
126118736|NCT02164929|453728539|FG001|Overall Study|Failed regional block|0|||
126118737|NCT02164929|453728540|FG002|Overall Study|Failed regional block|1|||
126118738|NCT02164929|453728541|FG003|Overall Study|Failed regional block|0|||
126118739|NCT00971178|453728542|FG000|Overall Study|Lost to Follow-up|2|||
126118740|NCT00971178|453728543|FG001|Overall Study|Lost to Follow-up|2|||
126118741|NCT00971178|453728544|FG002|Overall Study|Lost to Follow-up|2|||
126118742|NCT02161575|453728546|FG000|Overall Study|Protocol Violation|8|||
126118743|NCT02161575|453728546|FG000|Overall Study|Lack of Efficacy|1|||
126118744|NCT02161575|453728546|FG000|Overall Study|Adverse Event|2|||
126118745|NCT00424749|453728548|FG000|Overall Study|Withdrawal by Subject|1|||
126118746|NCT04109222|453728549|FG000|Overall Study|Adverse Event|1|||
126118747|NCT04109222|453728550|FG001|Overall Study|Adverse Event|0|||
126118748|NCT04109222|453728551|FG002|Overall Study|Adverse Event|0|||
126118749|NCT03023059|453728552|FG000|Overall Study|Withdrawal by Subject|5|||
126118750|NCT02138617|453728553|FG000|Overall Study|Death|1|||
126118751|NCT02138617|453728554|FG001|Overall Study|Death|2|||
126118752|NCT02138617|453728555|FG002|Overall Study|Death|2|||
126118753|NCT02138617|453728553|FG000|Overall Study|Adverse Event|8|||
126118754|NCT02138617|453728554|FG001|Overall Study|Adverse Event|5|||
126118755|NCT02138617|453728555|FG002|Overall Study|Adverse Event|2|||
126118756|NCT02138617|453728553|FG000|Overall Study|Disease Progression|20|||
126118757|NCT02138617|453728554|FG001|Overall Study|Disease Progression|13|||
126118758|NCT02138617|453728555|FG002|Overall Study|Disease Progression|4|||
126118759|NCT02138617|453728553|FG000|Overall Study|Withdrawal by Subject|7|||
126118760|NCT02138617|453728554|FG001|Overall Study|Withdrawal by Subject|10|||
126118761|NCT02138617|453728555|FG002|Overall Study|Withdrawal by Subject|2|||
126118762|NCT02138617|453728553|FG000|Overall Study|other complicating disease|0|||
126118763|NCT02138617|453728554|FG001|Overall Study|other complicating disease|2|||
125960664|NCT01969838|453149255|FG000|Open-label Phase|Adverse Event|0|||
126118764|NCT02138617|453728555|FG002|Overall Study|other complicating disease|0|||
126118765|NCT02138617|453728553|FG000|Overall Study|Protocol Violation|1|||
126118766|NCT02138617|453728554|FG001|Overall Study|Protocol Violation|0|||
126118767|NCT02138617|453728555|FG002|Overall Study|Protocol Violation|0|||
126118768|NCT02138617|453728553|FG000|Overall Study|Physician Decision|7|||
126118769|NCT02138617|453728554|FG001|Overall Study|Physician Decision|6|||
126118770|NCT02138617|453728555|FG002|Overall Study|Physician Decision|0|||
126118771|NCT02138617|453728553|FG000|Overall Study|financial reason|0|||
126118772|NCT02138617|453728554|FG001|Overall Study|financial reason|1|||
126118773|NCT02138617|453728555|FG002|Overall Study|financial reason|0|||
126118774|NCT02138617|453728553|FG000|Overall Study|other therapy|3|||
126118775|NCT02138617|453728554|FG001|Overall Study|other therapy|4|||
126118776|NCT02138617|453728555|FG002|Overall Study|other therapy|0|||
126118777|NCT00596947|453728560|FG000|Overall Study|study halted due to low enrollment|5|||
126118778|NCT00596947|453728561|FG001|Overall Study|study halted due to low enrollment|3|||
126118779|NCT00596947|453728560|FG000|Overall Study|Lost to Follow-up|1|||
126118780|NCT00596947|453728561|FG001|Overall Study|Lost to Follow-up|0|||
126118781|NCT00496730|453728562|FG000|Overall Study|Lost to Follow-up|4|||
126118782|NCT00496730|453728563|FG001|Overall Study|Lost to Follow-up|3|||
126118783|NCT00496730|453728562|FG000|Overall Study|Withdrawal by Subject|2|||
126118784|NCT00496730|453728563|FG001|Overall Study|Withdrawal by Subject|2|||
126118785|NCT00574288|453728564|FG000|Overall Study|Adverse Event|2|||
126118786|NCT00574288|453728565|FG001|Overall Study|Adverse Event|0|||
126118787|NCT00574288|453728566|FG002|Overall Study|Adverse Event|0|||
126118788|NCT00574288|453728567|FG003|Overall Study|Adverse Event|0|||
126118789|NCT00574288|453728568|FG004|Overall Study|Adverse Event|1|||
126118790|NCT00574288|453728569|FG005|Overall Study|Adverse Event|0|||
126118791|NCT00574288|453728570|FG006|Overall Study|Adverse Event|0|||
126118792|NCT00574288|453728564|FG000|Overall Study|Death|0|||
126118793|NCT00574288|453728565|FG001|Overall Study|Death|0|||
126118794|NCT00574288|453728566|FG002|Overall Study|Death|0|||
126118795|NCT00574288|453728567|FG003|Overall Study|Death|0|||
126118796|NCT00574288|453728568|FG004|Overall Study|Death|0|||
126118797|NCT00574288|453728569|FG005|Overall Study|Death|25|||
126118798|NCT00574288|453728570|FG006|Overall Study|Death|21|||
126118799|NCT00574288|453728564|FG000|Overall Study|Lost to Follow-up|0|||
126118800|NCT00574288|453728565|FG001|Overall Study|Lost to Follow-up|0|||
126118801|NCT00574288|453728566|FG002|Overall Study|Lost to Follow-up|0|||
126118802|NCT00574288|453728567|FG003|Overall Study|Lost to Follow-up|0|||
126118803|NCT00574288|453728568|FG004|Overall Study|Lost to Follow-up|0|||
126118804|NCT00574288|453728569|FG005|Overall Study|Lost to Follow-up|1|||
126118805|NCT00574288|453728570|FG006|Overall Study|Lost to Follow-up|2|||
126118806|NCT00574288|453728564|FG000|Overall Study|Study Terminated By Sponsor|0|||
126118807|NCT00574288|453728565|FG001|Overall Study|Study Terminated By Sponsor|0|||
126118808|NCT00574288|453728566|FG002|Overall Study|Study Terminated By Sponsor|0|||
126118809|NCT00574288|453728567|FG003|Overall Study|Study Terminated By Sponsor|0|||
126118810|NCT00574288|453728568|FG004|Overall Study|Study Terminated By Sponsor|0|||
126118811|NCT00574288|453728569|FG005|Overall Study|Study Terminated By Sponsor|0|||
126118812|NCT00574288|453728570|FG006|Overall Study|Study Terminated By Sponsor|5|||
126118813|NCT00574288|453728564|FG000|Overall Study|Progressive Disease|17|||
126118814|NCT00574288|453728565|FG001|Overall Study|Progressive Disease|2|||
126118815|NCT00574288|453728566|FG002|Overall Study|Progressive Disease|3|||
126118816|NCT00574288|453728567|FG003|Overall Study|Progressive Disease|2|||
126118817|NCT00574288|453728568|FG004|Overall Study|Progressive Disease|1|||
126118818|NCT00574288|453728569|FG005|Overall Study|Progressive Disease|0|||
126118819|NCT00574288|453728570|FG006|Overall Study|Progressive Disease|0|||
126118820|NCT00574288|453728564|FG000|Overall Study|Other|1|||
126118821|NCT00574288|453728565|FG001|Overall Study|Other|1|||
126118822|NCT00574288|453728566|FG002|Overall Study|Other|0|||
126118823|NCT00574288|453728567|FG003|Overall Study|Other|0|||
126118824|NCT00574288|453728568|FG004|Overall Study|Other|0|||
126118825|NCT00574288|453728569|FG005|Overall Study|Other|0|||
126118826|NCT00574288|453728570|FG006|Overall Study|Other|0|||
126118827|NCT02361944|453728571|FG000|Overall Study|surgery cancellation|0|||
126118828|NCT02361944|453728572|FG001|Overall Study|surgery cancellation|1|||
126118829|NCT02811549|453728573|FG000|Overall Study|Lost to Follow-up|1|||
126118830|NCT02811549|453728573|FG000|Overall Study|Withdrawal by Subject|3|||
126118831|NCT02811549|453728573|FG000|Overall Study|Subject screen failed|4|||
126118832|NCT02811549|453728573|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
126118833|NCT03472924|453728575|FG000|Overall Study|Adverse Event|1|||
126118834|NCT03472924|453728576|FG001|Overall Study|Adverse Event|0|||
126118835|NCT00427349|453728577|FG000|Overall Study|Lack of Efficacy|23|||
126118836|NCT00427349|453728577|FG000|Overall Study|Adverse Event|14|||
126118837|NCT00427349|453728577|FG000|Overall Study|Death|1|||
126118838|NCT00427349|453728577|FG000|Overall Study|Withdrawal by Subject|3|||
126118839|NCT00427349|453728577|FG000|Overall Study|Alternative therapy|1|||
126118840|NCT00427349|453728577|FG000|Overall Study|Other|2|||
126118841|NCT00427349|453728577|FG000|Overall Study|Ineligible|1|||
126118842|NCT00427349|453728577|FG000|Overall Study|Never started therapy|1|||
126118843|NCT05082376|453728580|FG000|Overall Study|Lost to Follow-up|2|||
126118844|NCT04425720|453728586|FG000|Overall Study|Withdrawal by Subject|0|||
126118845|NCT04425720|453728587|FG001|Overall Study|Withdrawal by Subject|20|||
126118846|NCT00290186|453728588|FG000|Overall Study|Adverse Event|1|||
126118847|NCT00290186|453728589|FG001|Overall Study|Adverse Event|1|||
126118848|NCT00290186|453728588|FG000|Overall Study|Lost to Follow-up|3|||
126118849|NCT00290186|453728589|FG001|Overall Study|Lost to Follow-up|2|||
126118850|NCT00290186|453728588|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
126118851|NCT00290186|453728589|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
126118852|NCT00290186|453728588|FG000|Overall Study|Withdrawal by Subject|0|||
126118853|NCT00290186|453728589|FG001|Overall Study|Withdrawal by Subject|1|||
126118854|NCT00445224|453728590|FG000|Specific Exercises|Withdrawal by Subject|3|||
126118855|NCT00445224|453728591|FG001|Specific Exercises|Withdrawal by Subject|3|||
126118856|NCT00445224|453728590|FG000|Specific Exercises|Withdrawal by Subject|1|||
126118857|NCT00445224|453728591|FG001|Specific Exercises|Withdrawal by Subject|0|||
126118858|NCT04085523|453728596|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126118859|NCT04085523|453728597|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126118860|NCT04085523|453728598|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126118861|NCT04085523|453728599|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126118862|NCT04085523|453728600|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126118863|NCT04085523|453728601|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
126118864|NCT01877915|453728602|FG000|Overall Study|Lost to Follow-up|10|||
126118865|NCT01877915|453728603|FG001|Overall Study|Lost to Follow-up|9|||
126118866|NCT01877915|453728602|FG000|Overall Study|Withdrawal by Subject|42|||
126118867|NCT01877915|453728603|FG001|Overall Study|Withdrawal by Subject|55|||
126118868|NCT01877915|453728602|FG000|Overall Study|Other|2|||
126118869|NCT01877915|453728603|FG001|Overall Study|Other|4|||
126118870|NCT00943579|453728604|FG000|Overall Study|Adverse Event|4|||
126118871|NCT00943579|453728605|FG001|Overall Study|Adverse Event|3|||
126118872|NCT00943579|453728604|FG000|Overall Study|Lack of Efficacy|2|||
126118873|NCT00943579|453728605|FG001|Overall Study|Lack of Efficacy|2|||
126118874|NCT01502709|453729627|FG000|Overall Study|Lost to Follow-up|4|||
126118875|NCT01502709|453729628|FG001|Overall Study|Lost to Follow-up|0|||
126118876|NCT00937937|453729630|FG000|Overall Study|Adverse Event|6|||
126118877|NCT00937937|453729630|FG000|Overall Study|Withdrawal by Subject|2|||
126118878|NCT00937937|453729630|FG000|Overall Study|Progression/relapse|61|||
126118879|NCT00937937|453729630|FG000|Overall Study|Death|1|||
126118880|NCT00937937|453729630|FG000|Overall Study|Other|2|||
126118881|NCT04024228|453729632|FG000|Overall Study|Adverse Event|1|||
126118882|NCT04024228|453729633|FG001|Overall Study|Adverse Event|0|||
126118883|NCT04024228|453729632|FG000|Overall Study|Protocol Deviation|0|||
126118884|NCT04024228|453729633|FG001|Overall Study|Protocol Deviation|2|||
126118885|NCT04024228|453729632|FG000|Overall Study|Withdrawal by Subject|3|||
126118886|NCT04024228|453729633|FG001|Overall Study|Withdrawal by Subject|4|||
126118887|NCT02932410|453729634|FG000|Overall Study|Death|7|||
126118888|NCT02932410|453729635|FG001|Overall Study|Death|6|||
126118889|NCT02932410|453729636|FG002|Overall Study|Death|0|||
126118890|NCT02932410|453729637|FG003|Overall Study|Death|0|||
126118891|NCT02932410|453729634|FG000|Overall Study|Lost to Follow-up|1|||
126118892|NCT02932410|453729635|FG001|Overall Study|Lost to Follow-up|2|||
126118893|NCT02932410|453729636|FG002|Overall Study|Lost to Follow-up|0|||
126118894|NCT02932410|453729637|FG003|Overall Study|Lost to Follow-up|0|||
126118895|NCT02932410|453729634|FG000|Overall Study|Parent/Subjects decision|6|||
126118896|NCT02932410|453729635|FG001|Overall Study|Parent/Subjects decision|6|||
126118897|NCT02932410|453729636|FG002|Overall Study|Parent/Subjects decision|1|||
126118898|NCT02932410|453729637|FG003|Overall Study|Parent/Subjects decision|0|||
126118899|NCT02932410|453729634|FG000|Overall Study|Physician Decision|0|||
126118900|NCT02932410|453729635|FG001|Overall Study|Physician Decision|1|||
126118901|NCT02932410|453729636|FG002|Overall Study|Physician Decision|0|||
126118902|NCT02932410|453729637|FG003|Overall Study|Physician Decision|0|||
126118903|NCT01007032|453729643|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
126118904|NCT01007032|453729644|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
126118905|NCT01007032|453729645|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
126118906|NCT01007032|453729646|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
126118907|NCT01007032|453729643|FG000|Overall Study|Withdrawal by Subject|0|||
126118908|NCT01007032|453729644|FG001|Overall Study|Withdrawal by Subject|0|||
126118909|NCT01007032|453729645|FG002|Overall Study|Withdrawal by Subject|0|||
126118910|NCT01007032|453729646|FG003|Overall Study|Withdrawal by Subject|1|||
126118911|NCT01841749|453729647|FG000|Overall Study|Protocol Violation|1|||
126118912|NCT05197049|453729653|FG000|Overall Study|Death|0|||
126118913|NCT05197049|453729654|FG001|Overall Study|Death|1|||
126118914|NCT05197049|453729655|FG002|Overall Study|Death|0|||
126118915|NCT05197049|453729653|FG000|Overall Study|Lost to Follow-up|3|||
126118916|NCT05197049|453729654|FG001|Overall Study|Lost to Follow-up|1|||
126118917|NCT05197049|453729655|FG002|Overall Study|Lost to Follow-up|0|||
126118918|NCT05197049|453729653|FG000|Overall Study|Withdrawal by Subject|15|||
126118919|NCT05197049|453729654|FG001|Overall Study|Withdrawal by Subject|3|||
126118920|NCT05197049|453729655|FG002|Overall Study|Withdrawal by Subject|1|||
126118921|NCT05197049|453729653|FG000|Overall Study|GCP non-compliance|1|||
126118922|NCT05197049|453729654|FG001|Overall Study|GCP non-compliance|2|||
126118923|NCT05197049|453729655|FG002|Overall Study|GCP non-compliance|0|||
126118924|NCT02577406|453729662|FG000|Randomized Period|Death|1|||
126118925|NCT02577406|453729663|FG001|Randomized Period|Death|0|||
126118926|NCT02577406|453729662|FG000|Randomized Period|Other reasons|0|||
126118927|NCT02577406|453729663|FG001|Randomized Period|Other reasons|20|||
126118928|NCT02577406|453729662|FG000|Treatment Period|Death|38|||
126118929|NCT02577406|453729663|FG001|Treatment Period|Death|23|||
126118930|NCT02577406|453729662|FG000|Treatment Period|Adverse Event|17|||
126118931|NCT02577406|453729663|FG001|Treatment Period|Adverse Event|12|||
126118932|NCT02577406|453729662|FG000|Treatment Period|Progressive Disease|53|||
126118933|NCT02577406|453729663|FG001|Treatment Period|Progressive Disease|37|||
126118934|NCT02577406|453729662|FG000|Treatment Period|Withdrawal by Subject|10|||
126118935|NCT02577406|453729663|FG001|Treatment Period|Withdrawal by Subject|24|||
126118936|NCT02577406|453729662|FG000|Treatment Period|Lost to Follow-up|0|||
126118937|NCT02577406|453729663|FG001|Treatment Period|Lost to Follow-up|1|||
126118938|NCT02577406|453729662|FG000|Treatment Period|Transition to commercially available treatment|1|||
126118939|NCT02577406|453729663|FG001|Treatment Period|Transition to commercially available treatment|1|||
126118940|NCT02577406|453729662|FG000|Treatment Period|Physician Decision|1|||
126118941|NCT02577406|453729663|FG001|Treatment Period|Physician Decision|0|||
126118942|NCT02577406|453729662|FG000|Treatment Period|Disease Relapse|28|||
126118943|NCT02577406|453729663|FG001|Treatment Period|Disease Relapse|1|||
126118944|NCT02577406|453729662|FG000|Treatment Period|Protocol Violation|0|||
126118945|NCT02577406|453729663|FG001|Treatment Period|Protocol Violation|1|||
126118946|NCT02577406|453729662|FG000|Treatment Period|Other Reasons|3|||
126118947|NCT02577406|453729663|FG001|Treatment Period|Other Reasons|39|||
126118948|NCT02577406|453729662|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
126118949|NCT02577406|453729663|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
126118950|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
126118951|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
126118952|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118953|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118954|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118955|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
126118956|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
126118957|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118958|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118959|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118960|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118961|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118962|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118963|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126118964|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118965|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118966|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118967|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118968|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118969|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
126118970|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
126118971|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118972|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118973|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118974|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118975|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118976|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118977|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126118978|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
126118979|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118980|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125960665|NCT01969838|453149256|FG001|Open-label Phase|Adverse Event|0|||
126118981|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118982|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118983|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118984|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
125960666|NCT01969838|453149257|FG002|Open-label Phase|Adverse Event|37|||
126118985|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118986|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118987|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118988|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118989|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118990|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118991|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126118992|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126118993|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126118994|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126118995|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126118996|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126118997|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
126118998|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
126118999|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126119000|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126119001|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126119002|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126119003|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126119004|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126119005|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126119006|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119007|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119008|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119009|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119010|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119011|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119012|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
126119013|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119014|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119015|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119016|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119017|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119018|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119019|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126119020|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
126119021|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
126119022|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
126119023|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119024|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119025|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
126119026|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
126119027|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119028|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119029|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119030|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119031|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119032|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119033|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126119034|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119035|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
126119036|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119037|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119038|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119039|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
126119040|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119041|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119042|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119043|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119044|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119045|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119046|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119047|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126119048|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
126119049|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119050|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119051|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119052|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119053|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
126119054|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119055|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119056|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119057|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119058|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119059|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119060|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119061|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126119062|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119063|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119064|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119065|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
126119066|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
126119067|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119068|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119069|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
126119070|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
126119071|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119072|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119073|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119074|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119075|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126119076|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119077|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119078|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119079|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119080|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119081|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119082|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119083|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
126119084|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
126119085|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119086|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119087|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119088|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119089|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126119090|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119091|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119092|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119093|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119094|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119095|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119096|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119097|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119098|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
126119099|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119100|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119101|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119102|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119103|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126119104|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119105|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119106|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119107|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
126119108|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119109|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119110|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119111|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119112|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119113|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119114|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119115|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119116|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119117|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126119118|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119119|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119120|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119121|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119122|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119123|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119124|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119125|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
126119126|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
126119127|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119128|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119129|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119130|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119131|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126119132|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119133|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119134|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119135|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119136|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119137|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119138|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119139|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
126119140|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119141|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119142|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119143|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119144|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119145|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126119146|NCT04033445|453729664|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119147|NCT04033445|453729665|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119148|NCT04033445|453729666|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119149|NCT04033445|453729667|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119150|NCT04033445|453729668|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119151|NCT04033445|453729669|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119152|NCT04033445|453729670|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119153|NCT04033445|453729671|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
126119154|NCT04033445|453729672|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119155|NCT04033445|453729673|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119156|NCT04033445|453729674|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119157|NCT04033445|453729675|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119158|NCT04033445|453729676|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119159|NCT04033445|453729677|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126119160|NCT04033445|453729664|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119161|NCT04033445|453729665|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119162|NCT04033445|453729666|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119163|NCT04033445|453729667|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119164|NCT04033445|453729668|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119165|NCT04033445|453729669|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119166|NCT04033445|453729670|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119167|NCT04033445|453729671|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119168|NCT04033445|453729672|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126119169|NCT04033445|453729673|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
126119170|NCT04033445|453729674|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
126119171|NCT04033445|453729675|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
126119172|NCT04033445|453729676|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
126119173|NCT04033445|453729677|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
126119174|NCT04033445|453729664|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119175|NCT04033445|453729665|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119176|NCT04033445|453729666|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119177|NCT04033445|453729667|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119178|NCT04033445|453729668|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119179|NCT04033445|453729669|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119180|NCT04033445|453729670|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119181|NCT04033445|453729671|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119182|NCT04033445|453729672|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126119183|NCT04033445|453729673|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
125960667|NCT01969838|453149258|FG003|Open-label Phase|Adverse Event|49|||
125960668|NCT01969838|453149255|FG000|Open-label Phase|Disease Progression|0|||
126119184|NCT04033445|453729674|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
126119185|NCT04033445|453729675|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
126119186|NCT04033445|453729676|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
126119187|NCT04033445|453729677|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
126119188|NCT04033445|453729664|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119189|NCT04033445|453729665|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119190|NCT04033445|453729666|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119191|NCT04033445|453729667|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119192|NCT04033445|453729668|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119193|NCT04033445|453729669|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119194|NCT04033445|453729670|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119195|NCT04033445|453729671|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119196|NCT04033445|453729672|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119197|NCT04033445|453729673|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119198|NCT04033445|453729674|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
126119199|NCT04033445|453729675|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
126119200|NCT04033445|453729676|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126119201|NCT04033445|453729677|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
126119202|NCT04033445|453729664|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119203|NCT04033445|453729665|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119204|NCT04033445|453729666|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119205|NCT04033445|453729667|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119206|NCT04033445|453729668|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119207|NCT04033445|453729669|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119208|NCT04033445|453729670|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119209|NCT04033445|453729671|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119210|NCT04033445|453729672|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119211|NCT04033445|453729673|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126119212|NCT04033445|453729674|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
126119213|NCT04033445|453729675|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
126119214|NCT04033445|453729676|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
126119215|NCT04033445|453729677|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
126119216|NCT04033445|453729664|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119217|NCT04033445|453729665|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119218|NCT04033445|453729666|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119219|NCT04033445|453729667|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119220|NCT04033445|453729668|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119221|NCT04033445|453729669|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119222|NCT04033445|453729670|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119223|NCT04033445|453729671|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119224|NCT04033445|453729672|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126119225|NCT04033445|453729673|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
126119226|NCT04033445|453729674|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
126119227|NCT04033445|453729675|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
126119228|NCT04033445|453729676|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
126119229|NCT04033445|453729677|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
126119230|NCT04033445|453729664|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119231|NCT04033445|453729665|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119232|NCT04033445|453729666|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119233|NCT04033445|453729667|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119234|NCT04033445|453729668|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119235|NCT04033445|453729669|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119236|NCT04033445|453729670|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119237|NCT04033445|453729671|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119238|NCT04033445|453729672|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119239|NCT04033445|453729673|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119240|NCT04033445|453729674|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119241|NCT04033445|453729675|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119242|NCT04033445|453729676|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126119243|NCT04033445|453729677|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
126119244|NCT04033445|453729664|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119245|NCT04033445|453729665|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119246|NCT04033445|453729666|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119247|NCT04033445|453729667|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119248|NCT04033445|453729668|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119249|NCT04033445|453729669|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119250|NCT04033445|453729670|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119251|NCT04033445|453729671|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119252|NCT04033445|453729672|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
126119253|NCT04033445|453729673|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
126119254|NCT04033445|453729674|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
126119255|NCT04033445|453729675|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
126119256|NCT04033445|453729676|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
126119257|NCT04033445|453729677|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
126119258|NCT04033445|453729664|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119259|NCT04033445|453729665|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119260|NCT04033445|453729666|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119261|NCT04033445|453729667|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119262|NCT04033445|453729668|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119263|NCT04033445|453729669|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119264|NCT04033445|453729670|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119265|NCT04033445|453729671|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119266|NCT04033445|453729672|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119267|NCT04033445|453729673|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
126119268|NCT04033445|453729674|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119269|NCT04033445|453729675|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
126119270|NCT04033445|453729676|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
126119271|NCT04033445|453729677|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126119272|NCT04754802|453729683|FG000|Overall Study|Lost to Follow-up|0|||
126119273|NCT04754802|453729684|FG001|Overall Study|Lost to Follow-up|2|||
126119274|NCT04754802|453729683|FG000|Overall Study|Withdrawal by Subject|2|||
126119275|NCT04754802|453729684|FG001|Overall Study|Withdrawal by Subject|0|||
126119276|NCT04451161|453729685|FG000|Overall Study|Lost to Follow-up|28|||
126119277|NCT04451161|453729686|FG001|Overall Study|Lost to Follow-up|37|||
126119278|NCT04451161|453729687|FG002|Overall Study|Lost to Follow-up|22|||
126119279|NCT04451161|453729688|FG003|Overall Study|Lost to Follow-up|13|||
126119280|NCT04451161|453729689|FG004|Overall Study|Lost to Follow-up|11|||
126119281|NCT04451161|453729690|FG005|Overall Study|Lost to Follow-up|14|||
126119282|NCT04451161|453729685|FG000|Overall Study|Withdrawal by Subject|3|||
126119283|NCT04451161|453729686|FG001|Overall Study|Withdrawal by Subject|0|||
126119284|NCT04451161|453729687|FG002|Overall Study|Withdrawal by Subject|0|||
126119285|NCT04451161|453729688|FG003|Overall Study|Withdrawal by Subject|0|||
126119286|NCT04451161|453729689|FG004|Overall Study|Withdrawal by Subject|2|||
126119287|NCT04451161|453729690|FG005|Overall Study|Withdrawal by Subject|4|||
126119288|NCT05525689|453729691|FG000|Overall Study|Lost to Follow-up|1|||
126119289|NCT05525689|453729692|FG001|Overall Study|Lost to Follow-up|0|||
126119290|NCT01671111|453729693|FG000|Overall Study|Adverse Event|2|||
126119291|NCT01671111|453729693|FG000|Overall Study|Lack of Efficacy|1|||
126119292|NCT01671111|453729693|FG000|Overall Study|Withdrawal by Subject|2|||
126119293|NCT01671111|453729693|FG000|Overall Study|Physician Decision|1|||
126119294|NCT01671111|453729693|FG000|Overall Study|Other|24|||
126119295|NCT03680911|453729694|FG000|At Home Treatment|Study Termination|3|||
126119296|NCT03680911|453729695|FG001|At Home Treatment|Study Termination|0|||
126119297|NCT03680911|453729694|FG000|At Home Treatment|Lost to Follow-up|0|||
126119298|NCT03680911|453729695|FG001|At Home Treatment|Lost to Follow-up|1|||
126119299|NCT03680911|453729694|FG000|At Home Treatment|Withdrawal by Subject|0|||
126119300|NCT03680911|453729695|FG001|At Home Treatment|Withdrawal by Subject|2|||
126119301|NCT03680911|453729694|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
126119302|NCT03680911|453729695|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
126119303|NCT00898443|453729700|FG000|Overall Study|Withdrawal by Subject|1|||
126119304|NCT00898443|453729701|FG001|Overall Study|Withdrawal by Subject|0|||
126119305|NCT04695392|453729702|FG000|Overall Study|Withdrawn by parent/guardian|0|||
126119306|NCT04695392|453729703|FG001|Overall Study|Withdrawn by parent/guardian|1|||
126119307|NCT04695392|453729702|FG000|Overall Study|Withdrawn by physician|0|||
126119308|NCT04695392|453729703|FG001|Overall Study|Withdrawn by physician|1|||
126119309|NCT04702737|453729710|FG000|Overall Study|Decision by Sponsor|1|||
126119310|NCT04702737|453729710|FG000|Overall Study|Withdrawal of Consent from Study|3|||
126119311|NCT04702737|453729710|FG000|Overall Study|Lost to Follow-up|1|||
126119312|NCT04702737|453729710|FG000|Overall Study|Death|35|||
126119313|NCT00698997|453729711|FG000|Overall Study|Lost to Follow-up|3|||
126119314|NCT00698997|453729712|FG001|Overall Study|Lost to Follow-up|0|||
126119315|NCT00698997|453729711|FG000|Overall Study|Withdrawal by Subject|7|||
126119316|NCT00698997|453729712|FG001|Overall Study|Withdrawal by Subject|27|||
126119317|NCT01436084|453729715|FG000|Overall Study|Disease Progression|2|||
126119318|NCT01436084|453729715|FG000|Overall Study|Withdrawal by Subject|1|||
126119319|NCT01436084|453729715|FG000|Overall Study|Early Closure of Study|1|||
126119320|NCT03159091|453729721|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
126119321|NCT03159091|453729722|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
126119322|NCT03159091|453729721|FG000|Overall Study|Patient has taken no dose of study drug|0|||
126119323|NCT03159091|453729722|FG001|Overall Study|Patient has taken no dose of study drug|1|||
126119324|NCT00262522|453729723|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
126119325|NCT00262522|453729724|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
126119326|NCT00262522|453729725|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
126119327|NCT00262522|453729726|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
126119328|NCT00262522|453729723|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
126119329|NCT00262522|453729724|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
126119330|NCT00262522|453729725|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
126119331|NCT00262522|453729726|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
126119332|NCT00262522|453729723|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
126119333|NCT00262522|453729724|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
126119334|NCT00262522|453729725|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
126119335|NCT00262522|453729726|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
126119336|NCT00262522|453729723|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
126119337|NCT00262522|453729724|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
126119338|NCT00262522|453729725|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
126119339|NCT00262522|453729726|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
126119340|NCT00262522|453729723|FG000|Study Start Through 8 Weeks|Death|1|||
126119341|NCT00262522|453729724|FG001|Study Start Through 8 Weeks|Death|0|||
126119342|NCT00262522|453729725|FG002|Study Start Through 8 Weeks|Death|0|||
126119343|NCT00262522|453729726|FG003|Study Start Through 8 Weeks|Death|0|||
126119344|NCT00262522|453729723|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
126119345|NCT00262522|453729724|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
126119346|NCT00262522|453729725|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
126119347|NCT00262522|453729726|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
126119348|NCT00262522|453729723|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
126119349|NCT00262522|453729724|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
126119350|NCT00262522|453729725|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
126119351|NCT00262522|453729726|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
126119352|NCT00262522|453729723|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
126119353|NCT00262522|453729724|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
126119354|NCT00262522|453729725|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
126119355|NCT00262522|453729726|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
126119356|NCT00262522|453729723|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
126119357|NCT00262522|453729724|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
126119358|NCT00262522|453729725|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
126119359|NCT00262522|453729726|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
126119360|NCT00262522|453729723|FG000|Study Start Through 48 Weeks|Death|2|||
126119361|NCT00262522|453729724|FG001|Study Start Through 48 Weeks|Death|0|||
126119362|NCT00262522|453729725|FG002|Study Start Through 48 Weeks|Death|1|||
126119363|NCT00262522|453729726|FG003|Study Start Through 48 Weeks|Death|0|||
126119364|NCT00262522|453729723|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
126119365|NCT00262522|453729724|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
126119366|NCT00262522|453729725|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
126119367|NCT00262522|453729726|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
126119368|NCT00262522|453729723|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
126119369|NCT00262522|453729724|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
126119370|NCT00262522|453729725|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
126119371|NCT00262522|453729726|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
126119372|NCT00262522|453729723|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
126119373|NCT00262522|453729724|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
126119374|NCT00262522|453729725|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
126119375|NCT00262522|453729726|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
126119376|NCT00262522|453729723|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
126119377|NCT00262522|453729724|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
126119378|NCT00262522|453729725|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
126119379|NCT00262522|453729726|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
126119380|NCT00262522|453729723|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
126119381|NCT00262522|453729724|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
126119382|NCT00262522|453729725|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
126119383|NCT00262522|453729726|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
126119384|NCT00262522|453729723|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
126119385|NCT00262522|453729724|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
126119386|NCT00262522|453729725|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
126119387|NCT00262522|453729726|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
126119388|NCT00262522|453729723|FG000|Study Start Through 96 Weeks|Death|2|||
126119389|NCT00262522|453729724|FG001|Study Start Through 96 Weeks|Death|0|||
126119390|NCT00262522|453729725|FG002|Study Start Through 96 Weeks|Death|2|||
126119391|NCT00262522|453729726|FG003|Study Start Through 96 Weeks|Death|0|||
126119392|NCT00262522|453729723|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
126119393|NCT00262522|453729724|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
126119394|NCT00262522|453729725|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
126119395|NCT00262522|453729726|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
126119396|NCT00262522|453729723|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
126119397|NCT00262522|453729724|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
126119398|NCT00262522|453729725|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
126119399|NCT00262522|453729726|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
126119400|NCT04814823|453729727|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
126119401|NCT02044133|453729728|FG000|Overall Study|Lost to Follow-up|1|||
126119402|NCT02044133|453729729|FG001|Overall Study|Lost to Follow-up|1|||
126119403|NCT02044133|453729728|FG000|Overall Study|Death|1|||
126119404|NCT02044133|453729729|FG001|Overall Study|Death|0|||
126119405|NCT02044133|453729728|FG000|Overall Study|Release|3|||
126119406|NCT02044133|453729729|FG001|Overall Study|Release|4|||
126119407|NCT02044133|453729728|FG000|Overall Study|Transfer|1|||
126119408|NCT02044133|453729729|FG001|Overall Study|Transfer|0|||
126119409|NCT02044133|453729728|FG000|Overall Study|refusal of blood sampling|0|||
126119410|NCT02044133|453729729|FG001|Overall Study|refusal of blood sampling|1|||
126119411|NCT05318937|453729732|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126119412|NCT05318937|453729733|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126119413|NCT05318937|453729732|FG000|Overall Study|Lost to Follow-up|0|||
126119414|NCT05318937|453729733|FG001|Overall Study|Lost to Follow-up|1|||
126119415|NCT05318937|453729732|FG000|Overall Study|Withdrawal by Subject|0|||
126119416|NCT05318937|453729733|FG001|Overall Study|Withdrawal by Subject|2|||
126119417|NCT05318937|453729732|FG000|Overall Study|Protocol Violation|0|||
126119418|NCT05318937|453729733|FG001|Overall Study|Protocol Violation|1|||
126119419|NCT00121108|453729743|FG000|Overall Study|Lost to Follow-up|10|||
126119420|NCT00121108|453729744|FG001|Overall Study|Lost to Follow-up|22|||
126119421|NCT00121108|453729743|FG000|Overall Study|Withdrawal by Subject|106|||
126119422|NCT00121108|453729744|FG001|Overall Study|Withdrawal by Subject|195|||
126119423|NCT00121108|453729743|FG000|Overall Study|Death|5|||
126119424|NCT00121108|453729744|FG001|Overall Study|Death|8|||
126119425|NCT03977974|453729747|FG000|Period 2|Adverse Event|0|||
126119426|NCT03977974|453729748|FG001|Period 2|Adverse Event|0|||
126119427|NCT03977974|453729749|FG002|Period 2|Adverse Event|0|||
126119428|NCT03977974|453729750|FG003|Period 2|Adverse Event|0|||
126119429|NCT03977974|453729751|FG004|Period 2|Adverse Event|1|||
126119430|NCT03977974|453729752|FG005|Period 2|Adverse Event|0|||
126119431|NCT03977974|453729753|FG006|Period 2|Adverse Event|0|||
126119432|NCT03977974|453729754|FG007|Period 2|Adverse Event|0|||
126119433|NCT03977974|453729755|FG008|Period 2|Adverse Event|0|||
126119434|NCT03977974|453729756|FG009|Period 2|Adverse Event|0|||
126119435|NCT03977974|453729757|FG010|Period 2|Adverse Event|0|||
126119436|NCT03977974|453729758|FG011|Period 2|Adverse Event|0|||
126119437|NCT03977974|453729759|FG012|Period 2|Adverse Event|0|||
126119438|NCT03697720|453730780|FG000|Overall Study|Lost to Follow-up|7|||
126119439|NCT03496012|453730787|FG000|Overall Study|Withdrawal by Subject|2|||
126119440|NCT03496012|453730788|FG001|Overall Study|Withdrawal by Subject|0|||
126119441|NCT03496012|453730789|FG002|Overall Study|Withdrawal by Subject|2|||
126119442|NCT03496012|453730787|FG000|Overall Study|Adverse Event|0|||
126119443|NCT03496012|453730788|FG001|Overall Study|Adverse Event|0|||
126119444|NCT03496012|453730789|FG002|Overall Study|Adverse Event|1|||
126119445|NCT03496012|453730787|FG000|Overall Study|Reason Not Specified|2|||
126119446|NCT03496012|453730788|FG001|Overall Study|Reason Not Specified|0|||
126119447|NCT03496012|453730789|FG002|Overall Study|Reason Not Specified|1|||
126119448|NCT02322125|453730790|FG000|Overall Study|Withdrawal by Subject|2|||
126119449|NCT04183790|453730794|FG000|Overall Study|Participants did not rollover to Part B|12|||
126119450|NCT04183790|453730795|FG001|Overall Study|Participants did not rollover to Part B|0|||
126119451|NCT04183790|453730794|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
126119452|NCT04183790|453730795|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
126119453|NCT04183790|453730794|FG000|Overall Study|Commercial drug is available for participant|6|||
126119454|NCT04183790|453730795|FG001|Overall Study|Commercial drug is available for participant|0|||
126119455|NCT04183790|453730794|FG000|Overall Study|Adverse Event|1|||
126119456|NCT04183790|453730795|FG001|Overall Study|Adverse Event|0|||
126119457|NCT04183790|453730794|FG000|Overall Study|Not enrolled in 107 study|0|||
126119458|NCT04183790|453730795|FG001|Overall Study|Not enrolled in 107 study|2|||
126119459|NCT01251653|453730796|FG000|Overall Study|Progressive Disease|1|||
126119460|NCT01251653|453730797|FG001|Overall Study|Progressive Disease|7|||
126119461|NCT01251653|453730798|FG002|Overall Study|Progressive Disease|16|||
126119462|NCT01251653|453730799|FG003|Overall Study|Progressive Disease|4|||
126119463|NCT01251653|453730800|FG004|Overall Study|Progressive Disease|0|||
126119464|NCT01251653|453730801|FG005|Overall Study|Progressive Disease|17|||
126119465|NCT01251653|453730802|FG006|Overall Study|Progressive Disease|14|||
126119466|NCT01251653|453730803|FG007|Overall Study|Progressive Disease|7|||
126119467|NCT01251653|453730804|FG008|Overall Study|Progressive Disease|5|||
126119468|NCT01251653|453730796|FG000|Overall Study|Dose-limiting toxicity|0|||
126119469|NCT01251653|453730797|FG001|Overall Study|Dose-limiting toxicity|1|||
126119470|NCT01251653|453730798|FG002|Overall Study|Dose-limiting toxicity|1|||
126119471|NCT01251653|453730799|FG003|Overall Study|Dose-limiting toxicity|1|||
126119472|NCT01251653|453730800|FG004|Overall Study|Dose-limiting toxicity|0|||
126119473|NCT01251653|453730801|FG005|Overall Study|Dose-limiting toxicity|0|||
126119474|NCT01251653|453730802|FG006|Overall Study|Dose-limiting toxicity|2|||
126119475|NCT01251653|453730803|FG007|Overall Study|Dose-limiting toxicity|0|||
126119476|NCT01251653|453730804|FG008|Overall Study|Dose-limiting toxicity|0|||
126119477|NCT01251653|453730796|FG000|Overall Study|Adverse Event|1|||
126119478|NCT01251653|453730797|FG001|Overall Study|Adverse Event|0|||
126119479|NCT01251653|453730798|FG002|Overall Study|Adverse Event|2|||
126119480|NCT01251653|453730799|FG003|Overall Study|Adverse Event|1|||
126119481|NCT01251653|453730800|FG004|Overall Study|Adverse Event|1|||
126119482|NCT01251653|453730801|FG005|Overall Study|Adverse Event|0|||
126119483|NCT01251653|453730802|FG006|Overall Study|Adverse Event|2|||
126119484|NCT01251653|453730803|FG007|Overall Study|Adverse Event|2|||
126119485|NCT01251653|453730804|FG008|Overall Study|Adverse Event|1|||
126119486|NCT01251653|453730796|FG000|Overall Study|Withdrawal by Subject|1|||
126119487|NCT01251653|453730797|FG001|Overall Study|Withdrawal by Subject|0|||
126119488|NCT01251653|453730798|FG002|Overall Study|Withdrawal by Subject|1|||
126119489|NCT01251653|453730799|FG003|Overall Study|Withdrawal by Subject|0|||
126119490|NCT01251653|453730800|FG004|Overall Study|Withdrawal by Subject|1|||
126119491|NCT01251653|453730801|FG005|Overall Study|Withdrawal by Subject|1|||
126119492|NCT01251653|453730802|FG006|Overall Study|Withdrawal by Subject|0|||
126119493|NCT01251653|453730803|FG007|Overall Study|Withdrawal by Subject|1|||
126119494|NCT01251653|453730804|FG008|Overall Study|Withdrawal by Subject|0|||
126119495|NCT01251653|453730796|FG000|Overall Study|Other reason not mentioned above|0|||
126119496|NCT01251653|453730797|FG001|Overall Study|Other reason not mentioned above|0|||
126119497|NCT01251653|453730798|FG002|Overall Study|Other reason not mentioned above|0|||
126119498|NCT01251653|453730799|FG003|Overall Study|Other reason not mentioned above|0|||
126119499|NCT01251653|453730800|FG004|Overall Study|Other reason not mentioned above|0|||
126119500|NCT01251653|453730801|FG005|Overall Study|Other reason not mentioned above|0|||
126119501|NCT01251653|453730802|FG006|Overall Study|Other reason not mentioned above|0|||
126119502|NCT01251653|453730803|FG007|Overall Study|Other reason not mentioned above|2|||
126119503|NCT01251653|453730804|FG008|Overall Study|Other reason not mentioned above|0|||
126119504|NCT01439282|453730805|FG000|Overall Study|Adverse Event|5|||
126119505|NCT01439282|453730806|FG001|Overall Study|Adverse Event|0|||
126119506|NCT01439282|453730805|FG000|Overall Study|Withdrawal by Subject|2|||
126119507|NCT01439282|453730806|FG001|Overall Study|Withdrawal by Subject|0|||
126119508|NCT01439282|453730805|FG000|Overall Study|Other|1|||
126119509|NCT01439282|453730806|FG001|Overall Study|Other|1|||
126119510|NCT00885703|453730809|FG000|Overall Study|Death|9|||
126119511|NCT00885703|453730810|FG001|Overall Study|Death|7|||
126119512|NCT00885703|453730811|FG002|Overall Study|Death|8|||
126119513|NCT00885703|453730812|FG003|Overall Study|Death|7|||
126119514|NCT00885703|453730813|FG004|Overall Study|Death|7|||
126119515|NCT00885703|453730814|FG005|Overall Study|Death|8|||
126119516|NCT00885703|453730815|FG006|Overall Study|Death|4|||
126119517|NCT00885703|453730809|FG000|Overall Study|Lost to Follow-up|0|||
126119518|NCT00885703|453730810|FG001|Overall Study|Lost to Follow-up|0|||
126119519|NCT00885703|453730811|FG002|Overall Study|Lost to Follow-up|1|||
126119520|NCT00885703|453730812|FG003|Overall Study|Lost to Follow-up|0|||
126119521|NCT00885703|453730813|FG004|Overall Study|Lost to Follow-up|0|||
126119522|NCT00885703|453730814|FG005|Overall Study|Lost to Follow-up|1|||
126119523|NCT00885703|453730815|FG006|Overall Study|Lost to Follow-up|0|||
126119524|NCT00885703|453730809|FG000|Overall Study|Withdrawal by Subject|0|||
126119525|NCT00885703|453730810|FG001|Overall Study|Withdrawal by Subject|0|||
126119526|NCT00885703|453730811|FG002|Overall Study|Withdrawal by Subject|0|||
126119527|NCT00885703|453730812|FG003|Overall Study|Withdrawal by Subject|1|||
126119528|NCT00885703|453730813|FG004|Overall Study|Withdrawal by Subject|3|||
126119529|NCT00885703|453730814|FG005|Overall Study|Withdrawal by Subject|1|||
126119530|NCT00885703|453730815|FG006|Overall Study|Withdrawal by Subject|1|||
126119531|NCT00885703|453730809|FG000|Overall Study|Ineligible (no CM)|1|||
126119532|NCT00885703|453730810|FG001|Overall Study|Ineligible (no CM)|3|||
126119533|NCT00885703|453730811|FG002|Overall Study|Ineligible (no CM)|2|||
126119534|NCT00885703|453730812|FG003|Overall Study|Ineligible (no CM)|1|||
126119535|NCT00885703|453730813|FG004|Overall Study|Ineligible (no CM)|2|||
126119536|NCT00885703|453730814|FG005|Overall Study|Ineligible (no CM)|3|||
126119537|NCT00885703|453730815|FG006|Overall Study|Ineligible (no CM)|1|||
126119538|NCT01183143|453730816|FG000|Overall Study|Protocol Violation|115|||
126119539|NCT01183143|453730816|FG000|Overall Study|Withdrawal by Subject|19|||
126119540|NCT01183143|453730816|FG000|Overall Study|Subject Questionnaires not returned|5|||
126119541|NCT01183143|453730816|FG000|Overall Study|Subjects enrolled, but not treated|11|||
126119542|NCT04096274|453730819|FG000|Phase I|Lost to Follow-up|5|||
126119543|NCT04096274|453730820|FG001|Phase I|Lost to Follow-up|5|||
126119544|NCT04096274|453730819|FG000|Phase II|Lost to Follow-up|11|||
126119545|NCT04096274|453730820|FG001|Phase II|Lost to Follow-up|11|||
126119546|NCT02807480|453730821|FG000|Overall Study|Withdrawal by Subject|14|||
126119547|NCT02807480|453730822|FG001|Overall Study|Withdrawal by Subject|10|||
126119548|NCT02163187|453730823|FG000|Overall Study|Device removed|1|||
126119549|NCT02163187|453730824|FG001|Overall Study|Device removed|0|||
126119550|NCT02163187|453730823|FG000|Overall Study|Progressive disease|1|||
126119551|NCT02163187|453730824|FG001|Overall Study|Progressive disease|0|||
126119552|NCT02369848|453730825|FG000|Overall Study|Death|1|||
126119553|NCT02369848|453730825|FG000|Overall Study|Withdrawal by Subject|2|||
126119554|NCT02369848|453730825|FG000|Overall Study|Lost to Follow-up|1|||
126119555|NCT03281668|453730827|FG000|Overall Study|Physician Decision|1|||
126119556|NCT03281668|453730827|FG000|Overall Study|scheduling conflict, family circumstance|2|||
126119557|NCT03281668|453730827|FG000|Overall Study|Withdrawal by Subject|4|||
126119558|NCT03281668|453730827|FG000|Overall Study|Lost to Follow-up|1|||
126119559|NCT01543152|453730828|FG000|Overall Study|Withdrawal by Subject|0|||
126119560|NCT01543152|453730829|FG001|Overall Study|Withdrawal by Subject|2|||
126119561|NCT01543152|453730830|FG002|Overall Study|Withdrawal by Subject|0|||
126119562|NCT01543152|453730831|FG003|Overall Study|Withdrawal by Subject|0|||
126119563|NCT01543152|453730832|FG004|Overall Study|Withdrawal by Subject|0|||
126119564|NCT00762892|453730834|FG000|Overall Study|Lost to Follow-up|2|||
126119565|NCT00762892|453730835|FG001|Overall Study|Lost to Follow-up|5|||
126119566|NCT00762892|453730834|FG000|Overall Study|Withdrawal by Subject|0|||
126119567|NCT00762892|453730835|FG001|Overall Study|Withdrawal by Subject|1|||
126119568|NCT00762892|453730834|FG000|Overall Study|Death|1|||
126119569|NCT00762892|453730835|FG001|Overall Study|Death|0|||
126119570|NCT00762892|453730834|FG000|Overall Study|Pregnancy|1|||
126119571|NCT00762892|453730835|FG001|Overall Study|Pregnancy|0|||
126119572|NCT00762892|453730834|FG000|Overall Study|Incarceration|1|||
126119573|NCT00762892|453730835|FG001|Overall Study|Incarceration|0|||
126119574|NCT05500274|453730840|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
126119575|NCT05500274|453730841|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
126119576|NCT05500274|453730840|FG000|Overall Study|Lost to Follow-up|76|||
126119577|NCT05500274|453730841|FG001|Overall Study|Lost to Follow-up|51|||
126119578|NCT05807464|453730842|FG000|Overall Study|Adverse Event|1|||
126119579|NCT01555151|453730843|FG000|Overall Study|Withdrawal by Subject|6|||
126119580|NCT01555151|453730844|FG001|Overall Study|Withdrawal by Subject|2|||
126119581|NCT01555151|453730845|FG002|Overall Study|Withdrawal by Subject|0|||
126119582|NCT01555151|453730846|FG003|Overall Study|Withdrawal by Subject|2|||
126119583|NCT01555151|453730843|FG000|Overall Study|Administrative|3|||
126119584|NCT01555151|453730844|FG001|Overall Study|Administrative|1|||
126119585|NCT01555151|453730845|FG002|Overall Study|Administrative|2|||
126119586|NCT01555151|453730846|FG003|Overall Study|Administrative|0|||
126119587|NCT01555151|453730843|FG000|Overall Study|Protocol Violation|3|||
126119588|NCT01555151|453730844|FG001|Overall Study|Protocol Violation|3|||
126119589|NCT01555151|453730845|FG002|Overall Study|Protocol Violation|3|||
126119590|NCT01555151|453730846|FG003|Overall Study|Protocol Violation|5|||
126119591|NCT01555151|453730843|FG000|Overall Study|Adverse Event|1|||
126119592|NCT01555151|453730844|FG001|Overall Study|Adverse Event|2|||
126119593|NCT01555151|453730845|FG002|Overall Study|Adverse Event|1|||
126119594|NCT01555151|453730846|FG003|Overall Study|Adverse Event|2|||
126119595|NCT01555151|453730843|FG000|Overall Study|Lost to Follow-up|0|||
126119596|NCT01555151|453730844|FG001|Overall Study|Lost to Follow-up|0|||
126119597|NCT01555151|453730845|FG002|Overall Study|Lost to Follow-up|0|||
126119598|NCT01555151|453730846|FG003|Overall Study|Lost to Follow-up|1|||
126119599|NCT03596866|453730847|FG000|Overall Study|Site terminated by Sponsor|64|||
126119600|NCT03596866|453730848|FG001|Overall Study|Site terminated by Sponsor|65|||
126119601|NCT03596866|453730847|FG000|Overall Study|Death|37|||
126119602|NCT03596866|453730848|FG001|Overall Study|Death|24|||
126119603|NCT03596866|453730847|FG000|Overall Study|Withdrawal by Subject|4|||
126119604|NCT03596866|453730848|FG001|Overall Study|Withdrawal by Subject|6|||
126119605|NCT03596866|453730847|FG000|Overall Study|Missing|0|||
126119606|NCT03596866|453730848|FG001|Overall Study|Missing|6|||
126119607|NCT03596866|453730847|FG000|Overall Study|Lost to Follow-up|2|||
126119608|NCT03596866|453730848|FG001|Overall Study|Lost to Follow-up|3|||
126119609|NCT03596866|453730847|FG000|Overall Study|Protocol Violation|1|||
126119610|NCT03596866|453730848|FG001|Overall Study|Protocol Violation|0|||
126119611|NCT03596866|453730847|FG000|Overall Study|Reason Not Specified|14|||
126119612|NCT03596866|453730848|FG001|Overall Study|Reason Not Specified|13|||
126119613|NCT03740165|453730849|FG000|Overall Study|Death|232|||
126119614|NCT03740165|453730850|FG001|Overall Study|Death|242|||
126119615|NCT03740165|453730851|FG002|Overall Study|Death|229|||
126119616|NCT03740165|453730849|FG000|Overall Study|Lost to Follow-up|0|||
126119617|NCT03740165|453730850|FG001|Overall Study|Lost to Follow-up|0|||
126119618|NCT03740165|453730851|FG002|Overall Study|Lost to Follow-up|1|||
126119619|NCT03740165|453730849|FG000|Overall Study|Withdrawal by Subject|7|||
126119620|NCT03740165|453730850|FG001|Overall Study|Withdrawal by Subject|4|||
126119621|NCT03740165|453730851|FG002|Overall Study|Withdrawal by Subject|3|||
126119622|NCT03740165|453730849|FG000|Overall Study|Ongoing in Study|216|||
126119623|NCT03740165|453730850|FG001|Overall Study|Ongoing in Study|212|||
126119624|NCT03740165|453730851|FG002|Overall Study|Ongoing in Study|221|||
126119625|NCT05678257|453730852|FG000|Overall Study|Withdrawal by Subject|2|||
126119626|NCT05678257|453730853|FG001|Overall Study|Withdrawal by Subject|0|||
126119627|NCT05678257|453730854|FG002|Overall Study|Withdrawal by Subject|5|||
126119628|NCT05678257|453730852|FG000|Overall Study|Physician Decision|1|||
126119629|NCT05678257|453730853|FG001|Overall Study|Physician Decision|0|||
126119630|NCT05678257|453730854|FG002|Overall Study|Physician Decision|1|||
126119631|NCT05678257|453730852|FG000|Overall Study|Adverse Event|1|||
126119632|NCT05678257|453730853|FG001|Overall Study|Adverse Event|3|||
126119633|NCT05678257|453730854|FG002|Overall Study|Adverse Event|1|||
126119634|NCT05678257|453730852|FG000|Overall Study|Progressive disease|11|||
126119635|NCT05678257|453730853|FG001|Overall Study|Progressive disease|18|||
126119636|NCT05678257|453730854|FG002|Overall Study|Progressive disease|7|||
126119637|NCT05678257|453730852|FG000|Overall Study|No longer clinically benefitting|2|||
126119638|NCT05678257|453730853|FG001|Overall Study|No longer clinically benefitting|1|||
126119639|NCT05678257|453730854|FG002|Overall Study|No longer clinically benefitting|0|||
126119640|NCT05678257|453730852|FG000|Overall Study|Sponsor decision|5|||
126119641|NCT05678257|453730853|FG001|Overall Study|Sponsor decision|9|||
126119642|NCT05678257|453730854|FG002|Overall Study|Sponsor decision|8|||
126119643|NCT05678257|453730852|FG000|Overall Study|Protocol Violation|0|||
126119644|NCT05678257|453730853|FG001|Overall Study|Protocol Violation|0|||
126119645|NCT05678257|453730854|FG002|Overall Study|Protocol Violation|1|||
126119646|NCT05678257|453730852|FG000|Overall Study|Patient non-compliance|0|||
126119647|NCT05678257|453730853|FG001|Overall Study|Patient non-compliance|0|||
126119648|NCT05678257|453730854|FG002|Overall Study|Patient non-compliance|3|||
126119649|NCT05314517|453730855|FG000|Double-blind Period|Adverse Event|4|||
126119650|NCT05314517|453730856|FG001|Double-blind Period|Adverse Event|0|||
126119651|NCT05314517|453730857|FG002|Double-blind Period|Adverse Event|0|||
126119652|NCT05314517|453730858|FG003|Double-blind Period|Adverse Event|0|||
126119653|NCT05314517|453730855|FG000|Double-blind Period|Noncompliance|0|||
126119654|NCT05314517|453730856|FG001|Double-blind Period|Noncompliance|1|||
126119655|NCT05314517|453730857|FG002|Double-blind Period|Noncompliance|0|||
126119656|NCT05314517|453730858|FG003|Double-blind Period|Noncompliance|0|||
126119657|NCT05314517|453730855|FG000|Double-blind Period|Randomized, not treated|1|||
126119658|NCT05314517|453730856|FG001|Double-blind Period|Randomized, not treated|0|||
126119659|NCT05314517|453730857|FG002|Double-blind Period|Randomized, not treated|0|||
126119660|NCT05314517|453730858|FG003|Double-blind Period|Randomized, not treated|0|||
126119661|NCT05314517|453730855|FG000|Open-label Extension|Adverse Event|0|||
126119662|NCT05314517|453730856|FG001|Open-label Extension|Adverse Event|0|||
126119663|NCT05314517|453730857|FG002|Open-label Extension|Adverse Event|1|||
126119664|NCT05314517|453730858|FG003|Open-label Extension|Adverse Event|2|||
126119665|NCT05314517|453730855|FG000|Open-label Extension|Investigator decision|0|||
126119666|NCT05314517|453730856|FG001|Open-label Extension|Investigator decision|0|||
126119667|NCT05314517|453730857|FG002|Open-label Extension|Investigator decision|1|||
126119668|NCT05314517|453730858|FG003|Open-label Extension|Investigator decision|0|||
126119669|NCT05314517|453730855|FG000|Open-label Extension|Lost to Follow-up|0|||
126119670|NCT05314517|453730856|FG001|Open-label Extension|Lost to Follow-up|0|||
126119671|NCT05314517|453730857|FG002|Open-label Extension|Lost to Follow-up|0|||
126119672|NCT05314517|453730858|FG003|Open-label Extension|Lost to Follow-up|1|||
126119673|NCT05314517|453730855|FG000|Open-label Extension|Withdrawal by Subject|0|||
126119674|NCT05314517|453730856|FG001|Open-label Extension|Withdrawal by Subject|0|||
126119675|NCT05314517|453730857|FG002|Open-label Extension|Withdrawal by Subject|1|||
126119676|NCT05314517|453730858|FG003|Open-label Extension|Withdrawal by Subject|2|||
126119677|NCT05314517|453730855|FG000|Open-label Extension|Use of prohibited medication|0|||
126119678|NCT05314517|453730856|FG001|Open-label Extension|Use of prohibited medication|0|||
126119679|NCT05314517|453730857|FG002|Open-label Extension|Use of prohibited medication|1|||
126119680|NCT05314517|453730858|FG003|Open-label Extension|Use of prohibited medication|0|||
126119681|NCT05314517|453730855|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
126119682|NCT05314517|453730856|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
126119683|NCT05314517|453730857|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
126119684|NCT05314517|453730858|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
126119685|NCT04969276|453730859|FG000|Overall Study|Protocol Deviation|0|||
126119686|NCT04969276|453730860|FG001|Overall Study|Protocol Deviation|1|||
126119687|NCT04969276|453730861|FG002|Overall Study|Protocol Deviation|0|||
126119688|NCT04969276|453730859|FG000|Overall Study|Withdrawal by Subject|1|||
126119689|NCT04969276|453730860|FG001|Overall Study|Withdrawal by Subject|10|||
126119690|NCT04969276|453730861|FG002|Overall Study|Withdrawal by Subject|0|||
126119691|NCT04969276|453730859|FG000|Overall Study|Lost to Follow-up|0|||
126119692|NCT04969276|453730860|FG001|Overall Study|Lost to Follow-up|1|||
126119693|NCT04969276|453730861|FG002|Overall Study|Lost to Follow-up|0|||
126119694|NCT04655144|453730865|FG000|Overall Study|Consumed THC|1|||
126119695|NCT04655144|453730866|FG001|Overall Study|Consumed THC|0|||
126119696|NCT04655144|453730865|FG000|Overall Study|Unilateral embolization|0|||
126119697|NCT04655144|453730866|FG001|Overall Study|Unilateral embolization|1|||
126119698|NCT04490018|453730867|FG000|Overall Study|Protocol Violation|0|||
126119699|NCT04490018|453730868|FG001|Overall Study|Protocol Violation|2|||
126119700|NCT04490018|453730869|FG002|Overall Study|Protocol Violation|1|||
126119701|NCT04490018|453730867|FG000|Overall Study|Lost to Follow-up|2|||
126119702|NCT04490018|453730868|FG001|Overall Study|Lost to Follow-up|2|||
126119703|NCT04490018|453730869|FG002|Overall Study|Lost to Follow-up|0|||
126119704|NCT04490018|453730867|FG000|Overall Study|Withdrawal by Subject|2|||
126119705|NCT04490018|453730868|FG001|Overall Study|Withdrawal by Subject|1|||
126119706|NCT04490018|453730869|FG002|Overall Study|Withdrawal by Subject|0|||
126119707|NCT04490018|453730867|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126119708|NCT04490018|453730868|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126119709|NCT04490018|453730869|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126119710|NCT00282295|453730871|FG000|Overall Study|Adverse Event|0|||
126119711|NCT00282295|453730872|FG001|Overall Study|Adverse Event|1|||
126119712|NCT00282295|453730873|FG002|Overall Study|Adverse Event|0|||
126119713|NCT00282295|453730871|FG000|Overall Study|Serious Adverse Events|0|||
126119714|NCT00282295|453730872|FG001|Overall Study|Serious Adverse Events|0|||
126119715|NCT00282295|453730873|FG002|Overall Study|Serious Adverse Events|1|||
126119716|NCT00282295|453730871|FG000|Overall Study|Protocol Violation|0|||
126119717|NCT00282295|453730872|FG001|Overall Study|Protocol Violation|2|||
126119718|NCT00282295|453730873|FG002|Overall Study|Protocol Violation|1|||
126119719|NCT00282295|453730871|FG000|Overall Study|Withdrawal by Subject|2|||
126119720|NCT00282295|453730872|FG001|Overall Study|Withdrawal by Subject|6|||
126119721|NCT00282295|453730873|FG002|Overall Study|Withdrawal by Subject|4|||
126119722|NCT00282295|453730871|FG000|Overall Study|Lost to Follow-up|1|||
126119723|NCT00282295|453730872|FG001|Overall Study|Lost to Follow-up|7|||
126119724|NCT00282295|453730873|FG002|Overall Study|Lost to Follow-up|2|||
126119725|NCT00282295|453730871|FG000|Overall Study|Other|0|||
126119726|NCT00282295|453730872|FG001|Overall Study|Other|1|||
126119727|NCT00282295|453730873|FG002|Overall Study|Other|0|||
126119728|NCT03337542|453730874|FG000|Overall Study|Withdrew Consent|17|||
126119729|NCT03337542|453730874|FG000|Overall Study|Allergic Adverse Event|1|||
126119730|NCT03337542|453730874|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
126119731|NCT03337542|453730874|FG000|Overall Study|Lost to Follow-up|1|||
126119732|NCT03337542|453730874|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
126119733|NCT01401842|453730875|FG000|Overall Study|Withdrawal by Subject|3|||
126119734|NCT01401842|453730876|FG001|Overall Study|Withdrawal by Subject|2|||
126119735|NCT01401842|453730875|FG000|Overall Study|academic reason|4|||
126119736|NCT01401842|453730876|FG001|Overall Study|academic reason|1|||
126119737|NCT01401842|453730875|FG000|Overall Study|changed companies|20|||
126119738|NCT01401842|453730876|FG001|Overall Study|changed companies|34|||
126119739|NCT01401842|453730875|FG000|Overall Study|discharged from US Army|3|||
126119740|NCT01401842|453730876|FG001|Overall Study|discharged from US Army|4|||
126119741|NCT01401842|453730875|FG000|Overall Study|invalid follow-up strength data|1|||
126119742|NCT01401842|453730876|FG001|Overall Study|invalid follow-up strength data|4|||
126119743|NCT01401842|453730875|FG000|Overall Study|on profile|9|||
126119744|NCT01401842|453730876|FG001|Overall Study|on profile|5|||
126119745|NCT01401842|453730875|FG000|Overall Study|other/unknown|28|||
126119746|NCT01401842|453730876|FG001|Overall Study|other/unknown|17|||
126119747|NCT01380379|453730877|FG000|Overall Study|Pregnancy|1|||
126119748|NCT00766038|453732312|FG000|Overall Study|Lost to Follow-up|15|||
126119749|NCT00766038|453732313|FG001|Overall Study|Lost to Follow-up|14|||
126119750|NCT00449670|453732314|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
126119751|NCT00449670|453732315|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
126119752|NCT00449670|453732314|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
126119753|NCT00449670|453732315|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
126119754|NCT00449670|453732314|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
126119755|NCT00449670|453732315|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
126119756|NCT00449670|453732314|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
126119757|NCT00449670|453732315|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
126119758|NCT00449670|453732314|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
126119759|NCT00449670|453732315|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
126119760|NCT00449670|453732314|FG000|Booster Phase (Study no.109873)|Other|0|||
126119761|NCT00449670|453732315|FG001|Booster Phase (Study no.109873)|Other|2|||
126119762|NCT00847145|453732320|FG000|Overall Study|AE or Death|0|||
126119763|NCT00847145|453732321|FG001|Overall Study|AE or Death|1|||
126119764|NCT00847145|453732322|FG002|Overall Study|AE or Death|1|||
126119765|NCT00847145|453732323|FG003|Overall Study|AE or Death|0|||
126119766|NCT00847145|453732324|FG004|Overall Study|AE or Death|0|||
126119767|NCT00847145|453732325|FG005|Overall Study|AE or Death|0|||
126119768|NCT00847145|453732326|FG006|Overall Study|AE or Death|0|||
126119769|NCT00847145|453732327|FG007|Overall Study|AE or Death|0|||
126119770|NCT00847145|453732320|FG000|Overall Study|Withdrawal by Subject|3|||
126119771|NCT00847145|453732321|FG001|Overall Study|Withdrawal by Subject|4|||
126119772|NCT00847145|453732322|FG002|Overall Study|Withdrawal by Subject|6|||
126119773|NCT00847145|453732323|FG003|Overall Study|Withdrawal by Subject|1|||
126119774|NCT00847145|453732324|FG004|Overall Study|Withdrawal by Subject|0|||
126119775|NCT00847145|453732325|FG005|Overall Study|Withdrawal by Subject|0|||
126119776|NCT00847145|453732326|FG006|Overall Study|Withdrawal by Subject|1|||
126119777|NCT00847145|453732327|FG007|Overall Study|Withdrawal by Subject|1|||
126119778|NCT00847145|453732320|FG000|Overall Study|Lost to Follow-up|3|||
126119779|NCT00847145|453732321|FG001|Overall Study|Lost to Follow-up|1|||
126119780|NCT00847145|453732322|FG002|Overall Study|Lost to Follow-up|1|||
126119781|NCT00847145|453732323|FG003|Overall Study|Lost to Follow-up|0|||
126119782|NCT00847145|453732324|FG004|Overall Study|Lost to Follow-up|4|||
126119783|NCT00847145|453732325|FG005|Overall Study|Lost to Follow-up|4|||
126119784|NCT00847145|453732326|FG006|Overall Study|Lost to Follow-up|8|||
126119785|NCT00847145|453732327|FG007|Overall Study|Lost to Follow-up|2|||
126119786|NCT00847145|453732320|FG000|Overall Study|Inappropriate enrollment|0|||
126119787|NCT00847145|453732321|FG001|Overall Study|Inappropriate enrollment|0|||
126119788|NCT00847145|453732322|FG002|Overall Study|Inappropriate enrollment|0|||
126119789|NCT00847145|453732323|FG003|Overall Study|Inappropriate enrollment|0|||
126119790|NCT00847145|453732324|FG004|Overall Study|Inappropriate enrollment|1|||
126119791|NCT00847145|453732325|FG005|Overall Study|Inappropriate enrollment|0|||
126119792|NCT00847145|453732326|FG006|Overall Study|Inappropriate enrollment|0|||
126119793|NCT00847145|453732327|FG007|Overall Study|Inappropriate enrollment|0|||
126119794|NCT00847145|453732320|FG000|Overall Study|Protocol Violation|0|||
126119795|NCT00847145|453732321|FG001|Overall Study|Protocol Violation|0|||
126119796|NCT00847145|453732322|FG002|Overall Study|Protocol Violation|3|||
126119797|NCT00847145|453732323|FG003|Overall Study|Protocol Violation|0|||
126119798|NCT00847145|453732324|FG004|Overall Study|Protocol Violation|1|||
126119799|NCT00847145|453732325|FG005|Overall Study|Protocol Violation|0|||
126119800|NCT00847145|453732326|FG006|Overall Study|Protocol Violation|0|||
126119801|NCT00847145|453732327|FG007|Overall Study|Protocol Violation|1|||
126119802|NCT02833974|453732329|FG000|Overall Study|Lost to Follow-up|1|||
126119803|NCT02833974|453732330|FG001|Overall Study|Lost to Follow-up|0|||
126119804|NCT02833974|453732329|FG000|Overall Study|Adverse Event|0|||
126119805|NCT02833974|453732330|FG001|Overall Study|Adverse Event|3|||
126119806|NCT01524198|453732331|FG000|Overall Study|Protocol Violation|8|||
126119807|NCT01524198|453732332|FG001|Overall Study|Protocol Violation|6|||
126119808|NCT01524198|453732331|FG000|Overall Study|Withdrawal by Subject|15|||
126119809|NCT01524198|453732332|FG001|Overall Study|Withdrawal by Subject|10|||
126119810|NCT04419610|453732333|FG000|Overall Study|Withdrawal by Subject|3|||
126119811|NCT04419610|453732334|FG001|Overall Study|Withdrawal by Subject|1|||
126119812|NCT04419610|453732333|FG000|Overall Study|Adverse Event|1|||
126119813|NCT04419610|453732334|FG001|Overall Study|Adverse Event|0|||
126119814|NCT04419610|453732333|FG000|Overall Study|discharged early|1|||
126119815|NCT04419610|453732334|FG001|Overall Study|discharged early|1|||
126119816|NCT02232802|453732335|FG000|Period 1|Sponsor request|1|||
126119817|NCT02232802|453732336|FG001|Period 1|Sponsor request|0|||
126119818|NCT02232802|453732335|FG000|Period 1|Adverse Event|1|||
126119819|NCT02232802|453732336|FG001|Period 1|Adverse Event|1|||
126119820|NCT00307151|453732342|FG000|Overall Study|Death|4|||
126119821|NCT00307151|453732343|FG001|Overall Study|Death|3|||
126119822|NCT00307151|453732344|FG002|Overall Study|Death|10|||
126119823|NCT00307151|453732345|FG003|Overall Study|Death|3|||
126119824|NCT00307151|453732342|FG000|Overall Study|Severe debilitation, unable to continue|1|||
126119825|NCT00307151|453732343|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126119826|NCT00307151|453732344|FG002|Overall Study|Severe debilitation, unable to continue|0|||
126119827|NCT00307151|453732345|FG003|Overall Study|Severe debilitation, unable to continue|0|||
126119828|NCT00307151|453732342|FG000|Overall Study|Subject unable to get to clinic|1|||
126119829|NCT00307151|453732343|FG001|Overall Study|Subject unable to get to clinic|0|||
126119830|NCT00307151|453732344|FG002|Overall Study|Subject unable to get to clinic|6|||
126119831|NCT00307151|453732345|FG003|Overall Study|Subject unable to get to clinic|2|||
126119832|NCT00307151|453732342|FG000|Overall Study|Withdrew consent|0|||
126119833|NCT00307151|453732343|FG001|Overall Study|Withdrew consent|1|||
126119834|NCT00307151|453732344|FG002|Overall Study|Withdrew consent|1|||
126119835|NCT00307151|453732345|FG003|Overall Study|Withdrew consent|3|||
126119836|NCT00307151|453732342|FG000|Overall Study|Not willing to adhere to study reqs|2|||
126119837|NCT00307151|453732343|FG001|Overall Study|Not willing to adhere to study reqs|0|||
126119838|NCT00307151|453732344|FG002|Overall Study|Not willing to adhere to study reqs|2|||
126119839|NCT00307151|453732345|FG003|Overall Study|Not willing to adhere to study reqs|2|||
126119840|NCT00307151|453732342|FG000|Overall Study|Clinic unable to contact subject|3|||
126119841|NCT00307151|453732343|FG001|Overall Study|Clinic unable to contact subject|3|||
126119842|NCT00307151|453732344|FG002|Overall Study|Clinic unable to contact subject|1|||
126119843|NCT00307151|453732345|FG003|Overall Study|Clinic unable to contact subject|1|||
126119844|NCT01490450|453732348|FG000|Period 1|Lack of Efficacy|2|||
126119845|NCT01490450|453732349|FG001|Period 1|Lack of Efficacy|0|||
126119846|NCT01490450|453732350|FG002|Period 1|Lack of Efficacy|3|||
126119847|NCT01490450|453732351|FG003|Period 1|Lack of Efficacy|0|||
126119848|NCT01490450|453732348|FG000|Period 1|Adverse Event|0|||
126119849|NCT01490450|453732349|FG001|Period 1|Adverse Event|0|||
126119850|NCT01490450|453732350|FG002|Period 1|Adverse Event|0|||
126119851|NCT01490450|453732351|FG003|Period 1|Adverse Event|5|||
126119852|NCT01490450|453732348|FG000|Period 1|Request to discontinue treatment|1|||
126119853|NCT01490450|453732349|FG001|Period 1|Request to discontinue treatment|0|||
126119854|NCT01490450|453732350|FG002|Period 1|Request to discontinue treatment|0|||
126119855|NCT01490450|453732351|FG003|Period 1|Request to discontinue treatment|0|||
126119856|NCT01490450|453732348|FG000|Period 1|Withdrawal by Subject|0|||
126119857|NCT01490450|453732349|FG001|Period 1|Withdrawal by Subject|0|||
126119858|NCT01490450|453732350|FG002|Period 1|Withdrawal by Subject|0|||
126119859|NCT01490450|453732351|FG003|Period 1|Withdrawal by Subject|3|||
126119860|NCT01490450|453732348|FG000|Period 1|No longer met study criteria|0|||
126119861|NCT01490450|453732349|FG001|Period 1|No longer met study criteria|1|||
126119862|NCT01490450|453732350|FG002|Period 1|No longer met study criteria|1|||
126119863|NCT01490450|453732351|FG003|Period 1|No longer met study criteria|0|||
126119864|NCT01490450|453732348|FG000|Period 2|Lack of Efficacy|0|||
126119865|NCT01490450|453732349|FG001|Period 2|Lack of Efficacy|0|||
126119866|NCT01490450|453732350|FG002|Period 2|Lack of Efficacy|0|||
126119867|NCT01490450|453732351|FG003|Period 2|Lack of Efficacy|1|||
126119868|NCT01490450|453732348|FG000|Period 2|Adverse Event|1|||
126119869|NCT01490450|453732349|FG001|Period 2|Adverse Event|1|||
126119870|NCT01490450|453732350|FG002|Period 2|Adverse Event|0|||
126119871|NCT01490450|453732351|FG003|Period 2|Adverse Event|1|||
126119872|NCT01490450|453732348|FG000|Period 2|Withdrawal by Subject|1|||
126119873|NCT01490450|453732349|FG001|Period 2|Withdrawal by Subject|0|||
126119874|NCT01490450|453732350|FG002|Period 2|Withdrawal by Subject|0|||
126119875|NCT01490450|453732351|FG003|Period 2|Withdrawal by Subject|0|||
126119876|NCT01490450|453732348|FG000|Period 2|Lost to Follow-up|0|||
126119877|NCT01490450|453732349|FG001|Period 2|Lost to Follow-up|0|||
126119878|NCT01490450|453732350|FG002|Period 2|Lost to Follow-up|0|||
126119879|NCT01490450|453732351|FG003|Period 2|Lost to Follow-up|2|||
126119880|NCT03197493|453732352|FG000|Overall Study|Withdrawal by Subject|5|||
126119881|NCT00516048|453732355|FG000|Overall Study|Death|0|||
126119882|NCT00516048|453732356|FG001|Overall Study|Death|0|||
126119883|NCT00516048|453732357|FG002|Overall Study|Death|1|||
126119884|NCT00516048|453732355|FG000|Overall Study|Subject Decision|0|||
126119885|NCT00516048|453732356|FG001|Overall Study|Subject Decision|2|||
126119886|NCT00516048|453732357|FG002|Overall Study|Subject Decision|0|||
126119887|NCT00054704|453732360|FG000|Overall Study|Lack of Efficacy|2|||
126119888|NCT00054704|453732361|FG001|Overall Study|Lack of Efficacy|3|||
126119889|NCT00054704|453732360|FG000|Overall Study|Adverse Event|3|||
126119890|NCT00054704|453732361|FG001|Overall Study|Adverse Event|1|||
126119891|NCT00054704|453732360|FG000|Overall Study|Lost to Follow-up|0|||
126119892|NCT00054704|453732361|FG001|Overall Study|Lost to Follow-up|1|||
126119893|NCT00362414|453732362|FG000|Overall Study|Death|2|||
126119894|NCT00362414|453732362|FG000|Overall Study|Adverse Event|1|||
126119895|NCT02053168|453732363|FG000|Overall Study|Withdrawal by Subject|1|||
126119896|NCT02053168|453732363|FG000|Overall Study|Physician Decision|1|||
126119897|NCT02053168|453732363|FG000|Overall Study|Lost to Follow-up|1|||
126119898|NCT00636675|453732364|FG000|Overall Study|Lost to Follow-up|121|||
126119899|NCT00636675|453732365|FG001|Overall Study|Lost to Follow-up|31|||
126119900|NCT00636675|453732364|FG000|Overall Study|Withdrawal by Subject|19|||
126119901|NCT00636675|453732365|FG001|Overall Study|Withdrawal by Subject|10|||
126119902|NCT00096785|453732366|FG000|Overall Study|Lost to Follow-up|1|||
126119903|NCT00096785|453732367|FG001|Overall Study|Lost to Follow-up|0|||
126119904|NCT00096785|453732366|FG000|Overall Study|Withdrawal by Subject|0|||
126119905|NCT00096785|453732367|FG001|Overall Study|Withdrawal by Subject|1|||
126119906|NCT00096785|453732366|FG000|Overall Study|Relocated|1|||
126119907|NCT00096785|453732367|FG001|Overall Study|Relocated|0|||
126119908|NCT04053868|453732368|FG000|Overall Study|Withdrawal by Subject|1|||
126119909|NCT04053868|453732369|FG001|Overall Study|Withdrawal by Subject|0|||
126119910|NCT00833053|453732372|FG000|Overall Study|Adverse Event|4|||
126119911|NCT00833053|453732373|FG001|Overall Study|Adverse Event|0|||
126119912|NCT00833053|453732372|FG000|Overall Study|Treatment Failure|3|||
126119913|NCT00833053|453732373|FG001|Overall Study|Treatment Failure|1|||
126119914|NCT00833053|453732372|FG000|Overall Study|Withdrawal by Subject|0|||
126119915|NCT00833053|453732373|FG001|Overall Study|Withdrawal by Subject|1|||
126119916|NCT00833053|453732372|FG000|Overall Study|Protocol Violation|2|||
126119917|NCT00833053|453732373|FG001|Overall Study|Protocol Violation|1|||
126119918|NCT02187471|453732376|FG000|Overall Study|Protocol Violation|4|||
126119919|NCT02187471|453732377|FG001|Overall Study|Protocol Violation|5|||
126119920|NCT02187471|453732378|FG002|Overall Study|Protocol Violation|4|||
126119921|NCT02187471|453732379|FG003|Overall Study|Protocol Violation|4|||
126119922|NCT02187471|453732376|FG000|Overall Study|Missing|0|||
126119923|NCT02187471|453732377|FG001|Overall Study|Missing|0|||
126119924|NCT02187471|453732378|FG002|Overall Study|Missing|0|||
126119925|NCT02187471|453732379|FG003|Overall Study|Missing|1|||
126119926|NCT02187471|453732376|FG000|Overall Study|Lack of Efficacy|18|||
126119927|NCT02187471|453732377|FG001|Overall Study|Lack of Efficacy|9|||
126119928|NCT02187471|453732378|FG002|Overall Study|Lack of Efficacy|13|||
126119929|NCT02187471|453732379|FG003|Overall Study|Lack of Efficacy|11|||
126119930|NCT02187471|453732376|FG000|Overall Study|Adverse Event|24|||
126119931|NCT02187471|453732377|FG001|Overall Study|Adverse Event|34|||
126119932|NCT02187471|453732378|FG002|Overall Study|Adverse Event|44|||
126119933|NCT02187471|453732379|FG003|Overall Study|Adverse Event|36|||
126119934|NCT02187471|453732376|FG000|Overall Study|Withdrawal by Subject|23|||
126119935|NCT02187471|453732377|FG001|Overall Study|Withdrawal by Subject|29|||
126119936|NCT02187471|453732378|FG002|Overall Study|Withdrawal by Subject|22|||
126119937|NCT02187471|453732379|FG003|Overall Study|Withdrawal by Subject|24|||
126119938|NCT02187471|453732376|FG000|Overall Study|Other|7|||
126119939|NCT02187471|453732377|FG001|Overall Study|Other|5|||
126119940|NCT02187471|453732378|FG002|Overall Study|Other|3|||
126119941|NCT02187471|453732379|FG003|Overall Study|Other|4|||
126119942|NCT02236520|453732380|FG000|Overall Study|Physician Decision|0|||
126119943|NCT02236520|453732381|FG001|Overall Study|Physician Decision|5|||
126119944|NCT02236520|453732382|FG002|Overall Study|Physician Decision|0|||
126119945|NCT02236520|453732383|FG003|Overall Study|Physician Decision|0|||
126119946|NCT02236520|453732380|FG000|Overall Study|Withdrawal by Subject|1|||
126119947|NCT02236520|453732381|FG001|Overall Study|Withdrawal by Subject|0|||
126119948|NCT02236520|453732382|FG002|Overall Study|Withdrawal by Subject|0|||
126119949|NCT02236520|453732383|FG003|Overall Study|Withdrawal by Subject|1|||
126119950|NCT02236520|453732380|FG000|Overall Study|Pregnancy|1|||
126119951|NCT02236520|453732381|FG001|Overall Study|Pregnancy|0|||
126119952|NCT02236520|453732382|FG002|Overall Study|Pregnancy|0|||
126119953|NCT02236520|453732383|FG003|Overall Study|Pregnancy|0|||
126119954|NCT01785160|453732384|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
126119955|NCT01785160|453732384|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
126119956|NCT00957528|453732385|FG000|Overall Study|Protocol Violation|0|||
126119957|NCT00957528|453732386|FG001|Overall Study|Protocol Violation|1|||
126119958|NCT00957528|453732387|FG002|Overall Study|Protocol Violation|0|||
126119959|NCT00957528|453732385|FG000|Overall Study|Withdrawal by Subject|0|||
126119960|NCT00957528|453732386|FG001|Overall Study|Withdrawal by Subject|0|||
126119961|NCT00957528|453732387|FG002|Overall Study|Withdrawal by Subject|1|||
126119962|NCT02081534|453732392|FG000|Overall Study|Adverse Event|5|||
126119963|NCT02081534|453732393|FG001|Overall Study|Adverse Event|4|||
126119964|NCT02081534|453732394|FG002|Overall Study|Adverse Event|3|||
126119965|NCT02081534|453732395|FG003|Overall Study|Adverse Event|10|||
126119966|NCT02081534|453732396|FG004|Overall Study|Adverse Event|2|||
126119967|NCT02081534|453732397|FG005|Overall Study|Adverse Event|8|||
126119968|NCT02081534|453732398|FG006|Overall Study|Adverse Event|2|||
126119969|NCT02081534|453732392|FG000|Overall Study|Withdrawal by Subject|0|||
126119970|NCT02081534|453732393|FG001|Overall Study|Withdrawal by Subject|1|||
126119971|NCT02081534|453732394|FG002|Overall Study|Withdrawal by Subject|1|||
126119972|NCT02081534|453732395|FG003|Overall Study|Withdrawal by Subject|1|||
126119973|NCT02081534|453732396|FG004|Overall Study|Withdrawal by Subject|1|||
126119974|NCT02081534|453732397|FG005|Overall Study|Withdrawal by Subject|0|||
126119975|NCT02081534|453732398|FG006|Overall Study|Withdrawal by Subject|1|||
126119976|NCT02081534|453732392|FG000|Overall Study|Protocol Violation|0|||
126119977|NCT02081534|453732393|FG001|Overall Study|Protocol Violation|3|||
126119978|NCT02081534|453732394|FG002|Overall Study|Protocol Violation|0|||
126119979|NCT02081534|453732395|FG003|Overall Study|Protocol Violation|0|||
126119980|NCT02081534|453732396|FG004|Overall Study|Protocol Violation|0|||
126119981|NCT02081534|453732397|FG005|Overall Study|Protocol Violation|0|||
126119982|NCT02081534|453732398|FG006|Overall Study|Protocol Violation|1|||
126119983|NCT02081534|453732392|FG000|Overall Study|Lost to Follow-up|0|||
126119984|NCT02081534|453732393|FG001|Overall Study|Lost to Follow-up|0|||
126119985|NCT02081534|453732394|FG002|Overall Study|Lost to Follow-up|0|||
126119986|NCT02081534|453732395|FG003|Overall Study|Lost to Follow-up|2|||
126119987|NCT02081534|453732396|FG004|Overall Study|Lost to Follow-up|1|||
126119988|NCT02081534|453732397|FG005|Overall Study|Lost to Follow-up|1|||
126119989|NCT02081534|453732398|FG006|Overall Study|Lost to Follow-up|0|||
126119990|NCT02234479|453732399|FG000|Overall Study|Withdrawal by Subject|1|||
126119991|NCT02234479|453732400|FG001|Overall Study|Withdrawal by Subject|3|||
126119992|NCT02318667|453732401|FG000|Overall Study|Adverse Event|1|||
126119993|NCT02318667|453732401|FG000|Overall Study|Lack of Efficacy|6|||
126119994|NCT02318667|453732401|FG000|Overall Study|Protocol Violation|2|||
126119995|NCT02289742|453732402|FG000|First Wear Period|Adverse event prior to treatment|0|||
126119996|NCT02289742|453732403|FG001|First Wear Period|Adverse event prior to treatment|1|||
126119997|NCT02289742|453732404|FG002|First Wear Period|Adverse event prior to treatment|0|||
126119998|NCT02289742|453732405|FG003|First Wear Period|Adverse event prior to treatment|0|||
126119999|NCT02289742|453732402|FG000|First Wear Period|Adverse Event|0|||
126120000|NCT02289742|453732403|FG001|First Wear Period|Adverse Event|0|||
126120001|NCT02289742|453732404|FG002|First Wear Period|Adverse Event|1|||
126120002|NCT02289742|453732405|FG003|First Wear Period|Adverse Event|0|||
126120003|NCT02289742|453732402|FG000|First Wear Period|Other prior to treatment|0|||
126120004|NCT02289742|453732403|FG001|First Wear Period|Other prior to treatment|0|||
126120005|NCT02289742|453732404|FG002|First Wear Period|Other prior to treatment|0|||
126120006|NCT02289742|453732405|FG003|First Wear Period|Other prior to treatment|1|||
126120007|NCT02289742|453732402|FG000|Third Wear Period|Adverse Event|0|||
126120008|NCT02289742|453732403|FG001|Third Wear Period|Adverse Event|1|||
126120009|NCT02289742|453732404|FG002|Third Wear Period|Adverse Event|0|||
126120010|NCT02289742|453732405|FG003|Third Wear Period|Adverse Event|0|||
126120011|NCT02289742|453732402|FG000|Third Wear Period|Reason not given|0|||
126120012|NCT02289742|453732403|FG001|Third Wear Period|Reason not given|0|||
126120013|NCT02289742|453732404|FG002|Third Wear Period|Reason not given|0|||
126120014|NCT02289742|453732405|FG003|Third Wear Period|Reason not given|1|||
126120015|NCT01365039|453732406|FG000|Overall Study|Study related symptoms and complaints|1|||
126120016|NCT01365039|453732407|FG001|Overall Study|Study related symptoms and complaints|0|||
126120017|NCT00253643|453732412|FG000|Overall Study|Withdrawal by Subject|0|||
126120018|NCT00253643|453732413|FG001|Overall Study|Withdrawal by Subject|0|||
126120019|NCT00253643|453732414|FG002|Overall Study|Withdrawal by Subject|1|||
126120020|NCT00253643|453732415|FG003|Overall Study|Withdrawal by Subject|1|||
126120021|NCT00253643|453732412|FG000|Overall Study|Non-Compliance|0|||
126120022|NCT00253643|453732413|FG001|Overall Study|Non-Compliance|0|||
126120023|NCT00253643|453732414|FG002|Overall Study|Non-Compliance|0|||
126120024|NCT00253643|453732415|FG003|Overall Study|Non-Compliance|2|||
126120025|NCT00383084|453732416|FG000|Overall Study|Withdrawal by Subject|12|||
126120026|NCT00383084|453732417|FG001|Overall Study|Withdrawal by Subject|10|||
126120027|NCT02636582|453732418|FG000|Overall Study|Surgical Pathology|1|||
126120028|NCT02636582|453732419|FG001|Overall Study|Surgical Pathology|0|||
126120029|NCT01263483|453732420|FG000|Overall Study|Adverse Event|4|||
126120030|NCT01263483|453732421|FG001|Overall Study|Adverse Event|0|||
126120031|NCT01263483|453732422|FG002|Overall Study|Adverse Event|3|||
126120032|NCT01263483|453732420|FG000|Overall Study|Withdrawal by Subject|1|||
126120033|NCT01263483|453732421|FG001|Overall Study|Withdrawal by Subject|0|||
126120034|NCT01263483|453732422|FG002|Overall Study|Withdrawal by Subject|0|||
126120035|NCT01263483|453732420|FG000|Overall Study|Lack of Efficacy|2|||
126120036|NCT01263483|453732421|FG001|Overall Study|Lack of Efficacy|0|||
126120037|NCT01263483|453732422|FG002|Overall Study|Lack of Efficacy|0|||
126120038|NCT01263483|453732420|FG000|Overall Study|Protocol Violation|0|||
126120039|NCT01263483|453732421|FG001|Overall Study|Protocol Violation|1|||
126120040|NCT01263483|453732422|FG002|Overall Study|Protocol Violation|1|||
126120041|NCT01263483|453732420|FG000|Overall Study|Participant Unavailability|0|||
126120042|NCT01263483|453732421|FG001|Overall Study|Participant Unavailability|1|||
126120043|NCT01263483|453732422|FG002|Overall Study|Participant Unavailability|1|||
126120044|NCT00326209|453732423|FG000|Overall Study|Adverse Event|28|||
126120045|NCT00326209|453732423|FG000|Overall Study|Withdrawal by Subject|22|||
126120046|NCT00326209|453732423|FG000|Overall Study|Lack of Efficacy|31|||
126120047|NCT00326209|453732423|FG000|Overall Study|Lost to Follow-up|18|||
126120048|NCT00326209|453732423|FG000|Overall Study|Participant non-compliant|6|||
126120049|NCT00326209|453732423|FG000|Overall Study|Sponsor closed study|173|||
126120050|NCT00326209|453732423|FG000|Overall Study|Prohibited medication use|1|||
126120051|NCT00326209|453732423|FG000|Overall Study|Violation of entry criteria|1|||
126120052|NCT00326209|453732423|FG000|Overall Study|Withdrawn in error|1|||
126120053|NCT00326209|453732423|FG000|Overall Study|Pregnancy|1|||
126120054|NCT00714285|453732424|FG000|Overall Study|Lost to Follow-up|0|||
126120055|NCT00714285|453732425|FG001|Overall Study|Lost to Follow-up|2|||
126120056|NCT00714285|453732426|FG002|Overall Study|Lost to Follow-up|0|||
125960669|NCT01969838|453149256|FG001|Open-label Phase|Disease Progression|0|||
125960670|NCT01969838|453149257|FG002|Open-label Phase|Disease Progression|26|||
126120057|NCT00714285|453732427|FG003|Overall Study|Lost to Follow-up|1|||
126120058|NCT00714285|453732424|FG000|Overall Study|Migrated/moved from study area|0|||
126120059|NCT00714285|453732425|FG001|Overall Study|Migrated/moved from study area|1|||
126120060|NCT00714285|453732426|FG002|Overall Study|Migrated/moved from study area|0|||
126120061|NCT00714285|453732427|FG003|Overall Study|Migrated/moved from study area|0|||
126120062|NCT01372384|453732428|FG000|Overall Study|Progression of disease|3|||
126120063|NCT01131676|453732433|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
126120064|NCT01131676|453732434|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
126120065|NCT01131676|453732435|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
126120066|NCT01131676|453732433|FG000|Discontinuation From Treatment|Not treated|4|||
126120067|NCT01131676|453732434|FG001|Discontinuation From Treatment|Not treated|2|||
126120068|NCT01131676|453732435|FG002|Discontinuation From Treatment|Not treated|2|||
126120069|NCT01131676|453732433|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
126120070|NCT01131676|453732434|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
126120071|NCT01131676|453732435|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
126120072|NCT01131676|453732433|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
126120073|NCT01131676|453732434|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
126120074|NCT01131676|453732435|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
126120075|NCT01131676|453732433|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
126120076|NCT01131676|453732434|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
126120077|NCT01131676|453732435|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
126120078|NCT01131676|453732433|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
125960671|NCT01969838|453149258|FG003|Open-label Phase|Disease Progression|27|||
126120079|NCT01131676|453732434|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
126120080|NCT01131676|453732435|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
126120081|NCT01131676|453732433|FG000|Discontinuation From Treatment|Other than those specified|162|||
126120082|NCT01131676|453732434|FG001|Discontinuation From Treatment|Other than those specified|142|||
126120083|NCT01131676|453732435|FG002|Discontinuation From Treatment|Other than those specified|125|||
126120084|NCT01131676|453732433|FG000|Discontinuation From Treatment|Adverse Event|303|||
126120085|NCT01131676|453732434|FG001|Discontinuation From Treatment|Adverse Event|267|||
126120086|NCT01131676|453732435|FG002|Discontinuation From Treatment|Adverse Event|273|||
126120087|NCT01131676|453732433|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
126120088|NCT01131676|453732434|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
126120089|NCT01131676|453732435|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
126120090|NCT01131676|453732433|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
126120091|NCT01131676|453732434|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
126120092|NCT01131676|453732435|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
126120093|NCT01131676|453732433|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
126120094|NCT01131676|453732434|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
126120095|NCT01131676|453732435|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
126120096|NCT01131676|453732433|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
126120097|NCT01131676|453732434|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
126120098|NCT01131676|453732435|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
126120099|NCT01131676|453732433|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
126120100|NCT01131676|453732434|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
126120101|NCT01131676|453732435|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
126120102|NCT01131676|453732433|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
126120103|NCT01131676|453732434|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
126120104|NCT01131676|453732435|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
126120105|NCT00829179|453732438|FG000|Overall Study|Withdrawal by Subject|1|||
126120106|NCT03000179|453732439|FG000|Overall Study|Lost to Follow-up|2|||
126120107|NCT01075412|453732440|FG000|Overall Study|Withdrawal by Subject|0|||
126120108|NCT01075412|453732441|FG001|Overall Study|Withdrawal by Subject|1|||
126120109|NCT00865904|453732442|FG000|Overall Study|Randomized but not Treated|2|||
126120110|NCT00865904|453732443|FG001|Overall Study|Randomized but not Treated|0|||
126120111|NCT00865904|453732444|FG002|Overall Study|Randomized but not Treated|0|||
126120112|NCT00865904|453732445|FG003|Overall Study|Randomized but not Treated|1|||
126120113|NCT00865904|453732446|FG004|Overall Study|Randomized but not Treated|1|||
126120114|NCT03625687|453732447|FG000|Overall Study|Death|1|||
126120115|NCT00916149|453732452|FG000|Overall Study|Lost to Follow-up|3|||
126120116|NCT00916149|453732453|FG001|Overall Study|Lost to Follow-up|2|||
126120117|NCT00916149|453732454|FG002|Overall Study|Lost to Follow-up|0|||
126120118|NCT00916149|453732452|FG000|Overall Study|Unable to place scalp EEG leads|1|||
126120119|NCT00916149|453732453|FG001|Overall Study|Unable to place scalp EEG leads|0|||
126120120|NCT00916149|453732454|FG002|Overall Study|Unable to place scalp EEG leads|0|||
126120121|NCT00589420|453732455|FG000|Overall Study|screen failure|1|||
126120122|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
126120123|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
126120124|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
126120125|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
126120126|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
126120127|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
126120128|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126120129|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126120130|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
126120131|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
126120132|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
126120133|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
126120134|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
126120135|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
126120136|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
126120137|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
126120138|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
126120139|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
126120140|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
126120141|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
126120142|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
126120143|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
126120144|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
126120145|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
126120146|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Death|2|||
126120147|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Death|1|||
126120148|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Death|0|||
126120149|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Death|0|||
126120150|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
126120151|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
126120152|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
126120153|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
126120154|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
126120155|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
126120156|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
126120157|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
126120158|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
126120159|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
126120160|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126120161|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126120162|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
126120163|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
126120164|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
126120165|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
126120166|NCT01940471|453732456|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
126120167|NCT01940471|453732457|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
126120168|NCT01940471|453732458|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
126120169|NCT01940471|453732459|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
126120170|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
126120171|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
126120172|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
126120173|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
126120174|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126120175|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126120176|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
126120177|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
126120178|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
126120179|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
126120180|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
126120181|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
126120182|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
126120183|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
126120184|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
126120185|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
126120186|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126120187|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126120188|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
126120189|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
126120190|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126120191|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126120192|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
126120193|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
126120194|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126120195|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126120196|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
126120197|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126120198|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
126120199|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
126120200|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
126120201|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
126120202|NCT01940471|453732456|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126120203|NCT01940471|453732457|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126120204|NCT01940471|453732458|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
126120205|NCT01940471|453732459|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126120206|NCT01846624|453732460|FG000|Overall Study|Died during induction, no midostaurin|1|||
126120207|NCT03574753|453732461|FG000|Overall Study|Adverse Event|3|||
126120208|NCT03574753|453732461|FG000|Overall Study|Progression/relapse|19|||
126120209|NCT03574753|453732461|FG000|Overall Study|Death|1|||
126120210|NCT03462719|453732464|FG000|Overall Study|Withdrawal by Subject|4|||
126120211|NCT03462719|453732465|FG001|Overall Study|Withdrawal by Subject|3|||
126120212|NCT03462719|453732464|FG000|Overall Study|Ongoing|87|||
126120213|NCT03462719|453732465|FG001|Overall Study|Ongoing|72|||
126120214|NCT03451851|453732468|FG000|PCP: Week 0 -16|Adverse Event|1|||
126120215|NCT03451851|453732469|FG001|PCP: Week 0 -16|Adverse Event|0|||
126120216|NCT03451851|453732470|FG002|PCP: Week 0 -16|Adverse Event|0|||
126120217|NCT03451851|453732471|FG003|PCP: Week 0 -16|Adverse Event|0|||
126120218|NCT03451851|453732472|FG004|PCP: Week 0 -16|Adverse Event|0|||
126120219|NCT03451851|453732473|FG005|PCP: Week 0 -16|Adverse Event|0|||
126120220|NCT03451851|453732474|FG006|PCP: Week 0 -16|Adverse Event|1|||
126120221|NCT03451851|453732475|FG007|PCP: Week 0 -16|Adverse Event|0|||
126120222|NCT03451851|453732468|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
126120223|NCT03451851|453732469|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
126120224|NCT03451851|453732470|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
126087361|NCT05000216|453612960|FG010|Stage 2|Withdrawal by Subject|0|||
126087362|NCT05000216|453612961|FG011|Stage 2|Withdrawal by Subject|0|||
126087363|NCT05000216|453612962|FG012|Stage 2|Withdrawal by Subject|0|||
126087364|NCT05000216|453612963|FG013|Stage 2|Withdrawal by Subject|0|||
126087365|NCT05000216|453612964|FG014|Stage 2|Withdrawal by Subject|2|||
126087366|NCT05000216|453612965|FG015|Stage 2|Withdrawal by Subject|0|||
126087367|NCT05000216|453612966|FG016|Stage 2|Withdrawal by Subject|9|||
126087368|NCT05000216|453612967|FG017|Stage 2|Withdrawal by Subject|0|||
126087369|NCT05000216|453612968|FG018|Stage 2|Withdrawal by Subject|0|||
126087370|NCT05000216|453612969|FG019|Stage 2|Withdrawal by Subject|0|||
126087371|NCT05000216|453612970|FG020|Stage 2|Withdrawal by Subject|0|||
126087372|NCT05000216|453612971|FG021|Stage 2|Withdrawal by Subject|0|||
126087373|NCT05000216|453612950|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
126087374|NCT05000216|453612951|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
126087375|NCT05000216|453612952|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
126087376|NCT05000216|453612953|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
126087377|NCT05000216|453612954|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
126087378|NCT05000216|453612955|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
126087379|NCT05000216|453612956|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
126087380|NCT05000216|453612957|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
126087381|NCT05000216|453612958|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
126087382|NCT05000216|453612959|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
126087383|NCT05000216|453612960|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
126087384|NCT05000216|453612961|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
126087385|NCT05000216|453612962|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
126087386|NCT05000216|453612963|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
126087387|NCT05000216|453612964|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
126087388|NCT05000216|453612965|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
126087389|NCT05000216|453612966|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
126087390|NCT05000216|453612967|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
126087391|NCT05000216|453612968|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
126087392|NCT05000216|453612969|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
126087393|NCT05000216|453612970|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
126087394|NCT05000216|453612971|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
126087395|NCT05000216|453612950|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087396|NCT05000216|453612951|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087397|NCT05000216|453612952|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087398|NCT05000216|453612953|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087399|NCT05000216|453612954|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087400|NCT05000216|453612955|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087401|NCT05000216|453612956|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087402|NCT05000216|453612957|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087403|NCT05000216|453612958|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087404|NCT05000216|453612959|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087405|NCT05000216|453612960|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087406|NCT05000216|453612961|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087407|NCT05000216|453612962|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087408|NCT05000216|453612963|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087409|NCT05000216|453612964|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
126087410|NCT05000216|453612965|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087411|NCT05000216|453612966|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
126087412|NCT05000216|453612967|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087413|NCT05000216|453612968|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087414|NCT05000216|453612969|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087415|NCT05000216|453612970|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087416|NCT05000216|453612971|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126087417|NCT05000216|453612950|FG000|Stage 2|Other reason|0|||
126120225|NCT03451851|453732471|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
126120226|NCT03451851|453732472|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
126087418|NCT05000216|453612951|FG001|Stage 2|Other reason|0|||
126087419|NCT05000216|453612952|FG002|Stage 2|Other reason|0|||
126087420|NCT05000216|453612953|FG003|Stage 2|Other reason|0|||
126087421|NCT05000216|453612954|FG004|Stage 2|Other reason|0|||
126087422|NCT05000216|453612955|FG005|Stage 2|Other reason|0|||
126120227|NCT03451851|453732473|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
126120228|NCT03451851|453732474|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
126120229|NCT03451851|453732475|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
126120230|NCT03451851|453732468|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126120231|NCT03451851|453732469|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126120232|NCT03451851|453732470|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
126120233|NCT03451851|453732471|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126120234|NCT03451851|453732472|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126120235|NCT03451851|453732473|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126120236|NCT03451851|453732474|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126120237|NCT03451851|453732475|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126120238|NCT03451851|453732468|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126120239|NCT03451851|453732469|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126120240|NCT03451851|453732470|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126120241|NCT03451851|453732471|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126120242|NCT03451851|453732472|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
126120243|NCT03451851|453732473|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
126120244|NCT03451851|453732474|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126120245|NCT03451851|453732475|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126120246|NCT03451851|453732468|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126120247|NCT03451851|453732469|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126120248|NCT03451851|453732470|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126120249|NCT03451851|453732471|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126120250|NCT03451851|453732472|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
126120251|NCT03451851|453732473|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126120252|NCT03451851|453732474|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126120253|NCT03451851|453732475|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126120254|NCT03451851|453732468|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126120255|NCT03451851|453732469|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126120256|NCT03451851|453732470|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126120257|NCT03451851|453732471|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126120258|NCT03451851|453732472|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
126120259|NCT03451851|453732473|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126120260|NCT03451851|453732474|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126120261|NCT03451851|453732475|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126120262|NCT05885737|453732476|FG000|DB Period|Adverse Event|4|||
126120263|NCT05885737|453732477|FG001|DB Period|Adverse Event|4|||
126120264|NCT05885737|453732476|FG000|DB Period|Lost to Follow-up|0|||
126120265|NCT05885737|453732477|FG001|DB Period|Lost to Follow-up|1|||
126120266|NCT05885737|453732476|FG000|DB Period|Physician Decision|2|||
126120267|NCT05885737|453732477|FG001|DB Period|Physician Decision|0|||
126120268|NCT05885737|453732476|FG000|DB Period|Withdrawal by Subject|12|||
126120269|NCT05885737|453732477|FG001|DB Period|Withdrawal by Subject|6|||
126120270|NCT05885737|453732476|FG000|DB Period|Other: Unspecified|2|||
126120271|NCT05885737|453732477|FG001|DB Period|Other: Unspecified|2|||
126120272|NCT05885737|453732476|FG000|OLE Period|Adverse Event|3|||
126120273|NCT05885737|453732477|FG001|OLE Period|Adverse Event|2|||
126120274|NCT05885737|453732476|FG000|OLE Period|Physician Decision|1|||
126120275|NCT05885737|453732477|FG001|OLE Period|Physician Decision|0|||
126120276|NCT05885737|453732476|FG000|OLE Period|Withdrawal by Subject|5|||
126120277|NCT05885737|453732477|FG001|OLE Period|Withdrawal by Subject|5|||
126120278|NCT05885737|453732476|FG000|OLE Period|Other: Unspecified|2|||
126120279|NCT05885737|453732477|FG001|OLE Period|Other: Unspecified|1|||
126120280|NCT00003535|453733442|FG000|Overall Study|Not evaluable|5|||
126120281|NCT02181816|453733443|FG000|Overall Study|Case Report Forms Uncollected|38|||
126120282|NCT02181816|453733443|FG000|Overall Study|Protocol Deviation|21|||
126120283|NCT03807349|453733446|FG000|Overall Study|Early Study Termination|9|||
126120284|NCT00294060|453733447|FG000|Overall Study|Death|225|||
126120285|NCT00294060|453733447|FG000|Overall Study|Other|59|||
126120286|NCT00294060|453733447|FG000|Overall Study|Lost to Follow-up|55|||
126120287|NCT00294060|453733447|FG000|Overall Study|Withdrawal by Subject|11|||
126120288|NCT00294060|453733447|FG000|Overall Study|Physician Decision|797|||
126120289|NCT00294060|453733447|FG000|Overall Study|Medical condition|3|||
126120290|NCT00294060|453733447|FG000|Overall Study|Device explanted/not replaced|23|||
126120291|NCT01360554|453733448|FG000|Overall Study|Death|359|||
126120292|NCT01360554|453733449|FG001|Overall Study|Death|371|||
126120293|NCT01360554|453733448|FG000|Overall Study|Lost to Follow-up|4|||
126120294|NCT01360554|453733449|FG001|Overall Study|Lost to Follow-up|4|||
126120295|NCT01360554|453733448|FG000|Overall Study|Withdrawal by Subject|23|||
126120296|NCT01360554|453733449|FG001|Overall Study|Withdrawal by Subject|24|||
126120297|NCT01360554|453733448|FG000|Overall Study|Study terminated by sponsor|49|||
126120298|NCT01360554|453733449|FG001|Overall Study|Study terminated by sponsor|37|||
126120299|NCT01360554|453733448|FG000|Overall Study|Other, not specified|1|||
126120300|NCT01360554|453733449|FG001|Overall Study|Other, not specified|0|||
126120301|NCT01360554|453733448|FG000|Overall Study|Randomized but not treated.|3|||
126120302|NCT01360554|453733449|FG001|Overall Study|Randomized but not treated.|3|||
126120303|NCT00187096|453733451|FG000|Overall Study|unacceptable toxicity|0|||
126120304|NCT00187096|453733452|FG001|Overall Study|unacceptable toxicity|0|||
126120305|NCT00187096|453733453|FG002|Overall Study|unacceptable toxicity|1|||
126120306|NCT02113436|453733454|FG000|Period 1: 8 Weeks|Adverse Event|1|||
126120307|NCT02113436|453733455|FG001|Period 1: 8 Weeks|Adverse Event|0|||
126120308|NCT02113436|453733456|FG002|Period 1: 8 Weeks|Adverse Event|0|||
126120309|NCT02113436|453733457|FG003|Period 1: 8 Weeks|Adverse Event|0|||
126120310|NCT02113436|453733454|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
126120311|NCT02113436|453733455|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
126120312|NCT02113436|453733456|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
126120313|NCT02113436|453733457|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
126120314|NCT02113436|453733454|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
126120315|NCT02113436|453733455|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
126120316|NCT02113436|453733456|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
126120317|NCT02113436|453733457|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
126120318|NCT02113436|453733454|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
126120319|NCT02113436|453733455|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
126120320|NCT02113436|453733456|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
126120321|NCT02113436|453733457|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
126120322|NCT02113436|453733454|FG000|Period 2: 16 Weeks|Adverse Event|0|||
126120323|NCT02113436|453733455|FG001|Period 2: 16 Weeks|Adverse Event|0|||
126120324|NCT02113436|453733456|FG002|Period 2: 16 Weeks|Adverse Event|4|||
126120325|NCT02113436|453733457|FG003|Period 2: 16 Weeks|Adverse Event|5|||
126120326|NCT02113436|453733454|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
126120327|NCT02113436|453733455|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
126120328|NCT02113436|453733456|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
126120329|NCT02113436|453733457|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
126120330|NCT02113436|453733454|FG000|Period 2: 16 Weeks|Physician Decision|0|||
126120331|NCT02113436|453733455|FG001|Period 2: 16 Weeks|Physician Decision|0|||
126120332|NCT02113436|453733456|FG002|Period 2: 16 Weeks|Physician Decision|2|||
126120333|NCT02113436|453733457|FG003|Period 2: 16 Weeks|Physician Decision|0|||
126120334|NCT02113436|453733454|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
126120335|NCT02113436|453733455|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
126120336|NCT02113436|453733456|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
126120337|NCT02113436|453733457|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
126120338|NCT02159729|453733458|FG000|Overall Study|Adverse Event|0|||
126120339|NCT02159729|453733459|FG001|Overall Study|Adverse Event|1|||
126120340|NCT02159729|453733458|FG000|Overall Study|Subject's Request|13|||
126120341|NCT02159729|453733459|FG001|Overall Study|Subject's Request|10|||
126120342|NCT02159729|453733458|FG000|Overall Study|Lost to Follow-up|24|||
126120343|NCT02159729|453733459|FG001|Overall Study|Lost to Follow-up|9|||
126120344|NCT02159729|453733458|FG000|Overall Study|Non compliance|2|||
126120345|NCT02159729|453733459|FG001|Overall Study|Non compliance|0|||
126120346|NCT02159729|453733458|FG000|Overall Study|Other Unspecified|3|||
126120347|NCT02159729|453733459|FG001|Overall Study|Other Unspecified|1|||
126120348|NCT01111851|453733462|FG000|Overall Study|All planned PET scans were not obtained.|2|||
126120349|NCT01111851|453733463|FG001|Overall Study|All planned PET scans were not obtained.|0|||
126120350|NCT01816061|453733464|FG000|Overall Study|Lost to Follow-up|13|||
126120351|NCT01816061|453733465|FG001|Overall Study|Lost to Follow-up|24|||
126120352|NCT01961349|453733466|FG000|Overall Study|Withdrawal by Subject|1|||
126120353|NCT01961349|453733467|FG001|Overall Study|Withdrawal by Subject|4|||
126120354|NCT01961349|453733468|FG002|Overall Study|Withdrawal by Subject|0|||
126120355|NCT01961349|453733466|FG000|Overall Study|Adverse Event|0|||
126120356|NCT01961349|453733467|FG001|Overall Study|Adverse Event|0|||
126120357|NCT01961349|453733468|FG002|Overall Study|Adverse Event|1|||
126120358|NCT01961349|453733466|FG000|Overall Study|registration error, personal reason etc|2|||
126120359|NCT01961349|453733467|FG001|Overall Study|registration error, personal reason etc|2|||
126120360|NCT01961349|453733468|FG002|Overall Study|registration error, personal reason etc|1|||
126120361|NCT01471015|453733470|FG000|Overall Study|Death|0|||
126120362|NCT01471015|453733471|FG001|Overall Study|Death|1|||
126120363|NCT01471015|453733472|FG002|Overall Study|Death|1|||
126120364|NCT02576444|453733473|FG000|Overall Study|Death|1|||
126120365|NCT02576444|453733474|FG001|Overall Study|Death|1|||
125960672|NCT01969838|453149255|FG000|Open-label Phase|Lack of Efficacy|0|||
126120366|NCT02576444|453733475|FG002|Overall Study|Death|0|||
126120367|NCT02576444|453733476|FG003|Overall Study|Death|0|||
126120368|NCT02576444|453733473|FG000|Overall Study|Withdrawal by Subject|0|||
126120369|NCT02576444|453733474|FG001|Overall Study|Withdrawal by Subject|0|||
126120370|NCT02576444|453733475|FG002|Overall Study|Withdrawal by Subject|2|||
126120371|NCT02576444|453733476|FG003|Overall Study|Withdrawal by Subject|0|||
126120372|NCT02576444|453733473|FG000|Overall Study|Adverse Event|0|||
126120373|NCT02576444|453733474|FG001|Overall Study|Adverse Event|0|||
126120374|NCT02576444|453733475|FG002|Overall Study|Adverse Event|1|||
126087423|NCT05000216|453612956|FG006|Stage 2|Other reason|0|||
126087424|NCT05000216|453612957|FG007|Stage 2|Other reason|0|||
126087425|NCT05000216|453612958|FG008|Stage 2|Other reason|0|||
126087426|NCT05000216|453612959|FG009|Stage 2|Other reason|0|||
126087427|NCT05000216|453612960|FG010|Stage 2|Other reason|0|||
126087428|NCT05000216|453612961|FG011|Stage 2|Other reason|0|||
126087429|NCT05000216|453612962|FG012|Stage 2|Other reason|0|||
126087430|NCT05000216|453612963|FG013|Stage 2|Other reason|0|||
126087431|NCT05000216|453612964|FG014|Stage 2|Other reason|0|||
126087432|NCT05000216|453612965|FG015|Stage 2|Other reason|0|||
126087433|NCT05000216|453612966|FG016|Stage 2|Other reason|1|||
126087434|NCT05000216|453612967|FG017|Stage 2|Other reason|0|||
126087435|NCT05000216|453612968|FG018|Stage 2|Other reason|0|||
126087436|NCT05000216|453612969|FG019|Stage 2|Other reason|0|||
126087437|NCT05000216|453612970|FG020|Stage 2|Other reason|0|||
126087438|NCT05000216|453612971|FG021|Stage 2|Other reason|0|||
126087439|NCT05000216|453612950|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
126087440|NCT05000216|453612951|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
126087441|NCT05000216|453612952|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
126087442|NCT05000216|453612953|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
126087443|NCT05000216|453612954|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
126087444|NCT05000216|453612955|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
126087445|NCT05000216|453612956|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
126087446|NCT05000216|453612957|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
126087447|NCT05000216|453612958|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
126087448|NCT05000216|453612959|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
126087449|NCT05000216|453612960|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
126087450|NCT05000216|453612961|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
126087451|NCT05000216|453612962|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
126087452|NCT05000216|453612963|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
126087453|NCT05000216|453612964|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
126087454|NCT05000216|453612965|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
126087455|NCT05000216|453612966|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
126087456|NCT05000216|453612967|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
126087457|NCT05000216|453612968|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
126087458|NCT05000216|453612969|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
126087459|NCT05000216|453612970|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
126087460|NCT05000216|453612971|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
126087461|NCT05000216|453612950|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087462|NCT05000216|453612951|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087463|NCT05000216|453612952|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087464|NCT05000216|453612953|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087465|NCT05000216|453612954|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087466|NCT05000216|453612955|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087467|NCT05000216|453612956|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087468|NCT05000216|453612957|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087469|NCT05000216|453612958|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087470|NCT05000216|453612959|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087471|NCT05000216|453612960|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087472|NCT05000216|453612961|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087473|NCT05000216|453612962|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087474|NCT05000216|453612963|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087475|NCT05000216|453612964|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087476|NCT05000216|453612965|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
126087477|NCT05000216|453612966|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087478|NCT05000216|453612967|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087479|NCT05000216|453612968|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087480|NCT05000216|453612969|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087481|NCT05000216|453612970|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087482|NCT05000216|453612971|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
126087483|NCT05000216|453612950|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087484|NCT05000216|453612951|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087485|NCT05000216|453612952|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087486|NCT05000216|453612953|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087487|NCT05000216|453612954|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087488|NCT05000216|453612955|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087489|NCT05000216|453612956|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087490|NCT05000216|453612957|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087491|NCT05000216|453612958|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087492|NCT05000216|453612959|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087493|NCT05000216|453612960|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087494|NCT05000216|453612961|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087495|NCT05000216|453612962|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087496|NCT05000216|453612963|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
126087497|NCT05000216|453612964|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087498|NCT05000216|453612965|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
126087499|NCT05000216|453612966|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126120375|NCT02576444|453733476|FG003|Overall Study|Adverse Event|0|||
126120376|NCT02576444|453733473|FG000|Overall Study|Physician Decision|0|||
126120377|NCT02576444|453733474|FG001|Overall Study|Physician Decision|0|||
126120378|NCT02576444|453733475|FG002|Overall Study|Physician Decision|1|||
126120379|NCT02576444|453733476|FG003|Overall Study|Physician Decision|0|||
126120380|NCT01299376|453733478|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
126120381|NCT01299376|453733479|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
126120382|NCT01299376|453733478|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
126120383|NCT01299376|453733479|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
126120384|NCT01299376|453733478|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
126120385|NCT01299376|453733479|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
126120386|NCT01299376|453733478|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
126120387|NCT01299376|453733479|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
126120388|NCT01299376|453733478|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
126120389|NCT01299376|453733479|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
126120390|NCT01299376|453733478|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
126120391|NCT01299376|453733479|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
126120392|NCT01299376|453733478|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
126120393|NCT01299376|453733479|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
126120394|NCT01299376|453733478|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
126120395|NCT01299376|453733479|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
126120396|NCT01299376|453733478|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
126120397|NCT01299376|453733479|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
126120398|NCT01299376|453733478|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
126120399|NCT01299376|453733479|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
126120400|NCT01299376|453733478|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
126120401|NCT01299376|453733479|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
126120402|NCT02343159|453733482|FG000|Overall Study|Early Study Termination|16|||
126120403|NCT02343159|453733483|FG001|Overall Study|Early Study Termination|19|||
126120404|NCT02343159|453733484|FG002|Overall Study|Early Study Termination|23|||
126120405|NCT02343159|453733482|FG000|Overall Study|Physician Decision|2|||
126120406|NCT02343159|453733483|FG001|Overall Study|Physician Decision|0|||
126120407|NCT02343159|453733484|FG002|Overall Study|Physician Decision|1|||
126120408|NCT02343159|453733482|FG000|Overall Study|Withdrawal by Subject|3|||
126120409|NCT02343159|453733483|FG001|Overall Study|Withdrawal by Subject|0|||
126120410|NCT02343159|453733484|FG002|Overall Study|Withdrawal by Subject|2|||
126120411|NCT02343159|453733482|FG000|Overall Study|Lost to Follow-up|0|||
126120412|NCT02343159|453733483|FG001|Overall Study|Lost to Follow-up|2|||
126120413|NCT02343159|453733484|FG002|Overall Study|Lost to Follow-up|2|||
126120414|NCT02343159|453733482|FG000|Overall Study|Adverse Event|4|||
126120415|NCT02343159|453733483|FG001|Overall Study|Adverse Event|4|||
126120416|NCT02343159|453733484|FG002|Overall Study|Adverse Event|2|||
126120417|NCT02343159|453733482|FG000|Overall Study|Sponsor Decision|0|||
126120418|NCT02343159|453733483|FG001|Overall Study|Sponsor Decision|1|||
126120419|NCT02343159|453733484|FG002|Overall Study|Sponsor Decision|0|||
126120420|NCT02343159|453733482|FG000|Overall Study|Enrollment Error|1|||
126120421|NCT02343159|453733483|FG001|Overall Study|Enrollment Error|0|||
126120422|NCT02343159|453733484|FG002|Overall Study|Enrollment Error|0|||
126120423|NCT01431274|453733490|FG000|Overall Study|Adverse Event|51|||
126120424|NCT01431274|453733491|FG001|Overall Study|Adverse Event|37|||
126120425|NCT01431274|453733492|FG002|Overall Study|Adverse Event|43|||
126120426|NCT01431274|453733493|FG003|Overall Study|Adverse Event|30|||
126120427|NCT01431274|453733494|FG004|Overall Study|Adverse Event|37|||
126120428|NCT01431274|453733490|FG000|Overall Study|Consent withdrawn not due to AE|29|||
126120429|NCT01431274|453733491|FG001|Overall Study|Consent withdrawn not due to AE|20|||
126120430|NCT01431274|453733492|FG002|Overall Study|Consent withdrawn not due to AE|17|||
126120431|NCT01431274|453733493|FG003|Overall Study|Consent withdrawn not due to AE|20|||
126120432|NCT01431274|453733494|FG004|Overall Study|Consent withdrawn not due to AE|11|||
126120433|NCT01431274|453733490|FG000|Overall Study|Non compliant with protocol|5|||
126120434|NCT01431274|453733491|FG001|Overall Study|Non compliant with protocol|8|||
126120435|NCT01431274|453733492|FG002|Overall Study|Non compliant with protocol|4|||
126120436|NCT01431274|453733493|FG003|Overall Study|Non compliant with protocol|4|||
126120437|NCT01431274|453733494|FG004|Overall Study|Non compliant with protocol|4|||
126120438|NCT01431274|453733490|FG000|Overall Study|Lost to Follow-up|6|||
126120439|NCT01431274|453733491|FG001|Overall Study|Lost to Follow-up|7|||
126120440|NCT01431274|453733492|FG002|Overall Study|Lost to Follow-up|1|||
126120441|NCT01431274|453733493|FG003|Overall Study|Lost to Follow-up|4|||
126120442|NCT01431274|453733494|FG004|Overall Study|Lost to Follow-up|0|||
126120443|NCT01431274|453733490|FG000|Overall Study|Other reason not stated above|6|||
126120444|NCT01431274|453733491|FG001|Overall Study|Other reason not stated above|5|||
126120445|NCT01431274|453733492|FG002|Overall Study|Other reason not stated above|7|||
126120446|NCT01431274|453733493|FG003|Overall Study|Other reason not stated above|2|||
126120447|NCT01431274|453733494|FG004|Overall Study|Other reason not stated above|4|||
126120448|NCT00711425|453733495|FG000|Overall Study|Protocol Violation|1|||
126120449|NCT00711425|453733495|FG000|Overall Study|Death|2|||
126120450|NCT00711425|453733495|FG000|Overall Study|Lost to Follow-up|1|||
126120451|NCT04607148|453733498|FG000|Overall Study|Withdrawal by Subject|0|||
126120452|NCT04607148|453733499|FG001|Overall Study|Withdrawal by Subject|4|||
126120453|NCT04607148|453733500|FG002|Overall Study|Withdrawal by Subject|2|||
126120454|NCT04607148|453733501|FG003|Overall Study|Withdrawal by Subject|8|||
126120455|NCT04607148|453733498|FG000|Overall Study|Study Terminated by Sponsor|14|||
126120456|NCT04607148|453733499|FG001|Overall Study|Study Terminated by Sponsor|59|||
126120457|NCT04607148|453733500|FG002|Overall Study|Study Terminated by Sponsor|9|||
126120458|NCT04607148|453733501|FG003|Overall Study|Study Terminated by Sponsor|39|||
126120459|NCT04607148|453733498|FG000|Overall Study|Sponsor Decision|0|||
126120460|NCT04607148|453733499|FG001|Overall Study|Sponsor Decision|0|||
126120461|NCT04607148|453733500|FG002|Overall Study|Sponsor Decision|1|||
126120462|NCT04607148|453733501|FG003|Overall Study|Sponsor Decision|0|||
126120463|NCT04607148|453733498|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126120464|NCT04607148|453733499|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126120465|NCT04607148|453733500|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126120466|NCT04607148|453733501|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126120467|NCT04607148|453733498|FG000|Overall Study|Lost to Follow-up|0|||
126120468|NCT04607148|453733499|FG001|Overall Study|Lost to Follow-up|2|||
126120469|NCT04607148|453733500|FG002|Overall Study|Lost to Follow-up|0|||
126120470|NCT04607148|453733501|FG003|Overall Study|Lost to Follow-up|0|||
126120471|NCT04607148|453733498|FG000|Overall Study|Death|0|||
126120472|NCT04607148|453733499|FG001|Overall Study|Death|3|||
126120473|NCT04607148|453733500|FG002|Overall Study|Death|0|||
126120474|NCT04607148|453733501|FG003|Overall Study|Death|1|||
126120475|NCT04607148|453733498|FG000|Overall Study|Adverse Event|0|||
126120476|NCT04607148|453733499|FG001|Overall Study|Adverse Event|1|||
126120477|NCT04607148|453733500|FG002|Overall Study|Adverse Event|0|||
126120478|NCT04607148|453733501|FG003|Overall Study|Adverse Event|0|||
126120479|NCT00912028|453733502|FG000|Overall Study|Lost to Follow-up|2|||
126120480|NCT00912028|453733503|FG001|Overall Study|Lost to Follow-up|3|||
126120481|NCT00912028|453733504|FG002|Overall Study|Lost to Follow-up|0|||
126120482|NCT00912028|453733505|FG003|Overall Study|Lost to Follow-up|1|||
126120483|NCT00912028|453733506|FG004|Overall Study|Lost to Follow-up|3|||
126120484|NCT00912028|453733502|FG000|Overall Study|Withdrawal by Subject|3|||
126120485|NCT00912028|453733503|FG001|Overall Study|Withdrawal by Subject|0|||
126120486|NCT00912028|453733504|FG002|Overall Study|Withdrawal by Subject|0|||
126120487|NCT00912028|453733505|FG003|Overall Study|Withdrawal by Subject|0|||
126120488|NCT00912028|453733506|FG004|Overall Study|Withdrawal by Subject|0|||
126120489|NCT01744665|453733511|FG000|Monitoring Phase|Adverse Event|4|||
126120490|NCT01744665|453733511|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
126120491|NCT01744665|453733511|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
126120492|NCT01744665|453733511|FG000|Monitoring Phase|Withdrawal by Subject|5|||
126120493|NCT01744665|453733511|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
126120494|NCT01744665|453733511|FG000|Consolidation Phase|Adverse Event|2|||
126120495|NCT01744665|453733511|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
126120496|NCT01744665|453733511|FG000|Consolidation Phase|Withdrawal by Subject|4|||
126120497|NCT01744665|453733511|FG000|Consolidation Phase|Administrative problems|9|||
126120498|NCT01744665|453733511|FG000|Re-initiation Phase|Administrative problems|10|||
126120499|NCT01744665|453733511|FG000|Re-initiation Phase|Adverse Event|1|||
126120500|NCT01744665|453733511|FG000|Re-initiation Phase|No longer required treatment|1|||
126120501|NCT01744665|453733511|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
126120502|NCT03184077|453733513|FG000|Overall Study|Lost to Follow-up|21|||
126120503|NCT03184077|453733514|FG001|Overall Study|Lost to Follow-up|21|||
126120504|NCT02046096|453733522|FG000|Overall Study|Death|28|||
126120505|NCT02046096|453733523|FG001|Overall Study|Death|45|||
126120506|NCT02046096|453733522|FG000|Overall Study|Lost to Follow-up|9|||
126120507|NCT02046096|453733523|FG001|Overall Study|Lost to Follow-up|20|||
126120508|NCT02046096|453733522|FG000|Overall Study|Withdrawal by Subject|5|||
126120509|NCT02046096|453733523|FG001|Overall Study|Withdrawal by Subject|17|||
126120510|NCT02046096|453733522|FG000|Overall Study|Other endpoint|2|||
126120511|NCT02046096|453733523|FG001|Overall Study|Other endpoint|19|||
126120512|NCT02090413|453733524|FG000|Overall Study|Adverse Event|11|||
126120513|NCT02090413|453733525|FG001|Overall Study|Adverse Event|15|||
126120514|NCT02090413|453733526|FG002|Overall Study|Adverse Event|20|||
126120515|NCT02090413|453733524|FG000|Overall Study|Flushing event|2|||
126120516|NCT02090413|453733525|FG001|Overall Study|Flushing event|0|||
126120517|NCT02090413|453733526|FG002|Overall Study|Flushing event|1|||
126120518|NCT02090413|453733524|FG000|Overall Study|Withdrawal by Subject|2|||
126120519|NCT02090413|453733525|FG001|Overall Study|Withdrawal by Subject|2|||
126120520|NCT02090413|453733526|FG002|Overall Study|Withdrawal by Subject|2|||
126120521|NCT02090413|453733524|FG000|Overall Study|Investigator Decision|1|||
126120522|NCT02090413|453733525|FG001|Overall Study|Investigator Decision|1|||
126120523|NCT02090413|453733526|FG002|Overall Study|Investigator Decision|0|||
126120524|NCT02090413|453733524|FG000|Overall Study|Other|2|||
126120525|NCT02090413|453733525|FG001|Overall Study|Other|1|||
126120526|NCT02090413|453733526|FG002|Overall Study|Other|0|||
126120527|NCT02090413|453733524|FG000|Overall Study|Lost to Follow-up|1|||
126120528|NCT02090413|453733525|FG001|Overall Study|Lost to Follow-up|1|||
126120529|NCT02090413|453733526|FG002|Overall Study|Lost to Follow-up|0|||
126120530|NCT01045798|453733527|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
126120531|NCT01045798|453733528|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
126120532|NCT01045798|453733527|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
126120533|NCT01045798|453733528|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
126120534|NCT01045798|453733527|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
126120535|NCT01045798|453733528|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
126120536|NCT01045798|453733527|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
126120537|NCT01045798|453733528|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
126120538|NCT05321069|453733533|FG000|Overall Study|Adverse Event|52|||
126120539|NCT05321069|453733534|FG001|Overall Study|Adverse Event|52|||
126120540|NCT05321069|453733535|FG002|Overall Study|Adverse Event|64|||
126120541|NCT05321069|453733533|FG000|Overall Study|Protocol Violation|1|||
126120542|NCT05321069|453733534|FG001|Overall Study|Protocol Violation|1|||
126120543|NCT05321069|453733535|FG002|Overall Study|Protocol Violation|0|||
126120544|NCT05321069|453733533|FG000|Overall Study|Withdrawal by Subject|23|||
126120545|NCT05321069|453733534|FG001|Overall Study|Withdrawal by Subject|18|||
126120546|NCT05321069|453733535|FG002|Overall Study|Withdrawal by Subject|12|||
126120547|NCT05321069|453733533|FG000|Overall Study|Lost to Follow-up|1|||
126120548|NCT05321069|453733534|FG001|Overall Study|Lost to Follow-up|0|||
126120549|NCT05321069|453733535|FG002|Overall Study|Lost to Follow-up|1|||
126120550|NCT05321069|453733533|FG000|Overall Study|No reason stated by the participants|23|||
126120551|NCT05321069|453733534|FG001|Overall Study|No reason stated by the participants|22|||
126120552|NCT05321069|453733535|FG002|Overall Study|No reason stated by the participants|16|||
126120553|NCT05321069|453733533|FG000|Overall Study|Lack of Efficacy|1|||
126120554|NCT05321069|453733534|FG001|Overall Study|Lack of Efficacy|1|||
126120555|NCT05321069|453733535|FG002|Overall Study|Lack of Efficacy|0|||
126120556|NCT06156215|453733538|FG000|Overall Study|Withdrawal by Subject|2|||
126120557|NCT06156215|453733539|FG001|Overall Study|Withdrawal by Subject|4|||
126120558|NCT06156215|453733540|FG002|Overall Study|Withdrawal by Subject|4|||
126120559|NCT06156215|453733541|FG003|Overall Study|Withdrawal by Subject|0|||
126120560|NCT06156215|453733542|FG004|Overall Study|Withdrawal by Subject|2|||
126120561|NCT06156215|453733543|FG005|Overall Study|Withdrawal by Subject|2|||
126120562|NCT06156215|453733538|FG000|Overall Study|Left ED without completing study|9|||
126120563|NCT06156215|453733539|FG001|Overall Study|Left ED without completing study|3|||
126120564|NCT06156215|453733540|FG002|Overall Study|Left ED without completing study|9|||
126120565|NCT06156215|453733541|FG003|Overall Study|Left ED without completing study|0|||
126120566|NCT06156215|453733542|FG004|Overall Study|Left ED without completing study|8|||
126120567|NCT06156215|453733543|FG005|Overall Study|Left ED without completing study|16|||
126120568|NCT06156215|453733538|FG000|Overall Study|Physician Decision|1|||
126120569|NCT06156215|453733539|FG001|Overall Study|Physician Decision|0|||
126120570|NCT06156215|453733540|FG002|Overall Study|Physician Decision|0|||
126120571|NCT06156215|453733541|FG003|Overall Study|Physician Decision|0|||
126120572|NCT06156215|453733542|FG004|Overall Study|Physician Decision|0|||
126120573|NCT06156215|453733543|FG005|Overall Study|Physician Decision|0|||
126120574|NCT06156215|453733538|FG000|Overall Study|Became or found ineligible|2|||
126120575|NCT06156215|453733539|FG001|Overall Study|Became or found ineligible|0|||
126120576|NCT06156215|453733540|FG002|Overall Study|Became or found ineligible|2|||
126120577|NCT06156215|453733541|FG003|Overall Study|Became or found ineligible|0|||
126120578|NCT06156215|453733542|FG004|Overall Study|Became or found ineligible|1|||
126120579|NCT06156215|453733543|FG005|Overall Study|Became or found ineligible|2|||
126120580|NCT00597753|453733548|FG000|Overall Study|Adverse Event|6|||
126120581|NCT00597753|453733549|FG001|Overall Study|Adverse Event|2|||
126120582|NCT00597753|453733548|FG000|Overall Study|Death|55|||
126120583|NCT00597753|453733549|FG001|Overall Study|Death|29|||
126120584|NCT00597753|453733548|FG000|Overall Study|Lack of Efficacy|2|||
126120585|NCT00597753|453733549|FG001|Overall Study|Lack of Efficacy|0|||
126120586|NCT00597753|453733548|FG000|Overall Study|Lost to Follow-up|10|||
126120587|NCT00597753|453733549|FG001|Overall Study|Lost to Follow-up|3|||
126120588|NCT00597753|453733548|FG000|Overall Study|Physician Decision|5|||
126120589|NCT00597753|453733549|FG001|Overall Study|Physician Decision|1|||
126120590|NCT00597753|453733548|FG000|Overall Study|Pregnancy|1|||
126120591|NCT00597753|453733549|FG001|Overall Study|Pregnancy|0|||
126120592|NCT00597753|453733548|FG000|Overall Study|Withdrawal by Subject|35|||
126120593|NCT00597753|453733549|FG001|Overall Study|Withdrawal by Subject|12|||
126120594|NCT00597753|453733548|FG000|Overall Study|Discontinued Dialysis|0|||
126120595|NCT00597753|453733549|FG001|Overall Study|Discontinued Dialysis|1|||
126120596|NCT00597753|453733548|FG000|Overall Study|Never dosed|2|||
126120597|NCT00597753|453733549|FG001|Overall Study|Never dosed|0|||
126120598|NCT00597753|453733548|FG000|Overall Study|Noncompliance|2|||
126120599|NCT00597753|453733549|FG001|Overall Study|Noncompliance|1|||
126120600|NCT00597753|453733548|FG000|Overall Study|Relocation|17|||
126120601|NCT00597753|453733549|FG001|Overall Study|Relocation|6|||
126120602|NCT00597753|453733548|FG000|Overall Study|Renal transplant|10|||
126120603|NCT00597753|453733549|FG001|Overall Study|Renal transplant|3|||
126120604|NCT00597753|453733548|FG000|Overall Study|Site closed by sponsor|19|||
126120605|NCT00597753|453733549|FG001|Overall Study|Site closed by sponsor|7|||
126120606|NCT00597753|453733548|FG000|Overall Study|Site elected to close|2|||
126120607|NCT00597753|453733549|FG001|Overall Study|Site elected to close|4|||
126120608|NCT00736255|453735617|FG000|Overall Study|Adverse Event|1|||
126120609|NCT00736255|453735618|FG001|Overall Study|Adverse Event|0|||
126120610|NCT00736255|453735617|FG000|Overall Study|Physician Decision|1|||
126120611|NCT00736255|453735618|FG001|Overall Study|Physician Decision|0|||
126120612|NCT00736255|453735617|FG000|Overall Study|Non-compliance|1|||
126120613|NCT00736255|453735618|FG001|Overall Study|Non-compliance|1|||
126120614|NCT02966509|453735622|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
126120615|NCT02966509|453735623|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
126120616|NCT02966509|453735622|FG000|Baseline Satisfaction Survey|Death|0|||
126120617|NCT02966509|453735623|FG001|Baseline Satisfaction Survey|Death|1|||
126120618|NCT02966509|453735622|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
126120619|NCT02966509|453735623|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
126120620|NCT02966509|453735622|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
126120621|NCT02966509|453735623|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
126120622|NCT02966509|453735622|FG000|6 Month Satisfaction Decision Survey|Death|22|||
126120623|NCT02966509|453735623|FG001|6 Month Satisfaction Decision Survey|Death|25|||
126120624|NCT02966509|453735622|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
126120625|NCT02966509|453735623|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
126120626|NCT02966509|453735622|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
126120627|NCT02966509|453735623|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
126120628|NCT02966509|453735622|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
126120629|NCT02966509|453735623|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
126120630|NCT02966509|453735622|FG000|6 Month Satisfaction Survey|Death|36|||
126120631|NCT02966509|453735623|FG001|6 Month Satisfaction Survey|Death|33|||
126120632|NCT02966509|453735622|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
126120633|NCT02966509|453735623|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
126120634|NCT02966509|453735622|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
126120635|NCT02966509|453735623|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
126120636|NCT02966509|453735622|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
126120637|NCT02966509|453735623|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
126120638|NCT02966509|453735622|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
126120639|NCT02966509|453735623|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
126120640|NCT02966509|453735622|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
126120641|NCT02966509|453735623|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
126120642|NCT01717287|453735624|FG000|Overall Study|Lost to Follow-up|0|||
126120643|NCT01717287|453735625|FG001|Overall Study|Lost to Follow-up|2|||
126120644|NCT01717287|453735624|FG000|Overall Study|Protocol Violation|0|||
126120645|NCT01717287|453735625|FG001|Overall Study|Protocol Violation|1|||
126120646|NCT00404820|453735626|FG000|Overall Study|Adverse Event|4|||
126120647|NCT00404820|453735627|FG001|Overall Study|Adverse Event|16|||
126120648|NCT00404820|453735626|FG000|Overall Study|Withdrawal by Subject|5|||
126120649|NCT00404820|453735627|FG001|Overall Study|Withdrawal by Subject|3|||
126120650|NCT00404820|453735626|FG000|Overall Study|Lost to Follow-up|7|||
126120651|NCT00404820|453735627|FG001|Overall Study|Lost to Follow-up|3|||
126120652|NCT00404820|453735626|FG000|Overall Study|Administrative problems|2|||
126120653|NCT00404820|453735627|FG001|Overall Study|Administrative problems|0|||
126120654|NCT00404820|453735626|FG000|Overall Study|Death|1|||
126120655|NCT00404820|453735627|FG001|Overall Study|Death|0|||
126120656|NCT00404820|453735626|FG000|Overall Study|Other|0|||
126120657|NCT00404820|453735627|FG001|Overall Study|Other|2|||
126120658|NCT01469182|453735632|FG000|Overall Study|Adverse Event|21|||
126120659|NCT01469182|453735633|FG001|Overall Study|Adverse Event|3|||
126120660|NCT01469182|453735632|FG000|Overall Study|Lost to Follow-up|3|||
126120661|NCT01469182|453735633|FG001|Overall Study|Lost to Follow-up|0|||
126120662|NCT01469182|453735632|FG000|Overall Study|Withdrawal by Subject|4|||
126120663|NCT01469182|453735633|FG001|Overall Study|Withdrawal by Subject|1|||
126120664|NCT01469182|453735632|FG000|Overall Study|Protocol Violation|4|||
126120665|NCT01469182|453735633|FG001|Overall Study|Protocol Violation|2|||
126120666|NCT01469182|453735632|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
126120667|NCT01469182|453735633|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
126120668|NCT02687542|453735634|FG000|Overall Study|Medication error without associated AEs|0|||
126120669|NCT02687542|453735635|FG001|Overall Study|Medication error without associated AEs|0|||
126120670|NCT02687542|453735636|FG002|Overall Study|Medication error without associated AEs|0|||
125960673|NCT01969838|453149256|FG001|Open-label Phase|Lack of Efficacy|0|||
125960674|NCT01969838|453149257|FG002|Open-label Phase|Lack of Efficacy|17|||
126120671|NCT02687542|453735637|FG003|Overall Study|Medication error without associated AEs|0|||
126120672|NCT02687542|453735638|FG004|Overall Study|Medication error without associated AEs|1|||
126120673|NCT02687542|453735634|FG000|Overall Study|Lost to Follow-up|0|||
126120674|NCT02687542|453735635|FG001|Overall Study|Lost to Follow-up|0|||
126120675|NCT02687542|453735636|FG002|Overall Study|Lost to Follow-up|0|||
126120676|NCT02687542|453735637|FG003|Overall Study|Lost to Follow-up|0|||
125960675|NCT01969838|453149258|FG003|Open-label Phase|Lack of Efficacy|19|||
125960676|NCT01969838|453149255|FG000|Open-label Phase|Subject Decision|0|||
125960677|NCT01969838|453149256|FG001|Open-label Phase|Subject Decision|0|||
125960678|NCT01969838|453149257|FG002|Open-label Phase|Subject Decision|14|||
125960679|NCT01969838|453149258|FG003|Open-label Phase|Subject Decision|15|||
125960680|NCT01969838|453149255|FG000|Open-label Phase|Death|0|||
125960681|NCT01969838|453149256|FG001|Open-label Phase|Death|0|||
125960682|NCT01969838|453149257|FG002|Open-label Phase|Death|13|||
125960683|NCT01969838|453149258|FG003|Open-label Phase|Death|11|||
125960684|NCT01969838|453149255|FG000|Open-label Phase|Physician Decision|0|||
125960685|NCT01969838|453149256|FG001|Open-label Phase|Physician Decision|0|||
125960686|NCT01969838|453149257|FG002|Open-label Phase|Physician Decision|9|||
125960687|NCT01969838|453149258|FG003|Open-label Phase|Physician Decision|14|||
125960688|NCT01969838|453149255|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
125960689|NCT01969838|453149256|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
125960690|NCT01969838|453149257|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
125960691|NCT01969838|453149258|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
125960692|NCT03087591|453149260|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
125960693|NCT03087591|453149260|FG000|Overall Study|Withdrawal by Subject|1|||
125960694|NCT00408993|453149261|FG000|Overall Study|Adverse Event|15|||
125960695|NCT00408993|453149262|FG001|Overall Study|Adverse Event|4|||
125960696|NCT00408993|453149261|FG000|Overall Study|Protocol Violation|1|||
125960697|NCT00408993|453149262|FG001|Overall Study|Protocol Violation|6|||
125960698|NCT00408993|453149261|FG000|Overall Study|Lack of Efficacy|1|||
125960699|NCT00408993|453149262|FG001|Overall Study|Lack of Efficacy|4|||
125960700|NCT00408993|453149261|FG000|Overall Study|Withdrawal by Subject|2|||
125960701|NCT00408993|453149262|FG001|Overall Study|Withdrawal by Subject|3|||
125960702|NCT03738865|453149263|FG000|Overall Study|Withdrawal by Subject|3|||
125960703|NCT03738865|453149264|FG001|Overall Study|Withdrawal by Subject|3|||
126120677|NCT02687542|453735638|FG004|Overall Study|Lost to Follow-up|1|||
126120678|NCT02687542|453735634|FG000|Overall Study|Protocol Violation|0|||
126120679|NCT02687542|453735635|FG001|Overall Study|Protocol Violation|1|||
126120680|NCT02687542|453735636|FG002|Overall Study|Protocol Violation|0|||
126120681|NCT02687542|453735637|FG003|Overall Study|Protocol Violation|0|||
126120682|NCT02687542|453735638|FG004|Overall Study|Protocol Violation|0|||
126120683|NCT02687542|453735634|FG000|Overall Study|Other|5|||
126120684|NCT02687542|453735635|FG001|Overall Study|Other|9|||
126120685|NCT02687542|453735636|FG002|Overall Study|Other|10|||
126120686|NCT02687542|453735637|FG003|Overall Study|Other|6|||
126120687|NCT02687542|453735638|FG004|Overall Study|Other|5|||
126120688|NCT02687542|453735634|FG000|Overall Study|Adverse Event|3|||
126120689|NCT02687542|453735635|FG001|Overall Study|Adverse Event|1|||
126120690|NCT02687542|453735636|FG002|Overall Study|Adverse Event|3|||
126120691|NCT02687542|453735637|FG003|Overall Study|Adverse Event|2|||
126120692|NCT02687542|453735638|FG004|Overall Study|Adverse Event|9|||
126120693|NCT02687542|453735634|FG000|Overall Study|Withdrawal by Subject|0|||
126120694|NCT02687542|453735635|FG001|Overall Study|Withdrawal by Subject|1|||
126120695|NCT02687542|453735636|FG002|Overall Study|Withdrawal by Subject|1|||
126120696|NCT02687542|453735637|FG003|Overall Study|Withdrawal by Subject|2|||
126120697|NCT02687542|453735638|FG004|Overall Study|Withdrawal by Subject|4|||
126120698|NCT01838616|453735641|FG000|Titration Period|Adverse Event|18|||
126120699|NCT01838616|453735642|FG001|Titration Period|Adverse Event|48|||
126120700|NCT01838616|453735641|FG000|Titration Period|Lack of Efficacy|5|||
126120701|NCT01838616|453735642|FG001|Titration Period|Lack of Efficacy|12|||
126120702|NCT01838616|453735641|FG000|Titration Period|Withdrawal by Subject|5|||
126120703|NCT01838616|453735642|FG001|Titration Period|Withdrawal by Subject|5|||
126120704|NCT01838616|453735641|FG000|Titration Period|Technical problems|1|||
126120705|NCT01838616|453735642|FG001|Titration Period|Technical problems|0|||
126120706|NCT01838616|453735641|FG000|Titration Period|Other|1|||
126120707|NCT01838616|453735642|FG001|Titration Period|Other|0|||
125960704|NCT03738865|453149263|FG000|Overall Study|Adverse Event|2|||
125960705|NCT03738865|453149264|FG001|Overall Study|Adverse Event|0|||
125960706|NCT03738865|453149263|FG000|Overall Study|Physician Decision|0|||
125960707|NCT03738865|453149264|FG001|Overall Study|Physician Decision|1|||
125960708|NCT02621606|453149265|FG000|Overall Study|Withdrawal by Subject|0|||
125960709|NCT02621606|453149266|FG001|Overall Study|Withdrawal by Subject|1|||
125960710|NCT02621606|453149267|FG002|Overall Study|Withdrawal by Subject|0|||
125960711|NCT01694706|453149268|FG000|Overall Study|Adverse Event|0|||
125960712|NCT01694706|453149269|FG001|Overall Study|Adverse Event|1|||
125960713|NCT01694706|453149270|FG002|Overall Study|Adverse Event|0|||
125960714|NCT01694706|453149268|FG000|Overall Study|other reason not defined above|1|||
126120708|NCT01838616|453735641|FG000|Titration Period|Protocol Violation|0|||
126120709|NCT01838616|453735642|FG001|Titration Period|Protocol Violation|1|||
126120710|NCT01838616|453735641|FG000|Continuation Period|Lack of Efficacy|3|||
126120711|NCT01838616|453735642|FG001|Continuation Period|Lack of Efficacy|5|||
126120712|NCT01838616|453735641|FG000|Continuation Period|Adverse Event|8|||
126120713|NCT01838616|453735642|FG001|Continuation Period|Adverse Event|4|||
126120714|NCT01838616|453735641|FG000|Continuation Period|Protocol Violation|2|||
126120715|NCT01838616|453735642|FG001|Continuation Period|Protocol Violation|0|||
126120716|NCT01838616|453735641|FG000|Continuation Period|Lost to Follow-up|1|||
126120717|NCT01838616|453735642|FG001|Continuation Period|Lost to Follow-up|0|||
126120718|NCT01838616|453735641|FG000|Continuation Period|Withdrawal by Subject|0|||
126120719|NCT01838616|453735642|FG001|Continuation Period|Withdrawal by Subject|4|||
126120720|NCT01838616|453735641|FG000|Continuation Period|Technical problems|0|||
126120721|NCT01838616|453735642|FG001|Continuation Period|Technical problems|1|||
126120722|NCT01838616|453735641|FG000|Pick-up Arm|Lack of Efficacy|4|||
126120723|NCT01838616|453735642|FG001|Pick-up Arm|Lack of Efficacy|0|||
126120724|NCT01838616|453735641|FG000|Pick-up Arm|Adverse Event|9|||
126120725|NCT01838616|453735642|FG001|Pick-up Arm|Adverse Event|0|||
126120726|NCT01838616|453735641|FG000|Pick-up Arm|Withdrawal by Subject|1|||
126120727|NCT01838616|453735642|FG001|Pick-up Arm|Withdrawal by Subject|0|||
126120728|NCT01838616|453735641|FG000|Pick-up Arm|Technical problems|1|||
126120729|NCT01838616|453735642|FG001|Pick-up Arm|Technical problems|0|||
126120730|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
126120731|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
126120732|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
126120733|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
126120734|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
126120735|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
126120736|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
126120737|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
126120738|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
126120739|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
126120740|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
126120741|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
126120742|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
126120743|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
126120744|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
126120745|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
126120746|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
126120747|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
126120748|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
126120749|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
126120750|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
126120751|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
126120752|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
126120753|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
126120754|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
126120755|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
126120756|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
126120757|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
126120758|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
126120759|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
126120760|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126120761|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126120762|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126120763|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126120764|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126120765|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126120766|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
126120767|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
126120768|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
126120769|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
126120770|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
126120771|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
126120772|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
126120773|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
126120774|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
126120775|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
126120776|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
126120777|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
126120778|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
126120779|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126120780|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126120781|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126120782|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126120783|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126120784|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126120785|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
126120786|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126120787|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126120788|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126120789|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126120790|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126120791|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
126120792|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126120793|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126120794|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126120795|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126120796|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126120797|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
126120798|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126120799|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126120800|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126120801|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126120802|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126120803|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
126120804|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126120805|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126120806|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126120807|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126120808|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126120809|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126120810|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126120811|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
126120812|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126120813|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126120814|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126120815|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126120816|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126120817|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
126120818|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126120819|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126120820|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126120821|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126120822|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126120823|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126120824|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
126120825|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126120826|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126120827|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126120828|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126120829|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126120830|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
126120831|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126120832|NCT00111800|453735643|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126120833|NCT00111800|453735644|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126120834|NCT00111800|453735645|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126120835|NCT00111800|453735646|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126120836|NCT00111800|453735647|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126120837|NCT00111800|453735648|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
126120838|NCT00111800|453735643|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
126120839|NCT00111800|453735644|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
126120840|NCT00111800|453735645|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
126120841|NCT00111800|453735646|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
126120842|NCT00111800|453735647|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
126120843|NCT00111800|453735648|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
126120844|NCT00111800|453735643|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
126120845|NCT00111800|453735644|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
126120846|NCT00111800|453735645|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
126120847|NCT00111800|453735646|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
126120848|NCT00111800|453735647|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
126120849|NCT00111800|453735648|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
126120850|NCT00111800|453735643|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
126120851|NCT00111800|453735644|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
126120852|NCT00111800|453735645|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
126120853|NCT00111800|453735646|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
126120854|NCT00111800|453735647|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
126120855|NCT00111800|453735648|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
126120856|NCT00111800|453735643|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
126120857|NCT00111800|453735644|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
126120858|NCT00111800|453735645|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
126120859|NCT00111800|453735646|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
126120860|NCT00111800|453735647|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
126120861|NCT00111800|453735648|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
126120862|NCT00111800|453735643|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126120863|NCT00111800|453735644|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126120864|NCT00111800|453735645|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126120865|NCT00111800|453735646|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126120866|NCT00111800|453735647|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126120867|NCT00111800|453735648|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126120868|NCT00111800|453735643|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126120869|NCT00111800|453735644|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
126120870|NCT00111800|453735645|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126120871|NCT00111800|453735646|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126120872|NCT00111800|453735647|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126120873|NCT00111800|453735648|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126120874|NCT00111800|453735643|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126120875|NCT00111800|453735644|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126120876|NCT00111800|453735645|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
126120877|NCT00111800|453735646|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126120878|NCT00111800|453735647|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126120879|NCT00111800|453735648|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126120880|NCT00111800|453735643|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126120881|NCT00111800|453735644|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126120882|NCT00111800|453735645|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
126120883|NCT00111800|453735646|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126120884|NCT00111800|453735647|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126120885|NCT00111800|453735648|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126120886|NCT01549275|453735649|FG000|Overall Study|Lost to Follow-up|1|||
126120887|NCT01549275|453735650|FG001|Overall Study|Lost to Follow-up|0|||
126120888|NCT02969187|453735655|FG000|Overall Study|Physician Decision|12|||
126120889|NCT02969187|453735656|FG001|Overall Study|Physician Decision|13|||
126120890|NCT01486927|453735657|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
126120891|NCT01486927|453735657|FG000|Overall Study|Physician Decision|1|||
126120892|NCT01486927|453735657|FG000|Overall Study|50 Exposure days not reached|2|||
126120893|NCT01486927|453735657|FG000|Overall Study|Withdrawal by Subject|8|||
126120894|NCT01486927|453735657|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
126120895|NCT00365456|453735658|FG000|Trial Period I (12 Months)|Adverse Event|84|||
126120896|NCT00365456|453735659|FG001|Trial Period I (12 Months)|Adverse Event|0|||
126120897|NCT00365456|453735658|FG000|Trial Period I (12 Months)|Non-compliance|3|||
126120898|NCT00365456|453735659|FG001|Trial Period I (12 Months)|Non-compliance|0|||
126120899|NCT00365456|453735658|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
126120900|NCT00365456|453735659|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
126120901|NCT00365456|453735658|FG000|Trial Period I (12 Months)|Other|11|||
126120902|NCT00365456|453735659|FG001|Trial Period I (12 Months)|Other|0|||
126120903|NCT00365456|453735658|FG000|Trial Period II (12 Months)|Adverse Event|0|||
126120904|NCT00365456|453735659|FG001|Trial Period II (12 Months)|Adverse Event|6|||
126120905|NCT00365456|453735658|FG000|Trial Period II (12 Months)|Non-compliance|0|||
126120906|NCT00365456|453735659|FG001|Trial Period II (12 Months)|Non-compliance|2|||
126120907|NCT00365456|453735658|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
126087500|NCT05000216|453612967|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087501|NCT05000216|453612968|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
126087502|NCT05000216|453612969|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087503|NCT05000216|453612970|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087504|NCT05000216|453612971|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126087505|NCT01572740|453612973|FG000|Overall Study|Adverse Event|1|||
126087506|NCT01572740|453612974|FG001|Overall Study|Adverse Event|1|||
126087507|NCT01572740|453612973|FG000|Overall Study|Withdrawal by Subject|1|||
126087508|NCT01572740|453612974|FG001|Overall Study|Withdrawal by Subject|1|||
126087509|NCT01572740|453612973|FG000|Overall Study|unclassified|4|||
126087510|NCT01572740|453612974|FG001|Overall Study|unclassified|3|||
126087511|NCT01289210|453612975|FG000|Overall Study|Adverse Event|1|||
126087512|NCT01110408|453612978|FG000|Overall Study|Protocol Violation|1|||
126087513|NCT01110408|453612979|FG001|Overall Study|Protocol Violation|0|||
126087514|NCT01509547|453612980|FG000|Overall Study|Lost to Follow-up|24|||
126087515|NCT01509547|453612981|FG001|Overall Study|Lost to Follow-up|14|||
126087516|NCT01509547|453612980|FG000|Overall Study|Withdrawal by Subject|11|||
126087517|NCT01509547|453612981|FG001|Overall Study|Withdrawal by Subject|24|||
126087518|NCT01509547|453612980|FG000|Overall Study|Physician Decision|0|||
126087519|NCT01509547|453612981|FG001|Overall Study|Physician Decision|1|||
126087520|NCT00402051|453612982|FG000|Overall Study|Progressive Disease|13|||
126087521|NCT00402051|453612983|FG001|Overall Study|Progressive Disease|20|||
126087522|NCT00402051|453612982|FG000|Overall Study|Adverse Event|11|||
126087523|NCT00402051|453612983|FG001|Overall Study|Adverse Event|4|||
126087524|NCT00402051|453612982|FG000|Overall Study|Physician Decision|7|||
126087525|NCT00402051|453612983|FG001|Overall Study|Physician Decision|3|||
126087526|NCT00402051|453612982|FG000|Overall Study|Withdrawal by Subject|3|||
126087527|NCT00402051|453612983|FG001|Overall Study|Withdrawal by Subject|3|||
126087528|NCT00402051|453612982|FG000|Overall Study|Death - Related to Study Drug|1|||
126087529|NCT00402051|453612983|FG001|Overall Study|Death - Related to Study Drug|2|||
126087530|NCT00402051|453612982|FG000|Overall Study|Death Due to Study Disease|2|||
126087531|NCT00402051|453612983|FG001|Overall Study|Death Due to Study Disease|1|||
126087532|NCT00402051|453612982|FG000|Overall Study|Death Due to Adverse Event|0|||
126087533|NCT00402051|453612983|FG001|Overall Study|Death Due to Adverse Event|2|||
126087534|NCT00402051|453612982|FG000|Overall Study|Lost to Follow-up|1|||
126087535|NCT00402051|453612983|FG001|Overall Study|Lost to Follow-up|0|||
126087536|NCT01213524|453612987|FG000|Baseline|Withdrawal by Subject|5|||
126087537|NCT01213524|453612987|FG000|Baseline|high breath alcohol levels|1|||
126087538|NCT01213524|453612987|FG000|Baseline|Physician Decision|1|||
126087539|NCT01213524|453612987|FG000|Session 2|Withdrawal by Subject|5|||
126087540|NCT01213524|453612987|FG000|Session 3|Withdrawal by Subject|4|||
126087541|NCT01213524|453612987|FG000|Session 4|Physician Decision|1|||
126087542|NCT01213524|453612987|FG000|Session 4|Withdrawal by Subject|2|||
126087543|NCT04147195|453612990|FG000|Overall Study|Adverse Event|0|||
126087544|NCT04147195|453612991|FG001|Overall Study|Adverse Event|3|||
126087545|NCT04147195|453612990|FG000|Overall Study|Study Terminated by Sponsor|4|||
126087546|NCT04147195|453612991|FG001|Overall Study|Study Terminated by Sponsor|2|||
126087547|NCT04147195|453612990|FG000|Overall Study|Withdrawal by Subject|0|||
126087548|NCT04147195|453612991|FG001|Overall Study|Withdrawal by Subject|1|||
126087549|NCT01424813|453612992|FG000|Overall Study|Withdrawal by Subject|3|||
126087550|NCT01424813|453612993|FG001|Overall Study|Withdrawal by Subject|0|||
126087551|NCT01424813|453612992|FG000|Overall Study|Protocol Violation|1|||
126087552|NCT01424813|453612993|FG001|Overall Study|Protocol Violation|0|||
126087553|NCT01424813|453612992|FG000|Overall Study|Other|1|||
126087554|NCT01424813|453612993|FG001|Overall Study|Other|2|||
126087555|NCT02614183|453612994|FG000|Double Blind Treatment Phase|Adverse Event|10|||
126087556|NCT02614183|453612995|FG001|Double Blind Treatment Phase|Adverse Event|9|||
126087557|NCT02614183|453612996|FG002|Double Blind Treatment Phase|Adverse Event|7|||
126087558|NCT02614183|453612994|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
126087559|NCT02614183|453612995|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
126087560|NCT02614183|453612996|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
126087561|NCT02614183|453612994|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
126087562|NCT02614183|453612995|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
126087563|NCT02614183|453612996|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
126087564|NCT02614183|453612994|FG000|Double Blind Treatment Phase|Physician Decision|7|||
126087565|NCT02614183|453612995|FG001|Double Blind Treatment Phase|Physician Decision|3|||
126087566|NCT02614183|453612996|FG002|Double Blind Treatment Phase|Physician Decision|2|||
126087567|NCT02614183|453612994|FG000|Double Blind Treatment Phase|Pregnancy|2|||
126087568|NCT02614183|453612995|FG001|Double Blind Treatment Phase|Pregnancy|1|||
126087569|NCT02614183|453612996|FG002|Double Blind Treatment Phase|Pregnancy|3|||
126087570|NCT02614183|453612994|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
126087571|NCT02614183|453612995|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
126087572|NCT02614183|453612996|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
126087573|NCT02614183|453612994|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
126120908|NCT00365456|453735659|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
126120909|NCT00365456|453735658|FG000|Trial Period II (12 Months)|Other|0|||
126120910|NCT00365456|453735659|FG001|Trial Period II (12 Months)|Other|1|||
126120911|NCT00365456|453735658|FG000|Trial Period III (12 Months)|Adverse Event|13|||
126120912|NCT00365456|453735659|FG001|Trial Period III (12 Months)|Adverse Event|3|||
126120913|NCT00365456|453735658|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
126120914|NCT00365456|453735659|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
126120915|NCT00365456|453735658|FG000|Trial Period III (12 Months)|Other|1|||
126120916|NCT00365456|453735659|FG001|Trial Period III (12 Months)|Other|1|||
126120917|NCT03668600|453735660|FG000|Overall Study|Study Terminated by the Sponsor|157|||
126120918|NCT03668600|453735660|FG000|Overall Study|Protocol Violation|1|||
126120919|NCT03668600|453735660|FG000|Overall Study|Pregnancy|1|||
126120920|NCT03668600|453735660|FG000|Overall Study|Lost to Follow-up|7|||
126120921|NCT03668600|453735660|FG000|Overall Study|Withdrawal by Subject|56|||
126120922|NCT03668600|453735660|FG000|Overall Study|Lack of Efficacy|7|||
126120923|NCT03668600|453735660|FG000|Overall Study|Adverse Event|1|||
126120924|NCT01476475|453735662|FG000|Overall Study|Adverse Event|6|||
126120925|NCT01476475|453735663|FG001|Overall Study|Adverse Event|0|||
126120926|NCT01476475|453735662|FG000|Overall Study|Poor compliance to protocol|1|||
126120927|NCT01476475|453735663|FG001|Overall Study|Poor compliance to protocol|1|||
126120928|NCT01476475|453735662|FG000|Overall Study|Other reasons|4|||
126120929|NCT01476475|453735663|FG001|Overall Study|Other reasons|2|||
126120930|NCT01278745|453735664|FG000|Overall Study|Death|2|||
126120931|NCT01278745|453735665|FG001|Overall Study|Death|5|||
126120932|NCT01278745|453735666|FG002|Overall Study|Death|7|||
126120933|NCT01278745|453735667|FG003|Overall Study|Death|0|||
126120934|NCT01278745|453735664|FG000|Overall Study|Physician Decision|1|||
126120935|NCT01278745|453735665|FG001|Overall Study|Physician Decision|0|||
126120936|NCT01278745|453735666|FG002|Overall Study|Physician Decision|0|||
126120937|NCT01278745|453735667|FG003|Overall Study|Physician Decision|9|||
126120938|NCT01278745|453735664|FG000|Overall Study|Withdrawal by Subject|1|||
126120939|NCT01278745|453735665|FG001|Overall Study|Withdrawal by Subject|1|||
126120940|NCT01278745|453735666|FG002|Overall Study|Withdrawal by Subject|5|||
126120941|NCT01278745|453735667|FG003|Overall Study|Withdrawal by Subject|1|||
126120942|NCT01278745|453735664|FG000|Overall Study|Sponsor Decision|1|||
126120943|NCT01278745|453735665|FG001|Overall Study|Sponsor Decision|0|||
126120944|NCT01278745|453735666|FG002|Overall Study|Sponsor Decision|62|||
126120945|NCT01278745|453735667|FG003|Overall Study|Sponsor Decision|6|||
126120946|NCT01278745|453735664|FG000|Overall Study|Ineligible|0|||
126120947|NCT01278745|453735665|FG001|Overall Study|Ineligible|0|||
126120948|NCT01278745|453735666|FG002|Overall Study|Ineligible|42|||
126120949|NCT01278745|453735667|FG003|Overall Study|Ineligible|61|||
126120950|NCT01278745|453735664|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
126120951|NCT01278745|453735665|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
126120952|NCT01278745|453735666|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
126120953|NCT01278745|453735667|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
126120954|NCT01265615|453735668|FG000|Overall Study|Protocol Violation|2|||
126120955|NCT01265615|453735669|FG001|Overall Study|Protocol Violation|2|||
126120956|NCT01265615|453735670|FG002|Overall Study|Protocol Violation|4|||
126120957|NCT01265615|453735671|FG003|Overall Study|Protocol Violation|3|||
126120958|NCT01843842|453735676|FG000|Overall Study|Do not meet inclusion criteria|1|||
126120959|NCT01843842|453735677|FG001|Overall Study|Do not meet inclusion criteria|1|||
126120960|NCT02953340|453735678|FG000|Overall Study|Death|0|||
126120961|NCT02953340|453735679|FG001|Overall Study|Death|1|||
126120962|NCT02953340|453735678|FG000|Overall Study|Investigator Decision|3|||
126120963|NCT02953340|453735679|FG001|Overall Study|Investigator Decision|3|||
126120964|NCT02953340|453735678|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
126120965|NCT02953340|453735679|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
126120966|NCT02953340|453735678|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
126120967|NCT02953340|453735679|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
126120968|NCT02953340|453735678|FG000|Overall Study|Withdrawal by Subject|9|||
126120969|NCT02953340|453735679|FG001|Overall Study|Withdrawal by Subject|9|||
126120970|NCT02953340|453735678|FG000|Overall Study|Sponsor decision|0|||
126120971|NCT02953340|453735679|FG001|Overall Study|Sponsor decision|2|||
126120972|NCT02953340|453735678|FG000|Overall Study|Lost to Follow-up|3|||
126120973|NCT02953340|453735679|FG001|Overall Study|Lost to Follow-up|2|||
126120974|NCT02953340|453735678|FG000|Overall Study|Reason not specified|2|||
126120975|NCT02953340|453735679|FG001|Overall Study|Reason not specified|2|||
126120976|NCT01376778|453735680|FG000|Overall Study|Lost to Follow-up|3|||
126120977|NCT01376778|453735681|FG001|Overall Study|Lost to Follow-up|2|||
126120978|NCT00928889|453735682|FG000|Overall Study|Lost to Follow-up|3|||
126120979|NCT00928889|453735683|FG001|Overall Study|Lost to Follow-up|1|||
126120980|NCT00928889|453735682|FG000|Overall Study|Protocol Violation|0|||
126120981|NCT00928889|453735683|FG001|Overall Study|Protocol Violation|1|||
126120982|NCT00928889|453735682|FG000|Overall Study|Adverse Event|1|||
126120983|NCT00928889|453735683|FG001|Overall Study|Adverse Event|0|||
126120984|NCT00928889|453735682|FG000|Overall Study|Other|1|||
126120985|NCT00928889|453735683|FG001|Overall Study|Other|0|||
126120986|NCT02375724|453735689|FG000|Overall Study|Lack of Efficacy|1|||
126120987|NCT02375724|453735690|FG001|Overall Study|Lack of Efficacy|1|||
126120988|NCT02375724|453735689|FG000|Overall Study|Withdrawal by Subject|1|||
126120989|NCT02375724|453735690|FG001|Overall Study|Withdrawal by Subject|1|||
126120990|NCT02375724|453735689|FG000|Overall Study|Lost to Follow-up|1|||
126120991|NCT02375724|453735690|FG001|Overall Study|Lost to Follow-up|0|||
126120992|NCT02375724|453735689|FG000|Overall Study|Protocol Violation|1|||
126120993|NCT02375724|453735690|FG001|Overall Study|Protocol Violation|0|||
126120994|NCT02375724|453735689|FG000|Overall Study|Adverse Event|2|||
126120995|NCT02375724|453735690|FG001|Overall Study|Adverse Event|4|||
126120996|NCT04712110|453735691|FG000|Overall Study|Lost to Follow-up|0|||
126120997|NCT04712110|453735692|FG001|Overall Study|Lost to Follow-up|1|||
126120998|NCT04712110|453735691|FG000|Overall Study|Withdrawal by Subject|0|||
126120999|NCT04712110|453735692|FG001|Overall Study|Withdrawal by Subject|4|||
126121000|NCT04712110|453735691|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
126121001|NCT04712110|453735692|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
126121002|NCT01517893|453735693|FG000|Overall Study|Withdrawal by Subject|3|||
126121003|NCT01517893|453735694|FG001|Overall Study|Withdrawal by Subject|0|||
126121004|NCT01309659|453735695|FG000|Overall Study|Protocol Violation|0|||
126121005|NCT01309659|453735696|FG001|Overall Study|Protocol Violation|1|||
126121006|NCT03462576|453735697|FG000|Overall Study|Protocol Violation|5|||
126121007|NCT03462576|453735698|FG001|Overall Study|Protocol Violation|11|||
126121008|NCT03462576|453735699|FG002|Overall Study|Protocol Violation|7|||
126121009|NCT03462576|453735697|FG000|Overall Study|Device Malfunction|0|||
126121010|NCT03462576|453735698|FG001|Overall Study|Device Malfunction|0|||
126121011|NCT03462576|453735699|FG002|Overall Study|Device Malfunction|1|||
126121012|NCT02285777|453735703|FG000|Overall Study|Withdrawal by Subject|1|||
126121013|NCT02285777|453735704|FG001|Overall Study|Withdrawal by Subject|1|||
126121014|NCT02285777|453735703|FG000|Overall Study|Lost to Follow-up|4|||
126121015|NCT02285777|453735704|FG001|Overall Study|Lost to Follow-up|2|||
126121016|NCT03962101|453735708|FG000|Overall Study|Adverse Event|1|||
126121017|NCT03962101|453735708|FG000|Overall Study|Physician Decision|2|||
126121018|NCT03962101|453735708|FG000|Overall Study|Not related to medical events|1|||
126121019|NCT00271596|453735715|FG000|Overall Study|Protocol Violation|1|||
126121020|NCT00271596|453735716|FG001|Overall Study|Protocol Violation|0|||
126121021|NCT00271596|453735715|FG000|Overall Study|Withdrawal by Subject|0|||
126121022|NCT00271596|453735716|FG001|Overall Study|Withdrawal by Subject|1|||
126121023|NCT01069172|453735721|FG000|Overall Study|Withdrawal by Subject|1|||
126121024|NCT01069172|453735722|FG001|Overall Study|Withdrawal by Subject|0|||
126121025|NCT04206605|453735723|FG000|Overall Study|Adverse Event|0|||
126121026|NCT04206605|453735724|FG001|Overall Study|Adverse Event|1|||
126121027|NCT04206605|453735723|FG000|Overall Study|Withdrawal by Subject|1|||
126121028|NCT04206605|453735724|FG001|Overall Study|Withdrawal by Subject|0|||
126121029|NCT04315181|453735725|FG000|Overall Study|Non-responsive to drug conditions.|1|||
126121030|NCT05879107|453735728|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
126121031|NCT05879107|453735729|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
126121032|NCT05879107|453735728|FG000|Overall Study|Migrated / moved from the study area|1|||
126121033|NCT05879107|453735729|FG001|Overall Study|Migrated / moved from the study area|1|||
126121034|NCT05879107|453735728|FG000|Overall Study|Lost to Follow-up|8|||
126121035|NCT05879107|453735729|FG001|Overall Study|Lost to Follow-up|13|||
126121036|NCT05879107|453735728|FG000|Overall Study|Death|0|||
126121037|NCT05879107|453735729|FG001|Overall Study|Death|2|||
126121038|NCT05879107|453735728|FG000|Overall Study|Other|0|||
126121039|NCT05879107|453735729|FG001|Overall Study|Other|3|||
126121040|NCT03901079|453735730|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
126121041|NCT00843518|453735731|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
126121042|NCT00843518|453735732|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
126121043|NCT00843518|453735731|FG000|Period 2 (Double-blind Treatment)|Death|0|||
126121044|NCT00843518|453735732|FG001|Period 2 (Double-blind Treatment)|Death|1|||
126121045|NCT00843518|453735731|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
126121046|NCT00843518|453735732|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
126121047|NCT00843518|453735731|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
126121048|NCT00843518|453735732|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
126121049|NCT00843518|453735731|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
126121050|NCT00843518|453735732|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
126121051|NCT00843518|453735731|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
126121052|NCT00843518|453735732|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
126121053|NCT00843518|453735731|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
126121054|NCT00843518|453735732|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
126121055|NCT00827606|453735735|FG000|Overall Study|Protocol Violation|4|||
126121056|NCT00827606|453735736|FG001|Overall Study|Protocol Violation|3|||
126121057|NCT00827606|453735735|FG000|Overall Study|Lost to Follow-up|3|||
126121058|NCT00827606|453735736|FG001|Overall Study|Lost to Follow-up|1|||
126121059|NCT00827606|453735735|FG000|Overall Study|Withdrawal by Subject|7|||
126121060|NCT00827606|453735736|FG001|Overall Study|Withdrawal by Subject|6|||
126087574|NCT02614183|453612995|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
126087575|NCT02614183|453612996|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
126087576|NCT02614183|453612994|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
126087577|NCT02614183|453612995|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
126087578|NCT02614183|453612996|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
126087579|NCT02614183|453612994|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
126087580|NCT02614183|453612995|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
126087581|NCT02614183|453612996|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
126087582|NCT02614183|453612994|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
126087583|NCT02614183|453612995|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
126087584|NCT02614183|453612996|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
126087585|NCT02614183|453612994|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
126087586|NCT02614183|453612995|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
126087587|NCT02614183|453612996|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
126087588|NCT02614183|453612994|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
126087589|NCT02614183|453612995|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
126087590|NCT02614183|453612996|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
126087591|NCT01006980|453614778|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
126087592|NCT01006980|453614779|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
126087593|NCT01006980|453614778|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
126087594|NCT01006980|453614779|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
126087595|NCT01006980|453614778|FG000|Vemurafenib and Dacarbazine|Death|13|||
126087596|NCT01006980|453614779|FG001|Vemurafenib and Dacarbazine|Death|12|||
126087597|NCT01006980|453614778|FG000|Vemurafenib and Dacarbazine|Progression|257|||
126087598|NCT01006980|453614779|FG001|Vemurafenib and Dacarbazine|Progression|218|||
126087599|NCT01006980|453614778|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
126087600|NCT01006980|453614779|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
126087601|NCT01006980|453614778|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
126087602|NCT01006980|453614779|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
126087603|NCT01006980|453614778|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
126087604|NCT01006980|453614779|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
126087605|NCT01006980|453614778|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
126087606|NCT01006980|453614779|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
126087607|NCT01006980|453614778|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
126087608|NCT01006980|453614779|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
126087609|NCT01006980|453614778|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
126087610|NCT01006980|453614779|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
126087611|NCT01006980|453614778|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
126087612|NCT01006980|453614779|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
126087613|NCT01006980|453614778|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
126087614|NCT01006980|453614779|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
126087615|NCT01006980|453614778|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
126087616|NCT01006980|453614779|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
126087617|NCT02706405|453614784|FG000|Overall Study|Death|3|||
126087618|NCT02706405|453614785|FG001|Overall Study|Death|2|||
126087619|NCT02706405|453614786|FG002|Overall Study|Death|0|||
126087620|NCT02706405|453614787|FG003|Overall Study|Death|1|||
126087621|NCT02706405|453614788|FG004|Overall Study|Death|0|||
126087622|NCT02706405|453614789|FG005|Overall Study|Death|0|||
126087623|NCT02706405|453614790|FG006|Overall Study|Death|3|||
126087624|NCT02706405|453614791|FG007|Overall Study|Death|4|||
126087625|NCT02706405|453614784|FG000|Overall Study|Disease progression|0|||
126087626|NCT02706405|453614785|FG001|Overall Study|Disease progression|0|||
126087627|NCT02706405|453614786|FG002|Overall Study|Disease progression|0|||
126087628|NCT02706405|453614787|FG003|Overall Study|Disease progression|0|||
126087629|NCT02706405|453614788|FG004|Overall Study|Disease progression|0|||
126087630|NCT02706405|453614789|FG005|Overall Study|Disease progression|0|||
126087631|NCT02706405|453614790|FG006|Overall Study|Disease progression|0|||
126087632|NCT02706405|453614791|FG007|Overall Study|Disease progression|1|||
126087633|NCT02706405|453614784|FG000|Overall Study|Pt moved to new therapy|0|||
126087634|NCT02706405|453614785|FG001|Overall Study|Pt moved to new therapy|0|||
126087635|NCT02706405|453614786|FG002|Overall Study|Pt moved to new therapy|0|||
126087636|NCT02706405|453614787|FG003|Overall Study|Pt moved to new therapy|0|||
126087637|NCT02706405|453614788|FG004|Overall Study|Pt moved to new therapy|0|||
126087638|NCT02706405|453614789|FG005|Overall Study|Pt moved to new therapy|1|||
126087639|NCT02706405|453614790|FG006|Overall Study|Pt moved to new therapy|0|||
126087640|NCT02706405|453614791|FG007|Overall Study|Pt moved to new therapy|1|||
126087641|NCT02706405|453614784|FG000|Overall Study|Physician Decision|1|||
126087642|NCT02706405|453614785|FG001|Overall Study|Physician Decision|0|||
126087643|NCT02706405|453614786|FG002|Overall Study|Physician Decision|0|||
126087644|NCT02706405|453614787|FG003|Overall Study|Physician Decision|0|||
126087645|NCT02706405|453614788|FG004|Overall Study|Physician Decision|0|||
126087646|NCT02706405|453614789|FG005|Overall Study|Physician Decision|0|||
126121061|NCT00827606|453735735|FG000|Overall Study|Pregnancy|0|||
126121062|NCT00827606|453735736|FG001|Overall Study|Pregnancy|1|||
126121063|NCT00827606|453735735|FG000|Overall Study|Other|5|||
126121064|NCT00827606|453735736|FG001|Overall Study|Other|13|||
126121065|NCT00827606|453735735|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
126121066|NCT00827606|453735736|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
126121067|NCT00827606|453735735|FG000|Overall Study|Adverse Event|4|||
126121068|NCT00827606|453735736|FG001|Overall Study|Adverse Event|2|||
126121069|NCT04037748|453735739|FG000|Treatment Period 1|Withdrawal by Subject|3|||
126121070|NCT04037748|453735740|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126121071|NCT04037748|453735739|FG000|Treatment Period 1|Adverse Event|1|||
126121072|NCT04037748|453735740|FG001|Treatment Period 1|Adverse Event|1|||
126121073|NCT04037748|453735739|FG000|Treatment Period 1|Protocol Violation|4|||
126121074|NCT04037748|453735740|FG001|Treatment Period 1|Protocol Violation|5|||
126121075|NCT04037748|453735739|FG000|Treatment Period 2|Adverse Event|0|||
126121076|NCT04037748|453735740|FG001|Treatment Period 2|Adverse Event|1|||
126121077|NCT04037748|453735739|FG000|Treatment Period 2|Protocol Violation|2|||
126121078|NCT04037748|453735740|FG001|Treatment Period 2|Protocol Violation|0|||
126121079|NCT04544475|453735745|FG000|Overall Study|Withdrawal by Subject|1|||
126121080|NCT04544475|453735746|FG001|Overall Study|Withdrawal by Subject|3|||
126121081|NCT01378858|453735747|FG000|Overall Study|Withdrawal by Subject|4|||
126121082|NCT01378858|453735748|FG001|Overall Study|Withdrawal by Subject|4|||
126121083|NCT00942175|453735749|FG000|Overall Study|Adverse Event|2|||
126121084|NCT00942175|453735750|FG001|Overall Study|Adverse Event|1|||
126121085|NCT00942175|453735751|FG002|Overall Study|Adverse Event|0|||
126121086|NCT00942175|453735752|FG003|Overall Study|Adverse Event|0|||
126121087|NCT00942175|453735749|FG000|Overall Study|Protocol Violation|0|||
126121088|NCT00942175|453735750|FG001|Overall Study|Protocol Violation|1|||
126121089|NCT00942175|453735751|FG002|Overall Study|Protocol Violation|2|||
126121090|NCT00942175|453735752|FG003|Overall Study|Protocol Violation|0|||
126121091|NCT00942175|453735749|FG000|Overall Study|Pregnancy|0|||
126121092|NCT00942175|453735750|FG001|Overall Study|Pregnancy|0|||
126121093|NCT00942175|453735751|FG002|Overall Study|Pregnancy|0|||
126121094|NCT00942175|453735752|FG003|Overall Study|Pregnancy|1|||
126121095|NCT00942175|453735749|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
126121096|NCT00942175|453735750|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
126121097|NCT00942175|453735751|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
126121098|NCT00942175|453735752|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
126121099|NCT00942175|453735749|FG000|Overall Study|Low Platelet Count|0|||
126121100|NCT00942175|453735750|FG001|Overall Study|Low Platelet Count|2|||
126121101|NCT00942175|453735751|FG002|Overall Study|Low Platelet Count|0|||
126121102|NCT00942175|453735752|FG003|Overall Study|Low Platelet Count|0|||
126121103|NCT02664272|453735753|FG000|Overall Study|Fluoroscopic images not made available|2|||
126121104|NCT03073980|453735754|FG000|Overall Study|Lost to Follow-up|10|||
126121105|NCT03073980|453735755|FG001|Overall Study|Lost to Follow-up|2|||
126121106|NCT03073980|453735756|FG002|Overall Study|Lost to Follow-up|9|||
126121107|NCT03073980|453735754|FG000|Overall Study|No post-procedure data|0|||
126121108|NCT03073980|453735755|FG001|Overall Study|No post-procedure data|0|||
126121109|NCT03073980|453735756|FG002|Overall Study|No post-procedure data|2|||
126121110|NCT00501007|453735757|FG000|Overall Study|Inclusion criteria not met.|29|||
126121111|NCT00501007|453735758|FG001|Overall Study|Inclusion criteria not met.|25|||
126121112|NCT00545064|453735759|FG000|Overall Study|Lost to Follow-up|3|||
126121113|NCT00545064|453735759|FG000|Overall Study|Withdrawal by Subject|2|||
126121114|NCT00545064|453735759|FG000|Overall Study|did not complete course of treatment|1|||
126121115|NCT00545064|453735759|FG000|Overall Study|cancel all appointments, no rebooking|1|||
126121116|NCT00545064|453735759|FG000|Overall Study|inclement weather|1|||
126121117|NCT00258674|453735762|FG000|Overall Study|Death|32|||
126121118|NCT00258674|453735763|FG001|Overall Study|Death|53|||
126121119|NCT00258674|453735764|FG002|Overall Study|Death|34|||
126121120|NCT03715153|453735765|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
126121121|NCT03715153|453735766|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
126121122|NCT03715153|453735765|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
126121123|NCT03715153|453735766|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
126121124|NCT03715153|453735765|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
126121125|NCT03715153|453735766|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
126121126|NCT03715153|453735765|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
126121127|NCT03715153|453735766|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
126121128|NCT03715153|453735765|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
126121129|NCT03715153|453735766|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
126121130|NCT03715153|453735765|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
126121131|NCT03715153|453735766|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
126121132|NCT02973087|453735769|FG000|Overall Study|Withdrawal by Subject|2|||
126121133|NCT02973087|453735770|FG001|Overall Study|Withdrawal by Subject|1|||
126121134|NCT02973087|453735769|FG000|Overall Study|Adverse Event|1|||
126121135|NCT02973087|453735770|FG001|Overall Study|Adverse Event|0|||
126121136|NCT02973087|453735769|FG000|Overall Study|other|1|||
126121137|NCT02973087|453735770|FG001|Overall Study|other|1|||
126121138|NCT01358760|453735773|FG000|Overall Study|Adverse Event|3|||
126121139|NCT01358760|453735774|FG001|Overall Study|Adverse Event|4|||
126121140|NCT01358760|453735775|FG002|Overall Study|Adverse Event|3|||
126121141|NCT01358760|453735773|FG000|Overall Study|Lost to Follow-up|1|||
126121142|NCT01358760|453735774|FG001|Overall Study|Lost to Follow-up|1|||
126121143|NCT01358760|453735775|FG002|Overall Study|Lost to Follow-up|3|||
126121144|NCT01358760|453735773|FG000|Overall Study|Withdrawal by Subject|5|||
126121145|NCT01358760|453735774|FG001|Overall Study|Withdrawal by Subject|3|||
126121146|NCT01358760|453735775|FG002|Overall Study|Withdrawal by Subject|2|||
126121147|NCT01358760|453735773|FG000|Overall Study|Physician Decision|1|||
126121148|NCT01358760|453735774|FG001|Overall Study|Physician Decision|0|||
126121149|NCT01358760|453735775|FG002|Overall Study|Physician Decision|1|||
126121150|NCT01358760|453735773|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
126121151|NCT01358760|453735774|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
126121152|NCT01358760|453735775|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
126121153|NCT01506960|453735776|FG000|Overall Study|Did not meet angiographic criteria|47|||
126121154|NCT00450723|453735778|FG000|Overall Study|Physician Decision|5|||
126121155|NCT00932360|453735779|FG000|Washout (One Week)|Withdrawal by Subject|0|||
126121156|NCT00932360|453735780|FG001|Washout (One Week)|Withdrawal by Subject|0|||
126121157|NCT00932360|453735781|FG002|Washout (One Week)|Withdrawal by Subject|0|||
126121158|NCT00932360|453735782|FG003|Washout (One Week)|Withdrawal by Subject|0|||
126121159|NCT00932360|453735783|FG004|Washout (One Week)|Withdrawal by Subject|2|||
126121160|NCT00932360|453735784|FG005|Washout (One Week)|Withdrawal by Subject|0|||
126121161|NCT01924182|453735785|FG000|Overall Study|Withdrawal by Subject|1|||
126121162|NCT01924182|453735786|FG001|Overall Study|Withdrawal by Subject|0|||
126121163|NCT04143009|453735787|FG000|Pilot Trial|Lost to Follow-up|0|||
126121164|NCT04143009|453735788|FG001|Pilot Trial|Lost to Follow-up|1|||
126121165|NCT04143009|453735789|FG002|Pilot Trial|Lost to Follow-up|1|||
126121166|NCT00993265|453735790|FG000|Overall Study|Adverse Event|1|||
126121167|NCT00993265|453735791|FG001|Overall Study|Adverse Event|0|||
126121168|NCT00993265|453735790|FG000|Overall Study|Changed dose of concomitant drug|2|||
126121169|NCT00993265|453735791|FG001|Overall Study|Changed dose of concomitant drug|0|||
126121170|NCT00993265|453735790|FG000|Overall Study|Non-compliant with study medication|1|||
126121171|NCT00993265|453735791|FG001|Overall Study|Non-compliant with study medication|0|||
126121172|NCT01357655|453735792|FG000|Overall Study|Administrative Reason by Sponsor|45|||
126121173|NCT01357655|453735793|FG001|Overall Study|Administrative Reason by Sponsor|0|||
126121174|NCT01357655|453735792|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126121175|NCT01357655|453735793|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126121176|NCT01357655|453735792|FG000|Overall Study|Disease Progression|1|||
126121177|NCT01357655|453735793|FG001|Overall Study|Disease Progression|0|||
126121178|NCT01357655|453735792|FG000|Overall Study|Lost to Follow-up|2|||
126121179|NCT01357655|453735793|FG001|Overall Study|Lost to Follow-up|0|||
126121180|NCT01357655|453735792|FG000|Overall Study|Maximum Clinical Benefit|2|||
126121181|NCT01357655|453735793|FG001|Overall Study|Maximum Clinical Benefit|0|||
126121182|NCT01357655|453735792|FG000|Overall Study|Reason Unspecified|1|||
126121183|NCT01357655|453735793|FG001|Overall Study|Reason Unspecified|0|||
126121184|NCT01357655|453735792|FG000|Overall Study|Study Drug Toxicity|11|||
126121185|NCT01357655|453735793|FG001|Overall Study|Study Drug Toxicity|0|||
126121186|NCT01357655|453735792|FG000|Overall Study|Subject Withdrew Consent|1|||
126121187|NCT01357655|453735793|FG001|Overall Study|Subject Withdrew Consent|0|||
126121188|NCT05003622|453735794|FG000|Overall Study|Progressive disease|2|||
126121189|NCT05003622|453735794|FG000|Overall Study|Withdrawal by Subject|1|||
126121190|NCT00609986|453735795|FG000|Overall Study|Did not receive transplant or treatment|8|||
126121191|NCT00609986|453735796|FG001|Overall Study|Did not receive transplant or treatment|3|||
126121192|NCT00840086|453737003|FG000|Overall Study|Adverse Event|1|||
126121193|NCT00840086|453737003|FG000|Overall Study|Protocol Violation|2|||
126121194|NCT00840086|453737003|FG000|Overall Study|Lost to Follow-up|1|||
126121195|NCT03332498|453737004|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
126121196|NCT03332498|453737005|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
126121197|NCT03332498|453737006|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
126121198|NCT01566773|453737007|FG000|Overall Study|Protocol specified criteria|4|||
126121199|NCT01566773|453737007|FG000|Overall Study|Protocol Violation|4|||
126121200|NCT01566773|453737007|FG000|Overall Study|Withdrawal by Subject|9|||
126121201|NCT01566773|453737007|FG000|Overall Study|Administrative reason|1|||
126121202|NCT01566773|453737007|FG000|Overall Study|Adverse Event|10|||
126121203|NCT01566773|453737007|FG000|Overall Study|Physician Decision|2|||
126121204|NCT04036708|453737008|FG000|Overall Study|Lost to Follow-up|14|||
126121205|NCT04036708|453737009|FG001|Overall Study|Lost to Follow-up|4|||
126121206|NCT04036708|453737010|FG002|Overall Study|Lost to Follow-up|14|||
126121207|NCT04036708|453737011|FG003|Overall Study|Lost to Follow-up|4|||
126121208|NCT01033734|453737012|FG000|Overall Study|Withdrawal by Subject|1|||
126121209|NCT01444742|453737015|FG000|Overall Study|Death|1|||
126121210|NCT02349048|453737017|FG000|Overall Study|Withdrawal by Subject|4|||
126121211|NCT02349048|453737018|FG001|Overall Study|Withdrawal by Subject|0|||
126121212|NCT02349048|453737017|FG000|Overall Study|Lost to Follow-up|1|||
126121213|NCT02349048|453737018|FG001|Overall Study|Lost to Follow-up|0|||
126121214|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
126121215|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
126121216|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
126121217|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
126121218|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
126121219|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
126121220|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
126121221|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
126121222|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
126121223|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
126121224|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
126121225|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
126121226|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
126121227|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
126121228|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
126121229|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
126121230|NCT00094770|453737021|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
126121231|NCT00094770|453737022|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
126121232|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
126121233|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
126121234|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
126121235|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
126121236|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
126121237|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
126121238|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
126121239|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
126121240|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
126121241|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
126121242|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
126121243|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
126121244|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
126121245|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
126121246|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
126121247|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
126121248|NCT00094770|453737021|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
126121249|NCT00094770|453737022|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
126121250|NCT01648790|453737023|FG000|Treatment 3|Withdrawal by Subject|0|||
126121251|NCT01648790|453737024|FG001|Treatment 3|Withdrawal by Subject|0|||
126121252|NCT01648790|453737025|FG002|Treatment 3|Withdrawal by Subject|0|||
126121253|NCT01648790|453737026|FG003|Treatment 3|Withdrawal by Subject|1|||
126121254|NCT01648790|453737027|FG004|Treatment 3|Withdrawal by Subject|0|||
126121255|NCT00454857|453737028|FG000|Overall Study|Withdrawal by Subject|15|||
126121256|NCT00454857|453737028|FG000|Overall Study|Lost to Follow-up|16|||
126121257|NCT00454857|453737028|FG000|Overall Study|Noncompliance|6|||
126121258|NCT00454857|453737028|FG000|Overall Study|Death|5|||
126121259|NCT00454857|453737028|FG000|Overall Study|Other|11|||
126121260|NCT00454857|453737028|FG000|Overall Study|Reason unknown|1|||
126121261|NCT04206020|453737031|FG000|Overall Study|Adverse Event|1|||
126121262|NCT04206020|453737032|FG001|Overall Study|Adverse Event|4|||
126121263|NCT04206020|453737031|FG000|Overall Study|Protocol Violation|2|||
126121264|NCT04206020|453737032|FG001|Overall Study|Protocol Violation|0|||
126121265|NCT04206020|453737031|FG000|Overall Study|Withdrawal by Subject|2|||
126121266|NCT04206020|453737032|FG001|Overall Study|Withdrawal by Subject|0|||
126121267|NCT04206020|453737031|FG000|Overall Study|Lost to Follow-up|2|||
126121268|NCT04206020|453737032|FG001|Overall Study|Lost to Follow-up|0|||
126121269|NCT04206020|453737031|FG000|Overall Study|Pregnancy|0|||
126121270|NCT04206020|453737032|FG001|Overall Study|Pregnancy|1|||
126121271|NCT04206020|453737031|FG000|Overall Study|Unable to attend visits|1|||
126121272|NCT04206020|453737032|FG001|Overall Study|Unable to attend visits|2|||
126121273|NCT03374189|453737033|FG000|Overall Study|Lost to Follow-up|1|||
126121274|NCT03374189|453737034|FG001|Overall Study|Lost to Follow-up|0|||
126121275|NCT01197521|453737039|FG000|Overall Study|Not reported|24|||
126121276|NCT01197521|453737040|FG001|Overall Study|Not reported|25|||
126121277|NCT01197521|453737041|FG002|Overall Study|Not reported|21|||
126121278|NCT01197521|453737039|FG000|Overall Study|Enrolment in long term extension|42|||
126121279|NCT01197521|453737040|FG001|Overall Study|Enrolment in long term extension|36|||
126121280|NCT01197521|453737041|FG002|Overall Study|Enrolment in long term extension|87|||
126121281|NCT01197521|453737039|FG000|Overall Study|Severe non-compliance to protocol|1|||
126121282|NCT01197521|453737040|FG001|Overall Study|Severe non-compliance to protocol|3|||
126121283|NCT01197521|453737041|FG002|Overall Study|Severe non-compliance to protocol|3|||
125960715|NCT01694706|453149269|FG001|Overall Study|other reason not defined above|0|||
125960716|NCT01694706|453149270|FG002|Overall Study|other reason not defined above|0|||
126121284|NCT01197521|453737039|FG000|Overall Study|Lack of therapeutic response|2|||
126121285|NCT01197521|453737040|FG001|Overall Study|Lack of therapeutic response|3|||
126121286|NCT01197521|453737041|FG002|Overall Study|Lack of therapeutic response|4|||
126121287|NCT01197521|453737039|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
126121288|NCT01197521|453737040|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
126121289|NCT01197521|453737041|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
126121290|NCT01197521|453737039|FG000|Overall Study|Lost to Follow-up|3|||
126121291|NCT01197521|453737040|FG001|Overall Study|Lost to Follow-up|2|||
126121292|NCT01197521|453737041|FG002|Overall Study|Lost to Follow-up|2|||
126121293|NCT01197521|453737039|FG000|Overall Study|Adverse Event|25|||
126121294|NCT01197521|453737040|FG001|Overall Study|Adverse Event|28|||
126121295|NCT01197521|453737041|FG002|Overall Study|Adverse Event|24|||
126121296|NCT00552175|453737042|FG000|Overall Study|Lack of Efficacy|2|||
126121297|NCT00552175|453737043|FG001|Overall Study|Lack of Efficacy|0|||
126121298|NCT00552175|453737044|FG002|Overall Study|Lack of Efficacy|1|||
126121299|NCT00552175|453737042|FG000|Overall Study|Adverse Event|9|||
126121300|NCT00552175|453737043|FG001|Overall Study|Adverse Event|9|||
126121301|NCT00552175|453737044|FG002|Overall Study|Adverse Event|10|||
126121302|NCT00552175|453737042|FG000|Overall Study|Withdrawal by Subject|2|||
126121303|NCT00552175|453737043|FG001|Overall Study|Withdrawal by Subject|2|||
126121304|NCT00552175|453737044|FG002|Overall Study|Withdrawal by Subject|1|||
126121305|NCT00552175|453737042|FG000|Overall Study|Lost to Follow-up|0|||
126121306|NCT00552175|453737043|FG001|Overall Study|Lost to Follow-up|0|||
126121307|NCT00552175|453737044|FG002|Overall Study|Lost to Follow-up|1|||
126121308|NCT00552175|453737042|FG000|Overall Study|Entry Criteria Not Met|1|||
126121309|NCT00552175|453737043|FG001|Overall Study|Entry Criteria Not Met|1|||
126121310|NCT00552175|453737044|FG002|Overall Study|Entry Criteria Not Met|0|||
126121311|NCT00552175|453737042|FG000|Overall Study|Reason Not Specified|3|||
126121312|NCT00552175|453737043|FG001|Overall Study|Reason Not Specified|1|||
126121313|NCT00552175|453737044|FG002|Overall Study|Reason Not Specified|1|||
126121314|NCT00078325|453737047|FG000|Overall Study|Adverse Event|15|||
126121315|NCT00078325|453737048|FG001|Overall Study|Adverse Event|10|||
126121316|NCT00078325|453737049|FG002|Overall Study|Adverse Event|5|||
126121317|NCT00078325|453737047|FG000|Overall Study|Protocol Violation|2|||
126121318|NCT00078325|453737048|FG001|Overall Study|Protocol Violation|2|||
126121319|NCT00078325|453737049|FG002|Overall Study|Protocol Violation|0|||
125960717|NCT02057757|453149271|FG000|Overall Study|Withdrawal by Subject|3|||
125960718|NCT02057757|453149272|FG001|Overall Study|Withdrawal by Subject|5|||
125960719|NCT02057757|453149271|FG000|Overall Study|Death|2|||
125960720|NCT02057757|453149272|FG001|Overall Study|Death|0|||
125960721|NCT02057757|453149271|FG000|Overall Study|Lost to Follow-up|8|||
125960722|NCT02057757|453149272|FG001|Overall Study|Lost to Follow-up|3|||
125960723|NCT02057757|453149271|FG000|Overall Study|Non-compliance|1|||
125960724|NCT02057757|453149272|FG001|Overall Study|Non-compliance|0|||
125960725|NCT03614793|453149273|FG000|Overall Study|Lost to Follow-up|1|||
125960726|NCT03614793|453149274|FG001|Overall Study|Lost to Follow-up|2|||
125960727|NCT03614793|453149273|FG000|Overall Study|Lack of Efficacy|0|||
125960728|NCT03614793|453149274|FG001|Overall Study|Lack of Efficacy|5|||
125960729|NCT03614793|453149273|FG000|Overall Study|Withdrawal by Subject|0|||
125960730|NCT03614793|453149274|FG001|Overall Study|Withdrawal by Subject|1|||
125960731|NCT03614793|453149273|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
125960732|NCT03614793|453149274|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
125960733|NCT02082522|453149275|FG000|Overall Study|Sponsor termination|5|||
125960734|NCT02082522|453149276|FG001|Overall Study|Sponsor termination|3|||
125960735|NCT02082522|453149275|FG000|Overall Study|Withdrawal by Subject|2|||
125960736|NCT02082522|453149276|FG001|Overall Study|Withdrawal by Subject|4|||
125960737|NCT02082522|453149275|FG000|Overall Study|Death|1|||
126121320|NCT00078325|453737047|FG000|Overall Study|Withdrawal by Subject|1|||
126121321|NCT00078325|453737048|FG001|Overall Study|Withdrawal by Subject|5|||
126121322|NCT00078325|453737049|FG002|Overall Study|Withdrawal by Subject|3|||
126121323|NCT00078325|453737047|FG000|Overall Study|Lost to Follow-up|0|||
126121324|NCT00078325|453737048|FG001|Overall Study|Lost to Follow-up|1|||
126121325|NCT00078325|453737049|FG002|Overall Study|Lost to Follow-up|1|||
125960738|NCT02082522|453149276|FG001|Overall Study|Death|0|||
125960739|NCT02082522|453149275|FG000|Overall Study|Lost to Follow-up|1|||
126121326|NCT00078325|453737047|FG000|Overall Study|Physician Decision|2|||
126121327|NCT00078325|453737048|FG001|Overall Study|Physician Decision|0|||
126121328|NCT00078325|453737049|FG002|Overall Study|Physician Decision|1|||
126121329|NCT00078325|453737047|FG000|Overall Study|Miscellaneous|1|||
126121330|NCT00078325|453737048|FG001|Overall Study|Miscellaneous|1|||
126121331|NCT00078325|453737049|FG002|Overall Study|Miscellaneous|1|||
126121332|NCT00578136|453737050|FG000|Overall Study|Not given intervention|1|||
125960740|NCT02082522|453149276|FG001|Overall Study|Lost to Follow-up|0|||
125960741|NCT02082522|453149275|FG000|Overall Study|Physician Decision|3|||
125960742|NCT02082522|453149276|FG001|Overall Study|Physician Decision|1|||
125960743|NCT02082522|453149275|FG000|Overall Study|Disease progression|2|||
125960744|NCT02082522|453149276|FG001|Overall Study|Disease progression|2|||
125960745|NCT02082522|453149275|FG000|Overall Study|Chemotherapy change|1|||
125960746|NCT02082522|453149276|FG001|Overall Study|Chemotherapy change|3|||
126121333|NCT00578136|453737051|FG001|Overall Study|Not given intervention|1|||
126121334|NCT02047253|453737052|FG000|Overall Study|Lost to Follow-up|8|||
125960747|NCT00456092|453149277|FG000|Extension Phase|Grade 2 or Greater AE|2|||
125960748|NCT00456092|453149278|FG001|Extension Phase|Grade 2 or Greater AE|2|||
125960749|NCT00456092|453149279|FG002|Extension Phase|Grade 2 or Greater AE|0|||
125960750|NCT00456092|453149280|FG003|Extension Phase|Grade 2 or Greater AE|0|||
125960751|NCT00456092|453149281|FG004|Extension Phase|Grade 2 or Greater AE|2|||
125960752|NCT00456092|453149277|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
125960753|NCT00456092|453149278|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
125960754|NCT00456092|453149279|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
125960755|NCT00456092|453149280|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
125960756|NCT00456092|453149281|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
125960757|NCT00456092|453149277|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
125960758|NCT00456092|453149278|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
125960759|NCT00456092|453149279|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
125960760|NCT00456092|453149280|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
125960761|NCT00456092|453149281|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
125960762|NCT00456092|453149277|FG000|Extension Phase|Withdrew Consent|2|||
125960763|NCT00456092|453149278|FG001|Extension Phase|Withdrew Consent|0|||
125960764|NCT00456092|453149279|FG002|Extension Phase|Withdrew Consent|0|||
125960765|NCT00456092|453149280|FG003|Extension Phase|Withdrew Consent|0|||
125960766|NCT00456092|453149281|FG004|Extension Phase|Withdrew Consent|0|||
125960767|NCT00456092|453149277|FG000|Extension Phase|Lost to Follow-up|1|||
125960768|NCT00456092|453149278|FG001|Extension Phase|Lost to Follow-up|1|||
125960769|NCT00456092|453149279|FG002|Extension Phase|Lost to Follow-up|0|||
126121335|NCT03710486|453737054|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
126121336|NCT03710486|453737055|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
126121337|NCT03710486|453737054|FG000|Overall Study|Missing|0|||
126121338|NCT03710486|453737055|FG001|Overall Study|Missing|2|||
126121339|NCT01987960|453737056|FG000|Period 1|Adverse Event|24|||
126121340|NCT01987960|453737057|FG001|Period 1|Adverse Event|0|||
126121341|NCT01987960|453737058|FG002|Period 1|Adverse Event|0|||
126121342|NCT01987960|453737059|FG003|Period 1|Adverse Event|0|||
126121343|NCT01987960|453737056|FG000|Period 1|Lack of Efficacy|4|||
126121344|NCT01987960|453737057|FG001|Period 1|Lack of Efficacy|0|||
125960770|NCT00456092|453149280|FG003|Extension Phase|Lost to Follow-up|0|||
125960771|NCT00456092|453149281|FG004|Extension Phase|Lost to Follow-up|1|||
125960772|NCT00456092|453149277|FG000|Extension Phase|Other|2|||
125960773|NCT00456092|453149278|FG001|Extension Phase|Other|0|||
125960774|NCT00456092|453149279|FG002|Extension Phase|Other|0|||
125960775|NCT00456092|453149280|FG003|Extension Phase|Other|1|||
125960776|NCT00456092|453149281|FG004|Extension Phase|Other|1|||
126121345|NCT01987960|453737058|FG002|Period 1|Lack of Efficacy|0|||
126121346|NCT01987960|453737059|FG003|Period 1|Lack of Efficacy|0|||
125960777|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
125960778|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
125960779|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
125960780|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
125960781|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
125960782|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
125960783|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
125960784|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
125960785|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
125960786|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
125960787|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
125960788|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
125960789|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
125960790|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
125960791|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
125960792|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
126121347|NCT01987960|453737056|FG000|Period 1|Non-compliance with IMP|6|||
125960793|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
125960794|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
125960795|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
125960796|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
125960797|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
125960798|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
125960799|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
125960800|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
125960801|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
126121348|NCT01987960|453737057|FG001|Period 1|Non-compliance with IMP|0|||
126121349|NCT01987960|453737058|FG002|Period 1|Non-compliance with IMP|0|||
126121350|NCT01987960|453737059|FG003|Period 1|Non-compliance with IMP|0|||
126121351|NCT01987960|453737056|FG000|Period 1|Protocol Violation|12|||
126121352|NCT01987960|453737057|FG001|Period 1|Protocol Violation|0|||
125960802|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
125960803|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
125960804|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
125960805|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
125960806|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
125960807|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
125960808|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
125960809|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
125960810|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
125960811|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
125960812|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125960813|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
125960814|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
125960815|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125960816|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125960817|NCT00456092|453149277|FG000|Treatment Phase (12 Weeks)|Other|1|||
125960818|NCT00456092|453149278|FG001|Treatment Phase (12 Weeks)|Other|0|||
125960819|NCT00456092|453149279|FG002|Treatment Phase (12 Weeks)|Other|1|||
125960820|NCT00456092|453149280|FG003|Treatment Phase (12 Weeks)|Other|0|||
125960821|NCT00456092|453149281|FG004|Treatment Phase (12 Weeks)|Other|0|||
125960822|NCT01863446|453149282|FG000|Overall Study|Withdrawal by Subject|1|||
125960823|NCT01863446|453149283|FG001|Overall Study|Withdrawal by Subject|0|||
125960824|NCT01863446|453149284|FG002|Overall Study|Withdrawal by Subject|1|||
125960825|NCT01863446|453149285|FG003|Overall Study|Withdrawal by Subject|2|||
125960826|NCT01863446|453149282|FG000|Overall Study|Physician Decision|0|||
125960827|NCT01863446|453149283|FG001|Overall Study|Physician Decision|0|||
125960828|NCT01863446|453149284|FG002|Overall Study|Physician Decision|1|||
125960829|NCT01863446|453149285|FG003|Overall Study|Physician Decision|0|||
125960830|NCT02840877|453149286|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
125960831|NCT02840877|453149286|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
125960832|NCT02840877|453149286|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
125960833|NCT02840877|453149286|FG000|Baseline to 12 Weeks|Death|1|||
125960834|NCT02840877|453149286|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
125960835|NCT02840877|453149286|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
125960836|NCT02840877|453149286|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
125960837|NCT02840877|453149286|FG000|12 Weeks to 6 Months|Treatment failure|1|||
125960838|NCT02840877|453149286|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
125960839|NCT02840877|453149286|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
125960840|NCT02840877|453149286|FG000|12 Weeks to 6 Months|Death|1|||
125960841|NCT02840877|453149286|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
125960842|NCT02840877|453149286|FG000|6 Months to 18 Months|Treatment failure|7|||
125960843|NCT02840877|453149286|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
125960844|NCT02840877|453149286|FG000|6 Months to 18 Months|Moved/transferred out|6|||
125960845|NCT02840877|453149286|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
125960846|NCT02840877|453149286|FG000|6 Months to 18 Months|Death|4|||
125960847|NCT02840877|453149286|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
125960848|NCT02840877|453149286|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
125960849|NCT02840877|453149286|FG000|6 Months to 18 Months|Still in study.|14|||
125960850|NCT02252081|453149289|FG000|Overall Study|Withdrawal by Subject|2|||
125960851|NCT02252081|453149290|FG001|Overall Study|Withdrawal by Subject|1|||
125960852|NCT02252081|453149289|FG000|Overall Study|Adverse Event|4|||
125960853|NCT02252081|453149290|FG001|Overall Study|Adverse Event|1|||
125960854|NCT02252081|453149289|FG000|Overall Study|non compliance & others|0|||
125960855|NCT02252081|453149290|FG001|Overall Study|non compliance & others|2|||
125960856|NCT01168999|453149295|FG000|Overall Study|Lost to Follow-up|2|||
125960857|NCT01168999|453149296|FG001|Overall Study|Lost to Follow-up|1|||
125960858|NCT01168999|453149297|FG002|Overall Study|Lost to Follow-up|0|||
125960859|NCT01168999|453149298|FG003|Overall Study|Lost to Follow-up|0|||
125960860|NCT03603964|453149299|FG000|Overall Study|Death|9|||
125960861|NCT03603964|453149299|FG000|Overall Study|Withdrawal by participant|7|||
125960862|NCT03603964|453149299|FG000|Overall Study|Study terminated by Sponsor|19|||
126121353|NCT01987960|453737058|FG002|Period 1|Protocol Violation|0|||
126121354|NCT01987960|453737059|FG003|Period 1|Protocol Violation|0|||
125960863|NCT00563797|453149300|FG000|Overall Study|Lost to Follow-up|7|||
125960864|NCT00563797|453149301|FG001|Overall Study|Lost to Follow-up|2|||
125960865|NCT04317586|453149302|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
125960866|NCT04317586|453149302|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
125960867|NCT01276327|453149305|FG000|Overall Study|Adverse Event|1|||
125960868|NCT01276327|453149306|FG001|Overall Study|Adverse Event|3|||
125960869|NCT01276327|453149305|FG000|Overall Study|Withdrawal by Subject|1|||
125960870|NCT01276327|453149306|FG001|Overall Study|Withdrawal by Subject|0|||
125960871|NCT00807092|453149307|FG000|Overall Study|Adverse Event|0|||
126121355|NCT01987960|453737056|FG000|Period 1|Withdrawal by Subject|21|||
125960872|NCT00807092|453149308|FG001|Overall Study|Adverse Event|1|||
125960873|NCT00807092|453149307|FG000|Overall Study|Protocol Violation|0|||
125960874|NCT00807092|453149308|FG001|Overall Study|Protocol Violation|2|||
125960875|NCT00807092|453149307|FG000|Overall Study|Withdrawal by Subject|1|||
125960876|NCT00807092|453149308|FG001|Overall Study|Withdrawal by Subject|0|||
125960877|NCT00807092|453149307|FG000|Overall Study|CGMS data collection failed|0|||
125960878|NCT00807092|453149308|FG001|Overall Study|CGMS data collection failed|1|||
125960879|NCT04116229|453149309|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
125960880|NCT04116229|453149310|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
125960881|NCT04116229|453149309|FG000|Overall Study|Scheduling not possible.|0|||
125960882|NCT04116229|453149310|FG001|Overall Study|Scheduling not possible.|1|||
125960883|NCT01794949|453149311|FG000|Overall Study|Lost to Follow-up|1|||
125960884|NCT01794949|453149312|FG001|Overall Study|Lost to Follow-up|0|||
125960885|NCT03003676|453149313|FG000|Overall Study|Lack of Efficacy|5|||
125960886|NCT03003676|453149314|FG001|Overall Study|Lack of Efficacy|7|||
125960887|NCT03003676|453149313|FG000|Overall Study|Withdrawal by Subject|0|||
125960888|NCT03003676|453149314|FG001|Overall Study|Withdrawal by Subject|1|||
125960889|NCT03003676|453149313|FG000|Overall Study|Hepatitis B infection|1|||
125960890|NCT03003676|453149314|FG001|Overall Study|Hepatitis B infection|0|||
125960891|NCT03766646|453149321|FG000|Overall Study|Withdrawal by Subject|1|||
125960892|NCT03766646|453149322|FG001|Overall Study|Withdrawal by Subject|0|||
125960893|NCT03766646|453149321|FG000|Overall Study|Protocol Violation|0|||
125960894|NCT03766646|453149322|FG001|Overall Study|Protocol Violation|3|||
125960895|NCT00659269|453149342|FG000|Overall Study|Physician Decision|1|||
125960896|NCT00659269|453149343|FG001|Overall Study|Physician Decision|1|||
125960897|NCT01158222|453149344|FG000|Overall Study|Not eligible for intermediate phase|17|||
125960898|NCT02443298|453149345|FG000|Overall Study|Adverse Event|3|||
125960899|NCT02443298|453149346|FG001|Overall Study|Adverse Event|3|||
125960900|NCT02443298|453149345|FG000|Overall Study|Withdrawal by Subject|1|||
125960901|NCT02443298|453149346|FG001|Overall Study|Withdrawal by Subject|2|||
125960902|NCT01490060|453149351|FG000|Cycle 1|Change of Treatment|0|||
125960903|NCT01490060|453149352|FG001|Cycle 1|Change of Treatment|1|||
125960904|NCT01490060|453149353|FG002|Cycle 1|Change of Treatment|1|||
125960905|NCT01490060|453149354|FG003|Cycle 1|Change of Treatment|1|||
125960906|NCT01490060|453149351|FG000|Cycle 1|Insurance Denied|0|||
125960907|NCT01490060|453149352|FG001|Cycle 1|Insurance Denied|0|||
125960908|NCT01490060|453149353|FG002|Cycle 1|Insurance Denied|2|||
125960909|NCT01490060|453149354|FG003|Cycle 1|Insurance Denied|0|||
125960910|NCT01490060|453149351|FG000|Cycle 1|Withdrawal by Subject|0|||
125960911|NCT01490060|453149352|FG001|Cycle 1|Withdrawal by Subject|0|||
125960912|NCT01490060|453149353|FG002|Cycle 1|Withdrawal by Subject|0|||
125960913|NCT01490060|453149354|FG003|Cycle 1|Withdrawal by Subject|1|||
125960914|NCT01490060|453149351|FG000|Cycle 1|Treatment at Another Facility|0|||
125960915|NCT01490060|453149352|FG001|Cycle 1|Treatment at Another Facility|0|||
125960916|NCT01490060|453149353|FG002|Cycle 1|Treatment at Another Facility|0|||
125960917|NCT01490060|453149354|FG003|Cycle 1|Treatment at Another Facility|1|||
125960918|NCT01490060|453149351|FG000|Cycle 2|Change of Treatment|1|||
125960919|NCT01490060|453149352|FG001|Cycle 2|Change of Treatment|1|||
125960920|NCT01490060|453149353|FG002|Cycle 2|Change of Treatment|0|||
125960921|NCT01490060|453149354|FG003|Cycle 2|Change of Treatment|0|||
125960922|NCT01490060|453149351|FG000|Cycle 2|Non-Compliance|0|||
125960923|NCT01490060|453149352|FG001|Cycle 2|Non-Compliance|0|||
125960924|NCT01490060|453149353|FG002|Cycle 2|Non-Compliance|1|||
125960925|NCT01490060|453149354|FG003|Cycle 2|Non-Compliance|0|||
125960926|NCT01490060|453149351|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
125960927|NCT01490060|453149352|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
125960928|NCT01490060|453149353|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
125960929|NCT01490060|453149354|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
125960930|NCT01877421|453149355|FG000|Phase 2|Lost to Follow-up|0|||
125960931|NCT01877421|453149356|FG001|Phase 2|Lost to Follow-up|0|||
125960932|NCT01877421|453149357|FG002|Phase 2|Lost to Follow-up|0|||
126121356|NCT01987960|453737057|FG001|Period 1|Withdrawal by Subject|0|||
126121357|NCT01987960|453737058|FG002|Period 1|Withdrawal by Subject|0|||
125960933|NCT01877421|453149358|FG003|Phase 2|Lost to Follow-up|0|||
125960934|NCT01877421|453149359|FG004|Phase 2|Lost to Follow-up|0|||
125960935|NCT01877421|453149360|FG005|Phase 2|Lost to Follow-up|0|||
125960936|NCT01877421|453149361|FG006|Phase 2|Lost to Follow-up|1|||
125960937|NCT01877421|453149362|FG007|Phase 2|Lost to Follow-up|0|||
125960938|NCT01877421|453149363|FG008|Phase 2|Lost to Follow-up|0|||
125960939|NCT01877421|453149364|FG009|Phase 2|Lost to Follow-up|0|||
125960940|NCT01877421|453149365|FG010|Phase 2|Lost to Follow-up|0|||
125960941|NCT01877421|453149366|FG011|Phase 2|Lost to Follow-up|0|||
125960942|NCT01877421|453149367|FG012|Phase 2|Lost to Follow-up|0|||
125960943|NCT01877421|453149368|FG013|Phase 2|Lost to Follow-up|0|||
125960944|NCT01877421|453149369|FG014|Phase 2|Lost to Follow-up|0|||
125960945|NCT01877421|453149370|FG015|Phase 2|Lost to Follow-up|0|||
125960946|NCT01877421|453149371|FG016|Phase 2|Lost to Follow-up|0|||
125960947|NCT01877421|453149372|FG017|Phase 2|Lost to Follow-up|0|||
125960948|NCT01877421|453149355|FG000|Phase 2|Withdrawal by Subject|0|||
125960949|NCT01877421|453149356|FG001|Phase 2|Withdrawal by Subject|0|||
125960950|NCT01877421|453149357|FG002|Phase 2|Withdrawal by Subject|0|||
125960951|NCT01877421|453149358|FG003|Phase 2|Withdrawal by Subject|0|||
125960952|NCT01877421|453149359|FG004|Phase 2|Withdrawal by Subject|0|||
125960953|NCT01877421|453149360|FG005|Phase 2|Withdrawal by Subject|0|||
125960954|NCT01877421|453149361|FG006|Phase 2|Withdrawal by Subject|0|||
125960955|NCT01877421|453149362|FG007|Phase 2|Withdrawal by Subject|0|||
125960956|NCT01877421|453149363|FG008|Phase 2|Withdrawal by Subject|1|||
125960957|NCT01877421|453149364|FG009|Phase 2|Withdrawal by Subject|0|||
125960958|NCT01877421|453149365|FG010|Phase 2|Withdrawal by Subject|1|||
125960959|NCT01877421|453149366|FG011|Phase 2|Withdrawal by Subject|0|||
125960960|NCT01877421|453149367|FG012|Phase 2|Withdrawal by Subject|1|||
125960961|NCT01877421|453149368|FG013|Phase 2|Withdrawal by Subject|0|||
125960962|NCT01877421|453149369|FG014|Phase 2|Withdrawal by Subject|0|||
125960963|NCT01877421|453149370|FG015|Phase 2|Withdrawal by Subject|1|||
125960964|NCT01877421|453149371|FG016|Phase 2|Withdrawal by Subject|0|||
125960965|NCT01877421|453149372|FG017|Phase 2|Withdrawal by Subject|0|||
125960966|NCT01877421|453149355|FG000|Phase 2|Protocol Violation|0|||
125960967|NCT01877421|453149356|FG001|Phase 2|Protocol Violation|0|||
125960968|NCT01877421|453149357|FG002|Phase 2|Protocol Violation|0|||
125960969|NCT01877421|453149358|FG003|Phase 2|Protocol Violation|0|||
125960970|NCT01877421|453149359|FG004|Phase 2|Protocol Violation|0|||
125960971|NCT01877421|453149360|FG005|Phase 2|Protocol Violation|0|||
125960972|NCT01877421|453149361|FG006|Phase 2|Protocol Violation|0|||
125960973|NCT01877421|453149362|FG007|Phase 2|Protocol Violation|0|||
125960974|NCT01877421|453149363|FG008|Phase 2|Protocol Violation|0|||
125960975|NCT01877421|453149364|FG009|Phase 2|Protocol Violation|0|||
125960976|NCT01877421|453149365|FG010|Phase 2|Protocol Violation|1|||
125960977|NCT01877421|453149366|FG011|Phase 2|Protocol Violation|0|||
125960978|NCT01877421|453149367|FG012|Phase 2|Protocol Violation|0|||
125960979|NCT01877421|453149368|FG013|Phase 2|Protocol Violation|0|||
125960980|NCT01877421|453149369|FG014|Phase 2|Protocol Violation|0|||
125960981|NCT01877421|453149370|FG015|Phase 2|Protocol Violation|0|||
125960982|NCT01877421|453149371|FG016|Phase 2|Protocol Violation|0|||
125960983|NCT01877421|453149372|FG017|Phase 2|Protocol Violation|0|||
125960984|NCT01047683|453149373|FG000|Overall Study|Adverse Event|3|||
125960985|NCT01047683|453149374|FG001|Overall Study|Adverse Event|1|||
125960986|NCT01047683|453149375|FG002|Overall Study|Adverse Event|0|||
125960987|NCT01047683|453149373|FG000|Overall Study|Withdrew Consent|1|||
125960988|NCT01047683|453149374|FG001|Overall Study|Withdrew Consent|4|||
125960989|NCT01047683|453149375|FG002|Overall Study|Withdrew Consent|2|||
125960990|NCT01047683|453149373|FG000|Overall Study|Lost to Follow-up|0|||
125960991|NCT01047683|453149374|FG001|Overall Study|Lost to Follow-up|1|||
125960992|NCT01047683|453149375|FG002|Overall Study|Lost to Follow-up|0|||
125960993|NCT01047683|453149373|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
125960994|NCT01047683|453149374|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
125960995|NCT01047683|453149375|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
125960996|NCT00908960|453149377|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
125960997|NCT00908960|453149378|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
125960998|NCT00908960|453149379|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
125960999|NCT05074433|453149380|FG000|Overall Study|Adverse Event|0|||
125961000|NCT05074433|453149381|FG001|Overall Study|Adverse Event|2|||
125961001|NCT05074433|453149382|FG002|Overall Study|Adverse Event|0|||
125961002|NCT05074433|453149383|FG003|Overall Study|Adverse Event|1|||
125961003|NCT05074433|453149380|FG000|Overall Study|Sponsor Request|0|||
125961004|NCT05074433|453149381|FG001|Overall Study|Sponsor Request|1|||
125961005|NCT05074433|453149382|FG002|Overall Study|Sponsor Request|1|||
125961006|NCT05074433|453149383|FG003|Overall Study|Sponsor Request|0|||
125961007|NCT05074433|453149380|FG000|Overall Study|Death|1|||
125961008|NCT05074433|453149381|FG001|Overall Study|Death|0|||
125961009|NCT05074433|453149382|FG002|Overall Study|Death|0|||
125961010|NCT05074433|453149383|FG003|Overall Study|Death|0|||
125961011|NCT05074433|453149380|FG000|Overall Study|Lost to Follow-up|0|||
125961012|NCT05074433|453149381|FG001|Overall Study|Lost to Follow-up|0|||
125961013|NCT05074433|453149382|FG002|Overall Study|Lost to Follow-up|2|||
125961014|NCT05074433|453149383|FG003|Overall Study|Lost to Follow-up|0|||
125961015|NCT05074433|453149380|FG000|Overall Study|Subject Decision|8|||
125961016|NCT05074433|453149381|FG001|Overall Study|Subject Decision|6|||
125961017|NCT05074433|453149382|FG002|Overall Study|Subject Decision|4|||
125961018|NCT05074433|453149383|FG003|Overall Study|Subject Decision|5|||
125961019|NCT01158924|453149385|FG000|Overall Study|Withdrawal by Subject|1|||
125961020|NCT01158924|453149386|FG001|Overall Study|Withdrawal by Subject|2|||
125961021|NCT01158924|453149385|FG000|Overall Study|Lost to Follow-up|0|||
125961022|NCT01158924|453149386|FG001|Overall Study|Lost to Follow-up|1|||
125961023|NCT03795922|453149387|FG000|Overall Study|Adverse Event|2|||
125961024|NCT03795922|453149388|FG001|Overall Study|Adverse Event|1|||
125961025|NCT03795922|453149387|FG000|Overall Study|Withdrawal by Subject|5|||
125961026|NCT03795922|453149388|FG001|Overall Study|Withdrawal by Subject|13|||
125961027|NCT03795922|453149387|FG000|Overall Study|Lost to Follow-up|2|||
125961028|NCT03795922|453149388|FG001|Overall Study|Lost to Follow-up|3|||
125961029|NCT03795922|453149387|FG000|Overall Study|Pregnancy|0|||
125961030|NCT03795922|453149388|FG001|Overall Study|Pregnancy|1|||
125961031|NCT03795922|453149387|FG000|Overall Study|Physician Decision|1|||
125961032|NCT03795922|453149388|FG001|Overall Study|Physician Decision|2|||
125961033|NCT03795922|453149387|FG000|Overall Study|Protocol Violation|0|||
125961034|NCT03795922|453149388|FG001|Overall Study|Protocol Violation|1|||
125961035|NCT03795922|453149387|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
125961036|NCT03795922|453149388|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
125961037|NCT00733824|453149391|FG000|Phase I|Withdrawal by Subject|1|||
125961038|NCT00733824|453149392|FG001|Phase I|Withdrawal by Subject|0|||
125961039|NCT00733824|453149393|FG002|Phase I|Withdrawal by Subject|0|||
125961040|NCT00733824|453149394|FG003|Phase I|Withdrawal by Subject|0|||
125961041|NCT00733824|453149395|FG004|Phase I|Withdrawal by Subject|0|||
125961042|NCT02480621|453149396|FG000|Randomization|Withdrawal by Subject|1|||
125961043|NCT02480621|453149397|FG001|Randomization|Withdrawal by Subject|0|||
125961044|NCT02480621|453149396|FG000|Randomization|Surgeon did not give intervention|0|||
125961045|NCT02480621|453149397|FG001|Randomization|Surgeon did not give intervention|1|||
125961046|NCT02480621|453149396|FG000|Follow Up|Lost to Follow-up|4|||
125961047|NCT02480621|453149397|FG001|Follow Up|Lost to Follow-up|2|||
125961048|NCT03056690|453149398|FG000|Overall Study|Adverse Event|3|||
125961049|NCT03056690|453149399|FG001|Overall Study|Adverse Event|2|||
125961050|NCT03056690|453149398|FG000|Overall Study|Lack of Efficacy|1|||
125961051|NCT03056690|453149399|FG001|Overall Study|Lack of Efficacy|2|||
125961052|NCT03056690|453149398|FG000|Overall Study|Lost to Follow-up|3|||
125961053|NCT03056690|453149399|FG001|Overall Study|Lost to Follow-up|2|||
125961054|NCT03056690|453149398|FG000|Overall Study|Protocol Violation|2|||
125961055|NCT03056690|453149399|FG001|Overall Study|Protocol Violation|2|||
125961056|NCT03056690|453149398|FG000|Overall Study|Withdrawal by Subject|3|||
125961057|NCT03056690|453149399|FG001|Overall Study|Withdrawal by Subject|6|||
125961058|NCT03056690|453149398|FG000|Overall Study|Non-compliance with Study Drug|1|||
125961059|NCT03056690|453149399|FG001|Overall Study|Non-compliance with Study Drug|0|||
125961060|NCT03056690|453149398|FG000|Overall Study|Miscellaneous|1|||
125961061|NCT03056690|453149399|FG001|Overall Study|Miscellaneous|2|||
125961062|NCT01440946|453149404|FG000|Overall Study|Lost to Follow-up|1|||
125961063|NCT01440946|453149405|FG001|Overall Study|Lost to Follow-up|1|||
125961064|NCT01440946|453149404|FG000|Overall Study|Physician Decision|1|||
125961065|NCT01440946|453149405|FG001|Overall Study|Physician Decision|0|||
125961066|NCT00235989|453149406|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
125961067|NCT00235989|453149407|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
125961068|NCT00235989|453149408|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
125961069|NCT00235989|453149409|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
125961070|NCT00235989|453149410|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
125961071|NCT00235989|453149411|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
125961072|NCT00235989|453149406|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
125961073|NCT00235989|453149407|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
125961074|NCT00235989|453149408|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
125961075|NCT00235989|453149409|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
125961076|NCT00235989|453149410|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
125961077|NCT00235989|453149411|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
125961078|NCT00235989|453149406|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
125961079|NCT00235989|453149407|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
125961080|NCT00235989|453149408|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
125961081|NCT00235989|453149409|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
125961082|NCT00235989|453149410|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
125961083|NCT00235989|453149411|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
125961084|NCT00235989|453149406|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
125961085|NCT00235989|453149407|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
125961086|NCT00235989|453149408|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
125961087|NCT00235989|453149409|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
126121358|NCT01987960|453737059|FG003|Period 1|Withdrawal by Subject|0|||
126121359|NCT01987960|453737056|FG000|Period 1|Lost to Follow-up|40|||
126121360|NCT01987960|453737057|FG001|Period 1|Lost to Follow-up|0|||
126121361|NCT01987960|453737058|FG002|Period 1|Lost to Follow-up|0|||
125961088|NCT00235989|453149410|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
125961089|NCT00235989|453149411|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
125961090|NCT00235989|453149406|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
125961091|NCT00235989|453149407|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
125961092|NCT00235989|453149408|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
125961093|NCT00235989|453149409|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
126121362|NCT01987960|453737059|FG003|Period 1|Lost to Follow-up|0|||
125961094|NCT00235989|453149410|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
125961095|NCT00235989|453149411|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
125961096|NCT00983580|453149412|FG000|Overall Study|Cancel Prior to treatment|1|||
125961097|NCT00983580|453149413|FG001|Overall Study|Cancel Prior to treatment|3|||
126121363|NCT01987960|453737056|FG000|Period 1|administrative or other reason|75|||
125961098|NCT00983580|453149412|FG000|Overall Study|Protocol Violation|1|||
125961099|NCT00983580|453149413|FG001|Overall Study|Protocol Violation|1|||
125961100|NCT00983580|453149412|FG000|Overall Study|Ineligible|3|||
125961101|NCT00983580|453149413|FG001|Overall Study|Ineligible|0|||
125961102|NCT03568461|453149416|FG000|Overall Study|Death|7|||
125961103|NCT03568461|453149416|FG000|Overall Study|Physician Decision|5|||
125961104|NCT03568461|453149416|FG000|Overall Study|Subject decision|5|||
125961105|NCT03568461|453149416|FG000|Overall Study|Lost to Follow-up|1|||
125961106|NCT03964454|453149417|FG000|Overall Study|Lost to Follow-up|13|||
125961107|NCT03964454|453149418|FG001|Overall Study|Lost to Follow-up|7|||
125961108|NCT03964454|453149417|FG000|Overall Study|Withdrawal by Subject|4|||
125961109|NCT03964454|453149418|FG001|Overall Study|Withdrawal by Subject|11|||
125961110|NCT03525834|453150918|FG000|Overall Study|Progressive disease|1|||
125961111|NCT03095417|453150919|FG000|Overall Study|missed|1|||
125961112|NCT03095417|453150920|FG001|Overall Study|missed|2|||
125961113|NCT03095417|453150921|FG002|Overall Study|missed|0|||
125961114|NCT03095417|453150922|FG003|Overall Study|missed|1|||
125961115|NCT03095417|453150919|FG000|Overall Study|Lost to Follow-up|2|||
125961116|NCT03095417|453150920|FG001|Overall Study|Lost to Follow-up|2|||
125961117|NCT03095417|453150921|FG002|Overall Study|Lost to Follow-up|1|||
125961118|NCT03095417|453150922|FG003|Overall Study|Lost to Follow-up|0|||
125961119|NCT03095417|453150919|FG000|Overall Study|refusal|0|||
125961120|NCT03095417|453150920|FG001|Overall Study|refusal|1|||
125961121|NCT03095417|453150921|FG002|Overall Study|refusal|0|||
125961122|NCT03095417|453150922|FG003|Overall Study|refusal|1|||
125961123|NCT03095417|453150919|FG000|Overall Study|Withdrawal by Subject|8|||
125961124|NCT03095417|453150920|FG001|Overall Study|Withdrawal by Subject|2|||
125961125|NCT03095417|453150921|FG002|Overall Study|Withdrawal by Subject|5|||
125961126|NCT03095417|453150922|FG003|Overall Study|Withdrawal by Subject|4|||
125961127|NCT03095417|453150919|FG000|Overall Study|Physician Decision|1|||
125961128|NCT03095417|453150920|FG001|Overall Study|Physician Decision|2|||
125961129|NCT03095417|453150921|FG002|Overall Study|Physician Decision|2|||
125961130|NCT03095417|453150922|FG003|Overall Study|Physician Decision|2|||
125961131|NCT03095417|453150919|FG000|Overall Study|Death|1|||
125961132|NCT03095417|453150920|FG001|Overall Study|Death|2|||
125961133|NCT03095417|453150921|FG002|Overall Study|Death|1|||
125961134|NCT03095417|453150922|FG003|Overall Study|Death|3|||
125961135|NCT00724451|453150926|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
125961136|NCT00724451|453150926|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
125961137|NCT00724451|453150926|FG000|Overall Study|Not Eligible for Treatment|431|||
125961138|NCT00724451|453150926|FG000|Overall Study|Participant Refused Treatment|89|||
125961139|NCT00724451|453150926|FG000|Overall Study|Never Started Treatment|89|||
125961140|NCT00724451|453150926|FG000|Overall Study|Unknown; No Data Sources Available|9|||
125961141|NCT00724451|453150926|FG000|Overall Study|Physician Decision|116|||
125961142|NCT00724451|453150926|FG000|Overall Study|Withdrawal by Subject|45|||
125961143|NCT00724451|453150926|FG000|Overall Study|Investigator + Participant Decision|13|||
125961144|NCT01260922|453150928|FG000|First Intervention|Withdrawal by Subject|0|||
125961145|NCT01260922|453150929|FG001|First Intervention|Withdrawal by Subject|1|||
125961146|NCT01260922|453150928|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
125961147|NCT01260922|453150929|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
125961148|NCT01260922|453150928|FG000|Second Intervention|Emesis|0|||
125961149|NCT01260922|453150929|FG001|Second Intervention|Emesis|2|||
125961150|NCT03732248|453150932|FG000|Overall Study|Withdrawal by Subject|1|||
126121364|NCT01987960|453737057|FG001|Period 1|administrative or other reason|0|||
126121365|NCT01987960|453737058|FG002|Period 1|administrative or other reason|0|||
126121366|NCT01987960|453737059|FG003|Period 1|administrative or other reason|0|||
125961151|NCT03732248|453150933|FG001|Overall Study|Withdrawal by Subject|0|||
125961152|NCT01410110|453150935|FG000|Overall Study|Withdrawal by Subject|4|||
125961153|NCT01410110|453150936|FG001|Overall Study|Withdrawal by Subject|2|||
125961154|NCT03653429|453150941|FG000|Overall Study|Physician Decision|4|||
125961155|NCT03653429|453150942|FG001|Overall Study|Physician Decision|10|||
125961156|NCT01525082|453150943|FG000|Overall Study|Death|1|||
125961157|NCT02543346|453150946|FG000|Second Priming Visit|Withdrawal by Subject|0|||
125961158|NCT02543346|453150947|FG001|Second Priming Visit|Withdrawal by Subject|2|||
125961159|NCT02543346|453150948|FG002|Second Priming Visit|Withdrawal by Subject|2|||
125961160|NCT02543346|453150949|FG003|Second Priming Visit|Withdrawal by Subject|2|||
125961161|NCT02543346|453150946|FG000|Second Priming Visit|Adverse Event|1|||
125961162|NCT02543346|453150947|FG001|Second Priming Visit|Adverse Event|0|||
126121367|NCT01987960|453737056|FG000|Period 1|Withdrawal of consent before treatment|4|||
125961163|NCT02543346|453150948|FG002|Second Priming Visit|Adverse Event|0|||
125961164|NCT02543346|453150949|FG003|Second Priming Visit|Adverse Event|0|||
125961165|NCT01767116|453150950|FG000|Overall Study|Lost to Follow-up|2|||
125961166|NCT01767116|453150951|FG001|Overall Study|Lost to Follow-up|2|||
125961167|NCT02141516|453150956|FG000|Overall Study|Adverse Event|0|||
125961168|NCT02141516|453150957|FG001|Overall Study|Adverse Event|1|||
125961169|NCT02141516|453150958|FG002|Overall Study|Adverse Event|0|||
125961170|NCT02141516|453150956|FG000|Overall Study|Lost to Follow-up|0|||
125961171|NCT02141516|453150957|FG001|Overall Study|Lost to Follow-up|1|||
125961172|NCT02141516|453150958|FG002|Overall Study|Lost to Follow-up|0|||
126121368|NCT01987960|453737057|FG001|Period 1|Withdrawal of consent before treatment|0|||
126121369|NCT01987960|453737058|FG002|Period 1|Withdrawal of consent before treatment|0|||
126121370|NCT01987960|453737059|FG003|Period 1|Withdrawal of consent before treatment|0|||
126121371|NCT01987960|453737056|FG000|Period 2|Adverse Event|0|||
126121372|NCT01987960|453737057|FG001|Period 2|Adverse Event|0|||
126121373|NCT01987960|453737058|FG002|Period 2|Adverse Event|1|||
126121374|NCT01987960|453737059|FG003|Period 2|Adverse Event|0|||
126121375|NCT01987960|453737056|FG000|Period 2|Withdrawal by Subject|0|||
126121376|NCT01987960|453737057|FG001|Period 2|Withdrawal by Subject|0|||
126121377|NCT01987960|453737058|FG002|Period 2|Withdrawal by Subject|1|||
126121378|NCT01987960|453737059|FG003|Period 2|Withdrawal by Subject|0|||
126121379|NCT01987960|453737056|FG000|Period 2|Administrative or other reason|0|||
126121380|NCT01987960|453737057|FG001|Period 2|Administrative or other reason|5|||
126121381|NCT01987960|453737058|FG002|Period 2|Administrative or other reason|7|||
126121382|NCT01987960|453737059|FG003|Period 2|Administrative or other reason|0|||
126121383|NCT01987960|453737056|FG000|Period 3|Adverse Event|0|||
126121384|NCT01987960|453737057|FG001|Period 3|Adverse Event|0|||
125961173|NCT02141516|453150956|FG000|Overall Study|Other|0|||
125961174|NCT02141516|453150957|FG001|Overall Study|Other|3|||
125961175|NCT02141516|453150958|FG002|Overall Study|Other|0|||
125961176|NCT00153101|453150961|FG000|Overall Study|Lost to Follow-up|14|||
125961177|NCT00153101|453150962|FG001|Overall Study|Lost to Follow-up|14|||
125961178|NCT00153101|453150963|FG002|Overall Study|Lost to Follow-up|12|||
125961179|NCT00153101|453150964|FG003|Overall Study|Lost to Follow-up|5|||
125961180|NCT00153101|453150965|FG004|Overall Study|Lost to Follow-up|5|||
125961181|NCT00153101|453150961|FG000|Overall Study|Withdrawal by Subject|3|||
125961182|NCT00153101|453150962|FG001|Overall Study|Withdrawal by Subject|4|||
125961183|NCT00153101|453150963|FG002|Overall Study|Withdrawal by Subject|3|||
125961184|NCT00153101|453150964|FG003|Overall Study|Withdrawal by Subject|3|||
125961185|NCT00153101|453150965|FG004|Overall Study|Withdrawal by Subject|5|||
125961186|NCT02610140|453150966|FG000|Randomization and Treatment Period|Radiological progression|23|||
125961187|NCT02610140|453150967|FG001|Randomization and Treatment Period|Radiological progression|15|||
125961188|NCT02610140|453150966|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
125961189|NCT02610140|453150967|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
125961190|NCT02610140|453150966|FG000|Randomization and Treatment Period|Protocol Violation|1|||
125961191|NCT02610140|453150967|FG001|Randomization and Treatment Period|Protocol Violation|0|||
125961192|NCT02610140|453150966|FG000|Randomization and Treatment Period|Physician Decision|0|||
125961193|NCT02610140|453150967|FG001|Randomization and Treatment Period|Physician Decision|1|||
125961194|NCT02610140|453150966|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
125961195|NCT02610140|453150967|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
125961196|NCT02610140|453150966|FG000|Randomization and Treatment Period|Death|7|||
125961197|NCT02610140|453150967|FG001|Randomization and Treatment Period|Death|1|||
125961198|NCT02610140|453150966|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
125961199|NCT02610140|453150967|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
125961200|NCT02610140|453150966|FG000|Randomization and Treatment Period|Adverse Event|44|||
125961201|NCT02610140|453150967|FG001|Randomization and Treatment Period|Adverse Event|13|||
125961202|NCT02610140|453150966|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
125961203|NCT02610140|453150967|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
125961204|NCT02610140|453150966|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
125961205|NCT02610140|453150967|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
125961206|NCT02610140|453150966|FG000|Randomization and Treatment Period|Not treated|3|||
125961207|NCT02610140|453150967|FG001|Randomization and Treatment Period|Not treated|10|||
125961208|NCT02610140|453150966|FG000|Safety Follow-up|Other|0|||
125961209|NCT02610140|453150967|FG001|Safety Follow-up|Other|2|||
125961210|NCT02610140|453150966|FG000|Safety Follow-up|Lost to Follow-up|1|||
125961211|NCT02610140|453150967|FG001|Safety Follow-up|Lost to Follow-up|0|||
125961212|NCT02610140|453150966|FG000|Safety Follow-up|No follow-up|5|||
125961213|NCT02610140|453150967|FG001|Safety Follow-up|No follow-up|3|||
125961214|NCT02610140|453150966|FG000|Safety Follow-up|Death|12|||
125961215|NCT02610140|453150967|FG001|Safety Follow-up|Death|2|||
125961216|NCT02610140|453150966|FG000|Safety Follow-up|Deterioration of general conditions|15|||
125961217|NCT02610140|453150967|FG001|Safety Follow-up|Deterioration of general conditions|5|||
125961218|NCT02610140|453150966|FG000|Safety Follow-up|Withdrawal by Subject|12|||
125961219|NCT02610140|453150967|FG001|Safety Follow-up|Withdrawal by Subject|12|||
126121385|NCT01987960|453737058|FG002|Period 3|Adverse Event|0|||
126121386|NCT01987960|453737059|FG003|Period 3|Adverse Event|7|||
125961220|NCT02610140|453150966|FG000|Active Follow-up|Progressive disease - radiological|30|||
125961221|NCT02610140|453150967|FG001|Active Follow-up|Progressive disease - radiological|22|||
125961222|NCT02610140|453150966|FG000|Active Follow-up|Death|8|||
125961223|NCT02610140|453150967|FG001|Active Follow-up|Death|1|||
125961224|NCT02610140|453150966|FG000|Active Follow-up|Withdrawal by Subject|4|||
125961225|NCT02610140|453150967|FG001|Active Follow-up|Withdrawal by Subject|0|||
125961226|NCT02610140|453150966|FG000|Active Follow-up|Progressive disease - clinical|1|||
125961227|NCT02610140|453150967|FG001|Active Follow-up|Progressive disease - clinical|2|||
125961228|NCT02610140|453150966|FG000|Active Follow-up|Deterioration of general conditions|1|||
125961229|NCT02610140|453150967|FG001|Active Follow-up|Deterioration of general conditions|0|||
125961230|NCT02610140|453150966|FG000|Active Follow-up|Ongoing but not completed|4|||
125961231|NCT02610140|453150967|FG001|Active Follow-up|Ongoing but not completed|1|||
125961232|NCT02610140|453150966|FG000|Long-term Follow-up|Death|86|||
125961233|NCT02610140|453150967|FG001|Long-term Follow-up|Death|44|||
125961234|NCT02610140|453150966|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
125961235|NCT02610140|453150967|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
125961236|NCT02610140|453150966|FG000|Long-term Follow-up|Lost to Follow-up|1|||
125961237|NCT02610140|453150967|FG001|Long-term Follow-up|Lost to Follow-up|2|||
125961238|NCT02610140|453150966|FG000|Long-term Follow-up|Ongoing but not completed|30|||
125961239|NCT02610140|453150967|FG001|Long-term Follow-up|Ongoing but not completed|17|||
125961240|NCT03169153|453150968|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
125961241|NCT03169153|453150969|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
125961242|NCT03169153|453150968|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
125961243|NCT03169153|453150969|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
125961244|NCT03169153|453150968|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
125961245|NCT03169153|453150969|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
125961246|NCT03169153|453150968|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
125961247|NCT03169153|453150969|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
125961248|NCT00887341|453150970|FG000|Overall Study|Refused treatment|1|||
125961249|NCT00887341|453150971|FG001|Overall Study|Refused treatment|0|||
125961250|NCT00887341|453150970|FG000|Overall Study|Withdrawal by Subject|1|||
125961251|NCT00887341|453150971|FG001|Overall Study|Withdrawal by Subject|1|||
125961252|NCT00887341|453150970|FG000|Overall Study|Adverse Event|0|||
125961253|NCT00887341|453150971|FG001|Overall Study|Adverse Event|1|||
125961254|NCT00887341|453150970|FG000|Overall Study|Lost to Follow-up|0|||
125961255|NCT00887341|453150971|FG001|Overall Study|Lost to Follow-up|1|||
125961256|NCT01649856|453150972|FG000|Overall Study|Withdrawal by Subject|14|||
125961257|NCT01649856|453150973|FG001|Overall Study|Withdrawal by Subject|14|||
125961258|NCT01649856|453150972|FG000|Overall Study|Protocol Violation|4|||
125961259|NCT01649856|453150973|FG001|Overall Study|Protocol Violation|4|||
125961260|NCT01649856|453150972|FG000|Overall Study|Treatment Failure|1|||
125961261|NCT01649856|453150973|FG001|Overall Study|Treatment Failure|1|||
125961262|NCT01649856|453150972|FG000|Overall Study|Death|69|||
125961263|NCT01649856|453150973|FG001|Overall Study|Death|34|||
125961264|NCT01649856|453150972|FG000|Overall Study|Stable or Progressed Disease|5|||
125961265|NCT01649856|453150973|FG001|Overall Study|Stable or Progressed Disease|3|||
125961266|NCT01649856|453150972|FG000|Overall Study|Lost to Follow-up|20|||
125961267|NCT01649856|453150973|FG001|Overall Study|Lost to Follow-up|16|||
125961268|NCT01649856|453150972|FG000|Overall Study|Lack of Compliance|6|||
125961269|NCT01649856|453150973|FG001|Overall Study|Lack of Compliance|1|||
125961270|NCT01649856|453150972|FG000|Overall Study|Other|20|||
125961271|NCT01649856|453150973|FG001|Overall Study|Other|5|||
125961272|NCT00622635|453150974|FG000|Treatment Period 1|Adverse Event|0|||
125961273|NCT00622635|453150975|FG001|Treatment Period 1|Adverse Event|0|||
125961274|NCT00622635|453150976|FG002|Treatment Period 1|Adverse Event|1|||
125961275|NCT00622635|453150977|FG003|Treatment Period 1|Adverse Event|0|||
125961276|NCT00622635|453150978|FG004|Treatment Period 1|Adverse Event|0|||
125961277|NCT00622635|453150979|FG005|Treatment Period 1|Adverse Event|0|||
125961278|NCT00622635|453150974|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125961279|NCT00622635|453150975|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125961280|NCT00622635|453150976|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125961281|NCT00622635|453150977|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125961282|NCT00622635|453150978|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126121387|NCT01987960|453737056|FG000|Period 3|Non-compliance with IMP|0|||
126121388|NCT01987960|453737057|FG001|Period 3|Non-compliance with IMP|0|||
125961283|NCT00622635|453150979|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125961284|NCT00622635|453150974|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
125961285|NCT00622635|453150975|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
125961286|NCT00622635|453150976|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
125961287|NCT00622635|453150977|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
125961288|NCT00622635|453150978|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
125961289|NCT00622635|453150979|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
125961290|NCT00622635|453150974|FG000|Treatment Period 2|Adverse Event|1|||
125961291|NCT00622635|453150975|FG001|Treatment Period 2|Adverse Event|0|||
125961292|NCT00622635|453150976|FG002|Treatment Period 2|Adverse Event|0|||
125961293|NCT00622635|453150977|FG003|Treatment Period 2|Adverse Event|0|||
125961294|NCT00622635|453150978|FG004|Treatment Period 2|Adverse Event|0|||
125961295|NCT00622635|453150979|FG005|Treatment Period 2|Adverse Event|0|||
125961296|NCT00622635|453150974|FG000|Treatment Period 3|Adverse Event|0|||
125961297|NCT00622635|453150975|FG001|Treatment Period 3|Adverse Event|0|||
125961298|NCT00622635|453150976|FG002|Treatment Period 3|Adverse Event|0|||
125961299|NCT00622635|453150977|FG003|Treatment Period 3|Adverse Event|2|||
125961300|NCT00622635|453150978|FG004|Treatment Period 3|Adverse Event|0|||
125961301|NCT00622635|453150979|FG005|Treatment Period 3|Adverse Event|0|||
125961302|NCT00622635|453150974|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125961303|NCT00622635|453150975|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125961304|NCT00622635|453150976|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125961305|NCT00622635|453150977|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125961306|NCT00622635|453150978|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125961307|NCT00622635|453150979|FG005|Treatment Period 3|Withdrawal by Subject|0|||
125961308|NCT00281840|453150980|FG000|Overall Study|Adverse Event|12|||
125961309|NCT00281840|453150980|FG000|Overall Study|Physician Decision|6|||
125961310|NCT00281840|453150980|FG000|Overall Study|Withdrawal by Subject|3|||
125961311|NCT00281840|453150980|FG000|Overall Study|Disease Progression|2|||
125961312|NCT00281840|453150980|FG000|Overall Study|exceed maximum delay in treatment|1|||
125961313|NCT00281840|453150980|FG000|Overall Study|Complicating Disease|1|||
125961314|NCT01975389|453150990|FG000|Overall Study|Adverse Event|10|||
125961315|NCT01975389|453150991|FG001|Overall Study|Adverse Event|6|||
125961316|NCT01975389|453150990|FG000|Overall Study|Death|61|||
125961317|NCT01975389|453150991|FG001|Overall Study|Death|54|||
125961318|NCT01975389|453150990|FG000|Overall Study|Lost to Follow-up|81|||
125961319|NCT01975389|453150991|FG001|Overall Study|Lost to Follow-up|86|||
125961320|NCT01975389|453150990|FG000|Overall Study|Withdrawal by Subject|90|||
125961321|NCT01975389|453150991|FG001|Overall Study|Withdrawal by Subject|76|||
125961322|NCT01975389|453150990|FG000|Overall Study|Other|6|||
125961323|NCT01975389|453150991|FG001|Overall Study|Other|9|||
125961324|NCT01975389|453150990|FG000|Overall Study|Randomized, not treated|4|||
125961325|NCT01975389|453150991|FG001|Overall Study|Randomized, not treated|5|||
125961326|NCT01079234|453150994|FG000|Main: Week 0 to 26|Adverse Event|5|||
125961327|NCT01079234|453150995|FG001|Main: Week 0 to 26|Adverse Event|4|||
125961328|NCT01079234|453150996|FG002|Main: Week 0 to 26|Adverse Event|1|||
125961329|NCT01079234|453150997|FG003|Main: Week 0 to 26|Adverse Event|0|||
125961330|NCT01079234|453150994|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
125961331|NCT01079234|453150995|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
125961332|NCT01079234|453150996|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
125961333|NCT01079234|453150997|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
125961334|NCT01079234|453150994|FG000|Main: Week 0 to 26|Protocol Violation|6|||
125961335|NCT01079234|453150995|FG001|Main: Week 0 to 26|Protocol Violation|2|||
125961336|NCT01079234|453150996|FG002|Main: Week 0 to 26|Protocol Violation|4|||
125961337|NCT01079234|453150997|FG003|Main: Week 0 to 26|Protocol Violation|0|||
125961338|NCT01079234|453150994|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
125961339|NCT01079234|453150995|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
125961340|NCT01079234|453150996|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
125961341|NCT01079234|453150997|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
125961342|NCT01079234|453150994|FG000|Main: Week 0 to 26|Unclassified|7|||
125961343|NCT01079234|453150995|FG001|Main: Week 0 to 26|Unclassified|13|||
125961344|NCT01079234|453150996|FG002|Main: Week 0 to 26|Unclassified|4|||
125961345|NCT01079234|453150997|FG003|Main: Week 0 to 26|Unclassified|0|||
125961346|NCT01079234|453150994|FG000|Extension: Week 27 to 52|Adverse Event|0|||
125961347|NCT01079234|453150995|FG001|Extension: Week 27 to 52|Adverse Event|0|||
125961348|NCT01079234|453150996|FG002|Extension: Week 27 to 52|Adverse Event|1|||
125961349|NCT01079234|453150997|FG003|Extension: Week 27 to 52|Adverse Event|0|||
125961350|NCT01079234|453150994|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
125961351|NCT01079234|453150995|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
125961352|NCT01079234|453150996|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
125961353|NCT01079234|453150997|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
125961354|NCT01079234|453150994|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
125961355|NCT01079234|453150995|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
125961356|NCT01079234|453150996|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
125961357|NCT01079234|453150997|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
125961358|NCT01079234|453150994|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
125961359|NCT01079234|453150995|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
125961360|NCT01079234|453150996|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
125961361|NCT01079234|453150997|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
125961362|NCT01079234|453150994|FG000|Extension: Week 27 to 52|Unclassified|0|||
125961363|NCT01079234|453150995|FG001|Extension: Week 27 to 52|Unclassified|0|||
126121389|NCT01987960|453737058|FG002|Period 3|Non-compliance with IMP|0|||
125961364|NCT01079234|453150996|FG002|Extension: Week 27 to 52|Unclassified|4|||
125961365|NCT01079234|453150997|FG003|Extension: Week 27 to 52|Unclassified|7|||
125961366|NCT01312961|453151003|FG000|Overall Study|Adverse Event|3|||
126121390|NCT01987960|453737059|FG003|Period 3|Non-compliance with IMP|1|||
125961367|NCT01312961|453151004|FG001|Overall Study|Adverse Event|3|||
125961368|NCT01312961|453151003|FG000|Overall Study|Lack of Efficacy|11|||
125961369|NCT01312961|453151004|FG001|Overall Study|Lack of Efficacy|1|||
125961370|NCT01312961|453151003|FG000|Overall Study|Poor compliance to protocol|1|||
125961371|NCT01312961|453151004|FG001|Overall Study|Poor compliance to protocol|0|||
125961372|NCT01312961|453151003|FG000|Overall Study|Other than specified above|2|||
125961373|NCT01312961|453151004|FG001|Overall Study|Other than specified above|3|||
125961374|NCT04278417|453151010|FG000|Overall Study|Withdrawal by Subject|20|||
126121391|NCT01987960|453737056|FG000|Period 3|Protocol Violation|0|||
125961375|NCT04278417|453151011|FG001|Overall Study|Withdrawal by Subject|20|||
125961376|NCT04278417|453151010|FG000|Overall Study|Progressive disease|0|||
125961377|NCT04278417|453151011|FG001|Overall Study|Progressive disease|2|||
125961378|NCT04278417|453151010|FG000|Overall Study|Physician Decision|4|||
125961379|NCT04278417|453151011|FG001|Overall Study|Physician Decision|6|||
125961380|NCT04278417|453151010|FG000|Overall Study|Lost to Follow-up|11|||
125961381|NCT04278417|453151011|FG001|Overall Study|Lost to Follow-up|13|||
125961382|NCT04278417|453151010|FG000|Overall Study|Death|8|||
125961383|NCT04278417|453151011|FG001|Overall Study|Death|9|||
125961384|NCT04278417|453151010|FG000|Overall Study|Adverse Event|3|||
125961385|NCT04278417|453151011|FG001|Overall Study|Adverse Event|5|||
125961386|NCT00205712|453151013|FG000|Overall Study|Lost to Follow-up|0|||
125961387|NCT00205712|453151014|FG001|Overall Study|Lost to Follow-up|1|||
125961388|NCT01603875|453151031|FG000|Overall Study|Preexisting rabies antibody|3|||
125961389|NCT01603875|453151032|FG001|Overall Study|Preexisting rabies antibody|4|||
125961390|NCT01603875|453151033|FG002|Overall Study|Preexisting rabies antibody|3|||
125961391|NCT01603875|453151031|FG000|Overall Study|Lost to Follow-up|4|||
125961392|NCT01603875|453151032|FG001|Overall Study|Lost to Follow-up|3|||
125961393|NCT01603875|453151033|FG002|Overall Study|Lost to Follow-up|6|||
125961394|NCT01603875|453151031|FG000|Overall Study|Protocol Violation|0|||
125961395|NCT01603875|453151032|FG001|Overall Study|Protocol Violation|1|||
125961396|NCT01603875|453151033|FG002|Overall Study|Protocol Violation|0|||
125961397|NCT01971346|453151034|FG000|Overall Study|Protocol Violation|3|||
125961398|NCT01971346|453151034|FG000|Overall Study|Lost to Follow-up|2|||
125961399|NCT01971346|453151034|FG000|Overall Study|Withdrawal by Subject|2|||
125961400|NCT01971346|453151034|FG000|Overall Study|Physician Decision|1|||
125961401|NCT01652716|453151035|FG000|Overall Study|Loss of glucose control|1|||
125961402|NCT01652716|453151036|FG001|Overall Study|Loss of glucose control|0|||
125961403|NCT01652716|453151035|FG000|Overall Study|Administrative|0|||
125961404|NCT01652716|453151036|FG001|Overall Study|Administrative|2|||
125961405|NCT01652716|453151035|FG000|Overall Study|Investigator decision|1|||
125961406|NCT01652716|453151036|FG001|Overall Study|Investigator decision|4|||
125961407|NCT01652716|453151035|FG000|Overall Study|Lost to Follow-up|12|||
125961408|NCT01652716|453151036|FG001|Overall Study|Lost to Follow-up|11|||
125961409|NCT01652716|453151035|FG000|Overall Study|Protocol Violation|2|||
125961410|NCT01652716|453151036|FG001|Overall Study|Protocol Violation|1|||
125961411|NCT01652716|453151035|FG000|Overall Study|Adverse Event|7|||
125961412|NCT01652716|453151036|FG001|Overall Study|Adverse Event|10|||
125961413|NCT01652716|453151035|FG000|Overall Study|Withdrawal by Subject|33|||
125961414|NCT01652716|453151036|FG001|Overall Study|Withdrawal by Subject|18|||
125961415|NCT01337297|453151039|FG000|Overall Study|They entered to single anodal tDCS|4|||
125961416|NCT01337297|453151040|FG001|Overall Study|They entered to single anodal tDCS|3|||
125961417|NCT01337297|453151039|FG000|Overall Study|Lost to Follow-up|1|||
125961418|NCT01337297|453151040|FG001|Overall Study|Lost to Follow-up|3|||
125961419|NCT02316717|453151041|FG000|Overall Study|Adverse Event|2|||
125961420|NCT02316717|453151042|FG001|Overall Study|Adverse Event|2|||
125961421|NCT02316717|453151043|FG002|Overall Study|Adverse Event|0|||
125961422|NCT02316717|453151041|FG000|Overall Study|Lost to Follow-up|1|||
125961423|NCT02316717|453151042|FG001|Overall Study|Lost to Follow-up|2|||
125961424|NCT02316717|453151043|FG002|Overall Study|Lost to Follow-up|1|||
125961425|NCT02316717|453151041|FG000|Overall Study|Non compliance|3|||
125961426|NCT02316717|453151042|FG001|Overall Study|Non compliance|1|||
125961427|NCT02316717|453151043|FG002|Overall Study|Non compliance|0|||
125961428|NCT02316717|453151041|FG000|Overall Study|Protocol Violation|2|||
125961429|NCT02316717|453151042|FG001|Overall Study|Protocol Violation|0|||
125961430|NCT02316717|453151043|FG002|Overall Study|Protocol Violation|0|||
125961431|NCT02316717|453151041|FG000|Overall Study|Withdrawal by Subject|2|||
125961432|NCT02316717|453151042|FG001|Overall Study|Withdrawal by Subject|1|||
125961433|NCT02316717|453151043|FG002|Overall Study|Withdrawal by Subject|1|||
125961434|NCT02316717|453151041|FG000|Overall Study|Death|0|||
125961435|NCT02316717|453151042|FG001|Overall Study|Death|0|||
125961436|NCT02316717|453151043|FG002|Overall Study|Death|1|||
125961437|NCT02316717|453151041|FG000|Overall Study|Physician Decision|0|||
125961438|NCT02316717|453151042|FG001|Overall Study|Physician Decision|1|||
125961439|NCT02316717|453151043|FG002|Overall Study|Physician Decision|0|||
125961440|NCT02316717|453151041|FG000|Overall Study|TBC|1|||
125961441|NCT02316717|453151042|FG001|Overall Study|TBC|0|||
125961442|NCT02316717|453151043|FG002|Overall Study|TBC|0|||
125961443|NCT02778204|453151044|FG000|Overall Study|Adverse Event|1|||
125961444|NCT02778204|453151045|FG001|Overall Study|Adverse Event|0|||
125961445|NCT02778204|453151046|FG002|Overall Study|Adverse Event|0|||
125961446|NCT02778204|453151047|FG003|Overall Study|Adverse Event|0|||
125961447|NCT02778204|453151044|FG000|Overall Study|Withdrawal by Subject|0|||
125961448|NCT02778204|453151045|FG001|Overall Study|Withdrawal by Subject|0|||
125961449|NCT02778204|453151046|FG002|Overall Study|Withdrawal by Subject|1|||
125961450|NCT02778204|453151047|FG003|Overall Study|Withdrawal by Subject|2|||
125961451|NCT02778204|453151044|FG000|Overall Study|Lost to Follow-up|1|||
125961452|NCT02778204|453151045|FG001|Overall Study|Lost to Follow-up|0|||
125961453|NCT02778204|453151046|FG002|Overall Study|Lost to Follow-up|2|||
125961454|NCT02778204|453151047|FG003|Overall Study|Lost to Follow-up|1|||
125961455|NCT02778204|453151044|FG000|Overall Study|Protocol Violation|0|||
125961456|NCT02778204|453151045|FG001|Overall Study|Protocol Violation|0|||
125961457|NCT02778204|453151046|FG002|Overall Study|Protocol Violation|1|||
125961458|NCT02778204|453151047|FG003|Overall Study|Protocol Violation|0|||
125961459|NCT02778204|453151044|FG000|Overall Study|Eligibility Violation|0|||
125961460|NCT02778204|453151045|FG001|Overall Study|Eligibility Violation|0|||
125961461|NCT02778204|453151046|FG002|Overall Study|Eligibility Violation|0|||
125961462|NCT02778204|453151047|FG003|Overall Study|Eligibility Violation|1|||
125961463|NCT00360334|453151048|FG000|Overall Study|Adverse Event|7|||
125961464|NCT00360334|453151049|FG001|Overall Study|Adverse Event|4|||
125961465|NCT00360334|453151048|FG000|Overall Study|Protocol Violation|1|||
125961466|NCT00360334|453151049|FG001|Overall Study|Protocol Violation|1|||
125961467|NCT00360334|453151048|FG000|Overall Study|Physician Decision|2|||
125961468|NCT00360334|453151049|FG001|Overall Study|Physician Decision|3|||
125961469|NCT00360334|453151048|FG000|Overall Study|Lack of Efficacy|0|||
125961470|NCT00360334|453151049|FG001|Overall Study|Lack of Efficacy|1|||
125961471|NCT00360334|453151048|FG000|Overall Study|Entry criterion not met|1|||
125961472|NCT00360334|453151049|FG001|Overall Study|Entry criterion not met|2|||
125961473|NCT00360334|453151048|FG000|Overall Study|Subject decision|8|||
125961474|NCT00360334|453151049|FG001|Overall Study|Subject decision|2|||
125961475|NCT01978184|453151052|FG000|Overall Study|Progressive disease|5|||
125961476|NCT01978184|453151053|FG001|Overall Study|Progressive disease|5|||
125961477|NCT01978184|453151052|FG000|Overall Study|Other than PDA|2|||
125961478|NCT01978184|453151053|FG001|Overall Study|Other than PDA|2|||
125961479|NCT01978184|453151052|FG000|Overall Study|Physician Decision|0|||
125961480|NCT01978184|453151053|FG001|Overall Study|Physician Decision|3|||
125961481|NCT01978184|453151052|FG000|Overall Study|Noncompliance|1|||
125961482|NCT01978184|453151053|FG001|Overall Study|Noncompliance|2|||
126121392|NCT01987960|453737057|FG001|Period 3|Protocol Violation|0|||
126121393|NCT01987960|453737058|FG002|Period 3|Protocol Violation|0|||
126121394|NCT01987960|453737059|FG003|Period 3|Protocol Violation|6|||
126121395|NCT01987960|453737056|FG000|Period 3|Withdrawal by Subject|0|||
126121396|NCT01987960|453737057|FG001|Period 3|Withdrawal by Subject|0|||
126121397|NCT01987960|453737058|FG002|Period 3|Withdrawal by Subject|0|||
125961483|NCT01978184|453151052|FG000|Overall Study|Death|1|||
125961484|NCT01978184|453151053|FG001|Overall Study|Death|0|||
125961485|NCT01978184|453151052|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
125961486|NCT01978184|453151053|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
125961487|NCT02447991|453151069|FG000|Overall Study|Withdrawn by subject - no data|0|||
125961488|NCT02447991|453151070|FG001|Overall Study|Withdrawn by subject - no data|2|||
125961489|NCT02447991|453151069|FG000|Overall Study|Withdrawn by Subject - with data|4|||
125961490|NCT02447991|453151070|FG001|Overall Study|Withdrawn by Subject - with data|4|||
125961491|NCT02447991|453151069|FG000|Overall Study|Lost to Follow-up - no data|3|||
125961492|NCT02447991|453151070|FG001|Overall Study|Lost to Follow-up - no data|6|||
125961493|NCT02447991|453151069|FG000|Overall Study|Lost to follow-up - with data|0|||
125961494|NCT02447991|453151070|FG001|Overall Study|Lost to follow-up - with data|3|||
125961495|NCT02447991|453151069|FG000|Overall Study|End of study - no treatment results|3|||
125961496|NCT02447991|453151070|FG001|Overall Study|End of study - no treatment results|6|||
125961497|NCT02447991|453151069|FG000|Overall Study|End of study - partial treatment results|0|||
125961498|NCT02447991|453151070|FG001|Overall Study|End of study - partial treatment results|9|||
125961499|NCT00459134|453151071|FG000|Overall Study|Physician Decision|1|||
125961500|NCT00459134|453151072|FG001|Overall Study|Physician Decision|1|||
125961501|NCT00459134|453151071|FG000|Overall Study|Withdrawal by Subject|8|||
125961502|NCT00459134|453151072|FG001|Overall Study|Withdrawal by Subject|7|||
125961503|NCT00459134|453151071|FG000|Overall Study|Lost to Follow-up|6|||
125961504|NCT00459134|453151072|FG001|Overall Study|Lost to Follow-up|7|||
125961505|NCT00459134|453151071|FG000|Overall Study|Surgery|1|||
125961506|NCT00459134|453151072|FG001|Overall Study|Surgery|2|||
125961507|NCT00459134|453151071|FG000|Overall Study|Toxicity|4|||
126121398|NCT01987960|453737059|FG003|Period 3|Withdrawal by Subject|9|||
126121399|NCT01987960|453737056|FG000|Period 3|Lost to Follow-up|0|||
126121400|NCT01987960|453737057|FG001|Period 3|Lost to Follow-up|0|||
126121401|NCT01987960|453737058|FG002|Period 3|Lost to Follow-up|0|||
125961508|NCT00459134|453151072|FG001|Overall Study|Toxicity|5|||
125961509|NCT00459134|453151071|FG000|Overall Study|Progression|1|||
125961510|NCT00459134|453151072|FG001|Overall Study|Progression|0|||
125961511|NCT00459134|453151071|FG000|Overall Study|Multiple Reasons|2|||
125961512|NCT00459134|453151072|FG001|Overall Study|Multiple Reasons|3|||
125961513|NCT01175824|453153373|FG000|Overall Study|Adverse Event|2|||
125961514|NCT01175824|453153374|FG001|Overall Study|Adverse Event|1|||
125961515|NCT01175824|453153373|FG000|Overall Study|Lack of Efficacy|2|||
125961516|NCT01175824|453153374|FG001|Overall Study|Lack of Efficacy|0|||
125961517|NCT01175824|453153373|FG000|Overall Study|Lost to Follow-up|0|||
125961518|NCT01175824|453153374|FG001|Overall Study|Lost to Follow-up|1|||
125961519|NCT01175824|453153373|FG000|Overall Study|Physician Decision|0|||
125961520|NCT01175824|453153374|FG001|Overall Study|Physician Decision|4|||
126121402|NCT01987960|453737059|FG003|Period 3|Lost to Follow-up|5|||
126121403|NCT01987960|453737056|FG000|Period 3|Administrative or other reason|0|||
125961521|NCT01175824|453153373|FG000|Overall Study|Protocol Violation|2|||
125961522|NCT01175824|453153374|FG001|Overall Study|Protocol Violation|5|||
126121404|NCT01987960|453737057|FG001|Period 3|Administrative or other reason|0|||
126121405|NCT01987960|453737058|FG002|Period 3|Administrative or other reason|0|||
126121406|NCT01987960|453737059|FG003|Period 3|Administrative or other reason|43|||
126121407|NCT01892163|453737067|FG000|Overall Study|Death|1|||
126121408|NCT01892163|453737068|FG001|Overall Study|Death|1|||
126121409|NCT01892163|453737067|FG000|Overall Study|Lost to Follow-up|1|||
126121410|NCT01892163|453737068|FG001|Overall Study|Lost to Follow-up|0|||
126121411|NCT03302975|453737070|FG000|Overall Study|Lost to Follow-up|4|||
126121412|NCT00219284|453737073|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
126121413|NCT00219284|453737074|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
126121414|NCT00219284|453737073|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
126121415|NCT00219284|453737074|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
126121416|NCT00219284|453737073|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
126121417|NCT00219284|453737074|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
126121418|NCT00219284|453737073|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
126121419|NCT00219284|453737074|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
126121420|NCT00219284|453737073|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
126121421|NCT00219284|453737074|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
126121422|NCT00219284|453737073|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
126121423|NCT00219284|453737074|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
126121424|NCT00219284|453737073|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
126121425|NCT00219284|453737074|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
126121426|NCT00219284|453737073|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
126121427|NCT00219284|453737074|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
126121428|NCT00219284|453737073|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
125961523|NCT01175824|453153373|FG000|Overall Study|Withdrawal by Subject|3|||
125961524|NCT01175824|453153374|FG001|Overall Study|Withdrawal by Subject|7|||
125961525|NCT01175824|453153373|FG000|Overall Study|Sponsor Decision|1|||
125961526|NCT01175824|453153374|FG001|Overall Study|Sponsor Decision|0|||
125961527|NCT01175824|453153373|FG000|Overall Study|Entry Criteria Not Met|6|||
125961528|NCT01175824|453153374|FG001|Overall Study|Entry Criteria Not Met|4|||
125961529|NCT00009737|453153378|FG000|Overall Study|Adverse Event|112|||
125961530|NCT00009737|453153379|FG001|Overall Study|Adverse Event|75|||
125961531|NCT00009737|453153378|FG000|Overall Study|Death|4|||
125961532|NCT00009737|453153379|FG001|Overall Study|Death|6|||
125961533|NCT00009737|453153378|FG000|Overall Study|Lack of Efficacy|17|||
125961534|NCT00009737|453153379|FG001|Overall Study|Lack of Efficacy|15|||
125961535|NCT00009737|453153378|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
126121429|NCT00219284|453737074|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
126121430|NCT04722042|453737075|FG000|Overall Study|Withdrawal by Subject|2|||
126121431|NCT04722042|453737076|FG001|Overall Study|Withdrawal by Subject|1|||
126121432|NCT04722042|453737077|FG002|Overall Study|Withdrawal by Subject|0|||
126121433|NCT02321930|453737084|FG000|Overall Study|Lost to Follow-up|1|||
126121434|NCT01293968|453737085|FG000|Overall Study|non-cooperation|3|||
126121435|NCT01293968|453737086|FG001|Overall Study|non-cooperation|3|||
126121436|NCT00853749|453737087|FG000|Overall Study|Lost to Follow-up|0|||
126121437|NCT00853749|453737088|FG001|Overall Study|Lost to Follow-up|1|||
126121438|NCT02269787|453737091|FG000|Overall Study|Lost to Follow-up|20|||
126121439|NCT02269787|453737092|FG001|Overall Study|Lost to Follow-up|6|||
126121440|NCT02269787|453737091|FG000|Overall Study|Death|2|||
126121441|NCT02269787|453737092|FG001|Overall Study|Death|3|||
126121442|NCT02269787|453737091|FG000|Overall Study|Incapacitated|0|||
126121443|NCT02269787|453737092|FG001|Overall Study|Incapacitated|1|||
126121444|NCT00687440|453737093|FG000|Overall Study|Adverse Event|3|||
126121445|NCT00687440|453737093|FG000|Overall Study|Lost to Follow-up|3|||
126121446|NCT00687440|453737093|FG000|Overall Study|Lack of Efficacy|2|||
126121447|NCT00687440|453737093|FG000|Overall Study|Death|2|||
126121448|NCT00687440|453737093|FG000|Overall Study|Other|1|||
126121449|NCT00687440|453737093|FG000|Overall Study|Missing|1|||
126121450|NCT02228720|453737094|FG000|Open Label - Day 30|Lost to Follow-up|1|||
126121451|NCT01392677|453737099|FG000|Overall Study|Adverse Event|3|||
126121452|NCT01392677|453737100|FG001|Overall Study|Adverse Event|1|||
126121453|NCT01392677|453737099|FG000|Overall Study|Withdrawal by Subject|0|||
126121454|NCT01392677|453737100|FG001|Overall Study|Withdrawal by Subject|2|||
125961536|NCT00009737|453153379|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
126121455|NCT01392677|453737099|FG000|Overall Study|Incorrect enrollment|2|||
126121456|NCT01392677|453737100|FG001|Overall Study|Incorrect enrollment|3|||
126121457|NCT01392677|453737099|FG000|Overall Study|Other reason|3|||
126121458|NCT01392677|453737100|FG001|Overall Study|Other reason|2|||
126121459|NCT03996876|453737101|FG000|Overall Study|Incomplete Data|2|||
126121460|NCT03996876|453737102|FG001|Overall Study|Incomplete Data|4|||
126121461|NCT05264740|453737107|FG000|Baseline|Withdrawal by Subject|0|||
125961537|NCT00009737|453153378|FG000|Overall Study|Other Protocol Violation|1|||
125961538|NCT00009737|453153379|FG001|Overall Study|Other Protocol Violation|0|||
125961539|NCT00009737|453153378|FG000|Overall Study|Refused Treatment|15|||
125961540|NCT00009737|453153379|FG001|Overall Study|Refused Treatment|16|||
125961541|NCT00009737|453153378|FG000|Overall Study|Lost to Follow-up|1|||
126121462|NCT05264740|453737108|FG001|Baseline|Withdrawal by Subject|1|||
126121463|NCT05264740|453737107|FG000|Follow Up 1|Lost to Follow-up|1|||
126121464|NCT05264740|453737108|FG001|Follow Up 1|Lost to Follow-up|1|||
126121465|NCT05264740|453737107|FG000|Follow Up 1|Withdrawal by Subject|0|||
126121466|NCT05264740|453737108|FG001|Follow Up 1|Withdrawal by Subject|1|||
126121467|NCT05264740|453737107|FG000|Follow Up 2|Lost to Follow-up|1|||
126121468|NCT05264740|453737108|FG001|Follow Up 2|Lost to Follow-up|4|||
125961542|NCT00009737|453153379|FG001|Overall Study|Lost to Follow-up|1|||
125961543|NCT00009737|453153378|FG000|Overall Study|Administrative/Other Reasons|7|||
125961544|NCT00009737|453153379|FG001|Overall Study|Administrative/Other Reasons|1|||
125961545|NCT01172938|453153383|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
125961546|NCT01172938|453153384|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
125961547|NCT01172938|453153385|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
125961548|NCT01172938|453153386|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125961549|NCT01172938|453153387|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125961550|NCT01172938|453153388|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125961551|NCT01172938|453153389|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125961552|NCT01172938|453153390|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125961553|NCT01172938|453153391|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125961554|NCT01172938|453153383|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
125961555|NCT01172938|453153384|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
125961556|NCT01172938|453153385|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
126087647|NCT02706405|453614790|FG006|Overall Study|Physician Decision|0|||
126087648|NCT02706405|453614791|FG007|Overall Study|Physician Decision|0|||
126087649|NCT01182441|453614796|FG000|Overall Study|Patient Still in Follow-up|152|||
126087650|NCT01182441|453614797|FG001|Overall Study|Patient Still in Follow-up|72|||
126087651|NCT01182441|453614796|FG000|Overall Study|Death|37|||
126087652|NCT01182441|453614797|FG001|Overall Study|Death|25|||
126087653|NCT01182441|453614796|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
126087654|NCT01182441|453614797|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
126087655|NCT01182441|453614796|FG000|Overall Study|Lost to Follow-up|5|||
126087656|NCT01182441|453614797|FG001|Overall Study|Lost to Follow-up|8|||
126087657|NCT01182441|453614796|FG000|Overall Study|Withdrawal by Subject|6|||
126087658|NCT01182441|453614797|FG001|Overall Study|Withdrawal by Subject|13|||
126087659|NCT01182441|453614796|FG000|Overall Study|Implant Not Attempted|4|||
126087660|NCT01182441|453614797|FG001|Overall Study|Implant Not Attempted|0|||
126087661|NCT01182441|453614796|FG000|Overall Study|Adverse Event|2|||
126087662|NCT01182441|453614797|FG001|Overall Study|Adverse Event|0|||
126087663|NCT01182441|453614796|FG000|Overall Study|Physician Decision|1|||
126087664|NCT01182441|453614797|FG001|Overall Study|Physician Decision|1|||
126087665|NCT00603525|453614798|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
126087666|NCT00603525|453614799|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
126087667|NCT00603525|453614800|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126087668|NCT00603525|453614798|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
126087669|NCT00603525|453614799|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126087670|NCT00603525|453614800|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126087671|NCT00603525|453614798|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
126087672|NCT00603525|453614799|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
126087673|NCT00603525|453614800|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126087674|NCT00603525|453614798|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126087675|NCT00603525|453614799|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
126087676|NCT00603525|453614800|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126087677|NCT00603525|453614798|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
126087678|NCT00603525|453614799|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
126087679|NCT00603525|453614800|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126087680|NCT00603525|453614798|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
126087681|NCT00603525|453614799|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
126087682|NCT00603525|453614800|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
126087683|NCT00603525|453614798|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
126087684|NCT00603525|453614799|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
126087685|NCT00603525|453614800|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
126087686|NCT00603525|453614798|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
126087687|NCT00603525|453614799|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
126087688|NCT00603525|453614800|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
126087689|NCT00603525|453614798|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
126087690|NCT00603525|453614799|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
126087691|NCT00603525|453614800|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
126087692|NCT00603525|453614798|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
126087693|NCT00603525|453614799|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
126121469|NCT05264740|453737107|FG000|Follow Up 3|Lost to Follow-up|7|||
126121470|NCT05264740|453737108|FG001|Follow Up 3|Lost to Follow-up|4|||
126121471|NCT01538628|453737109|FG000|Overall Study|Withdrawal by Subject|1|||
125961557|NCT01172938|453153386|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125961558|NCT01172938|453153387|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125961559|NCT01172938|453153388|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125961560|NCT01172938|453153389|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125961561|NCT01172938|453153390|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125961562|NCT01172938|453153391|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125961563|NCT01172938|453153383|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125961564|NCT01172938|453153384|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
125961565|NCT01172938|453153385|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
125961566|NCT01172938|453153386|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125961567|NCT01172938|453153387|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125961568|NCT01172938|453153388|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125961569|NCT01172938|453153389|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125961570|NCT01172938|453153390|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125961571|NCT01172938|453153391|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125961572|NCT01172938|453153383|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
125961573|NCT01172938|453153384|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
125961574|NCT01172938|453153385|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
125961575|NCT01172938|453153386|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125961576|NCT01172938|453153387|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125961577|NCT01172938|453153388|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125961578|NCT01172938|453153389|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125961579|NCT01172938|453153390|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125961580|NCT01172938|453153391|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125961581|NCT01172938|453153383|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
125961582|NCT01172938|453153384|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
125961583|NCT01172938|453153385|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
125961584|NCT01172938|453153386|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
125961585|NCT01172938|453153387|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
125961586|NCT01172938|453153388|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
125961587|NCT01172938|453153389|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
125961588|NCT01172938|453153390|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
125961589|NCT01172938|453153391|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
125961590|NCT01172938|453153383|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
125961591|NCT01172938|453153384|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125961592|NCT01172938|453153385|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125961593|NCT01172938|453153386|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125961594|NCT01172938|453153387|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125961595|NCT01172938|453153388|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125961596|NCT01172938|453153389|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125961597|NCT01172938|453153390|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125961598|NCT01172938|453153391|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125961599|NCT01172938|453153383|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
125961600|NCT01172938|453153384|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
125961601|NCT01172938|453153385|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
125961602|NCT01172938|453153386|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
125961603|NCT01172938|453153387|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
125961604|NCT01172938|453153388|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
125961605|NCT01172938|453153389|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
125961606|NCT01172938|453153390|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
125961607|NCT01172938|453153391|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
125961608|NCT01172938|453153383|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
125961609|NCT01172938|453153384|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
125961610|NCT01172938|453153385|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
125961611|NCT01172938|453153386|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
125961612|NCT01172938|453153387|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
125961613|NCT01172938|453153388|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
125961614|NCT01172938|453153389|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
125961615|NCT01172938|453153390|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
125961616|NCT01172938|453153391|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
125961617|NCT01172938|453153383|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
125961618|NCT01172938|453153384|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
125961619|NCT01172938|453153385|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
125961620|NCT01172938|453153386|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
125961621|NCT01172938|453153387|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
125961622|NCT01172938|453153388|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
125961623|NCT01172938|453153389|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
125961624|NCT01172938|453153390|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
125961625|NCT01172938|453153391|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
125961626|NCT01172938|453153383|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125961627|NCT01172938|453153384|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125961628|NCT01172938|453153385|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
125961629|NCT01172938|453153386|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125961630|NCT01172938|453153387|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125961631|NCT01172938|453153388|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125961632|NCT01172938|453153389|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125961633|NCT01172938|453153390|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125961634|NCT01172938|453153391|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125961635|NCT01172938|453153383|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
125961636|NCT01172938|453153384|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
125961637|NCT01172938|453153385|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
125961638|NCT01172938|453153386|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
125961639|NCT01172938|453153387|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
125961640|NCT01172938|453153388|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
125961641|NCT01172938|453153389|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
125961642|NCT01172938|453153390|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
125961643|NCT01172938|453153391|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
125961644|NCT01172938|453153383|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125961645|NCT01172938|453153384|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
125961646|NCT01172938|453153385|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
125961647|NCT01172938|453153386|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
125961648|NCT01172938|453153387|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125961649|NCT01172938|453153388|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125961650|NCT01172938|453153389|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125961651|NCT01172938|453153390|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125961652|NCT01172938|453153391|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125961653|NCT01172938|453153383|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
125961654|NCT01172938|453153384|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
125961655|NCT01172938|453153385|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
125961656|NCT01172938|453153386|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
125961657|NCT01172938|453153387|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
125961658|NCT01172938|453153388|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
125961659|NCT01172938|453153389|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
125961660|NCT01172938|453153390|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
125961661|NCT01172938|453153391|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
125961662|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125961663|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
125961664|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
125961665|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125961666|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
126121472|NCT01538628|453737110|FG001|Overall Study|Withdrawal by Subject|1|||
125961667|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125961668|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125961669|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
125961670|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
125961671|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125961672|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
125961673|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
125961674|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
126121473|NCT01538628|453737109|FG000|Overall Study|Lost to Follow-up|0|||
126121474|NCT01538628|453737110|FG001|Overall Study|Lost to Follow-up|1|||
126121475|NCT03080883|453737111|FG000|Overall Study|Withdrawal by Subject|11|||
125961675|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125961676|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125961677|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125961678|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
125961679|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125961680|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126121476|NCT03080883|453737112|FG001|Overall Study|Withdrawal by Subject|15|||
126121477|NCT03080883|453737111|FG000|Overall Study|Adverse Event|22|||
125961681|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125961682|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
125961683|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125961684|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125961685|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125961686|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125961687|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125961688|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125961689|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125961690|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
125961691|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
125961692|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125961693|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125961694|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125961695|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125961696|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
125961697|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
125961698|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125961699|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125961700|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
125961701|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125961702|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125961703|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125961704|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125961705|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125961706|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125961707|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125961708|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
125961709|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
125961710|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125961711|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125961712|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125961713|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125961714|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
125961715|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125961716|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125961717|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
125961718|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125961719|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125961720|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125961721|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125961722|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125961723|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125961724|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
125961725|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125961726|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
125961727|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125961728|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125961729|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125961730|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125961731|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126121478|NCT03080883|453737112|FG001|Overall Study|Adverse Event|22|||
126121479|NCT03080883|453737111|FG000|Overall Study|Alternative Therapy|0|||
125961732|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125961733|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125961734|NCT01172938|453153383|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125961735|NCT01172938|453153384|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125961736|NCT01172938|453153385|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125961737|NCT01172938|453153386|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125961738|NCT01172938|453153387|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125961739|NCT01172938|453153388|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125961740|NCT01172938|453153389|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125961741|NCT01172938|453153390|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125961742|NCT01172938|453153391|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
126121480|NCT03080883|453737112|FG001|Overall Study|Alternative Therapy|3|||
126121481|NCT03080883|453737111|FG000|Overall Study|Other Complicating Disease|9|||
125961743|NCT01172938|453153383|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125961744|NCT01172938|453153384|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
125961745|NCT01172938|453153385|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
125961746|NCT01172938|453153386|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125961747|NCT01172938|453153387|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125961748|NCT01172938|453153388|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125961749|NCT01172938|453153389|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125961750|NCT01172938|453153390|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
125961751|NCT01172938|453153391|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
125961752|NCT01172938|453153383|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125961753|NCT01172938|453153384|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
125961754|NCT01172938|453153385|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
125961755|NCT01172938|453153386|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125961756|NCT01172938|453153387|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125961757|NCT01172938|453153388|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125961758|NCT01172938|453153389|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125961759|NCT01172938|453153390|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
125961760|NCT01172938|453153391|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
125961761|NCT01172938|453153383|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
125961762|NCT01172938|453153384|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
125961763|NCT01172938|453153385|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
125961764|NCT01172938|453153386|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
125961765|NCT01172938|453153387|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
125961766|NCT01172938|453153388|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
125961767|NCT01172938|453153389|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
125961768|NCT01172938|453153390|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
125961769|NCT01172938|453153391|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
125961770|NCT01172938|453153383|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125961771|NCT01172938|453153384|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
125961772|NCT01172938|453153385|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125961773|NCT01172938|453153386|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125961774|NCT01172938|453153387|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125961775|NCT01172938|453153388|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125961776|NCT01172938|453153389|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125961777|NCT01172938|453153390|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125961778|NCT01172938|453153391|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125961779|NCT01172938|453153383|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125961780|NCT01172938|453153384|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125961781|NCT01172938|453153385|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
125961782|NCT01172938|453153386|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125961783|NCT01172938|453153387|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125961784|NCT01172938|453153388|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125961785|NCT01172938|453153389|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125961786|NCT01172938|453153390|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125961787|NCT01172938|453153391|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125961788|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125961789|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
125961790|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
125961791|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125961792|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125961793|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125961794|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125961795|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
125961796|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125961797|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125961798|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
125961799|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
125961800|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125961801|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125961802|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125961803|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125961804|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
125961805|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
125961806|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125961807|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
125961808|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
125961809|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125961810|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125961811|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125961812|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125961813|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
125961814|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
125961815|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125961816|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125961817|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
125961818|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125961819|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125961820|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125961821|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125961822|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125961823|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
125961824|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125961825|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125961826|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125961827|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125961828|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125961829|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125961830|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125961831|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
125961832|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126121482|NCT03080883|453737112|FG001|Overall Study|Other Complicating Disease|5|||
126121483|NCT03080883|453737111|FG000|Overall Study|Death|21|||
126121484|NCT03080883|453737112|FG001|Overall Study|Death|16|||
126121485|NCT03080883|453737111|FG000|Overall Study|Physician Decision|2|||
125961833|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125961834|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125961835|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
125961836|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125961837|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125961838|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125961839|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125961840|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
125961841|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
125961842|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125961843|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125961844|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
125961845|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125961846|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125961847|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126121486|NCT03080883|453737112|FG001|Overall Study|Physician Decision|2|||
125961848|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125961849|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125961850|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125961851|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125961852|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
125961853|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125961854|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125961855|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125961856|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125961857|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125961858|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
126121487|NCT03080883|453737111|FG000|Overall Study|Disease Progression|2|||
126121488|NCT03080883|453737112|FG001|Overall Study|Disease Progression|8|||
126121489|NCT03080883|453737111|FG000|Overall Study|Lost to Follow-up|1|||
126121490|NCT03080883|453737112|FG001|Overall Study|Lost to Follow-up|1|||
126121491|NCT04360551|453738308|FG000|Overall Study|Withdrawal by Subject|1|||
125961859|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125961860|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
126121492|NCT04360551|453738309|FG001|Overall Study|Withdrawal by Subject|0|||
126121493|NCT00388973|453738314|FG000|Overall Study|Adverse Event|16|||
126121494|NCT00388973|453738315|FG001|Overall Study|Adverse Event|6|||
125961861|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
125961862|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
125961863|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125961864|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125961865|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125961866|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125961867|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
125961868|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125961869|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125961870|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125961871|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
125961872|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125961873|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125961874|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125961875|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125961876|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125961877|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125961878|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125961879|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125961880|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
125961881|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125961882|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125961883|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125961884|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125961885|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125961886|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125961887|NCT01172938|453153383|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125961888|NCT01172938|453153384|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125961889|NCT01172938|453153385|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125961890|NCT01172938|453153386|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125961891|NCT01172938|453153387|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125961892|NCT01172938|453153388|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125961893|NCT01172938|453153389|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125961894|NCT01172938|453153390|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125961895|NCT01172938|453153391|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
125961896|NCT00003498|453153392|FG000|Overall Study|Not evaluable.|4|||
125961897|NCT05282004|453153396|FG000|Overall Study|Adverse Event|2|||
125961898|NCT04808609|453153397|FG000|Overall Study|Lost to Follow-up|0|||
125961899|NCT04808609|453153398|FG001|Overall Study|Lost to Follow-up|2|||
125961900|NCT04808609|453153397|FG000|Overall Study|Administrative Withdrawal|0|||
125961901|NCT04808609|453153398|FG001|Overall Study|Administrative Withdrawal|1|||
125961902|NCT01993719|453153402|FG000|First Drug Administration|Not treated|1|||
125961903|NCT01993719|453153403|FG001|First Drug Administration|Not treated|0|||
125961904|NCT01993719|453153404|FG002|First Drug Administration|Not treated|0|||
125961905|NCT01993719|453153405|FG003|First Drug Administration|Not treated|0|||
125961906|NCT01993719|453153406|FG004|First Drug Administration|Not treated|0|||
125961907|NCT04382326|453153410|FG000|Overall Study|Adverse Event, not serious|1|||
125961908|NCT04382326|453153411|FG001|Overall Study|Adverse Event, not serious|2|||
125961909|NCT04382326|453153410|FG000|Overall Study|Other|1|||
125961910|NCT04382326|453153411|FG001|Overall Study|Other|0|||
125961911|NCT04382326|453153410|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
125961912|NCT04382326|453153411|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
125961913|NCT04382326|453153410|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
125961914|NCT04382326|453153411|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
125961915|NCT04382326|453153410|FG000|Overall Study|Protocol Violation|29|||
125961916|NCT04382326|453153411|FG001|Overall Study|Protocol Violation|23|||
125961917|NCT04382326|453153410|FG000|Overall Study|Physician Decision|0|||
125961918|NCT04382326|453153411|FG001|Overall Study|Physician Decision|1|||
125961919|NCT04382326|453153410|FG000|Overall Study|Lost to Follow-up|48|||
125961920|NCT04382326|453153411|FG001|Overall Study|Lost to Follow-up|63|||
125961921|NCT04382326|453153410|FG000|Overall Study|Adverse Event, non-fatal|1|||
125961922|NCT04382326|453153411|FG001|Overall Study|Adverse Event, non-fatal|1|||
125961923|NCT03224468|453153421|FG000|Overall Study|Did not obtain MM card|53|||
125961924|NCT03224468|453153422|FG001|Overall Study|Did not obtain MM card|0|||
125961925|NCT03224468|453153421|FG000|Overall Study|Lost to Follow-up|4|||
125961926|NCT03224468|453153422|FG001|Overall Study|Lost to Follow-up|11|||
125961927|NCT03224468|453153421|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
125961928|NCT03224468|453153422|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
125961929|NCT02461589|453153423|FG000|Overall Study|Withdrawal by Subject|5|||
126087694|NCT00603525|453614800|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
126121495|NCT00388973|453738314|FG000|Overall Study|Lack of Efficacy|1|||
125961930|NCT02461589|453153424|FG001|Overall Study|Withdrawal by Subject|1|||
125961931|NCT02461589|453153425|FG002|Overall Study|Withdrawal by Subject|3|||
125961932|NCT02461589|453153426|FG003|Overall Study|Withdrawal by Subject|2|||
125961933|NCT02461589|453153427|FG004|Overall Study|Withdrawal by Subject|1|||
125961934|NCT02461589|453153428|FG005|Overall Study|Withdrawal by Subject|2|||
125961935|NCT02461589|453153429|FG006|Overall Study|Withdrawal by Subject|1|||
125961936|NCT02461589|453153430|FG007|Overall Study|Withdrawal by Subject|3|||
125961937|NCT02461589|453153431|FG008|Overall Study|Withdrawal by Subject|3|||
125961938|NCT02461589|453153432|FG009|Overall Study|Withdrawal by Subject|1|||
125961939|NCT02461589|453153423|FG000|Overall Study|Lost to Follow-up|0|||
125961940|NCT02461589|453153424|FG001|Overall Study|Lost to Follow-up|0|||
125961941|NCT02461589|453153425|FG002|Overall Study|Lost to Follow-up|2|||
125961942|NCT02461589|453153426|FG003|Overall Study|Lost to Follow-up|3|||
125961943|NCT02461589|453153427|FG004|Overall Study|Lost to Follow-up|1|||
125961944|NCT02461589|453153428|FG005|Overall Study|Lost to Follow-up|1|||
125961945|NCT02461589|453153429|FG006|Overall Study|Lost to Follow-up|3|||
125961946|NCT02461589|453153430|FG007|Overall Study|Lost to Follow-up|1|||
125961947|NCT02461589|453153431|FG008|Overall Study|Lost to Follow-up|3|||
125961948|NCT02461589|453153432|FG009|Overall Study|Lost to Follow-up|1|||
125961949|NCT02461589|453153423|FG000|Overall Study|Death|0|||
125961950|NCT02461589|453153424|FG001|Overall Study|Death|0|||
126121496|NCT00388973|453738315|FG001|Overall Study|Lack of Efficacy|12|||
126121497|NCT00388973|453738314|FG000|Overall Study|Protocol Violation|3|||
126121498|NCT00388973|453738315|FG001|Overall Study|Protocol Violation|0|||
126121499|NCT00388973|453738314|FG000|Overall Study|Withdrawal by Subject|14|||
126121500|NCT00388973|453738315|FG001|Overall Study|Withdrawal by Subject|17|||
126121501|NCT00388973|453738314|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
126121502|NCT00388973|453738315|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
126121503|NCT00388973|453738314|FG000|Overall Study|Did not complete 61 days of treatment|5|||
126121504|NCT00388973|453738315|FG001|Overall Study|Did not complete 61 days of treatment|4|||
126121505|NCT00388973|453738314|FG000|Overall Study|Left region|0|||
126121506|NCT00388973|453738315|FG001|Overall Study|Left region|1|||
126121507|NCT00388973|453738314|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
126121508|NCT00388973|453738315|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
126121509|NCT04179734|453738330|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
126121510|NCT04179734|453738331|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
126121511|NCT04179734|453738330|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
126121512|NCT04179734|453738331|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
126121513|NCT01761292|453738333|FG000|Part 1|Adverse Event|1|||
126121514|NCT01761292|453738333|FG000|Part 1|not receiving treatment in Part 1|1|||
126121515|NCT01761292|453738333|FG000|Extension 1|Withdrawal by Subject|1|||
125961951|NCT02461589|453153425|FG002|Overall Study|Death|0|||
125961952|NCT02461589|453153426|FG003|Overall Study|Death|0|||
125961953|NCT02461589|453153427|FG004|Overall Study|Death|0|||
125961954|NCT02461589|453153428|FG005|Overall Study|Death|0|||
125961955|NCT02461589|453153429|FG006|Overall Study|Death|0|||
125961956|NCT02461589|453153430|FG007|Overall Study|Death|1|||
125961957|NCT02461589|453153431|FG008|Overall Study|Death|0|||
125961958|NCT02461589|453153432|FG009|Overall Study|Death|0|||
125961959|NCT02461589|453153423|FG000|Overall Study|Unclassified|0|||
125961960|NCT02461589|453153424|FG001|Overall Study|Unclassified|0|||
126121516|NCT02535715|453738334|FG000|Overall Study|Withdrawal by Subject|0|||
126121517|NCT02535715|453738335|FG001|Overall Study|Withdrawal by Subject|0|||
125961961|NCT02461589|453153425|FG002|Overall Study|Unclassified|0|||
125961962|NCT02461589|453153426|FG003|Overall Study|Unclassified|0|||
125961963|NCT02461589|453153427|FG004|Overall Study|Unclassified|0|||
125961964|NCT02461589|453153428|FG005|Overall Study|Unclassified|0|||
125961965|NCT02461589|453153429|FG006|Overall Study|Unclassified|1|||
125961966|NCT02461589|453153430|FG007|Overall Study|Unclassified|0|||
125961967|NCT02461589|453153431|FG008|Overall Study|Unclassified|0|||
126121518|NCT02535715|453738336|FG002|Overall Study|Withdrawal by Subject|1|||
126121519|NCT00909181|453738337|FG000|Overall Study|Lost to Follow-up|39|||
126121520|NCT00909181|453738338|FG001|Overall Study|Lost to Follow-up|18|||
126121521|NCT00909181|453738339|FG002|Overall Study|Lost to Follow-up|33|||
126121522|NCT00914927|453738341|FG000|Overall Study|Adverse Event|0|||
125961968|NCT02461589|453153432|FG009|Overall Study|Unclassified|2|||
125961969|NCT02461589|453153423|FG000|Overall Study|Missing follow-up information|1|||
125961970|NCT02461589|453153424|FG001|Overall Study|Missing follow-up information|1|||
125961971|NCT02461589|453153425|FG002|Overall Study|Missing follow-up information|0|||
126121523|NCT00914927|453738342|FG001|Overall Study|Adverse Event|0|||
126121524|NCT00914927|453738343|FG002|Overall Study|Adverse Event|0|||
125961972|NCT02461589|453153426|FG003|Overall Study|Missing follow-up information|0|||
125961973|NCT02461589|453153427|FG004|Overall Study|Missing follow-up information|0|||
126121525|NCT00914927|453738344|FG003|Overall Study|Adverse Event|0|||
125961974|NCT02461589|453153428|FG005|Overall Study|Missing follow-up information|0|||
125961975|NCT02461589|453153429|FG006|Overall Study|Missing follow-up information|1|||
125961976|NCT02461589|453153430|FG007|Overall Study|Missing follow-up information|0|||
125961977|NCT02461589|453153431|FG008|Overall Study|Missing follow-up information|0|||
125961978|NCT02461589|453153432|FG009|Overall Study|Missing follow-up information|0|||
125961979|NCT02461589|453153423|FG000|Overall Study|Withdrawal from trial before exposure|0|||
125961980|NCT02461589|453153424|FG001|Overall Study|Withdrawal from trial before exposure|0|||
125961981|NCT02461589|453153425|FG002|Overall Study|Withdrawal from trial before exposure|0|||
125961982|NCT02461589|453153426|FG003|Overall Study|Withdrawal from trial before exposure|0|||
125961983|NCT02461589|453153427|FG004|Overall Study|Withdrawal from trial before exposure|0|||
125961984|NCT02461589|453153428|FG005|Overall Study|Withdrawal from trial before exposure|0|||
125961985|NCT02461589|453153429|FG006|Overall Study|Withdrawal from trial before exposure|0|||
125961986|NCT02461589|453153430|FG007|Overall Study|Withdrawal from trial before exposure|0|||
125961987|NCT02461589|453153431|FG008|Overall Study|Withdrawal from trial before exposure|0|||
125961988|NCT02461589|453153432|FG009|Overall Study|Withdrawal from trial before exposure|1|||
125961989|NCT04067141|453153433|FG000|First Intervention|Withdrawal by Subject|0|||
125961990|NCT04067141|453153434|FG001|First Intervention|Withdrawal by Subject|1|||
125961991|NCT04067141|453153433|FG000|Second Intervention|Adverse Event|0|||
125961992|NCT04067141|453153434|FG001|Second Intervention|Adverse Event|2|||
125961993|NCT01038921|453153435|FG000|Overall Study|Withdrawal by Subject|1|||
125961994|NCT01038921|453153436|FG001|Overall Study|Withdrawal by Subject|0|||
125961995|NCT01038921|453153435|FG000|Overall Study|Physician Decision|1|||
125961996|NCT01038921|453153436|FG001|Overall Study|Physician Decision|0|||
125961997|NCT01978119|453153437|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
125961998|NCT01978119|453153438|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
125961999|NCT01978119|453153437|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
125962000|NCT01978119|453153438|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125962001|NCT01978119|453153437|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125962002|NCT01978119|453153438|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
125962003|NCT02352493|453153439|FG000|Overall Study|Pregnancy|0|||
125962004|NCT02352493|453153440|FG001|Overall Study|Pregnancy|0|||
125962005|NCT02352493|453153441|FG002|Overall Study|Pregnancy|0|||
125962006|NCT02352493|453153442|FG003|Overall Study|Pregnancy|0|||
125962007|NCT02352493|453153443|FG004|Overall Study|Pregnancy|0|||
125962008|NCT02352493|453153444|FG005|Overall Study|Pregnancy|0|||
125962009|NCT02352493|453153445|FG006|Overall Study|Pregnancy|1|||
125962010|NCT02352493|453153446|FG007|Overall Study|Pregnancy|0|||
125962011|NCT02352493|453153447|FG008|Overall Study|Pregnancy|1|||
125962012|NCT02352493|453153448|FG009|Overall Study|Pregnancy|0|||
125962013|NCT02352493|453153449|FG010|Overall Study|Pregnancy|0|||
125962014|NCT02352493|453153450|FG011|Overall Study|Pregnancy|0|||
125962015|NCT02352493|453153451|FG012|Overall Study|Pregnancy|0|||
125962016|NCT02352493|453153452|FG013|Overall Study|Pregnancy|0|||
125962017|NCT02352493|453153453|FG014|Overall Study|Pregnancy|0|||
125962018|NCT02352493|453153454|FG015|Overall Study|Pregnancy|0|||
125962019|NCT02352493|453153455|FG016|Overall Study|Pregnancy|0|||
125962020|NCT02352493|453153456|FG017|Overall Study|Pregnancy|0|||
125962021|NCT02352493|453153439|FG000|Overall Study|Withdrawal by Subject|0|||
125962022|NCT02352493|453153440|FG001|Overall Study|Withdrawal by Subject|0|||
125962023|NCT02352493|453153441|FG002|Overall Study|Withdrawal by Subject|0|||
125962024|NCT02352493|453153442|FG003|Overall Study|Withdrawal by Subject|0|||
126121526|NCT00914927|453738345|FG004|Overall Study|Adverse Event|1|||
126121527|NCT00914927|453738346|FG005|Overall Study|Adverse Event|0|||
126121528|NCT00914927|453738347|FG006|Overall Study|Adverse Event|0|||
126121529|NCT00914927|453738341|FG000|Overall Study|Withdrawal by Subject|0|||
126121530|NCT00914927|453738342|FG001|Overall Study|Withdrawal by Subject|1|||
126121531|NCT00914927|453738343|FG002|Overall Study|Withdrawal by Subject|0|||
126121532|NCT00914927|453738344|FG003|Overall Study|Withdrawal by Subject|1|||
126121533|NCT00914927|453738345|FG004|Overall Study|Withdrawal by Subject|0|||
126121534|NCT00914927|453738346|FG005|Overall Study|Withdrawal by Subject|0|||
126121535|NCT00914927|453738347|FG006|Overall Study|Withdrawal by Subject|0|||
126121536|NCT00914927|453738341|FG000|Overall Study|Lost to Follow-up|0|||
125962025|NCT02352493|453153443|FG004|Overall Study|Withdrawal by Subject|0|||
125962026|NCT02352493|453153444|FG005|Overall Study|Withdrawal by Subject|0|||
125962027|NCT02352493|453153445|FG006|Overall Study|Withdrawal by Subject|0|||
125962028|NCT02352493|453153446|FG007|Overall Study|Withdrawal by Subject|0|||
125962029|NCT02352493|453153447|FG008|Overall Study|Withdrawal by Subject|1|||
125962030|NCT02352493|453153448|FG009|Overall Study|Withdrawal by Subject|0|||
125962031|NCT02352493|453153449|FG010|Overall Study|Withdrawal by Subject|0|||
125962032|NCT02352493|453153450|FG011|Overall Study|Withdrawal by Subject|0|||
125962033|NCT02352493|453153451|FG012|Overall Study|Withdrawal by Subject|0|||
126121537|NCT00914927|453738342|FG001|Overall Study|Lost to Follow-up|0|||
126121538|NCT00914927|453738343|FG002|Overall Study|Lost to Follow-up|0|||
125962034|NCT02352493|453153452|FG013|Overall Study|Withdrawal by Subject|0|||
125962035|NCT02352493|453153453|FG014|Overall Study|Withdrawal by Subject|1|||
125962036|NCT02352493|453153454|FG015|Overall Study|Withdrawal by Subject|0|||
125962037|NCT02352493|453153455|FG016|Overall Study|Withdrawal by Subject|0|||
125962038|NCT02352493|453153456|FG017|Overall Study|Withdrawal by Subject|0|||
125962039|NCT02352493|453153439|FG000|Overall Study|Lost to Follow-up|0|||
126121539|NCT00914927|453738344|FG003|Overall Study|Lost to Follow-up|1|||
126121540|NCT00914927|453738345|FG004|Overall Study|Lost to Follow-up|0|||
126121541|NCT00914927|453738346|FG005|Overall Study|Lost to Follow-up|0|||
126121542|NCT00914927|453738347|FG006|Overall Study|Lost to Follow-up|0|||
126121543|NCT00914927|453738341|FG000|Overall Study|Administrative/Other|2|||
126121544|NCT00914927|453738342|FG001|Overall Study|Administrative/Other|1|||
126121545|NCT00914927|453738343|FG002|Overall Study|Administrative/Other|0|||
126121546|NCT00914927|453738344|FG003|Overall Study|Administrative/Other|0|||
126121547|NCT00914927|453738345|FG004|Overall Study|Administrative/Other|1|||
126121548|NCT00914927|453738346|FG005|Overall Study|Administrative/Other|0|||
126121549|NCT00914927|453738347|FG006|Overall Study|Administrative/Other|0|||
126121550|NCT04773106|453738348|FG000|Overall Study|Withdrawal by Subject|3|||
126121551|NCT04773106|453738348|FG000|Overall Study|Death|1|||
126121552|NCT01349465|453738349|FG000|Overall Study|Adverse Event|1|||
126121553|NCT01349465|453738350|FG001|Overall Study|Adverse Event|0|||
126121554|NCT01349465|453738349|FG000|Overall Study|Death|3|||
126121555|NCT01349465|453738350|FG001|Overall Study|Death|0|||
126121556|NCT01349465|453738349|FG000|Overall Study|Lost to Follow-up|10|||
126121557|NCT01349465|453738350|FG001|Overall Study|Lost to Follow-up|1|||
126121558|NCT01349465|453738349|FG000|Overall Study|Withdrawal by Subject|4|||
126121559|NCT01349465|453738350|FG001|Overall Study|Withdrawal by Subject|2|||
126121560|NCT01349465|453738349|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
126121561|NCT01349465|453738350|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
126121562|NCT03370120|453738353|FG000|Overall Study|Adverse event, non-fatal|24|||
126121563|NCT03370120|453738353|FG000|Overall Study|Withdrawal by Subject|6|||
126121564|NCT03370120|453738353|FG000|Overall Study|Lost to Follow-up|1|||
126121565|NCT03370120|453738353|FG000|Overall Study|Lack of Efficacy|37|||
126121566|NCT03370120|453738353|FG000|Overall Study|Per sponsor's instructions|1|||
126121567|NCT03370120|453738353|FG000|Overall Study|Study was terminated by parent company UCB|2|||
126121568|NCT03370120|453738353|FG000|Overall Study|The study was ended by the promoter|3|||
126121569|NCT03370120|453738353|FG000|Overall Study|Discontinuation of drug development|3|||
126121570|NCT03370120|453738353|FG000|Overall Study|End of project|2|||
125962040|NCT02352493|453153440|FG001|Overall Study|Lost to Follow-up|0|||
125962041|NCT02352493|453153441|FG002|Overall Study|Lost to Follow-up|0|||
125962042|NCT02352493|453153442|FG003|Overall Study|Lost to Follow-up|0|||
125962043|NCT02352493|453153443|FG004|Overall Study|Lost to Follow-up|0|||
125962044|NCT02352493|453153444|FG005|Overall Study|Lost to Follow-up|0|||
125962045|NCT02352493|453153445|FG006|Overall Study|Lost to Follow-up|0|||
125962046|NCT02352493|453153446|FG007|Overall Study|Lost to Follow-up|0|||
125962047|NCT02352493|453153447|FG008|Overall Study|Lost to Follow-up|0|||
125962048|NCT02352493|453153448|FG009|Overall Study|Lost to Follow-up|1|||
125962049|NCT02352493|453153449|FG010|Overall Study|Lost to Follow-up|0|||
125962050|NCT02352493|453153450|FG011|Overall Study|Lost to Follow-up|0|||
125962051|NCT02352493|453153451|FG012|Overall Study|Lost to Follow-up|1|||
125962052|NCT02352493|453153452|FG013|Overall Study|Lost to Follow-up|2|||
125962053|NCT02352493|453153453|FG014|Overall Study|Lost to Follow-up|0|||
125962054|NCT02352493|453153454|FG015|Overall Study|Lost to Follow-up|0|||
125962055|NCT02352493|453153455|FG016|Overall Study|Lost to Follow-up|0|||
125962056|NCT02352493|453153456|FG017|Overall Study|Lost to Follow-up|0|||
125962057|NCT03295201|453153457|FG000|Overall Study|Lost to Follow-up|1|||
125962058|NCT03295201|453153458|FG001|Overall Study|Lost to Follow-up|1|||
125962059|NCT03295201|453153457|FG000|Overall Study|Hospital admission|0|||
125962060|NCT03295201|453153458|FG001|Overall Study|Hospital admission|1|||
125962061|NCT01465334|453153459|FG000|Overall Study|Disease Progression|1|||
125962062|NCT01465334|453153460|FG001|Overall Study|Disease Progression|0|||
125962063|NCT01465334|453153459|FG000|Overall Study|Adverse Event|1|||
125962064|NCT01465334|453153460|FG001|Overall Study|Adverse Event|0|||
125962065|NCT01465334|453153459|FG000|Overall Study|Richter's transformation|0|||
125962066|NCT01465334|453153460|FG001|Overall Study|Richter's transformation|3|||
126121571|NCT03370120|453738353|FG000|Overall Study|Premature study closure|2|||
126121572|NCT03370120|453738353|FG000|Overall Study|Premature program termination|1|||
126121573|NCT03370120|453738353|FG000|Overall Study|Premature study termination|7|||
125962067|NCT01465334|453153459|FG000|Overall Study|Refractory Disease|0|||
125962068|NCT01465334|453153460|FG001|Overall Study|Refractory Disease|3|||
125962069|NCT00572572|453153461|FG000|Overall Study|Withdrawal by Subject|3|||
125962070|NCT00572572|453153462|FG001|Overall Study|Withdrawal by Subject|6|||
125962071|NCT01831089|453153463|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
125962072|NCT01831089|453153464|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
125962073|NCT01831089|453153465|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
126121574|NCT03370120|453738353|FG000|Overall Study|Trial terminated by sponsor|2|||
126121575|NCT03370120|453738353|FG000|Overall Study|Trial discontinued by sponsor|2|||
125962074|NCT01831089|453153466|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
126121576|NCT03370120|453738353|FG000|Overall Study|Study ended|15|||
126121577|NCT03370120|453738353|FG000|Overall Study|Clinical trial has been cancelled|1|||
126121578|NCT03370120|453738353|FG000|Overall Study|End of study per sponsor decision|2|||
125962075|NCT01831089|453153467|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
125962076|NCT01831089|453153468|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
125962077|NCT01831089|453153463|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
125962078|NCT01831089|453153464|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
125962079|NCT01831089|453153465|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
125962080|NCT01831089|453153466|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
125962081|NCT01831089|453153467|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
125962082|NCT01831089|453153468|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
125962083|NCT01831089|453153463|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125962084|NCT01831089|453153464|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
125962085|NCT01831089|453153465|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125962086|NCT01831089|453153466|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125962087|NCT01831089|453153467|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125962088|NCT01831089|453153468|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125962089|NCT01831089|453153463|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
125962090|NCT01831089|453153464|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
125962091|NCT01831089|453153465|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
125962092|NCT01831089|453153466|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
125962093|NCT01831089|453153467|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
125962094|NCT01831089|453153468|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
125962095|NCT01831089|453153463|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125962096|NCT01831089|453153464|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125962097|NCT01831089|453153465|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
125962098|NCT01831089|453153466|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125962099|NCT01831089|453153467|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125962100|NCT01831089|453153468|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125962101|NCT01831089|453153463|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
125962102|NCT01831089|453153464|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
125962103|NCT01831089|453153465|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
126121579|NCT03370120|453738353|FG000|Overall Study|Promoter's decision|2|||
126121580|NCT03370120|453738353|FG000|Overall Study|The trial has been suspended|3|||
126121581|NCT03370120|453738353|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
126121582|NCT03370120|453738353|FG000|Overall Study|Early termination by order of sponsor|2|||
126121583|NCT03370120|453738353|FG000|Overall Study|Discontinuation of the study|5|||
126121584|NCT03370120|453738353|FG000|Overall Study|End of clinical trial discontinuation|1|||
126121585|NCT03370120|453738353|FG000|Overall Study|Because the clinical trial ended halfway|4|||
126121586|NCT03370120|453738353|FG000|Overall Study|Development discontinued|5|||
126121587|NCT03370120|453738353|FG000|Overall Study|Padsenovil program closed|3|||
126121588|NCT03370120|453738353|FG000|Overall Study|End of project|2|||
126121589|NCT03370120|453738353|FG000|Overall Study|Termination of project|1|||
126121590|NCT03370120|453738353|FG000|Overall Study|The study was interrupted by sponsor|4|||
126121591|NCT03370120|453738353|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
125962104|NCT01831089|453153466|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
125962105|NCT01831089|453153467|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
125962106|NCT01831089|453153468|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
125962107|NCT01831089|453153463|FG000|Cohort III: Dose Level 3|Global end of study|0|||
125962108|NCT01831089|453153464|FG001|Cohort III: Dose Level 3|Global end of study|0|||
125962109|NCT01831089|453153465|FG002|Cohort III: Dose Level 3|Global end of study|1|||
125962110|NCT01831089|453153466|FG003|Cohort III: Dose Level 3|Global end of study|0|||
125962111|NCT01831089|453153467|FG004|Cohort III: Dose Level 3|Global end of study|0|||
125962112|NCT01831089|453153468|FG005|Cohort III: Dose Level 3|Global end of study|0|||
125962113|NCT01831089|453153463|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
125962114|NCT01831089|453153464|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
125962115|NCT01831089|453153465|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
125962116|NCT01831089|453153466|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
125962117|NCT01831089|453153467|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
125962118|NCT01831089|453153468|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
125962119|NCT01831089|453153463|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
125962120|NCT01831089|453153464|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
125962121|NCT01831089|453153465|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
126121592|NCT03370120|453738353|FG000|Overall Study|End of sponsor decision|1|||
125962122|NCT01831089|453153466|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
125962123|NCT01831089|453153467|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
125962124|NCT01831089|453153468|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
125962125|NCT01831089|453153463|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125962126|NCT01831089|453153464|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125962127|NCT01831089|453153465|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125962128|NCT01831089|453153466|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125962129|NCT01831089|453153467|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
125962130|NCT01831089|453153468|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125962131|NCT01831089|453153463|FG000|Cohort V: Dose Level 5|Death|0|||
126121593|NCT03370120|453738353|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
125962132|NCT01831089|453153464|FG001|Cohort V: Dose Level 5|Death|0|||
125962133|NCT01831089|453153465|FG002|Cohort V: Dose Level 5|Death|0|||
125962134|NCT01831089|453153466|FG003|Cohort V: Dose Level 5|Death|0|||
125962135|NCT01831089|453153467|FG004|Cohort V: Dose Level 5|Death|1|||
125962136|NCT01831089|453153468|FG005|Cohort V: Dose Level 5|Death|0|||
125962137|NCT01831089|453153463|FG000|Cohort V: Dose Level 5|Global end of study|0|||
125962138|NCT01831089|453153464|FG001|Cohort V: Dose Level 5|Global end of study|0|||
125962139|NCT01831089|453153465|FG002|Cohort V: Dose Level 5|Global end of study|0|||
125962140|NCT01831089|453153466|FG003|Cohort V: Dose Level 5|Global end of study|0|||
125962141|NCT01831089|453153467|FG004|Cohort V: Dose Level 5|Global end of study|2|||
125962142|NCT01831089|453153468|FG005|Cohort V: Dose Level 5|Global end of study|0|||
125962143|NCT01831089|453153463|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125962144|NCT01831089|453153464|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125962145|NCT01831089|453153465|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125962146|NCT01831089|453153466|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125962147|NCT01831089|453153467|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
125962148|NCT01831089|453153468|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125962149|NCT01831089|453153463|FG000|Cohort B: Arm B|Progressive disease|0|||
125962150|NCT01831089|453153464|FG001|Cohort B: Arm B|Progressive disease|0|||
125962151|NCT01831089|453153465|FG002|Cohort B: Arm B|Progressive disease|0|||
125962152|NCT01831089|453153466|FG003|Cohort B: Arm B|Progressive disease|0|||
125962153|NCT01831089|453153467|FG004|Cohort B: Arm B|Progressive disease|0|||
125962154|NCT01831089|453153468|FG005|Cohort B: Arm B|Progressive disease|8|||
125962155|NCT01831089|453153463|FG000|Cohort B: Arm B|Physician Decision|0|||
125962156|NCT01831089|453153464|FG001|Cohort B: Arm B|Physician Decision|0|||
125962157|NCT01831089|453153465|FG002|Cohort B: Arm B|Physician Decision|0|||
125962158|NCT01831089|453153466|FG003|Cohort B: Arm B|Physician Decision|0|||
125962159|NCT01831089|453153467|FG004|Cohort B: Arm B|Physician Decision|0|||
125962160|NCT01831089|453153468|FG005|Cohort B: Arm B|Physician Decision|2|||
125962161|NCT01831089|453153463|FG000|Cohort B: Arm B|Never treated|0|||
125962162|NCT01831089|453153464|FG001|Cohort B: Arm B|Never treated|0|||
125962163|NCT01831089|453153465|FG002|Cohort B: Arm B|Never treated|0|||
125962164|NCT01831089|453153466|FG003|Cohort B: Arm B|Never treated|0|||
125962165|NCT01831089|453153467|FG004|Cohort B: Arm B|Never treated|0|||
125962166|NCT01831089|453153468|FG005|Cohort B: Arm B|Never treated|2|||
125962167|NCT01831089|453153463|FG000|Cohort B: Arm B|Adverse Event|0|||
125962168|NCT01831089|453153464|FG001|Cohort B: Arm B|Adverse Event|0|||
125962169|NCT01831089|453153465|FG002|Cohort B: Arm B|Adverse Event|0|||
125962170|NCT01831089|453153466|FG003|Cohort B: Arm B|Adverse Event|0|||
125962171|NCT01831089|453153467|FG004|Cohort B: Arm B|Adverse Event|0|||
125962172|NCT01831089|453153468|FG005|Cohort B: Arm B|Adverse Event|1|||
125962173|NCT01831089|453153463|FG000|Cohort B: Arm B|Global end of study|0|||
125962174|NCT01831089|453153464|FG001|Cohort B: Arm B|Global end of study|0|||
125962175|NCT01831089|453153465|FG002|Cohort B: Arm B|Global end of study|0|||
125962176|NCT01831089|453153466|FG003|Cohort B: Arm B|Global end of study|0|||
125962177|NCT01831089|453153467|FG004|Cohort B: Arm B|Global end of study|0|||
125962178|NCT01831089|453153468|FG005|Cohort B: Arm B|Global end of study|1|||
125962179|NCT00889421|453153469|FG000|Overall Study|Lack of Efficacy|3|||
125962180|NCT01958918|453153470|FG000|Overall Study|Death|1|||
125962181|NCT01958918|453153471|FG001|Overall Study|Death|3|||
125962182|NCT01958918|453153470|FG000|Overall Study|Lost to Follow-up|4|||
125962183|NCT01958918|453153471|FG001|Overall Study|Lost to Follow-up|7|||
125962184|NCT01958918|453153470|FG000|Overall Study|Withdrawal by Subject|13|||
125962185|NCT01958918|453153471|FG001|Overall Study|Withdrawal by Subject|8|||
125962186|NCT01958918|453153470|FG000|Overall Study|Lack of Efficacy|13|||
125962187|NCT01958918|453153471|FG001|Overall Study|Lack of Efficacy|10|||
125962188|NCT01958918|453153470|FG000|Overall Study|Adverse Event|12|||
125962189|NCT01958918|453153471|FG001|Overall Study|Adverse Event|12|||
125962190|NCT01958918|453153470|FG000|Overall Study|administrative problems|0|||
125962191|NCT01958918|453153471|FG001|Overall Study|administrative problems|2|||
125962192|NCT01925183|453153472|FG000|Overall Study|Adverse Event|1|||
125962193|NCT01925183|453153473|FG001|Overall Study|Adverse Event|0|||
125962194|NCT02114892|453153474|FG000|Overall Study|Lost to Follow-up|1|||
125962195|NCT02114892|453153475|FG001|Overall Study|Lost to Follow-up|2|||
125962196|NCT04327934|453153478|FG000|Overall Study|Did not qualify|7|||
125962197|NCT04327934|453153479|FG001|Overall Study|Did not qualify|4|||
125962198|NCT04327934|453153478|FG000|Overall Study|Physician Decision|0|||
125962199|NCT04327934|453153479|FG001|Overall Study|Physician Decision|1|||
125962200|NCT03783923|453153486|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
125962201|NCT03783923|453153487|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
125962202|NCT03783923|453153486|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
125962203|NCT03783923|453153487|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
125962204|NCT03783923|453153486|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
125962205|NCT03783923|453153487|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
125962206|NCT03783923|453153486|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
125962207|NCT03783923|453153487|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
125962208|NCT03783923|453153486|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
125962209|NCT03783923|453153487|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
125962210|NCT00298831|453153489|FG000|Overall Study|Adverse Event|1|||
125962211|NCT00298831|453153489|FG000|Overall Study|Lost to Follow-up|3|||
125962212|NCT00298831|453153489|FG000|Overall Study|Withdrawal by Subject|1|||
125962213|NCT00298831|453153489|FG000|Overall Study|Participants did not receive treatment|27|||
125962214|NCT04122443|453153490|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
125962215|NCT04122443|453153491|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
125962216|NCT04122443|453153492|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
125962217|NCT04122443|453153490|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
125962218|NCT04122443|453153491|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
125962219|NCT04122443|453153492|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
125962220|NCT01072201|453153493|FG000|Overall Study|Lost to Follow-up|0|||
125962221|NCT01072201|453153494|FG001|Overall Study|Lost to Follow-up|1|||
125962222|NCT02052466|453153495|FG000|Overall Study|Withdrawal by Subject|1|||
125962223|NCT02052466|453153495|FG000|Overall Study|Acromial fracture|1|||
125962224|NCT00595582|453153496|FG000|Overall Study|Pilot study that PI terminated|2|||
125962225|NCT00595582|453153496|FG000|Overall Study|Lost to Follow-up|1|||
125962226|NCT00595582|453153496|FG000|Overall Study|Adverse Event|2|||
125962227|NCT00595582|453153496|FG000|Overall Study|Physician Decision|5|||
125962228|NCT00965848|453153498|FG000|Overall Study|Protocol Violation|3|||
125962229|NCT00965848|453153499|FG001|Overall Study|Protocol Violation|0|||
125962230|NCT00965848|453153500|FG002|Overall Study|Protocol Violation|1|||
125962231|NCT00965848|453153498|FG000|Overall Study|Death|11|||
125962232|NCT00965848|453153499|FG001|Overall Study|Death|1|||
125962233|NCT00965848|453153500|FG002|Overall Study|Death|5|||
125962234|NCT00965848|453153498|FG000|Overall Study|Lost to Follow-up|0|||
125962235|NCT00965848|453153499|FG001|Overall Study|Lost to Follow-up|0|||
125962236|NCT00965848|453153500|FG002|Overall Study|Lost to Follow-up|1|||
125962237|NCT00965848|453153498|FG000|Overall Study|Withdrawal by Subject|1|||
125962238|NCT00965848|453153499|FG001|Overall Study|Withdrawal by Subject|0|||
125962239|NCT00965848|453153500|FG002|Overall Study|Withdrawal by Subject|0|||
125962240|NCT00965848|453153498|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
125962241|NCT00965848|453153499|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
125962242|NCT00965848|453153500|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
125962243|NCT00965848|453153498|FG000|Overall Study|Not Clinically Evaluable|7|||
125962244|NCT00965848|453153499|FG001|Overall Study|Not Clinically Evaluable|1|||
125962245|NCT00965848|453153500|FG002|Overall Study|Not Clinically Evaluable|1|||
125962246|NCT00965848|453153498|FG000|Overall Study|Other|5|||
125962247|NCT00965848|453153499|FG001|Overall Study|Other|0|||
125962248|NCT00965848|453153500|FG002|Overall Study|Other|1|||
125962249|NCT01306617|453153501|FG000|Overall Study|Adverse Event|1|||
125962250|NCT01306617|453153502|FG001|Overall Study|Adverse Event|0|||
125962251|NCT01306617|453153503|FG002|Overall Study|Adverse Event|0|||
125962252|NCT01306617|453153501|FG000|Overall Study|Virologic Failure|0|||
125962253|NCT01306617|453153502|FG001|Overall Study|Virologic Failure|0|||
125962254|NCT01306617|453153503|FG002|Overall Study|Virologic Failure|5|||
125962255|NCT01306617|453153501|FG000|Overall Study|Non-compliance|0|||
125962256|NCT01306617|453153502|FG001|Overall Study|Non-compliance|1|||
125962257|NCT01306617|453153503|FG002|Overall Study|Non-compliance|0|||
125962258|NCT04028388|453153512|FG000|Overall Study|Evaluations missing|3|||
125962259|NCT04028388|453153513|FG001|Overall Study|Evaluations missing|6|||
125962260|NCT04028388|453153512|FG000|Overall Study|Not started|2|||
125962261|NCT04028388|453153513|FG001|Overall Study|Not started|0|||
125962262|NCT00555438|453153514|FG000|10 Days Post-operative|Death|4|||
125962263|NCT00555438|453153514|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
125962264|NCT00061048|453153515|FG000|Overall Study|Adverse Event|2|||
125962265|NCT00061048|453153515|FG000|Overall Study|disease progression|20|||
125962266|NCT01114516|453153516|FG000|Overall Study|Lost to Follow-up|2|||
125962267|NCT01114516|453153517|FG001|Overall Study|Lost to Follow-up|1|||
125962268|NCT01431508|453153518|FG000|Overall Study|Lack of Efficacy|1|||
125962269|NCT01431508|453153518|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
125962270|NCT00129259|453153519|FG000|Overall Study|Lost to Follow-up|1|||
125962271|NCT00129259|453153520|FG001|Overall Study|Lost to Follow-up|1|||
126121594|NCT03370120|453738353|FG000|Overall Study|Early termination of studies|5|||
126121595|NCT03370120|453738353|FG000|Overall Study|This study is ended early|1|||
126121596|NCT03370120|453738353|FG000|Overall Study|End of padsevonil program|2|||
125962272|NCT00129259|453153519|FG000|Overall Study|Withdrawal by Subject|2|||
125962273|NCT00129259|453153520|FG001|Overall Study|Withdrawal by Subject|1|||
125962274|NCT00129259|453153519|FG000|Overall Study|Only available minimal phone assessments|0|||
125962275|NCT00129259|453153520|FG001|Overall Study|Only available minimal phone assessments|1|||
125962276|NCT01609556|453153525|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962277|NCT01609556|453153526|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962278|NCT01609556|453153527|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962279|NCT01609556|453153528|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962280|NCT01609556|453153529|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125962281|NCT01609556|453153530|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962282|NCT01609556|453153531|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962283|NCT01609556|453153532|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125962284|NCT01609556|453153533|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125962285|NCT01609556|453153534|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962286|NCT01609556|453153535|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125962287|NCT01609556|453153536|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125962288|NCT01609556|453153537|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962289|NCT01609556|453153538|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962290|NCT01609556|453153539|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962291|NCT01609556|453153540|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125962292|NCT01609556|453153525|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125962293|NCT01609556|453153526|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
125962294|NCT01609556|453153527|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
125962295|NCT01609556|453153528|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
125962296|NCT01609556|453153529|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
125962297|NCT01609556|453153530|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
125962298|NCT01609556|453153531|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
125962299|NCT01609556|453153532|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
125962300|NCT01609556|453153533|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
125962301|NCT01609556|453153534|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
125962302|NCT01609556|453153535|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
125962303|NCT01609556|453153536|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
125962304|NCT01609556|453153537|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125962305|NCT01609556|453153538|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125962306|NCT01609556|453153539|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125962307|NCT01609556|453153540|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125962308|NCT01609556|453153525|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962309|NCT01609556|453153526|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962310|NCT01609556|453153527|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962311|NCT01609556|453153528|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962312|NCT01609556|453153529|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962313|NCT01609556|453153530|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
125962314|NCT01609556|453153531|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
125962315|NCT01609556|453153532|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962316|NCT01609556|453153533|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962317|NCT01609556|453153534|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
125962318|NCT01609556|453153535|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
125962319|NCT01609556|453153536|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
125962320|NCT01609556|453153537|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962321|NCT01609556|453153538|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962322|NCT01609556|453153539|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962323|NCT01609556|453153540|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125962324|NCT01609556|453153525|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962325|NCT01609556|453153526|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962326|NCT01609556|453153527|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962327|NCT01609556|453153528|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962328|NCT01609556|453153529|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962329|NCT01609556|453153530|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
125962330|NCT01609556|453153531|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962331|NCT01609556|453153532|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962332|NCT01609556|453153533|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962333|NCT01609556|453153534|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962334|NCT01609556|453153535|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962335|NCT01609556|453153536|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
125962336|NCT01609556|453153537|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962337|NCT01609556|453153538|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962338|NCT01609556|453153539|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962339|NCT01609556|453153540|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125962340|NCT01609556|453153525|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962341|NCT01609556|453153526|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962342|NCT01609556|453153527|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962343|NCT01609556|453153528|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962344|NCT01609556|453153529|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962345|NCT01609556|453153530|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
125962346|NCT01609556|453153531|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962347|NCT01609556|453153532|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962348|NCT01609556|453153533|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962349|NCT01609556|453153534|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962350|NCT01609556|453153535|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126121597|NCT03370120|453738353|FG000|Overall Study|Decision of sponsor|6|||
126121598|NCT03370120|453738353|FG000|Overall Study|Asked by the sponsor|3|||
126121599|NCT03370120|453738353|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
126121600|NCT03370120|453738353|FG000|Overall Study|PI decision poor compliance from participant|1|||
126121601|NCT03370120|453738353|FG000|Overall Study|Promoter ended the study|3|||
126121602|NCT03370120|453738353|FG000|Overall Study|Premature study close by sponsor's decision|4|||
126121603|NCT03370120|453738353|FG000|Overall Study|Study terminated by sponsor|33|||
126121604|NCT03370120|453738353|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
126121605|NCT03370120|453738353|FG000|Overall Study|Sponsor decision to terminate study|63|||
125962351|NCT01609556|453153536|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962352|NCT01609556|453153537|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962353|NCT01609556|453153538|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962354|NCT01609556|453153539|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962355|NCT01609556|453153540|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125962356|NCT01609556|453153525|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962357|NCT01609556|453153526|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962358|NCT01609556|453153527|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962359|NCT01609556|453153528|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962360|NCT01609556|453153529|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962361|NCT01609556|453153530|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962362|NCT01609556|453153531|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962363|NCT01609556|453153532|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962364|NCT01609556|453153533|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
125962365|NCT01609556|453153534|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962366|NCT01609556|453153535|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962367|NCT01609556|453153536|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962368|NCT01609556|453153537|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962369|NCT01609556|453153538|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962370|NCT01609556|453153539|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962371|NCT01609556|453153540|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125962372|NCT01609556|453153525|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
125962373|NCT01609556|453153526|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962374|NCT01609556|453153527|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962375|NCT01609556|453153528|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962376|NCT01609556|453153529|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962377|NCT01609556|453153530|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
125962378|NCT01609556|453153531|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962379|NCT01609556|453153532|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962380|NCT01609556|453153533|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962381|NCT01609556|453153534|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962382|NCT01609556|453153535|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
125962383|NCT01609556|453153536|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962384|NCT01609556|453153537|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962385|NCT01609556|453153538|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962386|NCT01609556|453153539|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962387|NCT01609556|453153540|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125962388|NCT01609556|453153525|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962389|NCT01609556|453153526|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962390|NCT01609556|453153527|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962391|NCT01609556|453153528|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126121606|NCT03370120|453738353|FG000|Overall Study|Program closure|3|||
126121607|NCT03370120|453738353|FG000|Overall Study|Study ended prematurely|1|||
126121608|NCT03370120|453738353|FG000|Overall Study|Study stopped by sponsor|2|||
126121609|NCT03370120|453738353|FG000|Overall Study|Program termination|55|||
125962392|NCT01609556|453153529|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962393|NCT01609556|453153530|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962394|NCT01609556|453153531|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962395|NCT01609556|453153532|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126121610|NCT03370120|453738353|FG000|Overall Study|Sponsor decision|62|||
126121611|NCT03370120|453738353|FG000|Overall Study|Sponsor study closure|10|||
125962396|NCT01609556|453153533|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962397|NCT01609556|453153534|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962398|NCT01609556|453153535|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962399|NCT01609556|453153536|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125962400|NCT01609556|453153537|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
125962401|NCT01609556|453153538|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
125962402|NCT01609556|453153539|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
125962403|NCT01609556|453153540|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
125962404|NCT01609556|453153525|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962405|NCT01609556|453153526|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962406|NCT01609556|453153527|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962407|NCT01609556|453153528|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962408|NCT01609556|453153529|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962409|NCT01609556|453153530|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962410|NCT01609556|453153531|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962411|NCT01609556|453153532|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962412|NCT01609556|453153533|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962413|NCT01609556|453153534|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962414|NCT01609556|453153535|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962415|NCT01609556|453153536|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125962416|NCT01609556|453153537|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
125962417|NCT01609556|453153538|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
125962418|NCT01609556|453153539|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
125962419|NCT01609556|453153540|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
125962420|NCT01609556|453153525|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962421|NCT01609556|453153526|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962422|NCT01609556|453153527|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962423|NCT01609556|453153528|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962424|NCT01609556|453153529|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962425|NCT01609556|453153530|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962426|NCT01609556|453153531|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962427|NCT01609556|453153532|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962428|NCT01609556|453153533|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962429|NCT01609556|453153534|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962430|NCT01609556|453153535|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962431|NCT01609556|453153536|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125962432|NCT01609556|453153537|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
125962433|NCT01609556|453153538|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
125962434|NCT01609556|453153539|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
125962435|NCT01609556|453153540|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
125962436|NCT01609556|453153525|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962437|NCT01609556|453153526|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962438|NCT01609556|453153527|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962439|NCT01609556|453153528|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962440|NCT01609556|453153529|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962441|NCT01609556|453153530|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962442|NCT01609556|453153531|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962443|NCT01609556|453153532|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962444|NCT01609556|453153533|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962445|NCT01609556|453153534|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962446|NCT01609556|453153535|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962447|NCT01609556|453153536|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962448|NCT01609556|453153537|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
125962449|NCT01609556|453153538|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962450|NCT01609556|453153539|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962451|NCT01609556|453153540|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125962452|NCT01609556|453153525|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962453|NCT01609556|453153526|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962454|NCT01609556|453153527|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962455|NCT01609556|453153528|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962456|NCT01609556|453153529|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962457|NCT01609556|453153530|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126121612|NCT02700412|453738355|FG000|Overall Study|Adverse Event|6|||
126121613|NCT02700412|453738355|FG000|Overall Study|Death|1|||
126121614|NCT02700412|453738355|FG000|Overall Study|Lack of Efficacy|19|||
126121615|NCT02700412|453738355|FG000|Overall Study|Protocol Violation|5|||
125962458|NCT01609556|453153531|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962459|NCT01609556|453153532|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962460|NCT01609556|453153533|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962461|NCT01609556|453153534|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962462|NCT01609556|453153535|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962463|NCT01609556|453153536|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125962464|NCT01609556|453153537|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
125962465|NCT01609556|453153538|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
125962466|NCT01609556|453153539|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
126121616|NCT02700412|453738355|FG000|Overall Study|Withdrawal by Subject|2|||
126121617|NCT00632099|453738356|FG000|Overall Study|Lost to Follow-up|3|||
126121618|NCT00632099|453738357|FG001|Overall Study|Lost to Follow-up|3|||
126121619|NCT01543828|453738359|FG000|Treatment 2|Lost to Follow-up|1|||
126121620|NCT01543828|453738360|FG001|Treatment 2|Lost to Follow-up|0|||
126121621|NCT03975920|453738361|FG000|Overall Study|Lost to Follow-up|1|||
126121622|NCT03975920|453738362|FG001|Overall Study|Lost to Follow-up|2|||
126121623|NCT03975920|453738361|FG000|Overall Study|Protocol Violation|1|||
126121624|NCT03975920|453738362|FG001|Overall Study|Protocol Violation|1|||
126121625|NCT03975920|453738361|FG000|Overall Study|Did not complete survey|2|||
126121626|NCT03975920|453738362|FG001|Overall Study|Did not complete survey|1|||
126121627|NCT00884273|453738365|FG000|Overall Study|Adverse Event|0|||
126121628|NCT00884273|453738366|FG001|Overall Study|Adverse Event|2|||
126121629|NCT00884273|453738365|FG000|Overall Study|Protocol Violation|1|||
126121630|NCT00884273|453738366|FG001|Overall Study|Protocol Violation|3|||
126121631|NCT00884273|453738365|FG000|Overall Study|Practical reasons|1|||
126121632|NCT00884273|453738366|FG001|Overall Study|Practical reasons|0|||
126121633|NCT01147744|453738372|FG000|Overall Study|Protocol Violation|1|||
126121634|NCT01147744|453738373|FG001|Overall Study|Protocol Violation|0|||
126121635|NCT01147744|453738374|FG002|Overall Study|Protocol Violation|1|||
126121636|NCT01147744|453738375|FG003|Overall Study|Protocol Violation|0|||
126121637|NCT01147744|453738376|FG004|Overall Study|Protocol Violation|1|||
126121638|NCT01147744|453738377|FG005|Overall Study|Protocol Violation|3|||
126121639|NCT01147744|453738378|FG006|Overall Study|Protocol Violation|1|||
126121640|NCT01147744|453738372|FG000|Overall Study|Physician Decision|0|||
126121641|NCT01147744|453738373|FG001|Overall Study|Physician Decision|1|||
126121642|NCT01147744|453738374|FG002|Overall Study|Physician Decision|1|||
126121643|NCT01147744|453738375|FG003|Overall Study|Physician Decision|0|||
126121644|NCT01147744|453738376|FG004|Overall Study|Physician Decision|0|||
126121645|NCT01147744|453738377|FG005|Overall Study|Physician Decision|0|||
126121646|NCT01147744|453738378|FG006|Overall Study|Physician Decision|1|||
126121647|NCT01147744|453738372|FG000|Overall Study|Lack of Efficacy|11|||
126121648|NCT01147744|453738373|FG001|Overall Study|Lack of Efficacy|11|||
126121649|NCT01147744|453738374|FG002|Overall Study|Lack of Efficacy|9|||
126121650|NCT01147744|453738375|FG003|Overall Study|Lack of Efficacy|11|||
126121651|NCT01147744|453738376|FG004|Overall Study|Lack of Efficacy|13|||
126121652|NCT01147744|453738377|FG005|Overall Study|Lack of Efficacy|8|||
126121653|NCT01147744|453738378|FG006|Overall Study|Lack of Efficacy|7|||
126121654|NCT01147744|453738372|FG000|Overall Study|Adverse Event|1|||
126121655|NCT01147744|453738373|FG001|Overall Study|Adverse Event|2|||
126121656|NCT01147744|453738374|FG002|Overall Study|Adverse Event|3|||
126121657|NCT01147744|453738375|FG003|Overall Study|Adverse Event|0|||
126121658|NCT01147744|453738376|FG004|Overall Study|Adverse Event|2|||
126121659|NCT01147744|453738377|FG005|Overall Study|Adverse Event|1|||
126121660|NCT01147744|453738378|FG006|Overall Study|Adverse Event|2|||
126121661|NCT01147744|453738372|FG000|Overall Study|Withdrawal by Subject|8|||
126121662|NCT01147744|453738373|FG001|Overall Study|Withdrawal by Subject|4|||
126121663|NCT01147744|453738374|FG002|Overall Study|Withdrawal by Subject|2|||
126121664|NCT01147744|453738375|FG003|Overall Study|Withdrawal by Subject|2|||
126121665|NCT01147744|453738376|FG004|Overall Study|Withdrawal by Subject|2|||
126121666|NCT01147744|453738377|FG005|Overall Study|Withdrawal by Subject|5|||
126121667|NCT01147744|453738378|FG006|Overall Study|Withdrawal by Subject|2|||
126121668|NCT01147744|453738372|FG000|Overall Study|Lost to Follow-up|0|||
126121669|NCT01147744|453738373|FG001|Overall Study|Lost to Follow-up|1|||
126121670|NCT01147744|453738374|FG002|Overall Study|Lost to Follow-up|0|||
126121671|NCT01147744|453738375|FG003|Overall Study|Lost to Follow-up|0|||
126121672|NCT01147744|453738376|FG004|Overall Study|Lost to Follow-up|0|||
126121673|NCT01147744|453738377|FG005|Overall Study|Lost to Follow-up|0|||
126121674|NCT01147744|453738378|FG006|Overall Study|Lost to Follow-up|0|||
126121675|NCT01147744|453738372|FG000|Overall Study|Sponsor decision to amend protocol|7|||
126121676|NCT01147744|453738373|FG001|Overall Study|Sponsor decision to amend protocol|4|||
126121677|NCT01147744|453738374|FG002|Overall Study|Sponsor decision to amend protocol|2|||
126121678|NCT01147744|453738375|FG003|Overall Study|Sponsor decision to amend protocol|5|||
126121679|NCT01147744|453738376|FG004|Overall Study|Sponsor decision to amend protocol|7|||
126121680|NCT01147744|453738377|FG005|Overall Study|Sponsor decision to amend protocol|2|||
126121681|NCT01147744|453738378|FG006|Overall Study|Sponsor decision to amend protocol|6|||
126121682|NCT01147744|453738372|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126121683|NCT01147744|453738373|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126121684|NCT01147744|453738374|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126121685|NCT01147744|453738375|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126121686|NCT01147744|453738376|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126121687|NCT01147744|453738377|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126121688|NCT01147744|453738378|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126121689|NCT02536313|453738379|FG000|Overall Study|Lack of Efficacy|0|||
126121690|NCT02536313|453738380|FG001|Overall Study|Lack of Efficacy|1|||
126121691|NCT02437864|453738390|FG000|Overall Study|Protocol Violation|4|||
126121692|NCT02437864|453738391|FG001|Overall Study|Protocol Violation|0|||
126121693|NCT00807742|453738393|FG000|Overall Study|Death|9|||
126121694|NCT00807742|453738394|FG001|Overall Study|Death|2|||
126121695|NCT00807742|453738393|FG000|Overall Study|Withdrawal by Subject|2|||
126121696|NCT00807742|453738394|FG001|Overall Study|Withdrawal by Subject|1|||
126121697|NCT00807742|453738393|FG000|Overall Study|Lost to Follow-up|35|||
126121698|NCT00807742|453738394|FG001|Overall Study|Lost to Follow-up|51|||
126121699|NCT00492752|453738395|FG000|Double Blind Treatment|Death|13|||
126121700|NCT00492752|453738396|FG001|Double Blind Treatment|Death|0|||
126121701|NCT00492752|453738397|FG002|Double Blind Treatment|Death|2|||
126121702|NCT00492752|453738398|FG003|Double Blind Treatment|Death|0|||
126121703|NCT00492752|453738395|FG000|Double Blind Treatment|Adverse Event|1|||
126121704|NCT00492752|453738396|FG001|Double Blind Treatment|Adverse Event|0|||
126121705|NCT00492752|453738397|FG002|Double Blind Treatment|Adverse Event|0|||
126121706|NCT00492752|453738398|FG003|Double Blind Treatment|Adverse Event|0|||
126121707|NCT00492752|453738395|FG000|Double Blind Treatment|Protocol Violation|0|||
126121708|NCT00492752|453738396|FG001|Double Blind Treatment|Protocol Violation|0|||
126121709|NCT00492752|453738397|FG002|Double Blind Treatment|Protocol Violation|1|||
126121710|NCT00492752|453738398|FG003|Double Blind Treatment|Protocol Violation|0|||
126121711|NCT00492752|453738395|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
126121712|NCT00492752|453738396|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
126121713|NCT00492752|453738397|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
126121714|NCT00492752|453738398|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
126121715|NCT00492752|453738395|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
126121716|NCT00492752|453738396|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
126121717|NCT00492752|453738397|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
126121718|NCT00492752|453738398|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
126121719|NCT00492752|453738395|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
126121720|NCT00492752|453738396|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
126121721|NCT00492752|453738397|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
126121722|NCT00492752|453738398|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
126121723|NCT00492752|453738395|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
126121724|NCT00492752|453738396|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
126121725|NCT00492752|453738397|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
126121726|NCT00492752|453738398|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
126121727|NCT00492752|453738395|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
126121728|NCT00492752|453738396|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
126121729|NCT00492752|453738397|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
126121730|NCT00492752|453738398|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
126121731|NCT00492752|453738395|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
126121732|NCT00492752|453738396|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
126121733|NCT00492752|453738397|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
126121734|NCT00492752|453738398|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
126121735|NCT00492752|453738395|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
126121736|NCT00492752|453738396|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
126121737|NCT00492752|453738397|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
126121738|NCT00492752|453738398|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
126121739|NCT00492752|453738395|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
126121740|NCT00492752|453738396|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
126121741|NCT00492752|453738397|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
126121742|NCT00492752|453738398|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
126121743|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
126121744|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
126121745|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
126121746|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
126151410|NCT00488631|453841977|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
125962467|NCT01609556|453153540|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
125962468|NCT01609556|453153525|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126087695|NCT00603525|453614798|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
126087696|NCT00603525|453614799|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
126087697|NCT00603525|453614800|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
126087698|NCT00603525|453614798|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
126087699|NCT00603525|453614799|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
126087700|NCT00603525|453614800|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
126087701|NCT00603525|453614798|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
126087702|NCT00603525|453614799|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
126087703|NCT00603525|453614800|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
126087704|NCT00603525|453614798|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
126087705|NCT00603525|453614799|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
126087706|NCT00603525|453614800|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
126087707|NCT00603525|453614798|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
126087708|NCT00603525|453614799|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
126087709|NCT00603525|453614800|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
126087710|NCT02304705|453614801|FG000|Overall Study|Withdrawal by Subject|2|||
126087711|NCT02304705|453614802|FG001|Overall Study|Withdrawal by Subject|0|||
126087712|NCT02304705|453614801|FG000|Overall Study|Physician Decision|2|||
126087713|NCT02304705|453614802|FG001|Overall Study|Physician Decision|4|||
126087714|NCT02304705|453614801|FG000|Overall Study|Death|0|||
126087715|NCT02304705|453614802|FG001|Overall Study|Death|1|||
126087716|NCT02304705|453614801|FG000|Overall Study|Lost to Follow-up|0|||
126087717|NCT02304705|453614802|FG001|Overall Study|Lost to Follow-up|2|||
126087718|NCT02124811|453614803|FG000|Overall Study|Early termination|2|||
126087719|NCT02124811|453614804|FG001|Overall Study|Early termination|2|||
126087720|NCT02124811|453614803|FG000|Overall Study|Withdrawal by Subject|1|||
126087721|NCT02124811|453614804|FG001|Overall Study|Withdrawal by Subject|0|||
126087722|NCT03480932|453614805|FG000|Overall Study|Death|1|||
126087723|NCT03480932|453614806|FG001|Overall Study|Death|1|||
126087724|NCT03480932|453614807|FG002|Overall Study|Death|0|||
126087725|NCT03480932|453614805|FG000|Overall Study|Lost to Follow-up|0|||
126087726|NCT03480932|453614806|FG001|Overall Study|Lost to Follow-up|2|||
126087727|NCT03480932|453614807|FG002|Overall Study|Lost to Follow-up|3|||
126087728|NCT03480932|453614805|FG000|Overall Study|Incarcerated|2|||
126087729|NCT03480932|453614806|FG001|Overall Study|Incarcerated|2|||
126087730|NCT03480932|453614807|FG002|Overall Study|Incarcerated|2|||
126087731|NCT01174446|453614814|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
126087732|NCT01174446|453614815|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
126087733|NCT01174446|453614816|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
126087734|NCT01174446|453614817|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
126087735|NCT01174446|453614814|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
126087736|NCT01174446|453614815|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
126087737|NCT01174446|453614816|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
126087738|NCT01174446|453614817|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
126087739|NCT01174446|453614814|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
126087740|NCT01174446|453614815|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
126087741|NCT01174446|453614816|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
126087742|NCT01174446|453614817|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
126087743|NCT01174446|453614814|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
126087744|NCT01174446|453614815|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
126087745|NCT01174446|453614816|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
126087746|NCT01174446|453614817|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
126087747|NCT00847626|453614820|FG000|Overall Study|Adverse Event|10|||
126087748|NCT00847626|453614821|FG001|Overall Study|Adverse Event|10|||
126087749|NCT00847626|453614822|FG002|Overall Study|Adverse Event|6|||
126087750|NCT00847626|453614823|FG003|Overall Study|Adverse Event|19|||
126087751|NCT00847626|453614824|FG004|Overall Study|Adverse Event|11|||
126087752|NCT00847626|453614825|FG005|Overall Study|Adverse Event|22|||
126087753|NCT00847626|453614826|FG006|Overall Study|Adverse Event|4|||
126087754|NCT00847626|453614827|FG007|Overall Study|Adverse Event|6|||
126087755|NCT00847626|453614828|FG008|Overall Study|Adverse Event|3|||
126087756|NCT00847626|453614829|FG009|Overall Study|Adverse Event|6|||
126087757|NCT00847626|453614830|FG010|Overall Study|Adverse Event|6|||
126087758|NCT00847626|453614820|FG000|Overall Study|Protocol Violation|2|||
126087759|NCT00847626|453614821|FG001|Overall Study|Protocol Violation|1|||
126087760|NCT00847626|453614822|FG002|Overall Study|Protocol Violation|2|||
126087761|NCT00847626|453614823|FG003|Overall Study|Protocol Violation|1|||
126087762|NCT00847626|453614824|FG004|Overall Study|Protocol Violation|1|||
126087763|NCT00847626|453614825|FG005|Overall Study|Protocol Violation|1|||
126087764|NCT00847626|453614826|FG006|Overall Study|Protocol Violation|1|||
126087765|NCT00847626|453614827|FG007|Overall Study|Protocol Violation|1|||
126087766|NCT00847626|453614828|FG008|Overall Study|Protocol Violation|0|||
126121747|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
126121748|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
126121749|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
126121750|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
126121751|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to death|4|||
126121752|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to death|3|||
126121753|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
126121754|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
126121755|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
126121756|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
126121757|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
126121758|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
126121759|NCT02258451|453738399|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
126121760|NCT02258451|453738400|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
126121761|NCT02258451|453738399|FG000|Overall Study|Other reason|1|||
126121762|NCT02258451|453738400|FG001|Overall Study|Other reason|1|||
126121763|NCT02258451|453738399|FG000|Overall Study|Never treated|2|||
126121764|NCT02258451|453738400|FG001|Overall Study|Never treated|3|||
126121765|NCT05419128|453738401|FG000|Overall Study|Withdrawal by Subject|1|||
126121766|NCT05419128|453738402|FG001|Overall Study|Withdrawal by Subject|1|||
126121767|NCT05419128|453738403|FG002|Overall Study|Withdrawal by Subject|0|||
126121768|NCT05419128|453738404|FG003|Overall Study|Withdrawal by Subject|1|||
126121769|NCT05419128|453738405|FG004|Overall Study|Withdrawal by Subject|1|||
126121770|NCT05419128|453738406|FG005|Overall Study|Withdrawal by Subject|0|||
126121771|NCT05419128|453738401|FG000|Overall Study|Lost to Follow-up|0|||
126121772|NCT05419128|453738402|FG001|Overall Study|Lost to Follow-up|0|||
126121773|NCT05419128|453738403|FG002|Overall Study|Lost to Follow-up|1|||
126121774|NCT05419128|453738404|FG003|Overall Study|Lost to Follow-up|0|||
126121775|NCT05419128|453738405|FG004|Overall Study|Lost to Follow-up|0|||
126121776|NCT05419128|453738406|FG005|Overall Study|Lost to Follow-up|1|||
126121777|NCT03834519|453738407|FG000|Overall Study|Lost to Follow-up|2|||
126121778|NCT03834519|453738408|FG001|Overall Study|Lost to Follow-up|1|||
126121779|NCT03834519|453738407|FG000|Overall Study|Withdrawal by Subject|5|||
126121780|NCT03834519|453738408|FG001|Overall Study|Withdrawal by Subject|8|||
126121781|NCT03834519|453738407|FG000|Overall Study|Death|368|||
126121782|NCT03834519|453738408|FG001|Overall Study|Death|174|||
126121783|NCT03834519|453738407|FG000|Overall Study|Physician Decision|5|||
126121784|NCT03834519|453738408|FG001|Overall Study|Physician Decision|1|||
126121785|NCT03834519|453738407|FG000|Overall Study|Sponsor decision|149|||
126121786|NCT03834519|453738408|FG001|Overall Study|Sponsor decision|80|||
126121787|NCT04066491|453738409|FG000|Overall Study|Randomized, not treated|0|||
126121788|NCT04066491|453738410|FG001|Overall Study|Randomized, not treated|0|||
126121789|NCT04066491|453738411|FG002|Overall Study|Randomized, not treated|2|||
126121790|NCT04506086|453738412|FG000|Overall Study|Withdrawal by Subject|2|||
126121791|NCT00517751|453738413|FG000|Overall Study|Death|3|||
126121792|NCT00517751|453738413|FG000|Overall Study|Withdrawal by Subject|37|||
126121793|NCT00517751|453738413|FG000|Overall Study|Lost to Follow-up|4|||
126121794|NCT00517751|453738413|FG000|Overall Study|patient not over due|6|||
126121795|NCT00517751|453738413|FG000|Overall Study|Patient not due for visit|76|||
126121796|NCT00517751|453738413|FG000|Overall Study|Missing|3|||
126121797|NCT01484977|453738418|FG000|Overall Study|Adverse Event|8|||
126121798|NCT01484977|453738418|FG000|Overall Study|Lack of Efficacy|4|||
126121799|NCT01484977|453738418|FG000|Overall Study|Protocol Violation|6|||
126121800|NCT01484977|453738418|FG000|Overall Study|Lost to Follow-up|1|||
126121801|NCT01484977|453738418|FG000|Overall Study|Withdrawal by Subject|4|||
126121802|NCT01484977|453738418|FG000|Overall Study|Subject Protocol Non-compliant|1|||
126121803|NCT01484977|453738418|FG000|Overall Study|Moving Overseas|1|||
126121804|NCT01484977|453738418|FG000|Overall Study|Low White Blood Cell Count|1|||
126121805|NCT01484977|453738418|FG000|Overall Study|Lack of Compliance|1|||
126121806|NCT00495820|453738419|FG000|Overall Study|Adverse Event|1|||
126121807|NCT00495820|453738420|FG001|Overall Study|Adverse Event|1|||
126121808|NCT04857996|453738421|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
126121809|NCT04857996|453738422|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
126121810|NCT04857996|453738421|FG000|Overall Study|Lost to Follow-up|1|||
126121811|NCT04857996|453738422|FG001|Overall Study|Lost to Follow-up|3|||
126121812|NCT04857996|453738421|FG000|Overall Study|Site Closure|1|||
126121813|NCT04857996|453738422|FG001|Overall Study|Site Closure|0|||
126121814|NCT04857996|453738421|FG000|Overall Study|Withdrawal by Subject|1|||
126121815|NCT04857996|453738422|FG001|Overall Study|Withdrawal by Subject|0|||
126121816|NCT00820950|453738423|FG000|Overall Study|Scheduling Conflict|0|||
126121817|NCT00820950|453738424|FG001|Overall Study|Scheduling Conflict|0|||
126121818|NCT00820950|453738425|FG002|Overall Study|Scheduling Conflict|0|||
126121819|NCT00820950|453738426|FG003|Overall Study|Scheduling Conflict|0|||
126121820|NCT00820950|453738427|FG004|Overall Study|Scheduling Conflict|0|||
126121821|NCT00820950|453738428|FG005|Overall Study|Scheduling Conflict|0|||
126121822|NCT00820950|453738429|FG006|Overall Study|Scheduling Conflict|1|||
126121823|NCT00820950|453738430|FG007|Overall Study|Scheduling Conflict|1|||
126121824|NCT00820950|453738431|FG008|Overall Study|Scheduling Conflict|0|||
126121825|NCT00820950|453738432|FG009|Overall Study|Scheduling Conflict|0|||
126121826|NCT00820950|453738423|FG000|Overall Study|Protocol Violation|1|||
126121827|NCT00820950|453738424|FG001|Overall Study|Protocol Violation|1|||
126121828|NCT00820950|453738425|FG002|Overall Study|Protocol Violation|0|||
126121829|NCT00820950|453738426|FG003|Overall Study|Protocol Violation|0|||
126121830|NCT00820950|453738427|FG004|Overall Study|Protocol Violation|0|||
126121831|NCT00820950|453738428|FG005|Overall Study|Protocol Violation|0|||
126121832|NCT00820950|453738429|FG006|Overall Study|Protocol Violation|0|||
126121833|NCT00820950|453738430|FG007|Overall Study|Protocol Violation|0|||
126121834|NCT00820950|453738431|FG008|Overall Study|Protocol Violation|0|||
126121835|NCT00820950|453738432|FG009|Overall Study|Protocol Violation|0|||
126121836|NCT00798135|453738433|FG000|Overall Study|Disease progression, relapse|11|||
126121837|NCT00798135|453738433|FG000|Overall Study|Disease progression, refractory|1|||
126121838|NCT00798135|453738433|FG000|Overall Study|Physician Decision|1|||
126121839|NCT01423851|453738437|FG000|Whole Study|Disease progression|2|||
126121840|NCT01423851|453738438|FG001|Whole Study|Disease progression|1|||
126121841|NCT01423851|453738439|FG002|Whole Study|Disease progression|1|||
126121842|NCT01423851|453738440|FG003|Whole Study|Disease progression|4|||
126121843|NCT01423851|453738441|FG004|Whole Study|Disease progression|1|||
126121844|NCT01423851|453738442|FG005|Whole Study|Disease progression|3|||
126121845|NCT01423851|453738443|FG006|Whole Study|Disease progression|1|||
126121846|NCT01423851|453738444|FG007|Whole Study|Disease progression|4|||
126121847|NCT01423851|453738445|FG008|Whole Study|Disease progression|0|||
126121848|NCT01423851|453738446|FG009|Whole Study|Disease progression|2|||
126121849|NCT01423851|453738447|FG010|Whole Study|Disease progression|10|||
126121850|NCT01423851|453738437|FG000|Whole Study|Physician Decision|0|||
126121851|NCT01423851|453738438|FG001|Whole Study|Physician Decision|1|||
126121852|NCT01423851|453738439|FG002|Whole Study|Physician Decision|2|||
126121853|NCT01423851|453738440|FG003|Whole Study|Physician Decision|0|||
126121854|NCT01423851|453738441|FG004|Whole Study|Physician Decision|2|||
126121855|NCT01423851|453738442|FG005|Whole Study|Physician Decision|0|||
126121856|NCT01423851|453738443|FG006|Whole Study|Physician Decision|2|||
126121857|NCT01423851|453738444|FG007|Whole Study|Physician Decision|1|||
126121858|NCT01423851|453738445|FG008|Whole Study|Physician Decision|3|||
126121859|NCT01423851|453738446|FG009|Whole Study|Physician Decision|4|||
126121860|NCT01423851|453738447|FG010|Whole Study|Physician Decision|12|||
126121861|NCT01423851|453738437|FG000|Whole Study|Withdrawal by Subject|1|||
126121862|NCT01423851|453738438|FG001|Whole Study|Withdrawal by Subject|1|||
126121863|NCT01423851|453738439|FG002|Whole Study|Withdrawal by Subject|0|||
126121864|NCT01423851|453738440|FG003|Whole Study|Withdrawal by Subject|0|||
126121865|NCT01423851|453738441|FG004|Whole Study|Withdrawal by Subject|0|||
126121866|NCT01423851|453738442|FG005|Whole Study|Withdrawal by Subject|0|||
126121867|NCT01423851|453738443|FG006|Whole Study|Withdrawal by Subject|0|||
126121868|NCT01423851|453738444|FG007|Whole Study|Withdrawal by Subject|0|||
126121869|NCT01423851|453738445|FG008|Whole Study|Withdrawal by Subject|2|||
126121870|NCT01423851|453738446|FG009|Whole Study|Withdrawal by Subject|0|||
126121871|NCT01423851|453738447|FG010|Whole Study|Withdrawal by Subject|4|||
126121872|NCT01423851|453738437|FG000|Whole Study|Adverse Event|0|||
126121873|NCT01423851|453738438|FG001|Whole Study|Adverse Event|0|||
126121874|NCT01423851|453738439|FG002|Whole Study|Adverse Event|0|||
126121875|NCT01423851|453738440|FG003|Whole Study|Adverse Event|2|||
126121876|NCT01423851|453738441|FG004|Whole Study|Adverse Event|0|||
126121877|NCT01423851|453738442|FG005|Whole Study|Adverse Event|0|||
126121878|NCT01423851|453738443|FG006|Whole Study|Adverse Event|0|||
126121879|NCT01423851|453738444|FG007|Whole Study|Adverse Event|3|||
126121880|NCT01423851|453738445|FG008|Whole Study|Adverse Event|3|||
126121881|NCT01423851|453738446|FG009|Whole Study|Adverse Event|2|||
126121882|NCT01423851|453738447|FG010|Whole Study|Adverse Event|3|||
126121883|NCT00346073|453740133|FG000|Overall Study|Serious Adverse Event|2|||
126121884|NCT00346073|453740134|FG001|Overall Study|Serious Adverse Event|0|||
126121885|NCT00346073|453740133|FG000|Overall Study|Lost to Follow-up|39|||
126121886|NCT00346073|453740134|FG001|Overall Study|Lost to Follow-up|24|||
126121887|NCT01617460|453740135|FG000|Overall Study|Adverse Event|10|||
126121888|NCT01617460|453740135|FG000|Overall Study|Physician Decision|16|||
126121889|NCT01617460|453740135|FG000|Overall Study|Protocol Violation|5|||
126121890|NCT01617460|453740135|FG000|Overall Study|Withdrawal by Subject|9|||
126121891|NCT03703882|453740136|FG000|Overall Study|Adverse Event|1|||
126121892|NCT03703882|453740137|FG001|Overall Study|Adverse Event|0|||
126121893|NCT03703882|453740136|FG000|Overall Study|Lost to Follow-up|0|||
126121894|NCT03703882|453740137|FG001|Overall Study|Lost to Follow-up|2|||
126121895|NCT03703882|453740136|FG000|Overall Study|Non-compliance with study drug|0|||
126121896|NCT03703882|453740137|FG001|Overall Study|Non-compliance with study drug|1|||
126121897|NCT03703882|453740136|FG000|Overall Study|Physician Decision|0|||
126121898|NCT03703882|453740137|FG001|Overall Study|Physician Decision|1|||
126121899|NCT03703882|453740136|FG000|Overall Study|Progressive disease|1|||
126121900|NCT03703882|453740137|FG001|Overall Study|Progressive disease|0|||
126121901|NCT03703882|453740136|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126121902|NCT03703882|453740137|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126121903|NCT03703882|453740136|FG000|Overall Study|Starting another treatment|0|||
125962469|NCT01609556|453153526|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962470|NCT01609556|453153527|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126087767|NCT00847626|453614829|FG009|Overall Study|Protocol Violation|1|||
126087768|NCT00847626|453614830|FG010|Overall Study|Protocol Violation|1|||
126087769|NCT00847626|453614820|FG000|Overall Study|Lost to Follow-up|0|||
126087770|NCT00847626|453614821|FG001|Overall Study|Lost to Follow-up|1|||
126087771|NCT00847626|453614822|FG002|Overall Study|Lost to Follow-up|1|||
126087772|NCT00847626|453614823|FG003|Overall Study|Lost to Follow-up|1|||
126087773|NCT00847626|453614824|FG004|Overall Study|Lost to Follow-up|0|||
126087774|NCT00847626|453614825|FG005|Overall Study|Lost to Follow-up|3|||
126087775|NCT00847626|453614826|FG006|Overall Study|Lost to Follow-up|1|||
126087776|NCT00847626|453614827|FG007|Overall Study|Lost to Follow-up|3|||
126087777|NCT00847626|453614828|FG008|Overall Study|Lost to Follow-up|1|||
126087778|NCT00847626|453614829|FG009|Overall Study|Lost to Follow-up|0|||
126087779|NCT00847626|453614830|FG010|Overall Study|Lost to Follow-up|1|||
126087780|NCT00847626|453614820|FG000|Overall Study|Withdrawal by Subject|5|||
126087781|NCT00847626|453614821|FG001|Overall Study|Withdrawal by Subject|5|||
126087782|NCT00847626|453614822|FG002|Overall Study|Withdrawal by Subject|3|||
126087783|NCT00847626|453614823|FG003|Overall Study|Withdrawal by Subject|8|||
126087784|NCT00847626|453614824|FG004|Overall Study|Withdrawal by Subject|12|||
126087785|NCT00847626|453614825|FG005|Overall Study|Withdrawal by Subject|9|||
126087786|NCT00847626|453614826|FG006|Overall Study|Withdrawal by Subject|8|||
126087787|NCT00847626|453614827|FG007|Overall Study|Withdrawal by Subject|4|||
126087788|NCT00847626|453614828|FG008|Overall Study|Withdrawal by Subject|4|||
126087789|NCT00847626|453614829|FG009|Overall Study|Withdrawal by Subject|5|||
126087790|NCT00847626|453614830|FG010|Overall Study|Withdrawal by Subject|2|||
126087791|NCT00847626|453614820|FG000|Overall Study|Lack of Efficacy|3|||
126087792|NCT00847626|453614821|FG001|Overall Study|Lack of Efficacy|1|||
126087793|NCT00847626|453614822|FG002|Overall Study|Lack of Efficacy|0|||
126087794|NCT00847626|453614823|FG003|Overall Study|Lack of Efficacy|1|||
126087795|NCT00847626|453614824|FG004|Overall Study|Lack of Efficacy|2|||
126087796|NCT00847626|453614825|FG005|Overall Study|Lack of Efficacy|0|||
126087797|NCT00847626|453614826|FG006|Overall Study|Lack of Efficacy|6|||
126087798|NCT00847626|453614827|FG007|Overall Study|Lack of Efficacy|2|||
126087799|NCT00847626|453614828|FG008|Overall Study|Lack of Efficacy|5|||
126087800|NCT00847626|453614829|FG009|Overall Study|Lack of Efficacy|1|||
126087801|NCT00847626|453614830|FG010|Overall Study|Lack of Efficacy|7|||
126087802|NCT00847626|453614820|FG000|Overall Study|Other|1|||
126087803|NCT00847626|453614821|FG001|Overall Study|Other|5|||
126087804|NCT00847626|453614822|FG002|Overall Study|Other|4|||
126087805|NCT00847626|453614823|FG003|Overall Study|Other|1|||
126087806|NCT00847626|453614824|FG004|Overall Study|Other|2|||
126087807|NCT00847626|453614825|FG005|Overall Study|Other|2|||
126087808|NCT00847626|453614826|FG006|Overall Study|Other|2|||
126087809|NCT00847626|453614827|FG007|Overall Study|Other|3|||
126087810|NCT00847626|453614828|FG008|Overall Study|Other|1|||
126087811|NCT00847626|453614829|FG009|Overall Study|Other|1|||
126087812|NCT00847626|453614830|FG010|Overall Study|Other|3|||
126087813|NCT03057847|453614831|FG000|Overall Study|Lost to Follow-up|16|||
126087814|NCT02138786|453614832|FG000|Overall Study|Adverse Event|0|||
126087815|NCT02138786|453614833|FG001|Overall Study|Adverse Event|2|||
126087816|NCT02138786|453614834|FG002|Overall Study|Adverse Event|1|||
126087817|NCT02138786|453614832|FG000|Overall Study|Death|1|||
126087818|NCT02138786|453614833|FG001|Overall Study|Death|7|||
126087819|NCT02138786|453614834|FG002|Overall Study|Death|2|||
126087820|NCT02138786|453614832|FG000|Overall Study|Disease Progression|1|||
126087821|NCT02138786|453614833|FG001|Overall Study|Disease Progression|1|||
126087822|NCT02138786|453614834|FG002|Overall Study|Disease Progression|3|||
126087823|NCT02138786|453614832|FG000|Overall Study|Withdrawal by Subject|1|||
126087824|NCT02138786|453614833|FG001|Overall Study|Withdrawal by Subject|2|||
126087825|NCT02138786|453614834|FG002|Overall Study|Withdrawal by Subject|0|||
126087826|NCT02138786|453614832|FG000|Overall Study|Patient's Wish|0|||
126087827|NCT02138786|453614833|FG001|Overall Study|Patient's Wish|2|||
126087828|NCT02138786|453614834|FG002|Overall Study|Patient's Wish|0|||
126087829|NCT02138786|453614832|FG000|Overall Study|Sponsor Terminated Study|0|||
126087830|NCT02138786|453614833|FG001|Overall Study|Sponsor Terminated Study|1|||
126087831|NCT02138786|453614834|FG002|Overall Study|Sponsor Terminated Study|1|||
126087832|NCT02138786|453614832|FG000|Overall Study|Non-Compliance|0|||
126087833|NCT02138786|453614833|FG001|Overall Study|Non-Compliance|0|||
126087834|NCT02138786|453614834|FG002|Overall Study|Non-Compliance|1|||
126087835|NCT01923662|453614835|FG000|Overall Study|Withdrawal by Subject|1|||
126087836|NCT00659880|453614838|FG000|Overall Study|Lost to Follow-up|5|||
126121904|NCT03703882|453740137|FG001|Overall Study|Starting another treatment|1|||
126121905|NCT03703882|453740136|FG000|Overall Study|noncompliance with study procedures|0|||
126121906|NCT03703882|453740137|FG001|Overall Study|noncompliance with study procedures|1|||
126121907|NCT00075023|453740143|FG000|Pilot Study|Physician Decision|1|||
126121908|NCT00075023|453740144|FG001|Pilot Study|Physician Decision|2|||
126121909|NCT00075023|453740143|FG000|Pilot Study|Withdrawal by Subject|1|||
126121910|NCT00075023|453740144|FG001|Pilot Study|Withdrawal by Subject|0|||
126121911|NCT03670953|453740145|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
126121912|NCT03670953|453740146|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
126121913|NCT03670953|453740147|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
126121914|NCT03670953|453740148|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
126121915|NCT03670953|453740145|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
126121916|NCT03670953|453740146|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
126121917|NCT03670953|453740147|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
126121918|NCT03670953|453740148|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
126121919|NCT03670953|453740145|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
126121920|NCT03670953|453740146|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
126121921|NCT03670953|453740147|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
126121922|NCT03670953|453740148|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
126121923|NCT03670953|453740145|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
126121924|NCT03670953|453740146|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
126121925|NCT03670953|453740147|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
126121926|NCT03670953|453740148|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
126121927|NCT03670953|453740145|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
126121928|NCT03670953|453740146|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
126121929|NCT03670953|453740147|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
126121930|NCT03670953|453740148|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
126121931|NCT03670953|453740145|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
126121932|NCT03670953|453740146|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
126121933|NCT03670953|453740147|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
126121934|NCT03670953|453740148|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
126121935|NCT03670953|453740145|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
126121936|NCT03670953|453740146|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
126121937|NCT03670953|453740147|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
126121938|NCT03670953|453740148|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
126121939|NCT03670953|453740145|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
126121940|NCT03670953|453740146|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
126121941|NCT03670953|453740147|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
126121942|NCT03670953|453740148|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
126121943|NCT03670953|453740145|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
126121944|NCT03670953|453740146|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
126121945|NCT03670953|453740147|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
126121946|NCT03670953|453740148|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
126121947|NCT03670953|453740145|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
126121948|NCT03670953|453740146|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
126121949|NCT03670953|453740147|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
126121950|NCT03670953|453740148|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
126121951|NCT03670953|453740145|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
126121952|NCT03670953|453740146|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
126121953|NCT03670953|453740147|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
126121954|NCT03670953|453740148|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
126121955|NCT03670953|453740145|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
126121956|NCT03670953|453740146|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
126121957|NCT03670953|453740147|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
126121958|NCT03670953|453740148|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
126121959|NCT03670953|453740145|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
126121960|NCT03670953|453740146|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
126121961|NCT03670953|453740147|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
126121962|NCT03670953|453740148|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
126121963|NCT03670953|453740145|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
126121964|NCT03670953|453740146|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
126121965|NCT03670953|453740147|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
126121966|NCT03670953|453740148|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
126121967|NCT03670953|453740145|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
126121968|NCT03670953|453740146|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
126121969|NCT03670953|453740147|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
126121970|NCT03670953|453740148|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
126121971|NCT03670953|453740145|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
126121972|NCT03670953|453740146|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
126121973|NCT03670953|453740147|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
126121974|NCT03670953|453740148|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
126121975|NCT03670953|453740145|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
126121976|NCT03670953|453740146|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
126121977|NCT03670953|453740147|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
126121978|NCT03670953|453740148|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
126121979|NCT03670953|453740145|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
126121980|NCT03670953|453740146|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
126121981|NCT03670953|453740147|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
126121982|NCT03670953|453740148|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
126121983|NCT04342871|453740149|FG000|Overall Study|Death|4|||
126121984|NCT04342871|453740149|FG000|Overall Study|Clinical deterioration/illness progression|2|||
126121985|NCT04342871|453740149|FG000|Overall Study|Did not complete baseline assessments|5|||
126121986|NCT04342871|453740149|FG000|Overall Study|Lost to Follow-up|13|||
126121987|NCT02982954|453740150|FG000|Overall Study|Death|55|||
126121988|NCT02982954|453740151|FG001|Overall Study|Death|29|||
126121989|NCT02982954|453740152|FG002|Overall Study|Death|15|||
126121990|NCT02982954|453740153|FG003|Overall Study|Death|20|||
126121991|NCT02982954|453740150|FG000|Overall Study|Lost to Follow-up|2|||
126121992|NCT02982954|453740151|FG001|Overall Study|Lost to Follow-up|1|||
126121993|NCT02982954|453740152|FG002|Overall Study|Lost to Follow-up|0|||
126121994|NCT02982954|453740153|FG003|Overall Study|Lost to Follow-up|0|||
126121995|NCT02982954|453740150|FG000|Overall Study|Participant withdrew consent|7|||
126121996|NCT02982954|453740151|FG001|Overall Study|Participant withdrew consent|5|||
126121997|NCT02982954|453740152|FG002|Overall Study|Participant withdrew consent|1|||
126121998|NCT02982954|453740153|FG003|Overall Study|Participant withdrew consent|1|||
126121999|NCT02982954|453740150|FG000|Overall Study|Other reasons|42|||
126122000|NCT02982954|453740151|FG001|Overall Study|Other reasons|17|||
126122001|NCT02982954|453740152|FG002|Overall Study|Other reasons|12|||
126122002|NCT02982954|453740153|FG003|Overall Study|Other reasons|3|||
126122003|NCT02982954|453740150|FG000|Overall Study|Premature site closure|0|||
126122004|NCT02982954|453740151|FG001|Overall Study|Premature site closure|0|||
126122005|NCT02982954|453740152|FG002|Overall Study|Premature site closure|0|||
126122006|NCT02982954|453740153|FG003|Overall Study|Premature site closure|1|||
126122007|NCT01429584|453740154|FG000|Overall Study|Withdrawal by Subject|1|||
126122008|NCT01429584|453740155|FG001|Overall Study|Withdrawal by Subject|0|||
126122009|NCT01429584|453740154|FG000|Overall Study|Protocol Violation|0|||
126122010|NCT01429584|453740155|FG001|Overall Study|Protocol Violation|1|||
126122011|NCT00750698|453740159|FG000|Overall Study|Withdrawal by Subject|1|||
126122012|NCT00750698|453740160|FG001|Overall Study|Withdrawal by Subject|0|||
126122013|NCT00750698|453740159|FG000|Overall Study|Progressive disease|5|||
126122014|NCT00750698|453740160|FG001|Overall Study|Progressive disease|2|||
126122015|NCT02263079|453740161|FG000|Overall Study|Physician Decision|1|||
126122016|NCT02263079|453740162|FG001|Overall Study|Physician Decision|0|||
126122017|NCT02263079|453740163|FG002|Overall Study|Physician Decision|0|||
126122018|NCT02263079|453740161|FG000|Overall Study|Withdrawal by Subject|2|||
126122019|NCT02263079|453740162|FG001|Overall Study|Withdrawal by Subject|8|||
126122020|NCT02263079|453740163|FG002|Overall Study|Withdrawal by Subject|0|||
126122021|NCT02603120|453740164|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
126122022|NCT02603120|453740165|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
126122023|NCT02603120|453740164|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
126122024|NCT02603120|453740165|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
126122025|NCT02603120|453740164|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
126122026|NCT02603120|453740165|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
126122027|NCT02603120|453740164|FG000|Double-Blind Treatment Phase|Death|2|||
126122028|NCT02603120|453740165|FG001|Double-Blind Treatment Phase|Death|0|||
126122029|NCT02603120|453740164|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
126122030|NCT02603120|453740165|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
126122031|NCT02603120|453740164|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
126122032|NCT02603120|453740165|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
126122033|NCT02603120|453740164|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
126122034|NCT02603120|453740165|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
126122035|NCT02603120|453740164|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
126122036|NCT02603120|453740165|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
126122037|NCT02603120|453740164|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
126122038|NCT02603120|453740165|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
126122039|NCT02603120|453740164|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
126122040|NCT02603120|453740165|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
126122041|NCT02603120|453740164|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
126122042|NCT02603120|453740165|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
126122043|NCT02603120|453740164|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
126122044|NCT02603120|453740165|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
126122045|NCT02603120|453740164|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
126122046|NCT02603120|453740165|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
126122047|NCT02603120|453740164|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
126122048|NCT02603120|453740165|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
126122049|NCT01199042|453740168|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
126122050|NCT01199042|453740168|FG000|At Home (3 Months)|Lost to Follow-up|1|||
126122051|NCT00176605|453740171|FG000|Overall Study|Withdrawal by Subject|2|||
126122052|NCT01321710|453740174|FG000|Overall Study|Lost to Follow-up|4|||
126122053|NCT01321710|453740175|FG001|Overall Study|Lost to Follow-up|5|||
126122054|NCT01321710|453740176|FG002|Overall Study|Lost to Follow-up|0|||
126122055|NCT01227187|453740177|FG000|Overall Study|Physician Decision|0|||
126122056|NCT01227187|453740178|FG001|Overall Study|Physician Decision|0|||
126122057|NCT01227187|453740179|FG002|Overall Study|Physician Decision|0|||
126122058|NCT01227187|453740180|FG003|Overall Study|Physician Decision|1|||
126122059|NCT02463409|453740181|FG000|Overall Study|Withdrawal by Subject|1|||
126122060|NCT02463409|453740181|FG000|Overall Study|Screen failure|1|||
126122061|NCT03577730|453740183|FG000|Overall Study|Physician Decision|3|||
126122062|NCT03577730|453740184|FG001|Overall Study|Physician Decision|1|||
126122063|NCT03577730|453740183|FG000|Overall Study|Did not receive allocated intervention|1|||
126122064|NCT03577730|453740184|FG001|Overall Study|Did not receive allocated intervention|0|||
126122065|NCT00880399|453740185|FG000|Overall Study|Adverse Event|4|||
126122066|NCT00880399|453740186|FG001|Overall Study|Adverse Event|6|||
126122067|NCT00880399|453740187|FG002|Overall Study|Adverse Event|5|||
126122068|NCT00880399|453740185|FG000|Overall Study|Lack of Efficacy|1|||
126122069|NCT00880399|453740186|FG001|Overall Study|Lack of Efficacy|4|||
126122070|NCT00880399|453740187|FG002|Overall Study|Lack of Efficacy|2|||
126122071|NCT00880399|453740185|FG000|Overall Study|Protocol Violation|4|||
126122072|NCT00880399|453740186|FG001|Overall Study|Protocol Violation|4|||
126122073|NCT00880399|453740187|FG002|Overall Study|Protocol Violation|6|||
126122074|NCT00880399|453740185|FG000|Overall Study|Study closed/terminated|3|||
126122075|NCT00880399|453740186|FG001|Overall Study|Study closed/terminated|7|||
126122076|NCT00880399|453740187|FG002|Overall Study|Study closed/terminated|4|||
126122077|NCT00880399|453740185|FG000|Overall Study|Lost to Follow-up|8|||
126122078|NCT00880399|453740186|FG001|Overall Study|Lost to Follow-up|5|||
126122079|NCT00880399|453740187|FG002|Overall Study|Lost to Follow-up|3|||
126122080|NCT00880399|453740185|FG000|Overall Study|Physician Decision|5|||
126122081|NCT00880399|453740186|FG001|Overall Study|Physician Decision|0|||
126122082|NCT00880399|453740187|FG002|Overall Study|Physician Decision|3|||
126122083|NCT00880399|453740185|FG000|Overall Study|Withdrawal by Subject|6|||
126122084|NCT00880399|453740186|FG001|Overall Study|Withdrawal by Subject|3|||
126122085|NCT00880399|453740187|FG002|Overall Study|Withdrawal by Subject|3|||
126122086|NCT01911442|453740188|FG000|Overall Study|Adverse Event|2|||
126122087|NCT01911442|453740189|FG001|Overall Study|Adverse Event|2|||
126122088|NCT01911442|453740190|FG002|Overall Study|Adverse Event|4|||
126122089|NCT01911442|453740188|FG000|Overall Study|Lack of Efficacy|1|||
126122090|NCT01911442|453740189|FG001|Overall Study|Lack of Efficacy|1|||
126122091|NCT01911442|453740190|FG002|Overall Study|Lack of Efficacy|1|||
126122092|NCT01911442|453740188|FG000|Overall Study|Lost to Follow-up|2|||
126122093|NCT01911442|453740189|FG001|Overall Study|Lost to Follow-up|0|||
126122094|NCT01911442|453740190|FG002|Overall Study|Lost to Follow-up|1|||
126122095|NCT01911442|453740188|FG000|Overall Study|Withdrawal by Subject|1|||
126122096|NCT01911442|453740189|FG001|Overall Study|Withdrawal by Subject|0|||
126122097|NCT01911442|453740190|FG002|Overall Study|Withdrawal by Subject|6|||
126122098|NCT01911442|453740188|FG000|Overall Study|Mother's Work Schedule|0|||
126122099|NCT01911442|453740189|FG001|Overall Study|Mother's Work Schedule|1|||
126122100|NCT01911442|453740190|FG002|Overall Study|Mother's Work Schedule|0|||
126122101|NCT00122681|453740196|FG000|Overall Study|Adverse Event|20|||
126122102|NCT00122681|453740197|FG001|Overall Study|Adverse Event|16|||
126122103|NCT00122681|453740196|FG000|Overall Study|Lost to Follow-up|1080|||
126122104|NCT00122681|453740197|FG001|Overall Study|Lost to Follow-up|1097|||
126122105|NCT00122681|453740196|FG000|Overall Study|Protocol Violation|7|||
126122106|NCT00122681|453740197|FG001|Overall Study|Protocol Violation|10|||
126122107|NCT00122681|453740196|FG000|Overall Study|Withdrawal by Subject|257|||
126122108|NCT00122681|453740197|FG001|Overall Study|Withdrawal by Subject|251|||
126122109|NCT00122681|453740196|FG000|Overall Study|Personal reasons|150|||
126122110|NCT00122681|453740197|FG001|Overall Study|Personal reasons|147|||
126122111|NCT02819635|453740199|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
126122112|NCT02819635|453740200|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
126122113|NCT02819635|453740201|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
126122114|NCT02819635|453740202|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
126122115|NCT02819635|453740203|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
126122116|NCT02819635|453740204|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
126122117|NCT02819635|453740205|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
126122118|NCT02819635|453740206|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126122119|NCT02819635|453740207|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126122120|NCT02819635|453740208|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126087837|NCT00669877|453614845|FG000|Overall Study|Disease Progression/Death|4|||
126087838|NCT01465763|453614846|FG000|Overall Study|Withdrawal by Subject|4|||
126087839|NCT01465763|453614847|FG001|Overall Study|Withdrawal by Subject|0|||
126087840|NCT01465763|453614848|FG002|Overall Study|Withdrawal by Subject|1|||
126087841|NCT01465763|453614846|FG000|Overall Study|Insufficient Clinical Response|11|||
126087842|NCT01465763|453614847|FG001|Overall Study|Insufficient Clinical Response|0|||
126087843|NCT01465763|453614848|FG002|Overall Study|Insufficient Clinical Response|1|||
126087844|NCT01465763|453614846|FG000|Overall Study|Adverse Event|9|||
126087845|NCT01465763|453614847|FG001|Overall Study|Adverse Event|0|||
126087846|NCT01465763|453614848|FG002|Overall Study|Adverse Event|1|||
126087847|NCT01465763|453614846|FG000|Overall Study|Other|2|||
126087848|NCT01465763|453614847|FG001|Overall Study|Other|0|||
126087849|NCT01465763|453614848|FG002|Overall Study|Other|0|||
126087850|NCT01465763|453614846|FG000|Overall Study|Protocol Violation|4|||
126087851|NCT01465763|453614847|FG001|Overall Study|Protocol Violation|1|||
126087852|NCT01465763|453614848|FG002|Overall Study|Protocol Violation|1|||
126087853|NCT01465763|453614846|FG000|Overall Study|Death|1|||
126087854|NCT01465763|453614847|FG001|Overall Study|Death|0|||
126087855|NCT01465763|453614848|FG002|Overall Study|Death|0|||
126087856|NCT02920970|453614849|FG000|First Intervention|Protocol Violation|0|||
126087857|NCT02920970|453614850|FG001|First Intervention|Protocol Violation|1|||
126087858|NCT02920970|453614849|FG000|First Intervention|Adverse Event|0|||
126087859|NCT02920970|453614850|FG001|First Intervention|Adverse Event|1|||
126087860|NCT02920970|453614849|FG000|Second Intervention|Poor Lens Fit|1|||
126087861|NCT02920970|453614850|FG001|Second Intervention|Poor Lens Fit|0|||
126087862|NCT01711853|453614852|FG000|Overall Study|Not treated|3|||
126087863|NCT02992691|453614857|FG000|Overall Study|Adverse Event|2|||
126087864|NCT02992691|453614857|FG000|Overall Study|Withdrawal by Subject|1|||
126087865|NCT01427725|453614858|FG000|Overall Study|Lost to Follow-up|17|||
126087866|NCT01427725|453614858|FG000|Overall Study|Protocol Violation|1|||
126087867|NCT01427725|453614858|FG000|Overall Study|Drug not administered|1|||
126087868|NCT01427725|453614858|FG000|Overall Study|Failure to visit|7|||
126087869|NCT01427725|453614858|FG000|Overall Study|Adverse Event|46|||
126087870|NCT01427725|453614858|FG000|Overall Study|Failure to visit after administration|40|||
126087871|NCT01427725|453614858|FG000|Overall Study|Patient's rejection|27|||
126087872|NCT01427725|453614858|FG000|Overall Study|Transfer to a different hospital|17|||
126087873|NCT01427725|453614858|FG000|Overall Study|Lack of Efficacy|8|||
126087874|NCT01427725|453614858|FG000|Overall Study|Death|7|||
126087875|NCT01427725|453614858|FG000|Overall Study|Symptom improvement|6|||
126087876|NCT01427725|453614858|FG000|Overall Study|AE and Patient's rejection|5|||
126087877|NCT01427725|453614858|FG000|Overall Study|Physician Decision|5|||
126087878|NCT01427725|453614858|FG000|Overall Study|Exacerbation of underlying disease|5|||
126087879|NCT01427725|453614858|FG000|Overall Study|Oral feeding difficulty|5|||
126087880|NCT01427725|453614858|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
126087881|NCT01427725|453614858|FG000|Overall Study|Forgetting prescription|1|||
126087882|NCT01427725|453614858|FG000|Overall Study|Other|2|||
126087883|NCT04276051|453614860|FG000|Overall Study|Lost to Follow-up|0|||
126087884|NCT04276051|453614861|FG001|Overall Study|Lost to Follow-up|1|||
126087885|NCT04276051|453614860|FG000|Overall Study|Physician Decision|0|||
126087886|NCT04276051|453614861|FG001|Overall Study|Physician Decision|1|||
126087887|NCT04276051|453614860|FG000|Overall Study|Withdrawal by Subject|1|||
126087888|NCT04276051|453614861|FG001|Overall Study|Withdrawal by Subject|1|||
126087889|NCT00392925|453614862|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
126087890|NCT00392925|453614863|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
126087891|NCT00392925|453614864|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
126087892|NCT00392925|453614865|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
126087893|NCT00392925|453614862|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
126087894|NCT00392925|453614863|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
126087895|NCT00392925|453614864|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
126087896|NCT00392925|453614865|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
126087897|NCT00392925|453614862|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
126087898|NCT00392925|453614863|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
126087899|NCT00392925|453614864|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
126087900|NCT00392925|453614865|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
126087901|NCT00392925|453614862|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
126087902|NCT00392925|453614863|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
126087903|NCT00392925|453614864|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
126087904|NCT00392925|453614865|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
126087905|NCT00392925|453614862|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
126087906|NCT00392925|453614863|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
126087907|NCT00392925|453614864|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
126087908|NCT00392925|453614865|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
126087909|NCT00392925|453614862|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
126122121|NCT02819635|453740209|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126122122|NCT02819635|453740210|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126122123|NCT02819635|453740199|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122124|NCT02819635|453740200|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122125|NCT02819635|453740201|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122126|NCT02819635|453740202|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122127|NCT02819635|453740203|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
126122128|NCT02819635|453740204|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
126122129|NCT02819635|453740205|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
126122130|NCT02819635|453740206|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122131|NCT02819635|453740207|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122132|NCT02819635|453740208|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122133|NCT02819635|453740209|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122134|NCT02819635|453740210|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126122135|NCT02819635|453740199|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122136|NCT02819635|453740200|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122137|NCT02819635|453740201|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122138|NCT02819635|453740202|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122139|NCT02819635|453740203|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122140|NCT02819635|453740204|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
126122141|NCT02819635|453740205|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
126122142|NCT02819635|453740206|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122143|NCT02819635|453740207|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122144|NCT02819635|453740208|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122145|NCT02819635|453740209|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122146|NCT02819635|453740210|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126122147|NCT02819635|453740199|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122148|NCT02819635|453740200|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122149|NCT02819635|453740201|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122150|NCT02819635|453740202|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122151|NCT02819635|453740203|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122152|NCT02819635|453740204|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122153|NCT02819635|453740205|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
126122154|NCT02819635|453740206|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122155|NCT02819635|453740207|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122156|NCT02819635|453740208|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122157|NCT02819635|453740209|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122158|NCT02819635|453740210|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126122159|NCT02819635|453740199|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
126122160|NCT02819635|453740200|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
126122161|NCT02819635|453740201|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
126122162|NCT02819635|453740202|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
126122163|NCT02819635|453740203|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
126122164|NCT02819635|453740204|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
126122165|NCT02819635|453740205|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
126122166|NCT02819635|453740206|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126122167|NCT02819635|453740207|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126122168|NCT02819635|453740208|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126122169|NCT02819635|453740209|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126122170|NCT02819635|453740210|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126122171|NCT02819635|453740199|FG000|Substudy 2, Part 2|Adverse Event|0|||
126122172|NCT02819635|453740200|FG001|Substudy 2, Part 2|Adverse Event|0|||
126122173|NCT02819635|453740201|FG002|Substudy 2, Part 2|Adverse Event|0|||
126122174|NCT02819635|453740202|FG003|Substudy 2, Part 2|Adverse Event|0|||
126122175|NCT02819635|453740203|FG004|Substudy 2, Part 2|Adverse Event|0|||
126122176|NCT02819635|453740204|FG005|Substudy 2, Part 2|Adverse Event|4|||
126122177|NCT02819635|453740205|FG006|Substudy 2, Part 2|Adverse Event|0|||
126122178|NCT02819635|453740206|FG007|Substudy 2, Part 2|Adverse Event|0|||
126122179|NCT02819635|453740207|FG008|Substudy 2, Part 2|Adverse Event|0|||
126122180|NCT02819635|453740208|FG009|Substudy 2, Part 2|Adverse Event|0|||
126122181|NCT02819635|453740209|FG010|Substudy 2, Part 2|Adverse Event|0|||
126122182|NCT02819635|453740210|FG011|Substudy 2, Part 2|Adverse Event|0|||
126122183|NCT02819635|453740199|FG000|Substudy 2, Part 2|Withdrew consent|0|||
126122184|NCT02819635|453740200|FG001|Substudy 2, Part 2|Withdrew consent|0|||
126122185|NCT02819635|453740201|FG002|Substudy 2, Part 2|Withdrew consent|0|||
126122186|NCT02819635|453740202|FG003|Substudy 2, Part 2|Withdrew consent|0|||
126122187|NCT02819635|453740203|FG004|Substudy 2, Part 2|Withdrew consent|0|||
126122188|NCT02819635|453740204|FG005|Substudy 2, Part 2|Withdrew consent|3|||
126122189|NCT02819635|453740205|FG006|Substudy 2, Part 2|Withdrew consent|1|||
126122190|NCT02819635|453740206|FG007|Substudy 2, Part 2|Withdrew consent|0|||
126122191|NCT02819635|453740207|FG008|Substudy 2, Part 2|Withdrew consent|0|||
126122192|NCT02819635|453740208|FG009|Substudy 2, Part 2|Withdrew consent|0|||
126122193|NCT02819635|453740209|FG010|Substudy 2, Part 2|Withdrew consent|0|||
126122194|NCT02819635|453740210|FG011|Substudy 2, Part 2|Withdrew consent|0|||
126122195|NCT02819635|453740199|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
126122196|NCT02819635|453740200|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
126122197|NCT02819635|453740201|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
126122198|NCT02819635|453740202|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
126122199|NCT02819635|453740203|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
126122200|NCT02819635|453740204|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
126122201|NCT02819635|453740205|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
126122202|NCT02819635|453740206|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
126122203|NCT02819635|453740207|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
126122204|NCT02819635|453740208|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
126122205|NCT02819635|453740209|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
126122206|NCT02819635|453740210|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
126122207|NCT02819635|453740199|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122208|NCT02819635|453740200|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122209|NCT02819635|453740201|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122210|NCT02819635|453740202|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122211|NCT02819635|453740203|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122212|NCT02819635|453740204|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122213|NCT02819635|453740205|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
126122214|NCT02819635|453740206|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122215|NCT02819635|453740207|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122216|NCT02819635|453740208|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122217|NCT02819635|453740209|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122218|NCT02819635|453740210|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126122219|NCT02819635|453740199|FG000|Substudy 2, Part 2|Other, not specified|0|||
126122220|NCT02819635|453740200|FG001|Substudy 2, Part 2|Other, not specified|0|||
126122221|NCT02819635|453740201|FG002|Substudy 2, Part 2|Other, not specified|0|||
126122222|NCT02819635|453740202|FG003|Substudy 2, Part 2|Other, not specified|0|||
126122223|NCT02819635|453740203|FG004|Substudy 2, Part 2|Other, not specified|0|||
126122224|NCT02819635|453740204|FG005|Substudy 2, Part 2|Other, not specified|4|||
126122225|NCT02819635|453740205|FG006|Substudy 2, Part 2|Other, not specified|8|||
126122226|NCT02819635|453740206|FG007|Substudy 2, Part 2|Other, not specified|0|||
126122227|NCT02819635|453740207|FG008|Substudy 2, Part 2|Other, not specified|0|||
126122228|NCT02819635|453740208|FG009|Substudy 2, Part 2|Other, not specified|0|||
126122229|NCT02819635|453740209|FG010|Substudy 2, Part 2|Other, not specified|0|||
126122230|NCT02819635|453740210|FG011|Substudy 2, Part 2|Other, not specified|0|||
126122231|NCT02819635|453740199|FG000|Substudy 3|Adverse Event|0|||
126122232|NCT02819635|453740200|FG001|Substudy 3|Adverse Event|0|||
126122233|NCT02819635|453740201|FG002|Substudy 3|Adverse Event|0|||
126122234|NCT02819635|453740202|FG003|Substudy 3|Adverse Event|0|||
126122235|NCT02819635|453740203|FG004|Substudy 3|Adverse Event|0|||
126122236|NCT02819635|453740204|FG005|Substudy 3|Adverse Event|0|||
126122237|NCT02819635|453740205|FG006|Substudy 3|Adverse Event|0|||
126122238|NCT02819635|453740206|FG007|Substudy 3|Adverse Event|0|||
126122239|NCT02819635|453740207|FG008|Substudy 3|Adverse Event|32|||
126122240|NCT02819635|453740208|FG009|Substudy 3|Adverse Event|3|||
126122241|NCT02819635|453740209|FG010|Substudy 3|Adverse Event|12|||
126122242|NCT02819635|453740210|FG011|Substudy 3|Adverse Event|18|||
126122243|NCT02819635|453740199|FG000|Substudy 3|Withdrew consent|0|||
126122244|NCT02819635|453740200|FG001|Substudy 3|Withdrew consent|0|||
126122245|NCT02819635|453740201|FG002|Substudy 3|Withdrew consent|0|||
126122246|NCT02819635|453740202|FG003|Substudy 3|Withdrew consent|0|||
126122247|NCT02819635|453740203|FG004|Substudy 3|Withdrew consent|0|||
126122248|NCT02819635|453740204|FG005|Substudy 3|Withdrew consent|0|||
126122249|NCT02819635|453740205|FG006|Substudy 3|Withdrew consent|0|||
126122250|NCT02819635|453740206|FG007|Substudy 3|Withdrew consent|0|||
126122251|NCT02819635|453740207|FG008|Substudy 3|Withdrew consent|11|||
126122252|NCT02819635|453740208|FG009|Substudy 3|Withdrew consent|1|||
126122253|NCT02819635|453740209|FG010|Substudy 3|Withdrew consent|4|||
126122254|NCT02819635|453740210|FG011|Substudy 3|Withdrew consent|9|||
126122255|NCT02819635|453740199|FG000|Substudy 3|Lost to Follow-up|0|||
126122256|NCT02819635|453740200|FG001|Substudy 3|Lost to Follow-up|0|||
126122257|NCT02819635|453740201|FG002|Substudy 3|Lost to Follow-up|0|||
126122258|NCT02819635|453740202|FG003|Substudy 3|Lost to Follow-up|0|||
126122259|NCT02819635|453740203|FG004|Substudy 3|Lost to Follow-up|0|||
126122260|NCT02819635|453740204|FG005|Substudy 3|Lost to Follow-up|0|||
126122261|NCT02819635|453740205|FG006|Substudy 3|Lost to Follow-up|0|||
126122262|NCT02819635|453740206|FG007|Substudy 3|Lost to Follow-up|0|||
126122263|NCT02819635|453740207|FG008|Substudy 3|Lost to Follow-up|1|||
126122264|NCT02819635|453740208|FG009|Substudy 3|Lost to Follow-up|0|||
126122265|NCT02819635|453740209|FG010|Substudy 3|Lost to Follow-up|1|||
126122266|NCT02819635|453740210|FG011|Substudy 3|Lost to Follow-up|1|||
126122267|NCT02819635|453740199|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122268|NCT02819635|453740200|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122269|NCT02819635|453740201|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122270|NCT02819635|453740202|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122271|NCT02819635|453740203|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122272|NCT02819635|453740204|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122273|NCT02819635|453740205|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122274|NCT02819635|453740206|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122275|NCT02819635|453740207|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122276|NCT02819635|453740208|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122277|NCT02819635|453740209|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
126122278|NCT02819635|453740210|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
126122279|NCT02819635|453740199|FG000|Substudy 3|Other, not specified|0|||
126122280|NCT02819635|453740200|FG001|Substudy 3|Other, not specified|0|||
126122281|NCT02819635|453740201|FG002|Substudy 3|Other, not specified|0|||
126122282|NCT02819635|453740202|FG003|Substudy 3|Other, not specified|0|||
126122283|NCT02819635|453740203|FG004|Substudy 3|Other, not specified|0|||
126122284|NCT02819635|453740204|FG005|Substudy 3|Other, not specified|0|||
126122285|NCT02819635|453740205|FG006|Substudy 3|Other, not specified|0|||
126122286|NCT02819635|453740206|FG007|Substudy 3|Other, not specified|0|||
126122287|NCT02819635|453740207|FG008|Substudy 3|Other, not specified|202|||
126122288|NCT02819635|453740208|FG009|Substudy 3|Other, not specified|5|||
126122289|NCT02819635|453740209|FG010|Substudy 3|Other, not specified|89|||
126122290|NCT02819635|453740210|FG011|Substudy 3|Other, not specified|39|||
126122291|NCT03179891|453740211|FG000|First Intervention|Withdrawal by Subject|1|||
126122292|NCT03179891|453740212|FG001|First Intervention|Withdrawal by Subject|1|||
126122293|NCT03179891|453740211|FG000|First Intervention|Unspecified reason|1|||
126122294|NCT03179891|453740212|FG001|First Intervention|Unspecified reason|0|||
126122295|NCT03179891|453740211|FG000|First Intervention|Protocol Violation|0|||
126122296|NCT03179891|453740212|FG001|First Intervention|Protocol Violation|1|||
126122297|NCT04416555|453740214|FG000|Overall Study|Withdrawal by Subject|0|||
126122298|NCT04416555|453740215|FG001|Overall Study|Withdrawal by Subject|3|||
126122299|NCT02004262|453740226|FG000|Overall Study|Death|67|||
126122300|NCT02004262|453740227|FG001|Overall Study|Death|64|||
126122301|NCT02004262|453740228|FG002|Overall Study|Death|66|||
126122302|NCT02004262|453740229|FG003|Overall Study|Death|28|||
126122303|NCT02004262|453740230|FG004|Overall Study|Death|29|||
126122304|NCT02004262|453740231|FG005|Overall Study|Death|22|||
126122305|NCT02004262|453740226|FG000|Overall Study|Withdrawal by Subject|1|||
126122306|NCT02004262|453740227|FG001|Overall Study|Withdrawal by Subject|0|||
125962471|NCT01609556|453153528|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962472|NCT01609556|453153529|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962473|NCT01609556|453153530|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962474|NCT01609556|453153531|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962475|NCT01609556|453153532|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962476|NCT01609556|453153533|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962477|NCT01609556|453153534|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962478|NCT01609556|453153535|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962479|NCT01609556|453153536|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962480|NCT01609556|453153537|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962481|NCT01609556|453153538|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962482|NCT01609556|453153539|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125962483|NCT01609556|453153540|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
125962484|NCT01609556|453153525|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962485|NCT01609556|453153526|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962486|NCT01609556|453153527|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962487|NCT01609556|453153528|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962488|NCT01609556|453153529|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962489|NCT01609556|453153530|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962490|NCT01609556|453153531|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962491|NCT01609556|453153532|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962492|NCT01609556|453153533|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
126122307|NCT02004262|453740228|FG002|Overall Study|Withdrawal by Subject|4|||
126122308|NCT02004262|453740229|FG003|Overall Study|Withdrawal by Subject|0|||
126122309|NCT02004262|453740230|FG004|Overall Study|Withdrawal by Subject|1|||
126122310|NCT02004262|453740231|FG005|Overall Study|Withdrawal by Subject|3|||
126122311|NCT02004262|453740226|FG000|Overall Study|Lost to Follow-up|1|||
126122312|NCT02004262|453740227|FG001|Overall Study|Lost to Follow-up|1|||
126122313|NCT02004262|453740228|FG002|Overall Study|Lost to Follow-up|0|||
126122314|NCT02004262|453740229|FG003|Overall Study|Lost to Follow-up|0|||
126122315|NCT02004262|453740230|FG004|Overall Study|Lost to Follow-up|0|||
126122316|NCT02004262|453740231|FG005|Overall Study|Lost to Follow-up|0|||
126122317|NCT02004262|453740226|FG000|Overall Study|Study Terminated by Sponsor|4|||
126122318|NCT02004262|453740227|FG001|Overall Study|Study Terminated by Sponsor|3|||
126122319|NCT02004262|453740228|FG002|Overall Study|Study Terminated by Sponsor|2|||
126122320|NCT02004262|453740229|FG003|Overall Study|Study Terminated by Sponsor|1|||
126122321|NCT02004262|453740230|FG004|Overall Study|Study Terminated by Sponsor|1|||
126122322|NCT02004262|453740231|FG005|Overall Study|Study Terminated by Sponsor|5|||
126122323|NCT01923285|453740232|FG000|Overall Study|Withdrawal by Subject|7|||
126122324|NCT01923285|453740233|FG001|Overall Study|Withdrawal by Subject|6|||
126122325|NCT03200366|453740238|FG000|Patient Navigation Intervention Given|Death|0|||
126122326|NCT03200366|453740239|FG001|Patient Navigation Intervention Given|Death|2|||
126122327|NCT03200366|453740240|FG002|Patient Navigation Intervention Given|Death|0|||
126122328|NCT03200366|453740238|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
126122329|NCT03200366|453740239|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
126122330|NCT03200366|453740240|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
126122331|NCT03200366|453740238|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
126122332|NCT03200366|453740239|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
126122333|NCT03200366|453740240|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
126122334|NCT03200366|453740238|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
126122335|NCT03200366|453740239|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
126122336|NCT03200366|453740240|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
126122337|NCT03200366|453740238|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
126122338|NCT03200366|453740239|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
126122339|NCT03200366|453740240|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
126122340|NCT03200366|453740238|FG000|6 Month Post-Baseline Interview|Death|1|||
126122341|NCT03200366|453740239|FG001|6 Month Post-Baseline Interview|Death|1|||
126122342|NCT03200366|453740240|FG002|6 Month Post-Baseline Interview|Death|1|||
126122343|NCT03200366|453740238|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
126122344|NCT03200366|453740239|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
126122345|NCT03200366|453740240|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
126122346|NCT03200366|453740238|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
126122347|NCT03200366|453740239|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
126122348|NCT03200366|453740240|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
126122349|NCT03200366|453740238|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
126122350|NCT03200366|453740239|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
126122351|NCT03200366|453740240|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
126122352|NCT03200366|453740238|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
126122353|NCT03200366|453740239|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
126122354|NCT03200366|453740240|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
126122355|NCT03200366|453740238|FG000|9 Month Post-Baseline Interview|Death|1|||
126122356|NCT03200366|453740239|FG001|9 Month Post-Baseline Interview|Death|1|||
126122357|NCT03200366|453740240|FG002|9 Month Post-Baseline Interview|Death|1|||
126122358|NCT03200366|453740238|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
126122359|NCT03200366|453740239|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
126122360|NCT03200366|453740240|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
126122361|NCT03200366|453740238|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
126122362|NCT03200366|453740239|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
126122363|NCT03200366|453740240|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
126122364|NCT03200366|453740238|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
126122365|NCT03200366|453740239|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
126122366|NCT03200366|453740240|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
126122367|NCT03201458|453740241|FG000|Overall Study|No longer eligible|2|||
126122368|NCT03201458|453740242|FG001|Overall Study|No longer eligible|5|||
126122369|NCT03201458|453740241|FG000|Overall Study|Health event before starting|1|||
126122370|NCT03201458|453740242|FG001|Overall Study|Health event before starting|0|||
126122371|NCT03201458|453740241|FG000|Overall Study|Physician Decision|1|||
126122372|NCT03201458|453740242|FG001|Overall Study|Physician Decision|0|||
126122373|NCT00715026|453740245|FG000|Overall Study|Withdrawal by Subject|5|||
126122374|NCT00715026|453740245|FG000|Overall Study|Lost to Follow-up|3|||
126122375|NCT00715026|453740245|FG000|Overall Study|Protocol Violation|1|||
126122376|NCT00715026|453740245|FG000|Overall Study|Surgery done on non-study consented hip|1|||
126122377|NCT00750737|453740246|FG000|Overall Study|Withdrawal by Subject|3|||
126122378|NCT00750737|453740247|FG001|Overall Study|Withdrawal by Subject|3|||
126122379|NCT04707157|453740248|FG000|Overall Study|Adverse Event|12|||
126122380|NCT04707157|453740249|FG001|Overall Study|Adverse Event|3|||
126122381|NCT04707157|453740248|FG000|Overall Study|Lost to Follow-up|2|||
126122382|NCT04707157|453740249|FG001|Overall Study|Lost to Follow-up|0|||
126122383|NCT04707157|453740248|FG000|Overall Study|Sponsor's decision|1|||
126122384|NCT04707157|453740249|FG001|Overall Study|Sponsor's decision|0|||
126122385|NCT04707157|453740248|FG000|Overall Study|Physician Decision|8|||
126122386|NCT04707157|453740249|FG001|Overall Study|Physician Decision|5|||
126122387|NCT04707157|453740248|FG000|Overall Study|Protocol Deviation|1|||
126122388|NCT04707157|453740249|FG001|Overall Study|Protocol Deviation|0|||
126122389|NCT04707157|453740248|FG000|Overall Study|Withdrawal by Subject|1|||
126122390|NCT04707157|453740249|FG001|Overall Study|Withdrawal by Subject|1|||
126122391|NCT00804570|453740250|FG000|Overall Study|Adverse Event|14|||
126122392|NCT00804570|453740251|FG001|Overall Study|Adverse Event|7|||
126122393|NCT00804570|453740250|FG000|Overall Study|Lack of Efficacy|0|||
126122394|NCT00804570|453740251|FG001|Overall Study|Lack of Efficacy|1|||
126122395|NCT00804570|453740250|FG000|Overall Study|Lost to Follow-up|18|||
126122396|NCT00804570|453740251|FG001|Overall Study|Lost to Follow-up|21|||
126122397|NCT00804570|453740250|FG000|Overall Study|Entry criteria not met|5|||
126122398|NCT00804570|453740251|FG001|Overall Study|Entry criteria not met|5|||
126122399|NCT00804570|453740250|FG000|Overall Study|Protocol Violation|12|||
126122400|NCT00804570|453740251|FG001|Overall Study|Protocol Violation|16|||
126122401|NCT00804570|453740250|FG000|Overall Study|Physician Decision|1|||
126122402|NCT00804570|453740251|FG001|Overall Study|Physician Decision|2|||
126122403|NCT00804570|453740250|FG000|Overall Study|Sponsor decision|1|||
126122404|NCT00804570|453740251|FG001|Overall Study|Sponsor decision|4|||
126122405|NCT00804570|453740250|FG000|Overall Study|Withdrawal by Subject|21|||
126122406|NCT00804570|453740251|FG001|Overall Study|Withdrawal by Subject|38|||
126122407|NCT00290342|453740252|FG000|Overall Study|Other|0|||
126122408|NCT00290342|453740253|FG001|Overall Study|Other|1|||
126122409|NCT00290342|453740252|FG000|Overall Study|Withdrawal by Subject|6|||
126122410|NCT00290342|453740253|FG001|Overall Study|Withdrawal by Subject|4|||
126122411|NCT00290342|453740252|FG000|Overall Study|Lost to Follow-up|1|||
126122412|NCT00290342|453740253|FG001|Overall Study|Lost to Follow-up|0|||
126122413|NCT01056510|453740256|FG000|Overall Study|Dropout Before Start of Treatment|1|||
126122414|NCT01056510|453740257|FG001|Overall Study|Dropout Before Start of Treatment|1|||
126122415|NCT01056510|453740256|FG000|Overall Study|Withdrawal by Subject|4|||
126122416|NCT01056510|453740257|FG001|Overall Study|Withdrawal by Subject|2|||
126122417|NCT01056510|453740256|FG000|Overall Study|Death|29|||
126122418|NCT01056510|453740257|FG001|Overall Study|Death|34|||
126122419|NCT01056510|453740256|FG000|Overall Study|Noncompliance|1|||
126122420|NCT01056510|453740257|FG001|Overall Study|Noncompliance|3|||
126122421|NCT01056510|453740256|FG000|Overall Study|Physician Decision|4|||
126122422|NCT01056510|453740257|FG001|Overall Study|Physician Decision|5|||
126122423|NCT01056510|453740256|FG000|Overall Study|Lost to Follow-up|5|||
126122424|NCT01056510|453740257|FG001|Overall Study|Lost to Follow-up|6|||
126122425|NCT01056510|453740256|FG000|Overall Study|Other|10|||
126122426|NCT01056510|453740257|FG001|Overall Study|Other|12|||
126122427|NCT01056510|453740256|FG000|Overall Study|Missing|0|||
126122428|NCT01056510|453740257|FG001|Overall Study|Missing|1|||
126122429|NCT00243386|453740258|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
126122430|NCT00243386|453740259|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
126122431|NCT00243386|453740260|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
126122432|NCT00243386|453740258|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
126122433|NCT00243386|453740259|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
126122434|NCT00243386|453740260|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
126122435|NCT00243386|453740258|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
126122436|NCT00243386|453740259|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
126122437|NCT00243386|453740260|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
126122438|NCT00243386|453740258|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
126122439|NCT00243386|453740259|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
126122440|NCT00243386|453740260|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
126122441|NCT00243386|453740258|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
126122442|NCT00243386|453740259|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
126122443|NCT00243386|453740260|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
126122444|NCT00243386|453740258|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
126122445|NCT00243386|453740259|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
126122446|NCT00243386|453740260|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
126122447|NCT00243386|453740258|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
126122448|NCT00243386|453740259|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
126122449|NCT00243386|453740260|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
126122450|NCT00243386|453740258|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
126122451|NCT00243386|453740259|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
126122452|NCT00243386|453740260|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
126122453|NCT02285998|453740261|FG000|Overall Study|Adverse Event|9|||
126122454|NCT02285998|453740262|FG001|Overall Study|Adverse Event|8|||
126122455|NCT02285998|453740261|FG000|Overall Study|Physician Decision|1|||
126122456|NCT02285998|453740262|FG001|Overall Study|Physician Decision|2|||
126122457|NCT02285998|453740261|FG000|Overall Study|Lost to Follow-up|176|||
126122458|NCT02285998|453740262|FG001|Overall Study|Lost to Follow-up|172|||
126122459|NCT02285998|453740261|FG000|Overall Study|Withdrawal by Subject|53|||
126122460|NCT02285998|453740262|FG001|Overall Study|Withdrawal by Subject|61|||
126122461|NCT02285998|453740261|FG000|Overall Study|Other Reasons|7|||
126122462|NCT02285998|453740262|FG001|Overall Study|Other Reasons|10|||
126122463|NCT00545298|453740263|FG000|Overall Study|Issues with Standard of Care|2|||
126122464|NCT00545298|453740264|FG001|Overall Study|Issues with Standard of Care|0|||
126122465|NCT00545298|453740265|FG002|Overall Study|Issues with Standard of Care|1|||
126122466|NCT01820364|453740269|FG000|Part I: LGX818|Death|1|||
126122467|NCT01820364|453740270|FG001|Part I: LGX818|Death|0|||
126122468|NCT01820364|453740269|FG000|Part I: LGX818|Administrative Problems|3|||
126122469|NCT01820364|453740270|FG001|Part I: LGX818|Administrative Problems|0|||
126122470|NCT01820364|453740269|FG000|Part I: LGX818|Adverse Event|6|||
126122471|NCT01820364|453740270|FG001|Part I: LGX818|Adverse Event|0|||
126122472|NCT01820364|453740269|FG000|Part I: LGX818|Disease Progression|4|||
126122473|NCT01820364|453740270|FG001|Part I: LGX818|Disease Progression|0|||
126122474|NCT01820364|453740269|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
126122475|NCT01820364|453740270|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
126122476|NCT01793142|453740273|FG000|Overall Study|Randomized not treated|7|||
126122477|NCT03451084|453740279|FG000|Overall Study|Withdrawal by Subject|2|||
126122478|NCT03451084|453740280|FG001|Overall Study|Withdrawal by Subject|1|||
126122479|NCT03451084|453740281|FG002|Overall Study|Withdrawal by Subject|2|||
126122480|NCT03451084|453740282|FG003|Overall Study|Withdrawal by Subject|1|||
126122481|NCT03451084|453740279|FG000|Overall Study|Disease recurrence|0|||
126122482|NCT03451084|453740280|FG001|Overall Study|Disease recurrence|2|||
126122483|NCT03451084|453740281|FG002|Overall Study|Disease recurrence|0|||
126122484|NCT03451084|453740282|FG003|Overall Study|Disease recurrence|0|||
126122485|NCT03451084|453740279|FG000|Overall Study|Lack of Efficacy|0|||
126122486|NCT03451084|453740280|FG001|Overall Study|Lack of Efficacy|3|||
126122487|NCT03451084|453740281|FG002|Overall Study|Lack of Efficacy|0|||
126122488|NCT03451084|453740282|FG003|Overall Study|Lack of Efficacy|1|||
126122489|NCT03451084|453740279|FG000|Overall Study|Death|1|||
126122490|NCT03451084|453740280|FG001|Overall Study|Death|0|||
126122491|NCT03451084|453740281|FG002|Overall Study|Death|2|||
126122492|NCT03451084|453740282|FG003|Overall Study|Death|0|||
126122493|NCT03451084|453740279|FG000|Overall Study|Physician Decision|0|||
126122494|NCT03451084|453740280|FG001|Overall Study|Physician Decision|0|||
126122495|NCT03451084|453740281|FG002|Overall Study|Physician Decision|2|||
126122496|NCT03451084|453740282|FG003|Overall Study|Physician Decision|2|||
126122497|NCT03451084|453740279|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
126122498|NCT03451084|453740280|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
126122499|NCT03451084|453740281|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
126122500|NCT03451084|453740282|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
125962493|NCT01609556|453153534|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962494|NCT01609556|453153535|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962495|NCT01609556|453153536|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962496|NCT01609556|453153537|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
125962497|NCT01609556|453153538|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
125962498|NCT01609556|453153539|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
125962499|NCT01609556|453153540|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
125962500|NCT01609556|453153525|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962501|NCT01609556|453153526|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962502|NCT01609556|453153527|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962503|NCT01609556|453153528|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962504|NCT01609556|453153529|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962505|NCT01609556|453153530|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962506|NCT01609556|453153531|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962507|NCT01609556|453153532|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962508|NCT01609556|453153533|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962509|NCT01609556|453153534|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962510|NCT01609556|453153535|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962511|NCT01609556|453153536|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126122501|NCT04995055|453740285|FG000|Period 1|COVID-19 Related|1|||
126122502|NCT04995055|453740286|FG001|Period 1|COVID-19 Related|0|||
126122503|NCT04995055|453740285|FG000|Period 1|Withdrawal by Subject|0|||
126122504|NCT04995055|453740286|FG001|Period 1|Withdrawal by Subject|1|||
126122505|NCT04995055|453740285|FG000|Period 1|Subject discontinued due to timing|4|||
125962512|NCT01609556|453153537|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
125962513|NCT01609556|453153538|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126122506|NCT04995055|453740286|FG001|Period 1|Subject discontinued due to timing|4|||
126122507|NCT03418129|453740289|FG000|Overall Study|Lost to Follow-up|11|||
126122508|NCT03418129|453740290|FG001|Overall Study|Lost to Follow-up|20|||
126122509|NCT03418129|453740291|FG002|Overall Study|Lost to Follow-up|15|||
126122510|NCT03418129|453740289|FG000|Overall Study|Withdrawal by Subject|3|||
126122511|NCT03418129|453740290|FG001|Overall Study|Withdrawal by Subject|6|||
126122512|NCT03418129|453740291|FG002|Overall Study|Withdrawal by Subject|4|||
126122513|NCT01553188|453740295|FG000|Overall Study|Patient choice|1|||
125962514|NCT01609556|453153539|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962515|NCT01609556|453153540|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125962516|NCT02758236|453153541|FG000|Overall Study|Investigator discretion|43|||
125962517|NCT04452344|453153542|FG000|Overall Study|Withdrawal by Subject|3|||
125962518|NCT04452344|453153543|FG001|Overall Study|Withdrawal by Subject|6|||
125962519|NCT04452344|453153542|FG000|Overall Study|Adverse Event|1|||
125962520|NCT04452344|453153543|FG001|Overall Study|Adverse Event|2|||
125962521|NCT04452344|453153542|FG000|Overall Study|Lost to Follow-up|2|||
125962522|NCT04452344|453153543|FG001|Overall Study|Lost to Follow-up|2|||
125962523|NCT04452344|453153542|FG000|Overall Study|No Post-Op Visit|6|||
125962524|NCT04452344|453153543|FG001|Overall Study|No Post-Op Visit|7|||
125962525|NCT00023452|453153544|FG000|Overall Study|Ineligible for Study|163|||
125962526|NCT00023452|453153545|FG001|Overall Study|Ineligible for Study|159|||
125962527|NCT00023452|453153544|FG000|Overall Study|Out of Window|129|||
125962528|NCT00023452|453153545|FG001|Overall Study|Out of Window|69|||
125962529|NCT00023452|453153544|FG000|Overall Study|Death|2|||
125962530|NCT00023452|453153545|FG001|Overall Study|Death|0|||
125962531|NCT00023452|453153544|FG000|Overall Study|Withdrawal by Subject|66|||
125962532|NCT00023452|453153545|FG001|Overall Study|Withdrawal by Subject|54|||
125962533|NCT00023452|453153544|FG000|Overall Study|Adverse Event|139|||
125962534|NCT00023452|453153545|FG001|Overall Study|Adverse Event|196|||
125962535|NCT00023452|453153544|FG000|Overall Study|Lost to Follow-up|293|||
125962536|NCT00023452|453153545|FG001|Overall Study|Lost to Follow-up|60|||
125962537|NCT00023452|453153544|FG000|Overall Study|Physician Decision|49|||
125962538|NCT00023452|453153545|FG001|Overall Study|Physician Decision|21|||
125962539|NCT00023452|453153544|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
125962540|NCT00023452|453153545|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
125962541|NCT00023452|453153544|FG000|Overall Study|Pregnant|53|||
125962542|NCT00023452|453153545|FG001|Overall Study|Pregnant|20|||
125962543|NCT00023452|453153544|FG000|Overall Study|Other|204|||
125962544|NCT00023452|453153545|FG001|Overall Study|Other|69|||
125962545|NCT05789875|453153546|FG000|Overall Study|Lost to Follow-up|6|||
125962546|NCT01994395|453153547|FG000|Overall Study|Withdrawal by Subject|1|||
125962547|NCT01994395|453153548|FG001|Overall Study|Withdrawal by Subject|2|||
125962548|NCT01940705|453153550|FG000|Overall Study|Lost to Follow-up|1|||
125962549|NCT01940705|453153551|FG001|Overall Study|Lost to Follow-up|3|||
125962550|NCT01940705|453153552|FG002|Overall Study|Lost to Follow-up|2|||
125962551|NCT01940705|453153553|FG003|Overall Study|Lost to Follow-up|2|||
125962552|NCT01940705|453153550|FG000|Overall Study|Withdrawal by Subject|2|||
125962553|NCT01940705|453153551|FG001|Overall Study|Withdrawal by Subject|2|||
125962554|NCT01940705|453153552|FG002|Overall Study|Withdrawal by Subject|3|||
125962555|NCT01940705|453153553|FG003|Overall Study|Withdrawal by Subject|2|||
125962556|NCT01940705|453153550|FG000|Overall Study|Intervention not given|0|||
125962557|NCT01940705|453153551|FG001|Overall Study|Intervention not given|3|||
125962558|NCT01940705|453153552|FG002|Overall Study|Intervention not given|3|||
125962559|NCT01940705|453153553|FG003|Overall Study|Intervention not given|0|||
125962560|NCT01940705|453153550|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
125962561|NCT01940705|453153551|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
125962562|NCT01940705|453153552|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
125962563|NCT01940705|453153553|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
125962564|NCT03779841|453153556|FG000|Randomized Population|Did Not Receive Treatment|3|||
125962565|NCT03779841|453153557|FG001|Randomized Population|Did Not Receive Treatment|1|||
125962566|NCT03779841|453153558|FG002|Randomized Population|Did Not Receive Treatment|0|||
125962567|NCT03779841|453153556|FG000|Treated (Safety) Population|Adverse Event|1|||
125962568|NCT03779841|453153557|FG001|Treated (Safety) Population|Adverse Event|1|||
125962569|NCT03779841|453153558|FG002|Treated (Safety) Population|Adverse Event|0|||
125962570|NCT03779841|453153556|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
125962571|NCT03779841|453153557|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
125962572|NCT03779841|453153558|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
125962573|NCT03779841|453153556|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
126122514|NCT01553188|453740296|FG001|Overall Study|Patient choice|0|||
125962574|NCT03779841|453153557|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
125962575|NCT03779841|453153558|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
125962576|NCT03779841|453153556|FG000|Treated (Safety) Population|Death|1|||
125962577|NCT03779841|453153557|FG001|Treated (Safety) Population|Death|0|||
125962578|NCT03779841|453153558|FG002|Treated (Safety) Population|Death|2|||
125962579|NCT01632579|453153559|FG000|Washout Period|Adverse Event|1|||
125962580|NCT01632579|453153560|FG001|Washout Period|Adverse Event|0|||
125962581|NCT01632579|453153561|FG002|Washout Period|Adverse Event|0|||
125962582|NCT01632579|453153562|FG003|Washout Period|Adverse Event|0|||
125962583|NCT01632579|453153563|FG004|Washout Period|Adverse Event|0|||
125962584|NCT01632579|453153564|FG005|Washout Period|Adverse Event|0|||
125962585|NCT01632579|453153565|FG006|Washout Period|Adverse Event|0|||
125962586|NCT01632579|453153566|FG007|Washout Period|Adverse Event|0|||
125962587|NCT01632579|453153567|FG008|Washout Period|Adverse Event|0|||
125962588|NCT01632579|453153559|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
126122515|NCT01553188|453740297|FG002|Overall Study|Patient choice|0|||
125962589|NCT01632579|453153560|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
125962590|NCT01632579|453153561|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
125962591|NCT01632579|453153562|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
125962592|NCT01632579|453153563|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
125962593|NCT01632579|453153564|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
125962594|NCT01632579|453153565|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
125962595|NCT01632579|453153566|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
125962596|NCT01632579|453153567|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
125962597|NCT00162136|453153568|FG000|Overall Study|Adverse Event|1|||
125962598|NCT00162136|453153568|FG000|Overall Study|Death|1|||
125962599|NCT00162136|453153568|FG000|Overall Study|Disease Progression/Relapse|23|||
125962600|NCT00162136|453153568|FG000|Overall Study|Investigator Request|5|||
125962601|NCT00162136|453153568|FG000|Overall Study|Study Drug Toxicity|4|||
125962602|NCT00162136|453153568|FG000|Overall Study|Withdrawal by Subject|1|||
125962603|NCT02788175|453153569|FG000|Overall Study|Protocol Violation|3|||
125962604|NCT02788175|453153569|FG000|Overall Study|Withdrawal by Subject|4|||
125962605|NCT02788175|453153569|FG000|Overall Study|Ineligible prior to study agent|6|||
125962606|NCT03930745|453153570|FG000|Overall Study|Lost to Follow-up|10|||
125962607|NCT03930745|453153571|FG001|Overall Study|Lost to Follow-up|5|||
125962608|NCT03930745|453153570|FG000|Overall Study|Withdrawal by Subject|1|||
125962609|NCT03930745|453153571|FG001|Overall Study|Withdrawal by Subject|2|||
125962610|NCT03930745|453153570|FG000|Overall Study|Protocol Violation|2|||
125962611|NCT03930745|453153571|FG001|Overall Study|Protocol Violation|2|||
125962612|NCT03930745|453153570|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
125962613|NCT03930745|453153571|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
125962614|NCT03930745|453153570|FG000|Overall Study|Adverse Event|0|||
125962615|NCT03930745|453153571|FG001|Overall Study|Adverse Event|1|||
125962616|NCT03930745|453153570|FG000|Overall Study|Pregnancy|0|||
125962617|NCT03930745|453153571|FG001|Overall Study|Pregnancy|1|||
125962618|NCT00818441|453153576|FG000|Overall Study|Death|69|||
125962619|NCT00818441|453153577|FG001|Overall Study|Death|26|||
125962620|NCT00818441|453153576|FG000|Overall Study|Other|5|||
125962621|NCT00818441|453153577|FG001|Overall Study|Other|0|||
125962622|NCT00818441|453153576|FG000|Overall Study|Lost to Follow-up|2|||
125962623|NCT00818441|453153577|FG001|Overall Study|Lost to Follow-up|1|||
125962624|NCT00818441|453153576|FG000|Overall Study|Withdrawal by Subject|2|||
125962625|NCT00818441|453153577|FG001|Overall Study|Withdrawal by Subject|0|||
125962626|NCT00818441|453153576|FG000|Overall Study|Adverse Event|0|||
125962627|NCT00818441|453153577|FG001|Overall Study|Adverse Event|1|||
125962628|NCT00818441|453153576|FG000|Overall Study|Study terminated by sponsor|11|||
125962629|NCT00818441|453153577|FG001|Overall Study|Study terminated by sponsor|2|||
125962630|NCT04095858|453153578|FG000|Overall Study|Death|1|||
125962631|NCT04095858|453153579|FG001|Overall Study|Death|0|||
125962632|NCT04095858|453153578|FG000|Overall Study|Study terminated by Sponsor|2|||
125962633|NCT04095858|453153579|FG001|Overall Study|Study terminated by Sponsor|4|||
125962634|NCT03483623|453153581|FG000|Overall Study|43 complete sets achieved|1|||
125962635|NCT02770391|453153582|FG000|Overall Study|Lost to Follow-up|2|||
125962636|NCT02770391|453153582|FG000|Overall Study|Withdrawal by Subject|1|||
125962637|NCT02770391|453153582|FG000|Overall Study|Surgery delayed unevaluable|2|||
125962638|NCT02770391|453153582|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
125962639|NCT00612313|453153586|FG000|Overall Study|Withdrawal by Subject|6|||
125962640|NCT00612313|453153587|FG001|Overall Study|Withdrawal by Subject|9|||
125962641|NCT00612313|453153586|FG000|Overall Study|Lost to Follow-up|11|||
125962642|NCT00612313|453153587|FG001|Overall Study|Lost to Follow-up|4|||
125962643|NCT01043874|453155365|FG000|Overall Study|Adverse Event|3|||
125962644|NCT01043874|453155365|FG000|Overall Study|Withdrawal by Subject|1|||
125962645|NCT01043874|453155365|FG000|Overall Study|Lack of Efficacy|1|||
125962646|NCT01043874|453155365|FG000|Overall Study|Administrative Problems|1|||
125962647|NCT00182689|453155371|FG000|Overall Study|Adverse Event|8|||
125962648|NCT00182689|453155372|FG001|Overall Study|Adverse Event|11|||
125962649|NCT00182689|453155371|FG000|Overall Study|Withdrawal by Subject|2|||
125962650|NCT00182689|453155372|FG001|Overall Study|Withdrawal by Subject|2|||
125962651|NCT00182689|453155371|FG000|Overall Study|Progression|27|||
125962652|NCT00182689|453155372|FG001|Overall Study|Progression|29|||
125962653|NCT00182689|453155371|FG000|Overall Study|Death|1|||
125962654|NCT00182689|453155372|FG001|Overall Study|Death|0|||
125962655|NCT00182689|453155371|FG000|Overall Study|not protocol specified|0|||
125962656|NCT00182689|453155372|FG001|Overall Study|not protocol specified|3|||
125962657|NCT00182689|453155371|FG000|Overall Study|Ineligible|1|||
125962658|NCT00182689|453155372|FG001|Overall Study|Ineligible|4|||
125962659|NCT00182689|453155371|FG000|Overall Study|Never received treatment|1|||
126087910|NCT00392925|453614863|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
125962660|NCT00182689|453155372|FG001|Overall Study|Never received treatment|0|||
125962661|NCT03422003|453155373|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
125962662|NCT03422003|453155374|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
125962663|NCT03422003|453155373|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
125962664|NCT03422003|453155374|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
125962665|NCT01337089|453155375|FG000|Overall Study|Adverse Event|237|||
125962666|NCT01337089|453155375|FG000|Overall Study|Withdrawal by Subject|129|||
125962667|NCT01337089|453155375|FG000|Overall Study|Withdrawal by Investigator|33|||
125962668|NCT01337089|453155375|FG000|Overall Study|Met Withdrawal Criteria|3|||
125962669|NCT01337089|453155375|FG000|Overall Study|Lost to Follow-up|2|||
125962670|NCT01040871|453155380|FG000|Overall Study|Adverse Event|6|||
125962671|NCT01040871|453155381|FG001|Overall Study|Adverse Event|2|||
125962672|NCT01040871|453155380|FG000|Overall Study|Withdrawal by Subject|2|||
125962673|NCT01040871|453155381|FG001|Overall Study|Withdrawal by Subject|0|||
125962674|NCT01040871|453155380|FG000|Overall Study|Death|1|||
125962675|NCT01040871|453155381|FG001|Overall Study|Death|3|||
125962676|NCT01040871|453155380|FG000|Overall Study|Lack of Efficacy|1|||
125962677|NCT01040871|453155381|FG001|Overall Study|Lack of Efficacy|1|||
125962678|NCT01040871|453155380|FG000|Overall Study|drug supply issue|1|||
125962679|NCT01040871|453155381|FG001|Overall Study|drug supply issue|0|||
125962680|NCT01040871|453155380|FG000|Overall Study|Randomized and Not Treated|2|||
125962681|NCT01040871|453155381|FG001|Overall Study|Randomized and Not Treated|1|||
125962682|NCT00673049|453155386|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
125962683|NCT00673049|453155387|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
125962684|NCT00673049|453155388|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
125962685|NCT00673049|453155389|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
125962686|NCT00673049|453155386|FG000|Before Progression on Erlotinib|Death|235|||
125962687|NCT00673049|453155387|FG001|Before Progression on Erlotinib|Death|167|||
125962688|NCT00673049|453155388|FG002|Before Progression on Erlotinib|Death|1|||
125962689|NCT00673049|453155389|FG003|Before Progression on Erlotinib|Death|0|||
125962690|NCT00673049|453155386|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
125962691|NCT00673049|453155387|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
125962692|NCT00673049|453155388|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
125962693|NCT00673049|453155389|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
125962694|NCT00673049|453155386|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
125962695|NCT00673049|453155387|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
125962696|NCT00673049|453155388|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
125962697|NCT00673049|453155389|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
125962698|NCT00673049|453155386|FG000|Before Progression on Erlotinib|Other|1|||
125962699|NCT00673049|453155387|FG001|Before Progression on Erlotinib|Other|2|||
125962700|NCT00673049|453155388|FG002|Before Progression on Erlotinib|Other|0|||
125962701|NCT00673049|453155389|FG003|Before Progression on Erlotinib|Other|0|||
125962702|NCT00673049|453155386|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
125962703|NCT00673049|453155387|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
125962704|NCT00673049|453155388|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
125962705|NCT00673049|453155389|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
125962706|NCT00673049|453155386|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
125962707|NCT00673049|453155387|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
125962708|NCT00673049|453155388|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
125962709|NCT00673049|453155389|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
125962710|NCT00673049|453155386|FG000|After Progression on Erlotinib|Death|0|||
125962711|NCT00673049|453155387|FG001|After Progression on Erlotinib|Death|0|||
125962712|NCT00673049|453155388|FG002|After Progression on Erlotinib|Death|0|||
125962713|NCT00673049|453155389|FG003|After Progression on Erlotinib|Death|71|||
125962714|NCT00673049|453155386|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
125962715|NCT00673049|453155387|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
125962716|NCT00673049|453155388|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
125962717|NCT00673049|453155389|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
125962718|NCT00673049|453155386|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
125962719|NCT00673049|453155387|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
125962720|NCT00673049|453155388|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
125962721|NCT00673049|453155389|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
125962722|NCT00673049|453155386|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
125962723|NCT00673049|453155387|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
126122516|NCT01553188|453740298|FG003|Overall Study|Patient choice|0|||
126122517|NCT01553188|453740295|FG000|Overall Study|Intercurrent illness and adverse event|0|||
126122518|NCT01553188|453740296|FG001|Overall Study|Intercurrent illness and adverse event|1|||
126122519|NCT01553188|453740297|FG002|Overall Study|Intercurrent illness and adverse event|2|||
126122520|NCT01553188|453740298|FG003|Overall Study|Intercurrent illness and adverse event|0|||
126122521|NCT01066585|453740304|FG000|Overall Study|Protocol Violation|1|||
126122522|NCT01066585|453740305|FG001|Overall Study|Protocol Violation|0|||
126122523|NCT01066585|453740304|FG000|Overall Study|Withdrawal by Subject|0|||
126122524|NCT01066585|453740305|FG001|Overall Study|Withdrawal by Subject|3|||
126122525|NCT04126083|453740306|FG000|Overall Study|Withdrawal by Subject|1|||
126122526|NCT01279850|453740307|FG000|Overall Study|Protocol Violation|50|||
125962724|NCT00673049|453155388|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
125962725|NCT00673049|453155389|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
125962726|NCT00924950|453155390|FG000|Overall Study|Lost to Follow-up|2|||
125962727|NCT02979535|453155391|FG000|Overall Study|Non compliance with the protocol|78|||
125962728|NCT02979535|453155392|FG001|Overall Study|Non compliance with the protocol|82|||
125962729|NCT02979535|453155391|FG000|Overall Study|Consent withdrawn by participant|11|||
125962730|NCT02979535|453155392|FG001|Overall Study|Consent withdrawn by participant|18|||
125962731|NCT02979535|453155391|FG000|Overall Study|Lost to Follow-up|6|||
125962732|NCT02979535|453155392|FG001|Overall Study|Lost to Follow-up|1|||
125962733|NCT04820673|453155393|FG000|Overall Study|Adverse Event|6|||
125962734|NCT04820673|453155393|FG000|Overall Study|Due to Lack of Effectiveness|1|||
125962735|NCT04820673|453155393|FG000|Overall Study|Pregnancy|1|||
125962736|NCT04820673|453155393|FG000|Overall Study|Voluntary Withdrawal|20|||
125962737|NCT04820673|453155393|FG000|Overall Study|Lost to Follow-up|10|||
125962738|NCT00587587|453155396|FG000|Overall Study|Lost to Follow-up|6|||
125962739|NCT00587587|453155397|FG001|Overall Study|Lost to Follow-up|1|||
125962740|NCT00633984|453155404|FG000|Overall Study|Lost to Follow-up|0|||
125962741|NCT00633984|453155405|FG001|Overall Study|Lost to Follow-up|6|||
125962742|NCT00633984|453155404|FG000|Overall Study|Withdrawal by Subject|8|||
125962743|NCT00633984|453155405|FG001|Overall Study|Withdrawal by Subject|7|||
125962744|NCT00633984|453155404|FG000|Overall Study|Hospitalized|1|||
125962745|NCT00633984|453155405|FG001|Overall Study|Hospitalized|0|||
125962746|NCT00097591|453155406|FG000|Overall Study|Withdrawal of consent|342|||
125962747|NCT00097591|453155407|FG001|Overall Study|Withdrawal of consent|323|||
125962748|NCT00097591|453155406|FG000|Overall Study|Less than 6 months on study drug|9|||
125962749|NCT00097591|453155407|FG001|Overall Study|Less than 6 months on study drug|7|||
125962750|NCT00097591|453155406|FG000|Overall Study|Unable to attend termination visit|53|||
125962751|NCT00097591|453155407|FG001|Overall Study|Unable to attend termination visit|51|||
125962752|NCT00097591|453155406|FG000|Overall Study|Lost to follow up|6|||
125962753|NCT00097591|453155407|FG001|Overall Study|Lost to follow up|10|||
125962754|NCT00097591|453155406|FG000|Overall Study|Other|0|||
125962755|NCT00097591|453155407|FG001|Overall Study|Other|3|||
125962756|NCT02530619|453155408|FG000|Registered for Study|Withdrawal by Subject|2|||
125962757|NCT02530619|453155408|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
125962758|NCT02530619|453155408|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
125962759|NCT02530619|453155408|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
125962760|NCT02530619|453155408|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
125962761|NCT02530619|453155408|FG000|Follow-up Period (6 Months)|Death|4|||
125962762|NCT02530619|453155408|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
125962763|NCT02530619|453155408|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
125962764|NCT01163682|453155413|FG000|Overall Study|Lost to Follow-up|6|||
125962765|NCT01163682|453155414|FG001|Overall Study|Lost to Follow-up|9|||
125962766|NCT00359762|453155420|FG000|Period II|Adverse Event|17|||
125962767|NCT00359762|453155421|FG001|Period II|Adverse Event|0|||
125962768|NCT00359762|453155422|FG002|Period II|Adverse Event|0|||
125962769|NCT00359762|453155423|FG003|Period II|Adverse Event|0|||
125962770|NCT00359762|453155424|FG004|Period II|Adverse Event|49|||
125962771|NCT00359762|453155420|FG000|Period II|Protocol Violation|18|||
125962772|NCT00359762|453155421|FG001|Period II|Protocol Violation|0|||
125962773|NCT00359762|453155422|FG002|Period II|Protocol Violation|0|||
125962774|NCT00359762|453155423|FG003|Period II|Protocol Violation|0|||
125962775|NCT00359762|453155424|FG004|Period II|Protocol Violation|11|||
125962776|NCT00359762|453155420|FG000|Period II|Physician Decision|17|||
125962777|NCT00359762|453155421|FG001|Period II|Physician Decision|0|||
126122527|NCT01279850|453740307|FG000|Overall Study|No Drug Administration Information|7|||
126122528|NCT01279850|453740307|FG000|Overall Study|No Visit After Treatment|34|||
126122529|NCT01131520|453740308|FG000|Overall Study|Computer problem|1|||
126122530|NCT01131520|453740309|FG001|Overall Study|Computer problem|0|||
126122531|NCT01131520|453740308|FG000|Overall Study|Counselor not available|0|||
126122532|NCT01131520|453740309|FG001|Overall Study|Counselor not available|3|||
126122533|NCT01131520|453740308|FG000|Overall Study|Subject changed history after enrollment|0|||
126122534|NCT01131520|453740309|FG001|Overall Study|Subject changed history after enrollment|1|||
126122535|NCT02186847|453740310|FG000|Overall Study|Protocol Violation|3|||
125962778|NCT00359762|453155422|FG002|Period II|Physician Decision|0|||
125962779|NCT00359762|453155423|FG003|Period II|Physician Decision|0|||
125962780|NCT00359762|453155424|FG004|Period II|Physician Decision|23|||
125962781|NCT00359762|453155420|FG000|Period II|Death|2|||
125962782|NCT00359762|453155421|FG001|Period II|Death|0|||
126122536|NCT02186847|453740311|FG001|Overall Study|Protocol Violation|0|||
126122537|NCT03416153|453740312|FG000|Overall Study|Physician Decision|1|||
126122538|NCT03416153|453740313|FG001|Overall Study|Physician Decision|1|||
125962783|NCT00359762|453155422|FG002|Period II|Death|0|||
125962784|NCT00359762|453155423|FG003|Period II|Death|0|||
125962785|NCT00359762|453155424|FG004|Period II|Death|4|||
125962786|NCT00359762|453155420|FG000|Period II|Lack of Efficacy|11|||
125962787|NCT00359762|453155421|FG001|Period II|Lack of Efficacy|0|||
125962788|NCT00359762|453155422|FG002|Period II|Lack of Efficacy|0|||
125962789|NCT00359762|453155423|FG003|Period II|Lack of Efficacy|0|||
126122539|NCT03416153|453740312|FG000|Overall Study|Withdrawal by Subject|1|||
126122540|NCT03416153|453740313|FG001|Overall Study|Withdrawal by Subject|0|||
126122541|NCT00666458|453742059|FG000|Overall Study|Adverse Event|8|||
126122542|NCT00666458|453742060|FG001|Overall Study|Adverse Event|7|||
126122543|NCT00666458|453742059|FG000|Overall Study|Withdrawal by Subject|5|||
126122544|NCT00666458|453742060|FG001|Overall Study|Withdrawal by Subject|4|||
126122545|NCT00666458|453742059|FG000|Overall Study|Lost to Follow-up|0|||
126122546|NCT00666458|453742060|FG001|Overall Study|Lost to Follow-up|3|||
126122547|NCT00666458|453742059|FG000|Overall Study|Administrative reason by sponsor|1|||
126122548|NCT00666458|453742060|FG001|Overall Study|Administrative reason by sponsor|1|||
126122549|NCT00666458|453742059|FG000|Overall Study|Incorrect enrollment|7|||
126122550|NCT00666458|453742060|FG001|Overall Study|Incorrect enrollment|1|||
126122551|NCT00666458|453742059|FG000|Overall Study|Study specific discontinuation criteria|14|||
126122552|NCT00666458|453742060|FG001|Overall Study|Study specific discontinuation criteria|7|||
126122553|NCT00666458|453742059|FG000|Overall Study|Severe non-compliance to the protocol|1|||
126122554|NCT00666458|453742060|FG001|Overall Study|Severe non-compliance to the protocol|1|||
126122555|NCT00666458|453742059|FG000|Overall Study|Safety reasons|1|||
126122556|NCT00666458|453742060|FG001|Overall Study|Safety reasons|0|||
126122557|NCT00666458|453742059|FG000|Overall Study|Medical history of anemia|1|||
126122558|NCT00666458|453742060|FG001|Overall Study|Medical history of anemia|0|||
126122559|NCT02222207|453742061|FG000|Overall Study|Death|1|||
126122560|NCT02222207|453742061|FG000|Overall Study|Other reasons|2|||
126122561|NCT02222207|453742061|FG000|Overall Study|Adverse Event|1|||
126122562|NCT00747643|453742062|FG000|Overall Study|Withdrawal by Subject|36|||
126122563|NCT00747643|453742063|FG001|Overall Study|Withdrawal by Subject|27|||
126122564|NCT02554019|453742064|FG000|Overall Study|Withdrawal by Subject|1|||
126122565|NCT02554019|453742065|FG001|Overall Study|Withdrawal by Subject|0|||
126122566|NCT02554019|453742066|FG002|Overall Study|Withdrawal by Subject|2|||
126122567|NCT02554019|453742064|FG000|Overall Study|Adverse Event|1|||
125962790|NCT00359762|453155424|FG004|Period II|Lack of Efficacy|8|||
126122568|NCT02554019|453742065|FG001|Overall Study|Adverse Event|0|||
126122569|NCT02554019|453742066|FG002|Overall Study|Adverse Event|0|||
125962791|NCT00359762|453155420|FG000|Period II|Lost to follow up|5|||
125962792|NCT00359762|453155421|FG001|Period II|Lost to follow up|0|||
125962793|NCT00359762|453155422|FG002|Period II|Lost to follow up|0|||
125962794|NCT00359762|453155423|FG003|Period II|Lost to follow up|0|||
126122570|NCT00772954|453742067|FG000|Overall Study|Adverse Event|0|||
126122571|NCT00772954|453742068|FG001|Overall Study|Adverse Event|0|||
126122572|NCT00772954|453742069|FG002|Overall Study|Adverse Event|1|||
126122573|NCT02495844|453742070|FG000|Overall Study|Lack of Efficacy|1|||
126122574|NCT02495844|453742071|FG001|Overall Study|Lack of Efficacy|2|||
126122575|NCT02495844|453742070|FG000|Overall Study|AE, non-fatal|0|||
126122576|NCT02495844|453742071|FG001|Overall Study|AE, non-fatal|1|||
126122577|NCT02495844|453742070|FG000|Overall Study|Hepatitis Positivity|0|||
126122578|NCT02495844|453742071|FG001|Overall Study|Hepatitis Positivity|1|||
126122579|NCT02325219|453742072|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
126122580|NCT02325219|453742073|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
125962795|NCT00359762|453155424|FG004|Period II|Lost to follow up|5|||
125962796|NCT00359762|453155420|FG000|Period II|Entry Criteria Not Met|8|||
125962797|NCT00359762|453155421|FG001|Period II|Entry Criteria Not Met|0|||
125962798|NCT00359762|453155422|FG002|Period II|Entry Criteria Not Met|0|||
125962799|NCT00359762|453155423|FG003|Period II|Entry Criteria Not Met|0|||
125962800|NCT00359762|453155424|FG004|Period II|Entry Criteria Not Met|4|||
125962801|NCT00359762|453155420|FG000|Period II|Subject Decision|50|||
125962802|NCT00359762|453155421|FG001|Period II|Subject Decision|0|||
125962803|NCT00359762|453155422|FG002|Period II|Subject Decision|0|||
125962804|NCT00359762|453155423|FG003|Period II|Subject Decision|0|||
125962805|NCT00359762|453155424|FG004|Period II|Subject Decision|70|||
125962806|NCT00359762|453155420|FG000|Period III|Protocol Violation|0|||
125962807|NCT00359762|453155421|FG001|Period III|Protocol Violation|5|||
125962808|NCT00359762|453155422|FG002|Period III|Protocol Violation|3|||
126122581|NCT02325219|453742074|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
126122582|NCT02325219|453742075|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
126122583|NCT02325219|453742076|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
126122584|NCT02325219|453742072|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
126122585|NCT02325219|453742073|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
126122586|NCT02325219|453742074|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126122587|NCT02325219|453742075|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126122588|NCT02325219|453742076|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126122589|NCT02325219|453742072|FG000|Controlled Period (Week 0 - 16)|Other|0|||
126122590|NCT02325219|453742073|FG001|Controlled Period (Week 0 - 16)|Other|0|||
126122591|NCT02325219|453742074|FG002|Controlled Period (Week 0 - 16)|Other|1|||
125962809|NCT00359762|453155423|FG003|Period III|Protocol Violation|8|||
125962810|NCT00359762|453155424|FG004|Period III|Protocol Violation|0|||
125962811|NCT00359762|453155420|FG000|Period III|Adverse Event|0|||
125962812|NCT00359762|453155421|FG001|Period III|Adverse Event|3|||
125962813|NCT00359762|453155422|FG002|Period III|Adverse Event|4|||
126122592|NCT02325219|453742075|FG003|Controlled Period (Week 0 - 16)|Other|0|||
126122593|NCT02325219|453742076|FG004|Controlled Period (Week 0 - 16)|Other|0|||
126122594|NCT02325219|453742072|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126122595|NCT02325219|453742073|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126122596|NCT02325219|453742074|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126122597|NCT02325219|453742075|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126122598|NCT02325219|453742076|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
126122599|NCT02325219|453742072|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
126122600|NCT02325219|453742073|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
126122601|NCT02325219|453742074|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
126122602|NCT02325219|453742075|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
126122603|NCT02325219|453742076|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
126122604|NCT02325219|453742072|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126122605|NCT02325219|453742073|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
126122606|NCT02325219|453742074|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126122607|NCT02325219|453742075|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126122608|NCT02325219|453742076|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126122609|NCT02634151|453742077|FG000|Overall Study|Withdrawal by Subject|1|||
126122610|NCT02634151|453742078|FG001|Overall Study|Withdrawal by Subject|0|||
126122611|NCT02634151|453742077|FG000|Overall Study|Non-Compliance|0|||
126122612|NCT02634151|453742078|FG001|Overall Study|Non-Compliance|1|||
126122613|NCT02634151|453742077|FG000|Overall Study|Other|0|||
126122614|NCT02634151|453742078|FG001|Overall Study|Other|1|||
126122615|NCT04640272|453742079|FG000|Overall Study|Subject moved out of area|1|||
126122616|NCT04353284|453742084|FG000|Overall Study|Adverse Event|1|||
126122617|NCT04353284|453742085|FG001|Overall Study|Adverse Event|1|||
126122618|NCT04353284|453742084|FG000|Overall Study|Lost to Follow-up|1|||
126122619|NCT04353284|453742085|FG001|Overall Study|Lost to Follow-up|0|||
126122620|NCT00751400|453742088|FG000|Overall Study|Lost to Follow-up|10|||
126122621|NCT00441974|453742093|FG000|Overall Study|Adverse Event|6|||
126122622|NCT00441974|453742093|FG000|Overall Study|Consent Withdrawn|35|||
126122623|NCT00441974|453742093|FG000|Overall Study|Lost to Follow-up|80|||
126122624|NCT00441974|453742093|FG000|Overall Study|Protocol Violation|7|||
126122625|NCT02770547|453742094|FG000|Overall Study|Patient non-compliant|1|||
126122626|NCT02770547|453742095|FG001|Overall Study|Patient non-compliant|0|||
126122627|NCT02770547|453742094|FG000|Overall Study|Adverse Event|0|||
126122628|NCT02770547|453742095|FG001|Overall Study|Adverse Event|1|||
126122629|NCT01148537|453742096|FG000|Overall Study|Withdrawal by Subject|1|||
126122630|NCT01148537|453742097|FG001|Overall Study|Withdrawal by Subject|0|||
126122631|NCT01148537|453742098|FG002|Overall Study|Withdrawal by Subject|2|||
126122632|NCT01148537|453742096|FG000|Overall Study|Adverse Event|2|||
126122633|NCT01148537|453742097|FG001|Overall Study|Adverse Event|0|||
126122634|NCT01148537|453742098|FG002|Overall Study|Adverse Event|1|||
126122635|NCT00393887|453742099|FG000|Overall Study|Physician Decision|5|||
126122636|NCT00393887|453742100|FG001|Overall Study|Physician Decision|0|||
126122637|NCT00393887|453742099|FG000|Overall Study|Lost to Follow-up|11|||
126122638|NCT00393887|453742100|FG001|Overall Study|Lost to Follow-up|9|||
126122639|NCT02055820|453742104|FG000|Phase I: Dose-Finding|Death|1|||
126122640|NCT02055820|453742105|FG001|Phase I: Dose-Finding|Death|0|||
126122641|NCT02055820|453742106|FG002|Phase I: Dose-Finding|Death|1|||
126122642|NCT02055820|453742107|FG003|Phase I: Dose-Finding|Death|2|||
126122643|NCT02055820|453742108|FG004|Phase I: Dose-Finding|Death|0|||
126122644|NCT02055820|453742109|FG005|Phase I: Dose-Finding|Death|1|||
126122645|NCT02055820|453742110|FG006|Phase I: Dose-Finding|Death|1|||
126122646|NCT02055820|453742111|FG007|Phase I: Dose-Finding|Death|0|||
126122647|NCT02055820|453742112|FG008|Phase I: Dose-Finding|Death|0|||
126122648|NCT02055820|453742113|FG009|Phase I: Dose-Finding|Death|0|||
126122649|NCT02055820|453742104|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122650|NCT02055820|453742105|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122651|NCT02055820|453742106|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122652|NCT02055820|453742107|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122653|NCT02055820|453742108|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122654|NCT02055820|453742109|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
126122655|NCT02055820|453742110|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122656|NCT02055820|453742111|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122657|NCT02055820|453742112|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122658|NCT02055820|453742113|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126122659|NCT02055820|453742104|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
126122660|NCT02055820|453742105|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
126122661|NCT02055820|453742106|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
126122662|NCT02055820|453742107|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
126122663|NCT02055820|453742108|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
126122664|NCT02055820|453742109|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
126122665|NCT02055820|453742110|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
126122666|NCT02055820|453742111|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
126122667|NCT02055820|453742112|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
126122668|NCT02055820|453742113|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
126122669|NCT02055820|453742104|FG000|Phase II: Expansion|Death|0|||
126122670|NCT02055820|453742105|FG001|Phase II: Expansion|Death|0|||
126122671|NCT02055820|453742106|FG002|Phase II: Expansion|Death|0|||
126122672|NCT02055820|453742107|FG003|Phase II: Expansion|Death|0|||
126122673|NCT02055820|453742108|FG004|Phase II: Expansion|Death|33|||
126122674|NCT02055820|453742109|FG005|Phase II: Expansion|Death|0|||
126122675|NCT02055820|453742110|FG006|Phase II: Expansion|Death|0|||
126122676|NCT02055820|453742111|FG007|Phase II: Expansion|Death|0|||
126122677|NCT02055820|453742112|FG008|Phase II: Expansion|Death|0|||
126122678|NCT02055820|453742113|FG009|Phase II: Expansion|Death|0|||
126122679|NCT02055820|453742104|FG000|Phase II: Expansion|Lost to Follow-up|0|||
126122680|NCT02055820|453742105|FG001|Phase II: Expansion|Lost to Follow-up|0|||
126122681|NCT02055820|453742106|FG002|Phase II: Expansion|Lost to Follow-up|0|||
126122682|NCT02055820|453742107|FG003|Phase II: Expansion|Lost to Follow-up|0|||
126122683|NCT02055820|453742108|FG004|Phase II: Expansion|Lost to Follow-up|4|||
126122684|NCT02055820|453742109|FG005|Phase II: Expansion|Lost to Follow-up|0|||
126122685|NCT02055820|453742110|FG006|Phase II: Expansion|Lost to Follow-up|0|||
126122686|NCT02055820|453742111|FG007|Phase II: Expansion|Lost to Follow-up|0|||
126122687|NCT02055820|453742112|FG008|Phase II: Expansion|Lost to Follow-up|0|||
126122688|NCT02055820|453742113|FG009|Phase II: Expansion|Lost to Follow-up|0|||
126122689|NCT02055820|453742104|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
126122690|NCT02055820|453742105|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
126122691|NCT02055820|453742106|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
126122692|NCT02055820|453742107|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
126122693|NCT02055820|453742108|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
126122694|NCT02055820|453742109|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
126122695|NCT02055820|453742110|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
126122696|NCT02055820|453742111|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
126122697|NCT02055820|453742112|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
126122698|NCT02055820|453742113|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
125962814|NCT00359762|453155423|FG003|Period III|Adverse Event|10|||
125962815|NCT00359762|453155424|FG004|Period III|Adverse Event|0|||
125962816|NCT00359762|453155420|FG000|Period III|Physician Decision|0|||
125962817|NCT00359762|453155421|FG001|Period III|Physician Decision|5|||
125962818|NCT00359762|453155422|FG002|Period III|Physician Decision|9|||
125962819|NCT00359762|453155423|FG003|Period III|Physician Decision|15|||
125962820|NCT00359762|453155424|FG004|Period III|Physician Decision|0|||
125962821|NCT00359762|453155420|FG000|Period III|Lack of Efficacy|0|||
125962822|NCT00359762|453155421|FG001|Period III|Lack of Efficacy|7|||
125962823|NCT00359762|453155422|FG002|Period III|Lack of Efficacy|5|||
125962824|NCT00359762|453155423|FG003|Period III|Lack of Efficacy|9|||
125962825|NCT00359762|453155424|FG004|Period III|Lack of Efficacy|0|||
125962826|NCT00359762|453155420|FG000|Period III|Lost to follow up|0|||
125962827|NCT00359762|453155421|FG001|Period III|Lost to follow up|1|||
125962828|NCT00359762|453155422|FG002|Period III|Lost to follow up|1|||
125962829|NCT00359762|453155423|FG003|Period III|Lost to follow up|2|||
125962830|NCT00359762|453155424|FG004|Period III|Lost to follow up|0|||
125962831|NCT00359762|453155420|FG000|Period III|Entry Criteria Not Met|0|||
125962832|NCT00359762|453155421|FG001|Period III|Entry Criteria Not Met|1|||
125962833|NCT00359762|453155422|FG002|Period III|Entry Criteria Not Met|0|||
125962834|NCT00359762|453155423|FG003|Period III|Entry Criteria Not Met|1|||
125962835|NCT00359762|453155424|FG004|Period III|Entry Criteria Not Met|0|||
125962836|NCT00359762|453155420|FG000|Period III|Subject Decision|0|||
125962837|NCT00359762|453155421|FG001|Period III|Subject Decision|7|||
125962838|NCT00359762|453155422|FG002|Period III|Subject Decision|8|||
125962839|NCT00359762|453155423|FG003|Period III|Subject Decision|20|||
125962840|NCT00359762|453155424|FG004|Period III|Subject Decision|0|||
125962841|NCT00530023|453155425|FG000|Overall Study|Withdrawal by Subject|0|||
125962842|NCT00530023|453155426|FG001|Overall Study|Withdrawal by Subject|1|||
125962843|NCT01557946|453155429|FG000|Overall Study|Adverse Event|3|||
125962844|NCT01557946|453155430|FG001|Overall Study|Adverse Event|0|||
125962845|NCT03586999|453155437|FG000|Overall Study|Lack of Efficacy|2|||
125962846|NCT04096560|453155438|FG000|Overall Study|Reason not Specified|1|||
125962847|NCT04096560|453155439|FG001|Overall Study|Reason not Specified|0|||
126122699|NCT02018822|453742114|FG000|Overall Study|filling replaced by crown|0|||
126122700|NCT02018822|453742115|FG001|Overall Study|filling replaced by crown|1|||
126122701|NCT02018822|453742116|FG002|Overall Study|filling replaced by crown|0|||
126122702|NCT02018822|453742114|FG000|Overall Study|Physician Decision|0|||
126122703|NCT02018822|453742115|FG001|Overall Study|Physician Decision|1|||
126122704|NCT02018822|453742116|FG002|Overall Study|Physician Decision|1|||
125962848|NCT04096560|453155440|FG002|Overall Study|Reason not Specified|0|||
125962849|NCT04096560|453155441|FG003|Overall Study|Reason not Specified|0|||
125962850|NCT04096560|453155442|FG004|Overall Study|Reason not Specified|1|||
125962851|NCT04096560|453155443|FG005|Overall Study|Reason not Specified|1|||
125962852|NCT04096560|453155444|FG006|Overall Study|Reason not Specified|1|||
126122705|NCT02018822|453742114|FG000|Overall Study|Lost to Follow-up|6|||
126122706|NCT02018822|453742115|FG001|Overall Study|Lost to Follow-up|6|||
126122707|NCT02018822|453742116|FG002|Overall Study|Lost to Follow-up|5|||
126122708|NCT01389752|453742119|FG000|Study Period 1|Sponsor decision|0|||
126122709|NCT01389752|453742120|FG001|Study Period 1|Sponsor decision|2|||
126122710|NCT01389752|453742119|FG000|Study Period 2|Sponsor decision|1|||
126122711|NCT01389752|453742120|FG001|Study Period 2|Sponsor decision|0|||
126122712|NCT01157364|453742125|FG000|Overall Study|Other Reasons|1|||
126122713|NCT01157364|453742126|FG001|Overall Study|Other Reasons|1|||
126122714|NCT01157364|453742127|FG002|Overall Study|Other Reasons|2|||
126122715|NCT01157364|453742128|FG003|Overall Study|Other Reasons|1|||
126122716|NCT01157364|453742129|FG004|Overall Study|Other Reasons|0|||
126122717|NCT01157364|453742130|FG005|Overall Study|Other Reasons|0|||
126122718|NCT01157364|453742125|FG000|Overall Study|Personal Reasons|0|||
126122719|NCT01157364|453742126|FG001|Overall Study|Personal Reasons|2|||
126122720|NCT01157364|453742127|FG002|Overall Study|Personal Reasons|0|||
126122721|NCT01157364|453742128|FG003|Overall Study|Personal Reasons|0|||
126122722|NCT01157364|453742129|FG004|Overall Study|Personal Reasons|1|||
126122723|NCT01157364|453742130|FG005|Overall Study|Personal Reasons|1|||
126122724|NCT01157364|453742125|FG000|Overall Study|Lost to Follow-up|1|||
126122725|NCT01157364|453742126|FG001|Overall Study|Lost to Follow-up|0|||
126122726|NCT01157364|453742127|FG002|Overall Study|Lost to Follow-up|1|||
126122727|NCT01157364|453742128|FG003|Overall Study|Lost to Follow-up|0|||
125962853|NCT04096560|453155445|FG007|Overall Study|Reason not Specified|0|||
125962854|NCT04096560|453155438|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125962855|NCT04096560|453155439|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125962856|NCT04096560|453155440|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125962857|NCT04096560|453155441|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125962858|NCT04096560|453155442|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125962859|NCT04096560|453155443|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
125962860|NCT04096560|453155444|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
125962861|NCT04096560|453155445|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
126122728|NCT01157364|453742129|FG004|Overall Study|Lost to Follow-up|0|||
126122729|NCT01157364|453742130|FG005|Overall Study|Lost to Follow-up|0|||
126122730|NCT01157364|453742125|FG000|Overall Study|Lack of Efficacy|0|||
126122731|NCT01157364|453742126|FG001|Overall Study|Lack of Efficacy|0|||
126122732|NCT01157364|453742127|FG002|Overall Study|Lack of Efficacy|0|||
126122733|NCT01157364|453742128|FG003|Overall Study|Lack of Efficacy|1|||
126122734|NCT01157364|453742129|FG004|Overall Study|Lack of Efficacy|0|||
126122735|NCT01157364|453742130|FG005|Overall Study|Lack of Efficacy|0|||
126122736|NCT01157364|453742125|FG000|Overall Study|Adverse Event|0|||
126122737|NCT01157364|453742126|FG001|Overall Study|Adverse Event|1|||
126122738|NCT01157364|453742127|FG002|Overall Study|Adverse Event|1|||
126122739|NCT01157364|453742128|FG003|Overall Study|Adverse Event|0|||
126122740|NCT01157364|453742129|FG004|Overall Study|Adverse Event|1|||
126122741|NCT01157364|453742130|FG005|Overall Study|Adverse Event|0|||
126122742|NCT04251910|453742144|FG000|Overall Study|Covid 19 lockdown|0|||
126122743|NCT04251910|453742145|FG001|Overall Study|Covid 19 lockdown|5|||
126122744|NCT04251910|453742146|FG002|Overall Study|Covid 19 lockdown|0|||
126122745|NCT04251910|453742147|FG003|Overall Study|Covid 19 lockdown|4|||
126122746|NCT04251910|453742148|FG004|Overall Study|Covid 19 lockdown|0|||
126122747|NCT04251910|453742149|FG005|Overall Study|Covid 19 lockdown|0|||
126122748|NCT04251910|453742144|FG000|Overall Study|Assisted living facility was closed|0|||
126122749|NCT04251910|453742145|FG001|Overall Study|Assisted living facility was closed|0|||
126122750|NCT04251910|453742146|FG002|Overall Study|Assisted living facility was closed|0|||
126122751|NCT04251910|453742147|FG003|Overall Study|Assisted living facility was closed|0|||
126122752|NCT04251910|453742148|FG004|Overall Study|Assisted living facility was closed|1|||
126122753|NCT04251910|453742149|FG005|Overall Study|Assisted living facility was closed|0|||
126122754|NCT00841568|453742152|FG000|Overall Study|Adverse Event|1|||
126122755|NCT00841568|453742152|FG000|Overall Study|Death|1|||
126122756|NCT00841568|453742152|FG000|Overall Study|Withdrawal by Subject|2|||
126122757|NCT00841568|453742152|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
126122758|NCT00133991|453742153|FG000|Overall Study|Death|4|||
126122759|NCT03002155|453742154|FG000|Overall Study|Lost to Follow-up|1|||
126122760|NCT03002155|453742155|FG001|Overall Study|Lost to Follow-up|2|||
126122761|NCT03002155|453742154|FG000|Overall Study|Withdrawal by Subject|1|||
126122762|NCT03002155|453742155|FG001|Overall Study|Withdrawal by Subject|0|||
126122763|NCT03002155|453742154|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
126122764|NCT03002155|453742155|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
126122765|NCT00978029|453742156|FG000|Overall Study|Adverse Event|1|||
126122766|NCT00978029|453742157|FG001|Overall Study|Adverse Event|2|||
126122767|NCT00978029|453742158|FG002|Overall Study|Adverse Event|5|||
126122768|NCT00978029|453742156|FG000|Overall Study|Withdrawal by Subject|0|||
126122769|NCT00978029|453742157|FG001|Overall Study|Withdrawal by Subject|0|||
126122770|NCT00978029|453742158|FG002|Overall Study|Withdrawal by Subject|1|||
126122771|NCT00978029|453742156|FG000|Overall Study|Protocol Violation|0|||
126122772|NCT00978029|453742157|FG001|Overall Study|Protocol Violation|1|||
125962862|NCT04096560|453155438|FG000|Overall Study|Study Terminated by Sponsor|0|||
125962863|NCT04096560|453155439|FG001|Overall Study|Study Terminated by Sponsor|0|||
125962864|NCT04096560|453155440|FG002|Overall Study|Study Terminated by Sponsor|0|||
125962865|NCT04096560|453155441|FG003|Overall Study|Study Terminated by Sponsor|5|||
125962866|NCT04096560|453155442|FG004|Overall Study|Study Terminated by Sponsor|6|||
125962867|NCT04096560|453155443|FG005|Overall Study|Study Terminated by Sponsor|4|||
125962868|NCT04096560|453155444|FG006|Overall Study|Study Terminated by Sponsor|6|||
125962869|NCT04096560|453155445|FG007|Overall Study|Study Terminated by Sponsor|1|||
125962870|NCT04096560|453155438|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125962871|NCT04096560|453155439|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125962872|NCT04096560|453155440|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125962873|NCT04096560|453155441|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125962874|NCT04096560|453155442|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125962875|NCT04096560|453155443|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125962876|NCT04096560|453155444|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125962877|NCT04096560|453155445|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
125962878|NCT02464969|453155446|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
125962879|NCT02464969|453155447|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
125962880|NCT02464969|453155446|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
126122773|NCT00978029|453742158|FG002|Overall Study|Protocol Violation|0|||
126122774|NCT04744207|453742160|FG000|Treatment|Withdrawal by Subject|2|||
126122775|NCT04744207|453742161|FG001|Treatment|Withdrawal by Subject|0|||
126122776|NCT04744207|453742160|FG000|Treatment|Adverse Event|1|||
126122777|NCT04744207|453742161|FG001|Treatment|Adverse Event|2|||
126122778|NCT01617070|453742166|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
126122779|NCT05289570|453742167|FG000|Overall Study|Physician Decision|1|||
126122780|NCT00777101|453742170|FG000|Overall Study|Death|48|||
126122781|NCT00777101|453742171|FG001|Overall Study|Death|43|||
126122782|NCT00777101|453742170|FG000|Overall Study|Withdrawal by Subject|11|||
126122783|NCT00777101|453742171|FG001|Overall Study|Withdrawal by Subject|6|||
126122784|NCT00777101|453742170|FG000|Overall Study|Lost to Follow-up|2|||
126122785|NCT00777101|453742171|FG001|Overall Study|Lost to Follow-up|1|||
126122786|NCT00777101|453742170|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
126122787|NCT00777101|453742171|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126122788|NCT00777101|453742170|FG000|Overall Study|Failed to Return|0|||
126122789|NCT00777101|453742171|FG001|Overall Study|Failed to Return|1|||
126122790|NCT02230384|453742172|FG000|Phase 1|Lost to Follow-up|1|||
126122791|NCT02230384|453742173|FG001|Phase 1|Lost to Follow-up|0|||
126122792|NCT02230384|453742172|FG000|Phase 1|Physician Decision|0|||
126122793|NCT02230384|453742173|FG001|Phase 1|Physician Decision|1|||
126122794|NCT02230384|453742172|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
126122795|NCT02230384|453742173|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
126122796|NCT02230384|453742172|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
126122797|NCT02230384|453742173|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
126122798|NCT02230384|453742172|FG000|Phase 2 - Switch|Adverse Event|2|||
126122799|NCT02230384|453742173|FG001|Phase 2 - Switch|Adverse Event|0|||
126122800|NCT00808236|453742174|FG000|Overall Study|Was not resuscitated|50|||
126122801|NCT00808236|453742175|FG001|Overall Study|Was not resuscitated|56|||
126122802|NCT00808236|453742174|FG000|Overall Study|Pre-defined exclusion|13|||
126122803|NCT00808236|453742175|FG001|Overall Study|Pre-defined exclusion|3|||
126122804|NCT00808236|453742174|FG000|Overall Study|Lost to Follow-up|1|||
126122805|NCT00808236|453742175|FG001|Overall Study|Lost to Follow-up|1|||
126122806|NCT00808236|453742174|FG000|Overall Study|Physician Decision|0|||
126122807|NCT00808236|453742175|FG001|Overall Study|Physician Decision|1|||
126122808|NCT00808236|453742174|FG000|Overall Study|Death|18|||
126122809|NCT00808236|453742175|FG001|Overall Study|Death|30|||
126122810|NCT00961220|453742176|FG000|Overall Study|Adverse Event|3|||
126122811|NCT00961220|453742176|FG000|Overall Study|Lack of Efficacy|1|||
126122812|NCT00961220|453742176|FG000|Overall Study|No IV access for O6BG|1|||
126122813|NCT00961220|453742176|FG000|Overall Study|O6BG no longer supplied|1|||
126122814|NCT00961220|453742176|FG000|Overall Study|Complete Response prior to 12 courses|1|||
126122815|NCT05376215|453742177|FG000|Overall Study|Withdrawal by Subject|2|||
126122816|NCT05376215|453742178|FG001|Overall Study|Withdrawal by Subject|1|||
126122817|NCT05376215|453742177|FG000|Overall Study|Lost to Follow-up|0|||
126122818|NCT05376215|453742178|FG001|Overall Study|Lost to Follow-up|1|||
126122819|NCT01301950|453742185|FG000|Overall Study|Surgery was cancelled by patient|0|||
126122820|NCT01301950|453742186|FG001|Overall Study|Surgery was cancelled by patient|1|||
126122821|NCT00786565|453742196|FG000|Enrollment Prior to Surgery|Site Closed|3|||
126122822|NCT00786565|453742196|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
126122823|NCT00786565|453742196|FG000|Post Surgery|Abnormal macular pucker|1|||
126122824|NCT00786565|453742196|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
126122825|NCT05248295|453742202|FG000|Overall Study|found ineligible|4|||
126122826|NCT05248295|453742203|FG001|Overall Study|found ineligible|1|||
126122827|NCT05248295|453742202|FG000|Overall Study|Withdrawal by Subject|0|||
125962881|NCT02464969|453155447|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
126122828|NCT05248295|453742203|FG001|Overall Study|Withdrawal by Subject|1|||
126122829|NCT05248295|453742202|FG000|Overall Study|Data loss: audio recording error|1|||
126122830|NCT05248295|453742203|FG001|Overall Study|Data loss: audio recording error|1|||
126122831|NCT03021499|453742204|FG000|Overall Study|Adverse Event|1|||
126122832|NCT03021499|453742205|FG001|Overall Study|Adverse Event|0|||
126122833|NCT03021499|453742204|FG000|Overall Study|Death|1|||
126122834|NCT03021499|453742205|FG001|Overall Study|Death|5|||
126122835|NCT03021499|453742204|FG000|Overall Study|Lack of Efficacy|0|||
126122836|NCT03021499|453742205|FG001|Overall Study|Lack of Efficacy|1|||
125962882|NCT02464969|453155446|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
125962883|NCT02464969|453155447|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
125962884|NCT02464969|453155446|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
125962885|NCT02464969|453155447|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
125962886|NCT02464969|453155446|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
125962887|NCT02464969|453155447|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
125962888|NCT02464969|453155446|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
125962889|NCT02464969|453155447|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
125962890|NCT02464969|453155446|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
125962891|NCT02464969|453155447|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
125962892|NCT02464969|453155446|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
125962893|NCT02464969|453155447|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
125962894|NCT02464969|453155446|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
125962895|NCT02464969|453155447|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
125962896|NCT02464969|453155446|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
125962897|NCT02464969|453155447|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
125962898|NCT02464969|453155446|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
125962899|NCT02464969|453155447|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
125962900|NCT00534352|453155448|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
125962901|NCT00534352|453155448|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
125962902|NCT00534352|453155448|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
125962903|NCT00534352|453155448|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
125962904|NCT00534352|453155448|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
125962905|NCT00534352|453155448|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
125962906|NCT02399085|453155453|FG000|Overall Study|Adverse Event|16|||
125962907|NCT02399085|453155453|FG000|Overall Study|Death|2|||
125962908|NCT02399085|453155453|FG000|Overall Study|Withdrawal by Subject|8|||
125962909|NCT02399085|453155453|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
125962910|NCT02399085|453155453|FG000|Overall Study|Physician Decision|5|||
125962911|NCT00833924|453155454|FG000|Overall Study|Death|21|||
125962912|NCT00833924|453155454|FG000|Overall Study|Conversion|2|||
125962913|NCT00833924|453155454|FG000|Overall Study|Lost to Follow-up|2|||
125962914|NCT00833924|453155454|FG000|Overall Study|Withdrawal by Subject|13|||
125962915|NCT00833924|453155454|FG000|Overall Study|In study follow-up|71|||
125962916|NCT01485861|453155455|FG000|Phase Ib|Death|1|||
125962917|NCT01485861|453155456|FG001|Phase Ib|Death|0|||
125962918|NCT01485861|453155457|FG002|Phase Ib|Death|0|||
125962919|NCT01485861|453155458|FG003|Phase Ib|Death|0|||
125962920|NCT01485861|453155459|FG004|Phase Ib|Death|0|||
125962921|NCT01485861|453155460|FG005|Phase Ib|Death|0|||
125962922|NCT01485861|453155455|FG000|Phase Ib|Physician Decision|1|||
125962923|NCT01485861|453155456|FG001|Phase Ib|Physician Decision|1|||
125962924|NCT01485861|453155457|FG002|Phase Ib|Physician Decision|0|||
125962925|NCT01485861|453155458|FG003|Phase Ib|Physician Decision|0|||
125962926|NCT01485861|453155459|FG004|Phase Ib|Physician Decision|0|||
125962927|NCT01485861|453155460|FG005|Phase Ib|Physician Decision|0|||
125962928|NCT01485861|453155455|FG000|Phase Ib|Adverse Event|0|||
125962929|NCT01485861|453155456|FG001|Phase Ib|Adverse Event|4|||
125962930|NCT01485861|453155457|FG002|Phase Ib|Adverse Event|0|||
125962931|NCT01485861|453155458|FG003|Phase Ib|Adverse Event|0|||
125962932|NCT01485861|453155459|FG004|Phase Ib|Adverse Event|0|||
125962933|NCT01485861|453155460|FG005|Phase Ib|Adverse Event|0|||
125962934|NCT01485861|453155455|FG000|Phase Ib|Progression of disease|5|||
125962935|NCT01485861|453155456|FG001|Phase Ib|Progression of disease|0|||
125962936|NCT01485861|453155457|FG002|Phase Ib|Progression of disease|0|||
126122837|NCT03021499|453742204|FG000|Overall Study|Lost to Follow-up|1|||
126122838|NCT03021499|453742205|FG001|Overall Study|Lost to Follow-up|3|||
126122839|NCT03021499|453742204|FG000|Overall Study|Physician Decision|2|||
125962937|NCT01485861|453155458|FG003|Phase Ib|Progression of disease|0|||
125962938|NCT01485861|453155459|FG004|Phase Ib|Progression of disease|0|||
125962939|NCT01485861|453155460|FG005|Phase Ib|Progression of disease|0|||
126122840|NCT03021499|453742205|FG001|Overall Study|Physician Decision|3|||
126122841|NCT03021499|453742204|FG000|Overall Study|Pregnancy|1|||
125962940|NCT01485861|453155455|FG000|Phase Ib|Other|3|||
125962941|NCT01485861|453155456|FG001|Phase Ib|Other|0|||
125962942|NCT01485861|453155457|FG002|Phase Ib|Other|0|||
125962943|NCT01485861|453155458|FG003|Phase Ib|Other|0|||
125962944|NCT01485861|453155459|FG004|Phase Ib|Other|0|||
126122842|NCT03021499|453742205|FG001|Overall Study|Pregnancy|0|||
125962945|NCT01485861|453155460|FG005|Phase Ib|Other|0|||
125962946|NCT01485861|453155455|FG000|Phase Ib|Withdrawal by Subject|4|||
125962947|NCT01485861|453155456|FG001|Phase Ib|Withdrawal by Subject|1|||
125962948|NCT01485861|453155457|FG002|Phase Ib|Withdrawal by Subject|0|||
125962949|NCT01485861|453155458|FG003|Phase Ib|Withdrawal by Subject|0|||
125962950|NCT01485861|453155459|FG004|Phase Ib|Withdrawal by Subject|0|||
125962951|NCT01485861|453155460|FG005|Phase Ib|Withdrawal by Subject|0|||
125962952|NCT01485861|453155455|FG000|Phase II|Death|0|||
125962953|NCT01485861|453155456|FG001|Phase II|Death|0|||
125962954|NCT01485861|453155457|FG002|Phase II|Death|67|||
125962955|NCT01485861|453155458|FG003|Phase II|Death|71|||
125962956|NCT01485861|453155459|FG004|Phase II|Death|68|||
125962957|NCT01485861|453155460|FG005|Phase II|Death|0|||
125962958|NCT01485861|453155455|FG000|Phase II|Progression of Disease|0|||
125962959|NCT01485861|453155456|FG001|Phase II|Progression of Disease|0|||
125962960|NCT01485861|453155457|FG002|Phase II|Progression of Disease|1|||
125962961|NCT01485861|453155458|FG003|Phase II|Progression of Disease|0|||
125962962|NCT01485861|453155459|FG004|Phase II|Progression of Disease|0|||
125962963|NCT01485861|453155460|FG005|Phase II|Progression of Disease|0|||
125962964|NCT01485861|453155455|FG000|Phase II|Other|0|||
125962965|NCT01485861|453155456|FG001|Phase II|Other|0|||
125962966|NCT01485861|453155457|FG002|Phase II|Other|0|||
125962967|NCT01485861|453155458|FG003|Phase II|Other|1|||
125962968|NCT01485861|453155459|FG004|Phase II|Other|0|||
125962969|NCT01485861|453155460|FG005|Phase II|Other|0|||
126122843|NCT03021499|453742204|FG000|Overall Study|Withdrawal by Subject|7|||
126122844|NCT03021499|453742205|FG001|Overall Study|Withdrawal by Subject|14|||
126122845|NCT03021499|453742204|FG000|Overall Study|Prohibited medication required|1|||
126122846|NCT03021499|453742205|FG001|Overall Study|Prohibited medication required|0|||
125962970|NCT01485861|453155455|FG000|Phase II|Withdrawal by Subject|0|||
125962971|NCT01485861|453155456|FG001|Phase II|Withdrawal by Subject|0|||
125962972|NCT01485861|453155457|FG002|Phase II|Withdrawal by Subject|6|||
125962973|NCT01485861|453155458|FG003|Phase II|Withdrawal by Subject|3|||
125962974|NCT01485861|453155459|FG004|Phase II|Withdrawal by Subject|4|||
125962975|NCT01485861|453155460|FG005|Phase II|Withdrawal by Subject|0|||
125962976|NCT01485861|453155455|FG000|Phase II|Lost to Follow-up|0|||
125962977|NCT01485861|453155456|FG001|Phase II|Lost to Follow-up|0|||
125962978|NCT01485861|453155457|FG002|Phase II|Lost to Follow-up|2|||
125962979|NCT01485861|453155458|FG003|Phase II|Lost to Follow-up|3|||
125962980|NCT01485861|453155459|FG004|Phase II|Lost to Follow-up|5|||
125962981|NCT01485861|453155460|FG005|Phase II|Lost to Follow-up|0|||
125962982|NCT01485861|453155455|FG000|Phase II|Study Ended|0|||
125962983|NCT01485861|453155456|FG001|Phase II|Study Ended|0|||
125962984|NCT01485861|453155457|FG002|Phase II|Study Ended|7|||
125962985|NCT01485861|453155458|FG003|Phase II|Study Ended|8|||
125962986|NCT01485861|453155459|FG004|Phase II|Study Ended|6|||
125962987|NCT01485861|453155460|FG005|Phase II|Study Ended|0|||
125962988|NCT01485861|453155455|FG000|Safety Phase|Death|0|||
125962989|NCT01485861|453155456|FG001|Safety Phase|Death|0|||
126122847|NCT03021499|453742204|FG000|Overall Study|Protocol non-compliance|1|||
126122848|NCT03021499|453742205|FG001|Overall Study|Protocol non-compliance|1|||
126122849|NCT03021499|453742204|FG000|Overall Study|None of the above|0|||
126122850|NCT03021499|453742205|FG001|Overall Study|None of the above|4|||
126122851|NCT03021499|453742204|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
126122852|NCT03021499|453742205|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
126122853|NCT01210690|453742206|FG000|Overall Study|Adverse Event|7|||
126122854|NCT01210690|453742206|FG000|Overall Study|Lack of Efficacy|12|||
126122855|NCT01210690|453742206|FG000|Overall Study|Lost to Follow-up|3|||
126122856|NCT01210690|453742206|FG000|Overall Study|Disease Remission|1|||
126122857|NCT01210690|453742206|FG000|Overall Study|Withdrawal by Subject|1|||
126122858|NCT01210690|453742206|FG000|Overall Study|Patient refused to swallow|1|||
126122859|NCT01210690|453742206|FG000|Overall Study|Patient could not take glucose|1|||
126122860|NCT00470054|453742207|FG000|Overall Study|Ineligible|1|||
126122861|NCT04869345|453742214|FG000|Overall Study|Lost to Follow-up|8|||
126122862|NCT04869345|453742215|FG001|Overall Study|Lost to Follow-up|3|||
126122863|NCT00528021|453742219|FG000|Overall Study|Lack of Efficacy|17|||
126122864|NCT00528021|453742220|FG001|Overall Study|Lack of Efficacy|13|||
126122865|NCT00528021|453742221|FG002|Overall Study|Lack of Efficacy|7|||
125962990|NCT01485861|453155457|FG002|Safety Phase|Death|0|||
125962991|NCT01485861|453155458|FG003|Safety Phase|Death|0|||
125962992|NCT01485861|453155459|FG004|Safety Phase|Death|0|||
125962993|NCT01485861|453155460|FG005|Safety Phase|Death|2|||
125962994|NCT01485861|453155455|FG000|Safety Phase|Adverse Event|0|||
125962995|NCT01485861|453155456|FG001|Safety Phase|Adverse Event|0|||
125962996|NCT01485861|453155457|FG002|Safety Phase|Adverse Event|0|||
125962997|NCT01485861|453155458|FG003|Safety Phase|Adverse Event|0|||
125962998|NCT01485861|453155459|FG004|Safety Phase|Adverse Event|0|||
125962999|NCT01485861|453155460|FG005|Safety Phase|Adverse Event|1|||
125963000|NCT01485861|453155455|FG000|Safety Phase|Other|0|||
125963001|NCT01485861|453155456|FG001|Safety Phase|Other|0|||
125963002|NCT01485861|453155457|FG002|Safety Phase|Other|0|||
125963003|NCT01485861|453155458|FG003|Safety Phase|Other|0|||
125963004|NCT01485861|453155459|FG004|Safety Phase|Other|0|||
126122866|NCT00528021|453742222|FG003|Overall Study|Lack of Efficacy|9|||
126122867|NCT04050982|453742223|FG000|Overall Study|Did not meet eligibility criteria|0|||
126122868|NCT04050982|453742224|FG001|Overall Study|Did not meet eligibility criteria|1|||
126122869|NCT04050982|453742225|FG002|Overall Study|Did not meet eligibility criteria|0|||
126122870|NCT04050982|453742223|FG000|Overall Study|Withdrawal by Subject|1|||
126122871|NCT04050982|453742224|FG001|Overall Study|Withdrawal by Subject|0|||
126122872|NCT04050982|453742225|FG002|Overall Study|Withdrawal by Subject|0|||
126122873|NCT04050982|453742223|FG000|Overall Study|Unable to enroll on platform|1|||
126122874|NCT04050982|453742224|FG001|Overall Study|Unable to enroll on platform|0|||
126122875|NCT04050982|453742225|FG002|Overall Study|Unable to enroll on platform|0|||
126122876|NCT05054114|453742226|FG000|Overall Study|Protocol Violation|13|||
126122877|NCT05054114|453742227|FG001|Overall Study|Protocol Violation|1|||
126122878|NCT05054114|453742226|FG000|Overall Study|Pregnancy|0|||
126122879|NCT05054114|453742227|FG001|Overall Study|Pregnancy|1|||
126122880|NCT00733954|453742228|FG000|Overall Study|Lost to Follow-up|5|||
126122881|NCT00733954|453742229|FG001|Overall Study|Lost to Follow-up|2|||
126122882|NCT00733954|453742228|FG000|Overall Study|Protocol Violation|1|||
126122883|NCT00733954|453742229|FG001|Overall Study|Protocol Violation|0|||
126122884|NCT00733954|453742228|FG000|Overall Study|Withdrawal by Subject|2|||
126122885|NCT00733954|453742229|FG001|Overall Study|Withdrawal by Subject|0|||
126122886|NCT02663453|453742230|FG000|Overall Study|Death|4|||
126122887|NCT02663453|453742231|FG001|Overall Study|Death|4|||
126122888|NCT02663453|453742230|FG000|Overall Study|Withdrawal by Subject|1|||
126122889|NCT02663453|453742231|FG001|Overall Study|Withdrawal by Subject|0|||
126122890|NCT03557281|453743780|FG000|Overall Study|Investigator discretion|0|||
126122891|NCT03557281|453743781|FG001|Overall Study|Investigator discretion|0|||
126122892|NCT03557281|453743782|FG002|Overall Study|Investigator discretion|1|||
126122893|NCT03557281|453743783|FG003|Overall Study|Investigator discretion|0|||
126122894|NCT03557281|453743784|FG004|Overall Study|Investigator discretion|0|||
126122895|NCT03557281|453743780|FG000|Overall Study|Withdrawal by Subject|0|||
126122896|NCT03557281|453743781|FG001|Overall Study|Withdrawal by Subject|1|||
126122897|NCT03557281|453743782|FG002|Overall Study|Withdrawal by Subject|1|||
126122898|NCT03557281|453743783|FG003|Overall Study|Withdrawal by Subject|1|||
126122899|NCT03557281|453743784|FG004|Overall Study|Withdrawal by Subject|2|||
126122900|NCT03557281|453743780|FG000|Overall Study|Randomized, but did not receive treatment|0|||
126122901|NCT03557281|453743781|FG001|Overall Study|Randomized, but did not receive treatment|0|||
126122902|NCT03557281|453743782|FG002|Overall Study|Randomized, but did not receive treatment|0|||
126122903|NCT03557281|453743783|FG003|Overall Study|Randomized, but did not receive treatment|0|||
126122904|NCT03557281|453743784|FG004|Overall Study|Randomized, but did not receive treatment|1|||
126122905|NCT00402649|453743785|FG000|Overall Study|Lost to Follow-up|1|||
126122906|NCT00402649|453743785|FG000|Overall Study|Withdrawal by Subject|1|||
126122907|NCT01999465|453743786|FG000|Overall Study|Lost to Follow-up|0|||
126122908|NCT01999465|453743787|FG001|Overall Study|Lost to Follow-up|2|||
126122909|NCT01999465|453743786|FG000|Overall Study|Protocol Violation|0|||
126122910|NCT01999465|453743787|FG001|Overall Study|Protocol Violation|1|||
126122911|NCT01611974|453743796|FG000|Overall Study|Death|10|||
126122912|NCT01611974|453743797|FG001|Overall Study|Death|12|||
126122913|NCT01611974|453743798|FG002|Overall Study|Death|10|||
126122914|NCT01611974|453743796|FG000|Overall Study|Lost to Follow-up|0|||
126122915|NCT01611974|453743797|FG001|Overall Study|Lost to Follow-up|1|||
126122916|NCT01611974|453743798|FG002|Overall Study|Lost to Follow-up|0|||
126122917|NCT01611974|453743796|FG000|Overall Study|Physician Decision|5|||
126122918|NCT01611974|453743797|FG001|Overall Study|Physician Decision|1|||
126122919|NCT01611974|453743798|FG002|Overall Study|Physician Decision|2|||
125963005|NCT01485861|453155460|FG005|Safety Phase|Other|5|||
126122920|NCT01611974|453743796|FG000|Overall Study|Withdrawal by Subject|0|||
126122921|NCT01611974|453743797|FG001|Overall Study|Withdrawal by Subject|1|||
126122922|NCT01611974|453743798|FG002|Overall Study|Withdrawal by Subject|4|||
126122923|NCT00916357|453743799|FG000|Period 1|Withdrawal by Subject|1|||
126122924|NCT00916357|453743800|FG001|Period 1|Withdrawal by Subject|0|||
126122925|NCT00916357|453743801|FG002|Period 1|Withdrawal by Subject|0|||
126122926|NCT00916357|453743802|FG003|Period 1|Withdrawal by Subject|0|||
126122927|NCT00916357|453743803|FG004|Period 1|Withdrawal by Subject|0|||
126122928|NCT00916357|453743804|FG005|Period 1|Withdrawal by Subject|0|||
126122929|NCT00916357|453743799|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
126122930|NCT00916357|453743800|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
126122931|NCT00916357|453743801|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
125963006|NCT01485861|453155455|FG000|Safety Phase|Progression of Disease|0|||
125963007|NCT01485861|453155456|FG001|Safety Phase|Progression of Disease|0|||
126122932|NCT00916357|453743802|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
126122933|NCT00916357|453743803|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
125963008|NCT01485861|453155457|FG002|Safety Phase|Progression of Disease|0|||
126122934|NCT00916357|453743804|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
126122935|NCT01308008|453743805|FG000|4 Weeks|Illness, disinterest, time|9|||
126122936|NCT01308008|453743806|FG001|4 Weeks|Illness, disinterest, time|2|||
126122937|NCT01417195|453743807|FG000|Overall Study|Stimulation failure|1|||
126122938|NCT01417195|453743808|FG001|Overall Study|Stimulation failure|0|||
126122939|NCT01417195|453743807|FG000|Overall Study|No embryos for transfer|0|||
126122940|NCT01417195|453743808|FG001|Overall Study|No embryos for transfer|1|||
125963009|NCT01485861|453155458|FG003|Safety Phase|Progression of Disease|0|||
125963010|NCT01485861|453155459|FG004|Safety Phase|Progression of Disease|0|||
125963011|NCT01485861|453155460|FG005|Safety Phase|Progression of Disease|9|||
125963012|NCT01485861|453155455|FG000|Safety Phase|Withdrawal by Subject|0|||
125963013|NCT01485861|453155456|FG001|Safety Phase|Withdrawal by Subject|0|||
125963014|NCT01485861|453155457|FG002|Safety Phase|Withdrawal by Subject|0|||
125963015|NCT01485861|453155458|FG003|Safety Phase|Withdrawal by Subject|0|||
125963016|NCT01485861|453155459|FG004|Safety Phase|Withdrawal by Subject|0|||
125963017|NCT01485861|453155460|FG005|Safety Phase|Withdrawal by Subject|6|||
125963018|NCT01485861|453155455|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
125963019|NCT01485861|453155456|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
126122941|NCT01417195|453743807|FG000|Overall Study|No transfer due to risk of OHSS|1|||
126122942|NCT01417195|453743808|FG001|Overall Study|No transfer due to risk of OHSS|0|||
126122943|NCT01417195|453743807|FG000|Overall Study|No transfer due to elevated progesterone|1|||
126122944|NCT01417195|453743808|FG001|Overall Study|No transfer due to elevated progesterone|0|||
126122945|NCT03357731|453743809|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
126122946|NCT03357731|453743810|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
126122947|NCT03357731|453743811|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
126122948|NCT03357731|453743812|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
126122949|NCT03357731|453743813|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
126122950|NCT03357731|453743814|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
126122951|NCT03357731|453743809|FG000|Overall Study|Acute bradycardia and hypotension|0|||
125963020|NCT01485861|453155457|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
125963021|NCT01485861|453155458|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
125963022|NCT01485861|453155459|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
125963023|NCT01485861|453155460|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
125963024|NCT01328002|453155465|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
125963025|NCT01328002|453155466|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
125963026|NCT01328002|453155465|FG000|Open-Label Period|Adverse Event|8|||
125963027|NCT01328002|453155466|FG001|Open-Label Period|Adverse Event|0|||
125963028|NCT01328002|453155465|FG000|Open-Label Period|Lack of Efficacy|3|||
125963029|NCT01328002|453155466|FG001|Open-Label Period|Lack of Efficacy|0|||
125963030|NCT01328002|453155465|FG000|Open-Label Period|Protocol Violation|2|||
125963031|NCT01328002|453155466|FG001|Open-Label Period|Protocol Violation|0|||
125963032|NCT01328002|453155465|FG000|Open-Label Period|Withdrawal by Subject|9|||
125963033|NCT01328002|453155466|FG001|Open-Label Period|Withdrawal by Subject|0|||
125963034|NCT01328002|453155465|FG000|Open-Label Period|Lost to Follow-up|6|||
125963035|NCT01328002|453155466|FG001|Open-Label Period|Lost to Follow-up|0|||
125963036|NCT01328002|453155465|FG000|Open-Label Period|Other Reason|2|||
125963037|NCT01328002|453155466|FG001|Open-Label Period|Other Reason|0|||
125963038|NCT01328002|453155465|FG000|Double-Blind Period|Adverse Event|1|||
125963039|NCT01328002|453155466|FG001|Double-Blind Period|Adverse Event|0|||
125963040|NCT01328002|453155465|FG000|Double-Blind Period|Lack of Efficacy|1|||
125963041|NCT01328002|453155466|FG001|Double-Blind Period|Lack of Efficacy|0|||
125963042|NCT03149328|453155467|FG000|Overall Study|Withdrawal by Subject|30|||
125963043|NCT03149328|453155468|FG001|Overall Study|Withdrawal by Subject|26|||
125963044|NCT03149328|453155467|FG000|Overall Study|Changed Dialysis Modality|18|||
125963045|NCT03149328|453155468|FG001|Overall Study|Changed Dialysis Modality|1|||
125963046|NCT03149328|453155467|FG000|Overall Study|Transplant|9|||
125963047|NCT03149328|453155468|FG001|Overall Study|Transplant|1|||
125963048|NCT03149328|453155467|FG000|Overall Study|Lost to Follow-up|25|||
125963049|NCT03149328|453155468|FG001|Overall Study|Lost to Follow-up|16|||
125963050|NCT03149328|453155467|FG000|Overall Study|Left Study Site|1|||
125963051|NCT03149328|453155468|FG001|Overall Study|Left Study Site|2|||
125963052|NCT03149328|453155467|FG000|Overall Study|Language Barrier|1|||
126122952|NCT03357731|453743810|FG001|Overall Study|Acute bradycardia and hypotension|0|||
126122953|NCT03357731|453743811|FG002|Overall Study|Acute bradycardia and hypotension|0|||
126122954|NCT03357731|453743812|FG003|Overall Study|Acute bradycardia and hypotension|1|||
125963053|NCT03149328|453155468|FG001|Overall Study|Language Barrier|0|||
125963054|NCT00813761|453155469|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
125963055|NCT00813761|453155470|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
125963056|NCT00813761|453155471|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
125963057|NCT00813761|453155472|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
126122955|NCT03357731|453743813|FG004|Overall Study|Acute bradycardia and hypotension|0|||
125963058|NCT00813761|453155469|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
125963059|NCT00813761|453155470|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
125963060|NCT00813761|453155471|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
125963061|NCT00813761|453155472|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
125963062|NCT00813761|453155469|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
125963063|NCT00813761|453155470|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
125963064|NCT00813761|453155471|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
125963065|NCT00813761|453155472|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
125963066|NCT00813761|453155469|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
125963067|NCT00813761|453155470|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
125963068|NCT00813761|453155471|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
125963069|NCT00813761|453155472|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
125963070|NCT00813761|453155469|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
125963071|NCT00813761|453155470|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
125963072|NCT00813761|453155471|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
125963073|NCT00813761|453155472|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
125963074|NCT00813761|453155469|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
125963075|NCT00813761|453155470|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
125963076|NCT00813761|453155471|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
125963077|NCT00813761|453155472|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
125963078|NCT00813761|453155469|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
125963079|NCT00813761|453155470|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
125963080|NCT00813761|453155471|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
125963081|NCT00813761|453155472|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
125963082|NCT00813761|453155469|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
125963083|NCT00813761|453155470|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
125963084|NCT00813761|453155471|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
125963085|NCT00813761|453155472|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
125963086|NCT00813761|453155469|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
125963087|NCT00813761|453155470|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
125963088|NCT00813761|453155471|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
125963089|NCT00813761|453155472|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
125963090|NCT00813761|453155469|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
125963091|NCT00813761|453155470|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
125963092|NCT00813761|453155471|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
125963093|NCT00813761|453155472|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
125963094|NCT00813761|453155469|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
126122956|NCT03357731|453743814|FG005|Overall Study|Acute bradycardia and hypotension|0|||
126122957|NCT03357731|453743809|FG000|Overall Study|Adverse Event|0|||
126122958|NCT03357731|453743810|FG001|Overall Study|Adverse Event|0|||
126122959|NCT03357731|453743811|FG002|Overall Study|Adverse Event|0|||
126122960|NCT03357731|453743812|FG003|Overall Study|Adverse Event|0|||
126122961|NCT03357731|453743813|FG004|Overall Study|Adverse Event|0|||
126122962|NCT03357731|453743814|FG005|Overall Study|Adverse Event|1|||
126122963|NCT03357731|453743809|FG000|Overall Study|Hypotension|0|||
126122964|NCT03357731|453743810|FG001|Overall Study|Hypotension|0|||
126122965|NCT03357731|453743811|FG002|Overall Study|Hypotension|1|||
126122966|NCT03357731|453743812|FG003|Overall Study|Hypotension|1|||
126122967|NCT03357731|453743813|FG004|Overall Study|Hypotension|0|||
126122968|NCT03357731|453743814|FG005|Overall Study|Hypotension|0|||
126122969|NCT03357731|453743809|FG000|Overall Study|Lost to Follow-up|0|||
126122970|NCT03357731|453743810|FG001|Overall Study|Lost to Follow-up|0|||
126122971|NCT03357731|453743811|FG002|Overall Study|Lost to Follow-up|0|||
126122972|NCT03357731|453743812|FG003|Overall Study|Lost to Follow-up|1|||
126087911|NCT00392925|453614864|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
126087912|NCT00392925|453614865|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
126087913|NCT00392925|453614862|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
126087914|NCT00392925|453614863|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
126122973|NCT03357731|453743813|FG004|Overall Study|Lost to Follow-up|0|||
126122974|NCT03357731|453743814|FG005|Overall Study|Lost to Follow-up|0|||
126122975|NCT01773109|453743815|FG000|Overall Study|Symptomatic Progression|2|||
126122976|NCT01773109|453743815|FG000|Overall Study|Death|1|||
126122977|NCT01239342|453743816|FG000|Overall Study|Adverse Event|1|||
126122978|NCT01239342|453743817|FG001|Overall Study|Adverse Event|0|||
126122979|NCT01239342|453743816|FG000|Overall Study|Withdrawal by Subject|1|||
126122980|NCT01239342|453743817|FG001|Overall Study|Withdrawal by Subject|5|||
126122981|NCT01239342|453743816|FG000|Overall Study|Reason Unknown|1|||
126122982|NCT01239342|453743817|FG001|Overall Study|Reason Unknown|1|||
126122983|NCT02918864|453743820|FG000|Overall Study|Withdrawal by Subject|1|||
126122984|NCT02918864|453743821|FG001|Overall Study|Withdrawal by Subject|1|||
126122985|NCT02918864|453743820|FG000|Overall Study|Lost to Follow-up|3|||
126122986|NCT02918864|453743821|FG001|Overall Study|Lost to Follow-up|2|||
126122987|NCT00573430|453743829|FG000|Overall Study|Incorrect enrollment of randomization|0|||
125963095|NCT00813761|453155470|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
125963096|NCT00813761|453155471|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
126087915|NCT00392925|453614864|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
126087916|NCT00392925|453614865|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
126087917|NCT00392925|453614862|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
126122988|NCT00573430|453743830|FG001|Overall Study|Incorrect enrollment of randomization|4|||
126122989|NCT00573430|453743831|FG002|Overall Study|Incorrect enrollment of randomization|3|||
126122990|NCT00573430|453743829|FG000|Overall Study|Adverse Event|0|||
126122991|NCT00573430|453743830|FG001|Overall Study|Adverse Event|0|||
126122992|NCT00573430|453743831|FG002|Overall Study|Adverse Event|2|||
126122993|NCT00573430|453743829|FG000|Overall Study|Withdrawal by Subject|1|||
126122994|NCT00573430|453743830|FG001|Overall Study|Withdrawal by Subject|0|||
126122995|NCT00573430|453743831|FG002|Overall Study|Withdrawal by Subject|1|||
126122996|NCT00573430|453743829|FG000|Overall Study|Protocol Violation|0|||
126122997|NCT00573430|453743830|FG001|Overall Study|Protocol Violation|1|||
126122998|NCT00573430|453743831|FG002|Overall Study|Protocol Violation|1|||
126122999|NCT00573430|453743829|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126123000|NCT00573430|453743830|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126123001|NCT00573430|453743831|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
126123002|NCT03134599|453743834|FG000|Week 1|Lost to Follow-up|0|||
126123003|NCT03134599|453743835|FG001|Week 1|Lost to Follow-up|0|||
126123004|NCT03134599|453743836|FG002|Week 1|Lost to Follow-up|0|||
126123005|NCT03134599|453743837|FG003|Week 1|Lost to Follow-up|0|||
126123006|NCT03134599|453743838|FG004|Week 1|Lost to Follow-up|1|||
126123007|NCT03134599|453743839|FG005|Week 1|Lost to Follow-up|0|||
126123008|NCT03134599|453743834|FG000|Week 2|Lost to Follow-up|1|||
126123009|NCT03134599|453743835|FG001|Week 2|Lost to Follow-up|0|||
126123010|NCT03134599|453743836|FG002|Week 2|Lost to Follow-up|0|||
126123011|NCT03134599|453743837|FG003|Week 2|Lost to Follow-up|1|||
126123012|NCT03134599|453743838|FG004|Week 2|Lost to Follow-up|1|||
126123013|NCT03134599|453743839|FG005|Week 2|Lost to Follow-up|0|||
125963097|NCT00813761|453155472|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
125963098|NCT00813761|453155469|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
125963099|NCT00813761|453155470|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
125963100|NCT00813761|453155471|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
125963101|NCT00813761|453155472|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
125963102|NCT00691210|453155473|FG000|Overall Study|Progression of Disease|0|||
125963103|NCT00691210|453155474|FG001|Overall Study|Progression of Disease|0|||
125963104|NCT00691210|453155475|FG002|Overall Study|Progression of Disease|0|||
125963105|NCT00691210|453155476|FG003|Overall Study|Progression of Disease|2|||
125963106|NCT00691210|453155477|FG004|Overall Study|Progression of Disease|0|||
125963107|NCT00691210|453155478|FG005|Overall Study|Progression of Disease|0|||
125963108|NCT00691210|453155479|FG006|Overall Study|Progression of Disease|0|||
125963109|NCT00691210|453155480|FG007|Overall Study|Progression of Disease|0|||
125963110|NCT00691210|453155473|FG000|Overall Study|Lack of Efficacy|0|||
125963111|NCT00691210|453155474|FG001|Overall Study|Lack of Efficacy|0|||
125963112|NCT00691210|453155475|FG002|Overall Study|Lack of Efficacy|0|||
125963113|NCT00691210|453155476|FG003|Overall Study|Lack of Efficacy|1|||
125963114|NCT00691210|453155477|FG004|Overall Study|Lack of Efficacy|0|||
125963115|NCT00691210|453155478|FG005|Overall Study|Lack of Efficacy|1|||
125963116|NCT00691210|453155479|FG006|Overall Study|Lack of Efficacy|0|||
125963117|NCT00691210|453155480|FG007|Overall Study|Lack of Efficacy|0|||
125963118|NCT01208233|453155481|FG000|Overall Study|Adverse Event|0|||
125963119|NCT01208233|453155482|FG001|Overall Study|Adverse Event|1|||
125963120|NCT01208233|453155483|FG002|Overall Study|Adverse Event|2|||
125963121|NCT01208233|453155484|FG003|Overall Study|Adverse Event|0|||
125963122|NCT01208233|453155485|FG004|Overall Study|Adverse Event|3|||
125963123|NCT01208233|453155486|FG005|Overall Study|Adverse Event|5|||
125963124|NCT01208233|453155481|FG000|Overall Study|Death|0|||
125963125|NCT01208233|453155482|FG001|Overall Study|Death|0|||
125963126|NCT01208233|453155483|FG002|Overall Study|Death|0|||
125963127|NCT01208233|453155484|FG003|Overall Study|Death|0|||
125963128|NCT01208233|453155485|FG004|Overall Study|Death|3|||
125963129|NCT01208233|453155486|FG005|Overall Study|Death|5|||
125963130|NCT01208233|453155481|FG000|Overall Study|Did not meet entrance criteria|2|||
125963131|NCT01208233|453155482|FG001|Overall Study|Did not meet entrance criteria|1|||
125963132|NCT01208233|453155483|FG002|Overall Study|Did not meet entrance criteria|1|||
126123014|NCT03134599|453743834|FG000|Week 3|Lost to Follow-up|0|||
126123015|NCT03134599|453743835|FG001|Week 3|Lost to Follow-up|0|||
126123016|NCT03134599|453743836|FG002|Week 3|Lost to Follow-up|0|||
126123017|NCT03134599|453743837|FG003|Week 3|Lost to Follow-up|1|||
126123018|NCT03134599|453743838|FG004|Week 3|Lost to Follow-up|0|||
126123019|NCT03134599|453743839|FG005|Week 3|Lost to Follow-up|1|||
126123020|NCT04962022|453743840|FG000|Period 1|Withdrawal by Subject|1|||
126123021|NCT04962022|453743841|FG001|Period 1|Withdrawal by Subject|0|||
126123022|NCT01146873|453743845|FG000|Overall Study|Transfer out|0|||
126123023|NCT01146873|453743846|FG001|Overall Study|Transfer out|6|||
125963133|NCT01208233|453155484|FG003|Overall Study|Did not meet entrance criteria|0|||
125963134|NCT01208233|453155485|FG004|Overall Study|Did not meet entrance criteria|1|||
125963135|NCT01208233|453155486|FG005|Overall Study|Did not meet entrance criteria|0|||
125963136|NCT01208233|453155481|FG000|Overall Study|Medication error without adverse event|0|||
125963137|NCT01208233|453155482|FG001|Overall Study|Medication error without adverse event|0|||
126123024|NCT01967628|453743847|FG000|Overall Study|Withdrawal by Subject|2|||
126123025|NCT01967628|453743848|FG001|Overall Study|Withdrawal by Subject|0|||
126123026|NCT01967628|453743847|FG000|Overall Study|Unable to complete bronchoscopy|4|||
126123027|NCT01967628|453743848|FG001|Overall Study|Unable to complete bronchoscopy|6|||
126123028|NCT01967628|453743847|FG000|Overall Study|Lost to Follow-up|1|||
125963138|NCT01208233|453155483|FG002|Overall Study|Medication error without adverse event|0|||
125963139|NCT01208233|453155484|FG003|Overall Study|Medication error without adverse event|0|||
125963140|NCT01208233|453155485|FG004|Overall Study|Medication error without adverse event|0|||
125963141|NCT01208233|453155486|FG005|Overall Study|Medication error without adverse event|1|||
125963142|NCT01208233|453155481|FG000|Overall Study|Study terminated by sponsor|0|||
125963143|NCT01208233|453155482|FG001|Overall Study|Study terminated by sponsor|0|||
125963144|NCT01208233|453155483|FG002|Overall Study|Study terminated by sponsor|0|||
125963145|NCT01208233|453155484|FG003|Overall Study|Study terminated by sponsor|0|||
125963146|NCT01208233|453155485|FG004|Overall Study|Study terminated by sponsor|10|||
125963147|NCT01208233|453155486|FG005|Overall Study|Study terminated by sponsor|7|||
125963148|NCT01208233|453155481|FG000|Overall Study|Protocol Violation|0|||
126123029|NCT01967628|453743848|FG001|Overall Study|Lost to Follow-up|0|||
126123030|NCT01967628|453743847|FG000|Overall Study|Low protein concentration in sample|20|||
126123031|NCT01967628|453743848|FG001|Overall Study|Low protein concentration in sample|25|||
126123032|NCT01356407|453743849|FG000|Overall Study|Lost to Follow-up|2|||
126123033|NCT01356407|453743850|FG001|Overall Study|Lost to Follow-up|0|||
126123034|NCT01356407|453743849|FG000|Overall Study|Patient Withdrew Consent|2|||
126123035|NCT01356407|453743850|FG001|Overall Study|Patient Withdrew Consent|1|||
126123036|NCT01356407|453743849|FG000|Overall Study|Could not afford IMP administration|0|||
126123037|NCT01356407|453743850|FG001|Overall Study|Could not afford IMP administration|1|||
126123038|NCT01356407|453743849|FG000|Overall Study|Not complete Endoscopy|2|||
125963149|NCT01208233|453155482|FG001|Overall Study|Protocol Violation|0|||
125963150|NCT01208233|453155483|FG002|Overall Study|Protocol Violation|0|||
125963151|NCT01208233|453155484|FG003|Overall Study|Protocol Violation|0|||
125963152|NCT01208233|453155485|FG004|Overall Study|Protocol Violation|3|||
125963153|NCT01208233|453155486|FG005|Overall Study|Protocol Violation|0|||
125963154|NCT01208233|453155481|FG000|Overall Study|Other|2|||
125963155|NCT01208233|453155482|FG001|Overall Study|Other|1|||
125963156|NCT01208233|453155483|FG002|Overall Study|Other|0|||
125963157|NCT01208233|453155484|FG003|Overall Study|Other|0|||
125963158|NCT01208233|453155485|FG004|Overall Study|Other|0|||
125963159|NCT01208233|453155486|FG005|Overall Study|Other|1|||
125963160|NCT01208233|453155481|FG000|Overall Study|Withdrawal by Subject|1|||
125963161|NCT01208233|453155482|FG001|Overall Study|Withdrawal by Subject|0|||
125963162|NCT01208233|453155483|FG002|Overall Study|Withdrawal by Subject|1|||
125963163|NCT01208233|453155484|FG003|Overall Study|Withdrawal by Subject|1|||
125963164|NCT01208233|453155485|FG004|Overall Study|Withdrawal by Subject|4|||
125963165|NCT01208233|453155486|FG005|Overall Study|Withdrawal by Subject|2|||
125963166|NCT01181895|453155490|FG000|Overall Study|Adverse Event|3|||
125963167|NCT01181895|453155491|FG001|Overall Study|Adverse Event|1|||
125963168|NCT01181895|453155492|FG002|Overall Study|Adverse Event|1|||
125963169|NCT01181895|453155490|FG000|Overall Study|Lack of Efficacy|8|||
125963170|NCT01181895|453155491|FG001|Overall Study|Lack of Efficacy|9|||
125963171|NCT01181895|453155492|FG002|Overall Study|Lack of Efficacy|9|||
125963172|NCT01181895|453155490|FG000|Overall Study|Protocol Violation|2|||
125963173|NCT01181895|453155491|FG001|Overall Study|Protocol Violation|1|||
125963174|NCT01181895|453155492|FG002|Overall Study|Protocol Violation|0|||
125963175|NCT01181895|453155490|FG000|Overall Study|Lost to Follow-up|0|||
125963176|NCT01181895|453155491|FG001|Overall Study|Lost to Follow-up|1|||
125963177|NCT01181895|453155492|FG002|Overall Study|Lost to Follow-up|2|||
125963178|NCT01181895|453155490|FG000|Overall Study|Investigator Discretion|1|||
125963179|NCT01181895|453155491|FG001|Overall Study|Investigator Discretion|2|||
125963180|NCT01181895|453155492|FG002|Overall Study|Investigator Discretion|1|||
125963181|NCT01181895|453155490|FG000|Overall Study|Withdrawal by Subject|3|||
125963182|NCT01181895|453155491|FG001|Overall Study|Withdrawal by Subject|0|||
125963183|NCT01181895|453155492|FG002|Overall Study|Withdrawal by Subject|5|||
125963184|NCT00766415|453155495|FG000|Overall Study|Withdrawal by Subject|0|||
125963185|NCT00766415|453155496|FG001|Overall Study|Withdrawal by Subject|1|||
125963186|NCT00560833|453155509|FG000|Overall Study|Adverse Event|16|||
125963187|NCT00560833|453155510|FG001|Overall Study|Adverse Event|10|||
125963188|NCT00560833|453155511|FG002|Overall Study|Adverse Event|25|||
125963189|NCT00560833|453155512|FG003|Overall Study|Adverse Event|23|||
125963190|NCT00560833|453155513|FG004|Overall Study|Adverse Event|35|||
125963191|NCT00560833|453155509|FG000|Overall Study|Lost to Follow-up|0|||
125963192|NCT00560833|453155510|FG001|Overall Study|Lost to Follow-up|0|||
125963193|NCT00560833|453155511|FG002|Overall Study|Lost to Follow-up|1|||
125963194|NCT00560833|453155512|FG003|Overall Study|Lost to Follow-up|0|||
125963195|NCT00560833|453155513|FG004|Overall Study|Lost to Follow-up|0|||
125963196|NCT00560833|453155509|FG000|Overall Study|Lack of Efficacy|22|||
125963197|NCT00560833|453155510|FG001|Overall Study|Lack of Efficacy|9|||
126123039|NCT01356407|453743850|FG001|Overall Study|Not complete Endoscopy|2|||
125963198|NCT00560833|453155511|FG002|Overall Study|Lack of Efficacy|6|||
125963199|NCT00560833|453155512|FG003|Overall Study|Lack of Efficacy|4|||
125963200|NCT00560833|453155513|FG004|Overall Study|Lack of Efficacy|4|||
125963201|NCT00560833|453155509|FG000|Overall Study|Participant uncooperative|5|||
125963202|NCT00560833|453155510|FG001|Overall Study|Participant uncooperative|5|||
125963203|NCT00560833|453155511|FG002|Overall Study|Participant uncooperative|4|||
125963204|NCT00560833|453155512|FG003|Overall Study|Participant uncooperative|4|||
125963205|NCT00560833|453155513|FG004|Overall Study|Participant uncooperative|2|||
125963206|NCT00560833|453155509|FG000|Overall Study|Other|1|||
125963207|NCT00560833|453155510|FG001|Overall Study|Other|1|||
125963208|NCT00560833|453155511|FG002|Overall Study|Other|3|||
125963209|NCT00560833|453155512|FG003|Overall Study|Other|0|||
125963210|NCT00560833|453155513|FG004|Overall Study|Other|0|||
125963211|NCT00560833|453155509|FG000|Overall Study|Never received drug|0|||
125963212|NCT00560833|453155510|FG001|Overall Study|Never received drug|1|||
126123040|NCT01087775|453743851|FG000|Overall Study|failed inclusion criteria|2|||
126123041|NCT00825162|453743858|FG000|Overall Study|Withdrawal by Subject|11|||
126123042|NCT00825162|453743859|FG001|Overall Study|Withdrawal by Subject|13|||
126123043|NCT00825162|453743860|FG002|Overall Study|Withdrawal by Subject|3|||
126123044|NCT00825162|453743858|FG000|Overall Study|Lost to Follow-up|9|||
126123045|NCT00825162|453743859|FG001|Overall Study|Lost to Follow-up|6|||
125963213|NCT00560833|453155511|FG002|Overall Study|Never received drug|0|||
125963214|NCT00560833|453155512|FG003|Overall Study|Never received drug|0|||
125963215|NCT00560833|453155513|FG004|Overall Study|Never received drug|1|||
125963216|NCT00898677|453155516|FG000|Overall Study|Adverse Event|0|||
125963217|NCT00898677|453155517|FG001|Overall Study|Adverse Event|0|||
125963218|NCT00898677|453155518|FG002|Overall Study|Adverse Event|1|||
125963219|NCT00898677|453155519|FG003|Overall Study|Adverse Event|0|||
125963220|NCT00898677|453155516|FG000|Overall Study|Lost to Follow-up|0|||
125963221|NCT00898677|453155517|FG001|Overall Study|Lost to Follow-up|0|||
125963222|NCT00898677|453155518|FG002|Overall Study|Lost to Follow-up|2|||
125963223|NCT00898677|453155519|FG003|Overall Study|Lost to Follow-up|0|||
125963224|NCT00898677|453155516|FG000|Overall Study|Protocol Violation|1|||
125963225|NCT00898677|453155517|FG001|Overall Study|Protocol Violation|1|||
125963226|NCT00898677|453155518|FG002|Overall Study|Protocol Violation|2|||
125963227|NCT00898677|453155519|FG003|Overall Study|Protocol Violation|0|||
125963228|NCT00898677|453155516|FG000|Overall Study|Withdrawal by Subject|0|||
125963229|NCT00898677|453155517|FG001|Overall Study|Withdrawal by Subject|0|||
125963230|NCT00898677|453155518|FG002|Overall Study|Withdrawal by Subject|0|||
125963231|NCT00898677|453155519|FG003|Overall Study|Withdrawal by Subject|1|||
125963232|NCT00898677|453155516|FG000|Overall Study|Not Treated: Adverse Event|0|||
125963233|NCT00898677|453155517|FG001|Overall Study|Not Treated: Adverse Event|2|||
125963234|NCT00898677|453155518|FG002|Overall Study|Not Treated: Adverse Event|1|||
125963235|NCT00898677|453155519|FG003|Overall Study|Not Treated: Adverse Event|0|||
125963236|NCT00898677|453155516|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
125963237|NCT00898677|453155517|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
125963238|NCT00898677|453155518|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
125963239|NCT00898677|453155519|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
125963240|NCT00898677|453155516|FG000|Overall Study|Not Treated: Pregnancy|0|||
125963241|NCT00898677|453155517|FG001|Overall Study|Not Treated: Pregnancy|0|||
125963242|NCT00898677|453155518|FG002|Overall Study|Not Treated: Pregnancy|1|||
125963243|NCT00898677|453155519|FG003|Overall Study|Not Treated: Pregnancy|0|||
125963244|NCT00898677|453155516|FG000|Overall Study|Not Treated: Protocol Violation|2|||
125963245|NCT00898677|453155517|FG001|Overall Study|Not Treated: Protocol Violation|0|||
125963246|NCT00898677|453155518|FG002|Overall Study|Not Treated: Protocol Violation|2|||
125963247|NCT00898677|453155519|FG003|Overall Study|Not Treated: Protocol Violation|0|||
125963248|NCT00898677|453155516|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
125963249|NCT00898677|453155517|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
125963250|NCT00898677|453155518|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
125963251|NCT00898677|453155519|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
125963252|NCT00898677|453155516|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
125963253|NCT00898677|453155517|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
125963254|NCT00898677|453155518|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
125963255|NCT00898677|453155519|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
125963256|NCT00898677|453155516|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
125963257|NCT00898677|453155517|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
125963258|NCT00898677|453155518|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
125963259|NCT00898677|453155519|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
125963260|NCT00898677|453155516|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
125963261|NCT00898677|453155517|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
126123046|NCT00825162|453743860|FG002|Overall Study|Lost to Follow-up|3|||
126123047|NCT00825162|453743858|FG000|Overall Study|Physician Decision|2|||
126123048|NCT00825162|453743859|FG001|Overall Study|Physician Decision|0|||
126123049|NCT00825162|453743860|FG002|Overall Study|Physician Decision|0|||
126123050|NCT00825162|453743858|FG000|Overall Study|Move away from the study area|1|||
126123051|NCT00825162|453743859|FG001|Overall Study|Move away from the study area|0|||
126123052|NCT00825162|453743860|FG002|Overall Study|Move away from the study area|0|||
126123053|NCT00825162|453743858|FG000|Overall Study|Unable to attend the study visit|5|||
125963262|NCT00898677|453155518|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
125963263|NCT00898677|453155519|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
125963264|NCT00898677|453155516|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
125963265|NCT00898677|453155517|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
126123054|NCT00825162|453743859|FG001|Overall Study|Unable to attend the study visit|2|||
125963266|NCT00898677|453155518|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
125963267|NCT00898677|453155519|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
125963268|NCT00898677|453155516|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
125963269|NCT00898677|453155517|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
125963270|NCT00898677|453155518|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
125963271|NCT00898677|453155519|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
125963272|NCT00898677|453155516|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
125963273|NCT00898677|453155517|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
125963274|NCT00898677|453155518|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
125963275|NCT00898677|453155519|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
125963276|NCT02199691|453155522|FG000|Overall Study|Protocol Violation|3|||
125963277|NCT02199691|453155523|FG001|Overall Study|Protocol Violation|3|||
125963278|NCT02199691|453155524|FG002|Overall Study|Protocol Violation|6|||
125963279|NCT02199691|453155525|FG003|Overall Study|Protocol Violation|7|||
125963280|NCT02199691|453155522|FG000|Overall Study|Withdrawal by Subject|5|||
125963281|NCT02199691|453155523|FG001|Overall Study|Withdrawal by Subject|3|||
125963282|NCT02199691|453155524|FG002|Overall Study|Withdrawal by Subject|12|||
125963283|NCT02199691|453155525|FG003|Overall Study|Withdrawal by Subject|13|||
125963284|NCT02199691|453155522|FG000|Overall Study|Lost to Follow-up|2|||
125963285|NCT02199691|453155523|FG001|Overall Study|Lost to Follow-up|1|||
125963286|NCT02199691|453155524|FG002|Overall Study|Lost to Follow-up|9|||
125963287|NCT02199691|453155525|FG003|Overall Study|Lost to Follow-up|10|||
126123055|NCT00825162|453743860|FG002|Overall Study|Unable to attend the study visit|0|||
126123056|NCT00964743|453743861|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
126123057|NCT00781911|453743862|FG000|Overall Study|Adverse Event|4|||
126123058|NCT00781911|453743863|FG001|Overall Study|Adverse Event|4|||
125963288|NCT00836875|453155528|FG000|Overall Study|Death|3|||
125963289|NCT00836875|453155529|FG001|Overall Study|Death|2|||
125963290|NCT00836875|453155528|FG000|Overall Study|Withdrawal by Subject|0|||
125963291|NCT00836875|453155529|FG001|Overall Study|Withdrawal by Subject|1|||
125963292|NCT03403634|453155530|FG000|Overall Study|Disease progression|3|||
125963293|NCT03403634|453155530|FG000|Overall Study|Did not meet eligibility criteria|4|||
125963294|NCT00428610|453155531|FG000|Overall Study|Death Due to Adverse Event|3|||
125963295|NCT00428610|453155532|FG001|Overall Study|Death Due to Adverse Event|0|||
126123059|NCT00781911|453743862|FG000|Overall Study|Withdrawal by Subject|1|||
126123060|NCT00781911|453743863|FG001|Overall Study|Withdrawal by Subject|2|||
126123061|NCT00781911|453743862|FG000|Overall Study|Physician Decision|0|||
126123062|NCT00781911|453743863|FG001|Overall Study|Physician Decision|2|||
126123063|NCT00781911|453743862|FG000|Overall Study|Sponsor Decision|1|||
126123064|NCT00781911|453743863|FG001|Overall Study|Sponsor Decision|0|||
126123065|NCT03317795|453743864|FG000|Overall Study|IUD Expulsion|1|||
126123066|NCT03317795|453743865|FG001|Overall Study|IUD Expulsion|0|||
126123067|NCT03317795|453743864|FG000|Overall Study|Lost to Follow-up|1|||
126123068|NCT03317795|453743865|FG001|Overall Study|Lost to Follow-up|3|||
126123069|NCT03317795|453743864|FG000|Overall Study|Treatment change|0|||
126123070|NCT03317795|453743865|FG001|Overall Study|Treatment change|3|||
126123071|NCT03317795|453743864|FG000|Overall Study|Intolerance of medication|0|||
126123072|NCT03317795|453743865|FG001|Overall Study|Intolerance of medication|1|||
126123073|NCT01549002|453743871|FG000|Overall Study|Excessive pain|0|||
126123074|NCT01549002|453743872|FG001|Overall Study|Excessive pain|2|||
125963296|NCT00428610|453155533|FG002|Overall Study|Death Due to Adverse Event|5|||
125963297|NCT00428610|453155531|FG000|Overall Study|Death Due to Progressive Disease|0|||
125963298|NCT00428610|453155532|FG001|Overall Study|Death Due to Progressive Disease|0|||
125963299|NCT00428610|453155533|FG002|Overall Study|Death Due to Progressive Disease|2|||
126123075|NCT01549002|453743871|FG000|Overall Study|Moderate sedation required|0|||
126123076|NCT01549002|453743872|FG001|Overall Study|Moderate sedation required|2|||
125963300|NCT00428610|453155531|FG000|Overall Study|Adverse Event|2|||
125963301|NCT00428610|453155532|FG001|Overall Study|Adverse Event|3|||
125963302|NCT00428610|453155533|FG002|Overall Study|Adverse Event|2|||
125963303|NCT00428610|453155531|FG000|Overall Study|Investigator Decision|2|||
125963304|NCT00428610|453155532|FG001|Overall Study|Investigator Decision|1|||
125963305|NCT00428610|453155533|FG002|Overall Study|Investigator Decision|1|||
125963306|NCT00428610|453155531|FG000|Overall Study|Progressive Disease|42|||
125963307|NCT00428610|453155532|FG001|Overall Study|Progressive Disease|14|||
126123077|NCT02255409|453743877|FG000|Overall Study|Administrative Reason|3|||
126123078|NCT02255409|453743878|FG001|Overall Study|Administrative Reason|7|||
126123079|NCT02255409|453743877|FG000|Overall Study|Withdrawal by Subject|1|||
126123080|NCT02255409|453743878|FG001|Overall Study|Withdrawal by Subject|5|||
126123081|NCT02255409|453743877|FG000|Overall Study|Lost to Follow-up|10|||
126123082|NCT02255409|453743878|FG001|Overall Study|Lost to Follow-up|19|||
126123083|NCT01251367|453743879|FG000|Overall Study|Protocol Violation|1|||
126123084|NCT01251367|453743879|FG000|Overall Study|Lack of Efficacy|2|||
125963308|NCT00428610|453155533|FG002|Overall Study|Progressive Disease|22|||
125963309|NCT00428610|453155531|FG000|Overall Study|Withdrawal by Subject|4|||
125963310|NCT00428610|453155532|FG001|Overall Study|Withdrawal by Subject|0|||
125963311|NCT00428610|453155533|FG002|Overall Study|Withdrawal by Subject|0|||
125963312|NCT05350449|453155534|FG000|Overall Study|Withdrawal by Subject|4|||
125963313|NCT05350449|453155535|FG001|Overall Study|Withdrawal by Subject|8|||
125963314|NCT01076400|453157048|FG000|Overall Study|Adverse Event|2|||
125963315|NCT01076400|453157049|FG001|Overall Study|Adverse Event|0|||
125963316|NCT01076400|453157050|FG002|Overall Study|Adverse Event|0|||
125963317|NCT01076400|453157048|FG000|Overall Study|Progressive Disease|5|||
125963318|NCT01076400|453157049|FG001|Overall Study|Progressive Disease|0|||
125963319|NCT01076400|453157050|FG002|Overall Study|Progressive Disease|0|||
125963320|NCT00796718|453157053|FG000|Overall Study|Adverse Event|2|||
125963321|NCT00796718|453157053|FG000|Overall Study|Exclusion Criteria|1|||
125963322|NCT00796718|453157053|FG000|Overall Study|Lost to Follow-up|5|||
125963323|NCT00796718|453157053|FG000|Overall Study|Withdrawal by Informed Consent|1|||
125963324|NCT02696850|453157054|FG000|Overall Study|Withdrawal by Subject|3|||
125963325|NCT02696850|453157055|FG001|Overall Study|Withdrawal by Subject|3|||
125963326|NCT02696850|453157054|FG000|Overall Study|Lost to Follow-up|8|||
125963327|NCT02696850|453157055|FG001|Overall Study|Lost to Follow-up|5|||
125963328|NCT02044510|453157056|FG000|Overall Study|Adverse Event|1|||
125963329|NCT02044510|453157057|FG001|Overall Study|Adverse Event|2|||
125963330|NCT03455855|453157058|FG000|Overall Study|Lost to Follow-up|4|||
125963331|NCT03455855|453157059|FG001|Overall Study|Lost to Follow-up|2|||
125963332|NCT04193202|453157060|FG000|Overall Study|Adverse Event|2|||
125963333|NCT04193202|453157061|FG001|Overall Study|Adverse Event|1|||
125963334|NCT04193202|453157060|FG000|Overall Study|Death|0|||
125963335|NCT04193202|453157061|FG001|Overall Study|Death|1|||
125963336|NCT04193202|453157060|FG000|Overall Study|Physician Decision|1|||
125963337|NCT04193202|453157061|FG001|Overall Study|Physician Decision|1|||
125963338|NCT04193202|453157060|FG000|Overall Study|Protocol Violation|2|||
125963339|NCT04193202|453157061|FG001|Overall Study|Protocol Violation|2|||
125963340|NCT04193202|453157060|FG000|Overall Study|Withdrawal by Subject|11|||
125963341|NCT04193202|453157061|FG001|Overall Study|Withdrawal by Subject|5|||
125963342|NCT00581945|453157064|FG000|Overall Study|Adverse Event|4|||
125963343|NCT00581945|453157065|FG001|Overall Study|Adverse Event|4|||
125963344|NCT00581945|453157064|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125963345|NCT00581945|453157065|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125963346|NCT00581945|453157064|FG000|Overall Study|Withdrawal by Subject|2|||
125963347|NCT00581945|453157065|FG001|Overall Study|Withdrawal by Subject|6|||
125963348|NCT00581945|453157064|FG000|Overall Study|Death|1|||
125963349|NCT00581945|453157065|FG001|Overall Study|Death|0|||
125963350|NCT01075321|453157070|FG000|Overall Study|Withdrawal by Subject|0|||
125963351|NCT01075321|453157071|FG001|Overall Study|Withdrawal by Subject|0|||
125963352|NCT01075321|453157072|FG002|Overall Study|Withdrawal by Subject|1|||
125963353|NCT01075321|453157073|FG003|Overall Study|Withdrawal by Subject|1|||
125963354|NCT01075321|453157070|FG000|Overall Study|Protocol Violation|0|||
125963355|NCT01075321|453157071|FG001|Overall Study|Protocol Violation|0|||
125963356|NCT01075321|453157072|FG002|Overall Study|Protocol Violation|1|||
125963357|NCT01075321|453157073|FG003|Overall Study|Protocol Violation|0|||
125963358|NCT01075321|453157070|FG000|Overall Study|Treatment Incomplete due to progression|1|||
125963359|NCT01075321|453157071|FG001|Overall Study|Treatment Incomplete due to progression|0|||
125963360|NCT01075321|453157072|FG002|Overall Study|Treatment Incomplete due to progression|0|||
125963361|NCT01075321|453157073|FG003|Overall Study|Treatment Incomplete due to progression|0|||
125963362|NCT01075321|453157070|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
125963363|NCT01075321|453157071|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
125963364|NCT01075321|453157072|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
125963365|NCT01075321|453157073|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
125963366|NCT01933334|453157077|FG000|Overall Study|Adverse Event|5|||
125963367|NCT01933334|453157078|FG001|Overall Study|Adverse Event|1|||
125963368|NCT01933334|453157077|FG000|Overall Study|Withdrawal by Subject|0|||
125963369|NCT01933334|453157078|FG001|Overall Study|Withdrawal by Subject|1|||
125963370|NCT00767000|453157079|FG000|54-week Study|Adverse Event|4|||
125963371|NCT00767000|453157080|FG001|54-week Study|Adverse Event|6|||
125963372|NCT00767000|453157081|FG002|54-week Study|Adverse Event|6|||
125963373|NCT00767000|453157082|FG003|54-week Study|Adverse Event|8|||
125963374|NCT00767000|453157083|FG004|54-week Study|Adverse Event|4|||
125963375|NCT00767000|453157079|FG000|54-week Study|Creaninine/creatinine clearance|2|||
125963376|NCT00767000|453157080|FG001|54-week Study|Creaninine/creatinine clearance|1|||
125963377|NCT00767000|453157081|FG002|54-week Study|Creaninine/creatinine clearance|2|||
125963378|NCT00767000|453157082|FG003|54-week Study|Creaninine/creatinine clearance|2|||
125963379|NCT00767000|453157083|FG004|54-week Study|Creaninine/creatinine clearance|4|||
125963380|NCT00767000|453157079|FG000|54-week Study|Hyperglycemia|0|||
125963381|NCT00767000|453157080|FG001|54-week Study|Hyperglycemia|0|||
125963382|NCT00767000|453157081|FG002|54-week Study|Hyperglycemia|1|||
126123085|NCT01251367|453743879|FG000|Overall Study|Adverse Event|19|||
125963383|NCT00767000|453157082|FG003|54-week Study|Hyperglycemia|0|||
125963384|NCT00767000|453157083|FG004|54-week Study|Hyperglycemia|1|||
125963385|NCT00767000|453157079|FG000|54-week Study|Hypoglycemia|0|||
125963386|NCT00767000|453157080|FG001|54-week Study|Hypoglycemia|1|||
125963387|NCT00767000|453157081|FG002|54-week Study|Hypoglycemia|0|||
125963388|NCT00767000|453157082|FG003|54-week Study|Hypoglycemia|0|||
125963389|NCT00767000|453157083|FG004|54-week Study|Hypoglycemia|0|||
125963390|NCT00767000|453157079|FG000|54-week Study|Interruption of study medication|0|||
125963391|NCT00767000|453157080|FG001|54-week Study|Interruption of study medication|0|||
125963392|NCT00767000|453157081|FG002|54-week Study|Interruption of study medication|1|||
125963393|NCT00767000|453157082|FG003|54-week Study|Interruption of study medication|0|||
125963394|NCT00767000|453157083|FG004|54-week Study|Interruption of study medication|0|||
125963395|NCT00767000|453157079|FG000|54-week Study|Lack of Efficacy|2|||
125963396|NCT00767000|453157080|FG001|54-week Study|Lack of Efficacy|0|||
125963397|NCT00767000|453157081|FG002|54-week Study|Lack of Efficacy|1|||
126123086|NCT01251367|453743879|FG000|Overall Study|Withdrawal by Subject|36|||
126123087|NCT01251367|453743879|FG000|Overall Study|Lost to Follow-up|5|||
125963398|NCT00767000|453157082|FG003|54-week Study|Lack of Efficacy|0|||
125963399|NCT00767000|453157083|FG004|54-week Study|Lack of Efficacy|5|||
125963400|NCT00767000|453157079|FG000|54-week Study|Lost to Follow-up|4|||
125963401|NCT00767000|453157080|FG001|54-week Study|Lost to Follow-up|0|||
125963402|NCT00767000|453157081|FG002|54-week Study|Lost to Follow-up|1|||
125963403|NCT00767000|453157082|FG003|54-week Study|Lost to Follow-up|4|||
125963404|NCT00767000|453157083|FG004|54-week Study|Lost to Follow-up|2|||
125963405|NCT00767000|453157079|FG000|54-week Study|Physician Decision|4|||
125963406|NCT00767000|453157080|FG001|54-week Study|Physician Decision|0|||
125963407|NCT00767000|453157081|FG002|54-week Study|Physician Decision|1|||
125963408|NCT00767000|453157082|FG003|54-week Study|Physician Decision|1|||
125963409|NCT00767000|453157083|FG004|54-week Study|Physician Decision|1|||
125963410|NCT00767000|453157079|FG000|54-week Study|Progressive disease|0|||
125963411|NCT00767000|453157080|FG001|54-week Study|Progressive disease|0|||
125963412|NCT00767000|453157081|FG002|54-week Study|Progressive disease|1|||
125963413|NCT00767000|453157082|FG003|54-week Study|Progressive disease|0|||
125963414|NCT00767000|453157083|FG004|54-week Study|Progressive disease|0|||
125963415|NCT00767000|453157079|FG000|54-week Study|Protocol Violation|0|||
125963416|NCT00767000|453157080|FG001|54-week Study|Protocol Violation|0|||
125963417|NCT00767000|453157081|FG002|54-week Study|Protocol Violation|1|||
125963418|NCT00767000|453157082|FG003|54-week Study|Protocol Violation|2|||
125963419|NCT00767000|453157083|FG004|54-week Study|Protocol Violation|0|||
125963420|NCT00767000|453157079|FG000|54-week Study|Withdrawal by Subject|2|||
125963421|NCT00767000|453157080|FG001|54-week Study|Withdrawal by Subject|3|||
125963422|NCT00767000|453157081|FG002|54-week Study|Withdrawal by Subject|5|||
125963423|NCT00767000|453157082|FG003|54-week Study|Withdrawal by Subject|11|||
125963424|NCT00767000|453157083|FG004|54-week Study|Withdrawal by Subject|13|||
125963425|NCT00767000|453157079|FG000|54-week Study|Study terminated by sponsor|90|||
125963426|NCT00767000|453157080|FG001|54-week Study|Study terminated by sponsor|102|||
125963427|NCT00767000|453157081|FG002|54-week Study|Study terminated by sponsor|89|||
125963428|NCT00767000|453157082|FG003|54-week Study|Study terminated by sponsor|196|||
125963429|NCT00767000|453157083|FG004|54-week Study|Study terminated by sponsor|194|||
125963430|NCT00767000|453157079|FG000|54-week Study|Reason not reported|0|||
125963431|NCT00767000|453157080|FG001|54-week Study|Reason not reported|0|||
125963432|NCT00767000|453157081|FG002|54-week Study|Reason not reported|0|||
125963433|NCT00767000|453157082|FG003|54-week Study|Reason not reported|1|||
125963434|NCT00767000|453157083|FG004|54-week Study|Reason not reported|0|||
125963435|NCT00767000|453157079|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
125963436|NCT00767000|453157080|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
126123088|NCT01251367|453743879|FG000|Overall Study|Subject Required Alternative Treatment|7|||
125963437|NCT00767000|453157081|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
126123089|NCT01251367|453743879|FG000|Overall Study|No Study Drug Available|1|||
126123090|NCT01251367|453743879|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
126123091|NCT01251367|453743879|FG000|Overall Study|End of Study Visit Performed in Error|1|||
125963438|NCT00767000|453157082|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
126123092|NCT02016820|453743882|FG000|Overall Study|Lost to Follow-up|2|||
126123093|NCT02016820|453743883|FG001|Overall Study|Lost to Follow-up|4|||
126123094|NCT01227044|453743884|FG000|Overall Study|Lost to Follow-up|5|||
126123095|NCT01227044|453743885|FG001|Overall Study|Lost to Follow-up|7|||
126123096|NCT01227044|453743884|FG000|Overall Study|Discontinued Intervention|1|||
126123097|NCT01227044|453743885|FG001|Overall Study|Discontinued Intervention|2|||
125963439|NCT00767000|453157083|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
125963440|NCT02039505|453157084|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
125963441|NCT02039505|453157085|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
125963442|NCT02039505|453157086|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
125963443|NCT02039505|453157087|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
125963444|NCT02039505|453157088|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
125963445|NCT02039505|453157089|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
125963446|NCT02039505|453157090|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
125963447|NCT02039505|453157084|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
125963448|NCT02039505|453157085|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
125963449|NCT02039505|453157086|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
125963450|NCT02039505|453157087|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
125963451|NCT02039505|453157088|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
125963452|NCT02039505|453157089|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
125963453|NCT02039505|453157090|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
125963454|NCT02039505|453157084|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
125963455|NCT02039505|453157085|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125963456|NCT02039505|453157086|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125963457|NCT02039505|453157087|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125963458|NCT02039505|453157088|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125963459|NCT02039505|453157089|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125963460|NCT02039505|453157090|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125963461|NCT02039505|453157084|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
125963462|NCT02039505|453157085|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
125963463|NCT02039505|453157086|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
125963464|NCT02039505|453157087|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
125963465|NCT02039505|453157088|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
125963466|NCT02039505|453157089|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
125963467|NCT02039505|453157090|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
125963468|NCT02039505|453157084|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
125963469|NCT02039505|453157085|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
125963470|NCT02039505|453157086|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
125963471|NCT02039505|453157087|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
125963472|NCT02039505|453157088|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
125963473|NCT02039505|453157089|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
125963474|NCT02039505|453157090|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
125963475|NCT02039505|453157084|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
125963476|NCT02039505|453157085|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
125963477|NCT02039505|453157086|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
125963478|NCT02039505|453157087|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
125963479|NCT02039505|453157088|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
125963480|NCT02039505|453157089|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
125963481|NCT02039505|453157090|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
125963482|NCT02039505|453157084|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125963483|NCT02039505|453157085|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125963484|NCT02039505|453157086|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125963485|NCT02039505|453157087|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
125963486|NCT02039505|453157088|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125963487|NCT02039505|453157089|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125963488|NCT02039505|453157090|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125963489|NCT02039505|453157084|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125963490|NCT02039505|453157085|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125963491|NCT02039505|453157086|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125963492|NCT02039505|453157087|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125963493|NCT02039505|453157088|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125963494|NCT02039505|453157089|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125963495|NCT02039505|453157090|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
125963496|NCT02039505|453157084|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125963497|NCT02039505|453157085|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125963498|NCT02039505|453157086|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125963499|NCT02039505|453157087|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125963500|NCT02039505|453157088|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125963501|NCT02039505|453157089|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125963502|NCT02039505|453157090|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
125963503|NCT02039505|453157084|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125963504|NCT02039505|453157085|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125963505|NCT02039505|453157086|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125963506|NCT02039505|453157087|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125963507|NCT02039505|453157088|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125963508|NCT02039505|453157089|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125963509|NCT02039505|453157090|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
125963510|NCT02039505|453157084|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125963511|NCT02039505|453157085|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125963512|NCT02039505|453157086|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125963513|NCT02039505|453157087|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125963514|NCT02039505|453157088|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125963515|NCT02039505|453157089|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125963516|NCT02039505|453157090|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
125963517|NCT00003457|453157091|FG000|Overall Study|Not evaluable|9|||
125963518|NCT02246998|453157095|FG000|Overall Study|Adverse Event|0|||
125963519|NCT02246998|453157096|FG001|Overall Study|Adverse Event|1|||
125963520|NCT02246998|453157097|FG002|Overall Study|Adverse Event|1|||
125963521|NCT02246998|453157098|FG003|Overall Study|Adverse Event|0|||
125963522|NCT02246998|453157095|FG000|Overall Study|Lost to Follow-up|1|||
125963523|NCT02246998|453157096|FG001|Overall Study|Lost to Follow-up|0|||
125963524|NCT02246998|453157097|FG002|Overall Study|Lost to Follow-up|0|||
125963525|NCT02246998|453157098|FG003|Overall Study|Lost to Follow-up|1|||
125963526|NCT02246998|453157095|FG000|Overall Study|Randomized but Never Dosed|1|||
125963527|NCT02246998|453157096|FG001|Overall Study|Randomized but Never Dosed|2|||
125963528|NCT02246998|453157097|FG002|Overall Study|Randomized but Never Dosed|2|||
125963529|NCT02246998|453157098|FG003|Overall Study|Randomized but Never Dosed|1|||
125963530|NCT02525133|453157101|FG000|Overall Study|Adverse Event|0|||
125963531|NCT02525133|453157102|FG001|Overall Study|Adverse Event|1|||
125963532|NCT02525133|453157101|FG000|Overall Study|Death|0|||
125963533|NCT02525133|453157102|FG001|Overall Study|Death|1|||
125963534|NCT02525133|453157101|FG000|Overall Study|did not meet randomization criteria|1|||
125963535|NCT02525133|453157102|FG001|Overall Study|did not meet randomization criteria|0|||
125963536|NCT02525133|453157101|FG000|Overall Study|Lost to Follow-up|5|||
125963537|NCT02525133|453157102|FG001|Overall Study|Lost to Follow-up|1|||
125963538|NCT02525133|453157101|FG000|Overall Study|randomized not enrolled|3|||
125963539|NCT02525133|453157102|FG001|Overall Study|randomized not enrolled|0|||
125963540|NCT02525133|453157101|FG000|Overall Study|Withdrawal by Subject|1|||
125963541|NCT02525133|453157102|FG001|Overall Study|Withdrawal by Subject|0|||
125963542|NCT01343082|453157103|FG000|The run-in Period|Not meeting criteria|3|||
125963543|NCT01343082|453157104|FG001|The run-in Period|Not meeting criteria|4|||
125963544|NCT01343082|453157105|FG002|The run-in Period|Not meeting criteria|5|||
125963545|NCT01343082|453157103|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
125963546|NCT01343082|453157104|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
125963547|NCT01343082|453157105|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
125963548|NCT01343082|453157103|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
125963549|NCT01343082|453157104|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
125963550|NCT01343082|453157105|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
125963551|NCT01343082|453157103|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
125963552|NCT01343082|453157104|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
125963553|NCT01343082|453157105|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
125963554|NCT01343082|453157103|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
125963555|NCT01343082|453157104|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
125963556|NCT01343082|453157105|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
125963557|NCT01075074|453157106|FG000|Overall Study|Surgeon changed to open incisional case|1|||
125963558|NCT01075074|453157107|FG001|Overall Study|Surgeon changed to open incisional case|2|||
125963559|NCT01075074|453157108|FG002|Overall Study|Surgeon changed to open incisional case|2|||
125963560|NCT04265755|453157109|FG000|Overall Study|Withdrawal by Subject|39|||
125963561|NCT04265755|453157109|FG000|Overall Study|Decision by sponsor|2|||
125963562|NCT04265755|453157109|FG000|Overall Study|Lost to Follow-up|11|||
126123098|NCT02424253|453743886|FG000|Overall Study|Other, unspecified|1|||
126123099|NCT02424253|453743887|FG001|Overall Study|Other, unspecified|0|||
126123100|NCT02424253|453743886|FG000|Overall Study|Compliance problems|1|||
126123101|NCT02424253|453743887|FG001|Overall Study|Compliance problems|0|||
126123102|NCT02424253|453743886|FG000|Overall Study|Physician Decision|2|||
126123103|NCT02424253|453743887|FG001|Overall Study|Physician Decision|0|||
126123104|NCT02424253|453743886|FG000|Overall Study|Lack of Efficacy|0|||
126123105|NCT02424253|453743887|FG001|Overall Study|Lack of Efficacy|7|||
126123106|NCT02424253|453743886|FG000|Overall Study|Adverse Event|2|||
126123107|NCT02424253|453743887|FG001|Overall Study|Adverse Event|0|||
126123108|NCT02424253|453743886|FG000|Overall Study|Consent withdrawn by subject|4|||
125963563|NCT04265755|453157109|FG000|Overall Study|Death|1|||
125963564|NCT01575561|453157110|FG000|Overall Study|Adverse Event|9|||
126123109|NCT02424253|453743887|FG001|Overall Study|Consent withdrawn by subject|1|||
126123110|NCT02424253|453743886|FG000|Overall Study|Lost to Follow-up|1|||
126123111|NCT02424253|453743887|FG001|Overall Study|Lost to Follow-up|1|||
126123112|NCT00583362|453743888|FG000|Overall Study|Adverse Event|44|||
126123113|NCT00583362|453743888|FG000|Overall Study|Lack of Efficacy|22|||
125963565|NCT01575561|453157110|FG000|Overall Study|Lack of Efficacy|8|||
125963566|NCT01575561|453157110|FG000|Overall Study|Lost to Follow-up|6|||
125963567|NCT01575561|453157110|FG000|Overall Study|Protocol Violation|4|||
126123114|NCT00583362|453743888|FG000|Overall Study|Lost to Follow-up|4|||
126123115|NCT00583362|453743888|FG000|Overall Study|Non-compliance with study drug|28|||
126123116|NCT00583362|453743888|FG000|Overall Study|Pregnancy|7|||
126123117|NCT00583362|453743888|FG000|Overall Study|Miscommunication of visit window|5|||
126123118|NCT00583362|453743888|FG000|Overall Study|Current site closed|7|||
126123119|NCT00583362|453743888|FG000|Overall Study|Subject not dosed in LBSL99|1|||
126123120|NCT00583362|453743888|FG000|Overall Study|Subject moved out of the country/state|2|||
126123121|NCT00583362|453743888|FG000|Overall Study|Missed visits due to staff changes|1|||
126123122|NCT00583362|453743888|FG000|Overall Study|Misunderstanding of protocol|1|||
126123123|NCT00583362|453743888|FG000|Overall Study|Behavioral problems and non-compliance|1|||
126123124|NCT00583362|453743888|FG000|Overall Study|Sponsor request due to missed doses|1|||
126123125|NCT00583362|453743888|FG000|Overall Study|Physician Decision|19|||
126123126|NCT00583362|453743888|FG000|Overall Study|Protocol Violation|2|||
126123127|NCT00583362|453743888|FG000|Overall Study|Withdrawal by Subject|57|||
126123128|NCT04247061|453743889|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
126123129|NCT04247061|453743889|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
126123130|NCT04247061|453743889|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
126123131|NCT02290873|453743896|FG000|Overall Study|Withdrawal by Subject|0|||
126123132|NCT02290873|453743897|FG001|Overall Study|Withdrawal by Subject|1|||
126123133|NCT02290873|453743898|FG002|Overall Study|Withdrawal by Subject|1|||
126123134|NCT02290873|453743896|FG000|Overall Study|Nellcor device error|1|||
126123135|NCT02290873|453743897|FG001|Overall Study|Nellcor device error|0|||
126123136|NCT02290873|453743898|FG002|Overall Study|Nellcor device error|0|||
126123137|NCT02290873|453743896|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
126123138|NCT02290873|453743897|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
126123139|NCT02290873|453743898|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
126123140|NCT02290873|453743896|FG000|Overall Study|Protocol Violation|0|||
126123141|NCT02290873|453743897|FG001|Overall Study|Protocol Violation|0|||
126123142|NCT02290873|453743898|FG002|Overall Study|Protocol Violation|1|||
126123143|NCT01136655|453743902|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
126123144|NCT01136655|453743902|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
126123145|NCT01136655|453743902|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
126123146|NCT01136655|453743902|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
126123147|NCT01378104|453743903|FG000|Overall Study|Adverse Event|8|||
126123148|NCT01378104|453743904|FG001|Overall Study|Adverse Event|8|||
126123149|NCT01378104|453743903|FG000|Overall Study|Lack of Efficacy|7|||
126123150|NCT01378104|453743904|FG001|Overall Study|Lack of Efficacy|5|||
126123151|NCT01378104|453743903|FG000|Overall Study|Withdrawal by Subject|12|||
126123152|NCT01378104|453743904|FG001|Overall Study|Withdrawal by Subject|13|||
126123153|NCT02287623|453743905|FG000|Overall Study|Protocol Violation|0|||
126123154|NCT02287623|453743906|FG001|Overall Study|Protocol Violation|1|||
126123155|NCT02700997|453743907|FG000|Overall Study|Did not undergo CT imaging|1|||
126123156|NCT02700997|453743907|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
126123157|NCT03610724|453743908|FG000|Overall Study|Death|17|||
126123158|NCT03610724|453743908|FG000|Overall Study|Lost to Follow-up|1|||
126123159|NCT03610724|453743908|FG000|Overall Study|Physician Decision|1|||
126123160|NCT03610724|453743908|FG000|Overall Study|Died prior to infusion|1|||
126123161|NCT01519765|453743909|FG000|Overall Study|Adverse Event|0|||
126123162|NCT01519765|453743910|FG001|Overall Study|Adverse Event|1|||
126123163|NCT01519765|453743909|FG000|Overall Study|Lack of Efficacy|2|||
126123164|NCT01519765|453743910|FG001|Overall Study|Lack of Efficacy|0|||
126123165|NCT01519765|453743909|FG000|Overall Study|Protocol Violation|1|||
126123166|NCT01519765|453743910|FG001|Overall Study|Protocol Violation|0|||
126123167|NCT01519765|453743909|FG000|Overall Study|Withdrawal by Subject|0|||
126123168|NCT01519765|453743910|FG001|Overall Study|Withdrawal by Subject|1|||
126123169|NCT01473563|453743911|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
126123170|NCT02354222|453743912|FG000|Overall Study|Adverse Event|0|||
126123171|NCT02354222|453743913|FG001|Overall Study|Adverse Event|3|||
126123172|NCT02354222|453743912|FG000|Overall Study|Physician Decision|1|||
126123173|NCT02354222|453743913|FG001|Overall Study|Physician Decision|1|||
126123174|NCT02354222|453743912|FG000|Overall Study|Pregnancy|1|||
126123175|NCT02354222|453743913|FG001|Overall Study|Pregnancy|0|||
126123176|NCT02354222|453743912|FG000|Overall Study|Withdrawal by Subject|2|||
126123177|NCT02354222|453743913|FG001|Overall Study|Withdrawal by Subject|3|||
126123178|NCT02354222|453743912|FG000|Overall Study|Conflict with the stopping criteria|0|||
126123179|NCT02354222|453743913|FG001|Overall Study|Conflict with the stopping criteria|4|||
126123180|NCT01342484|453743918|FG000|Overall Study|Other Reasons|1|||
126123181|NCT01342484|453743919|FG001|Overall Study|Other Reasons|0|||
126123182|NCT01342484|453743920|FG002|Overall Study|Other Reasons|0|||
126123183|NCT01342484|453743918|FG000|Overall Study|Protocol Violation|0|||
126123184|NCT01342484|453743919|FG001|Overall Study|Protocol Violation|0|||
126123185|NCT01342484|453743920|FG002|Overall Study|Protocol Violation|1|||
126123186|NCT01342484|453743918|FG000|Overall Study|Withdrawal by Subject|1|||
126123187|NCT01342484|453743919|FG001|Overall Study|Withdrawal by Subject|0|||
126123188|NCT01342484|453743920|FG002|Overall Study|Withdrawal by Subject|0|||
126123189|NCT01840579|453743921|FG000|Overall Study|Status not recorded|0|||
126123190|NCT01840579|453743922|FG001|Overall Study|Status not recorded|0|||
126123191|NCT01840579|453743923|FG002|Overall Study|Status not recorded|2|||
126123192|NCT01840579|453743924|FG003|Overall Study|Status not recorded|3|||
126123193|NCT01840579|453743925|FG004|Overall Study|Status not recorded|4|||
126123194|NCT01840579|453743926|FG005|Overall Study|Status not recorded|3|||
126123195|NCT01840579|453743927|FG006|Overall Study|Status not recorded|0|||
126123196|NCT01840579|453743928|FG007|Overall Study|Status not recorded|3|||
126123197|NCT01840579|453743929|FG008|Overall Study|Status not recorded|3|||
126123198|NCT01840579|453743930|FG009|Overall Study|Status not recorded|3|||
126123199|NCT01840579|453743921|FG000|Overall Study|Progressive disease|3|||
126123200|NCT01840579|453743922|FG001|Overall Study|Progressive disease|5|||
126123201|NCT01840579|453743923|FG002|Overall Study|Progressive disease|0|||
126123202|NCT01840579|453743924|FG003|Overall Study|Progressive disease|0|||
126123203|NCT01840579|453743925|FG004|Overall Study|Progressive disease|0|||
126123204|NCT01840579|453743926|FG005|Overall Study|Progressive disease|0|||
126123205|NCT01840579|453743927|FG006|Overall Study|Progressive disease|0|||
126123206|NCT01840579|453743928|FG007|Overall Study|Progressive disease|0|||
126123207|NCT01840579|453743929|FG008|Overall Study|Progressive disease|0|||
126123208|NCT01840579|453743930|FG009|Overall Study|Progressive disease|0|||
126123209|NCT01840579|453743921|FG000|Overall Study|Ongoing in study|0|||
126123210|NCT01840579|453743922|FG001|Overall Study|Ongoing in study|1|||
126123211|NCT01840579|453743923|FG002|Overall Study|Ongoing in study|0|||
126123212|NCT01840579|453743924|FG003|Overall Study|Ongoing in study|0|||
126123213|NCT01840579|453743925|FG004|Overall Study|Ongoing in study|0|||
126123214|NCT01840579|453743926|FG005|Overall Study|Ongoing in study|0|||
126123215|NCT01840579|453743927|FG006|Overall Study|Ongoing in study|0|||
126123216|NCT01840579|453743928|FG007|Overall Study|Ongoing in study|0|||
126123217|NCT01840579|453743929|FG008|Overall Study|Ongoing in study|0|||
126123218|NCT01840579|453743930|FG009|Overall Study|Ongoing in study|0|||
126123219|NCT01840579|453743921|FG000|Overall Study|Death|0|||
126123220|NCT01840579|453743922|FG001|Overall Study|Death|0|||
126123221|NCT01840579|453743923|FG002|Overall Study|Death|0|||
126123222|NCT01840579|453743924|FG003|Overall Study|Death|0|||
126123223|NCT01840579|453743925|FG004|Overall Study|Death|0|||
126123224|NCT01840579|453743926|FG005|Overall Study|Death|1|||
126123225|NCT01840579|453743927|FG006|Overall Study|Death|0|||
126123226|NCT01840579|453743928|FG007|Overall Study|Death|0|||
126123227|NCT01840579|453743929|FG008|Overall Study|Death|0|||
126123228|NCT01840579|453743930|FG009|Overall Study|Death|0|||
126123229|NCT01840579|453743921|FG000|Overall Study|Adverse Event|0|||
126123230|NCT01840579|453743922|FG001|Overall Study|Adverse Event|1|||
126123231|NCT01840579|453743923|FG002|Overall Study|Adverse Event|0|||
126123232|NCT01840579|453743924|FG003|Overall Study|Adverse Event|0|||
126123233|NCT01840579|453743925|FG004|Overall Study|Adverse Event|0|||
126123234|NCT01840579|453743926|FG005|Overall Study|Adverse Event|0|||
126123235|NCT01840579|453743927|FG006|Overall Study|Adverse Event|0|||
126123236|NCT01840579|453743928|FG007|Overall Study|Adverse Event|0|||
126123237|NCT01840579|453743929|FG008|Overall Study|Adverse Event|0|||
126123238|NCT01840579|453743930|FG009|Overall Study|Adverse Event|0|||
126123239|NCT01840579|453743921|FG000|Overall Study|Follow-up ended by Sponsor|0|||
126123240|NCT01840579|453743922|FG001|Overall Study|Follow-up ended by Sponsor|0|||
126123241|NCT01840579|453743923|FG002|Overall Study|Follow-up ended by Sponsor|0|||
126123242|NCT01840579|453743924|FG003|Overall Study|Follow-up ended by Sponsor|0|||
126123243|NCT01840579|453743925|FG004|Overall Study|Follow-up ended by Sponsor|0|||
126123244|NCT01840579|453743926|FG005|Overall Study|Follow-up ended by Sponsor|0|||
126123245|NCT01840579|453743927|FG006|Overall Study|Follow-up ended by Sponsor|2|||
126123246|NCT01840579|453743928|FG007|Overall Study|Follow-up ended by Sponsor|0|||
126123247|NCT01840579|453743929|FG008|Overall Study|Follow-up ended by Sponsor|0|||
126123248|NCT01840579|453743930|FG009|Overall Study|Follow-up ended by Sponsor|0|||
126123249|NCT00432042|453743931|FG000|Overall Study|Protocol Violation|2|||
126123250|NCT00432042|453743932|FG001|Overall Study|Protocol Violation|0|||
126123251|NCT00432042|453743933|FG002|Overall Study|Protocol Violation|0|||
126123252|NCT00432042|453743931|FG000|Overall Study|Withdrawal by Subject|0|||
126123253|NCT00432042|453743932|FG001|Overall Study|Withdrawal by Subject|0|||
126123254|NCT00432042|453743933|FG002|Overall Study|Withdrawal by Subject|2|||
126123255|NCT00432042|453743931|FG000|Overall Study|Lost to Follow-up|5|||
125963568|NCT01575561|453157110|FG000|Overall Study|Withdrawal by Subject|11|||
126123256|NCT00432042|453743932|FG001|Overall Study|Lost to Follow-up|1|||
126123257|NCT00432042|453743933|FG002|Overall Study|Lost to Follow-up|0|||
126123258|NCT04013529|453743937|FG000|Overall Study|Withdrawal by Subject|1|||
126123259|NCT04013529|453743938|FG001|Overall Study|Withdrawal by Subject|1|||
126123260|NCT03116698|453743939|FG000|Overall Study|Adverse Event|1|||
126123261|NCT03116698|453743940|FG001|Overall Study|Adverse Event|1|||
126123262|NCT03116698|453743941|FG002|Overall Study|Adverse Event|1|||
126123263|NCT03116698|453743942|FG003|Overall Study|Adverse Event|0|||
126123264|NCT03116698|453743939|FG000|Overall Study|Withdrawal by Subject|1|||
126123265|NCT03116698|453743940|FG001|Overall Study|Withdrawal by Subject|4|||
126123266|NCT03116698|453743941|FG002|Overall Study|Withdrawal by Subject|5|||
126123267|NCT03116698|453743942|FG003|Overall Study|Withdrawal by Subject|2|||
126123268|NCT03116698|453743939|FG000|Overall Study|Lost to Follow-up|2|||
126123269|NCT03116698|453743940|FG001|Overall Study|Lost to Follow-up|0|||
126123270|NCT03116698|453743941|FG002|Overall Study|Lost to Follow-up|0|||
126123271|NCT03116698|453743942|FG003|Overall Study|Lost to Follow-up|0|||
126123272|NCT03116698|453743939|FG000|Overall Study|Physician Decision|1|||
126123273|NCT03116698|453743940|FG001|Overall Study|Physician Decision|1|||
126123274|NCT03116698|453743941|FG002|Overall Study|Physician Decision|0|||
126123275|NCT03116698|453743942|FG003|Overall Study|Physician Decision|0|||
126123276|NCT03116698|453743939|FG000|Overall Study|Protocol Violation|1|||
126123277|NCT03116698|453743940|FG001|Overall Study|Protocol Violation|0|||
126123278|NCT03116698|453743941|FG002|Overall Study|Protocol Violation|0|||
126123279|NCT03116698|453743942|FG003|Overall Study|Protocol Violation|0|||
126123280|NCT03116698|453743939|FG000|Overall Study|Death|0|||
126123281|NCT03116698|453743940|FG001|Overall Study|Death|0|||
126123282|NCT03116698|453743941|FG002|Overall Study|Death|2|||
126123283|NCT03116698|453743942|FG003|Overall Study|Death|0|||
126123284|NCT00788372|453743943|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
126123285|NCT00788372|453743943|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
126123286|NCT00788372|453743943|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
126123287|NCT00788372|453743943|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
126123288|NCT00788372|453743943|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
126123289|NCT00788372|453743943|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
126123290|NCT00788372|453743943|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
126123291|NCT04766021|453745320|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
126123292|NCT04766021|453745320|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
126123293|NCT00789529|453745321|FG000|Overall Study|Withdrawal by Subject|0|||
126123294|NCT00789529|453745322|FG001|Overall Study|Withdrawal by Subject|1|||
126123295|NCT00789529|453745321|FG000|Overall Study|Other Reason|1|||
126123296|NCT00789529|453745322|FG001|Overall Study|Other Reason|0|||
126123297|NCT01849874|453745323|FG000|Overall Study|Death|89|||
126123298|NCT01849874|453745324|FG001|Overall Study|Death|42|||
126123299|NCT01849874|453745323|FG000|Overall Study|Withdrawal by Subject|17|||
126123300|NCT01849874|453745324|FG001|Overall Study|Withdrawal by Subject|16|||
126123301|NCT01849874|453745323|FG000|Overall Study|Lost to Follow-up|3|||
126123302|NCT01849874|453745324|FG001|Overall Study|Lost to Follow-up|2|||
126123303|NCT01849874|453745323|FG000|Overall Study|Study Termination By Sponsor|93|||
126123304|NCT01849874|453745324|FG001|Overall Study|Study Termination By Sponsor|48|||
126123305|NCT01849874|453745323|FG000|Overall Study|Completed as per protocol amendment 6|3|||
126123306|NCT01849874|453745324|FG001|Overall Study|Completed as per protocol amendment 6|0|||
126123307|NCT01849874|453745323|FG000|Overall Study|Physician Decision|7|||
126123308|NCT01849874|453745324|FG001|Overall Study|Physician Decision|1|||
126123309|NCT01849874|453745323|FG000|Overall Study|Other|16|||
126123310|NCT01849874|453745324|FG001|Overall Study|Other|4|||
126123311|NCT02347098|453745325|FG000|Overall Study|Death|1|||
126123312|NCT02347098|453745326|FG001|Overall Study|Death|0|||
126123313|NCT02347098|453745325|FG000|Overall Study|Withdrawal by Subject|1|||
126123314|NCT02347098|453745326|FG001|Overall Study|Withdrawal by Subject|0|||
126123315|NCT02347098|453745325|FG000|Overall Study|Lost to Follow-up|2|||
126123316|NCT02347098|453745326|FG001|Overall Study|Lost to Follow-up|2|||
126123317|NCT02347098|453745325|FG000|Overall Study|Refuse Follow-up Visit|1|||
126123318|NCT02347098|453745326|FG001|Overall Study|Refuse Follow-up Visit|5|||
126123319|NCT02347098|453745325|FG000|Overall Study|no visit due to illness|2|||
126123320|NCT02347098|453745326|FG001|Overall Study|no visit due to illness|1|||
126123321|NCT02187172|453745327|FG000|Overall Study|Lost to Follow-up|1|||
126123322|NCT02187172|453745328|FG001|Overall Study|Lost to Follow-up|2|||
126123323|NCT02187172|453745327|FG000|Overall Study|Lack of Efficacy|1|||
126123324|NCT02187172|453745328|FG001|Overall Study|Lack of Efficacy|2|||
126123325|NCT02187172|453745327|FG000|Overall Study|Adverse Event|0|||
126123326|NCT02187172|453745328|FG001|Overall Study|Adverse Event|1|||
126123327|NCT02187172|453745327|FG000|Overall Study|Physician Decision|1|||
126123328|NCT02187172|453745328|FG001|Overall Study|Physician Decision|1|||
126123329|NCT01230242|453745332|FG000|Overall Study|Physician Decision|2|||
126123330|NCT01230242|453745332|FG000|Overall Study|Withdrawal by Subject|1|||
126123331|NCT04329702|453745336|FG000|Overall Study|illness|3|||
126123332|NCT04329702|453745337|FG001|Overall Study|illness|4|||
126123333|NCT04329702|453745338|FG002|Overall Study|illness|0|||
126123334|NCT04329702|453745336|FG000|Overall Study|Lost to Follow-up|0|||
126123335|NCT04329702|453745337|FG001|Overall Study|Lost to Follow-up|0|||
126123336|NCT04329702|453745338|FG002|Overall Study|Lost to Follow-up|2|||
126123337|NCT04329702|453745336|FG000|Overall Study|Death|0|||
126123338|NCT04329702|453745337|FG001|Overall Study|Death|2|||
126123339|NCT04329702|453745338|FG002|Overall Study|Death|0|||
126123340|NCT01438489|453745339|FG000|Overall Study|Lost to Follow-up|4|||
126123341|NCT01438489|453745340|FG001|Overall Study|Lost to Follow-up|2|||
126123342|NCT01438489|453745341|FG002|Overall Study|Lost to Follow-up|2|||
126123343|NCT01438489|453745339|FG000|Overall Study|Withdrawal by Subject|11|||
126123344|NCT01438489|453745340|FG001|Overall Study|Withdrawal by Subject|3|||
126123345|NCT01438489|453745341|FG002|Overall Study|Withdrawal by Subject|8|||
126123346|NCT01438489|453745339|FG000|Overall Study|Death|0|||
126123347|NCT01438489|453745340|FG001|Overall Study|Death|0|||
126123348|NCT01438489|453745341|FG002|Overall Study|Death|1|||
126123349|NCT01438489|453745339|FG000|Overall Study|Sponsor decision|4|||
126123350|NCT01438489|453745340|FG001|Overall Study|Sponsor decision|1|||
126123351|NCT01438489|453745341|FG002|Overall Study|Sponsor decision|4|||
126123352|NCT01438489|453745339|FG000|Overall Study|Subject choice/Subject moved|2|||
126123353|NCT01438489|453745340|FG001|Overall Study|Subject choice/Subject moved|1|||
126123354|NCT01438489|453745341|FG002|Overall Study|Subject choice/Subject moved|1|||
126123355|NCT01438489|453745339|FG000|Overall Study|Investigator decision|0|||
126123356|NCT01438489|453745340|FG001|Overall Study|Investigator decision|1|||
126123357|NCT01438489|453745341|FG002|Overall Study|Investigator decision|0|||
126123358|NCT01438489|453745339|FG000|Overall Study|AE/SAEs|2|||
126123359|NCT01438489|453745340|FG001|Overall Study|AE/SAEs|1|||
126123360|NCT01438489|453745341|FG002|Overall Study|AE/SAEs|1|||
126123361|NCT01438489|453745339|FG000|Overall Study|Received prohibited medication|1|||
126123362|NCT01438489|453745340|FG001|Overall Study|Received prohibited medication|0|||
126123363|NCT01438489|453745341|FG002|Overall Study|Received prohibited medication|0|||
126123364|NCT01438489|453745339|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
126123365|NCT01438489|453745340|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
126123366|NCT01438489|453745341|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
126123367|NCT01438489|453745339|FG000|Overall Study|Inadequate venous access|0|||
126123368|NCT01438489|453745340|FG001|Overall Study|Inadequate venous access|2|||
126123369|NCT01438489|453745341|FG002|Overall Study|Inadequate venous access|0|||
126123370|NCT00766532|453745342|FG000|Overall Study|Protocol Violation|2|||
126123371|NCT02037295|453745347|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
126123372|NCT02037295|453745348|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
126123373|NCT02037295|453745349|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
126123374|NCT02037295|453745350|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
126123375|NCT01140451|453745351|FG000|Overall Study|Withdrawal by Subject|26|||
126123376|NCT01140451|453745352|FG001|Overall Study|Withdrawal by Subject|33|||
126123377|NCT01140451|453745351|FG000|Overall Study|Adverse Event|2|||
126123378|NCT01140451|453745352|FG001|Overall Study|Adverse Event|6|||
126123379|NCT01140451|453745351|FG000|Overall Study|Physician Decision|5|||
126123380|NCT01140451|453745352|FG001|Overall Study|Physician Decision|3|||
126123381|NCT01140451|453745351|FG000|Overall Study|Lost to Follow-up|2|||
126123382|NCT01140451|453745352|FG001|Overall Study|Lost to Follow-up|0|||
126123383|NCT01140451|453745351|FG000|Overall Study|Participants Planning Pregnancy|3|||
126123384|NCT01140451|453745352|FG001|Overall Study|Participants Planning Pregnancy|0|||
126123385|NCT00960661|453745356|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
126123386|NCT00960661|453745357|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
126123387|NCT00960661|453745358|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
126123388|NCT00960661|453745356|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
126123389|NCT00960661|453745357|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
126123390|NCT00960661|453745358|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
126123391|NCT00960661|453745356|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
126123392|NCT00960661|453745357|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
126123393|NCT00960661|453745358|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
126123394|NCT00960661|453745356|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
126123395|NCT00960661|453745357|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
126123396|NCT00960661|453745358|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
126123397|NCT00960661|453745356|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
126123398|NCT00960661|453745357|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
126123399|NCT00960661|453745358|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
126123400|NCT00960661|453745356|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
126123401|NCT00960661|453745357|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
126123402|NCT00960661|453745358|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
126123403|NCT00960661|453745356|FG000|Interventional Phase|Adverse Event|0|||
126123404|NCT00960661|453745357|FG001|Interventional Phase|Adverse Event|17|||
126123405|NCT00960661|453745358|FG002|Interventional Phase|Adverse Event|8|||
126123406|NCT00960661|453745356|FG000|Interventional Phase|Death|0|||
126123407|NCT00960661|453745357|FG001|Interventional Phase|Death|1|||
126123408|NCT00960661|453745358|FG002|Interventional Phase|Death|0|||
126123409|NCT00960661|453745356|FG000|Interventional Phase|Lost to Follow-up|0|||
126123410|NCT00960661|453745357|FG001|Interventional Phase|Lost to Follow-up|0|||
126123411|NCT00960661|453745358|FG002|Interventional Phase|Lost to Follow-up|2|||
126123412|NCT00960661|453745356|FG000|Interventional Phase|entry criteria not met|0|||
126123413|NCT00960661|453745357|FG001|Interventional Phase|entry criteria not met|3|||
126123414|NCT00960661|453745358|FG002|Interventional Phase|entry criteria not met|0|||
126123415|NCT00960661|453745356|FG000|Interventional Phase|Protocol Violation|0|||
126123416|NCT00960661|453745357|FG001|Interventional Phase|Protocol Violation|7|||
126123417|NCT00960661|453745358|FG002|Interventional Phase|Protocol Violation|2|||
126123418|NCT00960661|453745356|FG000|Interventional Phase|Withdrawal by Subject|0|||
126123419|NCT00960661|453745357|FG001|Interventional Phase|Withdrawal by Subject|18|||
126123420|NCT00960661|453745358|FG002|Interventional Phase|Withdrawal by Subject|29|||
126123421|NCT00960661|453745356|FG000|Interventional Phase|Physician Decision|0|||
126123422|NCT00960661|453745357|FG001|Interventional Phase|Physician Decision|3|||
126123423|NCT00960661|453745358|FG002|Interventional Phase|Physician Decision|5|||
126123424|NCT00960661|453745356|FG000|Interventional Phase|sponsor decision|0|||
126123425|NCT00960661|453745357|FG001|Interventional Phase|sponsor decision|1|||
126123426|NCT00960661|453745358|FG002|Interventional Phase|sponsor decision|0|||
126123427|NCT00960661|453745356|FG000|Interventional Phase|Lack of Efficacy|0|||
126123428|NCT00960661|453745357|FG001|Interventional Phase|Lack of Efficacy|2|||
126123429|NCT00960661|453745358|FG002|Interventional Phase|Lack of Efficacy|0|||
126123430|NCT02699892|453745359|FG000|Overall Study|Other|36|||
126123431|NCT01324232|453745366|FG000|Overall Study|Protocol Violation|0|||
126123432|NCT01324232|453745367|FG001|Overall Study|Protocol Violation|0|||
126123433|NCT01324232|453745368|FG002|Overall Study|Protocol Violation|0|||
126123434|NCT01324232|453745369|FG003|Overall Study|Protocol Violation|2|||
126123435|NCT01324232|453745366|FG000|Overall Study|Missing|0|||
126123436|NCT01324232|453745367|FG001|Overall Study|Missing|0|||
126123437|NCT01324232|453745368|FG002|Overall Study|Missing|1|||
126123438|NCT01324232|453745369|FG003|Overall Study|Missing|0|||
126123439|NCT01324232|453745366|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
126123440|NCT01324232|453745367|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
126123441|NCT01324232|453745368|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
126123442|NCT01324232|453745369|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
126123443|NCT01324232|453745366|FG000|Overall Study|Lack of Efficacy|2|||
126123444|NCT01324232|453745367|FG001|Overall Study|Lack of Efficacy|1|||
126123445|NCT01324232|453745368|FG002|Overall Study|Lack of Efficacy|2|||
126123446|NCT01324232|453745369|FG003|Overall Study|Lack of Efficacy|2|||
126123447|NCT01324232|453745366|FG000|Overall Study|Participant Refused Medication|0|||
126123448|NCT01324232|453745367|FG001|Overall Study|Participant Refused Medication|1|||
126123449|NCT01324232|453745368|FG002|Overall Study|Participant Refused Medication|0|||
126123450|NCT01324232|453745369|FG003|Overall Study|Participant Refused Medication|0|||
126123451|NCT01324232|453745366|FG000|Overall Study|Intercurrent illness|0|||
126123452|NCT01324232|453745367|FG001|Overall Study|Intercurrent illness|0|||
126123453|NCT01324232|453745368|FG002|Overall Study|Intercurrent illness|0|||
126123454|NCT01324232|453745369|FG003|Overall Study|Intercurrent illness|1|||
126123455|NCT01324232|453745366|FG000|Overall Study|Adverse Event|2|||
126123456|NCT01324232|453745367|FG001|Overall Study|Adverse Event|5|||
126123457|NCT01324232|453745368|FG002|Overall Study|Adverse Event|6|||
126123458|NCT01324232|453745369|FG003|Overall Study|Adverse Event|6|||
126123459|NCT01324232|453745366|FG000|Overall Study|Withdrawal by Subject|0|||
126123460|NCT01324232|453745367|FG001|Overall Study|Withdrawal by Subject|3|||
126123461|NCT01324232|453745368|FG002|Overall Study|Withdrawal by Subject|4|||
126123462|NCT01324232|453745369|FG003|Overall Study|Withdrawal by Subject|0|||
126123463|NCT01324232|453745366|FG000|Overall Study|Lost to Follow-up|1|||
126123464|NCT01324232|453745367|FG001|Overall Study|Lost to Follow-up|0|||
126123465|NCT01324232|453745368|FG002|Overall Study|Lost to Follow-up|0|||
126123466|NCT01324232|453745369|FG003|Overall Study|Lost to Follow-up|0|||
126123467|NCT00661531|453745370|FG000|Overall Study|Withdrawal by Subject|3|||
126123468|NCT02614859|453745373|FG000|Overall Study|Physician Decision|0|||
126123469|NCT02614859|453745374|FG001|Overall Study|Physician Decision|1|||
126123470|NCT04081363|453745379|FG000|Overall Study|Withdrawal by Subject|1|||
126123471|NCT04081363|453745380|FG001|Overall Study|Withdrawal by Subject|0|||
126123472|NCT00618410|453745381|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
126123473|NCT00618410|453745382|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
126123474|NCT00705783|453745383|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
126123475|NCT00705783|453745384|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
126123476|NCT00705783|453745385|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
126123477|NCT00705783|453745383|FG000|Conversion Phase|Lost to Follow-up|13|||
126123478|NCT00705783|453745384|FG001|Conversion Phase|Lost to Follow-up|0|||
126123479|NCT00705783|453745385|FG002|Conversion Phase|Lost to Follow-up|0|||
126123480|NCT00705783|453745383|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
126123481|NCT00705783|453745384|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
126123482|NCT00705783|453745385|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
126123483|NCT00705783|453745383|FG000|Conversion Phase|Withdrawn by Investigator|4|||
126123484|NCT00705783|453745384|FG001|Conversion Phase|Withdrawn by Investigator|0|||
126123485|NCT00705783|453745385|FG002|Conversion Phase|Withdrawn by Investigator|0|||
126123486|NCT00705783|453745383|FG000|Conversion Phase|Withdrew Consent|24|||
126123487|NCT00705783|453745384|FG001|Conversion Phase|Withdrew Consent|0|||
126123488|NCT00705783|453745385|FG002|Conversion Phase|Withdrew Consent|0|||
126123489|NCT00705783|453745383|FG000|Conversion Phase|Protocol Deviation|2|||
126123490|NCT00705783|453745384|FG001|Conversion Phase|Protocol Deviation|0|||
126123491|NCT00705783|453745385|FG002|Conversion Phase|Protocol Deviation|0|||
126123492|NCT00705783|453745383|FG000|Conversion Phase|Adverse Event|11|||
126123493|NCT00705783|453745384|FG001|Conversion Phase|Adverse Event|0|||
126123494|NCT00705783|453745385|FG002|Conversion Phase|Adverse Event|0|||
126123495|NCT00705783|453745383|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
126123496|NCT00705783|453745384|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126123497|NCT00705783|453745385|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126123498|NCT00705783|453745383|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
126123499|NCT00705783|453745384|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126123500|NCT00705783|453745385|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126123501|NCT00705783|453745383|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
126123502|NCT00705783|453745384|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
126123503|NCT00705783|453745385|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
126123504|NCT00705783|453745383|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
126123505|NCT00705783|453745384|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
126123506|NCT00705783|453745385|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
126123507|NCT00705783|453745383|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
126123508|NCT00705783|453745384|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126123509|NCT00705783|453745385|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126123510|NCT00705783|453745383|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
126123511|NCT00705783|453745384|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126123512|NCT00705783|453745385|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126123513|NCT00705783|453745383|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
126123514|NCT00705783|453745384|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
126123515|NCT00705783|453745385|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
126123516|NCT00705783|453745383|FG000|Oral Stabilization Phase|Adverse Event|14|||
126123517|NCT00705783|453745384|FG001|Oral Stabilization Phase|Adverse Event|0|||
126123518|NCT00705783|453745385|FG002|Oral Stabilization Phase|Adverse Event|0|||
126123519|NCT00705783|453745383|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
126123520|NCT00705783|453745384|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126123521|NCT00705783|453745385|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126123522|NCT00705783|453745383|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
126123523|NCT00705783|453745384|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126123524|NCT00705783|453745385|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126123525|NCT00705783|453745383|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
126123526|NCT00705783|453745384|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
126123527|NCT00705783|453745385|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
126123528|NCT00705783|453745383|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
126123529|NCT00705783|453745384|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
126123530|NCT00705783|453745385|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
126123531|NCT00705783|453745383|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
126123532|NCT00705783|453745384|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
126123533|NCT00705783|453745385|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
126123534|NCT00705783|453745383|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
126123535|NCT00705783|453745384|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
126123536|NCT00705783|453745385|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
126123537|NCT00705783|453745383|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
126123538|NCT00705783|453745384|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
126123539|NCT00705783|453745385|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
126123540|NCT00705783|453745383|FG000|Depot Stabilization Phase|Adverse Event|17|||
126123541|NCT00705783|453745384|FG001|Depot Stabilization Phase|Adverse Event|0|||
126123542|NCT00705783|453745385|FG002|Depot Stabilization Phase|Adverse Event|0|||
126087918|NCT00392925|453614863|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
126087919|NCT00392925|453614864|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
126087920|NCT00392925|453614865|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
126087921|NCT00392925|453614862|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
126087922|NCT00392925|453614863|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
126087923|NCT00392925|453614864|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
126087924|NCT00392925|453614865|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
126087925|NCT02269423|453614869|FG000|Overall Study|Discontinued due to change in residence|0|||
126087926|NCT02269423|453614870|FG001|Overall Study|Discontinued due to change in residence|1|||
126087927|NCT02269423|453614871|FG002|Overall Study|Discontinued due to change in residence|0|||
126087928|NCT02269423|453614872|FG003|Overall Study|Discontinued due to change in residence|1|||
126087929|NCT00755105|453614875|FG000|Overall Study|Withdrawal by Subject|9|||
126087930|NCT00755105|453614876|FG001|Overall Study|Withdrawal by Subject|11|||
126087931|NCT00755105|453614877|FG002|Overall Study|Withdrawal by Subject|4|||
126087932|NCT01281839|453614879|FG000|Overall Study|Lost to Follow-up|6|||
126087933|NCT01281839|453614880|FG001|Overall Study|Lost to Follow-up|3|||
126087934|NCT01281839|453614879|FG000|Overall Study|Withdrawal by Subject|4|||
126087935|NCT01281839|453614880|FG001|Overall Study|Withdrawal by Subject|10|||
126087936|NCT01281839|453614879|FG000|Overall Study|Reason not specified|0|||
126087937|NCT01281839|453614880|FG001|Overall Study|Reason not specified|1|||
126087938|NCT01277887|453614882|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
126123543|NCT00705783|453745383|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
126123544|NCT00705783|453745384|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126123545|NCT00705783|453745385|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126123546|NCT00705783|453745383|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
126123547|NCT00705783|453745384|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126123548|NCT00705783|453745385|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126123549|NCT00705783|453745383|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
126123550|NCT00705783|453745384|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
126123551|NCT00705783|453745385|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
126123552|NCT00705783|453745383|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
126123553|NCT00705783|453745384|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
126123554|NCT00705783|453745385|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
126123555|NCT00705783|453745383|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
126123556|NCT00705783|453745384|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
126123557|NCT00705783|453745385|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
126123558|NCT00705783|453745383|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
126123559|NCT00705783|453745384|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
126123560|NCT00705783|453745385|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
126123561|NCT00705783|453745383|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
126123562|NCT00705783|453745384|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
126123563|NCT00705783|453745385|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
126123564|NCT00705783|453745383|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
126123565|NCT00705783|453745384|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
126123566|NCT00705783|453745385|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
126123567|NCT00705783|453745383|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
126123568|NCT00705783|453745384|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
126123569|NCT00705783|453745385|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
126123570|NCT00705783|453745383|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
126123571|NCT00705783|453745384|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
126123572|NCT00705783|453745385|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
126123573|NCT00705783|453745383|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
125963569|NCT01575561|453157110|FG000|Overall Study|administration|1|||
125963570|NCT02496884|453157111|FG000|Overall Study|Counted twice as enrolled|2|||
125963571|NCT02496884|453157112|FG001|Overall Study|Counted twice as enrolled|0|||
125963572|NCT02496884|453157113|FG002|Overall Study|Counted twice as enrolled|0|||
125963573|NCT02496884|453157114|FG003|Overall Study|Counted twice as enrolled|0|||
125963574|NCT02496884|453157111|FG000|Overall Study|Withdrawal by Subject|0|||
125963575|NCT02496884|453157112|FG001|Overall Study|Withdrawal by Subject|3|||
125963576|NCT02496884|453157113|FG002|Overall Study|Withdrawal by Subject|0|||
125963577|NCT02496884|453157114|FG003|Overall Study|Withdrawal by Subject|0|||
125963578|NCT01114646|453157115|FG000|Overall Study|Withdrawal by Subject|3|||
125963579|NCT01114646|453157116|FG001|Overall Study|Withdrawal by Subject|2|||
125963580|NCT01046110|453157117|FG000|Overall Study|Adverse Event|9|||
125963581|NCT01046110|453157118|FG001|Overall Study|Adverse Event|2|||
125963582|NCT01046110|453157117|FG000|Overall Study|Lack of Efficacy|0|||
125963583|NCT01046110|453157118|FG001|Overall Study|Lack of Efficacy|1|||
125963584|NCT01046110|453157117|FG000|Overall Study|Protocol Violation|7|||
125963585|NCT01046110|453157118|FG001|Overall Study|Protocol Violation|12|||
125963586|NCT01046110|453157117|FG000|Overall Study|Withdrawal Criteria|3|||
125963587|NCT01046110|453157118|FG001|Overall Study|Withdrawal Criteria|5|||
125963588|NCT01046110|453157117|FG000|Overall Study|Unclassified|36|||
125963589|NCT01046110|453157118|FG001|Overall Study|Unclassified|35|||
125963590|NCT02013765|453157128|FG000|Overall Study|Trial was terminated by sponsor|1|||
125963591|NCT00718042|453157133|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125963592|NCT00718042|453157134|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125963593|NCT00718042|453157135|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125963594|NCT00718042|453157136|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125963595|NCT00718042|453157137|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
125963596|NCT00718042|453157138|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125963597|NCT00718042|453157133|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
125963598|NCT00718042|453157134|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
125963599|NCT00718042|453157135|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
126123574|NCT00705783|453745384|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
126123575|NCT00705783|453745385|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
125963600|NCT00718042|453157136|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
125963601|NCT00718042|453157137|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
125963602|NCT00718042|453157138|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
125963603|NCT00718042|453157133|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
125963604|NCT00718042|453157134|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
125963605|NCT00718042|453157135|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
126123576|NCT02184195|453745386|FG000|Overall Study|Patient decision|5|||
126123577|NCT02184195|453745387|FG001|Overall Study|Patient decision|2|||
126123578|NCT02184195|453745386|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126123579|NCT02184195|453745387|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126123580|NCT02184195|453745386|FG000|Overall Study|Death|67|||
126123581|NCT02184195|453745387|FG001|Overall Study|Death|44|||
126123582|NCT02184195|453745386|FG000|Overall Study|Lost to Follow-up|1|||
126123583|NCT02184195|453745387|FG001|Overall Study|Lost to Follow-up|5|||
126123584|NCT02184195|453745386|FG000|Overall Study|Other|0|||
126123585|NCT02184195|453745387|FG001|Overall Study|Other|3|||
126123586|NCT03029143|453745390|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
126123587|NCT03029143|453745391|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
126123588|NCT03029143|453745392|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
126123589|NCT03029143|453745390|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
126123590|NCT03029143|453745391|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
126123591|NCT03029143|453745392|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
126123592|NCT03029143|453745390|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
126123593|NCT03029143|453745391|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
126123594|NCT03029143|453745392|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
126123595|NCT03029143|453745390|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
126123596|NCT03029143|453745391|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
126123597|NCT03029143|453745392|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
126123598|NCT03029143|453745390|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
125963606|NCT00718042|453157136|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
125963607|NCT00718042|453157137|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
126123599|NCT03029143|453745391|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
126123600|NCT03029143|453745392|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
126123601|NCT03029143|453745390|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
126123602|NCT03029143|453745391|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
126123603|NCT03029143|453745392|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
126123604|NCT03029143|453745390|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
126123605|NCT03029143|453745391|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
126123606|NCT03029143|453745392|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
126123607|NCT03029143|453745390|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126123608|NCT03029143|453745391|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126123609|NCT03029143|453745392|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
126123610|NCT03029143|453745390|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
126123611|NCT03029143|453745391|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
126123612|NCT03029143|453745392|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
126123613|NCT03029143|453745390|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126123614|NCT03029143|453745391|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
126123615|NCT03029143|453745392|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
126123616|NCT03029143|453745390|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
126123617|NCT03029143|453745391|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
126123618|NCT03029143|453745392|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
126123619|NCT00974675|453745395|FG000|Overall Study|Adverse Event|2|||
126123620|NCT00974675|453745396|FG001|Overall Study|Adverse Event|1|||
126123621|NCT00974675|453745397|FG002|Overall Study|Adverse Event|1|||
126123622|NCT00974675|453745398|FG003|Overall Study|Adverse Event|1|||
126123623|NCT00974675|453745395|FG000|Overall Study|Physician Decision|0|||
126123624|NCT00974675|453745396|FG001|Overall Study|Physician Decision|0|||
126123625|NCT00974675|453745397|FG002|Overall Study|Physician Decision|1|||
126123626|NCT00974675|453745398|FG003|Overall Study|Physician Decision|0|||
126123627|NCT00974675|453745395|FG000|Overall Study|Participant on holiday; unable to attend|0|||
126123628|NCT00974675|453745396|FG001|Overall Study|Participant on holiday; unable to attend|0|||
126123629|NCT00974675|453745397|FG002|Overall Study|Participant on holiday; unable to attend|0|||
126123630|NCT00974675|453745398|FG003|Overall Study|Participant on holiday; unable to attend|1|||
126123631|NCT02121262|453745399|FG000|Overall Study|Adverse Event|6|||
126123632|NCT02121262|453745400|FG001|Overall Study|Adverse Event|3|||
126123633|NCT02121262|453745399|FG000|Overall Study|Lack of Efficacy|3|||
126123634|NCT02121262|453745400|FG001|Overall Study|Lack of Efficacy|0|||
126123635|NCT02121262|453745399|FG000|Overall Study|Personal Reasons|19|||
126123636|NCT02121262|453745400|FG001|Overall Study|Personal Reasons|5|||
126123637|NCT02121262|453745399|FG000|Overall Study|Protocol Violation|1|||
125963608|NCT00718042|453157138|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
126123638|NCT02121262|453745400|FG001|Overall Study|Protocol Violation|1|||
126123639|NCT02121262|453745399|FG000|Overall Study|Participant Dropped-out|0|||
126123640|NCT02121262|453745400|FG001|Overall Study|Participant Dropped-out|1|||
126123641|NCT02121262|453745399|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
126123642|NCT02121262|453745400|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
126123643|NCT02121262|453745399|FG000|Overall Study|Consent Withdrawn|1|||
126123644|NCT02121262|453745400|FG001|Overall Study|Consent Withdrawn|0|||
126123645|NCT02025907|453745406|FG000|Overall Study|Lack of Efficacy|1|||
126123646|NCT02025907|453745407|FG001|Overall Study|Lack of Efficacy|0|||
126123647|NCT02025907|453745406|FG000|Overall Study|Withdrawal by Subject|15|||
126123648|NCT02025907|453745407|FG001|Overall Study|Withdrawal by Subject|8|||
126123649|NCT02025907|453745406|FG000|Overall Study|Protocol Violation|2|||
126123650|NCT02025907|453745407|FG001|Overall Study|Protocol Violation|0|||
126123651|NCT02025907|453745406|FG000|Overall Study|Physician Decision|2|||
126123652|NCT02025907|453745407|FG001|Overall Study|Physician Decision|0|||
126123653|NCT02025907|453745406|FG000|Overall Study|Lost to Follow-up|2|||
126123654|NCT02025907|453745407|FG001|Overall Study|Lost to Follow-up|2|||
126123655|NCT02025907|453745406|FG000|Overall Study|Adverse Event|3|||
126123656|NCT02025907|453745407|FG001|Overall Study|Adverse Event|1|||
126123657|NCT02025907|453745406|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
126123658|NCT02025907|453745407|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
126123659|NCT00282334|453745408|FG000|Overall Study|Withdrawal by Subject|8|||
126123660|NCT00282334|453745409|FG001|Overall Study|Withdrawal by Subject|5|||
126123661|NCT00939783|453745413|FG000|Overall Study|Death|6|||
126123662|NCT00939783|453745413|FG000|Overall Study|Adverse Event|39|||
126123663|NCT00939783|453745413|FG000|Overall Study|Study Terminated by Sponsor|498|||
126123664|NCT00939783|453745413|FG000|Overall Study|Withdrawal by Subject|78|||
126123665|NCT00939783|453745413|FG000|Overall Study|Other|16|||
126123666|NCT00939783|453745413|FG000|Overall Study|Lost to Follow-up|8|||
126123667|NCT00939783|453745413|FG000|Overall Study|Protocol Violation|3|||
126123668|NCT00939783|453745413|FG000|Overall Study|Enrolled but not treated|1|||
126123669|NCT00473343|453745414|FG000|Overall Study|Adverse Event|9|||
126123670|NCT00473343|453745414|FG000|Overall Study|Lost to Follow-up|8|||
126123671|NCT00473343|453745414|FG000|Overall Study|Treatment failure|27|||
126123672|NCT00473343|453745414|FG000|Overall Study|Withdrew consent|3|||
126123673|NCT00473343|453745414|FG000|Overall Study|Other un-specified reason|3|||
126123674|NCT02370615|453745415|FG000|Overall Study|Adverse Event|1|||
126123675|NCT02370615|453745416|FG001|Overall Study|Adverse Event|0|||
126123676|NCT01585272|453745417|FG000|Overall Study|Adverse Event|22|||
126123677|NCT01585272|453745417|FG000|Overall Study|Protocol Violation|7|||
126123678|NCT01585272|453745417|FG000|Overall Study|Withdrawal by Subject|10|||
126123679|NCT00645593|453745418|FG000|Overall Study|Later found to be ineligible|1|||
126123680|NCT00645593|453745419|FG001|Overall Study|Later found to be ineligible|0|||
126123681|NCT02577146|453745424|FG000|Overall Study|Lost to Follow-up|8|||
126123682|NCT02577146|453745424|FG000|Overall Study|Physician Decision|3|||
126123683|NCT02577146|453745424|FG000|Overall Study|Screen Failure|17|||
126123684|NCT03765138|453745425|FG000|Overall Study|Lost to Follow-up|1|||
126123685|NCT01970501|453745426|FG000|Overall Study|Discontinuation of study by sponsor|16|||
126123686|NCT01970501|453745427|FG001|Overall Study|Discontinuation of study by sponsor|14|||
126123687|NCT01970501|453745426|FG000|Overall Study|Withdrawal by Subject|6|||
126123688|NCT01970501|453745427|FG001|Overall Study|Withdrawal by Subject|7|||
126123689|NCT01970501|453745426|FG000|Overall Study|Adverse Event|2|||
126123690|NCT01970501|453745427|FG001|Overall Study|Adverse Event|4|||
126123691|NCT01970501|453745426|FG000|Overall Study|Death|1|||
126123692|NCT01970501|453745427|FG001|Overall Study|Death|3|||
126123693|NCT01970501|453745426|FG000|Overall Study|Physician Decision|2|||
126123694|NCT01970501|453745427|FG001|Overall Study|Physician Decision|0|||
126123695|NCT03803059|453745429|FG000|Overall Study|Protocol Violation|2|||
126123696|NCT03803059|453745429|FG000|Overall Study|Lost to Follow-up|1|||
126123697|NCT02116777|453745430|FG000|Overall Study|Adverse Event|0|||
126123698|NCT02116777|453745431|FG001|Overall Study|Adverse Event|0|||
126123699|NCT02116777|453745432|FG002|Overall Study|Adverse Event|0|||
126123700|NCT02116777|453745433|FG003|Overall Study|Adverse Event|0|||
126123701|NCT02116777|453745434|FG004|Overall Study|Adverse Event|2|||
126123702|NCT02116777|453745435|FG005|Overall Study|Adverse Event|2|||
126123703|NCT02116777|453745436|FG006|Overall Study|Adverse Event|0|||
126123704|NCT02116777|453745430|FG000|Overall Study|Death|0|||
126123705|NCT02116777|453745431|FG001|Overall Study|Death|0|||
126123706|NCT02116777|453745432|FG002|Overall Study|Death|0|||
126123707|NCT02116777|453745433|FG003|Overall Study|Death|1|||
126123708|NCT02116777|453745434|FG004|Overall Study|Death|0|||
126123709|NCT02116777|453745435|FG005|Overall Study|Death|0|||
126123710|NCT02116777|453745436|FG006|Overall Study|Death|0|||
126123711|NCT02116777|453745430|FG000|Overall Study|Lack of Efficacy|3|||
126123712|NCT02116777|453745431|FG001|Overall Study|Lack of Efficacy|3|||
126123713|NCT02116777|453745432|FG002|Overall Study|Lack of Efficacy|3|||
126123714|NCT02116777|453745433|FG003|Overall Study|Lack of Efficacy|8|||
126123715|NCT02116777|453745434|FG004|Overall Study|Lack of Efficacy|4|||
126123716|NCT02116777|453745435|FG005|Overall Study|Lack of Efficacy|1|||
126123717|NCT02116777|453745436|FG006|Overall Study|Lack of Efficacy|9|||
126123718|NCT02116777|453745430|FG000|Overall Study|Physician Decision|0|||
126123719|NCT02116777|453745431|FG001|Overall Study|Physician Decision|0|||
126123720|NCT02116777|453745432|FG002|Overall Study|Physician Decision|0|||
126123721|NCT02116777|453745433|FG003|Overall Study|Physician Decision|2|||
126123722|NCT02116777|453745434|FG004|Overall Study|Physician Decision|0|||
126087939|NCT01277887|453614883|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
126087940|NCT01277887|453614882|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
126087941|NCT01277887|453614883|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
126087942|NCT01277887|453614882|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
126087943|NCT01277887|453614883|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
126087944|NCT00415051|453614884|FG000|Overall Study|Protocol Violation|1|||
126087945|NCT00780559|453614887|FG000|Overall Study|Lost to Follow-up|2|||
126087946|NCT00780559|453614888|FG001|Overall Study|Lost to Follow-up|7|||
126087947|NCT00780559|453614887|FG000|Overall Study|Death|1|||
126087948|NCT00780559|453614888|FG001|Overall Study|Death|0|||
126087949|NCT04462289|453614891|FG000|Overall Study|Lost to Follow-up|4|||
126087950|NCT04462289|453614892|FG001|Overall Study|Lost to Follow-up|5|||
126087951|NCT04462289|453614891|FG000|Overall Study|Death|0|||
126087952|NCT04462289|453614892|FG001|Overall Study|Death|3|||
126087953|NCT04462289|453614891|FG000|Overall Study|Withdrawal by Subject|1|||
126087954|NCT04462289|453614892|FG001|Overall Study|Withdrawal by Subject|3|||
126087955|NCT01518153|453614893|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
126087956|NCT01518153|453614894|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
126087957|NCT01518153|453614895|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
126087958|NCT01518153|453614893|FG000|Stem Cell Transplant|Death|2|||
126087959|NCT01518153|453614894|FG001|Stem Cell Transplant|Death|0|||
126087960|NCT01518153|453614895|FG002|Stem Cell Transplant|Death|0|||
126087961|NCT01518153|453614893|FG000|Stem Cell Transplant|Secondary graft failure|1|||
126087962|NCT01518153|453614894|FG001|Stem Cell Transplant|Secondary graft failure|0|||
126087963|NCT01518153|453614895|FG002|Stem Cell Transplant|Secondary graft failure|0|||
126087964|NCT01518153|453614893|FG000|Stem Cell Transplant|Adverse Event|1|||
126087965|NCT01518153|453614894|FG001|Stem Cell Transplant|Adverse Event|0|||
126087966|NCT01518153|453614895|FG002|Stem Cell Transplant|Adverse Event|0|||
126087967|NCT01518153|453614893|FG000|Donor Lymphocyte Infusion|Death|0|||
126087968|NCT01518153|453614894|FG001|Donor Lymphocyte Infusion|Death|2|||
126087969|NCT01518153|453614895|FG002|Donor Lymphocyte Infusion|Death|1|||
126087970|NCT00856245|453614896|FG000|Overall Study|Was not transplanted|5|||
126087971|NCT01250509|453614899|FG000|Overall Study|Lost to Follow-up|5|||
126087972|NCT01250509|453614900|FG001|Overall Study|Lost to Follow-up|2|||
126087973|NCT00203268|453614907|FG000|Early Treatment|only treated one headache|2|||
126087974|NCT00203268|453614907|FG000|Early Treatment|Lost to Follow-up|1|||
126087975|NCT00203268|453614907|FG000|Early Treatment|Withdrawal by Subject|1|||
126087976|NCT00600613|453614908|FG000|Overall Study|Protocol Deviation|1|||
126087977|NCT00839956|453614910|FG000|Overall Study|Adverse Event|2|||
126087978|NCT00839956|453614910|FG000|Overall Study|Lack of Efficacy|6|||
126087979|NCT00839956|453614910|FG000|Overall Study|Physician Decision|1|||
126087980|NCT00839956|453614910|FG000|Overall Study|Withdrawal by Subject|3|||
126087981|NCT02807883|453614911|FG000|Overall Study|Withdrawal by Subject|2|||
126087982|NCT02514551|453614914|FG000|Overall Study|Lost to Follow-up|0|||
126087983|NCT02514551|453614915|FG001|Overall Study|Lost to Follow-up|1|||
126087984|NCT02514551|453614914|FG000|Overall Study|Participant Never Treated|0|||
126087985|NCT02514551|453614915|FG001|Overall Study|Participant Never Treated|2|||
126087986|NCT00277095|453614916|FG000|Overall Study|Death|2|||
126087987|NCT00277095|453614916|FG000|Overall Study|Explanted|7|||
126087988|NCT00277095|453614916|FG000|Overall Study|Lost to Follow-up|2|||
126087989|NCT00277095|453614916|FG000|Overall Study|Missed Follow-up|9|||
126087990|NCT00277095|453614916|FG000|Overall Study|Physician Decision|1|||
126087991|NCT02998476|453614935|FG000|Overall Study|Lost to Follow-up|1|||
126087992|NCT02998476|453614936|FG001|Overall Study|Lost to Follow-up|0|||
126087993|NCT02998476|453614935|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
126087994|NCT02998476|453614936|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
126087995|NCT02998476|453614935|FG000|Overall Study|Withdrawal by Subject|1|||
126087996|NCT02998476|453614936|FG001|Overall Study|Withdrawal by Subject|2|||
126087997|NCT02998476|453614935|FG000|Overall Study|Death|45|||
126087998|NCT02998476|453614936|FG001|Overall Study|Death|2|||
126087999|NCT02998476|453614935|FG000|Overall Study|Other|6|||
126088000|NCT02998476|453614936|FG001|Overall Study|Other|1|||
126088001|NCT03832595|453614937|FG000|Overall Study|Death|142|||
126088002|NCT03832595|453614938|FG001|Overall Study|Death|130|||
126088003|NCT03832595|453614937|FG000|Overall Study|Medical management without dialysis|37|||
126088004|NCT03832595|453614938|FG001|Overall Study|Medical management without dialysis|1|||
126088005|NCT03277352|453614939|FG000|Overall Study|Study Terminated By Sponsor|2|||
126088006|NCT03277352|453614939|FG000|Overall Study|Withdrawal by Subject|4|||
126088007|NCT03277352|453614939|FG000|Overall Study|Death|4|||
126088008|NCT02397447|453614940|FG000|Overall Study|Lost to Follow-up|2|||
126088009|NCT02397447|453614941|FG001|Overall Study|Lost to Follow-up|2|||
126088010|NCT01435772|453614942|FG000|Overall Study|Adverse Event|1|||
126088011|NCT01435772|453614943|FG001|Overall Study|Adverse Event|0|||
126088012|NCT01435772|453614944|FG002|Overall Study|Adverse Event|2|||
126088013|NCT01435772|453614942|FG000|Overall Study|Withdrawal by Subject|0|||
126088014|NCT01435772|453614943|FG001|Overall Study|Withdrawal by Subject|1|||
126088015|NCT01435772|453614944|FG002|Overall Study|Withdrawal by Subject|3|||
126123723|NCT02116777|453745435|FG005|Overall Study|Physician Decision|0|||
126123724|NCT02116777|453745436|FG006|Overall Study|Physician Decision|0|||
126123725|NCT02116777|453745430|FG000|Overall Study|Protocol Violation|0|||
126123726|NCT02116777|453745431|FG001|Overall Study|Protocol Violation|0|||
126123727|NCT02116777|453745432|FG002|Overall Study|Protocol Violation|0|||
126123728|NCT02116777|453745433|FG003|Overall Study|Protocol Violation|1|||
126123729|NCT02116777|453745434|FG004|Overall Study|Protocol Violation|0|||
126123730|NCT02116777|453745435|FG005|Overall Study|Protocol Violation|0|||
126123731|NCT02116777|453745436|FG006|Overall Study|Protocol Violation|0|||
126123732|NCT02116777|453745430|FG000|Overall Study|Withdrawal by Subject|0|||
126123733|NCT02116777|453745431|FG001|Overall Study|Withdrawal by Subject|0|||
126123734|NCT02116777|453745432|FG002|Overall Study|Withdrawal by Subject|0|||
126123735|NCT02116777|453745433|FG003|Overall Study|Withdrawal by Subject|1|||
126123736|NCT02116777|453745434|FG004|Overall Study|Withdrawal by Subject|0|||
126123737|NCT02116777|453745435|FG005|Overall Study|Withdrawal by Subject|0|||
126123738|NCT02116777|453745436|FG006|Overall Study|Withdrawal by Subject|0|||
126123739|NCT00102960|453745438|FG000|Overall Study|Death|23|||
126123740|NCT00102960|453745439|FG001|Overall Study|Death|11|||
126123741|NCT00102960|453745440|FG002|Overall Study|Death|11|||
126123742|NCT00102960|453745438|FG000|Overall Study|Lost to Follow-up|6|||
126123743|NCT00102960|453745439|FG001|Overall Study|Lost to Follow-up|12|||
126123744|NCT00102960|453745440|FG002|Overall Study|Lost to Follow-up|16|||
126123745|NCT00102960|453745438|FG000|Overall Study|Withdrawal by Subject|1|||
126123746|NCT00102960|453745439|FG001|Overall Study|Withdrawal by Subject|0|||
126123747|NCT00102960|453745440|FG002|Overall Study|Withdrawal by Subject|1|||
126123748|NCT00980200|453746998|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
126123749|NCT00980200|453746999|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
126123750|NCT00980200|453747000|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
126123751|NCT00980200|453747001|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
126123752|NCT00980200|453747002|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
126123753|NCT00980200|453746998|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
126123754|NCT00980200|453746999|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
126123755|NCT00980200|453747000|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
126123756|NCT00980200|453747001|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
126123757|NCT00980200|453747002|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
126123758|NCT00457015|453747003|FG000|Overall Study|Left study site against medical advice|0|||
126123759|NCT00457015|453747004|FG001|Overall Study|Left study site against medical advice|1|||
126123760|NCT02257372|453747007|FG000|Overall Study|Adverse Event|3|||
126123761|NCT02257372|453747008|FG001|Overall Study|Adverse Event|7|||
126123762|NCT02257372|453747007|FG000|Overall Study|Lack of Efficacy|2|||
126123763|NCT02257372|453747008|FG001|Overall Study|Lack of Efficacy|1|||
126123764|NCT02257372|453747007|FG000|Overall Study|Protocol Violation|1|||
126123765|NCT02257372|453747008|FG001|Overall Study|Protocol Violation|1|||
126123766|NCT02257372|453747007|FG000|Overall Study|Lost to Follow-up|0|||
126123767|NCT02257372|453747008|FG001|Overall Study|Lost to Follow-up|1|||
126123768|NCT02257372|453747007|FG000|Overall Study|Withdrew consent|1|||
126123769|NCT02257372|453747008|FG001|Overall Study|Withdrew consent|0|||
126123770|NCT01135498|453747010|FG000|Overall Study|Adverse Event|20|||
126123771|NCT01135498|453747010|FG000|Overall Study|Progressive disease|38|||
126123772|NCT01135498|453747010|FG000|Overall Study|Investigator judgement|25|||
126123773|NCT01135498|453747010|FG000|Overall Study|Withdrawal by Subject|4|||
126123774|NCT01135498|453747010|FG000|Overall Study|Death|1|||
126123775|NCT01135498|453747010|FG000|Overall Study|Ongoing at time of analysis|2|||
126123776|NCT02104583|453747011|FG000|Overall Study|New ICD or CRT-D implanted|2|||
126123777|NCT02104583|453747012|FG001|Overall Study|New ICD or CRT-D implanted|0|||
126123778|NCT02104583|453747013|FG002|Overall Study|New ICD or CRT-D implanted|1|||
126123779|NCT02104583|453747014|FG003|Overall Study|New ICD or CRT-D implanted|0|||
126123780|NCT02104583|453747015|FG004|Overall Study|New ICD or CRT-D implanted|0|||
126123781|NCT02104583|453747011|FG000|Overall Study|Death|2|||
126123782|NCT02104583|453747012|FG001|Overall Study|Death|1|||
126123783|NCT02104583|453747013|FG002|Overall Study|Death|3|||
125963609|NCT00718042|453157133|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
126123784|NCT02104583|453747014|FG003|Overall Study|Death|3|||
126123785|NCT02104583|453747015|FG004|Overall Study|Death|5|||
126123786|NCT02104583|453747011|FG000|Overall Study|Subject required cardiac ablation|6|||
126123787|NCT02104583|453747012|FG001|Overall Study|Subject required cardiac ablation|4|||
126123788|NCT02104583|453747013|FG002|Overall Study|Subject required cardiac ablation|4|||
125963610|NCT00718042|453157134|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
126123789|NCT02104583|453747014|FG003|Overall Study|Subject required cardiac ablation|5|||
126123790|NCT02104583|453747015|FG004|Overall Study|Subject required cardiac ablation|4|||
126123791|NCT02104583|453747011|FG000|Overall Study|Subject required prohibited medication|0|||
126123792|NCT02104583|453747012|FG001|Overall Study|Subject required prohibited medication|1|||
126123793|NCT02104583|453747013|FG002|Overall Study|Subject required prohibited medication|1|||
126123794|NCT02104583|453747014|FG003|Overall Study|Subject required prohibited medication|0|||
126123795|NCT02104583|453747015|FG004|Overall Study|Subject required prohibited medication|1|||
126123796|NCT02104583|453747011|FG000|Overall Study|Withdrew Consent|3|||
126123797|NCT02104583|453747012|FG001|Overall Study|Withdrew Consent|2|||
126123798|NCT02104583|453747013|FG002|Overall Study|Withdrew Consent|0|||
126123799|NCT02104583|453747014|FG003|Overall Study|Withdrew Consent|2|||
126123800|NCT02104583|453747015|FG004|Overall Study|Withdrew Consent|1|||
126123801|NCT02104583|453747011|FG000|Overall Study|Investigator's Discretion|1|||
126123802|NCT02104583|453747012|FG001|Overall Study|Investigator's Discretion|0|||
126123803|NCT02104583|453747013|FG002|Overall Study|Investigator's Discretion|0|||
126123804|NCT02104583|453747014|FG003|Overall Study|Investigator's Discretion|0|||
126123805|NCT02104583|453747015|FG004|Overall Study|Investigator's Discretion|0|||
126123806|NCT02104583|453747011|FG000|Overall Study|Protocol Violation|0|||
126123807|NCT02104583|453747012|FG001|Overall Study|Protocol Violation|0|||
126123808|NCT02104583|453747013|FG002|Overall Study|Protocol Violation|1|||
126123809|NCT02104583|453747014|FG003|Overall Study|Protocol Violation|0|||
126123810|NCT02104583|453747015|FG004|Overall Study|Protocol Violation|0|||
126123811|NCT02104583|453747011|FG000|Overall Study|Adverse Event|3|||
126123812|NCT02104583|453747012|FG001|Overall Study|Adverse Event|3|||
126123813|NCT02104583|453747013|FG002|Overall Study|Adverse Event|6|||
126123814|NCT02104583|453747014|FG003|Overall Study|Adverse Event|6|||
126123815|NCT02104583|453747015|FG004|Overall Study|Adverse Event|1|||
126123816|NCT02104583|453747011|FG000|Overall Study|Lost to Follow-up|1|||
126123817|NCT02104583|453747012|FG001|Overall Study|Lost to Follow-up|0|||
126123818|NCT02104583|453747013|FG002|Overall Study|Lost to Follow-up|0|||
126123819|NCT02104583|453747014|FG003|Overall Study|Lost to Follow-up|0|||
126123820|NCT02104583|453747015|FG004|Overall Study|Lost to Follow-up|0|||
126123821|NCT02104583|453747011|FG000|Overall Study|Randomized but Never Treated|0|||
126123822|NCT02104583|453747012|FG001|Overall Study|Randomized but Never Treated|0|||
126123823|NCT02104583|453747013|FG002|Overall Study|Randomized but Never Treated|0|||
126123824|NCT02104583|453747014|FG003|Overall Study|Randomized but Never Treated|1|||
126123825|NCT02104583|453747015|FG004|Overall Study|Randomized but Never Treated|0|||
126123826|NCT02830880|453747017|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
126123827|NCT02830880|453747017|FG000|Overall Study|Death|1|||
126123828|NCT02830880|453747017|FG000|Overall Study|Physician Decision|1|||
126123829|NCT03551509|453747026|FG000|Overall Study|Lost to Follow-up|0|||
126123830|NCT03551509|453747027|FG001|Overall Study|Lost to Follow-up|1|||
126123831|NCT03551509|453747028|FG002|Overall Study|Lost to Follow-up|0|||
126123832|NCT01918007|453747033|FG000|Overall Study|Baseline oximetry not acceptable|11|||
126123833|NCT01918007|453747034|FG001|Overall Study|Baseline oximetry not acceptable|7|||
126123834|NCT01918007|453747033|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
126123835|NCT01918007|453747034|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
126123836|NCT01918007|453747033|FG000|Overall Study|Lost to Follow-up|4|||
126123837|NCT01918007|453747034|FG001|Overall Study|Lost to Follow-up|7|||
126123838|NCT01732796|453747040|FG000|Overall Study|Adverse Event|16|||
126123839|NCT01732796|453747041|FG001|Overall Study|Adverse Event|16|||
126123840|NCT01732796|453747042|FG002|Overall Study|Adverse Event|4|||
126123841|NCT01732796|453747040|FG000|Overall Study|Lack of Efficacy|21|||
126123842|NCT01732796|453747041|FG001|Overall Study|Lack of Efficacy|18|||
126123843|NCT01732796|453747042|FG002|Overall Study|Lack of Efficacy|5|||
126123844|NCT01732796|453747040|FG000|Overall Study|Lost to Follow-up|2|||
126123845|NCT01732796|453747041|FG001|Overall Study|Lost to Follow-up|0|||
126123846|NCT01732796|453747042|FG002|Overall Study|Lost to Follow-up|0|||
126123847|NCT01732796|453747040|FG000|Overall Study|Withdrawal by Subject|6|||
126123848|NCT01732796|453747041|FG001|Overall Study|Withdrawal by Subject|8|||
126123849|NCT01732796|453747042|FG002|Overall Study|Withdrawal by Subject|2|||
126123850|NCT01732796|453747040|FG000|Overall Study|Other reason not defined above|1|||
126123851|NCT01732796|453747041|FG001|Overall Study|Other reason not defined above|0|||
126123852|NCT01732796|453747042|FG002|Overall Study|Other reason not defined above|2|||
126123853|NCT00530270|453747046|FG000|Overall Study|Protocol Violation|1|||
126123854|NCT00530270|453747047|FG001|Overall Study|Protocol Violation|0|||
126123855|NCT01399788|453747052|FG000|First Intervention Period|Adverse Event|1|||
126123856|NCT01399788|453747053|FG001|First Intervention Period|Adverse Event|0|||
126123857|NCT02919436|453747055|FG000|Overall Study|Did not undergo surgery|16|||
126123858|NCT02919436|453747056|FG001|Overall Study|Did not undergo surgery|20|||
126123859|NCT02919436|453747055|FG000|Overall Study|Enrolled before trial registration|44|||
126123860|NCT02919436|453747056|FG001|Overall Study|Enrolled before trial registration|33|||
126123861|NCT03699007|453747057|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
126123862|NCT03699007|453747058|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
126123863|NCT03699007|453747057|FG000|6-month Follow Up|Lost to Follow-up|2|||
126123864|NCT03699007|453747058|FG001|6-month Follow Up|Lost to Follow-up|3|||
126123865|NCT04718974|453747061|FG000|Overall Study|Death|0|||
126123866|NCT04718974|453747062|FG001|Overall Study|Death|2|||
126123867|NCT04718974|453747061|FG000|Overall Study|Lost to Follow-up|10|||
126123868|NCT04718974|453747062|FG001|Overall Study|Lost to Follow-up|20|||
126123869|NCT04718974|453747061|FG000|Overall Study|Transferred out|2|||
126123870|NCT04718974|453747062|FG001|Overall Study|Transferred out|4|||
126123871|NCT03259074|453747063|FG000|Overall Study|Adverse Event|9|||
126123872|NCT03259074|453747064|FG001|Overall Study|Adverse Event|12|||
126123873|NCT03259074|453747065|FG002|Overall Study|Adverse Event|8|||
126123874|NCT03259074|453747063|FG000|Overall Study|Death|1|||
126123875|NCT03259074|453747064|FG001|Overall Study|Death|1|||
126123876|NCT03259074|453747065|FG002|Overall Study|Death|3|||
126123877|NCT03259074|453747063|FG000|Overall Study|Lost to Follow-up|2|||
126123878|NCT03259074|453747064|FG001|Overall Study|Lost to Follow-up|4|||
126123879|NCT03259074|453747065|FG002|Overall Study|Lost to Follow-up|3|||
126123880|NCT03259074|453747063|FG000|Overall Study|New Therapy For Study Indication|1|||
126123881|NCT03259074|453747064|FG001|Overall Study|New Therapy For Study Indication|2|||
126123882|NCT03259074|453747065|FG002|Overall Study|New Therapy For Study Indication|2|||
126123883|NCT03259074|453747063|FG000|Overall Study|Physician Decision|4|||
126123884|NCT03259074|453747064|FG001|Overall Study|Physician Decision|12|||
126123885|NCT03259074|453747065|FG002|Overall Study|Physician Decision|10|||
126123886|NCT03259074|453747063|FG000|Overall Study|Pregnancy|1|||
126123887|NCT03259074|453747064|FG001|Overall Study|Pregnancy|1|||
126123888|NCT03259074|453747065|FG002|Overall Study|Pregnancy|0|||
126123889|NCT03259074|453747063|FG000|Overall Study|Progressive Disease|1|||
126123890|NCT03259074|453747064|FG001|Overall Study|Progressive Disease|0|||
126123891|NCT03259074|453747065|FG002|Overall Study|Progressive Disease|0|||
126123892|NCT03259074|453747063|FG000|Overall Study|Protocol Deviation|1|||
126123893|NCT03259074|453747064|FG001|Overall Study|Protocol Deviation|1|||
126123894|NCT03259074|453747065|FG002|Overall Study|Protocol Deviation|3|||
126123895|NCT03259074|453747063|FG000|Overall Study|Subject/Guardian Decision|13|||
126123896|NCT03259074|453747064|FG001|Overall Study|Subject/Guardian Decision|16|||
126123897|NCT03259074|453747065|FG002|Overall Study|Subject/Guardian Decision|14|||
126123898|NCT01780662|453747066|FG000|Overall Study|Adverse Event|1|||
126123899|NCT01780662|453747067|FG001|Overall Study|Adverse Event|0|||
126123900|NCT01780662|453747068|FG002|Overall Study|Adverse Event|2|||
126123901|NCT01780662|453747066|FG000|Overall Study|Physician Decision|0|||
126123902|NCT01780662|453747067|FG001|Overall Study|Physician Decision|5|||
126123903|NCT01780662|453747068|FG002|Overall Study|Physician Decision|7|||
126123904|NCT01780662|453747066|FG000|Overall Study|Protocol Violation|0|||
126123905|NCT01780662|453747067|FG001|Overall Study|Protocol Violation|1|||
126123906|NCT01780662|453747068|FG002|Overall Study|Protocol Violation|0|||
126123907|NCT01780662|453747066|FG000|Overall Study|Ineligible|0|||
126123908|NCT01780662|453747067|FG001|Overall Study|Ineligible|0|||
126123909|NCT01780662|453747068|FG002|Overall Study|Ineligible|1|||
126123910|NCT00183274|453747069|FG000|Phase 1: Open-Label|Adverse Event|31|||
126123911|NCT00183274|453747070|FG001|Phase 1: Open-Label|Adverse Event|0|||
126123912|NCT00183274|453747071|FG002|Phase 1: Open-Label|Adverse Event|0|||
126123913|NCT00183274|453747072|FG003|Phase 1: Open-Label|Adverse Event|0|||
126123914|NCT00183274|453747073|FG004|Phase 1: Open-Label|Adverse Event|0|||
126123915|NCT00183274|453747074|FG005|Phase 1: Open-Label|Adverse Event|0|||
126123916|NCT00183274|453747069|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
126123917|NCT00183274|453747070|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
126123918|NCT00183274|453747071|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
126123919|NCT00183274|453747072|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
126123920|NCT00183274|453747073|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
126123921|NCT00183274|453747074|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
126123922|NCT00183274|453747069|FG000|Phase 1: Open-Label|Protocol Violation|11|||
126123923|NCT00183274|453747070|FG001|Phase 1: Open-Label|Protocol Violation|0|||
126123924|NCT00183274|453747071|FG002|Phase 1: Open-Label|Protocol Violation|0|||
126123925|NCT00183274|453747072|FG003|Phase 1: Open-Label|Protocol Violation|0|||
126123926|NCT00183274|453747073|FG004|Phase 1: Open-Label|Protocol Violation|0|||
126123927|NCT00183274|453747074|FG005|Phase 1: Open-Label|Protocol Violation|0|||
126123928|NCT00183274|453747069|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
126123929|NCT00183274|453747070|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
126123930|NCT00183274|453747071|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
126123931|NCT00183274|453747072|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
126123932|NCT00183274|453747073|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
126123933|NCT00183274|453747074|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
126123934|NCT00183274|453747069|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
126123935|NCT00183274|453747070|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
126123936|NCT00183274|453747071|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
126123937|NCT00183274|453747072|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
126123938|NCT00183274|453747073|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
126123939|NCT00183274|453747074|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
126123940|NCT00183274|453747069|FG000|Phase 1: Open-Label|Other|9|||
126123941|NCT00183274|453747070|FG001|Phase 1: Open-Label|Other|0|||
126123942|NCT00183274|453747071|FG002|Phase 1: Open-Label|Other|0|||
126123943|NCT00183274|453747072|FG003|Phase 1: Open-Label|Other|0|||
126123944|NCT00183274|453747073|FG004|Phase 1: Open-Label|Other|0|||
126123945|NCT00183274|453747074|FG005|Phase 1: Open-Label|Other|0|||
126123946|NCT00183274|453747069|FG000|Phase 2: Double-Blind|Relapsed|0|||
126123947|NCT00183274|453747070|FG001|Phase 2: Double-Blind|Relapsed|8|||
126123948|NCT00183274|453747071|FG002|Phase 2: Double-Blind|Relapsed|29|||
126123949|NCT00183274|453747072|FG003|Phase 2: Double-Blind|Relapsed|0|||
126123950|NCT00183274|453747073|FG004|Phase 2: Double-Blind|Relapsed|0|||
126123951|NCT00183274|453747074|FG005|Phase 2: Double-Blind|Relapsed|0|||
126123952|NCT00183274|453747069|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
126123953|NCT00183274|453747070|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
126123954|NCT00183274|453747071|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
126123955|NCT00183274|453747072|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
126123956|NCT00183274|453747073|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
126123957|NCT00183274|453747074|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
126123958|NCT00183274|453747069|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
126123959|NCT00183274|453747070|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
126123960|NCT00183274|453747071|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
126123961|NCT00183274|453747072|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
126123962|NCT00183274|453747073|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
126123963|NCT00183274|453747074|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
126123964|NCT00183274|453747069|FG000|Phase 3: Double-Blind|Relapsed|0|||
126123965|NCT00183274|453747070|FG001|Phase 3: Double-Blind|Relapsed|0|||
126123966|NCT00183274|453747071|FG002|Phase 3: Double-Blind|Relapsed|0|||
126123967|NCT00183274|453747072|FG003|Phase 3: Double-Blind|Relapsed|1|||
126123968|NCT00183274|453747073|FG004|Phase 3: Double-Blind|Relapsed|11|||
126123969|NCT00183274|453747074|FG005|Phase 3: Double-Blind|Relapsed|2|||
126123970|NCT02409290|453747075|FG000|Overall Study|Protocol Violation|3|||
126123971|NCT02409290|453747076|FG001|Overall Study|Protocol Violation|6|||
126123972|NCT02409290|453747077|FG002|Overall Study|Protocol Violation|9|||
126123973|NCT02409290|453747078|FG003|Overall Study|Protocol Violation|4|||
126123974|NCT02409290|453747075|FG000|Overall Study|No positive culture/no baseline sample|3|||
126123975|NCT02409290|453747076|FG001|Overall Study|No positive culture/no baseline sample|9|||
126123976|NCT02409290|453747077|FG002|Overall Study|No positive culture/no baseline sample|6|||
126123977|NCT02409290|453747078|FG003|Overall Study|No positive culture/no baseline sample|5|||
126123978|NCT02409290|453747075|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
126123979|NCT02409290|453747076|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
126123980|NCT02409290|453747077|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
126123981|NCT02409290|453747078|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
126123982|NCT00708500|453747079|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
126123983|NCT00708500|453747080|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
126123984|NCT00708500|453747081|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
126123985|NCT00708500|453747079|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
126123986|NCT00708500|453747080|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
126123987|NCT00708500|453747081|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
126123988|NCT00708500|453747079|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
126123989|NCT00708500|453747080|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
126123990|NCT00708500|453747081|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
126123991|NCT00708500|453747079|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
126123992|NCT00708500|453747080|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
126123993|NCT00708500|453747081|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
126123994|NCT00708500|453747079|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
126123995|NCT00708500|453747080|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
126123996|NCT00708500|453747081|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
126123997|NCT00708500|453747079|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
126123998|NCT00708500|453747080|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
126123999|NCT00708500|453747081|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
126124000|NCT00708500|453747079|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
126124001|NCT00708500|453747080|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
126124002|NCT00708500|453747081|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
126124003|NCT00708500|453747079|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
126124004|NCT00708500|453747080|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
126124005|NCT00708500|453747081|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
126124006|NCT00708500|453747079|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
126124007|NCT00708500|453747080|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
126124008|NCT00708500|453747081|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
126124009|NCT00708500|453747079|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
126124010|NCT00708500|453747080|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
126124011|NCT00708500|453747081|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
126124012|NCT00708500|453747079|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
126124013|NCT00708500|453747080|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
126124014|NCT00708500|453747081|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
126124015|NCT00708500|453747079|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
126124016|NCT00708500|453747080|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
126124017|NCT00708500|453747081|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
126124018|NCT00708500|453747079|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
126124019|NCT00708500|453747080|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
126124020|NCT00708500|453747081|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
126124021|NCT00708500|453747079|FG000|FOLLOWUP|Adverse Event|0|||
126124022|NCT00708500|453747080|FG001|FOLLOWUP|Adverse Event|1|||
126124023|NCT00708500|453747081|FG002|FOLLOWUP|Adverse Event|0|||
126124024|NCT00708500|453747079|FG000|FOLLOWUP|Lost to Follow-up|1|||
126124025|NCT00708500|453747080|FG001|FOLLOWUP|Lost to Follow-up|6|||
126124026|NCT00708500|453747081|FG002|FOLLOWUP|Lost to Follow-up|4|||
126124027|NCT00708500|453747079|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
126124028|NCT00708500|453747080|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
126124029|NCT00708500|453747081|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
126124030|NCT00708500|453747079|FG000|FOLLOWUP|Subject withdrew consent|31|||
126124031|NCT00708500|453747080|FG001|FOLLOWUP|Subject withdrew consent|4|||
126124032|NCT00708500|453747081|FG002|FOLLOWUP|Subject withdrew consent|5|||
126124033|NCT00708500|453747079|FG000|FOLLOWUP|Non-compliance with protocol|5|||
126124034|NCT00708500|453747080|FG001|FOLLOWUP|Non-compliance with protocol|0|||
126124035|NCT00708500|453747081|FG002|FOLLOWUP|Non-compliance with protocol|1|||
126124036|NCT01394627|453747091|FG000|First Intervention (1 Day)|poor intravenous access|0|||
126124037|NCT01394627|453747092|FG001|First Intervention (1 Day)|poor intravenous access|1|||
126124038|NCT01394627|453747091|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
126124039|NCT01394627|453747092|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
126124040|NCT01765920|453747093|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
126124041|NCT01765920|453747094|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
126124042|NCT01765920|453747093|FG000|Overall Study|Patient code disclosure|0|||
126124043|NCT01765920|453747094|FG001|Overall Study|Patient code disclosure|1|||
126124044|NCT01081249|453747095|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
126124045|NCT01081249|453747096|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
126124046|NCT02411539|453747097|FG000|Overall Study|Lost to Follow-up|2|||
126124047|NCT02411539|453747098|FG001|Overall Study|Lost to Follow-up|0|||
126124048|NCT02411539|453747097|FG000|Overall Study|Confounding medical condition|0|||
126124049|NCT02411539|453747098|FG001|Overall Study|Confounding medical condition|1|||
126124050|NCT03681119|453747099|FG000|Overall Study|No specific reason|4|||
126124051|NCT03681119|453747100|FG001|Overall Study|No specific reason|0|||
126124052|NCT03681119|453747099|FG000|Overall Study|Sickness|2|||
126124053|NCT03681119|453747100|FG001|Overall Study|Sickness|0|||
126124054|NCT00879645|453747104|FG000|Overall Study|Adverse Event|1|||
126124055|NCT00879645|453747105|FG001|Overall Study|Adverse Event|0|||
126124056|NCT00879645|453747106|FG002|Overall Study|Adverse Event|0|||
126124057|NCT00879645|453747107|FG003|Overall Study|Adverse Event|0|||
126124058|NCT03631732|453747108|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
126124059|NCT03631732|453747109|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
126124060|NCT03631732|453747108|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
126124061|NCT03631732|453747109|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
126124062|NCT03631732|453747108|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
126124063|NCT03631732|453747109|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
126124064|NCT03631732|453747108|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
126124065|NCT03631732|453747109|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
126124066|NCT03631732|453747108|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
126124067|NCT03631732|453747109|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
126124068|NCT03631732|453747108|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
126124069|NCT03631732|453747109|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
126124070|NCT03631732|453747108|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
126124071|NCT03631732|453747109|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
126124072|NCT03631732|453747108|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
126124073|NCT03631732|453747109|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
126124074|NCT03631732|453747108|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
126124075|NCT03631732|453747109|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
126124076|NCT03631732|453747108|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
126124077|NCT03631732|453747109|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
126124078|NCT04288154|453747110|FG000|Overall Study|Withdrawal by Subject|9|||
126124079|NCT04288154|453747111|FG001|Overall Study|Withdrawal by Subject|9|||
126124080|NCT02873936|453747117|FG000|Overall Study|Withdrew Consent|4|||
126124081|NCT02873936|453747118|FG001|Overall Study|Withdrew Consent|11|||
125963611|NCT00718042|453157135|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
125963612|NCT00718042|453157136|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
125963613|NCT00718042|453157137|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
126124082|NCT02873936|453747119|FG002|Overall Study|Withdrew Consent|20|||
126124083|NCT02873936|453747117|FG000|Overall Study|Investigator's Discretion|3|||
126124084|NCT02873936|453747118|FG001|Overall Study|Investigator's Discretion|5|||
126124085|NCT02873936|453747119|FG002|Overall Study|Investigator's Discretion|4|||
126124086|NCT02873936|453747117|FG000|Overall Study|Adverse Event|3|||
126124087|NCT02873936|453747118|FG001|Overall Study|Adverse Event|5|||
126124088|NCT02873936|453747119|FG002|Overall Study|Adverse Event|3|||
126124089|NCT02873936|453747117|FG000|Overall Study|Protocol Violation|0|||
126124090|NCT02873936|453747118|FG001|Overall Study|Protocol Violation|1|||
126124091|NCT02873936|453747119|FG002|Overall Study|Protocol Violation|3|||
126124092|NCT02873936|453747117|FG000|Overall Study|Lost to Follow-up|1|||
126124093|NCT02873936|453747118|FG001|Overall Study|Lost to Follow-up|1|||
126124094|NCT02873936|453747119|FG002|Overall Study|Lost to Follow-up|1|||
126124095|NCT02873936|453747117|FG000|Overall Study|Non-compliance With Study Drug|1|||
126124096|NCT02873936|453747118|FG001|Overall Study|Non-compliance With Study Drug|0|||
126124097|NCT02873936|453747119|FG002|Overall Study|Non-compliance With Study Drug|1|||
126124098|NCT02873936|453747117|FG000|Overall Study|Randomized but not Dosed|1|||
126124099|NCT02873936|453747118|FG001|Overall Study|Randomized but not Dosed|0|||
126124100|NCT02873936|453747119|FG002|Overall Study|Randomized but not Dosed|0|||
126124101|NCT05513625|453747120|FG000|Overall Study|Withdrawal by Subject|1|||
126124102|NCT00917150|453747121|FG000|Overall Study|Adverse Event|12|||
126124103|NCT00917150|453747122|FG001|Overall Study|Adverse Event|7|||
126124104|NCT00917150|453747123|FG002|Overall Study|Adverse Event|12|||
126124105|NCT00917150|453747124|FG003|Overall Study|Adverse Event|11|||
126124106|NCT00917150|453747121|FG000|Overall Study|Death|1|||
126124107|NCT00917150|453747122|FG001|Overall Study|Death|4|||
126124108|NCT00917150|453747123|FG002|Overall Study|Death|3|||
126124109|NCT00917150|453747124|FG003|Overall Study|Death|2|||
126124110|NCT00917150|453747121|FG000|Overall Study|Lost to Follow-up|1|||
126124111|NCT00917150|453747122|FG001|Overall Study|Lost to Follow-up|0|||
126124112|NCT00917150|453747123|FG002|Overall Study|Lost to Follow-up|4|||
126124113|NCT00917150|453747124|FG003|Overall Study|Lost to Follow-up|2|||
126124114|NCT00917150|453747121|FG000|Overall Study|Physician Decision|0|||
126124115|NCT00917150|453747122|FG001|Overall Study|Physician Decision|2|||
126124116|NCT00917150|453747123|FG002|Overall Study|Physician Decision|0|||
126124117|NCT00917150|453747124|FG003|Overall Study|Physician Decision|1|||
126124118|NCT00917150|453747121|FG000|Overall Study|Protocol Violation|5|||
126124119|NCT00917150|453747122|FG001|Overall Study|Protocol Violation|5|||
126124120|NCT00917150|453747123|FG002|Overall Study|Protocol Violation|3|||
126124121|NCT00917150|453747124|FG003|Overall Study|Protocol Violation|5|||
126124122|NCT00917150|453747121|FG000|Overall Study|Withdrawal by Subject|15|||
126124123|NCT00917150|453747122|FG001|Overall Study|Withdrawal by Subject|16|||
126124124|NCT00917150|453747123|FG002|Overall Study|Withdrawal by Subject|18|||
126124125|NCT00917150|453747124|FG003|Overall Study|Withdrawal by Subject|11|||
126124126|NCT00917150|453747121|FG000|Overall Study|Other than specified|3|||
126124127|NCT00917150|453747122|FG001|Overall Study|Other than specified|3|||
126124128|NCT00917150|453747123|FG002|Overall Study|Other than specified|2|||
126124129|NCT00917150|453747124|FG003|Overall Study|Other than specified|2|||
126124130|NCT01624662|453747125|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
126124131|NCT01624662|453747126|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
126124132|NCT01624662|453747127|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
126124133|NCT01624662|453747128|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
126124134|NCT01624662|453747125|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
126124135|NCT01624662|453747126|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
126124136|NCT01624662|453747127|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
126124137|NCT01624662|453747128|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
126124138|NCT01624662|453747125|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126124139|NCT01624662|453747126|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
126124140|NCT01624662|453747127|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126124141|NCT01624662|453747128|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126124142|NCT01624662|453747125|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
126124143|NCT01624662|453747126|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
126124144|NCT01624662|453747127|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
126124145|NCT01624662|453747128|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
126124146|NCT01624662|453747125|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
126124147|NCT01624662|453747126|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
126124148|NCT01624662|453747127|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
126124149|NCT01624662|453747128|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
126124150|NCT01624662|453747125|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126124151|NCT01624662|453747126|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
126124152|NCT01624662|453747127|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126124153|NCT01624662|453747128|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126124154|NCT01624662|453747125|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
126124155|NCT01624662|453747126|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
126124156|NCT01624662|453747127|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
126124157|NCT01624662|453747128|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
126124158|NCT03099187|453747134|FG000|Double-blind Treatment|Adverse Event|19|||
126124159|NCT03099187|453747135|FG001|Double-blind Treatment|Adverse Event|1|||
126124160|NCT03099187|453747136|FG002|Double-blind Treatment|Adverse Event|0|||
126124161|NCT03099187|453747137|FG003|Double-blind Treatment|Adverse Event|0|||
126124162|NCT03099187|453747134|FG000|Double-blind Treatment|Death|1|||
126124163|NCT03099187|453747135|FG001|Double-blind Treatment|Death|3|||
126124164|NCT03099187|453747136|FG002|Double-blind Treatment|Death|0|||
126124165|NCT03099187|453747137|FG003|Double-blind Treatment|Death|0|||
126124166|NCT03099187|453747134|FG000|Double-blind Treatment|Lack of Efficacy|1|||
126124167|NCT03099187|453747135|FG001|Double-blind Treatment|Lack of Efficacy|0|||
126124168|NCT03099187|453747136|FG002|Double-blind Treatment|Lack of Efficacy|0|||
126124169|NCT03099187|453747137|FG003|Double-blind Treatment|Lack of Efficacy|0|||
126124170|NCT03099187|453747134|FG000|Double-blind Treatment|Physician Decision|2|||
126124171|NCT03099187|453747135|FG001|Double-blind Treatment|Physician Decision|1|||
126124172|NCT03099187|453747136|FG002|Double-blind Treatment|Physician Decision|0|||
126124173|NCT03099187|453747137|FG003|Double-blind Treatment|Physician Decision|0|||
126124174|NCT03099187|453747134|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
126124175|NCT03099187|453747135|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
126124176|NCT03099187|453747136|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
126124177|NCT03099187|453747137|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
126124178|NCT03099187|453747134|FG000|Double-blind Treatment|Lung transplantation|0|||
126124179|NCT03099187|453747135|FG001|Double-blind Treatment|Lung transplantation|1|||
126124180|NCT03099187|453747136|FG002|Double-blind Treatment|Lung transplantation|0|||
126124181|NCT03099187|453747137|FG003|Double-blind Treatment|Lung transplantation|0|||
126124182|NCT03099187|453747134|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
126124183|NCT03099187|453747135|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
126124184|NCT03099187|453747136|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
126124185|NCT03099187|453747137|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
126124186|NCT03099187|453747134|FG000|Double-blind Treatment|Disease progression|0|||
126124187|NCT03099187|453747135|FG001|Double-blind Treatment|Disease progression|1|||
126124188|NCT03099187|453747136|FG002|Double-blind Treatment|Disease progression|0|||
126124189|NCT03099187|453747137|FG003|Double-blind Treatment|Disease progression|0|||
126124190|NCT03099187|453747134|FG000|Double-blind Treatment|Randomization error|0|||
126124191|NCT03099187|453747135|FG001|Double-blind Treatment|Randomization error|2|||
126124192|NCT03099187|453747136|FG002|Double-blind Treatment|Randomization error|0|||
126124193|NCT03099187|453747137|FG003|Double-blind Treatment|Randomization error|0|||
126124194|NCT03099187|453747134|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
126124195|NCT03099187|453747135|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
126124196|NCT03099187|453747136|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
126124197|NCT03099187|453747137|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
126124198|NCT03099187|453747134|FG000|12-month Safety Follow-up|Adverse Event|0|||
126124199|NCT03099187|453747135|FG001|12-month Safety Follow-up|Adverse Event|0|||
126124200|NCT03099187|453747136|FG002|12-month Safety Follow-up|Adverse Event|5|||
126124201|NCT03099187|453747137|FG003|12-month Safety Follow-up|Adverse Event|12|||
126124202|NCT03099187|453747134|FG000|12-month Safety Follow-up|Death|0|||
126124203|NCT03099187|453747135|FG001|12-month Safety Follow-up|Death|0|||
126124204|NCT03099187|453747136|FG002|12-month Safety Follow-up|Death|7|||
126124205|NCT03099187|453747137|FG003|12-month Safety Follow-up|Death|9|||
126124206|NCT03099187|453747134|FG000|12-month Safety Follow-up|Lung transplantation|0|||
126124207|NCT03099187|453747135|FG001|12-month Safety Follow-up|Lung transplantation|0|||
126124208|NCT03099187|453747136|FG002|12-month Safety Follow-up|Lung transplantation|2|||
126124209|NCT03099187|453747137|FG003|12-month Safety Follow-up|Lung transplantation|1|||
126124210|NCT03099187|453747134|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
126124211|NCT03099187|453747135|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
126124212|NCT03099187|453747136|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
126124213|NCT03099187|453747137|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
126124214|NCT03099187|453747134|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
126124215|NCT03099187|453747135|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
126124216|NCT03099187|453747136|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
126124217|NCT03099187|453747137|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
126124218|NCT03099187|453747134|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
126124219|NCT03099187|453747135|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
126124220|NCT03099187|453747136|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
126124221|NCT03099187|453747137|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
126124222|NCT03099187|453747134|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
126124223|NCT03099187|453747135|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
126124224|NCT03099187|453747136|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
126124225|NCT03099187|453747137|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
126124226|NCT01439555|453747138|FG000|Overall Study|Protocol Violation|1|||
126124227|NCT01246583|453747139|FG000|Overall Study|Lost to Follow-up|0|||
126124228|NCT01246583|453747140|FG001|Overall Study|Lost to Follow-up|0|||
126124229|NCT01246583|453747141|FG002|Overall Study|Lost to Follow-up|0|||
126124230|NCT01246583|453747142|FG003|Overall Study|Lost to Follow-up|1|||
126124231|NCT01246583|453747139|FG000|Overall Study|Protocol Violation|0|||
126124232|NCT01246583|453747140|FG001|Overall Study|Protocol Violation|0|||
126124233|NCT01246583|453747141|FG002|Overall Study|Protocol Violation|1|||
126124234|NCT01246583|453747142|FG003|Overall Study|Protocol Violation|0|||
126124235|NCT01246583|453747139|FG000|Overall Study|Withdrawal by Subject|1|||
126124236|NCT01246583|453747140|FG001|Overall Study|Withdrawal by Subject|0|||
126124237|NCT01246583|453747141|FG002|Overall Study|Withdrawal by Subject|0|||
126124238|NCT01246583|453747142|FG003|Overall Study|Withdrawal by Subject|0|||
126124239|NCT04218201|453749212|FG000|Overall Study|Death|0|||
126124240|NCT04218201|453749213|FG001|Overall Study|Death|0|||
126124241|NCT04218201|453749214|FG002|Overall Study|Death|2|||
126124242|NCT04218201|453749215|FG003|Overall Study|Death|0|||
126124243|NCT04218201|453749212|FG000|Overall Study|Unable to contact participant|4|||
126124244|NCT04218201|453749213|FG001|Overall Study|Unable to contact participant|0|||
126124245|NCT04218201|453749214|FG002|Overall Study|Unable to contact participant|3|||
126124246|NCT04218201|453749215|FG003|Overall Study|Unable to contact participant|0|||
126124247|NCT04218201|453749212|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
126124248|NCT04218201|453749213|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
126124249|NCT04218201|453749214|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
126124250|NCT04218201|453749215|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
126124251|NCT04218201|453749212|FG000|Overall Study|Withdrawal by Subject|2|||
126124252|NCT04218201|453749213|FG001|Overall Study|Withdrawal by Subject|0|||
126124253|NCT04218201|453749214|FG002|Overall Study|Withdrawal by Subject|0|||
126124254|NCT04218201|453749215|FG003|Overall Study|Withdrawal by Subject|0|||
126124255|NCT04218201|453749212|FG000|Overall Study|PCP plans to leave practice|0|||
126124256|NCT04218201|453749213|FG001|Overall Study|PCP plans to leave practice|8|||
126124257|NCT04218201|453749214|FG002|Overall Study|PCP plans to leave practice|0|||
126124258|NCT04218201|453749215|FG003|Overall Study|PCP plans to leave practice|5|||
126124259|NCT04218201|453749212|FG000|Overall Study|Reduced panel|0|||
126124260|NCT04218201|453749213|FG001|Overall Study|Reduced panel|0|||
126124261|NCT04218201|453749214|FG002|Overall Study|Reduced panel|0|||
126124262|NCT04218201|453749215|FG003|Overall Study|Reduced panel|1|||
126124263|NCT04218201|453749212|FG000|Overall Study|No longer interested in participating|0|||
126124264|NCT04218201|453749213|FG001|Overall Study|No longer interested in participating|1|||
126124265|NCT04218201|453749214|FG002|Overall Study|No longer interested in participating|0|||
126124266|NCT04218201|453749215|FG003|Overall Study|No longer interested in participating|0|||
126124267|NCT03723707|453749222|FG000|Overall Study|Death|32|||
126124268|NCT03723707|453749223|FG001|Overall Study|Death|32|||
126124269|NCT03723707|453749222|FG000|Overall Study|Admitted to long term care|12|||
126124270|NCT03723707|453749223|FG001|Overall Study|Admitted to long term care|12|||
126124271|NCT03723707|453749222|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
126124272|NCT03723707|453749223|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
126124273|NCT03723707|453749222|FG000|Overall Study|Lost to Follow-up|40|||
126124274|NCT03723707|453749223|FG001|Overall Study|Lost to Follow-up|22|||
126124275|NCT03723707|453749222|FG000|Overall Study|Discontinued after study closure|24|||
126124276|NCT03723707|453749223|FG001|Overall Study|Discontinued after study closure|12|||
126124277|NCT05121480|453749224|FG000|Overall Study|Lack of Efficacy|2|||
126124278|NCT05121480|453749225|FG001|Overall Study|Lack of Efficacy|2|||
126124279|NCT05121480|453749226|FG002|Overall Study|Lack of Efficacy|1|||
126124280|NCT05121480|453749227|FG003|Overall Study|Lack of Efficacy|4|||
126124281|NCT05121480|453749228|FG004|Overall Study|Lack of Efficacy|0|||
126124282|NCT05121480|453749229|FG005|Overall Study|Lack of Efficacy|1|||
126124283|NCT05121480|453749230|FG006|Overall Study|Lack of Efficacy|0|||
126124284|NCT05121480|453749231|FG007|Overall Study|Lack of Efficacy|2|||
126124285|NCT05121480|453749224|FG000|Overall Study|Treatment Failure|0|||
126124286|NCT05121480|453749225|FG001|Overall Study|Treatment Failure|2|||
126124287|NCT05121480|453749226|FG002|Overall Study|Treatment Failure|0|||
126124288|NCT05121480|453749227|FG003|Overall Study|Treatment Failure|1|||
126124289|NCT05121480|453749228|FG004|Overall Study|Treatment Failure|0|||
126124290|NCT05121480|453749229|FG005|Overall Study|Treatment Failure|0|||
126124291|NCT05121480|453749230|FG006|Overall Study|Treatment Failure|0|||
126124292|NCT05121480|453749231|FG007|Overall Study|Treatment Failure|0|||
126124293|NCT05121480|453749224|FG000|Overall Study|Adverse Event|0|||
126124294|NCT05121480|453749225|FG001|Overall Study|Adverse Event|1|||
126124295|NCT05121480|453749226|FG002|Overall Study|Adverse Event|0|||
126124296|NCT05121480|453749227|FG003|Overall Study|Adverse Event|5|||
126124297|NCT05121480|453749228|FG004|Overall Study|Adverse Event|3|||
126124298|NCT05121480|453749229|FG005|Overall Study|Adverse Event|2|||
126124299|NCT05121480|453749230|FG006|Overall Study|Adverse Event|0|||
126124300|NCT05121480|453749231|FG007|Overall Study|Adverse Event|4|||
126124301|NCT05121480|453749224|FG000|Overall Study|Withdrawal by Subject|4|||
126124302|NCT05121480|453749225|FG001|Overall Study|Withdrawal by Subject|9|||
126124303|NCT05121480|453749226|FG002|Overall Study|Withdrawal by Subject|1|||
126124304|NCT05121480|453749227|FG003|Overall Study|Withdrawal by Subject|8|||
126124305|NCT05121480|453749228|FG004|Overall Study|Withdrawal by Subject|0|||
126124306|NCT05121480|453749229|FG005|Overall Study|Withdrawal by Subject|9|||
126124307|NCT05121480|453749230|FG006|Overall Study|Withdrawal by Subject|0|||
126124308|NCT05121480|453749231|FG007|Overall Study|Withdrawal by Subject|4|||
125963614|NCT00718042|453157138|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
125963615|NCT00718042|453157133|FG000|Donor Follow-up|Lost to Follow-up|13|||
125963616|NCT00718042|453157134|FG001|Donor Follow-up|Lost to Follow-up|0|||
125963617|NCT00718042|453157135|FG002|Donor Follow-up|Lost to Follow-up|0|||
125963618|NCT00718042|453157136|FG003|Donor Follow-up|Lost to Follow-up|0|||
125963619|NCT00718042|453157137|FG004|Donor Follow-up|Lost to Follow-up|19|||
125963620|NCT00718042|453157138|FG005|Donor Follow-up|Lost to Follow-up|0|||
126088016|NCT01435772|453614942|FG000|Overall Study|Other - study termination|2|||
126088017|NCT01435772|453614943|FG001|Overall Study|Other - study termination|2|||
126088018|NCT01435772|453614944|FG002|Overall Study|Other - study termination|10|||
126088019|NCT03238963|453614945|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
126088020|NCT03238963|453614946|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
126088021|NCT03238963|453614945|FG000|Overall Study|Withdrawal by Subject|1|||
126088022|NCT03238963|453614946|FG001|Overall Study|Withdrawal by Subject|1|||
126088023|NCT03238963|453614945|FG000|Overall Study|Lost to Follow-up|1|||
126088024|NCT03238963|453614946|FG001|Overall Study|Lost to Follow-up|0|||
126088025|NCT03238963|453614945|FG000|Overall Study|Protocol Violation|1|||
126088026|NCT03238963|453614946|FG001|Overall Study|Protocol Violation|1|||
126088027|NCT03238963|453614945|FG000|Overall Study|Adverse Event|1|||
126088028|NCT03238963|453614946|FG001|Overall Study|Adverse Event|0|||
126088029|NCT03838731|453616995|FG000|Overall Study|Pregnancy|0|||
126088030|NCT03838731|453616996|FG001|Overall Study|Pregnancy|1|||
126088031|NCT03838731|453616995|FG000|Overall Study|Withdrawal of consent|1|||
126088032|NCT03838731|453616996|FG001|Overall Study|Withdrawal of consent|0|||
126088033|NCT01195948|453617002|FG000|Overall Study|Lost to Follow-up|0|||
126088034|NCT01195948|453617003|FG001|Overall Study|Lost to Follow-up|1|||
126088035|NCT01195948|453617004|FG002|Overall Study|Lost to Follow-up|2|||
126088036|NCT00770029|453617005|FG000|Overall Study|Lost to Follow-up|2|||
126088037|NCT00770029|453617006|FG001|Overall Study|Lost to Follow-up|0|||
126088038|NCT00770029|453617005|FG000|Overall Study|Withdrawal by Subject|3|||
126088039|NCT00770029|453617006|FG001|Overall Study|Withdrawal by Subject|3|||
126088040|NCT00770029|453617005|FG000|Overall Study|Adverse Event|1|||
126088041|NCT00770029|453617006|FG001|Overall Study|Adverse Event|0|||
126088042|NCT03809039|453617009|FG000|Part 1|Withdrawal by Subject|1|||
126088043|NCT03809039|453617010|FG001|Part 1|Withdrawal by Subject|0|||
126088044|NCT03809039|453617011|FG002|Part 1|Withdrawal by Subject|0|||
126088045|NCT03809039|453617012|FG003|Part 1|Withdrawal by Subject|1|||
126088046|NCT03809039|453617013|FG004|Part 1|Withdrawal by Subject|0|||
126088047|NCT03809039|453617014|FG005|Part 1|Withdrawal by Subject|0|||
126088048|NCT03809039|453617015|FG006|Part 1|Withdrawal by Subject|0|||
126088049|NCT03809039|453617016|FG007|Part 1|Withdrawal by Subject|0|||
126088050|NCT03809039|453617017|FG008|Part 1|Withdrawal by Subject|0|||
126088051|NCT03809039|453617009|FG000|Part 3|Withdrawn by study termination|0|||
126088052|NCT03809039|453617010|FG001|Part 3|Withdrawn by study termination|0|||
126088053|NCT03809039|453617011|FG002|Part 3|Withdrawn by study termination|0|||
126088054|NCT03809039|453617012|FG003|Part 3|Withdrawn by study termination|0|||
126088055|NCT03809039|453617013|FG004|Part 3|Withdrawn by study termination|0|||
126088056|NCT03809039|453617014|FG005|Part 3|Withdrawn by study termination|0|||
126088057|NCT03809039|453617015|FG006|Part 3|Withdrawn by study termination|0|||
126088058|NCT03809039|453617016|FG007|Part 3|Withdrawn by study termination|2|||
126088059|NCT03809039|453617017|FG008|Part 3|Withdrawn by study termination|6|||
126088060|NCT05627258|453617018|FG000|Overall Study|Lost to Follow-up|1|||
126088061|NCT05627258|453617019|FG001|Overall Study|Lost to Follow-up|0|||
126088062|NCT05627258|453617020|FG002|Overall Study|Lost to Follow-up|0|||
126088063|NCT05627258|453617021|FG003|Overall Study|Lost to Follow-up|0|||
126088064|NCT05627258|453617022|FG004|Overall Study|Lost to Follow-up|0|||
126088065|NCT05627258|453617023|FG005|Overall Study|Lost to Follow-up|0|||
126088066|NCT05627258|453617018|FG000|Overall Study|Withdrawal by Subject|0|||
126088067|NCT05627258|453617019|FG001|Overall Study|Withdrawal by Subject|0|||
126088068|NCT05627258|453617020|FG002|Overall Study|Withdrawal by Subject|0|||
126088069|NCT05627258|453617021|FG003|Overall Study|Withdrawal by Subject|0|||
126088070|NCT05627258|453617022|FG004|Overall Study|Withdrawal by Subject|2|||
126088071|NCT05627258|453617023|FG005|Overall Study|Withdrawal by Subject|0|||
126088072|NCT05627258|453617018|FG000|Overall Study|Enrolled, but product not administered|1|||
126088073|NCT05627258|453617019|FG001|Overall Study|Enrolled, but product not administered|0|||
126088074|NCT05627258|453617020|FG002|Overall Study|Enrolled, but product not administered|0|||
126088075|NCT05627258|453617021|FG003|Overall Study|Enrolled, but product not administered|0|||
126088076|NCT05627258|453617022|FG004|Overall Study|Enrolled, but product not administered|0|||
126088077|NCT05627258|453617023|FG005|Overall Study|Enrolled, but product not administered|0|||
126088078|NCT05627258|453617018|FG000|Overall Study|Other subject illness/injury|1|||
126088079|NCT05627258|453617019|FG001|Overall Study|Other subject illness/injury|0|||
126088080|NCT05627258|453617020|FG002|Overall Study|Other subject illness/injury|0|||
126088081|NCT05627258|453617021|FG003|Overall Study|Other subject illness/injury|0|||
126088082|NCT05627258|453617022|FG004|Overall Study|Other subject illness/injury|0|||
126088083|NCT05627258|453617023|FG005|Overall Study|Other subject illness/injury|0|||
126088084|NCT05627258|453617018|FG000|Overall Study|Subject moved from area|0|||
126124309|NCT05121480|453749224|FG000|Overall Study|Non-compliance with the protocol|0|||
126124310|NCT05121480|453749225|FG001|Overall Study|Non-compliance with the protocol|0|||
126124311|NCT05121480|453749226|FG002|Overall Study|Non-compliance with the protocol|0|||
126124312|NCT05121480|453749227|FG003|Overall Study|Non-compliance with the protocol|0|||
126124313|NCT05121480|453749228|FG004|Overall Study|Non-compliance with the protocol|1|||
126124314|NCT05121480|453749229|FG005|Overall Study|Non-compliance with the protocol|6|||
126124315|NCT05121480|453749230|FG006|Overall Study|Non-compliance with the protocol|0|||
126124316|NCT05121480|453749231|FG007|Overall Study|Non-compliance with the protocol|1|||
126124317|NCT05121480|453749224|FG000|Overall Study|Lost to Follow-up|0|||
126124318|NCT05121480|453749225|FG001|Overall Study|Lost to Follow-up|4|||
126124319|NCT05121480|453749226|FG002|Overall Study|Lost to Follow-up|1|||
126124320|NCT05121480|453749227|FG003|Overall Study|Lost to Follow-up|3|||
126124321|NCT05121480|453749228|FG004|Overall Study|Lost to Follow-up|1|||
126124322|NCT05121480|453749229|FG005|Overall Study|Lost to Follow-up|1|||
126124323|NCT05121480|453749230|FG006|Overall Study|Lost to Follow-up|1|||
126124324|NCT05121480|453749231|FG007|Overall Study|Lost to Follow-up|4|||
126124325|NCT05121480|453749224|FG000|Overall Study|Physician Decision|0|||
126124326|NCT05121480|453749225|FG001|Overall Study|Physician Decision|0|||
126124327|NCT05121480|453749226|FG002|Overall Study|Physician Decision|0|||
126124328|NCT05121480|453749227|FG003|Overall Study|Physician Decision|0|||
126124329|NCT05121480|453749228|FG004|Overall Study|Physician Decision|0|||
126124330|NCT05121480|453749229|FG005|Overall Study|Physician Decision|1|||
126124331|NCT05121480|453749230|FG006|Overall Study|Physician Decision|0|||
126124332|NCT05121480|453749231|FG007|Overall Study|Physician Decision|1|||
126124333|NCT05121480|453749224|FG000|Overall Study|Other Reason|0|||
126124334|NCT05121480|453749225|FG001|Overall Study|Other Reason|0|||
126124335|NCT05121480|453749226|FG002|Overall Study|Other Reason|0|||
126124336|NCT05121480|453749227|FG003|Overall Study|Other Reason|0|||
126124337|NCT05121480|453749228|FG004|Overall Study|Other Reason|0|||
126124338|NCT05121480|453749229|FG005|Overall Study|Other Reason|1|||
126124339|NCT05121480|453749230|FG006|Overall Study|Other Reason|1|||
126124340|NCT05121480|453749231|FG007|Overall Study|Other Reason|1|||
126124341|NCT02831673|453749234|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
126124342|NCT02831673|453749235|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
126124343|NCT02831673|453749236|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
126124344|NCT02831673|453749237|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
126124345|NCT02831673|453749238|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
126124346|NCT02831673|453749234|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
126124347|NCT02831673|453749235|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
126124348|NCT02831673|453749236|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
126124349|NCT02831673|453749237|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
126124350|NCT02831673|453749238|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
126124351|NCT02831673|453749234|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
126124352|NCT02831673|453749235|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
126124353|NCT02831673|453749236|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
126124354|NCT02831673|453749237|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
126124355|NCT02831673|453749238|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
126124356|NCT02831673|453749234|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
126124357|NCT02831673|453749235|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
126124358|NCT02831673|453749236|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
126124359|NCT02831673|453749237|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
126124360|NCT02831673|453749238|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
126124361|NCT02831673|453749234|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
126124362|NCT02831673|453749235|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
126124363|NCT02831673|453749236|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
126124364|NCT02831673|453749237|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
126124365|NCT02831673|453749238|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
126124366|NCT02831673|453749234|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
125963621|NCT00575588|453157139|FG000|Overall Study|Adverse Event|11|||
125963622|NCT00575588|453157140|FG001|Overall Study|Adverse Event|13|||
125963623|NCT00575588|453157139|FG000|Overall Study|Withdrawal by Subject|27|||
126124367|NCT02831673|453749235|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
126124368|NCT02831673|453749236|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
126124369|NCT02831673|453749237|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
126124370|NCT02831673|453749238|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
126124371|NCT02831673|453749234|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
126124372|NCT02831673|453749235|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
126124373|NCT02831673|453749236|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
126124374|NCT02831673|453749237|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
126124375|NCT02831673|453749238|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
126124376|NCT02831673|453749234|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
125963624|NCT00575588|453157140|FG001|Overall Study|Withdrawal by Subject|31|||
126124377|NCT02831673|453749235|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
126124378|NCT02831673|453749236|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
126124379|NCT02831673|453749237|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
126124380|NCT02831673|453749238|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
126124381|NCT02831673|453749234|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126124382|NCT02831673|453749235|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126124383|NCT02831673|453749236|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
126124384|NCT02831673|453749237|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
126124385|NCT02831673|453749238|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126124386|NCT02831673|453749234|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126124387|NCT02831673|453749235|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126124388|NCT02831673|453749236|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
126124389|NCT02831673|453749237|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
126124390|NCT02831673|453749238|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126124391|NCT02831673|453749234|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126124392|NCT02831673|453749235|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126124393|NCT02831673|453749236|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126124394|NCT02831673|453749237|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
126124395|NCT02831673|453749238|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126124396|NCT02831673|453749234|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
126124397|NCT02831673|453749235|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
126124398|NCT02831673|453749236|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
126124399|NCT02831673|453749237|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
126124400|NCT02831673|453749238|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
126124401|NCT02831673|453749234|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126124402|NCT02831673|453749235|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126124403|NCT02831673|453749236|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
126124404|NCT02831673|453749237|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
126124405|NCT02831673|453749238|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126124406|NCT02831673|453749234|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126124407|NCT02831673|453749235|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126124408|NCT02831673|453749236|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
126124409|NCT02831673|453749237|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
126124410|NCT02831673|453749238|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126124411|NCT02831673|453749234|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126124412|NCT02831673|453749235|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126124413|NCT02831673|453749236|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
126124414|NCT02831673|453749237|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
126124415|NCT02831673|453749238|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126124416|NCT02831673|453749234|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
126124417|NCT02831673|453749235|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
126124418|NCT02831673|453749236|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
126124419|NCT02831673|453749237|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
126124420|NCT02831673|453749238|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
126124421|NCT02831673|453749234|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126124422|NCT02831673|453749235|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126124423|NCT02831673|453749236|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126124424|NCT02831673|453749237|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126124425|NCT02831673|453749238|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
126124426|NCT02831673|453749234|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126124427|NCT02831673|453749235|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126124428|NCT02831673|453749236|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126124429|NCT02831673|453749237|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126124430|NCT02831673|453749238|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
126124431|NCT02831673|453749234|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126124432|NCT02831673|453749235|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126124433|NCT02831673|453749236|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126124434|NCT02831673|453749237|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126124435|NCT02831673|453749238|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
126124436|NCT02831673|453749234|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126124437|NCT02831673|453749235|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126124438|NCT02831673|453749236|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126124439|NCT02831673|453749237|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126124440|NCT02831673|453749238|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
126124441|NCT02356562|453749239|FG000|Overall Study|Withdrawal by Subject|0|||
126124442|NCT02356562|453749240|FG001|Overall Study|Withdrawal by Subject|1|||
126124443|NCT02356562|453749239|FG000|Overall Study|Re-entered treatment in a previous study|1|||
126124444|NCT02356562|453749240|FG001|Overall Study|Re-entered treatment in a previous study|0|||
126124445|NCT02356562|453749239|FG000|Overall Study|site closure|1|||
126124446|NCT02356562|453749240|FG001|Overall Study|site closure|0|||
126124447|NCT01351389|453749250|FG000|Overall Study|Withdrawal by Subject|7|||
126124448|NCT01351389|453749251|FG001|Overall Study|Withdrawal by Subject|0|||
126124449|NCT01351389|453749250|FG000|Overall Study|did not complete intervention|23|||
126124450|NCT01351389|453749251|FG001|Overall Study|did not complete intervention|15|||
126124451|NCT02646982|453749252|FG000|Overall Study|Adverse Event|1|||
126124452|NCT02646982|453749253|FG001|Overall Study|Adverse Event|1|||
126124453|NCT02646982|453749252|FG000|Overall Study|Withdrawal by Subject|2|||
126124454|NCT02646982|453749253|FG001|Overall Study|Withdrawal by Subject|1|||
126124455|NCT00713700|453749254|FG000|Overall Study|Lost to Follow-up|3|||
126124456|NCT00713700|453749254|FG000|Overall Study|Withdrawal by Subject|1|||
126124457|NCT01040351|453749255|FG000|Overall Study|poor ovarian response|1|||
126124458|NCT01040351|453749256|FG001|Overall Study|poor ovarian response|2|||
126124459|NCT01230307|453749257|FG000|Overall Study|LVAD Placement|0|||
126124460|NCT01230307|453749258|FG001|Overall Study|LVAD Placement|2|||
126124461|NCT00530894|453749263|FG000|Overall Study|Death|84|||
126124462|NCT00530894|453749264|FG001|Overall Study|Death|89|||
126124463|NCT00530894|453749265|FG002|Overall Study|Death|55|||
126124464|NCT00530894|453749266|FG003|Overall Study|Death|89|||
126124465|NCT00530894|453749263|FG000|Overall Study|Lost to Follow-up|1|||
126124466|NCT00530894|453749264|FG001|Overall Study|Lost to Follow-up|3|||
126124467|NCT00530894|453749265|FG002|Overall Study|Lost to Follow-up|0|||
126124468|NCT00530894|453749266|FG003|Overall Study|Lost to Follow-up|0|||
126124469|NCT00530894|453749263|FG000|Overall Study|Withdrawal by Subject|1|||
126124470|NCT00530894|453749264|FG001|Overall Study|Withdrawal by Subject|23|||
126124471|NCT00530894|453749265|FG002|Overall Study|Withdrawal by Subject|0|||
126124472|NCT00530894|453749266|FG003|Overall Study|Withdrawal by Subject|5|||
126124473|NCT00530894|453749263|FG000|Overall Study|Alive and censored prior to 1 year|2|||
126124474|NCT00530894|453749264|FG001|Overall Study|Alive and censored prior to 1 year|0|||
126124475|NCT00530894|453749265|FG002|Overall Study|Alive and censored prior to 1 year|0|||
126124476|NCT00530894|453749266|FG003|Overall Study|Alive and censored prior to 1 year|0|||
126124477|NCT02256540|453749267|FG000|Overall Study|Withdrawal by Subject|0|||
126124478|NCT02256540|453749268|FG001|Overall Study|Withdrawal by Subject|1|||
126124479|NCT02256540|453749269|FG002|Overall Study|Withdrawal by Subject|1|||
126124480|NCT02256540|453749267|FG000|Overall Study|Back pain preventing exercise|0|||
126124481|NCT02256540|453749268|FG001|Overall Study|Back pain preventing exercise|0|||
126124482|NCT02256540|453749269|FG002|Overall Study|Back pain preventing exercise|1|||
126124483|NCT03923426|453749276|FG000|Overall Study|Other|19|||
126124484|NCT03923426|453749276|FG000|Overall Study|Lost to Follow-up|16|||
126124485|NCT03923426|453749276|FG000|Overall Study|Death|107|||
126124486|NCT03923426|453749276|FG000|Overall Study|Incomplete response to question|13|||
126124487|NCT03719690|453749277|FG000|Overall Study|Withdrawal by Subject|5|||
126124488|NCT03719690|453749278|FG001|Overall Study|Withdrawal by Subject|10|||
126124489|NCT03719690|453749277|FG000|Overall Study|Death|40|||
126124490|NCT03719690|453749278|FG001|Overall Study|Death|149|||
126124491|NCT03719690|453749277|FG000|Overall Study|Miscellaneous|12|||
126124492|NCT03719690|453749278|FG001|Overall Study|Miscellaneous|56|||
126124493|NCT03719690|453749277|FG000|Overall Study|Lost to Follow-up|2|||
126124494|NCT03719690|453749278|FG001|Overall Study|Lost to Follow-up|18|||
126124495|NCT03719690|453749277|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
126124496|NCT03719690|453749278|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
126124497|NCT00769002|453749279|FG000|Overall Study|Study was not completed, no data|9|||
126124498|NCT00769002|453749280|FG001|Overall Study|Study was not completed, no data|9|||
126124499|NCT00847912|453749283|FG000|Overall Study|Protocol Violation|6|||
126124500|NCT00847912|453749284|FG001|Overall Study|Protocol Violation|7|||
126124501|NCT00847912|453749283|FG000|Overall Study|Withdrawal by Subject|3|||
126124502|NCT00847912|453749284|FG001|Overall Study|Withdrawal by Subject|6|||
126124503|NCT00838331|453749293|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
126124504|NCT03972969|453749294|FG000|3-month Follow-up|Death|1|||
126124505|NCT03972969|453749295|FG001|3-month Follow-up|Death|1|||
126124506|NCT03972969|453749296|FG002|3-month Follow-up|Death|0|||
126124507|NCT03972969|453749294|FG000|6-month Follow-up|Death|1|||
126124508|NCT03972969|453749295|FG001|6-month Follow-up|Death|1|||
126124509|NCT03972969|453749296|FG002|6-month Follow-up|Death|1|||
126124510|NCT03972969|453749294|FG000|6-month Follow-up|Lost to Follow-up|2|||
126124511|NCT03972969|453749295|FG001|6-month Follow-up|Lost to Follow-up|2|||
126124512|NCT03972969|453749296|FG002|6-month Follow-up|Lost to Follow-up|2|||
126124513|NCT00264875|453749297|FG000|Overall Study|Adverse Event|6|||
126124514|NCT00264875|453749297|FG000|Overall Study|Lost to Follow-up|6|||
126124515|NCT00264875|453749297|FG000|Overall Study|Protocol Violation|11|||
126124516|NCT00264875|453749297|FG000|Overall Study|Withdrawal by Subject|7|||
126124517|NCT00732303|453749298|FG000|Overall Study|Study Terminated|2|||
126124518|NCT01074190|453749299|FG000|Overall Study|Emergency Cesarean Delivery|1|||
126124519|NCT01074190|453749300|FG001|Overall Study|Emergency Cesarean Delivery|2|||
126124520|NCT01074190|453749301|FG002|Overall Study|Emergency Cesarean Delivery|1|||
126124521|NCT01074190|453749299|FG000|Overall Study|Protocol Violation|2|||
126124522|NCT01074190|453749300|FG001|Overall Study|Protocol Violation|1|||
126124523|NCT01074190|453749301|FG002|Overall Study|Protocol Violation|0|||
126124524|NCT01074190|453749299|FG000|Overall Study|Delivered in under 90 minutes|0|||
126124525|NCT01074190|453749300|FG001|Overall Study|Delivered in under 90 minutes|2|||
126124526|NCT01074190|453749301|FG002|Overall Study|Delivered in under 90 minutes|1|||
126124527|NCT01074190|453749299|FG000|Overall Study|Subject withdrew consent|1|||
126124528|NCT01074190|453749300|FG001|Overall Study|Subject withdrew consent|1|||
126124529|NCT01074190|453749301|FG002|Overall Study|Subject withdrew consent|1|||
126124530|NCT01500278|453749308|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
126124531|NCT01500278|453749309|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
126124532|NCT01500278|453749308|FG000|Week 0 - Week 12|Protocol Violation|10|||
126124533|NCT01500278|453749309|FG001|Week 0 - Week 12|Protocol Violation|16|||
126124534|NCT01500278|453749308|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
126124535|NCT01500278|453749309|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
126124536|NCT01500278|453749308|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
126124537|NCT01500278|453749309|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
126124538|NCT01500278|453749308|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
126124539|NCT01500278|453749309|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
126124540|NCT01500278|453749308|FG000|Week 0 - Week 12|Patient decision|1|||
126124541|NCT01500278|453749309|FG001|Week 0 - Week 12|Patient decision|0|||
126124542|NCT01500278|453749308|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
126124543|NCT01500278|453749309|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
126124544|NCT01500278|453749308|FG000|Week 0 - Week 12|Investigator decision|1|||
126124545|NCT01500278|453749309|FG001|Week 0 - Week 12|Investigator decision|0|||
126124546|NCT01500278|453749308|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
126124547|NCT01500278|453749309|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
126124548|NCT01500278|453749308|FG000|Week 0 - Week 12|Sponsor decision|1|||
126124549|NCT01500278|453749309|FG001|Week 0 - Week 12|Sponsor decision|0|||
126124550|NCT01500278|453749308|FG000|Week 0 - Week 12|Personal reason|0|||
126124551|NCT01500278|453749309|FG001|Week 0 - Week 12|Personal reason|1|||
126124552|NCT01500278|453749308|FG000|Week 0 - Week 12|Other serious disease|0|||
126124553|NCT01500278|453749309|FG001|Week 0 - Week 12|Other serious disease|1|||
126124554|NCT01500278|453749308|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
126124555|NCT01500278|453749309|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
126124556|NCT01500278|453749308|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
126124557|NCT01500278|453749309|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
126124558|NCT01500278|453749308|FG000|Week 13 - Week 104|Protocol Violation|6|||
126124559|NCT01500278|453749309|FG001|Week 13 - Week 104|Protocol Violation|6|||
126124560|NCT01500278|453749308|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
126124561|NCT01500278|453749309|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
126124562|NCT01500278|453749308|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
126124563|NCT01500278|453749309|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
126124564|NCT01500278|453749308|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
126124565|NCT01500278|453749309|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
126124566|NCT01500278|453749308|FG000|Week 13 - Week 104|Non/bad compliance|7|||
126124567|NCT01500278|453749309|FG001|Week 13 - Week 104|Non/bad compliance|5|||
126124568|NCT01500278|453749308|FG000|Week 13 - Week 104|Recurrent infections|1|||
126124569|NCT01500278|453749309|FG001|Week 13 - Week 104|Recurrent infections|0|||
126124570|NCT01500278|453749308|FG000|Week 13 - Week 104|False positive test|1|||
126124571|NCT01500278|453749309|FG001|Week 13 - Week 104|False positive test|2|||
126124572|NCT01500278|453749308|FG000|Week 13 - Week 104|Sponsor request|4|||
126124573|NCT01500278|453749309|FG001|Week 13 - Week 104|Sponsor request|0|||
125963625|NCT00575588|453157139|FG000|Overall Study|Lost to Follow-up|1|||
126124574|NCT01500278|453749308|FG000|Week 13 - Week 104|Withdrawn in error|1|||
126124575|NCT01500278|453749309|FG001|Week 13 - Week 104|Withdrawn in error|0|||
126124576|NCT01500278|453749308|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
126124577|NCT01500278|453749309|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
126124578|NCT01500278|453749308|FG000|Week 13 - Week 104|Protocol deviation|1|||
126124579|NCT01500278|453749309|FG001|Week 13 - Week 104|Protocol deviation|0|||
126124580|NCT01500278|453749308|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
126124581|NCT01500278|453749309|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
126124582|NCT01500278|453749308|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
126124583|NCT01500278|453749309|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
126124584|NCT01500278|453749308|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
126124585|NCT01500278|453749309|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
126124586|NCT01500278|453749308|FG000|Week 13 - Week 104|Relocation|0|||
126124587|NCT01500278|453749309|FG001|Week 13 - Week 104|Relocation|1|||
126124588|NCT01500278|453749308|FG000|Week 13 - Week 104|Sponsor decision|0|||
126124589|NCT01500278|453749309|FG001|Week 13 - Week 104|Sponsor decision|2|||
126124590|NCT01500278|453749308|FG000|Week 13 - Week 104|Medical monitor decision|0|||
126124591|NCT01500278|453749309|FG001|Week 13 - Week 104|Medical monitor decision|2|||
126124592|NCT01500278|453749308|FG000|Week 13 - Week 104|Personal reason|0|||
126124593|NCT01500278|453749309|FG001|Week 13 - Week 104|Personal reason|1|||
126124594|NCT01500278|453749308|FG000|Week 13 - Week 104|Not completed|0|||
126124595|NCT01500278|453749309|FG001|Week 13 - Week 104|Not completed|1|||
126124596|NCT01500278|453749308|FG000|Week 13 - Week 104|Death|2|||
126124597|NCT01500278|453749309|FG001|Week 13 - Week 104|Death|4|||
126124598|NCT01500278|453749308|FG000|Week 13 - Week 104|Adverse Event|54|||
126124599|NCT01500278|453749309|FG001|Week 13 - Week 104|Adverse Event|54|||
126124600|NCT01709435|453749313|FG000|Overall Study|Adverse Event|1|||
126124601|NCT01709435|453749314|FG001|Overall Study|Adverse Event|1|||
126124602|NCT01709435|453749315|FG002|Overall Study|Adverse Event|1|||
126124603|NCT01709435|453749316|FG003|Overall Study|Adverse Event|0|||
126124604|NCT01709435|453749317|FG004|Overall Study|Adverse Event|0|||
126124605|NCT01709435|453749318|FG005|Overall Study|Adverse Event|1|||
126124606|NCT01709435|453749313|FG000|Overall Study|Lack of Efficacy|5|||
126124607|NCT01709435|453749314|FG001|Overall Study|Lack of Efficacy|7|||
126124608|NCT01709435|453749315|FG002|Overall Study|Lack of Efficacy|2|||
126124609|NCT01709435|453749316|FG003|Overall Study|Lack of Efficacy|2|||
126124610|NCT01709435|453749317|FG004|Overall Study|Lack of Efficacy|6|||
126124611|NCT01709435|453749318|FG005|Overall Study|Lack of Efficacy|3|||
126124612|NCT01709435|453749313|FG000|Overall Study|Physician Decision|0|||
126124613|NCT01709435|453749314|FG001|Overall Study|Physician Decision|1|||
126124614|NCT01709435|453749315|FG002|Overall Study|Physician Decision|0|||
126124615|NCT01709435|453749316|FG003|Overall Study|Physician Decision|1|||
126124616|NCT01709435|453749317|FG004|Overall Study|Physician Decision|2|||
126124617|NCT01709435|453749318|FG005|Overall Study|Physician Decision|0|||
126124618|NCT01709435|453749313|FG000|Overall Study|Withdrawal by Subject|0|||
126124619|NCT01709435|453749314|FG001|Overall Study|Withdrawal by Subject|0|||
126124620|NCT01709435|453749315|FG002|Overall Study|Withdrawal by Subject|3|||
126124621|NCT01709435|453749316|FG003|Overall Study|Withdrawal by Subject|0|||
126124622|NCT01709435|453749317|FG004|Overall Study|Withdrawal by Subject|2|||
126124623|NCT01709435|453749318|FG005|Overall Study|Withdrawal by Subject|2|||
126124624|NCT00053417|453749319|FG000|Overall Study|Adverse Event|1|||
126124625|NCT00053417|453749320|FG001|Overall Study|Adverse Event|0|||
126124626|NCT00053417|453749321|FG002|Overall Study|Adverse Event|1|||
126124627|NCT00053417|453749322|FG003|Overall Study|Adverse Event|5|||
126124628|NCT00053417|453749319|FG000|Overall Study|Non-Compliance|0|||
126124629|NCT00053417|453749320|FG001|Overall Study|Non-Compliance|0|||
126124630|NCT00053417|453749321|FG002|Overall Study|Non-Compliance|0|||
126124631|NCT00053417|453749322|FG003|Overall Study|Non-Compliance|1|||
126124632|NCT00053417|453749319|FG000|Overall Study|Withdrawal by Subject|0|||
126124633|NCT00053417|453749320|FG001|Overall Study|Withdrawal by Subject|1|||
126124634|NCT00053417|453749321|FG002|Overall Study|Withdrawal by Subject|0|||
126124635|NCT00053417|453749322|FG003|Overall Study|Withdrawal by Subject|0|||
126124636|NCT00053417|453749319|FG000|Overall Study|Lost to Follow-up|1|||
126124637|NCT00053417|453749320|FG001|Overall Study|Lost to Follow-up|1|||
126124638|NCT00053417|453749321|FG002|Overall Study|Lost to Follow-up|0|||
126124639|NCT00053417|453749322|FG003|Overall Study|Lost to Follow-up|0|||
126124640|NCT02182687|453749329|FG000|Overall Study|Withdrawal by Subject|4|||
126124641|NCT02182687|453749330|FG001|Overall Study|Withdrawal by Subject|0|||
126124642|NCT02182687|453749329|FG000|Overall Study|Adverse Event|1|||
126124643|NCT02182687|453749330|FG001|Overall Study|Adverse Event|0|||
126124644|NCT02182687|453749329|FG000|Overall Study|Lost to Follow-up|0|||
126124645|NCT02182687|453749330|FG001|Overall Study|Lost to Follow-up|1|||
126124646|NCT01297270|453749331|FG000|Overall Study|Adverse Event|19|||
126124647|NCT01297270|453749332|FG001|Overall Study|Adverse Event|32|||
126124648|NCT01297270|453749333|FG002|Overall Study|Adverse Event|5|||
126124649|NCT01297270|453749331|FG000|Overall Study|Lack of Efficacy|15|||
126124650|NCT01297270|453749332|FG001|Overall Study|Lack of Efficacy|17|||
126124651|NCT01297270|453749333|FG002|Overall Study|Lack of Efficacy|15|||
126124652|NCT01297270|453749331|FG000|Overall Study|Lost to Follow-up|1|||
126124653|NCT01297270|453749332|FG001|Overall Study|Lost to Follow-up|2|||
126124654|NCT01297270|453749333|FG002|Overall Study|Lost to Follow-up|1|||
126124655|NCT01297270|453749331|FG000|Overall Study|Protocol Violation|0|||
126124656|NCT01297270|453749332|FG001|Overall Study|Protocol Violation|2|||
126124657|NCT01297270|453749333|FG002|Overall Study|Protocol Violation|0|||
126124658|NCT01297270|453749331|FG000|Overall Study|Withdrawal by Subject|7|||
126124659|NCT01297270|453749332|FG001|Overall Study|Withdrawal by Subject|15|||
126124660|NCT01297270|453749333|FG002|Overall Study|Withdrawal by Subject|7|||
126124661|NCT01297270|453749331|FG000|Overall Study|Other reason not defined above|3|||
126124662|NCT01297270|453749332|FG001|Overall Study|Other reason not defined above|3|||
126124663|NCT01297270|453749333|FG002|Overall Study|Other reason not defined above|1|||
126124664|NCT01297270|453749331|FG000|Overall Study|Not treated|0|||
126124665|NCT01297270|453749332|FG001|Overall Study|Not treated|1|||
126124666|NCT01297270|453749333|FG002|Overall Study|Not treated|0|||
126124667|NCT02863809|453749336|FG000|Overall Study|Adverse Event|8|||
126124668|NCT02863809|453749337|FG001|Overall Study|Adverse Event|8|||
126124669|NCT02863809|453749336|FG000|Overall Study|Withdrawal by Subject|0|||
126124670|NCT02863809|453749337|FG001|Overall Study|Withdrawal by Subject|1|||
126124671|NCT02863809|453749336|FG000|Overall Study|Lost to Follow-up|1|||
126124672|NCT02863809|453749337|FG001|Overall Study|Lost to Follow-up|1|||
126124673|NCT02863809|453749336|FG000|Overall Study|Death|1|||
126124674|NCT02863809|453749337|FG001|Overall Study|Death|0|||
126124675|NCT02829138|453749338|FG000|Overall Study|Withdrawal by Subject|1|||
126124676|NCT02829138|453749339|FG001|Overall Study|Withdrawal by Subject|0|||
126124677|NCT04041284|453749342|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
126124678|NCT04041284|453749343|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
126124679|NCT04041284|453749342|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
126124680|NCT04041284|453749343|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
126124681|NCT04041284|453749342|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
126124682|NCT04041284|453749343|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
126124683|NCT04041284|453749342|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
126124684|NCT04041284|453749343|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
126124685|NCT04041284|453749342|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
126124686|NCT04041284|453749343|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
126124687|NCT04041284|453749342|FG000|DB Phase (12 Weeks)|Other than specified|1|||
126124688|NCT04041284|453749343|FG001|DB Phase (12 Weeks)|Other than specified|0|||
126124689|NCT04041284|453749342|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
126124690|NCT04041284|453749343|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
126124691|NCT04041284|453749342|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
126124692|NCT04041284|453749343|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
126124693|NCT04041284|453749342|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
126124694|NCT04041284|453749343|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
126124695|NCT04041284|453749342|FG000|OL Phase (12 Weeks)|Other than specified|6|||
126124696|NCT04041284|453749343|FG001|OL Phase (12 Weeks)|Other than specified|2|||
126124697|NCT00563186|453749344|FG000|Overall Study|LOS<48 hours|97|||
126124698|NCT00563186|453749345|FG001|Overall Study|LOS<48 hours|74|||
126124699|NCT00563186|453749344|FG000|Overall Study|Incomplete data|1|||
126124700|NCT00563186|453749345|FG001|Overall Study|Incomplete data|1|||
126124701|NCT00886600|453749346|FG000|Double-blind Monotherapy|Adverse Event|1|||
126124702|NCT00886600|453749347|FG001|Double-blind Monotherapy|Adverse Event|1|||
126124703|NCT00886600|453749348|FG002|Double-blind Monotherapy|Adverse Event|1|||
126124704|NCT00886600|453749349|FG003|Double-blind Monotherapy|Adverse Event|1|||
126124705|NCT00886600|453749346|FG000|Double-blind Monotherapy|Protocol Violation|0|||
126124706|NCT00886600|453749347|FG001|Double-blind Monotherapy|Protocol Violation|0|||
126124707|NCT00886600|453749348|FG002|Double-blind Monotherapy|Protocol Violation|0|||
126124708|NCT00886600|453749349|FG003|Double-blind Monotherapy|Protocol Violation|1|||
126124709|NCT00886600|453749346|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
126124710|NCT00886600|453749347|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
126124711|NCT00886600|453749348|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
126124712|NCT00886600|453749349|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
126124713|NCT00886600|453749346|FG000|Combination Therapy Period|Adverse Event|0|||
126124714|NCT00886600|453749347|FG001|Combination Therapy Period|Adverse Event|0|||
126124715|NCT00886600|453749348|FG002|Combination Therapy Period|Adverse Event|1|||
126124716|NCT00886600|453749349|FG003|Combination Therapy Period|Adverse Event|0|||
126124717|NCT00886600|453749346|FG000|Combination Therapy Period|Protocol Violation|0|||
126124718|NCT00886600|453749347|FG001|Combination Therapy Period|Protocol Violation|0|||
126124719|NCT00886600|453749348|FG002|Combination Therapy Period|Protocol Violation|1|||
126124720|NCT00886600|453749349|FG003|Combination Therapy Period|Protocol Violation|0|||
126124721|NCT01439204|453749350|FG000|Overall Study|Withdrawal by Subject|0|||
126124722|NCT01439204|453749351|FG001|Overall Study|Withdrawal by Subject|1|||
126124723|NCT01439204|453749350|FG000|Overall Study|Lost to Follow-up|0|||
126124724|NCT01439204|453749351|FG001|Overall Study|Lost to Follow-up|2|||
126124725|NCT01439204|453749350|FG000|Overall Study|No longer meets study criteria|1|||
126124726|NCT01439204|453749351|FG001|Overall Study|No longer meets study criteria|0|||
126124727|NCT01439204|453749350|FG000|Overall Study|poor/non-compliance|3|||
126124728|NCT01439204|453749351|FG001|Overall Study|poor/non-compliance|0|||
126124729|NCT03917823|453749354|FG000|Overall Study|Lost to Follow-up|1|||
126124730|NCT03917823|453749355|FG001|Overall Study|Lost to Follow-up|1|||
126124731|NCT03917823|453749354|FG000|Overall Study|Withdrawal by Subject|0|||
126124732|NCT03917823|453749355|FG001|Overall Study|Withdrawal by Subject|1|||
126124733|NCT03775421|453749356|FG000|Overall Study|Lost to Follow-up|2|||
126124734|NCT03775421|453749356|FG000|Overall Study|Withdrawal by Subject|10|||
126124735|NCT03775421|453749356|FG000|Overall Study|Physician Decision|3|||
126124736|NCT03775421|453749356|FG000|Overall Study|Death|1|||
126124737|NCT03775421|453749356|FG000|Overall Study|Study Terminated by Sponsor|94|||
126124738|NCT00135668|453749357|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
126124739|NCT00135668|453749358|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
126124740|NCT00135668|453749359|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
126124741|NCT00135668|453749360|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
126124742|NCT00455013|453749365|FG000|Short Term Period|Adverse Event|2|||
126124743|NCT00455013|453749366|FG001|Short Term Period|Adverse Event|5|||
126124744|NCT00455013|453749367|FG002|Short Term Period|Adverse Event|0|||
126124745|NCT00455013|453749365|FG000|Short Term Period|Withdrawal by Subject|0|||
126124746|NCT00455013|453749366|FG001|Short Term Period|Withdrawal by Subject|0|||
126124747|NCT00455013|453749367|FG002|Short Term Period|Withdrawal by Subject|1|||
126124748|NCT00455013|453749365|FG000|Short Term Period|Lack of Efficacy|4|||
126124749|NCT00455013|453749366|FG001|Short Term Period|Lack of Efficacy|0|||
126124750|NCT00455013|453749367|FG002|Short Term Period|Lack of Efficacy|0|||
126124751|NCT00455013|453749365|FG000|Short Term Period|Other|0|||
126124752|NCT00455013|453749366|FG001|Short Term Period|Other|0|||
126124753|NCT00455013|453749367|FG002|Short Term Period|Other|1|||
126124754|NCT00455013|453749365|FG000|Long Term Extension (LTE)|Adverse Event|0|||
126124755|NCT00455013|453749366|FG001|Long Term Extension (LTE)|Adverse Event|1|||
126124756|NCT00455013|453749367|FG002|Long Term Extension (LTE)|Adverse Event|1|||
126124757|NCT00455013|453749365|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
126124758|NCT00455013|453749366|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
126124759|NCT00455013|453749367|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
126124760|NCT00455013|453749365|FG000|Long Term Extension (LTE)|Death|1|||
126124761|NCT00455013|453749366|FG001|Long Term Extension (LTE)|Death|1|||
126124762|NCT00455013|453749367|FG002|Long Term Extension (LTE)|Death|0|||
126124763|NCT00455013|453749365|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
126124764|NCT00455013|453749366|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
126124765|NCT00455013|453749367|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
126124766|NCT00455013|453749365|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
126124767|NCT00455013|453749366|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
126124768|NCT00455013|453749367|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
126124769|NCT00455013|453749365|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
126124770|NCT00455013|453749366|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
126124771|NCT00455013|453749367|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
126124772|NCT00455013|453749365|FG000|Long Term Extension (LTE)|non-specified|0|||
126124773|NCT00455013|453749366|FG001|Long Term Extension (LTE)|non-specified|0|||
126124774|NCT00455013|453749367|FG002|Long Term Extension (LTE)|non-specified|1|||
126124775|NCT02739620|453749370|FG000|Overall Study|Lost to Follow-up|3|||
126124776|NCT02739620|453749371|FG001|Overall Study|Lost to Follow-up|1|||
126124777|NCT02739620|453749370|FG000|Overall Study|Adverse Event|0|||
126124778|NCT02739620|453749371|FG001|Overall Study|Adverse Event|1|||
126124779|NCT00754793|453749372|FG000|Overall Study|voluntary withdrawn from study|0|||
126124780|NCT00754793|453749373|FG001|Overall Study|voluntary withdrawn from study|1|||
126124781|NCT03891264|453749379|FG000|Overall Study|Adverse Event|1|||
126124782|NCT03891264|453749379|FG000|Overall Study|Withdrawal by Subject|2|||
126124783|NCT03891264|453749379|FG000|Overall Study|Physician Decision|2|||
126124784|NCT01692275|453749380|FG000|Overall Study|Lost to Follow-up|57|||
126124785|NCT01692275|453749381|FG001|Overall Study|Lost to Follow-up|48|||
126124786|NCT01692275|453749380|FG000|Overall Study|Withdrawal by Subject|9|||
126124787|NCT01692275|453749381|FG001|Overall Study|Withdrawal by Subject|11|||
126124788|NCT01033825|453749382|FG000|Overall Study|Withdrawal by Subject|2|||
126124789|NCT01033825|453749383|FG001|Overall Study|Withdrawal by Subject|3|||
126124790|NCT01033825|453749384|FG002|Overall Study|Withdrawal by Subject|2|||
126124791|NCT01033825|453749385|FG003|Overall Study|Withdrawal by Subject|1|||
126124792|NCT01033825|453749386|FG004|Overall Study|Withdrawal by Subject|1|||
126124793|NCT01033825|453749387|FG005|Overall Study|Withdrawal by Subject|0|||
126124794|NCT01033825|453749388|FG006|Overall Study|Withdrawal by Subject|0|||
126124795|NCT01033825|453749382|FG000|Overall Study|Adverse Event|0|||
126124796|NCT01033825|453749383|FG001|Overall Study|Adverse Event|0|||
126124797|NCT01033825|453749384|FG002|Overall Study|Adverse Event|0|||
126124798|NCT01033825|453749385|FG003|Overall Study|Adverse Event|1|||
126124799|NCT01033825|453749386|FG004|Overall Study|Adverse Event|0|||
126124800|NCT01033825|453749387|FG005|Overall Study|Adverse Event|0|||
126124801|NCT01033825|453749388|FG006|Overall Study|Adverse Event|0|||
126124802|NCT01033825|453749382|FG000|Overall Study|Protocol Violation|1|||
126124803|NCT01033825|453749383|FG001|Overall Study|Protocol Violation|0|||
126124804|NCT01033825|453749384|FG002|Overall Study|Protocol Violation|0|||
126124805|NCT01033825|453749385|FG003|Overall Study|Protocol Violation|0|||
126124806|NCT01033825|453749386|FG004|Overall Study|Protocol Violation|0|||
126124807|NCT01033825|453749387|FG005|Overall Study|Protocol Violation|0|||
126124808|NCT01033825|453749388|FG006|Overall Study|Protocol Violation|0|||
126124809|NCT01033825|453749382|FG000|Overall Study|Other|0|||
126124810|NCT01033825|453749383|FG001|Overall Study|Other|0|||
126124811|NCT01033825|453749384|FG002|Overall Study|Other|0|||
126124812|NCT01033825|453749385|FG003|Overall Study|Other|0|||
126124813|NCT01033825|453749386|FG004|Overall Study|Other|1|||
126124814|NCT01033825|453749387|FG005|Overall Study|Other|0|||
126124815|NCT01033825|453749388|FG006|Overall Study|Other|0|||
126124816|NCT03077685|453749391|FG000|Overall Study|Lost to Follow-up|0|||
126124817|NCT03077685|453749392|FG001|Overall Study|Lost to Follow-up|0|||
126124818|NCT03077685|453749393|FG002|Overall Study|Lost to Follow-up|0|||
126124819|NCT03077685|453749394|FG003|Overall Study|Lost to Follow-up|0|||
126124820|NCT03077685|453749395|FG004|Overall Study|Lost to Follow-up|1|||
126124821|NCT03077685|453749391|FG000|Overall Study|Death|0|||
126124822|NCT03077685|453749392|FG001|Overall Study|Death|0|||
126124823|NCT03077685|453749393|FG002|Overall Study|Death|1|||
126124824|NCT03077685|453749394|FG003|Overall Study|Death|1|||
126124825|NCT03077685|453749395|FG004|Overall Study|Death|3|||
126124826|NCT03077685|453749391|FG000|Overall Study|Withdrawal by Subject|0|||
126124827|NCT03077685|453749392|FG001|Overall Study|Withdrawal by Subject|0|||
126124828|NCT03077685|453749393|FG002|Overall Study|Withdrawal by Subject|0|||
126124829|NCT03077685|453749394|FG003|Overall Study|Withdrawal by Subject|2|||
126124830|NCT03077685|453749395|FG004|Overall Study|Withdrawal by Subject|1|||
126124831|NCT03077685|453749391|FG000|Overall Study|Physician Decision|0|||
126124832|NCT03077685|453749392|FG001|Overall Study|Physician Decision|0|||
126124833|NCT03077685|453749393|FG002|Overall Study|Physician Decision|1|||
126124834|NCT03077685|453749394|FG003|Overall Study|Physician Decision|0|||
126124835|NCT03077685|453749395|FG004|Overall Study|Physician Decision|3|||
126124836|NCT03077685|453749391|FG000|Overall Study|Disease Progression|1|||
126124837|NCT03077685|453749392|FG001|Overall Study|Disease Progression|0|||
126124838|NCT03077685|453749393|FG002|Overall Study|Disease Progression|0|||
126124839|NCT03077685|453749394|FG003|Overall Study|Disease Progression|2|||
126124840|NCT03077685|453749395|FG004|Overall Study|Disease Progression|1|||
126124841|NCT03077685|453749391|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
126124842|NCT03077685|453749392|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
126124843|NCT03077685|453749393|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
126124844|NCT03077685|453749394|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
126124845|NCT03077685|453749395|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
126124846|NCT03077685|453749391|FG000|Overall Study|Subject entered hospice care|0|||
126124847|NCT03077685|453749392|FG001|Overall Study|Subject entered hospice care|0|||
126124848|NCT03077685|453749393|FG002|Overall Study|Subject entered hospice care|0|||
126124849|NCT03077685|453749394|FG003|Overall Study|Subject entered hospice care|0|||
126124850|NCT03077685|453749395|FG004|Overall Study|Subject entered hospice care|1|||
126124851|NCT01806779|453749400|FG000|Overall Study|Physician Decision|2|||
126124852|NCT01806779|453749401|FG001|Overall Study|Physician Decision|0|||
126124853|NCT01806779|453749402|FG002|Overall Study|Physician Decision|1|||
126124854|NCT01806779|453749400|FG000|Overall Study|Lack of Efficacy|1|||
126124855|NCT01806779|453749401|FG001|Overall Study|Lack of Efficacy|1|||
126124856|NCT01806779|453749402|FG002|Overall Study|Lack of Efficacy|0|||
126124857|NCT01806779|453749400|FG000|Overall Study|Lost to Follow-up|19|||
126124858|NCT01806779|453749401|FG001|Overall Study|Lost to Follow-up|20|||
126124859|NCT01806779|453749402|FG002|Overall Study|Lost to Follow-up|0|||
126124860|NCT01806779|453749400|FG000|Overall Study|Withdrawal by Subject|20|||
126124861|NCT01806779|453749401|FG001|Overall Study|Withdrawal by Subject|23|||
126124862|NCT01806779|453749402|FG002|Overall Study|Withdrawal by Subject|22|||
126124863|NCT04294901|453749405|FG000|Overall Study|Death|86|||
126124864|NCT04294901|453749406|FG001|Overall Study|Death|110|||
126124865|NCT04294901|453749405|FG000|Overall Study|Provider did not have historical control patients|581|||
126124866|NCT04294901|453749406|FG001|Overall Study|Provider did not have historical control patients|0|||
126124867|NCT04294901|453749405|FG000|Overall Study|Provider did not have intervention patients|0|||
126124868|NCT04294901|453749406|FG001|Overall Study|Provider did not have intervention patients|98|||
126124869|NCT03770260|453750847|FG000|Overall Study|Disease progression|0|||
126124870|NCT03770260|453750848|FG001|Overall Study|Disease progression|1|||
126124871|NCT03770260|453750849|FG002|Overall Study|Disease progression|0|||
126124872|NCT03770260|453750850|FG003|Overall Study|Disease progression|0|||
126124873|NCT04649255|453750853|FG000|Overall Study|Death|9|||
126124874|NCT04649255|453750853|FG000|Overall Study|Withdrawal by Subject|1|||
126124875|NCT00075400|453750857|FG000|Overall Study|Ineligible: wrong primary|1|||
126124876|NCT00075400|453750857|FG000|Overall Study|Never treated|2|||
125963626|NCT00575588|453157140|FG001|Overall Study|Lost to Follow-up|3|||
125963627|NCT00575588|453157139|FG000|Overall Study|Death|4|||
125963628|NCT00575588|453157140|FG001|Overall Study|Death|2|||
125963629|NCT00575588|453157139|FG000|Overall Study|Incorrect enrollment|8|||
125963630|NCT00575588|453157140|FG001|Overall Study|Incorrect enrollment|4|||
125963631|NCT00575588|453157139|FG000|Overall Study|Study specific discontinuation criteria|203|||
125963632|NCT00575588|453157140|FG001|Overall Study|Study specific discontinuation criteria|218|||
125963633|NCT00575588|453157139|FG000|Overall Study|Severe non-compliance to protocol|5|||
125963634|NCT00575588|453157140|FG001|Overall Study|Severe non-compliance to protocol|7|||
125963635|NCT00575588|453157139|FG000|Overall Study|Safety reasons|2|||
126124877|NCT01652885|453750858|FG000|Overall Study|Adverse Event|1|||
126124878|NCT00490568|453750859|FG000|Overall Study|Adverse Event|116|||
126124879|NCT00490568|453750859|FG000|Overall Study|Lost to Follow-up|13|||
126124880|NCT00490568|453750859|FG000|Overall Study|Protocol Violation|45|||
126124881|NCT00490568|453750859|FG000|Overall Study|Withdrawal by Subject|135|||
126124882|NCT00490568|453750859|FG000|Overall Study|Still in the study at termination|974|||
126124883|NCT00490568|453750859|FG000|Overall Study|Other|1|||
126124884|NCT00490568|453750859|FG000|Overall Study|Exclusion criteria met|1|||
126124885|NCT00490568|453750859|FG000|Overall Study|Caregiver related|20|||
126124886|NCT00490568|453750859|FG000|Overall Study|Abnormal ECG|25|||
125963636|NCT00575588|453157140|FG001|Overall Study|Safety reasons|1|||
125963637|NCT00575588|453157139|FG000|Overall Study|Elevated triglyceride|1|||
125963638|NCT00575588|453157140|FG001|Overall Study|Elevated triglyceride|0|||
125963639|NCT00575588|453157139|FG000|Overall Study|Patient moved|1|||
125963640|NCT00575588|453157140|FG001|Overall Study|Patient moved|3|||
125963641|NCT00575588|453157139|FG000|Overall Study|Impossible to determine HbA1c|0|||
125963642|NCT00575588|453157140|FG001|Overall Study|Impossible to determine HbA1c|1|||
125963643|NCT00614939|453157141|FG000|Overall Study|Withdrawal by Subject|10|||
125963644|NCT00614939|453157142|FG001|Overall Study|Withdrawal by Subject|17|||
125963645|NCT00614939|453157141|FG000|Overall Study|Study specific discontinuation criteris|13|||
125963646|NCT00614939|453157142|FG001|Overall Study|Study specific discontinuation criteris|16|||
125963647|NCT00614939|453157141|FG000|Overall Study|Adverse Event|2|||
125963648|NCT00614939|453157142|FG001|Overall Study|Adverse Event|5|||
125963649|NCT00614939|453157141|FG000|Overall Study|Incorrect enrollment|1|||
125963650|NCT00614939|453157142|FG001|Overall Study|Incorrect enrollment|2|||
125963651|NCT00614939|453157141|FG000|Overall Study|Death|4|||
125963652|NCT00614939|453157142|FG001|Overall Study|Death|3|||
126124887|NCT00490568|453750859|FG000|Overall Study|Participant refused follow-up|9|||
126124888|NCT00490568|453750859|FG000|Overall Study|Legal representative withdrew consent|1|||
126124889|NCT00490568|453750859|FG000|Overall Study|Disease progression|4|||
126124890|NCT00490568|453750859|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
126124891|NCT00490568|453750859|FG000|Overall Study|Investigator decision|3|||
126124892|NCT00490568|453750859|FG000|Overall Study|Non-Compliance|7|||
126124893|NCT00490568|453750859|FG000|Overall Study|Efficacy related|3|||
126124894|NCT00490568|453750859|FG000|Overall Study|Participant died|1|||
126124895|NCT00490568|453750859|FG000|Overall Study|Participant withdrawal due to surgery|1|||
126124896|NCT01395394|453750860|FG000|Baseline Study Visit|Protocol Violation|1|||
126124897|NCT01395394|453750861|FG001|Baseline Study Visit|Protocol Violation|0|||
126124898|NCT01395394|453750862|FG002|Baseline Study Visit|Protocol Violation|0|||
126124899|NCT03451773|453750865|FG000|Overall Study|Death on study|1|||
126124900|NCT03451773|453750866|FG001|Overall Study|Death on study|5|||
126124901|NCT03451773|453750865|FG000|Overall Study|Death during follow-up period|0|||
126124902|NCT03451773|453750866|FG001|Overall Study|Death during follow-up period|1|||
126124903|NCT03468855|453750867|FG000|Overall Study|Adverse Event|2|||
126124904|NCT03468855|453750867|FG000|Overall Study|Lost to Follow-up|5|||
126124905|NCT03468855|453750867|FG000|Overall Study|Withdrawal by Subject|3|||
126124906|NCT03468855|453750867|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
126124907|NCT01908101|453750868|FG000|Overall Study|Physician Decision|1|||
126124908|NCT01908101|453750868|FG000|Overall Study|Withdrawal by Subject|1|||
126124909|NCT01908101|453750868|FG000|Overall Study|Incorrect Diagnosis|2|||
126124910|NCT01908101|453750868|FG000|Overall Study|Incorrect Starting Dose|1|||
126124911|NCT01908101|453750868|FG000|Overall Study|Did not complete the first cycle|4|||
126124912|NCT00412750|453750870|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126124913|NCT00412750|453750871|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126124914|NCT00412750|453750872|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126124915|NCT00412750|453750870|FG000|Overall Study|Administrative problems|21|||
126124916|NCT00412750|453750871|FG001|Overall Study|Administrative problems|17|||
126124917|NCT00412750|453750872|FG002|Overall Study|Administrative problems|14|||
126124918|NCT00412750|453750870|FG000|Overall Study|Adverse Event|8|||
126124919|NCT00412750|453750871|FG001|Overall Study|Adverse Event|3|||
126124920|NCT00412750|453750872|FG002|Overall Study|Adverse Event|3|||
126124921|NCT00412750|453750870|FG000|Overall Study|Lost to Follow-up|1|||
126124922|NCT00412750|453750871|FG001|Overall Study|Lost to Follow-up|0|||
126124923|NCT00412750|453750872|FG002|Overall Study|Lost to Follow-up|1|||
126124924|NCT00412750|453750870|FG000|Overall Study|Withdrawal by Subject|0|||
126124925|NCT00412750|453750871|FG001|Overall Study|Withdrawal by Subject|1|||
126124926|NCT00412750|453750872|FG002|Overall Study|Withdrawal by Subject|2|||
126124927|NCT00412750|453750870|FG000|Overall Study|Lack of Efficacy|0|||
126124928|NCT00412750|453750871|FG001|Overall Study|Lack of Efficacy|0|||
126124929|NCT00412750|453750872|FG002|Overall Study|Lack of Efficacy|3|||
126124930|NCT04091087|453750873|FG000|Overall Study|Not treated|1|||
126124931|NCT04091087|453750874|FG001|Overall Study|Not treated|0|||
126124932|NCT04091087|453750873|FG000|Overall Study|Adverse Event|4|||
126124933|NCT04091087|453750874|FG001|Overall Study|Adverse Event|4|||
126124934|NCT04091087|453750873|FG000|Overall Study|Protocol Violation|0|||
125963653|NCT00614939|453157141|FG000|Overall Study|Poor/non-compliance|4|||
126124935|NCT04091087|453750874|FG001|Overall Study|Protocol Violation|1|||
126124936|NCT04091087|453750873|FG000|Overall Study|Withdrawal by Subject|5|||
125963654|NCT00614939|453157142|FG001|Overall Study|Poor/non-compliance|0|||
125963655|NCT00614939|453157141|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
125963656|NCT00614939|453157142|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
125963657|NCT00840970|453157143|FG000|Overall Study|Adverse Event|0|||
126124937|NCT04091087|453750874|FG001|Overall Study|Withdrawal by Subject|2|||
126124938|NCT03882970|453750875|FG000|Overall Study|Adverse Event|5|||
126124939|NCT03882970|453750876|FG001|Overall Study|Adverse Event|7|||
126124940|NCT03882970|453750877|FG002|Overall Study|Adverse Event|3|||
126124941|NCT03882970|453750878|FG003|Overall Study|Adverse Event|1|||
126124942|NCT03882970|453750875|FG000|Overall Study|Death|1|||
126124943|NCT03882970|453750876|FG001|Overall Study|Death|2|||
126124944|NCT03882970|453750877|FG002|Overall Study|Death|1|||
126124945|NCT03882970|453750878|FG003|Overall Study|Death|1|||
126124946|NCT03882970|453750875|FG000|Overall Study|Lost to Follow-up|8|||
126124947|NCT03882970|453750876|FG001|Overall Study|Lost to Follow-up|9|||
126124948|NCT03882970|453750877|FG002|Overall Study|Lost to Follow-up|5|||
126124949|NCT03882970|453750878|FG003|Overall Study|Lost to Follow-up|5|||
126124950|NCT03882970|453750875|FG000|Overall Study|Physician Decision|0|||
126124951|NCT03882970|453750876|FG001|Overall Study|Physician Decision|2|||
126124952|NCT03882970|453750877|FG002|Overall Study|Physician Decision|2|||
126124953|NCT03882970|453750878|FG003|Overall Study|Physician Decision|2|||
126124954|NCT03882970|453750875|FG000|Overall Study|Protocol Violation|2|||
126124955|NCT03882970|453750876|FG001|Overall Study|Protocol Violation|0|||
126124956|NCT03882970|453750877|FG002|Overall Study|Protocol Violation|0|||
126124957|NCT03882970|453750878|FG003|Overall Study|Protocol Violation|0|||
126124958|NCT03882970|453750875|FG000|Overall Study|Withdrawal by Subject|8|||
126124959|NCT03882970|453750876|FG001|Overall Study|Withdrawal by Subject|17|||
126124960|NCT03882970|453750877|FG002|Overall Study|Withdrawal by Subject|7|||
126124961|NCT03882970|453750878|FG003|Overall Study|Withdrawal by Subject|22|||
126124962|NCT03882970|453750875|FG000|Overall Study|Personal Reason|2|||
126124963|NCT03882970|453750876|FG001|Overall Study|Personal Reason|3|||
126124964|NCT03882970|453750877|FG002|Overall Study|Personal Reason|1|||
126124965|NCT03882970|453750878|FG003|Overall Study|Personal Reason|3|||
126124966|NCT02830776|453750892|FG000|Overall Study|Lost to Follow-up|1|||
126124967|NCT00607386|453750893|FG000|Overall Study|Physician Decision|1|||
126124968|NCT00440947|453750894|FG000|36-Week Induction Phase|Adverse Event|16|||
126124969|NCT00440947|453750895|FG001|36-Week Induction Phase|Adverse Event|0|||
126124970|NCT00440947|453750896|FG002|36-Week Induction Phase|Adverse Event|0|||
126124971|NCT00440947|453750897|FG003|36-Week Induction Phase|Adverse Event|0|||
126124972|NCT00440947|453750898|FG004|36-Week Induction Phase|Adverse Event|0|||
126124973|NCT00440947|453750894|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
126124974|NCT00440947|453750895|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
126124975|NCT00440947|453750896|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
126124976|NCT00440947|453750897|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
126124977|NCT00440947|453750898|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
126124978|NCT00440947|453750894|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
126124979|NCT00440947|453750895|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
126124980|NCT00440947|453750896|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
126124981|NCT00440947|453750897|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
126124982|NCT00440947|453750898|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
126124983|NCT00440947|453750894|FG000|36-Week Induction Phase|Non-compliance|10|||
126124984|NCT00440947|453750895|FG001|36-Week Induction Phase|Non-compliance|0|||
126124985|NCT00440947|453750896|FG002|36-Week Induction Phase|Non-compliance|0|||
126124986|NCT00440947|453750897|FG003|36-Week Induction Phase|Non-compliance|0|||
126124987|NCT00440947|453750898|FG004|36-Week Induction Phase|Non-compliance|0|||
126124988|NCT00440947|453750894|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
126124989|NCT00440947|453750895|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
126124990|NCT00440947|453750896|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
126124991|NCT00440947|453750897|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
126124992|NCT00440947|453750898|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
126124993|NCT00440947|453750894|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
126124994|NCT00440947|453750895|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
126124995|NCT00440947|453750896|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
126124996|NCT00440947|453750897|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
126124997|NCT00440947|453750898|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
126124998|NCT00440947|453750894|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
126124999|NCT00440947|453750895|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
126125000|NCT00440947|453750896|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
126125001|NCT00440947|453750897|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
126125002|NCT00440947|453750898|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
126125003|NCT00440947|453750894|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
126125004|NCT00440947|453750895|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
126125005|NCT00440947|453750896|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
126125006|NCT00440947|453750897|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
126125007|NCT00440947|453750898|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
126125008|NCT00440947|453750894|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
126125009|NCT00440947|453750895|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
126125010|NCT00440947|453750896|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
126125011|NCT00440947|453750897|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
126125012|NCT00440947|453750898|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
126125013|NCT00440947|453750894|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
126088085|NCT05627258|453617019|FG001|Overall Study|Subject moved from area|0|||
126088086|NCT05627258|453617020|FG002|Overall Study|Subject moved from area|1|||
126088087|NCT05627258|453617021|FG003|Overall Study|Subject moved from area|0|||
126088088|NCT05627258|453617022|FG004|Overall Study|Subject moved from area|0|||
126088089|NCT05627258|453617023|FG005|Overall Study|Subject moved from area|0|||
126088090|NCT01199068|453617026|FG000|Overall Study|Unacceptable toxicity|0|||
126088091|NCT01199068|453617027|FG001|Overall Study|Unacceptable toxicity|0|||
126088092|NCT01199068|453617028|FG002|Overall Study|Unacceptable toxicity|2|||
126088093|NCT01199068|453617026|FG000|Overall Study|Progressive disease|3|||
126088094|NCT01199068|453617027|FG001|Overall Study|Progressive disease|3|||
126088095|NCT01199068|453617028|FG002|Overall Study|Progressive disease|6|||
126088096|NCT01199068|453617026|FG000|Overall Study|Withdrawal by Subject|0|||
126088097|NCT01199068|453617027|FG001|Overall Study|Withdrawal by Subject|0|||
126088098|NCT01199068|453617028|FG002|Overall Study|Withdrawal by Subject|1|||
126088099|NCT01294397|453617029|FG000|Overall Study|Withdrawal by Subject|1|||
126088100|NCT01294397|453617029|FG000|Overall Study|Administrative Decision|1|||
126088101|NCT01250925|453617030|FG000|Overall Study|Lost to Follow-up|1|||
126088102|NCT01250925|453617031|FG001|Overall Study|Lost to Follow-up|1|||
126088103|NCT01250925|453617032|FG002|Overall Study|Lost to Follow-up|0|||
126088104|NCT01250925|453617030|FG000|Overall Study|Withdrawal by Subject|2|||
126088105|NCT01250925|453617031|FG001|Overall Study|Withdrawal by Subject|0|||
126088106|NCT01250925|453617032|FG002|Overall Study|Withdrawal by Subject|0|||
126088107|NCT01250925|453617030|FG000|Overall Study|Protocol Violation|2|||
126088108|NCT01250925|453617031|FG001|Overall Study|Protocol Violation|0|||
126088109|NCT01250925|453617032|FG002|Overall Study|Protocol Violation|0|||
126088110|NCT01250925|453617030|FG000|Overall Study|Physician Decision|0|||
126088111|NCT01250925|453617031|FG001|Overall Study|Physician Decision|2|||
126088112|NCT01250925|453617032|FG002|Overall Study|Physician Decision|1|||
126088113|NCT01250925|453617030|FG000|Overall Study|Adverse Event|0|||
126088114|NCT01250925|453617031|FG001|Overall Study|Adverse Event|0|||
126088115|NCT01250925|453617032|FG002|Overall Study|Adverse Event|1|||
126088116|NCT00678301|453617033|FG000|Overall Study|Non-compliance with study procedures|0|||
126088117|NCT00678301|453617034|FG001|Overall Study|Non-compliance with study procedures|1|||
126088118|NCT00678301|453617033|FG000|Overall Study|Adverse Event|1|||
126088119|NCT00678301|453617034|FG001|Overall Study|Adverse Event|0|||
126088120|NCT00678301|453617033|FG000|Overall Study|Withdrawal by Subject|4|||
126088121|NCT00678301|453617034|FG001|Overall Study|Withdrawal by Subject|0|||
126088122|NCT00678301|453617033|FG000|Overall Study|Lost to Follow-up|3|||
126088123|NCT00678301|453617034|FG001|Overall Study|Lost to Follow-up|1|||
126088124|NCT03338296|453617035|FG000|Overall Study|Adverse Event|0|||
126088125|NCT03338296|453617036|FG001|Overall Study|Adverse Event|1|||
126088126|NCT03338296|453617035|FG000|Overall Study|Withdrawal by Subject|14|||
126088127|NCT03338296|453617036|FG001|Overall Study|Withdrawal by Subject|13|||
126088128|NCT03338296|453617035|FG000|Overall Study|Lost to Follow-up|10|||
126088129|NCT03338296|453617036|FG001|Overall Study|Lost to Follow-up|10|||
126088130|NCT03338296|453617035|FG000|Overall Study|Study Terminated by Sponsor|77|||
126088131|NCT03338296|453617036|FG001|Overall Study|Study Terminated by Sponsor|76|||
126088132|NCT03338296|453617035|FG000|Overall Study|Other|2|||
126088133|NCT03338296|453617036|FG001|Overall Study|Other|7|||
126088134|NCT03338296|453617035|FG000|Overall Study|Missing|0|||
126088135|NCT03338296|453617036|FG001|Overall Study|Missing|1|||
126088136|NCT04421950|453617037|FG000|Overall Study|Dropped or lost to follow up|4|||
126088137|NCT04421950|453617038|FG001|Overall Study|Dropped or lost to follow up|2|||
126088138|NCT01252355|453617040|FG000|Overall Study|Adverse Event|9|||
126088139|NCT01252355|453617041|FG001|Overall Study|Adverse Event|17|||
126088140|NCT01252355|453617042|FG002|Overall Study|Adverse Event|22|||
126088141|NCT01252355|453617040|FG000|Overall Study|Lack of Efficacy|6|||
126088142|NCT01252355|453617041|FG001|Overall Study|Lack of Efficacy|4|||
126088143|NCT01252355|453617042|FG002|Overall Study|Lack of Efficacy|2|||
126088144|NCT01252355|453617040|FG000|Overall Study|Lost to Follow-up|0|||
126088145|NCT01252355|453617041|FG001|Overall Study|Lost to Follow-up|0|||
126088146|NCT01252355|453617042|FG002|Overall Study|Lost to Follow-up|1|||
126088147|NCT01252355|453617040|FG000|Overall Study|Poor Compliance to Protocol|1|||
126088148|NCT01252355|453617041|FG001|Overall Study|Poor Compliance to Protocol|1|||
126088149|NCT01252355|453617042|FG002|Overall Study|Poor Compliance to Protocol|1|||
126088150|NCT01252355|453617040|FG000|Overall Study|Progressive Disease|2|||
126088151|NCT01252355|453617041|FG001|Overall Study|Progressive Disease|0|||
126088152|NCT01252355|453617042|FG002|Overall Study|Progressive Disease|0|||
126088153|NCT01252355|453617040|FG000|Overall Study|Sponsor Early Termination of Study|149|||
126088154|NCT01252355|453617041|FG001|Overall Study|Sponsor Early Termination of Study|149|||
126088155|NCT01252355|453617042|FG002|Overall Study|Sponsor Early Termination of Study|146|||
126088156|NCT01252355|453617040|FG000|Overall Study|Randomized but not Treated|2|||
126088157|NCT01252355|453617041|FG001|Overall Study|Randomized but not Treated|0|||
126088158|NCT01252355|453617042|FG002|Overall Study|Randomized but not Treated|0|||
126088159|NCT01252355|453617040|FG000|Overall Study|Other Than Above|8|||
126088160|NCT01252355|453617041|FG001|Overall Study|Other Than Above|7|||
126088161|NCT01252355|453617042|FG002|Overall Study|Other Than Above|7|||
126088162|NCT01725126|453617043|FG000|Overall Study|Protocol Violation|0|||
126125014|NCT00440947|453750895|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
126125015|NCT00440947|453750896|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
126125016|NCT00440947|453750897|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
126125017|NCT00440947|453750898|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
126125018|NCT00440947|453750894|FG000|36-Week Induction Phase|Incarceration|3|||
126125019|NCT00440947|453750895|FG001|36-Week Induction Phase|Incarceration|0|||
126125020|NCT00440947|453750896|FG002|36-Week Induction Phase|Incarceration|0|||
126125021|NCT00440947|453750897|FG003|36-Week Induction Phase|Incarceration|0|||
126125022|NCT00440947|453750898|FG004|36-Week Induction Phase|Incarceration|0|||
126125023|NCT00440947|453750894|FG000|36-Week Induction Phase|Pregnancy|1|||
126125024|NCT00440947|453750895|FG001|36-Week Induction Phase|Pregnancy|0|||
126125025|NCT00440947|453750896|FG002|36-Week Induction Phase|Pregnancy|0|||
126125026|NCT00440947|453750897|FG003|36-Week Induction Phase|Pregnancy|0|||
126125027|NCT00440947|453750898|FG004|36-Week Induction Phase|Pregnancy|0|||
126125028|NCT00440947|453750894|FG000|48-Week Randomization Phase|Adverse Event|0|||
126125029|NCT00440947|453750895|FG001|48-Week Randomization Phase|Adverse Event|2|||
126125030|NCT00440947|453750896|FG002|48-Week Randomization Phase|Adverse Event|5|||
126125031|NCT00440947|453750897|FG003|48-Week Randomization Phase|Adverse Event|0|||
126125032|NCT00440947|453750898|FG004|48-Week Randomization Phase|Adverse Event|0|||
126125033|NCT00440947|453750894|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
126125034|NCT00440947|453750895|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
126125035|NCT00440947|453750896|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
126125036|NCT00440947|453750897|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
126125037|NCT00440947|453750898|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
126125038|NCT00440947|453750894|FG000|48-Week Randomization Phase|Non-compliance|0|||
126125039|NCT00440947|453750895|FG001|48-Week Randomization Phase|Non-compliance|3|||
126125040|NCT00440947|453750896|FG002|48-Week Randomization Phase|Non-compliance|4|||
126125041|NCT00440947|453750897|FG003|48-Week Randomization Phase|Non-compliance|0|||
126125042|NCT00440947|453750898|FG004|48-Week Randomization Phase|Non-compliance|0|||
126125043|NCT00440947|453750894|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
126125044|NCT00440947|453750895|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
126125045|NCT00440947|453750896|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
126125046|NCT00440947|453750897|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
126125047|NCT00440947|453750898|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
126125048|NCT00440947|453750894|FG000|48-Week Randomization Phase|Protocol Violation|0|||
126125049|NCT00440947|453750895|FG001|48-Week Randomization Phase|Protocol Violation|0|||
126125050|NCT00440947|453750896|FG002|48-Week Randomization Phase|Protocol Violation|1|||
126125051|NCT00440947|453750897|FG003|48-Week Randomization Phase|Protocol Violation|0|||
126125052|NCT00440947|453750898|FG004|48-Week Randomization Phase|Protocol Violation|0|||
126125053|NCT00440947|453750894|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
126125054|NCT00440947|453750895|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
126125055|NCT00440947|453750896|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
126125056|NCT00440947|453750897|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
126125057|NCT00440947|453750898|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
126125058|NCT00440947|453750894|FG000|48-Week Randomization Phase|Pregnancy|0|||
126125059|NCT00440947|453750895|FG001|48-Week Randomization Phase|Pregnancy|0|||
126125060|NCT00440947|453750896|FG002|48-Week Randomization Phase|Pregnancy|1|||
126125061|NCT00440947|453750897|FG003|48-Week Randomization Phase|Pregnancy|0|||
126125062|NCT00440947|453750898|FG004|48-Week Randomization Phase|Pregnancy|0|||
126125063|NCT00440947|453750894|FG000|48-Week Randomization Phase|Incarceration|0|||
126125064|NCT00440947|453750895|FG001|48-Week Randomization Phase|Incarceration|3|||
126125065|NCT00440947|453750896|FG002|48-Week Randomization Phase|Incarceration|0|||
126125066|NCT00440947|453750897|FG003|48-Week Randomization Phase|Incarceration|0|||
126125067|NCT00440947|453750898|FG004|48-Week Randomization Phase|Incarceration|0|||
126125068|NCT00440947|453750894|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
126125069|NCT00440947|453750895|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
126125070|NCT00440947|453750896|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
126125071|NCT00440947|453750897|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
126125072|NCT00440947|453750898|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
126125073|NCT00440947|453750894|FG000|48-Week Randomization Phase|Physician Decision|0|||
126125074|NCT00440947|453750895|FG001|48-Week Randomization Phase|Physician Decision|2|||
126125075|NCT00440947|453750896|FG002|48-Week Randomization Phase|Physician Decision|0|||
126125076|NCT00440947|453750897|FG003|48-Week Randomization Phase|Physician Decision|0|||
126125077|NCT00440947|453750898|FG004|48-Week Randomization Phase|Physician Decision|0|||
126125078|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
126125079|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
126125080|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
126125081|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
126125082|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
126125083|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
126125084|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
126125085|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
126125086|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
126125087|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
126125088|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
126125089|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
126125090|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
126125091|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
126125092|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
126125093|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
126125094|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
126125095|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
126125096|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
126125097|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
126125098|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
126125099|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
126125100|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
126125101|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
126125102|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
126125103|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
126125104|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
126125105|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
126125106|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
126125107|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
126125108|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
126125109|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
126125110|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
126125111|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
126125112|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
126125113|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
126125114|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
126125115|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
126125116|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
126125117|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
126125118|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
126125119|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
126125120|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
126125121|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
126125122|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
126125123|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
126125124|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
126125125|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
126125126|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
126125127|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
126125128|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
126125129|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
126125130|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
126125131|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
126125132|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
126125133|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Other|0|||
126125134|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Other|0|||
126125135|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Other|0|||
126125136|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Other|1|||
126125137|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Other|0|||
126125138|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
126125139|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
126125140|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
126125141|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
126125142|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
126125143|NCT00440947|453750894|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
126125144|NCT00440947|453750895|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
126125145|NCT00440947|453750896|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
126125146|NCT00440947|453750897|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
126125147|NCT00440947|453750898|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
126125148|NCT02716987|453750899|FG000|Overall Study|Ligand synthesis failure|0|||
126125149|NCT02716987|453750900|FG001|Overall Study|Ligand synthesis failure|0|||
126125150|NCT02716987|453750901|FG002|Overall Study|Ligand synthesis failure|1|||
126125151|NCT02716987|453750902|FG003|Overall Study|Ligand synthesis failure|0|||
126125152|NCT02716987|453750903|FG004|Overall Study|Ligand synthesis failure|0|||
126125153|NCT02716987|453750904|FG005|Overall Study|Ligand synthesis failure|0|||
126125154|NCT02716987|453750899|FG000|Overall Study|Withdrawal by Subject|0|||
126125155|NCT02716987|453750900|FG001|Overall Study|Withdrawal by Subject|0|||
126125156|NCT02716987|453750901|FG002|Overall Study|Withdrawal by Subject|0|||
126125157|NCT02716987|453750902|FG003|Overall Study|Withdrawal by Subject|0|||
126125158|NCT02716987|453750903|FG004|Overall Study|Withdrawal by Subject|1|||
126125159|NCT02716987|453750904|FG005|Overall Study|Withdrawal by Subject|1|||
126125160|NCT03223428|453750908|FG000|Overall Study|No longer taking Xermelo|27|||
126125161|NCT03223428|453750908|FG000|Overall Study|Declined Consent|1|||
126125162|NCT03223428|453750908|FG000|Overall Study|Non-responders|56|||
126125163|NCT03223428|453750908|FG000|Overall Study|Withdrawal by Subject|14|||
126125164|NCT01834274|453750909|FG000|Overall Study|Study Termination|41|||
126125165|NCT01834274|453750910|FG001|Overall Study|Study Termination|38|||
126125166|NCT01834274|453750909|FG000|Overall Study|Withdrawal by Subject|1|||
126125167|NCT01834274|453750910|FG001|Overall Study|Withdrawal by Subject|1|||
126125168|NCT01834274|453750909|FG000|Overall Study|Lost to Follow-up|3|||
126125169|NCT01834274|453750910|FG001|Overall Study|Lost to Follow-up|1|||
126125170|NCT01834274|453750909|FG000|Overall Study|Other|2|||
126125171|NCT01834274|453750910|FG001|Overall Study|Other|1|||
126125172|NCT01265797|453750919|FG000|Run-in Month|Withdrawal by Subject|0|||
126125173|NCT01265797|453750920|FG001|Run-in Month|Withdrawal by Subject|4|||
126125174|NCT01265797|453750919|FG000|Run-in Month|1st seizure during run-in month|0|||
126125175|NCT01265797|453750920|FG001|Run-in Month|1st seizure during run-in month|1|||
126125176|NCT01265797|453750919|FG000|Blinded Month|Lack of Efficacy|5|||
126125177|NCT01265797|453750920|FG001|Blinded Month|Lack of Efficacy|0|||
126125178|NCT01265797|453750919|FG000|Blinded Month|Lost to Follow-up|1|||
126125179|NCT01265797|453750920|FG001|Blinded Month|Lost to Follow-up|0|||
126125180|NCT01265797|453750919|FG000|Blinded Month|Protocol Violation|2|||
126125181|NCT01265797|453750920|FG001|Blinded Month|Protocol Violation|1|||
126125182|NCT01265797|453750919|FG000|Blinded Month|Adverse Event|2|||
126125183|NCT01265797|453750920|FG001|Blinded Month|Adverse Event|0|||
126125184|NCT01265797|453750919|FG000|Blinded Month|Diary data incomplete|0|||
126125185|NCT01265797|453750920|FG001|Blinded Month|Diary data incomplete|1|||
126125186|NCT01265797|453750919|FG000|Open Label Month|Lost to Follow-up|0|||
126125187|NCT01265797|453750920|FG001|Open Label Month|Lost to Follow-up|1|||
126125188|NCT02813694|453750921|FG000|Overall Study|Physician Decision|0|||
126125189|NCT02813694|453750922|FG001|Overall Study|Physician Decision|1|||
126125190|NCT02813694|453750921|FG000|Overall Study|Withdrawal by Subject|10|||
126125191|NCT02813694|453750922|FG001|Overall Study|Withdrawal by Subject|9|||
126125192|NCT02813694|453750921|FG000|Overall Study|Lost to Follow-up|1|||
126125193|NCT02813694|453750922|FG001|Overall Study|Lost to Follow-up|1|||
126125194|NCT02813694|453750921|FG000|Overall Study|Death|3|||
126125195|NCT02813694|453750922|FG001|Overall Study|Death|3|||
126125196|NCT02813694|453750921|FG000|Overall Study|Randomized- did not receive study drug|2|||
126125197|NCT02813694|453750922|FG001|Overall Study|Randomized- did not receive study drug|0|||
126125198|NCT02813694|453750921|FG000|Overall Study|Patient hospitalized|1|||
126125199|NCT02813694|453750922|FG001|Overall Study|Patient hospitalized|0|||
126125200|NCT02980224|453750925|FG000|Overall Study|Adverse Event|4|||
126125201|NCT02980224|453750926|FG001|Overall Study|Adverse Event|1|||
126125202|NCT02980224|453750925|FG000|Overall Study|Withdrawal by Subject|0|||
126125203|NCT02980224|453750926|FG001|Overall Study|Withdrawal by Subject|2|||
126125204|NCT00606320|453750927|FG000|Overall Study|Adverse Event|3|||
126125205|NCT00606320|453750927|FG000|Overall Study|Lack of Efficacy|5|||
126125206|NCT00606320|453750927|FG000|Overall Study|Physician Decision|7|||
126125207|NCT00606320|453750927|FG000|Overall Study|Protocol Violation|8|||
126125208|NCT00606320|453750927|FG000|Overall Study|Withdrawal by Subject|10|||
126125209|NCT00606320|453750927|FG000|Overall Study|Progression to depressive phase|4|||
126125210|NCT04839380|453750928|FG000|Overall Study|Withdrawal by Subject|2|||
126125211|NCT04839380|453750928|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
125963658|NCT00840970|453157144|FG001|Overall Study|Adverse Event|0|||
125963659|NCT00840970|453157145|FG002|Overall Study|Adverse Event|1|||
125963660|NCT00504829|453157146|FG000|Overall Study|Protocol Violation|6|||
125963661|NCT00504829|453157147|FG001|Overall Study|Protocol Violation|4|||
126125212|NCT01087905|453750929|FG000|Overall Study|Lost to Follow-up|24|||
126125213|NCT01087905|453750930|FG001|Overall Study|Lost to Follow-up|28|||
126125214|NCT01087905|453750931|FG002|Overall Study|Lost to Follow-up|18|||
126125215|NCT01087905|453750932|FG003|Overall Study|Lost to Follow-up|31|||
126125216|NCT01087905|453750933|FG004|Overall Study|Lost to Follow-up|27|||
126125217|NCT01087905|453750934|FG005|Overall Study|Lost to Follow-up|25|||
126125218|NCT01087905|453750935|FG006|Overall Study|Lost to Follow-up|20|||
126125219|NCT01087905|453750936|FG007|Overall Study|Lost to Follow-up|24|||
126125220|NCT01087905|453750929|FG000|Overall Study|Withdrawal by Subject|5|||
126125221|NCT01087905|453750930|FG001|Overall Study|Withdrawal by Subject|4|||
126125222|NCT01087905|453750931|FG002|Overall Study|Withdrawal by Subject|4|||
126125223|NCT01087905|453750932|FG003|Overall Study|Withdrawal by Subject|5|||
126125224|NCT01087905|453750933|FG004|Overall Study|Withdrawal by Subject|4|||
126125225|NCT01087905|453750934|FG005|Overall Study|Withdrawal by Subject|3|||
126125226|NCT01087905|453750935|FG006|Overall Study|Withdrawal by Subject|3|||
126125227|NCT01087905|453750936|FG007|Overall Study|Withdrawal by Subject|5|||
126125228|NCT01347554|453750937|FG000|Overall Study|Lack of Efficacy|7|||
126125229|NCT01347554|453750938|FG001|Overall Study|Lack of Efficacy|11|||
126125230|NCT02937818|453750942|FG000|Overall Study|Participants decision|2|||
126125231|NCT02937818|453750943|FG001|Overall Study|Participants decision|1|||
126125232|NCT02937818|453750944|FG002|Overall Study|Participants decision|1|||
126125233|NCT02937818|453750945|FG003|Overall Study|Participants decision|1|||
126125234|NCT02937818|453750942|FG000|Overall Study|Adverse Event|2|||
125963662|NCT00504829|453157148|FG002|Overall Study|Protocol Violation|10|||
125963663|NCT01854827|453157149|FG000|Overall Study|Death|1|||
125963664|NCT02571452|453157150|FG000|Overall Study Treatment|Protocol Violation|0|||
125963665|NCT02571452|453157151|FG001|Overall Study Treatment|Protocol Violation|1|||
125963666|NCT02571452|453157150|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
125963667|NCT02571452|453157151|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
125963668|NCT02571452|453157150|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
125963669|NCT02571452|453157151|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
126125235|NCT02937818|453750943|FG001|Overall Study|Adverse Event|4|||
126125236|NCT02937818|453750944|FG002|Overall Study|Adverse Event|1|||
126125237|NCT02937818|453750945|FG003|Overall Study|Adverse Event|1|||
126125238|NCT02937818|453750942|FG000|Overall Study|Disease progression|17|||
126125239|NCT02937818|453750943|FG001|Overall Study|Disease progression|15|||
126125240|NCT02937818|453750944|FG002|Overall Study|Disease progression|7|||
126125241|NCT02937818|453750945|FG003|Overall Study|Disease progression|19|||
126125242|NCT02937818|453750942|FG000|Overall Study|Condition under investigation worsened|0|||
126125243|NCT02937818|453750943|FG001|Overall Study|Condition under investigation worsened|0|||
126125244|NCT02937818|453750944|FG002|Overall Study|Condition under investigation worsened|1|||
126125245|NCT02937818|453750945|FG003|Overall Study|Condition under investigation worsened|0|||
126125246|NCT00205855|453750946|FG000|Overall Study|Only received temporary implants|16|||
126125247|NCT00205855|453750946|FG000|Overall Study|Withdrawal by Subject|5|||
126125248|NCT01015768|453750948|FG000|Overall Study|Some subject data unuseable|4|||
126125249|NCT01015768|453750949|FG001|Overall Study|Some subject data unuseable|4|||
126125250|NCT02943564|453750950|FG000|Overall Study|Miscellaneous Reasons|0|||
126125251|NCT02943564|453750951|FG001|Overall Study|Miscellaneous Reasons|0|||
126125252|NCT02943564|453750952|FG002|Overall Study|Miscellaneous Reasons|3|||
126125253|NCT02943564|453750950|FG000|Overall Study|Site terminated by sponsor|0|||
126125254|NCT02943564|453750951|FG001|Overall Study|Site terminated by sponsor|1|||
126125255|NCT02943564|453750952|FG002|Overall Study|Site terminated by sponsor|0|||
126125256|NCT02943564|453750950|FG000|Overall Study|Non-compliance with study drug|0|||
126125257|NCT02943564|453750951|FG001|Overall Study|Non-compliance with study drug|1|||
126125258|NCT02943564|453750952|FG002|Overall Study|Non-compliance with study drug|0|||
126125259|NCT02943564|453750950|FG000|Overall Study|Pregnancy|0|||
126125260|NCT02943564|453750951|FG001|Overall Study|Pregnancy|1|||
126125261|NCT02943564|453750952|FG002|Overall Study|Pregnancy|1|||
126125262|NCT02943564|453750950|FG000|Overall Study|Protocol Violation|2|||
126125263|NCT02943564|453750951|FG001|Overall Study|Protocol Violation|2|||
126125264|NCT02943564|453750952|FG002|Overall Study|Protocol Violation|2|||
126125265|NCT02943564|453750950|FG000|Overall Study|Lost to Follow-up|1|||
126125266|NCT02943564|453750951|FG001|Overall Study|Lost to Follow-up|0|||
126125267|NCT02943564|453750952|FG002|Overall Study|Lost to Follow-up|0|||
126125268|NCT02943564|453750950|FG000|Overall Study|Withdrawal by Subject|6|||
126125269|NCT02943564|453750951|FG001|Overall Study|Withdrawal by Subject|5|||
126125270|NCT02943564|453750952|FG002|Overall Study|Withdrawal by Subject|2|||
126125271|NCT02943564|453750950|FG000|Overall Study|Adverse Event|1|||
126125272|NCT02943564|453750951|FG001|Overall Study|Adverse Event|2|||
126125273|NCT02943564|453750952|FG002|Overall Study|Adverse Event|1|||
126125274|NCT02943564|453750950|FG000|Overall Study|Lack of Efficacy|0|||
126125275|NCT02943564|453750951|FG001|Overall Study|Lack of Efficacy|1|||
126125276|NCT02943564|453750952|FG002|Overall Study|Lack of Efficacy|0|||
126125277|NCT01073267|453750955|FG000|Overall Study|Disease Progression|3|||
126125278|NCT01225731|453750956|FG000|Part 1|Did not meet eligibility criteria|1|||
126125279|NCT01225731|453750957|FG001|Part 1|Did not meet eligibility criteria|0|||
125963670|NCT04796610|453157152|FG000|Overall Study|Withdrawal by Subject|1|||
125963671|NCT04796610|453157153|FG001|Overall Study|Withdrawal by Subject|0|||
125963672|NCT04796610|453157154|FG002|Overall Study|Withdrawal by Subject|0|||
125963673|NCT04796610|453157155|FG003|Overall Study|Withdrawal by Subject|0|||
125963674|NCT04796610|453157152|FG000|Overall Study|Lost to Follow-up|2|||
125963675|NCT04796610|453157153|FG001|Overall Study|Lost to Follow-up|0|||
126125280|NCT01225731|453750958|FG002|Part 1|Did not meet eligibility criteria|0|||
126125281|NCT01225731|453750959|FG003|Part 1|Did not meet eligibility criteria|0|||
126125282|NCT01225731|453750960|FG004|Part 1|Did not meet eligibility criteria|1|||
126125283|NCT01225731|453750961|FG005|Part 1|Did not meet eligibility criteria|0|||
126125284|NCT01225731|453750962|FG006|Part 1|Did not meet eligibility criteria|0|||
126125285|NCT01225731|453750963|FG007|Part 1|Did not meet eligibility criteria|0|||
126125286|NCT01225731|453750964|FG008|Part 1|Did not meet eligibility criteria|0|||
126125287|NCT01225731|453750965|FG009|Part 1|Did not meet eligibility criteria|0|||
126125288|NCT01225731|453750966|FG010|Part 1|Did not meet eligibility criteria|0|||
126125289|NCT01225731|453750967|FG011|Part 1|Did not meet eligibility criteria|0|||
126125290|NCT01225731|453750968|FG012|Part 1|Did not meet eligibility criteria|0|||
126125291|NCT01225731|453750956|FG000|Part 1|Adverse Event|1|||
126125292|NCT01225731|453750957|FG001|Part 1|Adverse Event|2|||
126125293|NCT01225731|453750958|FG002|Part 1|Adverse Event|1|||
126125294|NCT01225731|453750959|FG003|Part 1|Adverse Event|1|||
126125295|NCT01225731|453750960|FG004|Part 1|Adverse Event|1|||
126125296|NCT01225731|453750961|FG005|Part 1|Adverse Event|0|||
126125297|NCT01225731|453750962|FG006|Part 1|Adverse Event|0|||
126125298|NCT01225731|453750963|FG007|Part 1|Adverse Event|0|||
126125299|NCT01225731|453750964|FG008|Part 1|Adverse Event|0|||
126125300|NCT01225731|453750965|FG009|Part 1|Adverse Event|0|||
126125301|NCT01225731|453750966|FG010|Part 1|Adverse Event|0|||
126125302|NCT01225731|453750967|FG011|Part 1|Adverse Event|0|||
126125303|NCT01225731|453750968|FG012|Part 1|Adverse Event|0|||
126125304|NCT01225731|453750956|FG000|Part 1|Withdrawal by Subject|0|||
126125305|NCT01225731|453750957|FG001|Part 1|Withdrawal by Subject|3|||
126125306|NCT01225731|453750958|FG002|Part 1|Withdrawal by Subject|0|||
126125307|NCT01225731|453750959|FG003|Part 1|Withdrawal by Subject|0|||
126125308|NCT01225731|453750960|FG004|Part 1|Withdrawal by Subject|4|||
126125309|NCT01225731|453750961|FG005|Part 1|Withdrawal by Subject|0|||
126125310|NCT01225731|453750962|FG006|Part 1|Withdrawal by Subject|0|||
126125311|NCT01225731|453750963|FG007|Part 1|Withdrawal by Subject|0|||
126125312|NCT01225731|453750964|FG008|Part 1|Withdrawal by Subject|0|||
126125313|NCT01225731|453750965|FG009|Part 1|Withdrawal by Subject|0|||
126125314|NCT01225731|453750966|FG010|Part 1|Withdrawal by Subject|0|||
126125315|NCT01225731|453750967|FG011|Part 1|Withdrawal by Subject|0|||
126125316|NCT01225731|453750968|FG012|Part 1|Withdrawal by Subject|0|||
126125317|NCT01225731|453750956|FG000|Part 1|Protocol Violation|0|||
126125318|NCT01225731|453750957|FG001|Part 1|Protocol Violation|0|||
126125319|NCT01225731|453750958|FG002|Part 1|Protocol Violation|0|||
126125320|NCT01225731|453750959|FG003|Part 1|Protocol Violation|1|||
126125321|NCT01225731|453750960|FG004|Part 1|Protocol Violation|0|||
126125322|NCT01225731|453750961|FG005|Part 1|Protocol Violation|0|||
126125323|NCT01225731|453750962|FG006|Part 1|Protocol Violation|0|||
126125324|NCT01225731|453750963|FG007|Part 1|Protocol Violation|0|||
126125325|NCT01225731|453750964|FG008|Part 1|Protocol Violation|0|||
126125326|NCT01225731|453750965|FG009|Part 1|Protocol Violation|0|||
126125327|NCT01225731|453750966|FG010|Part 1|Protocol Violation|0|||
126125328|NCT01225731|453750967|FG011|Part 1|Protocol Violation|0|||
126125329|NCT01225731|453750968|FG012|Part 1|Protocol Violation|0|||
126125330|NCT01225731|453750956|FG000|Part 2|Protocol Violation|0|||
126125331|NCT01225731|453750957|FG001|Part 2|Protocol Violation|0|||
126125332|NCT01225731|453750958|FG002|Part 2|Protocol Violation|0|||
126125333|NCT01225731|453750959|FG003|Part 2|Protocol Violation|0|||
126125334|NCT01225731|453750960|FG004|Part 2|Protocol Violation|0|||
126125335|NCT01225731|453750961|FG005|Part 2|Protocol Violation|1|||
126125336|NCT01225731|453750962|FG006|Part 2|Protocol Violation|0|||
126125337|NCT01225731|453750963|FG007|Part 2|Protocol Violation|0|||
126125338|NCT01225731|453750964|FG008|Part 2|Protocol Violation|1|||
126125339|NCT01225731|453750965|FG009|Part 2|Protocol Violation|0|||
126125340|NCT01225731|453750966|FG010|Part 2|Protocol Violation|0|||
126125341|NCT01225731|453750967|FG011|Part 2|Protocol Violation|0|||
126125342|NCT01225731|453750968|FG012|Part 2|Protocol Violation|0|||
126125343|NCT01225731|453750956|FG000|Part 2|Adverse Event|0|||
126125344|NCT01225731|453750957|FG001|Part 2|Adverse Event|0|||
126125345|NCT01225731|453750958|FG002|Part 2|Adverse Event|0|||
126125346|NCT01225731|453750959|FG003|Part 2|Adverse Event|0|||
126125347|NCT01225731|453750960|FG004|Part 2|Adverse Event|0|||
126125348|NCT01225731|453750961|FG005|Part 2|Adverse Event|0|||
126125349|NCT01225731|453750962|FG006|Part 2|Adverse Event|4|||
126125350|NCT01225731|453750963|FG007|Part 2|Adverse Event|4|||
125963676|NCT04796610|453157154|FG002|Overall Study|Lost to Follow-up|1|||
125963677|NCT04796610|453157155|FG003|Overall Study|Lost to Follow-up|1|||
125963678|NCT02059148|453157156|FG000|Treatment 1|Protocol Violation|0|||
126125351|NCT01225731|453750964|FG008|Part 2|Adverse Event|2|||
126125352|NCT01225731|453750965|FG009|Part 2|Adverse Event|0|||
126125353|NCT01225731|453750966|FG010|Part 2|Adverse Event|0|||
126125354|NCT01225731|453750967|FG011|Part 2|Adverse Event|0|||
126125355|NCT01225731|453750968|FG012|Part 2|Adverse Event|0|||
126125356|NCT01225731|453750956|FG000|Part 2|Lack of Efficacy|0|||
126125357|NCT01225731|453750957|FG001|Part 2|Lack of Efficacy|0|||
126125358|NCT01225731|453750958|FG002|Part 2|Lack of Efficacy|0|||
126125359|NCT01225731|453750959|FG003|Part 2|Lack of Efficacy|0|||
126125360|NCT01225731|453750960|FG004|Part 2|Lack of Efficacy|0|||
126125361|NCT01225731|453750961|FG005|Part 2|Lack of Efficacy|1|||
126125362|NCT01225731|453750962|FG006|Part 2|Lack of Efficacy|0|||
126125363|NCT01225731|453750963|FG007|Part 2|Lack of Efficacy|12|||
126125364|NCT01225731|453750964|FG008|Part 2|Lack of Efficacy|3|||
126125365|NCT01225731|453750965|FG009|Part 2|Lack of Efficacy|0|||
126125366|NCT01225731|453750966|FG010|Part 2|Lack of Efficacy|0|||
126125367|NCT01225731|453750967|FG011|Part 2|Lack of Efficacy|0|||
126125368|NCT01225731|453750968|FG012|Part 2|Lack of Efficacy|0|||
126125369|NCT01225731|453750956|FG000|Part 2|Pregnancy|0|||
126125370|NCT01225731|453750957|FG001|Part 2|Pregnancy|0|||
126125371|NCT01225731|453750958|FG002|Part 2|Pregnancy|0|||
126125372|NCT01225731|453750959|FG003|Part 2|Pregnancy|0|||
126125373|NCT01225731|453750960|FG004|Part 2|Pregnancy|0|||
126125374|NCT01225731|453750961|FG005|Part 2|Pregnancy|0|||
126125375|NCT01225731|453750962|FG006|Part 2|Pregnancy|1|||
126125376|NCT01225731|453750963|FG007|Part 2|Pregnancy|0|||
126125377|NCT01225731|453750964|FG008|Part 2|Pregnancy|1|||
126125378|NCT01225731|453750965|FG009|Part 2|Pregnancy|0|||
126125379|NCT01225731|453750966|FG010|Part 2|Pregnancy|0|||
126125380|NCT01225731|453750967|FG011|Part 2|Pregnancy|0|||
126125381|NCT01225731|453750968|FG012|Part 2|Pregnancy|0|||
126125382|NCT01225731|453750956|FG000|Part 2|Lost to Follow-up|0|||
126125383|NCT01225731|453750957|FG001|Part 2|Lost to Follow-up|0|||
126125384|NCT01225731|453750958|FG002|Part 2|Lost to Follow-up|0|||
126125385|NCT01225731|453750959|FG003|Part 2|Lost to Follow-up|0|||
126125386|NCT01225731|453750960|FG004|Part 2|Lost to Follow-up|0|||
126125387|NCT01225731|453750961|FG005|Part 2|Lost to Follow-up|0|||
126125388|NCT01225731|453750962|FG006|Part 2|Lost to Follow-up|0|||
126125389|NCT01225731|453750963|FG007|Part 2|Lost to Follow-up|3|||
126125390|NCT01225731|453750964|FG008|Part 2|Lost to Follow-up|1|||
126125391|NCT01225731|453750965|FG009|Part 2|Lost to Follow-up|0|||
126125392|NCT01225731|453750966|FG010|Part 2|Lost to Follow-up|0|||
126125393|NCT01225731|453750967|FG011|Part 2|Lost to Follow-up|0|||
126125394|NCT01225731|453750968|FG012|Part 2|Lost to Follow-up|0|||
126125395|NCT01225731|453750956|FG000|Part 2|Physician Decision|0|||
126125396|NCT01225731|453750957|FG001|Part 2|Physician Decision|0|||
126125397|NCT01225731|453750958|FG002|Part 2|Physician Decision|0|||
126125398|NCT01225731|453750959|FG003|Part 2|Physician Decision|0|||
126125399|NCT01225731|453750960|FG004|Part 2|Physician Decision|0|||
126125400|NCT01225731|453750961|FG005|Part 2|Physician Decision|0|||
126125401|NCT01225731|453750962|FG006|Part 2|Physician Decision|0|||
126125402|NCT01225731|453750963|FG007|Part 2|Physician Decision|2|||
126125403|NCT01225731|453750964|FG008|Part 2|Physician Decision|2|||
126125404|NCT01225731|453750965|FG009|Part 2|Physician Decision|0|||
126125405|NCT01225731|453750966|FG010|Part 2|Physician Decision|0|||
126125406|NCT01225731|453750967|FG011|Part 2|Physician Decision|0|||
126125407|NCT01225731|453750968|FG012|Part 2|Physician Decision|0|||
126125408|NCT01225731|453750956|FG000|Part 2|Withdrawal by Subject|0|||
126125409|NCT01225731|453750957|FG001|Part 2|Withdrawal by Subject|0|||
126125410|NCT01225731|453750958|FG002|Part 2|Withdrawal by Subject|0|||
126125411|NCT01225731|453750959|FG003|Part 2|Withdrawal by Subject|0|||
126125412|NCT01225731|453750960|FG004|Part 2|Withdrawal by Subject|0|||
126125413|NCT01225731|453750961|FG005|Part 2|Withdrawal by Subject|1|||
126125414|NCT01225731|453750962|FG006|Part 2|Withdrawal by Subject|3|||
126125415|NCT01225731|453750963|FG007|Part 2|Withdrawal by Subject|4|||
126125416|NCT01225731|453750964|FG008|Part 2|Withdrawal by Subject|1|||
126125417|NCT01225731|453750965|FG009|Part 2|Withdrawal by Subject|0|||
126125418|NCT01225731|453750966|FG010|Part 2|Withdrawal by Subject|0|||
126125419|NCT01225731|453750967|FG011|Part 2|Withdrawal by Subject|0|||
126125420|NCT01225731|453750968|FG012|Part 2|Withdrawal by Subject|0|||
126125421|NCT01225731|453750956|FG000|Part 3|Adverse Event|0|||
126125422|NCT01225731|453750957|FG001|Part 3|Adverse Event|0|||
126125423|NCT01225731|453750958|FG002|Part 3|Adverse Event|0|||
126125424|NCT01225731|453750959|FG003|Part 3|Adverse Event|0|||
126125425|NCT01225731|453750960|FG004|Part 3|Adverse Event|0|||
126125426|NCT01225731|453750961|FG005|Part 3|Adverse Event|0|||
126125427|NCT01225731|453750962|FG006|Part 3|Adverse Event|0|||
126125428|NCT01225731|453750963|FG007|Part 3|Adverse Event|0|||
126125429|NCT01225731|453750964|FG008|Part 3|Adverse Event|0|||
126125430|NCT01225731|453750965|FG009|Part 3|Adverse Event|0|||
126125431|NCT01225731|453750966|FG010|Part 3|Adverse Event|1|||
125963679|NCT02059148|453157157|FG001|Treatment 1|Protocol Violation|0|||
125963680|NCT02059148|453157158|FG002|Treatment 1|Protocol Violation|0|||
125963681|NCT02059148|453157159|FG003|Treatment 1|Protocol Violation|0|||
125963682|NCT02059148|453157160|FG004|Treatment 1|Protocol Violation|0|||
125963683|NCT02059148|453157161|FG005|Treatment 1|Protocol Violation|1|||
125963684|NCT00403546|453157167|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
125963685|NCT00403546|453157168|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
126125432|NCT01225731|453750967|FG011|Part 3|Adverse Event|1|||
126125433|NCT01225731|453750968|FG012|Part 3|Adverse Event|0|||
126125434|NCT01225731|453750956|FG000|Part 3|Lost to Follow-up|0|||
126125435|NCT01225731|453750957|FG001|Part 3|Lost to Follow-up|0|||
126125436|NCT01225731|453750958|FG002|Part 3|Lost to Follow-up|0|||
126125437|NCT01225731|453750959|FG003|Part 3|Lost to Follow-up|0|||
126125438|NCT01225731|453750960|FG004|Part 3|Lost to Follow-up|0|||
126125439|NCT01225731|453750961|FG005|Part 3|Lost to Follow-up|0|||
126125440|NCT01225731|453750962|FG006|Part 3|Lost to Follow-up|0|||
126125441|NCT01225731|453750963|FG007|Part 3|Lost to Follow-up|0|||
126125442|NCT01225731|453750964|FG008|Part 3|Lost to Follow-up|0|||
126125443|NCT01225731|453750965|FG009|Part 3|Lost to Follow-up|0|||
126125444|NCT01225731|453750966|FG010|Part 3|Lost to Follow-up|1|||
126125445|NCT01225731|453750967|FG011|Part 3|Lost to Follow-up|2|||
126125446|NCT01225731|453750968|FG012|Part 3|Lost to Follow-up|1|||
126125447|NCT01225731|453750956|FG000|Part 3|Physician Decision|0|||
126125448|NCT01225731|453750957|FG001|Part 3|Physician Decision|0|||
126125449|NCT01225731|453750958|FG002|Part 3|Physician Decision|0|||
126125450|NCT01225731|453750959|FG003|Part 3|Physician Decision|0|||
126125451|NCT01225731|453750960|FG004|Part 3|Physician Decision|0|||
126125452|NCT01225731|453750961|FG005|Part 3|Physician Decision|0|||
126125453|NCT01225731|453750962|FG006|Part 3|Physician Decision|0|||
126125454|NCT01225731|453750963|FG007|Part 3|Physician Decision|0|||
126125455|NCT01225731|453750964|FG008|Part 3|Physician Decision|0|||
126125456|NCT01225731|453750965|FG009|Part 3|Physician Decision|0|||
126125457|NCT01225731|453750966|FG010|Part 3|Physician Decision|0|||
126125458|NCT01225731|453750967|FG011|Part 3|Physician Decision|1|||
126125459|NCT01225731|453750968|FG012|Part 3|Physician Decision|2|||
126125460|NCT01225731|453750956|FG000|Part 3|Withdrawal by Subject|0|||
126125461|NCT01225731|453750957|FG001|Part 3|Withdrawal by Subject|0|||
126125462|NCT01225731|453750958|FG002|Part 3|Withdrawal by Subject|0|||
126125463|NCT01225731|453750959|FG003|Part 3|Withdrawal by Subject|0|||
126125464|NCT01225731|453750960|FG004|Part 3|Withdrawal by Subject|0|||
126125465|NCT01225731|453750961|FG005|Part 3|Withdrawal by Subject|0|||
126125466|NCT01225731|453750962|FG006|Part 3|Withdrawal by Subject|0|||
126125467|NCT01225731|453750963|FG007|Part 3|Withdrawal by Subject|0|||
126125468|NCT01225731|453750964|FG008|Part 3|Withdrawal by Subject|0|||
126125469|NCT01225731|453750965|FG009|Part 3|Withdrawal by Subject|0|||
126125470|NCT01225731|453750966|FG010|Part 3|Withdrawal by Subject|4|||
126125471|NCT01225731|453750967|FG011|Part 3|Withdrawal by Subject|6|||
126125472|NCT01225731|453750968|FG012|Part 3|Withdrawal by Subject|4|||
126125473|NCT00577642|453750969|FG000|Overall Study|Clinical Disease Progression|1|||
126125474|NCT01505634|453750974|FG000|Overall Study|Withdrawal by Subject|2|||
126125475|NCT01505634|453750975|FG001|Overall Study|Withdrawal by Subject|5|||
126125476|NCT01505634|453750976|FG002|Overall Study|Withdrawal by Subject|1|||
126125477|NCT01505634|453750974|FG000|Overall Study|Physician Decision|1|||
126125478|NCT01505634|453750975|FG001|Overall Study|Physician Decision|1|||
126125479|NCT01505634|453750976|FG002|Overall Study|Physician Decision|0|||
126125480|NCT01505634|453750974|FG000|Overall Study|Adverse Event|1|||
126125481|NCT01505634|453750975|FG001|Overall Study|Adverse Event|0|||
126125482|NCT01505634|453750976|FG002|Overall Study|Adverse Event|0|||
126125483|NCT01505634|453750974|FG000|Overall Study|Insufficient supply of drug at site|1|||
126125484|NCT01505634|453750975|FG001|Overall Study|Insufficient supply of drug at site|0|||
126125485|NCT01505634|453750976|FG002|Overall Study|Insufficient supply of drug at site|0|||
126125486|NCT01505634|453750974|FG000|Overall Study|Protocol Violation|2|||
126125487|NCT01505634|453750975|FG001|Overall Study|Protocol Violation|0|||
126125488|NCT01505634|453750976|FG002|Overall Study|Protocol Violation|0|||
126125489|NCT01505634|453750974|FG000|Overall Study|Lost to Follow-up|1|||
126125490|NCT01505634|453750975|FG001|Overall Study|Lost to Follow-up|4|||
126125491|NCT01505634|453750976|FG002|Overall Study|Lost to Follow-up|4|||
126125492|NCT01505634|453750974|FG000|Overall Study|Death|1|||
126125493|NCT01505634|453750975|FG001|Overall Study|Death|0|||
126125494|NCT01505634|453750976|FG002|Overall Study|Death|0|||
126125495|NCT01505634|453750974|FG000|Overall Study|In a conflict zone|0|||
126125496|NCT01505634|453750975|FG001|Overall Study|In a conflict zone|0|||
126125497|NCT01505634|453750976|FG002|Overall Study|In a conflict zone|1|||
126125498|NCT02054897|453750977|FG000|Overall Study|Withdrawal by Subject|2|||
126125499|NCT02054897|453750978|FG001|Overall Study|Withdrawal by Subject|0|||
126125500|NCT02054897|453750979|FG002|Overall Study|Withdrawal by Subject|2|||
126125501|NCT02054897|453750977|FG000|Overall Study|Missing follow-up information|3|||
126125502|NCT02054897|453750978|FG001|Overall Study|Missing follow-up information|5|||
126125503|NCT02054897|453750979|FG002|Overall Study|Missing follow-up information|3|||
126125504|NCT02054897|453750977|FG000|Overall Study|Lost to Follow-up|4|||
126125505|NCT02054897|453750978|FG001|Overall Study|Lost to Follow-up|2|||
126125506|NCT02054897|453750979|FG002|Overall Study|Lost to Follow-up|7|||
126125507|NCT02054897|453750977|FG000|Overall Study|Randomized but not exposed|1|||
126125508|NCT02054897|453750978|FG001|Overall Study|Randomized but not exposed|0|||
126125509|NCT02054897|453750979|FG002|Overall Study|Randomized but not exposed|0|||
126125510|NCT00794157|453750980|FG000|Overall Study|Adverse Event|4|||
126125511|NCT00794157|453750981|FG001|Overall Study|Adverse Event|1|||
126125512|NCT00794157|453750982|FG002|Overall Study|Adverse Event|8|||
126125513|NCT00794157|453750980|FG000|Overall Study|Subject withdrew consent|2|||
126125514|NCT00794157|453750981|FG001|Overall Study|Subject withdrew consent|0|||
126125515|NCT00794157|453750982|FG002|Overall Study|Subject withdrew consent|3|||
126125516|NCT00794157|453750980|FG000|Overall Study|Lost to Follow-up|2|||
126125517|NCT00794157|453750981|FG001|Overall Study|Lost to Follow-up|0|||
126125518|NCT00794157|453750982|FG002|Overall Study|Lost to Follow-up|1|||
126125519|NCT00794157|453750980|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126125520|NCT00794157|453750981|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126125521|NCT00794157|453750982|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126125522|NCT00794157|453750980|FG000|Overall Study|Administrative problems|1|||
126125523|NCT00794157|453750981|FG001|Overall Study|Administrative problems|7|||
126125524|NCT00794157|453750982|FG002|Overall Study|Administrative problems|4|||
126125525|NCT00794157|453750980|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126125526|NCT00794157|453750981|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126125527|NCT00794157|453750982|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126125528|NCT00794157|453750980|FG000|Overall Study|Protocol deviation|0|||
125963686|NCT00403546|453157169|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
125963687|NCT00403546|453157167|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
125963688|NCT00403546|453157168|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
126088163|NCT01725126|453617044|FG001|Overall Study|Protocol Violation|1|||
126088164|NCT01725126|453617045|FG002|Overall Study|Protocol Violation|0|||
126088165|NCT01725126|453617046|FG003|Overall Study|Protocol Violation|0|||
126088166|NCT01725126|453617047|FG004|Overall Study|Protocol Violation|0|||
126088167|NCT01725126|453617048|FG005|Overall Study|Protocol Violation|0|||
126088168|NCT01725126|453617043|FG000|Overall Study|Withdrawal by Subject|0|||
126088169|NCT01725126|453617044|FG001|Overall Study|Withdrawal by Subject|0|||
126088170|NCT01725126|453617045|FG002|Overall Study|Withdrawal by Subject|0|||
126088171|NCT01725126|453617046|FG003|Overall Study|Withdrawal by Subject|1|||
126088172|NCT01725126|453617047|FG004|Overall Study|Withdrawal by Subject|0|||
126088173|NCT01725126|453617048|FG005|Overall Study|Withdrawal by Subject|0|||
126088174|NCT00677534|453617053|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
126088175|NCT00677534|453617053|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
126088176|NCT00677534|453617053|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
126088177|NCT02687035|453617054|FG000|Overall Study|Withdrawal by Subject|1|||
126088178|NCT02687035|453617054|FG000|Overall Study|Death|87|||
126088179|NCT02687035|453617054|FG000|Overall Study|Lost to Follow-up|1|||
126088180|NCT02687035|453617054|FG000|Overall Study|Missed Visit|87|||
126088181|NCT02687035|453617054|FG000|Overall Study|Did not receive Study Device|8|||
126088182|NCT04076943|453617063|FG000|Overall Study|Withdrawal by Subject|12|||
126088183|NCT04076943|453617063|FG000|Overall Study|Adverse Event|1|||
126088184|NCT04076943|453617063|FG000|Overall Study|Progressive Disease|2|||
126088185|NCT04076943|453617063|FG000|Overall Study|Death|13|||
126088186|NCT04076943|453617063|FG000|Overall Study|Other than specified|6|||
126088187|NCT02224703|453617069|FG000|Overall Study|Adverse Event|0|||
126088188|NCT02224703|453617070|FG001|Overall Study|Adverse Event|5|||
126088189|NCT02224703|453617071|FG002|Overall Study|Adverse Event|0|||
126088190|NCT02224703|453617069|FG000|Overall Study|Withdrawn by investigator|1|||
126088191|NCT02224703|453617070|FG001|Overall Study|Withdrawn by investigator|0|||
126088192|NCT02224703|453617071|FG002|Overall Study|Withdrawn by investigator|0|||
126088193|NCT02224703|453617069|FG000|Overall Study|Advised by medical monitor|1|||
126088194|NCT02224703|453617070|FG001|Overall Study|Advised by medical monitor|0|||
126088195|NCT02224703|453617071|FG002|Overall Study|Advised by medical monitor|0|||
126088196|NCT02224703|453617069|FG000|Overall Study|Withdrawn by parent/guardian|0|||
126088197|NCT02224703|453617070|FG001|Overall Study|Withdrawn by parent/guardian|1|||
126088198|NCT02224703|453617071|FG002|Overall Study|Withdrawn by parent/guardian|0|||
126088199|NCT02224703|453617069|FG000|Overall Study|Lack of Efficacy|1|||
126088200|NCT02224703|453617070|FG001|Overall Study|Lack of Efficacy|0|||
126088201|NCT02224703|453617071|FG002|Overall Study|Lack of Efficacy|0|||
126088202|NCT00863681|453617072|FG000|Overall Study|Other|2|||
126088203|NCT00863681|453617073|FG001|Overall Study|Other|0|||
126088204|NCT00863681|453617074|FG002|Overall Study|Other|0|||
126088205|NCT00863681|453617072|FG000|Overall Study|Missing|1|||
126088206|NCT00863681|453617073|FG001|Overall Study|Missing|0|||
126088207|NCT00863681|453617074|FG002|Overall Study|Missing|0|||
126088208|NCT00863681|453617072|FG000|Overall Study|Death|40|||
126088209|NCT00863681|453617073|FG001|Overall Study|Death|23|||
126088210|NCT00863681|453617074|FG002|Overall Study|Death|6|||
126088211|NCT00863681|453617072|FG000|Overall Study|Withdrawal by Subject|12|||
126088212|NCT00863681|453617073|FG001|Overall Study|Withdrawal by Subject|5|||
126088213|NCT00863681|453617074|FG002|Overall Study|Withdrawal by Subject|2|||
126088214|NCT00863681|453617072|FG000|Overall Study|Protocol Violation|2|||
126088215|NCT00863681|453617073|FG001|Overall Study|Protocol Violation|0|||
126088216|NCT00863681|453617074|FG002|Overall Study|Protocol Violation|0|||
126088217|NCT00863681|453617072|FG000|Overall Study|Lost to Follow-up|3|||
126088218|NCT00863681|453617073|FG001|Overall Study|Lost to Follow-up|0|||
126088219|NCT00863681|453617074|FG002|Overall Study|Lost to Follow-up|3|||
126088220|NCT00863681|453617072|FG000|Overall Study|Adverse Event|28|||
126088221|NCT00863681|453617073|FG001|Overall Study|Adverse Event|10|||
126088222|NCT00863681|453617074|FG002|Overall Study|Adverse Event|6|||
126088223|NCT00863681|453617072|FG000|Overall Study|Lack of Efficacy|2|||
126088224|NCT00863681|453617073|FG001|Overall Study|Lack of Efficacy|2|||
126088225|NCT00863681|453617074|FG002|Overall Study|Lack of Efficacy|1|||
126088226|NCT00863681|453617072|FG000|Overall Study|Non-compliance with study drug|1|||
126088227|NCT00863681|453617073|FG001|Overall Study|Non-compliance with study drug|3|||
126088228|NCT00863681|453617074|FG002|Overall Study|Non-compliance with study drug|0|||
126088229|NCT02922023|453617075|FG000|Overall Study|Lost to Follow-up|2|||
126088230|NCT02922023|453617076|FG001|Overall Study|Lost to Follow-up|0|||
126088231|NCT03031496|453617077|FG000|Period 1|Adverse Event|2|||
126088232|NCT03031496|453617078|FG001|Period 1|Adverse Event|0|||
126088233|NCT03031496|453617077|FG000|Period 1|Withdrawal by Subject|0|||
126088234|NCT03031496|453617078|FG001|Period 1|Withdrawal by Subject|2|||
126125529|NCT00794157|453750981|FG001|Overall Study|Protocol deviation|1|||
126125530|NCT00794157|453750982|FG002|Overall Study|Protocol deviation|1|||
126125531|NCT00677014|453750983|FG000|Overall Study|Lost to Follow-up|20|||
126125532|NCT00677014|453750984|FG001|Overall Study|Lost to Follow-up|12|||
126125533|NCT00677014|453750985|FG002|Overall Study|Lost to Follow-up|24|||
126125534|NCT00677014|453750983|FG000|Overall Study|Death|6|||
126125535|NCT00677014|453750984|FG001|Overall Study|Death|15|||
126125536|NCT00677014|453750985|FG002|Overall Study|Death|7|||
126125537|NCT00677014|453750983|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
126125538|NCT00677014|453750984|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
126125539|NCT00677014|453750985|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
126125540|NCT02374099|453750986|FG000|Overall Study|Adverse Event|1|||
126125541|NCT02374099|453750987|FG001|Overall Study|Adverse Event|0|||
126125542|NCT02374099|453750986|FG000|Overall Study|Progressive Disease|35|||
126125543|NCT02374099|453750987|FG001|Overall Study|Progressive Disease|40|||
126125544|NCT02374099|453750986|FG000|Overall Study|Withdrawal by Subject|5|||
126125545|NCT02374099|453750987|FG001|Overall Study|Withdrawal by Subject|1|||
126125546|NCT02374099|453750986|FG000|Overall Study|Miscellaneous|2|||
126125547|NCT02374099|453750987|FG001|Overall Study|Miscellaneous|3|||
126125548|NCT02374099|453750986|FG000|Overall Study|Randomized, but not treated|2|||
126125549|NCT02374099|453750987|FG001|Overall Study|Randomized, but not treated|1|||
126125550|NCT02374099|453750986|FG000|Overall Study|Study Terminated by Sponsor|3|||
126125551|NCT02374099|453750987|FG001|Overall Study|Study Terminated by Sponsor|4|||
126125552|NCT00081159|453750988|FG000|Overall Study|Withdrawal by Subject|0|||
126125553|NCT00081159|453750989|FG001|Overall Study|Withdrawal by Subject|3|||
126125554|NCT00081159|453750988|FG000|Overall Study|Myelosuppression prior to treatment|0|||
126125555|NCT00081159|453750989|FG001|Overall Study|Myelosuppression prior to treatment|1|||
126125556|NCT00081159|453750988|FG000|Overall Study|Lost to Follow-up|2|||
126125557|NCT00081159|453750989|FG001|Overall Study|Lost to Follow-up|1|||
126125558|NCT01553136|453750990|FG000|Overall Study|Adverse Event|3|||
126125559|NCT01553136|453750991|FG001|Overall Study|Adverse Event|2|||
126125560|NCT01553136|453750990|FG000|Overall Study|Withdrawal by Subject|2|||
126125561|NCT01553136|453750991|FG001|Overall Study|Withdrawal by Subject|3|||
126125562|NCT01553136|453750990|FG000|Overall Study|Lost to Follow-up|4|||
126125563|NCT01553136|453750991|FG001|Overall Study|Lost to Follow-up|10|||
126125564|NCT01553136|453750990|FG000|Overall Study|Physician Decision|2|||
126125565|NCT01553136|453750991|FG001|Overall Study|Physician Decision|3|||
126125566|NCT01553136|453750990|FG000|Overall Study|Scheduling Difficulties|5|||
126125567|NCT01553136|453750991|FG001|Overall Study|Scheduling Difficulties|4|||
126125568|NCT01100437|453750992|FG000|Titration/Stabilization|Adverse Event|0|||
126125569|NCT01100437|453750993|FG001|Titration/Stabilization|Adverse Event|0|||
126125570|NCT01100437|453750994|FG002|Titration/Stabilization|Adverse Event|4|||
126125571|NCT01100437|453750992|FG000|Titration/Stabilization|Non-compliance|0|||
126125572|NCT01100437|453750993|FG001|Titration/Stabilization|Non-compliance|0|||
126125573|NCT01100437|453750994|FG002|Titration/Stabilization|Non-compliance|1|||
126125574|NCT01100437|453750992|FG000|Titration/Stabilization|Sponsor canceled study|0|||
126125575|NCT01100437|453750993|FG001|Titration/Stabilization|Sponsor canceled study|0|||
126125576|NCT01100437|453750994|FG002|Titration/Stabilization|Sponsor canceled study|1|||
126125577|NCT01100437|453750992|FG000|Maintenance|Withdrawal by Subject|0|||
126125578|NCT01100437|453750993|FG001|Maintenance|Withdrawal by Subject|0|||
126125579|NCT01100437|453750994|FG002|Maintenance|Withdrawal by Subject|1|||
126125580|NCT01100437|453750992|FG000|Maintenance|Sponsor termination of study|0|||
126125581|NCT01100437|453750993|FG001|Maintenance|Sponsor termination of study|0|||
126125582|NCT01100437|453750994|FG002|Maintenance|Sponsor termination of study|1|||
126125583|NCT00894556|453750995|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
126125584|NCT00894556|453750996|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
126125585|NCT00894556|453750997|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
126125586|NCT00894556|453750998|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
126125587|NCT00894556|453750995|FG000|Treatment Phase|Lost to Follow-up|2|||
126125588|NCT00894556|453750996|FG001|Treatment Phase|Lost to Follow-up|3|||
126125589|NCT00894556|453750997|FG002|Treatment Phase|Lost to Follow-up|1|||
126125590|NCT00894556|453750998|FG003|Treatment Phase|Lost to Follow-up|0|||
126125591|NCT00894556|453750995|FG000|Treatment Phase|Lack of Qualifying Event|2|||
126125592|NCT00894556|453750996|FG001|Treatment Phase|Lack of Qualifying Event|1|||
126125593|NCT00894556|453750997|FG002|Treatment Phase|Lack of Qualifying Event|0|||
126125594|NCT00894556|453750998|FG003|Treatment Phase|Lack of Qualifying Event|0|||
126125595|NCT03921424|453751006|FG000|Overall Study|Lost to Follow-up|0|||
126125596|NCT03921424|453751007|FG001|Overall Study|Lost to Follow-up|1|||
126125597|NCT03921424|453751006|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126125598|NCT03921424|453751007|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
126125599|NCT02581202|453751016|FG000|Overall Study|Lack of Efficacy|2|||
126125600|NCT02581202|453751016|FG000|Overall Study|Withdrawal by Subject|4|||
126125601|NCT02581202|453751016|FG000|Overall Study|Lost to Follow-up|5|||
126125602|NCT02581202|453751016|FG000|Overall Study|Pregnancy|3|||
126125603|NCT02595450|453751023|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
126125604|NCT02595450|453751023|FG000|Overall Study|Enrolled, but not treated|8|||
126125605|NCT01934556|453751025|FG000|Overall Study|Withdrawal by Subject|0|||
126125606|NCT01934556|453751026|FG001|Overall Study|Withdrawal by Subject|1|||
126125607|NCT01934556|453751027|FG002|Overall Study|Withdrawal by Subject|1|||
126125608|NCT01934556|453751025|FG000|Overall Study|Lost to Follow-up|4|||
126125609|NCT01934556|453751026|FG001|Overall Study|Lost to Follow-up|10|||
126125610|NCT01934556|453751027|FG002|Overall Study|Lost to Follow-up|7|||
126125611|NCT01934556|453751025|FG000|Overall Study|Death|1|||
126125612|NCT01934556|453751026|FG001|Overall Study|Death|5|||
126125613|NCT01934556|453751027|FG002|Overall Study|Death|2|||
126125614|NCT02135692|453752606|FG000|Overall Study|Adverse Event|3|||
126125615|NCT02135692|453752606|FG000|Overall Study|Lack of Efficacy|2|||
126125616|NCT02135692|453752606|FG000|Overall Study|Protocol Violation|2|||
126125617|NCT02135692|453752606|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
126125618|NCT02135692|453752606|FG000|Overall Study|Product commercially available|159|||
126125619|NCT02135692|453752606|FG000|Overall Study|Study closed/terminated|153|||
126125620|NCT02135692|453752606|FG000|Overall Study|Lost to Follow-up|4|||
126125621|NCT02135692|453752606|FG000|Overall Study|Withdrawal by Subject|15|||
126125622|NCT04429061|453752609|FG000|Overall Study|Lost to Follow-up|62|||
126125623|NCT04429061|453752610|FG001|Overall Study|Lost to Follow-up|87|||
126125624|NCT04429061|453752609|FG000|Overall Study|Withdrawal by Subject|3|||
126125625|NCT04429061|453752610|FG001|Overall Study|Withdrawal by Subject|4|||
126125626|NCT00879229|453752616|FG000|Overall Study|Study terminated by Sponsor|13|||
126125627|NCT00879229|453752617|FG001|Overall Study|Study terminated by Sponsor|12|||
126125628|NCT00879229|453752616|FG000|Overall Study|Death|4|||
126125629|NCT00879229|453752617|FG001|Overall Study|Death|2|||
126125630|NCT00879229|453752616|FG000|Overall Study|Adverse Event|2|||
126125631|NCT00879229|453752617|FG001|Overall Study|Adverse Event|0|||
126125632|NCT00879229|453752616|FG000|Overall Study|Withdrawal by Subject|1|||
126125633|NCT00879229|453752617|FG001|Overall Study|Withdrawal by Subject|0|||
126125634|NCT00879229|453752616|FG000|Overall Study|Clinical status did not improve|1|||
126125635|NCT00879229|453752617|FG001|Overall Study|Clinical status did not improve|0|||
126125636|NCT00879229|453752616|FG000|Overall Study|Other|1|||
126125637|NCT00879229|453752617|FG001|Overall Study|Other|0|||
125963689|NCT00403546|453157169|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
125963690|NCT00403546|453157167|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
125963691|NCT00403546|453157168|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
125963692|NCT00403546|453157169|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
125963693|NCT00403546|453157167|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
125963694|NCT00403546|453157168|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
125963695|NCT00403546|453157169|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
125963696|NCT00403546|453157167|FG000|Screening Phase|Screening Failure|22|||
125963697|NCT00403546|453157168|FG001|Screening Phase|Screening Failure|0|||
125963698|NCT00403546|453157169|FG002|Screening Phase|Screening Failure|0|||
125963699|NCT00403546|453157167|FG000|Screening Phase|Adverse Event|1|||
125963700|NCT00403546|453157168|FG001|Screening Phase|Adverse Event|0|||
125963701|NCT00403546|453157169|FG002|Screening Phase|Adverse Event|0|||
125963702|NCT00403546|453157167|FG000|Screening Phase|Terminated Prior to Randomization|5|||
125963703|NCT00403546|453157168|FG001|Screening Phase|Terminated Prior to Randomization|0|||
125963704|NCT00403546|453157169|FG002|Screening Phase|Terminated Prior to Randomization|0|||
125963705|NCT00403546|453157167|FG000|Randomized Trial|Early Terminations|0|||
125963706|NCT00403546|453157168|FG001|Randomized Trial|Early Terminations|17|||
125963707|NCT00403546|453157169|FG002|Randomized Trial|Early Terminations|16|||
125963708|NCT02673697|453157170|FG000|Overall Study|Adverse Event|2|||
125963709|NCT02673697|453157171|FG001|Overall Study|Adverse Event|0|||
125963710|NCT02673697|453157170|FG000|Overall Study|Death|32|||
125963711|NCT02673697|453157171|FG001|Overall Study|Death|24|||
125963712|NCT02673697|453157170|FG000|Overall Study|Lost to Follow-up|5|||
125963713|NCT02673697|453157171|FG001|Overall Study|Lost to Follow-up|2|||
125963714|NCT02673697|453157170|FG000|Overall Study|Physician Decision|2|||
125963715|NCT02673697|453157171|FG001|Overall Study|Physician Decision|1|||
125963716|NCT02673697|453157170|FG000|Overall Study|Withdrawal by Subject|10|||
125963717|NCT02673697|453157171|FG001|Overall Study|Withdrawal by Subject|7|||
125963718|NCT02673697|453157170|FG000|Overall Study|Change subj medical status|1|||
125963719|NCT02673697|453157171|FG001|Overall Study|Change subj medical status|2|||
125963720|NCT02673697|453157170|FG000|Overall Study|Explant|10|||
125963721|NCT02673697|453157171|FG001|Overall Study|Explant|5|||
125963722|NCT02673697|453157170|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
126125638|NCT01097746|453752618|FG000|Overall Study|Adverse Event|4|||
126125639|NCT01097746|453752618|FG000|Overall Study|taken off study before any treatment given|1|||
126125640|NCT00631371|453752625|FG000|Overall Study|Lost to Follow-up|24|||
125963723|NCT02673697|453157171|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
125963724|NCT00437489|453157172|FG000|Overall Study|Study terminated by sponsor|23|||
126125641|NCT00631371|453752626|FG001|Overall Study|Lost to Follow-up|19|||
126125642|NCT00631371|453752625|FG000|Overall Study|Other reason|5|||
126125643|NCT00631371|453752626|FG001|Overall Study|Other reason|12|||
126125644|NCT00631371|453752625|FG000|Overall Study|subject request|38|||
126125645|NCT00631371|453752626|FG001|Overall Study|subject request|45|||
125963725|NCT00437489|453157173|FG001|Overall Study|Study terminated by sponsor|21|||
125963726|NCT00437489|453157172|FG000|Overall Study|Lost to Follow-up|0|||
125963727|NCT00437489|453157173|FG001|Overall Study|Lost to Follow-up|1|||
125963728|NCT03893448|453157179|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
125963729|NCT03893448|453157180|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
125963730|NCT03893448|453157179|FG000|Overall Study|Physician Decision|8|||
125963731|NCT03893448|453157180|FG001|Overall Study|Physician Decision|14|||
125963732|NCT03893448|453157179|FG000|Overall Study|Lost to Follow-up|34|||
125963733|NCT03893448|453157180|FG001|Overall Study|Lost to Follow-up|27|||
125963734|NCT03893448|453157179|FG000|Overall Study|Death|1|||
125963735|NCT03893448|453157180|FG001|Overall Study|Death|0|||
125963736|NCT05061446|453157188|FG000|Overall Study|Adverse Event|2|||
125963737|NCT05061446|453157189|FG001|Overall Study|Adverse Event|0|||
125963738|NCT05061446|453157190|FG002|Overall Study|Adverse Event|0|||
125963739|NCT05061446|453157188|FG000|Overall Study|Participant no longer available due to personal reason|0|||
125963740|NCT05061446|453157189|FG001|Overall Study|Participant no longer available due to personal reason|1|||
125963741|NCT05061446|453157190|FG002|Overall Study|Participant no longer available due to personal reason|0|||
125963742|NCT03880578|453157191|FG000|Overall Study|Withdrawal by Subject|0|||
125963743|NCT03880578|453157192|FG001|Overall Study|Withdrawal by Subject|3|||
125963744|NCT03880578|453157193|FG002|Overall Study|Withdrawal by Subject|1|||
125963745|NCT03880578|453157191|FG000|Overall Study|Death|0|||
125963746|NCT03880578|453157192|FG001|Overall Study|Death|1|||
125963747|NCT03880578|453157193|FG002|Overall Study|Death|0|||
125963748|NCT04934670|453157194|FG000|Overall Study|Death|4|||
125963749|NCT04934670|453157195|FG001|Overall Study|Death|0|||
125963750|NCT04934670|453157194|FG000|Overall Study|Lost to Follow-up|1|||
125963751|NCT04934670|453157195|FG001|Overall Study|Lost to Follow-up|4|||
125963752|NCT02041429|453157200|FG000|Overall Study|Progressive Disease|2|||
125963753|NCT02041429|453157201|FG001|Overall Study|Progressive Disease|2|||
125963754|NCT02041429|453157202|FG002|Overall Study|Progressive Disease|3|||
125963755|NCT02041429|453157203|FG003|Overall Study|Progressive Disease|2|||
125963756|NCT02041429|453157200|FG000|Overall Study|Toxicity|0|||
125963757|NCT02041429|453157201|FG001|Overall Study|Toxicity|1|||
125963758|NCT02041429|453157202|FG002|Overall Study|Toxicity|4|||
125963759|NCT02041429|453157203|FG003|Overall Study|Toxicity|2|||
125963760|NCT02041429|453157200|FG000|Overall Study|Withdrawal by Subject|0|||
125963761|NCT02041429|453157201|FG001|Overall Study|Withdrawal by Subject|1|||
125963762|NCT02041429|453157202|FG002|Overall Study|Withdrawal by Subject|0|||
125963763|NCT02041429|453157203|FG003|Overall Study|Withdrawal by Subject|0|||
126125646|NCT00631371|453752625|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
126125647|NCT00631371|453752626|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
126125648|NCT00631371|453752625|FG000|Overall Study|Death|263|||
126125649|NCT00631371|453752626|FG001|Overall Study|Death|239|||
126125650|NCT00390546|453752627|FG000|Overall Study|Renal impairment|1|||
126125651|NCT00390546|453752628|FG001|Overall Study|Renal impairment|0|||
126125652|NCT00390546|453752627|FG000|Overall Study|Physician Decision|5|||
126125653|NCT00390546|453752628|FG001|Overall Study|Physician Decision|5|||
126125654|NCT00812214|453752634|FG000|Overall Study|Lost to Follow-up|3|||
126125655|NCT00812214|453752635|FG001|Overall Study|Lost to Follow-up|1|||
126125656|NCT02145741|453752637|FG000|Overall Study|Progressive disease|3|||
126125657|NCT02145741|453752638|FG001|Overall Study|Progressive disease|6|||
126125658|NCT02145741|453752639|FG002|Overall Study|Progressive disease|6|||
126125659|NCT02145741|453752637|FG000|Overall Study|quality issue with the administered drug|3|||
126125660|NCT02145741|453752638|FG001|Overall Study|quality issue with the administered drug|0|||
126125661|NCT02145741|453752639|FG002|Overall Study|quality issue with the administered drug|0|||
126125662|NCT01192022|453752640|FG000|Overall Study|Withdrawal of Consent|3|||
126125663|NCT01192022|453752641|FG001|Overall Study|Withdrawal of Consent|1|||
126125664|NCT01192022|453752642|FG002|Overall Study|Withdrawal of Consent|0|||
126125665|NCT01192022|453752643|FG003|Overall Study|Withdrawal of Consent|0|||
125963764|NCT02041429|453157200|FG000|Overall Study|On Maintenance Therapy|1|||
125963765|NCT02041429|453157201|FG001|Overall Study|On Maintenance Therapy|0|||
125963766|NCT02041429|453157202|FG002|Overall Study|On Maintenance Therapy|0|||
125963767|NCT02041429|453157203|FG003|Overall Study|On Maintenance Therapy|2|||
125963768|NCT00861341|453157204|FG000|Overall Study|Withdrawal by Subject|2|||
125963769|NCT03299192|453157205|FG000|Overall Study|Fell before classes started|1|||
125963770|NCT03299192|453157206|FG001|Overall Study|Fell before classes started|0|||
125963771|NCT03299192|453157207|FG002|Overall Study|Fell before classes started|0|||
125963772|NCT03299192|453157205|FG000|Overall Study|Other|0|||
125963773|NCT03299192|453157206|FG001|Overall Study|Other|2|||
125963774|NCT03299192|453157207|FG002|Overall Study|Other|1|||
125963775|NCT01418209|453157208|FG000|Overall Study|Withdrawal by Subject|1|||
125963776|NCT01418209|453157209|FG001|Overall Study|Withdrawal by Subject|0|||
125963777|NCT01418209|453157210|FG002|Overall Study|Withdrawal by Subject|1|||
125963778|NCT01418209|453157208|FG000|Overall Study|Did not provide hot flash diary data|1|||
126125666|NCT01192022|453752644|FG004|Overall Study|Withdrawal of Consent|0|||
126125667|NCT01192022|453752640|FG000|Overall Study|Lost to Follow-up|4|||
125963779|NCT01418209|453157209|FG001|Overall Study|Did not provide hot flash diary data|3|||
126125668|NCT01192022|453752641|FG001|Overall Study|Lost to Follow-up|2|||
126125669|NCT01192022|453752642|FG002|Overall Study|Lost to Follow-up|1|||
126125670|NCT01192022|453752643|FG003|Overall Study|Lost to Follow-up|1|||
126125671|NCT01192022|453752644|FG004|Overall Study|Lost to Follow-up|0|||
126125672|NCT01192022|453752640|FG000|Overall Study|Adverse Event|1|||
126125673|NCT01192022|453752641|FG001|Overall Study|Adverse Event|0|||
126125674|NCT01192022|453752642|FG002|Overall Study|Adverse Event|0|||
126125675|NCT01192022|453752643|FG003|Overall Study|Adverse Event|0|||
126125676|NCT01192022|453752644|FG004|Overall Study|Adverse Event|0|||
126125677|NCT01192022|453752640|FG000|Overall Study|Fatal Adverse Event|4|||
126125678|NCT01192022|453752641|FG001|Overall Study|Fatal Adverse Event|6|||
126125679|NCT01192022|453752642|FG002|Overall Study|Fatal Adverse Event|0|||
126125680|NCT01192022|453752643|FG003|Overall Study|Fatal Adverse Event|0|||
126125681|NCT01192022|453752644|FG004|Overall Study|Fatal Adverse Event|1|||
126125682|NCT01192022|453752640|FG000|Overall Study|Physician withdrew-patient hardship|1|||
126125683|NCT01192022|453752641|FG001|Overall Study|Physician withdrew-patient hardship|0|||
126125684|NCT01192022|453752642|FG002|Overall Study|Physician withdrew-patient hardship|0|||
126125685|NCT01192022|453752643|FG003|Overall Study|Physician withdrew-patient hardship|0|||
126125686|NCT01192022|453752644|FG004|Overall Study|Physician withdrew-patient hardship|0|||
126125687|NCT01192022|453752640|FG000|Overall Study|Patient too sick from chemotherapy|0|||
126125688|NCT01192022|453752641|FG001|Overall Study|Patient too sick from chemotherapy|1|||
126125689|NCT01192022|453752642|FG002|Overall Study|Patient too sick from chemotherapy|0|||
126125690|NCT01192022|453752643|FG003|Overall Study|Patient too sick from chemotherapy|0|||
126125691|NCT01192022|453752644|FG004|Overall Study|Patient too sick from chemotherapy|0|||
126125692|NCT01192022|453752640|FG000|Overall Study|Patient needed surgery|0|||
126125693|NCT01192022|453752641|FG001|Overall Study|Patient needed surgery|1|||
126125694|NCT01192022|453752642|FG002|Overall Study|Patient needed surgery|0|||
126125695|NCT01192022|453752643|FG003|Overall Study|Patient needed surgery|0|||
126125696|NCT01192022|453752644|FG004|Overall Study|Patient needed surgery|0|||
126125697|NCT01192022|453752640|FG000|Overall Study|Parents did not allow all follow up|0|||
126125698|NCT01192022|453752641|FG001|Overall Study|Parents did not allow all follow up|0|||
126125699|NCT01192022|453752642|FG002|Overall Study|Parents did not allow all follow up|0|||
126125700|NCT01192022|453752643|FG003|Overall Study|Parents did not allow all follow up|1|||
126125701|NCT01192022|453752644|FG004|Overall Study|Parents did not allow all follow up|0|||
126125702|NCT00129766|453752646|FG000|Overall Study|Death|3|||
126125703|NCT00129766|453752647|FG001|Overall Study|Death|8|||
126125704|NCT00129766|453752646|FG000|Overall Study|Withdrawal of consent|31|||
126125705|NCT00129766|453752647|FG001|Overall Study|Withdrawal of consent|30|||
126125706|NCT00129766|453752646|FG000|Overall Study|Lost to Follow-up|26|||
126125707|NCT00129766|453752647|FG001|Overall Study|Lost to Follow-up|21|||
126125708|NCT05440539|453752649|FG000|Overall Study|Lost to Follow-up|4|||
126125709|NCT05440539|453752650|FG001|Overall Study|Lost to Follow-up|4|||
126125710|NCT05440539|453752649|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
126125711|NCT05440539|453752650|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
126125712|NCT03808077|453752651|FG000|Overall Study|Physician Decision|2|||
126125713|NCT03808077|453752652|FG001|Overall Study|Physician Decision|3|||
126125714|NCT03808077|453752651|FG000|Overall Study|Withdrawal by Subject|1|||
126125715|NCT03808077|453752652|FG001|Overall Study|Withdrawal by Subject|0|||
126125716|NCT03808077|453752651|FG000|Overall Study|Equipment Issues|2|||
126125717|NCT03808077|453752652|FG001|Overall Study|Equipment Issues|1|||
126125718|NCT04152161|453752653|FG000|Overall Study|Death|0|||
126125719|NCT04152161|453752654|FG001|Overall Study|Death|1|||
126125720|NCT04152161|453752653|FG000|Overall Study|Physician Decision|0|||
126125721|NCT04152161|453752654|FG001|Overall Study|Physician Decision|1|||
126125722|NCT04152161|453752653|FG000|Overall Study|Lost to Follow-up|9|||
126125723|NCT04152161|453752654|FG001|Overall Study|Lost to Follow-up|3|||
126125724|NCT04152161|453752653|FG000|Overall Study|Protocol Violation|1|||
126125725|NCT04152161|453752654|FG001|Overall Study|Protocol Violation|0|||
126125726|NCT04152161|453752653|FG000|Overall Study|Withdrawal by Subject|29|||
125963780|NCT01418209|453157210|FG002|Overall Study|Did not provide hot flash diary data|3|||
125963781|NCT01916304|453157215|FG000|Overall Study|Screening failure|17|||
126125727|NCT04152161|453752654|FG001|Overall Study|Withdrawal by Subject|28|||
126125728|NCT04152161|453752653|FG000|Overall Study|Sponsor termination of study|750|||
126125729|NCT04152161|453752654|FG001|Overall Study|Sponsor termination of study|755|||
126125730|NCT04152161|453752653|FG000|Overall Study|Other|20|||
125963782|NCT02460198|453157217|FG000|Overall Study|Adverse Event|1|||
125963783|NCT02460198|453157218|FG001|Overall Study|Adverse Event|3|||
125963784|NCT02460198|453157217|FG000|Overall Study|Death|36|||
126125731|NCT04152161|453752654|FG001|Overall Study|Other|18|||
126125732|NCT00001379|453752655|FG000|Initial Treatment|Disease progression|21|||
126125733|NCT00001379|453752656|FG001|Initial Treatment|Disease progression|3|||
126125734|NCT00001379|453752657|FG002|Initial Treatment|Disease progression|0|||
126125735|NCT00001379|453752658|FG003|Initial Treatment|Disease progression|0|||
126125736|NCT00001379|453752655|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
126125737|NCT00001379|453752656|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
126125738|NCT00001379|453752657|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
126125739|NCT00001379|453752658|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
126125740|NCT00001379|453752655|FG000|Initial Treatment|Received alternative treatment|2|||
126125741|NCT00001379|453752656|FG001|Initial Treatment|Received alternative treatment|1|||
126125742|NCT00001379|453752657|FG002|Initial Treatment|Received alternative treatment|0|||
126125743|NCT00001379|453752658|FG003|Initial Treatment|Received alternative treatment|0|||
126125744|NCT00001379|453752655|FG000|Initial Treatment|Refused further treatment|2|||
126125745|NCT00001379|453752656|FG001|Initial Treatment|Refused further treatment|0|||
126125746|NCT00001379|453752657|FG002|Initial Treatment|Refused further treatment|0|||
126125747|NCT00001379|453752658|FG003|Initial Treatment|Refused further treatment|0|||
126125748|NCT00001379|453752655|FG000|Initial Treatment|Did not receive protocol treatment|0|||
126125749|NCT00001379|453752656|FG001|Initial Treatment|Did not receive protocol treatment|0|||
126125750|NCT00001379|453752657|FG002|Initial Treatment|Did not receive protocol treatment|5|||
126125751|NCT00001379|453752658|FG003|Initial Treatment|Did not receive protocol treatment|0|||
126125752|NCT00001379|453752655|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
126125753|NCT00001379|453752656|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
126125754|NCT00001379|453752657|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
126125755|NCT00001379|453752658|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
126125756|NCT00001379|453752655|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
126125757|NCT00001379|453752656|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
126125758|NCT00001379|453752657|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
126125759|NCT00001379|453752658|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
126125760|NCT00001379|453752655|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
126125761|NCT00001379|453752656|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
126125762|NCT00001379|453752657|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
126125763|NCT00001379|453752658|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
126125764|NCT00001379|453752655|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
126125765|NCT00001379|453752656|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
126125766|NCT00001379|453752657|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
126125767|NCT00001379|453752658|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
126125768|NCT00001379|453752655|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
126125769|NCT00001379|453752656|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
126125770|NCT00001379|453752657|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
126125771|NCT00001379|453752658|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
126125772|NCT03246958|453752659|FG000|Overall Study|Withdrawal by Subject|0|||
126125773|NCT03246958|453752660|FG001|Overall Study|Withdrawal by Subject|1|||
126125774|NCT03246958|453752661|FG002|Overall Study|Withdrawal by Subject|0|||
126125775|NCT03246958|453752662|FG003|Overall Study|Withdrawal by Subject|0|||
126125776|NCT03246958|453752663|FG004|Overall Study|Withdrawal by Subject|0|||
126125777|NCT03246958|453752664|FG005|Overall Study|Withdrawal by Subject|1|||
126125778|NCT03246958|453752665|FG006|Overall Study|Withdrawal by Subject|0|||
126125779|NCT03246958|453752659|FG000|Overall Study|Progression|13|||
126125780|NCT03246958|453752660|FG001|Overall Study|Progression|9|||
126125781|NCT03246958|453752661|FG002|Overall Study|Progression|3|||
126125782|NCT03246958|453752662|FG003|Overall Study|Progression|2|||
126125783|NCT03246958|453752663|FG004|Overall Study|Progression|1|||
126125784|NCT03246958|453752664|FG005|Overall Study|Progression|2|||
126125785|NCT03246958|453752665|FG006|Overall Study|Progression|1|||
126125786|NCT03246958|453752659|FG000|Overall Study|Adverse Event|2|||
126125787|NCT03246958|453752660|FG001|Overall Study|Adverse Event|2|||
126125788|NCT03246958|453752661|FG002|Overall Study|Adverse Event|0|||
126125789|NCT03246958|453752662|FG003|Overall Study|Adverse Event|1|||
126125790|NCT03246958|453752663|FG004|Overall Study|Adverse Event|1|||
126125791|NCT03246958|453752664|FG005|Overall Study|Adverse Event|0|||
126125792|NCT03246958|453752665|FG006|Overall Study|Adverse Event|2|||
126125793|NCT03246958|453752659|FG000|Overall Study|Death|0|||
126125794|NCT03246958|453752660|FG001|Overall Study|Death|1|||
126125795|NCT03246958|453752661|FG002|Overall Study|Death|0|||
126125796|NCT03246958|453752662|FG003|Overall Study|Death|0|||
126125797|NCT03246958|453752663|FG004|Overall Study|Death|0|||
126125798|NCT03246958|453752664|FG005|Overall Study|Death|0|||
126125799|NCT03246958|453752665|FG006|Overall Study|Death|0|||
126125800|NCT03246958|453752659|FG000|Overall Study|Physician Decision|0|||
125963785|NCT02460198|453157218|FG001|Overall Study|Death|28|||
126125801|NCT03246958|453752660|FG001|Overall Study|Physician Decision|0|||
125963786|NCT02460198|453157217|FG000|Overall Study|Lost to Follow-up|1|||
126125802|NCT03246958|453752661|FG002|Overall Study|Physician Decision|0|||
126125803|NCT03246958|453752662|FG003|Overall Study|Physician Decision|1|||
126125804|NCT03246958|453752663|FG004|Overall Study|Physician Decision|0|||
126125805|NCT03246958|453752664|FG005|Overall Study|Physician Decision|0|||
126125806|NCT03246958|453752665|FG006|Overall Study|Physician Decision|0|||
126125807|NCT03246958|453752659|FG000|Overall Study|Never start treatment|1|||
126125808|NCT03246958|453752660|FG001|Overall Study|Never start treatment|0|||
126125809|NCT03246958|453752661|FG002|Overall Study|Never start treatment|0|||
126125810|NCT03246958|453752662|FG003|Overall Study|Never start treatment|0|||
126125811|NCT03246958|453752663|FG004|Overall Study|Never start treatment|0|||
126125812|NCT03246958|453752664|FG005|Overall Study|Never start treatment|0|||
126125813|NCT03246958|453752665|FG006|Overall Study|Never start treatment|0|||
126125814|NCT03246958|453752659|FG000|Overall Study|Over enrollment|0|||
126125815|NCT03246958|453752660|FG001|Overall Study|Over enrollment|2|||
126125816|NCT03246958|453752661|FG002|Overall Study|Over enrollment|0|||
126125817|NCT03246958|453752662|FG003|Overall Study|Over enrollment|0|||
126125818|NCT03246958|453752663|FG004|Overall Study|Over enrollment|0|||
126125819|NCT03246958|453752664|FG005|Overall Study|Over enrollment|0|||
126125820|NCT03246958|453752665|FG006|Overall Study|Over enrollment|0|||
126125821|NCT03703102|453752666|FG000|Overall Study|Adverse Event|4|||
126125822|NCT03703102|453752667|FG001|Overall Study|Adverse Event|3|||
126125823|NCT03703102|453752668|FG002|Overall Study|Adverse Event|7|||
126125824|NCT03703102|453752669|FG003|Overall Study|Adverse Event|3|||
126125825|NCT03703102|453752670|FG004|Overall Study|Adverse Event|13|||
126125826|NCT03703102|453752666|FG000|Overall Study|Lack of Efficacy|4|||
126125827|NCT03703102|453752667|FG001|Overall Study|Lack of Efficacy|0|||
126125828|NCT03703102|453752668|FG002|Overall Study|Lack of Efficacy|1|||
126125829|NCT03703102|453752669|FG003|Overall Study|Lack of Efficacy|4|||
126125830|NCT03703102|453752670|FG004|Overall Study|Lack of Efficacy|1|||
126125831|NCT03703102|453752666|FG000|Overall Study|Lost to Follow-up|0|||
126125832|NCT03703102|453752667|FG001|Overall Study|Lost to Follow-up|0|||
126125833|NCT03703102|453752668|FG002|Overall Study|Lost to Follow-up|1|||
126125834|NCT03703102|453752669|FG003|Overall Study|Lost to Follow-up|2|||
126125835|NCT03703102|453752670|FG004|Overall Study|Lost to Follow-up|2|||
126125836|NCT03703102|453752666|FG000|Overall Study|Physician Decision|2|||
126125837|NCT03703102|453752667|FG001|Overall Study|Physician Decision|2|||
126125838|NCT03703102|453752668|FG002|Overall Study|Physician Decision|2|||
126125839|NCT03703102|453752669|FG003|Overall Study|Physician Decision|2|||
126125840|NCT03703102|453752670|FG004|Overall Study|Physician Decision|4|||
126125841|NCT03703102|453752666|FG000|Overall Study|Withdrawal by Subject|7|||
126125842|NCT03703102|453752667|FG001|Overall Study|Withdrawal by Subject|5|||
126125843|NCT03703102|453752668|FG002|Overall Study|Withdrawal by Subject|5|||
126125844|NCT03703102|453752669|FG003|Overall Study|Withdrawal by Subject|5|||
126125845|NCT03703102|453752670|FG004|Overall Study|Withdrawal by Subject|9|||
126125846|NCT03703102|453752666|FG000|Overall Study|Ineligibility|0|||
126125847|NCT03703102|453752667|FG001|Overall Study|Ineligibility|0|||
126125848|NCT03703102|453752668|FG002|Overall Study|Ineligibility|1|||
126125849|NCT03703102|453752669|FG003|Overall Study|Ineligibility|0|||
126125850|NCT03703102|453752670|FG004|Overall Study|Ineligibility|0|||
126125851|NCT03703102|453752666|FG000|Overall Study|Protocol Deviation|4|||
126125852|NCT03703102|453752667|FG001|Overall Study|Protocol Deviation|4|||
126125853|NCT03703102|453752668|FG002|Overall Study|Protocol Deviation|3|||
126125854|NCT03703102|453752669|FG003|Overall Study|Protocol Deviation|0|||
126125855|NCT03703102|453752670|FG004|Overall Study|Protocol Deviation|0|||
126125856|NCT03703102|453752666|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126125857|NCT03703102|453752667|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126125858|NCT03703102|453752668|FG002|Overall Study|Non-Compliance with Study Drug|2|||
126125859|NCT03703102|453752669|FG003|Overall Study|Non-Compliance with Study Drug|1|||
126125860|NCT03703102|453752670|FG004|Overall Study|Non-Compliance with Study Drug|4|||
126125861|NCT02311153|453752671|FG000|Overall Study|Lost to Follow-up|5|||
126125862|NCT02311153|453752672|FG001|Overall Study|Lost to Follow-up|7|||
126125863|NCT01379274|453752673|FG000|Overall Study|funding withdrawn|1|||
126125864|NCT03363321|453752675|FG000|Overall Study|Withdrawal by Subject|0|||
126125865|NCT03363321|453752676|FG001|Overall Study|Withdrawal by Subject|1|||
126125866|NCT03363321|453752677|FG002|Overall Study|Withdrawal by Subject|0|||
126125867|NCT03363321|453752678|FG003|Overall Study|Withdrawal by Subject|1|||
126125868|NCT03363321|453752679|FG004|Overall Study|Withdrawal by Subject|0|||
126125869|NCT00631020|453752682|FG000|Overall Study|Lost to Follow-up|7|||
126125870|NCT00631020|453752682|FG000|Overall Study|Incarcerated|1|||
126125871|NCT03221751|453752686|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
126125872|NCT03221751|453752687|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
126125873|NCT03571646|453752688|FG000|Overall Study|Adverse Event|1|||
126125874|NCT03571646|453752689|FG001|Overall Study|Adverse Event|0|||
126125875|NCT03571646|453752688|FG000|Overall Study|Withdrawal by Subject|1|||
126125876|NCT03571646|453752689|FG001|Overall Study|Withdrawal by Subject|1|||
126125877|NCT03548935|453752690|FG000|Overall Study|Withdrawal by Subject|26|||
126125878|NCT03548935|453752691|FG001|Overall Study|Withdrawal by Subject|17|||
126125879|NCT03548935|453752690|FG000|Overall Study|Lost to Follow-up|39|||
126125880|NCT03548935|453752691|FG001|Overall Study|Lost to Follow-up|28|||
126125881|NCT03548935|453752690|FG000|Overall Study|Death|1|||
126125882|NCT03548935|453752691|FG001|Overall Study|Death|1|||
126125883|NCT00763815|453752692|FG000|Overall Study|Adverse Event|14|||
126125884|NCT00763815|453752693|FG001|Overall Study|Adverse Event|29|||
126125885|NCT00763815|453752692|FG000|Overall Study|Lack of Efficacy|10|||
126125886|NCT00763815|453752693|FG001|Overall Study|Lack of Efficacy|11|||
126125887|NCT00763815|453752692|FG000|Overall Study|Poor Compliance to Protocol|6|||
126125888|NCT00763815|453752693|FG001|Overall Study|Poor Compliance to Protocol|6|||
126125889|NCT00763815|453752692|FG000|Overall Study|Lost to Follow-up|2|||
126125890|NCT00763815|453752693|FG001|Overall Study|Lost to Follow-up|4|||
126125891|NCT00763815|453752692|FG000|Overall Study|Early Termination|1|||
126125892|NCT00763815|453752693|FG001|Overall Study|Early Termination|0|||
126125893|NCT00763815|453752692|FG000|Overall Study|Familial and Personal Reasons|9|||
126125894|NCT00763815|453752693|FG001|Overall Study|Familial and Personal Reasons|16|||
126125895|NCT00763815|453752692|FG000|Overall Study|Physician Decision|1|||
126125896|NCT00763815|453752693|FG001|Overall Study|Physician Decision|0|||
126125897|NCT00763815|453752692|FG000|Overall Study|Withdrawal by Subject|7|||
126125898|NCT00763815|453752693|FG001|Overall Study|Withdrawal by Subject|12|||
126125899|NCT00763815|453752692|FG000|Overall Study|Protocol Violation|2|||
126125900|NCT00763815|453752693|FG001|Overall Study|Protocol Violation|5|||
126125901|NCT00763815|453752692|FG000|Overall Study|Sponsor's Decision|0|||
126125902|NCT00763815|453752693|FG001|Overall Study|Sponsor's Decision|1|||
126125903|NCT00283595|453752694|FG000|Overall Study|Withdrawal by Subject|1|||
126125904|NCT00283595|453752695|FG001|Overall Study|Withdrawal by Subject|2|||
126125905|NCT01263639|453752696|FG000|Overall Study|Lost to Follow-up|66|||
126125906|NCT01263639|453752697|FG001|Overall Study|Lost to Follow-up|70|||
126125907|NCT01263639|453752696|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
126125908|NCT01263639|453752697|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
126125909|NCT01576549|453752698|FG000|Overall Study|Sponsor Decision|2|||
126125910|NCT04951037|453752699|FG000|Overall Study|Lost to Follow-up|16|||
126125911|NCT04951037|453752699|FG000|Overall Study|Withdrawal by Subject|5|||
126125912|NCT04951037|453752699|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
126125913|NCT05630937|453752700|FG000|Overall Study|Study terminated by sponsor|1|||
126125914|NCT05630937|453752701|FG001|Overall Study|Study terminated by sponsor|1|||
126125915|NCT05630937|453752702|FG002|Overall Study|Study terminated by sponsor|8|||
126125916|NCT05630937|453752703|FG003|Overall Study|Study terminated by sponsor|0|||
126125917|NCT05630937|453752700|FG000|Overall Study|Lost to Follow-up|0|||
126125918|NCT05630937|453752701|FG001|Overall Study|Lost to Follow-up|0|||
126125919|NCT05630937|453752702|FG002|Overall Study|Lost to Follow-up|1|||
126125920|NCT05630937|453752703|FG003|Overall Study|Lost to Follow-up|0|||
126125921|NCT05630937|453752700|FG000|Overall Study|Enrolled but not treated|0|||
126125922|NCT05630937|453752701|FG001|Overall Study|Enrolled but not treated|0|||
126125923|NCT05630937|453752702|FG002|Overall Study|Enrolled but not treated|0|||
126125924|NCT05630937|453752703|FG003|Overall Study|Enrolled but not treated|1|||
126125925|NCT01604265|453752706|FG000|Overall Study|Adverse Event|1|||
126125926|NCT01604265|453752707|FG001|Overall Study|Adverse Event|0|||
126125927|NCT01604265|453752706|FG000|Overall Study|Withdrawal by Subject|1|||
126125928|NCT01604265|453752707|FG001|Overall Study|Withdrawal by Subject|0|||
126125929|NCT02706873|453752708|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
126125930|NCT02706873|453752709|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
126125931|NCT02706873|453752710|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
126125932|NCT02706873|453752711|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
126125933|NCT02706873|453752708|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
126125934|NCT02706873|453752709|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
126125935|NCT02706873|453752710|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
126125936|NCT02706873|453752711|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
126125937|NCT02706873|453752708|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
126125938|NCT02706873|453752709|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
126125939|NCT02706873|453752710|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
126125940|NCT02706873|453752711|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
126125941|NCT02706873|453752708|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
126125942|NCT02706873|453752709|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
126125943|NCT02706873|453752710|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
126125944|NCT02706873|453752711|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
126125945|NCT02706873|453752708|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
126125946|NCT02706873|453752709|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
125963787|NCT02460198|453157218|FG001|Overall Study|Lost to Follow-up|1|||
125963788|NCT02460198|453157217|FG000|Overall Study|Transferred to Extension Study|15|||
125963789|NCT02460198|453157218|FG001|Overall Study|Transferred to Extension Study|15|||
125963790|NCT02460198|453157217|FG000|Overall Study|Withdrawal by Subject|2|||
126125947|NCT02706873|453752710|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
126125948|NCT02706873|453752711|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
126125949|NCT02706873|453752708|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
126125950|NCT02706873|453752709|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
126125951|NCT02706873|453752710|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
126125952|NCT02706873|453752711|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
126125953|NCT02706873|453752708|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
126125954|NCT02706873|453752709|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
126125955|NCT02706873|453752710|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
126125956|NCT02706873|453752711|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
126125957|NCT02706873|453752708|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
126125958|NCT02706873|453752709|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
126125959|NCT02706873|453752710|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
126125960|NCT02706873|453752711|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
126125961|NCT02706873|453752708|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
126125962|NCT02706873|453752709|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
126125963|NCT02706873|453752710|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
126125964|NCT02706873|453752711|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
126125965|NCT02706873|453752708|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
126125966|NCT02706873|453752709|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
126125967|NCT02706873|453752710|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
126125968|NCT02706873|453752711|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
126125969|NCT02706873|453752708|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
126125970|NCT02706873|453752709|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
126125971|NCT02706873|453752710|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
126125972|NCT02706873|453752711|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
126125973|NCT02706873|453752708|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
126125974|NCT02706873|453752709|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
126125975|NCT02706873|453752710|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
126125976|NCT02706873|453752711|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
126125977|NCT02706873|453752708|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
126125978|NCT02706873|453752709|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
126125979|NCT02706873|453752710|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
126125980|NCT02706873|453752711|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
126125981|NCT00586495|453752712|FG000|Treatment Period|Adverse Event|11|||
126125982|NCT00586495|453752712|FG000|Treatment Period|Death|1|||
126125983|NCT00586495|453752712|FG000|Treatment Period|Protocol Violation|1|||
126125984|NCT00586495|453752712|FG000|Treatment Period|Withdrawal by Subject|1|||
126125985|NCT00586495|453752712|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
126125986|NCT00586495|453752712|FG000|Treatment Period|Switch to commercial drug|10|||
126125987|NCT00586495|453752712|FG000|Follow-up|Death|40|||
126125988|NCT00586495|453752712|FG000|Follow-up|Lost to Follow-up|1|||
126125989|NCT00586495|453752712|FG000|Follow-up|Withdrawal by Subject|4|||
126125990|NCT00586495|453752712|FG000|Follow-up|Protocol driven decision point|37|||
126125991|NCT00586495|453752712|FG000|Follow-up|Switch to commercial drug|10|||
126125992|NCT02595723|453752713|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
126125993|NCT02595723|453752714|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
126125994|NCT02595723|453752715|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
126125995|NCT02595723|453752713|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
126125996|NCT02595723|453752714|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
126125997|NCT02595723|453752715|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
126125998|NCT00004259|453752716|FG000|Overall Study|Protocol Violation|1|||
126125999|NCT00004259|453752717|FG001|Overall Study|Protocol Violation|2|||
126126000|NCT00004259|453752718|FG002|Overall Study|Protocol Violation|0|||
126126001|NCT00004259|453752719|FG003|Overall Study|Protocol Violation|0|||
126126002|NCT00004259|453752716|FG000|Overall Study|Withdrawal by Subject|0|||
126126003|NCT00004259|453752717|FG001|Overall Study|Withdrawal by Subject|2|||
126126004|NCT00004259|453752718|FG002|Overall Study|Withdrawal by Subject|0|||
126126005|NCT00004259|453752719|FG003|Overall Study|Withdrawal by Subject|0|||
126126006|NCT00996944|453752720|FG000|Double-blind Treatment Period|Adverse Event|2|||
126126007|NCT00996944|453752721|FG001|Double-blind Treatment Period|Adverse Event|1|||
126126008|NCT00996944|453752720|FG000|Double-blind Treatment Period|Protocol Violation|1|||
126126009|NCT00996944|453752721|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126126010|NCT00996944|453752720|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
126126011|NCT00996944|453752721|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
126126012|NCT00996944|453752720|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126126013|NCT00996944|453752721|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126126014|NCT00996944|453752720|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
126126015|NCT00996944|453752721|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
126126016|NCT00769184|453752722|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
126126017|NCT00769184|453752723|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
126126018|NCT00769184|453752722|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
125963791|NCT02460198|453157218|FG001|Overall Study|Withdrawal by Subject|4|||
126126019|NCT00769184|453752723|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
126126020|NCT00769184|453752722|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
126126021|NCT00769184|453752723|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
126126022|NCT00531752|453752724|FG000|First Double-blind Intervention Period|Adverse Event|2|||
126126023|NCT00531752|453752725|FG001|First Double-blind Intervention Period|Adverse Event|0|||
126126024|NCT00531752|453752726|FG002|First Double-blind Intervention Period|Adverse Event|1|||
125963792|NCT02460198|453157217|FG000|Overall Study|Site Terminated By Sponsor|0|||
126126025|NCT00531752|453752727|FG003|First Double-blind Intervention Period|Adverse Event|1|||
126126026|NCT00531752|453752724|FG000|First Double-blind Intervention Period|Other|1|||
126126027|NCT00531752|453752725|FG001|First Double-blind Intervention Period|Other|4|||
126126028|NCT00531752|453752726|FG002|First Double-blind Intervention Period|Other|4|||
126126029|NCT00531752|453752727|FG003|First Double-blind Intervention Period|Other|0|||
126126030|NCT00531752|453752724|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
126126031|NCT00531752|453752725|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
126126032|NCT00531752|453752726|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
126126033|NCT00531752|453752727|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
126126034|NCT00531752|453752724|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
126126035|NCT00531752|453752725|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
126126036|NCT00531752|453752726|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
126126037|NCT00531752|453752727|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
126126038|NCT00531752|453752724|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
126126039|NCT00531752|453752725|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
126126040|NCT00531752|453752726|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
126126041|NCT00531752|453752727|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
126126042|NCT00531752|453752724|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
126126043|NCT00531752|453752725|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
126126044|NCT00531752|453752726|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
126126045|NCT00531752|453752727|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
126126046|NCT00531752|453752724|FG000|Second Double-blind Intervention Period|Other|1|||
126126047|NCT00531752|453752725|FG001|Second Double-blind Intervention Period|Other|1|||
126126048|NCT00531752|453752726|FG002|Second Double-blind Intervention Period|Other|0|||
126126049|NCT00531752|453752727|FG003|Second Double-blind Intervention Period|Other|0|||
126126050|NCT00531752|453752724|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
126126051|NCT00531752|453752725|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
126126052|NCT00531752|453752726|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
126126053|NCT00531752|453752727|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
126126054|NCT00531752|453752724|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
126126055|NCT00531752|453752725|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
126126056|NCT00531752|453752726|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
126126057|NCT00531752|453752727|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
126126058|NCT00401375|453752730|FG000|Overall Study|Protocol Violation|2|||
126126059|NCT00401375|453752731|FG001|Overall Study|Protocol Violation|2|||
125963793|NCT02460198|453157218|FG001|Overall Study|Site Terminated By Sponsor|1|||
125963794|NCT02460198|453157217|FG000|Overall Study|Did Not Continue on Extension Study|6|||
126126060|NCT00401375|453752732|FG002|Overall Study|Protocol Violation|1|||
126126061|NCT00401375|453752730|FG000|Overall Study|Adverse Event|6|||
126126062|NCT00401375|453752731|FG001|Overall Study|Adverse Event|11|||
126126063|NCT00401375|453752732|FG002|Overall Study|Adverse Event|10|||
126126064|NCT00401375|453752730|FG000|Overall Study|Withdrawal by Subject|9|||
126126065|NCT00401375|453752731|FG001|Overall Study|Withdrawal by Subject|7|||
126126066|NCT00401375|453752732|FG002|Overall Study|Withdrawal by Subject|7|||
126126067|NCT00401375|453752730|FG000|Overall Study|Lost to Follow-up|0|||
126126068|NCT00401375|453752731|FG001|Overall Study|Lost to Follow-up|1|||
126126069|NCT00401375|453752732|FG002|Overall Study|Lost to Follow-up|1|||
126126070|NCT00401375|453752730|FG000|Overall Study|Other than specified|2|||
126126071|NCT00401375|453752731|FG001|Overall Study|Other than specified|1|||
126126072|NCT00401375|453752732|FG002|Overall Study|Other than specified|3|||
126126073|NCT00401375|453752730|FG000|Overall Study|Randomized but not treated|3|||
126126074|NCT00401375|453752731|FG001|Overall Study|Randomized but not treated|3|||
126126075|NCT00401375|453752732|FG002|Overall Study|Randomized but not treated|3|||
126126076|NCT00361270|453752733|FG000|Overall Study|Death|0|||
126126077|NCT00361270|453752734|FG001|Overall Study|Death|0|||
126126078|NCT00361270|453752735|FG002|Overall Study|Death|0|||
126126079|NCT00361270|453752736|FG003|Overall Study|Death|2|||
126126080|NCT00361270|453752733|FG000|Overall Study|Lost to Follow-up|4|||
126126081|NCT00361270|453752734|FG001|Overall Study|Lost to Follow-up|1|||
126126082|NCT00361270|453752735|FG002|Overall Study|Lost to Follow-up|0|||
126126083|NCT00361270|453752736|FG003|Overall Study|Lost to Follow-up|0|||
126126084|NCT00361270|453752733|FG000|Overall Study|Physician Decision|0|||
125963795|NCT02460198|453157218|FG001|Overall Study|Did Not Continue on Extension Study|11|||
125963796|NCT04382612|453157219|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
126126085|NCT00361270|453752734|FG001|Overall Study|Physician Decision|0|||
126126086|NCT00361270|453752735|FG002|Overall Study|Physician Decision|1|||
125963797|NCT04666441|453157220|FG000|Overall Study|Lost to Follow-up|1|||
125963798|NCT04666441|453157221|FG001|Overall Study|Lost to Follow-up|4|||
125963799|NCT04666441|453157222|FG002|Overall Study|Lost to Follow-up|1|||
126126087|NCT00361270|453752736|FG003|Overall Study|Physician Decision|0|||
126126088|NCT00361270|453752733|FG000|Overall Study|Protocol Violation|9|||
125963800|NCT04666441|453157223|FG003|Overall Study|Lost to Follow-up|3|||
126126089|NCT00361270|453752734|FG001|Overall Study|Protocol Violation|4|||
126126090|NCT00361270|453752735|FG002|Overall Study|Protocol Violation|5|||
126126091|NCT00361270|453752736|FG003|Overall Study|Protocol Violation|4|||
126126092|NCT00361270|453752733|FG000|Overall Study|Withdrawal by Subject|6|||
126126093|NCT00361270|453752734|FG001|Overall Study|Withdrawal by Subject|6|||
126126094|NCT00361270|453752735|FG002|Overall Study|Withdrawal by Subject|3|||
126126095|NCT00361270|453752736|FG003|Overall Study|Withdrawal by Subject|7|||
126126096|NCT00361270|453752733|FG000|Overall Study|Afraid of Hypnosis|1|||
126126097|NCT00361270|453752734|FG001|Overall Study|Afraid of Hypnosis|2|||
126126098|NCT00361270|453752735|FG002|Overall Study|Afraid of Hypnosis|0|||
126126099|NCT00361270|453752736|FG003|Overall Study|Afraid of Hypnosis|0|||
126126100|NCT00361270|453752733|FG000|Overall Study|Problems with Transportation|4|||
126126101|NCT00361270|453752734|FG001|Overall Study|Problems with Transportation|0|||
126126102|NCT00361270|453752735|FG002|Overall Study|Problems with Transportation|0|||
126126103|NCT00361270|453752736|FG003|Overall Study|Problems with Transportation|0|||
126126104|NCT00361270|453752733|FG000|Overall Study|Adverse Event|0|||
126126105|NCT00361270|453752734|FG001|Overall Study|Adverse Event|1|||
126126106|NCT00361270|453752735|FG002|Overall Study|Adverse Event|1|||
126126107|NCT00361270|453752736|FG003|Overall Study|Adverse Event|0|||
126126108|NCT00950664|453752738|FG000|First Intervention|Lost to Follow-up|1|||
126126109|NCT00950664|453752739|FG001|First Intervention|Lost to Follow-up|3|||
126126110|NCT00950664|453752738|FG000|First Intervention|Withdrawal by Subject|2|||
126126111|NCT00950664|453752739|FG001|First Intervention|Withdrawal by Subject|2|||
126126112|NCT02821715|453752740|FG000|Overall Study|Protocol Violation|1|||
126126113|NCT02821715|453752741|FG001|Overall Study|Protocol Violation|0|||
126126114|NCT02821715|453752742|FG002|Overall Study|Protocol Violation|0|||
126126115|NCT02821715|453752743|FG003|Overall Study|Protocol Violation|0|||
126126116|NCT02821715|453752744|FG004|Overall Study|Protocol Violation|0|||
126126117|NCT02821715|453752745|FG005|Overall Study|Protocol Violation|0|||
126126118|NCT00640328|453752746|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126126119|NCT00640328|453752747|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
126126120|NCT00640328|453752748|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126126121|NCT00640328|453752749|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126126122|NCT00640328|453752750|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126126123|NCT00640328|453752751|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126126124|NCT00640328|453752746|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126126125|NCT00640328|453752747|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126126126|NCT00640328|453752748|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126126127|NCT00640328|453752749|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126126128|NCT00640328|453752750|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
126126129|NCT00640328|453752751|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126126130|NCT00640328|453752746|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126126131|NCT00640328|453752747|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126126132|NCT00640328|453752748|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
126126133|NCT00640328|453752749|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126126134|NCT00640328|453752750|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126126135|NCT00640328|453752751|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126126136|NCT00640328|453752746|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
126126137|NCT00640328|453752747|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
126126138|NCT00640328|453752748|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
126126139|NCT00640328|453752749|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
125963801|NCT04666441|453157224|FG004|Overall Study|Lost to Follow-up|0|||
125963802|NCT04666441|453157225|FG005|Overall Study|Lost to Follow-up|2|||
125963803|NCT04666441|453157226|FG006|Overall Study|Lost to Follow-up|2|||
126126140|NCT00640328|453752750|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
126126141|NCT00640328|453752751|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
126126142|NCT01326546|453752752|FG000|Overall Study|Lost to Follow-up|8|||
126126143|NCT01326546|453752753|FG001|Overall Study|Lost to Follow-up|7|||
126126144|NCT01326546|453752752|FG000|Overall Study|Protocol Violation|3|||
126126145|NCT01326546|453752753|FG001|Overall Study|Protocol Violation|4|||
126126146|NCT01326546|453752752|FG000|Overall Study|Pregnancy|0|||
126126147|NCT01326546|453752753|FG001|Overall Study|Pregnancy|1|||
126126148|NCT01326546|453752752|FG000|Overall Study|Adverse Event|1|||
126126149|NCT01326546|453752753|FG001|Overall Study|Adverse Event|0|||
126126150|NCT01326546|453752752|FG000|Overall Study|Withdrawal by Subject|5|||
126126151|NCT01326546|453752753|FG001|Overall Study|Withdrawal by Subject|1|||
126126152|NCT04294719|453752754|FG000|Overall Study|Withdrawal by Subject|1|||
126126153|NCT01714687|453752755|FG000|Overall Study|Withdrawal by Subject|1|||
126126154|NCT01714687|453752756|FG001|Overall Study|Withdrawal by Subject|0|||
126126155|NCT01714687|453752755|FG000|Overall Study|Lost to Follow-up|2|||
126126156|NCT01714687|453752756|FG001|Overall Study|Lost to Follow-up|4|||
125963804|NCT04666441|453157227|FG007|Overall Study|Lost to Follow-up|2|||
126126157|NCT01979536|453752762|FG000|Overall Study|Physician Decision|2|||
126126158|NCT01979536|453752763|FG001|Overall Study|Physician Decision|3|||
126126159|NCT01979536|453752762|FG000|Overall Study|Withdrawal by Subject|0|||
126126160|NCT01979536|453752763|FG001|Overall Study|Withdrawal by Subject|1|||
126126161|NCT01979536|453752762|FG000|Overall Study|Refusal|0|||
126126162|NCT01979536|453752763|FG001|Overall Study|Refusal|1|||
126126163|NCT01979536|453752762|FG000|Overall Study|Relapse|0|||
126126164|NCT01979536|453752763|FG001|Overall Study|Relapse|1|||
126126165|NCT01979536|453752762|FG000|Overall Study|Study terminated by Sponsor|0|||
126126166|NCT01979536|453752763|FG001|Overall Study|Study terminated by Sponsor|1|||
126126167|NCT01979536|453752762|FG000|Overall Study|Did not start treatment|0|||
126126168|NCT01979536|453752763|FG001|Overall Study|Did not start treatment|1|||
126126169|NCT05038020|453752764|FG000|Overall Study|Early Termination|3|||
126126170|NCT05038020|453752765|FG001|Overall Study|Early Termination|0|||
126126171|NCT00609791|453754837|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
126126172|NCT02484911|453754838|FG000|Overall Study|Withdrawal by Subject|2|||
126126173|NCT02484911|453754839|FG001|Overall Study|Withdrawal by Subject|1|||
126126174|NCT02484911|453754838|FG000|Overall Study|Protocol Violation|2|||
126126175|NCT02484911|453754839|FG001|Overall Study|Protocol Violation|1|||
126126176|NCT04129528|453754840|FG000|Overall Study|Adverse Event|1|||
126126177|NCT04129528|453754841|FG001|Overall Study|Adverse Event|0|||
126126178|NCT04129528|453754840|FG000|Overall Study|Physician Decision|1|||
126126179|NCT04129528|453754841|FG001|Overall Study|Physician Decision|1|||
126126180|NCT04129528|453754840|FG000|Overall Study|Withdrawal by Subject|1|||
126126181|NCT04129528|453754841|FG001|Overall Study|Withdrawal by Subject|1|||
126126182|NCT01964352|453754846|FG000|Overall Study|Adverse Event|13|||
126126183|NCT01964352|453754847|FG001|Overall Study|Adverse Event|3|||
126126184|NCT01964352|453754848|FG002|Overall Study|Adverse Event|4|||
126126185|NCT01964352|453754849|FG003|Overall Study|Adverse Event|3|||
126126186|NCT01964352|453754846|FG000|Overall Study|Lack of Efficacy|6|||
126126187|NCT01964352|453754847|FG001|Overall Study|Lack of Efficacy|0|||
126126188|NCT01964352|453754848|FG002|Overall Study|Lack of Efficacy|0|||
126126189|NCT01964352|453754849|FG003|Overall Study|Lack of Efficacy|0|||
126126190|NCT01964352|453754846|FG000|Overall Study|Protocol Violation|2|||
126126191|NCT01964352|453754847|FG001|Overall Study|Protocol Violation|4|||
126126192|NCT01964352|453754848|FG002|Overall Study|Protocol Violation|0|||
126126193|NCT01964352|453754849|FG003|Overall Study|Protocol Violation|2|||
126126194|NCT01964352|453754846|FG000|Overall Study|Lost to Follow-up|1|||
126126195|NCT01964352|453754847|FG001|Overall Study|Lost to Follow-up|0|||
126126196|NCT01964352|453754848|FG002|Overall Study|Lost to Follow-up|0|||
126126197|NCT01964352|453754849|FG003|Overall Study|Lost to Follow-up|1|||
126126198|NCT01964352|453754846|FG000|Overall Study|Withdrawal by Subject|4|||
126126199|NCT01964352|453754847|FG001|Overall Study|Withdrawal by Subject|2|||
126126200|NCT01964352|453754848|FG002|Overall Study|Withdrawal by Subject|1|||
126126201|NCT01964352|453754849|FG003|Overall Study|Withdrawal by Subject|0|||
126126202|NCT01964352|453754846|FG000|Overall Study|Other than stated above|0|||
126126203|NCT01964352|453754847|FG001|Overall Study|Other than stated above|2|||
126126204|NCT01964352|453754848|FG002|Overall Study|Other than stated above|1|||
126126205|NCT01964352|453754849|FG003|Overall Study|Other than stated above|2|||
126126206|NCT00477165|453754852|FG000|Overall Study|Adverse Event|7|||
126126207|NCT00477165|453754853|FG001|Overall Study|Adverse Event|2|||
126126208|NCT00105443|453754854|FG000|Double-Blind Treatment|Adverse Event|1|||
126126209|NCT00105443|453754855|FG001|Double-Blind Treatment|Adverse Event|0|||
126126210|NCT00105443|453754856|FG002|Double-Blind Treatment|Adverse Event|0|||
126126211|NCT00105443|453754857|FG003|Double-Blind Treatment|Adverse Event|0|||
126126212|NCT00105443|453754854|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
126126213|NCT00105443|453754855|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
126126214|NCT00105443|453754856|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
125963805|NCT04666441|453157220|FG000|Overall Study|Subject Decision|1|||
125963806|NCT04666441|453157221|FG001|Overall Study|Subject Decision|1|||
125963807|NCT04666441|453157222|FG002|Overall Study|Subject Decision|3|||
125963808|NCT04666441|453157223|FG003|Overall Study|Subject Decision|1|||
126126215|NCT00105443|453754857|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
126126216|NCT00105443|453754854|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
126126217|NCT00105443|453754855|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
126126218|NCT00105443|453754856|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
126126219|NCT00105443|453754857|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
126126220|NCT00105443|453754854|FG000|Double-Blind Treatment|Physician Decision|1|||
126126221|NCT00105443|453754855|FG001|Double-Blind Treatment|Physician Decision|0|||
126126222|NCT00105443|453754856|FG002|Double-Blind Treatment|Physician Decision|2|||
126126223|NCT00105443|453754857|FG003|Double-Blind Treatment|Physician Decision|0|||
126126224|NCT00105443|453754854|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
126126225|NCT00105443|453754855|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
126126226|NCT00105443|453754856|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
126126227|NCT00105443|453754857|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
125963809|NCT04666441|453157224|FG004|Overall Study|Subject Decision|0|||
126126228|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
126126229|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
126126230|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
126126231|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
126126232|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
126126233|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
126126234|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
126126235|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
126126236|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
126126237|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
126126238|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
126126239|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
126126240|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
126126241|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
126126242|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
126126243|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
126126244|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
126126245|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
126126246|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
126126247|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
126126248|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
126126249|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
126126250|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
126126251|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
126126252|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
126126253|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
126126254|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
126126255|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
126126256|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
126126257|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
126126258|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
126126259|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
126126260|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
126126261|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
126126262|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
126126263|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
126126264|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
126126265|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
126126266|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
126126267|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
126126268|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
126126269|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
126126270|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
126126271|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
126126272|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
126126273|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
126126274|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
126126275|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
126126276|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
126126277|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
126126278|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
126126279|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
126126280|NCT00105443|453754854|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
126126281|NCT00105443|453754855|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
126126282|NCT00105443|453754856|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
126126283|NCT00105443|453754857|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
126126284|NCT01157078|453754858|FG000|Overall Study|Withdrawal by Subject|12|||
126126285|NCT01157078|453754859|FG001|Overall Study|Withdrawal by Subject|14|||
126126286|NCT01157078|453754858|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126126287|NCT01157078|453754859|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126126288|NCT01157078|453754858|FG000|Overall Study|Adverse Event|6|||
126126289|NCT01157078|453754859|FG001|Overall Study|Adverse Event|6|||
126126290|NCT01157078|453754858|FG000|Overall Study|Severe non-compliance to protocol|2|||
126126291|NCT01157078|453754859|FG001|Overall Study|Severe non-compliance to protocol|4|||
126126292|NCT01157078|453754858|FG000|Overall Study|Condition under investigation worsened|0|||
126126293|NCT01157078|453754859|FG001|Overall Study|Condition under investigation worsened|1|||
126126294|NCT01157078|453754858|FG000|Overall Study|Lack of Efficacy|2|||
126126295|NCT01157078|453754859|FG001|Overall Study|Lack of Efficacy|0|||
126126296|NCT01157078|453754858|FG000|Overall Study|Study-specific withdrawal criteria|2|||
126126297|NCT01157078|453754859|FG001|Overall Study|Study-specific withdrawal criteria|2|||
126126298|NCT01157078|453754858|FG000|Overall Study|Lost to Follow-up|7|||
126126299|NCT01157078|453754859|FG001|Overall Study|Lost to Follow-up|5|||
126126300|NCT01157078|453754858|FG000|Overall Study|Other|2|||
126126301|NCT01157078|453754859|FG001|Overall Study|Other|4|||
126126302|NCT00513409|453754864|FG000|Overall Study|Adverse Event|0|||
126126303|NCT00513409|453754865|FG001|Overall Study|Adverse Event|1|||
126126304|NCT00513409|453754864|FG000|Overall Study|Withdrawal by Subject|0|||
126126305|NCT00513409|453754865|FG001|Overall Study|Withdrawal by Subject|2|||
126126306|NCT00513409|453754864|FG000|Overall Study|Lost to Follow-up|0|||
126126307|NCT00513409|453754865|FG001|Overall Study|Lost to Follow-up|1|||
126126308|NCT00513409|453754864|FG000|Overall Study|Physician Decision|1|||
126126309|NCT00513409|453754865|FG001|Overall Study|Physician Decision|0|||
126126310|NCT00513409|453754864|FG000|Overall Study|Visit 3 not done|1|||
126126311|NCT00513409|453754865|FG001|Overall Study|Visit 3 not done|2|||
126126312|NCT03189446|453754866|FG000|Overall Study|Adverse Event|2|||
126126313|NCT03189446|453754866|FG000|Overall Study|Withdrawal by Subject|2|||
126126314|NCT03189446|453754866|FG000|Overall Study|Physician Decision|1|||
126126315|NCT05634577|453754867|FG000|Overall Study|Lost to Follow-up|1|||
126126316|NCT05634577|453754867|FG000|Overall Study|Withdrawal by Subject|1|||
126126317|NCT04839978|453754868|FG000|Overall Study|Lost to Follow-up|135|||
126126318|NCT04839978|453754869|FG001|Overall Study|Lost to Follow-up|147|||
126126319|NCT03865706|453754870|FG000|Overall Study|Death|0|||
126126320|NCT03865706|453754871|FG001|Overall Study|Death|3|||
126126321|NCT03865706|453754872|FG002|Overall Study|Death|1|||
126126322|NCT00781456|453754873|FG000|Overall Study|Adverse Event|3|||
126126323|NCT00781456|453754874|FG001|Overall Study|Adverse Event|3|||
126126324|NCT00781456|453754873|FG000|Overall Study|Withdrawal by Subject|3|||
126126325|NCT00781456|453754874|FG001|Overall Study|Withdrawal by Subject|5|||
126126326|NCT00781456|453754873|FG000|Overall Study|Protocol Violation|4|||
126126327|NCT00781456|453754874|FG001|Overall Study|Protocol Violation|1|||
126126328|NCT00781456|453754873|FG000|Overall Study|Noncompliance With Protocol|1|||
126126329|NCT00781456|453754874|FG001|Overall Study|Noncompliance With Protocol|1|||
126126330|NCT00781456|453754873|FG000|Overall Study|Lost to Follow-up|10|||
126126331|NCT00781456|453754874|FG001|Overall Study|Lost to Follow-up|5|||
126126332|NCT00781456|453754873|FG000|Overall Study|Other Reason, Unknown|0|||
126126333|NCT00781456|453754874|FG001|Overall Study|Other Reason, Unknown|1|||
126126334|NCT01594853|453754875|FG000|Overall Study|Withdrawal by Subject|1|||
126126335|NCT01594853|453754876|FG001|Overall Study|Withdrawal by Subject|1|||
126126336|NCT01594853|453754875|FG000|Overall Study|Lost to Follow-up|1|||
126126337|NCT01594853|453754876|FG001|Overall Study|Lost to Follow-up|1|||
126126338|NCT01594853|453754875|FG000|Overall Study|noncompliance with exercise|0|||
126126339|NCT01594853|453754876|FG001|Overall Study|noncompliance with exercise|1|||
126126340|NCT03709654|453754877|FG000|Overall Study|Lost to Follow-up|1|||
126126341|NCT03709654|453754878|FG001|Overall Study|Lost to Follow-up|1|||
126126342|NCT03709654|453754877|FG000|Overall Study|Withdrawal by Subject|1|||
126126343|NCT03709654|453754878|FG001|Overall Study|Withdrawal by Subject|1|||
126126344|NCT03709654|453754877|FG000|Overall Study|Adverse Event|1|||
126126345|NCT03709654|453754878|FG001|Overall Study|Adverse Event|0|||
126126346|NCT01902966|453754879|FG000|Overall Study|Death|1|||
126126347|NCT01902966|453754879|FG000|Overall Study|Physician Decision|1|||
126126348|NCT01902966|453754879|FG000|Overall Study|Withdrawal by Subject|1|||
126126349|NCT02631200|453754882|FG000|First Period|Death|1|||
126126350|NCT02631200|453754883|FG001|First Period|Death|2|||
125963810|NCT04666441|453157225|FG005|Overall Study|Subject Decision|1|||
125963811|NCT04666441|453157226|FG006|Overall Study|Subject Decision|3|||
126126351|NCT02631200|453754882|FG000|First Period|Patient ill-health|2|||
126126352|NCT02631200|453754883|FG001|First Period|Patient ill-health|4|||
126126353|NCT02631200|453754882|FG000|First Period|Withdrawal by Subject|4|||
126126354|NCT02631200|453754883|FG001|First Period|Withdrawal by Subject|1|||
126126355|NCT02631200|453754882|FG000|Deferred Period|Death|0|||
126126356|NCT02631200|453754883|FG001|Deferred Period|Death|1|||
126126357|NCT02631200|453754882|FG000|Deferred Period|Received kidney transplant|0|||
126126358|NCT02631200|453754883|FG001|Deferred Period|Received kidney transplant|1|||
126126359|NCT02631200|453754882|FG000|Deferred Period|Withdrawal by Subject|0|||
126126360|NCT02631200|453754883|FG001|Deferred Period|Withdrawal by Subject|2|||
126126361|NCT02631200|453754882|FG000|Deferred Period|Lost to Follow-up|0|||
126126362|NCT02631200|453754883|FG001|Deferred Period|Lost to Follow-up|1|||
126126363|NCT01081912|453754885|FG000|Conversion/Titration|Adverse Event|47|||
126126364|NCT01081912|453754886|FG001|Conversion/Titration|Adverse Event|0|||
126126365|NCT01081912|453754887|FG002|Conversion/Titration|Adverse Event|0|||
126126366|NCT01081912|453754885|FG000|Conversion/Titration|Lack of Efficacy|17|||
126126367|NCT01081912|453754886|FG001|Conversion/Titration|Lack of Efficacy|0|||
126126368|NCT01081912|453754887|FG002|Conversion/Titration|Lack of Efficacy|0|||
126126369|NCT01081912|453754885|FG000|Conversion/Titration|Lost to Follow-up|5|||
126126370|NCT01081912|453754886|FG001|Conversion/Titration|Lost to Follow-up|0|||
126126371|NCT01081912|453754887|FG002|Conversion/Titration|Lost to Follow-up|0|||
126126372|NCT01081912|453754885|FG000|Conversion/Titration|Physician Decision|2|||
126126373|NCT01081912|453754886|FG001|Conversion/Titration|Physician Decision|0|||
126126374|NCT01081912|453754887|FG002|Conversion/Titration|Physician Decision|0|||
126126375|NCT01081912|453754885|FG000|Conversion/Titration|Protocol Violation|67|||
126126376|NCT01081912|453754886|FG001|Conversion/Titration|Protocol Violation|0|||
126126377|NCT01081912|453754887|FG002|Conversion/Titration|Protocol Violation|0|||
126126378|NCT01081912|453754885|FG000|Conversion/Titration|Withdrawal by Subject|23|||
126126379|NCT01081912|453754886|FG001|Conversion/Titration|Withdrawal by Subject|0|||
126126380|NCT01081912|453754887|FG002|Conversion/Titration|Withdrawal by Subject|0|||
126126381|NCT01081912|453754885|FG000|Conversion/Titration|Non-Compliance|47|||
126126382|NCT01081912|453754886|FG001|Conversion/Titration|Non-Compliance|0|||
126126383|NCT01081912|453754887|FG002|Conversion/Titration|Non-Compliance|0|||
126126384|NCT01081912|453754885|FG000|Maintenance Treatment|Adverse Event|0|||
126126385|NCT01081912|453754886|FG001|Maintenance Treatment|Adverse Event|2|||
126126386|NCT01081912|453754887|FG002|Maintenance Treatment|Adverse Event|12|||
126126387|NCT01081912|453754885|FG000|Maintenance Treatment|Lack of Efficacy|0|||
126126388|NCT01081912|453754886|FG001|Maintenance Treatment|Lack of Efficacy|14|||
126126389|NCT01081912|453754887|FG002|Maintenance Treatment|Lack of Efficacy|64|||
126126390|NCT01081912|453754885|FG000|Maintenance Treatment|Lost to Follow-up|0|||
126126391|NCT01081912|453754886|FG001|Maintenance Treatment|Lost to Follow-up|1|||
126126392|NCT01081912|453754887|FG002|Maintenance Treatment|Lost to Follow-up|0|||
126126393|NCT01081912|453754885|FG000|Maintenance Treatment|Physician Decision|0|||
126126394|NCT01081912|453754886|FG001|Maintenance Treatment|Physician Decision|0|||
126126395|NCT01081912|453754887|FG002|Maintenance Treatment|Physician Decision|1|||
126126396|NCT01081912|453754885|FG000|Maintenance Treatment|Protocol Violation|0|||
126126397|NCT01081912|453754886|FG001|Maintenance Treatment|Protocol Violation|1|||
126126398|NCT01081912|453754887|FG002|Maintenance Treatment|Protocol Violation|2|||
126126399|NCT01081912|453754885|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
126126400|NCT01081912|453754886|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
126126401|NCT01081912|453754887|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
126126402|NCT01081912|453754885|FG000|Maintenance Treatment|Non-Compliance|0|||
126126403|NCT01081912|453754886|FG001|Maintenance Treatment|Non-Compliance|4|||
126126404|NCT01081912|453754887|FG002|Maintenance Treatment|Non-Compliance|7|||
126126405|NCT01081912|453754885|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
126126406|NCT01081912|453754886|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
126126407|NCT01081912|453754887|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
126126408|NCT03776175|453754889|FG000|Treatment Period (42 Days)|Adverse Event|0|||
126126409|NCT03776175|453754890|FG001|Treatment Period (42 Days)|Adverse Event|1|||
126126410|NCT03776175|453754891|FG002|Treatment Period (42 Days)|Adverse Event|1|||
126126411|NCT03776175|453754892|FG003|Treatment Period (42 Days)|Adverse Event|0|||
126126412|NCT03776175|453754889|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
126126413|NCT03776175|453754890|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
126126414|NCT03776175|453754891|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
126126415|NCT03776175|453754892|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
126126416|NCT03776175|453754889|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
126126417|NCT03776175|453754890|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
126126418|NCT03776175|453754891|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
126126419|NCT03776175|453754892|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
126126420|NCT03776175|453754889|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
126126421|NCT03776175|453754890|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
126126422|NCT03776175|453754891|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
126126423|NCT03776175|453754892|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
126126424|NCT03776175|453754889|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
126126425|NCT03776175|453754890|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
126126426|NCT03776175|453754891|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
126126427|NCT03776175|453754892|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
126126428|NCT03776175|453754889|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
126126429|NCT03776175|453754890|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
126126430|NCT03776175|453754891|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
126126431|NCT03776175|453754892|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
126126432|NCT04677712|453754894|FG000|Overall Study|Lost to Follow-up|0|||
126126433|NCT04677712|453754895|FG001|Overall Study|Lost to Follow-up|1|||
126126434|NCT04677712|453754896|FG002|Overall Study|Lost to Follow-up|0|||
126126435|NCT04677712|453754897|FG003|Overall Study|Lost to Follow-up|0|||
126126436|NCT04677712|453754898|FG004|Overall Study|Lost to Follow-up|0|||
126126437|NCT04677712|453754899|FG005|Overall Study|Lost to Follow-up|0|||
126126438|NCT00711100|453754900|FG000|Overall Study|Lack of Efficacy|5|||
126126439|NCT00711100|453754900|FG000|Overall Study|Withdrawal by Subject|8|||
126126440|NCT00783094|453754901|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
126126441|NCT00783094|453754902|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
126126442|NCT00783094|453754903|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
126126443|NCT00783094|453754901|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
126126444|NCT00783094|453754902|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
126126445|NCT00783094|453754903|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
126126446|NCT00783094|453754901|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
126126447|NCT00783094|453754902|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
126126448|NCT00783094|453754903|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
126126449|NCT00783094|453754901|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
126126450|NCT00783094|453754902|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
126126451|NCT00783094|453754903|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
126126452|NCT00783094|453754901|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
126126453|NCT00783094|453754902|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
126126454|NCT00783094|453754903|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
126126455|NCT00783094|453754901|FG000|Open-Label Extension Period|Adverse Event|12|||
126126456|NCT00783094|453754902|FG001|Open-Label Extension Period|Adverse Event|7|||
126126457|NCT00783094|453754903|FG002|Open-Label Extension Period|Adverse Event|16|||
126126458|NCT00783094|453754901|FG000|Open-Label Extension Period|Death|0|||
126126459|NCT00783094|453754902|FG001|Open-Label Extension Period|Death|0|||
126126460|NCT00783094|453754903|FG002|Open-Label Extension Period|Death|1|||
126126461|NCT00783094|453754901|FG000|Open-Label Extension Period|Protocol Violation|4|||
126126462|NCT00783094|453754902|FG001|Open-Label Extension Period|Protocol Violation|5|||
126126463|NCT00783094|453754903|FG002|Open-Label Extension Period|Protocol Violation|7|||
126126464|NCT00783094|453754901|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
126126465|NCT00783094|453754902|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
126126466|NCT00783094|453754903|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
126126467|NCT00783094|453754901|FG000|Open-Label Extension Period|Physician Decision|4|||
126126468|NCT00783094|453754902|FG001|Open-Label Extension Period|Physician Decision|2|||
126126469|NCT00783094|453754903|FG002|Open-Label Extension Period|Physician Decision|3|||
126126470|NCT00783094|453754901|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
126126471|NCT00783094|453754902|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
126126472|NCT00783094|453754903|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
126126473|NCT02513329|453754904|FG000|Overall Study|Lost to Follow-up|5|||
126126474|NCT02513329|453754905|FG001|Overall Study|Lost to Follow-up|2|||
126126475|NCT01294670|453754906|FG000|Overall Study|Not treated|1|||
126126476|NCT01294670|453754907|FG001|Overall Study|Not treated|0|||
126126477|NCT01294670|453754908|FG002|Overall Study|Not treated|0|||
126126478|NCT01294670|453754909|FG003|Overall Study|Not treated|0|||
126126479|NCT01294670|453754910|FG004|Overall Study|Not treated|0|||
126126480|NCT02083380|453754914|FG000|Overall Study|Lack of Efficacy|68|||
126126481|NCT02083380|453754915|FG001|Overall Study|Lack of Efficacy|79|||
126126482|NCT02083380|453754916|FG002|Overall Study|Lack of Efficacy|64|||
126126483|NCT02083380|453754914|FG000|Overall Study|Withdrawal by Subject|9|||
126126484|NCT02083380|453754915|FG001|Overall Study|Withdrawal by Subject|3|||
126126485|NCT02083380|453754916|FG002|Overall Study|Withdrawal by Subject|7|||
126126486|NCT02083380|453754914|FG000|Overall Study|Physician Decision|1|||
126126487|NCT02083380|453754915|FG001|Overall Study|Physician Decision|6|||
126126488|NCT02083380|453754916|FG002|Overall Study|Physician Decision|3|||
126126489|NCT02083380|453754914|FG000|Overall Study|Adverse Event|0|||
126126490|NCT02083380|453754915|FG001|Overall Study|Adverse Event|0|||
126126491|NCT02083380|453754916|FG002|Overall Study|Adverse Event|1|||
126126492|NCT02083380|453754914|FG000|Overall Study|Lost to Follow-up|5|||
126126493|NCT02083380|453754915|FG001|Overall Study|Lost to Follow-up|3|||
126126494|NCT02083380|453754916|FG002|Overall Study|Lost to Follow-up|3|||
126126495|NCT02083380|453754914|FG000|Overall Study|Other|8|||
126126496|NCT02083380|453754915|FG001|Overall Study|Other|4|||
126126497|NCT02083380|453754916|FG002|Overall Study|Other|6|||
126126498|NCT02412787|453754917|FG000|Overall Study|Withdrawal by Subject|9|||
126126499|NCT02412787|453754917|FG000|Overall Study|Participation Terminated by Investigator|1|||
126126500|NCT02412787|453754917|FG000|Overall Study|Site Terminated by Sponsor|21|||
126126501|NCT02412787|453754917|FG000|Overall Study|Technical Problems|1|||
126126502|NCT02412787|453754917|FG000|Overall Study|Reason Not Specified|1|||
126126503|NCT00876187|453754923|FG000|Overall Study|Adverse Event|14|||
126126504|NCT00876187|453754924|FG001|Overall Study|Adverse Event|12|||
126126505|NCT00876187|453754925|FG002|Overall Study|Adverse Event|19|||
126126506|NCT00876187|453754926|FG003|Overall Study|Adverse Event|29|||
126126507|NCT00876187|453754927|FG004|Overall Study|Adverse Event|10|||
126126508|NCT00876187|453754923|FG000|Overall Study|Lack of Efficacy|59|||
126126509|NCT00876187|453754924|FG001|Overall Study|Lack of Efficacy|34|||
126126510|NCT00876187|453754925|FG002|Overall Study|Lack of Efficacy|45|||
126126511|NCT00876187|453754926|FG003|Overall Study|Lack of Efficacy|34|||
126126512|NCT00876187|453754927|FG004|Overall Study|Lack of Efficacy|59|||
126126513|NCT00876187|453754923|FG000|Overall Study|Lost to Follow-up|9|||
126126514|NCT00876187|453754924|FG001|Overall Study|Lost to Follow-up|10|||
126126515|NCT00876187|453754925|FG002|Overall Study|Lost to Follow-up|8|||
126126516|NCT00876187|453754926|FG003|Overall Study|Lost to Follow-up|8|||
126126517|NCT00876187|453754927|FG004|Overall Study|Lost to Follow-up|11|||
126126518|NCT00876187|453754923|FG000|Overall Study|Protocol Violation|6|||
126126519|NCT00876187|453754924|FG001|Overall Study|Protocol Violation|7|||
126126520|NCT00876187|453754925|FG002|Overall Study|Protocol Violation|7|||
126126521|NCT00876187|453754926|FG003|Overall Study|Protocol Violation|6|||
126126522|NCT00876187|453754927|FG004|Overall Study|Protocol Violation|3|||
126126523|NCT00876187|453754923|FG000|Overall Study|Withdrawal by Subject|16|||
126126524|NCT00876187|453754924|FG001|Overall Study|Withdrawal by Subject|26|||
126126525|NCT00876187|453754925|FG002|Overall Study|Withdrawal by Subject|32|||
126126526|NCT00876187|453754926|FG003|Overall Study|Withdrawal by Subject|38|||
126126527|NCT00876187|453754927|FG004|Overall Study|Withdrawal by Subject|37|||
126126528|NCT00876187|453754923|FG000|Overall Study|Entered extension study|101|||
126126529|NCT00876187|453754924|FG001|Overall Study|Entered extension study|120|||
126126530|NCT00876187|453754925|FG002|Overall Study|Entered extension study|156|||
126126531|NCT00876187|453754926|FG003|Overall Study|Entered extension study|151|||
126126532|NCT00876187|453754927|FG004|Overall Study|Entered extension study|144|||
126126533|NCT00876187|453754923|FG000|Overall Study|Randomized but not treated|3|||
126126534|NCT00876187|453754924|FG001|Overall Study|Randomized but not treated|1|||
126126535|NCT00876187|453754925|FG002|Overall Study|Randomized but not treated|3|||
126126536|NCT00876187|453754926|FG003|Overall Study|Randomized but not treated|2|||
126126537|NCT00876187|453754927|FG004|Overall Study|Randomized but not treated|3|||
126126538|NCT00876187|453754923|FG000|Overall Study|Other|2|||
126126539|NCT00876187|453754924|FG001|Overall Study|Other|5|||
126126540|NCT00876187|453754925|FG002|Overall Study|Other|9|||
126126541|NCT00876187|453754926|FG003|Overall Study|Other|7|||
126126542|NCT00876187|453754927|FG004|Overall Study|Other|4|||
126126543|NCT00405067|453754932|FG000|Overall Study|Adverse Event|4|||
126126544|NCT00405067|453754933|FG001|Overall Study|Adverse Event|9|||
126126545|NCT00405067|453754934|FG002|Overall Study|Adverse Event|4|||
126126546|NCT00405067|453754932|FG000|Overall Study|Lost to Follow-up|0|||
126126547|NCT00405067|453754933|FG001|Overall Study|Lost to Follow-up|0|||
126126548|NCT00405067|453754934|FG002|Overall Study|Lost to Follow-up|1|||
126126549|NCT01650636|453754935|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
126126550|NCT01650636|453754936|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
126126551|NCT01650636|453754935|FG000|Washout up to 5 Months|Physician Decision|2|||
126126552|NCT01650636|453754936|FG001|Washout up to 5 Months|Physician Decision|2|||
126126553|NCT01650636|453754935|FG000|Washout up to 5 Months|Death|1|||
126126554|NCT01650636|453754936|FG001|Washout up to 5 Months|Death|0|||
126126555|NCT01650636|453754935|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
126126556|NCT01650636|453754936|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
126126557|NCT01650636|453754935|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
126126558|NCT01650636|453754936|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
126126559|NCT01650636|453754935|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
126126560|NCT01650636|453754936|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
126126561|NCT01560780|453754937|FG000|Overall Study|Death|2|||
126126562|NCT01560780|453754938|FG001|Overall Study|Death|1|||
126126563|NCT01560780|453754937|FG000|Overall Study|Patient Preference|11|||
126126564|NCT01560780|453754938|FG001|Overall Study|Patient Preference|11|||
126126565|NCT01032915|453754939|FG000|Overall Study|Adverse Event|2|||
126126566|NCT01032915|453754940|FG001|Overall Study|Adverse Event|2|||
126126567|NCT01032915|453754941|FG002|Overall Study|Adverse Event|1|||
126126568|NCT01032915|453754942|FG003|Overall Study|Adverse Event|1|||
126126569|NCT01032915|453754939|FG000|Overall Study|Abnormal test procedure result|0|||
126126570|NCT01032915|453754940|FG001|Overall Study|Abnormal test procedure result|0|||
126126571|NCT01032915|453754941|FG002|Overall Study|Abnormal test procedure result|1|||
126126572|NCT01032915|453754942|FG003|Overall Study|Abnormal test procedure result|0|||
125963812|NCT04666441|453157227|FG007|Overall Study|Subject Decision|2|||
125963813|NCT02752048|453157228|FG000|Overall Study|Withdrawal by Subject|0|||
125963814|NCT02752048|453157229|FG001|Overall Study|Withdrawal by Subject|0|||
125963815|NCT02752048|453157230|FG002|Overall Study|Withdrawal by Subject|3|||
125963816|NCT01312467|453157233|FG000|Overall Study|Adverse Event|4|||
126126573|NCT01032915|453754939|FG000|Overall Study|Withdrawal by Subject|0|||
126126574|NCT01032915|453754940|FG001|Overall Study|Withdrawal by Subject|3|||
126126575|NCT01032915|453754941|FG002|Overall Study|Withdrawal by Subject|1|||
126126576|NCT01032915|453754942|FG003|Overall Study|Withdrawal by Subject|1|||
126126577|NCT01032915|453754939|FG000|Overall Study|Administrative reasons|5|||
125963817|NCT01312467|453157233|FG000|Overall Study|Lost to Follow-up|1|||
125963818|NCT01312467|453157233|FG000|Overall Study|Withdrawal by Subject|2|||
126126578|NCT01032915|453754940|FG001|Overall Study|Administrative reasons|6|||
126126579|NCT01032915|453754941|FG002|Overall Study|Administrative reasons|4|||
126126580|NCT01032915|453754942|FG003|Overall Study|Administrative reasons|4|||
126126581|NCT01032915|453754939|FG000|Overall Study|Protocol Violation|1|||
126126582|NCT01032915|453754940|FG001|Overall Study|Protocol Violation|0|||
126126583|NCT01032915|453754941|FG002|Overall Study|Protocol Violation|0|||
126126584|NCT01032915|453754942|FG003|Overall Study|Protocol Violation|1|||
125963819|NCT01312467|453157233|FG000|Overall Study|Deported to country of origin|1|||
126126585|NCT01577186|453754943|FG000|Overall Study|Adverse Event|23|||
126126586|NCT01577186|453754943|FG000|Overall Study|Death|1|||
126126587|NCT01577186|453754943|FG000|Overall Study|Lost to Follow-up|28|||
126126588|NCT01577186|453754943|FG000|Overall Study|Withdrawal by Subject|35|||
126126589|NCT01577186|453754943|FG000|Overall Study|Insufficient Response|18|||
126126590|NCT01577186|453754943|FG000|Overall Study|Ineligible to Continue|15|||
126126591|NCT01577186|453754943|FG000|Overall Study|Non-Compliant|8|||
126126592|NCT01577186|453754943|FG000|Overall Study|Other|2|||
126126593|NCT02915523|453754945|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
126126594|NCT02915523|453754946|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
126126595|NCT02915523|453754947|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
126126596|NCT02915523|453754948|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
126126597|NCT02915523|453754945|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
126126598|NCT02915523|453754946|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
126126599|NCT02915523|453754947|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
126126600|NCT02915523|453754948|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
126126601|NCT02915523|453754945|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
126126602|NCT02915523|453754946|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
126126603|NCT02915523|453754947|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
126126604|NCT02915523|453754948|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
126126605|NCT02915523|453754945|FG000|Expansion Phase (Phase 2)|Death|0|||
126126606|NCT02915523|453754946|FG001|Expansion Phase (Phase 2)|Death|0|||
126126607|NCT02915523|453754947|FG002|Expansion Phase (Phase 2)|Death|26|||
126126608|NCT02915523|453754948|FG003|Expansion Phase (Phase 2)|Death|53|||
126126609|NCT02915523|453754945|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
126126610|NCT02915523|453754946|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
126126611|NCT02915523|453754947|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
126126612|NCT02915523|453754948|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
126126613|NCT02915523|453754945|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
126126614|NCT02915523|453754946|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
126126615|NCT02915523|453754947|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
126126616|NCT02915523|453754948|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
126126617|NCT02915523|453754945|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
126126618|NCT02915523|453754946|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
126126619|NCT02915523|453754947|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
126126620|NCT02915523|453754948|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
126126621|NCT03287219|453754949|FG000|Overall Study|Protocol Violation|0|||
126126622|NCT03287219|453754950|FG001|Overall Study|Protocol Violation|2|||
126126623|NCT00930761|453754951|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
126126624|NCT00930761|453754952|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
126126625|NCT00930761|453754951|FG000|Overall Study|less than 3 music therapy sessions|0|||
126126626|NCT00930761|453754952|FG001|Overall Study|less than 3 music therapy sessions|3|||
126126627|NCT00957008|453754953|FG000|Overall Study|Withdrawal by Subject|13|||
126126628|NCT00957008|453754954|FG001|Overall Study|Withdrawal by Subject|10|||
126126629|NCT00957008|453754955|FG002|Overall Study|Withdrawal by Subject|12|||
126126630|NCT00957008|453754956|FG003|Overall Study|Withdrawal by Subject|16|||
126126631|NCT00957008|453754953|FG000|Overall Study|Lost to Follow-up|3|||
126126632|NCT00957008|453754954|FG001|Overall Study|Lost to Follow-up|1|||
126126633|NCT00957008|453754955|FG002|Overall Study|Lost to Follow-up|3|||
126126634|NCT00957008|453754956|FG003|Overall Study|Lost to Follow-up|4|||
126126635|NCT00957008|453754953|FG000|Overall Study|Physician Decision|1|||
125963820|NCT01312467|453157233|FG000|Overall Study|Another medical condition|1|||
125963821|NCT01312467|453157233|FG000|Overall Study|Ineligible|4|||
125963822|NCT00132769|453157234|FG000|Overall Study|Withdrawal by Subject|1|||
125963823|NCT00132769|453157235|FG001|Overall Study|Withdrawal by Subject|3|||
125963824|NCT00132769|453157234|FG000|Overall Study|Lack of Efficacy|7|||
126126636|NCT00957008|453754954|FG001|Overall Study|Physician Decision|0|||
126126637|NCT00957008|453754955|FG002|Overall Study|Physician Decision|1|||
126126638|NCT00957008|453754956|FG003|Overall Study|Physician Decision|1|||
126126639|NCT00957008|453754953|FG000|Overall Study|Relocated; Family conflict|4|||
126126640|NCT00957008|453754954|FG001|Overall Study|Relocated; Family conflict|1|||
126126641|NCT00957008|453754955|FG002|Overall Study|Relocated; Family conflict|1|||
126126642|NCT00957008|453754956|FG003|Overall Study|Relocated; Family conflict|3|||
126126643|NCT00915681|453754957|FG000|Overall Study|Screening failures|46|||
126126644|NCT01118351|453754958|FG000|Overall Study|Adverse Event|3|||
126126645|NCT01118351|453754958|FG000|Overall Study|Withdrawal by Subject|1|||
126126646|NCT00811135|453754959|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
125963825|NCT00132769|453157235|FG001|Overall Study|Lack of Efficacy|6|||
125963826|NCT00132769|453157234|FG000|Overall Study|Adverse Event|2|||
125963827|NCT00132769|453157235|FG001|Overall Study|Adverse Event|1|||
126126647|NCT00811135|453754959|FG000|Overall Study|Death|3|||
126126648|NCT00811135|453754959|FG000|Overall Study|Protocol Violation|2|||
126126649|NCT00811135|453754959|FG000|Overall Study|Violation of Selection Criteria|1|||
125963828|NCT00132769|453157234|FG000|Overall Study|Protocol Violation|1|||
125963829|NCT00132769|453157235|FG001|Overall Study|Protocol Violation|1|||
126126650|NCT00811135|453754959|FG000|Overall Study|Refused Treatment|1|||
126126651|NCT00811135|453754959|FG000|Overall Study|Withdrawal by Subject|3|||
126126652|NCT00811135|453754959|FG000|Overall Study|Administrative/Other Unspecified|11|||
126126653|NCT00811135|453754959|FG000|Overall Study|Ongoing|59|||
126126654|NCT04677959|453754971|FG000|Overall Study|Adverse Event|1|||
126126655|NCT04677959|453754972|FG001|Overall Study|Adverse Event|9|||
126126656|NCT04677959|453754971|FG000|Overall Study|Withdrawal by Subject|2|||
126126657|NCT04677959|453754972|FG001|Overall Study|Withdrawal by Subject|15|||
126126658|NCT04677959|453754971|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126126659|NCT04677959|453754972|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126126660|NCT04677959|453754971|FG000|Overall Study|Non-compliance with study drug|0|||
126126661|NCT04677959|453754972|FG001|Overall Study|Non-compliance with study drug|2|||
126126662|NCT04677959|453754971|FG000|Overall Study|Protocol deviation|0|||
126126663|NCT04677959|453754972|FG001|Overall Study|Protocol deviation|11|||
126126664|NCT04677959|453754971|FG000|Overall Study|Lost to Follow-up|9|||
126126665|NCT04677959|453754972|FG001|Overall Study|Lost to Follow-up|13|||
126126666|NCT04677959|453754971|FG000|Overall Study|Other than specified|0|||
126126667|NCT04677959|453754972|FG001|Overall Study|Other than specified|8|||
126126668|NCT01970995|453754973|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
126126669|NCT01970995|453754974|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
126126670|NCT01970995|453754975|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
126126671|NCT01970995|453754973|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
126126672|NCT01970995|453754974|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
126126673|NCT01970995|453754975|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
126126674|NCT00845728|453754976|FG000|Overall Study|Abnormal laboratory value (s)|2|||
126126675|NCT00845728|453754977|FG001|Overall Study|Abnormal laboratory value (s)|2|||
126126676|NCT00845728|453754976|FG000|Overall Study|Patient's inability to use the device|4|||
126126677|NCT00845728|453754977|FG001|Overall Study|Patient's inability to use the device|6|||
126126678|NCT00845728|453754976|FG000|Overall Study|Abnormal test procedure result (s)|7|||
126126679|NCT00845728|453754977|FG001|Overall Study|Abnormal test procedure result (s)|2|||
126126680|NCT00845728|453754976|FG000|Overall Study|Lost to Follow-up|22|||
126126681|NCT00845728|453754977|FG001|Overall Study|Lost to Follow-up|13|||
126126682|NCT00845728|453754976|FG000|Overall Study|Death|24|||
126126683|NCT00845728|453754977|FG001|Overall Study|Death|26|||
126126684|NCT00845728|453754976|FG000|Overall Study|Administrative Problems|34|||
126126685|NCT00845728|453754977|FG001|Overall Study|Administrative Problems|26|||
126126686|NCT00845728|453754976|FG000|Overall Study|Protocol Violation|36|||
125963830|NCT03136068|453159280|FG000|Overall Study|Lost to Follow-up|1|||
125963831|NCT03136068|453159281|FG001|Overall Study|Lost to Follow-up|1|||
125963832|NCT03136068|453159280|FG000|Overall Study|Protocol Violation|1|||
125963833|NCT03136068|453159281|FG001|Overall Study|Protocol Violation|0|||
125963834|NCT00432380|453159287|FG000|Overall Study|Migrated/moved from study area|3|||
125963835|NCT00432380|453159288|FG001|Overall Study|Migrated/moved from study area|4|||
125963836|NCT00432380|453159289|FG002|Overall Study|Migrated/moved from study area|1|||
125963837|NCT00432380|453159287|FG000|Overall Study|Adverse Event|1|||
125963838|NCT00432380|453159288|FG001|Overall Study|Adverse Event|0|||
125963839|NCT00432380|453159289|FG002|Overall Study|Adverse Event|0|||
125963840|NCT01071395|453159297|FG000|Overall Study|Withdrawal by Subject|2|||
125963841|NCT01071395|453159298|FG001|Overall Study|Withdrawal by Subject|1|||
125963842|NCT01071395|453159297|FG000|Overall Study|Adverse Event|3|||
125963843|NCT01071395|453159298|FG001|Overall Study|Adverse Event|1|||
125963844|NCT01539291|453159299|FG000|Study GS-US-312-0116|Adverse Event|9|||
125963845|NCT01539291|453159300|FG001|Study GS-US-312-0116|Adverse Event|0|||
125963846|NCT01539291|453159301|FG002|Study GS-US-312-0116|Adverse Event|0|||
125963847|NCT01539291|453159302|FG003|Study GS-US-312-0116|Adverse Event|0|||
125963848|NCT01539291|453159299|FG000|Study GS-US-312-0116|Physician Decision|1|||
125963849|NCT01539291|453159300|FG001|Study GS-US-312-0116|Physician Decision|0|||
125963850|NCT01539291|453159301|FG002|Study GS-US-312-0116|Physician Decision|0|||
126126687|NCT00845728|453754977|FG001|Overall Study|Protocol Violation|24|||
126126688|NCT00845728|453754976|FG000|Overall Study|Lack of Efficacy|51|||
125963851|NCT01539291|453159302|FG003|Study GS-US-312-0116|Physician Decision|0|||
125963852|NCT01539291|453159299|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
125963853|NCT01539291|453159300|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
125963854|NCT01539291|453159301|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
125963855|NCT01539291|453159302|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
125963856|NCT01539291|453159299|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
125963857|NCT01539291|453159300|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
125963858|NCT01539291|453159301|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
126126689|NCT00845728|453754977|FG001|Overall Study|Lack of Efficacy|39|||
126126690|NCT00845728|453754976|FG000|Overall Study|Adverse Event|101|||
126126691|NCT00845728|453754977|FG001|Overall Study|Adverse Event|96|||
125963859|NCT01539291|453159302|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
126126692|NCT00845728|453754976|FG000|Overall Study|Withdrawal by Subject|105|||
126126693|NCT00845728|453754977|FG001|Overall Study|Withdrawal by Subject|108|||
126126694|NCT02599961|453754984|FG000|Overall Study|Withdrawal by Subject|1|||
126126695|NCT02599961|453754984|FG000|Overall Study|Subject Non-Compliance|2|||
126126696|NCT02599961|453754984|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
126126697|NCT02599961|453754984|FG000|Overall Study|Other, Not Specified|3|||
126126698|NCT00464334|453754987|FG000|Overall Study|Adverse Event|0|||
126126699|NCT00464334|453754988|FG001|Overall Study|Adverse Event|0|||
126126700|NCT00464334|453754989|FG002|Overall Study|Adverse Event|0|||
126126701|NCT00464334|453754990|FG003|Overall Study|Adverse Event|1|||
126126702|NCT00464334|453754991|FG004|Overall Study|Adverse Event|1|||
126126703|NCT00464334|453754992|FG005|Overall Study|Adverse Event|1|||
126126704|NCT00464334|453754993|FG006|Overall Study|Adverse Event|0|||
126126705|NCT00464334|453754994|FG007|Overall Study|Adverse Event|0|||
126126706|NCT00464334|453754995|FG008|Overall Study|Adverse Event|2|||
126126707|NCT00464334|453754996|FG009|Overall Study|Adverse Event|1|||
126126708|NCT00464334|453754997|FG010|Overall Study|Adverse Event|2|||
126126709|NCT00464334|453754987|FG000|Overall Study|Lack of Efficacy|0|||
126126710|NCT00464334|453754988|FG001|Overall Study|Lack of Efficacy|1|||
126126711|NCT00464334|453754989|FG002|Overall Study|Lack of Efficacy|0|||
126126712|NCT00464334|453754990|FG003|Overall Study|Lack of Efficacy|0|||
126126713|NCT00464334|453754991|FG004|Overall Study|Lack of Efficacy|0|||
126126714|NCT00464334|453754992|FG005|Overall Study|Lack of Efficacy|0|||
126126715|NCT00464334|453754993|FG006|Overall Study|Lack of Efficacy|0|||
126126716|NCT00464334|453754994|FG007|Overall Study|Lack of Efficacy|0|||
126126717|NCT00464334|453754995|FG008|Overall Study|Lack of Efficacy|0|||
126126718|NCT00464334|453754996|FG009|Overall Study|Lack of Efficacy|0|||
126126719|NCT00464334|453754997|FG010|Overall Study|Lack of Efficacy|0|||
126126720|NCT00464334|453754987|FG000|Overall Study|Lost to Follow-up|0|||
126126721|NCT00464334|453754988|FG001|Overall Study|Lost to Follow-up|0|||
126126722|NCT00464334|453754989|FG002|Overall Study|Lost to Follow-up|1|||
126126723|NCT00464334|453754990|FG003|Overall Study|Lost to Follow-up|0|||
126126724|NCT00464334|453754991|FG004|Overall Study|Lost to Follow-up|1|||
126126725|NCT00464334|453754992|FG005|Overall Study|Lost to Follow-up|0|||
126126726|NCT00464334|453754993|FG006|Overall Study|Lost to Follow-up|1|||
126126727|NCT00464334|453754994|FG007|Overall Study|Lost to Follow-up|0|||
126126728|NCT00464334|453754995|FG008|Overall Study|Lost to Follow-up|0|||
126126729|NCT00464334|453754996|FG009|Overall Study|Lost to Follow-up|0|||
126126730|NCT00464334|453754997|FG010|Overall Study|Lost to Follow-up|2|||
126126731|NCT00464334|453754987|FG000|Overall Study|Progressive Disease|0|||
126126732|NCT00464334|453754988|FG001|Overall Study|Progressive Disease|0|||
126126733|NCT00464334|453754989|FG002|Overall Study|Progressive Disease|0|||
126126734|NCT00464334|453754990|FG003|Overall Study|Progressive Disease|0|||
126126735|NCT00464334|453754991|FG004|Overall Study|Progressive Disease|0|||
126126736|NCT00464334|453754992|FG005|Overall Study|Progressive Disease|1|||
126126737|NCT00464334|453754993|FG006|Overall Study|Progressive Disease|0|||
126126738|NCT00464334|453754994|FG007|Overall Study|Progressive Disease|0|||
126126739|NCT00464334|453754995|FG008|Overall Study|Progressive Disease|1|||
126126740|NCT00464334|453754996|FG009|Overall Study|Progressive Disease|0|||
126126741|NCT00464334|453754997|FG010|Overall Study|Progressive Disease|0|||
126126742|NCT00464334|453754987|FG000|Overall Study|Study Terminated by Sponsor|0|||
126126743|NCT00464334|453754988|FG001|Overall Study|Study Terminated by Sponsor|0|||
126126744|NCT00464334|453754989|FG002|Overall Study|Study Terminated by Sponsor|0|||
126126745|NCT00464334|453754990|FG003|Overall Study|Study Terminated by Sponsor|1|||
126126746|NCT00464334|453754991|FG004|Overall Study|Study Terminated by Sponsor|0|||
126126747|NCT00464334|453754992|FG005|Overall Study|Study Terminated by Sponsor|0|||
126126748|NCT00464334|453754993|FG006|Overall Study|Study Terminated by Sponsor|0|||
126126749|NCT00464334|453754994|FG007|Overall Study|Study Terminated by Sponsor|0|||
126126750|NCT00464334|453754995|FG008|Overall Study|Study Terminated by Sponsor|0|||
126126751|NCT00464334|453754996|FG009|Overall Study|Study Terminated by Sponsor|0|||
125963860|NCT01539291|453159299|FG000|Study GS-US-312-0116|Other|1|||
125963861|NCT01539291|453159300|FG001|Study GS-US-312-0116|Other|0|||
125963862|NCT01539291|453159301|FG002|Study GS-US-312-0116|Other|0|||
125963863|NCT01539291|453159302|FG003|Study GS-US-312-0116|Other|0|||
126126752|NCT00464334|453754997|FG010|Overall Study|Study Terminated by Sponsor|0|||
126126753|NCT00464334|453754987|FG000|Overall Study|Withdrawal by Subject|1|||
126126754|NCT00464334|453754988|FG001|Overall Study|Withdrawal by Subject|7|||
126126755|NCT00464334|453754989|FG002|Overall Study|Withdrawal by Subject|4|||
126126756|NCT00464334|453754990|FG003|Overall Study|Withdrawal by Subject|2|||
126126757|NCT00464334|453754991|FG004|Overall Study|Withdrawal by Subject|2|||
126126758|NCT00464334|453754992|FG005|Overall Study|Withdrawal by Subject|2|||
126126759|NCT00464334|453754993|FG006|Overall Study|Withdrawal by Subject|2|||
126126760|NCT00464334|453754994|FG007|Overall Study|Withdrawal by Subject|1|||
126126761|NCT00464334|453754995|FG008|Overall Study|Withdrawal by Subject|3|||
126126762|NCT00464334|453754996|FG009|Overall Study|Withdrawal by Subject|0|||
126126763|NCT00464334|453754997|FG010|Overall Study|Withdrawal by Subject|0|||
126126764|NCT01422915|453755006|FG000|Overall Study|Adverse Event|1|||
126126765|NCT01152021|453755008|FG000|Overall Study|Adverse Event|4|||
126126766|NCT01152021|453755009|FG001|Overall Study|Adverse Event|4|||
126126767|NCT01152021|453755008|FG000|Overall Study|Study drug had expired|1|||
126126768|NCT01152021|453755009|FG001|Overall Study|Study drug had expired|0|||
126126769|NCT01152021|453755008|FG000|Overall Study|Physician Decision|1|||
126126770|NCT01152021|453755009|FG001|Overall Study|Physician Decision|1|||
126126771|NCT01152021|453755008|FG000|Overall Study|No access to study drug in Pharmacy|0|||
126126772|NCT01152021|453755009|FG001|Overall Study|No access to study drug in Pharmacy|1|||
126126773|NCT00517829|453755010|FG000|Overall Study|Adverse Event|22|||
126126774|NCT00517829|453755011|FG001|Overall Study|Adverse Event|34|||
126126775|NCT00517829|453755010|FG000|Overall Study|Disease Progression|39|||
126126776|NCT00517829|453755011|FG001|Overall Study|Disease Progression|32|||
126126777|NCT00517829|453755010|FG000|Overall Study|Patient Request|6|||
126126778|NCT00517829|453755011|FG001|Overall Study|Patient Request|5|||
126126779|NCT00517829|453755010|FG000|Overall Study|Investigator Request|5|||
126126780|NCT00517829|453755011|FG001|Overall Study|Investigator Request|3|||
126126781|NCT00517829|453755010|FG000|Overall Study|Other|3|||
126126782|NCT00517829|453755011|FG001|Overall Study|Other|1|||
126126783|NCT00385255|453755012|FG000|Overall Study|Serious Adverse Event|1|||
126126784|NCT00385255|453755013|FG001|Overall Study|Serious Adverse Event|2|||
126126785|NCT00385255|453755012|FG000|Overall Study|Protocol Violation|0|||
126126786|NCT00385255|453755013|FG001|Overall Study|Protocol Violation|4|||
126126787|NCT00385255|453755012|FG000|Overall Study|Withdrawal by Subject|0|||
126126788|NCT00385255|453755013|FG001|Overall Study|Withdrawal by Subject|8|||
126126789|NCT00385255|453755012|FG000|Overall Study|Migrated/moved from study area|0|||
126126790|NCT00385255|453755013|FG001|Overall Study|Migrated/moved from study area|1|||
126126791|NCT00385255|453755012|FG000|Overall Study|Lost to Follow-up|20|||
126126792|NCT00385255|453755013|FG001|Overall Study|Lost to Follow-up|58|||
126126793|NCT02443883|453755014|FG000|Overall Study|Adverse Event|0|||
126126794|NCT02443883|453755015|FG001|Overall Study|Adverse Event|1|||
126126795|NCT02443883|453755016|FG002|Overall Study|Adverse Event|0|||
126126796|NCT02443883|453755017|FG003|Overall Study|Adverse Event|0|||
126126797|NCT02443883|453755014|FG000|Overall Study|Lost to Follow-up|3|||
126126798|NCT02443883|453755015|FG001|Overall Study|Lost to Follow-up|2|||
126126799|NCT02443883|453755016|FG002|Overall Study|Lost to Follow-up|1|||
126126800|NCT02443883|453755017|FG003|Overall Study|Lost to Follow-up|0|||
126126801|NCT02443883|453755014|FG000|Overall Study|Physician Decision|1|||
126126802|NCT02443883|453755015|FG001|Overall Study|Physician Decision|1|||
126126803|NCT02443883|453755016|FG002|Overall Study|Physician Decision|0|||
126126804|NCT02443883|453755017|FG003|Overall Study|Physician Decision|3|||
126126805|NCT02443883|453755014|FG000|Overall Study|Withdrawal by Subject|1|||
126126806|NCT02443883|453755015|FG001|Overall Study|Withdrawal by Subject|0|||
126126807|NCT02443883|453755016|FG002|Overall Study|Withdrawal by Subject|0|||
126126808|NCT02443883|453755017|FG003|Overall Study|Withdrawal by Subject|2|||
126126809|NCT02443883|453755014|FG000|Overall Study|Randomized, but never treated|1|||
126126810|NCT02443883|453755015|FG001|Overall Study|Randomized, but never treated|0|||
126126811|NCT02443883|453755016|FG002|Overall Study|Randomized, but never treated|0|||
126126812|NCT02443883|453755017|FG003|Overall Study|Randomized, but never treated|0|||
126126813|NCT00506883|453755029|FG000|Overall Study|Lost to Follow-up|1|||
126126814|NCT00506883|453755030|FG001|Overall Study|Lost to Follow-up|1|||
126126815|NCT00506883|453755031|FG002|Overall Study|Lost to Follow-up|1|||
126126816|NCT00506883|453755029|FG000|Overall Study|Withdrawal by Subject|1|||
126126817|NCT00506883|453755030|FG001|Overall Study|Withdrawal by Subject|0|||
126126818|NCT00506883|453755031|FG002|Overall Study|Withdrawal by Subject|1|||
126126819|NCT00506883|453755029|FG000|Overall Study|Lack of Efficacy|0|||
126126820|NCT00506883|453755030|FG001|Overall Study|Lack of Efficacy|1|||
126126821|NCT00506883|453755031|FG002|Overall Study|Lack of Efficacy|1|||
126126822|NCT00506883|453755029|FG000|Overall Study|Other|5|||
126126823|NCT00506883|453755030|FG001|Overall Study|Other|1|||
126126824|NCT00506883|453755031|FG002|Overall Study|Other|1|||
126126825|NCT01445951|453755032|FG000|Overall Study|Adverse Event|16|||
126126826|NCT01445951|453755033|FG001|Overall Study|Adverse Event|9|||
126126827|NCT01445951|453755034|FG002|Overall Study|Adverse Event|0|||
126126828|NCT01445951|453755032|FG000|Overall Study|Protocol Violation|2|||
126126829|NCT01445951|453755033|FG001|Overall Study|Protocol Violation|2|||
126126830|NCT01445951|453755034|FG002|Overall Study|Protocol Violation|2|||
126126831|NCT01445951|453755032|FG000|Overall Study|Withdrawal by Subject|21|||
126126832|NCT01445951|453755033|FG001|Overall Study|Withdrawal by Subject|16|||
126126833|NCT01445951|453755034|FG002|Overall Study|Withdrawal by Subject|8|||
126126834|NCT01445951|453755032|FG000|Overall Study|Physician Decision|3|||
126126835|NCT01445951|453755033|FG001|Overall Study|Physician Decision|1|||
126126836|NCT01445951|453755034|FG002|Overall Study|Physician Decision|0|||
126126837|NCT01445951|453755032|FG000|Overall Study|Lost to Follow-up|1|||
126126838|NCT01445951|453755033|FG001|Overall Study|Lost to Follow-up|2|||
126126839|NCT01445951|453755034|FG002|Overall Study|Lost to Follow-up|4|||
126126840|NCT01445951|453755032|FG000|Overall Study|Pregnancy|0|||
126126841|NCT01445951|453755033|FG001|Overall Study|Pregnancy|1|||
126126842|NCT01445951|453755034|FG002|Overall Study|Pregnancy|4|||
126126843|NCT01445951|453755032|FG000|Overall Study|Death|0|||
126126844|NCT01445951|453755033|FG001|Overall Study|Death|0|||
126126845|NCT01445951|453755034|FG002|Overall Study|Death|1|||
126126846|NCT01445951|453755032|FG000|Overall Study|Non-compliance with study drug|1|||
126126847|NCT01445951|453755033|FG001|Overall Study|Non-compliance with study drug|2|||
126088235|NCT02766777|453617082|FG000|Overall Study|Adverse Event|12|||
126088236|NCT02766777|453617082|FG000|Overall Study|Lost to Follow-up|16|||
126088237|NCT02766777|453617082|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126088238|NCT02766777|453617082|FG000|Overall Study|Protocol Violation|1|||
126088239|NCT02766777|453617082|FG000|Overall Study|Withdrawal by Subject|4|||
126088240|NCT01886287|453617083|FG000|Overall Study|Radiographic disease progression|1|||
126088241|NCT01886287|453617083|FG000|Overall Study|Clinical progression due to disease|1|||
126088242|NCT03596762|453617084|FG000|Overall Study|Protocol Violation|0|||
126088243|NCT03596762|453617085|FG001|Overall Study|Protocol Violation|0|||
126088244|NCT03596762|453617086|FG002|Overall Study|Protocol Violation|0|||
126088245|NCT03596762|453617087|FG003|Overall Study|Protocol Violation|0|||
126088246|NCT03596762|453617088|FG004|Overall Study|Protocol Violation|1|||
126088247|NCT03596762|453617084|FG000|Overall Study|Adverse Event|2|||
126088248|NCT03596762|453617085|FG001|Overall Study|Adverse Event|0|||
126088249|NCT03596762|453617086|FG002|Overall Study|Adverse Event|1|||
126088250|NCT03596762|453617087|FG003|Overall Study|Adverse Event|0|||
126088251|NCT03596762|453617088|FG004|Overall Study|Adverse Event|5|||
126088252|NCT03596762|453617084|FG000|Overall Study|Withdrawal by Subject|2|||
126088253|NCT03596762|453617085|FG001|Overall Study|Withdrawal by Subject|1|||
126088254|NCT03596762|453617086|FG002|Overall Study|Withdrawal by Subject|0|||
126088255|NCT03596762|453617087|FG003|Overall Study|Withdrawal by Subject|1|||
126088256|NCT03596762|453617088|FG004|Overall Study|Withdrawal by Subject|1|||
126088257|NCT01031628|453617089|FG000|Overall Study|Study terminated early|0|||
126088258|NCT01031628|453617090|FG001|Overall Study|Study terminated early|1|||
126088259|NCT01031628|453617091|FG002|Overall Study|Study terminated early|3|||
126088260|NCT01031628|453617092|FG003|Overall Study|Study terminated early|0|||
126088261|NCT00967005|453617095|FG000|Overall Study|Lost to Follow-up|7|||
126088262|NCT00967005|453617096|FG001|Overall Study|Lost to Follow-up|10|||
126088263|NCT01371825|453617099|FG000|Overall Study|Death|4|||
126088264|NCT00895895|453617100|FG000|Period 1|Adverse Event|7|||
126088265|NCT00895895|453617101|FG001|Period 1|Adverse Event|6|||
126088266|NCT00895895|453617102|FG002|Period 1|Adverse Event|4|||
126088267|NCT00895895|453617103|FG003|Period 1|Adverse Event|6|||
126088268|NCT00895895|453617104|FG004|Period 1|Adverse Event|7|||
126088269|NCT00895895|453617100|FG000|Period 1|Death|0|||
126088270|NCT00895895|453617101|FG001|Period 1|Death|0|||
126088271|NCT00895895|453617102|FG002|Period 1|Death|0|||
126088272|NCT00895895|453617103|FG003|Period 1|Death|0|||
126088273|NCT00895895|453617104|FG004|Period 1|Death|1|||
126088274|NCT00895895|453617100|FG000|Period 1|discontinued by sponsor|2|||
126088275|NCT00895895|453617101|FG001|Period 1|discontinued by sponsor|1|||
126088276|NCT00895895|453617102|FG002|Period 1|discontinued by sponsor|2|||
126088277|NCT00895895|453617103|FG003|Period 1|discontinued by sponsor|1|||
126088278|NCT00895895|453617104|FG004|Period 1|discontinued by sponsor|1|||
126088279|NCT00895895|453617100|FG000|Period 1|failed to return|0|||
126088280|NCT00895895|453617101|FG001|Period 1|failed to return|0|||
126088281|NCT00895895|453617102|FG002|Period 1|failed to return|1|||
126088282|NCT00895895|453617103|FG003|Period 1|failed to return|0|||
126088283|NCT00895895|453617104|FG004|Period 1|failed to return|1|||
126088284|NCT00895895|453617100|FG000|Period 1|investigator request|0|||
126088285|NCT00895895|453617101|FG001|Period 1|investigator request|1|||
126088286|NCT00895895|453617102|FG002|Period 1|investigator request|0|||
126088287|NCT00895895|453617103|FG003|Period 1|investigator request|0|||
126088288|NCT00895895|453617104|FG004|Period 1|investigator request|0|||
126088289|NCT00895895|453617100|FG000|Period 1|Lost to Follow-up|2|||
126088290|NCT00895895|453617101|FG001|Period 1|Lost to Follow-up|1|||
126088291|NCT00895895|453617102|FG002|Period 1|Lost to Follow-up|3|||
126088292|NCT00895895|453617103|FG003|Period 1|Lost to Follow-up|2|||
126088293|NCT00895895|453617104|FG004|Period 1|Lost to Follow-up|3|||
126088294|NCT00895895|453617100|FG000|Period 1|Other|1|||
126088295|NCT00895895|453617101|FG001|Period 1|Other|2|||
126088296|NCT00895895|453617102|FG002|Period 1|Other|1|||
126088297|NCT00895895|453617103|FG003|Period 1|Other|1|||
126088298|NCT00895895|453617104|FG004|Period 1|Other|1|||
126088299|NCT00895895|453617100|FG000|Period 1|Protocol Violation|0|||
126088300|NCT00895895|453617101|FG001|Period 1|Protocol Violation|1|||
126088301|NCT00895895|453617102|FG002|Period 1|Protocol Violation|0|||
126088302|NCT00895895|453617103|FG003|Period 1|Protocol Violation|0|||
126088303|NCT00895895|453617104|FG004|Period 1|Protocol Violation|0|||
126088304|NCT00895895|453617100|FG000|Period 1|Withdrawal by Subject|6|||
126088305|NCT00895895|453617101|FG001|Period 1|Withdrawal by Subject|6|||
126088306|NCT00895895|453617102|FG002|Period 1|Withdrawal by Subject|8|||
126088307|NCT00895895|453617103|FG003|Period 1|Withdrawal by Subject|2|||
126088308|NCT00895895|453617104|FG004|Period 1|Withdrawal by Subject|4|||
126088309|NCT00895895|453617100|FG000|Period 1|unsatisfactory response-efficacy|2|||
126088310|NCT00895895|453617101|FG001|Period 1|unsatisfactory response-efficacy|0|||
126088311|NCT00895895|453617102|FG002|Period 1|unsatisfactory response-efficacy|0|||
126088312|NCT00895895|453617103|FG003|Period 1|unsatisfactory response-efficacy|0|||
126088313|NCT00895895|453617104|FG004|Period 1|unsatisfactory response-efficacy|0|||
126126848|NCT01445951|453755034|FG002|Overall Study|Non-compliance with study drug|0|||
126126849|NCT01445951|453755032|FG000|Overall Study|Non-compliance with protocol|0|||
126126850|NCT01445951|453755033|FG001|Overall Study|Non-compliance with protocol|1|||
126126851|NCT01445951|453755034|FG002|Overall Study|Non-compliance with protocol|0|||
126126852|NCT01445951|453755032|FG000|Overall Study|Sponsor decision - subject travel|0|||
126126853|NCT01445951|453755033|FG001|Overall Study|Sponsor decision - subject travel|1|||
126126854|NCT01445951|453755034|FG002|Overall Study|Sponsor decision - subject travel|0|||
126126855|NCT01445951|453755032|FG000|Overall Study|Cough|0|||
126126856|NCT01445951|453755033|FG001|Overall Study|Cough|1|||
126126857|NCT01445951|453755034|FG002|Overall Study|Cough|0|||
126126858|NCT03152019|453755039|FG000|Overall Study|Adverse Event|0|||
126126859|NCT03152019|453755040|FG001|Overall Study|Adverse Event|1|||
126126860|NCT00254501|453755046|FG000|Overall Study|Lost to Follow-up|1|||
126126861|NCT00254501|453755047|FG001|Overall Study|Lost to Follow-up|1|||
126126862|NCT00923130|453755048|FG000|Overall Study|Stopped treatment due to progression|17|||
126126863|NCT00923130|453755048|FG000|Overall Study|Death|1|||
126126864|NCT00923130|453755048|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
126126865|NCT00923130|453755048|FG000|Overall Study|Switched to alternative treatment|2|||
126126866|NCT00923130|453755048|FG000|Overall Study|Refused further treatment|2|||
126126867|NCT00414453|453756322|FG000|Overall Study|Abnormal lab work|16|||
126126868|NCT02429414|453756326|FG000|Overall Study|Physician Decision|0|||
126126869|NCT02429414|453756327|FG001|Overall Study|Physician Decision|1|||
126126870|NCT03245450|453756328|FG000|Overall Study|Radiological disease progression|3|||
126126871|NCT03245450|453756329|FG001|Overall Study|Radiological disease progression|3|||
126126872|NCT03245450|453756330|FG002|Overall Study|Radiological disease progression|2|||
126126873|NCT03245450|453756331|FG003|Overall Study|Radiological disease progression|2|||
126126874|NCT03245450|453756332|FG004|Overall Study|Radiological disease progression|7|||
126126875|NCT03245450|453756333|FG005|Overall Study|Radiological disease progression|6|||
126126876|NCT03245450|453756334|FG006|Overall Study|Radiological disease progression|6|||
126126877|NCT03245450|453756328|FG000|Overall Study|Clinical disease progression|0|||
126126878|NCT03245450|453756329|FG001|Overall Study|Clinical disease progression|0|||
126126879|NCT03245450|453756330|FG002|Overall Study|Clinical disease progression|1|||
126126880|NCT03245450|453756331|FG003|Overall Study|Clinical disease progression|0|||
126126881|NCT03245450|453756332|FG004|Overall Study|Clinical disease progression|0|||
126126882|NCT03245450|453756333|FG005|Overall Study|Clinical disease progression|2|||
126126883|NCT03245450|453756334|FG006|Overall Study|Clinical disease progression|0|||
126126884|NCT03245450|453756328|FG000|Overall Study|Other|0|||
126126885|NCT03245450|453756329|FG001|Overall Study|Other|0|||
126126886|NCT03245450|453756330|FG002|Overall Study|Other|0|||
126126887|NCT03245450|453756331|FG003|Overall Study|Other|1|||
126126888|NCT03245450|453756332|FG004|Overall Study|Other|1|||
126126889|NCT03245450|453756333|FG005|Overall Study|Other|1|||
126126890|NCT03245450|453756334|FG006|Overall Study|Other|1|||
126126891|NCT03245450|453756328|FG000|Overall Study|Withdrawal by Subject|0|||
126126892|NCT03245450|453756329|FG001|Overall Study|Withdrawal by Subject|1|||
126126893|NCT03245450|453756330|FG002|Overall Study|Withdrawal by Subject|0|||
126126894|NCT03245450|453756331|FG003|Overall Study|Withdrawal by Subject|0|||
126126895|NCT03245450|453756332|FG004|Overall Study|Withdrawal by Subject|0|||
126126896|NCT03245450|453756333|FG005|Overall Study|Withdrawal by Subject|0|||
126126897|NCT03245450|453756334|FG006|Overall Study|Withdrawal by Subject|0|||
126126898|NCT03245450|453756328|FG000|Overall Study|Adverse Event|0|||
126126899|NCT03245450|453756329|FG001|Overall Study|Adverse Event|0|||
126126900|NCT03245450|453756330|FG002|Overall Study|Adverse Event|0|||
126126901|NCT03245450|453756331|FG003|Overall Study|Adverse Event|0|||
126126902|NCT03245450|453756332|FG004|Overall Study|Adverse Event|1|||
126126903|NCT03245450|453756333|FG005|Overall Study|Adverse Event|0|||
126126904|NCT03245450|453756334|FG006|Overall Study|Adverse Event|2|||
126126905|NCT02432235|453756335|FG000|Overall Study|Death|1|||
126126906|NCT02432235|453756336|FG001|Overall Study|Death|1|||
126126907|NCT02432235|453756337|FG002|Overall Study|Death|2|||
126126908|NCT02432235|453756338|FG003|Overall Study|Death|2|||
126126909|NCT02432235|453756339|FG004|Overall Study|Death|1|||
126126910|NCT02432235|453756340|FG005|Overall Study|Death|3|||
126126911|NCT02432235|453756341|FG006|Overall Study|Death|11|||
126126912|NCT02432235|453756342|FG007|Overall Study|Death|15|||
126126913|NCT02432235|453756343|FG008|Overall Study|Death|15|||
126126914|NCT02432235|453756344|FG009|Overall Study|Death|3|||
126126915|NCT02432235|453756345|FG010|Overall Study|Death|1|||
126126916|NCT02432235|453756346|FG011|Overall Study|Death|0|||
126126917|NCT02432235|453756335|FG000|Overall Study|Withdrawal by Subject|0|||
126126918|NCT02432235|453756336|FG001|Overall Study|Withdrawal by Subject|1|||
126126919|NCT02432235|453756337|FG002|Overall Study|Withdrawal by Subject|0|||
126126920|NCT02432235|453756338|FG003|Overall Study|Withdrawal by Subject|0|||
126126921|NCT02432235|453756339|FG004|Overall Study|Withdrawal by Subject|0|||
126126922|NCT02432235|453756340|FG005|Overall Study|Withdrawal by Subject|2|||
126126923|NCT02432235|453756341|FG006|Overall Study|Withdrawal by Subject|5|||
126126924|NCT02432235|453756342|FG007|Overall Study|Withdrawal by Subject|3|||
126126925|NCT02432235|453756343|FG008|Overall Study|Withdrawal by Subject|1|||
126126926|NCT02432235|453756344|FG009|Overall Study|Withdrawal by Subject|0|||
126126927|NCT02432235|453756345|FG010|Overall Study|Withdrawal by Subject|0|||
126126928|NCT02432235|453756346|FG011|Overall Study|Withdrawal by Subject|0|||
126126929|NCT02432235|453756335|FG000|Overall Study|Lost to Follow-up|0|||
126126930|NCT02432235|453756336|FG001|Overall Study|Lost to Follow-up|0|||
126126931|NCT02432235|453756337|FG002|Overall Study|Lost to Follow-up|0|||
126126932|NCT02432235|453756338|FG003|Overall Study|Lost to Follow-up|0|||
126126933|NCT02432235|453756339|FG004|Overall Study|Lost to Follow-up|0|||
126126934|NCT02432235|453756340|FG005|Overall Study|Lost to Follow-up|1|||
126126935|NCT02432235|453756341|FG006|Overall Study|Lost to Follow-up|0|||
126126936|NCT02432235|453756342|FG007|Overall Study|Lost to Follow-up|0|||
126126937|NCT02432235|453756343|FG008|Overall Study|Lost to Follow-up|1|||
126126938|NCT02432235|453756344|FG009|Overall Study|Lost to Follow-up|0|||
126126939|NCT02432235|453756345|FG010|Overall Study|Lost to Follow-up|0|||
126126940|NCT02432235|453756346|FG011|Overall Study|Lost to Follow-up|0|||
126126941|NCT02432235|453756335|FG000|Overall Study|Miscellaneous|0|||
126126942|NCT02432235|453756336|FG001|Overall Study|Miscellaneous|0|||
126126943|NCT02432235|453756337|FG002|Overall Study|Miscellaneous|0|||
126126944|NCT02432235|453756338|FG003|Overall Study|Miscellaneous|0|||
126126945|NCT02432235|453756339|FG004|Overall Study|Miscellaneous|1|||
126126946|NCT02432235|453756340|FG005|Overall Study|Miscellaneous|6|||
126126947|NCT02432235|453756341|FG006|Overall Study|Miscellaneous|2|||
126126948|NCT02432235|453756342|FG007|Overall Study|Miscellaneous|2|||
126126949|NCT02432235|453756343|FG008|Overall Study|Miscellaneous|4|||
126126950|NCT02432235|453756344|FG009|Overall Study|Miscellaneous|0|||
126126951|NCT02432235|453756345|FG010|Overall Study|Miscellaneous|0|||
126126952|NCT02432235|453756346|FG011|Overall Study|Miscellaneous|1|||
126126953|NCT00794677|453756355|FG000|First Intervention|Withdrawal by Subject|2|||
126126954|NCT00794677|453756356|FG001|First Intervention|Withdrawal by Subject|0|||
126126955|NCT01965262|453756367|FG000|Second Intervention (7 Days)|Discontinued|0|||
126126956|NCT01965262|453756368|FG001|Second Intervention (7 Days)|Discontinued|1|||
126126957|NCT01965262|453756367|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
126126958|NCT01965262|453756368|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
126126959|NCT01965262|453756367|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
126126960|NCT01965262|453756368|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
126126961|NCT00143312|453756369|FG000|Overall Study|Death|11|||
126126962|NCT00143312|453756369|FG000|Overall Study|Adverse Event|2|||
126126963|NCT00143312|453756369|FG000|Overall Study|Lost to Follow-up|1|||
126126964|NCT00143312|453756369|FG000|Overall Study|Other|1|||
126126965|NCT00143312|453756369|FG000|Overall Study|Withdrawal by Subject|1|||
126126966|NCT01029366|453756370|FG000|Overall Study|Withdrawal by Subject|1|||
126126967|NCT01029366|453756371|FG001|Overall Study|Withdrawal by Subject|0|||
126126968|NCT01029366|453756370|FG000|Overall Study|Death|1|||
126126969|NCT01029366|453756371|FG001|Overall Study|Death|1|||
126126970|NCT01029366|453756370|FG000|Overall Study|disease progression|2|||
126126971|NCT01029366|453756371|FG001|Overall Study|disease progression|0|||
126126972|NCT01029366|453756370|FG000|Overall Study|manufacturing failure|0|||
126126973|NCT01029366|453756371|FG001|Overall Study|manufacturing failure|1|||
126126974|NCT00906087|453756377|FG000|Initial Washout|Withdrawal by Subject|1|||
126126975|NCT00906087|453756377|FG000|Initial Washout|Physician Decision|1|||
126126976|NCT00796315|453756386|FG000|Overall Study|Protocol Violation|0|||
126126977|NCT00796315|453756387|FG001|Overall Study|Protocol Violation|1|||
126126978|NCT00796315|453756388|FG002|Overall Study|Protocol Violation|0|||
126126979|NCT01627860|453756393|FG000|Overall Study|Adverse Event|9|||
126126980|NCT01627860|453756394|FG001|Overall Study|Adverse Event|4|||
126126981|NCT01627860|453756393|FG000|Overall Study|Withdrawal by Subject|2|||
126126982|NCT01627860|453756394|FG001|Overall Study|Withdrawal by Subject|1|||
126126983|NCT01627860|453756393|FG000|Overall Study|Seizure frequency doubled|0|||
126126984|NCT01627860|453756394|FG001|Overall Study|Seizure frequency doubled|1|||
126126985|NCT01627860|453756393|FG000|Overall Study|Protocol Violation|1|||
126126986|NCT01627860|453756394|FG001|Overall Study|Protocol Violation|0|||
126126987|NCT03215771|453756395|FG000|Overall Study|Withdrawal by Subject|2|||
126126988|NCT03215771|453756395|FG000|Overall Study|Physician Decision|1|||
126126989|NCT02039375|453756396|FG000|Overall Study|Lost to Follow-up|2|||
126126990|NCT04770389|453756397|FG000|Overall Study|Adverse Event|1|||
126126991|NCT04770389|453756398|FG001|Overall Study|Adverse Event|2|||
126126992|NCT04770389|453756399|FG002|Overall Study|Adverse Event|0|||
126126993|NCT04770389|453756400|FG003|Overall Study|Adverse Event|1|||
126126994|NCT04770389|453756397|FG000|Overall Study|Withdrawal by Subject|0|||
126126995|NCT04770389|453756398|FG001|Overall Study|Withdrawal by Subject|2|||
126126996|NCT04770389|453756399|FG002|Overall Study|Withdrawal by Subject|1|||
126126997|NCT04770389|453756400|FG003|Overall Study|Withdrawal by Subject|0|||
126126998|NCT04770389|453756397|FG000|Overall Study|Failed attempt to draw blood|1|||
126126999|NCT04770389|453756398|FG001|Overall Study|Failed attempt to draw blood|0|||
126127000|NCT04770389|453756399|FG002|Overall Study|Failed attempt to draw blood|0|||
126127001|NCT04770389|453756400|FG003|Overall Study|Failed attempt to draw blood|0|||
126127002|NCT04770389|453756397|FG000|Overall Study|Left the country|0|||
126127003|NCT04770389|453756398|FG001|Overall Study|Left the country|0|||
126127004|NCT04770389|453756399|FG002|Overall Study|Left the country|1|||
126127005|NCT04770389|453756400|FG003|Overall Study|Left the country|2|||
126127006|NCT04770389|453756397|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
126127007|NCT04770389|453756398|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
126127008|NCT04770389|453756399|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
126127009|NCT04770389|453756400|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
126127010|NCT04770389|453756397|FG000|Overall Study|Lost to Follow-up|0|||
126127011|NCT04770389|453756398|FG001|Overall Study|Lost to Follow-up|0|||
126127012|NCT04770389|453756399|FG002|Overall Study|Lost to Follow-up|0|||
126127013|NCT04770389|453756400|FG003|Overall Study|Lost to Follow-up|1|||
126127014|NCT04770389|453756397|FG000|Overall Study|Moved away from study site|0|||
126127015|NCT04770389|453756398|FG001|Overall Study|Moved away from study site|1|||
126127016|NCT04770389|453756399|FG002|Overall Study|Moved away from study site|0|||
126127017|NCT04770389|453756400|FG003|Overall Study|Moved away from study site|0|||
126127018|NCT00689871|453756405|FG000|Overall Study|Lost to Follow-up|123|||
126127019|NCT00689871|453756406|FG001|Overall Study|Lost to Follow-up|13|||
126127020|NCT00689871|453756407|FG002|Overall Study|Lost to Follow-up|37|||
126127021|NCT00689871|453756408|FG003|Overall Study|Lost to Follow-up|1|||
126127022|NCT00689871|453756405|FG000|Overall Study|Explanted of All Study Devices|36|||
126127023|NCT00689871|453756406|FG001|Overall Study|Explanted of All Study Devices|25|||
126127024|NCT00689871|453756407|FG002|Overall Study|Explanted of All Study Devices|29|||
126127025|NCT00689871|453756408|FG003|Overall Study|Explanted of All Study Devices|3|||
126127026|NCT00689871|453756405|FG000|Overall Study|Withdrawal by Subject|13|||
126127027|NCT00689871|453756406|FG001|Overall Study|Withdrawal by Subject|3|||
126127028|NCT00689871|453756407|FG002|Overall Study|Withdrawal by Subject|4|||
126127029|NCT00689871|453756408|FG003|Overall Study|Withdrawal by Subject|1|||
126127030|NCT00689871|453756405|FG000|Overall Study|Death|1|||
126127031|NCT00689871|453756406|FG001|Overall Study|Death|10|||
126127032|NCT00689871|453756407|FG002|Overall Study|Death|2|||
126127033|NCT00689871|453756408|FG003|Overall Study|Death|2|||
126127034|NCT00689871|453756405|FG000|Overall Study|Physician Decision|2|||
126127035|NCT00689871|453756406|FG001|Overall Study|Physician Decision|1|||
126127036|NCT00689871|453756407|FG002|Overall Study|Physician Decision|1|||
126127037|NCT00689871|453756408|FG003|Overall Study|Physician Decision|0|||
126127038|NCT00889265|453756413|FG000|Overall Study|Adverse Event|1|||
126127039|NCT00889265|453756413|FG000|Overall Study|Lost to Follow-up|5|||
126127040|NCT00889265|453756413|FG000|Overall Study|Protocol Violation|1|||
126127041|NCT00250835|453756416|FG000|Overall Study|Withdrawal by Subject|1|||
126127042|NCT00159861|453756417|FG000|Core Study - 16 Weeks|Death|3|||
126127043|NCT00159861|453756418|FG001|Core Study - 16 Weeks|Death|0|||
126127044|NCT00159861|453756417|FG000|Core Study - 16 Weeks|Adverse Event|12|||
126127045|NCT00159861|453756418|FG001|Core Study - 16 Weeks|Adverse Event|6|||
126127046|NCT00159861|453756417|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
126127047|NCT00159861|453756418|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
126127048|NCT00159861|453756417|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
126127049|NCT00159861|453756418|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
126127050|NCT00159861|453756417|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
126127051|NCT00159861|453756418|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
126127052|NCT00159861|453756417|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
126127053|NCT00159861|453756418|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
126127054|NCT00159861|453756417|FG000|Extension Study - up to 3 Years|Death|24|||
126127055|NCT00159861|453756418|FG001|Extension Study - up to 3 Years|Death|28|||
126127056|NCT00159861|453756417|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
126127057|NCT00159861|453756418|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
126127058|NCT00159861|453756417|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
126127059|NCT00159861|453756418|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
126127060|NCT00159861|453756417|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
126127061|NCT00159861|453756418|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
126127062|NCT00159861|453756417|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
126127063|NCT00159861|453756418|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
126127064|NCT03885089|453756420|FG000|Overall Study|No informed consent for publication of study results|2|||
125963864|NCT01539291|453159299|FG000|Study GS-US-312-0117|Adverse Event|22|||
126127065|NCT04489888|453756423|FG000|Overall Study|Death|75|||
126127066|NCT04489888|453756423|FG000|Overall Study|Sponsor Decision|26|||
125963865|NCT01539291|453159300|FG001|Study GS-US-312-0117|Adverse Event|1|||
126127067|NCT03349099|453756426|FG000|Overall Study|Physician Decision|3|||
126127068|NCT03349099|453756427|FG001|Overall Study|Physician Decision|4|||
126127069|NCT03349099|453756426|FG000|Overall Study|Stone migrated from the kidney|1|||
126127070|NCT03349099|453756427|FG001|Overall Study|Stone migrated from the kidney|0|||
126127071|NCT00278993|453756428|FG000|Overall Study|Adverse Event|24|||
126127072|NCT00278993|453756428|FG000|Overall Study|Withdrawal by Subject|5|||
126127073|NCT00278993|453756428|FG000|Overall Study|Progressive Disease|65|||
126127074|NCT00278993|453756428|FG000|Overall Study|Physician Decision|9|||
126127075|NCT00278993|453756428|FG000|Overall Study|Not Otherwise Specified|4|||
126127076|NCT02043548|453756432|FG000|Overall Study|Lack of Efficacy|1|||
126127077|NCT02043548|453756433|FG001|Overall Study|Lack of Efficacy|0|||
126127078|NCT02043548|453756432|FG000|Overall Study|Adverse Event|0|||
126127079|NCT02043548|453756433|FG001|Overall Study|Adverse Event|1|||
126127080|NCT03829657|453756441|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
126127081|NCT03829657|453756442|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
126127082|NCT03829657|453756443|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
126127083|NCT03829657|453756444|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
126127084|NCT03829657|453756445|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
126127085|NCT03829657|453756441|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
126127086|NCT03829657|453756442|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
126127087|NCT03829657|453756443|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
126127088|NCT03829657|453756444|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
126127089|NCT03829657|453756445|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
126127090|NCT03829657|453756441|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
126127091|NCT03829657|453756442|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
126127092|NCT03829657|453756443|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
126127093|NCT03829657|453756444|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
126127094|NCT03829657|453756445|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
126127095|NCT03829657|453756441|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
126127096|NCT03829657|453756442|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
126127097|NCT03829657|453756443|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
126127098|NCT03829657|453756444|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
126127099|NCT03829657|453756445|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
126127100|NCT03829657|453756441|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
126127101|NCT03829657|453756442|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
126127102|NCT03829657|453756443|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
126127103|NCT03829657|453756444|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
126127104|NCT03829657|453756445|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
126127105|NCT03829657|453756441|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
126127106|NCT03829657|453756442|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
126127107|NCT03829657|453756443|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
126127108|NCT03829657|453756444|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
126127109|NCT03829657|453756445|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
126127110|NCT03829657|453756441|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
126127111|NCT03829657|453756442|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
126127112|NCT03829657|453756443|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
126127113|NCT03829657|453756444|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
126127114|NCT03829657|453756445|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
126127115|NCT03829657|453756441|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
126127116|NCT03829657|453756442|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
126127117|NCT03829657|453756443|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
126127118|NCT03829657|453756444|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
126127119|NCT03829657|453756445|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
126127120|NCT03829657|453756441|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
126127121|NCT03829657|453756442|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
126127122|NCT03829657|453756443|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
126127123|NCT03829657|453756444|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
126127124|NCT03829657|453756445|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
126127125|NCT03829657|453756441|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
126127126|NCT03829657|453756442|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
126127127|NCT03829657|453756443|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
126127128|NCT03829657|453756444|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
126127129|NCT03829657|453756445|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
126127130|NCT04194528|453756446|FG000|Overall Study|Adverse Event|1|||
126127131|NCT00333359|453756449|FG000|Overall Study|Adverse Event|29|||
126127132|NCT00333359|453756450|FG001|Overall Study|Adverse Event|35|||
126127133|NCT00333359|453756449|FG000|Overall Study|Withdrawal by Subject|19|||
126127134|NCT00333359|453756450|FG001|Overall Study|Withdrawal by Subject|37|||
126127135|NCT00333359|453756449|FG000|Overall Study|Physician Decision|2|||
126127136|NCT00333359|453756450|FG001|Overall Study|Physician Decision|2|||
126127137|NCT00333359|453756449|FG000|Overall Study|Protocol Non-compliance|2|||
126127138|NCT00333359|453756450|FG001|Overall Study|Protocol Non-compliance|8|||
126127139|NCT00333359|453756449|FG000|Overall Study|Lost to Follow-up|15|||
126127140|NCT00333359|453756450|FG001|Overall Study|Lost to Follow-up|25|||
126127141|NCT00333359|453756449|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
126127142|NCT00333359|453756450|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
126127143|NCT00333359|453756449|FG000|Overall Study|Treatment Failure|3|||
126127144|NCT00333359|453756450|FG001|Overall Study|Treatment Failure|8|||
126127145|NCT00333359|453756449|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
126127146|NCT00333359|453756450|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
126127147|NCT01394939|453757691|FG000|Overall Study|Adverse Event|1|||
126127148|NCT01394939|453757692|FG001|Overall Study|Adverse Event|3|||
126127149|NCT01394939|453757693|FG002|Overall Study|Adverse Event|0|||
126127150|NCT01394939|453757694|FG003|Overall Study|Adverse Event|2|||
126127151|NCT01394939|453757691|FG000|Overall Study|Death|0|||
126127152|NCT01394939|453757692|FG001|Overall Study|Death|2|||
126127153|NCT01394939|453757693|FG002|Overall Study|Death|0|||
126127154|NCT01394939|453757694|FG003|Overall Study|Death|0|||
126127155|NCT01394939|453757691|FG000|Overall Study|Physician Decision|0|||
126127156|NCT01394939|453757692|FG001|Overall Study|Physician Decision|1|||
126127157|NCT01394939|453757693|FG002|Overall Study|Physician Decision|0|||
126127158|NCT01394939|453757694|FG003|Overall Study|Physician Decision|0|||
126127159|NCT01394939|453757691|FG000|Overall Study|Withdrawal by Subject|0|||
126127160|NCT01394939|453757692|FG001|Overall Study|Withdrawal by Subject|2|||
126127161|NCT01394939|453757693|FG002|Overall Study|Withdrawal by Subject|0|||
126127162|NCT01394939|453757694|FG003|Overall Study|Withdrawal by Subject|2|||
126127163|NCT01394939|453757691|FG000|Overall Study|Others|0|||
126127164|NCT01394939|453757692|FG001|Overall Study|Others|2|||
126127165|NCT01394939|453757693|FG002|Overall Study|Others|0|||
126127166|NCT01394939|453757694|FG003|Overall Study|Others|3|||
126127167|NCT04682405|453757696|FG000|Overall Study|Adverse Event|0|||
126127168|NCT04682405|453757697|FG001|Overall Study|Adverse Event|1|||
126127169|NCT01339559|453757700|FG000|Overall Study|Adverse Event|92|||
126127170|NCT01339559|453757700|FG000|Overall Study|Death|5|||
126127171|NCT01339559|453757700|FG000|Overall Study|Lack of Efficacy|164|||
126127172|NCT01339559|453757700|FG000|Overall Study|Lost to Follow-up|22|||
126127173|NCT01339559|453757700|FG000|Overall Study|Subject choice|89|||
126127174|NCT01339559|453757700|FG000|Overall Study|Protocol Violation|15|||
126127175|NCT01339559|453757700|FG000|Overall Study|Study closure at site|1|||
126127176|NCT01339559|453757700|FG000|Overall Study|Incarcerated|2|||
126127177|NCT01339559|453757700|FG000|Overall Study|Epilepsy surgery|1|||
126127178|NCT01339559|453757700|FG000|Overall Study|Pregnancy planned|2|||
126127179|NCT01339559|453757700|FG000|Overall Study|Left the country|1|||
126127180|NCT01339559|453757700|FG000|Overall Study|Investigator decision|2|||
126127181|NCT01339559|453757700|FG000|Overall Study|Patient didn't wish to continue|1|||
126127182|NCT01339559|453757700|FG000|Overall Study|PI decision|1|||
126127183|NCT01049035|453757701|FG000|Overall Study|Serious adverse event|0|||
126127184|NCT01049035|453757702|FG001|Overall Study|Serious adverse event|1|||
126127185|NCT01049035|453757703|FG002|Overall Study|Serious adverse event|1|||
126127186|NCT01049035|453757704|FG003|Overall Study|Serious adverse event|2|||
126127187|NCT01049035|453757705|FG004|Overall Study|Serious adverse event|0|||
126127188|NCT01049035|453757706|FG005|Overall Study|Serious adverse event|0|||
126127189|NCT01049035|453757707|FG006|Overall Study|Serious adverse event|0|||
126127190|NCT01049035|453757701|FG000|Overall Study|Other adverse event (AE)|0|||
126127191|NCT01049035|453757702|FG001|Overall Study|Other adverse event (AE)|0|||
126127192|NCT01049035|453757703|FG002|Overall Study|Other adverse event (AE)|0|||
126127193|NCT01049035|453757704|FG003|Overall Study|Other adverse event (AE)|1|||
126127194|NCT01049035|453757705|FG004|Overall Study|Other adverse event (AE)|0|||
126127195|NCT01049035|453757706|FG005|Overall Study|Other adverse event (AE)|0|||
126127196|NCT01049035|453757707|FG006|Overall Study|Other adverse event (AE)|0|||
126127197|NCT01049035|453757701|FG000|Overall Study|Non-compliance with the protocol|12|||
126127198|NCT01049035|453757702|FG001|Overall Study|Non-compliance with the protocol|6|||
126127199|NCT01049035|453757703|FG002|Overall Study|Non-compliance with the protocol|14|||
126127200|NCT01049035|453757704|FG003|Overall Study|Non-compliance with the protocol|5|||
126127201|NCT01049035|453757705|FG004|Overall Study|Non-compliance with the protocol|3|||
126127202|NCT01049035|453757706|FG005|Overall Study|Non-compliance with the protocol|4|||
126127203|NCT01049035|453757707|FG006|Overall Study|Non-compliance with the protocol|10|||
126127204|NCT01049035|453757701|FG000|Overall Study|Lost to Follow-up|5|||
126127205|NCT01049035|453757702|FG001|Overall Study|Lost to Follow-up|4|||
126127206|NCT01049035|453757703|FG002|Overall Study|Lost to Follow-up|4|||
126127207|NCT01049035|453757704|FG003|Overall Study|Lost to Follow-up|1|||
126127208|NCT01049035|453757705|FG004|Overall Study|Lost to Follow-up|0|||
126127209|NCT01049035|453757706|FG005|Overall Study|Lost to Follow-up|3|||
126127210|NCT01049035|453757707|FG006|Overall Study|Lost to Follow-up|3|||
126127211|NCT01049035|453757701|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
126127212|NCT01049035|453757702|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
126127213|NCT01049035|453757703|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
126127214|NCT01049035|453757704|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
126127215|NCT01049035|453757705|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
126127216|NCT01049035|453757706|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
126127217|NCT01049035|453757707|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
126127218|NCT02095535|453757708|FG000|Recruitment|Protocol Violation|2|||
126127219|NCT00623480|453757709|FG000|Overall Study|Lost to Follow-up|0|||
126127220|NCT00623480|453757710|FG001|Overall Study|Lost to Follow-up|1|||
126127221|NCT00623480|453757709|FG000|Overall Study|Withdrawal by Subject|2|||
126127222|NCT00623480|453757710|FG001|Overall Study|Withdrawal by Subject|4|||
126127223|NCT00623480|453757709|FG000|Overall Study|Lack of Efficacy|1|||
126127224|NCT00623480|453757710|FG001|Overall Study|Lack of Efficacy|0|||
126127225|NCT00623480|453757709|FG000|Overall Study|Non-compliant with study medication|4|||
126127226|NCT00623480|453757710|FG001|Overall Study|Non-compliant with study medication|0|||
126127227|NCT00623480|453757709|FG000|Overall Study|Protocol Violation|0|||
126127228|NCT00623480|453757710|FG001|Overall Study|Protocol Violation|1|||
126127229|NCT00623480|453757709|FG000|Overall Study|Site closed by sponsor|0|||
126127230|NCT00623480|453757710|FG001|Overall Study|Site closed by sponsor|1|||
126127231|NCT01877187|453757711|FG000|Overall Study|Death|2|||
126127232|NCT01877187|453757711|FG000|Overall Study|Withdrawal by Subject|4|||
126127233|NCT01877187|453757711|FG000|Overall Study|Lost to Follow-up|3|||
126127234|NCT01877187|453757711|FG000|Overall Study|Declining clinical status|11|||
126127235|NCT01877187|453757711|FG000|Overall Study|Liver transplant|2|||
126127236|NCT02559687|453757717|FG000|Overall Study|Death|112|||
126127237|NCT02559687|453757717|FG000|Overall Study|Sponsor Decision|5|||
126127238|NCT02559687|453757717|FG000|Overall Study|Withdrawal by Subject|4|||
126127239|NCT01784861|453757719|FG000|Overall Study|Adverse Event|0|||
126127240|NCT01784861|453757720|FG001|Overall Study|Adverse Event|0|||
126127241|NCT01784861|453757721|FG002|Overall Study|Adverse Event|1|||
126127242|NCT01784861|453757722|FG003|Overall Study|Adverse Event|2|||
126127243|NCT01784861|453757723|FG004|Overall Study|Adverse Event|1|||
126127244|NCT01784861|453757724|FG005|Overall Study|Adverse Event|0|||
126127245|NCT01784861|453757719|FG000|Overall Study|Withdrawal by Subject|0|||
126127246|NCT01784861|453757720|FG001|Overall Study|Withdrawal by Subject|0|||
126127247|NCT01784861|453757721|FG002|Overall Study|Withdrawal by Subject|0|||
126127248|NCT01784861|453757722|FG003|Overall Study|Withdrawal by Subject|1|||
125963866|NCT01539291|453159301|FG002|Study GS-US-312-0117|Adverse Event|9|||
125963867|NCT01539291|453159302|FG003|Study GS-US-312-0117|Adverse Event|12|||
125963868|NCT01539291|453159299|FG000|Study GS-US-312-0117|Physician Decision|9|||
125963869|NCT01539291|453159300|FG001|Study GS-US-312-0117|Physician Decision|0|||
125963870|NCT01539291|453159301|FG002|Study GS-US-312-0117|Physician Decision|6|||
125963871|NCT01539291|453159302|FG003|Study GS-US-312-0117|Physician Decision|4|||
125963872|NCT01539291|453159299|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
125963873|NCT01539291|453159300|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
126127249|NCT01784861|453757723|FG004|Overall Study|Withdrawal by Subject|0|||
126127250|NCT01784861|453757724|FG005|Overall Study|Withdrawal by Subject|0|||
126127251|NCT01784861|453757719|FG000|Overall Study|Physician Decision|0|||
126127252|NCT01784861|453757720|FG001|Overall Study|Physician Decision|0|||
126127253|NCT01784861|453757721|FG002|Overall Study|Physician Decision|0|||
126127254|NCT01784861|453757722|FG003|Overall Study|Physician Decision|2|||
126127255|NCT01784861|453757723|FG004|Overall Study|Physician Decision|0|||
126127256|NCT01784861|453757724|FG005|Overall Study|Physician Decision|1|||
126127257|NCT03948178|453757725|FG000|Overall Study|Protocol Violation|1|||
126127258|NCT03948178|453757725|FG000|Overall Study|Lost to Follow-up|2|||
126127259|NCT03948178|453757725|FG000|Overall Study|Withdrawal by Subject|2|||
126127260|NCT03948178|453757725|FG000|Overall Study|Reason not known|2|||
126127261|NCT03948178|453757725|FG000|Overall Study|Personal reason|14|||
126127262|NCT03948178|453757725|FG000|Overall Study|Disease progression|30|||
126127263|NCT03948178|453757725|FG000|Overall Study|Adverse Event|12|||
126127264|NCT03948178|453757725|FG000|Overall Study|Sponsor terminated study|164|||
126127265|NCT02970292|453757728|FG000|Overall Study|Physician Decision|1|||
126127266|NCT02970292|453757729|FG001|Overall Study|Physician Decision|1|||
125963874|NCT01539291|453159301|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
125963875|NCT01539291|453159302|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
125963876|NCT01539291|453159299|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
125963877|NCT01539291|453159300|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
125963878|NCT01539291|453159301|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
125963879|NCT01539291|453159302|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
125963880|NCT01539291|453159299|FG000|Study GS-US-312-0117|Other|2|||
125963881|NCT01539291|453159300|FG001|Study GS-US-312-0117|Other|1|||
125963882|NCT01539291|453159301|FG002|Study GS-US-312-0117|Other|1|||
125963883|NCT01539291|453159302|FG003|Study GS-US-312-0117|Other|1|||
126127267|NCT02970292|453757728|FG000|Overall Study|Withdrawal by Subject|11|||
126127268|NCT02970292|453757729|FG001|Overall Study|Withdrawal by Subject|5|||
126127269|NCT02970292|453757728|FG000|Overall Study|Noncompliance with study drug|2|||
126127270|NCT02970292|453757729|FG001|Overall Study|Noncompliance with study drug|2|||
126127271|NCT02970292|453757728|FG000|Overall Study|Adverse Event|5|||
126127272|NCT02970292|453757729|FG001|Overall Study|Adverse Event|0|||
126127273|NCT02970292|453757728|FG000|Overall Study|Lack of Efficacy|1|||
126127274|NCT02970292|453757729|FG001|Overall Study|Lack of Efficacy|0|||
126127275|NCT02970292|453757728|FG000|Overall Study|Lost to Follow-up|1|||
126127276|NCT02970292|453757729|FG001|Overall Study|Lost to Follow-up|0|||
126127277|NCT02970292|453757728|FG000|Overall Study|Protocol Violation|2|||
126127278|NCT02970292|453757729|FG001|Overall Study|Protocol Violation|0|||
126127279|NCT02970292|453757728|FG000|Overall Study|Other|1|||
126127280|NCT02970292|453757729|FG001|Overall Study|Other|0|||
126127281|NCT00513500|453757732|FG000|Overall Study|Lost to Follow-up|35|||
126127282|NCT00513500|453757733|FG001|Overall Study|Lost to Follow-up|39|||
126127283|NCT00513500|453757732|FG000|Overall Study|Death|2|||
126127284|NCT00513500|453757733|FG001|Overall Study|Death|1|||
126127285|NCT00513500|453757732|FG000|Overall Study|Hospitalized|4|||
126127286|NCT00513500|453757733|FG001|Overall Study|Hospitalized|14|||
126127287|NCT00749996|453757736|FG000|Overall Study|Lost to Follow-up|7|||
126127288|NCT00749996|453757737|FG001|Overall Study|Lost to Follow-up|4|||
126127289|NCT00749996|453757736|FG000|Overall Study|Withdrawal by Subject|5|||
126127290|NCT00749996|453757737|FG001|Overall Study|Withdrawal by Subject|4|||
126127291|NCT00749996|453757736|FG000|Overall Study|Protocol Violation|2|||
126127292|NCT00749996|453757737|FG001|Overall Study|Protocol Violation|3|||
126127293|NCT00749996|453757736|FG000|Overall Study|Physician Decision|2|||
126127294|NCT00749996|453757737|FG001|Overall Study|Physician Decision|0|||
126127295|NCT00749996|453757736|FG000|Overall Study|Pregnancy|0|||
126127296|NCT00749996|453757737|FG001|Overall Study|Pregnancy|2|||
126127297|NCT00749996|453757736|FG000|Overall Study|Adverse Event|1|||
126127298|NCT00749996|453757737|FG001|Overall Study|Adverse Event|0|||
126127299|NCT00749996|453757736|FG000|Overall Study|Death|1|||
126127300|NCT00749996|453757737|FG001|Overall Study|Death|0|||
126127301|NCT00109707|453757738|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
126127302|NCT00109707|453757739|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
126127303|NCT00109707|453757740|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
126127304|NCT00109707|453757738|FG000|Overall Study|Abnormal laboratory values|1|||
126127305|NCT00109707|453757739|FG001|Overall Study|Abnormal laboratory values|0|||
126127306|NCT00109707|453757740|FG002|Overall Study|Abnormal laboratory values|0|||
126127307|NCT00109707|453757738|FG000|Overall Study|Administrative problems|2|||
126127308|NCT00109707|453757739|FG001|Overall Study|Administrative problems|0|||
126127309|NCT00109707|453757740|FG002|Overall Study|Administrative problems|1|||
126127310|NCT00109707|453757738|FG000|Overall Study|Adverse Event|10|||
126127311|NCT00109707|453757739|FG001|Overall Study|Adverse Event|2|||
126127312|NCT00109707|453757740|FG002|Overall Study|Adverse Event|3|||
126127313|NCT00109707|453757738|FG000|Overall Study|Death|4|||
126127314|NCT00109707|453757739|FG001|Overall Study|Death|0|||
126127315|NCT00109707|453757740|FG002|Overall Study|Death|0|||
126127316|NCT00109707|453757738|FG000|Overall Study|Disease progression|12|||
126127317|NCT00109707|453757739|FG001|Overall Study|Disease progression|4|||
126127318|NCT00109707|453757740|FG002|Overall Study|Disease progression|3|||
126127319|NCT00109707|453757738|FG000|Overall Study|Lost to Follow-up|3|||
126127320|NCT00109707|453757739|FG001|Overall Study|Lost to Follow-up|0|||
126127321|NCT00109707|453757740|FG002|Overall Study|Lost to Follow-up|0|||
126127322|NCT00109707|453757738|FG000|Overall Study|Protocol Violation|1|||
126127323|NCT00109707|453757739|FG001|Overall Study|Protocol Violation|0|||
126127324|NCT00109707|453757740|FG002|Overall Study|Protocol Violation|0|||
126127325|NCT00109707|453757738|FG000|Overall Study|Patient withdrew consent|6|||
126127326|NCT00109707|453757739|FG001|Overall Study|Patient withdrew consent|1|||
126127327|NCT00109707|453757740|FG002|Overall Study|Patient withdrew consent|0|||
126127328|NCT00446511|453757741|FG000|Overall Study|Adverse Event|7|||
126127329|NCT00446511|453757742|FG001|Overall Study|Adverse Event|2|||
126127330|NCT00446511|453757743|FG002|Overall Study|Adverse Event|3|||
126127331|NCT00446511|453757744|FG003|Overall Study|Adverse Event|1|||
126127332|NCT00446511|453757741|FG000|Overall Study|Protocol Violation|0|||
126127333|NCT00446511|453757742|FG001|Overall Study|Protocol Violation|0|||
126127334|NCT00446511|453757743|FG002|Overall Study|Protocol Violation|0|||
126127335|NCT00446511|453757744|FG003|Overall Study|Protocol Violation|1|||
126127336|NCT00446511|453757741|FG000|Overall Study|Withdrawal by Subject|0|||
126127337|NCT00446511|453757742|FG001|Overall Study|Withdrawal by Subject|0|||
126127338|NCT00446511|453757743|FG002|Overall Study|Withdrawal by Subject|0|||
126127339|NCT00446511|453757744|FG003|Overall Study|Withdrawal by Subject|3|||
125963884|NCT02239510|453159305|FG000|Overall Study|Lost to Follow-up|2|||
125963885|NCT02239510|453159306|FG001|Overall Study|Lost to Follow-up|1|||
125963886|NCT03019536|453159310|FG000|Overall Study|Withdrawal by Subject|1|||
126127340|NCT00446511|453757741|FG000|Overall Study|Administrative Problems|3|||
126127341|NCT00446511|453757742|FG001|Overall Study|Administrative Problems|0|||
126127342|NCT00446511|453757743|FG002|Overall Study|Administrative Problems|4|||
126127343|NCT00446511|453757744|FG003|Overall Study|Administrative Problems|1|||
126127344|NCT00606086|453757747|FG000|Overall Study|Adverse Event|1|||
126127345|NCT00606086|453757748|FG001|Overall Study|Adverse Event|1|||
126127346|NCT00606086|453757747|FG000|Overall Study|Lost to Follow-up|4|||
126127347|NCT00606086|453757748|FG001|Overall Study|Lost to Follow-up|8|||
125963887|NCT03019536|453159311|FG001|Overall Study|Withdrawal by Subject|1|||
126127348|NCT00606086|453757747|FG000|Overall Study|Protocol Violation|1|||
126127349|NCT00606086|453757748|FG001|Overall Study|Protocol Violation|0|||
125963888|NCT03019536|453159312|FG002|Overall Study|Withdrawal by Subject|0|||
126127350|NCT00606086|453757747|FG000|Overall Study|Withdrawal by Subject|5|||
126127351|NCT00606086|453757748|FG001|Overall Study|Withdrawal by Subject|3|||
126127352|NCT00606086|453757747|FG000|Overall Study|Non-compliance|0|||
126127353|NCT00606086|453757748|FG001|Overall Study|Non-compliance|1|||
126127354|NCT00606086|453757747|FG000|Overall Study|Randomized, not treated|1|||
126127355|NCT00606086|453757748|FG001|Overall Study|Randomized, not treated|2|||
126127356|NCT00542269|453757753|FG000|Overall Study|Adverse Event|10|||
126127357|NCT00542269|453757754|FG001|Overall Study|Adverse Event|4|||
126127358|NCT00542269|453757755|FG002|Overall Study|Adverse Event|5|||
126127359|NCT00542269|453757753|FG000|Overall Study|Protocol Violation|1|||
126127360|NCT00542269|453757754|FG001|Overall Study|Protocol Violation|1|||
126127361|NCT00542269|453757755|FG002|Overall Study|Protocol Violation|0|||
126127362|NCT00542269|453757753|FG000|Overall Study|Withdrawal by Subject|1|||
126127363|NCT00542269|453757754|FG001|Overall Study|Withdrawal by Subject|0|||
126127364|NCT00542269|453757755|FG002|Overall Study|Withdrawal by Subject|0|||
126127365|NCT00542269|453757753|FG000|Overall Study|Administrative problems|1|||
126127366|NCT00542269|453757754|FG001|Overall Study|Administrative problems|1|||
126127367|NCT00542269|453757755|FG002|Overall Study|Administrative problems|1|||
126127368|NCT03873714|453757756|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
126127369|NCT03028870|453757757|FG000|Overall Study|Adverse Event|7|||
126127370|NCT03028870|453757758|FG001|Overall Study|Adverse Event|4|||
126127371|NCT03028870|453757759|FG002|Overall Study|Adverse Event|3|||
126127372|NCT03028870|453757760|FG003|Overall Study|Adverse Event|3|||
126127373|NCT03028870|453757757|FG000|Overall Study|Withdrawal by Subject|1|||
126127374|NCT03028870|453757758|FG001|Overall Study|Withdrawal by Subject|1|||
126127375|NCT03028870|453757759|FG002|Overall Study|Withdrawal by Subject|1|||
126127376|NCT03028870|453757760|FG003|Overall Study|Withdrawal by Subject|2|||
126127377|NCT03028870|453757757|FG000|Overall Study|Lost to Follow-up|1|||
126127378|NCT03028870|453757758|FG001|Overall Study|Lost to Follow-up|0|||
126127379|NCT03028870|453757759|FG002|Overall Study|Lost to Follow-up|0|||
126127380|NCT03028870|453757760|FG003|Overall Study|Lost to Follow-up|0|||
126127381|NCT03028870|453757757|FG000|Overall Study|Lack of Efficacy|3|||
126127382|NCT03028870|453757758|FG001|Overall Study|Lack of Efficacy|0|||
126127383|NCT03028870|453757759|FG002|Overall Study|Lack of Efficacy|0|||
126127384|NCT03028870|453757760|FG003|Overall Study|Lack of Efficacy|0|||
126127385|NCT03028870|453757757|FG000|Overall Study|Administrative|5|||
126127386|NCT03028870|453757758|FG001|Overall Study|Administrative|5|||
126127387|NCT03028870|453757759|FG002|Overall Study|Administrative|12|||
126127388|NCT03028870|453757760|FG003|Overall Study|Administrative|4|||
126127389|NCT00708123|453757763|FG000|Period 1|Protocol Violation|0|||
126127390|NCT00708123|453757764|FG001|Period 1|Protocol Violation|1|||
126127391|NCT00708123|453757765|FG002|Period 1|Protocol Violation|0|||
126127392|NCT00708123|453757766|FG003|Period 1|Protocol Violation|1|||
126127393|NCT00708123|453757767|FG004|Period 1|Protocol Violation|0|||
126127394|NCT00708123|453757763|FG000|Period 1|Adverse Event|0|||
126127395|NCT00708123|453757764|FG001|Period 1|Adverse Event|0|||
126127396|NCT00708123|453757765|FG002|Period 1|Adverse Event|1|||
126127397|NCT00708123|453757766|FG003|Period 1|Adverse Event|0|||
126127398|NCT00708123|453757767|FG004|Period 1|Adverse Event|0|||
126127399|NCT00708123|453757763|FG000|Period 2|Protocol Violation|0|||
126127400|NCT00708123|453757764|FG001|Period 2|Protocol Violation|0|||
126127401|NCT00708123|453757765|FG002|Period 2|Protocol Violation|0|||
126127402|NCT00708123|453757766|FG003|Period 2|Protocol Violation|1|||
126127403|NCT00708123|453757767|FG004|Period 2|Protocol Violation|0|||
126127404|NCT00708123|453757763|FG000|Period 2|Other Reason|1|||
126127405|NCT00708123|453757764|FG001|Period 2|Other Reason|0|||
126127406|NCT00708123|453757765|FG002|Period 2|Other Reason|0|||
126127407|NCT00708123|453757766|FG003|Period 2|Other Reason|0|||
126127408|NCT00708123|453757767|FG004|Period 2|Other Reason|0|||
126127409|NCT00708123|453757763|FG000|Period 3|Lost to Follow-up|0|||
126127410|NCT00708123|453757764|FG001|Period 3|Lost to Follow-up|0|||
126127411|NCT00708123|453757765|FG002|Period 3|Lost to Follow-up|1|||
126127412|NCT00708123|453757766|FG003|Period 3|Lost to Follow-up|1|||
126127413|NCT00708123|453757767|FG004|Period 3|Lost to Follow-up|0|||
126127414|NCT00708123|453757763|FG000|Period 4|Protocol Violation|0|||
126127415|NCT00708123|453757764|FG001|Period 4|Protocol Violation|1|||
126127416|NCT00708123|453757765|FG002|Period 4|Protocol Violation|0|||
126127417|NCT00708123|453757766|FG003|Period 4|Protocol Violation|0|||
126127418|NCT00708123|453757767|FG004|Period 4|Protocol Violation|0|||
126127419|NCT00845650|453757768|FG000|Overall Study|Withdrawal by Subject|0|||
126127420|NCT00845650|453757769|FG001|Overall Study|Withdrawal by Subject|0|||
126127421|NCT00845650|453757770|FG002|Overall Study|Withdrawal by Subject|0|||
126127422|NCT00845650|453757771|FG003|Overall Study|Withdrawal by Subject|0|||
126127423|NCT00845650|453757772|FG004|Overall Study|Withdrawal by Subject|2|||
126127424|NCT00845650|453757773|FG005|Overall Study|Withdrawal by Subject|0|||
126127425|NCT00845650|453757768|FG000|Overall Study|Lost to Follow-up|0|||
126127426|NCT00845650|453757769|FG001|Overall Study|Lost to Follow-up|0|||
126127427|NCT00845650|453757770|FG002|Overall Study|Lost to Follow-up|3|||
126127428|NCT00845650|453757771|FG003|Overall Study|Lost to Follow-up|1|||
126127429|NCT00845650|453757772|FG004|Overall Study|Lost to Follow-up|0|||
126127430|NCT00845650|453757773|FG005|Overall Study|Lost to Follow-up|1|||
126127431|NCT00845650|453757768|FG000|Overall Study|Sponsor hold on dosing|0|||
126127432|NCT00845650|453757769|FG001|Overall Study|Sponsor hold on dosing|0|||
126127433|NCT00845650|453757770|FG002|Overall Study|Sponsor hold on dosing|0|||
126127434|NCT00845650|453757771|FG003|Overall Study|Sponsor hold on dosing|0|||
126127435|NCT00845650|453757772|FG004|Overall Study|Sponsor hold on dosing|1|||
126127436|NCT00845650|453757773|FG005|Overall Study|Sponsor hold on dosing|1|||
126127437|NCT00845650|453757768|FG000|Overall Study|Unable to access IV line|1|||
126127438|NCT00845650|453757769|FG001|Overall Study|Unable to access IV line|0|||
126127439|NCT00845650|453757770|FG002|Overall Study|Unable to access IV line|0|||
126127440|NCT00845650|453757771|FG003|Overall Study|Unable to access IV line|0|||
126127441|NCT00845650|453757772|FG004|Overall Study|Unable to access IV line|0|||
126127442|NCT00845650|453757773|FG005|Overall Study|Unable to access IV line|0|||
126127443|NCT00814892|453757774|FG000|Overall Study|Disease Progression|1|||
126127444|NCT00814892|453757774|FG000|Overall Study|Study Termination|1|||
126127445|NCT04486950|453757775|FG000|Overall Study|Lost to Follow-up|0|||
126127446|NCT04486950|453757776|FG001|Overall Study|Lost to Follow-up|0|||
126127447|NCT04486950|453757777|FG002|Overall Study|Lost to Follow-up|0|||
126127448|NCT04486950|453757778|FG003|Overall Study|Lost to Follow-up|0|||
126127449|NCT04486950|453757779|FG004|Overall Study|Lost to Follow-up|0|||
126127450|NCT04486950|453757780|FG005|Overall Study|Lost to Follow-up|1|||
126127451|NCT04486950|453757781|FG006|Overall Study|Lost to Follow-up|0|||
126127452|NCT01119248|453757786|FG000|Overall Study|Physician Decision|5|||
126127453|NCT00550680|453757787|FG000|Overall Study|Administrative Reasons|1|||
126127454|NCT00550680|453757787|FG000|Overall Study|Adverse Event|5|||
126127455|NCT00550680|453757787|FG000|Overall Study|Death|3|||
126127456|NCT00550680|453757787|FG000|Overall Study|Early Improvement|1|||
126127457|NCT00550680|453757787|FG000|Overall Study|Lost to Follow-up|3|||
126127458|NCT00550680|453757787|FG000|Overall Study|Lack of Efficacy|1|||
126127459|NCT00550680|453757787|FG000|Overall Study|Other|10|||
126127460|NCT00550680|453757787|FG000|Overall Study|Protocol Violation|7|||
126127461|NCT00550680|453757787|FG000|Overall Study|Refused Treatment|19|||
126127462|NCT00550680|453757787|FG000|Overall Study|Screen Failure|6|||
126127463|NCT00562354|453757788|FG000|Overall Study|Physician Decision|0|||
126127464|NCT00562354|453757789|FG001|Overall Study|Physician Decision|1|||
126127465|NCT00562354|453757788|FG000|Overall Study|Lost to Follow-up|0|||
126127466|NCT00562354|453757789|FG001|Overall Study|Lost to Follow-up|1|||
126127467|NCT00317109|453757790|FG000|Overall Study|Withdrawal by Subject|2|||
126127468|NCT00317109|453757791|FG001|Overall Study|Withdrawal by Subject|0|||
126127469|NCT00317109|453757790|FG000|Overall Study|Migated/moved from study area|1|||
126127470|NCT00317109|453757791|FG001|Overall Study|Migated/moved from study area|0|||
126127471|NCT03693625|453757793|FG000|Overall Study|Adverse Event|2|||
126127472|NCT03693625|453757794|FG001|Overall Study|Adverse Event|0|||
126127473|NCT03693625|453757793|FG000|Overall Study|Study Terminated By Sponsor|20|||
126127474|NCT03693625|453757794|FG001|Overall Study|Study Terminated By Sponsor|7|||
126127475|NCT03693625|453757793|FG000|Overall Study|Withdrawal by Subject|1|||
126127476|NCT03693625|453757794|FG001|Overall Study|Withdrawal by Subject|1|||
126127477|NCT01508702|453757795|FG000|Overall Study|Adverse Event|7|||
126127478|NCT01508702|453757796|FG001|Overall Study|Adverse Event|3|||
126127479|NCT01508702|453757795|FG000|Overall Study|Gout flare|2|||
126127480|NCT01508702|453757796|FG001|Overall Study|Gout flare|0|||
126127481|NCT01508702|453757795|FG000|Overall Study|Protocol Violation|2|||
126127482|NCT01508702|453757796|FG001|Overall Study|Protocol Violation|1|||
126127483|NCT01508702|453757795|FG000|Overall Study|Lost to Follow-up|1|||
125963889|NCT03019536|453159310|FG000|Overall Study|Adverse Event|0|||
126127484|NCT01508702|453757796|FG001|Overall Study|Lost to Follow-up|2|||
126127485|NCT01508702|453757795|FG000|Overall Study|Withdrawal by Subject|11|||
126127486|NCT01508702|453757796|FG001|Overall Study|Withdrawal by Subject|7|||
126127487|NCT01883635|453757798|FG000|Overall Study|Withdrawal by Subject|4|||
126127488|NCT01883635|453757799|FG001|Overall Study|Withdrawal by Subject|0|||
126127489|NCT01187953|453757800|FG000|Overall Study|Death|11|||
126127490|NCT01187953|453757801|FG001|Overall Study|Death|13|||
125963890|NCT03019536|453159311|FG001|Overall Study|Adverse Event|0|||
125963891|NCT03019536|453159312|FG002|Overall Study|Adverse Event|2|||
125963892|NCT01782131|453159315|FG000|Overall Study|Death|93|||
125963893|NCT01782131|453159316|FG001|Overall Study|Death|96|||
125963894|NCT01782131|453159315|FG000|Overall Study|Lost to Follow-up|1|||
125963895|NCT01782131|453159316|FG001|Overall Study|Lost to Follow-up|3|||
125963896|NCT01782131|453159315|FG000|Overall Study|Withdrawal by Subject|10|||
125963897|NCT01782131|453159316|FG001|Overall Study|Withdrawal by Subject|10|||
126127491|NCT01187953|453757800|FG000|Overall Study|Adverse Event|1|||
126127492|NCT01187953|453757801|FG001|Overall Study|Adverse Event|2|||
126127493|NCT01187953|453757800|FG000|Overall Study|Lost to Follow-up|0|||
126127494|NCT01187953|453757801|FG001|Overall Study|Lost to Follow-up|3|||
126127495|NCT01187953|453757800|FG000|Overall Study|Withdrawal by Subject|3|||
126127496|NCT01187953|453757801|FG001|Overall Study|Withdrawal by Subject|3|||
126127497|NCT01464307|453757802|FG000|Main Period|Death|0|||
126127498|NCT01464307|453757803|FG001|Main Period|Death|1|||
126127499|NCT01464307|453757802|FG000|Main Period|Adverse Event|6|||
126127500|NCT01464307|453757803|FG001|Main Period|Adverse Event|1|||
126127501|NCT01464307|453757802|FG000|Main Period|Lack of Efficacy|2|||
126127502|NCT01464307|453757803|FG001|Main Period|Lack of Efficacy|0|||
126127503|NCT01464307|453757802|FG000|Main Period|Withdrawal by Subject|5|||
126127504|NCT01464307|453757803|FG001|Main Period|Withdrawal by Subject|2|||
126127505|NCT01464307|453757802|FG000|Main Period|Predefined discontinuation criteria|2|||
126127506|NCT01464307|453757803|FG001|Main Period|Predefined discontinuation criteria|1|||
126127507|NCT01464307|453757802|FG000|Open-Label Extension Period|Adverse Event|15|||
126127508|NCT01464307|453757803|FG001|Open-Label Extension Period|Adverse Event|0|||
126127509|NCT01464307|453757802|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
126127510|NCT01464307|453757803|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
126127511|NCT01464307|453757802|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
126127512|NCT01464307|453757803|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
126127513|NCT01464307|453757802|FG000|Open-Label Extension Period|Death|1|||
126127514|NCT01464307|453757803|FG001|Open-Label Extension Period|Death|0|||
126127515|NCT01464307|453757802|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
126127516|NCT01464307|453757803|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
126127517|NCT01464307|453757802|FG000|Open-Label Extension Period|Non-compliance|9|||
126127518|NCT01464307|453757803|FG001|Open-Label Extension Period|Non-compliance|0|||
126127519|NCT01464307|453757802|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
126127520|NCT01464307|453757803|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
126127521|NCT00761514|453757808|FG000|Overall Study|Adverse Event|1|||
126127522|NCT00761514|453757808|FG000|Overall Study|Withdrawal by Subject|2|||
126127523|NCT00761514|453757808|FG000|Overall Study|Lost to Follow-up|1|||
126127524|NCT00761514|453757808|FG000|Overall Study|Health insurance didn't cover study drug|1|||
126127525|NCT00761514|453757808|FG000|Overall Study|Problem complying with study visit|1|||
126127526|NCT00761514|453757808|FG000|Overall Study|Unable to pay for medications|1|||
126127527|NCT02457637|453757809|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
126127528|NCT01836783|453757812|FG000|Overall Study|Withdrawal by Subject|0|||
126127529|NCT01836783|453757813|FG001|Overall Study|Withdrawal by Subject|2|||
126127530|NCT04942925|453757814|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
126127531|NCT04942925|453757815|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
126127532|NCT04942925|453757814|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
126127533|NCT04942925|453757815|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
126127534|NCT01273883|453757816|FG000|First Intervention|Adverse Event|2|||
126127535|NCT01273883|453757817|FG001|First Intervention|Adverse Event|1|||
126127536|NCT01273883|453757816|FG000|Second Intervention|Lost to Follow-up|1|||
126127537|NCT01273883|453757817|FG001|Second Intervention|Lost to Follow-up|1|||
126127538|NCT01273883|453757816|FG000|Second Intervention|Lack of Efficacy|1|||
126127539|NCT01273883|453757817|FG001|Second Intervention|Lack of Efficacy|0|||
126127540|NCT01430455|453757818|FG000|Overall Study|Withdrawal by Subject|1|||
126127541|NCT01430455|453757818|FG000|Overall Study|Switched to follow-up phase|1|||
126127542|NCT01014689|453757820|FG000|Overall Study|Lack of Efficacy|0|||
126127543|NCT01014689|453757821|FG001|Overall Study|Lack of Efficacy|1|||
126127544|NCT01014689|453757820|FG000|Overall Study|Adverse Event|3|||
126127545|NCT01014689|453757821|FG001|Overall Study|Adverse Event|0|||
126127546|NCT01014689|453757820|FG000|Overall Study|Withdrawal by Subject|5|||
126127547|NCT01014689|453757821|FG001|Overall Study|Withdrawal by Subject|4|||
126127548|NCT01014689|453757820|FG000|Overall Study|Protocol Violation|1|||
126127549|NCT01014689|453757821|FG001|Overall Study|Protocol Violation|1|||
126127550|NCT01014689|453757820|FG000|Overall Study|Lost to Follow-up|3|||
126127551|NCT01014689|453757821|FG001|Overall Study|Lost to Follow-up|7|||
126127552|NCT01014689|453757820|FG000|Overall Study|Pregnancy|1|||
126127553|NCT01014689|453757821|FG001|Overall Study|Pregnancy|0|||
126127554|NCT02867995|453757824|FG000|Overall Study|Withdrawal by Subject|0|||
126127555|NCT02867995|453757825|FG001|Overall Study|Withdrawal by Subject|1|||
126127556|NCT02867995|453757824|FG000|Overall Study|Lost to Follow-up|0|||
126127557|NCT02867995|453757825|FG001|Overall Study|Lost to Follow-up|2|||
126127558|NCT02404103|453761104|FG000|Overall Study|Adverse Event|1|||
126127559|NCT02404103|453761105|FG001|Overall Study|Adverse Event|0|||
126127560|NCT02404103|453761104|FG000|Overall Study|Lost to Follow-up|3|||
126127561|NCT02404103|453761105|FG001|Overall Study|Lost to Follow-up|3|||
126127562|NCT00328627|453761106|FG000|Overall Study|Hyperglycemic Rescue|41|||
126127563|NCT00328627|453761107|FG001|Overall Study|Hyperglycemic Rescue|18|||
126127564|NCT00328627|453761108|FG002|Overall Study|Hyperglycemic Rescue|16|||
126127565|NCT00328627|453761109|FG003|Overall Study|Hyperglycemic Rescue|13|||
126127566|NCT00328627|453761110|FG004|Overall Study|Hyperglycemic Rescue|6|||
126127567|NCT00328627|453761111|FG005|Overall Study|Hyperglycemic Rescue|5|||
126127568|NCT00328627|453761112|FG006|Overall Study|Hyperglycemic Rescue|19|||
126127569|NCT00328627|453761113|FG007|Overall Study|Hyperglycemic Rescue|6|||
126127570|NCT00328627|453761114|FG008|Overall Study|Hyperglycemic Rescue|6|||
126127571|NCT00328627|453761115|FG009|Overall Study|Hyperglycemic Rescue|11|||
126127572|NCT00328627|453761116|FG010|Overall Study|Hyperglycemic Rescue|3|||
126127573|NCT00328627|453761117|FG011|Overall Study|Hyperglycemic Rescue|2|||
126127574|NCT00328627|453761106|FG000|Overall Study|Adverse Event|3|||
126127575|NCT00328627|453761107|FG001|Overall Study|Adverse Event|1|||
126127576|NCT00328627|453761108|FG002|Overall Study|Adverse Event|2|||
126127577|NCT00328627|453761109|FG003|Overall Study|Adverse Event|3|||
126127578|NCT00328627|453761110|FG004|Overall Study|Adverse Event|1|||
126127579|NCT00328627|453761111|FG005|Overall Study|Adverse Event|2|||
126127580|NCT00328627|453761112|FG006|Overall Study|Adverse Event|1|||
126127581|NCT00328627|453761113|FG007|Overall Study|Adverse Event|2|||
126127582|NCT00328627|453761114|FG008|Overall Study|Adverse Event|0|||
126127583|NCT00328627|453761115|FG009|Overall Study|Adverse Event|7|||
126127584|NCT00328627|453761116|FG010|Overall Study|Adverse Event|5|||
126127585|NCT00328627|453761117|FG011|Overall Study|Adverse Event|4|||
126127586|NCT00328627|453761106|FG000|Overall Study|Protocol Violation|2|||
126127587|NCT00328627|453761107|FG001|Overall Study|Protocol Violation|2|||
126127588|NCT00328627|453761108|FG002|Overall Study|Protocol Violation|2|||
126127589|NCT00328627|453761109|FG003|Overall Study|Protocol Violation|8|||
126127590|NCT00328627|453761110|FG004|Overall Study|Protocol Violation|5|||
126127591|NCT00328627|453761111|FG005|Overall Study|Protocol Violation|5|||
126127592|NCT00328627|453761112|FG006|Overall Study|Protocol Violation|6|||
126127593|NCT00328627|453761113|FG007|Overall Study|Protocol Violation|2|||
126127594|NCT00328627|453761114|FG008|Overall Study|Protocol Violation|1|||
126127595|NCT00328627|453761115|FG009|Overall Study|Protocol Violation|4|||
126127596|NCT00328627|453761116|FG010|Overall Study|Protocol Violation|6|||
126127597|NCT00328627|453761117|FG011|Overall Study|Protocol Violation|2|||
126127598|NCT00328627|453761106|FG000|Overall Study|Lost to Follow-up|4|||
126127599|NCT00328627|453761107|FG001|Overall Study|Lost to Follow-up|2|||
126127600|NCT00328627|453761108|FG002|Overall Study|Lost to Follow-up|2|||
126127601|NCT00328627|453761109|FG003|Overall Study|Lost to Follow-up|4|||
126127602|NCT00328627|453761110|FG004|Overall Study|Lost to Follow-up|0|||
126127603|NCT00328627|453761111|FG005|Overall Study|Lost to Follow-up|2|||
126127604|NCT00328627|453761112|FG006|Overall Study|Lost to Follow-up|3|||
126127605|NCT00328627|453761113|FG007|Overall Study|Lost to Follow-up|0|||
126127606|NCT00328627|453761114|FG008|Overall Study|Lost to Follow-up|3|||
126127607|NCT00328627|453761115|FG009|Overall Study|Lost to Follow-up|2|||
126127608|NCT00328627|453761116|FG010|Overall Study|Lost to Follow-up|0|||
126127609|NCT00328627|453761117|FG011|Overall Study|Lost to Follow-up|1|||
126127610|NCT00328627|453761106|FG000|Overall Study|Withdrawal by Subject|5|||
126127611|NCT00328627|453761107|FG001|Overall Study|Withdrawal by Subject|4|||
126127612|NCT00328627|453761108|FG002|Overall Study|Withdrawal by Subject|5|||
126127613|NCT00328627|453761109|FG003|Overall Study|Withdrawal by Subject|6|||
126127614|NCT00328627|453761110|FG004|Overall Study|Withdrawal by Subject|2|||
126127615|NCT00328627|453761111|FG005|Overall Study|Withdrawal by Subject|5|||
126127616|NCT00328627|453761112|FG006|Overall Study|Withdrawal by Subject|4|||
126127617|NCT00328627|453761113|FG007|Overall Study|Withdrawal by Subject|4|||
126127618|NCT00328627|453761114|FG008|Overall Study|Withdrawal by Subject|4|||
126127619|NCT00328627|453761115|FG009|Overall Study|Withdrawal by Subject|5|||
126127620|NCT00328627|453761116|FG010|Overall Study|Withdrawal by Subject|2|||
126127621|NCT00328627|453761117|FG011|Overall Study|Withdrawal by Subject|7|||
126127622|NCT00328627|453761106|FG000|Overall Study|Pregnancy|0|||
126127623|NCT00328627|453761107|FG001|Overall Study|Pregnancy|1|||
126127624|NCT00328627|453761108|FG002|Overall Study|Pregnancy|0|||
126127625|NCT00328627|453761109|FG003|Overall Study|Pregnancy|0|||
126127626|NCT00328627|453761110|FG004|Overall Study|Pregnancy|0|||
126127627|NCT00328627|453761111|FG005|Overall Study|Pregnancy|0|||
126127628|NCT00328627|453761112|FG006|Overall Study|Pregnancy|0|||
126127629|NCT00328627|453761113|FG007|Overall Study|Pregnancy|0|||
126127630|NCT00328627|453761114|FG008|Overall Study|Pregnancy|0|||
126127631|NCT00328627|453761115|FG009|Overall Study|Pregnancy|0|||
126127632|NCT00328627|453761116|FG010|Overall Study|Pregnancy|0|||
126127633|NCT00328627|453761117|FG011|Overall Study|Pregnancy|0|||
126127634|NCT00328627|453761106|FG000|Overall Study|Physician Decision|4|||
126127635|NCT00328627|453761107|FG001|Overall Study|Physician Decision|3|||
126127636|NCT00328627|453761108|FG002|Overall Study|Physician Decision|1|||
126127637|NCT00328627|453761109|FG003|Overall Study|Physician Decision|2|||
126127638|NCT00328627|453761110|FG004|Overall Study|Physician Decision|1|||
126127639|NCT00328627|453761111|FG005|Overall Study|Physician Decision|1|||
126127640|NCT00328627|453761112|FG006|Overall Study|Physician Decision|1|||
126127641|NCT00328627|453761113|FG007|Overall Study|Physician Decision|0|||
126127642|NCT00328627|453761114|FG008|Overall Study|Physician Decision|3|||
126127643|NCT00328627|453761115|FG009|Overall Study|Physician Decision|2|||
126127644|NCT00328627|453761116|FG010|Overall Study|Physician Decision|1|||
126127645|NCT00328627|453761117|FG011|Overall Study|Physician Decision|0|||
126127646|NCT00328627|453761106|FG000|Overall Study|Other|0|||
126127647|NCT00328627|453761107|FG001|Overall Study|Other|0|||
126127648|NCT00328627|453761108|FG002|Overall Study|Other|0|||
126127649|NCT00328627|453761109|FG003|Overall Study|Other|1|||
126127650|NCT00328627|453761110|FG004|Overall Study|Other|0|||
126127651|NCT00328627|453761111|FG005|Overall Study|Other|0|||
126127652|NCT00328627|453761112|FG006|Overall Study|Other|1|||
126127653|NCT00328627|453761113|FG007|Overall Study|Other|0|||
126127654|NCT00328627|453761114|FG008|Overall Study|Other|0|||
126127655|NCT00328627|453761115|FG009|Overall Study|Other|1|||
126127656|NCT00328627|453761116|FG010|Overall Study|Other|1|||
126127657|NCT00328627|453761117|FG011|Overall Study|Other|0|||
126127658|NCT00522431|453761118|FG000|Overall Study|Adverse Event|5|||
126127659|NCT00522431|453761118|FG000|Overall Study|Protocol Violation|2|||
126127660|NCT00522431|453761118|FG000|Overall Study|Withdrawal by Subject|2|||
126127661|NCT00522431|453761118|FG000|Overall Study|Subject non-compliance|1|||
126127662|NCT00522431|453761118|FG000|Overall Study|Other/unknown|1|||
126127663|NCT01137773|453761119|FG000|Overall Study|Death|3|||
126127664|NCT01137773|453761120|FG001|Overall Study|Death|3|||
126127665|NCT01137773|453761119|FG000|Overall Study|Lost to Follow-up|6|||
126127666|NCT01137773|453761120|FG001|Overall Study|Lost to Follow-up|0|||
126127667|NCT03548051|453761121|FG000|Overall Study|Death|1|||
126127668|NCT03548051|453761122|FG001|Overall Study|Death|1|||
126127669|NCT03548051|453761121|FG000|Overall Study|Withdrawal by Subject|1|||
126127670|NCT03548051|453761122|FG001|Overall Study|Withdrawal by Subject|0|||
126127671|NCT03548558|453761123|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
126127672|NCT03548558|453761124|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
126127673|NCT03548558|453761125|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
126127674|NCT03548558|453761126|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
126127675|NCT03548558|453761127|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
126127676|NCT03548558|453761128|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
126127677|NCT03548558|453761129|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
126127678|NCT03548558|453761123|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
126127679|NCT03548558|453761124|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
126127680|NCT03548558|453761125|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
126127681|NCT03548558|453761126|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
126127682|NCT03548558|453761127|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
126127683|NCT03548558|453761128|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
126127684|NCT03548558|453761129|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
126127685|NCT03548558|453761123|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
126127686|NCT03548558|453761124|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
126127687|NCT03548558|453761125|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
126127688|NCT03548558|453761126|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
126127689|NCT03548558|453761127|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
126127690|NCT03548558|453761128|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
126127691|NCT03548558|453761129|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
126127692|NCT03548558|453761123|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
126127693|NCT03548558|453761124|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
126127694|NCT03548558|453761125|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
126127695|NCT03548558|453761126|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
126127696|NCT03548558|453761127|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
126127697|NCT03548558|453761128|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
126127698|NCT03548558|453761129|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
126127699|NCT03548558|453761123|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
126127700|NCT03548558|453761124|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
126127701|NCT03548558|453761125|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
126127702|NCT03548558|453761126|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
126127703|NCT03548558|453761127|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
126127704|NCT03548558|453761128|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
126127705|NCT03548558|453761129|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
126127706|NCT03548558|453761123|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
126127707|NCT03548558|453761124|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
126127708|NCT03548558|453761125|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
126127709|NCT03548558|453761126|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
126127710|NCT03548558|453761127|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
126127711|NCT03548558|453761128|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
126127712|NCT03548558|453761129|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
126127713|NCT03273166|453761139|FG000|Overall Study|Withdrawn prior to Completion|31|||
126127714|NCT02669017|453761140|FG000|Overall Study|Death|1|||
126127715|NCT02669017|453761141|FG001|Overall Study|Death|2|||
126127716|NCT02669017|453761142|FG002|Overall Study|Death|2|||
126127717|NCT02669017|453761143|FG003|Overall Study|Death|3|||
126127718|NCT02669017|453761144|FG004|Overall Study|Death|8|||
126127719|NCT02669017|453761145|FG005|Overall Study|Death|18|||
126127720|NCT02669017|453761146|FG006|Overall Study|Death|10|||
126127721|NCT02669017|453761147|FG007|Overall Study|Death|47|||
126127722|NCT02669017|453761148|FG008|Overall Study|Death|20|||
126127723|NCT02669017|453761140|FG000|Overall Study|Withdrawal by Subject|0|||
126127724|NCT02669017|453761141|FG001|Overall Study|Withdrawal by Subject|0|||
126127725|NCT02669017|453761142|FG002|Overall Study|Withdrawal by Subject|0|||
126127726|NCT02669017|453761143|FG003|Overall Study|Withdrawal by Subject|1|||
126127727|NCT02669017|453761144|FG004|Overall Study|Withdrawal by Subject|2|||
126127728|NCT02669017|453761145|FG005|Overall Study|Withdrawal by Subject|0|||
126127729|NCT02669017|453761146|FG006|Overall Study|Withdrawal by Subject|0|||
126127730|NCT02669017|453761147|FG007|Overall Study|Withdrawal by Subject|2|||
126127731|NCT02669017|453761148|FG008|Overall Study|Withdrawal by Subject|2|||
126127732|NCT02669017|453761140|FG000|Overall Study|Lost to Follow-up|0|||
126127733|NCT02669017|453761141|FG001|Overall Study|Lost to Follow-up|0|||
126127734|NCT02669017|453761142|FG002|Overall Study|Lost to Follow-up|0|||
126127735|NCT02669017|453761143|FG003|Overall Study|Lost to Follow-up|0|||
126127736|NCT02669017|453761144|FG004|Overall Study|Lost to Follow-up|0|||
126127737|NCT02669017|453761145|FG005|Overall Study|Lost to Follow-up|0|||
126127738|NCT02669017|453761146|FG006|Overall Study|Lost to Follow-up|0|||
126127739|NCT02669017|453761147|FG007|Overall Study|Lost to Follow-up|0|||
126127740|NCT02669017|453761148|FG008|Overall Study|Lost to Follow-up|1|||
126127741|NCT02669017|453761140|FG000|Overall Study|Miscellaneous|0|||
126127742|NCT02669017|453761141|FG001|Overall Study|Miscellaneous|0|||
126127743|NCT02669017|453761142|FG002|Overall Study|Miscellaneous|0|||
126127744|NCT02669017|453761143|FG003|Overall Study|Miscellaneous|0|||
126127745|NCT02669017|453761144|FG004|Overall Study|Miscellaneous|2|||
126127746|NCT02669017|453761145|FG005|Overall Study|Miscellaneous|1|||
126127747|NCT02669017|453761146|FG006|Overall Study|Miscellaneous|1|||
126127748|NCT02669017|453761147|FG007|Overall Study|Miscellaneous|13|||
126127749|NCT02669017|453761148|FG008|Overall Study|Miscellaneous|2|||
126127750|NCT01289015|453761149|FG000|Overall Study|Protocol Violation|12|||
126127751|NCT01289015|453761150|FG001|Overall Study|Protocol Violation|9|||
126127752|NCT01289015|453761149|FG000|Overall Study|Adverse Event|3|||
126127753|NCT01289015|453761150|FG001|Overall Study|Adverse Event|0|||
126127754|NCT01289015|453761149|FG000|Overall Study|Lost to Follow-up|33|||
126127755|NCT01289015|453761150|FG001|Overall Study|Lost to Follow-up|17|||
126127756|NCT01289015|453761149|FG000|Overall Study|Withdrawal by Subject|17|||
126127757|NCT01289015|453761150|FG001|Overall Study|Withdrawal by Subject|8|||
126127758|NCT01289015|453761149|FG000|Overall Study|Disease progression|1|||
126127759|NCT01289015|453761150|FG001|Overall Study|Disease progression|0|||
126127760|NCT01289015|453761149|FG000|Overall Study|Negative baseline culture and others|33|||
126127761|NCT01289015|453761150|FG001|Overall Study|Negative baseline culture and others|20|||
126127762|NCT02797808|453761155|FG000|Overall Study|Withdrawal by Subject|1|||
126127763|NCT02797808|453761156|FG001|Overall Study|Withdrawal by Subject|1|||
126127764|NCT02797808|453761155|FG000|Overall Study|Physician Decision|6|||
126127765|NCT02797808|453761156|FG001|Overall Study|Physician Decision|2|||
126127766|NCT03509350|453761157|FG000|Overall Study|Withdrawal by Subject|0|||
126127767|NCT03509350|453761158|FG001|Overall Study|Withdrawal by Subject|2|||
126127768|NCT01425203|453761159|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
126127769|NCT01425203|453761160|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
126127770|NCT01425203|453761161|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
126127771|NCT01425203|453761159|FG000|Treatment Phase|Failure at futility timepoint|8|||
126127772|NCT01425203|453761160|FG001|Treatment Phase|Failure at futility timepoint|27|||
126127773|NCT01425203|453761161|FG002|Treatment Phase|Failure at futility timepoint|0|||
126127774|NCT01425203|453761159|FG000|Treatment Phase|Other virologic failure criteria|5|||
126127775|NCT01425203|453761160|FG001|Treatment Phase|Other virologic failure criteria|3|||
126127776|NCT01425203|453761161|FG002|Treatment Phase|Other virologic failure criteria|0|||
126127777|NCT01425203|453761159|FG000|Treatment Phase|Unidentified reasons|11|||
126127778|NCT01425203|453761160|FG001|Treatment Phase|Unidentified reasons|5|||
126127779|NCT01425203|453761161|FG002|Treatment Phase|Unidentified reasons|0|||
126127780|NCT01425203|453761159|FG000|Treatment Phase|Did not receive treatment|0|||
126127781|NCT01425203|453761160|FG001|Treatment Phase|Did not receive treatment|1|||
126127782|NCT01425203|453761161|FG002|Treatment Phase|Did not receive treatment|0|||
126127783|NCT01425203|453761159|FG000|Crossover Phase|Failure at futility timepoint|0|||
126127784|NCT01425203|453761160|FG001|Crossover Phase|Failure at futility timepoint|0|||
126127785|NCT01425203|453761161|FG002|Crossover Phase|Failure at futility timepoint|3|||
126127786|NCT01425203|453761159|FG000|Crossover Phase|Other virologic failure criteria|0|||
126127787|NCT01425203|453761160|FG001|Crossover Phase|Other virologic failure criteria|0|||
126127788|NCT01425203|453761161|FG002|Crossover Phase|Other virologic failure criteria|3|||
126127789|NCT00535132|453761164|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
126127790|NCT00535132|453761165|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
126127791|NCT00535132|453761164|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
126127792|NCT00535132|453761165|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
126127793|NCT02590588|453761166|FG000|Overall Study|Adverse Event|1|||
126127794|NCT00290433|453761169|FG000|Overall Study|Disease Progression|13|||
126127795|NCT00290433|453761169|FG000|Overall Study|Adverse Event|14|||
126127796|NCT00290433|453761169|FG000|Overall Study|Withdrawal by Subject|1|||
126127797|NCT00290433|453761169|FG000|Overall Study|Non-Compliance|1|||
126127798|NCT00290433|453761169|FG000|Overall Study|Congestive Heart Failure|1|||
126127799|NCT00290433|453761169|FG000|Overall Study|Transplant in CR|5|||
126127800|NCT00290433|453761169|FG000|Overall Study|Unrelated Infection/Death|1|||
126127801|NCT03031301|453761172|FG000|Overall Study|Protocol Violation|4|||
126127802|NCT03031301|453761173|FG001|Overall Study|Protocol Violation|8|||
126127803|NCT03031301|453761172|FG000|Overall Study|Withdrawal by Subject|7|||
126127804|NCT03031301|453761173|FG001|Overall Study|Withdrawal by Subject|4|||
126127805|NCT03031301|453761172|FG000|Overall Study|Lost to Follow-up|4|||
126127806|NCT03031301|453761173|FG001|Overall Study|Lost to Follow-up|12|||
126127807|NCT03031301|453761172|FG000|Overall Study|Noncompliance|1|||
126127808|NCT03031301|453761173|FG001|Overall Study|Noncompliance|3|||
126127809|NCT03031301|453761172|FG000|Overall Study|Technical issue|1|||
126127810|NCT03031301|453761173|FG001|Overall Study|Technical issue|1|||
126127811|NCT03031301|453761172|FG000|Overall Study|Adverse Event|1|||
126127812|NCT03031301|453761173|FG001|Overall Study|Adverse Event|0|||
126127813|NCT05098041|453761180|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
126127814|NCT00382993|453761182|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
126127815|NCT00382993|453761183|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
126127816|NCT00382993|453761182|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
126127817|NCT00382993|453761183|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
126127818|NCT00382993|453761182|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
126127819|NCT00382993|453761183|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
126127820|NCT00382993|453761182|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
126127821|NCT00382993|453761183|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
126127822|NCT00382993|453761182|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
126127823|NCT00382993|453761183|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
126127824|NCT00382993|453761182|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
126127825|NCT00382993|453761183|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
126127826|NCT00382993|453761182|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
126127827|NCT00382993|453761183|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
126127828|NCT00382993|453761182|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
126127829|NCT00382993|453761183|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
126127830|NCT00382993|453761182|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
126127831|NCT00382993|453761183|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
126127832|NCT00382993|453761182|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
126127833|NCT00382993|453761183|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
126127834|NCT01857869|453761184|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
126127835|NCT01857869|453761185|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
126127836|NCT01857869|453761186|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
126127837|NCT01857869|453761187|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
126127838|NCT01857869|453761188|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
126127839|NCT01857869|453761189|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
126127840|NCT01857869|453761190|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
126127841|NCT01857869|453761191|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
126127842|NCT01857869|453761192|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
126127843|NCT01857869|453761193|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
126127844|NCT01857869|453761184|FG000|Primary/Challenge Phase|Pregnancy|1|||
126127845|NCT01857869|453761185|FG001|Primary/Challenge Phase|Pregnancy|0|||
126127846|NCT01857869|453761186|FG002|Primary/Challenge Phase|Pregnancy|0|||
126127847|NCT01857869|453761187|FG003|Primary/Challenge Phase|Pregnancy|0|||
126127848|NCT01857869|453761188|FG004|Primary/Challenge Phase|Pregnancy|0|||
126127849|NCT01857869|453761189|FG005|Primary/Challenge Phase|Pregnancy|0|||
126127850|NCT01857869|453761190|FG006|Primary/Challenge Phase|Pregnancy|0|||
126127851|NCT01857869|453761191|FG007|Primary/Challenge Phase|Pregnancy|0|||
126127852|NCT01857869|453761192|FG008|Primary/Challenge Phase|Pregnancy|0|||
126127853|NCT01857869|453761193|FG009|Primary/Challenge Phase|Pregnancy|0|||
126127854|NCT01857869|453761184|FG000|Primary/Challenge Phase|Protocol Violation|1|||
126127855|NCT01857869|453761185|FG001|Primary/Challenge Phase|Protocol Violation|0|||
126127856|NCT01857869|453761186|FG002|Primary/Challenge Phase|Protocol Violation|0|||
125963898|NCT01782131|453159315|FG000|Overall Study|Randomized but not treated|5|||
125963899|NCT01782131|453159316|FG001|Overall Study|Randomized but not treated|5|||
125963900|NCT01782131|453159315|FG000|Overall Study|Reason not provided|0|||
125963901|NCT01782131|453159316|FG001|Overall Study|Reason not provided|1|||
125963902|NCT01627249|453159317|FG000|Overall Study|Death|3|||
125963903|NCT01627249|453159318|FG001|Overall Study|Death|5|||
125963904|NCT01627249|453159319|FG002|Overall Study|Death|3|||
125963905|NCT01627249|453159317|FG000|Overall Study|Withdrawal by Subject|12|||
125963906|NCT01627249|453159318|FG001|Overall Study|Withdrawal by Subject|6|||
125963907|NCT01627249|453159319|FG002|Overall Study|Withdrawal by Subject|9|||
125963908|NCT01627249|453159317|FG000|Overall Study|Missed Visit|1|||
125963909|NCT01627249|453159318|FG001|Overall Study|Missed Visit|1|||
126127857|NCT01857869|453761187|FG003|Primary/Challenge Phase|Protocol Violation|0|||
125963910|NCT01627249|453159319|FG002|Overall Study|Missed Visit|0|||
125963911|NCT03266588|453159320|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
125963912|NCT03266588|453159321|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
125963913|NCT03266588|453159322|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
125963914|NCT03266588|453159320|FG000|Observational Period|Withdrawal by Subject|44|||
125963915|NCT03266588|453159321|FG001|Observational Period|Withdrawal by Subject|22|||
125963916|NCT03266588|453159322|FG002|Observational Period|Withdrawal by Subject|13|||
125963917|NCT03266588|453159320|FG000|Observational Period|Non-compliance|18|||
125963918|NCT03266588|453159321|FG001|Observational Period|Non-compliance|12|||
125963919|NCT03266588|453159322|FG002|Observational Period|Non-compliance|10|||
125963920|NCT03266588|453159320|FG000|Observational Period|Lost to Follow-up|8|||
125963921|NCT03266588|453159321|FG001|Observational Period|Lost to Follow-up|12|||
125963922|NCT03266588|453159322|FG002|Observational Period|Lost to Follow-up|4|||
125963923|NCT03266588|453159320|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
125963924|NCT03266588|453159321|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
125963925|NCT03266588|453159322|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
125963926|NCT03266588|453159320|FG000|Observational Period|Protocol Deviation|1|||
125963927|NCT03266588|453159321|FG001|Observational Period|Protocol Deviation|0|||
125963928|NCT03266588|453159322|FG002|Observational Period|Protocol Deviation|0|||
125963929|NCT03266588|453159320|FG000|Observational Period|Other Reasons|3|||
125963930|NCT03266588|453159321|FG001|Observational Period|Other Reasons|0|||
126127858|NCT01857869|453761188|FG004|Primary/Challenge Phase|Protocol Violation|0|||
126127859|NCT01857869|453761189|FG005|Primary/Challenge Phase|Protocol Violation|0|||
126127860|NCT01857869|453761190|FG006|Primary/Challenge Phase|Protocol Violation|0|||
126127861|NCT01857869|453761191|FG007|Primary/Challenge Phase|Protocol Violation|0|||
126127862|NCT01857869|453761192|FG008|Primary/Challenge Phase|Protocol Violation|0|||
126127863|NCT01857869|453761193|FG009|Primary/Challenge Phase|Protocol Violation|0|||
126127864|NCT01857869|453761184|FG000|Primary/Challenge Phase|Other|1|||
126127865|NCT01857869|453761185|FG001|Primary/Challenge Phase|Other|1|||
126127866|NCT01857869|453761186|FG002|Primary/Challenge Phase|Other|0|||
126127867|NCT01857869|453761187|FG003|Primary/Challenge Phase|Other|0|||
126127868|NCT01857869|453761188|FG004|Primary/Challenge Phase|Other|0|||
126127869|NCT01857869|453761189|FG005|Primary/Challenge Phase|Other|0|||
126127870|NCT01857869|453761190|FG006|Primary/Challenge Phase|Other|0|||
126127871|NCT01857869|453761191|FG007|Primary/Challenge Phase|Other|0|||
125963931|NCT03266588|453159322|FG002|Observational Period|Other Reasons|1|||
126127872|NCT01857869|453761192|FG008|Primary/Challenge Phase|Other|0|||
126127873|NCT01857869|453761193|FG009|Primary/Challenge Phase|Other|0|||
126127874|NCT01857869|453761184|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127875|NCT01857869|453761185|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127876|NCT01857869|453761186|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127877|NCT01857869|453761187|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
126127878|NCT01857869|453761188|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127879|NCT01857869|453761189|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127880|NCT01857869|453761190|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127881|NCT01857869|453761191|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127882|NCT01857869|453761192|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127883|NCT01857869|453761193|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126127884|NCT01857869|453761184|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127885|NCT01857869|453761185|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127886|NCT01857869|453761186|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127887|NCT01857869|453761187|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
126127888|NCT01857869|453761188|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127889|NCT01857869|453761189|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127890|NCT01857869|453761190|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127891|NCT01857869|453761191|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127892|NCT01857869|453761192|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127893|NCT01857869|453761193|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126127894|NCT02898259|453761194|FG000|Overall Study|Adverse Event|0|||
126127895|NCT02898259|453761195|FG001|Overall Study|Adverse Event|0|||
126127896|NCT02898259|453761196|FG002|Overall Study|Adverse Event|1|||
126127897|NCT02898259|453761197|FG003|Overall Study|Adverse Event|0|||
126127898|NCT02898259|453761198|FG004|Overall Study|Adverse Event|0|||
126127899|NCT02898259|453761194|FG000|Overall Study|Lack of Efficacy|1|||
126127900|NCT02898259|453761195|FG001|Overall Study|Lack of Efficacy|1|||
126127901|NCT02898259|453761196|FG002|Overall Study|Lack of Efficacy|3|||
126127902|NCT02898259|453761197|FG003|Overall Study|Lack of Efficacy|0|||
126127903|NCT02898259|453761198|FG004|Overall Study|Lack of Efficacy|0|||
126127904|NCT02898259|453761194|FG000|Overall Study|Lost to Follow-up|0|||
126127905|NCT02898259|453761195|FG001|Overall Study|Lost to Follow-up|0|||
126127906|NCT02898259|453761196|FG002|Overall Study|Lost to Follow-up|1|||
126127907|NCT02898259|453761197|FG003|Overall Study|Lost to Follow-up|0|||
126127908|NCT02898259|453761198|FG004|Overall Study|Lost to Follow-up|0|||
126127909|NCT02898259|453761194|FG000|Overall Study|Transformation before study began|0|||
126127910|NCT02898259|453761195|FG001|Overall Study|Transformation before study began|0|||
126127911|NCT02898259|453761196|FG002|Overall Study|Transformation before study began|0|||
126127912|NCT02898259|453761197|FG003|Overall Study|Transformation before study began|1|||
125963932|NCT03266588|453159320|FG000|Long-term Treatment Period|Adverse Event|33|||
125963933|NCT03266588|453159321|FG001|Long-term Treatment Period|Adverse Event|17|||
126127913|NCT02898259|453761198|FG004|Overall Study|Transformation before study began|0|||
126127914|NCT01046877|453761199|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
126127915|NCT01046877|453761199|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
126127916|NCT03016325|453761200|FG000|Treatment Period|Participant withdrew consent|0|||
126127917|NCT03016325|453761201|FG001|Treatment Period|Participant withdrew consent|1|||
126127918|NCT03016325|453761202|FG002|Treatment Period|Participant withdrew consent|0|||
126127919|NCT03016325|453761203|FG003|Treatment Period|Participant withdrew consent|0|||
126127920|NCT03016325|453761204|FG004|Treatment Period|Participant withdrew consent|0|||
126127921|NCT03016325|453761205|FG005|Treatment Period|Participant withdrew consent|0|||
126127922|NCT03016325|453761206|FG006|Treatment Period|Participant withdrew consent|0|||
126127923|NCT03016325|453761207|FG007|Treatment Period|Participant withdrew consent|0|||
126127924|NCT03016325|453761200|FG000|Treatment Period|Death|0|||
126127925|NCT03016325|453761201|FG001|Treatment Period|Death|0|||
126127926|NCT03016325|453761202|FG002|Treatment Period|Death|0|||
126127927|NCT03016325|453761203|FG003|Treatment Period|Death|0|||
126127928|NCT03016325|453761204|FG004|Treatment Period|Death|2|||
126127929|NCT03016325|453761205|FG005|Treatment Period|Death|0|||
126127930|NCT03016325|453761206|FG006|Treatment Period|Death|0|||
126127931|NCT03016325|453761207|FG007|Treatment Period|Death|0|||
126127932|NCT03016325|453761200|FG000|Treatment Period|Participant refuses assessments|0|||
126127933|NCT03016325|453761201|FG001|Treatment Period|Participant refuses assessments|0|||
126127934|NCT03016325|453761202|FG002|Treatment Period|Participant refuses assessments|1|||
126127935|NCT03016325|453761203|FG003|Treatment Period|Participant refuses assessments|0|||
126127936|NCT03016325|453761204|FG004|Treatment Period|Participant refuses assessments|0|||
126127937|NCT03016325|453761205|FG005|Treatment Period|Participant refuses assessments|0|||
126127938|NCT03016325|453761206|FG006|Treatment Period|Participant refuses assessments|0|||
126127939|NCT03016325|453761207|FG007|Treatment Period|Participant refuses assessments|0|||
126127940|NCT03016325|453761200|FG000|32-Day Follow-Up Period|Death|2|||
126127941|NCT03016325|453761201|FG001|32-Day Follow-Up Period|Death|0|||
126127942|NCT03016325|453761202|FG002|32-Day Follow-Up Period|Death|5|||
126127943|NCT03016325|453761203|FG003|32-Day Follow-Up Period|Death|6|||
126127944|NCT03016325|453761204|FG004|32-Day Follow-Up Period|Death|3|||
126127945|NCT03016325|453761205|FG005|32-Day Follow-Up Period|Death|0|||
126127946|NCT03016325|453761206|FG006|32-Day Follow-Up Period|Death|0|||
126127947|NCT03016325|453761207|FG007|32-Day Follow-Up Period|Death|0|||
126127948|NCT03016325|453761200|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
126127949|NCT03016325|453761201|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
126127950|NCT03016325|453761202|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
126127951|NCT03016325|453761203|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
126127952|NCT03016325|453761204|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
126127953|NCT03016325|453761205|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
126127954|NCT03016325|453761206|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
126127955|NCT03016325|453761207|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
126127956|NCT03016325|453761200|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
126127957|NCT03016325|453761201|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
126127958|NCT03016325|453761202|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
126127959|NCT03016325|453761203|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
126127960|NCT03016325|453761204|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
126127961|NCT03016325|453761205|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
126127962|NCT03016325|453761206|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
126127963|NCT03016325|453761207|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
126127964|NCT03016325|453761200|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
126127965|NCT03016325|453761201|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
126127966|NCT03016325|453761202|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
126127967|NCT03016325|453761203|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
126127968|NCT03016325|453761204|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
126127969|NCT03016325|453761205|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
126127970|NCT03016325|453761206|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
126127971|NCT03016325|453761207|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
126127972|NCT03016325|453761200|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
126127973|NCT03016325|453761201|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
126127974|NCT03016325|453761202|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
126127975|NCT03016325|453761203|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
126127976|NCT03016325|453761204|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
126127977|NCT03016325|453761205|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
126127978|NCT03016325|453761206|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
126127979|NCT03016325|453761207|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
126127980|NCT03016325|453761200|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126127981|NCT03016325|453761201|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126127982|NCT03016325|453761202|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
126127983|NCT03016325|453761203|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126127984|NCT03016325|453761204|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126127985|NCT03016325|453761205|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126127986|NCT03016325|453761206|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126127987|NCT03016325|453761207|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126127988|NCT03016325|453761200|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126127989|NCT03016325|453761201|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
126127990|NCT03016325|453761202|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126127991|NCT03016325|453761203|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126127992|NCT03016325|453761204|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126127993|NCT03016325|453761205|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126127994|NCT03016325|453761206|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126127995|NCT03016325|453761207|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126127996|NCT03016325|453761200|FG000|182-Day Follow-Up Period|Death|3|||
126127997|NCT03016325|453761201|FG001|182-Day Follow-Up Period|Death|3|||
126127998|NCT03016325|453761202|FG002|182-Day Follow-Up Period|Death|11|||
126127999|NCT03016325|453761203|FG003|182-Day Follow-Up Period|Death|12|||
126128000|NCT03016325|453761204|FG004|182-Day Follow-Up Period|Death|9|||
126128001|NCT03016325|453761205|FG005|182-Day Follow-Up Period|Death|0|||
126128002|NCT03016325|453761206|FG006|182-Day Follow-Up Period|Death|0|||
126128003|NCT03016325|453761207|FG007|182-Day Follow-Up Period|Death|1|||
126128004|NCT03016325|453761200|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
126128005|NCT03016325|453761201|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126128006|NCT03016325|453761202|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126128007|NCT03016325|453761203|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126128008|NCT03016325|453761204|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126128009|NCT03016325|453761205|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126128010|NCT03016325|453761206|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126128011|NCT03016325|453761207|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126128012|NCT03016325|453761200|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
126128013|NCT03016325|453761201|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
126128014|NCT03016325|453761202|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
126128015|NCT03016325|453761203|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
126128016|NCT03016325|453761204|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
126128017|NCT03016325|453761205|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
126128018|NCT03016325|453761206|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
126128019|NCT03016325|453761207|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
126128020|NCT03016325|453761200|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126128021|NCT03016325|453761201|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126128022|NCT03016325|453761202|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126128023|NCT03016325|453761203|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126128024|NCT03016325|453761204|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
126128025|NCT03016325|453761205|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126128026|NCT03016325|453761206|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126128027|NCT03016325|453761207|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126128028|NCT03016325|453761200|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
126128029|NCT03016325|453761201|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
126128030|NCT03016325|453761202|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
126128031|NCT03016325|453761203|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
126128032|NCT03016325|453761204|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
126128033|NCT03016325|453761205|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
126128034|NCT03016325|453761206|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
126128035|NCT03016325|453761207|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
126128036|NCT03016325|453761200|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126128037|NCT03016325|453761201|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126128038|NCT03016325|453761202|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126128039|NCT03016325|453761203|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
126128040|NCT03016325|453761204|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126128041|NCT03016325|453761205|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126128042|NCT03016325|453761206|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126128043|NCT03016325|453761207|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126128044|NCT03016325|453761200|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126128045|NCT03016325|453761201|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
126128046|NCT03016325|453761202|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126128047|NCT03016325|453761203|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126128048|NCT03016325|453761204|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126128049|NCT03016325|453761205|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126128050|NCT03016325|453761206|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126128051|NCT03016325|453761207|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126128052|NCT03016325|453761200|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126128053|NCT03016325|453761201|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126128054|NCT03016325|453761202|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126128055|NCT03016325|453761203|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126128056|NCT03016325|453761204|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126128057|NCT03016325|453761205|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
126128058|NCT03016325|453761206|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
126128059|NCT03016325|453761207|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
126128060|NCT01902290|453761212|FG000|Overall Study|Withdrawal by Subject|19|||
126128061|NCT01902290|453761213|FG001|Overall Study|Withdrawal by Subject|27|||
126128062|NCT01902290|453761212|FG000|Overall Study|Lost to Follow-up|2|||
126128063|NCT01902290|453761213|FG001|Overall Study|Lost to Follow-up|2|||
126128064|NCT01902290|453761212|FG000|Overall Study|Death|1|||
126128065|NCT01902290|453761213|FG001|Overall Study|Death|0|||
126128066|NCT01902290|453761212|FG000|Overall Study|Sponsor Decision|26|||
126128067|NCT01902290|453761213|FG001|Overall Study|Sponsor Decision|24|||
126128068|NCT02199080|453761222|FG000|Overall Study|Protocol Violation|12|||
126128069|NCT02250274|453761223|FG000|Overall Study|Insufficient blood draw amount|7|||
126128070|NCT02250274|453761224|FG001|Overall Study|Insufficient blood draw amount|6|||
126128071|NCT01277549|453761225|FG000|Overall Study|Failed to meet eligibility criteria|13|||
126128072|NCT01277549|453761226|FG001|Overall Study|Failed to meet eligibility criteria|9|||
126128073|NCT01277549|453761225|FG000|Overall Study|Withdrawal by Subject|1|||
126128074|NCT01277549|453761226|FG001|Overall Study|Withdrawal by Subject|3|||
126128075|NCT01277549|453761225|FG000|Overall Study|Protocol Violation|10|||
126128076|NCT01277549|453761226|FG001|Overall Study|Protocol Violation|1|||
126128077|NCT01277549|453761225|FG000|Overall Study|Physician Decision|2|||
126128078|NCT01277549|453761226|FG001|Overall Study|Physician Decision|1|||
126128079|NCT01618214|453761227|FG000|Overall Study|Adverse Event|3|||
126128080|NCT01618214|453761228|FG001|Overall Study|Adverse Event|1|||
126128081|NCT01618214|453761227|FG000|Overall Study|Lack of Efficacy|1|||
126128082|NCT01618214|453761228|FG001|Overall Study|Lack of Efficacy|1|||
126128083|NCT01618214|453761227|FG000|Overall Study|Protocol Violation|1|||
126128084|NCT01618214|453761228|FG001|Overall Study|Protocol Violation|4|||
126128085|NCT01618214|453761227|FG000|Overall Study|Withdrawal Criteria|1|||
126128086|NCT01618214|453761228|FG001|Overall Study|Withdrawal Criteria|2|||
126128087|NCT01618214|453761227|FG000|Overall Study|Unclassified|4|||
126128088|NCT01618214|453761228|FG001|Overall Study|Unclassified|5|||
126128089|NCT00391222|453761229|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
126128090|NCT00391222|453761230|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
126128091|NCT00391222|453761231|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
126128092|NCT00391222|453761232|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
126128093|NCT00391222|453761229|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
126128094|NCT00391222|453761230|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
126128095|NCT00391222|453761231|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
126128096|NCT00391222|453761232|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
126128097|NCT00391222|453761229|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
126128098|NCT00391222|453761230|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
126128099|NCT00391222|453761231|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
126128100|NCT00391222|453761232|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
126128101|NCT00391222|453761229|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
126128102|NCT00391222|453761230|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
126128103|NCT00391222|453761231|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
126128104|NCT00391222|453761232|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
126128105|NCT00391222|453761229|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
126128106|NCT00391222|453761230|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
126128107|NCT00391222|453761231|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
126128108|NCT00391222|453761232|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
126128109|NCT00391222|453761229|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
126128110|NCT00391222|453761230|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
126128111|NCT00391222|453761231|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
126128112|NCT00391222|453761232|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
126128113|NCT00391222|453761229|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
126128114|NCT00391222|453761230|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
126128115|NCT00391222|453761231|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
126128116|NCT00391222|453761232|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
126128117|NCT00391222|453761229|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
126128118|NCT00391222|453761230|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
126128119|NCT00391222|453761231|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
126128120|NCT00391222|453761232|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
126128121|NCT00391222|453761229|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
126128122|NCT00391222|453761230|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
126128123|NCT00391222|453761231|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
126128124|NCT00391222|453761232|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
126128125|NCT00391222|453761229|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
126128126|NCT00391222|453761230|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
126128127|NCT00391222|453761231|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
126128128|NCT00391222|453761232|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
126128129|NCT00391222|453761229|FG000|Period III (Double-Blind Treatment)|Other|6|||
126128130|NCT00391222|453761230|FG001|Period III (Double-Blind Treatment)|Other|1|||
126128131|NCT00391222|453761231|FG002|Period III (Double-Blind Treatment)|Other|6|||
126128132|NCT00391222|453761232|FG003|Period III (Double-Blind Treatment)|Other|0|||
126128133|NCT00574275|453761233|FG000|Overall Study|Randomized but not treated|2|||
126128134|NCT00574275|453761234|FG001|Overall Study|Randomized but not treated|3|||
126128135|NCT00574275|453761233|FG000|Overall Study|Adverse Event|32|||
126128136|NCT00574275|453761234|FG001|Overall Study|Adverse Event|76|||
126128137|NCT00574275|453761233|FG000|Overall Study|Disease progression|160|||
126128138|NCT00574275|453761234|FG001|Overall Study|Disease progression|146|||
126128139|NCT00574275|453761233|FG000|Overall Study|Lost to Follow-up|2|||
126128140|NCT00574275|453761234|FG001|Overall Study|Lost to Follow-up|1|||
126128141|NCT00574275|453761233|FG000|Overall Study|Study stopped based on DMC decision|62|||
126128142|NCT00574275|453761234|FG001|Overall Study|Study stopped based on DMC decision|23|||
126128143|NCT00574275|453761233|FG000|Overall Study|Withdrawal by Subject|15|||
126128144|NCT00574275|453761234|FG001|Overall Study|Withdrawal by Subject|17|||
126128145|NCT00574275|453761233|FG000|Overall Study|Error calculating tumor measurement|1|||
126128146|NCT00574275|453761234|FG001|Overall Study|Error calculating tumor measurement|0|||
126128147|NCT00574275|453761233|FG000|Overall Study|Physician Decision|1|||
126128148|NCT00574275|453761234|FG001|Overall Study|Physician Decision|1|||
126128149|NCT00574275|453761233|FG000|Overall Study|Protocol Violation|0|||
126128150|NCT00574275|453761234|FG001|Overall Study|Protocol Violation|1|||
126128151|NCT00574275|453761233|FG000|Overall Study|Patient and Investigator decision|0|||
126128152|NCT00574275|453761234|FG001|Overall Study|Patient and Investigator decision|1|||
126128153|NCT00574275|453761233|FG000|Overall Study|Insurance change|0|||
126128154|NCT00574275|453761234|FG001|Overall Study|Insurance change|1|||
126128155|NCT00574275|453761233|FG000|Overall Study|Operation for curative intent|0|||
126128156|NCT00574275|453761234|FG001|Overall Study|Operation for curative intent|1|||
126128157|NCT00652366|453761235|FG000|Overall Study|Adverse Event|8|||
126128158|NCT00652366|453761236|FG001|Overall Study|Adverse Event|4|||
126128159|NCT00652366|453761237|FG002|Overall Study|Adverse Event|7|||
126128160|NCT00652366|453761238|FG003|Overall Study|Adverse Event|17|||
126128161|NCT00652366|453761239|FG004|Overall Study|Adverse Event|13|||
126128162|NCT00652366|453761235|FG000|Overall Study|Death|5|||
126128163|NCT00652366|453761236|FG001|Overall Study|Death|4|||
126128164|NCT00652366|453761237|FG002|Overall Study|Death|1|||
126128165|NCT00652366|453761238|FG003|Overall Study|Death|8|||
126128166|NCT00652366|453761239|FG004|Overall Study|Death|5|||
126128167|NCT00652366|453761235|FG000|Overall Study|Lack of Efficacy|84|||
126128168|NCT00652366|453761236|FG001|Overall Study|Lack of Efficacy|58|||
126128169|NCT00652366|453761237|FG002|Overall Study|Lack of Efficacy|53|||
126128170|NCT00652366|453761238|FG003|Overall Study|Lack of Efficacy|133|||
126128171|NCT00652366|453761239|FG004|Overall Study|Lack of Efficacy|13|||
126128172|NCT00652366|453761235|FG000|Overall Study|Violation of Selection Criteria|0|||
126128173|NCT00652366|453761236|FG001|Overall Study|Violation of Selection Criteria|0|||
126128174|NCT00652366|453761237|FG002|Overall Study|Violation of Selection Criteria|1|||
126128175|NCT00652366|453761238|FG003|Overall Study|Violation of Selection Criteria|0|||
126128176|NCT00652366|453761239|FG004|Overall Study|Violation of Selection Criteria|0|||
126128177|NCT00652366|453761235|FG000|Overall Study|Protocol Violation|1|||
126128178|NCT00652366|453761236|FG001|Overall Study|Protocol Violation|0|||
126128179|NCT00652366|453761237|FG002|Overall Study|Protocol Violation|0|||
126128180|NCT00652366|453761238|FG003|Overall Study|Protocol Violation|0|||
126128181|NCT00652366|453761239|FG004|Overall Study|Protocol Violation|0|||
126128182|NCT00652366|453761235|FG000|Overall Study|Refused treatment|3|||
126128183|NCT00652366|453761236|FG001|Overall Study|Refused treatment|7|||
126128184|NCT00652366|453761237|FG002|Overall Study|Refused treatment|6|||
126128185|NCT00652366|453761238|FG003|Overall Study|Refused treatment|17|||
126128186|NCT00652366|453761239|FG004|Overall Study|Refused treatment|5|||
126128187|NCT00652366|453761235|FG000|Overall Study|Other|5|||
126128188|NCT00652366|453761236|FG001|Overall Study|Other|2|||
126128189|NCT00652366|453761237|FG002|Overall Study|Other|3|||
126128190|NCT00652366|453761238|FG003|Overall Study|Other|4|||
126128191|NCT00652366|453761239|FG004|Overall Study|Other|0|||
126128192|NCT00137111|453761245|FG000|Total Therapy|Death|35|||
126128193|NCT00137111|453761246|FG001|Total Therapy|Death|0|||
126128194|NCT00137111|453761247|FG002|Total Therapy|Death|0|||
126128195|NCT00137111|453761248|FG003|Total Therapy|Death|0|||
126128196|NCT00137111|453761245|FG000|Total Therapy|Non Compliance|5|||
126128197|NCT00137111|453761246|FG001|Total Therapy|Non Compliance|0|||
126128198|NCT00137111|453761247|FG002|Total Therapy|Non Compliance|0|||
126128199|NCT00137111|453761248|FG003|Total Therapy|Non Compliance|0|||
126128200|NCT04703075|453761249|FG000|Overall Study|Adverse Event|11|||
126128201|NCT04703075|453761250|FG001|Overall Study|Adverse Event|7|||
126128202|NCT04703075|453761249|FG000|Overall Study|Lost to Follow-up|6|||
126128203|NCT04703075|453761250|FG001|Overall Study|Lost to Follow-up|12|||
126128204|NCT04703075|453761249|FG000|Overall Study|Physician Decision|3|||
126128205|NCT04703075|453761250|FG001|Overall Study|Physician Decision|0|||
126128206|NCT04703075|453761249|FG000|Overall Study|Moved|0|||
126128207|NCT04703075|453761250|FG001|Overall Study|Moved|2|||
126128208|NCT04703075|453761249|FG000|Overall Study|Index INH Resistant|0|||
126128209|NCT04703075|453761250|FG001|Overall Study|Index INH Resistant|1|||
126128210|NCT04703075|453761249|FG000|Overall Study|Lack of Efficacy|6|||
126128211|NCT04703075|453761250|FG001|Overall Study|Lack of Efficacy|18|||
126128212|NCT02425826|453761254|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
126128213|NCT02425826|453761255|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
126128214|NCT02425826|453761256|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
126128215|NCT02425826|453761254|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
126128216|NCT02425826|453761255|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
126128217|NCT02425826|453761256|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
126128218|NCT02425826|453761254|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
126128219|NCT02425826|453761255|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
126128220|NCT02425826|453761256|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
126128221|NCT02425826|453761254|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
126128222|NCT02425826|453761255|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
126128223|NCT02425826|453761256|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
126128224|NCT02425826|453761254|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
126128225|NCT02425826|453761255|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
126128226|NCT02425826|453761256|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
126128227|NCT02425826|453761254|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
126128228|NCT02425826|453761255|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
126128229|NCT02425826|453761256|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
126128230|NCT02425826|453761254|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
126128231|NCT02425826|453761255|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
125963934|NCT03266588|453159322|FG002|Long-term Treatment Period|Adverse Event|8|||
125963935|NCT03266588|453159320|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
125963936|NCT03266588|453159321|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
125963937|NCT03266588|453159322|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
125963938|NCT03266588|453159320|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
126128232|NCT02425826|453761256|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
126128233|NCT02425826|453761254|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
126128234|NCT02425826|453761255|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
126128235|NCT02425826|453761256|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
126128236|NCT02425826|453761254|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
126128237|NCT02425826|453761255|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
126128238|NCT02425826|453761256|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
126128239|NCT02425826|453761254|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
126128240|NCT02425826|453761255|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
126128241|NCT02425826|453761256|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
126128242|NCT02124564|453761261|FG000|Treatment Period|Adverse Event|2|||
126128243|NCT02124564|453761261|FG000|Treatment Period|Lack of Efficacy|3|||
126128244|NCT02124564|453761261|FG000|Treatment Period|Withdrawal by Subject|2|||
126128245|NCT01425008|453761268|FG000|Dose Escalation Phase|Progressive Disease|2|||
126128246|NCT01425008|453761269|FG001|Dose Escalation Phase|Progressive Disease|3|||
126128247|NCT01425008|453761270|FG002|Dose Escalation Phase|Progressive Disease|2|||
126128248|NCT01425008|453761271|FG003|Dose Escalation Phase|Progressive Disease|3|||
126128249|NCT01425008|453761272|FG004|Dose Escalation Phase|Progressive Disease|5|||
126128250|NCT01425008|453761273|FG005|Dose Escalation Phase|Progressive Disease|4|||
126128251|NCT01425008|453761274|FG006|Dose Escalation Phase|Progressive Disease|0|||
126128252|NCT01425008|453761275|FG007|Dose Escalation Phase|Progressive Disease|2|||
126128253|NCT01425008|453761276|FG008|Dose Escalation Phase|Progressive Disease|6|||
126128254|NCT01425008|453761277|FG009|Dose Escalation Phase|Progressive Disease|2|||
126128255|NCT01425008|453761278|FG010|Dose Escalation Phase|Progressive Disease|0|||
126128256|NCT01425008|453761279|FG011|Dose Escalation Phase|Progressive Disease|0|||
126128257|NCT01425008|453761280|FG012|Dose Escalation Phase|Progressive Disease|0|||
126128258|NCT01425008|453761281|FG013|Dose Escalation Phase|Progressive Disease|0|||
126128259|NCT01425008|453761282|FG014|Dose Escalation Phase|Progressive Disease|0|||
126128260|NCT01425008|453761283|FG015|Dose Escalation Phase|Progressive Disease|0|||
126128261|NCT01425008|453761284|FG016|Dose Escalation Phase|Progressive Disease|0|||
125963939|NCT03266588|453159321|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
125963940|NCT03266588|453159322|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
126128262|NCT01425008|453761285|FG017|Dose Escalation Phase|Progressive Disease|0|||
126128263|NCT01425008|453761286|FG018|Dose Escalation Phase|Progressive Disease|0|||
126128264|NCT01425008|453761268|FG000|Dose Escalation Phase|Adverse Event|2|||
126128265|NCT01425008|453761269|FG001|Dose Escalation Phase|Adverse Event|0|||
126128266|NCT01425008|453761270|FG002|Dose Escalation Phase|Adverse Event|0|||
126128267|NCT01425008|453761271|FG003|Dose Escalation Phase|Adverse Event|0|||
126128268|NCT01425008|453761272|FG004|Dose Escalation Phase|Adverse Event|0|||
126128269|NCT01425008|453761273|FG005|Dose Escalation Phase|Adverse Event|2|||
126128270|NCT01425008|453761274|FG006|Dose Escalation Phase|Adverse Event|0|||
126128271|NCT01425008|453761275|FG007|Dose Escalation Phase|Adverse Event|0|||
126128272|NCT01425008|453761276|FG008|Dose Escalation Phase|Adverse Event|2|||
126128273|NCT01425008|453761277|FG009|Dose Escalation Phase|Adverse Event|0|||
126128274|NCT01425008|453761278|FG010|Dose Escalation Phase|Adverse Event|0|||
126128275|NCT01425008|453761279|FG011|Dose Escalation Phase|Adverse Event|0|||
126128276|NCT01425008|453761280|FG012|Dose Escalation Phase|Adverse Event|0|||
126128277|NCT01425008|453761281|FG013|Dose Escalation Phase|Adverse Event|0|||
126128278|NCT01425008|453761282|FG014|Dose Escalation Phase|Adverse Event|0|||
126128279|NCT01425008|453761283|FG015|Dose Escalation Phase|Adverse Event|0|||
126128280|NCT01425008|453761284|FG016|Dose Escalation Phase|Adverse Event|0|||
126128281|NCT01425008|453761285|FG017|Dose Escalation Phase|Adverse Event|0|||
126128282|NCT01425008|453761286|FG018|Dose Escalation Phase|Adverse Event|0|||
126128283|NCT01425008|453761268|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128284|NCT01425008|453761269|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128285|NCT01425008|453761270|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128286|NCT01425008|453761271|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128287|NCT01425008|453761272|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
126128288|NCT01425008|453761273|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128289|NCT01425008|453761274|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
126128290|NCT01425008|453761275|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
126128291|NCT01425008|453761276|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
126128292|NCT01425008|453761277|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128293|NCT01425008|453761278|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128294|NCT01425008|453761279|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128295|NCT01425008|453761280|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128296|NCT01425008|453761281|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128297|NCT01425008|453761282|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128298|NCT01425008|453761283|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128299|NCT01425008|453761284|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128300|NCT01425008|453761285|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128301|NCT01425008|453761286|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126128302|NCT01425008|453761268|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126128303|NCT01425008|453761269|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126128304|NCT01425008|453761270|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126128305|NCT01425008|453761271|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126128306|NCT01425008|453761272|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
126128307|NCT01425008|453761273|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
126128308|NCT01425008|453761274|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
126128309|NCT01425008|453761275|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
126128310|NCT01425008|453761276|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
126128311|NCT01425008|453761277|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
126128312|NCT01425008|453761278|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
126128313|NCT01425008|453761279|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
126128314|NCT01425008|453761280|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
126128315|NCT01425008|453761281|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
126128316|NCT01425008|453761282|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
126128317|NCT01425008|453761283|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
126128318|NCT01425008|453761284|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
126128319|NCT01425008|453761285|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
126128320|NCT01425008|453761286|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
126128321|NCT01425008|453761268|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128322|NCT01425008|453761269|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128323|NCT01425008|453761270|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
126128324|NCT01425008|453761271|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128325|NCT01425008|453761272|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128326|NCT01425008|453761273|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128327|NCT01425008|453761274|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128328|NCT01425008|453761275|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128329|NCT01425008|453761276|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
126128330|NCT01425008|453761277|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
125963941|NCT03266588|453159320|FG000|Long-term Treatment Period|Non-Compliance|126|||
126128331|NCT01425008|453761278|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128332|NCT01425008|453761279|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128333|NCT01425008|453761280|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128334|NCT01425008|453761281|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128335|NCT01425008|453761282|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128336|NCT01425008|453761283|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128337|NCT01425008|453761284|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128338|NCT01425008|453761285|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128339|NCT01425008|453761286|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
126128340|NCT01425008|453761268|FG000|Dose Escalation Phase|Other|0|||
126128341|NCT01425008|453761269|FG001|Dose Escalation Phase|Other|0|||
126128342|NCT01425008|453761270|FG002|Dose Escalation Phase|Other|0|||
126128343|NCT01425008|453761271|FG003|Dose Escalation Phase|Other|0|||
126128344|NCT01425008|453761272|FG004|Dose Escalation Phase|Other|0|||
126128345|NCT01425008|453761273|FG005|Dose Escalation Phase|Other|0|||
126128346|NCT01425008|453761274|FG006|Dose Escalation Phase|Other|0|||
126128347|NCT01425008|453761275|FG007|Dose Escalation Phase|Other|0|||
126128348|NCT01425008|453761276|FG008|Dose Escalation Phase|Other|1|||
126128349|NCT01425008|453761277|FG009|Dose Escalation Phase|Other|0|||
126128350|NCT01425008|453761278|FG010|Dose Escalation Phase|Other|0|||
126128351|NCT01425008|453761279|FG011|Dose Escalation Phase|Other|0|||
126128352|NCT01425008|453761280|FG012|Dose Escalation Phase|Other|0|||
126128353|NCT01425008|453761281|FG013|Dose Escalation Phase|Other|0|||
126128354|NCT01425008|453761282|FG014|Dose Escalation Phase|Other|0|||
126128355|NCT01425008|453761283|FG015|Dose Escalation Phase|Other|0|||
126128356|NCT01425008|453761284|FG016|Dose Escalation Phase|Other|0|||
126128357|NCT01425008|453761285|FG017|Dose Escalation Phase|Other|0|||
126128358|NCT01425008|453761286|FG018|Dose Escalation Phase|Other|0|||
126128359|NCT01425008|453761268|FG000|Dose Expansion Phase|Progressive Disease|0|||
126128360|NCT01425008|453761269|FG001|Dose Expansion Phase|Progressive Disease|0|||
126128361|NCT01425008|453761270|FG002|Dose Expansion Phase|Progressive Disease|0|||
126128362|NCT01425008|453761271|FG003|Dose Expansion Phase|Progressive Disease|0|||
126128363|NCT01425008|453761272|FG004|Dose Expansion Phase|Progressive Disease|0|||
126128364|NCT01425008|453761273|FG005|Dose Expansion Phase|Progressive Disease|0|||
126128365|NCT01425008|453761274|FG006|Dose Expansion Phase|Progressive Disease|0|||
126128366|NCT01425008|453761275|FG007|Dose Expansion Phase|Progressive Disease|0|||
126128367|NCT01425008|453761276|FG008|Dose Expansion Phase|Progressive Disease|0|||
126128368|NCT01425008|453761277|FG009|Dose Expansion Phase|Progressive Disease|0|||
126128369|NCT01425008|453761278|FG010|Dose Expansion Phase|Progressive Disease|10|||
126128370|NCT01425008|453761279|FG011|Dose Expansion Phase|Progressive Disease|4|||
126128371|NCT01425008|453761280|FG012|Dose Expansion Phase|Progressive Disease|12|||
126128372|NCT01425008|453761281|FG013|Dose Expansion Phase|Progressive Disease|1|||
126128373|NCT01425008|453761282|FG014|Dose Expansion Phase|Progressive Disease|5|||
126128374|NCT01425008|453761283|FG015|Dose Expansion Phase|Progressive Disease|8|||
126128375|NCT01425008|453761284|FG016|Dose Expansion Phase|Progressive Disease|9|||
126128376|NCT01425008|453761285|FG017|Dose Expansion Phase|Progressive Disease|2|||
126128377|NCT01425008|453761286|FG018|Dose Expansion Phase|Progressive Disease|10|||
126128378|NCT01425008|453761268|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
126128379|NCT01425008|453761269|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
126128380|NCT01425008|453761270|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
126128381|NCT01425008|453761271|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
126128382|NCT01425008|453761272|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
126128383|NCT01425008|453761273|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
126128384|NCT01425008|453761274|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
126128385|NCT01425008|453761275|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
126128386|NCT01425008|453761276|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
126128387|NCT01425008|453761277|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
126128388|NCT01425008|453761278|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
126128389|NCT01425008|453761279|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
126128390|NCT01425008|453761280|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
126128391|NCT01425008|453761281|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
126128392|NCT01425008|453761282|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
126128393|NCT01425008|453761283|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
126128394|NCT01425008|453761284|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
126128395|NCT01425008|453761285|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
126128396|NCT01425008|453761286|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
126128397|NCT01425008|453761268|FG000|Dose Expansion Phase|Other|0|||
126128398|NCT01425008|453761269|FG001|Dose Expansion Phase|Other|0|||
126128399|NCT01425008|453761270|FG002|Dose Expansion Phase|Other|0|||
126128400|NCT01425008|453761271|FG003|Dose Expansion Phase|Other|0|||
126128401|NCT01425008|453761272|FG004|Dose Expansion Phase|Other|0|||
126128402|NCT01425008|453761273|FG005|Dose Expansion Phase|Other|0|||
126128403|NCT01425008|453761274|FG006|Dose Expansion Phase|Other|0|||
126128404|NCT01425008|453761275|FG007|Dose Expansion Phase|Other|0|||
126128405|NCT01425008|453761276|FG008|Dose Expansion Phase|Other|0|||
126128406|NCT01425008|453761277|FG009|Dose Expansion Phase|Other|0|||
126128407|NCT01425008|453761278|FG010|Dose Expansion Phase|Other|0|||
126128408|NCT01425008|453761279|FG011|Dose Expansion Phase|Other|0|||
126128409|NCT01425008|453761280|FG012|Dose Expansion Phase|Other|1|||
126128410|NCT01425008|453761281|FG013|Dose Expansion Phase|Other|0|||
126128411|NCT01425008|453761282|FG014|Dose Expansion Phase|Other|0|||
126128412|NCT01425008|453761283|FG015|Dose Expansion Phase|Other|0|||
126128413|NCT01425008|453761284|FG016|Dose Expansion Phase|Other|2|||
126128414|NCT01425008|453761285|FG017|Dose Expansion Phase|Other|0|||
126128415|NCT01425008|453761286|FG018|Dose Expansion Phase|Other|4|||
126128416|NCT01425008|453761268|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128417|NCT01425008|453761269|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128418|NCT01425008|453761270|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128419|NCT01425008|453761271|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128420|NCT01425008|453761272|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128421|NCT01425008|453761273|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128422|NCT01425008|453761274|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128423|NCT01425008|453761275|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128424|NCT01425008|453761276|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128425|NCT01425008|453761277|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128426|NCT01425008|453761278|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
126128427|NCT01425008|453761279|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
126128428|NCT01425008|453761280|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128429|NCT01425008|453761281|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128430|NCT01425008|453761282|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128431|NCT01425008|453761283|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
126128432|NCT01425008|453761284|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
126128433|NCT01425008|453761285|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
126128434|NCT01425008|453761286|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
126128435|NCT01425008|453761268|FG000|Dose Expansion Phase|Adverse Event|0|||
126128436|NCT01425008|453761269|FG001|Dose Expansion Phase|Adverse Event|0|||
126128437|NCT01425008|453761270|FG002|Dose Expansion Phase|Adverse Event|0|||
126128438|NCT01425008|453761271|FG003|Dose Expansion Phase|Adverse Event|0|||
126128439|NCT01425008|453761272|FG004|Dose Expansion Phase|Adverse Event|0|||
126128440|NCT01425008|453761273|FG005|Dose Expansion Phase|Adverse Event|0|||
126128441|NCT01425008|453761274|FG006|Dose Expansion Phase|Adverse Event|0|||
126128442|NCT01425008|453761275|FG007|Dose Expansion Phase|Adverse Event|0|||
126128443|NCT01425008|453761276|FG008|Dose Expansion Phase|Adverse Event|0|||
126128444|NCT01425008|453761277|FG009|Dose Expansion Phase|Adverse Event|0|||
126128445|NCT01425008|453761278|FG010|Dose Expansion Phase|Adverse Event|2|||
126128446|NCT01425008|453761279|FG011|Dose Expansion Phase|Adverse Event|3|||
126128447|NCT01425008|453761280|FG012|Dose Expansion Phase|Adverse Event|3|||
126128448|NCT01425008|453761281|FG013|Dose Expansion Phase|Adverse Event|0|||
126128449|NCT01425008|453761282|FG014|Dose Expansion Phase|Adverse Event|1|||
126128450|NCT01425008|453761283|FG015|Dose Expansion Phase|Adverse Event|1|||
126128451|NCT01425008|453761284|FG016|Dose Expansion Phase|Adverse Event|5|||
126128452|NCT01425008|453761285|FG017|Dose Expansion Phase|Adverse Event|0|||
126128453|NCT01425008|453761286|FG018|Dose Expansion Phase|Adverse Event|3|||
126128454|NCT01425008|453761268|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
126128455|NCT01425008|453761269|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
126128456|NCT01425008|453761270|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
126128457|NCT01425008|453761271|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
126128458|NCT01425008|453761272|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
126128459|NCT01425008|453761273|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
126128460|NCT01425008|453761274|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
126128461|NCT01425008|453761275|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
126128462|NCT01425008|453761276|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
126128463|NCT01425008|453761277|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
126128464|NCT01425008|453761278|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
126128465|NCT01425008|453761279|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
126128466|NCT01425008|453761280|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
126128467|NCT01425008|453761281|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
126128468|NCT01425008|453761282|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
126128469|NCT01425008|453761283|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
126128470|NCT01425008|453761284|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
126128471|NCT01425008|453761285|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
126128472|NCT01425008|453761286|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
126128473|NCT01425008|453761268|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128474|NCT01425008|453761269|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128475|NCT01425008|453761270|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128476|NCT01425008|453761271|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128477|NCT01425008|453761272|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128478|NCT01425008|453761273|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128479|NCT01425008|453761274|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128480|NCT01425008|453761275|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128481|NCT01425008|453761276|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128482|NCT01425008|453761277|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128483|NCT01425008|453761278|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128484|NCT01425008|453761279|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128485|NCT01425008|453761280|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128486|NCT01425008|453761281|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128487|NCT01425008|453761282|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128488|NCT01425008|453761283|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128489|NCT01425008|453761284|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128490|NCT01425008|453761285|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126128491|NCT01425008|453761286|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
126128492|NCT00562588|453761287|FG000|Overall Study|Adverse Event|40|||
126128493|NCT00562588|453761288|FG001|Overall Study|Adverse Event|58|||
126128494|NCT00562588|453761287|FG000|Overall Study|Protocol Violation|30|||
126128495|NCT00562588|453761288|FG001|Overall Study|Protocol Violation|26|||
126128496|NCT00562588|453761287|FG000|Overall Study|Lost to Follow-up|12|||
126128497|NCT00562588|453761288|FG001|Overall Study|Lost to Follow-up|4|||
126128498|NCT00562588|453761287|FG000|Overall Study|Withdrawal by Subject|10|||
126128499|NCT00562588|453761288|FG001|Overall Study|Withdrawal by Subject|9|||
126128500|NCT00562588|453761287|FG000|Overall Study|Other|0|||
126128501|NCT00562588|453761288|FG001|Overall Study|Other|2|||
126128502|NCT03315871|453761289|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
126128503|NCT03315871|453761290|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
126128504|NCT03315871|453761291|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
126128505|NCT03315871|453761289|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
126128506|NCT03315871|453761290|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
126128507|NCT03315871|453761291|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
126128508|NCT03315871|453761289|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
126128509|NCT03315871|453761290|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
126128510|NCT03315871|453761291|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
126128511|NCT03315871|453761289|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
126128512|NCT03315871|453761290|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
126128513|NCT03315871|453761291|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
126128514|NCT03315871|453761289|FG000|PROSTVAC + CV301|Progressive disease|0|||
126128515|NCT03315871|453761290|FG001|PROSTVAC + CV301|Progressive disease|0|||
126128516|NCT03315871|453761291|FG002|PROSTVAC + CV301|Progressive disease|1|||
126128517|NCT03315871|453761289|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
126128518|NCT03315871|453761290|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
126128519|NCT03315871|453761291|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
126128520|NCT05032157|453763241|FG000|Overall Study|Adverse Event|12|||
126128521|NCT05032157|453763242|FG001|Overall Study|Adverse Event|7|||
126128522|NCT05032157|453763241|FG000|Overall Study|Pregnancy|0|||
126128523|NCT05032157|453763242|FG001|Overall Study|Pregnancy|2|||
126128524|NCT05032157|453763241|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126128525|NCT05032157|453763242|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
126128526|NCT05032157|453763241|FG000|Overall Study|Protocol Deviation|8|||
126128527|NCT05032157|453763242|FG001|Overall Study|Protocol Deviation|4|||
126128528|NCT05032157|453763241|FG000|Overall Study|Lost to Follow-up|1|||
126128529|NCT05032157|453763242|FG001|Overall Study|Lost to Follow-up|3|||
126128530|NCT05032157|453763241|FG000|Overall Study|Physician Decision|7|||
126128531|NCT05032157|453763242|FG001|Overall Study|Physician Decision|2|||
126128532|NCT05032157|453763241|FG000|Overall Study|Patient Decision|38|||
126128533|NCT05032157|453763242|FG001|Overall Study|Patient Decision|19|||
126128534|NCT00150592|453763243|FG000|Overall Study|Adverse Event|4|||
126128535|NCT00150592|453763244|FG001|Overall Study|Adverse Event|1|||
126128536|NCT00150592|453763243|FG000|Overall Study|Protocol Violation|1|||
126128537|NCT00150592|453763244|FG001|Overall Study|Protocol Violation|0|||
126128538|NCT00150592|453763243|FG000|Overall Study|Withdrawal by Subject|1|||
126128539|NCT00150592|453763244|FG001|Overall Study|Withdrawal by Subject|2|||
126128540|NCT00150592|453763243|FG000|Overall Study|Non-compliance|1|||
126128541|NCT00150592|453763244|FG001|Overall Study|Non-compliance|0|||
126128542|NCT03047980|453763245|FG000|Overall Study|Adverse Event|1|||
126128543|NCT00874120|453763250|FG000|First Intervention|Adverse Event|0|||
126128544|NCT00874120|453763251|FG001|First Intervention|Adverse Event|1|||
126128545|NCT00874120|453763250|FG000|First Intervention|Withdrawal by Subject|2|||
126128546|NCT00874120|453763251|FG001|First Intervention|Withdrawal by Subject|0|||
126128547|NCT00874120|453763250|FG000|First Intervention|Lost to Follow-up|0|||
126128548|NCT00874120|453763251|FG001|First Intervention|Lost to Follow-up|1|||
126128549|NCT00874120|453763250|FG000|First Intervention|Protocol Violation|3|||
126128550|NCT00874120|453763251|FG001|First Intervention|Protocol Violation|0|||
126128551|NCT00874120|453763250|FG000|First Intervention|positive drug test|1|||
126128552|NCT00874120|453763251|FG001|First Intervention|positive drug test|0|||
126128553|NCT00874120|453763250|FG000|Second Intervention|Withdrawal by Subject|1|||
126128554|NCT00874120|453763251|FG001|Second Intervention|Withdrawal by Subject|0|||
126128555|NCT00874120|453763250|FG000|Second Intervention|Protocol Violation|1|||
126128556|NCT00874120|453763251|FG001|Second Intervention|Protocol Violation|0|||
126128557|NCT01823679|453763252|FG000|Overall Study|Death|1|||
126128558|NCT02164981|453763253|FG000|Started|Withdrawal by Subject|2|||
126128559|NCT02164981|453763254|FG001|Started|Withdrawal by Subject|1|||
126128560|NCT02164981|453763255|FG002|Started|Withdrawal by Subject|0|||
126128561|NCT02164981|453763253|FG000|Started|Protocol Violation|2|||
126128562|NCT02164981|453763254|FG001|Started|Protocol Violation|0|||
126128563|NCT02164981|453763255|FG002|Started|Protocol Violation|0|||
126128564|NCT02164981|453763253|FG000|Started|Adverse Event|1|||
126128565|NCT02164981|453763254|FG001|Started|Adverse Event|2|||
126128566|NCT02164981|453763255|FG002|Started|Adverse Event|0|||
126128567|NCT02164981|453763253|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
126128568|NCT02164981|453763254|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
126128569|NCT02164981|453763255|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
126128570|NCT02164981|453763253|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
126128571|NCT02164981|453763254|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
126128572|NCT02164981|453763255|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
126128573|NCT02164981|453763253|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
126128574|NCT02164981|453763254|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
126128575|NCT02164981|453763255|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
126128576|NCT03311711|453763256|FG000|Overall Study|Death|1|||
126128577|NCT03311711|453763257|FG001|Overall Study|Death|0|||
126128578|NCT03311711|453763258|FG002|Overall Study|Death|0|||
126128579|NCT03311711|453763259|FG003|Overall Study|Death|0|||
126128580|NCT03311711|453763260|FG004|Overall Study|Death|0|||
126128581|NCT03311711|453763261|FG005|Overall Study|Death|0|||
126128582|NCT03311711|453763262|FG006|Overall Study|Death|1|||
126128583|NCT03311711|453763263|FG007|Overall Study|Death|0|||
126128584|NCT03311711|453763264|FG008|Overall Study|Death|1|||
126128585|NCT03311711|453763265|FG009|Overall Study|Death|0|||
126128586|NCT03311711|453763256|FG000|Overall Study|Death of dyad partner|0|||
126128587|NCT03311711|453763257|FG001|Overall Study|Death of dyad partner|1|||
126128588|NCT03311711|453763258|FG002|Overall Study|Death of dyad partner|0|||
126128589|NCT03311711|453763259|FG003|Overall Study|Death of dyad partner|0|||
126128590|NCT03311711|453763260|FG004|Overall Study|Death of dyad partner|0|||
126128591|NCT03311711|453763261|FG005|Overall Study|Death of dyad partner|0|||
126128592|NCT03311711|453763262|FG006|Overall Study|Death of dyad partner|0|||
126128593|NCT03311711|453763263|FG007|Overall Study|Death of dyad partner|1|||
126128594|NCT03311711|453763264|FG008|Overall Study|Death of dyad partner|0|||
126128595|NCT03311711|453763265|FG009|Overall Study|Death of dyad partner|1|||
126128596|NCT03311711|453763256|FG000|Overall Study|Lost to Follow-up|2|||
126128597|NCT03311711|453763257|FG001|Overall Study|Lost to Follow-up|2|||
126128598|NCT03311711|453763258|FG002|Overall Study|Lost to Follow-up|0|||
126128599|NCT03311711|453763259|FG003|Overall Study|Lost to Follow-up|0|||
126128600|NCT03311711|453763260|FG004|Overall Study|Lost to Follow-up|0|||
126128601|NCT03311711|453763261|FG005|Overall Study|Lost to Follow-up|0|||
126128602|NCT03311711|453763262|FG006|Overall Study|Lost to Follow-up|1|||
126128603|NCT03311711|453763263|FG007|Overall Study|Lost to Follow-up|1|||
126128604|NCT03311711|453763264|FG008|Overall Study|Lost to Follow-up|0|||
126128605|NCT03311711|453763265|FG009|Overall Study|Lost to Follow-up|0|||
126128606|NCT03311711|453763256|FG000|Overall Study|Withdrawal by Subject|1|||
126128607|NCT03311711|453763257|FG001|Overall Study|Withdrawal by Subject|1|||
126128608|NCT03311711|453763258|FG002|Overall Study|Withdrawal by Subject|0|||
126128609|NCT03311711|453763259|FG003|Overall Study|Withdrawal by Subject|0|||
126128610|NCT03311711|453763260|FG004|Overall Study|Withdrawal by Subject|0|||
126128611|NCT03311711|453763261|FG005|Overall Study|Withdrawal by Subject|0|||
126128612|NCT03311711|453763262|FG006|Overall Study|Withdrawal by Subject|3|||
126128613|NCT03311711|453763263|FG007|Overall Study|Withdrawal by Subject|3|||
126128614|NCT03311711|453763264|FG008|Overall Study|Withdrawal by Subject|0|||
126128615|NCT03311711|453763265|FG009|Overall Study|Withdrawal by Subject|0|||
126128616|NCT03927105|453763267|FG000|Overall Study|Death|1|||
126128617|NCT03927105|453763267|FG000|Overall Study|In observation for potential re-treatment|2|||
126128618|NCT03927105|453763267|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
126128619|NCT00082888|453763270|FG000|Overall Study|Ineligible|1|||
126128620|NCT00082888|453763271|FG001|Overall Study|Ineligible|0|||
126128621|NCT00082888|453763272|FG002|Overall Study|Ineligible|0|||
126128622|NCT02684981|453763275|FG000|Overall Study|Permanently discontinued the treatment|157|||
126128623|NCT02684981|453763276|FG001|Overall Study|Permanently discontinued the treatment|161|||
126128624|NCT02684981|453763277|FG002|Overall Study|Permanently discontinued the treatment|110|||
126128625|NCT02684981|453763275|FG000|Overall Study|Other|83|||
126128626|NCT02684981|453763276|FG001|Overall Study|Other|49|||
126128627|NCT02684981|453763277|FG002|Overall Study|Other|17|||
126128628|NCT01745146|453763278|FG000|Overall Study|Withdrawal by Subject|1|||
126128629|NCT01745146|453763279|FG001|Overall Study|Withdrawal by Subject|3|||
126128630|NCT01745146|453763278|FG000|Overall Study|Lost to Follow-up|2|||
126128631|NCT01745146|453763279|FG001|Overall Study|Lost to Follow-up|0|||
126128632|NCT04623242|453763280|FG000|Overall Study|Withdrawal by Subject|7|||
126128633|NCT04623242|453763281|FG001|Overall Study|Withdrawal by Subject|12|||
126128634|NCT04623242|453763282|FG002|Overall Study|Withdrawal by Subject|5|||
126128635|NCT04623242|453763283|FG003|Overall Study|Withdrawal by Subject|7|||
126128636|NCT04623242|453763284|FG004|Overall Study|Withdrawal by Subject|0|||
126128637|NCT04623242|453763280|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
126128638|NCT04623242|453763281|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
126128639|NCT04623242|453763282|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
126128640|NCT04623242|453763283|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
126128641|NCT04623242|453763284|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
126128642|NCT04623242|453763280|FG000|Overall Study|Subject unblinded to mutation status|0|||
126128643|NCT04623242|453763281|FG001|Overall Study|Subject unblinded to mutation status|0|||
126128644|NCT04623242|453763282|FG002|Overall Study|Subject unblinded to mutation status|0|||
126128645|NCT04623242|453763283|FG003|Overall Study|Subject unblinded to mutation status|13|||
126128646|NCT04623242|453763284|FG004|Overall Study|Subject unblinded to mutation status|0|||
126128647|NCT00820898|453763285|FG000|Overall Study|Inelgible - wrong primary site|1|||
126128648|NCT05594173|453763288|FG000|Overall Study|Adverse Event|1|||
126128649|NCT05594173|453763288|FG000|Overall Study|COVID-19 Pandemic|2|||
126128650|NCT00647556|453763289|FG000|Overall Study|Adverse Event|0|||
126128651|NCT00647556|453763290|FG001|Overall Study|Adverse Event|1|||
126128652|NCT00647556|453763289|FG000|Overall Study|Lost to Follow-up|1|||
126128653|NCT00647556|453763290|FG001|Overall Study|Lost to Follow-up|0|||
126128654|NCT00647556|453763289|FG000|Overall Study|Protocol Violation|0|||
126128655|NCT00647556|453763290|FG001|Overall Study|Protocol Violation|1|||
126128656|NCT00647556|453763289|FG000|Overall Study|Withdrawal by Subject|1|||
126128657|NCT00647556|453763290|FG001|Overall Study|Withdrawal by Subject|0|||
126128658|NCT00647556|453763289|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
126128659|NCT00647556|453763290|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
126128660|NCT01652287|453763291|FG000|Overall Study|Withdrawal by Subject|2|||
126128661|NCT01652287|453763292|FG001|Overall Study|Withdrawal by Subject|0|||
126128662|NCT00763139|453763296|FG000|Overall Study|Adverse Event|4|||
126128663|NCT00763139|453763297|FG001|Overall Study|Adverse Event|2|||
126128664|NCT00763139|453763296|FG000|Overall Study|Withdrawal by Subject|0|||
126128665|NCT00763139|453763297|FG001|Overall Study|Withdrawal by Subject|1|||
126128666|NCT00763139|453763296|FG000|Overall Study|med change not allowed by protocol|1|||
126128667|NCT00763139|453763297|FG001|Overall Study|med change not allowed by protocol|0|||
126128668|NCT00179309|453763298|FG000|Treatment|Toxicity|2|||
126128669|NCT00179309|453763299|FG001|Treatment|Toxicity|3|||
126128670|NCT00179309|453763298|FG000|Treatment|Withdrawal by Subject|1|||
126128671|NCT00179309|453763299|FG001|Treatment|Withdrawal by Subject|2|||
126128672|NCT00179309|453763298|FG000|Treatment|Allergy|1|||
126128673|NCT00179309|453763299|FG001|Treatment|Allergy|0|||
126128674|NCT01709149|453763304|FG000|Open-label Lead-in Phase|Adverse Event|109|||
126128675|NCT01709149|453763305|FG001|Open-label Lead-in Phase|Adverse Event|0|||
126128676|NCT01709149|453763306|FG002|Open-label Lead-in Phase|Adverse Event|0|||
126128677|NCT01709149|453763304|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
126128678|NCT01709149|453763305|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
126128679|NCT01709149|453763306|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
126128680|NCT01709149|453763304|FG000|Open-label Lead-in Phase|Death|1|||
126128681|NCT01709149|453763305|FG001|Open-label Lead-in Phase|Death|0|||
126128682|NCT01709149|453763306|FG002|Open-label Lead-in Phase|Death|0|||
126128683|NCT01709149|453763304|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
126128684|NCT01709149|453763305|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
126128685|NCT01709149|453763306|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
126128686|NCT01709149|453763304|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
126128687|NCT01709149|453763305|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
126128688|NCT01709149|453763306|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
126128689|NCT01709149|453763304|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126128690|NCT01709149|453763305|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
126128691|NCT01709149|453763306|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
126128692|NCT01709149|453763304|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
126128693|NCT01709149|453763305|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
126128694|NCT01709149|453763306|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
126128695|NCT01709149|453763304|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
126128696|NCT01709149|453763305|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
126128697|NCT01709149|453763306|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
126128698|NCT01709149|453763304|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
126128699|NCT01709149|453763305|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
126128700|NCT01709149|453763306|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
126128701|NCT01709149|453763304|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126128702|NCT01709149|453763305|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
126128703|NCT01709149|453763306|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126128704|NCT02192827|453763307|FG000|Overall Study|Lost to Follow-up|25|||
126128705|NCT02192827|453763308|FG001|Overall Study|Lost to Follow-up|27|||
126128706|NCT02192827|453763307|FG000|Overall Study|Given additional steroids with admission|13|||
126128707|NCT02192827|453763308|FG001|Overall Study|Given additional steroids with admission|11|||
126128708|NCT02941627|453763343|FG000|Overall Study|Death|1|||
126128709|NCT02941627|453763343|FG000|Overall Study|Surgical failure|1|||
126128710|NCT02941627|453763343|FG000|Overall Study|cholesteatoma prevented implantation|1|||
126128711|NCT03594227|453763344|FG000|Overall Study|Adverse Event|2|||
126128712|NCT03594227|453763345|FG001|Overall Study|Adverse Event|1|||
126128713|NCT03594227|453763346|FG002|Overall Study|Adverse Event|0|||
126128714|NCT03594227|453763347|FG003|Overall Study|Adverse Event|2|||
126128715|NCT03594227|453763344|FG000|Overall Study|Lost to Follow-up|1|||
126128716|NCT03594227|453763345|FG001|Overall Study|Lost to Follow-up|1|||
126128717|NCT03594227|453763346|FG002|Overall Study|Lost to Follow-up|1|||
126128718|NCT03594227|453763347|FG003|Overall Study|Lost to Follow-up|0|||
126128719|NCT03594227|453763344|FG000|Overall Study|Withdrawal by Subject|1|||
126128720|NCT03594227|453763345|FG001|Overall Study|Withdrawal by Subject|1|||
126128721|NCT03594227|453763346|FG002|Overall Study|Withdrawal by Subject|1|||
126128722|NCT03594227|453763347|FG003|Overall Study|Withdrawal by Subject|1|||
126128723|NCT03594227|453763344|FG000|Overall Study|Pregnancy|0|||
126128724|NCT03594227|453763345|FG001|Overall Study|Pregnancy|1|||
126128725|NCT03594227|453763346|FG002|Overall Study|Pregnancy|0|||
126128726|NCT03594227|453763347|FG003|Overall Study|Pregnancy|0|||
126128727|NCT03594227|453763344|FG000|Overall Study|Sponsor Decision|0|||
126128728|NCT03594227|453763345|FG001|Overall Study|Sponsor Decision|0|||
126128729|NCT03594227|453763346|FG002|Overall Study|Sponsor Decision|0|||
126128730|NCT03594227|453763347|FG003|Overall Study|Sponsor Decision|1|||
126128731|NCT03594227|453763344|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
126128732|NCT03594227|453763345|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
126128733|NCT03594227|453763346|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
126128734|NCT03594227|453763347|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
126128735|NCT00790907|453763348|FG000|Overall Study|Adverse Event|9|||
126128736|NCT00790907|453763349|FG001|Overall Study|Adverse Event|7|||
126128737|NCT00790907|453763350|FG002|Overall Study|Adverse Event|6|||
126128738|NCT00790907|453763348|FG000|Overall Study|Physician Decision|304|||
126128739|NCT00790907|453763349|FG001|Overall Study|Physician Decision|271|||
126128740|NCT00790907|453763350|FG002|Overall Study|Physician Decision|255|||
126128741|NCT00790907|453763348|FG000|Overall Study|Withdrawal by Subject|1|||
126128742|NCT00790907|453763349|FG001|Overall Study|Withdrawal by Subject|7|||
126128743|NCT00790907|453763350|FG002|Overall Study|Withdrawal by Subject|5|||
126128744|NCT00790907|453763348|FG000|Overall Study|Bleeding Event|11|||
126128745|NCT00790907|453763349|FG001|Overall Study|Bleeding Event|16|||
126128746|NCT00790907|453763350|FG002|Overall Study|Bleeding Event|21|||
126128747|NCT00790907|453763348|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
126128748|NCT00790907|453763349|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
126128749|NCT00790907|453763350|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
126128750|NCT00790907|453763348|FG000|Overall Study|Qualifying Condition Not Present|29|||
126128751|NCT00790907|453763349|FG001|Overall Study|Qualifying Condition Not Present|14|||
126128752|NCT00790907|453763350|FG002|Overall Study|Qualifying Condition Not Present|16|||
126128753|NCT00790907|453763348|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
126128754|NCT00790907|453763349|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
126128755|NCT00790907|453763350|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
126128756|NCT00790907|453763348|FG000|Overall Study|Did Not Receive Study Drug|10|||
126128757|NCT00790907|453763349|FG001|Overall Study|Did Not Receive Study Drug|0|||
126128758|NCT00790907|453763350|FG002|Overall Study|Did Not Receive Study Drug|0|||
126128759|NCT01888640|453763351|FG000|Overall Study|Lost to Follow-up|1|||
126128760|NCT01888640|453763352|FG001|Overall Study|Lost to Follow-up|2|||
126128761|NCT01888640|453763353|FG002|Overall Study|Lost to Follow-up|0|||
126128762|NCT01888640|453763351|FG000|Overall Study|Withdrawal by Subject|15|||
126128763|NCT01888640|453763352|FG001|Overall Study|Withdrawal by Subject|11|||
126128764|NCT01888640|453763353|FG002|Overall Study|Withdrawal by Subject|4|||
126128765|NCT01888640|453763351|FG000|Overall Study|Minimum dose not met|10|||
126128766|NCT01888640|453763352|FG001|Overall Study|Minimum dose not met|16|||
126128767|NCT01888640|453763353|FG002|Overall Study|Minimum dose not met|0|||
126128768|NCT01888640|453763351|FG000|Overall Study|Given wrong unit (placebo)|1|||
126128769|NCT01888640|453763352|FG001|Overall Study|Given wrong unit (placebo)|0|||
126128770|NCT01888640|453763353|FG002|Overall Study|Given wrong unit (placebo)|0|||
126128771|NCT01888640|453763351|FG000|Overall Study|Excluded for prior TENS|0|||
126128772|NCT01888640|453763352|FG001|Overall Study|Excluded for prior TENS|1|||
126128773|NCT01888640|453763353|FG002|Overall Study|Excluded for prior TENS|0|||
126128774|NCT01888640|453763351|FG000|Overall Study|Researcher Termination of Participant|0|||
126128775|NCT01888640|453763352|FG001|Overall Study|Researcher Termination of Participant|1|||
126128776|NCT01888640|453763353|FG002|Overall Study|Researcher Termination of Participant|1|||
126128777|NCT03436862|453763356|FG000|Overall Study|Adverse Event|4|||
126128778|NCT03436862|453763356|FG000|Overall Study|Progressive Disease|2|||
126128779|NCT02228590|453763358|FG000|Overall Study|Withdrawal by Subject|1|||
126128780|NCT01097863|453763359|FG000|Overall Study|Discomfort|1|||
126128781|NCT01097863|453763360|FG001|Overall Study|Discomfort|0|||
126128782|NCT01097863|453763361|FG002|Overall Study|Discomfort|1|||
126128783|NCT01097863|453763359|FG000|Overall Study|Did not return for final visit|0|||
126128784|NCT01097863|453763360|FG001|Overall Study|Did not return for final visit|0|||
126128785|NCT01097863|453763361|FG002|Overall Study|Did not return for final visit|1|||
126128786|NCT00960843|453763362|FG000|Overall Study|Lost to Follow-up|2|||
126128787|NCT00960843|453763363|FG001|Overall Study|Lost to Follow-up|0|||
126128788|NCT00960843|453763362|FG000|Overall Study|Protocol Violation|0|||
126128789|NCT00960843|453763363|FG001|Overall Study|Protocol Violation|4|||
126128790|NCT00960843|453763362|FG000|Overall Study|Repeated needle dislodgment|0|||
126128791|NCT00960843|453763363|FG001|Overall Study|Repeated needle dislodgment|1|||
126128792|NCT00490451|453763366|FG000|Overall Study|Adverse Event|3|||
126128793|NCT00490451|453763367|FG001|Overall Study|Adverse Event|3|||
126128794|NCT00490451|453763366|FG000|Overall Study|Death|3|||
126128795|NCT00490451|453763367|FG001|Overall Study|Death|1|||
126128796|NCT00490451|453763366|FG000|Overall Study|Withdrawal by Subject|2|||
126128797|NCT00490451|453763367|FG001|Overall Study|Withdrawal by Subject|0|||
126128798|NCT00490451|453763366|FG000|Overall Study|Investigator Decision|1|||
126128799|NCT00490451|453763367|FG001|Overall Study|Investigator Decision|0|||
126128800|NCT00490451|453763366|FG000|Overall Study|Protocol Violation|1|||
126128801|NCT00490451|453763367|FG001|Overall Study|Protocol Violation|0|||
126128802|NCT00490451|453763366|FG000|Overall Study|Progressive Disease|53|||
126128803|NCT00490451|453763367|FG001|Overall Study|Progressive Disease|34|||
126128804|NCT01181011|453763368|FG000|Overall Study|Adverse Event|2|||
126128805|NCT01181011|453763368|FG000|Overall Study|Lost to Follow-up|1|||
126128806|NCT02788747|453763369|FG000|Overall Study|Adverse Event|1|||
126128807|NCT02788747|453763370|FG001|Overall Study|Adverse Event|0|||
126128808|NCT02788747|453763371|FG002|Overall Study|Adverse Event|0|||
126128809|NCT01967550|453763372|FG000|Overall Study|Withdrawal by Subject|1|||
126128810|NCT01967550|453763373|FG001|Overall Study|Withdrawal by Subject|0|||
126128811|NCT01967550|453763372|FG000|Overall Study|Adverse Event|2|||
126128812|NCT01967550|453763373|FG001|Overall Study|Adverse Event|0|||
126128813|NCT01967550|453763372|FG000|Overall Study|Protocol Violation|2|||
126128814|NCT01967550|453763373|FG001|Overall Study|Protocol Violation|1|||
126128815|NCT01967550|453763372|FG000|Overall Study|Non Compliance|0|||
126128816|NCT01967550|453763373|FG001|Overall Study|Non Compliance|1|||
126128817|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
126128818|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
126128819|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
126128820|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
126128821|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
126128822|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
126128823|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
126128824|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
126128825|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
126128826|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
126128827|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
126128828|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
126128829|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
126128830|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
126128831|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
126128832|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
126128833|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
126128834|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
126128835|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
126128836|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
126128837|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
126128838|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
126128839|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
126128840|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
126128841|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
126128842|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
126128843|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
126128844|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
126128845|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
126128846|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
126128847|NCT00784654|453763376|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
126128848|NCT00784654|453763377|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
126128849|NCT00784654|453763378|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
126128850|NCT00784654|453763376|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
126128851|NCT00784654|453763377|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
126128852|NCT00784654|453763378|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
126128853|NCT00784654|453763376|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
126128854|NCT00784654|453763377|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
126128855|NCT00784654|453763378|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
126128856|NCT00784654|453763376|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126128857|NCT00784654|453763377|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
126128858|NCT00784654|453763378|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
126128859|NCT00784654|453763376|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
126128860|NCT00784654|453763377|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
126128861|NCT00784654|453763378|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
126128862|NCT00784654|453763376|FG000|Randomized Withdrawal Period|Adverse Event|0|||
126128863|NCT00784654|453763377|FG001|Randomized Withdrawal Period|Adverse Event|1|||
126128864|NCT00784654|453763378|FG002|Randomized Withdrawal Period|Adverse Event|1|||
126128865|NCT00784654|453763376|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
126128866|NCT00784654|453763377|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
126128867|NCT00784654|453763378|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
126128868|NCT00784654|453763376|FG000|Randomized Withdrawal Period|Family reasons|0|||
126128869|NCT00784654|453763377|FG001|Randomized Withdrawal Period|Family reasons|0|||
126128870|NCT00784654|453763378|FG002|Randomized Withdrawal Period|Family reasons|1|||
126128871|NCT01180660|453763379|FG000|Overall Study|Changed to open surgery|1|||
126128872|NCT01180660|453763380|FG001|Overall Study|Changed to open surgery|0|||
126128873|NCT00852995|453763382|FG000|Overall Study|Adverse Event|1|||
126128874|NCT00852995|453763383|FG001|Overall Study|Adverse Event|0|||
126128875|NCT00852995|453763384|FG002|Overall Study|Adverse Event|4|||
126128876|NCT00852995|453763385|FG003|Overall Study|Adverse Event|0|||
126128877|NCT00852995|453763386|FG004|Overall Study|Adverse Event|0|||
126128878|NCT00852995|453763382|FG000|Overall Study|Lost to Follow-up|0|||
126128879|NCT00852995|453763383|FG001|Overall Study|Lost to Follow-up|1|||
126128880|NCT00852995|453763384|FG002|Overall Study|Lost to Follow-up|1|||
126128881|NCT00852995|453763385|FG003|Overall Study|Lost to Follow-up|0|||
126128882|NCT00852995|453763386|FG004|Overall Study|Lost to Follow-up|0|||
126128883|NCT00852995|453763382|FG000|Overall Study|Withdrawal by Subject|4|||
126128884|NCT00852995|453763383|FG001|Overall Study|Withdrawal by Subject|0|||
126128885|NCT00852995|453763384|FG002|Overall Study|Withdrawal by Subject|0|||
126128886|NCT00852995|453763385|FG003|Overall Study|Withdrawal by Subject|1|||
126128887|NCT00852995|453763386|FG004|Overall Study|Withdrawal by Subject|2|||
126128888|NCT00852995|453763382|FG000|Overall Study|Non-Compliance|0|||
126128889|NCT00852995|453763383|FG001|Overall Study|Non-Compliance|0|||
126128890|NCT00852995|453763384|FG002|Overall Study|Non-Compliance|0|||
126128891|NCT00852995|453763385|FG003|Overall Study|Non-Compliance|2|||
126128892|NCT00852995|453763386|FG004|Overall Study|Non-Compliance|0|||
126128893|NCT00852995|453763382|FG000|Overall Study|Progressive Disease|1|||
126128894|NCT00852995|453763383|FG001|Overall Study|Progressive Disease|0|||
126128895|NCT00852995|453763384|FG002|Overall Study|Progressive Disease|0|||
126128896|NCT00852995|453763385|FG003|Overall Study|Progressive Disease|2|||
126128897|NCT00852995|453763386|FG004|Overall Study|Progressive Disease|1|||
126128898|NCT00852995|453763382|FG000|Overall Study|Physician Decision|1|||
126128899|NCT00852995|453763383|FG001|Overall Study|Physician Decision|0|||
126128900|NCT00852995|453763384|FG002|Overall Study|Physician Decision|0|||
126128901|NCT00852995|453763385|FG003|Overall Study|Physician Decision|0|||
126128902|NCT00852995|453763386|FG004|Overall Study|Physician Decision|0|||
126128903|NCT00852995|453763382|FG000|Overall Study|Protocol Violation|0|||
126128904|NCT00852995|453763383|FG001|Overall Study|Protocol Violation|0|||
126128905|NCT00852995|453763384|FG002|Overall Study|Protocol Violation|0|||
126128906|NCT00852995|453763385|FG003|Overall Study|Protocol Violation|0|||
126128907|NCT00852995|453763386|FG004|Overall Study|Protocol Violation|1|||
126128908|NCT00852995|453763382|FG000|Overall Study|Moved Out of Area|1|||
126128909|NCT00852995|453763383|FG001|Overall Study|Moved Out of Area|0|||
126128910|NCT00852995|453763384|FG002|Overall Study|Moved Out of Area|0|||
126128911|NCT00852995|453763385|FG003|Overall Study|Moved Out of Area|0|||
126128912|NCT00852995|453763386|FG004|Overall Study|Moved Out of Area|0|||
126128913|NCT04518462|453763389|FG000|Overall Study|Withdrawal by Subject|0|||
126128914|NCT04518462|453763390|FG001|Overall Study|Withdrawal by Subject|0|||
126128915|NCT04518462|453763391|FG002|Overall Study|Withdrawal by Subject|1|||
126128916|NCT04518462|453763389|FG000|Overall Study|Physician Decision|1|||
126128917|NCT04518462|453763390|FG001|Overall Study|Physician Decision|1|||
126128918|NCT04518462|453763391|FG002|Overall Study|Physician Decision|0|||
126128919|NCT04418076|453763395|FG000|Overall Study|Death|1|||
126128920|NCT04418076|453763396|FG001|Overall Study|Death|0|||
126128921|NCT04418076|453763397|FG002|Overall Study|Death|0|||
126128922|NCT04418076|453763398|FG003|Overall Study|Death|0|||
126128923|NCT04418076|453763395|FG000|Overall Study|Lost to Follow-up|2|||
126128924|NCT04418076|453763396|FG001|Overall Study|Lost to Follow-up|5|||
126128925|NCT04418076|453763397|FG002|Overall Study|Lost to Follow-up|1|||
126128926|NCT04418076|453763398|FG003|Overall Study|Lost to Follow-up|2|||
126128927|NCT04418076|453763395|FG000|Overall Study|Withdrawal by Subject|1|||
126128928|NCT04418076|453763396|FG001|Overall Study|Withdrawal by Subject|0|||
126128929|NCT04418076|453763397|FG002|Overall Study|Withdrawal by Subject|1|||
126128930|NCT04418076|453763398|FG003|Overall Study|Withdrawal by Subject|1|||
126128931|NCT04418076|453763395|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
126128932|NCT04418076|453763396|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
126128933|NCT04418076|453763397|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
126128934|NCT04418076|453763398|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
126128935|NCT01471782|453763399|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
126128936|NCT01471782|453763400|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
126128937|NCT01471782|453763401|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
126128938|NCT01471782|453763402|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
126128939|NCT01471782|453763403|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
126128940|NCT01471782|453763404|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
126128941|NCT01471782|453763399|FG000|Overall Study|Lack of Efficacy|1|||
126128942|NCT01471782|453763400|FG001|Overall Study|Lack of Efficacy|2|||
126128943|NCT01471782|453763401|FG002|Overall Study|Lack of Efficacy|1|||
126128944|NCT01471782|453763402|FG003|Overall Study|Lack of Efficacy|1|||
126128945|NCT01471782|453763403|FG004|Overall Study|Lack of Efficacy|5|||
126128946|NCT01471782|453763404|FG005|Overall Study|Lack of Efficacy|18|||
126128947|NCT01471782|453763399|FG000|Overall Study|Adverse Event|1|||
126128948|NCT01471782|453763400|FG001|Overall Study|Adverse Event|1|||
126128949|NCT01471782|453763401|FG002|Overall Study|Adverse Event|2|||
126128950|NCT01471782|453763402|FG003|Overall Study|Adverse Event|2|||
126128951|NCT01471782|453763403|FG004|Overall Study|Adverse Event|3|||
126128952|NCT01471782|453763404|FG005|Overall Study|Adverse Event|1|||
126128953|NCT01471782|453763399|FG000|Overall Study|Other|0|||
126128954|NCT01471782|453763400|FG001|Overall Study|Other|0|||
126128955|NCT01471782|453763401|FG002|Overall Study|Other|1|||
126128956|NCT01471782|453763402|FG003|Overall Study|Other|1|||
126128957|NCT01471782|453763403|FG004|Overall Study|Other|6|||
126128958|NCT01471782|453763404|FG005|Overall Study|Other|5|||
126128959|NCT01471782|453763399|FG000|Overall Study|Change of Chemotherapy|1|||
126128960|NCT01471782|453763400|FG001|Overall Study|Change of Chemotherapy|1|||
126128961|NCT01471782|453763401|FG002|Overall Study|Change of Chemotherapy|0|||
126128962|NCT01471782|453763402|FG003|Overall Study|Change of Chemotherapy|0|||
126128963|NCT01471782|453763403|FG004|Overall Study|Change of Chemotherapy|1|||
126128964|NCT01471782|453763404|FG005|Overall Study|Change of Chemotherapy|4|||
126128965|NCT01471782|453763399|FG000|Overall Study|Disease Relapse|0|||
126128966|NCT01471782|453763400|FG001|Overall Study|Disease Relapse|0|||
126128967|NCT01471782|453763401|FG002|Overall Study|Disease Relapse|0|||
126128968|NCT01471782|453763402|FG003|Overall Study|Disease Relapse|1|||
126128969|NCT01471782|453763403|FG004|Overall Study|Disease Relapse|2|||
126128970|NCT01471782|453763404|FG005|Overall Study|Disease Relapse|1|||
126128971|NCT01471782|453763399|FG000|Overall Study|Physician Decision|0|||
126128972|NCT01471782|453763400|FG001|Overall Study|Physician Decision|0|||
126128973|NCT01471782|453763401|FG002|Overall Study|Physician Decision|0|||
126128974|NCT01471782|453763402|FG003|Overall Study|Physician Decision|0|||
126128975|NCT01471782|453763403|FG004|Overall Study|Physician Decision|3|||
126128976|NCT01471782|453763404|FG005|Overall Study|Physician Decision|8|||
126128977|NCT01471782|453763399|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126128978|NCT01471782|453763400|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126128979|NCT01471782|453763401|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126128980|NCT01471782|453763402|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126128981|NCT01471782|453763403|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
126128982|NCT01471782|453763404|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126128983|NCT01471782|453763399|FG000|Overall Study|Death|0|||
126128984|NCT01471782|453763400|FG001|Overall Study|Death|0|||
126128985|NCT01471782|453763401|FG002|Overall Study|Death|0|||
126128986|NCT01471782|453763402|FG003|Overall Study|Death|0|||
126128987|NCT01471782|453763403|FG004|Overall Study|Death|0|||
126128988|NCT01471782|453763404|FG005|Overall Study|Death|1|||
126128989|NCT01314716|453763405|FG000|Double-Blind Phase|Randomized but not treated|1|||
126128990|NCT01314716|453763406|FG001|Double-Blind Phase|Randomized but not treated|1|||
126128991|NCT01314716|453763405|FG000|Double-Blind Phase|Adverse Event|10|||
126128992|NCT01314716|453763406|FG001|Double-Blind Phase|Adverse Event|4|||
126128993|NCT01314716|453763405|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
126128994|NCT01314716|453763406|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
126128995|NCT01314716|453763405|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126128996|NCT01314716|453763406|FG001|Double-Blind Phase|Lost to Follow-up|1|||
126128997|NCT01314716|453763405|FG000|Double-Blind Phase|Sponsor request|1|||
126128998|NCT01314716|453763406|FG001|Double-Blind Phase|Sponsor request|2|||
126128999|NCT01314716|453763405|FG000|Double-Blind Phase|Physician Decision|0|||
126129000|NCT01314716|453763406|FG001|Double-Blind Phase|Physician Decision|1|||
126129001|NCT01314716|453763405|FG000|Open-Label Phase|Adverse Event|4|||
126129002|NCT01314716|453763406|FG001|Open-Label Phase|Adverse Event|6|||
126129003|NCT01314716|453763405|FG000|Open-Label Phase|Withdrawal by Subject|1|||
126129004|NCT01314716|453763406|FG001|Open-Label Phase|Withdrawal by Subject|2|||
126129005|NCT01314716|453763405|FG000|Open-Label Phase|Physician Decision|5|||
126129006|NCT01314716|453763406|FG001|Open-Label Phase|Physician Decision|4|||
126129007|NCT00805480|453763409|FG000|Overall Study|Withdrawal by Subject|13|||
126129008|NCT00805480|453763410|FG001|Overall Study|Withdrawal by Subject|5|||
126129009|NCT00805480|453763411|FG002|Overall Study|Withdrawal by Subject|11|||
126129010|NCT00805480|453763412|FG003|Overall Study|Withdrawal by Subject|5|||
126129011|NCT00805480|453763409|FG000|Overall Study|Lost to Follow-up|1|||
126129012|NCT00805480|453763410|FG001|Overall Study|Lost to Follow-up|2|||
126129013|NCT00805480|453763411|FG002|Overall Study|Lost to Follow-up|0|||
126129014|NCT00805480|453763412|FG003|Overall Study|Lost to Follow-up|0|||
126129015|NCT00805480|453763409|FG000|Overall Study|Adverse Event|0|||
126129016|NCT00805480|453763410|FG001|Overall Study|Adverse Event|0|||
126129017|NCT00805480|453763411|FG002|Overall Study|Adverse Event|1|||
126129018|NCT00805480|453763412|FG003|Overall Study|Adverse Event|0|||
126129019|NCT01452152|453763413|FG000|Overall Study|Study termination by sponsor|5|||
126129020|NCT01452152|453763414|FG001|Overall Study|Study termination by sponsor|0|||
126129021|NCT01452152|453763415|FG002|Overall Study|Study termination by sponsor|4|||
126129022|NCT04099251|453764855|FG000|Pre-Treatment|Other reasons|1|||
126129023|NCT04099251|453764856|FG001|Pre-Treatment|Other reasons|0|||
126129024|NCT04099251|453764855|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
126129025|NCT04099251|453764856|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
126129026|NCT04099251|453764855|FG000|Blinded Treatment Phase|Other reasons|16|||
126129027|NCT04099251|453764856|FG001|Blinded Treatment Phase|Other reasons|7|||
126129028|NCT04099251|453764855|FG000|Blinded Treatment Phase|Disease recurrence|26|||
126129029|NCT04099251|453764856|FG001|Blinded Treatment Phase|Disease recurrence|41|||
126129030|NCT04099251|453764855|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
126129031|NCT04099251|453764856|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
126129032|NCT04099251|453764855|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
126129033|NCT04099251|453764856|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
126129034|NCT04099251|453764855|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
126129035|NCT04099251|453764856|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
126129036|NCT04099251|453764855|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
126129037|NCT04099251|453764856|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
126129038|NCT04099251|453764855|FG000|Blinded Treatment Phase|Death|6|||
126129039|NCT04099251|453764856|FG001|Blinded Treatment Phase|Death|2|||
126129040|NCT04099251|453764855|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
126129041|NCT04099251|453764856|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
126129042|NCT04099251|453764855|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
126129043|NCT04099251|453764856|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
126129044|NCT04099251|453764855|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
126129045|NCT04099251|453764856|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
126129046|NCT04099251|453764855|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
126129047|NCT04099251|453764856|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
126129048|NCT04099251|453764855|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
126129049|NCT04099251|453764856|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
126129050|NCT04099251|453764855|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
126129051|NCT04099251|453764856|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
126129052|NCT04099251|453764855|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
126129053|NCT04099251|453764856|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
126129054|NCT04099251|453764855|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
126129055|NCT04099251|453764856|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
126129056|NCT04099251|453764855|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
126129057|NCT04099251|453764856|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
126129058|NCT00880893|453764857|FG000|Overall Study|Protocol Violation|13|||
126129059|NCT00880893|453764858|FG001|Overall Study|Protocol Violation|1|||
126129060|NCT00880893|453764857|FG000|Overall Study|Withdrawal by Subject|15|||
126129061|NCT00880893|453764858|FG001|Overall Study|Withdrawal by Subject|11|||
126129062|NCT00880893|453764857|FG000|Overall Study|Lost to Follow-up|76|||
126129063|NCT00880893|453764858|FG001|Overall Study|Lost to Follow-up|33|||
126129064|NCT00880893|453764857|FG000|Overall Study|Serious adverse event|3|||
126129065|NCT00880893|453764858|FG001|Overall Study|Serious adverse event|0|||
126129066|NCT01783678|453764859|FG000|Overall Study|Randomized but Not Treated|0|||
126129067|NCT01783678|453764860|FG001|Overall Study|Randomized but Not Treated|0|||
126129068|NCT01783678|453764861|FG002|Overall Study|Randomized but Not Treated|0|||
126129069|NCT01783678|453764862|FG003|Overall Study|Randomized but Not Treated|1|||
126129070|NCT01783678|453764863|FG004|Overall Study|Randomized but Not Treated|0|||
126129071|NCT01783678|453764864|FG005|Overall Study|Randomized but Not Treated|0|||
126129072|NCT01783678|453764859|FG000|Overall Study|Lack of Efficacy|1|||
126129073|NCT01783678|453764860|FG001|Overall Study|Lack of Efficacy|13|||
126129074|NCT01783678|453764861|FG002|Overall Study|Lack of Efficacy|1|||
126129075|NCT01783678|453764862|FG003|Overall Study|Lack of Efficacy|3|||
126129076|NCT01783678|453764863|FG004|Overall Study|Lack of Efficacy|6|||
126129077|NCT01783678|453764864|FG005|Overall Study|Lack of Efficacy|5|||
126129078|NCT01783678|453764859|FG000|Overall Study|Lost to Follow-up|0|||
126129079|NCT01783678|453764860|FG001|Overall Study|Lost to Follow-up|4|||
126129080|NCT01783678|453764861|FG002|Overall Study|Lost to Follow-up|0|||
126129081|NCT01783678|453764862|FG003|Overall Study|Lost to Follow-up|2|||
126129082|NCT01783678|453764863|FG004|Overall Study|Lost to Follow-up|1|||
126129083|NCT01783678|453764864|FG005|Overall Study|Lost to Follow-up|0|||
126129084|NCT01783678|453764859|FG000|Overall Study|Withdrew Consent|1|||
126129085|NCT01783678|453764860|FG001|Overall Study|Withdrew Consent|1|||
126129086|NCT01783678|453764861|FG002|Overall Study|Withdrew Consent|0|||
126129087|NCT01783678|453764862|FG003|Overall Study|Withdrew Consent|2|||
126129088|NCT01783678|453764863|FG004|Overall Study|Withdrew Consent|0|||
126129089|NCT01783678|453764864|FG005|Overall Study|Withdrew Consent|0|||
126129090|NCT01995071|453764865|FG000|Overall Study|Adverse Event|0|||
126129091|NCT01995071|453764866|FG001|Overall Study|Adverse Event|0|||
126129092|NCT01995071|453764867|FG002|Overall Study|Adverse Event|0|||
126129093|NCT01995071|453764868|FG003|Overall Study|Adverse Event|0|||
126129094|NCT01995071|453764869|FG004|Overall Study|Adverse Event|0|||
126129095|NCT01995071|453764870|FG005|Overall Study|Adverse Event|0|||
126129096|NCT01995071|453764871|FG006|Overall Study|Adverse Event|1|||
126129097|NCT01995071|453764872|FG007|Overall Study|Adverse Event|0|||
126129098|NCT01995071|453764873|FG008|Overall Study|Adverse Event|0|||
126129099|NCT01995071|453764874|FG009|Overall Study|Adverse Event|0|||
126129100|NCT01995071|453764875|FG010|Overall Study|Adverse Event|0|||
126129101|NCT01995071|453764876|FG011|Overall Study|Adverse Event|0|||
126129102|NCT01995071|453764865|FG000|Overall Study|Moved|0|||
126129103|NCT01995071|453764866|FG001|Overall Study|Moved|0|||
126129104|NCT01995071|453764867|FG002|Overall Study|Moved|1|||
126129105|NCT01995071|453764868|FG003|Overall Study|Moved|0|||
126129106|NCT01995071|453764869|FG004|Overall Study|Moved|1|||
126129107|NCT01995071|453764870|FG005|Overall Study|Moved|0|||
126129108|NCT01995071|453764871|FG006|Overall Study|Moved|0|||
126129109|NCT01995071|453764872|FG007|Overall Study|Moved|0|||
126129110|NCT01995071|453764873|FG008|Overall Study|Moved|0|||
126129111|NCT01995071|453764874|FG009|Overall Study|Moved|0|||
126129112|NCT01995071|453764875|FG010|Overall Study|Moved|1|||
126129113|NCT01995071|453764876|FG011|Overall Study|Moved|0|||
126129114|NCT01995071|453764865|FG000|Overall Study|Lost to Follow-up|1|||
126129115|NCT01995071|453764866|FG001|Overall Study|Lost to Follow-up|0|||
126129116|NCT01995071|453764867|FG002|Overall Study|Lost to Follow-up|0|||
126129117|NCT01995071|453764868|FG003|Overall Study|Lost to Follow-up|0|||
126129118|NCT01995071|453764869|FG004|Overall Study|Lost to Follow-up|0|||
126129119|NCT01995071|453764870|FG005|Overall Study|Lost to Follow-up|0|||
126129120|NCT01995071|453764871|FG006|Overall Study|Lost to Follow-up|0|||
126129121|NCT01995071|453764872|FG007|Overall Study|Lost to Follow-up|1|||
126129122|NCT01995071|453764873|FG008|Overall Study|Lost to Follow-up|1|||
126129123|NCT01995071|453764874|FG009|Overall Study|Lost to Follow-up|0|||
126129124|NCT01995071|453764875|FG010|Overall Study|Lost to Follow-up|0|||
126129125|NCT01995071|453764876|FG011|Overall Study|Lost to Follow-up|0|||
126129126|NCT01995071|453764865|FG000|Overall Study|Incarcerated|0|||
126129127|NCT01995071|453764866|FG001|Overall Study|Incarcerated|0|||
126129128|NCT01995071|453764867|FG002|Overall Study|Incarcerated|0|||
126129129|NCT01995071|453764868|FG003|Overall Study|Incarcerated|0|||
126129130|NCT01995071|453764869|FG004|Overall Study|Incarcerated|0|||
126129131|NCT01995071|453764870|FG005|Overall Study|Incarcerated|0|||
126129132|NCT01995071|453764871|FG006|Overall Study|Incarcerated|0|||
126129133|NCT01995071|453764872|FG007|Overall Study|Incarcerated|1|||
126129134|NCT01995071|453764873|FG008|Overall Study|Incarcerated|0|||
126129135|NCT01995071|453764874|FG009|Overall Study|Incarcerated|0|||
126129136|NCT01995071|453764875|FG010|Overall Study|Incarcerated|0|||
126129137|NCT01995071|453764876|FG011|Overall Study|Incarcerated|0|||
126129138|NCT02543528|453764877|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
126129139|NCT02543528|453764878|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
126129140|NCT02543528|453764879|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
126129141|NCT02543528|453764880|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
126129142|NCT02543528|453764881|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
126129143|NCT02543528|453764877|FG000|Adaptation Period|Lens Handling Difficultes|0|||
126129144|NCT02543528|453764878|FG001|Adaptation Period|Lens Handling Difficultes|0|||
126129145|NCT02543528|453764879|FG002|Adaptation Period|Lens Handling Difficultes|0|||
126129146|NCT02543528|453764880|FG003|Adaptation Period|Lens Handling Difficultes|0|||
126129147|NCT02543528|453764881|FG004|Adaptation Period|Lens Handling Difficultes|8|||
126129148|NCT02543528|453764877|FG000|Adaptation Period|Lost to Follow-up|0|||
126129149|NCT02543528|453764878|FG001|Adaptation Period|Lost to Follow-up|0|||
126129150|NCT02543528|453764879|FG002|Adaptation Period|Lost to Follow-up|0|||
126129151|NCT02543528|453764880|FG003|Adaptation Period|Lost to Follow-up|0|||
126129152|NCT02543528|453764881|FG004|Adaptation Period|Lost to Follow-up|14|||
126129153|NCT02543528|453764877|FG000|Adaptation Period|Adverse Event|0|||
126129154|NCT02543528|453764878|FG001|Adaptation Period|Adverse Event|0|||
126129155|NCT02543528|453764879|FG002|Adaptation Period|Adverse Event|0|||
126129156|NCT02543528|453764880|FG003|Adaptation Period|Adverse Event|0|||
126129157|NCT02543528|453764881|FG004|Adaptation Period|Adverse Event|2|||
126129158|NCT02543528|453764877|FG000|Extended Wear Period|Adverse Event|17|||
126129159|NCT02543528|453764878|FG001|Extended Wear Period|Adverse Event|11|||
126129160|NCT02543528|453764879|FG002|Extended Wear Period|Adverse Event|16|||
126129161|NCT02543528|453764880|FG003|Extended Wear Period|Adverse Event|3|||
126129162|NCT02543528|453764881|FG004|Extended Wear Period|Adverse Event|0|||
126129163|NCT02543528|453764877|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
126129164|NCT02543528|453764878|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
126129165|NCT02543528|453764879|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
126129166|NCT02543528|453764880|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
126129167|NCT02543528|453764881|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
126129168|NCT02543528|453764877|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
126129169|NCT02543528|453764878|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
126129170|NCT02543528|453764879|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
126129171|NCT02543528|453764880|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
126129172|NCT02543528|453764881|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
126129173|NCT02543528|453764877|FG000|Extended Wear Period|Lost to Follow-up|0|||
126129174|NCT02543528|453764878|FG001|Extended Wear Period|Lost to Follow-up|1|||
126129175|NCT02543528|453764879|FG002|Extended Wear Period|Lost to Follow-up|2|||
126129176|NCT02543528|453764880|FG003|Extended Wear Period|Lost to Follow-up|1|||
126129177|NCT02543528|453764881|FG004|Extended Wear Period|Lost to Follow-up|0|||
126129178|NCT02543528|453764877|FG000|Extended Wear Period|Withdrawal by Subject|10|||
126129179|NCT02543528|453764878|FG001|Extended Wear Period|Withdrawal by Subject|9|||
126129180|NCT02543528|453764879|FG002|Extended Wear Period|Withdrawal by Subject|4|||
126129181|NCT02543528|453764880|FG003|Extended Wear Period|Withdrawal by Subject|5|||
126129182|NCT02543528|453764881|FG004|Extended Wear Period|Withdrawal by Subject|0|||
126129183|NCT02049944|453764882|FG000|Overall Study|Protocol Violation|2|||
126129184|NCT00112905|453764883|FG000|Overall Study|Adverse Event|4|||
126129185|NCT00112905|453764883|FG000|Overall Study|Death|1|||
126129186|NCT00112905|453764883|FG000|Overall Study|Ineligibility|5|||
126129187|NCT00112905|453764883|FG000|Overall Study|Alternative treatment|1|||
126129188|NCT00112905|453764883|FG000|Overall Study|performance status was deteiorating|1|||
126129189|NCT01765673|453764884|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
126129190|NCT01042600|453764885|FG000|Overall Study|Ineligible|1|||
126129191|NCT01042600|453764886|FG001|Overall Study|Ineligible|0|||
126129192|NCT02600507|453764887|FG000|Overall Study|Adverse Event|3|||
126129193|NCT02600507|453764888|FG001|Overall Study|Adverse Event|15|||
126129194|NCT02600507|453764889|FG002|Overall Study|Adverse Event|5|||
126129195|NCT02600507|453764887|FG000|Overall Study|Lack of Efficacy|3|||
126129196|NCT02600507|453764888|FG001|Overall Study|Lack of Efficacy|8|||
126129197|NCT02600507|453764889|FG002|Overall Study|Lack of Efficacy|5|||
126129198|NCT02600507|453764887|FG000|Overall Study|Lost to Follow-up|3|||
126129199|NCT02600507|453764888|FG001|Overall Study|Lost to Follow-up|5|||
126129200|NCT02600507|453764889|FG002|Overall Study|Lost to Follow-up|2|||
126129201|NCT02600507|453764887|FG000|Overall Study|Protocol Violation|12|||
126129202|NCT02600507|453764888|FG001|Overall Study|Protocol Violation|4|||
126129203|NCT02600507|453764889|FG002|Overall Study|Protocol Violation|4|||
126129204|NCT02600507|453764887|FG000|Overall Study|Physician Decision|1|||
126129205|NCT02600507|453764888|FG001|Overall Study|Physician Decision|0|||
126129206|NCT02600507|453764889|FG002|Overall Study|Physician Decision|1|||
126129207|NCT02600507|453764887|FG000|Overall Study|Withdrawal by Subject|7|||
126129208|NCT02600507|453764888|FG001|Overall Study|Withdrawal by Subject|11|||
126129209|NCT02600507|453764889|FG002|Overall Study|Withdrawal by Subject|7|||
126129210|NCT02600507|453764887|FG000|Overall Study|Other|0|||
126129211|NCT02600507|453764888|FG001|Overall Study|Other|1|||
126129212|NCT02600507|453764889|FG002|Overall Study|Other|1|||
126129213|NCT00621504|453764895|FG000|Overall Study|Adverse Event|1|||
126129214|NCT00621504|453764896|FG001|Overall Study|Adverse Event|3|||
126129215|NCT00621504|453764895|FG000|Overall Study|At the request of sponsor/investigator|1|||
126129216|NCT00621504|453764896|FG001|Overall Study|At the request of sponsor/investigator|0|||
126129217|NCT00621504|453764895|FG000|Overall Study|Withdrew consent|9|||
125963942|NCT03266588|453159321|FG001|Long-term Treatment Period|Non-Compliance|57|||
125963943|NCT03266588|453159322|FG002|Long-term Treatment Period|Non-Compliance|7|||
125963944|NCT03266588|453159320|FG000|Long-term Treatment Period|Pregnancy|11|||
125963945|NCT03266588|453159321|FG001|Long-term Treatment Period|Pregnancy|5|||
126129218|NCT00621504|453764896|FG001|Overall Study|Withdrew consent|6|||
126129219|NCT00621504|453764895|FG000|Overall Study|Lost to Follow-up|8|||
126129220|NCT00621504|453764896|FG001|Overall Study|Lost to Follow-up|10|||
126129221|NCT00621504|453764895|FG000|Overall Study|Other|1|||
126129222|NCT00621504|453764896|FG001|Overall Study|Other|0|||
126129223|NCT00621504|453764895|FG000|Overall Study|Death|6|||
126129224|NCT00621504|453764896|FG001|Overall Study|Death|6|||
126129225|NCT00605085|453764897|FG000|Overall Study|Withdrawal by Subject|8|||
126129226|NCT00605085|453764898|FG001|Overall Study|Withdrawal by Subject|5|||
126129227|NCT00605085|453764897|FG000|Overall Study|Adverse Event|9|||
126129228|NCT00605085|453764898|FG001|Overall Study|Adverse Event|5|||
126129229|NCT00605085|453764897|FG000|Overall Study|Pregnancy|2|||
126129230|NCT00605085|453764898|FG001|Overall Study|Pregnancy|0|||
126129231|NCT00605085|453764897|FG000|Overall Study|Protocol Violation|3|||
126129232|NCT00605085|453764898|FG001|Overall Study|Protocol Violation|2|||
126129233|NCT00605085|453764897|FG000|Overall Study|Lost to Follow-up|10|||
126129234|NCT00605085|453764898|FG001|Overall Study|Lost to Follow-up|5|||
126129235|NCT00605085|453764897|FG000|Overall Study|administrative reasons|18|||
126129236|NCT00605085|453764898|FG001|Overall Study|administrative reasons|8|||
126129237|NCT03257267|453764903|FG000|Overall Study|Adverse Event|17|||
126129238|NCT03257267|453764904|FG001|Overall Study|Adverse Event|7|||
126129239|NCT03257267|453764903|FG000|Overall Study|Death|96|||
126129240|NCT03257267|453764904|FG001|Overall Study|Death|98|||
126129241|NCT03257267|453764903|FG000|Overall Study|Lost to Follow-up|2|||
126129242|NCT03257267|453764904|FG001|Overall Study|Lost to Follow-up|2|||
126129243|NCT03257267|453764903|FG000|Overall Study|Non-compliance with Study Drug|0|||
126129244|NCT03257267|453764904|FG001|Overall Study|Non-compliance with Study Drug|2|||
126129245|NCT03257267|453764903|FG000|Overall Study|Participant Decision|35|||
126129246|NCT03257267|453764904|FG001|Overall Study|Participant Decision|43|||
126129247|NCT03257267|453764903|FG000|Overall Study|Sponsor Decision|1|||
126129248|NCT03257267|453764904|FG001|Overall Study|Sponsor Decision|0|||
126129249|NCT03257267|453764903|FG000|Overall Study|Physician Decision|1|||
126129250|NCT03257267|453764904|FG001|Overall Study|Physician Decision|3|||
126129251|NCT03257267|453764903|FG000|Overall Study|Disease Progression|109|||
126129252|NCT03257267|453764904|FG001|Overall Study|Disease Progression|121|||
126129253|NCT03257267|453764903|FG000|Overall Study|Withdrawal by Subject|8|||
126129254|NCT03257267|453764904|FG001|Overall Study|Withdrawal by Subject|26|||
126129255|NCT03257267|453764903|FG000|Overall Study|Other|0|||
126129256|NCT03257267|453764904|FG001|Overall Study|Other|2|||
126129257|NCT01979523|453764905|FG000|Overall Study|Withdrawal by Subject|1|||
126129258|NCT01979523|453764906|FG001|Overall Study|Withdrawal by Subject|0|||
126129259|NCT01623271|453764911|FG000|Overall Study|Withdrawal by Subject|2|||
126129260|NCT00706134|453764912|FG000|Overall Study|Adverse Event|8|||
126129261|NCT00706134|453764913|FG001|Overall Study|Adverse Event|7|||
126129262|NCT00706134|453764914|FG002|Overall Study|Adverse Event|2|||
126129263|NCT00706134|453764915|FG003|Overall Study|Adverse Event|3|||
126129264|NCT00706134|453764912|FG000|Overall Study|Lost to Follow-up|0|||
126129265|NCT00706134|453764913|FG001|Overall Study|Lost to Follow-up|1|||
126129266|NCT00706134|453764914|FG002|Overall Study|Lost to Follow-up|0|||
126129267|NCT00706134|453764915|FG003|Overall Study|Lost to Follow-up|0|||
126129268|NCT00706134|453764912|FG000|Overall Study|Protocol Violation|0|||
126129269|NCT00706134|453764913|FG001|Overall Study|Protocol Violation|6|||
126129270|NCT00706134|453764914|FG002|Overall Study|Protocol Violation|0|||
126129271|NCT00706134|453764915|FG003|Overall Study|Protocol Violation|3|||
126129272|NCT00706134|453764912|FG000|Overall Study|Withdrawal by Subject|1|||
125963946|NCT03266588|453159322|FG002|Long-term Treatment Period|Pregnancy|0|||
125963947|NCT03266588|453159320|FG000|Long-term Treatment Period|Protocol Deviation|17|||
125963948|NCT03266588|453159321|FG001|Long-term Treatment Period|Protocol Deviation|10|||
126129273|NCT00706134|453764913|FG001|Overall Study|Withdrawal by Subject|2|||
126129274|NCT00706134|453764914|FG002|Overall Study|Withdrawal by Subject|1|||
126129275|NCT00706134|453764915|FG003|Overall Study|Withdrawal by Subject|0|||
126129276|NCT00706134|453764912|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
126129277|NCT00706134|453764913|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126129278|NCT00706134|453764914|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
126129279|NCT00706134|453764915|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
126129280|NCT00706134|453764912|FG000|Overall Study|Did not meet study criteria|2|||
126129281|NCT00706134|453764913|FG001|Overall Study|Did not meet study criteria|0|||
126129282|NCT00706134|453764914|FG002|Overall Study|Did not meet study criteria|0|||
126129283|NCT00706134|453764915|FG003|Overall Study|Did not meet study criteria|0|||
126129284|NCT01982292|453764916|FG000|Overall Study|Adverse Event|2|||
126129285|NCT01982292|453764917|FG001|Overall Study|Adverse Event|0|||
126129286|NCT01982292|453764916|FG000|Overall Study|Death|1|||
126129287|NCT01982292|453764917|FG001|Overall Study|Death|0|||
126129288|NCT01982292|453764916|FG000|Overall Study|Lost to Follow-up|2|||
126129289|NCT01982292|453764917|FG001|Overall Study|Lost to Follow-up|0|||
126129290|NCT01982292|453764916|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
126129291|NCT01982292|453764917|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
126129292|NCT01982292|453764916|FG000|Overall Study|Protocol Deviation|1|||
126129293|NCT01982292|453764917|FG001|Overall Study|Protocol Deviation|0|||
126129294|NCT01982292|453764916|FG000|Overall Study|Patient/Guardian Decision|3|||
126129295|NCT01982292|453764917|FG001|Overall Study|Patient/Guardian Decision|1|||
126129296|NCT01982292|453764916|FG000|Overall Study|Technical Problems|2|||
126129297|NCT01982292|453764917|FG001|Overall Study|Technical Problems|0|||
126129298|NCT01659320|453764920|FG000|Overall Study|Withdrawal by Subject|2|||
126129299|NCT01659320|453764920|FG000|Overall Study|Physician Decision|1|||
126129300|NCT04312009|453764921|FG000|Overall Study|Withdrawal by Subject|2|||
126129301|NCT04312009|453764922|FG001|Overall Study|Withdrawal by Subject|1|||
126129302|NCT00488982|453764928|FG000|Course 1|Physician Decision|0|||
126129303|NCT00488982|453764929|FG001|Course 1|Physician Decision|2|||
126129304|NCT00488982|453764930|FG002|Course 1|Physician Decision|4|||
126129305|NCT00488982|453764928|FG000|Course 1|Withdrawal by Subject|0|||
126129306|NCT00488982|453764929|FG001|Course 1|Withdrawal by Subject|8|||
126129307|NCT00488982|453764930|FG002|Course 1|Withdrawal by Subject|2|||
126129308|NCT00488982|453764928|FG000|Course 1|nonprotocol therapy|0|||
126129309|NCT00488982|453764929|FG001|Course 1|nonprotocol therapy|2|||
126129310|NCT00488982|453764930|FG002|Course 1|nonprotocol therapy|2|||
126129311|NCT00488982|453764928|FG000|Course 1|Adverse Event|0|||
126129312|NCT00488982|453764929|FG001|Course 1|Adverse Event|0|||
126129313|NCT00488982|453764930|FG002|Course 1|Adverse Event|6|||
126129314|NCT01678144|453764931|FG000|Stage 1: MAR Classic|Adverse Event|1|||
126129315|NCT02363686|453764932|FG000|Overall Study|Withdrawal by Subject|22|||
126129316|NCT02363686|453764932|FG000|Overall Study|incomplete FEES examinations|13|||
126129317|NCT01780831|453764936|FG000|Overall Study|Withdrawal by Subject|0|||
126129318|NCT01780831|453764937|FG001|Overall Study|Withdrawal by Subject|0|||
126129319|NCT01780831|453764938|FG002|Overall Study|Withdrawal by Subject|4|||
126129320|NCT01780831|453764939|FG003|Overall Study|Withdrawal by Subject|0|||
126129321|NCT01780831|453764936|FG000|Overall Study|Lost to Follow-up|0|||
126129322|NCT01780831|453764937|FG001|Overall Study|Lost to Follow-up|0|||
126129323|NCT01780831|453764938|FG002|Overall Study|Lost to Follow-up|0|||
126129324|NCT01780831|453764939|FG003|Overall Study|Lost to Follow-up|1|||
126129325|NCT02264990|453764942|FG000|Overall Study|Death|255|||
126129326|NCT02264990|453764943|FG001|Overall Study|Death|250|||
126129327|NCT02264990|453764942|FG000|Overall Study|Withdrawal by Subject|4|||
126129328|NCT02264990|453764943|FG001|Overall Study|Withdrawal by Subject|5|||
126129329|NCT02264990|453764942|FG000|Overall Study|Lost to Follow-up|1|||
126129330|NCT02264990|453764943|FG001|Overall Study|Lost to Follow-up|3|||
126129331|NCT02264990|453764942|FG000|Overall Study|Other|0|||
126129332|NCT02264990|453764943|FG001|Overall Study|Other|1|||
126129333|NCT00267748|453764945|FG000|Non-randomized Period|Progressive disease|10|||
126129334|NCT00267748|453764946|FG001|Non-randomized Period|Progressive disease|0|||
126129335|NCT00267748|453764947|FG002|Non-randomized Period|Progressive disease|0|||
126129336|NCT00267748|453764945|FG000|Non-randomized Period|Adverse Event|8|||
126129337|NCT00267748|453764946|FG001|Non-randomized Period|Adverse Event|0|||
126129338|NCT00267748|453764947|FG002|Non-randomized Period|Adverse Event|0|||
126129339|NCT00267748|453764945|FG000|Non-randomized Period|Death|1|||
126129340|NCT00267748|453764946|FG001|Non-randomized Period|Death|0|||
126129341|NCT00267748|453764947|FG002|Non-randomized Period|Death|0|||
126129342|NCT00267748|453764945|FG000|Non-randomized Period|Participant not willing to participate|1|||
126129343|NCT00267748|453764946|FG001|Non-randomized Period|Participant not willing to participate|0|||
126129344|NCT00267748|453764947|FG002|Non-randomized Period|Participant not willing to participate|0|||
126129345|NCT00267748|453764945|FG000|Non-randomized Period|Other|3|||
126129346|NCT00267748|453764946|FG001|Non-randomized Period|Other|0|||
126129347|NCT00267748|453764947|FG002|Non-randomized Period|Other|0|||
126129348|NCT00267748|453764945|FG000|Randomized Period|Death|0|||
126129349|NCT00267748|453764946|FG001|Randomized Period|Death|2|||
126129350|NCT00267748|453764947|FG002|Randomized Period|Death|3|||
126129351|NCT00267748|453764945|FG000|Randomized Period|Adverse Event|0|||
126129352|NCT00267748|453764946|FG001|Randomized Period|Adverse Event|23|||
126129353|NCT00267748|453764947|FG002|Randomized Period|Adverse Event|25|||
126129354|NCT00267748|453764945|FG000|Randomized Period|Global deterioration of health status|0|||
126129355|NCT00267748|453764946|FG001|Randomized Period|Global deterioration of health status|6|||
126129356|NCT00267748|453764947|FG002|Randomized Period|Global deterioration of health status|7|||
126129357|NCT00267748|453764945|FG000|Randomized Period|Lost to Follow-up|0|||
126129358|NCT00267748|453764946|FG001|Randomized Period|Lost to Follow-up|1|||
126129359|NCT00267748|453764947|FG002|Randomized Period|Lost to Follow-up|0|||
126129360|NCT00267748|453764945|FG000|Randomized Period|Objective progression or relapse|0|||
126129361|NCT00267748|453764946|FG001|Randomized Period|Objective progression or relapse|77|||
126129362|NCT00267748|453764947|FG002|Randomized Period|Objective progression or relapse|86|||
126129363|NCT00267748|453764945|FG000|Randomized Period|Withdrawal by Subject|0|||
126129364|NCT00267748|453764946|FG001|Randomized Period|Withdrawal by Subject|9|||
126129365|NCT00267748|453764947|FG002|Randomized Period|Withdrawal by Subject|2|||
126129366|NCT00267748|453764945|FG000|Randomized Period|Other|0|||
126129367|NCT00267748|453764946|FG001|Randomized Period|Other|9|||
126129368|NCT00267748|453764947|FG002|Randomized Period|Other|6|||
126129369|NCT00267748|453764945|FG000|Randomized Period|randomized but not treated|0|||
126129370|NCT00267748|453764946|FG001|Randomized Period|randomized but not treated|0|||
126129371|NCT00267748|453764947|FG002|Randomized Period|randomized but not treated|3|||
126129372|NCT01294800|453764948|FG000|Overall Study|Adverse Event|7|||
126129373|NCT01294800|453764949|FG001|Overall Study|Adverse Event|6|||
126129374|NCT01294800|453764950|FG002|Overall Study|Adverse Event|12|||
126129375|NCT01294800|453764951|FG003|Overall Study|Adverse Event|5|||
126129376|NCT01294800|453764948|FG000|Overall Study|Subject Withdrew Consent|2|||
126129377|NCT01294800|453764949|FG001|Overall Study|Subject Withdrew Consent|2|||
126129378|NCT01294800|453764950|FG002|Overall Study|Subject Withdrew Consent|2|||
126129379|NCT01294800|453764951|FG003|Overall Study|Subject Withdrew Consent|11|||
126129380|NCT01294800|453764948|FG000|Overall Study|Lost to Follow-up|0|||
126129381|NCT01294800|453764949|FG001|Overall Study|Lost to Follow-up|0|||
126129382|NCT01294800|453764950|FG002|Overall Study|Lost to Follow-up|1|||
126129383|NCT01294800|453764951|FG003|Overall Study|Lost to Follow-up|0|||
126129384|NCT01294800|453764948|FG000|Overall Study|Non-compliance With Protocol|0|||
126129385|NCT01294800|453764949|FG001|Overall Study|Non-compliance With Protocol|1|||
126129386|NCT01294800|453764950|FG002|Overall Study|Non-compliance With Protocol|1|||
126129387|NCT01294800|453764951|FG003|Overall Study|Non-compliance With Protocol|0|||
126129388|NCT01294800|453764948|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
126129389|NCT01294800|453764949|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
126129390|NCT01294800|453764950|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
126129391|NCT01294800|453764951|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
126129392|NCT01662895|453764954|FG000|Overall Study|Lost to Follow-up|0|||
126129393|NCT01662895|453764955|FG001|Overall Study|Lost to Follow-up|1|||
126129394|NCT00797732|453764959|FG000|Overall Study|Withdrawal by Subject|3|||
126129395|NCT00797732|453764960|FG001|Overall Study|Withdrawal by Subject|3|||
126129396|NCT00797732|453764961|FG002|Overall Study|Withdrawal by Subject|0|||
126129397|NCT00797732|453764959|FG000|Overall Study|Lost to Follow-up|1|||
126129398|NCT00797732|453764960|FG001|Overall Study|Lost to Follow-up|0|||
126129399|NCT00797732|453764961|FG002|Overall Study|Lost to Follow-up|0|||
126129400|NCT00797732|453764959|FG000|Overall Study|Death|1|||
126129401|NCT00797732|453764960|FG001|Overall Study|Death|0|||
126129402|NCT00797732|453764961|FG002|Overall Study|Death|0|||
126129403|NCT00797732|453764959|FG000|Overall Study|Not meet inclusion criteria|0|||
126129404|NCT00797732|453764960|FG001|Overall Study|Not meet inclusion criteria|0|||
126129405|NCT00797732|453764961|FG002|Overall Study|Not meet inclusion criteria|7|||
126129406|NCT00797732|453764959|FG000|Overall Study|Excluded due to time constraints|0|||
126129407|NCT00797732|453764960|FG001|Overall Study|Excluded due to time constraints|0|||
126129408|NCT00797732|453764961|FG002|Overall Study|Excluded due to time constraints|24|||
126129409|NCT00797732|453764959|FG000|Overall Study|Refused to Participate|0|||
126129410|NCT00797732|453764960|FG001|Overall Study|Refused to Participate|0|||
126129411|NCT00797732|453764961|FG002|Overall Study|Refused to Participate|123|||
126129412|NCT00401752|453764964|FG000|Overall Study|Adverse Event|2|||
126129413|NCT00401752|453764965|FG001|Overall Study|Adverse Event|5|||
126129414|NCT00401752|453764964|FG000|Overall Study|Withdrawal by Subject|2|||
126129415|NCT00401752|453764965|FG001|Overall Study|Withdrawal by Subject|6|||
126129416|NCT00401752|453764964|FG000|Overall Study|Lost to Follow-up|1|||
126129417|NCT00401752|453764965|FG001|Overall Study|Lost to Follow-up|4|||
126129418|NCT00401752|453764964|FG000|Overall Study|Development of any exclusion criteria|4|||
126129419|NCT00401752|453764965|FG001|Overall Study|Development of any exclusion criteria|2|||
126129420|NCT00401752|453764964|FG000|Overall Study|Physician Decision|1|||
126129421|NCT00401752|453764965|FG001|Overall Study|Physician Decision|1|||
126129422|NCT01895322|453764966|FG000|Overall Study|Adverse Event|1|||
126129423|NCT01895322|453764966|FG000|Overall Study|Withdrawal by Subject|2|||
126129424|NCT01895322|453764966|FG000|Overall Study|Protocol Violation|10|||
126129425|NCT02275338|453764967|FG000|Overall Study|Adverse Event|15|||
126129426|NCT02275338|453764967|FG000|Overall Study|Lack of Efficacy|3|||
126129427|NCT02275338|453764967|FG000|Overall Study|Withdrawal by Subject|4|||
126129428|NCT02275338|453764967|FG000|Overall Study|Disease progression (death)|1|||
126129429|NCT02275338|453764967|FG000|Overall Study|Ineligible to start Phase 2|4|||
126129430|NCT02275338|453764967|FG000|Overall Study|Reason not specified|5|||
126129431|NCT02275338|453764967|FG000|Overall Study|Does not meet entry criteria|1|||
126129432|NCT04607733|453764973|FG000|Overall Study|Lost to Follow-up|1|||
126129433|NCT04607733|453764974|FG001|Overall Study|Lost to Follow-up|0|||
126129434|NCT04607733|453764975|FG002|Overall Study|Lost to Follow-up|0|||
126129435|NCT04607733|453764976|FG003|Overall Study|Lost to Follow-up|1|||
126129436|NCT04607733|453764977|FG004|Overall Study|Lost to Follow-up|1|||
126129437|NCT04607733|453764978|FG005|Overall Study|Lost to Follow-up|0|||
126129438|NCT04607733|453764973|FG000|Overall Study|Withdrawal by Subject|0|||
126129439|NCT04607733|453764974|FG001|Overall Study|Withdrawal by Subject|0|||
126129440|NCT04607733|453764975|FG002|Overall Study|Withdrawal by Subject|0|||
126129441|NCT04607733|453764976|FG003|Overall Study|Withdrawal by Subject|0|||
126129442|NCT04607733|453764977|FG004|Overall Study|Withdrawal by Subject|1|||
126129443|NCT04607733|453764978|FG005|Overall Study|Withdrawal by Subject|0|||
126129444|NCT01827670|453764979|FG000|Overall Study|Withdrawal of Consent|3|||
126129445|NCT01827670|453764980|FG001|Overall Study|Withdrawal of Consent|2|||
126129446|NCT01827670|453764979|FG000|Overall Study|Lost to Follow-up|0|||
126129447|NCT01827670|453764980|FG001|Overall Study|Lost to Follow-up|1|||
126129448|NCT03603496|453764987|FG000|Overall Study|Death|19|||
126129449|NCT03603496|453764988|FG001|Overall Study|Death|24|||
126129450|NCT03603496|453764987|FG000|Overall Study|Lost to Follow-up|141|||
126129451|NCT03603496|453764988|FG001|Overall Study|Lost to Follow-up|141|||
126129452|NCT03603496|453764987|FG000|Overall Study|Withdrawal by Subject|26|||
126129453|NCT03603496|453764988|FG001|Overall Study|Withdrawal by Subject|20|||
126129454|NCT00774345|453764989|FG000|Pre-treatment|Other reasons|2|||
126129455|NCT00774345|453764990|FG001|Pre-treatment|Other reasons|0|||
126129456|NCT00774345|453764989|FG000|Treatment|Adverse Event|61|||
126129457|NCT00774345|453764990|FG001|Treatment|Adverse Event|15|||
126129458|NCT00774345|453764989|FG000|Treatment|Progressive Disease without histologic transformation|51|||
126129459|NCT00774345|453764990|FG001|Treatment|Progressive Disease without histologic transformation|111|||
126129460|NCT00774345|453764989|FG000|Treatment|Progressive Disease with histologic transformation|4|||
126129461|NCT00774345|453764990|FG001|Treatment|Progressive Disease with histologic transformation|2|||
126129462|NCT00774345|453764989|FG000|Treatment|Withdrawal by Subject|5|||
126129463|NCT00774345|453764990|FG001|Treatment|Withdrawal by Subject|2|||
126129464|NCT00774345|453764989|FG000|Treatment|Lost to Follow-up|1|||
126129465|NCT00774345|453764990|FG001|Treatment|Lost to Follow-up|1|||
126129466|NCT00774345|453764989|FG000|Treatment|Death|4|||
126129467|NCT00774345|453764990|FG001|Treatment|Death|0|||
126129468|NCT00774345|453764989|FG000|Treatment|Other Reasons|32|||
126129469|NCT00774345|453764990|FG001|Treatment|Other Reasons|26|||
126129470|NCT00835237|453764991|FG000|Overall Study|Lost to Follow-up|4|||
126129471|NCT00835237|453764992|FG001|Overall Study|Lost to Follow-up|0|||
126129472|NCT00835237|453764991|FG000|Overall Study|Withdrawal by Subject|2|||
126129473|NCT00835237|453764992|FG001|Overall Study|Withdrawal by Subject|0|||
126129474|NCT01265550|453764993|FG000|Pre Randomization|Withdrawal by Subject|0|||
126129475|NCT01265550|453764994|FG001|Pre Randomization|Withdrawal by Subject|0|||
126129476|NCT01265550|453764995|FG002|Pre Randomization|Withdrawal by Subject|0|||
126129477|NCT01265550|453764996|FG003|Pre Randomization|Withdrawal by Subject|70|||
126129478|NCT01265550|453764993|FG000|Pre Randomization|Technical Exclusions|0|||
126129479|NCT01265550|453764994|FG001|Pre Randomization|Technical Exclusions|0|||
126129480|NCT01265550|453764995|FG002|Pre Randomization|Technical Exclusions|0|||
126129481|NCT01265550|453764996|FG003|Pre Randomization|Technical Exclusions|54|||
126129482|NCT01265550|453764993|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
126129483|NCT01265550|453764994|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
126129484|NCT01265550|453764995|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
126129485|NCT01265550|453764996|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
126129486|NCT01265550|453764993|FG000|Pre Randomization|Non-GERD organic disorders|0|||
126129487|NCT01265550|453764994|FG001|Pre Randomization|Non-GERD organic disorders|0|||
126129488|NCT01265550|453764995|FG002|Pre Randomization|Non-GERD organic disorders|0|||
126129489|NCT01265550|453764996|FG003|Pre Randomization|Non-GERD organic disorders|23|||
126129490|NCT01265550|453764993|FG000|Pre Randomization|Functional heartburn|0|||
126129491|NCT01265550|453764994|FG001|Pre Randomization|Functional heartburn|0|||
126129492|NCT01265550|453764995|FG002|Pre Randomization|Functional heartburn|0|||
126129493|NCT01265550|453764996|FG003|Pre Randomization|Functional heartburn|99|||
126129494|NCT00623428|453764999|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
126129495|NCT00623428|453765000|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
126129496|NCT00623428|453764999|FG000|Treatment Period|Death|0|||
126129497|NCT00623428|453765000|FG001|Treatment Period|Death|1|||
126129498|NCT00623428|453764999|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
126129499|NCT00623428|453765000|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
126129500|NCT00623428|453764999|FG000|Treatment Period|Insufficient therapeutic response|0|||
126129501|NCT00623428|453765000|FG001|Treatment Period|Insufficient therapeutic response|2|||
126129502|NCT00623428|453764999|FG000|Treatment Period|Other|0|||
126129503|NCT00623428|453765000|FG001|Treatment Period|Other|1|||
126129504|NCT00623428|453764999|FG000|Treatment Period|Withdrawal by Subject|0|||
126129505|NCT00623428|453765000|FG001|Treatment Period|Withdrawal by Subject|1|||
126129506|NCT00623428|453764999|FG000|Follow-up Period|Relapse post-treatment|11|||
126129507|NCT00623428|453765000|FG001|Follow-up Period|Relapse post-treatment|3|||
126129508|NCT00623428|453764999|FG000|Follow-up Period|Failure to return|10|||
126129509|NCT00623428|453765000|FG001|Follow-up Period|Failure to return|2|||
126129510|NCT00623428|453764999|FG000|Follow-up Period|Patient withdrew consent|5|||
126129511|NCT00623428|453765000|FG001|Follow-up Period|Patient withdrew consent|4|||
126129512|NCT00623428|453764999|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
126129513|NCT00623428|453765000|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
126129514|NCT00623428|453764999|FG000|Follow-up Period|Did not cooperate|0|||
126129515|NCT00623428|453765000|FG001|Follow-up Period|Did not cooperate|3|||
126129516|NCT00623428|453764999|FG000|Follow-up Period|Reason not specified|1|||
126129517|NCT00623428|453765000|FG001|Follow-up Period|Reason not specified|1|||
126129518|NCT00623428|453764999|FG000|Follow-up Period|Death|0|||
126129519|NCT00623428|453765000|FG001|Follow-up Period|Death|1|||
126129520|NCT01929408|453765004|FG000|Overall Study|received HCT as initial treatment|8|||
126129521|NCT00293579|453765005|FG000|Overall Study|Withdrawal by Subject|1|||
126129522|NCT03127384|453765006|FG000|Overall Study|Lost to Follow-up|4|||
126129523|NCT03127384|453765006|FG000|Overall Study|Subject request|2|||
126129524|NCT02703311|453765008|FG000|Overall Study|Death|5|||
126129525|NCT02703311|453765008|FG000|Overall Study|Withdrawal by Subject|3|||
126129526|NCT02069899|453765009|FG000|Overall Study|Adverse Event|6|||
126129527|NCT02069899|453765010|FG001|Overall Study|Adverse Event|0|||
126129528|NCT02069899|453765011|FG002|Overall Study|Adverse Event|1|||
126129529|NCT02069899|453765009|FG000|Overall Study|Withdrawal by Participant|2|||
126129530|NCT02069899|453765010|FG001|Overall Study|Withdrawal by Participant|0|||
126129531|NCT02069899|453765011|FG002|Overall Study|Withdrawal by Participant|0|||
126129532|NCT02069899|453765009|FG000|Overall Study|Lost to Follow-up|1|||
126129533|NCT02069899|453765010|FG001|Overall Study|Lost to Follow-up|0|||
126129534|NCT02069899|453765011|FG002|Overall Study|Lost to Follow-up|1|||
126129535|NCT02069899|453765009|FG000|Overall Study|Other|4|||
126129536|NCT02069899|453765010|FG001|Overall Study|Other|0|||
126129537|NCT02069899|453765011|FG002|Overall Study|Other|0|||
126129538|NCT02069899|453765009|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
126129539|NCT02069899|453765010|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
126129540|NCT02069899|453765011|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
126129541|NCT02069899|453765009|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
126129542|NCT02069899|453765010|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
126129543|NCT02069899|453765011|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
126129544|NCT01026831|453765014|FG000|Overall Study|Adverse Event|4|||
126129545|NCT01026831|453765015|FG001|Overall Study|Adverse Event|3|||
126129546|NCT01026831|453765014|FG000|Overall Study|Lost to Follow-up|2|||
126129547|NCT01026831|453765015|FG001|Overall Study|Lost to Follow-up|0|||
126129548|NCT01026831|453765014|FG000|Overall Study|Physician Decision|1|||
126129549|NCT01026831|453765015|FG001|Overall Study|Physician Decision|1|||
126129550|NCT01026831|453765014|FG000|Overall Study|Protocol Violation|0|||
126129551|NCT01026831|453765015|FG001|Overall Study|Protocol Violation|2|||
126129552|NCT01026831|453765014|FG000|Overall Study|Withdrawal by Subject|7|||
126129553|NCT01026831|453765015|FG001|Overall Study|Withdrawal by Subject|5|||
126129554|NCT04417894|453765016|FG000|Overall Study|Lost to Follow-up|3|||
126129555|NCT04417894|453765017|FG001|Overall Study|Lost to Follow-up|0|||
126129556|NCT04417894|453765016|FG000|Overall Study|Withdrawal by Subject|7|||
126129557|NCT04417894|453765017|FG001|Overall Study|Withdrawal by Subject|6|||
126129558|NCT04417894|453765016|FG000|Overall Study|Lack of Efficacy|3|||
126129559|NCT04417894|453765017|FG001|Overall Study|Lack of Efficacy|1|||
126129560|NCT00262873|453765020|FG000|Overall Study|Adverse Event|3|||
126129561|NCT00262873|453765020|FG000|Overall Study|Withdrawal by Subject|5|||
126129562|NCT00844753|453765021|FG000|Overall Study|Lack of Efficacy|1|||
126129563|NCT00844753|453765022|FG001|Overall Study|Lack of Efficacy|0|||
126129564|NCT00844753|453765023|FG002|Overall Study|Lack of Efficacy|2|||
126129565|NCT00844753|453765024|FG003|Overall Study|Lack of Efficacy|2|||
126129566|NCT00844753|453765021|FG000|Overall Study|Adverse Event|3|||
126129567|NCT00844753|453765022|FG001|Overall Study|Adverse Event|2|||
126129568|NCT00844753|453765023|FG002|Overall Study|Adverse Event|5|||
126129569|NCT00844753|453765024|FG003|Overall Study|Adverse Event|5|||
126129570|NCT00844753|453765021|FG000|Overall Study|Lost to Follow-up|1|||
126129571|NCT00844753|453765022|FG001|Overall Study|Lost to Follow-up|1|||
126129572|NCT00844753|453765023|FG002|Overall Study|Lost to Follow-up|0|||
126129573|NCT00844753|453765024|FG003|Overall Study|Lost to Follow-up|1|||
126129574|NCT00844753|453765021|FG000|Overall Study|could not swallow medication|2|||
126129575|NCT00844753|453765022|FG001|Overall Study|could not swallow medication|0|||
126129576|NCT00844753|453765023|FG002|Overall Study|could not swallow medication|0|||
126129577|NCT00844753|453765024|FG003|Overall Study|could not swallow medication|0|||
126129578|NCT00844753|453765021|FG000|Overall Study|Withdrawal by Subject|1|||
126129579|NCT00844753|453765022|FG001|Overall Study|Withdrawal by Subject|0|||
126129580|NCT00844753|453765023|FG002|Overall Study|Withdrawal by Subject|0|||
126129581|NCT00844753|453765024|FG003|Overall Study|Withdrawal by Subject|3|||
126129582|NCT02500121|453765027|FG000|Overall Study|Lost to Follow-up|0|||
126129583|NCT02500121|453765028|FG001|Overall Study|Lost to Follow-up|1|||
126129584|NCT02500121|453765027|FG000|Overall Study|Withdrawal by Subject|1|||
126129585|NCT02500121|453765028|FG001|Overall Study|Withdrawal by Subject|1|||
126129586|NCT02500121|453765027|FG000|Overall Study|Death|26|||
126129587|NCT02500121|453765028|FG001|Overall Study|Death|24|||
126129588|NCT03657043|453766679|FG000|Overall Study|Withdrawal by Subject|1|||
126129589|NCT03657043|453766680|FG001|Overall Study|Withdrawal by Subject|1|||
126129590|NCT03657043|453766681|FG002|Overall Study|Withdrawal by Subject|0|||
126129591|NCT03657043|453766682|FG003|Overall Study|Withdrawal by Subject|0|||
126129592|NCT03657043|453766683|FG004|Overall Study|Withdrawal by Subject|4|||
126129593|NCT03657043|453766679|FG000|Overall Study|Study closure by Sponsor|0|||
126129594|NCT03657043|453766680|FG001|Overall Study|Study closure by Sponsor|2|||
126129595|NCT03657043|453766681|FG002|Overall Study|Study closure by Sponsor|0|||
126129596|NCT03657043|453766682|FG003|Overall Study|Study closure by Sponsor|0|||
126129597|NCT03657043|453766683|FG004|Overall Study|Study closure by Sponsor|17|||
126129598|NCT03657043|453766679|FG000|Overall Study|Lost to Follow-up|0|||
126129599|NCT03657043|453766680|FG001|Overall Study|Lost to Follow-up|0|||
126129600|NCT03657043|453766681|FG002|Overall Study|Lost to Follow-up|0|||
126129601|NCT03657043|453766682|FG003|Overall Study|Lost to Follow-up|0|||
126129602|NCT03657043|453766683|FG004|Overall Study|Lost to Follow-up|4|||
125963949|NCT03266588|453159322|FG002|Long-term Treatment Period|Protocol Deviation|4|||
125963950|NCT03266588|453159320|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
126129603|NCT03657043|453766679|FG000|Overall Study|Death|6|||
126129604|NCT03657043|453766680|FG001|Overall Study|Death|5|||
126129605|NCT03657043|453766681|FG002|Overall Study|Death|0|||
126129606|NCT03657043|453766682|FG003|Overall Study|Death|0|||
126129607|NCT03657043|453766683|FG004|Overall Study|Death|53|||
126129608|NCT03657043|453766679|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
126129609|NCT03657043|453766680|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
126129610|NCT03657043|453766681|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
126129611|NCT03657043|453766682|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
126129612|NCT03657043|453766683|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
126129613|NCT03657043|453766679|FG000|Overall Study|Adverse Event|0|||
126129614|NCT03657043|453766680|FG001|Overall Study|Adverse Event|0|||
126129615|NCT03657043|453766681|FG002|Overall Study|Adverse Event|0|||
126129616|NCT03657043|453766682|FG003|Overall Study|Adverse Event|0|||
126129617|NCT03657043|453766683|FG004|Overall Study|Adverse Event|2|||
126129618|NCT03657043|453766679|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
126129619|NCT03657043|453766680|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
126129620|NCT03657043|453766681|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
126129621|NCT03657043|453766682|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
126129622|NCT03657043|453766683|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
126129623|NCT03657043|453766679|FG000|Overall Study|Withdrawal - declined follow-up|0|||
126129624|NCT03657043|453766680|FG001|Overall Study|Withdrawal - declined follow-up|0|||
126129625|NCT03657043|453766681|FG002|Overall Study|Withdrawal - declined follow-up|0|||
126129626|NCT03657043|453766682|FG003|Overall Study|Withdrawal - declined follow-up|0|||
126129627|NCT03657043|453766683|FG004|Overall Study|Withdrawal - declined follow-up|1|||
126129628|NCT02627495|453766686|FG000|Overall Study|Withdrawal by Subject|4|||
126129629|NCT01736579|453766687|FG000|Overall Study|Termination of Study by Sponsor|2|||
126129630|NCT01736579|453766688|FG001|Overall Study|Termination of Study by Sponsor|2|||
126129631|NCT01408147|453766696|FG000|Overall Study|Withdrawal by Subject|0|||
126129632|NCT01408147|453766697|FG001|Overall Study|Withdrawal by Subject|1|||
126129633|NCT01662440|453766698|FG000|Overall Study|Adverse Event|1|||
126129634|NCT01662440|453766699|FG001|Overall Study|Adverse Event|0|||
126129635|NCT01662440|453766700|FG002|Overall Study|Adverse Event|0|||
126129636|NCT01662440|453766701|FG003|Overall Study|Adverse Event|1|||
126129637|NCT01662440|453766698|FG000|Overall Study|Death|0|||
126129638|NCT01662440|453766699|FG001|Overall Study|Death|1|||
126129639|NCT01662440|453766700|FG002|Overall Study|Death|0|||
126129640|NCT01662440|453766701|FG003|Overall Study|Death|0|||
126129641|NCT01662440|453766698|FG000|Overall Study|Lost to Follow-up|2|||
126129642|NCT01662440|453766699|FG001|Overall Study|Lost to Follow-up|2|||
126129643|NCT01662440|453766700|FG002|Overall Study|Lost to Follow-up|4|||
126129644|NCT01662440|453766701|FG003|Overall Study|Lost to Follow-up|1|||
126129645|NCT01662440|453766698|FG000|Overall Study|Subject moved to another country.|0|||
126129646|NCT01662440|453766699|FG001|Overall Study|Subject moved to another country.|1|||
126129647|NCT01662440|453766700|FG002|Overall Study|Subject moved to another country.|0|||
126129648|NCT01662440|453766701|FG003|Overall Study|Subject moved to another country.|0|||
126129649|NCT01662440|453766698|FG000|Overall Study|Protocol Violation|1|||
126129650|NCT01662440|453766699|FG001|Overall Study|Protocol Violation|0|||
126129651|NCT01662440|453766700|FG002|Overall Study|Protocol Violation|0|||
126129652|NCT01662440|453766701|FG003|Overall Study|Protocol Violation|0|||
126129653|NCT01662440|453766698|FG000|Overall Study|Withdrawal by Subject|5|||
126129654|NCT01662440|453766699|FG001|Overall Study|Withdrawal by Subject|2|||
126129655|NCT01662440|453766700|FG002|Overall Study|Withdrawal by Subject|2|||
126129656|NCT01662440|453766701|FG003|Overall Study|Withdrawal by Subject|2|||
126129657|NCT05048719|453766702|FG000|Overall Study|Withdrawal by Subject|2|||
126129658|NCT05048719|453766703|FG001|Overall Study|Withdrawal by Subject|1|||
126129659|NCT05048719|453766704|FG002|Overall Study|Withdrawal by Subject|3|||
126129660|NCT05048719|453766705|FG003|Overall Study|Withdrawal by Subject|1|||
126129661|NCT05048719|453766706|FG004|Overall Study|Withdrawal by Subject|0|||
126129662|NCT05048719|453766707|FG005|Overall Study|Withdrawal by Subject|2|||
126129663|NCT05048719|453766708|FG006|Overall Study|Withdrawal by Subject|1|||
126129664|NCT05048719|453766709|FG007|Overall Study|Withdrawal by Subject|1|||
126129665|NCT05048719|453766710|FG008|Overall Study|Withdrawal by Subject|0|||
126129666|NCT05048719|453766702|FG000|Overall Study|Death|1|||
126129667|NCT05048719|453766703|FG001|Overall Study|Death|0|||
126129668|NCT05048719|453766704|FG002|Overall Study|Death|0|||
126129669|NCT05048719|453766705|FG003|Overall Study|Death|0|||
126129670|NCT05048719|453766706|FG004|Overall Study|Death|0|||
125963951|NCT03266588|453159321|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
125963952|NCT03266588|453159322|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
125963953|NCT03266588|453159320|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
125963954|NCT03266588|453159321|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
125963955|NCT03266588|453159322|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
126129671|NCT05048719|453766707|FG005|Overall Study|Death|0|||
126088314|NCT00895895|453617100|FG000|Period 1|randomized and not treated|1|||
126088315|NCT00895895|453617101|FG001|Period 1|randomized and not treated|3|||
126088316|NCT00895895|453617102|FG002|Period 1|randomized and not treated|1|||
126088317|NCT00895895|453617103|FG003|Period 1|randomized and not treated|1|||
126088318|NCT00895895|453617104|FG004|Period 1|randomized and not treated|2|||
126088319|NCT00895895|453617100|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
126088320|NCT00895895|453617101|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
126088321|NCT00895895|453617102|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
126088322|NCT00895895|453617103|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
126088323|NCT00895895|453617104|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
125963956|NCT03266588|453159320|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
125963957|NCT03266588|453159321|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
125963958|NCT03266588|453159322|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
125963959|NCT03266588|453159320|FG000|Long-term Treatment Period|Other Reasons|5|||
125963960|NCT03266588|453159321|FG001|Long-term Treatment Period|Other Reasons|0|||
125963961|NCT03266588|453159322|FG002|Long-term Treatment Period|Other Reasons|0|||
125963962|NCT03266588|453159320|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
125963963|NCT03266588|453159321|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
125963964|NCT03266588|453159322|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
125963965|NCT02627677|453159324|FG000|Overall Study|Adverse event (not progressive disease)|1|||
125963966|NCT02627677|453159325|FG001|Overall Study|Adverse event (not progressive disease)|4|||
125963967|NCT02627677|453159326|FG002|Overall Study|Adverse event (not progressive disease)|1|||
125963968|NCT02627677|453159324|FG000|Overall Study|Progressive disease|1|||
125963969|NCT02627677|453159325|FG001|Overall Study|Progressive disease|3|||
125963970|NCT02627677|453159326|FG002|Overall Study|Progressive disease|0|||
125963971|NCT02627677|453159324|FG000|Overall Study|Lack of Efficacy|1|||
125963972|NCT02627677|453159325|FG001|Overall Study|Lack of Efficacy|2|||
125963973|NCT02627677|453159326|FG002|Overall Study|Lack of Efficacy|0|||
125963974|NCT02627677|453159324|FG000|Overall Study|Lost to Follow-up|0|||
125963975|NCT02627677|453159325|FG001|Overall Study|Lost to Follow-up|0|||
125963976|NCT02627677|453159326|FG002|Overall Study|Lost to Follow-up|1|||
125963977|NCT02627677|453159324|FG000|Overall Study|Pregnancy|0|||
125963978|NCT02627677|453159325|FG001|Overall Study|Pregnancy|1|||
125963979|NCT02627677|453159326|FG002|Overall Study|Pregnancy|0|||
125963980|NCT02627677|453159324|FG000|Overall Study|Study Terminated by Sponsor|5|||
125963981|NCT02627677|453159325|FG001|Overall Study|Study Terminated by Sponsor|10|||
125963982|NCT02627677|453159326|FG002|Overall Study|Study Terminated by Sponsor|6|||
125963983|NCT02627677|453159324|FG000|Overall Study|Physician Decision|0|||
125963984|NCT02627677|453159325|FG001|Overall Study|Physician Decision|0|||
125963985|NCT02627677|453159326|FG002|Overall Study|Physician Decision|2|||
125963986|NCT02627677|453159324|FG000|Overall Study|Withdrawal by Subject|2|||
125963987|NCT02627677|453159325|FG001|Overall Study|Withdrawal by Subject|1|||
125963988|NCT02627677|453159326|FG002|Overall Study|Withdrawal by Subject|1|||
125963989|NCT02627677|453159324|FG000|Overall Study|Reason not Specified|0|||
125963990|NCT02627677|453159325|FG001|Overall Study|Reason not Specified|0|||
125963991|NCT02627677|453159326|FG002|Overall Study|Reason not Specified|1|||
125963992|NCT02627677|453159324|FG000|Overall Study|Randomized but not Treated|1|||
125963993|NCT02627677|453159325|FG001|Overall Study|Randomized but not Treated|0|||
125963994|NCT02627677|453159326|FG002|Overall Study|Randomized but not Treated|0|||
125963995|NCT00966940|453159327|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
125963996|NCT00966940|453159328|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
125963997|NCT00966940|453159327|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
125963998|NCT00966940|453159328|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
125963999|NCT01073618|453159329|FG000|Overall Study|Death|208|||
125964000|NCT01073618|453159329|FG000|Overall Study|Adverse Event|19|||
125964001|NCT01073618|453159329|FG000|Overall Study|Other|80|||
125964002|NCT02032901|453159332|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
125964003|NCT02032901|453159333|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
125964004|NCT02032901|453159332|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
126088324|NCT00895895|453617100|FG000|After Period 1, Prior to Period 2|Other|0|||
126088325|NCT00895895|453617101|FG001|After Period 1, Prior to Period 2|Other|0|||
126088326|NCT00895895|453617102|FG002|After Period 1, Prior to Period 2|Other|1|||
125964005|NCT02032901|453159333|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
125964006|NCT00982020|453159334|FG000|Overall Study|Adverse Event|19|||
125964007|NCT00982020|453159335|FG001|Overall Study|Adverse Event|15|||
125964008|NCT00982020|453159334|FG000|Overall Study|Withdrawal by Subject|11|||
126088327|NCT00895895|453617103|FG003|After Period 1, Prior to Period 2|Other|0|||
125964009|NCT00982020|453159335|FG001|Overall Study|Withdrawal by Subject|14|||
125964010|NCT00982020|453159334|FG000|Overall Study|Lost to Follow-up|5|||
125964011|NCT00982020|453159335|FG001|Overall Study|Lost to Follow-up|11|||
126088328|NCT00895895|453617104|FG004|After Period 1, Prior to Period 2|Other|0|||
126129672|NCT05048719|453766708|FG006|Overall Study|Death|0|||
125964012|NCT00982020|453159334|FG000|Overall Study|Lack of Efficacy|10|||
125964013|NCT00982020|453159335|FG001|Overall Study|Lack of Efficacy|4|||
125964014|NCT00982020|453159334|FG000|Overall Study|Parent/Caregiver Decision|5|||
126129673|NCT05048719|453766709|FG007|Overall Study|Death|0|||
126129674|NCT05048719|453766710|FG008|Overall Study|Death|0|||
126129675|NCT05048719|453766702|FG000|Overall Study|Adverse Event|0|||
126129676|NCT05048719|453766703|FG001|Overall Study|Adverse Event|1|||
126129677|NCT05048719|453766704|FG002|Overall Study|Adverse Event|2|||
126129678|NCT05048719|453766705|FG003|Overall Study|Adverse Event|0|||
126129679|NCT05048719|453766706|FG004|Overall Study|Adverse Event|1|||
126129680|NCT05048719|453766707|FG005|Overall Study|Adverse Event|0|||
126129681|NCT05048719|453766708|FG006|Overall Study|Adverse Event|0|||
126129682|NCT05048719|453766709|FG007|Overall Study|Adverse Event|0|||
126129683|NCT05048719|453766710|FG008|Overall Study|Adverse Event|0|||
126129684|NCT05048719|453766702|FG000|Overall Study|Lost to Follow-up|0|||
126129685|NCT05048719|453766703|FG001|Overall Study|Lost to Follow-up|0|||
126129686|NCT05048719|453766704|FG002|Overall Study|Lost to Follow-up|1|||
126129687|NCT05048719|453766705|FG003|Overall Study|Lost to Follow-up|3|||
126129688|NCT05048719|453766706|FG004|Overall Study|Lost to Follow-up|1|||
126129689|NCT05048719|453766707|FG005|Overall Study|Lost to Follow-up|1|||
126129690|NCT05048719|453766708|FG006|Overall Study|Lost to Follow-up|1|||
126129691|NCT05048719|453766709|FG007|Overall Study|Lost to Follow-up|1|||
126129692|NCT05048719|453766710|FG008|Overall Study|Lost to Follow-up|0|||
126129693|NCT05048719|453766702|FG000|Overall Study|Physician Decision|0|||
126129694|NCT05048719|453766703|FG001|Overall Study|Physician Decision|0|||
126129695|NCT05048719|453766704|FG002|Overall Study|Physician Decision|0|||
126129696|NCT05048719|453766705|FG003|Overall Study|Physician Decision|0|||
126129697|NCT05048719|453766706|FG004|Overall Study|Physician Decision|0|||
126129698|NCT05048719|453766707|FG005|Overall Study|Physician Decision|0|||
126129699|NCT05048719|453766708|FG006|Overall Study|Physician Decision|0|||
126129700|NCT05048719|453766709|FG007|Overall Study|Physician Decision|1|||
126129701|NCT05048719|453766710|FG008|Overall Study|Physician Decision|1|||
126129702|NCT05048719|453766702|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
126129703|NCT05048719|453766703|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126129704|NCT05048719|453766704|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126129705|NCT05048719|453766705|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126129706|NCT05048719|453766706|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126129707|NCT05048719|453766707|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126129708|NCT05048719|453766708|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126129709|NCT05048719|453766709|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126129710|NCT05048719|453766710|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126129711|NCT05048719|453766702|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126129712|NCT05048719|453766703|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
126129713|NCT05048719|453766704|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126129714|NCT05048719|453766705|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126129715|NCT05048719|453766706|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126129716|NCT05048719|453766707|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126129717|NCT05048719|453766708|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126129718|NCT05048719|453766709|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126129719|NCT05048719|453766710|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126129720|NCT05048719|453766702|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126129721|NCT05048719|453766703|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
126129722|NCT05048719|453766704|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126129723|NCT05048719|453766705|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126129724|NCT05048719|453766706|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126129725|NCT05048719|453766707|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126129726|NCT05048719|453766708|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126129727|NCT05048719|453766709|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126129728|NCT05048719|453766710|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126129729|NCT05048719|453766702|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126129730|NCT05048719|453766703|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126129731|NCT05048719|453766704|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126129732|NCT05048719|453766705|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
126129733|NCT05048719|453766706|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126129734|NCT05048719|453766707|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126129735|NCT05048719|453766708|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126129736|NCT05048719|453766709|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126129737|NCT05048719|453766710|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126129738|NCT05048719|453766702|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126129739|NCT05048719|453766703|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126129740|NCT05048719|453766704|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126129741|NCT05048719|453766705|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126129742|NCT05048719|453766706|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126129743|NCT05048719|453766707|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
126129744|NCT05048719|453766708|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126129745|NCT05048719|453766709|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126129746|NCT05048719|453766710|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126129747|NCT04541004|453766711|FG000|Overall Study|Adverse Event|2|||
126129748|NCT02229552|453766713|FG000|Baseline|Withdrawal by Subject|6|||
126129749|NCT02229552|453766713|FG000|1-year Follow up|Withdrawal by Subject|7|||
126129750|NCT02229552|453766713|FG000|1-year Follow up|Lost to Follow-up|18|||
126129751|NCT02229552|453766713|FG000|2-Year Follow up|Withdrawal by Subject|9|||
126129752|NCT02229552|453766713|FG000|2-Year Follow up|Lost to Follow-up|17|||
126129753|NCT04872101|453766714|FG000|Overall Study|Withdrawal by Subject|10|||
126129754|NCT04872101|453766715|FG001|Overall Study|Withdrawal by Subject|16|||
126129755|NCT04872101|453766714|FG000|Overall Study|Lack of Efficacy|6|||
126129756|NCT04872101|453766715|FG001|Overall Study|Lack of Efficacy|14|||
126129757|NCT04872101|453766714|FG000|Overall Study|Adverse Event|1|||
126129758|NCT04872101|453766715|FG001|Overall Study|Adverse Event|6|||
126129759|NCT04872101|453766714|FG000|Overall Study|Lost to Follow-up|2|||
126129760|NCT04872101|453766715|FG001|Overall Study|Lost to Follow-up|1|||
126129761|NCT04872101|453766714|FG000|Overall Study|Pregnancy|2|||
126129762|NCT04872101|453766715|FG001|Overall Study|Pregnancy|0|||
126129763|NCT04872101|453766714|FG000|Overall Study|Prohibited Medication|1|||
126129764|NCT04872101|453766715|FG001|Overall Study|Prohibited Medication|0|||
126129765|NCT04872101|453766714|FG000|Overall Study|Not dosed|1|||
126129766|NCT04872101|453766715|FG001|Overall Study|Not dosed|0|||
126129767|NCT00971945|453766716|FG000|Overall Study|Progressive Disease|3|||
126129768|NCT00971945|453766716|FG000|Overall Study|Change in treatment policy|1|||
126129769|NCT00971945|453766716|FG000|Overall Study|Other reasons|2|||
126129770|NCT03354663|453766717|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
126129771|NCT03354663|453766717|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
126129772|NCT03354663|453766717|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
126129773|NCT03354663|453766717|FG000|Completed 30-day Visit|Missed Visit|1|||
126129774|NCT03691974|453766718|FG000|Overall Study|Physician Decision|1|||
126129775|NCT03691974|453766719|FG001|Overall Study|Physician Decision|0|||
126129776|NCT03691974|453766718|FG000|Overall Study|Adverse Event|1|||
126129777|NCT03691974|453766719|FG001|Overall Study|Adverse Event|0|||
126129778|NCT03691974|453766718|FG000|Overall Study|Withdrawal by Subject|11|||
126129779|NCT03691974|453766719|FG001|Overall Study|Withdrawal by Subject|9|||
126129780|NCT03691974|453766718|FG000|Overall Study|Protocol Violation|1|||
126129781|NCT03691974|453766719|FG001|Overall Study|Protocol Violation|0|||
126129782|NCT03691974|453766718|FG000|Overall Study|Lost to Follow-up|8|||
126129783|NCT03691974|453766719|FG001|Overall Study|Lost to Follow-up|7|||
126129784|NCT01661140|453766720|FG000|Open-Label Period|Adverse Event|44|||
126129785|NCT01661140|453766721|FG001|Open-Label Period|Adverse Event|0|||
126129786|NCT01661140|453766722|FG002|Open-Label Period|Adverse Event|0|||
126129787|NCT01661140|453766720|FG000|Open-Label Period|Protocol Violation|3|||
126129788|NCT01661140|453766721|FG001|Open-Label Period|Protocol Violation|0|||
126129789|NCT01661140|453766722|FG002|Open-Label Period|Protocol Violation|0|||
126129790|NCT01661140|453766720|FG000|Open-Label Period|Withdrawal by Subject|5|||
126129791|NCT01661140|453766721|FG001|Open-Label Period|Withdrawal by Subject|0|||
126129792|NCT01661140|453766722|FG002|Open-Label Period|Withdrawal by Subject|0|||
126129793|NCT01661140|453766720|FG000|Open-Label Period|Investigator Decision|3|||
126129794|NCT01661140|453766721|FG001|Open-Label Period|Investigator Decision|0|||
126129795|NCT01661140|453766722|FG002|Open-Label Period|Investigator Decision|0|||
126129796|NCT01661140|453766720|FG000|Open-Label Period|Death|1|||
125964015|NCT00982020|453159335|FG001|Overall Study|Parent/Caregiver Decision|5|||
125964016|NCT00982020|453159334|FG000|Overall Study|Treatment Non-compliance|3|||
126129797|NCT01661140|453766721|FG001|Open-Label Period|Death|0|||
126129798|NCT01661140|453766722|FG002|Open-Label Period|Death|0|||
126129799|NCT01661140|453766720|FG000|Open-Label Period|Administrative/Other|1|||
126129800|NCT01661140|453766721|FG001|Open-Label Period|Administrative/Other|0|||
126129801|NCT01661140|453766722|FG002|Open-Label Period|Administrative/Other|0|||
126129802|NCT01661140|453766720|FG000|Open-Label Period|Sponsor termination|16|||
126129803|NCT01661140|453766721|FG001|Open-Label Period|Sponsor termination|0|||
126129804|NCT01661140|453766722|FG002|Open-Label Period|Sponsor termination|0|||
126129805|NCT01661140|453766720|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
126129806|NCT01661140|453766721|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
126129807|NCT01661140|453766722|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
126129808|NCT01661140|453766720|FG000|Open-Label Period|Lost to Follow-up|2|||
126129809|NCT01661140|453766721|FG001|Open-Label Period|Lost to Follow-up|0|||
126129810|NCT01661140|453766722|FG002|Open-Label Period|Lost to Follow-up|0|||
126129811|NCT01661140|453766720|FG000|Double-Blind Period|Refused Treatment|0|||
126129812|NCT01661140|453766721|FG001|Double-Blind Period|Refused Treatment|0|||
126129813|NCT01661140|453766722|FG002|Double-Blind Period|Refused Treatment|1|||
126129814|NCT01661140|453766720|FG000|Double-Blind Period|Adverse Event|0|||
126129815|NCT01661140|453766721|FG001|Double-Blind Period|Adverse Event|16|||
126129816|NCT01661140|453766722|FG002|Double-Blind Period|Adverse Event|18|||
126129817|NCT01661140|453766720|FG000|Double-Blind Period|Protocol Violation|0|||
126129818|NCT01661140|453766721|FG001|Double-Blind Period|Protocol Violation|2|||
126129819|NCT01661140|453766722|FG002|Double-Blind Period|Protocol Violation|3|||
126129820|NCT01661140|453766720|FG000|Double-Blind Period|Withdrawal by Subject|0|||
126129821|NCT01661140|453766721|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126129822|NCT01661140|453766722|FG002|Double-Blind Period|Withdrawal by Subject|3|||
126129823|NCT01661140|453766720|FG000|Double-Blind Period|Investigator's Decision|0|||
126129824|NCT01661140|453766721|FG001|Double-Blind Period|Investigator's Decision|1|||
126129825|NCT01661140|453766722|FG002|Double-Blind Period|Investigator's Decision|2|||
126129826|NCT01661140|453766720|FG000|Double-Blind Period|Sponsor Termination|0|||
126129827|NCT01661140|453766721|FG001|Double-Blind Period|Sponsor Termination|14|||
126129828|NCT01661140|453766722|FG002|Double-Blind Period|Sponsor Termination|17|||
126129829|NCT01661140|453766720|FG000|Double-Blind Period|Administrative/Other|0|||
126129830|NCT01661140|453766721|FG001|Double-Blind Period|Administrative/Other|7|||
126129831|NCT01661140|453766722|FG002|Double-Blind Period|Administrative/Other|6|||
126129832|NCT00746252|453766723|FG000|Overall Study|weight gain >7.5 %|1|||
126129833|NCT00746252|453766724|FG001|Overall Study|weight gain >7.5 %|2|||
126129834|NCT02239939|453766725|FG000|Overall Study|Adverse Event|1|||
126129835|NCT02239939|453766726|FG001|Overall Study|Adverse Event|0|||
126129836|NCT02239939|453766725|FG000|Overall Study|Withdrawal by Subject|1|||
126129837|NCT02239939|453766726|FG001|Overall Study|Withdrawal by Subject|1|||
126129838|NCT02239939|453766725|FG000|Overall Study|Lost to Follow-up|0|||
126129839|NCT02239939|453766726|FG001|Overall Study|Lost to Follow-up|1|||
126129840|NCT03325673|453766735|FG000|Overall Study|Adverse Event|4|||
126129841|NCT03325673|453766736|FG001|Overall Study|Adverse Event|0|||
126129842|NCT00590590|453766737|FG000|Overall Study|Lack of Efficacy|1|||
126129843|NCT00590590|453766738|FG001|Overall Study|Lack of Efficacy|2|||
126129844|NCT00590590|453766739|FG002|Overall Study|Lack of Efficacy|0|||
126129845|NCT00590590|453766737|FG000|Overall Study|Adverse Event|1|||
126129846|NCT00590590|453766738|FG001|Overall Study|Adverse Event|0|||
126129847|NCT00590590|453766739|FG002|Overall Study|Adverse Event|0|||
125964017|NCT00982020|453159335|FG001|Overall Study|Treatment Non-compliance|6|||
125964018|NCT00982020|453159334|FG000|Overall Study|Physician Decision|2|||
125964019|NCT00982020|453159335|FG001|Overall Study|Physician Decision|5|||
125964020|NCT00982020|453159334|FG000|Overall Study|Entry Criteria Not Met|2|||
125964021|NCT00982020|453159335|FG001|Overall Study|Entry Criteria Not Met|1|||
125964022|NCT00982020|453159334|FG000|Overall Study|Protocol Violation|0|||
125964023|NCT00982020|453159335|FG001|Overall Study|Protocol Violation|2|||
126129848|NCT00590590|453766737|FG000|Overall Study|Protocol Violation|0|||
126129849|NCT00590590|453766738|FG001|Overall Study|Protocol Violation|0|||
126129850|NCT00590590|453766739|FG002|Overall Study|Protocol Violation|2|||
126129851|NCT00590590|453766737|FG000|Overall Study|Lost to Follow-up|4|||
126129852|NCT00590590|453766738|FG001|Overall Study|Lost to Follow-up|1|||
126129853|NCT00590590|453766739|FG002|Overall Study|Lost to Follow-up|2|||
126129854|NCT00590590|453766737|FG000|Overall Study|Withdrawal by Subject|0|||
126129855|NCT00590590|453766738|FG001|Overall Study|Withdrawal by Subject|1|||
126129856|NCT00590590|453766739|FG002|Overall Study|Withdrawal by Subject|1|||
126129857|NCT00590590|453766737|FG000|Overall Study|Did not complete due to study closure|1|||
125964024|NCT00982020|453159334|FG000|Overall Study|Clinical Relapse|0|||
125964025|NCT00982020|453159335|FG001|Overall Study|Clinical Relapse|1|||
125964026|NCT01722331|453159336|FG000|Part 1|Adverse Event|5|||
125964027|NCT01722331|453159337|FG001|Part 1|Adverse Event|0|||
126129858|NCT00590590|453766738|FG001|Overall Study|Did not complete due to study closure|1|||
126129859|NCT00590590|453766739|FG002|Overall Study|Did not complete due to study closure|1|||
126129860|NCT00590590|453766737|FG000|Overall Study|Did not complete study|0|||
126129861|NCT00590590|453766738|FG001|Overall Study|Did not complete study|1|||
126129862|NCT00590590|453766739|FG002|Overall Study|Did not complete study|0|||
126129863|NCT01514682|453766740|FG000|Overall Study|Withdrawal by Subject|2|||
126129864|NCT01514682|453766741|FG001|Overall Study|Withdrawal by Subject|3|||
126129865|NCT01514682|453766740|FG000|Overall Study|Physician Decision|4|||
126129866|NCT01514682|453766741|FG001|Overall Study|Physician Decision|3|||
126129867|NCT01870401|453766742|FG000|Overall Study|Death|48|||
125964028|NCT01722331|453159338|FG002|Part 1|Adverse Event|0|||
125964029|NCT01722331|453159339|FG003|Part 1|Adverse Event|0|||
125964030|NCT01722331|453159340|FG004|Part 1|Adverse Event|0|||
126129868|NCT01870401|453766743|FG001|Overall Study|Death|24|||
126129869|NCT01870401|453766742|FG000|Overall Study|Withdrawal by Subject|39|||
126129870|NCT01870401|453766743|FG001|Overall Study|Withdrawal by Subject|26|||
126129871|NCT01870401|453766742|FG000|Overall Study|Lost to Follow-up|19|||
126129872|NCT01870401|453766743|FG001|Overall Study|Lost to Follow-up|14|||
126129873|NCT01870401|453766742|FG000|Overall Study|Other|9|||
126129874|NCT01870401|453766743|FG001|Overall Study|Other|7|||
126129875|NCT01870401|453766742|FG000|Overall Study|On-going in the Study|35|||
126129876|NCT01870401|453766743|FG001|Overall Study|On-going in the Study|25|||
126129877|NCT02105454|453766746|FG000|Overall Study|Withdrawal by Subject|1|||
126129878|NCT00493870|453766748|FG000|Overall Study|Lost to Follow-up|12|||
126129879|NCT00493870|453766749|FG001|Overall Study|Lost to Follow-up|15|||
126129880|NCT00272038|453766750|FG000|Overall Study|withdrew before they received 2 cycles|7|||
126129881|NCT02721355|453766751|FG000|Overall Study|Lost to Follow-up|6|||
126129882|NCT02721355|453766752|FG001|Overall Study|Lost to Follow-up|1|||
126129883|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
126129884|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
126129885|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
126129886|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
126129887|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
126129888|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
126129889|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
126129890|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
126129891|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
126129892|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
126129893|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
126129894|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
126129895|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
126129896|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
126129897|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
126129898|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
126129899|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
126129900|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
126129901|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
126129902|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
126129903|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
126129904|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
126129905|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
126129906|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
126129907|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
126129908|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
126129909|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
126129910|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
126129911|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
126129912|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
126129913|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
126129914|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
126129915|NCT03605680|453766753|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
126129916|NCT03605680|453766754|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
126129917|NCT03605680|453766755|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
126129918|NCT03605680|453766756|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
126129919|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
126129920|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
126129921|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
126129922|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
126129923|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
126129924|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
126129925|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
126129926|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
126129927|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126129928|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126129929|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126129930|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
126129931|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
126129932|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
126129933|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
126129934|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
126129935|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
126129936|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
126129937|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
126151411|NCT00488631|453841978|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
126129938|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
126129939|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
126129940|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
126129941|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
126129942|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
126129943|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
126129944|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
126129945|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
126129946|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
126129947|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
126129948|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
126129949|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
126129950|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
126129951|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
126129952|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
126129953|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
126129954|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
126129955|NCT03605680|453766753|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
126129956|NCT03605680|453766754|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
126129957|NCT03605680|453766755|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
126129958|NCT03605680|453766756|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
126129959|NCT00356278|453766757|FG000|Overall Study|Withdrawal by Subject|25|||
126129960|NCT00356278|453766758|FG001|Overall Study|Withdrawal by Subject|15|||
126129961|NCT00356278|453766759|FG002|Overall Study|Withdrawal by Subject|19|||
126129962|NCT00883337|453766760|FG000|Core Treatment Period|Adverse Event|9|||
126129963|NCT00883337|453766761|FG001|Core Treatment Period|Adverse Event|12|||
126129964|NCT00883337|453766762|FG002|Core Treatment Period|Adverse Event|22|||
125964031|NCT01722331|453159341|FG005|Part 1|Adverse Event|0|||
125964032|NCT01722331|453159342|FG006|Part 1|Adverse Event|0|||
125964033|NCT01722331|453159336|FG000|Part 1|Lack of Efficacy|0|||
125964034|NCT01722331|453159337|FG001|Part 1|Lack of Efficacy|0|||
126129965|NCT00883337|453766760|FG000|Core Treatment Period|Lack of Efficacy|7|||
126129966|NCT00883337|453766761|FG001|Core Treatment Period|Lack of Efficacy|4|||
126129967|NCT00883337|453766762|FG002|Core Treatment Period|Lack of Efficacy|2|||
126129968|NCT00883337|453766760|FG000|Core Treatment Period|Lost to Follow-up|1|||
126129969|NCT00883337|453766761|FG001|Core Treatment Period|Lost to Follow-up|1|||
126129970|NCT00883337|453766762|FG002|Core Treatment Period|Lost to Follow-up|0|||
126129971|NCT00883337|453766760|FG000|Core Treatment Period|Withdrawal by Subject|2|||
126129972|NCT00883337|453766761|FG001|Core Treatment Period|Withdrawal by Subject|2|||
126129973|NCT00883337|453766762|FG002|Core Treatment Period|Withdrawal by Subject|6|||
126129974|NCT00883337|453766760|FG000|Core Treatment Period|Wish to be pregnant|1|||
126129975|NCT00883337|453766761|FG001|Core Treatment Period|Wish to be pregnant|2|||
126129976|NCT00883337|453766762|FG002|Core Treatment Period|Wish to be pregnant|1|||
126129977|NCT00883337|453766760|FG000|Core Treatment Period|Poor compliance to protocol|0|||
126129978|NCT00883337|453766761|FG001|Core Treatment Period|Poor compliance to protocol|0|||
126129979|NCT00883337|453766762|FG002|Core Treatment Period|Poor compliance to protocol|1|||
126129980|NCT00883337|453766760|FG000|Core Treatment Period|Other than above|0|||
126129981|NCT00883337|453766761|FG001|Core Treatment Period|Other than above|1|||
126129982|NCT00883337|453766762|FG002|Core Treatment Period|Other than above|1|||
126129983|NCT00883337|453766760|FG000|Extension Treatment Period|Adverse Event|8|||
126129984|NCT00883337|453766761|FG001|Extension Treatment Period|Adverse Event|5|||
126129985|NCT00883337|453766762|FG002|Extension Treatment Period|Adverse Event|5|||
126129986|NCT00883337|453766760|FG000|Extension Treatment Period|Lack of Efficacy|8|||
126129987|NCT00883337|453766761|FG001|Extension Treatment Period|Lack of Efficacy|8|||
126129988|NCT00883337|453766762|FG002|Extension Treatment Period|Lack of Efficacy|8|||
126129989|NCT00883337|453766760|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
126129990|NCT00883337|453766761|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
126129991|NCT00883337|453766762|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
126129992|NCT00883337|453766760|FG000|Extension Treatment Period|Lost to Follow-up|1|||
126129993|NCT00883337|453766761|FG001|Extension Treatment Period|Lost to Follow-up|0|||
126129994|NCT00883337|453766762|FG002|Extension Treatment Period|Lost to Follow-up|0|||
126129995|NCT00883337|453766760|FG000|Extension Treatment Period|Other than above|10|||
126129996|NCT00883337|453766761|FG001|Extension Treatment Period|Other than above|9|||
126129997|NCT00883337|453766762|FG002|Extension Treatment Period|Other than above|5|||
125964035|NCT01722331|453159338|FG002|Part 1|Lack of Efficacy|1|||
125964036|NCT01722331|453159339|FG003|Part 1|Lack of Efficacy|0|||
125964037|NCT01722331|453159340|FG004|Part 1|Lack of Efficacy|2|||
126129998|NCT00527605|453766763|FG000|Overall Study|Adverse Event|3|||
126129999|NCT00527605|453766764|FG001|Overall Study|Adverse Event|0|||
125964038|NCT01722331|453159341|FG005|Part 1|Lack of Efficacy|0|||
126130000|NCT00527605|453766763|FG000|Overall Study|Withdrawal by Subject|3|||
126130001|NCT00527605|453766764|FG001|Overall Study|Withdrawal by Subject|7|||
126130002|NCT00527605|453766763|FG000|Overall Study|Lost to Follow-up|6|||
126130003|NCT00527605|453766764|FG001|Overall Study|Lost to Follow-up|2|||
126130004|NCT00527605|453766763|FG000|Overall Study|Protocol Violation|1|||
126130005|NCT00527605|453766764|FG001|Overall Study|Protocol Violation|2|||
126130006|NCT01592760|453766765|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
126130007|NCT01592760|453766766|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
126130008|NCT01592760|453766767|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
126130009|NCT01485627|453766778|FG000|Overall Study|Patient withdrew|6|||
126130010|NCT01485627|453766779|FG001|Overall Study|Patient withdrew|5|||
126130011|NCT01485627|453766778|FG000|Overall Study|Patient died|3|||
126130012|NCT01485627|453766779|FG001|Overall Study|Patient died|1|||
126130013|NCT01485627|453766778|FG000|Overall Study|Patient lost to followup|0|||
126130014|NCT01485627|453766779|FG001|Overall Study|Patient lost to followup|1|||
126130015|NCT01485627|453766778|FG000|Overall Study|Caregiver withdrew|3|||
126130016|NCT01485627|453766779|FG001|Overall Study|Caregiver withdrew|3|||
126130017|NCT01485627|453766778|FG000|Overall Study|Caregiver lost to follow up|11|||
126130018|NCT01485627|453766779|FG001|Overall Study|Caregiver lost to follow up|12|||
126130019|NCT01485627|453766778|FG000|Overall Study|Caregiver died|1|||
126130020|NCT01485627|453766779|FG001|Overall Study|Caregiver died|0|||
126130021|NCT01485627|453766778|FG000|Overall Study|caregiver was not bereaved|42|||
126130022|NCT01485627|453766779|FG001|Overall Study|caregiver was not bereaved|35|||
126130023|NCT02728830|453766792|FG000|Overall Study|Exclusionary Surgery|9|||
126130024|NCT02728830|453766792|FG000|Overall Study|Exclusionary Pathology|6|||
126130025|NCT02728830|453766792|FG000|Overall Study|Physician Decision|3|||
126130026|NCT02728830|453766792|FG000|Overall Study|Withdrawal by Subject|2|||
126130027|NCT02728830|453766792|FG000|Overall Study|Lost to Follow-up|1|||
126130028|NCT02728830|453766792|FG000|Overall Study|Exclusionary Lab Values|1|||
126130029|NCT02728830|453766792|FG000|Overall Study|Contraindicated Illness|1|||
126130030|NCT02728830|453766792|FG000|Overall Study|Language Barrier|1|||
126130031|NCT00075504|453766793|FG000|Overall Study|Withdrawal by Subject|9|||
126130032|NCT00075504|453766794|FG001|Overall Study|Withdrawal by Subject|7|||
126130033|NCT01692301|453766795|FG000|Overall Study|Adverse Event|15|||
126130034|NCT01692301|453766796|FG001|Overall Study|Adverse Event|12|||
126130035|NCT01692301|453766795|FG000|Overall Study|Death|1|||
126130036|NCT01692301|453766796|FG001|Overall Study|Death|2|||
126130037|NCT01692301|453766795|FG000|Overall Study|Lack of Efficacy|0|||
126130038|NCT01692301|453766796|FG001|Overall Study|Lack of Efficacy|5|||
126130039|NCT01692301|453766795|FG000|Overall Study|Non-compliance with study treatment|1|||
126130040|NCT01692301|453766796|FG001|Overall Study|Non-compliance with study treatment|2|||
126130041|NCT01692301|453766795|FG000|Overall Study|Protocol deviation|9|||
126130042|NCT01692301|453766796|FG001|Overall Study|Protocol deviation|2|||
126130043|NCT01692301|453766795|FG000|Overall Study|Patient/guardian decision|16|||
126130044|NCT01692301|453766796|FG001|Overall Study|Patient/guardian decision|15|||
126130045|NCT01692301|453766795|FG000|Overall Study|Technical problems|0|||
126130046|NCT01692301|453766796|FG001|Overall Study|Technical problems|1|||
126130047|NCT01692301|453766795|FG000|Overall Study|Physician Decision|2|||
126130048|NCT01692301|453766796|FG001|Overall Study|Physician Decision|2|||
126130049|NCT01692301|453766795|FG000|Overall Study|Lost to Follow-up|1|||
126130050|NCT01692301|453766796|FG001|Overall Study|Lost to Follow-up|1|||
126130051|NCT01142726|453766797|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
126130052|NCT01142726|453766798|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
126130053|NCT01142726|453766799|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
126130054|NCT01142726|453766797|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
126130055|NCT01142726|453766798|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
126130056|NCT01142726|453766799|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
126130057|NCT01142726|453766797|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
126130058|NCT01142726|453766798|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
126130059|NCT01142726|453766799|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
126130060|NCT01142726|453766797|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
126130061|NCT01142726|453766798|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
126130062|NCT01142726|453766799|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
126130063|NCT01142726|453766797|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
125964039|NCT01722331|453159342|FG006|Part 1|Lack of Efficacy|0|||
126130064|NCT01142726|453766798|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
126130065|NCT01142726|453766799|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
126130066|NCT01142726|453766797|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
126130067|NCT01142726|453766798|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
126130068|NCT01142726|453766799|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
126130069|NCT01142726|453766797|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
126130070|NCT01142726|453766798|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
125964040|NCT01722331|453159336|FG000|Part 1|Lost to Follow-up|1|||
126130071|NCT01142726|453766799|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
126130072|NCT01142726|453766797|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
126130073|NCT01142726|453766798|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
126130074|NCT01142726|453766799|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
126130075|NCT01142726|453766797|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
126130076|NCT01142726|453766798|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
126130077|NCT01142726|453766799|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
126130078|NCT01142726|453766797|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
126130079|NCT01142726|453766798|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
126130080|NCT01142726|453766799|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
126130081|NCT01142726|453766797|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
126130082|NCT01142726|453766798|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
126130083|NCT01142726|453766799|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
126130084|NCT01142726|453766797|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
126130085|NCT01142726|453766798|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
126130086|NCT01142726|453766799|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
126130087|NCT01142726|453766797|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
126130088|NCT01142726|453766798|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
126130089|NCT01142726|453766799|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
126130090|NCT01142726|453766797|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
126130091|NCT01142726|453766798|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
126130092|NCT01142726|453766799|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
126130093|NCT01142726|453766797|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
126130094|NCT01142726|453766798|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
126130095|NCT01142726|453766799|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
126130096|NCT01142726|453766797|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
126130097|NCT01142726|453766798|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
126130098|NCT01142726|453766799|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
126130099|NCT01568593|453766800|FG000|Overall Study|Lack of Efficacy|4|||
126130100|NCT01568593|453766801|FG001|Overall Study|Lack of Efficacy|1|||
126130101|NCT01568593|453766800|FG000|Overall Study|Adverse Event|3|||
126130102|NCT01568593|453766801|FG001|Overall Study|Adverse Event|2|||
126130103|NCT02109484|453766802|FG000|Overall Study|Lost to Follow-up|0|||
126130104|NCT02109484|453766803|FG001|Overall Study|Lost to Follow-up|0|||
126130105|NCT02109484|453766804|FG002|Overall Study|Lost to Follow-up|0|||
126130106|NCT02109484|453766805|FG003|Overall Study|Lost to Follow-up|1|||
126130107|NCT02109484|453766806|FG004|Overall Study|Lost to Follow-up|1|||
126130108|NCT02109484|453766807|FG005|Overall Study|Lost to Follow-up|0|||
126130109|NCT02109484|453766808|FG006|Overall Study|Lost to Follow-up|1|||
126130110|NCT02109484|453766809|FG007|Overall Study|Lost to Follow-up|0|||
126130111|NCT02109484|453766802|FG000|Overall Study|Withdrawal by Subject|0|||
126130112|NCT02109484|453766803|FG001|Overall Study|Withdrawal by Subject|0|||
126130113|NCT02109484|453766804|FG002|Overall Study|Withdrawal by Subject|0|||
126130114|NCT02109484|453766805|FG003|Overall Study|Withdrawal by Subject|0|||
126130115|NCT02109484|453766806|FG004|Overall Study|Withdrawal by Subject|1|||
126130116|NCT02109484|453766807|FG005|Overall Study|Withdrawal by Subject|1|||
126130117|NCT02109484|453766808|FG006|Overall Study|Withdrawal by Subject|1|||
126130118|NCT02109484|453766809|FG007|Overall Study|Withdrawal by Subject|0|||
126130119|NCT02109484|453766802|FG000|Overall Study|Physician Decision|0|||
126130120|NCT02109484|453766803|FG001|Overall Study|Physician Decision|0|||
126130121|NCT02109484|453766804|FG002|Overall Study|Physician Decision|0|||
126130122|NCT02109484|453766805|FG003|Overall Study|Physician Decision|0|||
126130123|NCT02109484|453766806|FG004|Overall Study|Physician Decision|2|||
126130124|NCT02109484|453766807|FG005|Overall Study|Physician Decision|0|||
126130125|NCT02109484|453766808|FG006|Overall Study|Physician Decision|0|||
126130126|NCT02109484|453766809|FG007|Overall Study|Physician Decision|0|||
126130127|NCT02109484|453766802|FG000|Overall Study|Death|0|||
126130128|NCT02109484|453766803|FG001|Overall Study|Death|0|||
126130129|NCT02109484|453766804|FG002|Overall Study|Death|0|||
126130130|NCT02109484|453766805|FG003|Overall Study|Death|0|||
126130131|NCT02109484|453766806|FG004|Overall Study|Death|0|||
126130132|NCT02109484|453766807|FG005|Overall Study|Death|0|||
126130133|NCT02109484|453766808|FG006|Overall Study|Death|0|||
126130134|NCT02109484|453766809|FG007|Overall Study|Death|2|||
125964041|NCT01722331|453159337|FG001|Part 1|Lost to Follow-up|0|||
126130135|NCT02109484|453766802|FG000|Overall Study|Moved away from study area|0|||
126130136|NCT02109484|453766803|FG001|Overall Study|Moved away from study area|0|||
126130137|NCT02109484|453766804|FG002|Overall Study|Moved away from study area|0|||
125964042|NCT01722331|453159338|FG002|Part 1|Lost to Follow-up|2|||
126130138|NCT02109484|453766805|FG003|Overall Study|Moved away from study area|0|||
126130139|NCT02109484|453766806|FG004|Overall Study|Moved away from study area|0|||
126130140|NCT02109484|453766807|FG005|Overall Study|Moved away from study area|0|||
125964043|NCT01722331|453159339|FG003|Part 1|Lost to Follow-up|0|||
125964044|NCT01722331|453159340|FG004|Part 1|Lost to Follow-up|1|||
126130141|NCT02109484|453766808|FG006|Overall Study|Moved away from study area|1|||
126130142|NCT02109484|453766809|FG007|Overall Study|Moved away from study area|1|||
126130143|NCT02111993|453766814|FG000|Overall Study|Physician Decision|5|||
126130144|NCT02111993|453766815|FG001|Overall Study|Physician Decision|4|||
126130145|NCT03713944|453766816|FG000|Study Treatment|Patient non-compliance|1|||
126130146|NCT03713944|453766816|FG000|Study Treatment|Alternative Cancer Therapy|3|||
126130147|NCT03713944|453766816|FG000|Study Treatment|Disease Progression|18|||
126130148|NCT03713944|453766816|FG000|Study Treatment|AE/Side Effects/Complications|2|||
126130149|NCT03713944|453766816|FG000|Study Treatment|Death|2|||
126130150|NCT03713944|453766816|FG000|Study Treatment|Withdrawal by Subject|1|||
126130151|NCT03713944|453766816|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
126130152|NCT03713944|453766816|FG000|Study Treatment|Symptomatic Deterioration|2|||
126130153|NCT03713944|453766816|FG000|Follow up|Withdrawal by Subject|2|||
126130154|NCT03713944|453766816|FG000|Follow up|Death|11|||
126130155|NCT03713944|453766816|FG000|Follow up|Study Terminated|3|||
126130156|NCT00419380|453766817|FG000|Overall Study|Lack of Efficacy|1|||
126130157|NCT00419380|453766818|FG001|Overall Study|Lack of Efficacy|7|||
126130158|NCT00419380|453766817|FG000|Overall Study|Physician Decision|0|||
126130159|NCT00419380|453766818|FG001|Overall Study|Physician Decision|1|||
126130160|NCT00419380|453766817|FG000|Overall Study|Lost to Follow-up|0|||
126130161|NCT00419380|453766818|FG001|Overall Study|Lost to Follow-up|1|||
126130162|NCT00419380|453766817|FG000|Overall Study|Withdrawal by Subject|0|||
126130163|NCT00419380|453766818|FG001|Overall Study|Withdrawal by Subject|1|||
126130164|NCT03440814|453766839|FG000|Overall Study|Adverse Event|2|||
126130165|NCT03440814|453766840|FG001|Overall Study|Adverse Event|1|||
126130166|NCT03440814|453766839|FG000|Overall Study|Lost to Follow-up|2|||
126130167|NCT03440814|453766840|FG001|Overall Study|Lost to Follow-up|0|||
126130168|NCT03440814|453766839|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
126130169|NCT03440814|453766840|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
126130170|NCT00879697|453766841|FG000|Overall Study|Physician Decision|2|||
126130171|NCT00879697|453766842|FG001|Overall Study|Physician Decision|2|||
126130172|NCT02751502|453766843|FG000|Overall Study|Lack of funding|4|||
126130173|NCT00088374|453766844|FG000|Overall Study|patient did not receive any 17AAG|1|||
126130174|NCT00088374|453766844|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
126130175|NCT02678390|453766845|FG000|AE (1 Day)|Withdrawal by Subject|0|||
126130176|NCT02678390|453766846|FG001|AE (1 Day)|Withdrawal by Subject|1|||
126130177|NCT00498173|453766847|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
126130178|NCT00498173|453766848|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
126130179|NCT00498173|453766849|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
126130180|NCT01110200|453766850|FG000|Overall Study|Adverse Event|28|||
126130181|NCT01110200|453766851|FG001|Overall Study|Adverse Event|28|||
126130182|NCT01110200|453766850|FG000|Overall Study|Withdrawal by Subject|25|||
126130183|NCT01110200|453766851|FG001|Overall Study|Withdrawal by Subject|32|||
126130184|NCT01110200|453766850|FG000|Overall Study|Lack of Efficacy|16|||
126130185|NCT01110200|453766851|FG001|Overall Study|Lack of Efficacy|25|||
126130186|NCT01110200|453766850|FG000|Overall Study|Protocol Violation|14|||
126130187|NCT01110200|453766851|FG001|Overall Study|Protocol Violation|12|||
126130188|NCT01110200|453766850|FG000|Overall Study|Physician Decision|13|||
126130189|NCT01110200|453766851|FG001|Overall Study|Physician Decision|17|||
126130190|NCT01110200|453766850|FG000|Overall Study|Lost to Follow-up|10|||
126130191|NCT01110200|453766851|FG001|Overall Study|Lost to Follow-up|7|||
126130192|NCT01632566|453766852|FG000|Overall Study|Withdrawal by Subject|0|||
126130193|NCT01632566|453766853|FG001|Overall Study|Withdrawal by Subject|1|||
126130194|NCT01632566|453766854|FG002|Overall Study|Withdrawal by Subject|0|||
126130195|NCT01632566|453766855|FG003|Overall Study|Withdrawal by Subject|0|||
126130196|NCT01632566|453766856|FG004|Overall Study|Withdrawal by Subject|0|||
126130197|NCT01632566|453766852|FG000|Overall Study|Sponsor Decision|0|||
126130198|NCT01632566|453766853|FG001|Overall Study|Sponsor Decision|2|||
126130199|NCT01632566|453766854|FG002|Overall Study|Sponsor Decision|9|||
126130200|NCT01632566|453766855|FG003|Overall Study|Sponsor Decision|2|||
126130201|NCT01632566|453766856|FG004|Overall Study|Sponsor Decision|2|||
126130202|NCT01318109|453766857|FG000|Overall Study|Adverse Event|0|||
126130203|NCT01318109|453766858|FG001|Overall Study|Adverse Event|2|||
126130204|NCT01318109|453766859|FG002|Overall Study|Adverse Event|0|||
126130205|NCT01318109|453766857|FG000|Overall Study|Withdrawal by Subject|1|||
126130206|NCT01318109|453766858|FG001|Overall Study|Withdrawal by Subject|0|||
126130207|NCT01318109|453766859|FG002|Overall Study|Withdrawal by Subject|0|||
126130208|NCT01318109|453766857|FG000|Overall Study|Schedule Conflict|0|||
126130209|NCT01318109|453766858|FG001|Overall Study|Schedule Conflict|1|||
126130210|NCT01318109|453766859|FG002|Overall Study|Schedule Conflict|0|||
126130211|NCT00264238|453766862|FG000|Overall Study|Protocol Violation|1|||
126130212|NCT01411085|453766863|FG000|Overall Study|Physician Decision|1|||
126130213|NCT01411085|453766863|FG000|Overall Study|Protocol Violation|1|||
126130214|NCT01411085|453766863|FG000|Overall Study|Adverse Event|1|||
126130215|NCT02193074|453766864|FG000|Overall Study|Withdrawal by Subject|1|||
126130216|NCT02193074|453766865|FG001|Overall Study|Withdrawal by Subject|2|||
126130217|NCT02193074|453766864|FG000|Overall Study|Adverse Event|16|||
126130218|NCT02193074|453766865|FG001|Overall Study|Adverse Event|13|||
126130219|NCT01534533|453766866|FG000|Overall Study|Lost to Follow-up|3|||
126130220|NCT01534533|453766867|FG001|Overall Study|Lost to Follow-up|0|||
126130221|NCT01534533|453766868|FG002|Overall Study|Lost to Follow-up|4|||
126130222|NCT01534533|453766869|FG003|Overall Study|Lost to Follow-up|3|||
126130223|NCT01534533|453766866|FG000|Overall Study|Withdrawal by Subject|5|||
126130224|NCT01534533|453766867|FG001|Overall Study|Withdrawal by Subject|3|||
126130225|NCT01534533|453766868|FG002|Overall Study|Withdrawal by Subject|4|||
126130226|NCT01534533|453766869|FG003|Overall Study|Withdrawal by Subject|1|||
126130227|NCT04311502|453768273|FG000|Overall Study|Death|1|||
126130228|NCT04311502|453768274|FG001|Overall Study|Death|1|||
126130229|NCT04311502|453768275|FG002|Overall Study|Death|1|||
126130230|NCT04311502|453768273|FG000|Overall Study|Lost to Follow-up|2|||
126130231|NCT04311502|453768274|FG001|Overall Study|Lost to Follow-up|3|||
126130232|NCT04311502|453768275|FG002|Overall Study|Lost to Follow-up|0|||
126130233|NCT04311502|453768273|FG000|Overall Study|Participant is in prison|1|||
126130234|NCT04311502|453768274|FG001|Overall Study|Participant is in prison|0|||
126130235|NCT04311502|453768275|FG002|Overall Study|Participant is in prison|0|||
126130236|NCT04311502|453768273|FG000|Overall Study|Participant moved out of country|1|||
126130237|NCT04311502|453768274|FG001|Overall Study|Participant moved out of country|0|||
126130238|NCT04311502|453768275|FG002|Overall Study|Participant moved out of country|0|||
126130239|NCT04311502|453768273|FG000|Overall Study|Withdrawal by Subject|2|||
126130240|NCT04311502|453768274|FG001|Overall Study|Withdrawal by Subject|0|||
126130241|NCT04311502|453768275|FG002|Overall Study|Withdrawal by Subject|0|||
126130242|NCT04311502|453768273|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
126130243|NCT04311502|453768274|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
126130244|NCT04311502|453768275|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
126130245|NCT03040999|453768276|FG000|Overall Study|Lost to Follow-up|2|||
126130246|NCT03040999|453768277|FG001|Overall Study|Lost to Follow-up|2|||
126130247|NCT03040999|453768276|FG000|Overall Study|Withdrawal by Subject|12|||
126130248|NCT03040999|453768277|FG001|Overall Study|Withdrawal by Subject|13|||
126130249|NCT03040999|453768276|FG000|Overall Study|Death|155|||
126130250|NCT03040999|453768277|FG001|Overall Study|Death|171|||
126130251|NCT03040999|453768276|FG000|Overall Study|Physician Decision|0|||
126130252|NCT03040999|453768277|FG001|Overall Study|Physician Decision|3|||
126130253|NCT03368170|453768278|FG000|Overall Study|Adverse Event|2|||
126130254|NCT03368170|453768279|FG001|Overall Study|Adverse Event|1|||
126130255|NCT02068547|453768280|FG000|Overall Study|Lost to Follow-up|3|||
126130256|NCT02068547|453768281|FG001|Overall Study|Lost to Follow-up|3|||
126130257|NCT02068547|453768280|FG000|Overall Study|Physician Decision|1|||
126130258|NCT02068547|453768281|FG001|Overall Study|Physician Decision|0|||
126130259|NCT00691483|453768286|FG000|Overall Study|Adverse Event|14|||
126130260|NCT00691483|453768287|FG001|Overall Study|Adverse Event|6|||
126130261|NCT00691483|453768286|FG000|Overall Study|Lost to Follow-up|17|||
126130262|NCT00691483|453768287|FG001|Overall Study|Lost to Follow-up|10|||
126130263|NCT00691483|453768286|FG000|Overall Study|Withdrawal by Subject|24|||
126130264|NCT00691483|453768287|FG001|Overall Study|Withdrawal by Subject|7|||
126130265|NCT00691483|453768286|FG000|Overall Study|Other known cause|6|||
126130266|NCT00691483|453768287|FG001|Overall Study|Other known cause|1|||
126130267|NCT00691483|453768286|FG000|Overall Study|Randomized by not treated|7|||
126130268|NCT00691483|453768287|FG001|Overall Study|Randomized by not treated|1|||
126130269|NCT01391000|453768289|FG000|Overall Study|Lost to Follow-up|2|||
126130270|NCT01391000|453768290|FG001|Overall Study|Lost to Follow-up|0|||
126130271|NCT00049673|453768291|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
126130272|NCT00049673|453768292|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
126130273|NCT00817531|453768293|FG000|Overall Study|Adverse Event|1|||
126130274|NCT00817531|453768293|FG000|Overall Study|Lack of Efficacy|1|||
126130275|NCT02475681|453768294|FG000|Overall Study|Death|16|||
126130276|NCT02475681|453768295|FG001|Overall Study|Death|6|||
126130277|NCT02475681|453768296|FG002|Overall Study|Death|9|||
126130278|NCT02475681|453768294|FG000|Overall Study|Physician Decision|0|||
126130279|NCT02475681|453768295|FG001|Overall Study|Physician Decision|3|||
126130280|NCT02475681|453768296|FG002|Overall Study|Physician Decision|1|||
126130281|NCT02475681|453768294|FG000|Overall Study|Withdrawal by Subject|12|||
126130282|NCT02475681|453768295|FG001|Overall Study|Withdrawal by Subject|6|||
126130283|NCT02475681|453768296|FG002|Overall Study|Withdrawal by Subject|9|||
126130284|NCT02475681|453768294|FG000|Overall Study|Lost to Follow-up|2|||
126130285|NCT02475681|453768295|FG001|Overall Study|Lost to Follow-up|1|||
126130286|NCT02475681|453768296|FG002|Overall Study|Lost to Follow-up|3|||
126130287|NCT02475681|453768294|FG000|Overall Study|Ongoing in Study|0|||
126130288|NCT02475681|453768295|FG001|Overall Study|Ongoing in Study|163|||
126130289|NCT02475681|453768296|FG002|Overall Study|Ongoing in Study|157|||
126130290|NCT02475681|453768294|FG000|Overall Study|Reasons other than above listed|2|||
126130291|NCT02475681|453768295|FG001|Overall Study|Reasons other than above listed|0|||
126130292|NCT02475681|453768296|FG002|Overall Study|Reasons other than above listed|0|||
126130293|NCT00132132|453768300|FG000|Overall Study|Lost to Follow-up|7|||
126130294|NCT00132132|453768301|FG001|Overall Study|Lost to Follow-up|2|||
126130295|NCT00494091|453768304|FG000|Overall Study|Death|5|||
126130296|NCT00494091|453768305|FG001|Overall Study|Death|54|||
126130297|NCT00494091|453768304|FG000|Overall Study|Lost to Follow-up|0|||
126130298|NCT00494091|453768305|FG001|Overall Study|Lost to Follow-up|4|||
126130299|NCT00494091|453768304|FG000|Overall Study|Other|1|||
126130300|NCT00494091|453768305|FG001|Overall Study|Other|11|||
126130301|NCT00494091|453768304|FG000|Overall Study|Withdrawal by Subject|0|||
126130302|NCT00494091|453768305|FG001|Overall Study|Withdrawal by Subject|7|||
126130303|NCT00452699|453768308|FG000|Overall Study|Adverse Event|10|||
126130304|NCT00452699|453768309|FG001|Overall Study|Adverse Event|3|||
126130305|NCT00452699|453768308|FG000|Overall Study|Lack of Efficacy|6|||
126130306|NCT00452699|453768309|FG001|Overall Study|Lack of Efficacy|4|||
126130307|NCT00452699|453768308|FG000|Overall Study|Lost to Follow-up|6|||
126130308|NCT00452699|453768309|FG001|Overall Study|Lost to Follow-up|9|||
126130309|NCT00452699|453768308|FG000|Overall Study|Protocol Violation|21|||
126130310|NCT00452699|453768309|FG001|Overall Study|Protocol Violation|25|||
126130311|NCT00452699|453768308|FG000|Overall Study|Withdrawal by Subject|26|||
126130312|NCT00452699|453768309|FG001|Overall Study|Withdrawal by Subject|25|||
126130313|NCT00452699|453768308|FG000|Overall Study|Other|12|||
126130314|NCT00452699|453768309|FG001|Overall Study|Other|7|||
126130315|NCT00326898|453768310|FG000|Overall Study|Disease progression|52|||
126130316|NCT00326898|453768311|FG001|Overall Study|Disease progression|54|||
126130317|NCT00326898|453768312|FG002|Overall Study|Disease progression|102|||
126130318|NCT00326898|453768310|FG000|Overall Study|Adverse Event|124|||
126130319|NCT00326898|453768311|FG001|Overall Study|Adverse Event|128|||
126130320|NCT00326898|453768312|FG002|Overall Study|Adverse Event|33|||
126130321|NCT00326898|453768310|FG000|Overall Study|Death|2|||
126130322|NCT00326898|453768311|FG001|Overall Study|Death|0|||
126130323|NCT00326898|453768312|FG002|Overall Study|Death|0|||
126130324|NCT00326898|453768310|FG000|Overall Study|Withdrawal by Subject|134|||
126130325|NCT00326898|453768311|FG001|Overall Study|Withdrawal by Subject|128|||
126130326|NCT00326898|453768312|FG002|Overall Study|Withdrawal by Subject|32|||
126130327|NCT00326898|453768310|FG000|Overall Study|Alternative therapy|1|||
126130328|NCT00326898|453768311|FG001|Overall Study|Alternative therapy|0|||
126130329|NCT00326898|453768312|FG002|Overall Study|Alternative therapy|0|||
126130330|NCT00326898|453768310|FG000|Overall Study|Other complicating disease|5|||
126130331|NCT00326898|453768311|FG001|Overall Study|Other complicating disease|5|||
126130332|NCT00326898|453768312|FG002|Overall Study|Other complicating disease|4|||
126130333|NCT00326898|453768310|FG000|Overall Study|Other/Missing/Unknown|33|||
126130334|NCT00326898|453768311|FG001|Overall Study|Other/Missing/Unknown|28|||
126130335|NCT00326898|453768312|FG002|Overall Study|Other/Missing/Unknown|32|||
126130336|NCT03847987|453768313|FG000|Overall Study|Lost to Follow-up|1|||
126130337|NCT03847987|453768314|FG001|Overall Study|Lost to Follow-up|0|||
126130338|NCT03847987|453768313|FG000|Overall Study|Adverse Event|2|||
126130339|NCT03847987|453768314|FG001|Overall Study|Adverse Event|0|||
126130340|NCT02111564|453768317|FG000|Overall Study|Death|109|||
125964045|NCT01722331|453159341|FG005|Part 1|Lost to Follow-up|0|||
125964046|NCT01722331|453159342|FG006|Part 1|Lost to Follow-up|0|||
126130341|NCT02111564|453768318|FG001|Overall Study|Death|120|||
126130342|NCT02111564|453768317|FG000|Overall Study|Lost to Follow-up|2|||
126130343|NCT02111564|453768318|FG001|Overall Study|Lost to Follow-up|3|||
126130344|NCT02111564|453768317|FG000|Overall Study|Withdrawal by Subject|20|||
126130345|NCT02111564|453768318|FG001|Overall Study|Withdrawal by Subject|20|||
126130346|NCT00687362|453768319|FG000|Overall Study|Protocol Violation|2|||
126130347|NCT00687362|453768319|FG000|Overall Study|Withdrawal by Subject|1|||
126130348|NCT02354703|453768320|FG000|Overall Study|Withdrawal by Subject|1|||
126130349|NCT02354703|453768321|FG001|Overall Study|Withdrawal by Subject|1|||
126130350|NCT02354703|453768322|FG002|Overall Study|Withdrawal by Subject|1|||
126130351|NCT02354703|453768323|FG003|Overall Study|Withdrawal by Subject|1|||
126130352|NCT02354703|453768320|FG000|Overall Study|Lost to Follow-up|2|||
126130353|NCT02354703|453768321|FG001|Overall Study|Lost to Follow-up|7|||
126130354|NCT02354703|453768322|FG002|Overall Study|Lost to Follow-up|9|||
126130355|NCT02354703|453768323|FG003|Overall Study|Lost to Follow-up|2|||
126130356|NCT02354703|453768320|FG000|Overall Study|Adverse Event|0|||
125964047|NCT01722331|453159336|FG000|Part 1|Physician Decision|0|||
125964048|NCT01722331|453159337|FG001|Part 1|Physician Decision|0|||
125964049|NCT01722331|453159338|FG002|Part 1|Physician Decision|3|||
125964050|NCT01722331|453159339|FG003|Part 1|Physician Decision|0|||
126130357|NCT02354703|453768321|FG001|Overall Study|Adverse Event|0|||
125964051|NCT01722331|453159340|FG004|Part 1|Physician Decision|1|||
125964052|NCT01722331|453159341|FG005|Part 1|Physician Decision|0|||
125964053|NCT01722331|453159342|FG006|Part 1|Physician Decision|0|||
125964054|NCT01722331|453159336|FG000|Part 1|Pregnancy|1|||
125964055|NCT01722331|453159337|FG001|Part 1|Pregnancy|0|||
125964056|NCT01722331|453159338|FG002|Part 1|Pregnancy|0|||
125964057|NCT01722331|453159339|FG003|Part 1|Pregnancy|0|||
125964058|NCT01722331|453159340|FG004|Part 1|Pregnancy|0|||
125964059|NCT01722331|453159341|FG005|Part 1|Pregnancy|0|||
125964060|NCT01722331|453159342|FG006|Part 1|Pregnancy|0|||
126130358|NCT02354703|453768322|FG002|Overall Study|Adverse Event|1|||
126130359|NCT02354703|453768323|FG003|Overall Study|Adverse Event|0|||
126130360|NCT03468309|453768326|FG000|Overall Study|Lost to Follow-up|4|||
126130361|NCT03468309|453768326|FG000|Overall Study|Withdrawal by Subject|2|||
126130362|NCT01496885|453768330|FG000|Overall Study|Lost to Follow-up|13|||
126130363|NCT01496885|453768330|FG000|Overall Study|Withdrawal by Subject|7|||
126130364|NCT01496885|453768330|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
126130365|NCT01496885|453768330|FG000|Overall Study|Death|1|||
126130366|NCT03446885|453768332|FG000|Overall Study|Lost to Follow-up|1|||
126130367|NCT03446885|453768333|FG001|Overall Study|Lost to Follow-up|0|||
126130368|NCT03446885|453768332|FG000|Overall Study|Did not complete entire visit|1|||
126130369|NCT03446885|453768333|FG001|Overall Study|Did not complete entire visit|0|||
126130370|NCT00661271|453768337|FG000|Overall Study|Lost to Follow-up|28|||
126130371|NCT00661271|453768338|FG001|Overall Study|Lost to Follow-up|25|||
126130372|NCT01707693|453768339|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
126130373|NCT01707693|453768340|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
126130374|NCT01707693|453768339|FG000|Overall Study Allocation|Protocol Violation|4|||
126130375|NCT01707693|453768340|FG001|Overall Study Allocation|Protocol Violation|3|||
126130376|NCT01707693|453768339|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
126130377|NCT01707693|453768340|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
126130378|NCT01707693|453768339|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
126130379|NCT01707693|453768340|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
126130380|NCT00143455|453768341|FG000|Cohort 1|Adverse Event|8|||
126130381|NCT00143455|453768342|FG001|Cohort 1|Adverse Event|4|||
126130382|NCT00143455|453768343|FG002|Cohort 1|Adverse Event|0|||
126130383|NCT00143455|453768344|FG003|Cohort 1|Adverse Event|0|||
126130384|NCT00143455|453768341|FG000|Cohort 1|Death|5|||
126130385|NCT00143455|453768342|FG001|Cohort 1|Death|2|||
126130386|NCT00143455|453768343|FG002|Cohort 1|Death|0|||
126130387|NCT00143455|453768344|FG003|Cohort 1|Death|0|||
126130388|NCT00143455|453768341|FG000|Cohort 1|Progressive Disease|0|||
126130389|NCT00143455|453768342|FG001|Cohort 1|Progressive Disease|6|||
126130390|NCT00143455|453768343|FG002|Cohort 1|Progressive Disease|0|||
126130391|NCT00143455|453768344|FG003|Cohort 1|Progressive Disease|0|||
126130392|NCT00143455|453768341|FG000|Cohort 1|Withdrawal by Subject|1|||
126130393|NCT00143455|453768342|FG001|Cohort 1|Withdrawal by Subject|4|||
126130394|NCT00143455|453768343|FG002|Cohort 1|Withdrawal by Subject|0|||
126130395|NCT00143455|453768344|FG003|Cohort 1|Withdrawal by Subject|0|||
126130396|NCT00143455|453768341|FG000|Cohort 1|Randomized But Not Treated|0|||
126130397|NCT00143455|453768342|FG001|Cohort 1|Randomized But Not Treated|1|||
126130398|NCT00143455|453768343|FG002|Cohort 1|Randomized But Not Treated|0|||
126130399|NCT00143455|453768344|FG003|Cohort 1|Randomized But Not Treated|0|||
126130400|NCT00143455|453768341|FG000|Cohort 2|Adverse Event|0|||
126130401|NCT00143455|453768342|FG001|Cohort 2|Adverse Event|0|||
126130402|NCT00143455|453768343|FG002|Cohort 2|Adverse Event|42|||
126130403|NCT00143455|453768344|FG003|Cohort 2|Adverse Event|30|||
126130404|NCT00143455|453768341|FG000|Cohort 2|No Longer Required Study Treatment|0|||
126130405|NCT00143455|453768342|FG001|Cohort 2|No Longer Required Study Treatment|0|||
126130406|NCT00143455|453768343|FG002|Cohort 2|No Longer Required Study Treatment|1|||
126130407|NCT00143455|453768344|FG003|Cohort 2|No Longer Required Study Treatment|0|||
126130408|NCT00143455|453768341|FG000|Cohort 2|Protocol Violation|0|||
126130409|NCT00143455|453768342|FG001|Cohort 2|Protocol Violation|0|||
126130410|NCT00143455|453768343|FG002|Cohort 2|Protocol Violation|1|||
126130411|NCT00143455|453768344|FG003|Cohort 2|Protocol Violation|1|||
126130412|NCT00143455|453768341|FG000|Cohort 2|Lost to Follow-up|0|||
126130413|NCT00143455|453768342|FG001|Cohort 2|Lost to Follow-up|0|||
126130414|NCT00143455|453768343|FG002|Cohort 2|Lost to Follow-up|1|||
126130415|NCT00143455|453768344|FG003|Cohort 2|Lost to Follow-up|4|||
126130416|NCT00143455|453768341|FG000|Cohort 2|Death|0|||
126130417|NCT00143455|453768342|FG001|Cohort 2|Death|0|||
126130418|NCT00143455|453768343|FG002|Cohort 2|Death|20|||
126130419|NCT00143455|453768344|FG003|Cohort 2|Death|12|||
126130420|NCT00143455|453768341|FG000|Cohort 2|Progressive Disease|0|||
126130421|NCT00143455|453768342|FG001|Cohort 2|Progressive Disease|0|||
126130422|NCT00143455|453768343|FG002|Cohort 2|Progressive Disease|20|||
126130423|NCT00143455|453768344|FG003|Cohort 2|Progressive Disease|27|||
126130424|NCT00143455|453768341|FG000|Cohort 2|Withdrawal by Subject|0|||
126130425|NCT00143455|453768342|FG001|Cohort 2|Withdrawal by Subject|0|||
126130426|NCT00143455|453768343|FG002|Cohort 2|Withdrawal by Subject|13|||
126130427|NCT00143455|453768344|FG003|Cohort 2|Withdrawal by Subject|12|||
126130428|NCT00143455|453768341|FG000|Cohort 2|Other|0|||
126130429|NCT00143455|453768342|FG001|Cohort 2|Other|0|||
126130430|NCT00143455|453768343|FG002|Cohort 2|Other|7|||
126130431|NCT00143455|453768344|FG003|Cohort 2|Other|6|||
126130432|NCT00143455|453768341|FG000|Cohort 2|Randomized But Not Treated|0|||
126130433|NCT00143455|453768342|FG001|Cohort 2|Randomized But Not Treated|0|||
126130434|NCT00143455|453768343|FG002|Cohort 2|Randomized But Not Treated|1|||
126130435|NCT00143455|453768344|FG003|Cohort 2|Randomized But Not Treated|1|||
126130436|NCT01325428|453768345|FG000|Part A|Progressive disease according to RECIST|9|||
126130437|NCT01325428|453768345|FG000|Part A|Clinical signs, symptoms of progression|2|||
126130438|NCT01325428|453768345|FG000|Part A|Other adverse event|1|||
126130439|NCT01325428|453768345|FG000|Part A|Refused continue taking trial medication|2|||
126130440|NCT01325428|453768345|FG000|Part A|Other reason not defined above|2|||
125964061|NCT01722331|453159336|FG000|Part 1|Progressive Disease|0|||
125964062|NCT01722331|453159337|FG001|Part 1|Progressive Disease|0|||
125964063|NCT01722331|453159338|FG002|Part 1|Progressive Disease|0|||
125964064|NCT01722331|453159339|FG003|Part 1|Progressive Disease|0|||
125964065|NCT01722331|453159340|FG004|Part 1|Progressive Disease|1|||
125964066|NCT01722331|453159341|FG005|Part 1|Progressive Disease|0|||
125964067|NCT01722331|453159342|FG006|Part 1|Progressive Disease|0|||
126130441|NCT01325428|453768345|FG000|Part B|Refused continue taking trial medication|2|||
126130442|NCT01325428|453768345|FG000|Part B|Other reason not defined above|1|||
126130443|NCT03099707|453768348|FG000|Overall Study|Withdrawal by Subject|0|||
126130444|NCT03099707|453768349|FG001|Overall Study|Withdrawal by Subject|3|||
126130445|NCT03099707|453768348|FG000|Overall Study|Lost to Follow-up|0|||
125964068|NCT01722331|453159336|FG000|Part 1|Protocol Violation|1|||
125964069|NCT01722331|453159337|FG001|Part 1|Protocol Violation|0|||
125964070|NCT01722331|453159338|FG002|Part 1|Protocol Violation|0|||
125964071|NCT01722331|453159339|FG003|Part 1|Protocol Violation|0|||
125964072|NCT01722331|453159340|FG004|Part 1|Protocol Violation|1|||
125964073|NCT01722331|453159341|FG005|Part 1|Protocol Violation|0|||
125964074|NCT01722331|453159342|FG006|Part 1|Protocol Violation|0|||
125964075|NCT01722331|453159336|FG000|Part 1|Withdrawal by Subject|2|||
125964076|NCT01722331|453159337|FG001|Part 1|Withdrawal by Subject|0|||
125964077|NCT01722331|453159338|FG002|Part 1|Withdrawal by Subject|3|||
125964078|NCT01722331|453159339|FG003|Part 1|Withdrawal by Subject|0|||
125964079|NCT01722331|453159340|FG004|Part 1|Withdrawal by Subject|3|||
125964080|NCT01722331|453159341|FG005|Part 1|Withdrawal by Subject|0|||
125964081|NCT01722331|453159342|FG006|Part 1|Withdrawal by Subject|0|||
125964082|NCT01722331|453159336|FG000|Part 2|Adverse Event|3|||
125964083|NCT01722331|453159337|FG001|Part 2|Adverse Event|0|||
125964084|NCT01722331|453159338|FG002|Part 2|Adverse Event|0|||
125964085|NCT01722331|453159339|FG003|Part 2|Adverse Event|0|||
125964086|NCT01722331|453159340|FG004|Part 2|Adverse Event|0|||
125964087|NCT01722331|453159341|FG005|Part 2|Adverse Event|1|||
125964088|NCT01722331|453159342|FG006|Part 2|Adverse Event|0|||
125964089|NCT01722331|453159336|FG000|Part 2|Lack of Efficacy|3|||
125964090|NCT01722331|453159337|FG001|Part 2|Lack of Efficacy|0|||
125964091|NCT01722331|453159338|FG002|Part 2|Lack of Efficacy|11|||
126130446|NCT03099707|453768349|FG001|Overall Study|Lost to Follow-up|1|||
126130447|NCT00343889|453768360|FG000|Overall Study|Lost to Follow-up|2|||
126130448|NCT00343889|453768361|FG001|Overall Study|Lost to Follow-up|0|||
126130449|NCT00343889|453768360|FG000|Overall Study|Withdrawal by Subject|0|||
126130450|NCT00343889|453768361|FG001|Overall Study|Withdrawal by Subject|1|||
126130451|NCT00343889|453768360|FG000|Overall Study|Protocol Violation|1|||
126130452|NCT00343889|453768361|FG001|Overall Study|Protocol Violation|0|||
126130453|NCT01294579|453768362|FG000|Overall Study|Disease progression|12|||
126130454|NCT01294579|453768362|FG000|Overall Study|Adverse Event|11|||
126130455|NCT01294579|453768362|FG000|Overall Study|Study closed/terminated|3|||
126130456|NCT01294579|453768362|FG000|Overall Study|Lost to Follow-up|1|||
126130457|NCT01294579|453768362|FG000|Overall Study|Physician Decision|3|||
126130458|NCT01294579|453768362|FG000|Overall Study|Withdrawal by Subject|5|||
126130459|NCT00487539|453768363|FG000|Overall Study|Adverse Event|3|||
126130460|NCT00487539|453768364|FG001|Overall Study|Adverse Event|2|||
126130461|NCT00487539|453768365|FG002|Overall Study|Adverse Event|1|||
126130462|NCT00487539|453768366|FG003|Overall Study|Adverse Event|1|||
126130463|NCT00487539|453768363|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126130464|NCT00487539|453768364|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126130465|NCT00487539|453768365|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125964092|NCT01722331|453159339|FG003|Part 2|Lack of Efficacy|0|||
125964093|NCT01722331|453159340|FG004|Part 2|Lack of Efficacy|0|||
125964094|NCT01722331|453159341|FG005|Part 2|Lack of Efficacy|3|||
125964095|NCT01722331|453159342|FG006|Part 2|Lack of Efficacy|3|||
125964096|NCT01722331|453159336|FG000|Part 2|Lost to Follow-up|0|||
125964097|NCT01722331|453159337|FG001|Part 2|Lost to Follow-up|0|||
125964098|NCT01722331|453159338|FG002|Part 2|Lost to Follow-up|3|||
125964099|NCT01722331|453159339|FG003|Part 2|Lost to Follow-up|0|||
125964100|NCT01722331|453159340|FG004|Part 2|Lost to Follow-up|0|||
125964101|NCT01722331|453159341|FG005|Part 2|Lost to Follow-up|1|||
125964102|NCT01722331|453159342|FG006|Part 2|Lost to Follow-up|1|||
125964103|NCT01722331|453159336|FG000|Part 2|Non-Compliance with Study Drug|1|||
125964104|NCT01722331|453159337|FG001|Part 2|Non-Compliance with Study Drug|0|||
125964105|NCT01722331|453159338|FG002|Part 2|Non-Compliance with Study Drug|1|||
126130466|NCT00487539|453768366|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
126130467|NCT00487539|453768363|FG000|Overall Study|Other|3|||
126130468|NCT00487539|453768364|FG001|Overall Study|Other|1|||
126130469|NCT00487539|453768365|FG002|Overall Study|Other|2|||
126130470|NCT00487539|453768366|FG003|Overall Study|Other|2|||
126130471|NCT03499028|453768367|FG000|Overall Study|Lost to Follow-up|12|||
125964106|NCT01722331|453159339|FG003|Part 2|Non-Compliance with Study Drug|0|||
125964107|NCT01722331|453159340|FG004|Part 2|Non-Compliance with Study Drug|0|||
125964108|NCT01722331|453159341|FG005|Part 2|Non-Compliance with Study Drug|0|||
125964109|NCT01722331|453159342|FG006|Part 2|Non-Compliance with Study Drug|0|||
125964110|NCT01722331|453159336|FG000|Part 2|Physician Decision|0|||
125964111|NCT01722331|453159337|FG001|Part 2|Physician Decision|0|||
125964112|NCT01722331|453159338|FG002|Part 2|Physician Decision|2|||
125964113|NCT01722331|453159339|FG003|Part 2|Physician Decision|0|||
125964114|NCT01722331|453159340|FG004|Part 2|Physician Decision|0|||
126130472|NCT03499028|453768368|FG001|Overall Study|Lost to Follow-up|9|||
126130473|NCT03499028|453768367|FG000|Overall Study|Withdrawal by Subject|5|||
126130474|NCT03499028|453768368|FG001|Overall Study|Withdrawal by Subject|8|||
126130475|NCT03499028|453768367|FG000|Overall Study|Unplanned SNF discharge|5|||
126130476|NCT03499028|453768368|FG001|Overall Study|Unplanned SNF discharge|8|||
126130477|NCT01437397|453768369|FG000|Overall Study|Lost to Follow-up|9|||
126130478|NCT01437397|453768370|FG001|Overall Study|Lost to Follow-up|4|||
126130479|NCT01437397|453768371|FG002|Overall Study|Lost to Follow-up|2|||
126130480|NCT01437397|453768372|FG003|Overall Study|Lost to Follow-up|4|||
126130481|NCT01437397|453768373|FG004|Overall Study|Lost to Follow-up|5|||
126130482|NCT01437397|453768369|FG000|Overall Study|Withdrawal by Subject|11|||
126130483|NCT01437397|453768370|FG001|Overall Study|Withdrawal by Subject|12|||
126130484|NCT01437397|453768371|FG002|Overall Study|Withdrawal by Subject|24|||
126130485|NCT01437397|453768372|FG003|Overall Study|Withdrawal by Subject|11|||
126130486|NCT01437397|453768373|FG004|Overall Study|Withdrawal by Subject|22|||
126130487|NCT01437397|453768369|FG000|Overall Study|Protocol Violation|10|||
126130488|NCT01437397|453768370|FG001|Overall Study|Protocol Violation|12|||
126130489|NCT01437397|453768371|FG002|Overall Study|Protocol Violation|13|||
126130490|NCT01437397|453768372|FG003|Overall Study|Protocol Violation|21|||
126130491|NCT01437397|453768373|FG004|Overall Study|Protocol Violation|19|||
126130492|NCT01437397|453768369|FG000|Overall Study|Lack of Efficacy|5|||
126130493|NCT01437397|453768370|FG001|Overall Study|Lack of Efficacy|4|||
126130494|NCT01437397|453768371|FG002|Overall Study|Lack of Efficacy|8|||
126130495|NCT01437397|453768372|FG003|Overall Study|Lack of Efficacy|10|||
126130496|NCT01437397|453768373|FG004|Overall Study|Lack of Efficacy|20|||
126130497|NCT01437397|453768369|FG000|Overall Study|Adverse Event|21|||
126130498|NCT01437397|453768370|FG001|Overall Study|Adverse Event|22|||
126130499|NCT01437397|453768371|FG002|Overall Study|Adverse Event|16|||
126130500|NCT01437397|453768372|FG003|Overall Study|Adverse Event|14|||
126130501|NCT01437397|453768373|FG004|Overall Study|Adverse Event|21|||
126130502|NCT01437397|453768369|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
126130503|NCT01437397|453768370|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
126130504|NCT01437397|453768371|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
126130505|NCT01437397|453768372|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
126130506|NCT01437397|453768373|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
126130507|NCT00903175|453768374|FG000|Period 1 - First Line|Adverse Event|36|||
126130508|NCT00903175|453768375|FG001|Period 1 - First Line|Adverse Event|50|||
126130509|NCT00903175|453768374|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
126130510|NCT00903175|453768375|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
126130511|NCT00903175|453768374|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
126130512|NCT00903175|453768375|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
126130513|NCT00903175|453768374|FG000|Period 1 - First Line|Protocol Violation|3|||
126130514|NCT00903175|453768375|FG001|Period 1 - First Line|Protocol Violation|3|||
126130515|NCT00903175|453768374|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
126130516|NCT00903175|453768375|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
126130517|NCT00903175|453768374|FG000|Period 1 - First Line|Administrative problems|12|||
126130518|NCT00903175|453768375|FG001|Period 1 - First Line|Administrative problems|13|||
126130519|NCT00903175|453768374|FG000|Period 1 - First Line|Death|17|||
126130520|NCT00903175|453768375|FG001|Period 1 - First Line|Death|10|||
126130521|NCT00903175|453768374|FG000|Period 2 - Second Line|Missing|1|||
126130522|NCT00903175|453768375|FG001|Period 2 - Second Line|Missing|0|||
126130523|NCT00903175|453768374|FG000|Period 2 - Second Line|Adverse Event|16|||
126130524|NCT00903175|453768375|FG001|Period 2 - Second Line|Adverse Event|20|||
126130525|NCT00903175|453768374|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
126130526|NCT00903175|453768375|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
126130527|NCT00903175|453768374|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
126130528|NCT00903175|453768375|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
126130529|NCT00903175|453768374|FG000|Period 2 - Second Line|Administrative problems|19|||
126130530|NCT00903175|453768375|FG001|Period 2 - Second Line|Administrative problems|9|||
126130531|NCT00903175|453768374|FG000|Period 2 - Second Line|Death|5|||
126130532|NCT00903175|453768375|FG001|Period 2 - Second Line|Death|2|||
126130533|NCT03074474|453768380|FG000|Overall Study|Lost to Follow-up|10|||
126130534|NCT03074474|453768380|FG000|Overall Study|Withdrawal by Subject|10|||
126130535|NCT03074474|453768380|FG000|Overall Study|Death|4|||
126130536|NCT03074474|453768380|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
126130537|NCT01035905|453768383|FG000|Overall Study|Lack of Efficacy|1|||
126130538|NCT01035905|453768384|FG001|Overall Study|Lack of Efficacy|1|||
126130539|NCT00371865|453768385|FG000|Overall Study|Lack of Efficacy|0|||
126130540|NCT00371865|453768386|FG001|Overall Study|Lack of Efficacy|2|||
126130541|NCT00371865|453768385|FG000|Overall Study|Protocol Violation|3|||
126130542|NCT00371865|453768386|FG001|Overall Study|Protocol Violation|2|||
126130543|NCT00371865|453768385|FG000|Overall Study|Withdrawal by Subject|12|||
126130544|NCT00371865|453768386|FG001|Overall Study|Withdrawal by Subject|10|||
126130545|NCT01328951|453768388|FG000|Overall Study|Disease Progression|17|||
126130546|NCT01328951|453768389|FG001|Overall Study|Disease Progression|14|||
126130547|NCT01328951|453768388|FG000|Overall Study|Adverse Event|2|||
126130548|NCT01328951|453768389|FG001|Overall Study|Adverse Event|0|||
126130549|NCT01328951|453768388|FG000|Overall Study|Death|243|||
126130550|NCT01328951|453768389|FG001|Overall Study|Death|258|||
126130551|NCT01328951|453768388|FG000|Overall Study|Lost to Follow-up|6|||
126130552|NCT01328951|453768389|FG001|Overall Study|Lost to Follow-up|7|||
126130553|NCT01328951|453768388|FG000|Overall Study|Withdrawal by Subject|6|||
126130554|NCT01328951|453768389|FG001|Overall Study|Withdrawal by Subject|6|||
126130555|NCT01328951|453768388|FG000|Overall Study|Study Closed by the Sponsor|36|||
126130556|NCT01328951|453768389|FG001|Overall Study|Study Closed by the Sponsor|31|||
126130557|NCT01328951|453768388|FG000|Overall Study|Other|11|||
126130558|NCT01328951|453768389|FG001|Overall Study|Other|6|||
126130559|NCT04042103|453768392|FG000|Overall Study|Lost to Follow-up|1|||
126130560|NCT04042103|453768392|FG000|Overall Study|Withdrawal by Subject|1|||
126130561|NCT01003210|453768393|FG000|Overall Study|Lost to Follow-up|1|||
126130562|NCT01003210|453768394|FG001|Overall Study|Lost to Follow-up|3|||
126130563|NCT00271817|453768395|FG000|Part 1|Adverse Event|68|||
126130564|NCT00271817|453768396|FG001|Part 1|Adverse Event|25|||
126130565|NCT00271817|453768397|FG002|Part 1|Adverse Event|156|||
126130566|NCT00271817|453768395|FG000|Part 1|Lost to Follow-up|6|||
126130567|NCT00271817|453768396|FG001|Part 1|Lost to Follow-up|8|||
126130568|NCT00271817|453768397|FG002|Part 1|Lost to Follow-up|24|||
126130569|NCT00271817|453768395|FG000|Part 1|Protocol Violation|5|||
126130570|NCT00271817|453768396|FG001|Part 1|Protocol Violation|4|||
126130571|NCT00271817|453768397|FG002|Part 1|Protocol Violation|7|||
126130572|NCT00271817|453768395|FG000|Part 1|Patient Moved|3|||
126130573|NCT00271817|453768396|FG001|Part 1|Patient Moved|1|||
126130574|NCT00271817|453768397|FG002|Part 1|Patient Moved|5|||
126130575|NCT00271817|453768395|FG000|Part 1|Withdrawal by Subject|23|||
126130576|NCT00271817|453768396|FG001|Part 1|Withdrawal by Subject|17|||
126130577|NCT00271817|453768397|FG002|Part 1|Withdrawal by Subject|45|||
126130578|NCT00271817|453768395|FG000|Part 1|LDL < 50 mg/dL|1|||
126130579|NCT00271817|453768396|FG001|Part 1|LDL < 50 mg/dL|4|||
126130580|NCT00271817|453768397|FG002|Part 1|LDL < 50 mg/dL|48|||
126130581|NCT00271817|453768395|FG000|Part 2|Adverse Event|0|||
126130582|NCT00271817|453768396|FG001|Part 2|Adverse Event|17|||
126130583|NCT00271817|453768397|FG002|Part 2|Adverse Event|33|||
126130584|NCT00271817|453768395|FG000|Part 2|Lack of Efficacy|0|||
126130585|NCT00271817|453768396|FG001|Part 2|Lack of Efficacy|1|||
126130586|NCT00271817|453768397|FG002|Part 2|Lack of Efficacy|6|||
126130587|NCT00271817|453768395|FG000|Part 2|Lost to Follow-up|0|||
125964115|NCT01722331|453159341|FG005|Part 2|Physician Decision|0|||
125964116|NCT01722331|453159342|FG006|Part 2|Physician Decision|0|||
125964117|NCT01722331|453159336|FG000|Part 2|Pregnancy|0|||
125964118|NCT01722331|453159337|FG001|Part 2|Pregnancy|0|||
125964119|NCT01722331|453159338|FG002|Part 2|Pregnancy|0|||
125964120|NCT01722331|453159339|FG003|Part 2|Pregnancy|0|||
125964121|NCT01722331|453159340|FG004|Part 2|Pregnancy|0|||
125964122|NCT01722331|453159341|FG005|Part 2|Pregnancy|1|||
125964123|NCT01722331|453159342|FG006|Part 2|Pregnancy|0|||
125964124|NCT01722331|453159336|FG000|Part 2|Progressive Disease|0|||
125964125|NCT01722331|453159337|FG001|Part 2|Progressive Disease|0|||
125964126|NCT01722331|453159338|FG002|Part 2|Progressive Disease|1|||
125964127|NCT01722331|453159339|FG003|Part 2|Progressive Disease|0|||
125964128|NCT01722331|453159340|FG004|Part 2|Progressive Disease|0|||
125964129|NCT01722331|453159341|FG005|Part 2|Progressive Disease|0|||
125964130|NCT01722331|453159342|FG006|Part 2|Progressive Disease|0|||
125964131|NCT01722331|453159336|FG000|Part 2|Protocol Violation|1|||
125964132|NCT01722331|453159337|FG001|Part 2|Protocol Violation|0|||
125964133|NCT01722331|453159338|FG002|Part 2|Protocol Violation|0|||
125964134|NCT01722331|453159339|FG003|Part 2|Protocol Violation|0|||
125964135|NCT01722331|453159340|FG004|Part 2|Protocol Violation|0|||
125964136|NCT01722331|453159341|FG005|Part 2|Protocol Violation|0|||
125964137|NCT01722331|453159342|FG006|Part 2|Protocol Violation|0|||
125964138|NCT01722331|453159336|FG000|Part 2|Withdrawal by Subject|5|||
125964139|NCT01722331|453159337|FG001|Part 2|Withdrawal by Subject|0|||
125964140|NCT01722331|453159338|FG002|Part 2|Withdrawal by Subject|3|||
125964141|NCT01722331|453159339|FG003|Part 2|Withdrawal by Subject|0|||
125964142|NCT01722331|453159340|FG004|Part 2|Withdrawal by Subject|0|||
125964143|NCT01722331|453159341|FG005|Part 2|Withdrawal by Subject|2|||
126130588|NCT00271817|453768396|FG001|Part 2|Lost to Follow-up|6|||
126130589|NCT00271817|453768397|FG002|Part 2|Lost to Follow-up|18|||
126130590|NCT00271817|453768395|FG000|Part 2|Protocol Violation|0|||
126130591|NCT00271817|453768396|FG001|Part 2|Protocol Violation|3|||
126130592|NCT00271817|453768397|FG002|Part 2|Protocol Violation|5|||
126130593|NCT00271817|453768395|FG000|Part 2|Patient Moved|0|||
125964144|NCT01722331|453159342|FG006|Part 2|Withdrawal by Subject|2|||
125964145|NCT01722331|453159336|FG000|Part 2|Other Protocol Specified Criteria|6|||
125964146|NCT01722331|453159337|FG001|Part 2|Other Protocol Specified Criteria|0|||
126130594|NCT00271817|453768396|FG001|Part 2|Patient Moved|0|||
126130595|NCT00271817|453768397|FG002|Part 2|Patient Moved|5|||
126130596|NCT00271817|453768395|FG000|Part 2|Withdrawal by Subject|0|||
126130597|NCT00271817|453768396|FG001|Part 2|Withdrawal by Subject|2|||
126130598|NCT00271817|453768397|FG002|Part 2|Withdrawal by Subject|13|||
126130599|NCT00271817|453768395|FG000|Part 2|LDL < 50 mg/dL|0|||
126130600|NCT00271817|453768396|FG001|Part 2|LDL < 50 mg/dL|3|||
126130601|NCT00271817|453768397|FG002|Part 2|LDL < 50 mg/dL|4|||
126130602|NCT04153188|453768400|FG000|Overall Study|Lost to Follow-up|1|||
126130603|NCT04153188|453768401|FG001|Overall Study|Lost to Follow-up|1|||
126130604|NCT04153188|453768400|FG000|Overall Study|Withdrawal by Subject|2|||
126130605|NCT04153188|453768401|FG001|Overall Study|Withdrawal by Subject|0|||
126130606|NCT04153188|453768400|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
126130607|NCT04153188|453768401|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
126130608|NCT00700271|453768402|FG000|Overall Study|Adverse Event|4|||
126130609|NCT00700271|453768403|FG001|Overall Study|Adverse Event|6|||
126130610|NCT00700271|453768402|FG000|Overall Study|Protocol Violation|1|||
125964147|NCT01722331|453159338|FG002|Part 2|Other Protocol Specified Criteria|10|||
125964148|NCT01722331|453159339|FG003|Part 2|Other Protocol Specified Criteria|0|||
125964149|NCT01722331|453159340|FG004|Part 2|Other Protocol Specified Criteria|0|||
125964150|NCT01722331|453159341|FG005|Part 2|Other Protocol Specified Criteria|2|||
125964151|NCT01722331|453159342|FG006|Part 2|Other Protocol Specified Criteria|1|||
125964152|NCT01722331|453159336|FG000|Part 3|Adverse Event|2|||
125964153|NCT01722331|453159337|FG001|Part 3|Adverse Event|2|||
125964154|NCT01722331|453159338|FG002|Part 3|Adverse Event|0|||
125964155|NCT01722331|453159339|FG003|Part 3|Adverse Event|1|||
125964156|NCT01722331|453159340|FG004|Part 3|Adverse Event|0|||
125964157|NCT01722331|453159341|FG005|Part 3|Adverse Event|0|||
125964158|NCT01722331|453159342|FG006|Part 3|Adverse Event|0|||
125964159|NCT01722331|453159336|FG000|Part 3|Death|1|||
125964160|NCT01722331|453159337|FG001|Part 3|Death|0|||
126130611|NCT00700271|453768403|FG001|Overall Study|Protocol Violation|0|||
126130612|NCT00700271|453768402|FG000|Overall Study|Administrative Reasons|1|||
126130613|NCT00700271|453768403|FG001|Overall Study|Administrative Reasons|0|||
126130614|NCT00700271|453768402|FG000|Overall Study|Withdrawal by Subject|6|||
126130615|NCT00700271|453768403|FG001|Overall Study|Withdrawal by Subject|4|||
126130616|NCT00700271|453768402|FG000|Overall Study|Lost to Follow-up|2|||
126130617|NCT00700271|453768403|FG001|Overall Study|Lost to Follow-up|2|||
126130618|NCT00861744|453768404|FG000|Overall Study|Adverse Event|0|||
126130619|NCT00861744|453768405|FG001|Overall Study|Adverse Event|0|||
126130620|NCT00861744|453768406|FG002|Overall Study|Adverse Event|0|||
126130621|NCT00861744|453768407|FG003|Overall Study|Adverse Event|1|||
126130622|NCT00861744|453768404|FG000|Overall Study|Lost to Follow-up|7|||
126130623|NCT00861744|453768405|FG001|Overall Study|Lost to Follow-up|19|||
126130624|NCT00861744|453768406|FG002|Overall Study|Lost to Follow-up|17|||
126130625|NCT00861744|453768407|FG003|Overall Study|Lost to Follow-up|12|||
126130626|NCT00861744|453768404|FG000|Overall Study|Withdrawal by Subject|10|||
126130627|NCT00861744|453768405|FG001|Overall Study|Withdrawal by Subject|6|||
126130628|NCT00861744|453768406|FG002|Overall Study|Withdrawal by Subject|6|||
126130629|NCT00861744|453768407|FG003|Overall Study|Withdrawal by Subject|19|||
126130630|NCT00861744|453768404|FG000|Overall Study|Protocol Violation|0|||
126130631|NCT00861744|453768405|FG001|Overall Study|Protocol Violation|1|||
126130632|NCT00861744|453768406|FG002|Overall Study|Protocol Violation|0|||
126130633|NCT00861744|453768407|FG003|Overall Study|Protocol Violation|0|||
126130634|NCT00861744|453768404|FG000|Overall Study|Migration from study area|0|||
126130635|NCT00861744|453768405|FG001|Overall Study|Migration from study area|3|||
126130636|NCT00861744|453768406|FG002|Overall Study|Migration from study area|1|||
126130637|NCT00861744|453768407|FG003|Overall Study|Migration from study area|0|||
126130638|NCT00861744|453768404|FG000|Overall Study|Blood draws|0|||
126130639|NCT00861744|453768405|FG001|Overall Study|Blood draws|0|||
126130640|NCT00861744|453768406|FG002|Overall Study|Blood draws|0|||
126130641|NCT00861744|453768407|FG003|Overall Study|Blood draws|1|||
126130642|NCT05107765|453768408|FG000|Overall Study|Lost to Follow-up|4|||
126130643|NCT05107765|453768409|FG001|Overall Study|Lost to Follow-up|1|||
126130644|NCT05107765|453768408|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
126130645|NCT05107765|453768409|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
126130646|NCT05107765|453768408|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
125964161|NCT01722331|453159338|FG002|Part 3|Death|0|||
125964162|NCT01722331|453159339|FG003|Part 3|Death|0|||
125964163|NCT01722331|453159340|FG004|Part 3|Death|0|||
125964164|NCT01722331|453159341|FG005|Part 3|Death|0|||
125964165|NCT01722331|453159342|FG006|Part 3|Death|0|||
125964166|NCT01722331|453159336|FG000|Part 3|Lack of Efficacy|1|||
125964167|NCT01722331|453159337|FG001|Part 3|Lack of Efficacy|0|||
125964168|NCT01722331|453159338|FG002|Part 3|Lack of Efficacy|0|||
126130647|NCT05107765|453768409|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
126130648|NCT03124563|453768412|FG000|Overall Study|Lost to Follow-up|1|||
126130649|NCT03124563|453768413|FG001|Overall Study|Lost to Follow-up|1|||
126130650|NCT03124563|453768412|FG000|Overall Study|Withdrawal by Subject|1|||
126130651|NCT03124563|453768413|FG001|Overall Study|Withdrawal by Subject|1|||
125964169|NCT01722331|453159339|FG003|Part 3|Lack of Efficacy|0|||
125964170|NCT01722331|453159340|FG004|Part 3|Lack of Efficacy|0|||
126130652|NCT00264004|453769661|FG000|Overall Study|Adverse Event|2|||
126130653|NCT00264004|453769662|FG001|Overall Study|Adverse Event|3|||
126130654|NCT00264004|453769663|FG002|Overall Study|Adverse Event|6|||
126130655|NCT00264004|453769664|FG003|Overall Study|Adverse Event|4|||
126130656|NCT00264004|453769661|FG000|Overall Study|Withdrawal by Subject|0|||
126130657|NCT00264004|453769662|FG001|Overall Study|Withdrawal by Subject|1|||
126130658|NCT00264004|453769663|FG002|Overall Study|Withdrawal by Subject|2|||
126130659|NCT00264004|453769664|FG003|Overall Study|Withdrawal by Subject|2|||
126130660|NCT00264004|453769661|FG000|Overall Study|Other|2|||
126130661|NCT00264004|453769662|FG001|Overall Study|Other|2|||
126130662|NCT00264004|453769663|FG002|Overall Study|Other|0|||
126130663|NCT00264004|453769664|FG003|Overall Study|Other|3|||
126130664|NCT00264004|453769661|FG000|Overall Study|Development study specific disc. crit.|1|||
126130665|NCT00264004|453769662|FG001|Overall Study|Development study specific disc. crit.|0|||
126130666|NCT00264004|453769663|FG002|Overall Study|Development study specific disc. crit.|1|||
126130667|NCT00264004|453769664|FG003|Overall Study|Development study specific disc. crit.|0|||
126130668|NCT00264004|453769661|FG000|Overall Study|Cond. under inv. worsened|9|||
126130669|NCT00264004|453769662|FG001|Overall Study|Cond. under inv. worsened|5|||
126130670|NCT00264004|453769663|FG002|Overall Study|Cond. under inv. worsened|3|||
126130671|NCT00264004|453769664|FG003|Overall Study|Cond. under inv. worsened|4|||
126130672|NCT00264004|453769661|FG000|Overall Study|Not treated|3|||
126130673|NCT00264004|453769662|FG001|Overall Study|Not treated|0|||
126130674|NCT00264004|453769663|FG002|Overall Study|Not treated|2|||
126130675|NCT00264004|453769664|FG003|Overall Study|Not treated|2|||
126130676|NCT01262365|453769665|FG000|Overall Study|Lack of Efficacy|35|||
126130677|NCT01262365|453769666|FG001|Overall Study|Lack of Efficacy|30|||
126130678|NCT01262365|453769667|FG002|Overall Study|Lack of Efficacy|47|||
126130679|NCT01262365|453769665|FG000|Overall Study|Protocol Violation|3|||
126130680|NCT01262365|453769666|FG001|Overall Study|Protocol Violation|1|||
126130681|NCT01262365|453769667|FG002|Overall Study|Protocol Violation|1|||
126130682|NCT01262365|453769665|FG000|Overall Study|Lost to Follow-up|3|||
126130683|NCT01262365|453769666|FG001|Overall Study|Lost to Follow-up|7|||
126130684|NCT01262365|453769667|FG002|Overall Study|Lost to Follow-up|6|||
126130685|NCT01262365|453769665|FG000|Overall Study|Withdrawal by Subject|17|||
126130686|NCT01262365|453769666|FG001|Overall Study|Withdrawal by Subject|22|||
126130687|NCT01262365|453769667|FG002|Overall Study|Withdrawal by Subject|22|||
126130688|NCT01262365|453769665|FG000|Overall Study|Death|1|||
126130689|NCT01262365|453769666|FG001|Overall Study|Death|2|||
126130690|NCT01262365|453769667|FG002|Overall Study|Death|1|||
126130691|NCT01262365|453769665|FG000|Overall Study|Adverse Event|26|||
126130692|NCT01262365|453769666|FG001|Overall Study|Adverse Event|16|||
126130693|NCT01262365|453769667|FG002|Overall Study|Adverse Event|11|||
126130694|NCT01262365|453769665|FG000|Overall Study|sponsor decision|1|||
126130695|NCT01262365|453769666|FG001|Overall Study|sponsor decision|1|||
126130696|NCT01262365|453769667|FG002|Overall Study|sponsor decision|0|||
126130697|NCT01262365|453769665|FG000|Overall Study|Randomization error|1|||
126130698|NCT01262365|453769666|FG001|Overall Study|Randomization error|0|||
126130699|NCT01262365|453769667|FG002|Overall Study|Randomization error|2|||
126130700|NCT01262365|453769665|FG000|Overall Study|Non-compliance|1|||
126130701|NCT01262365|453769666|FG001|Overall Study|Non-compliance|0|||
126130702|NCT01262365|453769667|FG002|Overall Study|Non-compliance|2|||
126130703|NCT01262365|453769665|FG000|Overall Study|Suspected pregnancy|1|||
126130704|NCT01262365|453769666|FG001|Overall Study|Suspected pregnancy|0|||
126130705|NCT01262365|453769667|FG002|Overall Study|Suspected pregnancy|0|||
126130706|NCT01262365|453769665|FG000|Overall Study|Patient pregnant|1|||
126130707|NCT01262365|453769666|FG001|Overall Study|Patient pregnant|0|||
126130708|NCT01262365|453769667|FG002|Overall Study|Patient pregnant|1|||
126130709|NCT01262365|453769665|FG000|Overall Study|Toxicity related to study drug|0|||
126130710|NCT01262365|453769666|FG001|Overall Study|Toxicity related to study drug|1|||
126130711|NCT01262365|453769667|FG002|Overall Study|Toxicity related to study drug|0|||
126130712|NCT01262365|453769665|FG000|Overall Study|Cannot tolerate the protocol|0|||
126130713|NCT01262365|453769666|FG001|Overall Study|Cannot tolerate the protocol|1|||
126130714|NCT01262365|453769667|FG002|Overall Study|Cannot tolerate the protocol|0|||
126130715|NCT01262365|453769665|FG000|Overall Study|Patient unavailable|0|||
126130716|NCT01262365|453769666|FG001|Overall Study|Patient unavailable|0|||
126130717|NCT01262365|453769667|FG002|Overall Study|Patient unavailable|1|||
126130718|NCT03733392|453769671|FG000|Overall Study|Withdrawal by Subject|11|||
126130719|NCT03733392|453769672|FG001|Overall Study|Withdrawal by Subject|1|||
126130720|NCT03733392|453769671|FG000|Overall Study|Death|1|||
126130721|NCT03733392|453769672|FG001|Overall Study|Death|0|||
125964171|NCT01722331|453159341|FG005|Part 3|Lack of Efficacy|0|||
126130722|NCT03733392|453769671|FG000|Overall Study|Lost to Follow-up|5|||
126130723|NCT03733392|453769672|FG001|Overall Study|Lost to Follow-up|0|||
126130724|NCT03733392|453769671|FG000|Overall Study|Protocol Violation|0|||
126130725|NCT03733392|453769672|FG001|Overall Study|Protocol Violation|1|||
126130726|NCT03733392|453769671|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
126130727|NCT03733392|453769672|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
125964172|NCT01722331|453159342|FG006|Part 3|Lack of Efficacy|0|||
126130728|NCT03733392|453769671|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
126130729|NCT03733392|453769672|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
126130730|NCT03733392|453769671|FG000|Overall Study|Patient Non-Compliance|2|||
126130731|NCT03733392|453769672|FG001|Overall Study|Patient Non-Compliance|1|||
126130732|NCT03733392|453769671|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
126130733|NCT03733392|453769672|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
126130734|NCT03733392|453769671|FG000|Overall Study|Withdrawal prior to procedure|5|||
126130735|NCT03733392|453769672|FG001|Overall Study|Withdrawal prior to procedure|2|||
126130736|NCT02615990|453769680|FG000|Overall Study|study terminated|1|||
126130737|NCT02615990|453769681|FG001|Overall Study|study terminated|1|||
126130738|NCT01363986|453769682|FG000|Overall Study|Disease progression|1|||
126130739|NCT01637142|453769683|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
126130740|NCT00925015|453769684|FG000|Overall Study|Adverse Event|1|||
126130741|NCT00925015|453769685|FG001|Overall Study|Adverse Event|2|||
126130742|NCT00925015|453769686|FG002|Overall Study|Adverse Event|1|||
126130743|NCT00925015|453769684|FG000|Overall Study|Physician Decision|0|||
126130744|NCT00925015|453769685|FG001|Overall Study|Physician Decision|1|||
126130745|NCT00925015|453769686|FG002|Overall Study|Physician Decision|0|||
126130746|NCT00925015|453769684|FG000|Overall Study|Progressive Disease|7|||
126130747|NCT00925015|453769685|FG001|Overall Study|Progressive Disease|3|||
126130748|NCT00925015|453769686|FG002|Overall Study|Progressive Disease|4|||
126130749|NCT00925015|453769684|FG000|Overall Study|Withdrawal by Subject|0|||
126130750|NCT00925015|453769685|FG001|Overall Study|Withdrawal by Subject|0|||
126130751|NCT00925015|453769686|FG002|Overall Study|Withdrawal by Subject|1|||
126130752|NCT04986202|453769687|FG000|Overall Study|Death|10|||
126130753|NCT04986202|453769688|FG001|Overall Study|Death|3|||
126130754|NCT04986202|453769689|FG002|Overall Study|Death|10|||
126130755|NCT04986202|453769687|FG000|Overall Study|Physician Decision|3|||
126130756|NCT04986202|453769688|FG001|Overall Study|Physician Decision|1|||
126130757|NCT04986202|453769689|FG002|Overall Study|Physician Decision|2|||
126130758|NCT04986202|453769687|FG000|Overall Study|Withdrawal by Subject|4|||
126130759|NCT04986202|453769688|FG001|Overall Study|Withdrawal by Subject|2|||
126130760|NCT04986202|453769689|FG002|Overall Study|Withdrawal by Subject|4|||
126130761|NCT02468648|453769690|FG000|Overall Study|Death|1|||
126130762|NCT01368835|453769691|FG000|Overall Study|Inclusion criteria/photography quality|22|||
126130763|NCT01368835|453769691|FG000|Overall Study|Lost to Follow-up|11|||
126130764|NCT02754726|453769692|FG000|Overall Study|Progressive Disease by RECIST|13|||
126130765|NCT02754726|453769692|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
126130766|NCT02754726|453769692|FG000|Overall Study|Clinical Disease Progression|5|||
126130767|NCT02754726|453769692|FG000|Overall Study|Adverse Event|3|||
126130768|NCT02754726|453769692|FG000|Overall Study|Withdrawal by Subject|1|||
126130769|NCT02754726|453769692|FG000|Overall Study|Tolerability|1|||
126130770|NCT01885000|453769693|FG000|Overall Study|Adverse Event|1|||
126130771|NCT01885000|453769694|FG001|Overall Study|Adverse Event|0|||
126130772|NCT01885000|453769693|FG000|Overall Study|Withdrawal by Subject|1|||
126130773|NCT01885000|453769694|FG001|Overall Study|Withdrawal by Subject|1|||
126130774|NCT01885000|453769693|FG000|Overall Study|Protocol Violation|0|||
126130775|NCT01885000|453769694|FG001|Overall Study|Protocol Violation|1|||
126130776|NCT03124784|453769695|FG000|Overall Study|Adverse Event|1|||
126130777|NCT03124784|453769695|FG000|Overall Study|Computer/Equip Malfunction|1|||
126130778|NCT01777152|453769701|FG000|Overall Study|Withdrawal by Subject|22|||
126130779|NCT01777152|453769702|FG001|Overall Study|Withdrawal by Subject|16|||
126130780|NCT01777152|453769701|FG000|Overall Study|Lost to Follow-up|3|||
126130781|NCT01777152|453769702|FG001|Overall Study|Lost to Follow-up|5|||
126130782|NCT01777152|453769701|FG000|Overall Study|Death|68|||
126130783|NCT01777152|453769702|FG001|Overall Study|Death|89|||
126130784|NCT01777152|453769701|FG000|Overall Study|Not eligible, no study drug received|1|||
126130785|NCT01777152|453769702|FG001|Overall Study|Not eligible, no study drug received|0|||
126130786|NCT01777152|453769701|FG000|Overall Study|Change of diagnosis|1|||
126130787|NCT01777152|453769702|FG001|Overall Study|Change of diagnosis|0|||
126130788|NCT02792842|453769703|FG000|Overall Study|Adverse Event|4|||
126130789|NCT02792842|453769704|FG001|Overall Study|Adverse Event|2|||
126130790|NCT02792842|453769705|FG002|Overall Study|Adverse Event|3|||
126130791|NCT02792842|453769703|FG000|Overall Study|Withdrawal by Subject|0|||
126130792|NCT02792842|453769704|FG001|Overall Study|Withdrawal by Subject|1|||
126130793|NCT02792842|453769705|FG002|Overall Study|Withdrawal by Subject|2|||
126130794|NCT02792842|453769703|FG000|Overall Study|Lost to Follow-up|0|||
126130795|NCT02792842|453769704|FG001|Overall Study|Lost to Follow-up|0|||
126130796|NCT02792842|453769705|FG002|Overall Study|Lost to Follow-up|1|||
126130797|NCT02792842|453769703|FG000|Overall Study|Schedule delay|0|||
126130798|NCT02792842|453769704|FG001|Overall Study|Schedule delay|1|||
126130799|NCT02792842|453769705|FG002|Overall Study|Schedule delay|1|||
126130800|NCT01415752|453769709|FG000|Induction (Step 1)|Ineligible|4|||
126130801|NCT01415752|453769710|FG001|Induction (Step 1)|Ineligible|3|||
126130802|NCT01415752|453769711|FG002|Induction (Step 1)|Ineligible|4|||
126130803|NCT01415752|453769712|FG003|Induction (Step 1)|Ineligible|4|||
126130804|NCT01415752|453769709|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
126130805|NCT01415752|453769710|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
126130806|NCT01415752|453769711|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
126130807|NCT01415752|453769712|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
126130808|NCT01415752|453769709|FG000|Maintenance (Step 2)|Adverse Event|3|||
126130809|NCT01415752|453769710|FG001|Maintenance (Step 2)|Adverse Event|4|||
126130810|NCT01415752|453769711|FG002|Maintenance (Step 2)|Adverse Event|9|||
126130811|NCT01415752|453769712|FG003|Maintenance (Step 2)|Adverse Event|6|||
126130812|NCT01415752|453769709|FG000|Maintenance (Step 2)|Death|1|||
126130813|NCT01415752|453769710|FG001|Maintenance (Step 2)|Death|1|||
126130814|NCT01415752|453769711|FG002|Maintenance (Step 2)|Death|2|||
126130815|NCT01415752|453769712|FG003|Maintenance (Step 2)|Death|0|||
126130816|NCT01415752|453769709|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
126130817|NCT01415752|453769710|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
126130818|NCT01415752|453769711|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
126130819|NCT01415752|453769712|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
126130820|NCT01415752|453769709|FG000|Maintenance (Step 2)|Alternative therapy|0|||
126130821|NCT01415752|453769710|FG001|Maintenance (Step 2)|Alternative therapy|1|||
126130822|NCT01415752|453769711|FG002|Maintenance (Step 2)|Alternative therapy|0|||
126130823|NCT01415752|453769712|FG003|Maintenance (Step 2)|Alternative therapy|0|||
126130824|NCT01415752|453769709|FG000|Maintenance (Step 2)|Other reasons|3|||
126130825|NCT01415752|453769710|FG001|Maintenance (Step 2)|Other reasons|6|||
126130826|NCT01415752|453769711|FG002|Maintenance (Step 2)|Other reasons|4|||
126130827|NCT01415752|453769712|FG003|Maintenance (Step 2)|Other reasons|6|||
126130828|NCT01415752|453769709|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
126130829|NCT01415752|453769710|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
126130830|NCT01415752|453769711|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
126130831|NCT01415752|453769712|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
126130832|NCT01415752|453769709|FG000|Maintenance (Step 2)|ineligible|1|||
126130833|NCT01415752|453769710|FG001|Maintenance (Step 2)|ineligible|1|||
126130834|NCT01415752|453769711|FG002|Maintenance (Step 2)|ineligible|1|||
126130835|NCT01415752|453769712|FG003|Maintenance (Step 2)|ineligible|0|||
126130836|NCT01415752|453769709|FG000|Maintenance (Step 2)|Missing|4|||
126130837|NCT01415752|453769710|FG001|Maintenance (Step 2)|Missing|1|||
126130838|NCT01415752|453769711|FG002|Maintenance (Step 2)|Missing|4|||
126130839|NCT01415752|453769712|FG003|Maintenance (Step 2)|Missing|3|||
126130840|NCT00252057|453769715|FG000|Overall Study|Withdrawal by Subject|2|||
126130841|NCT00252057|453769716|FG001|Overall Study|Withdrawal by Subject|5|||
126130842|NCT00252057|453769715|FG000|Overall Study|Death|1|||
126130843|NCT00252057|453769716|FG001|Overall Study|Death|2|||
126130844|NCT00252057|453769715|FG000|Overall Study|Participant previously enrolled|0|||
126130845|NCT00252057|453769716|FG001|Overall Study|Participant previously enrolled|1|||
126130846|NCT01098071|453769722|FG000|Overall Study|Surgery (adenoidectomy)|2|||
126130847|NCT01098071|453769722|FG000|Overall Study|Lost to Follow-up|13|||
126130848|NCT01903837|453769725|FG000|Part A|Withdrawal by Subject|4|||
126130849|NCT01903837|453769726|FG001|Part A|Withdrawal by Subject|9|||
126130850|NCT01903837|453769727|FG002|Part A|Withdrawal by Subject|8|||
126130851|NCT01903837|453769728|FG003|Part A|Withdrawal by Subject|5|||
126130852|NCT01903837|453769725|FG000|Part A|Adverse Event|3|||
126130853|NCT01903837|453769726|FG001|Part A|Adverse Event|6|||
126130854|NCT01903837|453769727|FG002|Part A|Adverse Event|9|||
126130855|NCT01903837|453769728|FG003|Part A|Adverse Event|6|||
126130856|NCT01903837|453769725|FG000|Part A|Lost to Follow-up|9|||
126130857|NCT01903837|453769726|FG001|Part A|Lost to Follow-up|7|||
126130858|NCT01903837|453769727|FG002|Part A|Lost to Follow-up|7|||
126130859|NCT01903837|453769728|FG003|Part A|Lost to Follow-up|2|||
126130860|NCT01903837|453769725|FG000|Part A|Non-compliance with study drug|1|||
126130861|NCT01903837|453769726|FG001|Part A|Non-compliance with study drug|4|||
126130862|NCT01903837|453769727|FG002|Part A|Non-compliance with study drug|4|||
126130863|NCT01903837|453769728|FG003|Part A|Non-compliance with study drug|0|||
126130864|NCT01903837|453769725|FG000|Part A|Physician Decision|1|||
126130865|NCT01903837|453769726|FG001|Part A|Physician Decision|1|||
126130866|NCT01903837|453769727|FG002|Part A|Physician Decision|0|||
126130867|NCT01903837|453769728|FG003|Part A|Physician Decision|0|||
126130868|NCT01903837|453769725|FG000|Part A|Protocol Violation|1|||
125964173|NCT01722331|453159336|FG000|Part 3|Lost to Follow-up|3|||
126130869|NCT01903837|453769726|FG001|Part A|Protocol Violation|1|||
126130870|NCT01903837|453769727|FG002|Part A|Protocol Violation|0|||
126130871|NCT01903837|453769728|FG003|Part A|Protocol Violation|0|||
126130872|NCT01903837|453769725|FG000|Part B|Lost to Follow-up|0|||
126130873|NCT01903837|453769726|FG001|Part B|Lost to Follow-up|3|||
126130874|NCT01903837|453769727|FG002|Part B|Lost to Follow-up|3|||
126130875|NCT01903837|453769728|FG003|Part B|Lost to Follow-up|4|||
126130876|NCT01903837|453769725|FG000|Part B|Withdrawal by Subject|1|||
126130877|NCT01903837|453769726|FG001|Part B|Withdrawal by Subject|2|||
126130878|NCT01903837|453769727|FG002|Part B|Withdrawal by Subject|0|||
126130879|NCT01903837|453769728|FG003|Part B|Withdrawal by Subject|3|||
126130880|NCT01903837|453769725|FG000|Part B|Adverse Event|3|||
126130881|NCT01903837|453769726|FG001|Part B|Adverse Event|0|||
126130882|NCT01903837|453769727|FG002|Part B|Adverse Event|2|||
126130883|NCT01903837|453769728|FG003|Part B|Adverse Event|0|||
126130884|NCT01903837|453769725|FG000|Part B|Non-compliance with study drug|2|||
126130885|NCT01903837|453769726|FG001|Part B|Non-compliance with study drug|0|||
126130886|NCT01903837|453769727|FG002|Part B|Non-compliance with study drug|0|||
126130887|NCT01903837|453769728|FG003|Part B|Non-compliance with study drug|1|||
126130888|NCT01903837|453769725|FG000|Part B|Incarceration|2|||
126130889|NCT01903837|453769726|FG001|Part B|Incarceration|0|||
126130890|NCT01903837|453769727|FG002|Part B|Incarceration|0|||
126130891|NCT01903837|453769728|FG003|Part B|Incarceration|1|||
126130892|NCT01903837|453769725|FG000|Part B|Physician Decision|1|||
126130893|NCT01903837|453769726|FG001|Part B|Physician Decision|0|||
126130894|NCT01903837|453769727|FG002|Part B|Physician Decision|0|||
126130895|NCT01903837|453769728|FG003|Part B|Physician Decision|2|||
126130896|NCT01903837|453769725|FG000|Part B|Lack of Efficacy|0|||
126130897|NCT01903837|453769726|FG001|Part B|Lack of Efficacy|1|||
126130898|NCT01903837|453769727|FG002|Part B|Lack of Efficacy|0|||
126130899|NCT01903837|453769728|FG003|Part B|Lack of Efficacy|0|||
126130900|NCT04372927|453769730|FG000|Overall Study|Death|1|||
126130901|NCT01665807|453769731|FG000|Overall Study|Withdrawal by Subject|2|||
126130902|NCT01665807|453769732|FG001|Overall Study|Withdrawal by Subject|0|||
126130903|NCT01665807|453769733|FG002|Overall Study|Withdrawal by Subject|1|||
126130904|NCT01081795|453769734|FG000|Overall Study|Adverse Event|18|||
126130905|NCT01081795|453769735|FG001|Overall Study|Adverse Event|23|||
126130906|NCT01081795|453769736|FG002|Overall Study|Adverse Event|6|||
126130907|NCT01081795|453769734|FG000|Overall Study|Lack of Efficacy|7|||
126130908|NCT01081795|453769735|FG001|Overall Study|Lack of Efficacy|5|||
126130909|NCT01081795|453769736|FG002|Overall Study|Lack of Efficacy|19|||
126130910|NCT01081795|453769734|FG000|Overall Study|Subject's schedule|1|||
126130911|NCT01081795|453769735|FG001|Overall Study|Subject's schedule|1|||
126130912|NCT01081795|453769736|FG002|Overall Study|Subject's schedule|2|||
126130913|NCT01081795|453769734|FG000|Overall Study|Revocation of informed consent|2|||
126130914|NCT01081795|453769735|FG001|Overall Study|Revocation of informed consent|0|||
126130915|NCT01081795|453769736|FG002|Overall Study|Revocation of informed consent|0|||
126130916|NCT01081795|453769734|FG000|Overall Study|Ineligible for participation|1|||
126130917|NCT01081795|453769735|FG001|Overall Study|Ineligible for participation|0|||
126130918|NCT01081795|453769736|FG002|Overall Study|Ineligible for participation|0|||
126130919|NCT01081795|453769734|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
126130920|NCT01081795|453769735|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
126130921|NCT01081795|453769736|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
126130922|NCT01081795|453769734|FG000|Overall Study|Using drug with restricted days of use|2|||
126130923|NCT01081795|453769735|FG001|Overall Study|Using drug with restricted days of use|3|||
126130924|NCT01081795|453769736|FG002|Overall Study|Using drug with restricted days of use|2|||
126130925|NCT01081795|453769734|FG000|Overall Study|Other|1|||
126130926|NCT01081795|453769735|FG001|Overall Study|Other|2|||
126130927|NCT01081795|453769736|FG002|Overall Study|Other|0|||
126130928|NCT03847610|453769738|FG000|Overall Study|Withdrawal by Subject|1|||
126130929|NCT03298022|453769739|FG000|Overall Study|Lack of Efficacy|4|||
126130930|NCT03298022|453769739|FG000|Overall Study|Withdrawal by Subject|7|||
126130931|NCT03298022|453769739|FG000|Overall Study|Adverse Event|1|||
126130932|NCT03298022|453769739|FG000|Overall Study|disease relapse|1|||
126130933|NCT01445769|453769742|FG000|Overall Study|Consent Withdrawn|2|||
126130934|NCT01445769|453769742|FG000|Overall Study|Disease Progression|1|||
126130935|NCT01445769|453769742|FG000|Overall Study|Lost to Follow-up|5|||
126130936|NCT01967537|453769748|FG000|Overall Study|Withdrawal by Subject|52|||
126130937|NCT01967537|453769748|FG000|Overall Study|Refuse treatment|2|||
126130938|NCT01967537|453769748|FG000|Overall Study|Lost to Follow-up|6|||
126130939|NCT05130463|453769749|FG000|Overall Study|Unspecified reasons|2|||
126130940|NCT05130463|453769749|FG000|Overall Study|off-label indication dose|435|||
126130941|NCT03461757|453769750|FG000|Overall Study|Adverse Event|1|||
126130942|NCT03461757|453769751|FG001|Overall Study|Adverse Event|0|||
126130943|NCT03461757|453769750|FG000|Overall Study|Lost to Follow-up|13|||
126130944|NCT03461757|453769751|FG001|Overall Study|Lost to Follow-up|7|||
126130945|NCT03461757|453769750|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
126130946|NCT03461757|453769751|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
126130947|NCT03461757|453769750|FG000|Overall Study|Non-compliance with study treatment|0|||
126130948|NCT03461757|453769751|FG001|Overall Study|Non-compliance with study treatment|1|||
126130949|NCT03461757|453769750|FG000|Overall Study|Pregnancy|2|||
126130950|NCT03461757|453769751|FG001|Overall Study|Pregnancy|0|||
126130951|NCT03461757|453769750|FG000|Overall Study|Protocol Violation|1|||
125964174|NCT01722331|453159337|FG001|Part 3|Lost to Follow-up|4|||
125964175|NCT01722331|453159338|FG002|Part 3|Lost to Follow-up|0|||
126130952|NCT03461757|453769751|FG001|Overall Study|Protocol Violation|1|||
126130953|NCT03461757|453769750|FG000|Overall Study|Withdrawal by Subject|7|||
126130954|NCT03461757|453769751|FG001|Overall Study|Withdrawal by Subject|7|||
126130955|NCT03461757|453769750|FG000|Overall Study|Other Reasons|1|||
126130956|NCT03461757|453769751|FG001|Overall Study|Other Reasons|4|||
126130957|NCT03652662|453769752|FG000|Overall Study|Withdrawal by Subject|2|||
126130958|NCT03652662|453769753|FG001|Overall Study|Withdrawal by Subject|1|||
126130959|NCT03652662|453769752|FG000|Overall Study|Lost to Follow-up|1|||
126130960|NCT03652662|453769753|FG001|Overall Study|Lost to Follow-up|0|||
126130961|NCT03861559|453769754|FG000|Overall Study|Adverse Event|0|||
126130962|NCT03861559|453769755|FG001|Overall Study|Adverse Event|2|||
126130963|NCT03861559|453769754|FG000|Overall Study|Treatment failure|0|||
126130964|NCT03861559|453769755|FG001|Overall Study|Treatment failure|2|||
126130965|NCT03861559|453769754|FG000|Overall Study|Noncompliance|1|||
126130966|NCT03861559|453769755|FG001|Overall Study|Noncompliance|1|||
126130967|NCT03861559|453769754|FG000|Overall Study|Did not meet eligibility requirements|1|||
126130968|NCT03861559|453769755|FG001|Overall Study|Did not meet eligibility requirements|0|||
126130969|NCT00720109|453769756|FG000|Induction Period|Did not meet eligibility criteria|3|||
126130970|NCT00720109|453769757|FG001|Induction Period|Did not meet eligibility criteria|0|||
126130971|NCT00720109|453769758|FG002|Induction Period|Did not meet eligibility criteria|0|||
126130972|NCT00720109|453769756|FG000|Induction Period|Bone Marrow Transplant|2|||
126130973|NCT00720109|453769757|FG001|Induction Period|Bone Marrow Transplant|0|||
126130974|NCT00720109|453769758|FG002|Induction Period|Bone Marrow Transplant|0|||
126130975|NCT00720109|453769756|FG000|Induction Period|Physician Decision|1|||
126130976|NCT00720109|453769757|FG001|Induction Period|Physician Decision|0|||
126130977|NCT00720109|453769758|FG002|Induction Period|Physician Decision|0|||
126130978|NCT00720109|453769756|FG000|Risk Stratification Period|Adverse Event|0|||
126130979|NCT00720109|453769757|FG001|Risk Stratification Period|Adverse Event|1|||
126130980|NCT00720109|453769758|FG002|Risk Stratification Period|Adverse Event|0|||
126130981|NCT00720109|453769756|FG000|Risk Stratification Period|Physician Decision|0|||
126130982|NCT00720109|453769757|FG001|Risk Stratification Period|Physician Decision|2|||
126130983|NCT00720109|453769758|FG002|Risk Stratification Period|Physician Decision|1|||
126130984|NCT00720109|453769756|FG000|Risk Stratification Period|Bone marrow transplant|0|||
126130985|NCT00720109|453769757|FG001|Risk Stratification Period|Bone marrow transplant|9|||
126130986|NCT00720109|453769758|FG002|Risk Stratification Period|Bone marrow transplant|7|||
126130987|NCT00720109|453769756|FG000|Risk Stratification Period|Disease progression or relapse|0|||
126130988|NCT00720109|453769757|FG001|Risk Stratification Period|Disease progression or relapse|2|||
126130989|NCT00720109|453769758|FG002|Risk Stratification Period|Disease progression or relapse|0|||
126130990|NCT00720109|453769756|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
126130991|NCT00720109|453769757|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
126130992|NCT00720109|453769758|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
126130993|NCT03595553|453769759|FG000|Overall Study|Withdrawal by Subject|20|||
126130994|NCT03595553|453769760|FG001|Overall Study|Withdrawal by Subject|8|||
126130995|NCT03595553|453769759|FG000|Overall Study|Physician Decision|3|||
126130996|NCT03595553|453769760|FG001|Overall Study|Physician Decision|2|||
126130997|NCT03595553|453769759|FG000|Overall Study|Adverse Event|2|||
126130998|NCT03595553|453769760|FG001|Overall Study|Adverse Event|5|||
126130999|NCT03595553|453769759|FG000|Overall Study|Death|24|||
126131000|NCT03595553|453769760|FG001|Overall Study|Death|22|||
126131001|NCT03595553|453769759|FG000|Overall Study|Lost to Follow-up|6|||
126131002|NCT03595553|453769760|FG001|Overall Study|Lost to Follow-up|7|||
126131003|NCT03595553|453769759|FG000|Overall Study|Other as indicated in CSR|3|||
126131004|NCT03595553|453769760|FG001|Overall Study|Other as indicated in CSR|3|||
126131005|NCT03595553|453769759|FG000|Overall Study|Sponsor Decision|0|||
126131006|NCT03595553|453769760|FG001|Overall Study|Sponsor Decision|1|||
126131007|NCT01687712|453769761|FG000|Cycle 1|Not Biochemically Pregnant|386|||
126131008|NCT01687712|453769762|FG001|Cycle 1|Not Biochemically Pregnant|348|||
126131009|NCT01687712|453769761|FG000|Cycle 1|Early Pregnancy Loss|43|||
126131010|NCT01687712|453769762|FG001|Cycle 1|Early Pregnancy Loss|60|||
126131011|NCT01687712|453769761|FG000|Cycle 1|Ectopic Pregnancy|5|||
126131012|NCT01687712|453769762|FG001|Cycle 1|Ectopic Pregnancy|5|||
126131013|NCT01687712|453769761|FG000|Cycle 1|Heterotropic Pregnancy|1|||
126131014|NCT01687712|453769762|FG001|Cycle 1|Heterotropic Pregnancy|0|||
126131015|NCT01687712|453769761|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
126131016|NCT01687712|453769762|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
126131017|NCT01687712|453769761|FG000|Cycle 1|Abortion|3|||
126131018|NCT01687712|453769762|FG001|Cycle 1|Abortion|0|||
126131019|NCT01687712|453769761|FG000|Cycle 1|Intrauterine Fetal Death|0|||
126131020|NCT01687712|453769762|FG001|Cycle 1|Intrauterine Fetal Death|1|||
126131021|NCT01687712|453769761|FG000|Cycle 1|Lost to Follow-up|1|||
126131022|NCT01687712|453769762|FG001|Cycle 1|Lost to Follow-up|1|||
126131023|NCT01687712|453769761|FG000|Cycle 2|Not Biochemically Pregnant|74|||
126131024|NCT01687712|453769762|FG001|Cycle 2|Not Biochemically Pregnant|77|||
126131025|NCT01687712|453769761|FG000|Cycle 2|Early Pregnancy Loss|18|||
126131026|NCT01687712|453769762|FG001|Cycle 2|Early Pregnancy Loss|16|||
126131027|NCT01687712|453769761|FG000|Cycle 2|Ectopic Pregnancy|0|||
126131028|NCT01687712|453769762|FG001|Cycle 2|Ectopic Pregnancy|1|||
126131029|NCT01687712|453769761|FG000|Cycle 2|Still Birth|1|||
126131030|NCT01687712|453769762|FG001|Cycle 2|Still Birth|0|||
126131031|NCT01687712|453769761|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
126131032|NCT01687712|453769762|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
126131033|NCT01687712|453769761|FG000|Cycle 3|Not Biochemically Pregnant|21|||
126131034|NCT01687712|453769762|FG001|Cycle 3|Not Biochemically Pregnant|22|||
126131035|NCT01687712|453769761|FG000|Cycle 3|Early Pregnancy Loss|1|||
126131036|NCT01687712|453769762|FG001|Cycle 3|Early Pregnancy Loss|2|||
126131037|NCT01687712|453769761|FG000|Cycle 3|Ectopic Pregnancy|1|||
126131038|NCT01687712|453769762|FG001|Cycle 3|Ectopic Pregnancy|0|||
126131039|NCT01687712|453769761|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
126131040|NCT01687712|453769762|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
126131041|NCT03809611|453769763|FG000|Overall Study|Withdrawal by Subject|1|||
126131042|NCT03809611|453769764|FG001|Overall Study|Withdrawal by Subject|1|||
126131043|NCT02926950|453769765|FG000|Overall Study|Adverse Event|4|||
126131044|NCT02926950|453769766|FG001|Overall Study|Adverse Event|6|||
126131045|NCT02926950|453769765|FG000|Overall Study|At the participant's own request|21|||
126131046|NCT02926950|453769766|FG001|Overall Study|At the participant's own request|25|||
126131047|NCT02926950|453769765|FG000|Overall Study|Reason not Specified|17|||
126131048|NCT02926950|453769766|FG001|Overall Study|Reason not Specified|9|||
126131049|NCT02926950|453769765|FG000|Overall Study|Lost to Follow-up|7|||
126131050|NCT02926950|453769766|FG001|Overall Study|Lost to Follow-up|8|||
126131051|NCT04341948|453769767|FG000|Overall Study|Adverse Event|0|||
126131052|NCT04341948|453769768|FG001|Overall Study|Adverse Event|1|||
126131053|NCT04341948|453769767|FG000|Overall Study|Lost to Follow-up|6|||
126131054|NCT04341948|453769768|FG001|Overall Study|Lost to Follow-up|1|||
126131055|NCT04341948|453769767|FG000|Overall Study|Physician Decision|1|||
126131056|NCT04341948|453769768|FG001|Overall Study|Physician Decision|2|||
126131057|NCT04341948|453769767|FG000|Overall Study|Withdrawal by Participant|6|||
126131058|NCT04341948|453769768|FG001|Overall Study|Withdrawal by Participant|3|||
126131059|NCT04341948|453769767|FG000|Overall Study|Lack of compliance by Participant|1|||
126131060|NCT04341948|453769768|FG001|Overall Study|Lack of compliance by Participant|0|||
126131061|NCT01535729|453771407|FG000|Overall Study|Withdrawal by Subject|2|||
126131062|NCT01535729|453771407|FG000|Overall Study|Disease progression|230|||
126131063|NCT01535729|453771407|FG000|Overall Study|Discontinued treatment|25|||
126131064|NCT01535729|453771407|FG000|Overall Study|Lost to Follow-up|8|||
126131065|NCT01535729|453771407|FG000|Overall Study|Death|52|||
126131066|NCT01535729|453771407|FG000|Overall Study|Other|19|||
126131067|NCT01535729|453771407|FG000|Overall Study|Did not sign informed consent|1|||
126131068|NCT01535729|453771407|FG000|Overall Study|No previous chemotherapy|33|||
126131069|NCT01535729|453771407|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
126131070|NCT01535729|453771407|FG000|Overall Study|Protocol Violation|11|||
126131071|NCT01535729|453771407|FG000|Overall Study|Screening failure|1|||
126131072|NCT01535729|453771407|FG000|Overall Study|Not treated|9|||
126131073|NCT01535729|453771407|FG000|Overall Study|No participant record available|5|||
126131074|NCT02787850|453771408|FG000|Overall Study|Withdrawal by Subject|0|||
126131075|NCT02787850|453771409|FG001|Overall Study|Withdrawal by Subject|1|||
126131076|NCT02921971|453771412|FG000|Overall Study|Adverse Event|1|||
126131077|NCT02921971|453771413|FG001|Overall Study|Adverse Event|2|||
126131078|NCT02921971|453771412|FG000|Overall Study|Lack of Efficacy|3|||
126131079|NCT02921971|453771413|FG001|Overall Study|Lack of Efficacy|1|||
126131080|NCT02921971|453771412|FG000|Overall Study|Other than specified above|2|||
126131081|NCT02921971|453771413|FG001|Overall Study|Other than specified above|1|||
126131082|NCT02322710|453771414|FG000|Overall Study|No efficacy assessment post-baseline|0|||
126131083|NCT02322710|453771415|FG001|Overall Study|No efficacy assessment post-baseline|1|||
126131084|NCT02322710|453771414|FG000|Overall Study|Protocol Violation|20|||
126131085|NCT02322710|453771415|FG001|Overall Study|Protocol Violation|25|||
126131086|NCT04161131|453771416|FG000|Overall Study|Ineligible|2|||
126131087|NCT04161131|453771416|FG000|Overall Study|Lost to Follow-up|4|||
126131088|NCT04316585|453771417|FG000|Overall Study|Adverse Event|2|||
126131089|NCT04316585|453771418|FG001|Overall Study|Adverse Event|1|||
126131090|NCT04316585|453771417|FG000|Overall Study|Lost to Follow-up|1|||
126131091|NCT04316585|453771418|FG001|Overall Study|Lost to Follow-up|0|||
126131092|NCT04316585|453771417|FG000|Overall Study|Withdrawal by Subject|2|||
126131093|NCT04316585|453771418|FG001|Overall Study|Withdrawal by Subject|3|||
126131094|NCT04316585|453771417|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
126131095|NCT04316585|453771418|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
126131096|NCT04316585|453771417|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
126131097|NCT04316585|453771418|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
126131098|NCT00130832|453771419|FG000|Overall Study|Adverse Event|1|||
126131099|NCT00130832|453771420|FG001|Overall Study|Adverse Event|1|||
126131100|NCT00130832|453771419|FG000|Overall Study|Lost to Follow-up|1|||
126131101|NCT00130832|453771420|FG001|Overall Study|Lost to Follow-up|2|||
126131102|NCT00130832|453771419|FG000|Overall Study|Protocol Violation|6|||
126131103|NCT00130832|453771420|FG001|Overall Study|Protocol Violation|8|||
126131104|NCT00130832|453771419|FG000|Overall Study|Withdrawal by Subject|6|||
126131105|NCT00130832|453771420|FG001|Overall Study|Withdrawal by Subject|1|||
126131106|NCT00130832|453771419|FG000|Overall Study|Moved|2|||
126131107|NCT00130832|453771420|FG001|Overall Study|Moved|2|||
126131108|NCT00130832|453771419|FG000|Overall Study|Other|0|||
126131109|NCT00130832|453771420|FG001|Overall Study|Other|3|||
126131110|NCT03905863|453771421|FG000|Overall Study|Adverse Event|2|||
126131111|NCT03905863|453771422|FG001|Overall Study|Adverse Event|4|||
126131112|NCT03905863|453771421|FG000|Overall Study|Withdrawal by Subject|2|||
126131113|NCT03905863|453771422|FG001|Overall Study|Withdrawal by Subject|2|||
126131114|NCT03905863|453771421|FG000|Overall Study|Physician Decision|0|||
126131115|NCT03905863|453771422|FG001|Overall Study|Physician Decision|3|||
126131116|NCT03905863|453771421|FG000|Overall Study|Lost to Follow-up|1|||
126131117|NCT03905863|453771422|FG001|Overall Study|Lost to Follow-up|0|||
126131118|NCT03905863|453771421|FG000|Overall Study|Protocol Violation|0|||
126131119|NCT03905863|453771422|FG001|Overall Study|Protocol Violation|2|||
126131120|NCT03905863|453771421|FG000|Overall Study|Death|0|||
126131121|NCT03905863|453771422|FG001|Overall Study|Death|1|||
126131122|NCT02944448|453771424|FG000|Overall Study|Adverse Event|37|||
126131123|NCT02944448|453771425|FG001|Overall Study|Adverse Event|6|||
125964176|NCT01722331|453159339|FG003|Part 3|Lost to Follow-up|0|||
125964177|NCT01722331|453159340|FG004|Part 3|Lost to Follow-up|0|||
125964178|NCT01722331|453159341|FG005|Part 3|Lost to Follow-up|1|||
125964179|NCT01722331|453159342|FG006|Part 3|Lost to Follow-up|0|||
125964180|NCT01722331|453159336|FG000|Part 3|Non-Compliance with Study Drug|0|||
125964181|NCT01722331|453159337|FG001|Part 3|Non-Compliance with Study Drug|1|||
125964182|NCT01722331|453159338|FG002|Part 3|Non-Compliance with Study Drug|0|||
125964183|NCT01722331|453159339|FG003|Part 3|Non-Compliance with Study Drug|0|||
125964184|NCT01722331|453159340|FG004|Part 3|Non-Compliance with Study Drug|0|||
125964185|NCT01722331|453159341|FG005|Part 3|Non-Compliance with Study Drug|0|||
125964186|NCT01722331|453159342|FG006|Part 3|Non-Compliance with Study Drug|0|||
125964187|NCT01722331|453159336|FG000|Part 3|Physician Decision|1|||
125964188|NCT01722331|453159337|FG001|Part 3|Physician Decision|1|||
126131124|NCT02944448|453771424|FG000|Overall Study|Lack of Efficacy|8|||
126131125|NCT02944448|453771425|FG001|Overall Study|Lack of Efficacy|5|||
126131126|NCT02944448|453771424|FG000|Overall Study|Lost to Follow-up|3|||
126131127|NCT02944448|453771425|FG001|Overall Study|Lost to Follow-up|1|||
126131128|NCT02944448|453771424|FG000|Overall Study|Protocol Violation|25|||
126131129|NCT02944448|453771425|FG001|Overall Study|Protocol Violation|7|||
126131130|NCT02944448|453771424|FG000|Overall Study|Withdrawal by Subject|14|||
126131131|NCT02944448|453771425|FG001|Overall Study|Withdrawal by Subject|4|||
126131132|NCT02944448|453771424|FG000|Overall Study|Sponsor did not supply drug in time|0|||
126131133|NCT02944448|453771425|FG001|Overall Study|Sponsor did not supply drug in time|1|||
126131134|NCT02944448|453771424|FG000|Overall Study|Noncompliant with dosing|1|||
126131135|NCT02944448|453771425|FG001|Overall Study|Noncompliant with dosing|0|||
126131136|NCT02944448|453771424|FG000|Overall Study|Abnormal laboratory values|1|||
126131137|NCT02944448|453771425|FG001|Overall Study|Abnormal laboratory values|0|||
126131138|NCT05499559|453771428|FG000|Overall Study|Lost to Follow-up|467|||
126131139|NCT04681170|453771429|FG000|Stratified Enrolment & run-in|Death|1|||
126131140|NCT04681170|453771430|FG001|Stratified Enrolment & run-in|Death|0|||
126131141|NCT04681170|453771429|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
126131142|NCT04681170|453771430|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
126131143|NCT04681170|453771429|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
126131144|NCT04681170|453771430|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
126131145|NCT04681170|453771429|FG000|Open Label Efficacy Phase|Adverse Event|0|||
126131146|NCT04681170|453771430|FG001|Open Label Efficacy Phase|Adverse Event|2|||
126131147|NCT04681170|453771429|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
126131148|NCT04681170|453771430|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
126131149|NCT04681170|453771429|FG000|Open Label Safety Phase|AEs and none compliance|0|||
125964189|NCT01722331|453159338|FG002|Part 3|Physician Decision|0|||
125964190|NCT01722331|453159339|FG003|Part 3|Physician Decision|0|||
125964191|NCT01722331|453159340|FG004|Part 3|Physician Decision|0|||
125964192|NCT01722331|453159341|FG005|Part 3|Physician Decision|0|||
125964193|NCT01722331|453159342|FG006|Part 3|Physician Decision|1|||
125964194|NCT01722331|453159336|FG000|Part 3|Protocol Violation|2|||
125964195|NCT01722331|453159337|FG001|Part 3|Protocol Violation|1|||
125964196|NCT01722331|453159338|FG002|Part 3|Protocol Violation|0|||
125964197|NCT01722331|453159339|FG003|Part 3|Protocol Violation|0|||
125964198|NCT01722331|453159340|FG004|Part 3|Protocol Violation|0|||
125964199|NCT01722331|453159341|FG005|Part 3|Protocol Violation|0|||
125964200|NCT01722331|453159342|FG006|Part 3|Protocol Violation|0|||
125964201|NCT01722331|453159336|FG000|Part 3|Withdrawal by Subject|4|||
125964202|NCT01722331|453159337|FG001|Part 3|Withdrawal by Subject|7|||
125964203|NCT01722331|453159338|FG002|Part 3|Withdrawal by Subject|0|||
125964204|NCT01722331|453159339|FG003|Part 3|Withdrawal by Subject|0|||
125964205|NCT01722331|453159340|FG004|Part 3|Withdrawal by Subject|0|||
125964206|NCT01722331|453159341|FG005|Part 3|Withdrawal by Subject|2|||
125964207|NCT01722331|453159342|FG006|Part 3|Withdrawal by Subject|1|||
125964208|NCT01722331|453159336|FG000|Part 3|Other Protocol Specified Criteria|1|||
125964209|NCT01722331|453159337|FG001|Part 3|Other Protocol Specified Criteria|1|||
125964210|NCT01722331|453159338|FG002|Part 3|Other Protocol Specified Criteria|0|||
125964211|NCT01722331|453159339|FG003|Part 3|Other Protocol Specified Criteria|0|||
125964212|NCT01722331|453159340|FG004|Part 3|Other Protocol Specified Criteria|0|||
125964213|NCT01722331|453159341|FG005|Part 3|Other Protocol Specified Criteria|0|||
125964214|NCT01722331|453159342|FG006|Part 3|Other Protocol Specified Criteria|0|||
125964215|NCT00262834|453159343|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
125964216|NCT00262834|453159344|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
125964217|NCT00466193|453159345|FG000|Overall Study|Adverse Event|0|||
125964218|NCT00466193|453159346|FG001|Overall Study|Adverse Event|1|||
126131150|NCT04681170|453771430|FG001|Open Label Safety Phase|AEs and none compliance|1|||
126131151|NCT02118792|453771431|FG000|Overall Study|Withdrawal by Subject|6|||
125964219|NCT00466193|453159345|FG000|Overall Study|Lost to Follow-up|2|||
125964220|NCT00466193|453159346|FG001|Overall Study|Lost to Follow-up|4|||
125964221|NCT00466193|453159345|FG000|Overall Study|Physician Decision|1|||
125964222|NCT00466193|453159346|FG001|Overall Study|Physician Decision|0|||
125964223|NCT00466193|453159345|FG000|Overall Study|Protocol Violation|1|||
125964224|NCT00466193|453159346|FG001|Overall Study|Protocol Violation|1|||
125964225|NCT00466193|453159345|FG000|Overall Study|Withdrawal by Subject|7|||
125964226|NCT00466193|453159346|FG001|Overall Study|Withdrawal by Subject|2|||
125964227|NCT00466193|453159345|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
125964228|NCT00466193|453159346|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
125964229|NCT01054729|453159347|FG000|Overall Study|Randomized but Not Treated|0|||
125964230|NCT01054729|453159348|FG001|Overall Study|Randomized but Not Treated|1|||
125964231|NCT01054729|453159349|FG002|Overall Study|Randomized but Not Treated|0|||
125964232|NCT01054729|453159350|FG003|Overall Study|Randomized but Not Treated|0|||
125964233|NCT01054729|453159347|FG000|Overall Study|Adverse Event|1|||
125964234|NCT01054729|453159348|FG001|Overall Study|Adverse Event|1|||
126131152|NCT02118792|453771432|FG001|Overall Study|Withdrawal by Subject|3|||
126131153|NCT02118792|453771431|FG000|Overall Study|Lost to Follow-up|4|||
126131154|NCT02118792|453771432|FG001|Overall Study|Lost to Follow-up|4|||
126131155|NCT02118792|453771431|FG000|Overall Study|Adverse Event|5|||
126131156|NCT02118792|453771432|FG001|Overall Study|Adverse Event|4|||
126131157|NCT02118792|453771431|FG000|Overall Study|Withdrawal by parent/guardian|14|||
126131158|NCT02118792|453771432|FG001|Overall Study|Withdrawal by parent/guardian|20|||
126131159|NCT02118792|453771431|FG000|Overall Study|Other|1|||
126131160|NCT02118792|453771432|FG001|Overall Study|Other|6|||
126131161|NCT02118792|453771431|FG000|Overall Study|Randomised but not treated|1|||
126131162|NCT02118792|453771432|FG001|Overall Study|Randomised but not treated|0|||
126131163|NCT05131204|453771433|FG000|Overall Study|Sponsor request|2|||
126131164|NCT05131204|453771434|FG001|Overall Study|Sponsor request|1|||
126131165|NCT02787863|453771435|FG000|Overall Study|Death|1|||
126131166|NCT02787863|453771436|FG001|Overall Study|Death|0|||
126131167|NCT02787863|453771437|FG002|Overall Study|Death|1|||
126131168|NCT02787863|453771438|FG003|Overall Study|Death|0|||
126131169|NCT02787863|453771439|FG004|Overall Study|Death|0|||
126131170|NCT02787863|453771440|FG005|Overall Study|Death|0|||
126131171|NCT02787863|453771441|FG006|Overall Study|Death|0|||
126131172|NCT02787863|453771442|FG007|Overall Study|Death|0|||
126131173|NCT02787863|453771435|FG000|Overall Study|Withdrawal by Subject|0|||
126131174|NCT02787863|453771436|FG001|Overall Study|Withdrawal by Subject|1|||
126131175|NCT02787863|453771437|FG002|Overall Study|Withdrawal by Subject|1|||
126131176|NCT02787863|453771438|FG003|Overall Study|Withdrawal by Subject|0|||
126131177|NCT02787863|453771439|FG004|Overall Study|Withdrawal by Subject|0|||
126131178|NCT02787863|453771440|FG005|Overall Study|Withdrawal by Subject|0|||
126131179|NCT02787863|453771441|FG006|Overall Study|Withdrawal by Subject|0|||
126131180|NCT02787863|453771442|FG007|Overall Study|Withdrawal by Subject|0|||
126131181|NCT02926209|453771450|FG000|Study Cohort|Poor Bowel Preparation|1|||
126131182|NCT02926209|453771451|FG001|Study Cohort|Poor Bowel Preparation|0|||
126131183|NCT00705939|453771452|FG000|Overall Study|Protocol Violation|0|||
126131184|NCT00705939|453771453|FG001|Overall Study|Protocol Violation|0|||
126131185|NCT00705939|453771454|FG002|Overall Study|Protocol Violation|1|||
126131186|NCT00705939|453771452|FG000|Overall Study|Withdrawal by Subject|0|||
126131187|NCT00705939|453771453|FG001|Overall Study|Withdrawal by Subject|1|||
126131188|NCT00705939|453771454|FG002|Overall Study|Withdrawal by Subject|3|||
126131189|NCT00705939|453771452|FG000|Overall Study|Physician Decision|0|||
126131190|NCT00705939|453771453|FG001|Overall Study|Physician Decision|1|||
126131191|NCT00705939|453771454|FG002|Overall Study|Physician Decision|0|||
126131192|NCT05048342|453771455|FG000|Overall Study|Adverse Event|1|||
126131193|NCT05048342|453771455|FG000|Overall Study|Subject decision|2|||
126131194|NCT01441063|453771456|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
126131195|NCT01441063|453771456|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
126131196|NCT03345472|453771461|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
126131197|NCT03345472|453771461|FG000|Implant to 3 Months|Physician Decision|1|||
126131198|NCT03345472|453771461|FG000|Implant to 3 Months|Adverse Event|1|||
125964235|NCT01054729|453159349|FG002|Overall Study|Adverse Event|2|||
125964236|NCT01054729|453159350|FG003|Overall Study|Adverse Event|1|||
125964237|NCT01054729|453159347|FG000|Overall Study|Withdrawal by Subject|1|||
125964238|NCT01054729|453159348|FG001|Overall Study|Withdrawal by Subject|0|||
125964239|NCT01054729|453159349|FG002|Overall Study|Withdrawal by Subject|1|||
125964240|NCT01054729|453159350|FG003|Overall Study|Withdrawal by Subject|0|||
125964241|NCT01054729|453159347|FG000|Overall Study|Lost to Follow-up|0|||
125964242|NCT01054729|453159348|FG001|Overall Study|Lost to Follow-up|1|||
126131199|NCT03345472|453771461|FG000|3 Months to 12 Months|Physician Decision|3|||
126131200|NCT03345472|453771461|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
126131201|NCT03345472|453771461|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
126131202|NCT03345472|453771461|FG000|3 Months to 12 Months|Adverse Event|1|||
126131203|NCT03345472|453771461|FG000|3 Months to 12 Months|Death|1|||
126131204|NCT01926782|453771462|FG000|Overall Study|Participant moved|2|||
126131205|NCT01926782|453771463|FG001|Overall Study|Participant moved|0|||
125964243|NCT01054729|453159349|FG002|Overall Study|Lost to Follow-up|0|||
125964244|NCT01054729|453159350|FG003|Overall Study|Lost to Follow-up|0|||
125964245|NCT01054729|453159347|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
125964246|NCT01054729|453159348|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
125964247|NCT01054729|453159349|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
125964248|NCT01054729|453159350|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
125964249|NCT01054729|453159347|FG000|Overall Study|Non-responder|1|||
125964250|NCT01054729|453159348|FG001|Overall Study|Non-responder|0|||
125964251|NCT01054729|453159349|FG002|Overall Study|Non-responder|1|||
125964252|NCT01054729|453159350|FG003|Overall Study|Non-responder|1|||
125964253|NCT01054729|453159347|FG000|Overall Study|PEG/RBV Non-responder|1|||
125964254|NCT01054729|453159348|FG001|Overall Study|PEG/RBV Non-responder|0|||
125964255|NCT01054729|453159349|FG002|Overall Study|PEG/RBV Non-responder|1|||
125964256|NCT01054729|453159350|FG003|Overall Study|PEG/RBV Non-responder|0|||
125964257|NCT01054729|453159347|FG000|Overall Study|Personal/Obligations|0|||
125964258|NCT01054729|453159348|FG001|Overall Study|Personal/Obligations|1|||
125964259|NCT01054729|453159349|FG002|Overall Study|Personal/Obligations|0|||
125964260|NCT01054729|453159350|FG003|Overall Study|Personal/Obligations|0|||
125964261|NCT01054729|453159347|FG000|Overall Study|Subject moved|0|||
125964262|NCT01054729|453159348|FG001|Overall Study|Subject moved|0|||
125964263|NCT01054729|453159349|FG002|Overall Study|Subject moved|1|||
125964264|NCT01054729|453159350|FG003|Overall Study|Subject moved|0|||
125964265|NCT01054729|453159347|FG000|Overall Study|Lack of Efficacy|0|||
125964266|NCT01054729|453159348|FG001|Overall Study|Lack of Efficacy|0|||
125964267|NCT01054729|453159349|FG002|Overall Study|Lack of Efficacy|0|||
125964268|NCT01054729|453159350|FG003|Overall Study|Lack of Efficacy|1|||
125964269|NCT01033747|453159351|FG000|Overall Study|Adverse Event|9|||
125964270|NCT01033747|453159352|FG001|Overall Study|Adverse Event|4|||
125964271|NCT01033747|453159351|FG000|Overall Study|Abnormal Laboratory Value|1|||
125964272|NCT01033747|453159352|FG001|Overall Study|Abnormal Laboratory Value|0|||
125964273|NCT01033747|453159351|FG000|Overall Study|Abnormal test procedure|0|||
125964274|NCT01033747|453159352|FG001|Overall Study|Abnormal test procedure|1|||
125964275|NCT01033747|453159351|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
125964276|NCT01033747|453159352|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125964277|NCT01033747|453159351|FG000|Overall Study|Protocol Violation|1|||
125964278|NCT01033747|453159352|FG001|Overall Study|Protocol Violation|0|||
125964279|NCT01033747|453159351|FG000|Overall Study|Withdrawal by Subject|9|||
125964280|NCT01033747|453159352|FG001|Overall Study|Withdrawal by Subject|6|||
125964281|NCT01033747|453159351|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
125964282|NCT01033747|453159352|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
125964283|NCT01033747|453159351|FG000|Overall Study|Stopped at end of Extension 1|2|||
125964284|NCT01033747|453159352|FG001|Overall Study|Stopped at end of Extension 1|0|||
125964285|NCT02956629|453159353|FG000|Overall Study|Adverse Event|0|||
125964286|NCT02956629|453159354|FG001|Overall Study|Adverse Event|0|||
125964287|NCT02956629|453159355|FG002|Overall Study|Adverse Event|1|||
125964288|NCT02956629|453159356|FG003|Overall Study|Adverse Event|0|||
125964289|NCT02956629|453159357|FG004|Overall Study|Adverse Event|0|||
125964290|NCT02956629|453159358|FG005|Overall Study|Adverse Event|0|||
125964291|NCT02956629|453159353|FG000|Overall Study|Lost to Follow-up|2|||
125964292|NCT02956629|453159354|FG001|Overall Study|Lost to Follow-up|5|||
125964293|NCT02956629|453159355|FG002|Overall Study|Lost to Follow-up|3|||
125964294|NCT02956629|453159356|FG003|Overall Study|Lost to Follow-up|1|||
125964295|NCT02956629|453159357|FG004|Overall Study|Lost to Follow-up|0|||
125964296|NCT02956629|453159358|FG005|Overall Study|Lost to Follow-up|1|||
125964297|NCT02956629|453159353|FG000|Overall Study|Withdrawal by Subject|3|||
126131206|NCT01926782|453771464|FG002|Overall Study|Participant moved|1|||
126131207|NCT01926782|453771465|FG003|Overall Study|Participant moved|1|||
126131208|NCT01926782|453771466|FG004|Overall Study|Participant moved|0|||
126131209|NCT01926782|453771467|FG005|Overall Study|Participant moved|3|||
126131210|NCT01926782|453771462|FG000|Overall Study|Physician Decision|0|||
126131211|NCT01926782|453771463|FG001|Overall Study|Physician Decision|2|||
126131212|NCT01926782|453771464|FG002|Overall Study|Physician Decision|1|||
126131213|NCT01926782|453771465|FG003|Overall Study|Physician Decision|1|||
126131214|NCT01926782|453771466|FG004|Overall Study|Physician Decision|0|||
126131215|NCT01926782|453771467|FG005|Overall Study|Physician Decision|0|||
126131216|NCT01926782|453771462|FG000|Overall Study|Other than specified|2|||
126131217|NCT01926782|453771463|FG001|Overall Study|Other than specified|3|||
125964298|NCT02956629|453159354|FG001|Overall Study|Withdrawal by Subject|1|||
125964299|NCT02956629|453159355|FG002|Overall Study|Withdrawal by Subject|0|||
125964300|NCT02956629|453159356|FG003|Overall Study|Withdrawal by Subject|0|||
126131218|NCT01926782|453771464|FG002|Overall Study|Other than specified|5|||
125964301|NCT02956629|453159357|FG004|Overall Study|Withdrawal by Subject|0|||
125964302|NCT02956629|453159358|FG005|Overall Study|Withdrawal by Subject|0|||
125964303|NCT00844194|453159359|FG000|Overall Study|Adverse Event|17|||
126131219|NCT01926782|453771465|FG003|Overall Study|Other than specified|12|||
126131220|NCT01926782|453771466|FG004|Overall Study|Other than specified|4|||
126131221|NCT01926782|453771467|FG005|Overall Study|Other than specified|11|||
126131222|NCT01926782|453771462|FG000|Overall Study|Adverse Event|13|||
126131223|NCT01926782|453771463|FG001|Overall Study|Adverse Event|4|||
126131224|NCT01926782|453771464|FG002|Overall Study|Adverse Event|17|||
126131225|NCT01926782|453771465|FG003|Overall Study|Adverse Event|4|||
125964304|NCT00844194|453159360|FG001|Overall Study|Adverse Event|5|||
125964305|NCT00844194|453159359|FG000|Overall Study|Protocol Violation|1|||
125964306|NCT00844194|453159360|FG001|Overall Study|Protocol Violation|1|||
125964307|NCT00844194|453159359|FG000|Overall Study|Lost to Follow-up|1|||
125964308|NCT00844194|453159360|FG001|Overall Study|Lost to Follow-up|1|||
125964309|NCT00844194|453159359|FG000|Overall Study|Withdrawal by Subject|2|||
125964310|NCT00844194|453159360|FG001|Overall Study|Withdrawal by Subject|1|||
125964311|NCT00844194|453159359|FG000|Overall Study|Lack of Efficacy|3|||
125964312|NCT00844194|453159360|FG001|Overall Study|Lack of Efficacy|0|||
125964313|NCT00844194|453159359|FG000|Overall Study|Other reason (not specified)|1|||
125964314|NCT00844194|453159360|FG001|Overall Study|Other reason (not specified)|0|||
125964315|NCT00803023|453159365|FG000|Overall Study|Adverse Event|5|||
125964316|NCT00803023|453159366|FG001|Overall Study|Adverse Event|4|||
125964317|NCT00803023|453159367|FG002|Overall Study|Adverse Event|8|||
126131226|NCT01926782|453771466|FG004|Overall Study|Adverse Event|3|||
126131227|NCT01926782|453771467|FG005|Overall Study|Adverse Event|14|||
126131228|NCT01926782|453771462|FG000|Overall Study|Poor compliance to protocol|5|||
126131229|NCT01926782|453771463|FG001|Overall Study|Poor compliance to protocol|3|||
126131230|NCT01926782|453771464|FG002|Overall Study|Poor compliance to protocol|8|||
126131231|NCT01926782|453771465|FG003|Overall Study|Poor compliance to protocol|0|||
126131232|NCT01926782|453771466|FG004|Overall Study|Poor compliance to protocol|1|||
126131233|NCT01926782|453771467|FG005|Overall Study|Poor compliance to protocol|6|||
126131234|NCT01926782|453771462|FG000|Overall Study|Randomized and not treated|0|||
126131235|NCT01926782|453771463|FG001|Overall Study|Randomized and not treated|0|||
126131236|NCT01926782|453771464|FG002|Overall Study|Randomized and not treated|0|||
126131237|NCT01926782|453771465|FG003|Overall Study|Randomized and not treated|1|||
126131238|NCT01926782|453771466|FG004|Overall Study|Randomized and not treated|0|||
126131239|NCT01926782|453771467|FG005|Overall Study|Randomized and not treated|0|||
126131240|NCT01926782|453771462|FG000|Overall Study|Withdrawal by Subject|6|||
126131241|NCT01926782|453771463|FG001|Overall Study|Withdrawal by Subject|1|||
126131242|NCT01926782|453771464|FG002|Overall Study|Withdrawal by Subject|8|||
126131243|NCT01926782|453771465|FG003|Overall Study|Withdrawal by Subject|1|||
126131244|NCT01926782|453771466|FG004|Overall Study|Withdrawal by Subject|0|||
126131245|NCT01926782|453771467|FG005|Overall Study|Withdrawal by Subject|5|||
126131246|NCT01926782|453771462|FG000|Overall Study|Related to study drug administration|0|||
126131247|NCT01926782|453771463|FG001|Overall Study|Related to study drug administration|0|||
126131248|NCT01926782|453771464|FG002|Overall Study|Related to study drug administration|0|||
126131249|NCT01926782|453771465|FG003|Overall Study|Related to study drug administration|0|||
126131250|NCT01926782|453771466|FG004|Overall Study|Related to study drug administration|0|||
126131251|NCT01926782|453771467|FG005|Overall Study|Related to study drug administration|2|||
126131252|NCT02462473|453771470|FG000|Overall Study|Death|1|||
126131253|NCT02462473|453771470|FG000|Overall Study|Other|3|||
126131254|NCT01400451|453771472|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
126131255|NCT01400451|453771473|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
126131256|NCT01400451|453771474|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
126131257|NCT01400451|453771472|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
126131258|NCT01400451|453771473|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
126131259|NCT01400451|453771474|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
126131260|NCT01400451|453771472|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
126131261|NCT01400451|453771473|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
126131262|NCT01400451|453771474|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
126131263|NCT01400451|453771472|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
126131264|NCT01400451|453771473|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
126131265|NCT01400451|453771474|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
126131266|NCT01400451|453771472|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
126131267|NCT01400451|453771473|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
126131268|NCT01400451|453771474|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
126131269|NCT01079182|453771491|FG000|Overall Study|Lost to Follow-up|1634|||
126131270|NCT01079182|453771491|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
126131271|NCT01079182|453771491|FG000|Overall Study|Lack of Efficacy|514|||
126131272|NCT01079182|453771491|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
126131273|NCT01079182|453771491|FG000|Overall Study|Reasons not Evaluated|271|||
126131274|NCT00512798|453771497|FG000|Overall Study|Death|0|||
125964318|NCT00803023|453159368|FG003|Overall Study|Adverse Event|6|||
125964319|NCT00803023|453159365|FG000|Overall Study|Withdrawal by Subject|0|||
126131275|NCT00512798|453771498|FG001|Overall Study|Death|3|||
126131276|NCT00512798|453771497|FG000|Overall Study|Adverse Event|2|||
125964320|NCT00803023|453159366|FG001|Overall Study|Withdrawal by Subject|2|||
125964321|NCT00803023|453159367|FG002|Overall Study|Withdrawal by Subject|0|||
125964322|NCT00803023|453159368|FG003|Overall Study|Withdrawal by Subject|0|||
126131277|NCT00512798|453771498|FG001|Overall Study|Adverse Event|4|||
126131278|NCT00512798|453771497|FG000|Overall Study|Progression of disease|14|||
126131279|NCT00512798|453771498|FG001|Overall Study|Progression of disease|20|||
126131280|NCT00512798|453771497|FG000|Overall Study|Withdrawal by Subject|3|||
126131281|NCT00512798|453771498|FG001|Overall Study|Withdrawal by Subject|0|||
126131282|NCT02508194|453771501|FG000|Overall Study|Death|5|||
126131283|NCT02508194|453771502|FG001|Overall Study|Death|3|||
126131284|NCT02508194|453771501|FG000|Overall Study|Lost to Follow-up|25|||
126131285|NCT02508194|453771502|FG001|Overall Study|Lost to Follow-up|18|||
126131286|NCT02508194|453771501|FG000|Overall Study|Withdrawal by Subject|20|||
126131287|NCT02508194|453771502|FG001|Overall Study|Withdrawal by Subject|18|||
126131288|NCT02508194|453771501|FG000|Overall Study|Error in Randomization|1|||
126131289|NCT02508194|453771502|FG001|Overall Study|Error in Randomization|3|||
126131290|NCT02508194|453771501|FG000|Overall Study|Principal Investigator Decision|1|||
126131291|NCT02508194|453771502|FG001|Overall Study|Principal Investigator Decision|2|||
126131292|NCT00454805|453771507|FG000|Overall Study|Withdrawal by Subject|9|||
126131293|NCT00454805|453771508|FG001|Overall Study|Withdrawal by Subject|2|||
126131294|NCT00454805|453771507|FG000|Overall Study|Death|0|||
126131295|NCT00454805|453771508|FG001|Overall Study|Death|2|||
126131296|NCT00454805|453771507|FG000|Overall Study|Disease progression|16|||
126131297|NCT00454805|453771508|FG001|Overall Study|Disease progression|19|||
126131298|NCT00454805|453771507|FG000|Overall Study|In order to begin radiotherapy|1|||
126131299|NCT00454805|453771508|FG001|Overall Study|In order to begin radiotherapy|0|||
126131300|NCT02158091|453771514|FG000|Overall Study|DLT|2|||
126131301|NCT02158091|453771515|FG001|Overall Study|DLT|1|||
126131302|NCT02158091|453771516|FG002|Overall Study|DLT|0|||
126131303|NCT03977467|453771517|FG000|Overall Study|Disease Progression|1|||
126131304|NCT03977467|453771518|FG001|Overall Study|Disease Progression|1|||
126131305|NCT03977467|453771519|FG002|Overall Study|Disease Progression|30|||
126131306|NCT03977467|453771520|FG003|Overall Study|Disease Progression|0|||
126131307|NCT03977467|453771517|FG000|Overall Study|Adverse Event|0|||
126131308|NCT03977467|453771518|FG001|Overall Study|Adverse Event|1|||
126131309|NCT03977467|453771519|FG002|Overall Study|Adverse Event|0|||
126131310|NCT03977467|453771520|FG003|Overall Study|Adverse Event|0|||
126131311|NCT03977467|453771517|FG000|Overall Study|Death|0|||
126131312|NCT03977467|453771518|FG001|Overall Study|Death|0|||
126131313|NCT03977467|453771519|FG002|Overall Study|Death|3|||
126131314|NCT03977467|453771520|FG003|Overall Study|Death|0|||
126131315|NCT03977467|453771517|FG000|Overall Study|Lack of Efficacy|0|||
126131316|NCT03977467|453771518|FG001|Overall Study|Lack of Efficacy|0|||
126131317|NCT03977467|453771519|FG002|Overall Study|Lack of Efficacy|1|||
126131318|NCT03977467|453771520|FG003|Overall Study|Lack of Efficacy|0|||
126131319|NCT03977467|453771517|FG000|Overall Study|Withdrawal by Subject|2|||
126131320|NCT03977467|453771518|FG001|Overall Study|Withdrawal by Subject|1|||
126131321|NCT03977467|453771519|FG002|Overall Study|Withdrawal by Subject|4|||
126131322|NCT03977467|453771520|FG003|Overall Study|Withdrawal by Subject|0|||
126131323|NCT03977467|453771517|FG000|Overall Study|Study Terminated|1|||
126131324|NCT03977467|453771518|FG001|Overall Study|Study Terminated|0|||
126131325|NCT03977467|453771519|FG002|Overall Study|Study Terminated|0|||
126131326|NCT03977467|453771520|FG003|Overall Study|Study Terminated|1|||
126131327|NCT05913232|453771521|FG000|Overall Study|Adverse Event|0|||
126131328|NCT05913232|453771522|FG001|Overall Study|Adverse Event|2|||
126131329|NCT05913232|453771523|FG002|Overall Study|Adverse Event|1|||
126131330|NCT05913232|453771524|FG003|Overall Study|Adverse Event|1|||
126131331|NCT01627899|453771525|FG000|Overall Study|Study terminated early by sponsor.|5|||
126131332|NCT01358864|453771533|FG000|Overall Study|Adverse Event|0|||
126131333|NCT01358864|453771534|FG001|Overall Study|Adverse Event|6|||
126131334|NCT01358864|453771535|FG002|Overall Study|Adverse Event|9|||
126131335|NCT01358864|453771536|FG003|Overall Study|Adverse Event|0|||
126131336|NCT01358864|453771537|FG004|Overall Study|Adverse Event|4|||
126131337|NCT01358864|453771538|FG005|Overall Study|Adverse Event|8|||
126131338|NCT01358864|453771539|FG006|Overall Study|Adverse Event|12|||
126131339|NCT01358864|453771540|FG007|Overall Study|Adverse Event|7|||
126131340|NCT01358864|453771533|FG000|Overall Study|Lack of Efficacy|26|||
126131341|NCT01358864|453771534|FG001|Overall Study|Lack of Efficacy|3|||
126131342|NCT01358864|453771535|FG002|Overall Study|Lack of Efficacy|4|||
126131343|NCT01358864|453771536|FG003|Overall Study|Lack of Efficacy|19|||
126131344|NCT01358864|453771537|FG004|Overall Study|Lack of Efficacy|7|||
126131345|NCT01358864|453771538|FG005|Overall Study|Lack of Efficacy|4|||
126131346|NCT01358864|453771539|FG006|Overall Study|Lack of Efficacy|49|||
126131347|NCT01358864|453771540|FG007|Overall Study|Lack of Efficacy|44|||
126131348|NCT01358864|453771533|FG000|Overall Study|Lost to Follow-up|0|||
126131349|NCT01358864|453771534|FG001|Overall Study|Lost to Follow-up|0|||
126131350|NCT01358864|453771535|FG002|Overall Study|Lost to Follow-up|1|||
126131351|NCT01358864|453771536|FG003|Overall Study|Lost to Follow-up|0|||
126131352|NCT01358864|453771537|FG004|Overall Study|Lost to Follow-up|0|||
126131353|NCT01358864|453771538|FG005|Overall Study|Lost to Follow-up|0|||
126131354|NCT01358864|453771539|FG006|Overall Study|Lost to Follow-up|0|||
126131355|NCT01358864|453771540|FG007|Overall Study|Lost to Follow-up|1|||
126131356|NCT01358864|453771533|FG000|Overall Study|Withdrawal by Subject|3|||
126131357|NCT01358864|453771534|FG001|Overall Study|Withdrawal by Subject|4|||
126131358|NCT01358864|453771535|FG002|Overall Study|Withdrawal by Subject|2|||
126131359|NCT01358864|453771536|FG003|Overall Study|Withdrawal by Subject|0|||
126131360|NCT01358864|453771537|FG004|Overall Study|Withdrawal by Subject|0|||
126131361|NCT01358864|453771538|FG005|Overall Study|Withdrawal by Subject|1|||
126131362|NCT01358864|453771539|FG006|Overall Study|Withdrawal by Subject|1|||
126131363|NCT01358864|453771540|FG007|Overall Study|Withdrawal by Subject|3|||
126131364|NCT01358864|453771533|FG000|Overall Study|Other reason not defined above|2|||
126131365|NCT01358864|453771534|FG001|Overall Study|Other reason not defined above|0|||
126131366|NCT01358864|453771535|FG002|Overall Study|Other reason not defined above|0|||
126131367|NCT01358864|453771536|FG003|Overall Study|Other reason not defined above|0|||
126131368|NCT01358864|453771537|FG004|Overall Study|Other reason not defined above|0|||
126131369|NCT01358864|453771538|FG005|Overall Study|Other reason not defined above|0|||
126131370|NCT01358864|453771539|FG006|Overall Study|Other reason not defined above|2|||
126131371|NCT01358864|453771540|FG007|Overall Study|Other reason not defined above|0|||
126131372|NCT01358864|453771533|FG000|Overall Study|Not treated|0|||
126131373|NCT01358864|453771534|FG001|Overall Study|Not treated|0|||
126131374|NCT01358864|453771535|FG002|Overall Study|Not treated|0|||
126131375|NCT01358864|453771536|FG003|Overall Study|Not treated|0|||
126131376|NCT01358864|453771537|FG004|Overall Study|Not treated|0|||
126131377|NCT01358864|453771538|FG005|Overall Study|Not treated|0|||
126131378|NCT01358864|453771539|FG006|Overall Study|Not treated|1|||
126131379|NCT01358864|453771540|FG007|Overall Study|Not treated|0|||
126131380|NCT04158648|453771548|FG000|Overall Study|Ongoing in the Study|69|||
126131381|NCT04158648|453771548|FG000|Overall Study|Withdrawal by Subject|4|||
126131382|NCT04209855|453771549|FG000|Overall Study|Death|161|||
126131383|NCT04209855|453771550|FG001|Overall Study|Death|177|||
126131384|NCT04209855|453771549|FG000|Overall Study|PI Discretion|1|||
126131385|NCT04209855|453771550|FG001|Overall Study|PI Discretion|1|||
126131386|NCT04209855|453771549|FG000|Overall Study|Lost to Follow-up|5|||
126131387|NCT04209855|453771550|FG001|Overall Study|Lost to Follow-up|2|||
126131388|NCT04209855|453771549|FG000|Overall Study|Withdrew consent|10|||
126131389|NCT04209855|453771550|FG001|Overall Study|Withdrew consent|24|||
126131390|NCT04209855|453771549|FG000|Overall Study|Sponsor decision|44|||
126131391|NCT04209855|453771550|FG001|Overall Study|Sponsor decision|18|||
126131392|NCT04209855|453771549|FG000|Overall Study|Other than specified|6|||
126131393|NCT04209855|453771550|FG001|Overall Study|Other than specified|4|||
126131394|NCT01250379|453771553|FG000|Overall Study|Death|141|||
126131395|NCT01250379|453771554|FG001|Overall Study|Death|148|||
126131396|NCT01250379|453771553|FG000|Overall Study|Withdrawal by Subject|32|||
126131397|NCT01250379|453771554|FG001|Overall Study|Withdrawal by Subject|20|||
126131398|NCT01250379|453771553|FG000|Overall Study|Physician Decision|11|||
126131399|NCT01250379|453771554|FG001|Overall Study|Physician Decision|3|||
126131400|NCT01250379|453771553|FG000|Overall Study|Protocol Violation|2|||
126131401|NCT01250379|453771554|FG001|Overall Study|Protocol Violation|8|||
126131402|NCT01250379|453771553|FG000|Overall Study|Lost to Follow-up|9|||
126131403|NCT01250379|453771554|FG001|Overall Study|Lost to Follow-up|6|||
126131404|NCT01250379|453771553|FG000|Overall Study|Adverse Event|5|||
126131405|NCT01250379|453771554|FG001|Overall Study|Adverse Event|4|||
126131406|NCT01250379|453771553|FG000|Overall Study|Other|0|||
126131407|NCT01250379|453771554|FG001|Overall Study|Other|4|||
126131408|NCT01250379|453771553|FG000|Overall Study|Participant noncompliance|2|||
126131409|NCT01250379|453771554|FG001|Overall Study|Participant noncompliance|0|||
126131410|NCT05902364|453771555|FG000|Overall Study|Adverse Event|1|||
126131411|NCT05902364|453771556|FG001|Overall Study|Adverse Event|0|||
126131412|NCT01489527|453771558|FG000|Overall Study|Pregnancy|9|||
126131413|NCT01489527|453771559|FG001|Overall Study|Pregnancy|14|||
126131414|NCT01489527|453771558|FG000|Overall Study|Participant moved|6|||
126131415|NCT01489527|453771559|FG001|Overall Study|Participant moved|7|||
126131416|NCT01489527|453771558|FG000|Overall Study|Withdrawal by Subject|0|||
126131417|NCT01489527|453771559|FG001|Overall Study|Withdrawal by Subject|4|||
126131418|NCT01489527|453771558|FG000|Overall Study|Lost to Follow-up|5|||
126131419|NCT01489527|453771559|FG001|Overall Study|Lost to Follow-up|1|||
126131420|NCT01489527|453771558|FG000|Overall Study|Procedures|1|||
126131421|NCT01489527|453771559|FG001|Overall Study|Procedures|0|||
126131422|NCT01489527|453771558|FG000|Overall Study|Not compliant|1|||
126131423|NCT01489527|453771559|FG001|Overall Study|Not compliant|0|||
126131424|NCT01984268|453771560|FG000|Overall Study|Study Terminated|15|||
126131425|NCT04899232|453771561|FG000|Screening Period|Physician Decision|1|||
126131426|NCT04899232|453771562|FG001|Screening Period|Physician Decision|0|||
126131427|NCT04899232|453771563|FG002|Screening Period|Physician Decision|0|||
126131428|NCT04899232|453771561|FG000|Screening Period|Withdrawal by Subject|1|||
126131429|NCT04899232|453771562|FG001|Screening Period|Withdrawal by Subject|0|||
126131430|NCT04899232|453771563|FG002|Screening Period|Withdrawal by Subject|0|||
126131431|NCT04899232|453771561|FG000|Screening Period|Participant discharged before receiving intervention|3|||
126131432|NCT04899232|453771562|FG001|Screening Period|Participant discharged before receiving intervention|0|||
126131433|NCT04899232|453771563|FG002|Screening Period|Participant discharged before receiving intervention|0|||
126131434|NCT00936208|453771565|FG000|Overall Study|Protocol Violation|37|||
126131435|NCT00936208|453771566|FG001|Overall Study|Protocol Violation|22|||
126131436|NCT01344876|453771569|FG000|Overall Study|Adverse Event|0|||
126131437|NCT01344876|453771570|FG001|Overall Study|Adverse Event|0|||
126131438|NCT01344876|453771571|FG002|Overall Study|Adverse Event|0|||
126131439|NCT01344876|453771572|FG003|Overall Study|Adverse Event|0|||
126131440|NCT01344876|453771573|FG004|Overall Study|Adverse Event|1|||
126131441|NCT01344876|453771569|FG000|Overall Study|Withdrawal by Subject|0|||
126131442|NCT01344876|453771570|FG001|Overall Study|Withdrawal by Subject|0|||
126131443|NCT01344876|453771571|FG002|Overall Study|Withdrawal by Subject|1|||
126131444|NCT01344876|453771572|FG003|Overall Study|Withdrawal by Subject|0|||
126131445|NCT01344876|453771573|FG004|Overall Study|Withdrawal by Subject|0|||
126131446|NCT01344876|453771569|FG000|Overall Study|Definite progression of primary disease|1|||
126131447|NCT01344876|453771570|FG001|Overall Study|Definite progression of primary disease|0|||
126131448|NCT01344876|453771571|FG002|Overall Study|Definite progression of primary disease|0|||
126131449|NCT01344876|453771572|FG003|Overall Study|Definite progression of primary disease|3|||
126131450|NCT01344876|453771573|FG004|Overall Study|Definite progression of primary disease|0|||
126131451|NCT04428424|453771574|FG000|Overall Study|Does not meet entrance criteria|132|||
126131452|NCT04428424|453771574|FG000|Overall Study|Lost to Follow-up|115|||
126131453|NCT04526665|453771578|FG000|Overall Study|Withdrawal by Subject|6|||
126131454|NCT04526665|453771579|FG001|Overall Study|Withdrawal by Subject|3|||
126131455|NCT04526665|453771578|FG000|Overall Study|Adverse Event|4|||
126131456|NCT04526665|453771579|FG001|Overall Study|Adverse Event|1|||
126131457|NCT04526665|453771578|FG000|Overall Study|Physician Decision|2|||
126131458|NCT04526665|453771579|FG001|Overall Study|Physician Decision|2|||
126131459|NCT04526665|453771578|FG000|Overall Study|Death|2|||
126131460|NCT04526665|453771579|FG001|Overall Study|Death|0|||
126131461|NCT04526665|453771578|FG000|Overall Study|Other|0|||
126131462|NCT04526665|453771579|FG001|Overall Study|Other|1|||
126131463|NCT04622046|453771580|FG000|Intervention Period|Adverse Event|1|||
126131464|NCT04622046|453771580|FG000|Intervention Period|Withdrawal by Subject|2|||
126131465|NCT04622046|453771580|FG000|Extension Period|Ongoing in the Extension Period|21|||
126131466|NCT04647253|453771581|FG000|Overall Study|Death ≤ 365 Days|16|||
126131467|NCT04647253|453771582|FG001|Overall Study|Death ≤ 365 Days|7|||
126131468|NCT04647253|453771581|FG000|Overall Study|Physician Decision|0|||
126131469|NCT04647253|453771582|FG001|Overall Study|Physician Decision|1|||
126131470|NCT04647253|453771581|FG000|Overall Study|Withdrawal by Subject|7|||
126131471|NCT04647253|453771582|FG001|Overall Study|Withdrawal by Subject|2|||
126131472|NCT04647253|453771581|FG000|Overall Study|Missed 12-Month Visit|9|||
126131473|NCT04647253|453771582|FG001|Overall Study|Missed 12-Month Visit|7|||
126131474|NCT04647253|453771581|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
126131475|NCT04647253|453771582|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
126131476|NCT02396589|453771583|FG000|Intervention|Lost to Follow-up|1|||
126131477|NCT02396589|453771584|FG001|Intervention|Lost to Follow-up|0|||
126131478|NCT02396589|453771583|FG000|6 Month Follow-up|change in health status|0|||
126131479|NCT02396589|453771584|FG001|6 Month Follow-up|change in health status|1|||
126131480|NCT02396589|453771583|FG000|9 Month Follow-up|Death|0|||
126131481|NCT02396589|453771584|FG001|9 Month Follow-up|Death|1|||
126131482|NCT02396589|453771583|FG000|12 Month Follow up|Lost to Follow-up|0|||
126131483|NCT02396589|453771584|FG001|12 Month Follow up|Lost to Follow-up|2|||
126131484|NCT01284114|453772961|FG000|Overall Study|viral infection|1|||
126131485|NCT01284114|453772961|FG000|Overall Study|From the results of ALLTITUDE study|1|||
126131486|NCT01284114|453772961|FG000|Overall Study|Symptomatic hypotension|1|||
126131487|NCT01284114|453772961|FG000|Overall Study|dizziness|1|||
126131488|NCT03445000|453772963|FG000|Overall Study|Disease progression|8|||
126131489|NCT03445000|453772963|FG000|Overall Study|Adverse Event|3|||
126131490|NCT03445000|453772963|FG000|Overall Study|Death|2|||
126131491|NCT03445000|453772963|FG000|Overall Study|Physician Decision|1|||
126131492|NCT03409744|453772964|FG000|Overall Study|Death|2|||
126131493|NCT03409744|453772964|FG000|Overall Study|Physician Decision|5|||
126131494|NCT03409744|453772964|FG000|Overall Study|Pregnancy|1|||
126131495|NCT03409744|453772964|FG000|Overall Study|Lost to Follow-up|1|||
126131496|NCT03409744|453772964|FG000|Overall Study|Protocol Violation|1|||
126131497|NCT03704194|453772977|FG000|Overall Study|Withdrawal by Subject|0|||
126131498|NCT03704194|453772978|FG001|Overall Study|Withdrawal by Subject|1|||
126131499|NCT04656652|453772983|FG000|Overall Study|Lost to Follow-up|2|||
126131500|NCT04656652|453772984|FG001|Overall Study|Lost to Follow-up|2|||
126131501|NCT04656652|453772983|FG000|Overall Study|Death|213|||
126131502|NCT04656652|453772984|FG001|Overall Study|Death|212|||
126131503|NCT04656652|453772983|FG000|Overall Study|Other|1|||
126131504|NCT04656652|453772984|FG001|Overall Study|Other|0|||
125964323|NCT00803023|453159365|FG000|Overall Study|Lost to Follow-up|0|||
125964324|NCT00803023|453159366|FG001|Overall Study|Lost to Follow-up|1|||
126131505|NCT04656652|453772983|FG000|Overall Study|Withdrawal by Subject|15|||
126131506|NCT04656652|453772984|FG001|Overall Study|Withdrawal by Subject|29|||
126131507|NCT03118297|453772985|FG000|Overall Study|Lost to Follow-up|0|||
126131508|NCT03118297|453772986|FG001|Overall Study|Lost to Follow-up|2|||
126131509|NCT02479802|453772987|FG000|Overall Study|Lost to Follow-up|1|||
126131510|NCT02479802|453772987|FG000|Overall Study|Adverse Event|1|||
126131511|NCT01978093|453772988|FG000|Overall Study|Death|1|||
126131512|NCT01978093|453772989|FG001|Overall Study|Death|0|||
126131513|NCT01978093|453772988|FG000|Overall Study|Adverse Event|0|||
126131514|NCT01978093|453772989|FG001|Overall Study|Adverse Event|5|||
126131515|NCT01978093|453772988|FG000|Overall Study|Protocol Violation|8|||
126131516|NCT01978093|453772989|FG001|Overall Study|Protocol Violation|2|||
126131517|NCT01978093|453772988|FG000|Overall Study|Withdrawal by Subject|29|||
126131518|NCT01978093|453772989|FG001|Overall Study|Withdrawal by Subject|25|||
126131519|NCT01978093|453772988|FG000|Overall Study|Lost to Follow-up|11|||
126131520|NCT01978093|453772989|FG001|Overall Study|Lost to Follow-up|15|||
126131521|NCT01978093|453772988|FG000|Overall Study|Migrated/moved from study area|11|||
126131522|NCT01978093|453772989|FG001|Overall Study|Migrated/moved from study area|13|||
126131523|NCT01978093|453772988|FG000|Overall Study|Loss of kaiser coverage|4|||
126131524|NCT01978093|453772989|FG001|Overall Study|Loss of kaiser coverage|10|||
126131525|NCT01978093|453772988|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
126131526|NCT01978093|453772989|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
126131527|NCT01978093|453772988|FG000|Overall Study|Mother lost custody of child|0|||
126131528|NCT01978093|453772989|FG001|Overall Study|Mother lost custody of child|1|||
125964325|NCT00803023|453159367|FG002|Overall Study|Lost to Follow-up|2|||
126131529|NCT01978093|453772988|FG000|Overall Study|Child was in care of grandmother|0|||
126131530|NCT01978093|453772989|FG001|Overall Study|Child was in care of grandmother|1|||
126131531|NCT01978093|453772988|FG000|Overall Study|N/A for vaccine administration|0|||
126131532|NCT01978093|453772989|FG001|Overall Study|N/A for vaccine administration|1|||
126131533|NCT02469090|453772993|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
126131534|NCT02469090|453772994|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
126131535|NCT02469090|453772995|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
126131536|NCT02469090|453772993|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
126131537|NCT02469090|453772994|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
126131538|NCT02469090|453772995|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
126131539|NCT02469090|453772993|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
126131540|NCT02469090|453772994|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
126131541|NCT02469090|453772995|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
126131542|NCT02469090|453772993|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
126131543|NCT02469090|453772994|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
126131544|NCT02469090|453772995|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
126131545|NCT02469090|453772993|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
126131546|NCT02469090|453772994|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
126131547|NCT02469090|453772995|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
126131548|NCT02469090|453772993|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
126131549|NCT02469090|453772994|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
126131550|NCT02469090|453772995|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
126131551|NCT02469090|453772993|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
126131552|NCT02469090|453772994|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
126131553|NCT02469090|453772995|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
126131554|NCT02469090|453772993|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
126131555|NCT02469090|453772994|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
126131556|NCT02469090|453772995|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
126131557|NCT03286842|453772996|FG000|Overall Study|Patients rolled over to another study|80|||
126131558|NCT01391507|453773000|FG000|Overall Study|Death|0|||
126131559|NCT01391507|453773001|FG001|Overall Study|Death|0|||
126131560|NCT01391507|453773002|FG002|Overall Study|Death|0|||
126131561|NCT01391507|453773003|FG003|Overall Study|Death|1|||
126131562|NCT01391507|453773000|FG000|Overall Study|Adverse Event|1|||
126131563|NCT01391507|453773001|FG001|Overall Study|Adverse Event|1|||
126131564|NCT01391507|453773002|FG002|Overall Study|Adverse Event|2|||
126131565|NCT01391507|453773003|FG003|Overall Study|Adverse Event|2|||
126131566|NCT01391507|453773000|FG000|Overall Study|Withdrawal by Subject|1|||
126131567|NCT01391507|453773001|FG001|Overall Study|Withdrawal by Subject|2|||
126131568|NCT01391507|453773002|FG002|Overall Study|Withdrawal by Subject|1|||
126131569|NCT01391507|453773003|FG003|Overall Study|Withdrawal by Subject|1|||
126131570|NCT01391507|453773000|FG000|Overall Study|Lack of Efficacy|0|||
126131571|NCT01391507|453773001|FG001|Overall Study|Lack of Efficacy|0|||
126131572|NCT01391507|453773002|FG002|Overall Study|Lack of Efficacy|0|||
126131573|NCT01391507|453773003|FG003|Overall Study|Lack of Efficacy|1|||
126131574|NCT01391507|453773000|FG000|Overall Study|Protocol Violation|2|||
126131575|NCT01391507|453773001|FG001|Overall Study|Protocol Violation|1|||
126131576|NCT01391507|453773002|FG002|Overall Study|Protocol Violation|1|||
126131577|NCT01391507|453773003|FG003|Overall Study|Protocol Violation|2|||
126131578|NCT01453855|453773004|FG000|Overall Study|Adverse Event|3|||
125964326|NCT00803023|453159368|FG003|Overall Study|Lost to Follow-up|1|||
125964327|NCT00803023|453159365|FG000|Overall Study|Lack of Efficacy|0|||
126131579|NCT01453855|453773005|FG001|Overall Study|Adverse Event|4|||
126131580|NCT01453855|453773004|FG000|Overall Study|Lost to Follow-up|2|||
126131581|NCT01453855|453773005|FG001|Overall Study|Lost to Follow-up|1|||
126131582|NCT01453855|453773004|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
126131583|NCT01453855|453773005|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
126131584|NCT01453855|453773004|FG000|Overall Study|Noncompliance|1|||
126131585|NCT01453855|453773005|FG001|Overall Study|Noncompliance|0|||
126131586|NCT01453855|453773004|FG000|Overall Study|Inadequate Control of IOP|1|||
126131587|NCT01453855|453773005|FG001|Overall Study|Inadequate Control of IOP|5|||
126131588|NCT01453855|453773004|FG000|Overall Study|Other|0|||
126131589|NCT01453855|453773005|FG001|Overall Study|Other|1|||
126131590|NCT01562548|453773014|FG000|Overall Study|Lost to Follow-up|0|||
126131591|NCT01562548|453773015|FG001|Overall Study|Lost to Follow-up|0|||
126131592|NCT01562548|453773016|FG002|Overall Study|Lost to Follow-up|1|||
126131593|NCT01562548|453773017|FG003|Overall Study|Lost to Follow-up|0|||
126131594|NCT01496066|453773018|FG000|Overall Study|Lost to Follow-up|8|||
126131595|NCT01496066|453773019|FG001|Overall Study|Lost to Follow-up|5|||
126131596|NCT01496066|453773018|FG000|Overall Study|Explant|3|||
126131597|NCT01496066|453773019|FG001|Overall Study|Explant|0|||
126131598|NCT01496066|453773018|FG000|Overall Study|Death|1|||
126131599|NCT01496066|453773019|FG001|Overall Study|Death|4|||
126131600|NCT00070941|453773023|FG000|Overall Study|Adverse Event|10|||
126131601|NCT00070941|453773024|FG001|Overall Study|Adverse Event|8|||
126131602|NCT00070941|453773025|FG002|Overall Study|Adverse Event|4|||
126131603|NCT00094055|453773026|FG000|Overall Study|Adverse Event|11|||
126131604|NCT00094055|453773026|FG000|Overall Study|Death|4|||
126131605|NCT00094055|453773026|FG000|Overall Study|Lack of Efficacy|17|||
126131606|NCT00094055|453773026|FG000|Overall Study|Lost to Follow-up|2|||
126131607|NCT00094055|453773026|FG000|Overall Study|progressive disease|2|||
126131608|NCT00094055|453773026|FG000|Overall Study|clinical progression|1|||
126131609|NCT00094055|453773026|FG000|Overall Study|roll-over to another study|14|||
126131610|NCT00094055|453773026|FG000|Overall Study|Withdrawal by Subject|9|||
126131611|NCT00411554|453773030|FG000|Overall Study|Adverse Event|2|||
126131612|NCT00411554|453773031|FG001|Overall Study|Adverse Event|4|||
126131613|NCT00411554|453773030|FG000|Overall Study|Lack of Efficacy|2|||
126131614|NCT00411554|453773031|FG001|Overall Study|Lack of Efficacy|5|||
126131615|NCT00411554|453773030|FG000|Overall Study|Withdrawal by Subject|3|||
126131616|NCT00411554|453773031|FG001|Overall Study|Withdrawal by Subject|0|||
126131617|NCT00411554|453773030|FG000|Overall Study|Patient Moved|1|||
126131618|NCT00411554|453773031|FG001|Overall Study|Patient Moved|0|||
126131619|NCT00699907|453773032|FG000|Overall Study|Withdrawal by Subject|2|||
126131620|NCT00699907|453773033|FG001|Overall Study|Withdrawal by Subject|1|||
126131621|NCT00699907|453773034|FG002|Overall Study|Withdrawal by Subject|0|||
126131622|NCT00699907|453773032|FG000|Overall Study|No usable sample|0|||
126131623|NCT00699907|453773033|FG001|Overall Study|No usable sample|9|||
126131624|NCT00699907|453773034|FG002|Overall Study|No usable sample|8|||
126131625|NCT02161211|453773035|FG000|Overall Study|Lost to Follow-up|21|||
126131626|NCT02161211|453773036|FG001|Overall Study|Lost to Follow-up|27|||
126131627|NCT02161211|453773037|FG002|Overall Study|Lost to Follow-up|21|||
126131628|NCT02161211|453773035|FG000|Overall Study|Dropped|12|||
126131629|NCT02161211|453773036|FG001|Overall Study|Dropped|5|||
126131630|NCT02161211|453773037|FG002|Overall Study|Dropped|9|||
126131631|NCT00430508|453773038|FG000|Overall Study|Adverse Event|2|||
126131632|NCT00430508|453773039|FG001|Overall Study|Adverse Event|3|||
126131633|NCT00430508|453773040|FG002|Overall Study|Adverse Event|5|||
126131634|NCT00430508|453773041|FG003|Overall Study|Adverse Event|3|||
126131635|NCT00430508|453773038|FG000|Overall Study|Withdrawal by Subject|0|||
126131636|NCT00430508|453773039|FG001|Overall Study|Withdrawal by Subject|1|||
126131637|NCT00430508|453773040|FG002|Overall Study|Withdrawal by Subject|1|||
126131638|NCT00430508|453773041|FG003|Overall Study|Withdrawal by Subject|1|||
126131639|NCT00430508|453773038|FG000|Overall Study|responder at visit 4|0|||
126131640|NCT00430508|453773039|FG001|Overall Study|responder at visit 4|0|||
126131641|NCT00430508|453773040|FG002|Overall Study|responder at visit 4|2|||
126131642|NCT00430508|453773041|FG003|Overall Study|responder at visit 4|0|||
126131643|NCT00430508|453773038|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
126131644|NCT00430508|453773039|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
126131645|NCT00430508|453773040|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
126131646|NCT00430508|453773041|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
126131647|NCT00430508|453773038|FG000|Overall Study|Other|1|||
126131648|NCT00430508|453773039|FG001|Overall Study|Other|1|||
126131649|NCT00430508|453773040|FG002|Overall Study|Other|3|||
126131650|NCT00430508|453773041|FG003|Overall Study|Other|0|||
126131651|NCT04673786|453773046|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
126131652|NCT04673786|453773047|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
126131653|NCT04673786|453773048|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
126131654|NCT04673786|453773046|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
126131655|NCT04673786|453773047|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
126131656|NCT04673786|453773048|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
126131657|NCT04673786|453773046|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
126131658|NCT04673786|453773047|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
126131659|NCT04673786|453773048|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
126131660|NCT04673786|453773046|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
126131661|NCT04673786|453773047|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
126131662|NCT04673786|453773048|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
126131663|NCT04673786|453773046|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
126131664|NCT04673786|453773047|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
126131665|NCT04673786|453773048|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
126131666|NCT04673786|453773046|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
126131667|NCT04673786|453773047|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
126131668|NCT04673786|453773048|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
126131669|NCT01422239|453773051|FG000|Overall Study|Lost to Follow-up|4|||
126131670|NCT01422239|453773052|FG001|Overall Study|Lost to Follow-up|3|||
126131671|NCT00903929|453773053|FG000|Overall Study|Withdrawal by Subject|0|||
126131672|NCT00903929|453773054|FG001|Overall Study|Withdrawal by Subject|0|||
126131673|NCT00903929|453773055|FG002|Overall Study|Withdrawal by Subject|1|||
126131674|NCT00903929|453773056|FG003|Overall Study|Withdrawal by Subject|2|||
126131675|NCT00903929|453773053|FG000|Overall Study|Adverse Event|0|||
126131676|NCT00903929|453773054|FG001|Overall Study|Adverse Event|0|||
126131677|NCT00903929|453773055|FG002|Overall Study|Adverse Event|0|||
126131678|NCT00903929|453773056|FG003|Overall Study|Adverse Event|1|||
126131679|NCT00516737|453773062|FG000|Overall Study|Lost to Follow-up|2|||
126131680|NCT00516737|453773063|FG001|Overall Study|Lost to Follow-up|0|||
126131681|NCT00516737|453773062|FG000|Overall Study|Physician Decision|0|||
126131682|NCT00516737|453773063|FG001|Overall Study|Physician Decision|1|||
126131683|NCT00516737|453773062|FG000|Overall Study|Withdrawal by Subject|0|||
126131684|NCT00516737|453773063|FG001|Overall Study|Withdrawal by Subject|1|||
126131685|NCT00516737|453773062|FG000|Overall Study|Lack of Qualifying Event|9|||
126131686|NCT00516737|453773063|FG001|Overall Study|Lack of Qualifying Event|6|||
126131687|NCT01844895|453773064|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
126131688|NCT01844895|453773064|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
126131689|NCT01844895|453773064|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
126131690|NCT01844895|453773064|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
126131691|NCT01844895|453773064|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
126131692|NCT01844895|453773064|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
126131693|NCT01844895|453773064|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
126131694|NCT00511355|453773066|FG000|Overall Study|Adverse Event|4|||
126131695|NCT00511355|453773067|FG001|Overall Study|Adverse Event|4|||
126131696|NCT00511355|453773066|FG000|Overall Study|Pregnancy Wish|1|||
126131697|NCT00511355|453773067|FG001|Overall Study|Pregnancy Wish|0|||
126131698|NCT00511355|453773066|FG000|Overall Study|Lost to Follow-up|2|||
126131699|NCT00511355|453773067|FG001|Overall Study|Lost to Follow-up|1|||
126131700|NCT00511355|453773066|FG000|Overall Study|Other Reason|0|||
126131701|NCT00511355|453773067|FG001|Overall Study|Other Reason|1|||
126131702|NCT00511355|453773066|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
126131703|NCT00511355|453773067|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
126131704|NCT00511355|453773066|FG000|Overall Study|Withdrawal of informed consent|0|||
126131705|NCT00511355|453773067|FG001|Overall Study|Withdrawal of informed consent|1|||
126131706|NCT00511355|453773066|FG000|Overall Study|Other reason pre-treatment|0|||
126131707|NCT00511355|453773067|FG001|Overall Study|Other reason pre-treatment|1|||
126131708|NCT03208231|453773076|FG000|Overall Study|Death|1|||
126131709|NCT03208231|453773077|FG001|Overall Study|Death|2|||
126131710|NCT03208231|453773076|FG000|Overall Study|Moved and unable to get to clinic|1|||
126131711|NCT03208231|453773077|FG001|Overall Study|Moved and unable to get to clinic|0|||
126131712|NCT03208231|453773076|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
126131713|NCT03208231|453773077|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
126131714|NCT04347239|453773081|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
126131715|NCT04347239|453773082|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
126131716|NCT04347239|453773083|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
126131717|NCT04347239|453773081|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
126131718|NCT04347239|453773082|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
126131719|NCT04347239|453773083|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
126131720|NCT02289950|453773085|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
126131721|NCT02289950|453773086|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
126131722|NCT02289950|453773085|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
126131723|NCT02289950|453773086|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
126131724|NCT02289950|453773085|FG000|Overall Study|Lost to Follow-up|1|||
126131725|NCT02289950|453773086|FG001|Overall Study|Lost to Follow-up|0|||
126131726|NCT02289950|453773085|FG000|Overall Study|Physician Decision|9|||
126131727|NCT02289950|453773086|FG001|Overall Study|Physician Decision|3|||
126131728|NCT02289950|453773085|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
126131729|NCT02289950|453773086|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
126131730|NCT02289950|453773085|FG000|Overall Study|Withdrawal by Subject|1|||
126131731|NCT02289950|453773086|FG001|Overall Study|Withdrawal by Subject|3|||
126131732|NCT02289950|453773085|FG000|Overall Study|Test article held for greater than 28 days|0|||
126131733|NCT02289950|453773086|FG001|Overall Study|Test article held for greater than 28 days|1|||
126131734|NCT02289950|453773085|FG000|Overall Study|Adverse Event|11|||
126131735|NCT02289950|453773086|FG001|Overall Study|Adverse Event|3|||
126131736|NCT02289950|453773085|FG000|Overall Study|Death|1|||
126131737|NCT02289950|453773086|FG001|Overall Study|Death|1|||
126131738|NCT02289950|453773085|FG000|Overall Study|Other|5|||
126131739|NCT02289950|453773086|FG001|Overall Study|Other|2|||
126131740|NCT02289950|453773085|FG000|Overall Study|Not Treated|2|||
126131741|NCT02289950|453773086|FG001|Overall Study|Not Treated|1|||
126131742|NCT02270242|453773087|FG000|Overall Study|Withdrawal by Subject|18|||
126131743|NCT02270242|453773088|FG001|Overall Study|Withdrawal by Subject|25|||
126131744|NCT02270242|453773087|FG000|Overall Study|Lost to Follow-up|41|||
126131745|NCT02270242|453773088|FG001|Overall Study|Lost to Follow-up|27|||
126131746|NCT02270242|453773087|FG000|Overall Study|Physician Decision|0|||
126131747|NCT02270242|453773088|FG001|Overall Study|Physician Decision|1|||
126131748|NCT02321436|453773091|FG000|Overall Study|Withdrawal by Subject|1|||
126131749|NCT02321436|453773092|FG001|Overall Study|Withdrawal by Subject|0|||
126131750|NCT02321436|453773091|FG000|Overall Study|Lost to Follow-up|0|||
126131751|NCT02321436|453773092|FG001|Overall Study|Lost to Follow-up|1|||
126131752|NCT00644787|453773093|FG000|Period 1: Titration Phase|Adverse Event|11|||
126131753|NCT00644787|453773094|FG001|Period 1: Titration Phase|Adverse Event|0|||
126131754|NCT00644787|453773095|FG002|Period 1: Titration Phase|Adverse Event|0|||
126131755|NCT00644787|453773093|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
126131756|NCT00644787|453773094|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
126131757|NCT00644787|453773095|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
126131758|NCT00644787|453773093|FG000|Period 1: Titration Phase|Physician Decision|1|||
126131759|NCT00644787|453773094|FG001|Period 1: Titration Phase|Physician Decision|0|||
126131760|NCT00644787|453773095|FG002|Period 1: Titration Phase|Physician Decision|0|||
126131761|NCT00644787|453773093|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
126131762|NCT00644787|453773094|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
126131763|NCT00644787|453773095|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
126131764|NCT00644787|453773093|FG000|Period 1: Titration Phase|Worsening of complications|1|||
126131765|NCT00644787|453773094|FG001|Period 1: Titration Phase|Worsening of complications|0|||
126131766|NCT00644787|453773095|FG002|Period 1: Titration Phase|Worsening of complications|0|||
126131767|NCT00644787|453773093|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
126131768|NCT00644787|453773094|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
126131769|NCT00644787|453773095|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
126131770|NCT00644787|453773093|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
126131771|NCT00644787|453773094|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
126131772|NCT00644787|453773095|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
126131773|NCT00644787|453773093|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
126131774|NCT00644787|453773094|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
126131775|NCT00644787|453773095|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
126131776|NCT00644787|453773093|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
126131777|NCT00644787|453773094|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
126131778|NCT00644787|453773095|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
126131779|NCT00644787|453773093|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
126131780|NCT00644787|453773094|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
126131781|NCT00644787|453773095|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
126131782|NCT00644787|453773093|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
126131783|NCT00644787|453773094|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
126131784|NCT00644787|453773095|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
126131785|NCT00644787|453773093|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
126131786|NCT00644787|453773094|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
126131787|NCT00644787|453773095|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
126131788|NCT03355300|453773096|FG000|Overall Study|Physician Decision|0|||
126131789|NCT03355300|453773097|FG001|Overall Study|Physician Decision|1|||
126131790|NCT03355300|453773096|FG000|Overall Study|Lack of Efficacy|2|||
126131791|NCT03355300|453773097|FG001|Overall Study|Lack of Efficacy|1|||
126131792|NCT03355300|453773096|FG000|Overall Study|Other reason|1|||
126131793|NCT03355300|453773097|FG001|Overall Study|Other reason|0|||
126131794|NCT03048422|453773098|FG000|Overall Study|Death|1|||
126131795|NCT03048422|453773099|FG001|Overall Study|Death|0|||
126131796|NCT03048422|453773100|FG002|Overall Study|Death|0|||
126131797|NCT03048422|453773098|FG000|Overall Study|Lost to Follow-up|5|||
126131798|NCT03048422|453773099|FG001|Overall Study|Lost to Follow-up|0|||
126131799|NCT03048422|453773100|FG002|Overall Study|Lost to Follow-up|1|||
126131800|NCT03048422|453773098|FG000|Overall Study|Withdrawal by Subject|5|||
126131801|NCT03048422|453773099|FG001|Overall Study|Withdrawal by Subject|7|||
126131802|NCT03048422|453773100|FG002|Overall Study|Withdrawal by Subject|4|||
126131803|NCT03048422|453773098|FG000|Overall Study|Moved|3|||
126131804|NCT03048422|453773099|FG001|Overall Study|Moved|2|||
126131805|NCT03048422|453773100|FG002|Overall Study|Moved|2|||
126131806|NCT03048422|453773098|FG000|Overall Study|Noncompliant with Study Requirements|2|||
126131807|NCT03048422|453773099|FG001|Overall Study|Noncompliant with Study Requirements|1|||
126131808|NCT03048422|453773100|FG002|Overall Study|Noncompliant with Study Requirements|2|||
126131809|NCT03048422|453773098|FG000|Overall Study|Not Able to Get to Clinic|1|||
126131810|NCT03048422|453773099|FG001|Overall Study|Not Able to Get to Clinic|0|||
126131811|NCT03048422|453773100|FG002|Overall Study|Not Able to Get to Clinic|0|||
126131812|NCT03110224|453773101|FG000|Overall Study|Death|3|||
126131813|NCT03110224|453773101|FG000|Overall Study|Lost to Follow-up|132|||
126131814|NCT03110224|453773101|FG000|Overall Study|Physician Decision|2|||
126131815|NCT03110224|453773101|FG000|Overall Study|Site Closed by Physician|35|||
126131816|NCT03110224|453773101|FG000|Overall Study|Site Closed by Sponsor|202|||
126131817|NCT03110224|453773101|FG000|Overall Study|Withdrawal by Subject|9|||
126131818|NCT04818593|453773102|FG000|Overall Study|Low Oocyte Yield|8|||
126131819|NCT04818593|453773103|FG001|Overall Study|Low Oocyte Yield|8|||
126131820|NCT04818593|453773102|FG000|Overall Study|Not ICSI Insemination|7|||
126131821|NCT04818593|453773103|FG001|Overall Study|Not ICSI Insemination|7|||
125964328|NCT00803023|453159366|FG001|Overall Study|Lack of Efficacy|1|||
125964329|NCT00803023|453159367|FG002|Overall Study|Lack of Efficacy|1|||
126131822|NCT04818593|453773102|FG000|Overall Study|Poor Sperm Quality|2|||
126131823|NCT04818593|453773103|FG001|Overall Study|Poor Sperm Quality|2|||
126131824|NCT04818593|453773102|FG000|Overall Study|Withdrawal by Subject|2|||
126131825|NCT04818593|453773103|FG001|Overall Study|Withdrawal by Subject|2|||
126131826|NCT04818593|453773102|FG000|Overall Study|Conversion to IUI due to low response|1|||
126131827|NCT04818593|453773103|FG001|Overall Study|Conversion to IUI due to low response|1|||
126131828|NCT01564862|453773104|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
126131829|NCT01564862|453773105|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
126131830|NCT01564862|453773106|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
125964330|NCT00803023|453159368|FG003|Overall Study|Lack of Efficacy|1|||
125964331|NCT02647658|453159369|FG000|Overall Study|Consent refusal|15|||
125964332|NCT02647658|453159370|FG001|Overall Study|Consent refusal|24|||
125964333|NCT01542528|453159371|FG000|Overall Study|Lost to Follow-up|2|||
125964334|NCT01542528|453159372|FG001|Overall Study|Lost to Follow-up|1|||
125964335|NCT01542528|453159371|FG000|Overall Study|Physician Decision|1|||
125964336|NCT01542528|453159372|FG001|Overall Study|Physician Decision|0|||
125964337|NCT01542528|453159371|FG000|Overall Study|Withdrawal by Subject|9|||
125964338|NCT01542528|453159372|FG001|Overall Study|Withdrawal by Subject|6|||
125964339|NCT01931839|453159375|FG000|Overall Study|Death|0|||
125964340|NCT01931839|453159376|FG001|Overall Study|Death|1|||
125964341|NCT01931839|453159377|FG002|Overall Study|Death|2|||
125964342|NCT01931839|453159378|FG003|Overall Study|Death|0|||
125964343|NCT01931839|453159379|FG004|Overall Study|Death|0|||
125964344|NCT01931839|453159380|FG005|Overall Study|Death|0|||
125964345|NCT01931839|453159381|FG006|Overall Study|Death|0|||
125964346|NCT01931839|453159375|FG000|Overall Study|Physician Decision|1|||
125964347|NCT01931839|453159376|FG001|Overall Study|Physician Decision|0|||
125964348|NCT01931839|453159377|FG002|Overall Study|Physician Decision|1|||
126131831|NCT01564862|453773104|FG000|Overall Study|Major Protocol Deviation|3|||
126131832|NCT01564862|453773105|FG001|Overall Study|Major Protocol Deviation|3|||
126131833|NCT01564862|453773106|FG002|Overall Study|Major Protocol Deviation|4|||
126131834|NCT01564862|453773104|FG000|Overall Study|Lost to Follow-up|10|||
126131835|NCT01564862|453773105|FG001|Overall Study|Lost to Follow-up|8|||
126131836|NCT01564862|453773106|FG002|Overall Study|Lost to Follow-up|6|||
126131837|NCT01564862|453773104|FG000|Overall Study|Voluntary Withdrawal|9|||
126131838|NCT01564862|453773105|FG001|Overall Study|Voluntary Withdrawal|6|||
126131839|NCT01564862|453773106|FG002|Overall Study|Voluntary Withdrawal|8|||
126131840|NCT01564862|453773104|FG000|Overall Study|Lack of Efficacy|1|||
126131841|NCT01564862|453773105|FG001|Overall Study|Lack of Efficacy|5|||
125964349|NCT01931839|453159378|FG003|Overall Study|Physician Decision|0|||
125964350|NCT01931839|453159379|FG004|Overall Study|Physician Decision|0|||
125964351|NCT01931839|453159380|FG005|Overall Study|Physician Decision|0|||
125964352|NCT01931839|453159381|FG006|Overall Study|Physician Decision|1|||
125964353|NCT01931839|453159375|FG000|Overall Study|Withdrawal of consent|0|||
125964354|NCT01931839|453159376|FG001|Overall Study|Withdrawal of consent|0|||
125964355|NCT01931839|453159377|FG002|Overall Study|Withdrawal of consent|0|||
125964356|NCT01931839|453159378|FG003|Overall Study|Withdrawal of consent|0|||
126131842|NCT01564862|453773106|FG002|Overall Study|Lack of Efficacy|6|||
126131843|NCT01564862|453773104|FG000|Overall Study|Other reason(s)|1|||
126131844|NCT01564862|453773105|FG001|Overall Study|Other reason(s)|0|||
126131845|NCT01564862|453773106|FG002|Overall Study|Other reason(s)|0|||
126131846|NCT01844986|453773107|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
126131847|NCT01844986|453773108|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
125964357|NCT01931839|453159379|FG004|Overall Study|Withdrawal of consent|1|||
125964358|NCT01931839|453159380|FG005|Overall Study|Withdrawal of consent|0|||
125964359|NCT01931839|453159381|FG006|Overall Study|Withdrawal of consent|0|||
125964360|NCT01931839|453159375|FG000|Overall Study|Adverse Event|9|||
126131848|NCT01844986|453773107|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
126131849|NCT01844986|453773108|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
126131850|NCT01844986|453773107|FG000|Overall Study (Global Cohort)|Death|55|||
126131851|NCT01844986|453773108|FG001|Overall Study (Global Cohort)|Death|26|||
126131852|NCT01844986|453773107|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
126131853|NCT01844986|453773108|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
126131854|NCT01844986|453773107|FG000|Overall Study (China Cohort)|Death|10|||
126131855|NCT01844986|453773108|FG001|Overall Study (China Cohort)|Death|6|||
126131856|NCT02028455|453773109|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126131857|NCT02028455|453773110|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126131858|NCT02028455|453773111|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126131859|NCT02028455|453773112|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126131860|NCT02028455|453773113|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126131861|NCT02028455|453773114|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126131862|NCT02028455|453773115|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
126131863|NCT02028455|453773116|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
126131864|NCT02028455|453773109|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
126131865|NCT02028455|453773110|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
126131866|NCT02028455|453773111|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
126131867|NCT02028455|453773112|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
126131868|NCT02028455|453773113|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
126131869|NCT02028455|453773114|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
126131870|NCT02028455|453773115|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
126131871|NCT02028455|453773116|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
126131872|NCT02028455|453773109|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126131873|NCT02028455|453773110|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126131874|NCT02028455|453773111|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126131875|NCT02028455|453773112|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126131876|NCT02028455|453773113|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126131877|NCT02028455|453773114|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
126131878|NCT02028455|453773115|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126131879|NCT02028455|453773116|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
126131880|NCT02028455|453773109|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
126131881|NCT02028455|453773110|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
126131882|NCT02028455|453773111|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
126131883|NCT02028455|453773112|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
126131884|NCT02028455|453773113|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
126131885|NCT02028455|453773114|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
126131886|NCT02028455|453773115|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
126131887|NCT02028455|453773116|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
126131888|NCT01761266|453775102|FG000|Overall Study|Death|415|||
126131889|NCT01761266|453775103|FG001|Overall Study|Death|402|||
126131890|NCT01761266|453775102|FG000|Overall Study|Lost to Follow-up|8|||
126131891|NCT01761266|453775103|FG001|Overall Study|Lost to Follow-up|12|||
126131892|NCT01761266|453775102|FG000|Overall Study|Withdrawal by Subject|14|||
126131893|NCT01761266|453775103|FG001|Overall Study|Withdrawal by Subject|10|||
126131894|NCT01761266|453775102|FG000|Overall Study|Sponsor Decision|41|||
126131895|NCT01761266|453775103|FG001|Overall Study|Sponsor Decision|52|||
126131896|NCT02740478|453775104|FG000|Overall Study|Withdrawal by Subject|1|||
126131897|NCT00699348|453775105|FG000|Overall Study|Death|6|||
126131898|NCT00699348|453775105|FG000|Overall Study|Adverse Event|15|||
126131899|NCT00699348|453775105|FG000|Overall Study|Withdrawal by Subject|11|||
126131900|NCT00699348|453775105|FG000|Overall Study|Protocol Violation|10|||
126131901|NCT00699348|453775105|FG000|Overall Study|Lack of Efficacy|8|||
126131902|NCT00699348|453775105|FG000|Overall Study|Failure to return|1|||
126131903|NCT00699348|453775105|FG000|Overall Study|Blood transfusion|24|||
126131904|NCT00699348|453775105|FG000|Overall Study|Renal transplantation|10|||
126131905|NCT00699348|453775105|FG000|Overall Study|Other|5|||
125964361|NCT01931839|453159376|FG001|Overall Study|Adverse Event|4|||
125964362|NCT01931839|453159377|FG002|Overall Study|Adverse Event|1|||
125964363|NCT01931839|453159378|FG003|Overall Study|Adverse Event|3|||
125964364|NCT01931839|453159379|FG004|Overall Study|Adverse Event|0|||
125964365|NCT01931839|453159380|FG005|Overall Study|Adverse Event|0|||
126131906|NCT03269344|453775106|FG000|Overall Study|Protocol Violation|4|||
126131907|NCT03269344|453775107|FG001|Overall Study|Protocol Violation|3|||
126131908|NCT02597855|453775108|FG000|Overall Study|Lost to Follow-up|2|||
125964366|NCT01931839|453159381|FG006|Overall Study|Adverse Event|1|||
125964367|NCT01931839|453159375|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
125964368|NCT01931839|453159376|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
126131909|NCT02597855|453775109|FG001|Overall Study|Lost to Follow-up|1|||
126131910|NCT01449708|453775112|FG000|Overall Study|Protocol Violation|0|||
126131911|NCT01449708|453775113|FG001|Overall Study|Protocol Violation|1|||
126131912|NCT01449708|453775112|FG000|Overall Study|surgical complication|1|||
126131913|NCT01449708|453775113|FG001|Overall Study|surgical complication|2|||
126131914|NCT01449708|453775112|FG000|Overall Study|respiratory failure|1|||
126131915|NCT01449708|453775113|FG001|Overall Study|respiratory failure|0|||
126131916|NCT00223496|453775116|FG000|Overall Study|screen failure|9|||
126131917|NCT00223496|453775116|FG000|Overall Study|Lost to Follow-up|4|||
126131918|NCT00223496|453775116|FG000|Overall Study|Lack of Efficacy|6|||
126131919|NCT00223496|453775116|FG000|Overall Study|Withdrawal by Subject|1|||
126131920|NCT00223496|453775116|FG000|Overall Study|Physician Decision|2|||
126131921|NCT00559507|453775117|FG000|Overall Study|Not treated, patient ineligible|3|||
126131922|NCT02889796|453775118|FG000|Overall Study|Withdrew Consent|18|||
126131923|NCT02889796|453775119|FG001|Overall Study|Withdrew Consent|29|||
126131924|NCT02889796|453775120|FG002|Overall Study|Withdrew Consent|20|||
126131925|NCT02889796|453775121|FG003|Overall Study|Withdrew Consent|1|||
126131926|NCT02889796|453775122|FG004|Overall Study|Withdrew Consent|2|||
126131927|NCT02889796|453775123|FG005|Overall Study|Withdrew Consent|35|||
126131928|NCT02889796|453775118|FG000|Overall Study|Investigator's Discretion|10|||
126131929|NCT02889796|453775119|FG001|Overall Study|Investigator's Discretion|9|||
126131930|NCT02889796|453775120|FG002|Overall Study|Investigator's Discretion|10|||
126131931|NCT02889796|453775121|FG003|Overall Study|Investigator's Discretion|3|||
126131932|NCT02889796|453775122|FG004|Overall Study|Investigator's Discretion|0|||
126131933|NCT02889796|453775123|FG005|Overall Study|Investigator's Discretion|15|||
126131934|NCT02889796|453775118|FG000|Overall Study|Adverse Event|17|||
126131935|NCT02889796|453775119|FG001|Overall Study|Adverse Event|8|||
126131936|NCT02889796|453775120|FG002|Overall Study|Adverse Event|8|||
126131937|NCT02889796|453775121|FG003|Overall Study|Adverse Event|4|||
126131938|NCT02889796|453775122|FG004|Overall Study|Adverse Event|1|||
126131939|NCT02889796|453775123|FG005|Overall Study|Adverse Event|7|||
126131940|NCT02889796|453775118|FG000|Overall Study|Lost to Follow-up|5|||
126131941|NCT02889796|453775119|FG001|Overall Study|Lost to Follow-up|7|||
126131942|NCT02889796|453775120|FG002|Overall Study|Lost to Follow-up|2|||
126131943|NCT02889796|453775121|FG003|Overall Study|Lost to Follow-up|0|||
126131944|NCT02889796|453775122|FG004|Overall Study|Lost to Follow-up|2|||
126131945|NCT02889796|453775123|FG005|Overall Study|Lost to Follow-up|6|||
126131946|NCT02889796|453775118|FG000|Overall Study|Protocol Violation|0|||
126131947|NCT02889796|453775119|FG001|Overall Study|Protocol Violation|1|||
126131948|NCT02889796|453775120|FG002|Overall Study|Protocol Violation|3|||
126131949|NCT02889796|453775121|FG003|Overall Study|Protocol Violation|0|||
126131950|NCT02889796|453775122|FG004|Overall Study|Protocol Violation|0|||
126131951|NCT02889796|453775123|FG005|Overall Study|Protocol Violation|4|||
126131952|NCT02889796|453775118|FG000|Overall Study|Non-compliance With Study Drug|0|||
126131953|NCT02889796|453775119|FG001|Overall Study|Non-compliance With Study Drug|2|||
126131954|NCT02889796|453775120|FG002|Overall Study|Non-compliance With Study Drug|0|||
126131955|NCT02889796|453775121|FG003|Overall Study|Non-compliance With Study Drug|0|||
126131956|NCT02889796|453775122|FG004|Overall Study|Non-compliance With Study Drug|1|||
126131957|NCT02889796|453775123|FG005|Overall Study|Non-compliance With Study Drug|2|||
126131958|NCT02889796|453775118|FG000|Overall Study|Death|1|||
126131959|NCT02889796|453775119|FG001|Overall Study|Death|1|||
126131960|NCT02889796|453775120|FG002|Overall Study|Death|0|||
126131961|NCT02889796|453775121|FG003|Overall Study|Death|1|||
126131962|NCT02889796|453775122|FG004|Overall Study|Death|0|||
126131963|NCT02889796|453775123|FG005|Overall Study|Death|1|||
126131964|NCT02889796|453775118|FG000|Overall Study|Pregnancy|0|||
126131965|NCT02889796|453775119|FG001|Overall Study|Pregnancy|1|||
126131966|NCT02889796|453775120|FG002|Overall Study|Pregnancy|1|||
126131967|NCT02889796|453775121|FG003|Overall Study|Pregnancy|0|||
126131968|NCT02889796|453775122|FG004|Overall Study|Pregnancy|0|||
126131969|NCT02889796|453775123|FG005|Overall Study|Pregnancy|0|||
126131970|NCT02889796|453775118|FG000|Overall Study|Randomized but not Dosed|2|||
126131971|NCT02889796|453775119|FG001|Overall Study|Randomized but not Dosed|0|||
126131972|NCT02889796|453775120|FG002|Overall Study|Randomized but not Dosed|0|||
126131973|NCT02889796|453775121|FG003|Overall Study|Randomized but not Dosed|0|||
126131974|NCT02889796|453775122|FG004|Overall Study|Randomized but not Dosed|0|||
126131975|NCT02889796|453775123|FG005|Overall Study|Randomized but not Dosed|2|||
126131976|NCT01407926|453775129|FG000|Overall Study|Lost to Follow-up|55|||
126131977|NCT02814565|453775130|FG000|Overall Study|Lack of Efficacy|0|||
126131978|NCT02814565|453775131|FG001|Overall Study|Lack of Efficacy|1|||
126131979|NCT02814565|453775130|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
126131980|NCT02814565|453775131|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
126131981|NCT01414257|453775132|FG000|Overall Study|No Visit After First Day of Treatment|12|||
126131982|NCT01414257|453775132|FG000|Overall Study|Protocol Violation|10|||
126131983|NCT01882907|453775135|FG000|Overall Study|Adverse Event|3|||
126131984|NCT01882907|453775136|FG001|Overall Study|Adverse Event|1|||
126131985|NCT01882907|453775135|FG000|Overall Study|Lack of Efficacy|0|||
126131986|NCT01882907|453775136|FG001|Overall Study|Lack of Efficacy|3|||
126131987|NCT01882907|453775135|FG000|Overall Study|Lost to Follow-up|1|||
126131988|NCT01882907|453775136|FG001|Overall Study|Lost to Follow-up|4|||
126131989|NCT01882907|453775135|FG000|Overall Study|Protocol Violation|10|||
126131990|NCT01882907|453775136|FG001|Overall Study|Protocol Violation|14|||
126131991|NCT01882907|453775135|FG000|Overall Study|Withdrawal by Subject|0|||
126131992|NCT01882907|453775136|FG001|Overall Study|Withdrawal by Subject|6|||
126131993|NCT01784965|453775140|FG000|Overall Study|Withdrawal by Subject|6|||
126131994|NCT01784965|453775141|FG001|Overall Study|Withdrawal by Subject|3|||
126131995|NCT01784965|453775140|FG000|Overall Study|Adverse Event|0|||
126131996|NCT01784965|453775141|FG001|Overall Study|Adverse Event|8|||
126131997|NCT03178487|453775144|FG000|Period 1|Adverse Event|1|||
126131998|NCT03178487|453775145|FG001|Period 1|Adverse Event|2|||
126131999|NCT03178487|453775144|FG000|Period 1|Withdrawal by Subject|2|||
126132000|NCT03178487|453775145|FG001|Period 1|Withdrawal by Subject|1|||
126132001|NCT03178487|453775144|FG000|Period 1|Lost to Follow-up|1|||
126132002|NCT03178487|453775145|FG001|Period 1|Lost to Follow-up|0|||
126132003|NCT03178487|453775144|FG000|Period 1|Other|0|||
126132004|NCT03178487|453775145|FG001|Period 1|Other|1|||
126132005|NCT03178487|453775144|FG000|Period 2|Adverse Event|4|||
126132006|NCT03178487|453775145|FG001|Period 2|Adverse Event|4|||
126132007|NCT03178487|453775144|FG000|Period 2|Withdrawal by Subject|6|||
126132008|NCT03178487|453775145|FG001|Period 2|Withdrawal by Subject|6|||
126132009|NCT03178487|453775144|FG000|Period 2|Lost to Follow-up|2|||
126132010|NCT03178487|453775145|FG001|Period 2|Lost to Follow-up|2|||
126132011|NCT03178487|453775144|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
126132012|NCT03178487|453775145|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
126132013|NCT03178487|453775144|FG000|Period 2|Other|8|||
126132014|NCT03178487|453775145|FG001|Period 2|Other|7|||
126132015|NCT00493038|453775148|FG000|Treatment|Adverse Event|8|||
126132016|NCT00493038|453775149|FG001|Treatment|Adverse Event|4|||
126132017|NCT00493038|453775148|FG000|Treatment|Lost to Follow-up|5|||
126132018|NCT00493038|453775149|FG001|Treatment|Lost to Follow-up|3|||
126132019|NCT00493038|453775148|FG000|Treatment|Withdrawal by Subject|11|||
126132020|NCT00493038|453775149|FG001|Treatment|Withdrawal by Subject|12|||
126132021|NCT00493038|453775148|FG000|Treatment|Other|0|||
126132022|NCT00493038|453775149|FG001|Treatment|Other|1|||
126132023|NCT00493038|453775148|FG000|Follow-up|Lost to Follow-up|1|||
126132024|NCT00493038|453775149|FG001|Follow-up|Lost to Follow-up|0|||
126132025|NCT00577993|453775150|FG000|Overall Study|Adverse Event|1|||
126132026|NCT00577993|453775151|FG001|Overall Study|Adverse Event|0|||
126132027|NCT00577993|453775152|FG002|Overall Study|Adverse Event|0|||
126132028|NCT00577993|453775150|FG000|Overall Study|Death|0|||
126132029|NCT00577993|453775151|FG001|Overall Study|Death|1|||
126132030|NCT00577993|453775152|FG002|Overall Study|Death|1|||
126132031|NCT00577993|453775150|FG000|Overall Study|Lack of Efficacy|0|||
126132032|NCT00577993|453775151|FG001|Overall Study|Lack of Efficacy|1|||
126132033|NCT00577993|453775152|FG002|Overall Study|Lack of Efficacy|0|||
126132034|NCT00577993|453775150|FG000|Overall Study|Protocol Violation|2|||
126132035|NCT00577993|453775151|FG001|Overall Study|Protocol Violation|3|||
126132036|NCT00577993|453775152|FG002|Overall Study|Protocol Violation|0|||
126132037|NCT00577993|453775150|FG000|Overall Study|Withdrawal by Subject|1|||
126132038|NCT00577993|453775151|FG001|Overall Study|Withdrawal by Subject|0|||
126132039|NCT00577993|453775152|FG002|Overall Study|Withdrawal by Subject|2|||
126132040|NCT00577993|453775150|FG000|Overall Study|Conversion|2|||
126132041|NCT00577993|453775151|FG001|Overall Study|Conversion|5|||
126132042|NCT00577993|453775152|FG002|Overall Study|Conversion|0|||
126132043|NCT00577993|453775150|FG000|Overall Study|Uninsured|1|||
126132044|NCT00577993|453775151|FG001|Overall Study|Uninsured|0|||
126132045|NCT00577993|453775152|FG002|Overall Study|Uninsured|0|||
126132046|NCT02217566|453775153|FG000|Overall Study|Lost to Follow-up|2|||
126132047|NCT02217566|453775153|FG000|Overall Study|Death|3|||
126132048|NCT02217566|453775153|FG000|Overall Study|Early study termination|6|||
126132049|NCT01847885|453775155|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
126132050|NCT01847885|453775156|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
126132051|NCT01847885|453775157|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
126132052|NCT01847885|453775155|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
126132053|NCT01847885|453775156|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
126132054|NCT01847885|453775157|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
126132055|NCT01847885|453775155|FG000|Initial Enrollment (Consented)|Screen failure|39|||
126132056|NCT01847885|453775156|FG001|Initial Enrollment (Consented)|Screen failure|0|||
126132057|NCT01847885|453775157|FG002|Initial Enrollment (Consented)|Screen failure|0|||
126132058|NCT01847885|453775155|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
126132059|NCT01847885|453775156|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
126132060|NCT01847885|453775157|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
126132061|NCT01847885|453775155|FG000|Randomization|Protocol Violation|0|||
126132062|NCT01847885|453775156|FG001|Randomization|Protocol Violation|1|||
126132063|NCT01847885|453775157|FG002|Randomization|Protocol Violation|0|||
126132064|NCT01847885|453775155|FG000|Randomization|Withdrawal by Subject|0|||
126132065|NCT01847885|453775156|FG001|Randomization|Withdrawal by Subject|0|||
126132066|NCT01847885|453775157|FG002|Randomization|Withdrawal by Subject|2|||
126132067|NCT01847885|453775155|FG000|Randomization|Screen Failure|0|||
126132068|NCT01847885|453775156|FG001|Randomization|Screen Failure|3|||
126132069|NCT01847885|453775157|FG002|Randomization|Screen Failure|0|||
126132070|NCT02574637|453775160|FG000|Double-blind Period|Adverse Event|1|||
126132071|NCT02574637|453775161|FG001|Double-blind Period|Adverse Event|0|||
126132072|NCT02574637|453775162|FG002|Double-blind Period|Adverse Event|0|||
126132073|NCT02574637|453775163|FG003|Double-blind Period|Adverse Event|0|||
126132074|NCT02574637|453775164|FG004|Double-blind Period|Adverse Event|0|||
126132075|NCT02574637|453775165|FG005|Double-blind Period|Adverse Event|0|||
126132076|NCT02574637|453775166|FG006|Double-blind Period|Adverse Event|0|||
126132077|NCT02574637|453775167|FG007|Double-blind Period|Adverse Event|0|||
126132078|NCT02574637|453775168|FG008|Double-blind Period|Adverse Event|0|||
126132079|NCT02574637|453775169|FG009|Double-blind Period|Adverse Event|0|||
126132080|NCT02574637|453775160|FG000|Double-blind Period|Lack of Efficacy|0|||
126132081|NCT02574637|453775161|FG001|Double-blind Period|Lack of Efficacy|0|||
126132082|NCT02574637|453775162|FG002|Double-blind Period|Lack of Efficacy|2|||
126132083|NCT02574637|453775163|FG003|Double-blind Period|Lack of Efficacy|0|||
126132084|NCT02574637|453775164|FG004|Double-blind Period|Lack of Efficacy|0|||
126132085|NCT02574637|453775165|FG005|Double-blind Period|Lack of Efficacy|0|||
126132086|NCT02574637|453775166|FG006|Double-blind Period|Lack of Efficacy|0|||
126132087|NCT02574637|453775167|FG007|Double-blind Period|Lack of Efficacy|0|||
126132088|NCT02574637|453775168|FG008|Double-blind Period|Lack of Efficacy|0|||
126132089|NCT02574637|453775169|FG009|Double-blind Period|Lack of Efficacy|0|||
126132090|NCT02574637|453775160|FG000|Double-blind Period|Protocol Deviation|1|||
126132091|NCT02574637|453775161|FG001|Double-blind Period|Protocol Deviation|0|||
126132092|NCT02574637|453775162|FG002|Double-blind Period|Protocol Deviation|0|||
126132093|NCT02574637|453775163|FG003|Double-blind Period|Protocol Deviation|0|||
126132094|NCT02574637|453775164|FG004|Double-blind Period|Protocol Deviation|0|||
126132095|NCT02574637|453775165|FG005|Double-blind Period|Protocol Deviation|0|||
126132096|NCT02574637|453775166|FG006|Double-blind Period|Protocol Deviation|0|||
125964369|NCT01931839|453159377|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
125964370|NCT01931839|453159378|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
125964371|NCT01931839|453159379|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
125964372|NCT01931839|453159380|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
125964373|NCT01931839|453159381|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
125964374|NCT01931839|453159375|FG000|Overall Study|Other non-compliance|15|||
125964375|NCT01931839|453159376|FG001|Overall Study|Other non-compliance|9|||
125964376|NCT01931839|453159377|FG002|Overall Study|Other non-compliance|12|||
125964377|NCT01931839|453159378|FG003|Overall Study|Other non-compliance|3|||
125964378|NCT01931839|453159379|FG004|Overall Study|Other non-compliance|0|||
125964379|NCT01931839|453159380|FG005|Overall Study|Other non-compliance|3|||
125964380|NCT01931839|453159381|FG006|Overall Study|Other non-compliance|0|||
125964381|NCT01931839|453159375|FG000|Overall Study|Lost to Follow-up|1|||
125964382|NCT01931839|453159376|FG001|Overall Study|Lost to Follow-up|2|||
125964383|NCT01931839|453159377|FG002|Overall Study|Lost to Follow-up|4|||
125964384|NCT01931839|453159378|FG003|Overall Study|Lost to Follow-up|5|||
125964385|NCT01931839|453159379|FG004|Overall Study|Lost to Follow-up|0|||
125964386|NCT01931839|453159380|FG005|Overall Study|Lost to Follow-up|0|||
125964387|NCT01931839|453159381|FG006|Overall Study|Lost to Follow-up|0|||
125964388|NCT01931839|453159375|FG000|Overall Study|Other|4|||
125964389|NCT01931839|453159376|FG001|Overall Study|Other|2|||
125964390|NCT01931839|453159377|FG002|Overall Study|Other|6|||
125964391|NCT01931839|453159378|FG003|Overall Study|Other|0|||
125964392|NCT01931839|453159379|FG004|Overall Study|Other|0|||
125964393|NCT01931839|453159380|FG005|Overall Study|Other|0|||
125964394|NCT01931839|453159381|FG006|Overall Study|Other|0|||
125964395|NCT01762761|453159384|FG000|Overall Study|Adverse Event|15|||
125964396|NCT01762761|453159385|FG001|Overall Study|Adverse Event|17|||
125964397|NCT01762761|453159384|FG000|Overall Study|Lack of Efficacy|9|||
125964398|NCT01762761|453159385|FG001|Overall Study|Lack of Efficacy|25|||
125964399|NCT01762761|453159384|FG000|Overall Study|Protocol Violation|1|||
125964400|NCT01762761|453159385|FG001|Overall Study|Protocol Violation|1|||
125964401|NCT01762761|453159384|FG000|Overall Study|Study closed/terminated|0|||
125964402|NCT01762761|453159385|FG001|Overall Study|Study closed/terminated|2|||
126132097|NCT02574637|453775167|FG007|Double-blind Period|Protocol Deviation|0|||
126132098|NCT02574637|453775168|FG008|Double-blind Period|Protocol Deviation|0|||
126132099|NCT02574637|453775169|FG009|Double-blind Period|Protocol Deviation|0|||
126132100|NCT02574637|453775160|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
126132101|NCT02574637|453775161|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
125964403|NCT01762761|453159384|FG000|Overall Study|Lost to Follow-up|3|||
125964404|NCT01762761|453159385|FG001|Overall Study|Lost to Follow-up|6|||
125964405|NCT01762761|453159384|FG000|Overall Study|Physician Decision|4|||
125964406|NCT01762761|453159385|FG001|Overall Study|Physician Decision|6|||
125964407|NCT01762761|453159384|FG000|Overall Study|Withdrawal by Subject|7|||
125964408|NCT01762761|453159385|FG001|Overall Study|Withdrawal by Subject|8|||
125964409|NCT01751568|453159403|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
125964410|NCT01751568|453159404|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
125964411|NCT01751568|453159405|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
125964412|NCT02660944|453159406|FG000|Overall Study|Adverse Event|3|||
125964413|NCT02660944|453159407|FG001|Overall Study|Adverse Event|4|||
125964414|NCT02660944|453159406|FG000|Overall Study|Physician Decision|3|||
125964415|NCT02660944|453159407|FG001|Overall Study|Physician Decision|1|||
125964416|NCT02660944|453159406|FG000|Overall Study|Withdrawal by Subject|5|||
125964417|NCT02660944|453159407|FG001|Overall Study|Withdrawal by Subject|3|||
125964418|NCT02660944|453159406|FG000|Overall Study|Lost to Follow-up|4|||
125964419|NCT02660944|453159407|FG001|Overall Study|Lost to Follow-up|1|||
125964420|NCT02660944|453159406|FG000|Overall Study|Subject schedule|0|||
125964421|NCT02660944|453159407|FG001|Overall Study|Subject schedule|1|||
125964422|NCT02660944|453159406|FG000|Overall Study|Exclusion criteria met|2|||
125964423|NCT02660944|453159407|FG001|Overall Study|Exclusion criteria met|0|||
125964424|NCT04079933|453159411|FG000|Overall Study|Withdrawal by Subject|3|||
125964425|NCT04079933|453159412|FG001|Overall Study|Withdrawal by Subject|4|||
125964426|NCT04079933|453159411|FG000|Overall Study|Lost to Follow-up|0|||
125964427|NCT04079933|453159412|FG001|Overall Study|Lost to Follow-up|1|||
125964428|NCT01229436|453159413|FG000|Overall Study|Withdrawal by Subject|2|||
125964429|NCT01229436|453159413|FG000|Overall Study|Lost to Follow-up|3|||
125964430|NCT00345579|453159417|FG000|Overall Study|Adverse Event|9|||
125964431|NCT00345579|453159418|FG001|Overall Study|Adverse Event|6|||
125964432|NCT00345579|453159417|FG000|Overall Study|Protocol Violation|14|||
125964433|NCT00345579|453159418|FG001|Overall Study|Protocol Violation|5|||
125964434|NCT00345579|453159417|FG000|Overall Study|Withdrawal by Subject|50|||
125964435|NCT00345579|453159418|FG001|Overall Study|Withdrawal by Subject|17|||
125964436|NCT00345579|453159417|FG000|Overall Study|Lost to Follow-up|82|||
125964437|NCT00345579|453159418|FG001|Overall Study|Lost to Follow-up|36|||
125964438|NCT00345579|453159417|FG000|Overall Study|Other|9|||
125964439|NCT00345579|453159418|FG001|Overall Study|Other|1|||
125964440|NCT01731171|453159419|FG000|Overall Study|Withdrawal by Subject|4|||
125964441|NCT01731171|453159420|FG001|Overall Study|Withdrawal by Subject|1|||
125964442|NCT01731171|453159419|FG000|Overall Study|Lost to Follow-up|3|||
125964443|NCT01731171|453159420|FG001|Overall Study|Lost to Follow-up|2|||
125964444|NCT01731171|453159419|FG000|Overall Study|Moved out of Area|0|||
125964445|NCT01731171|453159420|FG001|Overall Study|Moved out of Area|2|||
125964446|NCT01731171|453159419|FG000|Overall Study|Terminated for Lack of Adherence|0|||
125964447|NCT01731171|453159420|FG001|Overall Study|Terminated for Lack of Adherence|1|||
125964448|NCT01731171|453159419|FG000|Overall Study|Terminated for Safety Reasons|0|||
125964449|NCT01731171|453159420|FG001|Overall Study|Terminated for Safety Reasons|1|||
125964450|NCT00413413|453159421|FG000|Single-Blind|Adverse Event|0|||
125964451|NCT00413413|453159422|FG001|Single-Blind|Adverse Event|9|||
125964452|NCT00413413|453159423|FG002|Single-Blind|Adverse Event|0|||
125964453|NCT00413413|453159421|FG000|Single-Blind|Lack of Efficacy|0|||
125964454|NCT00413413|453159422|FG001|Single-Blind|Lack of Efficacy|5|||
125964455|NCT00413413|453159423|FG002|Single-Blind|Lack of Efficacy|0|||
125964456|NCT00413413|453159421|FG000|Single-Blind|Subject no longer requires study drug|0|||
125964457|NCT00413413|453159422|FG001|Single-Blind|Subject no longer requires study drug|151|||
125964458|NCT00413413|453159423|FG002|Single-Blind|Subject no longer requires study drug|0|||
125964459|NCT00413413|453159421|FG000|Single-Blind|Protocol Violation|0|||
125964460|NCT00413413|453159422|FG001|Single-Blind|Protocol Violation|16|||
125964461|NCT00413413|453159423|FG002|Single-Blind|Protocol Violation|0|||
125964462|NCT00413413|453159421|FG000|Single-Blind|Withdrawal by Subject|0|||
125964463|NCT00413413|453159422|FG001|Single-Blind|Withdrawal by Subject|27|||
125964464|NCT00413413|453159423|FG002|Single-Blind|Withdrawal by Subject|0|||
125964465|NCT00413413|453159421|FG000|Single-Blind|Lost to Follow-up|0|||
125964466|NCT00413413|453159422|FG001|Single-Blind|Lost to Follow-up|8|||
125964467|NCT00413413|453159423|FG002|Single-Blind|Lost to Follow-up|0|||
125964468|NCT00413413|453159421|FG000|Double-Blind|Adverse Event|6|||
125964469|NCT00413413|453159422|FG001|Double-Blind|Adverse Event|0|||
125964470|NCT00413413|453159423|FG002|Double-Blind|Adverse Event|5|||
125964471|NCT00413413|453159421|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
126132102|NCT02574637|453775162|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
126132103|NCT02574637|453775163|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
125964472|NCT00413413|453159422|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
125964473|NCT00413413|453159423|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
125964474|NCT00413413|453159421|FG000|Double-Blind|Protocol deviation|1|||
125964475|NCT00413413|453159422|FG001|Double-Blind|Protocol deviation|2|||
125964476|NCT00413413|453159423|FG002|Double-Blind|Protocol deviation|1|||
125964477|NCT00413413|453159421|FG000|Double-Blind|Subject withdrew consent|4|||
125964478|NCT00413413|453159422|FG001|Double-Blind|Subject withdrew consent|6|||
125964479|NCT00413413|453159423|FG002|Double-Blind|Subject withdrew consent|9|||
125964480|NCT00413413|453159421|FG000|Double-Blind|Lost to Follow-up|3|||
125964481|NCT00413413|453159422|FG001|Double-Blind|Lost to Follow-up|4|||
125964482|NCT00413413|453159423|FG002|Double-Blind|Lost to Follow-up|2|||
125964483|NCT02604589|453159430|FG000|Overall Study|catheter dislodgement|0|||
125964484|NCT02604589|453159431|FG001|Overall Study|catheter dislodgement|0|||
125964485|NCT02604589|453159432|FG002|Overall Study|catheter dislodgement|1|||
125964486|NCT03321981|453159445|FG000|Overall Study|Progressive Disease (PD)|15|||
125964487|NCT03321981|453159446|FG001|Overall Study|Progressive Disease (PD)|30|||
125964488|NCT03321981|453159447|FG002|Overall Study|Progressive Disease (PD)|47|||
125964489|NCT03321981|453159445|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
125964490|NCT03321981|453159446|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
125964491|NCT03321981|453159447|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
125964492|NCT03321981|453159445|FG000|Overall Study|Adverse Event|0|||
125964493|NCT03321981|453159446|FG001|Overall Study|Adverse Event|0|||
125964494|NCT03321981|453159447|FG002|Overall Study|Adverse Event|2|||
125964495|NCT03321981|453159445|FG000|Overall Study|symptomatic deterioration|0|||
125964496|NCT03321981|453159446|FG001|Overall Study|symptomatic deterioration|1|||
125964497|NCT03321981|453159447|FG002|Overall Study|symptomatic deterioration|1|||
125964498|NCT03321981|453159445|FG000|Overall Study|Lack of compliance|0|||
125964499|NCT03321981|453159446|FG001|Overall Study|Lack of compliance|1|||
125964500|NCT03321981|453159447|FG002|Overall Study|Lack of compliance|0|||
125964501|NCT03321981|453159445|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
125964502|NCT03321981|453159446|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
125964503|NCT03321981|453159447|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
125964504|NCT03321981|453159445|FG000|Overall Study|Death|0|||
125964505|NCT03321981|453159446|FG001|Overall Study|Death|1|||
125964506|NCT03321981|453159447|FG002|Overall Study|Death|0|||
125964507|NCT03321981|453159445|FG000|Overall Study|Subject withdrawal of investigational product|0|||
125964508|NCT03321981|453159446|FG001|Overall Study|Subject withdrawal of investigational product|1|||
125964509|NCT03321981|453159447|FG002|Overall Study|Subject withdrawal of investigational product|0|||
125964510|NCT03321981|453159445|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
125964511|NCT03321981|453159446|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
125964512|NCT03321981|453159447|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
125964513|NCT03321981|453159445|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
125964514|NCT03321981|453159446|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
126132104|NCT02574637|453775164|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
126132105|NCT02574637|453775165|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
126132106|NCT02574637|453775166|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
126132107|NCT02574637|453775167|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
126132108|NCT02574637|453775168|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
126132109|NCT02574637|453775169|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
126132110|NCT02574637|453775160|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
126132111|NCT02574637|453775161|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
126132112|NCT02574637|453775162|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
126132113|NCT02574637|453775163|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
126132114|NCT02574637|453775164|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
126132115|NCT02574637|453775165|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
126132116|NCT02574637|453775166|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
126132117|NCT02574637|453775167|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
126132118|NCT02574637|453775168|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
126132119|NCT02574637|453775169|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
126132120|NCT02574637|453775160|FG000|Double-blind Period|Reason Not Specified|0|||
126132121|NCT02574637|453775161|FG001|Double-blind Period|Reason Not Specified|0|||
126132122|NCT02574637|453775162|FG002|Double-blind Period|Reason Not Specified|0|||
126132123|NCT02574637|453775163|FG003|Double-blind Period|Reason Not Specified|1|||
126132124|NCT02574637|453775164|FG004|Double-blind Period|Reason Not Specified|0|||
126132125|NCT02574637|453775165|FG005|Double-blind Period|Reason Not Specified|0|||
126132126|NCT02574637|453775166|FG006|Double-blind Period|Reason Not Specified|0|||
126132127|NCT02574637|453775167|FG007|Double-blind Period|Reason Not Specified|0|||
126132128|NCT02574637|453775168|FG008|Double-blind Period|Reason Not Specified|0|||
126132129|NCT02574637|453775169|FG009|Double-blind Period|Reason Not Specified|0|||
126132130|NCT02574637|453775160|FG000|Open-label (OL) Period|Adverse Event|0|||
126132131|NCT02574637|453775161|FG001|Open-label (OL) Period|Adverse Event|0|||
126132132|NCT02574637|453775162|FG002|Open-label (OL) Period|Adverse Event|0|||
126132133|NCT02574637|453775163|FG003|Open-label (OL) Period|Adverse Event|0|||
126132134|NCT02574637|453775164|FG004|Open-label (OL) Period|Adverse Event|0|||
125964515|NCT03321981|453159447|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
125964516|NCT03067441|453159449|FG000|Overall Study|Withdrawal by Subject|16|||
125964517|NCT03067441|453159450|FG001|Overall Study|Withdrawal by Subject|34|||
126132135|NCT02574637|453775165|FG005|Open-label (OL) Period|Adverse Event|0|||
126132136|NCT02574637|453775166|FG006|Open-label (OL) Period|Adverse Event|0|||
126132137|NCT02574637|453775167|FG007|Open-label (OL) Period|Adverse Event|0|||
126132138|NCT02574637|453775168|FG008|Open-label (OL) Period|Adverse Event|1|||
126132139|NCT02574637|453775169|FG009|Open-label (OL) Period|Adverse Event|0|||
126132140|NCT02574637|453775160|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
126132141|NCT02574637|453775161|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
126132142|NCT02574637|453775162|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
126132143|NCT02574637|453775163|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
126132144|NCT02574637|453775164|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
126132145|NCT02574637|453775165|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
126132146|NCT02574637|453775166|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
126132147|NCT02574637|453775167|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
126132148|NCT02574637|453775168|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
126132149|NCT02574637|453775169|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
126132150|NCT02574637|453775160|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126132151|NCT02574637|453775161|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126132152|NCT02574637|453775162|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126132153|NCT02574637|453775163|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126132154|NCT02574637|453775164|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126132155|NCT02574637|453775165|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
126132156|NCT02574637|453775166|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
126132157|NCT02574637|453775167|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
126132158|NCT02574637|453775168|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
126132159|NCT02574637|453775169|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126132160|NCT03728309|453775170|FG000|Overall Study|Randomized but not Treated|0|||
126132161|NCT03728309|453775171|FG001|Overall Study|Randomized but not Treated|1|||
126132162|NCT03728309|453775170|FG000|Overall Study|Adverse Event|0|||
126132163|NCT03728309|453775171|FG001|Overall Study|Adverse Event|1|||
126132164|NCT03728309|453775170|FG000|Overall Study|Withdrawal by Subject|2|||
126132165|NCT03728309|453775171|FG001|Overall Study|Withdrawal by Subject|8|||
126132166|NCT03728309|453775170|FG000|Overall Study|Lost to Follow-up|9|||
126132167|NCT03728309|453775171|FG001|Overall Study|Lost to Follow-up|10|||
126132168|NCT03728309|453775170|FG000|Overall Study|Protocol Deviation|0|||
126132169|NCT03728309|453775171|FG001|Overall Study|Protocol Deviation|1|||
126132170|NCT03728309|453775170|FG000|Overall Study|Due to COVID|1|||
126132171|NCT03728309|453775171|FG001|Overall Study|Due to COVID|3|||
126132172|NCT00953758|453775172|FG000|Overall Study|Death|2|||
126132173|NCT00953758|453775173|FG001|Overall Study|Death|0|||
126132174|NCT00953758|453775174|FG002|Overall Study|Death|1|||
126132175|NCT00953758|453775175|FG003|Overall Study|Death|1|||
126132176|NCT00953758|453775176|FG004|Overall Study|Death|1|||
126132177|NCT00953758|453775177|FG005|Overall Study|Death|1|||
125964518|NCT03067441|453159449|FG000|Overall Study|Lost to Follow-up|7|||
125964519|NCT03067441|453159450|FG001|Overall Study|Lost to Follow-up|5|||
125964520|NCT03067441|453159449|FG000|Overall Study|Adverse Event|7|||
125964521|NCT03067441|453159450|FG001|Overall Study|Adverse Event|14|||
125964522|NCT03067441|453159449|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
125964523|NCT03067441|453159450|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
125964524|NCT03067441|453159449|FG000|Overall Study|Physician Decision|1|||
125964525|NCT03067441|453159450|FG001|Overall Study|Physician Decision|3|||
125964526|NCT03067441|453159449|FG000|Overall Study|Other|1|||
125964527|NCT03067441|453159450|FG001|Overall Study|Other|1|||
125964528|NCT00817089|453159451|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
125964529|NCT00817089|453159452|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
125964530|NCT00817089|453159453|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
125964531|NCT00817089|453159454|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
125964532|NCT00817089|453159451|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
125964533|NCT00817089|453159452|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
125964534|NCT00817089|453159453|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
125964535|NCT00817089|453159454|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
125964536|NCT01592708|453159458|FG000|Overall Study|Protocol Violation|3|||
125964537|NCT01592708|453159459|FG001|Overall Study|Protocol Violation|0|||
125964538|NCT01785602|453159460|FG000|Overall Study|Withdrawal by Subject|2|||
126132178|NCT00953758|453775178|FG006|Overall Study|Death|1|||
126132179|NCT00953758|453775179|FG007|Overall Study|Death|3|||
126132180|NCT00953758|453775180|FG008|Overall Study|Death|1|||
126132181|NCT00953758|453775181|FG009|Overall Study|Death|0|||
126132182|NCT00953758|453775172|FG000|Overall Study|Participant refused further follow-up|0|||
125964539|NCT01785602|453159461|FG001|Overall Study|Withdrawal by Subject|0|||
125964540|NCT01785602|453159460|FG000|Overall Study|Lost to Follow-up|1|||
125964541|NCT01785602|453159461|FG001|Overall Study|Lost to Follow-up|1|||
125964542|NCT01785602|453159460|FG000|Overall Study|Adverse Event|3|||
125964543|NCT01785602|453159461|FG001|Overall Study|Adverse Event|5|||
125964544|NCT01785602|453159460|FG000|Overall Study|Administrative problems|7|||
125964545|NCT01785602|453159461|FG001|Overall Study|Administrative problems|3|||
125964546|NCT04177108|453159462|FG000|Overall Study|Withdrawal by Subject|4|||
125964547|NCT04177108|453159463|FG001|Overall Study|Withdrawal by Subject|8|||
125964548|NCT04177108|453159464|FG002|Overall Study|Withdrawal by Subject|9|||
125964549|NCT04177108|453159465|FG003|Overall Study|Withdrawal by Subject|11|||
126132183|NCT00953758|453775173|FG001|Overall Study|Participant refused further follow-up|0|||
126132184|NCT00953758|453775174|FG002|Overall Study|Participant refused further follow-up|1|||
126132185|NCT00953758|453775175|FG003|Overall Study|Participant refused further follow-up|0|||
126132186|NCT00953758|453775176|FG004|Overall Study|Participant refused further follow-up|3|||
126132187|NCT00953758|453775177|FG005|Overall Study|Participant refused further follow-up|0|||
126132188|NCT00953758|453775178|FG006|Overall Study|Participant refused further follow-up|0|||
126132189|NCT00953758|453775179|FG007|Overall Study|Participant refused further follow-up|0|||
126132190|NCT00953758|453775180|FG008|Overall Study|Participant refused further follow-up|1|||
126132191|NCT00953758|453775181|FG009|Overall Study|Participant refused further follow-up|0|||
126132192|NCT00953758|453775172|FG000|Overall Study|Lost to Follow-up|0|||
126132193|NCT00953758|453775173|FG001|Overall Study|Lost to Follow-up|0|||
126132194|NCT00953758|453775174|FG002|Overall Study|Lost to Follow-up|0|||
126132195|NCT00953758|453775175|FG003|Overall Study|Lost to Follow-up|1|||
126132196|NCT00953758|453775176|FG004|Overall Study|Lost to Follow-up|0|||
126132197|NCT00953758|453775177|FG005|Overall Study|Lost to Follow-up|0|||
126132198|NCT00953758|453775178|FG006|Overall Study|Lost to Follow-up|0|||
126132199|NCT00953758|453775179|FG007|Overall Study|Lost to Follow-up|1|||
126132200|NCT00953758|453775180|FG008|Overall Study|Lost to Follow-up|0|||
126132201|NCT00953758|453775181|FG009|Overall Study|Lost to Follow-up|1|||
126132202|NCT00953758|453775172|FG000|Overall Study|Physician Decision|0|||
125964550|NCT04177108|453159466|FG004|Overall Study|Withdrawal by Subject|13|||
126132203|NCT00953758|453775173|FG001|Overall Study|Physician Decision|0|||
126132204|NCT00953758|453775174|FG002|Overall Study|Physician Decision|0|||
126132205|NCT00953758|453775175|FG003|Overall Study|Physician Decision|0|||
126132206|NCT00953758|453775176|FG004|Overall Study|Physician Decision|1|||
126132207|NCT00953758|453775177|FG005|Overall Study|Physician Decision|0|||
126132208|NCT00953758|453775178|FG006|Overall Study|Physician Decision|0|||
126132209|NCT00953758|453775179|FG007|Overall Study|Physician Decision|0|||
126132210|NCT00953758|453775180|FG008|Overall Study|Physician Decision|0|||
126132211|NCT00953758|453775181|FG009|Overall Study|Physician Decision|0|||
126132212|NCT00953758|453775172|FG000|Overall Study|Disease progression|0|||
126132213|NCT00953758|453775173|FG001|Overall Study|Disease progression|0|||
126132214|NCT00953758|453775174|FG002|Overall Study|Disease progression|0|||
126132215|NCT00953758|453775175|FG003|Overall Study|Disease progression|0|||
126132216|NCT00953758|453775176|FG004|Overall Study|Disease progression|1|||
126132217|NCT00953758|453775177|FG005|Overall Study|Disease progression|0|||
126132218|NCT00953758|453775178|FG006|Overall Study|Disease progression|0|||
126132219|NCT00953758|453775179|FG007|Overall Study|Disease progression|0|||
126132220|NCT00953758|453775180|FG008|Overall Study|Disease progression|0|||
126132221|NCT00953758|453775181|FG009|Overall Study|Disease progression|0|||
126132222|NCT00953758|453775172|FG000|Overall Study|Participant went for transplant|0|||
126132223|NCT00953758|453775173|FG001|Overall Study|Participant went for transplant|0|||
126132224|NCT00953758|453775174|FG002|Overall Study|Participant went for transplant|0|||
126132225|NCT00953758|453775175|FG003|Overall Study|Participant went for transplant|0|||
126132226|NCT00953758|453775176|FG004|Overall Study|Participant went for transplant|0|||
126132227|NCT00953758|453775177|FG005|Overall Study|Participant went for transplant|0|||
126132228|NCT00953758|453775178|FG006|Overall Study|Participant went for transplant|0|||
126132229|NCT00953758|453775179|FG007|Overall Study|Participant went for transplant|0|||
126132230|NCT00953758|453775180|FG008|Overall Study|Participant went for transplant|1|||
126132231|NCT00953758|453775181|FG009|Overall Study|Participant went for transplant|0|||
126132232|NCT01164722|453775182|FG000|Overall Study|Adverse Event|0|||
125964551|NCT04177108|453159462|FG000|Overall Study|Physician Decision|23|||
125964552|NCT04177108|453159463|FG001|Overall Study|Physician Decision|15|||
125964553|NCT04177108|453159464|FG002|Overall Study|Physician Decision|18|||
125964554|NCT04177108|453159465|FG003|Overall Study|Physician Decision|29|||
125964555|NCT04177108|453159466|FG004|Overall Study|Physician Decision|23|||
125964556|NCT04177108|453159462|FG000|Overall Study|Reason Not Specified|0|||
126132233|NCT01164722|453775183|FG001|Overall Study|Adverse Event|1|||
126132234|NCT01164722|453775182|FG000|Overall Study|Withdrawal by Subject|3|||
126132235|NCT01164722|453775183|FG001|Overall Study|Withdrawal by Subject|4|||
126132236|NCT01164722|453775182|FG000|Overall Study|Lost to Follow-up|3|||
126132237|NCT01164722|453775183|FG001|Overall Study|Lost to Follow-up|6|||
126132238|NCT01164722|453775182|FG000|Overall Study|met protocol criteria for non-treatment|11|||
126132239|NCT01164722|453775183|FG001|Overall Study|met protocol criteria for non-treatment|1|||
126132240|NCT01164722|453775182|FG000|Overall Study|enrolled on other study, concomitant med|1|||
126132241|NCT01164722|453775183|FG001|Overall Study|enrolled on other study, concomitant med|3|||
126132242|NCT00999908|453775184|FG000|Treatment Period 1|Subject withdrew consent|2|||
126132243|NCT00999908|453775185|FG001|Treatment Period 1|Subject withdrew consent|0|||
126132244|NCT00999908|453775186|FG002|Treatment Period 1|Subject withdrew consent|0|||
126132245|NCT00999908|453775184|FG000|Treatment Period 2|Protocol Violation|1|||
126132246|NCT00999908|453775185|FG001|Treatment Period 2|Protocol Violation|0|||
126132247|NCT00999908|453775186|FG002|Treatment Period 2|Protocol Violation|0|||
126132248|NCT01703858|453775189|FG000|Overall Study|Withdrawal by Subject|0|||
126132249|NCT01703858|453775190|FG001|Overall Study|Withdrawal by Subject|1|||
126132250|NCT01703858|453775191|FG002|Overall Study|Withdrawal by Subject|0|||
126132251|NCT01290692|453775199|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
126132252|NCT02556255|453775200|FG000|Overall Study|Lost to Follow-up|4|||
126132253|NCT00993031|453775201|FG000|Overall Study|Death|0|||
126132254|NCT00993031|453775202|FG001|Overall Study|Death|1|||
126132255|NCT00993031|453775201|FG000|Overall Study|Physician Decision|0|||
126132256|NCT00993031|453775202|FG001|Overall Study|Physician Decision|2|||
126132257|NCT00993031|453775201|FG000|Overall Study|Withdrawal by Subject|3|||
126132258|NCT00993031|453775202|FG001|Overall Study|Withdrawal by Subject|3|||
126132259|NCT00993031|453775201|FG000|Overall Study|Lost to Follow-up|19|||
126132260|NCT00993031|453775202|FG001|Overall Study|Lost to Follow-up|13|||
126132261|NCT01543087|453775205|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
126132262|NCT01543087|453775206|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
126132263|NCT01543087|453775207|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
126132264|NCT01543087|453775208|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
126132265|NCT01543087|453775209|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
126132266|NCT01543087|453775210|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
126132267|NCT01543087|453775205|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
126132268|NCT01543087|453775206|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
126132269|NCT01543087|453775207|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
126132270|NCT01543087|453775208|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
125964557|NCT04177108|453159463|FG001|Overall Study|Reason Not Specified|1|||
125964558|NCT04177108|453159464|FG002|Overall Study|Reason Not Specified|0|||
125964559|NCT04177108|453159465|FG003|Overall Study|Reason Not Specified|0|||
125964560|NCT04177108|453159466|FG004|Overall Study|Reason Not Specified|2|||
125964561|NCT04177108|453159462|FG000|Overall Study|Lost to Follow-up|0|||
125964562|NCT04177108|453159463|FG001|Overall Study|Lost to Follow-up|0|||
125964563|NCT04177108|453159464|FG002|Overall Study|Lost to Follow-up|1|||
125964564|NCT04177108|453159465|FG003|Overall Study|Lost to Follow-up|1|||
125964565|NCT04177108|453159466|FG004|Overall Study|Lost to Follow-up|1|||
126132271|NCT01543087|453775209|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
126132272|NCT01543087|453775210|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
126132273|NCT01543087|453775205|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
126132274|NCT01543087|453775206|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
126132275|NCT01543087|453775207|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
126132276|NCT01543087|453775208|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
126132277|NCT01543087|453775209|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
126132278|NCT01543087|453775210|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
126132279|NCT01543087|453775205|FG000|Stage 1 (48 Months)|Other than specified|5|||
126132280|NCT01543087|453775206|FG001|Stage 1 (48 Months)|Other than specified|0|||
125964566|NCT04177108|453159462|FG000|Overall Study|Death|16|||
125964567|NCT04177108|453159463|FG001|Overall Study|Death|19|||
125964568|NCT04177108|453159464|FG002|Overall Study|Death|13|||
125964569|NCT04177108|453159465|FG003|Overall Study|Death|17|||
125964570|NCT04177108|453159466|FG004|Overall Study|Death|18|||
125964571|NCT01827904|453159470|FG000|Main Study|Withdrawal by Subject|1|||
125964572|NCT01827904|453159471|FG001|Main Study|Withdrawal by Subject|0|||
125964573|NCT01827904|453159472|FG002|Main Study|Withdrawal by Subject|0|||
125964574|NCT01827904|453159470|FG000|Main Study|Adverse Event|1|||
125964575|NCT01827904|453159471|FG001|Main Study|Adverse Event|0|||
125964576|NCT01827904|453159472|FG002|Main Study|Adverse Event|0|||
125964577|NCT01827904|453159470|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
125964578|NCT01827904|453159471|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
126132281|NCT01543087|453775207|FG002|Stage 1 (48 Months)|Other than specified|9|||
126132282|NCT01543087|453775208|FG003|Stage 1 (48 Months)|Other than specified|0|||
126132283|NCT01543087|453775209|FG004|Stage 1 (48 Months)|Other than specified|0|||
126132284|NCT01543087|453775210|FG005|Stage 1 (48 Months)|Other than specified|0|||
126132285|NCT01543087|453775205|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
126132286|NCT01543087|453775206|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
126132287|NCT01543087|453775207|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
125964579|NCT01827904|453159472|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
125964580|NCT01827904|453159470|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
125964581|NCT01827904|453159471|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
125964582|NCT01827904|453159472|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
125964583|NCT01827904|453159470|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
126132288|NCT01543087|453775208|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
126132289|NCT01543087|453775209|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
126132290|NCT01543087|453775210|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
126132291|NCT01543087|453775205|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
126132292|NCT01543087|453775206|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
126132293|NCT01543087|453775207|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
126132294|NCT01543087|453775208|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
126132295|NCT01543087|453775209|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
126132296|NCT01543087|453775210|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
126132297|NCT01543087|453775205|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
126132298|NCT01543087|453775206|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
126132299|NCT01543087|453775207|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
126132300|NCT01543087|453775208|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
126132301|NCT01543087|453775209|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
126132302|NCT01543087|453775210|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
126132303|NCT00706030|453775211|FG000|Overall Study|Disease Progression|4|||
126132304|NCT00706030|453775212|FG001|Overall Study|Disease Progression|6|||
126132305|NCT00706030|453775213|FG002|Overall Study|Disease Progression|46|||
126132306|NCT00706030|453775214|FG003|Overall Study|Disease Progression|12|||
125964584|NCT01827904|453159471|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
125964585|NCT01827904|453159472|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
125964586|NCT01827904|453159470|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
125964587|NCT01827904|453159471|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
125964588|NCT01827904|453159472|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
125964589|NCT01827904|453159470|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
125964590|NCT01827904|453159471|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
125964591|NCT01827904|453159472|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
125964592|NCT01827904|453159470|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
125964593|NCT01827904|453159471|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
125964594|NCT01827904|453159472|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
125964595|NCT01827904|453159470|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
125964596|NCT01827904|453159471|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
125964597|NCT01827904|453159472|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
125964598|NCT01827904|453159470|FG000|Long-term Annual Follow-up|Physician Decision|1|||
125964599|NCT01827904|453159471|FG001|Long-term Annual Follow-up|Physician Decision|0|||
125964600|NCT01827904|453159472|FG002|Long-term Annual Follow-up|Physician Decision|0|||
125964601|NCT01827904|453159470|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
125964602|NCT01827904|453159471|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
125964603|NCT01827904|453159472|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
125964604|NCT01827904|453159470|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
125964605|NCT01827904|453159471|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
125964606|NCT01827904|453159472|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
125964607|NCT00101101|453159473|FG000|Overall Study|never received vaccine|20|||
125964608|NCT01800903|453159474|FG000|Second Test Period|unable to catheterise|1|||
125964609|NCT01800903|453159475|FG001|Second Test Period|unable to catheterise|0|||
125964610|NCT01800903|453159476|FG002|Second Test Period|unable to catheterise|0|||
125964611|NCT01800903|453159477|FG003|Second Test Period|unable to catheterise|0|||
125964612|NCT01800903|453159478|FG004|Second Test Period|unable to catheterise|0|||
125964613|NCT01800903|453159479|FG005|Second Test Period|unable to catheterise|0|||
125964614|NCT01850004|453159484|FG000|Overall Study|Poor/Non-compliance|1|||
125964615|NCT01850004|453159484|FG000|Overall Study|Participant Withdrew Consent|9|||
125964616|NCT01850004|453159484|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
125964617|NCT01850004|453159484|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
125964618|NCT01850004|453159484|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
125964619|NCT01850004|453159484|FG000|Overall Study|Other Reasons|2|||
125964620|NCT01850004|453159484|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
125964621|NCT01850004|453159484|FG000|Overall Study|Maximum Clinical Benefit|4|||
125964622|NCT01992536|453161491|FG000|Overall Study|Administrative Reason|0|||
125964623|NCT01992536|453161492|FG001|Overall Study|Administrative Reason|0|||
125964624|NCT01992536|453161493|FG002|Overall Study|Administrative Reason|0|||
125964625|NCT01992536|453161494|FG003|Overall Study|Administrative Reason|0|||
125964626|NCT01992536|453161495|FG004|Overall Study|Administrative Reason|0|||
125964627|NCT01992536|453161496|FG005|Overall Study|Administrative Reason|0|||
125964628|NCT01992536|453161497|FG006|Overall Study|Administrative Reason|7|||
125964629|NCT01992536|453161498|FG007|Overall Study|Administrative Reason|0|||
125964630|NCT01992536|453161499|FG008|Overall Study|Administrative Reason|0|||
125964631|NCT01992536|453161500|FG009|Overall Study|Administrative Reason|0|||
126132307|NCT00706030|453775211|FG000|Overall Study|Adverse Event|1|||
126132308|NCT00706030|453775212|FG001|Overall Study|Adverse Event|0|||
125964632|NCT01992536|453161491|FG000|Overall Study|Lost to Follow-up|4|||
125964633|NCT01992536|453161492|FG001|Overall Study|Lost to Follow-up|2|||
125964634|NCT01992536|453161493|FG002|Overall Study|Lost to Follow-up|1|||
125964635|NCT01992536|453161494|FG003|Overall Study|Lost to Follow-up|0|||
125964636|NCT01992536|453161495|FG004|Overall Study|Lost to Follow-up|0|||
126132309|NCT00706030|453775213|FG002|Overall Study|Adverse Event|4|||
126132310|NCT00706030|453775214|FG003|Overall Study|Adverse Event|2|||
126132311|NCT00706030|453775211|FG000|Overall Study|Withdrawal by Subject|1|||
125964637|NCT01992536|453161496|FG005|Overall Study|Lost to Follow-up|1|||
125964638|NCT01992536|453161497|FG006|Overall Study|Lost to Follow-up|0|||
125964639|NCT01992536|453161498|FG007|Overall Study|Lost to Follow-up|0|||
125964640|NCT01992536|453161499|FG008|Overall Study|Lost to Follow-up|1|||
125964641|NCT01992536|453161500|FG009|Overall Study|Lost to Follow-up|1|||
125964642|NCT01992536|453161491|FG000|Overall Study|Withdrawal by Subject|0|||
125964643|NCT01992536|453161492|FG001|Overall Study|Withdrawal by Subject|1|||
126132312|NCT00706030|453775212|FG001|Overall Study|Withdrawal by Subject|0|||
126132313|NCT00706030|453775213|FG002|Overall Study|Withdrawal by Subject|2|||
126132314|NCT00706030|453775214|FG003|Overall Study|Withdrawal by Subject|0|||
126132315|NCT00706030|453775211|FG000|Overall Study|Physician Decision|0|||
126132316|NCT00706030|453775212|FG001|Overall Study|Physician Decision|0|||
126132317|NCT00706030|453775213|FG002|Overall Study|Physician Decision|2|||
126132318|NCT00706030|453775214|FG003|Overall Study|Physician Decision|0|||
126132319|NCT00706030|453775211|FG000|Overall Study|Not recorded|0|||
126132320|NCT00706030|453775212|FG001|Overall Study|Not recorded|0|||
126132321|NCT00706030|453775213|FG002|Overall Study|Not recorded|2|||
126132322|NCT00706030|453775214|FG003|Overall Study|Not recorded|0|||
126132323|NCT00706030|453775211|FG000|Overall Study|Protocol Violation|0|||
125964644|NCT01992536|453161493|FG002|Overall Study|Withdrawal by Subject|0|||
126132324|NCT00706030|453775212|FG001|Overall Study|Protocol Violation|0|||
126132325|NCT00706030|453775213|FG002|Overall Study|Protocol Violation|1|||
126132326|NCT00706030|453775214|FG003|Overall Study|Protocol Violation|1|||
126132327|NCT00706030|453775211|FG000|Overall Study|Failed to return|0|||
126132328|NCT00706030|453775212|FG001|Overall Study|Failed to return|0|||
126132329|NCT00706030|453775213|FG002|Overall Study|Failed to return|1|||
126132330|NCT00706030|453775214|FG003|Overall Study|Failed to return|0|||
126132331|NCT00706030|453775211|FG000|Overall Study|Symptomatic Deterioration|0|||
126132332|NCT00706030|453775212|FG001|Overall Study|Symptomatic Deterioration|0|||
126132333|NCT00706030|453775213|FG002|Overall Study|Symptomatic Deterioration|1|||
126132334|NCT00706030|453775214|FG003|Overall Study|Symptomatic Deterioration|0|||
126132335|NCT00706030|453775211|FG000|Overall Study|No treatment received|0|||
126132336|NCT00706030|453775212|FG001|Overall Study|No treatment received|0|||
126132337|NCT00706030|453775213|FG002|Overall Study|No treatment received|0|||
126132338|NCT00706030|453775214|FG003|Overall Study|No treatment received|1|||
126132339|NCT00706030|453775211|FG000|Overall Study|Death|0|||
126132340|NCT00706030|453775212|FG001|Overall Study|Death|0|||
126132341|NCT00706030|453775213|FG002|Overall Study|Death|1|||
125964645|NCT01992536|453161494|FG003|Overall Study|Withdrawal by Subject|2|||
125964646|NCT01992536|453161495|FG004|Overall Study|Withdrawal by Subject|0|||
125964647|NCT01992536|453161496|FG005|Overall Study|Withdrawal by Subject|0|||
125964648|NCT01992536|453161497|FG006|Overall Study|Withdrawal by Subject|0|||
125964649|NCT01992536|453161498|FG007|Overall Study|Withdrawal by Subject|0|||
125964650|NCT01992536|453161499|FG008|Overall Study|Withdrawal by Subject|0|||
125964651|NCT01992536|453161500|FG009|Overall Study|Withdrawal by Subject|0|||
125964652|NCT00406029|453161504|FG000|Overall Study|Adverse Event|12|||
125964653|NCT00406029|453161505|FG001|Overall Study|Adverse Event|2|||
125964654|NCT00406029|453161506|FG002|Overall Study|Adverse Event|5|||
125964655|NCT00406029|453161507|FG003|Overall Study|Adverse Event|10|||
125964656|NCT00406029|453161508|FG004|Overall Study|Adverse Event|7|||
125964657|NCT00406029|453161504|FG000|Overall Study|Withdrawal by Subject|3|||
125964658|NCT00406029|453161505|FG001|Overall Study|Withdrawal by Subject|4|||
125964659|NCT00406029|453161506|FG002|Overall Study|Withdrawal by Subject|2|||
125964660|NCT00406029|453161507|FG003|Overall Study|Withdrawal by Subject|2|||
125964661|NCT00406029|453161508|FG004|Overall Study|Withdrawal by Subject|0|||
125964662|NCT00406029|453161504|FG000|Overall Study|Protocol Violation|1|||
125964663|NCT00406029|453161505|FG001|Overall Study|Protocol Violation|2|||
125964664|NCT00406029|453161506|FG002|Overall Study|Protocol Violation|0|||
125964665|NCT00406029|453161507|FG003|Overall Study|Protocol Violation|2|||
125964666|NCT00406029|453161508|FG004|Overall Study|Protocol Violation|0|||
125964667|NCT00406029|453161504|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
125964668|NCT00406029|453161505|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
125964669|NCT00406029|453161506|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
125964670|NCT00406029|453161507|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
125964671|NCT00406029|453161508|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
125964672|NCT00406029|453161504|FG000|Overall Study|Randomized in Error|0|||
125964673|NCT00406029|453161505|FG001|Overall Study|Randomized in Error|0|||
125964674|NCT00406029|453161506|FG002|Overall Study|Randomized in Error|2|||
125964675|NCT00406029|453161507|FG003|Overall Study|Randomized in Error|3|||
125964676|NCT00406029|453161508|FG004|Overall Study|Randomized in Error|1|||
125964677|NCT01709227|453161509|FG000|Overall Study|Physician Decision|1|||
126132342|NCT00706030|453775214|FG003|Overall Study|Death|0|||
126132343|NCT03870555|453775215|FG000|Period 3 (2 Days)|Adverse Event|1|||
126132344|NCT03870555|453775216|FG001|Period 3 (2 Days)|Adverse Event|0|||
126132345|NCT03870555|453775217|FG002|Period 3 (2 Days)|Adverse Event|0|||
126132346|NCT03167073|453775219|FG000|Overall Study|Stillbirth|1|||
126132347|NCT03167073|453775220|FG001|Overall Study|Stillbirth|0|||
126132348|NCT01276236|453775221|FG000|Overall Study|Lack of Efficacy|2|||
126132349|NCT01276236|453775221|FG000|Overall Study|Withdrawal by Subject|4|||
125964678|NCT01709227|453161510|FG001|Overall Study|Physician Decision|0|||
125964679|NCT01709227|453161509|FG000|Overall Study|Pleural Peritoneal communication|0|||
126132350|NCT00044512|453775222|FG000|Follow Up|Lost to Follow-up|2|||
126132351|NCT00357500|453775226|FG000|Overall Study|Adverse Event|3|||
126132352|NCT00357500|453775226|FG000|Overall Study|Withdrawal by Subject|5|||
126132353|NCT00357500|453775226|FG000|Overall Study|Progressive Disease|65|||
126132354|NCT00357500|453775226|FG000|Overall Study|Not Started Protocol Therapy|4|||
126132355|NCT02695628|453775228|FG000|Overall Study|Withdrawal by Subject|1|||
126132356|NCT02573155|453775229|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
125964680|NCT01709227|453161510|FG001|Overall Study|Pleural Peritoneal communication|9|||
125964681|NCT03669081|453161512|FG000|Overall Study|Data could not be validated|1|||
125964682|NCT03669081|453161513|FG001|Overall Study|Data could not be validated|1|||
125964683|NCT00389324|453161515|FG000|Run-In Phase|Adverse Event|1|||
126132357|NCT02573155|453775230|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
126132358|NCT02573155|453775229|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
126132359|NCT02573155|453775230|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
126132360|NCT02573155|453775229|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
126132361|NCT02573155|453775230|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
126132362|NCT02573155|453775229|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
126132363|NCT02573155|453775230|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
126132364|NCT02573155|453775229|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
126132365|NCT02573155|453775230|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
126132366|NCT02573155|453775229|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
126132367|NCT02573155|453775230|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
126132368|NCT02573155|453775229|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
126132369|NCT02573155|453775230|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
126132370|NCT02573155|453775229|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
126132371|NCT02573155|453775230|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
126132372|NCT01681433|453775231|FG000|Overall Study|Lack of Efficacy|23|||
126132373|NCT01681433|453775232|FG001|Overall Study|Lack of Efficacy|23|||
126132374|NCT01681433|453775231|FG000|Overall Study|Withdrawal by Subject|5|||
126132375|NCT01681433|453775232|FG001|Overall Study|Withdrawal by Subject|5|||
126132376|NCT01681433|453775231|FG000|Overall Study|Protocol Violation|2|||
126132377|NCT01681433|453775232|FG001|Overall Study|Protocol Violation|0|||
126132378|NCT01681433|453775231|FG000|Overall Study|Adverse Event|2|||
126132379|NCT01681433|453775232|FG001|Overall Study|Adverse Event|4|||
126132380|NCT01681433|453775231|FG000|Overall Study|Lost to Follow-up|0|||
126132381|NCT01681433|453775232|FG001|Overall Study|Lost to Follow-up|1|||
126132382|NCT02301403|453775233|FG000|Overall Study|Withdrawal by Subject|28|||
126132383|NCT02301403|453775234|FG001|Overall Study|Withdrawal by Subject|41|||
126132384|NCT05036083|453775250|FG000|Overall Study|Physician Decision|1|||
126132385|NCT05036083|453775250|FG000|Overall Study|Withdrawal by Subject|1|||
126132386|NCT05036083|453775250|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
126132387|NCT05036083|453775250|FG000|Overall Study|IV not sustainable|1|||
126132388|NCT03505021|453775251|FG000|Overall Study|Protocol Violation|1|||
126132389|NCT03505021|453775252|FG001|Overall Study|Protocol Violation|0|||
126132390|NCT03505021|453775251|FG000|Overall Study|Death|9|||
126132391|NCT03505021|453775252|FG001|Overall Study|Death|8|||
126132392|NCT03505021|453775251|FG000|Overall Study|Consent withdrawn by subject|6|||
126132393|NCT03505021|453775252|FG001|Overall Study|Consent withdrawn by subject|1|||
126132394|NCT03505021|453775251|FG000|Overall Study|Lost to Follow-up|5|||
126132395|NCT03505021|453775252|FG001|Overall Study|Lost to Follow-up|3|||
126132396|NCT03505021|453775251|FG000|Overall Study|Adverse Event|26|||
126132397|NCT03505021|453775252|FG001|Overall Study|Adverse Event|9|||
126132398|NCT03505021|453775251|FG000|Overall Study|Disease progression|33|||
126132399|NCT03505021|453775252|FG001|Overall Study|Disease progression|17|||
126132400|NCT03505021|453775251|FG000|Overall Study|Other|11|||
126132401|NCT03505021|453775252|FG001|Overall Study|Other|5|||
126132402|NCT03505021|453775251|FG000|Overall Study|Personal reason|21|||
126132403|NCT03505021|453775252|FG001|Overall Study|Personal reason|12|||
126132404|NCT04705051|453777328|FG000|Overall Study|Enrolled but not treated|1|||
126132405|NCT04705051|453777328|FG000|Overall Study|Study terminated by sponsor|23|||
126132406|NCT02968810|453777329|FG000|Overall Study|Lost to Follow-up|1|||
126132407|NCT02968810|453777330|FG001|Overall Study|Lost to Follow-up|0|||
125964684|NCT00389324|453161515|FG000|Run-In Phase|Lost to Follow-up|1|||
126132408|NCT02968810|453777329|FG000|Overall Study|Physician Decision|1|||
126132409|NCT02968810|453777330|FG001|Overall Study|Physician Decision|0|||
126132410|NCT02968810|453777329|FG000|Overall Study|Withdrawal by Subject|1|||
126132411|NCT02968810|453777330|FG001|Overall Study|Withdrawal by Subject|3|||
126132412|NCT02968810|453777329|FG000|Overall Study|Disease Progression|0|||
126132413|NCT02968810|453777330|FG001|Overall Study|Disease Progression|1|||
126132414|NCT04137887|453777331|FG000|Overall Study|Death|102|||
126132415|NCT04137887|453777332|FG001|Overall Study|Death|92|||
125964685|NCT00389324|453161515|FG000|Run-In Phase|Withdrawal by Subject|1|||
126132416|NCT04137887|453777331|FG000|Overall Study|Withdrawal by Subject|2|||
126132417|NCT04137887|453777332|FG001|Overall Study|Withdrawal by Subject|3|||
126132418|NCT04137887|453777331|FG000|Overall Study|Randomized but not treated|0|||
126132419|NCT04137887|453777332|FG001|Overall Study|Randomized but not treated|1|||
126132420|NCT01790503|453777335|FG000|Overall Study|Adverse Event|1|||
126132421|NCT01790503|453777336|FG001|Overall Study|Adverse Event|0|||
126132422|NCT01790503|453777337|FG002|Overall Study|Adverse Event|0|||
126132423|NCT01790503|453777338|FG003|Overall Study|Adverse Event|0|||
126132424|NCT01790503|453777339|FG004|Overall Study|Adverse Event|0|||
126132425|NCT01790503|453777340|FG005|Overall Study|Adverse Event|2|||
126132426|NCT01790503|453777341|FG006|Overall Study|Adverse Event|0|||
126132427|NCT01790503|453777342|FG007|Overall Study|Adverse Event|0|||
126132428|NCT01790503|453777343|FG008|Overall Study|Adverse Event|2|||
126132429|NCT01790503|453777344|FG009|Overall Study|Adverse Event|4|||
126132430|NCT01790503|453777345|FG010|Overall Study|Adverse Event|7|||
126132431|NCT01790503|453777335|FG000|Overall Study|Withdrawal by Subject|0|||
126132432|NCT01790503|453777336|FG001|Overall Study|Withdrawal by Subject|0|||
126132433|NCT01790503|453777337|FG002|Overall Study|Withdrawal by Subject|1|||
126132434|NCT01790503|453777338|FG003|Overall Study|Withdrawal by Subject|1|||
126132435|NCT01790503|453777339|FG004|Overall Study|Withdrawal by Subject|1|||
126132436|NCT01790503|453777340|FG005|Overall Study|Withdrawal by Subject|2|||
126132437|NCT01790503|453777341|FG006|Overall Study|Withdrawal by Subject|1|||
126132438|NCT01790503|453777342|FG007|Overall Study|Withdrawal by Subject|0|||
126132439|NCT01790503|453777343|FG008|Overall Study|Withdrawal by Subject|0|||
126132440|NCT01790503|453777344|FG009|Overall Study|Withdrawal by Subject|0|||
126132441|NCT01790503|453777345|FG010|Overall Study|Withdrawal by Subject|1|||
126132442|NCT01790503|453777335|FG000|Overall Study|Disease progression|2|||
126132443|NCT01790503|453777336|FG001|Overall Study|Disease progression|1|||
126132444|NCT01790503|453777337|FG002|Overall Study|Disease progression|0|||
126132445|NCT01790503|453777338|FG003|Overall Study|Disease progression|1|||
126132446|NCT01790503|453777339|FG004|Overall Study|Disease progression|2|||
126132447|NCT01790503|453777340|FG005|Overall Study|Disease progression|1|||
126132448|NCT01790503|453777341|FG006|Overall Study|Disease progression|0|||
126132449|NCT01790503|453777342|FG007|Overall Study|Disease progression|1|||
126132450|NCT01790503|453777343|FG008|Overall Study|Disease progression|0|||
126132451|NCT01790503|453777344|FG009|Overall Study|Disease progression|17|||
126132452|NCT01790503|453777345|FG010|Overall Study|Disease progression|7|||
126132453|NCT01790503|453777335|FG000|Overall Study|Protocol Violation|0|||
126132454|NCT01790503|453777336|FG001|Overall Study|Protocol Violation|0|||
126132455|NCT01790503|453777337|FG002|Overall Study|Protocol Violation|0|||
126132456|NCT01790503|453777338|FG003|Overall Study|Protocol Violation|0|||
126132457|NCT01790503|453777339|FG004|Overall Study|Protocol Violation|0|||
126132458|NCT01790503|453777340|FG005|Overall Study|Protocol Violation|0|||
126132459|NCT01790503|453777341|FG006|Overall Study|Protocol Violation|0|||
126132460|NCT01790503|453777342|FG007|Overall Study|Protocol Violation|0|||
126132461|NCT01790503|453777343|FG008|Overall Study|Protocol Violation|0|||
126132462|NCT01790503|453777344|FG009|Overall Study|Protocol Violation|1|||
126132463|NCT01790503|453777345|FG010|Overall Study|Protocol Violation|0|||
126132464|NCT01790503|453777335|FG000|Overall Study|Physician Decision|0|||
126132465|NCT01790503|453777336|FG001|Overall Study|Physician Decision|0|||
126132466|NCT01790503|453777337|FG002|Overall Study|Physician Decision|0|||
126132467|NCT01790503|453777338|FG003|Overall Study|Physician Decision|0|||
126132468|NCT01790503|453777339|FG004|Overall Study|Physician Decision|0|||
126132469|NCT01790503|453777340|FG005|Overall Study|Physician Decision|0|||
126132470|NCT01790503|453777341|FG006|Overall Study|Physician Decision|0|||
126132471|NCT01790503|453777342|FG007|Overall Study|Physician Decision|0|||
126132472|NCT01790503|453777343|FG008|Overall Study|Physician Decision|0|||
126132473|NCT01790503|453777344|FG009|Overall Study|Physician Decision|1|||
126132474|NCT01790503|453777345|FG010|Overall Study|Physician Decision|1|||
126132475|NCT01790503|453777335|FG000|Overall Study|Death|0|||
126132476|NCT01790503|453777336|FG001|Overall Study|Death|0|||
126132477|NCT01790503|453777337|FG002|Overall Study|Death|0|||
126132478|NCT01790503|453777338|FG003|Overall Study|Death|0|||
126132479|NCT01790503|453777339|FG004|Overall Study|Death|0|||
126132480|NCT01790503|453777340|FG005|Overall Study|Death|0|||
126132481|NCT01790503|453777341|FG006|Overall Study|Death|0|||
126132482|NCT01790503|453777342|FG007|Overall Study|Death|0|||
126132483|NCT01790503|453777343|FG008|Overall Study|Death|0|||
126132484|NCT01790503|453777344|FG009|Overall Study|Death|1|||
126132485|NCT01790503|453777345|FG010|Overall Study|Death|0|||
126132486|NCT01790503|453777335|FG000|Overall Study|Non Compliance|0|||
126132487|NCT01790503|453777336|FG001|Overall Study|Non Compliance|0|||
126132488|NCT01790503|453777337|FG002|Overall Study|Non Compliance|0|||
126132489|NCT01790503|453777338|FG003|Overall Study|Non Compliance|0|||
126132490|NCT01790503|453777339|FG004|Overall Study|Non Compliance|1|||
126132491|NCT01790503|453777340|FG005|Overall Study|Non Compliance|0|||
126132492|NCT01790503|453777341|FG006|Overall Study|Non Compliance|0|||
126132493|NCT01790503|453777342|FG007|Overall Study|Non Compliance|0|||
126132494|NCT01790503|453777343|FG008|Overall Study|Non Compliance|0|||
126132495|NCT01790503|453777344|FG009|Overall Study|Non Compliance|0|||
126132496|NCT01790503|453777345|FG010|Overall Study|Non Compliance|0|||
126132497|NCT01790503|453777335|FG000|Overall Study|Other|0|||
126132498|NCT01790503|453777336|FG001|Overall Study|Other|0|||
126132499|NCT01790503|453777337|FG002|Overall Study|Other|0|||
126132500|NCT01790503|453777338|FG003|Overall Study|Other|0|||
126132501|NCT01790503|453777339|FG004|Overall Study|Other|1|||
126132502|NCT01790503|453777340|FG005|Overall Study|Other|0|||
126132503|NCT01790503|453777341|FG006|Overall Study|Other|0|||
126132504|NCT01790503|453777342|FG007|Overall Study|Other|0|||
126132505|NCT01790503|453777343|FG008|Overall Study|Other|1|||
126132506|NCT01790503|453777344|FG009|Overall Study|Other|2|||
126132507|NCT01790503|453777345|FG010|Overall Study|Other|0|||
126132508|NCT00984204|453777358|FG000|Overall Study|Death|1|||
126132509|NCT00984204|453777358|FG000|Overall Study|Lost to Follow-up|4|||
126132510|NCT00984204|453777358|FG000|Overall Study|Lack of Efficacy|10|||
126132511|NCT01268293|453777368|FG000|Overall Study|Disease progression|7|||
126132512|NCT01268293|453777368|FG000|Overall Study|Adverse Event|1|||
126132513|NCT01268293|453777368|FG000|Overall Study|Subject choice|1|||
126132514|NCT00618748|453777369|FG000|Overall Study|Adverse Event|4|||
126132515|NCT00618748|453777370|FG001|Overall Study|Adverse Event|3|||
126132516|NCT00618748|453777371|FG002|Overall Study|Adverse Event|8|||
126132517|NCT00618748|453777369|FG000|Overall Study|Physician Decision|3|||
126132518|NCT00618748|453777370|FG001|Overall Study|Physician Decision|1|||
126132519|NCT00618748|453777371|FG002|Overall Study|Physician Decision|1|||
126132520|NCT00618748|453777369|FG000|Overall Study|Withdrawal by Subject|4|||
126132521|NCT00618748|453777370|FG001|Overall Study|Withdrawal by Subject|1|||
126132522|NCT00618748|453777371|FG002|Overall Study|Withdrawal by Subject|5|||
126132523|NCT05702515|453777374|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
126132524|NCT01396005|453777375|FG000|Overall Study|Withdrawal by Subject|0|||
126132525|NCT01396005|453777376|FG001|Overall Study|Withdrawal by Subject|1|||
126132526|NCT01396005|453777375|FG000|Overall Study|Non-compliance with protocol|0|||
126132527|NCT01396005|453777376|FG001|Overall Study|Non-compliance with protocol|1|||
126132528|NCT00424827|453777377|FG000|Overall Study|Adverse Event|1|||
126132529|NCT03757988|453777378|FG000|Overall Study|Withdrawal by Subject|1|||
126132530|NCT03806127|453777379|FG000|Overall Study|Withdrawal by Subject|4|||
126132531|NCT03806127|453777380|FG001|Overall Study|Withdrawal by Subject|5|||
126132532|NCT03806127|453777379|FG000|Overall Study|Protocol Violation|3|||
126132533|NCT03806127|453777380|FG001|Overall Study|Protocol Violation|1|||
126132534|NCT03806127|453777379|FG000|Overall Study|Adverse Event|3|||
126132535|NCT03806127|453777380|FG001|Overall Study|Adverse Event|0|||
126132536|NCT03806127|453777379|FG000|Overall Study|Unable to Complete Procedures|0|||
126132537|NCT03806127|453777380|FG001|Overall Study|Unable to Complete Procedures|1|||
126132538|NCT03806127|453777379|FG000|Overall Study|Pregnancy|0|||
126132539|NCT03806127|453777380|FG001|Overall Study|Pregnancy|1|||
126132540|NCT03806127|453777379|FG000|Overall Study|Lost to Follow-up|5|||
126132541|NCT03806127|453777380|FG001|Overall Study|Lost to Follow-up|1|||
126132542|NCT03806127|453777379|FG000|Overall Study|Physician Decision|1|||
126132543|NCT03806127|453777380|FG001|Overall Study|Physician Decision|1|||
126132544|NCT03806127|453777379|FG000|Overall Study|Could Not Come Due to Covid|1|||
126132545|NCT03806127|453777380|FG001|Overall Study|Could Not Come Due to Covid|0|||
126132546|NCT03806127|453777379|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
126132547|NCT03806127|453777380|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
126132548|NCT03806127|453777379|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
126132549|NCT03806127|453777380|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
126132550|NCT03806127|453777379|FG000|Overall Study|Covid 19 Restrictions|2|||
126132551|NCT03806127|453777380|FG001|Overall Study|Covid 19 Restrictions|0|||
126132552|NCT03806127|453777379|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
126132553|NCT03806127|453777380|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
126132554|NCT03806127|453777379|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
126132555|NCT03806127|453777380|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
126132556|NCT01467492|453777381|FG000|Overall Study|Withdrawal by Subject|6|||
126132557|NCT01467492|453777382|FG001|Overall Study|Withdrawal by Subject|4|||
126132558|NCT01467492|453777381|FG000|Overall Study|Study Terminated by Sponsor|6|||
126132559|NCT01467492|453777382|FG001|Overall Study|Study Terminated by Sponsor|4|||
126132560|NCT01467492|453777381|FG000|Overall Study|Adverse Event|4|||
126132561|NCT01467492|453777382|FG001|Overall Study|Adverse Event|3|||
126132562|NCT01467492|453777381|FG000|Overall Study|Lost to Follow-up|3|||
126132563|NCT01467492|453777382|FG001|Overall Study|Lost to Follow-up|2|||
126132564|NCT01467492|453777381|FG000|Overall Study|Undefined|2|||
126132565|NCT01467492|453777382|FG001|Overall Study|Undefined|0|||
126132566|NCT01467492|453777381|FG000|Overall Study|Enrolled But Not Treated|1|||
126132567|NCT01467492|453777382|FG001|Overall Study|Enrolled But Not Treated|0|||
126132568|NCT00159432|453777385|FG000|Overall Study|Adverse Event|1|||
126132569|NCT00159432|453777385|FG000|Overall Study|Death|1|||
126132570|NCT00159432|453777385|FG000|Overall Study|Lack of Efficacy|8|||
126132571|NCT01491178|453777386|FG000|Overall Study|Adverse Event|1016|||
126132572|NCT01491178|453777386|FG000|Overall Study|Improvement of NVAF|210|||
126132573|NCT01491178|453777386|FG000|Overall Study|To conduct invasive treatment|59|||
126132574|NCT01491178|453777386|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
126132575|NCT01491178|453777386|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
126132576|NCT01491178|453777386|FG000|Overall Study|To take a contraindication|20|||
126132577|NCT01491178|453777386|FG000|Overall Study|Other than specified above|657|||
126132578|NCT05218499|453777387|FG000|Overall Study|Not treated|1|||
126132579|NCT05218499|453777388|FG001|Overall Study|Not treated|1|||
126132580|NCT05218499|453777389|FG002|Overall Study|Not treated|8|||
126132581|NCT05218499|453777387|FG000|Overall Study|Death|2|||
126132582|NCT05218499|453777388|FG001|Overall Study|Death|0|||
126132583|NCT05218499|453777389|FG002|Overall Study|Death|0|||
126132584|NCT05218499|453777387|FG000|Overall Study|Other than listed|3|||
126132585|NCT05218499|453777388|FG001|Overall Study|Other than listed|7|||
126132586|NCT05218499|453777389|FG002|Overall Study|Other than listed|10|||
126132587|NCT05218499|453777387|FG000|Overall Study|Protocol deviation|5|||
126132588|NCT05218499|453777388|FG001|Overall Study|Protocol deviation|6|||
126132589|NCT05218499|453777389|FG002|Overall Study|Protocol deviation|4|||
126132590|NCT05218499|453777387|FG000|Overall Study|Technical problems|0|||
126132591|NCT05218499|453777388|FG001|Overall Study|Technical problems|1|||
126132592|NCT05218499|453777389|FG002|Overall Study|Technical problems|0|||
126132593|NCT05218499|453777387|FG000|Overall Study|Burden of trial procedures|0|||
126132594|NCT05218499|453777388|FG001|Overall Study|Burden of trial procedures|1|||
126132595|NCT05218499|453777389|FG002|Overall Study|Burden of trial procedures|2|||
126132596|NCT05218499|453777387|FG000|Overall Study|Clinical disease progression|6|||
126132597|NCT05218499|453777388|FG001|Overall Study|Clinical disease progression|6|||
126132598|NCT05218499|453777389|FG002|Overall Study|Clinical disease progression|11|||
126132599|NCT05218499|453777387|FG000|Overall Study|Objective disease progression|44|||
126132600|NCT05218499|453777388|FG001|Overall Study|Objective disease progression|61|||
126132601|NCT05218499|453777389|FG002|Overall Study|Objective disease progression|42|||
126132602|NCT05218499|453777387|FG000|Overall Study|Adverse Event|11|||
126132603|NCT05218499|453777388|FG001|Overall Study|Adverse Event|36|||
126132604|NCT05218499|453777389|FG002|Overall Study|Adverse Event|9|||
126132605|NCT05218499|453777387|FG000|Overall Study|On treatment at time of snapshot|18|||
126132606|NCT05218499|453777388|FG001|Overall Study|On treatment at time of snapshot|29|||
126132607|NCT05218499|453777389|FG002|Overall Study|On treatment at time of snapshot|0|||
126132608|NCT05689047|453777390|FG000|Overall Study|Lost to Follow-up|0|||
126132609|NCT05689047|453777391|FG001|Overall Study|Lost to Follow-up|1|||
126132610|NCT05689047|453777390|FG000|Overall Study|Protocol Deviation|1|||
126132611|NCT05689047|453777391|FG001|Overall Study|Protocol Deviation|0|||
126132612|NCT01604512|453777392|FG000|Overall Study|Withdrawal by Subject|3|||
126132613|NCT01604512|453777392|FG000|Overall Study|Not treated|4|||
126132614|NCT03655756|453777393|FG000|Overall Study|Death|1|||
126132615|NCT00253630|453777394|FG000|Overall Study|ineligible|2|||
126132616|NCT03237065|453777395|FG000|Overall Study|Adverse Event|0|||
126132617|NCT03237065|453777396|FG001|Overall Study|Adverse Event|2|||
126132618|NCT03237065|453777395|FG000|Overall Study|Protocol Violation|0|||
126132619|NCT03237065|453777396|FG001|Overall Study|Protocol Violation|1|||
126132620|NCT03237065|453777395|FG000|Overall Study|Withdrawal by Subject|3|||
126132621|NCT03237065|453777396|FG001|Overall Study|Withdrawal by Subject|0|||
126132622|NCT03237065|453777395|FG000|Overall Study|Lost to Follow-up|1|||
126132623|NCT03237065|453777396|FG001|Overall Study|Lost to Follow-up|0|||
126132624|NCT03237065|453777395|FG000|Overall Study|Unable to obtain venous access|0|||
126132625|NCT03237065|453777396|FG001|Overall Study|Unable to obtain venous access|1|||
126132626|NCT00209339|453777397|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
126132627|NCT00209339|453777397|FG000|At 12 Months Follow-up|Death|1|||
126132628|NCT00209339|453777397|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
126132629|NCT00209339|453777397|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
126132630|NCT00209339|453777397|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
125964686|NCT00389324|453161515|FG000|Subcutaneous Phase|Adverse Event|2|||
125964687|NCT00389324|453161515|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
125964688|NCT00389324|453161515|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
125964689|NCT00389324|453161515|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
125964690|NCT02317575|453161516|FG000|Period 1|Difficulty with venous cannulation|0|||
125964691|NCT02317575|453161517|FG001|Period 1|Difficulty with venous cannulation|1|||
125964692|NCT02317575|453161518|FG002|Period 1|Difficulty with venous cannulation|0|||
125964693|NCT02317575|453161519|FG003|Period 1|Difficulty with venous cannulation|0|||
125964694|NCT02317575|453161520|FG004|Period 1|Difficulty with venous cannulation|0|||
125964695|NCT02317575|453161516|FG000|Period 1|Withdrawal by Subject|1|||
126132631|NCT00209339|453777397|FG000|At 24 Months Follow-up|Death|1|||
126132632|NCT00209339|453777397|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
126132633|NCT00209339|453777397|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
126132634|NCT00209339|453777397|FG000|At 4 Years Follow-up|Death|1|||
126132635|NCT00209339|453777397|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
126132636|NCT00209339|453777397|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
126132637|NCT00209339|453777397|FG000|At 5 Years Follow-up|Death|1|||
126132638|NCT00429858|453777398|FG000|Overall Study|Withdrawal by Subject|1|||
125964696|NCT02317575|453161517|FG001|Period 1|Withdrawal by Subject|0|||
125964697|NCT02317575|453161518|FG002|Period 1|Withdrawal by Subject|0|||
125964698|NCT02317575|453161519|FG003|Period 1|Withdrawal by Subject|0|||
125964699|NCT02317575|453161520|FG004|Period 1|Withdrawal by Subject|0|||
125964700|NCT01921348|453161521|FG000|Overall Study|Withdrawal by Subject|1|||
125964701|NCT01921348|453161522|FG001|Overall Study|Withdrawal by Subject|0|||
125964702|NCT01921348|453161521|FG000|Overall Study|Lost to Follow-up|0|||
125964703|NCT01921348|453161522|FG001|Overall Study|Lost to Follow-up|2|||
125964704|NCT00795600|453161528|FG000|Overall Study|Adverse Event|1|||
125964705|NCT00795600|453161529|FG001|Overall Study|Adverse Event|1|||
125964706|NCT00795600|453161528|FG000|Overall Study|Protocol Violation|1|||
125964707|NCT00795600|453161529|FG001|Overall Study|Protocol Violation|2|||
125964708|NCT00795600|453161528|FG000|Overall Study|Withdrawal by Subject|1|||
125964709|NCT00795600|453161529|FG001|Overall Study|Withdrawal by Subject|0|||
125964710|NCT00795600|453161528|FG000|Overall Study|Unclassified|1|||
125964711|NCT00795600|453161529|FG001|Overall Study|Unclassified|1|||
125964712|NCT03936244|453161530|FG000|Overall Study|Lost to Follow-up|5|||
125964713|NCT03936244|453161531|FG001|Overall Study|Lost to Follow-up|1|||
125964714|NCT03936244|453161530|FG000|Overall Study|Physician Decision|7|||
125964715|NCT03936244|453161531|FG001|Overall Study|Physician Decision|3|||
125964716|NCT01430130|453161538|FG000|Overall Study|Lost to Follow-up|1|||
125964717|NCT01430130|453161538|FG000|Overall Study|Infection on Control Side of Incision|1|||
125964718|NCT04788147|453161544|FG000|Overall Study|Screen Failure|3|||
125964719|NCT04788147|453161545|FG001|Overall Study|Screen Failure|10|||
125964720|NCT04788147|453161544|FG000|Overall Study|Incomplete RMRS image session|2|||
125964721|NCT04788147|453161545|FG001|Overall Study|Incomplete RMRS image session|0|||
125964722|NCT00781326|453161546|FG000|Phase I|Adverse Event|1|||
125964723|NCT00781326|453161546|FG000|Phase I|Withdrawal by Subject|1|||
125964724|NCT00781326|453161546|FG000|Phase I|Physician Decision|2|||
125964725|NCT05101252|453161547|FG000|Overall Study|Unsatisfactory Test Article|1|||
125964726|NCT05101252|453161548|FG001|Overall Study|Unsatisfactory Test Article|0|||
125964727|NCT05101252|453161547|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125964728|NCT05101252|453161548|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
125964729|NCT05101252|453161547|FG000|Overall Study|Withdrew Consent during study|0|||
125964730|NCT05101252|453161548|FG001|Overall Study|Withdrew Consent during study|1|||
125964731|NCT05101252|453161547|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
125964732|NCT05101252|453161548|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
125964733|NCT02266381|453161549|FG000|Overall Study|Physician Decision|3|||
125964734|NCT02266381|453161550|FG001|Overall Study|Physician Decision|5|||
125964735|NCT02266381|453161551|FG002|Overall Study|Physician Decision|4|||
125964736|NCT02401672|453161552|FG000|Overall Study|Withdrawal by Subject|1|||
125964737|NCT02401672|453161553|FG001|Overall Study|Withdrawal by Subject|3|||
125964738|NCT01459796|453161554|FG000|Overall Study|Non compliance with protocol|2|||
125964739|NCT01459796|453161555|FG001|Overall Study|Non compliance with protocol|4|||
125964740|NCT01459796|453161554|FG000|Overall Study|Adverse Event|5|||
125964741|NCT01459796|453161555|FG001|Overall Study|Adverse Event|5|||
125964742|NCT01459796|453161554|FG000|Overall Study|Withdrawal by Subject|6|||
125964743|NCT01459796|453161555|FG001|Overall Study|Withdrawal by Subject|3|||
125964744|NCT01459796|453161554|FG000|Overall Study|Lost to Follow-up|5|||
125964745|NCT01459796|453161555|FG001|Overall Study|Lost to Follow-up|4|||
125964746|NCT01459796|453161554|FG000|Overall Study|Reason unspecified|1|||
125964747|NCT01459796|453161555|FG001|Overall Study|Reason unspecified|2|||
125964748|NCT01459796|453161554|FG000|Overall Study|Decision by the sponsor|75|||
125964749|NCT01459796|453161555|FG001|Overall Study|Decision by the sponsor|108|||
125964750|NCT00701051|453161556|FG000|Screening|Failed Screening|40|||
125964751|NCT00701051|453161557|FG001|Screening|Failed Screening|0|||
125964752|NCT00701051|453161558|FG002|Screening|Failed Screening|0|||
125964753|NCT00701051|453161556|FG000|Screening|Time conflicts|19|||
125964754|NCT00701051|453161557|FG001|Screening|Time conflicts|0|||
125964755|NCT00701051|453161558|FG002|Screening|Time conflicts|0|||
125964756|NCT00701051|453161556|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
125964757|NCT00701051|453161557|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
125964758|NCT00701051|453161558|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
125964759|NCT03207750|453161569|FG000|Overall Study|Adverse Event|3|||
126132639|NCT00429858|453777398|FG000|Overall Study|Study Termination|1|||
126132640|NCT01764633|453777399|FG000|Overall Study|Withdrawal by Subject|105|||
125964760|NCT03207750|453161570|FG001|Overall Study|Adverse Event|2|||
125964761|NCT03207750|453161569|FG000|Overall Study|Lost to Follow-up|21|||
125964762|NCT03207750|453161570|FG001|Overall Study|Lost to Follow-up|29|||
125964763|NCT03207750|453161569|FG000|Overall Study|Protocol Violation|0|||
125964764|NCT03207750|453161570|FG001|Overall Study|Protocol Violation|1|||
125964765|NCT03207750|453161569|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
125964766|NCT03207750|453161570|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
125964767|NCT03207750|453161569|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
125964768|NCT03207750|453161570|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
125964769|NCT03207750|453161569|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
125964770|NCT03207750|453161570|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
125964771|NCT03207750|453161569|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
125964772|NCT03207750|453161570|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
125964773|NCT03207750|453161569|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
125964774|NCT03207750|453161570|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
125964775|NCT00793910|453161571|FG000|Overall Study|discarded study pills|0|||
125964776|NCT00793910|453161572|FG001|Overall Study|discarded study pills|1|||
125964777|NCT00793910|453161571|FG000|Overall Study|did not pick up medications|1|||
125964778|NCT00793910|453161572|FG001|Overall Study|did not pick up medications|1|||
125964779|NCT00793910|453161571|FG000|Overall Study|ineligible based on entry criteria|2|||
125964780|NCT00793910|453161572|FG001|Overall Study|ineligible based on entry criteria|3|||
125964781|NCT00793910|453161571|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
125964782|NCT00793910|453161572|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
125964783|NCT00793910|453161571|FG000|Overall Study|Withdrawal by Subject|0|||
125964784|NCT00793910|453161572|FG001|Overall Study|Withdrawal by Subject|1|||
125964785|NCT01700946|453161573|FG000|Overall Study|Lost to Follow-up|1|||
125964786|NCT01700946|453161574|FG001|Overall Study|Lost to Follow-up|0|||
125964787|NCT01700946|453161573|FG000|Overall Study|Physician Decision|7|||
125964788|NCT01700946|453161574|FG001|Overall Study|Physician Decision|12|||
125964789|NCT01700946|453161573|FG000|Overall Study|Withdrawal by Subject|0|||
125964790|NCT01700946|453161574|FG001|Overall Study|Withdrawal by Subject|2|||
125964791|NCT01700946|453161573|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
125964792|NCT01700946|453161574|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
125964793|NCT01700946|453161573|FG000|Overall Study|Relapse|2|||
125964794|NCT01700946|453161574|FG001|Overall Study|Relapse|1|||
125964795|NCT01700946|453161573|FG000|Overall Study|Unacceptable toxicity|1|||
125964796|NCT01700946|453161574|FG001|Overall Study|Unacceptable toxicity|0|||
125964797|NCT03634579|453161577|FG000|Overall Study|study termination|9|||
125964798|NCT04111497|453161578|FG000|Overall Study|relapse of primary disease|1|||
125964799|NCT04111497|453161578|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
125964800|NCT03321019|453161579|FG000|Overall Study|Withdrawal by Subject|0|||
125964801|NCT03321019|453161580|FG001|Overall Study|Withdrawal by Subject|6|||
125964802|NCT03321019|453161579|FG000|Overall Study|Lost to Follow-up|0|||
125964803|NCT03321019|453161580|FG001|Overall Study|Lost to Follow-up|22|||
125964804|NCT03433456|453161585|FG000|Overall Study|Death|1|||
125964805|NCT03433456|453161586|FG001|Overall Study|Death|1|||
125964806|NCT03433456|453161585|FG000|Overall Study|Lost to Follow-up|14|||
125964807|NCT03433456|453161586|FG001|Overall Study|Lost to Follow-up|11|||
125964808|NCT03433456|453161585|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
125964809|NCT03433456|453161586|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
125964810|NCT03694548|453161587|FG000|Part A Survey|Protocol Violation|3|||
125964811|NCT03694548|453161588|FG001|Part A Survey|Protocol Violation|3|||
125964812|NCT03694548|453161589|FG002|Part A Survey|Protocol Violation|0|||
125964813|NCT03694548|453161587|FG000|Part B Yoga Program|Protocol Violation|0|||
125964814|NCT03694548|453161588|FG001|Part B Yoga Program|Protocol Violation|0|||
125964815|NCT03694548|453161589|FG002|Part B Yoga Program|Protocol Violation|3|||
125964816|NCT03694548|453161587|FG000|Part B Yoga Program|Did not attend intervention|0|||
125964817|NCT03694548|453161588|FG001|Part B Yoga Program|Did not attend intervention|0|||
125964818|NCT03694548|453161589|FG002|Part B Yoga Program|Did not attend intervention|8|||
125964819|NCT04496258|453161590|FG000|Overall Study|Withdrawal by Subject|2|||
125964820|NCT04496258|453161591|FG001|Overall Study|Withdrawal by Subject|1|||
125964821|NCT04102501|453161592|FG000|Overall Study|Withdrawal by Subject|7|||
125964822|NCT04102501|453161593|FG001|Overall Study|Withdrawal by Subject|9|||
125964823|NCT04102501|453161592|FG000|Overall Study|Adverse Event|1|||
125964824|NCT04102501|453161593|FG001|Overall Study|Adverse Event|3|||
125964825|NCT01427712|453161594|FG000|Overall Study|Transfer to a different hospital|2|||
125964826|NCT01427712|453161594|FG000|Overall Study|Lost to Follow-up|1|||
125964827|NCT01427712|453161594|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
125964828|NCT01427712|453161594|FG000|Overall Study|Failure to visit|1|||
125964829|NCT00968617|453161596|FG000|Overall Study|Study terminated by sponsor|6|||
125964830|NCT00439777|453161600|FG000|Treatment Period|Death|29|||
125964831|NCT00439777|453161601|FG001|Treatment Period|Death|21|||
125964832|NCT00439777|453161600|FG000|Treatment Period|Study terminated by sponsor|125|||
125964833|NCT00439777|453161601|FG001|Treatment Period|Study terminated by sponsor|132|||
125964834|NCT00439777|453161600|FG000|Treatment Period|Site closed by investigator|0|||
125964835|NCT00439777|453161601|FG001|Treatment Period|Site closed by investigator|1|||
125964836|NCT00439777|453161600|FG000|Treatment Period|Did not take study treatment|7|||
125964837|NCT00439777|453161601|FG001|Treatment Period|Did not take study treatment|8|||
125964838|NCT00439777|453161600|FG000|Treatment Period|Adverse Event|111|||
125964839|NCT00439777|453161601|FG001|Treatment Period|Adverse Event|92|||
125964840|NCT00439777|453161600|FG000|Treatment Period|Protocol Violation|23|||
125964841|NCT00439777|453161601|FG001|Treatment Period|Protocol Violation|30|||
125964842|NCT00439777|453161600|FG000|Treatment Period|Withdrawal by Subject|66|||
125964843|NCT00439777|453161601|FG001|Treatment Period|Withdrawal by Subject|118|||
125964844|NCT00439777|453161600|FG000|Treatment Period|Lack of Efficacy|1|||
125964845|NCT00439777|453161601|FG001|Treatment Period|Lack of Efficacy|4|||
125964846|NCT00439777|453161600|FG000|Treatment Period|Lost to Follow-up|8|||
125964847|NCT00439777|453161601|FG001|Treatment Period|Lost to Follow-up|10|||
125964848|NCT00439777|453161600|FG000|Treatment Period|Protocol driven decision point|1|||
125964849|NCT00439777|453161601|FG001|Treatment Period|Protocol driven decision point|3|||
125964850|NCT00439777|453161600|FG000|Treatment Period|Physician Decision|7|||
125964851|NCT00439777|453161601|FG001|Treatment Period|Physician Decision|18|||
125964852|NCT00439777|453161600|FG000|Treatment Period|Clinical endpoint reached|26|||
125964853|NCT00439777|453161601|FG001|Treatment Period|Clinical endpoint reached|13|||
125964854|NCT00439777|453161600|FG000|Treatment Period|Technical problems|3|||
125964855|NCT00439777|453161601|FG001|Treatment Period|Technical problems|1|||
125964856|NCT00439777|453161600|FG000|Treatment Period|Participant convenience|12|||
125964857|NCT00439777|453161601|FG001|Treatment Period|Participant convenience|8|||
125964858|NCT00439777|453161600|FG000|Observational Period|Protocol Violation|0|||
125964859|NCT00439777|453161601|FG001|Observational Period|Protocol Violation|2|||
125964860|NCT00439777|453161600|FG000|Observational Period|Withdrawal by Subject|9|||
125964861|NCT00439777|453161601|FG001|Observational Period|Withdrawal by Subject|5|||
125964862|NCT00439777|453161600|FG000|Observational Period|Lost to Follow-up|1|||
125964863|NCT00439777|453161601|FG001|Observational Period|Lost to Follow-up|11|||
125964864|NCT00439777|453161600|FG000|Observational Period|Death|27|||
125964865|NCT00439777|453161601|FG001|Observational Period|Death|20|||
125964866|NCT00439777|453161600|FG000|Observational Period|Study terminated by sponsor|3|||
125964867|NCT00439777|453161601|FG001|Observational Period|Study terminated by sponsor|1|||
125964868|NCT00439777|453161600|FG000|Observational Period|Protocol driven decision point|0|||
125964869|NCT00439777|453161601|FG001|Observational Period|Protocol driven decision point|1|||
125964870|NCT00439777|453161600|FG000|Observational Period|Lack of Efficacy|1|||
125964871|NCT00439777|453161601|FG001|Observational Period|Lack of Efficacy|0|||
125964872|NCT00439777|453161600|FG000|Observational Period|Technical problems|0|||
125964873|NCT00439777|453161601|FG001|Observational Period|Technical problems|1|||
125964874|NCT00661492|453161604|FG000|Overall Study|Adverse Event|16|||
125964875|NCT00661492|453161605|FG001|Overall Study|Adverse Event|13|||
125964876|NCT00661492|453161604|FG000|Overall Study|Disease Progression|44|||
125964877|NCT00661492|453161605|FG001|Overall Study|Disease Progression|14|||
125964878|NCT00661492|453161604|FG000|Overall Study|Patient Request|6|||
125964879|NCT00661492|453161605|FG001|Overall Study|Patient Request|1|||
125964880|NCT00661492|453161604|FG000|Overall Study|Investigator Request|1|||
125964881|NCT00661492|453161605|FG001|Overall Study|Investigator Request|0|||
125964882|NCT00661492|453161604|FG000|Overall Study|Lost to Follow-up|0|||
125964883|NCT00661492|453161605|FG001|Overall Study|Lost to Follow-up|1|||
125964884|NCT00661492|453161604|FG000|Overall Study|Other|1|||
125964885|NCT00661492|453161605|FG001|Overall Study|Other|0|||
125964886|NCT01024387|453161606|FG000|Overall Study|Radiographic Progression|29|||
125964887|NCT01024387|453161606|FG000|Overall Study|Symptomatic Progression|10|||
125964888|NCT01024387|453161606|FG000|Overall Study|Physician Decision|5|||
125964889|NCT01024387|453161606|FG000|Overall Study|Withdrawal by Subject|5|||
125964890|NCT01024387|453161606|FG000|Overall Study|Death|2|||
125964891|NCT01024387|453161606|FG000|Overall Study|Prolonged Treatment Delay|1|||
125964892|NCT01024387|453161606|FG000|Overall Study|Adverse Event|3|||
125964893|NCT01024387|453161606|FG000|Overall Study|Other|5|||
125964894|NCT03864900|453161607|FG000|Overall Study|Withdrawal by Subject|1|||
125964895|NCT03864900|453161608|FG001|Overall Study|Withdrawal by Subject|1|||
125964896|NCT03864900|453161607|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
125964897|NCT03864900|453161608|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
125964898|NCT03165045|453161609|FG000|Visit 1|No registration after visit 1|9|||
125964899|NCT03165045|453161609|FG000|Visit 1|No treatment documented|10|||
125964900|NCT03165045|453161609|FG000|Visit 1|No visit 1|10|||
125964901|NCT03165045|453161609|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
125964902|NCT03165045|453161609|FG000|Visit 2|No available total CCQ score at all|29|||
125964903|NCT03165045|453161609|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
125964904|NCT03191903|453161610|FG000|Overall Study|Withdrawal by Subject|6|||
125964905|NCT03191903|453161611|FG001|Overall Study|Withdrawal by Subject|5|||
125964906|NCT03191903|453161612|FG002|Overall Study|Withdrawal by Subject|4|||
125964907|NCT03191903|453161610|FG000|Overall Study|Adverse Event|1|||
125964908|NCT03191903|453161611|FG001|Overall Study|Adverse Event|0|||
125964909|NCT03191903|453161612|FG002|Overall Study|Adverse Event|0|||
125964910|NCT01578551|453161615|FG000|Overall Study|Adverse Event|1|||
125964911|NCT01578551|453161616|FG001|Overall Study|Adverse Event|0|||
125964912|NCT04369469|453161623|FG000|Overall Study|Lost to Follow-up|2|||
125964913|NCT04369469|453161624|FG001|Overall Study|Lost to Follow-up|4|||
125964914|NCT04369469|453161623|FG000|Overall Study|Physician Decision|2|||
125964915|NCT04369469|453161624|FG001|Overall Study|Physician Decision|1|||
125964916|NCT04369469|453161623|FG000|Overall Study|Withdrawal by Subject|2|||
125964917|NCT04369469|453161624|FG001|Overall Study|Withdrawal by Subject|3|||
125964918|NCT04369469|453161623|FG000|Overall Study|Adverse Event|1|||
125964919|NCT04369469|453161624|FG001|Overall Study|Adverse Event|0|||
125964920|NCT04369469|453161623|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
125964921|NCT04369469|453161624|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
125964922|NCT04369469|453161623|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
125964923|NCT04369469|453161624|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
125964924|NCT04369469|453161623|FG000|Overall Study|Unable to Provide Consent|0|||
125964925|NCT04369469|453161624|FG001|Overall Study|Unable to Provide Consent|1|||
125964926|NCT03099382|453161627|FG000|Overall Study|Protocol Violation|2|||
125964927|NCT03099382|453161628|FG001|Overall Study|Protocol Violation|3|||
125964928|NCT00499369|453161629|FG000|Overall Study|Adverse Event|2|||
125964929|NCT00499369|453161630|FG001|Overall Study|Adverse Event|2|||
125964930|NCT00499369|453161631|FG002|Overall Study|Adverse Event|3|||
125964931|NCT00499369|453161632|FG003|Overall Study|Adverse Event|1|||
125964932|NCT00499369|453161633|FG004|Overall Study|Adverse Event|2|||
125964933|NCT00499369|453161629|FG000|Overall Study|Withdrawal by Subject|0|||
125964934|NCT00499369|453161630|FG001|Overall Study|Withdrawal by Subject|1|||
125964935|NCT00499369|453161631|FG002|Overall Study|Withdrawal by Subject|1|||
125964936|NCT00499369|453161632|FG003|Overall Study|Withdrawal by Subject|0|||
125964937|NCT00499369|453161633|FG004|Overall Study|Withdrawal by Subject|0|||
125964938|NCT00499369|453161629|FG000|Overall Study|Progression|10|||
125964939|NCT00499369|453161630|FG001|Overall Study|Progression|12|||
125964940|NCT00499369|453161631|FG002|Overall Study|Progression|9|||
125964941|NCT00499369|453161632|FG003|Overall Study|Progression|6|||
125964942|NCT00499369|453161633|FG004|Overall Study|Progression|10|||
125964943|NCT00499369|453161629|FG000|Overall Study|Death|0|||
125964944|NCT00499369|453161630|FG001|Overall Study|Death|1|||
125964945|NCT00499369|453161631|FG002|Overall Study|Death|0|||
125964946|NCT00499369|453161632|FG003|Overall Study|Death|0|||
125964947|NCT00499369|453161633|FG004|Overall Study|Death|0|||
125964948|NCT00499369|453161629|FG000|Overall Study|Not protocol specified|2|||
125964949|NCT00499369|453161630|FG001|Overall Study|Not protocol specified|0|||
125964950|NCT00499369|453161631|FG002|Overall Study|Not protocol specified|3|||
125964951|NCT00499369|453161632|FG003|Overall Study|Not protocol specified|1|||
125964952|NCT00499369|453161633|FG004|Overall Study|Not protocol specified|0|||
125964953|NCT00499369|453161629|FG000|Overall Study|Ineligible|2|||
125964954|NCT00499369|453161630|FG001|Overall Study|Ineligible|2|||
125964955|NCT00499369|453161631|FG002|Overall Study|Ineligible|1|||
125964956|NCT00499369|453161632|FG003|Overall Study|Ineligible|1|||
125964957|NCT00499369|453161633|FG004|Overall Study|Ineligible|0|||
125964958|NCT01802411|453161634|FG000|Overall Study|Death|2|||
125964959|NCT01802411|453161635|FG001|Overall Study|Death|1|||
125964960|NCT01802411|453161634|FG000|Overall Study|Adverse Event|2|||
125964961|NCT01802411|453161635|FG001|Overall Study|Adverse Event|7|||
125964962|NCT01802411|453161634|FG000|Overall Study|Lack of Efficacy|8|||
125964963|NCT01802411|453161635|FG001|Overall Study|Lack of Efficacy|10|||
125964964|NCT01802411|453161634|FG000|Overall Study|Withdrawal by Subject|0|||
125964965|NCT01802411|453161635|FG001|Overall Study|Withdrawal by Subject|2|||
125964966|NCT01802411|453161634|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
125964967|NCT01802411|453161635|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
125964968|NCT01802411|453161634|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
125964969|NCT01802411|453161635|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
125964970|NCT01802411|453161634|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
125964971|NCT01802411|453161635|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
125964972|NCT01344460|453161638|FG000|Overall Study|Withdrawal by Subject|1|||
125964973|NCT01344460|453161638|FG000|Overall Study|Lost to Follow-up|2|||
125964974|NCT03285477|453161639|FG000|Treatment and Response Assessment Period|Death|1|||
125964975|NCT03285477|453161640|FG001|Treatment and Response Assessment Period|Death|0|||
125964976|NCT03285477|453161639|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
125964977|NCT03285477|453161640|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
125964978|NCT03285477|453161639|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
125964979|NCT03285477|453161640|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
125964980|NCT03285477|453161639|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
125964981|NCT03285477|453161640|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
125964982|NCT03285477|453161639|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
125964983|NCT03285477|453161640|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
125964984|NCT03283670|453161643|FG000|Placebo Gas|Withdrawal by Subject|2|||
125964985|NCT03283670|453161643|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
125964986|NCT03283670|453161643|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
125964987|NCT00852397|453161646|FG000|Overall Study|Adverse Event|4|||
125964988|NCT00852397|453161647|FG001|Overall Study|Adverse Event|6|||
125964989|NCT00852397|453161648|FG002|Overall Study|Adverse Event|4|||
125964990|NCT00852397|453161646|FG000|Overall Study|Death|0|||
125964991|NCT00852397|453161647|FG001|Overall Study|Death|0|||
125964992|NCT00852397|453161648|FG002|Overall Study|Death|1|||
125964993|NCT00852397|453161646|FG000|Overall Study|Withdrawal by Subject|4|||
125964994|NCT00852397|453161647|FG001|Overall Study|Withdrawal by Subject|1|||
125964995|NCT00852397|453161648|FG002|Overall Study|Withdrawal by Subject|2|||
125964996|NCT00852397|453161646|FG000|Overall Study|Study terminated by sponsor|2|||
125964997|NCT00852397|453161647|FG001|Overall Study|Study terminated by sponsor|1|||
125964998|NCT00852397|453161648|FG002|Overall Study|Study terminated by sponsor|6|||
125964999|NCT00852397|453161646|FG000|Overall Study|Difficulty in study site visit|1|||
125965000|NCT00852397|453161647|FG001|Overall Study|Difficulty in study site visit|0|||
125965001|NCT00852397|453161648|FG002|Overall Study|Difficulty in study site visit|0|||
125965002|NCT00852397|453161646|FG000|Overall Study|Protocol Violation|0|||
125965003|NCT00852397|453161647|FG001|Overall Study|Protocol Violation|0|||
125965004|NCT00852397|453161648|FG002|Overall Study|Protocol Violation|1|||
125965005|NCT03823651|453161653|FG000|Overall Study|Death|5|||
125965006|NCT03823651|453161654|FG001|Overall Study|Death|0|||
125965007|NCT03823651|453161653|FG000|Overall Study|Physician Decision|1|||
125965008|NCT03823651|453161654|FG001|Overall Study|Physician Decision|0|||
125965009|NCT03823651|453161653|FG000|Overall Study|Caregiver to patient who died|0|||
125965010|NCT03823651|453161654|FG001|Overall Study|Caregiver to patient who died|5|||
125965011|NCT03823651|453161653|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
125965012|NCT03823651|453161654|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
125965013|NCT03864614|453161655|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
125965014|NCT03864614|453161656|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
125965015|NCT03864614|453161657|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
125965016|NCT03864614|453161658|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
125965017|NCT03864614|453161655|FG000|Overall Study|Withdrawal by Subject|72|||
125965018|NCT03864614|453161656|FG001|Overall Study|Withdrawal by Subject|100|||
125965019|NCT03864614|453161657|FG002|Overall Study|Withdrawal by Subject|1|||
125965020|NCT03864614|453161658|FG003|Overall Study|Withdrawal by Subject|21|||
125965021|NCT03864614|453161655|FG000|Overall Study|Lost to Follow-up|45|||
125965022|NCT03864614|453161656|FG001|Overall Study|Lost to Follow-up|54|||
125965023|NCT03864614|453161657|FG002|Overall Study|Lost to Follow-up|0|||
125965024|NCT03864614|453161658|FG003|Overall Study|Lost to Follow-up|9|||
125965025|NCT03864614|453161655|FG000|Overall Study|Adverse Event|42|||
125965026|NCT03864614|453161656|FG001|Overall Study|Adverse Event|30|||
125965027|NCT03864614|453161657|FG002|Overall Study|Adverse Event|1|||
125965028|NCT03864614|453161658|FG003|Overall Study|Adverse Event|9|||
125965029|NCT03864614|453161655|FG000|Overall Study|Protocol Deviation|6|||
125965030|NCT03864614|453161656|FG001|Overall Study|Protocol Deviation|26|||
125965031|NCT03864614|453161657|FG002|Overall Study|Protocol Deviation|0|||
125965032|NCT03864614|453161658|FG003|Overall Study|Protocol Deviation|1|||
125965033|NCT03864614|453161655|FG000|Overall Study|Physician Decision|7|||
125965034|NCT03864614|453161656|FG001|Overall Study|Physician Decision|10|||
125965035|NCT03864614|453161657|FG002|Overall Study|Physician Decision|1|||
125965036|NCT03864614|453161658|FG003|Overall Study|Physician Decision|5|||
125965037|NCT03864614|453161655|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
125965038|NCT03864614|453161656|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
125965039|NCT03864614|453161657|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
125965040|NCT03864614|453161658|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
125965041|NCT03864614|453161655|FG000|Overall Study|Sponsor Decision|1|||
125965042|NCT03864614|453161656|FG001|Overall Study|Sponsor Decision|2|||
125965043|NCT03864614|453161657|FG002|Overall Study|Sponsor Decision|0|||
125965044|NCT03864614|453161658|FG003|Overall Study|Sponsor Decision|0|||
125965045|NCT03864614|453161655|FG000|Overall Study|Pregnancy|0|||
125965046|NCT03864614|453161656|FG001|Overall Study|Pregnancy|1|||
125965047|NCT03864614|453161657|FG002|Overall Study|Pregnancy|0|||
125965048|NCT03864614|453161658|FG003|Overall Study|Pregnancy|0|||
125965049|NCT03864614|453161655|FG000|Overall Study|Other|7|||
125965050|NCT03864614|453161656|FG001|Overall Study|Other|9|||
125965051|NCT03864614|453161657|FG002|Overall Study|Other|1|||
125965052|NCT03864614|453161658|FG003|Overall Study|Other|4|||
125965053|NCT03864614|453161655|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
125965054|NCT03864614|453161656|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
125965055|NCT03864614|453161657|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
125965056|NCT03864614|453161658|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
125965057|NCT03859323|453163503|FG000|Overall Study|Lost to Follow-up|0|||
125965058|NCT03859323|453163504|FG001|Overall Study|Lost to Follow-up|0|||
125965059|NCT03859323|453163505|FG002|Overall Study|Lost to Follow-up|0|||
125965060|NCT03859323|453163506|FG003|Overall Study|Lost to Follow-up|0|||
125965061|NCT03859323|453163507|FG004|Overall Study|Lost to Follow-up|0|||
125965062|NCT03859323|453163508|FG005|Overall Study|Lost to Follow-up|0|||
125965063|NCT03859323|453163509|FG006|Overall Study|Lost to Follow-up|1|||
125965064|NCT03859323|453163510|FG007|Overall Study|Lost to Follow-up|0|||
125965065|NCT03859323|453163511|FG008|Overall Study|Lost to Follow-up|0|||
125965066|NCT03859323|453163512|FG009|Overall Study|Lost to Follow-up|0|||
125965067|NCT03859323|453163513|FG010|Overall Study|Lost to Follow-up|0|||
125965068|NCT03859323|453163514|FG011|Overall Study|Lost to Follow-up|0|||
125965069|NCT03859323|453163515|FG012|Overall Study|Lost to Follow-up|0|||
125965070|NCT03859323|453163503|FG000|Overall Study|Withdrawal by Subject|0|||
125965071|NCT03859323|453163504|FG001|Overall Study|Withdrawal by Subject|0|||
125965072|NCT03859323|453163505|FG002|Overall Study|Withdrawal by Subject|1|||
126132641|NCT01764633|453777400|FG001|Overall Study|Withdrawal by Subject|88|||
126132642|NCT01764633|453777399|FG000|Overall Study|Lost to Follow-up|13|||
126132643|NCT01764633|453777400|FG001|Overall Study|Lost to Follow-up|5|||
126132644|NCT02268058|453777401|FG000|Overall Study|Protocol Violation|1|||
126132645|NCT02268058|453777402|FG001|Overall Study|Protocol Violation|0|||
126132646|NCT02268058|453777403|FG002|Overall Study|Protocol Violation|0|||
126132647|NCT02268058|453777404|FG003|Overall Study|Protocol Violation|0|||
126132648|NCT04781816|453777405|FG000|Overall Study|Adverse Event|0|||
126132649|NCT04781816|453777406|FG001|Overall Study|Adverse Event|1|||
126132650|NCT04781816|453777405|FG000|Overall Study|Withdrawal by Subject|1|||
126132651|NCT04781816|453777406|FG001|Overall Study|Withdrawal by Subject|1|||
126132652|NCT04781816|453777405|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
126132653|NCT04781816|453777406|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
126132654|NCT01121393|453777407|FG000|Overall Study|Progressive disease|201|||
126132655|NCT01121393|453777408|FG001|Overall Study|Progressive disease|20|||
126132656|NCT01121393|453777407|FG000|Overall Study|Other Adverse events|24|||
126132657|NCT01121393|453777408|FG001|Overall Study|Other Adverse events|45|||
126132658|NCT01121393|453777407|FG000|Overall Study|Non-compliant with protocol|0|||
126132659|NCT01121393|453777408|FG001|Overall Study|Non-compliant with protocol|3|||
126132660|NCT01121393|453777407|FG000|Overall Study|Lost to Follow-up|1|||
126132661|NCT01121393|453777408|FG001|Overall Study|Lost to Follow-up|0|||
126132662|NCT01121393|453777407|FG000|Overall Study|Refused cont. medication|7|||
126132663|NCT01121393|453777408|FG001|Overall Study|Refused cont. medication|7|||
126132664|NCT01121393|453777407|FG000|Overall Study|Not treated|3|||
126132665|NCT01121393|453777408|FG001|Overall Study|Not treated|9|||
126132666|NCT01121393|453777407|FG000|Overall Study|Other than listed|6|||
126132667|NCT01121393|453777408|FG001|Overall Study|Other than listed|0|||
126132668|NCT01100944|453777409|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
126132669|NCT01100944|453777410|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
126132670|NCT01100944|453777411|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
126132671|NCT01100944|453777409|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
126132672|NCT01100944|453777410|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
126132673|NCT01100944|453777411|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
126132674|NCT01100944|453777409|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
126132675|NCT01100944|453777410|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
126132676|NCT01100944|453777411|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
126132677|NCT01100944|453777409|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
126132678|NCT01100944|453777410|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
126132679|NCT01100944|453777411|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
126132680|NCT02296242|453777414|FG000|Overall Study|Death|1|||
126132681|NCT02296242|453777415|FG001|Overall Study|Death|1|||
126132682|NCT02296242|453777416|FG002|Overall Study|Death|1|||
126132683|NCT02296242|453777417|FG003|Overall Study|Death|1|||
126132684|NCT02296242|453777418|FG004|Overall Study|Death|1|||
126132685|NCT02296242|453777414|FG000|Overall Study|Withdrawal by Subject|0|||
126132686|NCT02296242|453777415|FG001|Overall Study|Withdrawal by Subject|0|||
126132687|NCT02296242|453777416|FG002|Overall Study|Withdrawal by Subject|1|||
126132688|NCT02296242|453777417|FG003|Overall Study|Withdrawal by Subject|1|||
126132689|NCT02296242|453777418|FG004|Overall Study|Withdrawal by Subject|3|||
126132690|NCT02296242|453777414|FG000|Overall Study|Disease Progression|1|||
126132691|NCT02296242|453777415|FG001|Overall Study|Disease Progression|3|||
126132692|NCT02296242|453777416|FG002|Overall Study|Disease Progression|2|||
126132693|NCT02296242|453777417|FG003|Overall Study|Disease Progression|8|||
126132694|NCT02296242|453777418|FG004|Overall Study|Disease Progression|11|||
126132695|NCT02296242|453777414|FG000|Overall Study|Unacceptable Toxicity|0|||
126132696|NCT02296242|453777415|FG001|Overall Study|Unacceptable Toxicity|0|||
126132697|NCT02296242|453777416|FG002|Overall Study|Unacceptable Toxicity|0|||
126132698|NCT02296242|453777417|FG003|Overall Study|Unacceptable Toxicity|0|||
126132699|NCT02296242|453777418|FG004|Overall Study|Unacceptable Toxicity|1|||
126132700|NCT02296242|453777414|FG000|Overall Study|Patient Condition Changed|0|||
126132701|NCT02296242|453777415|FG001|Overall Study|Patient Condition Changed|0|||
125965073|NCT03859323|453163506|FG003|Overall Study|Withdrawal by Subject|0|||
126132702|NCT02296242|453777416|FG002|Overall Study|Patient Condition Changed|2|||
126132703|NCT02296242|453777417|FG003|Overall Study|Patient Condition Changed|0|||
126132704|NCT02296242|453777418|FG004|Overall Study|Patient Condition Changed|1|||
126132705|NCT02296242|453777414|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
126132706|NCT02296242|453777415|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
126132707|NCT02296242|453777416|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
126132708|NCT02296242|453777417|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
126132709|NCT02296242|453777418|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
126132710|NCT02296242|453777414|FG000|Overall Study|Lost to Follow-up|1|||
126132711|NCT02296242|453777415|FG001|Overall Study|Lost to Follow-up|0|||
126132712|NCT02296242|453777416|FG002|Overall Study|Lost to Follow-up|0|||
125965074|NCT03859323|453163507|FG004|Overall Study|Withdrawal by Subject|0|||
126132713|NCT02296242|453777417|FG003|Overall Study|Lost to Follow-up|0|||
126132714|NCT02296242|453777418|FG004|Overall Study|Lost to Follow-up|0|||
126132715|NCT02296242|453777414|FG000|Overall Study|Need for Hydroxyurea|2|||
126132716|NCT02296242|453777415|FG001|Overall Study|Need for Hydroxyurea|0|||
126132717|NCT02296242|453777416|FG002|Overall Study|Need for Hydroxyurea|0|||
126132718|NCT02296242|453777417|FG003|Overall Study|Need for Hydroxyurea|0|||
126132719|NCT02296242|453777418|FG004|Overall Study|Need for Hydroxyurea|0|||
126132720|NCT02296242|453777414|FG000|Overall Study|Screened for Other Protocol|0|||
126132721|NCT02296242|453777415|FG001|Overall Study|Screened for Other Protocol|1|||
126132722|NCT02296242|453777416|FG002|Overall Study|Screened for Other Protocol|0|||
126132723|NCT02296242|453777417|FG003|Overall Study|Screened for Other Protocol|0|||
126132724|NCT02296242|453777418|FG004|Overall Study|Screened for Other Protocol|0|||
126132725|NCT02296242|453777414|FG000|Overall Study|Physician Decision|0|||
125965075|NCT03859323|453163508|FG005|Overall Study|Withdrawal by Subject|1|||
125965076|NCT03859323|453163509|FG006|Overall Study|Withdrawal by Subject|0|||
125965077|NCT03859323|453163510|FG007|Overall Study|Withdrawal by Subject|0|||
125965078|NCT03859323|453163511|FG008|Overall Study|Withdrawal by Subject|0|||
125965079|NCT03859323|453163512|FG009|Overall Study|Withdrawal by Subject|1|||
125965080|NCT03859323|453163513|FG010|Overall Study|Withdrawal by Subject|1|||
125965081|NCT03859323|453163514|FG011|Overall Study|Withdrawal by Subject|2|||
125965082|NCT03859323|453163515|FG012|Overall Study|Withdrawal by Subject|1|||
125965083|NCT03859323|453163503|FG000|Overall Study|Pregnancy|0|||
126132726|NCT02296242|453777415|FG001|Overall Study|Physician Decision|1|||
126132727|NCT02296242|453777416|FG002|Overall Study|Physician Decision|0|||
126132728|NCT02296242|453777417|FG003|Overall Study|Physician Decision|1|||
126132729|NCT02296242|453777418|FG004|Overall Study|Physician Decision|0|||
126132730|NCT02296242|453777414|FG000|Overall Study|Alternative Treatment|0|||
126132731|NCT02296242|453777415|FG001|Overall Study|Alternative Treatment|0|||
126132732|NCT02296242|453777416|FG002|Overall Study|Alternative Treatment|0|||
126132733|NCT02296242|453777417|FG003|Overall Study|Alternative Treatment|1|||
126132734|NCT02296242|453777418|FG004|Overall Study|Alternative Treatment|0|||
126132735|NCT02296242|453777414|FG000|Overall Study|Adverse Event|0|||
126132736|NCT02296242|453777415|FG001|Overall Study|Adverse Event|0|||
126132737|NCT02296242|453777416|FG002|Overall Study|Adverse Event|0|||
126132738|NCT02296242|453777417|FG003|Overall Study|Adverse Event|1|||
126132739|NCT02296242|453777418|FG004|Overall Study|Adverse Event|0|||
126132740|NCT02296242|453777414|FG000|Overall Study|Lack of Efficacy|0|||
126132741|NCT02296242|453777415|FG001|Overall Study|Lack of Efficacy|0|||
126132742|NCT02296242|453777416|FG002|Overall Study|Lack of Efficacy|0|||
126132743|NCT02296242|453777417|FG003|Overall Study|Lack of Efficacy|0|||
126132744|NCT02296242|453777418|FG004|Overall Study|Lack of Efficacy|3|||
126132745|NCT01639833|453777420|FG000|Overall Study|Death|4|||
126132746|NCT01639833|453777421|FG001|Overall Study|Death|2|||
126132747|NCT01639833|453777420|FG000|Overall Study|Withdrawal by Subject|2|||
126132748|NCT01639833|453777421|FG001|Overall Study|Withdrawal by Subject|2|||
126132749|NCT04029519|453777423|FG000|Overall Study|Protocol Violation|1|||
126132750|NCT04029519|453777423|FG000|Overall Study|Withdrawal by Subject|3|||
126132751|NCT04029519|453777423|FG000|Overall Study|Lost to Follow-up|1|||
126132752|NCT02064387|453777424|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132753|NCT02064387|453777425|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132754|NCT02064387|453777426|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132755|NCT02064387|453777427|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132756|NCT02064387|453777428|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132757|NCT02064387|453777429|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132758|NCT02064387|453777430|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132759|NCT02064387|453777431|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
126132760|NCT02064387|453777432|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132761|NCT02064387|453777433|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
126132762|NCT02064387|453777434|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132763|NCT02064387|453777435|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126132764|NCT02064387|453777424|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132765|NCT02064387|453777425|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132766|NCT02064387|453777426|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132767|NCT02064387|453777427|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125965084|NCT03859323|453163504|FG001|Overall Study|Pregnancy|0|||
126132768|NCT02064387|453777428|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132769|NCT02064387|453777429|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132770|NCT02064387|453777430|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132771|NCT02064387|453777431|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
126132772|NCT02064387|453777432|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132773|NCT02064387|453777433|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132774|NCT02064387|453777434|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126132775|NCT02064387|453777435|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125965085|NCT03859323|453163505|FG002|Overall Study|Pregnancy|0|||
125965086|NCT03859323|453163506|FG003|Overall Study|Pregnancy|0|||
126132776|NCT02064387|453777424|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132777|NCT02064387|453777425|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132778|NCT02064387|453777426|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132779|NCT02064387|453777427|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132780|NCT02064387|453777428|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132781|NCT02064387|453777429|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132782|NCT02064387|453777430|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132783|NCT02064387|453777431|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132784|NCT02064387|453777432|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
126132785|NCT02064387|453777433|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125965087|NCT03859323|453163507|FG004|Overall Study|Pregnancy|0|||
125965088|NCT03859323|453163508|FG005|Overall Study|Pregnancy|0|||
125965089|NCT03859323|453163509|FG006|Overall Study|Pregnancy|0|||
125965090|NCT03859323|453163510|FG007|Overall Study|Pregnancy|0|||
125965091|NCT03859323|453163511|FG008|Overall Study|Pregnancy|0|||
125965092|NCT03859323|453163512|FG009|Overall Study|Pregnancy|1|||
125965093|NCT03859323|453163513|FG010|Overall Study|Pregnancy|0|||
125965094|NCT03859323|453163514|FG011|Overall Study|Pregnancy|0|||
125965095|NCT03859323|453163515|FG012|Overall Study|Pregnancy|0|||
125965096|NCT01404312|453163518|FG000|Overall Study|Death|21|||
125965097|NCT01404312|453163519|FG001|Overall Study|Death|27|||
125965098|NCT01404312|453163518|FG000|Overall Study|Withdrawal by Subject|15|||
125965099|NCT01404312|453163519|FG001|Overall Study|Withdrawal by Subject|18|||
125965100|NCT01404312|453163518|FG000|Overall Study|Participant Unable to get to clinic|93|||
125965101|NCT01404312|453163519|FG001|Overall Study|Participant Unable to get to clinic|103|||
125965102|NCT01404312|453163518|FG000|Overall Study|Lost to Follow-up|115|||
125965103|NCT01404312|453163519|FG001|Overall Study|Lost to Follow-up|111|||
125965104|NCT01404312|453163518|FG000|Overall Study|Site closed|22|||
125965105|NCT01404312|453163519|FG001|Overall Study|Site closed|21|||
125965106|NCT01404312|453163518|FG000|Overall Study|Participant not willing to adhere to req|31|||
125965107|NCT01404312|453163519|FG001|Overall Study|Participant not willing to adhere to req|29|||
125965108|NCT01404312|453163518|FG000|Overall Study|Severe debilitation, unable to continue|1|||
125965109|NCT01404312|453163519|FG001|Overall Study|Severe debilitation, unable to continue|2|||
125965110|NCT04419493|453163520|FG000|Wash-out After Period 1|Adverse Event|1|||
125965111|NCT04419493|453163521|FG001|Wash-out After Period 1|Adverse Event|2|||
125965112|NCT04419493|453163522|FG002|Wash-out After Period 1|Adverse Event|1|||
125965113|NCT04419493|453163523|FG003|Wash-out After Period 1|Adverse Event|0|||
125965114|NCT00524134|453163524|FG000|Overall Study|Withdrawal by Subject|1|||
125965115|NCT00524134|453163524|FG000|Overall Study|Physician Decision|1|||
125965116|NCT00129987|453163525|FG000|1st Educational Session|Withdrawal by Subject|141|||
125965117|NCT00129987|453163526|FG001|1st Educational Session|Withdrawal by Subject|109|||
125965118|NCT00129987|453163525|FG000|1 Year|Withdrawal by Subject|32|||
125965119|NCT00129987|453163526|FG001|1 Year|Withdrawal by Subject|21|||
125965120|NCT00116805|453163530|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
125965121|NCT00116805|453163531|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
125965122|NCT00116805|453163530|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
125965123|NCT00116805|453163531|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
125965124|NCT00116805|453163530|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
125965125|NCT00116805|453163531|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
126132786|NCT02064387|453777434|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132787|NCT02064387|453777435|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126132788|NCT02064387|453777424|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
126132789|NCT02064387|453777425|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
126132790|NCT02064387|453777426|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
126132791|NCT02064387|453777427|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
126132792|NCT02064387|453777428|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
126132793|NCT02064387|453777429|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
126132794|NCT02064387|453777430|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
126132795|NCT02064387|453777431|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
126132796|NCT02064387|453777432|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
126132797|NCT02064387|453777433|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
126132798|NCT02064387|453777434|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
126132799|NCT02064387|453777435|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
126132800|NCT02064387|453777424|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132801|NCT02064387|453777425|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125965126|NCT00116805|453163530|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
125965127|NCT00116805|453163531|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
125965128|NCT00116805|453163530|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
125965129|NCT00116805|453163531|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
125965130|NCT00116805|453163530|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
125965131|NCT00116805|453163531|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
126132802|NCT02064387|453777426|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132803|NCT02064387|453777427|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132804|NCT02064387|453777428|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132805|NCT02064387|453777429|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132806|NCT02064387|453777430|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132807|NCT02064387|453777431|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132808|NCT02064387|453777432|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132809|NCT02064387|453777433|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132810|NCT02064387|453777434|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
126132811|NCT02064387|453777435|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126132812|NCT02706730|453777436|FG000|Overall Study|Adverse Event|3|||
126132813|NCT02706730|453777436|FG000|Overall Study|Lack of Efficacy|5|||
126132814|NCT02706730|453777436|FG000|Overall Study|Withdrawal by Subject|11|||
126132815|NCT02706730|453777436|FG000|Overall Study|Study Terminated by Sponsor|11|||
126132816|NCT02706730|453777436|FG000|Overall Study|Subject chose not to receive injection|3|||
126132817|NCT02499029|453777437|FG000|Overall Study|Lost to Follow-up|2|||
126132818|NCT02499029|453777438|FG001|Overall Study|Lost to Follow-up|2|||
126132819|NCT02499029|453777437|FG000|Overall Study|Physician Decision|2|||
126132820|NCT02499029|453777438|FG001|Overall Study|Physician Decision|1|||
126132821|NCT02499029|453777437|FG000|Overall Study|Death|1|||
126132822|NCT02499029|453777438|FG001|Overall Study|Death|0|||
126132823|NCT01536860|453777441|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
126132824|NCT01536860|453777442|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
126132825|NCT01536860|453777443|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
126132826|NCT03889639|453777444|FG000|Overall Study|Withdrawal by Subject|0|||
126132827|NCT03889639|453777445|FG001|Overall Study|Withdrawal by Subject|0|||
126132828|NCT03889639|453777446|FG002|Overall Study|Withdrawal by Subject|0|||
126132829|NCT03889639|453777447|FG003|Overall Study|Withdrawal by Subject|0|||
126132830|NCT03889639|453777448|FG004|Overall Study|Withdrawal by Subject|0|||
126132831|NCT03889639|453777449|FG005|Overall Study|Withdrawal by Subject|0|||
126132832|NCT03889639|453777450|FG006|Overall Study|Withdrawal by Subject|0|||
126132833|NCT03889639|453777451|FG007|Overall Study|Withdrawal by Subject|1|||
126132834|NCT00927095|453777452|FG000|Overall Study|Adverse Event|3|||
126132835|NCT00927095|453777453|FG001|Overall Study|Adverse Event|1|||
126132836|NCT00927095|453777454|FG002|Overall Study|Adverse Event|0|||
126132837|NCT00927095|453777452|FG000|Overall Study|Withdrawal by Subject|2|||
126132838|NCT00927095|453777453|FG001|Overall Study|Withdrawal by Subject|1|||
126132839|NCT00927095|453777454|FG002|Overall Study|Withdrawal by Subject|1|||
126132840|NCT00927095|453777452|FG000|Overall Study|Physician Decision|1|||
126132841|NCT00927095|453777453|FG001|Overall Study|Physician Decision|2|||
126132842|NCT00927095|453777454|FG002|Overall Study|Physician Decision|1|||
126132843|NCT03115151|453777455|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
126132844|NCT03115151|453777456|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
126132845|NCT03115151|453777455|FG000|Overall Study|Epidural catheter removal|1|||
126132846|NCT03115151|453777456|FG001|Overall Study|Epidural catheter removal|0|||
126132847|NCT03115151|453777455|FG000|Overall Study|Withdrawal by Subject|0|||
126132848|NCT03115151|453777456|FG001|Overall Study|Withdrawal by Subject|1|||
126132849|NCT03115151|453777455|FG000|Overall Study|Intervention not received according to the protocol.|1|||
126132850|NCT03115151|453777456|FG001|Overall Study|Intervention not received according to the protocol.|1|||
126132851|NCT03115151|453777455|FG000|Overall Study|Physician Decision|1|||
126132852|NCT03115151|453777456|FG001|Overall Study|Physician Decision|0|||
126132853|NCT03115151|453777455|FG000|Overall Study|Randomization not applied|1|||
126132854|NCT03115151|453777456|FG001|Overall Study|Randomization not applied|1|||
126132855|NCT02682901|453777462|FG000|Overall Study|Adverse Event|10|||
126132856|NCT02682901|453777463|FG001|Overall Study|Adverse Event|3|||
126132857|NCT02682901|453777462|FG000|Overall Study|Lack of Efficacy|0|||
126132858|NCT02682901|453777463|FG001|Overall Study|Lack of Efficacy|1|||
126132859|NCT03694925|453777465|FG000|Overall Study|Inadequate laboratory testing|0|||
126132860|NCT03694925|453777466|FG001|Overall Study|Inadequate laboratory testing|3|||
126132861|NCT03694925|453777467|FG002|Overall Study|Inadequate laboratory testing|0|||
126132862|NCT02799069|453777470|FG000|Overall Study|Adverse Event|0|||
126132863|NCT02799069|453777471|FG001|Overall Study|Adverse Event|2|||
126132864|NCT02799069|453777472|FG002|Overall Study|Adverse Event|2|||
125965132|NCT00116805|453163530|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
125965133|NCT00116805|453163531|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
126132865|NCT02799069|453777470|FG000|Overall Study|Lack of Efficacy|2|||
126132866|NCT02799069|453777471|FG001|Overall Study|Lack of Efficacy|0|||
126132867|NCT02799069|453777472|FG002|Overall Study|Lack of Efficacy|0|||
126132868|NCT02799069|453777470|FG000|Overall Study|Lost to Follow-up|1|||
126132869|NCT02799069|453777471|FG001|Overall Study|Lost to Follow-up|1|||
126132870|NCT02799069|453777472|FG002|Overall Study|Lost to Follow-up|0|||
126132871|NCT02799069|453777470|FG000|Overall Study|Withdrawal by Subject|4|||
126132872|NCT02799069|453777471|FG001|Overall Study|Withdrawal by Subject|4|||
126132873|NCT02799069|453777472|FG002|Overall Study|Withdrawal by Subject|3|||
126132874|NCT02799069|453777470|FG000|Overall Study|Protocol Violation|1|||
126132875|NCT02799069|453777471|FG001|Overall Study|Protocol Violation|0|||
125965134|NCT00116805|453163530|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
125965135|NCT00116805|453163531|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
125965136|NCT00116805|453163530|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
125965137|NCT00116805|453163531|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
125965138|NCT00116805|453163530|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
125965139|NCT00116805|453163531|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
125965140|NCT00116805|453163530|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
126088329|NCT00895895|453617100|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
126088330|NCT00895895|453617101|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
126088331|NCT00895895|453617102|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
126088332|NCT00895895|453617103|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
126088333|NCT00895895|453617104|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
126088334|NCT00895895|453617100|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
126088335|NCT00895895|453617101|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
126088336|NCT00895895|453617102|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
126088337|NCT00895895|453617103|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
126088338|NCT00895895|453617104|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
126088339|NCT00895895|453617100|FG000|Period 2|Adverse Event|3|||
126088340|NCT00895895|453617101|FG001|Period 2|Adverse Event|3|||
126088341|NCT00895895|453617102|FG002|Period 2|Adverse Event|5|||
126088342|NCT00895895|453617103|FG003|Period 2|Adverse Event|2|||
126088343|NCT00895895|453617104|FG004|Period 2|Adverse Event|5|||
126088344|NCT00895895|453617100|FG000|Period 2|Death|0|||
126088345|NCT00895895|453617101|FG001|Period 2|Death|0|||
126088346|NCT00895895|453617102|FG002|Period 2|Death|1|||
126088347|NCT00895895|453617103|FG003|Period 2|Death|0|||
126088348|NCT00895895|453617104|FG004|Period 2|Death|0|||
126088349|NCT00895895|453617100|FG000|Period 2|discontinued by sponsor|44|||
126088350|NCT00895895|453617101|FG001|Period 2|discontinued by sponsor|44|||
126088351|NCT00895895|453617102|FG002|Period 2|discontinued by sponsor|38|||
126088352|NCT00895895|453617103|FG003|Period 2|discontinued by sponsor|46|||
126088353|NCT00895895|453617104|FG004|Period 2|discontinued by sponsor|37|||
126088354|NCT00895895|453617100|FG000|Period 2|failed to return|2|||
126088355|NCT00895895|453617101|FG001|Period 2|failed to return|0|||
126088356|NCT00895895|453617102|FG002|Period 2|failed to return|0|||
126088357|NCT00895895|453617103|FG003|Period 2|failed to return|0|||
126088358|NCT00895895|453617104|FG004|Period 2|failed to return|0|||
126088359|NCT00895895|453617100|FG000|Period 2|investigator request|2|||
126088360|NCT00895895|453617101|FG001|Period 2|investigator request|0|||
126088361|NCT00895895|453617102|FG002|Period 2|investigator request|0|||
126088362|NCT00895895|453617103|FG003|Period 2|investigator request|0|||
126088363|NCT00895895|453617104|FG004|Period 2|investigator request|0|||
126088364|NCT00895895|453617100|FG000|Period 2|Lost to Follow-up|1|||
126088365|NCT00895895|453617101|FG001|Period 2|Lost to Follow-up|2|||
126088366|NCT00895895|453617102|FG002|Period 2|Lost to Follow-up|1|||
126088367|NCT00895895|453617103|FG003|Period 2|Lost to Follow-up|1|||
126088368|NCT00895895|453617104|FG004|Period 2|Lost to Follow-up|0|||
126088369|NCT00895895|453617100|FG000|Period 2|Other|1|||
126088370|NCT00895895|453617101|FG001|Period 2|Other|1|||
126088371|NCT00895895|453617102|FG002|Period 2|Other|3|||
126088372|NCT00895895|453617103|FG003|Period 2|Other|1|||
126088373|NCT00895895|453617104|FG004|Period 2|Other|1|||
126088374|NCT00895895|453617100|FG000|Period 2|Protocol Violation|1|||
126088375|NCT00895895|453617101|FG001|Period 2|Protocol Violation|0|||
126088376|NCT00895895|453617102|FG002|Period 2|Protocol Violation|1|||
126088377|NCT00895895|453617103|FG003|Period 2|Protocol Violation|1|||
126088378|NCT00895895|453617104|FG004|Period 2|Protocol Violation|1|||
126088379|NCT00895895|453617100|FG000|Period 2|Withdrawal by Subject|0|||
126088380|NCT00895895|453617101|FG001|Period 2|Withdrawal by Subject|2|||
126088381|NCT00895895|453617102|FG002|Period 2|Withdrawal by Subject|0|||
126088382|NCT00895895|453617103|FG003|Period 2|Withdrawal by Subject|3|||
126088383|NCT00895895|453617104|FG004|Period 2|Withdrawal by Subject|5|||
126088384|NCT00895895|453617100|FG000|Period 2|unsatisfactory response-efficacy|2|||
126088385|NCT00895895|453617101|FG001|Period 2|unsatisfactory response-efficacy|1|||
126088386|NCT00895895|453617102|FG002|Period 2|unsatisfactory response-efficacy|0|||
126088387|NCT00895895|453617103|FG003|Period 2|unsatisfactory response-efficacy|0|||
126088388|NCT00895895|453617104|FG004|Period 2|unsatisfactory response-efficacy|0|||
126088389|NCT01261000|453617105|FG000|Overall Study|Screen failure|1|||
126088390|NCT00504777|453617106|FG000|Overall Study|Adverse Event|1|||
126088391|NCT00820170|453617111|FG000|Overall Study|Adverse Event|0|||
126088392|NCT00820170|453617112|FG001|Overall Study|Adverse Event|0|||
126088393|NCT00820170|453617113|FG002|Overall Study|Adverse Event|0|||
126088394|NCT00820170|453617114|FG003|Overall Study|Adverse Event|0|||
126088395|NCT00820170|453617115|FG004|Overall Study|Adverse Event|2|||
126088396|NCT00820170|453617111|FG000|Overall Study|Progressive Disease|0|||
126088397|NCT00820170|453617112|FG001|Overall Study|Progressive Disease|0|||
126132876|NCT02799069|453777472|FG002|Overall Study|Protocol Violation|2|||
126132877|NCT03033875|453777473|FG000|Overall Study|Withdrawal by Subject|5|||
126132878|NCT03033875|453777474|FG001|Overall Study|Withdrawal by Subject|9|||
126132879|NCT03033875|453777475|FG002|Overall Study|Withdrawal by Subject|4|||
126132880|NCT03033875|453777473|FG000|Overall Study|Other|14|||
126132881|NCT03033875|453777474|FG001|Overall Study|Other|15|||
126132882|NCT03033875|453777475|FG002|Overall Study|Other|8|||
126132883|NCT00730639|453777476|FG000|Overall Study|Adverse Event|3|||
126132884|NCT00730639|453777477|FG001|Overall Study|Adverse Event|0|||
126132885|NCT00730639|453777478|FG002|Overall Study|Adverse Event|9|||
126132886|NCT00730639|453777479|FG003|Overall Study|Adverse Event|8|||
125965141|NCT00116805|453163531|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
125965142|NCT00116805|453163530|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
125965143|NCT00116805|453163531|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
125965144|NCT00116805|453163530|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
125965145|NCT00116805|453163531|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
125965146|NCT00116805|453163530|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
125965147|NCT00116805|453163531|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
125965148|NCT00116805|453163530|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
125965149|NCT00116805|453163531|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
125965150|NCT00116805|453163530|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
125965151|NCT00116805|453163531|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
125965152|NCT00116805|453163530|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
125965153|NCT00116805|453163531|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
125965154|NCT00116805|453163530|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
125965155|NCT00116805|453163531|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
125965156|NCT00116805|453163530|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
125965157|NCT00116805|453163531|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
125965158|NCT00116805|453163530|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
125965159|NCT00116805|453163531|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
125965160|NCT00116805|453163530|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
125965161|NCT00116805|453163531|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
125965162|NCT00116805|453163530|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
125965163|NCT00116805|453163531|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
125965164|NCT00116805|453163530|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
125965165|NCT00116805|453163531|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
125965166|NCT00116805|453163530|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
125965167|NCT00116805|453163531|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
125965168|NCT00116805|453163530|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
125965169|NCT00116805|453163531|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
125965170|NCT00116805|453163530|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
125965171|NCT00116805|453163531|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
125965172|NCT00116805|453163530|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
125965173|NCT00116805|453163531|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
125965174|NCT00116805|453163530|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
125965175|NCT00116805|453163531|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
125965176|NCT00116805|453163530|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
125965177|NCT00116805|453163531|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
125965178|NCT00116805|453163530|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
125965179|NCT00116805|453163531|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
125965180|NCT00116805|453163530|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
125965181|NCT00116805|453163531|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
125965182|NCT00116805|453163530|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
125965183|NCT00116805|453163531|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
125965184|NCT00116805|453163530|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
125965185|NCT00116805|453163531|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
125965186|NCT00116805|453163530|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
125965187|NCT00116805|453163531|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
125965188|NCT00116805|453163530|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
125965189|NCT00116805|453163531|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
125965190|NCT00116805|453163530|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
126132887|NCT00730639|453777480|FG004|Overall Study|Adverse Event|23|||
126132888|NCT00730639|453777476|FG000|Overall Study|Complete Response|0|||
126132889|NCT00730639|453777477|FG001|Overall Study|Complete Response|0|||
126132890|NCT00730639|453777478|FG002|Overall Study|Complete Response|2|||
126132891|NCT00730639|453777479|FG003|Overall Study|Complete Response|2|||
126132892|NCT00730639|453777480|FG004|Overall Study|Complete Response|1|||
126132893|NCT00730639|453777476|FG000|Overall Study|Completed Maximum Cycles|0|||
125965191|NCT00116805|453163531|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
125965192|NCT00116805|453163530|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
125965193|NCT00116805|453163531|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
125965194|NCT00116805|453163530|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
125965195|NCT00116805|453163531|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
125965196|NCT00116805|453163530|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
125965197|NCT00116805|453163531|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
125965198|NCT00116805|453163530|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
125965199|NCT00116805|453163531|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
125965200|NCT00116805|453163530|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
125965201|NCT00116805|453163531|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
125965202|NCT00116805|453163530|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
125965203|NCT00116805|453163531|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
125965204|NCT00116805|453163530|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
125965205|NCT00116805|453163531|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
125965206|NCT00116805|453163530|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
125965207|NCT00116805|453163531|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
125965208|NCT00116805|453163530|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
125965209|NCT00116805|453163531|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
125965210|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
125965211|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
125965212|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
125965213|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
125965214|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Adverse Event|5|||
125965215|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Adverse Event|3|||
125965216|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Adverse Event|4|||
125965217|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Adverse Event|10|||
125965218|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
125965219|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
125965220|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
125965221|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
125965222|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
125965223|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
125965224|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
125965225|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
125965226|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Pregnancy|5|||
125965227|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Pregnancy|0|||
125965228|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Pregnancy|3|||
125965229|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Pregnancy|2|||
125965230|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Non-compliance|1|||
125965231|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Non-compliance|4|||
125965232|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Non-compliance|0|||
125965233|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Non-compliance|3|||
125965234|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Other|0|||
125965235|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Other|3|||
125965236|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Other|3|||
125965237|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Other|1|||
125965238|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
125965239|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
125965240|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
125965241|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
125965242|NCT01760954|453163532|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
125965243|NCT01760954|453163533|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
125965244|NCT01760954|453163534|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
125965245|NCT01760954|453163535|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
125965246|NCT01760954|453163532|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
125965247|NCT01760954|453163533|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
125965248|NCT01760954|453163534|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
125965249|NCT01760954|453163535|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
125965250|NCT01760954|453163532|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
125965251|NCT01760954|453163533|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
125965252|NCT01760954|453163534|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
125965253|NCT01760954|453163535|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
125965254|NCT01760954|453163532|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
125965255|NCT01760954|453163533|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
125965256|NCT01760954|453163534|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
125965257|NCT01760954|453163535|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
125965258|NCT01760954|453163532|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
125965259|NCT01760954|453163533|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
125965260|NCT01760954|453163534|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
125965261|NCT01760954|453163535|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
125965262|NCT01760954|453163532|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
125965263|NCT01760954|453163533|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
125965264|NCT01760954|453163534|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
125965265|NCT01760954|453163535|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
125965266|NCT01760954|453163532|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
125965267|NCT01760954|453163533|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
125965268|NCT01760954|453163534|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
125965269|NCT01760954|453163535|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
125965270|NCT03320070|453163536|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
125965271|NCT03320070|453163537|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
125965272|NCT03320070|453163536|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
125965273|NCT03320070|453163537|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
125965274|NCT03320070|453163536|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
125965275|NCT03320070|453163537|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
125965276|NCT03320070|453163536|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
125965277|NCT03320070|453163537|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
125965278|NCT03320070|453163536|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
125965279|NCT03320070|453163537|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
125965280|NCT03320070|453163536|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
125965281|NCT03320070|453163537|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
125965282|NCT00317772|453163541|FG000|Overall Study|Adverse Event|0|||
125965283|NCT00317772|453163542|FG001|Overall Study|Adverse Event|0|||
125965284|NCT00317772|453163543|FG002|Overall Study|Adverse Event|0|||
125965285|NCT00317772|453163544|FG003|Overall Study|Adverse Event|2|||
125965286|NCT00317772|453163541|FG000|Overall Study|Disease Progression|2|||
125965287|NCT00317772|453163542|FG001|Overall Study|Disease Progression|2|||
125965288|NCT00317772|453163543|FG002|Overall Study|Disease Progression|1|||
125965289|NCT00317772|453163544|FG003|Overall Study|Disease Progression|7|||
125965290|NCT00996996|453163555|FG000|Overall Study|Progressive Disease|10|||
125965291|NCT00996996|453163555|FG000|Overall Study|Non-compliance|8|||
125965292|NCT00996996|453163555|FG000|Overall Study|Lost to Follow-up|9|||
125965293|NCT00996996|453163555|FG000|Overall Study|Death|5|||
125965294|NCT00996996|453163555|FG000|Overall Study|Did Not Receive Study Medications|1|||
125965295|NCT01375049|453163556|FG000|Overall Study|Adverse Event|2|||
125965296|NCT01375049|453163556|FG000|Overall Study|Lost to Follow-up|1|||
125965297|NCT01375049|453163556|FG000|Overall Study|Withdrawal by Subject|2|||
125965298|NCT01375049|453163556|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
125965299|NCT01175382|453163559|FG000|Overall Study|Lost to Follow-up|4|||
125965300|NCT01175382|453163560|FG001|Overall Study|Lost to Follow-up|3|||
125965301|NCT01175382|453163561|FG002|Overall Study|Lost to Follow-up|1|||
125965302|NCT01175382|453163559|FG000|Overall Study|Physician Decision|0|||
125965303|NCT01175382|453163560|FG001|Overall Study|Physician Decision|1|||
125965304|NCT01175382|453163561|FG002|Overall Study|Physician Decision|0|||
125965305|NCT01175382|453163559|FG000|Overall Study|Withdrawal by Subject|0|||
125965306|NCT01175382|453163560|FG001|Overall Study|Withdrawal by Subject|0|||
125965307|NCT01175382|453163561|FG002|Overall Study|Withdrawal by Subject|1|||
125965308|NCT01175382|453163559|FG000|Overall Study|No longer having problem|1|||
125965309|NCT01175382|453163560|FG001|Overall Study|No longer having problem|0|||
125965310|NCT01175382|453163561|FG002|Overall Study|No longer having problem|1|||
125965311|NCT01175382|453163559|FG000|Overall Study|Unable/unwilling to attend visits|3|||
125965312|NCT01175382|453163560|FG001|Overall Study|Unable/unwilling to attend visits|1|||
125965313|NCT01175382|453163561|FG002|Overall Study|Unable/unwilling to attend visits|2|||
125965314|NCT01175382|453163559|FG000|Overall Study|Unwilling to follow protocol|0|||
125965315|NCT01175382|453163560|FG001|Overall Study|Unwilling to follow protocol|1|||
125965316|NCT01175382|453163561|FG002|Overall Study|Unwilling to follow protocol|0|||
125965317|NCT01175382|453163559|FG000|Overall Study|Unable to tolerate study meds|0|||
125965318|NCT01175382|453163560|FG001|Overall Study|Unable to tolerate study meds|1|||
125965319|NCT01175382|453163561|FG002|Overall Study|Unable to tolerate study meds|1|||
125965320|NCT00774787|453163562|FG000|Overall Study|Lost to Follow-up|1|||
125965321|NCT02554773|453163563|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
125965322|NCT02554773|453163564|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
125965323|NCT02554773|453163563|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
125965324|NCT02554773|453163564|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
125965325|NCT02554773|453163563|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
125965326|NCT02554773|453163564|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
125965327|NCT02554773|453163563|FG000|Original Dose Regimen (SAS 1)|Death|1|||
125965328|NCT02554773|453163564|FG001|Original Dose Regimen (SAS 1)|Death|0|||
125965329|NCT02554773|453163563|FG000|Original Dose Regimen (SAS 1)|Other|4|||
125965330|NCT02554773|453163564|FG001|Original Dose Regimen (SAS 1)|Other|0|||
125965331|NCT02554773|453163563|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
125965332|NCT02554773|453163564|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
125965333|NCT02554773|453163563|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
125965334|NCT02554773|453163564|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
125965335|NCT02554773|453163563|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
125965336|NCT02554773|453163564|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
125965337|NCT02554773|453163563|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
125965338|NCT02554773|453163564|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
125965339|NCT02031276|453163567|FG000|Period 1 Double-blind IV|Adverse Event|6|||
125965340|NCT02031276|453163568|FG001|Period 1 Double-blind IV|Adverse Event|5|||
125965341|NCT02031276|453163569|FG002|Period 1 Double-blind IV|Adverse Event|1|||
125965342|NCT02031276|453163567|FG000|Period 1 Double-blind IV|Other|0|||
125965343|NCT02031276|453163568|FG001|Period 1 Double-blind IV|Other|1|||
125965344|NCT02031276|453163569|FG002|Period 1 Double-blind IV|Other|0|||
125965345|NCT02031276|453163567|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
125965346|NCT02031276|453163568|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
125965347|NCT02031276|453163569|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
125965348|NCT02031276|453163567|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
125965349|NCT02031276|453163568|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
125965350|NCT02031276|453163569|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
125965351|NCT02031276|453163567|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
125965352|NCT02031276|453163568|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
125965353|NCT02031276|453163569|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
125965354|NCT02031276|453163567|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
125965355|NCT02031276|453163568|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
125965356|NCT02031276|453163569|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
125965357|NCT02031276|453163567|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
125965358|NCT02031276|453163568|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
125965359|NCT02031276|453163569|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
125965360|NCT02031276|453163567|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
125965361|NCT02031276|453163568|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
125965362|NCT02031276|453163569|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
125965363|NCT02031276|453163567|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
125965364|NCT02031276|453163568|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
125965365|NCT02031276|453163569|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
125965366|NCT01148810|453163570|FG000|Overall Study|Adverse Event|0|||
125965367|NCT01148810|453163571|FG001|Overall Study|Adverse Event|2|||
125965368|NCT01148810|453163570|FG000|Overall Study|Lack of Efficacy|0|||
125965369|NCT01148810|453163571|FG001|Overall Study|Lack of Efficacy|1|||
125965370|NCT01148810|453163570|FG000|Overall Study|Withdrawal by Subject|0|||
125965371|NCT01148810|453163571|FG001|Overall Study|Withdrawal by Subject|2|||
125965372|NCT01148810|453163570|FG000|Overall Study|Protocol Violation|1|||
125965373|NCT01148810|453163571|FG001|Overall Study|Protocol Violation|0|||
125965374|NCT01854554|453163572|FG000|Overall Study|Denial of Insurance Coverage|12|||
125965375|NCT01854554|453163573|FG001|Overall Study|Denial of Insurance Coverage|0|||
125965376|NCT01854554|453163572|FG000|Overall Study|Decided to get treatment locally|1|||
125965377|NCT01854554|453163573|FG001|Overall Study|Decided to get treatment locally|5|||
125965378|NCT01854554|453163572|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
125965379|NCT01854554|453163573|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
125965380|NCT01854554|453163572|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
125965381|NCT01854554|453163573|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
125965382|NCT01854554|453163572|FG000|Overall Study|Progression|0|||
125965383|NCT01854554|453163573|FG001|Overall Study|Progression|1|||
125965384|NCT01854554|453163572|FG000|Overall Study|Lost to Follow-up|0|||
125965385|NCT01854554|453163573|FG001|Overall Study|Lost to Follow-up|1|||
126132894|NCT00730639|453777477|FG001|Overall Study|Completed Maximum Cycles|0|||
125965386|NCT02819726|453163578|FG000|Part A (All Participants)|Lost to Follow-up|0|||
125965387|NCT02819726|453163579|FG001|Part A (All Participants)|Lost to Follow-up|1|||
125965388|NCT02819726|453163580|FG002|Part A (All Participants)|Lost to Follow-up|0|||
125965389|NCT02819726|453163581|FG003|Part A (All Participants)|Lost to Follow-up|0|||
125965390|NCT02819726|453163578|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
125965391|NCT02819726|453163579|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
125965392|NCT02819726|453163580|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
125965393|NCT02819726|453163581|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
125965394|NCT02819726|453163578|FG000|Part A (All Participants)|Protocol non-compliance|3|||
125965395|NCT02819726|453163579|FG001|Part A (All Participants)|Protocol non-compliance|4|||
125965396|NCT02819726|453163580|FG002|Part A (All Participants)|Protocol non-compliance|5|||
125965397|NCT02819726|453163581|FG003|Part A (All Participants)|Protocol non-compliance|0|||
125965398|NCT02819726|453163578|FG000|Part B (All Participants)|Lost to Follow-up|1|||
125965399|NCT02819726|453163579|FG001|Part B (All Participants)|Lost to Follow-up|1|||
125965400|NCT02819726|453163580|FG002|Part B (All Participants)|Lost to Follow-up|2|||
125965401|NCT02819726|453163581|FG003|Part B (All Participants)|Lost to Follow-up|2|||
125965402|NCT02819726|453163578|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
125965403|NCT02819726|453163579|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
125965404|NCT02819726|453163580|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
125965405|NCT02819726|453163581|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
125965406|NCT02819726|453163578|FG000|Part B (All Participants)|Protocol non-compliance|0|||
125965407|NCT02819726|453163579|FG001|Part B (All Participants)|Protocol non-compliance|0|||
125965408|NCT02819726|453163580|FG002|Part B (All Participants)|Protocol non-compliance|1|||
125965409|NCT02819726|453163581|FG003|Part B (All Participants)|Protocol non-compliance|0|||
125965410|NCT02613481|453163582|FG000|Overall Study|Lost to Follow-up|7|||
125965411|NCT02613481|453163582|FG000|Overall Study|Withdrawal by Subject|2|||
125965412|NCT02843568|453163583|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
125965413|NCT02843568|453163584|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
125965414|NCT02843568|453163583|FG000|Overall Study|Death|3|||
125965415|NCT02843568|453163584|FG001|Overall Study|Death|3|||
125965416|NCT02843568|453163583|FG000|Overall Study|Withdrawal by Subject|1|||
125965417|NCT02843568|453163584|FG001|Overall Study|Withdrawal by Subject|1|||
125965418|NCT02843568|453163583|FG000|Overall Study|Lost to Follow-up|2|||
125965419|NCT02843568|453163584|FG001|Overall Study|Lost to Follow-up|0|||
125965420|NCT01255358|453163585|FG000|Overall Study|Adverse Event|2|||
125965421|NCT01255358|453163585|FG000|Overall Study|Protocol Violation|2|||
125965422|NCT00096941|453163597|FG000|Overall Study|disease progression|3|||
125965423|NCT00022516|453163598|FG000|Overall Study|Adverse Event|0|||
125965424|NCT00022516|453163599|FG001|Overall Study|Adverse Event|59|||
125965425|NCT00022516|453163598|FG000|Overall Study|Lack of Efficacy|0|||
125965426|NCT00022516|453163599|FG001|Overall Study|Lack of Efficacy|27|||
125965427|NCT00022516|453163598|FG000|Overall Study|Physician Decision|0|||
125965428|NCT00022516|453163599|FG001|Overall Study|Physician Decision|1|||
125965429|NCT00022516|453163598|FG000|Overall Study|Protocol Violation|1|||
125965430|NCT00022516|453163599|FG001|Overall Study|Protocol Violation|3|||
125965431|NCT00022516|453163598|FG000|Overall Study|Withdrawal by Subject|2|||
125965432|NCT00022516|453163599|FG001|Overall Study|Withdrawal by Subject|113|||
125965433|NCT00022516|453163598|FG000|Overall Study|Incomplete documentation|0|||
125965434|NCT00022516|453163599|FG001|Overall Study|Incomplete documentation|27|||
125965435|NCT02056301|453163602|FG000|Overall Study|Protocol Violation|1|||
125965436|NCT02056301|453163603|FG001|Overall Study|Protocol Violation|2|||
125965437|NCT02056301|453163602|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
125965438|NCT02056301|453163603|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
125965439|NCT02056301|453163602|FG000|Overall Study|Withdrawal by Subject|0|||
125965440|NCT02056301|453163603|FG001|Overall Study|Withdrawal by Subject|1|||
125965441|NCT02056301|453163602|FG000|Overall Study|Issues with epidural|0|||
125965442|NCT02056301|453163603|FG001|Overall Study|Issues with epidural|3|||
125965443|NCT02209324|453163604|FG000|Overall Study|Adverse Event|2|||
125965444|NCT02209324|453163604|FG000|Overall Study|Lack of Efficacy|1|||
125965445|NCT02209324|453163604|FG000|Overall Study|Lost to Follow-up|1|||
125965446|NCT02209324|453163604|FG000|Overall Study|Physician Decision|3|||
125965447|NCT02209324|453163604|FG000|Overall Study|Protocol Violation|14|||
125965448|NCT02209324|453163604|FG000|Overall Study|Withdrawal by Subject|8|||
125965449|NCT02209324|453163604|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
125965450|NCT02209324|453163604|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
125965451|NCT02209324|453163604|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
125965452|NCT05799495|453163605|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
125965453|NCT05799495|453163606|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
126132895|NCT00730639|453777478|FG002|Overall Study|Completed Maximum Cycles|11|||
125965454|NCT05799495|453163607|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
125965455|NCT05799495|453163608|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
125965456|NCT05799495|453163605|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
125965457|NCT05799495|453163606|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
125965458|NCT05799495|453163607|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
125965459|NCT05799495|453163608|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
125965460|NCT05799495|453163605|FG000|Treatment (Up to 5 Days)|Other|0|||
125965461|NCT05799495|453163606|FG001|Treatment (Up to 5 Days)|Other|1|||
125965462|NCT05799495|453163607|FG002|Treatment (Up to 5 Days)|Other|0|||
125965463|NCT05799495|453163608|FG003|Treatment (Up to 5 Days)|Other|0|||
125965464|NCT05799495|453163605|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
125965465|NCT05799495|453163606|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
125965466|NCT05799495|453163607|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
125965467|NCT05799495|453163608|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
125965468|NCT05799495|453163605|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
125965469|NCT05799495|453163606|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
125965470|NCT05799495|453163607|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
125965471|NCT05799495|453163608|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
125965472|NCT05799495|453163605|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125965473|NCT05799495|453163606|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125965474|NCT05799495|453163607|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
125965475|NCT05799495|453163608|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125965476|NCT03105362|453163609|FG000|Overall Study|Withdrawal by Subject|1|||
125965477|NCT03105362|453163609|FG000|Overall Study|Lost to Follow-up|1|||
125965478|NCT01198600|453163610|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
125965479|NCT01198600|453163611|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
125965480|NCT01198600|453163612|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
125965481|NCT01198600|453163613|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
125965482|NCT01198600|453163610|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
125965483|NCT01198600|453163611|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
125965484|NCT01198600|453163612|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
125965485|NCT01198600|453163613|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
125965486|NCT01198600|453163610|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
125965487|NCT01198600|453163611|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
125965488|NCT01198600|453163612|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
125965489|NCT01198600|453163613|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
125965490|NCT01198600|453163610|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
125965491|NCT01198600|453163611|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
125965492|NCT01198600|453163612|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
125965493|NCT01198600|453163613|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
125965494|NCT01198600|453163610|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
125965495|NCT01198600|453163611|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
125965496|NCT01198600|453163612|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
125965497|NCT01198600|453163613|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
125965498|NCT01198600|453163610|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
125965499|NCT01198600|453163611|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
125965500|NCT01198600|453163612|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
125965501|NCT01198600|453163613|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
125965502|NCT01198600|453163610|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
125965503|NCT01198600|453163611|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
125965504|NCT01198600|453163612|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
125965505|NCT01198600|453163613|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
125965506|NCT01669343|453163614|FG000|Part A: All Patients|Withdrawal by Subject|7|||
125965507|NCT01669343|453163614|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
125965508|NCT01669343|453163614|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
125965509|NCT01669343|453163614|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
125965510|NCT01669343|453163614|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
125965511|NCT04798586|453163615|FG000|Overall Study|Death|2|||
125965512|NCT04433767|453163617|FG000|Overall Study|Adverse Event|1|||
125965513|NCT02371369|453163622|FG000|Part 1|Physician Decision|0|||
125965514|NCT02371369|453163623|FG001|Part 1|Physician Decision|3|||
125965515|NCT02371369|453163622|FG000|Part 1|Adverse Event|8|||
125965516|NCT02371369|453163623|FG001|Part 1|Adverse Event|0|||
125965517|NCT02371369|453163622|FG000|Part 1|Withdrawal by Subject|1|||
125965518|NCT02371369|453163623|FG001|Part 1|Withdrawal by Subject|6|||
125965519|NCT02371369|453163622|FG000|Part 1|Disease progression|0|||
125965520|NCT02371369|453163623|FG001|Part 1|Disease progression|1|||
125965521|NCT02371369|453163622|FG000|Part 1|Protocol Violation|0|||
125965522|NCT02371369|453163623|FG001|Part 1|Protocol Violation|1|||
125965523|NCT02371369|453163622|FG000|Part 2|Adverse Event|6|||
125965524|NCT02371369|453163623|FG001|Part 2|Adverse Event|5|||
125965525|NCT02371369|453163622|FG000|Part 2|Withdrawal by Subject|16|||
125965526|NCT02371369|453163623|FG001|Part 2|Withdrawal by Subject|6|||
125965527|NCT02371369|453163622|FG000|Part 2|Investigator decision|1|||
125965528|NCT02371369|453163623|FG001|Part 2|Investigator decision|2|||
125965529|NCT02371369|453163622|FG000|Part 2|Death|0|||
125965530|NCT02371369|453163623|FG001|Part 2|Death|1|||
125965531|NCT02371369|453163622|FG000|Part 2|Disease progression|1|||
125965532|NCT02371369|453163623|FG001|Part 2|Disease progression|0|||
125965533|NCT02371369|453163622|FG000|Part 2|Subject Noncompliance|1|||
125965534|NCT02371369|453163623|FG001|Part 2|Subject Noncompliance|0|||
125965535|NCT02371369|453163622|FG000|Part 2|Lost to Follow-up|1|||
125965536|NCT02371369|453163623|FG001|Part 2|Lost to Follow-up|1|||
125965537|NCT02371369|453163622|FG000|Part 2|Subject transitioned to commercial supply|6|||
125965538|NCT02371369|453163623|FG001|Part 2|Subject transitioned to commercial supply|4|||
125965539|NCT02371369|453163622|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
125965540|NCT02371369|453163623|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
125965541|NCT02371369|453163622|FG000|Part 2|Surgical resection of tumor|1|||
125965542|NCT02371369|453163623|FG001|Part 2|Surgical resection of tumor|1|||
125965543|NCT02371369|453163622|FG000|Part 2|Other|0|||
125965544|NCT02371369|453163623|FG001|Part 2|Other|1|||
125965545|NCT03855189|453163624|FG000|Overall Study|Adverse Event|5|||
125965546|NCT03855189|453163625|FG001|Overall Study|Adverse Event|2|||
125965547|NCT03855189|453163626|FG002|Overall Study|Adverse Event|4|||
125965548|NCT03855189|453163624|FG000|Overall Study|Treatment Failure|1|||
125965549|NCT03855189|453163625|FG001|Overall Study|Treatment Failure|1|||
125965550|NCT03855189|453163626|FG002|Overall Study|Treatment Failure|2|||
125965551|NCT03855189|453163624|FG000|Overall Study|Noncompliance with Protocol|0|||
125965552|NCT03855189|453163625|FG001|Overall Study|Noncompliance with Protocol|1|||
125965553|NCT03855189|453163626|FG002|Overall Study|Noncompliance with Protocol|0|||
125965554|NCT03855189|453163624|FG000|Overall Study|Did Not Return|4|||
125965555|NCT03855189|453163625|FG001|Overall Study|Did Not Return|3|||
125965556|NCT03855189|453163626|FG002|Overall Study|Did Not Return|0|||
125965557|NCT01143259|453163627|FG000|Overall Study|Withdrawal by Subject|3|||
125965558|NCT01143259|453163628|FG001|Overall Study|Withdrawal by Subject|2|||
125965559|NCT01143259|453163627|FG000|Overall Study|Protocol Violation|13|||
125965560|NCT01143259|453163628|FG001|Overall Study|Protocol Violation|9|||
125965561|NCT01143259|453163627|FG000|Overall Study|Screen Failure|7|||
125965562|NCT01143259|453163628|FG001|Overall Study|Screen Failure|9|||
125965563|NCT00099983|453163629|FG000|Overall Study|Lost to Follow-up|2|||
125965564|NCT00099983|453163630|FG001|Overall Study|Lost to Follow-up|3|||
125965565|NCT00099983|453163629|FG000|Overall Study|Missing Source Documents|14|||
125965566|NCT00099983|453163630|FG001|Overall Study|Missing Source Documents|15|||
125965567|NCT00099983|453163629|FG000|Overall Study|Withdrawal by Subject|3|||
125965568|NCT00099983|453163630|FG001|Overall Study|Withdrawal by Subject|2|||
125965569|NCT00099983|453163629|FG000|Overall Study|Adverse Event|1|||
125965570|NCT00099983|453163630|FG001|Overall Study|Adverse Event|1|||
125965571|NCT00099983|453163629|FG000|Overall Study|Lack of Efficacy|0|||
125965572|NCT00099983|453163630|FG001|Overall Study|Lack of Efficacy|1|||
125965573|NCT00099983|453163629|FG000|Overall Study|Unable to return for appointments|1|||
125965574|NCT00099983|453163630|FG001|Overall Study|Unable to return for appointments|1|||
125965575|NCT00099983|453163629|FG000|Overall Study|Moved|1|||
125965576|NCT00099983|453163630|FG001|Overall Study|Moved|0|||
125965577|NCT00099983|453163629|FG000|Overall Study|Other psychiatric problem|1|||
125965578|NCT00099983|453163630|FG001|Overall Study|Other psychiatric problem|0|||
125965579|NCT00099983|453163629|FG000|Overall Study|Incarcerated|0|||
125965580|NCT00099983|453163630|FG001|Overall Study|Incarcerated|1|||
125965581|NCT00099983|453163629|FG000|Overall Study|Intolerant of burden of visits|0|||
125965582|NCT00099983|453163630|FG001|Overall Study|Intolerant of burden of visits|1|||
125965583|NCT00099983|453163629|FG000|Overall Study|Other issue|1|||
125965584|NCT00099983|453163630|FG001|Overall Study|Other issue|0|||
125965585|NCT02641080|453163631|FG000|Overall Study|Physician Decision|2|||
125965586|NCT02641080|453163632|FG001|Overall Study|Physician Decision|0|||
125965587|NCT02641080|453163631|FG000|Overall Study|Withdrawal by Subject|0|||
125965588|NCT02641080|453163632|FG001|Overall Study|Withdrawal by Subject|1|||
125965589|NCT02641080|453163631|FG000|Overall Study|Rehab Center denied use of pumps|0|||
125965590|NCT02641080|453163632|FG001|Overall Study|Rehab Center denied use of pumps|3|||
125965591|NCT02641080|453163631|FG000|Overall Study|Lost to Follow-up|0|||
125965592|NCT02641080|453163632|FG001|Overall Study|Lost to Follow-up|3|||
125965593|NCT00803634|453163633|FG000|Overall Study|Withdrew Consent|1|||
125965594|NCT00803634|453163634|FG001|Overall Study|Withdrew Consent|0|||
125965595|NCT00803634|453163633|FG000|Overall Study|Lost to Follow-up|2|||
125965596|NCT00803634|453163634|FG001|Overall Study|Lost to Follow-up|3|||
125965597|NCT00803634|453163633|FG000|Overall Study|Death|3|||
125965598|NCT00803634|453163634|FG001|Overall Study|Death|2|||
125965599|NCT04307186|453163637|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
125965600|NCT04307186|453163637|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
125965601|NCT04307186|453163637|FG000|Washout 3-14 Days|Progressive disease|1|||
125965602|NCT04307186|453163637|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
125965603|NCT04307186|453163637|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
125965604|NCT00759109|453163642|FG000|Overall Study|Adverse Event|17|||
125965605|NCT00759109|453163643|FG001|Overall Study|Adverse Event|12|||
125965606|NCT00759109|453163642|FG000|Overall Study|Inability to comply|1|||
125965607|NCT00759109|453163643|FG001|Overall Study|Inability to comply|1|||
126132896|NCT00730639|453777479|FG003|Overall Study|Completed Maximum Cycles|3|||
125965608|NCT00759109|453163642|FG000|Overall Study|Withdrawal by Subject|9|||
125965609|NCT00759109|453163643|FG001|Overall Study|Withdrawal by Subject|5|||
125965610|NCT00759109|453163642|FG000|Overall Study|Death|4|||
125965611|NCT00759109|453163643|FG001|Overall Study|Death|3|||
125965612|NCT00759109|453163642|FG000|Overall Study|Lost to Follow-up|4|||
125965613|NCT00759109|453163643|FG001|Overall Study|Lost to Follow-up|6|||
125965614|NCT00759109|453163642|FG000|Overall Study|Started new therapy|2|||
125965615|NCT00759109|453163643|FG001|Overall Study|Started new therapy|6|||
125965616|NCT00759109|453163642|FG000|Overall Study|HCV RNA negative|1|||
125965617|NCT00759109|453163643|FG001|Overall Study|HCV RNA negative|0|||
125965618|NCT00759109|453163642|FG000|Overall Study|Participant moved to a different city|0|||
125965619|NCT00759109|453163643|FG001|Overall Study|Participant moved to a different city|1|||
125965620|NCT00759109|453163642|FG000|Overall Study|Participant had a liver transplant|0|||
125965621|NCT00759109|453163643|FG001|Overall Study|Participant had a liver transplant|1|||
125965622|NCT00759109|453163642|FG000|Overall Study|Lost during study|1|||
125965623|NCT00759109|453163643|FG001|Overall Study|Lost during study|0|||
125965624|NCT03238001|453163644|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
125965625|NCT03238001|453163644|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
125965626|NCT03238001|453163644|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
125965627|NCT03238001|453163644|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
125965628|NCT03238001|453163644|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
125965629|NCT03238001|453163644|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
125965630|NCT03238001|453163644|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
125965631|NCT03238001|453163644|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
125965632|NCT01866709|453163648|FG000|Overall Study|Adverse Event|1|||
125965633|NCT01866709|453163649|FG001|Overall Study|Adverse Event|0|||
125965634|NCT03791398|453163650|FG000|Overall Study|Progression of Disease Under Study|2|||
125965635|NCT03791398|453163651|FG001|Overall Study|Progression of Disease Under Study|0|||
125965636|NCT03791398|453163652|FG002|Overall Study|Progression of Disease Under Study|0|||
125965637|NCT00766376|453163653|FG000|Overall Study|Withdrawal by Subject|27|||
125965638|NCT02207829|453163654|FG000|Overall Study|Adverse Event|10|||
125965639|NCT02207829|453163655|FG001|Overall Study|Adverse Event|9|||
125965640|NCT02207829|453163654|FG000|Overall Study|Lack of Efficacy|7|||
125965641|NCT02207829|453163655|FG001|Overall Study|Lack of Efficacy|5|||
125965642|NCT02207829|453163654|FG000|Overall Study|Lost to Follow-up|2|||
125965643|NCT02207829|453163655|FG001|Overall Study|Lost to Follow-up|2|||
125965644|NCT02207829|453163654|FG000|Overall Study|Protocol deviation|5|||
125965645|NCT02207829|453163655|FG001|Overall Study|Protocol deviation|4|||
125965646|NCT02207829|453163654|FG000|Overall Study|Withdrew consent|18|||
125965647|NCT02207829|453163655|FG001|Overall Study|Withdrew consent|14|||
126088398|NCT00820170|453617113|FG002|Overall Study|Progressive Disease|0|||
126088399|NCT00820170|453617114|FG003|Overall Study|Progressive Disease|0|||
126088400|NCT00820170|453617115|FG004|Overall Study|Progressive Disease|2|||
126088401|NCT03552523|453617116|FG000|Overall Study|Withdrawal by Subject|1|||
126088402|NCT03552523|453617117|FG001|Overall Study|Withdrawal by Subject|1|||
126088403|NCT03538938|453617118|FG000|Overall Study|Death|0|||
126088404|NCT03538938|453617119|FG001|Overall Study|Death|0|||
126088405|NCT03538938|453617120|FG002|Overall Study|Death|2|||
126088406|NCT03538938|453617121|FG003|Overall Study|Death|0|||
126088407|NCT03538938|453617122|FG004|Overall Study|Death|0|||
126088408|NCT03538938|453617123|FG005|Overall Study|Death|1|||
126088409|NCT03538938|453617124|FG006|Overall Study|Death|0|||
126088410|NCT03538938|453617125|FG007|Overall Study|Death|1|||
126088411|NCT03538938|453617126|FG008|Overall Study|Death|1|||
126088412|NCT03538938|453617127|FG009|Overall Study|Death|1|||
126088413|NCT03538938|453617128|FG010|Overall Study|Death|0|||
126088414|NCT03538938|453617129|FG011|Overall Study|Death|0|||
126088415|NCT03538938|453617130|FG012|Overall Study|Death|1|||
126088416|NCT03538938|453617131|FG013|Overall Study|Death|1|||
126088417|NCT03538938|453617132|FG014|Overall Study|Death|0|||
126088418|NCT03538938|453617133|FG015|Overall Study|Death|1|||
126088419|NCT03538938|453617118|FG000|Overall Study|Withdrawal by Subject|4|||
126088420|NCT03538938|453617119|FG001|Overall Study|Withdrawal by Subject|6|||
126088421|NCT03538938|453617120|FG002|Overall Study|Withdrawal by Subject|5|||
126088422|NCT03538938|453617121|FG003|Overall Study|Withdrawal by Subject|3|||
126088423|NCT03538938|453617122|FG004|Overall Study|Withdrawal by Subject|0|||
126088424|NCT03538938|453617123|FG005|Overall Study|Withdrawal by Subject|0|||
126088425|NCT03538938|453617124|FG006|Overall Study|Withdrawal by Subject|3|||
126088426|NCT03538938|453617125|FG007|Overall Study|Withdrawal by Subject|1|||
126088427|NCT03538938|453617126|FG008|Overall Study|Withdrawal by Subject|5|||
126088428|NCT03538938|453617127|FG009|Overall Study|Withdrawal by Subject|1|||
126088429|NCT03538938|453617128|FG010|Overall Study|Withdrawal by Subject|2|||
126088430|NCT03538938|453617129|FG011|Overall Study|Withdrawal by Subject|1|||
126088431|NCT03538938|453617130|FG012|Overall Study|Withdrawal by Subject|3|||
126088432|NCT03538938|453617131|FG013|Overall Study|Withdrawal by Subject|0|||
126088433|NCT03538938|453617132|FG014|Overall Study|Withdrawal by Subject|2|||
126088434|NCT03538938|453617133|FG015|Overall Study|Withdrawal by Subject|4|||
126088435|NCT03538938|453617118|FG000|Overall Study|Incarcerated|0|||
126088436|NCT03538938|453617119|FG001|Overall Study|Incarcerated|0|||
126088437|NCT03538938|453617120|FG002|Overall Study|Incarcerated|0|||
126088438|NCT03538938|453617121|FG003|Overall Study|Incarcerated|0|||
126088439|NCT03538938|453617122|FG004|Overall Study|Incarcerated|0|||
126088440|NCT03538938|453617123|FG005|Overall Study|Incarcerated|0|||
126088441|NCT03538938|453617124|FG006|Overall Study|Incarcerated|0|||
126088442|NCT03538938|453617125|FG007|Overall Study|Incarcerated|0|||
126088443|NCT03538938|453617126|FG008|Overall Study|Incarcerated|0|||
126088444|NCT03538938|453617127|FG009|Overall Study|Incarcerated|0|||
126088445|NCT03538938|453617128|FG010|Overall Study|Incarcerated|0|||
126088446|NCT03538938|453617129|FG011|Overall Study|Incarcerated|1|||
126088447|NCT03538938|453617130|FG012|Overall Study|Incarcerated|0|||
126132897|NCT00730639|453777480|FG004|Overall Study|Completed Maximum Cycles|6|||
126132898|NCT00730639|453777476|FG000|Overall Study|Death|0|||
126132899|NCT00730639|453777477|FG001|Overall Study|Death|0|||
126132900|NCT00730639|453777478|FG002|Overall Study|Death|0|||
126132901|NCT00730639|453777479|FG003|Overall Study|Death|0|||
126132902|NCT00730639|453777480|FG004|Overall Study|Death|2|||
126132903|NCT00730639|453777476|FG000|Overall Study|Disease Progression|12|||
126132904|NCT00730639|453777477|FG001|Overall Study|Disease Progression|13|||
126132905|NCT00730639|453777478|FG002|Overall Study|Disease Progression|48|||
126132906|NCT00730639|453777479|FG003|Overall Study|Disease Progression|32|||
126132907|NCT00730639|453777480|FG004|Overall Study|Disease Progression|88|||
126132908|NCT00730639|453777476|FG000|Overall Study|non-specified|0|||
126132909|NCT00730639|453777477|FG001|Overall Study|non-specified|0|||
126132910|NCT00730639|453777478|FG002|Overall Study|non-specified|4|||
126132911|NCT00730639|453777479|FG003|Overall Study|non-specified|2|||
126132912|NCT00730639|453777480|FG004|Overall Study|non-specified|3|||
126132913|NCT00730639|453777476|FG000|Overall Study|Protocol Violation|0|||
126132914|NCT00730639|453777477|FG001|Overall Study|Protocol Violation|0|||
126132915|NCT00730639|453777478|FG002|Overall Study|Protocol Violation|1|||
126132916|NCT00730639|453777479|FG003|Overall Study|Protocol Violation|0|||
126132917|NCT00730639|453777480|FG004|Overall Study|Protocol Violation|0|||
126132918|NCT00730639|453777476|FG000|Overall Study|Withdrawal by Subject|0|||
126132919|NCT00730639|453777477|FG001|Overall Study|Withdrawal by Subject|0|||
126132920|NCT00730639|453777478|FG002|Overall Study|Withdrawal by Subject|6|||
126132921|NCT00730639|453777479|FG003|Overall Study|Withdrawal by Subject|3|||
126132922|NCT00730639|453777480|FG004|Overall Study|Withdrawal by Subject|4|||
126132923|NCT00730639|453777476|FG000|Overall Study|Treatment on-going|2|||
126132924|NCT00730639|453777477|FG001|Overall Study|Treatment on-going|5|||
126132925|NCT00730639|453777478|FG002|Overall Study|Treatment on-going|5|||
126132926|NCT00730639|453777479|FG003|Overall Study|Treatment on-going|4|||
126132927|NCT00730639|453777480|FG004|Overall Study|Treatment on-going|4|||
126132928|NCT02665286|453777481|FG000|Overall Study|Lost to Follow-up|3|||
126132929|NCT02665286|453777482|FG001|Overall Study|Lost to Follow-up|2|||
126132930|NCT02665286|453777483|FG002|Overall Study|Lost to Follow-up|1|||
126132931|NCT03064841|453777489|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
126132932|NCT03064841|453777489|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
126132933|NCT03064841|453777489|FG000|Overall Study|Screen failure|2|||
126132934|NCT03434977|453777490|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
126132935|NCT03434977|453777491|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
126132936|NCT00217087|453777492|FG000|Overall Study|decided to have esophagectomy|1|||
126132937|NCT00217087|453777493|FG001|Overall Study|decided to have esophagectomy|2|||
126132938|NCT00217087|453777492|FG000|Overall Study|completed less than 12 months return|10|||
126132939|NCT00217087|453777493|FG001|Overall Study|completed less than 12 months return|18|||
126132940|NCT03920670|453777494|FG000|Overall Study|Protocol Violation|2|||
126132941|NCT03920670|453777495|FG001|Overall Study|Protocol Violation|2|||
126132942|NCT03920670|453777494|FG000|Overall Study|Adverse Event|1|||
126132943|NCT03920670|453777495|FG001|Overall Study|Adverse Event|0|||
126132944|NCT05574062|453777496|FG000|Pre Run-In|Screening failure|3|||
126132945|NCT05574062|453777497|FG001|Pre Run-In|Screening failure|0|||
126132946|NCT05574062|453777498|FG002|Pre Run-In|Screening failure|0|||
126132947|NCT05574062|453777499|FG003|Pre Run-In|Screening failure|0|||
126132948|NCT05574062|453777500|FG004|Pre Run-In|Screening failure|0|||
126132949|NCT05574062|453777496|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
126132950|NCT05574062|453777497|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
126132951|NCT05574062|453777498|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
126132952|NCT05574062|453777499|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
126132953|NCT05574062|453777500|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
126132954|NCT05574062|453777496|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
126132955|NCT05574062|453777497|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
126132956|NCT05574062|453777498|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
126132957|NCT05574062|453777499|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
126132958|NCT05574062|453777500|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
126132959|NCT05574062|453777496|FG000|Continuation Phase Period 1|Physician Decision|1|||
126132960|NCT05574062|453777497|FG001|Continuation Phase Period 1|Physician Decision|0|||
126132961|NCT05574062|453777498|FG002|Continuation Phase Period 1|Physician Decision|0|||
126132962|NCT05574062|453777499|FG003|Continuation Phase Period 1|Physician Decision|0|||
126132963|NCT05574062|453777500|FG004|Continuation Phase Period 1|Physician Decision|0|||
126132964|NCT05574062|453777496|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
126132965|NCT05574062|453777497|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
126132966|NCT05574062|453777498|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
126132967|NCT05574062|453777499|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
126132968|NCT05574062|453777500|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
126132969|NCT05574062|453777496|FG000|Continuation Phase Period 1|Adverse Event|1|||
126132970|NCT05574062|453777497|FG001|Continuation Phase Period 1|Adverse Event|0|||
126132971|NCT05574062|453777498|FG002|Continuation Phase Period 1|Adverse Event|0|||
126132972|NCT05574062|453777499|FG003|Continuation Phase Period 1|Adverse Event|0|||
126132973|NCT05574062|453777500|FG004|Continuation Phase Period 1|Adverse Event|0|||
126132974|NCT05574062|453777496|FG000|Continuation Phase Period 1|Death|1|||
126132975|NCT05574062|453777497|FG001|Continuation Phase Period 1|Death|0|||
126132976|NCT05574062|453777498|FG002|Continuation Phase Period 1|Death|0|||
126132977|NCT05574062|453777499|FG003|Continuation Phase Period 1|Death|0|||
126132978|NCT05574062|453777500|FG004|Continuation Phase Period 1|Death|0|||
126132979|NCT05574062|453777496|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
126132980|NCT05574062|453777497|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
126132981|NCT05574062|453777498|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
126132982|NCT05574062|453777499|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
126132983|NCT05574062|453777500|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
126132984|NCT04770779|453777503|FG000|Overall Study|Randomized, never treated|0|||
126132985|NCT04770779|453777504|FG001|Overall Study|Randomized, never treated|1|||
126132986|NCT04770779|453777503|FG000|Overall Study|Adverse Event|9|||
126132987|NCT04770779|453777504|FG001|Overall Study|Adverse Event|1|||
126132988|NCT04770779|453777503|FG000|Overall Study|Withdrawal by Subject|7|||
126132989|NCT04770779|453777504|FG001|Overall Study|Withdrawal by Subject|1|||
126132990|NCT04770779|453777503|FG000|Overall Study|Pregnancy|0|||
126132991|NCT04770779|453777504|FG001|Overall Study|Pregnancy|1|||
126132992|NCT04820309|453777505|FG000|Overall Study|Adverse Event|96|||
126132993|NCT04820309|453777505|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
126132994|NCT04820309|453777505|FG000|Overall Study|Consent Withdrawn|93|||
126132995|NCT04820309|453777505|FG000|Overall Study|failure to adhere to protocol|32|||
126132996|NCT04820309|453777505|FG000|Overall Study|alcohol or drug use|6|||
126132997|NCT04820309|453777505|FG000|Overall Study|Lost to Follow-up|46|||
126132998|NCT04820309|453777505|FG000|Overall Study|Death|2|||
126132999|NCT04820309|453777505|FG000|Overall Study|Pregnancy|1|||
126133000|NCT04820309|453777505|FG000|Overall Study|Other reasons|12|||
126133001|NCT03692052|453777506|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
126133002|NCT03692052|453777506|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
126133003|NCT03692052|453777506|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
126133004|NCT03692052|453777506|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
126133005|NCT05600309|453777509|FG000|Overall Study|Death|41|||
126133006|NCT05600309|453777510|FG001|Overall Study|Death|38|||
126133007|NCT05600309|453777509|FG000|Overall Study|Sponsor Decision|9|||
126133008|NCT05600309|453777510|FG001|Overall Study|Sponsor Decision|6|||
126133009|NCT03864653|453777513|FG000|Overall Study|Withdrawal by Subject|1|||
126133010|NCT00546052|453777514|FG000|Overall Study|Adverse Event|47|||
126133011|NCT00546052|453777514|FG000|Overall Study|Lost to Follow-up|144|||
126133012|NCT00546052|453777514|FG000|Overall Study|Protocol Violation|9|||
126133013|NCT00546052|453777514|FG000|Overall Study|Withdrawal by Subject|20|||
126133014|NCT00546052|453777514|FG000|Overall Study|Non Compliance|7|||
126133015|NCT02482129|453777515|FG000|Overall Study|Adverse Event-prior to treatment|0|||
126133016|NCT02482129|453777516|FG001|Overall Study|Adverse Event-prior to treatment|1|||
126133017|NCT02482129|453777515|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
126133018|NCT02482129|453777516|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
126133019|NCT02482129|453777515|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
126133020|NCT02482129|453777516|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
126133021|NCT02482129|453777515|FG000|Overall Study|Criteria not met-prior to treatment|1|||
126133022|NCT02482129|453777516|FG001|Overall Study|Criteria not met-prior to treatment|0|||
126133023|NCT02482129|453777515|FG000|Overall Study|Adverse Event|1|||
126133024|NCT02482129|453777516|FG001|Overall Study|Adverse Event|0|||
126133025|NCT02482129|453777515|FG000|Overall Study|Withdrawal by Subject|2|||
126133026|NCT02482129|453777516|FG001|Overall Study|Withdrawal by Subject|0|||
126133027|NCT02482129|453777515|FG000|Overall Study|Criteria not met|1|||
126133028|NCT02482129|453777516|FG001|Overall Study|Criteria not met|0|||
126133029|NCT01928381|453777517|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
126133030|NCT01928381|453777518|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126133031|NCT01928381|453777519|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126133032|NCT01928381|453777520|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126133033|NCT01928381|453777521|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126133034|NCT01928381|453777522|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126133035|NCT01928381|453777523|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126133036|NCT01928381|453777517|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
126133037|NCT01928381|453777518|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
126133038|NCT01928381|453777519|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
126133039|NCT01928381|453777520|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
126133040|NCT01928381|453777521|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
126133041|NCT01928381|453777522|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
126133042|NCT01928381|453777523|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
126133043|NCT01928381|453777517|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
126133044|NCT01928381|453777518|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
126133045|NCT01928381|453777519|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
126133046|NCT01928381|453777520|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
126133047|NCT01928381|453777521|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
126133048|NCT01928381|453777522|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
126133049|NCT01928381|453777523|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
126133050|NCT01928381|453777517|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
126133051|NCT01928381|453777518|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
126133052|NCT01928381|453777519|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
126133053|NCT01928381|453777520|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
126133054|NCT01928381|453777521|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
126133055|NCT01928381|453777522|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
126133056|NCT01928381|453777523|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
126133057|NCT01928381|453777517|FG000|Part 1 - Pain Training|Protocol Violation|1|||
126133058|NCT01928381|453777518|FG001|Part 1 - Pain Training|Protocol Violation|0|||
126133059|NCT01928381|453777519|FG002|Part 1 - Pain Training|Protocol Violation|0|||
126133060|NCT01928381|453777520|FG003|Part 1 - Pain Training|Protocol Violation|0|||
126133061|NCT01928381|453777521|FG004|Part 1 - Pain Training|Protocol Violation|0|||
126133062|NCT01928381|453777522|FG005|Part 1 - Pain Training|Protocol Violation|0|||
126133063|NCT01928381|453777523|FG006|Part 1 - Pain Training|Protocol Violation|0|||
126133064|NCT01928381|453777517|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
126133065|NCT01928381|453777518|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126133066|NCT01928381|453777519|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126133067|NCT01928381|453777520|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126133068|NCT01928381|453777521|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126133069|NCT01928381|453777522|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126133070|NCT01928381|453777523|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126133071|NCT01928381|453777517|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
126133072|NCT01928381|453777518|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126133073|NCT01928381|453777519|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126133074|NCT01928381|453777520|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126133075|NCT01928381|453777521|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126133076|NCT01928381|453777522|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126133077|NCT01928381|453777523|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126133078|NCT01928381|453777517|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
126133079|NCT01928381|453777518|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126133080|NCT01928381|453777519|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126133081|NCT01928381|453777520|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126133082|NCT01928381|453777521|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126133083|NCT01928381|453777522|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126133084|NCT01928381|453777523|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126133085|NCT01928381|453777517|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
126133086|NCT01928381|453777518|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126133087|NCT01928381|453777519|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126133088|NCT01928381|453777520|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126133089|NCT01928381|453777521|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126133090|NCT01928381|453777522|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126133091|NCT01928381|453777523|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126133092|NCT01928381|453777517|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
126133093|NCT01928381|453777518|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
126133094|NCT01928381|453777519|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
126133095|NCT01928381|453777520|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
126133096|NCT01928381|453777521|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
126133097|NCT01928381|453777522|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
126133098|NCT01928381|453777523|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
126133099|NCT01928381|453777517|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126133100|NCT01928381|453777518|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126133101|NCT01928381|453777519|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
126133102|NCT01928381|453777520|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126133103|NCT01928381|453777521|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126133104|NCT01928381|453777522|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126133105|NCT01928381|453777523|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126133106|NCT01928381|453777517|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
125965648|NCT00927927|453163659|FG000|Overall Study|Withdrawal by Subject|0|||
126133107|NCT01928381|453777518|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
126133108|NCT01928381|453777519|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
126133109|NCT01928381|453777520|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
126133110|NCT01928381|453777521|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
126133111|NCT01928381|453777522|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
126133112|NCT01928381|453777523|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
126133113|NCT01928381|453777517|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
126133114|NCT01928381|453777518|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
126133115|NCT01928381|453777519|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
126133116|NCT01928381|453777520|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
126133117|NCT01928381|453777521|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
126133118|NCT01928381|453777522|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
126133119|NCT01928381|453777523|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
126133120|NCT01928381|453777517|FG000|Washout First Intervention|Protocol Violation|0|||
126133121|NCT01928381|453777518|FG001|Washout First Intervention|Protocol Violation|0|||
126133122|NCT01928381|453777519|FG002|Washout First Intervention|Protocol Violation|0|||
126133123|NCT01928381|453777520|FG003|Washout First Intervention|Protocol Violation|0|||
126133124|NCT01928381|453777521|FG004|Washout First Intervention|Protocol Violation|1|||
126133125|NCT01928381|453777522|FG005|Washout First Intervention|Protocol Violation|0|||
126133126|NCT01928381|453777523|FG006|Washout First Intervention|Protocol Violation|0|||
126133127|NCT01928381|453777517|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
126133128|NCT01928381|453777518|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
126133129|NCT01928381|453777519|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
126133130|NCT01928381|453777520|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
126133131|NCT01928381|453777521|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
126133132|NCT01928381|453777522|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
126133133|NCT01928381|453777523|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
126133134|NCT01928381|453777517|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
126133135|NCT01928381|453777518|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
126133136|NCT01928381|453777519|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
126133137|NCT01928381|453777520|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
126133138|NCT01928381|453777521|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
126133139|NCT01928381|453777522|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
126133140|NCT01928381|453777523|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
126133141|NCT03087955|453779670|FG000|Overall Study|Death|4|||
126133142|NCT03087955|453779671|FG001|Overall Study|Death|0|||
126133143|NCT03087955|453779670|FG000|Overall Study|Lack of Efficacy|2|||
126133144|NCT03087955|453779671|FG001|Overall Study|Lack of Efficacy|0|||
126133145|NCT03087955|453779670|FG000|Overall Study|Lost to Follow-up|1|||
126133146|NCT03087955|453779671|FG001|Overall Study|Lost to Follow-up|0|||
126133147|NCT02392429|453779672|FG000|Screening|Screen failure|15|||
126133148|NCT02392429|453779672|FG000|Enrolled Participants|Ineligible due to disease|3|||
126133149|NCT02392429|453779672|FG000|Enrolled Participants|Withdrawal by Subject|4|||
126133150|NCT02392429|453779672|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
126133151|NCT02392429|453779672|FG000|Evaluable|Death|5|||
126133152|NCT02392429|453779672|FG000|Evaluable|Withdrawal by Subject|1|||
126133153|NCT02392429|453779672|FG000|Evaluable|Adverse Event|1|||
126133154|NCT02392429|453779672|FG000|Evaluable|remission bone marrow biopsy|3|||
126133155|NCT03656562|453779673|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
126133156|NCT03656562|453779674|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
126133157|NCT03656562|453779675|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
126133158|NCT03656562|453779676|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
126133159|NCT03656562|453779673|FG000|Overall Study|Physician Decision|1|||
126133160|NCT03656562|453779674|FG001|Overall Study|Physician Decision|2|||
126133161|NCT03656562|453779675|FG002|Overall Study|Physician Decision|0|||
126133162|NCT03656562|453779676|FG003|Overall Study|Physician Decision|0|||
126133163|NCT03656562|453779673|FG000|Overall Study|Subject Decision|3|||
126133164|NCT03656562|453779674|FG001|Overall Study|Subject Decision|5|||
126133165|NCT03656562|453779675|FG002|Overall Study|Subject Decision|0|||
126133166|NCT03656562|453779676|FG003|Overall Study|Subject Decision|2|||
126133167|NCT00482014|453779677|FG000|Overall Study|Withdrawal by Subject|1|||
126133168|NCT00482014|453779678|FG001|Overall Study|Withdrawal by Subject|2|||
126133169|NCT00482014|453779679|FG002|Overall Study|Withdrawal by Subject|3|||
126133170|NCT00482014|453779680|FG003|Overall Study|Withdrawal by Subject|4|||
126133171|NCT00482014|453779677|FG000|Overall Study|Adverse Event|3|||
126133172|NCT00482014|453779678|FG001|Overall Study|Adverse Event|0|||
126133173|NCT00482014|453779679|FG002|Overall Study|Adverse Event|2|||
126133174|NCT00482014|453779680|FG003|Overall Study|Adverse Event|8|||
126133175|NCT00482014|453779677|FG000|Overall Study|Death|1|||
126133176|NCT00482014|453779678|FG001|Overall Study|Death|2|||
126133177|NCT00482014|453779679|FG002|Overall Study|Death|1|||
126133178|NCT00482014|453779680|FG003|Overall Study|Death|4|||
126133179|NCT00482014|453779677|FG000|Overall Study|Lack of Efficacy|1|||
125965649|NCT00927927|453163660|FG001|Overall Study|Withdrawal by Subject|0|||
126133180|NCT00482014|453779678|FG001|Overall Study|Lack of Efficacy|0|||
126133181|NCT00482014|453779679|FG002|Overall Study|Lack of Efficacy|4|||
126133182|NCT00482014|453779680|FG003|Overall Study|Lack of Efficacy|6|||
126133183|NCT00482014|453779677|FG000|Overall Study|Sponsor Decision|1|||
125965650|NCT00927927|453163661|FG002|Overall Study|Withdrawal by Subject|0|||
126133184|NCT00482014|453779678|FG001|Overall Study|Sponsor Decision|2|||
125965651|NCT00927927|453163662|FG003|Overall Study|Withdrawal by Subject|0|||
125965652|NCT00927927|453163663|FG004|Overall Study|Withdrawal by Subject|0|||
125965653|NCT00927927|453163664|FG005|Overall Study|Withdrawal by Subject|0|||
126133185|NCT00482014|453779679|FG002|Overall Study|Sponsor Decision|1|||
126133186|NCT00482014|453779680|FG003|Overall Study|Sponsor Decision|1|||
126133187|NCT01178138|453779681|FG000|Overall Study|Lost to Follow-up|8|||
126133188|NCT01178138|453779681|FG000|Overall Study|Withdrawal by Subject|7|||
126133189|NCT01178138|453779681|FG000|Overall Study|Physician Decision|8|||
126133190|NCT01241708|453779682|FG000|Overall Study|Withdrawal by Subject|6|||
126133191|NCT01241708|453779682|FG000|Overall Study|Screen Failure|6|||
126133192|NCT01241708|453779682|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
126133193|NCT01241708|453779682|FG000|Overall Study|Lost to Follow-up|5|||
126133194|NCT04183335|453779683|FG000|Overall Study|Adverse Event|1|||
126133195|NCT04183335|453779684|FG001|Overall Study|Adverse Event|0|||
126133196|NCT04183335|453779683|FG000|Overall Study|Withdrawal by Subject|12|||
126133197|NCT04183335|453779684|FG001|Overall Study|Withdrawal by Subject|3|||
126133198|NCT02605642|453779685|FG000|Overall Study|Other|11|||
126133199|NCT02605642|453779686|FG001|Overall Study|Other|1|||
126133200|NCT02605642|453779685|FG000|Overall Study|Participant non-compliance|2|||
126133201|NCT02605642|453779686|FG001|Overall Study|Participant non-compliance|4|||
126133202|NCT02605642|453779685|FG000|Overall Study|Physician Decision|10|||
126133203|NCT02605642|453779686|FG001|Overall Study|Physician Decision|0|||
126133204|NCT02605642|453779685|FG000|Overall Study|Lost to Follow-up|12|||
126133205|NCT02605642|453779686|FG001|Overall Study|Lost to Follow-up|1|||
126133206|NCT02605642|453779685|FG000|Overall Study|Adverse Event|14|||
126133207|NCT02605642|453779686|FG001|Overall Study|Adverse Event|2|||
126133208|NCT02605642|453779685|FG000|Overall Study|Withdrawal by Subject|23|||
126133209|NCT02605642|453779686|FG001|Overall Study|Withdrawal by Subject|2|||
126133210|NCT02605642|453779685|FG000|Overall Study|Lack of response|24|||
126133211|NCT02605642|453779686|FG001|Overall Study|Lack of response|11|||
126133212|NCT03946670|453779693|FG000|Overall Study|Progressive Disease|26|||
126133213|NCT03946670|453779694|FG001|Overall Study|Progressive Disease|23|||
126133214|NCT03946670|453779693|FG000|Overall Study|Adverse Event|7|||
126133215|NCT03946670|453779694|FG001|Overall Study|Adverse Event|9|||
126133216|NCT03946670|453779693|FG000|Overall Study|Death|5|||
126133217|NCT03946670|453779694|FG001|Overall Study|Death|6|||
126133218|NCT03946670|453779693|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
126133219|NCT03946670|453779694|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
126133220|NCT03946670|453779693|FG000|Overall Study|Subject Decision|4|||
126133221|NCT03946670|453779694|FG001|Overall Study|Subject Decision|4|||
126133222|NCT03946670|453779693|FG000|Overall Study|Physician Decision|3|||
126133223|NCT03946670|453779694|FG001|Overall Study|Physician Decision|3|||
126133224|NCT03946670|453779693|FG000|Overall Study|New Therapy for Study Indication|1|||
126133225|NCT03946670|453779694|FG001|Overall Study|New Therapy for Study Indication|0|||
126133226|NCT03946670|453779693|FG000|Overall Study|Not treated|1|||
126133227|NCT03946670|453779694|FG001|Overall Study|Not treated|1|||
126133228|NCT03132636|453779695|FG000|Overall Study|Adverse Event|1|||
126133229|NCT03132636|453779696|FG001|Overall Study|Adverse Event|2|||
126133230|NCT03132636|453779695|FG000|Overall Study|Death|4|||
126133231|NCT03132636|453779696|FG001|Overall Study|Death|7|||
126133232|NCT03132636|453779695|FG000|Overall Study|Lost to Follow-up|3|||
126133233|NCT03132636|453779696|FG001|Overall Study|Lost to Follow-up|2|||
126133234|NCT03132636|453779695|FG000|Overall Study|Non compliance with protocol by participant|1|||
126133235|NCT03132636|453779696|FG001|Overall Study|Non compliance with protocol by participant|1|||
126133236|NCT03132636|453779695|FG000|Overall Study|Subject decision|1|||
125965654|NCT00927927|453163665|FG006|Overall Study|Withdrawal by Subject|0|||
125965655|NCT00927927|453163666|FG007|Overall Study|Withdrawal by Subject|2|||
125965656|NCT00927927|453163667|FG008|Overall Study|Withdrawal by Subject|0|||
126133237|NCT03132636|453779696|FG001|Overall Study|Subject decision|9|||
126133238|NCT03132636|453779695|FG000|Overall Study|Sponsor decision|0|||
125965657|NCT00927927|453163668|FG009|Overall Study|Withdrawal by Subject|0|||
125965658|NCT00927927|453163669|FG010|Overall Study|Withdrawal by Subject|0|||
125965659|NCT00927927|453163670|FG011|Overall Study|Withdrawal by Subject|2|||
125965660|NCT00927927|453163671|FG012|Overall Study|Withdrawal by Subject|0|||
125965661|NCT00927927|453163672|FG013|Overall Study|Withdrawal by Subject|0|||
125965662|NCT00927927|453163673|FG014|Overall Study|Withdrawal by Subject|0|||
126133239|NCT03132636|453779696|FG001|Overall Study|Sponsor decision|1|||
126133240|NCT03132636|453779695|FG000|Overall Study|Physician Decision|1|||
126133241|NCT03132636|453779696|FG001|Overall Study|Physician Decision|0|||
126133242|NCT03132636|453779695|FG000|Overall Study|Progressive disease|33|||
125965663|NCT01110239|453163680|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
125965664|NCT01110239|453163681|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
126133243|NCT03132636|453779696|FG001|Overall Study|Progressive disease|36|||
126133244|NCT03132636|453779695|FG000|Overall Study|Withdrawal of consent|2|||
126133245|NCT03132636|453779696|FG001|Overall Study|Withdrawal of consent|5|||
126133246|NCT03132636|453779695|FG000|Overall Study|Did not re-consent|1|||
125965665|NCT01110239|453163682|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
126133247|NCT03132636|453779696|FG001|Overall Study|Did not re-consent|0|||
126133248|NCT03132636|453779695|FG000|Overall Study|Lost insurance coverage|1|||
126133249|NCT03132636|453779696|FG001|Overall Study|Lost insurance coverage|0|||
126133250|NCT03132636|453779695|FG000|Overall Study|Related to radiological outcomes|0|||
126133251|NCT03132636|453779696|FG001|Overall Study|Related to radiological outcomes|1|||
126133252|NCT03132636|453779695|FG000|Overall Study|Unable to come to site for continued visits|0|||
126133253|NCT03132636|453779696|FG001|Overall Study|Unable to come to site for continued visits|1|||
126133254|NCT04537208|453779701|FG000|Overall Study|Adverse Event|0|||
126133255|NCT04537208|453779702|FG001|Overall Study|Adverse Event|0|||
126133256|NCT04537208|453779703|FG002|Overall Study|Adverse Event|0|||
126133257|NCT04537208|453779704|FG003|Overall Study|Adverse Event|0|||
126133258|NCT04537208|453779705|FG004|Overall Study|Adverse Event|0|||
126133259|NCT04537208|453779706|FG005|Overall Study|Adverse Event|0|||
126133260|NCT04537208|453779707|FG006|Overall Study|Adverse Event|0|||
126133261|NCT04537208|453779708|FG007|Overall Study|Adverse Event|0|||
126133262|NCT04537208|453779709|FG008|Overall Study|Adverse Event|1|||
126133263|NCT04537208|453779710|FG009|Overall Study|Adverse Event|0|||
126133264|NCT04537208|453779711|FG010|Overall Study|Adverse Event|0|||
126133265|NCT04537208|453779701|FG000|Overall Study|Protocol deviation|0|||
126133266|NCT04537208|453779702|FG001|Overall Study|Protocol deviation|0|||
126133267|NCT04537208|453779703|FG002|Overall Study|Protocol deviation|2|||
126133268|NCT04537208|453779704|FG003|Overall Study|Protocol deviation|0|||
126133269|NCT04537208|453779705|FG004|Overall Study|Protocol deviation|0|||
126133270|NCT04537208|453779706|FG005|Overall Study|Protocol deviation|2|||
126133271|NCT04537208|453779707|FG006|Overall Study|Protocol deviation|4|||
126133272|NCT04537208|453779708|FG007|Overall Study|Protocol deviation|0|||
126133273|NCT04537208|453779709|FG008|Overall Study|Protocol deviation|1|||
126133274|NCT04537208|453779710|FG009|Overall Study|Protocol deviation|0|||
126133275|NCT04537208|453779711|FG010|Overall Study|Protocol deviation|2|||
126133276|NCT04537208|453779701|FG000|Overall Study|Withdrawal by Subject|4|||
126133277|NCT04537208|453779702|FG001|Overall Study|Withdrawal by Subject|2|||
126133278|NCT04537208|453779703|FG002|Overall Study|Withdrawal by Subject|1|||
126133279|NCT04537208|453779704|FG003|Overall Study|Withdrawal by Subject|3|||
126133280|NCT04537208|453779705|FG004|Overall Study|Withdrawal by Subject|5|||
126133281|NCT04537208|453779706|FG005|Overall Study|Withdrawal by Subject|1|||
126133282|NCT04537208|453779707|FG006|Overall Study|Withdrawal by Subject|6|||
126133283|NCT04537208|453779708|FG007|Overall Study|Withdrawal by Subject|1|||
125965666|NCT01110239|453163683|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
126133284|NCT04537208|453779709|FG008|Overall Study|Withdrawal by Subject|7|||
126133285|NCT04537208|453779710|FG009|Overall Study|Withdrawal by Subject|2|||
126133286|NCT04537208|453779711|FG010|Overall Study|Withdrawal by Subject|4|||
126133287|NCT04537208|453779701|FG000|Overall Study|Lost to Follow-up|4|||
126133288|NCT04537208|453779702|FG001|Overall Study|Lost to Follow-up|1|||
126133289|NCT04537208|453779703|FG002|Overall Study|Lost to Follow-up|3|||
126133290|NCT04537208|453779704|FG003|Overall Study|Lost to Follow-up|4|||
126133291|NCT04537208|453779705|FG004|Overall Study|Lost to Follow-up|3|||
126133292|NCT04537208|453779706|FG005|Overall Study|Lost to Follow-up|2|||
126133293|NCT04537208|453779707|FG006|Overall Study|Lost to Follow-up|3|||
126133294|NCT04537208|453779708|FG007|Overall Study|Lost to Follow-up|2|||
126133295|NCT04537208|453779709|FG008|Overall Study|Lost to Follow-up|7|||
126133296|NCT04537208|453779710|FG009|Overall Study|Lost to Follow-up|2|||
126133297|NCT04537208|453779711|FG010|Overall Study|Lost to Follow-up|2|||
126133298|NCT03042468|453779713|FG000|Overall Study|Death|0|||
126133299|NCT03042468|453779714|FG001|Overall Study|Death|1|||
126133300|NCT03042468|453779715|FG002|Overall Study|Death|1|||
125965667|NCT01110239|453163680|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
125965668|NCT01110239|453163681|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
125965669|NCT01110239|453163682|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
125965670|NCT01110239|453163683|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
125965671|NCT00080223|453163688|FG000|Overall Study|Adverse Event|23|||
125965672|NCT00080223|453163688|FG000|Overall Study|Death|21|||
125965673|NCT00080223|453163688|FG000|Overall Study|Withdrawal by Subject|13|||
125965674|NCT00080223|453163688|FG000|Overall Study|Lung Transplantation|9|||
125965675|NCT00080223|453163688|FG000|Overall Study|Non-compliance With Study Treatment|7|||
126133301|NCT03042468|453779716|FG003|Overall Study|Death|0|||
126133302|NCT03042468|453779717|FG004|Overall Study|Death|0|||
126133303|NCT03042468|453779718|FG005|Overall Study|Death|0|||
126133304|NCT03042468|453779713|FG000|Overall Study|Withdrawal by Subject|0|||
126133305|NCT03042468|453779714|FG001|Overall Study|Withdrawal by Subject|0|||
126133306|NCT03042468|453779715|FG002|Overall Study|Withdrawal by Subject|0|||
126133307|NCT03042468|453779716|FG003|Overall Study|Withdrawal by Subject|0|||
126133308|NCT03042468|453779717|FG004|Overall Study|Withdrawal by Subject|0|||
126133309|NCT03042468|453779718|FG005|Overall Study|Withdrawal by Subject|1|||
126133310|NCT03042468|453779713|FG000|Overall Study|Lost to Follow-up|0|||
125965676|NCT00080223|453163688|FG000|Overall Study|Participant unwilling to continue|2|||
126133311|NCT03042468|453779714|FG001|Overall Study|Lost to Follow-up|0|||
126133312|NCT03042468|453779715|FG002|Overall Study|Lost to Follow-up|0|||
126133313|NCT03042468|453779716|FG003|Overall Study|Lost to Follow-up|0|||
126133314|NCT03042468|453779717|FG004|Overall Study|Lost to Follow-up|1|||
126133315|NCT03042468|453779718|FG005|Overall Study|Lost to Follow-up|1|||
126133316|NCT03083886|453779719|FG000|Overall Study|Withdrawal by Subject|51|||
126133317|NCT03083886|453779720|FG001|Overall Study|Withdrawal by Subject|73|||
126133318|NCT03083886|453779721|FG002|Overall Study|Withdrawal by Subject|104|||
126133319|NCT03083886|453779719|FG000|Overall Study|Missing Baseline data|43|||
126133320|NCT03083886|453779720|FG001|Overall Study|Missing Baseline data|42|||
126133321|NCT03083886|453779721|FG002|Overall Study|Missing Baseline data|31|||
126133322|NCT03083886|453779719|FG000|Overall Study|Investigator terminated|1|||
126133323|NCT03083886|453779720|FG001|Overall Study|Investigator terminated|6|||
126133324|NCT03083886|453779721|FG002|Overall Study|Investigator terminated|3|||
126133325|NCT04161495|453779722|FG000|Overall Study|Withdrawal by Subject|3|||
126133326|NCT04161495|453779723|FG001|Overall Study|Withdrawal by Subject|0|||
126133327|NCT04161495|453779722|FG000|Overall Study|Protocol Violation|1|||
126133328|NCT04161495|453779723|FG001|Overall Study|Protocol Violation|0|||
126133329|NCT04161495|453779722|FG000|Overall Study|Prohibited concomitant medication|3|||
126133330|NCT04161495|453779723|FG001|Overall Study|Prohibited concomitant medication|0|||
126133331|NCT04161495|453779722|FG000|Overall Study|Adverse Event|1|||
126133332|NCT04161495|453779723|FG001|Overall Study|Adverse Event|0|||
126133333|NCT04161495|453779722|FG000|Overall Study|Other - Unspecified|1|||
126133334|NCT04161495|453779723|FG001|Overall Study|Other - Unspecified|0|||
126133335|NCT04161495|453779722|FG000|Overall Study|Death|0|||
126133336|NCT04161495|453779723|FG001|Overall Study|Death|1|||
126133337|NCT01587079|453779724|FG000|Overall Study|Protocol-specified criteria|9|||
126133338|NCT01587079|453779724|FG000|Overall Study|Protocol Violation|5|||
126133339|NCT01587079|453779724|FG000|Overall Study|Lost to Follow-up|2|||
126133340|NCT01587079|453779724|FG000|Overall Study|Physician Decision|2|||
126133341|NCT01587079|453779724|FG000|Overall Study|Withdrawal by Subject|7|||
126133342|NCT01587079|453779724|FG000|Overall Study|Adverse Event|14|||
126133343|NCT01239160|453779726|FG000|Overall Study|Lost to Follow-up|3|||
126133344|NCT01239160|453779727|FG001|Overall Study|Lost to Follow-up|5|||
126133345|NCT01239160|453779728|FG002|Overall Study|Lost to Follow-up|0|||
126133346|NCT01239160|453779726|FG000|Overall Study|Withdrawal by Subject|17|||
126133347|NCT01239160|453779727|FG001|Overall Study|Withdrawal by Subject|6|||
126133348|NCT01239160|453779728|FG002|Overall Study|Withdrawal by Subject|2|||
126133349|NCT01239160|453779726|FG000|Overall Study|Physician Decision|5|||
126133350|NCT01239160|453779727|FG001|Overall Study|Physician Decision|7|||
126133351|NCT01239160|453779728|FG002|Overall Study|Physician Decision|2|||
126133352|NCT01239160|453779726|FG000|Overall Study|Early Termination Due to Study Closure|0|||
126133353|NCT01239160|453779727|FG001|Overall Study|Early Termination Due to Study Closure|1|||
126133354|NCT01239160|453779728|FG002|Overall Study|Early Termination Due to Study Closure|6|||
126133355|NCT00704964|453779730|FG000|Overall Study|Not completed on time|328|||
126133356|NCT04418765|453779731|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
126133357|NCT04418765|453779732|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
126133358|NCT04418765|453779733|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
126133359|NCT04418765|453779731|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
125965677|NCT00080223|453163688|FG000|Overall Study|Physician Decision|1|||
125965678|NCT05204134|453163689|FG000|Overall Study|Withdrawal by Subject|3|||
125965679|NCT05204134|453163689|FG000|Overall Study|Physician Decision|1|||
125965680|NCT03135522|453163690|FG000|Overall Study|Adverse Event|1|||
125965681|NCT03135522|453163691|FG001|Overall Study|Adverse Event|0|||
125965682|NCT03794089|453165735|FG000|Overall Study|Lost to Follow-up|4|||
125965683|NCT03794089|453165736|FG001|Overall Study|Lost to Follow-up|1|||
125965684|NCT03794089|453165735|FG000|Overall Study|Withdrawal by Subject|2|||
126133360|NCT04418765|453779732|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
126133361|NCT04418765|453779733|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
126133362|NCT04418765|453779731|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
126133363|NCT04418765|453779732|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
126133364|NCT04418765|453779733|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
126133365|NCT04418765|453779731|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
126133366|NCT04418765|453779732|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
126133367|NCT04418765|453779733|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
126133368|NCT04418765|453779731|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
126133369|NCT04418765|453779732|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
126133370|NCT04418765|453779733|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
126133371|NCT04418765|453779731|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
125965685|NCT03794089|453165736|FG001|Overall Study|Withdrawal by Subject|0|||
125965686|NCT03985423|453165737|FG000|Overall Study|Adverse Event|1|||
125965687|NCT03985423|453165737|FG000|Overall Study|Death|2|||
126133372|NCT04418765|453779732|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
126133373|NCT04418765|453779733|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
126133374|NCT04418765|453779731|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
126133375|NCT04418765|453779732|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
126133376|NCT04418765|453779733|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
126133377|NCT04418765|453779731|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
126133378|NCT04418765|453779732|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
126133379|NCT04418765|453779733|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
126133380|NCT04418765|453779731|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
126133381|NCT04418765|453779732|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
126133382|NCT04418765|453779733|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
126133383|NCT04418765|453779731|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
126133384|NCT04418765|453779732|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
126133385|NCT04418765|453779733|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
126133386|NCT04418765|453779731|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
126133387|NCT04418765|453779732|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
126133388|NCT04418765|453779733|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
126133389|NCT04418765|453779731|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
126133390|NCT04418765|453779732|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
126133391|NCT04418765|453779733|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
126133392|NCT04418765|453779731|FG000|Extension Period (48 Weeks)|Other than specified|0|||
126133393|NCT04418765|453779732|FG001|Extension Period (48 Weeks)|Other than specified|5|||
126133394|NCT04418765|453779733|FG002|Extension Period (48 Weeks)|Other than specified|2|||
126133395|NCT01789970|453779734|FG000|Open-label Titration Period|Adverse Event|68|||
126133396|NCT01789970|453779735|FG001|Open-label Titration Period|Adverse Event|0|||
126133397|NCT01789970|453779736|FG002|Open-label Titration Period|Adverse Event|0|||
126133398|NCT01789970|453779734|FG000|Open-label Titration Period|Lack of Efficacy|31|||
126133399|NCT01789970|453779735|FG001|Open-label Titration Period|Lack of Efficacy|0|||
126133400|NCT01789970|453779736|FG002|Open-label Titration Period|Lack of Efficacy|0|||
126133401|NCT01789970|453779734|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
126133402|NCT01789970|453779735|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
126133403|NCT01789970|453779736|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
126133404|NCT01789970|453779734|FG000|Open-label Titration Period|Protocol Violation|18|||
126133405|NCT01789970|453779735|FG001|Open-label Titration Period|Protocol Violation|0|||
126133406|NCT01789970|453779736|FG002|Open-label Titration Period|Protocol Violation|0|||
126133407|NCT01789970|453779734|FG000|Open-label Titration Period|Lost to Follow-up|5|||
126133408|NCT01789970|453779735|FG001|Open-label Titration Period|Lost to Follow-up|0|||
126133409|NCT01789970|453779736|FG002|Open-label Titration Period|Lost to Follow-up|0|||
126133410|NCT01789970|453779734|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
126133411|NCT01789970|453779735|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
126133412|NCT01789970|453779736|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
126133413|NCT01789970|453779734|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
126133414|NCT01789970|453779735|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
126133415|NCT01789970|453779736|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
125965688|NCT03985423|453165737|FG000|Overall Study|Physician Decision|1|||
125965689|NCT03985423|453165737|FG000|Overall Study|Withdrawal by Subject|2|||
125965690|NCT03985423|453165737|FG000|Overall Study|Lack of insurance and citizenship|1|||
125965691|NCT01045447|453165748|FG000|Overall Study|Adverse Event|0|||
126133416|NCT01789970|453779734|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
126133417|NCT01789970|453779735|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
126133418|NCT01789970|453779736|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
125965692|NCT01045447|453165749|FG001|Overall Study|Adverse Event|1|||
125965693|NCT01045447|453165748|FG000|Overall Study|Lack of Efficacy|3|||
125965694|NCT01045447|453165749|FG001|Overall Study|Lack of Efficacy|1|||
125965695|NCT01045447|453165748|FG000|Overall Study|Protocol Violation|6|||
126133419|NCT01789970|453779734|FG000|Open-label Titration Period|Pregnancy|2|||
126133420|NCT01789970|453779735|FG001|Open-label Titration Period|Pregnancy|0|||
126133421|NCT01789970|453779736|FG002|Open-label Titration Period|Pregnancy|0|||
126133422|NCT01789970|453779734|FG000|Open-label Titration Period|Other|76|||
126133423|NCT01789970|453779735|FG001|Open-label Titration Period|Other|0|||
126133424|NCT01789970|453779736|FG002|Open-label Titration Period|Other|0|||
126133425|NCT01789970|453779734|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
126133426|NCT01789970|453779735|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
126133427|NCT01789970|453779736|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
126133428|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
126133429|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
125965696|NCT01045447|453165749|FG001|Overall Study|Protocol Violation|3|||
125965697|NCT01045447|453165748|FG000|Overall Study|Withdrawal Criteria|10|||
125965698|NCT01045447|453165749|FG001|Overall Study|Withdrawal Criteria|10|||
126133430|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
126133431|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126133432|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
126133433|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
126133434|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126133435|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
126133436|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
126133437|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125965699|NCT01045447|453165748|FG000|Overall Study|Unclassified|17|||
125965700|NCT01045447|453165749|FG001|Overall Study|Unclassified|13|||
125965701|NCT00489970|453165751|FG000|Persistence Year 9|Lost to Follow-up|2|||
125965702|NCT00489970|453165752|FG001|Persistence Year 9|Lost to Follow-up|2|||
125965703|NCT00489970|453165753|FG002|Persistence Year 9|Lost to Follow-up|3|||
125965704|NCT00489970|453165751|FG000|Persistence Year 9|Other|1|||
125965705|NCT00489970|453165752|FG001|Persistence Year 9|Other|0|||
125965706|NCT00489970|453165753|FG002|Persistence Year 9|Other|2|||
125965707|NCT02707055|453165760|FG000|Phase 1|Withdrawal by Subject|1|||
125965708|NCT02707055|453165761|FG001|Phase 1|Withdrawal by Subject|2|||
125965709|NCT02707055|453165760|FG000|Phase 1|Physician Decision|0|||
126133438|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
126133439|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
126133440|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
126133441|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
126133442|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
126133443|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
126133444|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
126133445|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
126133446|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
126133447|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
126133448|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
126133449|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
126133450|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
126133451|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
126133452|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
126133453|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
126133454|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
126133455|NCT01789970|453779734|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
126133456|NCT01789970|453779735|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
126133457|NCT01789970|453779736|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
126133458|NCT02450578|453779744|FG000|Overall Study|ECG abnormality so not treated|1|||
126133459|NCT02450578|453779745|FG001|Overall Study|ECG abnormality so not treated|0|||
126133460|NCT02450578|453779746|FG002|Overall Study|ECG abnormality so not treated|0|||
126133461|NCT02450578|453779747|FG003|Overall Study|ECG abnormality so not treated|0|||
126133462|NCT04016311|453779748|FG000|Overall Study|Withdrawal by Subject|1|||
126133463|NCT04016311|453779749|FG001|Overall Study|Withdrawal by Subject|0|||
126133464|NCT01999582|453779755|FG000|Overall Study|Withdrawal by Subject|0|||
126133465|NCT01999582|453779756|FG001|Overall Study|Withdrawal by Subject|0|||
126133466|NCT01999582|453779757|FG002|Overall Study|Withdrawal by Subject|0|||
126133467|NCT01999582|453779758|FG003|Overall Study|Withdrawal by Subject|1|||
126133468|NCT01999582|453779759|FG004|Overall Study|Withdrawal by Subject|0|||
126133469|NCT01999582|453779760|FG005|Overall Study|Withdrawal by Subject|0|||
126133470|NCT01999582|453779755|FG000|Overall Study|Adverse Event|0|||
126133471|NCT01999582|453779756|FG001|Overall Study|Adverse Event|0|||
126133472|NCT01999582|453779757|FG002|Overall Study|Adverse Event|3|||
126133473|NCT01999582|453779758|FG003|Overall Study|Adverse Event|0|||
126133474|NCT01999582|453779759|FG004|Overall Study|Adverse Event|1|||
126133475|NCT01999582|453779760|FG005|Overall Study|Adverse Event|0|||
126133476|NCT01999582|453779755|FG000|Overall Study|Other Reasons|1|||
126133477|NCT01999582|453779756|FG001|Overall Study|Other Reasons|0|||
125965710|NCT02707055|453165761|FG001|Phase 1|Physician Decision|1|||
125965711|NCT02707055|453165760|FG000|Phase 2|Adverse Event|1|||
126088448|NCT03538938|453617131|FG013|Overall Study|Incarcerated|0|||
126088449|NCT03538938|453617132|FG014|Overall Study|Incarcerated|0|||
126088450|NCT03538938|453617133|FG015|Overall Study|Incarcerated|0|||
126088451|NCT03995316|453617134|FG000|Overall Study|Lost to Follow-up|10|||
125965712|NCT02707055|453165761|FG001|Phase 2|Adverse Event|2|||
125965713|NCT03564496|453165762|FG000|Overall Study|Withdrawal by Subject|1|||
126088452|NCT03995316|453617135|FG001|Overall Study|Lost to Follow-up|3|||
126088453|NCT01361594|453617136|FG000|Overall Study|Withdrawal by Subject|1|||
126088454|NCT01361594|453617137|FG001|Overall Study|Withdrawal by Subject|2|||
126088455|NCT01754753|453617138|FG000|Overall Study|Study close|43|||
126088456|NCT01754753|453617139|FG001|Overall Study|Study close|44|||
126088457|NCT01754753|453617138|FG000|Overall Study|Lost to Follow-up|9|||
126088458|NCT01754753|453617139|FG001|Overall Study|Lost to Follow-up|5|||
126088459|NCT01399918|453617144|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
125965714|NCT03564496|453165763|FG001|Overall Study|Withdrawal by Subject|1|||
126133478|NCT01999582|453779757|FG002|Overall Study|Other Reasons|3|||
126133479|NCT01999582|453779758|FG003|Overall Study|Other Reasons|1|||
126133480|NCT01999582|453779759|FG004|Overall Study|Other Reasons|1|||
126133481|NCT01999582|453779760|FG005|Overall Study|Other Reasons|2|||
126133482|NCT01999582|453779755|FG000|Overall Study|Protocol Violation|1|||
126133483|NCT01999582|453779756|FG001|Overall Study|Protocol Violation|0|||
126133484|NCT01999582|453779757|FG002|Overall Study|Protocol Violation|0|||
126133485|NCT01999582|453779758|FG003|Overall Study|Protocol Violation|0|||
126133486|NCT01999582|453779759|FG004|Overall Study|Protocol Violation|0|||
126133487|NCT01999582|453779760|FG005|Overall Study|Protocol Violation|1|||
125965715|NCT03564496|453165764|FG002|Overall Study|Withdrawal by Subject|0|||
125965716|NCT03564496|453165762|FG000|Overall Study|Screen failure|0|||
125965717|NCT03564496|453165763|FG001|Overall Study|Screen failure|3|||
125965718|NCT03564496|453165764|FG002|Overall Study|Screen failure|0|||
125965719|NCT01159938|453165765|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
125965720|NCT01159938|453165766|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
126133488|NCT01999582|453779755|FG000|Overall Study|Lack of Efficacy|1|||
126133489|NCT01999582|453779756|FG001|Overall Study|Lack of Efficacy|3|||
126133490|NCT01999582|453779757|FG002|Overall Study|Lack of Efficacy|0|||
126133491|NCT01999582|453779758|FG003|Overall Study|Lack of Efficacy|1|||
126133492|NCT01999582|453779759|FG004|Overall Study|Lack of Efficacy|0|||
126133493|NCT01999582|453779760|FG005|Overall Study|Lack of Efficacy|0|||
126133494|NCT02436876|453779767|FG000|Overall Study|Lost to Follow-up|0|||
126133495|NCT02436876|453779768|FG001|Overall Study|Lost to Follow-up|1|||
126133496|NCT02436876|453779769|FG002|Overall Study|Lost to Follow-up|1|||
126133497|NCT02436876|453779770|FG003|Overall Study|Lost to Follow-up|1|||
126133498|NCT02436876|453779767|FG000|Overall Study|Withdrawal by Subject|1|||
126133499|NCT02436876|453779768|FG001|Overall Study|Withdrawal by Subject|0|||
125965721|NCT01159938|453165767|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
125965722|NCT01159938|453165768|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
125965723|NCT01159938|453165769|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
125965724|NCT02318329|453165773|FG000|Overall Study|Progressive Disease|2|||
125965725|NCT02318329|453165774|FG001|Overall Study|Progressive Disease|3|||
125965726|NCT02318329|453165775|FG002|Overall Study|Progressive Disease|2|||
126133500|NCT02436876|453779769|FG002|Overall Study|Withdrawal by Subject|0|||
126133501|NCT02436876|453779770|FG003|Overall Study|Withdrawal by Subject|1|||
126133502|NCT02436876|453779767|FG000|Overall Study|Physician Decision|0|||
126133503|NCT02436876|453779768|FG001|Overall Study|Physician Decision|2|||
125965727|NCT02318329|453165776|FG003|Overall Study|Progressive Disease|3|||
125965728|NCT02318329|453165777|FG004|Overall Study|Progressive Disease|3|||
125965729|NCT02318329|453165778|FG005|Overall Study|Progressive Disease|3|||
125965730|NCT02318329|453165779|FG006|Overall Study|Progressive Disease|1|||
125965731|NCT02318329|453165780|FG007|Overall Study|Progressive Disease|1|||
126133504|NCT02436876|453779769|FG002|Overall Study|Physician Decision|1|||
126133505|NCT02436876|453779770|FG003|Overall Study|Physician Decision|0|||
126133506|NCT02436876|453779767|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
126133507|NCT02436876|453779768|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
126133508|NCT02436876|453779769|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
126133509|NCT02436876|453779770|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
126133510|NCT02809833|453779771|FG000|Overall Study|Death|3|||
126133511|NCT02809833|453779771|FG000|Overall Study|Intolerance|54|||
126133512|NCT02809833|453779771|FG000|Overall Study|Lack of Efficacy|89|||
126133513|NCT02809833|453779771|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
126133514|NCT02809833|453779771|FG000|Overall Study|Noncompliance|1|||
126133515|NCT02809833|453779771|FG000|Overall Study|Withdrawal by Subject|34|||
126133516|NCT02809833|453779771|FG000|Overall Study|Lost to Follow-up|35|||
126133517|NCT02809833|453779771|FG000|Overall Study|Adverse Event (AE)|24|||
126133518|NCT02809833|453779771|FG000|Overall Study|Other|5|||
126133519|NCT02809833|453779771|FG000|Overall Study|Missing Information|52|||
126133520|NCT05779072|453779775|FG000|Overall Study|Lost to Follow-up|0|||
126133521|NCT05779072|453779776|FG001|Overall Study|Lost to Follow-up|1|||
126133522|NCT05779072|453779775|FG000|Overall Study|Withdrawal by Subject|1|||
126133523|NCT05779072|453779776|FG001|Overall Study|Withdrawal by Subject|5|||
126133524|NCT02387580|453779778|FG000|Overall Study|Withdrawal by Subject|0|||
126133525|NCT02387580|453779779|FG001|Overall Study|Withdrawal by Subject|0|||
126133526|NCT02387580|453779780|FG002|Overall Study|Withdrawal by Subject|0|||
126133527|NCT02387580|453779781|FG003|Overall Study|Withdrawal by Subject|1|||
126133528|NCT02387580|453779782|FG004|Overall Study|Withdrawal by Subject|0|||
126133529|NCT02387580|453779783|FG005|Overall Study|Withdrawal by Subject|0|||
126133530|NCT00725075|453779784|FG000|Overall Study|Use of Excluded Medication|0|||
126133531|NCT00725075|453779785|FG001|Overall Study|Use of Excluded Medication|1|||
125965732|NCT02318329|453165781|FG008|Overall Study|Progressive Disease|5|||
125965733|NCT02318329|453165782|FG009|Overall Study|Progressive Disease|39|||
125965734|NCT02318329|453165773|FG000|Overall Study|Death|0|||
125965735|NCT02318329|453165774|FG001|Overall Study|Death|0|||
125965736|NCT02318329|453165775|FG002|Overall Study|Death|0|||
125965737|NCT02318329|453165776|FG003|Overall Study|Death|0|||
126133532|NCT00725075|453779786|FG002|Overall Study|Use of Excluded Medication|0|||
126133533|NCT00725075|453779784|FG000|Overall Study|Protocol Violation|0|||
126133534|NCT00725075|453779785|FG001|Overall Study|Protocol Violation|0|||
126133535|NCT00725075|453779786|FG002|Overall Study|Protocol Violation|1|||
126133536|NCT00725075|453779784|FG000|Overall Study|Lost to Follow-up|1|||
126133537|NCT00725075|453779785|FG001|Overall Study|Lost to Follow-up|0|||
126133538|NCT00725075|453779786|FG002|Overall Study|Lost to Follow-up|0|||
126133539|NCT00725075|453779784|FG000|Overall Study|Withdrawal by Subject|4|||
126133540|NCT00725075|453779785|FG001|Overall Study|Withdrawal by Subject|5|||
126133541|NCT00725075|453779786|FG002|Overall Study|Withdrawal by Subject|4|||
126133542|NCT00725075|453779784|FG000|Overall Study|Adverse Event|2|||
126133543|NCT00725075|453779785|FG001|Overall Study|Adverse Event|1|||
126133544|NCT00725075|453779786|FG002|Overall Study|Adverse Event|1|||
126133545|NCT00725075|453779784|FG000|Overall Study|Worsening of Disease|2|||
126133546|NCT00725075|453779785|FG001|Overall Study|Worsening of Disease|1|||
126133547|NCT00725075|453779786|FG002|Overall Study|Worsening of Disease|2|||
126133548|NCT00725075|453779784|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
126133549|NCT00725075|453779785|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
126133550|NCT00725075|453779786|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
126133551|NCT00725075|453779784|FG000|Overall Study|Other|1|||
126133552|NCT00725075|453779785|FG001|Overall Study|Other|0|||
126133553|NCT00725075|453779786|FG002|Overall Study|Other|0|||
126133554|NCT03984305|453779788|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
126133555|NCT03984305|453779789|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
126133556|NCT03984305|453779788|FG000|Overall Study|Withdrawal by Subject|3|||
125965738|NCT02318329|453165777|FG004|Overall Study|Death|0|||
125965739|NCT02318329|453165778|FG005|Overall Study|Death|0|||
125965740|NCT02318329|453165779|FG006|Overall Study|Death|0|||
125965741|NCT02318329|453165780|FG007|Overall Study|Death|0|||
125965742|NCT02318329|453165781|FG008|Overall Study|Death|0|||
125965743|NCT02318329|453165782|FG009|Overall Study|Death|5|||
125965744|NCT02318329|453165773|FG000|Overall Study|Lost to Follow-up|0|||
125965745|NCT02318329|453165774|FG001|Overall Study|Lost to Follow-up|0|||
125965746|NCT02318329|453165775|FG002|Overall Study|Lost to Follow-up|0|||
125965747|NCT02318329|453165776|FG003|Overall Study|Lost to Follow-up|0|||
126088460|NCT03197766|453617145|FG000|Overall Study|Withdrawal by Subject|2|||
126088461|NCT03197766|453617146|FG001|Overall Study|Withdrawal by Subject|0|||
126088462|NCT05415748|453617153|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
126088463|NCT05415748|453617154|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
126088464|NCT05415748|453617155|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
126088465|NCT05415748|453617156|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
126088466|NCT05415748|453617153|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
126088467|NCT05415748|453617154|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
126088468|NCT05415748|453617155|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
126088469|NCT05415748|453617156|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
126088470|NCT04520659|453617157|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
126088471|NCT04520659|453617158|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
126088472|NCT04520659|453617159|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
126088473|NCT04520659|453617160|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
126088474|NCT03361865|453617161|FG000|Overall Study|Death|17|||
126088475|NCT03361865|453617162|FG001|Overall Study|Death|18|||
126088476|NCT03361865|453617161|FG000|Overall Study|Physician Decision|1|||
126088477|NCT03361865|453617162|FG001|Overall Study|Physician Decision|9|||
126088478|NCT03361865|453617161|FG000|Overall Study|Withdrawal by Subject|1|||
126088479|NCT03361865|453617162|FG001|Overall Study|Withdrawal by Subject|0|||
126088480|NCT03852719|453617163|FG000|Overall Study|Withdrawal of consent|8|||
126088481|NCT03852719|453617164|FG001|Overall Study|Withdrawal of consent|8|||
126088482|NCT03852719|453617165|FG002|Overall Study|Withdrawal of consent|9|||
126088483|NCT03852719|453617163|FG000|Overall Study|Physician Decision|5|||
126088484|NCT03852719|453617164|FG001|Overall Study|Physician Decision|4|||
126088485|NCT03852719|453617165|FG002|Overall Study|Physician Decision|1|||
126088486|NCT03852719|453617163|FG000|Overall Study|Pregnancy|2|||
126088487|NCT03852719|453617164|FG001|Overall Study|Pregnancy|1|||
126088488|NCT03852719|453617165|FG002|Overall Study|Pregnancy|0|||
126088489|NCT03852719|453617163|FG000|Overall Study|Death|1|||
126088490|NCT03852719|453617164|FG001|Overall Study|Death|0|||
126088491|NCT03852719|453617165|FG002|Overall Study|Death|0|||
126088492|NCT03852719|453617163|FG000|Overall Study|Reason not Specified|3|||
126088493|NCT03852719|453617164|FG001|Overall Study|Reason not Specified|3|||
126088494|NCT03852719|453617165|FG002|Overall Study|Reason not Specified|5|||
126088495|NCT03852719|453617163|FG000|Overall Study|Adverse Event|2|||
126088496|NCT03852719|453617164|FG001|Overall Study|Adverse Event|1|||
126088497|NCT03852719|453617165|FG002|Overall Study|Adverse Event|4|||
126088498|NCT03852719|453617163|FG000|Overall Study|Progressive disease|1|||
126088499|NCT03852719|453617164|FG001|Overall Study|Progressive disease|4|||
126088500|NCT03852719|453617165|FG002|Overall Study|Progressive disease|1|||
126088501|NCT03852719|453617163|FG000|Overall Study|Lost to Follow-up|1|||
126133557|NCT03984305|453779789|FG001|Overall Study|Withdrawal by Subject|3|||
126133558|NCT03984305|453779788|FG000|Overall Study|Lost to Follow-up|1|||
126133559|NCT03984305|453779789|FG001|Overall Study|Lost to Follow-up|0|||
126133560|NCT02340663|453779790|FG000|Overall Study|Lost to Follow-up|1|||
126133561|NCT02340663|453779791|FG001|Overall Study|Lost to Follow-up|0|||
126133562|NCT02340663|453779790|FG000|Overall Study|Protocol Violation|1|||
126133563|NCT02340663|453779791|FG001|Overall Study|Protocol Violation|0|||
126133564|NCT02340663|453779790|FG000|Overall Study|Withdrawal by Subject|3|||
126133565|NCT02340663|453779791|FG001|Overall Study|Withdrawal by Subject|1|||
126133566|NCT02979431|453779792|FG000|Overall Study|Parent/guardian withdrew consent|2|||
126133567|NCT02979431|453779793|FG001|Overall Study|Parent/guardian withdrew consent|1|||
126133568|NCT02979431|453779794|FG002|Overall Study|Parent/guardian withdrew consent|1|||
126133569|NCT02979431|453779795|FG003|Overall Study|Parent/guardian withdrew consent|1|||
126133570|NCT02979431|453779792|FG000|Overall Study|Randomized but received no study drug|1|||
126133571|NCT02979431|453779793|FG001|Overall Study|Randomized but received no study drug|1|||
126133572|NCT02979431|453779794|FG002|Overall Study|Randomized but received no study drug|0|||
126133573|NCT02979431|453779795|FG003|Overall Study|Randomized but received no study drug|0|||
126133574|NCT02979431|453779792|FG000|Overall Study|Adverse Event|0|||
126133575|NCT02979431|453779793|FG001|Overall Study|Adverse Event|0|||
126133576|NCT02979431|453779794|FG002|Overall Study|Adverse Event|1|||
126133577|NCT02979431|453779795|FG003|Overall Study|Adverse Event|0|||
126133578|NCT02979431|453779792|FG000|Overall Study|Subject left country after Day14|1|||
126133579|NCT02979431|453779793|FG001|Overall Study|Subject left country after Day14|0|||
126133580|NCT02979431|453779794|FG002|Overall Study|Subject left country after Day14|0|||
126133581|NCT02979431|453779795|FG003|Overall Study|Subject left country after Day14|0|||
126133582|NCT01656434|453779796|FG000|Overall Study|Adverse Event|199|||
126133583|NCT01656434|453779797|FG001|Overall Study|Adverse Event|63|||
126133584|NCT01656434|453779796|FG000|Overall Study|Enrollment terminated at trial site|2|||
126133585|NCT01656434|453779797|FG001|Overall Study|Enrollment terminated at trial site|0|||
126133586|NCT01656434|453779796|FG000|Overall Study|Lost to Follow-up|309|||
126133587|NCT01656434|453779797|FG001|Overall Study|Lost to Follow-up|76|||
126133588|NCT01656434|453779796|FG000|Overall Study|Site discontinued study participation|24|||
126133589|NCT01656434|453779797|FG001|Overall Study|Site discontinued study participation|9|||
126133590|NCT01656434|453779796|FG000|Overall Study|Screen failure|2|||
126133591|NCT01656434|453779797|FG001|Overall Study|Screen failure|0|||
126133592|NCT01656434|453779796|FG000|Overall Study|Protocol Violation|7|||
126133593|NCT01656434|453779797|FG001|Overall Study|Protocol Violation|0|||
126133594|NCT01656434|453779796|FG000|Overall Study|Pregnancy wish|18|||
126133595|NCT01656434|453779797|FG001|Overall Study|Pregnancy wish|6|||
126133596|NCT01656434|453779796|FG000|Overall Study|Pregnancy|45|||
126133597|NCT01656434|453779797|FG001|Overall Study|Pregnancy|10|||
126133598|NCT01656434|453779796|FG000|Overall Study|Physician Decision|7|||
126133599|NCT01656434|453779797|FG001|Overall Study|Physician Decision|2|||
126133600|NCT01656434|453779796|FG000|Overall Study|Non-compliance with study drug|48|||
126133601|NCT01656434|453779797|FG001|Overall Study|Non-compliance with study drug|9|||
125965748|NCT02318329|453165777|FG004|Overall Study|Lost to Follow-up|0|||
125965749|NCT02318329|453165778|FG005|Overall Study|Lost to Follow-up|0|||
125965750|NCT02318329|453165779|FG006|Overall Study|Lost to Follow-up|0|||
125965751|NCT02318329|453165780|FG007|Overall Study|Lost to Follow-up|0|||
125965752|NCT02318329|453165781|FG008|Overall Study|Lost to Follow-up|0|||
125965753|NCT02318329|453165782|FG009|Overall Study|Lost to Follow-up|1|||
125965754|NCT02318329|453165773|FG000|Overall Study|Withdrawal by Subject|0|||
125965755|NCT02318329|453165774|FG001|Overall Study|Withdrawal by Subject|0|||
125965756|NCT02318329|453165775|FG002|Overall Study|Withdrawal by Subject|0|||
125965757|NCT02318329|453165776|FG003|Overall Study|Withdrawal by Subject|0|||
125965758|NCT02318329|453165777|FG004|Overall Study|Withdrawal by Subject|0|||
125965759|NCT02318329|453165778|FG005|Overall Study|Withdrawal by Subject|0|||
125965760|NCT02318329|453165779|FG006|Overall Study|Withdrawal by Subject|0|||
125965761|NCT02318329|453165780|FG007|Overall Study|Withdrawal by Subject|0|||
125965762|NCT02318329|453165781|FG008|Overall Study|Withdrawal by Subject|0|||
125965763|NCT02318329|453165782|FG009|Overall Study|Withdrawal by Subject|6|||
125965764|NCT02318329|453165773|FG000|Overall Study|Other|1|||
125965765|NCT02318329|453165774|FG001|Overall Study|Other|1|||
125965766|NCT02318329|453165775|FG002|Overall Study|Other|1|||
126133602|NCT01656434|453779796|FG000|Overall Study|Study terminated by sponsor|1501|||
126133603|NCT01656434|453779797|FG001|Overall Study|Study terminated by sponsor|348|||
126133604|NCT01656434|453779796|FG000|Overall Study|Participant discontinued; drug related|13|||
126133605|NCT01656434|453779797|FG001|Overall Study|Participant discontinued; drug related|4|||
126133606|NCT01656434|453779796|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
126133607|NCT01656434|453779797|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
126133608|NCT01656434|453779796|FG000|Overall Study|Non-compliance with protocol|39|||
126133609|NCT01656434|453779797|FG001|Overall Study|Non-compliance with protocol|15|||
125965767|NCT02318329|453165776|FG003|Overall Study|Other|0|||
125965768|NCT02318329|453165777|FG004|Overall Study|Other|0|||
125965769|NCT02318329|453165778|FG005|Overall Study|Other|0|||
125965770|NCT02318329|453165779|FG006|Overall Study|Other|0|||
126133610|NCT01656434|453779796|FG000|Overall Study|Participant moved|40|||
126133611|NCT01656434|453779797|FG001|Overall Study|Participant moved|12|||
126133612|NCT01656434|453779796|FG000|Overall Study|Participant withdrew consent|28|||
126133613|NCT01656434|453779797|FG001|Overall Study|Participant withdrew consent|9|||
126133614|NCT01656434|453779796|FG000|Overall Study|Withdrawal by Subject|64|||
126133615|NCT01656434|453779797|FG001|Overall Study|Withdrawal by Subject|7|||
126133616|NCT02004873|453779798|FG000|Overall Study|Implant unsuccessful|6|||
126133617|NCT02004873|453779798|FG000|Overall Study|Awaiting 6-month visit|390|||
126133618|NCT02004873|453779798|FG000|Overall Study|Missed 6-month visit|4|||
126133619|NCT02004873|453779798|FG000|Overall Study|Death|23|||
126133620|NCT02004873|453779798|FG000|Overall Study|Withdrawal by Subject|1|||
126133621|NCT01614093|453779802|FG000|Overall Study|Withdrawal by Subject|1|||
126133622|NCT00848354|453779803|FG000|Phase 1|Adverse Event|5|||
126133623|NCT00848354|453779804|FG001|Phase 1|Adverse Event|4|||
126133624|NCT00848354|453779803|FG000|Phase 1|Discontinuation of study by sponsor|2|||
126133625|NCT00848354|453779804|FG001|Phase 1|Discontinuation of study by sponsor|1|||
126133626|NCT00848354|453779803|FG000|Phase 1|Failed to return|0|||
126133627|NCT00848354|453779804|FG001|Phase 1|Failed to return|1|||
126133628|NCT00848354|453779803|FG000|Phase 1|Lost to Follow-up|1|||
126133629|NCT00848354|453779804|FG001|Phase 1|Lost to Follow-up|1|||
126133630|NCT00848354|453779803|FG000|Phase 1|Unspecified Reason|1|||
126133631|NCT00848354|453779804|FG001|Phase 1|Unspecified Reason|1|||
126133632|NCT00848354|453779803|FG000|Phase 1|Protocol Violation|1|||
126133633|NCT00848354|453779804|FG001|Phase 1|Protocol Violation|1|||
126133634|NCT00848354|453779803|FG000|Phase 1|Withdrawal by Subject|2|||
126133635|NCT00848354|453779804|FG001|Phase 1|Withdrawal by Subject|4|||
126133636|NCT00848354|453779803|FG000|Phase 1|Lack of Efficacy|0|||
126133637|NCT00848354|453779804|FG001|Phase 1|Lack of Efficacy|1|||
126133638|NCT00848354|453779803|FG000|Phase 2 Year 1|Adverse Event|7|||
126133639|NCT00848354|453779804|FG001|Phase 2 Year 1|Adverse Event|2|||
126133640|NCT00848354|453779803|FG000|Phase 2 Year 1|Death|1|||
126133641|NCT00848354|453779804|FG001|Phase 2 Year 1|Death|0|||
126133642|NCT00848354|453779803|FG000|Phase 2 Year 1|Failed to Return|1|||
126133643|NCT00848354|453779804|FG001|Phase 2 Year 1|Failed to Return|1|||
126133644|NCT00848354|453779803|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
126133645|NCT00848354|453779804|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
126133646|NCT00848354|453779803|FG000|Phase 2 Year 1|Unspecified Reason|3|||
126133647|NCT00848354|453779804|FG001|Phase 2 Year 1|Unspecified Reason|0|||
126133648|NCT00848354|453779803|FG000|Phase 2 Year 1|Protocol Violation|4|||
126133649|NCT00848354|453779804|FG001|Phase 2 Year 1|Protocol Violation|1|||
126133650|NCT00848354|453779803|FG000|Phase 2 Year 1|Subject Request|1|||
126133651|NCT00848354|453779804|FG001|Phase 2 Year 1|Subject Request|2|||
126133652|NCT00848354|453779803|FG000|Phase 2 Year 2|Adverse Event|12|||
126133653|NCT00848354|453779804|FG001|Phase 2 Year 2|Adverse Event|2|||
126133654|NCT00848354|453779803|FG000|Phase 2 Year 2|Death|2|||
126133655|NCT00848354|453779804|FG001|Phase 2 Year 2|Death|0|||
126133656|NCT00848354|453779803|FG000|Phase 2 Year 2|Failed to return|3|||
126133657|NCT00848354|453779804|FG001|Phase 2 Year 2|Failed to return|0|||
126133658|NCT00848354|453779803|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
126133659|NCT00848354|453779804|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
126133660|NCT00848354|453779803|FG000|Phase 2 Year 2|Unspecified Reason|1|||
126133661|NCT00848354|453779804|FG001|Phase 2 Year 2|Unspecified Reason|0|||
126133662|NCT00848354|453779803|FG000|Phase 2 Year 2|Protocol Violation|1|||
126133663|NCT00848354|453779804|FG001|Phase 2 Year 2|Protocol Violation|1|||
126133664|NCT00848354|453779803|FG000|Phase 2 Year 2|Subject Request|1|||
125965771|NCT02318329|453165780|FG007|Overall Study|Other|0|||
125965772|NCT02318329|453165781|FG008|Overall Study|Other|1|||
125965773|NCT02318329|453165782|FG009|Overall Study|Other|1|||
126133665|NCT00848354|453779804|FG001|Phase 2 Year 2|Subject Request|1|||
126133666|NCT00848354|453779803|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
126133667|NCT00848354|453779804|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
126133668|NCT01972074|453779807|FG000|Overall Study|Adverse Event|4|||
126133669|NCT01972074|453779808|FG001|Overall Study|Adverse Event|1|||
126133670|NCT01972074|453779809|FG002|Overall Study|Adverse Event|0|||
126133671|NCT01972074|453779807|FG000|Overall Study|Lack of Efficacy|1|||
126133672|NCT01972074|453779808|FG001|Overall Study|Lack of Efficacy|1|||
126133673|NCT01972074|453779809|FG002|Overall Study|Lack of Efficacy|0|||
126133674|NCT01972074|453779807|FG000|Overall Study|Lost to Follow-up|0|||
126133675|NCT01972074|453779808|FG001|Overall Study|Lost to Follow-up|1|||
126133676|NCT01972074|453779809|FG002|Overall Study|Lost to Follow-up|1|||
126133677|NCT01972074|453779807|FG000|Overall Study|Withdrawal by Subject|1|||
126133678|NCT01972074|453779808|FG001|Overall Study|Withdrawal by Subject|1|||
126133679|NCT01972074|453779809|FG002|Overall Study|Withdrawal by Subject|1|||
126133680|NCT01972074|453779807|FG000|Overall Study|Scanner Unavailable|0|||
126133681|NCT01972074|453779808|FG001|Overall Study|Scanner Unavailable|0|||
126133682|NCT01972074|453779809|FG002|Overall Study|Scanner Unavailable|1|||
126133683|NCT04202679|453779814|FG000|Overall Study|Adverse Event|2|||
126133684|NCT04202679|453779815|FG001|Overall Study|Adverse Event|0|||
126133685|NCT04202679|453779814|FG000|Overall Study|Poor compliance to protocol|1|||
126133686|NCT04202679|453779815|FG001|Overall Study|Poor compliance to protocol|0|||
126133687|NCT04202679|453779814|FG000|Overall Study|Withdrawal by Subject|23|||
126133688|NCT04202679|453779815|FG001|Overall Study|Withdrawal by Subject|6|||
126133689|NCT00980538|453779816|FG000|Overall Study|Lost to Follow-up|20|||
126133690|NCT00980538|453779816|FG000|Overall Study|Sponsor's Decision|4|||
126133691|NCT00980538|453779816|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
126133692|NCT00980538|453779816|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
126133693|NCT00980538|453779816|FG000|Overall Study|Switch to Commercially Available Medication|25|||
126133694|NCT00980538|453779816|FG000|Overall Study|Participant Non-Compliant|9|||
126133695|NCT00980538|453779816|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
126133696|NCT00980538|453779816|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
125965774|NCT04495374|453165785|FG000|Overall Study|Protocol Violation|2|||
125965775|NCT04495374|453165786|FG001|Overall Study|Protocol Violation|1|||
125965776|NCT00353704|453165787|FG000|Overall Study|Protocol Violation|3|||
125965777|NCT00353704|453165788|FG001|Overall Study|Protocol Violation|1|||
126133697|NCT00980538|453779816|FG000|Overall Study|Other|60|||
126133698|NCT00980538|453779816|FG000|Overall Study|Other|1|||
126133699|NCT04441905|453781436|FG000|Overall Study|Lost to Follow-up|1|||
126133700|NCT04441905|453781437|FG001|Overall Study|Lost to Follow-up|0|||
126133701|NCT04441905|453781438|FG002|Overall Study|Lost to Follow-up|0|||
126133702|NCT04441905|453781439|FG003|Overall Study|Lost to Follow-up|0|||
126133703|NCT04441905|453781440|FG004|Overall Study|Lost to Follow-up|0|||
126133704|NCT04441905|453781441|FG005|Overall Study|Lost to Follow-up|0|||
126133705|NCT04441905|453781436|FG000|Overall Study|Enrolled but treatment not administered|0|||
126133706|NCT04441905|453781437|FG001|Overall Study|Enrolled but treatment not administered|1|||
126133707|NCT04441905|453781438|FG002|Overall Study|Enrolled but treatment not administered|0|||
126133708|NCT04441905|453781439|FG003|Overall Study|Enrolled but treatment not administered|0|||
126133709|NCT04441905|453781440|FG004|Overall Study|Enrolled but treatment not administered|0|||
126133710|NCT04441905|453781441|FG005|Overall Study|Enrolled but treatment not administered|0|||
126133711|NCT04441905|453781436|FG000|Overall Study|Became ineligible after enrollment|0|||
126133712|NCT04441905|453781437|FG001|Overall Study|Became ineligible after enrollment|0|||
126133713|NCT04441905|453781438|FG002|Overall Study|Became ineligible after enrollment|0|||
126133714|NCT04441905|453781439|FG003|Overall Study|Became ineligible after enrollment|0|||
126133715|NCT04441905|453781440|FG004|Overall Study|Became ineligible after enrollment|1|||
126133716|NCT04441905|453781441|FG005|Overall Study|Became ineligible after enrollment|0|||
126133717|NCT04770753|453781442|FG000|Overall Study|Randomized, never treated|1|||
126133718|NCT04770753|453781443|FG001|Overall Study|Randomized, never treated|1|||
126133719|NCT04770753|453781442|FG000|Overall Study|Withdrawal by Subject|3|||
126133720|NCT04770753|453781443|FG001|Overall Study|Withdrawal by Subject|1|||
126133721|NCT04770753|453781442|FG000|Overall Study|Adverse Event|2|||
126133722|NCT04770753|453781443|FG001|Overall Study|Adverse Event|0|||
126133723|NCT04770753|453781442|FG000|Overall Study|Pregnancy|1|||
126133724|NCT04770753|453781443|FG001|Overall Study|Pregnancy|0|||
126133725|NCT04770753|453781442|FG000|Overall Study|Other un-specified|1|||
126133726|NCT04770753|453781443|FG001|Overall Study|Other un-specified|0|||
126133727|NCT02775851|453781444|FG000|Overall Study|Adverse Event|1|||
126133728|NCT02775851|453781445|FG001|Overall Study|Adverse Event|10|||
126133729|NCT02775851|453781444|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
125965778|NCT02473614|453165789|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
125965779|NCT02473614|453165790|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
125965780|NCT01303627|453165791|FG000|Overall Study|the failure while performing URS|0|||
125965781|NCT01303627|453165792|FG001|Overall Study|the failure while performing URS|1|||
125965782|NCT02416791|453165794|FG000|6 Months|Lost to Follow-up|0|||
125965783|NCT02416791|453165795|FG001|6 Months|Lost to Follow-up|0|||
125965784|NCT02416791|453165796|FG002|6 Months|Lost to Follow-up|1|||
125965785|NCT01054820|453165797|FG000|Overall Study|Withdrawal by Subject|2|||
125965786|NCT01154166|453165799|FG000|Overall Study|Adverse Event|14|||
125965787|NCT01154166|453165800|FG001|Overall Study|Adverse Event|9|||
125965788|NCT01154166|453165799|FG000|Overall Study|Lost to Follow-up|1|||
125965789|NCT01154166|453165800|FG001|Overall Study|Lost to Follow-up|1|||
125965790|NCT01154166|453165799|FG000|Overall Study|Protocol Violation|4|||
125965791|NCT01154166|453165800|FG001|Overall Study|Protocol Violation|1|||
125965792|NCT01154166|453165799|FG000|Overall Study|Withdrawal by Subject|10|||
125965793|NCT01154166|453165800|FG001|Overall Study|Withdrawal by Subject|1|||
125965794|NCT01154166|453165799|FG000|Overall Study|Lack of Efficacy|3|||
125965795|NCT01154166|453165800|FG001|Overall Study|Lack of Efficacy|0|||
125965796|NCT01154166|453165799|FG000|Overall Study|Disease Progression|1|||
125965797|NCT01154166|453165800|FG001|Overall Study|Disease Progression|0|||
125965798|NCT01154166|453165799|FG000|Overall Study|Poor Compliance|1|||
125965799|NCT01154166|453165800|FG001|Overall Study|Poor Compliance|0|||
125965800|NCT04121962|453165803|FG000|Overall Study|Lost to Follow-up|42|||
125965801|NCT04121962|453165804|FG001|Overall Study|Lost to Follow-up|39|||
125965802|NCT02019719|453165805|FG000|Overall Study|Adverse Event|1|||
126133730|NCT02775851|453781445|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
126133731|NCT02775851|453781444|FG000|Overall Study|Progression/Relapse|0|||
126133732|NCT02775851|453781445|FG001|Overall Study|Progression/Relapse|4|||
125965803|NCT02019719|453165806|FG001|Overall Study|Adverse Event|0|||
125965804|NCT02019719|453165807|FG002|Overall Study|Adverse Event|0|||
125965805|NCT02019719|453165808|FG003|Overall Study|Adverse Event|1|||
125965806|NCT02019719|453165809|FG004|Overall Study|Adverse Event|1|||
125965807|NCT02019719|453165805|FG000|Overall Study|Protocol Violation|1|||
125965808|NCT02019719|453165806|FG001|Overall Study|Protocol Violation|1|||
125965809|NCT02019719|453165807|FG002|Overall Study|Protocol Violation|0|||
125965810|NCT02019719|453165808|FG003|Overall Study|Protocol Violation|0|||
125965811|NCT02019719|453165809|FG004|Overall Study|Protocol Violation|0|||
125965812|NCT02019719|453165805|FG000|Overall Study|Protocol defined stopping criteria|2|||
125965813|NCT02019719|453165806|FG001|Overall Study|Protocol defined stopping criteria|0|||
125965814|NCT02019719|453165807|FG002|Overall Study|Protocol defined stopping criteria|0|||
125965815|NCT02019719|453165808|FG003|Overall Study|Protocol defined stopping criteria|1|||
125965816|NCT02019719|453165809|FG004|Overall Study|Protocol defined stopping criteria|1|||
125965817|NCT02019719|453165805|FG000|Overall Study|Physician Decision|2|||
125965818|NCT02019719|453165806|FG001|Overall Study|Physician Decision|0|||
125965819|NCT02019719|453165807|FG002|Overall Study|Physician Decision|0|||
125965820|NCT02019719|453165808|FG003|Overall Study|Physician Decision|0|||
125965821|NCT02019719|453165809|FG004|Overall Study|Physician Decision|0|||
125965822|NCT04535037|453165810|FG000|Overall Study|Protocol Violation|1|||
125965823|NCT04535037|453165811|FG001|Overall Study|Protocol Violation|0|||
125965824|NCT04535037|453165810|FG000|Overall Study|Withdrawal by Subject|8|||
125965825|NCT04535037|453165811|FG001|Overall Study|Withdrawal by Subject|9|||
125965826|NCT04535037|453165810|FG000|Overall Study|Migrated / moved from the study area|1|||
125965827|NCT04535037|453165811|FG001|Overall Study|Migrated / moved from the study area|4|||
125965828|NCT04535037|453165810|FG000|Overall Study|Other|2|||
125965829|NCT04535037|453165811|FG001|Overall Study|Other|5|||
125965830|NCT02731131|453165812|FG000|Overall Study|Psychiatric Disorder|0|||
125965831|NCT02731131|453165813|FG001|Overall Study|Psychiatric Disorder|1|||
125965832|NCT02731131|453165812|FG000|Overall Study|Refused Therapy|0|||
125965833|NCT02731131|453165813|FG001|Overall Study|Refused Therapy|1|||
125965834|NCT00562159|453165814|FG000|Overall Study|Adverse Event|11|||
125965835|NCT00562159|453165815|FG001|Overall Study|Adverse Event|8|||
125965836|NCT00562159|453165814|FG000|Overall Study|Lost to Follow-up|5|||
125965837|NCT00562159|453165815|FG001|Overall Study|Lost to Follow-up|4|||
125965838|NCT00562159|453165814|FG000|Overall Study|Withdrawal by Subject|9|||
125965839|NCT00562159|453165815|FG001|Overall Study|Withdrawal by Subject|8|||
125965840|NCT00562159|453165814|FG000|Overall Study|Protocol Violation|12|||
125965841|NCT00562159|453165815|FG001|Overall Study|Protocol Violation|12|||
125965842|NCT00562159|453165814|FG000|Overall Study|Did not meet protocol eligibility|1|||
125965843|NCT00562159|453165815|FG001|Overall Study|Did not meet protocol eligibility|1|||
126088502|NCT03852719|453617164|FG001|Overall Study|Lost to Follow-up|0|||
126088503|NCT03852719|453617165|FG002|Overall Study|Lost to Follow-up|0|||
126088504|NCT05543187|453617166|FG000|Overall Study|Ongoing|3|||
126088505|NCT05543187|453617167|FG001|Overall Study|Ongoing|2|||
126088506|NCT02819024|453617169|FG000|Overall Study|Withdrawal by Subject|1|||
126088507|NCT00792948|453617170|FG000|Overall Study|Adverse Event|6|||
126088508|NCT00792948|453617170|FG000|Overall Study|Death|4|||
126088509|NCT00792948|453617170|FG000|Overall Study|Withdrawal by Subject|3|||
126088510|NCT00792948|453617170|FG000|Overall Study|Ineligible|2|||
126088511|NCT00792948|453617170|FG000|Overall Study|Insurance denial - not treated|1|||
126088512|NCT00792948|453617170|FG000|Overall Study|Physician Decision|11|||
126088513|NCT00792948|453617170|FG000|Overall Study|Protocol Violation|1|||
126088514|NCT01263509|453618747|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
126088515|NCT01263509|453618748|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
126088516|NCT01263509|453618749|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
126088517|NCT01263509|453618750|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
126088518|NCT01263509|453618747|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126088519|NCT01263509|453618748|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
126088520|NCT01263509|453618749|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126088521|NCT01263509|453618750|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126088522|NCT01263509|453618747|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126088523|NCT01263509|453618748|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126088524|NCT01263509|453618749|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126088525|NCT01263509|453618750|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126088526|NCT01263509|453618747|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
126088527|NCT01263509|453618748|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
126088528|NCT01263509|453618749|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126088529|NCT01263509|453618750|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126088530|NCT01263509|453618747|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
126088531|NCT01263509|453618748|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
126088532|NCT01263509|453618749|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
125965844|NCT02417246|453165816|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
125965845|NCT02417246|453165817|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
126133733|NCT02775851|453781444|FG000|Overall Study|Other - Not Protocol Specified|0|||
126133734|NCT02775851|453781445|FG001|Overall Study|Other - Not Protocol Specified|7|||
126133735|NCT02775851|453781444|FG000|Overall Study|Withdrawal by Subject|1|||
126133736|NCT02775851|453781445|FG001|Overall Study|Withdrawal by Subject|0|||
126133737|NCT03266016|453781449|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
126133738|NCT03266016|453781450|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
126133739|NCT03266016|453781451|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
126133740|NCT03266016|453781452|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
126133741|NCT03266016|453781449|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
126133742|NCT03266016|453781450|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
126133743|NCT03266016|453781451|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
126133744|NCT03266016|453781452|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
126133745|NCT03686397|453781453|FG000|Overall Study|Lack of Efficacy|3|||
126133746|NCT03686397|453781454|FG001|Overall Study|Lack of Efficacy|5|||
126133747|NCT03686397|453781453|FG000|Overall Study|Adverse Event|0|||
126133748|NCT03686397|453781454|FG001|Overall Study|Adverse Event|1|||
126133749|NCT03686397|453781453|FG000|Overall Study|Protocol Violation|0|||
126133750|NCT03686397|453781454|FG001|Overall Study|Protocol Violation|1|||
126133751|NCT03686397|453781453|FG000|Overall Study|Withdrawal by Subject|0|||
126133752|NCT03686397|453781454|FG001|Overall Study|Withdrawal by Subject|1|||
126133753|NCT03686397|453781453|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
126133754|NCT03686397|453781454|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
126133755|NCT03718143|453781461|FG000|Overall Study|Death|1|||
126133756|NCT03718143|453781462|FG001|Overall Study|Death|0|||
126133757|NCT03718143|453781463|FG002|Overall Study|Death|0|||
126133758|NCT03718143|453781461|FG000|Overall Study|Progression of Disease|1|||
126133759|NCT03718143|453781462|FG001|Overall Study|Progression of Disease|0|||
126133760|NCT03718143|453781463|FG002|Overall Study|Progression of Disease|0|||
126133761|NCT03718143|453781461|FG000|Overall Study|Withdrawal of Informed Consent|1|||
126133762|NCT03718143|453781462|FG001|Overall Study|Withdrawal of Informed Consent|2|||
126133763|NCT03718143|453781463|FG002|Overall Study|Withdrawal of Informed Consent|1|||
126133764|NCT05064059|453781464|FG000|Overall Study|Death|199|||
126133765|NCT05064059|453781465|FG001|Overall Study|Death|196|||
126133766|NCT05064059|453781464|FG000|Overall Study|Physician Decision|4|||
126133767|NCT05064059|453781465|FG001|Overall Study|Physician Decision|2|||
126133768|NCT05064059|453781464|FG000|Overall Study|Sponsor Decision|14|||
126133769|NCT05064059|453781465|FG001|Overall Study|Sponsor Decision|11|||
126133770|NCT05064059|453781464|FG000|Overall Study|Withdrawal by Subject|4|||
126133771|NCT05064059|453781465|FG001|Overall Study|Withdrawal by Subject|11|||
126133772|NCT01934140|453781466|FG000|Persistence Phase (Year 6-10)|Other|24|||
126133773|NCT01934140|453781467|FG001|Persistence Phase (Year 6-10)|Other|6|||
126133774|NCT01934140|453781466|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
126133775|NCT01934140|453781467|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
126133776|NCT01934140|453781466|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
126133777|NCT01934140|453781467|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
126133778|NCT01934140|453781466|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
126133779|NCT01934140|453781467|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
126133780|NCT01934140|453781466|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
126133781|NCT01934140|453781467|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
126133782|NCT01934140|453781466|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
126133783|NCT01934140|453781467|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
126133784|NCT01934140|453781466|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
126133785|NCT01934140|453781467|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
126133786|NCT01934140|453781466|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
126133787|NCT01934140|453781467|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
126133788|NCT00200850|453781468|FG000|Overall Study|relocation|1|||
126133789|NCT00200850|453781469|FG001|Overall Study|relocation|0|||
126133790|NCT00200850|453781470|FG002|Overall Study|relocation|1|||
126133791|NCT00200850|453781468|FG000|Overall Study|too busy|1|||
126133792|NCT00200850|453781469|FG001|Overall Study|too busy|0|||
126133793|NCT00200850|453781470|FG002|Overall Study|too busy|0|||
126133794|NCT00200850|453781468|FG000|Overall Study|Pregnancy|0|||
126133795|NCT00200850|453781469|FG001|Overall Study|Pregnancy|0|||
126133796|NCT00200850|453781470|FG002|Overall Study|Pregnancy|1|||
126133797|NCT00200850|453781468|FG000|Overall Study|Poor adherence|0|||
126133798|NCT00200850|453781469|FG001|Overall Study|Poor adherence|0|||
126133799|NCT00200850|453781470|FG002|Overall Study|Poor adherence|1|||
126133800|NCT00200850|453781468|FG000|Overall Study|optic neuritis|0|||
126133801|NCT00200850|453781469|FG001|Overall Study|optic neuritis|0|||
126133802|NCT00200850|453781470|FG002|Overall Study|optic neuritis|1|||
126133803|NCT00200850|453781468|FG000|Overall Study|Adverse Event|1|||
126133804|NCT00200850|453781469|FG001|Overall Study|Adverse Event|1|||
126133805|NCT00200850|453781470|FG002|Overall Study|Adverse Event|2|||
126133806|NCT00805740|453781471|FG000|Overall Study|Death|7|||
126133807|NCT00805740|453781472|FG001|Overall Study|Death|4|||
126133808|NCT00805740|453781471|FG000|Overall Study|Withdrawal by Subject|1|||
126133809|NCT00805740|453781472|FG001|Overall Study|Withdrawal by Subject|0|||
126133810|NCT00805740|453781471|FG000|Overall Study|Lost to Follow-up|1|||
126133811|NCT00805740|453781472|FG001|Overall Study|Lost to Follow-up|0|||
126133812|NCT00805740|453781471|FG000|Overall Study|Randomized, but not treated|2|||
126133813|NCT00805740|453781472|FG001|Overall Study|Randomized, but not treated|0|||
126133814|NCT02595879|453781473|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
126133815|NCT02595879|453781474|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
126133816|NCT04294459|453781475|FG000|Overall Study|Adverse Event|0|||
126133817|NCT04294459|453781476|FG001|Overall Study|Adverse Event|1|||
126133818|NCT01534676|453781477|FG000|Overall Study|Study closed due to poor enrollment|2|||
126133819|NCT01534676|453781478|FG001|Overall Study|Study closed due to poor enrollment|1|||
126133820|NCT02908880|453781480|FG000|Overall Study|Lost to Follow-up|4|||
126133821|NCT02908880|453781480|FG000|Overall Study|Explantation of the device|1|||
126133822|NCT02908880|453781480|FG000|Overall Study|Withdrawal by Subject|17|||
126133823|NCT02908880|453781480|FG000|Overall Study|Death|5|||
126133824|NCT03823391|453781483|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
126133825|NCT03823391|453781484|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
126133826|NCT03823391|453781483|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
126133827|NCT03823391|453781484|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
126133828|NCT02450487|453781485|FG000|Overall Study|Lost to Follow-up|3|||
126133829|NCT01790048|453781486|FG000|Overall Study|Incorrect Age|9|||
126133830|NCT01790048|453781487|FG001|Overall Study|Incorrect Age|14|||
126133831|NCT01790048|453781486|FG000|Overall Study|data entry error|0|||
126133832|NCT01790048|453781487|FG001|Overall Study|data entry error|1|||
126133833|NCT01790048|453781486|FG000|Overall Study|Other|0|||
126133834|NCT01790048|453781487|FG001|Overall Study|Other|2|||
125965846|NCT02417246|453165816|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
125965847|NCT02417246|453165817|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
125965848|NCT02417246|453165816|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
125965849|NCT02417246|453165817|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
125965850|NCT02417246|453165816|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
125965851|NCT02417246|453165817|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
125965852|NCT01181921|453165820|FG000|Overall Study|Lost to Follow-up|1|||
125965853|NCT04408469|453165821|FG000|Overall Study|Lost to Follow-up|6|||
125965854|NCT04408469|453165822|FG001|Overall Study|Lost to Follow-up|9|||
125965855|NCT04408469|453165821|FG000|Overall Study|Withdrawal by Subject|6|||
126133835|NCT01790048|453781486|FG000|Overall Study|SAM at Enrollment|2|||
126133836|NCT01790048|453781487|FG001|Overall Study|SAM at Enrollment|0|||
126133837|NCT01790048|453781486|FG000|Overall Study|Measurement error|1|||
126133838|NCT01790048|453781487|FG001|Overall Study|Measurement error|0|||
126133839|NCT05030311|453781488|FG000|Overall Study|Technical problems|0|||
126133840|NCT05030311|453781489|FG001|Overall Study|Technical problems|1|||
126133841|NCT05030311|453781488|FG000|Overall Study|Withdrawal by Subject|31|||
126133842|NCT05030311|453781489|FG001|Overall Study|Withdrawal by Subject|17|||
126133843|NCT05030311|453781488|FG000|Overall Study|Adverse Event|13|||
126133844|NCT05030311|453781489|FG001|Overall Study|Adverse Event|5|||
126133845|NCT05030311|453781488|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126133846|NCT05030311|453781489|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125965856|NCT04408469|453165822|FG001|Overall Study|Withdrawal by Subject|1|||
125965857|NCT04408469|453165821|FG000|Overall Study|Dismissal due to ineligibility|0|||
125965858|NCT04408469|453165822|FG001|Overall Study|Dismissal due to ineligibility|1|||
125965859|NCT04321460|453165825|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
125965860|NCT04321460|453165826|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
125965861|NCT02162810|453165829|FG000|Overall Study|Protocol Violation|1|||
125965862|NCT02162810|453165830|FG001|Overall Study|Protocol Violation|0|||
125965863|NCT02162810|453165829|FG000|Overall Study|patients did not report compliance|4|||
125965864|NCT02162810|453165830|FG001|Overall Study|patients did not report compliance|1|||
125965865|NCT01308749|453165835|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
125965866|NCT01308749|453165836|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
125965867|NCT01308749|453165835|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
125965868|NCT01308749|453165836|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
125965869|NCT01308749|453165835|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
125965870|NCT01308749|453165836|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
125965871|NCT02519504|453165837|FG000|Overall Study|Protocol Violation|6|||
125965872|NCT02519504|453165838|FG001|Overall Study|Protocol Violation|5|||
125965873|NCT02519504|453165837|FG000|Overall Study|Ineligible for direct testing|12|||
125965874|NCT02519504|453165838|FG001|Overall Study|Ineligible for direct testing|12|||
125965875|NCT02519504|453165837|FG000|Overall Study|Did not participate in direct testing|95|||
125965876|NCT02519504|453165838|FG001|Overall Study|Did not participate in direct testing|86|||
126133847|NCT05030311|453781488|FG000|Overall Study|Physician Decision|5|||
126133848|NCT05030311|453781489|FG001|Overall Study|Physician Decision|2|||
126133849|NCT05030311|453781488|FG000|Overall Study|Lost to Follow-up|5|||
126133850|NCT05030311|453781489|FG001|Overall Study|Lost to Follow-up|1|||
125965877|NCT04726709|453165839|FG000|Overall Study|Withdrawal by Subject|2|||
125965878|NCT04726709|453165840|FG001|Overall Study|Withdrawal by Subject|2|||
125965879|NCT02546544|453165841|FG000|Overall Study|Disease Progression|14|||
125965880|NCT02546544|453165841|FG000|Overall Study|Adverse Event|1|||
125965881|NCT02546544|453165841|FG000|Overall Study|Withdrawal by Subject|1|||
125965882|NCT02223390|453165842|FG000|Overall Study|Lost to Follow-up|9|||
125965883|NCT02223390|453165843|FG001|Overall Study|Lost to Follow-up|4|||
125965884|NCT01666002|453165845|FG000|Overall Study|Lost to Follow-up|5|||
125965885|NCT01666002|453165846|FG001|Overall Study|Lost to Follow-up|0|||
125965886|NCT02159482|453165847|FG000|Overall Study|Withdrawal by Subject|2|||
125965887|NCT02159482|453165847|FG000|Overall Study|Physician Decision|3|||
125965888|NCT01233817|453165848|FG000|Overall Study|Lost to Follow-up|1|||
125965889|NCT01233817|453165848|FG000|Overall Study|Withdrawal by Subject|2|||
125965890|NCT01248884|453165849|FG000|Overall Study|Withdrawal by Subject|1|||
125965891|NCT01248884|453165850|FG001|Overall Study|Withdrawal by Subject|3|||
125965892|NCT01248884|453165851|FG002|Overall Study|Withdrawal by Subject|1|||
125965893|NCT01248884|453165849|FG000|Overall Study|Adverse Event|1|||
125965894|NCT01248884|453165850|FG001|Overall Study|Adverse Event|0|||
125965895|NCT01248884|453165851|FG002|Overall Study|Adverse Event|0|||
125965896|NCT02511431|453165852|FG000|Treatment|Lost to Follow-up|0|||
125965897|NCT02511431|453165853|FG001|Treatment|Lost to Follow-up|0|||
125965898|NCT02511431|453165854|FG002|Treatment|Lost to Follow-up|1|||
125965899|NCT02511431|453165855|FG003|Treatment|Lost to Follow-up|0|||
125965900|NCT02511431|453165856|FG004|Treatment|Lost to Follow-up|0|||
125965901|NCT02511431|453165857|FG005|Treatment|Lost to Follow-up|1|||
125965902|NCT04479618|453165858|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
125965903|NCT04479618|453165859|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
125965904|NCT04479618|453165860|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
125965905|NCT04479618|453165858|FG000|Overall Study|Lack of Efficacy|1|||
125965906|NCT04479618|453165859|FG001|Overall Study|Lack of Efficacy|0|||
125965907|NCT04479618|453165860|FG002|Overall Study|Lack of Efficacy|0|||
125965908|NCT04479618|453165858|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
125965909|NCT04479618|453165859|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
125965910|NCT04479618|453165860|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
125965911|NCT04479618|453165858|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
125965912|NCT04479618|453165859|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
125965913|NCT04479618|453165860|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
125965914|NCT04479618|453165858|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
125965915|NCT04479618|453165859|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
125965916|NCT04479618|453165860|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
125965917|NCT04479618|453165858|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
125965918|NCT04479618|453165859|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
125965919|NCT04479618|453165860|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
125965920|NCT01202773|453165861|FG000|Overall Study|Adverse Event|4|||
125965921|NCT01202773|453165862|FG001|Overall Study|Adverse Event|5|||
126133851|NCT05030311|453781488|FG000|Overall Study|Protocol Violation|4|||
126133852|NCT05030311|453781489|FG001|Overall Study|Protocol Violation|4|||
126133853|NCT02062658|453781494|FG000|Overall Study|Withdrawal by Subject|1|||
125965922|NCT01202773|453165863|FG002|Overall Study|Adverse Event|5|||
125965923|NCT01202773|453165861|FG000|Overall Study|Lack of Efficacy|5|||
125965924|NCT01202773|453165862|FG001|Overall Study|Lack of Efficacy|4|||
125965925|NCT01202773|453165863|FG002|Overall Study|Lack of Efficacy|9|||
125965926|NCT01202773|453165861|FG000|Overall Study|Entry Criteria Not Met|2|||
125965927|NCT01202773|453165862|FG001|Overall Study|Entry Criteria Not Met|0|||
125965928|NCT01202773|453165863|FG002|Overall Study|Entry Criteria Not Met|1|||
125965929|NCT01202773|453165861|FG000|Overall Study|Lost to Follow-up|1|||
125965930|NCT01202773|453165862|FG001|Overall Study|Lost to Follow-up|2|||
125965931|NCT01202773|453165863|FG002|Overall Study|Lost to Follow-up|2|||
125965932|NCT01202773|453165861|FG000|Overall Study|Withdrawal by Subject|13|||
125965933|NCT01202773|453165862|FG001|Overall Study|Withdrawal by Subject|6|||
126088533|NCT01263509|453618750|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
126088534|NCT02593123|453618751|FG000|Overall Study|Physician Decision|2|||
126088535|NCT02593123|453618752|FG001|Overall Study|Physician Decision|1|||
126088536|NCT02593123|453618751|FG000|Overall Study|Relapse|1|||
126088537|NCT02593123|453618752|FG001|Overall Study|Relapse|1|||
126088538|NCT02440425|453618753|FG000|Overall Study|Death likely due to disease progression|1|||
126088539|NCT02440425|453618753|FG000|Overall Study|Withdrawal by Subject|2|||
126088540|NCT02440425|453618753|FG000|Overall Study|Adverse Event|1|||
126133854|NCT02062658|453781494|FG000|Overall Study|Lack of Efficacy|1|||
126133855|NCT02161562|453781495|FG000|Overall Study|Withdrawal by Subject|5|||
125965934|NCT01202773|453165863|FG002|Overall Study|Withdrawal by Subject|5|||
125965935|NCT01202773|453165861|FG000|Overall Study|Physician Decision|2|||
125965936|NCT01202773|453165862|FG001|Overall Study|Physician Decision|0|||
126133856|NCT02161562|453781496|FG001|Overall Study|Withdrawal by Subject|8|||
126133857|NCT02161562|453781495|FG000|Overall Study|Protocol Violation|9|||
126133858|NCT02161562|453781496|FG001|Overall Study|Protocol Violation|4|||
126133859|NCT02161562|453781495|FG000|Overall Study|Pregnancy|1|||
126133860|NCT02161562|453781496|FG001|Overall Study|Pregnancy|2|||
126133861|NCT02161562|453781495|FG000|Overall Study|Lost to Follow-up|3|||
126133862|NCT02161562|453781496|FG001|Overall Study|Lost to Follow-up|1|||
126133863|NCT02161562|453781495|FG000|Overall Study|Lack of Efficacy|4|||
126133864|NCT02161562|453781496|FG001|Overall Study|Lack of Efficacy|1|||
126133865|NCT02161562|453781495|FG000|Overall Study|Adverse Event|1|||
126133866|NCT02161562|453781496|FG001|Overall Study|Adverse Event|1|||
126133867|NCT02161562|453781495|FG000|Overall Study|Participant moved back to home country|1|||
126133868|NCT02161562|453781496|FG001|Overall Study|Participant moved back to home country|0|||
126133869|NCT02161562|453781495|FG000|Overall Study|Withdrew due to being out of the country|1|||
126133870|NCT02161562|453781496|FG001|Overall Study|Withdrew due to being out of the country|0|||
126133871|NCT02161562|453781495|FG000|Overall Study|Participant moved out of province|1|||
126133872|NCT02161562|453781496|FG001|Overall Study|Participant moved out of province|0|||
126133873|NCT00608985|453781500|FG000|Overall Study|Adverse Event|2|||
126133874|NCT00608985|453781501|FG001|Overall Study|Adverse Event|7|||
126133875|NCT00608985|453781502|FG002|Overall Study|Adverse Event|4|||
126133876|NCT00608985|453781503|FG003|Overall Study|Adverse Event|6|||
126133877|NCT00608985|453781500|FG000|Overall Study|Administrative/Other|7|||
126133878|NCT00608985|453781501|FG001|Overall Study|Administrative/Other|4|||
126133879|NCT00608985|453781502|FG002|Overall Study|Administrative/Other|1|||
126133880|NCT00608985|453781503|FG003|Overall Study|Administrative/Other|2|||
126133881|NCT00608985|453781500|FG000|Overall Study|Withdrawal of Consent|5|||
126133882|NCT00608985|453781501|FG001|Overall Study|Withdrawal of Consent|1|||
126133883|NCT00608985|453781502|FG002|Overall Study|Withdrawal of Consent|1|||
126133884|NCT00608985|453781503|FG003|Overall Study|Withdrawal of Consent|1|||
126133885|NCT00608985|453781500|FG000|Overall Study|Lost to Follow-up|2|||
126133886|NCT00608985|453781501|FG001|Overall Study|Lost to Follow-up|1|||
126133887|NCT00608985|453781502|FG002|Overall Study|Lost to Follow-up|0|||
126133888|NCT00608985|453781503|FG003|Overall Study|Lost to Follow-up|0|||
126133889|NCT03033745|453781504|FG000|Overall Study|Protocol Violation|0|||
126133890|NCT03033745|453781505|FG001|Overall Study|Protocol Violation|0|||
126133891|NCT03033745|453781506|FG002|Overall Study|Protocol Violation|1|||
126133892|NCT03033745|453781504|FG000|Overall Study|Adverse Event|1|||
126133893|NCT03033745|453781505|FG001|Overall Study|Adverse Event|0|||
126133894|NCT03033745|453781506|FG002|Overall Study|Adverse Event|1|||
126133895|NCT03033745|453781504|FG000|Overall Study|Withdrawal by Subject|0|||
126133896|NCT03033745|453781505|FG001|Overall Study|Withdrawal by Subject|1|||
126133897|NCT03033745|453781506|FG002|Overall Study|Withdrawal by Subject|0|||
126133898|NCT00662792|453781507|FG000|Period 1|Personal Reasons|0|||
126133899|NCT00662792|453781508|FG001|Period 1|Personal Reasons|0|||
126133900|NCT00662792|453781509|FG002|Period 1|Personal Reasons|1|||
126133901|NCT00662792|453781510|FG003|Period 1|Personal Reasons|0|||
126133902|NCT00662792|453781507|FG000|Period 1|Refused continuing medication|0|||
126133903|NCT00662792|453781508|FG001|Period 1|Refused continuing medication|1|||
126133904|NCT00662792|453781509|FG002|Period 1|Refused continuing medication|1|||
126133905|NCT00662792|453781510|FG003|Period 1|Refused continuing medication|0|||
126133906|NCT00662792|453781507|FG000|Period 1|Lost to Follow-up|1|||
126133907|NCT00662792|453781508|FG001|Period 1|Lost to Follow-up|0|||
126133908|NCT00662792|453781509|FG002|Period 1|Lost to Follow-up|0|||
126133909|NCT00662792|453781510|FG003|Period 1|Lost to Follow-up|0|||
126133910|NCT00662792|453781507|FG000|Period 1|Other adverse event (AE)|0|||
126133911|NCT00662792|453781508|FG001|Period 1|Other adverse event (AE)|2|||
126133912|NCT00662792|453781509|FG002|Period 1|Other adverse event (AE)|0|||
126133913|NCT00662792|453781510|FG003|Period 1|Other adverse event (AE)|0|||
126133914|NCT00662792|453781507|FG000|Period 1|Worsening of disease under study (AE)|1|||
126133915|NCT00662792|453781508|FG001|Period 1|Worsening of disease under study (AE)|3|||
126133916|NCT00662792|453781509|FG002|Period 1|Worsening of disease under study (AE)|2|||
126133917|NCT00662792|453781510|FG003|Period 1|Worsening of disease under study (AE)|0|||
126133918|NCT00662792|453781507|FG000|Period 1|Not treated|0|||
126133919|NCT00662792|453781508|FG001|Period 1|Not treated|1|||
125965937|NCT01202773|453165863|FG002|Overall Study|Physician Decision|0|||
126133920|NCT00662792|453781509|FG002|Period 1|Not treated|0|||
126133921|NCT00662792|453781510|FG003|Period 1|Not treated|0|||
126133922|NCT00662792|453781507|FG000|Period 2|Worsening of disease under study|1|||
126133923|NCT00662792|453781508|FG001|Period 2|Worsening of disease under study|0|||
126133924|NCT00662792|453781509|FG002|Period 2|Worsening of disease under study|0|||
126133925|NCT00662792|453781510|FG003|Period 2|Worsening of disease under study|3|||
126133926|NCT00662792|453781507|FG000|Period 3|Refused continuing medication|1|||
126133927|NCT00662792|453781508|FG001|Period 3|Refused continuing medication|0|||
126133928|NCT00662792|453781509|FG002|Period 3|Refused continuing medication|1|||
125965938|NCT01202773|453165861|FG000|Overall Study|Protocol Violation|11|||
126133929|NCT00662792|453781510|FG003|Period 3|Refused continuing medication|0|||
126133930|NCT00662792|453781507|FG000|Period 3|Other adverse event (AE)|0|||
126133931|NCT00662792|453781508|FG001|Period 3|Other adverse event (AE)|0|||
126133932|NCT00662792|453781509|FG002|Period 3|Other adverse event (AE)|1|||
125965939|NCT01202773|453165862|FG001|Overall Study|Protocol Violation|6|||
125965940|NCT01202773|453165863|FG002|Overall Study|Protocol Violation|10|||
125965941|NCT01202773|453165861|FG000|Overall Study|Sponsor Decision|19|||
125965942|NCT01202773|453165862|FG001|Overall Study|Sponsor Decision|20|||
125965943|NCT01202773|453165863|FG002|Overall Study|Sponsor Decision|23|||
125965944|NCT02828111|453165872|FG000|Overall Study|Withdrawal by Subject|0|||
125965945|NCT02828111|453165873|FG001|Overall Study|Withdrawal by Subject|0|||
125965946|NCT02828111|453165874|FG002|Overall Study|Withdrawal by Subject|2|||
125965947|NCT02828111|453165875|FG003|Overall Study|Withdrawal by Subject|0|||
125965948|NCT02828111|453165876|FG004|Overall Study|Withdrawal by Subject|0|||
126133933|NCT00662792|453781510|FG003|Period 3|Other adverse event (AE)|1|||
126133934|NCT00662792|453781507|FG000|Period 4|Refused continuing medication|0|||
126133935|NCT00662792|453781508|FG001|Period 4|Refused continuing medication|1|||
126133936|NCT00662792|453781509|FG002|Period 4|Refused continuing medication|0|||
126133937|NCT00662792|453781510|FG003|Period 4|Refused continuing medication|0|||
126133938|NCT00662792|453781507|FG000|Period 4|Other adverse event (AE)|1|||
126133939|NCT00662792|453781508|FG001|Period 4|Other adverse event (AE)|0|||
126133940|NCT00662792|453781509|FG002|Period 4|Other adverse event (AE)|0|||
126133941|NCT00662792|453781510|FG003|Period 4|Other adverse event (AE)|0|||
126133942|NCT00662792|453781507|FG000|Period 4|Worsening of disease under study (AE)|0|||
126133943|NCT00662792|453781508|FG001|Period 4|Worsening of disease under study (AE)|0|||
126133944|NCT00662792|453781509|FG002|Period 4|Worsening of disease under study (AE)|0|||
126133945|NCT00662792|453781510|FG003|Period 4|Worsening of disease under study (AE)|1|||
126133946|NCT00090545|453781513|FG000|Overall Study|Disease progression on study|21|||
126133947|NCT00090545|453781514|FG001|Overall Study|Disease progression on study|17|||
126133948|NCT00090545|453781513|FG000|Overall Study|Refused further treatment|1|||
126133949|NCT00090545|453781514|FG001|Overall Study|Refused further treatment|4|||
126133950|NCT00090545|453781513|FG000|Overall Study|Death|0|||
126133951|NCT00090545|453781514|FG001|Overall Study|Death|1|||
126133952|NCT00090545|453781513|FG000|Overall Study|Adverse Event|0|||
126133953|NCT00090545|453781514|FG001|Overall Study|Adverse Event|2|||
126133954|NCT00441545|453781515|FG000|First Intervention|Adverse Event|6|||
126133955|NCT00441545|453781516|FG001|First Intervention|Adverse Event|5|||
126133956|NCT00441545|453781515|FG000|First Intervention|Protocol Violation|2|||
126133957|NCT00441545|453781516|FG001|First Intervention|Protocol Violation|2|||
126133958|NCT00441545|453781515|FG000|First Intervention|Withdrawal by Subject|3|||
126133959|NCT00441545|453781516|FG001|First Intervention|Withdrawal by Subject|3|||
126133960|NCT00441545|453781515|FG000|First Intervention|Kidney transplant|1|||
126133961|NCT00441545|453781516|FG001|First Intervention|Kidney transplant|1|||
126133962|NCT00441545|453781515|FG000|First Intervention|Lack of Efficacy|2|||
126133963|NCT00441545|453781516|FG001|First Intervention|Lack of Efficacy|0|||
126133964|NCT00441545|453781515|FG000|First Intervention|Subject exceeded safety criteria|0|||
126133965|NCT00441545|453781516|FG001|First Intervention|Subject exceeded safety criteria|1|||
126133966|NCT00441545|453781515|FG000|First Intervention|Subject met an exclusionary criteria|1|||
126133967|NCT00441545|453781516|FG001|First Intervention|Subject met an exclusionary criteria|0|||
126133968|NCT00441545|453781515|FG000|First Intervention|Extended hospitalization|1|||
126133969|NCT00441545|453781516|FG001|First Intervention|Extended hospitalization|0|||
126133970|NCT00441545|453781515|FG000|First Intervention|Site error|1|||
126133971|NCT00441545|453781516|FG001|First Intervention|Site error|0|||
126133972|NCT00441545|453781515|FG000|First Intervention|Sponsor's request|1|||
126133973|NCT00441545|453781516|FG001|First Intervention|Sponsor's request|0|||
126133974|NCT00441545|453781515|FG000|Second Intervention|Adverse Event|5|||
126133975|NCT00441545|453781516|FG001|Second Intervention|Adverse Event|2|||
126133976|NCT00441545|453781515|FG000|Second Intervention|Protocol Violation|4|||
126133977|NCT00441545|453781516|FG001|Second Intervention|Protocol Violation|1|||
126133978|NCT00441545|453781515|FG000|Second Intervention|Withdrawal by Subject|1|||
126133979|NCT00441545|453781516|FG001|Second Intervention|Withdrawal by Subject|1|||
126133980|NCT00441545|453781515|FG000|Second Intervention|Kidney Transplant|1|||
126133981|NCT00441545|453781516|FG001|Second Intervention|Kidney Transplant|1|||
125965949|NCT02828111|453165872|FG000|Overall Study|Lost to Follow-up|0|||
125965950|NCT02828111|453165873|FG001|Overall Study|Lost to Follow-up|0|||
125965951|NCT02828111|453165874|FG002|Overall Study|Lost to Follow-up|0|||
126133982|NCT00441545|453781515|FG000|Second Intervention|Lack of Efficacy|0|||
126133983|NCT00441545|453781516|FG001|Second Intervention|Lack of Efficacy|1|||
126133984|NCT00441545|453781515|FG000|Second Intervention|Subject exceeded safety criteria|1|||
126133985|NCT00441545|453781516|FG001|Second Intervention|Subject exceeded safety criteria|0|||
125965952|NCT02828111|453165875|FG003|Overall Study|Lost to Follow-up|1|||
125965953|NCT02828111|453165876|FG004|Overall Study|Lost to Follow-up|1|||
126133986|NCT00441545|453781515|FG000|Second Intervention|Subject moved|0|||
126133987|NCT00441545|453781516|FG001|Second Intervention|Subject moved|1|||
126133988|NCT02347176|453781517|FG000|Overall Study|Lost to Follow-up|2|||
126133989|NCT02347176|453781518|FG001|Overall Study|Lost to Follow-up|3|||
126133990|NCT02347176|453781519|FG002|Overall Study|Lost to Follow-up|1|||
126133991|NCT02347176|453781520|FG003|Overall Study|Lost to Follow-up|1|||
126133992|NCT02347176|453781517|FG000|Overall Study|Withdrawal by Subject|9|||
126133993|NCT02347176|453781518|FG001|Overall Study|Withdrawal by Subject|5|||
126133994|NCT02347176|453781519|FG002|Overall Study|Withdrawal by Subject|5|||
126133995|NCT02347176|453781520|FG003|Overall Study|Withdrawal by Subject|3|||
126133996|NCT02347176|453781517|FG000|Overall Study|Other|1|||
126133997|NCT02347176|453781518|FG001|Overall Study|Other|2|||
126133998|NCT02347176|453781519|FG002|Overall Study|Other|2|||
126133999|NCT02347176|453781520|FG003|Overall Study|Other|0|||
126134000|NCT00744874|453781523|FG000|Overall Study|Lost to Follow-up|1|||
126134001|NCT00744874|453781523|FG000|Overall Study|Withdrawal by Subject|1|||
126134002|NCT00744874|453781523|FG000|Overall Study|Study Device not available at procedure|1|||
126134003|NCT00744874|453781523|FG000|Overall Study|Unable to accomodate schedule|1|||
126134004|NCT03403205|453781524|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
126134005|NCT03403205|453781525|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
126134006|NCT03403205|453781526|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
126134007|NCT03403205|453781527|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
126134008|NCT03403205|453781528|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126134009|NCT03403205|453781529|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126134010|NCT03403205|453781524|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
126134011|NCT03403205|453781525|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126134012|NCT03403205|453781526|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
126134013|NCT03403205|453781527|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126134014|NCT03403205|453781528|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126134015|NCT03403205|453781529|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126134016|NCT03403205|453781524|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
126134017|NCT03403205|453781525|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
126134018|NCT03403205|453781526|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
126134019|NCT03403205|453781527|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
126134020|NCT03403205|453781528|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
126134021|NCT03403205|453781529|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
126134022|NCT03403205|453781524|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
126134023|NCT03403205|453781525|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
126134024|NCT03403205|453781526|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
126134025|NCT03403205|453781527|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
126134026|NCT03403205|453781528|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
126134027|NCT03403205|453781529|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
126134028|NCT03403205|453781524|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
126134029|NCT03403205|453781525|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126134030|NCT03403205|453781526|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126134031|NCT03403205|453781527|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126134032|NCT03403205|453781528|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126134033|NCT03403205|453781529|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126134034|NCT03403205|453781524|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126134035|NCT03403205|453781525|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
126134036|NCT03403205|453781526|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126134037|NCT03403205|453781527|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126134038|NCT03403205|453781528|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126134039|NCT03403205|453781529|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126134040|NCT03403205|453781524|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
126134041|NCT03403205|453781525|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
126134042|NCT03403205|453781526|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
126134043|NCT03403205|453781527|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
126134044|NCT03403205|453781528|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
126134045|NCT03403205|453781529|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
126134046|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
126134047|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
126134048|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
126134049|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
126134050|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
126134051|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
126134052|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
126134053|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
126134054|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
126134055|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
126134056|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
126134057|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
126134058|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Death|1|||
126134059|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Death|0|||
126134060|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Death|0|||
126134061|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Death|0|||
126134062|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Death|0|||
126134063|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Death|0|||
126134064|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
126134065|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126134066|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126134067|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126134068|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126134069|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126134070|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
126134071|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
126134072|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
126134073|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
126134074|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
126134075|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
126134076|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
126134077|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126134078|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126134079|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126134080|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126134081|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126134082|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
126134083|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
126134084|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
126134085|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
126134086|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
126134087|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
126134088|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
126134089|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
126134090|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
126134091|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
126134092|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
126134093|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
126134094|NCT03403205|453781524|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
126134095|NCT03403205|453781525|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
126134096|NCT03403205|453781526|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
126134097|NCT03403205|453781527|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
126134098|NCT03403205|453781528|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
126134099|NCT03403205|453781529|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
126134100|NCT01834729|453781530|FG000|Overall Study|Did not return bowel diaries|0|||
126134101|NCT01834729|453781531|FG001|Overall Study|Did not return bowel diaries|0|||
126134102|NCT01834729|453781532|FG002|Overall Study|Did not return bowel diaries|3|||
126134103|NCT01834729|453781533|FG003|Overall Study|Did not return bowel diaries|0|||
126134104|NCT01834729|453781530|FG000|Overall Study|Withdrawal by Subject|1|||
126134105|NCT01834729|453781531|FG001|Overall Study|Withdrawal by Subject|1|||
126134106|NCT01834729|453781532|FG002|Overall Study|Withdrawal by Subject|0|||
126134107|NCT01834729|453781533|FG003|Overall Study|Withdrawal by Subject|0|||
126134108|NCT01834729|453781530|FG000|Overall Study|Adverse Event|0|||
126134109|NCT01834729|453781531|FG001|Overall Study|Adverse Event|0|||
126134110|NCT01834729|453781532|FG002|Overall Study|Adverse Event|0|||
126134111|NCT01834729|453781533|FG003|Overall Study|Adverse Event|2|||
126134112|NCT02971670|453781534|FG000|Overall Study|Withdrawal by Subject|4|||
126134113|NCT02971670|453781535|FG001|Overall Study|Withdrawal by Subject|1|||
126134114|NCT02971670|453781536|FG002|Overall Study|Withdrawal by Subject|1|||
126134115|NCT02971670|453781537|FG003|Overall Study|Withdrawal by Subject|2|||
126134116|NCT00288080|453781538|FG000|Overall Study|Withdrawal by Subject|1|||
126134117|NCT00288080|453781539|FG001|Overall Study|Withdrawal by Subject|3|||
126134118|NCT00288080|453781538|FG000|Overall Study|Protocol Violation|25|||
126134119|NCT00288080|453781539|FG001|Overall Study|Protocol Violation|20|||
126134120|NCT00087646|453781540|FG000|Overall Study|Adverse Event|37|||
126134121|NCT00087646|453781541|FG001|Overall Study|Adverse Event|6|||
126134122|NCT00087646|453781542|FG002|Overall Study|Adverse Event|18|||
126134123|NCT00087646|453781543|FG003|Overall Study|Adverse Event|20|||
126134124|NCT00087646|453781540|FG000|Overall Study|Death|0|||
125965954|NCT03465540|453165879|FG000|Overall Study|Withdrawal by Subject|0|||
125965955|NCT03465540|453165880|FG001|Overall Study|Withdrawal by Subject|0|||
126134125|NCT00087646|453781541|FG001|Overall Study|Death|1|||
126134126|NCT00087646|453781542|FG002|Overall Study|Death|0|||
125965956|NCT03465540|453165881|FG002|Overall Study|Withdrawal by Subject|1|||
125965957|NCT03465540|453165882|FG003|Overall Study|Withdrawal by Subject|1|||
125965958|NCT03465540|453165883|FG004|Overall Study|Withdrawal by Subject|1|||
125965959|NCT03465540|453165884|FG005|Overall Study|Withdrawal by Subject|0|||
125965960|NCT03465540|453165879|FG000|Overall Study|Lost to Follow-up|0|||
125965961|NCT03465540|453165880|FG001|Overall Study|Lost to Follow-up|1|||
125965962|NCT03465540|453165881|FG002|Overall Study|Lost to Follow-up|0|||
125965963|NCT03465540|453165882|FG003|Overall Study|Lost to Follow-up|0|||
125965964|NCT03465540|453165883|FG004|Overall Study|Lost to Follow-up|1|||
125965965|NCT03465540|453165884|FG005|Overall Study|Lost to Follow-up|0|||
125965966|NCT03465540|453165879|FG000|Overall Study|Death|1|||
125965967|NCT03465540|453165880|FG001|Overall Study|Death|1|||
125965968|NCT03465540|453165881|FG002|Overall Study|Death|0|||
125965969|NCT03465540|453165882|FG003|Overall Study|Death|2|||
125965970|NCT03465540|453165883|FG004|Overall Study|Death|0|||
125965971|NCT03465540|453165884|FG005|Overall Study|Death|2|||
125965972|NCT03465540|453165879|FG000|Overall Study|Protocol specified criteria|0|||
125965973|NCT03465540|453165880|FG001|Overall Study|Protocol specified criteria|2|||
125965974|NCT03465540|453165881|FG002|Overall Study|Protocol specified criteria|2|||
125965975|NCT03465540|453165882|FG003|Overall Study|Protocol specified criteria|0|||
125965976|NCT03465540|453165883|FG004|Overall Study|Protocol specified criteria|2|||
125965977|NCT03465540|453165884|FG005|Overall Study|Protocol specified criteria|0|||
125965978|NCT00736996|453165885|FG000|Overall Study|Lost to Follow-up|1|||
125965979|NCT00736996|453165886|FG001|Overall Study|Lost to Follow-up|9|||
125965980|NCT00736996|453165887|FG002|Overall Study|Lost to Follow-up|2|||
125965981|NCT02844946|453165888|FG000|Overall Study|Lost to Follow-up|7|||
125965982|NCT02844946|453165889|FG001|Overall Study|Lost to Follow-up|0|||
125965983|NCT02806986|453165890|FG000|Treatment Stage 1|Adverse Event|1|||
125965984|NCT02806986|453165890|FG000|Treatment Stage 2|Adverse Event|3|||
125965985|NCT02806986|453165890|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
125965986|NCT00462384|453165891|FG000|Overall Study|Adverse Event|2|||
125965987|NCT00462384|453165891|FG000|Overall Study|Death|2|||
125965988|NCT00462384|453165891|FG000|Overall Study|Withdrawal by Subject|1|||
125965989|NCT00462384|453165891|FG000|Overall Study|Other|4|||
125965990|NCT02667912|453165892|FG000|Overall Study|Death|3|||
125965991|NCT02667912|453165893|FG001|Overall Study|Death|1|||
125965992|NCT02667912|453165892|FG000|Overall Study|Withdrawal by Subject|1|||
125965993|NCT02667912|453165893|FG001|Overall Study|Withdrawal by Subject|2|||
125965994|NCT02667912|453165892|FG000|Overall Study|Withdrawal by Subject|1|||
125965995|NCT02667912|453165893|FG001|Overall Study|Withdrawal by Subject|0|||
125965996|NCT04443218|453165894|FG000|Overall Study|Exited study for other reasons|9|||
125965997|NCT04443218|453165894|FG000|Overall Study|Withdrawal by Subject|1|||
125965998|NCT04443218|453165894|FG000|Overall Study|Lost to Follow-up|4|||
125965999|NCT04443218|453165894|FG000|Overall Study|Death|19|||
125966000|NCT00346034|453165895|FG000|Overall Study|Adverse Event|34|||
125966001|NCT00346034|453165895|FG000|Overall Study|Lack of Efficacy|8|||
125966002|NCT00346034|453165895|FG000|Overall Study|Withdrawal by Subject|13|||
125966003|NCT00346034|453165895|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
125966004|NCT00346034|453165895|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
125966005|NCT04000165|453165896|FG000|Overall Study|Physician Decision|1|||
125966006|NCT04000165|453165896|FG000|Overall Study|Withdrawal by Subject|1|||
125966007|NCT00503685|453165900|FG000|Overall Study|Adverse Event|0|||
125966008|NCT00503685|453165901|FG001|Overall Study|Adverse Event|0|||
125966009|NCT00503685|453165902|FG002|Overall Study|Adverse Event|2|||
125966010|NCT00503685|453165900|FG000|Overall Study|Withdrawal by Subject|0|||
125966011|NCT00503685|453165901|FG001|Overall Study|Withdrawal by Subject|1|||
125966012|NCT00503685|453165902|FG002|Overall Study|Withdrawal by Subject|0|||
125966013|NCT00503685|453165900|FG000|Overall Study|Protocol Violation|0|||
125966014|NCT00503685|453165901|FG001|Overall Study|Protocol Violation|1|||
126134127|NCT00087646|453781543|FG003|Overall Study|Death|0|||
126134128|NCT00087646|453781540|FG000|Overall Study|Withdrawal by Subject|6|||
126134129|NCT00087646|453781541|FG001|Overall Study|Withdrawal by Subject|1|||
126134130|NCT00087646|453781542|FG002|Overall Study|Withdrawal by Subject|2|||
126134131|NCT00087646|453781543|FG003|Overall Study|Withdrawal by Subject|2|||
126134132|NCT00087646|453781540|FG000|Overall Study|Insufficient therapeutic response|64|||
126134133|NCT00087646|453781541|FG001|Overall Study|Insufficient therapeutic response|24|||
126134134|NCT00087646|453781542|FG002|Overall Study|Insufficient therapeutic response|38|||
126134135|NCT00087646|453781543|FG003|Overall Study|Insufficient therapeutic response|51|||
126134136|NCT00087646|453781540|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
125966015|NCT00503685|453165902|FG002|Overall Study|Protocol Violation|0|||
125966016|NCT00503685|453165900|FG000|Overall Study|Eligibility Criteria Not Met|0|||
125966017|NCT00503685|453165901|FG001|Overall Study|Eligibility Criteria Not Met|1|||
125966018|NCT00503685|453165902|FG002|Overall Study|Eligibility Criteria Not Met|0|||
125966019|NCT02838017|453165904|FG000|Overall Study|Lost to Follow-up|14|||
125966020|NCT02838017|453165905|FG001|Overall Study|Lost to Follow-up|11|||
125966021|NCT02120924|453165906|FG000|Overall Study|Lack of Efficacy|1|||
125966022|NCT02120924|453165907|FG001|Overall Study|Lack of Efficacy|2|||
125966023|NCT02120924|453165908|FG002|Overall Study|Lack of Efficacy|3|||
126134137|NCT00087646|453781541|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
126134138|NCT00087646|453781542|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
126134139|NCT00087646|453781543|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
126134140|NCT00087646|453781540|FG000|Overall Study|Failure to Return|5|||
126134141|NCT00087646|453781541|FG001|Overall Study|Failure to Return|2|||
126134142|NCT00087646|453781542|FG002|Overall Study|Failure to Return|2|||
125966024|NCT02120924|453165906|FG000|Overall Study|Adverse Event|0|||
125966025|NCT02120924|453165907|FG001|Overall Study|Adverse Event|1|||
125966026|NCT02120924|453165908|FG002|Overall Study|Adverse Event|3|||
125966027|NCT02120924|453165906|FG000|Overall Study|Withdrawal by Subject|16|||
125966028|NCT02120924|453165907|FG001|Overall Study|Withdrawal by Subject|20|||
125966029|NCT02120924|453165908|FG002|Overall Study|Withdrawal by Subject|8|||
125966030|NCT02120924|453165906|FG000|Overall Study|Lost to Follow-up|14|||
125966031|NCT02120924|453165907|FG001|Overall Study|Lost to Follow-up|14|||
125966032|NCT02120924|453165908|FG002|Overall Study|Lost to Follow-up|11|||
125966033|NCT02120924|453165906|FG000|Overall Study|Pregnancy|2|||
125966034|NCT02120924|453165907|FG001|Overall Study|Pregnancy|0|||
125966035|NCT02120924|453165908|FG002|Overall Study|Pregnancy|0|||
125966036|NCT02120924|453165906|FG000|Overall Study|Protocol Violation|3|||
125966037|NCT02120924|453165907|FG001|Overall Study|Protocol Violation|7|||
125966038|NCT02120924|453165908|FG002|Overall Study|Protocol Violation|2|||
125966039|NCT02120924|453165906|FG000|Overall Study|Physician Decision|0|||
125966040|NCT02120924|453165907|FG001|Overall Study|Physician Decision|1|||
125966041|NCT02120924|453165908|FG002|Overall Study|Physician Decision|1|||
125966042|NCT02120924|453165906|FG000|Overall Study|Death|1|||
125966043|NCT02120924|453165907|FG001|Overall Study|Death|0|||
125966044|NCT02120924|453165908|FG002|Overall Study|Death|0|||
125966045|NCT02120924|453165906|FG000|Overall Study|Compliance with IP|5|||
125966046|NCT02120924|453165907|FG001|Overall Study|Compliance with IP|1|||
125966047|NCT02120924|453165908|FG002|Overall Study|Compliance with IP|1|||
125966048|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
125966049|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
125966050|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
125966051|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
125966052|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
125966053|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
125966054|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
125966055|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
125966056|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
125966057|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
125966058|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
125966059|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
125966060|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
125966061|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
125966062|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
125966063|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
125966064|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
125966065|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
125966066|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
125966067|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
125966068|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
125966069|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
125966070|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
125966071|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
125966072|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
125966073|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
125966074|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
125966075|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
126134143|NCT00087646|453781543|FG003|Overall Study|Failure to Return|3|||
126134144|NCT00087646|453781540|FG000|Overall Study|Administrative/Other|6|||
126134145|NCT00087646|453781541|FG001|Overall Study|Administrative/Other|1|||
126134146|NCT00087646|453781542|FG002|Overall Study|Administrative/Other|1|||
126134147|NCT00087646|453781543|FG003|Overall Study|Administrative/Other|2|||
126134148|NCT00087646|453781540|FG000|Overall Study|Other Protocol Violation|3|||
126134149|NCT00087646|453781541|FG001|Overall Study|Other Protocol Violation|1|||
126134150|NCT00087646|453781542|FG002|Overall Study|Other Protocol Violation|0|||
126134151|NCT00087646|453781543|FG003|Overall Study|Other Protocol Violation|0|||
126134152|NCT00087646|453781540|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125966076|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
125966077|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
126134153|NCT00087646|453781541|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
126134154|NCT00087646|453781542|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
126134155|NCT00087646|453781543|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
126134156|NCT01235962|453781544|FG000|Overall Study|Withdrawal by Subject|20|||
126134157|NCT01235962|453781545|FG001|Overall Study|Withdrawal by Subject|19|||
126134158|NCT01235962|453781546|FG002|Overall Study|Withdrawal by Subject|62|||
126134159|NCT01235962|453781547|FG003|Overall Study|Withdrawal by Subject|49|||
125966078|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
125966079|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
125966080|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
125966081|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
125966082|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
125966083|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
125966084|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
125966085|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
125966086|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
125966087|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
125966088|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
125966089|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
125966090|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
125966091|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
125966092|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
125966093|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
125966094|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
125966095|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
125966096|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
125966097|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
125966098|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
125966099|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
126134160|NCT01235962|453781544|FG000|Overall Study|Lost to Follow-up|21|||
126134161|NCT01235962|453781545|FG001|Overall Study|Lost to Follow-up|16|||
126134162|NCT01235962|453781546|FG002|Overall Study|Lost to Follow-up|47|||
126134163|NCT01235962|453781547|FG003|Overall Study|Lost to Follow-up|32|||
126134164|NCT01235962|453781544|FG000|Overall Study|Physician Decision|5|||
125966100|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
125966101|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
125966102|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
125966103|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
125966104|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
125966105|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
126134165|NCT01235962|453781545|FG001|Overall Study|Physician Decision|0|||
126134166|NCT01235962|453781546|FG002|Overall Study|Physician Decision|9|||
126134167|NCT01235962|453781547|FG003|Overall Study|Physician Decision|5|||
126134168|NCT01580397|453781550|FG000|Overall Study|Lack of Efficacy|14|||
126134169|NCT01353703|453781552|FG000|Overall Study|Migrated/moved from study area|1|||
126134170|NCT01353703|453781553|FG001|Overall Study|Migrated/moved from study area|0|||
126134171|NCT06098729|453781567|FG000|Overall Study|Withdrawal by Subject|1|||
126134172|NCT04925752|453781576|FG000|Overall Study|Still on Study|1826|||
126134173|NCT04925752|453781577|FG001|Overall Study|Still on Study|926|||
126134174|NCT04925752|453781576|FG000|Overall Study|Withdrew Consent|128|||
126134175|NCT04925752|453781577|FG001|Overall Study|Withdrew Consent|59|||
126134176|NCT04925752|453781576|FG000|Overall Study|Lost to Follow-up|73|||
126134177|NCT04925752|453781577|FG001|Overall Study|Lost to Follow-up|47|||
126134178|NCT04925752|453781576|FG000|Overall Study|Randomized but Never Treated|12|||
125966106|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
125966107|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
125966108|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
125966109|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
125966110|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
125966111|NCT01884350|453165909|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
125966112|NCT01884350|453165910|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
125966113|NCT01884350|453165911|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
125966114|NCT01059617|453165912|FG000|Overall Study|Other|7|||
125966115|NCT01059617|453165913|FG001|Overall Study|Other|1|||
126134179|NCT04925752|453781577|FG001|Overall Study|Randomized but Never Treated|9|||
126134180|NCT04925752|453781576|FG000|Overall Study|Hiv-1 Infection|6|||
126134181|NCT04925752|453781577|FG001|Overall Study|Hiv-1 Infection|7|||
126134182|NCT04925752|453781576|FG000|Overall Study|Investigator's discretion|8|||
125966116|NCT01059617|453165914|FG002|Overall Study|Other|8|||
125966117|NCT01059617|453165915|FG003|Overall Study|Other|6|||
125966118|NCT02345512|453165916|FG000|Overall Study|Adverse Event|1|||
125966119|NCT02345512|453165916|FG000|Overall Study|Withdrawal by Subject|1|||
125966120|NCT02663817|453165917|FG000|Overall Study|Screen failure|2|||
125966121|NCT01438541|453165918|FG000|Overall Study|Physician Decision|1|||
125966122|NCT01438541|453165918|FG000|Overall Study|Withdrawal by Subject|1|||
125966123|NCT01438541|453165918|FG000|Overall Study|discharge from the hospital|5|||
125966124|NCT01968434|453165921|FG000|Overall Study|Lost to Follow-up|3|||
125966125|NCT01968434|453165922|FG001|Overall Study|Lost to Follow-up|6|||
125966126|NCT02091167|453165923|FG000|Overall Study|Lost to Follow-up|0|||
125966127|NCT02091167|453165924|FG001|Overall Study|Lost to Follow-up|2|||
125966128|NCT00074282|453167462|FG000|Step 1|Adverse Event|32|||
125966129|NCT00074282|453167463|FG001|Step 1|Adverse Event|0|||
125966130|NCT00074282|453167464|FG002|Step 1|Adverse Event|0|||
125966131|NCT00074282|453167462|FG000|Step 1|Death|6|||
125966132|NCT00074282|453167463|FG001|Step 1|Death|0|||
125966133|NCT00074282|453167464|FG002|Step 1|Death|0|||
125966134|NCT00074282|453167462|FG000|Step 1|Withdrawal by Subject|7|||
125966135|NCT00074282|453167463|FG001|Step 1|Withdrawal by Subject|0|||
125966136|NCT00074282|453167464|FG002|Step 1|Withdrawal by Subject|0|||
125966137|NCT00074282|453167462|FG000|Step 1|Disease progression|2|||
125966138|NCT00074282|453167463|FG001|Step 1|Disease progression|0|||
125966139|NCT00074282|453167464|FG002|Step 1|Disease progression|0|||
125966140|NCT00074282|453167462|FG000|Step 1|Alternative therapy|2|||
125966141|NCT00074282|453167463|FG001|Step 1|Alternative therapy|0|||
125966142|NCT00074282|453167464|FG002|Step 1|Alternative therapy|0|||
125966143|NCT00074282|453167462|FG000|Step 1|Other complicating disease|2|||
125966144|NCT00074282|453167463|FG001|Step 1|Other complicating disease|0|||
125966145|NCT00074282|453167464|FG002|Step 1|Other complicating disease|0|||
125966146|NCT00074282|453167462|FG000|Step 1|Physician Decision|1|||
125966147|NCT00074282|453167463|FG001|Step 1|Physician Decision|0|||
125966148|NCT00074282|453167464|FG002|Step 1|Physician Decision|0|||
125966149|NCT00074282|453167462|FG000|Step 1|Ineligible|4|||
125966150|NCT00074282|453167463|FG001|Step 1|Ineligible|0|||
125966151|NCT00074282|453167464|FG002|Step 1|Ineligible|0|||
125966152|NCT00074282|453167462|FG000|Step 1|Never started treatment|2|||
125966153|NCT00074282|453167463|FG001|Step 1|Never started treatment|0|||
125966154|NCT00074282|453167464|FG002|Step 1|Never started treatment|0|||
125966155|NCT00074282|453167462|FG000|Step 2|Adverse Event|0|||
125966156|NCT00074282|453167463|FG001|Step 2|Adverse Event|2|||
125966157|NCT00074282|453167464|FG002|Step 2|Adverse Event|12|||
125966158|NCT00074282|453167462|FG000|Step 2|Disease progression|0|||
125966159|NCT00074282|453167463|FG001|Step 2|Disease progression|0|||
125966160|NCT00074282|453167464|FG002|Step 2|Disease progression|5|||
125966161|NCT00074282|453167462|FG000|Step 2|Death|0|||
125966162|NCT00074282|453167463|FG001|Step 2|Death|0|||
125966163|NCT00074282|453167464|FG002|Step 2|Death|3|||
125966164|NCT00074282|453167462|FG000|Step 2|Withdrawal by Subject|0|||
125966165|NCT00074282|453167463|FG001|Step 2|Withdrawal by Subject|0|||
125966166|NCT00074282|453167464|FG002|Step 2|Withdrawal by Subject|2|||
125966167|NCT00074282|453167462|FG000|Step 2|Physician Decision|0|||
125966168|NCT00074282|453167463|FG001|Step 2|Physician Decision|0|||
125966169|NCT00074282|453167464|FG002|Step 2|Physician Decision|1|||
125966170|NCT00074282|453167462|FG000|Step 2|Ineligible|0|||
125966171|NCT00074282|453167463|FG001|Step 2|Ineligible|0|||
125966172|NCT00074282|453167464|FG002|Step 2|Ineligible|1|||
125966173|NCT00464542|453167465|FG000|Pre-treatment|Withdrawal by Subject|2|||
125966174|NCT01773226|453167467|FG000|Overall Study|Withdrawal by Subject|1|||
125966175|NCT02055352|453167472|FG000|Overall Study|Adverse Event|0|||
125966176|NCT02055352|453167473|FG001|Overall Study|Adverse Event|1|||
125966177|NCT02055352|453167472|FG000|Overall Study|Non-eligible|0|||
125966178|NCT02055352|453167473|FG001|Overall Study|Non-eligible|1|||
125966179|NCT02055352|453167472|FG000|Overall Study|Poor compliance|1|||
125966180|NCT02055352|453167473|FG001|Overall Study|Poor compliance|1|||
125966181|NCT02055352|453167472|FG000|Overall Study|Death|1|||
125966182|NCT02055352|453167473|FG001|Overall Study|Death|2|||
125966183|NCT02055352|453167472|FG000|Overall Study|Patient decision|1|||
125966184|NCT02055352|453167473|FG001|Overall Study|Patient decision|1|||
125966185|NCT02055352|453167472|FG000|Overall Study|Use of prohibited treatment|0|||
125966186|NCT02055352|453167473|FG001|Overall Study|Use of prohibited treatment|3|||
125966187|NCT02055352|453167472|FG000|Overall Study|AE, study drug would be detrimental|1|||
125966188|NCT02055352|453167473|FG001|Overall Study|AE, study drug would be detrimental|3|||
125966189|NCT02055352|453167472|FG000|Overall Study|Withdrawal of informed consent|1|||
125966190|NCT02055352|453167473|FG001|Overall Study|Withdrawal of informed consent|0|||
125966191|NCT02055352|453167472|FG000|Overall Study|Reason unknown|1|||
125966192|NCT02055352|453167473|FG001|Overall Study|Reason unknown|5|||
125966193|NCT00086346|453167480|FG000|Randomization|Did not receive test article|4|||
125966194|NCT00086346|453167481|FG001|Randomization|Did not receive test article|4|||
125966195|NCT00086346|453167480|FG000|Patients Dosed With Test Article|Adverse Event|94|||
125966196|NCT00086346|453167481|FG001|Patients Dosed With Test Article|Adverse Event|11|||
125966197|NCT00086346|453167480|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
125966198|NCT00086346|453167481|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
125966199|NCT00086346|453167480|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
125966200|NCT00086346|453167481|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
125966201|NCT00086346|453167480|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
125966202|NCT00086346|453167481|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
125966203|NCT00086346|453167480|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
125966204|NCT00086346|453167481|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
125966205|NCT00086346|453167480|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
125966206|NCT00086346|453167481|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
125966207|NCT03268811|453167482|FG000|Overall Study|Adverse Event|0|||
125966208|NCT03268811|453167483|FG001|Overall Study|Adverse Event|1|||
125966209|NCT02348216|453167491|FG000|Overall Study|Death|5|||
125966210|NCT02348216|453167492|FG001|Overall Study|Death|53|||
125966211|NCT02348216|453167493|FG002|Overall Study|Death|11|||
125966212|NCT02348216|453167494|FG003|Overall Study|Death|20|||
125966213|NCT02348216|453167495|FG004|Overall Study|Death|16|||
125966214|NCT02348216|453167496|FG005|Overall Study|Death|32|||
125966215|NCT02348216|453167497|FG006|Overall Study|Death|17|||
125966216|NCT02348216|453167491|FG000|Overall Study|Full consent withdrawal|0|||
125966217|NCT02348216|453167492|FG001|Overall Study|Full consent withdrawal|0|||
125966218|NCT02348216|453167493|FG002|Overall Study|Full consent withdrawal|0|||
125966219|NCT02348216|453167494|FG003|Overall Study|Full consent withdrawal|1|||
125966220|NCT02348216|453167495|FG004|Overall Study|Full consent withdrawal|3|||
125966221|NCT02348216|453167496|FG005|Overall Study|Full consent withdrawal|0|||
125966222|NCT02348216|453167497|FG006|Overall Study|Full consent withdrawal|3|||
125966223|NCT02348216|453167491|FG000|Overall Study|Lost to Follow-up|0|||
125966224|NCT02348216|453167492|FG001|Overall Study|Lost to Follow-up|5|||
125966225|NCT02348216|453167493|FG002|Overall Study|Lost to Follow-up|2|||
125966226|NCT02348216|453167494|FG003|Overall Study|Lost to Follow-up|0|||
125966227|NCT02348216|453167495|FG004|Overall Study|Lost to Follow-up|1|||
125966228|NCT02348216|453167496|FG005|Overall Study|Lost to Follow-up|1|||
125966229|NCT02348216|453167497|FG006|Overall Study|Lost to Follow-up|1|||
125966230|NCT02348216|453167491|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
125966231|NCT02348216|453167492|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
125966232|NCT02348216|453167493|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
125966233|NCT02348216|453167494|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
125966234|NCT02348216|453167495|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
125966235|NCT02348216|453167496|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
125966236|NCT02348216|453167497|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
125966237|NCT02348216|453167491|FG000|Overall Study|Reason not specified|2|||
125966238|NCT02348216|453167492|FG001|Overall Study|Reason not specified|19|||
125966239|NCT02348216|453167493|FG002|Overall Study|Reason not specified|11|||
125966240|NCT02348216|453167494|FG003|Overall Study|Reason not specified|17|||
125966241|NCT02348216|453167495|FG004|Overall Study|Reason not specified|21|||
125966242|NCT02348216|453167496|FG005|Overall Study|Reason not specified|17|||
125966243|NCT02348216|453167497|FG006|Overall Study|Reason not specified|19|||
125966244|NCT01055639|453167498|FG000|Overall Study|Adverse Event|0|||
125966245|NCT01055639|453167499|FG001|Overall Study|Adverse Event|1|||
125966246|NCT01055639|453167498|FG000|Overall Study|Lack of Efficacy|0|||
125966247|NCT01055639|453167499|FG001|Overall Study|Lack of Efficacy|1|||
125966248|NCT01055639|453167498|FG000|Overall Study|Lost to Follow-up|8|||
125966249|NCT01055639|453167499|FG001|Overall Study|Lost to Follow-up|11|||
125966250|NCT01055639|453167498|FG000|Overall Study|Protocol Violation|5|||
125966251|NCT01055639|453167499|FG001|Overall Study|Protocol Violation|5|||
125966252|NCT01055639|453167498|FG000|Overall Study|Withdrawal by Subject|8|||
125966253|NCT01055639|453167499|FG001|Overall Study|Withdrawal by Subject|11|||
125966254|NCT00765245|453167500|FG000|Overall Study|disease progression|3|||
125966255|NCT00765245|453167501|FG001|Overall Study|disease progression|2|||
126134183|NCT04925752|453781577|FG001|Overall Study|Investigator's discretion|5|||
126134184|NCT04925752|453781576|FG000|Overall Study|Non-compliance with Study Drug|8|||
126134185|NCT04925752|453781577|FG001|Overall Study|Non-compliance with Study Drug|5|||
126134186|NCT04925752|453781576|FG000|Overall Study|Adverse Event|5|||
126134187|NCT04925752|453781577|FG001|Overall Study|Adverse Event|2|||
125966256|NCT00765245|453167500|FG000|Overall Study|Withdrawal by Subject|3|||
125966257|NCT00765245|453167501|FG001|Overall Study|Withdrawal by Subject|0|||
126134188|NCT04925752|453781576|FG000|Overall Study|Death|4|||
125966258|NCT00765245|453167500|FG000|Overall Study|Adverse Event|5|||
125966259|NCT00765245|453167501|FG001|Overall Study|Adverse Event|0|||
125966260|NCT00765245|453167500|FG000|Overall Study|Physician Decision|1|||
125966261|NCT00765245|453167501|FG001|Overall Study|Physician Decision|0|||
125966262|NCT00765245|453167500|FG000|Overall Study|Death|1|||
125966263|NCT00765245|453167501|FG001|Overall Study|Death|0|||
125966264|NCT02548962|453167503|FG000|Overall Study|Withdrawal by Subject|1|||
125966265|NCT02548962|453167504|FG001|Overall Study|Withdrawal by Subject|0|||
126134189|NCT04925752|453781577|FG001|Overall Study|Death|2|||
125966266|NCT01197950|453167505|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
125971519|NCT00791765|453184716|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
126134190|NCT04925752|453781576|FG000|Overall Study|Protocol Violation|1|||
126134191|NCT04925752|453781577|FG001|Overall Study|Protocol Violation|3|||
126134192|NCT04925752|453781576|FG000|Overall Study|Withdrew Assent|1|||
126134193|NCT04925752|453781577|FG001|Overall Study|Withdrew Assent|0|||
126134194|NCT03467958|453781579|FG000|Overall Study|Adverse Event|20|||
126134195|NCT03467958|453781580|FG001|Overall Study|Adverse Event|32|||
126134196|NCT03467958|453781581|FG002|Overall Study|Adverse Event|5|||
126134197|NCT03467958|453781582|FG003|Overall Study|Adverse Event|3|||
126134198|NCT03467958|453781583|FG004|Overall Study|Adverse Event|3|||
126134199|NCT03467958|453781584|FG005|Overall Study|Adverse Event|3|||
126134200|NCT03467958|453781585|FG006|Overall Study|Adverse Event|6|||
126134201|NCT03467958|453781586|FG007|Overall Study|Adverse Event|5|||
126134202|NCT03467958|453781587|FG008|Overall Study|Adverse Event|0|||
126134203|NCT03467958|453781579|FG000|Overall Study|Lack of Efficacy|59|||
126134204|NCT03467958|453781580|FG001|Overall Study|Lack of Efficacy|120|||
126134205|NCT03467958|453781581|FG002|Overall Study|Lack of Efficacy|6|||
126134206|NCT03467958|453781582|FG003|Overall Study|Lack of Efficacy|9|||
126134207|NCT03467958|453781583|FG004|Overall Study|Lack of Efficacy|8|||
126134208|NCT03467958|453781584|FG005|Overall Study|Lack of Efficacy|9|||
126134209|NCT03467958|453781585|FG006|Overall Study|Lack of Efficacy|11|||
126134210|NCT03467958|453781586|FG007|Overall Study|Lack of Efficacy|9|||
126134211|NCT03467958|453781587|FG008|Overall Study|Lack of Efficacy|3|||
126134212|NCT03467958|453781579|FG000|Overall Study|Lost to Follow-up|1|||
126134213|NCT03467958|453781580|FG001|Overall Study|Lost to Follow-up|2|||
126134214|NCT03467958|453781581|FG002|Overall Study|Lost to Follow-up|1|||
126134215|NCT03467958|453781582|FG003|Overall Study|Lost to Follow-up|0|||
126134216|NCT03467958|453781583|FG004|Overall Study|Lost to Follow-up|4|||
126134217|NCT03467958|453781584|FG005|Overall Study|Lost to Follow-up|0|||
126134218|NCT03467958|453781585|FG006|Overall Study|Lost to Follow-up|0|||
126134219|NCT03467958|453781586|FG007|Overall Study|Lost to Follow-up|0|||
126134220|NCT03467958|453781587|FG008|Overall Study|Lost to Follow-up|0|||
126134221|NCT03467958|453781579|FG000|Overall Study|Other reasons|8|||
126134222|NCT03467958|453781580|FG001|Overall Study|Other reasons|14|||
126134223|NCT03467958|453781581|FG002|Overall Study|Other reasons|2|||
126134224|NCT03467958|453781582|FG003|Overall Study|Other reasons|1|||
126134225|NCT03467958|453781583|FG004|Overall Study|Other reasons|4|||
126134226|NCT03467958|453781584|FG005|Overall Study|Other reasons|0|||
126134227|NCT03467958|453781585|FG006|Overall Study|Other reasons|1|||
126134228|NCT03467958|453781586|FG007|Overall Study|Other reasons|0|||
126134229|NCT03467958|453781587|FG008|Overall Study|Other reasons|1|||
126134230|NCT03467958|453781579|FG000|Overall Study|Pregnancy|1|||
126134231|NCT03467958|453781580|FG001|Overall Study|Pregnancy|0|||
126134232|NCT03467958|453781581|FG002|Overall Study|Pregnancy|0|||
126134233|NCT03467958|453781582|FG003|Overall Study|Pregnancy|0|||
126134234|NCT03467958|453781583|FG004|Overall Study|Pregnancy|0|||
126134235|NCT03467958|453781584|FG005|Overall Study|Pregnancy|1|||
126134236|NCT03467958|453781585|FG006|Overall Study|Pregnancy|0|||
126134237|NCT03467958|453781586|FG007|Overall Study|Pregnancy|0|||
126134238|NCT03467958|453781587|FG008|Overall Study|Pregnancy|0|||
126134239|NCT03467958|453781579|FG000|Overall Study|Study terminated by sponsor|65|||
126134240|NCT03467958|453781580|FG001|Overall Study|Study terminated by sponsor|117|||
126134241|NCT03467958|453781581|FG002|Overall Study|Study terminated by sponsor|45|||
126134242|NCT03467958|453781582|FG003|Overall Study|Study terminated by sponsor|64|||
126134243|NCT03467958|453781583|FG004|Overall Study|Study terminated by sponsor|66|||
126134244|NCT03467958|453781584|FG005|Overall Study|Study terminated by sponsor|17|||
126134245|NCT03467958|453781585|FG006|Overall Study|Study terminated by sponsor|11|||
126134246|NCT03467958|453781586|FG007|Overall Study|Study terminated by sponsor|5|||
126134247|NCT03467958|453781587|FG008|Overall Study|Study terminated by sponsor|5|||
126134248|NCT03467958|453781579|FG000|Overall Study|Withdrawal by Subject|25|||
126134249|NCT03467958|453781580|FG001|Overall Study|Withdrawal by Subject|44|||
126134250|NCT03467958|453781581|FG002|Overall Study|Withdrawal by Subject|7|||
126134251|NCT03467958|453781582|FG003|Overall Study|Withdrawal by Subject|8|||
126134252|NCT03467958|453781583|FG004|Overall Study|Withdrawal by Subject|6|||
126134253|NCT03467958|453781584|FG005|Overall Study|Withdrawal by Subject|8|||
126134254|NCT03467958|453781585|FG006|Overall Study|Withdrawal by Subject|4|||
126134255|NCT03467958|453781586|FG007|Overall Study|Withdrawal by Subject|1|||
126134256|NCT03467958|453781587|FG008|Overall Study|Withdrawal by Subject|4|||
126134257|NCT00866307|453781588|FG000|Induction|Adverse Event|5|||
126134258|NCT00866307|453781589|FG001|Induction|Adverse Event|0|||
126134259|NCT00866307|453781590|FG002|Induction|Adverse Event|0|||
126134260|NCT00866307|453781588|FG000|Induction|Death|2|||
126134261|NCT00866307|453781589|FG001|Induction|Death|0|||
126134262|NCT00866307|453781590|FG002|Induction|Death|0|||
126134263|NCT00866307|453781588|FG000|Induction|Physician Decision|5|||
126134264|NCT00866307|453781589|FG001|Induction|Physician Decision|0|||
126134265|NCT00866307|453781590|FG002|Induction|Physician Decision|0|||
126134266|NCT00866307|453781588|FG000|Induction|Progressive Disease|1|||
126134267|NCT00866307|453781589|FG001|Induction|Progressive Disease|0|||
126134268|NCT00866307|453781590|FG002|Induction|Progressive Disease|0|||
126134269|NCT00866307|453781588|FG000|Induction|Identification of Patients with Day 29 M|3|||
126134270|NCT00866307|453781589|FG001|Induction|Identification of Patients with Day 29 M|0|||
126134271|NCT00866307|453781590|FG002|Induction|Identification of Patients with Day 29 M|0|||
126134272|NCT00866307|453781588|FG000|Induction|Inadequate cytognetic samples th|1|||
126134273|NCT00866307|453781589|FG001|Induction|Inadequate cytognetic samples th|0|||
126134274|NCT00866307|453781590|FG002|Induction|Inadequate cytognetic samples th|0|||
126134275|NCT00866307|453781588|FG000|Induction|Improper post-induction consent|2|||
126134276|NCT00866307|453781589|FG001|Induction|Improper post-induction consent|0|||
126134277|NCT00866307|453781590|FG002|Induction|Improper post-induction consent|0|||
126134278|NCT00866307|453781588|FG000|Induction|Study was closed at the time|1|||
126134279|NCT00866307|453781589|FG001|Induction|Study was closed at the time|0|||
126134280|NCT00866307|453781590|FG002|Induction|Study was closed at the time|0|||
126134281|NCT00866307|453781588|FG000|Consolidation/Maintenance|Adverse Event|0|||
126134282|NCT00866307|453781589|FG001|Consolidation/Maintenance|Adverse Event|0|||
126134283|NCT00866307|453781590|FG002|Consolidation/Maintenance|Adverse Event|8|||
126134284|NCT00866307|453781588|FG000|Consolidation/Maintenance|Death|0|||
126134285|NCT00866307|453781589|FG001|Consolidation/Maintenance|Death|0|||
126134286|NCT00866307|453781590|FG002|Consolidation/Maintenance|Death|1|||
126134287|NCT00866307|453781588|FG000|Consolidation/Maintenance|Physician Decision|0|||
126134288|NCT00866307|453781589|FG001|Consolidation/Maintenance|Physician Decision|3|||
126134289|NCT00866307|453781590|FG002|Consolidation/Maintenance|Physician Decision|2|||
126134290|NCT00866307|453781588|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
126134291|NCT00866307|453781589|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
126134292|NCT00866307|453781590|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
126134293|NCT00866307|453781588|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
126134294|NCT00866307|453781589|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
126134295|NCT00866307|453781590|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
126134296|NCT00866307|453781588|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
126134297|NCT00866307|453781589|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
126134298|NCT00866307|453781590|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
126134299|NCT00866307|453781588|FG000|Consolidation/Maintenance|Therapy error|0|||
126134300|NCT00866307|453781589|FG001|Consolidation/Maintenance|Therapy error|1|||
126134301|NCT00866307|453781590|FG002|Consolidation/Maintenance|Therapy error|0|||
126134302|NCT00866307|453781588|FG000|Consolidation/Maintenance|Non-compliance|0|||
126134303|NCT00866307|453781589|FG001|Consolidation/Maintenance|Non-compliance|0|||
126134304|NCT00866307|453781590|FG002|Consolidation/Maintenance|Non-compliance|1|||
126134305|NCT00866307|453781588|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
126134306|NCT00866307|453781589|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
126134307|NCT00866307|453781590|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
126134308|NCT02925156|453781591|FG000|Overall Study|Lost to Follow-up|27|||
126134309|NCT02925156|453781592|FG001|Overall Study|Lost to Follow-up|53|||
126134310|NCT02925156|453781593|FG002|Overall Study|Lost to Follow-up|51|||
126134311|NCT02925156|453781594|FG003|Overall Study|Lost to Follow-up|59|||
126134312|NCT02925156|453781595|FG004|Overall Study|Lost to Follow-up|89|||
126134313|NCT02925156|453781596|FG005|Overall Study|Lost to Follow-up|107|||
126134314|NCT02925156|453781597|FG006|Overall Study|Lost to Follow-up|34|||
126134315|NCT02925156|453781598|FG007|Overall Study|Lost to Follow-up|36|||
126134316|NCT02925156|453781599|FG008|Overall Study|Lost to Follow-up|73|||
126134317|NCT02925156|453781600|FG009|Overall Study|Lost to Follow-up|34|||
126134318|NCT02286947|453781603|FG000|Overall Study|Withdrawal by Subject|2|||
126134319|NCT01060059|453781604|FG000|Overall Study|Adverse Event|1|||
126134320|NCT01060059|453781605|FG001|Overall Study|Adverse Event|1|||
126134321|NCT01060059|453781604|FG000|Overall Study|Death|2|||
126134322|NCT01060059|453781605|FG001|Overall Study|Death|3|||
126134323|NCT01060059|453781604|FG000|Overall Study|Lost to Follow-up|18|||
126134324|NCT01060059|453781605|FG001|Overall Study|Lost to Follow-up|34|||
126134325|NCT01060059|453781604|FG000|Overall Study|entry criteria not met|4|||
126134326|NCT01060059|453781605|FG001|Overall Study|entry criteria not met|3|||
126134327|NCT01060059|453781604|FG000|Overall Study|Withdrawal by Subject|35|||
126134328|NCT01060059|453781605|FG001|Overall Study|Withdrawal by Subject|23|||
126134329|NCT01060059|453781604|FG000|Overall Study|lack of glycemic control|2|||
126134330|NCT01060059|453781605|FG001|Overall Study|lack of glycemic control|1|||
126134331|NCT01060059|453781604|FG000|Overall Study|lack of compliance|5|||
125966267|NCT01197950|453167506|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
126134332|NCT01060059|453781605|FG001|Overall Study|lack of compliance|2|||
126134333|NCT01777581|453781606|FG000|Overall Study|Lost to Follow-up|1|||
126134334|NCT01777581|453781607|FG001|Overall Study|Lost to Follow-up|1|||
126134335|NCT01777581|453781606|FG000|Overall Study|Adverse Event|2|||
126134336|NCT01777581|453781607|FG001|Overall Study|Adverse Event|0|||
126134337|NCT01777581|453781606|FG000|Overall Study|Lack of Efficacy|0|||
126134338|NCT01777581|453781607|FG001|Overall Study|Lack of Efficacy|1|||
126134339|NCT03406897|453781610|FG000|Overall Study|Lost to Follow-up|1|||
126134340|NCT03406897|453781611|FG001|Overall Study|Lost to Follow-up|2|||
126134341|NCT03406897|453781610|FG000|Overall Study|Withdrawal by Subject|4|||
126134342|NCT03406897|453781611|FG001|Overall Study|Withdrawal by Subject|4|||
126134343|NCT03406897|453781610|FG000|Overall Study|Physician Decision|0|||
126134344|NCT03406897|453781611|FG001|Overall Study|Physician Decision|1|||
126134345|NCT00598975|453783673|FG000|Overall Study|Adverse Event|1|||
126134346|NCT00598975|453783674|FG001|Overall Study|Adverse Event|1|||
126134347|NCT00598975|453783673|FG000|Overall Study|Brain metastases|1|||
126134348|NCT00598975|453783674|FG001|Overall Study|Brain metastases|0|||
126134349|NCT00598975|453783673|FG000|Overall Study|Withdrawal by Subject|1|||
126134350|NCT00598975|453783674|FG001|Overall Study|Withdrawal by Subject|1|||
126134351|NCT00598975|453783673|FG000|Overall Study|Withdrawal of consent|0|||
126134352|NCT00598975|453783674|FG001|Overall Study|Withdrawal of consent|1|||
126134353|NCT00598975|453783673|FG000|Overall Study|Disease progression|8|||
125966268|NCT01197950|453167507|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
125966269|NCT04831736|453167508|FG000|Overall Study|Withdrawal by Subject|0|||
125966270|NCT04831736|453167509|FG001|Overall Study|Withdrawal by Subject|1|||
125966271|NCT02265705|453167516|FG000|Treatment Period Week 0-24|Adverse Event|3|||
125966272|NCT02265705|453167517|FG001|Treatment Period Week 0-24|Adverse Event|2|||
125966273|NCT02265705|453167518|FG002|Treatment Period Week 0-24|Adverse Event|0|||
125966274|NCT02265705|453167519|FG003|Treatment Period Week 0-24|Adverse Event|0|||
125966275|NCT02265705|453167520|FG004|Treatment Period Week 0-24|Adverse Event|0|||
125966276|NCT02265705|453167521|FG005|Treatment Period Week 0-24|Adverse Event|0|||
125966277|NCT02265705|453167522|FG006|Treatment Period Week 0-24|Adverse Event|0|||
125966278|NCT02265705|453167516|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
125966279|NCT02265705|453167517|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
126134354|NCT00598975|453783674|FG001|Overall Study|Disease progression|3|||
126134355|NCT00598975|453783673|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
126134356|NCT00598975|453783674|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
126134357|NCT05227690|453783684|FG000|Overall Study|Adverse Event|5|||
126134358|NCT05227690|453783685|FG001|Overall Study|Adverse Event|6|||
126134359|NCT05227690|453783686|FG002|Overall Study|Adverse Event|10|||
126134360|NCT05227690|453783684|FG000|Overall Study|Lack of Efficacy|2|||
126134361|NCT05227690|453783685|FG001|Overall Study|Lack of Efficacy|4|||
126134362|NCT05227690|453783686|FG002|Overall Study|Lack of Efficacy|1|||
126134363|NCT05227690|453783684|FG000|Overall Study|Physician Decision|6|||
126134364|NCT05227690|453783685|FG001|Overall Study|Physician Decision|0|||
126134365|NCT05227690|453783686|FG002|Overall Study|Physician Decision|4|||
126134366|NCT05227690|453783684|FG000|Overall Study|Withdrawal of consent|28|||
126134367|NCT05227690|453783685|FG001|Overall Study|Withdrawal of consent|27|||
126134368|NCT05227690|453783686|FG002|Overall Study|Withdrawal of consent|21|||
126134369|NCT05227690|453783684|FG000|Overall Study|Other, not specified|2|||
126134370|NCT05227690|453783685|FG001|Overall Study|Other, not specified|2|||
126134371|NCT05227690|453783686|FG002|Overall Study|Other, not specified|1|||
126134372|NCT04033367|453783687|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
126134373|NCT04033367|453783688|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
126134374|NCT04033367|453783687|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
126134375|NCT04033367|453783688|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
126134376|NCT04033367|453783687|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
126134377|NCT04033367|453783688|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
126134378|NCT04033367|453783687|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
126134379|NCT04033367|453783688|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
126134380|NCT02723201|453783689|FG000|Second Intervention Period|Protocol Violation|1|||
126134381|NCT02723201|453783690|FG001|Second Intervention Period|Protocol Violation|0|||
126134382|NCT02723201|453783691|FG002|Second Intervention Period|Protocol Violation|0|||
126134383|NCT02723201|453783689|FG000|Second Intervention Period|Adverse Event|1|||
126134384|NCT02723201|453783690|FG001|Second Intervention Period|Adverse Event|0|||
126134385|NCT02723201|453783691|FG002|Second Intervention Period|Adverse Event|0|||
126134386|NCT03472560|453783692|FG000|Overall Study|Subject transfer to continuation protocol|0|||
126134387|NCT03472560|453783693|FG001|Overall Study|Subject transfer to continuation protocol|1|||
126134388|NCT03472560|453783692|FG000|Overall Study|Withdrawal by Subject|4|||
125966280|NCT02265705|453167518|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
125966281|NCT02265705|453167519|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
125966282|NCT02265705|453167520|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
125966283|NCT02265705|453167521|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
126134389|NCT03472560|453783693|FG001|Overall Study|Withdrawal by Subject|0|||
126134390|NCT03472560|453783692|FG000|Overall Study|Progressive disease|24|||
126134391|NCT03472560|453783693|FG001|Overall Study|Progressive disease|8|||
125966284|NCT02265705|453167522|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
126134392|NCT03472560|453783692|FG000|Overall Study|Physician Decision|1|||
126134393|NCT03472560|453783693|FG001|Overall Study|Physician Decision|0|||
126134394|NCT03472560|453783692|FG000|Overall Study|Death|7|||
126134395|NCT03472560|453783693|FG001|Overall Study|Death|4|||
126134396|NCT03472560|453783692|FG000|Overall Study|Adverse Event|5|||
126134397|NCT03472560|453783693|FG001|Overall Study|Adverse Event|3|||
126134398|NCT03472560|453783692|FG000|Overall Study|Global deterioration of health status|0|||
126134399|NCT03472560|453783693|FG001|Overall Study|Global deterioration of health status|4|||
126134400|NCT02421887|453783694|FG000|Overall Study|Lost to Follow-up|5|||
126134401|NCT02421887|453783695|FG001|Overall Study|Lost to Follow-up|0|||
126134402|NCT02421887|453783694|FG000|Overall Study|Withdrawal by Subject|8|||
126134403|NCT02421887|453783695|FG001|Overall Study|Withdrawal by Subject|5|||
126134404|NCT02421887|453783694|FG000|Overall Study|Physician Decision|2|||
126134405|NCT02421887|453783695|FG001|Overall Study|Physician Decision|4|||
126134406|NCT02421887|453783694|FG000|Overall Study|Adverse Event|2|||
126134407|NCT02421887|453783695|FG001|Overall Study|Adverse Event|0|||
126134408|NCT00491179|453783698|FG000|Overall Study|Adverse Event|5|||
126134409|NCT00491179|453783699|FG001|Overall Study|Adverse Event|1|||
126134410|NCT00491179|453783698|FG000|Overall Study|Withdrawal by Subject|2|||
126134411|NCT00491179|453783699|FG001|Overall Study|Withdrawal by Subject|1|||
126134412|NCT01505894|453783700|FG000|Overall Study|Adverse Event|1|||
126134413|NCT01505894|453783701|FG001|Overall Study|Adverse Event|0|||
126134414|NCT01505894|453783702|FG002|Overall Study|Adverse Event|0|||
126134415|NCT01505894|453783703|FG003|Overall Study|Adverse Event|0|||
126134416|NCT01505894|453783704|FG004|Overall Study|Adverse Event|0|||
126134417|NCT01505894|453783705|FG005|Overall Study|Adverse Event|0|||
126134418|NCT01505894|453783706|FG006|Overall Study|Adverse Event|0|||
126134419|NCT01505894|453783707|FG007|Overall Study|Adverse Event|0|||
126134420|NCT01505894|453783708|FG008|Overall Study|Adverse Event|0|||
126134421|NCT01505894|453783700|FG000|Overall Study|Other than specified|0|||
126134422|NCT01505894|453783701|FG001|Overall Study|Other than specified|0|||
126134423|NCT01505894|453783702|FG002|Overall Study|Other than specified|0|||
126134424|NCT01505894|453783703|FG003|Overall Study|Other than specified|0|||
126134425|NCT01505894|453783704|FG004|Overall Study|Other than specified|1|||
126134426|NCT01505894|453783705|FG005|Overall Study|Other than specified|0|||
126134427|NCT01505894|453783706|FG006|Overall Study|Other than specified|0|||
126134428|NCT01505894|453783707|FG007|Overall Study|Other than specified|0|||
126134429|NCT01505894|453783708|FG008|Overall Study|Other than specified|0|||
126134430|NCT04269395|453783709|FG000|Overall Study|Lost to Follow-up|1|||
126134431|NCT04269395|453783710|FG001|Overall Study|Lost to Follow-up|0|||
126134432|NCT04269395|453783709|FG000|Overall Study|Study terminated by Sponsor|13|||
126134433|NCT04269395|453783710|FG001|Overall Study|Study terminated by Sponsor|10|||
126134434|NCT00584233|453783711|FG000|Overall Study|Withdrawal by Subject|5|||
126134435|NCT00584233|453783711|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
126134436|NCT03529773|453783712|FG000|Overall Study|Adverse Event|0|||
126134437|NCT03529773|453783713|FG001|Overall Study|Adverse Event|0|||
126134438|NCT03529773|453783714|FG002|Overall Study|Adverse Event|0|||
126134439|NCT03529773|453783715|FG003|Overall Study|Adverse Event|0|||
126134440|NCT03529773|453783716|FG004|Overall Study|Adverse Event|0|||
126134441|NCT03529773|453783717|FG005|Overall Study|Adverse Event|0|||
126134442|NCT03529773|453783718|FG006|Overall Study|Adverse Event|0|||
126134443|NCT03529773|453783719|FG007|Overall Study|Adverse Event|0|||
126134444|NCT03529773|453783720|FG008|Overall Study|Adverse Event|0|||
126134445|NCT03529773|453783721|FG009|Overall Study|Adverse Event|0|||
126134446|NCT03529773|453783722|FG010|Overall Study|Adverse Event|0|||
126134447|NCT03529773|453783723|FG011|Overall Study|Adverse Event|0|||
126134448|NCT03529773|453783724|FG012|Overall Study|Adverse Event|0|||
126134449|NCT03529773|453783725|FG013|Overall Study|Adverse Event|0|||
126134450|NCT03529773|453783726|FG014|Overall Study|Adverse Event|0|||
126134451|NCT03529773|453783727|FG015|Overall Study|Adverse Event|0|||
126134452|NCT03529773|453783728|FG016|Overall Study|Adverse Event|0|||
126134453|NCT03529773|453783729|FG017|Overall Study|Adverse Event|0|||
126134454|NCT03529773|453783730|FG018|Overall Study|Adverse Event|0|||
126134455|NCT03529773|453783731|FG019|Overall Study|Adverse Event|0|||
126134456|NCT03529773|453783732|FG020|Overall Study|Adverse Event|0|||
126134457|NCT03529773|453783733|FG021|Overall Study|Adverse Event|0|||
126134458|NCT03529773|453783734|FG022|Overall Study|Adverse Event|0|||
126134459|NCT03529773|453783735|FG023|Overall Study|Adverse Event|0|||
126134460|NCT03529773|453783736|FG024|Overall Study|Adverse Event|0|||
126134461|NCT03529773|453783737|FG025|Overall Study|Adverse Event|0|||
126134462|NCT03529773|453783738|FG026|Overall Study|Adverse Event|0|||
126134463|NCT03529773|453783739|FG027|Overall Study|Adverse Event|0|||
126134464|NCT03529773|453783740|FG028|Overall Study|Adverse Event|0|||
126134465|NCT03529773|453783741|FG029|Overall Study|Adverse Event|0|||
126134466|NCT03529773|453783742|FG030|Overall Study|Adverse Event|1|||
126134467|NCT03529773|453783743|FG031|Overall Study|Adverse Event|0|||
126134468|NCT03529773|453783744|FG032|Overall Study|Adverse Event|0|||
126134469|NCT03529773|453783745|FG033|Overall Study|Adverse Event|0|||
126134470|NCT03529773|453783746|FG034|Overall Study|Adverse Event|0|||
126134471|NCT03529773|453783747|FG035|Overall Study|Adverse Event|1|||
126134472|NCT03529773|453783748|FG036|Overall Study|Adverse Event|0|||
126134473|NCT03529773|453783749|FG037|Overall Study|Adverse Event|0|||
126134474|NCT03529773|453783750|FG038|Overall Study|Adverse Event|1|||
126134475|NCT03529773|453783751|FG039|Overall Study|Adverse Event|1|||
126134476|NCT03529773|453783712|FG000|Overall Study|Death|0|||
126088541|NCT02440425|453618753|FG000|Overall Study|Adverse Event/Ineligible|1|||
126088542|NCT02807272|453618756|FG000|Overall Study|Death|9|||
126088543|NCT02807272|453618757|FG001|Overall Study|Death|5|||
126088544|NCT02807272|453618758|FG002|Overall Study|Death|2|||
126088545|NCT02807272|453618759|FG003|Overall Study|Death|0|||
126088546|NCT02807272|453618760|FG004|Overall Study|Death|1|||
126088547|NCT02807272|453618756|FG000|Overall Study|Lost to Follow-up|1|||
126088548|NCT02807272|453618757|FG001|Overall Study|Lost to Follow-up|0|||
126088549|NCT02807272|453618758|FG002|Overall Study|Lost to Follow-up|0|||
126088550|NCT02807272|453618759|FG003|Overall Study|Lost to Follow-up|0|||
126088551|NCT02807272|453618760|FG004|Overall Study|Lost to Follow-up|0|||
126088552|NCT02807272|453618756|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
126088553|NCT02807272|453618757|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
126088554|NCT02807272|453618758|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
126088555|NCT02807272|453618759|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
126088556|NCT02807272|453618760|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
126088557|NCT02807272|453618756|FG000|Overall Study|Protocol-defined Disease Progression|0|||
126088558|NCT02807272|453618757|FG001|Overall Study|Protocol-defined Disease Progression|1|||
126088559|NCT02807272|453618758|FG002|Overall Study|Protocol-defined Disease Progression|0|||
126088560|NCT02807272|453618759|FG003|Overall Study|Protocol-defined Disease Progression|0|||
126088561|NCT02807272|453618760|FG004|Overall Study|Protocol-defined Disease Progression|1|||
126088562|NCT02807272|453618756|FG000|Overall Study|Study Terminated by Sponsor|1|||
126088563|NCT02807272|453618757|FG001|Overall Study|Study Terminated by Sponsor|0|||
126088564|NCT02807272|453618758|FG002|Overall Study|Study Terminated by Sponsor|0|||
126088565|NCT02807272|453618759|FG003|Overall Study|Study Terminated by Sponsor|1|||
126088566|NCT02807272|453618760|FG004|Overall Study|Study Terminated by Sponsor|0|||
126088567|NCT02807272|453618756|FG000|Overall Study|Other|1|||
126088568|NCT02807272|453618757|FG001|Overall Study|Other|0|||
126088569|NCT02807272|453618758|FG002|Overall Study|Other|0|||
126088570|NCT02807272|453618759|FG003|Overall Study|Other|0|||
126088571|NCT02807272|453618760|FG004|Overall Study|Other|1|||
126088572|NCT01038427|453618761|FG000|Overall Study|Lost to follow up|1|||
126088573|NCT01038427|453618762|FG001|Overall Study|Lost to follow up|1|||
126088574|NCT01038427|453618763|FG002|Overall Study|Lost to follow up|0|||
126088575|NCT01038427|453618761|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
126088576|NCT01038427|453618762|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
126088577|NCT01038427|453618763|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
126088578|NCT01038427|453618761|FG000|Overall Study|Withdrew consent|0|||
126088579|NCT01038427|453618762|FG001|Overall Study|Withdrew consent|0|||
126088580|NCT01038427|453618763|FG002|Overall Study|Withdrew consent|1|||
126088581|NCT01038427|453618761|FG000|Overall Study|Adverse Event|2|||
126088582|NCT01038427|453618762|FG001|Overall Study|Adverse Event|2|||
126088583|NCT01038427|453618763|FG002|Overall Study|Adverse Event|1|||
126088584|NCT01038427|453618761|FG000|Overall Study|Enrolled in error|0|||
126088585|NCT01038427|453618762|FG001|Overall Study|Enrolled in error|1|||
126088586|NCT01038427|453618763|FG002|Overall Study|Enrolled in error|1|||
126088587|NCT01038427|453618761|FG000|Overall Study|Other|0|||
126088588|NCT01038427|453618762|FG001|Overall Study|Other|2|||
126088589|NCT01038427|453618763|FG002|Overall Study|Other|0|||
126088590|NCT01162863|453618764|FG000|Overall Study|Lack of Efficacy|1|||
126088591|NCT01162863|453618765|FG001|Overall Study|Lack of Efficacy|0|||
126088592|NCT01162863|453618766|FG002|Overall Study|Lack of Efficacy|0|||
126088593|NCT01162863|453618764|FG000|Overall Study|Adverse Event|0|||
126088594|NCT01162863|453618765|FG001|Overall Study|Adverse Event|1|||
126088595|NCT01162863|453618766|FG002|Overall Study|Adverse Event|0|||
126088596|NCT00588692|453618767|FG000|Overall Study|Withdrawal by Subject|4|||
126088597|NCT00588692|453618768|FG001|Overall Study|Withdrawal by Subject|2|||
126088598|NCT00588692|453618767|FG000|Overall Study|Hip Surgery|0|||
126088599|NCT00588692|453618768|FG001|Overall Study|Hip Surgery|1|||
126088600|NCT00588692|453618767|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
126088601|NCT00588692|453618768|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
126088602|NCT00588692|453618767|FG000|Overall Study|Cancer|1|||
126088603|NCT00588692|453618768|FG001|Overall Study|Cancer|0|||
126088604|NCT00588692|453618767|FG000|Overall Study|Death|1|||
126088605|NCT00588692|453618768|FG001|Overall Study|Death|0|||
126088606|NCT01374568|453618769|FG000|Overall Study|Lab unable to analyze BTM|0|||
126088607|NCT01374568|453618770|FG001|Overall Study|Lab unable to analyze BTM|2|||
126088608|NCT01912404|453618771|FG000|Overall Study|Due to personal reasons|1|||
126088609|NCT01912404|453618772|FG001|Overall Study|Due to personal reasons|0|||
126088610|NCT00604708|453618773|FG000|Overall Study|Withdrawal by Subject|9|||
126088611|NCT00604708|453618774|FG001|Overall Study|Withdrawal by Subject|10|||
126088612|NCT00604708|453618773|FG000|Overall Study|Protocol Violation|2|||
126088613|NCT00604708|453618774|FG001|Overall Study|Protocol Violation|8|||
126088614|NCT00604708|453618773|FG000|Overall Study|Lost to Follow-up|5|||
126088615|NCT00604708|453618774|FG001|Overall Study|Lost to Follow-up|5|||
126088616|NCT00604708|453618773|FG000|Overall Study|administrative reasons|9|||
126088617|NCT00604708|453618774|FG001|Overall Study|administrative reasons|11|||
126088618|NCT00604708|453618773|FG000|Overall Study|Adverse Event|6|||
126134477|NCT03529773|453783713|FG001|Overall Study|Death|0|||
126134478|NCT03529773|453783714|FG002|Overall Study|Death|0|||
126134479|NCT03529773|453783715|FG003|Overall Study|Death|0|||
126134480|NCT03529773|453783716|FG004|Overall Study|Death|0|||
126134481|NCT03529773|453783717|FG005|Overall Study|Death|0|||
126134482|NCT03529773|453783718|FG006|Overall Study|Death|0|||
126134483|NCT03529773|453783719|FG007|Overall Study|Death|0|||
126134484|NCT03529773|453783720|FG008|Overall Study|Death|0|||
126134485|NCT03529773|453783721|FG009|Overall Study|Death|0|||
126134486|NCT03529773|453783722|FG010|Overall Study|Death|0|||
126134487|NCT03529773|453783723|FG011|Overall Study|Death|0|||
126134488|NCT03529773|453783724|FG012|Overall Study|Death|1|||
126134489|NCT03529773|453783725|FG013|Overall Study|Death|0|||
126134490|NCT03529773|453783726|FG014|Overall Study|Death|0|||
126134491|NCT03529773|453783727|FG015|Overall Study|Death|0|||
126134492|NCT03529773|453783728|FG016|Overall Study|Death|0|||
126134493|NCT03529773|453783729|FG017|Overall Study|Death|0|||
126134494|NCT03529773|453783730|FG018|Overall Study|Death|0|||
126134495|NCT03529773|453783731|FG019|Overall Study|Death|1|||
126134496|NCT03529773|453783732|FG020|Overall Study|Death|0|||
126134497|NCT03529773|453783733|FG021|Overall Study|Death|0|||
126134498|NCT03529773|453783734|FG022|Overall Study|Death|1|||
126134499|NCT03529773|453783735|FG023|Overall Study|Death|0|||
126134500|NCT03529773|453783736|FG024|Overall Study|Death|0|||
126134501|NCT03529773|453783737|FG025|Overall Study|Death|0|||
126134502|NCT03529773|453783738|FG026|Overall Study|Death|0|||
126134503|NCT03529773|453783739|FG027|Overall Study|Death|0|||
126134504|NCT03529773|453783740|FG028|Overall Study|Death|0|||
126134505|NCT03529773|453783741|FG029|Overall Study|Death|0|||
126134506|NCT03529773|453783742|FG030|Overall Study|Death|0|||
126134507|NCT03529773|453783743|FG031|Overall Study|Death|0|||
126134508|NCT03529773|453783744|FG032|Overall Study|Death|0|||
126134509|NCT03529773|453783745|FG033|Overall Study|Death|1|||
126134510|NCT03529773|453783746|FG034|Overall Study|Death|1|||
126134511|NCT03529773|453783747|FG035|Overall Study|Death|0|||
126134512|NCT03529773|453783748|FG036|Overall Study|Death|1|||
126134513|NCT03529773|453783749|FG037|Overall Study|Death|0|||
126134514|NCT03529773|453783750|FG038|Overall Study|Death|0|||
126134515|NCT03529773|453783751|FG039|Overall Study|Death|0|||
126134516|NCT03529773|453783712|FG000|Overall Study|Lost to Follow-up|0|||
126134517|NCT03529773|453783713|FG001|Overall Study|Lost to Follow-up|0|||
126134518|NCT03529773|453783714|FG002|Overall Study|Lost to Follow-up|1|||
126134519|NCT03529773|453783715|FG003|Overall Study|Lost to Follow-up|0|||
126134520|NCT03529773|453783716|FG004|Overall Study|Lost to Follow-up|1|||
126134521|NCT03529773|453783717|FG005|Overall Study|Lost to Follow-up|1|||
126134522|NCT03529773|453783718|FG006|Overall Study|Lost to Follow-up|0|||
126134523|NCT03529773|453783719|FG007|Overall Study|Lost to Follow-up|0|||
126134524|NCT03529773|453783720|FG008|Overall Study|Lost to Follow-up|0|||
126134525|NCT03529773|453783721|FG009|Overall Study|Lost to Follow-up|0|||
126134526|NCT03529773|453783722|FG010|Overall Study|Lost to Follow-up|0|||
126134527|NCT03529773|453783723|FG011|Overall Study|Lost to Follow-up|0|||
126134528|NCT03529773|453783724|FG012|Overall Study|Lost to Follow-up|0|||
126134529|NCT03529773|453783725|FG013|Overall Study|Lost to Follow-up|1|||
126134530|NCT03529773|453783726|FG014|Overall Study|Lost to Follow-up|4|||
126134531|NCT03529773|453783727|FG015|Overall Study|Lost to Follow-up|1|||
126134532|NCT03529773|453783728|FG016|Overall Study|Lost to Follow-up|1|||
126134533|NCT03529773|453783729|FG017|Overall Study|Lost to Follow-up|0|||
126134534|NCT03529773|453783730|FG018|Overall Study|Lost to Follow-up|1|||
126134535|NCT03529773|453783731|FG019|Overall Study|Lost to Follow-up|1|||
126134536|NCT03529773|453783732|FG020|Overall Study|Lost to Follow-up|2|||
126134537|NCT03529773|453783733|FG021|Overall Study|Lost to Follow-up|4|||
126134538|NCT03529773|453783734|FG022|Overall Study|Lost to Follow-up|3|||
126134539|NCT03529773|453783735|FG023|Overall Study|Lost to Follow-up|4|||
126134540|NCT03529773|453783736|FG024|Overall Study|Lost to Follow-up|3|||
126134541|NCT03529773|453783737|FG025|Overall Study|Lost to Follow-up|5|||
126134542|NCT03529773|453783738|FG026|Overall Study|Lost to Follow-up|5|||
126134543|NCT03529773|453783739|FG027|Overall Study|Lost to Follow-up|0|||
126134544|NCT03529773|453783740|FG028|Overall Study|Lost to Follow-up|0|||
126134545|NCT03529773|453783741|FG029|Overall Study|Lost to Follow-up|0|||
126134546|NCT03529773|453783742|FG030|Overall Study|Lost to Follow-up|1|||
126134547|NCT03529773|453783743|FG031|Overall Study|Lost to Follow-up|0|||
126134548|NCT03529773|453783744|FG032|Overall Study|Lost to Follow-up|0|||
126134549|NCT03529773|453783745|FG033|Overall Study|Lost to Follow-up|1|||
126134550|NCT03529773|453783746|FG034|Overall Study|Lost to Follow-up|1|||
126134551|NCT03529773|453783747|FG035|Overall Study|Lost to Follow-up|0|||
126134552|NCT03529773|453783748|FG036|Overall Study|Lost to Follow-up|0|||
126134553|NCT03529773|453783749|FG037|Overall Study|Lost to Follow-up|3|||
126134554|NCT03529773|453783750|FG038|Overall Study|Lost to Follow-up|1|||
126134555|NCT03529773|453783751|FG039|Overall Study|Lost to Follow-up|1|||
126134556|NCT03529773|453783712|FG000|Overall Study|No longer meets eligibility criteria|0|||
126134557|NCT03529773|453783713|FG001|Overall Study|No longer meets eligibility criteria|0|||
126134558|NCT03529773|453783714|FG002|Overall Study|No longer meets eligibility criteria|0|||
126134559|NCT03529773|453783715|FG003|Overall Study|No longer meets eligibility criteria|0|||
126134560|NCT03529773|453783716|FG004|Overall Study|No longer meets eligibility criteria|0|||
126134561|NCT03529773|453783717|FG005|Overall Study|No longer meets eligibility criteria|0|||
126134562|NCT03529773|453783718|FG006|Overall Study|No longer meets eligibility criteria|0|||
126134563|NCT03529773|453783719|FG007|Overall Study|No longer meets eligibility criteria|0|||
126134564|NCT03529773|453783720|FG008|Overall Study|No longer meets eligibility criteria|0|||
126134565|NCT03529773|453783721|FG009|Overall Study|No longer meets eligibility criteria|0|||
126134566|NCT03529773|453783722|FG010|Overall Study|No longer meets eligibility criteria|0|||
126134567|NCT03529773|453783723|FG011|Overall Study|No longer meets eligibility criteria|0|||
126134568|NCT03529773|453783724|FG012|Overall Study|No longer meets eligibility criteria|0|||
126134569|NCT03529773|453783725|FG013|Overall Study|No longer meets eligibility criteria|0|||
126134570|NCT03529773|453783726|FG014|Overall Study|No longer meets eligibility criteria|0|||
126134571|NCT03529773|453783727|FG015|Overall Study|No longer meets eligibility criteria|0|||
126134572|NCT03529773|453783728|FG016|Overall Study|No longer meets eligibility criteria|0|||
126134573|NCT03529773|453783729|FG017|Overall Study|No longer meets eligibility criteria|0|||
126134574|NCT03529773|453783730|FG018|Overall Study|No longer meets eligibility criteria|0|||
126134575|NCT03529773|453783731|FG019|Overall Study|No longer meets eligibility criteria|0|||
126134576|NCT03529773|453783732|FG020|Overall Study|No longer meets eligibility criteria|0|||
126134577|NCT03529773|453783733|FG021|Overall Study|No longer meets eligibility criteria|0|||
126134578|NCT03529773|453783734|FG022|Overall Study|No longer meets eligibility criteria|1|||
126134579|NCT03529773|453783735|FG023|Overall Study|No longer meets eligibility criteria|0|||
126134580|NCT03529773|453783736|FG024|Overall Study|No longer meets eligibility criteria|0|||
126134581|NCT03529773|453783737|FG025|Overall Study|No longer meets eligibility criteria|0|||
126134582|NCT03529773|453783738|FG026|Overall Study|No longer meets eligibility criteria|0|||
126134583|NCT03529773|453783739|FG027|Overall Study|No longer meets eligibility criteria|0|||
126134584|NCT03529773|453783740|FG028|Overall Study|No longer meets eligibility criteria|0|||
126134585|NCT03529773|453783741|FG029|Overall Study|No longer meets eligibility criteria|0|||
126134586|NCT03529773|453783742|FG030|Overall Study|No longer meets eligibility criteria|0|||
126134587|NCT03529773|453783743|FG031|Overall Study|No longer meets eligibility criteria|0|||
126134588|NCT03529773|453783744|FG032|Overall Study|No longer meets eligibility criteria|0|||
126134589|NCT03529773|453783745|FG033|Overall Study|No longer meets eligibility criteria|0|||
126134590|NCT03529773|453783746|FG034|Overall Study|No longer meets eligibility criteria|0|||
126134591|NCT03529773|453783747|FG035|Overall Study|No longer meets eligibility criteria|0|||
126134592|NCT03529773|453783748|FG036|Overall Study|No longer meets eligibility criteria|0|||
126134593|NCT03529773|453783749|FG037|Overall Study|No longer meets eligibility criteria|0|||
126134594|NCT03529773|453783750|FG038|Overall Study|No longer meets eligibility criteria|1|||
126134595|NCT03529773|453783751|FG039|Overall Study|No longer meets eligibility criteria|0|||
126134596|NCT03529773|453783712|FG000|Overall Study|Other|0|||
126134597|NCT03529773|453783713|FG001|Overall Study|Other|0|||
126134598|NCT03529773|453783714|FG002|Overall Study|Other|0|||
126134599|NCT03529773|453783715|FG003|Overall Study|Other|0|||
126088619|NCT00604708|453618774|FG001|Overall Study|Adverse Event|6|||
126088620|NCT02817906|453618778|FG000|Overall Study|Adverse Event|3|||
126088621|NCT02817906|453618779|FG001|Overall Study|Adverse Event|0|||
126088622|NCT02817906|453618778|FG000|Overall Study|Lack of Efficacy|1|||
126088623|NCT02817906|453618779|FG001|Overall Study|Lack of Efficacy|0|||
126088624|NCT02817906|453618778|FG000|Overall Study|Protocol Violation|1|||
126088625|NCT02817906|453618779|FG001|Overall Study|Protocol Violation|1|||
126088626|NCT02817906|453618778|FG000|Overall Study|Study Terminated by Sponsor|2|||
126088627|NCT02817906|453618779|FG001|Overall Study|Study Terminated by Sponsor|2|||
126088628|NCT02817906|453618778|FG000|Overall Study|Withdrawal by Subject|7|||
126088629|NCT02817906|453618779|FG001|Overall Study|Withdrawal by Subject|0|||
126088630|NCT02817906|453618778|FG000|Overall Study|Other|2|||
126088631|NCT02817906|453618779|FG001|Overall Study|Other|2|||
126088632|NCT03686423|453618780|FG000|Overall Study|Withdrawal by Subject|9|||
126088633|NCT03686423|453618780|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
126088634|NCT02833077|453618781|FG000|Overall Study|Adverse Event|1|||
126088635|NCT02833077|453618782|FG001|Overall Study|Adverse Event|2|||
126088636|NCT02833077|453618781|FG000|Overall Study|Lost to Follow-up|10|||
126088637|NCT02833077|453618782|FG001|Overall Study|Lost to Follow-up|1|||
126088638|NCT02833077|453618781|FG000|Overall Study|Personal Reasons|6|||
126088639|NCT02833077|453618782|FG001|Overall Study|Personal Reasons|4|||
126088640|NCT02833077|453618781|FG000|Overall Study|Protocol Deviation|0|||
126088641|NCT02833077|453618782|FG001|Overall Study|Protocol Deviation|1|||
126088642|NCT00972322|453618783|FG000|Overall Study|Adverse Event|2|||
126088643|NCT00972322|453618784|FG001|Overall Study|Adverse Event|1|||
126088644|NCT00972322|453618783|FG000|Overall Study|Positive drug screen|0|||
126088645|NCT00972322|453618784|FG001|Overall Study|Positive drug screen|1|||
126088646|NCT00972322|453618783|FG000|Overall Study|Lost to Follow-up|0|||
126088647|NCT00972322|453618784|FG001|Overall Study|Lost to Follow-up|1|||
126088648|NCT00972322|453618783|FG000|Overall Study|Consistently high glucose values|1|||
126088649|NCT00972322|453618784|FG001|Overall Study|Consistently high glucose values|0|||
126088650|NCT01077518|453618785|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
126134600|NCT03529773|453783716|FG004|Overall Study|Other|0|||
126134601|NCT03529773|453783717|FG005|Overall Study|Other|0|||
126134602|NCT03529773|453783718|FG006|Overall Study|Other|0|||
126134603|NCT03529773|453783719|FG007|Overall Study|Other|0|||
126134604|NCT03529773|453783720|FG008|Overall Study|Other|0|||
126134605|NCT03529773|453783721|FG009|Overall Study|Other|0|||
126134606|NCT03529773|453783722|FG010|Overall Study|Other|0|||
126134607|NCT03529773|453783723|FG011|Overall Study|Other|0|||
126134608|NCT03529773|453783724|FG012|Overall Study|Other|1|||
126134609|NCT03529773|453783725|FG013|Overall Study|Other|0|||
126134610|NCT03529773|453783726|FG014|Overall Study|Other|2|||
126134611|NCT03529773|453783727|FG015|Overall Study|Other|0|||
126134612|NCT03529773|453783728|FG016|Overall Study|Other|0|||
126134613|NCT03529773|453783729|FG017|Overall Study|Other|3|||
126134614|NCT03529773|453783730|FG018|Overall Study|Other|0|||
126134615|NCT03529773|453783731|FG019|Overall Study|Other|0|||
126134616|NCT03529773|453783732|FG020|Overall Study|Other|1|||
126134617|NCT03529773|453783733|FG021|Overall Study|Other|0|||
126134618|NCT03529773|453783734|FG022|Overall Study|Other|1|||
126134619|NCT03529773|453783735|FG023|Overall Study|Other|0|||
126134620|NCT03529773|453783736|FG024|Overall Study|Other|3|||
126134621|NCT03529773|453783737|FG025|Overall Study|Other|2|||
126134622|NCT03529773|453783738|FG026|Overall Study|Other|2|||
126134623|NCT03529773|453783739|FG027|Overall Study|Other|0|||
126134624|NCT03529773|453783740|FG028|Overall Study|Other|0|||
126134625|NCT03529773|453783741|FG029|Overall Study|Other|0|||
126134626|NCT03529773|453783742|FG030|Overall Study|Other|0|||
126134627|NCT03529773|453783743|FG031|Overall Study|Other|0|||
126134628|NCT03529773|453783744|FG032|Overall Study|Other|0|||
126134629|NCT03529773|453783745|FG033|Overall Study|Other|0|||
126134630|NCT03529773|453783746|FG034|Overall Study|Other|1|||
126134631|NCT03529773|453783747|FG035|Overall Study|Other|1|||
126134632|NCT03529773|453783748|FG036|Overall Study|Other|0|||
126134633|NCT03529773|453783749|FG037|Overall Study|Other|0|||
126134634|NCT03529773|453783750|FG038|Overall Study|Other|0|||
126134635|NCT03529773|453783751|FG039|Overall Study|Other|0|||
126134636|NCT03529773|453783712|FG000|Overall Study|Physician Decision|0|||
126134637|NCT03529773|453783713|FG001|Overall Study|Physician Decision|0|||
126134638|NCT03529773|453783714|FG002|Overall Study|Physician Decision|0|||
126134639|NCT03529773|453783715|FG003|Overall Study|Physician Decision|0|||
126134640|NCT03529773|453783716|FG004|Overall Study|Physician Decision|0|||
126134641|NCT03529773|453783717|FG005|Overall Study|Physician Decision|0|||
126134642|NCT03529773|453783718|FG006|Overall Study|Physician Decision|0|||
126134643|NCT03529773|453783719|FG007|Overall Study|Physician Decision|0|||
126134644|NCT03529773|453783720|FG008|Overall Study|Physician Decision|0|||
126134645|NCT03529773|453783721|FG009|Overall Study|Physician Decision|0|||
126134646|NCT03529773|453783722|FG010|Overall Study|Physician Decision|0|||
126134647|NCT03529773|453783723|FG011|Overall Study|Physician Decision|0|||
126134648|NCT03529773|453783724|FG012|Overall Study|Physician Decision|0|||
126134649|NCT03529773|453783725|FG013|Overall Study|Physician Decision|0|||
126134650|NCT03529773|453783726|FG014|Overall Study|Physician Decision|0|||
126134651|NCT03529773|453783727|FG015|Overall Study|Physician Decision|0|||
126134652|NCT03529773|453783728|FG016|Overall Study|Physician Decision|0|||
126134653|NCT03529773|453783729|FG017|Overall Study|Physician Decision|0|||
126134654|NCT03529773|453783730|FG018|Overall Study|Physician Decision|0|||
126134655|NCT03529773|453783731|FG019|Overall Study|Physician Decision|1|||
126134656|NCT03529773|453783732|FG020|Overall Study|Physician Decision|1|||
126134657|NCT03529773|453783733|FG021|Overall Study|Physician Decision|0|||
126134658|NCT03529773|453783734|FG022|Overall Study|Physician Decision|0|||
126134659|NCT03529773|453783735|FG023|Overall Study|Physician Decision|0|||
126134660|NCT03529773|453783736|FG024|Overall Study|Physician Decision|0|||
126134661|NCT03529773|453783737|FG025|Overall Study|Physician Decision|0|||
126134662|NCT03529773|453783738|FG026|Overall Study|Physician Decision|0|||
126134663|NCT03529773|453783739|FG027|Overall Study|Physician Decision|0|||
126134664|NCT03529773|453783740|FG028|Overall Study|Physician Decision|0|||
126134665|NCT03529773|453783741|FG029|Overall Study|Physician Decision|0|||
126134666|NCT03529773|453783742|FG030|Overall Study|Physician Decision|0|||
126134667|NCT03529773|453783743|FG031|Overall Study|Physician Decision|0|||
126134668|NCT03529773|453783744|FG032|Overall Study|Physician Decision|0|||
126134669|NCT03529773|453783745|FG033|Overall Study|Physician Decision|0|||
126134670|NCT03529773|453783746|FG034|Overall Study|Physician Decision|0|||
126134671|NCT03529773|453783747|FG035|Overall Study|Physician Decision|0|||
126134672|NCT03529773|453783748|FG036|Overall Study|Physician Decision|0|||
126134673|NCT03529773|453783749|FG037|Overall Study|Physician Decision|0|||
126134674|NCT03529773|453783750|FG038|Overall Study|Physician Decision|0|||
126134675|NCT03529773|453783751|FG039|Overall Study|Physician Decision|0|||
126134676|NCT03529773|453783712|FG000|Overall Study|Protocol Violation|0|||
126134677|NCT03529773|453783713|FG001|Overall Study|Protocol Violation|0|||
126134678|NCT03529773|453783714|FG002|Overall Study|Protocol Violation|0|||
126134679|NCT03529773|453783715|FG003|Overall Study|Protocol Violation|0|||
126134680|NCT03529773|453783716|FG004|Overall Study|Protocol Violation|0|||
126134681|NCT03529773|453783717|FG005|Overall Study|Protocol Violation|0|||
126134682|NCT03529773|453783718|FG006|Overall Study|Protocol Violation|0|||
126134683|NCT03529773|453783719|FG007|Overall Study|Protocol Violation|0|||
126134684|NCT03529773|453783720|FG008|Overall Study|Protocol Violation|0|||
126134685|NCT03529773|453783721|FG009|Overall Study|Protocol Violation|0|||
126134686|NCT03529773|453783722|FG010|Overall Study|Protocol Violation|0|||
126134687|NCT03529773|453783723|FG011|Overall Study|Protocol Violation|0|||
126134688|NCT03529773|453783724|FG012|Overall Study|Protocol Violation|0|||
126134689|NCT03529773|453783725|FG013|Overall Study|Protocol Violation|0|||
126134690|NCT03529773|453783726|FG014|Overall Study|Protocol Violation|0|||
126134691|NCT03529773|453783727|FG015|Overall Study|Protocol Violation|0|||
126134692|NCT03529773|453783728|FG016|Overall Study|Protocol Violation|0|||
126134693|NCT03529773|453783729|FG017|Overall Study|Protocol Violation|0|||
126134694|NCT03529773|453783730|FG018|Overall Study|Protocol Violation|0|||
126134695|NCT03529773|453783731|FG019|Overall Study|Protocol Violation|0|||
126134696|NCT03529773|453783732|FG020|Overall Study|Protocol Violation|0|||
126134697|NCT03529773|453783733|FG021|Overall Study|Protocol Violation|0|||
126134698|NCT03529773|453783734|FG022|Overall Study|Protocol Violation|0|||
126134699|NCT03529773|453783735|FG023|Overall Study|Protocol Violation|0|||
126134700|NCT03529773|453783736|FG024|Overall Study|Protocol Violation|0|||
126134701|NCT03529773|453783737|FG025|Overall Study|Protocol Violation|0|||
126134702|NCT03529773|453783738|FG026|Overall Study|Protocol Violation|0|||
126134703|NCT03529773|453783739|FG027|Overall Study|Protocol Violation|0|||
126134704|NCT03529773|453783740|FG028|Overall Study|Protocol Violation|0|||
126134705|NCT03529773|453783741|FG029|Overall Study|Protocol Violation|0|||
126134706|NCT03529773|453783742|FG030|Overall Study|Protocol Violation|1|||
126134707|NCT03529773|453783743|FG031|Overall Study|Protocol Violation|0|||
126134708|NCT03529773|453783744|FG032|Overall Study|Protocol Violation|0|||
126134709|NCT03529773|453783745|FG033|Overall Study|Protocol Violation|0|||
126134710|NCT03529773|453783746|FG034|Overall Study|Protocol Violation|0|||
126134711|NCT03529773|453783747|FG035|Overall Study|Protocol Violation|0|||
126134712|NCT03529773|453783748|FG036|Overall Study|Protocol Violation|0|||
126134713|NCT03529773|453783749|FG037|Overall Study|Protocol Violation|0|||
126134714|NCT03529773|453783750|FG038|Overall Study|Protocol Violation|0|||
126134715|NCT03529773|453783751|FG039|Overall Study|Protocol Violation|0|||
126134716|NCT03529773|453783712|FG000|Overall Study|Withdrawal by Subject|0|||
126134717|NCT03529773|453783713|FG001|Overall Study|Withdrawal by Subject|0|||
126134718|NCT03529773|453783714|FG002|Overall Study|Withdrawal by Subject|0|||
126134719|NCT03529773|453783715|FG003|Overall Study|Withdrawal by Subject|0|||
126134720|NCT03529773|453783716|FG004|Overall Study|Withdrawal by Subject|0|||
126134721|NCT03529773|453783717|FG005|Overall Study|Withdrawal by Subject|0|||
126134722|NCT03529773|453783718|FG006|Overall Study|Withdrawal by Subject|0|||
126134723|NCT03529773|453783719|FG007|Overall Study|Withdrawal by Subject|1|||
126134724|NCT03529773|453783720|FG008|Overall Study|Withdrawal by Subject|0|||
126134725|NCT03529773|453783721|FG009|Overall Study|Withdrawal by Subject|1|||
126134726|NCT03529773|453783722|FG010|Overall Study|Withdrawal by Subject|1|||
126134727|NCT03529773|453783723|FG011|Overall Study|Withdrawal by Subject|0|||
126134728|NCT03529773|453783724|FG012|Overall Study|Withdrawal by Subject|0|||
126134729|NCT03529773|453783725|FG013|Overall Study|Withdrawal by Subject|0|||
126134730|NCT03529773|453783726|FG014|Overall Study|Withdrawal by Subject|0|||
126134731|NCT03529773|453783727|FG015|Overall Study|Withdrawal by Subject|3|||
126134732|NCT03529773|453783728|FG016|Overall Study|Withdrawal by Subject|0|||
126134733|NCT03529773|453783729|FG017|Overall Study|Withdrawal by Subject|2|||
126134734|NCT03529773|453783730|FG018|Overall Study|Withdrawal by Subject|3|||
126134735|NCT03529773|453783731|FG019|Overall Study|Withdrawal by Subject|1|||
126134736|NCT03529773|453783732|FG020|Overall Study|Withdrawal by Subject|3|||
126134737|NCT03529773|453783733|FG021|Overall Study|Withdrawal by Subject|1|||
126134738|NCT03529773|453783734|FG022|Overall Study|Withdrawal by Subject|1|||
126134739|NCT03529773|453783735|FG023|Overall Study|Withdrawal by Subject|2|||
126134740|NCT03529773|453783736|FG024|Overall Study|Withdrawal by Subject|2|||
126134741|NCT03529773|453783737|FG025|Overall Study|Withdrawal by Subject|4|||
126134742|NCT03529773|453783738|FG026|Overall Study|Withdrawal by Subject|2|||
125966285|NCT02265705|453167516|FG000|Treatment Period Week 0-24|Physician Decision|1|||
125966286|NCT02265705|453167517|FG001|Treatment Period Week 0-24|Physician Decision|0|||
126134743|NCT03529773|453783739|FG027|Overall Study|Withdrawal by Subject|1|||
126134744|NCT03529773|453783740|FG028|Overall Study|Withdrawal by Subject|1|||
126134745|NCT03529773|453783741|FG029|Overall Study|Withdrawal by Subject|0|||
125966287|NCT02265705|453167518|FG002|Treatment Period Week 0-24|Physician Decision|0|||
126134746|NCT03529773|453783742|FG030|Overall Study|Withdrawal by Subject|0|||
126134747|NCT03529773|453783743|FG031|Overall Study|Withdrawal by Subject|0|||
126134748|NCT03529773|453783744|FG032|Overall Study|Withdrawal by Subject|0|||
126134749|NCT03529773|453783745|FG033|Overall Study|Withdrawal by Subject|0|||
125966288|NCT02265705|453167519|FG003|Treatment Period Week 0-24|Physician Decision|0|||
126134750|NCT03529773|453783746|FG034|Overall Study|Withdrawal by Subject|1|||
126134751|NCT03529773|453783747|FG035|Overall Study|Withdrawal by Subject|2|||
126134752|NCT03529773|453783748|FG036|Overall Study|Withdrawal by Subject|0|||
126134753|NCT03529773|453783749|FG037|Overall Study|Withdrawal by Subject|2|||
126134754|NCT03529773|453783750|FG038|Overall Study|Withdrawal by Subject|1|||
126134755|NCT03529773|453783751|FG039|Overall Study|Withdrawal by Subject|1|||
126134756|NCT03529773|453783712|FG000|Overall Study|Screen Failure|0|||
126134757|NCT03529773|453783713|FG001|Overall Study|Screen Failure|0|||
126134758|NCT03529773|453783714|FG002|Overall Study|Screen Failure|0|||
126134759|NCT03529773|453783715|FG003|Overall Study|Screen Failure|0|||
126134760|NCT03529773|453783716|FG004|Overall Study|Screen Failure|0|||
126134761|NCT03529773|453783717|FG005|Overall Study|Screen Failure|0|||
126134762|NCT03529773|453783718|FG006|Overall Study|Screen Failure|0|||
126134763|NCT03529773|453783719|FG007|Overall Study|Screen Failure|0|||
126134764|NCT03529773|453783720|FG008|Overall Study|Screen Failure|0|||
126134765|NCT03529773|453783721|FG009|Overall Study|Screen Failure|0|||
126134766|NCT03529773|453783722|FG010|Overall Study|Screen Failure|0|||
126134767|NCT03529773|453783723|FG011|Overall Study|Screen Failure|0|||
126134768|NCT03529773|453783724|FG012|Overall Study|Screen Failure|0|||
126134769|NCT03529773|453783725|FG013|Overall Study|Screen Failure|0|||
126134770|NCT03529773|453783726|FG014|Overall Study|Screen Failure|0|||
125966289|NCT02265705|453167520|FG004|Treatment Period Week 0-24|Physician Decision|0|||
125966290|NCT02265705|453167521|FG005|Treatment Period Week 0-24|Physician Decision|0|||
125966291|NCT02265705|453167522|FG006|Treatment Period Week 0-24|Physician Decision|0|||
125966292|NCT02265705|453167516|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
125966293|NCT02265705|453167517|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
125966294|NCT02265705|453167518|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125966295|NCT02265705|453167519|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125966296|NCT02265705|453167520|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125966297|NCT02265705|453167521|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125966298|NCT02265705|453167522|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125966299|NCT02265705|453167516|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
125966300|NCT02265705|453167517|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
125966301|NCT02265705|453167518|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
125966302|NCT02265705|453167519|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
125966303|NCT02265705|453167520|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
125966304|NCT02265705|453167521|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
125966305|NCT02265705|453167522|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
125966306|NCT02265705|453167516|FG000|Rescue Period|Withdrawal by Subject|0|||
125966307|NCT02265705|453167517|FG001|Rescue Period|Withdrawal by Subject|0|||
125966308|NCT02265705|453167518|FG002|Rescue Period|Withdrawal by Subject|1|||
125966309|NCT02265705|453167519|FG003|Rescue Period|Withdrawal by Subject|0|||
125966310|NCT02265705|453167520|FG004|Rescue Period|Withdrawal by Subject|0|||
125966311|NCT02265705|453167521|FG005|Rescue Period|Withdrawal by Subject|0|||
125966312|NCT02265705|453167522|FG006|Rescue Period|Withdrawal by Subject|0|||
125966313|NCT02265705|453167516|FG000|Rescue Period|Death|0|||
125966314|NCT02265705|453167517|FG001|Rescue Period|Death|0|||
125966315|NCT02265705|453167518|FG002|Rescue Period|Death|1|||
125966316|NCT02265705|453167519|FG003|Rescue Period|Death|0|||
125966317|NCT02265705|453167520|FG004|Rescue Period|Death|0|||
125966318|NCT02265705|453167521|FG005|Rescue Period|Death|0|||
125966319|NCT02265705|453167522|FG006|Rescue Period|Death|0|||
125966320|NCT02265705|453167516|FG000|Rescue Period|Lack of Efficacy|0|||
125966321|NCT02265705|453167517|FG001|Rescue Period|Lack of Efficacy|0|||
125966322|NCT02265705|453167518|FG002|Rescue Period|Lack of Efficacy|1|||
125966323|NCT02265705|453167519|FG003|Rescue Period|Lack of Efficacy|0|||
125966324|NCT02265705|453167520|FG004|Rescue Period|Lack of Efficacy|0|||
125966325|NCT02265705|453167521|FG005|Rescue Period|Lack of Efficacy|0|||
125966326|NCT02265705|453167522|FG006|Rescue Period|Lack of Efficacy|0|||
125966327|NCT02265705|453167516|FG000|Open Label Period|Adverse Event|0|||
125966328|NCT02265705|453167517|FG001|Open Label Period|Adverse Event|0|||
125966329|NCT02265705|453167518|FG002|Open Label Period|Adverse Event|0|||
125966330|NCT02265705|453167519|FG003|Open Label Period|Adverse Event|2|||
126134771|NCT03529773|453783727|FG015|Overall Study|Screen Failure|0|||
126134772|NCT03529773|453783728|FG016|Overall Study|Screen Failure|0|||
126134773|NCT03529773|453783729|FG017|Overall Study|Screen Failure|0|||
126134774|NCT03529773|453783730|FG018|Overall Study|Screen Failure|0|||
126134775|NCT03529773|453783731|FG019|Overall Study|Screen Failure|0|||
126134776|NCT03529773|453783732|FG020|Overall Study|Screen Failure|0|||
126134777|NCT03529773|453783733|FG021|Overall Study|Screen Failure|0|||
126134778|NCT03529773|453783734|FG022|Overall Study|Screen Failure|0|||
126134779|NCT03529773|453783735|FG023|Overall Study|Screen Failure|0|||
125966331|NCT02265705|453167520|FG004|Open Label Period|Adverse Event|2|||
125966332|NCT02265705|453167521|FG005|Open Label Period|Adverse Event|0|||
125966333|NCT02265705|453167522|FG006|Open Label Period|Adverse Event|0|||
125966334|NCT02265705|453167516|FG000|Open Label Period|Physician Decision|0|||
126134780|NCT03529773|453783736|FG024|Overall Study|Screen Failure|0|||
126134781|NCT03529773|453783737|FG025|Overall Study|Screen Failure|0|||
126134782|NCT03529773|453783738|FG026|Overall Study|Screen Failure|0|||
126134783|NCT03529773|453783739|FG027|Overall Study|Screen Failure|0|||
126134784|NCT03529773|453783740|FG028|Overall Study|Screen Failure|0|||
125966335|NCT02265705|453167517|FG001|Open Label Period|Physician Decision|0|||
125966336|NCT02265705|453167518|FG002|Open Label Period|Physician Decision|0|||
126134785|NCT03529773|453783741|FG029|Overall Study|Screen Failure|0|||
126134786|NCT03529773|453783742|FG030|Overall Study|Screen Failure|0|||
126134787|NCT03529773|453783743|FG031|Overall Study|Screen Failure|0|||
126134788|NCT03529773|453783744|FG032|Overall Study|Screen Failure|0|||
126134789|NCT03529773|453783745|FG033|Overall Study|Screen Failure|0|||
126134790|NCT03529773|453783746|FG034|Overall Study|Screen Failure|0|||
126134791|NCT03529773|453783747|FG035|Overall Study|Screen Failure|0|||
126134792|NCT03529773|453783748|FG036|Overall Study|Screen Failure|1|||
126134793|NCT03529773|453783749|FG037|Overall Study|Screen Failure|1|||
126134794|NCT03529773|453783750|FG038|Overall Study|Screen Failure|0|||
126134795|NCT03529773|453783751|FG039|Overall Study|Screen Failure|1|||
126134796|NCT03529773|453783712|FG000|Overall Study|Randomized but not vaccinated|0|||
126134797|NCT03529773|453783713|FG001|Overall Study|Randomized but not vaccinated|0|||
126134798|NCT03529773|453783714|FG002|Overall Study|Randomized but not vaccinated|0|||
126134799|NCT03529773|453783715|FG003|Overall Study|Randomized but not vaccinated|0|||
126134800|NCT03529773|453783716|FG004|Overall Study|Randomized but not vaccinated|0|||
126134801|NCT03529773|453783717|FG005|Overall Study|Randomized but not vaccinated|0|||
126134802|NCT03529773|453783718|FG006|Overall Study|Randomized but not vaccinated|0|||
126134803|NCT03529773|453783719|FG007|Overall Study|Randomized but not vaccinated|0|||
126134804|NCT03529773|453783720|FG008|Overall Study|Randomized but not vaccinated|0|||
126134805|NCT03529773|453783721|FG009|Overall Study|Randomized but not vaccinated|0|||
126134806|NCT03529773|453783722|FG010|Overall Study|Randomized but not vaccinated|0|||
126134807|NCT03529773|453783723|FG011|Overall Study|Randomized but not vaccinated|0|||
126134808|NCT03529773|453783724|FG012|Overall Study|Randomized but not vaccinated|0|||
126134809|NCT03529773|453783725|FG013|Overall Study|Randomized but not vaccinated|0|||
126134810|NCT03529773|453783726|FG014|Overall Study|Randomized but not vaccinated|0|||
126134811|NCT03529773|453783727|FG015|Overall Study|Randomized but not vaccinated|0|||
126134812|NCT03529773|453783728|FG016|Overall Study|Randomized but not vaccinated|0|||
126134813|NCT03529773|453783729|FG017|Overall Study|Randomized but not vaccinated|1|||
126134814|NCT03529773|453783730|FG018|Overall Study|Randomized but not vaccinated|0|||
125966337|NCT02265705|453167519|FG003|Open Label Period|Physician Decision|0|||
125966338|NCT02265705|453167520|FG004|Open Label Period|Physician Decision|1|||
125966339|NCT02265705|453167521|FG005|Open Label Period|Physician Decision|0|||
125966340|NCT02265705|453167522|FG006|Open Label Period|Physician Decision|0|||
125966341|NCT02265705|453167516|FG000|Open Label Period|Withdrawal by Subject|0|||
125966342|NCT02265705|453167517|FG001|Open Label Period|Withdrawal by Subject|0|||
125966343|NCT02265705|453167518|FG002|Open Label Period|Withdrawal by Subject|0|||
125966344|NCT02265705|453167519|FG003|Open Label Period|Withdrawal by Subject|0|||
125966345|NCT02265705|453167520|FG004|Open Label Period|Withdrawal by Subject|2|||
125966346|NCT02265705|453167521|FG005|Open Label Period|Withdrawal by Subject|0|||
125966347|NCT02265705|453167522|FG006|Open Label Period|Withdrawal by Subject|0|||
125966348|NCT02265705|453167516|FG000|Follow-up Period|Sponsor Decision|0|||
125966349|NCT02265705|453167517|FG001|Follow-up Period|Sponsor Decision|0|||
125966350|NCT02265705|453167518|FG002|Follow-up Period|Sponsor Decision|0|||
125966351|NCT02265705|453167519|FG003|Follow-up Period|Sponsor Decision|0|||
125966352|NCT02265705|453167520|FG004|Follow-up Period|Sponsor Decision|0|||
125966353|NCT02265705|453167521|FG005|Follow-up Period|Sponsor Decision|1|||
125966354|NCT02265705|453167522|FG006|Follow-up Period|Sponsor Decision|6|||
125966355|NCT02265705|453167516|FG000|Follow-up Period|Adverse Event|0|||
125966356|NCT02265705|453167517|FG001|Follow-up Period|Adverse Event|0|||
125966357|NCT02265705|453167518|FG002|Follow-up Period|Adverse Event|0|||
125966358|NCT02265705|453167519|FG003|Follow-up Period|Adverse Event|0|||
125966359|NCT02265705|453167520|FG004|Follow-up Period|Adverse Event|0|||
125966360|NCT02265705|453167521|FG005|Follow-up Period|Adverse Event|0|||
125966361|NCT02265705|453167522|FG006|Follow-up Period|Adverse Event|3|||
125966362|NCT02265705|453167516|FG000|Follow-up Period|Physician Decision|0|||
125966363|NCT02265705|453167517|FG001|Follow-up Period|Physician Decision|0|||
125966364|NCT02265705|453167518|FG002|Follow-up Period|Physician Decision|0|||
125966365|NCT02265705|453167519|FG003|Follow-up Period|Physician Decision|0|||
125966366|NCT02265705|453167520|FG004|Follow-up Period|Physician Decision|0|||
125966367|NCT02265705|453167521|FG005|Follow-up Period|Physician Decision|0|||
125966368|NCT02265705|453167522|FG006|Follow-up Period|Physician Decision|1|||
125966369|NCT02265705|453167516|FG000|Follow-up Period|Withdrawal by Subject|0|||
125966370|NCT02265705|453167517|FG001|Follow-up Period|Withdrawal by Subject|0|||
125966371|NCT02265705|453167518|FG002|Follow-up Period|Withdrawal by Subject|0|||
125966372|NCT02265705|453167519|FG003|Follow-up Period|Withdrawal by Subject|0|||
125966373|NCT02265705|453167520|FG004|Follow-up Period|Withdrawal by Subject|0|||
125966374|NCT02265705|453167521|FG005|Follow-up Period|Withdrawal by Subject|0|||
126134815|NCT03529773|453783731|FG019|Overall Study|Randomized but not vaccinated|0|||
126134816|NCT03529773|453783732|FG020|Overall Study|Randomized but not vaccinated|0|||
126134817|NCT03529773|453783733|FG021|Overall Study|Randomized but not vaccinated|0|||
126134818|NCT03529773|453783734|FG022|Overall Study|Randomized but not vaccinated|0|||
126134819|NCT03529773|453783735|FG023|Overall Study|Randomized but not vaccinated|0|||
126134820|NCT03529773|453783736|FG024|Overall Study|Randomized but not vaccinated|0|||
126134821|NCT03529773|453783737|FG025|Overall Study|Randomized but not vaccinated|0|||
125966375|NCT02265705|453167522|FG006|Follow-up Period|Withdrawal by Subject|1|||
125966376|NCT00779246|453167523|FG000|Overall Study|Missing sufficient data for analysis|33|||
125966377|NCT00779246|453167524|FG001|Overall Study|Missing sufficient data for analysis|53|||
125966378|NCT00383435|453167527|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
125966379|NCT00383435|453167528|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
125966380|NCT00383435|453167529|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
125966381|NCT00383435|453167530|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
125966382|NCT00383435|453167531|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
125966383|NCT00383435|453167527|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
125966384|NCT00383435|453167528|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
125966385|NCT00383435|453167529|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
125966386|NCT00383435|453167530|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
125966387|NCT00383435|453167531|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
125966388|NCT00383435|453167527|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
125966389|NCT00383435|453167528|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
125966390|NCT00383435|453167529|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
125966391|NCT00383435|453167530|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
125966392|NCT00383435|453167531|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
125966393|NCT00383435|453167527|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
125966394|NCT00383435|453167528|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
125966395|NCT00383435|453167529|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
125966396|NCT00383435|453167530|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
125966397|NCT00383435|453167531|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
125966398|NCT00383435|453167527|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
125966399|NCT00383435|453167528|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
125966400|NCT00383435|453167529|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
125966401|NCT00383435|453167530|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
125966402|NCT00383435|453167531|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
125966403|NCT00383435|453167527|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
125966404|NCT00383435|453167528|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
125966405|NCT00383435|453167529|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
125966406|NCT00383435|453167530|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
125966407|NCT00383435|453167531|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
125966408|NCT00383435|453167527|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
125966409|NCT00383435|453167528|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
125966410|NCT00383435|453167529|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
125966411|NCT00383435|453167530|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
125966412|NCT00383435|453167531|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
125966413|NCT00383435|453167527|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
125966414|NCT00383435|453167528|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
125966415|NCT00383435|453167529|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
125966416|NCT00383435|453167530|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
125966417|NCT00383435|453167531|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
125966418|NCT00383435|453167527|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
125966419|NCT00383435|453167528|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
125966420|NCT00383435|453167529|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
125966421|NCT00383435|453167530|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
125966422|NCT00383435|453167531|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
125966423|NCT00383435|453167527|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125966424|NCT00383435|453167528|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125966425|NCT00383435|453167529|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125966426|NCT00383435|453167530|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125966427|NCT00383435|453167531|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
125966428|NCT00383435|453167527|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
125966429|NCT00383435|453167528|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
125966430|NCT00383435|453167529|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
125966431|NCT00383435|453167530|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
125966432|NCT00383435|453167531|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
125966433|NCT00383435|453167527|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
125966434|NCT00383435|453167528|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
125966435|NCT00383435|453167529|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
125966436|NCT00383435|453167530|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
125966437|NCT00383435|453167531|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
125966438|NCT00383435|453167527|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125966439|NCT00383435|453167528|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
125966440|NCT00383435|453167529|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
125966441|NCT00383435|453167530|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
125966442|NCT00383435|453167531|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125966443|NCT00383435|453167527|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
125966444|NCT00383435|453167528|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125966445|NCT00383435|453167529|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125966446|NCT00383435|453167530|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125966447|NCT00383435|453167531|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
125966448|NCT00383435|453167527|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125966449|NCT00383435|453167528|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125966450|NCT00383435|453167529|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125966451|NCT00383435|453167530|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125966452|NCT00383435|453167531|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125966453|NCT00383435|453167527|FG000|26-Week Treatment Safety Extension|Administrative|1|||
125966454|NCT00383435|453167528|FG001|26-Week Treatment Safety Extension|Administrative|1|||
125966455|NCT00383435|453167529|FG002|26-Week Treatment Safety Extension|Administrative|0|||
125966456|NCT00383435|453167530|FG003|26-Week Treatment Safety Extension|Administrative|1|||
125966457|NCT00383435|453167531|FG004|26-Week Treatment Safety Extension|Administrative|0|||
125966458|NCT01753193|453167532|FG000|Overall Study|Withdrawal by Subject|23|||
125966459|NCT01753193|453167532|FG000|Overall Study|Lost to Follow-up|6|||
125966460|NCT01753193|453167532|FG000|Overall Study|Death|1|||
125966461|NCT01753193|453167532|FG000|Overall Study|Other|16|||
125966462|NCT00583557|453167533|FG000|Overall Study|Withdrawal by Subject|18|||
125966463|NCT00583557|453167533|FG000|Overall Study|Adverse Event|9|||
125966464|NCT00583557|453167533|FG000|Overall Study|Lack of Efficacy|31|||
125966465|NCT00583557|453167533|FG000|Overall Study|Lack of Compliance|5|||
125966466|NCT00583557|453167533|FG000|Overall Study|Other|5|||
125966467|NCT00583557|453167533|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
125966468|NCT01131312|453167534|FG000|Overall Study|Lost to Follow-up|425|||
125966469|NCT01131312|453167535|FG001|Overall Study|Lost to Follow-up|229|||
125966470|NCT01131312|453167536|FG002|Overall Study|Lost to Follow-up|351|||
125966471|NCT02682264|453167537|FG000|Overall Study|Withdrawal by Subject|56|||
125966472|NCT02682264|453167538|FG001|Overall Study|Withdrawal by Subject|45|||
125966473|NCT02682264|453167537|FG000|Overall Study|Lost to Follow-up|49|||
125966474|NCT02682264|453167538|FG001|Overall Study|Lost to Follow-up|41|||
125966475|NCT02682264|453167537|FG000|Overall Study|Lack of Efficacy|14|||
125966476|NCT02682264|453167538|FG001|Overall Study|Lack of Efficacy|16|||
125966477|NCT02682264|453167537|FG000|Overall Study|Withdrawal by Parent|6|||
125966478|NCT02682264|453167538|FG001|Overall Study|Withdrawal by Parent|7|||
126134822|NCT03529773|453783738|FG026|Overall Study|Randomized but not vaccinated|0|||
126134823|NCT03529773|453783739|FG027|Overall Study|Randomized but not vaccinated|1|||
126134824|NCT03529773|453783740|FG028|Overall Study|Randomized but not vaccinated|0|||
126134825|NCT03529773|453783741|FG029|Overall Study|Randomized but not vaccinated|0|||
126134826|NCT03529773|453783742|FG030|Overall Study|Randomized but not vaccinated|0|||
126134827|NCT03529773|453783743|FG031|Overall Study|Randomized but not vaccinated|0|||
126134828|NCT03529773|453783744|FG032|Overall Study|Randomized but not vaccinated|0|||
126134829|NCT03529773|453783745|FG033|Overall Study|Randomized but not vaccinated|0|||
126134830|NCT03529773|453783746|FG034|Overall Study|Randomized but not vaccinated|0|||
126134831|NCT03529773|453783747|FG035|Overall Study|Randomized but not vaccinated|0|||
126134832|NCT03529773|453783748|FG036|Overall Study|Randomized but not vaccinated|0|||
126134833|NCT03529773|453783749|FG037|Overall Study|Randomized but not vaccinated|0|||
126134834|NCT03529773|453783750|FG038|Overall Study|Randomized but not vaccinated|0|||
126134835|NCT03529773|453783751|FG039|Overall Study|Randomized but not vaccinated|0|||
126134836|NCT01340209|453783752|FG000|Overall Study|Adverse Event|1|||
126134837|NCT01340209|453783753|FG001|Overall Study|Adverse Event|1|||
126134838|NCT01340209|453783754|FG002|Overall Study|Adverse Event|2|||
126134839|NCT01340209|453783752|FG000|Overall Study|Protocol Violation|1|||
126134840|NCT01340209|453783753|FG001|Overall Study|Protocol Violation|2|||
126134841|NCT01340209|453783754|FG002|Overall Study|Protocol Violation|1|||
126134842|NCT01340209|453783752|FG000|Overall Study|Withdrawal by Subject|0|||
126134843|NCT01340209|453783753|FG001|Overall Study|Withdrawal by Subject|0|||
126134844|NCT01340209|453783754|FG002|Overall Study|Withdrawal by Subject|1|||
126134845|NCT01340209|453783752|FG000|Overall Study|Other reason not defined above|3|||
126134846|NCT01340209|453783753|FG001|Overall Study|Other reason not defined above|5|||
126134847|NCT01340209|453783754|FG002|Overall Study|Other reason not defined above|4|||
125966479|NCT02682264|453167537|FG000|Overall Study|Adverse Event|9|||
125966480|NCT02682264|453167538|FG001|Overall Study|Adverse Event|0|||
125966481|NCT02682264|453167537|FG000|Overall Study|Noncompliance with study drug|1|||
126134848|NCT01537211|453783755|FG000|Overall Study|Lost to Follow-up|0|||
126134849|NCT01537211|453783756|FG001|Overall Study|Lost to Follow-up|1|||
126134850|NCT04142983|453783757|FG000|Overall Study|Lost to Follow-up|73|||
126134851|NCT04142983|453783757|FG000|Overall Study|Withdrawal by Subject|10|||
126134852|NCT04142983|453783757|FG000|Overall Study|Physician Decision|1|||
126134853|NCT04142983|453783757|FG000|Overall Study|Adverse Event|1|||
126134854|NCT04142983|453783757|FG000|Overall Study|No longer eligible|4|||
126134855|NCT04142983|453783757|FG000|Overall Study|Screen Failure|10|||
126134856|NCT02475655|453783760|FG000|Overall Study|Lost to Follow-up|0|||
126134857|NCT02475655|453783761|FG001|Overall Study|Lost to Follow-up|1|||
126134858|NCT00257010|453783782|FG000|Overall Study|Lack of Efficacy|11|||
126134859|NCT00257010|453783782|FG000|Overall Study|Lost to Follow-up|53|||
126134860|NCT00257010|453783782|FG000|Overall Study|Withdrawal by Subject|34|||
126134861|NCT00257010|453783782|FG000|Overall Study|Adverse Event|10|||
126134862|NCT00257010|453783782|FG000|Overall Study|various|11|||
126134863|NCT00257010|453783782|FG000|Overall Study|no headache reported|9|||
125966482|NCT02682264|453167538|FG001|Overall Study|Noncompliance with study drug|4|||
125966483|NCT02682264|453167537|FG000|Overall Study|Pregnancy|1|||
125966484|NCT02682264|453167538|FG001|Overall Study|Pregnancy|2|||
125966485|NCT02682264|453167537|FG000|Overall Study|Recovery|1|||
125966486|NCT02682264|453167538|FG001|Overall Study|Recovery|2|||
125966487|NCT02682264|453167537|FG000|Overall Study|Progressive Disease|1|||
125966488|NCT02682264|453167538|FG001|Overall Study|Progressive Disease|0|||
125966489|NCT02682264|453167537|FG000|Overall Study|Technical Problems|0|||
125966490|NCT02682264|453167538|FG001|Overall Study|Technical Problems|1|||
125966491|NCT02682264|453167537|FG000|Overall Study|Moved abroad and unable to continue|0|||
125966492|NCT02682264|453167538|FG001|Overall Study|Moved abroad and unable to continue|3|||
125966493|NCT02682264|453167537|FG000|Overall Study|Stopped test article application|0|||
125966494|NCT02682264|453167538|FG001|Overall Study|Stopped test article application|1|||
125966495|NCT03447769|453167540|FG000|Overall Study|Progressive disease|138|||
125966496|NCT03447769|453167541|FG001|Overall Study|Progressive disease|148|||
125966497|NCT03447769|453167540|FG000|Overall Study|Study terminated by Sponsor|60|||
125966498|NCT03447769|453167541|FG001|Overall Study|Study terminated by Sponsor|44|||
125966499|NCT03447769|453167540|FG000|Overall Study|Adverse Event|34|||
125966500|NCT03447769|453167541|FG001|Overall Study|Adverse Event|31|||
125966501|NCT03447769|453167540|FG000|Overall Study|Patient decision|27|||
125966502|NCT03447769|453167541|FG001|Overall Study|Patient decision|27|||
125966503|NCT03447769|453167540|FG000|Overall Study|Protocol deviation|4|||
125966504|NCT03447769|453167541|FG001|Overall Study|Protocol deviation|6|||
125966505|NCT03447769|453167540|FG000|Overall Study|Death|2|||
125966506|NCT03447769|453167541|FG001|Overall Study|Death|7|||
125966507|NCT03447769|453167540|FG000|Overall Study|Technical problems|1|||
125966508|NCT03447769|453167541|FG001|Overall Study|Technical problems|0|||
125966509|NCT03447769|453167540|FG000|Overall Study|Lost to Follow-up|0|||
125966510|NCT03447769|453167541|FG001|Overall Study|Lost to Follow-up|1|||
125966511|NCT03447769|453167540|FG000|Overall Study|Physician Decision|13|||
125966512|NCT03447769|453167541|FG001|Overall Study|Physician Decision|5|||
125966513|NCT01343407|453167543|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
125966514|NCT01343407|453167544|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
125966515|NCT01343407|453167545|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
125966516|NCT01343407|453167546|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
125966517|NCT01343407|453167547|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
125966518|NCT01343407|453167548|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
125966519|NCT01343407|453167543|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
125966520|NCT01343407|453167544|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
125966521|NCT01343407|453167545|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
125966522|NCT01343407|453167546|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
125966523|NCT01343407|453167547|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
125966524|NCT01343407|453167548|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
125966525|NCT03950739|453167549|FG000|Treatment Phase|Adverse Event|2|||
125966526|NCT03950739|453167549|FG000|Optional Extension Phase|Death|1|||
125966527|NCT03950739|453167549|FG000|Optional Extension Phase|Progressive Disease|5|||
125966528|NCT03950739|453167549|FG000|Optional Extension Phase|Adverse Event|7|||
125966529|NCT03950739|453167549|FG000|Optional Extension Phase|Lost to Follow-up|2|||
125966530|NCT03950739|453167549|FG000|Optional Extension Phase|Site Closure|2|||
126134864|NCT00323557|453783783|FG000|Overall Study|Physician Decision|1|||
125966531|NCT03950739|453167549|FG000|Optional Extension Phase|Pregnancy|1|||
125966532|NCT03264989|453167553|FG000|Overall Study|Lost to Follow-up|1|||
125966533|NCT03264989|453167554|FG001|Overall Study|Lost to Follow-up|0|||
125966534|NCT03264989|453167553|FG000|Overall Study|New Therapy for study Indication|1|||
125966535|NCT03264989|453167554|FG001|Overall Study|New Therapy for study Indication|0|||
125966536|NCT03264989|453167553|FG000|Overall Study|Protocol Violation|0|||
125966537|NCT03264989|453167554|FG001|Overall Study|Protocol Violation|1|||
125966538|NCT03264989|453167553|FG000|Overall Study|Patient decision|13|||
126134865|NCT00323557|453783784|FG001|Overall Study|Physician Decision|0|||
125966539|NCT03264989|453167554|FG001|Overall Study|Patient decision|0|||
125966540|NCT03264989|453167553|FG000|Overall Study|Physician Decision|6|||
126134866|NCT00197054|453783785|FG000|Overall Study|Withdrawal by Subject|9|||
126134867|NCT00197054|453783786|FG001|Overall Study|Withdrawal by Subject|3|||
126134868|NCT00197054|453783787|FG002|Overall Study|Withdrawal by Subject|3|||
126134869|NCT00197054|453783785|FG000|Overall Study|Moved from area|7|||
125966541|NCT03264989|453167554|FG001|Overall Study|Physician Decision|4|||
125966542|NCT03264989|453167553|FG000|Overall Study|Adverse Event|2|||
125966543|NCT03264989|453167554|FG001|Overall Study|Adverse Event|1|||
125966544|NCT03264989|453167553|FG000|Overall Study|Death|1|||
125966545|NCT03264989|453167554|FG001|Overall Study|Death|1|||
125966546|NCT03264989|453167553|FG000|Overall Study|Pregnancy|2|||
125966547|NCT03264989|453167554|FG001|Overall Study|Pregnancy|0|||
125966548|NCT03264989|453167553|FG000|Overall Study|End of Study|19|||
125966549|NCT03264989|453167554|FG001|Overall Study|End of Study|5|||
125966550|NCT00797667|453167555|FG000|Overall Study|Lack of Efficacy|0|||
125966551|NCT00797667|453167556|FG001|Overall Study|Lack of Efficacy|1|||
125966552|NCT00797667|453167557|FG002|Overall Study|Lack of Efficacy|0|||
125966553|NCT00797667|453167555|FG000|Overall Study|Lost to Follow-up|8|||
125966554|NCT00797667|453167556|FG001|Overall Study|Lost to Follow-up|12|||
125966555|NCT00797667|453167557|FG002|Overall Study|Lost to Follow-up|2|||
125966556|NCT00797667|453167555|FG000|Overall Study|Physician Decision|3|||
125966557|NCT00797667|453167556|FG001|Overall Study|Physician Decision|1|||
125966558|NCT00797667|453167557|FG002|Overall Study|Physician Decision|0|||
125966559|NCT00797667|453167555|FG000|Overall Study|Pregnancy|2|||
125966560|NCT00797667|453167556|FG001|Overall Study|Pregnancy|0|||
125966561|NCT00797667|453167557|FG002|Overall Study|Pregnancy|0|||
125966562|NCT00797667|453167555|FG000|Overall Study|Protocol Violation|2|||
125966563|NCT00797667|453167556|FG001|Overall Study|Protocol Violation|7|||
125966564|NCT00797667|453167557|FG002|Overall Study|Protocol Violation|0|||
125966565|NCT00797667|453167555|FG000|Overall Study|Study Terminated by Sponsor|217|||
125966566|NCT00797667|453167556|FG001|Overall Study|Study Terminated by Sponsor|216|||
125966567|NCT00797667|453167557|FG002|Overall Study|Study Terminated by Sponsor|115|||
125966568|NCT00797667|453167555|FG000|Overall Study|Withdrawal by Subject|9|||
125966569|NCT00797667|453167556|FG001|Overall Study|Withdrawal by Subject|14|||
125966570|NCT00797667|453167557|FG002|Overall Study|Withdrawal by Subject|2|||
125966571|NCT00797667|453167555|FG000|Overall Study|Adverse Event|19|||
125966572|NCT00797667|453167556|FG001|Overall Study|Adverse Event|8|||
125966573|NCT00797667|453167557|FG002|Overall Study|Adverse Event|8|||
125966574|NCT01986829|453167558|FG000|Overall Study|Death|1|||
125966575|NCT02504866|453167559|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
125966576|NCT02504866|453167560|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
125966577|NCT02504866|453167561|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
125966578|NCT01775137|453167564|FG000|Overall Study|Death|1|||
125966579|NCT01775137|453167564|FG000|Overall Study|Protocol deviation|2|||
125966580|NCT01775137|453167564|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125966581|NCT01775137|453167564|FG000|Overall Study|Adverse Event|1|||
125966582|NCT01775137|453167564|FG000|Overall Study|Withdrawal by participants|5|||
125966583|NCT01343056|453167565|FG000|Overall Study|Lost to Follow-up|7|||
125966584|NCT01343056|453167566|FG001|Overall Study|Lost to Follow-up|5|||
125966585|NCT01343056|453167567|FG002|Overall Study|Lost to Follow-up|3|||
125966586|NCT01343056|453167568|FG003|Overall Study|Lost to Follow-up|9|||
125966587|NCT03231371|453167569|FG000|Overall Study|Withdrawal by Subject|1|||
125966588|NCT03231371|453167569|FG000|Overall Study|chose or were ineligible to have MRI|12|||
125966589|NCT03029208|453167573|FG000|Overall Study|Withdrawal by Subject|2|||
125966590|NCT03029208|453167574|FG001|Overall Study|Withdrawal by Subject|3|||
125966591|NCT03029208|453167573|FG000|Overall Study|Lost to Follow-up|0|||
125966592|NCT03029208|453167574|FG001|Overall Study|Lost to Follow-up|1|||
125966593|NCT01732835|453167577|FG000|6-month Primary Endpoint|Did not receive device|19|||
125966594|NCT01732835|453167577|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
125966595|NCT01732835|453167577|FG000|6-month Primary Endpoint|Adverse Event|3|||
125966596|NCT01732835|453167577|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
125966597|NCT01732835|453167577|FG000|2-year Extended Follow-up|Adverse Event|3|||
125966598|NCT01732835|453167577|FG000|2-year Extended Follow-up|Death|1|||
125966599|NCT02493361|453167578|FG000|Overall Study|Withdrawal by Subject|3|||
125966600|NCT02334748|453167579|FG000|Overall Study|Adverse Event|1|||
125966601|NCT02334748|453167579|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
125966602|NCT02334748|453167579|FG000|Overall Study|Patient no longer required study drug|2|||
125966603|NCT02334748|453167579|FG000|Overall Study|Lack of Efficacy|4|||
125966604|NCT01046643|453167580|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
125966605|NCT01046643|453167581|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
125966606|NCT01046643|453167582|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
125966607|NCT01046643|453167583|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
125966608|NCT00305058|453167590|FG000|Overall Study|Participant too young|1|||
125966609|NCT00305058|453167591|FG001|Overall Study|Participant too young|0|||
125966610|NCT00305058|453167590|FG000|Overall Study|Missing data collection instrument|3|||
125966611|NCT00305058|453167591|FG001|Overall Study|Missing data collection instrument|2|||
125966612|NCT00305058|453167590|FG000|Overall Study|Missing outcome data|3|||
125966613|NCT00305058|453167591|FG001|Overall Study|Missing outcome data|2|||
126088651|NCT01077518|453618786|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
126088652|NCT01077518|453618787|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
126088653|NCT01077518|453618785|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
125966614|NCT03965052|453167597|FG000|Overall Study|Protocol Violation|1|||
125966615|NCT03965052|453167598|FG001|Overall Study|Protocol Violation|0|||
125966616|NCT04266028|453167602|FG000|Overall Study|Adverse Event|0|||
125966617|NCT04266028|453167603|FG001|Overall Study|Adverse Event|0|||
125966618|NCT04266028|453167604|FG002|Overall Study|Adverse Event|1|||
125966619|NCT04266028|453167605|FG003|Overall Study|Adverse Event|0|||
125966620|NCT04266028|453167606|FG004|Overall Study|Adverse Event|1|||
125966621|NCT04266028|453167607|FG005|Overall Study|Adverse Event|0|||
125966622|NCT04266028|453167608|FG006|Overall Study|Adverse Event|2|||
125966623|NCT04266028|453167609|FG007|Overall Study|Adverse Event|0|||
125966624|NCT04266028|453167602|FG000|Overall Study|temporary halt of the study|0|||
125966625|NCT04266028|453167603|FG001|Overall Study|temporary halt of the study|0|||
125966626|NCT04266028|453167604|FG002|Overall Study|temporary halt of the study|0|||
125966627|NCT04266028|453167605|FG003|Overall Study|temporary halt of the study|0|||
125966628|NCT04266028|453167606|FG004|Overall Study|temporary halt of the study|0|||
125966629|NCT04266028|453167607|FG005|Overall Study|temporary halt of the study|0|||
125966630|NCT04266028|453167608|FG006|Overall Study|temporary halt of the study|2|||
125966631|NCT04266028|453167609|FG007|Overall Study|temporary halt of the study|1|||
125966632|NCT04266028|453167602|FG000|Overall Study|Onset of birch pollen season|0|||
125966633|NCT04266028|453167603|FG001|Overall Study|Onset of birch pollen season|0|||
125966634|NCT04266028|453167604|FG002|Overall Study|Onset of birch pollen season|0|||
125966635|NCT04266028|453167605|FG003|Overall Study|Onset of birch pollen season|0|||
125966636|NCT04266028|453167606|FG004|Overall Study|Onset of birch pollen season|1|||
125966637|NCT04266028|453167607|FG005|Overall Study|Onset of birch pollen season|0|||
125966638|NCT04266028|453167608|FG006|Overall Study|Onset of birch pollen season|0|||
125966639|NCT04266028|453167609|FG007|Overall Study|Onset of birch pollen season|0|||
125966640|NCT02863991|453167610|FG000|Overall Study|Death|0|||
125966641|NCT02863991|453167611|FG001|Overall Study|Death|3|||
125966642|NCT02863991|453167610|FG000|Overall Study|Lack of Efficacy|0|||
125966643|NCT02863991|453167611|FG001|Overall Study|Lack of Efficacy|1|||
125966644|NCT02863991|453167610|FG000|Overall Study|Study Terminated|2|||
125966645|NCT02863991|453167611|FG001|Overall Study|Study Terminated|8|||
125966646|NCT03096782|453167612|FG000|Overall Study|Death|1|||
125966647|NCT03096782|453167612|FG000|Overall Study|Participant Relapsed|1|||
125966648|NCT03073603|453169662|FG000|Overall Study|Noncompliance|3|||
125966649|NCT03073603|453169663|FG001|Overall Study|Noncompliance|1|||
125966650|NCT03073603|453169662|FG000|Overall Study|Adverse Event|5|||
125966651|NCT03073603|453169663|FG001|Overall Study|Adverse Event|3|||
125966652|NCT03073603|453169662|FG000|Overall Study|Physician Decision|1|||
125966653|NCT03073603|453169663|FG001|Overall Study|Physician Decision|2|||
125966654|NCT03073603|453169662|FG000|Overall Study|Required treatment not allowed by protocol|1|||
125966655|NCT03073603|453169663|FG001|Overall Study|Required treatment not allowed by protocol|0|||
125966656|NCT03073603|453169662|FG000|Overall Study|Financial or insurance-related|8|||
125966657|NCT03073603|453169663|FG001|Overall Study|Financial or insurance-related|0|||
125966658|NCT03073603|453169662|FG000|Overall Study|Withdrawal by Subject|0|||
125966659|NCT03073603|453169663|FG001|Overall Study|Withdrawal by Subject|1|||
125966660|NCT03073603|453169662|FG000|Overall Study|Discontinued DMT|4|||
125966661|NCT03073603|453169663|FG001|Overall Study|Discontinued DMT|0|||
125966662|NCT03073603|453169662|FG000|Overall Study|Restarted DMT|0|||
125966663|NCT03073603|453169663|FG001|Overall Study|Restarted DMT|1|||
125966664|NCT02553330|453169666|FG000|Overall Study|Study Terminated by Sponsor|2|||
125966665|NCT02553330|453169667|FG001|Overall Study|Study Terminated by Sponsor|13|||
125966666|NCT02553330|453169668|FG002|Overall Study|Study Terminated by Sponsor|12|||
125966667|NCT02553330|453169666|FG000|Overall Study|Withdrawal by Subject|3|||
125966668|NCT02553330|453169667|FG001|Overall Study|Withdrawal by Subject|19|||
125966669|NCT02553330|453169668|FG002|Overall Study|Withdrawal by Subject|21|||
125966670|NCT02553330|453169666|FG000|Overall Study|Other|0|||
125966671|NCT02553330|453169667|FG001|Overall Study|Other|1|||
125966672|NCT02553330|453169668|FG002|Overall Study|Other|0|||
125966673|NCT02553330|453169666|FG000|Overall Study|Non compliance to study treatment|0|||
125966674|NCT02553330|453169667|FG001|Overall Study|Non compliance to study treatment|1|||
125966675|NCT02553330|453169668|FG002|Overall Study|Non compliance to study treatment|0|||
125966676|NCT02553330|453169666|FG000|Overall Study|Adverse Event|0|||
125966677|NCT02553330|453169667|FG001|Overall Study|Adverse Event|1|||
125966678|NCT02553330|453169668|FG002|Overall Study|Adverse Event|0|||
125966679|NCT02553330|453169666|FG000|Overall Study|Lost to Follow-up|0|||
125966680|NCT02553330|453169667|FG001|Overall Study|Lost to Follow-up|4|||
125966681|NCT02553330|453169668|FG002|Overall Study|Lost to Follow-up|4|||
125966682|NCT01659021|453169671|FG000|Main Study|Adverse Event|2|||
125966683|NCT01659021|453169672|FG001|Main Study|Adverse Event|3|||
125966684|NCT01659021|453169671|FG000|Main Study|Lost to Follow-up|1|||
125966685|NCT01659021|453169672|FG001|Main Study|Lost to Follow-up|0|||
125966686|NCT01659021|453169671|FG000|Main Study|Unknown Reasons|2|||
125966687|NCT01659021|453169672|FG001|Main Study|Unknown Reasons|1|||
125966688|NCT01659021|453169671|FG000|Main Study|Physician Decision|34|||
125966689|NCT01659021|453169672|FG001|Main Study|Physician Decision|16|||
125966690|NCT01659021|453169671|FG000|Main Study|Withdrawal by Subject|19|||
125966691|NCT01659021|453169672|FG001|Main Study|Withdrawal by Subject|16|||
125966692|NCT01659021|453169671|FG000|Main Study|Study Terminated by Sponsor|16|||
125966693|NCT01659021|453169672|FG001|Main Study|Study Terminated by Sponsor|1|||
125966694|NCT01659021|453169671|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
125966695|NCT01659021|453169672|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
125966696|NCT01659021|453169671|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
125966697|NCT01659021|453169672|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
125966698|NCT03551938|453169673|FG000|3-Month Follow Up|Lost to Follow-up|39|||
125966699|NCT03551938|453169674|FG001|3-Month Follow Up|Lost to Follow-up|38|||
125966700|NCT03551938|453169673|FG000|6-Month Follow Up|Lost to Follow-up|46|||
125966701|NCT03551938|453169674|FG001|6-Month Follow Up|Lost to Follow-up|42|||
125966702|NCT03551938|453169673|FG000|9-Month Follow Up|Lost to Follow-up|44|||
125966703|NCT03551938|453169674|FG001|9-Month Follow Up|Lost to Follow-up|43|||
125966704|NCT01205685|453169675|FG000|Overall Study|Disease Progression|10|||
125966705|NCT01205685|453169675|FG000|Overall Study|Withdrawal by Subject|1|||
125966706|NCT04827212|453169679|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
125966707|NCT04827212|453169680|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
125966708|NCT04827212|453169679|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
125966709|NCT04827212|453169680|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
125966710|NCT03058679|453169681|FG000|Baseline to Week 6|Lost to Follow-up|3|||
125966711|NCT03058679|453169682|FG001|Baseline to Week 6|Lost to Follow-up|2|||
125966712|NCT03058679|453169681|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
125966713|NCT03058679|453169682|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
125966714|NCT03058679|453169681|FG000|Baseline to Week 6|Adverse Event|6|||
125966715|NCT03058679|453169682|FG001|Baseline to Week 6|Adverse Event|6|||
125966716|NCT03058679|453169681|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
125966717|NCT03058679|453169682|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
125966718|NCT03058679|453169681|FG000|Baseline to Week 6|Difficulty following the diet|0|||
125966719|NCT03058679|453169682|FG001|Baseline to Week 6|Difficulty following the diet|2|||
125966720|NCT03058679|453169681|FG000|Baseline to Week 6|Physician Decision|1|||
125966721|NCT03058679|453169682|FG001|Baseline to Week 6|Physician Decision|0|||
125966722|NCT03058679|453169681|FG000|Week 6 to Week 12|Change in medication|5|||
125966723|NCT03058679|453169682|FG001|Week 6 to Week 12|Change in medication|7|||
125966724|NCT03058679|453169681|FG000|Week 6 to Week 12|Adverse Event|4|||
125966725|NCT03058679|453169682|FG001|Week 6 to Week 12|Adverse Event|3|||
125966726|NCT03058679|453169681|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
125966727|NCT03058679|453169682|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
125966728|NCT03058679|453169681|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
125966729|NCT03058679|453169682|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
125966730|NCT00599326|453169691|FG000|Overall Study|Lost to Follow-up|1|||
125966731|NCT00599326|453169691|FG000|Overall Study|Noncompliant|1|||
125966732|NCT00784810|453169694|FG000|Overall Study|Adverse Event|32|||
125966733|NCT00784810|453169695|FG001|Overall Study|Adverse Event|20|||
125966734|NCT00784810|453169694|FG000|Overall Study|Lack of Efficacy|14|||
125966735|NCT00784810|453169695|FG001|Overall Study|Lack of Efficacy|11|||
125966736|NCT00784810|453169694|FG000|Overall Study|Withdrawal by Subject|11|||
125966737|NCT00784810|453169695|FG001|Overall Study|Withdrawal by Subject|9|||
125966738|NCT00784810|453169694|FG000|Overall Study|Administrative|5|||
125966739|NCT00784810|453169695|FG001|Overall Study|Administrative|8|||
125966740|NCT00784810|453169694|FG000|Overall Study|Lost to Follow-up|1|||
125966741|NCT00784810|453169695|FG001|Overall Study|Lost to Follow-up|1|||
125966742|NCT02862106|453169696|FG000|Overall Study|Adverse Event|4|||
125966743|NCT02862106|453169697|FG001|Overall Study|Adverse Event|0|||
125966744|NCT02862106|453169696|FG000|Overall Study|Protocol Violation|16|||
125966745|NCT02862106|453169697|FG001|Overall Study|Protocol Violation|1|||
126134870|NCT00197054|453783786|FG001|Overall Study|Moved from area|14|||
126134871|NCT00197054|453783787|FG002|Overall Study|Moved from area|9|||
126134872|NCT00197054|453783785|FG000|Overall Study|Lost to Follow-up|1|||
126134873|NCT00197054|453783786|FG001|Overall Study|Lost to Follow-up|4|||
126134874|NCT00197054|453783787|FG002|Overall Study|Lost to Follow-up|0|||
126134875|NCT01699087|453783791|FG000|Overall Study|Lost to Follow-up|7|||
126134876|NCT01699087|453783791|FG000|Overall Study|Screen failure (prior to treatment)|15|||
126134877|NCT01699087|453783791|FG000|Overall Study|Unable to make future visits|2|||
126134878|NCT03021642|453783792|FG000|Washout Period (21 Days)|Adverse Event|1|||
125966746|NCT02862106|453169696|FG000|Overall Study|Lost to Follow-up|15|||
125966747|NCT02862106|453169697|FG001|Overall Study|Lost to Follow-up|5|||
125966748|NCT02862106|453169696|FG000|Overall Study|Withdrawal by Subject|2|||
125966749|NCT02862106|453169697|FG001|Overall Study|Withdrawal by Subject|0|||
125966750|NCT02862106|453169696|FG000|Overall Study|Subjects moved to other city|1|||
125966751|NCT02862106|453169697|FG001|Overall Study|Subjects moved to other city|0|||
126134879|NCT03021642|453783793|FG001|Washout Period (21 Days)|Adverse Event|1|||
126134880|NCT02474082|453783794|FG000|Overall Study|Adverse Event|2|||
125966752|NCT04137380|453169700|FG000|Overall Study|Physician Decision|0|||
125966753|NCT04137380|453169701|FG001|Overall Study|Physician Decision|0|||
125966754|NCT04137380|453169702|FG002|Overall Study|Physician Decision|0|||
125966755|NCT04137380|453169703|FG003|Overall Study|Physician Decision|1|||
125966756|NCT04137380|453169704|FG004|Overall Study|Physician Decision|0|||
126134881|NCT02474082|453783795|FG001|Overall Study|Adverse Event|32|||
126134882|NCT02474082|453783794|FG000|Overall Study|Withdrawal of informed consent|1|||
126134883|NCT02474082|453783795|FG001|Overall Study|Withdrawal of informed consent|11|||
126134884|NCT02474082|453783794|FG000|Overall Study|Lost to Follow-up|2|||
126134885|NCT02474082|453783795|FG001|Overall Study|Lost to Follow-up|2|||
126134886|NCT02474082|453783794|FG000|Overall Study|Dose tapering not achieved|0|||
126134887|NCT02474082|453783795|FG001|Overall Study|Dose tapering not achieved|4|||
126134888|NCT02474082|453783794|FG000|Overall Study|Participant/guardian decision|1|||
126134889|NCT02474082|453783795|FG001|Overall Study|Participant/guardian decision|2|||
126134890|NCT02474082|453783794|FG000|Overall Study|Non-compliance with study treatment|0|||
126134891|NCT02474082|453783795|FG001|Overall Study|Non-compliance with study treatment|2|||
126134892|NCT02474082|453783794|FG000|Overall Study|Protocol deviation|0|||
126134893|NCT02474082|453783795|FG001|Overall Study|Protocol deviation|1|||
126134894|NCT00523991|453783800|FG000|Overall Study|Adverse Event|6|||
126134895|NCT00523991|453783801|FG001|Overall Study|Adverse Event|5|||
126134896|NCT00523991|453783800|FG000|Overall Study|Protocol Violation|1|||
126134897|NCT00523991|453783801|FG001|Overall Study|Protocol Violation|4|||
126134898|NCT00523991|453783800|FG000|Overall Study|Lost to Follow-up|4|||
126134899|NCT00523991|453783801|FG001|Overall Study|Lost to Follow-up|1|||
126134900|NCT00523991|453783800|FG000|Overall Study|Withdrawal by Subject|7|||
126134901|NCT00523991|453783801|FG001|Overall Study|Withdrawal by Subject|17|||
126134902|NCT00523991|453783800|FG000|Overall Study|Other reason (not specified)|3|||
126134903|NCT00523991|453783801|FG001|Overall Study|Other reason (not specified)|0|||
126134904|NCT00193063|453783802|FG000|Overall Study|Lack of Efficacy|3|||
126134905|NCT00193063|453783802|FG000|Overall Study|Adverse Event|1|||
126134906|NCT01017952|453783804|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
126134907|NCT01017952|453783805|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126134908|NCT01017952|453783806|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126134909|NCT01017952|453783807|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126134910|NCT01017952|453783808|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126134911|NCT01017952|453783804|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
126134912|NCT01017952|453783805|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
126134913|NCT01017952|453783806|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
126134914|NCT01017952|453783807|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
126134915|NCT01017952|453783808|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
126134916|NCT01017952|453783804|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
126134917|NCT01017952|453783805|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
126134918|NCT01017952|453783806|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
126134919|NCT01017952|453783807|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125966757|NCT04137380|453169705|FG005|Overall Study|Physician Decision|0|||
125966758|NCT04137380|453169706|FG006|Overall Study|Physician Decision|0|||
125966759|NCT00563784|453169709|FG000|Overall Study|Withdrawal by Subject|2|||
125966760|NCT00563784|453169709|FG000|Overall Study|Screen Failures|20|||
125966761|NCT03434119|453169712|FG000|Overall Study|Randomized but not treated|1|||
125966762|NCT03434119|453169713|FG001|Overall Study|Randomized but not treated|0|||
125966763|NCT03434119|453169712|FG000|Overall Study|Adverse Event|1|||
125966764|NCT03434119|453169713|FG001|Overall Study|Adverse Event|0|||
125966765|NCT03434119|453169712|FG000|Overall Study|Poor Compliance to Protocol|0|||
125966766|NCT03434119|453169713|FG001|Overall Study|Poor Compliance to Protocol|1|||
125966767|NCT03434119|453169712|FG000|Overall Study|Study Terminated by Sponsor|91|||
125966768|NCT03434119|453169713|FG001|Overall Study|Study Terminated by Sponsor|102|||
125966769|NCT03434119|453169712|FG000|Overall Study|Withdrawal by Subject|7|||
125966770|NCT03434119|453169713|FG001|Overall Study|Withdrawal by Subject|5|||
125966771|NCT03434119|453169712|FG000|Overall Study|Other than specified|7|||
125966772|NCT03434119|453169713|FG001|Overall Study|Other than specified|5|||
126134920|NCT01017952|453783808|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
126134921|NCT01017952|453783804|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
126134922|NCT01017952|453783805|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125966773|NCT04360824|453169716|FG000|Overall Study|Withdrawal by Subject|2|||
125966774|NCT04360824|453169717|FG001|Overall Study|Withdrawal by Subject|1|||
126134923|NCT01017952|453783806|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126134924|NCT01017952|453783807|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126134925|NCT01017952|453783808|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126134926|NCT01017952|453783804|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
126134927|NCT01017952|453783805|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
126134928|NCT01017952|453783806|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
125966775|NCT04360824|453169716|FG000|Overall Study|Did not receive assigned treatment|1|||
125966776|NCT04360824|453169717|FG001|Overall Study|Did not receive assigned treatment|3|||
125966777|NCT00304070|453169718|FG000|Overall Study|Death|0|||
125966778|NCT00304070|453169719|FG001|Overall Study|Death|0|||
126134929|NCT01017952|453783807|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
126134930|NCT01017952|453783808|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
126134931|NCT01017952|453783804|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
126134932|NCT01017952|453783805|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126134933|NCT01017952|453783806|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126134934|NCT01017952|453783807|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126134935|NCT01017952|453783808|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126134936|NCT01017952|453783804|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
126134937|NCT01017952|453783805|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
126134938|NCT01017952|453783806|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
126134939|NCT01017952|453783807|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
126134940|NCT01017952|453783808|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
126134941|NCT01017952|453783804|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126134942|NCT01017952|453783805|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
126134943|NCT01017952|453783806|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
126134944|NCT01017952|453783807|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
126134945|NCT01017952|453783808|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
126134946|NCT01017952|453783804|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
126134947|NCT01017952|453783805|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
126134948|NCT01017952|453783806|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
126134949|NCT01017952|453783807|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
126134950|NCT01017952|453783808|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
126134951|NCT01017952|453783804|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
126134952|NCT01017952|453783805|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
126134953|NCT01017952|453783806|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
126134954|NCT01017952|453783807|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
126134955|NCT01017952|453783808|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
126134956|NCT01017952|453783804|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126134957|NCT01017952|453783805|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
126134958|NCT01017952|453783806|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
126134959|NCT01017952|453783807|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
126134960|NCT01017952|453783808|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
126134961|NCT01017952|453783804|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126134962|NCT01017952|453783805|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
126134963|NCT01017952|453783806|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
126134964|NCT01017952|453783807|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126134965|NCT01017952|453783808|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126134966|NCT01017952|453783804|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126134967|NCT01017952|453783805|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
126134968|NCT01017952|453783806|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
126134969|NCT01017952|453783807|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
126134970|NCT01017952|453783808|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
126134971|NCT01017952|453783804|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
126134972|NCT01017952|453783805|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
126134973|NCT01017952|453783806|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
126134974|NCT01017952|453783807|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
126134975|NCT01017952|453783808|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
126134976|NCT01064167|453783809|FG000|Overall Study|Protocol Violation|14|||
126134977|NCT01064167|453783810|FG001|Overall Study|Protocol Violation|15|||
126134978|NCT02902120|453783811|FG000|Overall Study|Lack of Efficacy|1|||
126134979|NCT02435914|453783812|FG000|Overall Study|Ocular Adverse Event|1|||
126134980|NCT02435914|453783813|FG001|Overall Study|Ocular Adverse Event|0|||
126134981|NCT02435914|453783814|FG002|Overall Study|Ocular Adverse Event|0|||
126134982|NCT02435914|453783815|FG003|Overall Study|Ocular Adverse Event|0|||
126134983|NCT02435914|453783812|FG000|Overall Study|Withdrawal by Subject|0|||
126134984|NCT02435914|453783813|FG001|Overall Study|Withdrawal by Subject|1|||
126134985|NCT02435914|453783814|FG002|Overall Study|Withdrawal by Subject|0|||
126134986|NCT02435914|453783815|FG003|Overall Study|Withdrawal by Subject|0|||
126134987|NCT02435914|453783812|FG000|Overall Study|Other Miscellaneous Reason|0|||
126134988|NCT02435914|453783813|FG001|Overall Study|Other Miscellaneous Reason|0|||
126134989|NCT02435914|453783814|FG002|Overall Study|Other Miscellaneous Reason|1|||
126134990|NCT02435914|453783815|FG003|Overall Study|Other Miscellaneous Reason|0|||
126134991|NCT02175680|453783824|FG000|Overall Study|non-compliance|1|||
126134992|NCT02175680|453783824|FG000|Overall Study|other non-medical reason|1|||
126134993|NCT03979274|453783825|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125966779|NCT00304070|453169720|FG002|Overall Study|Death|3|||
125966780|NCT00304070|453169718|FG000|Overall Study|Lost to Follow-up|0|||
125966781|NCT00304070|453169719|FG001|Overall Study|Lost to Follow-up|0|||
126134994|NCT03979274|453783826|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126134995|NCT01665144|453783827|FG000|Core Part|Withdrawal by Subject|96|||
126134996|NCT01665144|453783828|FG001|Core Part|Withdrawal by Subject|77|||
126134997|NCT01665144|453783829|FG002|Core Part|Withdrawal by Subject|0|||
126134998|NCT01665144|453783827|FG000|Core Part|Adverse Event|45|||
126134999|NCT01665144|453783828|FG001|Core Part|Adverse Event|18|||
126135000|NCT01665144|453783829|FG002|Core Part|Adverse Event|0|||
126135001|NCT01665144|453783827|FG000|Core Part|Lack of Efficacy|16|||
126135002|NCT01665144|453783828|FG001|Core Part|Lack of Efficacy|11|||
126135003|NCT01665144|453783829|FG002|Core Part|Lack of Efficacy|0|||
126135004|NCT01665144|453783827|FG000|Core Part|Lost to Follow-up|9|||
126135005|NCT01665144|453783828|FG001|Core Part|Lost to Follow-up|8|||
126135006|NCT01665144|453783829|FG002|Core Part|Lost to Follow-up|0|||
126135007|NCT01665144|453783827|FG000|Core Part|Physician Decision|13|||
126135008|NCT01665144|453783828|FG001|Core Part|Physician Decision|1|||
126135009|NCT01665144|453783829|FG002|Core Part|Physician Decision|0|||
126135010|NCT01665144|453783827|FG000|Core Part|Progressive disease|8|||
126135011|NCT01665144|453783828|FG001|Core Part|Progressive disease|4|||
126135012|NCT01665144|453783829|FG002|Core Part|Progressive disease|0|||
126135013|NCT01665144|453783827|FG000|Core Part|Non-compliance with study treatment|5|||
126135014|NCT01665144|453783828|FG001|Core Part|Non-compliance with study treatment|0|||
126135015|NCT01665144|453783829|FG002|Core Part|Non-compliance with study treatment|0|||
126135016|NCT01665144|453783827|FG000|Core Part|Death|3|||
126135017|NCT01665144|453783828|FG001|Core Part|Death|1|||
126135018|NCT01665144|453783829|FG002|Core Part|Death|0|||
126135019|NCT01665144|453783827|FG000|Core Part|Protocol deviation|3|||
126135020|NCT01665144|453783828|FG001|Core Part|Protocol deviation|1|||
126135021|NCT01665144|453783829|FG002|Core Part|Protocol deviation|0|||
126135022|NCT01665144|453783827|FG000|Core Part|New therapy for study indication|2|||
126135023|NCT01665144|453783828|FG001|Core Part|New therapy for study indication|1|||
126135024|NCT01665144|453783829|FG002|Core Part|New therapy for study indication|0|||
126135025|NCT01665144|453783827|FG000|Core Part|Technical problems|2|||
126135026|NCT01665144|453783828|FG001|Core Part|Technical problems|0|||
125966782|NCT00304070|453169720|FG002|Overall Study|Lost to Follow-up|1|||
125966783|NCT00304070|453169718|FG000|Overall Study|Physician Decision|0|||
126135027|NCT01665144|453783829|FG002|Core Part|Technical problems|0|||
126135028|NCT01665144|453783827|FG000|Extension Part|Patient/guardian decision|180|||
126135029|NCT01665144|453783828|FG001|Extension Part|Patient/guardian decision|0|||
126135030|NCT01665144|453783829|FG002|Extension Part|Patient/guardian decision|98|||
126135031|NCT01665144|453783827|FG000|Extension Part|Adverse Event|104|||
126135032|NCT01665144|453783828|FG001|Extension Part|Adverse Event|0|||
126135033|NCT01665144|453783829|FG002|Extension Part|Adverse Event|59|||
126135034|NCT01665144|453783827|FG000|Extension Part|Study closed early|42|||
126135035|NCT01665144|453783828|FG001|Extension Part|Study closed early|0|||
126135036|NCT01665144|453783829|FG002|Extension Part|Study closed early|19|||
125966784|NCT00304070|453169719|FG001|Overall Study|Physician Decision|0|||
125966785|NCT00304070|453169720|FG002|Overall Study|Physician Decision|3|||
125966786|NCT00304070|453169718|FG000|Overall Study|Withdrawal by Subject|0|||
125966787|NCT00304070|453169719|FG001|Overall Study|Withdrawal by Subject|0|||
125966788|NCT00304070|453169720|FG002|Overall Study|Withdrawal by Subject|1|||
125966789|NCT00304070|453169718|FG000|Overall Study|Progressive Disease|3|||
125966790|NCT00304070|453169719|FG001|Overall Study|Progressive Disease|7|||
125966791|NCT00304070|453169720|FG002|Overall Study|Progressive Disease|4|||
125966792|NCT00320216|453169721|FG000|Overall Study|Adverse Event|0|||
125966793|NCT00320216|453169722|FG001|Overall Study|Adverse Event|6|||
125966794|NCT00320216|453169723|FG002|Overall Study|Adverse Event|0|||
125966795|NCT00320216|453169724|FG003|Overall Study|Adverse Event|2|||
125966796|NCT00320216|453169725|FG004|Overall Study|Adverse Event|2|||
125966797|NCT00320216|453169721|FG000|Overall Study|Lack of Efficacy|6|||
125966798|NCT00320216|453169722|FG001|Overall Study|Lack of Efficacy|2|||
125966799|NCT00320216|453169723|FG002|Overall Study|Lack of Efficacy|1|||
125966800|NCT00320216|453169724|FG003|Overall Study|Lack of Efficacy|0|||
125966801|NCT00320216|453169725|FG004|Overall Study|Lack of Efficacy|1|||
125966802|NCT00320216|453169721|FG000|Overall Study|Lost to Follow-up|3|||
125966803|NCT00320216|453169722|FG001|Overall Study|Lost to Follow-up|0|||
125966804|NCT00320216|453169723|FG002|Overall Study|Lost to Follow-up|0|||
125966805|NCT00320216|453169724|FG003|Overall Study|Lost to Follow-up|0|||
125966806|NCT00320216|453169725|FG004|Overall Study|Lost to Follow-up|0|||
126135037|NCT01665144|453783827|FG000|Extension Part|Progressive disease|36|||
125966807|NCT00320216|453169721|FG000|Overall Study|Other|7|||
125966808|NCT00320216|453169722|FG001|Overall Study|Other|2|||
125966809|NCT00320216|453169723|FG002|Overall Study|Other|5|||
126135038|NCT01665144|453783828|FG001|Extension Part|Progressive disease|0|||
125966810|NCT00320216|453169724|FG003|Overall Study|Other|1|||
126135039|NCT01665144|453783829|FG002|Extension Part|Progressive disease|14|||
125966811|NCT00320216|453169725|FG004|Overall Study|Other|3|||
125966812|NCT00377676|453169727|FG000|Overall Study|Adverse Event|498|||
126135040|NCT01665144|453783827|FG000|Extension Part|Lack of Efficacy|37|||
126135041|NCT01665144|453783828|FG001|Extension Part|Lack of Efficacy|0|||
126135042|NCT01665144|453783829|FG002|Extension Part|Lack of Efficacy|12|||
126135043|NCT01665144|453783827|FG000|Extension Part|Physician Decision|29|||
126135044|NCT01665144|453783828|FG001|Extension Part|Physician Decision|0|||
126135045|NCT01665144|453783829|FG002|Extension Part|Physician Decision|13|||
126135046|NCT01665144|453783827|FG000|Extension Part|Technical problems|20|||
126135047|NCT01665144|453783828|FG001|Extension Part|Technical problems|0|||
125966813|NCT00377676|453169728|FG001|Overall Study|Adverse Event|107|||
125966814|NCT00377676|453169727|FG000|Overall Study|Protocol Violation|33|||
125966815|NCT00377676|453169728|FG001|Overall Study|Protocol Violation|27|||
125966816|NCT00377676|453169727|FG000|Overall Study|Death|5|||
125966817|NCT00377676|453169728|FG001|Overall Study|Death|2|||
125966818|NCT00377676|453169727|FG000|Overall Study|Withdrawal by Subject|187|||
125966819|NCT00377676|453169728|FG001|Overall Study|Withdrawal by Subject|72|||
125966820|NCT00377676|453169727|FG000|Overall Study|Lost to Follow-up|120|||
125966821|NCT00377676|453169728|FG001|Overall Study|Lost to Follow-up|56|||
125966822|NCT00377676|453169727|FG000|Overall Study|Other|118|||
125966823|NCT00377676|453169728|FG001|Overall Study|Other|58|||
125966824|NCT00148343|453169733|FG000|Overall Study|Withdrawal by Subject|12|||
125966825|NCT00148343|453169734|FG001|Overall Study|Withdrawal by Subject|7|||
125966826|NCT00148343|453169733|FG000|Overall Study|Physician Decision|3|||
125966827|NCT00148343|453169734|FG001|Overall Study|Physician Decision|4|||
125966828|NCT03579459|453169737|FG000|Overall Study|Adverse Event|7|||
125966829|NCT03579459|453169738|FG001|Overall Study|Adverse Event|6|||
125966830|NCT03579459|453169739|FG002|Overall Study|Adverse Event|2|||
125966831|NCT03579459|453169740|FG003|Overall Study|Adverse Event|6|||
125966832|NCT03579459|453169737|FG000|Overall Study|Death|1|||
125966833|NCT03579459|453169738|FG001|Overall Study|Death|0|||
125966834|NCT03579459|453169739|FG002|Overall Study|Death|1|||
125966835|NCT03579459|453169740|FG003|Overall Study|Death|2|||
125966836|NCT03579459|453169737|FG000|Overall Study|Lost to Follow-up|6|||
125966837|NCT03579459|453169738|FG001|Overall Study|Lost to Follow-up|2|||
125966838|NCT03579459|453169739|FG002|Overall Study|Lost to Follow-up|4|||
125966839|NCT03579459|453169740|FG003|Overall Study|Lost to Follow-up|1|||
125966840|NCT03579459|453169737|FG000|Overall Study|Physician Decision|0|||
125966841|NCT03579459|453169738|FG001|Overall Study|Physician Decision|1|||
125966842|NCT03579459|453169739|FG002|Overall Study|Physician Decision|0|||
125966843|NCT03579459|453169740|FG003|Overall Study|Physician Decision|1|||
125966844|NCT03579459|453169737|FG000|Overall Study|Protocol Violation|1|||
125966845|NCT03579459|453169738|FG001|Overall Study|Protocol Violation|2|||
125966846|NCT03579459|453169739|FG002|Overall Study|Protocol Violation|3|||
125966847|NCT03579459|453169740|FG003|Overall Study|Protocol Violation|5|||
125966848|NCT03579459|453169737|FG000|Overall Study|Withdrawal by Subject|12|||
125966849|NCT03579459|453169738|FG001|Overall Study|Withdrawal by Subject|8|||
125966850|NCT03579459|453169739|FG002|Overall Study|Withdrawal by Subject|11|||
125966851|NCT03579459|453169740|FG003|Overall Study|Withdrawal by Subject|8|||
125966852|NCT03579459|453169737|FG000|Overall Study|Medication error without associated adverse event|2|||
125966853|NCT03579459|453169738|FG001|Overall Study|Medication error without associated adverse event|1|||
125966854|NCT03579459|453169739|FG002|Overall Study|Medication error without associated adverse event|1|||
125966855|NCT03579459|453169740|FG003|Overall Study|Medication error without associated adverse event|0|||
125966856|NCT03579459|453169737|FG000|Overall Study|Other|0|||
125966857|NCT03579459|453169738|FG001|Overall Study|Other|1|||
125966858|NCT03579459|453169739|FG002|Overall Study|Other|1|||
125966859|NCT03579459|453169740|FG003|Overall Study|Other|0|||
125966860|NCT03579459|453169737|FG000|Overall Study|Randomized not vaccinated|0|||
125966861|NCT03579459|453169738|FG001|Overall Study|Randomized not vaccinated|2|||
125966862|NCT03579459|453169739|FG002|Overall Study|Randomized not vaccinated|0|||
125966863|NCT03579459|453169740|FG003|Overall Study|Randomized not vaccinated|1|||
125966864|NCT02528214|453169748|FG000|Overall Study|Protocol Violation|0|||
125966865|NCT02528214|453169749|FG001|Overall Study|Protocol Violation|1|||
125966866|NCT02528214|453169748|FG000|Overall Study|Adverse Event|0|||
125966867|NCT02528214|453169749|FG001|Overall Study|Adverse Event|1|||
125966868|NCT02528214|453169748|FG000|Overall Study|Other than specified above|0|||
125966869|NCT02528214|453169749|FG001|Overall Study|Other than specified above|1|||
125966870|NCT00941603|453169753|FG000|Overall Study|Adverse Event|10|||
125966871|NCT00941603|453169754|FG001|Overall Study|Adverse Event|15|||
125966872|NCT00941603|453169755|FG002|Overall Study|Adverse Event|5|||
125966873|NCT00941603|453169756|FG003|Overall Study|Adverse Event|1|||
125966874|NCT00941603|453169757|FG004|Overall Study|Adverse Event|4|||
125966875|NCT00941603|453169758|FG005|Overall Study|Adverse Event|0|||
125966876|NCT00941603|453169753|FG000|Overall Study|Lost to Follow-up|0|||
125966877|NCT00941603|453169754|FG001|Overall Study|Lost to Follow-up|0|||
125966878|NCT00941603|453169755|FG002|Overall Study|Lost to Follow-up|0|||
125966879|NCT00941603|453169756|FG003|Overall Study|Lost to Follow-up|1|||
125966880|NCT00941603|453169757|FG004|Overall Study|Lost to Follow-up|0|||
125966881|NCT00941603|453169758|FG005|Overall Study|Lost to Follow-up|2|||
125966882|NCT00941603|453169753|FG000|Overall Study|Withdrawal by Subject|0|||
125966883|NCT00941603|453169754|FG001|Overall Study|Withdrawal by Subject|0|||
125966884|NCT00941603|453169755|FG002|Overall Study|Withdrawal by Subject|0|||
125966885|NCT00941603|453169756|FG003|Overall Study|Withdrawal by Subject|2|||
125966886|NCT00941603|453169757|FG004|Overall Study|Withdrawal by Subject|0|||
125966887|NCT00941603|453169758|FG005|Overall Study|Withdrawal by Subject|1|||
125966888|NCT00941603|453169753|FG000|Overall Study|Protocol Violation|0|||
125966889|NCT00941603|453169754|FG001|Overall Study|Protocol Violation|1|||
125966890|NCT00941603|453169755|FG002|Overall Study|Protocol Violation|0|||
125966891|NCT00941603|453169756|FG003|Overall Study|Protocol Violation|0|||
125966892|NCT00941603|453169757|FG004|Overall Study|Protocol Violation|0|||
125966893|NCT00941603|453169758|FG005|Overall Study|Protocol Violation|0|||
125966894|NCT00941603|453169753|FG000|Overall Study|Did not meet protocol eligibility|1|||
125966895|NCT00941603|453169754|FG001|Overall Study|Did not meet protocol eligibility|0|||
125966896|NCT00941603|453169755|FG002|Overall Study|Did not meet protocol eligibility|0|||
125966897|NCT00941603|453169756|FG003|Overall Study|Did not meet protocol eligibility|0|||
125966898|NCT00941603|453169757|FG004|Overall Study|Did not meet protocol eligibility|0|||
125966899|NCT00941603|453169758|FG005|Overall Study|Did not meet protocol eligibility|0|||
125966900|NCT02079805|453169759|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125966901|NCT02079805|453169760|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125966902|NCT02079805|453169759|FG000|Overall Study|Voluntary Withdrawal|0|||
125966903|NCT02079805|453169760|FG001|Overall Study|Voluntary Withdrawal|1|||
125966904|NCT02014116|453169761|FG000|Overall Study|Progressive Disease|3|||
125966905|NCT02014116|453169762|FG001|Overall Study|Progressive Disease|4|||
125966906|NCT02014116|453169763|FG002|Overall Study|Progressive Disease|2|||
125966907|NCT02014116|453169764|FG003|Overall Study|Progressive Disease|6|||
125966908|NCT02014116|453169765|FG004|Overall Study|Progressive Disease|1|||
125966909|NCT02014116|453169766|FG005|Overall Study|Progressive Disease|13|||
125966910|NCT02014116|453169767|FG006|Overall Study|Progressive Disease|1|||
125966911|NCT02014116|453169768|FG007|Overall Study|Progressive Disease|3|||
125966912|NCT02014116|453169769|FG008|Overall Study|Progressive Disease|7|||
125966913|NCT02014116|453169761|FG000|Overall Study|Adverse Event|0|||
125966914|NCT02014116|453169762|FG001|Overall Study|Adverse Event|0|||
125966915|NCT02014116|453169763|FG002|Overall Study|Adverse Event|0|||
125966916|NCT02014116|453169764|FG003|Overall Study|Adverse Event|0|||
125966917|NCT02014116|453169765|FG004|Overall Study|Adverse Event|1|||
125966918|NCT02014116|453169766|FG005|Overall Study|Adverse Event|0|||
125966919|NCT02014116|453169767|FG006|Overall Study|Adverse Event|0|||
125966920|NCT02014116|453169768|FG007|Overall Study|Adverse Event|1|||
125966921|NCT02014116|453169769|FG008|Overall Study|Adverse Event|0|||
125966922|NCT02014116|453169761|FG000|Overall Study|Lost to Follow-up|0|||
125966923|NCT02014116|453169762|FG001|Overall Study|Lost to Follow-up|0|||
125966924|NCT02014116|453169763|FG002|Overall Study|Lost to Follow-up|0|||
125966925|NCT02014116|453169764|FG003|Overall Study|Lost to Follow-up|0|||
126088654|NCT01077518|453618786|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
126088655|NCT01077518|453618787|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
126088656|NCT01077518|453618785|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
126088657|NCT01077518|453618786|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
126088658|NCT01077518|453618787|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
126088659|NCT01077518|453618785|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
126088660|NCT01077518|453618786|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
126088661|NCT01077518|453618787|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
126088662|NCT01077518|453618785|FG000|Optional Ofa Phase|Physician Decision|0|||
126088663|NCT01077518|453618786|FG001|Optional Ofa Phase|Physician Decision|0|||
126088664|NCT01077518|453618787|FG002|Optional Ofa Phase|Physician Decision|1|||
126088665|NCT01077518|453618785|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
126088666|NCT01077518|453618786|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
126088667|NCT01077518|453618787|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
126088668|NCT01077518|453618785|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
126088669|NCT01077518|453618786|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
126088670|NCT01077518|453618787|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
126088671|NCT01495598|453618788|FG000|Overall Study|Death during follow up period|2|||
126088672|NCT01495598|453618788|FG000|Overall Study|Death on study|1|||
126088673|NCT01495598|453618788|FG000|Overall Study|Lost to Follow-up|3|||
126088674|NCT01495598|453618788|FG000|Overall Study|Physician Decision|8|||
126088675|NCT05511038|453618792|FG000|Overall|Withdrawal by Subject|5|||
126088676|NCT05511038|453618793|FG001|Overall|Withdrawal by Subject|3|||
126088677|NCT05511038|453618792|FG000|Overall|Screen Failure|20|||
126088678|NCT05511038|453618793|FG001|Overall|Screen Failure|1|||
126088679|NCT05511038|453618792|FG000|Overall|Physician Decision|3|||
126088680|NCT05511038|453618793|FG001|Overall|Physician Decision|0|||
126088681|NCT05511038|453618792|FG000|Overall|Lost to Follow-up|3|||
126088682|NCT05511038|453618793|FG001|Overall|Lost to Follow-up|0|||
126088683|NCT05511038|453618792|FG000|Overall|Death|1|||
126088684|NCT05511038|453618793|FG001|Overall|Death|0|||
126088685|NCT05511038|453618792|FG000|Screening|Withdrawal by Subject|1|||
126088686|NCT05511038|453618793|FG001|Screening|Withdrawal by Subject|0|||
126088687|NCT05511038|453618792|FG000|Screening|Lost to Follow Up (1 participant)|1|||
126088688|NCT05511038|453618793|FG001|Screening|Lost to Follow Up (1 participant)|0|||
126088689|NCT05511038|453618792|FG000|Screening|Screen Failure|3|||
126088690|NCT05511038|453618793|FG001|Screening|Screen Failure|0|||
126088691|NCT05511038|453618792|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
125966926|NCT02014116|453169765|FG004|Overall Study|Lost to Follow-up|0|||
125966927|NCT02014116|453169766|FG005|Overall Study|Lost to Follow-up|1|||
125966928|NCT02014116|453169767|FG006|Overall Study|Lost to Follow-up|0|||
125966929|NCT02014116|453169768|FG007|Overall Study|Lost to Follow-up|0|||
125966930|NCT02014116|453169769|FG008|Overall Study|Lost to Follow-up|1|||
125966931|NCT02014116|453169761|FG000|Overall Study|Death|0|||
125966932|NCT02014116|453169762|FG001|Overall Study|Death|0|||
125966933|NCT02014116|453169763|FG002|Overall Study|Death|0|||
125966934|NCT02014116|453169764|FG003|Overall Study|Death|0|||
125966935|NCT02014116|453169765|FG004|Overall Study|Death|0|||
125966936|NCT02014116|453169766|FG005|Overall Study|Death|0|||
125966937|NCT02014116|453169767|FG006|Overall Study|Death|0|||
125966938|NCT02014116|453169768|FG007|Overall Study|Death|1|||
125966939|NCT02014116|453169769|FG008|Overall Study|Death|1|||
125966940|NCT02014116|453169761|FG000|Overall Study|Withdrawal by Subject|0|||
125966941|NCT02014116|453169762|FG001|Overall Study|Withdrawal by Subject|0|||
125966942|NCT02014116|453169763|FG002|Overall Study|Withdrawal by Subject|1|||
125966943|NCT02014116|453169764|FG003|Overall Study|Withdrawal by Subject|1|||
125966944|NCT02014116|453169765|FG004|Overall Study|Withdrawal by Subject|0|||
125966945|NCT02014116|453169766|FG005|Overall Study|Withdrawal by Subject|1|||
125966946|NCT02014116|453169767|FG006|Overall Study|Withdrawal by Subject|0|||
125966947|NCT02014116|453169768|FG007|Overall Study|Withdrawal by Subject|0|||
125966948|NCT02014116|453169769|FG008|Overall Study|Withdrawal by Subject|0|||
125966949|NCT02014116|453169761|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
125966950|NCT02014116|453169762|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
125966951|NCT02014116|453169763|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
125966952|NCT02014116|453169764|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
125966953|NCT02014116|453169765|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
125966954|NCT02014116|453169766|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
125966955|NCT02014116|453169767|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
125966956|NCT02014116|453169768|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
125966957|NCT02014116|453169769|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
125966958|NCT02014116|453169761|FG000|Overall Study|Physician Decision|0|||
125966959|NCT02014116|453169762|FG001|Overall Study|Physician Decision|0|||
125966960|NCT02014116|453169763|FG002|Overall Study|Physician Decision|0|||
125966961|NCT02014116|453169764|FG003|Overall Study|Physician Decision|0|||
125966962|NCT02014116|453169765|FG004|Overall Study|Physician Decision|0|||
125966963|NCT02014116|453169766|FG005|Overall Study|Physician Decision|0|||
125966964|NCT02014116|453169767|FG006|Overall Study|Physician Decision|0|||
125966965|NCT02014116|453169768|FG007|Overall Study|Physician Decision|0|||
125966966|NCT02014116|453169769|FG008|Overall Study|Physician Decision|1|||
125966967|NCT02347761|453169770|FG000|All Collected|Death|1|||
125966968|NCT02347761|453169771|FG001|All Collected|Death|0|||
125966969|NCT02347761|453169772|FG002|All Collected|Death|0|||
125966970|NCT02347761|453169770|FG000|All Collected|Lost to Follow-up|3|||
125966971|NCT02347761|453169771|FG001|All Collected|Lost to Follow-up|2|||
125966972|NCT02347761|453169772|FG002|All Collected|Lost to Follow-up|3|||
125966973|NCT02347761|453169770|FG000|All Collected|Withdrawal by Subject|11|||
125966974|NCT02347761|453169771|FG001|All Collected|Withdrawal by Subject|11|||
125966975|NCT02347761|453169772|FG002|All Collected|Withdrawal by Subject|22|||
125966976|NCT02347761|453169770|FG000|All Collected|invetigator disretion|2|||
125966977|NCT02347761|453169771|FG001|All Collected|invetigator disretion|0|||
125966978|NCT02347761|453169772|FG002|All Collected|invetigator disretion|0|||
125966979|NCT02347761|453169770|FG000|All Collected|instillation site pain|0|||
125966980|NCT02347761|453169771|FG001|All Collected|instillation site pain|0|||
125966981|NCT02347761|453169772|FG002|All Collected|instillation site pain|1|||
125966982|NCT02347761|453169770|FG000|All Collected|exacerbation of COPD|0|||
125966983|NCT02347761|453169771|FG001|All Collected|exacerbation of COPD|0|||
125966984|NCT02347761|453169772|FG002|All Collected|exacerbation of COPD|1|||
125966985|NCT02347761|453169770|FG000|All Collected|moved/travel|0|||
125966986|NCT02347761|453169771|FG001|All Collected|moved/travel|1|||
125966987|NCT02347761|453169772|FG002|All Collected|moved/travel|0|||
125966988|NCT02347761|453169770|FG000|On Study Treatment|Lack of Efficacy|2|||
125966989|NCT02347761|453169771|FG001|On Study Treatment|Lack of Efficacy|3|||
125966990|NCT02347761|453169772|FG002|On Study Treatment|Lack of Efficacy|4|||
125966991|NCT02347761|453169770|FG000|On Study Treatment|non-compliance with study medication|0|||
125966992|NCT02347761|453169771|FG001|On Study Treatment|non-compliance with study medication|0|||
125966993|NCT02347761|453169772|FG002|On Study Treatment|non-compliance with study medication|2|||
125966994|NCT02347761|453169770|FG000|On Study Treatment|Withdrawal by Subject|7|||
125966995|NCT02347761|453169771|FG001|On Study Treatment|Withdrawal by Subject|3|||
125966996|NCT02347761|453169772|FG002|On Study Treatment|Withdrawal by Subject|5|||
125966997|NCT02347761|453169770|FG000|On Study Treatment|move/travel|2|||
125966998|NCT02347761|453169771|FG001|On Study Treatment|move/travel|6|||
125966999|NCT02347761|453169772|FG002|On Study Treatment|move/travel|5|||
125967000|NCT02347761|453169770|FG000|On Study Treatment|dissastisfaction with device|2|||
125967001|NCT02347761|453169771|FG001|On Study Treatment|dissastisfaction with device|1|||
125967002|NCT02347761|453169772|FG002|On Study Treatment|dissastisfaction with device|4|||
125967003|NCT02347761|453169770|FG000|On Study Treatment|Lost to Follow-up|2|||
125967004|NCT02347761|453169771|FG001|On Study Treatment|Lost to Follow-up|1|||
125967005|NCT02347761|453169772|FG002|On Study Treatment|Lost to Follow-up|1|||
125967006|NCT02347761|453169770|FG000|On Study Treatment|investigator discretion|2|||
125967007|NCT02347761|453169771|FG001|On Study Treatment|investigator discretion|0|||
125967008|NCT02347761|453169772|FG002|On Study Treatment|investigator discretion|0|||
125967009|NCT02347761|453169770|FG000|On Study Treatment|durg not working|0|||
125967010|NCT02347761|453169771|FG001|On Study Treatment|durg not working|1|||
125967011|NCT02347761|453169772|FG002|On Study Treatment|durg not working|1|||
125967012|NCT02347761|453169770|FG000|On Study Treatment|Adverse Event|10|||
125967013|NCT02347761|453169771|FG001|On Study Treatment|Adverse Event|8|||
125967014|NCT02347761|453169772|FG002|On Study Treatment|Adverse Event|20|||
125967015|NCT03879798|453169773|FG000|Overall Study|Adverse Event|0|||
125967016|NCT03879798|453169774|FG001|Overall Study|Adverse Event|0|||
125967017|NCT03879798|453169775|FG002|Overall Study|Adverse Event|0|||
125967018|NCT03879798|453169776|FG003|Overall Study|Adverse Event|0|||
125967019|NCT03879798|453169777|FG004|Overall Study|Adverse Event|0|||
125967020|NCT03879798|453169778|FG005|Overall Study|Adverse Event|1|||
125967021|NCT03879798|453169773|FG000|Overall Study|Lack of Efficacy|0|||
125967022|NCT03879798|453169774|FG001|Overall Study|Lack of Efficacy|0|||
125967023|NCT03879798|453169775|FG002|Overall Study|Lack of Efficacy|0|||
125967024|NCT03879798|453169776|FG003|Overall Study|Lack of Efficacy|0|||
125967025|NCT03879798|453169777|FG004|Overall Study|Lack of Efficacy|0|||
126135048|NCT01665144|453783829|FG002|Extension Part|Technical problems|8|||
126135049|NCT01665144|453783827|FG000|Extension Part|Death|20|||
126135050|NCT01665144|453783828|FG001|Extension Part|Death|0|||
126135051|NCT01665144|453783829|FG002|Extension Part|Death|4|||
125967026|NCT03879798|453169778|FG005|Overall Study|Lack of Efficacy|1|||
125967027|NCT03879798|453169773|FG000|Overall Study|Withdrawal by Subject|0|||
125967028|NCT03879798|453169774|FG001|Overall Study|Withdrawal by Subject|0|||
125967029|NCT03879798|453169775|FG002|Overall Study|Withdrawal by Subject|0|||
125967030|NCT03879798|453169776|FG003|Overall Study|Withdrawal by Subject|0|||
125967031|NCT03879798|453169777|FG004|Overall Study|Withdrawal by Subject|0|||
125967032|NCT03879798|453169778|FG005|Overall Study|Withdrawal by Subject|1|||
125967033|NCT03625570|453169779|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
125967034|NCT03625570|453169780|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
125967035|NCT03625570|453169779|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
125967036|NCT03625570|453169780|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
125967037|NCT03625570|453169779|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
125967038|NCT03625570|453169780|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
125967039|NCT01040130|453169788|FG000|Overall Study|Adverse Event|1|||
125967040|NCT01040130|453169789|FG001|Overall Study|Adverse Event|1|||
125967041|NCT01040130|453169790|FG002|Overall Study|Adverse Event|0|||
125967042|NCT01040130|453169791|FG003|Overall Study|Adverse Event|5|||
125967043|NCT01040130|453169792|FG004|Overall Study|Adverse Event|0|||
125967044|NCT01040130|453169793|FG005|Overall Study|Adverse Event|3|||
125967045|NCT01040130|453169788|FG000|Overall Study|Protocol Violation|0|||
125967046|NCT01040130|453169789|FG001|Overall Study|Protocol Violation|0|||
125967047|NCT01040130|453169790|FG002|Overall Study|Protocol Violation|2|||
125967048|NCT01040130|453169791|FG003|Overall Study|Protocol Violation|0|||
125967049|NCT01040130|453169792|FG004|Overall Study|Protocol Violation|0|||
125967050|NCT01040130|453169793|FG005|Overall Study|Protocol Violation|0|||
125967051|NCT01040130|453169788|FG000|Overall Study|Withdrawal by Subject|0|||
125967052|NCT01040130|453169789|FG001|Overall Study|Withdrawal by Subject|2|||
125967053|NCT01040130|453169790|FG002|Overall Study|Withdrawal by Subject|0|||
125967054|NCT01040130|453169791|FG003|Overall Study|Withdrawal by Subject|0|||
125967055|NCT01040130|453169792|FG004|Overall Study|Withdrawal by Subject|0|||
125967056|NCT01040130|453169793|FG005|Overall Study|Withdrawal by Subject|1|||
125967057|NCT01040130|453169788|FG000|Overall Study|Other reasons not listed above|2|||
125967058|NCT01040130|453169789|FG001|Overall Study|Other reasons not listed above|0|||
125967059|NCT01040130|453169790|FG002|Overall Study|Other reasons not listed above|0|||
125967060|NCT01040130|453169791|FG003|Overall Study|Other reasons not listed above|0|||
125967061|NCT01040130|453169792|FG004|Overall Study|Other reasons not listed above|0|||
125967062|NCT01040130|453169793|FG005|Overall Study|Other reasons not listed above|0|||
126135052|NCT01665144|453783827|FG000|Extension Part|Missing|12|||
125967063|NCT01310036|453169802|FG000|Overall Study|Administrative/other|10|||
125967064|NCT01310036|453169802|FG000|Overall Study|Withdrew Consent|11|||
125967065|NCT01310036|453169802|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
125967066|NCT01310036|453169802|FG000|Overall Study|Progression of Disease|164|||
125967067|NCT01310036|453169802|FG000|Overall Study|Death|1|||
125967068|NCT01310036|453169802|FG000|Overall Study|Adverse event or intercurrent illness|12|||
125967069|NCT00553267|453169803|FG000|Overall Study|Adverse Event|8|||
125967070|NCT00553267|453169804|FG001|Overall Study|Adverse Event|10|||
125967071|NCT00553267|453169805|FG002|Overall Study|Adverse Event|5|||
125967072|NCT00553267|453169803|FG000|Overall Study|Non compliant with protocol|3|||
125967073|NCT00553267|453169804|FG001|Overall Study|Non compliant with protocol|3|||
125967074|NCT00553267|453169805|FG002|Overall Study|Non compliant with protocol|2|||
125967075|NCT00553267|453169803|FG000|Overall Study|Lost to Follow-up|0|||
126135053|NCT01665144|453783828|FG001|Extension Part|Missing|0|||
126135054|NCT01665144|453783829|FG002|Extension Part|Missing|6|||
125967076|NCT00553267|453169804|FG001|Overall Study|Lost to Follow-up|0|||
125967077|NCT00553267|453169805|FG002|Overall Study|Lost to Follow-up|1|||
125967078|NCT00553267|453169803|FG000|Overall Study|Consent withdrawn|2|||
125967079|NCT00553267|453169804|FG001|Overall Study|Consent withdrawn|3|||
125967080|NCT00553267|453169805|FG002|Overall Study|Consent withdrawn|1|||
125967081|NCT00553267|453169803|FG000|Overall Study|Specified category|1|||
125967082|NCT00553267|453169804|FG001|Overall Study|Specified category|2|||
125967083|NCT00553267|453169805|FG002|Overall Study|Specified category|1|||
125967084|NCT01175668|453169806|FG000|Overall Study|Withdrawal by Subject|2|||
125967085|NCT01175668|453169807|FG001|Overall Study|Withdrawal by Subject|0|||
125967086|NCT00096135|453169813|FG000|Overall Study|Physician Decision|20|||
125967087|NCT00096135|453169814|FG001|Overall Study|Physician Decision|4|||
125967088|NCT00096135|453169813|FG000|Overall Study|Refusal of further protocol therapy|4|||
125967089|NCT00096135|453169814|FG001|Overall Study|Refusal of further protocol therapy|1|||
125967090|NCT00096135|453169813|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
125967091|NCT00096135|453169814|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
125967092|NCT00096135|453169813|FG000|Overall Study|Other, specify|15|||
125967093|NCT00096135|453169814|FG001|Overall Study|Other, specify|3|||
125967094|NCT00096135|453169813|FG000|Overall Study|Ineligible|2|||
125967095|NCT00096135|453169814|FG001|Overall Study|Ineligible|0|||
125967096|NCT01568047|453169816|FG000|Overall Study|Ineligibility|1|||
125967097|NCT01568047|453169817|FG001|Overall Study|Ineligibility|0|||
125967098|NCT01568047|453169818|FG002|Overall Study|Ineligibility|0|||
125967099|NCT01568047|453169819|FG003|Overall Study|Ineligibility|0|||
125967100|NCT01568047|453169816|FG000|Overall Study|Withdrawal by Subject|0|||
125967101|NCT01568047|453169817|FG001|Overall Study|Withdrawal by Subject|1|||
125967102|NCT01568047|453169818|FG002|Overall Study|Withdrawal by Subject|0|||
125967103|NCT01568047|453169819|FG003|Overall Study|Withdrawal by Subject|0|||
125967104|NCT01568047|453169816|FG000|Overall Study|Adverse Event|0|||
125967105|NCT01568047|453169817|FG001|Overall Study|Adverse Event|0|||
125967106|NCT01568047|453169818|FG002|Overall Study|Adverse Event|1|||
125967107|NCT01568047|453169819|FG003|Overall Study|Adverse Event|1|||
125967108|NCT00874029|453169820|FG000|Overall Study|Withdrawal by Subject|10|||
125967109|NCT00874029|453169820|FG000|Overall Study|Pregnancy|4|||
125967110|NCT00874029|453169820|FG000|Overall Study|Physician Decision|1|||
125967111|NCT00874029|453169820|FG000|Overall Study|Adverse Event|1|||
125967112|NCT00874029|453169820|FG000|Overall Study|Lost to Follow-up|5|||
125967113|NCT03359096|453169821|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
125967114|NCT03359096|453169822|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
125967115|NCT03359096|453169821|FG000|First Intervention (4 Weeks)|Death|1|||
125967116|NCT03359096|453169822|FG001|First Intervention (4 Weeks)|Death|0|||
125967117|NCT03359096|453169821|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
125967118|NCT03359096|453169822|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
125967119|NCT00856583|453169823|FG000|Overall Study|Lack of Efficacy|389|||
125967120|NCT00856583|453169824|FG001|Overall Study|Lack of Efficacy|377|||
125967121|NCT00856583|453169823|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
125967122|NCT00856583|453169824|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
125967123|NCT00856583|453169823|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
125967124|NCT00856583|453169824|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
125967125|NCT00856583|453169823|FG000|Overall Study|Non-compliance|305|||
125967126|NCT00856583|453169824|FG001|Overall Study|Non-compliance|262|||
125967127|NCT00856583|453169823|FG000|Overall Study|Withdrawal by Subject|1092|||
125967128|NCT00856583|453169824|FG001|Overall Study|Withdrawal by Subject|919|||
125967129|NCT00856583|453169823|FG000|Overall Study|Physician Decision|59|||
125967130|NCT00856583|453169824|FG001|Overall Study|Physician Decision|82|||
125967131|NCT00856583|453169823|FG000|Overall Study|Pregnancy|14|||
125967132|NCT00856583|453169824|FG001|Overall Study|Pregnancy|5|||
125967133|NCT00856583|453169823|FG000|Overall Study|Other|92|||
125967134|NCT00856583|453169824|FG001|Overall Study|Other|104|||
125967135|NCT00856583|453169823|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
125967136|NCT00856583|453169824|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
125967137|NCT01944046|453169827|FG000|Randomized to DB|Adverse Event|5|||
125967138|NCT01944046|453169828|FG001|Randomized to DB|Adverse Event|2|||
125967139|NCT01944046|453169827|FG000|Randomized to DB|Clinical Worsening|3|||
125967140|NCT01944046|453169828|FG001|Randomized to DB|Clinical Worsening|2|||
125967141|NCT01944046|453169827|FG000|Randomized to DB|Lost to Follow-up|3|||
125967142|NCT01944046|453169828|FG001|Randomized to DB|Lost to Follow-up|3|||
125967143|NCT01944046|453169827|FG000|Randomized to DB|Withdrawal by Subject|2|||
125967144|NCT01944046|453169828|FG001|Randomized to DB|Withdrawal by Subject|4|||
125967145|NCT01944046|453169827|FG000|Randomized to DB|Physician Decision|1|||
125967146|NCT01944046|453169828|FG001|Randomized to DB|Physician Decision|2|||
125967147|NCT01944046|453169827|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
125967148|NCT01944046|453169828|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
125967149|NCT01944046|453169827|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
125967150|NCT01944046|453169828|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
125967151|NCT01944046|453169827|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
125967152|NCT01944046|453169828|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
125967153|NCT01944046|453169827|FG000|Open Label Eligible and Consented|Adverse Event|6|||
125967154|NCT01944046|453169828|FG001|Open Label Eligible and Consented|Adverse Event|1|||
125967155|NCT01944046|453169827|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
125967156|NCT01944046|453169828|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
125967157|NCT01944046|453169827|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
125967158|NCT01944046|453169828|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
125967159|NCT02328326|453169831|FG000|Overall Study|Withdrawal by Subject|10|||
125967160|NCT02328326|453169832|FG001|Overall Study|Withdrawal by Subject|3|||
125967161|NCT02328326|453169831|FG000|Overall Study|Death|2|||
125967162|NCT02328326|453169832|FG001|Overall Study|Death|1|||
125967163|NCT02328326|453169831|FG000|Overall Study|Lost to Follow-up|10|||
125967164|NCT02328326|453169832|FG001|Overall Study|Lost to Follow-up|4|||
125967165|NCT01618838|453169844|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
125967166|NCT01910519|453169851|FG000|Overall Study|Withdrawal by Subject|2|||
126135055|NCT01665144|453783827|FG000|Extension Part|Lost to Follow-up|9|||
126135056|NCT01665144|453783828|FG001|Extension Part|Lost to Follow-up|0|||
126135057|NCT01665144|453783829|FG002|Extension Part|Lost to Follow-up|5|||
126135058|NCT01665144|453783827|FG000|Extension Part|New therapy for study indication|3|||
125967167|NCT01910519|453169852|FG001|Overall Study|Withdrawal by Subject|0|||
125967168|NCT01910519|453169851|FG000|Overall Study|Adverse Event|2|||
125967169|NCT01910519|453169852|FG001|Overall Study|Adverse Event|0|||
125967170|NCT00136955|453171514|FG000|Overall Study|Adverse Event|8|||
125967171|NCT00136955|453171514|FG000|Overall Study|Lost to Follow-up|1|||
125967172|NCT00136955|453171514|FG000|Overall Study|Withdrawal by Subject|2|||
125967173|NCT00136955|453171514|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
125967174|NCT00993447|453171518|FG000|Overall Study|Withdrawal by Subject|23|||
125967175|NCT00993447|453171519|FG001|Overall Study|Withdrawal by Subject|8|||
125967176|NCT00993447|453171518|FG000|Overall Study|Protocol Violation|12|||
125967177|NCT00993447|453171519|FG001|Overall Study|Protocol Violation|8|||
125967178|NCT00993447|453171518|FG000|Overall Study|Lost to Follow-up|1|||
126135059|NCT01665144|453783828|FG001|Extension Part|New therapy for study indication|0|||
126135060|NCT01665144|453783829|FG002|Extension Part|New therapy for study indication|2|||
126135061|NCT01665144|453783827|FG000|Extension Part|Protocol deviation|3|||
126135062|NCT01665144|453783828|FG001|Extension Part|Protocol deviation|0|||
126135063|NCT01665144|453783829|FG002|Extension Part|Protocol deviation|0|||
126135064|NCT01913483|453783836|FG000|Overall Study|Withdrawal by Subject|1|||
125967179|NCT00993447|453171519|FG001|Overall Study|Lost to Follow-up|3|||
125967180|NCT00993447|453171518|FG000|Overall Study|Adverse Event|1|||
125967181|NCT00993447|453171519|FG001|Overall Study|Adverse Event|0|||
125967182|NCT00970502|453171522|FG000|Overall Study|Withdrawal by Subject|1|||
125967183|NCT03811912|453171523|FG000|Overall Study|Withdrew Consent|4|||
125967184|NCT03811912|453171524|FG001|Overall Study|Withdrew Consent|2|||
125967185|NCT04401579|453171525|FG000|Overall Study|Death|23|||
125967186|NCT04401579|453171526|FG001|Overall Study|Death|36|||
125967187|NCT04401579|453171525|FG000|Overall Study|Lost to Follow-up|40|||
125967188|NCT04401579|453171526|FG001|Overall Study|Lost to Follow-up|41|||
125967189|NCT04401579|453171525|FG000|Overall Study|Withdrawal by Subject|8|||
125967190|NCT04401579|453171526|FG001|Overall Study|Withdrawal by Subject|16|||
125967191|NCT04401579|453171525|FG000|Overall Study|Physician Decision|1|||
125967192|NCT04401579|453171526|FG001|Overall Study|Physician Decision|2|||
125967193|NCT04401579|453171525|FG000|Overall Study|Became ineligible after enrollment|1|||
125967194|NCT04401579|453171526|FG001|Overall Study|Became ineligible after enrollment|1|||
125967195|NCT04401579|453171525|FG000|Overall Study|Enrolled but treatment not administered|7|||
125967196|NCT04401579|453171526|FG001|Overall Study|Enrolled but treatment not administered|9|||
125967197|NCT04401579|453171525|FG000|Overall Study|Adverse Event|2|||
125967198|NCT04401579|453171526|FG001|Overall Study|Adverse Event|1|||
125967199|NCT04401579|453171525|FG000|Overall Study|Scheduling error|1|||
125967200|NCT04401579|453171526|FG001|Overall Study|Scheduling error|2|||
125967201|NCT04401579|453171525|FG000|Overall Study|Transferred to another hospital|1|||
125967202|NCT04401579|453171526|FG001|Overall Study|Transferred to another hospital|2|||
125967203|NCT01438411|453171527|FG000|Overall Study|Adverse Event|8|||
125967204|NCT01438411|453171527|FG000|Overall Study|Lost to Follow-up|1|||
125967205|NCT01438411|453171527|FG000|Overall Study|Lack of Efficacy|1|||
125967206|NCT01438411|453171527|FG000|Overall Study|Withdrawal by Subject|3|||
125967207|NCT01863680|453171528|FG000|Overall Study|Adverse Event|17|||
125967208|NCT01863680|453171528|FG000|Overall Study|Risk of OHSS|17|||
125967209|NCT01863680|453171528|FG000|Overall Study|Spontaneous pregnancy|2|||
125967210|NCT01863680|453171528|FG000|Overall Study|Withdrawal by Subject|1|||
125967211|NCT01863680|453171528|FG000|Overall Study|Did not undergo IVF/ET|14|||
126135065|NCT01913483|453783837|FG001|Overall Study|Withdrawal by Subject|2|||
126135066|NCT01913483|453783836|FG000|Overall Study|Lost to Follow-up|6|||
125967212|NCT01863680|453171528|FG000|Overall Study|Other|6|||
125967213|NCT00618514|453171529|FG000|Overall Study|Lost to Follow-up|11|||
125967214|NCT00618514|453171530|FG001|Overall Study|Lost to Follow-up|12|||
125967215|NCT00618514|453171531|FG002|Overall Study|Lost to Follow-up|4|||
125967216|NCT00566228|453171532|FG000|Overall Study|Withdrawal by Subject|1|||
126135067|NCT01913483|453783837|FG001|Overall Study|Lost to Follow-up|3|||
125967217|NCT00566228|453171533|FG001|Overall Study|Withdrawal by Subject|0|||
125967218|NCT00566228|453171532|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
125967219|NCT00566228|453171533|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
125967220|NCT00566228|453171532|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
125967221|NCT00566228|453171533|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
125967222|NCT00566228|453171532|FG000|Overall Study|progressed before infusion could occur|0|||
125967223|NCT00566228|453171533|FG001|Overall Study|progressed before infusion could occur|1|||
125967224|NCT02053350|453171534|FG000|Overall Study|Withdrawal by Subject|1|||
125967225|NCT02053350|453171534|FG000|Overall Study|Adverse Event|4|||
125967226|NCT03521635|453171535|FG000|Overall Study|Adverse Event|1|||
125967227|NCT03521635|453171536|FG001|Overall Study|Adverse Event|1|||
125967228|NCT03521635|453171535|FG000|Overall Study|Refused to complete study visit|1|||
125967229|NCT03521635|453171536|FG001|Overall Study|Refused to complete study visit|0|||
125967230|NCT03521635|453171535|FG000|Overall Study|Refused to continue trial medication|2|||
125967231|NCT03521635|453171536|FG001|Overall Study|Refused to continue trial medication|2|||
125967232|NCT03521635|453171535|FG000|Overall Study|Lost to Follow-up|0|||
125967233|NCT03521635|453171536|FG001|Overall Study|Lost to Follow-up|1|||
125967234|NCT03521635|453171535|FG000|Overall Study|Meet exclusion criteria|0|||
125967235|NCT03521635|453171536|FG001|Overall Study|Meet exclusion criteria|1|||
125967236|NCT03521635|453171535|FG000|Overall Study|Patient not taken study medicine|0|||
125967237|NCT03521635|453171536|FG001|Overall Study|Patient not taken study medicine|1|||
125967238|NCT02244944|453171537|FG000|Overall Study|Withdrawal by Subject|1|||
125967239|NCT02244944|453171537|FG000|Overall Study|Study Terminated|1|||
125967240|NCT02367911|453171544|FG000|Overall Study|Withdrawal by Subject|3|||
125967241|NCT02367911|453171545|FG001|Overall Study|Withdrawal by Subject|2|||
125967242|NCT02367911|453171544|FG000|Overall Study|Lost to Follow-up|2|||
125967243|NCT02367911|453171545|FG001|Overall Study|Lost to Follow-up|2|||
125967244|NCT00902304|453171547|FG000|Overall Study|Adverse Event|4|||
125967245|NCT00902304|453171548|FG001|Overall Study|Adverse Event|10|||
125967246|NCT00902304|453171549|FG002|Overall Study|Adverse Event|25|||
125967247|NCT00902304|453171547|FG000|Overall Study|Investigator discretion|3|||
125967248|NCT00902304|453171548|FG001|Overall Study|Investigator discretion|5|||
125967249|NCT00902304|453171549|FG002|Overall Study|Investigator discretion|13|||
125967250|NCT00902304|453171547|FG000|Overall Study|Lost to Follow-up|7|||
125967251|NCT00902304|453171548|FG001|Overall Study|Lost to Follow-up|7|||
125967252|NCT00902304|453171549|FG002|Overall Study|Lost to Follow-up|7|||
125967253|NCT00902304|453171547|FG000|Overall Study|Protocol Violation|9|||
125967254|NCT00902304|453171548|FG001|Overall Study|Protocol Violation|18|||
125967255|NCT00902304|453171549|FG002|Overall Study|Protocol Violation|20|||
125967256|NCT00902304|453171547|FG000|Overall Study|Withdrawal by Subject|32|||
125967257|NCT00902304|453171548|FG001|Overall Study|Withdrawal by Subject|22|||
125967258|NCT00902304|453171549|FG002|Overall Study|Withdrawal by Subject|43|||
125967259|NCT00902304|453171547|FG000|Overall Study|includes pregnancy|3|||
125967260|NCT00902304|453171548|FG001|Overall Study|includes pregnancy|9|||
126135068|NCT01913483|453783836|FG000|Overall Study|Death|14|||
126135069|NCT01913483|453783837|FG001|Overall Study|Death|17|||
126135070|NCT02302963|453783838|FG000|Overall Study|Withdrawal by Subject|2|||
126135071|NCT02302963|453783839|FG001|Overall Study|Withdrawal by Subject|1|||
126135072|NCT02302963|453783838|FG000|Overall Study|Steroid injection|0|||
126135073|NCT02302963|453783839|FG001|Overall Study|Steroid injection|1|||
125967261|NCT00902304|453171549|FG002|Overall Study|includes pregnancy|2|||
125967262|NCT04579757|453171550|FG000|Overall Study|Adverse Event|0|||
125967263|NCT04579757|453171551|FG001|Overall Study|Adverse Event|0|||
125967264|NCT04579757|453171552|FG002|Overall Study|Adverse Event|0|||
125967265|NCT04579757|453171553|FG003|Overall Study|Adverse Event|2|||
125967266|NCT04579757|453171554|FG004|Overall Study|Adverse Event|1|||
125967267|NCT04579757|453171555|FG005|Overall Study|Adverse Event|1|||
125967268|NCT04579757|453171556|FG006|Overall Study|Adverse Event|0|||
125967269|NCT04579757|453171557|FG007|Overall Study|Adverse Event|0|||
125967270|NCT04579757|453171558|FG008|Overall Study|Adverse Event|0|||
125967271|NCT04579757|453171550|FG000|Overall Study|Death|4|||
125967272|NCT04579757|453171551|FG001|Overall Study|Death|1|||
125967273|NCT04579757|453171552|FG002|Overall Study|Death|14|||
125967274|NCT04579757|453171553|FG003|Overall Study|Death|3|||
125967275|NCT04579757|453171554|FG004|Overall Study|Death|2|||
125967276|NCT04579757|453171555|FG005|Overall Study|Death|7|||
125967277|NCT04579757|453171556|FG006|Overall Study|Death|0|||
125967278|NCT04579757|453171557|FG007|Overall Study|Death|1|||
126135074|NCT02302963|453783838|FG000|Overall Study|Physician Decision|1|||
126135075|NCT02302963|453783839|FG001|Overall Study|Physician Decision|0|||
125967279|NCT04579757|453171558|FG008|Overall Study|Death|3|||
125967280|NCT04579757|453171550|FG000|Overall Study|Physician Decision|0|||
125967281|NCT04579757|453171551|FG001|Overall Study|Physician Decision|0|||
125967282|NCT04579757|453171552|FG002|Overall Study|Physician Decision|0|||
125967283|NCT04579757|453171553|FG003|Overall Study|Physician Decision|2|||
125967284|NCT04579757|453171554|FG004|Overall Study|Physician Decision|1|||
125967285|NCT04579757|453171555|FG005|Overall Study|Physician Decision|1|||
125967286|NCT04579757|453171556|FG006|Overall Study|Physician Decision|1|||
125967287|NCT04579757|453171557|FG007|Overall Study|Physician Decision|0|||
125967288|NCT04579757|453171558|FG008|Overall Study|Physician Decision|0|||
125967289|NCT04579757|453171550|FG000|Overall Study|Study Terminated By Sponsor|0|||
125967290|NCT04579757|453171551|FG001|Overall Study|Study Terminated By Sponsor|0|||
125967291|NCT04579757|453171552|FG002|Overall Study|Study Terminated By Sponsor|0|||
125967292|NCT04579757|453171553|FG003|Overall Study|Study Terminated By Sponsor|0|||
125967293|NCT04579757|453171554|FG004|Overall Study|Study Terminated By Sponsor|2|||
125967294|NCT04579757|453171555|FG005|Overall Study|Study Terminated By Sponsor|0|||
125967295|NCT04579757|453171556|FG006|Overall Study|Study Terminated By Sponsor|0|||
125967296|NCT04579757|453171557|FG007|Overall Study|Study Terminated By Sponsor|2|||
125967297|NCT04579757|453171558|FG008|Overall Study|Study Terminated By Sponsor|0|||
125967298|NCT04579757|453171550|FG000|Overall Study|Withdrawal by Subject|1|||
125967299|NCT04579757|453171551|FG001|Overall Study|Withdrawal by Subject|1|||
125967300|NCT04579757|453171552|FG002|Overall Study|Withdrawal by Subject|0|||
125967301|NCT04579757|453171553|FG003|Overall Study|Withdrawal by Subject|0|||
125967302|NCT04579757|453171554|FG004|Overall Study|Withdrawal by Subject|2|||
125967303|NCT04579757|453171555|FG005|Overall Study|Withdrawal by Subject|1|||
125967304|NCT04579757|453171556|FG006|Overall Study|Withdrawal by Subject|0|||
125967305|NCT04579757|453171557|FG007|Overall Study|Withdrawal by Subject|3|||
125967306|NCT04579757|453171558|FG008|Overall Study|Withdrawal by Subject|0|||
125967307|NCT04579757|453171550|FG000|Overall Study|Radiological or Clinical PD|1|||
125967308|NCT04579757|453171551|FG001|Overall Study|Radiological or Clinical PD|4|||
125967309|NCT04579757|453171552|FG002|Overall Study|Radiological or Clinical PD|1|||
125967310|NCT04579757|453171553|FG003|Overall Study|Radiological or Clinical PD|3|||
125967311|NCT04579757|453171554|FG004|Overall Study|Radiological or Clinical PD|9|||
125967312|NCT04579757|453171555|FG005|Overall Study|Radiological or Clinical PD|4|||
125967313|NCT04579757|453171556|FG006|Overall Study|Radiological or Clinical PD|2|||
125967314|NCT04579757|453171557|FG007|Overall Study|Radiological or Clinical PD|2|||
125967315|NCT04579757|453171558|FG008|Overall Study|Radiological or Clinical PD|0|||
125967316|NCT04579757|453171550|FG000|Overall Study|Start of New Therapy|0|||
125967317|NCT04579757|453171551|FG001|Overall Study|Start of New Therapy|0|||
125967318|NCT04579757|453171552|FG002|Overall Study|Start of New Therapy|0|||
125967319|NCT04579757|453171553|FG003|Overall Study|Start of New Therapy|0|||
125967320|NCT04579757|453171554|FG004|Overall Study|Start of New Therapy|2|||
125967321|NCT04579757|453171555|FG005|Overall Study|Start of New Therapy|1|||
125967322|NCT04579757|453171556|FG006|Overall Study|Start of New Therapy|0|||
125967323|NCT04579757|453171557|FG007|Overall Study|Start of New Therapy|0|||
125967324|NCT04579757|453171558|FG008|Overall Study|Start of New Therapy|0|||
125967325|NCT01153633|453171559|FG000|Overall Study|Protocol Violation|1|||
125967326|NCT01153633|453171560|FG001|Overall Study|Protocol Violation|1|||
125967327|NCT01153633|453171559|FG000|Overall Study|Therapeutic failure|3|||
125967328|NCT01153633|453171560|FG001|Overall Study|Therapeutic failure|3|||
125967329|NCT00384085|453171561|FG000|Overall Study|Adverse Event|5|||
125967330|NCT00384085|453171562|FG001|Overall Study|Adverse Event|5|||
125967331|NCT00384085|453171563|FG002|Overall Study|Adverse Event|4|||
125967332|NCT00384085|453171561|FG000|Overall Study|Lack of Efficacy|0|||
125967333|NCT00384085|453171562|FG001|Overall Study|Lack of Efficacy|3|||
125967334|NCT00384085|453171563|FG002|Overall Study|Lack of Efficacy|2|||
125967335|NCT00384085|453171561|FG000|Overall Study|No longer Requires Study Treatment|1|||
125967336|NCT00384085|453171562|FG001|Overall Study|No longer Requires Study Treatment|0|||
125967337|NCT00384085|453171563|FG002|Overall Study|No longer Requires Study Treatment|1|||
125967338|NCT00384085|453171561|FG000|Overall Study|Protocol Violation|2|||
125967339|NCT00384085|453171562|FG001|Overall Study|Protocol Violation|2|||
125967340|NCT00384085|453171563|FG002|Overall Study|Protocol Violation|2|||
125967341|NCT00384085|453171561|FG000|Overall Study|Lost to Follow-up|9|||
125967342|NCT00384085|453171562|FG001|Overall Study|Lost to Follow-up|9|||
125967343|NCT00384085|453171563|FG002|Overall Study|Lost to Follow-up|10|||
125967344|NCT00384085|453171561|FG000|Overall Study|Progressive Disease|0|||
125967345|NCT00384085|453171562|FG001|Overall Study|Progressive Disease|1|||
125967346|NCT00384085|453171563|FG002|Overall Study|Progressive Disease|0|||
125967347|NCT00384085|453171561|FG000|Overall Study|Withdrawal by Subject|14|||
125967348|NCT00384085|453171562|FG001|Overall Study|Withdrawal by Subject|19|||
125967349|NCT00384085|453171563|FG002|Overall Study|Withdrawal by Subject|29|||
125967350|NCT00384085|453171561|FG000|Overall Study|Patient non-compliant|4|||
125967351|NCT00384085|453171562|FG001|Overall Study|Patient non-compliant|4|||
125967352|NCT00384085|453171563|FG002|Overall Study|Patient non-compliant|5|||
125967353|NCT00384085|453171561|FG000|Overall Study|Physician Decision|1|||
125967354|NCT00384085|453171562|FG001|Overall Study|Physician Decision|0|||
125967355|NCT00384085|453171563|FG002|Overall Study|Physician Decision|0|||
125967356|NCT00384085|453171561|FG000|Overall Study|Loss of site personnel|1|||
125967357|NCT00384085|453171562|FG001|Overall Study|Loss of site personnel|0|||
125967358|NCT00384085|453171563|FG002|Overall Study|Loss of site personnel|1|||
125967359|NCT00384085|453171561|FG000|Overall Study|Sponsor decision|1|||
125967360|NCT00384085|453171562|FG001|Overall Study|Sponsor decision|2|||
125967361|NCT00384085|453171563|FG002|Overall Study|Sponsor decision|1|||
125967362|NCT00384085|453171561|FG000|Overall Study|Patient moved|1|||
125967363|NCT00384085|453171562|FG001|Overall Study|Patient moved|0|||
125967364|NCT00384085|453171563|FG002|Overall Study|Patient moved|1|||
125967365|NCT00384085|453171561|FG000|Overall Study|Patient required surgery|0|||
125967366|NCT00384085|453171562|FG001|Overall Study|Patient required surgery|1|||
125967367|NCT00384085|453171563|FG002|Overall Study|Patient required surgery|0|||
125967368|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Adverse Event|5|||
125967369|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Adverse Event|8|||
125967370|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Adverse Event|4|||
125967371|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Adverse Event|8|||
125967372|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
125967373|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
125967374|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
125967375|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
125967376|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
125967377|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
125967378|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
125967379|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
125967380|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Physician Decision|1|||
126135076|NCT00915343|453783840|FG000|Part B - Open Label Period|Treatment switch|0|||
126135077|NCT00915343|453783841|FG001|Part B - Open Label Period|Treatment switch|0|||
126135078|NCT00915343|453783842|FG002|Part B - Open Label Period|Treatment switch|1|||
126135079|NCT00915343|453783840|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
126135080|NCT00915343|453783841|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
126135081|NCT00915343|453783842|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
125967381|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Physician Decision|0|||
125967382|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Physician Decision|0|||
125967383|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Physician Decision|0|||
125967384|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
125967385|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
125967386|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
125967387|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
125967388|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Pregnancy|0|||
125967389|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Pregnancy|1|||
125967390|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Pregnancy|0|||
125967391|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Pregnancy|0|||
125967392|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
125967393|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
125967394|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
125967395|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
125967396|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Death|0|||
125967397|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Death|1|||
125967398|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Death|0|||
125967399|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Death|0|||
125967400|NCT00071487|453171564|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
125967401|NCT00071487|453171565|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
125967402|NCT00071487|453171566|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
125967403|NCT00071487|453171567|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
126135082|NCT01920711|453783843|FG000|Overall Study|Death|347|||
126135083|NCT01920711|453783844|FG001|Overall Study|Death|356|||
126135084|NCT01920711|453783843|FG000|Overall Study|Lost to Follow-up|13|||
126135085|NCT01920711|453783844|FG001|Overall Study|Lost to Follow-up|14|||
126135086|NCT01920711|453783843|FG000|Overall Study|Withdrawal by Subject|4|||
126135087|NCT01920711|453783844|FG001|Overall Study|Withdrawal by Subject|3|||
126135088|NCT03687502|453783847|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
126135089|NCT03687502|453783847|FG000|Overall Study|Lumason not available|1|||
126135090|NCT01724528|453783848|FG000|Overall Study|Death|3|||
126135091|NCT01724528|453783849|FG001|Overall Study|Death|0|||
126135092|NCT01724528|453783848|FG000|Overall Study|Withdrawal by Subject|0|||
126135093|NCT01724528|453783849|FG001|Overall Study|Withdrawal by Subject|2|||
126135094|NCT01724528|453783848|FG000|Overall Study|Protocol Violation|0|||
126135095|NCT01724528|453783849|FG001|Overall Study|Protocol Violation|1|||
126135096|NCT01724528|453783848|FG000|Overall Study|Patient refused to attend last visit|1|||
126135097|NCT01724528|453783849|FG001|Overall Study|Patient refused to attend last visit|0|||
126135098|NCT04949841|453783850|FG000|Overall Study|Adverse Event|7|||
126135099|NCT04949841|453783850|FG000|Overall Study|Death|1|||
126135100|NCT04949841|453783850|FG000|Overall Study|Withdrawal by Subject|52|||
125967404|NCT00071487|453171564|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
125967405|NCT00071487|453171565|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
125967406|NCT00071487|453171566|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
125967407|NCT00071487|453171567|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
125967408|NCT00071487|453171564|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125967409|NCT00071487|453171565|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125967410|NCT00071487|453171566|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125967411|NCT00071487|453171567|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
126135101|NCT04949841|453783850|FG000|Overall Study|Pregnancy|4|||
126135102|NCT04949841|453783850|FG000|Overall Study|Lost to Follow-up|9|||
126135103|NCT04949841|453783850|FG000|Overall Study|Lack of Efficacy|55|||
126135104|NCT04949841|453783850|FG000|Overall Study|Various reasons|9|||
125967412|NCT00071487|453171564|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125967413|NCT00071487|453171565|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125967414|NCT00071487|453171566|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125967415|NCT00071487|453171567|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
125967416|NCT00071487|453171564|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
125967417|NCT00071487|453171565|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
125967418|NCT00071487|453171566|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
125967419|NCT00071487|453171567|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
125967420|NCT00071487|453171564|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125967421|NCT00071487|453171565|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125967422|NCT00071487|453171566|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125967423|NCT00071487|453171567|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
125967424|NCT00071487|453171564|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125967425|NCT00071487|453171565|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125967426|NCT00071487|453171566|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125967427|NCT00071487|453171567|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
125967428|NCT03725982|453171570|FG000|First Intervention|Withdrawal by Subject|0|||
125967429|NCT03725982|453171571|FG001|First Intervention|Withdrawal by Subject|1|||
125967430|NCT03725982|453171570|FG000|First Intervention|Physician Decision|1|||
125967431|NCT03725982|453171571|FG001|First Intervention|Physician Decision|1|||
125967432|NCT00352365|453171572|FG000|Induction Therapy|Adverse Event|7|||
125967433|NCT00352365|453171572|FG000|Induction Therapy|Progression/Relapse|8|||
125967434|NCT00352365|453171572|FG000|Induction Therapy|Death|7|||
125967435|NCT00352365|453171572|FG000|Induction Therapy|Not protocol specified|1|||
125967436|NCT00352365|453171572|FG000|Induction Therapy|Not eligible|3|||
125967437|NCT00352365|453171572|FG000|Induction Therapy|Death before starting protocol therapy|1|||
125967438|NCT00352365|453171572|FG000|Maintenance Therapy|Progression/Relapse|3|||
125967439|NCT00352365|453171572|FG000|Maintenance Therapy|Death|2|||
125967440|NCT00352365|453171572|FG000|Maintenance Therapy|Not protocol specified|3|||
125967441|NCT00352365|453171572|FG000|Maintenance Therapy|Not eligible|4|||
125967442|NCT00987467|453171576|FG000|Overall Study|Lost to Follow-up|2|||
125967443|NCT00512135|453171577|FG000|Overall Study|Not Treated|5|||
125967444|NCT00512135|453171577|FG000|Overall Study|Lack of Efficacy|2|||
125967445|NCT00512135|453171577|FG000|Overall Study|Adverse Event|6|||
125967446|NCT00512135|453171577|FG000|Overall Study|Withdrawal by Subject|22|||
125967447|NCT00512135|453171577|FG000|Overall Study|Lost to Follow-up|27|||
125967448|NCT00512135|453171577|FG000|Overall Study|Other|22|||
125967449|NCT02646423|453171578|FG000|Overall Study|Adverse Event|5|||
125967450|NCT02646423|453171579|FG001|Overall Study|Adverse Event|7|||
125967451|NCT02646423|453171578|FG000|Overall Study|Ineligible|2|||
125967452|NCT02646423|453171579|FG001|Overall Study|Ineligible|1|||
125967453|NCT02807948|453171580|FG000|Overall Study|Physician Decision|1|||
125967454|NCT02807948|453171581|FG001|Overall Study|Physician Decision|0|||
125967455|NCT02624804|453171582|FG000|Overall Study|Screen Failure|5|||
125967456|NCT01227889|453171586|FG000|Randomized Phase (RP)|Adverse Event|13|||
125967457|NCT01227889|453171587|FG001|Randomized Phase (RP)|Adverse Event|0|||
125967458|NCT01227889|453171586|FG000|Randomized Phase (RP)|Physician Decision|13|||
125967459|NCT01227889|453171587|FG001|Randomized Phase (RP)|Physician Decision|5|||
125967460|NCT01227889|453171586|FG000|Randomized Phase (RP)|Progressive Disease|135|||
125967461|NCT01227889|453171587|FG001|Randomized Phase (RP)|Progressive Disease|52|||
126135105|NCT01634555|453783853|FG000|Overall Study|Adverse Event|3|||
126135106|NCT01634555|453783853|FG000|Overall Study|Physician Decision|1|||
126135107|NCT06228586|453783854|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
125967462|NCT01227889|453171586|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
125967463|NCT01227889|453171587|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
125967464|NCT01227889|453171586|FG000|Randomized Phase (RP)|Missing|1|||
125967465|NCT01227889|453171587|FG001|Randomized Phase (RP)|Missing|3|||
125967466|NCT01227889|453171586|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
125967467|NCT01227889|453171587|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
125967468|NCT01227889|453171586|FG000|Crossover Phase|Adverse Event|0|||
125967469|NCT01227889|453171587|FG001|Crossover Phase|Adverse Event|1|||
125967470|NCT01227889|453171586|FG000|Crossover Phase|Physician Decision|0|||
125967471|NCT01227889|453171587|FG001|Crossover Phase|Physician Decision|3|||
125967472|NCT01227889|453171586|FG000|Crossover Phase|Progressive Disease|0|||
125967473|NCT01227889|453171587|FG001|Crossover Phase|Progressive Disease|31|||
125967474|NCT01227889|453171586|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
125967475|NCT01227889|453171587|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
125967476|NCT01227889|453171586|FG000|Crossover Phase|Withdrawal by Subject|0|||
125967477|NCT01227889|453171587|FG001|Crossover Phase|Withdrawal by Subject|1|||
126135108|NCT06228586|453783855|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
126135109|NCT01299766|453785186|FG000|Overall Study|Death|5|||
125967478|NCT05348681|453171588|FG000|Overall Study|Study terminated by Sponsor|8|||
125967479|NCT05348681|453171589|FG001|Overall Study|Study terminated by Sponsor|3|||
125967480|NCT05348681|453171588|FG000|Overall Study|Withdrawal by Subject|1|||
125967481|NCT05348681|453171589|FG001|Overall Study|Withdrawal by Subject|1|||
125967482|NCT05348681|453171588|FG000|Overall Study|Lost to Follow-up|1|||
125967483|NCT05348681|453171589|FG001|Overall Study|Lost to Follow-up|1|||
125967484|NCT05348681|453171588|FG000|Overall Study|Adverse Event|1|||
125967485|NCT05348681|453171589|FG001|Overall Study|Adverse Event|0|||
125967486|NCT05348681|453171588|FG000|Overall Study|Other|2|||
125967487|NCT05348681|453171589|FG001|Overall Study|Other|1|||
125967488|NCT02937545|453171591|FG000|Overall Study|Withdrawal by Subject|1|||
125967489|NCT02937545|453171592|FG001|Overall Study|Withdrawal by Subject|2|||
125967490|NCT02937545|453171593|FG002|Overall Study|Withdrawal by Subject|6|||
125967491|NCT02937545|453171594|FG003|Overall Study|Withdrawal by Subject|7|||
125967492|NCT02937545|453171591|FG000|Overall Study|Lost to Follow-up|1|||
125967493|NCT02937545|453171592|FG001|Overall Study|Lost to Follow-up|0|||
125967494|NCT02937545|453171593|FG002|Overall Study|Lost to Follow-up|0|||
125967495|NCT02937545|453171594|FG003|Overall Study|Lost to Follow-up|0|||
125967496|NCT02007577|453171595|FG000|Overall Study|Adverse Event|1|||
125967497|NCT02007577|453171596|FG001|Overall Study|Adverse Event|0|||
125967498|NCT02007577|453171595|FG000|Overall Study|Withdrawal by Subject|0|||
125967499|NCT02007577|453171596|FG001|Overall Study|Withdrawal by Subject|1|||
125967500|NCT02504294|453171597|FG000|Overall Study|Adverse Event|15|||
125967501|NCT02504294|453171598|FG001|Overall Study|Adverse Event|12|||
125967502|NCT02504294|453171597|FG000|Overall Study|Withdrawal by Subject|7|||
125967503|NCT02504294|453171598|FG001|Overall Study|Withdrawal by Subject|1|||
125967504|NCT02504294|453171597|FG000|Overall Study|Protocol Violation|27|||
125967505|NCT02504294|453171598|FG001|Overall Study|Protocol Violation|26|||
125967506|NCT02504294|453171597|FG000|Overall Study|Physician Decision|1|||
125967507|NCT02504294|453171598|FG001|Overall Study|Physician Decision|2|||
125967508|NCT02504294|453171597|FG000|Overall Study|Lost to Follow-up|6|||
125967509|NCT02504294|453171598|FG001|Overall Study|Lost to Follow-up|7|||
125967510|NCT00784043|453171600|FG000|Overall Study|Withdrawal by Subject|8|||
125967511|NCT00784043|453171601|FG001|Overall Study|Withdrawal by Subject|5|||
125967512|NCT00784043|453171600|FG000|Overall Study|Protocol Terminated|23|||
125967513|NCT00784043|453171601|FG001|Overall Study|Protocol Terminated|1|||
125967514|NCT06281548|453171602|FG000|Overall Study|Lost to Follow-up|3|||
125967515|NCT00288587|453171603|FG000|Overall Study|Death|4|||
125967516|NCT00288587|453171604|FG001|Overall Study|Death|4|||
125967517|NCT00288587|453171603|FG000|Overall Study|Transplant|0|||
125967518|NCT00288587|453171604|FG001|Overall Study|Transplant|3|||
125967519|NCT00288587|453171603|FG000|Overall Study|Adverse Event|0|||
125967520|NCT00288587|453171604|FG001|Overall Study|Adverse Event|1|||
125967521|NCT00288587|453171603|FG000|Overall Study|Physician Decision|0|||
125967522|NCT00288587|453171604|FG001|Overall Study|Physician Decision|2|||
125967523|NCT00288587|453171603|FG000|Overall Study|Severe Aortic Stenosis|1|||
125967524|NCT00288587|453171604|FG001|Overall Study|Severe Aortic Stenosis|0|||
125967525|NCT03538626|453171605|FG000|Overall Study|Withdrawal by Subject|0|||
125967526|NCT03538626|453171606|FG001|Overall Study|Withdrawal by Subject|1|||
125967527|NCT03538626|453171607|FG002|Overall Study|Withdrawal by Subject|0|||
125967528|NCT03538626|453171608|FG003|Overall Study|Withdrawal by Subject|0|||
125967529|NCT03538626|453171609|FG004|Overall Study|Withdrawal by Subject|0|||
125967530|NCT03538626|453171610|FG005|Overall Study|Withdrawal by Subject|0|||
125967531|NCT03538626|453171611|FG006|Overall Study|Withdrawal by Subject|0|||
126135110|NCT01299766|453785187|FG001|Overall Study|Death|4|||
126135111|NCT01299766|453785186|FG000|Overall Study|Withdrawal by Subject|29|||
125967532|NCT03538626|453171612|FG007|Overall Study|Withdrawal by Subject|0|||
125967533|NCT03538626|453171605|FG000|Overall Study|Lost to Follow-up|0|||
125967534|NCT03538626|453171606|FG001|Overall Study|Lost to Follow-up|0|||
125967535|NCT03538626|453171607|FG002|Overall Study|Lost to Follow-up|0|||
125967536|NCT03538626|453171608|FG003|Overall Study|Lost to Follow-up|0|||
125967537|NCT03538626|453171609|FG004|Overall Study|Lost to Follow-up|0|||
125967538|NCT03538626|453171610|FG005|Overall Study|Lost to Follow-up|0|||
125967539|NCT03538626|453171611|FG006|Overall Study|Lost to Follow-up|1|||
125967540|NCT03538626|453171612|FG007|Overall Study|Lost to Follow-up|0|||
125967541|NCT01434602|453171617|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
125967542|NCT01434602|453171618|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
125967543|NCT01434602|453171619|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
125967544|NCT01434602|453171620|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
125967545|NCT01434602|453171621|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
125967546|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
125967547|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
125967548|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
125967549|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
126135112|NCT01299766|453785187|FG001|Overall Study|Withdrawal by Subject|19|||
126135113|NCT00403260|453785190|FG000|Overall Study|Adverse Event|5|||
126135114|NCT00403260|453785191|FG001|Overall Study|Adverse Event|4|||
126135115|NCT00403260|453785190|FG000|Overall Study|Withdrawal by Subject|5|||
125967550|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
125967551|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
125967552|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
125967553|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
125967554|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
125967555|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
125967556|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
125967557|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
125967558|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
125967559|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
125967560|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
125967561|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
125967562|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
125967563|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
125967564|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
125967565|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
125967566|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
125967567|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
125967568|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
125967569|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
125967570|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
125967571|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
125967572|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
125967573|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
125967574|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
125967575|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
125967576|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
125967577|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
125967578|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
125967579|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
125967580|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
125967581|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
125967582|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
125967583|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
125967584|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
125967585|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
125967586|NCT01434602|453171617|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
125967587|NCT01434602|453171618|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
125967588|NCT01434602|453171619|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
125967589|NCT01434602|453171620|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
125967590|NCT01434602|453171621|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
125967591|NCT00499889|453171635|FG000|Overall Study|Infection prior to treatment|1|||
125967592|NCT00142909|453171639|FG000|Randomization|Various Reasons|7|||
125967593|NCT00142909|453171640|FG001|Randomization|Various Reasons|10|||
125967594|NCT00142909|453171639|FG000|Medications Begin|Protocol Violation|2|||
125967595|NCT00142909|453171640|FG001|Medications Begin|Protocol Violation|0|||
126135116|NCT00403260|453785191|FG001|Overall Study|Withdrawal by Subject|6|||
126135117|NCT00403260|453785190|FG000|Overall Study|Lost to Follow-up|49|||
126135118|NCT00403260|453785191|FG001|Overall Study|Lost to Follow-up|25|||
126135119|NCT00403260|453785190|FG000|Overall Study|Re-appearance of P. falciparum|34|||
126135120|NCT00403260|453785191|FG001|Overall Study|Re-appearance of P. falciparum|25|||
126135121|NCT00403260|453785190|FG000|Overall Study|P. vivax infection|26|||
126135122|NCT00403260|453785191|FG001|Overall Study|P. vivax infection|4|||
126135123|NCT00403260|453785190|FG000|Overall Study|Mixed infection with P. vivax|2|||
125967596|NCT00142909|453171639|FG000|Medications Begin|Withdrawal by Subject|5|||
125967597|NCT00142909|453171640|FG001|Medications Begin|Withdrawal by Subject|3|||
126135124|NCT00403260|453785191|FG001|Overall Study|Mixed infection with P. vivax|0|||
126135125|NCT00403260|453785190|FG000|Overall Study|Mixed infection with P. falciparum|1|||
126135126|NCT00403260|453785191|FG001|Overall Study|Mixed infection with P. falciparum|0|||
126135127|NCT00403260|453785190|FG000|Overall Study|P. vivax infection at screening|1|||
125967598|NCT00142909|453171639|FG000|Medications Begin|Withdrawal by Subject|2|||
125967599|NCT00142909|453171640|FG001|Medications Begin|Withdrawal by Subject|0|||
125967600|NCT00345397|453171641|FG000|Overall Study|Death|1|||
125967601|NCT03351049|453171648|FG000|Overall Study|Withdrawal|26|||
125967602|NCT03351049|453171649|FG001|Overall Study|Withdrawal|22|||
125967603|NCT03832192|453171654|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
125967604|NCT03832192|453171655|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
125967605|NCT03738150|453171656|FG000|Base Study|Withdrawal by Subject|1|||
125967606|NCT03738150|453171656|FG000|Extension Study|Withdrawal by Subject|1|||
125967607|NCT01898195|453171661|FG000|Smoking Abstinence|Did not have good measurements|35|||
125967608|NCT01898195|453171662|FG001|Smoking Abstinence|Did not have good measurements|38|||
125967609|NCT01898195|453171663|FG002|Smoking Abstinence|Did not have good measurements|36|||
125967610|NCT02720484|453171668|FG000|Treatment on Study|Adverse Event|1|||
125967611|NCT02720484|453171668|FG000|Treatment on Study|Withdrawal by Subject|1|||
125967612|NCT02720484|453171668|FG000|Treatment on Study|Progressive Disease|4|||
125967613|NCT02720484|453171668|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
125967614|NCT02720484|453171668|FG000|Follow Up for 2 Years|Death|3|||
125967615|NCT02720484|453171668|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
125967616|NCT05070897|453171671|FG000|Overall Study|Protocol Violation|123|||
125967617|NCT05070897|453171672|FG001|Overall Study|Protocol Violation|68|||
125967618|NCT01617629|453171673|FG000|Overall Study|Death|2|||
125967619|NCT01617629|453171673|FG000|Overall Study|Investigator's Clinical Judgement|1|||
125967620|NCT01617629|453171673|FG000|Overall Study|Reason Not Specified|1|||
125967621|NCT01617629|453171673|FG000|Overall Study|Participant Withdrew Consent|2|||
125967622|NCT01663636|453171674|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
125967623|NCT01663636|453171675|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
125967624|NCT01337245|453171676|FG000|Overall Study|Lost to Follow-up|1|||
125967625|NCT03832946|453171677|FG000|Overall Study|Adverse Event|3|||
125967626|NCT03832946|453171678|FG001|Overall Study|Adverse Event|1|||
125967627|NCT03832946|453171677|FG000|Overall Study|Lost to Follow-up|1|||
125967628|NCT03832946|453171678|FG001|Overall Study|Lost to Follow-up|0|||
125967629|NCT03832946|453171677|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
125967630|NCT03832946|453171678|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
125967631|NCT03832946|453171677|FG000|Overall Study|Lack of Efficacy|1|||
126135128|NCT00403260|453785191|FG001|Overall Study|P. vivax infection at screening|0|||
126135129|NCT00403260|453785190|FG000|Overall Study|P. ovale infection|1|||
126135130|NCT00403260|453785191|FG001|Overall Study|P. ovale infection|0|||
126135131|NCT00403260|453785190|FG000|Overall Study|Gametocyte re-appearance|1|||
126135132|NCT00403260|453785191|FG001|Overall Study|Gametocyte re-appearance|1|||
126135133|NCT00403260|453785190|FG000|Overall Study|Withdrawn from study accidentally|0|||
126135134|NCT00403260|453785191|FG001|Overall Study|Withdrawn from study accidentally|1|||
126135135|NCT01354028|453785192|FG000|Overall Study|Physician Decision|0|||
125967632|NCT03832946|453171678|FG001|Overall Study|Lack of Efficacy|0|||
125967633|NCT03832946|453171677|FG000|Overall Study|Withdrawal by Subject|12|||
125967634|NCT03832946|453171678|FG001|Overall Study|Withdrawal by Subject|9|||
125967635|NCT01307501|453171679|FG000|Overall Study|Treatment Failure|1|||
126135136|NCT01354028|453785193|FG001|Overall Study|Physician Decision|2|||
126135137|NCT01354028|453785192|FG000|Overall Study|Discharged before study start|2|||
126135138|NCT01354028|453785193|FG001|Overall Study|Discharged before study start|2|||
126135139|NCT01354028|453785192|FG000|Overall Study|No quiet alert state|0|||
126135140|NCT01354028|453785193|FG001|Overall Study|No quiet alert state|1|||
126135141|NCT00935883|453785196|FG000|Treatment Period|Physician Decision|1|||
126135142|NCT00935883|453785197|FG001|Treatment Period|Physician Decision|0|||
126135143|NCT00935883|453785196|FG000|Treatment Period|Withdrawal by Subject|0|||
126135144|NCT00935883|453785197|FG001|Treatment Period|Withdrawal by Subject|2|||
126135145|NCT00808444|453785201|FG000|Overall Study|Withdrawal by Subject|1|||
126135146|NCT00808444|453785202|FG001|Overall Study|Withdrawal by Subject|0|||
126135147|NCT00808444|453785201|FG000|Overall Study|Lost to Follow-up|0|||
125967636|NCT01307501|453171679|FG000|Overall Study|Death|20|||
125967637|NCT01307501|453171679|FG000|Overall Study|Lost to Follow-up|1|||
125967638|NCT01307501|453171679|FG000|Overall Study|Starting Hospice|1|||
126135148|NCT00808444|453785202|FG001|Overall Study|Lost to Follow-up|1|||
126135149|NCT00975156|453785208|FG000|Overall Study|Protocol Violation|0|||
125967639|NCT02005471|453171680|FG000|Main Study|Adverse Event|0|||
125967640|NCT02005471|453171681|FG001|Main Study|Adverse Event|1|||
125967641|NCT02005471|453171682|FG002|Main Study|Adverse Event|0|||
125967642|NCT02005471|453171683|FG003|Main Study|Adverse Event|0|||
125967643|NCT02005471|453171680|FG000|Main Study|Death|83|||
125967644|NCT02005471|453171681|FG001|Main Study|Death|52|||
125967645|NCT02005471|453171682|FG002|Main Study|Death|0|||
125967646|NCT02005471|453171683|FG003|Main Study|Death|0|||
125967647|NCT02005471|453171680|FG000|Main Study|Lost to Follow-up|4|||
125967648|NCT02005471|453171681|FG001|Main Study|Lost to Follow-up|5|||
126135150|NCT00975156|453785209|FG001|Overall Study|Protocol Violation|1|||
126135151|NCT02770326|453785214|FG000|Overall Study|Death|3|||
125967649|NCT02005471|453171682|FG002|Main Study|Lost to Follow-up|0|||
125967650|NCT02005471|453171683|FG003|Main Study|Lost to Follow-up|0|||
125967651|NCT02005471|453171680|FG000|Main Study|Physician Decision|3|||
125967652|NCT02005471|453171681|FG001|Main Study|Physician Decision|1|||
125967653|NCT02005471|453171682|FG002|Main Study|Physician Decision|0|||
125967654|NCT02005471|453171683|FG003|Main Study|Physician Decision|0|||
125967655|NCT02005471|453171680|FG000|Main Study|Withdrawal by Subject|26|||
125967656|NCT02005471|453171681|FG001|Main Study|Withdrawal by Subject|11|||
125967657|NCT02005471|453171682|FG002|Main Study|Withdrawal by Subject|0|||
125967658|NCT02005471|453171683|FG003|Main Study|Withdrawal by Subject|0|||
125967659|NCT02005471|453171680|FG000|Main Study|Reason not Specified|0|||
125967660|NCT02005471|453171681|FG001|Main Study|Reason not Specified|6|||
125967661|NCT02005471|453171682|FG002|Main Study|Reason not Specified|0|||
125967662|NCT02005471|453171683|FG003|Main Study|Reason not Specified|0|||
125967663|NCT02005471|453171680|FG000|Main Study|Randomized but not Dosed|8|||
125967664|NCT02005471|453171681|FG001|Main Study|Randomized but not Dosed|0|||
125967665|NCT02005471|453171682|FG002|Main Study|Randomized but not Dosed|0|||
125967666|NCT02005471|453171683|FG003|Main Study|Randomized but not Dosed|0|||
125967667|NCT02005471|453171680|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
125967668|NCT02005471|453171681|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
125967669|NCT02005471|453171682|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
125967670|NCT02005471|453171683|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
125967671|NCT02005471|453171680|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
125967672|NCT02005471|453171681|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
125967673|NCT02005471|453171682|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
125967674|NCT02005471|453171683|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
125967675|NCT02005471|453171680|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
125967676|NCT02005471|453171681|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
125967677|NCT02005471|453171682|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
125967678|NCT02005471|453171683|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
125967679|NCT03478891|453171684|FG000|Overall Study|Enrolled, but product never administered|0|||
125967680|NCT03478891|453171685|FG001|Overall Study|Enrolled, but product never administered|0|||
125967681|NCT03478891|453171686|FG002|Overall Study|Enrolled, but product never administered|1|||
125967682|NCT03478891|453171684|FG000|Overall Study|Moved from area|0|||
125967683|NCT03478891|453171685|FG001|Overall Study|Moved from area|0|||
125967684|NCT03478891|453171686|FG002|Overall Study|Moved from area|1|||
125967685|NCT03478891|453171684|FG000|Overall Study|Lost to Follow-up|1|||
125967686|NCT03478891|453171685|FG001|Overall Study|Lost to Follow-up|0|||
125967687|NCT03478891|453171686|FG002|Overall Study|Lost to Follow-up|1|||
125967688|NCT03662750|453171687|FG000|Overall Study|Withdrawal by Subject|1|||
125967689|NCT00932893|453171688|FG000|Overall Study|Death|115|||
125967690|NCT00932893|453171689|FG001|Overall Study|Death|24|||
125967691|NCT00932893|453171688|FG000|Overall Study|Lost to Follow-up|8|||
125967692|NCT00932893|453171689|FG001|Overall Study|Lost to Follow-up|0|||
125967693|NCT00932893|453171688|FG000|Overall Study|Withdrawal by Subject|5|||
125967694|NCT00932893|453171689|FG001|Overall Study|Withdrawal by Subject|2|||
125967695|NCT00932893|453171688|FG000|Overall Study|Other|5|||
125967696|NCT00932893|453171689|FG001|Overall Study|Other|144|||
125967697|NCT04450264|453173671|FG000|Overall Study|Incomplete survey|13|||
125967698|NCT04450264|453173672|FG001|Overall Study|Incomplete survey|19|||
125967699|NCT05349617|453173673|FG000|Overall Study|Death|1|||
125967700|NCT05349617|453173674|FG001|Overall Study|Death|1|||
125967701|NCT05349617|453173673|FG000|Overall Study|Lost to Follow-up|3|||
125967702|NCT05349617|453173674|FG001|Overall Study|Lost to Follow-up|8|||
125967703|NCT05349617|453173673|FG000|Overall Study|Withdrawal by Subject|2|||
125967704|NCT05349617|453173674|FG001|Overall Study|Withdrawal by Subject|10|||
125967705|NCT01262651|453173675|FG000|Overall Study|Adverse Event|40|||
125967706|NCT01262651|453173676|FG001|Overall Study|Adverse Event|35|||
125967707|NCT01262651|453173675|FG000|Overall Study|Withdrawal by Subject|15|||
125967708|NCT01262651|453173676|FG001|Overall Study|Withdrawal by Subject|11|||
125967709|NCT01262651|453173675|FG000|Overall Study|Withdrawal by Investigator|2|||
126135152|NCT02770326|453785214|FG000|Overall Study|Lost to Follow-up|1|||
126135153|NCT02971202|453785215|FG000|Overall Study|Pregnancy|1|||
126135154|NCT02971202|453785216|FG001|Overall Study|Pregnancy|0|||
126135155|NCT02971202|453785217|FG002|Overall Study|Pregnancy|0|||
126135156|NCT02971202|453785215|FG000|Overall Study|screen fail after consent|1|||
126135157|NCT02971202|453785216|FG001|Overall Study|screen fail after consent|0|||
125967710|NCT01262651|453173676|FG001|Overall Study|Withdrawal by Investigator|2|||
125967711|NCT01262651|453173675|FG000|Overall Study|Met Withdrawal Criteria|1|||
125967712|NCT01262651|453173676|FG001|Overall Study|Met Withdrawal Criteria|0|||
125967713|NCT04743908|453173677|FG000|Overall Study|Death|1|||
125967714|NCT04743908|453173678|FG001|Overall Study|Death|0|||
125967715|NCT04743908|453173677|FG000|Overall Study|Lost to Follow-up|181|||
125967716|NCT04743908|453173678|FG001|Overall Study|Lost to Follow-up|180|||
125967717|NCT04743908|453173677|FG000|Overall Study|Withdrawal by Subject|1|||
125967718|NCT04743908|453173678|FG001|Overall Study|Withdrawal by Subject|2|||
125967719|NCT04969783|453173679|FG000|Overall Study|Lost to Follow-up|2|||
126135158|NCT02971202|453785217|FG002|Overall Study|screen fail after consent|1|||
126135159|NCT01946178|453785218|FG000|Overall Study|Pregnancy|1|||
125967720|NCT04969783|453173680|FG001|Overall Study|Lost to Follow-up|0|||
125967721|NCT04969783|453173679|FG000|Overall Study|Withdrawal by Subject|4|||
125967722|NCT04969783|453173680|FG001|Overall Study|Withdrawal by Subject|0|||
125967723|NCT04969783|453173679|FG000|Overall Study|Physician Decision|6|||
125967724|NCT04969783|453173680|FG001|Overall Study|Physician Decision|0|||
125967725|NCT04837482|453173681|FG000|Period 2|Withdrawal by Subject|0|||
125967726|NCT04837482|453173682|FG001|Period 2|Withdrawal by Subject|1|||
125967727|NCT00407537|453173687|FG000|Overall Study|Death|5|||
125967728|NCT00407537|453173688|FG001|Overall Study|Death|2|||
125967729|NCT00407537|453173687|FG000|Overall Study|Adverse Event|36|||
125967730|NCT00407537|453173688|FG001|Overall Study|Adverse Event|0|||
125967731|NCT00407537|453173687|FG000|Overall Study|Lost to Follow-up|12|||
125967732|NCT00407537|453173688|FG001|Overall Study|Lost to Follow-up|19|||
125967733|NCT00407537|453173687|FG000|Overall Study|Other|6|||
125967734|NCT00407537|453173688|FG001|Overall Study|Other|7|||
125967735|NCT00407537|453173687|FG000|Overall Study|Withdrawal by Subject|34|||
125967736|NCT00407537|453173688|FG001|Overall Study|Withdrawal by Subject|16|||
125967737|NCT01519206|453173689|FG000|Overall Study|Lost to Follow-up|3|||
125967738|NCT01519206|453173689|FG000|Overall Study|Missed Visit|2|||
125967739|NCT06027216|453173690|FG000|Overall Study|Did not qualify|8|||
125967740|NCT03646513|453173694|FG000|Overall Study|Premature study termination|4|||
125967741|NCT00782340|453173695|FG000|Open Label Titration|Adverse Event|12|||
125967742|NCT00782340|453173696|FG001|Open Label Titration|Adverse Event|0|||
125967743|NCT00782340|453173697|FG002|Open Label Titration|Adverse Event|0|||
125967744|NCT00782340|453173695|FG000|Open Label Titration|Treatment failure|50|||
125967745|NCT00782340|453173696|FG001|Open Label Titration|Treatment failure|0|||
125967746|NCT00782340|453173697|FG002|Open Label Titration|Treatment failure|0|||
126135160|NCT01946178|453785218|FG000|Overall Study|Lost to Follow-up|1|||
126135161|NCT02634580|453785219|FG000|Double-blind Treatment Period|Subject Request|1|||
126135162|NCT02634580|453785220|FG001|Double-blind Treatment Period|Subject Request|0|||
125967747|NCT00782340|453173695|FG000|Open Label Titration|Protocol Violation|5|||
125967748|NCT00782340|453173696|FG001|Open Label Titration|Protocol Violation|0|||
125967749|NCT00782340|453173697|FG002|Open Label Titration|Protocol Violation|0|||
125967750|NCT00782340|453173695|FG000|Open Label Titration|Withdrawal by Subject|5|||
125967751|NCT00782340|453173696|FG001|Open Label Titration|Withdrawal by Subject|0|||
125967752|NCT00782340|453173697|FG002|Open Label Titration|Withdrawal by Subject|0|||
125967753|NCT00782340|453173695|FG000|Open Label Titration|Enrollment capped|16|||
125967754|NCT00782340|453173696|FG001|Open Label Titration|Enrollment capped|0|||
125967755|NCT00782340|453173697|FG002|Open Label Titration|Enrollment capped|0|||
125967756|NCT00782340|453173695|FG000|Open Label Titration|Did not meet responder criteria|2|||
126135163|NCT02634580|453785221|FG002|Double-blind Treatment Period|Subject Request|1|||
126135164|NCT02634580|453785222|FG003|Double-blind Treatment Period|Subject Request|1|||
126135165|NCT02634580|453785219|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126135166|NCT02634580|453785220|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
126135167|NCT02634580|453785221|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
126135168|NCT02634580|453785222|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
125967757|NCT00782340|453173696|FG001|Open Label Titration|Did not meet responder criteria|0|||
125967758|NCT00782340|453173697|FG002|Open Label Titration|Did not meet responder criteria|0|||
125967759|NCT00782340|453173695|FG000|Open Label Titration|Lost to Follow-up|5|||
125967760|NCT00782340|453173696|FG001|Open Label Titration|Lost to Follow-up|0|||
125967761|NCT00782340|453173697|FG002|Open Label Titration|Lost to Follow-up|0|||
125967762|NCT00782340|453173695|FG000|Open Label Titration|Randomized in error|6|||
125967763|NCT00782340|453173696|FG001|Open Label Titration|Randomized in error|0|||
125967764|NCT00782340|453173697|FG002|Open Label Titration|Randomized in error|0|||
125967765|NCT02219932|453173702|FG000|Overall Study|Other|5|||
125967766|NCT02219932|453173703|FG001|Overall Study|Other|11|||
125967767|NCT02219932|453173702|FG000|Overall Study|Death|1|||
125967768|NCT02219932|453173703|FG001|Overall Study|Death|1|||
125967769|NCT02219932|453173702|FG000|Overall Study|Investigator Decision|0|||
125967770|NCT02219932|453173703|FG001|Overall Study|Investigator Decision|1|||
125967771|NCT02219932|453173702|FG000|Overall Study|Consent Withdrawn|11|||
125967772|NCT02219932|453173703|FG001|Overall Study|Consent Withdrawn|7|||
125967773|NCT02219932|453173702|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
125967774|NCT02219932|453173703|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
125967775|NCT02219932|453173702|FG000|Overall Study|Protocol Violation|10|||
125967776|NCT02219932|453173703|FG001|Overall Study|Protocol Violation|6|||
125967777|NCT02219932|453173702|FG000|Overall Study|Pregnancy|1|||
126135169|NCT01622569|453785223|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
125967778|NCT02219932|453173703|FG001|Overall Study|Pregnancy|0|||
125967779|NCT02219932|453173702|FG000|Overall Study|Lost to Follow-up|4|||
125967780|NCT02219932|453173703|FG001|Overall Study|Lost to Follow-up|2|||
125967781|NCT02219932|453173702|FG000|Overall Study|Adverse Event|23|||
125967782|NCT02219932|453173703|FG001|Overall Study|Adverse Event|21|||
125967783|NCT00093145|453173705|FG000|Overall Study|Unacceptable Toxicity Only|2|||
125967784|NCT00093145|453173705|FG000|Overall Study|Physician Decision|5|||
126135170|NCT01622569|453785224|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
125967785|NCT00093145|453173705|FG000|Overall Study|Withdrawal by Subject|9|||
125967786|NCT00093145|453173705|FG000|Overall Study|Other|1|||
125967787|NCT04389840|453173706|FG000|Overall Study|Adverse Event|0|||
125967788|NCT04389840|453173707|FG001|Overall Study|Adverse Event|0|||
125967789|NCT04389840|453173708|FG002|Overall Study|Adverse Event|0|||
125967790|NCT04389840|453173709|FG003|Overall Study|Adverse Event|1|||
125967791|NCT04389840|453173710|FG004|Overall Study|Adverse Event|0|||
125967792|NCT04389840|453173711|FG005|Overall Study|Adverse Event|0|||
125967793|NCT04389840|453173706|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
125967794|NCT04389840|453173707|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
125967795|NCT04389840|453173708|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
125967796|NCT04389840|453173709|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
125967797|NCT04389840|453173710|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
125967798|NCT04389840|453173711|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
125967799|NCT04389840|453173706|FG000|Overall Study|Death|0|||
125967800|NCT04389840|453173707|FG001|Overall Study|Death|1|||
125967801|NCT04389840|453173708|FG002|Overall Study|Death|0|||
125967802|NCT04389840|453173709|FG003|Overall Study|Death|0|||
125967803|NCT04389840|453173710|FG004|Overall Study|Death|0|||
125967804|NCT04389840|453173711|FG005|Overall Study|Death|0|||
125967805|NCT02252211|453173712|FG000|Overall Study|Adverse Event|0|||
125967806|NCT02252211|453173713|FG001|Overall Study|Adverse Event|1|||
125967807|NCT02252211|453173714|FG002|Overall Study|Adverse Event|0|||
125967808|NCT02252211|453173712|FG000|Overall Study|Progressive disease|3|||
125967809|NCT02252211|453173713|FG001|Overall Study|Progressive disease|2|||
125967810|NCT02252211|453173714|FG002|Overall Study|Progressive disease|0|||
125967811|NCT02252211|453173712|FG000|Overall Study|Withdrawal by Subject|1|||
125967812|NCT02252211|453173713|FG001|Overall Study|Withdrawal by Subject|0|||
125967813|NCT02252211|453173714|FG002|Overall Study|Withdrawal by Subject|0|||
125967814|NCT02252211|453173712|FG000|Overall Study|Serious Adverse Event During Screening|1|||
125967815|NCT02252211|453173713|FG001|Overall Study|Serious Adverse Event During Screening|0|||
125967816|NCT02252211|453173714|FG002|Overall Study|Serious Adverse Event During Screening|1|||
125967817|NCT01985126|453173715|FG000|Overall Study|Death|15|||
125967818|NCT01985126|453173716|FG001|Overall Study|Death|69|||
125967819|NCT01985126|453173715|FG000|Overall Study|Lost to Follow-up|0|||
125967820|NCT01985126|453173716|FG001|Overall Study|Lost to Follow-up|8|||
125967821|NCT01985126|453173715|FG000|Overall Study|Study Terminated By Sponsor|1|||
125967822|NCT01985126|453173716|FG001|Overall Study|Study Terminated By Sponsor|22|||
125967823|NCT01985126|453173715|FG000|Overall Study|Withdrawal by Subject|2|||
125967824|NCT01985126|453173716|FG001|Overall Study|Withdrawal by Subject|7|||
125967825|NCT00968669|453173719|FG000|Overall Study|Lost to Follow-up|5|||
125967826|NCT00968669|453173720|FG001|Overall Study|Lost to Follow-up|2|||
125967827|NCT00968669|453173721|FG002|Overall Study|Lost to Follow-up|1|||
125967828|NCT00968669|453173722|FG003|Overall Study|Lost to Follow-up|4|||
125967829|NCT00968669|453173719|FG000|Overall Study|Withdrawal by Subject|9|||
125967830|NCT00968669|453173720|FG001|Overall Study|Withdrawal by Subject|7|||
125967831|NCT00968669|453173721|FG002|Overall Study|Withdrawal by Subject|5|||
125967832|NCT00968669|453173722|FG003|Overall Study|Withdrawal by Subject|3|||
125967833|NCT00968669|453173719|FG000|Overall Study|Pregnancy|0|||
125967834|NCT00968669|453173720|FG001|Overall Study|Pregnancy|0|||
125967835|NCT00968669|453173721|FG002|Overall Study|Pregnancy|2|||
125967836|NCT00968669|453173722|FG003|Overall Study|Pregnancy|0|||
125967837|NCT00968669|453173719|FG000|Overall Study|AE|1|||
125967838|NCT00968669|453173720|FG001|Overall Study|AE|0|||
125967839|NCT00968669|453173721|FG002|Overall Study|AE|0|||
125967840|NCT00968669|453173722|FG003|Overall Study|AE|0|||
125967841|NCT00968669|453173719|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
125967842|NCT00968669|453173720|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
125967843|NCT00968669|453173721|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
126135171|NCT01622569|453785225|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
126135172|NCT01622569|453785226|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
126135173|NCT01622569|453785223|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
125967844|NCT00968669|453173722|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
125967845|NCT00968669|453173719|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
125967846|NCT00968669|453173720|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
125967847|NCT00968669|453173721|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
125967848|NCT00968669|453173722|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
125967849|NCT00968669|453173719|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
125967850|NCT00968669|453173720|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
125967851|NCT00968669|453173721|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
125967852|NCT00968669|453173722|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
125967853|NCT00968669|453173719|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
125967854|NCT00968669|453173720|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
125967855|NCT00968669|453173721|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
125967856|NCT00968669|453173722|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
125967857|NCT00968669|453173719|FG000|Overall Study|EARLY WITHDRAWAL|0|||
125967858|NCT00968669|453173720|FG001|Overall Study|EARLY WITHDRAWAL|1|||
125967859|NCT00968669|453173721|FG002|Overall Study|EARLY WITHDRAWAL|0|||
125967860|NCT00968669|453173722|FG003|Overall Study|EARLY WITHDRAWAL|0|||
125967861|NCT00968669|453173719|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
125967862|NCT00968669|453173720|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
125967863|NCT00968669|453173721|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
125967864|NCT00968669|453173722|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
125967865|NCT00968669|453173719|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
125967866|NCT00968669|453173720|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
125967867|NCT00968669|453173721|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
125967868|NCT00968669|453173722|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
125967869|NCT00968669|453173719|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
125967870|NCT00968669|453173720|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
125967871|NCT00968669|453173721|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
125967872|NCT00968669|453173722|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
125967873|NCT00968669|453173719|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
125967874|NCT00968669|453173720|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
125967875|NCT00968669|453173721|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
125967876|NCT00968669|453173722|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
125967877|NCT00968669|453173719|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
125967878|NCT00968669|453173720|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
125967879|NCT00968669|453173721|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
125967880|NCT00968669|453173722|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
125967881|NCT00968669|453173719|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
125967882|NCT00968669|453173720|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
125967883|NCT00968669|453173721|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
125967884|NCT00968669|453173722|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
125967885|NCT00968669|453173719|FG000|Overall Study|SPONSOR DECISION|0|||
125967886|NCT00968669|453173720|FG001|Overall Study|SPONSOR DECISION|1|||
125967887|NCT00968669|453173721|FG002|Overall Study|SPONSOR DECISION|0|||
125967888|NCT00968669|453173722|FG003|Overall Study|SPONSOR DECISION|0|||
125967889|NCT00968669|453173719|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
125967890|NCT00968669|453173720|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
125967891|NCT00968669|453173721|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
125967892|NCT00968669|453173722|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
125967893|NCT00968669|453173719|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
125967894|NCT00968669|453173720|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
125967895|NCT00968669|453173721|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
125967896|NCT00968669|453173722|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
125967897|NCT00968669|453173719|FG000|Overall Study|SUBJECT INCARCERATED|0|||
125967898|NCT00968669|453173720|FG001|Overall Study|SUBJECT INCARCERATED|1|||
125967899|NCT00968669|453173721|FG002|Overall Study|SUBJECT INCARCERATED|0|||
125967900|NCT00968669|453173722|FG003|Overall Study|SUBJECT INCARCERATED|0|||
125967901|NCT00968669|453173719|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
125967902|NCT00968669|453173720|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
125967903|NCT00968669|453173721|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
125967904|NCT00968669|453173722|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
125967905|NCT00968669|453173719|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
125967906|NCT00968669|453173720|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
125967907|NCT00968669|453173721|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
125967908|NCT00968669|453173722|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
125967909|NCT01953926|453173723|FG000|Overall Study|Withdrawal by Subject|23|||
125967910|NCT01953926|453173724|FG001|Overall Study|Withdrawal by Subject|3|||
125967911|NCT01953926|453173725|FG002|Overall Study|Withdrawal by Subject|3|||
125967912|NCT01953926|453173726|FG003|Overall Study|Withdrawal by Subject|5|||
125967913|NCT01953926|453173727|FG004|Overall Study|Withdrawal by Subject|6|||
125967914|NCT01953926|453173728|FG005|Overall Study|Withdrawal by Subject|0|||
125967915|NCT01953926|453173729|FG006|Overall Study|Withdrawal by Subject|1|||
125967916|NCT01953926|453173723|FG000|Overall Study|Physician Decision|1|||
125967917|NCT01953926|453173724|FG001|Overall Study|Physician Decision|0|||
125967918|NCT01953926|453173725|FG002|Overall Study|Physician Decision|0|||
125967919|NCT01953926|453173726|FG003|Overall Study|Physician Decision|0|||
125967920|NCT01953926|453173727|FG004|Overall Study|Physician Decision|2|||
125967921|NCT01953926|453173728|FG005|Overall Study|Physician Decision|0|||
125967922|NCT01953926|453173729|FG006|Overall Study|Physician Decision|0|||
125967923|NCT01953926|453173723|FG000|Overall Study|Lost to Follow-up|18|||
125967924|NCT01953926|453173724|FG001|Overall Study|Lost to Follow-up|3|||
125967925|NCT01953926|453173725|FG002|Overall Study|Lost to Follow-up|0|||
125967926|NCT01953926|453173726|FG003|Overall Study|Lost to Follow-up|5|||
125967927|NCT01953926|453173727|FG004|Overall Study|Lost to Follow-up|3|||
125967928|NCT01953926|453173728|FG005|Overall Study|Lost to Follow-up|0|||
125967929|NCT01953926|453173729|FG006|Overall Study|Lost to Follow-up|0|||
125967930|NCT01953926|453173723|FG000|Overall Study|Protocol Violation|1|||
125967931|NCT01953926|453173724|FG001|Overall Study|Protocol Violation|0|||
125967932|NCT01953926|453173725|FG002|Overall Study|Protocol Violation|0|||
125967933|NCT01953926|453173726|FG003|Overall Study|Protocol Violation|0|||
125967934|NCT01953926|453173727|FG004|Overall Study|Protocol Violation|0|||
125967935|NCT01953926|453173728|FG005|Overall Study|Protocol Violation|0|||
125967936|NCT01953926|453173729|FG006|Overall Study|Protocol Violation|0|||
125967937|NCT01953926|453173723|FG000|Overall Study|Other, Disease progression|2|||
125967938|NCT01953926|453173724|FG001|Overall Study|Other, Disease progression|1|||
125967939|NCT01953926|453173725|FG002|Overall Study|Other, Disease progression|0|||
125967940|NCT01953926|453173726|FG003|Overall Study|Other, Disease progression|0|||
125967941|NCT01953926|453173727|FG004|Overall Study|Other, Disease progression|1|||
125967942|NCT01953926|453173728|FG005|Overall Study|Other, Disease progression|0|||
125967943|NCT01953926|453173729|FG006|Overall Study|Other, Disease progression|0|||
125967944|NCT01953926|453173723|FG000|Overall Study|Discontinuation of study by sponsor|41|||
125967945|NCT01953926|453173724|FG001|Overall Study|Discontinuation of study by sponsor|7|||
125967946|NCT01953926|453173725|FG002|Overall Study|Discontinuation of study by sponsor|5|||
125967947|NCT01953926|453173726|FG003|Overall Study|Discontinuation of study by sponsor|12|||
125967948|NCT01953926|453173727|FG004|Overall Study|Discontinuation of study by sponsor|46|||
125967949|NCT01953926|453173728|FG005|Overall Study|Discontinuation of study by sponsor|5|||
125967950|NCT01953926|453173729|FG006|Overall Study|Discontinuation of study by sponsor|6|||
125967951|NCT01953926|453173723|FG000|Overall Study|Not Treated|1|||
125967952|NCT01953926|453173724|FG001|Overall Study|Not Treated|0|||
125967953|NCT01953926|453173725|FG002|Overall Study|Not Treated|1|||
125967954|NCT01953926|453173726|FG003|Overall Study|Not Treated|0|||
125967955|NCT01953926|453173727|FG004|Overall Study|Not Treated|0|||
125967956|NCT01953926|453173728|FG005|Overall Study|Not Treated|0|||
125967957|NCT01953926|453173729|FG006|Overall Study|Not Treated|0|||
125967958|NCT00144339|453173732|FG000|Overall Study|Adverse Event|746|||
125967959|NCT00144339|453173733|FG001|Overall Study|Adverse Event|627|||
125967960|NCT00144339|453173732|FG000|Overall Study|Protocol Violation|75|||
125967961|NCT00144339|453173733|FG001|Overall Study|Protocol Violation|48|||
125967962|NCT00144339|453173732|FG000|Overall Study|Withdrawal by Subject|403|||
125967963|NCT00144339|453173733|FG001|Overall Study|Withdrawal by Subject|300|||
125967964|NCT00144339|453173732|FG000|Overall Study|Lost to Follow-up|76|||
125967965|NCT00144339|453173733|FG001|Overall Study|Lost to Follow-up|64|||
125967966|NCT00144339|453173732|FG000|Overall Study|Other|58|||
125967967|NCT00144339|453173733|FG001|Overall Study|Other|60|||
125967968|NCT01109992|453173734|FG000|Overall Study|Withdrawal by Subject|0|||
125967969|NCT01109992|453173735|FG001|Overall Study|Withdrawal by Subject|1|||
125967970|NCT01109992|453173734|FG000|Overall Study|Movement during rest scan.|0|||
125967971|NCT01109992|453173735|FG001|Overall Study|Movement during rest scan.|1|||
125967972|NCT02338362|453173738|FG000|Overall Study|Withdrawal by Subject|1|||
125967973|NCT02338362|453173739|FG001|Overall Study|Withdrawal by Subject|1|||
125967974|NCT00690755|453173740|FG000|Overall Study|Physician Decision|2|||
125967975|NCT00690755|453173741|FG001|Overall Study|Physician Decision|0|||
125967976|NCT00690755|453173742|FG002|Overall Study|Physician Decision|46|||
125967977|NCT00690755|453173743|FG003|Overall Study|Physician Decision|5|||
125967978|NCT00690755|453173744|FG004|Overall Study|Physician Decision|0|||
125967979|NCT00690755|453173745|FG005|Overall Study|Physician Decision|4|||
125967980|NCT00690755|453173746|FG006|Overall Study|Physician Decision|0|||
125967981|NCT03585244|453173753|FG000|Overall Study|Withdrawal by Subject|15|||
125967982|NCT01764945|453173756|FG000|Overall Study|Adverse Event|0|||
125967983|NCT01764945|453173757|FG001|Overall Study|Adverse Event|1|||
125967984|NCT01764945|453173758|FG002|Overall Study|Adverse Event|0|||
125967985|NCT01764945|453173759|FG003|Overall Study|Adverse Event|0|||
125967986|NCT01764945|453173760|FG004|Overall Study|Adverse Event|0|||
125967987|NCT01764945|453173761|FG005|Overall Study|Adverse Event|0|||
125967988|NCT01764945|453173762|FG006|Overall Study|Adverse Event|1|||
125967989|NCT01764945|453173763|FG007|Overall Study|Adverse Event|0|||
125967990|NCT05077267|453173764|FG000|Treatment Period|Lost to Follow-up|0|||
125967991|NCT05077267|453173765|FG001|Treatment Period|Lost to Follow-up|1|||
125967992|NCT05077267|453173766|FG002|Treatment Period|Lost to Follow-up|0|||
125967993|NCT05077267|453173764|FG000|Treatment Period|Withdrawal by Subject|0|||
125967994|NCT05077267|453173765|FG001|Treatment Period|Withdrawal by Subject|1|||
125967995|NCT05077267|453173766|FG002|Treatment Period|Withdrawal by Subject|0|||
125967996|NCT05077267|453173764|FG000|Follow-up Period|Lost to Follow-up|0|||
125967997|NCT05077267|453173765|FG001|Follow-up Period|Lost to Follow-up|5|||
125967998|NCT05077267|453173766|FG002|Follow-up Period|Lost to Follow-up|7|||
126135174|NCT01622569|453785224|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
125967999|NCT05077267|453173764|FG000|Follow-up Period|Withdrawal by Subject|0|||
125968000|NCT05077267|453173765|FG001|Follow-up Period|Withdrawal by Subject|2|||
125968001|NCT05077267|453173766|FG002|Follow-up Period|Withdrawal by Subject|5|||
125968002|NCT05077267|453173764|FG000|Follow-up Period|Study terminated by sponsor|0|||
125968003|NCT05077267|453173765|FG001|Follow-up Period|Study terminated by sponsor|27|||
125968004|NCT05077267|453173766|FG002|Follow-up Period|Study terminated by sponsor|23|||
125968005|NCT05077267|453173764|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
125968006|NCT05077267|453173765|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
125968007|NCT05077267|453173766|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
125968008|NCT05077267|453173764|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
125968009|NCT05077267|453173765|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
125968010|NCT05077267|453173766|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
126135175|NCT01622569|453785225|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
126135176|NCT01622569|453785226|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
126135177|NCT01622569|453785223|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
126135178|NCT01622569|453785224|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
126135179|NCT01622569|453785225|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
126135180|NCT01622569|453785226|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
126135181|NCT01622569|453785223|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126135182|NCT01622569|453785224|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
126135183|NCT01622569|453785225|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126135184|NCT01622569|453785226|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
126135185|NCT01622569|453785223|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
126135186|NCT01622569|453785224|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
126135187|NCT01622569|453785225|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
126135188|NCT01622569|453785226|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
126135189|NCT01622569|453785223|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
126135190|NCT01622569|453785224|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
125968011|NCT02911948|453173767|FG000|Overall Study|Protocol Violation|0|||
125968012|NCT02911948|453173768|FG001|Overall Study|Protocol Violation|1|||
125968013|NCT02911948|453173767|FG000|Overall Study|Withdrawal by Subject|0|||
125968014|NCT02911948|453173768|FG001|Overall Study|Withdrawal by Subject|2|||
125968015|NCT02911948|453173767|FG000|Overall Study|Lack of Efficacy|0|||
125968016|NCT02911948|453173768|FG001|Overall Study|Lack of Efficacy|1|||
125968017|NCT02911948|453173767|FG000|Overall Study|Unclassified|0|||
125968018|NCT02911948|453173768|FG001|Overall Study|Unclassified|3|||
125968019|NCT00586105|453173769|FG000|Overall Study|Adverse Event|4|||
125968020|NCT00586105|453173769|FG000|Overall Study|Death|2|||
125968021|NCT00586105|453173769|FG000|Overall Study|Protocol Violation|1|||
125968022|NCT00586105|453173769|FG000|Overall Study|Withdrawal by Subject|3|||
125968023|NCT00586105|453173769|FG000|Overall Study|Disease progression|19|||
125968024|NCT00586105|453173769|FG000|Overall Study|Switched to commercial drug|9|||
125968025|NCT00586105|453173769|FG000|Overall Study|Reason not reported|1|||
125968026|NCT03835533|453173771|FG000|Overall Study|Death|5|||
125968027|NCT03835533|453173772|FG001|Overall Study|Death|10|||
125968028|NCT03835533|453173773|FG002|Overall Study|Death|9|||
125968029|NCT03835533|453173771|FG000|Overall Study|Withdrawal by Subject|2|||
125968030|NCT03835533|453173772|FG001|Overall Study|Withdrawal by Subject|2|||
125968031|NCT03835533|453173773|FG002|Overall Study|Withdrawal by Subject|2|||
125968032|NCT03835533|453173771|FG000|Overall Study|Lost to Follow-up|1|||
125968033|NCT03835533|453173772|FG001|Overall Study|Lost to Follow-up|0|||
125968034|NCT03835533|453173773|FG002|Overall Study|Lost to Follow-up|0|||
125968035|NCT03867734|453173774|FG000|Overall Study|Lost to Follow-up|2|||
125968036|NCT01136291|453173775|FG000|Overall Study|Lost to Follow-up|1|||
125968037|NCT01136291|453173776|FG001|Overall Study|Lost to Follow-up|1|||
125968038|NCT02308033|453173779|FG000|Overall Study|Normal Gram stain at Baseline|13|||
125968039|NCT02308033|453173780|FG001|Overall Study|Normal Gram stain at Baseline|10|||
125968040|NCT02308033|453173779|FG000|Overall Study|Positive for STD at Baseline|7|||
125968041|NCT02308033|453173780|FG001|Overall Study|Positive for STD at Baseline|4|||
125968042|NCT02308033|453173779|FG000|Overall Study|Lost to Follow-up|6|||
125968043|NCT02308033|453173780|FG001|Overall Study|Lost to Follow-up|5|||
125968044|NCT01870843|453173786|FG000|Overall Study|Adverse Event|10|||
125968045|NCT01870843|453173786|FG000|Overall Study|Lost to Follow-up|24|||
125968046|NCT01870843|453173786|FG000|Overall Study|Death|1|||
125968047|NCT01870843|453173786|FG000|Overall Study|Withdrawal by Subject|18|||
125968048|NCT03021187|453173787|FG000|Overall Study|Death|0|||
125968049|NCT03021187|453173788|FG001|Overall Study|Death|0|||
125968050|NCT03021187|453173789|FG002|Overall Study|Death|3|||
125968051|NCT03021187|453173790|FG003|Overall Study|Death|0|||
125968052|NCT03021187|453173787|FG000|Overall Study|Withdrawal by Subject|0|||
125968053|NCT03021187|453173788|FG001|Overall Study|Withdrawal by Subject|6|||
125968054|NCT03021187|453173789|FG002|Overall Study|Withdrawal by Subject|2|||
125968055|NCT03021187|453173790|FG003|Overall Study|Withdrawal by Subject|5|||
125968056|NCT03021187|453173787|FG000|Overall Study|Lost to Follow-up|10|||
125968057|NCT03021187|453173788|FG001|Overall Study|Lost to Follow-up|3|||
125968058|NCT03021187|453173789|FG002|Overall Study|Lost to Follow-up|1|||
125968059|NCT03021187|453173790|FG003|Overall Study|Lost to Follow-up|4|||
125968060|NCT01664078|453173791|FG000|Overall Study|Death|9|||
125968061|NCT01664078|453173791|FG000|Overall Study|Withdrawal by Subject|4|||
125968062|NCT01664078|453173791|FG000|Overall Study|Lost to Follow-up|2|||
125968063|NCT01664078|453173791|FG000|Overall Study|missed 5 year visit|1|||
125968064|NCT01664078|453173791|FG000|Overall Study|Other|53|||
126135191|NCT01622569|453785225|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
126135192|NCT01622569|453785226|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
126135193|NCT01622569|453785223|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
126135194|NCT01622569|453785224|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
126135195|NCT01622569|453785225|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
126135196|NCT01622569|453785226|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
126135197|NCT01622569|453785223|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126135198|NCT01622569|453785224|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126135199|NCT01622569|453785225|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126135200|NCT01622569|453785226|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
126135201|NCT01001702|453785227|FG000|Overall Study|Lost to Follow-up|7|||
126135202|NCT01001702|453785227|FG000|Overall Study|Adverse Event|7|||
126135203|NCT01001702|453785227|FG000|Overall Study|Sponsor Discontinued Study|4|||
126135204|NCT01001702|453785227|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
126135205|NCT01001702|453785227|FG000|Overall Study|Investigator withdrew Subject|10|||
126135206|NCT01001702|453785227|FG000|Overall Study|Withdrawal by Subject|19|||
126135207|NCT01001702|453785227|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
126135208|NCT02222714|453785230|FG000|Overall Study|Death|0|||
126135209|NCT02222714|453785231|FG001|Overall Study|Death|2|||
126135210|NCT02222714|453785232|FG002|Overall Study|Death|3|||
126135211|NCT02222714|453785233|FG003|Overall Study|Death|4|||
126135212|NCT02222714|453785234|FG004|Overall Study|Death|6|||
126135213|NCT02222714|453785230|FG000|Overall Study|Withdrawal by Subject|0|||
126135214|NCT02222714|453785231|FG001|Overall Study|Withdrawal by Subject|0|||
126135215|NCT02222714|453785232|FG002|Overall Study|Withdrawal by Subject|1|||
126135216|NCT02222714|453785233|FG003|Overall Study|Withdrawal by Subject|0|||
126135217|NCT02222714|453785234|FG004|Overall Study|Withdrawal by Subject|1|||
126135218|NCT01940484|453785235|FG000|Overall Study|Withdrawal by Subject|3|||
126135219|NCT01940484|453785235|FG000|Overall Study|Underwent transplantation|4|||
126135220|NCT01940484|453785235|FG000|Overall Study|Death|2|||
125968065|NCT00363766|453173801|FG000|Overall Study|Progressive Disease|15|||
125968066|NCT00363766|453173802|FG001|Overall Study|Progressive Disease|9|||
125968067|NCT00363766|453173801|FG000|Overall Study|Adverse Event|10|||
125968068|NCT00363766|453173802|FG001|Overall Study|Adverse Event|2|||
126135221|NCT01940484|453785235|FG000|Overall Study|Adverse Event|1|||
126135222|NCT01285908|453785236|FG000|Baseline Measurement|unable to insert catheter|1|||
126135223|NCT01285908|453785237|FG001|Baseline Measurement|unable to insert catheter|0|||
126135224|NCT01285908|453785238|FG002|Baseline Measurement|unable to insert catheter|0|||
126135225|NCT01285908|453785236|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
126135226|NCT01285908|453785237|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
126135227|NCT01285908|453785238|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
126135228|NCT01285908|453785236|FG000|Baseline Measurement|unable to tolerate procedure|1|||
126135229|NCT01285908|453785237|FG001|Baseline Measurement|unable to tolerate procedure|0|||
126135230|NCT01285908|453785238|FG002|Baseline Measurement|unable to tolerate procedure|0|||
126135231|NCT00643994|453785243|FG000|Overall Study|Death|24|||
126135232|NCT00643994|453785243|FG000|Overall Study|Lost to Follow-up|72|||
126135233|NCT04823949|453785244|FG000|Overall Study|Withdrawal by Subject|0|||
126135234|NCT04823949|453785245|FG001|Overall Study|Withdrawal by Subject|4|||
126135235|NCT04823949|453785244|FG000|Overall Study|Physician Decision|0|||
126135236|NCT04823949|453785245|FG001|Overall Study|Physician Decision|1|||
126135237|NCT04317274|453785246|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
126135238|NCT04317274|453785247|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
126135239|NCT04317274|453785248|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
126135240|NCT04317274|453785249|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
126135241|NCT00797823|453785251|FG000|First Period (Initial Randomization)|Physician Decision|1|||
126135242|NCT00797823|453785252|FG001|First Period (Initial Randomization)|Physician Decision|0|||
126135243|NCT00797823|453785253|FG002|First Period (Initial Randomization)|Physician Decision|0|||
126135244|NCT02568046|453785254|FG000|Overall Study|Adverse Event|0|||
126135245|NCT02568046|453785255|FG001|Overall Study|Adverse Event|1|||
126135246|NCT02568046|453785254|FG000|Overall Study|Death|2|||
126135247|NCT02568046|453785255|FG001|Overall Study|Death|0|||
126135248|NCT02568046|453785254|FG000|Overall Study|Progressive Disease|1|||
126135249|NCT02568046|453785255|FG001|Overall Study|Progressive Disease|0|||
126135250|NCT02568046|453785254|FG000|Overall Study|Withdrawal by Subject|2|||
126135251|NCT02568046|453785255|FG001|Overall Study|Withdrawal by Subject|1|||
126135252|NCT02568046|453785254|FG000|Overall Study|Other Events|0|||
126135253|NCT02568046|453785255|FG001|Overall Study|Other Events|1|||
126135254|NCT01127165|453785261|FG000|Overall Study|Adverse Event|2|||
126135255|NCT01127165|453785262|FG001|Overall Study|Adverse Event|2|||
126135256|NCT01127165|453785261|FG000|Overall Study|Lack of Efficacy|10|||
125968069|NCT00363766|453173801|FG000|Overall Study|Disease Related Death|1|||
125968070|NCT00363766|453173802|FG001|Overall Study|Disease Related Death|3|||
126135257|NCT01127165|453785262|FG001|Overall Study|Lack of Efficacy|8|||
126135258|NCT01127165|453785261|FG000|Overall Study|Lost to Follow-up|3|||
126135259|NCT01127165|453785262|FG001|Overall Study|Lost to Follow-up|5|||
126135260|NCT01127165|453785261|FG000|Overall Study|Withdrawal by Subject|1|||
126135261|NCT01127165|453785262|FG001|Overall Study|Withdrawal by Subject|3|||
126135262|NCT01127165|453785261|FG000|Overall Study|Protocol Violation|0|||
126135263|NCT01127165|453785262|FG001|Overall Study|Protocol Violation|1|||
126135264|NCT00379795|453785263|FG000|Overall Study|Death|31|||
126135265|NCT00379795|453785264|FG001|Overall Study|Death|8|||
126135266|NCT00379795|453785265|FG002|Overall Study|Death|6|||
126135267|NCT00379795|453785266|FG003|Overall Study|Death|4|||
126135268|NCT00379795|453785267|FG004|Overall Study|Death|7|||
126135269|NCT00379795|453785263|FG000|Overall Study|Adverse Event|17|||
126135270|NCT00379795|453785264|FG001|Overall Study|Adverse Event|3|||
126135271|NCT00379795|453785265|FG002|Overall Study|Adverse Event|3|||
126135272|NCT00379795|453785266|FG003|Overall Study|Adverse Event|1|||
126135273|NCT00379795|453785267|FG004|Overall Study|Adverse Event|4|||
126135274|NCT00379795|453785263|FG000|Overall Study|Lost to Follow-up|8|||
126135275|NCT00379795|453785264|FG001|Overall Study|Lost to Follow-up|1|||
126135276|NCT00379795|453785265|FG002|Overall Study|Lost to Follow-up|2|||
126135277|NCT00379795|453785266|FG003|Overall Study|Lost to Follow-up|1|||
126135278|NCT00379795|453785267|FG004|Overall Study|Lost to Follow-up|4|||
126135279|NCT00379795|453785263|FG000|Overall Study|Physician Decision|25|||
126135280|NCT00379795|453785264|FG001|Overall Study|Physician Decision|0|||
126135281|NCT00379795|453785265|FG002|Overall Study|Physician Decision|2|||
126135282|NCT00379795|453785266|FG003|Overall Study|Physician Decision|2|||
126135283|NCT00379795|453785267|FG004|Overall Study|Physician Decision|2|||
126135284|NCT00379795|453785263|FG000|Overall Study|Withdrawal by Subject|94|||
126135285|NCT00379795|453785264|FG001|Overall Study|Withdrawal by Subject|11|||
126135286|NCT00379795|453785265|FG002|Overall Study|Withdrawal by Subject|19|||
126135287|NCT00379795|453785266|FG003|Overall Study|Withdrawal by Subject|7|||
126135288|NCT00379795|453785267|FG004|Overall Study|Withdrawal by Subject|14|||
126135289|NCT00379795|453785263|FG000|Overall Study|Subject non-compliance|7|||
125968071|NCT00363766|453173801|FG000|Overall Study|Not Disease Related Death|3|||
125968072|NCT00363766|453173802|FG001|Overall Study|Not Disease Related Death|4|||
125968073|NCT00363766|453173801|FG000|Overall Study|Withdrawal by Subject|2|||
125968074|NCT00363766|453173802|FG001|Overall Study|Withdrawal by Subject|0|||
125968075|NCT00363766|453173801|FG000|Overall Study|Physician Decision|1|||
125968076|NCT00363766|453173802|FG001|Overall Study|Physician Decision|2|||
125968077|NCT00558285|453173803|FG000|Overall Study|Adverse Event|1|||
125968078|NCT00558285|453173804|FG001|Overall Study|Adverse Event|1|||
125968079|NCT00558285|453173805|FG002|Overall Study|Adverse Event|4|||
125968080|NCT00558285|453173806|FG003|Overall Study|Adverse Event|1|||
125968081|NCT00558285|453173807|FG004|Overall Study|Adverse Event|2|||
125968082|NCT00558285|453173803|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125968083|NCT00558285|453173804|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125968084|NCT00558285|453173805|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125968085|NCT00558285|453173806|FG003|Overall Study|Abnormal test procedure result(s)|0|||
125968086|NCT00558285|453173807|FG004|Overall Study|Abnormal test procedure result(s)|0|||
125968087|NCT00558285|453173803|FG000|Overall Study|Subject withdrew consent|2|||
125968088|NCT00558285|453173804|FG001|Overall Study|Subject withdrew consent|0|||
125968089|NCT00558285|453173805|FG002|Overall Study|Subject withdrew consent|1|||
125968090|NCT00558285|453173806|FG003|Overall Study|Subject withdrew consent|1|||
125968091|NCT00558285|453173807|FG004|Overall Study|Subject withdrew consent|1|||
125968092|NCT00558285|453173803|FG000|Overall Study|Lost to Follow-up|1|||
125968093|NCT00558285|453173804|FG001|Overall Study|Lost to Follow-up|1|||
125968094|NCT00558285|453173805|FG002|Overall Study|Lost to Follow-up|0|||
125968095|NCT00558285|453173806|FG003|Overall Study|Lost to Follow-up|0|||
125968096|NCT00558285|453173807|FG004|Overall Study|Lost to Follow-up|0|||
125968097|NCT00558285|453173803|FG000|Overall Study|Administrative problems|0|||
125968098|NCT00558285|453173804|FG001|Overall Study|Administrative problems|0|||
125968099|NCT00558285|453173805|FG002|Overall Study|Administrative problems|0|||
125968100|NCT00558285|453173806|FG003|Overall Study|Administrative problems|1|||
125968101|NCT00558285|453173807|FG004|Overall Study|Administrative problems|1|||
125968102|NCT00558285|453173803|FG000|Overall Study|Protocol deviation|1|||
125968103|NCT00558285|453173804|FG001|Overall Study|Protocol deviation|1|||
125968104|NCT00558285|453173805|FG002|Overall Study|Protocol deviation|0|||
126135290|NCT00379795|453785264|FG001|Overall Study|Subject non-compliance|2|||
126135291|NCT00379795|453785265|FG002|Overall Study|Subject non-compliance|0|||
126135292|NCT00379795|453785266|FG003|Overall Study|Subject non-compliance|0|||
126135293|NCT00379795|453785267|FG004|Overall Study|Subject non-compliance|1|||
126135294|NCT00379795|453785263|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
125968105|NCT00558285|453173806|FG003|Overall Study|Protocol deviation|1|||
125968106|NCT00558285|453173807|FG004|Overall Study|Protocol deviation|0|||
125968107|NCT02730819|453173808|FG000|Overall Study|Lost to Follow-up|9|||
125968108|NCT01660906|453173809|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
126135295|NCT00379795|453785264|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
126135296|NCT00379795|453785265|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
125968109|NCT02121847|453173810|FG000|Overall Study|Administrative Reasons|1|||
125968110|NCT02121847|453173810|FG000|Overall Study|Adverse Event|2|||
125968111|NCT00809757|453173817|FG000|Overall Study|Adverse Event|2|||
125968112|NCT00809757|453173818|FG001|Overall Study|Adverse Event|3|||
125968113|NCT00809757|453173819|FG002|Overall Study|Adverse Event|3|||
125968114|NCT00809757|453173817|FG000|Overall Study|Lost to Follow-up|0|||
125968115|NCT00809757|453173818|FG001|Overall Study|Lost to Follow-up|0|||
125968116|NCT00809757|453173819|FG002|Overall Study|Lost to Follow-up|1|||
125968117|NCT00809757|453173817|FG000|Overall Study|Protocol Violation|1|||
125968118|NCT00809757|453173818|FG001|Overall Study|Protocol Violation|1|||
125968119|NCT00809757|453173819|FG002|Overall Study|Protocol Violation|1|||
125968120|NCT00809757|453173817|FG000|Overall Study|Withdrawal by Subject|2|||
125968121|NCT00809757|453173818|FG001|Overall Study|Withdrawal by Subject|1|||
125968122|NCT00809757|453173819|FG002|Overall Study|Withdrawal by Subject|3|||
125968123|NCT00809757|453173817|FG000|Overall Study|Subject Uncooperative|1|||
125968124|NCT00809757|453173818|FG001|Overall Study|Subject Uncooperative|0|||
125968125|NCT00809757|453173819|FG002|Overall Study|Subject Uncooperative|2|||
125968126|NCT00809757|453173817|FG000|Overall Study|Noncompliance with Medication|0|||
125968127|NCT00809757|453173818|FG001|Overall Study|Noncompliance with Medication|0|||
125968128|NCT00809757|453173819|FG002|Overall Study|Noncompliance with Medication|1|||
125968129|NCT00659334|453173820|FG000|Overall Study|Screen Failure|8|||
125968130|NCT00659334|453173821|FG001|Overall Study|Screen Failure|5|||
125968131|NCT00659334|453173822|FG002|Overall Study|Screen Failure|0|||
125968132|NCT00659334|453173823|FG003|Overall Study|Screen Failure|0|||
125968133|NCT00659334|453173824|FG004|Overall Study|Screen Failure|0|||
125968134|NCT00659334|453173825|FG005|Overall Study|Screen Failure|0|||
125968135|NCT00659334|453173826|FG006|Overall Study|Screen Failure|1|||
125968136|NCT00253864|453173827|FG000|Overall Study|Lost to Follow-up|5|||
125968137|NCT00253864|453173828|FG001|Overall Study|Lost to Follow-up|8|||
125968138|NCT01174342|453173832|FG000|Overall Study|Conversion to cesarean section|4|||
125968139|NCT01410448|453173833|FG000|Overall Study|No conversion to everolimus|0|||
125968140|NCT01410448|453173834|FG001|Overall Study|No conversion to everolimus|24|||
125968141|NCT01410448|453173833|FG000|Overall Study|Graft loss|4|||
125968142|NCT01410448|453173834|FG001|Overall Study|Graft loss|1|||
125968143|NCT01410448|453173833|FG000|Overall Study|Administrative issues|2|||
125968144|NCT01410448|453173834|FG001|Overall Study|Administrative issues|1|||
125968145|NCT01410448|453173833|FG000|Overall Study|Lost to Follow-up|1|||
125968146|NCT01410448|453173834|FG001|Overall Study|Lost to Follow-up|0|||
125968147|NCT01410448|453173833|FG000|Overall Study|Withdrawal by Subject|3|||
125968148|NCT01410448|453173834|FG001|Overall Study|Withdrawal by Subject|2|||
125968149|NCT01410448|453173833|FG000|Overall Study|Protocol Violation|0|||
125968150|NCT01410448|453173834|FG001|Overall Study|Protocol Violation|4|||
125968151|NCT01410448|453173833|FG000|Overall Study|Death|2|||
125968152|NCT01410448|453173834|FG001|Overall Study|Death|3|||
125968153|NCT01308580|453173835|FG000|Overall Study|Lost to Follow-up|12|||
125968154|NCT01308580|453173836|FG001|Overall Study|Lost to Follow-up|7|||
125968155|NCT00360529|453173837|FG000|Overall Study|Adverse Event|10|||
125968156|NCT00360529|453173838|FG001|Overall Study|Adverse Event|23|||
125968157|NCT00360529|453173839|FG002|Overall Study|Adverse Event|33|||
125968158|NCT00360529|453173837|FG000|Overall Study|Protocol Violation|3|||
125968159|NCT00360529|453173838|FG001|Overall Study|Protocol Violation|3|||
125968160|NCT00360529|453173839|FG002|Overall Study|Protocol Violation|11|||
125968161|NCT00360529|453173837|FG000|Overall Study|Lost to Follow-up|14|||
125968162|NCT00360529|453173838|FG001|Overall Study|Lost to Follow-up|10|||
125968163|NCT00360529|453173839|FG002|Overall Study|Lost to Follow-up|13|||
125968164|NCT00360529|453173837|FG000|Overall Study|Withdrawal by Subject|22|||
125968165|NCT00360529|453173838|FG001|Overall Study|Withdrawal by Subject|14|||
125968166|NCT00360529|453173839|FG002|Overall Study|Withdrawal by Subject|18|||
126135297|NCT00379795|453785266|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
126135298|NCT00379795|453785267|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
125968167|NCT00360529|453173837|FG000|Overall Study|Lack of Efficacy|8|||
125968168|NCT00360529|453173838|FG001|Overall Study|Lack of Efficacy|6|||
125968169|NCT00360529|453173839|FG002|Overall Study|Lack of Efficacy|5|||
125968170|NCT00360529|453173837|FG000|Overall Study|Reason discontinued not explained above|4|||
125968171|NCT00360529|453173838|FG001|Overall Study|Reason discontinued not explained above|9|||
125968172|NCT00360529|453173839|FG002|Overall Study|Reason discontinued not explained above|11|||
125968173|NCT03712917|453173840|FG000|Overall Study|Pregnancy|0|||
125968174|NCT03712917|453173841|FG001|Overall Study|Pregnancy|0|||
125968175|NCT03712917|453173842|FG002|Overall Study|Pregnancy|1|||
125968176|NCT03712917|453173840|FG000|Overall Study|Adverse Event|0|||
125968177|NCT03712917|453173841|FG001|Overall Study|Adverse Event|4|||
125968178|NCT03712917|453173842|FG002|Overall Study|Adverse Event|3|||
125968179|NCT03712917|453173840|FG000|Overall Study|Lost to Follow-up|9|||
125968180|NCT03712917|453173841|FG001|Overall Study|Lost to Follow-up|4|||
125968181|NCT03712917|453173842|FG002|Overall Study|Lost to Follow-up|5|||
125968182|NCT04295564|453175729|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
125968183|NCT04295564|453175730|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
125968184|NCT01682460|453175731|FG000|Overall Study|Withdrawal by Subject|2|||
125968185|NCT01682460|453175731|FG000|Overall Study|Did not meet inclusion criteria|2|||
125968186|NCT00724282|453175733|FG000|Overall Study|Withdrawal by Subject|3|||
125968187|NCT00724282|453175733|FG000|Overall Study|Physician Decision|1|||
125968188|NCT01159691|453175734|FG000|Overall Study|Lost to Follow-up|2|||
125968189|NCT01159691|453175734|FG000|Overall Study|Unknown reasons|1|||
125968190|NCT01159691|453175734|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
125968191|NCT01159691|453175734|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
125968192|NCT01159691|453175734|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
125968193|NCT01159691|453175734|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
125968194|NCT01159691|453175734|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
125968195|NCT01159691|453175734|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
125968196|NCT01928719|453175735|FG000|Overall Study|Lost to Follow-up|26|||
125968197|NCT01928719|453175736|FG001|Overall Study|Lost to Follow-up|11|||
125968198|NCT01928719|453175735|FG000|Overall Study|Withdrawal by Subject|22|||
125968199|NCT01928719|453175736|FG001|Overall Study|Withdrawal by Subject|7|||
125968200|NCT01928719|453175735|FG000|Overall Study|Protocol Violation|3|||
126135299|NCT00379795|453785263|FG000|Overall Study|Subjects condition mandated intervention|34|||
126135300|NCT00379795|453785264|FG001|Overall Study|Subjects condition mandated intervention|9|||
126135301|NCT00379795|453785265|FG002|Overall Study|Subjects condition mandated intervention|7|||
126135302|NCT00379795|453785266|FG003|Overall Study|Subjects condition mandated intervention|5|||
126135303|NCT00379795|453785267|FG004|Overall Study|Subjects condition mandated intervention|7|||
126135304|NCT00379795|453785263|FG000|Overall Study|Sponsor's decision|257|||
126135305|NCT00379795|453785264|FG001|Overall Study|Sponsor's decision|17|||
126135306|NCT00379795|453785265|FG002|Overall Study|Sponsor's decision|54|||
126135307|NCT00379795|453785266|FG003|Overall Study|Sponsor's decision|47|||
126135308|NCT00379795|453785267|FG004|Overall Study|Sponsor's decision|10|||
126135309|NCT03175549|453785268|FG000|Overall Study|Lost to Follow-up|2|||
126135310|NCT03175549|453785269|FG001|Overall Study|Lost to Follow-up|2|||
126135311|NCT03175549|453785268|FG000|Overall Study|Medication non-compliance|2|||
126135312|NCT03175549|453785269|FG001|Overall Study|Medication non-compliance|2|||
126135313|NCT00763321|453785270|FG000|Open-label Period|Adverse Event|24|||
126135314|NCT00763321|453785271|FG001|Open-label Period|Adverse Event|0|||
126135315|NCT00763321|453785272|FG002|Open-label Period|Adverse Event|0|||
126135316|NCT00763321|453785270|FG000|Open-label Period|Lost to Follow-up|14|||
126135317|NCT00763321|453785271|FG001|Open-label Period|Lost to Follow-up|0|||
126135318|NCT00763321|453785272|FG002|Open-label Period|Lost to Follow-up|0|||
126135319|NCT00763321|453785270|FG000|Open-label Period|Withdrawal by Subject|7|||
126135320|NCT00763321|453785271|FG001|Open-label Period|Withdrawal by Subject|0|||
126135321|NCT00763321|453785272|FG002|Open-label Period|Withdrawal by Subject|0|||
126135322|NCT00763321|453785270|FG000|Open-label Period|Subject noncompliant|7|||
126135323|NCT00763321|453785271|FG001|Open-label Period|Subject noncompliant|0|||
126135324|NCT00763321|453785272|FG002|Open-label Period|Subject noncompliant|0|||
126135325|NCT00763321|453785270|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
126135326|NCT00763321|453785271|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
126135327|NCT00763321|453785272|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
126135328|NCT00763321|453785270|FG000|Open-label Period|Lack of Efficacy|2|||
126135329|NCT00763321|453785271|FG001|Open-label Period|Lack of Efficacy|0|||
126135330|NCT00763321|453785272|FG002|Open-label Period|Lack of Efficacy|0|||
126135331|NCT00763321|453785270|FG000|Open-label Period|Other|4|||
126135332|NCT00763321|453785271|FG001|Open-label Period|Other|0|||
126135333|NCT00763321|453785272|FG002|Open-label Period|Other|0|||
126135334|NCT00763321|453785270|FG000|Double-blind Period|Lack of Efficacy|0|||
126135335|NCT00763321|453785271|FG001|Double-blind Period|Lack of Efficacy|9|||
126135336|NCT00763321|453785272|FG002|Double-blind Period|Lack of Efficacy|17|||
126135337|NCT00763321|453785270|FG000|Double-blind Period|Adverse Event|0|||
126135338|NCT00763321|453785271|FG001|Double-blind Period|Adverse Event|4|||
126135339|NCT00763321|453785272|FG002|Double-blind Period|Adverse Event|4|||
126135340|NCT00763321|453785270|FG000|Double-blind Period|Lost to Follow-up|0|||
126135341|NCT00763321|453785271|FG001|Double-blind Period|Lost to Follow-up|4|||
126135342|NCT00763321|453785272|FG002|Double-blind Period|Lost to Follow-up|2|||
126135343|NCT00763321|453785270|FG000|Double-blind Period|Withdrawal by Subject|0|||
126135344|NCT00763321|453785271|FG001|Double-blind Period|Withdrawal by Subject|2|||
126135345|NCT00763321|453785272|FG002|Double-blind Period|Withdrawal by Subject|3|||
126135346|NCT00763321|453785270|FG000|Double-blind Period|Other|0|||
126135347|NCT00763321|453785271|FG001|Double-blind Period|Other|2|||
126135348|NCT00763321|453785272|FG002|Double-blind Period|Other|3|||
126135349|NCT02435849|453785273|FG000|Overall Study|Death|23|||
125968201|NCT01928719|453175736|FG001|Overall Study|Protocol Violation|1|||
125968202|NCT01928719|453175735|FG000|Overall Study|Adverse Event|1|||
125968203|NCT01928719|453175736|FG001|Overall Study|Adverse Event|0|||
125968204|NCT00773968|453175742|FG000|Overall Study|Adverse Event|2|||
125968205|NCT00773968|453175742|FG000|Overall Study|Death|1|||
125968206|NCT00773968|453175742|FG000|Overall Study|Failure to Return|2|||
126135350|NCT02435849|453785274|FG001|Overall Study|Death|0|||
126135351|NCT02435849|453785273|FG000|Overall Study|Lack of Efficacy|10|||
126135352|NCT02435849|453785274|FG001|Overall Study|Lack of Efficacy|0|||
126135353|NCT02435849|453785273|FG000|Overall Study|New therapy for study indication|8|||
126135354|NCT02435849|453785274|FG001|Overall Study|New therapy for study indication|0|||
126135355|NCT02435849|453785273|FG000|Overall Study|Subject/guardian decision|5|||
126135356|NCT02435849|453785274|FG001|Overall Study|Subject/guardian decision|1|||
126135357|NCT02435849|453785273|FG000|Overall Study|Lost to Follow-up|1|||
126135358|NCT02435849|453785274|FG001|Overall Study|Lost to Follow-up|0|||
126135359|NCT02435849|453785273|FG000|Overall Study|Physician Decision|1|||
126135360|NCT02435849|453785274|FG001|Overall Study|Physician Decision|0|||
126135361|NCT02486757|453785275|FG000|Overall Study|Lost to Follow-up|1|||
126135362|NCT04849780|453785276|FG000|Period 1|Covid-19 Related|1|||
126135363|NCT04849780|453785277|FG001|Period 1|Covid-19 Related|0|||
126135364|NCT04849780|453785276|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
126135365|NCT04849780|453785277|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
126135366|NCT04849780|453785276|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
126135367|NCT04849780|453785277|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
126135368|NCT01405053|453785278|FG000|Overall Study|Adverse Event|3|||
126135369|NCT01405053|453785279|FG001|Overall Study|Adverse Event|0|||
126135370|NCT01405053|453785278|FG000|Overall Study|Lost to Follow-up|0|||
126135371|NCT01405053|453785279|FG001|Overall Study|Lost to Follow-up|1|||
126135372|NCT01405053|453785278|FG000|Overall Study|Participant choice|2|||
126135373|NCT01405053|453785279|FG001|Overall Study|Participant choice|1|||
126135374|NCT01405053|453785278|FG000|Overall Study|Inadequate therapeutic effect|2|||
126135375|NCT01405053|453785279|FG001|Overall Study|Inadequate therapeutic effect|1|||
126135376|NCT01405053|453785278|FG000|Overall Study|Withdrawal by Subject|3|||
126135377|NCT01405053|453785279|FG001|Overall Study|Withdrawal by Subject|4|||
126135378|NCT01405053|453785278|FG000|Overall Study|Other|0|||
126135379|NCT01405053|453785279|FG001|Overall Study|Other|1|||
126135380|NCT00993928|453785280|FG000|Overall Study|Withdrawal by Subject|4|||
126135381|NCT00993928|453785281|FG001|Overall Study|Withdrawal by Subject|7|||
126135382|NCT00993928|453785280|FG000|Overall Study|ineligible|1|||
126135383|NCT00993928|453785281|FG001|Overall Study|ineligible|0|||
126135384|NCT01816243|453785282|FG000|Overall Study|Adverse Event|6|||
126135385|NCT01816243|453785282|FG000|Overall Study|Lost to Follow-up|1|||
126135386|NCT01816243|453785282|FG000|Overall Study|Lack of Efficacy|1|||
126135387|NCT01816243|453785282|FG000|Overall Study|Not eligible for the study|1|||
126135388|NCT01816243|453785282|FG000|Overall Study|Amputation|3|||
126135389|NCT02319044|453785283|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
126135390|NCT02319044|453785284|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
126135391|NCT02319044|453785285|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
126135392|NCT02319044|453785283|FG000|Overall Study|Withdrawal by Subject|3|||
126135393|NCT02319044|453785284|FG001|Overall Study|Withdrawal by Subject|3|||
126135394|NCT02319044|453785285|FG002|Overall Study|Withdrawal by Subject|6|||
126135395|NCT02319044|453785283|FG000|Overall Study|Condition under investigation worsened|100|||
126135396|NCT02319044|453785284|FG001|Overall Study|Condition under investigation worsened|50|||
126135397|NCT02319044|453785285|FG002|Overall Study|Condition under investigation worsened|46|||
126135398|NCT02319044|453785283|FG000|Overall Study|Adverse Event|17|||
126135399|NCT02319044|453785284|FG001|Overall Study|Adverse Event|2|||
126135400|NCT02319044|453785285|FG002|Overall Study|Adverse Event|8|||
126135401|NCT02319044|453785283|FG000|Overall Study|Study specific discontinuation criteria|2|||
126135402|NCT02319044|453785284|FG001|Overall Study|Study specific discontinuation criteria|2|||
126135403|NCT02319044|453785285|FG002|Overall Study|Study specific discontinuation criteria|1|||
126135404|NCT02319044|453785283|FG000|Overall Study|Not treated|0|||
126135405|NCT02319044|453785284|FG001|Overall Study|Not treated|2|||
126135406|NCT02319044|453785285|FG002|Overall Study|Not treated|2|||
126135407|NCT03434379|453785286|FG000|Global Period|Lost to Follow-up|3|||
125968207|NCT00773968|453175742|FG000|Overall Study|Lack of Efficacy|3|||
125968208|NCT00773968|453175742|FG000|Overall Study|Protocol Violation|1|||
125968209|NCT00773968|453175742|FG000|Overall Study|Withdrawal by Subject|11|||
125968210|NCT00773968|453175742|FG000|Overall Study|Screen Failure|17|||
125968211|NCT00773968|453175742|FG000|Overall Study|Other|8|||
125968212|NCT05706506|453175743|FG000|Overall Study|Adverse Event|1|||
125968213|NCT05706506|453175743|FG000|Overall Study|Withdrawal by Subject|4|||
126135408|NCT03434379|453785287|FG001|Global Period|Lost to Follow-up|6|||
126135409|NCT03434379|453785288|FG002|Global Period|Lost to Follow-up|0|||
126135410|NCT03434379|453785289|FG003|Global Period|Lost to Follow-up|0|||
126135411|NCT03434379|453785286|FG000|Global Period|Death|115|||
126135412|NCT03434379|453785287|FG001|Global Period|Death|228|||
126135413|NCT03434379|453785288|FG002|Global Period|Death|0|||
126135414|NCT03434379|453785289|FG003|Global Period|Death|0|||
126135415|NCT03434379|453785286|FG000|Global Period|Withdrawal by Subject|20|||
125968214|NCT05706506|453175743|FG000|Overall Study|Lost to Follow-up|2|||
125968215|NCT05706506|453175743|FG000|Overall Study|Inadvertent Enrolment|12|||
125968216|NCT05706506|453175743|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
126135416|NCT03434379|453785287|FG001|Global Period|Withdrawal by Subject|21|||
126135417|NCT03434379|453785288|FG002|Global Period|Withdrawal by Subject|0|||
126135418|NCT03434379|453785289|FG003|Global Period|Withdrawal by Subject|0|||
126135419|NCT03434379|453785286|FG000|Global Period|Reason Unspecified|0|||
126135420|NCT03434379|453785287|FG001|Global Period|Reason Unspecified|1|||
126135421|NCT03434379|453785288|FG002|Global Period|Reason Unspecified|0|||
126135422|NCT03434379|453785289|FG003|Global Period|Reason Unspecified|0|||
126135423|NCT03434379|453785286|FG000|Global Period|Study Ended by Sponsor|26|||
126135424|NCT03434379|453785287|FG001|Global Period|Study Ended by Sponsor|80|||
126135425|NCT03434379|453785288|FG002|Global Period|Study Ended by Sponsor|0|||
126135426|NCT03434379|453785289|FG003|Global Period|Study Ended by Sponsor|0|||
126135427|NCT03434379|453785286|FG000|Global Period|Physician Decision|1|||
126135428|NCT03434379|453785287|FG001|Global Period|Physician Decision|0|||
126135429|NCT03434379|453785288|FG002|Global Period|Physician Decision|0|||
126135430|NCT03434379|453785289|FG003|Global Period|Physician Decision|0|||
126135431|NCT03434379|453785286|FG000|China Extension Period|Lost to Follow-up|0|||
126135432|NCT03434379|453785287|FG001|China Extension Period|Lost to Follow-up|0|||
126135433|NCT03434379|453785288|FG002|China Extension Period|Lost to Follow-up|2|||
126135434|NCT03434379|453785289|FG003|China Extension Period|Lost to Follow-up|3|||
126135435|NCT03434379|453785286|FG000|China Extension Period|Death|0|||
126135436|NCT03434379|453785287|FG001|China Extension Period|Death|0|||
126135437|NCT03434379|453785288|FG002|China Extension Period|Death|46|||
126135438|NCT03434379|453785289|FG003|China Extension Period|Death|88|||
126135439|NCT03434379|453785286|FG000|China Extension Period|Withdrawal by Subject|0|||
126135440|NCT03434379|453785287|FG001|China Extension Period|Withdrawal by Subject|0|||
126135441|NCT03434379|453785288|FG002|China Extension Period|Withdrawal by Subject|8|||
126135442|NCT03434379|453785289|FG003|China Extension Period|Withdrawal by Subject|6|||
126135443|NCT03434379|453785286|FG000|China Extension Period|Study Ended by Sponsor|0|||
126135444|NCT03434379|453785287|FG001|China Extension Period|Study Ended by Sponsor|0|||
126135445|NCT03434379|453785288|FG002|China Extension Period|Study Ended by Sponsor|5|||
126135446|NCT03434379|453785289|FG003|China Extension Period|Study Ended by Sponsor|36|||
126135447|NCT00911989|453785290|FG000|Overall Study|Adverse Event|1|||
126135448|NCT01145066|453785291|FG000|Overall Study|To resume NSAIDs|2|||
126135449|NCT01145066|453785292|FG001|Overall Study|To resume NSAIDs|2|||
126135450|NCT01145066|453785293|FG002|Overall Study|To resume NSAIDs|1|||
126135451|NCT01145066|453785291|FG000|Overall Study|Non-related surgery|0|||
126135452|NCT01145066|453785292|FG001|Overall Study|Non-related surgery|0|||
126135453|NCT01145066|453785293|FG002|Overall Study|Non-related surgery|1|||
126135454|NCT01145066|453785291|FG000|Overall Study|Withdrawal by Subject|0|||
126135455|NCT01145066|453785292|FG001|Overall Study|Withdrawal by Subject|0|||
126135456|NCT01145066|453785293|FG002|Overall Study|Withdrawal by Subject|2|||
126135457|NCT01145066|453785291|FG000|Overall Study|To start new med|1|||
126135458|NCT01145066|453785292|FG001|Overall Study|To start new med|0|||
126135459|NCT01145066|453785293|FG002|Overall Study|To start new med|0|||
126135460|NCT01145066|453785291|FG000|Overall Study|problems swallowing capsule|1|||
126135461|NCT01145066|453785292|FG001|Overall Study|problems swallowing capsule|0|||
126135462|NCT01145066|453785293|FG002|Overall Study|problems swallowing capsule|0|||
126135463|NCT01145066|453785291|FG000|Overall Study|Abdominal discomfort|0|||
126135464|NCT01145066|453785292|FG001|Overall Study|Abdominal discomfort|1|||
126135465|NCT01145066|453785293|FG002|Overall Study|Abdominal discomfort|0|||
126135466|NCT01145066|453785291|FG000|Overall Study|Low platelet count|0|||
126135467|NCT01145066|453785292|FG001|Overall Study|Low platelet count|1|||
126135468|NCT01145066|453785293|FG002|Overall Study|Low platelet count|0|||
126135469|NCT00500682|453785305|FG000|Overall Study|Adverse Event|37|||
126135470|NCT00500682|453785306|FG001|Overall Study|Adverse Event|29|||
126135471|NCT00500682|453785305|FG000|Overall Study|Death|25|||
126135472|NCT00500682|453785306|FG001|Overall Study|Death|16|||
126135473|NCT00500682|453785305|FG000|Overall Study|Lost to Follow-up|11|||
126135474|NCT00500682|453785306|FG001|Overall Study|Lost to Follow-up|11|||
126135475|NCT00500682|453785305|FG000|Overall Study|Physician Decision|6|||
126135476|NCT00500682|453785306|FG001|Overall Study|Physician Decision|10|||
126135477|NCT00500682|453785305|FG000|Overall Study|Pregnancy|2|||
126135478|NCT00500682|453785306|FG001|Overall Study|Pregnancy|0|||
126135479|NCT00500682|453785305|FG000|Overall Study|Protocol Violation|1|||
126135480|NCT00500682|453785306|FG001|Overall Study|Protocol Violation|3|||
126135481|NCT00500682|453785305|FG000|Overall Study|Withdrawal by Subject|80|||
126135482|NCT00500682|453785306|FG001|Overall Study|Withdrawal by Subject|74|||
126135483|NCT00500682|453785305|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
126135484|NCT00500682|453785306|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
126135485|NCT01182428|453785309|FG000|Overall Study|Physician Decision|1|||
126135486|NCT01182428|453785310|FG001|Overall Study|Physician Decision|0|||
126135487|NCT01182428|453785309|FG000|Overall Study|Lost to Follow-up|9|||
126135488|NCT01182428|453785310|FG001|Overall Study|Lost to Follow-up|1|||
126135489|NCT01182428|453785309|FG000|Overall Study|Withdrawal by Subject|1|||
126135490|NCT01182428|453785310|FG001|Overall Study|Withdrawal by Subject|0|||
126135491|NCT01227902|453787029|FG000|Overall Study|Adverse Event|12|||
126135492|NCT01227902|453787030|FG001|Overall Study|Adverse Event|8|||
126135493|NCT01227902|453787031|FG002|Overall Study|Adverse Event|11|||
126135494|NCT01227902|453787032|FG003|Overall Study|Adverse Event|4|||
126135495|NCT01227902|453787029|FG000|Overall Study|Lack of Efficacy|1|||
125968217|NCT05706506|453175743|FG000|Overall Study|Participant Moved Out of State|1|||
126135496|NCT01227902|453787030|FG001|Overall Study|Lack of Efficacy|2|||
126135497|NCT01227902|453787031|FG002|Overall Study|Lack of Efficacy|2|||
126135498|NCT01227902|453787032|FG003|Overall Study|Lack of Efficacy|1|||
126135499|NCT01227902|453787029|FG000|Overall Study|Protocol Violation|1|||
126135500|NCT01227902|453787030|FG001|Overall Study|Protocol Violation|0|||
126135501|NCT01227902|453787031|FG002|Overall Study|Protocol Violation|0|||
126135502|NCT01227902|453787032|FG003|Overall Study|Protocol Violation|0|||
126135503|NCT01227902|453787029|FG000|Overall Study|Lost to Follow-up|0|||
126135504|NCT01227902|453787030|FG001|Overall Study|Lost to Follow-up|0|||
126135505|NCT01227902|453787031|FG002|Overall Study|Lost to Follow-up|1|||
126135506|NCT01227902|453787032|FG003|Overall Study|Lost to Follow-up|2|||
126135507|NCT01227902|453787029|FG000|Overall Study|Physician Decision|0|||
126135508|NCT01227902|453787030|FG001|Overall Study|Physician Decision|1|||
126135509|NCT01227902|453787031|FG002|Overall Study|Physician Decision|1|||
126135510|NCT01227902|453787032|FG003|Overall Study|Physician Decision|0|||
126135511|NCT01227902|453787029|FG000|Overall Study|Withdrawal by Subject|4|||
126135512|NCT01227902|453787030|FG001|Overall Study|Withdrawal by Subject|2|||
126135513|NCT01227902|453787031|FG002|Overall Study|Withdrawal by Subject|4|||
126135514|NCT01227902|453787032|FG003|Overall Study|Withdrawal by Subject|3|||
126135515|NCT05280756|453787033|FG000|Overall Study|Lost to Follow-up|1|||
126135516|NCT05280756|453787034|FG001|Overall Study|Lost to Follow-up|1|||
126135517|NCT02527707|453787039|FG000|Overall Study|Adverse Event|1|||
126135518|NCT02527707|453787039|FG000|Overall Study|Adverse Event|1|||
126135519|NCT00930059|453787040|FG000|Overall Study|Death|1|||
126135520|NCT00930059|453787041|FG001|Overall Study|Death|0|||
126135521|NCT00930059|453787040|FG000|Overall Study|Did not meet entrance criteria|1|||
126135522|NCT00930059|453787041|FG001|Overall Study|Did not meet entrance criteria|1|||
126135523|NCT00930059|453787040|FG000|Overall Study|Withdrawal by Subject|3|||
126135524|NCT00930059|453787041|FG001|Overall Study|Withdrawal by Subject|4|||
126135525|NCT00930059|453787040|FG000|Overall Study|Other|1|||
126135526|NCT00930059|453787041|FG001|Overall Study|Other|0|||
126135527|NCT00930059|453787040|FG000|Overall Study|1 site terminated by sponsor|1|||
126135528|NCT00930059|453787041|FG001|Overall Study|1 site terminated by sponsor|1|||
126135529|NCT00930059|453787040|FG000|Overall Study|Adverse Event|1|||
126135530|NCT00930059|453787041|FG001|Overall Study|Adverse Event|6|||
126135531|NCT04002310|453787044|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
126135532|NCT04002310|453787045|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
126135533|NCT04002310|453787046|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
126135534|NCT04002310|453787047|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
126135535|NCT04002310|453787048|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
126135536|NCT00542997|453787049|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
126135537|NCT00542997|453787049|FG000|Wash in / Wash Out Period|Adverse Event|3|||
126135538|NCT00542997|453787049|FG000|Efficacy Period|Adverse Event|3|||
126135539|NCT02949128|453787052|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
126135540|NCT02949128|453787052|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
126135541|NCT02949128|453787052|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
126135542|NCT02949128|453787052|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
126135543|NCT02949128|453787052|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
126135544|NCT02949128|453787052|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
126135545|NCT02949128|453787052|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
126135546|NCT02949128|453787052|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
126135547|NCT02949128|453787052|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
126135548|NCT02949128|453787052|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
126135549|NCT03064763|453787056|FG000|Overall Study|Lost to Follow-up|1|||
126135550|NCT03064763|453787056|FG000|Overall Study|Death|8|||
126135551|NCT01461044|453787065|FG000|Overall Study|Death|58|||
126135552|NCT01461044|453787066|FG001|Overall Study|Death|35|||
126135553|NCT01461044|453787065|FG000|Overall Study|Lost to Follow-up|12|||
126135554|NCT01461044|453787066|FG001|Overall Study|Lost to Follow-up|5|||
126135555|NCT00716976|453787067|FG000|Overall Study|Adverse Event|2|||
126135556|NCT00716976|453787068|FG001|Overall Study|Adverse Event|0|||
126135557|NCT00716976|453787067|FG000|Overall Study|Death|1|||
126135558|NCT00716976|453787068|FG001|Overall Study|Death|0|||
126135559|NCT00716976|453787067|FG000|Overall Study|Physician Decision|2|||
126135560|NCT00716976|453787068|FG001|Overall Study|Physician Decision|2|||
126135561|NCT00716976|453787067|FG000|Overall Study|Withdrawal by Subject|5|||
126135562|NCT00716976|453787068|FG001|Overall Study|Withdrawal by Subject|1|||
126135563|NCT00716976|453787067|FG000|Overall Study|Premature discontinuation cisplatin|5|||
126135564|NCT00716976|453787068|FG001|Overall Study|Premature discontinuation cisplatin|4|||
126135565|NCT00716976|453787067|FG000|Overall Study|Radiation during protocol|1|||
126135566|NCT00716976|453787068|FG001|Overall Study|Radiation during protocol|0|||
126135567|NCT00716976|453787067|FG000|Overall Study|Ineligibles|4|||
126135568|NCT00716976|453787068|FG001|Overall Study|Ineligibles|2|||
126135569|NCT00122135|453787069|FG000|Overall Study|Withdrawal by Subject|3|||
126135570|NCT00122135|453787070|FG001|Overall Study|Withdrawal by Subject|0|||
126135571|NCT03106779|453787074|FG000|Overall Study|Lack of Efficacy|33|||
126135572|NCT03106779|453787075|FG001|Overall Study|Lack of Efficacy|24|||
126135573|NCT03106779|453787074|FG000|Overall Study|Adverse Event|8|||
126135574|NCT03106779|453787075|FG001|Overall Study|Adverse Event|16|||
126135575|NCT03106779|453787074|FG000|Overall Study|Physician Decision|10|||
126135576|NCT03106779|453787075|FG001|Overall Study|Physician Decision|6|||
126135577|NCT03106779|453787074|FG000|Overall Study|Patient/guardian decision|4|||
126135578|NCT03106779|453787075|FG001|Overall Study|Patient/guardian decision|3|||
126135579|NCT03106779|453787074|FG000|Overall Study|Progressive disease|1|||
126135580|NCT03106779|453787075|FG001|Overall Study|Progressive disease|3|||
126135581|NCT03106779|453787074|FG000|Overall Study|Lost to Follow-up|1|||
126135582|NCT03106779|453787075|FG001|Overall Study|Lost to Follow-up|2|||
126135583|NCT03106779|453787074|FG000|Overall Study|Death|1|||
126135584|NCT03106779|453787075|FG001|Overall Study|Death|0|||
126135585|NCT03106779|453787074|FG000|Overall Study|Protocol Violation|1|||
126135586|NCT03106779|453787075|FG001|Overall Study|Protocol Violation|0|||
126135587|NCT03106779|453787074|FG000|Overall Study|Not treated|1|||
126135588|NCT03106779|453787075|FG001|Overall Study|Not treated|0|||
126135589|NCT02288247|453787076|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
126135590|NCT02288247|453787077|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
126135591|NCT02288247|453787076|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
126135592|NCT02288247|453787077|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
126135593|NCT02288247|453787076|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
126135594|NCT02288247|453787077|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
126135595|NCT02288247|453787076|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
126135596|NCT02288247|453787077|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
126135597|NCT02288247|453787076|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
126135598|NCT02288247|453787077|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
126135599|NCT02288247|453787076|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
126135600|NCT02288247|453787077|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
126135601|NCT02288247|453787076|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
126135602|NCT02288247|453787077|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
126135603|NCT02288247|453787076|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
126135604|NCT02288247|453787077|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
126135605|NCT02288247|453787076|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
126135606|NCT02288247|453787077|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
126135607|NCT02288247|453787076|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
126135608|NCT02288247|453787077|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
126135609|NCT02288247|453787076|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
126135610|NCT02288247|453787077|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
126135611|NCT02288247|453787076|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
126135612|NCT02288247|453787077|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
126135613|NCT02288247|453787076|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
126135614|NCT02288247|453787077|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
126135615|NCT02288247|453787076|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
126135616|NCT02288247|453787077|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
126135617|NCT02288247|453787076|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
126135618|NCT02288247|453787077|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
126135619|NCT02288247|453787076|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
126135620|NCT02288247|453787077|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
126135621|NCT04093531|453787078|FG000|Overall Study|failed screening|4|||
126135622|NCT00634569|453787079|FG000|Overall Study|Withdrawal by Subject|0|||
126135623|NCT00634569|453787080|FG001|Overall Study|Withdrawal by Subject|4|||
126135624|NCT00634569|453787079|FG000|Overall Study|Physician Decision|0|||
126135625|NCT00634569|453787080|FG001|Overall Study|Physician Decision|1|||
126135626|NCT02918019|453787081|FG000|Overall Study|Death|0|||
126135627|NCT02918019|453787082|FG001|Overall Study|Death|0|||
126135628|NCT02918019|453787083|FG002|Overall Study|Death|1|||
126135629|NCT02918019|453787084|FG003|Overall Study|Death|0|||
126135630|NCT02918019|453787081|FG000|Overall Study|Lost to Follow-up|1|||
126135631|NCT02918019|453787082|FG001|Overall Study|Lost to Follow-up|1|||
125968218|NCT05732454|453175744|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
126135632|NCT02918019|453787083|FG002|Overall Study|Lost to Follow-up|0|||
125968219|NCT05732454|453175745|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
125968220|NCT05732454|453175744|FG000|Part 1: DB Period|Adverse Event|1|||
126135633|NCT02918019|453787084|FG003|Overall Study|Lost to Follow-up|1|||
126135634|NCT02918019|453787081|FG000|Overall Study|Principal investigator request|0|||
126135635|NCT02918019|453787082|FG001|Overall Study|Principal investigator request|0|||
126135636|NCT02918019|453787083|FG002|Overall Study|Principal investigator request|0|||
126135637|NCT02918019|453787084|FG003|Overall Study|Principal investigator request|1|||
126135638|NCT02918019|453787081|FG000|Overall Study|Physician Decision|1|||
126135639|NCT02918019|453787082|FG001|Overall Study|Physician Decision|3|||
125968221|NCT05732454|453175745|FG001|Part 1: DB Period|Adverse Event|0|||
126135640|NCT02918019|453787083|FG002|Overall Study|Physician Decision|2|||
126135641|NCT02918019|453787084|FG003|Overall Study|Physician Decision|0|||
126135642|NCT02918019|453787081|FG000|Overall Study|Protocol deviation|1|||
126135643|NCT02918019|453787082|FG001|Overall Study|Protocol deviation|1|||
126135644|NCT02918019|453787083|FG002|Overall Study|Protocol deviation|0|||
126135645|NCT02918019|453787084|FG003|Overall Study|Protocol deviation|2|||
126135646|NCT02918019|453787081|FG000|Overall Study|Withdrawal by Subject|3|||
126135647|NCT02918019|453787082|FG001|Overall Study|Withdrawal by Subject|4|||
126135648|NCT02918019|453787083|FG002|Overall Study|Withdrawal by Subject|6|||
126135649|NCT02918019|453787084|FG003|Overall Study|Withdrawal by Subject|4|||
126135650|NCT02918019|453787081|FG000|Overall Study|Adverse Event|0|||
126135651|NCT02918019|453787082|FG001|Overall Study|Adverse Event|1|||
126135652|NCT02918019|453787083|FG002|Overall Study|Adverse Event|0|||
126135653|NCT02918019|453787084|FG003|Overall Study|Adverse Event|1|||
126135654|NCT01212185|453787085|FG000|Overall Study|Protocol Violation|2|||
126135655|NCT01212185|453787086|FG001|Overall Study|Protocol Violation|1|||
126135656|NCT03222349|453787087|FG000|Overall Study|Treatment B not done|5|||
126135657|NCT03222349|453787088|FG001|Overall Study|Treatment B not done|0|||
126135658|NCT03222349|453787087|FG000|Overall Study|Lost to Follow-up|1|||
126135659|NCT03222349|453787088|FG001|Overall Study|Lost to Follow-up|2|||
126135660|NCT03222349|453787087|FG000|Overall Study|Withdrawal by Subject|1|||
126135661|NCT03222349|453787088|FG001|Overall Study|Withdrawal by Subject|0|||
126135662|NCT03222349|453787087|FG000|Overall Study|Treatment A not done|0|||
126135663|NCT03222349|453787088|FG001|Overall Study|Treatment A not done|5|||
126135664|NCT03222349|453787087|FG000|Overall Study|Study terminated by sponsor|1|||
126135665|NCT03222349|453787088|FG001|Overall Study|Study terminated by sponsor|0|||
126135666|NCT00094757|453787092|FG000|Overall Study|Adverse Event|11|||
126135667|NCT00094757|453787093|FG001|Overall Study|Adverse Event|9|||
126135668|NCT00094757|453787094|FG002|Overall Study|Adverse Event|6|||
126135669|NCT00094757|453787092|FG000|Overall Study|Lack of Efficacy|11|||
126135670|NCT00094757|453787093|FG001|Overall Study|Lack of Efficacy|15|||
126135671|NCT00094757|453787094|FG002|Overall Study|Lack of Efficacy|8|||
126135672|NCT00094757|453787092|FG000|Overall Study|Lost to Follow-up|3|||
126135673|NCT00094757|453787093|FG001|Overall Study|Lost to Follow-up|5|||
126135674|NCT00094757|453787094|FG002|Overall Study|Lost to Follow-up|6|||
126135675|NCT00094757|453787092|FG000|Overall Study|Patient Moved|2|||
126135676|NCT00094757|453787093|FG001|Overall Study|Patient Moved|1|||
126135677|NCT00094757|453787094|FG002|Overall Study|Patient Moved|1|||
126135678|NCT00094757|453787092|FG000|Overall Study|Protocol Violation|8|||
126135679|NCT00094757|453787093|FG001|Overall Study|Protocol Violation|5|||
126135680|NCT00094757|453787094|FG002|Overall Study|Protocol Violation|3|||
126135681|NCT00094757|453787092|FG000|Overall Study|Withdrawal by Subject|14|||
126135682|NCT00094757|453787093|FG001|Overall Study|Withdrawal by Subject|21|||
126135683|NCT00094757|453787094|FG002|Overall Study|Withdrawal by Subject|5|||
126135684|NCT00094757|453787092|FG000|Overall Study|Other|3|||
126135685|NCT00094757|453787093|FG001|Overall Study|Other|3|||
126135686|NCT00094757|453787094|FG002|Overall Study|Other|1|||
126135687|NCT00094757|453787092|FG000|Overall Study|Protocol specified discontinuation|1|||
126135688|NCT00094757|453787093|FG001|Overall Study|Protocol specified discontinuation|3|||
126135689|NCT00094757|453787094|FG002|Overall Study|Protocol specified discontinuation|0|||
126135690|NCT00756938|453787095|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
126135691|NCT00756938|453787096|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
126135692|NCT00756938|453787097|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
126135693|NCT00756938|453787098|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
126135694|NCT00756938|453787095|FG000|12-week Base Study|Protocol Violation|0|||
126135695|NCT00756938|453787096|FG001|12-week Base Study|Protocol Violation|0|||
126135696|NCT00756938|453787097|FG002|12-week Base Study|Protocol Violation|1|||
126135697|NCT00756938|453787098|FG003|12-week Base Study|Protocol Violation|0|||
126135698|NCT00756938|453787095|FG000|12-week Base Study|Lost to Follow-up|1|||
126135699|NCT00756938|453787096|FG001|12-week Base Study|Lost to Follow-up|0|||
126135700|NCT00756938|453787097|FG002|12-week Base Study|Lost to Follow-up|0|||
126135701|NCT00756938|453787098|FG003|12-week Base Study|Lost to Follow-up|0|||
126135702|NCT00756938|453787095|FG000|Optional Extension|Lack of Efficacy|0|||
126135703|NCT00756938|453787096|FG001|Optional Extension|Lack of Efficacy|0|||
126135704|NCT00756938|453787097|FG002|Optional Extension|Lack of Efficacy|0|||
126135705|NCT00756938|453787098|FG003|Optional Extension|Lack of Efficacy|1|||
126135706|NCT00756938|453787095|FG000|Optional Extension|End of Study|0|||
126135707|NCT00756938|453787096|FG001|Optional Extension|End of Study|0|||
126135708|NCT00756938|453787097|FG002|Optional Extension|End of Study|0|||
126135709|NCT00756938|453787098|FG003|Optional Extension|End of Study|11|||
126135710|NCT00756938|453787095|FG000|Optional Extension|Protocol-specific criteria met|0|||
126135711|NCT00756938|453787096|FG001|Optional Extension|Protocol-specific criteria met|0|||
126135712|NCT00756938|453787097|FG002|Optional Extension|Protocol-specific criteria met|0|||
126135713|NCT00756938|453787098|FG003|Optional Extension|Protocol-specific criteria met|9|||
126135714|NCT00756938|453787095|FG000|Optional Extension|Physician Decision|0|||
126135715|NCT00756938|453787096|FG001|Optional Extension|Physician Decision|0|||
126135716|NCT00756938|453787097|FG002|Optional Extension|Physician Decision|0|||
126135717|NCT00756938|453787098|FG003|Optional Extension|Physician Decision|3|||
126135718|NCT00756938|453787095|FG000|Optional Extension|Lost to Follow-up|0|||
126135719|NCT00756938|453787096|FG001|Optional Extension|Lost to Follow-up|0|||
126135720|NCT00756938|453787097|FG002|Optional Extension|Lost to Follow-up|0|||
126135721|NCT00756938|453787098|FG003|Optional Extension|Lost to Follow-up|1|||
126135722|NCT00756938|453787095|FG000|Optional Extension|Protocol Violation|0|||
126135723|NCT00756938|453787096|FG001|Optional Extension|Protocol Violation|0|||
126135724|NCT00756938|453787097|FG002|Optional Extension|Protocol Violation|0|||
126135725|NCT00756938|453787098|FG003|Optional Extension|Protocol Violation|1|||
126135726|NCT00756938|453787095|FG000|Optional Extension|Withdrawal by Subject|0|||
126135727|NCT00756938|453787096|FG001|Optional Extension|Withdrawal by Subject|0|||
126135728|NCT00756938|453787097|FG002|Optional Extension|Withdrawal by Subject|0|||
126135729|NCT00756938|453787098|FG003|Optional Extension|Withdrawal by Subject|10|||
126135730|NCT00756938|453787095|FG000|Optional Extension|Adverse Event|0|||
126135731|NCT00756938|453787096|FG001|Optional Extension|Adverse Event|0|||
126135732|NCT00756938|453787097|FG002|Optional Extension|Adverse Event|0|||
126135733|NCT00756938|453787098|FG003|Optional Extension|Adverse Event|1|||
126135734|NCT01808612|453787099|FG000|Treatment Period|Adverse Event|8|||
126135735|NCT01808612|453787100|FG001|Treatment Period|Adverse Event|4|||
126135736|NCT01808612|453787101|FG002|Treatment Period|Adverse Event|3|||
126135737|NCT01808612|453787099|FG000|Treatment Period|Lost to Follow-up|2|||
126135738|NCT01808612|453787100|FG001|Treatment Period|Lost to Follow-up|2|||
126135739|NCT01808612|453787101|FG002|Treatment Period|Lost to Follow-up|1|||
126135740|NCT01808612|453787099|FG000|Treatment Period|Protocol Violation|1|||
126135741|NCT01808612|453787100|FG001|Treatment Period|Protocol Violation|0|||
126135742|NCT01808612|453787101|FG002|Treatment Period|Protocol Violation|0|||
126135743|NCT01808612|453787099|FG000|Treatment Period|Withdrawal by Subject|1|||
126135744|NCT01808612|453787100|FG001|Treatment Period|Withdrawal by Subject|0|||
126135745|NCT01808612|453787101|FG002|Treatment Period|Withdrawal by Subject|4|||
126135746|NCT01808612|453787099|FG000|Treatment Period|Physician Decision|1|||
126135747|NCT01808612|453787100|FG001|Treatment Period|Physician Decision|0|||
126135748|NCT01808612|453787101|FG002|Treatment Period|Physician Decision|4|||
126135749|NCT01808612|453787099|FG000|Treatment Period|Sponsor Decision|1|||
126135750|NCT01808612|453787100|FG001|Treatment Period|Sponsor Decision|0|||
126135751|NCT01808612|453787101|FG002|Treatment Period|Sponsor Decision|0|||
126135752|NCT01808612|453787099|FG000|Treatment Period|Lack of Efficacy|1|||
126135753|NCT01808612|453787100|FG001|Treatment Period|Lack of Efficacy|1|||
126135754|NCT01808612|453787101|FG002|Treatment Period|Lack of Efficacy|2|||
126135755|NCT01808612|453787099|FG000|Discontinuation Period|Adverse Event|1|||
126135756|NCT01808612|453787100|FG001|Discontinuation Period|Adverse Event|0|||
126135757|NCT01808612|453787101|FG002|Discontinuation Period|Adverse Event|0|||
126135758|NCT01808612|453787099|FG000|Discontinuation Period|Physician Decision|1|||
126135759|NCT01808612|453787100|FG001|Discontinuation Period|Physician Decision|0|||
126135760|NCT01808612|453787101|FG002|Discontinuation Period|Physician Decision|0|||
126135761|NCT01808612|453787099|FG000|Discontinuation Period|Lost to Follow-up|0|||
126135762|NCT01808612|453787100|FG001|Discontinuation Period|Lost to Follow-up|1|||
126135763|NCT01808612|453787101|FG002|Discontinuation Period|Lost to Follow-up|0|||
126135764|NCT01700192|453787102|FG000|Overall Study|Adverse Event|73|||
126135765|NCT01700192|453787103|FG001|Overall Study|Adverse Event|18|||
126135766|NCT01700192|453787102|FG000|Overall Study|Lack of Efficacy|1|||
126135767|NCT01700192|453787103|FG001|Overall Study|Lack of Efficacy|0|||
126135768|NCT01700192|453787102|FG000|Overall Study|Lost to Follow-up|42|||
126135769|NCT01700192|453787103|FG001|Overall Study|Lost to Follow-up|29|||
126135770|NCT01700192|453787102|FG000|Overall Study|Noncompliance with study drug|0|||
126135771|NCT01700192|453787103|FG001|Overall Study|Noncompliance with study drug|5|||
126135772|NCT01700192|453787102|FG000|Overall Study|Physician Decision|2|||
126135773|NCT01700192|453787103|FG001|Overall Study|Physician Decision|3|||
126135774|NCT01700192|453787102|FG000|Overall Study|Pregnancy|1|||
126135775|NCT01700192|453787103|FG001|Overall Study|Pregnancy|4|||
126135776|NCT01700192|453787102|FG000|Overall Study|Progressive disease|1|||
126135777|NCT01700192|453787103|FG001|Overall Study|Progressive disease|0|||
126135778|NCT01700192|453787102|FG000|Overall Study|Protocol Violation|3|||
126135779|NCT01700192|453787103|FG001|Overall Study|Protocol Violation|4|||
126135780|NCT01700192|453787102|FG000|Overall Study|Technical problems|0|||
125968222|NCT05732454|453175744|FG000|Part 1: DB Period|Lost to Follow-up|1|||
126135781|NCT01700192|453787103|FG001|Overall Study|Technical problems|1|||
126135782|NCT01700192|453787102|FG000|Overall Study|Withdrawal by Subject|56|||
126135783|NCT01700192|453787103|FG001|Overall Study|Withdrawal by Subject|64|||
126135784|NCT01700192|453787102|FG000|Overall Study|Never received study drug|1|||
126135785|NCT01700192|453787103|FG001|Overall Study|Never received study drug|0|||
126135786|NCT03403192|453787106|FG000|Overall Study|Lost to Follow-up|1|||
126135787|NCT03403192|453787107|FG001|Overall Study|Lost to Follow-up|2|||
126135788|NCT03403192|453787108|FG002|Overall Study|Lost to Follow-up|0|||
126135789|NCT03403192|453787109|FG003|Overall Study|Lost to Follow-up|0|||
126135790|NCT03403192|453787106|FG000|Overall Study|Unable to respond|0|||
126135791|NCT03403192|453787107|FG001|Overall Study|Unable to respond|1|||
126135792|NCT03403192|453787108|FG002|Overall Study|Unable to respond|0|||
126135793|NCT03403192|453787109|FG003|Overall Study|Unable to respond|0|||
126135794|NCT03403192|453787106|FG000|Overall Study|Incomplete|3|||
126135795|NCT03403192|453787107|FG001|Overall Study|Incomplete|1|||
126135796|NCT03403192|453787108|FG002|Overall Study|Incomplete|3|||
126135797|NCT03403192|453787109|FG003|Overall Study|Incomplete|6|||
126135798|NCT02793232|453787110|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126135799|NCT02793232|453787111|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126135800|NCT02793232|453787112|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126135801|NCT02793232|453787113|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126135802|NCT02793232|453787114|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
126135803|NCT02793232|453787115|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126135804|NCT02793232|453787116|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
126135805|NCT02793232|453787117|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126135806|NCT02793232|453787118|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126135807|NCT01298492|453787119|FG000|Overall Study|Death|2|||
126135808|NCT01298492|453787119|FG000|Overall Study|Insufficient Clinical Response|22|||
126135809|NCT01298492|453787119|FG000|Overall Study|Lost to Follow-up|12|||
126135810|NCT01298492|453787119|FG000|Overall Study|Withdrawal by Subject|47|||
126135811|NCT01298492|453787119|FG000|Overall Study|Other (Unspecified)|7|||
126135812|NCT01298492|453787119|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
126135813|NCT01298492|453787119|FG000|Overall Study|Protocol Violation|2|||
126135814|NCT01298492|453787119|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
126135815|NCT01298492|453787119|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
126135816|NCT00352105|453787120|FG000|Overall Study|Death|5|||
126135817|NCT00352105|453787120|FG000|Overall Study|Withdrawal by Subject|5|||
126135818|NCT00352105|453787120|FG000|Overall Study|Lack of Efficacy|9|||
126135819|NCT00352105|453787120|FG000|Overall Study|Adverse Event|19|||
126135820|NCT00352105|453787120|FG000|Overall Study|Protocol Violation|2|||
126135821|NCT02551159|453787121|FG000|Overall Study|Death|352|||
126135822|NCT02551159|453787122|FG001|Overall Study|Death|174|||
126135823|NCT02551159|453787123|FG002|Overall Study|Death|161|||
126135824|NCT02551159|453787121|FG000|Overall Study|Withdrawal by Subject|8|||
126135825|NCT02551159|453787122|FG001|Overall Study|Withdrawal by Subject|5|||
126135826|NCT02551159|453787123|FG002|Overall Study|Withdrawal by Subject|16|||
126135827|NCT02551159|453787121|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
126135828|NCT02551159|453787122|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
126135829|NCT02551159|453787123|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
126135830|NCT00268242|453787124|FG000|Overall Study|Death|1|||
126135831|NCT04871711|453787125|FG000|Overall Study|Withdrawal by Subject|11|||
126135832|NCT04871711|453787126|FG001|Overall Study|Withdrawal by Subject|5|||
126135833|NCT04871711|453787125|FG000|Overall Study|Lack of Efficacy|5|||
126135834|NCT04871711|453787126|FG001|Overall Study|Lack of Efficacy|7|||
126135835|NCT04871711|453787125|FG000|Overall Study|Adverse Event|2|||
126135836|NCT04871711|453787126|FG001|Overall Study|Adverse Event|6|||
126135837|NCT04871711|453787125|FG000|Overall Study|Various reasons|2|||
126135838|NCT04871711|453787126|FG001|Overall Study|Various reasons|1|||
126135839|NCT04871711|453787125|FG000|Overall Study|Lost to Follow-up|0|||
126135840|NCT04871711|453787126|FG001|Overall Study|Lost to Follow-up|2|||
126135841|NCT03551743|453787130|FG000|Overall Study|Adverse Event|1|||
126135842|NCT03551743|453787131|FG001|Overall Study|Adverse Event|0|||
126135843|NCT03551743|453787132|FG002|Overall Study|Adverse Event|0|||
126135844|NCT03551743|453787133|FG003|Overall Study|Adverse Event|0|||
126135845|NCT03551743|453787130|FG000|Overall Study|Withdrawal by Subject|1|||
126135846|NCT03551743|453787131|FG001|Overall Study|Withdrawal by Subject|0|||
126135847|NCT03551743|453787132|FG002|Overall Study|Withdrawal by Subject|0|||
126135848|NCT03551743|453787133|FG003|Overall Study|Withdrawal by Subject|0|||
126135849|NCT04556617|453787138|FG000|Overall Study|progressive disease|0|||
126135850|NCT04556617|453787139|FG001|Overall Study|progressive disease|2|||
126135851|NCT04556617|453787140|FG002|Overall Study|progressive disease|2|||
126135852|NCT04556617|453787141|FG003|Overall Study|progressive disease|1|||
126135853|NCT04556617|453787142|FG004|Overall Study|progressive disease|1|||
126135854|NCT04556617|453787138|FG000|Overall Study|Physician Decision|0|||
126135855|NCT04556617|453787139|FG001|Overall Study|Physician Decision|0|||
126135856|NCT04556617|453787140|FG002|Overall Study|Physician Decision|2|||
126135857|NCT04556617|453787141|FG003|Overall Study|Physician Decision|0|||
126135858|NCT04556617|453787142|FG004|Overall Study|Physician Decision|0|||
126135859|NCT04556617|453787138|FG000|Overall Study|Adverse Event|0|||
126135860|NCT04556617|453787139|FG001|Overall Study|Adverse Event|0|||
126135861|NCT04556617|453787140|FG002|Overall Study|Adverse Event|2|||
126135862|NCT04556617|453787141|FG003|Overall Study|Adverse Event|3|||
126135863|NCT04556617|453787142|FG004|Overall Study|Adverse Event|0|||
126135864|NCT04556617|453787138|FG000|Overall Study|Withdrawal by Subject|0|||
126135865|NCT04556617|453787139|FG001|Overall Study|Withdrawal by Subject|2|||
126135866|NCT04556617|453787140|FG002|Overall Study|Withdrawal by Subject|1|||
126135867|NCT04556617|453787141|FG003|Overall Study|Withdrawal by Subject|1|||
126135868|NCT04556617|453787142|FG004|Overall Study|Withdrawal by Subject|0|||
126135869|NCT04556617|453787138|FG000|Overall Study|PSA increase|0|||
126135870|NCT04556617|453787139|FG001|Overall Study|PSA increase|1|||
126135871|NCT04556617|453787140|FG002|Overall Study|PSA increase|0|||
126135872|NCT04556617|453787141|FG003|Overall Study|PSA increase|0|||
126135873|NCT04556617|453787142|FG004|Overall Study|PSA increase|0|||
126135874|NCT04556617|453787138|FG000|Overall Study|Sponsor study termination|1|||
126135875|NCT04556617|453787139|FG001|Overall Study|Sponsor study termination|0|||
126135876|NCT04556617|453787140|FG002|Overall Study|Sponsor study termination|0|||
126135877|NCT04556617|453787141|FG003|Overall Study|Sponsor study termination|0|||
126135878|NCT04556617|453787142|FG004|Overall Study|Sponsor study termination|0|||
126135879|NCT03179436|453787143|FG000|Overall Study|Withdrawal by Subject|1|||
126135880|NCT03179436|453787144|FG001|Overall Study|Withdrawal by Subject|0|||
126135881|NCT03179436|453787145|FG002|Overall Study|Withdrawal by Subject|0|||
126135882|NCT03179436|453787146|FG003|Overall Study|Withdrawal by Subject|4|||
126135883|NCT03179436|453787147|FG004|Overall Study|Withdrawal by Subject|2|||
126135884|NCT03179436|453787148|FG005|Overall Study|Withdrawal by Subject|2|||
126135885|NCT03179436|453787149|FG006|Overall Study|Withdrawal by Subject|5|||
126135886|NCT03179436|453787150|FG007|Overall Study|Withdrawal by Subject|0|||
126135887|NCT03179436|453787151|FG008|Overall Study|Withdrawal by Subject|3|||
126135888|NCT03179436|453787152|FG009|Overall Study|Withdrawal by Subject|0|||
126135889|NCT03179436|453787153|FG010|Overall Study|Withdrawal by Subject|0|||
126135890|NCT03179436|453787154|FG011|Overall Study|Withdrawal by Subject|0|||
126135891|NCT03179436|453787143|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126135892|NCT03179436|453787144|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126135893|NCT03179436|453787145|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126135894|NCT03179436|453787146|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126135895|NCT03179436|453787147|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126135896|NCT03179436|453787148|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126135897|NCT03179436|453787149|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
126135898|NCT03179436|453787150|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
126135899|NCT03179436|453787151|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
126135900|NCT03179436|453787152|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
126135901|NCT03179436|453787153|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
126135902|NCT03179436|453787154|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
126135903|NCT03179436|453787143|FG000|Overall Study|Sponsor Decision|0|||
126135904|NCT03179436|453787144|FG001|Overall Study|Sponsor Decision|0|||
126135905|NCT03179436|453787145|FG002|Overall Study|Sponsor Decision|1|||
126135906|NCT03179436|453787146|FG003|Overall Study|Sponsor Decision|3|||
126135907|NCT03179436|453787147|FG004|Overall Study|Sponsor Decision|9|||
126135908|NCT03179436|453787148|FG005|Overall Study|Sponsor Decision|7|||
126135909|NCT03179436|453787149|FG006|Overall Study|Sponsor Decision|2|||
126135910|NCT03179436|453787150|FG007|Overall Study|Sponsor Decision|4|||
126135911|NCT03179436|453787151|FG008|Overall Study|Sponsor Decision|23|||
126135912|NCT03179436|453787152|FG009|Overall Study|Sponsor Decision|6|||
126135913|NCT03179436|453787153|FG010|Overall Study|Sponsor Decision|7|||
126135914|NCT03179436|453787154|FG011|Overall Study|Sponsor Decision|5|||
126135915|NCT03179436|453787143|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135916|NCT03179436|453787144|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
126135917|NCT03179436|453787145|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135918|NCT03179436|453787146|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135919|NCT03179436|453787147|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135920|NCT03179436|453787148|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
126135921|NCT03179436|453787149|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135922|NCT03179436|453787150|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135923|NCT03179436|453787151|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135924|NCT03179436|453787152|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135925|NCT03179436|453787153|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135926|NCT03179436|453787154|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
126135927|NCT03179436|453787143|FG000|Overall Study|Lost to Follow-up|1|||
126135928|NCT03179436|453787144|FG001|Overall Study|Lost to Follow-up|0|||
126135929|NCT03179436|453787145|FG002|Overall Study|Lost to Follow-up|0|||
125968223|NCT05732454|453175745|FG001|Part 1: DB Period|Lost to Follow-up|0|||
125968224|NCT05732454|453175744|FG000|Part 1: DB Period|Protocol Violation|0|||
125968225|NCT05732454|453175745|FG001|Part 1: DB Period|Protocol Violation|1|||
125968226|NCT05732454|453175744|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
125968227|NCT05732454|453175745|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
125968228|NCT05732454|453175744|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
125968229|NCT05732454|453175745|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
126135930|NCT03179436|453787146|FG003|Overall Study|Lost to Follow-up|1|||
126135931|NCT03179436|453787147|FG004|Overall Study|Lost to Follow-up|0|||
126135932|NCT03179436|453787148|FG005|Overall Study|Lost to Follow-up|1|||
126135933|NCT03179436|453787149|FG006|Overall Study|Lost to Follow-up|0|||
126135934|NCT03179436|453787150|FG007|Overall Study|Lost to Follow-up|0|||
126135935|NCT03179436|453787151|FG008|Overall Study|Lost to Follow-up|1|||
126135936|NCT03179436|453787152|FG009|Overall Study|Lost to Follow-up|1|||
126135937|NCT03179436|453787153|FG010|Overall Study|Lost to Follow-up|0|||
126135938|NCT03179436|453787154|FG011|Overall Study|Lost to Follow-up|0|||
126135939|NCT03179436|453787143|FG000|Overall Study|Death|12|||
126135940|NCT03179436|453787144|FG001|Overall Study|Death|17|||
126135941|NCT03179436|453787145|FG002|Overall Study|Death|7|||
126135942|NCT03179436|453787146|FG003|Overall Study|Death|32|||
126135943|NCT03179436|453787147|FG004|Overall Study|Death|29|||
126135944|NCT03179436|453787148|FG005|Overall Study|Death|30|||
126135945|NCT03179436|453787149|FG006|Overall Study|Death|33|||
126135946|NCT03179436|453787150|FG007|Overall Study|Death|9|||
126135947|NCT03179436|453787151|FG008|Overall Study|Death|84|||
126135948|NCT03179436|453787152|FG009|Overall Study|Death|33|||
126135949|NCT03179436|453787153|FG010|Overall Study|Death|22|||
126135950|NCT03179436|453787154|FG011|Overall Study|Death|15|||
126135951|NCT05168267|453787155|FG000|Overall Study|Withdrawal by Subject|2|||
126135952|NCT05168267|453787156|FG001|Overall Study|Withdrawal by Subject|1|||
126135953|NCT05168267|453787155|FG000|Overall Study|Withdrawn by Therapist|1|||
126135954|NCT05168267|453787156|FG001|Overall Study|Withdrawn by Therapist|1|||
126135955|NCT05168267|453787155|FG000|Overall Study|Left Facility|1|||
126135956|NCT05168267|453787156|FG001|Overall Study|Left Facility|0|||
126135957|NCT00803179|453787158|FG000|Overall Study|Lost to Follow-up|3|||
126135958|NCT04811716|453787161|FG000|Overall Study|Withdrawal by Subject|2|||
126135959|NCT04811716|453787162|FG001|Overall Study|Withdrawal by Subject|0|||
126135960|NCT01877083|453787166|FG000|Treatment Phase|Disease Progression|10|||
126135961|NCT01877083|453787166|FG000|Treatment Phase|Clinical Progression|1|||
126135962|NCT01877083|453787166|FG000|Treatment Phase|Adverse Event|6|||
126135963|NCT01877083|453787166|FG000|Treatment Phase|Withdrawal by Subject|2|||
126135964|NCT01877083|453787166|FG000|Treatment Phase|Lost to Follow-up|1|||
126135965|NCT01877083|453787166|FG000|Extension Phase|Disease Progression|3|||
126135966|NCT01877083|453787166|FG000|Extension Phase|Adverse Event|2|||
126135967|NCT00429585|453787169|FG000|Overall Study|Death|1|||
126135968|NCT00429585|453787170|FG001|Overall Study|Death|0|||
126135969|NCT00429585|453787169|FG000|Overall Study|Lost to Follow-up|27|||
126135970|NCT00429585|453787170|FG001|Overall Study|Lost to Follow-up|20|||
125968230|NCT05732454|453175744|FG000|Part 1: OLE Period|Adverse Event|0|||
125968231|NCT05732454|453175745|FG001|Part 1: OLE Period|Adverse Event|1|||
125968232|NCT05732454|453175744|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
125968233|NCT05732454|453175745|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
125968234|NCT00328510|453175749|FG000|Overall Study|Gag disorder, could not use frame|4|||
125968235|NCT00328510|453175750|FG001|Overall Study|Gag disorder, could not use frame|0|||
125968236|NCT00328510|453175749|FG000|Overall Study|Dentition problems, could not use frame|1|||
125968237|NCT00328510|453175750|FG001|Overall Study|Dentition problems, could not use frame|0|||
125968238|NCT00328510|453175749|FG000|Overall Study|Withdrawal by Subject|4|||
126135971|NCT00429585|453787169|FG000|Overall Study|Physician Decision|2|||
126135972|NCT00429585|453787170|FG001|Overall Study|Physician Decision|0|||
126135973|NCT01582308|453787171|FG000|Period 1|Withdrawal by Subject|0|||
126135974|NCT01582308|453787172|FG001|Period 1|Withdrawal by Subject|0|||
126135975|NCT01582308|453787173|FG002|Period 1|Withdrawal by Subject|0|||
126135976|NCT01582308|453787174|FG003|Period 1|Withdrawal by Subject|0|||
126135977|NCT01582308|453787175|FG004|Period 1|Withdrawal by Subject|0|||
126135978|NCT01582308|453787176|FG005|Period 1|Withdrawal by Subject|0|||
126135979|NCT01582308|453787177|FG006|Period 1|Withdrawal by Subject|1|||
126135980|NCT01582308|453787178|FG007|Period 1|Withdrawal by Subject|0|||
126135981|NCT01582308|453787179|FG008|Period 1|Withdrawal by Subject|0|||
126135982|NCT01582308|453787180|FG009|Period 1|Withdrawal by Subject|0|||
125968239|NCT00328510|453175750|FG001|Overall Study|Withdrawal by Subject|2|||
125968240|NCT00328510|453175749|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
125968241|NCT00328510|453175750|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
126135983|NCT01582308|453787171|FG000|10-day Washout Following Period 1|Physician Decision|0|||
126135984|NCT01582308|453787172|FG001|10-day Washout Following Period 1|Physician Decision|0|||
126135985|NCT01582308|453787173|FG002|10-day Washout Following Period 1|Physician Decision|0|||
126135986|NCT01582308|453787174|FG003|10-day Washout Following Period 1|Physician Decision|0|||
126135987|NCT01582308|453787175|FG004|10-day Washout Following Period 1|Physician Decision|1|||
126135988|NCT01582308|453787176|FG005|10-day Washout Following Period 1|Physician Decision|0|||
126135989|NCT01582308|453787177|FG006|10-day Washout Following Period 1|Physician Decision|0|||
126135990|NCT01582308|453787178|FG007|10-day Washout Following Period 1|Physician Decision|0|||
126135991|NCT01582308|453787179|FG008|10-day Washout Following Period 1|Physician Decision|0|||
126135992|NCT01582308|453787180|FG009|10-day Washout Following Period 1|Physician Decision|0|||
126135993|NCT01582308|453787171|FG000|Period 4|Physician Decision|1|||
126135994|NCT01582308|453787172|FG001|Period 4|Physician Decision|0|||
126135995|NCT01582308|453787173|FG002|Period 4|Physician Decision|0|||
126135996|NCT01582308|453787174|FG003|Period 4|Physician Decision|0|||
126135997|NCT01582308|453787175|FG004|Period 4|Physician Decision|0|||
126135998|NCT01582308|453787176|FG005|Period 4|Physician Decision|1|||
125968242|NCT00328510|453175749|FG000|Overall Study|Treatment changed to a single fraction|1|||
125968243|NCT00328510|453175750|FG001|Overall Study|Treatment changed to a single fraction|1|||
126135999|NCT01582308|453787177|FG006|Period 4|Physician Decision|0|||
126136000|NCT01582308|453787178|FG007|Period 4|Physician Decision|0|||
126136001|NCT01582308|453787179|FG008|Period 4|Physician Decision|0|||
126136002|NCT01582308|453787180|FG009|Period 4|Physician Decision|1|||
126136003|NCT02320487|453787181|FG000|Overall Study|Reason not Specified|1|||
126136004|NCT02320487|453787181|FG000|Overall Study|Physician Decision|5|||
126136005|NCT02320487|453787181|FG000|Overall Study|Withdrawal by Subject|1|||
126136006|NCT02320487|453787181|FG000|Overall Study|Death|3|||
126136007|NCT02320487|453787181|FG000|Overall Study|Adverse Event|11|||
126136008|NCT00684957|453787185|FG000|Overall Study|Withdrawal by Subject|1|||
126136009|NCT00684957|453787186|FG001|Overall Study|Withdrawal by Subject|1|||
126136010|NCT00684957|453787185|FG000|Overall Study|Lost to Follow-up|1|||
126136011|NCT00684957|453787186|FG001|Overall Study|Lost to Follow-up|0|||
126136012|NCT02363478|453788895|FG000|Overall Study|Lost to Follow-up|4|||
126136013|NCT02363478|453788895|FG000|Overall Study|Adverse Event|4|||
126136014|NCT00768898|453788896|FG000|Overall Study|Unrelated injury|1|||
126136015|NCT00768898|453788896|FG000|Overall Study|Headache|1|||
126136016|NCT03160560|453788899|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
126136017|NCT03160560|453788900|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126136018|NCT03160560|453788901|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126136019|NCT03160560|453788902|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
126136020|NCT03160560|453788899|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
126136021|NCT03160560|453788900|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126136022|NCT03160560|453788901|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126136023|NCT03160560|453788902|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126136024|NCT01430442|453788905|FG000|Overall Study|Subject Withdrew Consent|3|||
126136025|NCT01430442|453788906|FG001|Overall Study|Subject Withdrew Consent|0|||
126136026|NCT01430442|453788907|FG002|Overall Study|Subject Withdrew Consent|1|||
126136027|NCT01430442|453788908|FG003|Overall Study|Subject Withdrew Consent|0|||
126136028|NCT01430442|453788909|FG004|Overall Study|Subject Withdrew Consent|2|||
126136029|NCT01430442|453788910|FG005|Overall Study|Subject Withdrew Consent|1|||
126136030|NCT01430442|453788911|FG006|Overall Study|Subject Withdrew Consent|5|||
126136031|NCT01430442|453788912|FG007|Overall Study|Subject Withdrew Consent|2|||
126136032|NCT01430442|453788905|FG000|Overall Study|Lost to Follow-up|2|||
126136033|NCT01430442|453788906|FG001|Overall Study|Lost to Follow-up|0|||
126136034|NCT01430442|453788907|FG002|Overall Study|Lost to Follow-up|1|||
126136035|NCT01430442|453788908|FG003|Overall Study|Lost to Follow-up|2|||
126136036|NCT01430442|453788909|FG004|Overall Study|Lost to Follow-up|2|||
126136037|NCT01430442|453788910|FG005|Overall Study|Lost to Follow-up|1|||
126136038|NCT01430442|453788911|FG006|Overall Study|Lost to Follow-up|5|||
126136039|NCT01430442|453788912|FG007|Overall Study|Lost to Follow-up|1|||
126136040|NCT01430442|453788905|FG000|Overall Study|Pregnancy|1|||
126136041|NCT01430442|453788906|FG001|Overall Study|Pregnancy|0|||
126136042|NCT01430442|453788907|FG002|Overall Study|Pregnancy|0|||
126136043|NCT01430442|453788908|FG003|Overall Study|Pregnancy|0|||
126136044|NCT01430442|453788909|FG004|Overall Study|Pregnancy|0|||
126136045|NCT01430442|453788910|FG005|Overall Study|Pregnancy|1|||
126136046|NCT01430442|453788911|FG006|Overall Study|Pregnancy|0|||
126136047|NCT01430442|453788912|FG007|Overall Study|Pregnancy|0|||
126136048|NCT01430442|453788905|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
126136049|NCT01430442|453788906|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
126136050|NCT01430442|453788907|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
126136051|NCT01430442|453788908|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
126136052|NCT01430442|453788909|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
126136053|NCT01430442|453788910|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
126136054|NCT01430442|453788911|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
126136055|NCT01430442|453788912|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
126136056|NCT01641939|453788913|FG000|Overall Study|Death|90|||
126136057|NCT01641939|453788914|FG001|Overall Study|Death|187|||
126136058|NCT01641939|453788915|FG002|Overall Study|Death|61|||
126136059|NCT01641939|453788913|FG000|Overall Study|Lost to Follow-up|3|||
125968244|NCT03240588|453175752|FG000|Overall Study|Death|3|||
125968245|NCT03240588|453175753|FG001|Overall Study|Death|0|||
125968246|NCT03240588|453175754|FG002|Overall Study|Death|0|||
126136060|NCT01641939|453788914|FG001|Overall Study|Lost to Follow-up|2|||
126136061|NCT01641939|453788915|FG002|Overall Study|Lost to Follow-up|1|||
126136062|NCT01641939|453788913|FG000|Overall Study|Withdrawal by Subject|14|||
126136063|NCT01641939|453788914|FG001|Overall Study|Withdrawal by Subject|11|||
126136064|NCT01641939|453788915|FG002|Overall Study|Withdrawal by Subject|5|||
126136065|NCT01641939|453788913|FG000|Overall Study|Study Terminated by Sponsor|10|||
126136066|NCT01641939|453788914|FG001|Overall Study|Study Terminated by Sponsor|28|||
126136067|NCT01641939|453788915|FG002|Overall Study|Study Terminated by Sponsor|3|||
126136068|NCT03068325|453788916|FG000|Overall Study|Lost to Follow-up|5|||
126136069|NCT00454779|453788919|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
126136070|NCT00454779|453788920|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
126136071|NCT00454779|453788919|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
126136072|NCT00454779|453788920|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
126136073|NCT00454779|453788919|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
126136074|NCT00454779|453788920|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
126136075|NCT00454779|453788919|FG000|First-line Treatment Phase|Protocol Violation|0|||
126136076|NCT00454779|453788920|FG001|First-line Treatment Phase|Protocol Violation|1|||
126136077|NCT00454779|453788919|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
126136078|NCT00454779|453788920|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
126136079|NCT00454779|453788919|FG000|First-line Treatment Phase|Ongoing|1|||
126136080|NCT00454779|453788920|FG001|First-line Treatment Phase|Ongoing|0|||
126136081|NCT00454779|453788919|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
126136082|NCT00454779|453788920|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
126136083|NCT00454779|453788919|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
126136084|NCT00454779|453788920|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
126136085|NCT00454779|453788919|FG000|Second-line Treatment Phase|Ongoing|0|||
126136086|NCT00454779|453788920|FG001|Second-line Treatment Phase|Ongoing|1|||
126136087|NCT05425563|453788924|FG000|Overall Study|Withdrawal by Subject|17|||
126136088|NCT00168831|453788928|FG000|Overall Study|Adverse Event|36|||
126136089|NCT00168831|453788929|FG001|Overall Study|Adverse Event|47|||
126136090|NCT00168831|453788930|FG002|Overall Study|Adverse Event|74|||
126136091|NCT00168831|453788928|FG000|Overall Study|Lost to Follow-up|5|||
126136092|NCT00168831|453788929|FG001|Overall Study|Lost to Follow-up|6|||
126136093|NCT00168831|453788930|FG002|Overall Study|Lost to Follow-up|4|||
126136094|NCT00168831|453788928|FG000|Overall Study|Withdrawal by Subject|7|||
126136095|NCT00168831|453788929|FG001|Overall Study|Withdrawal by Subject|14|||
126136096|NCT00168831|453788930|FG002|Overall Study|Withdrawal by Subject|19|||
126136097|NCT00168831|453788928|FG000|Overall Study|Protocol Violation|6|||
126136098|NCT00168831|453788929|FG001|Overall Study|Protocol Violation|11|||
126136099|NCT00168831|453788930|FG002|Overall Study|Protocol Violation|11|||
126136100|NCT00168831|453788928|FG000|Overall Study|Other|6|||
126136101|NCT00168831|453788929|FG001|Overall Study|Other|3|||
126136102|NCT00168831|453788930|FG002|Overall Study|Other|6|||
126136103|NCT02009878|453788931|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
126136104|NCT02009878|453788932|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
126136105|NCT02009878|453788933|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
126136106|NCT04652804|453788936|FG000|Overall Study|Ineligible post randomization|1|||
126136107|NCT04652804|453788937|FG001|Overall Study|Ineligible post randomization|0|||
126136108|NCT04652804|453788938|FG002|Overall Study|Ineligible post randomization|1|||
126136109|NCT04652804|453788939|FG003|Overall Study|Ineligible post randomization|0|||
126136110|NCT04652804|453788940|FG004|Overall Study|Ineligible post randomization|1|||
126136111|NCT04652804|453788941|FG005|Overall Study|Ineligible post randomization|1|||
126136112|NCT04652804|453788936|FG000|Overall Study|Missing SVR lab results|2|||
126136113|NCT04652804|453788937|FG001|Overall Study|Missing SVR lab results|0|||
126136114|NCT04652804|453788938|FG002|Overall Study|Missing SVR lab results|0|||
126136115|NCT04652804|453788939|FG003|Overall Study|Missing SVR lab results|0|||
126136116|NCT04652804|453788940|FG004|Overall Study|Missing SVR lab results|0|||
126136117|NCT04652804|453788941|FG005|Overall Study|Missing SVR lab results|0|||
126136118|NCT03634800|453788942|FG000|Overall Study|Adverse Event|1|||
126136119|NCT03634800|453788942|FG000|Overall Study|Disease Progression|4|||
126136120|NCT03634800|453788942|FG000|Overall Study|Withdrawal by Subject|1|||
126136121|NCT00343512|453788949|FG000|Overall Study|Withdrawal by Subject|2|||
126136122|NCT00191451|453788952|FG000|Overall Study|Withdrawal by Subject|2|||
126136123|NCT00191451|453788953|FG001|Overall Study|Withdrawal by Subject|3|||
126136124|NCT00191451|453788954|FG002|Overall Study|Withdrawal by Subject|5|||
126136125|NCT00191451|453788952|FG000|Overall Study|Physician Decision|2|||
126136126|NCT00191451|453788953|FG001|Overall Study|Physician Decision|9|||
126136127|NCT00191451|453788954|FG002|Overall Study|Physician Decision|6|||
126136128|NCT00191451|453788952|FG000|Overall Study|Sponsor Decision|1|||
126136129|NCT00191451|453788953|FG001|Overall Study|Sponsor Decision|0|||
126136130|NCT00191451|453788954|FG002|Overall Study|Sponsor Decision|0|||
126136131|NCT00191451|453788952|FG000|Overall Study|Ineligible|0|||
126136132|NCT00191451|453788953|FG001|Overall Study|Ineligible|1|||
126136133|NCT00191451|453788954|FG002|Overall Study|Ineligible|0|||
126136134|NCT00191451|453788952|FG000|Overall Study|Reason Not Specified|2|||
126136135|NCT00191451|453788953|FG001|Overall Study|Reason Not Specified|1|||
126136136|NCT00191451|453788954|FG002|Overall Study|Reason Not Specified|3|||
126136137|NCT00684515|453788955|FG000|Overall Study|Adverse Event|3|||
126136138|NCT00684515|453788956|FG001|Overall Study|Adverse Event|3|||
126136139|NCT00684515|453788957|FG002|Overall Study|Adverse Event|1|||
126136140|NCT00684515|453788955|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
126136141|NCT00684515|453788956|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
126136142|NCT00684515|453788957|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
126136143|NCT00272987|453788958|FG000|Overall Study|Adverse Event|1|||
126136144|NCT00272987|453788959|FG001|Overall Study|Adverse Event|0|||
126136145|NCT00272987|453788960|FG002|Overall Study|Adverse Event|0|||
126136146|NCT00272987|453788958|FG000|Overall Study|Lost to Follow-up|3|||
126136147|NCT00272987|453788959|FG001|Overall Study|Lost to Follow-up|1|||
126136148|NCT00272987|453788960|FG002|Overall Study|Lost to Follow-up|1|||
126136149|NCT00272987|453788958|FG000|Overall Study|Withdrawal by Subject|1|||
126136150|NCT00272987|453788959|FG001|Overall Study|Withdrawal by Subject|0|||
126136151|NCT00272987|453788960|FG002|Overall Study|Withdrawal by Subject|3|||
126136152|NCT00272987|453788958|FG000|Overall Study|Sponsor Terminated study|0|||
126136153|NCT00272987|453788959|FG001|Overall Study|Sponsor Terminated study|1|||
126136154|NCT00272987|453788960|FG002|Overall Study|Sponsor Terminated study|1|||
126136155|NCT00272987|453788958|FG000|Overall Study|Disease progression|1|||
126136156|NCT00272987|453788959|FG001|Overall Study|Disease progression|1|||
126136157|NCT00272987|453788960|FG002|Overall Study|Disease progression|2|||
126136158|NCT00272987|453788958|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
126136159|NCT00272987|453788959|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
126136160|NCT00272987|453788960|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
126136161|NCT00272987|453788958|FG000|Overall Study|Death|1|||
126136162|NCT00272987|453788959|FG001|Overall Study|Death|0|||
126136163|NCT00272987|453788960|FG002|Overall Study|Death|0|||
126136164|NCT04428411|453788961|FG000|Overall Study|Lost to Follow-up|114|||
126136165|NCT01163786|453788962|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
126136166|NCT01163786|453788962|FG000|Treatment With Bortezomib|Adverse Event|2|||
126136167|NCT01163786|453788962|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
126136168|NCT03555266|453788963|FG000|Overall Study|Protocol Violation|6|||
126136169|NCT03555266|453788964|FG001|Overall Study|Protocol Violation|4|||
126136170|NCT01554579|453788965|FG000|Overall Study|Adverse Event|6|||
126136171|NCT01554579|453788966|FG001|Overall Study|Adverse Event|25|||
126136172|NCT01554579|453788965|FG000|Overall Study|Lack of Efficacy|2|||
126136173|NCT01554579|453788966|FG001|Overall Study|Lack of Efficacy|1|||
126136174|NCT01554579|453788965|FG000|Overall Study|Withdrawal by Subject|2|||
126136175|NCT01554579|453788966|FG001|Overall Study|Withdrawal by Subject|1|||
126136176|NCT01192347|453788970|FG000|Overall Study|Death|3|||
126136177|NCT01192347|453788970|FG000|Overall Study|Lost to Follow-up|3|||
126136178|NCT01192347|453788970|FG000|Overall Study|Withdrawal by Subject|1|||
126136179|NCT01192347|453788970|FG000|Overall Study|Adverse Event|1|||
126136180|NCT01192347|453788970|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
126136181|NCT01192347|453788970|FG000|Overall Study|Patient seen in different hospital|1|||
126136182|NCT01192347|453788970|FG000|Overall Study|Patient not visiting hospital regularly|1|||
126136183|NCT01192347|453788970|FG000|Overall Study|Patient did not show up for visits|1|||
126136184|NCT03543410|453788972|FG000|Overall Study|Adverse Event|10|||
126136185|NCT03543410|453788973|FG001|Overall Study|Adverse Event|8|||
126136186|NCT03543410|453788974|FG002|Overall Study|Adverse Event|2|||
126136187|NCT03543410|453788972|FG000|Overall Study|Lack of Efficacy|0|||
126136188|NCT03543410|453788973|FG001|Overall Study|Lack of Efficacy|1|||
126136189|NCT03543410|453788974|FG002|Overall Study|Lack of Efficacy|0|||
126136190|NCT03543410|453788972|FG000|Overall Study|Lost to Follow-up|0|||
126136191|NCT03543410|453788973|FG001|Overall Study|Lost to Follow-up|1|||
126136192|NCT03543410|453788974|FG002|Overall Study|Lost to Follow-up|0|||
126136193|NCT03543410|453788972|FG000|Overall Study|Withdrawal by Subject|5|||
126136194|NCT03543410|453788973|FG001|Overall Study|Withdrawal by Subject|2|||
126136195|NCT03543410|453788974|FG002|Overall Study|Withdrawal by Subject|8|||
126136196|NCT03543410|453788972|FG000|Overall Study|Protocol Violation|0|||
126136197|NCT03543410|453788973|FG001|Overall Study|Protocol Violation|1|||
126136198|NCT03543410|453788974|FG002|Overall Study|Protocol Violation|0|||
126136199|NCT03543410|453788972|FG000|Overall Study|Due to COVID-19|4|||
126136200|NCT03543410|453788973|FG001|Overall Study|Due to COVID-19|0|||
126136201|NCT03543410|453788974|FG002|Overall Study|Due to COVID-19|2|||
126136202|NCT03543410|453788972|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
126136203|NCT03543410|453788973|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
126136204|NCT03543410|453788974|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
126136205|NCT03543410|453788972|FG000|Overall Study|Not Due to COVID-19|2|||
126136206|NCT03543410|453788973|FG001|Overall Study|Not Due to COVID-19|0|||
126136207|NCT03543410|453788974|FG002|Overall Study|Not Due to COVID-19|1|||
126136208|NCT02883244|453788975|FG000|Overall Study|Lost to Follow-up|0|||
126136209|NCT02883244|453788976|FG001|Overall Study|Lost to Follow-up|1|||
126136210|NCT02317562|453788983|FG000|Overall Study|Physician Decision|1|||
125968247|NCT03240588|453175752|FG000|Overall Study|Adverse Event|5|||
126136211|NCT02317562|453788983|FG000|Overall Study|early termination of the study|8|||
126136212|NCT02317562|453788983|FG000|Overall Study|Lack of Efficacy|4|||
126136213|NCT02317562|453788983|FG000|Overall Study|Withdrawal by Subject|1|||
126136214|NCT00626093|453788984|FG000|Overall Study|Lost to Follow-up|5|||
126136215|NCT00626093|453788984|FG000|Overall Study|Death|1|||
126136216|NCT00626093|453788984|FG000|Overall Study|Physician Decision|4|||
126136217|NCT00626093|453788984|FG000|Overall Study|Withdrawal by Subject|6|||
126136218|NCT00626093|453788984|FG000|Overall Study|Protocol Violation|1|||
126136219|NCT00626093|453788984|FG000|Overall Study|One of the required devices not implante|6|||
126136220|NCT03891901|453788985|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
126136221|NCT03891901|453788986|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126136222|NCT03891901|453788987|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126136223|NCT03891901|453788988|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126136224|NCT03891901|453788989|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126136225|NCT03891901|453788990|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126136226|NCT03891901|453788991|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126136227|NCT03891901|453788992|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126136228|NCT03891901|453788993|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126136229|NCT03891901|453788985|FG000|Overall Study|Adverse Event|2|||
126136230|NCT03891901|453788986|FG001|Overall Study|Adverse Event|2|||
126136231|NCT03891901|453788987|FG002|Overall Study|Adverse Event|0|||
126136232|NCT03891901|453788988|FG003|Overall Study|Adverse Event|0|||
126136233|NCT03891901|453788989|FG004|Overall Study|Adverse Event|0|||
126136234|NCT03891901|453788990|FG005|Overall Study|Adverse Event|0|||
126136235|NCT03891901|453788991|FG006|Overall Study|Adverse Event|0|||
126136236|NCT03891901|453788992|FG007|Overall Study|Adverse Event|0|||
126136237|NCT03891901|453788993|FG008|Overall Study|Adverse Event|0|||
126136238|NCT03891901|453788985|FG000|Overall Study|Poor venous access|1|||
126136239|NCT03891901|453788986|FG001|Overall Study|Poor venous access|0|||
126136240|NCT03891901|453788987|FG002|Overall Study|Poor venous access|0|||
126136241|NCT03891901|453788988|FG003|Overall Study|Poor venous access|0|||
126136242|NCT03891901|453788989|FG004|Overall Study|Poor venous access|0|||
126136243|NCT03891901|453788990|FG005|Overall Study|Poor venous access|0|||
126136244|NCT03891901|453788991|FG006|Overall Study|Poor venous access|0|||
126136245|NCT03891901|453788992|FG007|Overall Study|Poor venous access|0|||
126136246|NCT03891901|453788993|FG008|Overall Study|Poor venous access|0|||
126136247|NCT03891901|453788985|FG000|Overall Study|Withdrawal by Subject|0|||
126136248|NCT03891901|453788986|FG001|Overall Study|Withdrawal by Subject|2|||
126136249|NCT03891901|453788987|FG002|Overall Study|Withdrawal by Subject|0|||
126136250|NCT03891901|453788988|FG003|Overall Study|Withdrawal by Subject|0|||
126136251|NCT03891901|453788989|FG004|Overall Study|Withdrawal by Subject|0|||
126136252|NCT03891901|453788990|FG005|Overall Study|Withdrawal by Subject|0|||
126136253|NCT03891901|453788991|FG006|Overall Study|Withdrawal by Subject|0|||
126136254|NCT03891901|453788992|FG007|Overall Study|Withdrawal by Subject|0|||
126136255|NCT03891901|453788993|FG008|Overall Study|Withdrawal by Subject|0|||
126136256|NCT00603915|453788994|FG000|Overall Study|Physician Decision|1|||
126136257|NCT00573794|453789000|FG000|Overall Study|Adverse Event|81|||
126136258|NCT00573794|453789000|FG000|Overall Study|Withdrew Consent|90|||
126136259|NCT00573794|453789000|FG000|Overall Study|Lost to Follow-up|13|||
126136260|NCT00573794|453789000|FG000|Overall Study|Protocol Violation|6|||
126136261|NCT00573794|453789000|FG000|Overall Study|Lack of Efficacy|94|||
126136262|NCT00573794|453789000|FG000|Overall Study|Other|46|||
126136263|NCT02026063|453789003|FG000|Overall Study|Physician Decision|0|||
126136264|NCT02026063|453789004|FG001|Overall Study|Physician Decision|10|||
126136265|NCT02026063|453789003|FG000|Overall Study|Noncompliance with Study Drug|1|||
126136266|NCT02026063|453789004|FG001|Overall Study|Noncompliance with Study Drug|1|||
126136267|NCT02026063|453789003|FG000|Overall Study|Withdrawal of Consent|1|||
126136268|NCT02026063|453789004|FG001|Overall Study|Withdrawal of Consent|6|||
126136269|NCT02026063|453789003|FG000|Overall Study|Adverse Event|5|||
126136270|NCT02026063|453789004|FG001|Overall Study|Adverse Event|20|||
126136271|NCT02026063|453789003|FG000|Overall Study|Lack of Efficacy|0|||
126136272|NCT02026063|453789004|FG001|Overall Study|Lack of Efficacy|4|||
126136273|NCT02026063|453789003|FG000|Overall Study|Lost to Follow-up|0|||
126136274|NCT02026063|453789004|FG001|Overall Study|Lost to Follow-up|1|||
126136275|NCT02026063|453789003|FG000|Overall Study|Reason not Specified|2|||
126136276|NCT02026063|453789004|FG001|Overall Study|Reason not Specified|7|||
126136277|NCT01116544|453789006|FG000|Overall Study|Protocol Violation|1|||
126136278|NCT01116544|453789007|FG001|Overall Study|Protocol Violation|0|||
126136279|NCT01116544|453789006|FG000|Overall Study|Withdrawal by Subject|1|||
126136280|NCT01116544|453789007|FG001|Overall Study|Withdrawal by Subject|1|||
126136281|NCT02183519|453789008|FG000|Overall Study|computer error|3|||
126136282|NCT02183519|453789009|FG001|Overall Study|computer error|0|||
125968248|NCT03240588|453175753|FG001|Overall Study|Adverse Event|4|||
125968249|NCT03240588|453175754|FG002|Overall Study|Adverse Event|0|||
126136283|NCT02183519|453789008|FG000|Overall Study|Did not respond to cough inducter|0|||
126136284|NCT02183519|453789009|FG001|Overall Study|Did not respond to cough inducter|3|||
126136285|NCT02542072|453789010|FG000|First Intervention (1 Month)|Adverse Event|1|||
126136286|NCT02542072|453789011|FG001|First Intervention (1 Month)|Adverse Event|1|||
126136287|NCT02542072|453789010|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
126136288|NCT02542072|453789011|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
126136289|NCT02542072|453789010|FG000|First Intervention (1 Month)|Lens discomfort|1|||
126136290|NCT02542072|453789011|FG001|First Intervention (1 Month)|Lens discomfort|2|||
126136291|NCT02542072|453789010|FG000|First Intervention (1 Month)|Protocol Violation|1|||
126136292|NCT02542072|453789011|FG001|First Intervention (1 Month)|Protocol Violation|0|||
126136293|NCT02542072|453789010|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
126136294|NCT02542072|453789011|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
126136295|NCT02542072|453789010|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
126136296|NCT02542072|453789011|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
126136297|NCT05702736|453789015|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
126136298|NCT05702736|453789016|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
126136299|NCT05702736|453789015|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
126136300|NCT05702736|453789016|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
126136301|NCT01356589|453789019|FG000|Overall Study|Enrolled, but not treated|3|||
126136302|NCT01356589|453789019|FG000|Overall Study|Dose data not recorded|2|||
126136303|NCT02937350|453789020|FG000|Overall Study|Withdrawal by Subject|0|||
126136304|NCT02937350|453789021|FG001|Overall Study|Withdrawal by Subject|1|||
126136305|NCT02937350|453789022|FG002|Overall Study|Withdrawal by Subject|0|||
126136306|NCT00695565|453789023|FG000|Overall Study|Lost to Follow-up|4|||
126136307|NCT00695565|453789024|FG001|Overall Study|Lost to Follow-up|4|||
126136308|NCT00695565|453789023|FG000|Overall Study|Adverse Event|3|||
126136309|NCT00695565|453789024|FG001|Overall Study|Adverse Event|1|||
126136310|NCT00695565|453789023|FG000|Overall Study|Protocol Violation|3|||
126136311|NCT00695565|453789024|FG001|Overall Study|Protocol Violation|1|||
126136312|NCT00695565|453789023|FG000|Overall Study|Withdrawal by Subject|1|||
126136313|NCT00695565|453789024|FG001|Overall Study|Withdrawal by Subject|1|||
126136314|NCT00695565|453789023|FG000|Overall Study|Lack of Efficacy|1|||
126136315|NCT00695565|453789024|FG001|Overall Study|Lack of Efficacy|1|||
126136316|NCT00695565|453789023|FG000|Overall Study|Subject did not follow instructions|1|||
126136317|NCT00695565|453789024|FG001|Overall Study|Subject did not follow instructions|1|||
126136318|NCT01462266|453789025|FG000|Overall Study|Adverse Event|7|||
126136319|NCT01462266|453789026|FG001|Overall Study|Adverse Event|6|||
126136320|NCT01462266|453789025|FG000|Overall Study|Death|2|||
126136321|NCT01462266|453789026|FG001|Overall Study|Death|1|||
126136322|NCT01462266|453789025|FG000|Overall Study|Lack of Efficacy|0|||
126136323|NCT01462266|453789026|FG001|Overall Study|Lack of Efficacy|2|||
126136324|NCT01462266|453789025|FG000|Overall Study|Lost to Follow-up|4|||
126136325|NCT01462266|453789026|FG001|Overall Study|Lost to Follow-up|3|||
126136326|NCT01462266|453789025|FG000|Overall Study|Non-compliance with study drug|3|||
126136327|NCT01462266|453789026|FG001|Overall Study|Non-compliance with study drug|0|||
126136328|NCT01462266|453789025|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
126136329|NCT01462266|453789026|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
126136330|NCT01462266|453789025|FG000|Overall Study|Physician Decision|2|||
126136331|NCT01462266|453789026|FG001|Overall Study|Physician Decision|5|||
126136332|NCT01462266|453789025|FG000|Overall Study|Protocol Violation|1|||
126136333|NCT01462266|453789026|FG001|Overall Study|Protocol Violation|3|||
126136334|NCT01462266|453789025|FG000|Overall Study|Withdrawal by Subject|7|||
126136335|NCT01462266|453789026|FG001|Overall Study|Withdrawal by Subject|2|||
126136336|NCT01462266|453789025|FG000|Overall Study|Screen failure|1|||
126136337|NCT01462266|453789026|FG001|Overall Study|Screen failure|1|||
126136338|NCT01106846|453789027|FG000|Overall Study|Change in surgical procedure|0|||
126136339|NCT01106846|453789028|FG001|Overall Study|Change in surgical procedure|1|||
126136340|NCT02419508|453789037|FG000|Overall Study|Adverse Event|9|||
126136341|NCT02419508|453789038|FG001|Overall Study|Adverse Event|3|||
126136342|NCT02419508|453789037|FG000|Overall Study|Withdrawal by Subject|1|||
126136343|NCT02419508|453789038|FG001|Overall Study|Withdrawal by Subject|0|||
126136344|NCT02419508|453789037|FG000|Overall Study|Other - Reason not specified|0|||
126136345|NCT02419508|453789038|FG001|Overall Study|Other - Reason not specified|1|||
126136346|NCT03110900|453789039|FG000|Overall Study|Sponsor withdrew|1|||
126136347|NCT03110900|453789040|FG001|Overall Study|Sponsor withdrew|1|||
126136348|NCT01031446|453789041|FG000|Overall Study|Disease Progression|38|||
126136349|NCT01031446|453789041|FG000|Overall Study|Adverse Event|9|||
126136350|NCT01031446|453789041|FG000|Overall Study|Physician Decision|4|||
126136351|NCT01031446|453789041|FG000|Overall Study|Withdrawal by Subject|3|||
126136352|NCT01031446|453789041|FG000|Overall Study|Still on treatment|1|||
126136353|NCT02447848|453789042|FG000|Overall Study|Patient discharged|3|||
126136354|NCT02447848|453789042|FG000|Overall Study|Lack of Efficacy|4|||
126136355|NCT02447848|453789042|FG000|Overall Study|Withdrawal by Subject|4|||
126136356|NCT04439175|453790532|FG000|Overall Study|Never started treatment|4|||
126136357|NCT04439175|453790532|FG000|Overall Study|Ineligible|5|||
126136358|NCT04439175|453790532|FG000|Overall Study|Adverse Event|6|||
126136359|NCT04439175|453790532|FG000|Overall Study|Death|4|||
126136360|NCT04439175|453790532|FG000|Overall Study|Disease progression|44|||
126136361|NCT04439175|453790532|FG000|Overall Study|Withdrawal by Subject|4|||
126136362|NCT04439175|453790532|FG000|Overall Study|Alternative Therapy|1|||
126136363|NCT04439175|453790532|FG000|Overall Study|Other|2|||
126136364|NCT02554929|453790533|FG000|Overall Study|Lost to Follow-up|4|||
126136365|NCT02554929|453790534|FG001|Overall Study|Lost to Follow-up|4|||
126136366|NCT02554929|453790533|FG000|Overall Study|Withdrawal by Subject|2|||
126136367|NCT02554929|453790534|FG001|Overall Study|Withdrawal by Subject|8|||
126136368|NCT00546364|453790535|FG000|Overall Study|Disease progression|5|||
126136369|NCT00546364|453790536|FG001|Overall Study|Disease progression|11|||
126136370|NCT00546364|453790537|FG002|Overall Study|Disease progression|8|||
126136371|NCT00546364|453790535|FG000|Overall Study|Completed and off treatment|1|||
126136372|NCT00546364|453790536|FG001|Overall Study|Completed and off treatment|0|||
126136373|NCT00546364|453790537|FG002|Overall Study|Completed and off treatment|2|||
126136374|NCT00546364|453790535|FG000|Overall Study|Administrative reason by sponsor|1|||
126136375|NCT00546364|453790536|FG001|Overall Study|Administrative reason by sponsor|0|||
126136376|NCT00546364|453790537|FG002|Overall Study|Administrative reason by sponsor|0|||
126136377|NCT00546364|453790535|FG000|Overall Study|Poor compliance/noncompliance|0|||
126136378|NCT00546364|453790536|FG001|Overall Study|Poor compliance/noncompliance|0|||
126136379|NCT00546364|453790537|FG002|Overall Study|Poor compliance/noncompliance|1|||
126136380|NCT00546364|453790535|FG000|Overall Study|No longer meets study criteria|1|||
126136381|NCT00546364|453790536|FG001|Overall Study|No longer meets study criteria|1|||
126136382|NCT00546364|453790537|FG002|Overall Study|No longer meets study criteria|0|||
126136383|NCT00546364|453790535|FG000|Overall Study|Withdrawal by Subject|5|||
126136384|NCT00546364|453790536|FG001|Overall Study|Withdrawal by Subject|6|||
126136385|NCT00546364|453790537|FG002|Overall Study|Withdrawal by Subject|3|||
126136386|NCT00546364|453790535|FG000|Overall Study|Prior taxotere|1|||
126136387|NCT00546364|453790536|FG001|Overall Study|Prior taxotere|0|||
126136388|NCT00546364|453790537|FG002|Overall Study|Prior taxotere|0|||
126136389|NCT00546364|453790535|FG000|Overall Study|Mixed response|1|||
126136390|NCT00546364|453790536|FG001|Overall Study|Mixed response|0|||
126136391|NCT00546364|453790537|FG002|Overall Study|Mixed response|0|||
126136392|NCT00546364|453790535|FG000|Overall Study|Palliative treatment|1|||
126136393|NCT00546364|453790536|FG001|Overall Study|Palliative treatment|0|||
126136394|NCT00546364|453790537|FG002|Overall Study|Palliative treatment|1|||
126136395|NCT00546364|453790535|FG000|Overall Study|Target lesions resected|1|||
126136396|NCT00546364|453790536|FG001|Overall Study|Target lesions resected|0|||
126136397|NCT00546364|453790537|FG002|Overall Study|Target lesions resected|0|||
126136398|NCT00546364|453790535|FG000|Overall Study|Physician Decision|0|||
126136399|NCT00546364|453790536|FG001|Overall Study|Physician Decision|0|||
126136400|NCT00546364|453790537|FG002|Overall Study|Physician Decision|1|||
126136401|NCT00546364|453790535|FG000|Overall Study|Sponsor decision|0|||
126136402|NCT00546364|453790536|FG001|Overall Study|Sponsor decision|0|||
126136403|NCT00546364|453790537|FG002|Overall Study|Sponsor decision|1|||
126136404|NCT00667576|453790538|FG000|Overall Study|Withdrawal by Subject|1|||
126136405|NCT00667576|453790539|FG001|Overall Study|Withdrawal by Subject|0|||
126136406|NCT00667576|453790540|FG002|Overall Study|Withdrawal by Subject|1|||
126136407|NCT00667576|453790541|FG003|Overall Study|Withdrawal by Subject|1|||
126136408|NCT00667576|453790542|FG004|Overall Study|Withdrawal by Subject|1|||
126136409|NCT00667576|453790538|FG000|Overall Study|Adverse Event|1|||
126136410|NCT00667576|453790539|FG001|Overall Study|Adverse Event|1|||
126136411|NCT00667576|453790540|FG002|Overall Study|Adverse Event|0|||
126136412|NCT00667576|453790541|FG003|Overall Study|Adverse Event|0|||
126136413|NCT00667576|453790542|FG004|Overall Study|Adverse Event|0|||
126136414|NCT00667576|453790538|FG000|Overall Study|Lost to Follow-up|0|||
126136415|NCT00667576|453790539|FG001|Overall Study|Lost to Follow-up|0|||
126136416|NCT00667576|453790540|FG002|Overall Study|Lost to Follow-up|1|||
126136417|NCT00667576|453790541|FG003|Overall Study|Lost to Follow-up|0|||
126136418|NCT00667576|453790542|FG004|Overall Study|Lost to Follow-up|0|||
126136419|NCT00667576|453790538|FG000|Overall Study|Protocol Violation|0|||
126136420|NCT00667576|453790539|FG001|Overall Study|Protocol Violation|0|||
126136421|NCT00667576|453790540|FG002|Overall Study|Protocol Violation|0|||
126136422|NCT00667576|453790541|FG003|Overall Study|Protocol Violation|1|||
126136423|NCT00667576|453790542|FG004|Overall Study|Protocol Violation|0|||
126136424|NCT00667576|453790538|FG000|Overall Study|Physician Decision|0|||
126136425|NCT00667576|453790539|FG001|Overall Study|Physician Decision|0|||
126136426|NCT00667576|453790540|FG002|Overall Study|Physician Decision|0|||
126136427|NCT00667576|453790541|FG003|Overall Study|Physician Decision|1|||
126136428|NCT00667576|453790542|FG004|Overall Study|Physician Decision|0|||
126136429|NCT00667576|453790538|FG000|Overall Study|Missed Visit|0|||
126136430|NCT00667576|453790539|FG001|Overall Study|Missed Visit|0|||
126136431|NCT00667576|453790540|FG002|Overall Study|Missed Visit|0|||
126136432|NCT00667576|453790541|FG003|Overall Study|Missed Visit|1|||
126136433|NCT00667576|453790542|FG004|Overall Study|Missed Visit|0|||
126136434|NCT01390389|453790543|FG000|Overall Study|Withdrawal by Subject|2|||
126136435|NCT01390389|453790544|FG001|Overall Study|Withdrawal by Subject|0|||
126136436|NCT01390389|453790543|FG000|Overall Study|Screen Fail|2|||
126136437|NCT01390389|453790544|FG001|Overall Study|Screen Fail|1|||
126136438|NCT02002975|453790545|FG000|Overall Study|Case Report Forms Uncollected|135|||
126136439|NCT02002975|453790545|FG000|Overall Study|Protocol Deviation|437|||
126136440|NCT00772629|453790546|FG000|Overall Study|Subject was not vaccinated|1|||
126136441|NCT00772629|453790547|FG001|Overall Study|Subject was not vaccinated|0|||
126136442|NCT05162066|453790551|FG000|Overall Study|Adverse Event|1|||
126136443|NCT05162066|453790552|FG001|Overall Study|Adverse Event|0|||
126136444|NCT05162066|453790553|FG002|Overall Study|Adverse Event|0|||
126136445|NCT05162066|453790551|FG000|Overall Study|Perceived lack of efficacy|1|||
126136446|NCT05162066|453790552|FG001|Overall Study|Perceived lack of efficacy|0|||
126136447|NCT05162066|453790553|FG002|Overall Study|Perceived lack of efficacy|0|||
126136448|NCT01072344|453790554|FG000|Overall Study|Relasped-reached end point|7|||
126136449|NCT01072344|453790555|FG001|Overall Study|Relasped-reached end point|12|||
126136450|NCT01072344|453790554|FG000|Overall Study|Protocol Violation|1|||
126136451|NCT01072344|453790555|FG001|Overall Study|Protocol Violation|2|||
126136452|NCT01072344|453790554|FG000|Overall Study|Lost to Follow-up|3|||
126136453|NCT01072344|453790555|FG001|Overall Study|Lost to Follow-up|4|||
126136454|NCT01871090|453790556|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
126136455|NCT01871090|453790557|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
126136456|NCT01871090|453790556|FG000|Overall Study|Interrogation not completed correctly|1|||
126136457|NCT01871090|453790557|FG001|Overall Study|Interrogation not completed correctly|0|||
126136458|NCT01871090|453790556|FG000|Overall Study|Subject Non-Compliance|0|||
126136459|NCT01871090|453790557|FG001|Overall Study|Subject Non-Compliance|1|||
126136460|NCT03569202|453790567|FG000|Part 3|Physician Decision|1|||
126136461|NCT03569202|453790568|FG001|Part 3|Physician Decision|0|||
126136462|NCT03569202|453790567|FG000|Part 3|Other|1|||
126136463|NCT03569202|453790568|FG001|Part 3|Other|1|||
126136464|NCT00420511|453790569|FG000|Overall Study|Adverse Event|1|||
126136465|NCT00420511|453790570|FG001|Overall Study|Adverse Event|1|||
126136466|NCT00420511|453790569|FG000|Overall Study|Lost to Follow-up|1|||
126136467|NCT00420511|453790570|FG001|Overall Study|Lost to Follow-up|0|||
126136468|NCT02415712|453790571|FG000|Overall Study|Protocol Violation|16|||
126136469|NCT01668654|453790572|FG000|Overall Study|Study Closed/Terminated|3|||
126136470|NCT01668654|453790572|FG000|Overall Study|Withdrawal by Subject|1|||
126136471|NCT04557384|453790573|FG000|Overall Study|Study Terminated by Sponsor|1|||
126136472|NCT04557384|453790573|FG000|Overall Study|Death|1|||
126136473|NCT02397473|453790575|FG000|Treatment Phase|Adverse Event|1|||
126136474|NCT02397473|453790576|FG001|Treatment Phase|Adverse Event|2|||
126136475|NCT02397473|453790575|FG000|Treatment Phase|Lack of Efficacy|8|||
126136476|NCT02397473|453790576|FG001|Treatment Phase|Lack of Efficacy|1|||
126136477|NCT02397473|453790575|FG000|Treatment Phase|Lost to Follow-up|1|||
126136478|NCT02397473|453790576|FG001|Treatment Phase|Lost to Follow-up|0|||
126136479|NCT02397473|453790575|FG000|Treatment Phase|Withdrawal by Subject|2|||
126136480|NCT02397473|453790576|FG001|Treatment Phase|Withdrawal by Subject|1|||
126136481|NCT02397473|453790575|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
126136482|NCT02397473|453790576|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
126136483|NCT02397473|453790575|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
126136484|NCT02397473|453790576|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
126136485|NCT02397473|453790575|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
126136486|NCT02397473|453790576|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
126136487|NCT02397473|453790575|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
126136488|NCT02397473|453790576|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
126136489|NCT02397473|453790575|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
126136490|NCT02397473|453790576|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
126136491|NCT01337973|453790577|FG000|Overall Study|Lost to Follow-up|2|||
126136492|NCT01337973|453790578|FG001|Overall Study|Lost to Follow-up|4|||
126136493|NCT01337973|453790579|FG002|Overall Study|Lost to Follow-up|3|||
126136494|NCT01337973|453790577|FG000|Overall Study|Death|1|||
126136495|NCT01337973|453790578|FG001|Overall Study|Death|2|||
126136496|NCT01337973|453790579|FG002|Overall Study|Death|1|||
126136497|NCT01337973|453790577|FG000|Overall Study|Withdrawal by Subject|10|||
126136498|NCT01337973|453790578|FG001|Overall Study|Withdrawal by Subject|8|||
126136499|NCT01337973|453790579|FG002|Overall Study|Withdrawal by Subject|4|||
126136500|NCT01337973|453790577|FG000|Overall Study|missing data on primary outcome|3|||
126136501|NCT01337973|453790578|FG001|Overall Study|missing data on primary outcome|1|||
126136502|NCT01337973|453790579|FG002|Overall Study|missing data on primary outcome|3|||
126136503|NCT02494596|453790581|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126136504|NCT02494596|453790582|FG001|Overall Study|Insufficient Therapeutic Response|3|||
126136505|NCT02494596|453790583|FG002|Overall Study|Insufficient Therapeutic Response|1|||
126136506|NCT02494596|453790581|FG000|Overall Study|Adverse Event|0|||
126136507|NCT02494596|453790582|FG001|Overall Study|Adverse Event|1|||
126136508|NCT02494596|453790583|FG002|Overall Study|Adverse Event|0|||
126136509|NCT02494596|453790581|FG000|Overall Study|Refused Treatment|0|||
126136510|NCT02494596|453790582|FG001|Overall Study|Refused Treatment|1|||
126136511|NCT02494596|453790583|FG002|Overall Study|Refused Treatment|0|||
126136512|NCT00254566|453790584|FG000|Overall Study|Death|1|||
126136513|NCT00254566|453790585|FG001|Overall Study|Death|0|||
126136514|NCT00254566|453790584|FG000|Overall Study|Adverse Event|5|||
126136515|NCT00254566|453790585|FG001|Overall Study|Adverse Event|4|||
126136516|NCT00254566|453790584|FG000|Overall Study|Lack of Efficacy|12|||
126136517|NCT00254566|453790585|FG001|Overall Study|Lack of Efficacy|9|||
126136518|NCT00254566|453790584|FG000|Overall Study|Other|1|||
126136519|NCT00254566|453790585|FG001|Overall Study|Other|5|||
126136520|NCT00254566|453790584|FG000|Overall Study|Withdrawal by Subject|5|||
126136521|NCT00254566|453790585|FG001|Overall Study|Withdrawal by Subject|6|||
126136522|NCT00254566|453790584|FG000|Overall Study|Lost to Follow-up|7|||
126136523|NCT00254566|453790585|FG001|Overall Study|Lost to Follow-up|2|||
126136524|NCT00059202|453790586|FG000|Overall Study|Withdrawal by Subject|5|||
126136525|NCT00059202|453790587|FG001|Overall Study|Withdrawal by Subject|9|||
126136526|NCT00059202|453790586|FG000|Overall Study|Protocol Violation|1|||
126136527|NCT00059202|453790587|FG001|Overall Study|Protocol Violation|3|||
126136528|NCT00059202|453790586|FG000|Overall Study|drug toxicity|0|||
126136529|NCT00059202|453790587|FG001|Overall Study|drug toxicity|3|||
126136530|NCT00584194|453790588|FG000|Overall Study|Other|135|||
126136531|NCT00927368|453790592|FG000|Overall Study|enrollment in another study|1|||
126136532|NCT00927368|453790593|FG001|Overall Study|enrollment in another study|1|||
126136533|NCT00927368|453790594|FG002|Overall Study|enrollment in another study|2|||
126136534|NCT00927368|453790592|FG000|Overall Study|Lost to Follow-up|4|||
126136535|NCT00927368|453790593|FG001|Overall Study|Lost to Follow-up|0|||
126136536|NCT00927368|453790594|FG002|Overall Study|Lost to Follow-up|0|||
126136537|NCT00927368|453790592|FG000|Overall Study|equipment failure|1|||
126136538|NCT00927368|453790593|FG001|Overall Study|equipment failure|0|||
126136539|NCT00927368|453790594|FG002|Overall Study|equipment failure|0|||
126136540|NCT00927368|453790592|FG000|Overall Study|ineligible post randomization|0|||
126136541|NCT00927368|453790593|FG001|Overall Study|ineligible post randomization|3|||
126136542|NCT00927368|453790594|FG002|Overall Study|ineligible post randomization|1|||
126136543|NCT00927368|453790592|FG000|Overall Study|cancellation of surgery|0|||
126136544|NCT00927368|453790593|FG001|Overall Study|cancellation of surgery|1|||
126136545|NCT00927368|453790594|FG002|Overall Study|cancellation of surgery|2|||
126136546|NCT02624492|453790595|FG000|Overall Study|Adverse Event|2|||
126136547|NCT02624492|453790596|FG001|Overall Study|Adverse Event|2|||
126136548|NCT02624492|453790597|FG002|Overall Study|Adverse Event|2|||
126136549|NCT02624492|453790595|FG000|Overall Study|Progressive disease|0|||
126136550|NCT02624492|453790596|FG001|Overall Study|Progressive disease|2|||
126136551|NCT02624492|453790597|FG002|Overall Study|Progressive disease|3|||
126136552|NCT00364689|453790599|FG000|Overall Study|Lost to Follow-up|1|||
126136553|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
126136554|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
126136555|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
126136556|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
126136557|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
126136558|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
126136559|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
126136560|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
126136561|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
126136562|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
126136563|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
126136564|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
126136565|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
126136566|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
126136567|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
126136568|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
126136569|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
126136570|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
126136571|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
126136572|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
126136573|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
126136574|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
126136575|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
126136576|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
126136577|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Death|2|||
126136578|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Death|1|||
126136579|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Death|2|||
126136580|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Graft loss|0|||
126136581|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Graft loss|2|||
126136582|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Graft loss|0|||
126136583|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
126136584|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
126136585|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
126136586|NCT01114529|453790603|FG000|Completed Study Medication at Month 24|Missing|2|||
126136587|NCT01114529|453790604|FG001|Completed Study Medication at Month 24|Missing|0|||
126136588|NCT01114529|453790605|FG002|Completed Study Medication at Month 24|Missing|0|||
126136589|NCT01114529|453790603|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
126136590|NCT01114529|453790604|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
126136591|NCT01114529|453790605|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
126136592|NCT01114529|453790603|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
126136593|NCT01114529|453790604|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
126136594|NCT01114529|453790605|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
126136595|NCT01114529|453790603|FG000|Completed Study Phase at Month 24|Death|8|||
126136596|NCT01114529|453790604|FG001|Completed Study Phase at Month 24|Death|5|||
126136597|NCT01114529|453790605|FG002|Completed Study Phase at Month 24|Death|4|||
126136598|NCT01114529|453790603|FG000|Completed Study Phase at Month 24|Other|2|||
126136599|NCT01114529|453790604|FG001|Completed Study Phase at Month 24|Other|0|||
126136600|NCT01114529|453790605|FG002|Completed Study Phase at Month 24|Other|0|||
126136601|NCT01114529|453790603|FG000|Completed Study Phase at Month 24|Missing|2|||
126136602|NCT01114529|453790604|FG001|Completed Study Phase at Month 24|Missing|0|||
126136603|NCT01114529|453790605|FG002|Completed Study Phase at Month 24|Missing|0|||
126136604|NCT00331409|453790610|FG000|Overall Study|Lack of Efficacy|4|||
126136605|NCT02167945|453790615|FG000|Overall Study|Adverse Event|16|||
126136606|NCT02167945|453790615|FG000|Overall Study|Withdrew Consent|42|||
126136607|NCT02167945|453790615|FG000|Overall Study|Lost to Follow-up|122|||
126136608|NCT02167945|453790615|FG000|Overall Study|COVID-19 logistical restrictions|6|||
126136609|NCT02167945|453790615|FG000|Overall Study|Other, not specified|63|||
126136610|NCT00132730|453790616|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
126136611|NCT00132730|453790617|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
126136612|NCT00132730|453790618|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
126136613|NCT00132730|453790619|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
126136614|NCT00132730|453790620|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
126136615|NCT00132730|453790621|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
126136616|NCT00132730|453790616|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
126136617|NCT00132730|453790617|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
126136618|NCT00132730|453790618|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
126136619|NCT00132730|453790619|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
126136620|NCT00132730|453790620|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
126136621|NCT00132730|453790621|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
126136622|NCT00132730|453790616|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
126136623|NCT00132730|453790617|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
126136624|NCT00132730|453790618|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
126136625|NCT00132730|453790619|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
126136626|NCT00132730|453790620|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
126136627|NCT00132730|453790621|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
126136628|NCT00132730|453790616|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
126136629|NCT00132730|453790617|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
126136630|NCT00132730|453790618|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
126136631|NCT00132730|453790619|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
126136632|NCT00132730|453790620|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
126136633|NCT00132730|453790621|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
126136634|NCT00132730|453790616|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
126136635|NCT00132730|453790617|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
126136636|NCT00132730|453790618|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
126136637|NCT00132730|453790619|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
126136638|NCT00132730|453790620|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
126136639|NCT00132730|453790621|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
126136640|NCT00132730|453790616|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126136641|NCT00132730|453790617|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126136642|NCT00132730|453790618|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126136643|NCT00132730|453790619|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
126136644|NCT00132730|453790620|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126136645|NCT00132730|453790621|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126136646|NCT00132730|453790616|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
126136647|NCT00132730|453790617|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
126136648|NCT00132730|453790618|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
126136649|NCT00132730|453790619|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
126136650|NCT00132730|453790620|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
126136651|NCT00132730|453790621|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
126136652|NCT00132730|453790616|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
126136653|NCT00132730|453790617|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
126136654|NCT00132730|453790618|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
126136655|NCT00132730|453790619|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
126136656|NCT00132730|453790620|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
126136657|NCT00132730|453790621|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
126136658|NCT00132730|453790616|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126136659|NCT00132730|453790617|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126136660|NCT00132730|453790618|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126136661|NCT00132730|453790619|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126136662|NCT00132730|453790620|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
126136663|NCT00132730|453790621|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126136664|NCT00132730|453790616|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126136665|NCT00132730|453790617|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126136666|NCT00132730|453790618|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126136667|NCT00132730|453790619|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126136668|NCT00132730|453790620|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
126136669|NCT00132730|453790621|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126136670|NCT00132730|453790616|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126136671|NCT00132730|453790617|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126136672|NCT00132730|453790618|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126136673|NCT00132730|453790619|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126136674|NCT00132730|453790620|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
126136675|NCT00132730|453790621|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126136676|NCT00132730|453790616|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
126136677|NCT00132730|453790617|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
126136678|NCT00132730|453790618|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
126136679|NCT00132730|453790619|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
126136680|NCT00132730|453790620|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
126136681|NCT00132730|453790621|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
126136682|NCT02623335|453790622|FG000|Overall Study|Death|8|||
126136683|NCT02623335|453790623|FG001|Overall Study|Death|7|||
126136684|NCT02623335|453790622|FG000|Overall Study|Lost to Follow-up|15|||
126136685|NCT02623335|453790623|FG001|Overall Study|Lost to Follow-up|23|||
126136686|NCT02623335|453790622|FG000|Overall Study|Withdrawal by Subject|2|||
126136687|NCT02623335|453790623|FG001|Overall Study|Withdrawal by Subject|5|||
126136688|NCT02623335|453790622|FG000|Overall Study|Protocol Violation|2|||
126136689|NCT02623335|453790623|FG001|Overall Study|Protocol Violation|1|||
126136690|NCT03739528|453790624|FG000|Overall Study|Not treated|8|||
126136691|NCT03739528|453790625|FG001|Overall Study|Not treated|12|||
126136692|NCT03739528|453790624|FG000|Overall Study|Treatment and study discontinued|6|||
126136693|NCT03739528|453790625|FG001|Overall Study|Treatment and study discontinued|2|||
126136694|NCT03739528|453790624|FG000|Overall Study|Treatment discontinued + study completed|1|||
126136695|NCT03739528|453790625|FG001|Overall Study|Treatment discontinued + study completed|3|||
126136696|NCT01046695|453790626|FG000|Overall Study|Subject had a pacemaker|0|||
126136697|NCT01046695|453790627|FG001|Overall Study|Subject had a pacemaker|1|||
126136698|NCT01046695|453790626|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
126136699|NCT01046695|453790627|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
126136700|NCT01058096|453790628|FG000|Double-blind Treatment Phase|Adverse Event|11|||
126136701|NCT01058096|453790629|FG001|Double-blind Treatment Phase|Adverse Event|15|||
126136702|NCT01058096|453790628|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
126136703|NCT01058096|453790629|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
126136704|NCT01058096|453790628|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
126136705|NCT01058096|453790629|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
126136706|NCT01058096|453790628|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
126136707|NCT01058096|453790629|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
125968250|NCT03240588|453175752|FG000|Overall Study|Lost to Follow-up|9|||
125968251|NCT03240588|453175753|FG001|Overall Study|Lost to Follow-up|4|||
126136708|NCT01058096|453790628|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126136709|NCT01058096|453790629|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
126136710|NCT01058096|453790628|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
126136711|NCT01058096|453790629|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
126136712|NCT00939692|453790630|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
126136713|NCT00939692|453790631|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
126136714|NCT00939692|453790630|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
126136715|NCT00939692|453790631|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
126136716|NCT03433781|453790637|FG000|Overall Study|Progression of Disease|1|||
126136717|NCT03433781|453790638|FG001|Overall Study|Progression of Disease|0|||
126136718|NCT03433781|453790639|FG002|Overall Study|Progression of Disease|0|||
126136719|NCT03433781|453790637|FG000|Overall Study|Physician Decision|0|||
126136720|NCT03433781|453790638|FG001|Overall Study|Physician Decision|1|||
126136721|NCT03433781|453790639|FG002|Overall Study|Physician Decision|0|||
126136722|NCT00408694|453790640|FG000|Overall Study|Ineligible|1|||
126136723|NCT00408694|453790640|FG000|Overall Study|No protocol treatment|1|||
126136724|NCT03261531|453790643|FG000|Overall Study|Withdrawal by Subject|4|||
126136725|NCT00820755|453790646|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
126136726|NCT00820755|453790647|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
126136727|NCT00820755|453790648|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
126136728|NCT00820755|453790646|FG000|Period 1: Combination Therapy Phase|Death|28|||
126136729|NCT00820755|453790647|FG001|Period 1: Combination Therapy Phase|Death|0|||
126136730|NCT00820755|453790648|FG002|Period 1: Combination Therapy Phase|Death|0|||
126136731|NCT00820755|453790646|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
126136732|NCT00820755|453790647|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
126136733|NCT00820755|453790648|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
126136734|NCT00820755|453790646|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
126136735|NCT00820755|453790647|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
126136736|NCT00820755|453790648|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
126136737|NCT00820755|453790646|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
126136738|NCT00820755|453790647|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
126136739|NCT00820755|453790648|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
126136740|NCT00820755|453790646|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
126136741|NCT00820755|453790647|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
126136742|NCT00820755|453790648|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
126136743|NCT00820755|453790646|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
126136744|NCT00820755|453790647|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
126136745|NCT00820755|453790648|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
126136746|NCT00820755|453790646|FG000|Period 1: Combination Therapy Phase|Other|11|||
126136747|NCT00820755|453790647|FG001|Period 1: Combination Therapy Phase|Other|0|||
126136748|NCT00820755|453790648|FG002|Period 1: Combination Therapy Phase|Other|0|||
126136749|NCT00820755|453790646|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
126136750|NCT00820755|453790647|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
126136751|NCT00820755|453790648|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
126136752|NCT00880256|453790651|FG000|Overall Study|Lost to Follow-up|28|||
126136753|NCT00091832|453790662|FG000|Overall Study|Physician Decision|1|||
126136754|NCT00091832|453790663|FG001|Overall Study|Physician Decision|0|||
126136755|NCT00091832|453790664|FG002|Overall Study|Physician Decision|0|||
126136756|NCT00091832|453790665|FG003|Overall Study|Physician Decision|0|||
126136757|NCT00091832|453790666|FG004|Overall Study|Physician Decision|0|||
126136758|NCT00091832|453790667|FG005|Overall Study|Physician Decision|0|||
126136759|NCT00091832|453790662|FG000|Overall Study|Adverse Event|0|||
126136760|NCT00091832|453790663|FG001|Overall Study|Adverse Event|0|||
126136761|NCT00091832|453790664|FG002|Overall Study|Adverse Event|0|||
126136762|NCT00091832|453790665|FG003|Overall Study|Adverse Event|1|||
126136763|NCT00091832|453790666|FG004|Overall Study|Adverse Event|3|||
126136764|NCT00091832|453790667|FG005|Overall Study|Adverse Event|0|||
126136765|NCT00091832|453790662|FG000|Overall Study|Withdrawal by Subject|4|||
126136766|NCT00091832|453790663|FG001|Overall Study|Withdrawal by Subject|5|||
126136767|NCT00091832|453790664|FG002|Overall Study|Withdrawal by Subject|0|||
126136768|NCT00091832|453790665|FG003|Overall Study|Withdrawal by Subject|1|||
126136769|NCT00091832|453790666|FG004|Overall Study|Withdrawal by Subject|3|||
126136770|NCT00091832|453790667|FG005|Overall Study|Withdrawal by Subject|1|||
126136771|NCT00091832|453790662|FG000|Overall Study|Death|6|||
126136772|NCT00091832|453790663|FG001|Overall Study|Death|4|||
126136773|NCT00091832|453790664|FG002|Overall Study|Death|5|||
126136774|NCT00091832|453790665|FG003|Overall Study|Death|8|||
126136775|NCT00091832|453790666|FG004|Overall Study|Death|5|||
126136776|NCT00091832|453790667|FG005|Overall Study|Death|6|||
126136777|NCT00091832|453790662|FG000|Overall Study|Disease Progression|2|||
126136778|NCT00091832|453790663|FG001|Overall Study|Disease Progression|0|||
126136779|NCT00091832|453790664|FG002|Overall Study|Disease Progression|0|||
126136780|NCT00091832|453790665|FG003|Overall Study|Disease Progression|1|||
126136781|NCT00091832|453790666|FG004|Overall Study|Disease Progression|1|||
126136782|NCT00091832|453790667|FG005|Overall Study|Disease Progression|2|||
126136783|NCT00091832|453790662|FG000|Overall Study|Ineligibility Determined|0|||
126136784|NCT00091832|453790663|FG001|Overall Study|Ineligibility Determined|0|||
126136785|NCT00091832|453790664|FG002|Overall Study|Ineligibility Determined|1|||
126136786|NCT00091832|453790665|FG003|Overall Study|Ineligibility Determined|0|||
126136787|NCT00091832|453790666|FG004|Overall Study|Ineligibility Determined|1|||
126136788|NCT00091832|453790667|FG005|Overall Study|Ineligibility Determined|0|||
126136789|NCT00091832|453790662|FG000|Overall Study|Lost to Follow-up|1|||
126136790|NCT00091832|453790663|FG001|Overall Study|Lost to Follow-up|0|||
126136791|NCT00091832|453790664|FG002|Overall Study|Lost to Follow-up|3|||
126136792|NCT00091832|453790665|FG003|Overall Study|Lost to Follow-up|3|||
126136793|NCT00091832|453790666|FG004|Overall Study|Lost to Follow-up|2|||
126136794|NCT00091832|453790667|FG005|Overall Study|Lost to Follow-up|1|||
126136795|NCT00091832|453790662|FG000|Overall Study|Noncompliance|0|||
126136796|NCT00091832|453790663|FG001|Overall Study|Noncompliance|1|||
126136797|NCT00091832|453790664|FG002|Overall Study|Noncompliance|0|||
126136798|NCT00091832|453790665|FG003|Overall Study|Noncompliance|0|||
126136799|NCT00091832|453790666|FG004|Overall Study|Noncompliance|0|||
126136800|NCT00091832|453790667|FG005|Overall Study|Noncompliance|0|||
126136801|NCT00091832|453790662|FG000|Overall Study|Other|0|||
126136802|NCT00091832|453790663|FG001|Overall Study|Other|1|||
126136803|NCT00091832|453790664|FG002|Overall Study|Other|2|||
126136804|NCT00091832|453790665|FG003|Overall Study|Other|0|||
126136805|NCT00091832|453790666|FG004|Overall Study|Other|0|||
126136806|NCT00091832|453790667|FG005|Overall Study|Other|0|||
126136807|NCT00091832|453790662|FG000|Overall Study|Protocol Violation|0|||
126136808|NCT00091832|453790663|FG001|Overall Study|Protocol Violation|0|||
126136809|NCT00091832|453790664|FG002|Overall Study|Protocol Violation|1|||
126136810|NCT00091832|453790665|FG003|Overall Study|Protocol Violation|0|||
126136811|NCT00091832|453790666|FG004|Overall Study|Protocol Violation|0|||
126136812|NCT00091832|453790667|FG005|Overall Study|Protocol Violation|1|||
126136813|NCT02154087|453790672|FG000|Overall Study|Study Termination|1|||
126136814|NCT00486278|453790673|FG000|Overall Study|Adverse Event|5|||
126136815|NCT00486278|453790673|FG000|Overall Study|Withdrawal by Subject|2|||
126136816|NCT00486278|453790673|FG000|Overall Study|Physician Decision|2|||
126136817|NCT05501119|453790674|FG000|Overall Study|Withdrawal by Subject|2|||
126136818|NCT05501119|453790674|FG000|Overall Study|Lost to Follow-up|5|||
126136819|NCT01738971|453790688|FG000|Overall Study|Lost to Follow-up|19|||
126136820|NCT01738971|453790689|FG001|Overall Study|Lost to Follow-up|30|||
126136821|NCT01738971|453790690|FG002|Overall Study|Lost to Follow-up|17|||
126136822|NCT00772668|453790696|FG000|Overall Study|Physician Decision|3|||
126136823|NCT04484285|453792645|FG000|Overall Study|Unable to operate stimulator|3|||
126136824|NCT04484285|453792646|FG001|Overall Study|Unable to operate stimulator|0|||
126136825|NCT05888103|453792647|FG000|Overall Study|Participant decision|3|||
126136826|NCT05888103|453792648|FG001|Overall Study|Participant decision|3|||
126136827|NCT02324270|453792649|FG000|Overall Study|Withdrawal by Subject|0|||
126136828|NCT02324270|453792650|FG001|Overall Study|Withdrawal by Subject|1|||
126136829|NCT02324270|453792651|FG002|Overall Study|Withdrawal by Subject|0|||
126136830|NCT02324270|453792649|FG000|Overall Study|Lost to Follow-up|4|||
126136831|NCT02324270|453792650|FG001|Overall Study|Lost to Follow-up|3|||
126136832|NCT02324270|453792651|FG002|Overall Study|Lost to Follow-up|4|||
126136833|NCT02324270|453792649|FG000|Overall Study|Protocol Violation|0|||
126136834|NCT02324270|453792650|FG001|Overall Study|Protocol Violation|1|||
126136835|NCT02324270|453792651|FG002|Overall Study|Protocol Violation|1|||
126136836|NCT02324270|453792649|FG000|Overall Study|Non Compliance with Study Drug|1|||
126136837|NCT02324270|453792650|FG001|Overall Study|Non Compliance with Study Drug|2|||
126136838|NCT02324270|453792651|FG002|Overall Study|Non Compliance with Study Drug|0|||
126136839|NCT00680836|453792652|FG000|Overall Study|Withdrawal by Subject|3|||
126136840|NCT00680836|453792653|FG001|Overall Study|Withdrawal by Subject|0|||
126136841|NCT00680836|453792652|FG000|Overall Study|Lost to Follow-up|3|||
126136842|NCT00680836|453792653|FG001|Overall Study|Lost to Follow-up|1|||
126136843|NCT00680836|453792652|FG000|Overall Study|Physician Decision|2|||
126136844|NCT00680836|453792653|FG001|Overall Study|Physician Decision|1|||
126136845|NCT03968419|453792655|FG000|Treatment Period|Adverse Event|0|||
126136846|NCT03968419|453792656|FG001|Treatment Period|Adverse Event|0|||
126136847|NCT03968419|453792657|FG002|Treatment Period|Adverse Event|1|||
126136848|NCT03968419|453792655|FG000|Safety Follow-up Period|Death|3|||
126136849|NCT03968419|453792656|FG001|Safety Follow-up Period|Death|2|||
126136850|NCT03968419|453792657|FG002|Safety Follow-up Period|Death|1|||
126136851|NCT03968419|453792655|FG000|Safety Follow-up Period|Subject Decision|2|||
126136852|NCT03968419|453792656|FG001|Safety Follow-up Period|Subject Decision|1|||
126136853|NCT03968419|453792657|FG002|Safety Follow-up Period|Subject Decision|0|||
126136854|NCT03593915|453792658|FG000|Overall Study|Adverse Event|0|||
126136855|NCT03593915|453792659|FG001|Overall Study|Adverse Event|0|||
126136856|NCT03593915|453792660|FG002|Overall Study|Adverse Event|0|||
126136857|NCT03593915|453792661|FG003|Overall Study|Adverse Event|1|||
126136858|NCT03593915|453792662|FG004|Overall Study|Adverse Event|0|||
126136859|NCT03593915|453792663|FG005|Overall Study|Adverse Event|0|||
126136860|NCT03593915|453792658|FG000|Overall Study|Physician Decision|0|||
126136861|NCT03593915|453792659|FG001|Overall Study|Physician Decision|0|||
126136862|NCT03593915|453792660|FG002|Overall Study|Physician Decision|0|||
126136863|NCT03593915|453792661|FG003|Overall Study|Physician Decision|0|||
126136864|NCT03593915|453792662|FG004|Overall Study|Physician Decision|0|||
126136865|NCT03593915|453792663|FG005|Overall Study|Physician Decision|1|||
126136866|NCT02894840|453792664|FG000|Overall Study|Lost to Follow-up|1|||
126136867|NCT02894840|453792665|FG001|Overall Study|Lost to Follow-up|0|||
126136868|NCT02894840|453792666|FG002|Overall Study|Lost to Follow-up|3|||
126136869|NCT02894840|453792667|FG003|Overall Study|Lost to Follow-up|0|||
126136870|NCT00167245|453792669|FG000|Overall Study|Lost to Follow-up|20|||
126136871|NCT00167245|453792670|FG001|Overall Study|Lost to Follow-up|31|||
126136872|NCT00167245|453792669|FG000|Overall Study|Withdrawal by Subject|5|||
126136873|NCT00167245|453792670|FG001|Overall Study|Withdrawal by Subject|8|||
126136874|NCT00167245|453792669|FG000|Overall Study|Incarcerated|3|||
126136875|NCT00167245|453792670|FG001|Overall Study|Incarcerated|2|||
126136876|NCT00167245|453792669|FG000|Overall Study|Drowsy|1|||
126136877|NCT00167245|453792670|FG001|Overall Study|Drowsy|0|||
126136878|NCT00804687|453792675|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
126136879|NCT00804687|453792676|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
126136880|NCT00804687|453792677|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
126136881|NCT00804687|453792678|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
126136882|NCT00804687|453792679|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
126136883|NCT00804687|453792680|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
126136884|NCT00804687|453792675|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
126136885|NCT00804687|453792676|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
126136886|NCT00804687|453792677|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
126136887|NCT00804687|453792678|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
126136888|NCT00804687|453792679|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
126136889|NCT00804687|453792680|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
126136890|NCT00804687|453792675|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
126136891|NCT00804687|453792676|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
126136892|NCT00804687|453792677|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
126136893|NCT00804687|453792678|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
126136894|NCT00804687|453792679|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
126136895|NCT00804687|453792680|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
126136896|NCT00804687|453792675|FG000|Period 5: Treatment Period|Positive drug test|1|||
126136897|NCT00804687|453792676|FG001|Period 5: Treatment Period|Positive drug test|0|||
126136898|NCT00804687|453792677|FG002|Period 5: Treatment Period|Positive drug test|0|||
126136899|NCT00804687|453792678|FG003|Period 5: Treatment Period|Positive drug test|0|||
126136900|NCT00804687|453792679|FG004|Period 5: Treatment Period|Positive drug test|0|||
126136901|NCT00804687|453792680|FG005|Period 5: Treatment Period|Positive drug test|0|||
126136902|NCT00688909|453792683|FG000|Overall Study|Adverse Event|28|||
126136903|NCT00688909|453792683|FG000|Overall Study|Patient withdrew consent|2|||
126136904|NCT00688909|453792683|FG000|Overall Study|Administrative problems|1|||
126136905|NCT00688909|453792683|FG000|Overall Study|Protocol Violation|2|||
126136906|NCT01220414|453792684|FG000|Overall Study|Withdrawal by Subject|1|||
126136907|NCT01220414|453792685|FG001|Overall Study|Withdrawal by Subject|0|||
126136908|NCT01220414|453792686|FG002|Overall Study|Withdrawal by Subject|0|||
126136909|NCT01220414|453792687|FG003|Overall Study|Withdrawal by Subject|1|||
126136910|NCT00860158|453792695|FG000|Overall Study|Study Terminated|1|||
126136911|NCT00669617|453792697|FG000|Period 1|Withdrawal by Subject|0|||
126136912|NCT00669617|453792698|FG001|Period 1|Withdrawal by Subject|0|||
126136913|NCT00669617|453792699|FG002|Period 1|Withdrawal by Subject|1|||
126136914|NCT00669617|453792700|FG003|Period 1|Withdrawal by Subject|0|||
126136915|NCT00669617|453792701|FG004|Period 1|Withdrawal by Subject|0|||
126136916|NCT00669617|453792697|FG000|Period 1|Protocol Deviation|0|||
126136917|NCT00669617|453792698|FG001|Period 1|Protocol Deviation|0|||
126136918|NCT00669617|453792699|FG002|Period 1|Protocol Deviation|0|||
126136919|NCT00669617|453792700|FG003|Period 1|Protocol Deviation|0|||
126136920|NCT00669617|453792701|FG004|Period 1|Protocol Deviation|1|||
126136921|NCT00669617|453792697|FG000|Period 3|Lost to Follow-up|1|||
126136922|NCT00669617|453792698|FG001|Period 3|Lost to Follow-up|0|||
126136923|NCT00669617|453792699|FG002|Period 3|Lost to Follow-up|0|||
126136924|NCT00669617|453792700|FG003|Period 3|Lost to Follow-up|0|||
126136925|NCT00669617|453792701|FG004|Period 3|Lost to Follow-up|0|||
126136926|NCT05499520|453792702|FG000|Overall Study|Lost to Follow-up|0|||
126136927|NCT05499520|453792703|FG001|Overall Study|Lost to Follow-up|0|||
126136928|NCT05499520|453792704|FG002|Overall Study|Lost to Follow-up|38|||
126136929|NCT05499520|453792705|FG003|Overall Study|Lost to Follow-up|41|||
126136930|NCT05499520|453792706|FG004|Overall Study|Lost to Follow-up|46|||
126136931|NCT05499520|453792707|FG005|Overall Study|Lost to Follow-up|0|||
126136932|NCT05499520|453792708|FG006|Overall Study|Lost to Follow-up|31|||
126136933|NCT05499520|453792709|FG007|Overall Study|Lost to Follow-up|45|||
126136934|NCT05499520|453792710|FG008|Overall Study|Lost to Follow-up|42|||
126136935|NCT05499520|453792711|FG009|Overall Study|Lost to Follow-up|0|||
126136936|NCT05499520|453792712|FG010|Overall Study|Lost to Follow-up|0|||
126136937|NCT05499520|453792713|FG011|Overall Study|Lost to Follow-up|37|||
126136938|NCT05499520|453792714|FG012|Overall Study|Lost to Follow-up|53|||
126136939|NCT05499520|453792715|FG013|Overall Study|Lost to Follow-up|49|||
126136940|NCT05499520|453792716|FG014|Overall Study|Lost to Follow-up|0|||
126136941|NCT05499520|453792717|FG015|Overall Study|Lost to Follow-up|36|||
126136942|NCT05499520|453792718|FG016|Overall Study|Lost to Follow-up|58|||
126136943|NCT05499520|453792719|FG017|Overall Study|Lost to Follow-up|53|||
126136944|NCT01613326|453792720|FG000|Overall Study|Adverse Event|7|||
126136945|NCT01613326|453792721|FG001|Overall Study|Adverse Event|5|||
126136946|NCT01613326|453792720|FG000|Overall Study|Withdrawal by Subject|3|||
126136947|NCT01613326|453792721|FG001|Overall Study|Withdrawal by Subject|4|||
126136948|NCT01613326|453792720|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126136949|NCT01613326|453792721|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126136950|NCT01613326|453792720|FG000|Overall Study|inability to use device|1|||
126136951|NCT01613326|453792721|FG001|Overall Study|inability to use device|0|||
126136952|NCT01613326|453792720|FG000|Overall Study|Lack of Efficacy|0|||
126136953|NCT01613326|453792721|FG001|Overall Study|Lack of Efficacy|1|||
126136954|NCT01613326|453792720|FG000|Overall Study|Lost to Follow-up|0|||
126136955|NCT01613326|453792721|FG001|Overall Study|Lost to Follow-up|1|||
126136956|NCT01613326|453792720|FG000|Overall Study|Administrative|0|||
126136957|NCT01613326|453792721|FG001|Overall Study|Administrative|2|||
126136958|NCT01613326|453792720|FG000|Overall Study|Protocol Violation|0|||
126136959|NCT01613326|453792721|FG001|Overall Study|Protocol Violation|1|||
126136960|NCT03980938|453792722|FG000|Treatment Period 1|Study Terminated|1|||
126136961|NCT03980938|453792723|FG001|Treatment Period 1|Study Terminated|1|||
126136962|NCT03980938|453792722|FG000|Treatment Period 2|Study Terminated|2|||
126136963|NCT03980938|453792723|FG001|Treatment Period 2|Study Terminated|2|||
126136964|NCT00840827|453792724|FG000|Overall Study|Adverse Event|1|||
126136965|NCT00840827|453792724|FG000|Overall Study|Lack of Efficacy|4|||
126136966|NCT00840827|453792724|FG000|Overall Study|Physician Decision|1|||
126136967|NCT01445535|453792725|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
126136968|NCT01445535|453792726|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
126136969|NCT01445535|453792727|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
126136970|NCT01445535|453792728|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
126136971|NCT01445535|453792725|FG000|Overall Study|Disease progression|1|||
126136972|NCT01445535|453792726|FG001|Overall Study|Disease progression|0|||
126136973|NCT01445535|453792727|FG002|Overall Study|Disease progression|1|||
126136974|NCT01445535|453792728|FG003|Overall Study|Disease progression|0|||
126136975|NCT01445535|453792725|FG000|Overall Study|PI discretion|0|||
126136976|NCT01445535|453792726|FG001|Overall Study|PI discretion|0|||
126136977|NCT01445535|453792727|FG002|Overall Study|PI discretion|0|||
126136978|NCT01445535|453792728|FG003|Overall Study|PI discretion|1|||
126136979|NCT02658448|453792734|FG000|Overall Study|Lost to Follow-up|1|||
126136980|NCT03072160|453792735|FG000|Overall Study|Adverse Event|3|||
126136981|NCT03072160|453792736|FG001|Overall Study|Adverse Event|1|||
126136982|NCT03072160|453792735|FG000|Overall Study|Refused further treatment|6|||
126136983|NCT03072160|453792736|FG001|Overall Study|Refused further treatment|1|||
126136984|NCT03072160|453792735|FG000|Overall Study|Physician Decision|1|||
126136985|NCT03072160|453792736|FG001|Overall Study|Physician Decision|0|||
126136986|NCT03072160|453792735|FG000|Overall Study|Disease progression on study|1|||
126136987|NCT03072160|453792736|FG001|Overall Study|Disease progression on study|1|||
126136988|NCT03072160|453792735|FG000|Overall Study|No contact|0|||
126136989|NCT03072160|453792736|FG001|Overall Study|No contact|1|||
126136990|NCT02239263|453792737|FG000|Overall Study|Protocol Violation|6|||
126136991|NCT04276207|453792739|FG000|Period 1|Withdrawal by Subject|0|||
126136992|NCT04276207|453792740|FG001|Period 1|Withdrawal by Subject|1|||
126136993|NCT01463098|453792741|FG000|Part A (11 Days)|Participant Choice|2|||
126136994|NCT01463098|453792742|FG001|Part A (11 Days)|Participant Choice|0|||
126136995|NCT01463098|453792743|FG002|Part A (11 Days)|Participant Choice|0|||
126136996|NCT01463098|453792744|FG003|Part A (11 Days)|Participant Choice|0|||
126136997|NCT01463098|453792745|FG004|Part A (11 Days)|Participant Choice|0|||
126136998|NCT01463098|453792746|FG005|Part A (11 Days)|Participant Choice|0|||
126136999|NCT01463098|453792747|FG006|Part A (11 Days)|Participant Choice|0|||
126137000|NCT01463098|453792748|FG007|Part A (11 Days)|Participant Choice|0|||
126137001|NCT01463098|453792749|FG008|Part A (11 Days)|Participant Choice|1|||
126137002|NCT01463098|453792750|FG009|Part A (11 Days)|Participant Choice|0|||
126137003|NCT01463098|453792751|FG010|Part A (11 Days)|Participant Choice|0|||
126137004|NCT01463098|453792752|FG011|Part A (11 Days)|Participant Choice|0|||
126137005|NCT01463098|453792753|FG012|Part A (11 Days)|Participant Choice|0|||
126137006|NCT01463098|453792754|FG013|Part A (11 Days)|Participant Choice|0|||
126137007|NCT01463098|453792741|FG000|Part A (11 Days)|Lost to Follow-up|0|||
126137008|NCT01463098|453792742|FG001|Part A (11 Days)|Lost to Follow-up|0|||
126137009|NCT01463098|453792743|FG002|Part A (11 Days)|Lost to Follow-up|0|||
126137010|NCT01463098|453792744|FG003|Part A (11 Days)|Lost to Follow-up|0|||
126137011|NCT01463098|453792745|FG004|Part A (11 Days)|Lost to Follow-up|1|||
126137012|NCT01463098|453792746|FG005|Part A (11 Days)|Lost to Follow-up|0|||
126137013|NCT01463098|453792747|FG006|Part A (11 Days)|Lost to Follow-up|0|||
126137014|NCT01463098|453792748|FG007|Part A (11 Days)|Lost to Follow-up|0|||
126137015|NCT01463098|453792749|FG008|Part A (11 Days)|Lost to Follow-up|0|||
126137016|NCT01463098|453792750|FG009|Part A (11 Days)|Lost to Follow-up|0|||
126137017|NCT01463098|453792751|FG010|Part A (11 Days)|Lost to Follow-up|0|||
126137018|NCT01463098|453792752|FG011|Part A (11 Days)|Lost to Follow-up|0|||
126137019|NCT01463098|453792753|FG012|Part A (11 Days)|Lost to Follow-up|0|||
126137020|NCT01463098|453792754|FG013|Part A (11 Days)|Lost to Follow-up|0|||
126137021|NCT01463098|453792741|FG000|Part B (11 Days)|Participant Choice|0|||
126137022|NCT01463098|453792742|FG001|Part B (11 Days)|Participant Choice|0|||
126137023|NCT01463098|453792743|FG002|Part B (11 Days)|Participant Choice|0|||
126137024|NCT01463098|453792744|FG003|Part B (11 Days)|Participant Choice|0|||
126137025|NCT01463098|453792745|FG004|Part B (11 Days)|Participant Choice|0|||
126137026|NCT01463098|453792746|FG005|Part B (11 Days)|Participant Choice|0|||
126137027|NCT01463098|453792747|FG006|Part B (11 Days)|Participant Choice|0|||
126137028|NCT01463098|453792748|FG007|Part B (11 Days)|Participant Choice|0|||
126137029|NCT01463098|453792749|FG008|Part B (11 Days)|Participant Choice|0|||
126137030|NCT01463098|453792750|FG009|Part B (11 Days)|Participant Choice|0|||
126137031|NCT01463098|453792751|FG010|Part B (11 Days)|Participant Choice|0|||
126137032|NCT01463098|453792752|FG011|Part B (11 Days)|Participant Choice|1|||
126137033|NCT01463098|453792753|FG012|Part B (11 Days)|Participant Choice|0|||
126137034|NCT01463098|453792754|FG013|Part B (11 Days)|Participant Choice|0|||
126137035|NCT02769624|453792759|FG000|Overall Study|Lost to Follow-up|0|||
126137036|NCT02769624|453792760|FG001|Overall Study|Lost to Follow-up|1|||
126137037|NCT04451330|453792761|FG000|Overall Study|Adverse Event|1|||
126137038|NCT04451330|453792762|FG001|Overall Study|Adverse Event|2|||
126137039|NCT04451330|453792761|FG000|Overall Study|Lost to Follow-up|5|||
126137040|NCT04451330|453792762|FG001|Overall Study|Lost to Follow-up|0|||
126137041|NCT04451330|453792761|FG000|Overall Study|Withdrawal by Subject|3|||
126137042|NCT04451330|453792762|FG001|Overall Study|Withdrawal by Subject|1|||
126137043|NCT04451330|453792761|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126137044|NCT04451330|453792762|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126137045|NCT04451330|453792761|FG000|Overall Study|Other than specified|0|||
126137046|NCT04451330|453792762|FG001|Overall Study|Other than specified|1|||
126137047|NCT05099640|453792763|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
126137048|NCT05099640|453792764|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
126137049|NCT05099640|453792765|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
126137050|NCT05099640|453792763|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
126137051|NCT05099640|453792764|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
126137052|NCT05099640|453792765|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
126137053|NCT05099640|453792763|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
126137054|NCT05099640|453792764|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
126137055|NCT05099640|453792765|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
126137056|NCT05099640|453792763|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
126137057|NCT05099640|453792764|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
126137058|NCT05099640|453792765|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
126137059|NCT05099640|453792763|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
126137060|NCT05099640|453792764|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
126137061|NCT05099640|453792765|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
126137062|NCT05099640|453792763|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
126137063|NCT05099640|453792764|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
126137064|NCT05099640|453792765|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
126137065|NCT00179959|453792766|FG000|Overall Study|Lost to Follow-up|3|||
126137066|NCT00179959|453792767|FG001|Overall Study|Lost to Follow-up|1|||
126137067|NCT00179959|453792766|FG000|Overall Study|Withdrawal by Subject|3|||
126137068|NCT00179959|453792767|FG001|Overall Study|Withdrawal by Subject|2|||
126137069|NCT01528787|453792768|FG000|Overall Study|Withdrawal by Subject|0|||
126137070|NCT01528787|453792769|FG001|Overall Study|Withdrawal by Subject|0|||
126137071|NCT01528787|453792770|FG002|Overall Study|Withdrawal by Subject|0|||
126137072|NCT01528787|453792771|FG003|Overall Study|Withdrawal by Subject|1|||
126137073|NCT01528787|453792768|FG000|Overall Study|Family Emergency|0|||
126137074|NCT01528787|453792769|FG001|Overall Study|Family Emergency|0|||
126137075|NCT01528787|453792770|FG002|Overall Study|Family Emergency|1|||
126137076|NCT01528787|453792771|FG003|Overall Study|Family Emergency|0|||
126137077|NCT00448708|453792772|FG000|Overall Study|Death|21|||
126137078|NCT00448708|453792773|FG001|Overall Study|Death|17|||
126137079|NCT00448708|453792772|FG000|Overall Study|Withdrawal by Subject|8|||
126137080|NCT00448708|453792773|FG001|Overall Study|Withdrawal by Subject|4|||
126137081|NCT00448708|453792772|FG000|Overall Study|Lost to Follow-up|6|||
126137082|NCT00448708|453792773|FG001|Overall Study|Lost to Follow-up|8|||
126137083|NCT00448708|453792772|FG000|Overall Study|not listed|0|||
126137084|NCT00448708|453792773|FG001|Overall Study|not listed|2|||
126137085|NCT00666926|453792775|FG000|Overall Study|Adverse Event|0|||
126137086|NCT00666926|453792776|FG001|Overall Study|Adverse Event|0|||
126137087|NCT00666926|453792777|FG002|Overall Study|Adverse Event|0|||
126137088|NCT00666926|453792778|FG003|Overall Study|Adverse Event|0|||
126137089|NCT00666926|453792779|FG004|Overall Study|Adverse Event|0|||
126137090|NCT00666926|453792780|FG005|Overall Study|Adverse Event|0|||
126137091|NCT00666926|453792781|FG006|Overall Study|Adverse Event|0|||
126137092|NCT00666926|453792782|FG007|Overall Study|Adverse Event|0|||
126137093|NCT00666926|453792783|FG008|Overall Study|Adverse Event|0|||
126137094|NCT00666926|453792784|FG009|Overall Study|Adverse Event|2|||
126137095|NCT00666926|453792785|FG010|Overall Study|Adverse Event|2|||
126137096|NCT00666926|453792786|FG011|Overall Study|Adverse Event|2|||
126137097|NCT00666926|453792787|FG012|Overall Study|Adverse Event|0|||
126137098|NCT00666926|453792788|FG013|Overall Study|Adverse Event|1|||
126137099|NCT00666926|453792789|FG014|Overall Study|Adverse Event|0|||
126137100|NCT00666926|453792790|FG015|Overall Study|Adverse Event|0|||
125968252|NCT03240588|453175754|FG002|Overall Study|Lost to Follow-up|0|||
126137101|NCT00666926|453792775|FG000|Overall Study|Laboratory abnormality|0|||
126137102|NCT00666926|453792776|FG001|Overall Study|Laboratory abnormality|0|||
126137103|NCT00666926|453792777|FG002|Overall Study|Laboratory abnormality|0|||
126137104|NCT00666926|453792778|FG003|Overall Study|Laboratory abnormality|0|||
126137105|NCT00666926|453792779|FG004|Overall Study|Laboratory abnormality|0|||
126137106|NCT00666926|453792780|FG005|Overall Study|Laboratory abnormality|0|||
126137107|NCT00666926|453792781|FG006|Overall Study|Laboratory abnormality|0|||
126137108|NCT00666926|453792782|FG007|Overall Study|Laboratory abnormality|0|||
126137109|NCT00666926|453792783|FG008|Overall Study|Laboratory abnormality|0|||
126137110|NCT00666926|453792784|FG009|Overall Study|Laboratory abnormality|0|||
126137111|NCT00666926|453792785|FG010|Overall Study|Laboratory abnormality|1|||
126137112|NCT00666926|453792786|FG011|Overall Study|Laboratory abnormality|0|||
126137113|NCT00666926|453792787|FG012|Overall Study|Laboratory abnormality|0|||
126137114|NCT00666926|453792788|FG013|Overall Study|Laboratory abnormality|0|||
126137115|NCT00666926|453792789|FG014|Overall Study|Laboratory abnormality|0|||
126137116|NCT00666926|453792790|FG015|Overall Study|Laboratory abnormality|1|||
126137117|NCT00666926|453792775|FG000|Overall Study|Lack of Efficacy|0|||
126137118|NCT00666926|453792776|FG001|Overall Study|Lack of Efficacy|0|||
126137119|NCT00666926|453792777|FG002|Overall Study|Lack of Efficacy|0|||
126137120|NCT00666926|453792778|FG003|Overall Study|Lack of Efficacy|0|||
126137121|NCT00666926|453792779|FG004|Overall Study|Lack of Efficacy|0|||
126137122|NCT00666926|453792780|FG005|Overall Study|Lack of Efficacy|1|||
126137123|NCT00666926|453792781|FG006|Overall Study|Lack of Efficacy|0|||
126137124|NCT00666926|453792782|FG007|Overall Study|Lack of Efficacy|0|||
126137125|NCT00666926|453792783|FG008|Overall Study|Lack of Efficacy|0|||
126137126|NCT00666926|453792784|FG009|Overall Study|Lack of Efficacy|0|||
126137127|NCT00666926|453792785|FG010|Overall Study|Lack of Efficacy|0|||
126137128|NCT00666926|453792786|FG011|Overall Study|Lack of Efficacy|1|||
126137129|NCT00666926|453792787|FG012|Overall Study|Lack of Efficacy|0|||
126137130|NCT00666926|453792788|FG013|Overall Study|Lack of Efficacy|0|||
126137131|NCT00666926|453792789|FG014|Overall Study|Lack of Efficacy|0|||
126137132|NCT00666926|453792790|FG015|Overall Study|Lack of Efficacy|0|||
126137133|NCT00666926|453792775|FG000|Overall Study|Lost to Follow-up|0|||
126137134|NCT00666926|453792776|FG001|Overall Study|Lost to Follow-up|0|||
126137135|NCT00666926|453792777|FG002|Overall Study|Lost to Follow-up|0|||
126137136|NCT00666926|453792778|FG003|Overall Study|Lost to Follow-up|1|||
126137137|NCT00666926|453792779|FG004|Overall Study|Lost to Follow-up|0|||
126137138|NCT00666926|453792780|FG005|Overall Study|Lost to Follow-up|0|||
126137139|NCT00666926|453792781|FG006|Overall Study|Lost to Follow-up|0|||
126137140|NCT00666926|453792782|FG007|Overall Study|Lost to Follow-up|0|||
126137141|NCT00666926|453792783|FG008|Overall Study|Lost to Follow-up|0|||
126137142|NCT00666926|453792784|FG009|Overall Study|Lost to Follow-up|0|||
126137143|NCT00666926|453792785|FG010|Overall Study|Lost to Follow-up|0|||
126137144|NCT00666926|453792786|FG011|Overall Study|Lost to Follow-up|0|||
126137145|NCT00666926|453792787|FG012|Overall Study|Lost to Follow-up|0|||
126137146|NCT00666926|453792788|FG013|Overall Study|Lost to Follow-up|0|||
126137147|NCT00666926|453792789|FG014|Overall Study|Lost to Follow-up|0|||
126137148|NCT00666926|453792790|FG015|Overall Study|Lost to Follow-up|0|||
126137149|NCT00666926|453792775|FG000|Overall Study|Other|2|||
126137150|NCT00666926|453792776|FG001|Overall Study|Other|4|||
126137151|NCT00666926|453792777|FG002|Overall Study|Other|3|||
126137152|NCT00666926|453792778|FG003|Overall Study|Other|3|||
126137153|NCT00666926|453792779|FG004|Overall Study|Other|3|||
126137154|NCT00666926|453792780|FG005|Overall Study|Other|3|||
126137155|NCT00666926|453792781|FG006|Overall Study|Other|4|||
126137156|NCT00666926|453792782|FG007|Overall Study|Other|0|||
126137157|NCT00666926|453792783|FG008|Overall Study|Other|3|||
126137158|NCT00666926|453792784|FG009|Overall Study|Other|5|||
126137159|NCT00666926|453792785|FG010|Overall Study|Other|3|||
126137160|NCT00666926|453792786|FG011|Overall Study|Other|26|||
126137161|NCT00666926|453792787|FG012|Overall Study|Other|3|||
126137162|NCT00666926|453792788|FG013|Overall Study|Other|2|||
126137163|NCT00666926|453792789|FG014|Overall Study|Other|4|||
126137164|NCT00666926|453792790|FG015|Overall Study|Other|4|||
126137165|NCT00666926|453792775|FG000|Overall Study|Withdrawal by Subject|0|||
126137166|NCT00666926|453792776|FG001|Overall Study|Withdrawal by Subject|0|||
126137167|NCT00666926|453792777|FG002|Overall Study|Withdrawal by Subject|0|||
126137168|NCT00666926|453792778|FG003|Overall Study|Withdrawal by Subject|0|||
126137169|NCT00666926|453792779|FG004|Overall Study|Withdrawal by Subject|0|||
126137170|NCT00666926|453792780|FG005|Overall Study|Withdrawal by Subject|0|||
126137171|NCT00666926|453792781|FG006|Overall Study|Withdrawal by Subject|0|||
126137172|NCT00666926|453792782|FG007|Overall Study|Withdrawal by Subject|1|||
126137173|NCT00666926|453792783|FG008|Overall Study|Withdrawal by Subject|0|||
126137174|NCT00666926|453792784|FG009|Overall Study|Withdrawal by Subject|3|||
125968253|NCT03240588|453175752|FG000|Overall Study|Physician Decision|3|||
126137175|NCT00666926|453792785|FG010|Overall Study|Withdrawal by Subject|0|||
126137176|NCT00666926|453792786|FG011|Overall Study|Withdrawal by Subject|3|||
126137177|NCT00666926|453792787|FG012|Overall Study|Withdrawal by Subject|0|||
126137178|NCT00666926|453792788|FG013|Overall Study|Withdrawal by Subject|1|||
126137179|NCT00666926|453792789|FG014|Overall Study|Withdrawal by Subject|3|||
126137180|NCT00666926|453792790|FG015|Overall Study|Withdrawal by Subject|3|||
126137181|NCT00666926|453792775|FG000|Overall Study|Death|0|||
126137182|NCT00666926|453792776|FG001|Overall Study|Death|0|||
126137183|NCT00666926|453792777|FG002|Overall Study|Death|0|||
126137184|NCT00666926|453792778|FG003|Overall Study|Death|0|||
126137185|NCT00666926|453792779|FG004|Overall Study|Death|0|||
126137186|NCT00666926|453792780|FG005|Overall Study|Death|0|||
126137187|NCT00666926|453792781|FG006|Overall Study|Death|0|||
126137188|NCT00666926|453792782|FG007|Overall Study|Death|0|||
126137189|NCT00666926|453792783|FG008|Overall Study|Death|0|||
126137190|NCT00666926|453792784|FG009|Overall Study|Death|0|||
126137191|NCT00666926|453792785|FG010|Overall Study|Death|0|||
126137192|NCT00666926|453792786|FG011|Overall Study|Death|1|||
126137193|NCT00666926|453792787|FG012|Overall Study|Death|0|||
126137194|NCT00666926|453792788|FG013|Overall Study|Death|0|||
126137195|NCT00666926|453792789|FG014|Overall Study|Death|0|||
126137196|NCT00666926|453792790|FG015|Overall Study|Death|0|||
126137197|NCT00713219|453792794|FG000|Overall Study|Death|1|||
126137198|NCT00713219|453792794|FG000|Overall Study|Protocol Violation|1|||
126137199|NCT00480857|453792795|FG000|Overall Study|Lack of Efficacy|2|||
126137200|NCT01890421|453792796|FG000|Overall Study|Adverse Event|1|||
126137201|NCT01890421|453792796|FG000|Overall Study|Other reason|10|||
126137202|NCT00464178|453792797|FG000|Overall Study|Protocol Violation|1|||
126137203|NCT00464178|453792797|FG000|Overall Study|Withdrawal by Subject|1|||
126137204|NCT01557166|453792802|FG000|Overall Study|Adverse Event|20|||
126137205|NCT01557166|453792803|FG001|Overall Study|Adverse Event|6|||
126137206|NCT01557166|453792802|FG000|Overall Study|Lack of Efficacy|2|||
126137207|NCT01557166|453792803|FG001|Overall Study|Lack of Efficacy|1|||
126137208|NCT01557166|453792802|FG000|Overall Study|Protocol Violation|8|||
126137209|NCT01557166|453792803|FG001|Overall Study|Protocol Violation|5|||
126137210|NCT01557166|453792802|FG000|Overall Study|Withdrawn consent|12|||
126137211|NCT01557166|453792803|FG001|Overall Study|Withdrawn consent|20|||
126137212|NCT01557166|453792802|FG000|Overall Study|Target dose not tolerated|1|||
126137213|NCT01557166|453792803|FG001|Overall Study|Target dose not tolerated|0|||
126137214|NCT01557166|453792802|FG000|Overall Study|Psychiatric disorder|1|||
126137215|NCT01557166|453792803|FG001|Overall Study|Psychiatric disorder|0|||
126137216|NCT01557166|453792802|FG000|Overall Study|Unclassified|2|||
126137217|NCT01557166|453792803|FG001|Overall Study|Unclassified|5|||
126137218|NCT00946309|453792804|FG000|Overall Study|Protocol Violation|1|||
126137219|NCT00946309|453792805|FG001|Overall Study|Protocol Violation|0|||
126137220|NCT00946309|453792804|FG000|Overall Study|Lost to Follow-up|0|||
126137221|NCT00946309|453792805|FG001|Overall Study|Lost to Follow-up|1|||
126137222|NCT00946309|453792804|FG000|Overall Study|Procedure cancelled/discontinued|0|||
126137223|NCT00946309|453792805|FG001|Overall Study|Procedure cancelled/discontinued|3|||
126137224|NCT00428597|453792815|FG000|Overall Study|Randomized but not treated|3|||
126137225|NCT00428597|453792816|FG001|Overall Study|Randomized but not treated|3|||
126137226|NCT00428597|453792815|FG000|Overall Study|Objective Progression or Relapse|19|||
126137227|NCT00428597|453792816|FG001|Overall Study|Objective Progression or Relapse|47|||
126137228|NCT00428597|453792815|FG000|Overall Study|Study Terminated by Sponsor|41|||
126137229|NCT00428597|453792816|FG001|Overall Study|Study Terminated by Sponsor|16|||
126137230|NCT00428597|453792815|FG000|Overall Study|Adverse Event|15|||
126137231|NCT00428597|453792816|FG001|Overall Study|Adverse Event|7|||
126137232|NCT00428597|453792815|FG000|Overall Study|Global Deterioration of Health Status|1|||
126137233|NCT00428597|453792816|FG001|Overall Study|Global Deterioration of Health Status|5|||
126137234|NCT00428597|453792815|FG000|Overall Study|Protocol Violation|2|||
126137235|NCT00428597|453792816|FG001|Overall Study|Protocol Violation|1|||
126137236|NCT00428597|453792815|FG000|Overall Study|Withdrawal by Subject|2|||
126137237|NCT00428597|453792816|FG001|Overall Study|Withdrawal by Subject|1|||
126137238|NCT00428597|453792815|FG000|Overall Study|Other|1|||
126137239|NCT00428597|453792816|FG001|Overall Study|Other|1|||
126137240|NCT00428597|453792815|FG000|Overall Study|Lost to Follow-up|0|||
126137241|NCT00428597|453792816|FG001|Overall Study|Lost to Follow-up|1|||
126137242|NCT00428597|453792815|FG000|Overall Study|Pregnancy|1|||
126137243|NCT00428597|453792816|FG001|Overall Study|Pregnancy|0|||
126137244|NCT00428597|453792815|FG000|Overall Study|Death|1|||
126137245|NCT00428597|453792816|FG001|Overall Study|Death|3|||
126137246|NCT01469000|453792817|FG000|Overall Study|Withdrawal by Subject|16|||
126137247|NCT01469000|453792818|FG001|Overall Study|Withdrawal by Subject|3|||
126137248|NCT01469000|453792817|FG000|Overall Study|Sponsor Decision|4|||
126137249|NCT01469000|453792818|FG001|Overall Study|Sponsor Decision|1|||
126137250|NCT00686647|453792820|FG000|Overall Study|Lost to Follow-up|1|||
126137251|NCT00686647|453792820|FG000|Overall Study|Death|1|||
126137252|NCT01725750|453792831|FG000|Overall Study|Adverse Event|1|||
126137253|NCT01725750|453792832|FG001|Overall Study|Adverse Event|0|||
126137254|NCT01725750|453792831|FG000|Overall Study|Lost to Follow-up|1|||
126137255|NCT01725750|453792832|FG001|Overall Study|Lost to Follow-up|1|||
126137256|NCT01725750|453792831|FG000|Overall Study|Withdrawal by Subject|0|||
126137257|NCT01725750|453792832|FG001|Overall Study|Withdrawal by Subject|9|||
125968254|NCT03240588|453175753|FG001|Overall Study|Physician Decision|2|||
126137258|NCT00654498|453792837|FG000|Overall Study|Not Treated|1|||
126137259|NCT00654498|453792838|FG001|Overall Study|Not Treated|0|||
126137260|NCT00654498|453792837|FG000|Overall Study|Adverse Event|6|||
126137261|NCT00654498|453792838|FG001|Overall Study|Adverse Event|1|||
126137262|NCT00654498|453792837|FG000|Overall Study|Protocol Violation|1|||
126137263|NCT00654498|453792838|FG001|Overall Study|Protocol Violation|1|||
126137264|NCT00654498|453792837|FG000|Overall Study|Lost to Follow-up|1|||
126137265|NCT00654498|453792838|FG001|Overall Study|Lost to Follow-up|5|||
126137266|NCT00654498|453792837|FG000|Overall Study|Withdrawal by Subject|1|||
126137267|NCT00654498|453792838|FG001|Overall Study|Withdrawal by Subject|0|||
126137268|NCT00654498|453792837|FG000|Overall Study|Other reason not defined above|4|||
126137269|NCT00654498|453792838|FG001|Overall Study|Other reason not defined above|5|||
126137270|NCT02531646|453792840|FG000|Overall Study|equip. image processing issue|5|||
126137271|NCT02531646|453792841|FG001|Overall Study|equip. image processing issue|1|||
126137272|NCT02531646|453792842|FG002|Overall Study|equip. image processing issue|0|||
126137273|NCT03631706|453792847|FG000|Overall Study|Randomized, not treated|1|||
126137274|NCT03631706|453792848|FG001|Overall Study|Randomized, not treated|0|||
126137275|NCT06272370|453794359|FG000|Overall Study|Lost to Follow-up|0|||
126137276|NCT06272370|453794360|FG001|Overall Study|Lost to Follow-up|3|||
126137277|NCT06272370|453794361|FG002|Overall Study|Lost to Follow-up|1|||
126137278|NCT06272370|453794362|FG003|Overall Study|Lost to Follow-up|1|||
126137279|NCT02152345|453794363|FG000|Overall Study|Case Cancellations|2|||
126137280|NCT02152345|453794364|FG001|Overall Study|Case Cancellations|4|||
126137281|NCT02152345|453794363|FG000|Overall Study|Withdrawal by Subject|2|||
126137282|NCT02152345|453794364|FG001|Overall Study|Withdrawal by Subject|1|||
126137283|NCT01916980|453794365|FG000|Overall Study|Adverse Event|4|||
126137284|NCT01916980|453794366|FG001|Overall Study|Adverse Event|2|||
126137285|NCT01916980|453794365|FG000|Overall Study|Lack of Efficacy|2|||
126137286|NCT01916980|453794366|FG001|Overall Study|Lack of Efficacy|2|||
126137287|NCT01916980|453794365|FG000|Overall Study|Withdrawal by Subject|1|||
126137288|NCT01916980|453794366|FG001|Overall Study|Withdrawal by Subject|0|||
126137289|NCT04439279|453794367|FG000|Overall Study|Adverse Event|7|||
126137290|NCT04439279|453794367|FG000|Overall Study|Death|4|||
126137291|NCT04439279|453794367|FG000|Overall Study|Disease progression|17|||
126137292|NCT04439279|453794367|FG000|Overall Study|Complicating disease|3|||
126137293|NCT04439279|453794367|FG000|Overall Study|Withdrawal by Subject|2|||
126137294|NCT04439279|453794367|FG000|Overall Study|Ineligible|1|||
126137295|NCT04439279|453794367|FG000|Overall Study|Treatment still ongoing|1|||
126137296|NCT03521791|453794368|FG000|Overall Study|Protocol Violation|7|||
126137297|NCT03521791|453794369|FG001|Overall Study|Protocol Violation|17|||
126137298|NCT03786432|453794371|FG000|Overall Study|Screen Failure after consent|1|||
126137299|NCT03786432|453794371|FG000|Overall Study|Lost to Follow-up|4|||
126137300|NCT03786432|453794371|FG000|Overall Study|did not complete 12 month CT scan|1|||
126137301|NCT00544869|453794372|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
126137302|NCT00544869|453794373|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
126137303|NCT00544869|453794374|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
126137304|NCT00544869|453794372|FG000|Overall Study|Adverse Event|6|||
126137305|NCT00544869|453794373|FG001|Overall Study|Adverse Event|1|||
126137306|NCT00544869|453794374|FG002|Overall Study|Adverse Event|0|||
126137307|NCT00544869|453794372|FG000|Overall Study|Lack of Efficacy|1|||
126137308|NCT00544869|453794373|FG001|Overall Study|Lack of Efficacy|1|||
126137309|NCT00544869|453794374|FG002|Overall Study|Lack of Efficacy|0|||
126137310|NCT00544869|453794372|FG000|Overall Study|Physician Decision|2|||
126137311|NCT00544869|453794373|FG001|Overall Study|Physician Decision|0|||
126137312|NCT00544869|453794374|FG002|Overall Study|Physician Decision|0|||
126137313|NCT05512949|453794377|FG000|Overall Study|Lost to Follow-up|4|||
126137314|NCT05512949|453794378|FG001|Overall Study|Lost to Follow-up|6|||
126137315|NCT05512949|453794379|FG002|Overall Study|Lost to Follow-up|2|||
126137316|NCT05512949|453794377|FG000|Overall Study|Protocol Violation|0|||
126137317|NCT05512949|453794378|FG001|Overall Study|Protocol Violation|0|||
126137318|NCT05512949|453794379|FG002|Overall Study|Protocol Violation|1|||
126137319|NCT05512949|453794377|FG000|Overall Study|Withdrawal by Subject|1|||
126137320|NCT05512949|453794378|FG001|Overall Study|Withdrawal by Subject|1|||
126137321|NCT05512949|453794379|FG002|Overall Study|Withdrawal by Subject|2|||
126137322|NCT05512949|453794377|FG000|Overall Study|Completion status unknown|1|||
126137323|NCT05512949|453794378|FG001|Overall Study|Completion status unknown|3|||
126137324|NCT05512949|453794379|FG002|Overall Study|Completion status unknown|0|||
126137325|NCT00568555|453794381|FG000|Overall Study|Withdrawal by Subject|1|||
126137326|NCT00568555|453794382|FG001|Overall Study|Withdrawal by Subject|1|||
126137327|NCT00700180|453794383|FG000|Overall Study|Death|99|||
126137328|NCT00700180|453794384|FG001|Overall Study|Death|114|||
126137329|NCT00700180|453794383|FG000|Overall Study|Alive on treatment|5|||
126137330|NCT00700180|453794384|FG001|Overall Study|Alive on treatment|3|||
126137331|NCT00700180|453794383|FG000|Overall Study|Alive in follow-up|46|||
126137332|NCT00700180|453794384|FG001|Overall Study|Alive in follow-up|27|||
126137333|NCT00700180|453794383|FG000|Overall Study|Lost to Follow-up|4|||
126137334|NCT00700180|453794384|FG001|Overall Study|Lost to Follow-up|5|||
126137335|NCT02614079|453794387|FG000|Overall Study|Withdrawal by Subject|1|||
126137336|NCT03683394|453794388|FG000|Overall Study|Withdrawal by Subject|4|||
126137337|NCT03683394|453794389|FG001|Overall Study|Withdrawal by Subject|8|||
126137338|NCT03683394|453794388|FG000|Overall Study|Lost to Follow-up|7|||
126137339|NCT03683394|453794389|FG001|Overall Study|Lost to Follow-up|0|||
126137340|NCT03683394|453794388|FG000|Overall Study|Death|3|||
126137341|NCT03683394|453794389|FG001|Overall Study|Death|1|||
126137342|NCT03882424|453794390|FG000|Overall Study|Lost to Follow-up|3|||
126137343|NCT03882424|453794391|FG001|Overall Study|Lost to Follow-up|0|||
126137344|NCT03882424|453794392|FG002|Overall Study|Lost to Follow-up|0|||
126137345|NCT03882424|453794390|FG000|Overall Study|schedule conflict|1|||
126137346|NCT03882424|453794391|FG001|Overall Study|schedule conflict|0|||
126137347|NCT03882424|453794392|FG002|Overall Study|schedule conflict|0|||
126137348|NCT00236080|453794393|FG000|Overall Study|Adverse Event|0|||
126137349|NCT00236080|453794394|FG001|Overall Study|Adverse Event|0|||
126137350|NCT00236080|453794395|FG002|Overall Study|Adverse Event|3|||
126137351|NCT00236080|453794396|FG003|Overall Study|Adverse Event|1|||
126137352|NCT00236080|453794397|FG004|Overall Study|Adverse Event|0|||
126137353|NCT00236080|453794393|FG000|Overall Study|Lost to Follow-up|0|||
126137354|NCT00236080|453794394|FG001|Overall Study|Lost to Follow-up|1|||
126137355|NCT00236080|453794395|FG002|Overall Study|Lost to Follow-up|0|||
126137356|NCT00236080|453794396|FG003|Overall Study|Lost to Follow-up|0|||
126137357|NCT00236080|453794397|FG004|Overall Study|Lost to Follow-up|0|||
126137358|NCT00236080|453794393|FG000|Overall Study|Physician Decision|1|||
126137359|NCT00236080|453794394|FG001|Overall Study|Physician Decision|0|||
126137360|NCT00236080|453794395|FG002|Overall Study|Physician Decision|1|||
126137361|NCT00236080|453794396|FG003|Overall Study|Physician Decision|1|||
126137362|NCT00236080|453794397|FG004|Overall Study|Physician Decision|1|||
126137363|NCT00236080|453794393|FG000|Overall Study|Withdrawal by Subject|1|||
126137364|NCT00236080|453794394|FG001|Overall Study|Withdrawal by Subject|0|||
126137365|NCT00236080|453794395|FG002|Overall Study|Withdrawal by Subject|0|||
126137366|NCT00236080|453794396|FG003|Overall Study|Withdrawal by Subject|0|||
126137367|NCT00236080|453794397|FG004|Overall Study|Withdrawal by Subject|0|||
126137368|NCT00236080|453794393|FG000|Overall Study|Miscellaneous|0|||
126137369|NCT00236080|453794394|FG001|Overall Study|Miscellaneous|0|||
126137370|NCT00236080|453794395|FG002|Overall Study|Miscellaneous|1|||
126137371|NCT00236080|453794396|FG003|Overall Study|Miscellaneous|0|||
126137372|NCT00236080|453794397|FG004|Overall Study|Miscellaneous|0|||
126137373|NCT02400255|453794398|FG000|Overall Study|Relapse|4|||
126137374|NCT02400255|453794399|FG001|Overall Study|Relapse|1|||
126137375|NCT02400255|453794400|FG002|Overall Study|Relapse|1|||
126137376|NCT02400255|453794401|FG003|Overall Study|Relapse|2|||
126137377|NCT02400255|453794398|FG000|Overall Study|Adverse Event|6|||
126137378|NCT02400255|453794399|FG001|Overall Study|Adverse Event|3|||
126137379|NCT02400255|453794400|FG002|Overall Study|Adverse Event|0|||
126137380|NCT02400255|453794401|FG003|Overall Study|Adverse Event|0|||
126137381|NCT02400255|453794398|FG000|Overall Study|Physician Decision|6|||
126137382|NCT02400255|453794399|FG001|Overall Study|Physician Decision|0|||
126137383|NCT02400255|453794400|FG002|Overall Study|Physician Decision|0|||
126137384|NCT02400255|453794401|FG003|Overall Study|Physician Decision|0|||
126137385|NCT02400255|453794398|FG000|Overall Study|Loss of insurance|1|||
126137386|NCT02400255|453794399|FG001|Overall Study|Loss of insurance|0|||
126137387|NCT02400255|453794400|FG002|Overall Study|Loss of insurance|0|||
126137388|NCT02400255|453794401|FG003|Overall Study|Loss of insurance|0|||
126137389|NCT01961544|453794405|FG000|Overall Study|Protocol Violation|1|||
126137390|NCT01961544|453794405|FG000|Overall Study|Withdrawal by Subject|7|||
126137391|NCT01961544|453794405|FG000|Overall Study|Adverse Event|1|||
126137392|NCT01961544|453794405|FG000|Overall Study|Physician Decision|2|||
126137393|NCT01961544|453794405|FG000|Overall Study|Poor Tolerance|1|||
126137394|NCT01961544|453794405|FG000|Overall Study|Aggravation of Steral Pain|1|||
126137395|NCT00354601|453794406|FG000|Overall Study|Protocol Violation|1|||
126137396|NCT00354601|453794406|FG000|Overall Study|progression|1|||
126137397|NCT03603652|453794407|FG000|Overall Study|Death|2|||
126137398|NCT03213366|453794410|FG000|Overall Study|Lost to Follow-up|9|||
126137399|NCT03213366|453794411|FG001|Overall Study|Lost to Follow-up|4|||
126137400|NCT01727258|453794412|FG000|Overall Study|Adverse Event|0|||
126137401|NCT01727258|453794413|FG001|Overall Study|Adverse Event|2|||
126137402|NCT01727258|453794414|FG002|Overall Study|Adverse Event|0|||
126137403|NCT01727258|453794412|FG000|Overall Study|Noncompliance with Study Drug|0|||
126137404|NCT01727258|453794413|FG001|Overall Study|Noncompliance with Study Drug|0|||
126137405|NCT01727258|453794414|FG002|Overall Study|Noncompliance with Study Drug|1|||
126137406|NCT01727258|453794412|FG000|Overall Study|Withdrawal by Subject|1|||
126137407|NCT01727258|453794413|FG001|Overall Study|Withdrawal by Subject|1|||
126137408|NCT01727258|453794414|FG002|Overall Study|Withdrawal by Subject|0|||
126137409|NCT01727258|453794412|FG000|Overall Study|Lost to Follow-up|1|||
126137410|NCT01727258|453794413|FG001|Overall Study|Lost to Follow-up|0|||
126137411|NCT01727258|453794414|FG002|Overall Study|Lost to Follow-up|0|||
126137412|NCT01960855|453794415|FG000|Overall Study|Subject noncompliant|1|||
126137413|NCT01960855|453794416|FG001|Overall Study|Subject noncompliant|0|||
126137414|NCT01960855|453794417|FG002|Overall Study|Subject noncompliant|0|||
126137415|NCT01960855|453794418|FG003|Overall Study|Subject noncompliant|0|||
126137416|NCT01960855|453794419|FG004|Overall Study|Subject noncompliant|0|||
126137417|NCT01960855|453794415|FG000|Overall Study|Adverse Event|2|||
126137418|NCT01960855|453794416|FG001|Overall Study|Adverse Event|0|||
126137419|NCT01960855|453794417|FG002|Overall Study|Adverse Event|6|||
126137420|NCT01960855|453794418|FG003|Overall Study|Adverse Event|2|||
126137421|NCT01960855|453794419|FG004|Overall Study|Adverse Event|2|||
126137422|NCT01960855|453794415|FG000|Overall Study|Lack of Efficacy|1|||
126137423|NCT01960855|453794416|FG001|Overall Study|Lack of Efficacy|1|||
126137424|NCT01960855|453794417|FG002|Overall Study|Lack of Efficacy|0|||
126137425|NCT01960855|453794418|FG003|Overall Study|Lack of Efficacy|0|||
126137426|NCT01960855|453794419|FG004|Overall Study|Lack of Efficacy|0|||
126137427|NCT01960855|453794415|FG000|Overall Study|Other|2|||
126137428|NCT01960855|453794416|FG001|Overall Study|Other|1|||
126137429|NCT01960855|453794417|FG002|Overall Study|Other|1|||
126137430|NCT01960855|453794418|FG003|Overall Study|Other|1|||
126137431|NCT01960855|453794419|FG004|Overall Study|Other|0|||
126137432|NCT01960855|453794415|FG000|Overall Study|Consent withdrawn by subject|3|||
126137433|NCT01960855|453794416|FG001|Overall Study|Consent withdrawn by subject|1|||
126137434|NCT01960855|453794417|FG002|Overall Study|Consent withdrawn by subject|2|||
126137435|NCT01960855|453794418|FG003|Overall Study|Consent withdrawn by subject|1|||
126137436|NCT01960855|453794419|FG004|Overall Study|Consent withdrawn by subject|1|||
126137437|NCT01960855|453794415|FG000|Overall Study|Lost to Follow-up|2|||
126137438|NCT01960855|453794416|FG001|Overall Study|Lost to Follow-up|1|||
126137439|NCT01960855|453794417|FG002|Overall Study|Lost to Follow-up|0|||
126137440|NCT01960855|453794418|FG003|Overall Study|Lost to Follow-up|0|||
126137441|NCT01960855|453794419|FG004|Overall Study|Lost to Follow-up|2|||
126137442|NCT02058147|453794420|FG000|Overall Study|Randomized but not treated|0|||
126137443|NCT02058147|453794421|FG001|Overall Study|Randomized but not treated|0|||
126137444|NCT02058147|453794422|FG002|Overall Study|Randomized but not treated|1|||
126137445|NCT02058147|453794420|FG000|Overall Study|Adverse Event|12|||
126137446|NCT02058147|453794421|FG001|Overall Study|Adverse Event|9|||
126137447|NCT02058147|453794422|FG002|Overall Study|Adverse Event|21|||
126137448|NCT02058147|453794420|FG000|Overall Study|Lack of Efficacy|1|||
126137449|NCT02058147|453794421|FG001|Overall Study|Lack of Efficacy|0|||
126137450|NCT02058147|453794422|FG002|Overall Study|Lack of Efficacy|3|||
126137451|NCT02058147|453794420|FG000|Overall Study|Poor compliance to protocol|8|||
126137452|NCT02058147|453794421|FG001|Overall Study|Poor compliance to protocol|9|||
126137453|NCT02058147|453794422|FG002|Overall Study|Poor compliance to protocol|4|||
126137454|NCT02058147|453794420|FG000|Overall Study|Other than specified|8|||
126137455|NCT02058147|453794421|FG001|Overall Study|Other than specified|9|||
126137456|NCT02058147|453794422|FG002|Overall Study|Other than specified|0|||
126137457|NCT02471716|453794427|FG000|Overall Study|Withdrawal by Subject|0|||
126137458|NCT02471716|453794428|FG001|Overall Study|Withdrawal by Subject|1|||
126137459|NCT02471716|453794429|FG002|Overall Study|Withdrawal by Subject|0|||
126137460|NCT02471716|453794430|FG003|Overall Study|Withdrawal by Subject|2|||
126137461|NCT02471716|453794431|FG004|Overall Study|Withdrawal by Subject|5|||
126137462|NCT02471716|453794427|FG000|Overall Study|Study Terminiated by sponsor|0|||
126137463|NCT02471716|453794428|FG001|Overall Study|Study Terminiated by sponsor|0|||
126137464|NCT02471716|453794429|FG002|Overall Study|Study Terminiated by sponsor|0|||
126137465|NCT02471716|453794430|FG003|Overall Study|Study Terminiated by sponsor|1|||
126137466|NCT02471716|453794431|FG004|Overall Study|Study Terminiated by sponsor|0|||
126137467|NCT02471716|453794427|FG000|Overall Study|Lost to Follow-up|0|||
126137468|NCT02471716|453794428|FG001|Overall Study|Lost to Follow-up|0|||
126137469|NCT02471716|453794429|FG002|Overall Study|Lost to Follow-up|0|||
126137470|NCT02471716|453794430|FG003|Overall Study|Lost to Follow-up|3|||
126137471|NCT02471716|453794431|FG004|Overall Study|Lost to Follow-up|2|||
126137472|NCT02471716|453794427|FG000|Overall Study|Death|0|||
126137473|NCT02471716|453794428|FG001|Overall Study|Death|0|||
126137474|NCT02471716|453794429|FG002|Overall Study|Death|0|||
126137475|NCT02471716|453794430|FG003|Overall Study|Death|1|||
126137476|NCT02471716|453794431|FG004|Overall Study|Death|0|||
126137477|NCT02471716|453794427|FG000|Overall Study|Other|0|||
126137478|NCT02471716|453794428|FG001|Overall Study|Other|0|||
126137479|NCT02471716|453794429|FG002|Overall Study|Other|0|||
126137480|NCT02471716|453794430|FG003|Overall Study|Other|8|||
126137481|NCT02471716|453794431|FG004|Overall Study|Other|9|||
126137482|NCT00130286|453794434|FG000|Overall Study|Withdrawal by Subject|0|||
126137483|NCT00130286|453794435|FG001|Overall Study|Withdrawal by Subject|1|||
126137484|NCT00130286|453794436|FG002|Overall Study|Withdrawal by Subject|2|||
126137485|NCT00130286|453794437|FG003|Overall Study|Withdrawal by Subject|2|||
126137486|NCT00130286|453794434|FG000|Overall Study|Adverse Event|0|||
126137487|NCT00130286|453794435|FG001|Overall Study|Adverse Event|0|||
126137488|NCT00130286|453794436|FG002|Overall Study|Adverse Event|2|||
126137489|NCT00130286|453794437|FG003|Overall Study|Adverse Event|0|||
126137490|NCT00130286|453794434|FG000|Overall Study|Missing lab specimens|0|||
126137491|NCT00130286|453794435|FG001|Overall Study|Missing lab specimens|2|||
126137492|NCT00130286|453794436|FG002|Overall Study|Missing lab specimens|0|||
126137493|NCT00130286|453794437|FG003|Overall Study|Missing lab specimens|0|||
126137494|NCT03604445|453794438|FG000|Overall Study|Death|0|||
126137495|NCT03604445|453794439|FG001|Overall Study|Death|0|||
126137496|NCT03604445|453794440|FG002|Overall Study|Death|0|||
126137497|NCT03604445|453794441|FG003|Overall Study|Death|0|||
126137498|NCT03604445|453794442|FG004|Overall Study|Death|0|||
126137499|NCT03604445|453794443|FG005|Overall Study|Death|0|||
126137500|NCT03604445|453794444|FG006|Overall Study|Death|0|||
126137501|NCT03604445|453794445|FG007|Overall Study|Death|0|||
126137502|NCT03604445|453794446|FG008|Overall Study|Death|1|||
126137503|NCT03604445|453794438|FG000|Overall Study|Withdrawal by Subject|0|||
126137504|NCT03604445|453794439|FG001|Overall Study|Withdrawal by Subject|0|||
126137505|NCT03604445|453794440|FG002|Overall Study|Withdrawal by Subject|0|||
126137506|NCT03604445|453794441|FG003|Overall Study|Withdrawal by Subject|0|||
126137507|NCT03604445|453794442|FG004|Overall Study|Withdrawal by Subject|0|||
126137508|NCT03604445|453794443|FG005|Overall Study|Withdrawal by Subject|0|||
126137509|NCT03604445|453794444|FG006|Overall Study|Withdrawal by Subject|1|||
126137510|NCT03604445|453794445|FG007|Overall Study|Withdrawal by Subject|0|||
126137511|NCT03604445|453794446|FG008|Overall Study|Withdrawal by Subject|0|||
126137512|NCT03604445|453794438|FG000|Overall Study|Missing visit|0|||
126137513|NCT03604445|453794439|FG001|Overall Study|Missing visit|0|||
126137514|NCT03604445|453794440|FG002|Overall Study|Missing visit|0|||
126137515|NCT03604445|453794441|FG003|Overall Study|Missing visit|0|||
126137516|NCT03604445|453794442|FG004|Overall Study|Missing visit|0|||
126137517|NCT03604445|453794443|FG005|Overall Study|Missing visit|1|||
125968255|NCT03240588|453175754|FG002|Overall Study|Physician Decision|0|||
125968256|NCT03240588|453175752|FG000|Overall Study|Did not meet eligibility criteria|0|||
125968257|NCT03240588|453175753|FG001|Overall Study|Did not meet eligibility criteria|6|||
125968258|NCT03240588|453175754|FG002|Overall Study|Did not meet eligibility criteria|0|||
125968259|NCT03240588|453175752|FG000|Overall Study|No longer meets protocol criteria|12|||
125968260|NCT03240588|453175753|FG001|Overall Study|No longer meets protocol criteria|7|||
125968261|NCT03240588|453175754|FG002|Overall Study|No longer meets protocol criteria|0|||
125968262|NCT03240588|453175752|FG000|Overall Study|Withdrawal by Subject|60|||
126137518|NCT03604445|453794444|FG006|Overall Study|Missing visit|0|||
126137519|NCT03604445|453794445|FG007|Overall Study|Missing visit|1|||
126137520|NCT03604445|453794446|FG008|Overall Study|Missing visit|0|||
126137521|NCT03604445|453794438|FG000|Overall Study|Adverse Event|0|||
126137522|NCT03604445|453794439|FG001|Overall Study|Adverse Event|0|||
126137523|NCT03604445|453794440|FG002|Overall Study|Adverse Event|0|||
126137524|NCT03604445|453794441|FG003|Overall Study|Adverse Event|1|||
126137525|NCT03604445|453794442|FG004|Overall Study|Adverse Event|0|||
126137526|NCT03604445|453794443|FG005|Overall Study|Adverse Event|0|||
126137527|NCT03604445|453794444|FG006|Overall Study|Adverse Event|0|||
126137528|NCT03604445|453794445|FG007|Overall Study|Adverse Event|0|||
126137529|NCT03604445|453794446|FG008|Overall Study|Adverse Event|1|||
126137530|NCT01360645|453794451|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
126137531|NCT01360645|453794452|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
126137532|NCT01360645|453794453|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
126137533|NCT01360645|453794454|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
126137534|NCT01360645|453794451|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
126137535|NCT01360645|453794452|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
126137536|NCT01360645|453794453|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
126137537|NCT01360645|453794454|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
126137538|NCT01360645|453794451|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
126137539|NCT01360645|453794452|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
126137540|NCT01360645|453794453|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
126137541|NCT01360645|453794454|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
126137542|NCT01360645|453794451|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
126137543|NCT01360645|453794452|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
126137544|NCT01360645|453794453|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
126137545|NCT01360645|453794454|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
126137546|NCT01360645|453794451|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
126137547|NCT01360645|453794452|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
126137548|NCT01360645|453794453|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
126137549|NCT01360645|453794454|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
126137550|NCT01360645|453794451|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
126137551|NCT01360645|453794452|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
126137552|NCT01360645|453794453|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
125968263|NCT03240588|453175753|FG001|Overall Study|Withdrawal by Subject|52|||
125968264|NCT03240588|453175754|FG002|Overall Study|Withdrawal by Subject|7|||
126137553|NCT01360645|453794454|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
126137554|NCT01360645|453794451|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
126137555|NCT01360645|453794452|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
126137556|NCT01360645|453794453|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
126137557|NCT01360645|453794454|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
126137558|NCT01360645|453794451|FG000|Phase B (6 Weeks)|Adverse Event|0|||
126137559|NCT01360645|453794452|FG001|Phase B (6 Weeks)|Adverse Event|6|||
126137560|NCT01360645|453794453|FG002|Phase B (6 Weeks)|Adverse Event|0|||
126137561|NCT01360645|453794454|FG003|Phase B (6 Weeks)|Adverse Event|0|||
126137562|NCT01360645|453794451|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126137563|NCT01360645|453794452|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
126137564|NCT01360645|453794453|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
126137565|NCT01360645|453794454|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126137566|NCT01360645|453794451|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
126137567|NCT01360645|453794452|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
126137568|NCT01360645|453794453|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
126137569|NCT01360645|453794454|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
126137570|NCT01360645|453794451|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
126137571|NCT01360645|453794452|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
126137572|NCT01360645|453794453|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
126137573|NCT01360645|453794454|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
126137574|NCT01360645|453794451|FG000|Phase A+|Lost to Follow-up|0|||
126137575|NCT01360645|453794452|FG001|Phase A+|Lost to Follow-up|0|||
126137576|NCT01360645|453794453|FG002|Phase A+|Lost to Follow-up|0|||
126137577|NCT01360645|453794454|FG003|Phase A+|Lost to Follow-up|7|||
126137578|NCT01360645|453794451|FG000|Phase A+|Adverse Event|0|||
126137579|NCT01360645|453794452|FG001|Phase A+|Adverse Event|0|||
126137580|NCT01360645|453794453|FG002|Phase A+|Adverse Event|0|||
126137581|NCT01360645|453794454|FG003|Phase A+|Adverse Event|2|||
126137582|NCT01360645|453794451|FG000|Phase A+|Met Withdrawal Criteria|0|||
126137583|NCT01360645|453794452|FG001|Phase A+|Met Withdrawal Criteria|0|||
126137584|NCT01360645|453794453|FG002|Phase A+|Met Withdrawal Criteria|0|||
126137585|NCT01360645|453794454|FG003|Phase A+|Met Withdrawal Criteria|4|||
126137586|NCT01360645|453794451|FG000|Phase A+|Physician Decision|0|||
126137587|NCT01360645|453794452|FG001|Phase A+|Physician Decision|0|||
126137588|NCT01360645|453794453|FG002|Phase A+|Physician Decision|0|||
126137589|NCT01360645|453794454|FG003|Phase A+|Physician Decision|2|||
126137590|NCT01360645|453794451|FG000|Phase A+|Withdrawal by Subject|0|||
126137591|NCT01360645|453794452|FG001|Phase A+|Withdrawal by Subject|0|||
126137592|NCT01360645|453794453|FG002|Phase A+|Withdrawal by Subject|0|||
126137593|NCT01360645|453794454|FG003|Phase A+|Withdrawal by Subject|5|||
126137594|NCT01360645|453794451|FG000|Phase A+|Protocol Deviation|0|||
126137595|NCT01360645|453794452|FG001|Phase A+|Protocol Deviation|0|||
126137596|NCT01360645|453794453|FG002|Phase A+|Protocol Deviation|0|||
126137597|NCT01360645|453794454|FG003|Phase A+|Protocol Deviation|4|||
126137598|NCT01014585|453794455|FG000|Overall Study|Adverse Event|0|||
126137599|NCT01014585|453794456|FG001|Overall Study|Adverse Event|2|||
126137600|NCT01014585|453794457|FG002|Overall Study|Adverse Event|0|||
126137601|NCT01014585|453794458|FG003|Overall Study|Adverse Event|3|||
126137602|NCT01014585|453794455|FG000|Overall Study|Withdrawal by Subject|2|||
126137603|NCT01014585|453794456|FG001|Overall Study|Withdrawal by Subject|0|||
126137604|NCT01014585|453794457|FG002|Overall Study|Withdrawal by Subject|1|||
126137605|NCT01014585|453794458|FG003|Overall Study|Withdrawal by Subject|3|||
126137606|NCT01014585|453794455|FG000|Overall Study|Lost to Follow-up|0|||
126137607|NCT01014585|453794456|FG001|Overall Study|Lost to Follow-up|0|||
126137608|NCT01014585|453794457|FG002|Overall Study|Lost to Follow-up|0|||
126137609|NCT01014585|453794458|FG003|Overall Study|Lost to Follow-up|2|||
126137610|NCT01014585|453794455|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
126137611|NCT01014585|453794456|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
126137612|NCT01014585|453794457|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
126137613|NCT01014585|453794458|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
126137614|NCT02154425|453794459|FG000|Screening Period|Adverse Event|1|||
126137615|NCT00773279|453794463|FG000|Period 1|Adverse Event|2|||
126137616|NCT00773279|453794464|FG001|Period 1|Adverse Event|1|||
126137617|NCT00773279|453794463|FG000|Period 1|Lack of Efficacy|0|||
126137618|NCT00773279|453794464|FG001|Period 1|Lack of Efficacy|2|||
126137619|NCT00773279|453794463|FG000|Period 1|Unclassified|5|||
126137620|NCT00773279|453794464|FG001|Period 1|Unclassified|1|||
126137621|NCT00773279|453794463|FG000|Period 2|Adverse Event|0|||
126137622|NCT00773279|453794464|FG001|Period 2|Adverse Event|1|||
126137623|NCT00773279|453794463|FG000|Period 2|Lack of Efficacy|1|||
126137624|NCT00773279|453794464|FG001|Period 2|Lack of Efficacy|0|||
126137625|NCT00773279|453794463|FG000|Period 2|Protocol Violation|0|||
126137626|NCT00773279|453794464|FG001|Period 2|Protocol Violation|3|||
126137627|NCT00773279|453794463|FG000|Period 2|Unclassified|2|||
126137628|NCT00773279|453794464|FG001|Period 2|Unclassified|2|||
126137629|NCT04178772|453794465|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
125968265|NCT03240588|453175752|FG000|Overall Study|Other, additional details not available.|0|||
126137630|NCT04178772|453794465|FG000|Overall Study|study terminated early due to COVID-19|7|||
126137631|NCT02817087|453794474|FG000|Overall Study|Withdrawal by Subject|2|||
126137632|NCT02817087|453794475|FG001|Overall Study|Withdrawal by Subject|0|||
126137633|NCT00508391|453794476|FG000|First Treatment|Withdrawal by Subject|6|||
126137634|NCT00508391|453794477|FG001|First Treatment|Withdrawal by Subject|3|||
126137635|NCT00508391|453794476|FG000|Second Treatment|Withdrawal by Subject|2|||
126137636|NCT00508391|453794477|FG001|Second Treatment|Withdrawal by Subject|0|||
126137637|NCT00802360|453794478|FG000|Overall Study|Stimulation failure|4|||
126137638|NCT00802360|453794479|FG001|Overall Study|Stimulation failure|0|||
126137639|NCT00802360|453794480|FG002|Overall Study|Stimulation failure|3|||
126137640|NCT00802360|453794481|FG003|Overall Study|Stimulation failure|3|||
126137641|NCT00802360|453794478|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
126137642|NCT00802360|453794479|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
126137643|NCT00802360|453794480|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
126137644|NCT00802360|453794481|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
126137645|NCT00802360|453794478|FG000|Overall Study|Cycle cancelled|0|||
126137646|NCT00802360|453794479|FG001|Overall Study|Cycle cancelled|1|||
126137647|NCT00802360|453794480|FG002|Overall Study|Cycle cancelled|1|||
126137648|NCT00802360|453794481|FG003|Overall Study|Cycle cancelled|1|||
126137649|NCT00802360|453794478|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
126137650|NCT00802360|453794479|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
126137651|NCT00802360|453794480|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
126137652|NCT00802360|453794481|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
126137653|NCT00802360|453794478|FG000|Overall Study|No positive serum pregnancy|17|||
126137654|NCT00802360|453794479|FG001|Overall Study|No positive serum pregnancy|20|||
126137655|NCT00802360|453794480|FG002|Overall Study|No positive serum pregnancy|14|||
126137656|NCT00802360|453794481|FG003|Overall Study|No positive serum pregnancy|10|||
126137657|NCT00802360|453794478|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
126137658|NCT00802360|453794479|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
126137659|NCT00802360|453794480|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
126137660|NCT00802360|453794481|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
126137661|NCT00802360|453794478|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
126137662|NCT00802360|453794479|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
126137663|NCT00802360|453794480|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
126137664|NCT00802360|453794481|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
126137665|NCT00802360|453794478|FG000|Overall Study|Other|2|||
126137666|NCT00802360|453794479|FG001|Overall Study|Other|3|||
126137667|NCT00802360|453794480|FG002|Overall Study|Other|6|||
126137668|NCT00802360|453794481|FG003|Overall Study|Other|3|||
126137669|NCT02041962|453794482|FG000|Overall Study|Lost Aetna Coverage|43|||
126137670|NCT02041962|453794483|FG001|Overall Study|Lost Aetna Coverage|40|||
126137671|NCT02041962|453794482|FG000|Overall Study|Death|1|||
126137672|NCT02041962|453794483|FG001|Overall Study|Death|1|||
126137673|NCT02041962|453794482|FG000|Overall Study|Lost to Follow-up|37|||
126137674|NCT02041962|453794483|FG001|Overall Study|Lost to Follow-up|32|||
126137675|NCT02041962|453794482|FG000|Overall Study|Withdrawal by Subject|0|||
126137676|NCT02041962|453794483|FG001|Overall Study|Withdrawal by Subject|11|||
126137677|NCT01225562|453794484|FG000|Overall Study|Withdrawal by Subject|52|||
126137678|NCT01225562|453794485|FG001|Overall Study|Withdrawal by Subject|50|||
126137679|NCT01225562|453794486|FG002|Overall Study|Withdrawal by Subject|52|||
126137680|NCT01225562|453794484|FG000|Overall Study|Lost to Follow-up|3|||
126137681|NCT01225562|453794485|FG001|Overall Study|Lost to Follow-up|6|||
126137682|NCT01225562|453794486|FG002|Overall Study|Lost to Follow-up|1|||
126137683|NCT01481896|453794487|FG000|Overall Study|Lost to Follow-up|12|||
126137684|NCT01818726|453794490|FG000|Overall Study|Administrative reasons|5|||
126137685|NCT01818726|453794491|FG001|Overall Study|Administrative reasons|1|||
126137686|NCT01818726|453794490|FG000|Overall Study|Withdrawal by Subject|0|||
126137687|NCT01818726|453794491|FG001|Overall Study|Withdrawal by Subject|1|||
126137688|NCT01818726|453794490|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
126137689|NCT01818726|453794491|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
126137690|NCT01162421|453794492|FG000|Overall Study|Did not receive study drug|2|||
126137691|NCT01162421|453794493|FG001|Overall Study|Did not receive study drug|1|||
126137692|NCT01162421|453794492|FG000|Overall Study|Adverse Event|2|||
126137693|NCT01162421|453794493|FG001|Overall Study|Adverse Event|5|||
126137694|NCT01162421|453794492|FG000|Overall Study|Lost to Follow-up|0|||
126137695|NCT01162421|453794493|FG001|Overall Study|Lost to Follow-up|2|||
126137696|NCT01162421|453794492|FG000|Overall Study|Lack of Efficacy|2|||
126137697|NCT01162421|453794493|FG001|Overall Study|Lack of Efficacy|2|||
126137698|NCT01162421|453794492|FG000|Overall Study|Other|2|||
126137699|NCT01162421|453794493|FG001|Overall Study|Other|3|||
126137700|NCT03336502|453794494|FG000|Overall Study|Physician Decision|0|||
126137701|NCT03336502|453794495|FG001|Overall Study|Physician Decision|1|||
126137702|NCT03336502|453794494|FG000|Overall Study|Prohibited Drugs|1|||
126137703|NCT03336502|453794495|FG001|Overall Study|Prohibited Drugs|1|||
126137704|NCT03336502|453794494|FG000|Overall Study|Death|1|||
126137705|NCT03336502|453794495|FG001|Overall Study|Death|2|||
126137706|NCT03336502|453794494|FG000|Overall Study|Adverse Event|2|||
126137707|NCT03336502|453794495|FG001|Overall Study|Adverse Event|5|||
126137708|NCT00611247|453794497|FG000|Overall Study|Death|1|||
126137709|NCT00611247|453794498|FG001|Overall Study|Death|5|||
126137710|NCT00611247|453794497|FG000|Overall Study|Lack of Efficacy|1|||
126137711|NCT00611247|453794498|FG001|Overall Study|Lack of Efficacy|16|||
126137712|NCT00565617|453794499|FG000|Overall Study|Withdrawal by Subject|1|||
126137713|NCT01446419|453794506|FG000|Overall Study|Death|1|||
126137714|NCT01446419|453794507|FG001|Overall Study|Death|0|||
126137715|NCT01446419|453794506|FG000|Overall Study|Withdrawal by Subject|1|||
126137716|NCT01446419|453794507|FG001|Overall Study|Withdrawal by Subject|1|||
126137717|NCT01446419|453794506|FG000|Overall Study|Terminated per protocol|3|||
126137718|NCT01446419|453794507|FG001|Overall Study|Terminated per protocol|0|||
126137719|NCT02867761|453794508|FG000|Overall Study|Participant withdrawn by investigator|0|||
126137720|NCT02867761|453794509|FG001|Overall Study|Participant withdrawn by investigator|1|||
126137721|NCT02867761|453794508|FG000|Overall Study|Lost to Follow-up|25|||
126137722|NCT02867761|453794509|FG001|Overall Study|Lost to Follow-up|18|||
126137723|NCT02867761|453794508|FG000|Overall Study|Unable to complete protocol|3|||
126137724|NCT02867761|453794509|FG001|Overall Study|Unable to complete protocol|7|||
126137725|NCT04506294|453794510|FG000|Overall Study|Lost to Follow-up|70|||
126137726|NCT04506294|453794511|FG001|Overall Study|Lost to Follow-up|20|||
126137727|NCT04506294|453794510|FG000|Overall Study|Withdrawal by Subject|16|||
126137728|NCT04506294|453794511|FG001|Overall Study|Withdrawal by Subject|2|||
126137729|NCT01465659|453794512|FG000|Completed 1 Cycle of Treatment|Death|0|||
126137730|NCT01465659|453794513|FG001|Completed 1 Cycle of Treatment|Death|1|||
126137731|NCT01465659|453794514|FG002|Completed 1 Cycle of Treatment|Death|0|||
126137732|NCT01465659|453794515|FG003|Completed 1 Cycle of Treatment|Death|0|||
126137733|NCT01465659|453794512|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
126137734|NCT01465659|453794513|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
126137735|NCT01465659|453794514|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
126137736|NCT01465659|453794515|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
126137737|NCT01465659|453794512|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
126137738|NCT01465659|453794513|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
126137739|NCT01465659|453794514|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
126137740|NCT01465659|453794515|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
126137741|NCT01465659|453794512|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
126137742|NCT01465659|453794513|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
126137743|NCT01465659|453794514|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
126137744|NCT01465659|453794515|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
126137745|NCT01465659|453794512|FG000|Completed Follow for 1 Year|Death|6|||
126137746|NCT01465659|453794513|FG001|Completed Follow for 1 Year|Death|3|||
126137747|NCT01465659|453794514|FG002|Completed Follow for 1 Year|Death|2|||
126137748|NCT01465659|453794515|FG003|Completed Follow for 1 Year|Death|4|||
126137749|NCT02445586|453794517|FG000|Overall Study|Death|14|||
126137750|NCT02445586|453794517|FG000|Overall Study|Withdrawal by Subject|13|||
126137751|NCT02445586|453794517|FG000|Overall Study|Disease Progression|10|||
126137752|NCT02445586|453794517|FG000|Overall Study|Protocol Violation|1|||
126137753|NCT02445586|453794517|FG000|Overall Study|Medical Condition|1|||
126137754|NCT00578643|453794518|FG000|Overall Study|Death|1|||
126137755|NCT00578643|453794518|FG000|Overall Study|Lost to Follow-up|1|||
126137756|NCT01990261|453794519|FG000|Overall Study|Death Before Treatment Start|2|||
126137757|NCT01990261|453794519|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
126137758|NCT01990261|453794519|FG000|Overall Study|Death From other Causes|1|||
126137759|NCT01990261|453794519|FG000|Overall Study|Disease Progression (PD)|8|||
126137760|NCT01990261|453794519|FG000|Overall Study|PD Before Treatment Start|1|||
126137761|NCT01990261|453794519|FG000|Overall Study|Dossier not Approved|1|||
126137762|NCT01990261|453794519|FG000|Overall Study|Lost to Follow-up|2|||
126137763|NCT01445678|453794528|FG000|Overall Study|Adverse Event|12|||
126137764|NCT01445678|453794529|FG001|Overall Study|Adverse Event|8|||
126137765|NCT01445678|453794528|FG000|Overall Study|Lack of Efficacy|0|||
126137766|NCT01445678|453794529|FG001|Overall Study|Lack of Efficacy|2|||
126137767|NCT01445678|453794528|FG000|Overall Study|Lost to Follow-up|8|||
126137768|NCT01445678|453794529|FG001|Overall Study|Lost to Follow-up|5|||
126137769|NCT01445678|453794528|FG000|Overall Study|Protocol Violation|1|||
126137770|NCT01445678|453794529|FG001|Overall Study|Protocol Violation|1|||
126137771|NCT01445678|453794528|FG000|Overall Study|Withdrawal by Subject|9|||
126137772|NCT01445678|453794529|FG001|Overall Study|Withdrawal by Subject|5|||
126137773|NCT02307370|453794530|FG000|Overall Study|Death|5|||
126137774|NCT02307370|453794530|FG000|Overall Study|Lost to Follow-up|1|||
126137775|NCT02307370|453794530|FG000|Overall Study|Withdrawal by Subject|1|||
126137776|NCT02307370|453794530|FG000|Overall Study|Declined Addendum ICF|6|||
126137777|NCT02307370|453794530|FG000|Overall Study|No response during telephone contact|5|||
126137778|NCT02307370|453794530|FG000|Overall Study|Protocol Violation|1|||
126137779|NCT04698629|453794531|FG000|Overall Study|Adverse Event|1|||
126137780|NCT03344003|453794532|FG000|Overall Study|Switched to alternative treatment|1|||
126137781|NCT03344003|453794533|FG001|Overall Study|Switched to alternative treatment|0|||
126137782|NCT03344003|453794532|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
126137783|NCT03344003|453794533|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
126137784|NCT05847686|453797761|FG000|Overall Study|Withdrawal by Subject|3|||
126137785|NCT00352534|453797763|FG000|Initial Staging|Ineligible|8|||
126137786|NCT00352534|453797764|FG001|Initial Staging|Ineligible|9|||
126137787|NCT00352534|453797765|FG002|Initial Staging|Ineligible|0|||
126137788|NCT00352534|453797766|FG003|Initial Staging|Ineligible|0|||
126137789|NCT00352534|453797767|FG004|Initial Staging|Ineligible|0|||
126137790|NCT00352534|453797768|FG005|Initial Staging|Ineligible|0|||
126137791|NCT00352534|453797769|FG006|Initial Staging|Ineligible|0|||
126137792|NCT00352534|453797763|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
126137793|NCT00352534|453797764|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
126137794|NCT00352534|453797765|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
126137795|NCT00352534|453797766|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
126137796|NCT00352534|453797767|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
126137797|NCT00352534|453797768|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
126137798|NCT00352534|453797769|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
126137799|NCT00352534|453797763|FG000|Final Risk Group Assignment|Physician Decision|0|||
126137800|NCT00352534|453797764|FG001|Final Risk Group Assignment|Physician Decision|0|||
126137801|NCT00352534|453797765|FG002|Final Risk Group Assignment|Physician Decision|0|||
126137802|NCT00352534|453797766|FG003|Final Risk Group Assignment|Physician Decision|0|||
126137803|NCT00352534|453797767|FG004|Final Risk Group Assignment|Physician Decision|0|||
126137804|NCT00352534|453797768|FG005|Final Risk Group Assignment|Physician Decision|8|||
126137805|NCT00352534|453797769|FG006|Final Risk Group Assignment|Physician Decision|0|||
126137806|NCT00352534|453797763|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
126137807|NCT00352534|453797764|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
126137808|NCT00352534|453797765|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
126137809|NCT00352534|453797766|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
126137810|NCT00352534|453797767|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
126137811|NCT00352534|453797768|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
126137812|NCT00352534|453797769|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
126137813|NCT00352534|453797763|FG000|Final Risk Group Assignment|Ineligible|0|||
126137814|NCT00352534|453797764|FG001|Final Risk Group Assignment|Ineligible|0|||
126137815|NCT00352534|453797765|FG002|Final Risk Group Assignment|Ineligible|3|||
126137816|NCT00352534|453797766|FG003|Final Risk Group Assignment|Ineligible|1|||
126137817|NCT00352534|453797767|FG004|Final Risk Group Assignment|Ineligible|0|||
126137818|NCT00352534|453797768|FG005|Final Risk Group Assignment|Ineligible|13|||
126137819|NCT00352534|453797769|FG006|Final Risk Group Assignment|Ineligible|0|||
126137820|NCT00352534|453797763|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126137821|NCT00352534|453797764|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126137822|NCT00352534|453797765|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126137823|NCT00352534|453797766|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126137824|NCT00352534|453797767|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126137825|NCT00352534|453797768|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126137826|NCT00352534|453797769|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
126137827|NCT00352534|453797763|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126137828|NCT00352534|453797764|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126137829|NCT00352534|453797765|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126137830|NCT00352534|453797766|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126137831|NCT00352534|453797767|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126137832|NCT00352534|453797768|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126137833|NCT00352534|453797769|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
126137834|NCT00352534|453797763|FG000|Final Risk Group Assignment|Death|0|||
126137835|NCT00352534|453797764|FG001|Final Risk Group Assignment|Death|0|||
126137836|NCT00352534|453797765|FG002|Final Risk Group Assignment|Death|0|||
126137837|NCT00352534|453797766|FG003|Final Risk Group Assignment|Death|0|||
126137838|NCT00352534|453797767|FG004|Final Risk Group Assignment|Death|0|||
126137839|NCT00352534|453797768|FG005|Final Risk Group Assignment|Death|2|||
126137840|NCT00352534|453797769|FG006|Final Risk Group Assignment|Death|0|||
126137841|NCT01602341|453797770|FG000|Overall Study|Adverse Event|0|||
126137842|NCT01602341|453797771|FG001|Overall Study|Adverse Event|1|||
126137843|NCT02090855|453797772|FG000|Overall Study|no evaluable Standard of Truth results|2|||
126137844|NCT00388947|453797773|FG000|Overall Study|Protocol Violation|47|||
126137845|NCT03038308|453797774|FG000|Overall Study|Surgical resection|1|||
126137846|NCT03038308|453797774|FG000|Overall Study|Withdrawal by Subject|2|||
126137847|NCT03038308|453797774|FG000|Overall Study|Lost to Follow-up|1|||
126137848|NCT04187092|453797775|FG000|Overall Study|Lost to Follow-up|1|||
126137849|NCT04187092|453797776|FG001|Overall Study|Lost to Follow-up|1|||
126137850|NCT04187092|453797775|FG000|Overall Study|Withdrawal by Subject|1|||
126137851|NCT04187092|453797776|FG001|Overall Study|Withdrawal by Subject|1|||
126137852|NCT04187092|453797775|FG000|Overall Study|Adverse Event|0|||
126137853|NCT04187092|453797776|FG001|Overall Study|Adverse Event|1|||
126137854|NCT01777763|453797791|FG000|Overall Study|Adverse Event|2|||
126137855|NCT01777763|453797792|FG001|Overall Study|Adverse Event|32|||
126137856|NCT01777763|453797791|FG000|Overall Study|Protocol Violation|1|||
126137857|NCT01777763|453797792|FG001|Overall Study|Protocol Violation|7|||
126137858|NCT01777763|453797791|FG000|Overall Study|Withdrawal by Subject|0|||
126137859|NCT01777763|453797792|FG001|Overall Study|Withdrawal by Subject|2|||
126137860|NCT01777763|453797791|FG000|Overall Study|Treatment Failure|1|||
126137861|NCT01777763|453797792|FG001|Overall Study|Treatment Failure|6|||
126137862|NCT00925600|453797799|FG000|Overall Study|Withdrawal by Subject|16|||
126137863|NCT00925600|453797800|FG001|Overall Study|Withdrawal by Subject|14|||
126137864|NCT00925600|453797799|FG000|Overall Study|Death|4|||
126137865|NCT00925600|453797800|FG001|Overall Study|Death|3|||
126137866|NCT00925600|453797799|FG000|Overall Study|Lost to Follow-up|2|||
126137867|NCT00925600|453797800|FG001|Overall Study|Lost to Follow-up|2|||
126137868|NCT00925600|453797799|FG000|Overall Study|Disease Progression|1|||
126137869|NCT00925600|453797800|FG001|Overall Study|Disease Progression|3|||
126137870|NCT00925600|453797799|FG000|Overall Study|Administrative Decision|1|||
126137871|NCT00925600|453797800|FG001|Overall Study|Administrative Decision|1|||
126137872|NCT00925600|453797799|FG000|Overall Study|Noncompliance|2|||
126137873|NCT00925600|453797800|FG001|Overall Study|Noncompliance|0|||
126137874|NCT00925600|453797799|FG000|Overall Study|Ineligibility Determined|2|||
126137875|NCT00925600|453797800|FG001|Overall Study|Ineligibility Determined|0|||
126137876|NCT00925600|453797799|FG000|Overall Study|Protocol Deviation|0|||
126137877|NCT00925600|453797800|FG001|Overall Study|Protocol Deviation|1|||
126137878|NCT00925600|453797799|FG000|Overall Study|Requirement for Alternative Therapy|0|||
126137879|NCT00925600|453797800|FG001|Overall Study|Requirement for Alternative Therapy|1|||
126137880|NCT00925600|453797799|FG000|Overall Study|Other|3|||
126137881|NCT00925600|453797800|FG001|Overall Study|Other|1|||
126137882|NCT00925600|453797799|FG000|Overall Study|Adverse Event|1|||
126137883|NCT00925600|453797800|FG001|Overall Study|Adverse Event|2|||
126137884|NCT01974817|453797801|FG000|Overall Study|Death|4|||
126137885|NCT01974817|453797801|FG000|Overall Study|Lost to Follow-up|2|||
126137886|NCT01974817|453797801|FG000|Overall Study|Protocol Violation|2|||
126137887|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
126137888|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
126137889|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
126137890|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
126137891|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
126137892|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
126137893|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
126137894|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
126137895|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
126137896|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
126137897|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
126137898|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
126137899|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
126137900|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
126137901|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
126137902|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
126137903|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
126137904|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
126137905|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
126137906|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
126137907|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
126137908|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
126137909|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
126137910|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
126137911|NCT04660643|453797802|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
126137912|NCT04660643|453797803|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
126137913|NCT04660643|453797804|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
126137914|NCT04660643|453797802|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
126137915|NCT04660643|453797803|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
126137916|NCT04660643|453797804|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
126137917|NCT04660643|453797802|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
126137918|NCT04660643|453797803|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
126137919|NCT04660643|453797804|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
126137920|NCT04660643|453797802|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
126137921|NCT04660643|453797803|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
126137922|NCT04660643|453797804|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
126137923|NCT04660643|453797802|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
126137924|NCT04660643|453797803|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
126137925|NCT04660643|453797804|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
126137926|NCT04660643|453797802|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
126137927|NCT04660643|453797803|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
126137928|NCT04660643|453797804|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
126137929|NCT04660643|453797802|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
126137930|NCT04660643|453797803|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
126137931|NCT04660643|453797804|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
126137932|NCT04660643|453797802|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
126137933|NCT04660643|453797803|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
126137934|NCT04660643|453797804|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
126137935|NCT03988907|453797805|FG000|Overall Study|Unable to complete visit|0|||
126137936|NCT03988907|453797806|FG001|Overall Study|Unable to complete visit|1|||
126137937|NCT02810964|453797807|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
126137938|NCT02810964|453797808|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
126137939|NCT02810964|453797807|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
126137940|NCT02810964|453797808|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
126137941|NCT02810964|453797807|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
126137942|NCT02810964|453797808|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
126137943|NCT02810964|453797807|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
126137944|NCT02810964|453797808|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
126137945|NCT03969875|453797817|FG000|Overall Study|did not receive allocated intervention|3|||
126137946|NCT03969875|453797818|FG001|Overall Study|did not receive allocated intervention|3|||
126137947|NCT03969875|453797819|FG002|Overall Study|did not receive allocated intervention|4|||
126137948|NCT03969875|453797817|FG000|Overall Study|Protocol Violation|4|||
126137949|NCT03969875|453797818|FG001|Overall Study|Protocol Violation|2|||
126137950|NCT03969875|453797819|FG002|Overall Study|Protocol Violation|2|||
126137951|NCT01307033|453797820|FG000|8-week Double-blind Period|Adverse Event|2|||
126137952|NCT01307033|453797821|FG001|8-week Double-blind Period|Adverse Event|0|||
126137953|NCT01307033|453797822|FG002|8-week Double-blind Period|Adverse Event|0|||
126137954|NCT01307033|453797823|FG003|8-week Double-blind Period|Adverse Event|0|||
126137955|NCT01307033|453797820|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
126137956|NCT01307033|453797821|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
126137957|NCT01307033|453797822|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
126137958|NCT01307033|453797823|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
126137959|NCT01307033|453797820|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
126137960|NCT01307033|453797821|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
126137961|NCT01307033|453797822|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
126137962|NCT01307033|453797823|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
126137963|NCT01307033|453797820|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
126137964|NCT01307033|453797821|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
126137965|NCT01307033|453797822|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
126137966|NCT01307033|453797823|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
126137967|NCT01307033|453797820|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
126137968|NCT01307033|453797821|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
126137969|NCT01307033|453797822|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
126137970|NCT01307033|453797823|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
126137971|NCT01307033|453797820|FG000|44-week Open-label Extension|Adverse Event|0|||
126137972|NCT01307033|453797821|FG001|44-week Open-label Extension|Adverse Event|0|||
126137973|NCT01307033|453797822|FG002|44-week Open-label Extension|Adverse Event|2|||
126137974|NCT01307033|453797823|FG003|44-week Open-label Extension|Adverse Event|1|||
126137975|NCT01307033|453797820|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
126137976|NCT01307033|453797821|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
126137977|NCT01307033|453797822|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
126137978|NCT01307033|453797823|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
126137979|NCT01307033|453797820|FG000|44-week Open-label Extension|Physician Decision|0|||
126137980|NCT01307033|453797821|FG001|44-week Open-label Extension|Physician Decision|0|||
126137981|NCT01307033|453797822|FG002|44-week Open-label Extension|Physician Decision|1|||
126137982|NCT01307033|453797823|FG003|44-week Open-label Extension|Physician Decision|0|||
126137983|NCT01307033|453797820|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
126137984|NCT01307033|453797821|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
126137985|NCT01307033|453797822|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
126137986|NCT01307033|453797823|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
126137987|NCT01307033|453797820|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
126137988|NCT01307033|453797821|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
126137989|NCT01307033|453797822|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
126137990|NCT01307033|453797823|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
126137991|NCT01307033|453797820|FG000|44-week Open-label Extension|Death|0|||
126137992|NCT01307033|453797821|FG001|44-week Open-label Extension|Death|0|||
126137993|NCT01307033|453797822|FG002|44-week Open-label Extension|Death|0|||
126137994|NCT01307033|453797823|FG003|44-week Open-label Extension|Death|1|||
126137995|NCT01231555|453797824|FG000|Overall Study|Study terminated|8|||
126137996|NCT01231555|453797825|FG001|Overall Study|Study terminated|5|||
126137997|NCT01231555|453797826|FG002|Overall Study|Study terminated|8|||
125968266|NCT03240588|453175753|FG001|Overall Study|Other, additional details not available.|12|||
125968267|NCT03240588|453175754|FG002|Overall Study|Other, additional details not available.|1|||
126137998|NCT01231555|453797824|FG000|Overall Study|Withdrawal by Subject|0|||
126137999|NCT01231555|453797825|FG001|Overall Study|Withdrawal by Subject|2|||
126138000|NCT01231555|453797826|FG002|Overall Study|Withdrawal by Subject|0|||
126138001|NCT00947531|453797827|FG000|Overall Study|Withdrawal by Subject|10|||
126138002|NCT00947531|453797828|FG001|Overall Study|Withdrawal by Subject|7|||
126138003|NCT00947531|453797827|FG000|Overall Study|Administrative Reason|0|||
126138004|NCT00947531|453797828|FG001|Overall Study|Administrative Reason|1|||
126138005|NCT00947531|453797827|FG000|Overall Study|Adverse Event|2|||
126138006|NCT00947531|453797828|FG001|Overall Study|Adverse Event|2|||
126138007|NCT00947531|453797827|FG000|Overall Study|Lack of Efficacy|1|||
126138008|NCT00947531|453797828|FG001|Overall Study|Lack of Efficacy|0|||
126138009|NCT00947531|453797827|FG000|Overall Study|Other|1|||
126138010|NCT00947531|453797828|FG001|Overall Study|Other|1|||
126138011|NCT01773421|453797830|FG000|Treatment Phase|Other|0|||
126138012|NCT01773421|453797831|FG001|Treatment Phase|Other|0|||
126138013|NCT01773421|453797832|FG002|Treatment Phase|Other|2|||
126138014|NCT01773421|453797833|FG003|Treatment Phase|Other|0|||
126138015|NCT01773421|453797834|FG004|Treatment Phase|Other|0|||
126138016|NCT01773421|453797835|FG005|Treatment Phase|Other|0|||
126138017|NCT01773421|453797836|FG006|Treatment Phase|Other|0|||
126138018|NCT01773421|453797830|FG000|Treatment Phase|Adverse Event|0|||
126138019|NCT01773421|453797831|FG001|Treatment Phase|Adverse Event|0|||
126138020|NCT01773421|453797832|FG002|Treatment Phase|Adverse Event|3|||
126138021|NCT01773421|453797833|FG003|Treatment Phase|Adverse Event|1|||
126138022|NCT01773421|453797834|FG004|Treatment Phase|Adverse Event|0|||
126138023|NCT01773421|453797835|FG005|Treatment Phase|Adverse Event|0|||
126138024|NCT01773421|453797836|FG006|Treatment Phase|Adverse Event|0|||
126138025|NCT01773421|453797830|FG000|Treatment Phase|Withdrawal by Subject|0|||
126138026|NCT01773421|453797831|FG001|Treatment Phase|Withdrawal by Subject|0|||
126138027|NCT01773421|453797832|FG002|Treatment Phase|Withdrawal by Subject|1|||
126138028|NCT01773421|453797833|FG003|Treatment Phase|Withdrawal by Subject|1|||
126138029|NCT01773421|453797834|FG004|Treatment Phase|Withdrawal by Subject|0|||
126138030|NCT01773421|453797835|FG005|Treatment Phase|Withdrawal by Subject|0|||
126138031|NCT01773421|453797836|FG006|Treatment Phase|Withdrawal by Subject|0|||
126138032|NCT01773421|453797830|FG000|Extension Phase|Other|0|||
126138033|NCT01773421|453797831|FG001|Extension Phase|Other|0|||
126138034|NCT01773421|453797832|FG002|Extension Phase|Other|0|||
126138035|NCT01773421|453797833|FG003|Extension Phase|Other|0|||
126138036|NCT01773421|453797834|FG004|Extension Phase|Other|1|||
126138037|NCT01773421|453797835|FG005|Extension Phase|Other|2|||
126138038|NCT01773421|453797836|FG006|Extension Phase|Other|0|||
126138039|NCT01773421|453797830|FG000|Extension Phase|Adverse Event|0|||
126138040|NCT01773421|453797831|FG001|Extension Phase|Adverse Event|0|||
126138041|NCT01773421|453797832|FG002|Extension Phase|Adverse Event|0|||
126138042|NCT01773421|453797833|FG003|Extension Phase|Adverse Event|0|||
126138043|NCT01773421|453797834|FG004|Extension Phase|Adverse Event|2|||
126138044|NCT01773421|453797835|FG005|Extension Phase|Adverse Event|0|||
126138045|NCT01773421|453797836|FG006|Extension Phase|Adverse Event|0|||
126138046|NCT02327260|453797837|FG000|Overall Study|Lost to Follow-up|2|||
126138047|NCT02327260|453797838|FG001|Overall Study|Lost to Follow-up|3|||
126138048|NCT02327260|453797839|FG002|Overall Study|Lost to Follow-up|2|||
126138049|NCT02327260|453797837|FG000|Overall Study|invalid phone number|1|||
126138050|NCT02327260|453797838|FG001|Overall Study|invalid phone number|1|||
126138051|NCT02327260|453797839|FG002|Overall Study|invalid phone number|0|||
126138052|NCT02327260|453797837|FG000|Overall Study|non-adherence to protocol|2|||
126138053|NCT02327260|453797838|FG001|Overall Study|non-adherence to protocol|0|||
126138054|NCT02327260|453797839|FG002|Overall Study|non-adherence to protocol|0|||
126138055|NCT02327260|453797837|FG000|Overall Study|cognitive concerns|1|||
126138056|NCT02327260|453797838|FG001|Overall Study|cognitive concerns|0|||
126138057|NCT02327260|453797839|FG002|Overall Study|cognitive concerns|0|||
126138058|NCT03502330|453797840|FG000|Overall Study|Adverse Event|2|||
126138059|NCT03502330|453797841|FG001|Overall Study|Adverse Event|1|||
126138060|NCT03502330|453797842|FG002|Overall Study|Adverse Event|0|||
125968268|NCT03240588|453175752|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
125968269|NCT03240588|453175753|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
125968270|NCT03240588|453175754|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
125968271|NCT03240588|453175752|FG000|Overall Study|Closure of study|55|||
126138061|NCT03502330|453797843|FG003|Overall Study|Adverse Event|0|||
126138062|NCT03502330|453797844|FG004|Overall Study|Adverse Event|1|||
126138063|NCT03502330|453797845|FG005|Overall Study|Adverse Event|0|||
126138064|NCT03502330|453797846|FG006|Overall Study|Adverse Event|1|||
126138065|NCT03502330|453797847|FG007|Overall Study|Adverse Event|1|||
126138066|NCT03502330|453797848|FG008|Overall Study|Adverse Event|0|||
126138067|NCT03502330|453797840|FG000|Overall Study|Lack of Efficacy|1|||
126138068|NCT03502330|453797841|FG001|Overall Study|Lack of Efficacy|5|||
126138069|NCT03502330|453797842|FG002|Overall Study|Lack of Efficacy|3|||
126138070|NCT03502330|453797843|FG003|Overall Study|Lack of Efficacy|5|||
126138071|NCT03502330|453797844|FG004|Overall Study|Lack of Efficacy|1|||
126138072|NCT03502330|453797845|FG005|Overall Study|Lack of Efficacy|5|||
126138073|NCT03502330|453797846|FG006|Overall Study|Lack of Efficacy|5|||
126138074|NCT03502330|453797847|FG007|Overall Study|Lack of Efficacy|6|||
126138075|NCT03502330|453797848|FG008|Overall Study|Lack of Efficacy|0|||
126138076|NCT03502330|453797840|FG000|Overall Study|Physician Decision|0|||
126138077|NCT03502330|453797841|FG001|Overall Study|Physician Decision|0|||
126138078|NCT03502330|453797842|FG002|Overall Study|Physician Decision|0|||
126138079|NCT03502330|453797843|FG003|Overall Study|Physician Decision|0|||
126138080|NCT03502330|453797844|FG004|Overall Study|Physician Decision|1|||
126138081|NCT03502330|453797845|FG005|Overall Study|Physician Decision|0|||
126138082|NCT03502330|453797846|FG006|Overall Study|Physician Decision|0|||
126138083|NCT03502330|453797847|FG007|Overall Study|Physician Decision|0|||
126138084|NCT03502330|453797848|FG008|Overall Study|Physician Decision|0|||
126138085|NCT03502330|453797840|FG000|Overall Study|Withdrawal by Subject|0|||
126138086|NCT03502330|453797841|FG001|Overall Study|Withdrawal by Subject|0|||
126138087|NCT03502330|453797842|FG002|Overall Study|Withdrawal by Subject|0|||
126138088|NCT03502330|453797843|FG003|Overall Study|Withdrawal by Subject|0|||
126138089|NCT03502330|453797844|FG004|Overall Study|Withdrawal by Subject|0|||
126138090|NCT03502330|453797845|FG005|Overall Study|Withdrawal by Subject|1|||
126138091|NCT03502330|453797846|FG006|Overall Study|Withdrawal by Subject|0|||
126138092|NCT03502330|453797847|FG007|Overall Study|Withdrawal by Subject|1|||
126138093|NCT03502330|453797848|FG008|Overall Study|Withdrawal by Subject|0|||
126138094|NCT03502330|453797840|FG000|Overall Study|Death|0|||
126138095|NCT03502330|453797841|FG001|Overall Study|Death|0|||
126138096|NCT03502330|453797842|FG002|Overall Study|Death|0|||
126138097|NCT03502330|453797843|FG003|Overall Study|Death|0|||
126138098|NCT03502330|453797844|FG004|Overall Study|Death|0|||
126138099|NCT03502330|453797845|FG005|Overall Study|Death|0|||
126138100|NCT03502330|453797846|FG006|Overall Study|Death|2|||
126138101|NCT03502330|453797847|FG007|Overall Study|Death|0|||
126138102|NCT03502330|453797848|FG008|Overall Study|Death|0|||
126138103|NCT02804763|453797849|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
126138104|NCT02804763|453797850|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
126138105|NCT02804763|453797851|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
126138106|NCT02804763|453797852|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
126138107|NCT02804763|453797849|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
126138108|NCT02804763|453797850|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
126138109|NCT02804763|453797851|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
126138110|NCT02804763|453797852|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
126138111|NCT02804763|453797849|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
126138112|NCT02804763|453797850|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
126138113|NCT02804763|453797851|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
126138114|NCT02804763|453797852|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
126138115|NCT02804763|453797849|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
126138116|NCT02804763|453797850|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
126138117|NCT02804763|453797851|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
126138118|NCT02804763|453797852|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
126138119|NCT02804763|453797849|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
126138120|NCT02804763|453797850|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
126138121|NCT02804763|453797851|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
126138122|NCT02804763|453797852|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
126138123|NCT02804763|453797849|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
126138124|NCT02804763|453797850|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
126138125|NCT02804763|453797851|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
126138126|NCT02804763|453797852|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
126138127|NCT04656990|453797853|FG000|Baseline|pandemic|20|||
126138128|NCT04656990|453797854|FG001|Baseline|pandemic|24|||
126138129|NCT04656990|453797853|FG000|Follow Up Period|Lost to Follow-up|61|||
126138130|NCT04656990|453797854|FG001|Follow Up Period|Lost to Follow-up|73|||
126138131|NCT00282243|453797857|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
126138132|NCT00282243|453797857|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
126138133|NCT00282243|453797857|FG000|Extension Treatment Period|Adverse Event|15|||
126138134|NCT00282243|453797857|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
126138135|NCT00282243|453797857|FG000|Extension Treatment Period|Non-compliance|2|||
126138136|NCT00282243|453797857|FG000|Extension Treatment Period|Physician Decision|1|||
126138137|NCT01070329|453797858|FG000|Overall Study|Adverse Event|13|||
126138138|NCT01070329|453797859|FG001|Overall Study|Adverse Event|10|||
126138139|NCT01070329|453797858|FG000|Overall Study|Lost to Follow-up|22|||
126138140|NCT01070329|453797859|FG001|Overall Study|Lost to Follow-up|12|||
126138141|NCT01070329|453797858|FG000|Overall Study|Withdrawal by Subject|9|||
126138142|NCT01070329|453797859|FG001|Overall Study|Withdrawal by Subject|11|||
126138143|NCT01070329|453797858|FG000|Overall Study|Protocol Violation|3|||
126138144|NCT01070329|453797859|FG001|Overall Study|Protocol Violation|8|||
126138145|NCT01070329|453797858|FG000|Overall Study|Lack of Efficacy|2|||
125968272|NCT03240588|453175753|FG001|Overall Study|Closure of study|3|||
126138146|NCT01070329|453797859|FG001|Overall Study|Lack of Efficacy|6|||
126138147|NCT01070329|453797858|FG000|Overall Study|Physician Decision|2|||
126138148|NCT01070329|453797859|FG001|Overall Study|Physician Decision|1|||
126138149|NCT01070329|453797858|FG000|Overall Study|Entry Criteria Not Met|1|||
126138150|NCT01070329|453797859|FG001|Overall Study|Entry Criteria Not Met|0|||
126138151|NCT01070329|453797858|FG000|Overall Study|Sponsor Decision|0|||
126138152|NCT01070329|453797859|FG001|Overall Study|Sponsor Decision|1|||
126138153|NCT02863848|453797860|FG000|Overall Study|Lost to Follow-up|1|||
126138154|NCT02863848|453797861|FG001|Overall Study|Lost to Follow-up|1|||
126138155|NCT02863848|453797860|FG000|Overall Study|Protocol Violation|1|||
126138156|NCT02863848|453797861|FG001|Overall Study|Protocol Violation|2|||
126138157|NCT03588741|453797866|FG000|Overall Study|Withdrawal by Subject|1|||
126138158|NCT00793793|453797867|FG000|Overall Study|Adverse Event|0|||
126138159|NCT00793793|453797868|FG001|Overall Study|Adverse Event|0|||
126138160|NCT00793793|453797869|FG002|Overall Study|Adverse Event|1|||
126138161|NCT00793793|453797870|FG003|Overall Study|Adverse Event|1|||
126138162|NCT00793793|453797871|FG004|Overall Study|Adverse Event|0|||
126138163|NCT00793793|453797872|FG005|Overall Study|Adverse Event|1|||
126138164|NCT00793793|453797873|FG006|Overall Study|Adverse Event|2|||
126138165|NCT00793793|453797874|FG007|Overall Study|Adverse Event|0|||
126138166|NCT00793793|453797875|FG008|Overall Study|Adverse Event|0|||
126138167|NCT00793793|453797876|FG009|Overall Study|Adverse Event|0|||
126138168|NCT00793793|453797877|FG010|Overall Study|Adverse Event|0|||
126138169|NCT00793793|453797878|FG011|Overall Study|Adverse Event|2|||
126138170|NCT00793793|453797867|FG000|Overall Study|Protocol Violation|0|||
126138171|NCT00793793|453797868|FG001|Overall Study|Protocol Violation|0|||
126138172|NCT00793793|453797869|FG002|Overall Study|Protocol Violation|0|||
126138173|NCT00793793|453797870|FG003|Overall Study|Protocol Violation|1|||
126138174|NCT00793793|453797871|FG004|Overall Study|Protocol Violation|0|||
126138175|NCT00793793|453797872|FG005|Overall Study|Protocol Violation|0|||
126138176|NCT00793793|453797873|FG006|Overall Study|Protocol Violation|0|||
126138177|NCT00793793|453797874|FG007|Overall Study|Protocol Violation|0|||
126138178|NCT00793793|453797875|FG008|Overall Study|Protocol Violation|0|||
126138179|NCT00793793|453797876|FG009|Overall Study|Protocol Violation|0|||
126138180|NCT00793793|453797877|FG010|Overall Study|Protocol Violation|0|||
126138181|NCT00793793|453797878|FG011|Overall Study|Protocol Violation|0|||
126138182|NCT00793793|453797867|FG000|Overall Study|Lost to Follow-up|0|||
126138183|NCT00793793|453797868|FG001|Overall Study|Lost to Follow-up|0|||
126138184|NCT00793793|453797869|FG002|Overall Study|Lost to Follow-up|1|||
126138185|NCT00793793|453797870|FG003|Overall Study|Lost to Follow-up|0|||
126138186|NCT00793793|453797871|FG004|Overall Study|Lost to Follow-up|0|||
126138187|NCT00793793|453797872|FG005|Overall Study|Lost to Follow-up|0|||
126138188|NCT00793793|453797873|FG006|Overall Study|Lost to Follow-up|0|||
126138189|NCT00793793|453797874|FG007|Overall Study|Lost to Follow-up|0|||
126138190|NCT00793793|453797875|FG008|Overall Study|Lost to Follow-up|1|||
125968273|NCT03240588|453175754|FG002|Overall Study|Closure of study|0|||
125968274|NCT03240588|453175752|FG000|Overall Study|Subject non-compliance|23|||
125968275|NCT03240588|453175753|FG001|Overall Study|Subject non-compliance|2|||
125968276|NCT03240588|453175754|FG002|Overall Study|Subject non-compliance|1|||
125968277|NCT03240588|453175752|FG000|Overall Study|Device Deficiency|1|||
125968278|NCT03240588|453175753|FG001|Overall Study|Device Deficiency|0|||
125968279|NCT03240588|453175754|FG002|Overall Study|Device Deficiency|0|||
125968280|NCT03240588|453175752|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
125968281|NCT03240588|453175753|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
125968282|NCT03240588|453175754|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
125968283|NCT00377819|453175757|FG000|Overall Study|Adverse Event|2|||
125968284|NCT00377819|453175758|FG001|Overall Study|Adverse Event|3|||
125968285|NCT00377819|453175757|FG000|Overall Study|Withdrawal by Subject|10|||
125968286|NCT00377819|453175758|FG001|Overall Study|Withdrawal by Subject|4|||
126138191|NCT00793793|453797876|FG009|Overall Study|Lost to Follow-up|3|||
126138192|NCT00793793|453797877|FG010|Overall Study|Lost to Follow-up|1|||
126138193|NCT00793793|453797878|FG011|Overall Study|Lost to Follow-up|0|||
126138194|NCT00793793|453797867|FG000|Overall Study|Withdrawal by Subject|0|||
126138195|NCT00793793|453797868|FG001|Overall Study|Withdrawal by Subject|0|||
126138196|NCT00793793|453797869|FG002|Overall Study|Withdrawal by Subject|0|||
126138197|NCT00793793|453797870|FG003|Overall Study|Withdrawal by Subject|0|||
126138198|NCT00793793|453797871|FG004|Overall Study|Withdrawal by Subject|1|||
126138199|NCT00793793|453797872|FG005|Overall Study|Withdrawal by Subject|0|||
126138200|NCT00793793|453797873|FG006|Overall Study|Withdrawal by Subject|0|||
126138201|NCT00793793|453797874|FG007|Overall Study|Withdrawal by Subject|0|||
126138202|NCT00793793|453797875|FG008|Overall Study|Withdrawal by Subject|1|||
126138203|NCT00793793|453797876|FG009|Overall Study|Withdrawal by Subject|0|||
126138204|NCT00793793|453797877|FG010|Overall Study|Withdrawal by Subject|0|||
126138205|NCT00793793|453797878|FG011|Overall Study|Withdrawal by Subject|0|||
126138206|NCT00793793|453797867|FG000|Overall Study|reason not specified|0|||
126138207|NCT00793793|453797868|FG001|Overall Study|reason not specified|1|||
126138208|NCT00793793|453797869|FG002|Overall Study|reason not specified|0|||
126138209|NCT00793793|453797870|FG003|Overall Study|reason not specified|1|||
126138210|NCT00793793|453797871|FG004|Overall Study|reason not specified|1|||
126138211|NCT00793793|453797872|FG005|Overall Study|reason not specified|1|||
125968287|NCT00377819|453175757|FG000|Overall Study|Death|0|||
126138212|NCT00793793|453797873|FG006|Overall Study|reason not specified|2|||
126138213|NCT00793793|453797874|FG007|Overall Study|reason not specified|0|||
126138214|NCT00793793|453797875|FG008|Overall Study|reason not specified|7|||
126138215|NCT00793793|453797876|FG009|Overall Study|reason not specified|6|||
126138216|NCT00793793|453797877|FG010|Overall Study|reason not specified|2|||
126138217|NCT00793793|453797878|FG011|Overall Study|reason not specified|4|||
126138218|NCT00950170|453797879|FG000|Overall Study|Parent/Legal Guardian Request|1|||
126138219|NCT00950170|453797879|FG000|Overall Study|Adverse Event|2|||
126138220|NCT00950170|453797879|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
126138221|NCT02661594|453797880|FG000|Overall Study|Protocol Violation|1|||
126138222|NCT02661594|453797881|FG001|Overall Study|Protocol Violation|0|||
126138223|NCT02661594|453797882|FG002|Overall Study|Protocol Violation|1|||
126138224|NCT02661594|453797883|FG003|Overall Study|Protocol Violation|0|||
126138225|NCT02522767|453797884|FG000|Double-blind|Withdrawal by Subject|8|||
126138226|NCT02522767|453797885|FG001|Double-blind|Withdrawal by Subject|11|||
126138227|NCT02522767|453797884|FG000|Double-blind|Lost to Follow-up|1|||
126138228|NCT02522767|453797885|FG001|Double-blind|Lost to Follow-up|0|||
126138229|NCT02522767|453797884|FG000|Double-blind|Adverse Event|1|||
126138230|NCT02522767|453797885|FG001|Double-blind|Adverse Event|10|||
126138231|NCT02522767|453797884|FG000|Double-blind|Protocol Violation|0|||
126138232|NCT02522767|453797885|FG001|Double-blind|Protocol Violation|1|||
126138233|NCT02522767|453797884|FG000|Double-blind|Lack of Efficacy|0|||
126138234|NCT02522767|453797885|FG001|Double-blind|Lack of Efficacy|2|||
126138235|NCT02522767|453797884|FG000|Double-blind|Protocol Deviation|1|||
126138236|NCT02522767|453797885|FG001|Double-blind|Protocol Deviation|0|||
126138237|NCT02522767|453797884|FG000|Open-label|Withdrawal by Subject|2|||
126138238|NCT02522767|453797885|FG001|Open-label|Withdrawal by Subject|3|||
126138239|NCT02522767|453797884|FG000|Open-label|Lost to Follow-up|0|||
126138240|NCT02522767|453797885|FG001|Open-label|Lost to Follow-up|1|||
126138241|NCT02522767|453797884|FG000|Open-label|Adverse Event|2|||
126138242|NCT02522767|453797885|FG001|Open-label|Adverse Event|1|||
126138243|NCT02522767|453797884|FG000|Open-label|Lack of Efficacy|1|||
126138244|NCT02522767|453797885|FG001|Open-label|Lack of Efficacy|1|||
126138245|NCT02522767|453797884|FG000|Open-label|Protocol Violation|0|||
126138246|NCT02522767|453797885|FG001|Open-label|Protocol Violation|1|||
126138247|NCT00548548|453797886|FG000|Overall Study|Death|345|||
126138248|NCT00548548|453797887|FG001|Overall Study|Death|348|||
126138249|NCT00548548|453797886|FG000|Overall Study|Lost to Follow-up|17|||
126138250|NCT00548548|453797887|FG001|Overall Study|Lost to Follow-up|18|||
126138251|NCT01705691|453797888|FG000|Overall Study|Death|1|||
126138252|NCT01705691|453797889|FG001|Overall Study|Death|2|||
126138253|NCT01705691|453797888|FG000|Overall Study|Withdrawal by Subject|1|||
126138254|NCT01705691|453797889|FG001|Overall Study|Withdrawal by Subject|2|||
126138255|NCT01705691|453797888|FG000|Overall Study|Lost to Follow-up|1|||
126138256|NCT01705691|453797889|FG001|Overall Study|Lost to Follow-up|1|||
126138257|NCT01705691|453797888|FG000|Overall Study|Other|0|||
126138258|NCT01705691|453797889|FG001|Overall Study|Other|1|||
126138259|NCT00214461|453797890|FG000|Overall Study|Adverse Event|0|||
126138260|NCT00214461|453797891|FG001|Overall Study|Adverse Event|0|||
126138261|NCT00214461|453797892|FG002|Overall Study|Adverse Event|1|||
126138262|NCT00214461|453797893|FG003|Overall Study|Adverse Event|1|||
126138263|NCT00214461|453797890|FG000|Overall Study|Withdrawal by Subject|0|||
126138264|NCT00214461|453797891|FG001|Overall Study|Withdrawal by Subject|0|||
126138265|NCT00214461|453797892|FG002|Overall Study|Withdrawal by Subject|1|||
126138266|NCT00214461|453797893|FG003|Overall Study|Withdrawal by Subject|0|||
126138267|NCT03502187|453797894|FG000|Overall Study|Withdrawal by Subject|4|||
126138268|NCT03502187|453797895|FG001|Overall Study|Withdrawal by Subject|3|||
126138269|NCT03502187|453797896|FG002|Overall Study|Withdrawal by Subject|3|||
126138270|NCT03502187|453797894|FG000|Overall Study|Lost to Follow-up|5|||
126138271|NCT03502187|453797895|FG001|Overall Study|Lost to Follow-up|4|||
126138272|NCT03502187|453797896|FG002|Overall Study|Lost to Follow-up|5|||
126138273|NCT02913313|453797897|FG000|Overall Study|DISEASE PROGRESSION|1|||
126138274|NCT02913313|453797898|FG001|Overall Study|DISEASE PROGRESSION|2|||
126138275|NCT02913313|453797899|FG002|Overall Study|DISEASE PROGRESSION|2|||
126138276|NCT02913313|453797900|FG003|Overall Study|DISEASE PROGRESSION|4|||
126138277|NCT02913313|453797901|FG004|Overall Study|DISEASE PROGRESSION|6|||
126138278|NCT02913313|453797902|FG005|Overall Study|DISEASE PROGRESSION|4|||
126138279|NCT02913313|453797903|FG006|Overall Study|DISEASE PROGRESSION|19|||
125968288|NCT00377819|453175758|FG001|Overall Study|Death|1|||
125968289|NCT00377819|453175757|FG000|Overall Study|Lost to Follow-up|0|||
125968290|NCT00377819|453175758|FG001|Overall Study|Lost to Follow-up|1|||
125968291|NCT00377819|453175757|FG000|Overall Study|Protocol Violation|1|||
126138280|NCT02913313|453797904|FG007|Overall Study|DISEASE PROGRESSION|3|||
126138281|NCT02913313|453797905|FG008|Overall Study|DISEASE PROGRESSION|4|||
126138282|NCT02913313|453797906|FG009|Overall Study|DISEASE PROGRESSION|4|||
125968292|NCT00377819|453175758|FG001|Overall Study|Protocol Violation|1|||
126138283|NCT02913313|453797907|FG010|Overall Study|DISEASE PROGRESSION|11|||
126138284|NCT02913313|453797908|FG011|Overall Study|DISEASE PROGRESSION|5|||
126138285|NCT02913313|453797909|FG012|Overall Study|DISEASE PROGRESSION|14|||
126138286|NCT02913313|453797910|FG013|Overall Study|DISEASE PROGRESSION|3|||
126138287|NCT02913313|453797897|FG000|Overall Study|Not Reported|0|||
126138288|NCT02913313|453797898|FG001|Overall Study|Not Reported|0|||
126138289|NCT02913313|453797899|FG002|Overall Study|Not Reported|0|||
126138290|NCT02913313|453797900|FG003|Overall Study|Not Reported|0|||
126138291|NCT02913313|453797901|FG004|Overall Study|Not Reported|1|||
126138292|NCT02913313|453797902|FG005|Overall Study|Not Reported|0|||
126138293|NCT02913313|453797903|FG006|Overall Study|Not Reported|0|||
126138294|NCT02913313|453797904|FG007|Overall Study|Not Reported|0|||
126138295|NCT02913313|453797905|FG008|Overall Study|Not Reported|0|||
126138296|NCT02913313|453797906|FG009|Overall Study|Not Reported|0|||
126138297|NCT02913313|453797907|FG010|Overall Study|Not Reported|4|||
126138298|NCT02913313|453797908|FG011|Overall Study|Not Reported|0|||
126138299|NCT02913313|453797909|FG012|Overall Study|Not Reported|0|||
126138300|NCT02913313|453797910|FG013|Overall Study|Not Reported|0|||
126138301|NCT02913313|453797897|FG000|Overall Study|Other reasons|0|||
126138302|NCT02913313|453797898|FG001|Overall Study|Other reasons|0|||
126138303|NCT02913313|453797899|FG002|Overall Study|Other reasons|0|||
126138304|NCT02913313|453797900|FG003|Overall Study|Other reasons|0|||
126138305|NCT02913313|453797901|FG004|Overall Study|Other reasons|1|||
126138306|NCT02913313|453797902|FG005|Overall Study|Other reasons|0|||
126138307|NCT02913313|453797903|FG006|Overall Study|Other reasons|0|||
126138308|NCT02913313|453797904|FG007|Overall Study|Other reasons|0|||
126138309|NCT02913313|453797905|FG008|Overall Study|Other reasons|0|||
126138310|NCT02913313|453797906|FG009|Overall Study|Other reasons|0|||
126138311|NCT02913313|453797907|FG010|Overall Study|Other reasons|1|||
126138312|NCT02913313|453797908|FG011|Overall Study|Other reasons|0|||
126138313|NCT02913313|453797909|FG012|Overall Study|Other reasons|0|||
126138314|NCT02913313|453797910|FG013|Overall Study|Other reasons|0|||
126138315|NCT02913313|453797897|FG000|Overall Study|Withdrawal by Subject|0|||
126138316|NCT02913313|453797898|FG001|Overall Study|Withdrawal by Subject|0|||
126138317|NCT02913313|453797899|FG002|Overall Study|Withdrawal by Subject|1|||
126138318|NCT02913313|453797900|FG003|Overall Study|Withdrawal by Subject|0|||
126138319|NCT02913313|453797901|FG004|Overall Study|Withdrawal by Subject|0|||
126138320|NCT02913313|453797902|FG005|Overall Study|Withdrawal by Subject|0|||
126138321|NCT02913313|453797903|FG006|Overall Study|Withdrawal by Subject|1|||
126138322|NCT02913313|453797904|FG007|Overall Study|Withdrawal by Subject|1|||
126138323|NCT02913313|453797905|FG008|Overall Study|Withdrawal by Subject|0|||
126138324|NCT02913313|453797906|FG009|Overall Study|Withdrawal by Subject|0|||
126138325|NCT02913313|453797907|FG010|Overall Study|Withdrawal by Subject|1|||
126138326|NCT02913313|453797908|FG011|Overall Study|Withdrawal by Subject|0|||
126138327|NCT02913313|453797909|FG012|Overall Study|Withdrawal by Subject|0|||
126138328|NCT02913313|453797910|FG013|Overall Study|Withdrawal by Subject|0|||
126138329|NCT02913313|453797897|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138330|NCT02913313|453797898|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138331|NCT02913313|453797899|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138332|NCT02913313|453797900|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138333|NCT02913313|453797901|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138334|NCT02913313|453797902|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138335|NCT02913313|453797903|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138336|NCT02913313|453797904|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138337|NCT02913313|453797905|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138338|NCT02913313|453797906|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138339|NCT02913313|453797907|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
126138340|NCT02913313|453797908|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126138341|NCT02913313|453797909|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
126138342|NCT02913313|453797910|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
126138343|NCT02913313|453797897|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
126138344|NCT02913313|453797898|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
126138345|NCT02913313|453797899|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
126138346|NCT02913313|453797900|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
126138347|NCT02913313|453797901|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
126138348|NCT02913313|453797902|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
126138349|NCT02913313|453797903|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
126138350|NCT02913313|453797904|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
126138351|NCT02913313|453797905|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
126138352|NCT02913313|453797906|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
126138353|NCT02913313|453797907|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
126138354|NCT02913313|453797908|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
126138355|NCT02913313|453797909|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
126138356|NCT02913313|453797910|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
126138357|NCT02908100|453797912|FG000|Overall Study|Adverse Event|7|||
126138358|NCT02908100|453797913|FG001|Overall Study|Adverse Event|6|||
126138359|NCT02908100|453797914|FG002|Overall Study|Adverse Event|9|||
126138360|NCT02908100|453797912|FG000|Overall Study|Death|2|||
126138361|NCT02908100|453797913|FG001|Overall Study|Death|0|||
126138362|NCT02908100|453797914|FG002|Overall Study|Death|0|||
126138363|NCT02908100|453797912|FG000|Overall Study|Lack of Efficacy|2|||
126138364|NCT02908100|453797913|FG001|Overall Study|Lack of Efficacy|3|||
126138365|NCT02908100|453797914|FG002|Overall Study|Lack of Efficacy|3|||
126138366|NCT02908100|453797912|FG000|Overall Study|Lost to Follow-up|0|||
126138367|NCT02908100|453797913|FG001|Overall Study|Lost to Follow-up|1|||
126138368|NCT02908100|453797914|FG002|Overall Study|Lost to Follow-up|2|||
126138369|NCT02908100|453797912|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126138370|NCT02908100|453797913|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126138371|NCT02908100|453797914|FG002|Overall Study|Non-Compliance With Study Drug|2|||
126138372|NCT02908100|453797912|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
126138373|NCT02908100|453797913|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
126138374|NCT02908100|453797914|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
126138375|NCT02908100|453797912|FG000|Overall Study|Physician Decision|0|||
126138376|NCT02908100|453797913|FG001|Overall Study|Physician Decision|1|||
126138377|NCT02908100|453797914|FG002|Overall Study|Physician Decision|0|||
126138378|NCT02908100|453797912|FG000|Overall Study|Pregnancy|1|||
126138379|NCT02908100|453797913|FG001|Overall Study|Pregnancy|2|||
126138380|NCT02908100|453797914|FG002|Overall Study|Pregnancy|0|||
126138381|NCT02908100|453797912|FG000|Overall Study|Withdrawal by Subject|8|||
126138382|NCT02908100|453797913|FG001|Overall Study|Withdrawal by Subject|7|||
126138383|NCT02908100|453797914|FG002|Overall Study|Withdrawal by Subject|5|||
126138384|NCT02908100|453797912|FG000|Overall Study|Randomised in Error|1|||
126138385|NCT02908100|453797913|FG001|Overall Study|Randomised in Error|0|||
126138386|NCT02908100|453797914|FG002|Overall Study|Randomised in Error|0|||
126138387|NCT04088409|453797915|FG000|Part A|Withdrawal by Subject|2|||
126138388|NCT04088409|453797916|FG001|Part A|Withdrawal by Subject|1|||
126138389|NCT04088409|453797915|FG000|Part A|Did Not Meet Randomization Criteria|2|||
126138390|NCT04088409|453797916|FG001|Part A|Did Not Meet Randomization Criteria|0|||
126138391|NCT04088409|453797915|FG000|Part A|Lack of Efficacy|9|||
126138392|NCT04088409|453797916|FG001|Part A|Lack of Efficacy|0|||
126138393|NCT04088409|453797915|FG000|Part A|Lost to Follow-up|1|||
126138394|NCT04088409|453797916|FG001|Part A|Lost to Follow-up|0|||
126138395|NCT04088409|453797915|FG000|Part A|Adverse Event|1|||
126138396|NCT04088409|453797916|FG001|Part A|Adverse Event|0|||
126138397|NCT04088409|453797915|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
126138398|NCT04088409|453797916|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
126138399|NCT04088409|453797915|FG000|Part B|Ongoing Treatment|10|||
126138400|NCT04088409|453797916|FG001|Part B|Ongoing Treatment|0|||
126138401|NCT04233229|453797919|FG000|Overall Study|Withdrawal by Subject|0|||
126138402|NCT04233229|453797920|FG001|Overall Study|Withdrawal by Subject|1|||
126138403|NCT04233229|453797919|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
126138404|NCT04233229|453797920|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
126138405|NCT04233229|453797919|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
126138406|NCT04233229|453797920|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
126138407|NCT00841763|453797921|FG000|Overall Study|Withdrawal by Subject|60|||
126138408|NCT00841763|453797922|FG001|Overall Study|Withdrawal by Subject|17|||
126138409|NCT00841763|453797923|FG002|Overall Study|Withdrawal by Subject|4|||
126138410|NCT00841763|453797924|FG003|Overall Study|Withdrawal by Subject|1|||
126138411|NCT00841763|453797921|FG000|Overall Study|Adverse Event|9|||
126138412|NCT00841763|453797922|FG001|Overall Study|Adverse Event|10|||
126138413|NCT00841763|453797923|FG002|Overall Study|Adverse Event|3|||
126138414|NCT00841763|453797924|FG003|Overall Study|Adverse Event|2|||
126138415|NCT00841763|453797921|FG000|Overall Study|Lost to Follow-up|63|||
126138416|NCT00841763|453797922|FG001|Overall Study|Lost to Follow-up|25|||
126138417|NCT00841763|453797923|FG002|Overall Study|Lost to Follow-up|0|||
126138418|NCT00841763|453797924|FG003|Overall Study|Lost to Follow-up|0|||
126138419|NCT00841763|453797921|FG000|Overall Study|Protocol Violation|20|||
126138420|NCT00841763|453797922|FG001|Overall Study|Protocol Violation|3|||
126138421|NCT00841763|453797923|FG002|Overall Study|Protocol Violation|1|||
126138422|NCT00841763|453797924|FG003|Overall Study|Protocol Violation|0|||
126138423|NCT00841763|453797921|FG000|Overall Study|Administrative Reasons|3|||
125968293|NCT02091726|453175759|FG000|Overall Study|Lost to Follow-up|6|||
125968294|NCT03727750|453175760|FG000|Overall Study|Death|45|||
125968295|NCT03727750|453175760|FG000|Overall Study|Withdrawal by Subject|2|||
125968296|NCT03727750|453175760|FG000|Overall Study|Lost to Follow-up|1|||
125968297|NCT03727750|453175760|FG000|Overall Study|Other|1|||
126138424|NCT00841763|453797922|FG001|Overall Study|Administrative Reasons|1|||
126138425|NCT00841763|453797923|FG002|Overall Study|Administrative Reasons|0|||
126138426|NCT00841763|453797924|FG003|Overall Study|Administrative Reasons|0|||
126138427|NCT00841763|453797921|FG000|Overall Study|Unable to Classify|7|||
126138428|NCT00841763|453797922|FG001|Overall Study|Unable to Classify|1|||
126138429|NCT00841763|453797923|FG002|Overall Study|Unable to Classify|0|||
126138430|NCT00841763|453797924|FG003|Overall Study|Unable to Classify|0|||
126138431|NCT02631538|453797925|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
126138432|NCT02631538|453797926|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
126138433|NCT02631538|453797927|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
126138434|NCT02631538|453797928|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
126138435|NCT02631538|453797925|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
126138436|NCT02631538|453797926|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
126138437|NCT02631538|453797927|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
126138438|NCT02631538|453797928|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
126138439|NCT02631538|453797925|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
126138440|NCT02631538|453797926|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
126138441|NCT02631538|453797927|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
126138442|NCT02631538|453797928|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
126138443|NCT02631538|453797925|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
126138444|NCT02631538|453797926|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
126138445|NCT02631538|453797927|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
126138446|NCT02631538|453797928|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
126138447|NCT02631538|453797925|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
126138448|NCT02631538|453797926|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
126138449|NCT02631538|453797927|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
126138450|NCT02631538|453797928|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
126138451|NCT02631538|453797925|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
126138452|NCT02631538|453797926|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
126138453|NCT02631538|453797927|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
126138454|NCT02631538|453797928|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
126138455|NCT00400400|453797929|FG000|Overall Study|Adverse Event|9|||
126138456|NCT00400400|453797930|FG001|Overall Study|Adverse Event|8|||
126138457|NCT00400400|453797929|FG000|Overall Study|Protocol Violation|2|||
126138458|NCT00400400|453797930|FG001|Overall Study|Protocol Violation|0|||
126138459|NCT00400400|453797929|FG000|Overall Study|Withdrawal by Subject|1|||
126138460|NCT00400400|453797930|FG001|Overall Study|Withdrawal by Subject|3|||
126138461|NCT00400400|453797929|FG000|Overall Study|Administrative Problem|1|||
126138462|NCT00400400|453797930|FG001|Overall Study|Administrative Problem|0|||
126138463|NCT00400400|453797929|FG000|Overall Study|Lost to Follow-up|0|||
126138464|NCT00400400|453797930|FG001|Overall Study|Lost to Follow-up|1|||
126138465|NCT00400400|453797929|FG000|Overall Study|Did not receive study drug|1|||
126138466|NCT00400400|453797930|FG001|Overall Study|Did not receive study drug|3|||
126138467|NCT00648167|453797931|FG000|Overall Study|Adverse Event|6|||
126138468|NCT00648167|453797931|FG000|Overall Study|unable to swallow tablets|1|||
126138469|NCT01688050|453797932|FG000|Overall Study|Death|7|||
126138470|NCT01688050|453797932|FG000|Overall Study|Conversion to open repair|1|||
126138471|NCT01688050|453797932|FG000|Overall Study|Lost to Follow-up|13|||
126138472|NCT01688050|453797932|FG000|Overall Study|Withdrawal by Subject|10|||
126138473|NCT00440726|453797937|FG000|Phase 1|Dose-Limiting Toxicity|0|||
126138474|NCT00440726|453797938|FG001|Phase 1|Dose-Limiting Toxicity|1|||
126138475|NCT00440726|453797939|FG002|Phase 1|Dose-Limiting Toxicity|0|||
126138476|NCT00440726|453797937|FG000|Phase 1|Physician Decision|1|||
126138477|NCT00440726|453797938|FG001|Phase 1|Physician Decision|0|||
126138478|NCT00440726|453797939|FG002|Phase 1|Physician Decision|0|||
126138479|NCT00440726|453797937|FG000|Phase 2|Death|0|||
126138480|NCT00440726|453797938|FG001|Phase 2|Death|0|||
126138481|NCT00440726|453797939|FG002|Phase 2|Death|1|||
126138482|NCT00440726|453797937|FG000|Phase 2|Adverse Event|0|||
126138483|NCT00440726|453797938|FG001|Phase 2|Adverse Event|0|||
126138484|NCT00440726|453797939|FG002|Phase 2|Adverse Event|1|||
126138485|NCT01482910|453797940|FG000|Overall Study|Adverse Event|6|||
126138486|NCT01482910|453797941|FG001|Overall Study|Adverse Event|5|||
126138487|NCT01482910|453797940|FG000|Overall Study|Lost to Follow-up|0|||
126138488|NCT01482910|453797941|FG001|Overall Study|Lost to Follow-up|1|||
126138489|NCT01482910|453797940|FG000|Overall Study|Protocol Violation|1|||
126138490|NCT01482910|453797941|FG001|Overall Study|Protocol Violation|1|||
126138491|NCT01482910|453797940|FG000|Overall Study|Withdrawal by Subject|7|||
126138492|NCT01482910|453797941|FG001|Overall Study|Withdrawal by Subject|2|||
126138493|NCT01482910|453797940|FG000|Overall Study|Death|1|||
126138494|NCT01482910|453797941|FG001|Overall Study|Death|0|||
126138495|NCT03370770|453797943|FG000|Overall Study|Patient was followed in another hospital center|1|||
126138496|NCT03370770|453797943|FG000|Overall Study|Progressive Disease|98|||
126138497|NCT03370770|453797943|FG000|Overall Study|Adverse Event|2|||
126138498|NCT03370770|453797943|FG000|Overall Study|Death|5|||
126138499|NCT00234039|453797944|FG000|Overall Study|Adverse Event|2|||
126138500|NCT00234039|453797944|FG000|Overall Study|Progression/relapse|34|||
126138501|NCT00234039|453797944|FG000|Overall Study|Other - Not Protocol Specified|3|||
126138502|NCT00234039|453797944|FG000|Overall Study|Ineligible|9|||
126138503|NCT00234039|453797944|FG000|Overall Study|No Protocol Treatment Received|2|||
126138504|NCT00110019|453797947|FG000|Overall Study|Lack of Efficacy|253|||
126138505|NCT00110019|453797948|FG001|Overall Study|Lack of Efficacy|285|||
126138506|NCT00110019|453797947|FG000|Overall Study|Adverse Event|61|||
126138507|NCT00110019|453797948|FG001|Overall Study|Adverse Event|40|||
126138508|NCT00110019|453797947|FG000|Overall Study|Death|13|||
126138509|NCT00110019|453797948|FG001|Overall Study|Death|15|||
126138510|NCT00110019|453797947|FG000|Overall Study|Withdrawal by Subject|21|||
126138511|NCT00110019|453797948|FG001|Overall Study|Withdrawal by Subject|9|||
126138512|NCT00110019|453797947|FG000|Overall Study|alternative therapy|5|||
126138513|NCT00110019|453797948|FG001|Overall Study|alternative therapy|1|||
126138514|NCT00110019|453797947|FG000|Overall Study|complicating disease|1|||
126138515|NCT00110019|453797948|FG001|Overall Study|complicating disease|1|||
126138516|NCT00110019|453797947|FG000|Overall Study|symptom deterioration|13|||
126138517|NCT00110019|453797948|FG001|Overall Study|symptom deterioration|16|||
126138518|NCT00110019|453797947|FG000|Overall Study|Not start protocol therapy|17|||
126138519|NCT00110019|453797948|FG001|Overall Study|Not start protocol therapy|16|||
126138520|NCT00110019|453797947|FG000|Overall Study|other reasons|22|||
126138521|NCT00110019|453797948|FG001|Overall Study|other reasons|30|||
126138522|NCT04426695|453797951|FG000|Overall Study|Death|2|||
126138523|NCT04426695|453797952|FG001|Overall Study|Death|0|||
126138524|NCT04426695|453797953|FG002|Overall Study|Death|1|||
126138525|NCT04426695|453797954|FG003|Overall Study|Death|27|||
126138526|NCT04426695|453797955|FG004|Overall Study|Death|25|||
126138527|NCT04426695|453797956|FG005|Overall Study|Death|21|||
126138528|NCT04426695|453797957|FG006|Overall Study|Death|42|||
126138529|NCT04426695|453797958|FG007|Overall Study|Death|23|||
126138530|NCT04426695|453797959|FG008|Overall Study|Death|37|||
126138531|NCT04426695|453797960|FG009|Overall Study|Death|14|||
126138532|NCT04426695|453797961|FG010|Overall Study|Death|8|||
126138533|NCT04426695|453797962|FG011|Overall Study|Death|7|||
126138534|NCT04426695|453797963|FG012|Overall Study|Death|13|||
126138535|NCT04426695|453797964|FG013|Overall Study|Death|25|||
126138536|NCT04426695|453797965|FG014|Overall Study|Death|19|||
126138537|NCT04426695|453797966|FG015|Overall Study|Death|7|||
126138538|NCT04426695|453797967|FG016|Overall Study|Death|8|||
126138539|NCT04426695|453797968|FG017|Overall Study|Death|4|||
126138540|NCT04426695|453797951|FG000|Overall Study|Lost to Follow-up|2|||
126138541|NCT04426695|453797952|FG001|Overall Study|Lost to Follow-up|4|||
126138542|NCT04426695|453797953|FG002|Overall Study|Lost to Follow-up|1|||
126138543|NCT04426695|453797954|FG003|Overall Study|Lost to Follow-up|19|||
126138544|NCT04426695|453797955|FG004|Overall Study|Lost to Follow-up|10|||
126138545|NCT04426695|453797956|FG005|Overall Study|Lost to Follow-up|14|||
126138546|NCT04426695|453797957|FG006|Overall Study|Lost to Follow-up|5|||
126138547|NCT04426695|453797958|FG007|Overall Study|Lost to Follow-up|14|||
126138548|NCT04426695|453797959|FG008|Overall Study|Lost to Follow-up|10|||
126138549|NCT04426695|453797960|FG009|Overall Study|Lost to Follow-up|11|||
126138550|NCT04426695|453797961|FG010|Overall Study|Lost to Follow-up|12|||
126138551|NCT04426695|453797962|FG011|Overall Study|Lost to Follow-up|6|||
126138552|NCT04426695|453797963|FG012|Overall Study|Lost to Follow-up|2|||
126138553|NCT04426695|453797964|FG013|Overall Study|Lost to Follow-up|2|||
126138554|NCT04426695|453797965|FG014|Overall Study|Lost to Follow-up|2|||
126138555|NCT04426695|453797966|FG015|Overall Study|Lost to Follow-up|0|||
126138556|NCT04426695|453797967|FG016|Overall Study|Lost to Follow-up|0|||
126138557|NCT04426695|453797968|FG017|Overall Study|Lost to Follow-up|0|||
126138558|NCT04426695|453797951|FG000|Overall Study|Participant Decision|1|||
126138559|NCT04426695|453797952|FG001|Overall Study|Participant Decision|2|||
126138560|NCT04426695|453797953|FG002|Overall Study|Participant Decision|2|||
126138561|NCT04426695|453797954|FG003|Overall Study|Participant Decision|12|||
126138562|NCT04426695|453797955|FG004|Overall Study|Participant Decision|18|||
126138563|NCT04426695|453797956|FG005|Overall Study|Participant Decision|22|||
126138564|NCT04426695|453797957|FG006|Overall Study|Participant Decision|13|||
126138565|NCT04426695|453797958|FG007|Overall Study|Participant Decision|13|||
126138566|NCT04426695|453797959|FG008|Overall Study|Participant Decision|10|||
126138567|NCT04426695|453797960|FG009|Overall Study|Participant Decision|15|||
126138568|NCT04426695|453797961|FG010|Overall Study|Participant Decision|16|||
126138569|NCT04426695|453797962|FG011|Overall Study|Participant Decision|17|||
125968298|NCT01914926|453175768|FG000|Overall Study|Adverse Event|1|||
125968299|NCT01914926|453175769|FG001|Overall Study|Adverse Event|0|||
125968300|NCT01914926|453175768|FG000|Overall Study|uncooperative, agitated and removed|0|||
125968301|NCT01914926|453175769|FG001|Overall Study|uncooperative, agitated and removed|1|||
125968302|NCT00467870|453175770|FG000|Overall Study|Adverse Event|13|||
125968303|NCT00467870|453175771|FG001|Overall Study|Adverse Event|9|||
126138570|NCT04426695|453797963|FG012|Overall Study|Participant Decision|2|||
126138571|NCT04426695|453797964|FG013|Overall Study|Participant Decision|1|||
126138572|NCT04426695|453797965|FG014|Overall Study|Participant Decision|2|||
126138573|NCT04426695|453797966|FG015|Overall Study|Participant Decision|0|||
126138574|NCT04426695|453797967|FG016|Overall Study|Participant Decision|0|||
126138575|NCT04426695|453797968|FG017|Overall Study|Participant Decision|0|||
126138576|NCT04426695|453797951|FG000|Overall Study|Adverse Event|0|||
126138577|NCT04426695|453797952|FG001|Overall Study|Adverse Event|0|||
126138578|NCT04426695|453797953|FG002|Overall Study|Adverse Event|0|||
126138579|NCT04426695|453797954|FG003|Overall Study|Adverse Event|0|||
126138580|NCT04426695|453797955|FG004|Overall Study|Adverse Event|0|||
126138581|NCT04426695|453797956|FG005|Overall Study|Adverse Event|0|||
126138582|NCT04426695|453797957|FG006|Overall Study|Adverse Event|0|||
126138583|NCT04426695|453797958|FG007|Overall Study|Adverse Event|1|||
126138584|NCT04426695|453797959|FG008|Overall Study|Adverse Event|0|||
126138585|NCT04426695|453797960|FG009|Overall Study|Adverse Event|0|||
126138586|NCT04426695|453797961|FG010|Overall Study|Adverse Event|1|||
126138587|NCT04426695|453797962|FG011|Overall Study|Adverse Event|1|||
126138588|NCT04426695|453797963|FG012|Overall Study|Adverse Event|0|||
126138589|NCT04426695|453797964|FG013|Overall Study|Adverse Event|0|||
126138590|NCT04426695|453797965|FG014|Overall Study|Adverse Event|0|||
126138591|NCT04426695|453797966|FG015|Overall Study|Adverse Event|0|||
126138592|NCT04426695|453797967|FG016|Overall Study|Adverse Event|0|||
126138593|NCT04426695|453797968|FG017|Overall Study|Adverse Event|0|||
125968304|NCT00467870|453175772|FG002|Overall Study|Adverse Event|1|||
125968305|NCT00467870|453175773|FG003|Overall Study|Adverse Event|15|||
125968306|NCT00467870|453175774|FG004|Overall Study|Adverse Event|15|||
126138594|NCT04426695|453797951|FG000|Overall Study|Sponsor Request|0|||
126138595|NCT04426695|453797952|FG001|Overall Study|Sponsor Request|0|||
126138596|NCT04426695|453797953|FG002|Overall Study|Sponsor Request|0|||
126138597|NCT04426695|453797954|FG003|Overall Study|Sponsor Request|0|||
126138598|NCT04426695|453797955|FG004|Overall Study|Sponsor Request|0|||
126138599|NCT04426695|453797956|FG005|Overall Study|Sponsor Request|0|||
126138600|NCT04426695|453797957|FG006|Overall Study|Sponsor Request|1|||
126138601|NCT04426695|453797958|FG007|Overall Study|Sponsor Request|0|||
126138602|NCT04426695|453797959|FG008|Overall Study|Sponsor Request|0|||
126138603|NCT04426695|453797960|FG009|Overall Study|Sponsor Request|0|||
126138604|NCT04426695|453797961|FG010|Overall Study|Sponsor Request|0|||
126138605|NCT04426695|453797962|FG011|Overall Study|Sponsor Request|0|||
126138606|NCT04426695|453797963|FG012|Overall Study|Sponsor Request|0|||
126138607|NCT04426695|453797964|FG013|Overall Study|Sponsor Request|0|||
126138608|NCT04426695|453797965|FG014|Overall Study|Sponsor Request|0|||
126138609|NCT04426695|453797966|FG015|Overall Study|Sponsor Request|0|||
126138610|NCT04426695|453797967|FG016|Overall Study|Sponsor Request|0|||
126138611|NCT04426695|453797968|FG017|Overall Study|Sponsor Request|0|||
126138612|NCT04426695|453797951|FG000|Overall Study|Physician Decision|0|||
126138613|NCT04426695|453797952|FG001|Overall Study|Physician Decision|0|||
126138614|NCT04426695|453797953|FG002|Overall Study|Physician Decision|0|||
126138615|NCT04426695|453797954|FG003|Overall Study|Physician Decision|0|||
126138616|NCT04426695|453797955|FG004|Overall Study|Physician Decision|0|||
126138617|NCT04426695|453797956|FG005|Overall Study|Physician Decision|0|||
126138618|NCT04426695|453797957|FG006|Overall Study|Physician Decision|0|||
126138619|NCT04426695|453797958|FG007|Overall Study|Physician Decision|0|||
126138620|NCT04426695|453797959|FG008|Overall Study|Physician Decision|0|||
126138621|NCT04426695|453797960|FG009|Overall Study|Physician Decision|1|||
126138622|NCT04426695|453797961|FG010|Overall Study|Physician Decision|0|||
126138623|NCT04426695|453797962|FG011|Overall Study|Physician Decision|0|||
126138624|NCT04426695|453797963|FG012|Overall Study|Physician Decision|1|||
126138625|NCT04426695|453797964|FG013|Overall Study|Physician Decision|0|||
126138626|NCT04426695|453797965|FG014|Overall Study|Physician Decision|0|||
126138627|NCT04426695|453797966|FG015|Overall Study|Physician Decision|0|||
126138628|NCT04426695|453797967|FG016|Overall Study|Physician Decision|0|||
126138629|NCT04426695|453797968|FG017|Overall Study|Physician Decision|0|||
126138630|NCT04426695|453797951|FG000|Overall Study|Randomized but Never Treated|3|||
126138631|NCT04426695|453797952|FG001|Overall Study|Randomized but Never Treated|1|||
126138632|NCT04426695|453797953|FG002|Overall Study|Randomized but Never Treated|0|||
126138633|NCT04426695|453797954|FG003|Overall Study|Randomized but Never Treated|4|||
126138634|NCT04426695|453797955|FG004|Overall Study|Randomized but Never Treated|5|||
126138635|NCT04426695|453797956|FG005|Overall Study|Randomized but Never Treated|5|||
126138636|NCT04426695|453797957|FG006|Overall Study|Randomized but Never Treated|4|||
126138637|NCT04426695|453797958|FG007|Overall Study|Randomized but Never Treated|6|||
126138638|NCT04426695|453797959|FG008|Overall Study|Randomized but Never Treated|6|||
126138639|NCT04426695|453797960|FG009|Overall Study|Randomized but Never Treated|3|||
126138640|NCT04426695|453797961|FG010|Overall Study|Randomized but Never Treated|3|||
126138641|NCT04426695|453797962|FG011|Overall Study|Randomized but Never Treated|6|||
126138642|NCT04426695|453797963|FG012|Overall Study|Randomized but Never Treated|1|||
126138643|NCT04426695|453797964|FG013|Overall Study|Randomized but Never Treated|2|||
126138644|NCT04426695|453797965|FG014|Overall Study|Randomized but Never Treated|0|||
126138645|NCT04426695|453797966|FG015|Overall Study|Randomized but Never Treated|0|||
126138646|NCT04426695|453797967|FG016|Overall Study|Randomized but Never Treated|0|||
126138647|NCT04426695|453797968|FG017|Overall Study|Randomized but Never Treated|0|||
126138648|NCT04303000|453797969|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
125968307|NCT00467870|453175775|FG005|Overall Study|Adverse Event|1|||
126138649|NCT04303000|453797970|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
126138650|NCT04303000|453797971|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
126138651|NCT00559273|453797972|FG000|Correction Period (20 Weeks)|Death|3|||
126138652|NCT00559273|453797973|FG001|Correction Period (20 Weeks)|Death|4|||
126138653|NCT00559273|453797972|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
126138654|NCT00559273|453797973|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
126138655|NCT00559273|453797972|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
126138656|NCT00559273|453797973|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
126151412|NCT00488631|453841979|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
126138657|NCT00559273|453797972|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
126138658|NCT00559273|453797973|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
126138659|NCT00559273|453797972|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
126138660|NCT00559273|453797973|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
126138661|NCT00559273|453797972|FG000|Evaluation Period (8 Weeks)|Death|1|||
126138662|NCT00559273|453797973|FG001|Evaluation Period (8 Weeks)|Death|3|||
126138663|NCT00559273|453797972|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
126138664|NCT00559273|453797973|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
126138665|NCT00559273|453797972|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
126138666|NCT00559273|453797973|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
126138667|NCT00559273|453797972|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
126138668|NCT00559273|453797973|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
126138669|NCT00395967|453797978|FG000|Treatment Period|Failed Mobilization|1|||
126138670|NCT00395967|453797978|FG000|Follow-up Period|Death|1|||
126138671|NCT00395967|453797978|FG000|Follow-up Period|Lost to Follow-up|1|||
126138672|NCT01109940|453797979|FG000|Overall Study|Administrative problems|2|||
126138673|NCT01109940|453797980|FG001|Overall Study|Administrative problems|0|||
126138674|NCT01109940|453797981|FG002|Overall Study|Administrative problems|0|||
126138675|NCT01109940|453797982|FG003|Overall Study|Administrative problems|0|||
126138676|NCT01109940|453797979|FG000|Overall Study|Serious Adverse Event|2|||
126138677|NCT01109940|453797980|FG001|Overall Study|Serious Adverse Event|1|||
126138678|NCT01109940|453797981|FG002|Overall Study|Serious Adverse Event|0|||
126138679|NCT01109940|453797982|FG003|Overall Study|Serious Adverse Event|0|||
126138680|NCT01109940|453797979|FG000|Overall Study|Lost to Follow-up|1|||
126138681|NCT01109940|453797980|FG001|Overall Study|Lost to Follow-up|0|||
126138682|NCT01109940|453797981|FG002|Overall Study|Lost to Follow-up|0|||
126138683|NCT01109940|453797982|FG003|Overall Study|Lost to Follow-up|0|||
126138684|NCT01109940|453797979|FG000|Overall Study|Patient withdrew consent|1|||
126138685|NCT01109940|453797980|FG001|Overall Study|Patient withdrew consent|1|||
126138686|NCT01109940|453797981|FG002|Overall Study|Patient withdrew consent|0|||
126138687|NCT01109940|453797982|FG003|Overall Study|Patient withdrew consent|0|||
126138688|NCT01109940|453797979|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126138689|NCT01109940|453797980|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126138690|NCT01109940|453797981|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
126138691|NCT01109940|453797982|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126138692|NCT03653390|453797983|FG000|Overall Study|Lost to Follow-up|12|||
126138693|NCT03653390|453797984|FG001|Overall Study|Lost to Follow-up|8|||
126138694|NCT03653390|453797985|FG002|Overall Study|Lost to Follow-up|7|||
126138695|NCT03653390|453797983|FG000|Overall Study|Withdrawal by Subject|6|||
126138696|NCT03653390|453797984|FG001|Overall Study|Withdrawal by Subject|1|||
126138697|NCT03653390|453797985|FG002|Overall Study|Withdrawal by Subject|1|||
126138698|NCT03653390|453797983|FG000|Overall Study|Death|1|||
126138699|NCT03653390|453797984|FG001|Overall Study|Death|0|||
126138700|NCT03653390|453797985|FG002|Overall Study|Death|0|||
126138701|NCT03653390|453797983|FG000|Overall Study|Paper Survey Lost|1|||
126138702|NCT03653390|453797984|FG001|Overall Study|Paper Survey Lost|0|||
126138703|NCT03653390|453797985|FG002|Overall Study|Paper Survey Lost|0|||
126138704|NCT03118947|453797986|FG000|Overall Study|Adverse Event|7|||
126138705|NCT03118947|453797986|FG000|Overall Study|Death|3|||
126138706|NCT03118947|453797986|FG000|Overall Study|Lack of Efficacy|4|||
126138707|NCT03118947|453797986|FG000|Overall Study|Non-compliance with study drug|1|||
126138708|NCT03118947|453797986|FG000|Overall Study|Protocol Violation|2|||
126138709|NCT03118947|453797986|FG000|Overall Study|Withdrawal by Subject|3|||
126138710|NCT03118947|453797986|FG000|Overall Study|Withdrawal by caregiver|3|||
126138711|NCT03118947|453797986|FG000|Overall Study|Change in patient's living situation|4|||
126138712|NCT03118947|453797986|FG000|Overall Study|Lost to Follow-up|2|||
126138713|NCT01262976|453797993|FG000|Up to Month 2|Serious Adverse Event|0|||
126138714|NCT01262976|453797994|FG001|Up to Month 2|Serious Adverse Event|0|||
125968308|NCT00467870|453175770|FG000|Overall Study|Protocol Violation|2|||
126138715|NCT01262976|453797995|FG002|Up to Month 2|Serious Adverse Event|1|||
126138716|NCT01262976|453797996|FG003|Up to Month 2|Serious Adverse Event|0|||
126138717|NCT01262976|453797997|FG004|Up to Month 2|Serious Adverse Event|0|||
126138718|NCT01262976|453797998|FG005|Up to Month 2|Serious Adverse Event|0|||
126138719|NCT01262976|453797993|FG000|Up to Month 2|Withdrawal by Subject|1|||
126138720|NCT01262976|453797994|FG001|Up to Month 2|Withdrawal by Subject|0|||
126138721|NCT01262976|453797995|FG002|Up to Month 2|Withdrawal by Subject|0|||
126138722|NCT01262976|453797996|FG003|Up to Month 2|Withdrawal by Subject|0|||
126138723|NCT01262976|453797997|FG004|Up to Month 2|Withdrawal by Subject|0|||
126138724|NCT01262976|453797998|FG005|Up to Month 2|Withdrawal by Subject|0|||
126138725|NCT01262976|453797993|FG000|Up to Month 2|Migrated/moved from study area|0|||
126138726|NCT01262976|453797994|FG001|Up to Month 2|Migrated/moved from study area|1|||
126138727|NCT01262976|453797995|FG002|Up to Month 2|Migrated/moved from study area|0|||
126138728|NCT01262976|453797996|FG003|Up to Month 2|Migrated/moved from study area|0|||
126138729|NCT01262976|453797997|FG004|Up to Month 2|Migrated/moved from study area|1|||
126138730|NCT01262976|453797998|FG005|Up to Month 2|Migrated/moved from study area|1|||
126138731|NCT01262976|453797993|FG000|Up to Month 2|Lost to Follow-up|1|||
126138732|NCT01262976|453797994|FG001|Up to Month 2|Lost to Follow-up|0|||
126138733|NCT01262976|453797995|FG002|Up to Month 2|Lost to Follow-up|0|||
126138734|NCT01262976|453797996|FG003|Up to Month 2|Lost to Follow-up|1|||
126138735|NCT01262976|453797997|FG004|Up to Month 2|Lost to Follow-up|1|||
126138736|NCT01262976|453797998|FG005|Up to Month 2|Lost to Follow-up|1|||
126138737|NCT01262976|453797993|FG000|Up to Month 2|Other|1|||
126138738|NCT01262976|453797994|FG001|Up to Month 2|Other|0|||
126138739|NCT01262976|453797995|FG002|Up to Month 2|Other|0|||
126138740|NCT01262976|453797996|FG003|Up to Month 2|Other|1|||
126138741|NCT01262976|453797997|FG004|Up to Month 2|Other|0|||
126138742|NCT01262976|453797998|FG005|Up to Month 2|Other|2|||
126138743|NCT01262976|453797993|FG000|Up to Month 7|Serious Adverse Event|0|||
126138744|NCT01262976|453797994|FG001|Up to Month 7|Serious Adverse Event|0|||
126138745|NCT01262976|453797995|FG002|Up to Month 7|Serious Adverse Event|2|||
126138746|NCT01262976|453797996|FG003|Up to Month 7|Serious Adverse Event|0|||
126138747|NCT01262976|453797997|FG004|Up to Month 7|Serious Adverse Event|0|||
126138748|NCT01262976|453797998|FG005|Up to Month 7|Serious Adverse Event|0|||
126138749|NCT01262976|453797993|FG000|Up to Month 7|Withdrawal by Subject|1|||
126138750|NCT01262976|453797994|FG001|Up to Month 7|Withdrawal by Subject|0|||
126138751|NCT01262976|453797995|FG002|Up to Month 7|Withdrawal by Subject|0|||
126138752|NCT01262976|453797996|FG003|Up to Month 7|Withdrawal by Subject|0|||
126138753|NCT01262976|453797997|FG004|Up to Month 7|Withdrawal by Subject|0|||
126138754|NCT01262976|453797998|FG005|Up to Month 7|Withdrawal by Subject|0|||
126138755|NCT01262976|453797993|FG000|Up to Month 7|Migrated/moved from study area|0|||
126138756|NCT01262976|453797994|FG001|Up to Month 7|Migrated/moved from study area|0|||
126138757|NCT01262976|453797995|FG002|Up to Month 7|Migrated/moved from study area|1|||
126138758|NCT01262976|453797996|FG003|Up to Month 7|Migrated/moved from study area|3|||
126138759|NCT01262976|453797997|FG004|Up to Month 7|Migrated/moved from study area|1|||
126138760|NCT01262976|453797998|FG005|Up to Month 7|Migrated/moved from study area|1|||
126138761|NCT01262976|453797993|FG000|Up to Month 7|Lost to Follow-up|1|||
126138762|NCT01262976|453797994|FG001|Up to Month 7|Lost to Follow-up|0|||
126138763|NCT01262976|453797995|FG002|Up to Month 7|Lost to Follow-up|1|||
126138764|NCT01262976|453797996|FG003|Up to Month 7|Lost to Follow-up|3|||
126138765|NCT01262976|453797997|FG004|Up to Month 7|Lost to Follow-up|1|||
126138766|NCT01262976|453797998|FG005|Up to Month 7|Lost to Follow-up|3|||
126138767|NCT01262976|453797993|FG000|Up to Month 7|Other|3|||
126138768|NCT01262976|453797994|FG001|Up to Month 7|Other|0|||
126138769|NCT01262976|453797995|FG002|Up to Month 7|Other|2|||
126138770|NCT01262976|453797996|FG003|Up to Month 7|Other|0|||
126138771|NCT01262976|453797997|FG004|Up to Month 7|Other|0|||
126138772|NCT01262976|453797998|FG005|Up to Month 7|Other|0|||
126138773|NCT01262976|453797993|FG000|Up to Year 1|Serious Adverse Event|0|||
126138774|NCT01262976|453797994|FG001|Up to Year 1|Serious Adverse Event|0|||
126138775|NCT01262976|453797995|FG002|Up to Year 1|Serious Adverse Event|2|||
126138776|NCT01262976|453797996|FG003|Up to Year 1|Serious Adverse Event|0|||
126138777|NCT01262976|453797997|FG004|Up to Year 1|Serious Adverse Event|0|||
126138778|NCT01262976|453797998|FG005|Up to Year 1|Serious Adverse Event|0|||
126138779|NCT01262976|453797993|FG000|Up to Year 1|Withdrawal by Subject|1|||
126138780|NCT01262976|453797994|FG001|Up to Year 1|Withdrawal by Subject|0|||
126138781|NCT01262976|453797995|FG002|Up to Year 1|Withdrawal by Subject|0|||
126138782|NCT01262976|453797996|FG003|Up to Year 1|Withdrawal by Subject|0|||
126138783|NCT01262976|453797997|FG004|Up to Year 1|Withdrawal by Subject|0|||
126138784|NCT01262976|453797998|FG005|Up to Year 1|Withdrawal by Subject|0|||
126138785|NCT01262976|453797993|FG000|Up to Year 1|Migrated/moved from study area|1|||
126138786|NCT01262976|453797994|FG001|Up to Year 1|Migrated/moved from study area|0|||
126138787|NCT01262976|453797995|FG002|Up to Year 1|Migrated/moved from study area|0|||
126138788|NCT01262976|453797996|FG003|Up to Year 1|Migrated/moved from study area|3|||
126138789|NCT01262976|453797997|FG004|Up to Year 1|Migrated/moved from study area|3|||
126138790|NCT01262976|453797998|FG005|Up to Year 1|Migrated/moved from study area|2|||
126138791|NCT01262976|453797993|FG000|Up to Year 1|Lost to Follow-up|4|||
126138792|NCT01262976|453797994|FG001|Up to Year 1|Lost to Follow-up|0|||
126138793|NCT01262976|453797995|FG002|Up to Year 1|Lost to Follow-up|0|||
126138794|NCT01262976|453797996|FG003|Up to Year 1|Lost to Follow-up|1|||
126138795|NCT01262976|453797997|FG004|Up to Year 1|Lost to Follow-up|6|||
126138796|NCT01262976|453797998|FG005|Up to Year 1|Lost to Follow-up|5|||
126138797|NCT01262976|453797993|FG000|Up to Year 1|Other|3|||
126138798|NCT01262976|453797994|FG001|Up to Year 1|Other|1|||
126138799|NCT01262976|453797995|FG002|Up to Year 1|Other|0|||
126138800|NCT01262976|453797996|FG003|Up to Year 1|Other|0|||
126138801|NCT01262976|453797997|FG004|Up to Year 1|Other|2|||
126138802|NCT01262976|453797998|FG005|Up to Year 1|Other|1|||
126138803|NCT01262976|453797993|FG000|Up to Year 1|Subjects with unknown completion status|0|||
126138804|NCT01262976|453797994|FG001|Up to Year 1|Subjects with unknown completion status|0|||
126138805|NCT01262976|453797995|FG002|Up to Year 1|Subjects with unknown completion status|1|||
126138806|NCT01262976|453797996|FG003|Up to Year 1|Subjects with unknown completion status|0|||
126138807|NCT01262976|453797997|FG004|Up to Year 1|Subjects with unknown completion status|0|||
126138808|NCT01262976|453797998|FG005|Up to Year 1|Subjects with unknown completion status|1|||
126138809|NCT01262976|453797993|FG000|Up to Year 2|Serious Adverse Event|0|||
126138810|NCT01262976|453797994|FG001|Up to Year 2|Serious Adverse Event|0|||
126138811|NCT01262976|453797995|FG002|Up to Year 2|Serious Adverse Event|2|||
126138812|NCT01262976|453797996|FG003|Up to Year 2|Serious Adverse Event|0|||
126138813|NCT01262976|453797997|FG004|Up to Year 2|Serious Adverse Event|0|||
126138814|NCT01262976|453797998|FG005|Up to Year 2|Serious Adverse Event|0|||
126138815|NCT01262976|453797993|FG000|Up to Year 2|Withdrawal by Subject|1|||
126138816|NCT01262976|453797994|FG001|Up to Year 2|Withdrawal by Subject|0|||
126138817|NCT01262976|453797995|FG002|Up to Year 2|Withdrawal by Subject|0|||
126138818|NCT01262976|453797996|FG003|Up to Year 2|Withdrawal by Subject|0|||
126138819|NCT01262976|453797997|FG004|Up to Year 2|Withdrawal by Subject|0|||
126138820|NCT01262976|453797998|FG005|Up to Year 2|Withdrawal by Subject|0|||
126138821|NCT01262976|453797993|FG000|Up to Year 2|Migrated/moved from study area|0|||
126138822|NCT01262976|453797994|FG001|Up to Year 2|Migrated/moved from study area|0|||
126138823|NCT01262976|453797995|FG002|Up to Year 2|Migrated/moved from study area|0|||
126138824|NCT01262976|453797996|FG003|Up to Year 2|Migrated/moved from study area|2|||
126138825|NCT01262976|453797997|FG004|Up to Year 2|Migrated/moved from study area|1|||
126138826|NCT01262976|453797998|FG005|Up to Year 2|Migrated/moved from study area|2|||
126138827|NCT01262976|453797993|FG000|Up to Year 2|Lost to Follow-up|1|||
126138828|NCT01262976|453797994|FG001|Up to Year 2|Lost to Follow-up|1|||
126138829|NCT01262976|453797995|FG002|Up to Year 2|Lost to Follow-up|2|||
126138830|NCT01262976|453797996|FG003|Up to Year 2|Lost to Follow-up|2|||
126138831|NCT01262976|453797997|FG004|Up to Year 2|Lost to Follow-up|3|||
126138832|NCT01262976|453797998|FG005|Up to Year 2|Lost to Follow-up|3|||
126138833|NCT01262976|453797993|FG000|Up to Year 2|Subjects with unknown completion status|0|||
126138834|NCT01262976|453797994|FG001|Up to Year 2|Subjects with unknown completion status|0|||
126138835|NCT01262976|453797995|FG002|Up to Year 2|Subjects with unknown completion status|1|||
126138836|NCT01262976|453797996|FG003|Up to Year 2|Subjects with unknown completion status|0|||
126138837|NCT01262976|453797997|FG004|Up to Year 2|Subjects with unknown completion status|0|||
126138838|NCT01262976|453797998|FG005|Up to Year 2|Subjects with unknown completion status|0|||
126138839|NCT01262976|453797993|FG000|Up to Year 2|Other|3|||
126138840|NCT01262976|453797994|FG001|Up to Year 2|Other|0|||
126138841|NCT01262976|453797995|FG002|Up to Year 2|Other|0|||
126138842|NCT01262976|453797996|FG003|Up to Year 2|Other|0|||
126138843|NCT01262976|453797997|FG004|Up to Year 2|Other|0|||
126138844|NCT01262976|453797998|FG005|Up to Year 2|Other|0|||
126138845|NCT01262976|453797993|FG000|Up to Year 3|Serious Adverse Event|0|||
126138846|NCT01262976|453797994|FG001|Up to Year 3|Serious Adverse Event|0|||
126138847|NCT01262976|453797995|FG002|Up to Year 3|Serious Adverse Event|2|||
126138848|NCT01262976|453797996|FG003|Up to Year 3|Serious Adverse Event|0|||
126138849|NCT01262976|453797997|FG004|Up to Year 3|Serious Adverse Event|0|||
126138850|NCT01262976|453797998|FG005|Up to Year 3|Serious Adverse Event|0|||
126138851|NCT01262976|453797993|FG000|Up to Year 3|Withdrawal by Subject|1|||
126138852|NCT01262976|453797994|FG001|Up to Year 3|Withdrawal by Subject|0|||
126138853|NCT01262976|453797995|FG002|Up to Year 3|Withdrawal by Subject|0|||
126138854|NCT01262976|453797996|FG003|Up to Year 3|Withdrawal by Subject|0|||
126138855|NCT01262976|453797997|FG004|Up to Year 3|Withdrawal by Subject|0|||
126138856|NCT01262976|453797998|FG005|Up to Year 3|Withdrawal by Subject|0|||
126138857|NCT01262976|453797993|FG000|Up to Year 3|Migrated/moved from study area|0|||
126138858|NCT01262976|453797994|FG001|Up to Year 3|Migrated/moved from study area|0|||
126138859|NCT01262976|453797995|FG002|Up to Year 3|Migrated/moved from study area|0|||
126138860|NCT01262976|453797996|FG003|Up to Year 3|Migrated/moved from study area|2|||
126138861|NCT01262976|453797997|FG004|Up to Year 3|Migrated/moved from study area|1|||
126138862|NCT01262976|453797998|FG005|Up to Year 3|Migrated/moved from study area|1|||
126138863|NCT01262976|453797993|FG000|Up to Year 3|Lost to Follow-up|2|||
126138864|NCT01262976|453797994|FG001|Up to Year 3|Lost to Follow-up|2|||
126138865|NCT01262976|453797995|FG002|Up to Year 3|Lost to Follow-up|4|||
126138866|NCT01262976|453797996|FG003|Up to Year 3|Lost to Follow-up|3|||
126138867|NCT01262976|453797997|FG004|Up to Year 3|Lost to Follow-up|1|||
126138868|NCT01262976|453797998|FG005|Up to Year 3|Lost to Follow-up|3|||
125968309|NCT00467870|453175771|FG001|Overall Study|Protocol Violation|1|||
125968310|NCT00467870|453175772|FG002|Overall Study|Protocol Violation|1|||
126138869|NCT01262976|453797993|FG000|Up to Year 3|Subjects with unknown completion status|0|||
125968311|NCT00467870|453175773|FG003|Overall Study|Protocol Violation|2|||
125968312|NCT00467870|453175774|FG004|Overall Study|Protocol Violation|0|||
126138870|NCT01262976|453797994|FG001|Up to Year 3|Subjects with unknown completion status|0|||
126138871|NCT01262976|453797995|FG002|Up to Year 3|Subjects with unknown completion status|1|||
126138872|NCT01262976|453797996|FG003|Up to Year 3|Subjects with unknown completion status|0|||
126138873|NCT01262976|453797997|FG004|Up to Year 3|Subjects with unknown completion status|0|||
126138874|NCT01262976|453797998|FG005|Up to Year 3|Subjects with unknown completion status|0|||
126138875|NCT01262976|453797993|FG000|Up to Year 3|Other|3|||
126138876|NCT01262976|453797994|FG001|Up to Year 3|Other|0|||
126138877|NCT01262976|453797995|FG002|Up to Year 3|Other|0|||
126138878|NCT01262976|453797996|FG003|Up to Year 3|Other|0|||
126138879|NCT01262976|453797997|FG004|Up to Year 3|Other|0|||
126138880|NCT01262976|453797998|FG005|Up to Year 3|Other|0|||
126138881|NCT01552681|453797999|FG000|Overall Study|Withdrawal by Subject|4|||
126138882|NCT01552681|453798000|FG001|Overall Study|Withdrawal by Subject|0|||
126138883|NCT01552681|453797999|FG000|Overall Study|Physician Decision|1|||
126138884|NCT01552681|453798000|FG001|Overall Study|Physician Decision|0|||
126138885|NCT01552681|453797999|FG000|Overall Study|Subject moved away|0|||
126138886|NCT01552681|453798000|FG001|Overall Study|Subject moved away|1|||
126138887|NCT02690194|453798002|FG000|Overall Study|Withdrawal by Subject|1|||
126138888|NCT02690194|453798003|FG001|Overall Study|Withdrawal by Subject|4|||
126138889|NCT02690194|453798004|FG002|Overall Study|Withdrawal by Subject|0|||
126138890|NCT01987908|453798005|FG000|Placebo Lead-in Period|Adverse Event|2|||
126138891|NCT01987908|453798006|FG001|Placebo Lead-in Period|Adverse Event|0|||
126138892|NCT01987908|453798007|FG002|Placebo Lead-in Period|Adverse Event|0|||
126138893|NCT01987908|453798005|FG000|Placebo Lead-in Period|Physician Decision|2|||
126138894|NCT01987908|453798006|FG001|Placebo Lead-in Period|Physician Decision|0|||
126138895|NCT01987908|453798007|FG002|Placebo Lead-in Period|Physician Decision|0|||
126138896|NCT01987908|453798005|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
126138897|NCT01987908|453798006|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
126138898|NCT01987908|453798007|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
126138899|NCT01987908|453798005|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
126138900|NCT01987908|453798006|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
126138901|NCT01987908|453798007|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
126138902|NCT01987908|453798005|FG000|Treatment Period|Adverse Event|0|||
126138903|NCT01987908|453798006|FG001|Treatment Period|Adverse Event|1|||
126138904|NCT01987908|453798007|FG002|Treatment Period|Adverse Event|1|||
126138905|NCT01987908|453798005|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
126138906|NCT01987908|453798006|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
126138907|NCT01987908|453798007|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
126138908|NCT01987908|453798005|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
126138909|NCT01987908|453798006|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
126138910|NCT01987908|453798007|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
126138911|NCT03665285|453798008|FG000|Overall Study|Started New Anticancer Treatment|1|||
126138912|NCT03665285|453798009|FG001|Overall Study|Started New Anticancer Treatment|1|||
126138913|NCT03665285|453798010|FG002|Overall Study|Started New Anticancer Treatment|2|||
126138914|NCT03665285|453798011|FG003|Overall Study|Started New Anticancer Treatment|4|||
126138915|NCT03665285|453798012|FG004|Overall Study|Started New Anticancer Treatment|1|||
126138916|NCT03665285|453798013|FG005|Overall Study|Started New Anticancer Treatment|1|||
126138917|NCT03665285|453798014|FG006|Overall Study|Started New Anticancer Treatment|2|||
126138918|NCT03665285|453798015|FG007|Overall Study|Started New Anticancer Treatment|15|||
126138919|NCT03665285|453798016|FG008|Overall Study|Started New Anticancer Treatment|1|||
126138920|NCT03665285|453798008|FG000|Overall Study|Disease Progression|0|||
126138921|NCT03665285|453798009|FG001|Overall Study|Disease Progression|0|||
126138922|NCT03665285|453798010|FG002|Overall Study|Disease Progression|3|||
126138923|NCT03665285|453798011|FG003|Overall Study|Disease Progression|1|||
126138924|NCT03665285|453798012|FG004|Overall Study|Disease Progression|0|||
126138925|NCT03665285|453798013|FG005|Overall Study|Disease Progression|0|||
126138926|NCT03665285|453798014|FG006|Overall Study|Disease Progression|0|||
126138927|NCT03665285|453798015|FG007|Overall Study|Disease Progression|7|||
126138928|NCT03665285|453798016|FG008|Overall Study|Disease Progression|1|||
126138929|NCT03665285|453798008|FG000|Overall Study|Hospice|0|||
126138930|NCT03665285|453798009|FG001|Overall Study|Hospice|0|||
126138931|NCT03665285|453798010|FG002|Overall Study|Hospice|0|||
126138932|NCT03665285|453798011|FG003|Overall Study|Hospice|0|||
126138933|NCT03665285|453798012|FG004|Overall Study|Hospice|0|||
126138934|NCT03665285|453798013|FG005|Overall Study|Hospice|0|||
126138935|NCT03665285|453798014|FG006|Overall Study|Hospice|0|||
126138936|NCT03665285|453798015|FG007|Overall Study|Hospice|2|||
126138937|NCT03665285|453798016|FG008|Overall Study|Hospice|0|||
126138938|NCT03665285|453798008|FG000|Overall Study|Withdrawal by Subject|0|||
126138939|NCT03665285|453798009|FG001|Overall Study|Withdrawal by Subject|0|||
126138940|NCT03665285|453798010|FG002|Overall Study|Withdrawal by Subject|0|||
126138941|NCT03665285|453798011|FG003|Overall Study|Withdrawal by Subject|0|||
126138942|NCT03665285|453798012|FG004|Overall Study|Withdrawal by Subject|1|||
126138943|NCT03665285|453798013|FG005|Overall Study|Withdrawal by Subject|0|||
126138944|NCT03665285|453798014|FG006|Overall Study|Withdrawal by Subject|0|||
126138945|NCT03665285|453798015|FG007|Overall Study|Withdrawal by Subject|2|||
126138946|NCT03665285|453798016|FG008|Overall Study|Withdrawal by Subject|0|||
126138947|NCT03665285|453798008|FG000|Overall Study|Physician Decision|0|||
126138948|NCT03665285|453798009|FG001|Overall Study|Physician Decision|0|||
126138949|NCT03665285|453798010|FG002|Overall Study|Physician Decision|0|||
126138950|NCT03665285|453798011|FG003|Overall Study|Physician Decision|0|||
126138951|NCT03665285|453798012|FG004|Overall Study|Physician Decision|0|||
126138952|NCT03665285|453798013|FG005|Overall Study|Physician Decision|0|||
126138953|NCT03665285|453798014|FG006|Overall Study|Physician Decision|0|||
126138954|NCT03665285|453798015|FG007|Overall Study|Physician Decision|2|||
126138955|NCT03665285|453798016|FG008|Overall Study|Physician Decision|0|||
126138956|NCT02532855|453798019|FG000|Overall Study|Lost to Follow-up|4|||
126138957|NCT02532855|453798020|FG001|Overall Study|Lost to Follow-up|3|||
126138958|NCT02532855|453798019|FG000|Overall Study|Withdrawal by Subject|4|||
126138959|NCT02532855|453798020|FG001|Overall Study|Withdrawal by Subject|8|||
126138960|NCT02908516|453798023|FG000|Overall Study|Study Terminated|3|||
126138961|NCT02908516|453798024|FG001|Overall Study|Study Terminated|3|||
126138962|NCT01931059|453798027|FG000|Day 1|Pregnancy|0|||
126138963|NCT01931059|453798028|FG001|Day 1|Pregnancy|1|||
126138964|NCT01931059|453798027|FG000|Day3|Lost to Follow-up|1|||
126138965|NCT01931059|453798028|FG001|Day3|Lost to Follow-up|0|||
126138966|NCT00778830|453799749|FG000|Overall Study|Ongoing at data cut-off|0|||
126138967|NCT00778830|453799750|FG001|Overall Study|Ongoing at data cut-off|1|||
126138968|NCT01891643|453799751|FG000|Overall Study|Adverse event unrelated to study drug|2|||
126138969|NCT01891643|453799752|FG001|Overall Study|Adverse event unrelated to study drug|5|||
126138970|NCT01891643|453799751|FG000|Overall Study|Disease Progression|4|||
126138971|NCT01891643|453799752|FG001|Overall Study|Disease Progression|3|||
126138972|NCT01891643|453799751|FG000|Overall Study|Study Drug Toxicity|3|||
126138973|NCT01891643|453799752|FG001|Overall Study|Study Drug Toxicity|0|||
126138974|NCT01891643|453799751|FG000|Overall Study|Maximum Clinical Benefit|0|||
126138975|NCT01891643|453799752|FG001|Overall Study|Maximum Clinical Benefit|1|||
126138976|NCT01891643|453799751|FG000|Overall Study|Poor/Non-compliance|0|||
126138977|NCT01891643|453799752|FG001|Overall Study|Poor/Non-compliance|1|||
126138978|NCT01891643|453799751|FG000|Overall Study|Participant request to discontinue|1|||
126138979|NCT01891643|453799752|FG001|Overall Study|Participant request to discontinue|0|||
126138980|NCT01583179|453799753|FG000|Overall Study|Screen failure|1|||
126138981|NCT01583179|453799754|FG001|Overall Study|Screen failure|2|||
126138982|NCT01246206|453799755|FG000|Overall Study|Patient did not receive study regiments.|1|||
126138983|NCT04047797|453799756|FG000|Overall Study|Progressive Disease|1|||
126138984|NCT03523351|453799757|FG000|Overall Study|Death|13|||
126138985|NCT03523351|453799758|FG001|Overall Study|Death|11|||
126138986|NCT03523351|453799757|FG000|Overall Study|Lost to Follow-up|2|||
126138987|NCT03523351|453799758|FG001|Overall Study|Lost to Follow-up|3|||
126138988|NCT03523351|453799757|FG000|Overall Study|Withdrawal by Subject|4|||
126138989|NCT03523351|453799758|FG001|Overall Study|Withdrawal by Subject|0|||
126138990|NCT03523351|453799757|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
126138991|NCT03523351|453799758|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
126138992|NCT01097629|453799765|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
126138993|NCT01097629|453799766|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
126138994|NCT01097629|453799767|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
126138995|NCT01097629|453799768|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126138996|NCT01097629|453799769|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126138997|NCT01097629|453799770|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126138998|NCT01097629|453799771|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126138999|NCT01097629|453799772|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126139000|NCT01097629|453799765|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
126139001|NCT01097629|453799766|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
126139002|NCT01097629|453799767|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
126139003|NCT01097629|453799768|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126139004|NCT01097629|453799769|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126139005|NCT01097629|453799770|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126139006|NCT01097629|453799771|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126139007|NCT01097629|453799772|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126139008|NCT01097629|453799765|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
126139009|NCT01097629|453799766|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
126139010|NCT01097629|453799767|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
126139011|NCT01097629|453799768|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126139012|NCT01097629|453799769|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126139013|NCT01097629|453799770|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126139014|NCT01097629|453799771|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126139015|NCT01097629|453799772|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126139016|NCT01097629|453799765|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
126139017|NCT01097629|453799766|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
126139018|NCT01097629|453799767|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
126139019|NCT01097629|453799768|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125968313|NCT00467870|453175775|FG005|Overall Study|Protocol Violation|0|||
126139020|NCT01097629|453799769|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126139021|NCT01097629|453799770|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126139022|NCT01097629|453799771|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126139023|NCT01097629|453799772|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126139024|NCT01097629|453799765|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
126139025|NCT01097629|453799766|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
126139026|NCT01097629|453799767|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
126139027|NCT01097629|453799768|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126139028|NCT01097629|453799769|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126139029|NCT01097629|453799770|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126139030|NCT01097629|453799771|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126139031|NCT01097629|453799772|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126139032|NCT01097629|453799765|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
126139033|NCT01097629|453799766|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
126139034|NCT01097629|453799767|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126139035|NCT01097629|453799768|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126139036|NCT01097629|453799769|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126139037|NCT01097629|453799770|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126139038|NCT01097629|453799771|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126139039|NCT01097629|453799772|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126139040|NCT01097629|453799765|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
126139041|NCT01097629|453799766|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
126139042|NCT01097629|453799767|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
126139043|NCT01097629|453799768|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126139044|NCT01097629|453799769|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126139045|NCT01097629|453799770|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126139046|NCT01097629|453799771|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126139047|NCT01097629|453799772|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126139048|NCT01097629|453799765|FG000|DB RO Phase|Withdrawal by Subject|0|||
126139049|NCT01097629|453799766|FG001|DB RO Phase|Withdrawal by Subject|0|||
126139050|NCT01097629|453799767|FG002|DB RO Phase|Withdrawal by Subject|0|||
126139051|NCT01097629|453799768|FG003|DB RO Phase|Withdrawal by Subject|0|||
126139052|NCT01097629|453799769|FG004|DB RO Phase|Withdrawal by Subject|0|||
126139053|NCT01097629|453799770|FG005|DB RO Phase|Withdrawal by Subject|0|||
126139054|NCT01097629|453799771|FG006|DB RO Phase|Withdrawal by Subject|0|||
126139055|NCT01097629|453799772|FG007|DB RO Phase|Withdrawal by Subject|1|||
126139056|NCT01097629|453799765|FG000|DB RO Phase|Protocol Violation|0|||
126139057|NCT01097629|453799766|FG001|DB RO Phase|Protocol Violation|0|||
126139058|NCT01097629|453799767|FG002|DB RO Phase|Protocol Violation|0|||
126139059|NCT01097629|453799768|FG003|DB RO Phase|Protocol Violation|1|||
126139060|NCT01097629|453799769|FG004|DB RO Phase|Protocol Violation|0|||
126139061|NCT01097629|453799770|FG005|DB RO Phase|Protocol Violation|1|||
126139062|NCT01097629|453799771|FG006|DB RO Phase|Protocol Violation|1|||
126139063|NCT01097629|453799772|FG007|DB RO Phase|Protocol Violation|0|||
126139064|NCT01097629|453799765|FG000|DB RO Phase|Lost to Follow-up|0|||
126139065|NCT01097629|453799766|FG001|DB RO Phase|Lost to Follow-up|0|||
126139066|NCT01097629|453799767|FG002|DB RO Phase|Lost to Follow-up|0|||
126139067|NCT01097629|453799768|FG003|DB RO Phase|Lost to Follow-up|0|||
126139068|NCT01097629|453799769|FG004|DB RO Phase|Lost to Follow-up|0|||
126139069|NCT01097629|453799770|FG005|DB RO Phase|Lost to Follow-up|0|||
126139070|NCT01097629|453799771|FG006|DB RO Phase|Lost to Follow-up|2|||
126139071|NCT01097629|453799772|FG007|DB RO Phase|Lost to Follow-up|0|||
126139072|NCT00132041|453799773|FG000|Baseline|Ineligible|6|||
126139073|NCT00132041|453799773|FG000|3 Months Post Ablation|Transplant|1|||
126139074|NCT00132041|453799773|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
126139075|NCT00132041|453799773|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
126139076|NCT00132041|453799773|FG000|6 Months Post Ablation|Death|2|||
126139077|NCT00132041|453799773|FG000|6 Months Post Ablation|Transplant|6|||
126139078|NCT00132041|453799773|FG000|9 Months Post Ablation|Death|1|||
126139079|NCT00132041|453799773|FG000|9 Months Post Ablation|Transplant|1|||
126139080|NCT00132041|453799773|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
125968314|NCT00467870|453175770|FG000|Overall Study|Withdrawal by Subject|14|||
125968315|NCT00467870|453175771|FG001|Overall Study|Withdrawal by Subject|21|||
125968316|NCT00467870|453175772|FG002|Overall Study|Withdrawal by Subject|0|||
126139081|NCT00132041|453799773|FG000|12 Months Post Ablation|Death|1|||
126139082|NCT00132041|453799773|FG000|12 Months Post Ablation|Transplant|1|||
126139083|NCT00132041|453799773|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
126139084|NCT00132041|453799773|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
126139085|NCT00132041|453799773|FG000|15 Months Post Ablation|Death|1|||
126139086|NCT00132041|453799773|FG000|15 Months Post Ablation|Transplant|5|||
126139087|NCT00132041|453799773|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
126139088|NCT00132041|453799773|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
126139089|NCT00132041|453799773|FG000|18 Months Post Ablation|Transplant|1|||
126139090|NCT00132041|453799773|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
126139091|NCT00132041|453799773|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
126139092|NCT01171820|453799774|FG000|Overall Study|Death|3|||
126139093|NCT01171820|453799775|FG001|Overall Study|Death|3|||
126139094|NCT01171820|453799774|FG000|Overall Study|Lost to Follow-up|0|||
126139095|NCT01171820|453799775|FG001|Overall Study|Lost to Follow-up|1|||
126139096|NCT01171820|453799774|FG000|Overall Study|Withdrawal by Subject|2|||
126139097|NCT01171820|453799775|FG001|Overall Study|Withdrawal by Subject|0|||
126139098|NCT01171820|453799774|FG000|Overall Study|Physician Decision|0|||
126139099|NCT01171820|453799775|FG001|Overall Study|Physician Decision|1|||
126139100|NCT01171820|453799774|FG000|Overall Study|1-Year Missed Visit|1|||
126139101|NCT01171820|453799775|FG001|Overall Study|1-Year Missed Visit|1|||
126139102|NCT02613208|453799776|FG000|Overall Study|Withdrawal by Subject|1|||
126139103|NCT02613208|453799776|FG000|Overall Study|Change of address|2|||
126139104|NCT02613208|453799776|FG000|Overall Study|Physician Decision|2|||
126139105|NCT02613208|453799776|FG000|Overall Study|Lost to Follow-up|5|||
126139106|NCT02613208|453799776|FG000|Overall Study|Death|37|||
126139107|NCT02663895|453799777|FG000|Overall Study|Adverse Event|3|||
126139108|NCT02663895|453799777|FG000|Overall Study|Physician Decision|2|||
126139109|NCT02663895|453799777|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
126139110|NCT02663895|453799777|FG000|Overall Study|Withdrawal by Subject|1|||
125968317|NCT00467870|453175773|FG003|Overall Study|Withdrawal by Subject|9|||
125968318|NCT00467870|453175774|FG004|Overall Study|Withdrawal by Subject|10|||
125968319|NCT00467870|453175775|FG005|Overall Study|Withdrawal by Subject|1|||
125968320|NCT00467870|453175770|FG000|Overall Study|Lost to Follow-up|5|||
125968321|NCT00467870|453175771|FG001|Overall Study|Lost to Follow-up|3|||
125968322|NCT00467870|453175772|FG002|Overall Study|Lost to Follow-up|1|||
125968323|NCT00467870|453175773|FG003|Overall Study|Lost to Follow-up|1|||
125968324|NCT00467870|453175774|FG004|Overall Study|Lost to Follow-up|3|||
125968325|NCT00467870|453175775|FG005|Overall Study|Lost to Follow-up|0|||
125968326|NCT00467870|453175770|FG000|Overall Study|Subject Non-compliance|3|||
125968327|NCT00467870|453175771|FG001|Overall Study|Subject Non-compliance|4|||
125968328|NCT00467870|453175772|FG002|Overall Study|Subject Non-compliance|0|||
125968329|NCT00467870|453175773|FG003|Overall Study|Subject Non-compliance|1|||
125968330|NCT00467870|453175774|FG004|Overall Study|Subject Non-compliance|5|||
125968331|NCT00467870|453175775|FG005|Overall Study|Subject Non-compliance|0|||
125968332|NCT00467870|453175770|FG000|Overall Study|Other/Unknown|8|||
125968333|NCT00467870|453175771|FG001|Overall Study|Other/Unknown|5|||
125968334|NCT00467870|453175772|FG002|Overall Study|Other/Unknown|1|||
125968335|NCT00467870|453175773|FG003|Overall Study|Other/Unknown|5|||
125968336|NCT00467870|453175774|FG004|Overall Study|Other/Unknown|4|||
125968337|NCT00467870|453175775|FG005|Overall Study|Other/Unknown|0|||
125968338|NCT00321919|453175776|FG000|Overall Study|Adverse Event|17|||
125968339|NCT00321919|453175777|FG001|Overall Study|Adverse Event|10|||
125968340|NCT00321919|453175776|FG000|Overall Study|Death|21|||
125968341|NCT00321919|453175777|FG001|Overall Study|Death|17|||
125968342|NCT00321919|453175776|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125968343|NCT00321919|453175777|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125968344|NCT00321919|453175776|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125968345|NCT00321919|453175777|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125968346|NCT00321919|453175776|FG000|Overall Study|Refused Treatment|23|||
125968347|NCT00321919|453175777|FG001|Overall Study|Refused Treatment|14|||
125968348|NCT00321919|453175776|FG000|Overall Study|Other Protocol Violation|2|||
125968349|NCT00321919|453175777|FG001|Overall Study|Other Protocol Violation|3|||
125968350|NCT00321919|453175776|FG000|Overall Study|Failure to Return|3|||
125968351|NCT00321919|453175777|FG001|Overall Study|Failure to Return|1|||
125968352|NCT00321919|453175776|FG000|Overall Study|Other withdrawal reason|7|||
125968353|NCT00321919|453175777|FG001|Overall Study|Other withdrawal reason|6|||
125968354|NCT02261363|453175778|FG000|Overall Study|Lost to Follow-up|21|||
125968355|NCT01517802|453175779|FG000|Overall Study|Death|1|||
125968356|NCT02590354|453175780|FG000|Phase 1|Active hepatitis B or C infection|1|||
126139111|NCT02472847|453799779|FG000|Overall Study|Withdrawal by Subject|1|||
126139112|NCT02472847|453799780|FG001|Overall Study|Withdrawal by Subject|5|||
126139113|NCT00623831|453799781|FG000|Overall Study|Withdrawal by Subject|1|||
126139114|NCT00623831|453799782|FG001|Overall Study|Withdrawal by Subject|0|||
126139115|NCT00623831|453799781|FG000|Overall Study|Progressive Disease|0|||
126139116|NCT00623831|453799782|FG001|Overall Study|Progressive Disease|1|||
126139117|NCT00270894|453799783|FG000|Overall Study|Adverse Event|1|||
126139118|NCT00270894|453799783|FG000|Overall Study|Withdrawal by Subject|1|||
126139119|NCT01748071|453799786|FG000|Overall Study|Adverse Event|2|||
126139120|NCT01748071|453799787|FG001|Overall Study|Adverse Event|2|||
126139121|NCT01748071|453799788|FG002|Overall Study|Adverse Event|0|||
126139122|NCT02789657|453799791|FG000|Overall Study|Withdrawal by Subject|2|||
126139123|NCT02789657|453799792|FG001|Overall Study|Withdrawal by Subject|0|||
125968357|NCT02590354|453175780|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
126139124|NCT02789657|453799793|FG002|Overall Study|Withdrawal by Subject|0|||
125968358|NCT02590354|453175780|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
125968359|NCT02590354|453175780|FG000|Phase 1|Subject does not want to participate|20|||
125968360|NCT02590354|453175780|FG000|Phase 1|Lost to Follow-up|1|||
126139125|NCT02789657|453799794|FG003|Overall Study|Withdrawal by Subject|0|||
126139126|NCT01214044|453799795|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
126139127|NCT01214044|453799795|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
126139128|NCT01214044|453799795|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
126139129|NCT01214044|453799795|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
126139130|NCT01214044|453799795|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
126139131|NCT01214044|453799795|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
126139132|NCT02772757|453799796|FG000|Overall Study|Withdrawal by Subject|1|||
126139133|NCT02772757|453799797|FG001|Overall Study|Withdrawal by Subject|0|||
126139134|NCT02772757|453799798|FG002|Overall Study|Withdrawal by Subject|1|||
126139135|NCT02772757|453799796|FG000|Overall Study|Protocol Violation|0|||
126139136|NCT02772757|453799797|FG001|Overall Study|Protocol Violation|0|||
126139137|NCT02772757|453799798|FG002|Overall Study|Protocol Violation|1|||
126139138|NCT02772757|453799796|FG000|Overall Study|Physician Decision|0|||
126139139|NCT02772757|453799797|FG001|Overall Study|Physician Decision|3|||
126139140|NCT02772757|453799798|FG002|Overall Study|Physician Decision|3|||
126139141|NCT04698525|453799799|FG000|Overall Study|Lost to Follow-up|1|||
126139142|NCT04698525|453799800|FG001|Overall Study|Lost to Follow-up|2|||
126139143|NCT04698525|453799799|FG000|Overall Study|Three suffered of Covid-19|2|||
126139144|NCT04698525|453799800|FG001|Overall Study|Three suffered of Covid-19|1|||
126139145|NCT00510276|453799804|FG000|Acute Double-Blind Phase|Adverse Event|21|||
126139146|NCT00510276|453799805|FG001|Acute Double-Blind Phase|Adverse Event|6|||
126139147|NCT00510276|453799804|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
126139148|NCT00510276|453799805|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
126139149|NCT00510276|453799804|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
126139150|NCT00510276|453799805|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
126139151|NCT00510276|453799804|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
126139152|NCT00510276|453799805|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
126139153|NCT00510276|453799804|FG000|Acute Double-Blind Phase|Physician Decision|0|||
126139154|NCT00510276|453799805|FG001|Acute Double-Blind Phase|Physician Decision|3|||
126139155|NCT00510276|453799804|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
126139156|NCT00510276|453799805|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
126139157|NCT00510276|453799804|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
126139158|NCT00510276|453799805|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
126139159|NCT00510276|453799804|FG000|Acute Double-Blind Phase|Subject Decision|26|||
126139160|NCT00510276|453799805|FG001|Acute Double-Blind Phase|Subject Decision|28|||
126139161|NCT00510276|453799804|FG000|Extension Open-Label Phase|Adverse Event|9|||
126139162|NCT00510276|453799805|FG001|Extension Open-Label Phase|Adverse Event|18|||
126139163|NCT00510276|453799804|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
126139164|NCT00510276|453799805|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
126139165|NCT00510276|453799804|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
126139166|NCT00510276|453799805|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
126139167|NCT00510276|453799804|FG000|Extension Open-Label Phase|Physician Decision|2|||
126139168|NCT00510276|453799805|FG001|Extension Open-Label Phase|Physician Decision|3|||
126139169|NCT00510276|453799804|FG000|Extension Open-Label Phase|Protocol Violation|0|||
126139170|NCT00510276|453799805|FG001|Extension Open-Label Phase|Protocol Violation|1|||
126139171|NCT00510276|453799804|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
126139172|NCT00510276|453799805|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
126139173|NCT00510276|453799804|FG000|Extension Open-Label Phase|Subject Decision|7|||
126139174|NCT00510276|453799805|FG001|Extension Open-Label Phase|Subject Decision|9|||
126139175|NCT03486392|453799808|FG000|Overall Study|Lost to Follow-up|0|||
126139176|NCT03486392|453799809|FG001|Overall Study|Lost to Follow-up|0|||
126139177|NCT03486392|453799810|FG002|Overall Study|Lost to Follow-up|8|||
126139178|NCT03486392|453799811|FG003|Overall Study|Lost to Follow-up|5|||
126139179|NCT03486392|453799812|FG004|Overall Study|Lost to Follow-up|2|||
126139180|NCT03486392|453799808|FG000|Overall Study|Withdrawal by Subject|3|||
126139181|NCT03486392|453799809|FG001|Overall Study|Withdrawal by Subject|0|||
126139182|NCT03486392|453799810|FG002|Overall Study|Withdrawal by Subject|6|||
126139183|NCT03486392|453799811|FG003|Overall Study|Withdrawal by Subject|4|||
125968361|NCT02590354|453175780|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
125968362|NCT00760929|453175781|FG000|Overall Study|Adverse Event|2|||
125968363|NCT00760929|453175782|FG001|Overall Study|Adverse Event|0|||
126139184|NCT03486392|453799812|FG004|Overall Study|Withdrawal by Subject|1|||
126139185|NCT03486392|453799808|FG000|Overall Study|Death|0|||
126139186|NCT03486392|453799809|FG001|Overall Study|Death|0|||
126139187|NCT03486392|453799810|FG002|Overall Study|Death|0|||
126139188|NCT03486392|453799811|FG003|Overall Study|Death|0|||
126139189|NCT03486392|453799812|FG004|Overall Study|Death|1|||
126139190|NCT01731678|453799815|FG000|Overall Study|Withdrawal by Subject|3|||
125968364|NCT00760929|453175783|FG002|Overall Study|Adverse Event|6|||
125968365|NCT00760929|453175784|FG003|Overall Study|Adverse Event|10|||
126139191|NCT01731678|453799815|FG000|Overall Study|Did not meet inclusion criteria|1|||
126139192|NCT01731678|453799815|FG000|Overall Study|RMT too high, making TMS difficult|3|||
126139193|NCT00888355|453799822|FG000|Overall Study|Adverse Event|10|||
126139194|NCT00888355|453799823|FG001|Overall Study|Adverse Event|0|||
126139195|NCT00888355|453799824|FG002|Overall Study|Adverse Event|3|||
126139196|NCT00888355|453799825|FG003|Overall Study|Adverse Event|3|||
126139197|NCT00888355|453799822|FG000|Overall Study|Lack of Efficacy|9|||
126139198|NCT00888355|453799823|FG001|Overall Study|Lack of Efficacy|2|||
126139199|NCT00888355|453799824|FG002|Overall Study|Lack of Efficacy|5|||
126139200|NCT00888355|453799825|FG003|Overall Study|Lack of Efficacy|2|||
126139201|NCT00888355|453799822|FG000|Overall Study|Lost to Follow-up|0|||
126139202|NCT00888355|453799823|FG001|Overall Study|Lost to Follow-up|2|||
126139203|NCT00888355|453799824|FG002|Overall Study|Lost to Follow-up|2|||
126139204|NCT00888355|453799825|FG003|Overall Study|Lost to Follow-up|0|||
126139205|NCT00888355|453799822|FG000|Overall Study|Protocol Violation|3|||
126139206|NCT00888355|453799823|FG001|Overall Study|Protocol Violation|2|||
126139207|NCT00888355|453799824|FG002|Overall Study|Protocol Violation|1|||
126139208|NCT00888355|453799825|FG003|Overall Study|Protocol Violation|2|||
126139209|NCT00888355|453799822|FG000|Overall Study|Withdrawal by Subject|0|||
126139210|NCT00888355|453799823|FG001|Overall Study|Withdrawal by Subject|3|||
126139211|NCT00888355|453799824|FG002|Overall Study|Withdrawal by Subject|1|||
126139212|NCT00888355|453799825|FG003|Overall Study|Withdrawal by Subject|3|||
126139213|NCT01551693|453799827|FG000|Overall Study|Disease Progression|1|||
126139214|NCT01551693|453799828|FG001|Overall Study|Disease Progression|0|||
126139215|NCT01551693|453799827|FG000|Overall Study|Adverse Event|0|||
126139216|NCT01551693|453799828|FG001|Overall Study|Adverse Event|1|||
126139217|NCT01551693|453799827|FG000|Overall Study|Withdrawal by Subject|0|||
126139218|NCT01551693|453799828|FG001|Overall Study|Withdrawal by Subject|1|||
126139219|NCT04897867|453799830|FG000|Overall Study|Withdrawal of Consent|1|||
126139220|NCT04897867|453799830|FG000|Overall Study|Pregnancy|1|||
126139221|NCT04897867|453799830|FG000|Overall Study|Lost to Follow-up|7|||
126139222|NCT04897867|453799830|FG000|Overall Study|Reason not Specified|2|||
126139223|NCT02251912|453799831|FG000|Overall Study|Withdrawal by Subject|2|||
126139224|NCT02251912|453799832|FG001|Overall Study|Withdrawal by Subject|3|||
126139225|NCT02251912|453799831|FG000|Overall Study|Adverse Event|0|||
126139226|NCT02251912|453799832|FG001|Overall Study|Adverse Event|2|||
126139227|NCT01107444|453799833|FG000|Overall Study|Withdrawal by Subject|8|||
126139228|NCT01107444|453799834|FG001|Overall Study|Withdrawal by Subject|12|||
126139229|NCT01107444|453799833|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
126139230|NCT01107444|453799834|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
126139231|NCT01948830|453799837|FG000|Overall Study|Physician Decision|1|||
126139232|NCT01948830|453799838|FG001|Overall Study|Physician Decision|3|||
126139233|NCT01948830|453799837|FG000|Overall Study|Protocol deviation|1|||
126139234|NCT01948830|453799838|FG001|Overall Study|Protocol deviation|2|||
126139235|NCT01948830|453799837|FG000|Overall Study|Lost to Follow-up|5|||
126139236|NCT01948830|453799838|FG001|Overall Study|Lost to Follow-up|4|||
126139237|NCT01948830|453799837|FG000|Overall Study|Withdrawal by Subject|14|||
126139238|NCT01948830|453799838|FG001|Overall Study|Withdrawal by Subject|17|||
126139239|NCT01948830|453799837|FG000|Overall Study|Adverse Event|9|||
126139240|NCT01948830|453799838|FG001|Overall Study|Adverse Event|2|||
126139241|NCT01948830|453799837|FG000|Overall Study|Death|3|||
126139242|NCT01948830|453799838|FG001|Overall Study|Death|4|||
126139243|NCT01133171|453799839|FG000|Overall Study|Withdrawal by Subject|1|||
126139244|NCT01133171|453799840|FG001|Overall Study|Withdrawal by Subject|2|||
126139245|NCT01133171|453799841|FG002|Overall Study|Withdrawal by Subject|0|||
126139246|NCT02526550|453799842|FG000|Overall Study|Lost to Follow-up|1|||
126139247|NCT03969888|453799845|FG000|Overall Study|Never Received Study Drug|0|||
126139248|NCT03969888|453799846|FG001|Overall Study|Never Received Study Drug|0|||
126139249|NCT03969888|453799847|FG002|Overall Study|Never Received Study Drug|1|||
126139250|NCT03969888|453799848|FG003|Overall Study|Never Received Study Drug|0|||
126139251|NCT03969888|453799849|FG004|Overall Study|Never Received Study Drug|0|||
126139252|NCT03969888|453799850|FG005|Overall Study|Never Received Study Drug|0|||
126139253|NCT03969888|453799851|FG006|Overall Study|Never Received Study Drug|1|||
126139254|NCT03969888|453799852|FG007|Overall Study|Never Received Study Drug|0|||
126139255|NCT03969888|453799845|FG000|Overall Study|Reason Not Specified|0|||
125968366|NCT00760929|453175781|FG000|Overall Study|Lack of Efficacy|0|||
125968367|NCT00760929|453175782|FG001|Overall Study|Lack of Efficacy|2|||
125968368|NCT00760929|453175783|FG002|Overall Study|Lack of Efficacy|1|||
126139256|NCT03969888|453799846|FG001|Overall Study|Reason Not Specified|0|||
126139257|NCT03969888|453799847|FG002|Overall Study|Reason Not Specified|0|||
126139258|NCT03969888|453799848|FG003|Overall Study|Reason Not Specified|0|||
126139259|NCT03969888|453799849|FG004|Overall Study|Reason Not Specified|0|||
126139260|NCT03969888|453799850|FG005|Overall Study|Reason Not Specified|0|||
126139261|NCT03969888|453799851|FG006|Overall Study|Reason Not Specified|0|||
126139262|NCT03969888|453799852|FG007|Overall Study|Reason Not Specified|1|||
126139263|NCT01282229|453799862|FG000|Overall Study|Protocol Violation|2|||
125968369|NCT00760929|453175784|FG003|Overall Study|Lack of Efficacy|0|||
126139264|NCT00769119|453799864|FG000|Overall Study|Voluntary discontinuation|0|||
126139265|NCT00769119|453799865|FG001|Overall Study|Voluntary discontinuation|2|||
126139266|NCT00769119|453799864|FG000|Overall Study|Adverse Event|1|||
126139267|NCT00769119|453799865|FG001|Overall Study|Adverse Event|1|||
126139268|NCT00769119|453799864|FG000|Overall Study|Disallowed medication|1|||
125968370|NCT00760929|453175781|FG000|Overall Study|Withdrawal by Subject|1|||
126139269|NCT00769119|453799865|FG001|Overall Study|Disallowed medication|0|||
126139270|NCT03094195|453799873|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
126139271|NCT03094195|453799874|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
126139272|NCT03094195|453799875|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
126139273|NCT03094195|453799876|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126139274|NCT03094195|453799877|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126139275|NCT03094195|453799878|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126139276|NCT03094195|453799879|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126139277|NCT03094195|453799880|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126139278|NCT03094195|453799873|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
126139279|NCT03094195|453799874|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
126139280|NCT03094195|453799875|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
126139281|NCT03094195|453799876|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126139282|NCT03094195|453799877|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126139283|NCT03094195|453799878|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126139284|NCT03094195|453799879|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126139285|NCT03094195|453799880|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126139286|NCT03094195|453799873|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126139287|NCT03094195|453799874|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126139288|NCT03094195|453799875|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
126139289|NCT03094195|453799876|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126139290|NCT03094195|453799877|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126139291|NCT03094195|453799878|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126139292|NCT03094195|453799879|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126139293|NCT03094195|453799880|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126139294|NCT03094195|453799873|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126139295|NCT03094195|453799874|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
126139296|NCT03094195|453799875|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
126139297|NCT03094195|453799876|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126139298|NCT03094195|453799877|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126139299|NCT03094195|453799878|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126139300|NCT03094195|453799879|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126139301|NCT03094195|453799880|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126139302|NCT01961115|453799883|FG000|Overall Study|Disease Progression|1|||
126139303|NCT01961115|453799884|FG001|Overall Study|Disease Progression|0|||
126139304|NCT01961115|453799885|FG002|Overall Study|Disease Progression|3|||
126139305|NCT01961115|453799883|FG000|Overall Study|Adverse Event|1|||
126139306|NCT01961115|453799884|FG001|Overall Study|Adverse Event|0|||
126139307|NCT01961115|453799885|FG002|Overall Study|Adverse Event|1|||
126139308|NCT02440581|453799889|FG000|Overall Study|Death|0|||
126139309|NCT02440581|453799890|FG001|Overall Study|Death|0|||
126139310|NCT02440581|453799891|FG002|Overall Study|Death|7|||
126139311|NCT02440581|453799892|FG003|Overall Study|Death|5|||
126139312|NCT02440581|453799889|FG000|Overall Study|Transplanted|1|||
126139313|NCT02440581|453799890|FG001|Overall Study|Transplanted|0|||
126139314|NCT02440581|453799891|FG002|Overall Study|Transplanted|3|||
126139315|NCT02440581|453799892|FG003|Overall Study|Transplanted|2|||
126139316|NCT02440581|453799889|FG000|Overall Study|Withdrawal by Subject|4|||
126139317|NCT02440581|453799890|FG001|Overall Study|Withdrawal by Subject|11|||
126139318|NCT02440581|453799891|FG002|Overall Study|Withdrawal by Subject|3|||
126139319|NCT02440581|453799892|FG003|Overall Study|Withdrawal by Subject|7|||
126139320|NCT03828487|453799893|FG000|Overall Study|Physician Decision|1|||
126139321|NCT03430986|453799894|FG000|24-week Control Period|Adverse Event|1|||
126139322|NCT03430986|453799895|FG001|24-week Control Period|Adverse Event|0|||
126139323|NCT03430986|453799894|FG000|24-week Control Period|Lost to Follow-up|2|||
126139324|NCT03430986|453799895|FG001|24-week Control Period|Lost to Follow-up|2|||
126139325|NCT03430986|453799894|FG000|24-week Control Period|Withdrawal by Participant|5|||
126139326|NCT03430986|453799895|FG001|24-week Control Period|Withdrawal by Participant|0|||
126139327|NCT03430986|453799894|FG000|24-week Control Period|Protocol Deviation|0|||
126139328|NCT03430986|453799895|FG001|24-week Control Period|Protocol Deviation|2|||
126139329|NCT03430986|453799894|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
126139330|NCT03430986|453799895|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
126139331|NCT03430986|453799894|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
126139332|NCT03430986|453799895|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
126139333|NCT01078805|453799897|FG000|Overall Study|Clinically significant abnormal lab|5|||
126139334|NCT01078805|453799897|FG000|Overall Study|Death|134|||
126139335|NCT01078805|453799897|FG000|Overall Study|Lost to Follow-up|676|||
126139336|NCT01078805|453799897|FG000|Overall Study|Physician Decision|169|||
126139337|NCT01078805|453799897|FG000|Overall Study|Serious adverse event|26|||
126139338|NCT01078805|453799897|FG000|Overall Study|Sponsor decision|46|||
126139339|NCT01078805|453799897|FG000|Overall Study|Withdrawal by Subject|739|||
126139340|NCT01078805|453799897|FG000|Overall Study|Other|173|||
126139341|NCT01078805|453799897|FG000|Overall Study|Didn't take study drug|82|||
126139342|NCT01609842|453799898|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
126139343|NCT01609842|453799899|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
126139344|NCT02474329|453799900|FG000|Overall Study|Withdraw or did not contribute data.|13|||
126139345|NCT03186989|453799901|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126139346|NCT03186989|453799902|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126139347|NCT03186989|453799903|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
126139348|NCT03186989|453799904|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
126139349|NCT03186989|453799905|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
126139350|NCT03186989|453799906|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126139351|NCT03186989|453799907|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126139352|NCT03186989|453799908|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126139353|NCT03186989|453799909|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126139354|NCT03186989|453799910|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126139355|NCT03186989|453799911|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126139356|NCT03186989|453799901|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139357|NCT03186989|453799902|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139358|NCT03186989|453799903|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139359|NCT03186989|453799904|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139360|NCT03186989|453799905|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139361|NCT03186989|453799906|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
126139362|NCT03186989|453799907|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139363|NCT03186989|453799908|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139364|NCT03186989|453799909|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139365|NCT03186989|453799910|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139366|NCT03186989|453799911|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126139367|NCT03186989|453799901|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139368|NCT03186989|453799902|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139369|NCT03186989|453799903|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139370|NCT03186989|453799904|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139371|NCT03186989|453799905|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139372|NCT03186989|453799906|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139373|NCT03186989|453799907|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
126139374|NCT03186989|453799908|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139375|NCT03186989|453799909|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139376|NCT03186989|453799910|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139377|NCT03186989|453799911|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126139378|NCT03186989|453799901|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126139379|NCT03186989|453799902|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126139380|NCT03186989|453799903|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126139381|NCT03186989|453799904|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126139382|NCT03186989|453799905|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126139383|NCT03186989|453799906|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
126139384|NCT03186989|453799907|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
126139385|NCT03186989|453799908|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126139386|NCT03186989|453799909|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
126139387|NCT03186989|453799910|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126139388|NCT03186989|453799911|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126139389|NCT00865020|453799920|FG000|Overall Study|Withdrawal by Subject|22|||
126139390|NCT00865020|453799921|FG001|Overall Study|Withdrawal by Subject|16|||
126139391|NCT00865020|453799920|FG000|Overall Study|Adverse Event|9|||
126139392|NCT00865020|453799921|FG001|Overall Study|Adverse Event|14|||
126139393|NCT00865020|453799920|FG000|Overall Study|Abnormal test procedure result(s)|6|||
126139394|NCT00865020|453799921|FG001|Overall Study|Abnormal test procedure result(s)|8|||
126139395|NCT00865020|453799920|FG000|Overall Study|Lost to Follow-up|6|||
126139396|NCT00865020|453799921|FG001|Overall Study|Lost to Follow-up|4|||
126139397|NCT00865020|453799920|FG000|Overall Study|Protocol deviation|4|||
126139398|NCT00865020|453799921|FG001|Overall Study|Protocol deviation|1|||
126139399|NCT00865020|453799920|FG000|Overall Study|Administrative problems|0|||
126139400|NCT00865020|453799921|FG001|Overall Study|Administrative problems|2|||
126139401|NCT00865020|453799920|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126139402|NCT00865020|453799921|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126139403|NCT00865020|453799920|FG000|Overall Study|Death|0|||
126139404|NCT00865020|453799921|FG001|Overall Study|Death|1|||
126139405|NCT00865020|453799920|FG000|Overall Study|Randomized but discontinued|2|||
126139406|NCT00865020|453799921|FG001|Overall Study|Randomized but discontinued|4|||
126139407|NCT03641560|453799922|FG000|Overall Study|Withdrawal by Subject|6|||
126139408|NCT03641560|453799922|FG000|Overall Study|Progressive disease|40|||
126139409|NCT03641560|453799922|FG000|Overall Study|Death|6|||
126139410|NCT05900115|453801406|FG000|Overall Study|Lost to Follow-up|129|||
126139411|NCT05900115|453801407|FG001|Overall Study|Lost to Follow-up|98|||
126139412|NCT00619502|453801408|FG000|Overall Study|Lost to Follow-up|8|||
126139413|NCT00619502|453801409|FG001|Overall Study|Lost to Follow-up|10|||
126139414|NCT00771472|453801410|FG000|Overall Study|Physician Decision|2|||
126139415|NCT00771472|453801411|FG001|Overall Study|Physician Decision|3|||
126139416|NCT00771472|453801410|FG000|Overall Study|Progressive Disease|3|||
126139417|NCT00771472|453801411|FG001|Overall Study|Progressive Disease|1|||
126139418|NCT00771472|453801410|FG000|Overall Study|Protocol Violation|1|||
126139419|NCT00771472|453801411|FG001|Overall Study|Protocol Violation|0|||
126139420|NCT00880750|453801414|FG000|First Intervention|Adverse Event|1|||
126139421|NCT00880750|453801415|FG001|First Intervention|Adverse Event|0|||
126139422|NCT00880750|453801414|FG000|First Intervention|Unable to collect urine|4|||
126139423|NCT00880750|453801415|FG001|First Intervention|Unable to collect urine|0|||
126139424|NCT00880750|453801414|FG000|First Intervention|Non-compliance with meals|0|||
126139425|NCT00880750|453801415|FG001|First Intervention|Non-compliance with meals|1|||
126139426|NCT00880750|453801414|FG000|First Intervention|Withdrawal by Subject|2|||
126139427|NCT00880750|453801415|FG001|First Intervention|Withdrawal by Subject|0|||
126139428|NCT00880750|453801414|FG000|First Intervention|Lost to Follow-up|2|||
126139429|NCT00880750|453801415|FG001|First Intervention|Lost to Follow-up|0|||
126139430|NCT00880750|453801414|FG000|Second Intervention|Withdrawal by Subject|2|||
126139431|NCT00880750|453801415|FG001|Second Intervention|Withdrawal by Subject|2|||
126139432|NCT00880750|453801414|FG000|Second Intervention|Protocol Violation|1|||
126139433|NCT00880750|453801415|FG001|Second Intervention|Protocol Violation|0|||
126139434|NCT00880750|453801414|FG000|Second Intervention|Unable to collect urine|1|||
126139435|NCT00880750|453801415|FG001|Second Intervention|Unable to collect urine|0|||
126139436|NCT00483327|453801416|FG000|Overall Study|Adverse Event|1|||
126139437|NCT00483327|453801416|FG000|Overall Study|Withdrawal by Subject|3|||
126139438|NCT00483327|453801416|FG000|Overall Study|Lost to Follow-up|4|||
126139439|NCT00483327|453801416|FG000|Overall Study|Patient Non Compliance|2|||
126139440|NCT00670007|453801417|FG000|Overall Study|Drug abuse|1|||
126139441|NCT00670007|453801417|FG000|Overall Study|Lung transplant|1|||
126139442|NCT00670007|453801417|FG000|Overall Study|Travel/Vacation|1|||
126139443|NCT00670007|453801417|FG000|Overall Study|Adverse event, serious fatal|1|||
126139444|NCT00670007|453801417|FG000|Overall Study|Adverse Event|1|||
126139445|NCT00670007|453801417|FG000|Overall Study|Withdrawal by Subject|4|||
126139446|NCT00618722|453801418|FG000|Overall Study|Refusal of Treatment|0|||
126139447|NCT00618722|453801419|FG001|Overall Study|Refusal of Treatment|0|||
126139448|NCT00618722|453801420|FG002|Overall Study|Refusal of Treatment|1|||
126139449|NCT00618722|453801421|FG003|Overall Study|Refusal of Treatment|0|||
126139450|NCT00618722|453801418|FG000|Overall Study|Patient Request|1|||
126139451|NCT00618722|453801419|FG001|Overall Study|Patient Request|1|||
126139452|NCT00618722|453801420|FG002|Overall Study|Patient Request|1|||
126139453|NCT00618722|453801421|FG003|Overall Study|Patient Request|1|||
126139454|NCT00618722|453801418|FG000|Overall Study|Inability to Complete Study Procedure|0|||
126139455|NCT00618722|453801419|FG001|Overall Study|Inability to Complete Study Procedure|1|||
126139456|NCT00618722|453801420|FG002|Overall Study|Inability to Complete Study Procedure|0|||
126139457|NCT00618722|453801421|FG003|Overall Study|Inability to Complete Study Procedure|0|||
126139458|NCT00618722|453801418|FG000|Overall Study|Lost to Follow-up|2|||
126139459|NCT00618722|453801419|FG001|Overall Study|Lost to Follow-up|0|||
126139460|NCT00618722|453801420|FG002|Overall Study|Lost to Follow-up|0|||
126139461|NCT00618722|453801421|FG003|Overall Study|Lost to Follow-up|2|||
126139462|NCT00618722|453801418|FG000|Overall Study|Miscellaneous Reasons|0|||
126139463|NCT00618722|453801419|FG001|Overall Study|Miscellaneous Reasons|0|||
126139464|NCT00618722|453801420|FG002|Overall Study|Miscellaneous Reasons|1|||
126139465|NCT00618722|453801421|FG003|Overall Study|Miscellaneous Reasons|1|||
126139466|NCT00200057|453801424|FG000|Overall Study|Lack of Efficacy|3|||
126139467|NCT00200057|453801424|FG000|Overall Study|Exited due to terminal illness of PI|2|||
126139468|NCT00200057|453801424|FG000|Overall Study|Withdrawal by Subject|1|||
126139469|NCT00200057|453801424|FG000|Overall Study|Change in medical condition|1|||
126139470|NCT00200057|453801424|FG000|Overall Study|Infection|1|||
126139471|NCT00200057|453801424|FG000|Overall Study|Death|1|||
126139472|NCT02965716|453801425|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126139473|NCT02965716|453801426|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
126139474|NCT02965716|453801425|FG000|Overall Study|Progression/Relapse|8|||
126139475|NCT02965716|453801426|FG001|Overall Study|Progression/Relapse|16|||
126139476|NCT02965716|453801425|FG000|Overall Study|Death|1|||
126139477|NCT02965716|453801426|FG001|Overall Study|Death|0|||
126139478|NCT02965716|453801425|FG000|Overall Study|Not Protocol Specified|1|||
126139479|NCT02965716|453801426|FG001|Overall Study|Not Protocol Specified|3|||
126139480|NCT03609619|453801430|FG000|Overall Study|Adverse Event|1|||
126139481|NCT03609619|453801431|FG001|Overall Study|Adverse Event|0|||
126139482|NCT03609619|453801430|FG000|Overall Study|Lack of Efficacy|1|||
126139483|NCT03609619|453801431|FG001|Overall Study|Lack of Efficacy|2|||
126139484|NCT03609619|453801430|FG000|Overall Study|Protocol Violation|5|||
126139485|NCT03609619|453801431|FG001|Overall Study|Protocol Violation|0|||
126139486|NCT03609619|453801430|FG000|Overall Study|Withdrawal by Subject|2|||
126139487|NCT03609619|453801431|FG001|Overall Study|Withdrawal by Subject|3|||
126139488|NCT03609619|453801430|FG000|Overall Study|Lost to Follow-up|1|||
126139489|NCT03609619|453801431|FG001|Overall Study|Lost to Follow-up|1|||
126139490|NCT00956943|453801432|FG000|Overall Study|Lost to Follow-up|9|||
126139491|NCT00956943|453801433|FG001|Overall Study|Lost to Follow-up|10|||
126139492|NCT01400932|453801437|FG000|Overall Study|Adverse Event|10|||
126139493|NCT01400932|453801438|FG001|Overall Study|Adverse Event|5|||
126139494|NCT01400932|453801437|FG000|Overall Study|Lack of Efficacy|0|||
126139495|NCT01400932|453801438|FG001|Overall Study|Lack of Efficacy|3|||
126139496|NCT01400932|453801437|FG000|Overall Study|Withdrawal by Subject|2|||
126139497|NCT01400932|453801438|FG001|Overall Study|Withdrawal by Subject|6|||
126139498|NCT01400932|453801437|FG000|Overall Study|Lost to Follow-up|1|||
126139499|NCT01400932|453801438|FG001|Overall Study|Lost to Follow-up|0|||
126139500|NCT01400932|453801437|FG000|Overall Study|Protocol Deviation|0|||
126139501|NCT01400932|453801438|FG001|Overall Study|Protocol Deviation|1|||
126139502|NCT01400932|453801437|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126139503|NCT01400932|453801438|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126139504|NCT03244059|453801440|FG000|Specific Aim 1|Physician Decision|1|||
126139505|NCT03244059|453801441|FG001|Specific Aim 1|Physician Decision|0|||
126139506|NCT03244059|453801440|FG000|Specific Aim 2|Physician Decision|1|||
126139507|NCT03244059|453801441|FG001|Specific Aim 2|Physician Decision|0|||
126139508|NCT01276821|453801442|FG000|Overall Study|Protocol Violation|0|||
126139509|NCT01276821|453801443|FG001|Overall Study|Protocol Violation|1|||
126139510|NCT00605267|453801444|FG000|Overall Study|Adverse Event|0|||
126139511|NCT00605267|453801445|FG001|Overall Study|Adverse Event|1|||
126139512|NCT00605267|453801444|FG000|Overall Study|Lack of Efficacy|1|||
126139513|NCT00605267|453801445|FG001|Overall Study|Lack of Efficacy|5|||
126139514|NCT00605267|453801444|FG000|Overall Study|Withdrawal by Subject|2|||
126139515|NCT00605267|453801445|FG001|Overall Study|Withdrawal by Subject|3|||
126139516|NCT02939131|453801446|FG000|Overall Study|Unable to get to clinic|6|||
126139517|NCT02939131|453801447|FG001|Overall Study|Unable to get to clinic|4|||
126139518|NCT02939131|453801446|FG000|Overall Study|Lost to Follow-up|2|||
126139519|NCT02939131|453801447|FG001|Overall Study|Lost to Follow-up|4|||
126139520|NCT02939131|453801446|FG000|Overall Study|severe debilitation|1|||
126139521|NCT02939131|453801447|FG001|Overall Study|severe debilitation|0|||
126139522|NCT02939131|453801446|FG000|Overall Study|Other|0|||
126139523|NCT02939131|453801447|FG001|Overall Study|Other|1|||
126139524|NCT02939131|453801446|FG000|Overall Study|not willing to adhere to protocol|2|||
126139525|NCT02939131|453801447|FG001|Overall Study|not willing to adhere to protocol|0|||
126139526|NCT02720757|453801448|FG000|Overall Study|Other reason|5|||
126139527|NCT02720757|453801448|FG000|Overall Study|Loss of contact|4|||
126139528|NCT02720757|453801448|FG000|Overall Study|Informed consent withdrawal|1|||
126139529|NCT02720757|453801448|FG000|Overall Study|Patients wish to withdraw|2|||
126139530|NCT02720757|453801448|FG000|Overall Study|Missing|3|||
126139531|NCT02720757|453801448|FG000|Overall Study|General exclusion|3|||
126139532|NCT00883493|453801449|FG000|Overall Study|Adverse Event|11|||
126139533|NCT00883493|453801450|FG001|Overall Study|Adverse Event|12|||
126139534|NCT00883493|453801449|FG000|Overall Study|Lack of Efficacy|4|||
126139535|NCT00883493|453801450|FG001|Overall Study|Lack of Efficacy|3|||
126139536|NCT00883493|453801449|FG000|Overall Study|Lost to Follow-up|7|||
126139537|NCT00883493|453801450|FG001|Overall Study|Lost to Follow-up|6|||
126139538|NCT00883493|453801449|FG000|Overall Study|Withdrawal by Subject|11|||
126139539|NCT00883493|453801450|FG001|Overall Study|Withdrawal by Subject|20|||
126139540|NCT00883493|453801449|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
126139541|NCT00883493|453801450|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
126139542|NCT00883493|453801449|FG000|Overall Study|Study specific disc. criteria|2|||
126139543|NCT00883493|453801450|FG001|Overall Study|Study specific disc. criteria|0|||
126139544|NCT00883493|453801449|FG000|Overall Study|Other|5|||
126139545|NCT00883493|453801450|FG001|Overall Study|Other|3|||
126139546|NCT01084551|453801451|FG000|Overall Study|Adverse Event|2|||
126139547|NCT01084551|453801452|FG001|Overall Study|Adverse Event|9|||
126139548|NCT01084551|453801453|FG002|Overall Study|Adverse Event|4|||
126139549|NCT01084551|453801451|FG000|Overall Study|Lack of Efficacy|2|||
126139550|NCT01084551|453801452|FG001|Overall Study|Lack of Efficacy|0|||
126139551|NCT01084551|453801453|FG002|Overall Study|Lack of Efficacy|1|||
126139552|NCT01084551|453801451|FG000|Overall Study|Withdrawal by Subject|2|||
126139553|NCT01084551|453801452|FG001|Overall Study|Withdrawal by Subject|1|||
126139554|NCT01084551|453801453|FG002|Overall Study|Withdrawal by Subject|0|||
126139555|NCT01084551|453801451|FG000|Overall Study|Protocol Violation|2|||
126139556|NCT01084551|453801452|FG001|Overall Study|Protocol Violation|4|||
126139557|NCT01084551|453801453|FG002|Overall Study|Protocol Violation|0|||
126139558|NCT01084551|453801451|FG000|Overall Study|Lost to Follow-up|0|||
126139559|NCT01084551|453801452|FG001|Overall Study|Lost to Follow-up|0|||
126139560|NCT01084551|453801453|FG002|Overall Study|Lost to Follow-up|3|||
126139561|NCT01084551|453801451|FG000|Overall Study|Physician Decision|1|||
126139562|NCT01084551|453801452|FG001|Overall Study|Physician Decision|0|||
126139563|NCT01084551|453801453|FG002|Overall Study|Physician Decision|0|||
126139564|NCT00463476|453801454|FG000|Overall Study|Withdrawal by Subject|1|||
126139565|NCT00463476|453801455|FG001|Overall Study|Withdrawal by Subject|2|||
126139566|NCT00463476|453801454|FG000|Overall Study|Lost to Follow-up|1|||
126139567|NCT00463476|453801455|FG001|Overall Study|Lost to Follow-up|1|||
126139568|NCT00988247|453801456|FG000|Overall Study|Adverse Event|17|||
126139569|NCT00988247|453801457|FG001|Overall Study|Adverse Event|3|||
126139570|NCT00988247|453801456|FG000|Overall Study|Withdrawal by Subject|44|||
126139571|NCT00988247|453801457|FG001|Overall Study|Withdrawal by Subject|13|||
126139572|NCT00988247|453801456|FG000|Overall Study|Pregnancy|1|||
126139573|NCT00988247|453801457|FG001|Overall Study|Pregnancy|2|||
126139574|NCT00988247|453801456|FG000|Overall Study|Lost to Follow-up|11|||
126139575|NCT00988247|453801457|FG001|Overall Study|Lost to Follow-up|2|||
125968371|NCT00760929|453175782|FG001|Overall Study|Withdrawal by Subject|0|||
125968372|NCT00760929|453175783|FG002|Overall Study|Withdrawal by Subject|9|||
125968373|NCT00760929|453175784|FG003|Overall Study|Withdrawal by Subject|1|||
125968374|NCT00760929|453175781|FG000|Overall Study|Lost to Follow-up|0|||
125968375|NCT00760929|453175782|FG001|Overall Study|Lost to Follow-up|0|||
125968376|NCT00760929|453175783|FG002|Overall Study|Lost to Follow-up|1|||
125968377|NCT00760929|453175784|FG003|Overall Study|Lost to Follow-up|0|||
125968378|NCT00760929|453175781|FG000|Overall Study|Progression of Disease|21|||
125968379|NCT00760929|453175782|FG001|Overall Study|Progression of Disease|26|||
125968380|NCT00760929|453175783|FG002|Overall Study|Progression of Disease|38|||
125968381|NCT00760929|453175784|FG003|Overall Study|Progression of Disease|42|||
125968382|NCT00760929|453175781|FG000|Overall Study|Other|2|||
125968383|NCT00760929|453175782|FG001|Overall Study|Other|0|||
125968384|NCT00760929|453175783|FG002|Overall Study|Other|2|||
125968385|NCT00760929|453175784|FG003|Overall Study|Other|1|||
125968386|NCT00760929|453175781|FG000|Overall Study|Death|0|||
125968387|NCT00760929|453175782|FG001|Overall Study|Death|0|||
125968388|NCT00760929|453175783|FG002|Overall Study|Death|1|||
125968389|NCT00760929|453175784|FG003|Overall Study|Death|0|||
125968390|NCT00760929|453175781|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
125968391|NCT00760929|453175782|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
125968392|NCT00760929|453175783|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
125968393|NCT00760929|453175784|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
125968394|NCT02099838|453175785|FG000|Overall Study|Death|1|||
125968395|NCT02099838|453175786|FG001|Overall Study|Death|0|||
125968396|NCT02099838|453175785|FG000|Overall Study|Lost to Follow-up|3|||
125968397|NCT02099838|453175786|FG001|Overall Study|Lost to Follow-up|1|||
125968398|NCT02099838|453175785|FG000|Overall Study|Withdrawal by Subject|0|||
125968399|NCT02099838|453175786|FG001|Overall Study|Withdrawal by Subject|1|||
125968400|NCT02301143|453175787|FG000|Induction Period|Enrolled But Not Treated|1|||
125968401|NCT02301143|453175788|FG001|Induction Period|Enrolled But Not Treated|0|||
125968402|NCT02301143|453175787|FG000|Induction Period|Death|1|||
125968403|NCT02301143|453175788|FG001|Induction Period|Death|0|||
125968404|NCT02301143|453175787|FG000|Induction Period|Adverse Event|22|||
125968405|NCT02301143|453175788|FG001|Induction Period|Adverse Event|0|||
125968406|NCT02301143|453175787|FG000|Induction Period|Progressive Disease|8|||
125968407|NCT02301143|453175788|FG001|Induction Period|Progressive Disease|0|||
125968408|NCT02301143|453175787|FG000|Induction Period|Withdrawal by Subject|3|||
125968409|NCT02301143|453175788|FG001|Induction Period|Withdrawal by Subject|0|||
125968410|NCT02301143|453175787|FG000|Induction Period|Noncompliance with Study Drug|1|||
125968411|NCT02301143|453175788|FG001|Induction Period|Noncompliance with Study Drug|0|||
125968412|NCT02301143|453175787|FG000|Induction Period|Physician Decision|4|||
125968413|NCT02301143|453175788|FG001|Induction Period|Physician Decision|0|||
125968414|NCT02301143|453175787|FG000|Induction Period|Symptomatic Deterioration|2|||
125968415|NCT02301143|453175788|FG001|Induction Period|Symptomatic Deterioration|0|||
125968416|NCT02301143|453175787|FG000|Induction Period|Protocol Violation|2|||
125968417|NCT02301143|453175788|FG001|Induction Period|Protocol Violation|0|||
125968418|NCT02301143|453175787|FG000|Induction Period|Other|1|||
125968419|NCT02301143|453175788|FG001|Induction Period|Other|0|||
125968420|NCT02301143|453175787|FG000|Investigator's Choice|Adverse Event|0|||
125968421|NCT02301143|453175788|FG001|Investigator's Choice|Adverse Event|3|||
125968422|NCT02301143|453175787|FG000|Investigator's Choice|Progressive Disease|0|||
125968423|NCT02301143|453175788|FG001|Investigator's Choice|Progressive Disease|3|||
125968424|NCT02301143|453175787|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
126139576|NCT00988247|453801456|FG000|Overall Study|Protocol Violation|4|||
125968425|NCT02301143|453175788|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
125968426|NCT02301143|453175787|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
125968427|NCT02301143|453175788|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
125968428|NCT02301143|453175787|FG000|Investigator's Choice|Other|0|||
125968429|NCT02301143|453175788|FG001|Investigator's Choice|Other|1|||
125968430|NCT02301143|453175787|FG000|Investigator's Choice|Unresectable Surgery|0|||
126139577|NCT00988247|453801457|FG001|Overall Study|Protocol Violation|5|||
126139578|NCT00988247|453801456|FG000|Overall Study|Sponsor requested withdrawal|3|||
125968431|NCT02301143|453175788|FG001|Investigator's Choice|Unresectable Surgery|1|||
126139579|NCT00988247|453801457|FG001|Overall Study|Sponsor requested withdrawal|1|||
125968432|NCT02536508|453175791|FG000|Overall Study|Withdrawal by Subject|18|||
125968433|NCT02536508|453175792|FG001|Overall Study|Withdrawal by Subject|13|||
125968434|NCT02536508|453175793|FG002|Overall Study|Withdrawal by Subject|7|||
125968435|NCT02536508|453175791|FG000|Overall Study|Adverse Event|14|||
125968436|NCT02536508|453175792|FG001|Overall Study|Adverse Event|13|||
125968437|NCT02536508|453175793|FG002|Overall Study|Adverse Event|6|||
125968438|NCT02536508|453175791|FG000|Overall Study|Lost to Follow-up|12|||
125968439|NCT02536508|453175792|FG001|Overall Study|Lost to Follow-up|4|||
125968440|NCT02536508|453175793|FG002|Overall Study|Lost to Follow-up|0|||
125968441|NCT02536508|453175791|FG000|Overall Study|Lack of Efficacy|3|||
125968442|NCT02536508|453175792|FG001|Overall Study|Lack of Efficacy|5|||
125968443|NCT02536508|453175793|FG002|Overall Study|Lack of Efficacy|4|||
125968444|NCT02536508|453175791|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
125968445|NCT02536508|453175792|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
125968446|NCT02536508|453175793|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
126139580|NCT00988247|453801456|FG000|Overall Study|Other|3|||
126139581|NCT00988247|453801457|FG001|Overall Study|Other|0|||
126139582|NCT04173741|453801458|FG000|Overall Study|IVC measurement cannot be done|1|||
126139583|NCT04173741|453801459|FG001|Overall Study|IVC measurement cannot be done|1|||
126139584|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139585|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
126139586|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139587|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139588|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139589|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
126139590|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
126139591|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
126139592|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
126139593|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
126139594|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126139595|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126139596|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126139597|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126139598|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126139599|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
126139600|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
126139601|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
126139602|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
126139603|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
126139604|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139605|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139606|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139607|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
126139608|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139609|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
126139610|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
126139611|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126139612|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126139613|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126139614|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
126139615|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
126139616|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
126139617|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
126139618|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
126139619|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126139620|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
126139621|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
125968447|NCT02536508|453175791|FG000|Overall Study|Physician Decision|0|||
125968448|NCT02536508|453175792|FG001|Overall Study|Physician Decision|4|||
125968449|NCT02536508|453175793|FG002|Overall Study|Physician Decision|2|||
125968450|NCT02536508|453175791|FG000|Overall Study|Major Protocol Deviation|2|||
125968451|NCT02536508|453175792|FG001|Overall Study|Major Protocol Deviation|2|||
125968452|NCT02536508|453175793|FG002|Overall Study|Major Protocol Deviation|2|||
125968453|NCT02536508|453175791|FG000|Overall Study|Administrative Reasons|0|||
125968454|NCT02536508|453175792|FG001|Overall Study|Administrative Reasons|1|||
125968455|NCT02536508|453175793|FG002|Overall Study|Administrative Reasons|0|||
125968456|NCT02460991|453175800|FG000|Overall Study|Withdrawal by Subject|0|||
125968457|NCT02460991|453175801|FG001|Overall Study|Withdrawal by Subject|2|||
126139622|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
126139623|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126139624|NCT00289913|453801460|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
126139625|NCT00289913|453801461|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126139626|NCT00289913|453801462|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
126139627|NCT00289913|453801463|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126139628|NCT00289913|453801464|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126139629|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139630|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139631|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
126139632|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139633|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139634|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
126139635|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
126139636|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
126139637|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
126139638|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
126139639|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
126139640|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
126139641|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
126139642|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
126139643|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
126139644|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
126139645|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126139646|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
126139647|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126139648|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126139649|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
126139650|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139651|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
126139652|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139653|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139654|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126139655|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
126139656|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
126139657|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
126139658|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126139659|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
126139660|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
126139661|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
126139662|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
126139663|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
126139664|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
126139665|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
126139666|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
126139667|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
126139668|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
126139669|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
126139670|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
126139671|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
126139672|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
126139673|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
126139674|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
126139675|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
126139676|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
126139677|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
126139678|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
126139679|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
126139680|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
126139681|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
126139682|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
126139683|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
126139684|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
126139685|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
126139686|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
126139687|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
126139688|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
126139689|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
126139690|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
126139691|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
126139692|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
126139693|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
126139694|NCT00289913|453801460|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
126139695|NCT00289913|453801461|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
126139696|NCT00289913|453801462|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
126139697|NCT00289913|453801463|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
126139698|NCT00289913|453801464|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
126139699|NCT00289913|453801460|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139700|NCT00289913|453801461|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
126139701|NCT00289913|453801462|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139702|NCT00289913|453801463|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139703|NCT00289913|453801464|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126139704|NCT00289913|453801460|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
126139705|NCT00289913|453801461|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
126139706|NCT00289913|453801462|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
126139707|NCT00289913|453801463|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
126139708|NCT00289913|453801464|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
126139709|NCT00289913|453801460|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126139710|NCT00289913|453801461|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126139711|NCT00289913|453801462|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126139712|NCT00289913|453801463|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
126139713|NCT00289913|453801464|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126139714|NCT00289913|453801460|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139715|NCT00289913|453801461|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139716|NCT00289913|453801462|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139717|NCT00289913|453801463|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126139718|NCT00289913|453801464|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
126139719|NCT00289913|453801460|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
126139720|NCT00289913|453801461|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
126139721|NCT00289913|453801462|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
126139722|NCT00289913|453801463|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
126139723|NCT00289913|453801464|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
126139724|NCT00289913|453801460|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126139725|NCT00289913|453801461|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
126139726|NCT00289913|453801462|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
126139727|NCT00289913|453801463|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126139728|NCT00289913|453801464|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126139729|NCT00289913|453801460|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
126139730|NCT00289913|453801461|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
126139731|NCT00289913|453801462|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
126139732|NCT00289913|453801463|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
126139733|NCT00289913|453801464|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
126139734|NCT00289913|453801460|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126139735|NCT00289913|453801461|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
126139736|NCT00289913|453801462|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126139737|NCT00289913|453801463|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126139738|NCT00289913|453801464|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126139739|NCT01169779|453801467|FG000|Overall Study|Adverse Event|3|||
126139740|NCT01169779|453801468|FG001|Overall Study|Adverse Event|11|||
126139741|NCT01169779|453801467|FG000|Overall Study|Lack of Efficacy|1|||
126139742|NCT01169779|453801468|FG001|Overall Study|Lack of Efficacy|0|||
126139743|NCT01169779|453801467|FG000|Overall Study|Protocol Violation|1|||
126139744|NCT01169779|453801468|FG001|Overall Study|Protocol Violation|1|||
126139745|NCT01169779|453801467|FG000|Overall Study|Withdrawal by Subject|3|||
125968458|NCT00434057|453175802|FG000|Overall Study|Withdrawal by Subject|1|||
126139746|NCT01169779|453801468|FG001|Overall Study|Withdrawal by Subject|2|||
126139747|NCT01169779|453801467|FG000|Overall Study|Familial and personal reasons|3|||
126139748|NCT01169779|453801468|FG001|Overall Study|Familial and personal reasons|3|||
126139749|NCT03617705|453801473|FG000|Overall Study|Withdrawal by Subject|2|||
126139750|NCT03617705|453801473|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
126139751|NCT03617705|453801473|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
126139752|NCT01061008|453801474|FG000|Overall Study|Badiocephalic fistula failed|3|||
126139753|NCT01061008|453801475|FG001|Overall Study|Badiocephalic fistula failed|2|||
126139754|NCT01061008|453801474|FG000|Overall Study|Death|1|||
126139755|NCT01061008|453801475|FG001|Overall Study|Death|0|||
126139756|NCT01061008|453801474|FG000|Overall Study|Withdrawal by Subject|1|||
126139757|NCT01061008|453801475|FG001|Overall Study|Withdrawal by Subject|3|||
126139758|NCT01061008|453801474|FG000|Overall Study|Unable to exercise following surgery|1|||
126139759|NCT01061008|453801475|FG001|Overall Study|Unable to exercise following surgery|0|||
126139760|NCT01061008|453801474|FG000|Overall Study|Adverse Event|0|||
126139761|NCT01061008|453801475|FG001|Overall Study|Adverse Event|1|||
126139762|NCT02024971|453801476|FG000|Overall Study|Data Not Available|30|||
126139763|NCT02024971|453801476|FG000|Overall Study|Lost to Follow-up|6|||
126139764|NCT00189462|453801485|FG000|Overall Study|Lack of Efficacy|5|||
126139765|NCT00189462|453801486|FG001|Overall Study|Lack of Efficacy|1|||
126139766|NCT00189462|453801485|FG000|Overall Study|Lost to Follow-up|18|||
126139767|NCT00189462|453801486|FG001|Overall Study|Lost to Follow-up|20|||
126139768|NCT00849667|453801490|FG000|Overall Study|Withdrawal by Subject|16|||
126139769|NCT00849667|453801491|FG001|Overall Study|Withdrawal by Subject|33|||
126139770|NCT00849667|453801492|FG002|Overall Study|Withdrawal by Subject|35|||
126139771|NCT00849667|453801490|FG000|Overall Study|Lost to Follow-up|8|||
126139772|NCT00849667|453801491|FG001|Overall Study|Lost to Follow-up|8|||
126139773|NCT00849667|453801492|FG002|Overall Study|Lost to Follow-up|8|||
126139774|NCT00849667|453801490|FG000|Overall Study|Adverse Event|1|||
126139775|NCT00849667|453801491|FG001|Overall Study|Adverse Event|2|||
126139776|NCT00849667|453801492|FG002|Overall Study|Adverse Event|0|||
126139777|NCT00849667|453801490|FG000|Overall Study|Other|18|||
126139778|NCT00849667|453801491|FG001|Overall Study|Other|19|||
126139779|NCT00849667|453801492|FG002|Overall Study|Other|18|||
126139780|NCT00849667|453801490|FG000|Overall Study|Progressive disease|119|||
126139781|NCT00849667|453801491|FG001|Overall Study|Progressive disease|100|||
126139782|NCT00849667|453801492|FG002|Overall Study|Progressive disease|112|||
126139783|NCT00849667|453801490|FG000|Overall Study|Sponsor decision|208|||
126139784|NCT00849667|453801491|FG001|Overall Study|Sponsor decision|204|||
126139785|NCT00849667|453801492|FG002|Overall Study|Sponsor decision|190|||
126139786|NCT00849667|453801490|FG000|Overall Study|Investigator discretion|0|||
126139787|NCT00849667|453801491|FG001|Overall Study|Investigator discretion|0|||
126139788|NCT00849667|453801492|FG002|Overall Study|Investigator discretion|1|||
126139789|NCT01262625|453801493|FG000|Overall Study|Administrative Error|1|||
126139790|NCT01262625|453801494|FG001|Overall Study|Administrative Error|1|||
126139791|NCT01262625|453801493|FG000|Overall Study|Site Closed|1|||
126139792|NCT01262625|453801494|FG001|Overall Study|Site Closed|0|||
126139793|NCT00556426|453801495|FG000|Overall Study|Withdrawal by Subject|3|||
126139794|NCT00556426|453801495|FG000|Overall Study|Death|6|||
126139795|NCT01299727|453801498|FG000|Overall Study|Withdrawal by Subject|1|||
126139796|NCT01299727|453801499|FG001|Overall Study|Withdrawal by Subject|0|||
126139797|NCT01299727|453801500|FG002|Overall Study|Withdrawal by Subject|0|||
126139798|NCT01299727|453801498|FG000|Overall Study|Adverse Event|0|||
126139799|NCT01299727|453801499|FG001|Overall Study|Adverse Event|0|||
126139800|NCT01299727|453801500|FG002|Overall Study|Adverse Event|1|||
126139801|NCT01299727|453801498|FG000|Overall Study|Completed the Treatment Period|3|||
126139802|NCT01299727|453801499|FG001|Overall Study|Completed the Treatment Period|4|||
126139803|NCT01299727|453801500|FG002|Overall Study|Completed the Treatment Period|3|||
126139804|NCT00944034|453801504|FG000|Overall Study|Inappropriate enrollment|0|||
126139805|NCT00944034|453801505|FG001|Overall Study|Inappropriate enrollment|1|||
126139806|NCT00944034|453801506|FG002|Overall Study|Inappropriate enrollment|0|||
126139807|NCT00944034|453801507|FG003|Overall Study|Inappropriate enrollment|1|||
126139808|NCT00944034|453801508|FG004|Overall Study|Inappropriate enrollment|2|||
126139809|NCT00944034|453801509|FG005|Overall Study|Inappropriate enrollment|1|||
126139810|NCT00944034|453801510|FG006|Overall Study|Inappropriate enrollment|0|||
126139811|NCT00944034|453801511|FG007|Overall Study|Inappropriate enrollment|0|||
126139812|NCT00944034|453801512|FG008|Overall Study|Inappropriate enrollment|1|||
126139813|NCT00944034|453801513|FG009|Overall Study|Inappropriate enrollment|1|||
126139814|NCT00944034|453801514|FG010|Overall Study|Inappropriate enrollment|0|||
126139815|NCT00944034|453801515|FG011|Overall Study|Inappropriate enrollment|0|||
125968459|NCT02473952|453175803|FG000|Overall Study|Adverse Event|2|||
125968460|NCT02473952|453175804|FG001|Overall Study|Adverse Event|2|||
126139816|NCT00944034|453801504|FG000|Overall Study|Withdrawal by Subject|3|||
126139817|NCT00944034|453801505|FG001|Overall Study|Withdrawal by Subject|2|||
126139818|NCT00944034|453801506|FG002|Overall Study|Withdrawal by Subject|6|||
126139819|NCT00944034|453801507|FG003|Overall Study|Withdrawal by Subject|2|||
126139820|NCT00944034|453801508|FG004|Overall Study|Withdrawal by Subject|5|||
126139821|NCT00944034|453801509|FG005|Overall Study|Withdrawal by Subject|8|||
126139822|NCT00944034|453801510|FG006|Overall Study|Withdrawal by Subject|2|||
126139823|NCT00944034|453801511|FG007|Overall Study|Withdrawal by Subject|2|||
126139824|NCT00944034|453801512|FG008|Overall Study|Withdrawal by Subject|3|||
126139825|NCT00944034|453801513|FG009|Overall Study|Withdrawal by Subject|4|||
126139826|NCT00944034|453801514|FG010|Overall Study|Withdrawal by Subject|0|||
126139827|NCT00944034|453801515|FG011|Overall Study|Withdrawal by Subject|4|||
126139828|NCT00944034|453801504|FG000|Overall Study|Lost to Follow-up|0|||
126139829|NCT00944034|453801505|FG001|Overall Study|Lost to Follow-up|4|||
126139830|NCT00944034|453801506|FG002|Overall Study|Lost to Follow-up|2|||
126139831|NCT00944034|453801507|FG003|Overall Study|Lost to Follow-up|0|||
126139832|NCT00944034|453801508|FG004|Overall Study|Lost to Follow-up|5|||
126139833|NCT00944034|453801509|FG005|Overall Study|Lost to Follow-up|7|||
126139834|NCT00944034|453801510|FG006|Overall Study|Lost to Follow-up|0|||
126139835|NCT00944034|453801511|FG007|Overall Study|Lost to Follow-up|1|||
126139836|NCT00944034|453801512|FG008|Overall Study|Lost to Follow-up|5|||
126139837|NCT00944034|453801513|FG009|Overall Study|Lost to Follow-up|1|||
126139838|NCT00944034|453801514|FG010|Overall Study|Lost to Follow-up|1|||
126139839|NCT00944034|453801515|FG011|Overall Study|Lost to Follow-up|0|||
126139840|NCT00944034|453801504|FG000|Overall Study|Death|0|||
126139841|NCT00944034|453801505|FG001|Overall Study|Death|0|||
126139842|NCT00944034|453801506|FG002|Overall Study|Death|1|||
126139843|NCT00944034|453801507|FG003|Overall Study|Death|0|||
126139844|NCT00944034|453801508|FG004|Overall Study|Death|0|||
126139845|NCT00944034|453801509|FG005|Overall Study|Death|0|||
126139846|NCT00944034|453801510|FG006|Overall Study|Death|0|||
126139847|NCT00944034|453801511|FG007|Overall Study|Death|0|||
126139848|NCT00944034|453801512|FG008|Overall Study|Death|0|||
126139849|NCT00944034|453801513|FG009|Overall Study|Death|0|||
126139850|NCT00944034|453801514|FG010|Overall Study|Death|0|||
126139851|NCT00944034|453801515|FG011|Overall Study|Death|0|||
126139852|NCT00944034|453801504|FG000|Overall Study|Protocol Violation|2|||
126139853|NCT00944034|453801505|FG001|Overall Study|Protocol Violation|0|||
126139854|NCT00944034|453801506|FG002|Overall Study|Protocol Violation|0|||
126139855|NCT00944034|453801507|FG003|Overall Study|Protocol Violation|1|||
126139856|NCT00944034|453801508|FG004|Overall Study|Protocol Violation|2|||
126139857|NCT00944034|453801509|FG005|Overall Study|Protocol Violation|3|||
126139858|NCT00944034|453801510|FG006|Overall Study|Protocol Violation|0|||
126139859|NCT00944034|453801511|FG007|Overall Study|Protocol Violation|1|||
126139860|NCT00944034|453801512|FG008|Overall Study|Protocol Violation|1|||
126139861|NCT00944034|453801513|FG009|Overall Study|Protocol Violation|4|||
126139862|NCT00944034|453801514|FG010|Overall Study|Protocol Violation|0|||
126139863|NCT00944034|453801515|FG011|Overall Study|Protocol Violation|0|||
126139864|NCT00944034|453801504|FG000|Overall Study|Unable to classify|0|||
126139865|NCT00944034|453801505|FG001|Overall Study|Unable to classify|0|||
126139866|NCT00944034|453801506|FG002|Overall Study|Unable to classify|0|||
126139867|NCT00944034|453801507|FG003|Overall Study|Unable to classify|0|||
126139868|NCT00944034|453801508|FG004|Overall Study|Unable to classify|0|||
126139869|NCT00944034|453801509|FG005|Overall Study|Unable to classify|1|||
126139870|NCT00944034|453801510|FG006|Overall Study|Unable to classify|1|||
126139871|NCT00944034|453801511|FG007|Overall Study|Unable to classify|1|||
126139872|NCT00944034|453801512|FG008|Overall Study|Unable to classify|0|||
126139873|NCT00944034|453801513|FG009|Overall Study|Unable to classify|0|||
126139874|NCT00944034|453801514|FG010|Overall Study|Unable to classify|0|||
126139875|NCT00944034|453801515|FG011|Overall Study|Unable to classify|0|||
126139876|NCT00944034|453801504|FG000|Overall Study|Administrative reason|0|||
126139877|NCT00944034|453801505|FG001|Overall Study|Administrative reason|0|||
126139878|NCT00944034|453801506|FG002|Overall Study|Administrative reason|0|||
126139879|NCT00944034|453801507|FG003|Overall Study|Administrative reason|0|||
126139880|NCT00944034|453801508|FG004|Overall Study|Administrative reason|0|||
126139881|NCT00944034|453801509|FG005|Overall Study|Administrative reason|0|||
126139882|NCT00944034|453801510|FG006|Overall Study|Administrative reason|1|||
126139883|NCT00944034|453801511|FG007|Overall Study|Administrative reason|0|||
126139884|NCT00944034|453801512|FG008|Overall Study|Administrative reason|0|||
126139885|NCT00944034|453801513|FG009|Overall Study|Administrative reason|0|||
126139886|NCT00944034|453801514|FG010|Overall Study|Administrative reason|0|||
126139887|NCT00944034|453801515|FG011|Overall Study|Administrative reason|0|||
126139888|NCT00441792|453801522|FG000|Overall Study|Lost to Follow-up|0|||
126139889|NCT00441792|453801523|FG001|Overall Study|Lost to Follow-up|2|||
126139890|NCT02649634|453801528|FG000|Overall Study|Withdrawal by Subject|3|||
126139891|NCT02649634|453801529|FG001|Overall Study|Withdrawal by Subject|5|||
126139892|NCT02649634|453801528|FG000|Overall Study|Lost to Follow-up|0|||
126139893|NCT02649634|453801529|FG001|Overall Study|Lost to Follow-up|1|||
126139894|NCT01318122|453801530|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126139895|NCT01318122|453801531|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126139896|NCT01318122|453801532|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
126139897|NCT01318122|453801533|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
126139898|NCT01318122|453801530|FG000|Enrolled - Long-Term Extension Study|Other|1|||
126139899|NCT01318122|453801531|FG001|Enrolled - Long-Term Extension Study|Other|0|||
126139900|NCT01318122|453801532|FG002|Enrolled - Long-Term Extension Study|Other|0|||
126139901|NCT01318122|453801533|FG003|Enrolled - Long-Term Extension Study|Other|0|||
126139902|NCT01318122|453801530|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
126139903|NCT01318122|453801531|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
126139904|NCT01318122|453801532|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
126139905|NCT01318122|453801533|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
126139906|NCT01318122|453801530|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
126139907|NCT01318122|453801531|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126139908|NCT01318122|453801532|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126139909|NCT01318122|453801533|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126139910|NCT01318122|453801530|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126139911|NCT01318122|453801531|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
126139912|NCT01318122|453801532|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126139913|NCT01318122|453801533|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126139914|NCT01318122|453801530|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126139915|NCT01318122|453801531|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
126139916|NCT01318122|453801532|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
126139917|NCT01318122|453801533|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126139918|NCT01486199|453801534|FG000|Two Year Period Between Study Days|Physician Decision|1|||
126139919|NCT01486199|453801535|FG001|Two Year Period Between Study Days|Physician Decision|0|||
126139920|NCT02211261|453801539|FG000|Overall Study|Withdrawal by Subject|0|||
126139921|NCT02211261|453801540|FG001|Overall Study|Withdrawal by Subject|0|||
126139922|NCT02211261|453801541|FG002|Overall Study|Withdrawal by Subject|1|||
126139923|NCT02211261|453801542|FG003|Overall Study|Withdrawal by Subject|0|||
126139924|NCT02211261|453801543|FG004|Overall Study|Withdrawal by Subject|2|||
126139925|NCT02211261|453801544|FG005|Overall Study|Withdrawal by Subject|0|||
126139926|NCT02211261|453801545|FG006|Overall Study|Withdrawal by Subject|0|||
126139927|NCT02211261|453801546|FG007|Overall Study|Withdrawal by Subject|0|||
126139928|NCT02211261|453801547|FG008|Overall Study|Withdrawal by Subject|0|||
126139929|NCT02211261|453801548|FG009|Overall Study|Withdrawal by Subject|0|||
126139930|NCT02211261|453801549|FG010|Overall Study|Withdrawal by Subject|0|||
126139931|NCT02211261|453801539|FG000|Overall Study|Other|0|||
126139932|NCT02211261|453801540|FG001|Overall Study|Other|0|||
126139933|NCT02211261|453801541|FG002|Overall Study|Other|0|||
126139934|NCT02211261|453801542|FG003|Overall Study|Other|0|||
126139935|NCT02211261|453801543|FG004|Overall Study|Other|0|||
126139936|NCT02211261|453801544|FG005|Overall Study|Other|1|||
126139937|NCT02211261|453801545|FG006|Overall Study|Other|0|||
126139938|NCT02211261|453801546|FG007|Overall Study|Other|0|||
126139939|NCT02211261|453801547|FG008|Overall Study|Other|0|||
126139940|NCT02211261|453801548|FG009|Overall Study|Other|2|||
126139941|NCT02211261|453801549|FG010|Overall Study|Other|0|||
126139942|NCT02211261|453801539|FG000|Overall Study|Lost to Follow-up|0|||
126139943|NCT02211261|453801540|FG001|Overall Study|Lost to Follow-up|0|||
126139944|NCT02211261|453801541|FG002|Overall Study|Lost to Follow-up|0|||
126139945|NCT02211261|453801542|FG003|Overall Study|Lost to Follow-up|0|||
126139946|NCT02211261|453801543|FG004|Overall Study|Lost to Follow-up|0|||
126139947|NCT02211261|453801544|FG005|Overall Study|Lost to Follow-up|0|||
126139948|NCT02211261|453801545|FG006|Overall Study|Lost to Follow-up|0|||
126139949|NCT02211261|453801546|FG007|Overall Study|Lost to Follow-up|1|||
126139950|NCT02211261|453801547|FG008|Overall Study|Lost to Follow-up|0|||
126139951|NCT02211261|453801548|FG009|Overall Study|Lost to Follow-up|0|||
126139952|NCT02211261|453801549|FG010|Overall Study|Lost to Follow-up|0|||
126139953|NCT00600171|453802888|FG000|Overall Study|Adverse Event|0|||
126139954|NCT00600171|453802889|FG001|Overall Study|Adverse Event|1|||
126139955|NCT00600171|453802890|FG002|Overall Study|Adverse Event|0|||
126139956|NCT00600171|453802891|FG003|Overall Study|Adverse Event|0|||
126139957|NCT00600171|453802892|FG004|Overall Study|Adverse Event|1|||
126139958|NCT00600171|453802893|FG005|Overall Study|Adverse Event|0|||
126139959|NCT00600171|453802888|FG000|Overall Study|Lack of Efficacy|9|||
126139960|NCT00600171|453802889|FG001|Overall Study|Lack of Efficacy|12|||
126139961|NCT00600171|453802890|FG002|Overall Study|Lack of Efficacy|3|||
126139962|NCT00600171|453802891|FG003|Overall Study|Lack of Efficacy|5|||
126139963|NCT00600171|453802892|FG004|Overall Study|Lack of Efficacy|4|||
126139964|NCT00600171|453802893|FG005|Overall Study|Lack of Efficacy|0|||
126139965|NCT00600171|453802888|FG000|Overall Study|Protocol Violation|1|||
126139966|NCT00600171|453802889|FG001|Overall Study|Protocol Violation|2|||
126139967|NCT00600171|453802890|FG002|Overall Study|Protocol Violation|0|||
126139968|NCT00600171|453802891|FG003|Overall Study|Protocol Violation|1|||
126139969|NCT00600171|453802892|FG004|Overall Study|Protocol Violation|0|||
126139970|NCT00600171|453802893|FG005|Overall Study|Protocol Violation|0|||
126139971|NCT00600171|453802888|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
126139972|NCT00600171|453802889|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126139973|NCT00600171|453802890|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
126139974|NCT00600171|453802891|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
126139975|NCT00600171|453802892|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
126139976|NCT00600171|453802893|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125968461|NCT02473952|453175803|FG000|Overall Study|Withdrawal by Subject|0|||
126139977|NCT00600171|453802888|FG000|Overall Study|Withdrawal by Subject|3|||
126139978|NCT00600171|453802889|FG001|Overall Study|Withdrawal by Subject|0|||
126139979|NCT00600171|453802890|FG002|Overall Study|Withdrawal by Subject|0|||
126139980|NCT00600171|453802891|FG003|Overall Study|Withdrawal by Subject|1|||
126139981|NCT00600171|453802892|FG004|Overall Study|Withdrawal by Subject|1|||
126139982|NCT00600171|453802893|FG005|Overall Study|Withdrawal by Subject|1|||
126139983|NCT00600171|453802888|FG000|Overall Study|Physician Decision|0|||
126139984|NCT00600171|453802889|FG001|Overall Study|Physician Decision|1|||
126139985|NCT00600171|453802890|FG002|Overall Study|Physician Decision|0|||
126139986|NCT00600171|453802891|FG003|Overall Study|Physician Decision|1|||
126139987|NCT00600171|453802892|FG004|Overall Study|Physician Decision|0|||
126139988|NCT00600171|453802893|FG005|Overall Study|Physician Decision|2|||
126139989|NCT00600171|453802888|FG000|Overall Study|Lost to Follow-up|0|||
126139990|NCT00600171|453802889|FG001|Overall Study|Lost to Follow-up|0|||
126139991|NCT00600171|453802890|FG002|Overall Study|Lost to Follow-up|0|||
126139992|NCT00600171|453802891|FG003|Overall Study|Lost to Follow-up|1|||
126139993|NCT00600171|453802892|FG004|Overall Study|Lost to Follow-up|0|||
126139994|NCT00600171|453802893|FG005|Overall Study|Lost to Follow-up|0|||
126139995|NCT01279057|453802898|FG000|Overall Study|Adverse Event|1|||
126139996|NCT01279057|453802899|FG001|Overall Study|Adverse Event|0|||
126139997|NCT01279057|453802900|FG002|Overall Study|Adverse Event|1|||
126139998|NCT01279057|453802898|FG000|Overall Study|Insufficient therapeutic response|0|||
126139999|NCT01279057|453802899|FG001|Overall Study|Insufficient therapeutic response|0|||
126140000|NCT01279057|453802900|FG002|Overall Study|Insufficient therapeutic response|1|||
126140001|NCT01279057|453802898|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
126140002|NCT01279057|453802899|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
126140003|NCT01279057|453802900|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
126140004|NCT01279057|453802898|FG000|Overall Study|Withdrew consent|2|||
126140005|NCT01279057|453802899|FG001|Overall Study|Withdrew consent|0|||
126140006|NCT01279057|453802900|FG002|Overall Study|Withdrew consent|1|||
126140007|NCT01279057|453802898|FG000|Overall Study|Pregnancy|0|||
126140008|NCT01279057|453802899|FG001|Overall Study|Pregnancy|1|||
126140009|NCT01279057|453802900|FG002|Overall Study|Pregnancy|0|||
126140010|NCT01279057|453802898|FG000|Overall Study|Other|3|||
126140011|NCT01279057|453802899|FG001|Overall Study|Other|3|||
126140012|NCT01279057|453802900|FG002|Overall Study|Other|0|||
126140013|NCT01427309|453802902|FG000|Overall Study|Lost to Follow-up|130|||
126140014|NCT01427309|453802903|FG001|Overall Study|Lost to Follow-up|145|||
126140015|NCT01427309|453802904|FG002|Overall Study|Lost to Follow-up|122|||
126140016|NCT01427309|453802905|FG003|Overall Study|Lost to Follow-up|135|||
126140017|NCT01427309|453802902|FG000|Overall Study|Protocol Violation|42|||
126140018|NCT01427309|453802903|FG001|Overall Study|Protocol Violation|69|||
126140019|NCT01427309|453802904|FG002|Overall Study|Protocol Violation|125|||
126140020|NCT01427309|453802905|FG003|Overall Study|Protocol Violation|124|||
126140021|NCT01427309|453802902|FG000|Overall Study|Adverse Event|0|||
126140022|NCT01427309|453802903|FG001|Overall Study|Adverse Event|0|||
126140023|NCT01427309|453802904|FG002|Overall Study|Adverse Event|3|||
126140024|NCT01427309|453802905|FG003|Overall Study|Adverse Event|1|||
126140025|NCT01427309|453802902|FG000|Overall Study|Serious adverse event|52|||
126140026|NCT01427309|453802903|FG001|Overall Study|Serious adverse event|45|||
126140027|NCT01427309|453802904|FG002|Overall Study|Serious adverse event|50|||
126140028|NCT01427309|453802905|FG003|Overall Study|Serious adverse event|61|||
126140029|NCT01427309|453802902|FG000|Overall Study|Withdrawal by Subject|148|||
126140030|NCT01427309|453802903|FG001|Overall Study|Withdrawal by Subject|148|||
126140031|NCT01427309|453802904|FG002|Overall Study|Withdrawal by Subject|61|||
126140032|NCT01427309|453802905|FG003|Overall Study|Withdrawal by Subject|55|||
126140033|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
126140034|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
126140035|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
126140036|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
125968462|NCT02473952|453175804|FG001|Overall Study|Withdrawal by Subject|6|||
126140037|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
126140038|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
126140039|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
126140040|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
126140041|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
126140042|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
126140043|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
126140044|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
126140045|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
126140046|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
126140047|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
126140048|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
126140049|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
126140050|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
126140051|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
126140052|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
126140053|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
126140054|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
126140055|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
126140056|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
126140057|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
126140058|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
126140059|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
126140060|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
126140061|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
126140062|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
126140063|NCT00849017|453802906|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
126140064|NCT00849017|453802907|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
126140065|NCT00849017|453802908|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
126140066|NCT00849017|453802906|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
126140067|NCT00849017|453802907|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
126140068|NCT00849017|453802908|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
126140069|NCT00849017|453802906|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
126140070|NCT00849017|453802907|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
126140071|NCT00849017|453802908|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
126140072|NCT00849017|453802906|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
126140073|NCT00849017|453802907|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
126140074|NCT00849017|453802908|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
126140075|NCT00849017|453802906|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
126140076|NCT00849017|453802907|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
126140077|NCT00849017|453802908|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
126140078|NCT00849017|453802906|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
126140079|NCT00849017|453802907|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
126140080|NCT00849017|453802908|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
126140081|NCT00849017|453802906|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
126140082|NCT00849017|453802907|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
126140083|NCT00849017|453802908|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
126140084|NCT00849017|453802906|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
126140085|NCT00849017|453802907|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
126140086|NCT00849017|453802908|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
126140087|NCT00849017|453802906|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
126140088|NCT00849017|453802907|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
126140089|NCT00849017|453802908|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
126140090|NCT01869348|453802909|FG000|Overall Study|Withdrawal by Subject|1|||
126140091|NCT01869348|453802910|FG001|Overall Study|Withdrawal by Subject|1|||
126140092|NCT00624520|453802912|FG000|Overall Study|Withdrawal by Subject|12|||
125968463|NCT00823719|453175805|FG000|Overall Study|Adverse Event|1|||
125968464|NCT00823719|453175806|FG001|Overall Study|Adverse Event|2|||
125968465|NCT00823719|453175805|FG000|Overall Study|Physician Decision|1|||
126140093|NCT00624520|453802913|FG001|Overall Study|Withdrawal by Subject|7|||
126140094|NCT00624520|453802912|FG000|Overall Study|Death|0|||
126140095|NCT00624520|453802913|FG001|Overall Study|Death|1|||
126140096|NCT02796755|453802914|FG000|Overall Study|Adverse Event|2|||
126140097|NCT02796755|453802915|FG001|Overall Study|Adverse Event|0|||
126140098|NCT00110994|453802916|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
126140099|NCT00110994|453802917|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
126140100|NCT00110994|453802916|FG000|Double-blind (DB) Treatment|Death|1|||
126140101|NCT00110994|453802917|FG001|Double-blind (DB) Treatment|Death|0|||
126140102|NCT00110994|453802916|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
126140103|NCT00110994|453802917|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
126140104|NCT00110994|453802916|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
126140105|NCT00110994|453802917|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
126140106|NCT00110994|453802916|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
126140107|NCT00110994|453802917|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
126140108|NCT00110994|453802916|FG000|Double-blind (DB) Treatment|other reasons|2|||
126140109|NCT00110994|453802917|FG001|Double-blind (DB) Treatment|other reasons|3|||
126140110|NCT00110994|453802916|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
126140111|NCT00110994|453802917|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
126140112|NCT00110994|453802916|FG000|Active Follow-up|Other reasons|0|||
126140113|NCT00110994|453802917|FG001|Active Follow-up|Other reasons|2|||
126140114|NCT00110994|453802916|FG000|Long Term Follow-up|Death|19|||
126140115|NCT00110994|453802917|FG001|Long Term Follow-up|Death|17|||
125968466|NCT00823719|453175806|FG001|Overall Study|Physician Decision|4|||
126140116|NCT00531960|453802921|FG000|Overall Study|Adverse Event|5|||
126140117|NCT00531960|453802922|FG001|Overall Study|Adverse Event|4|||
126140118|NCT00531960|453802921|FG000|Overall Study|Death|3|||
126140119|NCT00531960|453802922|FG001|Overall Study|Death|2|||
126140120|NCT00531960|453802921|FG000|Overall Study|Lack of Efficacy|42|||
126140121|NCT00531960|453802922|FG001|Overall Study|Lack of Efficacy|41|||
126140122|NCT00531960|453802921|FG000|Overall Study|Violation of Selection Criteria|2|||
126140123|NCT00531960|453802922|FG001|Overall Study|Violation of Selection Criteria|0|||
126140124|NCT00531960|453802921|FG000|Overall Study|Refused Treatment|5|||
126140125|NCT00531960|453802922|FG001|Overall Study|Refused Treatment|6|||
126140126|NCT00531960|453802921|FG000|Overall Study|Other|4|||
126140127|NCT00531960|453802922|FG001|Overall Study|Other|10|||
126140128|NCT01500057|453802923|FG000|Overall Study|Lost to Follow-up|6|||
126140129|NCT01500057|453802924|FG001|Overall Study|Lost to Follow-up|4|||
126140130|NCT01737931|453802938|FG000|Overall Study|Withdrawal by Subject|0|||
126140131|NCT01737931|453802939|FG001|Overall Study|Withdrawal by Subject|1|||
126140132|NCT01737931|453802940|FG002|Overall Study|Withdrawal by Subject|1|||
126140133|NCT01737931|453802938|FG000|Overall Study|Physician Decision|0|||
126140134|NCT01737931|453802939|FG001|Overall Study|Physician Decision|1|||
126140135|NCT01737931|453802940|FG002|Overall Study|Physician Decision|0|||
126140136|NCT03183128|453802948|FG000|Overall Study|Adverse Event|1|||
126140137|NCT03183128|453802949|FG001|Overall Study|Adverse Event|2|||
126140138|NCT03183128|453802948|FG000|Overall Study|Withdrawal by Subject|1|||
126140139|NCT03183128|453802949|FG001|Overall Study|Withdrawal by Subject|8|||
126140140|NCT03183128|453802948|FG000|Overall Study|Protocol Violation|2|||
126140141|NCT03183128|453802949|FG001|Overall Study|Protocol Violation|0|||
126140142|NCT03183128|453802948|FG000|Overall Study|Lack of Efficacy|4|||
126140143|NCT03183128|453802949|FG001|Overall Study|Lack of Efficacy|27|||
126140144|NCT03183128|453802948|FG000|Overall Study|Lost to Follow-up|1|||
126140145|NCT03183128|453802949|FG001|Overall Study|Lost to Follow-up|0|||
126140146|NCT03183128|453802948|FG000|Overall Study|Death|2|||
126140147|NCT03183128|453802949|FG001|Overall Study|Death|0|||
126140148|NCT03183128|453802948|FG000|Overall Study|Physician Decision|1|||
126140149|NCT03183128|453802949|FG001|Overall Study|Physician Decision|0|||
126140150|NCT00330187|453802952|FG000|Overall Study|Lost to Follow-up|12|||
126140151|NCT00330187|453802953|FG001|Overall Study|Lost to Follow-up|13|||
126140152|NCT00330187|453802954|FG002|Overall Study|Lost to Follow-up|14|||
126140153|NCT00330187|453802955|FG003|Overall Study|Lost to Follow-up|10|||
126140154|NCT00330187|453802952|FG000|Overall Study|Withdrawal by Subject|8|||
126140155|NCT00330187|453802953|FG001|Overall Study|Withdrawal by Subject|5|||
126140156|NCT00330187|453802954|FG002|Overall Study|Withdrawal by Subject|4|||
126140157|NCT00330187|453802955|FG003|Overall Study|Withdrawal by Subject|4|||
126140158|NCT03258814|453802958|FG000|Overall Study|Early Termination|4|||
126140159|NCT03258814|453802959|FG001|Overall Study|Early Termination|3|||
126140160|NCT03258814|453802960|FG002|Overall Study|Early Termination|10|||
126140161|NCT01413958|453802961|FG000|Overall Study|Lost to Follow-up|0|||
126140162|NCT01413958|453802962|FG001|Overall Study|Lost to Follow-up|1|||
126140163|NCT01900002|453802963|FG000|Overall Study|Withdrawal by Subject|2|||
126140164|NCT01900002|453802963|FG000|Overall Study|ineligible for Y-90|4|||
126140165|NCT00364182|453802970|FG000|First Intervention|Secondary prophylaxis|1|||
126140166|NCT00364182|453802971|FG001|First Intervention|Secondary prophylaxis|0|||
126140167|NCT00364182|453802972|FG002|First Intervention|Secondary prophylaxis|0|||
126140168|NCT00364182|453802970|FG000|First Intervention|Withdrawal by Subject|2|||
126140169|NCT00364182|453802971|FG001|First Intervention|Withdrawal by Subject|0|||
126140170|NCT00364182|453802972|FG002|First Intervention|Withdrawal by Subject|0|||
126140171|NCT00364182|453802970|FG000|Second Intervention|non-compliance|0|||
126140172|NCT00364182|453802971|FG001|Second Intervention|non-compliance|1|||
126140173|NCT00364182|453802972|FG002|Second Intervention|non-compliance|1|||
126140174|NCT00364182|453802970|FG000|Second Intervention|Protocol Violation|0|||
126140175|NCT00364182|453802971|FG001|Second Intervention|Protocol Violation|1|||
126140176|NCT00364182|453802972|FG002|Second Intervention|Protocol Violation|0|||
126140177|NCT00364182|453802970|FG000|Second Intervention|Adverse Event|0|||
126140178|NCT00364182|453802971|FG001|Second Intervention|Adverse Event|0|||
126140179|NCT00364182|453802972|FG002|Second Intervention|Adverse Event|1|||
126140180|NCT00364182|453802970|FG000|Third Intervention|non-compliance|0|||
126140181|NCT00364182|453802971|FG001|Third Intervention|non-compliance|1|||
126140182|NCT00364182|453802972|FG002|Third Intervention|non-compliance|0|||
126140183|NCT00364182|453802970|FG000|Third Intervention|Lost to Follow-up|0|||
126140184|NCT00364182|453802971|FG001|Third Intervention|Lost to Follow-up|0|||
126140185|NCT00364182|453802972|FG002|Third Intervention|Lost to Follow-up|1|||
126140186|NCT02601573|453802976|FG000|Overall Study|Lost to Follow-up|0|||
126140187|NCT02601573|453802977|FG001|Overall Study|Lost to Follow-up|3|||
126140188|NCT02601573|453802978|FG002|Overall Study|Lost to Follow-up|1|||
126140189|NCT02601573|453802979|FG003|Overall Study|Lost to Follow-up|0|||
126140190|NCT02601573|453802980|FG004|Overall Study|Lost to Follow-up|2|||
126140191|NCT02601573|453802976|FG000|Overall Study|Withdrawal by Subject|0|||
126140192|NCT02601573|453802977|FG001|Overall Study|Withdrawal by Subject|1|||
126140193|NCT02601573|453802978|FG002|Overall Study|Withdrawal by Subject|0|||
126140194|NCT02601573|453802979|FG003|Overall Study|Withdrawal by Subject|1|||
126140195|NCT02601573|453802980|FG004|Overall Study|Withdrawal by Subject|0|||
126140196|NCT00974220|453802981|FG000|Treatment Period 1|Adverse Event|2|||
126140197|NCT00974220|453802982|FG001|Treatment Period 1|Adverse Event|1|||
126140198|NCT00974220|453802981|FG000|Treatment Period 1|noncompliant subjects|0|||
126140199|NCT00974220|453802982|FG001|Treatment Period 1|noncompliant subjects|1|||
126140200|NCT02921425|453802983|FG000|Overall Study|Protocol Violation|9|||
126140201|NCT03403400|453802984|FG000|Overall Study|Lost to Follow-up|1|||
126140202|NCT03403400|453802985|FG001|Overall Study|Lost to Follow-up|0|||
126140203|NCT03403400|453802986|FG002|Overall Study|Lost to Follow-up|1|||
126140204|NCT03403400|453802984|FG000|Overall Study|Hospitalization|1|||
125968467|NCT00823719|453175805|FG000|Overall Study|Withdrawal by Subject|0|||
125968468|NCT00823719|453175806|FG001|Overall Study|Withdrawal by Subject|1|||
125968469|NCT00823719|453175805|FG000|Overall Study|Disease Progression|4|||
125968470|NCT00823719|453175806|FG001|Overall Study|Disease Progression|4|||
125968471|NCT00455195|453175807|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
125968472|NCT00455195|453175808|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
125968473|NCT00455195|453175807|FG000|Double-blind Study AGLU02704|Death|1|||
125968474|NCT00455195|453175808|FG001|Double-blind Study AGLU02704|Death|0|||
125968475|NCT00455195|453175807|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
125968476|NCT00455195|453175808|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
125968477|NCT00455195|453175807|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
125968478|NCT00455195|453175808|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
125968479|NCT02117570|453175809|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
125968480|NCT02117570|453175810|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
125968481|NCT02117570|453175811|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
125968482|NCT02117570|453175809|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
126140205|NCT03403400|453802985|FG001|Overall Study|Hospitalization|0|||
126140206|NCT03403400|453802986|FG002|Overall Study|Hospitalization|0|||
126140207|NCT03403400|453802984|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
126140208|NCT03403400|453802985|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
126140209|NCT03403400|453802986|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
126140210|NCT01384292|453802990|FG000|Part B|Severe non-compliance to protocol|1|||
126140211|NCT01384292|453802991|FG001|Part B|Severe non-compliance to protocol|0|||
126140212|NCT01384292|453802992|FG002|Part B|Severe non-compliance to protocol|0|||
126140213|NCT01171612|453802993|FG000|Overall Study|Lost to Follow-up|51|||
126140214|NCT00243659|453802994|FG000|Overall Study|Withdrawal by Subject|1|||
126140215|NCT00243659|453802995|FG001|Overall Study|Withdrawal by Subject|1|||
126140216|NCT00243659|453802994|FG000|Overall Study|Protocol Violation|1|||
126140217|NCT00243659|453802995|FG001|Overall Study|Protocol Violation|2|||
126140218|NCT03310970|453802996|FG000|Overall Study|Withdrawal by Subject|0|||
126140219|NCT03310970|453802997|FG001|Overall Study|Withdrawal by Subject|1|||
126140220|NCT01273064|453802998|FG000|Overall Study|Adverse Event|5|||
126140221|NCT01273064|453802999|FG001|Overall Study|Adverse Event|1|||
126140222|NCT01273064|453803000|FG002|Overall Study|Adverse Event|3|||
126140223|NCT01273064|453803001|FG003|Overall Study|Adverse Event|2|||
126140224|NCT01273064|453803002|FG004|Overall Study|Adverse Event|1|||
126140225|NCT01273064|453802998|FG000|Overall Study|Withdrawal by Subject|4|||
126140226|NCT01273064|453802999|FG001|Overall Study|Withdrawal by Subject|2|||
126140227|NCT01273064|453803000|FG002|Overall Study|Withdrawal by Subject|2|||
126140228|NCT01273064|453803001|FG003|Overall Study|Withdrawal by Subject|2|||
126140229|NCT01273064|453803002|FG004|Overall Study|Withdrawal by Subject|0|||
126140230|NCT01273064|453802998|FG000|Overall Study|Study Termination|13|||
126140231|NCT01273064|453802999|FG001|Overall Study|Study Termination|27|||
126140232|NCT01273064|453803000|FG002|Overall Study|Study Termination|26|||
126140233|NCT01273064|453803001|FG003|Overall Study|Study Termination|16|||
126140234|NCT01273064|453803002|FG004|Overall Study|Study Termination|8|||
126140235|NCT01273064|453802998|FG000|Overall Study|Lost to Follow-up|1|||
126140236|NCT01273064|453802999|FG001|Overall Study|Lost to Follow-up|0|||
126140237|NCT01273064|453803000|FG002|Overall Study|Lost to Follow-up|0|||
126140238|NCT01273064|453803001|FG003|Overall Study|Lost to Follow-up|0|||
126140239|NCT01273064|453803002|FG004|Overall Study|Lost to Follow-up|0|||
126140240|NCT01273064|453802998|FG000|Overall Study|Physician Decision|0|||
126140241|NCT01273064|453802999|FG001|Overall Study|Physician Decision|0|||
126140242|NCT01273064|453803000|FG002|Overall Study|Physician Decision|0|||
126140243|NCT01273064|453803001|FG003|Overall Study|Physician Decision|0|||
126140244|NCT01273064|453803002|FG004|Overall Study|Physician Decision|1|||
126140245|NCT04062214|453803003|FG000|Week 12|Death|1|||
126140246|NCT04062214|453803004|FG001|Week 12|Death|1|||
126140247|NCT04062214|453803003|FG000|Week 12|Withdrawal by Subject|14|||
126140248|NCT04062214|453803004|FG001|Week 12|Withdrawal by Subject|13|||
126140249|NCT04062214|453803003|FG000|Week 12|Lost to Follow-up|55|||
125968483|NCT02117570|453175810|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
125968484|NCT02117570|453175811|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
126140250|NCT04062214|453803004|FG001|Week 12|Lost to Follow-up|68|||
126140251|NCT04062214|453803003|FG000|Week 12|Intermittent missing|31|||
126140252|NCT04062214|453803004|FG001|Week 12|Intermittent missing|29|||
126140253|NCT04062214|453803003|FG000|Week 36|Withdrawal by Subject|4|||
126140254|NCT04062214|453803004|FG001|Week 36|Withdrawal by Subject|5|||
126140255|NCT04062214|453803003|FG000|Week 36|Lost to Follow-up|50|||
126140256|NCT04062214|453803004|FG001|Week 36|Lost to Follow-up|46|||
126140257|NCT04062214|453803003|FG000|Week 36|Death|0|||
126140258|NCT04062214|453803004|FG001|Week 36|Death|1|||
126140259|NCT00291551|453803005|FG000|Overall Study|Death|7|||
126140260|NCT00291551|453803005|FG000|Overall Study|Withdrawal by Subject|6|||
126140261|NCT04666038|453803006|FG000|Overall Study|Progressive Disease|2|||
126140262|NCT04666038|453803007|FG001|Overall Study|Progressive Disease|0|||
126140263|NCT04666038|453803006|FG000|Overall Study|Death|38|||
126140264|NCT04666038|453803007|FG001|Overall Study|Death|32|||
126140265|NCT04666038|453803006|FG000|Overall Study|Withdrawal by Subject|10|||
126140266|NCT04666038|453803007|FG001|Overall Study|Withdrawal by Subject|19|||
126140267|NCT04666038|453803006|FG000|Overall Study|Lost to Follow-up|0|||
126140268|NCT04666038|453803007|FG001|Overall Study|Lost to Follow-up|2|||
126140269|NCT04666038|453803006|FG000|Overall Study|On Study Treatment|46|||
126140270|NCT04666038|453803007|FG001|Overall Study|On Study Treatment|5|||
126140271|NCT04666038|453803006|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
126140272|NCT04666038|453803007|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
126140273|NCT03887130|453803012|FG000|Overall Study|Progressive disease|23|||
126140274|NCT03887130|453803013|FG001|Overall Study|Progressive disease|14|||
126140275|NCT03887130|453803014|FG002|Overall Study|Progressive disease|7|||
126140276|NCT03887130|453803012|FG000|Overall Study|Protocol Violation|3|||
126140277|NCT03887130|453803013|FG001|Overall Study|Protocol Violation|1|||
126140278|NCT03887130|453803014|FG002|Overall Study|Protocol Violation|2|||
126140279|NCT03887130|453803012|FG000|Overall Study|Drug related toxicity|7|||
126140280|NCT03887130|453803013|FG001|Overall Study|Drug related toxicity|7|||
126140281|NCT03887130|453803014|FG002|Overall Study|Drug related toxicity|13|||
126140282|NCT03887130|453803012|FG000|Overall Study|Non drug related toxicity|3|||
126140283|NCT03887130|453803013|FG001|Overall Study|Non drug related toxicity|0|||
126140284|NCT03887130|453803014|FG002|Overall Study|Non drug related toxicity|0|||
126140285|NCT03887130|453803012|FG000|Overall Study|Death|2|||
126140286|NCT03887130|453803013|FG001|Overall Study|Death|2|||
126140287|NCT03887130|453803014|FG002|Overall Study|Death|1|||
126140288|NCT03887130|453803012|FG000|Overall Study|Withdrawal by Subject|7|||
126140289|NCT03887130|453803013|FG001|Overall Study|Withdrawal by Subject|6|||
126140290|NCT03887130|453803014|FG002|Overall Study|Withdrawal by Subject|11|||
126140291|NCT03887130|453803012|FG000|Overall Study|other reason|6|||
126140292|NCT03887130|453803013|FG001|Overall Study|other reason|20|||
126140293|NCT03887130|453803014|FG002|Overall Study|other reason|17|||
126140294|NCT04082663|453803015|FG000|Overall Study|Adverse Event|6|||
126140295|NCT04082663|453803015|FG000|Overall Study|Lost to Follow-up|1|||
126140296|NCT00705263|453803016|FG000|Overall Study|Withdrawal by Subject|2|||
126140297|NCT01752023|453803017|FG000|Overall Study|Physician Decision|2|||
126140298|NCT01752023|453803018|FG001|Overall Study|Physician Decision|1|||
126140299|NCT02899156|453803019|FG000|Overall Study|Death|1|||
126140300|NCT02899156|453803020|FG001|Overall Study|Death|0|||
126140301|NCT02899156|453803019|FG000|Overall Study|Physician Decision|0|||
125968485|NCT02117570|453175809|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
125968486|NCT02117570|453175810|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
125968487|NCT02117570|453175811|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
125968488|NCT02117570|453175809|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
125968489|NCT02117570|453175810|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
125968490|NCT02117570|453175811|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
125968491|NCT02117570|453175809|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
125968492|NCT02117570|453175810|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
125968493|NCT02117570|453175811|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
125968494|NCT02117570|453175809|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
125968495|NCT02117570|453175810|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
125968496|NCT02117570|453175811|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
125968497|NCT02117570|453175809|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
125968498|NCT02117570|453175810|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
125968499|NCT02117570|453175811|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
126140302|NCT02899156|453803020|FG001|Overall Study|Physician Decision|1|||
125968500|NCT03701555|453175812|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
125968501|NCT03701555|453175813|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
126140303|NCT00787787|453803024|FG000|Overall Study|Lack of Efficacy|4|||
126140304|NCT00787787|453803024|FG000|Overall Study|Adverse Event|3|||
126140305|NCT01412957|453803025|FG000|Overall Study|Withdrawal by Subject|6|||
126140306|NCT01412957|453803026|FG001|Overall Study|Withdrawal by Subject|22|||
126140307|NCT01412957|453803025|FG000|Overall Study|Lost to Follow-up|7|||
126140308|NCT01412957|453803026|FG001|Overall Study|Lost to Follow-up|2|||
126140309|NCT01412957|453803025|FG000|Overall Study|Death|136|||
126140310|NCT01412957|453803026|FG001|Overall Study|Death|133|||
126140311|NCT04722991|453803027|FG000|Overall Study|Adverse Event|12|||
126140312|NCT04722991|453803028|FG001|Overall Study|Adverse Event|4|||
126140313|NCT04722991|453803027|FG000|Overall Study|Death|2|||
126140314|NCT04722991|453803028|FG001|Overall Study|Death|0|||
126140315|NCT04722991|453803027|FG000|Overall Study|Lost to Follow-up|1|||
126140316|NCT04722991|453803028|FG001|Overall Study|Lost to Follow-up|1|||
126140317|NCT04722991|453803027|FG000|Overall Study|Withdrawal cirterion met|2|||
126140318|NCT04722991|453803028|FG001|Overall Study|Withdrawal cirterion met|2|||
126140319|NCT04722991|453803027|FG000|Overall Study|Other|1|||
126140320|NCT04722991|453803028|FG001|Overall Study|Other|0|||
126140321|NCT04722991|453803027|FG000|Overall Study|Non-compliance|0|||
126140322|NCT04722991|453803028|FG001|Overall Study|Non-compliance|1|||
126140323|NCT04722991|453803027|FG000|Overall Study|Withdrawal by Subject|0|||
126140324|NCT04722991|453803028|FG001|Overall Study|Withdrawal by Subject|1|||
126140325|NCT02246621|453803031|FG000|Overall Study|Withdrawal by Subject|28|||
126140326|NCT02246621|453803032|FG001|Overall Study|Withdrawal by Subject|16|||
126140327|NCT02246621|453803031|FG000|Overall Study|Lost to Follow-up|1|||
126140328|NCT02246621|453803032|FG001|Overall Study|Lost to Follow-up|0|||
126140329|NCT02246621|453803031|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
126140330|NCT02246621|453803032|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
126140331|NCT01583374|453803033|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
126140332|NCT01583374|453803034|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
126140333|NCT01583374|453803035|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
126140334|NCT01583374|453803036|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126140335|NCT01583374|453803037|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126140336|NCT01583374|453803038|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126140337|NCT01583374|453803039|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126140338|NCT01583374|453803040|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126140339|NCT01583374|453803041|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126140340|NCT01583374|453803033|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
126140341|NCT01583374|453803034|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
126140342|NCT01583374|453803035|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
126140343|NCT01583374|453803036|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126140344|NCT01583374|453803037|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126140345|NCT01583374|453803038|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126140346|NCT01583374|453803039|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126140347|NCT01583374|453803040|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126140348|NCT01583374|453803041|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126140349|NCT01583374|453803033|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
126140350|NCT01583374|453803034|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
126140351|NCT01583374|453803035|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126140352|NCT01583374|453803036|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126140353|NCT01583374|453803037|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126140354|NCT01583374|453803038|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126140355|NCT01583374|453803039|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126140356|NCT01583374|453803040|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126140357|NCT01583374|453803041|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126140358|NCT01583374|453803033|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
126140359|NCT01583374|453803034|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
126140360|NCT01583374|453803035|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
126140361|NCT01583374|453803036|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126140362|NCT01583374|453803037|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126140363|NCT01583374|453803038|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126140364|NCT01583374|453803039|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126140365|NCT01583374|453803040|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126140366|NCT01583374|453803041|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125968502|NCT03701555|453175814|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
125968503|NCT03701555|453175815|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
125968504|NCT03701555|453175816|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
125968505|NCT03701555|453175817|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
125968506|NCT03701555|453175818|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
125968507|NCT03701555|453175819|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
125968508|NCT03701555|453175820|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
125968509|NCT03701555|453175821|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
125968510|NCT03701555|453175822|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
125968511|NCT03701555|453175823|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
125968512|NCT03701555|453175824|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
125968513|NCT03701555|453175825|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
125968514|NCT03701555|453175826|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
125968515|NCT03701555|453175827|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
125968516|NCT03701555|453175828|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
125968517|NCT03701555|453175829|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
125968518|NCT03701555|453175830|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
125968519|NCT03701555|453175831|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
125968520|NCT03701555|453175832|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
125968521|NCT03701555|453175833|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
125968522|NCT03701555|453175834|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
125968523|NCT03701555|453175835|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
125968524|NCT03701555|453175836|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
125968525|NCT03701555|453175837|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
125968526|NCT03701555|453175838|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
125968527|NCT03701555|453175839|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
125968528|NCT03701555|453175840|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
126140367|NCT01583374|453803033|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
126140368|NCT01583374|453803034|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
126140369|NCT01583374|453803035|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126140370|NCT01583374|453803036|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126140371|NCT01583374|453803037|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126140372|NCT01583374|453803038|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126140373|NCT01583374|453803039|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126140374|NCT01583374|453803040|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126140375|NCT01583374|453803041|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126140376|NCT01583374|453803033|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126140377|NCT01583374|453803034|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126140378|NCT01583374|453803035|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
126140379|NCT01583374|453803036|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126140380|NCT01583374|453803037|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126140381|NCT01583374|453803038|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126140382|NCT01583374|453803039|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126140383|NCT01583374|453803040|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126140384|NCT01583374|453803041|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126140385|NCT01583374|453803033|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
126140386|NCT01583374|453803034|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
126140387|NCT01583374|453803035|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
126140388|NCT01583374|453803036|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
126140389|NCT01583374|453803037|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
126140390|NCT01583374|453803038|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
126140391|NCT01583374|453803039|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
126140392|NCT01583374|453803040|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
126140393|NCT01583374|453803041|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
126140394|NCT01583374|453803033|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126140395|NCT01583374|453803034|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126140396|NCT01583374|453803035|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126140397|NCT01583374|453803036|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126140398|NCT01583374|453803037|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126140399|NCT01583374|453803038|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126140400|NCT01583374|453803039|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126140401|NCT01583374|453803040|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
126140402|NCT01583374|453803041|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126140403|NCT01583374|453803033|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
126140404|NCT01583374|453803034|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126140405|NCT01583374|453803035|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
126140406|NCT01583374|453803036|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
126140407|NCT01583374|453803037|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126140408|NCT01583374|453803038|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126140409|NCT01583374|453803039|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
126140410|NCT01583374|453803040|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126140411|NCT01583374|453803041|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
126140412|NCT01583374|453803033|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
126140413|NCT01583374|453803034|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
126140414|NCT01583374|453803035|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
126140415|NCT01583374|453803036|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
126140416|NCT01583374|453803037|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
126140417|NCT01583374|453803038|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
126140418|NCT01583374|453803039|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
126140419|NCT01583374|453803040|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
126140420|NCT01583374|453803041|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
125968529|NCT03701555|453175841|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
125968530|NCT03701555|453175842|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
125968531|NCT03701555|453175843|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
125968532|NCT03701555|453175844|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
126140421|NCT01583374|453803033|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126140422|NCT01583374|453803034|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
126140423|NCT01583374|453803035|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
126140424|NCT01583374|453803036|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126140425|NCT01583374|453803037|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
126140426|NCT01583374|453803038|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126140427|NCT01583374|453803039|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126140428|NCT01583374|453803040|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126140429|NCT01583374|453803041|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126140430|NCT01583374|453803033|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126140431|NCT01583374|453803034|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126140432|NCT01583374|453803035|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
126140433|NCT01583374|453803036|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126140434|NCT01583374|453803037|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
126140435|NCT01583374|453803038|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
126140436|NCT01583374|453803039|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126140437|NCT01583374|453803040|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126140438|NCT01583374|453803041|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126140439|NCT01583374|453803033|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
126140440|NCT01583374|453803034|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
126140441|NCT01583374|453803035|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
126140442|NCT01583374|453803036|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
126140443|NCT01583374|453803037|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
126140444|NCT01583374|453803038|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
126140445|NCT01583374|453803039|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
126140446|NCT01583374|453803040|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
126140447|NCT01583374|453803041|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
126140448|NCT01583374|453803033|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
126140449|NCT01583374|453803034|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
126140450|NCT01583374|453803035|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
126140451|NCT01583374|453803036|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
126140452|NCT01583374|453803037|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
126140453|NCT01583374|453803038|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
126140454|NCT01583374|453803039|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
126140455|NCT01583374|453803040|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
126140456|NCT01583374|453803041|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
126140457|NCT01583374|453803033|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126140458|NCT01583374|453803034|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126140459|NCT01583374|453803035|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126140460|NCT01583374|453803036|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126140461|NCT01583374|453803037|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
126140462|NCT01583374|453803038|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126140463|NCT01583374|453803039|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126140464|NCT01583374|453803040|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
126140465|NCT01583374|453803041|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
126140466|NCT01583374|453803033|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
126140467|NCT01583374|453803034|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
126140468|NCT01583374|453803035|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
126140469|NCT01583374|453803036|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
126140470|NCT01583374|453803037|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
126140471|NCT01583374|453803038|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
126140472|NCT01583374|453803039|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
126140473|NCT01583374|453803040|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
126140474|NCT01583374|453803041|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
126140475|NCT01583374|453803033|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
126140476|NCT01583374|453803034|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
126140477|NCT01583374|453803035|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
126140478|NCT01583374|453803036|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
126140479|NCT01583374|453803037|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
126140480|NCT01583374|453803038|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
126140481|NCT01583374|453803039|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
125968533|NCT03701555|453175845|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
125968534|NCT03701555|453175846|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
125968535|NCT03701555|453175847|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
126140482|NCT01583374|453803040|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
126140483|NCT01583374|453803041|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
126140484|NCT01583374|453803033|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126140485|NCT01583374|453803034|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
126140486|NCT01583374|453803035|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126140487|NCT01583374|453803036|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
126140488|NCT01583374|453803037|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
126140489|NCT01583374|453803038|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126140490|NCT01583374|453803039|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
126140491|NCT01583374|453803040|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126140492|NCT01583374|453803041|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126140493|NCT01583374|453803033|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
126140494|NCT01583374|453803034|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
126140495|NCT01583374|453803035|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
126140496|NCT01583374|453803036|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
126140497|NCT01583374|453803037|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
126140498|NCT01583374|453803038|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
126140499|NCT01583374|453803039|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
126140500|NCT01583374|453803040|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
126140501|NCT01583374|453803041|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
126140502|NCT02591615|453805038|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
126140503|NCT02591615|453805039|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
126140504|NCT02591615|453805040|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
126140505|NCT02591615|453805041|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
126140506|NCT02591615|453805038|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
126140507|NCT02591615|453805039|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
126140508|NCT02591615|453805040|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
126140509|NCT02591615|453805041|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
126140510|NCT02591615|453805038|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
126140511|NCT02591615|453805039|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
126140512|NCT02591615|453805040|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
126140513|NCT02591615|453805041|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
126140514|NCT02591615|453805038|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
126140515|NCT02591615|453805039|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
126140516|NCT02591615|453805040|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
126140517|NCT02591615|453805041|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
126140518|NCT02591615|453805038|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
126140519|NCT02591615|453805039|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
126140520|NCT02591615|453805040|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
126140521|NCT02591615|453805041|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
126140522|NCT02591615|453805038|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
126140523|NCT02591615|453805039|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
126140524|NCT02591615|453805040|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
126140525|NCT02591615|453805041|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
126140526|NCT02591615|453805038|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
126140527|NCT02591615|453805039|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
126140528|NCT02591615|453805040|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
126140529|NCT02591615|453805041|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
126140530|NCT02591615|453805038|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
126140531|NCT02591615|453805039|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
126140532|NCT02591615|453805040|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
126140533|NCT02591615|453805041|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
126140534|NCT02591615|453805038|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
126140535|NCT02591615|453805039|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
126140536|NCT02591615|453805040|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
126140537|NCT02591615|453805041|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
126140538|NCT02591615|453805038|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
126140539|NCT02591615|453805039|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
126140540|NCT02591615|453805040|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
126140541|NCT02591615|453805041|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
126140542|NCT02591615|453805038|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
126140543|NCT02591615|453805039|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
126140544|NCT02591615|453805040|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
126140545|NCT02591615|453805041|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
126140546|NCT02591615|453805038|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
126140547|NCT02591615|453805039|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
126140548|NCT02591615|453805040|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
126140549|NCT02591615|453805041|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
126140550|NCT02591615|453805038|FG000|Maintenance MK-3475|Adverse Event|0|||
126140551|NCT02591615|453805039|FG001|Maintenance MK-3475|Adverse Event|3|||
126140552|NCT02591615|453805040|FG002|Maintenance MK-3475|Adverse Event|1|||
126140553|NCT02591615|453805041|FG003|Maintenance MK-3475|Adverse Event|2|||
126140554|NCT02591615|453805038|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
126140555|NCT02591615|453805039|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
126140556|NCT02591615|453805040|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
126140557|NCT02591615|453805041|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
125968536|NCT03701555|453175812|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
125968537|NCT03701555|453175813|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
125968538|NCT03701555|453175814|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
125968539|NCT03701555|453175815|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
125968540|NCT03701555|453175816|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
125968541|NCT03701555|453175817|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
125968542|NCT03701555|453175818|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
126140558|NCT02591615|453805038|FG000|Maintenance MK-3475|Death|0|||
126140559|NCT02591615|453805039|FG001|Maintenance MK-3475|Death|1|||
126140560|NCT02591615|453805040|FG002|Maintenance MK-3475|Death|1|||
126140561|NCT02591615|453805041|FG003|Maintenance MK-3475|Death|0|||
126140562|NCT02591615|453805038|FG000|Maintenance MK-3475|Physician discretion|0|||
126140563|NCT02591615|453805039|FG001|Maintenance MK-3475|Physician discretion|0|||
126140564|NCT02591615|453805040|FG002|Maintenance MK-3475|Physician discretion|1|||
126140565|NCT02591615|453805041|FG003|Maintenance MK-3475|Physician discretion|0|||
126140566|NCT02591615|453805038|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
126140567|NCT02591615|453805039|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
126140568|NCT02591615|453805040|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
126140569|NCT02591615|453805041|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
126140570|NCT02591615|453805038|FG000|Maintenance MK-3475|In active treatment|2|||
126140571|NCT02591615|453805039|FG001|Maintenance MK-3475|In active treatment|0|||
126140572|NCT02591615|453805040|FG002|Maintenance MK-3475|In active treatment|0|||
126140573|NCT02591615|453805041|FG003|Maintenance MK-3475|In active treatment|1|||
126140574|NCT04188197|453805042|FG000|Overall Study|Lost to Follow-up|4|||
126140575|NCT04188197|453805043|FG001|Overall Study|Lost to Follow-up|1|||
126140576|NCT04188197|453805042|FG000|Overall Study|Withdrawal by Subject|1|||
126140577|NCT04188197|453805043|FG001|Overall Study|Withdrawal by Subject|1|||
126140578|NCT04188197|453805042|FG000|Overall Study|Pregnancy|0|||
126140579|NCT04188197|453805043|FG001|Overall Study|Pregnancy|1|||
126140580|NCT02107703|453805044|FG000|Overall Study|Withdrawal by Subject|46|||
126140581|NCT02107703|453805045|FG001|Overall Study|Withdrawal by Subject|21|||
126140582|NCT02107703|453805044|FG000|Overall Study|Lost to Follow-up|20|||
126140583|NCT02107703|453805045|FG001|Overall Study|Lost to Follow-up|9|||
126140584|NCT02107703|453805044|FG000|Overall Study|On study treatment/follow up|48|||
126140585|NCT02107703|453805045|FG001|Overall Study|On study treatment/follow up|5|||
126140586|NCT04574999|453805046|FG000|Overall Study|Adverse Event|1|||
126140587|NCT04574999|453805047|FG001|Overall Study|Adverse Event|0|||
126140588|NCT04574999|453805046|FG000|Overall Study|Lack of Efficacy|2|||
126140589|NCT04574999|453805047|FG001|Overall Study|Lack of Efficacy|3|||
126140590|NCT04574999|453805046|FG000|Overall Study|Protocol Violation|1|||
126140591|NCT04574999|453805047|FG001|Overall Study|Protocol Violation|0|||
126140592|NCT04574999|453805046|FG000|Overall Study|Withdrawal by Subject|2|||
126140593|NCT04574999|453805047|FG001|Overall Study|Withdrawal by Subject|2|||
126140594|NCT04574999|453805046|FG000|Overall Study|Lost to Follow-up|1|||
126140595|NCT04574999|453805047|FG001|Overall Study|Lost to Follow-up|0|||
126140596|NCT04574999|453805046|FG000|Overall Study|Personal problems|1|||
126140597|NCT04574999|453805047|FG001|Overall Study|Personal problems|0|||
126140598|NCT04574999|453805046|FG000|Overall Study|Previous planned surgery|1|||
126140599|NCT04574999|453805047|FG001|Overall Study|Previous planned surgery|0|||
126140600|NCT00008385|453805065|FG000|Overall Study|Off treatment reasons not reported|79|||
126140601|NCT00008385|453805066|FG001|Overall Study|Off treatment reasons not reported|70|||
125968543|NCT03701555|453175819|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
125968544|NCT03701555|453175820|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
125968545|NCT03701555|453175821|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
126140602|NCT00008385|453805065|FG000|Overall Study|Progressive disease|52|||
126140603|NCT00008385|453805066|FG001|Overall Study|Progressive disease|117|||
126140604|NCT00008385|453805065|FG000|Overall Study|Adverse Event|8|||
126140605|NCT00008385|453805066|FG001|Overall Study|Adverse Event|20|||
126140606|NCT00008385|453805065|FG000|Overall Study|Death|12|||
126140607|NCT00008385|453805066|FG001|Overall Study|Death|18|||
126140608|NCT00008385|453805065|FG000|Overall Study|Withdrawal by Subject|67|||
126140609|NCT00008385|453805066|FG001|Overall Study|Withdrawal by Subject|157|||
126140610|NCT00008385|453805065|FG000|Overall Study|Start non-protocol therapy|3|||
126140611|NCT00008385|453805066|FG001|Overall Study|Start non-protocol therapy|1|||
126140612|NCT00008385|453805065|FG000|Overall Study|Other complicating disease|17|||
126140613|NCT00008385|453805066|FG001|Overall Study|Other complicating disease|30|||
126140614|NCT00008385|453805065|FG000|Overall Study|Maximum dose reached|0|||
126140615|NCT00008385|453805066|FG001|Overall Study|Maximum dose reached|2|||
126140616|NCT00008385|453805065|FG000|Overall Study|Other|105|||
126140617|NCT00008385|453805066|FG001|Overall Study|Other|212|||
126140618|NCT00008385|453805065|FG000|Overall Study|Not start protocol therapy|44|||
126140619|NCT00008385|453805066|FG001|Overall Study|Not start protocol therapy|175|||
126140620|NCT00398112|453805067|FG000|Overall Study|Adverse Event|4|||
126140621|NCT00398112|453805067|FG000|Overall Study|Disease progression|9|||
126140622|NCT00398112|453805067|FG000|Overall Study|Alternative treatment|1|||
126140623|NCT00398112|453805067|FG000|Overall Study|Withdrawal by Subject|3|||
126140624|NCT00398112|453805067|FG000|Overall Study|Death|1|||
126140625|NCT00365989|453805070|FG000|Overall Study|Withdrawal by Subject|1|||
126140626|NCT00365989|453805070|FG000|Overall Study|Non-compliance|1|||
126140627|NCT02318095|453805071|FG000|Overall Study|Adverse Event|1|||
126140628|NCT00686127|453805072|FG000|Overall Study|Withdrawal by Subject|14|||
126140629|NCT00686127|453805073|FG001|Overall Study|Withdrawal by Subject|6|||
126140630|NCT06441877|453805074|FG000|Overall Study|Withdrawal by Subject|0|||
126140631|NCT06441877|453805075|FG001|Overall Study|Withdrawal by Subject|2|||
126140632|NCT06441877|453805076|FG002|Overall Study|Withdrawal by Subject|0|||
126140633|NCT06441877|453805077|FG003|Overall Study|Withdrawal by Subject|0|||
126140634|NCT00066690|453805078|FG000|Overall Study|Adverse Event|145|||
126140635|NCT00066690|453805079|FG001|Overall Study|Adverse Event|58|||
126140636|NCT00066690|453805080|FG002|Overall Study|Adverse Event|126|||
126140637|NCT00066690|453805078|FG000|Overall Study|Death|3|||
126140638|NCT00066690|453805079|FG001|Overall Study|Death|0|||
126140639|NCT00066690|453805080|FG002|Overall Study|Death|2|||
126140640|NCT00066690|453805078|FG000|Overall Study|Lack of Efficacy|114|||
126140641|NCT00066690|453805079|FG001|Overall Study|Lack of Efficacy|110|||
126140642|NCT00066690|453805080|FG002|Overall Study|Lack of Efficacy|76|||
126140643|NCT00066690|453805078|FG000|Overall Study|Lost to Follow-up|40|||
126140644|NCT00066690|453805079|FG001|Overall Study|Lost to Follow-up|21|||
126140645|NCT00066690|453805080|FG002|Overall Study|Lost to Follow-up|29|||
126140646|NCT00066690|453805078|FG000|Overall Study|Withdrawal by Subject|50|||
126140647|NCT00066690|453805079|FG001|Overall Study|Withdrawal by Subject|55|||
126140648|NCT00066690|453805080|FG002|Overall Study|Withdrawal by Subject|49|||
126140649|NCT00066690|453805078|FG000|Overall Study|Treatment Ongoing|246|||
126140650|NCT00066690|453805079|FG001|Overall Study|Treatment Ongoing|278|||
126140651|NCT00066690|453805080|FG002|Overall Study|Treatment Ongoing|282|||
126140652|NCT03706365|453805084|FG000|Overall Study|Lost to Follow-up|7|||
126140653|NCT03706365|453805085|FG001|Overall Study|Lost to Follow-up|0|||
126140654|NCT03706365|453805084|FG000|Overall Study|Withdrawal by Subject|17|||
126140655|NCT03706365|453805085|FG001|Overall Study|Withdrawal by Subject|15|||
126140656|NCT03706365|453805084|FG000|Overall Study|On Study Treatment|51|||
126140657|NCT03706365|453805085|FG001|Overall Study|On Study Treatment|51|||
126140658|NCT02162862|453805086|FG000|Overall Study|Lost to Follow-up|0|||
126140659|NCT02162862|453805087|FG001|Overall Study|Lost to Follow-up|11|||
126140660|NCT02162862|453805088|FG002|Overall Study|Lost to Follow-up|0|||
126140661|NCT02162862|453805086|FG000|Overall Study|Subject did not feel the med was needed|0|||
126140662|NCT02162862|453805087|FG001|Overall Study|Subject did not feel the med was needed|0|||
126140663|NCT02162862|453805088|FG002|Overall Study|Subject did not feel the med was needed|4|||
126140664|NCT03116113|453805089|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126140665|NCT03116113|453805090|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126140666|NCT03116113|453805091|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126140667|NCT03116113|453805092|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126140668|NCT03116113|453805093|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126140669|NCT03116113|453805094|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126140670|NCT03116113|453805095|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126140671|NCT03116113|453805096|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
126140672|NCT03116113|453805097|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
126140673|NCT02159807|453805098|FG000|Overall Study|Adverse Event|0|||
126140674|NCT02159807|453805099|FG001|Overall Study|Adverse Event|0|||
126140675|NCT02159807|453805100|FG002|Overall Study|Adverse Event|1|||
126140676|NCT02159807|453805098|FG000|Overall Study|No CSF|1|||
126140677|NCT02159807|453805099|FG001|Overall Study|No CSF|1|||
126140678|NCT02159807|453805100|FG002|Overall Study|No CSF|1|||
126140679|NCT02159807|453805098|FG000|Overall Study|elevated blood pressure|0|||
126140680|NCT02159807|453805099|FG001|Overall Study|elevated blood pressure|0|||
126140681|NCT02159807|453805100|FG002|Overall Study|elevated blood pressure|1|||
126140682|NCT05195528|453805102|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
126140683|NCT05195528|453805103|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
126140684|NCT05195528|453805104|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
126140685|NCT05195528|453805105|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
126140686|NCT05195528|453805106|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
126140687|NCT05195528|453805102|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
126151413|NCT00488631|453841980|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126140688|NCT05195528|453805103|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
126140689|NCT05195528|453805104|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
126140690|NCT05195528|453805105|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126140691|NCT05195528|453805106|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126140692|NCT05195528|453805102|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126140693|NCT05195528|453805103|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
126140694|NCT05195528|453805104|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
126140695|NCT05195528|453805105|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126140696|NCT05195528|453805106|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126140697|NCT05195528|453805102|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
126140698|NCT05195528|453805103|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
126140699|NCT05195528|453805104|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
126140700|NCT05195528|453805105|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
126140701|NCT05195528|453805106|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
126140702|NCT05195528|453805102|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
126140703|NCT05195528|453805103|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
126140704|NCT05195528|453805104|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
126140705|NCT05195528|453805105|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
126140706|NCT05195528|453805106|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
126140707|NCT05195528|453805102|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
126140708|NCT05195528|453805103|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
126140709|NCT05195528|453805104|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
126140710|NCT05195528|453805105|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
126140711|NCT05195528|453805106|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
126140712|NCT05195528|453805102|FG000|Placebo-controlled Treatment Period|Other|0|||
126140713|NCT05195528|453805103|FG001|Placebo-controlled Treatment Period|Other|0|||
126140714|NCT05195528|453805104|FG002|Placebo-controlled Treatment Period|Other|1|||
126140715|NCT05195528|453805105|FG003|Placebo-controlled Treatment Period|Other|0|||
126140716|NCT05195528|453805106|FG004|Placebo-controlled Treatment Period|Other|0|||
126140717|NCT05195528|453805102|FG000|Extension Period|PTE or AE or SAE|0|||
126140718|NCT05195528|453805103|FG001|Extension Period|PTE or AE or SAE|4|||
126140719|NCT05195528|453805104|FG002|Extension Period|PTE or AE or SAE|5|||
126140720|NCT05195528|453805105|FG003|Extension Period|PTE or AE or SAE|4|||
126140721|NCT05195528|453805106|FG004|Extension Period|PTE or AE or SAE|4|||
126140722|NCT05195528|453805102|FG000|Extension Period|Protocol Violation|0|||
126140723|NCT05195528|453805103|FG001|Extension Period|Protocol Violation|2|||
126140724|NCT05195528|453805104|FG002|Extension Period|Protocol Violation|1|||
126140725|NCT05195528|453805105|FG003|Extension Period|Protocol Violation|0|||
126140726|NCT05195528|453805106|FG004|Extension Period|Protocol Violation|1|||
126140727|NCT05195528|453805102|FG000|Extension Period|Lost to Follow-up|0|||
126140728|NCT05195528|453805103|FG001|Extension Period|Lost to Follow-up|6|||
126140729|NCT05195528|453805104|FG002|Extension Period|Lost to Follow-up|13|||
126140730|NCT05195528|453805105|FG003|Extension Period|Lost to Follow-up|3|||
126140731|NCT05195528|453805106|FG004|Extension Period|Lost to Follow-up|7|||
126140732|NCT05195528|453805102|FG000|Extension Period|Withdrawal by Subject|0|||
126140733|NCT05195528|453805103|FG001|Extension Period|Withdrawal by Subject|12|||
126140734|NCT05195528|453805104|FG002|Extension Period|Withdrawal by Subject|9|||
126140735|NCT05195528|453805105|FG003|Extension Period|Withdrawal by Subject|6|||
126140736|NCT05195528|453805106|FG004|Extension Period|Withdrawal by Subject|5|||
126140737|NCT05195528|453805102|FG000|Extension Period|Lack of Efficacy|0|||
126140738|NCT05195528|453805103|FG001|Extension Period|Lack of Efficacy|3|||
126140739|NCT05195528|453805104|FG002|Extension Period|Lack of Efficacy|0|||
126140740|NCT05195528|453805105|FG003|Extension Period|Lack of Efficacy|0|||
126140741|NCT05195528|453805106|FG004|Extension Period|Lack of Efficacy|2|||
126140742|NCT05195528|453805102|FG000|Extension Period|Not Treated|0|||
126140743|NCT05195528|453805103|FG001|Extension Period|Not Treated|0|||
126140744|NCT05195528|453805104|FG002|Extension Period|Not Treated|2|||
126140745|NCT05195528|453805105|FG003|Extension Period|Not Treated|3|||
126140746|NCT05195528|453805106|FG004|Extension Period|Not Treated|0|||
126140747|NCT05195528|453805102|FG000|Extension Period|Other|0|||
126140748|NCT05195528|453805103|FG001|Extension Period|Other|1|||
125968546|NCT03701555|453175822|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
125968547|NCT03701555|453175823|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
125968548|NCT03701555|453175824|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
125968549|NCT03701555|453175825|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
125968550|NCT03701555|453175826|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
126140749|NCT05195528|453805104|FG002|Extension Period|Other|1|||
126140750|NCT05195528|453805105|FG003|Extension Period|Other|0|||
126140751|NCT05195528|453805106|FG004|Extension Period|Other|0|||
126140752|NCT01552902|453805107|FG000|Overall Study|Adverse Event|1|||
126140753|NCT01552902|453805108|FG001|Overall Study|Adverse Event|15|||
126140754|NCT01552902|453805109|FG002|Overall Study|Adverse Event|14|||
126140755|NCT01552902|453805107|FG000|Overall Study|Protocol Violation|3|||
126140756|NCT01552902|453805108|FG001|Overall Study|Protocol Violation|3|||
126140757|NCT01552902|453805109|FG002|Overall Study|Protocol Violation|3|||
126140758|NCT01552902|453805107|FG000|Overall Study|Lack of Efficacy|4|||
126140759|NCT01552902|453805108|FG001|Overall Study|Lack of Efficacy|3|||
126140760|NCT01552902|453805109|FG002|Overall Study|Lack of Efficacy|1|||
126140761|NCT01552902|453805107|FG000|Overall Study|Withdrawal by Subject|1|||
126140762|NCT01552902|453805108|FG001|Overall Study|Withdrawal by Subject|9|||
126140763|NCT01552902|453805109|FG002|Overall Study|Withdrawal by Subject|6|||
126140764|NCT01552902|453805107|FG000|Overall Study|Lost to Follow-up|1|||
126140765|NCT01552902|453805108|FG001|Overall Study|Lost to Follow-up|3|||
126140766|NCT01552902|453805109|FG002|Overall Study|Lost to Follow-up|6|||
126140767|NCT01552902|453805107|FG000|Overall Study|Other|3|||
126140768|NCT01552902|453805108|FG001|Overall Study|Other|4|||
126140769|NCT01552902|453805109|FG002|Overall Study|Other|3|||
126140770|NCT02487108|453805113|FG000|Overall Study|Adverse Event|1|||
126140771|NCT02487108|453805114|FG001|Overall Study|Adverse Event|6|||
126140772|NCT02487108|453805115|FG002|Overall Study|Adverse Event|12|||
126140773|NCT02487108|453805116|FG003|Overall Study|Adverse Event|6|||
126140774|NCT02487108|453805113|FG000|Overall Study|Withdrawal by Subject|8|||
126140775|NCT02487108|453805114|FG001|Overall Study|Withdrawal by Subject|5|||
126140776|NCT02487108|453805115|FG002|Overall Study|Withdrawal by Subject|5|||
126140777|NCT02487108|453805116|FG003|Overall Study|Withdrawal by Subject|0|||
126140778|NCT02487108|453805113|FG000|Overall Study|Non-compliance to study medication|3|||
126140779|NCT02487108|453805114|FG001|Overall Study|Non-compliance to study medication|2|||
126140780|NCT02487108|453805115|FG002|Overall Study|Non-compliance to study medication|5|||
126140781|NCT02487108|453805116|FG003|Overall Study|Non-compliance to study medication|4|||
126140782|NCT02487108|453805113|FG000|Overall Study|Protocol Violation|1|||
126140783|NCT02487108|453805114|FG001|Overall Study|Protocol Violation|1|||
126140784|NCT02487108|453805115|FG002|Overall Study|Protocol Violation|2|||
126140785|NCT02487108|453805116|FG003|Overall Study|Protocol Violation|0|||
126140786|NCT02487108|453805113|FG000|Overall Study|Non-compliance to study procedures|0|||
126140787|NCT02487108|453805114|FG001|Overall Study|Non-compliance to study procedures|0|||
126140788|NCT02487108|453805115|FG002|Overall Study|Non-compliance to study procedures|0|||
126140789|NCT02487108|453805116|FG003|Overall Study|Non-compliance to study procedures|1|||
126140790|NCT02487108|453805113|FG000|Overall Study|Other than specified|3|||
126140791|NCT02487108|453805114|FG001|Overall Study|Other than specified|2|||
126140792|NCT02487108|453805115|FG002|Overall Study|Other than specified|2|||
126140793|NCT02487108|453805116|FG003|Overall Study|Other than specified|0|||
126140794|NCT01254669|453805117|FG000|Overall Study|Withdrawal by Subject|0|||
126140795|NCT01254669|453805118|FG001|Overall Study|Withdrawal by Subject|1|||
126140796|NCT01254669|453805117|FG000|Overall Study|time constraint|2|||
126140797|NCT01254669|453805118|FG001|Overall Study|time constraint|2|||
126140798|NCT01254669|453805117|FG000|Overall Study|called to clinic during intervention|1|||
126140799|NCT01254669|453805118|FG001|Overall Study|called to clinic during intervention|1|||
126140800|NCT02367521|453805119|FG000|Overall Study|severe headache after intervention|2|||
126140801|NCT02367521|453805120|FG001|Overall Study|severe headache after intervention|0|||
126140802|NCT02367521|453805119|FG000|Overall Study|unable to find transportation|2|||
126140803|NCT02367521|453805120|FG001|Overall Study|unable to find transportation|0|||
126140804|NCT00542191|453805124|FG000|Overall Study|Death|3|||
126140805|NCT00469612|453805125|FG000|Overall Study|Study terminated before data collected|2|||
126140806|NCT00469612|453805126|FG001|Overall Study|Study terminated before data collected|0|||
126140807|NCT04684420|453805127|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126140808|NCT04684420|453805128|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126140809|NCT04684420|453805129|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
126140810|NCT04684420|453805130|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
126140811|NCT04684420|453805127|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
126140812|NCT04684420|453805128|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
126140813|NCT04684420|453805129|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
126140814|NCT04684420|453805130|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
126140815|NCT03480802|453805131|FG000|Overall Study|Lost to Follow-up|5|||
126140816|NCT03480802|453805132|FG001|Overall Study|Lost to Follow-up|1|||
126140817|NCT03480802|453805131|FG000|Overall Study|Withdrawal by Subject|2|||
126140818|NCT03480802|453805132|FG001|Overall Study|Withdrawal by Subject|1|||
125968551|NCT03701555|453175827|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
125968552|NCT03701555|453175828|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
126140819|NCT03480802|453805131|FG000|Overall Study|Relocated|0|||
126140820|NCT03480802|453805132|FG001|Overall Study|Relocated|1|||
126140821|NCT03822884|453805133|FG000|Overall Study|Withdrawal by Subject|0|||
126140822|NCT03822884|453805134|FG001|Overall Study|Withdrawal by Subject|0|||
126140823|NCT03822884|453805135|FG002|Overall Study|Withdrawal by Subject|0|||
126140824|NCT03822884|453805136|FG003|Overall Study|Withdrawal by Subject|0|||
126140825|NCT03822884|453805137|FG004|Overall Study|Withdrawal by Subject|1|||
126140826|NCT03822884|453805138|FG005|Overall Study|Withdrawal by Subject|0|||
126140827|NCT05254418|453805146|FG000|Overall Study|Adverse Event|2|||
126140828|NCT03624946|453805151|FG000|Overall Study|Lost to Follow-up|0|||
126140829|NCT03624946|453805152|FG001|Overall Study|Lost to Follow-up|1|||
126140830|NCT03075163|453805153|FG000|Overall Study|not eligible for treatment limb|138|||
126140831|NCT03075163|453805154|FG001|Overall Study|not eligible for treatment limb|138|||
126140832|NCT01925209|453805155|FG000|Treatment Epoch|Physician Decision|1|||
126140833|NCT01925209|453805156|FG001|Treatment Epoch|Physician Decision|0|||
126140834|NCT01925209|453805157|FG002|Treatment Epoch|Physician Decision|0|||
126140835|NCT01925209|453805158|FG003|Treatment Epoch|Physician Decision|0|||
126140836|NCT01925209|453805155|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
126140837|NCT01925209|453805156|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
126140838|NCT01925209|453805157|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
126140839|NCT01925209|453805158|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
126140840|NCT01925209|453805155|FG000|Treatment Epoch|Death|1|||
126140841|NCT01925209|453805156|FG001|Treatment Epoch|Death|0|||
126140842|NCT01925209|453805157|FG002|Treatment Epoch|Death|0|||
126140843|NCT01925209|453805158|FG003|Treatment Epoch|Death|0|||
126140844|NCT01925209|453805155|FG000|Treatment Epoch|Protocol deviation|0|||
126140845|NCT01925209|453805156|FG001|Treatment Epoch|Protocol deviation|0|||
126140846|NCT01925209|453805157|FG002|Treatment Epoch|Protocol deviation|1|||
126140847|NCT01925209|453805158|FG003|Treatment Epoch|Protocol deviation|1|||
126140848|NCT01925209|453805155|FG000|Treatment Epoch|Withdrawal by Subject|4|||
126140849|NCT01925209|453805156|FG001|Treatment Epoch|Withdrawal by Subject|3|||
126140850|NCT01925209|453805157|FG002|Treatment Epoch|Withdrawal by Subject|3|||
126140851|NCT01925209|453805158|FG003|Treatment Epoch|Withdrawal by Subject|2|||
126140852|NCT01925209|453805155|FG000|Treatment Epoch|Adverse Event|3|||
126140853|NCT01925209|453805156|FG001|Treatment Epoch|Adverse Event|5|||
126140854|NCT01925209|453805157|FG002|Treatment Epoch|Adverse Event|3|||
126140855|NCT01925209|453805158|FG003|Treatment Epoch|Adverse Event|1|||
126140856|NCT01925209|453805155|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
126140857|NCT01925209|453805156|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
126140858|NCT01925209|453805157|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
126140859|NCT01925209|453805158|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
126140860|NCT01925209|453805155|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
126140861|NCT01925209|453805156|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
126140862|NCT01925209|453805157|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
126140863|NCT01925209|453805158|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
126140864|NCT01925209|453805155|FG000|Follow-up|Adverse Event|1|||
126140865|NCT01925209|453805156|FG001|Follow-up|Adverse Event|4|||
126140866|NCT01925209|453805157|FG002|Follow-up|Adverse Event|0|||
126140867|NCT01925209|453805158|FG003|Follow-up|Adverse Event|1|||
126140868|NCT01925209|453805155|FG000|Follow-up|Physician Decision|0|||
126140869|NCT01925209|453805156|FG001|Follow-up|Physician Decision|0|||
126140870|NCT01925209|453805157|FG002|Follow-up|Physician Decision|1|||
126140871|NCT01925209|453805158|FG003|Follow-up|Physician Decision|0|||
126140872|NCT01925209|453805155|FG000|Follow-up|Non-compliance with study treatment|0|||
126140873|NCT01925209|453805156|FG001|Follow-up|Non-compliance with study treatment|0|||
126140874|NCT01925209|453805157|FG002|Follow-up|Non-compliance with study treatment|0|||
126140875|NCT01925209|453805158|FG003|Follow-up|Non-compliance with study treatment|1|||
126140876|NCT01925209|453805155|FG000|Follow-up|Withdrawal by Subject|0|||
126140877|NCT01925209|453805156|FG001|Follow-up|Withdrawal by Subject|2|||
126140878|NCT01925209|453805157|FG002|Follow-up|Withdrawal by Subject|0|||
126140879|NCT01925209|453805158|FG003|Follow-up|Withdrawal by Subject|2|||
126140880|NCT01950819|453805159|FG000|Overall Study|Graft Loss|35|||
126140881|NCT01950819|453805160|FG001|Overall Study|Graft Loss|30|||
126140882|NCT01950819|453805159|FG000|Overall Study|Death|29|||
126140883|NCT01950819|453805160|FG001|Overall Study|Death|34|||
126140884|NCT01950819|453805159|FG000|Overall Study|Subject / Gardian decision|54|||
126140885|NCT01950819|453805160|FG001|Overall Study|Subject / Gardian decision|51|||
126140886|NCT01950819|453805159|FG000|Overall Study|technical problems|2|||
126140887|NCT01950819|453805160|FG001|Overall Study|technical problems|0|||
126140888|NCT01950819|453805159|FG000|Overall Study|Pregnancy|0|||
126140889|NCT01950819|453805160|FG001|Overall Study|Pregnancy|2|||
126140890|NCT01950819|453805159|FG000|Overall Study|Lost to Follow-up|9|||
126140891|NCT01950819|453805160|FG001|Overall Study|Lost to Follow-up|17|||
126140892|NCT01879410|453805161|FG000|Overall Study|Adverse Event|9|||
126140893|NCT01879410|453805162|FG001|Overall Study|Adverse Event|14|||
126140894|NCT01879410|453805161|FG000|Overall Study|Lack of Efficacy|4|||
126140895|NCT01879410|453805162|FG001|Overall Study|Lack of Efficacy|6|||
126140896|NCT01879410|453805161|FG000|Overall Study|Protocol Violation|1|||
126140897|NCT01879410|453805162|FG001|Overall Study|Protocol Violation|7|||
126140898|NCT01879410|453805161|FG000|Overall Study|Lost to Follow-up|2|||
126140899|NCT01879410|453805162|FG001|Overall Study|Lost to Follow-up|1|||
126140900|NCT01879410|453805161|FG000|Overall Study|Withdrawal by Subject|7|||
126140901|NCT01879410|453805162|FG001|Overall Study|Withdrawal by Subject|8|||
126140902|NCT01879410|453805161|FG000|Overall Study|Randomised in Error|1|||
126140903|NCT01879410|453805162|FG001|Overall Study|Randomised in Error|2|||
126140904|NCT01756456|453805163|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
126140905|NCT01756456|453805164|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
126140906|NCT01756456|453805165|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
126140907|NCT01756456|453805166|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
126140908|NCT01756456|453805167|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
126140909|NCT01756456|453805168|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
126140910|NCT01756456|453805163|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
126140911|NCT01756456|453805164|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
126140912|NCT01756456|453805165|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
126140913|NCT01756456|453805166|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
126140914|NCT01756456|453805167|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
126140915|NCT01756456|453805168|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
126140916|NCT01756456|453805163|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126140917|NCT01756456|453805164|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
126140918|NCT01756456|453805165|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126140919|NCT01756456|453805166|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126140920|NCT01756456|453805167|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126140921|NCT01756456|453805168|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126140922|NCT01756456|453805163|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
126140923|NCT01756456|453805164|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
126140924|NCT01756456|453805165|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
126140925|NCT01756456|453805166|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
126140926|NCT01756456|453805167|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
126140927|NCT01756456|453805168|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
126140928|NCT01756456|453805163|FG000|Treatment Period: Phase I/II|Other causes|0|||
126140929|NCT01756456|453805164|FG001|Treatment Period: Phase I/II|Other causes|0|||
126140930|NCT01756456|453805165|FG002|Treatment Period: Phase I/II|Other causes|0|||
126140931|NCT01756456|453805166|FG003|Treatment Period: Phase I/II|Other causes|1|||
126140932|NCT01756456|453805167|FG004|Treatment Period: Phase I/II|Other causes|2|||
126140933|NCT01756456|453805168|FG005|Treatment Period: Phase I/II|Other causes|2|||
126140934|NCT01756456|453805163|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
126140935|NCT01756456|453805164|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
126140936|NCT01756456|453805165|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
126140937|NCT01756456|453805166|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
126140938|NCT01756456|453805167|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
126140939|NCT01756456|453805168|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
126140940|NCT01756456|453805163|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126140941|NCT01756456|453805164|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
126140942|NCT01756456|453805165|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126140943|NCT01756456|453805166|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126140944|NCT01756456|453805167|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126140945|NCT01756456|453805168|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126140946|NCT01756456|453805163|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126140947|NCT01756456|453805164|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126140948|NCT01756456|453805165|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126140949|NCT01756456|453805166|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126140950|NCT01756456|453805167|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126140951|NCT01756456|453805168|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
126140952|NCT01756456|453805163|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
126140953|NCT01756456|453805164|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
126140954|NCT01756456|453805165|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
126140955|NCT01756456|453805166|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
126140956|NCT01756456|453805167|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
126140957|NCT01756456|453805168|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
126140958|NCT01756456|453805163|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
126140959|NCT01756456|453805164|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
126140960|NCT01756456|453805165|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
125968553|NCT03701555|453175829|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
125968554|NCT03701555|453175830|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
125968555|NCT03701555|453175831|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
125968556|NCT03701555|453175832|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
125968557|NCT03701555|453175833|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
125968558|NCT03701555|453175834|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
125968559|NCT03701555|453175835|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
125968560|NCT03701555|453175836|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
125968561|NCT03701555|453175837|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
125968562|NCT03701555|453175838|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
125968563|NCT03701555|453175839|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
125968564|NCT03701555|453175840|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
125968565|NCT03701555|453175841|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
125968566|NCT03701555|453175842|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
126140961|NCT01756456|453805166|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
126140962|NCT01756456|453805167|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
126140963|NCT01756456|453805168|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
126140964|NCT01756456|453805163|FG000|Follow Up Period Phase I/II|Other causes|0|||
126140965|NCT01756456|453805164|FG001|Follow Up Period Phase I/II|Other causes|0|||
126140966|NCT01756456|453805165|FG002|Follow Up Period Phase I/II|Other causes|0|||
126140967|NCT01756456|453805166|FG003|Follow Up Period Phase I/II|Other causes|1|||
126140968|NCT01756456|453805167|FG004|Follow Up Period Phase I/II|Other causes|3|||
126140969|NCT01756456|453805168|FG005|Follow Up Period Phase I/II|Other causes|5|||
126140970|NCT01573910|453805169|FG000|Overall Study|Adverse Event|4|||
126140971|NCT01573910|453805170|FG001|Overall Study|Adverse Event|4|||
126140972|NCT01573910|453805169|FG000|Overall Study|Lost to Follow-up|2|||
126140973|NCT01573910|453805170|FG001|Overall Study|Lost to Follow-up|1|||
126140974|NCT01573910|453805169|FG000|Overall Study|Withdrawal by Subject|0|||
126140975|NCT01573910|453805170|FG001|Overall Study|Withdrawal by Subject|1|||
126140976|NCT01573910|453805169|FG000|Overall Study|Protocol Violation|3|||
126140977|NCT01573910|453805170|FG001|Overall Study|Protocol Violation|0|||
126140978|NCT01573910|453805169|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
126140979|NCT01573910|453805170|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
126140980|NCT01850615|453805177|FG000|Overall Study|Protocol Violation|4|||
126140981|NCT01850615|453805178|FG001|Overall Study|Protocol Violation|1|||
126140982|NCT01850615|453805177|FG000|Overall Study|Adverse Event|2|||
126140983|NCT01850615|453805178|FG001|Overall Study|Adverse Event|1|||
126140984|NCT01850615|453805177|FG000|Overall Study|Withdrawal by Subject|3|||
126140985|NCT01850615|453805178|FG001|Overall Study|Withdrawal by Subject|1|||
126140986|NCT01850615|453805177|FG000|Overall Study|Lost to Follow-up|0|||
126140987|NCT01850615|453805178|FG001|Overall Study|Lost to Follow-up|1|||
126140988|NCT01850615|453805177|FG000|Overall Study|Unclassified|0|||
126140989|NCT01850615|453805178|FG001|Overall Study|Unclassified|1|||
126140990|NCT01227967|453805179|FG000|Overall Study|Protocol Violation|3|||
126140991|NCT01227967|453805180|FG001|Overall Study|Protocol Violation|1|||
126140992|NCT01227967|453805179|FG000|Overall Study|Death|0|||
126140993|NCT01227967|453805180|FG001|Overall Study|Death|1|||
126140994|NCT01227967|453805179|FG000|Overall Study|Lost to Follow-up|8|||
126140995|NCT01227967|453805180|FG001|Overall Study|Lost to Follow-up|3|||
126140996|NCT01227967|453805179|FG000|Overall Study|Withdrawal by Subject|4|||
126140997|NCT01227967|453805180|FG001|Overall Study|Withdrawal by Subject|3|||
126140998|NCT01227967|453805179|FG000|Overall Study|Physician Decision|0|||
126140999|NCT01227967|453805180|FG001|Overall Study|Physician Decision|1|||
126141000|NCT01227967|453805179|FG000|Overall Study|Never Started Treatment|0|||
126141001|NCT01227967|453805180|FG001|Overall Study|Never Started Treatment|4|||
126141002|NCT01227967|453805179|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
126141003|NCT01227967|453805180|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
126141004|NCT01763164|453805181|FG000|Treatment Phase|Participant/Guardian decision|26|||
126141005|NCT01763164|453805182|FG001|Treatment Phase|Participant/Guardian decision|14|||
126141006|NCT01763164|453805181|FG000|Treatment Phase|Protocol Violation|1|||
126141007|NCT01763164|453805182|FG001|Treatment Phase|Protocol Violation|1|||
126141008|NCT01763164|453805181|FG000|Treatment Phase|Progressive Disease|142|||
126141009|NCT01763164|453805182|FG001|Treatment Phase|Progressive Disease|76|||
126141010|NCT01763164|453805181|FG000|Treatment Phase|Physician Decision|24|||
126141011|NCT01763164|453805182|FG001|Treatment Phase|Physician Decision|13|||
126141012|NCT01763164|453805181|FG000|Treatment Phase|Death|10|||
126141013|NCT01763164|453805182|FG001|Treatment Phase|Death|1|||
126141014|NCT01763164|453805181|FG000|Treatment Phase|Adverse Event|66|||
126141015|NCT01763164|453805182|FG001|Treatment Phase|Adverse Event|8|||
126141016|NCT01763164|453805181|FG000|Treatment Phase|Randomized but not Treated|0|||
126141017|NCT01763164|453805182|FG001|Treatment Phase|Randomized but not Treated|19|||
126141018|NCT01763164|453805181|FG000|Treatment Phase|Other|0|||
126141019|NCT01763164|453805182|FG001|Treatment Phase|Other|1|||
126141020|NCT01763164|453805181|FG000|Follow up Phase|New therapy for study indication|12|||
126141021|NCT01763164|453805182|FG001|Follow up Phase|New therapy for study indication|3|||
126141022|NCT01763164|453805181|FG000|Follow up Phase|Death|21|||
126141023|NCT01763164|453805182|FG001|Follow up Phase|Death|4|||
126141024|NCT01763164|453805181|FG000|Follow up Phase|Subject/guardian decision|9|||
126141025|NCT01763164|453805182|FG001|Follow up Phase|Subject/guardian decision|2|||
126141026|NCT01763164|453805181|FG000|Follow up Phase|Progressive disease|127|||
126141027|NCT01763164|453805182|FG001|Follow up Phase|Progressive disease|62|||
126141028|NCT01763164|453805181|FG000|Follow up Phase|Physician Decision|10|||
126141029|NCT01763164|453805182|FG001|Follow up Phase|Physician Decision|3|||
126141030|NCT01763164|453805181|FG000|Follow up Phase|Lost to Follow-up|1|||
126141031|NCT01763164|453805182|FG001|Follow up Phase|Lost to Follow-up|0|||
126141032|NCT01763164|453805181|FG000|Follow up Phase|Adverse Event|17|||
126141033|NCT01763164|453805182|FG001|Follow up Phase|Adverse Event|1|||
126141034|NCT03595280|453805184|FG000|Overall Study|Lost to Follow-up|6|||
126141035|NCT03595280|453805185|FG001|Overall Study|Lost to Follow-up|9|||
126141036|NCT03595280|453805186|FG002|Overall Study|Lost to Follow-up|15|||
126141037|NCT02658812|453805187|FG000|Overall Study|Disease Progression|7|||
126141038|NCT02658812|453805187|FG000|Overall Study|Unrelated to study treatment|1|||
126141039|NCT02658812|453805187|FG000|Overall Study|Adverse Event|1|||
126141040|NCT01512264|453805188|FG000|Overall Study|Lost to Follow-up|0|||
126141041|NCT01512264|453805189|FG001|Overall Study|Lost to Follow-up|0|||
126141042|NCT01512264|453805190|FG002|Overall Study|Lost to Follow-up|0|||
126141043|NCT01512264|453805191|FG003|Overall Study|Lost to Follow-up|1|||
126141044|NCT00854828|453805192|FG000|Overall Study|Death|1|||
126141045|NCT00854828|453805193|FG001|Overall Study|Death|0|||
126141046|NCT00854828|453805194|FG002|Overall Study|Death|0|||
126141047|NCT00854828|453805195|FG003|Overall Study|Death|0|||
126141048|NCT00854828|453805192|FG000|Overall Study|Withdrawal by Subject|1|||
126141049|NCT00854828|453805193|FG001|Overall Study|Withdrawal by Subject|1|||
126141050|NCT00854828|453805194|FG002|Overall Study|Withdrawal by Subject|0|||
126141051|NCT00854828|453805195|FG003|Overall Study|Withdrawal by Subject|9|||
126141052|NCT00854828|453805192|FG000|Overall Study|Missed 24mo visit|1|||
126141053|NCT00854828|453805193|FG001|Overall Study|Missed 24mo visit|1|||
126141054|NCT00854828|453805194|FG002|Overall Study|Missed 24mo visit|8|||
126141055|NCT00854828|453805195|FG003|Overall Study|Missed 24mo visit|8|||
126141056|NCT04957290|453805196|FG000|Overall Study|Progressive disease|3|||
126141057|NCT04957290|453805197|FG001|Overall Study|Progressive disease|3|||
126141058|NCT04957290|453805198|FG002|Overall Study|Progressive disease|2|||
126141059|NCT04957290|453805199|FG003|Overall Study|Progressive disease|0|||
126141060|NCT04957290|453805200|FG004|Overall Study|Progressive disease|0|||
126141061|NCT04957290|453805201|FG005|Overall Study|Progressive disease|0|||
126141062|NCT04957290|453805196|FG000|Overall Study|Withdrawal by Subject|1|||
126141063|NCT04957290|453805197|FG001|Overall Study|Withdrawal by Subject|0|||
126141064|NCT04957290|453805198|FG002|Overall Study|Withdrawal by Subject|1|||
126141065|NCT04957290|453805199|FG003|Overall Study|Withdrawal by Subject|0|||
126141066|NCT04957290|453805200|FG004|Overall Study|Withdrawal by Subject|0|||
126141067|NCT04957290|453805201|FG005|Overall Study|Withdrawal by Subject|0|||
126141068|NCT04957290|453805196|FG000|Overall Study|Death|0|||
126141069|NCT04957290|453805197|FG001|Overall Study|Death|2|||
126141070|NCT04957290|453805198|FG002|Overall Study|Death|1|||
126141071|NCT04957290|453805199|FG003|Overall Study|Death|0|||
126141072|NCT04957290|453805200|FG004|Overall Study|Death|0|||
126141073|NCT04957290|453805201|FG005|Overall Study|Death|0|||
126141074|NCT04957290|453805196|FG000|Overall Study|non compliance with study drug|0|||
126141075|NCT04957290|453805197|FG001|Overall Study|non compliance with study drug|1|||
126141076|NCT04957290|453805198|FG002|Overall Study|non compliance with study drug|0|||
126141077|NCT04957290|453805199|FG003|Overall Study|non compliance with study drug|0|||
126141078|NCT04957290|453805200|FG004|Overall Study|non compliance with study drug|0|||
126141079|NCT04957290|453805201|FG005|Overall Study|non compliance with study drug|0|||
126141080|NCT04957290|453805196|FG000|Overall Study|none specified.|0|||
126141081|NCT04957290|453805197|FG001|Overall Study|none specified.|1|||
126141082|NCT04957290|453805198|FG002|Overall Study|none specified.|2|||
126141083|NCT04957290|453805199|FG003|Overall Study|none specified.|0|||
126141084|NCT04957290|453805200|FG004|Overall Study|none specified.|0|||
126141085|NCT04957290|453805201|FG005|Overall Study|none specified.|0|||
126141086|NCT04957290|453805196|FG000|Overall Study|unacceptable toxicity|0|||
126141087|NCT04957290|453805197|FG001|Overall Study|unacceptable toxicity|0|||
126141088|NCT04957290|453805198|FG002|Overall Study|unacceptable toxicity|1|||
126141089|NCT04957290|453805199|FG003|Overall Study|unacceptable toxicity|0|||
126141090|NCT04957290|453805200|FG004|Overall Study|unacceptable toxicity|0|||
126141091|NCT04957290|453805201|FG005|Overall Study|unacceptable toxicity|0|||
126141092|NCT04957290|453805196|FG000|Overall Study|Adverse Event|0|||
126141093|NCT04957290|453805197|FG001|Overall Study|Adverse Event|0|||
126141094|NCT04957290|453805198|FG002|Overall Study|Adverse Event|1|||
126141095|NCT04957290|453805199|FG003|Overall Study|Adverse Event|0|||
126141096|NCT04957290|453805200|FG004|Overall Study|Adverse Event|0|||
126141097|NCT04957290|453805201|FG005|Overall Study|Adverse Event|0|||
126141098|NCT04957290|453805196|FG000|Overall Study|study terminated by sponsor|0|||
126141099|NCT04957290|453805197|FG001|Overall Study|study terminated by sponsor|0|||
126141100|NCT04957290|453805198|FG002|Overall Study|study terminated by sponsor|2|||
126141101|NCT04957290|453805199|FG003|Overall Study|study terminated by sponsor|0|||
126141102|NCT04957290|453805200|FG004|Overall Study|study terminated by sponsor|0|||
126141103|NCT04957290|453805201|FG005|Overall Study|study terminated by sponsor|0|||
126141104|NCT02411747|453805202|FG000|Overall Study|Withdrawal by Subject|1|||
126141105|NCT02411747|453805203|FG001|Overall Study|Withdrawal by Subject|0|||
126141106|NCT02411747|453805202|FG000|Overall Study|Protocol Violation|2|||
126141107|NCT02411747|453805203|FG001|Overall Study|Protocol Violation|4|||
126141108|NCT03158220|453805206|FG000|Overall Study|Screen Failure|0|||
126141109|NCT03158220|453805207|FG001|Overall Study|Screen Failure|1|||
126141110|NCT03158220|453805206|FG000|Overall Study|Withdrawal by Subject|8|||
126141111|NCT03158220|453805207|FG001|Overall Study|Withdrawal by Subject|9|||
126141112|NCT03158220|453805206|FG000|Overall Study|Status unknown|0|||
126141113|NCT03158220|453805207|FG001|Overall Study|Status unknown|1|||
126141114|NCT03158220|453805206|FG000|Overall Study|Lost to Follow-up|8|||
126141115|NCT03158220|453805207|FG001|Overall Study|Lost to Follow-up|5|||
126141116|NCT03158220|453805206|FG000|Overall Study|Physician Decision|1|||
126141117|NCT03158220|453805207|FG001|Overall Study|Physician Decision|0|||
126141118|NCT00996203|453805208|FG000|Overall Study|Adverse Event|3|||
126141119|NCT00996203|453805208|FG000|Overall Study|Lost to Follow-up|1|||
126141120|NCT00996203|453805208|FG000|Overall Study|Lack of Efficacy|1|||
126141121|NCT00996203|453805208|FG000|Overall Study|Protocol Violation|2|||
126141122|NCT01671280|453805209|FG000|Overall Study|Withdrawal by Subject|2|||
126141123|NCT03686969|453805211|FG000|Overall Study|Study terminated|1|||
126141124|NCT03686969|453805212|FG001|Overall Study|Study terminated|0|||
126141125|NCT00848120|453805213|FG000|Overall Study|Adverse Event|1|||
126141126|NCT00560755|453805214|FG000|Overall Study|Protocol Violation|15|||
126141127|NCT00560755|453805214|FG000|Overall Study|Withdrawal by Subject|26|||
126141128|NCT00560755|453805214|FG000|Overall Study|Lost to Follow-up|9|||
126141129|NCT00560755|453805214|FG000|Overall Study|Adverse Event|8|||
126141130|NCT00560755|453805214|FG000|Overall Study|Physician Decision|2|||
126141131|NCT01988090|453805218|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
126141132|NCT01988090|453805219|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
126141133|NCT01988090|453805218|FG000|Start Treament After Randomization|Protocol Violation|0|||
126141134|NCT01988090|453805219|FG001|Start Treament After Randomization|Protocol Violation|1|||
126141135|NCT01988090|453805218|FG000|Complete Study After Start|Withdrawal by Subject|2|||
126141136|NCT01988090|453805219|FG001|Complete Study After Start|Withdrawal by Subject|0|||
126141137|NCT01988090|453805218|FG000|Complete Study After Start|Protocol Violation|1|||
126141138|NCT01988090|453805219|FG001|Complete Study After Start|Protocol Violation|1|||
126141139|NCT01439945|453805224|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
126141140|NCT01439945|453805225|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
126141141|NCT01439945|453805226|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
126141142|NCT01439945|453805227|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
126141143|NCT01439945|453805224|FG000|Double-Blind Treatment Phase|Ineligible|1|||
126141144|NCT01439945|453805225|FG001|Double-Blind Treatment Phase|Ineligible|2|||
126141145|NCT01439945|453805226|FG002|Double-Blind Treatment Phase|Ineligible|0|||
126141146|NCT01439945|453805227|FG003|Double-Blind Treatment Phase|Ineligible|1|||
126141147|NCT00927563|453805228|FG000|Overall Study|Lost to Follow-up|1|||
126141148|NCT00927563|453805228|FG000|Overall Study|Withdrawal by Subject|1|||
126141149|NCT00413959|453805235|FG000|Overall Study|Pt had only one cycle.|1|||
126141150|NCT04343651|453805237|FG000|Overall Study|Physician Decision|2|||
126141151|NCT04343651|453805238|FG001|Overall Study|Physician Decision|1|||
126141152|NCT04343651|453805237|FG000|Overall Study|Lost to Follow-up|2|||
126141153|NCT04343651|453805238|FG001|Overall Study|Lost to Follow-up|1|||
126141154|NCT04343651|453805237|FG000|Overall Study|Protocol Violation|4|||
126141155|NCT04343651|453805238|FG001|Overall Study|Protocol Violation|6|||
126141156|NCT04343651|453805237|FG000|Overall Study|Missing|3|||
126141157|NCT04343651|453805238|FG001|Overall Study|Missing|9|||
126141158|NCT04343651|453805237|FG000|Overall Study|Withdrawal by Subject|0|||
126141159|NCT04343651|453805238|FG001|Overall Study|Withdrawal by Subject|4|||
126141160|NCT04343651|453805237|FG000|Overall Study|Death|0|||
126141161|NCT04343651|453805238|FG001|Overall Study|Death|1|||
126141162|NCT04343651|453805237|FG000|Overall Study|Did not start treatment|1|||
126141163|NCT04343651|453805238|FG001|Overall Study|Did not start treatment|1|||
126141164|NCT04343651|453805237|FG000|Overall Study|Patient did not complete visits 3-6|0|||
126141165|NCT04343651|453805238|FG001|Overall Study|Patient did not complete visits 3-6|1|||
126141166|NCT01292057|453805244|FG000|Overall Study|Protocol Violation|1|||
126141167|NCT01292057|453805245|FG001|Overall Study|Protocol Violation|1|||
125968567|NCT03701555|453175843|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
125968568|NCT03701555|453175844|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
126141168|NCT01292057|453805244|FG000|Overall Study|Lost to Follow-up|1|||
126141169|NCT01292057|453805245|FG001|Overall Study|Lost to Follow-up|1|||
126141170|NCT01459614|453805246|FG000|Overall Study|Adverse Event|1|||
126141171|NCT01459614|453805247|FG001|Overall Study|Adverse Event|0|||
126141172|NCT01506882|453805251|FG000|Overall Study|Lack of Efficacy|4|||
126141173|NCT01506882|453805252|FG001|Overall Study|Lack of Efficacy|3|||
126141174|NCT01506882|453805251|FG000|Overall Study|Lost to Follow-up|1|||
126141175|NCT01506882|453805252|FG001|Overall Study|Lost to Follow-up|0|||
126141176|NCT01506882|453805251|FG000|Overall Study|Withdrawal by Subject|9|||
126141177|NCT01506882|453805252|FG001|Overall Study|Withdrawal by Subject|3|||
126141178|NCT01506882|453805251|FG000|Overall Study|SAE, non-fatal|2|||
126141179|NCT01506882|453805252|FG001|Overall Study|SAE, non-fatal|0|||
126141180|NCT01506882|453805251|FG000|Overall Study|AE, non-serious non-fatal|3|||
126141181|NCT01506882|453805252|FG001|Overall Study|AE, non-serious non-fatal|1|||
126141182|NCT01506882|453805251|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
126141183|NCT01506882|453805252|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125968569|NCT03701555|453175845|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
126141184|NCT01506882|453805251|FG000|Overall Study|Other Reason|2|||
126141185|NCT01506882|453805252|FG001|Overall Study|Other Reason|0|||
126141186|NCT00821678|453805257|FG000|Overall Study|Withdrawal by Subject|8|||
126141187|NCT00821678|453805258|FG001|Overall Study|Withdrawal by Subject|0|||
126141188|NCT00821678|453805257|FG000|Overall Study|Lost to Follow-up|13|||
126141189|NCT00821678|453805258|FG001|Overall Study|Lost to Follow-up|12|||
126141190|NCT00821678|453805257|FG000|Overall Study|Death|0|||
126141191|NCT00821678|453805258|FG001|Overall Study|Death|2|||
126141192|NCT01475734|453807227|FG000|Overall Study|Withdrawal by Subject|1|||
126141193|NCT01475734|453807228|FG001|Overall Study|Withdrawal by Subject|0|||
126141194|NCT01475734|453807227|FG000|Overall Study|Protocol Violation|1|||
126141195|NCT01475734|453807228|FG001|Overall Study|Protocol Violation|0|||
126141196|NCT01475734|453807227|FG000|Overall Study|Physician Decision|0|||
126141197|NCT01475734|453807228|FG001|Overall Study|Physician Decision|1|||
126141198|NCT00376961|453807232|FG000|Initial Registration|Adverse Event|1|||
126141199|NCT00376961|453807233|FG001|Initial Registration|Adverse Event|0|||
126141200|NCT00376961|453807232|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
126141201|NCT00376961|453807233|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126141202|NCT00376961|453807232|FG000|Initial Registration|Progression/relapse|1|||
126141203|NCT00376961|453807233|FG001|Initial Registration|Progression/relapse|0|||
126141204|NCT00376961|453807232|FG000|Initial Registration|Ineligible|3|||
126141205|NCT00376961|453807233|FG001|Initial Registration|Ineligible|0|||
126141206|NCT00376961|453807232|FG000|Maintenance|Adverse Event|0|||
126141207|NCT00376961|453807233|FG001|Maintenance|Adverse Event|1|||
126141208|NCT00376961|453807232|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
126141209|NCT00376961|453807233|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
126141210|NCT00376961|453807232|FG000|Maintenance|Progression/relapse|0|||
126141211|NCT00376961|453807233|FG001|Maintenance|Progression/relapse|18|||
126141212|NCT00376961|453807232|FG000|Maintenance|Ineligible|0|||
126141213|NCT00376961|453807233|FG001|Maintenance|Ineligible|3|||
126141214|NCT01059448|453807234|FG000|Overall Study|Adverse Event|1|||
126141215|NCT01059448|453807235|FG001|Overall Study|Adverse Event|3|||
126141216|NCT01059448|453807236|FG002|Overall Study|Adverse Event|0|||
126141217|NCT01059448|453807237|FG003|Overall Study|Adverse Event|1|||
126141218|NCT01059448|453807234|FG000|Overall Study|Withdrawal by Subject|2|||
126141219|NCT01059448|453807235|FG001|Overall Study|Withdrawal by Subject|0|||
126141220|NCT01059448|453807236|FG002|Overall Study|Withdrawal by Subject|2|||
126141221|NCT01059448|453807237|FG003|Overall Study|Withdrawal by Subject|4|||
126141222|NCT01059448|453807234|FG000|Overall Study|Disease Progression|2|||
126141223|NCT01059448|453807235|FG001|Overall Study|Disease Progression|1|||
126141224|NCT01059448|453807236|FG002|Overall Study|Disease Progression|4|||
126141225|NCT01059448|453807237|FG003|Overall Study|Disease Progression|2|||
126141226|NCT01059448|453807234|FG000|Overall Study|Administrative Decision|43|||
126141227|NCT01059448|453807235|FG001|Overall Study|Administrative Decision|49|||
126141228|NCT01059448|453807236|FG002|Overall Study|Administrative Decision|45|||
126141229|NCT01059448|453807237|FG003|Overall Study|Administrative Decision|46|||
126141230|NCT01059448|453807234|FG000|Overall Study|Lost to Follow-up|0|||
126141231|NCT01059448|453807235|FG001|Overall Study|Lost to Follow-up|0|||
126141232|NCT01059448|453807236|FG002|Overall Study|Lost to Follow-up|2|||
126141233|NCT01059448|453807237|FG003|Overall Study|Lost to Follow-up|0|||
126141234|NCT01059448|453807234|FG000|Overall Study|Death|0|||
126141235|NCT01059448|453807235|FG001|Overall Study|Death|1|||
126141236|NCT01059448|453807236|FG002|Overall Study|Death|0|||
126141237|NCT01059448|453807237|FG003|Overall Study|Death|0|||
126141238|NCT01059448|453807234|FG000|Overall Study|Other|1|||
126141239|NCT01059448|453807235|FG001|Overall Study|Other|1|||
126141240|NCT01059448|453807236|FG002|Overall Study|Other|0|||
126141241|NCT01059448|453807237|FG003|Overall Study|Other|1|||
126141242|NCT00809328|453807240|FG000|Overall Study|Lack of Efficacy|18|||
126141243|NCT00809328|453807240|FG000|Overall Study|Adverse Event|6|||
126141244|NCT00809328|453807240|FG000|Overall Study|Protocol Violation|3|||
126141245|NCT00809328|453807240|FG000|Overall Study|Withdrawal by Subject|2|||
126141246|NCT02911688|453807241|FG000|Washout|Lost to Follow-up|1|||
126141247|NCT02911688|453807242|FG001|Washout|Lost to Follow-up|1|||
126141248|NCT02911688|453807241|FG000|Washout|Withdrawal by Subject|0|||
126141249|NCT02911688|453807242|FG001|Washout|Withdrawal by Subject|1|||
125968570|NCT03701555|453175846|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
125968571|NCT03701555|453175847|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
125968572|NCT03701555|453175812|FG000|Part 2 (Day 1)|Other|0|||
125968573|NCT03701555|453175813|FG001|Part 2 (Day 1)|Other|0|||
126141250|NCT05148884|453807249|FG000|Overall Study|Withdrawal by Subject|3|||
126141251|NCT05148884|453807250|FG001|Overall Study|Withdrawal by Subject|0|||
126141252|NCT05148884|453807249|FG000|Overall Study|Deep brain stimulation operation|0|||
126141253|NCT05148884|453807250|FG001|Overall Study|Deep brain stimulation operation|1|||
126141254|NCT01993888|453807251|FG000|Overall Study|Death|1|||
126141255|NCT01993888|453807252|FG001|Overall Study|Death|1|||
126141256|NCT01993888|453807251|FG000|Overall Study|Lost to Follow-up|1|||
126141257|NCT01993888|453807252|FG001|Overall Study|Lost to Follow-up|1|||
126141258|NCT01993888|453807251|FG000|Overall Study|Withdrawal by Subject|0|||
126141259|NCT01993888|453807252|FG001|Overall Study|Withdrawal by Subject|1|||
126141260|NCT00832819|453807254|FG000|Overall Study|Adverse Event|0|||
126141261|NCT00832819|453807255|FG001|Overall Study|Adverse Event|1|||
126141262|NCT00832819|453807256|FG002|Overall Study|Adverse Event|0|||
126141263|NCT00832819|453807254|FG000|Overall Study|Protocol Violation|0|||
126141264|NCT00832819|453807255|FG001|Overall Study|Protocol Violation|0|||
126141265|NCT00832819|453807256|FG002|Overall Study|Protocol Violation|1|||
126141266|NCT00317044|453807257|FG000|Overall Study|Protocol Violation|28|||
126141267|NCT00317044|453807258|FG001|Overall Study|Protocol Violation|22|||
126141268|NCT00317044|453807259|FG002|Overall Study|Protocol Violation|20|||
126141269|NCT00317044|453807257|FG000|Overall Study|Adverse Event|4|||
126141270|NCT00317044|453807258|FG001|Overall Study|Adverse Event|7|||
126141271|NCT00317044|453807259|FG002|Overall Study|Adverse Event|4|||
126141272|NCT00317044|453807257|FG000|Overall Study|Withdrawal by Subject|10|||
126141273|NCT00317044|453807258|FG001|Overall Study|Withdrawal by Subject|7|||
126141274|NCT00317044|453807259|FG002|Overall Study|Withdrawal by Subject|12|||
126141275|NCT00317044|453807257|FG000|Overall Study|Lost to Follow-up|0|||
126141276|NCT00317044|453807258|FG001|Overall Study|Lost to Follow-up|2|||
126141277|NCT00317044|453807259|FG002|Overall Study|Lost to Follow-up|3|||
126141278|NCT00317044|453807257|FG000|Overall Study|Multiple Reasons|6|||
126141279|NCT00317044|453807258|FG001|Overall Study|Multiple Reasons|2|||
126141280|NCT00317044|453807259|FG002|Overall Study|Multiple Reasons|6|||
126141281|NCT05742984|453807260|FG000|Overall Study|Adverse Event|0|||
126141282|NCT05742984|453807261|FG001|Overall Study|Adverse Event|0|||
126141283|NCT05742984|453807262|FG002|Overall Study|Adverse Event|1|||
126141284|NCT05742984|453807263|FG003|Overall Study|Adverse Event|0|||
126141285|NCT05742984|453807264|FG004|Overall Study|Adverse Event|1|||
126141286|NCT05742984|453807265|FG005|Overall Study|Adverse Event|1|||
126141287|NCT05742984|453807260|FG000|Overall Study|Withdrawal by Subject|0|||
126141288|NCT05742984|453807261|FG001|Overall Study|Withdrawal by Subject|1|||
126141289|NCT05742984|453807262|FG002|Overall Study|Withdrawal by Subject|0|||
126141290|NCT05742984|453807263|FG003|Overall Study|Withdrawal by Subject|0|||
126141291|NCT05742984|453807264|FG004|Overall Study|Withdrawal by Subject|0|||
126141292|NCT05742984|453807265|FG005|Overall Study|Withdrawal by Subject|2|||
126141293|NCT00379340|453807266|FG000|Overall Study|Death|0|||
126141294|NCT00379340|453807267|FG001|Overall Study|Death|0|||
126141295|NCT00379340|453807268|FG002|Overall Study|Death|0|||
126141296|NCT00379340|453807269|FG003|Overall Study|Death|2|||
126141297|NCT00379340|453807270|FG004|Overall Study|Death|0|||
126141298|NCT00379340|453807266|FG000|Overall Study|Lack of Efficacy|6|||
126141299|NCT00379340|453807267|FG001|Overall Study|Lack of Efficacy|1|||
126141300|NCT00379340|453807268|FG002|Overall Study|Lack of Efficacy|0|||
126141301|NCT00379340|453807269|FG003|Overall Study|Lack of Efficacy|4|||
126141302|NCT00379340|453807270|FG004|Overall Study|Lack of Efficacy|3|||
126141303|NCT00379340|453807266|FG000|Overall Study|Physician Decision|6|||
126141304|NCT00379340|453807267|FG001|Overall Study|Physician Decision|2|||
126141305|NCT00379340|453807268|FG002|Overall Study|Physician Decision|1|||
126141306|NCT00379340|453807269|FG003|Overall Study|Physician Decision|2|||
126141307|NCT00379340|453807270|FG004|Overall Study|Physician Decision|3|||
126141308|NCT00379340|453807266|FG000|Overall Study|Withdrawal by Subject|0|||
126141309|NCT00379340|453807267|FG001|Overall Study|Withdrawal by Subject|0|||
126141310|NCT00379340|453807268|FG002|Overall Study|Withdrawal by Subject|0|||
126141311|NCT00379340|453807269|FG003|Overall Study|Withdrawal by Subject|1|||
126141312|NCT00379340|453807270|FG004|Overall Study|Withdrawal by Subject|0|||
126141313|NCT00379340|453807266|FG000|Overall Study|Refusal of further protocol therapy|1|||
126141314|NCT00379340|453807267|FG001|Overall Study|Refusal of further protocol therapy|0|||
126141315|NCT00379340|453807268|FG002|Overall Study|Refusal of further protocol therapy|1|||
126141316|NCT00379340|453807269|FG003|Overall Study|Refusal of further protocol therapy|1|||
126141317|NCT00379340|453807270|FG004|Overall Study|Refusal of further protocol therapy|7|||
126141318|NCT00379340|453807266|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
126141319|NCT00379340|453807267|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
126141320|NCT00379340|453807268|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
126141321|NCT00379340|453807269|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
126141322|NCT00379340|453807270|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
126141323|NCT00379340|453807266|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
126141324|NCT00379340|453807267|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
126141325|NCT00379340|453807268|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
126141326|NCT00379340|453807269|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
126141327|NCT00379340|453807270|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
126141328|NCT00103012|453807276|FG000|Overall Study|Withdrawal by Subject|2|||
126141329|NCT00103012|453807277|FG001|Overall Study|Withdrawal by Subject|1|||
126141330|NCT00103012|453807278|FG002|Overall Study|Withdrawal by Subject|2|||
126141331|NCT00103012|453807276|FG000|Overall Study|Pregnancy|1|||
126141332|NCT00103012|453807277|FG001|Overall Study|Pregnancy|0|||
126141333|NCT00103012|453807278|FG002|Overall Study|Pregnancy|0|||
126141334|NCT00103012|453807276|FG000|Overall Study|Adverse Event|0|||
126141335|NCT00103012|453807277|FG001|Overall Study|Adverse Event|0|||
126141336|NCT00103012|453807278|FG002|Overall Study|Adverse Event|1|||
126141337|NCT00103012|453807276|FG000|Overall Study|Subject non-compliant with medications|0|||
126141338|NCT00103012|453807277|FG001|Overall Study|Subject non-compliant with medications|0|||
126141339|NCT00103012|453807278|FG002|Overall Study|Subject non-compliant with medications|1|||
126141340|NCT00430755|453807281|FG000|Overall Study|Withdrawal by Subject|53|||
126141341|NCT05019131|453807285|FG000|Overall Study|Lost to Follow-up|0|||
126141342|NCT05019131|453807286|FG001|Overall Study|Lost to Follow-up|3|||
126141343|NCT01703000|453807288|FG000|Overall Study|Death|1|||
126141344|NCT06118385|453807292|FG000|Overall Study|Protocol Violation|0|||
126141345|NCT06118385|453807293|FG001|Overall Study|Protocol Violation|0|||
126141346|NCT06118385|453807294|FG002|Overall Study|Protocol Violation|0|||
126141347|NCT06118385|453807295|FG003|Overall Study|Protocol Violation|0|||
126141348|NCT06118385|453807296|FG004|Overall Study|Protocol Violation|0|||
126141349|NCT06118385|453807297|FG005|Overall Study|Protocol Violation|0|||
126141350|NCT06118385|453807298|FG006|Overall Study|Protocol Violation|0|||
126141351|NCT06118385|453807299|FG007|Overall Study|Protocol Violation|0|||
126141352|NCT06118385|453807300|FG008|Overall Study|Protocol Violation|1|||
126141353|NCT06118385|453807301|FG009|Overall Study|Protocol Violation|0|||
126141354|NCT06118385|453807302|FG010|Overall Study|Protocol Violation|0|||
126141355|NCT06118385|453807303|FG011|Overall Study|Protocol Violation|0|||
126141356|NCT06118385|453807292|FG000|Overall Study|Out-of-range blood tests|0|||
126141357|NCT06118385|453807293|FG001|Overall Study|Out-of-range blood tests|0|||
126141358|NCT06118385|453807294|FG002|Overall Study|Out-of-range blood tests|0|||
126141359|NCT06118385|453807295|FG003|Overall Study|Out-of-range blood tests|0|||
126141360|NCT06118385|453807296|FG004|Overall Study|Out-of-range blood tests|0|||
126141361|NCT06118385|453807297|FG005|Overall Study|Out-of-range blood tests|0|||
126141362|NCT06118385|453807298|FG006|Overall Study|Out-of-range blood tests|0|||
126141363|NCT06118385|453807299|FG007|Overall Study|Out-of-range blood tests|0|||
126141364|NCT06118385|453807300|FG008|Overall Study|Out-of-range blood tests|1|||
126141365|NCT06118385|453807301|FG009|Overall Study|Out-of-range blood tests|0|||
126141366|NCT06118385|453807302|FG010|Overall Study|Out-of-range blood tests|0|||
126141367|NCT06118385|453807303|FG011|Overall Study|Out-of-range blood tests|0|||
126141368|NCT01323478|453807304|FG000|Overall Study|Adverse Event|7|||
126141369|NCT01323478|453807304|FG000|Overall Study|Lack of Efficacy|4|||
126141370|NCT01323478|453807304|FG000|Overall Study|Non-compliance With Study Product|3|||
126141371|NCT01323478|453807304|FG000|Overall Study|Protocol Violation|1|||
126141372|NCT01323478|453807304|FG000|Overall Study|Withdrawal of Consent|1|||
126141373|NCT01323478|453807304|FG000|Overall Study|Administrative or Other Reasons|8|||
126141374|NCT02411448|453807305|FG000|Overall Study|Withdrawal by Subject|1|||
126141375|NCT02411448|453807306|FG001|Overall Study|Withdrawal by Subject|14|||
126141376|NCT02411448|453807307|FG002|Overall Study|Withdrawal by Subject|9|||
126141377|NCT02411448|453807305|FG000|Overall Study|Other|0|||
126141378|NCT02411448|453807306|FG001|Overall Study|Other|2|||
126141379|NCT02411448|453807307|FG002|Overall Study|Other|0|||
126141380|NCT02411448|453807305|FG000|Overall Study|Did not receive study treatment|0|||
126141381|NCT02411448|453807306|FG001|Overall Study|Did not receive study treatment|3|||
126141382|NCT02411448|453807307|FG002|Overall Study|Did not receive study treatment|0|||
126141383|NCT02411448|453807305|FG000|Overall Study|Alive on study treatment|3|||
126141384|NCT02411448|453807306|FG001|Overall Study|Alive on study treatment|64|||
126141385|NCT02411448|453807307|FG002|Overall Study|Alive on study treatment|43|||
126141386|NCT02771522|453807310|FG000|Overall Study|Lost to Follow-up|3|||
126141387|NCT02771522|453807310|FG000|Overall Study|Withdrawal by Subject|2|||
126141388|NCT02771522|453807310|FG000|Overall Study|No white spot lesions|3|||
126141389|NCT05655377|453807313|FG000|Overall Study|Withdrawal by Subject|2|||
126141390|NCT01256177|453807314|FG000|Overall Study|Withdrawal by Subject|23|||
126141391|NCT01256177|453807315|FG001|Overall Study|Withdrawal by Subject|22|||
126141392|NCT01256177|453807314|FG000|Overall Study|Lost to Follow-up|2|||
126141393|NCT01256177|453807315|FG001|Overall Study|Lost to Follow-up|2|||
126141394|NCT01256177|453807314|FG000|Overall Study|Adverse Event|8|||
126141395|NCT01256177|453807315|FG001|Overall Study|Adverse Event|9|||
126141396|NCT01256177|453807314|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
126141397|NCT01256177|453807315|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
126141398|NCT01256177|453807314|FG000|Overall Study|Condition under Investigation Worsened|1|||
126141399|NCT01256177|453807315|FG001|Overall Study|Condition under Investigation Worsened|0|||
126141400|NCT01256177|453807314|FG000|Overall Study|Lack of Efficacy|11|||
126141401|NCT01256177|453807315|FG001|Overall Study|Lack of Efficacy|2|||
126141402|NCT01256177|453807314|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
126141403|NCT01256177|453807315|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
126141404|NCT00553462|453807317|FG000|Overall Study|Adverse Event|4|||
126141405|NCT00553462|453807317|FG000|Overall Study|Progression|4|||
126141406|NCT00553462|453807317|FG000|Overall Study|Withdrawal by Subject|5|||
126141407|NCT00553462|453807317|FG000|Overall Study|Physician Decision|1|||
126141408|NCT01728779|453807318|FG000|Overall Study|Withdrawal by Subject|1|||
126141409|NCT00675025|453807319|FG000|Overall Study|Study Terminated by Sponsor|38|||
126141410|NCT00675025|453807320|FG001|Overall Study|Study Terminated by Sponsor|42|||
126141411|NCT00675025|453807319|FG000|Overall Study|Adverse Event|6|||
126141412|NCT00675025|453807320|FG001|Overall Study|Adverse Event|11|||
126141413|NCT00675025|453807319|FG000|Overall Study|Lost to Follow-up|6|||
126141414|NCT00675025|453807320|FG001|Overall Study|Lost to Follow-up|4|||
126141415|NCT00675025|453807319|FG000|Overall Study|Withdrawal by Subject|4|||
126141416|NCT00675025|453807320|FG001|Overall Study|Withdrawal by Subject|6|||
126141417|NCT04398732|453807321|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
126141418|NCT01596257|453807323|FG000|Overall Study|Inadequate Collection|23|||
126141419|NCT01596257|453807324|FG001|Overall Study|Inadequate Collection|19|||
126141420|NCT01570244|453807325|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
126141421|NCT00792298|453807331|FG000|Treatment Period 1|Adverse Event|0|||
126141422|NCT00792298|453807332|FG001|Treatment Period 1|Adverse Event|1|||
126141423|NCT00792298|453807333|FG002|Treatment Period 1|Adverse Event|0|||
126141424|NCT00792298|453807334|FG003|Treatment Period 1|Adverse Event|1|||
126141425|NCT00792298|453807335|FG004|Treatment Period 1|Adverse Event|0|||
126141426|NCT00792298|453807336|FG005|Treatment Period 1|Adverse Event|1|||
126141427|NCT00792298|453807337|FG006|Treatment Period 1|Adverse Event|1|||
126141428|NCT00792298|453807338|FG007|Treatment Period 1|Adverse Event|0|||
126141429|NCT00792298|453807331|FG000|Treatment Period 1|Lack of Efficacy|0|||
126141430|NCT00792298|453807332|FG001|Treatment Period 1|Lack of Efficacy|0|||
126141431|NCT00792298|453807333|FG002|Treatment Period 1|Lack of Efficacy|1|||
126141432|NCT00792298|453807334|FG003|Treatment Period 1|Lack of Efficacy|0|||
126141433|NCT00792298|453807335|FG004|Treatment Period 1|Lack of Efficacy|0|||
126141434|NCT00792298|453807336|FG005|Treatment Period 1|Lack of Efficacy|0|||
126141435|NCT00792298|453807337|FG006|Treatment Period 1|Lack of Efficacy|0|||
126141436|NCT00792298|453807338|FG007|Treatment Period 1|Lack of Efficacy|0|||
126141437|NCT00792298|453807331|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126141438|NCT00792298|453807332|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126141439|NCT00792298|453807333|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126141440|NCT00792298|453807334|FG003|Treatment Period 1|Withdrawal by Subject|2|||
126141441|NCT00792298|453807335|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126141442|NCT00792298|453807336|FG005|Treatment Period 1|Withdrawal by Subject|2|||
126141443|NCT00792298|453807337|FG006|Treatment Period 1|Withdrawal by Subject|1|||
126141444|NCT00792298|453807338|FG007|Treatment Period 1|Withdrawal by Subject|0|||
126141445|NCT00792298|453807331|FG000|Treatment Period 1|Lost to Follow-up|0|||
126141446|NCT00792298|453807332|FG001|Treatment Period 1|Lost to Follow-up|0|||
126141447|NCT00792298|453807333|FG002|Treatment Period 1|Lost to Follow-up|0|||
126141448|NCT00792298|453807334|FG003|Treatment Period 1|Lost to Follow-up|0|||
126141449|NCT00792298|453807335|FG004|Treatment Period 1|Lost to Follow-up|0|||
126141450|NCT00792298|453807336|FG005|Treatment Period 1|Lost to Follow-up|0|||
126141451|NCT00792298|453807337|FG006|Treatment Period 1|Lost to Follow-up|1|||
126141452|NCT00792298|453807338|FG007|Treatment Period 1|Lost to Follow-up|0|||
126141453|NCT00792298|453807331|FG000|Treatment Period 1|Physician Decision|0|||
126141454|NCT00792298|453807332|FG001|Treatment Period 1|Physician Decision|0|||
126141455|NCT00792298|453807333|FG002|Treatment Period 1|Physician Decision|0|||
126141456|NCT00792298|453807334|FG003|Treatment Period 1|Physician Decision|1|||
126141457|NCT00792298|453807335|FG004|Treatment Period 1|Physician Decision|0|||
126141458|NCT00792298|453807336|FG005|Treatment Period 1|Physician Decision|0|||
126141459|NCT00792298|453807337|FG006|Treatment Period 1|Physician Decision|1|||
126141460|NCT00792298|453807338|FG007|Treatment Period 1|Physician Decision|0|||
126141461|NCT00792298|453807331|FG000|Treatment Period 1|Protocol Violation|0|||
126141462|NCT00792298|453807332|FG001|Treatment Period 1|Protocol Violation|0|||
126141463|NCT00792298|453807333|FG002|Treatment Period 1|Protocol Violation|0|||
126141464|NCT00792298|453807334|FG003|Treatment Period 1|Protocol Violation|0|||
126141465|NCT00792298|453807335|FG004|Treatment Period 1|Protocol Violation|0|||
126141466|NCT00792298|453807336|FG005|Treatment Period 1|Protocol Violation|0|||
126141467|NCT00792298|453807337|FG006|Treatment Period 1|Protocol Violation|0|||
126141468|NCT00792298|453807338|FG007|Treatment Period 1|Protocol Violation|1|||
126141469|NCT00792298|453807331|FG000|Washout|Adverse Event|0|||
126141470|NCT00792298|453807332|FG001|Washout|Adverse Event|0|||
126141471|NCT00792298|453807333|FG002|Washout|Adverse Event|0|||
126141472|NCT00792298|453807334|FG003|Washout|Adverse Event|0|||
126141473|NCT00792298|453807335|FG004|Washout|Adverse Event|0|||
126141474|NCT00792298|453807336|FG005|Washout|Adverse Event|1|||
126141475|NCT00792298|453807337|FG006|Washout|Adverse Event|0|||
126141476|NCT00792298|453807338|FG007|Washout|Adverse Event|0|||
126141477|NCT00792298|453807331|FG000|Washout|Withdrawal by Subject|0|||
126141478|NCT00792298|453807332|FG001|Washout|Withdrawal by Subject|0|||
126141479|NCT00792298|453807333|FG002|Washout|Withdrawal by Subject|1|||
126141480|NCT00792298|453807334|FG003|Washout|Withdrawal by Subject|0|||
126141481|NCT00792298|453807335|FG004|Washout|Withdrawal by Subject|0|||
126141482|NCT00792298|453807336|FG005|Washout|Withdrawal by Subject|1|||
126141483|NCT00792298|453807337|FG006|Washout|Withdrawal by Subject|0|||
126141484|NCT00792298|453807338|FG007|Washout|Withdrawal by Subject|0|||
126141485|NCT00792298|453807331|FG000|Treatment Period 2|Lack of Efficacy|0|||
126141486|NCT00792298|453807332|FG001|Treatment Period 2|Lack of Efficacy|0|||
126141487|NCT00792298|453807333|FG002|Treatment Period 2|Lack of Efficacy|0|||
126141488|NCT00792298|453807334|FG003|Treatment Period 2|Lack of Efficacy|0|||
126141489|NCT00792298|453807335|FG004|Treatment Period 2|Lack of Efficacy|1|||
126141490|NCT00792298|453807336|FG005|Treatment Period 2|Lack of Efficacy|0|||
126141491|NCT00792298|453807337|FG006|Treatment Period 2|Lack of Efficacy|0|||
126141492|NCT00792298|453807338|FG007|Treatment Period 2|Lack of Efficacy|0|||
126141493|NCT00792298|453807331|FG000|Treatment Period 2|Physician Decision|0|||
126141494|NCT00792298|453807332|FG001|Treatment Period 2|Physician Decision|0|||
126141495|NCT00792298|453807333|FG002|Treatment Period 2|Physician Decision|0|||
126141496|NCT00792298|453807334|FG003|Treatment Period 2|Physician Decision|0|||
126141497|NCT00792298|453807335|FG004|Treatment Period 2|Physician Decision|0|||
126141498|NCT00792298|453807336|FG005|Treatment Period 2|Physician Decision|0|||
126141499|NCT00792298|453807337|FG006|Treatment Period 2|Physician Decision|1|||
126141500|NCT00792298|453807338|FG007|Treatment Period 2|Physician Decision|0|||
126141501|NCT00792298|453807331|FG000|Treatment Period 2|Pregnancy|0|||
126141502|NCT00792298|453807332|FG001|Treatment Period 2|Pregnancy|0|||
126141503|NCT00792298|453807333|FG002|Treatment Period 2|Pregnancy|1|||
126141504|NCT00792298|453807334|FG003|Treatment Period 2|Pregnancy|0|||
126141505|NCT00792298|453807335|FG004|Treatment Period 2|Pregnancy|0|||
126141506|NCT00792298|453807336|FG005|Treatment Period 2|Pregnancy|0|||
126141507|NCT00792298|453807337|FG006|Treatment Period 2|Pregnancy|0|||
126141508|NCT00792298|453807338|FG007|Treatment Period 2|Pregnancy|0|||
126141509|NCT00792298|453807331|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126141510|NCT00792298|453807332|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126141511|NCT00792298|453807333|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126141512|NCT00792298|453807334|FG003|Treatment Period 2|Withdrawal by Subject|2|||
126141513|NCT00792298|453807335|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126141514|NCT00792298|453807336|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126141515|NCT00792298|453807337|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126141516|NCT00792298|453807338|FG007|Treatment Period 2|Withdrawal by Subject|2|||
126141517|NCT04258579|453807340|FG000|Overall Study|Withdrawal by Subject|7|||
126141518|NCT04258579|453807340|FG000|Overall Study|Lost to Follow-up|3|||
126141519|NCT04258579|453807340|FG000|Overall Study|Protocol Violation|2|||
126141520|NCT04258579|453807340|FG000|Overall Study|Adverse Event|1|||
126141521|NCT02388295|453807341|FG000|Dose Escalation Week 1|Adverse Event|1|||
126141522|NCT02388295|453807342|FG001|Dose Escalation Week 1|Adverse Event|2|||
126141523|NCT02388295|453807343|FG002|Dose Escalation Week 1|Adverse Event|1|||
126141524|NCT02388295|453807341|FG000|Dose Escalation Week 1|Determined not eligible|1|||
126141525|NCT02388295|453807342|FG001|Dose Escalation Week 1|Determined not eligible|1|||
126141526|NCT02388295|453807343|FG002|Dose Escalation Week 1|Determined not eligible|1|||
126141527|NCT02388295|453807341|FG000|Dose Escalation Week 2|Protocol Violation|0|||
126141528|NCT02388295|453807342|FG001|Dose Escalation Week 2|Protocol Violation|1|||
126141529|NCT02388295|453807343|FG002|Dose Escalation Week 2|Protocol Violation|0|||
126141530|NCT02388295|453807341|FG000|Dose Escalation Week 2|Determined not eligible|1|||
126141531|NCT02388295|453807342|FG001|Dose Escalation Week 2|Determined not eligible|1|||
126141532|NCT02388295|453807343|FG002|Dose Escalation Week 2|Determined not eligible|1|||
126141533|NCT02388295|453807341|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
126141534|NCT02388295|453807342|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
126141535|NCT02388295|453807343|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
126141536|NCT02076165|453807344|FG000|Overall Study|Lost to Follow-up|7|||
126141537|NCT02076165|453807345|FG001|Overall Study|Lost to Follow-up|5|||
126141538|NCT02076165|453807344|FG000|Overall Study|Refused follow-up assessment|1|||
126141539|NCT02076165|453807345|FG001|Overall Study|Refused follow-up assessment|1|||
126141540|NCT04134494|453807350|FG000|Overall Study|Lost to Follow-up|2|||
126141541|NCT00781365|453807351|FG000|Overall Study|Withdrawal by Subject|13|||
126141542|NCT00781365|453807352|FG001|Overall Study|Withdrawal by Subject|8|||
126141543|NCT00781365|453807351|FG000|Overall Study|Did Not Attend Visit|20|||
126141544|NCT00781365|453807352|FG001|Overall Study|Did Not Attend Visit|28|||
126141545|NCT00781365|453807351|FG000|Overall Study|Language barrier|1|||
126141546|NCT00781365|453807352|FG001|Overall Study|Language barrier|0|||
126141547|NCT01375764|453807362|FG000|Overall Study|Lost to Follow-up|0|||
126141548|NCT01375764|453807363|FG001|Overall Study|Lost to Follow-up|1|||
126141549|NCT01375764|453807364|FG002|Overall Study|Lost to Follow-up|0|||
126141550|NCT01375764|453807365|FG003|Overall Study|Lost to Follow-up|0|||
126141551|NCT01375764|453807366|FG004|Overall Study|Lost to Follow-up|0|||
126141552|NCT01375764|453807362|FG000|Overall Study|Withdrawal by Subject|2|||
126141553|NCT01375764|453807363|FG001|Overall Study|Withdrawal by Subject|0|||
126141554|NCT01375764|453807364|FG002|Overall Study|Withdrawal by Subject|0|||
126141555|NCT01375764|453807365|FG003|Overall Study|Withdrawal by Subject|0|||
126141556|NCT01375764|453807366|FG004|Overall Study|Withdrawal by Subject|1|||
126141557|NCT01375764|453807362|FG000|Overall Study|Other|0|||
126141558|NCT01375764|453807363|FG001|Overall Study|Other|0|||
126141559|NCT01375764|453807364|FG002|Overall Study|Other|0|||
126141560|NCT01375764|453807365|FG003|Overall Study|Other|1|||
126141561|NCT01375764|453807366|FG004|Overall Study|Other|0|||
126141562|NCT00584870|453807367|FG000|Overall Study|Adverse Event|4|||
126141563|NCT00584870|453807368|FG001|Overall Study|Adverse Event|3|||
126141564|NCT00584870|453807369|FG002|Overall Study|Adverse Event|2|||
126141565|NCT00584870|453807367|FG000|Overall Study|Lost to Follow-up|4|||
126141566|NCT00584870|453807368|FG001|Overall Study|Lost to Follow-up|1|||
126141567|NCT00584870|453807369|FG002|Overall Study|Lost to Follow-up|1|||
126141568|NCT00584870|453807367|FG000|Overall Study|Lack of Efficacy|7|||
126141569|NCT00584870|453807368|FG001|Overall Study|Lack of Efficacy|14|||
126141570|NCT00584870|453807369|FG002|Overall Study|Lack of Efficacy|8|||
126141571|NCT00584870|453807367|FG000|Overall Study|Withdrawal by Subject|10|||
126141572|NCT00584870|453807368|FG001|Overall Study|Withdrawal by Subject|5|||
126141573|NCT00584870|453807369|FG002|Overall Study|Withdrawal by Subject|3|||
126141574|NCT00584870|453807367|FG000|Overall Study|Protocol Violation|1|||
126141575|NCT00584870|453807368|FG001|Overall Study|Protocol Violation|1|||
126141576|NCT00584870|453807369|FG002|Overall Study|Protocol Violation|2|||
126141577|NCT00584870|453807367|FG000|Overall Study|Did not met entrance criteria|1|||
126141578|NCT00584870|453807368|FG001|Overall Study|Did not met entrance criteria|0|||
126141579|NCT00584870|453807369|FG002|Overall Study|Did not met entrance criteria|0|||
126141580|NCT00584870|453807367|FG000|Overall Study|Other|2|||
126141581|NCT00584870|453807368|FG001|Overall Study|Other|0|||
126141582|NCT00584870|453807369|FG002|Overall Study|Other|0|||
126141583|NCT00584870|453807367|FG000|Overall Study|Randomized but not treated|0|||
126141584|NCT00584870|453807368|FG001|Overall Study|Randomized but not treated|1|||
126141585|NCT00584870|453807369|FG002|Overall Study|Randomized but not treated|2|||
126141586|NCT01194440|453807370|FG000|Baseline (First Dose)|Reason not specified|4|||
126141587|NCT01194440|453807370|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
126141588|NCT01194440|453807370|FG000|Baseline (First Dose)|Change in therapy|1|||
126141589|NCT01194440|453807370|FG000|Baseline (First Dose)|Adverse Event|1|||
126141590|NCT01194440|453807370|FG000|6-months (2nd Dose)|Change in therapy|4|||
125968574|NCT03701555|453175814|FG002|Part 2 (Day 1)|Other|0|||
125968575|NCT03701555|453175815|FG003|Part 2 (Day 1)|Other|0|||
125968576|NCT03701555|453175816|FG004|Part 2 (Day 1)|Other|0|||
125968577|NCT03701555|453175817|FG005|Part 2 (Day 1)|Other|0|||
125968578|NCT03701555|453175818|FG006|Part 2 (Day 1)|Other|0|||
125968579|NCT03701555|453175819|FG007|Part 2 (Day 1)|Other|0|||
125968580|NCT03701555|453175820|FG008|Part 2 (Day 1)|Other|0|||
125968581|NCT03701555|453175821|FG009|Part 2 (Day 1)|Other|0|||
125968582|NCT03701555|453175822|FG010|Part 2 (Day 1)|Other|3|||
125968583|NCT03701555|453175823|FG011|Part 2 (Day 1)|Other|1|||
125968584|NCT03701555|453175824|FG012|Part 2 (Day 1)|Other|0|||
125968585|NCT03701555|453175825|FG013|Part 2 (Day 1)|Other|1|||
125968586|NCT03701555|453175826|FG014|Part 2 (Day 1)|Other|0|||
125968587|NCT03701555|453175827|FG015|Part 2 (Day 1)|Other|2|||
125968588|NCT03701555|453175828|FG016|Part 2 (Day 1)|Other|2|||
125968589|NCT03701555|453175829|FG017|Part 2 (Day 1)|Other|0|||
126141591|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141592|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141593|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141594|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
126141595|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141596|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
126141597|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141598|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141599|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141600|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141601|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141602|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141603|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141604|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141605|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141606|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141607|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141608|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141609|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141610|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141611|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141612|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141613|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126141614|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126141615|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
126141616|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126141617|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
126141618|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126141619|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126141620|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126141621|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141622|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141623|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141624|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141625|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125968590|NCT03701555|453175830|FG018|Part 2 (Day 1)|Other|0|||
125968591|NCT03701555|453175831|FG019|Part 2 (Day 1)|Other|0|||
125968592|NCT03701555|453175832|FG020|Part 2 (Day 1)|Other|0|||
125968593|NCT03701555|453175833|FG021|Part 2 (Day 1)|Other|0|||
125968594|NCT03701555|453175834|FG022|Part 2 (Day 1)|Other|0|||
125968595|NCT03701555|453175835|FG023|Part 2 (Day 1)|Other|0|||
126141626|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141627|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141628|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141629|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141630|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141631|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141632|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141633|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141634|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141635|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141636|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126141637|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
126141638|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
126141639|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
126141640|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
126141641|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
126141642|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
126141643|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
126141644|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
126141645|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141646|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141647|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141648|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141649|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141650|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141651|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141652|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141653|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141654|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141655|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141656|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141657|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141658|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141659|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126141660|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141661|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141662|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
126141663|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141664|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
126141665|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141666|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141667|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141668|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141669|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141670|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141671|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141672|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141673|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141674|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141675|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141676|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141677|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141678|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141679|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141680|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141681|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141682|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126141683|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
126141684|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141685|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141686|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
126141687|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141688|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141689|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141690|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141691|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141692|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141693|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141694|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141695|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141696|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141697|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141698|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141699|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141700|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141701|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141702|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141703|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141704|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141705|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126141706|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141707|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141708|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
126141709|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125968596|NCT03701555|453175836|FG024|Part 2 (Day 1)|Other|0|||
125968597|NCT03701555|453175837|FG025|Part 2 (Day 1)|Other|0|||
125968598|NCT03701555|453175838|FG026|Part 2 (Day 1)|Other|0|||
125968599|NCT03701555|453175839|FG027|Part 2 (Day 1)|Other|0|||
125968600|NCT03701555|453175840|FG028|Part 2 (Day 1)|Other|0|||
125968601|NCT03701555|453175841|FG029|Part 2 (Day 1)|Other|0|||
126141710|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141711|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141712|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141713|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141714|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141715|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141716|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141717|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141718|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141719|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141720|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141721|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141722|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141723|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141724|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141725|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141726|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141727|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141728|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126141729|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141730|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141731|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
126141732|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141733|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141734|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141735|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141736|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141737|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141738|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141739|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141740|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141741|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141742|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141743|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141744|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141745|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141746|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141747|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141748|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141749|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141750|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141751|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126141752|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141753|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141754|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141755|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
126141756|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141757|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141758|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141759|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141760|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141761|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141762|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141763|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141764|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141765|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141766|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141767|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141768|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141769|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141770|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141771|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141772|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141773|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141774|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126141775|NCT00896532|453807372|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141776|NCT00896532|453807373|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
126141777|NCT00896532|453807374|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141778|NCT00896532|453807375|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
126141779|NCT00896532|453807376|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
126141780|NCT00896532|453807377|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141781|NCT00896532|453807378|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141782|NCT00896532|453807379|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141783|NCT00896532|453807380|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141784|NCT00896532|453807381|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141785|NCT00896532|453807382|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141786|NCT00896532|453807383|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141787|NCT00896532|453807384|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141788|NCT00896532|453807385|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141789|NCT00896532|453807386|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141790|NCT00896532|453807387|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141791|NCT00896532|453807388|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141792|NCT00896532|453807389|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141793|NCT00896532|453807390|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141794|NCT00896532|453807391|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141795|NCT00896532|453807392|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141796|NCT00896532|453807393|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141797|NCT00896532|453807394|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126141798|NCT00896532|453807372|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141799|NCT00896532|453807373|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141800|NCT00896532|453807374|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141801|NCT00896532|453807375|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141802|NCT00896532|453807376|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141803|NCT00896532|453807377|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141804|NCT00896532|453807378|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141805|NCT00896532|453807379|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141806|NCT00896532|453807380|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
126141807|NCT00896532|453807381|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141808|NCT00896532|453807382|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141809|NCT00896532|453807383|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141810|NCT00896532|453807384|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125968602|NCT03701555|453175842|FG030|Part 2 (Day 1)|Other|0|||
125968603|NCT03701555|453175843|FG031|Part 2 (Day 1)|Other|0|||
126141811|NCT00896532|453807385|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141812|NCT00896532|453807386|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141813|NCT00896532|453807387|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141814|NCT00896532|453807388|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141815|NCT00896532|453807389|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141816|NCT00896532|453807390|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141817|NCT00896532|453807391|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141818|NCT00896532|453807392|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141819|NCT00896532|453807393|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141820|NCT00896532|453807394|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126141821|NCT00896532|453807372|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141822|NCT00896532|453807373|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141823|NCT00896532|453807374|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141824|NCT00896532|453807375|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141825|NCT00896532|453807376|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141826|NCT00896532|453807377|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141827|NCT00896532|453807378|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141828|NCT00896532|453807379|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141829|NCT00896532|453807380|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141830|NCT00896532|453807381|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141831|NCT00896532|453807382|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141832|NCT00896532|453807383|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141833|NCT00896532|453807384|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
126141834|NCT00896532|453807385|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141835|NCT00896532|453807386|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141836|NCT00896532|453807387|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141837|NCT00896532|453807388|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141838|NCT00896532|453807389|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141839|NCT00896532|453807390|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141840|NCT00896532|453807391|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141841|NCT00896532|453807392|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141842|NCT00896532|453807393|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141843|NCT00896532|453807394|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126141844|NCT00896532|453807372|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141845|NCT00896532|453807373|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141846|NCT00896532|453807374|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141847|NCT00896532|453807375|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141848|NCT00896532|453807376|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141849|NCT00896532|453807377|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141850|NCT00896532|453807378|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141851|NCT00896532|453807379|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141852|NCT00896532|453807380|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141853|NCT00896532|453807381|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141854|NCT00896532|453807382|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
126141855|NCT00896532|453807383|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141856|NCT00896532|453807384|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
126141857|NCT00896532|453807385|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141858|NCT00896532|453807386|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141859|NCT00896532|453807387|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141860|NCT00896532|453807388|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141861|NCT00896532|453807389|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141862|NCT00896532|453807390|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141863|NCT00896532|453807391|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141864|NCT00896532|453807392|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141865|NCT00896532|453807393|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141866|NCT00896532|453807394|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126141867|NCT00896532|453807372|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141868|NCT00896532|453807373|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141869|NCT00896532|453807374|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141870|NCT00896532|453807375|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141871|NCT00896532|453807376|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141872|NCT00896532|453807377|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141873|NCT00896532|453807378|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141874|NCT00896532|453807379|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141875|NCT00896532|453807380|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141876|NCT00896532|453807381|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141877|NCT00896532|453807382|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141878|NCT00896532|453807383|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141879|NCT00896532|453807384|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
126141880|NCT00896532|453807385|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
126141881|NCT00896532|453807386|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141882|NCT00896532|453807387|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141883|NCT00896532|453807388|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141884|NCT00896532|453807389|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141885|NCT00896532|453807390|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141886|NCT00896532|453807391|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141887|NCT00896532|453807392|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141888|NCT00896532|453807393|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141889|NCT00896532|453807394|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126141890|NCT00896532|453807372|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
126141891|NCT00896532|453807373|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
126141892|NCT00896532|453807374|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
126141893|NCT00896532|453807375|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
126141894|NCT00896532|453807376|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
126141895|NCT00896532|453807377|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
126141896|NCT00896532|453807378|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
126141897|NCT00896532|453807379|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
126141898|NCT00896532|453807380|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
126141899|NCT00896532|453807381|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
126141900|NCT00896532|453807382|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
126141901|NCT00896532|453807383|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
126141902|NCT00896532|453807384|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
126141903|NCT00896532|453807385|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
126141904|NCT00896532|453807386|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
126141905|NCT00896532|453807387|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
126141906|NCT00896532|453807388|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
126141907|NCT00896532|453807389|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
126141908|NCT00896532|453807390|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
126141909|NCT00896532|453807391|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
126141910|NCT00896532|453807392|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
126141911|NCT00896532|453807393|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
126141912|NCT00896532|453807394|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
126141913|NCT00896532|453807372|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141914|NCT00896532|453807373|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141915|NCT00896532|453807374|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141916|NCT00896532|453807375|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141917|NCT00896532|453807376|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141918|NCT00896532|453807377|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141919|NCT00896532|453807378|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141920|NCT00896532|453807379|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141921|NCT00896532|453807380|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141922|NCT00896532|453807381|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141923|NCT00896532|453807382|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141924|NCT00896532|453807383|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141925|NCT00896532|453807384|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141926|NCT00896532|453807385|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141927|NCT00896532|453807386|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141928|NCT00896532|453807387|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
126141929|NCT00896532|453807388|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
126141930|NCT00896532|453807389|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141931|NCT00896532|453807390|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141932|NCT00896532|453807391|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141933|NCT00896532|453807392|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141934|NCT00896532|453807393|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141935|NCT00896532|453807394|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126141936|NCT00896532|453807372|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141937|NCT00896532|453807373|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141938|NCT00896532|453807374|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141939|NCT00896532|453807375|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141940|NCT00896532|453807376|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141941|NCT00896532|453807377|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141942|NCT00896532|453807378|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141943|NCT00896532|453807379|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141944|NCT00896532|453807380|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141945|NCT00896532|453807381|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141946|NCT00896532|453807382|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141947|NCT00896532|453807383|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141948|NCT00896532|453807384|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141949|NCT00896532|453807385|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141950|NCT00896532|453807386|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141951|NCT00896532|453807387|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
126141952|NCT00896532|453807388|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
126141953|NCT00896532|453807389|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
126141954|NCT00896532|453807390|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141955|NCT00896532|453807391|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141956|NCT00896532|453807392|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141957|NCT00896532|453807393|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141958|NCT00896532|453807394|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126141959|NCT00896532|453807372|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141960|NCT00896532|453807373|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141961|NCT00896532|453807374|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141962|NCT00896532|453807375|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141963|NCT00896532|453807376|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141964|NCT00896532|453807377|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141965|NCT00896532|453807378|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141966|NCT00896532|453807379|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141967|NCT00896532|453807380|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141968|NCT00896532|453807381|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141969|NCT00896532|453807382|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141970|NCT00896532|453807383|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141971|NCT00896532|453807384|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125968604|NCT03701555|453175844|FG032|Part 2 (Day 1)|Other|0|||
125968605|NCT03701555|453175845|FG033|Part 2 (Day 1)|Other|0|||
125968606|NCT03701555|453175846|FG034|Part 2 (Day 1)|Other|0|||
125968607|NCT03701555|453175847|FG035|Part 2 (Day 1)|Other|0|||
126141972|NCT00896532|453807385|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141973|NCT00896532|453807386|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141974|NCT00896532|453807387|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141975|NCT00896532|453807388|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
126141976|NCT00896532|453807389|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141977|NCT00896532|453807390|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125968608|NCT03701555|453175812|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
125968609|NCT03701555|453175813|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
125968610|NCT03701555|453175814|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
125968611|NCT03701555|453175815|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
125968612|NCT03701555|453175816|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
125968613|NCT03701555|453175817|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
126141978|NCT00896532|453807391|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141979|NCT00896532|453807392|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141980|NCT00896532|453807393|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141981|NCT00896532|453807394|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126141982|NCT00896532|453807372|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
126141983|NCT00896532|453807373|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
126141984|NCT00896532|453807374|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
126141985|NCT00896532|453807375|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
126141986|NCT00896532|453807376|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
126141987|NCT00896532|453807377|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
126141988|NCT00896532|453807378|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
126141989|NCT00896532|453807379|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
126141990|NCT00896532|453807380|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
126141991|NCT00896532|453807381|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
126141992|NCT00896532|453807382|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
125968614|NCT03701555|453175818|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
125968615|NCT03701555|453175819|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
125968616|NCT03701555|453175820|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
125968617|NCT03701555|453175821|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
125968618|NCT03701555|453175822|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
126141993|NCT00896532|453807383|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
126141994|NCT00896532|453807384|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
126141995|NCT00896532|453807385|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
126141996|NCT00896532|453807386|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
126141997|NCT00896532|453807387|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
126141998|NCT00896532|453807388|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
126141999|NCT00896532|453807389|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
126142000|NCT00896532|453807390|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
126142001|NCT00896532|453807391|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
126142002|NCT00896532|453807392|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
126142003|NCT00896532|453807393|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
126142004|NCT00896532|453807394|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
126142005|NCT00896532|453807372|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142006|NCT00896532|453807373|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142007|NCT00896532|453807374|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142008|NCT00896532|453807375|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142009|NCT00896532|453807376|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142010|NCT00896532|453807377|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142011|NCT00896532|453807378|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142012|NCT00896532|453807379|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142013|NCT00896532|453807380|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142014|NCT00896532|453807381|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142015|NCT00896532|453807382|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142016|NCT00896532|453807383|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142017|NCT00896532|453807384|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142018|NCT00896532|453807385|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142019|NCT00896532|453807386|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142020|NCT00896532|453807387|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142021|NCT00896532|453807388|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
126142022|NCT00896532|453807389|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142023|NCT00896532|453807390|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142024|NCT00896532|453807391|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142025|NCT00896532|453807392|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142026|NCT00896532|453807393|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142027|NCT00896532|453807394|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126142028|NCT00896532|453807372|FG000|Months 48-72: Follow-on Phase|Death|0|||
126142029|NCT00896532|453807373|FG001|Months 48-72: Follow-on Phase|Death|0|||
126142030|NCT00896532|453807374|FG002|Months 48-72: Follow-on Phase|Death|0|||
126142031|NCT00896532|453807375|FG003|Months 48-72: Follow-on Phase|Death|0|||
126142032|NCT00896532|453807376|FG004|Months 48-72: Follow-on Phase|Death|0|||
126142033|NCT00896532|453807377|FG005|Months 48-72: Follow-on Phase|Death|0|||
126142034|NCT00896532|453807378|FG006|Months 48-72: Follow-on Phase|Death|0|||
126142035|NCT00896532|453807379|FG007|Months 48-72: Follow-on Phase|Death|0|||
126142036|NCT00896532|453807380|FG008|Months 48-72: Follow-on Phase|Death|0|||
126142037|NCT00896532|453807381|FG009|Months 48-72: Follow-on Phase|Death|0|||
126142038|NCT00896532|453807382|FG010|Months 48-72: Follow-on Phase|Death|0|||
126142039|NCT00896532|453807383|FG011|Months 48-72: Follow-on Phase|Death|0|||
126142040|NCT00896532|453807384|FG012|Months 48-72: Follow-on Phase|Death|0|||
126142041|NCT00896532|453807385|FG013|Months 48-72: Follow-on Phase|Death|0|||
126142042|NCT00896532|453807386|FG014|Months 48-72: Follow-on Phase|Death|0|||
126142043|NCT00896532|453807387|FG015|Months 48-72: Follow-on Phase|Death|0|||
126142044|NCT00896532|453807388|FG016|Months 48-72: Follow-on Phase|Death|0|||
126142045|NCT00896532|453807389|FG017|Months 48-72: Follow-on Phase|Death|0|||
126142046|NCT00896532|453807390|FG018|Months 48-72: Follow-on Phase|Death|1|||
126142047|NCT00896532|453807391|FG019|Months 48-72: Follow-on Phase|Death|0|||
126142048|NCT00896532|453807392|FG020|Months 48-72: Follow-on Phase|Death|0|||
126142049|NCT00896532|453807393|FG021|Months 48-72: Follow-on Phase|Death|0|||
126142050|NCT00896532|453807394|FG022|Months 48-72: Follow-on Phase|Death|0|||
126142051|NCT00896532|453807372|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142052|NCT00896532|453807373|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142053|NCT00896532|453807374|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142054|NCT00896532|453807375|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142055|NCT00896532|453807376|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142056|NCT00896532|453807377|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142057|NCT00896532|453807378|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142058|NCT00896532|453807379|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142059|NCT00896532|453807380|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142060|NCT00896532|453807381|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142061|NCT00896532|453807382|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142062|NCT00896532|453807383|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142063|NCT00896532|453807384|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142064|NCT00896532|453807385|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142065|NCT00896532|453807386|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142066|NCT00896532|453807387|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142067|NCT00896532|453807388|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142068|NCT00896532|453807389|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142069|NCT00896532|453807390|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142070|NCT00896532|453807391|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142071|NCT00896532|453807392|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142072|NCT00896532|453807393|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
126142073|NCT00896532|453807394|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126142074|NCT00896532|453807372|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142075|NCT00896532|453807373|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142076|NCT00896532|453807374|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142077|NCT00896532|453807375|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142078|NCT00896532|453807376|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142079|NCT00896532|453807377|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142080|NCT00896532|453807378|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142081|NCT00896532|453807379|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142082|NCT00896532|453807380|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142083|NCT00896532|453807381|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142084|NCT00896532|453807382|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142085|NCT00896532|453807383|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142086|NCT00896532|453807384|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142087|NCT00896532|453807385|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142088|NCT00896532|453807386|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142089|NCT00896532|453807387|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142090|NCT00896532|453807388|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142091|NCT00896532|453807389|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142092|NCT00896532|453807390|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142093|NCT00896532|453807391|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142094|NCT00896532|453807392|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142095|NCT00896532|453807393|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
126142096|NCT00896532|453807394|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126142097|NCT02149810|453807395|FG000|Overall Study|Physician Decision|1|||
126142098|NCT02149810|453807396|FG001|Overall Study|Physician Decision|2|||
126142099|NCT02149810|453807395|FG000|Overall Study|Lost to Follow-up|2|||
126142100|NCT02149810|453807396|FG001|Overall Study|Lost to Follow-up|1|||
126142101|NCT02149810|453807395|FG000|Overall Study|Withdrawal by Subject|5|||
126142102|NCT02149810|453807396|FG001|Overall Study|Withdrawal by Subject|1|||
126142103|NCT01176916|453807397|FG000|Overall Study|Adverse Event|61|||
126142104|NCT01176916|453807397|FG000|Overall Study|Death|1|||
126142105|NCT01176916|453807397|FG000|Overall Study|Lost to Follow-up|15|||
126142106|NCT01176916|453807397|FG000|Overall Study|Objective progression or relapse|17|||
126142107|NCT01176916|453807397|FG000|Overall Study|Protocol Violation|24|||
126142108|NCT01176916|453807397|FG000|Overall Study|Withdrawal by Subject|37|||
126142109|NCT01176916|453807397|FG000|Overall Study|Other|6|||
126142110|NCT01176916|453807397|FG000|Overall Study|Withdrawal prior to Treatment|6|||
126142111|NCT01015833|453807398|FG000|Overall Study|Death|1|||
126142112|NCT01015833|453807399|FG001|Overall Study|Death|0|||
126142113|NCT01015833|453807398|FG000|Overall Study|Withdrawal by Subject|3|||
126142114|NCT01015833|453807399|FG001|Overall Study|Withdrawal by Subject|2|||
126142115|NCT01015833|453807398|FG000|Overall Study|Adverse Event|0|||
126142116|NCT01015833|453807399|FG001|Overall Study|Adverse Event|1|||
126142117|NCT01015833|453807398|FG000|Overall Study|Physician Decision|2|||
126142118|NCT01015833|453807399|FG001|Overall Study|Physician Decision|0|||
126142119|NCT01015833|453807398|FG000|Overall Study|Symptomatic deterioration|0|||
126142120|NCT01015833|453807399|FG001|Overall Study|Symptomatic deterioration|1|||
126142121|NCT01015833|453807398|FG000|Overall Study|Other|5|||
126142122|NCT01015833|453807399|FG001|Overall Study|Other|1|||
126142123|NCT01015833|453807398|FG000|Overall Study|Motor Vehicle Accidents|1|||
126142124|NCT01015833|453807399|FG001|Overall Study|Motor Vehicle Accidents|0|||
126142125|NCT01015833|453807398|FG000|Overall Study|Did not start treatment|1|||
126142126|NCT01015833|453807399|FG001|Overall Study|Did not start treatment|0|||
126142127|NCT01959165|453807400|FG000|Overall Study|Adverse Event|0|||
126142128|NCT01959165|453807401|FG001|Overall Study|Adverse Event|0|||
126142129|NCT01959165|453807402|FG002|Overall Study|Adverse Event|0|||
126142130|NCT01959165|453807403|FG003|Overall Study|Adverse Event|1|||
126142131|NCT01959165|453807400|FG000|Overall Study|Lack of Efficacy|1|||
126142132|NCT01959165|453807401|FG001|Overall Study|Lack of Efficacy|0|||
126142133|NCT01959165|453807402|FG002|Overall Study|Lack of Efficacy|0|||
126142134|NCT01959165|453807403|FG003|Overall Study|Lack of Efficacy|0|||
126142135|NCT01959165|453807400|FG000|Overall Study|overdose|0|||
126142136|NCT01959165|453807401|FG001|Overall Study|overdose|0|||
126142137|NCT01959165|453807402|FG002|Overall Study|overdose|0|||
126142138|NCT01959165|453807403|FG003|Overall Study|overdose|1|||
126142139|NCT01959165|453807400|FG000|Overall Study|Welfare recipient|0|||
126142140|NCT01959165|453807401|FG001|Overall Study|Welfare recipient|1|||
126142141|NCT01959165|453807402|FG002|Overall Study|Welfare recipient|0|||
126142142|NCT01959165|453807403|FG003|Overall Study|Welfare recipient|0|||
126142143|NCT01468987|453807418|FG000|Overall Study|Adverse Event|12|||
126142144|NCT01468987|453807419|FG001|Overall Study|Adverse Event|9|||
126142145|NCT01468987|453807418|FG000|Overall Study|Death|4|||
126142146|NCT01468987|453807419|FG001|Overall Study|Death|1|||
126142147|NCT01468987|453807418|FG000|Overall Study|Lost to Follow-up|10|||
126142148|NCT01468987|453807419|FG001|Overall Study|Lost to Follow-up|5|||
126142149|NCT01468987|453807418|FG000|Overall Study|Protocol Violation|8|||
126142150|NCT01468987|453807419|FG001|Overall Study|Protocol Violation|2|||
126142151|NCT01468987|453807418|FG000|Overall Study|Withdrawal by Subject|28|||
126142152|NCT01468987|453807419|FG001|Overall Study|Withdrawal by Subject|28|||
126142153|NCT01468987|453807418|FG000|Overall Study|Physician Decision|8|||
126142154|NCT01468987|453807419|FG001|Overall Study|Physician Decision|15|||
126142155|NCT01468987|453807418|FG000|Overall Study|Sponsor Decision|1|||
126142156|NCT01468987|453807419|FG001|Overall Study|Sponsor Decision|0|||
126142157|NCT05032950|453807420|FG000|Overall Study|Adverse Event|0|||
126142158|NCT05032950|453807421|FG001|Overall Study|Adverse Event|0|||
126142159|NCT05032950|453807422|FG002|Overall Study|Adverse Event|1|||
126142160|NCT05032950|453807423|FG003|Overall Study|Adverse Event|1|||
126142161|NCT05032950|453807424|FG004|Overall Study|Adverse Event|0|||
126142162|NCT05032950|453807425|FG005|Overall Study|Adverse Event|0|||
126142163|NCT01929135|453807437|FG000|Overall Study|Lost to Follow-up|1|||
126142164|NCT01929135|453807438|FG001|Overall Study|Lost to Follow-up|1|||
126142165|NCT02425098|453807439|FG000|Overall Study|Lost to Follow-up|7|||
126142166|NCT02425098|453807440|FG001|Overall Study|Lost to Follow-up|7|||
126142167|NCT02425098|453807439|FG000|Overall Study|Withdrawal by Subject|4|||
126142168|NCT02425098|453807440|FG001|Overall Study|Withdrawal by Subject|8|||
126142169|NCT02425098|453807439|FG000|Overall Study|Pregnancy|2|||
126142170|NCT02425098|453807440|FG001|Overall Study|Pregnancy|0|||
126142171|NCT02425098|453807439|FG000|Overall Study|Reason not Specified|0|||
126142172|NCT02425098|453807440|FG001|Overall Study|Reason not Specified|1|||
126142173|NCT02078219|453807441|FG000|Overall Study|Other|2|||
126142174|NCT02078219|453807442|FG001|Overall Study|Other|2|||
126142175|NCT02078219|453807443|FG002|Overall Study|Other|3|||
126142176|NCT02078219|453807444|FG003|Overall Study|Other|0|||
126142177|NCT02078219|453807445|FG004|Overall Study|Other|1|||
126142178|NCT02078219|453807441|FG000|Overall Study|Withdrawal by Subject|0|||
126142179|NCT02078219|453807442|FG001|Overall Study|Withdrawal by Subject|1|||
126142180|NCT02078219|453807443|FG002|Overall Study|Withdrawal by Subject|0|||
126142181|NCT02078219|453807444|FG003|Overall Study|Withdrawal by Subject|1|||
126142182|NCT02078219|453807445|FG004|Overall Study|Withdrawal by Subject|1|||
126142183|NCT02078219|453807441|FG000|Overall Study|Protocol Violation|0|||
126142184|NCT02078219|453807442|FG001|Overall Study|Protocol Violation|0|||
126142185|NCT02078219|453807443|FG002|Overall Study|Protocol Violation|0|||
126142186|NCT02078219|453807444|FG003|Overall Study|Protocol Violation|1|||
126142187|NCT02078219|453807445|FG004|Overall Study|Protocol Violation|0|||
126142188|NCT02078219|453807441|FG000|Overall Study|Death|0|||
126142189|NCT02078219|453807442|FG001|Overall Study|Death|0|||
126142190|NCT02078219|453807443|FG002|Overall Study|Death|0|||
126142191|NCT02078219|453807444|FG003|Overall Study|Death|1|||
126142192|NCT02078219|453807445|FG004|Overall Study|Death|0|||
126142193|NCT02078219|453807441|FG000|Overall Study|Adverse Event|1|||
126142194|NCT02078219|453807442|FG001|Overall Study|Adverse Event|1|||
126142195|NCT02078219|453807443|FG002|Overall Study|Adverse Event|3|||
126142196|NCT02078219|453807444|FG003|Overall Study|Adverse Event|1|||
126142197|NCT02078219|453807445|FG004|Overall Study|Adverse Event|0|||
126142198|NCT03283085|453807452|FG000|Overall Study|Adverse Event|18|||
126142199|NCT03283085|453807453|FG001|Overall Study|Adverse Event|3|||
126142200|NCT03283085|453807454|FG002|Overall Study|Adverse Event|13|||
126142201|NCT03283085|453807455|FG003|Overall Study|Adverse Event|0|||
126142202|NCT03283085|453807456|FG004|Overall Study|Adverse Event|0|||
126142203|NCT03283085|453807457|FG005|Overall Study|Adverse Event|5|||
126142204|NCT03283085|453807452|FG000|Overall Study|Death|0|||
126142205|NCT03283085|453807453|FG001|Overall Study|Death|0|||
126142206|NCT03283085|453807454|FG002|Overall Study|Death|3|||
126142207|NCT03283085|453807455|FG003|Overall Study|Death|1|||
126142208|NCT03283085|453807456|FG004|Overall Study|Death|0|||
126142209|NCT03283085|453807457|FG005|Overall Study|Death|0|||
126142210|NCT03283085|453807452|FG000|Overall Study|Withdrawal by Subject|42|||
126142211|NCT03283085|453807453|FG001|Overall Study|Withdrawal by Subject|21|||
126142212|NCT03283085|453807454|FG002|Overall Study|Withdrawal by Subject|66|||
126142213|NCT03283085|453807455|FG003|Overall Study|Withdrawal by Subject|3|||
126142214|NCT03283085|453807456|FG004|Overall Study|Withdrawal by Subject|3|||
126142215|NCT03283085|453807457|FG005|Overall Study|Withdrawal by Subject|5|||
126142216|NCT03283085|453807452|FG000|Overall Study|Physician Decision|14|||
126142217|NCT03283085|453807453|FG001|Overall Study|Physician Decision|8|||
126142218|NCT03283085|453807454|FG002|Overall Study|Physician Decision|19|||
126142219|NCT03283085|453807455|FG003|Overall Study|Physician Decision|0|||
126142220|NCT03283085|453807456|FG004|Overall Study|Physician Decision|0|||
126142221|NCT03283085|453807457|FG005|Overall Study|Physician Decision|2|||
126142222|NCT03283085|453807452|FG000|Overall Study|Site Terminated by Sponsor|1|||
126142223|NCT03283085|453807453|FG001|Overall Study|Site Terminated by Sponsor|0|||
126142224|NCT03283085|453807454|FG002|Overall Study|Site Terminated by Sponsor|3|||
126142225|NCT03283085|453807455|FG003|Overall Study|Site Terminated by Sponsor|0|||
126142226|NCT03283085|453807456|FG004|Overall Study|Site Terminated by Sponsor|0|||
126142227|NCT03283085|453807457|FG005|Overall Study|Site Terminated by Sponsor|0|||
126142228|NCT03283085|453807452|FG000|Overall Study|Lost to Follow-up|2|||
126142229|NCT03283085|453807453|FG001|Overall Study|Lost to Follow-up|0|||
126142230|NCT03283085|453807454|FG002|Overall Study|Lost to Follow-up|2|||
126142231|NCT03283085|453807455|FG003|Overall Study|Lost to Follow-up|0|||
126142232|NCT03283085|453807456|FG004|Overall Study|Lost to Follow-up|0|||
126142233|NCT03283085|453807457|FG005|Overall Study|Lost to Follow-up|1|||
126142234|NCT03283085|453807452|FG000|Overall Study|Pregnancy|0|||
126142235|NCT03283085|453807453|FG001|Overall Study|Pregnancy|0|||
126142236|NCT03283085|453807454|FG002|Overall Study|Pregnancy|1|||
126142237|NCT03283085|453807455|FG003|Overall Study|Pregnancy|0|||
126142238|NCT03283085|453807456|FG004|Overall Study|Pregnancy|0|||
126142239|NCT03283085|453807457|FG005|Overall Study|Pregnancy|0|||
126142240|NCT03283085|453807452|FG000|Overall Study|Lack of Efficacy|12|||
126142241|NCT03283085|453807453|FG001|Overall Study|Lack of Efficacy|6|||
126142242|NCT03283085|453807454|FG002|Overall Study|Lack of Efficacy|24|||
126142243|NCT03283085|453807455|FG003|Overall Study|Lack of Efficacy|1|||
126142244|NCT03283085|453807456|FG004|Overall Study|Lack of Efficacy|1|||
126142245|NCT03283085|453807457|FG005|Overall Study|Lack of Efficacy|0|||
126142246|NCT03283085|453807452|FG000|Overall Study|Reason not Specified|0|||
126142247|NCT03283085|453807453|FG001|Overall Study|Reason not Specified|4|||
126142248|NCT03283085|453807454|FG002|Overall Study|Reason not Specified|8|||
126142249|NCT03283085|453807455|FG003|Overall Study|Reason not Specified|0|||
126142250|NCT03283085|453807456|FG004|Overall Study|Reason not Specified|0|||
126142251|NCT03283085|453807457|FG005|Overall Study|Reason not Specified|1|||
126142252|NCT03136107|453807458|FG000|Overall Study|Other (Not specified)|1|||
126142253|NCT02292771|453807462|FG000|Overall Study|Withdrawal by Subject|2|||
126142254|NCT02292771|453807463|FG001|Overall Study|Withdrawal by Subject|1|||
126142255|NCT02292771|453807462|FG000|Overall Study|Lost to Follow-up|2|||
126142256|NCT02292771|453807463|FG001|Overall Study|Lost to Follow-up|1|||
126142257|NCT00851903|453809602|FG000|Overall Study|Withdrawal by Subject|2|||
126142258|NCT02300129|453809603|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
126142259|NCT02300129|453809604|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
126142260|NCT02300129|453809605|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
126142261|NCT02300129|453809606|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
126142262|NCT02300129|453809603|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
126142263|NCT02300129|453809604|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
126142264|NCT02300129|453809605|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
126142265|NCT02300129|453809606|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
126142266|NCT02300129|453809603|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
126142267|NCT02300129|453809604|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
126142268|NCT02300129|453809605|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
126142269|NCT02300129|453809606|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
126142270|NCT00522392|453809609|FG000|Overall Study|Disease progression|0|||
126142271|NCT00522392|453809610|FG001|Overall Study|Disease progression|3|||
126142272|NCT00522392|453809609|FG000|Overall Study|Adverse Event|7|||
126142273|NCT00522392|453809610|FG001|Overall Study|Adverse Event|7|||
126142274|NCT00522392|453809609|FG000|Overall Study|Withdrawal by Subject|1|||
126142275|NCT00522392|453809610|FG001|Overall Study|Withdrawal by Subject|1|||
126142276|NCT00522392|453809609|FG000|Overall Study|Physician Decision|0|||
126142277|NCT00522392|453809610|FG001|Overall Study|Physician Decision|1|||
126142278|NCT00522392|453809609|FG000|Overall Study|Non-compliance|0|||
126142279|NCT00522392|453809610|FG001|Overall Study|Non-compliance|1|||
126142280|NCT05211336|453809617|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
126142281|NCT05211336|453809618|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
126142282|NCT05211336|453809617|FG000|Overall Study|Progressive disease|0|||
126142283|NCT05211336|453809618|FG001|Overall Study|Progressive disease|4|||
126142284|NCT05211336|453809617|FG000|Overall Study|Death due to myocardial infarction|0|||
126142285|NCT05211336|453809618|FG001|Overall Study|Death due to myocardial infarction|1|||
126142286|NCT05211336|453809617|FG000|Overall Study|Death due to unknown cause|0|||
126142287|NCT05211336|453809618|FG001|Overall Study|Death due to unknown cause|1|||
126142288|NCT05211336|453809617|FG000|Overall Study|Worsening kidney function and quality of response|0|||
126142289|NCT05211336|453809618|FG001|Overall Study|Worsening kidney function and quality of response|1|||
126142290|NCT00332709|453809624|FG000|Overall Study|Adverse Event|11|||
126142291|NCT00332709|453809625|FG001|Overall Study|Adverse Event|14|||
126142292|NCT00332709|453809624|FG000|Overall Study|Withdrawal by Subject|2|||
126142293|NCT00332709|453809625|FG001|Overall Study|Withdrawal by Subject|3|||
126142294|NCT00332709|453809624|FG000|Overall Study|Lost to Follow-up|2|||
126142295|NCT00332709|453809625|FG001|Overall Study|Lost to Follow-up|0|||
126142296|NCT00332709|453809624|FG000|Overall Study|Administrative Problems|0|||
126142297|NCT00332709|453809625|FG001|Overall Study|Administrative Problems|3|||
126142298|NCT00332709|453809624|FG000|Overall Study|Abnormal test procedure result|1|||
126142299|NCT00332709|453809625|FG001|Overall Study|Abnormal test procedure result|0|||
126142300|NCT03575104|453809626|FG000|Overall Study|Adverse Event|4|||
126142301|NCT03575104|453809627|FG001|Overall Study|Adverse Event|3|||
126142302|NCT03575104|453809628|FG002|Overall Study|Adverse Event|4|||
126142303|NCT03575104|453809626|FG000|Overall Study|Withdrawal by Subject|13|||
126142304|NCT03575104|453809627|FG001|Overall Study|Withdrawal by Subject|16|||
126142305|NCT03575104|453809628|FG002|Overall Study|Withdrawal by Subject|11|||
126142306|NCT03575104|453809626|FG000|Overall Study|Other reasons|6|||
126142307|NCT03575104|453809627|FG001|Overall Study|Other reasons|8|||
126142308|NCT03575104|453809628|FG002|Overall Study|Other reasons|6|||
126142309|NCT03575104|453809626|FG000|Overall Study|Lost to Follow-up|1|||
126142310|NCT03575104|453809627|FG001|Overall Study|Lost to Follow-up|2|||
126142311|NCT03575104|453809628|FG002|Overall Study|Lost to Follow-up|1|||
126142312|NCT01409928|453809630|FG000|Overall Study|Physician Decision|12|||
126142313|NCT00432237|453809633|FG000|Overall Study|Adverse Event|0|||
126142314|NCT00432237|453809634|FG001|Overall Study|Adverse Event|0|||
126142315|NCT00432237|453809635|FG002|Overall Study|Adverse Event|0|||
126142316|NCT00432237|453809636|FG003|Overall Study|Adverse Event|1|||
126142317|NCT00432237|453809633|FG000|Overall Study|Lack of Efficacy|0|||
126142318|NCT00432237|453809634|FG001|Overall Study|Lack of Efficacy|0|||
126142319|NCT00432237|453809635|FG002|Overall Study|Lack of Efficacy|0|||
126142320|NCT00432237|453809636|FG003|Overall Study|Lack of Efficacy|1|||
126142321|NCT00432237|453809633|FG000|Overall Study|Lost to Follow-up|10|||
126142322|NCT00432237|453809634|FG001|Overall Study|Lost to Follow-up|10|||
126142323|NCT00432237|453809635|FG002|Overall Study|Lost to Follow-up|18|||
126142324|NCT00432237|453809636|FG003|Overall Study|Lost to Follow-up|18|||
126142325|NCT00432237|453809633|FG000|Overall Study|Physician Decision|1|||
126142326|NCT00432237|453809634|FG001|Overall Study|Physician Decision|3|||
126142327|NCT00432237|453809635|FG002|Overall Study|Physician Decision|2|||
126142328|NCT00432237|453809636|FG003|Overall Study|Physician Decision|1|||
126142329|NCT00432237|453809633|FG000|Overall Study|Pregnancy|0|||
126142330|NCT00432237|453809634|FG001|Overall Study|Pregnancy|1|||
126142331|NCT00432237|453809635|FG002|Overall Study|Pregnancy|0|||
126142332|NCT00432237|453809636|FG003|Overall Study|Pregnancy|0|||
126142333|NCT00432237|453809633|FG000|Overall Study|Protocol Violation|13|||
126142334|NCT00432237|453809634|FG001|Overall Study|Protocol Violation|10|||
126142335|NCT00432237|453809635|FG002|Overall Study|Protocol Violation|11|||
126142336|NCT00432237|453809636|FG003|Overall Study|Protocol Violation|8|||
126142337|NCT00432237|453809633|FG000|Overall Study|Withdrawal by Subject|5|||
126142338|NCT00432237|453809634|FG001|Overall Study|Withdrawal by Subject|6|||
126142339|NCT00432237|453809635|FG002|Overall Study|Withdrawal by Subject|9|||
126142340|NCT00432237|453809636|FG003|Overall Study|Withdrawal by Subject|11|||
126142341|NCT00432237|453809633|FG000|Overall Study|Lack of Qualifying Event|38|||
126142342|NCT00432237|453809634|FG001|Overall Study|Lack of Qualifying Event|71|||
126142343|NCT00432237|453809635|FG002|Overall Study|Lack of Qualifying Event|69|||
126142344|NCT00432237|453809636|FG003|Overall Study|Lack of Qualifying Event|84|||
126142345|NCT00603239|453809637|FG000|Overall Study|Adverse Event|4|||
126142346|NCT00603239|453809638|FG001|Overall Study|Adverse Event|1|||
126142347|NCT00603239|453809637|FG000|Overall Study|Entry criteria not met|0|||
126142348|NCT00603239|453809638|FG001|Overall Study|Entry criteria not met|1|||
126142349|NCT00603239|453809637|FG000|Overall Study|Loss of glucose control|3|||
126142350|NCT00603239|453809638|FG001|Overall Study|Loss of glucose control|0|||
126142351|NCT00603239|453809637|FG000|Overall Study|Lost to Follow-up|2|||
126142352|NCT00603239|453809638|FG001|Overall Study|Lost to Follow-up|1|||
126142353|NCT00603239|453809637|FG000|Overall Study|Physician Decision|2|||
126142354|NCT00603239|453809638|FG001|Overall Study|Physician Decision|0|||
126142355|NCT00603239|453809637|FG000|Overall Study|Protocol Violation|2|||
126142356|NCT00603239|453809638|FG001|Overall Study|Protocol Violation|0|||
126142357|NCT00603239|453809637|FG000|Overall Study|Subject decision|2|||
126142358|NCT00603239|453809638|FG001|Overall Study|Subject decision|1|||
126142359|NCT01354132|453809639|FG000|Randomization|Physician Decision|1|||
126142360|NCT01354132|453809640|FG001|Randomization|Physician Decision|0|||
126142361|NCT01354132|453809639|FG000|Randomization|Withdrawal by Subject|0|||
126142362|NCT01354132|453809640|FG001|Randomization|Withdrawal by Subject|1|||
126142363|NCT01354132|453809639|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
126142364|NCT01354132|453809640|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
126142365|NCT01354132|453809639|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
126142366|NCT01354132|453809640|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
126142367|NCT01354132|453809639|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
126142368|NCT01354132|453809640|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
126142369|NCT02357420|453809641|FG000|Overall Study|Adverse Event|3|||
126142370|NCT02357420|453809642|FG001|Overall Study|Adverse Event|3|||
126142371|NCT02357420|453809643|FG002|Overall Study|Adverse Event|8|||
126142372|NCT02357420|453809644|FG003|Overall Study|Adverse Event|9|||
126142373|NCT02357420|453809641|FG000|Overall Study|Investigator Decision|1|||
126142374|NCT02357420|453809642|FG001|Overall Study|Investigator Decision|0|||
126142375|NCT02357420|453809643|FG002|Overall Study|Investigator Decision|0|||
126142376|NCT02357420|453809644|FG003|Overall Study|Investigator Decision|0|||
126142377|NCT02357420|453809641|FG000|Overall Study|Prohibited Medication|1|||
126142378|NCT02357420|453809642|FG001|Overall Study|Prohibited Medication|1|||
126142379|NCT02357420|453809643|FG002|Overall Study|Prohibited Medication|0|||
126142380|NCT02357420|453809644|FG003|Overall Study|Prohibited Medication|0|||
126142381|NCT02357420|453809641|FG000|Overall Study|Protocol Non-compliance|0|||
126142382|NCT02357420|453809642|FG001|Overall Study|Protocol Non-compliance|0|||
126142383|NCT02357420|453809643|FG002|Overall Study|Protocol Non-compliance|0|||
126142384|NCT02357420|453809644|FG003|Overall Study|Protocol Non-compliance|1|||
126142385|NCT02357420|453809641|FG000|Overall Study|Withdrawn Consent|4|||
126142386|NCT02357420|453809642|FG001|Overall Study|Withdrawn Consent|8|||
126142387|NCT02357420|453809643|FG002|Overall Study|Withdrawn Consent|6|||
126142388|NCT02357420|453809644|FG003|Overall Study|Withdrawn Consent|6|||
126142389|NCT02357420|453809641|FG000|Overall Study|Lost to Follow-up|3|||
126142390|NCT02357420|453809642|FG001|Overall Study|Lost to Follow-up|0|||
126142391|NCT02357420|453809643|FG002|Overall Study|Lost to Follow-up|2|||
126142392|NCT02357420|453809644|FG003|Overall Study|Lost to Follow-up|3|||
126142393|NCT00928070|453809647|FG000|Overall Study|Lost to Follow-up|1|||
126142394|NCT00928070|453809648|FG001|Overall Study|Lost to Follow-up|2|||
126142395|NCT00928070|453809647|FG000|Overall Study|Withdrawal by Subject|10|||
126142396|NCT00928070|453809648|FG001|Overall Study|Withdrawal by Subject|3|||
126142397|NCT00928070|453809647|FG000|Overall Study|Adverse Event|14|||
126142398|NCT00928070|453809648|FG001|Overall Study|Adverse Event|26|||
126142399|NCT00928070|453809647|FG000|Overall Study|Lack of Efficacy|9|||
126142400|NCT00928070|453809648|FG001|Overall Study|Lack of Efficacy|5|||
126142401|NCT00928070|453809647|FG000|Overall Study|Did not meet entrance criteria|16|||
126142402|NCT00928070|453809648|FG001|Overall Study|Did not meet entrance criteria|9|||
126142403|NCT00928070|453809647|FG000|Overall Study|Protocol Violation|6|||
126142404|NCT00928070|453809648|FG001|Overall Study|Protocol Violation|5|||
126142405|NCT00928070|453809647|FG000|Overall Study|Randomized but not treated|2|||
126142406|NCT00928070|453809648|FG001|Overall Study|Randomized but not treated|2|||
126142407|NCT00928070|453809647|FG000|Overall Study|Other|5|||
126142408|NCT00928070|453809648|FG001|Overall Study|Other|5|||
126142409|NCT00191854|453809649|FG000|Overall Study|Death|26|||
126142410|NCT00191854|453809650|FG001|Overall Study|Death|23|||
126142411|NCT00191854|453809651|FG002|Overall Study|Death|29|||
126142412|NCT00191854|453809649|FG000|Overall Study|Lost to Follow-up|7|||
126142413|NCT00191854|453809650|FG001|Overall Study|Lost to Follow-up|5|||
126142414|NCT00191854|453809651|FG002|Overall Study|Lost to Follow-up|5|||
126142415|NCT00191854|453809649|FG000|Overall Study|Withdrawal by Subject|4|||
126142416|NCT00191854|453809650|FG001|Overall Study|Withdrawal by Subject|2|||
126142417|NCT00191854|453809651|FG002|Overall Study|Withdrawal by Subject|3|||
126142418|NCT00191854|453809649|FG000|Overall Study|Sponsor Decision|0|||
126142419|NCT00191854|453809650|FG001|Overall Study|Sponsor Decision|0|||
126142420|NCT00191854|453809651|FG002|Overall Study|Sponsor Decision|1|||
126142421|NCT00191854|453809649|FG000|Overall Study|Screen Failure|0|||
126142422|NCT00191854|453809650|FG001|Overall Study|Screen Failure|0|||
126142423|NCT00191854|453809651|FG002|Overall Study|Screen Failure|1|||
126142424|NCT04067518|453809653|FG000|Overall Study|Adverse Event|1|||
126142425|NCT04067518|453809654|FG001|Overall Study|Adverse Event|3|||
126142426|NCT04067518|453809653|FG000|Overall Study|Screen failures|0|||
126142427|NCT04067518|453809654|FG001|Overall Study|Screen failures|1|||
126142428|NCT04067518|453809653|FG000|Overall Study|Enrolled but not treated|0|||
126142429|NCT04067518|453809654|FG001|Overall Study|Enrolled but not treated|1|||
126142430|NCT00862251|453809655|FG000|Overall Study|Adverse Event|8|||
126142431|NCT00862251|453809656|FG001|Overall Study|Adverse Event|3|||
126142432|NCT00862251|453809657|FG002|Overall Study|Adverse Event|1|||
126142433|NCT00862251|453809655|FG000|Overall Study|Lost to Follow-up|0|||
126142434|NCT00862251|453809656|FG001|Overall Study|Lost to Follow-up|0|||
126142435|NCT00862251|453809657|FG002|Overall Study|Lost to Follow-up|1|||
126142436|NCT00862251|453809655|FG000|Overall Study|Protocol Violation|2|||
126142437|NCT00862251|453809656|FG001|Overall Study|Protocol Violation|0|||
126142438|NCT00862251|453809657|FG002|Overall Study|Protocol Violation|1|||
126142439|NCT00862251|453809655|FG000|Overall Study|Withdrawal by Subject|9|||
126142440|NCT00862251|453809656|FG001|Overall Study|Withdrawal by Subject|2|||
126142441|NCT00862251|453809657|FG002|Overall Study|Withdrawal by Subject|6|||
126142442|NCT02054702|453809663|FG000|Overall Study|Lost to Follow-up|3|||
126142443|NCT02054702|453809664|FG001|Overall Study|Lost to Follow-up|5|||
126142444|NCT02054702|453809663|FG000|Overall Study|Adverse Event|3|||
126142445|NCT02054702|453809664|FG001|Overall Study|Adverse Event|1|||
126142446|NCT02054702|453809663|FG000|Overall Study|Met Withdrawal Criteria|4|||
126142447|NCT02054702|453809664|FG001|Overall Study|Met Withdrawal Criteria|1|||
126142448|NCT02054702|453809663|FG000|Overall Study|Physician Decision|0|||
126142449|NCT02054702|453809664|FG001|Overall Study|Physician Decision|1|||
126142450|NCT02054702|453809663|FG000|Overall Study|Withdrawal by Subject|14|||
126142451|NCT02054702|453809664|FG001|Overall Study|Withdrawal by Subject|4|||
126142452|NCT00934102|453809666|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
126142453|NCT00934102|453809667|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
126142454|NCT00934102|453809668|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
126142455|NCT02318784|453809669|FG000|Overall Study|Adverse Event|13|||
126142456|NCT02318784|453809669|FG000|Overall Study|Death|2|||
126142457|NCT02318784|453809669|FG000|Overall Study|Progressive Disease|37|||
126142458|NCT02318784|453809669|FG000|Overall Study|Withdrawal by Subject|10|||
126142459|NCT02304926|453809670|FG000|Overall Study|Lost to Follow-up|2|||
126142460|NCT02304926|453809671|FG001|Overall Study|Lost to Follow-up|1|||
126142461|NCT04007159|453809674|FG000|Induction Phase|(missed study visits)|16|||
126142462|NCT04007159|453809674|FG000|Induction Phase|Withdrawal by Subject|4|||
126142463|NCT04007159|453809674|FG000|Induction Phase|Adverse Event|2|||
126142464|NCT04007159|453809674|FG000|Challenge Phase|missed study visits|3|||
126142465|NCT03157531|453809675|FG000|Overall Study|Death|2|||
126142466|NCT03157531|453809675|FG000|Overall Study|Lost to Follow-up|4|||
126142467|NCT00331006|453809676|FG000|Screening Phase|Withdrawal by Subject|1|||
126142468|NCT00331006|453809676|FG000|Screening Phase|enrollment halted|1|||
126142469|NCT00331006|453809676|FG000|Screening Phase|Lost to Follow-up|1|||
126142470|NCT00331006|453809676|FG000|Screening Phase|Ineligible for treatment phase|4|||
126142471|NCT00331006|453809676|FG000|Treatment Phase|Withdrawal by Subject|1|||
126142472|NCT00331006|453809676|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
126142473|NCT00331006|453809676|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
126142474|NCT03804684|453809677|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
126142475|NCT03804684|453809678|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
126142476|NCT00238264|453809685|FG000|Overall Study|Death|7|||
126142477|NCT00238264|453809685|FG000|Overall Study|Lost to Follow-up|18|||
126142478|NCT00238264|453809685|FG000|Overall Study|Withdrawal by Subject|4|||
126142479|NCT00238264|453809685|FG000|Overall Study|Ineligible|7|||
126142480|NCT02706938|453809686|FG000|First Period, 6 Weeks|Adverse Event|8|||
126142481|NCT02706938|453809687|FG001|First Period, 6 Weeks|Adverse Event|0|||
126142482|NCT02706938|453809686|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
126142483|NCT02706938|453809687|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
126142484|NCT02706938|453809686|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
126142485|NCT02706938|453809687|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
126142486|NCT02706938|453809686|FG000|Second Period, 6 Weeks|Adverse Event|0|||
126142487|NCT02706938|453809687|FG001|Second Period, 6 Weeks|Adverse Event|7|||
126142488|NCT02706938|453809686|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
126142489|NCT02706938|453809687|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
126142490|NCT01838044|453809688|FG000|Overall Study|Adverse Event|4|||
126142491|NCT01838044|453809689|FG001|Overall Study|Adverse Event|6|||
126142492|NCT01838044|453809688|FG000|Overall Study|Protocol Violation|3|||
126142493|NCT01838044|453809689|FG001|Overall Study|Protocol Violation|3|||
126142494|NCT01838044|453809688|FG000|Overall Study|Withdrawal by Subject|0|||
126142495|NCT01838044|453809689|FG001|Overall Study|Withdrawal by Subject|2|||
126142496|NCT01838044|453809688|FG000|Overall Study|Insufficient clinical response|1|||
126142497|NCT01838044|453809689|FG001|Overall Study|Insufficient clinical response|2|||
126142498|NCT01838044|453809688|FG000|Overall Study|Medication error without associated AE|0|||
126142499|NCT01838044|453809689|FG001|Overall Study|Medication error without associated AE|1|||
126142500|NCT01838044|453809688|FG000|Overall Study|Lost to Follow-up|0|||
126142501|NCT01838044|453809689|FG001|Overall Study|Lost to Follow-up|2|||
126142502|NCT00860470|453809693|FG000|Overall Study|Death|6|||
126142503|NCT00860470|453809694|FG001|Overall Study|Death|10|||
126142504|NCT00860470|453809693|FG000|Overall Study|Moved away|8|||
126142505|NCT00860470|453809694|FG001|Overall Study|Moved away|10|||
126142506|NCT00860470|453809693|FG000|Overall Study|Lost to Follow-up|34|||
126142507|NCT00860470|453809694|FG001|Overall Study|Lost to Follow-up|39|||
126142508|NCT01662648|453809696|FG000|Overall Study|Death|1|||
126142509|NCT01662648|453809697|FG001|Overall Study|Death|3|||
126142510|NCT01662648|453809696|FG000|Overall Study|Adverse Event|40|||
126142511|NCT01662648|453809697|FG001|Overall Study|Adverse Event|37|||
126142512|NCT01662648|453809696|FG000|Overall Study|Lack of Efficacy|17|||
126142513|NCT01662648|453809697|FG001|Overall Study|Lack of Efficacy|16|||
126142514|NCT01662648|453809696|FG000|Overall Study|Participant ineligible to continue trial|1|||
126142515|NCT01662648|453809697|FG001|Overall Study|Participant ineligible to continue trial|1|||
126142516|NCT01662648|453809696|FG000|Overall Study|Lost to Follow-up|24|||
126142517|NCT01662648|453809697|FG001|Overall Study|Lost to Follow-up|36|||
126142518|NCT01662648|453809696|FG000|Overall Study|Withdrawal by Subject|36|||
126142519|NCT01662648|453809697|FG001|Overall Study|Withdrawal by Subject|53|||
126142520|NCT01662648|453809696|FG000|Overall Study|Participant non-compliant|16|||
126142521|NCT01662648|453809697|FG001|Overall Study|Participant non-compliant|20|||
126142522|NCT01662648|453809696|FG000|Overall Study|Other|8|||
126142523|NCT01662648|453809697|FG001|Overall Study|Other|11|||
126142524|NCT01662648|453809696|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
126142525|NCT01662648|453809697|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
126142526|NCT01662648|453809696|FG000|Overall Study|LOE and other reason unspecified|1|||
126142527|NCT01662648|453809697|FG001|Overall Study|LOE and other reason unspecified|0|||
126142528|NCT01662648|453809696|FG000|Overall Study|LOE and Participant non-compliant|0|||
126142529|NCT01662648|453809697|FG001|Overall Study|LOE and Participant non-compliant|1|||
126142530|NCT02928952|453809698|FG000|Overall Study|Lost to Follow-up|5|||
126142531|NCT02928952|453809699|FG001|Overall Study|Lost to Follow-up|5|||
126142532|NCT02928952|453809698|FG000|Overall Study|Withdrawal by Subject|5|||
126142533|NCT02928952|453809699|FG001|Overall Study|Withdrawal by Subject|1|||
126142534|NCT02928952|453809698|FG000|Overall Study|Physician Decision|0|||
126142535|NCT02928952|453809699|FG001|Overall Study|Physician Decision|1|||
126142536|NCT03751111|453809700|FG000|Overall Study|Lack of Efficacy|9|||
126142537|NCT03751111|453809701|FG001|Overall Study|Lack of Efficacy|30|||
126142538|NCT03751111|453809700|FG000|Overall Study|Adverse Event|3|||
126142539|NCT03751111|453809701|FG001|Overall Study|Adverse Event|2|||
126142540|NCT00723957|453809702|FG000|Overall Study|Adverse event unrelated to study drug|1|||
126142541|NCT00723957|453809703|FG001|Overall Study|Adverse event unrelated to study drug|4|||
126142542|NCT00723957|453809702|FG000|Overall Study|Death|3|||
126142543|NCT00723957|453809703|FG001|Overall Study|Death|4|||
126142544|NCT00723957|453809702|FG000|Overall Study|Disease progression|27|||
126142545|NCT00723957|453809703|FG001|Overall Study|Disease progression|25|||
126142546|NCT00723957|453809702|FG000|Overall Study|Maximum clinical benefit|4|||
126142547|NCT00723957|453809703|FG001|Overall Study|Maximum clinical benefit|5|||
126142548|NCT00723957|453809702|FG000|Overall Study|Investigator decision|1|||
126142549|NCT00723957|453809703|FG001|Overall Study|Investigator decision|1|||
126142550|NCT00723957|453809702|FG000|Overall Study|Study drug toxicity|4|||
126142551|NCT00723957|453809703|FG001|Overall Study|Study drug toxicity|6|||
126142552|NCT00723957|453809702|FG000|Overall Study|Withdrawal by Subject|7|||
126142553|NCT00723957|453809703|FG001|Overall Study|Withdrawal by Subject|5|||
126142554|NCT00723957|453809702|FG000|Overall Study|Reason not analyzed|1|||
126142555|NCT00723957|453809703|FG001|Overall Study|Reason not analyzed|0|||
126142556|NCT00723957|453809702|FG000|Overall Study|Never received treatment|3|||
126142557|NCT00723957|453809703|FG001|Overall Study|Never received treatment|3|||
126142558|NCT00706628|453809705|FG000|Overall Study|Other Adverse Event|16|||
126142559|NCT00706628|453809706|FG001|Overall Study|Other Adverse Event|5|||
126142560|NCT00706628|453809707|FG002|Overall Study|Other Adverse Event|5|||
126142561|NCT00706628|453809708|FG003|Overall Study|Other Adverse Event|2|||
126142562|NCT00706628|453809705|FG000|Overall Study|Non compliant with protocol|0|||
126142563|NCT00706628|453809706|FG001|Overall Study|Non compliant with protocol|1|||
126142564|NCT00706628|453809707|FG002|Overall Study|Non compliant with protocol|0|||
126142565|NCT00706628|453809708|FG003|Overall Study|Non compliant with protocol|0|||
126142566|NCT00706628|453809705|FG000|Overall Study|Consent withdrawn|6|||
126142567|NCT00706628|453809706|FG001|Overall Study|Consent withdrawn|1|||
126142568|NCT00706628|453809707|FG002|Overall Study|Consent withdrawn|3|||
126142569|NCT00706628|453809708|FG003|Overall Study|Consent withdrawn|0|||
126142570|NCT00706628|453809705|FG000|Overall Study|Progressive disease|20|||
126142571|NCT00706628|453809706|FG001|Overall Study|Progressive disease|13|||
126142572|NCT00706628|453809707|FG002|Overall Study|Progressive disease|8|||
126142573|NCT00706628|453809708|FG003|Overall Study|Progressive disease|1|||
126142574|NCT00706628|453809705|FG000|Overall Study|Other than those stated above|4|||
126142575|NCT00706628|453809706|FG001|Overall Study|Other than those stated above|0|||
126142576|NCT00706628|453809707|FG002|Overall Study|Other than those stated above|0|||
126142577|NCT00706628|453809708|FG003|Overall Study|Other than those stated above|0|||
126142578|NCT00706628|453809705|FG000|Overall Study|Not treated|1|||
126142579|NCT00706628|453809706|FG001|Overall Study|Not treated|1|||
126142580|NCT00706628|453809707|FG002|Overall Study|Not treated|0|||
126142581|NCT00706628|453809708|FG003|Overall Study|Not treated|0|||
126142582|NCT01264939|453809709|FG000|Overall Study|Adverse Event|1|||
126142583|NCT01264939|453809710|FG001|Overall Study|Adverse Event|3|||
126142584|NCT01264939|453809709|FG000|Overall Study|Lost to Follow-up|0|||
126142585|NCT01264939|453809710|FG001|Overall Study|Lost to Follow-up|3|||
126142586|NCT01264939|453809709|FG000|Overall Study|Physician Decision|1|||
126142587|NCT01264939|453809710|FG001|Overall Study|Physician Decision|1|||
126142588|NCT01264939|453809709|FG000|Overall Study|Patient/Guardian Decision|8|||
126142589|NCT01264939|453809710|FG001|Overall Study|Patient/Guardian Decision|10|||
126142590|NCT01264939|453809709|FG000|Overall Study|Disease Progression|8|||
126142591|NCT01264939|453809710|FG001|Overall Study|Disease Progression|11|||
126142592|NCT02266433|453809715|FG000|Overall Study|Lost to Follow-up|54|||
126142593|NCT02266433|453809716|FG001|Overall Study|Lost to Follow-up|46|||
126142594|NCT02266433|453809715|FG000|Overall Study|Withdrawal by Subject|5|||
126142595|NCT02266433|453809716|FG001|Overall Study|Withdrawal by Subject|7|||
126142596|NCT04525703|453809717|FG000|Overall Study|Lost to Follow-up|6|||
126142597|NCT04525703|453809718|FG001|Overall Study|Lost to Follow-up|15|||
126142598|NCT04525703|453809719|FG002|Overall Study|Lost to Follow-up|8|||
126142599|NCT01285349|453809720|FG000|Overall Study|Lost to Follow-up|27|||
126142600|NCT01285349|453809721|FG001|Overall Study|Lost to Follow-up|20|||
126142601|NCT01285349|453809722|FG002|Overall Study|Lost to Follow-up|27|||
126142602|NCT01145560|453809723|FG000|Overall Study|Withdrawal by Subject|2|||
126142603|NCT01145560|453809724|FG001|Overall Study|Withdrawal by Subject|1|||
126142604|NCT01145560|453809725|FG002|Overall Study|Withdrawal by Subject|0|||
126142605|NCT01145560|453809723|FG000|Overall Study|Lost to Follow-up|1|||
126142606|NCT01145560|453809724|FG001|Overall Study|Lost to Follow-up|1|||
126142607|NCT01145560|453809725|FG002|Overall Study|Lost to Follow-up|1|||
126142608|NCT01145560|453809723|FG000|Overall Study|No study drug by 24h after organ failure|1|||
126142609|NCT01145560|453809724|FG001|Overall Study|No study drug by 24h after organ failure|0|||
126142610|NCT01145560|453809725|FG002|Overall Study|No study drug by 24h after organ failure|0|||
126142611|NCT01145560|453809723|FG000|Overall Study|Accidental unblinding of study treatment|0|||
126142612|NCT01145560|453809724|FG001|Overall Study|Accidental unblinding of study treatment|1|||
126142613|NCT01145560|453809725|FG002|Overall Study|Accidental unblinding of study treatment|0|||
126142614|NCT01145560|453809723|FG000|Overall Study|False insurance information|0|||
126142615|NCT01145560|453809724|FG001|Overall Study|False insurance information|1|||
126142616|NCT01145560|453809725|FG002|Overall Study|False insurance information|0|||
126142617|NCT01145560|453809723|FG000|Overall Study|Withdrawal of therapy|0|||
126142618|NCT01145560|453809724|FG001|Overall Study|Withdrawal of therapy|0|||
126142619|NCT01145560|453809725|FG002|Overall Study|Withdrawal of therapy|1|||
126142620|NCT00712348|453809726|FG000|Overall Study|Withdrawal by Subject|1|||
126142621|NCT02452762|453809728|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
126142622|NCT02452762|453809729|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
126142623|NCT02452762|453809728|FG000|Overall Study|Withdrawal by Subject|1|||
126142624|NCT02452762|453809729|FG001|Overall Study|Withdrawal by Subject|0|||
126142625|NCT02675075|453809730|FG000|Overall Study|Lost to Follow-up|3|||
126142626|NCT02675075|453809731|FG001|Overall Study|Lost to Follow-up|0|||
126142627|NCT02292212|453809732|FG000|ViE Phase|Withdrawal by Subject|1|||
126142628|NCT02292212|453809732|FG000|ViE Phase|Protocol Violation|2|||
126142629|NCT00675597|453809733|FG000|Overall Study|Withdrawal by Subject|3|||
126142630|NCT00631137|453809734|FG000|Overall Study|Withdrawal by Subject|1|||
126142631|NCT00631137|453809735|FG001|Overall Study|Withdrawal by Subject|0|||
126142632|NCT03682120|453809736|FG000|Overall Study|Lost to Follow-up|11|||
126142633|NCT03682120|453809737|FG001|Overall Study|Lost to Follow-up|4|||
126142634|NCT03682120|453809738|FG002|Overall Study|Lost to Follow-up|5|||
126142635|NCT03682120|453809739|FG003|Overall Study|Lost to Follow-up|2|||
126142636|NCT03682120|453809736|FG000|Overall Study|Physician Decision|1|||
126142637|NCT03682120|453809737|FG001|Overall Study|Physician Decision|0|||
126142638|NCT03682120|453809738|FG002|Overall Study|Physician Decision|0|||
126142639|NCT03682120|453809739|FG003|Overall Study|Physician Decision|0|||
126142640|NCT03682120|453809736|FG000|Overall Study|Withdrawal by Subject|1|||
126142641|NCT03682120|453809737|FG001|Overall Study|Withdrawal by Subject|2|||
126142642|NCT03682120|453809738|FG002|Overall Study|Withdrawal by Subject|3|||
126142643|NCT03682120|453809739|FG003|Overall Study|Withdrawal by Subject|0|||
126142644|NCT03682120|453809736|FG000|Overall Study|Death|0|||
126142645|NCT03682120|453809737|FG001|Overall Study|Death|1|||
126142646|NCT03682120|453809738|FG002|Overall Study|Death|0|||
126142647|NCT03682120|453809739|FG003|Overall Study|Death|0|||
126142648|NCT03682120|453809736|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
126142649|NCT03682120|453809737|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
126142650|NCT03682120|453809738|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
126142651|NCT03682120|453809739|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
126142652|NCT03308188|453809740|FG000|Overall Study|Withdrawal by Subject|0|||
126142653|NCT03308188|453809741|FG001|Overall Study|Withdrawal by Subject|3|||
126142654|NCT03308188|453809740|FG000|Overall Study|Death|0|||
126142655|NCT03308188|453809741|FG001|Overall Study|Death|1|||
126142656|NCT01791855|453809742|FG000|Overall Study|Adverse Event|0|||
126142657|NCT01791855|453809743|FG001|Overall Study|Adverse Event|0|||
126142658|NCT01791855|453809744|FG002|Overall Study|Adverse Event|0|||
126142659|NCT01791855|453809745|FG003|Overall Study|Adverse Event|1|||
126142660|NCT01791855|453809742|FG000|Overall Study|Randomized, not treated|0|||
126142661|NCT01791855|453809743|FG001|Overall Study|Randomized, not treated|1|||
126142662|NCT01791855|453809744|FG002|Overall Study|Randomized, not treated|0|||
126142663|NCT01791855|453809745|FG003|Overall Study|Randomized, not treated|0|||
126142664|NCT00772447|453809746|FG000|Overall Study|Withdrawal by Subject|9|||
126142665|NCT00772447|453809747|FG001|Overall Study|Withdrawal by Subject|5|||
126142666|NCT00772447|453809746|FG000|Overall Study|Physician Decision|4|||
126142667|NCT00772447|453809747|FG001|Overall Study|Physician Decision|8|||
126142668|NCT00772447|453809746|FG000|Overall Study|Lost to Follow-up|2|||
126142669|NCT00772447|453809747|FG001|Overall Study|Lost to Follow-up|4|||
126142670|NCT00772447|453809746|FG000|Overall Study|incorrect enrolment|3|||
126142671|NCT00772447|453809747|FG001|Overall Study|incorrect enrolment|4|||
126142672|NCT00772447|453809746|FG000|Overall Study|Protocol Violation|0|||
126142673|NCT00772447|453809747|FG001|Overall Study|Protocol Violation|1|||
126142674|NCT00772447|453809746|FG000|Overall Study|all others|2|||
126142675|NCT00772447|453809747|FG001|Overall Study|all others|2|||
126142676|NCT01957137|453809748|FG000|Randomized Portion|Adverse Event|1|||
126142677|NCT01957137|453809748|FG000|Randomized Portion|Withdrawal by Subject|1|||
126142678|NCT02959814|453809750|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
126142679|NCT02959814|453809750|FG000|Overall Study|Excluded based on anatomical criteria|2|||
126142680|NCT02959814|453809750|FG000|Overall Study|Protocol Violation|7|||
126142681|NCT02959814|453809750|FG000|Overall Study|FFR not measured|2|||
126142682|NCT02959814|453809750|FG000|Overall Study|In-procedure QFR not computed|6|||
126142683|NCT02959814|453809750|FG000|Overall Study|Excluded by FFR core-lab|24|||
126142684|NCT02116621|453809751|FG000|Baseline|Withdrawal by Subject|0|||
126142685|NCT02116621|453809752|FG001|Baseline|Withdrawal by Subject|4|||
126142686|NCT02116621|453809751|FG000|Three Month Follow-up|Death|1|||
126142687|NCT02116621|453809752|FG001|Three Month Follow-up|Death|1|||
126142688|NCT02116621|453809751|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
126142689|NCT02116621|453809752|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
126142690|NCT02116621|453809751|FG000|Three Month Follow-up|Lost to Follow-up|0|||
126142691|NCT02116621|453809752|FG001|Three Month Follow-up|Lost to Follow-up|1|||
126142692|NCT02116621|453809751|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
126142693|NCT02116621|453809752|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
126142694|NCT02116621|453809751|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
126142695|NCT02116621|453809752|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
126142696|NCT02116621|453809751|FG000|Six Month Follow-up|Lost to Follow-up|2|||
126142697|NCT02116621|453809752|FG001|Six Month Follow-up|Lost to Follow-up|1|||
126142698|NCT02116621|453809751|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
126142699|NCT02116621|453809752|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
126142700|NCT02116621|453809751|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
126142701|NCT02116621|453809752|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
126142702|NCT02116621|453809751|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
126142703|NCT02116621|453809752|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
126142704|NCT02116621|453809751|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
126142705|NCT02116621|453809752|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
126142706|NCT02116621|453809751|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
126142707|NCT02116621|453809752|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
126142708|NCT00961961|453809753|FG000|Phase I|Withdrawal by Subject|7|||
126142709|NCT00961961|453809754|FG001|Phase I|Withdrawal by Subject|0|||
126142710|NCT00961961|453809755|FG002|Phase I|Withdrawal by Subject|0|||
126142711|NCT00961961|453809756|FG003|Phase I|Withdrawal by Subject|0|||
126142712|NCT00961961|453809753|FG000|Phase I|Lost to Follow-up|10|||
126142713|NCT00961961|453809754|FG001|Phase I|Lost to Follow-up|0|||
126142714|NCT00961961|453809755|FG002|Phase I|Lost to Follow-up|0|||
126142715|NCT00961961|453809756|FG003|Phase I|Lost to Follow-up|0|||
126142716|NCT00961961|453809753|FG000|Phase I|Lack of Efficacy|94|||
126142717|NCT00961961|453809754|FG001|Phase I|Lack of Efficacy|0|||
126142718|NCT00961961|453809755|FG002|Phase I|Lack of Efficacy|0|||
126142719|NCT00961961|453809756|FG003|Phase I|Lack of Efficacy|0|||
125968619|NCT03701555|453175823|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
125968620|NCT03701555|453175824|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
125968621|NCT03701555|453175825|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
125968622|NCT03701555|453175826|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
125968623|NCT03701555|453175827|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
125968624|NCT03701555|453175828|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
125968625|NCT03701555|453175829|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
125968626|NCT03701555|453175830|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
125968627|NCT03701555|453175831|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
125968628|NCT03701555|453175832|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
125968629|NCT03701555|453175833|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
125968630|NCT03701555|453175834|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
125968631|NCT03701555|453175835|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
125968632|NCT03701555|453175836|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
125968633|NCT03701555|453175837|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
126142720|NCT00961961|453809753|FG000|Phase I|Adverse Event|7|||
126142721|NCT00961961|453809754|FG001|Phase I|Adverse Event|0|||
126142722|NCT00961961|453809755|FG002|Phase I|Adverse Event|0|||
126142723|NCT00961961|453809756|FG003|Phase I|Adverse Event|0|||
126142724|NCT00961961|453809753|FG000|Phase I|Physician Decision|8|||
126142725|NCT00961961|453809754|FG001|Phase I|Physician Decision|0|||
126142726|NCT00961961|453809755|FG002|Phase I|Physician Decision|0|||
126142727|NCT00961961|453809756|FG003|Phase I|Physician Decision|0|||
126142728|NCT00961961|453809753|FG000|Phase II|Lost to Follow-up|0|||
126142729|NCT00961961|453809754|FG001|Phase II|Lost to Follow-up|0|||
126142730|NCT00961961|453809755|FG002|Phase II|Lost to Follow-up|10|||
126142731|NCT00961961|453809756|FG003|Phase II|Lost to Follow-up|7|||
126142732|NCT00961961|453809753|FG000|Phase II|Adverse Event|0|||
126142733|NCT00961961|453809754|FG001|Phase II|Adverse Event|0|||
125968634|NCT03701555|453175838|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
125968635|NCT03701555|453175839|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
125968636|NCT03701555|453175840|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
125968637|NCT03701555|453175841|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
125968638|NCT03701555|453175842|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
125968639|NCT03701555|453175843|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
125968640|NCT03701555|453175844|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
125968641|NCT03701555|453175845|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
125968642|NCT03701555|453175846|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
125968643|NCT03701555|453175847|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
125968644|NCT03701555|453175812|FG000|Part 3 (Day 1)|Subject Decision|0|||
125968645|NCT03701555|453175813|FG001|Part 3 (Day 1)|Subject Decision|0|||
125968646|NCT03701555|453175814|FG002|Part 3 (Day 1)|Subject Decision|0|||
125968647|NCT03701555|453175815|FG003|Part 3 (Day 1)|Subject Decision|0|||
125968648|NCT03701555|453175816|FG004|Part 3 (Day 1)|Subject Decision|0|||
125968649|NCT03701555|453175817|FG005|Part 3 (Day 1)|Subject Decision|0|||
126142734|NCT00961961|453809755|FG002|Phase II|Adverse Event|0|||
126142735|NCT00961961|453809756|FG003|Phase II|Adverse Event|1|||
126142736|NCT00961961|453809753|FG000|Phase II|Physician Decision|0|||
126142737|NCT00961961|453809754|FG001|Phase II|Physician Decision|0|||
126142738|NCT00961961|453809755|FG002|Phase II|Physician Decision|1|||
126142739|NCT00961961|453809756|FG003|Phase II|Physician Decision|0|||
126142740|NCT00961961|453809753|FG000|Phase II|Withdrawal by Subject|0|||
126142741|NCT00961961|453809754|FG001|Phase II|Withdrawal by Subject|0|||
126142742|NCT00961961|453809755|FG002|Phase II|Withdrawal by Subject|1|||
126142743|NCT00961961|453809756|FG003|Phase II|Withdrawal by Subject|0|||
126142744|NCT03437447|453809757|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126142745|NCT03437447|453809758|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126142746|NCT03437447|453809759|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126142747|NCT02764541|453809760|FG000|Overall Study|Withdrawal by Subject|0|||
126142748|NCT02764541|453809761|FG001|Overall Study|Withdrawal by Subject|0|||
126142749|NCT02764541|453809762|FG002|Overall Study|Withdrawal by Subject|0|||
126142750|NCT02764541|453809763|FG003|Overall Study|Withdrawal by Subject|0|||
126142751|NCT02764541|453809764|FG004|Overall Study|Withdrawal by Subject|1|||
126142752|NCT02764541|453809765|FG005|Overall Study|Withdrawal by Subject|1|||
126142753|NCT02764541|453809766|FG006|Overall Study|Withdrawal by Subject|0|||
126142754|NCT02764541|453809767|FG007|Overall Study|Withdrawal by Subject|1|||
126142755|NCT02764541|453809760|FG000|Overall Study|Adverse Event|1|||
126142756|NCT02764541|453809761|FG001|Overall Study|Adverse Event|0|||
126142757|NCT02764541|453809762|FG002|Overall Study|Adverse Event|0|||
126142758|NCT02764541|453809763|FG003|Overall Study|Adverse Event|0|||
126142759|NCT02764541|453809764|FG004|Overall Study|Adverse Event|0|||
126142760|NCT02764541|453809765|FG005|Overall Study|Adverse Event|0|||
126142761|NCT02764541|453809766|FG006|Overall Study|Adverse Event|1|||
126142762|NCT02764541|453809767|FG007|Overall Study|Adverse Event|0|||
126142763|NCT02764541|453809760|FG000|Overall Study|Metastasis|1|||
126142764|NCT02764541|453809761|FG001|Overall Study|Metastasis|0|||
126142765|NCT02764541|453809762|FG002|Overall Study|Metastasis|0|||
126142766|NCT02764541|453809763|FG003|Overall Study|Metastasis|0|||
126142767|NCT02764541|453809764|FG004|Overall Study|Metastasis|0|||
126142768|NCT02764541|453809765|FG005|Overall Study|Metastasis|0|||
126142769|NCT02764541|453809766|FG006|Overall Study|Metastasis|0|||
126142770|NCT02764541|453809767|FG007|Overall Study|Metastasis|0|||
126142771|NCT02764541|453809760|FG000|Overall Study|Disease progression|1|||
126142772|NCT02764541|453809761|FG001|Overall Study|Disease progression|1|||
126142773|NCT02764541|453809762|FG002|Overall Study|Disease progression|0|||
126142774|NCT02764541|453809763|FG003|Overall Study|Disease progression|0|||
126142775|NCT02764541|453809764|FG004|Overall Study|Disease progression|0|||
126142776|NCT02764541|453809765|FG005|Overall Study|Disease progression|0|||
126142777|NCT02764541|453809766|FG006|Overall Study|Disease progression|0|||
126142778|NCT02764541|453809767|FG007|Overall Study|Disease progression|1|||
126142779|NCT02764541|453809760|FG000|Overall Study|Protocol Violation|0|||
126142780|NCT02764541|453809761|FG001|Overall Study|Protocol Violation|0|||
126142781|NCT02764541|453809762|FG002|Overall Study|Protocol Violation|0|||
126142782|NCT02764541|453809763|FG003|Overall Study|Protocol Violation|1|||
126142783|NCT02764541|453809764|FG004|Overall Study|Protocol Violation|0|||
125968650|NCT03701555|453175818|FG006|Part 3 (Day 1)|Subject Decision|0|||
125968651|NCT03701555|453175819|FG007|Part 3 (Day 1)|Subject Decision|0|||
126142784|NCT02764541|453809765|FG005|Overall Study|Protocol Violation|1|||
126142785|NCT02764541|453809766|FG006|Overall Study|Protocol Violation|0|||
126142786|NCT02764541|453809767|FG007|Overall Study|Protocol Violation|0|||
126142787|NCT02764541|453809760|FG000|Overall Study|Physician Decision|0|||
126142788|NCT02764541|453809761|FG001|Overall Study|Physician Decision|0|||
126142789|NCT02764541|453809762|FG002|Overall Study|Physician Decision|0|||
126142790|NCT02764541|453809763|FG003|Overall Study|Physician Decision|1|||
126142791|NCT02764541|453809764|FG004|Overall Study|Physician Decision|0|||
126142792|NCT02764541|453809765|FG005|Overall Study|Physician Decision|0|||
126142793|NCT02764541|453809766|FG006|Overall Study|Physician Decision|0|||
125968652|NCT03701555|453175820|FG008|Part 3 (Day 1)|Subject Decision|0|||
126142794|NCT02764541|453809767|FG007|Overall Study|Physician Decision|1|||
126142795|NCT02764541|453809760|FG000|Overall Study|Three Cycles completed before surgery|0|||
125968653|NCT03701555|453175821|FG009|Part 3 (Day 1)|Subject Decision|0|||
125968654|NCT03701555|453175822|FG010|Part 3 (Day 1)|Subject Decision|0|||
126142796|NCT02764541|453809761|FG001|Overall Study|Three Cycles completed before surgery|0|||
126142797|NCT02764541|453809762|FG002|Overall Study|Three Cycles completed before surgery|0|||
126142798|NCT02764541|453809763|FG003|Overall Study|Three Cycles completed before surgery|1|||
126142799|NCT02764541|453809764|FG004|Overall Study|Three Cycles completed before surgery|0|||
126142800|NCT02764541|453809765|FG005|Overall Study|Three Cycles completed before surgery|0|||
126142801|NCT02764541|453809766|FG006|Overall Study|Three Cycles completed before surgery|0|||
126142802|NCT02764541|453809767|FG007|Overall Study|Three Cycles completed before surgery|0|||
126142803|NCT02764541|453809760|FG000|Overall Study|Patient Compliance|0|||
126142804|NCT02764541|453809761|FG001|Overall Study|Patient Compliance|0|||
126142805|NCT02764541|453809762|FG002|Overall Study|Patient Compliance|1|||
126142806|NCT02764541|453809763|FG003|Overall Study|Patient Compliance|0|||
126142807|NCT02764541|453809764|FG004|Overall Study|Patient Compliance|0|||
126142808|NCT02764541|453809765|FG005|Overall Study|Patient Compliance|0|||
126142809|NCT02764541|453809766|FG006|Overall Study|Patient Compliance|0|||
126142810|NCT02764541|453809767|FG007|Overall Study|Patient Compliance|0|||
126142811|NCT02764541|453809760|FG000|Overall Study|Death|0|||
126142812|NCT02764541|453809761|FG001|Overall Study|Death|0|||
126142813|NCT02764541|453809762|FG002|Overall Study|Death|0|||
126142814|NCT02764541|453809763|FG003|Overall Study|Death|0|||
126142815|NCT02764541|453809764|FG004|Overall Study|Death|0|||
126142816|NCT02764541|453809765|FG005|Overall Study|Death|0|||
126142817|NCT02764541|453809766|FG006|Overall Study|Death|1|||
126142818|NCT02764541|453809767|FG007|Overall Study|Death|0|||
126142819|NCT02764541|453809760|FG000|Overall Study|Insurance reasons|0|||
126142820|NCT02764541|453809761|FG001|Overall Study|Insurance reasons|0|||
126142821|NCT02764541|453809762|FG002|Overall Study|Insurance reasons|0|||
126142822|NCT02764541|453809763|FG003|Overall Study|Insurance reasons|0|||
126142823|NCT02764541|453809764|FG004|Overall Study|Insurance reasons|0|||
126142824|NCT02764541|453809765|FG005|Overall Study|Insurance reasons|0|||
126142825|NCT02764541|453809766|FG006|Overall Study|Insurance reasons|1|||
126142826|NCT02764541|453809767|FG007|Overall Study|Insurance reasons|0|||
126142827|NCT00749190|453809768|FG000|Overall Study|Adverse Event|0|||
126142828|NCT00749190|453809769|FG001|Overall Study|Adverse Event|2|||
126142829|NCT00749190|453809770|FG002|Overall Study|Adverse Event|0|||
126142830|NCT00749190|453809771|FG003|Overall Study|Adverse Event|4|||
126142831|NCT00749190|453809772|FG004|Overall Study|Adverse Event|0|||
126142832|NCT00749190|453809773|FG005|Overall Study|Adverse Event|3|||
126142833|NCT00749190|453809774|FG006|Overall Study|Adverse Event|0|||
126142834|NCT00749190|453809768|FG000|Overall Study|Lack of Efficacy|3|||
126142835|NCT00749190|453809769|FG001|Overall Study|Lack of Efficacy|1|||
126142836|NCT00749190|453809770|FG002|Overall Study|Lack of Efficacy|1|||
126142837|NCT00749190|453809771|FG003|Overall Study|Lack of Efficacy|0|||
126142838|NCT00749190|453809772|FG004|Overall Study|Lack of Efficacy|0|||
126142839|NCT00749190|453809773|FG005|Overall Study|Lack of Efficacy|1|||
126142840|NCT00749190|453809774|FG006|Overall Study|Lack of Efficacy|0|||
126142841|NCT00749190|453809768|FG000|Overall Study|Withdrawal by Subject|2|||
126142842|NCT00749190|453809769|FG001|Overall Study|Withdrawal by Subject|1|||
126142843|NCT00749190|453809770|FG002|Overall Study|Withdrawal by Subject|0|||
126142844|NCT00749190|453809771|FG003|Overall Study|Withdrawal by Subject|0|||
126142845|NCT00749190|453809772|FG004|Overall Study|Withdrawal by Subject|0|||
126142846|NCT00749190|453809773|FG005|Overall Study|Withdrawal by Subject|1|||
126142847|NCT00749190|453809774|FG006|Overall Study|Withdrawal by Subject|0|||
126142848|NCT00749190|453809768|FG000|Overall Study|Protocol Violation|0|||
126142849|NCT00749190|453809769|FG001|Overall Study|Protocol Violation|1|||
126142850|NCT00749190|453809770|FG002|Overall Study|Protocol Violation|0|||
126142851|NCT00749190|453809771|FG003|Overall Study|Protocol Violation|0|||
126142852|NCT00749190|453809772|FG004|Overall Study|Protocol Violation|0|||
126142853|NCT00749190|453809773|FG005|Overall Study|Protocol Violation|0|||
126142854|NCT00749190|453809774|FG006|Overall Study|Protocol Violation|1|||
126142855|NCT00749190|453809768|FG000|Overall Study|Other reason not defined above|0|||
126142856|NCT00749190|453809769|FG001|Overall Study|Other reason not defined above|0|||
126142857|NCT00749190|453809770|FG002|Overall Study|Other reason not defined above|0|||
126142858|NCT00749190|453809771|FG003|Overall Study|Other reason not defined above|1|||
126142859|NCT00749190|453809772|FG004|Overall Study|Other reason not defined above|0|||
126142860|NCT00749190|453809773|FG005|Overall Study|Other reason not defined above|0|||
126142861|NCT00749190|453809774|FG006|Overall Study|Other reason not defined above|0|||
126142862|NCT01245673|453809775|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
126142863|NCT00355121|453809777|FG000|Overall Study|Did not receive study vaccine|1|||
126142864|NCT00355121|453809778|FG001|Overall Study|Did not receive study vaccine|0|||
126142865|NCT00355121|453809779|FG002|Overall Study|Did not receive study vaccine|1|||
126142866|NCT00355121|453809777|FG000|Overall Study|Adverse Event|0|||
126142867|NCT00355121|453809778|FG001|Overall Study|Adverse Event|1|||
126142868|NCT00355121|453809779|FG002|Overall Study|Adverse Event|0|||
126142869|NCT00355121|453809777|FG000|Overall Study|Protocol Violation|7|||
126142870|NCT00355121|453809778|FG001|Overall Study|Protocol Violation|9|||
126142871|NCT00355121|453809779|FG002|Overall Study|Protocol Violation|1|||
126142872|NCT00355121|453809777|FG000|Overall Study|Lost to Follow-up|4|||
126142873|NCT00355121|453809778|FG001|Overall Study|Lost to Follow-up|7|||
126142874|NCT00355121|453809779|FG002|Overall Study|Lost to Follow-up|1|||
126142875|NCT00355121|453809777|FG000|Overall Study|Withdrawal by Subject|9|||
126142876|NCT00355121|453809778|FG001|Overall Study|Withdrawal by Subject|10|||
126142877|NCT00355121|453809779|FG002|Overall Study|Withdrawal by Subject|2|||
126142878|NCT00355121|453809777|FG000|Overall Study|Serious adverse events|0|||
126142879|NCT00355121|453809778|FG001|Overall Study|Serious adverse events|2|||
126142880|NCT00355121|453809779|FG002|Overall Study|Serious adverse events|0|||
126142881|NCT04640766|453809781|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
126142882|NCT00630331|453809782|FG000|Overall Study|Death|2|||
126142883|NCT00630331|453809783|FG001|Overall Study|Death|1|||
126142884|NCT00630331|453809784|FG002|Overall Study|Death|1|||
126142885|NCT00630331|453809782|FG000|Overall Study|Adverse Event|1|||
126142886|NCT00630331|453809783|FG001|Overall Study|Adverse Event|0|||
126142887|NCT00630331|453809784|FG002|Overall Study|Adverse Event|0|||
126142888|NCT00630331|453809782|FG000|Overall Study|Withdrawal by Subject|12|||
126142889|NCT00630331|453809783|FG001|Overall Study|Withdrawal by Subject|7|||
126142890|NCT00630331|453809784|FG002|Overall Study|Withdrawal by Subject|5|||
126142891|NCT00630331|453809782|FG000|Overall Study|Lost to Follow-up|175|||
126142892|NCT00630331|453809783|FG001|Overall Study|Lost to Follow-up|143|||
126142893|NCT00630331|453809784|FG002|Overall Study|Lost to Follow-up|170|||
126142894|NCT00630331|453809782|FG000|Overall Study|Inappropriate enrollment|3|||
126142895|NCT00630331|453809783|FG001|Overall Study|Inappropriate enrollment|6|||
126142896|NCT00630331|453809784|FG002|Overall Study|Inappropriate enrollment|3|||
126142897|NCT00630331|453809782|FG000|Overall Study|Unable to classify|9|||
126142898|NCT00630331|453809783|FG001|Overall Study|Unable to classify|4|||
126142899|NCT00630331|453809784|FG002|Overall Study|Unable to classify|3|||
126142900|NCT00630331|453809782|FG000|Overall Study|Protocol Violation|4|||
126142901|NCT00630331|453809783|FG001|Overall Study|Protocol Violation|5|||
126142902|NCT00630331|453809784|FG002|Overall Study|Protocol Violation|6|||
126142903|NCT01565980|453809786|FG000|Overall Study|Death|1|||
126142904|NCT01565980|453809787|FG001|Overall Study|Death|0|||
126142905|NCT01565980|453809786|FG000|Overall Study|Lost to Follow-up|1|||
126142906|NCT01565980|453809787|FG001|Overall Study|Lost to Follow-up|0|||
126142907|NCT01565980|453809786|FG000|Overall Study|health complications|1|||
126142908|NCT01565980|453809787|FG001|Overall Study|health complications|1|||
126142909|NCT01565980|453809786|FG000|Overall Study|stopped medical treatment|1|||
126142910|NCT01565980|453809787|FG001|Overall Study|stopped medical treatment|0|||
126142911|NCT01565980|453809786|FG000|Overall Study|Withdrawal by Subject|0|||
126142912|NCT01565980|453809787|FG001|Overall Study|Withdrawal by Subject|3|||
126142913|NCT03219164|453811616|FG000|Overall Study|Study Terminated by Sponsor|16|||
126142914|NCT03219164|453811617|FG001|Overall Study|Study Terminated by Sponsor|12|||
126142915|NCT03219164|453811616|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
126142916|NCT03219164|453811617|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
126142917|NCT03219164|453811616|FG000|Overall Study|Lost to Follow-up|1|||
126142918|NCT03219164|453811617|FG001|Overall Study|Lost to Follow-up|1|||
126142919|NCT03219164|453811616|FG000|Overall Study|Adverse Event|1|||
126142920|NCT03219164|453811617|FG001|Overall Study|Adverse Event|0|||
126142921|NCT03219164|453811616|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126142922|NCT03219164|453811617|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126142923|NCT03219164|453811616|FG000|Overall Study|Protocol Violation|0|||
126142924|NCT03219164|453811617|FG001|Overall Study|Protocol Violation|1|||
126142925|NCT03219164|453811616|FG000|Overall Study|Withdrew Assent|1|||
126142926|NCT03219164|453811617|FG001|Overall Study|Withdrew Assent|0|||
126142927|NCT02689492|453811618|FG000|Overall Study|Lost to Follow-up|61|||
126142928|NCT02689492|453811618|FG000|Overall Study|Withdrawal by Subject|11|||
126142929|NCT02689492|453811618|FG000|Overall Study|Death|9|||
126142930|NCT02689492|453811618|FG000|Overall Study|Physician Decision|2|||
126142931|NCT02689492|453811618|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
126142932|NCT02689492|453811618|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
126142933|NCT02689492|453811618|FG000|Overall Study|Other than listed|1|||
126142934|NCT02029976|453811619|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
126142935|NCT02029976|453811620|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
126142936|NCT02029976|453811619|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
126142937|NCT02029976|453811620|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
126142938|NCT02029976|453811619|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
126142939|NCT02029976|453811620|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
126142940|NCT02029976|453811619|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
126142941|NCT02029976|453811620|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
126142942|NCT04025632|453811621|FG000|Overall Study|Adverse Event|1|||
126142943|NCT04025632|453811622|FG001|Overall Study|Adverse Event|1|||
126142944|NCT04025632|453811621|FG000|Overall Study|Withdrawal by Subject|1|||
126142945|NCT04025632|453811622|FG001|Overall Study|Withdrawal by Subject|1|||
126142946|NCT04025632|453811621|FG000|Overall Study|Study Terminated by Sponsor|10|||
126142947|NCT04025632|453811622|FG001|Overall Study|Study Terminated by Sponsor|9|||
126142948|NCT04025632|453811621|FG000|Overall Study|Physician Decision|3|||
126142949|NCT04025632|453811622|FG001|Overall Study|Physician Decision|1|||
126142950|NCT00127127|453811623|FG000|Overall Study|Adverse Event|0|||
126142951|NCT00127127|453811624|FG001|Overall Study|Adverse Event|2|||
126142952|NCT00127127|453811625|FG002|Overall Study|Adverse Event|0|||
126142953|NCT00127127|453811626|FG003|Overall Study|Adverse Event|1|||
126142954|NCT00127127|453811623|FG000|Overall Study|Lack of Efficacy|1|||
126142955|NCT00127127|453811624|FG001|Overall Study|Lack of Efficacy|3|||
126142956|NCT00127127|453811625|FG002|Overall Study|Lack of Efficacy|0|||
126142957|NCT00127127|453811626|FG003|Overall Study|Lack of Efficacy|2|||
126142958|NCT01524991|453811629|FG000|Overall Study|Adverse Event|12|||
126142959|NCT01524991|453811629|FG000|Overall Study|Death|1|||
126142960|NCT01524991|453811629|FG000|Overall Study|Disease ProgressionDu|17|||
126142961|NCT01524991|453811629|FG000|Overall Study|Other complicating disease|1|||
126142962|NCT01524991|453811629|FG000|Overall Study|Withdrawal by Subject|2|||
126142963|NCT01524991|453811629|FG000|Overall Study|Symptomatic Deterioration|1|||
126142964|NCT01805180|453811632|FG000|Lead-in Donor Phase|screen failure|1|||
126142965|NCT01805180|453811633|FG001|Lead-in Donor Phase|screen failure|0|||
126142966|NCT01805180|453811634|FG002|Lead-in Donor Phase|screen failure|0|||
126142967|NCT00582556|453811638|FG000|Overall Study|Withdrawal by Subject|0|||
126142968|NCT00582556|453811639|FG001|Overall Study|Withdrawal by Subject|1|||
126142969|NCT00582556|453811640|FG002|Overall Study|Withdrawal by Subject|1|||
126142970|NCT00582556|453811638|FG000|Overall Study|Physician Decision|0|||
126142971|NCT00582556|453811639|FG001|Overall Study|Physician Decision|0|||
126142972|NCT00582556|453811640|FG002|Overall Study|Physician Decision|1|||
126142973|NCT01341457|453811641|FG000|Overall Study|Adverse Event|2|||
126142974|NCT01341457|453811642|FG001|Overall Study|Adverse Event|0|||
126142975|NCT03124459|453811643|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126142976|NCT03124459|453811644|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126142977|NCT03124459|453811645|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126142978|NCT03124459|453811646|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126142979|NCT03124459|453811647|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
126142980|NCT03124459|453811648|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126142981|NCT03124459|453811643|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126142982|NCT03124459|453811644|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126142983|NCT03124459|453811645|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126142984|NCT03124459|453811646|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126142985|NCT03124459|453811647|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
126142986|NCT03124459|453811648|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126142987|NCT03124459|453811643|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
126142988|NCT03124459|453811644|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
126142989|NCT03124459|453811645|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
126142990|NCT03124459|453811646|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
126142991|NCT03124459|453811647|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
126142992|NCT03124459|453811648|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
126142993|NCT03124459|453811643|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
126142994|NCT03124459|453811644|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
126142995|NCT03124459|453811645|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
126142996|NCT03124459|453811646|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
126142997|NCT03124459|453811647|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
126142998|NCT03124459|453811648|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
126142999|NCT03124459|453811643|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126143000|NCT03124459|453811644|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126143001|NCT03124459|453811645|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126143002|NCT03124459|453811646|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126143003|NCT03124459|453811647|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126143004|NCT03124459|453811648|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
126143005|NCT03124459|453811643|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126143006|NCT03124459|453811644|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126143007|NCT03124459|453811645|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126143008|NCT03124459|453811646|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126143009|NCT03124459|453811647|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126143010|NCT03124459|453811648|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
126143011|NCT00496366|453811649|FG000|Overall Study|Death|1|||
126143012|NCT01717638|453811650|FG000|Overall Study|Lost to Follow-up|0|||
125968655|NCT03701555|453175823|FG011|Part 3 (Day 1)|Subject Decision|0|||
125968656|NCT03701555|453175824|FG012|Part 3 (Day 1)|Subject Decision|0|||
125968657|NCT03701555|453175825|FG013|Part 3 (Day 1)|Subject Decision|0|||
125968658|NCT03701555|453175826|FG014|Part 3 (Day 1)|Subject Decision|0|||
125968659|NCT03701555|453175827|FG015|Part 3 (Day 1)|Subject Decision|0|||
125968660|NCT03701555|453175828|FG016|Part 3 (Day 1)|Subject Decision|0|||
126143013|NCT01717638|453811651|FG001|Overall Study|Lost to Follow-up|0|||
126143014|NCT01717638|453811652|FG002|Overall Study|Lost to Follow-up|0|||
126143015|NCT01717638|453811653|FG003|Overall Study|Lost to Follow-up|0|||
126143016|NCT01717638|453811654|FG004|Overall Study|Lost to Follow-up|0|||
125968661|NCT03701555|453175829|FG017|Part 3 (Day 1)|Subject Decision|0|||
125968662|NCT03701555|453175830|FG018|Part 3 (Day 1)|Subject Decision|0|||
125968663|NCT03701555|453175831|FG019|Part 3 (Day 1)|Subject Decision|0|||
125968664|NCT03701555|453175832|FG020|Part 3 (Day 1)|Subject Decision|0|||
126143017|NCT01717638|453811655|FG005|Overall Study|Lost to Follow-up|1|||
126143018|NCT01717638|453811656|FG006|Overall Study|Lost to Follow-up|0|||
126143019|NCT01717638|453811657|FG007|Overall Study|Lost to Follow-up|0|||
126143020|NCT01717638|453811658|FG008|Overall Study|Lost to Follow-up|0|||
126143021|NCT01717638|453811659|FG009|Overall Study|Lost to Follow-up|0|||
126143022|NCT01717638|453811660|FG010|Overall Study|Lost to Follow-up|0|||
126143023|NCT01717638|453811661|FG011|Overall Study|Lost to Follow-up|0|||
126143024|NCT01717638|453811662|FG012|Overall Study|Lost to Follow-up|0|||
126143025|NCT01717638|453811650|FG000|Overall Study|Father in hospital|0|||
126143026|NCT01717638|453811651|FG001|Overall Study|Father in hospital|0|||
126143027|NCT01717638|453811652|FG002|Overall Study|Father in hospital|0|||
126143028|NCT01717638|453811653|FG003|Overall Study|Father in hospital|0|||
126143029|NCT01717638|453811654|FG004|Overall Study|Father in hospital|0|||
126143030|NCT01717638|453811655|FG005|Overall Study|Father in hospital|0|||
126143031|NCT01717638|453811656|FG006|Overall Study|Father in hospital|0|||
126143032|NCT01717638|453811657|FG007|Overall Study|Father in hospital|0|||
126143033|NCT01717638|453811658|FG008|Overall Study|Father in hospital|0|||
126143034|NCT01717638|453811659|FG009|Overall Study|Father in hospital|0|||
126143035|NCT01717638|453811660|FG010|Overall Study|Father in hospital|0|||
126143036|NCT01717638|453811661|FG011|Overall Study|Father in hospital|0|||
126143037|NCT01717638|453811662|FG012|Overall Study|Father in hospital|1|||
126143038|NCT01717638|453811650|FG000|Overall Study|Withdrawal by Subject|0|||
126143039|NCT01717638|453811651|FG001|Overall Study|Withdrawal by Subject|1|||
126143040|NCT01717638|453811652|FG002|Overall Study|Withdrawal by Subject|1|||
126143041|NCT01717638|453811653|FG003|Overall Study|Withdrawal by Subject|0|||
126143042|NCT01717638|453811654|FG004|Overall Study|Withdrawal by Subject|1|||
126143043|NCT01717638|453811655|FG005|Overall Study|Withdrawal by Subject|0|||
126143044|NCT01717638|453811656|FG006|Overall Study|Withdrawal by Subject|2|||
126143045|NCT01717638|453811657|FG007|Overall Study|Withdrawal by Subject|1|||
126143046|NCT01717638|453811658|FG008|Overall Study|Withdrawal by Subject|2|||
126143047|NCT01717638|453811659|FG009|Overall Study|Withdrawal by Subject|1|||
126143048|NCT01717638|453811660|FG010|Overall Study|Withdrawal by Subject|0|||
126143049|NCT01717638|453811661|FG011|Overall Study|Withdrawal by Subject|0|||
126143050|NCT01717638|453811662|FG012|Overall Study|Withdrawal by Subject|18|||
126143051|NCT00501228|453811667|FG000|Overall Study|Withdrawal by Subject|1|||
126143052|NCT01756274|453811672|FG000|Overall Study|Protocol Violation|2|||
126143053|NCT01756274|453811672|FG000|Overall Study|Laboratory error|1|||
126143054|NCT01147926|453811673|FG000|Overall Study|Subject Withdrew Consent|9|||
126143055|NCT01147926|453811674|FG001|Overall Study|Subject Withdrew Consent|10|||
126143056|NCT01147926|453811673|FG000|Overall Study|Adverse Event|7|||
126143057|NCT01147926|453811674|FG001|Overall Study|Adverse Event|6|||
126143058|NCT01147926|453811673|FG000|Overall Study|Subject Non-Compliant|5|||
126143059|NCT01147926|453811674|FG001|Overall Study|Subject Non-Compliant|4|||
126143060|NCT01147926|453811673|FG000|Overall Study|Principal investigator left hospital|1|||
126143061|NCT01147926|453811674|FG001|Overall Study|Principal investigator left hospital|3|||
126143062|NCT01147926|453811673|FG000|Overall Study|Selection criteria not met|3|||
126143063|NCT01147926|453811674|FG001|Overall Study|Selection criteria not met|1|||
126143064|NCT01147926|453811673|FG000|Overall Study|Lost to Follow-up|0|||
126143065|NCT01147926|453811674|FG001|Overall Study|Lost to Follow-up|2|||
126143066|NCT01147926|453811673|FG000|Overall Study|Sponsor's Decision|0|||
126143067|NCT01147926|453811674|FG001|Overall Study|Sponsor's Decision|1|||
126143068|NCT01147926|453811673|FG000|Overall Study|Lack of Efficacy|1|||
126143069|NCT01147926|453811674|FG001|Overall Study|Lack of Efficacy|0|||
126143070|NCT01147926|453811673|FG000|Overall Study|Too busy, no time for study|1|||
126143071|NCT01147926|453811674|FG001|Overall Study|Too busy, no time for study|0|||
126143072|NCT01147926|453811673|FG000|Overall Study|Went on holiday|0|||
126143073|NCT01147926|453811674|FG001|Overall Study|Went on holiday|1|||
126143074|NCT01147926|453811673|FG000|Overall Study|Colonoscopy result|0|||
126143075|NCT01147926|453811674|FG001|Overall Study|Colonoscopy result|1|||
126143076|NCT03417440|453811678|FG000|Overall Study|Lost to Follow-up|0|||
126143077|NCT03417440|453811679|FG001|Overall Study|Lost to Follow-up|1|||
126143078|NCT03417440|453811680|FG002|Overall Study|Lost to Follow-up|0|||
126143079|NCT03417440|453811681|FG003|Overall Study|Lost to Follow-up|0|||
126143080|NCT03417440|453811682|FG004|Overall Study|Lost to Follow-up|1|||
126143081|NCT03417440|453811683|FG005|Overall Study|Lost to Follow-up|0|||
126143082|NCT03417440|453811684|FG006|Overall Study|Lost to Follow-up|0|||
126143083|NCT03417440|453811685|FG007|Overall Study|Lost to Follow-up|0|||
126143084|NCT03417440|453811678|FG000|Overall Study|Withdrawal by Subject|2|||
126143085|NCT03417440|453811679|FG001|Overall Study|Withdrawal by Subject|0|||
126143086|NCT03417440|453811680|FG002|Overall Study|Withdrawal by Subject|2|||
126143087|NCT03417440|453811681|FG003|Overall Study|Withdrawal by Subject|1|||
125968665|NCT03701555|453175833|FG021|Part 3 (Day 1)|Subject Decision|0|||
126143088|NCT03417440|453811682|FG004|Overall Study|Withdrawal by Subject|1|||
126143089|NCT03417440|453811683|FG005|Overall Study|Withdrawal by Subject|0|||
126143090|NCT03417440|453811684|FG006|Overall Study|Withdrawal by Subject|0|||
126143091|NCT03417440|453811685|FG007|Overall Study|Withdrawal by Subject|1|||
126143092|NCT03304522|453811688|FG000|Overall Study|Adverse Event|0|||
126143093|NCT03304522|453811689|FG001|Overall Study|Adverse Event|4|||
126143094|NCT03304522|453811688|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
126143095|NCT03304522|453811689|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
126143096|NCT03304522|453811688|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
126143097|NCT03304522|453811689|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
126143098|NCT03304522|453811688|FG000|Overall Study|Other|0|||
126143099|NCT03304522|453811689|FG001|Overall Study|Other|1|||
126143100|NCT00486603|453811690|FG000|Overall Study|Withdrawal by Subject|1|||
126143101|NCT00486603|453811691|FG001|Overall Study|Withdrawal by Subject|0|||
126143102|NCT00486603|453811692|FG002|Overall Study|Withdrawal by Subject|0|||
126143103|NCT00486603|453811693|FG003|Overall Study|Withdrawal by Subject|0|||
126143104|NCT00486603|453811694|FG004|Overall Study|Withdrawal by Subject|0|||
126143105|NCT00486603|453811690|FG000|Overall Study|Physician Decision|0|||
126143106|NCT00486603|453811691|FG001|Overall Study|Physician Decision|1|||
126143107|NCT00486603|453811692|FG002|Overall Study|Physician Decision|0|||
126143108|NCT00486603|453811693|FG003|Overall Study|Physician Decision|0|||
126143109|NCT00486603|453811694|FG004|Overall Study|Physician Decision|0|||
126143110|NCT01670994|453811695|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
126143111|NCT01670994|453811696|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
126143112|NCT01670994|453811695|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
126143113|NCT01670994|453811696|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
126143114|NCT01670994|453811695|FG000|Overall Study|Patient experienced DLT|0|||
126143115|NCT01670994|453811696|FG001|Overall Study|Patient experienced DLT|1|||
126143116|NCT02013544|453811697|FG000|Overall Study|Adverse Event|5|||
126143117|NCT02013544|453811698|FG001|Overall Study|Adverse Event|5|||
126143118|NCT02013544|453811697|FG000|Overall Study|Lost to Follow-up|2|||
126143119|NCT02013544|453811698|FG001|Overall Study|Lost to Follow-up|3|||
126143120|NCT02013544|453811697|FG000|Overall Study|Withdrawal by Subject|2|||
126143121|NCT02013544|453811698|FG001|Overall Study|Withdrawal by Subject|8|||
126143122|NCT02013544|453811697|FG000|Overall Study|Physician Decision|0|||
126143123|NCT02013544|453811698|FG001|Overall Study|Physician Decision|1|||
126143124|NCT02013544|453811697|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
126143125|NCT02013544|453811698|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
126143126|NCT01295125|453811699|FG000|Overall Study|Study stopped prematurely|9|||
126143127|NCT00885365|453811702|FG000|4 Weeks ON Treatment|Adverse Event|2|||
126143128|NCT00885365|453811703|FG001|4 Weeks ON Treatment|Adverse Event|4|||
126143129|NCT00885365|453811702|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
126143130|NCT00885365|453811703|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
126143131|NCT00885365|453811702|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
126143132|NCT00885365|453811703|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
126143133|NCT01824979|453811704|FG000|Overall Study|Withdrawal by Subject|5|||
126143134|NCT01824979|453811705|FG001|Overall Study|Withdrawal by Subject|0|||
126143135|NCT01824979|453811704|FG000|Overall Study|Physician Decision|2|||
126143136|NCT01824979|453811705|FG001|Overall Study|Physician Decision|0|||
126143137|NCT01824979|453811704|FG000|Overall Study|Protocol Violation|6|||
126143138|NCT01824979|453811705|FG001|Overall Study|Protocol Violation|13|||
126143139|NCT02507349|453811707|FG000|Overall Study|Death|12|||
126143140|NCT02507349|453811708|FG001|Overall Study|Death|16|||
126143141|NCT02507349|453811707|FG000|Overall Study|Withdrawal by Subject|1|||
126143142|NCT02507349|453811708|FG001|Overall Study|Withdrawal by Subject|1|||
126143143|NCT02507349|453811707|FG000|Overall Study|Lost to Follow-up|174|||
126143144|NCT02507349|453811708|FG001|Overall Study|Lost to Follow-up|144|||
126143145|NCT00888238|453811709|FG000|Washout Period After Period 2|Adverse Event|0|||
126143146|NCT00888238|453811710|FG001|Washout Period After Period 2|Adverse Event|0|||
126143147|NCT00888238|453811711|FG002|Washout Period After Period 2|Adverse Event|1|||
126143148|NCT03371355|453811722|FG000|Overall Study|Investigator judgment|0|||
126143149|NCT03371355|453811723|FG001|Overall Study|Investigator judgment|0|||
126143150|NCT03371355|453811724|FG002|Overall Study|Investigator judgment|1|||
126143151|NCT03371355|453811725|FG003|Overall Study|Investigator judgment|1|||
126143152|NCT03371355|453811722|FG000|Overall Study|Voluntary withdrawal|1|||
126143153|NCT03371355|453811723|FG001|Overall Study|Voluntary withdrawal|0|||
126143154|NCT03371355|453811724|FG002|Overall Study|Voluntary withdrawal|1|||
126143155|NCT03371355|453811725|FG003|Overall Study|Voluntary withdrawal|2|||
126143156|NCT03371355|453811722|FG000|Overall Study|Adverse Event|0|||
126143157|NCT03371355|453811723|FG001|Overall Study|Adverse Event|1|||
126143158|NCT03371355|453811724|FG002|Overall Study|Adverse Event|2|||
126143159|NCT03371355|453811725|FG003|Overall Study|Adverse Event|3|||
126143160|NCT03371355|453811722|FG000|Overall Study|Reason not Specified|0|||
126143161|NCT03371355|453811723|FG001|Overall Study|Reason not Specified|1|||
126143162|NCT03371355|453811724|FG002|Overall Study|Reason not Specified|0|||
126143163|NCT03371355|453811725|FG003|Overall Study|Reason not Specified|1|||
126143164|NCT00977470|453811728|FG000|Overall Study|Lack of Efficacy|32|||
126143165|NCT00977470|453811729|FG001|Overall Study|Lack of Efficacy|30|||
126143166|NCT00977470|453811728|FG000|Overall Study|Physician Decision|2|||
126143167|NCT00977470|453811729|FG001|Overall Study|Physician Decision|0|||
126143168|NCT00977470|453811728|FG000|Overall Study|Adverse Event|1|||
126143169|NCT00977470|453811729|FG001|Overall Study|Adverse Event|2|||
126143170|NCT00977470|453811728|FG000|Overall Study|Protocol Violation|1|||
126143171|NCT00977470|453811729|FG001|Overall Study|Protocol Violation|0|||
125968666|NCT03701555|453175834|FG022|Part 3 (Day 1)|Subject Decision|0|||
125968667|NCT03701555|453175835|FG023|Part 3 (Day 1)|Subject Decision|0|||
125968668|NCT03701555|453175836|FG024|Part 3 (Day 1)|Subject Decision|0|||
125968669|NCT03701555|453175837|FG025|Part 3 (Day 1)|Subject Decision|0|||
125968670|NCT03701555|453175838|FG026|Part 3 (Day 1)|Subject Decision|1|||
125968671|NCT03701555|453175839|FG027|Part 3 (Day 1)|Subject Decision|0|||
125968672|NCT03701555|453175840|FG028|Part 3 (Day 1)|Subject Decision|0|||
125968673|NCT03701555|453175841|FG029|Part 3 (Day 1)|Subject Decision|0|||
125968674|NCT03701555|453175842|FG030|Part 3 (Day 1)|Subject Decision|0|||
125968675|NCT03701555|453175843|FG031|Part 3 (Day 1)|Subject Decision|2|||
125968676|NCT03701555|453175844|FG032|Part 3 (Day 1)|Subject Decision|1|||
125968677|NCT03701555|453175845|FG033|Part 3 (Day 1)|Subject Decision|1|||
125968678|NCT03701555|453175846|FG034|Part 3 (Day 1)|Subject Decision|0|||
125968679|NCT03701555|453175847|FG035|Part 3 (Day 1)|Subject Decision|0|||
125968680|NCT03701555|453175812|FG000|Part 3 (Day 1)|Other|0|||
125968681|NCT03701555|453175813|FG001|Part 3 (Day 1)|Other|0|||
125968682|NCT03701555|453175814|FG002|Part 3 (Day 1)|Other|0|||
125968683|NCT03701555|453175815|FG003|Part 3 (Day 1)|Other|0|||
125968684|NCT03701555|453175816|FG004|Part 3 (Day 1)|Other|0|||
125968685|NCT03701555|453175817|FG005|Part 3 (Day 1)|Other|0|||
126143172|NCT00977470|453811728|FG000|Overall Study|Withdrawal by Subject|0|||
126143173|NCT00977470|453811729|FG001|Overall Study|Withdrawal by Subject|2|||
126143174|NCT00977470|453811728|FG000|Overall Study|Death|0|||
126143175|NCT00977470|453811729|FG001|Overall Study|Death|2|||
126143176|NCT00977470|453811728|FG000|Overall Study|clinical decline|0|||
126143177|NCT00977470|453811729|FG001|Overall Study|clinical decline|1|||
126143178|NCT00977470|453811728|FG000|Overall Study|prolonged recovery post-surgery|0|||
126143179|NCT00977470|453811729|FG001|Overall Study|prolonged recovery post-surgery|1|||
126143180|NCT00977470|453811728|FG000|Overall Study|Still on-study|2|||
126143181|NCT00977470|453811729|FG001|Overall Study|Still on-study|0|||
126143182|NCT03529409|453811735|FG000|Randomized|Lost to Follow-up|0|||
126143183|NCT03529409|453811736|FG001|Randomized|Lost to Follow-up|0|||
126143184|NCT03529409|453811737|FG002|Randomized|Lost to Follow-up|4|||
126143185|NCT03529409|453811735|FG000|Randomized|Excluded|0|||
126143186|NCT03529409|453811736|FG001|Randomized|Excluded|0|||
126143187|NCT03529409|453811737|FG002|Randomized|Excluded|1|||
126143188|NCT03529409|453811735|FG000|Post-treatment Assessment|Death|1|||
126143189|NCT03529409|453811736|FG001|Post-treatment Assessment|Death|0|||
126143190|NCT03529409|453811737|FG002|Post-treatment Assessment|Death|0|||
126143191|NCT03529409|453811735|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
126143192|NCT03529409|453811736|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
126143193|NCT03529409|453811737|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
126143194|NCT03529409|453811735|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
126143195|NCT03529409|453811736|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
126143196|NCT03529409|453811737|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
126143197|NCT03529409|453811735|FG000|Follow-up Assessment|Death|1|||
126143198|NCT03529409|453811736|FG001|Follow-up Assessment|Death|0|||
126143199|NCT03529409|453811737|FG002|Follow-up Assessment|Death|0|||
126143200|NCT03529409|453811735|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
126143201|NCT03529409|453811736|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
126143202|NCT03529409|453811737|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
126143203|NCT01497262|453811738|FG000|Overall Study|Abnormal Lab Values|4|||
126143204|NCT01497262|453811738|FG000|Overall Study|Abnormal Test Procedure Result|1|||
126143205|NCT01497262|453811738|FG000|Overall Study|Physician Decision|1|||
126143206|NCT01497262|453811738|FG000|Overall Study|Withdrawal by Subject|2|||
126143207|NCT01497262|453811738|FG000|Overall Study|Adverse Event|2|||
126143208|NCT01497262|453811738|FG000|Overall Study|Protocol Violation|1|||
126143209|NCT02497001|453811741|FG000|Overall Study|Lost to Follow-up|10|||
126143210|NCT02497001|453811742|FG001|Overall Study|Lost to Follow-up|2|||
126143211|NCT02497001|453811743|FG002|Overall Study|Lost to Follow-up|0|||
126143212|NCT02497001|453811744|FG003|Overall Study|Lost to Follow-up|2|||
126143213|NCT02497001|453811741|FG000|Overall Study|Adverse Event|28|||
126143214|NCT02497001|453811742|FG001|Overall Study|Adverse Event|30|||
126143215|NCT02497001|453811743|FG002|Overall Study|Adverse Event|11|||
126143216|NCT02497001|453811744|FG003|Overall Study|Adverse Event|11|||
126143217|NCT02497001|453811741|FG000|Overall Study|Withdrawal by Subject|14|||
126143218|NCT02497001|453811742|FG001|Overall Study|Withdrawal by Subject|37|||
126143219|NCT02497001|453811743|FG002|Overall Study|Withdrawal by Subject|19|||
126143220|NCT02497001|453811744|FG003|Overall Study|Withdrawal by Subject|15|||
126143221|NCT02497001|453811741|FG000|Overall Study|Physician Decision|5|||
125968686|NCT03701555|453175818|FG006|Part 3 (Day 1)|Other|0|||
126143222|NCT02497001|453811742|FG001|Overall Study|Physician Decision|11|||
126143223|NCT02497001|453811743|FG002|Overall Study|Physician Decision|5|||
126143224|NCT02497001|453811744|FG003|Overall Study|Physician Decision|1|||
126143225|NCT02497001|453811741|FG000|Overall Study|subjects that were not treated|1|||
126143226|NCT02497001|453811742|FG001|Overall Study|subjects that were not treated|2|||
126143227|NCT02497001|453811743|FG002|Overall Study|subjects that were not treated|2|||
126143228|NCT02497001|453811744|FG003|Overall Study|subjects that were not treated|1|||
126143229|NCT02497001|453811741|FG000|Overall Study|Major Protocol Deviation|3|||
126143230|NCT02497001|453811742|FG001|Overall Study|Major Protocol Deviation|4|||
126143231|NCT02497001|453811743|FG002|Overall Study|Major Protocol Deviation|4|||
126143232|NCT02497001|453811744|FG003|Overall Study|Major Protocol Deviation|4|||
126143233|NCT02497001|453811741|FG000|Overall Study|Lack of Efficacy|10|||
126143234|NCT02497001|453811742|FG001|Overall Study|Lack of Efficacy|16|||
126143235|NCT02497001|453811743|FG002|Overall Study|Lack of Efficacy|6|||
126143236|NCT02497001|453811744|FG003|Overall Study|Lack of Efficacy|6|||
126143237|NCT02497001|453811741|FG000|Overall Study|Protocol Violation|3|||
126143238|NCT02497001|453811742|FG001|Overall Study|Protocol Violation|1|||
126143239|NCT02497001|453811743|FG002|Overall Study|Protocol Violation|3|||
126143240|NCT02497001|453811744|FG003|Overall Study|Protocol Violation|1|||
126143241|NCT03898063|453811747|FG000|Overall Study|Withdrawal by Subject|10|||
126143242|NCT03898063|453811748|FG001|Overall Study|Withdrawal by Subject|8|||
126143243|NCT02949830|453811749|FG000|Overall Study|Adverse Event|1|||
126143244|NCT02949830|453811749|FG000|Overall Study|Withdrawal by Subject|1|||
126143245|NCT00054132|453811750|FG000|Overall Study|Not Treated|1|||
126143246|NCT01290887|453811751|FG000|Overall Study|Adverse Event|6|||
126143247|NCT01290887|453811752|FG001|Overall Study|Adverse Event|11|||
126143248|NCT01290887|453811751|FG000|Overall Study|Lack of Efficacy|4|||
126143249|NCT01290887|453811752|FG001|Overall Study|Lack of Efficacy|5|||
126143250|NCT01290887|453811751|FG000|Overall Study|Withdrawal by Subject|26|||
126143251|NCT01290887|453811752|FG001|Overall Study|Withdrawal by Subject|32|||
126143252|NCT01290887|453811751|FG000|Overall Study|Protocol Violation|2|||
126143253|NCT01290887|453811752|FG001|Overall Study|Protocol Violation|1|||
126143254|NCT01290887|453811751|FG000|Overall Study|Lost to Follow-up|4|||
126143255|NCT01290887|453811752|FG001|Overall Study|Lost to Follow-up|4|||
126143256|NCT01290887|453811751|FG000|Overall Study|Non-compliance to study procedures|0|||
126143257|NCT01290887|453811752|FG001|Overall Study|Non-compliance to study procedures|1|||
126143258|NCT01290887|453811751|FG000|Overall Study|Non-compliance to study medications|1|||
126143259|NCT01290887|453811752|FG001|Overall Study|Non-compliance to study medications|0|||
126143260|NCT01290887|453811751|FG000|Overall Study|Sponsor closure of study|420|||
126143261|NCT01290887|453811752|FG001|Overall Study|Sponsor closure of study|476|||
126143262|NCT01290887|453811751|FG000|Overall Study|Other|3|||
126143263|NCT01290887|453811752|FG001|Overall Study|Other|6|||
126143264|NCT01795547|453811753|FG000|Overall Study|Adverse Event|16|||
126143265|NCT01795547|453811754|FG001|Overall Study|Adverse Event|27|||
126143266|NCT01795547|453811753|FG000|Overall Study|Lack of Efficacy|8|||
126143267|NCT01795547|453811754|FG001|Overall Study|Lack of Efficacy|3|||
126143268|NCT01795547|453811753|FG000|Overall Study|Protocol Violation|6|||
126143269|NCT01795547|453811754|FG001|Overall Study|Protocol Violation|4|||
126143270|NCT01795547|453811753|FG000|Overall Study|Lost to Follow-up|2|||
126143271|NCT01795547|453811754|FG001|Overall Study|Lost to Follow-up|5|||
126143272|NCT01795547|453811753|FG000|Overall Study|Withdrawal of consent|7|||
126143273|NCT01795547|453811754|FG001|Overall Study|Withdrawal of consent|12|||
126143274|NCT01795547|453811753|FG000|Overall Study|Not Treated|4|||
126143275|NCT01795547|453811754|FG001|Overall Study|Not Treated|10|||
126143276|NCT01795547|453811753|FG000|Overall Study|Non-compliance with IMP|1|||
126143277|NCT01795547|453811754|FG001|Overall Study|Non-compliance with IMP|1|||
126143278|NCT01795547|453811753|FG000|Overall Study|Others|4|||
126143279|NCT01795547|453811754|FG001|Overall Study|Others|1|||
126143280|NCT01795547|453811753|FG000|Overall Study|Not stated|0|||
126143281|NCT01795547|453811754|FG001|Overall Study|Not stated|1|||
126143282|NCT02040142|453811755|FG000|Overall Study|Lost to Follow-up|5|||
126143283|NCT02040142|453811755|FG000|Overall Study|Death|17|||
126143284|NCT02040142|453811755|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
125968687|NCT03701555|453175819|FG007|Part 3 (Day 1)|Other|0|||
126143285|NCT02330419|453811757|FG000|Overall Study|Lost to Follow-up|3|||
126143286|NCT02330419|453811758|FG001|Overall Study|Lost to Follow-up|7|||
125968688|NCT03701555|453175820|FG008|Part 3 (Day 1)|Other|0|||
125968689|NCT03701555|453175821|FG009|Part 3 (Day 1)|Other|0|||
126143287|NCT01813890|453811761|FG000|Overall Study|Adverse Event|0|||
126143288|NCT01813890|453811762|FG001|Overall Study|Adverse Event|3|||
126143289|NCT01813890|453811763|FG002|Overall Study|Adverse Event|4|||
126143290|NCT01813890|453811761|FG000|Overall Study|Lack of Efficacy|9|||
126143291|NCT01813890|453811762|FG001|Overall Study|Lack of Efficacy|1|||
126143292|NCT01813890|453811763|FG002|Overall Study|Lack of Efficacy|2|||
126143293|NCT03952559|453811764|FG000|Double Blind Treatment Period|Adverse Event|0|||
126143294|NCT03952559|453811765|FG001|Double Blind Treatment Period|Adverse Event|2|||
125968690|NCT03701555|453175822|FG010|Part 3 (Day 1)|Other|0|||
126143295|NCT03952559|453811766|FG002|Double Blind Treatment Period|Adverse Event|1|||
126143296|NCT03952559|453811767|FG003|Double Blind Treatment Period|Adverse Event|0|||
126143297|NCT03952559|453811768|FG004|Double Blind Treatment Period|Adverse Event|1|||
126143298|NCT03952559|453811764|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
126143299|NCT03952559|453811765|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
126143300|NCT03952559|453811766|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
126143301|NCT03952559|453811767|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
126143302|NCT03952559|453811768|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
126143303|NCT03952559|453811764|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
126143304|NCT03952559|453811765|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
126143305|NCT03952559|453811766|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
126143306|NCT03952559|453811767|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
126143307|NCT03952559|453811768|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
126143308|NCT03952559|453811764|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
126143309|NCT03952559|453811765|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
126143310|NCT03952559|453811766|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
126143311|NCT03952559|453811767|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
126143312|NCT03952559|453811768|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
126143313|NCT01870739|453811771|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
126143314|NCT01870739|453811772|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
126143315|NCT01870739|453811771|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
126143316|NCT01870739|453811772|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
126143317|NCT01870739|453811771|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
126143318|NCT01870739|453811772|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
126143319|NCT01870739|453811771|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
126143320|NCT01870739|453811772|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
126143321|NCT01870739|453811771|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
126143322|NCT01870739|453811772|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
126143323|NCT01870739|453811771|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
126143324|NCT01870739|453811772|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
126143325|NCT01870739|453811771|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
126143326|NCT01870739|453811772|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
126143327|NCT01986062|453811773|FG000|Overall Study|Lost to Follow-up|1|||
126143328|NCT01986062|453811774|FG001|Overall Study|Lost to Follow-up|0|||
126143329|NCT01986062|453811773|FG000|Overall Study|Withdrawal by Subject|0|||
126143330|NCT01986062|453811774|FG001|Overall Study|Withdrawal by Subject|1|||
126143331|NCT03538743|453811775|FG000|Overall Study|Adverse Event|0|||
126143332|NCT03538743|453811776|FG001|Overall Study|Adverse Event|0|||
126143333|NCT03538743|453811777|FG002|Overall Study|Adverse Event|1|||
126143334|NCT03538743|453811778|FG003|Overall Study|Adverse Event|1|||
126143335|NCT03538743|453811779|FG004|Overall Study|Adverse Event|0|||
126143336|NCT03538743|453811780|FG005|Overall Study|Adverse Event|0|||
126143337|NCT03538743|453811781|FG006|Overall Study|Adverse Event|0|||
126143338|NCT03538743|453811782|FG007|Overall Study|Adverse Event|0|||
126143339|NCT03538743|453811783|FG008|Overall Study|Adverse Event|0|||
126143340|NCT03538743|453811775|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
126143341|NCT03538743|453811776|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
126143342|NCT03538743|453811777|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
126143343|NCT03538743|453811778|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
126143344|NCT03538743|453811779|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
126143345|NCT03538743|453811780|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
126143346|NCT03538743|453811781|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
126143347|NCT03538743|453811782|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
126143348|NCT03538743|453811783|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
126143349|NCT03538743|453811775|FG000|Overall Study|Withdrawal by Subject|0|||
126143350|NCT03538743|453811776|FG001|Overall Study|Withdrawal by Subject|0|||
126143351|NCT03538743|453811777|FG002|Overall Study|Withdrawal by Subject|0|||
126143352|NCT03538743|453811778|FG003|Overall Study|Withdrawal by Subject|1|||
126143353|NCT03538743|453811779|FG004|Overall Study|Withdrawal by Subject|0|||
126143354|NCT03538743|453811780|FG005|Overall Study|Withdrawal by Subject|0|||
126143355|NCT03538743|453811781|FG006|Overall Study|Withdrawal by Subject|0|||
125968691|NCT03701555|453175823|FG011|Part 3 (Day 1)|Other|0|||
125968692|NCT03701555|453175824|FG012|Part 3 (Day 1)|Other|0|||
126143356|NCT03538743|453811782|FG007|Overall Study|Withdrawal by Subject|0|||
126143357|NCT03538743|453811783|FG008|Overall Study|Withdrawal by Subject|0|||
126143358|NCT01827384|453811785|FG000|Overall Study|Switched to alternative treatment|0|||
126143359|NCT01827384|453811786|FG001|Overall Study|Switched to alternative treatment|0|||
126143360|NCT01827384|453811787|FG002|Overall Study|Switched to alternative treatment|0|||
126143361|NCT01827384|453811788|FG003|Overall Study|Switched to alternative treatment|0|||
126143362|NCT01827384|453811789|FG004|Overall Study|Switched to alternative treatment|0|||
126143363|NCT01827384|453811790|FG005|Overall Study|Switched to alternative treatment|0|||
126143364|NCT01827384|453811791|FG006|Overall Study|Switched to alternative treatment|0|||
126143365|NCT01827384|453811792|FG007|Overall Study|Switched to alternative treatment|0|||
126143366|NCT01827384|453811793|FG008|Overall Study|Switched to alternative treatment|0|||
126143367|NCT01827384|453811794|FG009|Overall Study|Switched to alternative treatment|0|||
126143368|NCT01827384|453811795|FG010|Overall Study|Switched to alternative treatment|0|||
126143369|NCT01827384|453811796|FG011|Overall Study|Switched to alternative treatment|0|||
126143370|NCT01827384|453811797|FG012|Overall Study|Switched to alternative treatment|0|||
126143371|NCT01827384|453811798|FG013|Overall Study|Switched to alternative treatment|2|||
126143372|NCT01827384|453811785|FG000|Overall Study|Disease progression before treatment|0|||
126143373|NCT01827384|453811786|FG001|Overall Study|Disease progression before treatment|0|||
126143374|NCT01827384|453811787|FG002|Overall Study|Disease progression before treatment|0|||
126143375|NCT01827384|453811788|FG003|Overall Study|Disease progression before treatment|0|||
126143376|NCT01827384|453811789|FG004|Overall Study|Disease progression before treatment|0|||
126143377|NCT01827384|453811790|FG005|Overall Study|Disease progression before treatment|0|||
126143378|NCT01827384|453811791|FG006|Overall Study|Disease progression before treatment|0|||
126143379|NCT01827384|453811792|FG007|Overall Study|Disease progression before treatment|0|||
126143380|NCT01827384|453811793|FG008|Overall Study|Disease progression before treatment|0|||
126143381|NCT01827384|453811794|FG009|Overall Study|Disease progression before treatment|0|||
126143382|NCT01827384|453811795|FG010|Overall Study|Disease progression before treatment|0|||
126143383|NCT01827384|453811796|FG011|Overall Study|Disease progression before treatment|0|||
126143384|NCT01827384|453811797|FG012|Overall Study|Disease progression before treatment|0|||
126143385|NCT01827384|453811798|FG013|Overall Study|Disease progression before treatment|4|||
126143386|NCT01827384|453811785|FG000|Overall Study|Ineligible|0|||
126143387|NCT01827384|453811786|FG001|Overall Study|Ineligible|0|||
126143388|NCT01827384|453811787|FG002|Overall Study|Ineligible|0|||
126143389|NCT01827384|453811788|FG003|Overall Study|Ineligible|0|||
126143390|NCT01827384|453811789|FG004|Overall Study|Ineligible|0|||
126143391|NCT01827384|453811790|FG005|Overall Study|Ineligible|0|||
126143392|NCT01827384|453811791|FG006|Overall Study|Ineligible|0|||
126143393|NCT01827384|453811792|FG007|Overall Study|Ineligible|0|||
126143394|NCT01827384|453811793|FG008|Overall Study|Ineligible|0|||
126143395|NCT01827384|453811794|FG009|Overall Study|Ineligible|0|||
126143396|NCT01827384|453811795|FG010|Overall Study|Ineligible|0|||
126143397|NCT01827384|453811796|FG011|Overall Study|Ineligible|0|||
126143398|NCT01827384|453811797|FG012|Overall Study|Ineligible|0|||
126143399|NCT01827384|453811798|FG013|Overall Study|Ineligible|19|||
126143400|NCT01827384|453811785|FG000|Overall Study|Participant died before treatment|0|||
126143401|NCT01827384|453811786|FG001|Overall Study|Participant died before treatment|0|||
126143402|NCT01827384|453811787|FG002|Overall Study|Participant died before treatment|0|||
126143403|NCT01827384|453811788|FG003|Overall Study|Participant died before treatment|0|||
126143404|NCT01827384|453811789|FG004|Overall Study|Participant died before treatment|0|||
126143405|NCT01827384|453811790|FG005|Overall Study|Participant died before treatment|0|||
126143406|NCT01827384|453811791|FG006|Overall Study|Participant died before treatment|0|||
126143407|NCT01827384|453811792|FG007|Overall Study|Participant died before treatment|0|||
126143408|NCT01827384|453811793|FG008|Overall Study|Participant died before treatment|0|||
126143409|NCT01827384|453811794|FG009|Overall Study|Participant died before treatment|0|||
126143410|NCT01827384|453811795|FG010|Overall Study|Participant died before treatment|0|||
126143411|NCT01827384|453811796|FG011|Overall Study|Participant died before treatment|0|||
126143412|NCT01827384|453811797|FG012|Overall Study|Participant died before treatment|0|||
126143413|NCT01827384|453811798|FG013|Overall Study|Participant died before treatment|5|||
126143414|NCT01827384|453811785|FG000|Overall Study|Insufficient tumor cells|0|||
126143415|NCT01827384|453811786|FG001|Overall Study|Insufficient tumor cells|0|||
126143416|NCT01827384|453811787|FG002|Overall Study|Insufficient tumor cells|0|||
126143417|NCT01827384|453811788|FG003|Overall Study|Insufficient tumor cells|0|||
126143418|NCT01827384|453811789|FG004|Overall Study|Insufficient tumor cells|0|||
126143419|NCT01827384|453811790|FG005|Overall Study|Insufficient tumor cells|0|||
126143420|NCT01827384|453811791|FG006|Overall Study|Insufficient tumor cells|0|||
126143421|NCT01827384|453811792|FG007|Overall Study|Insufficient tumor cells|0|||
126143422|NCT01827384|453811793|FG008|Overall Study|Insufficient tumor cells|0|||
126143423|NCT01827384|453811794|FG009|Overall Study|Insufficient tumor cells|0|||
126143424|NCT01827384|453811795|FG010|Overall Study|Insufficient tumor cells|0|||
126143425|NCT01827384|453811796|FG011|Overall Study|Insufficient tumor cells|0|||
126143426|NCT01827384|453811797|FG012|Overall Study|Insufficient tumor cells|0|||
125968693|NCT03701555|453175825|FG013|Part 3 (Day 1)|Other|0|||
126143427|NCT01827384|453811798|FG013|Overall Study|Insufficient tumor cells|13|||
126143428|NCT01827384|453811785|FG000|Overall Study|No actionable mutation|0|||
126143429|NCT01827384|453811786|FG001|Overall Study|No actionable mutation|0|||
126143430|NCT01827384|453811787|FG002|Overall Study|No actionable mutation|0|||
126143431|NCT01827384|453811788|FG003|Overall Study|No actionable mutation|0|||
126143432|NCT01827384|453811789|FG004|Overall Study|No actionable mutation|0|||
126143433|NCT01827384|453811790|FG005|Overall Study|No actionable mutation|0|||
126143434|NCT01827384|453811791|FG006|Overall Study|No actionable mutation|0|||
126143435|NCT01827384|453811792|FG007|Overall Study|No actionable mutation|0|||
126143436|NCT01827384|453811793|FG008|Overall Study|No actionable mutation|0|||
126143437|NCT01827384|453811794|FG009|Overall Study|No actionable mutation|0|||
126143438|NCT01827384|453811795|FG010|Overall Study|No actionable mutation|0|||
126143439|NCT01827384|453811796|FG011|Overall Study|No actionable mutation|0|||
126143440|NCT01827384|453811797|FG012|Overall Study|No actionable mutation|0|||
126143441|NCT01827384|453811798|FG013|Overall Study|No actionable mutation|73|||
126143442|NCT01827384|453811785|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
126143443|NCT01827384|453811786|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
126143444|NCT01827384|453811787|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
126143445|NCT01827384|453811788|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
126143446|NCT01827384|453811789|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
126143447|NCT01827384|453811790|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
126143448|NCT01827384|453811791|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
126143449|NCT01827384|453811792|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
126143450|NCT01827384|453811793|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
126143451|NCT01827384|453811794|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
126143452|NCT01827384|453811795|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
126143453|NCT01827384|453811796|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
126143454|NCT01827384|453811797|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
126143455|NCT01827384|453811798|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
126143456|NCT01750918|453813481|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
126143457|NCT01750918|453813482|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
126143458|NCT01750918|453813483|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
126143459|NCT01750918|453813484|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
126143460|NCT01750918|453813485|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
126143461|NCT01750918|453813486|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
126143462|NCT01750918|453813487|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
126143463|NCT01750918|453813488|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
126143464|NCT01750918|453813481|FG000|Overall Study|Lost to Follow-up|0|||
126143465|NCT01750918|453813482|FG001|Overall Study|Lost to Follow-up|0|||
126143466|NCT01750918|453813483|FG002|Overall Study|Lost to Follow-up|2|||
126143467|NCT01750918|453813484|FG003|Overall Study|Lost to Follow-up|2|||
126143468|NCT01750918|453813485|FG004|Overall Study|Lost to Follow-up|0|||
126143469|NCT01750918|453813486|FG005|Overall Study|Lost to Follow-up|0|||
126143470|NCT01750918|453813487|FG006|Overall Study|Lost to Follow-up|0|||
126143471|NCT01750918|453813488|FG007|Overall Study|Lost to Follow-up|1|||
126143472|NCT01750918|453813481|FG000|Overall Study|Withdrawal by Subject|0|||
126143473|NCT01750918|453813482|FG001|Overall Study|Withdrawal by Subject|0|||
126143474|NCT01750918|453813483|FG002|Overall Study|Withdrawal by Subject|1|||
126143475|NCT01750918|453813484|FG003|Overall Study|Withdrawal by Subject|2|||
126143476|NCT01750918|453813485|FG004|Overall Study|Withdrawal by Subject|1|||
126143477|NCT01750918|453813486|FG005|Overall Study|Withdrawal by Subject|1|||
126143478|NCT01750918|453813487|FG006|Overall Study|Withdrawal by Subject|2|||
126143479|NCT01750918|453813488|FG007|Overall Study|Withdrawal by Subject|2|||
126143480|NCT02338843|453813493|FG000|Overall Study|Adverse Event|2|||
126143481|NCT02338843|453813494|FG001|Overall Study|Adverse Event|1|||
126143482|NCT02338843|453813493|FG000|Overall Study|Death|40|||
126143483|NCT02338843|453813494|FG001|Overall Study|Death|53|||
126143484|NCT02338843|453813493|FG000|Overall Study|Physician Decision|1|||
126143485|NCT02338843|453813494|FG001|Overall Study|Physician Decision|0|||
126143486|NCT02338843|453813493|FG000|Overall Study|Withdrawal by Subject|0|||
126143487|NCT02338843|453813494|FG001|Overall Study|Withdrawal by Subject|2|||
126143488|NCT02338843|453813493|FG000|Overall Study|Subject Recovered|0|||
126143489|NCT02338843|453813494|FG001|Overall Study|Subject Recovered|2|||
126143490|NCT02338843|453813493|FG000|Overall Study|Discontinued prior to randomizat|1|||
126143491|NCT02338843|453813494|FG001|Overall Study|Discontinued prior to randomizat|0|||
126143492|NCT00023322|453813495|FG000|Overall Study|Lost to Follow-up|1|||
126143493|NCT01793792|453813496|FG000|Overall Study|Death|5|||
126143494|NCT01793792|453813496|FG000|Overall Study|Lost to Follow-up|5|||
126143495|NCT01793792|453813496|FG000|Overall Study|Withdrawal by Subject|1|||
125968694|NCT03701555|453175826|FG014|Part 3 (Day 1)|Other|0|||
125968695|NCT03701555|453175827|FG015|Part 3 (Day 1)|Other|0|||
125968696|NCT03701555|453175828|FG016|Part 3 (Day 1)|Other|0|||
125968697|NCT03701555|453175829|FG017|Part 3 (Day 1)|Other|0|||
125968698|NCT03701555|453175830|FG018|Part 3 (Day 1)|Other|0|||
125968699|NCT03701555|453175831|FG019|Part 3 (Day 1)|Other|0|||
126143496|NCT01793792|453813496|FG000|Overall Study|Device Not Implanted|1|||
126143497|NCT02185521|453813497|FG000|Overall Study|Withdrawal by Subject|1|||
125968700|NCT03701555|453175832|FG020|Part 3 (Day 1)|Other|0|||
125968701|NCT03701555|453175833|FG021|Part 3 (Day 1)|Other|0|||
126143498|NCT02185521|453813497|FG000|Overall Study|Protocol Violation|1|||
126143499|NCT00434967|453813502|FG000|Overall Study|Adverse Event|2|||
126143500|NCT00434967|453813503|FG001|Overall Study|Adverse Event|4|||
126143501|NCT00434967|453813504|FG002|Overall Study|Adverse Event|3|||
126143502|NCT00434967|453813505|FG003|Overall Study|Adverse Event|3|||
126143503|NCT00434967|453813502|FG000|Overall Study|Lost to Follow-up|0|||
126143504|NCT00434967|453813503|FG001|Overall Study|Lost to Follow-up|0|||
126143505|NCT00434967|453813504|FG002|Overall Study|Lost to Follow-up|1|||
126143506|NCT00434967|453813505|FG003|Overall Study|Lost to Follow-up|0|||
126143507|NCT00434967|453813502|FG000|Overall Study|Withdrawal by Subject|2|||
126143508|NCT00434967|453813503|FG001|Overall Study|Withdrawal by Subject|2|||
126143509|NCT00434967|453813504|FG002|Overall Study|Withdrawal by Subject|4|||
126143510|NCT00434967|453813505|FG003|Overall Study|Withdrawal by Subject|6|||
126143511|NCT00434967|453813502|FG000|Overall Study|Randomized in error|0|||
126143512|NCT00434967|453813503|FG001|Overall Study|Randomized in error|0|||
126143513|NCT00434967|453813504|FG002|Overall Study|Randomized in error|0|||
126143514|NCT00434967|453813505|FG003|Overall Study|Randomized in error|1|||
126143515|NCT00434967|453813502|FG000|Overall Study|Protocol Violation|0|||
126143516|NCT00434967|453813503|FG001|Overall Study|Protocol Violation|1|||
126143517|NCT00434967|453813504|FG002|Overall Study|Protocol Violation|0|||
126143518|NCT00434967|453813505|FG003|Overall Study|Protocol Violation|1|||
126143519|NCT00434967|453813502|FG000|Overall Study|Physician Decision|1|||
126143520|NCT00434967|453813503|FG001|Overall Study|Physician Decision|1|||
126143521|NCT00434967|453813504|FG002|Overall Study|Physician Decision|1|||
126143522|NCT00434967|453813505|FG003|Overall Study|Physician Decision|0|||
126143523|NCT00434967|453813502|FG000|Overall Study|Patient Disposition Challenges|2|||
126143524|NCT00434967|453813503|FG001|Overall Study|Patient Disposition Challenges|0|||
126143525|NCT00434967|453813504|FG002|Overall Study|Patient Disposition Challenges|0|||
126143526|NCT00434967|453813505|FG003|Overall Study|Patient Disposition Challenges|3|||
126143527|NCT00408005|453813506|FG000|Induction|Adverse Event|19|||
126143528|NCT00408005|453813507|FG001|Induction|Adverse Event|3|||
126143529|NCT00408005|453813508|FG002|Induction|Adverse Event|0|||
126143530|NCT00408005|453813509|FG003|Induction|Adverse Event|0|||
126143531|NCT00408005|453813510|FG004|Induction|Adverse Event|0|||
126143532|NCT00408005|453813511|FG005|Induction|Adverse Event|0|||
126143533|NCT00408005|453813512|FG006|Induction|Adverse Event|0|||
126143534|NCT00408005|453813513|FG007|Induction|Adverse Event|0|||
126143535|NCT00408005|453813506|FG000|Induction|Death|6|||
126143536|NCT00408005|453813507|FG001|Induction|Death|0|||
126143537|NCT00408005|453813508|FG002|Induction|Death|0|||
126143538|NCT00408005|453813509|FG003|Induction|Death|0|||
126143539|NCT00408005|453813510|FG004|Induction|Death|0|||
126143540|NCT00408005|453813511|FG005|Induction|Death|0|||
126143541|NCT00408005|453813512|FG006|Induction|Death|0|||
126143542|NCT00408005|453813513|FG007|Induction|Death|0|||
126143543|NCT00408005|453813506|FG000|Induction|Physician Decision|83|||
126143544|NCT00408005|453813507|FG001|Induction|Physician Decision|9|||
126143545|NCT00408005|453813508|FG002|Induction|Physician Decision|0|||
126143546|NCT00408005|453813509|FG003|Induction|Physician Decision|0|||
126143547|NCT00408005|453813510|FG004|Induction|Physician Decision|0|||
126143548|NCT00408005|453813511|FG005|Induction|Physician Decision|0|||
126143549|NCT00408005|453813512|FG006|Induction|Physician Decision|0|||
126143550|NCT00408005|453813513|FG007|Induction|Physician Decision|0|||
126143551|NCT00408005|453813506|FG000|Induction|Withdrawal by Subject|2|||
126143552|NCT00408005|453813507|FG001|Induction|Withdrawal by Subject|4|||
126143553|NCT00408005|453813508|FG002|Induction|Withdrawal by Subject|0|||
126143554|NCT00408005|453813509|FG003|Induction|Withdrawal by Subject|0|||
126143555|NCT00408005|453813510|FG004|Induction|Withdrawal by Subject|0|||
126143556|NCT00408005|453813511|FG005|Induction|Withdrawal by Subject|0|||
126143557|NCT00408005|453813512|FG006|Induction|Withdrawal by Subject|0|||
126143558|NCT00408005|453813513|FG007|Induction|Withdrawal by Subject|0|||
126143559|NCT00408005|453813506|FG000|Induction|Ineligible|33|||
126143560|NCT00408005|453813507|FG001|Induction|Ineligible|14|||
126143561|NCT00408005|453813508|FG002|Induction|Ineligible|0|||
126143562|NCT00408005|453813509|FG003|Induction|Ineligible|0|||
125968702|NCT03701555|453175834|FG022|Part 3 (Day 1)|Other|0|||
125968703|NCT03701555|453175835|FG023|Part 3 (Day 1)|Other|0|||
125968704|NCT03701555|453175836|FG024|Part 3 (Day 1)|Other|1|||
125968705|NCT03701555|453175837|FG025|Part 3 (Day 1)|Other|1|||
126143563|NCT00408005|453813510|FG004|Induction|Ineligible|0|||
125968706|NCT03701555|453175838|FG026|Part 3 (Day 1)|Other|0|||
126143564|NCT00408005|453813511|FG005|Induction|Ineligible|0|||
126143565|NCT00408005|453813512|FG006|Induction|Ineligible|0|||
126143566|NCT00408005|453813513|FG007|Induction|Ineligible|0|||
126143567|NCT00408005|453813506|FG000|Induction|Refusal of Further Protocol Therapy|225|||
126143568|NCT00408005|453813507|FG001|Induction|Refusal of Further Protocol Therapy|44|||
125968707|NCT03701555|453175839|FG027|Part 3 (Day 1)|Other|0|||
125968708|NCT03701555|453175840|FG028|Part 3 (Day 1)|Other|0|||
126143569|NCT00408005|453813508|FG002|Induction|Refusal of Further Protocol Therapy|0|||
126143570|NCT00408005|453813509|FG003|Induction|Refusal of Further Protocol Therapy|0|||
126143571|NCT00408005|453813510|FG004|Induction|Refusal of Further Protocol Therapy|0|||
126143572|NCT00408005|453813511|FG005|Induction|Refusal of Further Protocol Therapy|0|||
126143573|NCT00408005|453813512|FG006|Induction|Refusal of Further Protocol Therapy|0|||
126143574|NCT00408005|453813513|FG007|Induction|Refusal of Further Protocol Therapy|0|||
126143575|NCT00408005|453813506|FG000|Induction|Entered another COG therapeutic protocol|4|||
126143576|NCT00408005|453813507|FG001|Induction|Entered another COG therapeutic protocol|0|||
126143577|NCT00408005|453813508|FG002|Induction|Entered another COG therapeutic protocol|0|||
126143578|NCT00408005|453813509|FG003|Induction|Entered another COG therapeutic protocol|0|||
126143579|NCT00408005|453813510|FG004|Induction|Entered another COG therapeutic protocol|0|||
126143580|NCT00408005|453813511|FG005|Induction|Entered another COG therapeutic protocol|0|||
126143581|NCT00408005|453813512|FG006|Induction|Entered another COG therapeutic protocol|0|||
126143582|NCT00408005|453813513|FG007|Induction|Entered another COG therapeutic protocol|0|||
125968709|NCT03701555|453175841|FG029|Part 3 (Day 1)|Other|1|||
125968710|NCT03701555|453175842|FG030|Part 3 (Day 1)|Other|1|||
125968711|NCT03701555|453175843|FG031|Part 3 (Day 1)|Other|0|||
125968712|NCT03701555|453175844|FG032|Part 3 (Day 1)|Other|1|||
125968713|NCT03701555|453175845|FG033|Part 3 (Day 1)|Other|1|||
125968714|NCT03701555|453175846|FG034|Part 3 (Day 1)|Other|0|||
126143583|NCT00408005|453813506|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
126143584|NCT00408005|453813507|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
126143585|NCT00408005|453813508|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
126143586|NCT00408005|453813509|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
126143587|NCT00408005|453813510|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
126143588|NCT00408005|453813511|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
126143589|NCT00408005|453813512|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
126143590|NCT00408005|453813513|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
126143591|NCT00408005|453813506|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
126143592|NCT00408005|453813507|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
126143593|NCT00408005|453813508|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
126143594|NCT00408005|453813509|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
126143595|NCT00408005|453813510|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
126143596|NCT00408005|453813511|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
126143597|NCT00408005|453813512|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
126143598|NCT00408005|453813513|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
126143599|NCT00408005|453813506|FG000|Induction|Progressive Disease|0|||
126143600|NCT00408005|453813507|FG001|Induction|Progressive Disease|1|||
126143601|NCT00408005|453813508|FG002|Induction|Progressive Disease|0|||
126143602|NCT00408005|453813509|FG003|Induction|Progressive Disease|0|||
126143603|NCT00408005|453813510|FG004|Induction|Progressive Disease|0|||
126143604|NCT00408005|453813511|FG005|Induction|Progressive Disease|0|||
126143605|NCT00408005|453813512|FG006|Induction|Progressive Disease|0|||
126143606|NCT00408005|453813513|FG007|Induction|Progressive Disease|0|||
126143607|NCT00408005|453813506|FG000|Induction|Inevaluable|18|||
126143608|NCT00408005|453813507|FG001|Induction|Inevaluable|14|||
126143609|NCT00408005|453813508|FG002|Induction|Inevaluable|0|||
126143610|NCT00408005|453813509|FG003|Induction|Inevaluable|0|||
126143611|NCT00408005|453813510|FG004|Induction|Inevaluable|0|||
126143612|NCT00408005|453813511|FG005|Induction|Inevaluable|0|||
126143613|NCT00408005|453813512|FG006|Induction|Inevaluable|0|||
126143614|NCT00408005|453813513|FG007|Induction|Inevaluable|0|||
126143615|NCT00408005|453813506|FG000|Induction|Failed to Complete Randomization|3|||
126143616|NCT00408005|453813507|FG001|Induction|Failed to Complete Randomization|2|||
126143617|NCT00408005|453813508|FG002|Induction|Failed to Complete Randomization|0|||
126143618|NCT00408005|453813509|FG003|Induction|Failed to Complete Randomization|0|||
126143619|NCT00408005|453813510|FG004|Induction|Failed to Complete Randomization|0|||
126143620|NCT00408005|453813511|FG005|Induction|Failed to Complete Randomization|0|||
126143621|NCT00408005|453813512|FG006|Induction|Failed to Complete Randomization|0|||
126143622|NCT00408005|453813513|FG007|Induction|Failed to Complete Randomization|0|||
126143623|NCT00408005|453813506|FG000|Induction|Protocol Deviation|3|||
126143624|NCT00408005|453813507|FG001|Induction|Protocol Deviation|1|||
126143625|NCT00408005|453813508|FG002|Induction|Protocol Deviation|0|||
126143626|NCT00408005|453813509|FG003|Induction|Protocol Deviation|0|||
126143627|NCT00408005|453813510|FG004|Induction|Protocol Deviation|0|||
126143628|NCT00408005|453813511|FG005|Induction|Protocol Deviation|0|||
126143629|NCT00408005|453813512|FG006|Induction|Protocol Deviation|0|||
126143630|NCT00408005|453813513|FG007|Induction|Protocol Deviation|0|||
126143631|NCT00408005|453813506|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
126143632|NCT00408005|453813507|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
125968715|NCT03701555|453175847|FG035|Part 3 (Day 1)|Other|0|||
125968716|NCT04757649|453175848|FG000|Overall Study|Withdrawal by Subject|1|||
126143633|NCT00408005|453813508|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
126143634|NCT00408005|453813509|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
126143635|NCT00408005|453813510|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
126143636|NCT00408005|453813511|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
126143637|NCT00408005|453813512|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
126143638|NCT00408005|453813513|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
126143639|NCT00408005|453813506|FG000|Induction|Recurrent leukemia|1|||
126143640|NCT00408005|453813507|FG001|Induction|Recurrent leukemia|0|||
126143641|NCT00408005|453813508|FG002|Induction|Recurrent leukemia|0|||
126143642|NCT00408005|453813509|FG003|Induction|Recurrent leukemia|0|||
125968717|NCT04757649|453175848|FG000|Overall Study|Adverse Event|1|||
126143643|NCT00408005|453813510|FG004|Induction|Recurrent leukemia|0|||
126143644|NCT00408005|453813511|FG005|Induction|Recurrent leukemia|0|||
126143645|NCT00408005|453813512|FG006|Induction|Recurrent leukemia|0|||
126143646|NCT00408005|453813513|FG007|Induction|Recurrent leukemia|0|||
126143647|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126143648|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126143649|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
126143650|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
126143651|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
126143652|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
126143653|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
126143654|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126143655|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
126143656|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
126143657|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
126143658|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
126143659|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
126143660|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
126143661|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
126143662|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
126143663|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126143664|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126143665|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
126143666|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126143667|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
126143668|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126143669|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126143670|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126143671|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
126143672|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
126143673|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
126143674|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
126143675|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
126143676|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
126143677|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
126143678|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
126143679|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126143680|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126143681|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
126143682|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
126143683|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126143684|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
126143685|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126143686|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126143687|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
126143688|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
126143689|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
126143690|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
126143691|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
126143692|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
126143693|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
126143694|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
126143695|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126143696|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126143697|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126143698|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126143699|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
126143700|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126143701|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126143702|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126143703|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125968718|NCT01286779|453175849|FG000|Overall Study|Withdrawal by Subject|9|||
125968719|NCT01286779|453175849|FG000|Overall Study|Protocol Violation|5|||
126143704|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
126143705|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
126143706|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
126143707|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
126143708|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
126143709|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
126143710|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
126143711|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126143712|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126143713|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126143714|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126143715|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
126143716|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126143717|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
126143718|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
126143719|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126143720|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126143721|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126143722|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126143723|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126143724|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
126143725|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126143726|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126143727|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
126143728|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
126143729|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
126143730|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
126143731|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
126143732|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
126143733|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
126143734|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
126143735|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126143736|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126143737|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126143738|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126143739|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
126143740|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
126143741|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126143742|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126143743|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
126143744|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
126143745|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
126143746|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
126143747|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
126143748|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
126143749|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
126143750|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
126143751|NCT00408005|453813506|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
126143752|NCT00408005|453813507|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
126143753|NCT00408005|453813508|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
126143754|NCT00408005|453813509|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
126143755|NCT00408005|453813510|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
126143756|NCT00408005|453813511|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
126143757|NCT00408005|453813512|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
126143758|NCT00408005|453813513|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
126143759|NCT03155997|453813514|FG000|Overall Study|Withdrawal by Subject|119|||
126143760|NCT03155997|453813515|FG001|Overall Study|Withdrawal by Subject|134|||
126143761|NCT03155997|453813514|FG000|Overall Study|Lost to Follow-up|12|||
126143762|NCT03155997|453813515|FG001|Overall Study|Lost to Follow-up|13|||
126143763|NCT03155997|453813514|FG000|Overall Study|Missing disposition data|0|||
126143764|NCT03155997|453813515|FG001|Overall Study|Missing disposition data|1|||
126143765|NCT03155997|453813514|FG000|Overall Study|On study treatment|2027|||
126143766|NCT03155997|453813515|FG001|Overall Study|On study treatment|2074|||
126143767|NCT01848145|453813516|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
126143768|NCT01848145|453813516|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
126143769|NCT01848145|453813516|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
126143770|NCT01848145|453813516|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
126143771|NCT01848145|453813516|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
126143772|NCT01848145|453813516|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
126143773|NCT01848145|453813516|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
126143774|NCT02347631|453813519|FG000|First Intervention (2 Months)|Adverse Event|1|||
126143775|NCT02347631|453813520|FG001|First Intervention (2 Months)|Adverse Event|1|||
126143776|NCT02347631|453813519|FG000|First Intervention (2 Months)|Pregnancy|1|||
126143777|NCT02347631|453813520|FG001|First Intervention (2 Months)|Pregnancy|0|||
126143778|NCT02347631|453813519|FG000|First Intervention (2 Months)|Moved out of area|0|||
126143779|NCT02347631|453813520|FG001|First Intervention (2 Months)|Moved out of area|2|||
126143780|NCT02347631|453813519|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
126143781|NCT02347631|453813520|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
126143782|NCT02347631|453813519|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
126143783|NCT02347631|453813520|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
126143784|NCT02347631|453813519|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
126143785|NCT02347631|453813520|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
126143786|NCT02347631|453813519|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
126143787|NCT02347631|453813520|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
126143788|NCT02347631|453813519|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
126143789|NCT02347631|453813520|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
126143790|NCT02429856|453813521|FG000|Overall Study|Death|12|||
126143791|NCT02429856|453813522|FG001|Overall Study|Death|13|||
126143792|NCT02429856|453813521|FG000|Overall Study|Lost to Follow-up|6|||
126143793|NCT02429856|453813522|FG001|Overall Study|Lost to Follow-up|5|||
126143794|NCT02429856|453813521|FG000|Overall Study|Withdrawal by Subject|1|||
126143795|NCT02429856|453813522|FG001|Overall Study|Withdrawal by Subject|1|||
126143796|NCT03514914|453813524|FG000|Overall Study|Death|3|||
126143797|NCT03514914|453813525|FG001|Overall Study|Death|3|||
126143798|NCT03514914|453813524|FG000|Overall Study|Lost to Follow-up|117|||
126143799|NCT03514914|453813525|FG001|Overall Study|Lost to Follow-up|89|||
126143800|NCT01355289|453813527|FG000|Core Study|Adverse Event, Non-Fatal|1|||
126143801|NCT01355289|453813528|FG001|Core Study|Adverse Event, Non-Fatal|0|||
126143802|NCT01355289|453813529|FG002|Core Study|Adverse Event, Non-Fatal|0|||
126143803|NCT01355289|453813530|FG003|Core Study|Adverse Event, Non-Fatal|0|||
126143804|NCT01355289|453813531|FG004|Core Study|Adverse Event, Non-Fatal|0|||
126143805|NCT01355289|453813527|FG000|Core Study|Inadequate Therapeutic Effect|0|||
126143806|NCT01355289|453813528|FG001|Core Study|Inadequate Therapeutic Effect|0|||
126143807|NCT01355289|453813529|FG002|Core Study|Inadequate Therapeutic Effect|0|||
126143808|NCT01355289|453813530|FG003|Core Study|Inadequate Therapeutic Effect|1|||
126143809|NCT01355289|453813531|FG004|Core Study|Inadequate Therapeutic Effect|0|||
126143810|NCT01355289|453813527|FG000|Core Study|Other|0|||
126143811|NCT01355289|453813528|FG001|Core Study|Other|0|||
126143812|NCT01355289|453813529|FG002|Core Study|Other|0|||
126143813|NCT01355289|453813530|FG003|Core Study|Other|1|||
126143814|NCT01355289|453813531|FG004|Core Study|Other|0|||
126143815|NCT01355289|453813527|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
126143816|NCT01355289|453813528|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
126143817|NCT01355289|453813529|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
126143818|NCT01355289|453813530|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
126143819|NCT01355289|453813531|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
126143820|NCT01355289|453813527|FG000|Open Label Extension|Lost to Follow-up|0|||
126143821|NCT01355289|453813528|FG001|Open Label Extension|Lost to Follow-up|0|||
126143822|NCT01355289|453813529|FG002|Open Label Extension|Lost to Follow-up|0|||
126143823|NCT01355289|453813530|FG003|Open Label Extension|Lost to Follow-up|0|||
126143824|NCT01355289|453813531|FG004|Open Label Extension|Lost to Follow-up|1|||
126143825|NCT01355289|453813527|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
126143826|NCT01355289|453813528|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
126143827|NCT01355289|453813529|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
126143828|NCT01355289|453813530|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
126143829|NCT01355289|453813531|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
126143830|NCT01355289|453813527|FG000|Open Label Extension|Other|0|||
126143831|NCT01355289|453813528|FG001|Open Label Extension|Other|0|||
126143832|NCT01355289|453813529|FG002|Open Label Extension|Other|0|||
126143833|NCT01355289|453813530|FG003|Open Label Extension|Other|0|||
126143834|NCT01355289|453813531|FG004|Open Label Extension|Other|3|||
126143835|NCT04336163|453813532|FG000|Overall Study|Lost to Follow-up|55|||
126143836|NCT04336163|453813533|FG001|Overall Study|Lost to Follow-up|0|||
126143837|NCT01085682|453813534|FG000|Overall Study|Withdrawal by Subject|25|||
126143838|NCT01085682|453813535|FG001|Overall Study|Withdrawal by Subject|25|||
126143839|NCT00813995|453813540|FG000|Overall Study|Clinical adverse event|9|||
126143840|NCT00813995|453813541|FG001|Overall Study|Clinical adverse event|3|||
126143841|NCT00813995|453813540|FG000|Overall Study|Laboratory adverse event|0|||
126143842|NCT00813995|453813541|FG001|Overall Study|Laboratory adverse event|2|||
126143843|NCT00813995|453813540|FG000|Overall Study|Lack of Efficacy|1|||
126143844|NCT00813995|453813541|FG001|Overall Study|Lack of Efficacy|0|||
126143845|NCT00813995|453813540|FG000|Overall Study|Lost to Follow-up|4|||
126143846|NCT00813995|453813541|FG001|Overall Study|Lost to Follow-up|2|||
126143847|NCT00813995|453813540|FG000|Overall Study|Other reason|2|||
126143848|NCT00813995|453813541|FG001|Overall Study|Other reason|2|||
126143849|NCT00813995|453813540|FG000|Overall Study|Protocol Violation|3|||
126143850|NCT00813995|453813541|FG001|Overall Study|Protocol Violation|2|||
126143851|NCT00813995|453813540|FG000|Overall Study|Subject moved|4|||
126143852|NCT00813995|453813541|FG001|Overall Study|Subject moved|0|||
126143853|NCT00813995|453813540|FG000|Overall Study|Withdrawal by Subject|0|||
126143854|NCT00813995|453813541|FG001|Overall Study|Withdrawal by Subject|5|||
126143855|NCT01614964|453813542|FG000|Overall Study|Withdrawal by Subject|2|||
126143856|NCT01614964|453813543|FG001|Overall Study|Withdrawal by Subject|0|||
126143857|NCT01614964|453813542|FG000|Overall Study|Lost to Follow-up|3|||
126143858|NCT01614964|453813543|FG001|Overall Study|Lost to Follow-up|0|||
126143859|NCT02700984|453813552|FG000|Overall Study|Death|2|||
126143860|NCT02700984|453813553|FG001|Overall Study|Death|1|||
126143861|NCT02700984|453813552|FG000|Overall Study|Lost to Follow-up|2|||
126143862|NCT02700984|453813553|FG001|Overall Study|Lost to Follow-up|1|||
126143863|NCT02700984|453813552|FG000|Overall Study|Physician Decision|0|||
126143864|NCT02700984|453813553|FG001|Overall Study|Physician Decision|1|||
126143865|NCT02700984|453813552|FG000|Overall Study|Withdrawal by Subject|8|||
126143866|NCT02700984|453813553|FG001|Overall Study|Withdrawal by Subject|9|||
126143867|NCT02700984|453813552|FG000|Overall Study|Reason not specified|3|||
126143868|NCT02700984|453813553|FG001|Overall Study|Reason not specified|2|||
126143869|NCT00473876|453813555|FG000|Overall Study|Lost to Follow-up|3|||
126143870|NCT00473876|453813556|FG001|Overall Study|Lost to Follow-up|1|||
126143871|NCT00348140|453813557|FG000|Overall Study|Adverse Event|46|||
126143872|NCT00348140|453813558|FG001|Overall Study|Adverse Event|49|||
126143873|NCT00348140|453813559|FG002|Overall Study|Adverse Event|78|||
126143874|NCT00348140|453813557|FG000|Overall Study|Lost to Follow-up|4|||
126143875|NCT00348140|453813558|FG001|Overall Study|Lost to Follow-up|4|||
126143876|NCT00348140|453813559|FG002|Overall Study|Lost to Follow-up|4|||
126143877|NCT00348140|453813557|FG000|Overall Study|Protocol Violation|12|||
126143878|NCT00348140|453813558|FG001|Overall Study|Protocol Violation|13|||
126143879|NCT00348140|453813559|FG002|Overall Study|Protocol Violation|14|||
126143880|NCT00348140|453813557|FG000|Overall Study|Withdrawal by Subject|32|||
126143881|NCT00348140|453813558|FG001|Overall Study|Withdrawal by Subject|40|||
126143882|NCT00348140|453813559|FG002|Overall Study|Withdrawal by Subject|40|||
126143883|NCT00348140|453813557|FG000|Overall Study|Non-compliance|8|||
126143884|NCT00348140|453813558|FG001|Overall Study|Non-compliance|13|||
126143885|NCT00348140|453813559|FG002|Overall Study|Non-compliance|5|||
126143886|NCT00348140|453813557|FG000|Overall Study|Participant at risk due to study drug|2|||
126143887|NCT00348140|453813558|FG001|Overall Study|Participant at risk due to study drug|0|||
126143888|NCT00348140|453813559|FG002|Overall Study|Participant at risk due to study drug|0|||
126143889|NCT00348140|453813557|FG000|Overall Study|Conditional medication increased dose|1|||
126143890|NCT00348140|453813558|FG001|Overall Study|Conditional medication increased dose|0|||
126143891|NCT00348140|453813559|FG002|Overall Study|Conditional medication increased dose|0|||
126143892|NCT00348140|453813557|FG000|Overall Study|Caregiver related|4|||
126143893|NCT00348140|453813558|FG001|Overall Study|Caregiver related|7|||
126143894|NCT00348140|453813559|FG002|Overall Study|Caregiver related|3|||
126143895|NCT00348140|453813557|FG000|Overall Study|Participant hospitalised|3|||
126143896|NCT00348140|453813558|FG001|Overall Study|Participant hospitalised|0|||
126143897|NCT00348140|453813559|FG002|Overall Study|Participant hospitalised|0|||
126143898|NCT00348140|453813557|FG000|Overall Study|Efficacy related|1|||
126143899|NCT00348140|453813558|FG001|Overall Study|Efficacy related|1|||
126143900|NCT00348140|453813559|FG002|Overall Study|Efficacy related|0|||
125968720|NCT01286779|453175849|FG000|Overall Study|Physician Decision|2|||
125968721|NCT01286779|453175849|FG000|Overall Study|Participant had scheduled surgery|1|||
125968722|NCT01286779|453175849|FG000|Overall Study|Participant moved to another country|1|||
126143901|NCT00348140|453813557|FG000|Overall Study|Administration related|3|||
126143902|NCT00348140|453813558|FG001|Overall Study|Administration related|1|||
126143903|NCT00348140|453813559|FG002|Overall Study|Administration related|1|||
126143904|NCT00348140|453813557|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
126143905|NCT00348140|453813558|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
126143906|NCT00348140|453813559|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
126143907|NCT00348140|453813557|FG000|Overall Study|Participant unwell|1|||
126143908|NCT00348140|453813558|FG001|Overall Study|Participant unwell|0|||
125968723|NCT01286779|453175849|FG000|Overall Study|Discontinued by sponsor|1|||
126143909|NCT00348140|453813559|FG002|Overall Study|Participant unwell|0|||
126143910|NCT00348140|453813557|FG000|Overall Study|Screen failure|1|||
126143911|NCT00348140|453813558|FG001|Overall Study|Screen failure|0|||
126143912|NCT00348140|453813559|FG002|Overall Study|Screen failure|0|||
126143913|NCT00348140|453813557|FG000|Overall Study|Investigator decided to discontinue|4|||
126143914|NCT00348140|453813558|FG001|Overall Study|Investigator decided to discontinue|1|||
126143915|NCT00348140|453813559|FG002|Overall Study|Investigator decided to discontinue|4|||
126143916|NCT00348140|453813557|FG000|Overall Study|Decided to discontinue on their own|1|||
126143917|NCT00348140|453813558|FG001|Overall Study|Decided to discontinue on their own|4|||
126143918|NCT00348140|453813559|FG002|Overall Study|Decided to discontinue on their own|1|||
126143919|NCT00348140|453813557|FG000|Overall Study|Use of prohibited drug|1|||
126143920|NCT00348140|453813558|FG001|Overall Study|Use of prohibited drug|0|||
126143921|NCT00348140|453813559|FG002|Overall Study|Use of prohibited drug|2|||
126143922|NCT00348140|453813557|FG000|Overall Study|Disease progression|1|||
126143923|NCT00348140|453813558|FG001|Overall Study|Disease progression|2|||
126143924|NCT00348140|453813559|FG002|Overall Study|Disease progression|5|||
126143925|NCT00348140|453813557|FG000|Overall Study|Increased risk of cardiac infarction|0|||
126143926|NCT00348140|453813558|FG001|Overall Study|Increased risk of cardiac infarction|1|||
126143927|NCT00348140|453813559|FG002|Overall Study|Increased risk of cardiac infarction|0|||
126143928|NCT00348140|453813557|FG000|Overall Study|Serious adverse event|0|||
126143929|NCT00348140|453813558|FG001|Overall Study|Serious adverse event|1|||
126143930|NCT00348140|453813559|FG002|Overall Study|Serious adverse event|0|||
126143931|NCT00348140|453813557|FG000|Overall Study|Abnormal ECG|0|||
126143932|NCT00348140|453813558|FG001|Overall Study|Abnormal ECG|1|||
126143933|NCT00348140|453813559|FG002|Overall Study|Abnormal ECG|3|||
126143934|NCT00348140|453813557|FG000|Overall Study|Participant died|0|||
126143935|NCT00348140|453813558|FG001|Overall Study|Participant died|1|||
126143936|NCT00348140|453813559|FG002|Overall Study|Participant died|0|||
126143937|NCT00348140|453813557|FG000|Overall Study|Exclusion criteria met|0|||
126143938|NCT00348140|453813558|FG001|Overall Study|Exclusion criteria met|0|||
126143939|NCT00348140|453813559|FG002|Overall Study|Exclusion criteria met|1|||
126143940|NCT00348140|453813557|FG000|Overall Study|Memory declined|0|||
126143941|NCT00348140|453813558|FG001|Overall Study|Memory declined|0|||
126143942|NCT00348140|453813559|FG002|Overall Study|Memory declined|1|||
126143943|NCT01032629|453813560|FG000|Overall Study|Closed Site|21|||
126143944|NCT01032629|453813561|FG001|Overall Study|Closed Site|18|||
126143945|NCT01032629|453813562|FG002|Overall Study|Closed Site|16|||
126143946|NCT01032629|453813560|FG000|Overall Study|Withdrawal by Subject|50|||
126143947|NCT01032629|453813561|FG001|Overall Study|Withdrawal by Subject|36|||
126143948|NCT01032629|453813562|FG002|Overall Study|Withdrawal by Subject|35|||
126143949|NCT01032629|453813560|FG000|Overall Study|Lost to Follow-up|74|||
126143950|NCT01032629|453813561|FG001|Overall Study|Lost to Follow-up|47|||
126143951|NCT01032629|453813562|FG002|Overall Study|Lost to Follow-up|37|||
126143952|NCT03545282|453813563|FG000|Overall Study|Lost to Follow-up|15|||
126143953|NCT03545282|453813564|FG001|Overall Study|Lost to Follow-up|10|||
126143954|NCT03545282|453813563|FG000|Overall Study|Withdrawal by Subject|2|||
126143955|NCT03545282|453813564|FG001|Overall Study|Withdrawal by Subject|2|||
126143956|NCT00755079|453813565|FG000|Overall Study|Lost to Follow-up|1|||
126143957|NCT00755079|453813566|FG001|Overall Study|Lost to Follow-up|3|||
126143958|NCT00755079|453813565|FG000|Overall Study|Adverse Event|0|||
126143959|NCT00755079|453813566|FG001|Overall Study|Adverse Event|1|||
126143960|NCT00755079|453813565|FG000|Overall Study|Withdrawal by Subject|0|||
126143961|NCT00755079|453813566|FG001|Overall Study|Withdrawal by Subject|2|||
126143962|NCT03377634|453813570|FG000|Study Period|Adverse Event|1|||
126143963|NCT03377634|453813571|FG001|Study Period|Adverse Event|0|||
126143964|NCT03377634|453813570|FG000|Study Period|Withdrawal by Subject|1|||
126143965|NCT03377634|453813571|FG001|Study Period|Withdrawal by Subject|0|||
126143966|NCT00737529|453813576|FG000|Overall Study|Disease Progression|95|||
126143967|NCT00737529|453813576|FG000|Overall Study|Adverse Event|24|||
126143968|NCT00737529|453813576|FG000|Overall Study|Withdrawal by Subject|5|||
126143969|NCT00737529|453813576|FG000|Overall Study|Death|4|||
126143970|NCT00737529|453813576|FG000|Overall Study|Protocol Violation|1|||
126143971|NCT00737529|453813576|FG000|Overall Study|Other|4|||
126143972|NCT01173653|453813584|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
126143973|NCT01173653|453813585|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
126143974|NCT01818297|453813586|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
126143975|NCT01818297|453813587|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
126143976|NCT01818297|453813586|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
126143977|NCT01818297|453813587|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
126143978|NCT01818297|453813586|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
126143979|NCT01818297|453813587|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
126143980|NCT01412229|453813593|FG000|Overall Study|Physician Decision|1|||
126143981|NCT00151892|453813596|FG000|Overall Study|Lack of Efficacy|50|||
126143982|NCT00151892|453813597|FG001|Overall Study|Lack of Efficacy|57|||
126143983|NCT00151892|453813596|FG000|Overall Study|Patient request|10|||
126143984|NCT00151892|453813597|FG001|Overall Study|Patient request|7|||
126143985|NCT00151892|453813596|FG000|Overall Study|Lost to Follow-up|5|||
126143986|NCT00151892|453813597|FG001|Overall Study|Lost to Follow-up|10|||
126143987|NCT00151892|453813596|FG000|Overall Study|Adverse Event|6|||
126143988|NCT00151892|453813597|FG001|Overall Study|Adverse Event|3|||
126143989|NCT00151892|453813596|FG000|Overall Study|Protocol Violation|3|||
126143990|NCT00151892|453813597|FG001|Overall Study|Protocol Violation|3|||
126143991|NCT00151892|453813596|FG000|Overall Study|Non-compliance|0|||
126143992|NCT00151892|453813597|FG001|Overall Study|Non-compliance|1|||
126143993|NCT00151892|453813596|FG000|Overall Study|Pregnancy|0|||
126143994|NCT00151892|453813597|FG001|Overall Study|Pregnancy|1|||
126143995|NCT00151892|453813596|FG000|Overall Study|Did not return for a visit|1|||
126143996|NCT00151892|453813597|FG001|Overall Study|Did not return for a visit|0|||
126143997|NCT00151892|453813596|FG000|Overall Study|Used prohibited corticosteroids|1|||
126143998|NCT00151892|453813597|FG001|Overall Study|Used prohibited corticosteroids|0|||
126143999|NCT00151892|453813596|FG000|Overall Study|Lack of study medication at center|0|||
126144000|NCT00151892|453813597|FG001|Overall Study|Lack of study medication at center|1|||
126144001|NCT01889602|453813598|FG000|First Intervention|Adverse Event|1|||
126144002|NCT01889602|453813599|FG001|First Intervention|Adverse Event|1|||
126144003|NCT01889602|453813600|FG002|First Intervention|Adverse Event|1|||
126144004|NCT01889602|453813598|FG000|First Intervention|Protocol Violation|0|||
126144005|NCT01889602|453813599|FG001|First Intervention|Protocol Violation|1|||
126144006|NCT01889602|453813600|FG002|First Intervention|Protocol Violation|1|||
126144007|NCT01889602|453813598|FG000|First Intervention|Study ending|0|||
126144008|NCT01889602|453813599|FG001|First Intervention|Study ending|1|||
126144009|NCT01889602|453813600|FG002|First Intervention|Study ending|0|||
126144010|NCT01889602|453813598|FG000|Second Intervention|Adverse Event|0|||
126144011|NCT01889602|453813599|FG001|Second Intervention|Adverse Event|0|||
126144012|NCT01889602|453813600|FG002|Second Intervention|Adverse Event|1|||
126144013|NCT01889602|453813598|FG000|Second Intervention|Study ending|1|||
126144014|NCT01889602|453813599|FG001|Second Intervention|Study ending|0|||
126144015|NCT01889602|453813600|FG002|Second Intervention|Study ending|0|||
126144016|NCT01889602|453813598|FG000|Second Intervention|Withdrawal by Subject|0|||
126144017|NCT01889602|453813599|FG001|Second Intervention|Withdrawal by Subject|0|||
126144018|NCT01889602|453813600|FG002|Second Intervention|Withdrawal by Subject|1|||
126144019|NCT01889602|453813598|FG000|Third Intervention|Protocol Violation|1|||
126144020|NCT01889602|453813599|FG001|Third Intervention|Protocol Violation|0|||
126144021|NCT01889602|453813600|FG002|Third Intervention|Protocol Violation|0|||
126144022|NCT01889602|453813598|FG000|Third Intervention|Withdrawal by Subject|2|||
126144023|NCT01889602|453813599|FG001|Third Intervention|Withdrawal by Subject|2|||
126144024|NCT01889602|453813600|FG002|Third Intervention|Withdrawal by Subject|0|||
126144025|NCT00404092|453813601|FG000|Overall Study|Death|1|||
126144026|NCT00404092|453813602|FG001|Overall Study|Death|0|||
126144027|NCT00404092|453813603|FG002|Overall Study|Death|0|||
126144028|NCT00404092|453813604|FG003|Overall Study|Death|0|||
126144029|NCT00404092|453813601|FG000|Overall Study|Adverse Event|0|||
126144030|NCT00404092|453813602|FG001|Overall Study|Adverse Event|0|||
126144031|NCT00404092|453813603|FG002|Overall Study|Adverse Event|1|||
126144032|NCT00404092|453813604|FG003|Overall Study|Adverse Event|0|||
126144033|NCT01275222|453813607|FG000|Phase l by Treatment|Adverse Event|1|||
125968724|NCT02896855|453175850|FG000|Overall Study|Death|50|||
125968725|NCT02896855|453175851|FG001|Overall Study|Death|40|||
125968726|NCT02896855|453175850|FG000|Overall Study|Lost to Follow-up|15|||
125968727|NCT02896855|453175851|FG001|Overall Study|Lost to Follow-up|9|||
125968728|NCT02896855|453175850|FG000|Overall Study|Withdrawal by Subject|7|||
125968729|NCT02896855|453175851|FG001|Overall Study|Withdrawal by Subject|4|||
125968730|NCT02370602|453175852|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125968731|NCT02370602|453175853|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125968732|NCT02370602|453175854|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125968733|NCT02370602|453175855|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
125968734|NCT02370602|453175856|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
125968735|NCT02370602|453175857|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
125968736|NCT01296568|453175858|FG000|Continued Access Phase|Lost to Follow-up|1|||
125968737|NCT01296568|453175858|FG000|Continued Access Phase|Withdrawal by Subject|1|||
125968738|NCT01296568|453175858|FG000|Continued Access Phase|Disease Progression|1|||
125968739|NCT00237744|453175859|FG000|Overall Study|Withdrawal by Subject|3|||
125968740|NCT00237744|453175860|FG001|Overall Study|Withdrawal by Subject|1|||
125968741|NCT00237744|453175861|FG002|Overall Study|Withdrawal by Subject|0|||
125968742|NCT00574080|453175862|FG000|Overall Study|Death|10|||
125968743|NCT00574080|453175863|FG001|Overall Study|Death|10|||
126144034|NCT01275222|453813608|FG001|Phase l by Treatment|Adverse Event|4|||
126144035|NCT01275222|453813609|FG002|Phase l by Treatment|Adverse Event|2|||
126144036|NCT01275222|453813610|FG003|Phase l by Treatment|Adverse Event|3|||
126144037|NCT01275222|453813611|FG004|Phase l by Treatment|Adverse Event|0|||
125968744|NCT04139317|453175864|FG000|Overall Study|Adverse Event|10|||
125968745|NCT04139317|453175865|FG001|Overall Study|Adverse Event|2|||
126144038|NCT01275222|453813612|FG005|Phase l by Treatment|Adverse Event|0|||
126144039|NCT01275222|453813607|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126144040|NCT01275222|453813608|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126144041|NCT01275222|453813609|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
126144042|NCT01275222|453813610|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126144043|NCT01275222|453813611|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125968746|NCT04139317|453175864|FG000|Overall Study|Death|6|||
125968747|NCT04139317|453175865|FG001|Overall Study|Death|4|||
125968748|NCT04139317|453175864|FG000|Overall Study|Lost to Follow-up|1|||
125968749|NCT04139317|453175865|FG001|Overall Study|Lost to Follow-up|0|||
125968750|NCT04139317|453175864|FG000|Overall Study|Physician Decision|3|||
125968751|NCT04139317|453175865|FG001|Overall Study|Physician Decision|1|||
125968752|NCT04139317|453175864|FG000|Overall Study|Progressive Disease|19|||
125968753|NCT04139317|453175865|FG001|Overall Study|Progressive Disease|9|||
125968754|NCT04139317|453175864|FG000|Overall Study|Subject Decision|2|||
125968755|NCT04139317|453175865|FG001|Overall Study|Subject Decision|2|||
125968756|NCT00214136|453175868|FG000|Overall Study|Death|5|||
125968757|NCT01272934|453175869|FG000|Overall Study|Adverse Event|0|||
125968758|NCT01272934|453175870|FG001|Overall Study|Adverse Event|1|||
125968759|NCT01272934|453175869|FG000|Overall Study|Abnormal Laboratory Value|0|||
125968760|NCT01272934|453175870|FG001|Overall Study|Abnormal Laboratory Value|1|||
125968761|NCT04287920|453175871|FG000|Overall Study|Lost to Follow-up|1|||
125968762|NCT04287920|453175872|FG001|Overall Study|Lost to Follow-up|1|||
125968763|NCT04287920|453175871|FG000|Overall Study|Withdrawal by Subject|0|||
125968764|NCT04287920|453175872|FG001|Overall Study|Withdrawal by Subject|3|||
125968765|NCT04313634|453175873|FG000|Overall Study|Adverse Event|2|||
125968766|NCT04313634|453175874|FG001|Overall Study|Adverse Event|2|||
125968767|NCT04313634|453175875|FG002|Overall Study|Adverse Event|0|||
125968768|NCT04313634|453175873|FG000|Overall Study|Withdrawal by Subject|1|||
125968769|NCT04313634|453175874|FG001|Overall Study|Withdrawal by Subject|0|||
125968770|NCT04313634|453175875|FG002|Overall Study|Withdrawal by Subject|1|||
125968771|NCT04313634|453175873|FG000|Overall Study|Protocol Violation|0|||
125968772|NCT04313634|453175874|FG001|Overall Study|Protocol Violation|0|||
125968773|NCT04313634|453175875|FG002|Overall Study|Protocol Violation|1|||
125968774|NCT02276482|453175880|FG000|Overall Study|Adverse Event|1|||
125968775|NCT02276482|453175881|FG001|Overall Study|Adverse Event|0|||
125968776|NCT02276482|453175880|FG000|Overall Study|Withdrawal by Subject|1|||
125968777|NCT02276482|453175881|FG001|Overall Study|Withdrawal by Subject|0|||
125968778|NCT02276482|453175880|FG000|Overall Study|Gram-negative infection|1|||
125968779|NCT02276482|453175881|FG001|Overall Study|Gram-negative infection|0|||
125968780|NCT02276482|453175880|FG000|Overall Study|Reason not specified|0|||
125968781|NCT02276482|453175881|FG001|Overall Study|Reason not specified|1|||
125968782|NCT01165281|453175884|FG000|Overall Study|Adverse Event|12|||
125968783|NCT01165281|453175885|FG001|Overall Study|Adverse Event|14|||
125968784|NCT01165281|453175884|FG000|Overall Study|Death|3|||
125968785|NCT01165281|453175885|FG001|Overall Study|Death|4|||
125968786|NCT01165281|453175884|FG000|Overall Study|Lack of Efficacy|4|||
125968787|NCT01165281|453175885|FG001|Overall Study|Lack of Efficacy|1|||
125968788|NCT01165281|453175884|FG000|Overall Study|Lost to Follow-up|0|||
125968789|NCT01165281|453175885|FG001|Overall Study|Lost to Follow-up|1|||
125968790|NCT01165281|453175884|FG000|Overall Study|Physician Decision|8|||
125968791|NCT01165281|453175885|FG001|Overall Study|Physician Decision|1|||
125968792|NCT01165281|453175884|FG000|Overall Study|Protocol Violation|6|||
125968793|NCT01165281|453175885|FG001|Overall Study|Protocol Violation|5|||
125968794|NCT01165281|453175884|FG000|Overall Study|Withdrawal by Subject|8|||
125968795|NCT01165281|453175885|FG001|Overall Study|Withdrawal by Subject|7|||
125968796|NCT01165281|453175884|FG000|Overall Study|Noncompliance with Study Drug|1|||
125968797|NCT01165281|453175885|FG001|Overall Study|Noncompliance with Study Drug|4|||
125968798|NCT01165281|453175884|FG000|Overall Study|Progressive Disease|10|||
125968799|NCT01165281|453175885|FG001|Overall Study|Progressive Disease|14|||
125968800|NCT01165281|453175884|FG000|Overall Study|Other|6|||
125968801|NCT01165281|453175885|FG001|Overall Study|Other|0|||
125968802|NCT00364858|453175886|FG000|Overall Study|Adverse Event|1|||
125968803|NCT00364858|453175887|FG001|Overall Study|Adverse Event|5|||
125968804|NCT00364858|453175886|FG000|Overall Study|Withdrawal by Subject|1|||
126144044|NCT01275222|453813612|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126144045|NCT01275222|453813607|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
126144046|NCT01275222|453813608|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
126144047|NCT01275222|453813609|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125968805|NCT00364858|453175887|FG001|Overall Study|Withdrawal by Subject|1|||
125968806|NCT00364858|453175886|FG000|Overall Study|Pregnancy|1|||
125968807|NCT00364858|453175887|FG001|Overall Study|Pregnancy|1|||
125968808|NCT00364858|453175886|FG000|Overall Study|Clinical failure|2|||
125968809|NCT00364858|453175887|FG001|Overall Study|Clinical failure|13|||
125968810|NCT00364858|453175886|FG000|Overall Study|Discontinuation at baseline|1|||
125968811|NCT00364858|453175887|FG001|Overall Study|Discontinuation at baseline|0|||
125968812|NCT00364858|453175886|FG000|Overall Study|Non-compliant|1|||
125968813|NCT00364858|453175887|FG001|Overall Study|Non-compliant|0|||
125968814|NCT00364858|453175886|FG000|Overall Study|Return to Q2 regimen|0|||
125968815|NCT00364858|453175887|FG001|Overall Study|Return to Q2 regimen|1|||
125968816|NCT00364858|453175886|FG000|Overall Study|Clinical baseline issue|0|||
125968817|NCT00364858|453175887|FG001|Overall Study|Clinical baseline issue|1|||
125968818|NCT00627705|453175888|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
126144048|NCT01275222|453813610|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
125968819|NCT00627705|453175889|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
125968820|NCT00627705|453175888|FG000|Overall Study|Adverse Event|1|||
125968821|NCT00627705|453175889|FG001|Overall Study|Adverse Event|0|||
125968822|NCT00627705|453175888|FG000|Overall Study|Withdrawal by Subject|0|||
125968823|NCT00627705|453175889|FG001|Overall Study|Withdrawal by Subject|2|||
125968824|NCT00627705|453175888|FG000|Overall Study|Lost to Follow-up|0|||
125968825|NCT00627705|453175889|FG001|Overall Study|Lost to Follow-up|1|||
125968826|NCT01218438|453175893|FG000|Epoch 1|Physician Decision|2|||
125968827|NCT01218438|453175893|FG000|Epoch 1|Adverse Event|1|||
125968828|NCT01218438|453175893|FG000|Epoch 3|Withdrawal by Subject|3|||
125968829|NCT01218438|453175893|FG000|Epoch 3|Adverse Event|1|||
125968830|NCT01218438|453175893|FG000|Epoch 4|Physician Decision|1|||
125968831|NCT01218438|453175893|FG000|Epoch 4|Withdrawal by Subject|2|||
125968832|NCT01218646|453175895|FG000|Overall Study|Adverse Event|0|||
125968833|NCT01218646|453175896|FG001|Overall Study|Adverse Event|0|||
125968834|NCT01218646|453175897|FG002|Overall Study|Adverse Event|1|||
125968835|NCT01218646|453175898|FG003|Overall Study|Adverse Event|0|||
125968836|NCT01218646|453175895|FG000|Overall Study|Lost to Follow-up|1|||
125968837|NCT01218646|453175896|FG001|Overall Study|Lost to Follow-up|0|||
125968838|NCT01218646|453175897|FG002|Overall Study|Lost to Follow-up|0|||
125968839|NCT01218646|453175898|FG003|Overall Study|Lost to Follow-up|0|||
125968840|NCT01218646|453175895|FG000|Overall Study|Protocol Violation|0|||
125968841|NCT01218646|453175896|FG001|Overall Study|Protocol Violation|0|||
125968842|NCT01218646|453175897|FG002|Overall Study|Protocol Violation|1|||
125968843|NCT01218646|453175898|FG003|Overall Study|Protocol Violation|1|||
125968844|NCT05437510|453175901|FG000|Overall Study|Adverse Event|1|||
125968845|NCT05437510|453175902|FG001|Overall Study|Adverse Event|1|||
125968846|NCT05437510|453175901|FG000|Overall Study|Protocol Deviation|1|||
125968847|NCT05437510|453175902|FG001|Overall Study|Protocol Deviation|6|||
125968848|NCT05437510|453175901|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
125968849|NCT05437510|453175902|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
125968850|NCT05437510|453175901|FG000|Overall Study|Lost to Follow-up|219|||
125968851|NCT05437510|453175902|FG001|Overall Study|Lost to Follow-up|289|||
125968852|NCT05437510|453175901|FG000|Overall Study|Ongoing in the Study Extension|1387|||
125968853|NCT05437510|453175902|FG001|Overall Study|Ongoing in the Study Extension|1352|||
125968854|NCT00263666|453177798|FG000|Overall Study|Adverse Event|6|||
125968855|NCT00263666|453177799|FG001|Overall Study|Adverse Event|8|||
125968856|NCT00263666|453177798|FG000|Overall Study|Lost to Follow-up|1|||
125968857|NCT00263666|453177799|FG001|Overall Study|Lost to Follow-up|2|||
125968858|NCT00263666|453177798|FG000|Overall Study|Withdrawal by Subject|0|||
125968859|NCT00263666|453177799|FG001|Overall Study|Withdrawal by Subject|1|||
125968860|NCT00838110|453177802|FG000|Overall Study|Death|0|||
125968861|NCT00838110|453177803|FG001|Overall Study|Death|0|||
125968862|NCT00838110|453177804|FG002|Overall Study|Death|1|||
125968863|NCT00838110|453177805|FG003|Overall Study|Death|2|||
125968864|NCT00838110|453177802|FG000|Overall Study|Adverse Event|11|||
125968865|NCT00838110|453177803|FG001|Overall Study|Adverse Event|10|||
125968866|NCT00838110|453177804|FG002|Overall Study|Adverse Event|8|||
125968867|NCT00838110|453177805|FG003|Overall Study|Adverse Event|7|||
125968868|NCT00838110|453177802|FG000|Overall Study|Withdrawal by Subject|5|||
125968869|NCT00838110|453177803|FG001|Overall Study|Withdrawal by Subject|6|||
125968870|NCT00838110|453177804|FG002|Overall Study|Withdrawal by Subject|3|||
125968871|NCT00838110|453177805|FG003|Overall Study|Withdrawal by Subject|4|||
125968872|NCT00838110|453177802|FG000|Overall Study|Other|3|||
125968873|NCT00838110|453177803|FG001|Overall Study|Other|3|||
125968874|NCT00838110|453177804|FG002|Overall Study|Other|3|||
125968875|NCT00838110|453177805|FG003|Overall Study|Other|2|||
125968876|NCT00838110|453177802|FG000|Overall Study|Protocol Violation|0|||
125968877|NCT00838110|453177803|FG001|Overall Study|Protocol Violation|2|||
125968878|NCT00838110|453177804|FG002|Overall Study|Protocol Violation|1|||
125968879|NCT00838110|453177805|FG003|Overall Study|Protocol Violation|1|||
125968880|NCT00838110|453177802|FG000|Overall Study|Lost to Follow-up|3|||
125968881|NCT00838110|453177803|FG001|Overall Study|Lost to Follow-up|0|||
125968882|NCT00838110|453177804|FG002|Overall Study|Lost to Follow-up|0|||
125968883|NCT00838110|453177805|FG003|Overall Study|Lost to Follow-up|0|||
125968884|NCT00838110|453177802|FG000|Overall Study|Did not meet eligibility criteria|0|||
125968885|NCT00838110|453177803|FG001|Overall Study|Did not meet eligibility criteria|0|||
125968886|NCT00838110|453177804|FG002|Overall Study|Did not meet eligibility criteria|1|||
125968887|NCT00838110|453177805|FG003|Overall Study|Did not meet eligibility criteria|2|||
125968888|NCT00838110|453177802|FG000|Overall Study|Randomized but not treated|0|||
125968889|NCT00838110|453177803|FG001|Overall Study|Randomized but not treated|1|||
125968890|NCT00838110|453177804|FG002|Overall Study|Randomized but not treated|0|||
125968891|NCT00838110|453177805|FG003|Overall Study|Randomized but not treated|0|||
125968892|NCT02508311|453177811|FG000|Overall Study|Withdrawal by Subject|1|||
125968893|NCT02508311|453177812|FG001|Overall Study|Withdrawal by Subject|0|||
125968894|NCT02169674|453177813|FG000|Overall Study|Withdrawal by Subject|2|||
125968895|NCT02169674|453177814|FG001|Overall Study|Withdrawal by Subject|1|||
125968896|NCT02169674|453177813|FG000|Overall Study|Seroprotected|30|||
125968897|NCT02169674|453177814|FG001|Overall Study|Seroprotected|76|||
125968898|NCT02169674|453177813|FG000|Overall Study|Lost to Follow-up|0|||
125968899|NCT02169674|453177814|FG001|Overall Study|Lost to Follow-up|1|||
125968900|NCT03349710|453177815|FG000|Treatment Period|Death|0|||
125968901|NCT03349710|453177816|FG001|Treatment Period|Death|0|||
125968902|NCT03349710|453177817|FG002|Treatment Period|Death|1|||
125968903|NCT03349710|453177818|FG003|Treatment Period|Death|0|||
125968904|NCT03349710|453177815|FG000|Treatment Period|Disease Progression|0|||
125968905|NCT03349710|453177816|FG001|Treatment Period|Disease Progression|2|||
125968906|NCT03349710|453177817|FG002|Treatment Period|Disease Progression|0|||
125968907|NCT03349710|453177818|FG003|Treatment Period|Disease Progression|1|||
125968908|NCT03349710|453177815|FG000|Treatment Period|Study Drug Toxicity|1|||
125968909|NCT03349710|453177816|FG001|Treatment Period|Study Drug Toxicity|0|||
125968910|NCT03349710|453177817|FG002|Treatment Period|Study Drug Toxicity|1|||
125968911|NCT03349710|453177818|FG003|Treatment Period|Study Drug Toxicity|1|||
125968912|NCT03349710|453177815|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
125968913|NCT03349710|453177816|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
125968914|NCT03349710|453177817|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
125968915|NCT03349710|453177818|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
125968916|NCT03349710|453177815|FG000|Treatment Period|admin reason by sponsor|0|||
125968917|NCT03349710|453177816|FG001|Treatment Period|admin reason by sponsor|7|||
125968918|NCT03349710|453177817|FG002|Treatment Period|admin reason by sponsor|0|||
125968919|NCT03349710|453177818|FG003|Treatment Period|admin reason by sponsor|19|||
125968920|NCT03349710|453177815|FG000|Treatment Period|Other Reason|2|||
125968921|NCT03349710|453177816|FG001|Treatment Period|Other Reason|0|||
125968922|NCT03349710|453177817|FG002|Treatment Period|Other Reason|2|||
125968923|NCT03349710|453177818|FG003|Treatment Period|Other Reason|1|||
125968924|NCT03349710|453177815|FG000|Treatment Period|completed|6|||
125968925|NCT03349710|453177816|FG001|Treatment Period|completed|0|||
125968926|NCT03349710|453177817|FG002|Treatment Period|completed|18|||
125968927|NCT03349710|453177818|FG003|Treatment Period|completed|1|||
125968928|NCT03349710|453177815|FG000|Treatment Period|participant request to discontinue|0|||
125968929|NCT03349710|453177816|FG001|Treatment Period|participant request to discontinue|0|||
125968930|NCT03349710|453177817|FG002|Treatment Period|participant request to discontinue|4|||
125968931|NCT03349710|453177818|FG003|Treatment Period|participant request to discontinue|0|||
125968932|NCT03349710|453177815|FG000|Treatment Period|participant withdrew consent|1|||
125968933|NCT03349710|453177816|FG001|Treatment Period|participant withdrew consent|0|||
125968934|NCT03349710|453177817|FG002|Treatment Period|participant withdrew consent|0|||
125968935|NCT03349710|453177818|FG003|Treatment Period|participant withdrew consent|0|||
125968936|NCT04258020|453177823|FG000|Overall Study|Withdrawal by Subject|1|||
125968937|NCT04258020|453177824|FG001|Overall Study|Withdrawal by Subject|0|||
125968938|NCT01380327|453177825|FG000|Overall Study|Lost to Follow-up|0|||
125968939|NCT01380327|453177826|FG001|Overall Study|Lost to Follow-up|1|||
125968940|NCT01380327|453177827|FG002|Overall Study|Lost to Follow-up|1|||
125968941|NCT01380327|453177825|FG000|Overall Study|Protocol Violation|3|||
125968942|NCT01380327|453177826|FG001|Overall Study|Protocol Violation|2|||
125968943|NCT01380327|453177827|FG002|Overall Study|Protocol Violation|3|||
125968944|NCT01380327|453177825|FG000|Overall Study|Withdrawal by Subject|0|||
125968945|NCT01380327|453177826|FG001|Overall Study|Withdrawal by Subject|0|||
125968946|NCT01380327|453177827|FG002|Overall Study|Withdrawal by Subject|1|||
125968947|NCT01380327|453177825|FG000|Overall Study|Housing situation precluded ability to k|0|||
125968948|NCT01380327|453177826|FG001|Overall Study|Housing situation precluded ability to k|0|||
125968949|NCT01380327|453177827|FG002|Overall Study|Housing situation precluded ability to k|1|||
125968950|NCT01380327|453177825|FG000|Overall Study|Questionable onset of epilepsy|0|||
125968951|NCT01380327|453177826|FG001|Overall Study|Questionable onset of epilepsy|0|||
125968952|NCT01380327|453177827|FG002|Overall Study|Questionable onset of epilepsy|1|||
125968953|NCT04667117|453177828|FG000|Investigational Period|Lost to Follow-up|0|||
125968954|NCT04667117|453177829|FG001|Investigational Period|Lost to Follow-up|0|||
125968955|NCT04667117|453177830|FG002|Investigational Period|Lost to Follow-up|1|||
125968956|NCT04667117|453177828|FG000|Investigational Period|Protocol Deviation|0|||
125968957|NCT04667117|453177829|FG001|Investigational Period|Protocol Deviation|1|||
125968958|NCT04667117|453177830|FG002|Investigational Period|Protocol Deviation|0|||
125968959|NCT04667117|453177828|FG000|Extension Period|Lost to Follow-up|1|||
125968960|NCT04667117|453177829|FG001|Extension Period|Lost to Follow-up|0|||
125968961|NCT04667117|453177830|FG002|Extension Period|Lost to Follow-up|0|||
125968962|NCT01306162|453177831|FG000|Period 1|Adverse Event|0|||
125968963|NCT01306162|453177832|FG001|Period 1|Adverse Event|0|||
125968964|NCT01306162|453177833|FG002|Period 1|Adverse Event|0|||
125968965|NCT01306162|453177834|FG003|Period 1|Adverse Event|1|||
125968966|NCT01306162|453177831|FG000|Washout 1|Non-compliance to protocol|0|||
125968967|NCT01306162|453177832|FG001|Washout 1|Non-compliance to protocol|1|||
125968968|NCT01306162|453177833|FG002|Washout 1|Non-compliance to protocol|0|||
126144049|NCT01275222|453813611|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125968969|NCT01306162|453177834|FG003|Washout 1|Non-compliance to protocol|0|||
125968970|NCT02959437|453177835|FG000|Overall Study|Death|33|||
125968971|NCT02959437|453177836|FG001|Overall Study|Death|3|||
125968972|NCT02959437|453177837|FG002|Overall Study|Death|0|||
125968973|NCT02959437|453177838|FG003|Overall Study|Death|0|||
125968974|NCT02959437|453177835|FG000|Overall Study|Lost to Follow-up|3|||
125968975|NCT02959437|453177836|FG001|Overall Study|Lost to Follow-up|1|||
125968976|NCT02959437|453177837|FG002|Overall Study|Lost to Follow-up|0|||
125968977|NCT02959437|453177838|FG003|Overall Study|Lost to Follow-up|0|||
125968978|NCT02959437|453177835|FG000|Overall Study|Withdrawal by Subject|11|||
125968979|NCT02959437|453177836|FG001|Overall Study|Withdrawal by Subject|3|||
125968980|NCT02959437|453177837|FG002|Overall Study|Withdrawal by Subject|0|||
125968981|NCT02959437|453177838|FG003|Overall Study|Withdrawal by Subject|0|||
125968982|NCT02959437|453177835|FG000|Overall Study|Progressive Disease|9|||
125968983|NCT02959437|453177836|FG001|Overall Study|Progressive Disease|1|||
125968984|NCT02959437|453177837|FG002|Overall Study|Progressive Disease|0|||
125968985|NCT02959437|453177838|FG003|Overall Study|Progressive Disease|0|||
125968986|NCT02959437|453177835|FG000|Overall Study|Study Terminated by Sponsor|4|||
125968987|NCT02959437|453177836|FG001|Overall Study|Study Terminated by Sponsor|0|||
125968988|NCT02959437|453177837|FG002|Overall Study|Study Terminated by Sponsor|0|||
125968989|NCT02959437|453177838|FG003|Overall Study|Study Terminated by Sponsor|0|||
125968990|NCT02959437|453177835|FG000|Overall Study|Other Unspecified|2|||
125968991|NCT02959437|453177836|FG001|Overall Study|Other Unspecified|0|||
125968992|NCT02959437|453177837|FG002|Overall Study|Other Unspecified|0|||
125968993|NCT02959437|453177838|FG003|Overall Study|Other Unspecified|0|||
125968994|NCT00833989|453177841|FG000|Overall Study|Physician Decision|0|||
125968995|NCT00833989|453177842|FG001|Overall Study|Physician Decision|0|||
125968996|NCT00833989|453177843|FG002|Overall Study|Physician Decision|0|||
125968997|NCT00833989|453177844|FG003|Overall Study|Physician Decision|1|||
125968998|NCT00833989|453177841|FG000|Overall Study|Withdrawal by Subject|3|||
125968999|NCT00833989|453177842|FG001|Overall Study|Withdrawal by Subject|0|||
125969000|NCT00833989|453177843|FG002|Overall Study|Withdrawal by Subject|1|||
125969001|NCT00833989|453177844|FG003|Overall Study|Withdrawal by Subject|1|||
125969002|NCT01587651|453177856|FG000|Overall Study|Adverse Event|0|||
125969003|NCT01587651|453177857|FG001|Overall Study|Adverse Event|1|||
125969004|NCT01587651|453177858|FG002|Overall Study|Adverse Event|0|||
125969005|NCT01587651|453177856|FG000|Overall Study|Protocol Violation|0|||
125969006|NCT01587651|453177857|FG001|Overall Study|Protocol Violation|1|||
125969007|NCT01587651|453177858|FG002|Overall Study|Protocol Violation|1|||
125969008|NCT01587651|453177856|FG000|Overall Study|Withdrawal by Subject|0|||
125969009|NCT01587651|453177857|FG001|Overall Study|Withdrawal by Subject|1|||
125969010|NCT01587651|453177858|FG002|Overall Study|Withdrawal by Subject|0|||
125969011|NCT04323436|453177859|FG000|Overall Study|Adverse Event|7|||
125969012|NCT04323436|453177860|FG001|Overall Study|Adverse Event|0|||
125969013|NCT04323436|453177861|FG002|Overall Study|Adverse Event|0|||
125969014|NCT04323436|453177859|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
125969015|NCT04323436|453177860|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
125969016|NCT04323436|453177861|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
125969017|NCT04323436|453177859|FG000|Overall Study|Death|1|||
125969018|NCT04323436|453177860|FG001|Overall Study|Death|0|||
125969019|NCT04323436|453177861|FG002|Overall Study|Death|0|||
125969020|NCT04323436|453177859|FG000|Overall Study|Physician Decision|2|||
125969021|NCT04323436|453177860|FG001|Overall Study|Physician Decision|0|||
125969022|NCT04323436|453177861|FG002|Overall Study|Physician Decision|0|||
125969023|NCT04323436|453177859|FG000|Overall Study|Progressive disease|10|||
125969024|NCT04323436|453177860|FG001|Overall Study|Progressive disease|0|||
125969025|NCT04323436|453177861|FG002|Overall Study|Progressive disease|0|||
125969026|NCT04323436|453177859|FG000|Overall Study|Subject decision|3|||
125969027|NCT04323436|453177860|FG001|Overall Study|Subject decision|0|||
125969028|NCT04323436|453177861|FG002|Overall Study|Subject decision|0|||
125969029|NCT01660763|453177862|FG000|Overall Study|Lack of Efficacy|45|||
125969030|NCT01660763|453177863|FG001|Overall Study|Lack of Efficacy|50|||
125969031|NCT01660763|453177862|FG000|Overall Study|Adverse Event|22|||
125969032|NCT01660763|453177863|FG001|Overall Study|Adverse Event|7|||
125969033|NCT01660763|453177862|FG000|Overall Study|Protocol Violation|1|||
125969034|NCT01660763|453177863|FG001|Overall Study|Protocol Violation|0|||
125969035|NCT01660763|453177862|FG000|Overall Study|Withdrawal by Subject|4|||
125969036|NCT01660763|453177863|FG001|Overall Study|Withdrawal by Subject|0|||
125969037|NCT01660763|453177862|FG000|Overall Study|Patient ready for early discharge|28|||
125969038|NCT01660763|453177863|FG001|Overall Study|Patient ready for early discharge|4|||
125969039|NCT03325712|453177864|FG000|Overall Study|Protocol Violation|0|||
125969040|NCT03325712|453177865|FG001|Overall Study|Protocol Violation|0|||
125969041|NCT03325712|453177866|FG002|Overall Study|Protocol Violation|0|||
125969042|NCT03325712|453177867|FG003|Overall Study|Protocol Violation|0|||
125969043|NCT03325712|453177868|FG004|Overall Study|Protocol Violation|1|||
125969044|NCT03325712|453177869|FG005|Overall Study|Protocol Violation|0|||
125969045|NCT03325712|453177870|FG006|Overall Study|Protocol Violation|0|||
125969046|NCT03325712|453177871|FG007|Overall Study|Protocol Violation|0|||
125969047|NCT03325712|453177864|FG000|Overall Study|Adverse Event|0|||
125969048|NCT03325712|453177865|FG001|Overall Study|Adverse Event|0|||
125969049|NCT03325712|453177866|FG002|Overall Study|Adverse Event|0|||
125969050|NCT03325712|453177867|FG003|Overall Study|Adverse Event|0|||
125969051|NCT03325712|453177868|FG004|Overall Study|Adverse Event|1|||
125969052|NCT03325712|453177869|FG005|Overall Study|Adverse Event|0|||
125969053|NCT03325712|453177870|FG006|Overall Study|Adverse Event|0|||
125969054|NCT03325712|453177871|FG007|Overall Study|Adverse Event|0|||
125969055|NCT02265237|453177873|FG000|As Treated (Overall Study)|Adverse Event|1|||
125969056|NCT02265237|453177874|FG001|As Treated (Overall Study)|Adverse Event|1|||
125969057|NCT02265237|453177875|FG002|As Treated (Overall Study)|Adverse Event|0|||
125969058|NCT02265237|453177876|FG003|As Treated (Overall Study)|Adverse Event|0|||
125969059|NCT02265237|453177873|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
125969060|NCT02265237|453177874|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
125969061|NCT02265237|453177875|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
125969062|NCT02265237|453177876|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
125969063|NCT02265237|453177873|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
125969064|NCT02265237|453177874|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
125969065|NCT02265237|453177875|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
125969066|NCT02265237|453177876|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
125969067|NCT02265237|453177873|FG000|As Treated (Overall Study)|Other|2|||
125969068|NCT02265237|453177874|FG001|As Treated (Overall Study)|Other|0|||
125969069|NCT02265237|453177875|FG002|As Treated (Overall Study)|Other|3|||
125969070|NCT02265237|453177876|FG003|As Treated (Overall Study)|Other|1|||
125969071|NCT01178853|453177878|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
125969072|NCT01178853|453177879|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
125969073|NCT01178853|453177878|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
125969074|NCT01178853|453177879|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
125969075|NCT01178853|453177878|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
125969076|NCT01178853|453177879|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
125969077|NCT01178853|453177878|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
125969078|NCT01178853|453177879|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
125969079|NCT01178853|453177878|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
125969080|NCT01178853|453177879|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
125969081|NCT03550313|453177880|FG000|Overall Study|Adverse Event|0|||
125969082|NCT03550313|453177881|FG001|Overall Study|Adverse Event|1|||
125969083|NCT03550313|453177882|FG002|Overall Study|Adverse Event|0|||
125969084|NCT03550313|453177880|FG000|Overall Study|Lost to Follow-up|5|||
125969085|NCT03550313|453177881|FG001|Overall Study|Lost to Follow-up|7|||
125969086|NCT03550313|453177882|FG002|Overall Study|Lost to Follow-up|12|||
125969087|NCT03550313|453177880|FG000|Overall Study|Study terminated by sponsor|44|||
125969088|NCT03550313|453177881|FG001|Overall Study|Study terminated by sponsor|37|||
125969089|NCT03550313|453177882|FG002|Overall Study|Study terminated by sponsor|48|||
125969090|NCT03550313|453177880|FG000|Overall Study|No longer met eligibility criteria|3|||
125969091|NCT03550313|453177881|FG001|Overall Study|No longer met eligibility criteria|5|||
125969092|NCT03550313|453177882|FG002|Overall Study|No longer met eligibility criteria|6|||
125969093|NCT03550313|453177880|FG000|Overall Study|Withdrawal by parent/guardian|20|||
125969094|NCT03550313|453177881|FG001|Overall Study|Withdrawal by parent/guardian|18|||
125969095|NCT03550313|453177882|FG002|Overall Study|Withdrawal by parent/guardian|26|||
125969096|NCT03550313|453177880|FG000|Overall Study|Other|4|||
125969097|NCT03550313|453177881|FG001|Overall Study|Other|2|||
125969098|NCT03550313|453177882|FG002|Overall Study|Other|2|||
125969099|NCT03550313|453177880|FG000|Overall Study|Randomized but not vaccinated|3|||
125969100|NCT03550313|453177881|FG001|Overall Study|Randomized but not vaccinated|23|||
125969101|NCT03550313|453177882|FG002|Overall Study|Randomized but not vaccinated|2|||
125969102|NCT03550313|453177880|FG000|Overall Study|Sites terminated due to quality issues|18|||
125969103|NCT03550313|453177881|FG001|Overall Study|Sites terminated due to quality issues|17|||
125969104|NCT03550313|453177882|FG002|Overall Study|Sites terminated due to quality issues|18|||
125969105|NCT00839072|453177883|FG000|First Intervention Period|Withdrawal by Subject|1|||
125969106|NCT00839072|453177884|FG001|First Intervention Period|Withdrawal by Subject|0|||
125969107|NCT00839072|453177883|FG000|First Intervention Period|Adverse Event|1|||
125969108|NCT00839072|453177884|FG001|First Intervention Period|Adverse Event|1|||
125969109|NCT00839072|453177883|FG000|Second Intervention Period|Withdrawal by Subject|1|||
125969110|NCT00839072|453177884|FG001|Second Intervention Period|Withdrawal by Subject|0|||
125969111|NCT00380068|453177886|FG000|Overall Study|Adverse Event|40|||
125969112|NCT00380068|453177886|FG000|Overall Study|Withdrawal by Subject|10|||
125969113|NCT00380068|453177886|FG000|Overall Study|Not compliant|6|||
125969114|NCT00380068|453177886|FG000|Overall Study|Lost to Follow-up|1|||
125969115|NCT00380068|453177886|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
125969116|NCT00380068|453177886|FG000|Overall Study|Lung transplant|3|||
125969117|NCT00380068|453177886|FG000|Overall Study|Physician Decision|2|||
125969118|NCT00380068|453177886|FG000|Overall Study|Partipant moved away|1|||
125969119|NCT00380068|453177886|FG000|Overall Study|Lack of Efficacy|5|||
125969120|NCT01297062|453177887|FG000|Overall Study|Adverse Event|2|||
125969121|NCT01297062|453177888|FG001|Overall Study|Adverse Event|0|||
125969122|NCT01297062|453177889|FG002|Overall Study|Adverse Event|1|||
125969123|NCT01297062|453177890|FG003|Overall Study|Adverse Event|0|||
125969124|NCT01297062|453177891|FG004|Overall Study|Adverse Event|0|||
125969125|NCT01297062|453177892|FG005|Overall Study|Adverse Event|0|||
125969126|NCT01297062|453177893|FG006|Overall Study|Adverse Event|0|||
125969127|NCT01297062|453177887|FG000|Overall Study|Physician Decision|1|||
125969128|NCT01297062|453177888|FG001|Overall Study|Physician Decision|0|||
125969129|NCT01297062|453177889|FG002|Overall Study|Physician Decision|1|||
125969130|NCT01297062|453177890|FG003|Overall Study|Physician Decision|0|||
125969131|NCT01297062|453177891|FG004|Overall Study|Physician Decision|0|||
125969132|NCT01297062|453177892|FG005|Overall Study|Physician Decision|0|||
125969133|NCT01297062|453177893|FG006|Overall Study|Physician Decision|6|||
125969134|NCT01297062|453177887|FG000|Overall Study|Protocol Violation|0|||
125969135|NCT01297062|453177888|FG001|Overall Study|Protocol Violation|0|||
125969136|NCT01297062|453177889|FG002|Overall Study|Protocol Violation|0|||
125969137|NCT01297062|453177890|FG003|Overall Study|Protocol Violation|0|||
125969138|NCT01297062|453177891|FG004|Overall Study|Protocol Violation|1|||
125969139|NCT01297062|453177892|FG005|Overall Study|Protocol Violation|0|||
125969140|NCT01297062|453177893|FG006|Overall Study|Protocol Violation|0|||
125969141|NCT01297062|453177887|FG000|Overall Study|Subject Decision|1|||
125969142|NCT01297062|453177888|FG001|Overall Study|Subject Decision|1|||
125969143|NCT01297062|453177889|FG002|Overall Study|Subject Decision|0|||
125969144|NCT01297062|453177890|FG003|Overall Study|Subject Decision|1|||
125969145|NCT01297062|453177891|FG004|Overall Study|Subject Decision|1|||
125969146|NCT01297062|453177892|FG005|Overall Study|Subject Decision|1|||
125969147|NCT01297062|453177893|FG006|Overall Study|Subject Decision|2|||
125969148|NCT01458574|453177894|FG000|Overall Study|Adverse Event|5|||
125969149|NCT01458574|453177895|FG001|Overall Study|Adverse Event|9|||
125969150|NCT01458574|453177896|FG002|Overall Study|Adverse Event|7|||
125969151|NCT01458574|453177894|FG000|Overall Study|Lack of Efficacy|70|||
125969152|NCT01458574|453177895|FG001|Overall Study|Lack of Efficacy|53|||
125969153|NCT01458574|453177896|FG002|Overall Study|Lack of Efficacy|132|||
125969154|NCT01458574|453177894|FG000|Overall Study|Lost to Follow-up|3|||
125969155|NCT01458574|453177895|FG001|Overall Study|Lost to Follow-up|2|||
125969156|NCT01458574|453177896|FG002|Overall Study|Lost to Follow-up|1|||
125969157|NCT01458574|453177894|FG000|Overall Study|Pregnancy|1|||
125969158|NCT01458574|453177895|FG001|Overall Study|Pregnancy|1|||
125969159|NCT01458574|453177896|FG002|Overall Study|Pregnancy|0|||
125969160|NCT01458574|453177894|FG000|Overall Study|Protocol Violation|0|||
125969161|NCT01458574|453177895|FG001|Overall Study|Protocol Violation|1|||
125969162|NCT01458574|453177896|FG002|Overall Study|Protocol Violation|0|||
125969163|NCT01458574|453177894|FG000|Overall Study|Withdrawal by Subject|6|||
125969164|NCT01458574|453177895|FG001|Overall Study|Withdrawal by Subject|3|||
125969165|NCT01458574|453177896|FG002|Overall Study|Withdrawal by Subject|5|||
125969166|NCT01458574|453177894|FG000|Overall Study|Other|2|||
125969167|NCT01458574|453177895|FG001|Overall Study|Other|1|||
125969168|NCT01458574|453177896|FG002|Overall Study|Other|0|||
125969169|NCT01458574|453177894|FG000|Overall Study|Randomized but not treated|0|||
125969170|NCT01458574|453177895|FG001|Overall Study|Randomized but not treated|1|||
125969171|NCT01458574|453177896|FG002|Overall Study|Randomized but not treated|0|||
125969172|NCT02125786|453177897|FG000|Overall Study|Still in Follow-up|3|||
125969173|NCT02125786|453177897|FG000|Overall Study|Screen Failure|2|||
125969174|NCT02125786|453177897|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
125969175|NCT02125786|453177897|FG000|Overall Study|Progressive Disease|44|||
125969176|NCT02125786|453177897|FG000|Overall Study|Death|8|||
126144050|NCT01275222|453813612|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
126144051|NCT01275222|453813607|FG000|Phase l by Treatment|Disease progression|12|||
126144052|NCT01275222|453813608|FG001|Phase l by Treatment|Disease progression|8|||
126144053|NCT01275222|453813609|FG002|Phase l by Treatment|Disease progression|2|||
125969177|NCT04964089|453177898|FG000|Overall Study|Adverse Event|8|||
125969178|NCT04964089|453177899|FG001|Overall Study|Adverse Event|6|||
126144054|NCT01275222|453813610|FG003|Phase l by Treatment|Disease progression|5|||
126144055|NCT01275222|453813611|FG004|Phase l by Treatment|Disease progression|0|||
126144056|NCT01275222|453813612|FG005|Phase l by Treatment|Disease progression|0|||
125969179|NCT04964089|453177898|FG000|Overall Study|Non-compliance with study schedule|1|||
125969180|NCT04964089|453177899|FG001|Overall Study|Non-compliance with study schedule|0|||
125969181|NCT04964089|453177898|FG000|Overall Study|Withdrawal by Subject|6|||
125969182|NCT04964089|453177899|FG001|Overall Study|Withdrawal by Subject|5|||
126144057|NCT01275222|453813607|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
126144058|NCT01275222|453813608|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
126144059|NCT01275222|453813609|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
125969183|NCT04964089|453177898|FG000|Overall Study|Lost to Follow-up|1|||
125969184|NCT04964089|453177899|FG001|Overall Study|Lost to Follow-up|1|||
125969185|NCT04964089|453177898|FG000|Overall Study|Progressive disease|4|||
125969186|NCT04964089|453177899|FG001|Overall Study|Progressive disease|0|||
125969187|NCT04964089|453177898|FG000|Overall Study|Physician Decision|1|||
125969188|NCT04964089|453177899|FG001|Overall Study|Physician Decision|0|||
125969189|NCT04964089|453177898|FG000|Overall Study|Participant did not want to continue study treatment|1|||
125969190|NCT04964089|453177899|FG001|Overall Study|Participant did not want to continue study treatment|0|||
126144060|NCT01275222|453813610|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
126144061|NCT01275222|453813611|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
125969191|NCT04964089|453177898|FG000|Overall Study|Participant moved to different state|1|||
125969192|NCT04964089|453177899|FG001|Overall Study|Participant moved to different state|0|||
125969193|NCT04964089|453177898|FG000|Overall Study|Participant decided to discontinue|0|||
125969194|NCT04964089|453177899|FG001|Overall Study|Participant decided to discontinue|1|||
125969195|NCT01682837|453177900|FG000|Baseline|Withdrawal by Subject|5|||
125969196|NCT01196975|453177901|FG000|Overall Study|Adverse Event|2|||
125969197|NCT01196975|453177902|FG001|Overall Study|Adverse Event|2|||
125969198|NCT01196975|453177903|FG002|Overall Study|Adverse Event|0|||
125969199|NCT01196975|453177904|FG003|Overall Study|Adverse Event|0|||
125969200|NCT01196975|453177905|FG004|Overall Study|Adverse Event|2|||
125969201|NCT01196975|453177901|FG000|Overall Study|Withdrawal by Subject|2|||
125969202|NCT01196975|453177902|FG001|Overall Study|Withdrawal by Subject|1|||
125969203|NCT01196975|453177903|FG002|Overall Study|Withdrawal by Subject|0|||
125969204|NCT01196975|453177904|FG003|Overall Study|Withdrawal by Subject|1|||
125969205|NCT01196975|453177905|FG004|Overall Study|Withdrawal by Subject|0|||
125969206|NCT01196975|453177901|FG000|Overall Study|Lost to Follow-up|11|||
125969207|NCT01196975|453177902|FG001|Overall Study|Lost to Follow-up|6|||
125969208|NCT01196975|453177903|FG002|Overall Study|Lost to Follow-up|5|||
125969209|NCT01196975|453177904|FG003|Overall Study|Lost to Follow-up|5|||
125969210|NCT01196975|453177905|FG004|Overall Study|Lost to Follow-up|11|||
125969211|NCT01365494|453177908|FG000|Overall Study|Adverse Event|1|||
125969212|NCT01365494|453177909|FG001|Overall Study|Adverse Event|0|||
125969213|NCT01365494|453177908|FG000|Overall Study|Withdrawal by Subject|0|||
125969214|NCT01365494|453177909|FG001|Overall Study|Withdrawal by Subject|1|||
125969215|NCT01365494|453177908|FG000|Overall Study|Lost to Follow-up|1|||
125969216|NCT01365494|453177909|FG001|Overall Study|Lost to Follow-up|2|||
125969217|NCT00718718|453177910|FG000|Prior to Week 12|Adverse Event|0|||
125969218|NCT00718718|453177911|FG001|Prior to Week 12|Adverse Event|0|||
125969219|NCT00718718|453177912|FG002|Prior to Week 12|Adverse Event|0|||
125969220|NCT00718718|453177913|FG003|Prior to Week 12|Adverse Event|0|||
125969221|NCT00718718|453177914|FG004|Prior to Week 12|Adverse Event|0|||
125969222|NCT00718718|453177915|FG005|Prior to Week 12|Adverse Event|0|||
125969223|NCT00718718|453177916|FG006|Prior to Week 12|Adverse Event|0|||
125969224|NCT00718718|453177917|FG007|Prior to Week 12|Adverse Event|1|||
125969225|NCT00718718|453177918|FG008|Prior to Week 12|Adverse Event|1|||
125969226|NCT00718718|453177919|FG009|Prior to Week 12|Adverse Event|0|||
125969227|NCT00718718|453177910|FG000|Prior to Week 12|Withdrawal by Subject|0|||
125969228|NCT00718718|453177911|FG001|Prior to Week 12|Withdrawal by Subject|0|||
125969229|NCT00718718|453177912|FG002|Prior to Week 12|Withdrawal by Subject|0|||
125969230|NCT00718718|453177913|FG003|Prior to Week 12|Withdrawal by Subject|0|||
125969231|NCT00718718|453177914|FG004|Prior to Week 12|Withdrawal by Subject|3|||
125969232|NCT00718718|453177915|FG005|Prior to Week 12|Withdrawal by Subject|0|||
125969233|NCT00718718|453177916|FG006|Prior to Week 12|Withdrawal by Subject|1|||
125969234|NCT00718718|453177917|FG007|Prior to Week 12|Withdrawal by Subject|1|||
125969235|NCT00718718|453177918|FG008|Prior to Week 12|Withdrawal by Subject|1|||
125969236|NCT00718718|453177919|FG009|Prior to Week 12|Withdrawal by Subject|0|||
125969237|NCT00718718|453177910|FG000|Prior to Week 12|Other|1|||
125969238|NCT00718718|453177911|FG001|Prior to Week 12|Other|0|||
125969239|NCT00718718|453177912|FG002|Prior to Week 12|Other|1|||
125969240|NCT00718718|453177913|FG003|Prior to Week 12|Other|0|||
125969241|NCT00718718|453177914|FG004|Prior to Week 12|Other|0|||
125969242|NCT00718718|453177915|FG005|Prior to Week 12|Other|0|||
125969243|NCT00718718|453177916|FG006|Prior to Week 12|Other|0|||
125969244|NCT00718718|453177917|FG007|Prior to Week 12|Other|0|||
125969245|NCT00718718|453177918|FG008|Prior to Week 12|Other|0|||
125969246|NCT00718718|453177919|FG009|Prior to Week 12|Other|0|||
125969247|NCT00718718|453177910|FG000|Week 12 to End of Study|Adverse Event|0|||
125969248|NCT00718718|453177911|FG001|Week 12 to End of Study|Adverse Event|0|||
125969249|NCT00718718|453177912|FG002|Week 12 to End of Study|Adverse Event|0|||
125969250|NCT00718718|453177913|FG003|Week 12 to End of Study|Adverse Event|0|||
125969251|NCT00718718|453177914|FG004|Week 12 to End of Study|Adverse Event|0|||
125969252|NCT00718718|453177915|FG005|Week 12 to End of Study|Adverse Event|0|||
125969253|NCT00718718|453177916|FG006|Week 12 to End of Study|Adverse Event|0|||
125969254|NCT00718718|453177917|FG007|Week 12 to End of Study|Adverse Event|1|||
125969255|NCT00718718|453177918|FG008|Week 12 to End of Study|Adverse Event|0|||
125969256|NCT00718718|453177919|FG009|Week 12 to End of Study|Adverse Event|0|||
125969257|NCT00718718|453177910|FG000|Week 12 to End of Study|Death|0|||
125969258|NCT00718718|453177911|FG001|Week 12 to End of Study|Death|0|||
125969259|NCT00718718|453177912|FG002|Week 12 to End of Study|Death|0|||
125969260|NCT00718718|453177913|FG003|Week 12 to End of Study|Death|0|||
125969261|NCT00718718|453177914|FG004|Week 12 to End of Study|Death|0|||
125969262|NCT00718718|453177915|FG005|Week 12 to End of Study|Death|1|||
125969263|NCT00718718|453177916|FG006|Week 12 to End of Study|Death|0|||
125969264|NCT00718718|453177917|FG007|Week 12 to End of Study|Death|0|||
125969265|NCT00718718|453177918|FG008|Week 12 to End of Study|Death|0|||
125969266|NCT00718718|453177919|FG009|Week 12 to End of Study|Death|0|||
125969267|NCT00718718|453177910|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
125969268|NCT00718718|453177911|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
125969269|NCT00718718|453177912|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
125969270|NCT00718718|453177913|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
125969271|NCT00718718|453177914|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
125969272|NCT00718718|453177915|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
125969273|NCT00718718|453177916|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
125969274|NCT00718718|453177917|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
125969275|NCT00718718|453177918|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
125969276|NCT00718718|453177919|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
125969277|NCT00718718|453177910|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
125969278|NCT00718718|453177911|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
125969279|NCT00718718|453177912|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
125969280|NCT00718718|453177913|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
125969281|NCT00718718|453177914|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
125969282|NCT00718718|453177915|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
125969283|NCT00718718|453177916|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
125969284|NCT00718718|453177917|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
125969285|NCT00718718|453177918|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
126144062|NCT01275222|453813612|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
126144063|NCT01275222|453813607|FG000|Phase l by Treatment|Death|0|||
126144064|NCT01275222|453813608|FG001|Phase l by Treatment|Death|1|||
126144065|NCT01275222|453813609|FG002|Phase l by Treatment|Death|0|||
126144066|NCT01275222|453813610|FG003|Phase l by Treatment|Death|1|||
126144067|NCT01275222|453813611|FG004|Phase l by Treatment|Death|0|||
126144068|NCT01275222|453813612|FG005|Phase l by Treatment|Death|0|||
125969286|NCT00718718|453177919|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
125969287|NCT00718718|453177910|FG000|Week 12 to End of Study|Other|0|||
125969288|NCT00718718|453177911|FG001|Week 12 to End of Study|Other|1|||
125969289|NCT00718718|453177912|FG002|Week 12 to End of Study|Other|0|||
125969290|NCT00718718|453177913|FG003|Week 12 to End of Study|Other|1|||
125969291|NCT00718718|453177914|FG004|Week 12 to End of Study|Other|0|||
125969292|NCT00718718|453177915|FG005|Week 12 to End of Study|Other|0|||
125969293|NCT00718718|453177916|FG006|Week 12 to End of Study|Other|1|||
125969294|NCT00718718|453177917|FG007|Week 12 to End of Study|Other|0|||
125969295|NCT00718718|453177918|FG008|Week 12 to End of Study|Other|0|||
125969296|NCT00718718|453177919|FG009|Week 12 to End of Study|Other|0|||
125969297|NCT04558346|453177930|FG000|Overall Study|Withdrawal by Subject|2|||
125969298|NCT04558346|453177931|FG001|Overall Study|Withdrawal by Subject|0|||
125969299|NCT04558346|453177930|FG000|Overall Study|Lost to Follow-up|0|||
125969300|NCT04558346|453177931|FG001|Overall Study|Lost to Follow-up|1|||
125969301|NCT04558346|453177930|FG000|Overall Study|Adverse Event|0|||
125969302|NCT04558346|453177931|FG001|Overall Study|Adverse Event|1|||
125969303|NCT01462344|453177932|FG000|Overall Study|Withdrawal by Subject|245|||
125969304|NCT01462344|453177933|FG001|Overall Study|Withdrawal by Subject|226|||
125969305|NCT01462344|453177932|FG000|Overall Study|Adverse Event|24|||
125969306|NCT01462344|453177933|FG001|Overall Study|Adverse Event|23|||
125969307|NCT01462344|453177932|FG000|Overall Study|Asthma Exacerbation|34|||
125969308|NCT01462344|453177933|FG001|Overall Study|Asthma Exacerbation|35|||
125969309|NCT01462344|453177932|FG000|Overall Study|Lack of Efficacy|5|||
125969310|NCT01462344|453177933|FG001|Overall Study|Lack of Efficacy|6|||
125969311|NCT01462344|453177932|FG000|Overall Study|Protocol Violation|68|||
125969312|NCT01462344|453177933|FG001|Overall Study|Protocol Violation|53|||
125969313|NCT01462344|453177932|FG000|Overall Study|Lost to Follow-up|7|||
125969314|NCT01462344|453177933|FG001|Overall Study|Lost to Follow-up|7|||
125969315|NCT00724971|453177934|FG000|Overall Study|Adverse Event|5|||
125969316|NCT00724971|453177934|FG000|Overall Study|Withdrawal by Subject|1|||
125969317|NCT01003249|453177935|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125969318|NCT01003249|453177936|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125969319|NCT01003249|453177935|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
125969320|NCT01003249|453177936|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
125969321|NCT01003249|453177935|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125969322|NCT01003249|453177936|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126144069|NCT01275222|453813607|FG000|Phase ll by Stratum|Adverse Event|0|||
126144070|NCT01275222|453813608|FG001|Phase ll by Stratum|Adverse Event|0|||
125969323|NCT01003249|453177935|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
125969324|NCT01003249|453177936|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
125969325|NCT01962974|453177939|FG000|Overall Study|Study termination|7|||
125969326|NCT01692197|453177940|FG000|Overall Study|Failed Screening|3|||
125969327|NCT03086447|453177942|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125969328|NCT03086447|453177943|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
125969329|NCT03086447|453177942|FG000|Overall Study|Lost Lens|2|||
125969330|NCT03086447|453177943|FG001|Overall Study|Lost Lens|5|||
125969331|NCT03086447|453177942|FG000|Overall Study|Product quality complaint|0|||
125969332|NCT03086447|453177943|FG001|Overall Study|Product quality complaint|1|||
125969333|NCT03086447|453177942|FG000|Overall Study|Lens Damage|1|||
125969334|NCT03086447|453177943|FG001|Overall Study|Lens Damage|6|||
126144071|NCT01275222|453813609|FG002|Phase ll by Stratum|Adverse Event|0|||
126144072|NCT01275222|453813610|FG003|Phase ll by Stratum|Adverse Event|0|||
125969335|NCT03086447|453177942|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125969336|NCT03086447|453177943|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125969337|NCT03086447|453177942|FG000|Overall Study|Test Article No Longer Available|1|||
125969338|NCT03086447|453177943|FG001|Overall Study|Test Article No Longer Available|0|||
125969339|NCT03086447|453177942|FG000|Overall Study|Protocol Violation|2|||
125969340|NCT03086447|453177943|FG001|Overall Study|Protocol Violation|4|||
125969341|NCT03086447|453177942|FG000|Overall Study|Lost to Follow-up|0|||
125969342|NCT03086447|453177943|FG001|Overall Study|Lost to Follow-up|1|||
125969343|NCT03086447|453177942|FG000|Overall Study|Adverse Event|3|||
125969344|NCT03086447|453177943|FG001|Overall Study|Adverse Event|0|||
125969345|NCT03086447|453177942|FG000|Overall Study|Lens Discomfort|2|||
125969346|NCT03086447|453177943|FG001|Overall Study|Lens Discomfort|1|||
125969347|NCT03394924|453177949|FG000|Overall Study|Adverse Event|0|||
125969348|NCT03394924|453177950|FG001|Overall Study|Adverse Event|5|||
125969349|NCT03394924|453177951|FG002|Overall Study|Adverse Event|0|||
125969350|NCT03394924|453177949|FG000|Overall Study|Withdrawal by Subject|2|||
125969351|NCT03394924|453177950|FG001|Overall Study|Withdrawal by Subject|0|||
125969352|NCT03394924|453177951|FG002|Overall Study|Withdrawal by Subject|0|||
125969353|NCT03394924|453177949|FG000|Overall Study|Lost to Follow-up|0|||
125969354|NCT03394924|453177950|FG001|Overall Study|Lost to Follow-up|1|||
125969355|NCT03394924|453177951|FG002|Overall Study|Lost to Follow-up|0|||
125969356|NCT03394924|453177949|FG000|Overall Study|Did not meet all inclusion criteria|1|||
125969357|NCT03394924|453177950|FG001|Overall Study|Did not meet all inclusion criteria|0|||
125969358|NCT03394924|453177951|FG002|Overall Study|Did not meet all inclusion criteria|0|||
125969359|NCT03588572|453177954|FG000|Visitation 1|Lack of Efficacy|1|||
125969360|NCT03588572|453177955|FG001|Visitation 1|Lack of Efficacy|1|||
125969361|NCT03588572|453177954|FG000|Visitation 2|Lost to Follow-up|1|||
125969362|NCT03588572|453177955|FG001|Visitation 2|Lost to Follow-up|1|||
125969363|NCT03588572|453177954|FG000|Visitation 2|Lack of Efficacy|0|||
125969364|NCT03588572|453177955|FG001|Visitation 2|Lack of Efficacy|1|||
125969365|NCT03588572|453177954|FG000|Visitation 2|Withdrawal by Subject|1|||
125969366|NCT03588572|453177955|FG001|Visitation 2|Withdrawal by Subject|0|||
125969367|NCT03588572|453177954|FG000|Visitation 3|Lost to Follow-up|1|||
125969368|NCT03588572|453177955|FG001|Visitation 3|Lost to Follow-up|1|||
125969369|NCT03588572|453177954|FG000|Visitation 3|Physician Decision|1|||
125969370|NCT03588572|453177955|FG001|Visitation 3|Physician Decision|1|||
125969371|NCT03588572|453177954|FG000|Visitation 3|Withdrawal by Subject|1|||
125969372|NCT03588572|453177955|FG001|Visitation 3|Withdrawal by Subject|0|||
125969373|NCT02535065|453177961|FG000|Overall Study|Death|13|||
125969374|NCT02535065|453177961|FG000|Overall Study|Lost to Follow-up|1|||
125969375|NCT02535065|453177961|FG000|Overall Study|Withdrawal by Subject|6|||
125969376|NCT00110617|453177962|FG000|Overall Study|Adverse Event|2|||
125969377|NCT00110617|453177963|FG001|Overall Study|Adverse Event|4|||
125969378|NCT00110617|453177962|FG000|Overall Study|Abnormal Laboratory Value|4|||
125969379|NCT00110617|453177963|FG001|Overall Study|Abnormal Laboratory Value|2|||
125969380|NCT00110617|453177962|FG000|Overall Study|Lack of Efficacy|1|||
125969381|NCT00110617|453177963|FG001|Overall Study|Lack of Efficacy|0|||
125969382|NCT00110617|453177962|FG000|Overall Study|Patient no longer requires study drug|1|||
125969383|NCT00110617|453177963|FG001|Overall Study|Patient no longer requires study drug|0|||
125969384|NCT00110617|453177962|FG000|Overall Study|Protocol Violation|5|||
126144073|NCT01275222|453813611|FG004|Phase ll by Stratum|Adverse Event|2|||
126144074|NCT01275222|453813612|FG005|Phase ll by Stratum|Adverse Event|10|||
126144075|NCT01275222|453813607|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
126144076|NCT01275222|453813608|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
126144077|NCT01275222|453813609|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
126144078|NCT01275222|453813610|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
126144079|NCT01275222|453813611|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
126144080|NCT01275222|453813612|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
125969385|NCT00110617|453177963|FG001|Overall Study|Protocol Violation|0|||
125969386|NCT00110617|453177962|FG000|Overall Study|Withdrawal by Subject|10|||
125969387|NCT00110617|453177963|FG001|Overall Study|Withdrawal by Subject|4|||
125969388|NCT00110617|453177962|FG000|Overall Study|Lost to Follow-up|9|||
125969389|NCT00110617|453177963|FG001|Overall Study|Lost to Follow-up|1|||
125969390|NCT00110617|453177962|FG000|Overall Study|Administrative problems|6|||
125969391|NCT00110617|453177963|FG001|Overall Study|Administrative problems|5|||
125969392|NCT00110617|453177962|FG000|Overall Study|Death|1|||
125969393|NCT00110617|453177963|FG001|Overall Study|Death|1|||
125969394|NCT00110617|453177962|FG000|Overall Study|Did not receive study drug|0|||
125969395|NCT00110617|453177963|FG001|Overall Study|Did not receive study drug|12|||
125969396|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
126144081|NCT01275222|453813607|FG000|Phase ll by Stratum|Disease progression|0|||
126144082|NCT01275222|453813608|FG001|Phase ll by Stratum|Disease progression|0|||
125969397|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
125969398|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
125969399|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
125969400|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
125969401|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
125969402|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
125969403|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
125969404|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
125969405|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
125969406|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
125969407|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
125969408|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
125969409|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
125969410|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
125969411|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
125969412|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
125969413|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
125969414|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
125969415|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
125969416|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
125969417|NCT01781572|453177964|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
125969418|NCT01781572|453177965|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
125969419|NCT01781572|453177966|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
125969420|NCT01781572|453177964|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
125969421|NCT01781572|453177965|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
125969422|NCT01781572|453177966|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
125969423|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
125969424|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
125969425|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
125969426|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
125969427|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
125969428|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
125969429|NCT01781572|453177964|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
125969430|NCT01781572|453177965|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
125969431|NCT01781572|453177966|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
125969432|NCT01781572|453177964|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
126144083|NCT01275222|453813609|FG002|Phase ll by Stratum|Disease progression|0|||
126144084|NCT01275222|453813610|FG003|Phase ll by Stratum|Disease progression|0|||
126144085|NCT01275222|453813611|FG004|Phase ll by Stratum|Disease progression|23|||
126144086|NCT01275222|453813612|FG005|Phase ll by Stratum|Disease progression|31|||
126144087|NCT01275222|453813607|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
126144088|NCT01275222|453813608|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
126144089|NCT01275222|453813609|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
126144090|NCT01275222|453813610|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
126144091|NCT01275222|453813611|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
126144092|NCT01275222|453813612|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
125969433|NCT01781572|453177965|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
125969434|NCT01781572|453177966|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
125969435|NCT01781572|453177964|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
125969436|NCT01781572|453177965|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
125969437|NCT01781572|453177966|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
125969438|NCT01781572|453177964|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
125969439|NCT01781572|453177965|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
125969440|NCT01781572|453177966|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
125969441|NCT01781572|453177964|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
125969442|NCT01781572|453177965|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
125969443|NCT01781572|453177966|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
125969444|NCT01781572|453177964|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
125969445|NCT01781572|453177965|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
125969446|NCT01781572|453177966|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
125969447|NCT01781572|453177964|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
125969448|NCT01781572|453177965|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
125969449|NCT01781572|453177966|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
125969450|NCT00045110|453177967|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
125969451|NCT00045110|453177968|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
125969452|NCT00045110|453177969|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
125969453|NCT00045110|453177967|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
126144093|NCT01275222|453813607|FG000|Phase ll by Stratum|Death|0|||
125969454|NCT00045110|453177968|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
125969455|NCT00045110|453177969|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
125969456|NCT00045110|453177967|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
125969457|NCT00045110|453177968|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
125969458|NCT00045110|453177969|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
126144094|NCT01275222|453813608|FG001|Phase ll by Stratum|Death|0|||
126144095|NCT01275222|453813609|FG002|Phase ll by Stratum|Death|0|||
126144096|NCT01275222|453813610|FG003|Phase ll by Stratum|Death|0|||
125969459|NCT00660010|453177970|FG000|Overall Study|Withdrawal by Subject|2|||
125969460|NCT00660010|453177970|FG000|Overall Study|Lost to Follow-up|3|||
125969461|NCT00660010|453177970|FG000|Overall Study|Adverse Event|1|||
125969462|NCT00660010|453177970|FG000|Overall Study|Noncompliance with visit schedule|3|||
125969463|NCT02105116|453179960|FG000|Overall Study|not eligible for step 2 of trial|5|||
125969464|NCT02105116|453179960|FG000|Overall Study|Death|1|||
125969465|NCT00896168|453179961|FG000|Overall Study|Adverse Event|4|||
126144097|NCT01275222|453813611|FG004|Phase ll by Stratum|Death|1|||
126144098|NCT01275222|453813612|FG005|Phase ll by Stratum|Death|1|||
126144099|NCT00591734|453813613|FG000|Overall Study|Lack of Efficacy|35|||
126144100|NCT00591734|453813613|FG000|Overall Study|Adverse Event|5|||
126144101|NCT00591734|453813613|FG000|Overall Study|Physician Decision|5|||
126144102|NCT00591734|453813613|FG000|Overall Study|Intercurrent Illness|8|||
126144103|NCT00484315|453813614|FG000|12-Month Clinical Follow-up|Death|6|||
126144104|NCT00484315|453813615|FG001|12-Month Clinical Follow-up|Death|2|||
126144105|NCT00484315|453813614|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
126144106|NCT00484315|453813615|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
126144107|NCT00484315|453813614|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
126144108|NCT00484315|453813615|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
126144109|NCT00484315|453813614|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
126144110|NCT00484315|453813615|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
126144111|NCT00484315|453813614|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
126144112|NCT00484315|453813615|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
126144113|NCT00484315|453813614|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
126144114|NCT00484315|453813615|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
126144115|NCT00484315|453813614|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
126144116|NCT00484315|453813615|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
126144117|NCT00943683|453813616|FG000|Overall Study|Adverse Event|3|||
126144118|NCT00943683|453813617|FG001|Overall Study|Adverse Event|3|||
125969466|NCT00896168|453179962|FG001|Overall Study|Adverse Event|7|||
125969467|NCT00896168|453179961|FG000|Overall Study|Treatment failure|8|||
125969468|NCT00896168|453179962|FG001|Overall Study|Treatment failure|10|||
125969469|NCT00896168|453179961|FG000|Overall Study|Lost to Follow-up|1|||
125969470|NCT00896168|453179962|FG001|Overall Study|Lost to Follow-up|1|||
125969471|NCT00896168|453179961|FG000|Overall Study|Other|1|||
125969472|NCT00896168|453179962|FG001|Overall Study|Other|1|||
125969473|NCT02492100|453179963|FG000|Overall Study|Death|1|||
125969474|NCT01003899|453179965|FG000|Overall Study|Other Adverse Event|8|||
125969475|NCT01003899|453179965|FG000|Overall Study|Not entered|4|||
125969476|NCT01003899|453179965|FG000|Overall Study|Not treated|1|||
125969477|NCT01003899|453179965|FG000|Overall Study|Progressive disease|34|||
125969478|NCT03822533|453179967|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
125969479|NCT03822533|453179968|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
125969480|NCT03822533|453179967|FG000|3 Month Follow-up|Lost to Follow-up|2|||
125969481|NCT03822533|453179968|FG001|3 Month Follow-up|Lost to Follow-up|2|||
125969482|NCT03822533|453179967|FG000|6 Month Follow-up|Lost to Follow-up|3|||
125969483|NCT03822533|453179968|FG001|6 Month Follow-up|Lost to Follow-up|0|||
125969484|NCT03822533|453179967|FG000|12 Month Follow-up|Lost to Follow-up|2|||
125969485|NCT03822533|453179968|FG001|12 Month Follow-up|Lost to Follow-up|3|||
125969486|NCT03822533|453179967|FG000|12 Month Follow-up|Pregnancy|0|||
125969487|NCT03822533|453179968|FG001|12 Month Follow-up|Pregnancy|1|||
125969488|NCT03822533|453179967|FG000|12 Month Follow-up|Surgery|2|||
125969489|NCT03822533|453179968|FG001|12 Month Follow-up|Surgery|0|||
125969490|NCT03822533|453179967|FG000|12 Month Follow-up|Wrong address|1|||
125969491|NCT03822533|453179968|FG001|12 Month Follow-up|Wrong address|0|||
125969492|NCT03822533|453179967|FG000|12 Month Follow-up|No symptoms|1|||
125969493|NCT03822533|453179968|FG001|12 Month Follow-up|No symptoms|0|||
125969494|NCT03822533|453179967|FG000|12 Month Follow-up|Changed primary care center|0|||
125969495|NCT03822533|453179968|FG001|12 Month Follow-up|Changed primary care center|1|||
125969496|NCT02489500|453179971|FG000|Overall Study|Death|1|||
125969497|NCT02489500|453179972|FG001|Overall Study|Death|1|||
126144119|NCT00943683|453813616|FG000|Overall Study|Lost to Follow-up|1|||
126144120|NCT00943683|453813617|FG001|Overall Study|Lost to Follow-up|1|||
126144121|NCT00943683|453813616|FG000|Overall Study|Protocol Violation|1|||
125969498|NCT02863926|453179974|FG000|Overall Study|Physician Decision|1|||
125969499|NCT02863926|453179975|FG001|Overall Study|Physician Decision|0|||
125969500|NCT02863926|453179974|FG000|Overall Study|Lost to Follow-up|1|||
125969501|NCT02863926|453179975|FG001|Overall Study|Lost to Follow-up|1|||
125969502|NCT01259713|453179976|FG000|Overall Study|Adverse Event|54|||
126144122|NCT00943683|453813617|FG001|Overall Study|Protocol Violation|2|||
126144123|NCT00943683|453813616|FG000|Overall Study|Withdrawal by Subject|1|||
126144124|NCT00943683|453813617|FG001|Overall Study|Withdrawal by Subject|0|||
125969503|NCT01259713|453179977|FG001|Overall Study|Adverse Event|23|||
125969504|NCT01259713|453179976|FG000|Overall Study|Death Not Related to IFI|8|||
125969505|NCT01259713|453179977|FG001|Overall Study|Death Not Related to IFI|1|||
125969506|NCT01259713|453179976|FG000|Overall Study|Investigators Discretion|14|||
125969507|NCT01259713|453179977|FG001|Overall Study|Investigators Discretion|6|||
125969508|NCT01259713|453179976|FG000|Overall Study|Lack of Efficacy|2|||
125969509|NCT01259713|453179977|FG001|Overall Study|Lack of Efficacy|0|||
125969510|NCT01259713|453179976|FG000|Overall Study|Protocol Violation|5|||
125969511|NCT01259713|453179977|FG001|Overall Study|Protocol Violation|4|||
125969512|NCT01259713|453179976|FG000|Overall Study|Subject Withdrew Consent|12|||
125969513|NCT01259713|453179977|FG001|Overall Study|Subject Withdrew Consent|7|||
125969514|NCT03422250|453179978|FG000|Intervention|Adverse Event|0|||
125969515|NCT03422250|453179979|FG001|Intervention|Adverse Event|1|||
125969516|NCT03422250|453179980|FG002|Intervention|Adverse Event|0|||
125969517|NCT03422250|453179981|FG003|Intervention|Adverse Event|1|||
125969518|NCT03422250|453179978|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
125969519|NCT03422250|453179979|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
125969520|NCT03422250|453179980|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
125969521|NCT03422250|453179981|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
125969522|NCT03422250|453179978|FG000|Follow-up|Withdrawal by Subject|0|||
125969523|NCT03422250|453179979|FG001|Follow-up|Withdrawal by Subject|0|||
125969524|NCT03422250|453179980|FG002|Follow-up|Withdrawal by Subject|0|||
125969525|NCT03422250|453179981|FG003|Follow-up|Withdrawal by Subject|1|||
125969526|NCT03422250|453179978|FG000|Follow-up|Adverse Event|0|||
125969527|NCT03422250|453179979|FG001|Follow-up|Adverse Event|0|||
125969528|NCT03422250|453179980|FG002|Follow-up|Adverse Event|0|||
125969529|NCT03422250|453179981|FG003|Follow-up|Adverse Event|1|||
125969530|NCT06111742|453179990|FG000|Overall Study|Did not receive intervention|1|||
125969531|NCT06111742|453179991|FG001|Overall Study|Did not receive intervention|0|||
125969532|NCT06111742|453179992|FG002|Overall Study|Did not receive intervention|0|||
125969533|NCT06111742|453179990|FG000|Overall Study|Withdrawal by Subject|2|||
125969534|NCT06111742|453179991|FG001|Overall Study|Withdrawal by Subject|0|||
125969535|NCT06111742|453179992|FG002|Overall Study|Withdrawal by Subject|0|||
125969536|NCT01917526|453179993|FG000|Overall Study|Protocol Violation|1|||
125969537|NCT01917526|453179994|FG001|Overall Study|Protocol Violation|1|||
125969538|NCT04717596|453179995|FG000|Overall Study|Withdrawal by Subject|4|||
125969539|NCT02864082|453179997|FG000|Overall Study|Adverse Event|1|||
125969540|NCT02864082|453179998|FG001|Overall Study|Adverse Event|1|||
125969541|NCT02864082|453179997|FG000|Overall Study|Lost to Follow-up|0|||
125969542|NCT02864082|453179998|FG001|Overall Study|Lost to Follow-up|1|||
125969543|NCT02864082|453179997|FG000|Overall Study|Withdrawal by Subject|2|||
125969544|NCT02864082|453179998|FG001|Overall Study|Withdrawal by Subject|2|||
125969545|NCT01127178|453179999|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
125969546|NCT01127178|453180000|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
125969547|NCT01127178|453179999|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
125969548|NCT01127178|453180000|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
125969549|NCT01127178|453179999|FG000|Dose Escalation: Treatment Phase|Other|2|||
125969550|NCT01127178|453180000|FG001|Dose Escalation: Treatment Phase|Other|0|||
125969551|NCT01127178|453179999|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
125969552|NCT01127178|453180000|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
125969553|NCT01127178|453179999|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
125969554|NCT01127178|453180000|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
125969555|NCT01127178|453179999|FG000|Dose Escalation: Extension Phase|Other|1|||
125969556|NCT01127178|453180000|FG001|Dose Escalation: Extension Phase|Other|0|||
125969557|NCT03621696|453180001|FG000|Overall Study|Not eligible|0|||
125969558|NCT03621696|453180002|FG001|Overall Study|Not eligible|0|||
125969559|NCT03621696|453180003|FG002|Overall Study|Not eligible|0|||
125969560|NCT03621696|453180004|FG003|Overall Study|Not eligible|5|||
125969561|NCT03621696|453180001|FG000|Overall Study|Withdrawal by Subject|1|||
125969562|NCT03621696|453180002|FG001|Overall Study|Withdrawal by Subject|1|||
125969563|NCT03621696|453180003|FG002|Overall Study|Withdrawal by Subject|1|||
125969564|NCT03621696|453180004|FG003|Overall Study|Withdrawal by Subject|0|||
125969565|NCT03621696|453180001|FG000|Overall Study|Physician Decision|0|||
125969566|NCT03621696|453180002|FG001|Overall Study|Physician Decision|0|||
125969567|NCT03621696|453180003|FG002|Overall Study|Physician Decision|1|||
125969568|NCT03621696|453180004|FG003|Overall Study|Physician Decision|0|||
125969569|NCT04349553|453180005|FG000|Overall Study|Withdrawal by Subject|1|||
125969570|NCT04349553|453180006|FG001|Overall Study|Withdrawal by Subject|0|||
125969571|NCT04349553|453180007|FG002|Overall Study|Withdrawal by Subject|1|||
125969572|NCT04349553|453180008|FG003|Overall Study|Withdrawal by Subject|0|||
125969573|NCT02063724|453180009|FG000|Overall Study|Disease progression|1|||
126144125|NCT00943683|453813616|FG000|Overall Study|Patient Moved|1|||
125969574|NCT01715805|453180010|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
125969575|NCT01715805|453180011|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
125969576|NCT01715805|453180012|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
125969577|NCT01715805|453180013|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
125969578|NCT01715805|453180010|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
125969579|NCT01715805|453180011|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
126144126|NCT00943683|453813617|FG001|Overall Study|Patient Moved|0|||
126144127|NCT02500537|453813618|FG000|Overall Study|Death|2|||
125969580|NCT01715805|453180012|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
125969581|NCT01715805|453180013|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
125969582|NCT01715805|453180010|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
125969583|NCT01715805|453180011|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
125969584|NCT01715805|453180012|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
125969585|NCT01715805|453180013|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
125969586|NCT01715805|453180010|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
125969587|NCT01715805|453180011|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
125969588|NCT01715805|453180012|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
125969589|NCT01715805|453180013|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
125969590|NCT01715805|453180010|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
125969591|NCT01715805|453180011|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
125969592|NCT01715805|453180012|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
125969593|NCT01715805|453180013|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
125969594|NCT01715805|453180010|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
125969595|NCT01715805|453180011|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
126144128|NCT02500537|453813619|FG001|Overall Study|Death|0|||
126144129|NCT02500537|453813618|FG000|Overall Study|Lost to Follow-up|0|||
126144130|NCT02500537|453813619|FG001|Overall Study|Lost to Follow-up|1|||
126144131|NCT02500537|453813618|FG000|Overall Study|Withdrawal by Subject|1|||
126144132|NCT02500537|453813619|FG001|Overall Study|Withdrawal by Subject|0|||
126144133|NCT01551745|453813620|FG000|Overall Study|Withdrawal by Subject|1|||
125969596|NCT01715805|453180012|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
125969597|NCT01715805|453180013|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
126144134|NCT01551745|453813620|FG000|Overall Study|Disease Progression|2|||
126144135|NCT04752384|453813621|FG000|Overall Study|Withdrawal by Subject|1|||
126144136|NCT04752384|453813621|FG000|Overall Study|Death|1|||
126144137|NCT01955707|453813626|FG000|Overall Study|Adverse Event|1|||
126144138|NCT01955707|453813627|FG001|Overall Study|Adverse Event|2|||
126144139|NCT01955707|453813626|FG000|Overall Study|Lost to Follow-up|2|||
126144140|NCT01955707|453813627|FG001|Overall Study|Lost to Follow-up|1|||
126144141|NCT01955707|453813626|FG000|Overall Study|Withdrawal by Subject|0|||
126144142|NCT01955707|453813627|FG001|Overall Study|Withdrawal by Subject|3|||
126144143|NCT01955707|453813626|FG000|Overall Study|Death|13|||
126144144|NCT01955707|453813627|FG001|Overall Study|Death|14|||
126144145|NCT01955707|453813626|FG000|Overall Study|Other|4|||
126144146|NCT01955707|453813627|FG001|Overall Study|Other|2|||
126144147|NCT01817790|453813630|FG000|Overall Study|Adverse Event|0|||
126144148|NCT01817790|453813631|FG001|Overall Study|Adverse Event|2|||
126144149|NCT01817790|453813630|FG000|Overall Study|Lost to Follow-up|0|||
126144150|NCT01817790|453813631|FG001|Overall Study|Lost to Follow-up|1|||
126144151|NCT01817790|453813630|FG000|Overall Study|Protocol Violation|2|||
126144152|NCT01817790|453813631|FG001|Overall Study|Protocol Violation|1|||
126144153|NCT01817790|453813630|FG000|Overall Study|Withdrawal by Subject|1|||
126144154|NCT01817790|453813631|FG001|Overall Study|Withdrawal by Subject|3|||
126144155|NCT01817790|453813630|FG000|Overall Study|Other: Could not attend appointment|1|||
126144156|NCT01817790|453813631|FG001|Overall Study|Other: Could not attend appointment|1|||
126144157|NCT01671345|453813632|FG000|Overall Study|Lost to Follow-up|10|||
126144158|NCT01671345|453813633|FG001|Overall Study|Lost to Follow-up|6|||
126144159|NCT01671345|453813632|FG000|Overall Study|visit with non-participating physician|3|||
126144160|NCT01671345|453813633|FG001|Overall Study|visit with non-participating physician|3|||
126144161|NCT03636906|453813634|FG000|Overall Study|Adverse Event|0|||
125969598|NCT01715805|453180010|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
125969599|NCT01715805|453180011|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
125969600|NCT01715805|453180012|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
125969601|NCT01715805|453180013|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
125969602|NCT01715805|453180010|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
125969603|NCT01715805|453180011|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
125969604|NCT01715805|453180012|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
125969605|NCT01715805|453180013|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
125969606|NCT01715805|453180010|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
125969607|NCT01715805|453180011|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
126144162|NCT03636906|453813635|FG001|Overall Study|Adverse Event|0|||
126144163|NCT03636906|453813636|FG002|Overall Study|Adverse Event|1|||
126144164|NCT03636906|453813634|FG000|Overall Study|Lost to Follow-up|1|||
126144165|NCT03636906|453813635|FG001|Overall Study|Lost to Follow-up|0|||
126144166|NCT03636906|453813636|FG002|Overall Study|Lost to Follow-up|0|||
126144167|NCT03636906|453813634|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
126144168|NCT03636906|453813635|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
126144169|NCT03636906|453813636|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
126144170|NCT03636906|453813634|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
125969608|NCT01715805|453180012|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
125969609|NCT01715805|453180013|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
125969610|NCT01715805|453180010|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
125969611|NCT01715805|453180011|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
125969612|NCT01715805|453180012|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
125969613|NCT01715805|453180013|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
125969614|NCT01715805|453180010|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
125969615|NCT01715805|453180011|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
125969616|NCT01715805|453180012|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
125969617|NCT01715805|453180013|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
125969618|NCT01715805|453180010|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
125969619|NCT01715805|453180011|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
125969620|NCT01715805|453180012|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
125969621|NCT01715805|453180013|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
125969622|NCT01715805|453180010|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
125969623|NCT01715805|453180011|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
125969624|NCT01715805|453180012|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
125969625|NCT01715805|453180013|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
125969626|NCT01715805|453180010|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
125969627|NCT01715805|453180011|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
125969628|NCT01715805|453180012|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
125969629|NCT01715805|453180013|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
125969630|NCT05177770|453180016|FG000|Overall Study|Death|4|||
125969631|NCT05177770|453180016|FG000|Overall Study|Withdrawal by Subject|1|||
125969632|NCT05177770|453180016|FG000|Overall Study|Adverse Event prior to dosing|1|||
125969633|NCT02365467|453180017|FG000|Overall Study|Death|3|||
125969634|NCT00709722|453180018|FG000|Overall Study|Adverse Event|1|||
125969635|NCT02043782|453180019|FG000|Period 1|Adverse Event|0|||
125969636|NCT02043782|453180020|FG001|Period 1|Adverse Event|0|||
125969637|NCT02043782|453180021|FG002|Period 1|Adverse Event|1|||
125969638|NCT02043782|453180022|FG003|Period 1|Adverse Event|0|||
125969639|NCT02043782|453180023|FG004|Period 1|Adverse Event|0|||
125969640|NCT02043782|453180024|FG005|Period 1|Adverse Event|0|||
125969641|NCT01949480|453180037|FG000|Overall Study|Physician Decision|5|||
125969642|NCT01949480|453180038|FG001|Overall Study|Physician Decision|8|||
125969643|NCT02372396|453180039|FG000|Overall Study|Lost to Follow-up|7|||
125969644|NCT02372396|453180040|FG001|Overall Study|Lost to Follow-up|9|||
125969645|NCT02310750|453180047|FG000|HP Period 1|Lost to Follow-up|0|||
125969646|NCT02310750|453180048|FG001|HP Period 1|Lost to Follow-up|0|||
125969647|NCT02310750|453180049|FG002|HP Period 1|Lost to Follow-up|0|||
125969648|NCT02310750|453180050|FG003|HP Period 1|Lost to Follow-up|0|||
125969649|NCT02310750|453180051|FG004|HP Period 1|Lost to Follow-up|0|||
125969650|NCT02310750|453180052|FG005|HP Period 1|Lost to Follow-up|0|||
125969651|NCT02310750|453180053|FG006|HP Period 1|Lost to Follow-up|1|||
125969652|NCT02310750|453180054|FG007|HP Period 1|Lost to Follow-up|0|||
125969653|NCT02310750|453180055|FG008|HP Period 1|Lost to Follow-up|0|||
125969654|NCT02310750|453180056|FG009|HP Period 1|Lost to Follow-up|0|||
125969655|NCT02310750|453180057|FG010|HP Period 1|Lost to Follow-up|0|||
125969656|NCT02310750|453180058|FG011|HP Period 1|Lost to Follow-up|0|||
125969657|NCT02310750|453180059|FG012|HP Period 1|Lost to Follow-up|0|||
125969658|NCT02310750|453180060|FG013|HP Period 1|Lost to Follow-up|0|||
125969659|NCT02310750|453180061|FG014|HP Period 1|Lost to Follow-up|0|||
125969660|NCT02310750|453180062|FG015|HP Period 1|Lost to Follow-up|0|||
125969661|NCT02310750|453180047|FG000|HP Period 1|Withdrawal by Subject|1|||
125969662|NCT02310750|453180048|FG001|HP Period 1|Withdrawal by Subject|0|||
125969663|NCT02310750|453180049|FG002|HP Period 1|Withdrawal by Subject|0|||
125969664|NCT02310750|453180050|FG003|HP Period 1|Withdrawal by Subject|1|||
126144171|NCT03636906|453813635|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126144172|NCT03636906|453813636|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
126144173|NCT03636906|453813634|FG000|Overall Study|Other|0|||
126144174|NCT03636906|453813635|FG001|Overall Study|Other|0|||
126144175|NCT03636906|453813636|FG002|Overall Study|Other|1|||
126144176|NCT01291017|453813637|FG000|Overall Study|Lost to Follow-up|2|||
126144177|NCT01291017|453813637|FG000|Overall Study|Withdrawal by Subject|3|||
126144178|NCT04980391|453813638|FG000|Overall Study|Death|0|||
125969665|NCT02310750|453180051|FG004|HP Period 1|Withdrawal by Subject|0|||
125969666|NCT02310750|453180052|FG005|HP Period 1|Withdrawal by Subject|0|||
125969667|NCT02310750|453180053|FG006|HP Period 1|Withdrawal by Subject|0|||
125969668|NCT02310750|453180054|FG007|HP Period 1|Withdrawal by Subject|0|||
125969669|NCT02310750|453180055|FG008|HP Period 1|Withdrawal by Subject|0|||
125969670|NCT02310750|453180056|FG009|HP Period 1|Withdrawal by Subject|0|||
125969671|NCT02310750|453180057|FG010|HP Period 1|Withdrawal by Subject|0|||
125969672|NCT02310750|453180058|FG011|HP Period 1|Withdrawal by Subject|0|||
126144179|NCT04980391|453813639|FG001|Overall Study|Death|0|||
126144180|NCT04980391|453813640|FG002|Overall Study|Death|1|||
126144181|NCT04980391|453813641|FG003|Overall Study|Death|1|||
125969673|NCT02310750|453180059|FG012|HP Period 1|Withdrawal by Subject|0|||
125969674|NCT02310750|453180060|FG013|HP Period 1|Withdrawal by Subject|0|||
125969675|NCT02310750|453180061|FG014|HP Period 1|Withdrawal by Subject|0|||
125969676|NCT02310750|453180062|FG015|HP Period 1|Withdrawal by Subject|0|||
125969677|NCT02310750|453180047|FG000|HP Washout 1|Lost to Follow-up|0|||
125969678|NCT02310750|453180048|FG001|HP Washout 1|Lost to Follow-up|0|||
125969679|NCT02310750|453180049|FG002|HP Washout 1|Lost to Follow-up|1|||
125969680|NCT02310750|453180050|FG003|HP Washout 1|Lost to Follow-up|1|||
125969681|NCT02310750|453180051|FG004|HP Washout 1|Lost to Follow-up|2|||
125969682|NCT02310750|453180052|FG005|HP Washout 1|Lost to Follow-up|2|||
125969683|NCT02310750|453180053|FG006|HP Washout 1|Lost to Follow-up|3|||
125969684|NCT02310750|453180054|FG007|HP Washout 1|Lost to Follow-up|0|||
125969685|NCT02310750|453180055|FG008|HP Washout 1|Lost to Follow-up|0|||
125969686|NCT02310750|453180056|FG009|HP Washout 1|Lost to Follow-up|0|||
125969687|NCT02310750|453180057|FG010|HP Washout 1|Lost to Follow-up|0|||
125969688|NCT02310750|453180058|FG011|HP Washout 1|Lost to Follow-up|0|||
125969689|NCT02310750|453180059|FG012|HP Washout 1|Lost to Follow-up|0|||
125969690|NCT02310750|453180060|FG013|HP Washout 1|Lost to Follow-up|0|||
125969691|NCT02310750|453180061|FG014|HP Washout 1|Lost to Follow-up|0|||
125969692|NCT02310750|453180062|FG015|HP Washout 1|Lost to Follow-up|0|||
125969693|NCT02310750|453180047|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969694|NCT02310750|453180048|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969695|NCT02310750|453180049|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969696|NCT02310750|453180050|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
125969697|NCT02310750|453180051|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969698|NCT02310750|453180052|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
125969699|NCT02310750|453180053|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969700|NCT02310750|453180054|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969701|NCT02310750|453180055|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
125969702|NCT02310750|453180056|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
125969703|NCT02310750|453180057|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126144182|NCT04980391|453813638|FG000|Overall Study|Lost to Follow-up|3|||
126144183|NCT04980391|453813639|FG001|Overall Study|Lost to Follow-up|3|||
126144184|NCT04980391|453813640|FG002|Overall Study|Lost to Follow-up|2|||
126144185|NCT04980391|453813641|FG003|Overall Study|Lost to Follow-up|3|||
126144186|NCT04980391|453813638|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
126144187|NCT04980391|453813639|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
126144188|NCT04980391|453813640|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
126144189|NCT04980391|453813641|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
126144190|NCT04980391|453813638|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126144191|NCT04980391|453813639|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125969704|NCT02310750|453180058|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969705|NCT02310750|453180059|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969706|NCT02310750|453180060|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969707|NCT02310750|453180061|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969708|NCT02310750|453180062|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125969709|NCT02310750|453180047|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969710|NCT02310750|453180048|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969711|NCT02310750|453180049|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969712|NCT02310750|453180050|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969713|NCT02310750|453180051|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969714|NCT02310750|453180052|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969715|NCT02310750|453180053|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969716|NCT02310750|453180054|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969717|NCT02310750|453180055|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969718|NCT02310750|453180056|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
125969719|NCT02310750|453180057|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969720|NCT02310750|453180058|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969721|NCT02310750|453180059|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969722|NCT02310750|453180060|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969723|NCT02310750|453180061|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125969724|NCT02310750|453180062|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126144192|NCT04980391|453813640|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126144193|NCT04980391|453813641|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126144194|NCT04980391|453813638|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
125969725|NCT02310750|453180047|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969726|NCT02310750|453180048|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969727|NCT02310750|453180049|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969728|NCT02310750|453180050|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969729|NCT02310750|453180051|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969730|NCT02310750|453180052|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969731|NCT02310750|453180053|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969732|NCT02310750|453180054|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
125969733|NCT02310750|453180055|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
125969734|NCT02310750|453180056|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
125969735|NCT02310750|453180057|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969736|NCT02310750|453180058|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969737|NCT02310750|453180059|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969738|NCT02310750|453180060|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969739|NCT02310750|453180061|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969740|NCT02310750|453180062|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125969741|NCT02310750|453180047|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969742|NCT02310750|453180048|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969743|NCT02310750|453180049|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969744|NCT02310750|453180050|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969745|NCT02310750|453180051|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969746|NCT02310750|453180052|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969747|NCT02310750|453180053|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969748|NCT02310750|453180054|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
125969749|NCT02310750|453180055|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
125969750|NCT02310750|453180056|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969751|NCT02310750|453180057|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969752|NCT02310750|453180058|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969753|NCT02310750|453180059|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969754|NCT02310750|453180060|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969755|NCT02310750|453180061|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969756|NCT02310750|453180062|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125969757|NCT02310750|453180047|FG000|HP Washout 2|Lost to Follow-up|0|||
125969758|NCT02310750|453180048|FG001|HP Washout 2|Lost to Follow-up|0|||
125969759|NCT02310750|453180049|FG002|HP Washout 2|Lost to Follow-up|0|||
125969760|NCT02310750|453180050|FG003|HP Washout 2|Lost to Follow-up|0|||
125969761|NCT02310750|453180051|FG004|HP Washout 2|Lost to Follow-up|1|||
125969762|NCT02310750|453180052|FG005|HP Washout 2|Lost to Follow-up|0|||
125969763|NCT02310750|453180053|FG006|HP Washout 2|Lost to Follow-up|7|||
125969764|NCT02310750|453180054|FG007|HP Washout 2|Lost to Follow-up|0|||
125969765|NCT02310750|453180055|FG008|HP Washout 2|Lost to Follow-up|0|||
125969766|NCT02310750|453180056|FG009|HP Washout 2|Lost to Follow-up|0|||
125969767|NCT02310750|453180057|FG010|HP Washout 2|Lost to Follow-up|0|||
125969768|NCT02310750|453180058|FG011|HP Washout 2|Lost to Follow-up|0|||
125969769|NCT02310750|453180059|FG012|HP Washout 2|Lost to Follow-up|0|||
125969770|NCT02310750|453180060|FG013|HP Washout 2|Lost to Follow-up|0|||
125969771|NCT02310750|453180061|FG014|HP Washout 2|Lost to Follow-up|0|||
125969772|NCT02310750|453180062|FG015|HP Washout 2|Lost to Follow-up|0|||
125969773|NCT02952924|453180065|FG000|Overall Study|Protocol Violation|0|||
125969774|NCT02952924|453180066|FG001|Overall Study|Protocol Violation|0|||
125969775|NCT02952924|453180067|FG002|Overall Study|Protocol Violation|0|||
125969776|NCT02952924|453180068|FG003|Overall Study|Protocol Violation|0|||
125969777|NCT02952924|453180069|FG004|Overall Study|Protocol Violation|0|||
125969778|NCT02952924|453180070|FG005|Overall Study|Protocol Violation|0|||
125969779|NCT02952924|453180071|FG006|Overall Study|Protocol Violation|0|||
125969780|NCT02952924|453180072|FG007|Overall Study|Protocol Violation|0|||
125969781|NCT02952924|453180073|FG008|Overall Study|Protocol Violation|0|||
125969782|NCT02952924|453180074|FG009|Overall Study|Protocol Violation|0|||
125969783|NCT02952924|453180075|FG010|Overall Study|Protocol Violation|0|||
125969784|NCT02952924|453180076|FG011|Overall Study|Protocol Violation|0|||
125969785|NCT02952924|453180077|FG012|Overall Study|Protocol Violation|0|||
125969786|NCT02952924|453180078|FG013|Overall Study|Protocol Violation|0|||
125969787|NCT02952924|453180079|FG014|Overall Study|Protocol Violation|0|||
125969788|NCT02952924|453180080|FG015|Overall Study|Protocol Violation|0|||
125969789|NCT02952924|453180081|FG016|Overall Study|Protocol Violation|0|||
125969790|NCT02952924|453180082|FG017|Overall Study|Protocol Violation|0|||
126144195|NCT04980391|453813639|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
126144196|NCT04980391|453813640|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
126144197|NCT04980391|453813641|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
125969791|NCT02952924|453180083|FG018|Overall Study|Protocol Violation|0|||
125969792|NCT02952924|453180084|FG019|Overall Study|Protocol Violation|1|||
125969793|NCT02952924|453180085|FG020|Overall Study|Protocol Violation|0|||
125969794|NCT02952924|453180086|FG021|Overall Study|Protocol Violation|0|||
125969795|NCT02952924|453180065|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
125969796|NCT02952924|453180066|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
125969797|NCT02952924|453180067|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
125969798|NCT02952924|453180068|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
125969799|NCT02952924|453180069|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
126144198|NCT03690869|453813642|FG000|Overall Study|Adverse Event|0|||
125969800|NCT02952924|453180070|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
125969801|NCT02952924|453180071|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
125969802|NCT02952924|453180072|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
125969803|NCT02952924|453180073|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
125969804|NCT02952924|453180074|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
125969805|NCT02952924|453180075|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
125969806|NCT02952924|453180076|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
125969807|NCT02952924|453180077|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
125969808|NCT02952924|453180078|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
125969809|NCT02952924|453180079|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
125969810|NCT02952924|453180080|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
125969811|NCT02952924|453180081|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
125969812|NCT02952924|453180082|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
125969813|NCT02952924|453180083|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
125969814|NCT02952924|453180084|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
125969815|NCT02952924|453180085|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
125969816|NCT02952924|453180086|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
125969817|NCT02952924|453180065|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969818|NCT02952924|453180066|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969819|NCT02952924|453180067|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969820|NCT02952924|453180068|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969821|NCT02952924|453180069|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969822|NCT02952924|453180070|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969823|NCT02952924|453180071|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969824|NCT02952924|453180072|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969825|NCT02952924|453180073|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969826|NCT02952924|453180074|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969827|NCT02952924|453180075|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969828|NCT02952924|453180076|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969829|NCT02952924|453180077|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969830|NCT02952924|453180078|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969831|NCT02952924|453180079|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969832|NCT02952924|453180080|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969833|NCT02952924|453180081|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969834|NCT02952924|453180082|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969835|NCT02952924|453180083|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969836|NCT02952924|453180084|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969837|NCT02952924|453180085|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
125969838|NCT02952924|453180086|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
125969839|NCT02952924|453180065|FG000|Overall Study|Noncompliance with study drug|0|||
125969840|NCT02952924|453180066|FG001|Overall Study|Noncompliance with study drug|0|||
125969841|NCT02952924|453180067|FG002|Overall Study|Noncompliance with study drug|0|||
126144199|NCT03690869|453813643|FG001|Overall Study|Adverse Event|0|||
126144200|NCT03690869|453813644|FG002|Overall Study|Adverse Event|0|||
126144201|NCT03690869|453813645|FG003|Overall Study|Adverse Event|1|||
126144202|NCT03690869|453813646|FG004|Overall Study|Adverse Event|0|||
126144203|NCT03690869|453813647|FG005|Overall Study|Adverse Event|0|||
126144204|NCT03690869|453813648|FG006|Overall Study|Adverse Event|0|||
126144205|NCT03690869|453813649|FG007|Overall Study|Adverse Event|1|||
126144206|NCT03690869|453813650|FG008|Overall Study|Adverse Event|0|||
126144207|NCT03690869|453813651|FG009|Overall Study|Adverse Event|1|||
126144208|NCT03690869|453813642|FG000|Overall Study|Death|1|||
126144209|NCT03690869|453813643|FG001|Overall Study|Death|1|||
126144210|NCT03690869|453813644|FG002|Overall Study|Death|1|||
126144211|NCT03690869|453813645|FG003|Overall Study|Death|4|||
126144212|NCT03690869|453813646|FG004|Overall Study|Death|2|||
126144213|NCT03690869|453813647|FG005|Overall Study|Death|5|||
125969842|NCT02952924|453180068|FG003|Overall Study|Noncompliance with study drug|0|||
125969843|NCT02952924|453180069|FG004|Overall Study|Noncompliance with study drug|0|||
126144214|NCT03690869|453813648|FG006|Overall Study|Death|3|||
126144215|NCT03690869|453813649|FG007|Overall Study|Death|2|||
126144216|NCT03690869|453813650|FG008|Overall Study|Death|0|||
126144217|NCT03690869|453813651|FG009|Overall Study|Death|3|||
126144218|NCT03690869|453813642|FG000|Overall Study|Lost to Follow-up|0|||
126144219|NCT03690869|453813643|FG001|Overall Study|Lost to Follow-up|0|||
126144220|NCT03690869|453813644|FG002|Overall Study|Lost to Follow-up|1|||
126144221|NCT03690869|453813645|FG003|Overall Study|Lost to Follow-up|0|||
126144222|NCT03690869|453813646|FG004|Overall Study|Lost to Follow-up|0|||
126144223|NCT03690869|453813647|FG005|Overall Study|Lost to Follow-up|0|||
126144224|NCT03690869|453813648|FG006|Overall Study|Lost to Follow-up|0|||
126144225|NCT03690869|453813649|FG007|Overall Study|Lost to Follow-up|0|||
126144226|NCT03690869|453813650|FG008|Overall Study|Lost to Follow-up|0|||
126144227|NCT03690869|453813651|FG009|Overall Study|Lost to Follow-up|0|||
126144228|NCT03690869|453813642|FG000|Overall Study|Other Treatment|1|||
126144229|NCT03690869|453813643|FG001|Overall Study|Other Treatment|1|||
126144230|NCT03690869|453813644|FG002|Overall Study|Other Treatment|1|||
126144231|NCT03690869|453813645|FG003|Overall Study|Other Treatment|2|||
126144232|NCT03690869|453813646|FG004|Overall Study|Other Treatment|3|||
126144233|NCT03690869|453813647|FG005|Overall Study|Other Treatment|1|||
126144234|NCT03690869|453813648|FG006|Overall Study|Other Treatment|2|||
126144235|NCT03690869|453813649|FG007|Overall Study|Other Treatment|7|||
126144236|NCT03690869|453813650|FG008|Overall Study|Other Treatment|0|||
126144237|NCT03690869|453813651|FG009|Overall Study|Other Treatment|3|||
126144238|NCT03690869|453813642|FG000|Overall Study|Physician Decision|0|||
126144239|NCT03690869|453813643|FG001|Overall Study|Physician Decision|1|||
126144240|NCT03690869|453813644|FG002|Overall Study|Physician Decision|0|||
126144241|NCT03690869|453813645|FG003|Overall Study|Physician Decision|0|||
126144242|NCT03690869|453813646|FG004|Overall Study|Physician Decision|0|||
126144243|NCT03690869|453813647|FG005|Overall Study|Physician Decision|0|||
126144244|NCT03690869|453813648|FG006|Overall Study|Physician Decision|0|||
126144245|NCT03690869|453813649|FG007|Overall Study|Physician Decision|0|||
126144246|NCT03690869|453813650|FG008|Overall Study|Physician Decision|0|||
126144247|NCT03690869|453813651|FG009|Overall Study|Physician Decision|0|||
126144248|NCT03690869|453813642|FG000|Overall Study|Progressive Disease|1|||
126144249|NCT03690869|453813643|FG001|Overall Study|Progressive Disease|2|||
126144250|NCT03690869|453813644|FG002|Overall Study|Progressive Disease|0|||
126144251|NCT03690869|453813645|FG003|Overall Study|Progressive Disease|1|||
125969844|NCT02952924|453180070|FG005|Overall Study|Noncompliance with study drug|0|||
125969845|NCT02952924|453180071|FG006|Overall Study|Noncompliance with study drug|0|||
125969846|NCT02952924|453180072|FG007|Overall Study|Noncompliance with study drug|0|||
125969847|NCT02952924|453180073|FG008|Overall Study|Noncompliance with study drug|0|||
125969848|NCT02952924|453180074|FG009|Overall Study|Noncompliance with study drug|0|||
125969849|NCT02952924|453180075|FG010|Overall Study|Noncompliance with study drug|0|||
125969850|NCT02952924|453180076|FG011|Overall Study|Noncompliance with study drug|0|||
125969851|NCT02952924|453180077|FG012|Overall Study|Noncompliance with study drug|0|||
125969852|NCT02952924|453180078|FG013|Overall Study|Noncompliance with study drug|0|||
125969853|NCT02952924|453180079|FG014|Overall Study|Noncompliance with study drug|0|||
125969854|NCT02952924|453180080|FG015|Overall Study|Noncompliance with study drug|0|||
125969855|NCT02952924|453180081|FG016|Overall Study|Noncompliance with study drug|0|||
125969856|NCT02952924|453180082|FG017|Overall Study|Noncompliance with study drug|0|||
125969857|NCT02952924|453180083|FG018|Overall Study|Noncompliance with study drug|0|||
125969858|NCT02952924|453180084|FG019|Overall Study|Noncompliance with study drug|0|||
125969859|NCT02952924|453180085|FG020|Overall Study|Noncompliance with study drug|0|||
125969860|NCT02952924|453180086|FG021|Overall Study|Noncompliance with study drug|1|||
125969861|NCT01226745|453180089|FG000|Overall Study|Did not complete schedule of assessments|8|||
125969862|NCT01226745|453180090|FG001|Overall Study|Did not complete schedule of assessments|3|||
125969863|NCT01226745|453180091|FG002|Overall Study|Did not complete schedule of assessments|6|||
125969864|NCT01226745|453180092|FG003|Overall Study|Did not complete schedule of assessments|0|||
125969865|NCT01226745|453180093|FG004|Overall Study|Did not complete schedule of assessments|0|||
125969866|NCT01226745|453180094|FG005|Overall Study|Did not complete schedule of assessments|1|||
125969867|NCT01226745|453180089|FG000|Overall Study|Lost to Follow-up|2|||
125969868|NCT01226745|453180090|FG001|Overall Study|Lost to Follow-up|6|||
125969869|NCT01226745|453180091|FG002|Overall Study|Lost to Follow-up|6|||
125969870|NCT01226745|453180092|FG003|Overall Study|Lost to Follow-up|1|||
125969871|NCT01226745|453180093|FG004|Overall Study|Lost to Follow-up|1|||
125969872|NCT01226745|453180094|FG005|Overall Study|Lost to Follow-up|2|||
125969873|NCT01226745|453180089|FG000|Overall Study|Death|1|||
125969874|NCT01226745|453180090|FG001|Overall Study|Death|0|||
125969875|NCT01226745|453180091|FG002|Overall Study|Death|0|||
126144252|NCT03690869|453813646|FG004|Overall Study|Progressive Disease|0|||
126144253|NCT03690869|453813647|FG005|Overall Study|Progressive Disease|0|||
126144254|NCT03690869|453813648|FG006|Overall Study|Progressive Disease|0|||
126144255|NCT03690869|453813649|FG007|Overall Study|Progressive Disease|0|||
125969876|NCT01226745|453180092|FG003|Overall Study|Death|0|||
125969877|NCT01226745|453180093|FG004|Overall Study|Death|0|||
125969878|NCT01226745|453180094|FG005|Overall Study|Death|1|||
125969879|NCT01226745|453180089|FG000|Overall Study|Other|6|||
126144256|NCT03690869|453813650|FG008|Overall Study|Progressive Disease|1|||
126144257|NCT03690869|453813651|FG009|Overall Study|Progressive Disease|1|||
125969880|NCT01226745|453180090|FG001|Overall Study|Other|7|||
125969881|NCT01226745|453180091|FG002|Overall Study|Other|8|||
125969882|NCT01226745|453180092|FG003|Overall Study|Other|4|||
126144258|NCT03690869|453813642|FG000|Overall Study|Subject Decision|0|||
126144259|NCT03690869|453813643|FG001|Overall Study|Subject Decision|0|||
126144260|NCT03690869|453813644|FG002|Overall Study|Subject Decision|0|||
125969883|NCT01226745|453180093|FG004|Overall Study|Other|3|||
125969884|NCT01226745|453180094|FG005|Overall Study|Other|1|||
125969885|NCT01435577|453180095|FG000|Overall Study|Adverse Event|10|||
125969886|NCT01435577|453180096|FG001|Overall Study|Adverse Event|0|||
125969887|NCT01435577|453180095|FG000|Overall Study|Lack of Efficacy|7|||
125969888|NCT01435577|453180096|FG001|Overall Study|Lack of Efficacy|51|||
125969889|NCT01435577|453180095|FG000|Overall Study|Alternative treatment started|0|||
125969890|NCT01435577|453180096|FG001|Overall Study|Alternative treatment started|1|||
125969891|NCT02105948|453180099|FG000|Overall Study|Adverse Event|10|||
125969892|NCT02105948|453180100|FG001|Overall Study|Adverse Event|7|||
125969893|NCT02105948|453180101|FG002|Overall Study|Adverse Event|11|||
125969894|NCT02105948|453180102|FG003|Overall Study|Adverse Event|11|||
125969895|NCT02105948|453180099|FG000|Overall Study|Lack of Efficacy|0|||
125969896|NCT02105948|453180100|FG001|Overall Study|Lack of Efficacy|1|||
125969897|NCT02105948|453180101|FG002|Overall Study|Lack of Efficacy|3|||
125969898|NCT02105948|453180102|FG003|Overall Study|Lack of Efficacy|2|||
125969899|NCT02105948|453180099|FG000|Overall Study|Lost to Follow-up|0|||
125969900|NCT02105948|453180100|FG001|Overall Study|Lost to Follow-up|0|||
125969901|NCT02105948|453180101|FG002|Overall Study|Lost to Follow-up|2|||
125969902|NCT02105948|453180102|FG003|Overall Study|Lost to Follow-up|1|||
125969903|NCT02105948|453180099|FG000|Overall Study|Physician Decision|2|||
125969904|NCT02105948|453180100|FG001|Overall Study|Physician Decision|2|||
125969905|NCT02105948|453180101|FG002|Overall Study|Physician Decision|2|||
125969906|NCT02105948|453180102|FG003|Overall Study|Physician Decision|2|||
125969907|NCT02105948|453180099|FG000|Overall Study|Withdrawal by Subject|15|||
125969908|NCT02105948|453180100|FG001|Overall Study|Withdrawal by Subject|10|||
125969909|NCT02105948|453180101|FG002|Overall Study|Withdrawal by Subject|10|||
125969910|NCT02105948|453180102|FG003|Overall Study|Withdrawal by Subject|11|||
125969911|NCT01934218|453180103|FG000|Double-blind Phase|Adverse Event|8|||
125969912|NCT01934218|453180104|FG001|Double-blind Phase|Adverse Event|8|||
125969913|NCT01934218|453180103|FG000|Double-blind Phase|Lack of Efficacy|6|||
125969914|NCT01934218|453180104|FG001|Double-blind Phase|Lack of Efficacy|7|||
125969915|NCT01934218|453180103|FG000|Double-blind Phase|Lost to Follow-up|7|||
125969916|NCT01934218|453180104|FG001|Double-blind Phase|Lost to Follow-up|14|||
125969917|NCT01934218|453180103|FG000|Double-blind Phase|Physician Decision|1|||
125969918|NCT01934218|453180104|FG001|Double-blind Phase|Physician Decision|2|||
125969919|NCT01934218|453180103|FG000|Double-blind Phase|Protocol Violation|4|||
125969920|NCT01934218|453180104|FG001|Double-blind Phase|Protocol Violation|0|||
125969921|NCT01934218|453180103|FG000|Double-blind Phase|Withdrawal by Subject|16|||
125969922|NCT01934218|453180104|FG001|Double-blind Phase|Withdrawal by Subject|13|||
125969923|NCT01934218|453180103|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
125969924|NCT01934218|453180104|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
125969925|NCT01934218|453180103|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
125969926|NCT01934218|453180104|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
125969927|NCT01934218|453180103|FG000|Open-Label Phase|Adverse Event|2|||
125969928|NCT01934218|453180104|FG001|Open-Label Phase|Adverse Event|4|||
125969929|NCT01934218|453180103|FG000|Open-Label Phase|Lack of Efficacy|1|||
125969930|NCT01934218|453180104|FG001|Open-Label Phase|Lack of Efficacy|4|||
125969931|NCT01934218|453180103|FG000|Open-Label Phase|Lost to Follow-up|4|||
125969932|NCT01934218|453180104|FG001|Open-Label Phase|Lost to Follow-up|2|||
125969933|NCT01934218|453180103|FG000|Open-Label Phase|Physician Decision|1|||
125969934|NCT01934218|453180104|FG001|Open-Label Phase|Physician Decision|0|||
125969935|NCT01934218|453180103|FG000|Open-Label Phase|Protocol Violation|1|||
125969936|NCT01934218|453180104|FG001|Open-Label Phase|Protocol Violation|0|||
125969937|NCT01934218|453180103|FG000|Open-Label Phase|Withdrawal by Subject|13|||
125969938|NCT01934218|453180104|FG001|Open-Label Phase|Withdrawal by Subject|11|||
125969939|NCT01934218|453180103|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
125969940|NCT01934218|453180104|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
125969941|NCT01934218|453180103|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
125969942|NCT01934218|453180104|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
125969943|NCT02232893|453180105|FG000|Overall Study|Withdrawal by Subject|4|||
126144261|NCT03690869|453813645|FG003|Overall Study|Subject Decision|1|||
126144262|NCT03690869|453813646|FG004|Overall Study|Subject Decision|0|||
125969944|NCT02232893|453180106|FG001|Overall Study|Withdrawal by Subject|1|||
125969945|NCT02232893|453180105|FG000|Overall Study|Adverse Event|0|||
125969946|NCT02232893|453180106|FG001|Overall Study|Adverse Event|1|||
125969947|NCT02232893|453180105|FG000|Overall Study|Sponsor request early termination|0|||
125969948|NCT02232893|453180106|FG001|Overall Study|Sponsor request early termination|1|||
125969949|NCT02232893|453180105|FG000|Overall Study|Developed exclusion criteria|0|||
125969950|NCT02232893|453180106|FG001|Overall Study|Developed exclusion criteria|1|||
125969951|NCT02232893|453180105|FG000|Overall Study|Other|0|||
125969952|NCT02232893|453180106|FG001|Overall Study|Other|3|||
125969953|NCT00355082|453180107|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
125969954|NCT00355082|453180108|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
125969955|NCT00355082|453180109|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
126144263|NCT03690869|453813647|FG005|Overall Study|Subject Decision|0|||
125969956|NCT00355082|453180107|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
125969957|NCT00355082|453180108|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
125969958|NCT00355082|453180109|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
125969959|NCT00355082|453180107|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
125969960|NCT00355082|453180108|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
125969961|NCT00355082|453180109|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
125969962|NCT00355082|453180107|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
125969963|NCT00355082|453180108|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
125969964|NCT00355082|453180109|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
125969965|NCT00355082|453180107|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
125969966|NCT00355082|453180108|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
125969967|NCT00355082|453180109|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
125969968|NCT00355082|453180107|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
125969969|NCT00355082|453180108|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
125969970|NCT00355082|453180109|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
125969971|NCT00355082|453180107|FG000|Continuation Phase|Adverse Event|2|||
125969972|NCT00355082|453180108|FG001|Continuation Phase|Adverse Event|0|||
125969973|NCT00355082|453180109|FG002|Continuation Phase|Adverse Event|1|||
125969974|NCT00355082|453180107|FG000|Continuation Phase|Lost to Follow-up|2|||
125969975|NCT00355082|453180108|FG001|Continuation Phase|Lost to Follow-up|0|||
125969976|NCT00355082|453180109|FG002|Continuation Phase|Lost to Follow-up|1|||
125969977|NCT00355082|453180107|FG000|Continuation Phase|Protocol Violation|1|||
125969978|NCT00355082|453180108|FG001|Continuation Phase|Protocol Violation|0|||
125969979|NCT00355082|453180109|FG002|Continuation Phase|Protocol Violation|1|||
125969980|NCT00355082|453180107|FG000|Continuation Phase|Withdrawal by Subject|4|||
125969981|NCT00355082|453180108|FG001|Continuation Phase|Withdrawal by Subject|0|||
125969982|NCT00355082|453180109|FG002|Continuation Phase|Withdrawal by Subject|0|||
125969983|NCT00355082|453180107|FG000|Continuation Phase|Lack of Efficacy|5|||
125969984|NCT00355082|453180108|FG001|Continuation Phase|Lack of Efficacy|0|||
125969985|NCT00355082|453180109|FG002|Continuation Phase|Lack of Efficacy|0|||
125969986|NCT00355082|453180107|FG000|Continuation Phase|Site Closed by Sponsor|8|||
125969987|NCT00355082|453180108|FG001|Continuation Phase|Site Closed by Sponsor|0|||
125969988|NCT00355082|453180109|FG002|Continuation Phase|Site Closed by Sponsor|0|||
125969989|NCT00355082|453180107|FG000|Continuation Phase|Scheduling Error|1|||
125969990|NCT00355082|453180108|FG001|Continuation Phase|Scheduling Error|0|||
125969991|NCT00355082|453180109|FG002|Continuation Phase|Scheduling Error|0|||
125969992|NCT00355082|453180107|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
125969993|NCT00355082|453180108|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
125969994|NCT00355082|453180109|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
125969995|NCT04782323|453180113|FG000|Overall Study|Death|1|||
125969996|NCT04782323|453180114|FG001|Overall Study|Death|0|||
125969997|NCT04782323|453180115|FG002|Overall Study|Death|0|||
125969998|NCT04782323|453180116|FG003|Overall Study|Death|0|||
125969999|NCT04782323|453180117|FG004|Overall Study|Death|1|||
125970000|NCT04782323|453180118|FG005|Overall Study|Death|1|||
125970001|NCT04782323|453180119|FG006|Overall Study|Death|1|||
125970002|NCT04782323|453180120|FG007|Overall Study|Death|0|||
125970003|NCT04782323|453180113|FG000|Overall Study|Withdrawal by Subject|0|||
125970004|NCT04782323|453180114|FG001|Overall Study|Withdrawal by Subject|0|||
125970005|NCT04782323|453180115|FG002|Overall Study|Withdrawal by Subject|1|||
125970006|NCT04782323|453180116|FG003|Overall Study|Withdrawal by Subject|0|||
125970007|NCT04782323|453180117|FG004|Overall Study|Withdrawal by Subject|0|||
125970008|NCT04782323|453180118|FG005|Overall Study|Withdrawal by Subject|1|||
125970009|NCT04782323|453180119|FG006|Overall Study|Withdrawal by Subject|0|||
125970010|NCT04782323|453180120|FG007|Overall Study|Withdrawal by Subject|1|||
125970011|NCT04782323|453180113|FG000|Overall Study|Lost to Follow-up|0|||
125970012|NCT04782323|453180114|FG001|Overall Study|Lost to Follow-up|1|||
125970013|NCT04782323|453180115|FG002|Overall Study|Lost to Follow-up|1|||
125970014|NCT04782323|453180116|FG003|Overall Study|Lost to Follow-up|0|||
125970015|NCT04782323|453180117|FG004|Overall Study|Lost to Follow-up|0|||
125970016|NCT04782323|453180118|FG005|Overall Study|Lost to Follow-up|1|||
125970017|NCT04782323|453180119|FG006|Overall Study|Lost to Follow-up|1|||
125970018|NCT04782323|453180120|FG007|Overall Study|Lost to Follow-up|2|||
125970019|NCT04782323|453180113|FG000|Overall Study|randomization in error|1|||
125970020|NCT04782323|453180114|FG001|Overall Study|randomization in error|0|||
125970021|NCT04782323|453180115|FG002|Overall Study|randomization in error|0|||
125970022|NCT04782323|453180116|FG003|Overall Study|randomization in error|0|||
125970023|NCT04782323|453180117|FG004|Overall Study|randomization in error|0|||
125970024|NCT04782323|453180118|FG005|Overall Study|randomization in error|0|||
125970025|NCT04782323|453180119|FG006|Overall Study|randomization in error|0|||
125970026|NCT04782323|453180120|FG007|Overall Study|randomization in error|0|||
125970027|NCT02663128|453180125|FG000|Period 2|Physician Decision|0|||
125970028|NCT02663128|453180126|FG001|Period 2|Physician Decision|0|||
125970029|NCT02663128|453180127|FG002|Period 2|Physician Decision|0|||
125970030|NCT02663128|453180128|FG003|Period 2|Physician Decision|0|||
125970031|NCT02663128|453180129|FG004|Period 2|Physician Decision|1|||
125970032|NCT02663128|453180130|FG005|Period 2|Physician Decision|0|||
125970033|NCT02715765|453180131|FG000|Overall Study|Study Termination|3|||
125970034|NCT02715765|453180132|FG001|Overall Study|Study Termination|0|||
125970035|NCT02715765|453180133|FG002|Overall Study|Study Termination|0|||
125970036|NCT03387852|453180139|FG000|Overall Study|Adverse event (AE)|3|||
125970037|NCT03387852|453180140|FG001|Overall Study|Adverse event (AE)|0|||
125970038|NCT03387852|453180141|FG002|Overall Study|Adverse event (AE)|2|||
125970039|NCT03387852|453180142|FG003|Overall Study|Adverse event (AE)|0|||
125970040|NCT03387852|453180139|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
125970041|NCT03387852|453180140|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
125970042|NCT03387852|453180141|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
125970043|NCT03387852|453180142|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
125970044|NCT03387852|453180139|FG000|Overall Study|Withdrawal by participant|1|||
125970045|NCT03387852|453180140|FG001|Overall Study|Withdrawal by participant|1|||
125970046|NCT03387852|453180141|FG002|Overall Study|Withdrawal by participant|3|||
125970047|NCT03387852|453180142|FG003|Overall Study|Withdrawal by participant|2|||
125970048|NCT03387852|453180139|FG000|Overall Study|Other- Unspecified|1|||
125970049|NCT03387852|453180140|FG001|Overall Study|Other- Unspecified|1|||
125970050|NCT03387852|453180141|FG002|Overall Study|Other- Unspecified|2|||
125970051|NCT03387852|453180142|FG003|Overall Study|Other- Unspecified|1|||
125970052|NCT03387852|453180139|FG000|Overall Study|Poor compliance to protocol|0|||
125970053|NCT03387852|453180140|FG001|Overall Study|Poor compliance to protocol|0|||
125970054|NCT03387852|453180141|FG002|Overall Study|Poor compliance to protocol|0|||
125970055|NCT03387852|453180142|FG003|Overall Study|Poor compliance to protocol|1|||
125970056|NCT03387852|453180139|FG000|Overall Study|Randomized and not treated|0|||
125970057|NCT03387852|453180140|FG001|Overall Study|Randomized and not treated|0|||
125970058|NCT03387852|453180141|FG002|Overall Study|Randomized and not treated|0|||
125970059|NCT03387852|453180142|FG003|Overall Study|Randomized and not treated|1|||
125970060|NCT04827576|453182640|FG000|Overall Study|Death|5|||
125970061|NCT04827576|453182641|FG001|Overall Study|Death|17|||
125970062|NCT04827576|453182642|FG002|Overall Study|Death|17|||
125970063|NCT04827576|453182643|FG003|Overall Study|Death|32|||
125970064|NCT04827576|453182640|FG000|Overall Study|Study Terminated by Sponsor|2|||
125970065|NCT04827576|453182641|FG001|Overall Study|Study Terminated by Sponsor|9|||
125970066|NCT04827576|453182642|FG002|Overall Study|Study Terminated by Sponsor|7|||
125970067|NCT04827576|453182643|FG003|Overall Study|Study Terminated by Sponsor|5|||
125970068|NCT04827576|453182640|FG000|Overall Study|Investigator's Discretion|1|||
125970069|NCT04827576|453182641|FG001|Overall Study|Investigator's Discretion|0|||
125970070|NCT04827576|453182642|FG002|Overall Study|Investigator's Discretion|2|||
125970071|NCT04827576|453182643|FG003|Overall Study|Investigator's Discretion|5|||
125970072|NCT04827576|453182640|FG000|Overall Study|Withdrew Consent|0|||
125970073|NCT04827576|453182641|FG001|Overall Study|Withdrew Consent|3|||
125970074|NCT04827576|453182642|FG002|Overall Study|Withdrew Consent|0|||
125970075|NCT04827576|453182643|FG003|Overall Study|Withdrew Consent|0|||
125970076|NCT04827576|453182640|FG000|Overall Study|Lost to Follow-up|1|||
125970077|NCT04827576|453182641|FG001|Overall Study|Lost to Follow-up|0|||
125970078|NCT04827576|453182642|FG002|Overall Study|Lost to Follow-up|0|||
125970079|NCT04827576|453182643|FG003|Overall Study|Lost to Follow-up|0|||
125970080|NCT03069482|453182644|FG000|Overall Study|Lost to Follow-up|0|||
125970081|NCT03069482|453182645|FG001|Overall Study|Lost to Follow-up|1|||
125970082|NCT03069482|453182644|FG000|Overall Study|Physician Decision|1|||
125970083|NCT03069482|453182645|FG001|Overall Study|Physician Decision|0|||
125970084|NCT04537923|453182646|FG000|Overall Study|Adverse Event|2|||
125970085|NCT04537923|453182647|FG001|Overall Study|Adverse Event|1|||
125970086|NCT04537923|453182648|FG002|Overall Study|Adverse Event|2|||
125970087|NCT04537923|453182649|FG003|Overall Study|Adverse Event|4|||
125970088|NCT04537923|453182646|FG000|Overall Study|Death|3|||
125970089|NCT04537923|453182647|FG001|Overall Study|Death|3|||
125970090|NCT04537923|453182648|FG002|Overall Study|Death|1|||
125970091|NCT04537923|453182649|FG003|Overall Study|Death|11|||
125970092|NCT04537923|453182646|FG000|Overall Study|Lost to Follow-up|1|||
125970093|NCT04537923|453182647|FG001|Overall Study|Lost to Follow-up|2|||
125970094|NCT04537923|453182648|FG002|Overall Study|Lost to Follow-up|1|||
125970095|NCT04537923|453182649|FG003|Overall Study|Lost to Follow-up|6|||
125970096|NCT04537923|453182646|FG000|Overall Study|Physician Decision|1|||
125970097|NCT04537923|453182647|FG001|Overall Study|Physician Decision|0|||
125970098|NCT04537923|453182648|FG002|Overall Study|Physician Decision|2|||
125970099|NCT04537923|453182649|FG003|Overall Study|Physician Decision|5|||
125970100|NCT04537923|453182646|FG000|Overall Study|Pregnancy|1|||
125970101|NCT04537923|453182647|FG001|Overall Study|Pregnancy|0|||
125970102|NCT04537923|453182648|FG002|Overall Study|Pregnancy|0|||
125970103|NCT04537923|453182649|FG003|Overall Study|Pregnancy|0|||
125970104|NCT04537923|453182646|FG000|Overall Study|Withdrawal by Subject|4|||
125970105|NCT04537923|453182647|FG001|Overall Study|Withdrawal by Subject|4|||
125970106|NCT04537923|453182648|FG002|Overall Study|Withdrawal by Subject|4|||
125970107|NCT04537923|453182649|FG003|Overall Study|Withdrawal by Subject|58|||
125970108|NCT04537923|453182646|FG000|Overall Study|Missed study visits|2|||
125970109|NCT04537923|453182647|FG001|Overall Study|Missed study visits|0|||
125970110|NCT04537923|453182648|FG002|Overall Study|Missed study visits|0|||
125970111|NCT04537923|453182649|FG003|Overall Study|Missed study visits|3|||
125970112|NCT04537923|453182646|FG000|Overall Study|Sponsor's decision|0|||
125970113|NCT04537923|453182647|FG001|Overall Study|Sponsor's decision|0|||
125970114|NCT04537923|453182648|FG002|Overall Study|Sponsor's decision|1|||
125970115|NCT04537923|453182649|FG003|Overall Study|Sponsor's decision|1|||
125970116|NCT04537923|453182646|FG000|Overall Study|Safety reasons|1|||
125970117|NCT04537923|453182647|FG001|Overall Study|Safety reasons|0|||
125970118|NCT04537923|453182648|FG002|Overall Study|Safety reasons|0|||
125970119|NCT04537923|453182649|FG003|Overall Study|Safety reasons|0|||
125970120|NCT01261611|453182650|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
125970121|NCT01261611|453182651|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
125970122|NCT01261611|453182652|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
125970123|NCT01261611|453182650|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
125970124|NCT01261611|453182651|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
125970125|NCT01261611|453182652|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
125970126|NCT01261611|453182650|FG000|Treatment Cycle 1|Adverse Event|0|||
125970127|NCT01261611|453182651|FG001|Treatment Cycle 1|Adverse Event|1|||
125970128|NCT01261611|453182652|FG002|Treatment Cycle 1|Adverse Event|0|||
125970129|NCT01261611|453182650|FG000|Treatment Cycle 1|Protocol Violation|0|||
125970130|NCT01261611|453182651|FG001|Treatment Cycle 1|Protocol Violation|0|||
125970131|NCT01261611|453182652|FG002|Treatment Cycle 1|Protocol Violation|2|||
125970132|NCT01261611|453182650|FG000|Treatment Cycle 2|Completed study|4|||
125970133|NCT01261611|453182651|FG001|Treatment Cycle 2|Completed study|0|||
125970134|NCT01261611|453182652|FG002|Treatment Cycle 2|Completed study|0|||
125970135|NCT01261611|453182650|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
125970136|NCT01261611|453182651|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
125970137|NCT01261611|453182652|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
125970138|NCT01261611|453182650|FG000|Treatment Cycle 2|Adverse Event|1|||
125970139|NCT01261611|453182651|FG001|Treatment Cycle 2|Adverse Event|0|||
125970140|NCT01261611|453182652|FG002|Treatment Cycle 2|Adverse Event|0|||
125970141|NCT01261611|453182650|FG000|Treatment Cycle 2|Protocol Violation|2|||
125970142|NCT01261611|453182651|FG001|Treatment Cycle 2|Protocol Violation|0|||
125970143|NCT01261611|453182652|FG002|Treatment Cycle 2|Protocol Violation|0|||
125970144|NCT01261611|453182650|FG000|Treatment Cycle 2|Not otherwise specified|2|||
125970145|NCT01261611|453182651|FG001|Treatment Cycle 2|Not otherwise specified|0|||
125970146|NCT01261611|453182652|FG002|Treatment Cycle 2|Not otherwise specified|0|||
125970147|NCT01261611|453182650|FG000|Treatment Cycle 3|Completed study|24|||
125970148|NCT01261611|453182651|FG001|Treatment Cycle 3|Completed study|0|||
125970149|NCT01261611|453182652|FG002|Treatment Cycle 3|Completed study|0|||
125970150|NCT01261611|453182650|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
125970151|NCT01261611|453182651|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
125970152|NCT01261611|453182652|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
125970153|NCT01261611|453182650|FG000|Treatment Cycle 3|Adverse Event|1|||
125970154|NCT01261611|453182651|FG001|Treatment Cycle 3|Adverse Event|0|||
125970155|NCT01261611|453182652|FG002|Treatment Cycle 3|Adverse Event|0|||
125970156|NCT01261611|453182650|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
125970157|NCT01261611|453182651|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
125970158|NCT01261611|453182652|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
125970159|NCT01261611|453182650|FG000|Treatment Cycle 4|Completed study|87|||
125970160|NCT01261611|453182651|FG001|Treatment Cycle 4|Completed study|0|||
125970161|NCT01261611|453182652|FG002|Treatment Cycle 4|Completed study|0|||
125970162|NCT01261611|453182650|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
125970163|NCT01261611|453182651|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
125970164|NCT01261611|453182652|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
125970165|NCT01261611|453182650|FG000|Treatment Cycle 4|Adverse Event|1|||
125970166|NCT01261611|453182651|FG001|Treatment Cycle 4|Adverse Event|0|||
125970167|NCT01261611|453182652|FG002|Treatment Cycle 4|Adverse Event|0|||
125970168|NCT01261611|453182650|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
125970169|NCT01261611|453182651|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
125970170|NCT01261611|453182652|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
125970171|NCT01261611|453182650|FG000|Treatment Cycle 4|Not otherwise specified|3|||
125970172|NCT01261611|453182651|FG001|Treatment Cycle 4|Not otherwise specified|0|||
125970173|NCT01261611|453182652|FG002|Treatment Cycle 4|Not otherwise specified|0|||
125970174|NCT01261611|453182650|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
125970175|NCT01261611|453182651|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
125970176|NCT01261611|453182652|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
125970177|NCT01261611|453182650|FG000|Treatment Cycle 5|Adverse Event|1|||
125970178|NCT01261611|453182651|FG001|Treatment Cycle 5|Adverse Event|0|||
125970179|NCT01261611|453182652|FG002|Treatment Cycle 5|Adverse Event|0|||
125970180|NCT01261611|453182650|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
125970181|NCT01261611|453182651|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
125970182|NCT01261611|453182652|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
125970183|NCT02527798|453182653|FG000|Overall Study|Physician Decision|1|||
125970184|NCT02527798|453182654|FG001|Overall Study|Physician Decision|0|||
125970185|NCT02527798|453182655|FG002|Overall Study|Physician Decision|1|||
125970186|NCT02527798|453182656|FG003|Overall Study|Physician Decision|1|||
125970187|NCT02527798|453182657|FG004|Overall Study|Physician Decision|0|||
125970188|NCT02527798|453182658|FG005|Overall Study|Physician Decision|0|||
125970189|NCT02527798|453182653|FG000|Overall Study|Death|0|||
125970190|NCT02527798|453182654|FG001|Overall Study|Death|0|||
125970191|NCT02527798|453182655|FG002|Overall Study|Death|1|||
125970192|NCT02527798|453182656|FG003|Overall Study|Death|0|||
125970193|NCT02527798|453182657|FG004|Overall Study|Death|0|||
125970194|NCT02527798|453182658|FG005|Overall Study|Death|0|||
125970195|NCT02527798|453182653|FG000|Overall Study|Withdrawal by Subject|0|||
125970196|NCT02527798|453182654|FG001|Overall Study|Withdrawal by Subject|1|||
125970197|NCT02527798|453182655|FG002|Overall Study|Withdrawal by Subject|2|||
125970198|NCT02527798|453182656|FG003|Overall Study|Withdrawal by Subject|0|||
125970199|NCT02527798|453182657|FG004|Overall Study|Withdrawal by Subject|0|||
125970200|NCT02527798|453182658|FG005|Overall Study|Withdrawal by Subject|0|||
125970201|NCT02527798|453182653|FG000|Overall Study|Reason undisclosed|1|||
125970202|NCT02527798|453182654|FG001|Overall Study|Reason undisclosed|0|||
125970203|NCT02527798|453182655|FG002|Overall Study|Reason undisclosed|1|||
125970204|NCT02527798|453182656|FG003|Overall Study|Reason undisclosed|0|||
125970205|NCT02527798|453182657|FG004|Overall Study|Reason undisclosed|0|||
125970206|NCT02527798|453182658|FG005|Overall Study|Reason undisclosed|0|||
125970207|NCT02527798|453182653|FG000|Overall Study|Did not receive intervention|1|||
125970208|NCT02527798|453182654|FG001|Overall Study|Did not receive intervention|1|||
125970209|NCT02527798|453182655|FG002|Overall Study|Did not receive intervention|0|||
125970210|NCT02527798|453182656|FG003|Overall Study|Did not receive intervention|0|||
125970211|NCT02527798|453182657|FG004|Overall Study|Did not receive intervention|0|||
125970212|NCT02527798|453182658|FG005|Overall Study|Did not receive intervention|0|||
125970213|NCT00156065|453182663|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
125970214|NCT00156065|453182664|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
125970215|NCT00156065|453182665|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
125970216|NCT00156065|453182663|FG000|Overall Study|Adverse Event|8|||
125970217|NCT00156065|453182664|FG001|Overall Study|Adverse Event|11|||
125970218|NCT00156065|453182665|FG002|Overall Study|Adverse Event|4|||
125970219|NCT00156065|453182663|FG000|Overall Study|Lack of Efficacy|2|||
125970220|NCT00156065|453182664|FG001|Overall Study|Lack of Efficacy|9|||
125970221|NCT00156065|453182665|FG002|Overall Study|Lack of Efficacy|3|||
125970222|NCT00156065|453182663|FG000|Overall Study|Withdrawal by Subject|13|||
125970223|NCT00156065|453182664|FG001|Overall Study|Withdrawal by Subject|26|||
125970224|NCT00156065|453182665|FG002|Overall Study|Withdrawal by Subject|16|||
125970225|NCT00156065|453182663|FG000|Overall Study|Lost to Follow-up|5|||
125970226|NCT00156065|453182664|FG001|Overall Study|Lost to Follow-up|7|||
125970227|NCT00156065|453182665|FG002|Overall Study|Lost to Follow-up|1|||
125970228|NCT00156065|453182663|FG000|Overall Study|Other|2|||
125970229|NCT00156065|453182664|FG001|Overall Study|Other|9|||
125970230|NCT00156065|453182665|FG002|Overall Study|Other|3|||
125970231|NCT04745169|453182666|FG000|Overall Study|Kidney transplantation|1|||
125970232|NCT04745169|453182666|FG000|Overall Study|Participant health problems|3|||
125970233|NCT04745169|453182666|FG000|Overall Study|Physician Decision|2|||
125970234|NCT00920426|453182667|FG000|ITZ111451|Adverse Event|1|||
125970235|NCT00920426|453182668|FG001|ITZ111451|Adverse Event|0|||
125970236|NCT00920426|453182669|FG002|ITZ111451|Adverse Event|0|||
125970237|NCT00920426|453182670|FG003|ITZ111451|Adverse Event|0|||
125970238|NCT01292603|453182671|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125970239|NCT01292603|453182672|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125970240|NCT01292603|453182673|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125970241|NCT01292603|453182674|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
125970242|NCT01292603|453182675|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125970243|NCT01292603|453182676|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125970244|NCT01292603|453182671|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
125970245|NCT01292603|453182672|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
125970246|NCT01292603|453182673|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
125970247|NCT01292603|453182674|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
125970248|NCT01292603|453182675|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
125970249|NCT01292603|453182676|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
125970250|NCT01292603|453182671|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125970251|NCT01292603|453182672|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125970252|NCT01292603|453182673|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125970253|NCT01292603|453182674|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
125970254|NCT01292603|453182675|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125970255|NCT01292603|453182676|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125970256|NCT01292603|453182671|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125970257|NCT01292603|453182672|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125970258|NCT01292603|453182673|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125970259|NCT01292603|453182674|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
125970260|NCT01292603|453182675|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125970261|NCT01292603|453182676|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125970262|NCT01292603|453182671|FG000|Part 1: Regular Follow-Up Period|Death|3|||
125970263|NCT01292603|453182672|FG001|Part 1: Regular Follow-Up Period|Death|1|||
125970264|NCT01292603|453182673|FG002|Part 1: Regular Follow-Up Period|Death|3|||
125970265|NCT01292603|453182674|FG003|Part 1: Regular Follow-Up Period|Death|1|||
125970266|NCT01292603|453182675|FG004|Part 1: Regular Follow-Up Period|Death|0|||
125970267|NCT01292603|453182676|FG005|Part 1: Regular Follow-Up Period|Death|0|||
125970268|NCT01292603|453182671|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
125970269|NCT01292603|453182672|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
125970270|NCT01292603|453182673|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
125970271|NCT01292603|453182674|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
125970272|NCT01292603|453182675|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
125970273|NCT01292603|453182676|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
125970274|NCT01292603|453182671|FG000|Part 2: Dose Confirmation Period|Death|0|||
125970275|NCT01292603|453182672|FG001|Part 2: Dose Confirmation Period|Death|0|||
125970276|NCT01292603|453182673|FG002|Part 2: Dose Confirmation Period|Death|0|||
125970277|NCT01292603|453182674|FG003|Part 2: Dose Confirmation Period|Death|0|||
125970278|NCT01292603|453182675|FG004|Part 2: Dose Confirmation Period|Death|1|||
125970279|NCT01292603|453182676|FG005|Part 2: Dose Confirmation Period|Death|0|||
125970280|NCT01292603|453182671|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
125970281|NCT01292603|453182672|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
125970282|NCT01292603|453182673|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
125970283|NCT01292603|453182674|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
125970284|NCT01292603|453182675|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
125970285|NCT01292603|453182676|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
125970286|NCT01292603|453182671|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
125970287|NCT01292603|453182672|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
125970288|NCT01292603|453182673|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
125970289|NCT01292603|453182674|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
125970290|NCT01292603|453182675|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
125970291|NCT01292603|453182676|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
125970292|NCT01292603|453182671|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
125970293|NCT01292603|453182672|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
125970294|NCT01292603|453182673|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
125970295|NCT01292603|453182674|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
125970296|NCT01292603|453182675|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
125970297|NCT01292603|453182676|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
125970298|NCT01292603|453182671|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
125970299|NCT01292603|453182672|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
125970300|NCT01292603|453182673|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
125970301|NCT01292603|453182674|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
125970302|NCT01292603|453182675|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
125970303|NCT01292603|453182676|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
125970304|NCT01292603|453182671|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125970305|NCT01292603|453182672|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125970306|NCT01292603|453182673|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125970307|NCT01292603|453182674|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125970308|NCT01292603|453182675|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125970309|NCT01292603|453182676|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
125970310|NCT01292603|453182671|FG000|Part 2: Regular Follow-Up|Death|0|||
125970311|NCT01292603|453182672|FG001|Part 2: Regular Follow-Up|Death|0|||
125970312|NCT01292603|453182673|FG002|Part 2: Regular Follow-Up|Death|0|||
125970313|NCT01292603|453182674|FG003|Part 2: Regular Follow-Up|Death|0|||
125970314|NCT01292603|453182675|FG004|Part 2: Regular Follow-Up|Death|6|||
125970315|NCT01292603|453182676|FG005|Part 2: Regular Follow-Up|Death|3|||
125970316|NCT01292603|453182671|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
125970317|NCT01292603|453182672|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
125970318|NCT01292603|453182673|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
125970319|NCT01292603|453182674|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
125970320|NCT01292603|453182675|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
125970321|NCT01292603|453182676|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
125970322|NCT01292603|453182671|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
125970323|NCT01292603|453182672|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
125970324|NCT01292603|453182673|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
125970325|NCT01292603|453182674|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
125970326|NCT01292603|453182675|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
125970327|NCT01292603|453182676|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
125970328|NCT01292603|453182671|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125970329|NCT01292603|453182672|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125970330|NCT01292603|453182673|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125970331|NCT01292603|453182674|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125970332|NCT01292603|453182675|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
126144264|NCT03690869|453813648|FG006|Overall Study|Subject Decision|0|||
125970333|NCT01292603|453182676|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
125970334|NCT01292603|453182671|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
125970335|NCT01292603|453182672|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
126144265|NCT03690869|453813649|FG007|Overall Study|Subject Decision|1|||
126144266|NCT03690869|453813650|FG008|Overall Study|Subject Decision|0|||
126144267|NCT03690869|453813651|FG009|Overall Study|Subject Decision|0|||
126144268|NCT04280081|453813653|FG000|Overall Study|Adverse Event|4|||
126144269|NCT04280081|453813653|FG000|Overall Study|Death|2|||
126144270|NCT04280081|453813653|FG000|Overall Study|Progressive Disease|6|||
126144271|NCT01468311|453813654|FG000|Overall Study|mobilization failure|1|||
126144272|NCT01468311|453813654|FG000|Overall Study|Withdrawal by Subject|1|||
126144273|NCT04840667|453815518|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
126144274|NCT03195894|453815519|FG000|Overall Study|"An example is Started other treatment."|4|||
126144275|NCT03195894|453815520|FG001|Overall Study|"An example is Started other treatment."|5|||
126144276|NCT03195894|453815519|FG000|Overall Study|Withdrawal by Subject|15|||
126144277|NCT03195894|453815520|FG001|Overall Study|Withdrawal by Subject|4|||
126144278|NCT03195894|453815519|FG000|Overall Study|Lost to Follow-up|14|||
126144279|NCT03195894|453815520|FG001|Overall Study|Lost to Follow-up|19|||
126144280|NCT03902080|453815538|FG000|Overall Study|Adverse Event|17|||
126144281|NCT03902080|453815539|FG001|Overall Study|Adverse Event|15|||
126144282|NCT03902080|453815538|FG000|Overall Study|Withdrawal by Subject|28|||
126144283|NCT03902080|453815539|FG001|Overall Study|Withdrawal by Subject|35|||
126144284|NCT03902080|453815538|FG000|Overall Study|Lost to Follow-up|6|||
126144285|NCT03902080|453815539|FG001|Overall Study|Lost to Follow-up|7|||
126144286|NCT03902080|453815538|FG000|Overall Study|Other|3|||
126144287|NCT03902080|453815539|FG001|Overall Study|Other|5|||
126144288|NCT03902080|453815538|FG000|Overall Study|Non compliance|4|||
126144289|NCT03902080|453815539|FG001|Overall Study|Non compliance|3|||
126144290|NCT03902080|453815538|FG000|Overall Study|Physician Decision|5|||
126144291|NCT03902080|453815539|FG001|Overall Study|Physician Decision|1|||
126144292|NCT03902080|453815538|FG000|Overall Study|Protocol Violation|3|||
126144293|NCT03902080|453815539|FG001|Overall Study|Protocol Violation|3|||
126144294|NCT03902080|453815538|FG000|Overall Study|Lack of Efficacy|1|||
126144295|NCT03902080|453815539|FG001|Overall Study|Lack of Efficacy|3|||
126144296|NCT03902080|453815538|FG000|Overall Study|Withdrawn prior to dosing|0|||
126144297|NCT03902080|453815539|FG001|Overall Study|Withdrawn prior to dosing|1|||
126144298|NCT01919307|453815544|FG000|Overall Study|Withdrawal by Subject|9|||
126144299|NCT01701258|453815546|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
126144300|NCT01701258|453815547|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
126144301|NCT01701258|453815548|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
126144302|NCT01701258|453815549|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
126144303|NCT01701258|453815550|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
126144304|NCT01701258|453815551|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
126144305|NCT01701258|453815552|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
126144306|NCT01701258|453815553|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
126144307|NCT01701258|453815554|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
126144308|NCT01701258|453815555|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
126144309|NCT01701258|453815556|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
126144310|NCT01701258|453815557|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
126144311|NCT01701258|453815558|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
126144312|NCT01701258|453815546|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
126144313|NCT01701258|453815547|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
126144314|NCT01701258|453815548|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
126144315|NCT01701258|453815549|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
126144316|NCT01701258|453815550|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
126144317|NCT01701258|453815551|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
126144318|NCT01701258|453815552|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
126144319|NCT01701258|453815553|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
126144320|NCT01701258|453815554|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
126144321|NCT01701258|453815555|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
126144322|NCT01701258|453815556|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
126144323|NCT01701258|453815557|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
126144324|NCT01701258|453815558|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
126144325|NCT01701258|453815546|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
126144326|NCT01701258|453815547|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
125970336|NCT01292603|453182673|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
126144327|NCT01701258|453815548|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
126144328|NCT01701258|453815549|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
126144329|NCT01701258|453815550|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
126144330|NCT01701258|453815551|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
126144331|NCT01701258|453815552|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
126144332|NCT01701258|453815553|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
126144333|NCT01701258|453815554|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
126144334|NCT01701258|453815555|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
126144335|NCT01701258|453815556|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
126144336|NCT01701258|453815557|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
126144337|NCT01701258|453815558|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
126144338|NCT01701258|453815546|FG000|Assessment and Scheduling|Investigator Terminated|2|||
126144339|NCT01701258|453815547|FG001|Assessment and Scheduling|Investigator Terminated|0|||
126144340|NCT01701258|453815548|FG002|Assessment and Scheduling|Investigator Terminated|0|||
126144341|NCT01701258|453815549|FG003|Assessment and Scheduling|Investigator Terminated|0|||
126144342|NCT01701258|453815550|FG004|Assessment and Scheduling|Investigator Terminated|0|||
126144343|NCT01701258|453815551|FG005|Assessment and Scheduling|Investigator Terminated|0|||
126144344|NCT01701258|453815552|FG006|Assessment and Scheduling|Investigator Terminated|0|||
126144345|NCT01701258|453815553|FG007|Assessment and Scheduling|Investigator Terminated|0|||
126144346|NCT01701258|453815554|FG008|Assessment and Scheduling|Investigator Terminated|0|||
126144347|NCT01701258|453815555|FG009|Assessment and Scheduling|Investigator Terminated|0|||
126144348|NCT01701258|453815556|FG010|Assessment and Scheduling|Investigator Terminated|0|||
126144349|NCT01701258|453815557|FG011|Assessment and Scheduling|Investigator Terminated|0|||
126144350|NCT01701258|453815558|FG012|Assessment and Scheduling|Investigator Terminated|0|||
126144351|NCT03093402|453815559|FG000|Overall Study|Lost to Follow-up|1|||
126144352|NCT03093402|453815560|FG001|Overall Study|Lost to Follow-up|0|||
126144353|NCT03093402|453815561|FG002|Overall Study|Lost to Follow-up|0|||
126144354|NCT03093402|453815562|FG003|Overall Study|Lost to Follow-up|0|||
126144355|NCT03093402|453815559|FG000|Overall Study|Withdrawal by Subject|3|||
126144356|NCT03093402|453815560|FG001|Overall Study|Withdrawal by Subject|3|||
126144357|NCT03093402|453815561|FG002|Overall Study|Withdrawal by Subject|0|||
126144358|NCT03093402|453815562|FG003|Overall Study|Withdrawal by Subject|1|||
126144359|NCT03093402|453815559|FG000|Overall Study|Withdrew prior to dosing|2|||
126144360|NCT03093402|453815560|FG001|Overall Study|Withdrew prior to dosing|1|||
126144361|NCT03093402|453815561|FG002|Overall Study|Withdrew prior to dosing|2|||
126144362|NCT03093402|453815562|FG003|Overall Study|Withdrew prior to dosing|3|||
126144363|NCT03093402|453815559|FG000|Overall Study|Ineligible for study|1|||
126144364|NCT03093402|453815560|FG001|Overall Study|Ineligible for study|0|||
126144365|NCT03093402|453815561|FG002|Overall Study|Ineligible for study|0|||
126144366|NCT03093402|453815562|FG003|Overall Study|Ineligible for study|0|||
126144367|NCT03093402|453815559|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
126144368|NCT03093402|453815560|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
126144369|NCT03093402|453815561|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
126144370|NCT03093402|453815562|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
126144371|NCT02886702|453815563|FG000|Overall Study|Other|4|||
126144372|NCT02886702|453815564|FG001|Overall Study|Other|3|||
126144373|NCT02886702|453815565|FG002|Overall Study|Other|9|||
126144374|NCT02886702|453815563|FG000|Overall Study|Withdrawal by Subject|24|||
126144375|NCT02886702|453815564|FG001|Overall Study|Withdrawal by Subject|18|||
126144376|NCT02886702|453815565|FG002|Overall Study|Withdrawal by Subject|22|||
126144377|NCT02886702|453815563|FG000|Overall Study|Significant Worsening of Condition|0|||
126144378|NCT02886702|453815564|FG001|Overall Study|Significant Worsening of Condition|1|||
126144379|NCT02886702|453815565|FG002|Overall Study|Significant Worsening of Condition|0|||
126144380|NCT02886702|453815563|FG000|Overall Study|Protocol Violation|2|||
126144381|NCT02886702|453815564|FG001|Overall Study|Protocol Violation|2|||
126144382|NCT02886702|453815565|FG002|Overall Study|Protocol Violation|1|||
126144383|NCT02886702|453815563|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126144384|NCT02886702|453815564|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126144385|NCT02886702|453815565|FG002|Overall Study|Non-Compliance With Study Drug|4|||
126144386|NCT02886702|453815563|FG000|Overall Study|Lost to Follow-up|11|||
126144387|NCT02886702|453815564|FG001|Overall Study|Lost to Follow-up|13|||
126144388|NCT02886702|453815565|FG002|Overall Study|Lost to Follow-up|8|||
126144389|NCT02886702|453815563|FG000|Overall Study|Lack of Efficacy|3|||
126144390|NCT02886702|453815564|FG001|Overall Study|Lack of Efficacy|4|||
126144391|NCT02886702|453815565|FG002|Overall Study|Lack of Efficacy|5|||
126144392|NCT02886702|453815563|FG000|Overall Study|Adverse Event|4|||
126144393|NCT02886702|453815564|FG001|Overall Study|Adverse Event|9|||
126144394|NCT02886702|453815565|FG002|Overall Study|Adverse Event|3|||
125970337|NCT01292603|453182674|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
126144395|NCT02886702|453815563|FG000|Overall Study|Administrative Reasons|0|||
126144396|NCT02886702|453815564|FG001|Overall Study|Administrative Reasons|0|||
126144397|NCT02886702|453815565|FG002|Overall Study|Administrative Reasons|1|||
126144398|NCT01451645|453815574|FG000|Overall Study|Protocol Violation|1|||
126144399|NCT01451645|453815575|FG001|Overall Study|Protocol Violation|0|||
126144400|NCT01451645|453815574|FG000|Overall Study|Adverse Event|0|||
126144401|NCT01451645|453815575|FG001|Overall Study|Adverse Event|3|||
126144402|NCT01451645|453815574|FG000|Overall Study|Withdrawal by Subject|4|||
126144403|NCT01451645|453815575|FG001|Overall Study|Withdrawal by Subject|2|||
126144404|NCT01451645|453815574|FG000|Overall Study|Lost to Follow-up|4|||
126144405|NCT01451645|453815575|FG001|Overall Study|Lost to Follow-up|3|||
126144406|NCT03663166|453815578|FG000|Overall Study|Withdrawal by Subject|1|||
126144407|NCT01686568|453815581|FG000|Main Study|Withdrawal by Subject|1|||
126144408|NCT01686568|453815582|FG001|Main Study|Withdrawal by Subject|3|||
126144409|NCT01686568|453815581|FG000|Main Study|Noncompliance with protocol|0|||
126144410|NCT01686568|453815582|FG001|Main Study|Noncompliance with protocol|1|||
126144411|NCT01686568|453815581|FG000|Main Study|Liver enzymes above range of exclusion|1|||
126144412|NCT01686568|453815582|FG001|Main Study|Liver enzymes above range of exclusion|0|||
126144413|NCT01686568|453815581|FG000|Sub-Study|Not consented for sub-study|2|||
126144414|NCT01686568|453815582|FG001|Sub-Study|Not consented for sub-study|2|||
126144415|NCT02978222|453815583|FG000|Overall Study|Withdrawal by Subject|2|||
126144416|NCT02978222|453815584|FG001|Overall Study|Withdrawal by Subject|2|||
126144417|NCT02978222|453815583|FG000|Overall Study|Physician Decision|2|||
126144418|NCT02978222|453815584|FG001|Overall Study|Physician Decision|0|||
126144419|NCT02978222|453815583|FG000|Overall Study|Adverse Event|0|||
126144420|NCT02978222|453815584|FG001|Overall Study|Adverse Event|1|||
126144421|NCT02978222|453815583|FG000|Overall Study|Death|1|||
126144422|NCT02978222|453815584|FG001|Overall Study|Death|0|||
126144423|NCT02978222|453815583|FG000|Overall Study|Disease Progression|32|||
126144424|NCT02978222|453815584|FG001|Overall Study|Disease Progression|32|||
126144425|NCT02978222|453815583|FG000|Overall Study|Early Study Termination|24|||
126144426|NCT02978222|453815584|FG001|Overall Study|Early Study Termination|21|||
126144427|NCT05340504|453815587|FG000|Overall Study|Withdrawal by Subject|1|||
126144428|NCT05340504|453815588|FG001|Overall Study|Withdrawal by Subject|0|||
126144429|NCT02868892|453815591|FG000|Overall Study|Investigator left site and no follow-up|6|||
126144430|NCT02393209|453815595|FG000|Overall Study|Study Terminated by Sponsor|1|||
126144431|NCT02393209|453815596|FG001|Overall Study|Study Terminated by Sponsor|1|||
126144432|NCT02393209|453815597|FG002|Overall Study|Study Terminated by Sponsor|0|||
126144433|NCT02393209|453815598|FG003|Overall Study|Study Terminated by Sponsor|0|||
126144434|NCT02393209|453815595|FG000|Overall Study|Withdrawal by Patient|1|||
126144435|NCT02393209|453815596|FG001|Overall Study|Withdrawal by Patient|0|||
126144436|NCT02393209|453815597|FG002|Overall Study|Withdrawal by Patient|0|||
126144437|NCT02393209|453815598|FG003|Overall Study|Withdrawal by Patient|0|||
126144438|NCT02393209|453815595|FG000|Overall Study|Death|2|||
126144439|NCT02393209|453815596|FG001|Overall Study|Death|2|||
126144440|NCT02393209|453815597|FG002|Overall Study|Death|0|||
126144441|NCT02393209|453815598|FG003|Overall Study|Death|0|||
126144442|NCT02393209|453815595|FG000|Overall Study|Death due to Disease Progression|2|||
126144443|NCT02393209|453815596|FG001|Overall Study|Death due to Disease Progression|2|||
126144444|NCT02393209|453815597|FG002|Overall Study|Death due to Disease Progression|0|||
126144445|NCT02393209|453815598|FG003|Overall Study|Death due to Disease Progression|0|||
126144446|NCT02393209|453815595|FG000|Overall Study|Death from Legionella Infection|0|||
126144447|NCT02393209|453815596|FG001|Overall Study|Death from Legionella Infection|1|||
126144448|NCT02393209|453815597|FG002|Overall Study|Death from Legionella Infection|0|||
126144449|NCT02393209|453815598|FG003|Overall Study|Death from Legionella Infection|0|||
126144450|NCT02393209|453815595|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
126144451|NCT02393209|453815596|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
126144452|NCT02393209|453815597|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
126144453|NCT02393209|453815598|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
126144454|NCT02393209|453815595|FG000|Overall Study|Lost to Follow-up|0|||
126144455|NCT02393209|453815596|FG001|Overall Study|Lost to Follow-up|1|||
126144456|NCT02393209|453815597|FG002|Overall Study|Lost to Follow-up|0|||
126144457|NCT02393209|453815598|FG003|Overall Study|Lost to Follow-up|0|||
126144458|NCT00619957|453815599|FG000|Month 24 Double-Blind|Adverse Event|9|||
126144459|NCT00619957|453815600|FG001|Month 24 Double-Blind|Adverse Event|7|||
126144460|NCT00619957|453815599|FG000|Month 24 Double-Blind|Protocol Violation|1|||
126144461|NCT00619957|453815600|FG001|Month 24 Double-Blind|Protocol Violation|0|||
126144462|NCT00619957|453815599|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
126144463|NCT00619957|453815600|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
126144464|NCT00619957|453815599|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
126144465|NCT00619957|453815600|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
126144466|NCT00619957|453815599|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
125970338|NCT01292603|453182675|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
125970339|NCT01292603|453182676|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
125970340|NCT01292603|453182671|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
125970341|NCT01292603|453182672|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
126144467|NCT00619957|453815600|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
126144468|NCT00619957|453815599|FG000|Month 48 Open-Label|Adverse Event|4|||
125970342|NCT01292603|453182673|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
126144469|NCT00619957|453815600|FG001|Month 48 Open-Label|Adverse Event|4|||
126144470|NCT00619957|453815599|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
126144471|NCT00619957|453815600|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
126144472|NCT00619957|453815599|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
126144473|NCT00619957|453815600|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
126144474|NCT00868790|453815601|FG000|Period 1|Adverse Event|1|||
126144475|NCT00868790|453815602|FG001|Period 1|Adverse Event|0|||
126144476|NCT00868790|453815603|FG002|Period 1|Adverse Event|0|||
126144477|NCT00868790|453815604|FG003|Period 1|Adverse Event|0|||
126144478|NCT00868790|453815605|FG004|Period 1|Adverse Event|0|||
126144479|NCT00868790|453815606|FG005|Period 1|Adverse Event|0|||
126144480|NCT00868790|453815607|FG006|Period 1|Adverse Event|0|||
126144481|NCT00868790|453815608|FG007|Period 1|Adverse Event|3|||
126144482|NCT00868790|453815609|FG008|Period 1|Adverse Event|1|||
126144483|NCT00868790|453815610|FG009|Period 1|Adverse Event|0|||
126144484|NCT00868790|453815611|FG010|Period 1|Adverse Event|0|||
126144485|NCT00868790|453815612|FG011|Period 1|Adverse Event|0|||
126144486|NCT00868790|453815613|FG012|Period 1|Adverse Event|0|||
126144487|NCT00868790|453815614|FG013|Period 1|Adverse Event|1|||
126144488|NCT00868790|453815601|FG000|Period 1|Protocol Violation|1|||
126144489|NCT00868790|453815602|FG001|Period 1|Protocol Violation|0|||
126144490|NCT00868790|453815603|FG002|Period 1|Protocol Violation|0|||
126144491|NCT00868790|453815604|FG003|Period 1|Protocol Violation|0|||
126144492|NCT00868790|453815605|FG004|Period 1|Protocol Violation|0|||
126144493|NCT00868790|453815606|FG005|Period 1|Protocol Violation|0|||
126144494|NCT00868790|453815607|FG006|Period 1|Protocol Violation|0|||
126144495|NCT00868790|453815608|FG007|Period 1|Protocol Violation|0|||
126144496|NCT00868790|453815609|FG008|Period 1|Protocol Violation|0|||
126144497|NCT00868790|453815610|FG009|Period 1|Protocol Violation|0|||
126144498|NCT00868790|453815611|FG010|Period 1|Protocol Violation|0|||
126144499|NCT00868790|453815612|FG011|Period 1|Protocol Violation|0|||
126144500|NCT00868790|453815613|FG012|Period 1|Protocol Violation|0|||
126144501|NCT00868790|453815614|FG013|Period 1|Protocol Violation|0|||
126144502|NCT00868790|453815601|FG000|Period 1|Withdrawal by Subject|0|||
126144503|NCT00868790|453815602|FG001|Period 1|Withdrawal by Subject|1|||
126144504|NCT00868790|453815603|FG002|Period 1|Withdrawal by Subject|0|||
126144505|NCT00868790|453815604|FG003|Period 1|Withdrawal by Subject|0|||
126144506|NCT00868790|453815605|FG004|Period 1|Withdrawal by Subject|0|||
126144507|NCT00868790|453815606|FG005|Period 1|Withdrawal by Subject|0|||
126144508|NCT00868790|453815607|FG006|Period 1|Withdrawal by Subject|0|||
126144509|NCT00868790|453815608|FG007|Period 1|Withdrawal by Subject|0|||
126144510|NCT00868790|453815609|FG008|Period 1|Withdrawal by Subject|0|||
126144511|NCT00868790|453815610|FG009|Period 1|Withdrawal by Subject|0|||
126144512|NCT00868790|453815611|FG010|Period 1|Withdrawal by Subject|0|||
126144513|NCT00868790|453815612|FG011|Period 1|Withdrawal by Subject|0|||
126144514|NCT00868790|453815613|FG012|Period 1|Withdrawal by Subject|0|||
126144515|NCT00868790|453815614|FG013|Period 1|Withdrawal by Subject|1|||
126144516|NCT00868790|453815601|FG000|Period 1|Abnormal Triglycerides|0|||
126144517|NCT00868790|453815602|FG001|Period 1|Abnormal Triglycerides|0|||
126144518|NCT00868790|453815603|FG002|Period 1|Abnormal Triglycerides|0|||
126144519|NCT00868790|453815604|FG003|Period 1|Abnormal Triglycerides|0|||
126144520|NCT00868790|453815605|FG004|Period 1|Abnormal Triglycerides|1|||
126144521|NCT00868790|453815606|FG005|Period 1|Abnormal Triglycerides|0|||
126144522|NCT00868790|453815607|FG006|Period 1|Abnormal Triglycerides|0|||
126144523|NCT00868790|453815608|FG007|Period 1|Abnormal Triglycerides|0|||
126144524|NCT00868790|453815609|FG008|Period 1|Abnormal Triglycerides|0|||
126144525|NCT00868790|453815610|FG009|Period 1|Abnormal Triglycerides|0|||
126144526|NCT00868790|453815611|FG010|Period 1|Abnormal Triglycerides|0|||
126144527|NCT00868790|453815612|FG011|Period 1|Abnormal Triglycerides|0|||
126144528|NCT00868790|453815613|FG012|Period 1|Abnormal Triglycerides|0|||
126144529|NCT00868790|453815614|FG013|Period 1|Abnormal Triglycerides|0|||
126144530|NCT00868790|453815601|FG000|Period 1|Lost to Follow-up|0|||
126144531|NCT00868790|453815602|FG001|Period 1|Lost to Follow-up|0|||
126144532|NCT00868790|453815603|FG002|Period 1|Lost to Follow-up|0|||
126144533|NCT00868790|453815604|FG003|Period 1|Lost to Follow-up|0|||
126144534|NCT00868790|453815605|FG004|Period 1|Lost to Follow-up|0|||
126144535|NCT00868790|453815606|FG005|Period 1|Lost to Follow-up|1|||
126144536|NCT00868790|453815607|FG006|Period 1|Lost to Follow-up|0|||
126144537|NCT00868790|453815608|FG007|Period 1|Lost to Follow-up|0|||
126144538|NCT00868790|453815609|FG008|Period 1|Lost to Follow-up|0|||
126144539|NCT00868790|453815610|FG009|Period 1|Lost to Follow-up|0|||
125970343|NCT01292603|453182674|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
125970344|NCT01292603|453182675|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
126144540|NCT00868790|453815611|FG010|Period 1|Lost to Follow-up|0|||
126144541|NCT00868790|453815612|FG011|Period 1|Lost to Follow-up|0|||
126144542|NCT00868790|453815613|FG012|Period 1|Lost to Follow-up|0|||
126144543|NCT00868790|453815614|FG013|Period 1|Lost to Follow-up|0|||
126144544|NCT00868790|453815601|FG000|Period 2|Adverse Event|0|||
126144545|NCT00868790|453815602|FG001|Period 2|Adverse Event|0|||
126144546|NCT00868790|453815603|FG002|Period 2|Adverse Event|0|||
126144547|NCT00868790|453815604|FG003|Period 2|Adverse Event|0|||
126144548|NCT00868790|453815605|FG004|Period 2|Adverse Event|0|||
126144549|NCT00868790|453815606|FG005|Period 2|Adverse Event|0|||
126144550|NCT00868790|453815607|FG006|Period 2|Adverse Event|0|||
126144551|NCT00868790|453815608|FG007|Period 2|Adverse Event|0|||
126144552|NCT00868790|453815609|FG008|Period 2|Adverse Event|1|||
126144553|NCT00868790|453815610|FG009|Period 2|Adverse Event|0|||
126144554|NCT00868790|453815611|FG010|Period 2|Adverse Event|0|||
126144555|NCT00868790|453815612|FG011|Period 2|Adverse Event|0|||
126144556|NCT00868790|453815613|FG012|Period 2|Adverse Event|0|||
126144557|NCT00868790|453815614|FG013|Period 2|Adverse Event|0|||
126144558|NCT00868790|453815601|FG000|Period 2|Lost to Follow-up|0|||
126144559|NCT00868790|453815602|FG001|Period 2|Lost to Follow-up|1|||
126144560|NCT00868790|453815603|FG002|Period 2|Lost to Follow-up|0|||
126144561|NCT00868790|453815604|FG003|Period 2|Lost to Follow-up|0|||
126144562|NCT00868790|453815605|FG004|Period 2|Lost to Follow-up|0|||
126144563|NCT00868790|453815606|FG005|Period 2|Lost to Follow-up|1|||
126144564|NCT00868790|453815607|FG006|Period 2|Lost to Follow-up|0|||
126144565|NCT00868790|453815608|FG007|Period 2|Lost to Follow-up|0|||
126144566|NCT00868790|453815609|FG008|Period 2|Lost to Follow-up|0|||
126144567|NCT00868790|453815610|FG009|Period 2|Lost to Follow-up|0|||
126144568|NCT00868790|453815611|FG010|Period 2|Lost to Follow-up|0|||
126144569|NCT00868790|453815612|FG011|Period 2|Lost to Follow-up|0|||
126144570|NCT00868790|453815613|FG012|Period 2|Lost to Follow-up|0|||
126144571|NCT00868790|453815614|FG013|Period 2|Lost to Follow-up|0|||
126144572|NCT00868790|453815601|FG000|Period 2|Withdrawal by Subject|0|||
126144573|NCT00868790|453815602|FG001|Period 2|Withdrawal by Subject|0|||
126144574|NCT00868790|453815603|FG002|Period 2|Withdrawal by Subject|0|||
126144575|NCT00868790|453815604|FG003|Period 2|Withdrawal by Subject|0|||
126144576|NCT00868790|453815605|FG004|Period 2|Withdrawal by Subject|0|||
126144577|NCT00868790|453815606|FG005|Period 2|Withdrawal by Subject|0|||
126144578|NCT00868790|453815607|FG006|Period 2|Withdrawal by Subject|0|||
126144579|NCT00868790|453815608|FG007|Period 2|Withdrawal by Subject|0|||
126144580|NCT00868790|453815609|FG008|Period 2|Withdrawal by Subject|1|||
126144581|NCT00868790|453815610|FG009|Period 2|Withdrawal by Subject|0|||
126144582|NCT00868790|453815611|FG010|Period 2|Withdrawal by Subject|0|||
126144583|NCT00868790|453815612|FG011|Period 2|Withdrawal by Subject|0|||
126144584|NCT00868790|453815613|FG012|Period 2|Withdrawal by Subject|0|||
126144585|NCT00868790|453815614|FG013|Period 2|Withdrawal by Subject|1|||
126144586|NCT00868790|453815601|FG000|Period 3|Adverse Event|0|||
126144587|NCT00868790|453815602|FG001|Period 3|Adverse Event|0|||
126144588|NCT00868790|453815603|FG002|Period 3|Adverse Event|0|||
126144589|NCT00868790|453815604|FG003|Period 3|Adverse Event|0|||
126144590|NCT00868790|453815605|FG004|Period 3|Adverse Event|0|||
126144591|NCT00868790|453815606|FG005|Period 3|Adverse Event|0|||
126144592|NCT00868790|453815607|FG006|Period 3|Adverse Event|0|||
126144593|NCT00868790|453815608|FG007|Period 3|Adverse Event|0|||
126144594|NCT00868790|453815609|FG008|Period 3|Adverse Event|0|||
126144595|NCT00868790|453815610|FG009|Period 3|Adverse Event|1|||
126144596|NCT00868790|453815611|FG010|Period 3|Adverse Event|0|||
126144597|NCT00868790|453815612|FG011|Period 3|Adverse Event|0|||
126144598|NCT00868790|453815613|FG012|Period 3|Adverse Event|0|||
126144599|NCT00868790|453815614|FG013|Period 3|Adverse Event|0|||
126144600|NCT00868790|453815601|FG000|Period 3|Protocol Violation|0|||
126144601|NCT00868790|453815602|FG001|Period 3|Protocol Violation|0|||
126144602|NCT00868790|453815603|FG002|Period 3|Protocol Violation|0|||
126144603|NCT00868790|453815604|FG003|Period 3|Protocol Violation|0|||
126144604|NCT00868790|453815605|FG004|Period 3|Protocol Violation|0|||
126144605|NCT00868790|453815606|FG005|Period 3|Protocol Violation|0|||
126144606|NCT00868790|453815607|FG006|Period 3|Protocol Violation|0|||
126144607|NCT00868790|453815608|FG007|Period 3|Protocol Violation|0|||
126144608|NCT00868790|453815609|FG008|Period 3|Protocol Violation|0|||
126144609|NCT00868790|453815610|FG009|Period 3|Protocol Violation|0|||
126144610|NCT00868790|453815611|FG010|Period 3|Protocol Violation|1|||
126144611|NCT00868790|453815612|FG011|Period 3|Protocol Violation|0|||
126144612|NCT00868790|453815613|FG012|Period 3|Protocol Violation|0|||
126144613|NCT00868790|453815614|FG013|Period 3|Protocol Violation|0|||
126144614|NCT00868790|453815601|FG000|Period 3|Study Terminated by Sponsor|0|||
126144615|NCT00868790|453815602|FG001|Period 3|Study Terminated by Sponsor|0|||
126144616|NCT00868790|453815603|FG002|Period 3|Study Terminated by Sponsor|0|||
126144617|NCT00868790|453815604|FG003|Period 3|Study Terminated by Sponsor|1|||
126144618|NCT00868790|453815605|FG004|Period 3|Study Terminated by Sponsor|0|||
126144619|NCT00868790|453815606|FG005|Period 3|Study Terminated by Sponsor|0|||
126144620|NCT00868790|453815607|FG006|Period 3|Study Terminated by Sponsor|0|||
126144621|NCT00868790|453815608|FG007|Period 3|Study Terminated by Sponsor|0|||
126144622|NCT00868790|453815609|FG008|Period 3|Study Terminated by Sponsor|0|||
126144623|NCT00868790|453815610|FG009|Period 3|Study Terminated by Sponsor|0|||
126144624|NCT00868790|453815611|FG010|Period 3|Study Terminated by Sponsor|0|||
126144625|NCT00868790|453815612|FG011|Period 3|Study Terminated by Sponsor|0|||
126144626|NCT00868790|453815613|FG012|Period 3|Study Terminated by Sponsor|0|||
126144627|NCT00868790|453815614|FG013|Period 3|Study Terminated by Sponsor|0|||
126144628|NCT00868790|453815601|FG000|Period 4|Adverse Event|0|||
126144629|NCT00868790|453815602|FG001|Period 4|Adverse Event|0|||
126144630|NCT00868790|453815603|FG002|Period 4|Adverse Event|0|||
126144631|NCT00868790|453815604|FG003|Period 4|Adverse Event|0|||
126144632|NCT00868790|453815605|FG004|Period 4|Adverse Event|0|||
126144633|NCT00868790|453815606|FG005|Period 4|Adverse Event|0|||
126144634|NCT00868790|453815607|FG006|Period 4|Adverse Event|0|||
126144635|NCT00868790|453815608|FG007|Period 4|Adverse Event|1|||
126144636|NCT00868790|453815609|FG008|Period 4|Adverse Event|0|||
126144637|NCT00868790|453815610|FG009|Period 4|Adverse Event|0|||
126144638|NCT00868790|453815611|FG010|Period 4|Adverse Event|1|||
126144639|NCT00868790|453815612|FG011|Period 4|Adverse Event|0|||
126144640|NCT00868790|453815613|FG012|Period 4|Adverse Event|1|||
126144641|NCT00868790|453815614|FG013|Period 4|Adverse Event|0|||
126144642|NCT00868790|453815601|FG000|Period 4|Lost to Follow-up|0|||
126144643|NCT00868790|453815602|FG001|Period 4|Lost to Follow-up|0|||
126144644|NCT00868790|453815603|FG002|Period 4|Lost to Follow-up|0|||
126144645|NCT00868790|453815604|FG003|Period 4|Lost to Follow-up|0|||
126144646|NCT00868790|453815605|FG004|Period 4|Lost to Follow-up|0|||
126144647|NCT00868790|453815606|FG005|Period 4|Lost to Follow-up|0|||
126144648|NCT00868790|453815607|FG006|Period 4|Lost to Follow-up|0|||
126144649|NCT00868790|453815608|FG007|Period 4|Lost to Follow-up|1|||
126144650|NCT00868790|453815609|FG008|Period 4|Lost to Follow-up|0|||
126144651|NCT00868790|453815610|FG009|Period 4|Lost to Follow-up|0|||
126144652|NCT00868790|453815611|FG010|Period 4|Lost to Follow-up|0|||
126144653|NCT00868790|453815612|FG011|Period 4|Lost to Follow-up|0|||
126144654|NCT00868790|453815613|FG012|Period 4|Lost to Follow-up|0|||
126144655|NCT00868790|453815614|FG013|Period 4|Lost to Follow-up|0|||
126144656|NCT00868790|453815601|FG000|Period 4|Study Terminated by Sponsor|2|||
126144657|NCT00868790|453815602|FG001|Period 4|Study Terminated by Sponsor|0|||
126144658|NCT00868790|453815603|FG002|Period 4|Study Terminated by Sponsor|0|||
126144659|NCT00868790|453815604|FG003|Period 4|Study Terminated by Sponsor|0|||
126144660|NCT00868790|453815605|FG004|Period 4|Study Terminated by Sponsor|0|||
126144661|NCT00868790|453815606|FG005|Period 4|Study Terminated by Sponsor|0|||
126144662|NCT00868790|453815607|FG006|Period 4|Study Terminated by Sponsor|0|||
126144663|NCT00868790|453815608|FG007|Period 4|Study Terminated by Sponsor|1|||
126144664|NCT00868790|453815609|FG008|Period 4|Study Terminated by Sponsor|2|||
126144665|NCT00868790|453815610|FG009|Period 4|Study Terminated by Sponsor|0|||
126144666|NCT00868790|453815611|FG010|Period 4|Study Terminated by Sponsor|2|||
126144667|NCT00868790|453815612|FG011|Period 4|Study Terminated by Sponsor|1|||
126144668|NCT00868790|453815613|FG012|Period 4|Study Terminated by Sponsor|0|||
126144669|NCT00868790|453815614|FG013|Period 4|Study Terminated by Sponsor|1|||
126144670|NCT00868790|453815601|FG000|Period 4|Abnormal ALT/AST|0|||
126144671|NCT00868790|453815602|FG001|Period 4|Abnormal ALT/AST|0|||
126144672|NCT00868790|453815603|FG002|Period 4|Abnormal ALT/AST|1|||
126144673|NCT00868790|453815604|FG003|Period 4|Abnormal ALT/AST|0|||
126144674|NCT00868790|453815605|FG004|Period 4|Abnormal ALT/AST|0|||
126144675|NCT00868790|453815606|FG005|Period 4|Abnormal ALT/AST|0|||
126144676|NCT00868790|453815607|FG006|Period 4|Abnormal ALT/AST|0|||
126144677|NCT00868790|453815608|FG007|Period 4|Abnormal ALT/AST|0|||
126144678|NCT00868790|453815609|FG008|Period 4|Abnormal ALT/AST|0|||
126144679|NCT00868790|453815610|FG009|Period 4|Abnormal ALT/AST|0|||
126144680|NCT00868790|453815611|FG010|Period 4|Abnormal ALT/AST|0|||
126144681|NCT00868790|453815612|FG011|Period 4|Abnormal ALT/AST|0|||
126144682|NCT00868790|453815613|FG012|Period 4|Abnormal ALT/AST|0|||
126144683|NCT00868790|453815614|FG013|Period 4|Abnormal ALT/AST|0|||
126144684|NCT00868790|453815601|FG000|Post-study|Withdrawal by Subject|0|||
126144685|NCT00868790|453815602|FG001|Post-study|Withdrawal by Subject|0|||
126144686|NCT00868790|453815603|FG002|Post-study|Withdrawal by Subject|0|||
126144687|NCT00868790|453815604|FG003|Post-study|Withdrawal by Subject|0|||
126144688|NCT00868790|453815605|FG004|Post-study|Withdrawal by Subject|1|||
126144689|NCT00868790|453815606|FG005|Post-study|Withdrawal by Subject|0|||
126144690|NCT00868790|453815607|FG006|Post-study|Withdrawal by Subject|0|||
126144691|NCT00868790|453815608|FG007|Post-study|Withdrawal by Subject|0|||
126144692|NCT00868790|453815609|FG008|Post-study|Withdrawal by Subject|0|||
126144693|NCT00868790|453815610|FG009|Post-study|Withdrawal by Subject|0|||
126144694|NCT00868790|453815611|FG010|Post-study|Withdrawal by Subject|0|||
126144695|NCT00868790|453815612|FG011|Post-study|Withdrawal by Subject|0|||
126144696|NCT00868790|453815613|FG012|Post-study|Withdrawal by Subject|0|||
126144697|NCT00868790|453815614|FG013|Post-study|Withdrawal by Subject|0|||
126144698|NCT00868790|453815601|FG000|Post-study|Excluded Medication|0|||
126144699|NCT00868790|453815602|FG001|Post-study|Excluded Medication|0|||
126144700|NCT00868790|453815603|FG002|Post-study|Excluded Medication|0|||
126144701|NCT00868790|453815604|FG003|Post-study|Excluded Medication|0|||
126144702|NCT00868790|453815605|FG004|Post-study|Excluded Medication|0|||
125970345|NCT01292603|453182676|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
126144703|NCT00868790|453815606|FG005|Post-study|Excluded Medication|0|||
126144704|NCT00868790|453815607|FG006|Post-study|Excluded Medication|0|||
126144705|NCT00868790|453815608|FG007|Post-study|Excluded Medication|2|||
126144706|NCT00868790|453815609|FG008|Post-study|Excluded Medication|0|||
126144707|NCT00868790|453815610|FG009|Post-study|Excluded Medication|1|||
126144708|NCT00868790|453815611|FG010|Post-study|Excluded Medication|0|||
126144709|NCT00868790|453815612|FG011|Post-study|Excluded Medication|0|||
126144710|NCT00868790|453815613|FG012|Post-study|Excluded Medication|0|||
126144711|NCT00868790|453815614|FG013|Post-study|Excluded Medication|0|||
126144712|NCT03040024|453815615|FG000|Overall Study|Adverse Event|0|||
126144713|NCT03040024|453815616|FG001|Overall Study|Adverse Event|1|||
126144714|NCT03040024|453815617|FG002|Overall Study|Adverse Event|0|||
126144715|NCT03040024|453815615|FG000|Overall Study|Death|0|||
126144716|NCT03040024|453815616|FG001|Overall Study|Death|1|||
126144717|NCT03040024|453815617|FG002|Overall Study|Death|0|||
126144718|NCT03040024|453815615|FG000|Overall Study|Physician Decision|0|||
126144719|NCT03040024|453815616|FG001|Overall Study|Physician Decision|0|||
126144720|NCT03040024|453815617|FG002|Overall Study|Physician Decision|1|||
126144721|NCT01526148|453815618|FG000|Overall Study|Adverse Event|6|||
126144722|NCT01526148|453815619|FG001|Overall Study|Adverse Event|5|||
126144723|NCT01526148|453815618|FG000|Overall Study|Lost to Follow-up|3|||
126144724|NCT01526148|453815619|FG001|Overall Study|Lost to Follow-up|6|||
126144725|NCT01526148|453815618|FG000|Overall Study|Withdrawal by Subject|2|||
126144726|NCT01526148|453815619|FG001|Overall Study|Withdrawal by Subject|0|||
126144727|NCT01526148|453815618|FG000|Overall Study|Unstable Medical Condition|1|||
126144728|NCT01526148|453815619|FG001|Overall Study|Unstable Medical Condition|0|||
126144729|NCT01526148|453815618|FG000|Overall Study|Unable to discontinue concomitant med|1|||
126144730|NCT01526148|453815619|FG001|Overall Study|Unable to discontinue concomitant med|0|||
126144731|NCT01526148|453815618|FG000|Overall Study|Moved out of state|1|||
126144732|NCT01526148|453815619|FG001|Overall Study|Moved out of state|0|||
126144733|NCT01526148|453815618|FG000|Overall Study|Incarcerated|0|||
126144734|NCT01526148|453815619|FG001|Overall Study|Incarcerated|2|||
126144735|NCT01651780|453815620|FG000|Overall Study|Physician decision: No 30-day visit|2|||
126144736|NCT01651780|453815621|FG001|Overall Study|Physician decision: No 30-day visit|1|||
126144737|NCT01651780|453815620|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
126144738|NCT01651780|453815621|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
126144739|NCT01651780|453815620|FG000|Overall Study|Withdrawal by Subject|2|||
126144740|NCT01651780|453815621|FG001|Overall Study|Withdrawal by Subject|0|||
126144741|NCT01651780|453815620|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
126144742|NCT01651780|453815621|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126144743|NCT01651780|453815620|FG000|Overall Study|Lost to Follow-up|1|||
126144744|NCT01651780|453815621|FG001|Overall Study|Lost to Follow-up|2|||
126144745|NCT01651780|453815620|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
126144746|NCT01651780|453815621|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
126144747|NCT02901431|453815626|FG000|PK Part|Adverse Event|0|||
126144748|NCT02901431|453815627|FG001|PK Part|Adverse Event|1|||
126144749|NCT02901431|453815628|FG002|PK Part|Adverse Event|0|||
126144750|NCT02901431|453815629|FG003|PK Part|Adverse Event|0|||
126144751|NCT02901431|453815630|FG004|PK Part|Adverse Event|0|||
126144752|NCT02901431|453815631|FG005|PK Part|Adverse Event|0|||
126144753|NCT02901431|453815632|FG006|PK Part|Adverse Event|0|||
126144754|NCT02901431|453815633|FG007|PK Part|Adverse Event|0|||
126144755|NCT02901431|453815634|FG008|PK Part|Adverse Event|0|||
126144756|NCT02901431|453815635|FG009|PK Part|Adverse Event|0|||
126144757|NCT02901431|453815636|FG010|PK Part|Adverse Event|0|||
126144758|NCT02901431|453815637|FG011|PK Part|Adverse Event|0|||
126144759|NCT02901431|453815638|FG012|PK Part|Adverse Event|0|||
126144760|NCT02901431|453815626|FG000|PK Part|Lost to Follow-up|0|||
126144761|NCT02901431|453815627|FG001|PK Part|Lost to Follow-up|0|||
126144762|NCT02901431|453815628|FG002|PK Part|Lost to Follow-up|1|||
126144763|NCT02901431|453815629|FG003|PK Part|Lost to Follow-up|0|||
126144764|NCT02901431|453815630|FG004|PK Part|Lost to Follow-up|0|||
126144765|NCT02901431|453815631|FG005|PK Part|Lost to Follow-up|0|||
126144766|NCT02901431|453815632|FG006|PK Part|Lost to Follow-up|0|||
126144767|NCT02901431|453815633|FG007|PK Part|Lost to Follow-up|0|||
126144768|NCT02901431|453815634|FG008|PK Part|Lost to Follow-up|0|||
126144769|NCT02901431|453815635|FG009|PK Part|Lost to Follow-up|0|||
126144770|NCT02901431|453815636|FG010|PK Part|Lost to Follow-up|0|||
126144771|NCT02901431|453815637|FG011|PK Part|Lost to Follow-up|0|||
126144772|NCT02901431|453815638|FG012|PK Part|Lost to Follow-up|0|||
126144773|NCT02901431|453815626|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
126144774|NCT02901431|453815627|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144775|NCT02901431|453815628|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144776|NCT02901431|453815629|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144777|NCT02901431|453815630|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144778|NCT02901431|453815631|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144779|NCT02901431|453815632|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144780|NCT02901431|453815633|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144781|NCT02901431|453815634|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144782|NCT02901431|453815635|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144783|NCT02901431|453815636|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144784|NCT02901431|453815637|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144785|NCT02901431|453815638|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126144786|NCT02901431|453815626|FG000|PK Part|Pending dose confirmation|0|||
126144787|NCT02901431|453815627|FG001|PK Part|Pending dose confirmation|1|||
126144788|NCT02901431|453815628|FG002|PK Part|Pending dose confirmation|0|||
126144789|NCT02901431|453815629|FG003|PK Part|Pending dose confirmation|0|||
126144790|NCT02901431|453815630|FG004|PK Part|Pending dose confirmation|0|||
126144791|NCT02901431|453815631|FG005|PK Part|Pending dose confirmation|0|||
126144792|NCT02901431|453815632|FG006|PK Part|Pending dose confirmation|0|||
126144793|NCT02901431|453815633|FG007|PK Part|Pending dose confirmation|0|||
126144794|NCT02901431|453815634|FG008|PK Part|Pending dose confirmation|0|||
126144795|NCT02901431|453815635|FG009|PK Part|Pending dose confirmation|0|||
126144796|NCT02901431|453815636|FG010|PK Part|Pending dose confirmation|0|||
126144797|NCT02901431|453815637|FG011|PK Part|Pending dose confirmation|0|||
126144798|NCT02901431|453815638|FG012|PK Part|Pending dose confirmation|0|||
126144799|NCT02901431|453815626|FG000|PK Part|8 weeks of treatment ran out|2|||
126144800|NCT02901431|453815627|FG001|PK Part|8 weeks of treatment ran out|0|||
126144801|NCT02901431|453815628|FG002|PK Part|8 weeks of treatment ran out|0|||
126144802|NCT02901431|453815629|FG003|PK Part|8 weeks of treatment ran out|0|||
126144803|NCT02901431|453815630|FG004|PK Part|8 weeks of treatment ran out|0|||
126144804|NCT02901431|453815631|FG005|PK Part|8 weeks of treatment ran out|0|||
126144805|NCT02901431|453815632|FG006|PK Part|8 weeks of treatment ran out|0|||
126144806|NCT02901431|453815633|FG007|PK Part|8 weeks of treatment ran out|0|||
126144807|NCT02901431|453815634|FG008|PK Part|8 weeks of treatment ran out|0|||
126144808|NCT02901431|453815635|FG009|PK Part|8 weeks of treatment ran out|0|||
126144809|NCT02901431|453815636|FG010|PK Part|8 weeks of treatment ran out|0|||
126144810|NCT02901431|453815637|FG011|PK Part|8 weeks of treatment ran out|0|||
126144811|NCT02901431|453815638|FG012|PK Part|8 weeks of treatment ran out|0|||
126144812|NCT02901431|453815626|FG000|PK Part|Stopped treatment after 8 weeks|1|||
126144813|NCT02901431|453815627|FG001|PK Part|Stopped treatment after 8 weeks|0|||
126144814|NCT02901431|453815628|FG002|PK Part|Stopped treatment after 8 weeks|1|||
126144815|NCT02901431|453815629|FG003|PK Part|Stopped treatment after 8 weeks|0|||
126144816|NCT02901431|453815630|FG004|PK Part|Stopped treatment after 8 weeks|0|||
126144817|NCT02901431|453815631|FG005|PK Part|Stopped treatment after 8 weeks|0|||
126144818|NCT02901431|453815632|FG006|PK Part|Stopped treatment after 8 weeks|0|||
126144819|NCT02901431|453815633|FG007|PK Part|Stopped treatment after 8 weeks|0|||
126144820|NCT02901431|453815634|FG008|PK Part|Stopped treatment after 8 weeks|0|||
126144821|NCT02901431|453815635|FG009|PK Part|Stopped treatment after 8 weeks|0|||
126144822|NCT02901431|453815636|FG010|PK Part|Stopped treatment after 8 weeks|0|||
126144823|NCT02901431|453815637|FG011|PK Part|Stopped treatment after 8 weeks|0|||
126144824|NCT02901431|453815638|FG012|PK Part|Stopped treatment after 8 weeks|0|||
126144825|NCT02901431|453815626|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
126144826|NCT02901431|453815627|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144827|NCT02901431|453815628|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
126144828|NCT02901431|453815629|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144829|NCT02901431|453815630|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144830|NCT02901431|453815631|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144831|NCT02901431|453815632|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144832|NCT02901431|453815633|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144833|NCT02901431|453815634|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144834|NCT02901431|453815635|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144835|NCT02901431|453815636|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144836|NCT02901431|453815637|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144837|NCT02901431|453815638|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126144838|NCT02901431|453815626|FG000|PK Part|Discontinued per Sponsor|0|||
126144839|NCT02901431|453815627|FG001|PK Part|Discontinued per Sponsor|3|||
126144840|NCT02901431|453815628|FG002|PK Part|Discontinued per Sponsor|0|||
126144841|NCT02901431|453815629|FG003|PK Part|Discontinued per Sponsor|0|||
126144842|NCT02901431|453815630|FG004|PK Part|Discontinued per Sponsor|0|||
126144843|NCT02901431|453815631|FG005|PK Part|Discontinued per Sponsor|0|||
126144844|NCT02901431|453815632|FG006|PK Part|Discontinued per Sponsor|0|||
126144845|NCT02901431|453815633|FG007|PK Part|Discontinued per Sponsor|0|||
126144846|NCT02901431|453815634|FG008|PK Part|Discontinued per Sponsor|0|||
126144847|NCT02901431|453815635|FG009|PK Part|Discontinued per Sponsor|0|||
126144848|NCT02901431|453815636|FG010|PK Part|Discontinued per Sponsor|0|||
126144849|NCT02901431|453815637|FG011|PK Part|Discontinued per Sponsor|0|||
126144850|NCT02901431|453815638|FG012|PK Part|Discontinued per Sponsor|0|||
126144851|NCT02901431|453815626|FG000|PK Part|Withdrawal by Subject|1|||
126144852|NCT02901431|453815627|FG001|PK Part|Withdrawal by Subject|1|||
126144853|NCT02901431|453815628|FG002|PK Part|Withdrawal by Subject|3|||
126144854|NCT02901431|453815629|FG003|PK Part|Withdrawal by Subject|0|||
126144855|NCT02901431|453815630|FG004|PK Part|Withdrawal by Subject|0|||
126144856|NCT02901431|453815631|FG005|PK Part|Withdrawal by Subject|0|||
126144857|NCT02901431|453815632|FG006|PK Part|Withdrawal by Subject|0|||
126144858|NCT02901431|453815633|FG007|PK Part|Withdrawal by Subject|0|||
126144859|NCT02901431|453815634|FG008|PK Part|Withdrawal by Subject|0|||
126144860|NCT02901431|453815635|FG009|PK Part|Withdrawal by Subject|0|||
126144861|NCT02901431|453815636|FG010|PK Part|Withdrawal by Subject|0|||
126144862|NCT02901431|453815637|FG011|PK Part|Withdrawal by Subject|0|||
126144863|NCT02901431|453815638|FG012|PK Part|Withdrawal by Subject|0|||
126144864|NCT02901431|453815626|FG000|Main Treatment Part|Adverse Event|0|||
126144865|NCT02901431|453815627|FG001|Main Treatment Part|Adverse Event|0|||
126144866|NCT02901431|453815628|FG002|Main Treatment Part|Adverse Event|0|||
126144867|NCT02901431|453815629|FG003|Main Treatment Part|Adverse Event|3|||
126144868|NCT02901431|453815630|FG004|Main Treatment Part|Adverse Event|3|||
126144869|NCT02901431|453815631|FG005|Main Treatment Part|Adverse Event|4|||
126144870|NCT02901431|453815632|FG006|Main Treatment Part|Adverse Event|1|||
126144871|NCT02901431|453815633|FG007|Main Treatment Part|Adverse Event|0|||
126144872|NCT02901431|453815634|FG008|Main Treatment Part|Adverse Event|0|||
126144873|NCT02901431|453815635|FG009|Main Treatment Part|Adverse Event|0|||
126144874|NCT02901431|453815636|FG010|Main Treatment Part|Adverse Event|0|||
126144875|NCT02901431|453815637|FG011|Main Treatment Part|Adverse Event|0|||
126144876|NCT02901431|453815638|FG012|Main Treatment Part|Adverse Event|0|||
126144877|NCT02901431|453815626|FG000|Main Treatment Part|Lack of Efficacy|0|||
126144878|NCT02901431|453815627|FG001|Main Treatment Part|Lack of Efficacy|0|||
126144879|NCT02901431|453815628|FG002|Main Treatment Part|Lack of Efficacy|0|||
126144880|NCT02901431|453815629|FG003|Main Treatment Part|Lack of Efficacy|1|||
126144881|NCT02901431|453815630|FG004|Main Treatment Part|Lack of Efficacy|0|||
126144882|NCT02901431|453815631|FG005|Main Treatment Part|Lack of Efficacy|0|||
126144883|NCT02901431|453815632|FG006|Main Treatment Part|Lack of Efficacy|0|||
126144884|NCT02901431|453815633|FG007|Main Treatment Part|Lack of Efficacy|0|||
126144885|NCT02901431|453815634|FG008|Main Treatment Part|Lack of Efficacy|0|||
126144886|NCT02901431|453815635|FG009|Main Treatment Part|Lack of Efficacy|0|||
126144887|NCT02901431|453815636|FG010|Main Treatment Part|Lack of Efficacy|0|||
126144888|NCT02901431|453815637|FG011|Main Treatment Part|Lack of Efficacy|0|||
126144889|NCT02901431|453815638|FG012|Main Treatment Part|Lack of Efficacy|0|||
126144890|NCT02901431|453815626|FG000|Main Treatment Part|Lost to Follow-up|0|||
126144891|NCT02901431|453815627|FG001|Main Treatment Part|Lost to Follow-up|0|||
126144892|NCT02901431|453815628|FG002|Main Treatment Part|Lost to Follow-up|0|||
126144893|NCT02901431|453815629|FG003|Main Treatment Part|Lost to Follow-up|3|||
126144894|NCT02901431|453815630|FG004|Main Treatment Part|Lost to Follow-up|1|||
126144895|NCT02901431|453815631|FG005|Main Treatment Part|Lost to Follow-up|2|||
126144896|NCT02901431|453815632|FG006|Main Treatment Part|Lost to Follow-up|3|||
126144897|NCT02901431|453815633|FG007|Main Treatment Part|Lost to Follow-up|0|||
126144898|NCT02901431|453815634|FG008|Main Treatment Part|Lost to Follow-up|0|||
126144899|NCT02901431|453815635|FG009|Main Treatment Part|Lost to Follow-up|0|||
126144900|NCT02901431|453815636|FG010|Main Treatment Part|Lost to Follow-up|0|||
126144901|NCT02901431|453815637|FG011|Main Treatment Part|Lost to Follow-up|0|||
126144902|NCT02901431|453815638|FG012|Main Treatment Part|Lost to Follow-up|0|||
126144903|NCT02901431|453815626|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
126144904|NCT02901431|453815627|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
126144905|NCT02901431|453815628|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
126144906|NCT02901431|453815629|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
126144907|NCT02901431|453815630|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
126144908|NCT02901431|453815631|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
126144909|NCT02901431|453815632|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
126144910|NCT02901431|453815633|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
126144911|NCT02901431|453815634|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
126144912|NCT02901431|453815635|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
126144913|NCT02901431|453815636|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
126144914|NCT02901431|453815637|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
126144915|NCT02901431|453815638|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
126144916|NCT02901431|453815626|FG000|Main Treatment Part|Physician Decision|0|||
126144917|NCT02901431|453815627|FG001|Main Treatment Part|Physician Decision|0|||
126144918|NCT02901431|453815628|FG002|Main Treatment Part|Physician Decision|0|||
126144919|NCT02901431|453815629|FG003|Main Treatment Part|Physician Decision|1|||
126144920|NCT02901431|453815630|FG004|Main Treatment Part|Physician Decision|0|||
126144921|NCT02901431|453815631|FG005|Main Treatment Part|Physician Decision|0|||
126144922|NCT02901431|453815632|FG006|Main Treatment Part|Physician Decision|1|||
126144923|NCT02901431|453815633|FG007|Main Treatment Part|Physician Decision|0|||
126144924|NCT02901431|453815634|FG008|Main Treatment Part|Physician Decision|0|||
126144925|NCT02901431|453815635|FG009|Main Treatment Part|Physician Decision|0|||
126144926|NCT02901431|453815636|FG010|Main Treatment Part|Physician Decision|0|||
126144927|NCT02901431|453815637|FG011|Main Treatment Part|Physician Decision|0|||
126144928|NCT02901431|453815638|FG012|Main Treatment Part|Physician Decision|0|||
126144929|NCT02901431|453815626|FG000|Main Treatment Part|Withdrawal by Subject|0|||
126144930|NCT02901431|453815627|FG001|Main Treatment Part|Withdrawal by Subject|0|||
126144931|NCT02901431|453815628|FG002|Main Treatment Part|Withdrawal by Subject|0|||
126144932|NCT02901431|453815629|FG003|Main Treatment Part|Withdrawal by Subject|18|||
126144933|NCT02901431|453815630|FG004|Main Treatment Part|Withdrawal by Subject|3|||
126144934|NCT02901431|453815631|FG005|Main Treatment Part|Withdrawal by Subject|5|||
126144935|NCT02901431|453815632|FG006|Main Treatment Part|Withdrawal by Subject|6|||
126144936|NCT02901431|453815633|FG007|Main Treatment Part|Withdrawal by Subject|0|||
126144937|NCT02901431|453815634|FG008|Main Treatment Part|Withdrawal by Subject|0|||
126144938|NCT02901431|453815635|FG009|Main Treatment Part|Withdrawal by Subject|0|||
126144939|NCT02901431|453815636|FG010|Main Treatment Part|Withdrawal by Subject|0|||
126144940|NCT02901431|453815637|FG011|Main Treatment Part|Withdrawal by Subject|0|||
126144941|NCT02901431|453815638|FG012|Main Treatment Part|Withdrawal by Subject|0|||
126144942|NCT02901431|453815626|FG000|Open Label Part|Adverse Event|0|||
126144943|NCT02901431|453815627|FG001|Open Label Part|Adverse Event|0|||
126144944|NCT02901431|453815628|FG002|Open Label Part|Adverse Event|0|||
126144945|NCT02901431|453815629|FG003|Open Label Part|Adverse Event|0|||
126144946|NCT02901431|453815630|FG004|Open Label Part|Adverse Event|0|||
126144947|NCT02901431|453815631|FG005|Open Label Part|Adverse Event|0|||
126144948|NCT02901431|453815632|FG006|Open Label Part|Adverse Event|0|||
126144949|NCT02901431|453815633|FG007|Open Label Part|Adverse Event|0|||
126144950|NCT02901431|453815634|FG008|Open Label Part|Adverse Event|4|||
126144951|NCT02901431|453815635|FG009|Open Label Part|Adverse Event|4|||
126144952|NCT02901431|453815636|FG010|Open Label Part|Adverse Event|0|||
125970346|NCT01292603|453182671|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
125970347|NCT01292603|453182672|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
125970348|NCT01292603|453182673|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
125970349|NCT01292603|453182674|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
125970350|NCT01292603|453182675|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
125970351|NCT01292603|453182676|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
125970352|NCT01292603|453182671|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
125970353|NCT01292603|453182672|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
125970354|NCT01292603|453182673|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
125970355|NCT01292603|453182674|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
125970356|NCT01292603|453182675|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
125970357|NCT01292603|453182676|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
125970358|NCT01292603|453182671|FG000|Overall Survival Status|Death|3|||
125970359|NCT01292603|453182672|FG001|Overall Survival Status|Death|1|||
125970360|NCT01292603|453182673|FG002|Overall Survival Status|Death|3|||
125970361|NCT01292603|453182674|FG003|Overall Survival Status|Death|1|||
125970362|NCT01292603|453182675|FG004|Overall Survival Status|Death|16|||
125970363|NCT01292603|453182676|FG005|Overall Survival Status|Death|10|||
125970364|NCT01432366|453182679|FG000|Overall Study|Non-Responder|7|||
125970365|NCT01432366|453182679|FG000|Overall Study|Adverse Event|8|||
125970366|NCT01432366|453182679|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
125970367|NCT01432366|453182679|FG000|Overall Study|Pregnancy|1|||
125970368|NCT01432366|453182679|FG000|Overall Study|Lost to Follow-up|13|||
125970369|NCT01432366|453182679|FG000|Overall Study|Lack of Efficacy|1|||
125970370|NCT01432366|453182679|FG000|Overall Study|Site Closed|20|||
125970371|NCT01432366|453182679|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
125970372|NCT01432366|453182679|FG000|Overall Study|Other|14|||
125970373|NCT01808690|453182680|FG000|Overall Study|Withdrawal by Subject|1|||
125970374|NCT01808690|453182681|FG001|Overall Study|Withdrawal by Subject|2|||
125970375|NCT03870763|453182682|FG000|Overall Study|Study terminated by sponsor|0|||
125970376|NCT03870763|453182683|FG001|Overall Study|Study terminated by sponsor|2|||
125970377|NCT03870763|453182684|FG002|Overall Study|Study terminated by sponsor|0|||
125970378|NCT03870763|453182682|FG000|Overall Study|Withdrawal by Subject|0|||
125970379|NCT03870763|453182683|FG001|Overall Study|Withdrawal by Subject|1|||
125970380|NCT03870763|453182684|FG002|Overall Study|Withdrawal by Subject|0|||
125970381|NCT03870763|453182682|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
125970382|NCT03870763|453182683|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
125970383|NCT03870763|453182684|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
125970384|NCT02891187|453182685|FG000|Overall Study|Lost to Follow-up|1|||
126144953|NCT02901431|453815637|FG011|Open Label Part|Adverse Event|4|||
126144954|NCT02901431|453815638|FG012|Open Label Part|Adverse Event|1|||
126144955|NCT02901431|453815626|FG000|Open Label Part|Lost to Follow-up|0|||
126144956|NCT02901431|453815627|FG001|Open Label Part|Lost to Follow-up|0|||
126144957|NCT02901431|453815628|FG002|Open Label Part|Lost to Follow-up|0|||
126144958|NCT02901431|453815629|FG003|Open Label Part|Lost to Follow-up|0|||
126144959|NCT02901431|453815630|FG004|Open Label Part|Lost to Follow-up|0|||
126144960|NCT02901431|453815631|FG005|Open Label Part|Lost to Follow-up|0|||
126144961|NCT02901431|453815632|FG006|Open Label Part|Lost to Follow-up|0|||
126144962|NCT02901431|453815633|FG007|Open Label Part|Lost to Follow-up|0|||
126144963|NCT02901431|453815634|FG008|Open Label Part|Lost to Follow-up|2|||
126144964|NCT02901431|453815635|FG009|Open Label Part|Lost to Follow-up|2|||
126144965|NCT02901431|453815636|FG010|Open Label Part|Lost to Follow-up|1|||
126144966|NCT02901431|453815637|FG011|Open Label Part|Lost to Follow-up|1|||
126144967|NCT02901431|453815638|FG012|Open Label Part|Lost to Follow-up|1|||
126144968|NCT02901431|453815626|FG000|Open Label Part|Physician Decision|0|||
126144969|NCT02901431|453815627|FG001|Open Label Part|Physician Decision|0|||
126144970|NCT02901431|453815628|FG002|Open Label Part|Physician Decision|0|||
126144971|NCT02901431|453815629|FG003|Open Label Part|Physician Decision|0|||
126144972|NCT02901431|453815630|FG004|Open Label Part|Physician Decision|0|||
126144973|NCT02901431|453815631|FG005|Open Label Part|Physician Decision|0|||
126144974|NCT02901431|453815632|FG006|Open Label Part|Physician Decision|0|||
126144975|NCT02901431|453815633|FG007|Open Label Part|Physician Decision|0|||
126144976|NCT02901431|453815634|FG008|Open Label Part|Physician Decision|1|||
125970385|NCT02891187|453182686|FG001|Overall Study|Lost to Follow-up|2|||
125970386|NCT03586648|453182691|FG000|Period 1|Withdrawal by Subject|0|||
125970387|NCT03586648|453182692|FG001|Period 1|Withdrawal by Subject|1|||
125970388|NCT03586648|453182691|FG000|Period 1|Lost to Follow-up|1|||
125970389|NCT03586648|453182692|FG001|Period 1|Lost to Follow-up|1|||
126144977|NCT02901431|453815635|FG009|Open Label Part|Physician Decision|1|||
125970390|NCT03586648|453182691|FG000|Period 1|Adverse Event|1|||
125970391|NCT03586648|453182692|FG001|Period 1|Adverse Event|0|||
126144978|NCT02901431|453815636|FG010|Open Label Part|Physician Decision|0|||
126144979|NCT02901431|453815637|FG011|Open Label Part|Physician Decision|0|||
126144980|NCT02901431|453815638|FG012|Open Label Part|Physician Decision|0|||
126144981|NCT02901431|453815626|FG000|Open Label Part|Study Terminated By Sponsor|0|||
126144982|NCT02901431|453815627|FG001|Open Label Part|Study Terminated By Sponsor|0|||
126144983|NCT02901431|453815628|FG002|Open Label Part|Study Terminated By Sponsor|0|||
126144984|NCT02901431|453815629|FG003|Open Label Part|Study Terminated By Sponsor|0|||
126144985|NCT02901431|453815630|FG004|Open Label Part|Study Terminated By Sponsor|0|||
125970392|NCT03586648|453182691|FG000|Period 1|Study related symptoms or complaints|2|||
125970393|NCT03586648|453182692|FG001|Period 1|Study related symptoms or complaints|1|||
125970394|NCT03586648|453182691|FG000|Period 1|Physician Decision|0|||
125970395|NCT03586648|453182692|FG001|Period 1|Physician Decision|1|||
125970396|NCT03586648|453182691|FG000|Period 2|Adverse Event|1|||
125970397|NCT03586648|453182692|FG001|Period 2|Adverse Event|0|||
125970398|NCT02041195|453182693|FG000|Overall Study|Adverse Event|1|||
125970399|NCT02041195|453182694|FG001|Overall Study|Adverse Event|2|||
125970400|NCT02041195|453182695|FG002|Overall Study|Adverse Event|0|||
125970401|NCT02041195|453182696|FG003|Overall Study|Adverse Event|0|||
125970402|NCT02041195|453182697|FG004|Overall Study|Adverse Event|0|||
125970403|NCT02041195|453182698|FG005|Overall Study|Adverse Event|0|||
125970404|NCT02041195|453182699|FG006|Overall Study|Adverse Event|3|||
125970405|NCT02041195|453182700|FG007|Overall Study|Adverse Event|0|||
125970406|NCT02041195|453182693|FG000|Overall Study|Withdrawal by Subject|1|||
125970407|NCT02041195|453182694|FG001|Overall Study|Withdrawal by Subject|0|||
125970408|NCT02041195|453182695|FG002|Overall Study|Withdrawal by Subject|0|||
125970409|NCT02041195|453182696|FG003|Overall Study|Withdrawal by Subject|0|||
125970410|NCT02041195|453182697|FG004|Overall Study|Withdrawal by Subject|0|||
125970411|NCT02041195|453182698|FG005|Overall Study|Withdrawal by Subject|0|||
125970412|NCT02041195|453182699|FG006|Overall Study|Withdrawal by Subject|4|||
125970413|NCT02041195|453182700|FG007|Overall Study|Withdrawal by Subject|3|||
125970414|NCT02041195|453182693|FG000|Overall Study|Unable to comply with study visits|0|||
125970415|NCT02041195|453182694|FG001|Overall Study|Unable to comply with study visits|1|||
125970416|NCT02041195|453182695|FG002|Overall Study|Unable to comply with study visits|0|||
125970417|NCT02041195|453182696|FG003|Overall Study|Unable to comply with study visits|0|||
125970418|NCT02041195|453182697|FG004|Overall Study|Unable to comply with study visits|1|||
125970419|NCT02041195|453182698|FG005|Overall Study|Unable to comply with study visits|0|||
125970420|NCT02041195|453182699|FG006|Overall Study|Unable to comply with study visits|0|||
125970421|NCT02041195|453182700|FG007|Overall Study|Unable to comply with study visits|0|||
125970422|NCT02395120|453182701|FG000|Overall Study|Missed follow-up dental exam|57|||
125970423|NCT02395120|453182702|FG001|Overall Study|Missed follow-up dental exam|62|||
125970424|NCT02395120|453182703|FG002|Overall Study|Missed follow-up dental exam|6|||
125970425|NCT02395120|453182704|FG003|Overall Study|Missed follow-up dental exam|6|||
125970426|NCT02395120|453182705|FG004|Overall Study|Missed follow-up dental exam|51|||
125970427|NCT00674986|453182707|FG000|Overall Study|Adverse Event|2|||
125970428|NCT00674986|453182708|FG001|Overall Study|Adverse Event|1|||
125970429|NCT00674986|453182707|FG000|Overall Study|Subject withdrew consent|12|||
125970430|NCT00674986|453182708|FG001|Overall Study|Subject withdrew consent|19|||
125970431|NCT00674986|453182707|FG000|Overall Study|Lost to Follow-up|25|||
125970432|NCT00674986|453182708|FG001|Overall Study|Lost to Follow-up|53|||
125970433|NCT00674986|453182707|FG000|Overall Study|Other reasons|4|||
125970434|NCT00674986|453182708|FG001|Overall Study|Other reasons|8|||
125970435|NCT02526693|453182712|FG000|Overall Study|Physician Decision|3|||
125970436|NCT02526693|453182713|FG001|Overall Study|Physician Decision|1|||
125970437|NCT01275625|453182714|FG000|Overall Study|Death|1|||
125970438|NCT01275625|453182714|FG000|Overall Study|Lack of Efficacy|2|||
125970439|NCT01275625|453182714|FG000|Overall Study|Lost to Follow-up|1|||
125970440|NCT01275625|453182714|FG000|Overall Study|Withdrawal by Subject|3|||
125970441|NCT01275625|453182714|FG000|Overall Study|Protocol Violation|1|||
125970442|NCT01275625|453182714|FG000|Overall Study|Adverse Event|4|||
125970443|NCT01275625|453182714|FG000|Overall Study|Other|1|||
125970444|NCT01585103|453182716|FG000|Overall Study|Unable to swallow Cytosponge|6|||
125970445|NCT01349569|453182718|FG000|Overall Study|Lack of Efficacy|4|||
125970446|NCT03581305|453182719|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
126144986|NCT02901431|453815631|FG005|Open Label Part|Study Terminated By Sponsor|0|||
126144987|NCT02901431|453815632|FG006|Open Label Part|Study Terminated By Sponsor|0|||
126144988|NCT02901431|453815633|FG007|Open Label Part|Study Terminated By Sponsor|0|||
126144989|NCT02901431|453815634|FG008|Open Label Part|Study Terminated By Sponsor|35|||
125970447|NCT03581305|453182720|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
125970448|NCT03581305|453182719|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
125970449|NCT03581305|453182720|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
125970450|NCT03581305|453182719|FG000|Serotonergic Study|Withdrawal by Subject|5|||
125970451|NCT03581305|453182720|FG001|Serotonergic Study|Withdrawal by Subject|1|||
125970452|NCT01798927|453182723|FG000|Overall Study|Withdrawal by Subject|1|||
125970453|NCT03750552|453182724|FG000|Overall Study|Adverse Event|5|||
125970454|NCT03750552|453182725|FG001|Overall Study|Adverse Event|1|||
126144990|NCT02901431|453815635|FG009|Open Label Part|Study Terminated By Sponsor|12|||
126144991|NCT02901431|453815636|FG010|Open Label Part|Study Terminated By Sponsor|21|||
125970455|NCT03750552|453182724|FG000|Overall Study|Withdrawal by Subject|1|||
125970456|NCT03750552|453182725|FG001|Overall Study|Withdrawal by Subject|1|||
125970457|NCT03750552|453182724|FG000|Overall Study|Other|2|||
125970458|NCT03750552|453182725|FG001|Overall Study|Other|0|||
125970459|NCT00626522|453182728|FG000|Overall Study|Protocol Violation|0|||
125970460|NCT00626522|453182729|FG001|Overall Study|Protocol Violation|0|||
125970461|NCT00626522|453182730|FG002|Overall Study|Protocol Violation|0|||
125970462|NCT00626522|453182731|FG003|Overall Study|Protocol Violation|0|||
125970463|NCT00626522|453182732|FG004|Overall Study|Protocol Violation|1|||
125970464|NCT00626522|453182733|FG005|Overall Study|Protocol Violation|0|||
125970465|NCT00626522|453182728|FG000|Overall Study|Adverse Event|2|||
125970466|NCT00626522|453182729|FG001|Overall Study|Adverse Event|1|||
125970467|NCT00626522|453182730|FG002|Overall Study|Adverse Event|2|||
125970468|NCT00626522|453182731|FG003|Overall Study|Adverse Event|0|||
125970469|NCT00626522|453182732|FG004|Overall Study|Adverse Event|1|||
125970470|NCT00626522|453182733|FG005|Overall Study|Adverse Event|1|||
125970471|NCT00626522|453182728|FG000|Overall Study|Withdrawal by Subject|2|||
126144992|NCT02901431|453815637|FG011|Open Label Part|Study Terminated By Sponsor|31|||
126144993|NCT02901431|453815638|FG012|Open Label Part|Study Terminated By Sponsor|0|||
126144994|NCT02901431|453815626|FG000|Open Label Part|Withdrawal by Subject|0|||
126144995|NCT02901431|453815627|FG001|Open Label Part|Withdrawal by Subject|0|||
126144996|NCT02901431|453815628|FG002|Open Label Part|Withdrawal by Subject|0|||
126144997|NCT02901431|453815629|FG003|Open Label Part|Withdrawal by Subject|0|||
126144998|NCT02901431|453815630|FG004|Open Label Part|Withdrawal by Subject|0|||
126144999|NCT02901431|453815631|FG005|Open Label Part|Withdrawal by Subject|0|||
126145000|NCT02901431|453815632|FG006|Open Label Part|Withdrawal by Subject|0|||
126145001|NCT02901431|453815633|FG007|Open Label Part|Withdrawal by Subject|0|||
126145002|NCT02901431|453815634|FG008|Open Label Part|Withdrawal by Subject|6|||
126145003|NCT02901431|453815635|FG009|Open Label Part|Withdrawal by Subject|5|||
126145004|NCT02901431|453815636|FG010|Open Label Part|Withdrawal by Subject|7|||
126145005|NCT02901431|453815637|FG011|Open Label Part|Withdrawal by Subject|3|||
126145006|NCT02901431|453815638|FG012|Open Label Part|Withdrawal by Subject|1|||
126145007|NCT04223609|453815641|FG000|Overall Study|Adverse Event|0|||
126145008|NCT04223609|453815642|FG001|Overall Study|Adverse Event|1|||
126145009|NCT04223609|453815641|FG000|Overall Study|Missed last visit|0|||
126145010|NCT04223609|453815642|FG001|Overall Study|Missed last visit|1|||
126145011|NCT03440944|453815645|FG000|Overall Study|Physician Decision|1|||
126145012|NCT03440944|453815646|FG001|Overall Study|Physician Decision|0|||
126145013|NCT03440944|453815645|FG000|Overall Study|No Acceptable Vasculature|0|||
126145014|NCT03440944|453815646|FG001|Overall Study|No Acceptable Vasculature|1|||
126145015|NCT04672083|453815647|FG000|Overall Study|Lost to Follow-up|1|||
126145016|NCT04672083|453815648|FG001|Overall Study|Lost to Follow-up|0|||
126145017|NCT04672083|453815649|FG002|Overall Study|Lost to Follow-up|0|||
126145018|NCT04672083|453815650|FG003|Overall Study|Lost to Follow-up|0|||
126145019|NCT04672083|453815651|FG004|Overall Study|Lost to Follow-up|0|||
126145020|NCT01661790|453815652|FG000|Overall Study|Lost to Follow-up|0|||
126145021|NCT01661790|453815653|FG001|Overall Study|Lost to Follow-up|2|||
126145022|NCT02048904|453815658|FG000|Overall Study|Withdrawal by Subject|7|||
126145023|NCT02048904|453815658|FG000|Overall Study|Physician Decision|70|||
126145024|NCT00784758|453815666|FG000|Overall Study|Withdrawal by Subject|3|||
126145025|NCT00784758|453815667|FG001|Overall Study|Withdrawal by Subject|0|||
126145026|NCT00784758|453815666|FG000|Overall Study|Adverse Event|1|||
126145027|NCT00784758|453815667|FG001|Overall Study|Adverse Event|0|||
126145028|NCT04439123|453815671|FG000|Overall Study|Adverse Event|11|||
126145029|NCT04439123|453815671|FG000|Overall Study|Death|1|||
126145030|NCT04439123|453815671|FG000|Overall Study|Disease progression|19|||
126145031|NCT04439123|453815671|FG000|Overall Study|Withdrawal by Subject|2|||
126145032|NCT04439123|453815671|FG000|Overall Study|Still on treatment|2|||
126145033|NCT02875223|453815672|FG000|Overall Study|Other reasons|0|||
126145034|NCT02875223|453815673|FG001|Overall Study|Other reasons|0|||
126145035|NCT02875223|453815674|FG002|Overall Study|Other reasons|1|||
126145036|NCT02875223|453815675|FG003|Overall Study|Other reasons|0|||
126145037|NCT02875223|453815676|FG004|Overall Study|Other reasons|1|||
126145038|NCT02875223|453815677|FG005|Overall Study|Other reasons|2|||
125970472|NCT00626522|453182729|FG001|Overall Study|Withdrawal by Subject|5|||
126145039|NCT02875223|453815678|FG006|Overall Study|Other reasons|0|||
126145040|NCT02875223|453815679|FG007|Overall Study|Other reasons|2|||
126145041|NCT02875223|453815680|FG008|Overall Study|Other reasons|0|||
126145042|NCT02875223|453815681|FG009|Overall Study|Other reasons|0|||
125970473|NCT00626522|453182730|FG002|Overall Study|Withdrawal by Subject|5|||
125970474|NCT00626522|453182731|FG003|Overall Study|Withdrawal by Subject|0|||
125970475|NCT00626522|453182732|FG004|Overall Study|Withdrawal by Subject|4|||
126145043|NCT02875223|453815682|FG010|Overall Study|Other reasons|0|||
126145044|NCT02875223|453815683|FG011|Overall Study|Other reasons|0|||
126145045|NCT02875223|453815684|FG012|Overall Study|Other reasons|0|||
126145046|NCT02875223|453815672|FG000|Overall Study|Withdrawal by Subject|0|||
125970476|NCT00626522|453182733|FG005|Overall Study|Withdrawal by Subject|1|||
125970477|NCT00626522|453182728|FG000|Overall Study|COPD exacerbation|0|||
126145047|NCT02875223|453815673|FG001|Overall Study|Withdrawal by Subject|0|||
126145048|NCT02875223|453815674|FG002|Overall Study|Withdrawal by Subject|0|||
125970478|NCT00626522|453182729|FG001|Overall Study|COPD exacerbation|0|||
126145049|NCT02875223|453815675|FG003|Overall Study|Withdrawal by Subject|0|||
126145050|NCT02875223|453815676|FG004|Overall Study|Withdrawal by Subject|1|||
126145051|NCT02875223|453815677|FG005|Overall Study|Withdrawal by Subject|1|||
126145052|NCT02875223|453815678|FG006|Overall Study|Withdrawal by Subject|0|||
126145053|NCT02875223|453815679|FG007|Overall Study|Withdrawal by Subject|0|||
126145054|NCT02875223|453815680|FG008|Overall Study|Withdrawal by Subject|1|||
126145055|NCT02875223|453815681|FG009|Overall Study|Withdrawal by Subject|0|||
126145056|NCT02875223|453815682|FG010|Overall Study|Withdrawal by Subject|0|||
126145057|NCT02875223|453815683|FG011|Overall Study|Withdrawal by Subject|0|||
126145058|NCT02875223|453815684|FG012|Overall Study|Withdrawal by Subject|0|||
126145059|NCT02875223|453815672|FG000|Overall Study|Progressive disease|0|||
126145060|NCT02875223|453815673|FG001|Overall Study|Progressive disease|0|||
126145061|NCT02875223|453815674|FG002|Overall Study|Progressive disease|1|||
126145062|NCT02875223|453815675|FG003|Overall Study|Progressive disease|0|||
126145063|NCT02875223|453815676|FG004|Overall Study|Progressive disease|0|||
126145064|NCT02875223|453815677|FG005|Overall Study|Progressive disease|0|||
126145065|NCT02875223|453815678|FG006|Overall Study|Progressive disease|0|||
126145066|NCT02875223|453815679|FG007|Overall Study|Progressive disease|0|||
126145067|NCT02875223|453815680|FG008|Overall Study|Progressive disease|0|||
126145068|NCT02875223|453815681|FG009|Overall Study|Progressive disease|12|||
126145069|NCT02875223|453815682|FG010|Overall Study|Progressive disease|2|||
126145070|NCT02875223|453815683|FG011|Overall Study|Progressive disease|3|||
126145071|NCT02875223|453815684|FG012|Overall Study|Progressive disease|6|||
126145072|NCT02875223|453815672|FG000|Overall Study|Death|4|||
126145073|NCT02875223|453815673|FG001|Overall Study|Death|4|||
126145074|NCT02875223|453815674|FG002|Overall Study|Death|3|||
126145075|NCT02875223|453815675|FG003|Overall Study|Death|4|||
126145076|NCT02875223|453815676|FG004|Overall Study|Death|2|||
126145077|NCT02875223|453815677|FG005|Overall Study|Death|3|||
126145078|NCT02875223|453815678|FG006|Overall Study|Death|5|||
126145079|NCT02875223|453815679|FG007|Overall Study|Death|7|||
126145080|NCT02875223|453815680|FG008|Overall Study|Death|3|||
126145081|NCT02875223|453815681|FG009|Overall Study|Death|2|||
126145082|NCT02875223|453815682|FG010|Overall Study|Death|0|||
126145083|NCT02875223|453815683|FG011|Overall Study|Death|0|||
126145084|NCT02875223|453815684|FG012|Overall Study|Death|0|||
126145085|NCT02875223|453815672|FG000|Overall Study|Lost to Follow-up|0|||
126145086|NCT02875223|453815673|FG001|Overall Study|Lost to Follow-up|1|||
126145087|NCT02875223|453815674|FG002|Overall Study|Lost to Follow-up|1|||
126145088|NCT02875223|453815675|FG003|Overall Study|Lost to Follow-up|0|||
126145089|NCT02875223|453815676|FG004|Overall Study|Lost to Follow-up|1|||
126145090|NCT02875223|453815677|FG005|Overall Study|Lost to Follow-up|0|||
126145091|NCT02875223|453815678|FG006|Overall Study|Lost to Follow-up|1|||
126145092|NCT02875223|453815679|FG007|Overall Study|Lost to Follow-up|1|||
126145093|NCT02875223|453815680|FG008|Overall Study|Lost to Follow-up|0|||
126145094|NCT02875223|453815681|FG009|Overall Study|Lost to Follow-up|0|||
126145095|NCT02875223|453815682|FG010|Overall Study|Lost to Follow-up|0|||
126145096|NCT02875223|453815683|FG011|Overall Study|Lost to Follow-up|0|||
126145097|NCT02875223|453815684|FG012|Overall Study|Lost to Follow-up|0|||
126145098|NCT04211337|453815688|FG000|Overall Study|On Treatment|175|||
126145099|NCT04211337|453815689|FG001|Overall Study|On Treatment|40|||
126145100|NCT04211337|453815688|FG000|Overall Study|Withdrawal by Subject|0|||
126145101|NCT04211337|453815689|FG001|Overall Study|Withdrawal by Subject|2|||
126145102|NCT06119191|453815694|FG000|Overall Study|Adverse Event|0|||
126145103|NCT06119191|453815695|FG001|Overall Study|Adverse Event|1|||
126145104|NCT06119191|453815694|FG000|Overall Study|Protocol Violation|1|||
126145105|NCT06119191|453815695|FG001|Overall Study|Protocol Violation|0|||
126145106|NCT02732951|453818109|FG000|Overall Study|Other than listed|1|||
126145107|NCT02732951|453818110|FG001|Overall Study|Other than listed|0|||
126145108|NCT02732951|453818109|FG000|Overall Study|Lost to Follow-up|0|||
126145109|NCT02732951|453818110|FG001|Overall Study|Lost to Follow-up|1|||
126145110|NCT02732951|453818109|FG000|Overall Study|Adverse Event|4|||
126145111|NCT02732951|453818110|FG001|Overall Study|Adverse Event|4|||
126145112|NCT02732951|453818109|FG000|Overall Study|Protocol Violation|0|||
126145113|NCT02732951|453818110|FG001|Overall Study|Protocol Violation|1|||
126145114|NCT03263806|453818111|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
126145115|NCT03263806|453818112|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
126145116|NCT03263806|453818111|FG000|Overall Study|Withdrawal by Subject|0|||
126145117|NCT03263806|453818112|FG001|Overall Study|Withdrawal by Subject|1|||
126145118|NCT03263806|453818111|FG000|Overall Study|Study Termination|5|||
126145119|NCT03263806|453818112|FG001|Overall Study|Study Termination|6|||
126145120|NCT01412879|453818113|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
126145121|NCT01412879|453818114|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
126145122|NCT01412879|453818115|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
126145123|NCT01412879|453818113|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
126145124|NCT01412879|453818114|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
126145125|NCT01412879|453818115|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
126145126|NCT01412879|453818113|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
126145127|NCT01412879|453818114|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
126145128|NCT01412879|453818115|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
126145129|NCT01412879|453818113|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
126145130|NCT01412879|453818114|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
126145131|NCT01412879|453818115|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
126145132|NCT01412879|453818113|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
126145133|NCT01412879|453818114|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
126145134|NCT01412879|453818115|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
126145135|NCT01445171|453818116|FG000|Overall Study|Lost to Follow-up|11|||
126145136|NCT01445171|453818116|FG000|Overall Study|Withdrawal by Subject|16|||
126145137|NCT01445171|453818116|FG000|Overall Study|Death|51|||
126145138|NCT01445171|453818116|FG000|Overall Study|Subjects declined to return for followup|9|||
126145139|NCT01445171|453818116|FG000|Overall Study|Consented but did not receive device|8|||
126145140|NCT00162773|453818126|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
126145141|NCT05047523|453818141|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126145142|NCT05047523|453818142|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126145143|NCT05047523|453818143|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
126145144|NCT05047523|453818144|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126145145|NCT05047523|453818145|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126145146|NCT05047523|453818146|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126145147|NCT05047523|453818141|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126145148|NCT05047523|453818142|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
126145149|NCT05047523|453818143|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126145150|NCT05047523|453818144|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126145151|NCT05047523|453818145|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126145152|NCT05047523|453818146|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126145153|NCT05047523|453818141|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
126145154|NCT05047523|453818142|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
126145155|NCT05047523|453818143|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
126145156|NCT05047523|453818144|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
126145157|NCT05047523|453818145|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
126145158|NCT05047523|453818146|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
126145159|NCT05047523|453818141|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
126145160|NCT05047523|453818142|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126145161|NCT05047523|453818143|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126145162|NCT05047523|453818144|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126145163|NCT05047523|453818145|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126145164|NCT05047523|453818146|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126145165|NCT05047523|453818141|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
126145166|NCT05047523|453818142|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
126145167|NCT05047523|453818143|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
126145168|NCT05047523|453818144|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
126145169|NCT05047523|453818145|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
126145170|NCT05047523|453818146|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
126145171|NCT05047523|453818141|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
126145172|NCT05047523|453818142|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
126145173|NCT05047523|453818143|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
126145174|NCT05047523|453818144|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
126145175|NCT05047523|453818145|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
126145176|NCT05047523|453818146|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
126145177|NCT03658889|453818147|FG000|Overall Study|Protocol Violation|2|||
126145178|NCT03658889|453818148|FG001|Overall Study|Protocol Violation|0|||
126145179|NCT01903876|453818156|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
126145180|NCT01903876|453818157|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
126145181|NCT01903876|453818156|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
126145182|NCT01903876|453818157|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
126145183|NCT04317690|453818160|FG000|Overall Study|did not have complete information for primary outcome|0|||
126145184|NCT04317690|453818161|FG001|Overall Study|did not have complete information for primary outcome|4|||
126145185|NCT04317690|453818162|FG002|Overall Study|did not have complete information for primary outcome|0|||
126145186|NCT04317690|453818163|FG003|Overall Study|did not have complete information for primary outcome|2|||
126145187|NCT04317690|453818164|FG004|Overall Study|did not have complete information for primary outcome|0|||
126145188|NCT02612909|453818165|FG000|Phase 2|Withdrawal by Subject|2|||
126145189|NCT02612909|453818166|FG001|Phase 2|Withdrawal by Subject|5|||
126145190|NCT02612909|453818167|FG002|Phase 2|Withdrawal by Subject|0|||
126145191|NCT02612909|453818168|FG003|Phase 2|Withdrawal by Subject|0|||
126145192|NCT02612909|453818169|FG004|Phase 2|Withdrawal by Subject|0|||
126145193|NCT02612909|453818165|FG000|Phase 2|Pregnancy|0|||
126145194|NCT02612909|453818166|FG001|Phase 2|Pregnancy|0|||
126145195|NCT02612909|453818167|FG002|Phase 2|Pregnancy|1|||
126145196|NCT02612909|453818168|FG003|Phase 2|Pregnancy|0|||
126145197|NCT02612909|453818169|FG004|Phase 2|Pregnancy|0|||
126145198|NCT02612909|453818165|FG000|Phase 3|Withdrawal by Subject|0|||
126145199|NCT02612909|453818166|FG001|Phase 3|Withdrawal by Subject|0|||
126145200|NCT02612909|453818167|FG002|Phase 3|Withdrawal by Subject|0|||
126145201|NCT02612909|453818168|FG003|Phase 3|Withdrawal by Subject|1|||
126145202|NCT02612909|453818169|FG004|Phase 3|Withdrawal by Subject|0|||
126145203|NCT03323749|453818170|FG000|Double-blind Period|Lost to Follow-up|4|||
126145204|NCT03323749|453818171|FG001|Double-blind Period|Lost to Follow-up|5|||
126145205|NCT03323749|453818170|FG000|Double-blind Period|Adverse Event|3|||
126145206|NCT03323749|453818171|FG001|Double-blind Period|Adverse Event|1|||
126145207|NCT03323749|453818170|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
126145208|NCT03323749|453818171|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
126145209|NCT03323749|453818170|FG000|Open-Label Period|Adverse Event|3|||
126145210|NCT03323749|453818171|FG001|Open-Label Period|Adverse Event|10|||
126145211|NCT03323749|453818170|FG000|Open-Label Period|Withdrawal by Subject|7|||
126145212|NCT03323749|453818171|FG001|Open-Label Period|Withdrawal by Subject|5|||
126145213|NCT01719757|453818173|FG000|Overall Study|Adverse Event|38|||
126145214|NCT01719757|453818173|FG000|Overall Study|Withdrawal by Subject|15|||
126145215|NCT01719757|453818173|FG000|Overall Study|Lost to Follow-up|20|||
126145216|NCT01719757|453818173|FG000|Overall Study|Protocol Violation|1|||
126145217|NCT01719757|453818173|FG000|Overall Study|well controlled pain|27|||
126145218|NCT02626338|453818174|FG000|Overall Study|Lack of Efficacy|3|||
126145219|NCT02626338|453818175|FG001|Overall Study|Lack of Efficacy|2|||
126145220|NCT02626338|453818176|FG002|Overall Study|Lack of Efficacy|0|||
126145221|NCT01901224|453818177|FG000|Overall Study|study was not funded and terminated|2|||
126145222|NCT00450580|453818178|FG000|Overall Study|Adverse Event|5|||
126145223|NCT00450580|453818179|FG001|Overall Study|Adverse Event|7|||
126145224|NCT00450580|453818178|FG000|Overall Study|Lost to Follow-up|4|||
126145225|NCT00450580|453818179|FG001|Overall Study|Lost to Follow-up|5|||
126145226|NCT00450580|453818178|FG000|Overall Study|Withdrawal by Subject|2|||
126145227|NCT00450580|453818179|FG001|Overall Study|Withdrawal by Subject|2|||
126145228|NCT00450580|453818178|FG000|Overall Study|Protocol Violation|1|||
126145229|NCT00450580|453818179|FG001|Overall Study|Protocol Violation|1|||
126145230|NCT00450580|453818178|FG000|Overall Study|Protocol-defined virologic failure|1|||
126145231|NCT00450580|453818179|FG001|Overall Study|Protocol-defined virologic failure|0|||
126145232|NCT00450580|453818178|FG000|Overall Study|Could not comply with scheduled visits|1|||
126145233|NCT00450580|453818179|FG001|Overall Study|Could not comply with scheduled visits|0|||
126145234|NCT00450580|453818178|FG000|Overall Study|Patient went to Brazil|1|||
126145235|NCT00450580|453818179|FG001|Overall Study|Patient went to Brazil|0|||
126145236|NCT00450580|453818178|FG000|Overall Study|Patient could not swallow Norvir|1|||
126145237|NCT00450580|453818179|FG001|Overall Study|Patient could not swallow Norvir|0|||
126145238|NCT00450580|453818178|FG000|Overall Study|Withdrawal due to pregnancy|0|||
126145239|NCT00450580|453818179|FG001|Overall Study|Withdrawal due to pregnancy|1|||
126145240|NCT00393718|453818180|FG000|Overall Study|Adverse Event|20|||
126145241|NCT00393718|453818181|FG001|Overall Study|Adverse Event|8|||
126145242|NCT00393718|453818180|FG000|Overall Study|Protocol Violation|1|||
126145243|NCT00393718|453818181|FG001|Overall Study|Protocol Violation|2|||
126145244|NCT00393718|453818180|FG000|Overall Study|Lack of Efficacy|10|||
126145245|NCT00393718|453818181|FG001|Overall Study|Lack of Efficacy|9|||
126145246|NCT00393718|453818180|FG000|Overall Study|Hypoglycaemia|3|||
126145247|NCT00393718|453818181|FG001|Overall Study|Hypoglycaemia|2|||
126145248|NCT00393718|453818180|FG000|Overall Study|Subject decision|5|||
126145249|NCT00393718|453818181|FG001|Overall Study|Subject decision|0|||
126145250|NCT00393718|453818180|FG000|Overall Study|Withdrawal of consent|2|||
126145251|NCT00393718|453818181|FG001|Overall Study|Withdrawal of consent|1|||
126145252|NCT00393718|453818180|FG000|Overall Study|Missed measurement|1|||
126145253|NCT00393718|453818181|FG001|Overall Study|Missed measurement|0|||
126145254|NCT00393718|453818180|FG000|Overall Study|Move|1|||
126145255|NCT00393718|453818181|FG001|Overall Study|Move|0|||
126145256|NCT04938648|453818182|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
126145257|NCT04938648|453818183|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
126145258|NCT04938648|453818182|FG000|Overall Study|Patient too ill|0|||
126145259|NCT04938648|453818183|FG001|Overall Study|Patient too ill|1|||
126145260|NCT04938648|453818182|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
126145261|NCT04938648|453818183|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
126145262|NCT04938648|453818182|FG000|Overall Study|Patient did not have memory problems|1|||
126145263|NCT04938648|453818183|FG001|Overall Study|Patient did not have memory problems|1|||
126145264|NCT04938648|453818182|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
126145265|NCT04938648|453818183|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
126145266|NCT04938648|453818182|FG000|Overall Study|Care partner could not be reached|0|||
126145267|NCT04938648|453818183|FG001|Overall Study|Care partner could not be reached|1|||
126145268|NCT04938648|453818182|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
126145269|NCT04938648|453818183|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
126145270|NCT04938648|453818182|FG000|Overall Study|Withdrawal by Subject|2|||
126145271|NCT04938648|453818183|FG001|Overall Study|Withdrawal by Subject|1|||
126145272|NCT03293654|453818184|FG000|Overall Study|Lost to Follow-up|0|||
126145273|NCT03293654|453818185|FG001|Overall Study|Lost to Follow-up|1|||
126145274|NCT03293654|453818186|FG002|Overall Study|Lost to Follow-up|0|||
126145275|NCT00391976|453818187|FG000|Overall Study|Adverse Event|0|||
126145276|NCT00391976|453818188|FG001|Overall Study|Adverse Event|0|||
126145277|NCT00391976|453818189|FG002|Overall Study|Adverse Event|1|||
126145278|NCT00391976|453818187|FG000|Overall Study|Withdrawal of consent|0|||
126145279|NCT00391976|453818188|FG001|Overall Study|Withdrawal of consent|1|||
126145280|NCT00391976|453818189|FG002|Overall Study|Withdrawal of consent|1|||
126145281|NCT00391976|453818187|FG000|Overall Study|Lost to Follow-up|1|||
126145282|NCT00391976|453818188|FG001|Overall Study|Lost to Follow-up|2|||
126145283|NCT00391976|453818189|FG002|Overall Study|Lost to Follow-up|0|||
126145284|NCT00391976|453818187|FG000|Overall Study|Inappropriate enrollment|1|||
126145285|NCT00391976|453818188|FG001|Overall Study|Inappropriate enrollment|1|||
126145286|NCT00391976|453818189|FG002|Overall Study|Inappropriate enrollment|0|||
126145287|NCT00391976|453818187|FG000|Overall Study|Protocol deviation/violation|4|||
126145288|NCT00391976|453818188|FG001|Overall Study|Protocol deviation/violation|2|||
126145289|NCT00391976|453818189|FG002|Overall Study|Protocol deviation/violation|1|||
126145290|NCT00391976|453818187|FG000|Overall Study|Recurrence/no eradication of infection|21|||
126145291|NCT00391976|453818188|FG001|Overall Study|Recurrence/no eradication of infection|19|||
126145292|NCT00391976|453818189|FG002|Overall Study|Recurrence/no eradication of infection|0|||
126145293|NCT00391976|453818187|FG000|Overall Study|Unable to classify|0|||
126145294|NCT00391976|453818188|FG001|Overall Study|Unable to classify|0|||
126145295|NCT00391976|453818189|FG002|Overall Study|Unable to classify|1|||
126145296|NCT00391976|453818187|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
126145297|NCT00391976|453818188|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
126145298|NCT00391976|453818189|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
126145299|NCT00763009|453818194|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
126145300|NCT00891735|453818196|FG000|Overall Study|Adverse Event|2|||
126145301|NCT00891735|453818197|FG001|Overall Study|Adverse Event|0|||
126145302|NCT00891735|453818198|FG002|Overall Study|Adverse Event|2|||
126145303|NCT00891735|453818199|FG003|Overall Study|Adverse Event|0|||
126145304|NCT00891735|453818196|FG000|Overall Study|Death|8|||
126145305|NCT00891735|453818197|FG001|Overall Study|Death|5|||
126145306|NCT00891735|453818198|FG002|Overall Study|Death|4|||
126145307|NCT00891735|453818199|FG003|Overall Study|Death|5|||
126145308|NCT00891735|453818196|FG000|Overall Study|Lost to Follow-up|2|||
126145309|NCT00891735|453818197|FG001|Overall Study|Lost to Follow-up|2|||
126145310|NCT00891735|453818198|FG002|Overall Study|Lost to Follow-up|2|||
126145311|NCT00891735|453818199|FG003|Overall Study|Lost to Follow-up|2|||
126145312|NCT00891735|453818196|FG000|Overall Study|Physician's decision to withdraw patient|1|||
126145313|NCT00891735|453818197|FG001|Overall Study|Physician's decision to withdraw patient|0|||
126145314|NCT00891735|453818198|FG002|Overall Study|Physician's decision to withdraw patient|0|||
126145315|NCT00891735|453818199|FG003|Overall Study|Physician's decision to withdraw patient|0|||
126145316|NCT00891735|453818196|FG000|Overall Study|Patient's decision to withdraw|4|||
126145317|NCT00891735|453818197|FG001|Overall Study|Patient's decision to withdraw|9|||
126145318|NCT00891735|453818198|FG002|Overall Study|Patient's decision to withdraw|4|||
126145319|NCT00891735|453818199|FG003|Overall Study|Patient's decision to withdraw|8|||
126145320|NCT03838484|453818202|FG000|Overall Study|Lost to Follow-up|0|||
126145321|NCT03838484|453818203|FG001|Overall Study|Lost to Follow-up|1|||
126145322|NCT03838484|453818204|FG002|Overall Study|Lost to Follow-up|0|||
126145323|NCT03838484|453818205|FG003|Overall Study|Lost to Follow-up|0|||
126145324|NCT00158184|453818211|FG000|Overall Study|personal issues|3|||
126145325|NCT00158184|453818212|FG001|Overall Study|personal issues|1|||
126145326|NCT00158184|453818211|FG000|Overall Study|failed for follow unit/study rules|2|||
126145327|NCT00158184|453818212|FG001|Overall Study|failed for follow unit/study rules|0|||
126145328|NCT00158184|453818211|FG000|Overall Study|Adverse Event|1|||
126145329|NCT00158184|453818212|FG001|Overall Study|Adverse Event|1|||
126145330|NCT02582671|453818213|FG000|Overall Study|Failure to return|1|||
126145331|NCT02582671|453818213|FG000|Overall Study|Other, not specified|1|||
126145332|NCT03068715|453818214|FG000|Overall Study|No longer met inclusion criteria|1|||
126145333|NCT03068715|453818215|FG001|Overall Study|No longer met inclusion criteria|0|||
126145334|NCT01276288|453818216|FG000|Overall Study|Adverse Event|1|||
126145335|NCT01276288|453818217|FG001|Overall Study|Adverse Event|1|||
126145336|NCT01276288|453818218|FG002|Overall Study|Adverse Event|0|||
126145337|NCT01276288|453818219|FG003|Overall Study|Adverse Event|0|||
126145338|NCT01276288|453818216|FG000|Overall Study|not treated|1|||
126145339|NCT01276288|453818217|FG001|Overall Study|not treated|0|||
126145340|NCT01276288|453818218|FG002|Overall Study|not treated|0|||
126145341|NCT01276288|453818219|FG003|Overall Study|not treated|0|||
126145342|NCT03168867|453818221|FG000|Overall Study|Withdrawal by Subject|1|||
126145343|NCT03168867|453818222|FG001|Overall Study|Withdrawal by Subject|5|||
126145344|NCT04348851|453818223|FG000|Post-Test 1|Withdrawal by Subject|0|||
126145345|NCT04348851|453818224|FG001|Post-Test 1|Withdrawal by Subject|1|||
126145346|NCT04348851|453818225|FG002|Post-Test 1|Withdrawal by Subject|0|||
126145347|NCT04348851|453818226|FG003|Post-Test 1|Withdrawal by Subject|0|||
126145348|NCT04348851|453818223|FG000|Post-Test 1|Lost to Follow-up|0|||
126145349|NCT04348851|453818224|FG001|Post-Test 1|Lost to Follow-up|1|||
126145350|NCT04348851|453818225|FG002|Post-Test 1|Lost to Follow-up|0|||
126145351|NCT04348851|453818226|FG003|Post-Test 1|Lost to Follow-up|0|||
126145352|NCT04348851|453818223|FG000|Post-Test 2|Stroke survivor death|0|||
126145353|NCT04348851|453818224|FG001|Post-Test 2|Stroke survivor death|1|||
126145354|NCT04348851|453818225|FG002|Post-Test 2|Stroke survivor death|0|||
126145355|NCT04348851|453818226|FG003|Post-Test 2|Stroke survivor death|1|||
126145356|NCT00190775|453818227|FG000|Overall Study|Adverse Event|57|||
126145357|NCT00190775|453818228|FG001|Overall Study|Adverse Event|22|||
126145358|NCT00190775|453818227|FG000|Overall Study|Satisfactory Response|1|||
126145359|NCT00190775|453818228|FG001|Overall Study|Satisfactory Response|0|||
126145360|NCT00190775|453818227|FG000|Overall Study|Lack of Efficacy|28|||
126145361|NCT00190775|453818228|FG001|Overall Study|Lack of Efficacy|32|||
126145362|NCT00190775|453818227|FG000|Overall Study|Lost to Follow-up|31|||
126145363|NCT00190775|453818228|FG001|Overall Study|Lost to Follow-up|23|||
126145364|NCT00190775|453818227|FG000|Overall Study|Participant Moved|0|||
126145365|NCT00190775|453818228|FG001|Overall Study|Participant Moved|1|||
126145366|NCT00190775|453818227|FG000|Overall Study|Withdrawal by Subject|24|||
126145367|NCT00190775|453818228|FG001|Overall Study|Withdrawal by Subject|13|||
126145368|NCT00190775|453818227|FG000|Overall Study|Sponsor Decision|1|||
126145369|NCT00190775|453818228|FG001|Overall Study|Sponsor Decision|0|||
126145370|NCT00190775|453818227|FG000|Overall Study|Physician Decision|3|||
126145371|NCT00190775|453818228|FG001|Overall Study|Physician Decision|0|||
126145372|NCT00190775|453818227|FG000|Overall Study|Noncompliance|3|||
126145373|NCT00190775|453818228|FG001|Overall Study|Noncompliance|5|||
126145374|NCT00190775|453818227|FG000|Overall Study|Protocol Violation|0|||
126145375|NCT00190775|453818228|FG001|Overall Study|Protocol Violation|1|||
126145376|NCT00190775|453818227|FG000|Overall Study|Exclusion Criteria Met|1|||
126145377|NCT00190775|453818228|FG001|Overall Study|Exclusion Criteria Met|3|||
126145378|NCT00519077|453818229|FG000|Overall Study|Death|6|||
126145379|NCT00519077|453818229|FG000|Overall Study|Other|2|||
126145380|NCT01967225|453818230|FG000|Overall Study|Adverse Event|3|||
126145381|NCT01967225|453818231|FG001|Overall Study|Adverse Event|1|||
126145382|NCT01967225|453818230|FG000|Overall Study|Withdrawal by Subject|2|||
126145383|NCT01967225|453818231|FG001|Overall Study|Withdrawal by Subject|1|||
126145384|NCT01967225|453818230|FG000|Overall Study|Lack of Efficacy|1|||
126145385|NCT01967225|453818231|FG001|Overall Study|Lack of Efficacy|1|||
126145386|NCT01967225|453818230|FG000|Overall Study|Switching to other therapy|2|||
126145387|NCT01967225|453818231|FG001|Overall Study|Switching to other therapy|0|||
126145388|NCT01967225|453818230|FG000|Overall Study|Protocol driven decision point|1|||
126145389|NCT01967225|453818231|FG001|Overall Study|Protocol driven decision point|0|||
126145390|NCT01967225|453818230|FG000|Overall Study|Logistical difficulties|1|||
126145391|NCT01967225|453818231|FG001|Overall Study|Logistical difficulties|0|||
126145392|NCT01967225|453818230|FG000|Overall Study|Protocol Violation|2|||
126145393|NCT01967225|453818231|FG001|Overall Study|Protocol Violation|0|||
126145394|NCT00481065|453818232|FG000|Overall Study|Adverse event or death|1|||
126145395|NCT00481065|453818233|FG001|Overall Study|Adverse event or death|1|||
126145396|NCT00481065|453818234|FG002|Overall Study|Adverse event or death|3|||
126145397|NCT00481065|453818235|FG003|Overall Study|Adverse event or death|0|||
126145398|NCT00481065|453818236|FG004|Overall Study|Adverse event or death|2|||
126145399|NCT00481065|453818237|FG005|Overall Study|Adverse event or death|0|||
126145400|NCT00481065|453818238|FG006|Overall Study|Adverse event or death|1|||
126145401|NCT00481065|453818239|FG007|Overall Study|Adverse event or death|1|||
126145402|NCT00481065|453818232|FG000|Overall Study|Withdrawal by Subject|11|||
126145403|NCT00481065|453818233|FG001|Overall Study|Withdrawal by Subject|12|||
126145404|NCT00481065|453818234|FG002|Overall Study|Withdrawal by Subject|7|||
126145405|NCT00481065|453818235|FG003|Overall Study|Withdrawal by Subject|11|||
126145406|NCT00481065|453818236|FG004|Overall Study|Withdrawal by Subject|13|||
126145407|NCT00481065|453818237|FG005|Overall Study|Withdrawal by Subject|12|||
126145408|NCT00481065|453818238|FG006|Overall Study|Withdrawal by Subject|9|||
126145409|NCT00481065|453818239|FG007|Overall Study|Withdrawal by Subject|10|||
126145410|NCT00481065|453818232|FG000|Overall Study|Lost to Follow-up|4|||
126145411|NCT00481065|453818233|FG001|Overall Study|Lost to Follow-up|2|||
126145412|NCT00481065|453818234|FG002|Overall Study|Lost to Follow-up|4|||
126145413|NCT00481065|453818235|FG003|Overall Study|Lost to Follow-up|3|||
126145414|NCT00481065|453818236|FG004|Overall Study|Lost to Follow-up|3|||
126145415|NCT00481065|453818237|FG005|Overall Study|Lost to Follow-up|3|||
126145416|NCT00481065|453818238|FG006|Overall Study|Lost to Follow-up|2|||
126145417|NCT00481065|453818239|FG007|Overall Study|Lost to Follow-up|5|||
126145418|NCT00481065|453818232|FG000|Overall Study|Inappropriate enrollment|4|||
126145419|NCT00481065|453818233|FG001|Overall Study|Inappropriate enrollment|0|||
126145420|NCT00481065|453818234|FG002|Overall Study|Inappropriate enrollment|2|||
126145421|NCT00481065|453818235|FG003|Overall Study|Inappropriate enrollment|0|||
126145422|NCT00481065|453818236|FG004|Overall Study|Inappropriate enrollment|2|||
126145423|NCT00481065|453818237|FG005|Overall Study|Inappropriate enrollment|1|||
126145424|NCT00481065|453818238|FG006|Overall Study|Inappropriate enrollment|0|||
126145425|NCT00481065|453818239|FG007|Overall Study|Inappropriate enrollment|1|||
126145426|NCT00481065|453818232|FG000|Overall Study|Administrative reason|0|||
126145427|NCT00481065|453818233|FG001|Overall Study|Administrative reason|0|||
126145428|NCT00481065|453818234|FG002|Overall Study|Administrative reason|0|||
126145429|NCT00481065|453818235|FG003|Overall Study|Administrative reason|0|||
126145430|NCT00481065|453818236|FG004|Overall Study|Administrative reason|0|||
126145431|NCT00481065|453818237|FG005|Overall Study|Administrative reason|2|||
126145432|NCT00481065|453818238|FG006|Overall Study|Administrative reason|1|||
126145433|NCT00481065|453818239|FG007|Overall Study|Administrative reason|0|||
126145434|NCT00481065|453818232|FG000|Overall Study|Protocol Violation|2|||
126145435|NCT00481065|453818233|FG001|Overall Study|Protocol Violation|1|||
126145436|NCT00481065|453818234|FG002|Overall Study|Protocol Violation|1|||
126145437|NCT00481065|453818235|FG003|Overall Study|Protocol Violation|1|||
126145438|NCT00481065|453818236|FG004|Overall Study|Protocol Violation|2|||
126145439|NCT00481065|453818237|FG005|Overall Study|Protocol Violation|6|||
126145440|NCT00481065|453818238|FG006|Overall Study|Protocol Violation|3|||
126145441|NCT00481065|453818239|FG007|Overall Study|Protocol Violation|2|||
126145442|NCT00481065|453818232|FG000|Overall Study|Unable to classify|0|||
126145443|NCT00481065|453818233|FG001|Overall Study|Unable to classify|1|||
126145444|NCT00481065|453818234|FG002|Overall Study|Unable to classify|2|||
126145445|NCT00481065|453818235|FG003|Overall Study|Unable to classify|0|||
126145446|NCT00481065|453818236|FG004|Overall Study|Unable to classify|1|||
126145447|NCT00481065|453818237|FG005|Overall Study|Unable to classify|0|||
126145448|NCT00481065|453818238|FG006|Overall Study|Unable to classify|0|||
126145449|NCT00481065|453818239|FG007|Overall Study|Unable to classify|0|||
126145450|NCT01709331|453818242|FG000|Overall Study|Adverse Event|1|||
126145451|NCT03029832|453818245|FG000|Overall Study|Safety Follow-Up Completed|2|||
126145452|NCT03029832|453818246|FG001|Overall Study|Safety Follow-Up Completed|0|||
126145453|NCT03029832|453818245|FG000|Overall Study|Death due to Disease Progression|1|||
126145454|NCT03029832|453818246|FG001|Overall Study|Death due to Disease Progression|0|||
126145455|NCT03029832|453818245|FG000|Overall Study|Study Terminated By Sponsor|1|||
126145456|NCT03029832|453818246|FG001|Overall Study|Study Terminated By Sponsor|1|||
126145457|NCT01628926|453818247|FG000|Overall Study|Adverse Event|13|||
126145458|NCT01628926|453818248|FG001|Overall Study|Adverse Event|11|||
126145459|NCT01628926|453818249|FG002|Overall Study|Adverse Event|9|||
126145460|NCT01628926|453818247|FG000|Overall Study|Lack of Efficacy|2|||
126145461|NCT01628926|453818248|FG001|Overall Study|Lack of Efficacy|1|||
126145462|NCT01628926|453818249|FG002|Overall Study|Lack of Efficacy|5|||
126145463|NCT01628926|453818247|FG000|Overall Study|Withdrawal by Subject|6|||
126145464|NCT01628926|453818248|FG001|Overall Study|Withdrawal by Subject|4|||
126145465|NCT01628926|453818249|FG002|Overall Study|Withdrawal by Subject|2|||
126145466|NCT01628926|453818247|FG000|Overall Study|Protocol Violation|0|||
126145467|NCT01628926|453818248|FG001|Overall Study|Protocol Violation|1|||
126145468|NCT01628926|453818249|FG002|Overall Study|Protocol Violation|0|||
126145469|NCT01628926|453818247|FG000|Overall Study|Discontinuation criteria|3|||
126145470|NCT01628926|453818248|FG001|Overall Study|Discontinuation criteria|4|||
126145471|NCT01628926|453818249|FG002|Overall Study|Discontinuation criteria|0|||
126145472|NCT01628926|453818247|FG000|Overall Study|Physician Decision|2|||
126145473|NCT01628926|453818248|FG001|Overall Study|Physician Decision|2|||
126145474|NCT01628926|453818249|FG002|Overall Study|Physician Decision|1|||
126145475|NCT04906707|453818253|FG000|Overall Study|Withdrawal by Subject|2|||
126145476|NCT04906707|453818254|FG001|Overall Study|Withdrawal by Subject|0|||
126145477|NCT04906707|453818253|FG000|Overall Study|Withdrawal due to PI decision|1|||
126145478|NCT04906707|453818254|FG001|Overall Study|Withdrawal due to PI decision|0|||
126145479|NCT04906707|453818253|FG000|Overall Study|Lost to Follow-up|0|||
126145480|NCT04906707|453818254|FG001|Overall Study|Lost to Follow-up|1|||
126145481|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
125970479|NCT00626522|453182730|FG002|Overall Study|COPD exacerbation|0|||
125970480|NCT00626522|453182731|FG003|Overall Study|COPD exacerbation|1|||
125970481|NCT00626522|453182732|FG004|Overall Study|COPD exacerbation|1|||
125970482|NCT00626522|453182733|FG005|Overall Study|COPD exacerbation|0|||
125970483|NCT00626522|453182728|FG000|Overall Study|Lost to Follow-up|0|||
125970484|NCT00626522|453182729|FG001|Overall Study|Lost to Follow-up|1|||
125970485|NCT00626522|453182730|FG002|Overall Study|Lost to Follow-up|0|||
125970486|NCT00626522|453182731|FG003|Overall Study|Lost to Follow-up|0|||
125970487|NCT00626522|453182732|FG004|Overall Study|Lost to Follow-up|0|||
125970488|NCT00626522|453182733|FG005|Overall Study|Lost to Follow-up|0|||
126145482|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
126145483|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
126145484|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
126145485|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
125970489|NCT00626522|453182728|FG000|Overall Study|Inconsistent reason reported|1|||
125970490|NCT00626522|453182729|FG001|Overall Study|Inconsistent reason reported|0|||
125970491|NCT00626522|453182730|FG002|Overall Study|Inconsistent reason reported|0|||
125970492|NCT00626522|453182731|FG003|Overall Study|Inconsistent reason reported|0|||
126145486|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
126145487|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
126145488|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
126145489|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
126145490|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
126145491|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
126145492|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
126145493|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
126145494|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
126145495|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
126145496|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
126145497|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
126145498|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
126145499|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
126145500|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126145501|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126145502|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126145503|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126145504|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126145505|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
126145506|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
126145507|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
126145508|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
126145509|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
126145510|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
126145511|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
126145512|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
126145513|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
126145514|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
126145515|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
126145516|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
126145517|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
126145518|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
126145519|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
126145520|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
126145521|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
126145522|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
126145523|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
126145524|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
126145525|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
126145526|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
126145527|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
126145528|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
126145529|NCT01707992|453818255|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
126145530|NCT01707992|453818256|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
126145531|NCT01707992|453818257|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
126145532|NCT01707992|453818258|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
126145533|NCT01707992|453818259|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
126145534|NCT01707992|453818260|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
126145535|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
126145536|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
126145537|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
126145538|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
126145539|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
126145540|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
126145541|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
126145542|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
126145543|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
126145544|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
126145545|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
126145546|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
126145547|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
126145548|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
125970493|NCT00626522|453182732|FG004|Overall Study|Inconsistent reason reported|0|||
125970494|NCT00626522|453182733|FG005|Overall Study|Inconsistent reason reported|0|||
125970495|NCT00626522|453182728|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
125970496|NCT00626522|453182729|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
126145549|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
126145550|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
126145551|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
126145552|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
126145553|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
126145554|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
126145555|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
126145556|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
126145557|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
126145558|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
126145559|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
126145560|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
126145561|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
126145562|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
126145563|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
126145564|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
126145565|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Death|0|||
126145566|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Death|0|||
126145567|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Death|0|||
126145568|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Death|2|||
126145569|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Death|0|||
126145570|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Death|0|||
126145571|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
126145572|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
126145573|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
126145574|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
126145575|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
126145576|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
126145577|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
126145578|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
126145579|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
126145580|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
126145581|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
126145582|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
126145583|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
126145584|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
126145585|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
126145586|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
126145587|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
126145588|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
126145589|NCT01707992|453818255|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126145590|NCT01707992|453818256|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126145591|NCT01707992|453818257|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126145592|NCT01707992|453818258|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126145593|NCT01707992|453818259|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
126145594|NCT01707992|453818260|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126145595|NCT01976806|453818261|FG000|Overall Study|Lost to Follow-up|1|||
126145596|NCT01976806|453818262|FG001|Overall Study|Lost to Follow-up|4|||
126145597|NCT01976806|453818261|FG000|Overall Study|Adverse Event|1|||
126145598|NCT01976806|453818262|FG001|Overall Study|Adverse Event|1|||
126145599|NCT01976806|453818261|FG000|Overall Study|Withdrawal by Subject|1|||
126145600|NCT01976806|453818262|FG001|Overall Study|Withdrawal by Subject|1|||
126145601|NCT02654002|453818270|FG000|Overall Study|Adverse Event|0|||
126145602|NCT02654002|453818271|FG001|Overall Study|Adverse Event|0|||
126145603|NCT02654002|453818272|FG002|Overall Study|Adverse Event|0|||
126145604|NCT02654002|453818273|FG003|Overall Study|Adverse Event|0|||
126145605|NCT02654002|453818274|FG004|Overall Study|Adverse Event|0|||
126145606|NCT02654002|453818275|FG005|Overall Study|Adverse Event|0|||
126145607|NCT02654002|453818276|FG006|Overall Study|Adverse Event|1|||
126145608|NCT02654002|453818277|FG007|Overall Study|Adverse Event|0|||
126145609|NCT02654002|453818278|FG008|Overall Study|Adverse Event|0|||
126145610|NCT02654002|453818270|FG000|Overall Study|Withdrew Consent|0|||
126145611|NCT02654002|453818271|FG001|Overall Study|Withdrew Consent|0|||
126145612|NCT02654002|453818272|FG002|Overall Study|Withdrew Consent|0|||
126145613|NCT02654002|453818273|FG003|Overall Study|Withdrew Consent|0|||
126145614|NCT02654002|453818274|FG004|Overall Study|Withdrew Consent|0|||
126145615|NCT02654002|453818275|FG005|Overall Study|Withdrew Consent|1|||
126145616|NCT02654002|453818276|FG006|Overall Study|Withdrew Consent|0|||
126145617|NCT02654002|453818277|FG007|Overall Study|Withdrew Consent|1|||
126145618|NCT02654002|453818278|FG008|Overall Study|Withdrew Consent|0|||
126145619|NCT01523873|453818279|FG000|Overall Study|Protocol Violation|422|||
126145620|NCT00891202|453818280|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
126145621|NCT00891202|453818281|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
126145622|NCT00891202|453818282|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
126145623|NCT00891202|453818283|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
126145624|NCT00891202|453818280|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
126145625|NCT00891202|453818281|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
126145626|NCT00891202|453818282|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
126145627|NCT00891202|453818283|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
126145628|NCT00891202|453818280|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
126145629|NCT00891202|453818281|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
126145630|NCT00891202|453818282|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
126145631|NCT00891202|453818283|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
126145632|NCT00891202|453818280|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
126145633|NCT00891202|453818281|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
126145634|NCT00891202|453818282|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
126145635|NCT00891202|453818283|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
126145636|NCT03313050|453818287|FG000|Stage 2: 12 Months|Adverse Event|0|||
126145637|NCT03313050|453818288|FG001|Stage 2: 12 Months|Adverse Event|0|||
126145638|NCT03313050|453818289|FG002|Stage 2: 12 Months|Adverse Event|0|||
126145639|NCT03313050|453818290|FG003|Stage 2: 12 Months|Adverse Event|1|||
126145640|NCT03313050|453818287|FG000|Stage 2: 12 Months|Death|0|||
126145641|NCT03313050|453818288|FG001|Stage 2: 12 Months|Death|0|||
126145642|NCT03313050|453818289|FG002|Stage 2: 12 Months|Death|3|||
126145643|NCT03313050|453818290|FG003|Stage 2: 12 Months|Death|0|||
126145644|NCT03313050|453818287|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
126145645|NCT03313050|453818288|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
126145646|NCT03313050|453818289|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
126145647|NCT03313050|453818290|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
126145648|NCT03313050|453818287|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
126145649|NCT03313050|453818288|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
126145650|NCT03313050|453818289|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
126145651|NCT03313050|453818290|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
126145652|NCT03313050|453818287|FG000|Stage 2: 12 Months|Protocol deviation|0|||
126145653|NCT03313050|453818288|FG001|Stage 2: 12 Months|Protocol deviation|0|||
126145654|NCT03313050|453818289|FG002|Stage 2: 12 Months|Protocol deviation|7|||
126145655|NCT03313050|453818290|FG003|Stage 2: 12 Months|Protocol deviation|7|||
126145656|NCT03313050|453818287|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
126145657|NCT03313050|453818288|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
126145658|NCT03313050|453818289|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
126145659|NCT03313050|453818290|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
126145660|NCT03313050|453818287|FG000|Stage 2: 12 Months|Other|0|||
126145661|NCT03313050|453818288|FG001|Stage 2: 12 Months|Other|0|||
126145662|NCT03313050|453818289|FG002|Stage 2: 12 Months|Other|0|||
126145663|NCT03313050|453818290|FG003|Stage 2: 12 Months|Other|1|||
126145664|NCT02847598|453818293|FG000|Overall Study|Adverse Event|0|||
126145665|NCT02847598|453818294|FG001|Overall Study|Adverse Event|0|||
126145666|NCT02847598|453818295|FG002|Overall Study|Adverse Event|0|||
126145667|NCT02847598|453818296|FG003|Overall Study|Adverse Event|0|||
126145668|NCT02847598|453818297|FG004|Overall Study|Adverse Event|0|||
126145669|NCT02847598|453818298|FG005|Overall Study|Adverse Event|0|||
126145670|NCT02847598|453818299|FG006|Overall Study|Adverse Event|0|||
126145671|NCT02847598|453818300|FG007|Overall Study|Adverse Event|1|||
126145672|NCT02847598|453818293|FG000|Overall Study|Consent withdrawn|2|||
126145673|NCT02847598|453818294|FG001|Overall Study|Consent withdrawn|0|||
125970497|NCT00626522|453182730|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
125970498|NCT00626522|453182731|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
125970499|NCT00626522|453182732|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
125970500|NCT00626522|453182733|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
125970501|NCT02280044|453182734|FG000|Overall Study|Planned alternate|0|||
125970502|NCT02280044|453182735|FG001|Overall Study|Planned alternate|2|||
125970503|NCT01490632|453182739|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
125970504|NCT01490632|453182740|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
125970505|NCT01490632|453182741|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
126145674|NCT02847598|453818295|FG002|Overall Study|Consent withdrawn|0|||
126145675|NCT02847598|453818296|FG003|Overall Study|Consent withdrawn|4|||
126145676|NCT02847598|453818297|FG004|Overall Study|Consent withdrawn|3|||
126145677|NCT02847598|453818298|FG005|Overall Study|Consent withdrawn|2|||
126145678|NCT02847598|453818299|FG006|Overall Study|Consent withdrawn|1|||
126145679|NCT02847598|453818300|FG007|Overall Study|Consent withdrawn|3|||
126145680|NCT02847598|453818293|FG000|Overall Study|Death|3|||
126145681|NCT02847598|453818294|FG001|Overall Study|Death|0|||
126145682|NCT02847598|453818295|FG002|Overall Study|Death|0|||
126145683|NCT02847598|453818296|FG003|Overall Study|Death|0|||
126145684|NCT02847598|453818297|FG004|Overall Study|Death|0|||
125970506|NCT01490632|453182742|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
125970507|NCT01490632|453182743|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
125970508|NCT01490632|453182744|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
126145685|NCT02847598|453818298|FG005|Overall Study|Death|0|||
126145686|NCT02847598|453818299|FG006|Overall Study|Death|0|||
126145687|NCT02847598|453818300|FG007|Overall Study|Death|0|||
126145688|NCT02847598|453818293|FG000|Overall Study|Lost to Follow-up|0|||
126145689|NCT02847598|453818294|FG001|Overall Study|Lost to Follow-up|0|||
126145690|NCT02847598|453818295|FG002|Overall Study|Lost to Follow-up|0|||
126145691|NCT02847598|453818296|FG003|Overall Study|Lost to Follow-up|0|||
126145692|NCT02847598|453818297|FG004|Overall Study|Lost to Follow-up|0|||
126145693|NCT02847598|453818298|FG005|Overall Study|Lost to Follow-up|1|||
126145694|NCT02847598|453818299|FG006|Overall Study|Lost to Follow-up|1|||
126145695|NCT02847598|453818300|FG007|Overall Study|Lost to Follow-up|0|||
126145696|NCT02848833|453818301|FG000|Overall Study|subject who are duplicated|1|||
126145697|NCT02848833|453818301|FG000|Overall Study|have not taken the study drug|11|||
126145698|NCT02848833|453818301|FG000|Overall Study|follow-up failure|6|||
126145699|NCT02848833|453818301|FG000|Overall Study|Protocol Violation|119|||
126145700|NCT04167345|453818302|FG000|Overall Study|Other|1|||
126145701|NCT04167345|453818303|FG001|Overall Study|Other|1|||
126145702|NCT04167345|453818304|FG002|Overall Study|Other|0|||
126145703|NCT04167345|453818305|FG003|Overall Study|Other|0|||
126145704|NCT04167345|453818306|FG004|Overall Study|Other|0|||
126151414|NCT00488631|453841981|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
126151415|NCT00488631|453841982|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
126151416|NCT00488631|453841983|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126151417|NCT00488631|453841984|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126151418|NCT00488631|453841985|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126151419|NCT00488631|453841986|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126151420|NCT00488631|453841977|FG000|Double Blind Period (Week 0-54)|Other|6|||
126151421|NCT00488631|453841978|FG001|Double Blind Period (Week 0-54)|Other|12|||
126151422|NCT00488631|453841979|FG002|Double Blind Period (Week 0-54)|Other|10|||
126151423|NCT00488631|453841980|FG003|Double Blind Period (Week 0-54)|Other|11|||
126151424|NCT00488631|453841981|FG004|Double Blind Period (Week 0-54)|Other|14|||
126151425|NCT00488631|453841982|FG005|Double Blind Period (Week 0-54)|Other|34|||
126151426|NCT00488631|453841983|FG006|Double Blind Period (Week 0-54)|Other|0|||
126151427|NCT00488631|453841984|FG007|Double Blind Period (Week 0-54)|Other|0|||
126151428|NCT00488631|453841985|FG008|Double Blind Period (Week 0-54)|Other|0|||
126151429|NCT00488631|453841986|FG009|Double Blind Period (Week 0-54)|Other|0|||
126151430|NCT00488631|453841977|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126151431|NCT00488631|453841978|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126151432|NCT00488631|453841979|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126151433|NCT00488631|453841980|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126151434|NCT00488631|453841981|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126151435|NCT00488631|453841982|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126151436|NCT00488631|453841983|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
126151437|NCT00488631|453841984|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
126151438|NCT00488631|453841985|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
126151439|NCT00488631|453841986|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126151440|NCT00488631|453841977|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
126151441|NCT00488631|453841978|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
126151442|NCT00488631|453841979|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
126151443|NCT00488631|453841980|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
126151444|NCT00488631|453841981|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
126151445|NCT00488631|453841982|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
126151446|NCT00488631|453841983|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
126151447|NCT00488631|453841984|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
126151448|NCT00488631|453841985|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
126151449|NCT00488631|453841986|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
126151450|NCT00488631|453841977|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126151451|NCT00488631|453841978|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125970509|NCT01490632|453182745|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
125970510|NCT01490632|453182746|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
125970511|NCT01490632|453182747|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
126151452|NCT00488631|453841979|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126151453|NCT00488631|453841980|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126151454|NCT00488631|453841981|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126151455|NCT00488631|453841982|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126151456|NCT00488631|453841983|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
126151457|NCT00488631|453841984|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
126151458|NCT00488631|453841985|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
126145705|NCT01609933|453820015|FG000|Overall Study|Adverse Event|1|||
126145706|NCT01609933|453820015|FG000|Overall Study|Withdrawal by Subject|3|||
126145707|NCT00224016|453820016|FG000|Titration Period|Withdrawal by Subject|0|||
126145708|NCT00224016|453820017|FG001|Titration Period|Withdrawal by Subject|1|||
126145709|NCT00224016|453820016|FG000|Titration Period|Lost to Follow-up|1|||
126145710|NCT00224016|453820017|FG001|Titration Period|Lost to Follow-up|0|||
126145711|NCT00224016|453820016|FG000|Maintenance Period|Withdrawal by Subject|2|||
126145712|NCT00224016|453820017|FG001|Maintenance Period|Withdrawal by Subject|0|||
126145713|NCT00224016|453820016|FG000|Maintenance Period|Lost to Follow-up|0|||
126145714|NCT00224016|453820017|FG001|Maintenance Period|Lost to Follow-up|1|||
126145715|NCT01252966|453820018|FG000|Overall Study|Lost to Follow-up|16|||
126145716|NCT01252966|453820019|FG001|Overall Study|Lost to Follow-up|10|||
126145717|NCT01252966|453820018|FG000|Overall Study|Withdrawal by Subject|7|||
126145718|NCT01252966|453820019|FG001|Overall Study|Withdrawal by Subject|3|||
126145719|NCT00206726|453820026|FG000|Overall Study|Delayed recovery of blood counts|1|||
126145720|NCT00206726|453820026|FG000|Overall Study|Progressive disease or relapsed disease|18|||
126145721|NCT00206726|453820026|FG000|Overall Study|Placed on new protocol|1|||
126145722|NCT00206726|453820026|FG000|Overall Study|Bone marrow transplant|1|||
126145723|NCT00206726|453820026|FG000|Overall Study|Adverse Event|17|||
126145724|NCT00206726|453820026|FG000|Overall Study|Death|4|||
126145725|NCT00206726|453820026|FG000|Overall Study|Protocol Violation|1|||
126145726|NCT00206726|453820026|FG000|Overall Study|Withdrawal by Subject|8|||
126145727|NCT01028352|453820029|FG000|Overall Study|Ineligible due to baseline average pain|5|||
126145728|NCT01028352|453820029|FG000|Overall Study|Withdrawal by Subject|1|||
126145729|NCT00768222|453820030|FG000|Overall Study|Lost to Follow-up|1|||
126145730|NCT00768222|453820031|FG001|Overall Study|Lost to Follow-up|1|||
126145731|NCT00768222|453820030|FG000|Overall Study|Withdrawal by Subject|3|||
126145732|NCT00768222|453820031|FG001|Overall Study|Withdrawal by Subject|1|||
126145733|NCT00768222|453820030|FG000|Overall Study|Protocol Violation|0|||
126145734|NCT00768222|453820031|FG001|Overall Study|Protocol Violation|2|||
126145735|NCT02468193|453820032|FG000|Overall Study|Adverse Event|4|||
126145736|NCT02468193|453820032|FG000|Overall Study|Subject/ Guardian decision|2|||
126145737|NCT03312218|453820033|FG000|Overall Study|Never signed in to access the app|54|||
126145738|NCT03312218|453820034|FG001|Overall Study|Never signed in to access the app|58|||
126145739|NCT01887912|453820035|FG000|Overall Study|Serious adverse event|400|||
126145740|NCT01887912|453820036|FG001|Overall Study|Serious adverse event|198|||
126145741|NCT01887912|453820035|FG000|Overall Study|Other Adverse Event|34|||
126145742|NCT01887912|453820036|FG001|Overall Study|Other Adverse Event|15|||
126145743|NCT01887912|453820035|FG000|Overall Study|Protocol Violation|67|||
126145744|NCT01887912|453820036|FG001|Overall Study|Protocol Violation|37|||
126145745|NCT01887912|453820035|FG000|Overall Study|Lost to Follow-up|163|||
126145746|NCT01887912|453820036|FG001|Overall Study|Lost to Follow-up|74|||
126145747|NCT01887912|453820035|FG000|Overall Study|Withdrawal by Subject|606|||
126145748|NCT01887912|453820036|FG001|Overall Study|Withdrawal by Subject|349|||
126145749|NCT01887912|453820035|FG000|Overall Study|Other|122|||
126145750|NCT01887912|453820036|FG001|Overall Study|Other|58|||
126145751|NCT05067127|453820039|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
125970512|NCT01490632|453182748|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
125970513|NCT01490632|453182749|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
125970514|NCT01490632|453182750|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
125970515|NCT01490632|453182751|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
125970516|NCT01490632|453182752|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
125970517|NCT01490632|453182753|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
125970518|NCT01490632|453182754|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
125970519|NCT01490632|453182755|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
125970520|NCT01490632|453182756|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
125970521|NCT01490632|453182757|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
126145752|NCT05067127|453820040|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
126145753|NCT05067127|453820041|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
126145754|NCT05067127|453820042|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
126145755|NCT05067127|453820039|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
126145756|NCT05067127|453820040|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
126145757|NCT05067127|453820041|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
126145758|NCT05067127|453820042|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
126145759|NCT05067127|453820039|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
126145760|NCT05067127|453820040|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126145761|NCT05067127|453820041|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126145762|NCT05067127|453820042|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126145763|NCT05067127|453820039|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
125970522|NCT01490632|453182758|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
126145764|NCT05067127|453820040|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
126145765|NCT05067127|453820041|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
126145766|NCT05067127|453820042|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
126145767|NCT05067127|453820039|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
126145768|NCT05067127|453820040|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
126145769|NCT05067127|453820041|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
126145770|NCT05067127|453820042|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
126145771|NCT05067127|453820039|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
126145772|NCT05067127|453820040|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
126145773|NCT05067127|453820041|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
126145774|NCT05067127|453820042|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
126145775|NCT05067127|453820039|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126145776|NCT05067127|453820040|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126145777|NCT05067127|453820041|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
126145778|NCT05067127|453820042|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
126145779|NCT04462536|453820043|FG000|Overall Study|Withdrawal by Subject|3|||
126145780|NCT04462536|453820044|FG001|Overall Study|Withdrawal by Subject|9|||
126145781|NCT04462536|453820043|FG000|Overall Study|Lost to Follow-up|2|||
126145782|NCT04462536|453820044|FG001|Overall Study|Lost to Follow-up|4|||
126145783|NCT01154101|453820050|FG000|Overall Study|Adverse Event|0|||
126145784|NCT01154101|453820051|FG001|Overall Study|Adverse Event|2|||
126145785|NCT01154101|453820052|FG002|Overall Study|Adverse Event|1|||
126145786|NCT01154101|453820053|FG003|Overall Study|Adverse Event|1|||
126145787|NCT01154101|453820054|FG004|Overall Study|Adverse Event|0|||
126145788|NCT01154101|453820050|FG000|Overall Study|Lost to Follow-up|0|||
126145789|NCT01154101|453820051|FG001|Overall Study|Lost to Follow-up|1|||
126145790|NCT01154101|453820052|FG002|Overall Study|Lost to Follow-up|0|||
126145791|NCT01154101|453820053|FG003|Overall Study|Lost to Follow-up|1|||
126145792|NCT01154101|453820054|FG004|Overall Study|Lost to Follow-up|0|||
126145793|NCT01154101|453820050|FG000|Overall Study|Withdrawal by Subject|0|||
126145794|NCT01154101|453820051|FG001|Overall Study|Withdrawal by Subject|1|||
126145795|NCT01154101|453820052|FG002|Overall Study|Withdrawal by Subject|2|||
126145796|NCT01154101|453820053|FG003|Overall Study|Withdrawal by Subject|0|||
126145797|NCT01154101|453820054|FG004|Overall Study|Withdrawal by Subject|1|||
126145798|NCT04125680|453820056|FG000|Overall Study|Lost to Follow-up|15|||
126145799|NCT01562028|453820057|FG000|Overall Study|Withdrawal by Subject|1|||
126145800|NCT01562028|453820058|FG001|Overall Study|Withdrawal by Subject|1|||
126145801|NCT01562028|453820057|FG000|Overall Study|Lost to Follow-up|2|||
126145802|NCT01562028|453820058|FG001|Overall Study|Lost to Follow-up|1|||
126145803|NCT02360098|453820059|FG000|Overall Study|Physician Decision|7|||
126145804|NCT02731742|453820066|FG000|Overall Study|Death|1|||
126145805|NCT02731742|453820067|FG001|Overall Study|Death|2|||
126145806|NCT02731742|453820068|FG002|Overall Study|Death|5|||
126145807|NCT02731742|453820069|FG003|Overall Study|Death|0|||
126145808|NCT02731742|453820066|FG000|Overall Study|Physician Decision|0|||
126145809|NCT02731742|453820067|FG001|Overall Study|Physician Decision|0|||
126145810|NCT02731742|453820068|FG002|Overall Study|Physician Decision|0|||
126145811|NCT02731742|453820069|FG003|Overall Study|Physician Decision|1|||
126145812|NCT02731742|453820066|FG000|Overall Study|Study Terminated by Sponsor|2|||
126145813|NCT02731742|453820067|FG001|Overall Study|Study Terminated by Sponsor|1|||
126145814|NCT02731742|453820068|FG002|Overall Study|Study Terminated by Sponsor|1|||
126145815|NCT02731742|453820069|FG003|Overall Study|Study Terminated by Sponsor|1|||
126145816|NCT00619229|453820070|FG000|Overall Study|Withdrawal by Subject|1|||
126145817|NCT00619229|453820071|FG001|Overall Study|Withdrawal by Subject|1|||
126145818|NCT00619229|453820070|FG000|Overall Study|Lost to Follow-up|1|||
126145819|NCT00619229|453820071|FG001|Overall Study|Lost to Follow-up|0|||
126145820|NCT00619229|453820070|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
126145821|NCT00619229|453820071|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
126145822|NCT00619229|453820070|FG000|Overall Study|Investigator planned Cataract Operation|1|||
126145823|NCT00619229|453820071|FG001|Overall Study|Investigator planned Cataract Operation|0|||
126145824|NCT02786901|453820072|FG000|Overall Study|Adverse Event|1|||
126145825|NCT02786901|453820073|FG001|Overall Study|Adverse Event|1|||
126145826|NCT02786901|453820074|FG002|Overall Study|Adverse Event|2|||
126145827|NCT02786901|453820072|FG000|Overall Study|Physician Decision|1|||
126145828|NCT02786901|453820073|FG001|Overall Study|Physician Decision|0|||
126145829|NCT02786901|453820074|FG002|Overall Study|Physician Decision|0|||
126145830|NCT02786901|453820072|FG000|Overall Study|Rescue Therapy Use|71|||
126145831|NCT02786901|453820073|FG001|Overall Study|Rescue Therapy Use|49|||
126145832|NCT02786901|453820074|FG002|Overall Study|Rescue Therapy Use|33|||
126145833|NCT02786901|453820072|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
126145834|NCT02786901|453820073|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
126145835|NCT02786901|453820074|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
126145836|NCT02786901|453820072|FG000|Overall Study|Disallowed medication|1|||
126145837|NCT02786901|453820073|FG001|Overall Study|Disallowed medication|1|||
126145838|NCT02786901|453820074|FG002|Overall Study|Disallowed medication|0|||
126145839|NCT02786901|453820072|FG000|Overall Study|Randomized in error|2|||
126145840|NCT02786901|453820073|FG001|Overall Study|Randomized in error|0|||
126145841|NCT02786901|453820074|FG002|Overall Study|Randomized in error|1|||
126145842|NCT03367871|453820075|FG000|Overall Study|Lost to Follow-up|1|||
126145843|NCT01157117|453820076|FG000|Overall Study|Dosing Symptoms|0|||
126145844|NCT01157117|453820077|FG001|Overall Study|Dosing Symptoms|4|||
126145845|NCT01157117|453820078|FG002|Overall Study|Dosing Symptoms|0|||
126145846|NCT01157117|453820076|FG000|Overall Study|Withdrawal by Subject|4|||
126145847|NCT01157117|453820077|FG001|Overall Study|Withdrawal by Subject|1|||
126145848|NCT01157117|453820078|FG002|Overall Study|Withdrawal by Subject|1|||
126145849|NCT01157117|453820076|FG000|Overall Study|Lack of Efficacy|1|||
126145850|NCT01157117|453820077|FG001|Overall Study|Lack of Efficacy|1|||
126145851|NCT01157117|453820078|FG002|Overall Study|Lack of Efficacy|0|||
126145852|NCT01157117|453820076|FG000|Overall Study|Lost to Follow-up|0|||
126145853|NCT01157117|453820077|FG001|Overall Study|Lost to Follow-up|0|||
126145854|NCT01157117|453820078|FG002|Overall Study|Lost to Follow-up|1|||
126145855|NCT01157117|453820076|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
126145856|NCT01157117|453820077|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
126145857|NCT01157117|453820078|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
126145858|NCT01071070|453820084|FG000|Overall Study|Adverse Event|0|||
126145859|NCT01071070|453820085|FG001|Overall Study|Adverse Event|3|||
126145860|NCT01071070|453820084|FG000|Overall Study|Withdrawal by Subject|1|||
126145861|NCT01071070|453820085|FG001|Overall Study|Withdrawal by Subject|0|||
126145862|NCT01071070|453820084|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
126145863|NCT01071070|453820085|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
126145864|NCT01071070|453820084|FG000|Overall Study|Hypercalcemia|1|||
126145865|NCT01071070|453820085|FG001|Overall Study|Hypercalcemia|0|||
126145866|NCT02207907|453820086|FG000|Overall Study|Lost to Follow-up|3|||
126145867|NCT02207907|453820087|FG001|Overall Study|Lost to Follow-up|1|||
126145868|NCT02207907|453820086|FG000|Overall Study|Withdrawal by Subject|5|||
126145869|NCT02207907|453820087|FG001|Overall Study|Withdrawal by Subject|6|||
126145870|NCT02207907|453820086|FG000|Overall Study|Did not meet study criteria|3|||
126145871|NCT02207907|453820087|FG001|Overall Study|Did not meet study criteria|0|||
126145872|NCT02207907|453820086|FG000|Overall Study|Pregnancy|0|||
126145873|NCT02207907|453820087|FG001|Overall Study|Pregnancy|1|||
126145874|NCT02620020|453820088|FG000|Overall Study|Adverse Event|8|||
126145875|NCT02620020|453820089|FG001|Overall Study|Adverse Event|4|||
126145876|NCT02620020|453820090|FG002|Overall Study|Adverse Event|3|||
126145877|NCT02620020|453820091|FG003|Overall Study|Adverse Event|5|||
126145878|NCT02620020|453820088|FG000|Overall Study|Lost to Follow-up|4|||
126145879|NCT02620020|453820089|FG001|Overall Study|Lost to Follow-up|8|||
126145880|NCT02620020|453820090|FG002|Overall Study|Lost to Follow-up|1|||
126145881|NCT02620020|453820091|FG003|Overall Study|Lost to Follow-up|4|||
126145882|NCT02620020|453820088|FG000|Overall Study|Physician Decision|7|||
126145883|NCT02620020|453820089|FG001|Overall Study|Physician Decision|4|||
126145884|NCT02620020|453820090|FG002|Overall Study|Physician Decision|3|||
126145885|NCT02620020|453820091|FG003|Overall Study|Physician Decision|4|||
126145886|NCT02620020|453820088|FG000|Overall Study|Protocol Violation|5|||
126145887|NCT02620020|453820089|FG001|Overall Study|Protocol Violation|2|||
126145888|NCT02620020|453820090|FG002|Overall Study|Protocol Violation|1|||
126145889|NCT02620020|453820091|FG003|Overall Study|Protocol Violation|1|||
126145890|NCT02620020|453820088|FG000|Overall Study|Withdrawal by Subject|20|||
126145891|NCT02620020|453820089|FG001|Overall Study|Withdrawal by Subject|16|||
126145892|NCT02620020|453820090|FG002|Overall Study|Withdrawal by Subject|17|||
126145893|NCT02620020|453820091|FG003|Overall Study|Withdrawal by Subject|12|||
126145894|NCT02620020|453820088|FG000|Overall Study|Death|0|||
126145895|NCT02620020|453820089|FG001|Overall Study|Death|1|||
126145896|NCT02620020|453820090|FG002|Overall Study|Death|0|||
126145897|NCT02620020|453820091|FG003|Overall Study|Death|0|||
126145898|NCT02209506|453820093|FG000|Overall Study|Withdrawal by Subject|0|||
126145899|NCT02209506|453820094|FG001|Overall Study|Withdrawal by Subject|0|||
126145900|NCT02209506|453820095|FG002|Overall Study|Withdrawal by Subject|0|||
126145901|NCT02209506|453820096|FG003|Overall Study|Withdrawal by Subject|0|||
126145902|NCT02209506|453820097|FG004|Overall Study|Withdrawal by Subject|1|||
126145903|NCT01287104|453820098|FG000|Overall Study|Patient developed progressive disease|1|||
126145904|NCT01287104|453820099|FG001|Overall Study|Patient developed progressive disease|1|||
126145905|NCT01287104|453820100|FG002|Overall Study|Patient developed progressive disease|3|||
126145906|NCT01287104|453820101|FG003|Overall Study|Patient developed progressive disease|2|||
126145907|NCT01287104|453820098|FG000|Overall Study|Donor anaphylaxis|0|||
126145908|NCT01287104|453820099|FG001|Overall Study|Donor anaphylaxis|1|||
126145909|NCT01287104|453820100|FG002|Overall Study|Donor anaphylaxis|0|||
126145910|NCT01287104|453820101|FG003|Overall Study|Donor anaphylaxis|1|||
126145911|NCT01287104|453820098|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
126145912|NCT01287104|453820099|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
126145913|NCT01287104|453820100|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
126145914|NCT01287104|453820101|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
126145915|NCT01287104|453820098|FG000|Overall Study|Low donor chimerism|0|||
126145916|NCT01287104|453820099|FG001|Overall Study|Low donor chimerism|1|||
126145917|NCT01287104|453820100|FG002|Overall Study|Low donor chimerism|0|||
126145918|NCT01287104|453820101|FG003|Overall Study|Low donor chimerism|0|||
126145919|NCT01287104|453820098|FG000|Overall Study|NK cells did not meet release criteria|0|||
126145920|NCT01287104|453820099|FG001|Overall Study|NK cells did not meet release criteria|1|||
126145921|NCT01287104|453820100|FG002|Overall Study|NK cells did not meet release criteria|0|||
126145922|NCT01287104|453820101|FG003|Overall Study|NK cells did not meet release criteria|0|||
126145923|NCT02537678|453820106|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
126145924|NCT02537678|453820107|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
126145925|NCT02537678|453820106|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
126145926|NCT02537678|453820107|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
126145927|NCT02537678|453820106|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
126145928|NCT02537678|453820107|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
126145929|NCT02537678|453820106|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
126145930|NCT02537678|453820107|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
126145931|NCT02537678|453820106|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
126145932|NCT02537678|453820107|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
126145933|NCT02537678|453820106|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
126145934|NCT02537678|453820107|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
126145935|NCT02537678|453820106|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
126145936|NCT02537678|453820107|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
126145937|NCT02965378|453820108|FG000|Overall Study|Progression|16|||
126145938|NCT02965378|453820109|FG001|Overall Study|Progression|4|||
126145939|NCT02965378|453820108|FG000|Overall Study|Adverse Event|5|||
126145940|NCT02965378|453820109|FG001|Overall Study|Adverse Event|2|||
126145941|NCT02965378|453820108|FG000|Overall Study|Death|2|||
126145942|NCT02965378|453820109|FG001|Overall Study|Death|0|||
126145943|NCT02965378|453820108|FG000|Overall Study|Refusal|2|||
126145944|NCT02965378|453820109|FG001|Overall Study|Refusal|1|||
126145945|NCT02965378|453820108|FG000|Overall Study|Not protocol specified|0|||
126145946|NCT02965378|453820109|FG001|Overall Study|Not protocol specified|2|||
126145947|NCT00629083|453820114|FG000|Overall Study|Adverse Event|0|||
126145948|NCT00629083|453820115|FG001|Overall Study|Adverse Event|2|||
126145949|NCT00629083|453820114|FG000|Overall Study|Lack of Efficacy|3|||
126145950|NCT00629083|453820115|FG001|Overall Study|Lack of Efficacy|1|||
126145951|NCT00629083|453820114|FG000|Overall Study|Withdrawal by Subject|10|||
126145952|NCT00629083|453820115|FG001|Overall Study|Withdrawal by Subject|2|||
126145953|NCT00629083|453820114|FG000|Overall Study|Lost to Follow-up|12|||
126145954|NCT00629083|453820115|FG001|Overall Study|Lost to Follow-up|8|||
126145955|NCT00629083|453820114|FG000|Overall Study|Moved out of country/state|2|||
126145956|NCT00629083|453820115|FG001|Overall Study|Moved out of country/state|1|||
126145957|NCT00629083|453820114|FG000|Overall Study|Refused to return for 12 month visit|1|||
126145958|NCT00629083|453820115|FG001|Overall Study|Refused to return for 12 month visit|0|||
126145959|NCT02909153|453820116|FG000|Overall Study|Withdrawal by Subject|0|||
126145960|NCT02909153|453820117|FG001|Overall Study|Withdrawal by Subject|1|||
126145961|NCT02909153|453820118|FG002|Overall Study|Withdrawal by Subject|0|||
126145962|NCT02909153|453820119|FG003|Overall Study|Withdrawal by Subject|0|||
126145963|NCT02909153|453820120|FG004|Overall Study|Withdrawal by Subject|0|||
126145964|NCT01193686|453820121|FG000|Overall Study|Withdrawal by Subject|4|||
126145965|NCT01193686|453820122|FG001|Overall Study|Withdrawal by Subject|1|||
126145966|NCT01193686|453820121|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
126145967|NCT01193686|453820122|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
126145968|NCT03401749|453820123|FG000|Overall Study|Lost to Follow-up|20|||
126145969|NCT03401749|453820124|FG001|Overall Study|Lost to Follow-up|16|||
126145970|NCT03401749|453820125|FG002|Overall Study|Lost to Follow-up|26|||
126145971|NCT01147809|453820128|FG000|Phase I (168 Days)|Adverse Event|0|||
126145972|NCT01147809|453820129|FG001|Phase I (168 Days)|Adverse Event|0|||
126145973|NCT01147809|453820130|FG002|Phase I (168 Days)|Adverse Event|0|||
126145974|NCT01147809|453820131|FG003|Phase I (168 Days)|Adverse Event|1|||
126145975|NCT01147809|453820132|FG004|Phase I (168 Days)|Adverse Event|0|||
126145976|NCT01147809|453820133|FG005|Phase I (168 Days)|Adverse Event|0|||
126145977|NCT01147809|453820128|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
126145978|NCT01147809|453820129|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
126145979|NCT01147809|453820130|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
126145980|NCT01147809|453820131|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
126145981|NCT01147809|453820132|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
126145982|NCT01147809|453820133|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
126145983|NCT01147809|453820128|FG000|Phase I (168 Days)|Physician Decision|0|||
126145984|NCT01147809|453820129|FG001|Phase I (168 Days)|Physician Decision|1|||
126145985|NCT01147809|453820130|FG002|Phase I (168 Days)|Physician Decision|2|||
126145986|NCT01147809|453820131|FG003|Phase I (168 Days)|Physician Decision|0|||
126145987|NCT01147809|453820132|FG004|Phase I (168 Days)|Physician Decision|0|||
126145988|NCT01147809|453820133|FG005|Phase I (168 Days)|Physician Decision|0|||
126145989|NCT01147809|453820128|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
126145990|NCT01147809|453820129|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
126145991|NCT01147809|453820130|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
126145992|NCT01147809|453820131|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
126145993|NCT01147809|453820132|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
126145994|NCT01147809|453820133|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
126145995|NCT01147809|453820128|FG000|Phase II (168 Days)|Adverse Event|0|||
126145996|NCT01147809|453820129|FG001|Phase II (168 Days)|Adverse Event|0|||
126145997|NCT01147809|453820130|FG002|Phase II (168 Days)|Adverse Event|0|||
126145998|NCT01147809|453820131|FG003|Phase II (168 Days)|Adverse Event|0|||
126145999|NCT01147809|453820132|FG004|Phase II (168 Days)|Adverse Event|3|||
126146000|NCT01147809|453820133|FG005|Phase II (168 Days)|Adverse Event|6|||
126146001|NCT01147809|453820128|FG000|Phase II (168 Days)|Protocol Violation|0|||
126146002|NCT01147809|453820129|FG001|Phase II (168 Days)|Protocol Violation|0|||
126146003|NCT01147809|453820130|FG002|Phase II (168 Days)|Protocol Violation|0|||
126146004|NCT01147809|453820131|FG003|Phase II (168 Days)|Protocol Violation|0|||
126146005|NCT01147809|453820132|FG004|Phase II (168 Days)|Protocol Violation|0|||
126146006|NCT01147809|453820133|FG005|Phase II (168 Days)|Protocol Violation|1|||
126146007|NCT01147809|453820128|FG000|Phase II (168 Days)|Physician Decision|0|||
126146008|NCT01147809|453820129|FG001|Phase II (168 Days)|Physician Decision|0|||
126146009|NCT01147809|453820130|FG002|Phase II (168 Days)|Physician Decision|0|||
126146010|NCT01147809|453820131|FG003|Phase II (168 Days)|Physician Decision|0|||
126146011|NCT01147809|453820132|FG004|Phase II (168 Days)|Physician Decision|5|||
126146012|NCT01147809|453820133|FG005|Phase II (168 Days)|Physician Decision|11|||
126146013|NCT01147809|453820128|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
126146014|NCT01147809|453820129|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
126146015|NCT01147809|453820130|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
126146016|NCT01147809|453820131|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
126146017|NCT01147809|453820132|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
126146018|NCT01147809|453820133|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
126146019|NCT01147809|453820128|FG000|Phase II (168 Days)|Ongoing|0|||
126146020|NCT01147809|453820129|FG001|Phase II (168 Days)|Ongoing|0|||
126146021|NCT01147809|453820130|FG002|Phase II (168 Days)|Ongoing|0|||
126146022|NCT01147809|453820131|FG003|Phase II (168 Days)|Ongoing|0|||
126146023|NCT01147809|453820132|FG004|Phase II (168 Days)|Ongoing|1|||
126146024|NCT01147809|453820133|FG005|Phase II (168 Days)|Ongoing|0|||
126146025|NCT01307423|453820134|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
126146026|NCT01307423|453820135|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
126146027|NCT01307423|453820136|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
126146028|NCT01307423|453820137|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126146029|NCT01307423|453820138|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126146030|NCT01307423|453820139|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126146031|NCT01307423|453820140|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126146032|NCT01307423|453820141|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126146033|NCT01307423|453820142|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126146034|NCT01307423|453820134|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
126146035|NCT01307423|453820135|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
126146036|NCT01307423|453820136|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
126146037|NCT01307423|453820137|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126146038|NCT01307423|453820138|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126146039|NCT01307423|453820139|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126146040|NCT01307423|453820140|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126146041|NCT01307423|453820141|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126146042|NCT01307423|453820142|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126146043|NCT01307423|453820134|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
126146044|NCT01307423|453820135|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
126146045|NCT01307423|453820136|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
126146046|NCT01307423|453820137|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126146047|NCT01307423|453820138|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126146048|NCT01307423|453820139|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126146049|NCT01307423|453820140|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126146050|NCT01307423|453820141|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126146051|NCT01307423|453820142|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126146052|NCT01307423|453820134|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126146053|NCT01307423|453820135|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126146054|NCT01307423|453820136|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
126146055|NCT01307423|453820137|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126146056|NCT01307423|453820138|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126146057|NCT01307423|453820139|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126146058|NCT01307423|453820140|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126146059|NCT01307423|453820141|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126146060|NCT01307423|453820142|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126146061|NCT01307423|453820134|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
126146062|NCT01307423|453820135|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126146063|NCT01307423|453820136|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
126146064|NCT01307423|453820137|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126146065|NCT01307423|453820138|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126146066|NCT01307423|453820139|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126146067|NCT01307423|453820140|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126146068|NCT01307423|453820141|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126146069|NCT01307423|453820142|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126146070|NCT01307423|453820134|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126146071|NCT01307423|453820135|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126146072|NCT01307423|453820136|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126146073|NCT01307423|453820137|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126146074|NCT01307423|453820138|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126146075|NCT01307423|453820139|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126146076|NCT01307423|453820140|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126146077|NCT01307423|453820141|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126146078|NCT01307423|453820142|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126146079|NCT01307423|453820134|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
126146080|NCT01307423|453820135|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
126146081|NCT01307423|453820136|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126146082|NCT01307423|453820137|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126146083|NCT01307423|453820138|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126146084|NCT01307423|453820139|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126146085|NCT01307423|453820140|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126146086|NCT01307423|453820141|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126146087|NCT01307423|453820142|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126146088|NCT01307423|453820134|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126146089|NCT01307423|453820135|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
126146090|NCT01307423|453820136|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
126146091|NCT01307423|453820137|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126146092|NCT01307423|453820138|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126146093|NCT01307423|453820139|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126146094|NCT01307423|453820140|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126146095|NCT01307423|453820141|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126146096|NCT01307423|453820142|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126146097|NCT01307423|453820134|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126146098|NCT01307423|453820135|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
126146099|NCT01307423|453820136|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
126146100|NCT01307423|453820137|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
126146101|NCT01307423|453820138|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
126146102|NCT01307423|453820139|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126146103|NCT01307423|453820140|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126146104|NCT01307423|453820141|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126146105|NCT01307423|453820142|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126146106|NCT01307423|453820134|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126146107|NCT01307423|453820135|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
126146108|NCT01307423|453820136|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
126146109|NCT01307423|453820137|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
126146110|NCT01307423|453820138|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
126146111|NCT01307423|453820139|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126146112|NCT01307423|453820140|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126146113|NCT01307423|453820141|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126146114|NCT01307423|453820142|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126146115|NCT01307423|453820134|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126146116|NCT01307423|453820135|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126146117|NCT01307423|453820136|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126146118|NCT01307423|453820137|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126146119|NCT01307423|453820138|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126146120|NCT01307423|453820139|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
126199955|NCT01117428|454017804|FG000|Overall Study|Withdrawal by Subject|0|||
125970523|NCT01490632|453182739|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
125970524|NCT01490632|453182740|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
125970525|NCT01490632|453182741|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
126146121|NCT01307423|453820140|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126146122|NCT01307423|453820141|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126146123|NCT01307423|453820142|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126146124|NCT01307423|453820134|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126146125|NCT01307423|453820135|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
126146126|NCT01307423|453820136|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
126146127|NCT01307423|453820137|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126146128|NCT01307423|453820138|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126146129|NCT01307423|453820139|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
126146130|NCT01307423|453820140|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
126146131|NCT01307423|453820141|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126146132|NCT01307423|453820142|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126146133|NCT01307423|453820134|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126146134|NCT01307423|453820135|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126146135|NCT01307423|453820136|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126146136|NCT01307423|453820137|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
126146137|NCT01307423|453820138|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126146138|NCT01307423|453820139|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126146139|NCT01307423|453820140|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126146140|NCT01307423|453820141|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126146141|NCT01307423|453820142|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126146142|NCT01307423|453820134|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
126146143|NCT01307423|453820135|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
126146144|NCT01307423|453820136|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
126146145|NCT01307423|453820137|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
126146146|NCT01307423|453820138|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
126146147|NCT01307423|453820139|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
126146148|NCT01307423|453820140|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
126146149|NCT01307423|453820141|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
126146150|NCT01307423|453820142|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
126146151|NCT01307423|453820134|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126146152|NCT01307423|453820135|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126146153|NCT01307423|453820136|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126146154|NCT01307423|453820137|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126146155|NCT01307423|453820138|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126146156|NCT01307423|453820139|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
126146157|NCT01307423|453820140|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126146158|NCT01307423|453820141|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126146159|NCT01307423|453820142|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126146160|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126146161|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
126146162|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
126146163|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126146164|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126146165|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126146166|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126146167|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
126146168|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
126146169|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126146170|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
126146171|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
126146172|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126146173|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126146174|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126146175|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126146176|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
126146177|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
126146178|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126146179|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126146180|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
126146181|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126146182|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126146183|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126146184|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126146185|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126146186|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126146187|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126146188|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
126146189|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
126146190|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126146191|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126146192|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126146193|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126146194|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
126146195|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
126146196|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126146197|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
126146198|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126146199|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126146200|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126146201|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126146202|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126146203|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
126146204|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
126146205|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126146206|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
126146207|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
126146208|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126146209|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126146210|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126146211|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126146212|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
126146213|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
126146214|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126146215|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
126146216|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
126146217|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126146218|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126146219|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126146220|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126146221|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
126146222|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
126146223|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126146224|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
126146225|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
126146226|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126146227|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126146228|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126146229|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126146230|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126146231|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126146232|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126146233|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
126146234|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
126146235|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126146236|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126146237|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126146238|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126146239|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
126146240|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
126146241|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126146242|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
126146243|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
126146244|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126146245|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126146246|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126146247|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126146248|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
126146249|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
126146250|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126146251|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
126146252|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126146253|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126146254|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126146255|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126146256|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126146257|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
126146258|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126146259|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126146260|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
126146261|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126146262|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126146263|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126146264|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126146265|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126146266|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126146267|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126146268|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126146269|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
126146270|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126146271|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126146272|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126146273|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126146274|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126146275|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126146276|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
126146277|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126146278|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
126146279|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
126146280|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126146281|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126146282|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126146283|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126146284|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
126146285|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
126146286|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126146287|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126146288|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
126146289|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126146290|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126146291|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126146292|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126146293|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126146294|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126146295|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126146296|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126146297|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126146298|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126146299|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126146300|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126146301|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126146302|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
126146303|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126146304|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126146305|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
126146306|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
126146307|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126146308|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126146309|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126146310|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126146311|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126146312|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
126146313|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126146314|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
126146315|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
126146316|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126146317|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126146318|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126146319|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126146320|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126146321|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126146322|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126146323|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
126146324|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
126146325|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126146326|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126146327|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126146328|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126146329|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126146330|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
126146331|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126146332|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
126146333|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126146334|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126146335|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126146336|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126146337|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126146338|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126146339|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126146340|NCT01307423|453820134|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126146341|NCT01307423|453820135|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126146342|NCT01307423|453820136|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
126146343|NCT01307423|453820137|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126146344|NCT01307423|453820138|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126146345|NCT01307423|453820139|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126146346|NCT01307423|453820140|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126146347|NCT01307423|453820141|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
126146348|NCT01307423|453820142|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
126146349|NCT03896295|453820143|FG000|Overall Study|Adverse Event|0|||
126146350|NCT03896295|453820144|FG001|Overall Study|Adverse Event|1|||
126146351|NCT03896295|453820143|FG000|Overall Study|COVID-19|7|||
126146352|NCT03896295|453820144|FG001|Overall Study|COVID-19|29|||
126146353|NCT00700804|453820145|FG000|Overall Study|Withdrawal by Subject|1|||
126146354|NCT00700804|453820146|FG001|Overall Study|Withdrawal by Subject|2|||
126146355|NCT00700804|453820145|FG000|Overall Study|Protocol Violation|1|||
126146356|NCT00700804|453820146|FG001|Overall Study|Protocol Violation|1|||
126146357|NCT00700804|453820145|FG000|Overall Study|Loose Stools|1|||
126146358|NCT00700804|453820146|FG001|Overall Study|Loose Stools|1|||
126146359|NCT01511445|453820147|FG000|Overall Study|Lost to Follow-up|3|||
126146360|NCT01511445|453820148|FG001|Overall Study|Lost to Follow-up|1|||
126146361|NCT01511445|453820147|FG000|Overall Study|Protocol Violation|1|||
126146362|NCT01511445|453820148|FG001|Overall Study|Protocol Violation|3|||
126146363|NCT01511445|453820147|FG000|Overall Study|Protocol Violation|1|||
126146364|NCT01511445|453820148|FG001|Overall Study|Protocol Violation|0|||
126146365|NCT04696861|453820149|FG000|Overall Study|Death|1|||
126146366|NCT04696861|453820150|FG001|Overall Study|Death|0|||
126146367|NCT04696861|453820149|FG000|Overall Study|Lost to Follow-up|3|||
126146368|NCT04696861|453820150|FG001|Overall Study|Lost to Follow-up|0|||
126146369|NCT02382133|453820151|FG000|Overall Study|Death|22|||
126146370|NCT02382133|453820151|FG000|Overall Study|transfer out of ICU|4|||
126146371|NCT02382133|453820151|FG000|Overall Study|Physician Decision|2|||
126146372|NCT02382133|453820151|FG000|Overall Study|arterial catheter loss|4|||
126146373|NCT02382133|453820151|FG000|Overall Study|pressure injury both sites|1|||
126146374|NCT00655928|453820152|FG000|Overall Study|Withdrawal by Subject|2|||
126146375|NCT00655928|453820153|FG001|Overall Study|Withdrawal by Subject|1|||
126146376|NCT00655928|453820152|FG000|Overall Study|Physician Decision|1|||
126146377|NCT00655928|453820153|FG001|Overall Study|Physician Decision|1|||
126146378|NCT03946449|453820160|FG000|Treatment Extension II|Rolled over to another study|0|||
126146379|NCT03946449|453820161|FG001|Treatment Extension II|Rolled over to another study|0|||
126146380|NCT03946449|453820162|FG002|Treatment Extension II|Rolled over to another study|2|||
126146381|NCT03946449|453820160|FG000|Treatment Extension II|Withdrawal by Subject|0|||
126146382|NCT03946449|453820161|FG001|Treatment Extension II|Withdrawal by Subject|0|||
126146383|NCT03946449|453820162|FG002|Treatment Extension II|Withdrawal by Subject|1|||
126146384|NCT03896581|453823231|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
126146385|NCT03896581|453823232|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
126146386|NCT03896581|453823231|FG000|Overall Study|Withdrawal by Subject|4|||
126146387|NCT03896581|453823232|FG001|Overall Study|Withdrawal by Subject|1|||
126146388|NCT03896581|453823231|FG000|Overall Study|Lost to Follow-up|1|||
126146389|NCT03896581|453823232|FG001|Overall Study|Lost to Follow-up|0|||
126146390|NCT03896581|453823231|FG000|Overall Study|Lack of Efficacy|2|||
126146391|NCT03896581|453823232|FG001|Overall Study|Lack of Efficacy|1|||
126146392|NCT03896581|453823231|FG000|Overall Study|Adverse event, non-fatal|0|||
126146393|NCT03896581|453823232|FG001|Overall Study|Adverse event, non-fatal|2|||
126146394|NCT04375761|453823233|FG000|Overall Study|Death|1|||
126146395|NCT04375761|453823234|FG001|Overall Study|Death|2|||
126146396|NCT04375761|453823233|FG000|Overall Study|Lost to Follow-up|203|||
126146397|NCT04375761|453823234|FG001|Overall Study|Lost to Follow-up|380|||
126146398|NCT04375761|453823233|FG000|Overall Study|Withdrawal by Subject|47|||
126146399|NCT04375761|453823234|FG001|Overall Study|Withdrawal by Subject|98|||
126146400|NCT04375761|453823233|FG000|Overall Study|Noncompliance with study procedure|121|||
126146401|NCT04375761|453823234|FG001|Overall Study|Noncompliance with study procedure|251|||
126146402|NCT04375761|453823233|FG000|Overall Study|Reimbursement not enough|1|||
126146403|NCT04375761|453823234|FG001|Overall Study|Reimbursement not enough|2|||
126146404|NCT04375761|453823233|FG000|Overall Study|Unforeseen family circumstances|1|||
126146405|NCT04375761|453823234|FG001|Overall Study|Unforeseen family circumstances|3|||
126146406|NCT04375761|453823233|FG000|Overall Study|Test too painful|1|||
126146407|NCT04375761|453823234|FG001|Overall Study|Test too painful|1|||
126146408|NCT04375761|453823233|FG000|Overall Study|Moved|0|||
126146409|NCT04375761|453823234|FG001|Overall Study|Moved|2|||
126146410|NCT04375761|453823233|FG000|Overall Study|Nonresponsive|0|||
126146411|NCT04375761|453823234|FG001|Overall Study|Nonresponsive|5|||
126146412|NCT03797001|453823235|FG000|Overall Study|Withdrawn due to COVID19|4|||
126146413|NCT03797001|453823236|FG001|Overall Study|Withdrawn due to COVID19|0|||
126146414|NCT03797001|453823235|FG000|Overall Study|Withdrawal by Subject|7|||
126146415|NCT03797001|453823236|FG001|Overall Study|Withdrawal by Subject|6|||
126146416|NCT03797001|453823235|FG000|Overall Study|Adverse Event|0|||
126146417|NCT03797001|453823236|FG001|Overall Study|Adverse Event|1|||
126146418|NCT05630846|453823239|FG000|Overall Study|Death|1|||
126146419|NCT05630846|453823240|FG001|Overall Study|Death|0|||
126146420|NCT05630846|453823241|FG002|Overall Study|Death|0|||
126146421|NCT05630846|453823242|FG003|Overall Study|Death|0|||
126146422|NCT05630846|453823239|FG000|Overall Study|Withdrawal by Subject|3|||
126146423|NCT05630846|453823240|FG001|Overall Study|Withdrawal by Subject|3|||
126146424|NCT05630846|453823241|FG002|Overall Study|Withdrawal by Subject|4|||
126146425|NCT05630846|453823242|FG003|Overall Study|Withdrawal by Subject|1|||
126146426|NCT05630846|453823239|FG000|Overall Study|Lost to Follow-up|6|||
126146427|NCT05630846|453823240|FG001|Overall Study|Lost to Follow-up|5|||
126146428|NCT05630846|453823241|FG002|Overall Study|Lost to Follow-up|2|||
126146429|NCT05630846|453823242|FG003|Overall Study|Lost to Follow-up|5|||
126146430|NCT05630846|453823239|FG000|Overall Study|Other|1|||
126146431|NCT05630846|453823240|FG001|Overall Study|Other|0|||
126146432|NCT05630846|453823241|FG002|Overall Study|Other|0|||
126146433|NCT05630846|453823242|FG003|Overall Study|Other|0|||
126146434|NCT00960076|453823254|FG000|Overall Study|Adverse Event|1|||
126146435|NCT00960076|453823255|FG001|Overall Study|Adverse Event|7|||
126146436|NCT00960076|453823254|FG000|Overall Study|No longer met study criteria|1|||
126146437|NCT00960076|453823255|FG001|Overall Study|No longer met study criteria|5|||
126146438|NCT00960076|453823254|FG000|Overall Study|Withdrawal by Subject|1|||
126146439|NCT00960076|453823255|FG001|Overall Study|Withdrawal by Subject|2|||
126146440|NCT00960076|453823254|FG000|Overall Study|Lost to Follow-up|3|||
126146441|NCT00960076|453823255|FG001|Overall Study|Lost to Follow-up|3|||
126146442|NCT00960076|453823254|FG000|Overall Study|Severe non-compliance to protocol|1|||
126146443|NCT00960076|453823255|FG001|Overall Study|Severe non-compliance to protocol|2|||
126146444|NCT00960076|453823254|FG000|Overall Study|Hyperglycemia|1|||
126146445|NCT00960076|453823255|FG001|Overall Study|Hyperglycemia|5|||
126146446|NCT00960076|453823254|FG000|Overall Study|Did not attend the termination visit|0|||
126146447|NCT00960076|453823255|FG001|Overall Study|Did not attend the termination visit|1|||
126146448|NCT00500266|453823256|FG000|Overall Study|Death|3|||
126146449|NCT00500266|453823256|FG000|Overall Study|Lost to Follow-up|3|||
126146450|NCT00500266|453823256|FG000|Overall Study|Withdrawal by Subject|3|||
126146451|NCT00500266|453823256|FG000|Overall Study|Assigned, not treated|4|||
126146452|NCT01431287|453823257|FG000|Overall Study|not treated|0|||
126146453|NCT01431287|453823258|FG001|Overall Study|not treated|0|||
126146454|NCT01431287|453823259|FG002|Overall Study|not treated|1|||
126146455|NCT01431287|453823260|FG003|Overall Study|not treated|0|||
126146456|NCT01431287|453823261|FG004|Overall Study|not treated|0|||
126146457|NCT01431287|453823257|FG000|Overall Study|Adverse Event|59|||
126146458|NCT01431287|453823258|FG001|Overall Study|Adverse Event|57|||
126146459|NCT01431287|453823259|FG002|Overall Study|Adverse Event|53|||
126146460|NCT01431287|453823260|FG003|Overall Study|Adverse Event|33|||
126146461|NCT01431287|453823261|FG004|Overall Study|Adverse Event|41|||
126146462|NCT01431287|453823257|FG000|Overall Study|Non compliant with protocol|6|||
126146463|NCT01431287|453823258|FG001|Overall Study|Non compliant with protocol|6|||
126146464|NCT01431287|453823259|FG002|Overall Study|Non compliant with protocol|5|||
126146465|NCT01431287|453823260|FG003|Overall Study|Non compliant with protocol|6|||
126146466|NCT01431287|453823261|FG004|Overall Study|Non compliant with protocol|5|||
126146467|NCT01431287|453823257|FG000|Overall Study|Lost to Follow-up|0|||
126146468|NCT01431287|453823258|FG001|Overall Study|Lost to Follow-up|3|||
126146469|NCT01431287|453823259|FG002|Overall Study|Lost to Follow-up|2|||
126146470|NCT01431287|453823260|FG003|Overall Study|Lost to Follow-up|3|||
126146471|NCT01431287|453823261|FG004|Overall Study|Lost to Follow-up|1|||
126146472|NCT01431287|453823257|FG000|Overall Study|Consent withdrawn not due to AE|29|||
126146473|NCT01431287|453823258|FG001|Overall Study|Consent withdrawn not due to AE|30|||
126146474|NCT01431287|453823259|FG002|Overall Study|Consent withdrawn not due to AE|34|||
126146475|NCT01431287|453823260|FG003|Overall Study|Consent withdrawn not due to AE|19|||
126146476|NCT01431287|453823261|FG004|Overall Study|Consent withdrawn not due to AE|29|||
126146477|NCT01431287|453823257|FG000|Overall Study|not stated above|4|||
126146478|NCT01431287|453823258|FG001|Overall Study|not stated above|2|||
126146479|NCT01431287|453823259|FG002|Overall Study|not stated above|2|||
126146480|NCT01431287|453823260|FG003|Overall Study|not stated above|2|||
126146481|NCT01431287|453823261|FG004|Overall Study|not stated above|1|||
126146482|NCT00075881|453823262|FG000|Overall Study|Lack of Efficacy|18|||
126146483|NCT00075881|453823262|FG000|Overall Study|Adverse Event|7|||
126146484|NCT00075881|453823262|FG000|Overall Study|Death|1|||
126146485|NCT00075881|453823262|FG000|Overall Study|Withdrawal by Subject|2|||
126146486|NCT00075881|453823262|FG000|Overall Study|Protocol Violation|4|||
126146487|NCT00075881|453823262|FG000|Overall Study|other complicating disease|3|||
126146488|NCT00075881|453823262|FG000|Overall Study|other|4|||
126146489|NCT00075881|453823262|FG000|Overall Study|missing data|2|||
126146490|NCT00075881|453823262|FG000|Overall Study|Ineligible|1|||
126146491|NCT00075881|453823262|FG000|Overall Study|never start protocol therapy|1|||
126146492|NCT02224664|453823263|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
126146493|NCT02224664|453823264|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
126146494|NCT02224664|453823265|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
126146495|NCT02224664|453823266|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
126146496|NCT02224664|453823267|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
126146497|NCT02224664|453823263|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
126146498|NCT02224664|453823264|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
126146499|NCT02224664|453823265|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
126146500|NCT02224664|453823266|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
126146501|NCT02224664|453823267|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
126146502|NCT02224664|453823263|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
126146503|NCT02224664|453823264|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
126146504|NCT02224664|453823265|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
126146505|NCT02224664|453823266|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
126146506|NCT02224664|453823267|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
126146507|NCT03019549|453823268|FG000|Washout|DId not meet genotype criteria|11|||
126146508|NCT03019549|453823268|FG000|Period 2|Adverse Event|2|||
126146509|NCT03019549|453823268|FG000|Period 2|Physician Decision|2|||
126146510|NCT03019549|453823268|FG000|Period 2|Withdrawal by Subject|1|||
126146511|NCT02109029|453823271|FG000|Part B|Adverse Event|0|||
126146512|NCT02109029|453823272|FG001|Part B|Adverse Event|0|||
126146513|NCT02109029|453823273|FG002|Part B|Adverse Event|0|||
126146514|NCT02109029|453823274|FG003|Part B|Adverse Event|0|||
126146515|NCT02109029|453823275|FG004|Part B|Adverse Event|1|||
126146516|NCT02109029|453823276|FG005|Part B|Adverse Event|1|||
126146517|NCT00110305|453823277|FG000|Overall Study|Adverse Event|46|||
126146518|NCT00110305|453823278|FG001|Overall Study|Adverse Event|13|||
126146519|NCT00110305|453823277|FG000|Overall Study|Sponsors Decision|1|||
126146520|NCT00110305|453823278|FG001|Overall Study|Sponsors Decision|0|||
126146521|NCT00110305|453823277|FG000|Overall Study|Subject Non-Compliant|9|||
126146522|NCT00110305|453823278|FG001|Overall Study|Subject Non-Compliant|2|||
126146523|NCT00110305|453823277|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
126146524|NCT00110305|453823278|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
126146525|NCT00110305|453823277|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
126146526|NCT00110305|453823278|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
126146527|NCT00110305|453823277|FG000|Overall Study|Protocol Violation|0|||
126146528|NCT00110305|453823278|FG001|Overall Study|Protocol Violation|1|||
126146529|NCT00110305|453823277|FG000|Overall Study|Withdrawal by Subject|7|||
126146530|NCT00110305|453823278|FG001|Overall Study|Withdrawal by Subject|7|||
126146531|NCT00110305|453823277|FG000|Overall Study|Lost to Follow-up|20|||
126146532|NCT00110305|453823278|FG001|Overall Study|Lost to Follow-up|3|||
126146533|NCT00110305|453823277|FG000|Overall Study|Other|8|||
126146534|NCT00110305|453823278|FG001|Overall Study|Other|2|||
126146535|NCT00215150|453823282|FG000|Open Label Phase|Lost to Follow-up|7|||
126146536|NCT00215150|453823282|FG000|Open Label Phase|Withdrawal by Subject|1|||
126146537|NCT00215150|453823282|FG000|Open Label Phase|Did not complete a post base visit|13|||
126146538|NCT00215150|453823282|FG000|Open Label Phase|Did not meet randomization criteria|9|||
126146539|NCT00215150|453823282|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
126146540|NCT00215150|453823282|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
126146541|NCT00215150|453823282|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
126146542|NCT02251743|453823283|FG000|Overall Study|Withdrawal by Subject|1|||
126146543|NCT02251743|453823284|FG001|Overall Study|Withdrawal by Subject|1|||
126146544|NCT04439266|453823297|FG000|Overall Study|Ineligible|1|||
126146545|NCT04439266|453823297|FG000|Overall Study|Adverse Event|1|||
126146546|NCT04439266|453823297|FG000|Overall Study|Death|1|||
126146547|NCT04439266|453823297|FG000|Overall Study|Disease progression|1|||
126146548|NCT04439266|453823297|FG000|Overall Study|Still on treatment|1|||
126146549|NCT05040971|453823300|FG000|Overall Study|Withdrawal by Subject|0|||
126146550|NCT05040971|453823301|FG001|Overall Study|Withdrawal by Subject|2|||
126146551|NCT05040971|453823300|FG000|Overall Study|Lost to Follow-up|8|||
126146552|NCT05040971|453823301|FG001|Overall Study|Lost to Follow-up|3|||
126146553|NCT05040971|453823300|FG000|Overall Study|Death|2|||
126146554|NCT05040971|453823301|FG001|Overall Study|Death|0|||
126146555|NCT06161012|453823302|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
126146556|NCT06161012|453823303|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
126146557|NCT02601950|453823304|FG000|Overall Study|Participant enrolled in rollover study|0|||
126146558|NCT02601950|453823305|FG001|Overall Study|Participant enrolled in rollover study|0|||
126146559|NCT02601950|453823306|FG002|Overall Study|Participant enrolled in rollover study|1|||
126146560|NCT02601950|453823307|FG003|Overall Study|Participant enrolled in rollover study|0|||
126146561|NCT02601950|453823308|FG004|Overall Study|Participant enrolled in rollover study|1|||
126146562|NCT02601950|453823309|FG005|Overall Study|Participant enrolled in rollover study|1|||
126146563|NCT02601950|453823310|FG006|Overall Study|Participant enrolled in rollover study|1|||
126146564|NCT02601950|453823311|FG007|Overall Study|Participant enrolled in rollover study|0|||
126146565|NCT02601950|453823304|FG000|Overall Study|Disease progression - radiological|21|||
126146566|NCT02601950|453823305|FG001|Overall Study|Disease progression - radiological|26|||
126146567|NCT02601950|453823306|FG002|Overall Study|Disease progression - radiological|22|||
126146568|NCT02601950|453823307|FG003|Overall Study|Disease progression - radiological|11|||
126146569|NCT02601950|453823308|FG004|Overall Study|Disease progression - radiological|46|||
126146570|NCT02601950|453823309|FG005|Overall Study|Disease progression - radiological|52|||
126146571|NCT02601950|453823310|FG006|Overall Study|Disease progression - radiological|7|||
126146572|NCT02601950|453823311|FG007|Overall Study|Disease progression - radiological|5|||
126146573|NCT02601950|453823304|FG000|Overall Study|Disease progression - clinical|3|||
126146574|NCT02601950|453823305|FG001|Overall Study|Disease progression - clinical|5|||
126146575|NCT02601950|453823306|FG002|Overall Study|Disease progression - clinical|4|||
126146576|NCT02601950|453823307|FG003|Overall Study|Disease progression - clinical|2|||
126146577|NCT02601950|453823308|FG004|Overall Study|Disease progression - clinical|6|||
126146578|NCT02601950|453823309|FG005|Overall Study|Disease progression - clinical|6|||
126146579|NCT02601950|453823310|FG006|Overall Study|Disease progression - clinical|5|||
126146580|NCT02601950|453823311|FG007|Overall Study|Disease progression - clinical|1|||
126146581|NCT02601950|453823304|FG000|Overall Study|Death|6|||
126146582|NCT02601950|453823305|FG001|Overall Study|Death|0|||
126146583|NCT02601950|453823306|FG002|Overall Study|Death|3|||
126146584|NCT02601950|453823307|FG003|Overall Study|Death|1|||
126146585|NCT02601950|453823308|FG004|Overall Study|Death|4|||
126146586|NCT02601950|453823309|FG005|Overall Study|Death|1|||
126146587|NCT02601950|453823310|FG006|Overall Study|Death|0|||
126146588|NCT02601950|453823311|FG007|Overall Study|Death|0|||
126146589|NCT02601950|453823304|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126146590|NCT02601950|453823305|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126146591|NCT02601950|453823306|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126146592|NCT02601950|453823307|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126146593|NCT02601950|453823308|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126146594|NCT02601950|453823309|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
126146595|NCT02601950|453823310|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126146596|NCT02601950|453823311|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126146597|NCT02601950|453823304|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
126146598|NCT02601950|453823305|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
126146599|NCT02601950|453823306|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
126146600|NCT02601950|453823307|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
126146601|NCT02601950|453823308|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
126146602|NCT02601950|453823309|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
126146603|NCT02601950|453823310|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
126146604|NCT02601950|453823311|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
126146605|NCT02601950|453823304|FG000|Overall Study|Non-compliance|0|||
126146606|NCT02601950|453823305|FG001|Overall Study|Non-compliance|1|||
126146607|NCT02601950|453823306|FG002|Overall Study|Non-compliance|0|||
126146608|NCT02601950|453823307|FG003|Overall Study|Non-compliance|0|||
126146609|NCT02601950|453823308|FG004|Overall Study|Non-compliance|0|||
126146610|NCT02601950|453823309|FG005|Overall Study|Non-compliance|1|||
126146611|NCT02601950|453823310|FG006|Overall Study|Non-compliance|1|||
126146612|NCT02601950|453823311|FG007|Overall Study|Non-compliance|0|||
126146613|NCT02601950|453823304|FG000|Overall Study|Participant refused further study treatment|0|||
126146614|NCT02601950|453823305|FG001|Overall Study|Participant refused further study treatment|1|||
126146615|NCT02601950|453823306|FG002|Overall Study|Participant refused further study treatment|1|||
126146616|NCT02601950|453823307|FG003|Overall Study|Participant refused further study treatment|0|||
126146617|NCT02601950|453823308|FG004|Overall Study|Participant refused further study treatment|2|||
126146618|NCT02601950|453823309|FG005|Overall Study|Participant refused further study treatment|2|||
126146619|NCT02601950|453823310|FG006|Overall Study|Participant refused further study treatment|2|||
126146620|NCT02601950|453823311|FG007|Overall Study|Participant refused further study treatment|1|||
126146621|NCT02601950|453823304|FG000|Overall Study|Investigator discretion|1|||
126146622|NCT02601950|453823305|FG001|Overall Study|Investigator discretion|0|||
126146623|NCT02601950|453823306|FG002|Overall Study|Investigator discretion|1|||
126146624|NCT02601950|453823307|FG003|Overall Study|Investigator discretion|0|||
126146625|NCT02601950|453823308|FG004|Overall Study|Investigator discretion|1|||
126146626|NCT02601950|453823309|FG005|Overall Study|Investigator discretion|1|||
126146627|NCT02601950|453823310|FG006|Overall Study|Investigator discretion|1|||
126146628|NCT02601950|453823311|FG007|Overall Study|Investigator discretion|0|||
126146629|NCT02601950|453823304|FG000|Overall Study|Other|0|||
126146630|NCT02601950|453823305|FG001|Overall Study|Other|0|||
126146631|NCT02601950|453823306|FG002|Overall Study|Other|0|||
126146632|NCT02601950|453823307|FG003|Overall Study|Other|0|||
126146633|NCT02601950|453823308|FG004|Overall Study|Other|2|||
126146634|NCT02601950|453823309|FG005|Overall Study|Other|2|||
126146635|NCT02601950|453823310|FG006|Overall Study|Other|1|||
126146636|NCT02601950|453823311|FG007|Overall Study|Other|0|||
126146637|NCT05817045|453823318|FG000|Overall Study|Protocol Violation|0|||
126146638|NCT05817045|453823319|FG001|Overall Study|Protocol Violation|3|||
126146639|NCT05817045|453823318|FG000|Overall Study|Withdrawal by Subject|10|||
126146640|NCT05817045|453823319|FG001|Overall Study|Withdrawal by Subject|7|||
126146641|NCT05817045|453823318|FG000|Overall Study|Physician Decision|3|||
126146642|NCT05817045|453823319|FG001|Overall Study|Physician Decision|0|||
126146643|NCT05817045|453823318|FG000|Overall Study|Lost to Follow-up|0|||
126146644|NCT05817045|453823319|FG001|Overall Study|Lost to Follow-up|1|||
126146645|NCT05817045|453823318|FG000|Overall Study|Device Deficiency|1|||
126146646|NCT05817045|453823319|FG001|Overall Study|Device Deficiency|0|||
126146647|NCT05817045|453823318|FG000|Overall Study|System Error|1|||
126146648|NCT05817045|453823319|FG001|Overall Study|System Error|0|||
126146649|NCT04889209|453823320|FG000|All Cohorts Except 15E|Adverse Event|0|||
126146650|NCT04889209|453823321|FG001|All Cohorts Except 15E|Adverse Event|0|||
126146651|NCT04889209|453823322|FG002|All Cohorts Except 15E|Adverse Event|0|||
126146652|NCT04889209|453823323|FG003|All Cohorts Except 15E|Adverse Event|0|||
126146653|NCT04889209|453823324|FG004|All Cohorts Except 15E|Adverse Event|0|||
126146654|NCT04889209|453823325|FG005|All Cohorts Except 15E|Adverse Event|0|||
126146655|NCT04889209|453823326|FG006|All Cohorts Except 15E|Adverse Event|1|||
126146656|NCT04889209|453823327|FG007|All Cohorts Except 15E|Adverse Event|0|||
126146657|NCT04889209|453823328|FG008|All Cohorts Except 15E|Adverse Event|0|||
126146658|NCT04889209|453823329|FG009|All Cohorts Except 15E|Adverse Event|0|||
126146659|NCT04889209|453823330|FG010|All Cohorts Except 15E|Adverse Event|0|||
126146660|NCT04889209|453823331|FG011|All Cohorts Except 15E|Adverse Event|0|||
126146661|NCT04889209|453823332|FG012|All Cohorts Except 15E|Adverse Event|0|||
126146662|NCT04889209|453823333|FG013|All Cohorts Except 15E|Adverse Event|0|||
126146663|NCT04889209|453823334|FG014|All Cohorts Except 15E|Adverse Event|0|||
126146664|NCT04889209|453823335|FG015|All Cohorts Except 15E|Adverse Event|0|||
126146665|NCT04889209|453823336|FG016|All Cohorts Except 15E|Adverse Event|0|||
126146666|NCT04889209|453823337|FG017|All Cohorts Except 15E|Adverse Event|0|||
126146667|NCT04889209|453823320|FG000|All Cohorts Except 15E|Death|0|||
126146668|NCT04889209|453823321|FG001|All Cohorts Except 15E|Death|1|||
126146669|NCT04889209|453823322|FG002|All Cohorts Except 15E|Death|0|||
126146670|NCT04889209|453823323|FG003|All Cohorts Except 15E|Death|0|||
126146671|NCT04889209|453823324|FG004|All Cohorts Except 15E|Death|0|||
126146672|NCT04889209|453823325|FG005|All Cohorts Except 15E|Death|0|||
126146673|NCT04889209|453823326|FG006|All Cohorts Except 15E|Death|0|||
126146674|NCT04889209|453823327|FG007|All Cohorts Except 15E|Death|0|||
126146675|NCT04889209|453823328|FG008|All Cohorts Except 15E|Death|0|||
126146676|NCT04889209|453823329|FG009|All Cohorts Except 15E|Death|0|||
126146677|NCT04889209|453823330|FG010|All Cohorts Except 15E|Death|0|||
126146678|NCT04889209|453823331|FG011|All Cohorts Except 15E|Death|0|||
126146679|NCT04889209|453823332|FG012|All Cohorts Except 15E|Death|0|||
126146680|NCT04889209|453823333|FG013|All Cohorts Except 15E|Death|0|||
126146681|NCT04889209|453823334|FG014|All Cohorts Except 15E|Death|0|||
126146682|NCT04889209|453823335|FG015|All Cohorts Except 15E|Death|0|||
126146683|NCT04889209|453823336|FG016|All Cohorts Except 15E|Death|0|||
126146684|NCT04889209|453823337|FG017|All Cohorts Except 15E|Death|0|||
126146685|NCT04889209|453823320|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
126146686|NCT04889209|453823321|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
126146687|NCT04889209|453823322|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
126146688|NCT04889209|453823323|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
126146689|NCT04889209|453823324|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
126146690|NCT04889209|453823325|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
126146691|NCT04889209|453823326|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
126146692|NCT04889209|453823327|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
126146693|NCT04889209|453823328|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
126146694|NCT04889209|453823329|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
126146695|NCT04889209|453823330|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
126146696|NCT04889209|453823331|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
126146697|NCT04889209|453823332|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
126146698|NCT04889209|453823333|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
126146699|NCT04889209|453823334|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
126146700|NCT04889209|453823335|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
126146701|NCT04889209|453823336|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
126146702|NCT04889209|453823337|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
126146703|NCT04889209|453823320|FG000|All Cohorts Except 15E|Physician Decision|0|||
126146704|NCT04889209|453823321|FG001|All Cohorts Except 15E|Physician Decision|0|||
126146705|NCT04889209|453823322|FG002|All Cohorts Except 15E|Physician Decision|0|||
126146706|NCT04889209|453823323|FG003|All Cohorts Except 15E|Physician Decision|0|||
126146707|NCT04889209|453823324|FG004|All Cohorts Except 15E|Physician Decision|1|||
126146708|NCT04889209|453823325|FG005|All Cohorts Except 15E|Physician Decision|0|||
126146709|NCT04889209|453823326|FG006|All Cohorts Except 15E|Physician Decision|0|||
126146710|NCT04889209|453823327|FG007|All Cohorts Except 15E|Physician Decision|1|||
126146711|NCT04889209|453823328|FG008|All Cohorts Except 15E|Physician Decision|0|||
126146712|NCT04889209|453823329|FG009|All Cohorts Except 15E|Physician Decision|1|||
126146713|NCT04889209|453823330|FG010|All Cohorts Except 15E|Physician Decision|0|||
126146714|NCT04889209|453823331|FG011|All Cohorts Except 15E|Physician Decision|1|||
126146715|NCT04889209|453823332|FG012|All Cohorts Except 15E|Physician Decision|1|||
126146716|NCT04889209|453823333|FG013|All Cohorts Except 15E|Physician Decision|0|||
126146717|NCT04889209|453823334|FG014|All Cohorts Except 15E|Physician Decision|0|||
126146718|NCT04889209|453823335|FG015|All Cohorts Except 15E|Physician Decision|0|||
126146719|NCT04889209|453823336|FG016|All Cohorts Except 15E|Physician Decision|0|||
126146720|NCT04889209|453823337|FG017|All Cohorts Except 15E|Physician Decision|0|||
126146721|NCT04889209|453823320|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
126146722|NCT04889209|453823321|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
126146723|NCT04889209|453823322|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
126146724|NCT04889209|453823323|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
126146725|NCT04889209|453823324|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
126146726|NCT04889209|453823325|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
126146727|NCT04889209|453823326|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
126146728|NCT04889209|453823327|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
126146729|NCT04889209|453823328|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
126146730|NCT04889209|453823329|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
126146731|NCT04889209|453823330|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
126146732|NCT04889209|453823331|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
126146733|NCT04889209|453823332|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
126146734|NCT04889209|453823333|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
126146735|NCT04889209|453823334|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
126146736|NCT04889209|453823335|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
126146737|NCT04889209|453823336|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
126146738|NCT04889209|453823337|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
126146739|NCT04889209|453823320|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
126146740|NCT04889209|453823321|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
126146741|NCT04889209|453823322|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146742|NCT04889209|453823323|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146743|NCT04889209|453823324|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146744|NCT04889209|453823325|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
126146745|NCT04889209|453823326|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146746|NCT04889209|453823327|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
126146747|NCT04889209|453823328|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146748|NCT04889209|453823329|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
126146749|NCT04889209|453823330|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146750|NCT04889209|453823331|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146751|NCT04889209|453823332|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146752|NCT04889209|453823333|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146753|NCT04889209|453823334|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146754|NCT04889209|453823335|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146755|NCT04889209|453823336|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126146756|NCT04889209|453823337|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
126146757|NCT04889209|453823320|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146758|NCT04889209|453823321|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146759|NCT04889209|453823322|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146760|NCT04889209|453823323|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
126146761|NCT04889209|453823324|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146762|NCT04889209|453823325|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146763|NCT04889209|453823326|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146764|NCT04889209|453823327|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146765|NCT04889209|453823328|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126200125|NCT02394028|454017880|FG003|Induction Phase|Lost to Follow-up|1|||
126146766|NCT04889209|453823329|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146767|NCT04889209|453823330|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146768|NCT04889209|453823331|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146769|NCT04889209|453823332|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146770|NCT04889209|453823333|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146771|NCT04889209|453823334|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146772|NCT04889209|453823335|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146773|NCT04889209|453823336|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146774|NCT04889209|453823337|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126146775|NCT04889209|453823320|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146776|NCT04889209|453823321|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146777|NCT04889209|453823322|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146778|NCT04889209|453823323|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146779|NCT04889209|453823324|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126146780|NCT04889209|453823325|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146781|NCT04889209|453823326|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126146782|NCT04889209|453823327|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126146783|NCT04889209|453823328|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146784|NCT04889209|453823329|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126146785|NCT04889209|453823330|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126146786|NCT04889209|453823331|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146787|NCT04889209|453823332|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126146788|NCT04889209|453823333|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146789|NCT04889209|453823334|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146790|NCT04889209|453823335|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146791|NCT04889209|453823336|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126146792|NCT04889209|453823337|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126146793|NCT04889209|453823320|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146794|NCT04889209|453823321|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146795|NCT04889209|453823322|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146796|NCT04889209|453823323|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146797|NCT04889209|453823324|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146798|NCT04889209|453823325|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146799|NCT04889209|453823326|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146800|NCT04889209|453823327|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146801|NCT04889209|453823328|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146802|NCT04889209|453823329|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146803|NCT04889209|453823330|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146804|NCT04889209|453823331|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146805|NCT04889209|453823332|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146806|NCT04889209|453823333|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146807|NCT04889209|453823334|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146808|NCT04889209|453823335|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146809|NCT04889209|453823336|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126146810|NCT04889209|453823337|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
126146811|NCT04889209|453823320|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146812|NCT04889209|453823321|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146813|NCT04889209|453823322|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146814|NCT04889209|453823323|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146815|NCT04889209|453823324|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146816|NCT04889209|453823325|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146817|NCT04889209|453823326|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146818|NCT04889209|453823327|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146819|NCT04889209|453823328|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146820|NCT04889209|453823329|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146821|NCT04889209|453823330|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146822|NCT04889209|453823331|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146823|NCT04889209|453823332|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146824|NCT04889209|453823333|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146825|NCT04889209|453823334|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146826|NCT04889209|453823335|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146827|NCT04889209|453823336|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126146828|NCT04889209|453823337|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
126146829|NCT04889209|453823320|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146830|NCT04889209|453823321|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146831|NCT04889209|453823322|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146832|NCT04889209|453823323|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146833|NCT04889209|453823324|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146834|NCT04889209|453823325|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146835|NCT04889209|453823326|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146836|NCT04889209|453823327|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146837|NCT04889209|453823328|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146838|NCT04889209|453823329|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146839|NCT04889209|453823330|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146840|NCT04889209|453823331|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146841|NCT04889209|453823332|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146842|NCT04889209|453823333|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146843|NCT04889209|453823334|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
126146844|NCT04889209|453823335|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146845|NCT04889209|453823336|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146846|NCT04889209|453823337|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126146847|NCT01725165|453823344|FG000|Overall Study|Death|11|||
126146848|NCT01725165|453823345|FG001|Overall Study|Death|18|||
126146849|NCT05113940|453823348|FG000|Part A (18 Days)|Adverse Event|0|||
126146850|NCT05113940|453823349|FG001|Part A (18 Days)|Adverse Event|0|||
126146851|NCT05113940|453823350|FG002|Part A (18 Days)|Adverse Event|1|||
126146852|NCT05113940|453823351|FG003|Part A (18 Days)|Adverse Event|1|||
126146853|NCT05113940|453823352|FG004|Part A (18 Days)|Adverse Event|1|||
126146854|NCT05113940|453823353|FG005|Part A (18 Days)|Adverse Event|0|||
126146855|NCT05113940|453823354|FG006|Part A (18 Days)|Adverse Event|0|||
126146856|NCT05113940|453823355|FG007|Part A (18 Days)|Adverse Event|0|||
126146857|NCT05113940|453823356|FG008|Part A (18 Days)|Adverse Event|0|||
126146858|NCT05113940|453823357|FG009|Part A (18 Days)|Adverse Event|0|||
126146859|NCT05113940|453823358|FG010|Part A (18 Days)|Adverse Event|0|||
126146860|NCT05113940|453823359|FG011|Part A (18 Days)|Adverse Event|2|||
126146861|NCT05113940|453823360|FG012|Part A (18 Days)|Adverse Event|0|||
126146862|NCT05113940|453823361|FG013|Part A (18 Days)|Adverse Event|0|||
126146863|NCT05113940|453823362|FG014|Part A (18 Days)|Adverse Event|0|||
126146864|NCT05113940|453823348|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146865|NCT05113940|453823349|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146866|NCT05113940|453823350|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146867|NCT05113940|453823351|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146868|NCT05113940|453823352|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146869|NCT05113940|453823353|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146870|NCT05113940|453823354|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146871|NCT05113940|453823355|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146872|NCT05113940|453823356|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146873|NCT05113940|453823357|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146874|NCT05113940|453823358|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146875|NCT05113940|453823359|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146876|NCT05113940|453823360|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146877|NCT05113940|453823361|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
126146878|NCT05113940|453823362|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
126146879|NCT02688647|453823363|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
126146880|NCT02688647|453823364|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
126146881|NCT02688647|453823363|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
126146882|NCT02688647|453823364|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
126146883|NCT02688647|453823363|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
126146884|NCT02688647|453823364|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
126146885|NCT02688647|453823363|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
126146886|NCT02688647|453823364|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
126146887|NCT02688647|453823363|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
126146888|NCT02688647|453823364|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
126146889|NCT02688647|453823363|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
126146890|NCT02688647|453823364|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
126146891|NCT02688647|453823363|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
126146892|NCT02688647|453823364|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
126146893|NCT03619213|453823365|FG000|Overall Study|Lost to Follow-up|2|||
126146894|NCT03619213|453823366|FG001|Overall Study|Lost to Follow-up|1|||
126146895|NCT03619213|453823365|FG000|Overall Study|Withdrawal by Subject|8|||
126200126|NCT02394028|454017881|FG004|Induction Phase|Lost to Follow-up|0|||
126146896|NCT03619213|453823366|FG001|Overall Study|Withdrawal by Subject|10|||
126146897|NCT00382967|453823367|FG000|Overall Study|Protocol Violation|1|||
126146898|NCT00382967|453823368|FG001|Overall Study|Protocol Violation|1|||
126146899|NCT02542267|453823370|FG000|Overall Study|Withdrawal by Subject|10|||
126146900|NCT02542267|453823370|FG000|Overall Study|Physician Decision|6|||
126146901|NCT02542267|453823370|FG000|Overall Study|Lost to Follow-up|4|||
126146902|NCT02542267|453823370|FG000|Overall Study|Death|13|||
126146903|NCT02542267|453823370|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
126146904|NCT02542267|453823370|FG000|Overall Study|Other|9|||
126146905|NCT03049449|453823373|FG000|Overall Study|Did not receive treatment.|0|||
126146906|NCT03049449|453823374|FG001|Overall Study|Did not receive treatment.|0|||
126146907|NCT03049449|453823375|FG002|Overall Study|Did not receive treatment.|0|||
126146908|NCT03049449|453823376|FG003|Overall Study|Did not receive treatment.|0|||
126146909|NCT03049449|453823377|FG004|Overall Study|Did not receive treatment.|0|||
126146910|NCT03049449|453823378|FG005|Overall Study|Did not receive treatment.|0|||
126146911|NCT03049449|453823379|FG006|Overall Study|Did not receive treatment.|0|||
126146912|NCT03049449|453823380|FG007|Overall Study|Did not receive treatment.|0|||
126146913|NCT03049449|453823381|FG008|Overall Study|Did not receive treatment.|1|||
126146914|NCT03049449|453823382|FG009|Overall Study|Did not receive treatment.|0|||
126146915|NCT03049449|453823373|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
126146916|NCT03049449|453823374|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
126146917|NCT03049449|453823375|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
126146918|NCT03049449|453823376|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
126146919|NCT03049449|453823377|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
126146920|NCT03049449|453823378|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
126146921|NCT03049449|453823379|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
126146922|NCT03049449|453823380|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
126146923|NCT03049449|453823381|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
126146924|NCT03049449|453823382|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
126146925|NCT03049449|453823373|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126146926|NCT03049449|453823374|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126146927|NCT03049449|453823375|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126146928|NCT03049449|453823376|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126146929|NCT03049449|453823377|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126146930|NCT03049449|453823378|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126146931|NCT03049449|453823379|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126146932|NCT03049449|453823380|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
126146933|NCT03049449|453823381|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126146934|NCT03049449|453823382|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
126146935|NCT00474240|453823386|FG000|Overall Study|Withdrawal by Subject|1|||
126146936|NCT00474240|453823387|FG001|Overall Study|Withdrawal by Subject|1|||
126146937|NCT00474240|453823388|FG002|Overall Study|Withdrawal by Subject|0|||
126146938|NCT00474240|453823389|FG003|Overall Study|Withdrawal by Subject|2|||
126146939|NCT00474240|453823390|FG004|Overall Study|Withdrawal by Subject|3|||
126146940|NCT00474240|453823391|FG005|Overall Study|Withdrawal by Subject|1|||
126146941|NCT00474240|453823386|FG000|Overall Study|Adverse Event|0|||
126146942|NCT00474240|453823387|FG001|Overall Study|Adverse Event|0|||
126146943|NCT00474240|453823388|FG002|Overall Study|Adverse Event|9|||
126146944|NCT00474240|453823389|FG003|Overall Study|Adverse Event|14|||
126146945|NCT00474240|453823390|FG004|Overall Study|Adverse Event|5|||
126146946|NCT00474240|453823391|FG005|Overall Study|Adverse Event|16|||
126146947|NCT00474240|453823386|FG000|Overall Study|Removed due to lab value|0|||
126146948|NCT00474240|453823387|FG001|Overall Study|Removed due to lab value|0|||
126146949|NCT00474240|453823388|FG002|Overall Study|Removed due to lab value|0|||
126146950|NCT00474240|453823389|FG003|Overall Study|Removed due to lab value|0|||
126146951|NCT00474240|453823390|FG004|Overall Study|Removed due to lab value|0|||
126146952|NCT00474240|453823391|FG005|Overall Study|Removed due to lab value|1|||
126146953|NCT01147497|453823392|FG000|Overall Study|failed insertion|2|||
126146954|NCT01147497|453823393|FG001|Overall Study|failed insertion|0|||
126146955|NCT01974323|453823396|FG000|Overall Study|Other Reasons|25|||
126146956|NCT01974323|453823397|FG001|Overall Study|Other Reasons|28|||
126146957|NCT01974323|453823396|FG000|Overall Study|Protocol Violation|2|||
126146958|NCT01974323|453823397|FG001|Overall Study|Protocol Violation|2|||
126146959|NCT01974323|453823396|FG000|Overall Study|Personal Reasons|15|||
126146960|NCT01974323|453823397|FG001|Overall Study|Personal Reasons|19|||
126146961|NCT01974323|453823396|FG000|Overall Study|Lost to Follow-up|45|||
126146962|NCT01974323|453823397|FG001|Overall Study|Lost to Follow-up|40|||
126146963|NCT01974323|453823396|FG000|Overall Study|Pregnancy|2|||
126146964|NCT01974323|453823397|FG001|Overall Study|Pregnancy|1|||
126146965|NCT01974323|453823396|FG000|Overall Study|Lack of Efficacy|1|||
126146966|NCT01974323|453823397|FG001|Overall Study|Lack of Efficacy|1|||
126146967|NCT01974323|453823396|FG000|Overall Study|Adverse Event|2|||
126146968|NCT01974323|453823397|FG001|Overall Study|Adverse Event|2|||
126146969|NCT00331760|453823398|FG000|Overall Study|Ineligible / no protocol treatment|15|||
126146970|NCT00331760|453823399|FG001|Overall Study|Ineligible / no protocol treatment|8|||
126146971|NCT03093155|453823401|FG000|Overall Study|Not Eligible|1|||
126146972|NCT03093155|453823402|FG001|Overall Study|Not Eligible|0|||
126146973|NCT03093155|453823401|FG000|Overall Study|Withdrawal by Subject|0|||
126146974|NCT03093155|453823402|FG001|Overall Study|Withdrawal by Subject|1|||
126146975|NCT01075178|453823403|FG000|Subject Matching|eligible but not matched|130|||
126146976|NCT01075178|453823404|FG001|Subject Matching|eligible but not matched|403|||
126146977|NCT01075178|453823403|FG000|Subject Chart Review|died before chart review period|0|||
126146978|NCT01075178|453823404|FG001|Subject Chart Review|died before chart review period|2|||
126146979|NCT01075178|453823403|FG000|Subject Chart Review|no data collected due to site closure|3|||
126146980|NCT01075178|453823404|FG001|Subject Chart Review|no data collected due to site closure|4|||
126146981|NCT01075178|453823403|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
126146982|NCT01075178|453823404|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
126146983|NCT02983604|453823405|FG000|Overall Study|Enrolled but not Treated|0|||
126146984|NCT02983604|453823406|FG001|Overall Study|Enrolled but not Treated|0|||
126146985|NCT02983604|453823407|FG002|Overall Study|Enrolled but not Treated|1|||
126146986|NCT02983604|453823408|FG003|Overall Study|Enrolled but not Treated|0|||
126146987|NCT01111604|453823409|FG000|Overall Study|Lost to Follow-up|0|||
126146988|NCT01111604|453823410|FG001|Overall Study|Lost to Follow-up|0|||
126146989|NCT01111604|453823411|FG002|Overall Study|Lost to Follow-up|1|||
126146990|NCT01111604|453823409|FG000|Overall Study|Withdrew Consent|3|||
126146991|NCT01111604|453823410|FG001|Overall Study|Withdrew Consent|0|||
126146992|NCT01111604|453823411|FG002|Overall Study|Withdrew Consent|2|||
126146993|NCT01111604|453823409|FG000|Overall Study|Withdrawal by Subject|2|||
126146994|NCT01111604|453823410|FG001|Overall Study|Withdrawal by Subject|0|||
126146995|NCT01111604|453823411|FG002|Overall Study|Withdrawal by Subject|0|||
126146996|NCT01111604|453823409|FG000|Overall Study|Death|1|||
126146997|NCT01111604|453823410|FG001|Overall Study|Death|0|||
126146998|NCT01111604|453823411|FG002|Overall Study|Death|0|||
126146999|NCT01111604|453823409|FG000|Overall Study|Met Exclusion Criteria|2|||
126147000|NCT01111604|453823410|FG001|Overall Study|Met Exclusion Criteria|0|||
126147001|NCT01111604|453823411|FG002|Overall Study|Met Exclusion Criteria|0|||
126147002|NCT00316264|453823413|FG000|Overall Study|Lost to Follow-up|0|||
126147003|NCT00316264|453823414|FG001|Overall Study|Lost to Follow-up|1|||
126147004|NCT00316264|453823415|FG002|Overall Study|Lost to Follow-up|0|||
126147005|NCT00316264|453823413|FG000|Overall Study|Withdrawal of Consent|3|||
126147006|NCT00316264|453823414|FG001|Overall Study|Withdrawal of Consent|5|||
126147007|NCT00316264|453823415|FG002|Overall Study|Withdrawal of Consent|6|||
126147008|NCT00316264|453823413|FG000|Overall Study|Death|2|||
126147009|NCT00316264|453823414|FG001|Overall Study|Death|0|||
126147010|NCT00316264|453823415|FG002|Overall Study|Death|0|||
126147011|NCT00316264|453823413|FG000|Overall Study|Other|1|||
126147012|NCT00316264|453823414|FG001|Overall Study|Other|1|||
126147013|NCT00316264|453823415|FG002|Overall Study|Other|0|||
126147014|NCT00607048|453823416|FG000|Overall Study|Adverse Event|0|||
126147015|NCT00607048|453823417|FG001|Overall Study|Adverse Event|1|||
126147016|NCT00607048|453823418|FG002|Overall Study|Adverse Event|0|||
126147017|NCT00607048|453823419|FG003|Overall Study|Adverse Event|0|||
126147018|NCT00607048|453823420|FG004|Overall Study|Adverse Event|4|||
126147019|NCT00607048|453823421|FG005|Overall Study|Adverse Event|0|||
126147020|NCT00607048|453823416|FG000|Overall Study|Global deterioration of health|1|||
126147021|NCT00607048|453823417|FG001|Overall Study|Global deterioration of health|0|||
126147022|NCT00607048|453823418|FG002|Overall Study|Global deterioration of health|0|||
126147023|NCT00607048|453823419|FG003|Overall Study|Global deterioration of health|0|||
126147024|NCT00607048|453823420|FG004|Overall Study|Global deterioration of health|0|||
126147025|NCT00607048|453823421|FG005|Overall Study|Global deterioration of health|0|||
126147026|NCT00607048|453823416|FG000|Overall Study|Objective disease progression - relapse|1|||
126147027|NCT00607048|453823417|FG001|Overall Study|Objective disease progression - relapse|2|||
126147028|NCT00607048|453823418|FG002|Overall Study|Objective disease progression - relapse|4|||
126147029|NCT00607048|453823419|FG003|Overall Study|Objective disease progression - relapse|2|||
126147030|NCT00607048|453823420|FG004|Overall Study|Objective disease progression - relapse|2|||
126147031|NCT00607048|453823421|FG005|Overall Study|Objective disease progression - relapse|2|||
126147032|NCT00607048|453823416|FG000|Overall Study|Withdrawal by Subject|0|||
126147033|NCT00607048|453823417|FG001|Overall Study|Withdrawal by Subject|0|||
126147034|NCT00607048|453823418|FG002|Overall Study|Withdrawal by Subject|0|||
126147035|NCT00607048|453823419|FG003|Overall Study|Withdrawal by Subject|1|||
126147036|NCT00607048|453823420|FG004|Overall Study|Withdrawal by Subject|0|||
126147037|NCT00607048|453823421|FG005|Overall Study|Withdrawal by Subject|2|||
126147038|NCT00607048|453823416|FG000|Overall Study|Other|1|||
126147039|NCT00607048|453823417|FG001|Overall Study|Other|1|||
126147040|NCT00607048|453823418|FG002|Overall Study|Other|0|||
126147041|NCT00607048|453823419|FG003|Overall Study|Other|0|||
126147042|NCT00607048|453823420|FG004|Overall Study|Other|0|||
126147043|NCT00607048|453823421|FG005|Overall Study|Other|1|||
126147044|NCT00355264|453823422|FG000|Extension (Variable Duration)|Adverse Event|1|||
126147045|NCT00355264|453823422|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
126147046|NCT00826514|453823423|FG000|Overall Study|Adverse Event|1|||
126147047|NCT00826514|453823424|FG001|Overall Study|Adverse Event|1|||
126147048|NCT00826514|453823423|FG000|Overall Study|Lack of Efficacy|0|||
126147049|NCT00826514|453823424|FG001|Overall Study|Lack of Efficacy|1|||
126147050|NCT00826514|453823423|FG000|Overall Study|Withdrawal by Subject|2|||
126147051|NCT00826514|453823424|FG001|Overall Study|Withdrawal by Subject|3|||
126147052|NCT03926143|453823425|FG000|Overall Study|Physician Decision|3|||
126147053|NCT03926143|453823425|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
126147054|NCT03926143|453823425|FG000|Overall Study|Adverse Event|2|||
126147055|NCT03926143|453823425|FG000|Overall Study|Progressive disease|3|||
126147056|NCT02561156|453823427|FG000|Part 2|Adverse Event|0|||
126147057|NCT02561156|453823428|FG001|Part 2|Adverse Event|0|||
126147058|NCT02561156|453823429|FG002|Part 2|Adverse Event|0|||
126147059|NCT02561156|453823430|FG003|Part 2|Adverse Event|0|||
126147060|NCT02561156|453823431|FG004|Part 2|Adverse Event|0|||
126147061|NCT02561156|453823432|FG005|Part 2|Adverse Event|0|||
126147062|NCT02561156|453823433|FG006|Part 2|Adverse Event|0|||
126147063|NCT02561156|453823434|FG007|Part 2|Adverse Event|0|||
126147064|NCT02561156|453823435|FG008|Part 2|Adverse Event|0|||
126147065|NCT02561156|453823436|FG009|Part 2|Adverse Event|0|||
126147066|NCT02561156|453823437|FG010|Part 2|Adverse Event|0|||
126147067|NCT02561156|453823438|FG011|Part 2|Adverse Event|1|||
126147068|NCT02561156|453823439|FG012|Part 2|Adverse Event|0|||
126147069|NCT00098787|453823447|FG000|Overall Study|Never started treatment|3|||
126147070|NCT00098787|453823448|FG001|Overall Study|Never started treatment|2|||
126147071|NCT00098787|453823449|FG002|Overall Study|Never started treatment|1|||
126147072|NCT00098787|453823447|FG000|Overall Study|Ineligible|9|||
126147073|NCT00098787|453823448|FG001|Overall Study|Ineligible|7|||
126147074|NCT00098787|453823449|FG002|Overall Study|Ineligible|3|||
126147075|NCT00098787|453823447|FG000|Overall Study|Disease progression|28|||
126147076|NCT00098787|453823448|FG001|Overall Study|Disease progression|17|||
126147077|NCT00098787|453823449|FG002|Overall Study|Disease progression|23|||
126147078|NCT00098787|453823447|FG000|Overall Study|Adverse Event|8|||
126147079|NCT00098787|453823448|FG001|Overall Study|Adverse Event|17|||
126147080|NCT00098787|453823449|FG002|Overall Study|Adverse Event|8|||
126147081|NCT00098787|453823447|FG000|Overall Study|Death|6|||
126147082|NCT00098787|453823448|FG001|Overall Study|Death|1|||
126147083|NCT00098787|453823449|FG002|Overall Study|Death|0|||
126147084|NCT00098787|453823447|FG000|Overall Study|Withdrawal by Subject|4|||
126147085|NCT00098787|453823448|FG001|Overall Study|Withdrawal by Subject|12|||
126147086|NCT00098787|453823449|FG002|Overall Study|Withdrawal by Subject|6|||
126147087|NCT00098787|453823447|FG000|Overall Study|Alternative therapy|8|||
126147088|NCT00098787|453823448|FG001|Overall Study|Alternative therapy|13|||
126147089|NCT00098787|453823449|FG002|Overall Study|Alternative therapy|13|||
126147090|NCT00098787|453823447|FG000|Overall Study|Other|7|||
126147091|NCT00098787|453823448|FG001|Overall Study|Other|6|||
126147092|NCT00098787|453823449|FG002|Overall Study|Other|9|||
126147093|NCT02203149|453823452|FG000|Part 1|Adverse Event|0|||
126147094|NCT02203149|453823453|FG001|Part 1|Adverse Event|1|||
126147095|NCT02203149|453823454|FG002|Part 1|Adverse Event|0|||
126147096|NCT02203149|453823455|FG003|Part 1|Adverse Event|0|||
126147097|NCT02203149|453823456|FG004|Part 1|Adverse Event|0|||
126147098|NCT02203149|453823452|FG000|Part 2|Death|0|||
126147099|NCT02203149|453823453|FG001|Part 2|Death|0|||
126147100|NCT02203149|453823454|FG002|Part 2|Death|1|||
126147101|NCT02203149|453823455|FG003|Part 2|Death|1|||
126147102|NCT02203149|453823456|FG004|Part 2|Death|0|||
126147103|NCT02203149|453823452|FG000|Part 2|Withdrawal by Subject|0|||
126147104|NCT02203149|453823453|FG001|Part 2|Withdrawal by Subject|0|||
126147105|NCT02203149|453823454|FG002|Part 2|Withdrawal by Subject|0|||
126147106|NCT02203149|453823455|FG003|Part 2|Withdrawal by Subject|1|||
126147107|NCT02203149|453823456|FG004|Part 2|Withdrawal by Subject|0|||
126147108|NCT02203149|453823452|FG000|Part 2|Adverse Event|0|||
126147109|NCT02203149|453823453|FG001|Part 2|Adverse Event|0|||
126147110|NCT02203149|453823454|FG002|Part 2|Adverse Event|0|||
126147111|NCT02203149|453823455|FG003|Part 2|Adverse Event|1|||
126147112|NCT02203149|453823456|FG004|Part 2|Adverse Event|1|||
126147113|NCT01360996|453823457|FG000|Overall Study|Withdrawal by Subject|4|||
126147114|NCT01360996|453823458|FG001|Overall Study|Withdrawal by Subject|3|||
126147115|NCT01360996|453823459|FG002|Overall Study|Withdrawal by Subject|2|||
126147116|NCT01360996|453823457|FG000|Overall Study|Noncompliant|2|||
126147117|NCT01360996|453823458|FG001|Overall Study|Noncompliant|0|||
126147118|NCT01360996|453823459|FG002|Overall Study|Noncompliant|0|||
126147119|NCT01454076|453823460|FG000|Overall Study|Other|2|||
126147120|NCT01454076|453823461|FG001|Overall Study|Other|0|||
126147121|NCT01454076|453823462|FG002|Overall Study|Other|0|||
126147122|NCT01454076|453823463|FG003|Overall Study|Other|1|||
126147123|NCT01454076|453823464|FG004|Overall Study|Other|2|||
126147124|NCT01454076|453823460|FG000|Overall Study|Withdrawal by Subject|3|||
126147125|NCT01454076|453823461|FG001|Overall Study|Withdrawal by Subject|4|||
126147126|NCT01454076|453823462|FG002|Overall Study|Withdrawal by Subject|2|||
126147127|NCT01454076|453823463|FG003|Overall Study|Withdrawal by Subject|1|||
126147128|NCT01454076|453823464|FG004|Overall Study|Withdrawal by Subject|2|||
126147129|NCT01454076|453823460|FG000|Overall Study|Adverse Event|8|||
126147130|NCT01454076|453823461|FG001|Overall Study|Adverse Event|2|||
126147131|NCT01454076|453823462|FG002|Overall Study|Adverse Event|7|||
126147132|NCT01454076|453823463|FG003|Overall Study|Adverse Event|0|||
126147133|NCT01454076|453823464|FG004|Overall Study|Adverse Event|2|||
126147134|NCT04964258|453823465|FG000|Overall Study|Lost to Follow-up|1|||
126147135|NCT04964258|453823466|FG001|Overall Study|Lost to Follow-up|0|||
126147136|NCT04964258|453823467|FG002|Overall Study|Lost to Follow-up|0|||
126147137|NCT04964258|453823468|FG003|Overall Study|Lost to Follow-up|0|||
126147138|NCT04964258|453823469|FG004|Overall Study|Lost to Follow-up|0|||
126147139|NCT04964258|453823470|FG005|Overall Study|Lost to Follow-up|1|||
126147140|NCT04964258|453823471|FG006|Overall Study|Lost to Follow-up|0|||
126147141|NCT04964258|453823472|FG007|Overall Study|Lost to Follow-up|0|||
126147142|NCT04964258|453823473|FG008|Overall Study|Lost to Follow-up|0|||
126147143|NCT04964258|453823474|FG009|Overall Study|Lost to Follow-up|0|||
126147144|NCT04964258|453823475|FG010|Overall Study|Lost to Follow-up|0|||
126147145|NCT01478958|453823476|FG000|Overall Study|Withdrawal by Subject|1|||
126147146|NCT01478958|453823477|FG001|Overall Study|Withdrawal by Subject|1|||
126147147|NCT01478958|453823478|FG002|Overall Study|Withdrawal by Subject|1|||
126147148|NCT01478958|453823476|FG000|Overall Study|Weight loss|1|||
126147149|NCT01478958|453823477|FG001|Overall Study|Weight loss|0|||
126147150|NCT01478958|453823478|FG002|Overall Study|Weight loss|0|||
126147151|NCT01478958|453823476|FG000|Overall Study|Re-located|0|||
126147152|NCT01478958|453823477|FG001|Overall Study|Re-located|1|||
126147153|NCT01478958|453823478|FG002|Overall Study|Re-located|0|||
126147154|NCT01478958|453823476|FG000|Overall Study|Unable to comply|0|||
126147155|NCT01478958|453823477|FG001|Overall Study|Unable to comply|0|||
126147156|NCT01478958|453823478|FG002|Overall Study|Unable to comply|2|||
126147157|NCT03075839|453823479|FG000|Overall Study|Lost to Follow-up|4|||
126147158|NCT01499290|453823480|FG000|Overall Study|Withdrawal by Subject|22|||
126147159|NCT01499290|453823481|FG001|Overall Study|Withdrawal by Subject|15|||
126147160|NCT01499290|453823480|FG000|Overall Study|Not specified in study report|11|||
126147161|NCT01499290|453823481|FG001|Overall Study|Not specified in study report|5|||
126147162|NCT01499290|453823480|FG000|Overall Study|Condition improved/subject recovered|1|||
126147163|NCT01499290|453823481|FG001|Overall Study|Condition improved/subject recovered|0|||
126147164|NCT01499290|453823480|FG000|Overall Study|Lack of Efficacy|7|||
126147165|NCT01499290|453823481|FG001|Overall Study|Lack of Efficacy|8|||
126147166|NCT01499290|453823480|FG000|Overall Study|Adverse Event|14|||
126147167|NCT01499290|453823481|FG001|Overall Study|Adverse Event|7|||
126147168|NCT04052139|453823482|FG000|Overall Study|Lost to Follow-up|2|||
126147169|NCT04052139|453823483|FG001|Overall Study|Lost to Follow-up|0|||
126147170|NCT04052139|453823484|FG002|Overall Study|Lost to Follow-up|0|||
126147171|NCT04052139|453823482|FG000|Overall Study|Withdrawal by Subject|1|||
126147172|NCT04052139|453823483|FG001|Overall Study|Withdrawal by Subject|0|||
126147173|NCT04052139|453823484|FG002|Overall Study|Withdrawal by Subject|0|||
126147174|NCT02305563|453823485|FG000|Treatment Period|Disease progression|0|||
126147175|NCT02305563|453823486|FG001|Treatment Period|Disease progression|0|||
126147176|NCT02305563|453823487|FG002|Treatment Period|Disease progression|15|||
126147177|NCT02305563|453823488|FG003|Treatment Period|Disease progression|6|||
126147178|NCT02305563|453823489|FG004|Treatment Period|Disease progression|6|||
126147179|NCT02305563|453823485|FG000|Treatment Period|Study drug toxicity|0|||
126147180|NCT02305563|453823486|FG001|Treatment Period|Study drug toxicity|0|||
126147181|NCT02305563|453823487|FG002|Treatment Period|Study drug toxicity|0|||
126147182|NCT02305563|453823488|FG003|Treatment Period|Study drug toxicity|1|||
126147183|NCT02305563|453823489|FG004|Treatment Period|Study drug toxicity|2|||
126147184|NCT02305563|453823485|FG000|Treatment Period|Death|0|||
126147185|NCT02305563|453823486|FG001|Treatment Period|Death|0|||
126147186|NCT02305563|453823487|FG002|Treatment Period|Death|1|||
126147187|NCT02305563|453823488|FG003|Treatment Period|Death|2|||
126147188|NCT02305563|453823489|FG004|Treatment Period|Death|1|||
126147189|NCT02305563|453823485|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
126147190|NCT02305563|453823486|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
126147191|NCT02305563|453823487|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
126147192|NCT02305563|453823488|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
126147193|NCT02305563|453823489|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
126147194|NCT02305563|453823485|FG000|Treatment Period|Participant request to stop therapy|0|||
126147195|NCT02305563|453823486|FG001|Treatment Period|Participant request to stop therapy|2|||
126147196|NCT02305563|453823487|FG002|Treatment Period|Participant request to stop therapy|0|||
126147197|NCT02305563|453823488|FG003|Treatment Period|Participant request to stop therapy|1|||
126147198|NCT02305563|453823489|FG004|Treatment Period|Participant request to stop therapy|0|||
126147199|NCT02305563|453823485|FG000|Treatment Period|Participant withdrew consent|0|||
126147200|NCT02305563|453823486|FG001|Treatment Period|Participant withdrew consent|0|||
126147201|NCT02305563|453823487|FG002|Treatment Period|Participant withdrew consent|1|||
126147202|NCT02305563|453823488|FG003|Treatment Period|Participant withdrew consent|1|||
126147203|NCT02305563|453823489|FG004|Treatment Period|Participant withdrew consent|1|||
126147204|NCT02305563|453823485|FG000|Treatment Period|Maximum clinical benefit|0|||
126147205|NCT02305563|453823486|FG001|Treatment Period|Maximum clinical benefit|0|||
126147206|NCT02305563|453823487|FG002|Treatment Period|Maximum clinical benefit|0|||
126147207|NCT02305563|453823488|FG003|Treatment Period|Maximum clinical benefit|0|||
126147208|NCT02305563|453823489|FG004|Treatment Period|Maximum clinical benefit|1|||
126147209|NCT02305563|453823485|FG000|Treatment Period|Poor/non-compliance|0|||
126147210|NCT02305563|453823486|FG001|Treatment Period|Poor/non-compliance|0|||
126147211|NCT02305563|453823487|FG002|Treatment Period|Poor/non-compliance|0|||
126147212|NCT02305563|453823488|FG003|Treatment Period|Poor/non-compliance|0|||
126147213|NCT02305563|453823489|FG004|Treatment Period|Poor/non-compliance|1|||
126147214|NCT02305563|453823485|FG000|Treatment Period|Administrative reason by Sponsor|0|||
126147215|NCT02305563|453823486|FG001|Treatment Period|Administrative reason by Sponsor|0|||
126147216|NCT02305563|453823487|FG002|Treatment Period|Administrative reason by Sponsor|0|||
126147217|NCT02305563|453823488|FG003|Treatment Period|Administrative reason by Sponsor|0|||
126147218|NCT02305563|453823489|FG004|Treatment Period|Administrative reason by Sponsor|1|||
126147219|NCT02305563|453823485|FG000|Treatment Period|other reason|2|||
126147220|NCT02305563|453823486|FG001|Treatment Period|other reason|0|||
126147221|NCT02305563|453823487|FG002|Treatment Period|other reason|2|||
126147222|NCT02305563|453823488|FG003|Treatment Period|other reason|2|||
126147223|NCT02305563|453823489|FG004|Treatment Period|other reason|1|||
126147224|NCT02305563|453823485|FG000|Treatment Period|Randomized but not treated|0|||
126147225|NCT02305563|453823486|FG001|Treatment Period|Randomized but not treated|0|||
126147226|NCT02305563|453823487|FG002|Treatment Period|Randomized but not treated|0|||
126147227|NCT02305563|453823488|FG003|Treatment Period|Randomized but not treated|0|||
126147228|NCT02305563|453823489|FG004|Treatment Period|Randomized but not treated|2|||
126147229|NCT02305563|453823485|FG000|Treatment Period|added ULO, then disease progression|0|||
126147230|NCT02305563|453823486|FG001|Treatment Period|added ULO, then disease progression|0|||
126147231|NCT02305563|453823487|FG002|Treatment Period|added ULO, then disease progression|0|||
126147232|NCT02305563|453823488|FG003|Treatment Period|added ULO, then disease progression|0|||
126147233|NCT02305563|453823489|FG004|Treatment Period|added ULO, then disease progression|4|||
126147234|NCT02305563|453823485|FG000|Treatment Period|added ULO; then other reason|0|||
126147235|NCT02305563|453823486|FG001|Treatment Period|added ULO; then other reason|0|||
126147236|NCT02305563|453823487|FG002|Treatment Period|added ULO; then other reason|0|||
126147237|NCT02305563|453823488|FG003|Treatment Period|added ULO; then other reason|0|||
126147238|NCT02305563|453823489|FG004|Treatment Period|added ULO; then other reason|1|||
126147239|NCT02305563|453823485|FG000|Treatment Period|added ULO, then request to stop|0|||
126147240|NCT02305563|453823486|FG001|Treatment Period|added ULO, then request to stop|0|||
126147241|NCT02305563|453823487|FG002|Treatment Period|added ULO, then request to stop|0|||
126147242|NCT02305563|453823488|FG003|Treatment Period|added ULO, then request to stop|0|||
126147243|NCT02305563|453823489|FG004|Treatment Period|added ULO, then request to stop|1|||
126147244|NCT02305563|453823485|FG000|Follow-up Period|Death|0|||
126147245|NCT02305563|453823486|FG001|Follow-up Period|Death|0|||
126147246|NCT02305563|453823487|FG002|Follow-up Period|Death|5|||
126147247|NCT02305563|453823488|FG003|Follow-up Period|Death|4|||
126147248|NCT02305563|453823489|FG004|Follow-up Period|Death|7|||
126147249|NCT02305563|453823485|FG000|Follow-up Period|Participant withdrew consent|0|||
126147250|NCT02305563|453823486|FG001|Follow-up Period|Participant withdrew consent|0|||
126147251|NCT02305563|453823487|FG002|Follow-up Period|Participant withdrew consent|2|||
126147252|NCT02305563|453823488|FG003|Follow-up Period|Participant withdrew consent|1|||
126147253|NCT02305563|453823489|FG004|Follow-up Period|Participant withdrew consent|0|||
126147254|NCT02305563|453823485|FG000|Follow-up Period|other reason|0|||
126147255|NCT02305563|453823486|FG001|Follow-up Period|other reason|0|||
126147256|NCT02305563|453823487|FG002|Follow-up Period|other reason|0|||
126147257|NCT02305563|453823488|FG003|Follow-up Period|other reason|0|||
126147258|NCT02305563|453823489|FG004|Follow-up Period|other reason|1|||
126147259|NCT02305563|453823485|FG000|Follow-up Period|Followup no longer required per protocol|3|||
126147260|NCT02305563|453823486|FG001|Follow-up Period|Followup no longer required per protocol|3|||
126147261|NCT02305563|453823487|FG002|Follow-up Period|Followup no longer required per protocol|4|||
126147262|NCT02305563|453823488|FG003|Follow-up Period|Followup no longer required per protocol|1|||
126147263|NCT02305563|453823489|FG004|Follow-up Period|Followup no longer required per protocol|4|||
126147264|NCT01926626|453823492|FG000|Overall Study|Withdrawal by Subject|15|||
126147265|NCT01926626|453823492|FG000|Overall Study|Lost to Follow-up|7|||
126147266|NCT00998738|453823493|FG000|Overall Study|Uknown|1|||
126147267|NCT05556616|453825190|FG000|Overall Study|Withdrawal by Subject|1|||
126147268|NCT05556616|453825191|FG001|Overall Study|Withdrawal by Subject|0|||
126147269|NCT05556616|453825192|FG002|Overall Study|Withdrawal by Subject|0|||
126147270|NCT05556616|453825193|FG003|Overall Study|Withdrawal by Subject|0|||
126147271|NCT05556616|453825194|FG004|Overall Study|Withdrawal by Subject|0|||
126147272|NCT05556616|453825195|FG005|Overall Study|Withdrawal by Subject|0|||
126147273|NCT05556616|453825196|FG006|Overall Study|Withdrawal by Subject|0|||
126147274|NCT05556616|453825190|FG000|Overall Study|Death|0|||
126147275|NCT05556616|453825191|FG001|Overall Study|Death|0|||
126147276|NCT05556616|453825192|FG002|Overall Study|Death|2|||
126147277|NCT05556616|453825193|FG003|Overall Study|Death|1|||
126147278|NCT05556616|453825194|FG004|Overall Study|Death|0|||
126147279|NCT05556616|453825195|FG005|Overall Study|Death|0|||
126147280|NCT05556616|453825196|FG006|Overall Study|Death|0|||
126147281|NCT05556616|453825190|FG000|Overall Study|Study Terminated by Sponsor|0|||
126147282|NCT05556616|453825191|FG001|Overall Study|Study Terminated by Sponsor|3|||
125970526|NCT01490632|453182742|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
125970527|NCT01490632|453182743|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970528|NCT01490632|453182744|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970529|NCT01490632|453182745|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970530|NCT01490632|453182746|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970531|NCT01490632|453182747|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970532|NCT01490632|453182748|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970533|NCT01490632|453182749|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970534|NCT01490632|453182750|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970535|NCT01490632|453182751|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970536|NCT01490632|453182752|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970537|NCT01490632|453182753|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970538|NCT01490632|453182754|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970539|NCT01490632|453182755|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970540|NCT01490632|453182756|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970541|NCT01490632|453182757|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970542|NCT01490632|453182758|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125970543|NCT01490632|453182739|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970544|NCT01490632|453182740|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970545|NCT01490632|453182741|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
125970546|NCT01490632|453182742|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
125970547|NCT01490632|453182743|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
125970548|NCT01490632|453182744|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970549|NCT01490632|453182745|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970550|NCT01490632|453182746|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970551|NCT01490632|453182747|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970552|NCT01490632|453182748|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970553|NCT01490632|453182749|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970554|NCT01490632|453182750|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970555|NCT01490632|453182751|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970556|NCT01490632|453182752|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970557|NCT01490632|453182753|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970558|NCT01490632|453182754|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970559|NCT01490632|453182755|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970560|NCT01490632|453182756|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970561|NCT01490632|453182757|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970562|NCT01490632|453182758|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125970563|NCT01490632|453182739|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
125970564|NCT01490632|453182740|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
125970565|NCT01490632|453182741|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
125970566|NCT01490632|453182742|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
125970567|NCT01490632|453182743|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
125970568|NCT01490632|453182744|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
125970569|NCT01490632|453182745|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
125970570|NCT01490632|453182746|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
125970571|NCT01490632|453182747|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
125970572|NCT01490632|453182748|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
125970573|NCT01490632|453182749|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
125970574|NCT01490632|453182750|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
125970575|NCT01490632|453182751|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
125970576|NCT01490632|453182752|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
125970577|NCT01490632|453182753|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
125970578|NCT01490632|453182754|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
126147283|NCT05556616|453825192|FG002|Overall Study|Study Terminated by Sponsor|0|||
126147284|NCT05556616|453825193|FG003|Overall Study|Study Terminated by Sponsor|0|||
125970579|NCT01490632|453182755|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
125970580|NCT01490632|453182756|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
126147285|NCT05556616|453825194|FG004|Overall Study|Study Terminated by Sponsor|0|||
126147286|NCT05556616|453825195|FG005|Overall Study|Study Terminated by Sponsor|0|||
126147287|NCT05556616|453825196|FG006|Overall Study|Study Terminated by Sponsor|0|||
125970581|NCT01490632|453182757|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
125970582|NCT01490632|453182758|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
125970583|NCT01490632|453182739|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
125970584|NCT01490632|453182740|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970585|NCT01490632|453182741|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970586|NCT01490632|453182742|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970587|NCT01490632|453182743|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970588|NCT01490632|453182744|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970589|NCT01490632|453182745|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970590|NCT01490632|453182746|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970591|NCT01490632|453182747|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970592|NCT01490632|453182748|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970593|NCT01490632|453182749|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970594|NCT01490632|453182750|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970595|NCT01490632|453182751|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970596|NCT01490632|453182752|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970597|NCT01490632|453182753|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970598|NCT01490632|453182754|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970599|NCT01490632|453182755|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970600|NCT01490632|453182756|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970601|NCT01490632|453182757|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970602|NCT01490632|453182758|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
125970603|NCT01490632|453182739|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
125970604|NCT01490632|453182740|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
125970605|NCT01490632|453182741|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970606|NCT01490632|453182742|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
126147288|NCT00260208|453825198|FG000|Overall Study|Subject withdrew consent|11|||
126147289|NCT00260208|453825199|FG001|Overall Study|Subject withdrew consent|7|||
126147290|NCT00260208|453825198|FG000|Overall Study|Lost to Follow-up|6|||
126147291|NCT00260208|453825199|FG001|Overall Study|Lost to Follow-up|1|||
126147292|NCT00260208|453825198|FG000|Overall Study|Death|12|||
126147293|NCT00260208|453825199|FG001|Overall Study|Death|10|||
126147294|NCT00260208|453825198|FG000|Overall Study|Missing|18|||
126147295|NCT00260208|453825199|FG001|Overall Study|Missing|16|||
126147296|NCT02091440|453825200|FG000|Overall Study|Death|2|||
126147297|NCT00278629|453825207|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
126147298|NCT03263091|453825209|FG000|OL Component|Withdrawal by Subject|1|||
126147299|NCT03263091|453825210|FG001|OL Component|Withdrawal by Subject|1|||
126147300|NCT03263091|453825211|FG002|OL Component|Withdrawal by Subject|0|||
126147301|NCT03263091|453825212|FG003|OL Component|Withdrawal by Subject|0|||
126147302|NCT03263091|453825213|FG004|OL Component|Withdrawal by Subject|0|||
126147303|NCT03263091|453825214|FG005|OL Component|Withdrawal by Subject|0|||
126147304|NCT03263091|453825209|FG000|OL Component|Physician Decision|0|||
126147305|NCT03263091|453825210|FG001|OL Component|Physician Decision|1|||
126147306|NCT03263091|453825211|FG002|OL Component|Physician Decision|2|||
126147307|NCT03263091|453825212|FG003|OL Component|Physician Decision|0|||
126147308|NCT03263091|453825213|FG004|OL Component|Physician Decision|0|||
126147309|NCT03263091|453825214|FG005|OL Component|Physician Decision|0|||
126147310|NCT03263091|453825209|FG000|OL Component|Death|1|||
126147311|NCT03263091|453825210|FG001|OL Component|Death|0|||
126147312|NCT03263091|453825211|FG002|OL Component|Death|0|||
126147313|NCT03263091|453825212|FG003|OL Component|Death|0|||
126147314|NCT03263091|453825213|FG004|OL Component|Death|0|||
126147315|NCT03263091|453825214|FG005|OL Component|Death|0|||
126147316|NCT03263091|453825209|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
126147317|NCT03263091|453825210|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
126147318|NCT03263091|453825211|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
126147319|NCT03263091|453825212|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
126147320|NCT03263091|453825213|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
126147321|NCT03263091|453825214|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
126147322|NCT03263091|453825209|FG000|OL High-EPO Component|Physician Decision|0|||
126147323|NCT03263091|453825210|FG001|OL High-EPO Component|Physician Decision|0|||
126147324|NCT03263091|453825211|FG002|OL High-EPO Component|Physician Decision|0|||
126147325|NCT03263091|453825212|FG003|OL High-EPO Component|Physician Decision|1|||
126147326|NCT03263091|453825213|FG004|OL High-EPO Component|Physician Decision|0|||
125970607|NCT01490632|453182743|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
125970608|NCT01490632|453182744|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126147327|NCT03263091|453825214|FG005|OL High-EPO Component|Physician Decision|0|||
126147328|NCT03263091|453825209|FG000|OL High-EPO Component|Death|0|||
126147329|NCT03263091|453825210|FG001|OL High-EPO Component|Death|0|||
126147330|NCT03263091|453825211|FG002|OL High-EPO Component|Death|0|||
126147331|NCT03263091|453825212|FG003|OL High-EPO Component|Death|3|||
126147332|NCT03263091|453825213|FG004|OL High-EPO Component|Death|0|||
126147333|NCT03263091|453825214|FG005|OL High-EPO Component|Death|0|||
126147334|NCT03263091|453825209|FG000|DB Component|Withdrawal by Subject|0|||
125970609|NCT01490632|453182745|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970610|NCT01490632|453182746|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970611|NCT01490632|453182747|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970612|NCT01490632|453182748|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970613|NCT01490632|453182749|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970614|NCT01490632|453182750|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970615|NCT01490632|453182751|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970616|NCT01490632|453182752|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970617|NCT01490632|453182753|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970618|NCT01490632|453182754|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970619|NCT01490632|453182755|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970620|NCT01490632|453182756|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970621|NCT01490632|453182757|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970622|NCT01490632|453182758|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125970623|NCT01490632|453182739|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970624|NCT01490632|453182740|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970625|NCT01490632|453182741|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970626|NCT01490632|453182742|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970627|NCT01490632|453182743|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
125970628|NCT01490632|453182744|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970629|NCT01490632|453182745|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970630|NCT01490632|453182746|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970631|NCT01490632|453182747|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970632|NCT01490632|453182748|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970633|NCT01490632|453182749|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970634|NCT01490632|453182750|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970635|NCT01490632|453182751|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970636|NCT01490632|453182752|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970637|NCT01490632|453182753|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970638|NCT01490632|453182754|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970639|NCT01490632|453182755|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970640|NCT01490632|453182756|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970641|NCT01490632|453182757|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970642|NCT01490632|453182758|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125970643|NCT01490632|453182739|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970644|NCT01490632|453182740|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970645|NCT01490632|453182741|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970646|NCT01490632|453182742|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970647|NCT01490632|453182743|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970648|NCT01490632|453182744|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
125970649|NCT01490632|453182745|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
125970650|NCT01490632|453182746|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970651|NCT01490632|453182747|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970652|NCT01490632|453182748|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
125970653|NCT01490632|453182749|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
125970654|NCT01490632|453182750|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
125970655|NCT01490632|453182751|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970656|NCT01490632|453182752|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970657|NCT01490632|453182753|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970658|NCT01490632|453182754|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970659|NCT01490632|453182755|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970660|NCT01490632|453182756|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970661|NCT01490632|453182757|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970662|NCT01490632|453182758|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
125970663|NCT01490632|453182739|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970664|NCT01490632|453182740|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970665|NCT01490632|453182741|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970666|NCT01490632|453182742|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970667|NCT01490632|453182743|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970668|NCT01490632|453182744|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970669|NCT01490632|453182745|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
126147335|NCT03263091|453825210|FG001|DB Component|Withdrawal by Subject|0|||
126147336|NCT03263091|453825211|FG002|DB Component|Withdrawal by Subject|0|||
126147337|NCT03263091|453825212|FG003|DB Component|Withdrawal by Subject|0|||
126147338|NCT03263091|453825213|FG004|DB Component|Withdrawal by Subject|22|||
125970670|NCT01490632|453182746|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126147339|NCT03263091|453825214|FG005|DB Component|Withdrawal by Subject|8|||
126147340|NCT03263091|453825209|FG000|DB Component|Physician Decision|0|||
126147341|NCT03263091|453825210|FG001|DB Component|Physician Decision|0|||
126147342|NCT03263091|453825211|FG002|DB Component|Physician Decision|0|||
126147343|NCT03263091|453825212|FG003|DB Component|Physician Decision|0|||
126147344|NCT03263091|453825213|FG004|DB Component|Physician Decision|3|||
126147345|NCT03263091|453825214|FG005|DB Component|Physician Decision|1|||
126147346|NCT03263091|453825209|FG000|DB Component|Adverse Event|0|||
126147347|NCT03263091|453825210|FG001|DB Component|Adverse Event|0|||
126147348|NCT03263091|453825211|FG002|DB Component|Adverse Event|0|||
126147349|NCT03263091|453825212|FG003|DB Component|Adverse Event|0|||
126147350|NCT03263091|453825213|FG004|DB Component|Adverse Event|2|||
126147351|NCT03263091|453825214|FG005|DB Component|Adverse Event|1|||
126147352|NCT03263091|453825209|FG000|DB Component|Lost to Follow-up|0|||
126147353|NCT03263091|453825210|FG001|DB Component|Lost to Follow-up|0|||
125970671|NCT01490632|453182747|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
125970672|NCT01490632|453182748|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
125970673|NCT01490632|453182749|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
125970674|NCT01490632|453182750|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970675|NCT01490632|453182751|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126147354|NCT03263091|453825211|FG002|DB Component|Lost to Follow-up|0|||
126147355|NCT03263091|453825212|FG003|DB Component|Lost to Follow-up|0|||
126147356|NCT03263091|453825213|FG004|DB Component|Lost to Follow-up|2|||
126147357|NCT03263091|453825214|FG005|DB Component|Lost to Follow-up|1|||
126147358|NCT03263091|453825209|FG000|DB Component|Death|0|||
126147359|NCT03263091|453825210|FG001|DB Component|Death|0|||
126147360|NCT03263091|453825211|FG002|DB Component|Death|0|||
126147361|NCT03263091|453825212|FG003|DB Component|Death|0|||
125970676|NCT01490632|453182752|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970677|NCT01490632|453182753|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126147362|NCT03263091|453825213|FG004|DB Component|Death|7|||
126147363|NCT03263091|453825214|FG005|DB Component|Death|4|||
126147364|NCT03263091|453825209|FG000|DB Component|Other than specified|0|||
126147365|NCT03263091|453825210|FG001|DB Component|Other than specified|0|||
126147366|NCT03263091|453825211|FG002|DB Component|Other than specified|0|||
126147367|NCT03263091|453825212|FG003|DB Component|Other than specified|0|||
126147368|NCT03263091|453825213|FG004|DB Component|Other than specified|8|||
126147369|NCT03263091|453825214|FG005|DB Component|Other than specified|6|||
126147370|NCT00742781|453825215|FG000|Overall Study|Withdrawal by Subject|3|||
126147371|NCT00826748|453825216|FG000|Overall Study|Withdrawal by Subject|0|||
126147372|NCT00826748|453825217|FG001|Overall Study|Withdrawal by Subject|0|||
126147373|NCT00826748|453825218|FG002|Overall Study|Withdrawal by Subject|2|||
126147374|NCT00826748|453825216|FG000|Overall Study|Physician Decision|0|||
126147375|NCT00826748|453825217|FG001|Overall Study|Physician Decision|0|||
126147376|NCT00826748|453825218|FG002|Overall Study|Physician Decision|1|||
126147377|NCT00826748|453825216|FG000|Overall Study|Samples Did Not pass QC|0|||
126147378|NCT00826748|453825217|FG001|Overall Study|Samples Did Not pass QC|0|||
126147379|NCT00826748|453825218|FG002|Overall Study|Samples Did Not pass QC|1|||
126147380|NCT02443402|453825227|FG000|Overall Study|Withdrawal by Subject|3|||
126147381|NCT02443402|453825228|FG001|Overall Study|Withdrawal by Subject|1|||
126147382|NCT02443402|453825227|FG000|Overall Study|Screen Failure|1|||
126147383|NCT02443402|453825228|FG001|Overall Study|Screen Failure|2|||
126147384|NCT01552057|453825246|FG000|Overall Study|Adverse Event|14|||
126147385|NCT01552057|453825247|FG001|Overall Study|Adverse Event|15|||
126147386|NCT01552057|453825246|FG000|Overall Study|Lack of Efficacy|8|||
125970678|NCT01490632|453182754|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970679|NCT01490632|453182755|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970680|NCT01490632|453182756|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970681|NCT01490632|453182757|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970682|NCT01490632|453182758|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125970683|NCT01490632|453182739|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970684|NCT01490632|453182740|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126147387|NCT01552057|453825247|FG001|Overall Study|Lack of Efficacy|23|||
126147388|NCT01552057|453825246|FG000|Overall Study|Withdrawal by Subject|5|||
126147389|NCT01552057|453825247|FG001|Overall Study|Withdrawal by Subject|8|||
126147390|NCT01552057|453825246|FG000|Overall Study|Entry Criteria Not Met|2|||
126147391|NCT01552057|453825247|FG001|Overall Study|Entry Criteria Not Met|2|||
126147392|NCT01552057|453825246|FG000|Overall Study|Physician Decision|1|||
126147393|NCT01552057|453825247|FG001|Overall Study|Physician Decision|0|||
126147394|NCT01389245|453825249|FG000|Overall Study|Protocol Violation|10|||
126147395|NCT01389245|453825249|FG000|Overall Study|Lost to Follow-up|3|||
126147396|NCT01389245|453825249|FG000|Overall Study|Withdrawal by Subject|2|||
126147397|NCT05127486|453825250|FG000|Overall Study|Adverse Event|2|||
126147398|NCT05127486|453825251|FG001|Overall Study|Adverse Event|4|||
126147399|NCT05127486|453825250|FG000|Overall Study|Lack of Efficacy|1|||
126147400|NCT05127486|453825251|FG001|Overall Study|Lack of Efficacy|0|||
125970685|NCT01490632|453182741|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970686|NCT01490632|453182742|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970687|NCT01490632|453182743|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970688|NCT01490632|453182744|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970689|NCT01490632|453182745|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
125970690|NCT01490632|453182746|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970691|NCT01490632|453182747|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970692|NCT01490632|453182748|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
125970693|NCT01490632|453182749|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970694|NCT01490632|453182750|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970695|NCT01490632|453182751|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970696|NCT01490632|453182752|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970697|NCT01490632|453182753|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970698|NCT01490632|453182754|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970699|NCT01490632|453182755|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970700|NCT01490632|453182756|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970701|NCT01490632|453182757|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970702|NCT01490632|453182758|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125970703|NCT01490632|453182739|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970704|NCT01490632|453182740|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970705|NCT01490632|453182741|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970706|NCT01490632|453182742|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970707|NCT01490632|453182743|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970708|NCT01490632|453182744|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970709|NCT01490632|453182745|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
125970710|NCT01490632|453182746|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970711|NCT01490632|453182747|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970712|NCT01490632|453182748|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970713|NCT01490632|453182749|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
126147401|NCT05127486|453825250|FG000|Overall Study|Pregnancy|0|||
125970714|NCT01490632|453182750|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970715|NCT01490632|453182751|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970716|NCT01490632|453182752|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970717|NCT01490632|453182753|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970718|NCT01490632|453182754|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970719|NCT01490632|453182755|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970720|NCT01490632|453182756|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970721|NCT01490632|453182757|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
126147402|NCT05127486|453825251|FG001|Overall Study|Pregnancy|1|||
126147403|NCT05127486|453825250|FG000|Overall Study|Physician Decision|4|||
126147404|NCT05127486|453825251|FG001|Overall Study|Physician Decision|1|||
126147405|NCT05127486|453825250|FG000|Overall Study|Withdrawal by Subject|14|||
126147406|NCT05127486|453825251|FG001|Overall Study|Withdrawal by Subject|13|||
126147407|NCT05127486|453825250|FG000|Overall Study|Lost to Follow-up|5|||
126147408|NCT05127486|453825251|FG001|Overall Study|Lost to Follow-up|8|||
126147409|NCT01287754|453825252|FG000|Overall Study|Death|2|||
126147410|NCT01287754|453825253|FG001|Overall Study|Death|12|||
125970722|NCT01490632|453182758|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
125970723|NCT01490632|453182739|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970724|NCT01490632|453182740|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970725|NCT01490632|453182741|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970726|NCT01490632|453182742|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970727|NCT01490632|453182743|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970728|NCT01490632|453182744|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
125970729|NCT01490632|453182745|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126147411|NCT01287754|453825252|FG000|Overall Study|Lost to Follow-up|1|||
126147412|NCT01287754|453825253|FG001|Overall Study|Lost to Follow-up|6|||
126147413|NCT01287754|453825252|FG000|Overall Study|Protocol Violation|0|||
125970730|NCT01490632|453182746|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970731|NCT01490632|453182747|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970732|NCT01490632|453182748|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970733|NCT01490632|453182749|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970734|NCT01490632|453182750|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970735|NCT01490632|453182751|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970736|NCT01490632|453182752|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970737|NCT01490632|453182753|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126147414|NCT01287754|453825253|FG001|Overall Study|Protocol Violation|3|||
126147415|NCT04971226|453825254|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125970738|NCT01490632|453182754|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970739|NCT01490632|453182755|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970740|NCT01490632|453182756|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970741|NCT01490632|453182757|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970742|NCT01490632|453182758|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125970743|NCT01490632|453182739|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970744|NCT01490632|453182740|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970745|NCT01490632|453182741|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970746|NCT01490632|453182742|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970747|NCT01490632|453182743|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970748|NCT01490632|453182744|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126147416|NCT04971226|453825255|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
126147417|NCT04971226|453825256|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
126147418|NCT04971226|453825257|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
126147419|NCT04971226|453825254|FG000|Overall Study|Adverse Event|6|||
126147420|NCT04971226|453825255|FG001|Overall Study|Adverse Event|5|||
126147421|NCT04971226|453825256|FG002|Overall Study|Adverse Event|11|||
126147422|NCT04971226|453825257|FG003|Overall Study|Adverse Event|10|||
126147423|NCT04971226|453825254|FG000|Overall Study|Progressive disease|2|||
126147424|NCT04971226|453825255|FG001|Overall Study|Progressive disease|0|||
126147425|NCT04971226|453825256|FG002|Overall Study|Progressive disease|3|||
126147426|NCT04971226|453825257|FG003|Overall Study|Progressive disease|1|||
126147427|NCT04971226|453825254|FG000|Overall Study|Protocol Deviation|1|||
126147428|NCT04971226|453825255|FG001|Overall Study|Protocol Deviation|0|||
126147429|NCT04971226|453825256|FG002|Overall Study|Protocol Deviation|1|||
126147430|NCT04971226|453825257|FG003|Overall Study|Protocol Deviation|1|||
126147431|NCT04971226|453825254|FG000|Overall Study|Subject Decision|0|||
126147432|NCT04971226|453825255|FG001|Overall Study|Subject Decision|1|||
126147433|NCT04971226|453825256|FG002|Overall Study|Subject Decision|1|||
126147434|NCT04971226|453825257|FG003|Overall Study|Subject Decision|1|||
126147435|NCT04971226|453825254|FG000|Overall Study|Pregnancy|0|||
126147436|NCT04971226|453825255|FG001|Overall Study|Pregnancy|0|||
126147437|NCT04971226|453825256|FG002|Overall Study|Pregnancy|0|||
126147438|NCT04971226|453825257|FG003|Overall Study|Pregnancy|1|||
126147439|NCT04971226|453825254|FG000|Overall Study|Participants not treated|1|||
126147440|NCT04971226|453825255|FG001|Overall Study|Participants not treated|0|||
126147441|NCT04971226|453825256|FG002|Overall Study|Participants not treated|2|||
126147442|NCT04971226|453825257|FG003|Overall Study|Participants not treated|1|||
126147443|NCT00001337|453825259|FG000|Overall Study|Switched to alternate treatment|2|||
126147444|NCT00001337|453825260|FG001|Overall Study|Switched to alternate treatment|2|||
126147445|NCT00001337|453825261|FG002|Overall Study|Switched to alternate treatment|0|||
126147446|NCT00001337|453825259|FG000|Overall Study|Refused further treatment|2|||
125970749|NCT01490632|453182745|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
125970750|NCT01490632|453182746|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970751|NCT01490632|453182747|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
125970752|NCT01490632|453182748|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970753|NCT01490632|453182749|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
125970754|NCT01490632|453182750|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
125970755|NCT01490632|453182751|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970756|NCT01490632|453182752|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970757|NCT01490632|453182753|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970758|NCT01490632|453182754|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970759|NCT01490632|453182755|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970760|NCT01490632|453182756|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970761|NCT01490632|453182757|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970762|NCT01490632|453182758|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125970763|NCT01490632|453182739|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126147447|NCT00001337|453825260|FG001|Overall Study|Refused further treatment|1|||
126147448|NCT00001337|453825261|FG002|Overall Study|Refused further treatment|0|||
126147449|NCT00001337|453825259|FG000|Overall Study|Began other Tx|1|||
126147450|NCT00001337|453825260|FG001|Overall Study|Began other Tx|0|||
125970764|NCT01490632|453182740|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970765|NCT01490632|453182741|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970766|NCT01490632|453182742|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970767|NCT01490632|453182743|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126147451|NCT00001337|453825261|FG002|Overall Study|Began other Tx|0|||
126147452|NCT00001337|453825259|FG000|Overall Study|Physician Decision|3|||
126147453|NCT00001337|453825260|FG001|Overall Study|Physician Decision|1|||
126147454|NCT00001337|453825261|FG002|Overall Study|Physician Decision|0|||
126147455|NCT00001337|453825259|FG000|Overall Study|Doesn't have NHL|0|||
126147456|NCT00001337|453825260|FG001|Overall Study|Doesn't have NHL|1|||
126147457|NCT00001337|453825261|FG002|Overall Study|Doesn't have NHL|0|||
125970768|NCT01490632|453182744|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
125970769|NCT01490632|453182745|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
125970770|NCT01490632|453182746|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
125970771|NCT01490632|453182747|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
125970772|NCT01490632|453182748|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
125970773|NCT01490632|453182749|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
125970774|NCT01490632|453182750|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
125970775|NCT01490632|453182751|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970776|NCT01490632|453182752|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970777|NCT01490632|453182753|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970778|NCT01490632|453182754|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970779|NCT01490632|453182755|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970780|NCT01490632|453182756|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970781|NCT01490632|453182757|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970782|NCT01490632|453182758|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125970783|NCT01490632|453182739|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970784|NCT01490632|453182740|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970785|NCT01490632|453182741|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970786|NCT01490632|453182742|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970787|NCT01490632|453182743|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970788|NCT01490632|453182744|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970789|NCT01490632|453182745|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970790|NCT01490632|453182746|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970791|NCT01490632|453182747|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970792|NCT01490632|453182748|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970793|NCT01490632|453182749|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970794|NCT01490632|453182750|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970795|NCT01490632|453182751|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970796|NCT01490632|453182752|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970797|NCT01490632|453182753|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
125970798|NCT01490632|453182754|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
125970799|NCT01490632|453182755|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970800|NCT01490632|453182756|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970801|NCT01490632|453182757|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970802|NCT01490632|453182758|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
125970803|NCT01490632|453182739|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970804|NCT01490632|453182740|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970805|NCT01490632|453182741|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970806|NCT01490632|453182742|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970807|NCT01490632|453182743|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970808|NCT01490632|453182744|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126147458|NCT00001337|453825259|FG000|Overall Study|Non protocol tx needed|3|||
126147459|NCT00001337|453825260|FG001|Overall Study|Non protocol tx needed|1|||
126147460|NCT00001337|453825261|FG002|Overall Study|Non protocol tx needed|0|||
126147461|NCT00001337|453825259|FG000|Overall Study|Protocol change|1|||
126147462|NCT00001337|453825260|FG001|Overall Study|Protocol change|0|||
126147463|NCT00001337|453825261|FG002|Overall Study|Protocol change|0|||
126147464|NCT00001337|453825259|FG000|Overall Study|2nd primary disease|0|||
126147465|NCT00001337|453825260|FG001|Overall Study|2nd primary disease|0|||
126147466|NCT00001337|453825261|FG002|Overall Study|2nd primary disease|1|||
126147467|NCT00001337|453825259|FG000|Overall Study|Death during follow up period|9|||
126147468|NCT00001337|453825260|FG001|Overall Study|Death during follow up period|4|||
126147469|NCT00001337|453825261|FG002|Overall Study|Death during follow up period|0|||
126147470|NCT00001337|453825259|FG000|Overall Study|Death on study|19|||
126147471|NCT00001337|453825260|FG001|Overall Study|Death on study|9|||
126147472|NCT00001337|453825261|FG002|Overall Study|Death on study|0|||
126147473|NCT00001337|453825259|FG000|Overall Study|Disease progression during follow-up period|3|||
126147474|NCT00001337|453825260|FG001|Overall Study|Disease progression during follow-up period|1|||
126147475|NCT00001337|453825261|FG002|Overall Study|Disease progression during follow-up period|0|||
125970809|NCT01490632|453182745|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970810|NCT01490632|453182746|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970811|NCT01490632|453182747|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970812|NCT01490632|453182748|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126147476|NCT00001337|453825259|FG000|Overall Study|Disease progression on study|33|||
126147477|NCT00001337|453825260|FG001|Overall Study|Disease progression on study|41|||
126147478|NCT00001337|453825261|FG002|Overall Study|Disease progression on study|0|||
125970813|NCT01490632|453182749|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970814|NCT01490632|453182750|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970815|NCT01490632|453182751|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970816|NCT01490632|453182752|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
125970817|NCT01490632|453182753|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970818|NCT01490632|453182754|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970819|NCT01490632|453182755|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970820|NCT01490632|453182756|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970821|NCT01490632|453182757|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970822|NCT01490632|453182758|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125970823|NCT01490632|453182739|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970824|NCT01490632|453182740|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970825|NCT01490632|453182741|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970826|NCT01490632|453182742|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970827|NCT01490632|453182743|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970828|NCT01490632|453182744|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970829|NCT01490632|453182745|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970830|NCT01490632|453182746|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970831|NCT01490632|453182747|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970832|NCT01490632|453182748|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970833|NCT01490632|453182749|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970834|NCT01490632|453182750|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970835|NCT01490632|453182751|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970836|NCT01490632|453182752|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970837|NCT01490632|453182753|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
125970838|NCT01490632|453182754|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
125970839|NCT01490632|453182755|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970840|NCT01490632|453182756|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970841|NCT01490632|453182757|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970842|NCT01490632|453182758|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125970843|NCT01490632|453182739|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970844|NCT01490632|453182740|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970845|NCT01490632|453182741|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970846|NCT01490632|453182742|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970847|NCT01490632|453182743|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970848|NCT01490632|453182744|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970849|NCT01490632|453182745|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970850|NCT01490632|453182746|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970851|NCT01490632|453182747|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970852|NCT01490632|453182748|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970853|NCT01490632|453182749|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970854|NCT01490632|453182750|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970855|NCT01490632|453182751|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
125970856|NCT01490632|453182752|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
125970857|NCT01490632|453182753|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
125970858|NCT01490632|453182754|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
125970859|NCT01490632|453182755|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970860|NCT01490632|453182756|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970861|NCT01490632|453182757|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970862|NCT01490632|453182758|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125970863|NCT01490632|453182739|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
125970864|NCT01490632|453182740|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
125970865|NCT01490632|453182741|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
125970866|NCT01490632|453182742|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
125970867|NCT01490632|453182743|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
125970868|NCT01490632|453182744|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
125970869|NCT01490632|453182745|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
125970870|NCT01490632|453182746|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
125970871|NCT01490632|453182747|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
125970872|NCT01490632|453182748|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
125970873|NCT01490632|453182749|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
125970874|NCT01490632|453182750|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
126147479|NCT00001337|453825259|FG000|Overall Study|Lost to further follow-up|10|||
125970875|NCT01490632|453182751|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
125970876|NCT01490632|453182752|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
125970877|NCT01490632|453182753|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
125970878|NCT01490632|453182754|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
125970879|NCT01490632|453182755|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
125970880|NCT01490632|453182756|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
125970881|NCT01490632|453182757|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
125970882|NCT01490632|453182758|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
125970883|NCT01490632|453182739|FG000|Part D: Re-Treatment Period|Death|0|||
125970884|NCT01490632|453182740|FG001|Part D: Re-Treatment Period|Death|0|||
125970885|NCT01490632|453182741|FG002|Part D: Re-Treatment Period|Death|0|||
125970886|NCT01490632|453182742|FG003|Part D: Re-Treatment Period|Death|0|||
125970887|NCT01490632|453182743|FG004|Part D: Re-Treatment Period|Death|0|||
125970888|NCT01490632|453182744|FG005|Part D: Re-Treatment Period|Death|0|||
125970889|NCT01490632|453182745|FG006|Part D: Re-Treatment Period|Death|0|||
125970890|NCT01490632|453182746|FG007|Part D: Re-Treatment Period|Death|0|||
125970891|NCT01490632|453182747|FG008|Part D: Re-Treatment Period|Death|0|||
125970892|NCT01490632|453182748|FG009|Part D: Re-Treatment Period|Death|0|||
125970893|NCT01490632|453182749|FG010|Part D: Re-Treatment Period|Death|0|||
125970894|NCT01490632|453182750|FG011|Part D: Re-Treatment Period|Death|0|||
125970895|NCT01490632|453182751|FG012|Part D: Re-Treatment Period|Death|0|||
125970896|NCT01490632|453182752|FG013|Part D: Re-Treatment Period|Death|0|||
125970897|NCT01490632|453182753|FG014|Part D: Re-Treatment Period|Death|0|||
125970898|NCT01490632|453182754|FG015|Part D: Re-Treatment Period|Death|0|||
125970899|NCT01490632|453182755|FG016|Part D: Re-Treatment Period|Death|0|||
125970900|NCT01490632|453182756|FG017|Part D: Re-Treatment Period|Death|0|||
125970901|NCT01490632|453182757|FG018|Part D: Re-Treatment Period|Death|1|||
125970902|NCT01490632|453182758|FG019|Part D: Re-Treatment Period|Death|0|||
125970903|NCT01490632|453182739|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970904|NCT01490632|453182740|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970905|NCT01490632|453182741|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970906|NCT01490632|453182742|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970907|NCT01490632|453182743|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970908|NCT01490632|453182744|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970909|NCT01490632|453182745|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970910|NCT01490632|453182746|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970911|NCT01490632|453182747|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970912|NCT01490632|453182748|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970913|NCT01490632|453182749|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970914|NCT01490632|453182750|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970915|NCT01490632|453182751|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970916|NCT01490632|453182752|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970917|NCT01490632|453182753|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970918|NCT01490632|453182754|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970919|NCT01490632|453182755|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125970920|NCT01490632|453182756|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
125970921|NCT01490632|453182757|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
125970922|NCT01490632|453182758|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
125970923|NCT01490632|453182739|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970924|NCT01490632|453182740|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970925|NCT01490632|453182741|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970926|NCT01490632|453182742|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970927|NCT01490632|453182743|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970928|NCT01490632|453182744|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970929|NCT01490632|453182745|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970930|NCT01490632|453182746|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970931|NCT01490632|453182747|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970932|NCT01490632|453182748|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970933|NCT01490632|453182749|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970934|NCT01490632|453182750|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970935|NCT01490632|453182751|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970936|NCT01490632|453182752|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970937|NCT01490632|453182753|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970938|NCT01490632|453182754|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126147480|NCT00001337|453825260|FG001|Overall Study|Lost to further follow-up|6|||
126147481|NCT00001337|453825261|FG002|Overall Study|Lost to further follow-up|0|||
125970939|NCT01490632|453182755|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970940|NCT01490632|453182756|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970941|NCT01490632|453182757|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
125970942|NCT01490632|453182758|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125970943|NCT01490632|453182739|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
125970944|NCT01490632|453182740|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
125970945|NCT01490632|453182741|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
126147482|NCT00001337|453825259|FG000|Overall Study|2nd malignancy|1|||
125970946|NCT01490632|453182742|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
126147483|NCT00001337|453825260|FG001|Overall Study|2nd malignancy|0|||
126147484|NCT00001337|453825261|FG002|Overall Study|2nd malignancy|0|||
126147485|NCT00001337|453825259|FG000|Overall Study|Treatment for second lymphoma|0|||
126147486|NCT00001337|453825260|FG001|Overall Study|Treatment for second lymphoma|1|||
126147487|NCT00001337|453825261|FG002|Overall Study|Treatment for second lymphoma|0|||
126147488|NCT00001337|453825259|FG000|Overall Study|Transfer to transplant|0|||
126147489|NCT00001337|453825260|FG001|Overall Study|Transfer to transplant|1|||
126147490|NCT00001337|453825261|FG002|Overall Study|Transfer to transplant|0|||
126147491|NCT00442598|453825262|FG000|Overall Study|Adverse Event|1|||
126147492|NCT00442598|453825263|FG001|Overall Study|Adverse Event|0|||
126147493|NCT00442598|453825264|FG002|Overall Study|Adverse Event|0|||
126147494|NCT00442598|453825262|FG000|Overall Study|Tumor progression|3|||
126147495|NCT00442598|453825263|FG001|Overall Study|Tumor progression|4|||
126147496|NCT00442598|453825264|FG002|Overall Study|Tumor progression|0|||
126147497|NCT00442598|453825262|FG000|Overall Study|Clinical deterioration|1|||
126147498|NCT00442598|453825263|FG001|Overall Study|Clinical deterioration|2|||
126147499|NCT00442598|453825264|FG002|Overall Study|Clinical deterioration|0|||
126147500|NCT00442598|453825262|FG000|Overall Study|CA125 progression|0|||
126147501|NCT00442598|453825263|FG001|Overall Study|CA125 progression|1|||
126147502|NCT00442598|453825264|FG002|Overall Study|CA125 progression|0|||
126147503|NCT00442598|453825262|FG000|Overall Study|Reduced creatinine clearance|1|||
126147504|NCT00442598|453825263|FG001|Overall Study|Reduced creatinine clearance|0|||
126147505|NCT00442598|453825264|FG002|Overall Study|Reduced creatinine clearance|0|||
126147506|NCT00442598|453825262|FG000|Overall Study|Death|0|||
126147507|NCT00442598|453825263|FG001|Overall Study|Death|1|||
126147508|NCT00442598|453825264|FG002|Overall Study|Death|0|||
126147509|NCT01262898|453825265|FG000|Overall Study|Protocol Violation|1|||
126147510|NCT01262898|453825266|FG001|Overall Study|Protocol Violation|1|||
126147511|NCT01262898|453825267|FG002|Overall Study|Protocol Violation|0|||
126147512|NCT01262898|453825268|FG003|Overall Study|Protocol Violation|0|||
126147513|NCT01262898|453825265|FG000|Overall Study|Lost to Follow-up|1|||
126147514|NCT01262898|453825266|FG001|Overall Study|Lost to Follow-up|0|||
126147515|NCT01262898|453825267|FG002|Overall Study|Lost to Follow-up|0|||
126147516|NCT01262898|453825268|FG003|Overall Study|Lost to Follow-up|0|||
126147517|NCT01262898|453825265|FG000|Overall Study|Withdrawal by Subject|1|||
126147518|NCT01262898|453825266|FG001|Overall Study|Withdrawal by Subject|1|||
126147519|NCT01262898|453825267|FG002|Overall Study|Withdrawal by Subject|0|||
126147520|NCT01262898|453825268|FG003|Overall Study|Withdrawal by Subject|0|||
126147521|NCT04026568|453825269|FG000|Overall Study|study terminated|0|||
126147522|NCT04026568|453825270|FG001|Overall Study|study terminated|1|||
126147523|NCT02197377|453825271|FG000|Overall Study|Insertion Failure|0|||
126147524|NCT02197377|453825272|FG001|Overall Study|Insertion Failure|3|||
126147525|NCT00502840|453825273|FG000|Overall Study|Adverse Event|5|||
126147526|NCT00502840|453825273|FG000|Overall Study|Additional or changed therapy|48|||
126147527|NCT00502840|453825273|FG000|Overall Study|Lack of Efficacy|11|||
125970947|NCT01490632|453182743|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
125970948|NCT01490632|453182744|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
125970949|NCT01490632|453182745|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
125970950|NCT01490632|453182746|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
125970951|NCT01490632|453182747|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
125970952|NCT01490632|453182748|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
125970953|NCT01490632|453182749|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
125970954|NCT01490632|453182750|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
125970955|NCT01490632|453182751|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
125970956|NCT01490632|453182752|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
125970957|NCT01490632|453182753|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
125970958|NCT01490632|453182754|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
125970959|NCT01490632|453182755|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
125970960|NCT01490632|453182756|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
125970961|NCT01490632|453182757|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
125970962|NCT01490632|453182758|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
125970963|NCT01490632|453182739|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
125970964|NCT01490632|453182740|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
126147528|NCT00502840|453825273|FG000|Overall Study|Protocol Violation|4|||
126147529|NCT00502840|453825273|FG000|Overall Study|Withdrawal by Subject|5|||
126147530|NCT00502840|453825273|FG000|Overall Study|Lost to Follow-up|6|||
126147531|NCT00502840|453825273|FG000|Overall Study|Administrative problems|1|||
126147532|NCT00502840|453825273|FG000|Overall Study|Other|20|||
126147533|NCT00461175|453825274|FG000|Overall Study|Protocol Violation|522|||
125970965|NCT01490632|453182741|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
125970966|NCT01490632|453182742|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
126147534|NCT00461175|453825275|FG001|Overall Study|Protocol Violation|365|||
126147535|NCT01700829|453825276|FG000|Overall Study|Withdrawal by Subject|1|||
126147536|NCT01700829|453825277|FG001|Overall Study|Withdrawal by Subject|1|||
126147537|NCT03406962|453825278|FG000|Overall Study|Death|2|||
125970967|NCT01490632|453182743|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
125970968|NCT01490632|453182744|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
125970969|NCT01490632|453182745|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
125970970|NCT01490632|453182746|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
125970971|NCT01490632|453182747|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
125970972|NCT01490632|453182748|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
126147538|NCT03406962|453825278|FG000|Overall Study|Adverse Event|1|||
126147539|NCT00327444|453825279|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
125970973|NCT01490632|453182749|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
125970974|NCT01490632|453182750|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
125970975|NCT01490632|453182751|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
125970976|NCT01490632|453182752|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
125970977|NCT01490632|453182753|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
125970978|NCT01490632|453182754|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
125970979|NCT01490632|453182755|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
125970980|NCT01490632|453182756|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
125970981|NCT01490632|453182757|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
125970982|NCT01490632|453182758|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
125970983|NCT01490632|453182739|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970984|NCT01490632|453182740|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970985|NCT01490632|453182741|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970986|NCT01490632|453182742|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970987|NCT01490632|453182743|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970988|NCT01490632|453182744|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970989|NCT01490632|453182745|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970990|NCT01490632|453182746|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970991|NCT01490632|453182747|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970992|NCT01490632|453182748|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970993|NCT01490632|453182749|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970994|NCT01490632|453182750|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970995|NCT01490632|453182751|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970996|NCT01490632|453182752|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970997|NCT01490632|453182753|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970998|NCT01490632|453182754|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125970999|NCT01490632|453182755|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125971000|NCT01490632|453182756|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
125971001|NCT01490632|453182757|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
125971002|NCT01490632|453182758|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
125971003|NCT02332720|453182761|FG000|Part A and Part B|Lost to Follow-up|1|||
125971004|NCT02332720|453182762|FG001|Part A and Part B|Lost to Follow-up|0|||
125971005|NCT02332720|453182763|FG002|Part A and Part B|Lost to Follow-up|0|||
125971006|NCT02332720|453182764|FG003|Part A and Part B|Lost to Follow-up|0|||
125971007|NCT02332720|453182765|FG004|Part A and Part B|Lost to Follow-up|0|||
125971008|NCT02332720|453182766|FG005|Part A and Part B|Lost to Follow-up|2|||
125971009|NCT02332720|453182767|FG006|Part A and Part B|Lost to Follow-up|1|||
125971010|NCT02332720|453182768|FG007|Part A and Part B|Lost to Follow-up|1|||
125971011|NCT02332720|453182769|FG008|Part A and Part B|Lost to Follow-up|0|||
125971012|NCT02332720|453182770|FG009|Part A and Part B|Lost to Follow-up|0|||
125971013|NCT02332720|453182771|FG010|Part A and Part B|Lost to Follow-up|0|||
125971014|NCT02332720|453182772|FG011|Part A and Part B|Lost to Follow-up|0|||
125971015|NCT02332720|453182773|FG012|Part A and Part B|Lost to Follow-up|0|||
125971016|NCT02332720|453182774|FG013|Part A and Part B|Lost to Follow-up|0|||
126147540|NCT00327444|453825280|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
126147541|NCT00327444|453825279|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
126147542|NCT00327444|453825280|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
126147543|NCT00327444|453825279|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
125971017|NCT02332720|453182775|FG014|Part A and Part B|Lost to Follow-up|0|||
125971018|NCT02332720|453182776|FG015|Part A and Part B|Lost to Follow-up|1|||
125971019|NCT02332720|453182777|FG016|Part A and Part B|Lost to Follow-up|0|||
125971020|NCT02332720|453182778|FG017|Part A and Part B|Lost to Follow-up|0|||
125971021|NCT02332720|453182779|FG018|Part A and Part B|Lost to Follow-up|0|||
125971022|NCT02332720|453182780|FG019|Part A and Part B|Lost to Follow-up|0|||
125971023|NCT02332720|453182781|FG020|Part A and Part B|Lost to Follow-up|0|||
125971024|NCT02332720|453182782|FG021|Part A and Part B|Lost to Follow-up|0|||
125971025|NCT02332720|453182783|FG022|Part A and Part B|Lost to Follow-up|0|||
125971026|NCT02332720|453182761|FG000|Part A and Part B|Adverse Event|0|||
125971027|NCT02332720|453182762|FG001|Part A and Part B|Adverse Event|0|||
125971028|NCT02332720|453182763|FG002|Part A and Part B|Adverse Event|0|||
125971029|NCT02332720|453182764|FG003|Part A and Part B|Adverse Event|0|||
125971030|NCT02332720|453182765|FG004|Part A and Part B|Adverse Event|0|||
125971031|NCT02332720|453182766|FG005|Part A and Part B|Adverse Event|0|||
126147544|NCT00327444|453825280|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
125971032|NCT02332720|453182767|FG006|Part A and Part B|Adverse Event|0|||
125971033|NCT02332720|453182768|FG007|Part A and Part B|Adverse Event|0|||
125971034|NCT02332720|453182769|FG008|Part A and Part B|Adverse Event|0|||
125971035|NCT02332720|453182770|FG009|Part A and Part B|Adverse Event|0|||
125971036|NCT02332720|453182771|FG010|Part A and Part B|Adverse Event|0|||
125971037|NCT02332720|453182772|FG011|Part A and Part B|Adverse Event|0|||
125971038|NCT02332720|453182773|FG012|Part A and Part B|Adverse Event|0|||
125971039|NCT02332720|453182774|FG013|Part A and Part B|Adverse Event|0|||
125971040|NCT02332720|453182775|FG014|Part A and Part B|Adverse Event|0|||
125971041|NCT02332720|453182776|FG015|Part A and Part B|Adverse Event|0|||
125971042|NCT02332720|453182777|FG016|Part A and Part B|Adverse Event|0|||
125971043|NCT02332720|453182778|FG017|Part A and Part B|Adverse Event|1|||
125971044|NCT02332720|453182779|FG018|Part A and Part B|Adverse Event|0|||
125971045|NCT02332720|453182780|FG019|Part A and Part B|Adverse Event|0|||
125971046|NCT02332720|453182781|FG020|Part A and Part B|Adverse Event|0|||
125971047|NCT02332720|453182782|FG021|Part A and Part B|Adverse Event|0|||
125971048|NCT02332720|453182783|FG022|Part A and Part B|Adverse Event|0|||
126147545|NCT00327444|453825279|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
126147546|NCT00327444|453825280|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
126147547|NCT00327444|453825279|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
126147548|NCT00327444|453825280|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
126147549|NCT00327444|453825279|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
126147550|NCT00327444|453825280|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
126147551|NCT00327444|453825279|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
126147552|NCT00327444|453825280|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
126147553|NCT00327444|453825279|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
126147554|NCT00327444|453825280|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
125971049|NCT02332720|453182761|FG000|Part A and Part B|Physician Decision|0|||
125971050|NCT02332720|453182762|FG001|Part A and Part B|Physician Decision|0|||
125971051|NCT02332720|453182763|FG002|Part A and Part B|Physician Decision|0|||
125971052|NCT02332720|453182764|FG003|Part A and Part B|Physician Decision|0|||
125971053|NCT02332720|453182765|FG004|Part A and Part B|Physician Decision|0|||
125971054|NCT02332720|453182766|FG005|Part A and Part B|Physician Decision|0|||
125971055|NCT02332720|453182767|FG006|Part A and Part B|Physician Decision|0|||
125971056|NCT02332720|453182768|FG007|Part A and Part B|Physician Decision|0|||
126147555|NCT04439344|453825281|FG000|Overall Study|Never started threapy|3|||
126147556|NCT04439344|453825281|FG000|Overall Study|Ineligible|3|||
126147557|NCT04439344|453825281|FG000|Overall Study|Adverse Event|13|||
126147558|NCT04439344|453825281|FG000|Overall Study|Death|2|||
126147559|NCT04439344|453825281|FG000|Overall Study|Disease progression|29|||
126147560|NCT04439344|453825281|FG000|Overall Study|Withdrawal by Subject|2|||
126147561|NCT04439344|453825281|FG000|Overall Study|Alternative therapy|1|||
126147562|NCT00552110|453825282|FG000|Overall Study|Serious or Life-Threatening AE|0|||
126147563|NCT00552110|453825283|FG001|Overall Study|Serious or Life-Threatening AE|0|||
126147564|NCT00552110|453825284|FG002|Overall Study|Serious or Life-Threatening AE|1|||
126147565|NCT00552110|453825285|FG003|Overall Study|Serious or Life-Threatening AE|0|||
126147566|NCT00552110|453825286|FG004|Overall Study|Serious or Life-Threatening AE|0|||
126147567|NCT00552110|453825282|FG000|Overall Study|Lack of Efficacy|1|||
126147568|NCT00552110|453825283|FG001|Overall Study|Lack of Efficacy|0|||
126147569|NCT00552110|453825284|FG002|Overall Study|Lack of Efficacy|0|||
126147570|NCT00552110|453825285|FG003|Overall Study|Lack of Efficacy|1|||
126147571|NCT00552110|453825286|FG004|Overall Study|Lack of Efficacy|4|||
126147572|NCT00552110|453825282|FG000|Overall Study|Withdrawal by Subject|0|||
126147573|NCT00552110|453825283|FG001|Overall Study|Withdrawal by Subject|2|||
126147574|NCT00552110|453825284|FG002|Overall Study|Withdrawal by Subject|0|||
126147575|NCT00552110|453825285|FG003|Overall Study|Withdrawal by Subject|3|||
125971057|NCT02332720|453182769|FG008|Part A and Part B|Physician Decision|0|||
125971058|NCT02332720|453182770|FG009|Part A and Part B|Physician Decision|0|||
125971059|NCT02332720|453182771|FG010|Part A and Part B|Physician Decision|0|||
125971060|NCT02332720|453182772|FG011|Part A and Part B|Physician Decision|0|||
125971061|NCT02332720|453182773|FG012|Part A and Part B|Physician Decision|0|||
125971062|NCT02332720|453182774|FG013|Part A and Part B|Physician Decision|0|||
125971063|NCT02332720|453182775|FG014|Part A and Part B|Physician Decision|0|||
126147576|NCT00552110|453825286|FG004|Overall Study|Withdrawal by Subject|2|||
126147577|NCT00552110|453825282|FG000|Overall Study|Lost to Follow-up|0|||
126147578|NCT00552110|453825283|FG001|Overall Study|Lost to Follow-up|0|||
126147579|NCT00552110|453825284|FG002|Overall Study|Lost to Follow-up|0|||
126147580|NCT00552110|453825285|FG003|Overall Study|Lost to Follow-up|1|||
126147581|NCT00552110|453825286|FG004|Overall Study|Lost to Follow-up|1|||
126147582|NCT00552110|453825282|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
126147583|NCT00552110|453825283|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
126147584|NCT00552110|453825284|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
126147585|NCT00552110|453825285|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
126147586|NCT00552110|453825286|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
125971064|NCT02332720|453182776|FG015|Part A and Part B|Physician Decision|0|||
126147587|NCT00552110|453825282|FG000|Overall Study|Withdrawn per Sponsor|0|||
126147588|NCT00552110|453825283|FG001|Overall Study|Withdrawn per Sponsor|1|||
126147589|NCT00552110|453825284|FG002|Overall Study|Withdrawn per Sponsor|0|||
126147590|NCT00552110|453825285|FG003|Overall Study|Withdrawn per Sponsor|0|||
126147591|NCT00552110|453825286|FG004|Overall Study|Withdrawn per Sponsor|1|||
126147592|NCT00552110|453825282|FG000|Overall Study|Use of Prohibited Medication|1|||
126147593|NCT00552110|453825283|FG001|Overall Study|Use of Prohibited Medication|1|||
126147594|NCT00552110|453825284|FG002|Overall Study|Use of Prohibited Medication|0|||
126147595|NCT00552110|453825285|FG003|Overall Study|Use of Prohibited Medication|0|||
126147596|NCT00552110|453825286|FG004|Overall Study|Use of Prohibited Medication|0|||
126147597|NCT00552110|453825282|FG000|Overall Study|Delay of Study due to Relabeling|0|||
126147598|NCT00552110|453825283|FG001|Overall Study|Delay of Study due to Relabeling|0|||
125971065|NCT02332720|453182777|FG016|Part A and Part B|Physician Decision|0|||
125971066|NCT02332720|453182778|FG017|Part A and Part B|Physician Decision|0|||
125971067|NCT02332720|453182779|FG018|Part A and Part B|Physician Decision|1|||
125971068|NCT02332720|453182780|FG019|Part A and Part B|Physician Decision|0|||
125971069|NCT02332720|453182781|FG020|Part A and Part B|Physician Decision|0|||
125971070|NCT02332720|453182782|FG021|Part A and Part B|Physician Decision|0|||
125971071|NCT02332720|453182783|FG022|Part A and Part B|Physician Decision|0|||
125971072|NCT02332720|453182761|FG000|Part A and Part B|Withdrawal by Subject|0|||
125971073|NCT02332720|453182762|FG001|Part A and Part B|Withdrawal by Subject|0|||
126147599|NCT00552110|453825284|FG002|Overall Study|Delay of Study due to Relabeling|0|||
126147600|NCT00552110|453825285|FG003|Overall Study|Delay of Study due to Relabeling|1|||
126147601|NCT00552110|453825286|FG004|Overall Study|Delay of Study due to Relabeling|0|||
126147602|NCT00552110|453825282|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
126147603|NCT00552110|453825283|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
126147604|NCT00552110|453825284|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
126147605|NCT00552110|453825285|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
126147606|NCT00552110|453825286|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
126147607|NCT00552110|453825282|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
126147608|NCT00552110|453825283|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
126147609|NCT00552110|453825284|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
126147610|NCT00552110|453825285|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
126147611|NCT00552110|453825286|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
126147612|NCT02700451|453825287|FG000|Overall Study|Protocol Violation|2|||
125971074|NCT02332720|453182763|FG002|Part A and Part B|Withdrawal by Subject|0|||
125971075|NCT02332720|453182764|FG003|Part A and Part B|Withdrawal by Subject|0|||
125971076|NCT02332720|453182765|FG004|Part A and Part B|Withdrawal by Subject|0|||
125971077|NCT02332720|453182766|FG005|Part A and Part B|Withdrawal by Subject|1|||
125971078|NCT02332720|453182767|FG006|Part A and Part B|Withdrawal by Subject|0|||
125971079|NCT02332720|453182768|FG007|Part A and Part B|Withdrawal by Subject|0|||
125971080|NCT02332720|453182769|FG008|Part A and Part B|Withdrawal by Subject|0|||
125971081|NCT02332720|453182770|FG009|Part A and Part B|Withdrawal by Subject|0|||
125971082|NCT02332720|453182771|FG010|Part A and Part B|Withdrawal by Subject|0|||
125971083|NCT02332720|453182772|FG011|Part A and Part B|Withdrawal by Subject|0|||
125971084|NCT02332720|453182773|FG012|Part A and Part B|Withdrawal by Subject|0|||
125971085|NCT02332720|453182774|FG013|Part A and Part B|Withdrawal by Subject|0|||
125971086|NCT02332720|453182775|FG014|Part A and Part B|Withdrawal by Subject|0|||
125971087|NCT02332720|453182776|FG015|Part A and Part B|Withdrawal by Subject|0|||
125971088|NCT02332720|453182777|FG016|Part A and Part B|Withdrawal by Subject|0|||
125971089|NCT02332720|453182778|FG017|Part A and Part B|Withdrawal by Subject|0|||
125971090|NCT02332720|453182779|FG018|Part A and Part B|Withdrawal by Subject|0|||
125971091|NCT02332720|453182780|FG019|Part A and Part B|Withdrawal by Subject|1|||
125971092|NCT02332720|453182781|FG020|Part A and Part B|Withdrawal by Subject|0|||
125971093|NCT02332720|453182782|FG021|Part A and Part B|Withdrawal by Subject|0|||
125971094|NCT02332720|453182783|FG022|Part A and Part B|Withdrawal by Subject|0|||
125971095|NCT03832010|453182784|FG000|Overall Study|Withdrawal by Subject|2|||
125971096|NCT03832010|453182785|FG001|Overall Study|Withdrawal by Subject|1|||
125971097|NCT03832010|453182786|FG002|Overall Study|Withdrawal by Subject|0|||
125971098|NCT03832010|453182784|FG000|Overall Study|Lost to Follow-up|2|||
125971099|NCT03832010|453182785|FG001|Overall Study|Lost to Follow-up|1|||
125971100|NCT03832010|453182786|FG002|Overall Study|Lost to Follow-up|1|||
125971101|NCT02349295|453182787|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
125971102|NCT02349295|453182788|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
125971103|NCT02349295|453182789|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
125971104|NCT02349295|453182790|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971105|NCT02349295|453182791|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971106|NCT02349295|453182792|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126147613|NCT02700451|453825288|FG001|Overall Study|Protocol Violation|2|||
126147614|NCT02700451|453825289|FG002|Overall Study|Protocol Violation|3|||
126147615|NCT02700451|453825287|FG000|Overall Study|Discontinued intervention|14|||
125971107|NCT02349295|453182793|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971108|NCT02349295|453182794|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971109|NCT02349295|453182795|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971110|NCT02349295|453182796|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971111|NCT02349295|453182797|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971112|NCT02349295|453182798|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971113|NCT02349295|453182799|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971114|NCT02349295|453182800|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125971115|NCT02349295|453182787|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
125971116|NCT02349295|453182788|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
125971117|NCT02349295|453182789|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
125971118|NCT02349295|453182790|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971119|NCT02349295|453182791|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971120|NCT02349295|453182792|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971121|NCT02349295|453182793|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971122|NCT02349295|453182794|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971123|NCT02349295|453182795|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971124|NCT02349295|453182796|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971125|NCT02349295|453182797|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971126|NCT02349295|453182798|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971127|NCT02349295|453182799|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971128|NCT02349295|453182800|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125971129|NCT02349295|453182787|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
125971130|NCT02349295|453182788|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
125971131|NCT02349295|453182789|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
125971132|NCT02349295|453182790|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971133|NCT02349295|453182791|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971134|NCT02349295|453182792|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971135|NCT02349295|453182793|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971136|NCT02349295|453182794|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971137|NCT02349295|453182795|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971138|NCT02349295|453182796|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971139|NCT02349295|453182797|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971140|NCT02349295|453182798|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971141|NCT02349295|453182799|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971142|NCT02349295|453182800|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125971143|NCT02349295|453182787|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
126147616|NCT02700451|453825288|FG001|Overall Study|Discontinued intervention|15|||
125971144|NCT02349295|453182788|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
125971145|NCT02349295|453182789|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
125971146|NCT02349295|453182790|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971147|NCT02349295|453182791|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971148|NCT02349295|453182792|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971149|NCT02349295|453182793|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971150|NCT02349295|453182794|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971151|NCT02349295|453182795|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971152|NCT02349295|453182796|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971153|NCT02349295|453182797|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971154|NCT02349295|453182798|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971155|NCT02349295|453182799|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971156|NCT02349295|453182800|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125971157|NCT02349295|453182787|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971158|NCT02349295|453182788|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
125971159|NCT02349295|453182789|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
126147617|NCT02700451|453825289|FG002|Overall Study|Discontinued intervention|14|||
126147618|NCT04373460|453825290|FG000|Overall Study|Did not receive tranfusion|18|||
126147619|NCT04373460|453825291|FG001|Overall Study|Did not receive tranfusion|26|||
125971160|NCT02349295|453182790|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971161|NCT02349295|453182791|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971162|NCT02349295|453182792|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971163|NCT02349295|453182793|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971164|NCT02349295|453182794|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971165|NCT02349295|453182795|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971166|NCT02349295|453182796|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971167|NCT02349295|453182797|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126147620|NCT00454207|453825292|FG000|Overall Study|Adverse Event|3|||
126147621|NCT00454207|453825293|FG001|Overall Study|Adverse Event|1|||
126147622|NCT00454207|453825292|FG000|Overall Study|Lack of Efficacy|1|||
125971168|NCT02349295|453182798|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971169|NCT02349295|453182799|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971170|NCT02349295|453182800|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125971171|NCT02349295|453182787|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
125971172|NCT02349295|453182788|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
125971173|NCT02349295|453182789|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
125971174|NCT02349295|453182790|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
125971175|NCT02349295|453182791|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
125971176|NCT02349295|453182792|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
126147623|NCT00454207|453825293|FG001|Overall Study|Lack of Efficacy|0|||
126147624|NCT00454207|453825292|FG000|Overall Study|Protocol Violation|0|||
126147625|NCT00454207|453825293|FG001|Overall Study|Protocol Violation|1|||
126147626|NCT01672957|453825294|FG000|Overall Study|Protocol Violation|48|||
126147627|NCT01672957|453825294|FG000|Overall Study|Death|2|||
126147628|NCT01672957|453825294|FG000|Overall Study|ICF Signed After Transplantation|5|||
125971177|NCT02349295|453182793|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
125971178|NCT02349295|453182794|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
125971179|NCT02349295|453182795|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
125971180|NCT02349295|453182796|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
125971181|NCT02349295|453182797|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
125971182|NCT02349295|453182798|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
125971183|NCT02349295|453182799|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
125971184|NCT02349295|453182800|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
126147629|NCT02115308|453825296|FG000|Overall Study|Safety Screening|2|||
126147630|NCT02115308|453825297|FG001|Overall Study|Safety Screening|2|||
126147631|NCT00642642|453825298|FG000|Treatment & Follow Up|Adverse Event|2|||
126147632|NCT00642642|453825298|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
126147633|NCT00642642|453825298|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
126147634|NCT02344576|453825301|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
125971185|NCT02349295|453182787|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971186|NCT02349295|453182788|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971187|NCT02349295|453182789|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971188|NCT02349295|453182790|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971189|NCT02349295|453182791|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971190|NCT02349295|453182792|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971191|NCT02349295|453182793|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971192|NCT02349295|453182794|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
125971193|NCT02349295|453182795|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
125971194|NCT02349295|453182796|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
125971195|NCT02349295|453182797|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
125971196|NCT02349295|453182798|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971197|NCT02349295|453182799|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971198|NCT02349295|453182800|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125971199|NCT02349295|453182787|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971200|NCT02349295|453182788|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971201|NCT02349295|453182789|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126147635|NCT02344576|453825302|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
126147636|NCT02344576|453825303|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
126147637|NCT02344576|453825304|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
126147638|NCT02344576|453825301|FG000|1-Month Follow-Up|Death|13|||
126147639|NCT02344576|453825302|FG001|1-Month Follow-Up|Death|8|||
126147640|NCT02344576|453825303|FG002|1-Month Follow-Up|Death|0|||
126147641|NCT02344576|453825304|FG003|1-Month Follow-Up|Death|0|||
126147642|NCT02344576|453825301|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
126147643|NCT02344576|453825302|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
126147644|NCT02344576|453825303|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
126147645|NCT02344576|453825304|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
125971202|NCT02349295|453182790|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971203|NCT02349295|453182791|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971204|NCT02349295|453182792|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971205|NCT02349295|453182793|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971206|NCT02349295|453182794|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
125971207|NCT02349295|453182795|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
125971208|NCT02349295|453182796|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
125971209|NCT02349295|453182797|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
126147646|NCT02344576|453825301|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
126147647|NCT02344576|453825302|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
126147648|NCT02344576|453825303|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
126147649|NCT02344576|453825304|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
126147650|NCT02344576|453825301|FG000|6-Month Follow-Up|Death|14|||
126147651|NCT02344576|453825302|FG001|6-Month Follow-Up|Death|14|||
126147652|NCT02344576|453825303|FG002|6-Month Follow-Up|Death|0|||
126147653|NCT02344576|453825304|FG003|6-Month Follow-Up|Death|0|||
126147654|NCT02344576|453825301|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
126147655|NCT02344576|453825302|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
126147656|NCT02344576|453825303|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
126147657|NCT02344576|453825304|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
126147658|NCT02344576|453825301|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
126147659|NCT02344576|453825302|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
126147660|NCT02344576|453825303|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
126147661|NCT02344576|453825304|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
126147662|NCT02272790|453825307|FG000|Overall Study|Physician Decision|0|||
126147663|NCT02272790|453825308|FG001|Overall Study|Physician Decision|1|||
126147664|NCT02272790|453825309|FG002|Overall Study|Physician Decision|0|||
126147665|NCT02272790|453825310|FG003|Overall Study|Physician Decision|0|||
126147666|NCT02272790|453825311|FG004|Overall Study|Physician Decision|0|||
126147667|NCT02272790|453825312|FG005|Overall Study|Physician Decision|0|||
126147668|NCT00332202|453825313|FG000|Overall Study|Adverse Event|72|||
126147669|NCT00332202|453825314|FG001|Overall Study|Adverse Event|28|||
126147670|NCT00332202|453825313|FG000|Overall Study|Lost to Follow-up|2|||
125971210|NCT02349295|453182798|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971211|NCT02349295|453182799|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971212|NCT02349295|453182800|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125971213|NCT02349295|453182787|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971214|NCT02349295|453182788|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971215|NCT02349295|453182789|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971216|NCT02349295|453182790|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971217|NCT02349295|453182791|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971218|NCT02349295|453182792|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971219|NCT02349295|453182793|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971220|NCT02349295|453182794|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
125971221|NCT02349295|453182795|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971222|NCT02349295|453182796|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
125971223|NCT02349295|453182797|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971224|NCT02349295|453182798|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971225|NCT02349295|453182799|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971226|NCT02349295|453182800|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125971227|NCT02349295|453182787|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
125971228|NCT02349295|453182788|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
125971229|NCT02349295|453182789|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
125971230|NCT02349295|453182790|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
125971231|NCT02349295|453182791|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
125971232|NCT02349295|453182792|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
125971233|NCT02349295|453182793|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
125971234|NCT02349295|453182794|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
125971235|NCT02349295|453182795|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
125971236|NCT02349295|453182796|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
125971237|NCT02349295|453182797|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
125971238|NCT02349295|453182798|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
125971239|NCT02349295|453182799|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
125971240|NCT02349295|453182800|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
125971241|NCT02349295|453182787|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971242|NCT02349295|453182788|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971243|NCT02349295|453182789|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971244|NCT02349295|453182790|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971245|NCT02349295|453182791|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971246|NCT02349295|453182792|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971247|NCT02349295|453182793|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971248|NCT02349295|453182794|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
125971249|NCT02349295|453182795|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
125971250|NCT02349295|453182796|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
125971251|NCT02349295|453182797|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
125971252|NCT02349295|453182798|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971253|NCT02349295|453182799|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125971254|NCT02349295|453182800|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126147671|NCT00332202|453825314|FG001|Overall Study|Lost to Follow-up|1|||
126147672|NCT00332202|453825313|FG000|Overall Study|Physician Decision|6|||
126147673|NCT00332202|453825314|FG001|Overall Study|Physician Decision|8|||
126147674|NCT00332202|453825313|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
126147675|NCT00332202|453825314|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
126147676|NCT00332202|453825313|FG000|Overall Study|Protocol Violation|7|||
126147677|NCT00332202|453825314|FG001|Overall Study|Protocol Violation|2|||
125971255|NCT02349295|453182787|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971256|NCT02349295|453182788|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971257|NCT02349295|453182789|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971258|NCT02349295|453182790|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971259|NCT02349295|453182791|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971260|NCT02349295|453182792|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971261|NCT02349295|453182793|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971262|NCT02349295|453182794|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
125971263|NCT02349295|453182795|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
125971264|NCT02349295|453182796|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971265|NCT02349295|453182797|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971266|NCT02349295|453182798|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971267|NCT02349295|453182799|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971268|NCT02349295|453182800|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125971269|NCT02349295|453182787|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971270|NCT02349295|453182788|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971271|NCT02349295|453182789|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971272|NCT02349295|453182790|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971273|NCT02349295|453182791|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971274|NCT02349295|453182792|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971275|NCT02349295|453182793|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971276|NCT02349295|453182794|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
125971277|NCT02349295|453182795|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
125971278|NCT02349295|453182796|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971279|NCT02349295|453182797|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971280|NCT02349295|453182798|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971281|NCT02349295|453182799|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971282|NCT02349295|453182800|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125971283|NCT02349295|453182787|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971284|NCT02349295|453182788|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971285|NCT02349295|453182789|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971286|NCT02349295|453182790|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971287|NCT02349295|453182791|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971288|NCT02349295|453182792|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971289|NCT02349295|453182793|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971290|NCT02349295|453182794|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971291|NCT02349295|453182795|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971292|NCT02349295|453182796|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971293|NCT02349295|453182797|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125971294|NCT02349295|453182798|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
125971295|NCT02349295|453182799|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
125971296|NCT02349295|453182800|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
125971297|NCT02349295|453182787|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971298|NCT02349295|453182788|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971299|NCT02349295|453182789|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971300|NCT02349295|453182790|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971301|NCT02349295|453182791|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971302|NCT02349295|453182792|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971303|NCT02349295|453182793|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971304|NCT02349295|453182794|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971305|NCT02349295|453182795|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971306|NCT02349295|453182796|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971307|NCT02349295|453182797|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971308|NCT02349295|453182798|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
125971309|NCT02349295|453182799|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
125971310|NCT02349295|453182800|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125971311|NCT02349295|453182787|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971312|NCT02349295|453182788|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971313|NCT02349295|453182789|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971314|NCT02349295|453182790|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971315|NCT02349295|453182791|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971316|NCT02349295|453182792|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126147678|NCT00332202|453825313|FG000|Overall Study|Sponsor Decision|1|||
125971317|NCT02349295|453182793|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971318|NCT02349295|453182794|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971319|NCT02349295|453182795|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971320|NCT02349295|453182796|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971321|NCT02349295|453182797|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971322|NCT02349295|453182798|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
125971323|NCT02349295|453182799|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
125971324|NCT02349295|453182800|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125971325|NCT02349295|453182787|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971326|NCT02349295|453182788|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971327|NCT02349295|453182789|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971328|NCT02349295|453182790|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971329|NCT02349295|453182791|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971330|NCT02349295|453182792|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971331|NCT02349295|453182793|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971332|NCT02349295|453182794|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971333|NCT02349295|453182795|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971334|NCT02349295|453182796|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971335|NCT02349295|453182797|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125971336|NCT02349295|453182798|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
125971337|NCT02349295|453182799|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126147679|NCT00332202|453825314|FG001|Overall Study|Sponsor Decision|2|||
126147680|NCT00332202|453825313|FG000|Overall Study|Withdrawal by Subject|36|||
126147681|NCT00332202|453825314|FG001|Overall Study|Withdrawal by Subject|17|||
126147682|NCT00332202|453825313|FG000|Overall Study|Progressive Disease|106|||
126147683|NCT00332202|453825314|FG001|Overall Study|Progressive Disease|60|||
126147684|NCT00332202|453825313|FG000|Overall Study|Death|5|||
126147685|NCT00332202|453825314|FG001|Overall Study|Death|2|||
126147686|NCT03871491|453825315|FG000|Overall Study|Withdrawal by Subject|14|||
126147687|NCT03871491|453825316|FG001|Overall Study|Withdrawal by Subject|14|||
126147688|NCT03871491|453825317|FG002|Overall Study|Withdrawal by Subject|14|||
126147689|NCT03871491|453825318|FG003|Overall Study|Withdrawal by Subject|14|||
126147690|NCT03871491|453825315|FG000|Overall Study|Physician Decision|0|||
126147691|NCT03871491|453825316|FG001|Overall Study|Physician Decision|0|||
126147692|NCT03871491|453825317|FG002|Overall Study|Physician Decision|1|||
126147693|NCT03871491|453825318|FG003|Overall Study|Physician Decision|1|||
126147694|NCT03871491|453825315|FG000|Overall Study|Lost to Follow-up|50|||
126147695|NCT03871491|453825316|FG001|Overall Study|Lost to Follow-up|15|||
126147696|NCT03871491|453825317|FG002|Overall Study|Lost to Follow-up|36|||
126147697|NCT03871491|453825318|FG003|Overall Study|Lost to Follow-up|11|||
126147698|NCT04439331|453825319|FG000|Overall Study|Never Start Protocol Therapy|2|||
126147699|NCT04439331|453825319|FG000|Overall Study|Ineligible|2|||
126147700|NCT04439331|453825319|FG000|Overall Study|Mutation Status Not Confirmed|1|||
126147701|NCT04439331|453825319|FG000|Overall Study|Adverse Event|1|||
126147702|NCT04439331|453825319|FG000|Overall Study|Death|1|||
126147703|NCT04439331|453825319|FG000|Overall Study|Disease Progression|20|||
126147704|NCT04439331|453825319|FG000|Overall Study|Withdrawal by Subject|6|||
126147705|NCT04439331|453825319|FG000|Overall Study|Physician Decision|1|||
126147706|NCT04439331|453825319|FG000|Overall Study|Other Complicating Disease|1|||
126147707|NCT00490542|453825322|FG000|Overall Study|Lost to Follow-up|3|||
126147708|NCT00490542|453825323|FG001|Overall Study|Lost to Follow-up|0|||
126147709|NCT00490542|453825322|FG000|Overall Study|Adverse Event|3|||
126147710|NCT00490542|453825323|FG001|Overall Study|Adverse Event|3|||
126147711|NCT00490542|453825322|FG000|Overall Study|Lack of Efficacy|1|||
126147712|NCT00490542|453825323|FG001|Overall Study|Lack of Efficacy|1|||
126147713|NCT00818259|453825327|FG000|Part I|Withdrawal by Subject|1|||
126147714|NCT00818259|453825328|FG001|Part I|Withdrawal by Subject|0|||
126147715|NCT00818259|453825329|FG002|Part I|Withdrawal by Subject|0|||
126147716|NCT00818259|453825330|FG003|Part I|Withdrawal by Subject|0|||
126147717|NCT00818259|453825331|FG004|Part I|Withdrawal by Subject|0|||
126147718|NCT00818259|453825332|FG005|Part I|Withdrawal by Subject|0|||
126147719|NCT00818259|453825333|FG006|Part I|Withdrawal by Subject|0|||
126147720|NCT00818259|453825334|FG007|Part I|Withdrawal by Subject|0|||
126147721|NCT00818259|453825335|FG008|Part I|Withdrawal by Subject|0|||
126147722|NCT00818259|453825327|FG000|Part II|Physician Decision|0|||
126147723|NCT00818259|453825328|FG001|Part II|Physician Decision|0|||
125971338|NCT02349295|453182800|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126147724|NCT00818259|453825329|FG002|Part II|Physician Decision|1|||
126147725|NCT00818259|453825330|FG003|Part II|Physician Decision|0|||
126147726|NCT00818259|453825331|FG004|Part II|Physician Decision|0|||
126147727|NCT00818259|453825332|FG005|Part II|Physician Decision|0|||
126147728|NCT00818259|453825333|FG006|Part II|Physician Decision|0|||
126147729|NCT00818259|453825334|FG007|Part II|Physician Decision|0|||
126147730|NCT00818259|453825335|FG008|Part II|Physician Decision|0|||
126147731|NCT00818259|453825327|FG000|Part II|Lack of Efficacy|0|||
126147732|NCT00818259|453825328|FG001|Part II|Lack of Efficacy|0|||
126147733|NCT00818259|453825329|FG002|Part II|Lack of Efficacy|0|||
126147734|NCT00818259|453825330|FG003|Part II|Lack of Efficacy|1|||
126147735|NCT00818259|453825331|FG004|Part II|Lack of Efficacy|0|||
126147736|NCT00818259|453825332|FG005|Part II|Lack of Efficacy|0|||
126147737|NCT00818259|453825333|FG006|Part II|Lack of Efficacy|0|||
126147738|NCT00818259|453825334|FG007|Part II|Lack of Efficacy|0|||
126147739|NCT00818259|453825335|FG008|Part II|Lack of Efficacy|0|||
126147740|NCT00818259|453825327|FG000|Part II|Not Treated|0|||
125971339|NCT02349295|453182787|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971340|NCT02349295|453182788|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971341|NCT02349295|453182789|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971342|NCT02349295|453182790|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126147741|NCT00818259|453825328|FG001|Part II|Not Treated|0|||
126147742|NCT00818259|453825329|FG002|Part II|Not Treated|0|||
126147743|NCT00818259|453825330|FG003|Part II|Not Treated|1|||
126147744|NCT00818259|453825331|FG004|Part II|Not Treated|0|||
126147745|NCT00818259|453825332|FG005|Part II|Not Treated|0|||
126147746|NCT00818259|453825333|FG006|Part II|Not Treated|0|||
126147747|NCT00818259|453825334|FG007|Part II|Not Treated|0|||
126147748|NCT00818259|453825335|FG008|Part II|Not Treated|0|||
126147749|NCT00818259|453825327|FG000|Part IV|Physician Decision|0|||
126147750|NCT00818259|453825328|FG001|Part IV|Physician Decision|0|||
126147751|NCT00818259|453825329|FG002|Part IV|Physician Decision|0|||
126147752|NCT00818259|453825330|FG003|Part IV|Physician Decision|0|||
126147753|NCT00818259|453825331|FG004|Part IV|Physician Decision|0|||
126147754|NCT00818259|453825332|FG005|Part IV|Physician Decision|1|||
126147755|NCT00818259|453825333|FG006|Part IV|Physician Decision|0|||
126147756|NCT00818259|453825334|FG007|Part IV|Physician Decision|0|||
126147757|NCT00818259|453825335|FG008|Part IV|Physician Decision|0|||
126147758|NCT00818259|453825327|FG000|Part V|Adverse Event|0|||
126147759|NCT00818259|453825328|FG001|Part V|Adverse Event|0|||
126147760|NCT00818259|453825329|FG002|Part V|Adverse Event|0|||
126147761|NCT00818259|453825330|FG003|Part V|Adverse Event|0|||
126147762|NCT00818259|453825331|FG004|Part V|Adverse Event|0|||
126147763|NCT00818259|453825332|FG005|Part V|Adverse Event|0|||
126147764|NCT00818259|453825333|FG006|Part V|Adverse Event|0|||
126147765|NCT00818259|453825334|FG007|Part V|Adverse Event|1|||
126147766|NCT00818259|453825335|FG008|Part V|Adverse Event|0|||
126147767|NCT01237951|453825339|FG000|Overall Study|Death|1|||
126147768|NCT01053429|453825342|FG000|Overall Study|Adverse Event|64|||
126147769|NCT01053429|453825342|FG000|Overall Study|Other|309|||
126147770|NCT00924703|453825343|FG000|Overall Study|Withdrawal by Subject|11|||
126147771|NCT00924703|453825343|FG000|Overall Study|Physician Decision|5|||
126147772|NCT00924703|453825343|FG000|Overall Study|Lost to Follow-up|3|||
126147773|NCT00924703|453825343|FG000|Overall Study|Adverse Event|2|||
126147774|NCT00924703|453825343|FG000|Overall Study|Withdrawal by Sponsor|1|||
126147775|NCT00666562|453825344|FG000|Overall Study|Withdrawal by Subject|0|||
126147776|NCT00666562|453825345|FG001|Overall Study|Withdrawal by Subject|1|||
126147777|NCT00666562|453825346|FG002|Overall Study|Withdrawal by Subject|0|||
126147778|NCT00666562|453825344|FG000|Overall Study|Concomitant Medication|0|||
126147779|NCT00666562|453825345|FG001|Overall Study|Concomitant Medication|1|||
126147780|NCT00666562|453825346|FG002|Overall Study|Concomitant Medication|0|||
126147781|NCT04429022|453825349|FG000|Overall Study|Protocol Violation|18|||
126147782|NCT04429022|453825350|FG001|Overall Study|Protocol Violation|1|||
126147783|NCT02582658|453825355|FG000|Overall Study|Failure to Return|10|||
126147784|NCT02582658|453825355|FG000|Overall Study|Insufficient Virological Response|2|||
126147785|NCT02582658|453825355|FG000|Overall Study|Withdrawn Consent|1|||
126147786|NCT02582658|453825355|FG000|Overall Study|Death|1|||
126147787|NCT02582658|453825355|FG000|Overall Study|Not further specified|11|||
126147788|NCT03539432|453827093|FG000|Overall Study|Lost to Follow-up|0|||
126147789|NCT03539432|453827094|FG001|Overall Study|Lost to Follow-up|1|||
126147790|NCT00824564|453827095|FG000|Overall Study|Lost to Follow-up|5|||
126147791|NCT00824564|453827096|FG001|Overall Study|Lost to Follow-up|7|||
126147792|NCT00824564|453827095|FG000|Overall Study|Withdrawal by Subject|1|||
126147793|NCT00824564|453827096|FG001|Overall Study|Withdrawal by Subject|1|||
126147794|NCT00824564|453827095|FG000|Overall Study|Other|1|||
126147795|NCT00824564|453827096|FG001|Overall Study|Other|2|||
126147796|NCT00824564|453827095|FG000|Overall Study|Randomized, but not treated|1|||
126147797|NCT00824564|453827096|FG001|Overall Study|Randomized, but not treated|0|||
126147798|NCT00476086|453827097|FG000|Overall Study|Alternative therapy|1|||
126147799|NCT00476086|453827097|FG000|Overall Study|Progressive Disease|4|||
126147800|NCT04178590|453827098|FG000|Overall Study|Pregnancy|1|||
126147801|NCT04178590|453827098|FG000|Overall Study|Lost to Follow-up|1|||
126147802|NCT02292849|453827099|FG000|Overall Study|Lost to Follow-up|0|||
126147803|NCT02292849|453827100|FG001|Overall Study|Lost to Follow-up|2|||
126147804|NCT02292849|453827101|FG002|Overall Study|Lost to Follow-up|2|||
126147805|NCT02292849|453827099|FG000|Overall Study|Physician Decision|4|||
126147806|NCT02292849|453827100|FG001|Overall Study|Physician Decision|0|||
126147807|NCT02292849|453827101|FG002|Overall Study|Physician Decision|0|||
126147808|NCT00886938|453827102|FG000|Overall Study|Adverse Event|1|||
126147809|NCT00886938|453827102|FG000|Overall Study|Withdrawal by Subject|1|||
126147810|NCT00364793|453827103|FG000|Overall Study|Adverse Event|2|||
126147811|NCT00364793|453827104|FG001|Overall Study|Adverse Event|0|||
126147812|NCT00364793|453827105|FG002|Overall Study|Adverse Event|0|||
126147813|NCT00364793|453827106|FG003|Overall Study|Adverse Event|0|||
126147814|NCT00364793|453827103|FG000|Overall Study|Death|1|||
126147815|NCT00364793|453827104|FG001|Overall Study|Death|0|||
126147816|NCT00364793|453827105|FG002|Overall Study|Death|1|||
126147817|NCT00364793|453827106|FG003|Overall Study|Death|0|||
126147818|NCT00364793|453827103|FG000|Overall Study|Lack of Efficacy|3|||
126147819|NCT00364793|453827104|FG001|Overall Study|Lack of Efficacy|3|||
126147820|NCT00364793|453827105|FG002|Overall Study|Lack of Efficacy|1|||
126147821|NCT00364793|453827106|FG003|Overall Study|Lack of Efficacy|1|||
126147822|NCT00364793|453827103|FG000|Overall Study|Lost to Follow-up|1|||
126147823|NCT00364793|453827104|FG001|Overall Study|Lost to Follow-up|0|||
126147824|NCT00364793|453827105|FG002|Overall Study|Lost to Follow-up|2|||
126147825|NCT00364793|453827106|FG003|Overall Study|Lost to Follow-up|0|||
126147826|NCT00364793|453827103|FG000|Overall Study|Poor or non-compliance|1|||
126147827|NCT00364793|453827104|FG001|Overall Study|Poor or non-compliance|1|||
126147828|NCT00364793|453827105|FG002|Overall Study|Poor or non-compliance|0|||
126147829|NCT00364793|453827106|FG003|Overall Study|Poor or non-compliance|1|||
126147830|NCT00364793|453827103|FG000|Overall Study|No longer meets criteria|0|||
126147831|NCT00364793|453827104|FG001|Overall Study|No longer meets criteria|0|||
126147832|NCT00364793|453827105|FG002|Overall Study|No longer meets criteria|0|||
126147833|NCT00364793|453827106|FG003|Overall Study|No longer meets criteria|1|||
126147834|NCT00364793|453827103|FG000|Overall Study|Withdrawal by Subject|0|||
126147835|NCT00364793|453827104|FG001|Overall Study|Withdrawal by Subject|1|||
126147836|NCT00364793|453827105|FG002|Overall Study|Withdrawal by Subject|0|||
126147837|NCT00364793|453827106|FG003|Overall Study|Withdrawal by Subject|0|||
126147838|NCT00363415|453827109|FG000|Overall Study|Progressive Disease|196|||
126147839|NCT00363415|453827110|FG001|Overall Study|Progressive Disease|107|||
126147840|NCT00363415|453827109|FG000|Overall Study|Sponsor Decision|67|||
126147841|NCT00363415|453827110|FG001|Overall Study|Sponsor Decision|31|||
126147842|NCT00363415|453827109|FG000|Overall Study|Death|32|||
126147843|NCT00363415|453827110|FG001|Overall Study|Death|29|||
126147844|NCT00363415|453827109|FG000|Overall Study|Adverse Event|24|||
126147845|NCT00363415|453827110|FG001|Overall Study|Adverse Event|15|||
126147846|NCT00363415|453827109|FG000|Overall Study|Physician Decision|18|||
126147847|NCT00363415|453827110|FG001|Overall Study|Physician Decision|35|||
126147848|NCT00363415|453827109|FG000|Overall Study|Entry Criteria Not Met|11|||
126147849|NCT00363415|453827110|FG001|Overall Study|Entry Criteria Not Met|10|||
126147850|NCT00363415|453827109|FG000|Overall Study|Withdrawal by Subject|9|||
126147851|NCT00363415|453827110|FG001|Overall Study|Withdrawal by Subject|15|||
126147852|NCT00363415|453827109|FG000|Overall Study|Lost to Follow-up|3|||
126147853|NCT00363415|453827110|FG001|Overall Study|Lost to Follow-up|3|||
126147854|NCT00363415|453827109|FG000|Overall Study|Protocol Violation|1|||
126147855|NCT00363415|453827110|FG001|Overall Study|Protocol Violation|4|||
126147856|NCT00870688|453827113|FG000|Overall Study|Lost to Follow-up|2|||
126147857|NCT00870688|453827113|FG000|Overall Study|Death, Unrelated|1|||
126147858|NCT00870688|453827113|FG000|Overall Study|Granules in the Stools|1|||
126147859|NCT05027802|453827114|FG000|Overall Study|Adverse Event|2|||
126147860|NCT05027802|453827114|FG000|Overall Study|Withdrawal by Subject|18|||
126147861|NCT05027802|453827114|FG000|Overall Study|Death|2|||
126147862|NCT05027802|453827114|FG000|Overall Study|Other|1|||
126147863|NCT03872180|453827123|FG000|Overall Study|Adverse Event|4|||
126147864|NCT03872180|453827123|FG000|Overall Study|Lack of Efficacy|2|||
126147865|NCT01506141|453827124|FG000|Overall Study|Adverse Event|0|||
126147866|NCT01506141|453827125|FG001|Overall Study|Adverse Event|2|||
126147867|NCT01506141|453827124|FG000|Overall Study|Participation Terminated by Investigator|1|||
126147868|NCT01506141|453827125|FG001|Overall Study|Participation Terminated by Investigator|1|||
126147869|NCT01506141|453827124|FG000|Overall Study|Site Terminated by Sponsor|2|||
126147870|NCT01506141|453827125|FG001|Overall Study|Site Terminated by Sponsor|0|||
126147871|NCT01506141|453827124|FG000|Overall Study|Reason Not Specified|4|||
126147872|NCT01506141|453827125|FG001|Overall Study|Reason Not Specified|2|||
126147873|NCT04607408|453827126|FG000|Overall Study|Lost to Follow-up|0|||
126147874|NCT04607408|453827127|FG001|Overall Study|Lost to Follow-up|0|||
126147875|NCT04607408|453827128|FG002|Overall Study|Lost to Follow-up|0|||
126147876|NCT04607408|453827129|FG003|Overall Study|Lost to Follow-up|1|||
126147877|NCT04607408|453827130|FG004|Overall Study|Lost to Follow-up|0|||
126147878|NCT04607408|453827126|FG000|Overall Study|Withdrawal by Subject|0|||
126147879|NCT04607408|453827127|FG001|Overall Study|Withdrawal by Subject|1|||
126147880|NCT04607408|453827128|FG002|Overall Study|Withdrawal by Subject|0|||
126147881|NCT04607408|453827129|FG003|Overall Study|Withdrawal by Subject|1|||
126147882|NCT04607408|453827130|FG004|Overall Study|Withdrawal by Subject|0|||
126147883|NCT02725788|453827135|FG000|Overall Study|Lost to Follow-up|1|||
126147884|NCT02725788|453827136|FG001|Overall Study|Lost to Follow-up|1|||
126147885|NCT02725788|453827135|FG000|Overall Study|Protocol Violation|0|||
126147886|NCT02725788|453827136|FG001|Overall Study|Protocol Violation|1|||
126147887|NCT05590377|453827137|FG000|Overall Study|Death|1|||
126147888|NCT05590377|453827138|FG001|Overall Study|Death|1|||
126147889|NCT05590377|453827139|FG002|Overall Study|Death|2|||
126147890|NCT05590377|453827140|FG003|Overall Study|Death|0|||
126147891|NCT05590377|453827141|FG004|Overall Study|Death|0|||
126147892|NCT05590377|453827137|FG000|Overall Study|Study Terminated by Sponsor|1|||
126147893|NCT05590377|453827138|FG001|Overall Study|Study Terminated by Sponsor|5|||
126147894|NCT05590377|453827139|FG002|Overall Study|Study Terminated by Sponsor|4|||
126147895|NCT05590377|453827140|FG003|Overall Study|Study Terminated by Sponsor|0|||
126147896|NCT05590377|453827141|FG004|Overall Study|Study Terminated by Sponsor|0|||
126147897|NCT05590377|453827137|FG000|Overall Study|Withdrawal by Subject|1|||
126147898|NCT05590377|453827138|FG001|Overall Study|Withdrawal by Subject|0|||
126147899|NCT05590377|453827139|FG002|Overall Study|Withdrawal by Subject|0|||
126147900|NCT05590377|453827140|FG003|Overall Study|Withdrawal by Subject|0|||
126147901|NCT05590377|453827141|FG004|Overall Study|Withdrawal by Subject|0|||
126147902|NCT00828464|453827142|FG000|Overall Study|Withdrawal by Subject|1|||
126147903|NCT00809133|453827143|FG000|Overall Study|Progressive disease|2|||
126147904|NCT00809133|453827144|FG001|Overall Study|Progressive disease|5|||
126147905|NCT00809133|453827145|FG002|Overall Study|Progressive disease|5|||
126147906|NCT00809133|453827146|FG003|Overall Study|Progressive disease|3|||
126147907|NCT00809133|453827147|FG004|Overall Study|Progressive disease|4|||
126147908|NCT00809133|453827148|FG005|Overall Study|Progressive disease|1|||
126147909|NCT00809133|453827149|FG006|Overall Study|Progressive disease|3|||
126147910|NCT00809133|453827150|FG007|Overall Study|Progressive disease|3|||
126147911|NCT00809133|453827151|FG008|Overall Study|Progressive disease|3|||
126147912|NCT00809133|453827152|FG009|Overall Study|Progressive disease|9|||
126147913|NCT00809133|453827153|FG010|Overall Study|Progressive disease|5|||
126147914|NCT00809133|453827154|FG011|Overall Study|Progressive disease|7|||
126147915|NCT00809133|453827155|FG012|Overall Study|Progressive disease|5|||
126147916|NCT00809133|453827156|FG013|Overall Study|Progressive disease|4|||
126147917|NCT00809133|453827143|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147918|NCT00809133|453827144|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147919|NCT00809133|453827145|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147920|NCT00809133|453827146|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147921|NCT00809133|453827147|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147922|NCT00809133|453827148|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126147923|NCT00809133|453827149|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126147924|NCT00809133|453827150|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126147925|NCT00809133|453827151|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147926|NCT00809133|453827152|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147927|NCT00809133|453827153|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147928|NCT00809133|453827154|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147929|NCT00809133|453827155|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126147930|NCT00809133|453827156|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126147931|NCT00809133|453827143|FG000|Overall Study|Other adverse event|1|||
126147932|NCT00809133|453827144|FG001|Overall Study|Other adverse event|1|||
126147933|NCT00809133|453827145|FG002|Overall Study|Other adverse event|1|||
126147934|NCT00809133|453827146|FG003|Overall Study|Other adverse event|0|||
126147935|NCT00809133|453827147|FG004|Overall Study|Other adverse event|0|||
126147936|NCT00809133|453827148|FG005|Overall Study|Other adverse event|3|||
126147937|NCT00809133|453827149|FG006|Overall Study|Other adverse event|2|||
126147938|NCT00809133|453827150|FG007|Overall Study|Other adverse event|4|||
126147939|NCT00809133|453827151|FG008|Overall Study|Other adverse event|0|||
126147940|NCT00809133|453827152|FG009|Overall Study|Other adverse event|0|||
126147941|NCT00809133|453827153|FG010|Overall Study|Other adverse event|1|||
126147942|NCT00809133|453827154|FG011|Overall Study|Other adverse event|1|||
126147943|NCT00809133|453827155|FG012|Overall Study|Other adverse event|0|||
126147944|NCT00809133|453827156|FG013|Overall Study|Other adverse event|1|||
126147945|NCT00809133|453827143|FG000|Overall Study|Lost to Follow-up|0|||
126147946|NCT00809133|453827144|FG001|Overall Study|Lost to Follow-up|0|||
126147947|NCT00809133|453827145|FG002|Overall Study|Lost to Follow-up|0|||
126147948|NCT00809133|453827146|FG003|Overall Study|Lost to Follow-up|0|||
126147949|NCT00809133|453827147|FG004|Overall Study|Lost to Follow-up|0|||
126147950|NCT00809133|453827148|FG005|Overall Study|Lost to Follow-up|1|||
126147951|NCT00809133|453827149|FG006|Overall Study|Lost to Follow-up|0|||
126147952|NCT00809133|453827150|FG007|Overall Study|Lost to Follow-up|0|||
126147953|NCT00809133|453827151|FG008|Overall Study|Lost to Follow-up|0|||
126147954|NCT00809133|453827152|FG009|Overall Study|Lost to Follow-up|0|||
126147955|NCT00809133|453827153|FG010|Overall Study|Lost to Follow-up|0|||
126147956|NCT00809133|453827154|FG011|Overall Study|Lost to Follow-up|0|||
126147957|NCT00809133|453827155|FG012|Overall Study|Lost to Follow-up|0|||
126147958|NCT00809133|453827156|FG013|Overall Study|Lost to Follow-up|0|||
126147959|NCT00809133|453827143|FG000|Overall Study|Consent withdrawn|0|||
126147960|NCT00809133|453827144|FG001|Overall Study|Consent withdrawn|0|||
126147961|NCT00809133|453827145|FG002|Overall Study|Consent withdrawn|0|||
126147962|NCT00809133|453827146|FG003|Overall Study|Consent withdrawn|0|||
126147963|NCT00809133|453827147|FG004|Overall Study|Consent withdrawn|1|||
126147964|NCT00809133|453827148|FG005|Overall Study|Consent withdrawn|0|||
126147965|NCT00809133|453827149|FG006|Overall Study|Consent withdrawn|0|||
126147966|NCT00809133|453827150|FG007|Overall Study|Consent withdrawn|0|||
126147967|NCT00809133|453827151|FG008|Overall Study|Consent withdrawn|0|||
126147968|NCT00809133|453827152|FG009|Overall Study|Consent withdrawn|0|||
126147969|NCT00809133|453827153|FG010|Overall Study|Consent withdrawn|0|||
126147970|NCT00809133|453827154|FG011|Overall Study|Consent withdrawn|0|||
126147971|NCT00809133|453827155|FG012|Overall Study|Consent withdrawn|0|||
126147972|NCT00809133|453827156|FG013|Overall Study|Consent withdrawn|0|||
126147973|NCT00809133|453827143|FG000|Overall Study|Other not mentioned above|0|||
126147974|NCT00809133|453827144|FG001|Overall Study|Other not mentioned above|1|||
126147975|NCT00809133|453827145|FG002|Overall Study|Other not mentioned above|0|||
126147976|NCT00809133|453827146|FG003|Overall Study|Other not mentioned above|0|||
126147977|NCT00809133|453827147|FG004|Overall Study|Other not mentioned above|0|||
126147978|NCT00809133|453827148|FG005|Overall Study|Other not mentioned above|1|||
126147979|NCT00809133|453827149|FG006|Overall Study|Other not mentioned above|0|||
126147980|NCT00809133|453827150|FG007|Overall Study|Other not mentioned above|0|||
126147981|NCT00809133|453827151|FG008|Overall Study|Other not mentioned above|0|||
126147982|NCT00809133|453827152|FG009|Overall Study|Other not mentioned above|0|||
126147983|NCT00809133|453827153|FG010|Overall Study|Other not mentioned above|0|||
126147984|NCT00809133|453827154|FG011|Overall Study|Other not mentioned above|0|||
126147985|NCT00809133|453827155|FG012|Overall Study|Other not mentioned above|0|||
126147986|NCT00809133|453827156|FG013|Overall Study|Other not mentioned above|0|||
126147987|NCT01025635|453827160|FG000|Overall Study|Withdrawal by Subject|6|||
126147988|NCT01025635|453827161|FG001|Overall Study|Withdrawal by Subject|7|||
126147989|NCT01025635|453827160|FG000|Overall Study|Protocol Violation|4|||
126147990|NCT01025635|453827161|FG001|Overall Study|Protocol Violation|2|||
126147991|NCT01025635|453827160|FG000|Overall Study|Lack of Efficacy|0|||
126147992|NCT01025635|453827161|FG001|Overall Study|Lack of Efficacy|1|||
126147993|NCT01025635|453827160|FG000|Overall Study|Lost to Follow-up|9|||
126147994|NCT01025635|453827161|FG001|Overall Study|Lost to Follow-up|13|||
126147995|NCT01025635|453827160|FG000|Overall Study|Reason not known|4|||
126147996|NCT01025635|453827161|FG001|Overall Study|Reason not known|2|||
126147997|NCT00727402|453827162|FG000|Overall Study|Physician Decision|116|||
126147998|NCT05292755|453827163|FG000|Overall Study|Lost to Follow-up|5|||
126147999|NCT05292755|453827164|FG001|Overall Study|Lost to Follow-up|9|||
126148000|NCT00432809|453827166|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
126148001|NCT00432809|453827167|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
126148002|NCT00432809|453827168|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
126148003|NCT00432809|453827166|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
126148004|NCT00432809|453827167|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
126148005|NCT00432809|453827168|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
126148006|NCT04433117|453827169|FG000|Overall Study|Withdrawal by Subject|1|||
126148007|NCT04433117|453827170|FG001|Overall Study|Withdrawal by Subject|0|||
126148008|NCT01051739|453827171|FG000|Overall Study|Death|3|||
126148009|NCT01051739|453827172|FG001|Overall Study|Death|3|||
126148010|NCT01051739|453827171|FG000|Overall Study|Withdrawal by Subject|25|||
126148011|NCT01051739|453827172|FG001|Overall Study|Withdrawal by Subject|10|||
126148012|NCT00707577|453827173|FG000|Overall Study|Withdrawal by Subject|3|||
126148013|NCT00707577|453827174|FG001|Overall Study|Withdrawal by Subject|2|||
126148014|NCT00707577|453827173|FG000|Overall Study|Lost to Follow-up|34|||
126148015|NCT00707577|453827174|FG001|Overall Study|Lost to Follow-up|25|||
126148016|NCT00707577|453827173|FG000|Overall Study|Left employment|13|||
126148017|NCT00707577|453827174|FG001|Overall Study|Left employment|10|||
126148018|NCT00707577|453827173|FG000|Overall Study|Pregnancy|4|||
126148019|NCT00707577|453827174|FG001|Overall Study|Pregnancy|1|||
126148020|NCT03853694|453827175|FG000|Overall Study|Protocol Violation|3|||
126148021|NCT03853694|453827176|FG001|Overall Study|Protocol Violation|5|||
126148022|NCT03853694|453827177|FG002|Overall Study|Protocol Violation|3|||
126148023|NCT03853694|453827175|FG000|Overall Study|Delivered early|0|||
126148024|NCT03853694|453827176|FG001|Overall Study|Delivered early|1|||
126148025|NCT03853694|453827177|FG002|Overall Study|Delivered early|0|||
126148026|NCT03853694|453827175|FG000|Overall Study|not suitable to proceed|0|||
126148027|NCT03853694|453827176|FG001|Overall Study|not suitable to proceed|1|||
126148028|NCT03853694|453827177|FG002|Overall Study|not suitable to proceed|0|||
126148029|NCT03853694|453827175|FG000|Overall Study|difficult surgery|0|||
126148030|NCT03853694|453827176|FG001|Overall Study|difficult surgery|0|||
126148031|NCT03853694|453827177|FG002|Overall Study|difficult surgery|1|||
126148032|NCT03853694|453827175|FG000|Overall Study|Lost to Follow-up|0|||
126148033|NCT03853694|453827176|FG001|Overall Study|Lost to Follow-up|1|||
126148034|NCT03853694|453827177|FG002|Overall Study|Lost to Follow-up|0|||
126148035|NCT03853694|453827175|FG000|Overall Study|Withdrawal by Subject|0|||
126148036|NCT03853694|453827176|FG001|Overall Study|Withdrawal by Subject|1|||
126148037|NCT03853694|453827177|FG002|Overall Study|Withdrawal by Subject|0|||
126148038|NCT02499952|453827178|FG000|Overall Study|Lost to Follow-up|1|||
126148039|NCT02499952|453827178|FG000|Overall Study|Death|9|||
126148040|NCT05089708|453827179|FG000|Overall Study|Lost to Follow-up|9|||
126148041|NCT05089708|453827180|FG001|Overall Study|Lost to Follow-up|7|||
126148042|NCT05089708|453827179|FG000|Overall Study|Withdrawal by Subject|3|||
126148043|NCT05089708|453827180|FG001|Overall Study|Withdrawal by Subject|1|||
126148044|NCT05089708|453827179|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
126148045|NCT05089708|453827180|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
126148046|NCT05089708|453827179|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
126148047|NCT05089708|453827180|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
126148048|NCT02209766|453827182|FG000|Overall Study|Withdrawal by Subject|0|||
126148049|NCT02209766|453827183|FG001|Overall Study|Withdrawal by Subject|0|||
126148050|NCT02209766|453827184|FG002|Overall Study|Withdrawal by Subject|0|||
126148051|NCT02209766|453827185|FG003|Overall Study|Withdrawal by Subject|1|||
126148052|NCT02209766|453827186|FG004|Overall Study|Withdrawal by Subject|0|||
126148053|NCT00064701|453827187|FG000|One Year Post-transplant|Did not receive study drug|7|||
126148054|NCT00064701|453827188|FG001|One Year Post-transplant|Did not receive study drug|12|||
126148055|NCT00064701|453827189|FG002|One Year Post-transplant|Did not receive study drug|11|||
126148056|NCT00064701|453827187|FG000|One Year Post-transplant|Adverse Event|23|||
126148057|NCT00064701|453827188|FG001|One Year Post-transplant|Adverse Event|19|||
126148058|NCT00064701|453827189|FG002|One Year Post-transplant|Adverse Event|37|||
126148059|NCT00064701|453827187|FG000|One Year Post-transplant|Rejection|0|||
126148060|NCT00064701|453827188|FG001|One Year Post-transplant|Rejection|1|||
126148061|NCT00064701|453827189|FG002|One Year Post-transplant|Rejection|16|||
126148062|NCT00064701|453827187|FG000|One Year Post-transplant|Non-compliance|4|||
126148063|NCT00064701|453827188|FG001|One Year Post-transplant|Non-compliance|2|||
126148064|NCT00064701|453827189|FG002|One Year Post-transplant|Non-compliance|5|||
126148065|NCT00064701|453827187|FG000|One Year Post-transplant|Graft Failure|3|||
126148066|NCT00064701|453827188|FG001|One Year Post-transplant|Graft Failure|2|||
126148067|NCT00064701|453827189|FG002|One Year Post-transplant|Graft Failure|1|||
126148068|NCT00064701|453827187|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
126148069|NCT00064701|453827188|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
126148070|NCT00064701|453827189|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
126148071|NCT00064701|453827187|FG000|One Year Post-transplant|Lost to Follow-up|1|||
126148072|NCT00064701|453827188|FG001|One Year Post-transplant|Lost to Follow-up|0|||
126148073|NCT00064701|453827189|FG002|One Year Post-transplant|Lost to Follow-up|0|||
126148074|NCT00064701|453827187|FG000|One Year Post-transplant|Converted to rapamycin|1|||
126148075|NCT00064701|453827188|FG001|One Year Post-transplant|Converted to rapamycin|0|||
126148076|NCT00064701|453827189|FG002|One Year Post-transplant|Converted to rapamycin|0|||
126148077|NCT00064701|453827187|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
126148078|NCT00064701|453827188|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
126148079|NCT00064701|453827189|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
126148080|NCT00064701|453827187|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
126148081|NCT00064701|453827188|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
126148082|NCT00064701|453827189|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
126148083|NCT00064701|453827187|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
126148084|NCT00064701|453827188|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
126148085|NCT00064701|453827189|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
126148086|NCT00064701|453827187|FG000|One Year Post-transplant|Poor absorption|0|||
126148087|NCT00064701|453827188|FG001|One Year Post-transplant|Poor absorption|1|||
126148088|NCT00064701|453827189|FG002|One Year Post-transplant|Poor absorption|0|||
126148089|NCT00064701|453827187|FG000|One Year Post-transplant|Pancreas transplant|0|||
126148090|NCT00064701|453827188|FG001|One Year Post-transplant|Pancreas transplant|0|||
126148091|NCT00064701|453827189|FG002|One Year Post-transplant|Pancreas transplant|1|||
126148092|NCT00064701|453827187|FG000|Clinical Continuation Phase|Adverse Event|12|||
126148093|NCT00064701|453827188|FG001|Clinical Continuation Phase|Adverse Event|21|||
126148094|NCT00064701|453827189|FG002|Clinical Continuation Phase|Adverse Event|14|||
126148095|NCT00064701|453827187|FG000|Clinical Continuation Phase|Non-compliance|8|||
126148096|NCT00064701|453827188|FG001|Clinical Continuation Phase|Non-compliance|6|||
126148097|NCT00064701|453827189|FG002|Clinical Continuation Phase|Non-compliance|7|||
126148098|NCT00064701|453827187|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
126148099|NCT00064701|453827188|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
126148100|NCT00064701|453827189|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
126148101|NCT00064701|453827187|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
126148102|NCT00064701|453827188|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
126148103|NCT00064701|453827189|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
126148104|NCT00064701|453827187|FG000|Clinical Continuation Phase|Graft Failure|5|||
126148105|NCT00064701|453827188|FG001|Clinical Continuation Phase|Graft Failure|5|||
126148106|NCT00064701|453827189|FG002|Clinical Continuation Phase|Graft Failure|2|||
126148107|NCT00064701|453827187|FG000|Clinical Continuation Phase|Rejection|1|||
126148108|NCT00064701|453827188|FG001|Clinical Continuation Phase|Rejection|2|||
126148109|NCT00064701|453827189|FG002|Clinical Continuation Phase|Rejection|2|||
126148110|NCT00064701|453827187|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
126148111|NCT00064701|453827188|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
126148112|NCT00064701|453827189|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
126148113|NCT00064701|453827187|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
126148114|NCT00064701|453827188|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
126200127|NCT02394028|454017882|FG005|Induction Phase|Lost to Follow-up|0|||
126148115|NCT00064701|453827189|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
126148116|NCT00064701|453827187|FG000|Clinical Continuation Phase|Physician Decision|1|||
126148117|NCT00064701|453827188|FG001|Clinical Continuation Phase|Physician Decision|3|||
126148118|NCT00064701|453827189|FG002|Clinical Continuation Phase|Physician Decision|0|||
126148119|NCT00064701|453827187|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
126148120|NCT00064701|453827188|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
126148121|NCT00064701|453827189|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
126148122|NCT00064701|453827187|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
126148123|NCT00064701|453827188|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
126148124|NCT00064701|453827189|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
126148125|NCT00064701|453827187|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
126148126|NCT00064701|453827188|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
126148127|NCT00064701|453827189|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
126148128|NCT00064701|453827187|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
126148129|NCT00064701|453827188|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
126148130|NCT00064701|453827189|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
126148131|NCT00064701|453827187|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
126148132|NCT00064701|453827188|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
126148133|NCT00064701|453827189|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
126148134|NCT00064701|453827187|FG000|Clinical Continuation Phase|Patient opted out|0|||
126148135|NCT00064701|453827188|FG001|Clinical Continuation Phase|Patient opted out|0|||
126148136|NCT00064701|453827189|FG002|Clinical Continuation Phase|Patient opted out|1|||
126148137|NCT01491945|453827191|FG000|Overall Study|Death|30|||
126148138|NCT01491945|453827191|FG000|Overall Study|Withdrwan/LTF|16|||
126148139|NCT01491945|453827191|FG000|Overall Study|Conversion|4|||
126148140|NCT01491945|453827191|FG000|Overall Study|Missed Visit|1|||
126148141|NCT03770403|453827192|FG000|Overall Study|Adverse Event|8|||
126148142|NCT03770403|453827192|FG000|Overall Study|Death|5|||
126148143|NCT03770403|453827192|FG000|Overall Study|Physician Decision|1|||
126148144|NCT03770403|453827192|FG000|Overall Study|Sponsor decision|1|||
126148145|NCT03770403|453827192|FG000|Overall Study|Study terminated by Sponsor|1|||
126148146|NCT03770403|453827192|FG000|Overall Study|Withdrawal by Subject|13|||
126148147|NCT03770403|453827192|FG000|Overall Study|Other|88|||
126148148|NCT02337387|453827224|FG000|Overall Study|Adverse Event|0|||
126148149|NCT02337387|453827225|FG001|Overall Study|Adverse Event|1|||
126148150|NCT02337387|453827226|FG002|Overall Study|Adverse Event|0|||
126148151|NCT02337387|453827227|FG003|Overall Study|Adverse Event|0|||
126148152|NCT02337387|453827224|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
126148153|NCT02337387|453827225|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
126148154|NCT02337387|453827226|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
126148155|NCT02337387|453827227|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
126148156|NCT05202808|453827228|FG000|Overall Study|Lost to Follow-up|3|||
126148157|NCT05202808|453827229|FG001|Overall Study|Lost to Follow-up|1|||
126148158|NCT02495948|453827230|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
126148159|NCT02495948|453827231|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
126148160|NCT02495948|453827230|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
126148161|NCT02495948|453827231|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
126148162|NCT02747004|453827233|FG000|Overall Study|Withdrawal by Subject|8|||
126148163|NCT02747004|453827234|FG001|Overall Study|Withdrawal by Subject|5|||
126148164|NCT02747004|453827235|FG002|Overall Study|Withdrawal by Subject|4|||
126148165|NCT02747004|453827233|FG000|Overall Study|Lost to Follow-up|1|||
126148166|NCT02747004|453827234|FG001|Overall Study|Lost to Follow-up|2|||
126148167|NCT02747004|453827235|FG002|Overall Study|Lost to Follow-up|2|||
126148168|NCT02747004|453827233|FG000|Overall Study|on study treatment/follow-up|48|||
126148169|NCT02747004|453827234|FG001|Overall Study|on study treatment/follow-up|42|||
126148170|NCT02747004|453827235|FG002|Overall Study|on study treatment/follow-up|41|||
126148171|NCT06218251|453827236|FG000|Overall Study|Lost to Follow-up|4|||
126148172|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
126148173|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
126148174|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
126148175|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
126148176|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
126148177|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
126148178|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
126148179|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
126148180|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
126148181|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
126148182|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
126148183|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126148184|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126148185|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126148186|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126148187|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
126148188|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
126148189|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
126148190|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
126148191|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
126148192|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Death|0|||
126148193|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Death|1|||
126148194|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Death|0|||
126148195|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Death|0|||
126148196|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Death|0|||
126148197|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
126148198|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
126148199|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
126148200|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
126148201|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
126148202|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
126148203|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
126148204|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
126148205|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
126148206|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
126148207|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
126148208|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
126148209|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
126148210|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
126148211|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
126148212|NCT05087030|453827237|FG000|Main Period (Week 0 to Week 52)|Other|1|||
126148213|NCT05087030|453827238|FG001|Main Period (Week 0 to Week 52)|Other|2|||
126148214|NCT05087030|453827239|FG002|Main Period (Week 0 to Week 52)|Other|0|||
126148215|NCT05087030|453827240|FG003|Main Period (Week 0 to Week 52)|Other|0|||
126148216|NCT05087030|453827241|FG004|Main Period (Week 0 to Week 52)|Other|0|||
126148217|NCT05087030|453827237|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126148218|NCT05087030|453827238|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126148219|NCT05087030|453827239|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126148220|NCT05087030|453827240|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126148221|NCT05087030|453827241|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
126148222|NCT01444300|453827242|FG000|Overall Study|Adverse Event|4|||
126148223|NCT01444300|453827243|FG001|Overall Study|Adverse Event|0|||
126148224|NCT00752986|453827244|FG000|Overall Study|Withdrawal by Subject|2|||
126148225|NCT00752986|453827245|FG001|Overall Study|Withdrawal by Subject|1|||
126148226|NCT00752986|453827246|FG002|Overall Study|Withdrawal by Subject|2|||
126148227|NCT00752986|453827244|FG000|Overall Study|Protocol Violation|3|||
126148228|NCT00752986|453827245|FG001|Overall Study|Protocol Violation|0|||
126148229|NCT00752986|453827246|FG002|Overall Study|Protocol Violation|0|||
126148230|NCT02370121|453827250|FG000|Overall Study|Lost to Follow-up|1|||
126148231|NCT02370121|453827251|FG001|Overall Study|Lost to Follow-up|1|||
126148232|NCT01587989|453827252|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
126148233|NCT01587989|453827253|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
126148234|NCT01587989|453827254|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
126148235|NCT01587989|453827252|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
126148236|NCT01587989|453827253|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
126148237|NCT01587989|453827254|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
126148238|NCT01587989|453827252|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
126148239|NCT01587989|453827253|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
126148240|NCT01587989|453827254|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
126148241|NCT01587989|453827252|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
126148242|NCT01587989|453827253|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
126148243|NCT01587989|453827254|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
126148244|NCT01587989|453827252|FG000|Randomized Study Treatment|Screening failure|0|||
126148245|NCT01587989|453827253|FG001|Randomized Study Treatment|Screening failure|1|||
126148246|NCT01587989|453827254|FG002|Randomized Study Treatment|Screening failure|0|||
126148247|NCT01587989|453827252|FG000|Randomized Study Treatment|Physician Decision|0|||
126148248|NCT01587989|453827253|FG001|Randomized Study Treatment|Physician Decision|0|||
126148249|NCT01587989|453827254|FG002|Randomized Study Treatment|Physician Decision|1|||
126148250|NCT00275561|453827257|FG000|Overall Study|Withdrawal by Subject|0|||
126148251|NCT00275561|453827258|FG001|Overall Study|Withdrawal by Subject|1|||
126148252|NCT00275561|453827257|FG000|Overall Study|Travel|1|||
126148253|NCT00275561|453827258|FG001|Overall Study|Travel|1|||
126148254|NCT00275561|453827257|FG000|Overall Study|Scheduling|1|||
126148255|NCT00275561|453827258|FG001|Overall Study|Scheduling|2|||
126148256|NCT00275561|453827257|FG000|Overall Study|Family Issues|0|||
126148257|NCT00275561|453827258|FG001|Overall Study|Family Issues|2|||
126148258|NCT01769105|453827259|FG000|First Intervention|Protocol Violation|2|||
126148259|NCT01769105|453827260|FG001|First Intervention|Protocol Violation|2|||
126148260|NCT01769105|453827259|FG000|Cross-over|Lost to Follow-up|5|||
126148261|NCT01769105|453827260|FG001|Cross-over|Lost to Follow-up|0|||
126148262|NCT00963807|453827265|FG000|Overall Study|Physician Decision|2|||
126148263|NCT00963807|453827265|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
126148264|NCT00963807|453827265|FG000|Overall Study|Disease progression|15|||
126148265|NCT00684177|453827266|FG000|Overall Study|Adverse Event|4|||
126148266|NCT00684177|453827267|FG001|Overall Study|Adverse Event|3|||
126148267|NCT00684177|453827266|FG000|Overall Study|Lack of Efficacy|10|||
126148268|NCT00684177|453827267|FG001|Overall Study|Lack of Efficacy|15|||
126148269|NCT00684177|453827266|FG000|Overall Study|Protocol Violation|1|||
126148270|NCT00684177|453827267|FG001|Overall Study|Protocol Violation|0|||
126148271|NCT00684177|453827266|FG000|Overall Study|Lost to Follow-up|2|||
126148272|NCT00684177|453827267|FG001|Overall Study|Lost to Follow-up|1|||
126148273|NCT00684177|453827266|FG000|Overall Study|Physician Decision|2|||
126148274|NCT00684177|453827267|FG001|Overall Study|Physician Decision|0|||
126148275|NCT00684177|453827266|FG000|Overall Study|Withdrawal by Subject|1|||
126148276|NCT00684177|453827267|FG001|Overall Study|Withdrawal by Subject|2|||
126148277|NCT00684177|453827266|FG000|Overall Study|Other|1|||
126148278|NCT00684177|453827267|FG001|Overall Study|Other|2|||
126148279|NCT02031679|453830322|FG000|Overall Study|Protocol Violation|0|||
126148280|NCT02031679|453830323|FG001|Overall Study|Protocol Violation|1|||
126148281|NCT02031679|453830322|FG000|Overall Study|Lack of Efficacy|0|||
126148282|NCT02031679|453830323|FG001|Overall Study|Lack of Efficacy|1|||
126148283|NCT04030195|453830324|FG000|Overall Study|Withdrawal by Subject|2|||
126148284|NCT04030195|453830325|FG001|Overall Study|Withdrawal by Subject|0|||
126148285|NCT04030195|453830326|FG002|Overall Study|Withdrawal by Subject|0|||
126148286|NCT01024244|453830327|FG000|Overall Study|Adverse Event|1|||
126148287|NCT01024244|453830328|FG001|Overall Study|Adverse Event|2|||
126148288|NCT01024244|453830329|FG002|Overall Study|Adverse Event|0|||
126148289|NCT01024244|453830330|FG003|Overall Study|Adverse Event|1|||
126148290|NCT01024244|453830331|FG004|Overall Study|Adverse Event|2|||
126148291|NCT01024244|453830327|FG000|Overall Study|Entry Criteria Not Met|0|||
126148292|NCT01024244|453830328|FG001|Overall Study|Entry Criteria Not Met|1|||
126148293|NCT01024244|453830329|FG002|Overall Study|Entry Criteria Not Met|0|||
126148294|NCT01024244|453830330|FG003|Overall Study|Entry Criteria Not Met|0|||
126148295|NCT01024244|453830331|FG004|Overall Study|Entry Criteria Not Met|0|||
126148296|NCT01024244|453830327|FG000|Overall Study|Lack of Efficacy|1|||
126148297|NCT01024244|453830328|FG001|Overall Study|Lack of Efficacy|0|||
126148298|NCT01024244|453830329|FG002|Overall Study|Lack of Efficacy|0|||
126148299|NCT01024244|453830330|FG003|Overall Study|Lack of Efficacy|0|||
126148300|NCT01024244|453830331|FG004|Overall Study|Lack of Efficacy|0|||
126148301|NCT01024244|453830327|FG000|Overall Study|Protocol Violation|1|||
126148302|NCT01024244|453830328|FG001|Overall Study|Protocol Violation|0|||
126148303|NCT01024244|453830329|FG002|Overall Study|Protocol Violation|0|||
126148304|NCT01024244|453830330|FG003|Overall Study|Protocol Violation|0|||
126148305|NCT01024244|453830331|FG004|Overall Study|Protocol Violation|2|||
126148306|NCT01024244|453830327|FG000|Overall Study|Sponsor Decision|14|||
126148307|NCT01024244|453830328|FG001|Overall Study|Sponsor Decision|7|||
126148308|NCT01024244|453830329|FG002|Overall Study|Sponsor Decision|14|||
126148309|NCT01024244|453830330|FG003|Overall Study|Sponsor Decision|12|||
126148310|NCT01024244|453830331|FG004|Overall Study|Sponsor Decision|10|||
126148311|NCT01024244|453830327|FG000|Overall Study|Withdrawal by Subject|0|||
126148312|NCT01024244|453830328|FG001|Overall Study|Withdrawal by Subject|1|||
126148313|NCT01024244|453830329|FG002|Overall Study|Withdrawal by Subject|0|||
126148314|NCT01024244|453830330|FG003|Overall Study|Withdrawal by Subject|0|||
126148315|NCT01024244|453830331|FG004|Overall Study|Withdrawal by Subject|0|||
126148316|NCT02660580|453830338|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
126148317|NCT02660580|453830339|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
126148318|NCT02660580|453830340|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
126148319|NCT02660580|453830341|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
126148320|NCT02660580|453830342|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
126148321|NCT02660580|453830338|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
126148322|NCT02660580|453830339|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
126148323|NCT02660580|453830340|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
126148324|NCT02660580|453830341|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
126148325|NCT02660580|453830342|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
126148326|NCT02660580|453830338|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
126148327|NCT02660580|453830339|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
126148328|NCT02660580|453830340|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
126148329|NCT02660580|453830341|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
126148330|NCT02660580|453830342|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
126148331|NCT02660580|453830338|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
126148332|NCT02660580|453830339|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
126148333|NCT02660580|453830340|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
126148334|NCT02660580|453830341|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
126148335|NCT02660580|453830342|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
126148336|NCT02660580|453830338|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
126148337|NCT02660580|453830339|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
126148338|NCT02660580|453830340|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
126148339|NCT02660580|453830341|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
126148340|NCT02660580|453830342|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
126148341|NCT02660580|453830338|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
126148342|NCT02660580|453830339|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
126148343|NCT02660580|453830340|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
126148344|NCT02660580|453830341|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
126148345|NCT02660580|453830342|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
126148346|NCT02660580|453830338|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
126148347|NCT02660580|453830339|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
126148348|NCT02660580|453830340|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
126148349|NCT02660580|453830341|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
126148350|NCT02660580|453830342|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
126148351|NCT02660580|453830338|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
126148352|NCT02660580|453830339|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
126148353|NCT02660580|453830340|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
126148354|NCT02660580|453830341|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
126148355|NCT02660580|453830342|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
126148356|NCT02660580|453830338|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
126148357|NCT02660580|453830339|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
126148358|NCT02660580|453830340|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
126148359|NCT02660580|453830341|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
126148360|NCT02660580|453830342|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
126148361|NCT02660580|453830338|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
126148362|NCT02660580|453830339|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
126148363|NCT02660580|453830340|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
126148364|NCT02660580|453830341|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
126148365|NCT02660580|453830342|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
126148366|NCT02660580|453830338|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
126148367|NCT02660580|453830339|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
126148368|NCT02660580|453830340|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
126148369|NCT02660580|453830341|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
126148370|NCT02660580|453830342|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
126148371|NCT02660580|453830338|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
126148372|NCT02660580|453830339|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
126148373|NCT02660580|453830340|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
126148374|NCT02660580|453830341|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
126148375|NCT02660580|453830342|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
126148376|NCT02660580|453830338|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
126148377|NCT02660580|453830339|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
126148378|NCT02660580|453830340|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
126148379|NCT02660580|453830341|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
126148380|NCT02660580|453830342|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
126148381|NCT00377962|453830343|FG000|Core Study: 0-12 Months|Adverse Event|18|||
126148382|NCT00377962|453830344|FG001|Core Study: 0-12 Months|Adverse Event|2|||
126148383|NCT00377962|453830343|FG000|Core Study: 0-12 Months|Death|3|||
126148384|NCT00377962|453830344|FG001|Core Study: 0-12 Months|Death|0|||
126148385|NCT00377962|453830343|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
126148386|NCT00377962|453830344|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
126148387|NCT00377962|453830343|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
126148388|NCT00377962|453830344|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
126148389|NCT00377962|453830343|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
126148390|NCT00377962|453830344|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
126148391|NCT00377962|453830343|FG000|Extension Study: 12-24 Months|Death|1|||
126148392|NCT00377962|453830344|FG001|Extension Study: 12-24 Months|Death|1|||
126148393|NCT00377962|453830343|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
126148394|NCT00377962|453830344|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
126200128|NCT02394028|454017883|FG006|Induction Phase|Lost to Follow-up|1|||
126148395|NCT00377962|453830343|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
126148396|NCT00377962|453830344|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
126148397|NCT00377962|453830343|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
126148398|NCT00377962|453830344|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
126148399|NCT03095703|453830350|FG000|Overall Study|Withdrawal by Subject|1|||
126148400|NCT01381094|453830351|FG000|Overall Study|Adverse Event|1|||
126148401|NCT01381094|453830352|FG001|Overall Study|Adverse Event|2|||
126148402|NCT01381094|453830353|FG002|Overall Study|Adverse Event|0|||
126148403|NCT01381094|453830354|FG003|Overall Study|Adverse Event|1|||
126148404|NCT01381094|453830355|FG004|Overall Study|Adverse Event|0|||
126148405|NCT01381094|453830351|FG000|Overall Study|Lost to Follow-up|0|||
126148406|NCT01381094|453830352|FG001|Overall Study|Lost to Follow-up|0|||
126148407|NCT01381094|453830353|FG002|Overall Study|Lost to Follow-up|0|||
126148408|NCT01381094|453830354|FG003|Overall Study|Lost to Follow-up|0|||
126148409|NCT01381094|453830355|FG004|Overall Study|Lost to Follow-up|1|||
126148410|NCT01381094|453830351|FG000|Overall Study|Withdrawal of informed consent|0|||
126148411|NCT01381094|453830352|FG001|Overall Study|Withdrawal of informed consent|1|||
126148412|NCT01381094|453830353|FG002|Overall Study|Withdrawal of informed consent|0|||
126148413|NCT01381094|453830354|FG003|Overall Study|Withdrawal of informed consent|0|||
126148414|NCT01381094|453830355|FG004|Overall Study|Withdrawal of informed consent|0|||
126148415|NCT01381094|453830351|FG000|Overall Study|Participant given Aranesp injection|1|||
126148416|NCT01381094|453830352|FG001|Overall Study|Participant given Aranesp injection|0|||
126148417|NCT01381094|453830353|FG002|Overall Study|Participant given Aranesp injection|0|||
126148418|NCT01381094|453830354|FG003|Overall Study|Participant given Aranesp injection|0|||
126148419|NCT01381094|453830355|FG004|Overall Study|Participant given Aranesp injection|0|||
126148420|NCT01934504|453830358|FG000|Overall Study|Protocol Deviation|0|||
126148421|NCT01934504|453830359|FG001|Overall Study|Protocol Deviation|0|||
126148422|NCT01934504|453830360|FG002|Overall Study|Protocol Deviation|0|||
126148423|NCT01934504|453830361|FG003|Overall Study|Protocol Deviation|2|||
126148424|NCT01934504|453830358|FG000|Overall Study|Study Terminated by Sponsor|1|||
126148425|NCT01934504|453830359|FG001|Overall Study|Study Terminated by Sponsor|0|||
126148426|NCT01934504|453830360|FG002|Overall Study|Study Terminated by Sponsor|5|||
126148427|NCT01934504|453830361|FG003|Overall Study|Study Terminated by Sponsor|5|||
126148428|NCT02665689|453830362|FG000|Overall Study|Adverse Event|1|||
126148429|NCT02665689|453830363|FG001|Overall Study|Adverse Event|0|||
126148430|NCT02665689|453830362|FG000|Overall Study|Trial termination|1|||
126148431|NCT02665689|453830363|FG001|Overall Study|Trial termination|1|||
126148432|NCT02665689|453830362|FG000|Overall Study|Lost to Follow-up|0|||
126148433|NCT02665689|453830363|FG001|Overall Study|Lost to Follow-up|1|||
126148434|NCT00486902|453830364|FG000|Overall Study|Withdrawal by Subject|1|||
126148435|NCT00486902|453830365|FG001|Overall Study|Withdrawal by Subject|2|||
126148436|NCT00486902|453830364|FG000|Overall Study|decision for postpartum tubal ligation|3|||
126148437|NCT00486902|453830365|FG001|Overall Study|decision for postpartum tubal ligation|1|||
126148438|NCT00486902|453830364|FG000|Overall Study|spinal anesthetic protocal violation|1|||
126148439|NCT00486902|453830365|FG001|Overall Study|spinal anesthetic protocal violation|1|||
126148440|NCT00486902|453830364|FG000|Overall Study|Did not meet inclusion criteria|1|||
126148441|NCT00486902|453830365|FG001|Overall Study|Did not meet inclusion criteria|0|||
126148442|NCT00486902|453830364|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
126148443|NCT00486902|453830365|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
126148444|NCT00541307|453830368|FG000|Overall Study|Death|5|||
126148445|NCT00541307|453830368|FG000|Overall Study|Physician Decision|3|||
126148446|NCT00541307|453830368|FG000|Overall Study|Withdrawal by Subject|6|||
126148447|NCT00541307|453830368|FG000|Overall Study|Lost to Follow-up|4|||
126148448|NCT00541307|453830368|FG000|Overall Study|Subject returned early (outside window)|1|||
126148449|NCT00541307|453830368|FG000|Overall Study|Surgical Bypass|5|||
126148450|NCT02455557|453830369|FG000|Overall Study|Withdrawal by Subject|2|||
126148451|NCT03615222|453830370|FG000|Overall Study|Ineligible|26|||
126148452|NCT03615222|453830370|FG000|Overall Study|Withdrawal by Subject|7|||
126148453|NCT03615222|453830370|FG000|Overall Study|Death|1|||
126148454|NCT02900092|453830371|FG000|Overall Study|Adverse Event|1|||
126148455|NCT03895203|453830372|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
126148456|NCT03895203|453830373|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
126148457|NCT03895203|453830374|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
126148458|NCT03895203|453830375|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
126148459|NCT03895203|453830376|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
126148460|NCT03895203|453830377|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
126148461|NCT03895203|453830372|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
126148462|NCT03895203|453830373|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126148463|NCT03895203|453830374|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126148464|NCT03895203|453830375|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126148465|NCT03895203|453830376|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126148466|NCT03895203|453830377|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126148467|NCT03895203|453830372|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
126148468|NCT03895203|453830373|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126148469|NCT03895203|453830374|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126148470|NCT03895203|453830375|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126148471|NCT03895203|453830376|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126148472|NCT03895203|453830377|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126148473|NCT03895203|453830372|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
126148474|NCT03895203|453830373|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
126148475|NCT03895203|453830374|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
126148476|NCT03895203|453830375|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
126148477|NCT03895203|453830376|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
126148478|NCT03895203|453830377|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
126148479|NCT03895203|453830372|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126148480|NCT03895203|453830373|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
126148481|NCT03895203|453830374|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126148482|NCT03895203|453830375|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126148483|NCT03895203|453830376|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126148484|NCT03895203|453830377|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126148485|NCT03895203|453830372|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126148486|NCT03895203|453830373|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
126148487|NCT03895203|453830374|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126148488|NCT03895203|453830375|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126148489|NCT03895203|453830376|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126148490|NCT03895203|453830377|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126148491|NCT03895203|453830372|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126148492|NCT03895203|453830373|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126148493|NCT03895203|453830374|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126148494|NCT03895203|453830375|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
126148495|NCT03895203|453830376|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126148496|NCT03895203|453830377|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126148497|NCT03895203|453830372|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
126148498|NCT03895203|453830373|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
126148499|NCT03895203|453830374|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
126148500|NCT03895203|453830375|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
126148501|NCT03895203|453830376|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
126148502|NCT03895203|453830377|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
126148503|NCT03895203|453830372|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
126148504|NCT03895203|453830373|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
126148505|NCT03895203|453830374|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
126148506|NCT03895203|453830375|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
126148507|NCT03895203|453830376|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
126148508|NCT03895203|453830377|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
126148509|NCT03895203|453830372|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
126148510|NCT03895203|453830373|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
126148511|NCT03895203|453830374|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
126148512|NCT03895203|453830375|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
126148513|NCT03895203|453830376|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
126148514|NCT03895203|453830377|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
126148515|NCT03895203|453830372|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
126148516|NCT03895203|453830373|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
126148517|NCT03895203|453830374|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
126148518|NCT03895203|453830375|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
126148519|NCT03895203|453830376|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
126148520|NCT03895203|453830377|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
126148521|NCT03895203|453830372|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126148522|NCT03895203|453830373|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126148523|NCT03895203|453830374|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126148524|NCT03895203|453830375|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
126148525|NCT03895203|453830376|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126148526|NCT03895203|453830377|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126148527|NCT03895203|453830372|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126148528|NCT03895203|453830373|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126148529|NCT03895203|453830374|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126148530|NCT03895203|453830375|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
126148531|NCT03895203|453830376|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126148532|NCT03895203|453830377|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126148533|NCT03895203|453830372|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126148534|NCT03895203|453830373|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126148535|NCT03895203|453830374|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126148536|NCT03895203|453830375|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126148537|NCT03895203|453830376|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126148538|NCT03895203|453830377|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
126148539|NCT00996840|453830378|FG000|Overall Study|Adverse Event|0|||
126148540|NCT00996840|453830379|FG001|Overall Study|Adverse Event|1|||
126148541|NCT00996840|453830380|FG002|Overall Study|Adverse Event|0|||
126148542|NCT00996840|453830381|FG003|Overall Study|Adverse Event|0|||
126148543|NCT00996840|453830382|FG004|Overall Study|Adverse Event|0|||
126148544|NCT00996840|453830378|FG000|Overall Study|Physician Decision|0|||
126148545|NCT00996840|453830379|FG001|Overall Study|Physician Decision|0|||
126148546|NCT00996840|453830380|FG002|Overall Study|Physician Decision|1|||
126148547|NCT00996840|453830381|FG003|Overall Study|Physician Decision|1|||
126148548|NCT00996840|453830382|FG004|Overall Study|Physician Decision|2|||
126148549|NCT00996840|453830378|FG000|Overall Study|Withdrawal by Subject|1|||
126148550|NCT00996840|453830379|FG001|Overall Study|Withdrawal by Subject|1|||
126148551|NCT00996840|453830380|FG002|Overall Study|Withdrawal by Subject|0|||
126148552|NCT00996840|453830381|FG003|Overall Study|Withdrawal by Subject|0|||
126148553|NCT00996840|453830382|FG004|Overall Study|Withdrawal by Subject|0|||
126148554|NCT04645797|453830383|FG000|Overall Study|Disease Progression|3|||
126148555|NCT04645797|453830384|FG001|Overall Study|Disease Progression|3|||
126148556|NCT04645797|453830385|FG002|Overall Study|Disease Progression|1|||
126148557|NCT04645797|453830386|FG003|Overall Study|Disease Progression|0|||
126148558|NCT04645797|453830387|FG004|Overall Study|Disease Progression|0|||
126148559|NCT04645797|453830388|FG005|Overall Study|Disease Progression|0|||
126148560|NCT04645797|453830389|FG006|Overall Study|Disease Progression|0|||
126148561|NCT04645797|453830383|FG000|Overall Study|Death|3|||
126148562|NCT04645797|453830384|FG001|Overall Study|Death|1|||
126148563|NCT04645797|453830385|FG002|Overall Study|Death|0|||
126148564|NCT04645797|453830386|FG003|Overall Study|Death|0|||
126148565|NCT04645797|453830387|FG004|Overall Study|Death|0|||
126148566|NCT04645797|453830388|FG005|Overall Study|Death|0|||
126148567|NCT04645797|453830389|FG006|Overall Study|Death|0|||
126148568|NCT01485614|453830391|FG000|Randomization|Not Treated|1|||
126148569|NCT01485614|453830392|FG001|Randomization|Not Treated|0|||
126148570|NCT01485614|453830393|FG002|Randomization|Not Treated|0|||
126148571|NCT01485614|453830394|FG003|Randomization|Not Treated|0|||
126148572|NCT01485614|453830391|FG000|Weeks 0-20|Lost to Follow-up|2|||
126148573|NCT01485614|453830392|FG001|Weeks 0-20|Lost to Follow-up|0|||
126148574|NCT01485614|453830393|FG002|Weeks 0-20|Lost to Follow-up|0|||
126148575|NCT01485614|453830394|FG003|Weeks 0-20|Lost to Follow-up|0|||
126148576|NCT01485614|453830391|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
126148577|NCT01485614|453830392|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
126148578|NCT01485614|453830393|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
126148579|NCT01485614|453830394|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
126148580|NCT01485614|453830391|FG000|Weeks 0-20|Withdrawal by Subject|3|||
126148581|NCT01485614|453830392|FG001|Weeks 0-20|Withdrawal by Subject|2|||
126148582|NCT01485614|453830393|FG002|Weeks 0-20|Withdrawal by Subject|1|||
126148583|NCT01485614|453830394|FG003|Weeks 0-20|Withdrawal by Subject|0|||
126148584|NCT01485614|453830391|FG000|Weeks 20-54|Lost to Follow-up|4|||
126148585|NCT01485614|453830392|FG001|Weeks 20-54|Lost to Follow-up|3|||
126148586|NCT01485614|453830393|FG002|Weeks 20-54|Lost to Follow-up|1|||
126148587|NCT01485614|453830394|FG003|Weeks 20-54|Lost to Follow-up|0|||
126148588|NCT01485614|453830391|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
126148589|NCT01485614|453830392|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
126148590|NCT01485614|453830393|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
126148591|NCT01485614|453830394|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
126148592|NCT01485614|453830391|FG000|Weeks 20-54|Withdrawal by Subject|5|||
126148593|NCT01485614|453830392|FG001|Weeks 20-54|Withdrawal by Subject|3|||
126148594|NCT01485614|453830393|FG002|Weeks 20-54|Withdrawal by Subject|0|||
126148595|NCT01485614|453830394|FG003|Weeks 20-54|Withdrawal by Subject|0|||
126148596|NCT00733902|453830395|FG000|Overall Study|Death|0|||
126148597|NCT00733902|453830396|FG001|Overall Study|Death|0|||
126148598|NCT00733902|453830397|FG002|Overall Study|Death|0|||
126148599|NCT00733902|453830398|FG003|Overall Study|Death|1|||
126148600|NCT00733902|453830395|FG000|Overall Study|Adverse Event|3|||
126148601|NCT00733902|453830396|FG001|Overall Study|Adverse Event|4|||
126148602|NCT00733902|453830397|FG002|Overall Study|Adverse Event|7|||
126148603|NCT00733902|453830398|FG003|Overall Study|Adverse Event|11|||
126148604|NCT00733902|453830395|FG000|Overall Study|Lack of Efficacy|56|||
126148605|NCT00733902|453830396|FG001|Overall Study|Lack of Efficacy|21|||
126148606|NCT00733902|453830397|FG002|Overall Study|Lack of Efficacy|34|||
126148607|NCT00733902|453830398|FG003|Overall Study|Lack of Efficacy|23|||
126148608|NCT00733902|453830395|FG000|Overall Study|Protocol Violation|4|||
126148609|NCT00733902|453830396|FG001|Overall Study|Protocol Violation|6|||
126148610|NCT00733902|453830397|FG002|Overall Study|Protocol Violation|3|||
126148611|NCT00733902|453830398|FG003|Overall Study|Protocol Violation|3|||
126148612|NCT00733902|453830395|FG000|Overall Study|Withdrawal by Subject|10|||
126148613|NCT00733902|453830396|FG001|Overall Study|Withdrawal by Subject|5|||
126148614|NCT00733902|453830397|FG002|Overall Study|Withdrawal by Subject|4|||
126148615|NCT00733902|453830398|FG003|Overall Study|Withdrawal by Subject|16|||
126148616|NCT00733902|453830395|FG000|Overall Study|Entered extension study|89|||
126148617|NCT00733902|453830396|FG001|Overall Study|Entered extension study|124|||
126148618|NCT00733902|453830397|FG002|Overall Study|Entered extension study|111|||
126148619|NCT00733902|453830398|FG003|Overall Study|Entered extension study|109|||
126148620|NCT00733902|453830395|FG000|Overall Study|Randomized but not treated|2|||
126148621|NCT00733902|453830396|FG001|Overall Study|Randomized but not treated|2|||
126148622|NCT00733902|453830397|FG002|Overall Study|Randomized but not treated|2|||
126148623|NCT00733902|453830398|FG003|Overall Study|Randomized but not treated|1|||
126148624|NCT02210780|453830399|FG000|Overall Study|Adverse Event|0|||
126148625|NCT02210780|453830400|FG001|Overall Study|Adverse Event|5|||
126148626|NCT02210780|453830399|FG000|Overall Study|Lost to Follow-up|2|||
126148627|NCT02210780|453830400|FG001|Overall Study|Lost to Follow-up|1|||
126148628|NCT02210780|453830399|FG000|Overall Study|Withdrawal by Subject|1|||
126148629|NCT02210780|453830400|FG001|Overall Study|Withdrawal by Subject|1|||
126148630|NCT02210780|453830399|FG000|Overall Study|Physician Decision|1|||
126148631|NCT02210780|453830400|FG001|Overall Study|Physician Decision|0|||
126148632|NCT02210780|453830399|FG000|Overall Study|Protocol Violation|1|||
126148633|NCT02210780|453830400|FG001|Overall Study|Protocol Violation|0|||
126148634|NCT02210780|453830399|FG000|Overall Study|Other than specified above|0|||
126148635|NCT02210780|453830400|FG001|Overall Study|Other than specified above|1|||
126148636|NCT00049127|453830401|FG000|Overall Study|Withdrawal by Subject|0|||
126148637|NCT00049127|453830402|FG001|Overall Study|Withdrawal by Subject|0|||
126148638|NCT00049127|453830403|FG002|Overall Study|Withdrawal by Subject|1|||
126148639|NCT00049127|453830404|FG003|Overall Study|Withdrawal by Subject|0|||
126148640|NCT00049127|453830405|FG004|Overall Study|Withdrawal by Subject|0|||
126148641|NCT02582515|453830406|FG000|Overall Study|Withdrawal by Subject|0|||
126148642|NCT02582515|453830407|FG001|Overall Study|Withdrawal by Subject|1|||
126148643|NCT00775021|453830408|FG000|First Intervention|Lost to Follow-up|1|||
126148644|NCT00775021|453830409|FG001|First Intervention|Lost to Follow-up|0|||
126148645|NCT00775021|453830408|FG000|Second Intervention|Adverse Event|0|||
126148646|NCT00775021|453830409|FG001|Second Intervention|Adverse Event|1|||
126148647|NCT02599402|453830410|FG000|Overall Study|Disease progression|153|||
126148648|NCT02599402|453830410|FG000|Overall Study|Study drug toxicity|201|||
126148649|NCT02599402|453830410|FG000|Overall Study|Death|26|||
126148650|NCT02599402|453830410|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
126148651|NCT02599402|453830410|FG000|Overall Study|Participant request to discontinue study treatment|13|||
126148652|NCT02599402|453830410|FG000|Overall Study|Participant withdrew consent|5|||
126148653|NCT02599402|453830410|FG000|Overall Study|Lost to Follow-up|1|||
126148654|NCT02599402|453830410|FG000|Overall Study|Maximum Clinical Benefit|7|||
126148655|NCT02599402|453830410|FG000|Overall Study|Poor/non-compliance|1|||
126148656|NCT02599402|453830410|FG000|Overall Study|Pregnancy|1|||
126148657|NCT02599402|453830410|FG000|Overall Study|Participant no longer met study criteria|7|||
126148658|NCT02599402|453830410|FG000|Overall Study|Other Reasons|95|||
126148659|NCT00833092|453830411|FG000|Overall Study|Withdrawal by Subject|2|||
126148660|NCT00833092|453830412|FG001|Overall Study|Withdrawal by Subject|3|||
126148661|NCT00833092|453830411|FG000|Overall Study|Protocol Violation|2|||
126148662|NCT00833092|453830412|FG001|Overall Study|Protocol Violation|1|||
126148663|NCT00833092|453830411|FG000|Overall Study|Diarrhea|0|||
126148664|NCT00833092|453830412|FG001|Overall Study|Diarrhea|2|||
126148665|NCT00833092|453830411|FG000|Overall Study|constipation|0|||
126148666|NCT00833092|453830412|FG001|Overall Study|constipation|1|||
126148667|NCT00699192|453830413|FG000|Overall Study|Missing|1|||
126148668|NCT00699192|453830414|FG001|Overall Study|Missing|1|||
126148669|NCT00699192|453830415|FG002|Overall Study|Missing|1|||
126148670|NCT00699192|453830413|FG000|Overall Study|Adverse Event|9|||
126148671|NCT00699192|453830414|FG001|Overall Study|Adverse Event|4|||
126148672|NCT00699192|453830415|FG002|Overall Study|Adverse Event|3|||
126148673|NCT00699192|453830413|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126148674|NCT00699192|453830414|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126148675|NCT00699192|453830415|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126148676|NCT00699192|453830413|FG000|Overall Study|Lack of Efficacy|0|||
126148677|NCT00699192|453830414|FG001|Overall Study|Lack of Efficacy|0|||
126148678|NCT00699192|453830415|FG002|Overall Study|Lack of Efficacy|1|||
126148679|NCT00699192|453830413|FG000|Overall Study|Withdrawal by Subject|3|||
126148680|NCT00699192|453830414|FG001|Overall Study|Withdrawal by Subject|2|||
126148681|NCT00699192|453830415|FG002|Overall Study|Withdrawal by Subject|4|||
126148682|NCT00699192|453830413|FG000|Overall Study|Administrative problems|1|||
126148683|NCT00699192|453830414|FG001|Overall Study|Administrative problems|3|||
126148684|NCT00699192|453830415|FG002|Overall Study|Administrative problems|1|||
126148685|NCT00699192|453830413|FG000|Overall Study|Protocol Violation|2|||
126148686|NCT00699192|453830414|FG001|Overall Study|Protocol Violation|2|||
126148687|NCT00699192|453830415|FG002|Overall Study|Protocol Violation|0|||
126148688|NCT01773473|453830416|FG000|Overall Study|Adverse Event|3|||
126148689|NCT01773473|453830417|FG001|Overall Study|Adverse Event|2|||
126148690|NCT01773473|453830416|FG000|Overall Study|Protocol Violation|0|||
126148691|NCT01773473|453830417|FG001|Overall Study|Protocol Violation|4|||
126148692|NCT01773473|453830416|FG000|Overall Study|Physician Decision|3|||
126148693|NCT01773473|453830417|FG001|Overall Study|Physician Decision|5|||
126148694|NCT01773473|453830416|FG000|Overall Study|Sponsor Decision|2|||
126148695|NCT01773473|453830417|FG001|Overall Study|Sponsor Decision|0|||
126148696|NCT01773473|453830416|FG000|Overall Study|Lack of Efficacy|0|||
126148697|NCT01773473|453830417|FG001|Overall Study|Lack of Efficacy|1|||
126148698|NCT01773473|453830416|FG000|Overall Study|Non-Compliance with study drug|1|||
126148699|NCT01773473|453830417|FG001|Overall Study|Non-Compliance with study drug|4|||
126148700|NCT01773473|453830416|FG000|Overall Study|Withdrawal by Subject|5|||
126148701|NCT01773473|453830417|FG001|Overall Study|Withdrawal by Subject|3|||
126148702|NCT01773473|453830416|FG000|Overall Study|Lost to Follow-up|2|||
126148703|NCT01773473|453830417|FG001|Overall Study|Lost to Follow-up|0|||
126148704|NCT04927312|453830420|FG000|Overall Study|Adverse Event|1|||
126148705|NCT04927312|453830420|FG000|Overall Study|Death|1|||
126148706|NCT04927312|453830420|FG000|Overall Study|Withdrawal by Subject|1|||
126148707|NCT04927312|453830420|FG000|Overall Study|Other|1|||
126148708|NCT04919564|453830423|FG000|Overall Study|Lost to Follow-up|1|||
126148709|NCT04919564|453830424|FG001|Overall Study|Lost to Follow-up|0|||
126148710|NCT04919564|453830423|FG000|Overall Study|Physician Decision|1|||
126148711|NCT04919564|453830424|FG001|Overall Study|Physician Decision|1|||
126148712|NCT01241786|453830425|FG000|Overall Study|Lack of Efficacy|5|||
126148713|NCT00929240|453830430|FG000|Initial Treatment Phase|Adverse Event|31|||
126148714|NCT00929240|453830431|FG001|Initial Treatment Phase|Adverse Event|0|||
126148715|NCT00929240|453830432|FG002|Initial Treatment Phase|Adverse Event|0|||
126148716|NCT00929240|453830430|FG000|Initial Treatment Phase|Disease progression|41|||
126148717|NCT00929240|453830431|FG001|Initial Treatment Phase|Disease progression|0|||
126148718|NCT00929240|453830432|FG002|Initial Treatment Phase|Disease progression|0|||
126148719|NCT00929240|453830430|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
126148720|NCT00929240|453830431|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
126148721|NCT00929240|453830432|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
126148722|NCT00929240|453830430|FG000|Initial Treatment Phase|Protocol Violation|5|||
126148723|NCT00929240|453830431|FG001|Initial Treatment Phase|Protocol Violation|0|||
126148724|NCT00929240|453830432|FG002|Initial Treatment Phase|Protocol Violation|0|||
126148725|NCT00929240|453830430|FG000|Initial Treatment Phase|Death|2|||
126148726|NCT00929240|453830431|FG001|Initial Treatment Phase|Death|0|||
126148727|NCT00929240|453830432|FG002|Initial Treatment Phase|Death|0|||
126148728|NCT00929240|453830430|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
126148729|NCT00929240|453830431|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
126148730|NCT00929240|453830432|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
126148731|NCT00929240|453830430|FG000|Initial Treatment Phase|Physician Decision|4|||
126148732|NCT00929240|453830431|FG001|Initial Treatment Phase|Physician Decision|0|||
126148733|NCT00929240|453830432|FG002|Initial Treatment Phase|Physician Decision|0|||
126148734|NCT00929240|453830430|FG000|Maintenance Phase|Disease progression|0|||
126148735|NCT00929240|453830431|FG001|Maintenance Phase|Disease progression|73|||
126148736|NCT00929240|453830432|FG002|Maintenance Phase|Disease progression|60|||
126148737|NCT00929240|453830430|FG000|Maintenance Phase|Adverse Event|0|||
126148738|NCT00929240|453830431|FG001|Maintenance Phase|Adverse Event|9|||
126148739|NCT00929240|453830432|FG002|Maintenance Phase|Adverse Event|12|||
126148740|NCT00929240|453830430|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126148741|NCT00929240|453830431|FG001|Maintenance Phase|Withdrawal by Subject|2|||
126148742|NCT00929240|453830432|FG002|Maintenance Phase|Withdrawal by Subject|6|||
126148743|NCT00929240|453830430|FG000|Maintenance Phase|Protocol Violation|0|||
126148744|NCT00929240|453830431|FG001|Maintenance Phase|Protocol Violation|1|||
126148745|NCT00929240|453830432|FG002|Maintenance Phase|Protocol Violation|0|||
126148746|NCT00929240|453830430|FG000|Maintenance Phase|Health authority/Study termination|0|||
126148747|NCT00929240|453830431|FG001|Maintenance Phase|Health authority/Study termination|1|||
126148748|NCT00929240|453830432|FG002|Maintenance Phase|Health authority/Study termination|2|||
126148749|NCT00929240|453830430|FG000|Maintenance Phase|Physician Decision|0|||
126148750|NCT00929240|453830431|FG001|Maintenance Phase|Physician Decision|2|||
126148751|NCT00929240|453830432|FG002|Maintenance Phase|Physician Decision|1|||
126148752|NCT00929240|453830430|FG000|Maintenance Phase|Change of treatment|0|||
126148753|NCT00929240|453830431|FG001|Maintenance Phase|Change of treatment|4|||
126148754|NCT00929240|453830432|FG002|Maintenance Phase|Change of treatment|0|||
126148755|NCT00929240|453830430|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
126148756|NCT00929240|453830431|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
126148757|NCT00929240|453830432|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
126148758|NCT00929240|453830430|FG000|Maintenance Phase|Participant not treated|0|||
126148759|NCT00929240|453830431|FG001|Maintenance Phase|Participant not treated|2|||
126148760|NCT00929240|453830432|FG002|Maintenance Phase|Participant not treated|0|||
126148761|NCT02371629|453830433|FG000|Overall Study|Patient decision|14|||
126148762|NCT02371629|453830434|FG001|Overall Study|Patient decision|10|||
126148763|NCT02371629|453830433|FG000|Overall Study|Adverse Event|8|||
126148764|NCT02371629|453830434|FG001|Overall Study|Adverse Event|8|||
126148765|NCT02371629|453830433|FG000|Overall Study|Physician Decision|2|||
126148766|NCT02371629|453830434|FG001|Overall Study|Physician Decision|3|||
126148767|NCT02371629|453830433|FG000|Overall Study|Death|1|||
126148768|NCT02371629|453830434|FG001|Overall Study|Death|1|||
126148769|NCT02371629|453830433|FG000|Overall Study|Noncompliance with study treatment|1|||
126148770|NCT02371629|453830434|FG001|Overall Study|Noncompliance with study treatment|0|||
126148771|NCT02371629|453830433|FG000|Overall Study|Lack of Efficacy|0|||
126148772|NCT02371629|453830434|FG001|Overall Study|Lack of Efficacy|2|||
126148773|NCT02371629|453830433|FG000|Overall Study|Protocol deviation|0|||
126148774|NCT02371629|453830434|FG001|Overall Study|Protocol deviation|1|||
126148775|NCT00805207|453830435|FG000|Overall Study|Protocol Violation|0|||
126148776|NCT00805207|453830436|FG001|Overall Study|Protocol Violation|0|||
126148777|NCT00805207|453830437|FG002|Overall Study|Protocol Violation|1|||
126148778|NCT00805207|453830438|FG003|Overall Study|Protocol Violation|0|||
126148779|NCT00805207|453830439|FG004|Overall Study|Protocol Violation|0|||
126148780|NCT00805207|453830440|FG005|Overall Study|Protocol Violation|0|||
126148781|NCT00805207|453830441|FG006|Overall Study|Protocol Violation|0|||
126148782|NCT00805207|453830442|FG007|Overall Study|Protocol Violation|0|||
126148783|NCT00805207|453830443|FG008|Overall Study|Protocol Violation|0|||
126148784|NCT00805207|453830435|FG000|Overall Study|Physician Decision|0|||
126148785|NCT00805207|453830436|FG001|Overall Study|Physician Decision|1|||
126148786|NCT00805207|453830437|FG002|Overall Study|Physician Decision|0|||
126148787|NCT00805207|453830438|FG003|Overall Study|Physician Decision|0|||
126148788|NCT00805207|453830439|FG004|Overall Study|Physician Decision|0|||
126148789|NCT00805207|453830440|FG005|Overall Study|Physician Decision|1|||
126148790|NCT00805207|453830441|FG006|Overall Study|Physician Decision|0|||
126148791|NCT00805207|453830442|FG007|Overall Study|Physician Decision|0|||
126148792|NCT00805207|453830443|FG008|Overall Study|Physician Decision|0|||
126148793|NCT00805207|453830435|FG000|Overall Study|Withdrawal by Subject|0|||
126148794|NCT00805207|453830436|FG001|Overall Study|Withdrawal by Subject|1|||
126148795|NCT00805207|453830437|FG002|Overall Study|Withdrawal by Subject|0|||
126148796|NCT00805207|453830438|FG003|Overall Study|Withdrawal by Subject|0|||
126148797|NCT00805207|453830439|FG004|Overall Study|Withdrawal by Subject|1|||
126148798|NCT00805207|453830440|FG005|Overall Study|Withdrawal by Subject|2|||
126148799|NCT00805207|453830441|FG006|Overall Study|Withdrawal by Subject|0|||
126148800|NCT00805207|453830442|FG007|Overall Study|Withdrawal by Subject|0|||
126148801|NCT00805207|453830443|FG008|Overall Study|Withdrawal by Subject|0|||
126148802|NCT02469246|453830444|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
126148803|NCT02469246|453830445|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
126148804|NCT02469246|453830444|FG000|Double-Blind Phase|Adverse Event|12|||
126148805|NCT02469246|453830445|FG001|Double-Blind Phase|Adverse Event|9|||
126148806|NCT02469246|453830444|FG000|Double-Blind Phase|Death|2|||
126148807|NCT02469246|453830445|FG001|Double-Blind Phase|Death|0|||
126148808|NCT02469246|453830444|FG000|Double-Blind Phase|Lack of Efficacy|2|||
126148809|NCT02469246|453830445|FG001|Double-Blind Phase|Lack of Efficacy|1|||
126148810|NCT02469246|453830444|FG000|Double-Blind Phase|Investigator's Discretion|8|||
126148811|NCT02469246|453830445|FG001|Double-Blind Phase|Investigator's Discretion|8|||
126148812|NCT02469246|453830444|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
126148813|NCT02469246|453830445|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
126148814|NCT02469246|453830444|FG000|Double-Blind Phase|Protocol Violation|1|||
126148815|NCT02469246|453830445|FG001|Double-Blind Phase|Protocol Violation|1|||
126148816|NCT02469246|453830444|FG000|Double-Blind Phase|Withdrew Consent|25|||
126148817|NCT02469246|453830445|FG001|Double-Blind Phase|Withdrew Consent|25|||
126148818|NCT02469246|453830444|FG000|Double-Blind Phase|Lost to Follow-up|9|||
126148819|NCT02469246|453830445|FG001|Double-Blind Phase|Lost to Follow-up|5|||
126148820|NCT05681715|453830449|FG000|Training Period (6-weeks)|Adverse Event|3|||
126148821|NCT05681715|453830450|FG001|Training Period (6-weeks)|Adverse Event|0|||
126148822|NCT05681715|453830451|FG002|Training Period (6-weeks)|Adverse Event|0|||
126148823|NCT05681715|453830449|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
126148824|NCT05681715|453830450|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
126148825|NCT05681715|453830451|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
126148826|NCT05681715|453830449|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
126148827|NCT05681715|453830450|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
126148828|NCT05681715|453830451|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
126148829|NCT05681715|453830449|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
126148830|NCT05681715|453830450|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
126148831|NCT05681715|453830451|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
126148832|NCT05681715|453830449|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
126148833|NCT05681715|453830450|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
126148834|NCT05681715|453830451|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
126148835|NCT05681715|453830449|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
126148836|NCT05681715|453830450|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
126148837|NCT05681715|453830451|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
126148838|NCT05681715|453830449|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
126148839|NCT05681715|453830450|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
126148840|NCT05681715|453830451|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
126148841|NCT05681715|453830449|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
126148842|NCT05681715|453830450|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
126148843|NCT05681715|453830451|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
126148844|NCT05564052|453830452|FG000|Overall Study|Withdrawal by Subject|0|||
126148845|NCT05564052|453830453|FG001|Overall Study|Withdrawal by Subject|0|||
126148846|NCT05564052|453830454|FG002|Overall Study|Withdrawal by Subject|0|||
126148847|NCT05564052|453830455|FG003|Overall Study|Withdrawal by Subject|1|||
126148848|NCT05564052|453830452|FG000|Overall Study|Ongoing|8|||
126148849|NCT05564052|453830453|FG001|Overall Study|Ongoing|5|||
126148850|NCT05564052|453830454|FG002|Overall Study|Ongoing|4|||
126148851|NCT05564052|453830455|FG003|Overall Study|Ongoing|1|||
126148852|NCT04325503|453830469|FG000|Overall Study|Withdrawal by Subject|1|||
126148853|NCT04325503|453830469|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
126148854|NCT03832387|453830470|FG000|Overall Study|Protocol Violation|2|||
126148855|NCT03832387|453830471|FG001|Overall Study|Protocol Violation|6|||
126148856|NCT03832387|453830470|FG000|Overall Study|EXCLUSION CRITERIA|3|||
126148857|NCT03832387|453830471|FG001|Overall Study|EXCLUSION CRITERIA|1|||
126148858|NCT01856114|453830472|FG000|Overall Study|Withdrawal by Subject|1|||
126148859|NCT01856114|453830473|FG001|Overall Study|Withdrawal by Subject|0|||
126148860|NCT01856114|453830472|FG000|Overall Study|Adverse Event|1|||
126148861|NCT01856114|453830473|FG001|Overall Study|Adverse Event|0|||
126148862|NCT00144170|453830474|FG000|Overall Study|Adverse Event|84|||
126148863|NCT00144170|453830475|FG001|Overall Study|Adverse Event|41|||
126148864|NCT00144170|453830474|FG000|Overall Study|Protocol Violation|23|||
126148865|NCT00144170|453830475|FG001|Overall Study|Protocol Violation|16|||
126148866|NCT00144170|453830474|FG000|Overall Study|Lost to Follow-up|5|||
126148867|NCT00144170|453830475|FG001|Overall Study|Lost to Follow-up|10|||
126148868|NCT00144170|453830474|FG000|Overall Study|Withdrawal by Subject|29|||
126148869|NCT00144170|453830475|FG001|Overall Study|Withdrawal by Subject|13|||
126148870|NCT00144170|453830474|FG000|Overall Study|Other reason not defined above|211|||
126148871|NCT00144170|453830475|FG001|Overall Study|Other reason not defined above|316|||
126148872|NCT00981526|453830476|FG000|Overall Study|Withdrawal by Subject|0|||
126148873|NCT00981526|453830477|FG001|Overall Study|Withdrawal by Subject|2|||
126148874|NCT00981526|453830476|FG000|Overall Study|Physician Decision|4|||
126148875|NCT00981526|453830477|FG001|Overall Study|Physician Decision|4|||
126148876|NCT01564784|453830478|FG000|Overall Study|Other|1|||
126148877|NCT01564784|453830479|FG001|Overall Study|Other|0|||
126148878|NCT01564784|453830478|FG000|Overall Study|Subject refused further follow-up|1|||
126148879|NCT01564784|453830479|FG001|Overall Study|Subject refused further follow-up|6|||
126148880|NCT01564784|453830478|FG000|Overall Study|Lost to Follow-up|1|||
126148881|NCT01564784|453830479|FG001|Overall Study|Lost to Follow-up|1|||
126148882|NCT01564784|453830478|FG000|Overall Study|Death|131|||
126148883|NCT01564784|453830479|FG001|Overall Study|Death|126|||
126148884|NCT04238819|453830480|FG000|Overall Study|Ongoing Treatment|0|||
126148885|NCT04238819|453830481|FG001|Overall Study|Ongoing Treatment|0|||
126148886|NCT04238819|453830482|FG002|Overall Study|Ongoing Treatment|0|||
126148887|NCT04238819|453830483|FG003|Overall Study|Ongoing Treatment|0|||
126148888|NCT04238819|453830484|FG004|Overall Study|Ongoing Treatment|1|||
126148889|NCT04238819|453830485|FG005|Overall Study|Ongoing Treatment|4|||
126148890|NCT04238819|453830486|FG006|Overall Study|Ongoing Treatment|0|||
126148891|NCT04238819|453830480|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
126148892|NCT04238819|453830481|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
126148893|NCT04238819|453830482|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
126148894|NCT04238819|453830483|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
126148895|NCT04238819|453830484|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
126148896|NCT04238819|453830485|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
126148897|NCT04238819|453830486|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
126148898|NCT00045032|453830489|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
126148899|NCT00045032|453830490|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
126148900|NCT00045032|453830491|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
126148901|NCT00045032|453830489|FG000|Overall Study|Death|22|||
126148902|NCT00045032|453830490|FG001|Overall Study|Death|24|||
126148903|NCT00045032|453830491|FG002|Overall Study|Death|17|||
126148904|NCT00045032|453830489|FG000|Overall Study|Insufficient Therapeutic Response|542|||
126148905|NCT00045032|453830490|FG001|Overall Study|Insufficient Therapeutic Response|437|||
126148906|NCT00045032|453830491|FG002|Overall Study|Insufficient Therapeutic Response|445|||
126148907|NCT00045032|453830489|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
126148908|NCT00045032|453830490|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
126148909|NCT00045032|453830491|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
126148910|NCT00045032|453830489|FG000|Overall Study|Other Protocol Violation|2|||
126148911|NCT00045032|453830490|FG001|Overall Study|Other Protocol Violation|0|||
126148912|NCT00045032|453830491|FG002|Overall Study|Other Protocol Violation|1|||
126148913|NCT00045032|453830489|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
126148914|NCT00045032|453830490|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
126148915|NCT00045032|453830491|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
126148916|NCT00045032|453830489|FG000|Overall Study|Failure to Return|57|||
126148917|NCT00045032|453830490|FG001|Overall Study|Failure to Return|62|||
126148918|NCT00045032|453830491|FG002|Overall Study|Failure to Return|61|||
126148919|NCT00045032|453830489|FG000|Overall Study|Other|93|||
126148920|NCT00045032|453830490|FG001|Overall Study|Other|84|||
126148921|NCT00045032|453830491|FG002|Overall Study|Other|105|||
126148922|NCT02581995|453830499|FG000|Overall Study|Unspecified other|3|||
126148923|NCT02581995|453830499|FG000|Overall Study|Adverse Event|6|||
126148924|NCT02581995|453830499|FG000|Overall Study|Lost to Follow-up|5|||
126148925|NCT02581995|453830499|FG000|Overall Study|Withdrawal by participant|12|||
126148926|NCT02581995|453830499|FG000|Overall Study|Physician Decision|1|||
126148927|NCT02581995|453830499|FG000|Overall Study|Death|4|||
126148928|NCT01122927|453831820|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
126148929|NCT01122927|453831821|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
126148930|NCT01122927|453831820|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
126148931|NCT01122927|453831821|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
126148932|NCT01122927|453831820|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
126148933|NCT01122927|453831821|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
126148934|NCT01122927|453831820|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
126148935|NCT01122927|453831821|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
126148936|NCT01122927|453831820|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
126148937|NCT01122927|453831821|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
126148938|NCT01122927|453831820|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
126148939|NCT01122927|453831821|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
126148940|NCT01122927|453831820|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
126148941|NCT01122927|453831821|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
126148942|NCT01122927|453831820|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
126148943|NCT01122927|453831821|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
126148944|NCT01122927|453831820|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
126148945|NCT01122927|453831821|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
126148946|NCT01122927|453831820|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
126148947|NCT01122927|453831821|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
126148948|NCT01122927|453831820|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
126148949|NCT01122927|453831821|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
126148950|NCT01122927|453831820|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
126148951|NCT01122927|453831821|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
126148952|NCT02286102|453831824|FG000|Overall Study|Screen Failure|1|||
126148953|NCT02286102|453831825|FG001|Overall Study|Screen Failure|1|||
126148954|NCT01440101|453831826|FG000|Overall Study|Adverse Event|2|||
126148955|NCT01440101|453831827|FG001|Overall Study|Adverse Event|0|||
126148956|NCT01440101|453831828|FG002|Overall Study|Adverse Event|0|||
126148957|NCT01440101|453831826|FG000|Overall Study|Withdrawal by Subject|0|||
126148958|NCT01440101|453831827|FG001|Overall Study|Withdrawal by Subject|3|||
126148959|NCT01440101|453831828|FG002|Overall Study|Withdrawal by Subject|1|||
126148960|NCT01440101|453831826|FG000|Overall Study|Other|0|||
126148961|NCT01440101|453831827|FG001|Overall Study|Other|1|||
126148962|NCT01440101|453831828|FG002|Overall Study|Other|0|||
126148963|NCT00201851|453831829|FG000|Overall Study|Lost to Follow-up|2|||
126148964|NCT00201851|453831830|FG001|Overall Study|Lost to Follow-up|1|||
126148965|NCT00201851|453831831|FG002|Overall Study|Lost to Follow-up|0|||
126148966|NCT00201851|453831829|FG000|Overall Study|Ineligible post enrollment|6|||
126148967|NCT00201851|453831830|FG001|Overall Study|Ineligible post enrollment|1|||
126148968|NCT00201851|453831831|FG002|Overall Study|Ineligible post enrollment|1|||
126148969|NCT00636818|453831832|FG000|Overall Study|Adverse Event|1|||
126148970|NCT00636818|453831832|FG000|Overall Study|Lost to Follow-up|2|||
126148971|NCT00636818|453831832|FG000|Overall Study|Entry Criteria Exclusion|3|||
126148972|NCT00636818|453831832|FG000|Overall Study|Protocol Violation|1|||
126148973|NCT00636818|453831832|FG000|Overall Study|Withdrawal by Subject|4|||
126148974|NCT00074958|453831833|FG000|Overall Study|Adverse Event|1|||
126148975|NCT01658514|453831837|FG000|Overall Study|Protocol Violation|1|||
126148976|NCT01658514|453831838|FG001|Overall Study|Protocol Violation|0|||
126148977|NCT01658514|453831839|FG002|Overall Study|Protocol Violation|2|||
126148978|NCT02853760|453831840|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
126148979|NCT02853760|453831841|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
126148980|NCT02853760|453831842|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
126148981|NCT02853760|453831843|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
126148982|NCT02853760|453831844|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
126148983|NCT02853760|453831845|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
126148984|NCT01642212|453831846|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
126148985|NCT01642212|453831847|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
126148986|NCT01642212|453831848|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
126148987|NCT01642212|453831849|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
126148988|NCT01642212|453831850|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
126148989|NCT01642212|453831846|FG000|Double-blind Treatment|Other|0|||
126148990|NCT01642212|453831847|FG001|Double-blind Treatment|Other|2|||
126148991|NCT01642212|453831848|FG002|Double-blind Treatment|Other|1|||
126148992|NCT01642212|453831849|FG003|Double-blind Treatment|Other|0|||
126148993|NCT01642212|453831850|FG004|Double-blind Treatment|Other|0|||
126148994|NCT01642212|453831846|FG000|Double-blind Treatment|Non-compliance|0|||
126148995|NCT01642212|453831847|FG001|Double-blind Treatment|Non-compliance|1|||
126148996|NCT01642212|453831848|FG002|Double-blind Treatment|Non-compliance|0|||
126148997|NCT01642212|453831849|FG003|Double-blind Treatment|Non-compliance|0|||
126148998|NCT01642212|453831850|FG004|Double-blind Treatment|Non-compliance|0|||
126148999|NCT01642212|453831846|FG000|Double-blind Treatment|Adverse Event|0|||
126149000|NCT01642212|453831847|FG001|Double-blind Treatment|Adverse Event|0|||
126149001|NCT01642212|453831848|FG002|Double-blind Treatment|Adverse Event|1|||
126149002|NCT01642212|453831849|FG003|Double-blind Treatment|Adverse Event|0|||
126149003|NCT01642212|453831850|FG004|Double-blind Treatment|Adverse Event|0|||
126149004|NCT01642212|453831846|FG000|Open-label Extension|Adverse Event|0|||
126149005|NCT01642212|453831847|FG001|Open-label Extension|Adverse Event|0|||
126149006|NCT01642212|453831848|FG002|Open-label Extension|Adverse Event|0|||
126149007|NCT01642212|453831849|FG003|Open-label Extension|Adverse Event|3|||
126149008|NCT01642212|453831850|FG004|Open-label Extension|Adverse Event|0|||
126149009|NCT01642212|453831846|FG000|Open-label Extension|Sponsor Decision|0|||
126149010|NCT01642212|453831847|FG001|Open-label Extension|Sponsor Decision|0|||
126149011|NCT01642212|453831848|FG002|Open-label Extension|Sponsor Decision|0|||
126149012|NCT01642212|453831849|FG003|Open-label Extension|Sponsor Decision|7|||
126149013|NCT01642212|453831850|FG004|Open-label Extension|Sponsor Decision|4|||
126149014|NCT01642212|453831846|FG000|Open-label Extension|Consent Withdrawn|0|||
126149015|NCT01642212|453831847|FG001|Open-label Extension|Consent Withdrawn|0|||
126149016|NCT01642212|453831848|FG002|Open-label Extension|Consent Withdrawn|0|||
126149017|NCT01642212|453831849|FG003|Open-label Extension|Consent Withdrawn|0|||
126149018|NCT01642212|453831850|FG004|Open-label Extension|Consent Withdrawn|2|||
126149019|NCT01642212|453831846|FG000|Open-label Extension|Lost to Follow-up|0|||
126149020|NCT01642212|453831847|FG001|Open-label Extension|Lost to Follow-up|0|||
126149021|NCT01642212|453831848|FG002|Open-label Extension|Lost to Follow-up|0|||
126149022|NCT01642212|453831849|FG003|Open-label Extension|Lost to Follow-up|0|||
126149023|NCT01642212|453831850|FG004|Open-label Extension|Lost to Follow-up|1|||
126149024|NCT01642212|453831846|FG000|Open-label Extension|Other|0|||
126149025|NCT01642212|453831847|FG001|Open-label Extension|Other|0|||
126149026|NCT01642212|453831848|FG002|Open-label Extension|Other|0|||
126149027|NCT01642212|453831849|FG003|Open-label Extension|Other|0|||
126149028|NCT01642212|453831850|FG004|Open-label Extension|Other|1|||
126149029|NCT01243268|453831851|FG000|Overall Study|Lost to Follow-up|4|||
126149030|NCT01243268|453831851|FG000|Overall Study|Protocol Violation|51|||
126149031|NCT01243268|453831851|FG000|Overall Study|Deviation with contract date|7|||
126149032|NCT01243268|453831851|FG000|Overall Study|Duplicate subject|2|||
126149033|NCT00957853|453831852|FG000|Overall Study|Withdrawal by Subject|1|||
126149034|NCT00957853|453831853|FG001|Overall Study|Withdrawal by Subject|0|||
126149035|NCT00957853|453831854|FG002|Overall Study|Withdrawal by Subject|0|||
126149036|NCT00004980|453831855|FG000|Overall Study|Withdrawal by Subject|1|||
126149037|NCT00004980|453831856|FG001|Overall Study|Withdrawal by Subject|0|||
126149038|NCT00004980|453831855|FG000|Overall Study|memory difficulties|1|||
126149039|NCT00004980|453831856|FG001|Overall Study|memory difficulties|1|||
126149040|NCT00004980|453831855|FG000|Overall Study|Physician Decision|0|||
126149041|NCT00004980|453831856|FG001|Overall Study|Physician Decision|1|||
126149042|NCT00702143|453831857|FG000|Overall Study|Lost to Follow-up|0|||
126149043|NCT00702143|453831858|FG001|Overall Study|Lost to Follow-up|0|||
126149044|NCT00702143|453831859|FG002|Overall Study|Lost to Follow-up|1|||
126149045|NCT01822561|453831866|FG000|Overall Study|Withdrawal by Subject|2|||
126149046|NCT04826900|453831867|FG000|Overall Study|Family factor|1|||
126149047|NCT04826900|453831868|FG001|Overall Study|Family factor|1|||
126149048|NCT03372941|453831869|FG000|Overall Study|Lost to Follow-up|2|||
126149049|NCT03372941|453831870|FG001|Overall Study|Lost to Follow-up|4|||
126149050|NCT00741819|453831871|FG000|Overall Study|Adverse Event|3|||
126149051|NCT00741819|453831871|FG000|Overall Study|Withdrawal by Subject|3|||
126149052|NCT00741819|453831871|FG000|Overall Study|Death|1|||
126149053|NCT00741819|453831871|FG000|Overall Study|Disease progression|1|||
126149054|NCT01126580|453831872|FG000|Overall Study|Adverse Event|14|||
126149055|NCT01126580|453831873|FG001|Overall Study|Adverse Event|8|||
126149056|NCT01126580|453831874|FG002|Overall Study|Adverse Event|12|||
126149057|NCT01126580|453831872|FG000|Overall Study|Withdrawal by Subject|11|||
126149058|NCT01126580|453831873|FG001|Overall Study|Withdrawal by Subject|19|||
126149059|NCT01126580|453831874|FG002|Overall Study|Withdrawal by Subject|14|||
126149060|NCT01126580|453831872|FG000|Overall Study|Sponsor Decision|5|||
126149061|NCT01126580|453831873|FG001|Overall Study|Sponsor Decision|4|||
126149062|NCT01126580|453831874|FG002|Overall Study|Sponsor Decision|7|||
126149063|NCT01126580|453831872|FG000|Overall Study|Physician Decision|1|||
126149064|NCT01126580|453831873|FG001|Overall Study|Physician Decision|1|||
126149065|NCT01126580|453831874|FG002|Overall Study|Physician Decision|2|||
126149066|NCT01126580|453831872|FG000|Overall Study|Entry Criteria Not Met|1|||
126149067|NCT01126580|453831873|FG001|Overall Study|Entry Criteria Not Met|1|||
126149068|NCT01126580|453831874|FG002|Overall Study|Entry Criteria Not Met|2|||
126149069|NCT01126580|453831872|FG000|Overall Study|Lack of Efficacy|2|||
126149070|NCT01126580|453831873|FG001|Overall Study|Lack of Efficacy|3|||
126149071|NCT01126580|453831874|FG002|Overall Study|Lack of Efficacy|4|||
126149072|NCT01126580|453831872|FG000|Overall Study|Protocol Violation|0|||
126149073|NCT01126580|453831873|FG001|Overall Study|Protocol Violation|1|||
126149074|NCT01126580|453831874|FG002|Overall Study|Protocol Violation|2|||
126149075|NCT01126580|453831872|FG000|Overall Study|Lost to Follow-up|15|||
126149076|NCT01126580|453831873|FG001|Overall Study|Lost to Follow-up|13|||
126149077|NCT01126580|453831874|FG002|Overall Study|Lost to Follow-up|9|||
126149078|NCT01126580|453831872|FG000|Overall Study|Treatment Non-compliance|0|||
126149079|NCT01126580|453831873|FG001|Overall Study|Treatment Non-compliance|2|||
126149080|NCT01126580|453831874|FG002|Overall Study|Treatment Non-compliance|3|||
126149081|NCT00609622|453831875|FG000|Overall Study|Adverse Event|14|||
126149082|NCT00609622|453831876|FG001|Overall Study|Adverse Event|10|||
126149083|NCT00609622|453831875|FG000|Overall Study|Withdrawal by Subject|4|||
126149084|NCT00609622|453831876|FG001|Overall Study|Withdrawal by Subject|20|||
126149085|NCT00609622|453831875|FG000|Overall Study|Death|1|||
126149086|NCT00609622|453831876|FG001|Overall Study|Death|4|||
126149087|NCT00609622|453831875|FG000|Overall Study|Protocol Violation|1|||
126149088|NCT00609622|453831876|FG001|Overall Study|Protocol Violation|1|||
126149089|NCT00609622|453831875|FG000|Overall Study|Objective progression or relapse|47|||
126149090|NCT00609622|453831876|FG001|Overall Study|Objective progression or relapse|41|||
126149091|NCT00609622|453831875|FG000|Overall Study|Study terminated by sponsor|16|||
126149092|NCT00609622|453831876|FG001|Overall Study|Study terminated by sponsor|3|||
126149093|NCT00609622|453831875|FG000|Overall Study|Other|7|||
126149094|NCT00609622|453831876|FG001|Overall Study|Other|14|||
126149095|NCT00609622|453831875|FG000|Overall Study|Global deterioration of health status|6|||
126149096|NCT00609622|453831876|FG001|Overall Study|Global deterioration of health status|2|||
126149097|NCT00686543|453831877|FG000|Overall Study|Adverse Event|9|||
126149098|NCT00686543|453831878|FG001|Overall Study|Adverse Event|1|||
126149099|NCT00686543|453831879|FG002|Overall Study|Adverse Event|3|||
126149100|NCT00686543|453831880|FG003|Overall Study|Adverse Event|2|||
126149101|NCT00686543|453831877|FG000|Overall Study|Withdrawal by Subject|2|||
126149102|NCT00686543|453831878|FG001|Overall Study|Withdrawal by Subject|0|||
126149103|NCT00686543|453831879|FG002|Overall Study|Withdrawal by Subject|0|||
126149104|NCT00686543|453831880|FG003|Overall Study|Withdrawal by Subject|0|||
126149105|NCT00686543|453831877|FG000|Overall Study|Protocol Violation|3|||
126149106|NCT00686543|453831878|FG001|Overall Study|Protocol Violation|0|||
126149107|NCT00686543|453831879|FG002|Overall Study|Protocol Violation|2|||
126149108|NCT00686543|453831880|FG003|Overall Study|Protocol Violation|1|||
126149109|NCT01708057|453831884|FG000|Overall Study|Withdrawal due to study termination.|1|||
126149110|NCT01708057|453831885|FG001|Overall Study|Withdrawal due to study termination.|1|||
126149111|NCT01708057|453831886|FG002|Overall Study|Withdrawal due to study termination.|1|||
126149112|NCT00947349|453831889|FG000|Triple Treatment Combination Period|Adverse Event|0|||
126149113|NCT00947349|453831890|FG001|Triple Treatment Combination Period|Adverse Event|1|||
126149114|NCT00947349|453831891|FG002|Triple Treatment Combination Period|Adverse Event|0|||
126149115|NCT00947349|453831892|FG003|Triple Treatment Combination Period|Adverse Event|0|||
126149116|NCT00947349|453831889|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
126149117|NCT00947349|453831890|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
126149118|NCT00947349|453831891|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
126149119|NCT00947349|453831892|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
126149120|NCT00947349|453831889|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
126149121|NCT00947349|453831890|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
126149122|NCT00947349|453831891|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
126149123|NCT00947349|453831892|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
126149124|NCT00947349|453831889|FG000|Overall Study Standard of Care|Other|0|||
126149125|NCT00947349|453831890|FG001|Overall Study Standard of Care|Other|0|||
126149126|NCT00947349|453831891|FG002|Overall Study Standard of Care|Other|0|||
126149127|NCT00947349|453831892|FG003|Overall Study Standard of Care|Other|1|||
126149128|NCT00538681|453831893|FG000|Overall Study|Progressive Disease|7|||
126149129|NCT00538681|453831894|FG001|Overall Study|Progressive Disease|0|||
126149130|NCT00538681|453831895|FG002|Overall Study|Progressive Disease|1|||
126149131|NCT00538681|453831896|FG003|Overall Study|Progressive Disease|0|||
126149132|NCT00538681|453831893|FG000|Overall Study|Sponsor Decision|1|||
126149133|NCT00538681|453831894|FG001|Overall Study|Sponsor Decision|3|||
126149134|NCT00538681|453831895|FG002|Overall Study|Sponsor Decision|8|||
126149135|NCT00538681|453831896|FG003|Overall Study|Sponsor Decision|9|||
126149136|NCT00538681|453831893|FG000|Overall Study|Adverse Event|1|||
126149137|NCT00538681|453831894|FG001|Overall Study|Adverse Event|1|||
126149138|NCT00538681|453831895|FG002|Overall Study|Adverse Event|1|||
126149139|NCT00538681|453831896|FG003|Overall Study|Adverse Event|0|||
126149140|NCT00538681|453831893|FG000|Overall Study|Death|0|||
126149141|NCT00538681|453831894|FG001|Overall Study|Death|0|||
126149142|NCT00538681|453831895|FG002|Overall Study|Death|1|||
126149143|NCT00538681|453831896|FG003|Overall Study|Death|1|||
126149144|NCT00538681|453831893|FG000|Overall Study|Investigator Decision|0|||
126149145|NCT00538681|453831894|FG001|Overall Study|Investigator Decision|0|||
126149146|NCT00538681|453831895|FG002|Overall Study|Investigator Decision|0|||
126149147|NCT00538681|453831896|FG003|Overall Study|Investigator Decision|1|||
126149148|NCT02970929|453831897|FG000|Overall Study|Adverse Event|18|||
126149149|NCT02970929|453831897|FG000|Overall Study|Lack of Efficacy|8|||
126149150|NCT02970929|453831897|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
126149151|NCT02970929|453831897|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
126149152|NCT02970929|453831897|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
126149153|NCT02970929|453831897|FG000|Overall Study|LOST TO FOLLOWUP|6|||
126149154|NCT02970929|453831897|FG000|Overall Study|MOVED OUT OF STATE|1|||
126149155|NCT02970929|453831897|FG000|Overall Study|Withdrawal by Subject|16|||
126149156|NCT03929250|453831906|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
126149157|NCT03929250|453831907|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
126149158|NCT04321343|453831912|FG000|Overall Study|Adverse Event|0|||
126149159|NCT04321343|453831913|FG001|Overall Study|Adverse Event|0|||
126149160|NCT04321343|453831914|FG002|Overall Study|Adverse Event|1|||
126149161|NCT04321343|453831915|FG003|Overall Study|Adverse Event|0|||
126149162|NCT04321343|453831912|FG000|Overall Study|Death|0|||
126149163|NCT04321343|453831913|FG001|Overall Study|Death|0|||
126149164|NCT04321343|453831914|FG002|Overall Study|Death|0|||
126149165|NCT04321343|453831915|FG003|Overall Study|Death|1|||
126149166|NCT04321343|453831912|FG000|Overall Study|Pregnancy|1|||
126149167|NCT04321343|453831913|FG001|Overall Study|Pregnancy|0|||
126149168|NCT04321343|453831914|FG002|Overall Study|Pregnancy|0|||
126149169|NCT04321343|453831915|FG003|Overall Study|Pregnancy|0|||
126149170|NCT04321343|453831912|FG000|Overall Study|Protocol Violation|1|||
126149171|NCT04321343|453831913|FG001|Overall Study|Protocol Violation|1|||
126149172|NCT04321343|453831914|FG002|Overall Study|Protocol Violation|1|||
126149173|NCT04321343|453831915|FG003|Overall Study|Protocol Violation|1|||
126149174|NCT04321343|453831912|FG000|Overall Study|Withdrawal by Subject|0|||
126149175|NCT04321343|453831913|FG001|Overall Study|Withdrawal by Subject|6|||
126149176|NCT04321343|453831914|FG002|Overall Study|Withdrawal by Subject|0|||
126149177|NCT04321343|453831915|FG003|Overall Study|Withdrawal by Subject|2|||
126149178|NCT04321343|453831912|FG000|Overall Study|Lost to Follow-up|2|||
126149179|NCT04321343|453831913|FG001|Overall Study|Lost to Follow-up|2|||
126149180|NCT04321343|453831914|FG002|Overall Study|Lost to Follow-up|1|||
126149181|NCT04321343|453831915|FG003|Overall Study|Lost to Follow-up|3|||
126149182|NCT04194944|453831916|FG000|Overall Study|Lost to Follow-up|3|||
126149183|NCT04194944|453831917|FG001|Overall Study|Lost to Follow-up|0|||
126149184|NCT04194944|453831916|FG000|Overall Study|Withdrawal by Subject|2|||
126149185|NCT04194944|453831917|FG001|Overall Study|Withdrawal by Subject|2|||
126149186|NCT04194944|453831916|FG000|Overall Study|On Treatment|93|||
126149187|NCT04194944|453831917|FG001|Overall Study|On Treatment|30|||
126149188|NCT03277196|453831929|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
126149189|NCT03277196|453831929|FG000|Overall Study|Lost to Follow-up|3|||
126149190|NCT03277196|453831929|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
126149191|NCT03277196|453831929|FG000|Overall Study|Other|2|||
126149192|NCT05224258|453832981|FG000|Overall Study|Withdrawal by Subject|1|||
126149193|NCT05224258|453832982|FG001|Overall Study|Withdrawal by Subject|1|||
126149194|NCT05224258|453832981|FG000|Overall Study|Physician Decision|1|||
126149195|NCT05224258|453832982|FG001|Overall Study|Physician Decision|1|||
126149196|NCT05224258|453832981|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126149197|NCT05224258|453832982|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126149198|NCT05224258|453832981|FG000|Overall Study|Study Product No Longer in Use|1|||
126149199|NCT05224258|453832982|FG001|Overall Study|Study Product No Longer in Use|0|||
126149200|NCT05224258|453832981|FG000|Overall Study|Adverse Event|0|||
126149201|NCT05224258|453832982|FG001|Overall Study|Adverse Event|1|||
126149202|NCT05224258|453832981|FG000|Overall Study|Protocol Deviation|0|||
126149203|NCT05224258|453832982|FG001|Overall Study|Protocol Deviation|1|||
126149204|NCT00684814|453832992|FG000|Washout Period of 7 Days|Adverse Event|1|||
126149205|NCT00684814|453832993|FG001|Washout Period of 7 Days|Adverse Event|2|||
126149206|NCT00684814|453832992|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
126149207|NCT00684814|453832993|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
126149208|NCT00684814|453832992|FG000|Second Intervention|Adverse Event|1|||
126149209|NCT00684814|453832993|FG001|Second Intervention|Adverse Event|0|||
126149210|NCT01676961|453832994|FG000|Overall Study|Death|3|||
126149211|NCT01676961|453832994|FG000|Overall Study|Lost to Follow-up|1|||
126149212|NCT01676961|453832994|FG000|Overall Study|Withdrawal by Subject|1|||
126149213|NCT00117312|453832995|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
126149214|NCT00117312|453832996|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
126149215|NCT00117312|453832997|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
126149216|NCT00117312|453832998|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
126149217|NCT00117312|453832995|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
126149218|NCT00117312|453832996|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
126149219|NCT00117312|453832997|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
126149220|NCT00117312|453832998|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
126149221|NCT00117312|453832995|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
126149222|NCT00117312|453832996|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
126149223|NCT00117312|453832997|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
126149224|NCT00117312|453832998|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
126149225|NCT00117312|453832995|FG000|Overall Study|Other|0|||
126149226|NCT00117312|453832996|FG001|Overall Study|Other|1|||
126149227|NCT00117312|453832997|FG002|Overall Study|Other|3|||
126149228|NCT00117312|453832998|FG003|Overall Study|Other|1|||
126149229|NCT00117312|453832995|FG000|Overall Study|Patient choice|0|||
126149230|NCT00117312|453832996|FG001|Overall Study|Patient choice|0|||
126149231|NCT00117312|453832997|FG002|Overall Study|Patient choice|2|||
126149232|NCT00117312|453832998|FG003|Overall Study|Patient choice|1|||
126149233|NCT00117312|453832995|FG000|Overall Study|Adverse Event|0|||
126149234|NCT00117312|453832996|FG001|Overall Study|Adverse Event|2|||
126149235|NCT00117312|453832997|FG002|Overall Study|Adverse Event|0|||
126149236|NCT00117312|453832998|FG003|Overall Study|Adverse Event|0|||
126149237|NCT00117312|453832995|FG000|Overall Study|Protocol Violation|0|||
126149238|NCT00117312|453832996|FG001|Overall Study|Protocol Violation|1|||
126149239|NCT00117312|453832997|FG002|Overall Study|Protocol Violation|3|||
126149240|NCT00117312|453832998|FG003|Overall Study|Protocol Violation|0|||
126149241|NCT00117312|453832995|FG000|Overall Study|PSA decrease <=50%|0|||
126149242|NCT00117312|453832996|FG001|Overall Study|PSA decrease <=50%|2|||
126149243|NCT00117312|453832997|FG002|Overall Study|PSA decrease <=50%|2|||
126149244|NCT00117312|453832998|FG003|Overall Study|PSA decrease <=50%|4|||
126149245|NCT00117312|453832995|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
126149246|NCT00117312|453832996|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
126149247|NCT00117312|453832997|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
126149248|NCT00117312|453832998|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
126149249|NCT00117312|453832995|FG000|Overall Study|Hepatic abnormality|0|||
126149250|NCT00117312|453832996|FG001|Overall Study|Hepatic abnormality|1|||
126149251|NCT00117312|453832997|FG002|Overall Study|Hepatic abnormality|0|||
126149252|NCT00117312|453832998|FG003|Overall Study|Hepatic abnormality|1|||
126149253|NCT00117312|453832995|FG000|Overall Study|Withdrawal by Subject|0|||
126149254|NCT00117312|453832996|FG001|Overall Study|Withdrawal by Subject|2|||
126149255|NCT00117312|453832997|FG002|Overall Study|Withdrawal by Subject|0|||
126149256|NCT00117312|453832998|FG003|Overall Study|Withdrawal by Subject|0|||
126149257|NCT00195650|453832999|FG000|Overall Study|Adverse Event|194|||
126149258|NCT00195650|453832999|FG000|Overall Study|Lack of Efficacy|99|||
126149259|NCT00195650|453832999|FG000|Overall Study|Withdrawal by Subject|67|||
126149260|NCT00195650|453832999|FG000|Overall Study|Lost to Follow-up|44|||
126149261|NCT00195650|453832999|FG000|Overall Study|Death|23|||
126149262|NCT00195650|453832999|FG000|Overall Study|Protocol Violation|15|||
126149263|NCT00195650|453832999|FG000|Overall Study|Administrative reasons|83|||
126149264|NCT03375320|453833000|FG000|Overall Study|Adverse Event|34|||
126149265|NCT03375320|453833001|FG001|Overall Study|Adverse Event|9|||
126149266|NCT03375320|453833002|FG002|Overall Study|Adverse Event|10|||
126149267|NCT03375320|453833003|FG003|Overall Study|Adverse Event|0|||
126149268|NCT03375320|453833000|FG000|Overall Study|Death|6|||
126149269|NCT03375320|453833001|FG001|Overall Study|Death|3|||
126149270|NCT03375320|453833002|FG002|Overall Study|Death|0|||
126149271|NCT03375320|453833003|FG003|Overall Study|Death|0|||
126149272|NCT03375320|453833000|FG000|Overall Study|Withdrawal by Subject|7|||
126149273|NCT03375320|453833001|FG001|Overall Study|Withdrawal by Subject|4|||
126149274|NCT03375320|453833002|FG002|Overall Study|Withdrawal by Subject|5|||
126149275|NCT03375320|453833003|FG003|Overall Study|Withdrawal by Subject|4|||
126149276|NCT03375320|453833000|FG000|Overall Study|Progressive disease|55|||
126149277|NCT03375320|453833001|FG001|Overall Study|Progressive disease|41|||
126149278|NCT03375320|453833002|FG002|Overall Study|Progressive disease|29|||
126149279|NCT03375320|453833003|FG003|Overall Study|Progressive disease|24|||
126149280|NCT03375320|453833000|FG000|Overall Study|Alternative treatment|6|||
126149281|NCT03375320|453833001|FG001|Overall Study|Alternative treatment|1|||
126149282|NCT03375320|453833002|FG002|Overall Study|Alternative treatment|1|||
126149283|NCT03375320|453833003|FG003|Overall Study|Alternative treatment|0|||
126149284|NCT03375320|453833000|FG000|Overall Study|Other disease|1|||
126149285|NCT03375320|453833001|FG001|Overall Study|Other disease|1|||
126149286|NCT03375320|453833002|FG002|Overall Study|Other disease|3|||
126149287|NCT03375320|453833003|FG003|Overall Study|Other disease|0|||
126149288|NCT03375320|453833000|FG000|Overall Study|Withdrawal prior to initiation|2|||
126149289|NCT03375320|453833001|FG001|Overall Study|Withdrawal prior to initiation|2|||
126149290|NCT03375320|453833002|FG002|Overall Study|Withdrawal prior to initiation|1|||
126149291|NCT03375320|453833003|FG003|Overall Study|Withdrawal prior to initiation|0|||
126149292|NCT03375320|453833000|FG000|Overall Study|Physician Decision|1|||
126149293|NCT03375320|453833001|FG001|Overall Study|Physician Decision|1|||
126149294|NCT03375320|453833002|FG002|Overall Study|Physician Decision|1|||
126149295|NCT03375320|453833003|FG003|Overall Study|Physician Decision|1|||
126149296|NCT03375320|453833000|FG000|Overall Study|Non-compliance|1|||
126149297|NCT03375320|453833001|FG001|Overall Study|Non-compliance|0|||
126149298|NCT03375320|453833002|FG002|Overall Study|Non-compliance|0|||
126149299|NCT03375320|453833003|FG003|Overall Study|Non-compliance|0|||
126149300|NCT01128387|453833004|FG000|Overall Study|Physician Decision|0|||
126149301|NCT01128387|453833005|FG001|Overall Study|Physician Decision|1|||
126149302|NCT02635204|453833006|FG000|Overall Study|Adverse Event|1|||
126149303|NCT02635204|453833007|FG001|Overall Study|Adverse Event|0|||
126149304|NCT02635204|453833006|FG000|Overall Study|Lost to Follow-up|1|||
126149305|NCT02635204|453833007|FG001|Overall Study|Lost to Follow-up|1|||
126149306|NCT00858832|453833009|FG000|Overall Study|became ineligible: delivered vaginally|1|||
126149307|NCT00858832|453833010|FG001|Overall Study|became ineligible: delivered vaginally|0|||
126149308|NCT00858832|453833009|FG000|Overall Study|Adverse Event|0|||
126149309|NCT00858832|453833010|FG001|Overall Study|Adverse Event|1|||
126149310|NCT01535235|453833011|FG000|Overall Study|Adverse Event|1|||
126149311|NCT01535235|453833012|FG001|Overall Study|Adverse Event|0|||
126149312|NCT00389207|453833013|FG000|Overall Study|Adverse Event|26|||
126149313|NCT00389207|453833014|FG001|Overall Study|Adverse Event|32|||
126149314|NCT00389207|453833015|FG002|Overall Study|Adverse Event|10|||
126149315|NCT00389207|453833013|FG000|Overall Study|Protocol Violation|3|||
126149316|NCT00389207|453833014|FG001|Overall Study|Protocol Violation|1|||
126149317|NCT00389207|453833015|FG002|Overall Study|Protocol Violation|4|||
126149318|NCT00389207|453833013|FG000|Overall Study|Lost to Follow-up|12|||
126149319|NCT00389207|453833014|FG001|Overall Study|Lost to Follow-up|9|||
126149320|NCT00389207|453833015|FG002|Overall Study|Lost to Follow-up|7|||
126149321|NCT00389207|453833013|FG000|Overall Study|Withdrawal by Subject|5|||
126149322|NCT00389207|453833014|FG001|Overall Study|Withdrawal by Subject|7|||
126149323|NCT00389207|453833015|FG002|Overall Study|Withdrawal by Subject|11|||
126149324|NCT00389207|453833013|FG000|Overall Study|Other|17|||
126149325|NCT00389207|453833014|FG001|Overall Study|Other|23|||
126149326|NCT00389207|453833015|FG002|Overall Study|Other|9|||
126149327|NCT01794780|453833024|FG000|Overall Study|Adverse Event|0|||
126149328|NCT01794780|453833025|FG001|Overall Study|Adverse Event|1|||
126149329|NCT01794780|453833026|FG002|Overall Study|Adverse Event|2|||
126149330|NCT01794780|453833027|FG003|Overall Study|Adverse Event|0|||
126149331|NCT01794780|453833028|FG004|Overall Study|Adverse Event|0|||
126149332|NCT01794780|453833029|FG005|Overall Study|Adverse Event|0|||
126149333|NCT01794780|453833030|FG006|Overall Study|Adverse Event|0|||
126149334|NCT01794780|453833031|FG007|Overall Study|Adverse Event|0|||
126149335|NCT01794780|453833024|FG000|Overall Study|Death|0|||
126149336|NCT01794780|453833025|FG001|Overall Study|Death|2|||
126149337|NCT01794780|453833026|FG002|Overall Study|Death|14|||
126149338|NCT01794780|453833027|FG003|Overall Study|Death|1|||
126149339|NCT01794780|453833028|FG004|Overall Study|Death|0|||
126149340|NCT01794780|453833029|FG005|Overall Study|Death|9|||
126149341|NCT01794780|453833030|FG006|Overall Study|Death|4|||
126149342|NCT01794780|453833031|FG007|Overall Study|Death|0|||
126149343|NCT01794780|453833024|FG000|Overall Study|Lost to Follow-up|10|||
126149344|NCT01794780|453833025|FG001|Overall Study|Lost to Follow-up|64|||
126149345|NCT01794780|453833026|FG002|Overall Study|Lost to Follow-up|165|||
126149346|NCT01794780|453833027|FG003|Overall Study|Lost to Follow-up|53|||
126149347|NCT01794780|453833028|FG004|Overall Study|Lost to Follow-up|2|||
126149348|NCT01794780|453833029|FG005|Overall Study|Lost to Follow-up|99|||
126149349|NCT01794780|453833030|FG006|Overall Study|Lost to Follow-up|30|||
126149350|NCT01794780|453833031|FG007|Overall Study|Lost to Follow-up|5|||
126149351|NCT01794780|453833024|FG000|Overall Study|Withdrew informed consent|7|||
126149352|NCT01794780|453833025|FG001|Overall Study|Withdrew informed consent|17|||
126149353|NCT01794780|453833026|FG002|Overall Study|Withdrew informed consent|36|||
126149354|NCT01794780|453833027|FG003|Overall Study|Withdrew informed consent|9|||
126149355|NCT01794780|453833028|FG004|Overall Study|Withdrew informed consent|0|||
126149356|NCT01794780|453833029|FG005|Overall Study|Withdrew informed consent|48|||
126149357|NCT01794780|453833030|FG006|Overall Study|Withdrew informed consent|4|||
126149358|NCT01794780|453833031|FG007|Overall Study|Withdrew informed consent|3|||
126149359|NCT01794780|453833024|FG000|Overall Study|Other|0|||
126149360|NCT01794780|453833025|FG001|Overall Study|Other|12|||
126149361|NCT01794780|453833026|FG002|Overall Study|Other|25|||
126149362|NCT01794780|453833027|FG003|Overall Study|Other|20|||
126149363|NCT01794780|453833028|FG004|Overall Study|Other|1|||
126149364|NCT01794780|453833029|FG005|Overall Study|Other|24|||
126149365|NCT01794780|453833030|FG006|Overall Study|Other|4|||
126149366|NCT01794780|453833031|FG007|Overall Study|Other|1|||
126149367|NCT02690701|453833035|FG000|Treatment Period 1|Adverse Event|2|||
126149368|NCT02690701|453833036|FG001|Treatment Period 1|Adverse Event|2|||
126149369|NCT02690701|453833035|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126149370|NCT02690701|453833036|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126149371|NCT02690701|453833035|FG000|Treatment Period 2|Adverse Event|2|||
126149372|NCT02690701|453833036|FG001|Treatment Period 2|Adverse Event|0|||
126149373|NCT02690701|453833035|FG000|Treatment Period 2|Lack of Efficacy|1|||
126149374|NCT02690701|453833036|FG001|Treatment Period 2|Lack of Efficacy|0|||
126149375|NCT02690701|453833035|FG000|Treatment Period 2|Lost to Follow-up|0|||
126149376|NCT02690701|453833036|FG001|Treatment Period 2|Lost to Follow-up|2|||
126149377|NCT02690701|453833035|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126149378|NCT02690701|453833036|FG001|Treatment Period 2|Withdrawal by Subject|2|||
126149379|NCT02690701|453833035|FG000|Treatment Period 2|Protocol Violation|0|||
126149380|NCT02690701|453833036|FG001|Treatment Period 2|Protocol Violation|1|||
126149381|NCT01442181|453833037|FG000|Overall Study|patient refused surgery|1|||
126149382|NCT01442181|453833038|FG001|Overall Study|patient refused surgery|0|||
126149383|NCT01442181|453833037|FG000|Overall Study|no insurance for surgery|1|||
126149384|NCT01442181|453833038|FG001|Overall Study|no insurance for surgery|0|||
126149385|NCT01442181|453833037|FG000|Overall Study|low ejection factor|0|||
126149386|NCT01442181|453833038|FG001|Overall Study|low ejection factor|1|||
126149387|NCT01442181|453833037|FG000|Overall Study|Lost to Follow-up|1|||
126149388|NCT01442181|453833038|FG001|Overall Study|Lost to Follow-up|1|||
126149389|NCT01442181|453833037|FG000|Overall Study|patient in an additional study|1|||
126149390|NCT01442181|453833038|FG001|Overall Study|patient in an additional study|0|||
126149391|NCT01442181|453833037|FG000|Overall Study|atrial fibrillation not noted|0|||
126149392|NCT01442181|453833038|FG001|Overall Study|atrial fibrillation not noted|1|||
126149393|NCT00749203|453833039|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
126149394|NCT00749203|453833040|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
126149395|NCT00749203|453833039|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
126149396|NCT00749203|453833040|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
126149397|NCT00749203|453833039|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
126149398|NCT00749203|453833040|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
126149399|NCT00749203|453833039|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
126149400|NCT00749203|453833040|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
126149401|NCT00749203|453833039|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
126149402|NCT00749203|453833040|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
126149403|NCT00749203|453833039|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
126149404|NCT00749203|453833040|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
126149405|NCT01299025|453833042|FG000|Overall Study|Withdrawal by Subject|2|||
126149406|NCT01299025|453833043|FG001|Overall Study|Withdrawal by Subject|1|||
126149407|NCT01299025|453833042|FG000|Overall Study|Lost to Follow-up|1|||
126149408|NCT01299025|453833043|FG001|Overall Study|Lost to Follow-up|0|||
126149409|NCT03577990|453833044|FG000|Overall Study|Lost to Follow-up|4|||
126149410|NCT03577990|453833045|FG001|Overall Study|Lost to Follow-up|6|||
126149411|NCT03577990|453833044|FG000|Overall Study|Withdrawal by Subject|4|||
126149412|NCT03577990|453833045|FG001|Overall Study|Withdrawal by Subject|7|||
126149413|NCT04996797|453833046|FG000|Overall Study|Adverse Event|0|||
126149414|NCT04996797|453833047|FG001|Overall Study|Adverse Event|2|||
126149415|NCT04996797|453833048|FG002|Overall Study|Adverse Event|0|||
126149416|NCT04996797|453833049|FG003|Overall Study|Adverse Event|1|||
126149417|NCT04996797|453833046|FG000|Overall Study|Lack of Efficacy|0|||
126149418|NCT04996797|453833047|FG001|Overall Study|Lack of Efficacy|2|||
126149419|NCT04996797|453833048|FG002|Overall Study|Lack of Efficacy|0|||
126149420|NCT04996797|453833049|FG003|Overall Study|Lack of Efficacy|0|||
126149421|NCT04996797|453833046|FG000|Overall Study|Prohibited Medication|0|||
126149422|NCT04996797|453833047|FG001|Overall Study|Prohibited Medication|1|||
126149423|NCT04996797|453833048|FG002|Overall Study|Prohibited Medication|0|||
126149424|NCT04996797|453833049|FG003|Overall Study|Prohibited Medication|0|||
126149425|NCT04996797|453833046|FG000|Overall Study|Ongoing|68|||
126149426|NCT04996797|453833047|FG001|Overall Study|Ongoing|60|||
126149427|NCT04996797|453833048|FG002|Overall Study|Ongoing|22|||
126149428|NCT04996797|453833049|FG003|Overall Study|Ongoing|20|||
126149429|NCT04996797|453833046|FG000|Overall Study|Withdrawal by Subject|0|||
126149430|NCT04996797|453833047|FG001|Overall Study|Withdrawal by Subject|2|||
126149431|NCT04996797|453833048|FG002|Overall Study|Withdrawal by Subject|0|||
126149432|NCT04996797|453833049|FG003|Overall Study|Withdrawal by Subject|0|||
126149433|NCT02793544|453833050|FG000|Overall Study|Death|10|||
126149434|NCT02793544|453833051|FG001|Overall Study|Death|8|||
126149435|NCT02793544|453833050|FG000|Overall Study|Lost to Follow-up|2|||
126149436|NCT02793544|453833051|FG001|Overall Study|Lost to Follow-up|0|||
126149437|NCT02793544|453833050|FG000|Overall Study|Withdrawal by Subject|1|||
126149438|NCT02793544|453833051|FG001|Overall Study|Withdrawal by Subject|0|||
126149439|NCT00100048|453833052|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
126149440|NCT00100048|453833053|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
126149441|NCT00100048|453833054|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
126149442|NCT00100048|453833055|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
126149443|NCT00100048|453833056|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
126149444|NCT00100048|453833057|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
126149445|NCT00100048|453833052|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
126149446|NCT00100048|453833053|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
126149447|NCT00100048|453833054|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
126149448|NCT00100048|453833055|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
126149449|NCT00100048|453833056|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
126149450|NCT00100048|453833057|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
126149451|NCT00100048|453833052|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
126149452|NCT00100048|453833053|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
126149453|NCT00100048|453833054|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
126149454|NCT00100048|453833055|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
126149455|NCT00100048|453833056|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
126149456|NCT00100048|453833057|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
126149457|NCT00100048|453833052|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
126149458|NCT00100048|453833053|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
126149459|NCT00100048|453833054|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
126149460|NCT00100048|453833055|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
126149461|NCT00100048|453833056|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
126149462|NCT00100048|453833057|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
126149463|NCT00100048|453833052|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
126149464|NCT00100048|453833053|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
126149465|NCT00100048|453833054|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
126149466|NCT00100048|453833055|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
126149467|NCT00100048|453833056|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
126149468|NCT00100048|453833057|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
126149469|NCT00100048|453833052|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
126149470|NCT00100048|453833053|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
126149471|NCT00100048|453833054|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
126149472|NCT00100048|453833055|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
126149473|NCT00100048|453833056|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
126149474|NCT00100048|453833057|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
126149475|NCT00100048|453833052|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
126149476|NCT00100048|453833053|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
126149477|NCT00100048|453833054|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
126149478|NCT00100048|453833055|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
126149479|NCT00100048|453833056|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
126149480|NCT00100048|453833057|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
126149481|NCT00100048|453833052|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126149482|NCT00100048|453833053|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126149483|NCT00100048|453833054|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126149484|NCT00100048|453833055|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
126149485|NCT00100048|453833056|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126149486|NCT00100048|453833057|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126149487|NCT01624142|453833059|FG000|Overall Study|Withdrawal by Subject|14|||
126149488|NCT01624142|453833060|FG001|Overall Study|Withdrawal by Subject|4|||
126149489|NCT01624142|453833059|FG000|Overall Study|Death|3|||
126149490|NCT01624142|453833060|FG001|Overall Study|Death|6|||
126149491|NCT01624142|453833059|FG000|Overall Study|Study Closure|12|||
126149492|NCT01624142|453833060|FG001|Overall Study|Study Closure|6|||
126149493|NCT01624142|453833059|FG000|Overall Study|Lost to Follow-up|2|||
126149494|NCT01624142|453833060|FG001|Overall Study|Lost to Follow-up|0|||
126149495|NCT01624142|453833059|FG000|Overall Study|Other|1|||
126149496|NCT01624142|453833060|FG001|Overall Study|Other|0|||
126149497|NCT02597062|453833063|FG000|Overall Study|Ineligible|1|||
126149498|NCT01697345|453833066|FG000|Overall Study|Withdrawal by Subject|1|||
126149499|NCT05369806|453833067|FG000|Overall Study|Lost to Follow-up|1|||
126149500|NCT00140855|453833068|FG000|Overall Study|Progressive disease|2|||
126149501|NCT01392183|453833069|FG000|First Drug Administration|Adverse Event|3|||
126149502|NCT01392183|453833070|FG001|First Drug Administration|Adverse Event|2|||
126149503|NCT01392183|453833069|FG000|First Drug Administration|Death|1|||
126149504|NCT01392183|453833070|FG001|First Drug Administration|Death|0|||
126149505|NCT01392183|453833069|FG000|First Drug Administration|Withdrawal by Subject|10|||
126149506|NCT01392183|453833070|FG001|First Drug Administration|Withdrawal by Subject|17|||
126149507|NCT03430310|453833071|FG000|Overall Study|Protocol Violation|2|||
125971343|NCT02349295|453182791|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126149508|NCT03430310|453833072|FG001|Overall Study|Protocol Violation|0|||
126149509|NCT03430310|453833071|FG000|Overall Study|Withdrawal by Subject|3|||
126149510|NCT03430310|453833072|FG001|Overall Study|Withdrawal by Subject|2|||
126200129|NCT02394028|454017884|FG007|Induction Phase|Lost to Follow-up|0|||
126149511|NCT03430310|453833071|FG000|Overall Study|COVID shutdown March 2020|0|||
126149512|NCT03430310|453833072|FG001|Overall Study|COVID shutdown March 2020|1|||
126149513|NCT03476239|453833074|FG000|Overall Study|Withdrawal by Subject|10|||
126149514|NCT03476239|453833074|FG000|Overall Study|Death|80|||
126149515|NCT03476239|453833074|FG000|Overall Study|Lost to Follow-up|8|||
126149516|NCT01331161|453833078|FG000|Overall Study|Physician Decision|1|||
126149517|NCT01331161|453833079|FG001|Overall Study|Physician Decision|0|||
126149518|NCT01331161|453833078|FG000|Overall Study|Lost to Follow-up|0|||
126149519|NCT01331161|453833079|FG001|Overall Study|Lost to Follow-up|1|||
126149520|NCT01331161|453833078|FG000|Overall Study|Pregnancy|0|||
126149521|NCT01331161|453833079|FG001|Overall Study|Pregnancy|1|||
126149522|NCT01097044|453833080|FG000|Overall Study|Withdrawal by Subject|4|||
126149523|NCT01097044|453833081|FG001|Overall Study|Withdrawal by Subject|4|||
126149524|NCT01097044|453833080|FG000|Overall Study|Lost to Follow-up|1|||
126149525|NCT01097044|453833081|FG001|Overall Study|Lost to Follow-up|0|||
126149526|NCT01097044|453833080|FG000|Overall Study|Withdrawal by Sponsor|0|||
126149527|NCT01097044|453833081|FG001|Overall Study|Withdrawal by Sponsor|1|||
126149528|NCT01682044|453833082|FG000|Overall Study|Death|1|||
126149529|NCT01682044|453833082|FG000|Overall Study|Progression|3|||
126149530|NCT01659151|453833083|FG000|Overall Study|Inadequate TIL growth|1|||
126149531|NCT03972488|453833084|FG000|Overall Study|Progressive disease|42|||
126149532|NCT03972488|453833085|FG001|Overall Study|Progressive disease|44|||
126149533|NCT03972488|453833084|FG000|Overall Study|Physician Decision|13|||
126149534|NCT03972488|453833085|FG001|Overall Study|Physician Decision|7|||
126149535|NCT03972488|453833084|FG000|Overall Study|Adverse Event|8|||
126149536|NCT03972488|453833085|FG001|Overall Study|Adverse Event|1|||
126149537|NCT03972488|453833084|FG000|Overall Study|Death|4|||
126149538|NCT03972488|453833085|FG001|Overall Study|Death|4|||
126149539|NCT03972488|453833084|FG000|Overall Study|Withdrawal by Subject|3|||
126149540|NCT03972488|453833085|FG001|Overall Study|Withdrawal by Subject|4|||
126149541|NCT03972488|453833084|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
126149542|NCT03972488|453833085|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
126149543|NCT04865731|453833086|FG000|Overall Study|Physician Decision|2|||
126149544|NCT04865731|453833087|FG001|Overall Study|Physician Decision|1|||
126149545|NCT04865731|453833086|FG000|Overall Study|Adverse Event|1|||
126149546|NCT04865731|453833087|FG001|Overall Study|Adverse Event|0|||
126149547|NCT04865731|453833086|FG000|Overall Study|Withdrawal by Subject|0|||
126149548|NCT04865731|453833087|FG001|Overall Study|Withdrawal by Subject|1|||
126149549|NCT02770807|453833088|FG000|Overall Study|Adverse Event|3|||
126149550|NCT02770807|453833089|FG001|Overall Study|Adverse Event|3|||
126149551|NCT02770807|453833090|FG002|Overall Study|Adverse Event|1|||
126149552|NCT02770807|453833088|FG000|Overall Study|Withdrawal by Subject|7|||
126149553|NCT02770807|453833089|FG001|Overall Study|Withdrawal by Subject|3|||
126149554|NCT02770807|453833090|FG002|Overall Study|Withdrawal by Subject|4|||
126149555|NCT02770807|453833088|FG000|Overall Study|Other|0|||
126149556|NCT02770807|453833089|FG001|Overall Study|Other|1|||
126149557|NCT02770807|453833090|FG002|Overall Study|Other|0|||
126149558|NCT02770807|453833088|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
126149559|NCT02770807|453833089|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
126149560|NCT02770807|453833090|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
126149561|NCT02770807|453833088|FG000|Overall Study|Physician Decision|0|||
126149562|NCT02770807|453833089|FG001|Overall Study|Physician Decision|0|||
126149563|NCT02770807|453833090|FG002|Overall Study|Physician Decision|1|||
126149564|NCT01826214|453834627|FG000|Overall Study|Adverse Event|7|||
126149565|NCT01826214|453834628|FG001|Overall Study|Adverse Event|6|||
126149566|NCT01826214|453834627|FG000|Overall Study|Death|3|||
126149567|NCT01826214|453834628|FG001|Overall Study|Death|1|||
126149568|NCT01826214|453834627|FG000|Overall Study|Lost to Follow-up|1|||
126149569|NCT01826214|453834628|FG001|Overall Study|Lost to Follow-up|0|||
126149570|NCT01826214|453834627|FG000|Overall Study|Physician Decision|0|||
126149571|NCT01826214|453834628|FG001|Overall Study|Physician Decision|2|||
126149572|NCT01826214|453834627|FG000|Overall Study|Progressive disease|22|||
126149573|NCT01826214|453834628|FG001|Overall Study|Progressive disease|21|||
126149574|NCT01826214|453834627|FG000|Overall Study|Study terminated by Sponsor|0|||
126149575|NCT01826214|453834628|FG001|Overall Study|Study terminated by Sponsor|1|||
126149576|NCT01826214|453834627|FG000|Overall Study|Subject/guardian decision|2|||
126149577|NCT01826214|453834628|FG001|Overall Study|Subject/guardian decision|3|||
126149578|NCT01056107|453834641|FG000|Overall Study|Withdrawal by Subject|0|||
126149579|NCT01056107|453834642|FG001|Overall Study|Withdrawal by Subject|1|||
126149580|NCT01056107|453834643|FG002|Overall Study|Withdrawal by Subject|3|||
126149581|NCT01056107|453834644|FG003|Overall Study|Withdrawal by Subject|0|||
126149582|NCT02017444|453834645|FG000|Overall Study|Physician Decision|1|||
126149583|NCT02017444|453834646|FG001|Overall Study|Physician Decision|0|||
126149584|NCT02017444|453834645|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
126149585|NCT02017444|453834646|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
126149586|NCT01614457|453834647|FG000|Overall Study|Non-Compliance|1|||
126149587|NCT01614457|453834648|FG001|Overall Study|Non-Compliance|0|||
126149588|NCT01614457|453834647|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
126149589|NCT01614457|453834648|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
126149590|NCT00374556|453834649|FG000|Overall Study|Lost to Follow-up|1|||
126149591|NCT00374556|453834650|FG001|Overall Study|Lost to Follow-up|0|||
126149592|NCT00374556|453834649|FG000|Overall Study|Removed at baseline due to medical cond|0|||
126149593|NCT00374556|453834650|FG001|Overall Study|Removed at baseline due to medical cond|1|||
126149594|NCT00473694|453834652|FG000|Overall Study|Adverse Event|0|||
126149595|NCT00473694|453834653|FG001|Overall Study|Adverse Event|1|||
126149596|NCT00473694|453834654|FG002|Overall Study|Adverse Event|0|||
126149597|NCT00473694|453834655|FG003|Overall Study|Adverse Event|0|||
126149598|NCT00473694|453834652|FG000|Overall Study|Participants did not receive treatment|11|||
126149599|NCT00473694|453834653|FG001|Overall Study|Participants did not receive treatment|3|||
126149600|NCT00473694|453834654|FG002|Overall Study|Participants did not receive treatment|5|||
126149601|NCT00473694|453834655|FG003|Overall Study|Participants did not receive treatment|6|||
126149602|NCT00473694|453834652|FG000|Overall Study|Lost to Follow-up|0|||
126149603|NCT00473694|453834653|FG001|Overall Study|Lost to Follow-up|0|||
126149604|NCT00473694|453834654|FG002|Overall Study|Lost to Follow-up|0|||
126149605|NCT00473694|453834655|FG003|Overall Study|Lost to Follow-up|1|||
126149606|NCT03874234|453834665|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149607|NCT03874234|453834666|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149608|NCT03874234|453834667|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149609|NCT03874234|453834668|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
126149610|NCT03874234|453834669|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149611|NCT03874234|453834670|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149612|NCT03874234|453834671|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149613|NCT03874234|453834672|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149614|NCT03874234|453834673|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149615|NCT03874234|453834674|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149616|NCT03874234|453834675|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149617|NCT03874234|453834676|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149618|NCT03874234|453834677|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126149619|NCT03874234|453834665|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
126149620|NCT03874234|453834666|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149621|NCT03874234|453834667|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149622|NCT03874234|453834668|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149623|NCT03874234|453834669|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149624|NCT03874234|453834670|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149625|NCT03874234|453834671|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149626|NCT03874234|453834672|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149627|NCT03874234|453834673|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149628|NCT03874234|453834674|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149629|NCT03874234|453834675|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149630|NCT03874234|453834676|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149631|NCT03874234|453834677|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126149632|NCT03874234|453834665|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149633|NCT03874234|453834666|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149634|NCT03874234|453834667|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149635|NCT03874234|453834668|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
126149636|NCT03874234|453834669|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149637|NCT03874234|453834670|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149638|NCT03874234|453834671|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149639|NCT03874234|453834672|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149640|NCT03874234|453834673|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149641|NCT03874234|453834674|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149642|NCT03874234|453834675|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149643|NCT03874234|453834676|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149644|NCT03874234|453834677|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126149645|NCT03874234|453834665|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149646|NCT03874234|453834666|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149647|NCT03874234|453834667|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149648|NCT03874234|453834668|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149649|NCT03874234|453834669|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
126149650|NCT03874234|453834670|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149651|NCT03874234|453834671|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149652|NCT03874234|453834672|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149653|NCT03874234|453834673|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149654|NCT03874234|453834674|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149655|NCT03874234|453834675|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126200130|NCT02394028|454017885|FG008|Induction Phase|Lost to Follow-up|0|||
126149656|NCT03874234|453834676|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149657|NCT03874234|453834677|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126149658|NCT03874234|453834665|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149659|NCT03874234|453834666|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149660|NCT03874234|453834667|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149661|NCT03874234|453834668|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149662|NCT03874234|453834669|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149663|NCT03874234|453834670|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149664|NCT03874234|453834671|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149665|NCT03874234|453834672|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
126149666|NCT03874234|453834673|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149667|NCT03874234|453834674|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149668|NCT03874234|453834675|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149669|NCT03874234|453834676|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149670|NCT03874234|453834677|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126149671|NCT03874234|453834665|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149672|NCT03874234|453834666|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149673|NCT03874234|453834667|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149674|NCT03874234|453834668|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149675|NCT03874234|453834669|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
126149676|NCT03874234|453834670|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
126149677|NCT03874234|453834671|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149678|NCT03874234|453834672|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149679|NCT03874234|453834673|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149680|NCT03874234|453834674|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149681|NCT03874234|453834675|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149682|NCT03874234|453834676|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149683|NCT03874234|453834677|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126149684|NCT03874234|453834665|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149685|NCT03874234|453834666|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149686|NCT03874234|453834667|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149687|NCT03874234|453834668|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149688|NCT03874234|453834669|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149689|NCT03874234|453834670|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149690|NCT03874234|453834671|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
126149691|NCT03874234|453834672|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149692|NCT03874234|453834673|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149693|NCT03874234|453834674|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149694|NCT03874234|453834675|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149695|NCT03874234|453834676|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149696|NCT03874234|453834677|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126149697|NCT03874234|453834665|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149698|NCT03874234|453834666|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149699|NCT03874234|453834667|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149700|NCT03874234|453834668|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149701|NCT03874234|453834669|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
126149702|NCT03874234|453834670|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149703|NCT03874234|453834671|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149704|NCT03874234|453834672|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149705|NCT03874234|453834673|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149706|NCT03874234|453834674|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149707|NCT03874234|453834675|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149708|NCT03874234|453834676|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149709|NCT03874234|453834677|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126149710|NCT00783289|453834678|FG000|Overall Study|Protocol Violation|0|||
126149711|NCT00783289|453834679|FG001|Overall Study|Protocol Violation|1|||
126149712|NCT00783289|453834680|FG002|Overall Study|Protocol Violation|0|||
126149713|NCT00783289|453834681|FG003|Overall Study|Protocol Violation|0|||
126149714|NCT00506389|453834682|FG000|In-treatment Period|Other|3|||
126149715|NCT00506389|453834683|FG001|In-treatment Period|Other|3|||
126149716|NCT00506389|453834684|FG002|In-treatment Period|Other|4|||
126149717|NCT00506389|453834682|FG000|In-treatment Period|Lost to Follow-up|0|||
126149718|NCT00506389|453834683|FG001|In-treatment Period|Lost to Follow-up|0|||
126149719|NCT00506389|453834684|FG002|In-treatment Period|Lost to Follow-up|1|||
125971344|NCT02349295|453182792|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971345|NCT02349295|453182793|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971346|NCT02349295|453182794|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126200131|NCT02394028|454017886|FG009|Induction Phase|Lost to Follow-up|0|||
126149720|NCT00506389|453834682|FG000|In-treatment Period|Lack of compliance|1|||
126149721|NCT00506389|453834683|FG001|In-treatment Period|Lack of compliance|0|||
126149722|NCT00506389|453834684|FG002|In-treatment Period|Lack of compliance|0|||
126149723|NCT00506389|453834682|FG000|In-treatment Period|Reasons not related to trial|4|||
126149724|NCT00506389|453834683|FG001|In-treatment Period|Reasons not related to trial|1|||
126149725|NCT00506389|453834684|FG002|In-treatment Period|Reasons not related to trial|0|||
126149726|NCT00506389|453834682|FG000|In-treatment Period|Withdrawal by Subject|3|||
126149727|NCT00506389|453834683|FG001|In-treatment Period|Withdrawal by Subject|3|||
126149728|NCT00506389|453834684|FG002|In-treatment Period|Withdrawal by Subject|4|||
126149729|NCT00506389|453834682|FG000|In-treatment Period|Lack of Efficacy|0|||
126149730|NCT00506389|453834683|FG001|In-treatment Period|Lack of Efficacy|2|||
126149731|NCT00506389|453834684|FG002|In-treatment Period|Lack of Efficacy|0|||
126149732|NCT00506389|453834682|FG000|In-treatment Period|Adverse Event|11|||
126149733|NCT00506389|453834683|FG001|In-treatment Period|Adverse Event|5|||
126149734|NCT00506389|453834684|FG002|In-treatment Period|Adverse Event|2|||
126149735|NCT00506389|453834682|FG000|In-treatment Period|Randomized but not treated|4|||
126149736|NCT00506389|453834683|FG001|In-treatment Period|Randomized but not treated|1|||
126149737|NCT00506389|453834684|FG002|In-treatment Period|Randomized but not treated|1|||
126149738|NCT01503021|453834693|FG000|Overall Study|Adverse Event|7|||
126149739|NCT01503021|453834694|FG001|Overall Study|Adverse Event|6|||
126149740|NCT01503021|453834693|FG000|Overall Study|Death|0|||
126149741|NCT01503021|453834694|FG001|Overall Study|Death|2|||
126149742|NCT01503021|453834693|FG000|Overall Study|Lost to Follow-up|2|||
126149743|NCT01503021|453834694|FG001|Overall Study|Lost to Follow-up|0|||
126149744|NCT01503021|453834693|FG000|Overall Study|Physician Decision|3|||
126149745|NCT01503021|453834694|FG001|Overall Study|Physician Decision|0|||
126149746|NCT01503021|453834693|FG000|Overall Study|Protocol Violation|1|||
126149747|NCT01503021|453834694|FG001|Overall Study|Protocol Violation|3|||
126149748|NCT01503021|453834693|FG000|Overall Study|Withdrawal by Subject|9|||
126149749|NCT01503021|453834694|FG001|Overall Study|Withdrawal by Subject|8|||
126149750|NCT01503021|453834693|FG000|Overall Study|Moved, received transplant, etc.|5|||
126149751|NCT01503021|453834694|FG001|Overall Study|Moved, received transplant, etc.|7|||
126149752|NCT01931865|453834702|FG000|Overall Study|Lost to Follow-up|2|||
126149753|NCT01931865|453834702|FG000|Overall Study|Withdrawal by Subject|2|||
126149754|NCT00283387|453834703|FG000|First Intervention|Subject non-compliant|1|||
126149755|NCT00283387|453834704|FG001|First Intervention|Subject non-compliant|1|||
126149756|NCT00283387|453834703|FG000|First Intervention|Withdrawal by Subject|0|||
126149757|NCT00283387|453834704|FG001|First Intervention|Withdrawal by Subject|1|||
126149758|NCT00446030|453834705|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
126149759|NCT00446030|453834706|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
126149760|NCT00446030|453834705|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
126149761|NCT00446030|453834706|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
126149762|NCT00446030|453834705|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
126149763|NCT00446030|453834706|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
126149764|NCT00446030|453834705|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
126149765|NCT00446030|453834706|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
126149766|NCT00446030|453834705|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
126149767|NCT00446030|453834706|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
126149768|NCT00446030|453834705|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
126149769|NCT00446030|453834706|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
126149770|NCT00446030|453834705|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
126149771|NCT00446030|453834706|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
126149772|NCT00446030|453834705|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
126149773|NCT00446030|453834706|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
126149774|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
126149775|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
126149776|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
126149777|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
126149778|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
126149779|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
126149780|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
126149781|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
126149782|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
126149783|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
126149784|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
126149785|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
126149786|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
126149787|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
126149788|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
126149789|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
126149790|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
126149791|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
126149792|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
126149793|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
126149794|NCT00446030|453834705|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
126149795|NCT00446030|453834706|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
126149796|NCT02886715|453834707|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126149797|NCT02886715|453834708|FG001|Overall Study|Non-Compliance With Study Drug|2|||
126149798|NCT02886715|453834709|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126149799|NCT02886715|453834707|FG000|Overall Study|Adverse Event|4|||
126149800|NCT02886715|453834708|FG001|Overall Study|Adverse Event|2|||
126149801|NCT02886715|453834709|FG002|Overall Study|Adverse Event|0|||
126149802|NCT02886715|453834707|FG000|Overall Study|Lack of Efficacy|0|||
126149803|NCT02886715|453834708|FG001|Overall Study|Lack of Efficacy|2|||
126149804|NCT02886715|453834709|FG002|Overall Study|Lack of Efficacy|1|||
126149805|NCT02886715|453834707|FG000|Overall Study|Lost to Follow-up|29|||
126149806|NCT02886715|453834708|FG001|Overall Study|Lost to Follow-up|26|||
126149807|NCT02886715|453834709|FG002|Overall Study|Lost to Follow-up|10|||
126149808|NCT02886715|453834707|FG000|Overall Study|Pregnancy|1|||
126149809|NCT02886715|453834708|FG001|Overall Study|Pregnancy|1|||
126149810|NCT02886715|453834709|FG002|Overall Study|Pregnancy|1|||
126149811|NCT02886715|453834707|FG000|Overall Study|Protocol Violation|3|||
126149812|NCT02886715|453834708|FG001|Overall Study|Protocol Violation|2|||
126149813|NCT02886715|453834709|FG002|Overall Study|Protocol Violation|1|||
126149814|NCT02886715|453834707|FG000|Overall Study|Withdrawal by Subject|20|||
126149815|NCT02886715|453834708|FG001|Overall Study|Withdrawal by Subject|18|||
126149816|NCT02886715|453834709|FG002|Overall Study|Withdrawal by Subject|5|||
126149817|NCT02886715|453834707|FG000|Overall Study|missing|7|||
126149818|NCT02886715|453834708|FG001|Overall Study|missing|2|||
126149819|NCT02886715|453834709|FG002|Overall Study|missing|2|||
126149820|NCT00503399|453834712|FG000|Overall Study|Death|2|||
126149821|NCT00503399|453834713|FG001|Overall Study|Death|1|||
126149822|NCT00503399|453834712|FG000|Overall Study|Protocol Violation|1|||
125971347|NCT02349295|453182795|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971348|NCT02349295|453182796|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126149823|NCT00503399|453834713|FG001|Overall Study|Protocol Violation|0|||
126149824|NCT00503399|453834712|FG000|Overall Study|Withdrawal by Subject|4|||
126149825|NCT00503399|453834713|FG001|Overall Study|Withdrawal by Subject|2|||
126088692|NCT05511038|453618793|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
126088693|NCT05511038|453618792|FG000|Treatment|Withdrawal by Subject|5|||
126088694|NCT05511038|453618793|FG001|Treatment|Withdrawal by Subject|3|||
126088695|NCT05511038|453618792|FG000|Treatment|Physician Decision|4|||
126088696|NCT05511038|453618793|FG001|Treatment|Physician Decision|0|||
126088697|NCT05511038|453618792|FG000|Treatment|Lost to Follow-up|2|||
126088698|NCT05511038|453618793|FG001|Treatment|Lost to Follow-up|0|||
126088699|NCT05511038|453618792|FG000|Treatment|Death|1|||
126088700|NCT05511038|453618793|FG001|Treatment|Death|0|||
126088701|NCT05511038|453618792|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
126088702|NCT05511038|453618793|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
126088703|NCT05511038|453618792|FG000|Treatment|Refuse by subject|1|||
126088704|NCT05511038|453618793|FG001|Treatment|Refuse by subject|0|||
126088705|NCT05511038|453618792|FG000|Treatment|Subject did not go to the site for visit|1|||
126088706|NCT05511038|453618793|FG001|Treatment|Subject did not go to the site for visit|0|||
126088707|NCT05140915|453618794|FG000|Overall Study|Lost to Follow-up|2|||
126088708|NCT05140915|453618795|FG001|Overall Study|Lost to Follow-up|1|||
126088709|NCT04485611|453618796|FG000|Prehabilitation|Physician Decision|1|||
126088710|NCT04879849|453618797|FG000|Overall Study|Lost to Follow-up|0|||
126088711|NCT04879849|453618798|FG001|Overall Study|Lost to Follow-up|0|||
126088712|NCT04879849|453618799|FG002|Overall Study|Lost to Follow-up|0|||
126088713|NCT04879849|453618800|FG003|Overall Study|Lost to Follow-up|1|||
126088714|NCT04879849|453618801|FG004|Overall Study|Lost to Follow-up|0|||
126088715|NCT04879849|453618802|FG005|Overall Study|Lost to Follow-up|0|||
126088716|NCT04879849|453618803|FG006|Overall Study|Lost to Follow-up|0|||
126088717|NCT04879849|453618804|FG007|Overall Study|Lost to Follow-up|0|||
126088718|NCT04879849|453618797|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
126088719|NCT04879849|453618798|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
126088720|NCT04879849|453618799|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
126088721|NCT04879849|453618800|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
126088722|NCT04879849|453618801|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
126088723|NCT04879849|453618802|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
126088724|NCT04879849|453618803|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
126149826|NCT00503399|453834712|FG000|Overall Study|Adverse Event|0|||
126149827|NCT00503399|453834713|FG001|Overall Study|Adverse Event|3|||
126088725|NCT04879849|453618804|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
126088726|NCT04879849|453618797|FG000|Overall Study|Withdrawal by Subject|0|||
126088727|NCT04879849|453618798|FG001|Overall Study|Withdrawal by Subject|0|||
126149828|NCT00503399|453834712|FG000|Overall Study|Lost to Follow-up|0|||
126149829|NCT00503399|453834713|FG001|Overall Study|Lost to Follow-up|2|||
126149830|NCT03812510|453834714|FG000|Overall Study|Lost to Follow-up|39|||
126149831|NCT03812510|453834714|FG000|Overall Study|Withdrawal by Subject|42|||
126149832|NCT03812510|453834714|FG000|Overall Study|Physician Decision|2|||
126149833|NCT03812510|453834714|FG000|Overall Study|Study Terminated by Sponsor|9|||
126149834|NCT03812510|453834714|FG000|Overall Study|Did Not Start Study Medication|55|||
126149835|NCT03812510|453834714|FG000|Overall Study|Adverse Event|5|||
126149836|NCT00768560|453834715|FG000|Intervention Set 1|Adverse Event|0|||
126149837|NCT00768560|453834716|FG001|Intervention Set 1|Adverse Event|1|||
126149838|NCT00768560|453834717|FG002|Intervention Set 1|Adverse Event|0|||
126149839|NCT00768560|453834718|FG003|Intervention Set 1|Adverse Event|0|||
126149840|NCT00768560|453834719|FG004|Intervention Set 1|Adverse Event|0|||
126149841|NCT00768560|453834720|FG005|Intervention Set 1|Adverse Event|0|||
126149842|NCT01120626|453834721|FG000|Overall Study|Withdrawal by Subject|1|||
126149843|NCT01120626|453834722|FG001|Overall Study|Withdrawal by Subject|0|||
126149844|NCT01073943|453834723|FG000|Overall Study|Withdrawal by Subject|8|||
126149845|NCT01073943|453834724|FG001|Overall Study|Withdrawal by Subject|2|||
126149846|NCT01073943|453834723|FG000|Overall Study|Protocol Violation|2|||
126149847|NCT01073943|453834724|FG001|Overall Study|Protocol Violation|1|||
126149848|NCT01073943|453834723|FG000|Overall Study|Adverse Event|1|||
126149849|NCT01073943|453834724|FG001|Overall Study|Adverse Event|1|||
126149850|NCT01073943|453834723|FG000|Overall Study|Lost to Follow-up|0|||
126149851|NCT01073943|453834724|FG001|Overall Study|Lost to Follow-up|2|||
126149852|NCT01073943|453834723|FG000|Overall Study|Power outage; colonoscopy not done|1|||
126149853|NCT01073943|453834724|FG001|Overall Study|Power outage; colonoscopy not done|0|||
126149854|NCT01073943|453834723|FG000|Overall Study|Subject forgot|0|||
126149855|NCT01073943|453834724|FG001|Overall Study|Subject forgot|1|||
126149856|NCT01073943|453834723|FG000|Overall Study|Unable to return for follow-up|0|||
126149857|NCT01073943|453834724|FG001|Overall Study|Unable to return for follow-up|1|||
126149858|NCT01073943|453834723|FG000|Overall Study|Could not tolerate prep|1|||
126149859|NCT01073943|453834724|FG001|Overall Study|Could not tolerate prep|0|||
126149860|NCT03527043|453834733|FG000|Overall Study|Withdrawal by Subject|1|||
126149861|NCT03527043|453834734|FG001|Overall Study|Withdrawal by Subject|0|||
126149862|NCT03830281|453834735|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
126149863|NCT03830281|453834736|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
126149864|NCT03830281|453834735|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
126149865|NCT03830281|453834736|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
126149866|NCT03830281|453834735|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
126149867|NCT03830281|453834736|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
126149868|NCT03830281|453834735|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
126149869|NCT03830281|453834736|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
126149870|NCT03830281|453834735|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
126149871|NCT03830281|453834736|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
126149872|NCT03830281|453834735|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
126149873|NCT03830281|453834736|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
126149874|NCT03830281|453834735|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
126149875|NCT03830281|453834736|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
126149876|NCT03830281|453834735|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
126149877|NCT03830281|453834736|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
126149878|NCT03830281|453834735|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
126149879|NCT03830281|453834736|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
126149880|NCT01985321|453834737|FG000|Overall Study|Protocol Violation|4|||
126149881|NCT01985321|453834738|FG001|Overall Study|Protocol Violation|3|||
126149882|NCT01985321|453834737|FG000|Overall Study|Withdrawal by Subject|1|||
126149883|NCT01985321|453834738|FG001|Overall Study|Withdrawal by Subject|0|||
126149884|NCT01985321|453834737|FG000|Overall Study|Lost to Follow-up|5|||
126149885|NCT01985321|453834738|FG001|Overall Study|Lost to Follow-up|2|||
126149886|NCT01985321|453834737|FG000|Overall Study|Subject treated wrong type of sore|1|||
126149887|NCT01985321|453834738|FG001|Overall Study|Subject treated wrong type of sore|0|||
126149888|NCT03293680|453834739|FG000|Overall Study|Death|1|||
126149889|NCT03293680|453834739|FG000|Overall Study|Did not meet inclusion criteria|8|||
126149890|NCT02201940|453834740|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
126149891|NCT02201940|453834741|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
126149892|NCT02201940|453834740|FG000|Overall Study|Lack of Efficacy|2|||
126149893|NCT02201940|453834741|FG001|Overall Study|Lack of Efficacy|113|||
126149894|NCT02201940|453834740|FG000|Overall Study|Lost to Follow-up|5|||
126149895|NCT02201940|453834741|FG001|Overall Study|Lost to Follow-up|0|||
126149896|NCT02201940|453834740|FG000|Overall Study|Withdrew Consent|2|||
126149897|NCT02201940|453834741|FG001|Overall Study|Withdrew Consent|1|||
126149898|NCT02201940|453834740|FG000|Overall Study|Investigator's Discretion|1|||
126149899|NCT02201940|453834741|FG001|Overall Study|Investigator's Discretion|1|||
126149900|NCT02201940|453834740|FG000|Overall Study|Death|1|||
126149901|NCT02201940|453834741|FG001|Overall Study|Death|0|||
126149902|NCT02201940|453834740|FG000|Overall Study|Adverse Event|0|||
126149903|NCT02201940|453834741|FG001|Overall Study|Adverse Event|1|||
126149904|NCT03192904|453834742|FG000|Overall Study|Physician Decision|3|||
126149905|NCT03192904|453834743|FG001|Overall Study|Physician Decision|1|||
126149906|NCT03192904|453834742|FG000|Overall Study|Lost to Follow-up|0|||
126149907|NCT03192904|453834743|FG001|Overall Study|Lost to Follow-up|1|||
126149908|NCT01309737|453834744|FG000|Week 0 to 16|Death|1|||
126149909|NCT01309737|453834745|FG001|Week 0 to 16|Death|0|||
126149910|NCT01309737|453834746|FG002|Week 0 to 16|Death|1|||
126149911|NCT01309737|453834747|FG003|Week 0 to 16|Death|0|||
126149912|NCT01309737|453834748|FG004|Week 0 to 16|Death|0|||
126149913|NCT01309737|453834744|FG000|Week 0 to 16|Adverse Event|11|||
126149914|NCT01309737|453834745|FG001|Week 0 to 16|Adverse Event|10|||
126149915|NCT01309737|453834746|FG002|Week 0 to 16|Adverse Event|5|||
126149916|NCT01309737|453834747|FG003|Week 0 to 16|Adverse Event|0|||
126149917|NCT01309737|453834748|FG004|Week 0 to 16|Adverse Event|0|||
126149918|NCT01309737|453834744|FG000|Week 0 to 16|Lack of Efficacy|15|||
126149919|NCT01309737|453834745|FG001|Week 0 to 16|Lack of Efficacy|2|||
126149920|NCT01309737|453834746|FG002|Week 0 to 16|Lack of Efficacy|24|||
126149921|NCT01309737|453834747|FG003|Week 0 to 16|Lack of Efficacy|0|||
126149922|NCT01309737|453834748|FG004|Week 0 to 16|Lack of Efficacy|0|||
126149923|NCT01309737|453834744|FG000|Week 0 to 16|Lost to Follow-up|7|||
126149924|NCT01309737|453834745|FG001|Week 0 to 16|Lost to Follow-up|8|||
126149925|NCT01309737|453834746|FG002|Week 0 to 16|Lost to Follow-up|3|||
126149926|NCT01309737|453834747|FG003|Week 0 to 16|Lost to Follow-up|0|||
126149927|NCT01309737|453834748|FG004|Week 0 to 16|Lost to Follow-up|0|||
126149928|NCT01309737|453834744|FG000|Week 0 to 16|Withdrawal by Subject|7|||
126149929|NCT01309737|453834745|FG001|Week 0 to 16|Withdrawal by Subject|6|||
126149930|NCT01309737|453834746|FG002|Week 0 to 16|Withdrawal by Subject|7|||
126149931|NCT01309737|453834747|FG003|Week 0 to 16|Withdrawal by Subject|0|||
126149932|NCT01309737|453834748|FG004|Week 0 to 16|Withdrawal by Subject|0|||
126149933|NCT01309737|453834744|FG000|Week 0 to 16|Other|10|||
126149934|NCT01309737|453834745|FG001|Week 0 to 16|Other|14|||
126149935|NCT01309737|453834746|FG002|Week 0 to 16|Other|4|||
126149936|NCT01309737|453834747|FG003|Week 0 to 16|Other|0|||
126149937|NCT01309737|453834748|FG004|Week 0 to 16|Other|0|||
126149938|NCT01309737|453834744|FG000|Week 0 to 16|Randomized, but not treated|1|||
126149939|NCT01309737|453834745|FG001|Week 0 to 16|Randomized, but not treated|0|||
126149940|NCT01309737|453834746|FG002|Week 0 to 16|Randomized, but not treated|0|||
126149941|NCT01309737|453834747|FG003|Week 0 to 16|Randomized, but not treated|0|||
126149942|NCT01309737|453834748|FG004|Week 0 to 16|Randomized, but not treated|0|||
126149943|NCT01309737|453834744|FG000|Week 16 to 52|Death|0|||
126149944|NCT01309737|453834745|FG001|Week 16 to 52|Death|0|||
126149945|NCT01309737|453834746|FG002|Week 16 to 52|Death|0|||
126149946|NCT01309737|453834747|FG003|Week 16 to 52|Death|0|||
126149947|NCT01309737|453834748|FG004|Week 16 to 52|Death|1|||
126149948|NCT01309737|453834744|FG000|Week 16 to 52|Adverse Event|7|||
126149949|NCT01309737|453834745|FG001|Week 16 to 52|Adverse Event|7|||
126149950|NCT01309737|453834746|FG002|Week 16 to 52|Adverse Event|0|||
126149951|NCT01309737|453834747|FG003|Week 16 to 52|Adverse Event|6|||
126149952|NCT01309737|453834748|FG004|Week 16 to 52|Adverse Event|5|||
126149953|NCT01309737|453834744|FG000|Week 16 to 52|Lack of Efficacy|107|||
126149954|NCT01309737|453834745|FG001|Week 16 to 52|Lack of Efficacy|76|||
126149955|NCT01309737|453834746|FG002|Week 16 to 52|Lack of Efficacy|0|||
126149956|NCT01309737|453834747|FG003|Week 16 to 52|Lack of Efficacy|25|||
126149957|NCT01309737|453834748|FG004|Week 16 to 52|Lack of Efficacy|21|||
126149958|NCT01309737|453834744|FG000|Week 16 to 52|Lost to Follow-up|4|||
126149959|NCT01309737|453834745|FG001|Week 16 to 52|Lost to Follow-up|2|||
126149960|NCT01309737|453834746|FG002|Week 16 to 52|Lost to Follow-up|0|||
126149961|NCT01309737|453834747|FG003|Week 16 to 52|Lost to Follow-up|1|||
125971349|NCT02349295|453182797|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971350|NCT02349295|453182798|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
126149962|NCT01309737|453834748|FG004|Week 16 to 52|Lost to Follow-up|4|||
125971351|NCT02349295|453182799|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971352|NCT02349295|453182800|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125971353|NCT02148250|453182803|FG000|Screening|Withdrawal by Subject|5|||
125971354|NCT02148250|453182804|FG001|Screening|Withdrawal by Subject|0|||
125971355|NCT00695903|453182809|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
126149963|NCT01309737|453834744|FG000|Week 16 to 52|Withdrawal by Subject|5|||
126149964|NCT01309737|453834745|FG001|Week 16 to 52|Withdrawal by Subject|6|||
126149965|NCT01309737|453834746|FG002|Week 16 to 52|Withdrawal by Subject|0|||
126149966|NCT01309737|453834747|FG003|Week 16 to 52|Withdrawal by Subject|0|||
125971356|NCT00695903|453182810|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
126149967|NCT01309737|453834748|FG004|Week 16 to 52|Withdrawal by Subject|2|||
126149968|NCT01309737|453834744|FG000|Week 16 to 52|Other|10|||
126149969|NCT01309737|453834745|FG001|Week 16 to 52|Other|12|||
126149970|NCT01309737|453834746|FG002|Week 16 to 52|Other|0|||
126149971|NCT01309737|453834747|FG003|Week 16 to 52|Other|2|||
126149972|NCT01309737|453834748|FG004|Week 16 to 52|Other|0|||
126149973|NCT00709202|453834750|FG000|Overall Study|Withdrawal by Subject|6|||
126149974|NCT00709202|453834751|FG001|Overall Study|Withdrawal by Subject|6|||
126149975|NCT03934684|453834758|FG000|Overall Study|Participants continuing in study|11|||
126149976|NCT03934684|453834759|FG001|Overall Study|Participants continuing in study|4|||
126149977|NCT03934684|453834758|FG000|Overall Study|Discontinuation of carfilzomib|20|||
126149978|NCT03934684|453834759|FG001|Overall Study|Discontinuation of carfilzomib|30|||
126149979|NCT03934684|453834758|FG000|Overall Study|Death|2|||
126149980|NCT03934684|453834759|FG001|Overall Study|Death|2|||
126149981|NCT03934684|453834758|FG000|Overall Study|Lost to Follow-up|2|||
126149982|NCT03934684|453834759|FG001|Overall Study|Lost to Follow-up|5|||
126149983|NCT03934684|453834758|FG000|Overall Study|Withdrawal by Subject|7|||
126149984|NCT03934684|453834759|FG001|Overall Study|Withdrawal by Subject|8|||
126149985|NCT04091217|453834760|FG000|Overall Study|Lost to Follow-up|2|||
126149986|NCT05662332|453834761|FG000|Overall Study|Death|3|||
126149987|NCT05662332|453834762|FG001|Overall Study|Death|3|||
126149988|NCT05662332|453834761|FG000|Overall Study|Lost to Follow-up|3|||
126149989|NCT05662332|453834762|FG001|Overall Study|Lost to Follow-up|8|||
126149990|NCT05662332|453834761|FG000|Overall Study|Physician Decision|1|||
126149991|NCT05662332|453834762|FG001|Overall Study|Physician Decision|2|||
126149992|NCT05662332|453834761|FG000|Overall Study|Protocol Deviation|2|||
126149993|NCT05662332|453834762|FG001|Overall Study|Protocol Deviation|1|||
126149994|NCT05662332|453834761|FG000|Overall Study|Withdrawal by Subject|14|||
126149995|NCT05662332|453834762|FG001|Overall Study|Withdrawal by Subject|14|||
126149996|NCT05662332|453834761|FG000|Overall Study|Assigned Treatment by Mistake|5|||
126149997|NCT05662332|453834762|FG001|Overall Study|Assigned Treatment by Mistake|7|||
126149998|NCT05662332|453834761|FG000|Overall Study|Non-compliance with study drug|4|||
126149999|NCT05662332|453834762|FG001|Overall Study|Non-compliance with study drug|1|||
126150000|NCT05662332|453834761|FG000|Overall Study|Due to Bariatric surgery|1|||
126150001|NCT05662332|453834762|FG001|Overall Study|Due to Bariatric surgery|0|||
126150002|NCT05662332|453834761|FG000|Overall Study|Subject Moving out of State|0|||
126150003|NCT05662332|453834762|FG001|Overall Study|Subject Moving out of State|1|||
126150004|NCT05662332|453834761|FG000|Overall Study|Subject Missed the Schedule|1|||
126150005|NCT05662332|453834762|FG001|Overall Study|Subject Missed the Schedule|0|||
126150006|NCT05662332|453834761|FG000|Overall Study|The Patient Moved to Another City|1|||
126150007|NCT05662332|453834762|FG001|Overall Study|The Patient Moved to Another City|0|||
126150008|NCT05262764|453834764|FG000|Overall Study|Case report form not collected|9|||
126150009|NCT05262764|453834764|FG000|Overall Study|No patient visits after entry|23|||
126150010|NCT05262764|453834764|FG000|Overall Study|Registration rule not followed|2|||
126150011|NCT05262764|453834764|FG000|Overall Study|Patient of non-chronic heart failure|1|||
126150012|NCT01446809|453834765|FG000|Overall Study|Adverse Event|0|||
126150013|NCT01446809|453834766|FG001|Overall Study|Adverse Event|0|||
126150014|NCT01446809|453834767|FG002|Overall Study|Adverse Event|1|||
126150015|NCT01446809|453834765|FG000|Overall Study|Failure to complete study procedures|0|||
126150016|NCT01446809|453834766|FG001|Overall Study|Failure to complete study procedures|0|||
126150017|NCT01446809|453834767|FG002|Overall Study|Failure to complete study procedures|1|||
126150018|NCT00785577|453834768|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
126150019|NCT00785577|453834769|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
126150020|NCT00785577|453834770|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
126150021|NCT00785577|453834771|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
126150022|NCT00785577|453834772|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
126150023|NCT00785577|453834768|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126150024|NCT00785577|453834769|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126150025|NCT00785577|453834770|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126150026|NCT00785577|453834771|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126150027|NCT00785577|453834772|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
126150028|NCT00785577|453834768|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
126150029|NCT00785577|453834769|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
126150030|NCT00785577|453834770|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
126150031|NCT00785577|453834771|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
126150032|NCT00785577|453834772|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
126150033|NCT00785577|453834768|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
126150034|NCT00785577|453834769|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
126150035|NCT00785577|453834770|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
126150036|NCT00785577|453834771|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
126150037|NCT00785577|453834772|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
126150038|NCT00785577|453834768|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
126150039|NCT00785577|453834769|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
126150040|NCT00785577|453834770|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
126150041|NCT00785577|453834771|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
126150042|NCT00785577|453834772|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
126150043|NCT00785577|453834768|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
126150044|NCT00785577|453834769|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
126150045|NCT00785577|453834770|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
126150046|NCT00785577|453834771|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
126150047|NCT00785577|453834772|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
126150048|NCT00785577|453834768|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
126200132|NCT02394028|454017887|FG010|Induction Phase|Lost to Follow-up|0|||
126150049|NCT00785577|453834769|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
126150050|NCT00785577|453834770|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
126150051|NCT00785577|453834771|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
126150052|NCT00785577|453834772|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
126150053|NCT00785577|453834768|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
126150054|NCT00785577|453834769|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
126150055|NCT00785577|453834770|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
126150056|NCT00785577|453834771|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
126150057|NCT00785577|453834772|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
126150058|NCT00785577|453834768|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
126150059|NCT00785577|453834769|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
126150060|NCT00785577|453834770|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
126150061|NCT00785577|453834771|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
126150062|NCT00785577|453834772|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
126150063|NCT00785577|453834768|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
126150064|NCT00785577|453834769|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
126150065|NCT00785577|453834770|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
126150066|NCT00785577|453834771|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
126150067|NCT00785577|453834772|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
126150068|NCT00469079|453836205|FG000|Overall Study|Lack of Efficacy|3|||
126150069|NCT00469079|453836206|FG001|Overall Study|Lack of Efficacy|8|||
126150070|NCT00469079|453836207|FG002|Overall Study|Lack of Efficacy|5|||
126150071|NCT00469079|453836205|FG000|Overall Study|Adverse Event|1|||
126150072|NCT00469079|453836206|FG001|Overall Study|Adverse Event|3|||
126150073|NCT00469079|453836207|FG002|Overall Study|Adverse Event|2|||
126150074|NCT00469079|453836205|FG000|Overall Study|Lost to Follow-up|4|||
126150075|NCT00469079|453836206|FG001|Overall Study|Lost to Follow-up|8|||
126150076|NCT00469079|453836207|FG002|Overall Study|Lost to Follow-up|10|||
126150077|NCT00469079|453836205|FG000|Overall Study|Withdrawal by Subject|1|||
126150078|NCT00469079|453836206|FG001|Overall Study|Withdrawal by Subject|2|||
126150079|NCT00469079|453836207|FG002|Overall Study|Withdrawal by Subject|2|||
126150080|NCT00469079|453836205|FG000|Overall Study|Ineligible|0|||
126150081|NCT00469079|453836206|FG001|Overall Study|Ineligible|1|||
126150082|NCT00469079|453836207|FG002|Overall Study|Ineligible|0|||
126150083|NCT00942162|453836208|FG000|Overall Study|Death|45|||
126150084|NCT00942162|453836209|FG001|Overall Study|Death|35|||
126150085|NCT00942162|453836210|FG002|Overall Study|Death|0|||
126150086|NCT00942162|453836208|FG000|Overall Study|Withdrawal by Subject|7|||
126150087|NCT00942162|453836209|FG001|Overall Study|Withdrawal by Subject|2|||
126150088|NCT00942162|453836210|FG002|Overall Study|Withdrawal by Subject|0|||
126150089|NCT00942162|453836208|FG000|Overall Study|Lost to Follow-up|4|||
126150090|NCT00942162|453836209|FG001|Overall Study|Lost to Follow-up|0|||
126150091|NCT00942162|453836210|FG002|Overall Study|Lost to Follow-up|0|||
126150092|NCT00942162|453836208|FG000|Overall Study|Other|14|||
126150093|NCT00942162|453836209|FG001|Overall Study|Other|13|||
126150094|NCT00942162|453836210|FG002|Overall Study|Other|2|||
126150095|NCT02799381|453836220|FG000|Overall Study|Withdrew consent|3|||
126150096|NCT02799381|453836221|FG001|Overall Study|Withdrew consent|2|||
126150097|NCT02799381|453836220|FG000|Overall Study|Adverse Event|0|||
126150098|NCT02799381|453836221|FG001|Overall Study|Adverse Event|1|||
126150099|NCT02799381|453836220|FG000|Overall Study|Participant did not take any study drug|1|||
126150100|NCT02799381|453836221|FG001|Overall Study|Participant did not take any study drug|0|||
126150101|NCT01821963|453836222|FG000|Overall Study|Adverse Event|1|||
126150102|NCT03952130|453836223|FG000|Overall Study|Adverse Event|0|||
126150103|NCT03952130|453836224|FG001|Overall Study|Adverse Event|1|||
126150104|NCT03952130|453836223|FG000|Overall Study|Lost to Follow-up|1|||
126150105|NCT03952130|453836224|FG001|Overall Study|Lost to Follow-up|0|||
126150106|NCT03952130|453836223|FG000|Overall Study|Withdrawal by Subject|1|||
126150107|NCT03952130|453836224|FG001|Overall Study|Withdrawal by Subject|5|||
126150108|NCT01713348|453836225|FG000|Overall Study|Withdrawal by Subject|3|||
126150109|NCT01713348|453836226|FG001|Overall Study|Withdrawal by Subject|2|||
126150110|NCT01713348|453836227|FG002|Overall Study|Withdrawal by Subject|2|||
126150111|NCT01713348|453836228|FG003|Overall Study|Withdrawal by Subject|0|||
126150112|NCT01713348|453836225|FG000|Overall Study|Lost to Follow-up|1|||
126150113|NCT01713348|453836226|FG001|Overall Study|Lost to Follow-up|0|||
126150114|NCT01713348|453836227|FG002|Overall Study|Lost to Follow-up|0|||
126150115|NCT01713348|453836228|FG003|Overall Study|Lost to Follow-up|0|||
126150116|NCT01896232|453836229|FG000|Overall Study|Death|6|||
126150117|NCT01896232|453836230|FG001|Overall Study|Death|10|||
126150118|NCT01896232|453836229|FG000|Overall Study|Withdrawal by Subject|32|||
126150119|NCT01896232|453836230|FG001|Overall Study|Withdrawal by Subject|31|||
126150120|NCT01896232|453836229|FG000|Overall Study|Sponsor Decision|2|||
126150121|NCT01896232|453836230|FG001|Overall Study|Sponsor Decision|0|||
126150122|NCT01896232|453836229|FG000|Overall Study|Lost to Follow-up|9|||
126150123|NCT01896232|453836230|FG001|Overall Study|Lost to Follow-up|12|||
126150124|NCT00686205|453836239|FG000|Overall Study|Protocol Violation|127|||
126150125|NCT00686205|453836240|FG001|Overall Study|Protocol Violation|0|||
126150126|NCT00686205|453836239|FG000|Overall Study|Withdrawal by Subject|2|||
126150127|NCT00686205|453836240|FG001|Overall Study|Withdrawal by Subject|0|||
126150128|NCT00686205|453836239|FG000|Overall Study|Specimen handling procedure altered|5878|||
126150129|NCT00686205|453836240|FG001|Overall Study|Specimen handling procedure altered|0|||
126150130|NCT00686205|453836239|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
126150131|NCT00686205|453836240|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
126150132|NCT00265941|453836241|FG000|Overall Study|Protocol Violation|22|||
126150133|NCT00265941|453836242|FG001|Overall Study|Protocol Violation|25|||
126150134|NCT00265941|453836241|FG000|Overall Study|Lost to Follow-up|1|||
126150135|NCT00265941|453836242|FG001|Overall Study|Lost to Follow-up|1|||
126150136|NCT03816995|453836245|FG000|Overall Study|Withdrawal by Subject|3|||
126150137|NCT03816995|453836246|FG001|Overall Study|Withdrawal by Subject|1|||
126150138|NCT03816995|453836245|FG000|Overall Study|Cancelled Surgery|8|||
126150139|NCT03816995|453836246|FG001|Overall Study|Cancelled Surgery|12|||
126150140|NCT03816995|453836245|FG000|Overall Study|No wound protector used|11|||
126150141|NCT03816995|453836246|FG001|Overall Study|No wound protector used|17|||
126150142|NCT03816995|453836245|FG000|Overall Study|Protocol Violation|2|||
126150143|NCT03816995|453836246|FG001|Overall Study|Protocol Violation|3|||
126150144|NCT05882890|453836248|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
126150145|NCT00613314|453836251|FG000|Overall Study|Adverse Event|5|||
126150146|NCT00613314|453836251|FG000|Overall Study|Protocol Violation|14|||
126150147|NCT00613314|453836251|FG000|Overall Study|Lost to Follow-up|46|||
126150148|NCT00613314|453836251|FG000|Overall Study|Other reason not defined above|90|||
126150149|NCT00719810|453836252|FG000|Overall Study|Adverse Event|0|||
126150150|NCT00719810|453836253|FG001|Overall Study|Adverse Event|2|||
126150151|NCT00719810|453836254|FG002|Overall Study|Adverse Event|3|||
126150152|NCT00719810|453836252|FG000|Overall Study|Lost to Follow-up|2|||
126150153|NCT00719810|453836253|FG001|Overall Study|Lost to Follow-up|0|||
126150154|NCT00719810|453836254|FG002|Overall Study|Lost to Follow-up|3|||
126150155|NCT00719810|453836252|FG000|Overall Study|Physician Decision|0|||
126150156|NCT00719810|453836253|FG001|Overall Study|Physician Decision|1|||
126150157|NCT00719810|453836254|FG002|Overall Study|Physician Decision|0|||
126150158|NCT00719810|453836252|FG000|Overall Study|Withdrawal by Subject|1|||
126150159|NCT00719810|453836253|FG001|Overall Study|Withdrawal by Subject|1|||
126150160|NCT00719810|453836254|FG002|Overall Study|Withdrawal by Subject|2|||
126150161|NCT03090191|453836255|FG000|Overall Study|Adverse Event|90|||
126150162|NCT03090191|453836256|FG001|Overall Study|Adverse Event|72|||
126150163|NCT03090191|453836255|FG000|Overall Study|Death|365|||
126150164|NCT03090191|453836256|FG001|Overall Study|Death|358|||
126150165|NCT03090191|453836255|FG000|Overall Study|Lost to Follow-up|382|||
126150166|NCT03090191|453836256|FG001|Overall Study|Lost to Follow-up|394|||
126150167|NCT03090191|453836255|FG000|Overall Study|Physician Decision|77|||
126150168|NCT03090191|453836256|FG001|Overall Study|Physician Decision|66|||
126150169|NCT03090191|453836255|FG000|Overall Study|Protocol Violation|43|||
126150170|NCT03090191|453836256|FG001|Overall Study|Protocol Violation|52|||
126150171|NCT03090191|453836255|FG000|Overall Study|Withdrawal by Subject|2160|||
126150172|NCT03090191|453836256|FG001|Overall Study|Withdrawal by Subject|2133|||
126150173|NCT03090191|453836255|FG000|Overall Study|Site terminated|7|||
126150174|NCT03090191|453836256|FG001|Overall Study|Site terminated|8|||
126150175|NCT03090191|453836255|FG000|Overall Study|Other|66|||
126150176|NCT03090191|453836256|FG001|Overall Study|Other|60|||
126150177|NCT03090191|453836255|FG000|Overall Study|Withdrawn before any study vaccination|43|||
126150178|NCT03090191|453836256|FG001|Overall Study|Withdrawn before any study vaccination|52|||
126150179|NCT02432807|453836257|FG000|Overall Study|Adverse Event|0|||
126150180|NCT02432807|453836258|FG001|Overall Study|Adverse Event|2|||
126150181|NCT02432807|453836257|FG000|Overall Study|Lost to Follow-up|1|||
126150182|NCT02432807|453836258|FG001|Overall Study|Lost to Follow-up|0|||
126150183|NCT02432807|453836257|FG000|Overall Study|Withdrawal by Subject|1|||
126150184|NCT02432807|453836258|FG001|Overall Study|Withdrawal by Subject|1|||
126150185|NCT02432807|453836257|FG000|Overall Study|Other|1|||
126150186|NCT02432807|453836258|FG001|Overall Study|Other|1|||
126150187|NCT01845025|453836259|FG000|Overall Study|Adverse Event|6|||
126150188|NCT01845025|453836260|FG001|Overall Study|Adverse Event|3|||
126150189|NCT01845025|453836259|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126150190|NCT01845025|453836260|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126150191|NCT01845025|453836259|FG000|Overall Study|Withdrawal by Subject|48|||
126150192|NCT01845025|453836260|FG001|Overall Study|Withdrawal by Subject|44|||
126150193|NCT01845025|453836259|FG000|Overall Study|Lost to Follow-up|13|||
126150194|NCT01845025|453836260|FG001|Overall Study|Lost to Follow-up|13|||
126150195|NCT01845025|453836259|FG000|Overall Study|Administrative problems|8|||
126150196|NCT01845025|453836260|FG001|Overall Study|Administrative problems|8|||
126150197|NCT01845025|453836259|FG000|Overall Study|Death|2|||
126150198|NCT01845025|453836260|FG001|Overall Study|Death|0|||
126150199|NCT01845025|453836259|FG000|Overall Study|Protocol deviation|3|||
126150200|NCT01845025|453836260|FG001|Overall Study|Protocol deviation|6|||
126150201|NCT01845025|453836259|FG000|Overall Study|Missing|1|||
126150202|NCT01845025|453836260|FG001|Overall Study|Missing|1|||
126150203|NCT03976401|453836261|FG000|Overall Study|Adverse Event|2|||
126150204|NCT03976401|453836262|FG001|Overall Study|Adverse Event|0|||
126150205|NCT03976401|453836263|FG002|Overall Study|Adverse Event|4|||
126150206|NCT03976401|453836264|FG003|Overall Study|Adverse Event|1|||
126150207|NCT03976401|453836265|FG004|Overall Study|Adverse Event|1|||
126150208|NCT03976401|453836266|FG005|Overall Study|Adverse Event|0|||
126150209|NCT03976401|453836261|FG000|Overall Study|Withdrawal by Subject|0|||
126150210|NCT03976401|453836262|FG001|Overall Study|Withdrawal by Subject|1|||
126150211|NCT03976401|453836263|FG002|Overall Study|Withdrawal by Subject|0|||
126150212|NCT03976401|453836264|FG003|Overall Study|Withdrawal by Subject|0|||
126150213|NCT03976401|453836265|FG004|Overall Study|Withdrawal by Subject|0|||
126150214|NCT03976401|453836266|FG005|Overall Study|Withdrawal by Subject|1|||
126150215|NCT03976401|453836261|FG000|Overall Study|Physician Decision|0|||
126150216|NCT03976401|453836262|FG001|Overall Study|Physician Decision|0|||
126150217|NCT03976401|453836263|FG002|Overall Study|Physician Decision|1|||
126150218|NCT03976401|453836264|FG003|Overall Study|Physician Decision|0|||
126150219|NCT03976401|453836265|FG004|Overall Study|Physician Decision|0|||
126150220|NCT03976401|453836266|FG005|Overall Study|Physician Decision|0|||
126150221|NCT03976401|453836261|FG000|Overall Study|Lost to Follow-up|1|||
126150222|NCT03976401|453836262|FG001|Overall Study|Lost to Follow-up|2|||
126150223|NCT03976401|453836263|FG002|Overall Study|Lost to Follow-up|0|||
126150224|NCT03976401|453836264|FG003|Overall Study|Lost to Follow-up|0|||
126150225|NCT03976401|453836265|FG004|Overall Study|Lost to Follow-up|0|||
126150226|NCT03976401|453836266|FG005|Overall Study|Lost to Follow-up|0|||
126150227|NCT03976401|453836261|FG000|Overall Study|Protocol Violation|0|||
126150228|NCT03976401|453836262|FG001|Overall Study|Protocol Violation|1|||
126150229|NCT03976401|453836263|FG002|Overall Study|Protocol Violation|0|||
126150230|NCT03976401|453836264|FG003|Overall Study|Protocol Violation|0|||
126150231|NCT03976401|453836265|FG004|Overall Study|Protocol Violation|0|||
126150232|NCT03976401|453836266|FG005|Overall Study|Protocol Violation|0|||
126150233|NCT03976401|453836261|FG000|Overall Study|Withdrew Consent|0|||
126150234|NCT03976401|453836262|FG001|Overall Study|Withdrew Consent|0|||
126150235|NCT03976401|453836263|FG002|Overall Study|Withdrew Consent|0|||
126150236|NCT03976401|453836264|FG003|Overall Study|Withdrew Consent|1|||
126150237|NCT03976401|453836265|FG004|Overall Study|Withdrew Consent|0|||
126150238|NCT03976401|453836266|FG005|Overall Study|Withdrew Consent|0|||
126150239|NCT01324830|453836268|FG000|Overall Study|Progressive Disease|3|||
126150240|NCT01324830|453836269|FG001|Overall Study|Progressive Disease|2|||
126150241|NCT01324830|453836270|FG002|Overall Study|Progressive Disease|3|||
126150242|NCT01324830|453836271|FG003|Overall Study|Progressive Disease|3|||
126150243|NCT01324830|453836272|FG004|Overall Study|Progressive Disease|6|||
126150244|NCT01324830|453836273|FG005|Overall Study|Progressive Disease|6|||
126150245|NCT01324830|453836274|FG006|Overall Study|Progressive Disease|3|||
126150246|NCT01324830|453836275|FG007|Overall Study|Progressive Disease|3|||
126150247|NCT01324830|453836276|FG008|Overall Study|Progressive Disease|3|||
126150248|NCT01324830|453836277|FG009|Overall Study|Progressive Disease|6|||
126150249|NCT01324830|453836278|FG010|Overall Study|Progressive Disease|2|||
126150250|NCT01324830|453836279|FG011|Overall Study|Progressive Disease|1|||
126150251|NCT01324830|453836280|FG012|Overall Study|Progressive Disease|1|||
126150252|NCT01324830|453836281|FG013|Overall Study|Progressive Disease|1|||
126150253|NCT01324830|453836282|FG014|Overall Study|Progressive Disease|1|||
126150254|NCT01324830|453836283|FG015|Overall Study|Progressive Disease|3|||
126150255|NCT01324830|453836284|FG016|Overall Study|Progressive Disease|2|||
126150256|NCT01324830|453836285|FG017|Overall Study|Progressive Disease|3|||
126150257|NCT01324830|453836286|FG018|Overall Study|Progressive Disease|4|||
126150258|NCT01324830|453836268|FG000|Overall Study|Dose limiting toxicity|0|||
126150259|NCT01324830|453836269|FG001|Overall Study|Dose limiting toxicity|0|||
126150260|NCT01324830|453836270|FG002|Overall Study|Dose limiting toxicity|0|||
126150261|NCT01324830|453836271|FG003|Overall Study|Dose limiting toxicity|0|||
126150262|NCT01324830|453836272|FG004|Overall Study|Dose limiting toxicity|1|||
126150263|NCT01324830|453836273|FG005|Overall Study|Dose limiting toxicity|0|||
126150264|NCT01324830|453836274|FG006|Overall Study|Dose limiting toxicity|0|||
126150265|NCT01324830|453836275|FG007|Overall Study|Dose limiting toxicity|0|||
126150266|NCT01324830|453836276|FG008|Overall Study|Dose limiting toxicity|0|||
126150267|NCT01324830|453836277|FG009|Overall Study|Dose limiting toxicity|0|||
126150268|NCT01324830|453836278|FG010|Overall Study|Dose limiting toxicity|0|||
126150269|NCT01324830|453836279|FG011|Overall Study|Dose limiting toxicity|0|||
126150270|NCT01324830|453836280|FG012|Overall Study|Dose limiting toxicity|0|||
126150271|NCT01324830|453836281|FG013|Overall Study|Dose limiting toxicity|0|||
126150272|NCT01324830|453836282|FG014|Overall Study|Dose limiting toxicity|0|||
126150273|NCT01324830|453836283|FG015|Overall Study|Dose limiting toxicity|0|||
126150274|NCT01324830|453836284|FG016|Overall Study|Dose limiting toxicity|1|||
126150275|NCT01324830|453836285|FG017|Overall Study|Dose limiting toxicity|1|||
126150276|NCT01324830|453836286|FG018|Overall Study|Dose limiting toxicity|1|||
126150277|NCT01324830|453836268|FG000|Overall Study|Reason not mentioned above|0|||
126150278|NCT01324830|453836269|FG001|Overall Study|Reason not mentioned above|0|||
126150279|NCT01324830|453836270|FG002|Overall Study|Reason not mentioned above|0|||
126150280|NCT01324830|453836271|FG003|Overall Study|Reason not mentioned above|0|||
126150281|NCT01324830|453836272|FG004|Overall Study|Reason not mentioned above|0|||
126150282|NCT01324830|453836273|FG005|Overall Study|Reason not mentioned above|0|||
126150283|NCT01324830|453836274|FG006|Overall Study|Reason not mentioned above|0|||
126150284|NCT01324830|453836275|FG007|Overall Study|Reason not mentioned above|0|||
126150285|NCT01324830|453836276|FG008|Overall Study|Reason not mentioned above|0|||
126150286|NCT01324830|453836277|FG009|Overall Study|Reason not mentioned above|0|||
126150287|NCT01324830|453836278|FG010|Overall Study|Reason not mentioned above|0|||
126150288|NCT01324830|453836279|FG011|Overall Study|Reason not mentioned above|0|||
126150289|NCT01324830|453836280|FG012|Overall Study|Reason not mentioned above|0|||
126150290|NCT01324830|453836281|FG013|Overall Study|Reason not mentioned above|0|||
126150291|NCT01324830|453836282|FG014|Overall Study|Reason not mentioned above|0|||
126150292|NCT01324830|453836283|FG015|Overall Study|Reason not mentioned above|0|||
126150293|NCT01324830|453836284|FG016|Overall Study|Reason not mentioned above|0|||
126150294|NCT01324830|453836285|FG017|Overall Study|Reason not mentioned above|1|||
126150295|NCT01324830|453836286|FG018|Overall Study|Reason not mentioned above|0|||
126150296|NCT01324830|453836268|FG000|Overall Study|Adverse Event, serious fatal|0|||
126150297|NCT01324830|453836269|FG001|Overall Study|Adverse Event, serious fatal|1|||
126150298|NCT01324830|453836270|FG002|Overall Study|Adverse Event, serious fatal|0|||
126150299|NCT01324830|453836271|FG003|Overall Study|Adverse Event, serious fatal|0|||
126150300|NCT01324830|453836272|FG004|Overall Study|Adverse Event, serious fatal|0|||
126150301|NCT01324830|453836273|FG005|Overall Study|Adverse Event, serious fatal|0|||
126150302|NCT01324830|453836274|FG006|Overall Study|Adverse Event, serious fatal|0|||
126150303|NCT01324830|453836275|FG007|Overall Study|Adverse Event, serious fatal|0|||
126150304|NCT01324830|453836276|FG008|Overall Study|Adverse Event, serious fatal|0|||
126150305|NCT01324830|453836277|FG009|Overall Study|Adverse Event, serious fatal|0|||
126150306|NCT01324830|453836278|FG010|Overall Study|Adverse Event, serious fatal|0|||
126150307|NCT01324830|453836279|FG011|Overall Study|Adverse Event, serious fatal|0|||
126150308|NCT01324830|453836280|FG012|Overall Study|Adverse Event, serious fatal|0|||
126150309|NCT01324830|453836281|FG013|Overall Study|Adverse Event, serious fatal|0|||
126150310|NCT01324830|453836282|FG014|Overall Study|Adverse Event, serious fatal|0|||
126150311|NCT01324830|453836283|FG015|Overall Study|Adverse Event, serious fatal|0|||
126150312|NCT01324830|453836284|FG016|Overall Study|Adverse Event, serious fatal|0|||
126150313|NCT01324830|453836285|FG017|Overall Study|Adverse Event, serious fatal|0|||
126150314|NCT01324830|453836286|FG018|Overall Study|Adverse Event, serious fatal|0|||
126150315|NCT01324830|453836268|FG000|Overall Study|Adverse Event, non-fatal|0|||
126150316|NCT01324830|453836269|FG001|Overall Study|Adverse Event, non-fatal|0|||
126150317|NCT01324830|453836270|FG002|Overall Study|Adverse Event, non-fatal|0|||
126150318|NCT01324830|453836271|FG003|Overall Study|Adverse Event, non-fatal|0|||
126150319|NCT01324830|453836272|FG004|Overall Study|Adverse Event, non-fatal|0|||
126150320|NCT01324830|453836273|FG005|Overall Study|Adverse Event, non-fatal|0|||
126150321|NCT01324830|453836274|FG006|Overall Study|Adverse Event, non-fatal|0|||
126150322|NCT01324830|453836275|FG007|Overall Study|Adverse Event, non-fatal|0|||
126150323|NCT01324830|453836276|FG008|Overall Study|Adverse Event, non-fatal|2|||
126150324|NCT01324830|453836277|FG009|Overall Study|Adverse Event, non-fatal|0|||
126150325|NCT01324830|453836278|FG010|Overall Study|Adverse Event, non-fatal|1|||
126150326|NCT01324830|453836279|FG011|Overall Study|Adverse Event, non-fatal|0|||
126150327|NCT01324830|453836280|FG012|Overall Study|Adverse Event, non-fatal|0|||
126150328|NCT01324830|453836281|FG013|Overall Study|Adverse Event, non-fatal|0|||
126150329|NCT01324830|453836282|FG014|Overall Study|Adverse Event, non-fatal|0|||
126150330|NCT01324830|453836283|FG015|Overall Study|Adverse Event, non-fatal|0|||
126150331|NCT01324830|453836284|FG016|Overall Study|Adverse Event, non-fatal|0|||
126150332|NCT01324830|453836285|FG017|Overall Study|Adverse Event, non-fatal|1|||
126150333|NCT01324830|453836286|FG018|Overall Study|Adverse Event, non-fatal|0|||
126150334|NCT01324830|453836268|FG000|Overall Study|Withdrawal by Subject|0|||
126150335|NCT01324830|453836269|FG001|Overall Study|Withdrawal by Subject|0|||
126150336|NCT01324830|453836270|FG002|Overall Study|Withdrawal by Subject|0|||
126150337|NCT01324830|453836271|FG003|Overall Study|Withdrawal by Subject|0|||
126150338|NCT01324830|453836272|FG004|Overall Study|Withdrawal by Subject|0|||
126150339|NCT01324830|453836273|FG005|Overall Study|Withdrawal by Subject|1|||
126150340|NCT01324830|453836274|FG006|Overall Study|Withdrawal by Subject|0|||
126150341|NCT01324830|453836275|FG007|Overall Study|Withdrawal by Subject|0|||
126150342|NCT01324830|453836276|FG008|Overall Study|Withdrawal by Subject|0|||
126150343|NCT01324830|453836277|FG009|Overall Study|Withdrawal by Subject|0|||
126150344|NCT01324830|453836278|FG010|Overall Study|Withdrawal by Subject|1|||
126150345|NCT01324830|453836279|FG011|Overall Study|Withdrawal by Subject|0|||
126150346|NCT01324830|453836280|FG012|Overall Study|Withdrawal by Subject|0|||
126150347|NCT01324830|453836281|FG013|Overall Study|Withdrawal by Subject|0|||
125971357|NCT00695903|453182809|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
126150348|NCT01324830|453836282|FG014|Overall Study|Withdrawal by Subject|0|||
126150349|NCT01324830|453836283|FG015|Overall Study|Withdrawal by Subject|0|||
126150350|NCT01324830|453836284|FG016|Overall Study|Withdrawal by Subject|0|||
126150351|NCT01324830|453836285|FG017|Overall Study|Withdrawal by Subject|0|||
125971358|NCT00695903|453182810|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
126150352|NCT01324830|453836286|FG018|Overall Study|Withdrawal by Subject|1|||
126150353|NCT01973283|453836287|FG000|Overall Study|Lost to Follow-up|4|||
126150354|NCT00942409|453836288|FG000|Overall Study|Lack of Efficacy|1|||
126150355|NCT00942409|453836288|FG000|Overall Study|study drug unavailable|2|||
126150356|NCT00817414|453836293|FG000|Overall Study|Adverse Event|1|||
126150357|NCT00817414|453836294|FG001|Overall Study|Adverse Event|1|||
126150358|NCT00817414|453836295|FG002|Overall Study|Adverse Event|1|||
126150359|NCT00817414|453836296|FG003|Overall Study|Adverse Event|0|||
126150360|NCT00817414|453836297|FG004|Overall Study|Adverse Event|0|||
126150361|NCT00817414|453836293|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
126150362|NCT00817414|453836294|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
126150363|NCT00817414|453836295|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
126150364|NCT00817414|453836296|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
126150365|NCT00817414|453836297|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
126150366|NCT00817414|453836293|FG000|Overall Study|Withdrawal by Subject|1|||
126150367|NCT00817414|453836294|FG001|Overall Study|Withdrawal by Subject|1|||
126150368|NCT00817414|453836295|FG002|Overall Study|Withdrawal by Subject|0|||
126150369|NCT00817414|453836296|FG003|Overall Study|Withdrawal by Subject|0|||
126150370|NCT00817414|453836297|FG004|Overall Study|Withdrawal by Subject|0|||
126150371|NCT00817414|453836293|FG000|Overall Study|Lost to Follow-up|0|||
126150372|NCT00817414|453836294|FG001|Overall Study|Lost to Follow-up|0|||
126150373|NCT00817414|453836295|FG002|Overall Study|Lost to Follow-up|1|||
126150374|NCT00817414|453836296|FG003|Overall Study|Lost to Follow-up|1|||
126150375|NCT00817414|453836297|FG004|Overall Study|Lost to Follow-up|1|||
126150376|NCT00817414|453836293|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
126150377|NCT00817414|453836294|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
126150378|NCT00817414|453836295|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
126150379|NCT00817414|453836296|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
126150380|NCT00817414|453836297|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
126150381|NCT00817414|453836293|FG000|Overall Study|Protocol Violation|0|||
126150382|NCT00817414|453836294|FG001|Overall Study|Protocol Violation|0|||
126150383|NCT00817414|453836295|FG002|Overall Study|Protocol Violation|0|||
126150384|NCT00817414|453836296|FG003|Overall Study|Protocol Violation|0|||
126150385|NCT00817414|453836297|FG004|Overall Study|Protocol Violation|1|||
126150386|NCT00097539|453836300|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
126150387|NCT00097539|453836301|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
126150388|NCT00097539|453836302|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
126150389|NCT00097539|453836303|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
126150390|NCT00097539|453836304|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
126150391|NCT00097539|453836305|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
126150392|NCT00097539|453836306|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
126150393|NCT00097539|453836300|FG000|Overall Study|Withdrawal by Subject|925|||
126150394|NCT00097539|453836301|FG001|Overall Study|Withdrawal by Subject|323|||
126150395|NCT00097539|453836302|FG002|Overall Study|Withdrawal by Subject|346|||
126150396|NCT00097539|453836303|FG003|Overall Study|Withdrawal by Subject|217|||
126150397|NCT00097539|453836304|FG004|Overall Study|Withdrawal by Subject|68|||
126150398|NCT00097539|453836305|FG005|Overall Study|Withdrawal by Subject|229|||
126150399|NCT00097539|453836306|FG006|Overall Study|Withdrawal by Subject|3|||
126150400|NCT00097539|453836300|FG000|Overall Study|Participant Non-compliant|2140|||
126150401|NCT00097539|453836301|FG001|Overall Study|Participant Non-compliant|567|||
126150402|NCT00097539|453836302|FG002|Overall Study|Participant Non-compliant|1067|||
126150403|NCT00097539|453836303|FG003|Overall Study|Participant Non-compliant|353|||
126150404|NCT00097539|453836304|FG004|Overall Study|Participant Non-compliant|136|||
126150405|NCT00097539|453836305|FG005|Overall Study|Participant Non-compliant|543|||
126150406|NCT00097539|453836306|FG006|Overall Study|Participant Non-compliant|18|||
126150407|NCT00097539|453836300|FG000|Overall Study|Lack of Efficacy|249|||
126150408|NCT00097539|453836301|FG001|Overall Study|Lack of Efficacy|122|||
126150409|NCT00097539|453836302|FG002|Overall Study|Lack of Efficacy|202|||
126150410|NCT00097539|453836303|FG003|Overall Study|Lack of Efficacy|105|||
126150411|NCT00097539|453836304|FG004|Overall Study|Lack of Efficacy|45|||
126150412|NCT00097539|453836305|FG005|Overall Study|Lack of Efficacy|228|||
126150413|NCT00097539|453836306|FG006|Overall Study|Lack of Efficacy|5|||
126150414|NCT00097539|453836300|FG000|Overall Study|Adverse Event|78|||
126150415|NCT00097539|453836301|FG001|Overall Study|Adverse Event|133|||
126150416|NCT00097539|453836302|FG002|Overall Study|Adverse Event|37|||
125971359|NCT00695903|453182809|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
125971360|NCT00695903|453182810|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
125971361|NCT00695903|453182809|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
126150417|NCT00097539|453836303|FG003|Overall Study|Adverse Event|27|||
126150418|NCT00097539|453836304|FG004|Overall Study|Adverse Event|30|||
126150419|NCT00097539|453836305|FG005|Overall Study|Adverse Event|59|||
126150420|NCT00097539|453836306|FG006|Overall Study|Adverse Event|1|||
126150421|NCT00097539|453836300|FG000|Overall Study|Death|2|||
126150422|NCT00097539|453836301|FG001|Overall Study|Death|7|||
126150423|NCT00097539|453836302|FG002|Overall Study|Death|0|||
126150424|NCT00097539|453836303|FG003|Overall Study|Death|0|||
126150425|NCT00097539|453836304|FG004|Overall Study|Death|1|||
126150426|NCT00097539|453836305|FG005|Overall Study|Death|3|||
126150427|NCT00097539|453836306|FG006|Overall Study|Death|0|||
126150428|NCT00097539|453836300|FG000|Overall Study|Reasons Other Than Above|3602|||
126150429|NCT00097539|453836301|FG001|Overall Study|Reasons Other Than Above|1382|||
126150430|NCT00097539|453836302|FG002|Overall Study|Reasons Other Than Above|1757|||
126150431|NCT00097539|453836303|FG003|Overall Study|Reasons Other Than Above|692|||
126150432|NCT00097539|453836304|FG004|Overall Study|Reasons Other Than Above|361|||
126150433|NCT00097539|453836305|FG005|Overall Study|Reasons Other Than Above|1244|||
126150434|NCT00097539|453836306|FG006|Overall Study|Reasons Other Than Above|34|||
126150435|NCT00097539|453836300|FG000|Overall Study|Reason not Specified|111|||
126150436|NCT00097539|453836301|FG001|Overall Study|Reason not Specified|49|||
126150437|NCT00097539|453836302|FG002|Overall Study|Reason not Specified|53|||
126150438|NCT00097539|453836303|FG003|Overall Study|Reason not Specified|21|||
126150439|NCT00097539|453836304|FG004|Overall Study|Reason not Specified|11|||
126150440|NCT00097539|453836305|FG005|Overall Study|Reason not Specified|40|||
126150441|NCT00097539|453836306|FG006|Overall Study|Reason not Specified|2|||
126150442|NCT02966314|453836307|FG000|Overall Study|Lost to Follow-up|1|||
126150443|NCT02966314|453836308|FG001|Overall Study|Lost to Follow-up|0|||
126150444|NCT03941548|453836309|FG000|Overall Study|Adverse Event|0|||
126150445|NCT03941548|453836310|FG001|Overall Study|Adverse Event|1|||
126150446|NCT03941548|453836309|FG000|Overall Study|Lost to Follow-up|0|||
126150447|NCT03941548|453836310|FG001|Overall Study|Lost to Follow-up|1|||
126150448|NCT03941548|453836309|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
126150449|NCT03941548|453836310|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
126150450|NCT02015819|453836314|FG000|Overall Study|Rickham catheter was misaligned|0|||
126150451|NCT02015819|453836315|FG001|Overall Study|Rickham catheter was misaligned|0|||
126150452|NCT02015819|453836316|FG002|Overall Study|Rickham catheter was misaligned|0|||
126150453|NCT02015819|453836317|FG003|Overall Study|Rickham catheter was misaligned|1|||
126150454|NCT02945657|453836318|FG000|Overall Study|Adverse Event|1|||
126150455|NCT02945657|453836318|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
126150456|NCT00811252|453836320|FG000|Overall Study|Adverse Event|6|||
126150457|NCT00811252|453836321|FG001|Overall Study|Adverse Event|10|||
126150458|NCT00811252|453836322|FG002|Overall Study|Adverse Event|15|||
126150459|NCT00811252|453836320|FG000|Overall Study|Lack of Efficacy|7|||
126150460|NCT00811252|453836321|FG001|Overall Study|Lack of Efficacy|2|||
126150461|NCT00811252|453836322|FG002|Overall Study|Lack of Efficacy|0|||
126150462|NCT00811252|453836320|FG000|Overall Study|Protocol Violation|3|||
126150463|NCT00811252|453836321|FG001|Overall Study|Protocol Violation|3|||
126150464|NCT00811252|453836322|FG002|Overall Study|Protocol Violation|2|||
126150465|NCT00811252|453836320|FG000|Overall Study|Withdrawal of Consent|1|||
126150466|NCT00811252|453836321|FG001|Overall Study|Withdrawal of Consent|2|||
126150467|NCT00811252|453836322|FG002|Overall Study|Withdrawal of Consent|2|||
126150468|NCT00811252|453836320|FG000|Overall Study|Lost to Follow-up|0|||
126150469|NCT00811252|453836321|FG001|Overall Study|Lost to Follow-up|0|||
126150470|NCT00811252|453836322|FG002|Overall Study|Lost to Follow-up|2|||
126150471|NCT00811252|453836320|FG000|Overall Study|Administrative or Other Reasons|0|||
126150472|NCT00811252|453836321|FG001|Overall Study|Administrative or Other Reasons|3|||
126150473|NCT00811252|453836322|FG002|Overall Study|Administrative or Other Reasons|2|||
126150474|NCT01486264|453836323|FG000|Overall Study|Death|1|||
126150475|NCT01486264|453836324|FG001|Overall Study|Death|1|||
126150476|NCT01486264|453836323|FG000|Overall Study|Adverse Event|3|||
126150477|NCT01486264|453836324|FG001|Overall Study|Adverse Event|3|||
126150478|NCT01486264|453836323|FG000|Overall Study|Lack of Efficacy|6|||
126150479|NCT01486264|453836324|FG001|Overall Study|Lack of Efficacy|10|||
126150480|NCT01486264|453836323|FG000|Overall Study|Withdrawal by Subject|7|||
126150481|NCT01486264|453836324|FG001|Overall Study|Withdrawal by Subject|18|||
126150482|NCT01486264|453836323|FG000|Overall Study|Physician Decision|1|||
126150483|NCT01486264|453836324|FG001|Overall Study|Physician Decision|1|||
126150484|NCT01486264|453836323|FG000|Overall Study|Protocol Violation|3|||
126150485|NCT01486264|453836324|FG001|Overall Study|Protocol Violation|0|||
126150486|NCT01486264|453836323|FG000|Overall Study|Lost to Follow-up|3|||
126150487|NCT01486264|453836324|FG001|Overall Study|Lost to Follow-up|2|||
126150488|NCT01486264|453836323|FG000|Overall Study|Other|5|||
126150489|NCT01486264|453836324|FG001|Overall Study|Other|11|||
126150490|NCT01486264|453836323|FG000|Overall Study|Not treated|0|||
126150491|NCT01486264|453836324|FG001|Overall Study|Not treated|1|||
126150492|NCT00813748|453836325|FG000|Skin Test Substudy|Physician Decision|0|||
126150493|NCT00813748|453836326|FG001|Skin Test Substudy|Physician Decision|1|||
126150494|NCT03584009|453836331|FG000|Overall Study|Death|25|||
126150495|NCT03584009|453836332|FG001|Overall Study|Death|18|||
126150496|NCT03584009|453836331|FG000|Overall Study|Lost to Follow-up|0|||
126150497|NCT03584009|453836332|FG001|Overall Study|Lost to Follow-up|1|||
126150498|NCT03584009|453836331|FG000|Overall Study|Physician Decision|1|||
126150499|NCT03584009|453836332|FG001|Overall Study|Physician Decision|1|||
126150500|NCT03584009|453836331|FG000|Overall Study|Study Terminated by Sponsor|22|||
126150501|NCT03584009|453836332|FG001|Overall Study|Study Terminated by Sponsor|30|||
126150502|NCT03584009|453836331|FG000|Overall Study|Withdrawal by Subject|3|||
126150503|NCT03584009|453836332|FG001|Overall Study|Withdrawal by Subject|2|||
126150504|NCT00222105|453836333|FG000|Overall Study|Removed due to wrong diagnosis|1|||
126150505|NCT00222105|453836333|FG000|Overall Study|Withdrawal by Subject|1|||
126150506|NCT00222105|453836333|FG000|Overall Study|Adverse Event|8|||
126150507|NCT00222105|453836333|FG000|Overall Study|Treatment delays|2|||
126150508|NCT00222105|453836333|FG000|Overall Study|Death|2|||
126150509|NCT00824421|453836347|FG000|Overall Study|Adverse Event|6|||
126150510|NCT00824421|453836348|FG001|Overall Study|Adverse Event|6|||
126150511|NCT00824421|453836349|FG002|Overall Study|Adverse Event|6|||
126150512|NCT00824421|453836347|FG000|Overall Study|Death|0|||
126150513|NCT00824421|453836348|FG001|Overall Study|Death|1|||
126150514|NCT00824421|453836349|FG002|Overall Study|Death|0|||
126150515|NCT00824421|453836347|FG000|Overall Study|Lack of Efficacy|5|||
126150516|NCT00824421|453836348|FG001|Overall Study|Lack of Efficacy|7|||
126150517|NCT00824421|453836349|FG002|Overall Study|Lack of Efficacy|4|||
126150518|NCT00824421|453836347|FG000|Overall Study|Lost to Follow-up|2|||
126150519|NCT00824421|453836348|FG001|Overall Study|Lost to Follow-up|3|||
126150520|NCT00824421|453836349|FG002|Overall Study|Lost to Follow-up|0|||
126150521|NCT00824421|453836347|FG000|Overall Study|Pregnancy|1|||
126150522|NCT00824421|453836348|FG001|Overall Study|Pregnancy|0|||
126150523|NCT00824421|453836349|FG002|Overall Study|Pregnancy|1|||
126150524|NCT00824421|453836347|FG000|Overall Study|Withdrawal by Subject|2|||
126150525|NCT00824421|453836348|FG001|Overall Study|Withdrawal by Subject|3|||
126150526|NCT00824421|453836349|FG002|Overall Study|Withdrawal by Subject|3|||
126150527|NCT00824421|453836347|FG000|Overall Study|Randomized but not Treated|1|||
126150528|NCT00824421|453836348|FG001|Overall Study|Randomized but not Treated|1|||
126150529|NCT00824421|453836349|FG002|Overall Study|Randomized but not Treated|0|||
126150530|NCT00824421|453836347|FG000|Overall Study|Other|0|||
126150531|NCT00824421|453836348|FG001|Overall Study|Other|1|||
126150532|NCT00824421|453836349|FG002|Overall Study|Other|0|||
126150533|NCT02120417|453836351|FG000|Overall Study|Death|5|||
126150534|NCT02120417|453836352|FG001|Overall Study|Death|1|||
126150535|NCT02120417|453836351|FG000|Overall Study|Adverse Event|3|||
126150536|NCT02120417|453836352|FG001|Overall Study|Adverse Event|9|||
126150537|NCT02120417|453836351|FG000|Overall Study|Participant decision|4|||
126150538|NCT02120417|453836352|FG001|Overall Study|Participant decision|4|||
126150539|NCT02120417|453836351|FG000|Overall Study|Disease progression|41|||
126150540|NCT02120417|453836352|FG001|Overall Study|Disease progression|45|||
126150541|NCT02120417|453836351|FG000|Overall Study|Noncompliance with study treatment|0|||
126150542|NCT02120417|453836352|FG001|Overall Study|Noncompliance with study treatment|2|||
126150543|NCT02120417|453836351|FG000|Overall Study|Physician Decision|2|||
126150544|NCT02120417|453836352|FG001|Overall Study|Physician Decision|3|||
126150545|NCT02120417|453836351|FG000|Overall Study|Other unspecified|5|||
126150546|NCT02120417|453836352|FG001|Overall Study|Other unspecified|4|||
126150547|NCT00927485|453836353|FG000|Overall Study|Adverse Event|4|||
126150548|NCT00927485|453836354|FG001|Overall Study|Adverse Event|2|||
126150549|NCT00927485|453836353|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
126150550|NCT00927485|453836354|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
126150551|NCT02604264|453836356|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
126150552|NCT02604264|453836357|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
126150553|NCT00855439|453836360|FG000|Overall Study|Withdrawal by Subject|2|||
126150554|NCT00855439|453836361|FG001|Overall Study|Withdrawal by Subject|0|||
126150555|NCT00855439|453836360|FG000|Overall Study|Pregnancy|1|||
126150556|NCT00855439|453836361|FG001|Overall Study|Pregnancy|0|||
126150557|NCT00457639|453836363|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
126150558|NCT00457639|453836364|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
126150559|NCT00457639|453836363|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
126150560|NCT00457639|453836364|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
126150561|NCT00457639|453836363|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
126150562|NCT00457639|453836364|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
126150563|NCT04885257|453836365|FG000|Overall Study|Withdrawal by Subject|1|||
126150564|NCT04885257|453836366|FG001|Overall Study|Withdrawal by Subject|0|||
126150565|NCT00256295|453836367|FG000|Overall Study|Withdrawal by Subject|3|||
126150566|NCT00256295|453836367|FG000|Overall Study|Death|1|||
126150567|NCT01731002|453836377|FG000|Overall Study|Adverse Event|0|||
126150568|NCT01731002|453836378|FG001|Overall Study|Adverse Event|2|||
126150569|NCT01731002|453836379|FG002|Overall Study|Adverse Event|2|||
126150570|NCT01731002|453836377|FG000|Overall Study|Non-Compliant|0|||
126150571|NCT01731002|453836378|FG001|Overall Study|Non-Compliant|1|||
126150572|NCT01731002|453836379|FG002|Overall Study|Non-Compliant|0|||
126150573|NCT01731002|453836377|FG000|Overall Study|Lost to Follow-up|1|||
126150574|NCT01731002|453836378|FG001|Overall Study|Lost to Follow-up|0|||
126150575|NCT01731002|453836379|FG002|Overall Study|Lost to Follow-up|0|||
126150576|NCT01731002|453836377|FG000|Overall Study|Test Agent Discontinuation|0|||
126150577|NCT01731002|453836378|FG001|Overall Study|Test Agent Discontinuation|1|||
126150578|NCT01731002|453836379|FG002|Overall Study|Test Agent Discontinuation|0|||
126150579|NCT01731002|453836377|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
126150580|NCT01731002|453836378|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
126150581|NCT01731002|453836379|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
126150582|NCT01731002|453836377|FG000|Overall Study|Elevated IOP|1|||
126150583|NCT01731002|453836378|FG001|Overall Study|Elevated IOP|0|||
126150584|NCT01731002|453836379|FG002|Overall Study|Elevated IOP|0|||
126150585|NCT01731002|453836377|FG000|Overall Study|Inappropriate use of study medications|0|||
126150586|NCT01731002|453836378|FG001|Overall Study|Inappropriate use of study medications|0|||
126150587|NCT01731002|453836379|FG002|Overall Study|Inappropriate use of study medications|1|||
126150588|NCT00628355|453836382|FG000|Overall Study|Withdrawal by Subject|1|||
126150589|NCT00628355|453836383|FG001|Overall Study|Withdrawal by Subject|1|||
126150590|NCT03542682|453836384|FG000|Overall Study|COVID-19 Protocol|0|||
126150591|NCT03542682|453836385|FG001|Overall Study|COVID-19 Protocol|1|||
126150592|NCT00853632|453838029|FG000|Overall Study|Death|88|||
126150593|NCT00853632|453838029|FG000|Overall Study|Withdrawal by Subject|45|||
126150594|NCT00853632|453838029|FG000|Overall Study|Lost to Follow-up|30|||
126150595|NCT00853632|453838029|FG000|Overall Study|Reoperation/Explant|17|||
126150596|NCT00853632|453838029|FG000|Overall Study|Exit with other reason|22|||
126150597|NCT00886821|453838035|FG000|Stage 2|Adverse Event|0|||
126150598|NCT00886821|453838036|FG001|Stage 2|Adverse Event|0|||
126150599|NCT00886821|453838037|FG002|Stage 2|Adverse Event|0|||
126150600|NCT00886821|453838038|FG003|Stage 2|Adverse Event|0|||
126150601|NCT00886821|453838039|FG004|Stage 2|Adverse Event|0|||
126150602|NCT00886821|453838040|FG005|Stage 2|Adverse Event|0|||
126150603|NCT00886821|453838041|FG006|Stage 2|Adverse Event|0|||
126150604|NCT00886821|453838042|FG007|Stage 2|Adverse Event|0|||
126150605|NCT00886821|453838043|FG008|Stage 2|Adverse Event|0|||
126150606|NCT00886821|453838044|FG009|Stage 2|Adverse Event|0|||
126150607|NCT00886821|453838045|FG010|Stage 2|Adverse Event|0|||
126150608|NCT00886821|453838046|FG011|Stage 2|Adverse Event|1|||
126150609|NCT00886821|453838047|FG012|Stage 2|Adverse Event|3|||
126150610|NCT00886821|453838048|FG013|Stage 2|Adverse Event|0|||
126150611|NCT00886821|453838035|FG000|Stage 2|Lost to Follow-up|0|||
126150612|NCT00886821|453838036|FG001|Stage 2|Lost to Follow-up|0|||
126150613|NCT00886821|453838037|FG002|Stage 2|Lost to Follow-up|0|||
126150614|NCT00886821|453838038|FG003|Stage 2|Lost to Follow-up|0|||
126150615|NCT00886821|453838039|FG004|Stage 2|Lost to Follow-up|0|||
126150616|NCT00886821|453838040|FG005|Stage 2|Lost to Follow-up|0|||
126150617|NCT00886821|453838041|FG006|Stage 2|Lost to Follow-up|0|||
126150618|NCT00886821|453838042|FG007|Stage 2|Lost to Follow-up|0|||
126150619|NCT00886821|453838043|FG008|Stage 2|Lost to Follow-up|0|||
126150620|NCT00886821|453838044|FG009|Stage 2|Lost to Follow-up|0|||
126150621|NCT00886821|453838045|FG010|Stage 2|Lost to Follow-up|0|||
126150622|NCT00886821|453838046|FG011|Stage 2|Lost to Follow-up|0|||
126150623|NCT00886821|453838047|FG012|Stage 2|Lost to Follow-up|2|||
126150624|NCT00886821|453838048|FG013|Stage 2|Lost to Follow-up|1|||
126150625|NCT00914628|453838049|FG000|Overall Study|Death|35|||
126150626|NCT00914628|453838050|FG001|Overall Study|Death|17|||
126150627|NCT00914628|453838049|FG000|Overall Study|Medical decision|4|||
126150628|NCT00914628|453838050|FG001|Overall Study|Medical decision|0|||
126150629|NCT00914628|453838049|FG000|Overall Study|Protocol Violation|1|||
126150630|NCT00914628|453838050|FG001|Overall Study|Protocol Violation|0|||
126150631|NCT00914628|453838049|FG000|Overall Study|Lack of Efficacy|1|||
126150632|NCT00914628|453838050|FG001|Overall Study|Lack of Efficacy|0|||
126150633|NCT00914628|453838049|FG000|Overall Study|non-randomized|1|||
126150634|NCT00914628|453838050|FG001|Overall Study|non-randomized|0|||
126150635|NCT00914628|453838049|FG000|Overall Study|Relapse|1|||
126150636|NCT00914628|453838050|FG001|Overall Study|Relapse|2|||
126150637|NCT00914628|453838049|FG000|Overall Study|Study terminated by Sponsor|14|||
126150638|NCT00914628|453838050|FG001|Overall Study|Study terminated by Sponsor|8|||
126150639|NCT00914628|453838049|FG000|Overall Study|Patients who did not receive a single dose|7|||
126150640|NCT00914628|453838050|FG001|Overall Study|Patients who did not receive a single dose|1|||
126150641|NCT03404960|453838051|FG000|Overall Study|Adverse Event|0|||
126150642|NCT03404960|453838052|FG001|Overall Study|Adverse Event|2|||
126150643|NCT03404960|453838051|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
126150644|NCT03404960|453838052|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
126150645|NCT03404960|453838051|FG000|Overall Study|Bowel obstruction|0|||
126150646|NCT03404960|453838052|FG001|Overall Study|Bowel obstruction|1|||
126150647|NCT03404960|453838051|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
126150648|NCT03404960|453838052|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
126150649|NCT03311126|453838053|FG000|Induction|Death|1|||
126150650|NCT03311126|453838053|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
126150651|NCT03368859|453838056|FG000|Overall Study|Withdrew Consent|5|||
126150652|NCT03368859|453838057|FG001|Overall Study|Withdrew Consent|4|||
126150653|NCT03368859|453838056|FG000|Overall Study|Death|12|||
126150654|NCT03368859|453838057|FG001|Overall Study|Death|6|||
126150655|NCT03368859|453838056|FG000|Overall Study|Study terminated by Sponsor|18|||
126150656|NCT03368859|453838057|FG001|Overall Study|Study terminated by Sponsor|23|||
126150657|NCT03368859|453838056|FG000|Overall Study|Other|1|||
126150658|NCT03368859|453838057|FG001|Overall Study|Other|1|||
126150659|NCT02698410|453838058|FG000|Overall Study|Adverse Event|2|||
126150660|NCT02698410|453838058|FG000|Overall Study|Withdrawal by Subject|1|||
126150661|NCT02698410|453838058|FG000|Overall Study|Other|1|||
126150662|NCT02559505|453838059|FG000|Overall Study|Lost to Follow-up|23|||
126150663|NCT02559505|453838060|FG001|Overall Study|Lost to Follow-up|20|||
126150664|NCT02559505|453838059|FG000|Overall Study|Withdrawal by Subject|4|||
126150665|NCT02559505|453838060|FG001|Overall Study|Withdrawal by Subject|2|||
126150666|NCT01584024|453838061|FG000|Overall Study|Lost to Follow-up|10|||
126150667|NCT01584024|453838061|FG000|Overall Study|Withdrawal by Subject|3|||
126150668|NCT01217606|453838062|FG000|Initial Treatment Phase|Other Reasons|0|||
126150669|NCT01217606|453838063|FG001|Initial Treatment Phase|Other Reasons|2|||
126150670|NCT01217606|453838062|FG000|Initial Treatment Phase|Protocol Violation|3|||
126150671|NCT01217606|453838063|FG001|Initial Treatment Phase|Protocol Violation|2|||
126150672|NCT01217606|453838062|FG000|Initial Treatment Phase|Personal Reasons|0|||
126150673|NCT01217606|453838063|FG001|Initial Treatment Phase|Personal Reasons|2|||
126150674|NCT01217606|453838062|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
126150675|NCT01217606|453838063|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
126150676|NCT01217606|453838062|FG000|Initial Treatment Phase|Adverse Event|10|||
126150677|NCT01217606|453838063|FG001|Initial Treatment Phase|Adverse Event|6|||
126150678|NCT01217606|453838062|FG000|9-Month Masked Extension|Adverse Event|3|||
126150679|NCT01217606|453838063|FG001|9-Month Masked Extension|Adverse Event|6|||
126150680|NCT01217606|453838062|FG000|9-Month Masked Extension|Other Reasons|4|||
126150681|NCT01217606|453838063|FG001|9-Month Masked Extension|Other Reasons|4|||
126150682|NCT01217606|453838062|FG000|9-Month Masked Extension|Personal Reasons|2|||
126150683|NCT01217606|453838063|FG001|9-Month Masked Extension|Personal Reasons|1|||
126150684|NCT01217606|453838062|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
126150685|NCT01217606|453838063|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
126150686|NCT01217606|453838062|FG000|9-Month Masked Extension|Pregnancy|1|||
126150687|NCT01217606|453838063|FG001|9-Month Masked Extension|Pregnancy|0|||
126150688|NCT01217606|453838062|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
126150689|NCT01217606|453838063|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
126150690|NCT00893789|453838073|FG000|Overall Study|Withdrawal by Subject|3|||
126150691|NCT00893789|453838074|FG001|Overall Study|Withdrawal by Subject|1|||
126150692|NCT00893789|453838075|FG002|Overall Study|Withdrawal by Subject|3|||
126150693|NCT00893789|453838076|FG003|Overall Study|Withdrawal by Subject|1|||
126150694|NCT00893789|453838073|FG000|Overall Study|Noncompliance With Study Drug|1|||
126150695|NCT00893789|453838074|FG001|Overall Study|Noncompliance With Study Drug|0|||
126150696|NCT00893789|453838075|FG002|Overall Study|Noncompliance With Study Drug|1|||
126150697|NCT00893789|453838076|FG003|Overall Study|Noncompliance With Study Drug|2|||
126150698|NCT00893789|453838073|FG000|Overall Study|Noncompliance With Study Procedures|1|||
125971362|NCT00695903|453182810|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
125971363|NCT00695903|453182809|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
126150699|NCT00893789|453838074|FG001|Overall Study|Noncompliance With Study Procedures|0|||
126150700|NCT00893789|453838075|FG002|Overall Study|Noncompliance With Study Procedures|0|||
126150701|NCT00893789|453838076|FG003|Overall Study|Noncompliance With Study Procedures|0|||
126150702|NCT00893789|453838073|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
126150703|NCT00893789|453838074|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
126150704|NCT00893789|453838075|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
126150705|NCT00893789|453838076|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
126150706|NCT00893789|453838073|FG000|Overall Study|Adverse Event|0|||
126150707|NCT00893789|453838074|FG001|Overall Study|Adverse Event|2|||
126150708|NCT00893789|453838075|FG002|Overall Study|Adverse Event|1|||
126150709|NCT00893789|453838076|FG003|Overall Study|Adverse Event|5|||
126150710|NCT00893789|453838073|FG000|Overall Study|Protocol Violation|0|||
126150711|NCT00893789|453838074|FG001|Overall Study|Protocol Violation|1|||
126150712|NCT00893789|453838075|FG002|Overall Study|Protocol Violation|1|||
126150713|NCT00893789|453838076|FG003|Overall Study|Protocol Violation|4|||
126150714|NCT00893789|453838073|FG000|Overall Study|Lost to Follow-up|0|||
126150715|NCT00893789|453838074|FG001|Overall Study|Lost to Follow-up|0|||
126150716|NCT00893789|453838075|FG002|Overall Study|Lost to Follow-up|0|||
126150717|NCT00893789|453838076|FG003|Overall Study|Lost to Follow-up|1|||
126150718|NCT04723537|453838077|FG000|Overall Study|Withdrawal by Subject|3|||
126150719|NCT04723537|453838078|FG001|Overall Study|Withdrawal by Subject|0|||
126150720|NCT04723537|453838079|FG002|Overall Study|Withdrawal by Subject|0|||
126150721|NCT04723537|453838077|FG000|Overall Study|Physician Decision|0|||
126150722|NCT04723537|453838078|FG001|Overall Study|Physician Decision|0|||
126150723|NCT04723537|453838079|FG002|Overall Study|Physician Decision|1|||
126150724|NCT04723537|453838077|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
126150725|NCT04723537|453838078|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
126150726|NCT04723537|453838079|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
125971364|NCT00695903|453182810|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
126150727|NCT05408858|453838080|FG000|Overall Study|no longer met eligibility criteria|1|||
126150728|NCT04419506|453838081|FG000|Overall Study|Adverse Event|0|||
126150729|NCT04419506|453838082|FG001|Overall Study|Adverse Event|10|||
126150730|NCT04419506|453838083|FG002|Overall Study|Adverse Event|0|||
126150731|NCT04419506|453838084|FG003|Overall Study|Adverse Event|3|||
126150732|NCT04419506|453838081|FG000|Overall Study|Withdrawal by Subject|0|||
126150733|NCT04419506|453838082|FG001|Overall Study|Withdrawal by Subject|0|||
126150734|NCT04419506|453838083|FG002|Overall Study|Withdrawal by Subject|0|||
126150735|NCT04419506|453838084|FG003|Overall Study|Withdrawal by Subject|1|||
126150736|NCT04419506|453838081|FG000|Overall Study|poor-compliance|0|||
126150737|NCT04419506|453838082|FG001|Overall Study|poor-compliance|0|||
126150738|NCT04419506|453838083|FG002|Overall Study|poor-compliance|0|||
126150739|NCT04419506|453838084|FG003|Overall Study|poor-compliance|1|||
126150740|NCT03717922|453838091|FG000|Overall Study|Lost to Follow-up|2|||
126150741|NCT03717922|453838092|FG001|Overall Study|Lost to Follow-up|2|||
126150742|NCT01242111|453838093|FG000|Overall Study|Adverse Event|1|||
126150743|NCT01242111|453838093|FG000|Overall Study|Withdrawal by Subject|1|||
126150744|NCT01242111|453838093|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
126150745|NCT01021007|453838096|FG000|Overall Study|Lost to Follow-up|1|||
126150746|NCT01021007|453838097|FG001|Overall Study|Lost to Follow-up|1|||
126150747|NCT01021007|453838096|FG000|Overall Study|Adverse Event|1|||
126150748|NCT01021007|453838097|FG001|Overall Study|Adverse Event|3|||
126150749|NCT00087438|453838098|FG000|Overall Study|Ineligible / No protocol treatment|4|||
126150750|NCT00466505|453838099|FG000|Overall Study|disease progression|13|||
126150751|NCT00466505|453838099|FG000|Overall Study|Adverse Event|4|||
126150752|NCT00594399|453838102|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
126150753|NCT00594399|453838103|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
126150754|NCT00594399|453838104|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
126150755|NCT00594399|453838102|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
126150756|NCT00594399|453838103|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
126150757|NCT00594399|453838104|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
126150758|NCT00594399|453838102|FG000|Initial 3 Month Counseling|Personal issues|2|||
126150759|NCT00594399|453838103|FG001|Initial 3 Month Counseling|Personal issues|0|||
126150760|NCT00594399|453838104|FG002|Initial 3 Month Counseling|Personal issues|0|||
126150761|NCT00594399|453838102|FG000|Initial 3 Month Counseling|Too busy|7|||
126150762|NCT00594399|453838103|FG001|Initial 3 Month Counseling|Too busy|1|||
126150763|NCT00594399|453838104|FG002|Initial 3 Month Counseling|Too busy|0|||
126150764|NCT00594399|453838102|FG000|Initial 3 Month Counseling|Pain|2|||
126150765|NCT00594399|453838103|FG001|Initial 3 Month Counseling|Pain|0|||
126150766|NCT00594399|453838104|FG002|Initial 3 Month Counseling|Pain|0|||
126150767|NCT00594399|453838102|FG000|Initial 3 Month Counseling|Moved|1|||
126150768|NCT00594399|453838103|FG001|Initial 3 Month Counseling|Moved|0|||
126150769|NCT00594399|453838104|FG002|Initial 3 Month Counseling|Moved|0|||
126150770|NCT00594399|453838102|FG000|Initial 3 Month Counseling|Family illness|1|||
126150771|NCT00594399|453838103|FG001|Initial 3 Month Counseling|Family illness|0|||
126150772|NCT00594399|453838104|FG002|Initial 3 Month Counseling|Family illness|0|||
126150773|NCT00594399|453838102|FG000|Rerandomization Arm 1 Only|Death|2|||
126150774|NCT00594399|453838103|FG001|Rerandomization Arm 1 Only|Death|1|||
126150775|NCT00594399|453838104|FG002|Rerandomization Arm 1 Only|Death|0|||
126150776|NCT00594399|453838102|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
125971365|NCT00695903|453182809|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
125971366|NCT00695903|453182810|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
126150777|NCT00594399|453838103|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
126150778|NCT00594399|453838104|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
126150779|NCT03953118|453838105|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
126150780|NCT03953118|453838106|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
126150781|NCT00424398|453838108|FG000|Overall Study|Withdrawal by Subject|2|||
126150782|NCT00424398|453838109|FG001|Overall Study|Withdrawal by Subject|1|||
126150783|NCT00424398|453838110|FG002|Overall Study|Withdrawal by Subject|0|||
126150784|NCT00424398|453838108|FG000|Overall Study|Subject met exclusion criteria|1|||
126150785|NCT00424398|453838109|FG001|Overall Study|Subject met exclusion criteria|0|||
126150786|NCT00424398|453838110|FG002|Overall Study|Subject met exclusion criteria|0|||
126150787|NCT01023789|453838111|FG000|3 - Year Visit|Death|29|||
126150788|NCT01023789|453838111|FG000|3 - Year Visit|Withdrawal of consent|1|||
126150789|NCT01023789|453838111|FG000|3 - Year Visit|Lost to Follow-up|13|||
126150790|NCT02034123|453838113|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150791|NCT02034123|453838114|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125971367|NCT00695903|453182809|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
125971368|NCT00695903|453182810|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
126150792|NCT02034123|453838115|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150793|NCT02034123|453838116|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150794|NCT02034123|453838117|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
126150795|NCT02034123|453838118|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150796|NCT02034123|453838119|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150797|NCT02034123|453838120|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
126150798|NCT02034123|453838121|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
126150799|NCT02034123|453838122|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150800|NCT02034123|453838123|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150801|NCT02034123|453838124|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150802|NCT02034123|453838125|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150803|NCT02034123|453838126|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150804|NCT02034123|453838127|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150805|NCT02034123|453838128|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150806|NCT02034123|453838129|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150807|NCT02034123|453838130|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126150808|NCT02034123|453838113|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150809|NCT02034123|453838114|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150810|NCT02034123|453838115|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150811|NCT02034123|453838116|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
126150812|NCT02034123|453838117|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150813|NCT02034123|453838118|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150814|NCT02034123|453838119|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150815|NCT02034123|453838120|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150816|NCT02034123|453838121|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150817|NCT02034123|453838122|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150818|NCT02034123|453838123|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150819|NCT02034123|453838124|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150820|NCT02034123|453838125|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150821|NCT02034123|453838126|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150822|NCT02034123|453838127|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150823|NCT02034123|453838128|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150824|NCT02034123|453838129|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150825|NCT02034123|453838130|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126150826|NCT02034123|453838113|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150827|NCT02034123|453838114|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150828|NCT02034123|453838115|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150829|NCT02034123|453838116|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150830|NCT02034123|453838117|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150831|NCT02034123|453838118|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150832|NCT02034123|453838119|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150833|NCT02034123|453838120|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150834|NCT02034123|453838121|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
126150835|NCT02034123|453838122|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150836|NCT02034123|453838123|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150837|NCT02034123|453838124|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150838|NCT02034123|453838125|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150839|NCT02034123|453838126|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150840|NCT02034123|453838127|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150841|NCT02034123|453838128|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150842|NCT02034123|453838129|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150843|NCT02034123|453838130|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126150844|NCT02034123|453838113|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150845|NCT02034123|453838114|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150846|NCT02034123|453838115|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150847|NCT02034123|453838116|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
126150848|NCT02034123|453838117|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
126150849|NCT02034123|453838118|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150850|NCT02034123|453838119|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150851|NCT02034123|453838120|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150852|NCT02034123|453838121|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150853|NCT02034123|453838122|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150854|NCT02034123|453838123|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150855|NCT02034123|453838124|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150856|NCT02034123|453838125|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150857|NCT02034123|453838126|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150858|NCT02034123|453838127|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150859|NCT02034123|453838128|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150860|NCT02034123|453838129|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150861|NCT02034123|453838130|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126150862|NCT02698189|453838131|FG000|Overall Study|Physician Decision|3|||
126150863|NCT02698189|453838132|FG001|Overall Study|Physician Decision|0|||
126150864|NCT02698189|453838131|FG000|Overall Study|Progressive disease|0|||
126150865|NCT02698189|453838132|FG001|Overall Study|Progressive disease|5|||
126150866|NCT02698189|453838131|FG000|Overall Study|Study terminated by sponsor|0|||
126150867|NCT02698189|453838132|FG001|Overall Study|Study terminated by sponsor|1|||
126150868|NCT02240706|453838135|FG000|Overall Study|Lack of Efficacy|2|||
126150869|NCT02240706|453838136|FG001|Overall Study|Lack of Efficacy|2|||
126150870|NCT02240706|453838137|FG002|Overall Study|Lack of Efficacy|2|||
126150871|NCT02240706|453838138|FG003|Overall Study|Lack of Efficacy|2|||
126150872|NCT02240706|453838139|FG004|Overall Study|Lack of Efficacy|5|||
126150873|NCT02240706|453838140|FG005|Overall Study|Lack of Efficacy|0|||
126150874|NCT02240706|453838141|FG006|Overall Study|Lack of Efficacy|0|||
126150875|NCT02240706|453838135|FG000|Overall Study|Adverse Event|1|||
126150876|NCT02240706|453838136|FG001|Overall Study|Adverse Event|0|||
126150877|NCT02240706|453838137|FG002|Overall Study|Adverse Event|1|||
126150878|NCT02240706|453838138|FG003|Overall Study|Adverse Event|0|||
126150879|NCT02240706|453838139|FG004|Overall Study|Adverse Event|2|||
126150880|NCT02240706|453838140|FG005|Overall Study|Adverse Event|0|||
126150881|NCT02240706|453838141|FG006|Overall Study|Adverse Event|0|||
126150882|NCT02240706|453838135|FG000|Overall Study|Progressive disease|0|||
126150883|NCT02240706|453838136|FG001|Overall Study|Progressive disease|0|||
126150884|NCT02240706|453838137|FG002|Overall Study|Progressive disease|0|||
126150885|NCT02240706|453838138|FG003|Overall Study|Progressive disease|0|||
126150886|NCT02240706|453838139|FG004|Overall Study|Progressive disease|1|||
126150887|NCT02240706|453838140|FG005|Overall Study|Progressive disease|0|||
126150888|NCT02240706|453838141|FG006|Overall Study|Progressive disease|0|||
126150889|NCT02240706|453838135|FG000|Overall Study|Dose limiting toxicity|0|||
126150890|NCT02240706|453838136|FG001|Overall Study|Dose limiting toxicity|0|||
126150891|NCT02240706|453838137|FG002|Overall Study|Dose limiting toxicity|0|||
126150892|NCT02240706|453838138|FG003|Overall Study|Dose limiting toxicity|0|||
126150893|NCT02240706|453838139|FG004|Overall Study|Dose limiting toxicity|1|||
126150894|NCT02240706|453838140|FG005|Overall Study|Dose limiting toxicity|0|||
126150895|NCT02240706|453838141|FG006|Overall Study|Dose limiting toxicity|0|||
126150896|NCT02240706|453838135|FG000|Overall Study|Refused to continue taking medication|0|||
126150897|NCT02240706|453838136|FG001|Overall Study|Refused to continue taking medication|1|||
126150898|NCT02240706|453838137|FG002|Overall Study|Refused to continue taking medication|3|||
126150899|NCT02240706|453838138|FG003|Overall Study|Refused to continue taking medication|1|||
126150900|NCT02240706|453838139|FG004|Overall Study|Refused to continue taking medication|2|||
126150901|NCT02240706|453838140|FG005|Overall Study|Refused to continue taking medication|0|||
126150902|NCT02240706|453838141|FG006|Overall Study|Refused to continue taking medication|0|||
126150903|NCT02240706|453838135|FG000|Overall Study|Insurance billing concerns|0|||
126150904|NCT02240706|453838136|FG001|Overall Study|Insurance billing concerns|0|||
126150905|NCT02240706|453838137|FG002|Overall Study|Insurance billing concerns|0|||
126150906|NCT02240706|453838138|FG003|Overall Study|Insurance billing concerns|1|||
126150907|NCT02240706|453838139|FG004|Overall Study|Insurance billing concerns|0|||
126150908|NCT02240706|453838140|FG005|Overall Study|Insurance billing concerns|0|||
126150909|NCT02240706|453838141|FG006|Overall Study|Insurance billing concerns|0|||
126150910|NCT03301857|453838142|FG000|Overall Study|Death|0|||
126150911|NCT03301857|453838143|FG001|Overall Study|Death|2|||
126150912|NCT03301857|453838142|FG000|Overall Study|Lost to Follow-up|4|||
126150913|NCT03301857|453838143|FG001|Overall Study|Lost to Follow-up|2|||
126150914|NCT03301857|453838142|FG000|Overall Study|Decision by Sponsor|6|||
126150915|NCT03301857|453838143|FG001|Overall Study|Decision by Sponsor|0|||
126150916|NCT03301857|453838142|FG000|Overall Study|Withdrawal by Subject|12|||
126150917|NCT03301857|453838143|FG001|Overall Study|Withdrawal by Subject|4|||
126150918|NCT00613626|453838144|FG000|Overall Study|Ineligible|0|||
126150919|NCT00613626|453838145|FG001|Overall Study|Ineligible|1|||
126150920|NCT00613626|453838146|FG002|Overall Study|Ineligible|0|||
126150921|NCT00816036|453838147|FG000|Overall Study|Death|47|||
126150922|NCT00816036|453838148|FG001|Overall Study|Death|28|||
126150923|NCT00816036|453838147|FG000|Overall Study|Lost to Follow-up|75|||
126150924|NCT00816036|453838148|FG001|Overall Study|Lost to Follow-up|57|||
126150925|NCT00816036|453838147|FG000|Overall Study|Withdrawal by Subject|54|||
126150926|NCT00816036|453838148|FG001|Overall Study|Withdrawal by Subject|23|||
126150927|NCT03212261|453838149|FG000|Overall Study|Became ineligible d/t tech|2|||
126150928|NCT03212261|453838149|FG000|Overall Study|Tech Trouble- No first study visit|1|||
126150929|NCT03212261|453838149|FG000|Overall Study|Lost to Follow-up|7|||
126150930|NCT03212261|453838149|FG000|Overall Study|Family Emergency|1|||
126150931|NCT03212261|453838149|FG000|Overall Study|Too busy/ No time|5|||
126150932|NCT01076179|453838150|FG000|Overall Study|Withdrawal by Subject|1|||
126150933|NCT05480514|453838151|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
126150934|NCT05480514|453838152|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
126150935|NCT05480514|453838151|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
126150936|NCT05480514|453838152|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
126150937|NCT05480514|453838151|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
126150938|NCT05480514|453838152|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
126150939|NCT05480514|453838151|FG000|Period 1|Covid-19 Related|1|||
126150940|NCT05480514|453838152|FG001|Period 1|Covid-19 Related|0|||
126150941|NCT05480514|453838151|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
126150942|NCT05480514|453838152|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
126150943|NCT03232073|453838155|FG000|Overall Study|Death|1|||
126150944|NCT03232073|453838156|FG001|Overall Study|Death|0|||
126150945|NCT03232073|453838155|FG000|Overall Study|Adverse Event|7|||
126150946|NCT03232073|453838156|FG001|Overall Study|Adverse Event|12|||
126150947|NCT03232073|453838155|FG000|Overall Study|Lost to Follow-up|6|||
126150948|NCT03232073|453838156|FG001|Overall Study|Lost to Follow-up|6|||
126150949|NCT03232073|453838155|FG000|Overall Study|Lack of Efficacy|10|||
126150950|NCT03232073|453838156|FG001|Overall Study|Lack of Efficacy|8|||
126150951|NCT03232073|453838155|FG000|Overall Study|Physician Decision|9|||
126150952|NCT03232073|453838156|FG001|Overall Study|Physician Decision|2|||
126150953|NCT03232073|453838155|FG000|Overall Study|Withdrawal by Subject|54|||
126150954|NCT03232073|453838156|FG001|Overall Study|Withdrawal by Subject|39|||
126150955|NCT01672892|453839955|FG000|Overall Study|Protocol Violation|7|||
126150956|NCT01672892|453839956|FG001|Overall Study|Protocol Violation|3|||
126150957|NCT02579603|453839962|FG000|Overall Study|Not treated|1|||
126150958|NCT02579603|453839963|FG001|Overall Study|Not treated|0|||
126150959|NCT02579603|453839962|FG000|Overall Study|Adverse Event|2|||
126150960|NCT02579603|453839963|FG001|Overall Study|Adverse Event|2|||
126150961|NCT02579603|453839962|FG000|Overall Study|Other than stated|1|||
126150962|NCT02579603|453839963|FG001|Overall Study|Other than stated|0|||
126150963|NCT01006356|453839964|FG000|Overall Study|Adverse Event|6|||
126150964|NCT01006356|453839964|FG000|Overall Study|Physician Decision|1|||
126150965|NCT01006356|453839964|FG000|Overall Study|Paticipants did not cooperate|6|||
126150966|NCT01006356|453839964|FG000|Overall Study|Withdrawal by Subject|1|||
126150967|NCT01006356|453839964|FG000|Overall Study|Choice by participants|2|||
126150968|NCT01006356|453839964|FG000|Overall Study|Protocol Violation|3|||
126150969|NCT01006356|453839964|FG000|Overall Study|Other|23|||
126150970|NCT01756157|453839967|FG000|First Intervention Period|Withdrawal by Subject|1|||
126150971|NCT01756157|453839968|FG001|First Intervention Period|Withdrawal by Subject|0|||
126150972|NCT01756157|453839967|FG000|First Intervention Period|Lost to Follow-up|0|||
126150973|NCT01756157|453839968|FG001|First Intervention Period|Lost to Follow-up|2|||
126150974|NCT03715465|453839974|FG000|Overall Study|Withdrawal by Subject|1|||
126150975|NCT03715465|453839975|FG001|Overall Study|Withdrawal by Subject|2|||
126150976|NCT04331899|453839983|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
126150977|NCT04331899|453839984|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
126150978|NCT02424539|453839987|FG000|Overall Study|Adverse Event|0|||
126150979|NCT02424539|453839988|FG001|Overall Study|Adverse Event|0|||
126150980|NCT02424539|453839989|FG002|Overall Study|Adverse Event|1|||
126150981|NCT02424539|453839987|FG000|Overall Study|Physician Decision|0|||
126150982|NCT02424539|453839988|FG001|Overall Study|Physician Decision|0|||
126150983|NCT02424539|453839989|FG002|Overall Study|Physician Decision|1|||
126150984|NCT02424539|453839987|FG000|Overall Study|Withdrawal by Subject|3|||
126150985|NCT02424539|453839988|FG001|Overall Study|Withdrawal by Subject|1|||
126150986|NCT02424539|453839989|FG002|Overall Study|Withdrawal by Subject|0|||
126150987|NCT02424539|453839987|FG000|Overall Study|Other: Reached stopping criteria|11|||
126150988|NCT02424539|453839988|FG001|Overall Study|Other: Reached stopping criteria|7|||
126150989|NCT02424539|453839989|FG002|Overall Study|Other: Reached stopping criteria|6|||
126150990|NCT04893265|453839992|FG000|Overall Study|Withdrawal by Subject|2|||
126150991|NCT04893265|453839993|FG001|Overall Study|Withdrawal by Subject|5|||
126150992|NCT04893265|453839992|FG000|Overall Study|Lost to Follow-up|0|||
126150993|NCT04893265|453839993|FG001|Overall Study|Lost to Follow-up|4|||
126150994|NCT00573131|453839994|FG000|Overall Study|Withdrawal by Subject|10|||
126150995|NCT00573131|453839995|FG001|Overall Study|Withdrawal by Subject|8|||
126150996|NCT02024464|453839997|FG000|Overall Study|Discontinued|5|||
126150997|NCT02024464|453839998|FG001|Overall Study|Discontinued|4|||
126150998|NCT02024464|453839997|FG000|Overall Study|Missed Visits|1|||
126150999|NCT02024464|453839998|FG001|Overall Study|Missed Visits|0|||
126151000|NCT02024464|453839997|FG000|Overall Study|Lost to Follow-up|4|||
126151001|NCT02024464|453839998|FG001|Overall Study|Lost to Follow-up|7|||
126151002|NCT02037919|453840004|FG000|Overall Study|Lost to Follow-up|30|||
126151003|NCT02037919|453840005|FG001|Overall Study|Lost to Follow-up|45|||
126151004|NCT01697215|453840020|FG000|Overall Study|Physician Decision|5|||
126151005|NCT01697215|453840020|FG000|Overall Study|Malfunction|9|||
126151006|NCT01697215|453840020|FG000|Overall Study|CXR not available|9|||
126151007|NCT01829048|453840021|FG000|Overall Study|Withdrawal by Subject|0|||
126151008|NCT01829048|453840022|FG001|Overall Study|Withdrawal by Subject|0|||
126151009|NCT01829048|453840023|FG002|Overall Study|Withdrawal by Subject|0|||
126151010|NCT01829048|453840024|FG003|Overall Study|Withdrawal by Subject|2|||
126151011|NCT01829048|453840025|FG004|Overall Study|Withdrawal by Subject|0|||
126151012|NCT00504257|453840026|FG000|Overall Study|Withdrawal by Subject|2|||
126151013|NCT00504257|453840026|FG000|Overall Study|ineligible histology|2|||
126151014|NCT02317510|453840030|FG000|Overall Study|Adverse Event|0|||
126151015|NCT02317510|453840031|FG001|Overall Study|Adverse Event|1|||
126151016|NCT00728416|453840040|FG000|Overall Study|Adverse Event|1|||
126151017|NCT00728416|453840041|FG001|Overall Study|Adverse Event|1|||
126151018|NCT00728416|453840040|FG000|Overall Study|Treatment Failure|0|||
126151019|NCT00728416|453840041|FG001|Overall Study|Treatment Failure|1|||
126151020|NCT00728416|453840040|FG000|Overall Study|Withdrawal by Subject|1|||
126151021|NCT00728416|453840041|FG001|Overall Study|Withdrawal by Subject|0|||
126151022|NCT01244737|453840049|FG000|Overall Study|Physician Decision|2|||
126088728|NCT04879849|453618799|FG002|Overall Study|Withdrawal by Subject|0|||
126088729|NCT04879849|453618800|FG003|Overall Study|Withdrawal by Subject|0|||
126088730|NCT04879849|453618801|FG004|Overall Study|Withdrawal by Subject|2|||
126088731|NCT04879849|453618802|FG005|Overall Study|Withdrawal by Subject|0|||
126088732|NCT04879849|453618803|FG006|Overall Study|Withdrawal by Subject|1|||
126088733|NCT04879849|453618804|FG007|Overall Study|Withdrawal by Subject|0|||
126088734|NCT04879849|453618797|FG000|Overall Study|Progressive Disease|0|||
126088735|NCT04879849|453618798|FG001|Overall Study|Progressive Disease|0|||
126088736|NCT04879849|453618799|FG002|Overall Study|Progressive Disease|1|||
126088737|NCT04879849|453618800|FG003|Overall Study|Progressive Disease|0|||
126088738|NCT04879849|453618801|FG004|Overall Study|Progressive Disease|0|||
126088739|NCT04879849|453618802|FG005|Overall Study|Progressive Disease|0|||
126088740|NCT04879849|453618803|FG006|Overall Study|Progressive Disease|0|||
126088741|NCT04879849|453618804|FG007|Overall Study|Progressive Disease|0|||
126088742|NCT04879849|453618797|FG000|Overall Study|Death|0|||
126088743|NCT04879849|453618798|FG001|Overall Study|Death|0|||
126088744|NCT04879849|453618799|FG002|Overall Study|Death|1|||
126088745|NCT04879849|453618800|FG003|Overall Study|Death|1|||
126088746|NCT04879849|453618801|FG004|Overall Study|Death|1|||
126088747|NCT04879849|453618802|FG005|Overall Study|Death|2|||
126088748|NCT04879849|453618803|FG006|Overall Study|Death|1|||
126088749|NCT04879849|453618804|FG007|Overall Study|Death|2|||
126088750|NCT04879849|453618797|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
126088751|NCT04879849|453618798|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
126088752|NCT04879849|453618799|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
126088753|NCT04879849|453618800|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
126088754|NCT04879849|453618801|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
126088755|NCT04879849|453618802|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
126088756|NCT04879849|453618803|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
126088757|NCT04879849|453618804|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
126088758|NCT04879849|453618797|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126088759|NCT04879849|453618798|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126088760|NCT04879849|453618799|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126088761|NCT04879849|453618800|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126088762|NCT04879849|453618801|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126088763|NCT04879849|453618802|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126088764|NCT04879849|453618803|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
126088765|NCT04879849|453618804|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126088766|NCT04879849|453618797|FG000|Overall Study|Reason Not Specified|1|||
126088767|NCT04879849|453618798|FG001|Overall Study|Reason Not Specified|0|||
126088768|NCT04879849|453618799|FG002|Overall Study|Reason Not Specified|0|||
126088769|NCT04879849|453618800|FG003|Overall Study|Reason Not Specified|0|||
126088770|NCT04879849|453618801|FG004|Overall Study|Reason Not Specified|0|||
126088771|NCT04879849|453618802|FG005|Overall Study|Reason Not Specified|0|||
126088772|NCT04879849|453618803|FG006|Overall Study|Reason Not Specified|0|||
126088773|NCT04879849|453618804|FG007|Overall Study|Reason Not Specified|0|||
126088774|NCT03810235|453618807|FG000|Overall Study|Withdrawal by Subject|2|||
126088775|NCT03810235|453618808|FG001|Overall Study|Withdrawal by Subject|0|||
126088776|NCT04777864|453618809|FG000|Overall Study|Lost to Follow-up|8|||
126088777|NCT04777864|453618810|FG001|Overall Study|Lost to Follow-up|19|||
126088778|NCT01647542|453618811|FG000|Overall Study|Major Protocol Deviation|1|||
126088779|NCT01647542|453618812|FG001|Overall Study|Major Protocol Deviation|0|||
126088780|NCT01647542|453618813|FG002|Overall Study|Major Protocol Deviation|0|||
126088781|NCT01647542|453618811|FG000|Overall Study|Adverse Event|4|||
126088782|NCT01647542|453618812|FG001|Overall Study|Adverse Event|5|||
126088783|NCT01647542|453618813|FG002|Overall Study|Adverse Event|4|||
126088784|NCT01647542|453618811|FG000|Overall Study|Lost to Follow-up|0|||
126088785|NCT01647542|453618812|FG001|Overall Study|Lost to Follow-up|2|||
126088786|NCT01647542|453618813|FG002|Overall Study|Lost to Follow-up|2|||
126088787|NCT01647542|453618811|FG000|Overall Study|Withdrawal by Subject|6|||
126088788|NCT01647542|453618812|FG001|Overall Study|Withdrawal by Subject|4|||
126088789|NCT01647542|453618813|FG002|Overall Study|Withdrawal by Subject|0|||
126088790|NCT01647542|453618811|FG000|Overall Study|Study Termination|64|||
126088791|NCT01647542|453618812|FG001|Overall Study|Study Termination|61|||
126088792|NCT01647542|453618813|FG002|Overall Study|Study Termination|65|||
126088793|NCT01647542|453618811|FG000|Overall Study|Lack of Efficacy|1|||
126088794|NCT01647542|453618812|FG001|Overall Study|Lack of Efficacy|1|||
126151023|NCT01244737|453840050|FG001|Overall Study|Physician Decision|18|||
126151024|NCT01244737|453840051|FG002|Overall Study|Physician Decision|5|||
126151025|NCT01244737|453840049|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
126151026|NCT01244737|453840050|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
126151027|NCT01244737|453840051|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
126151028|NCT01244737|453840049|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
125971369|NCT00695903|453182809|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
126088795|NCT01647542|453618813|FG002|Overall Study|Lack of Efficacy|0|||
126088796|NCT01647542|453618811|FG000|Overall Study|Death|0|||
126088797|NCT01647542|453618812|FG001|Overall Study|Death|0|||
126088798|NCT01647542|453618813|FG002|Overall Study|Death|1|||
126088799|NCT03086655|453618814|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
126088800|NCT03086655|453618815|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
126088801|NCT03086655|453618814|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
126088802|NCT03086655|453618815|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
126088803|NCT03086655|453618814|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
126088804|NCT03086655|453618815|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
126088805|NCT03086655|453618814|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
126088806|NCT03086655|453618815|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
126088807|NCT03086655|453618814|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
126088808|NCT03086655|453618815|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
126088809|NCT03086655|453618814|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
126088810|NCT03086655|453618815|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
126088811|NCT03086655|453618814|FG000|12 Month Follow-up = Final Assessment|Death|0|||
126088812|NCT03086655|453618815|FG001|12 Month Follow-up = Final Assessment|Death|1|||
126088813|NCT05576662|453618816|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
126088814|NCT05576662|453618817|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
126088815|NCT05576662|453618816|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
126088816|NCT05576662|453618817|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
126088817|NCT05576662|453618816|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
126088818|NCT05576662|453618817|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
126088819|NCT05576662|453618816|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
126088820|NCT05576662|453618817|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
126088821|NCT03008005|453618818|FG000|Overall Study|Physician Decision|1|||
126088822|NCT03008005|453618819|FG001|Overall Study|Physician Decision|0|||
126088823|NCT03008005|453618820|FG002|Overall Study|Physician Decision|0|||
126088824|NCT03008005|453618818|FG000|Overall Study|Withdrawal by Subject|1|||
126088825|NCT03008005|453618819|FG001|Overall Study|Withdrawal by Subject|0|||
126088826|NCT03008005|453618820|FG002|Overall Study|Withdrawal by Subject|0|||
126088827|NCT03008005|453618818|FG000|Overall Study|Ineligible|0|||
126088828|NCT03008005|453618819|FG001|Overall Study|Ineligible|1|||
126088829|NCT03008005|453618820|FG002|Overall Study|Ineligible|0|||
126088830|NCT01040169|453618836|FG000|Overall Study|Lost to Follow-up|3|||
126088831|NCT01040169|453618837|FG001|Overall Study|Lost to Follow-up|8|||
126088832|NCT00350727|453618838|FG000|Phase I: Dose Escalation|Adverse Event|4|||
126088833|NCT00350727|453618839|FG001|Phase I: Dose Escalation|Adverse Event|0|||
126088834|NCT00350727|453618840|FG002|Phase I: Dose Escalation|Adverse Event|0|||
126088835|NCT00350727|453618838|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
126088836|NCT00350727|453618839|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
126088837|NCT00350727|453618840|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
126088838|NCT00350727|453618838|FG000|Phase I: Dose Escalation|Death|1|||
126088839|NCT00350727|453618839|FG001|Phase I: Dose Escalation|Death|0|||
126088840|NCT00350727|453618840|FG002|Phase I: Dose Escalation|Death|0|||
126088841|NCT00350727|453618838|FG000|Phase I: Dose Escalation|Physician Decision|1|||
126088842|NCT00350727|453618839|FG001|Phase I: Dose Escalation|Physician Decision|0|||
126088843|NCT00350727|453618840|FG002|Phase I: Dose Escalation|Physician Decision|0|||
126088844|NCT00350727|453618838|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
126088845|NCT00350727|453618839|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
126088846|NCT00350727|453618840|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
126088847|NCT00350727|453618838|FG000|Phase II|Disease Progression|0|||
126088848|NCT00350727|453618839|FG001|Phase II|Disease Progression|15|||
126088849|NCT00350727|453618840|FG002|Phase II|Disease Progression|16|||
126088850|NCT00350727|453618838|FG000|Phase II|Clinical Deterioration|0|||
126088851|NCT00350727|453618839|FG001|Phase II|Clinical Deterioration|1|||
126088852|NCT00350727|453618840|FG002|Phase II|Clinical Deterioration|0|||
126088853|NCT00350727|453618838|FG000|Phase II|Withdrawal by Subject|0|||
126088854|NCT00350727|453618839|FG001|Phase II|Withdrawal by Subject|2|||
126088855|NCT00350727|453618840|FG002|Phase II|Withdrawal by Subject|1|||
126088856|NCT00350727|453618838|FG000|Phase II|Adverse Event|0|||
126151029|NCT01244737|453840050|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
126151030|NCT01244737|453840051|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
126151031|NCT01244737|453840049|FG000|Overall Study|MIB immunopathology results not available|3|||
126151032|NCT01244737|453840050|FG001|Overall Study|MIB immunopathology results not available|2|||
126151033|NCT01244737|453840051|FG002|Overall Study|MIB immunopathology results not available|0|||
126151034|NCT01244737|453840049|FG000|Overall Study|PET data failure|0|||
126151035|NCT01244737|453840050|FG001|Overall Study|PET data failure|1|||
126151036|NCT01244737|453840051|FG002|Overall Study|PET data failure|0|||
126151037|NCT01244737|453840049|FG000|Overall Study|Withdrawal by Subject|0|||
126151038|NCT01244737|453840050|FG001|Overall Study|Withdrawal by Subject|0|||
126151039|NCT01244737|453840051|FG002|Overall Study|Withdrawal by Subject|1|||
126151040|NCT00730236|453840054|FG000|Overall Study|Adverse Event|4|||
126151041|NCT00730236|453840054|FG000|Overall Study|Withdrawal by Subject|1|||
126151042|NCT00730236|453840054|FG000|Overall Study|Non-compliance|1|||
126151043|NCT01772134|453840059|FG000|Overall Study|Adverse Event|6|||
126151044|NCT01772134|453840060|FG001|Overall Study|Adverse Event|5|||
126151045|NCT01772134|453840061|FG002|Overall Study|Adverse Event|10|||
126151046|NCT01772134|453840059|FG000|Overall Study|Withdrew Consent|3|||
126151047|NCT01772134|453840060|FG001|Overall Study|Withdrew Consent|1|||
126151048|NCT01772134|453840061|FG002|Overall Study|Withdrew Consent|5|||
126151049|NCT01772134|453840059|FG000|Overall Study|Lost to Follow-up|2|||
126151050|NCT01772134|453840060|FG001|Overall Study|Lost to Follow-up|0|||
126151051|NCT01772134|453840061|FG002|Overall Study|Lost to Follow-up|0|||
126151052|NCT01772134|453840059|FG000|Overall Study|Protocol Deviation|4|||
126151053|NCT01772134|453840060|FG001|Overall Study|Protocol Deviation|3|||
126151054|NCT01772134|453840061|FG002|Overall Study|Protocol Deviation|3|||
126151055|NCT01772134|453840059|FG000|Overall Study|Lack of Efficacy|11|||
126151056|NCT01772134|453840060|FG001|Overall Study|Lack of Efficacy|5|||
126151057|NCT01772134|453840061|FG002|Overall Study|Lack of Efficacy|3|||
126151058|NCT01772134|453840059|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
126151059|NCT01772134|453840060|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
126151060|NCT01772134|453840061|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
126151061|NCT01772134|453840059|FG000|Overall Study|Randomized Study Medication Not Received|2|||
126151062|NCT01772134|453840060|FG001|Overall Study|Randomized Study Medication Not Received|0|||
126151063|NCT01772134|453840061|FG002|Overall Study|Randomized Study Medication Not Received|1|||
126151064|NCT04003610|453840068|FG000|Overall Study|Lost to Follow-up|0|||
126151065|NCT04003610|453840069|FG001|Overall Study|Lost to Follow-up|1|||
126151066|NCT04003610|453840070|FG002|Overall Study|Lost to Follow-up|0|||
126151067|NCT04003610|453840068|FG000|Overall Study|Death|0|||
126151068|NCT04003610|453840069|FG001|Overall Study|Death|0|||
126151069|NCT04003610|453840070|FG002|Overall Study|Death|3|||
126151070|NCT04003610|453840068|FG000|Overall Study|Study Terminated by Sponsor|0|||
126151071|NCT04003610|453840069|FG001|Overall Study|Study Terminated by Sponsor|0|||
126151072|NCT04003610|453840070|FG002|Overall Study|Study Terminated by Sponsor|3|||
126151073|NCT00246259|453840077|FG000|Overall Study|Other|3|||
126151074|NCT00246259|453840078|FG001|Overall Study|Other|3|||
126151075|NCT00246259|453840077|FG000|Overall Study|Not stable by Week 18|2|||
126151076|NCT00246259|453840078|FG001|Overall Study|Not stable by Week 18|1|||
126151077|NCT00246259|453840077|FG000|Overall Study|Participant non-compliant|4|||
126151078|NCT00246259|453840078|FG001|Overall Study|Participant non-compliant|9|||
126151079|NCT00246259|453840077|FG000|Overall Study|Lack of Efficacy|2|||
126151080|NCT00246259|453840078|FG001|Overall Study|Lack of Efficacy|2|||
126151081|NCT00246259|453840077|FG000|Overall Study|Investigator withdrew participant|2|||
126151082|NCT00246259|453840078|FG001|Overall Study|Investigator withdrew participant|0|||
126151083|NCT00246259|453840077|FG000|Overall Study|Adverse Event|5|||
126151084|NCT00246259|453840078|FG001|Overall Study|Adverse Event|0|||
126151085|NCT00246259|453840077|FG000|Overall Study|Lost to Follow-up|3|||
126151086|NCT00246259|453840078|FG001|Overall Study|Lost to Follow-up|4|||
126151087|NCT00246259|453840077|FG000|Overall Study|Withdrawal by Subject|5|||
126151088|NCT00246259|453840078|FG001|Overall Study|Withdrawal by Subject|1|||
126151089|NCT00246259|453840077|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
126151090|NCT00246259|453840078|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
126151091|NCT03133767|453840085|FG000|Overall Study|Lost to Follow-up|38|||
126151092|NCT03133767|453840086|FG001|Overall Study|Lost to Follow-up|24|||
126151093|NCT03133767|453840085|FG000|Overall Study|Protocol Violation|0|||
126151094|NCT03133767|453840086|FG001|Overall Study|Protocol Violation|1|||
126151095|NCT05502289|453840091|FG000|Period 1|Out Of Window|1|||
126151096|NCT05502289|453840092|FG001|Period 1|Out Of Window|0|||
126151097|NCT02333227|453840098|FG000|Overall Study|Lost to Follow-up|137|||
126151098|NCT02333227|453840099|FG001|Overall Study|Lost to Follow-up|106|||
126151099|NCT02333227|453840098|FG000|Overall Study|Pregnancy Interrupted|42|||
126151100|NCT02333227|453840099|FG001|Overall Study|Pregnancy Interrupted|89|||
126151101|NCT02333227|453840098|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
126151102|NCT02333227|453840099|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
126151103|NCT01624194|453840102|FG000|Overall Study|Lost to Follow-up|1|||
126151104|NCT01624194|453840103|FG001|Overall Study|Lost to Follow-up|0|||
126151105|NCT01624194|453840102|FG000|Overall Study|Withdrawal by Subject|1|||
126151106|NCT01624194|453840103|FG001|Overall Study|Withdrawal by Subject|0|||
126151107|NCT00986349|453840106|FG000|Overall Study|Unsuccessful implant procedure|3|||
126151108|NCT00986349|453840106|FG000|Overall Study|Adverse Event|2|||
126151109|NCT00986349|453840106|FG000|Overall Study|Physician Decision|1|||
126151110|NCT00986349|453840106|FG000|Overall Study|device migration|1|||
126151111|NCT02299934|453840107|FG000|Overall Study|Termination of study|13|||
126151112|NCT02722044|453840108|FG000|Overall Study|Adverse Event|2|||
126151113|NCT02722044|453840108|FG000|Overall Study|Physician Decision|1|||
126151114|NCT02722044|453840108|FG000|Overall Study|Withdrawal by Subject|1|||
126151115|NCT02722044|453840108|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
126151116|NCT02117687|453840109|FG000|Overall Study|Lost to Follow-up|0|||
126151117|NCT02117687|453840110|FG001|Overall Study|Lost to Follow-up|1|||
126151118|NCT02117687|453840109|FG000|Overall Study|Adverse Event|0|||
126151119|NCT02117687|453840110|FG001|Overall Study|Adverse Event|2|||
126151120|NCT02117687|453840109|FG000|Overall Study|Other Reasons|1|||
126151121|NCT02117687|453840110|FG001|Overall Study|Other Reasons|1|||
126151122|NCT01901328|453840118|FG000|Overall Study|Lost to Follow-up|1|||
126151123|NCT01901328|453840119|FG001|Overall Study|Lost to Follow-up|0|||
126151124|NCT01901328|453840118|FG000|Overall Study|Physician Decision|0|||
126151125|NCT01901328|453840119|FG001|Overall Study|Physician Decision|1|||
126151126|NCT01901328|453840118|FG000|Overall Study|Protocol Violation|1|||
126151127|NCT01901328|453840119|FG001|Overall Study|Protocol Violation|1|||
126151128|NCT01901328|453840118|FG000|Overall Study|Study Terminated by Sponsor|19|||
126151129|NCT01901328|453840119|FG001|Overall Study|Study Terminated by Sponsor|16|||
126151130|NCT01901328|453840118|FG000|Overall Study|Withdrawal by Subject|1|||
126151131|NCT01901328|453840119|FG001|Overall Study|Withdrawal by Subject|2|||
126151132|NCT01901328|453840118|FG000|Overall Study|Lack of Efficacy|0|||
126151133|NCT01901328|453840119|FG001|Overall Study|Lack of Efficacy|1|||
126151134|NCT03528681|453841905|FG000|Open-Label Phase|Physician Decision|2|||
126151135|NCT03528681|453841906|FG001|Open-Label Phase|Physician Decision|0|||
126151136|NCT03528681|453841907|FG002|Open-Label Phase|Physician Decision|0|||
126151137|NCT03528681|453841908|FG003|Open-Label Phase|Physician Decision|0|||
126151138|NCT03528681|453841905|FG000|Open-Label Phase|Withdrawal by Subject|8|||
126151139|NCT03528681|453841906|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126151140|NCT03528681|453841907|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126151141|NCT03528681|453841908|FG003|Open-Label Phase|Withdrawal by Subject|0|||
126151142|NCT03528681|453841905|FG000|Open-Label Phase|(Not collected)|4|||
126151143|NCT03528681|453841906|FG001|Open-Label Phase|(Not collected)|0|||
126151144|NCT03528681|453841907|FG002|Open-Label Phase|(Not collected)|0|||
126151145|NCT03528681|453841908|FG003|Open-Label Phase|(Not collected)|0|||
126151146|NCT03528681|453841905|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
126151147|NCT03528681|453841906|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
126151148|NCT03528681|453841907|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
126151149|NCT03528681|453841908|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
126151150|NCT03528681|453841905|FG000|Randomized Treatment Phase|Physician Decision|0|||
126151151|NCT03528681|453841906|FG001|Randomized Treatment Phase|Physician Decision|5|||
126151152|NCT03528681|453841907|FG002|Randomized Treatment Phase|Physician Decision|1|||
126151153|NCT03528681|453841908|FG003|Randomized Treatment Phase|Physician Decision|2|||
126151154|NCT03528681|453841905|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
126151155|NCT03528681|453841906|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
126151156|NCT03528681|453841907|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
126151157|NCT03528681|453841908|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
126151158|NCT03528681|453841905|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
126151159|NCT03528681|453841906|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
126151160|NCT03528681|453841907|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
126151161|NCT03528681|453841908|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
126151162|NCT03528681|453841905|FG000|Randomized Treatment Phase|(Not collected)|0|||
126151163|NCT03528681|453841906|FG001|Randomized Treatment Phase|(Not collected)|4|||
126151164|NCT03528681|453841907|FG002|Randomized Treatment Phase|(Not collected)|6|||
126151165|NCT03528681|453841908|FG003|Randomized Treatment Phase|(Not collected)|5|||
126151166|NCT02981472|453841916|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
126151167|NCT02981472|453841917|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
126151168|NCT02981472|453841916|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126151169|NCT02981472|453841917|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126151170|NCT02981472|453841916|FG000|Treatment Period|Adverse Event|6|||
126151171|NCT02981472|453841917|FG001|Treatment Period|Adverse Event|1|||
126151172|NCT02981472|453841916|FG000|Treatment Period|Participant withdrew consent|1|||
126151173|NCT02981472|453841917|FG001|Treatment Period|Participant withdrew consent|0|||
126151174|NCT02981472|453841916|FG000|Treatment Period|Lost to Follow-up|0|||
126151175|NCT02981472|453841917|FG001|Treatment Period|Lost to Follow-up|1|||
126151176|NCT00621023|453841919|FG000|Overall Study|Death|5|||
126151177|NCT00621023|453841919|FG000|Overall Study|Follow up discontinued|1|||
126151178|NCT04430348|453841924|FG000|Overall Study|Death|3|||
126151179|NCT04430348|453841925|FG001|Overall Study|Death|2|||
126151180|NCT04430348|453841926|FG002|Overall Study|Death|2|||
126151181|NCT04430348|453841927|FG003|Overall Study|Death|2|||
126151182|NCT04430348|453841928|FG004|Overall Study|Death|2|||
126151183|NCT04430348|453841929|FG005|Overall Study|Death|3|||
126151184|NCT04430348|453841924|FG000|Overall Study|Lost to Follow-up|0|||
126151185|NCT04430348|453841925|FG001|Overall Study|Lost to Follow-up|0|||
126151186|NCT04430348|453841926|FG002|Overall Study|Lost to Follow-up|0|||
126151187|NCT04430348|453841927|FG003|Overall Study|Lost to Follow-up|1|||
126151188|NCT04430348|453841928|FG004|Overall Study|Lost to Follow-up|0|||
126151189|NCT04430348|453841929|FG005|Overall Study|Lost to Follow-up|0|||
126151190|NCT04430348|453841924|FG000|Overall Study|Adverse Event|0|||
126151191|NCT04430348|453841925|FG001|Overall Study|Adverse Event|0|||
126151192|NCT04430348|453841926|FG002|Overall Study|Adverse Event|0|||
126151193|NCT04430348|453841927|FG003|Overall Study|Adverse Event|0|||
126151194|NCT04430348|453841928|FG004|Overall Study|Adverse Event|0|||
126151195|NCT04430348|453841929|FG005|Overall Study|Adverse Event|1|||
126151196|NCT04430348|453841924|FG000|Overall Study|Withdrawal by Subject|0|||
126151197|NCT04430348|453841925|FG001|Overall Study|Withdrawal by Subject|1|||
125971370|NCT00695903|453182810|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
125971371|NCT00695903|453182809|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
126088857|NCT00350727|453618839|FG001|Phase II|Adverse Event|1|||
126088858|NCT00350727|453618840|FG002|Phase II|Adverse Event|1|||
126088859|NCT00350727|453618838|FG000|Phase II|Death|0|||
126088860|NCT00350727|453618839|FG001|Phase II|Death|0|||
126088861|NCT00350727|453618840|FG002|Phase II|Death|2|||
126088862|NCT00350727|453618838|FG000|Phase II|Sponsor Terminated Study|0|||
126088863|NCT00350727|453618839|FG001|Phase II|Sponsor Terminated Study|0|||
126088864|NCT00350727|453618840|FG002|Phase II|Sponsor Terminated Study|1|||
126088865|NCT00350727|453618838|FG000|Phase II|Enrolled in Rollover Study|0|||
126088866|NCT00350727|453618839|FG001|Phase II|Enrolled in Rollover Study|0|||
126088867|NCT00350727|453618840|FG002|Phase II|Enrolled in Rollover Study|1|||
126088868|NCT03633799|453618845|FG000|Overall Study|Adverse Event|349|||
126088869|NCT03633799|453618845|FG000|Overall Study|Withdrawal by Subject|288|||
126088870|NCT03633799|453618845|FG000|Overall Study|Lost to Follow-up|97|||
126088871|NCT03633799|453618845|FG000|Overall Study|Physician Decision|9|||
126088872|NCT03633799|453618845|FG000|Overall Study|Protocol Violation|4|||
126088873|NCT03633799|453618845|FG000|Overall Study|Pregnancy|20|||
126088874|NCT03633799|453618845|FG000|Overall Study|other|39|||
126088875|NCT03633799|453618845|FG000|Overall Study|ongoing within third year of study|106|||
126088876|NCT03633799|453618845|FG000|Overall Study|unsuccessful study drug placement|19|||
126088877|NCT03551691|453618846|FG000|Overall Study|Withdrawal by Subject|3|||
126088878|NCT03551691|453618847|FG001|Overall Study|Withdrawal by Subject|3|||
126088879|NCT03520712|453618848|FG000|Overall Study|Early termination of the study by Sponsor|2|||
126088880|NCT05855967|453618849|FG000|Overall Study|Withdrawal by Subject|7|||
126088881|NCT05855967|453618850|FG001|Overall Study|Withdrawal by Subject|5|||
126088882|NCT05855967|453618849|FG000|Overall Study|Lost to Follow-up|2|||
126088883|NCT05855967|453618850|FG001|Overall Study|Lost to Follow-up|1|||
126088884|NCT02446821|453618851|FG000|Overall Study|Adverse Event|28|||
126088885|NCT02446821|453618851|FG000|Overall Study|Withdrawal by Subject|6|||
126088886|NCT02446821|453618851|FG000|Overall Study|Lost to Follow-up|22|||
126088887|NCT02446821|453618851|FG000|Overall Study|other|9|||
126088888|NCT02446821|453618851|FG000|Overall Study|insertion failure|3|||
126088889|NCT02284009|453618853|FG000|Overall Study|Adverse Event|3|||
126088890|NCT02284009|453618854|FG001|Overall Study|Adverse Event|0|||
126088891|NCT02284009|453618853|FG000|Overall Study|Lost to Follow-up|1|||
126088892|NCT02284009|453618854|FG001|Overall Study|Lost to Follow-up|3|||
126088893|NCT02284009|453618853|FG000|Overall Study|Physician Decision|0|||
126088894|NCT02284009|453618854|FG001|Overall Study|Physician Decision|2|||
126088895|NCT02284009|453618853|FG000|Overall Study|Withdrawal by Subject|2|||
126088896|NCT02284009|453618854|FG001|Overall Study|Withdrawal by Subject|5|||
126088897|NCT04942366|453620000|FG000|Overall Study|Withdrawal by Subject|5|||
126088898|NCT04942366|453620001|FG001|Overall Study|Withdrawal by Subject|5|||
126088899|NCT01736189|453620002|FG000|Overall Study|Violation of registration criteria|41|||
126088900|NCT01736189|453620002|FG000|Overall Study|Protocol Violation|4|||
126088901|NCT01736189|453620002|FG000|Overall Study|Criteria and protocol violations|1|||
126088902|NCT03301155|453620003|FG000|Overall Study|Сompliance with exclusion criteria|8|||
126088903|NCT03301155|453620004|FG001|Overall Study|Сompliance with exclusion criteria|7|||
126088904|NCT00384189|453620006|FG000|Overall Study|Reason Not Specified|50|||
126088905|NCT00384189|453620007|FG001|Overall Study|Reason Not Specified|57|||
126088906|NCT00384189|453620008|FG002|Overall Study|Reason Not Specified|58|||
126088907|NCT00384189|453620009|FG003|Overall Study|Reason Not Specified|40|||
126088908|NCT00608868|453620010|FG000|Overall Study|Withdrawal by Subject|7|||
126088909|NCT00608868|453620010|FG000|Overall Study|Protocol Violation|3|||
126088910|NCT00608868|453620010|FG000|Overall Study|Lost to Follow-up|2|||
126088911|NCT00608868|453620010|FG000|Overall Study|Adverse Event|1|||
126088912|NCT00608868|453620010|FG000|Overall Study|Physician Decision|2|||
126151198|NCT04430348|453841926|FG002|Overall Study|Withdrawal by Subject|0|||
126151199|NCT04430348|453841927|FG003|Overall Study|Withdrawal by Subject|0|||
126151200|NCT04430348|453841928|FG004|Overall Study|Withdrawal by Subject|0|||
126151201|NCT04430348|453841929|FG005|Overall Study|Withdrawal by Subject|1|||
126151202|NCT04430348|453841924|FG000|Overall Study|Study Terminated by Sponsor|0|||
126151203|NCT04430348|453841925|FG001|Overall Study|Study Terminated by Sponsor|0|||
126151204|NCT04430348|453841926|FG002|Overall Study|Study Terminated by Sponsor|2|||
126151205|NCT04430348|453841927|FG003|Overall Study|Study Terminated by Sponsor|0|||
126151206|NCT04430348|453841928|FG004|Overall Study|Study Terminated by Sponsor|1|||
126151207|NCT04430348|453841929|FG005|Overall Study|Study Terminated by Sponsor|1|||
126151208|NCT00756002|453841930|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
126151209|NCT00756002|453841931|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
126151210|NCT00756002|453841930|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126151211|NCT00756002|453841931|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126151212|NCT00756002|453841930|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
126151213|NCT00756002|453841931|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
126151214|NCT00756002|453841930|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
126151215|NCT00756002|453841931|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
126151216|NCT00756002|453841930|FG000|Double-Blind Treatment Period|Other|2|||
126151217|NCT00756002|453841931|FG001|Double-Blind Treatment Period|Other|2|||
126151218|NCT04899271|453841938|FG000|Overall Study|Lost to Follow-up|1|||
126151219|NCT04899271|453841939|FG001|Overall Study|Lost to Follow-up|0|||
126151220|NCT04899271|453841938|FG000|Overall Study|Subject request/consent withdrawal|2|||
126151221|NCT04899271|453841939|FG001|Overall Study|Subject request/consent withdrawal|0|||
126151222|NCT01929083|453841942|FG000|Intervention 1|Lost to Follow-up|2|||
126151223|NCT01929083|453841943|FG001|Intervention 1|Lost to Follow-up|0|||
126151224|NCT01929083|453841942|FG000|Intervention 1|Nonadherent to study medications|1|||
126151225|NCT01929083|453841943|FG001|Intervention 1|Nonadherent to study medications|0|||
126151226|NCT01929083|453841942|FG000|Intervention 2|Adverse Event|0|||
126151227|NCT01929083|453841943|FG001|Intervention 2|Adverse Event|1|||
126151228|NCT02586805|453841948|FG000|Overall Study|Withdrawal by Subject|3|||
126151229|NCT02586805|453841949|FG001|Overall Study|Withdrawal by Subject|1|||
126151230|NCT02586805|453841950|FG002|Overall Study|Withdrawal by Subject|1|||
126151231|NCT02586805|453841951|FG003|Overall Study|Withdrawal by Subject|2|||
126151232|NCT02586805|453841948|FG000|Overall Study|Adverse Event|2|||
126151233|NCT02586805|453841949|FG001|Overall Study|Adverse Event|0|||
126151234|NCT02586805|453841950|FG002|Overall Study|Adverse Event|1|||
126151235|NCT02586805|453841951|FG003|Overall Study|Adverse Event|0|||
126151236|NCT02586805|453841948|FG000|Overall Study|Lost to Follow-up|0|||
126151237|NCT02586805|453841949|FG001|Overall Study|Lost to Follow-up|0|||
126151238|NCT02586805|453841950|FG002|Overall Study|Lost to Follow-up|1|||
126151239|NCT02586805|453841951|FG003|Overall Study|Lost to Follow-up|0|||
126151240|NCT02586805|453841948|FG000|Overall Study|Physician Decision|1|||
126151241|NCT02586805|453841949|FG001|Overall Study|Physician Decision|0|||
126151242|NCT02586805|453841950|FG002|Overall Study|Physician Decision|0|||
126151243|NCT02586805|453841951|FG003|Overall Study|Physician Decision|0|||
126151244|NCT02504541|453841952|FG000|Overall Study|Adverse Event|4|||
126151245|NCT02504541|453841952|FG000|Overall Study|Withdrawal by Subject|4|||
126151246|NCT02504541|453841952|FG000|Overall Study|Lost to Follow-up|1|||
126151247|NCT02504541|453841952|FG000|Overall Study|Met Stopping Criteria|1|||
126151248|NCT02504541|453841952|FG000|Overall Study|Protocol Violation|2|||
126151249|NCT02504541|453841952|FG000|Overall Study|Termination by Sponsor|1|||
126151250|NCT02504541|453841952|FG000|Overall Study|Other|2|||
126151251|NCT02504541|453841952|FG000|Overall Study|Multiple|5|||
126151252|NCT00500071|453841953|FG000|Screening and Washout Phase|Protocol Violation|1|||
126151253|NCT00500071|453841953|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
126151254|NCT00500071|453841953|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
126151255|NCT00500071|453841953|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
126151256|NCT00500071|453841953|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
126151257|NCT00500071|453841953|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
126151258|NCT00500071|453841953|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
126151259|NCT00472303|453841954|FG000|Titration Phase|Adverse Event|22|||
126151260|NCT00472303|453841955|FG001|Titration Phase|Adverse Event|12|||
126151261|NCT00472303|453841956|FG002|Titration Phase|Adverse Event|0|||
126151262|NCT00472303|453841954|FG000|Titration Phase|Death|4|||
126151263|NCT00472303|453841955|FG001|Titration Phase|Death|2|||
126151264|NCT00472303|453841956|FG002|Titration Phase|Death|0|||
126151265|NCT00472303|453841954|FG000|Titration Phase|Lack of Efficacy|10|||
125971372|NCT00695903|453182810|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
126151266|NCT00472303|453841955|FG001|Titration Phase|Lack of Efficacy|0|||
126151267|NCT00472303|453841956|FG002|Titration Phase|Lack of Efficacy|0|||
126151268|NCT00472303|453841954|FG000|Titration Phase|Withdrawal by Subject|16|||
126151269|NCT00472303|453841955|FG001|Titration Phase|Withdrawal by Subject|13|||
126151270|NCT00472303|453841956|FG002|Titration Phase|Withdrawal by Subject|0|||
126151271|NCT00472303|453841954|FG000|Titration Phase|Trial Medication non-compliant|4|||
126151272|NCT00472303|453841955|FG001|Titration Phase|Trial Medication non-compliant|1|||
126151273|NCT00472303|453841956|FG002|Titration Phase|Trial Medication non-compliant|0|||
126151274|NCT00472303|453841954|FG000|Titration Phase|Other|3|||
126151275|NCT00472303|453841955|FG001|Titration Phase|Other|1|||
126151276|NCT00472303|453841956|FG002|Titration Phase|Other|0|||
126151277|NCT00472303|453841954|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
126151278|NCT00472303|453841955|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
126151279|NCT00472303|453841956|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
126151280|NCT00472303|453841954|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
126151281|NCT00472303|453841955|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
126151282|NCT00472303|453841956|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
126151283|NCT00472303|453841954|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
126151284|NCT00472303|453841955|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
126151285|NCT00472303|453841956|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
126151286|NCT00472303|453841954|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
126151287|NCT00472303|453841955|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
126151288|NCT00472303|453841956|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
126151289|NCT00472303|453841954|FG000|Discontinuations After Titration Phase|Other|5|||
126151290|NCT00472303|453841955|FG001|Discontinuations After Titration Phase|Other|0|||
126151291|NCT00472303|453841956|FG002|Discontinuations After Titration Phase|Other|0|||
126151292|NCT00472303|453841954|FG000|Maintenance Phase|Adverse Event|5|||
126151293|NCT00472303|453841955|FG001|Maintenance Phase|Adverse Event|6|||
126151294|NCT00472303|453841956|FG002|Maintenance Phase|Adverse Event|6|||
126151295|NCT00472303|453841954|FG000|Maintenance Phase|Death|3|||
126151296|NCT00472303|453841955|FG001|Maintenance Phase|Death|0|||
126151297|NCT00472303|453841956|FG002|Maintenance Phase|Death|2|||
126151298|NCT00472303|453841954|FG000|Maintenance Phase|Lack of Efficacy|2|||
126151299|NCT00472303|453841955|FG001|Maintenance Phase|Lack of Efficacy|2|||
126151300|NCT00472303|453841956|FG002|Maintenance Phase|Lack of Efficacy|4|||
126151301|NCT00472303|453841954|FG000|Maintenance Phase|Withdrawal by Subject|6|||
126151302|NCT00472303|453841955|FG001|Maintenance Phase|Withdrawal by Subject|7|||
126151303|NCT00472303|453841956|FG002|Maintenance Phase|Withdrawal by Subject|3|||
126151304|NCT00472303|453841954|FG000|Maintenance Phase|Trial medication non-compliant|0|||
126151305|NCT00472303|453841955|FG001|Maintenance Phase|Trial medication non-compliant|0|||
126151306|NCT00472303|453841956|FG002|Maintenance Phase|Trial medication non-compliant|1|||
126151307|NCT00472303|453841954|FG000|Maintenance Phase|Resolution of pain|0|||
126151308|NCT00472303|453841955|FG001|Maintenance Phase|Resolution of pain|0|||
126151309|NCT00472303|453841956|FG002|Maintenance Phase|Resolution of pain|1|||
126151310|NCT00472303|453841954|FG000|Maintenance Phase|Other|1|||
126151311|NCT00472303|453841955|FG001|Maintenance Phase|Other|1|||
126151312|NCT00472303|453841956|FG002|Maintenance Phase|Other|0|||
126151313|NCT03182738|453841957|FG000|Overall Study|Lost to Follow-up|9|||
126151314|NCT03182738|453841958|FG001|Overall Study|Lost to Follow-up|3|||
126151315|NCT03182738|453841957|FG000|Overall Study|Pregnancy|0|||
126151316|NCT03182738|453841958|FG001|Overall Study|Pregnancy|1|||
126151317|NCT03182738|453841957|FG000|Overall Study|Withdrawal by Subject|0|||
126151318|NCT03182738|453841958|FG001|Overall Study|Withdrawal by Subject|1|||
126151319|NCT01486238|453841964|FG000|Overall Study|Death|0|||
126151320|NCT01486238|453841965|FG001|Overall Study|Death|2|||
126151321|NCT01486238|453841964|FG000|Overall Study|Withdrawal by Subject|2|||
126151322|NCT01486238|453841965|FG001|Overall Study|Withdrawal by Subject|1|||
126151323|NCT01486238|453841964|FG000|Overall Study|Lost to Follow-up|0|||
126151324|NCT01486238|453841965|FG001|Overall Study|Lost to Follow-up|3|||
126151325|NCT00356915|453841966|FG000|Overall Study|Non compliance|1|||
126151326|NCT00356915|453841967|FG001|Overall Study|Non compliance|2|||
126151327|NCT00356915|453841968|FG002|Overall Study|Non compliance|1|||
126151328|NCT00356915|453841966|FG000|Overall Study|Protocol Violation|2|||
126151329|NCT00356915|453841967|FG001|Overall Study|Protocol Violation|3|||
126151330|NCT00356915|453841968|FG002|Overall Study|Protocol Violation|2|||
126151331|NCT00356915|453841966|FG000|Overall Study|Withdrawal by Subject|14|||
126151332|NCT00356915|453841967|FG001|Overall Study|Withdrawal by Subject|14|||
126151333|NCT00356915|453841968|FG002|Overall Study|Withdrawal by Subject|10|||
126151334|NCT00356915|453841966|FG000|Overall Study|Lack of Efficacy|0|||
126151335|NCT00356915|453841967|FG001|Overall Study|Lack of Efficacy|0|||
126151336|NCT00356915|453841968|FG002|Overall Study|Lack of Efficacy|3|||
126151337|NCT00356915|453841966|FG000|Overall Study|Lost to Follow-up|27|||
126151338|NCT00356915|453841967|FG001|Overall Study|Lost to Follow-up|34|||
126151339|NCT00356915|453841968|FG002|Overall Study|Lost to Follow-up|14|||
126151340|NCT00356915|453841966|FG000|Overall Study|Administrative Decision|0|||
126151341|NCT00356915|453841967|FG001|Overall Study|Administrative Decision|0|||
126151342|NCT00356915|453841968|FG002|Overall Study|Administrative Decision|1|||
126151343|NCT00356915|453841966|FG000|Overall Study|Physician Decision|0|||
126151344|NCT00356915|453841967|FG001|Overall Study|Physician Decision|2|||
126151345|NCT00356915|453841968|FG002|Overall Study|Physician Decision|0|||
126151346|NCT00356915|453841966|FG000|Overall Study|Adverse Event|21|||
126151347|NCT00356915|453841967|FG001|Overall Study|Adverse Event|31|||
126151348|NCT00356915|453841968|FG002|Overall Study|Adverse Event|8|||
126151459|NCT00488631|453841986|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
126151460|NCT00488631|453841977|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126151461|NCT00488631|453841978|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126151462|NCT00488631|453841979|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126151463|NCT00488631|453841980|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126151464|NCT00488631|453841981|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126151465|NCT00488631|453841982|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126151466|NCT00488631|453841983|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
126151467|NCT00488631|453841984|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126151468|NCT00488631|453841985|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
126151469|NCT00488631|453841986|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126151470|NCT00488631|453841977|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126151471|NCT00488631|453841978|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126151472|NCT00488631|453841979|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126151473|NCT00488631|453841980|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126151474|NCT00488631|453841981|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126151475|NCT00488631|453841982|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126151476|NCT00488631|453841983|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
126151477|NCT00488631|453841984|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
126151478|NCT00488631|453841985|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
126151479|NCT00488631|453841986|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126151480|NCT01873950|453841987|FG000|Period 5|Withdrawal by Subject|0|||
126151481|NCT01873950|453841988|FG001|Period 5|Withdrawal by Subject|0|||
126151482|NCT01873950|453841989|FG002|Period 5|Withdrawal by Subject|0|||
126151483|NCT01873950|453841990|FG003|Period 5|Withdrawal by Subject|1|||
126151484|NCT01873950|453841991|FG004|Period 5|Withdrawal by Subject|0|||
126151485|NCT01193335|453841992|FG000|After Infant Series|Lost to Follow-up|1|||
126151486|NCT01193335|453841993|FG001|After Infant Series|Lost to Follow-up|2|||
126151487|NCT01193335|453841992|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
126151488|NCT01193335|453841993|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
126151489|NCT01193335|453841992|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
126151490|NCT01193335|453841993|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
126151491|NCT01193335|453841992|FG000|1-Year Follow-up|Lost to Follow-up|4|||
126151492|NCT01193335|453841993|FG001|1-Year Follow-up|Lost to Follow-up|0|||
126151493|NCT01193335|453841992|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
126151494|NCT01193335|453841993|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
126151495|NCT01193335|453841992|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
126151496|NCT01193335|453841993|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
126151497|NCT01733329|453841995|FG000|Overall Study|Protocol Violation|1|||
126151498|NCT01733329|453841996|FG001|Overall Study|Protocol Violation|1|||
126151499|NCT01733329|453841995|FG000|Overall Study|Uterine artery injury|1|||
126151500|NCT01733329|453841996|FG001|Overall Study|Uterine artery injury|0|||
126151501|NCT02500550|453842003|FG000|Overall Study|Death|7|||
126151502|NCT03486314|453842004|FG000|Part A|Adverse Event|1|||
126151503|NCT03486314|453842005|FG001|Part A|Adverse Event|0|||
126151504|NCT03486314|453842006|FG002|Part A|Adverse Event|0|||
126151505|NCT03486314|453842004|FG000|Part A|Symptomatic Deterioration|2|||
126151506|NCT03486314|453842005|FG001|Part A|Symptomatic Deterioration|0|||
126151507|NCT03486314|453842006|FG002|Part A|Symptomatic Deterioration|0|||
126151508|NCT00659438|453842007|FG000|Overall Study|Withdrawal by Subject|2|||
126151509|NCT00659438|453842008|FG001|Overall Study|Withdrawal by Subject|2|||
126151510|NCT00659438|453842007|FG000|Overall Study|Death|11|||
126151511|NCT00659438|453842008|FG001|Overall Study|Death|6|||
126151512|NCT00659438|453842007|FG000|Overall Study|Lost to Follow-up|1|||
126151513|NCT00659438|453842008|FG001|Overall Study|Lost to Follow-up|0|||
126151514|NCT02388776|453842009|FG000|Overall Study|Death|1|||
126151515|NCT02388776|453842009|FG000|Overall Study|Lost to Follow-up|1|||
126151516|NCT03826914|453842011|FG000|Overall Study|Withdrawal by Subject|1|||
126151517|NCT03826914|453842012|FG001|Overall Study|Withdrawal by Subject|1|||
126151518|NCT04334148|453842015|FG000|Overall Study|positive nasal swab at baseline|0|||
126151519|NCT04334148|453842016|FG001|Overall Study|positive nasal swab at baseline|1|||
126151520|NCT00542828|453842017|FG000|Overall Study|Physician Decision|1|||
126151521|NCT00542828|453842017|FG000|Overall Study|Need for Prohibited Treatment|3|||
126151522|NCT00542828|453842017|FG000|Overall Study|Study Prematurely Discontinued|7|||
126151523|NCT00542828|453842017|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
126151524|NCT03228186|453842020|FG000|Overall Study|Patient never started treatment|1|||
126151525|NCT04246047|453842023|FG000|Overall Study|Death|50|||
126151526|NCT04246047|453842024|FG001|Overall Study|Death|77|||
126151527|NCT04246047|453842023|FG000|Overall Study|Lost to Follow-up|1|||
126151528|NCT04246047|453842024|FG001|Overall Study|Lost to Follow-up|3|||
126151529|NCT04246047|453842023|FG000|Overall Study|Physician Decision|4|||
126151530|NCT04246047|453842024|FG001|Overall Study|Physician Decision|10|||
126151531|NCT04246047|453842023|FG000|Overall Study|Withdrawal by Subject|19|||
126151532|NCT04246047|453842024|FG001|Overall Study|Withdrawal by Subject|26|||
126151533|NCT04246047|453842023|FG000|Overall Study|Ongoing|169|||
126151534|NCT04246047|453842024|FG001|Overall Study|Ongoing|135|||
126151535|NCT05139030|453842028|FG000|Overall Study|Withdrawal by Subject|1|||
126151536|NCT05139030|453842029|FG001|Overall Study|Withdrawal by Subject|3|||
126151537|NCT05139030|453842028|FG000|Overall Study|Adverse Event|0|||
126151538|NCT05139030|453842029|FG001|Overall Study|Adverse Event|1|||
126151539|NCT05139030|453842028|FG000|Overall Study|Failure to meet continuation criteria|0|||
126151540|NCT05139030|453842029|FG001|Overall Study|Failure to meet continuation criteria|1|||
126151541|NCT02502864|453842030|FG000|Overall Study|Withdrawal by Subject|1|||
126151542|NCT03772327|453842031|FG000|Overall Study|Lost to Follow-up|3|||
126151543|NCT03772327|453842032|FG001|Overall Study|Lost to Follow-up|4|||
126151544|NCT03772327|453842031|FG000|Overall Study|Withdrawal by Subject|2|||
126151545|NCT03772327|453842032|FG001|Overall Study|Withdrawal by Subject|3|||
126151546|NCT04233424|453842033|FG000|Overall Study|Death|15|||
126151547|NCT04233424|453842034|FG001|Overall Study|Death|16|||
126151548|NCT04233424|453842033|FG000|Overall Study|Withdrawal by Subject|2|||
126151549|NCT04233424|453842034|FG001|Overall Study|Withdrawal by Subject|8|||
126151550|NCT04233424|453842033|FG000|Overall Study|Physician Decision|1|||
126151551|NCT04233424|453842034|FG001|Overall Study|Physician Decision|3|||
126151552|NCT04233424|453842033|FG000|Overall Study|Protocol Violation|3|||
126151553|NCT04233424|453842034|FG001|Overall Study|Protocol Violation|1|||
126151554|NCT04233424|453842033|FG000|Overall Study|Lost to Follow-up|1|||
126151555|NCT04233424|453842034|FG001|Overall Study|Lost to Follow-up|3|||
126151556|NCT04233424|453842033|FG000|Overall Study|subject refuse to visit site|2|||
126151557|NCT04233424|453842034|FG001|Overall Study|subject refuse to visit site|0|||
126151558|NCT03517436|453842035|FG000|Overall Study|Death|3|||
126151559|NCT03517436|453842035|FG000|Overall Study|Withdrawal by Subject|4|||
126151560|NCT03517436|453842035|FG000|Overall Study|Did not receive study valve.|1|||
126151561|NCT01254344|453842038|FG000|Overall Study|Adverse Event|2|||
126151562|NCT01254344|453842039|FG001|Overall Study|Adverse Event|5|||
126151563|NCT01254344|453842038|FG000|Overall Study|Physician Decision|7|||
126151564|NCT01254344|453842039|FG001|Overall Study|Physician Decision|4|||
126151565|NCT01254344|453842038|FG000|Overall Study|Protocol Violation|1|||
126151566|NCT01254344|453842039|FG001|Overall Study|Protocol Violation|4|||
126151567|NCT01254344|453842038|FG000|Overall Study|Withdrawal by Subject|3|||
126151568|NCT01254344|453842039|FG001|Overall Study|Withdrawal by Subject|6|||
126151569|NCT03022461|453842040|FG000|Overall Study|Death|3|||
126151570|NCT01982630|453842041|FG000|Overall Study|Adverse Event|2|||
125971520|NCT00791765|453184717|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
125971521|NCT00791765|453184716|FG000|Weeks 13 to 24|Disease progression|0|||
125971522|NCT00791765|453184717|FG001|Weeks 13 to 24|Disease progression|1|||
125971523|NCT00791765|453184716|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
125971524|NCT00791765|453184717|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
125971525|NCT00791765|453184716|FG000|Weeks 13 to 24|Other|0|||
125971526|NCT00791765|453184717|FG001|Weeks 13 to 24|Other|1|||
125971527|NCT01877408|453184726|FG000|Overall Study|Lost to Follow-up|0|||
126151571|NCT01982630|453842042|FG001|Overall Study|Adverse Event|0|||
126151572|NCT01982630|453842043|FG002|Overall Study|Adverse Event|1|||
126151573|NCT01982630|453842044|FG003|Overall Study|Adverse Event|0|||
126151574|NCT01982630|453842045|FG004|Overall Study|Adverse Event|1|||
126151575|NCT01982630|453842046|FG005|Overall Study|Adverse Event|2|||
126151576|NCT01982630|453842047|FG006|Overall Study|Adverse Event|1|||
126151577|NCT01982630|453842048|FG007|Overall Study|Adverse Event|0|||
126151578|NCT01982630|453842041|FG000|Overall Study|Physician Decision|1|||
126151579|NCT01982630|453842042|FG001|Overall Study|Physician Decision|0|||
125971528|NCT01877408|453184727|FG001|Overall Study|Lost to Follow-up|2|||
125971529|NCT04546581|453184735|FG000|Overall Study|Adverse Event|9|||
125971530|NCT04546581|453184736|FG001|Overall Study|Adverse Event|3|||
125971531|NCT04546581|453184735|FG000|Overall Study|Physician Decision|0|||
125971532|NCT04546581|453184736|FG001|Overall Study|Physician Decision|1|||
125971533|NCT04546581|453184735|FG000|Overall Study|Protocol Violation|1|||
126151580|NCT01982630|453842043|FG002|Overall Study|Physician Decision|2|||
126151581|NCT01982630|453842044|FG003|Overall Study|Physician Decision|1|||
126151582|NCT01982630|453842045|FG004|Overall Study|Physician Decision|2|||
126151583|NCT01982630|453842046|FG005|Overall Study|Physician Decision|0|||
126151584|NCT01982630|453842047|FG006|Overall Study|Physician Decision|0|||
126151585|NCT01982630|453842048|FG007|Overall Study|Physician Decision|0|||
126151586|NCT01982630|453842041|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126151587|NCT01982630|453842042|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126151588|NCT01982630|453842043|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
126151589|NCT01982630|453842044|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126151590|NCT01982630|453842045|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126151591|NCT01982630|453842046|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126151592|NCT01982630|453842047|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126151593|NCT01982630|453842048|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126151594|NCT01982630|453842041|FG000|Overall Study|Withdrawal by Subject|0|||
126151595|NCT01982630|453842042|FG001|Overall Study|Withdrawal by Subject|0|||
126151596|NCT01982630|453842043|FG002|Overall Study|Withdrawal by Subject|0|||
126151597|NCT01982630|453842044|FG003|Overall Study|Withdrawal by Subject|0|||
126151598|NCT01982630|453842045|FG004|Overall Study|Withdrawal by Subject|0|||
126151599|NCT01982630|453842046|FG005|Overall Study|Withdrawal by Subject|1|||
126151600|NCT01982630|453842047|FG006|Overall Study|Withdrawal by Subject|0|||
126151601|NCT01982630|453842048|FG007|Overall Study|Withdrawal by Subject|0|||
126151602|NCT03459040|453842049|FG000|Overall Study|Death|8|||
126151603|NCT03459040|453842049|FG000|Overall Study|Withdrawal by Subject|1|||
126151604|NCT00561353|453842050|FG000|Overall Study|Subject reached a virologic endpoint|2|||
126151605|NCT00561353|453842051|FG001|Overall Study|Subject reached a virologic endpoint|1|||
126151606|NCT00561353|453842052|FG002|Overall Study|Subject reached a virologic endpoint|1|||
126151607|NCT00561353|453842053|FG003|Overall Study|Subject reached a virologic endpoint|4|||
126151608|NCT00561353|453842054|FG004|Overall Study|Subject reached a virologic endpoint|1|||
126151609|NCT00561353|453842055|FG005|Overall Study|Subject reached a virologic endpoint|3|||
126151610|NCT00561353|453842056|FG006|Overall Study|Subject reached a virologic endpoint|4|||
126151611|NCT00561353|453842057|FG007|Overall Study|Subject reached a virologic endpoint|4|||
126151612|NCT00561353|453842058|FG008|Overall Study|Subject reached a virologic endpoint|5|||
126151613|NCT00561353|453842059|FG009|Overall Study|Subject reached a virologic endpoint|0|||
126151614|NCT00561353|453842050|FG000|Overall Study|Subject ineligible to continue the trial|0|||
126151615|NCT00561353|453842051|FG001|Overall Study|Subject ineligible to continue the trial|0|||
126151616|NCT00561353|453842052|FG002|Overall Study|Subject ineligible to continue the trial|0|||
126151617|NCT00561353|453842053|FG003|Overall Study|Subject ineligible to continue the trial|0|||
126151618|NCT00561353|453842054|FG004|Overall Study|Subject ineligible to continue the trial|0|||
126151619|NCT00561353|453842055|FG005|Overall Study|Subject ineligible to continue the trial|1|||
126151620|NCT00561353|453842056|FG006|Overall Study|Subject ineligible to continue the trial|1|||
126151621|NCT00561353|453842057|FG007|Overall Study|Subject ineligible to continue the trial|0|||
126151622|NCT00561353|453842058|FG008|Overall Study|Subject ineligible to continue the trial|2|||
126151623|NCT00561353|453842059|FG009|Overall Study|Subject ineligible to continue the trial|1|||
126151624|NCT00561353|453842050|FG000|Overall Study|Other|1|||
126151625|NCT00561353|453842051|FG001|Overall Study|Other|0|||
126151626|NCT00561353|453842052|FG002|Overall Study|Other|1|||
126151627|NCT00561353|453842053|FG003|Overall Study|Other|0|||
126151628|NCT00561353|453842054|FG004|Overall Study|Other|0|||
126151629|NCT00561353|453842055|FG005|Overall Study|Other|2|||
126151630|NCT00561353|453842056|FG006|Overall Study|Other|0|||
126151631|NCT00561353|453842057|FG007|Overall Study|Other|0|||
126151632|NCT00561353|453842058|FG008|Overall Study|Other|0|||
126151633|NCT00561353|453842059|FG009|Overall Study|Other|0|||
126151634|NCT00561353|453842050|FG000|Overall Study|Adverse Event|0|||
126151635|NCT00561353|453842051|FG001|Overall Study|Adverse Event|0|||
126151636|NCT00561353|453842052|FG002|Overall Study|Adverse Event|0|||
126151637|NCT00561353|453842053|FG003|Overall Study|Adverse Event|2|||
126151638|NCT00561353|453842054|FG004|Overall Study|Adverse Event|0|||
126151639|NCT00561353|453842055|FG005|Overall Study|Adverse Event|0|||
126151640|NCT00561353|453842056|FG006|Overall Study|Adverse Event|1|||
126151641|NCT00561353|453842057|FG007|Overall Study|Adverse Event|0|||
126151642|NCT00561353|453842058|FG008|Overall Study|Adverse Event|0|||
126151643|NCT00561353|453842059|FG009|Overall Study|Adverse Event|1|||
126151644|NCT00561353|453842050|FG000|Overall Study|Lost to Follow-up|2|||
126151645|NCT00561353|453842051|FG001|Overall Study|Lost to Follow-up|0|||
126151646|NCT00561353|453842052|FG002|Overall Study|Lost to Follow-up|1|||
126151647|NCT00561353|453842053|FG003|Overall Study|Lost to Follow-up|0|||
126151648|NCT00561353|453842054|FG004|Overall Study|Lost to Follow-up|0|||
126151649|NCT00561353|453842055|FG005|Overall Study|Lost to Follow-up|0|||
126151650|NCT00561353|453842056|FG006|Overall Study|Lost to Follow-up|0|||
126151651|NCT00561353|453842057|FG007|Overall Study|Lost to Follow-up|0|||
126151652|NCT00561353|453842058|FG008|Overall Study|Lost to Follow-up|0|||
126151653|NCT00561353|453842059|FG009|Overall Study|Lost to Follow-up|0|||
126151654|NCT00561353|453842050|FG000|Overall Study|Withdrawal by Subject|0|||
126151655|NCT00561353|453842051|FG001|Overall Study|Withdrawal by Subject|2|||
126151656|NCT00561353|453842052|FG002|Overall Study|Withdrawal by Subject|0|||
126151657|NCT00561353|453842053|FG003|Overall Study|Withdrawal by Subject|0|||
126151658|NCT00561353|453842054|FG004|Overall Study|Withdrawal by Subject|0|||
126151659|NCT00561353|453842055|FG005|Overall Study|Withdrawal by Subject|0|||
126151660|NCT00561353|453842056|FG006|Overall Study|Withdrawal by Subject|0|||
126151661|NCT00561353|453842057|FG007|Overall Study|Withdrawal by Subject|0|||
126151662|NCT00561353|453842058|FG008|Overall Study|Withdrawal by Subject|0|||
126151663|NCT00561353|453842059|FG009|Overall Study|Withdrawal by Subject|0|||
126151664|NCT01273818|453842060|FG000|Overall Study|Physician Decision|13|||
126151665|NCT01273818|453842061|FG001|Overall Study|Physician Decision|2|||
126151666|NCT01273818|453842062|FG002|Overall Study|Physician Decision|9|||
126151667|NCT03815175|453842063|FG000|Overall Study|Subject Lost to Follow-up|6|||
126151668|NCT03815175|453842063|FG000|Overall Study|Subject Withdrew Consent|48|||
126151669|NCT03815175|453842063|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
126151670|NCT03815175|453842063|FG000|Overall Study|Death|86|||
126151671|NCT03815175|453842063|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
126151672|NCT03815175|453842063|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
126151673|NCT03815175|453842063|FG000|Overall Study|Other Status Change Reason|1|||
126151674|NCT03815175|453842063|FG000|Overall Study|Missed Visit|12|||
126151675|NCT00820040|453842064|FG000|Overall Study|Death|1|||
126151676|NCT00820040|453842064|FG000|Overall Study|Sponsor terminated study|1|||
126151677|NCT00820040|453842064|FG000|Overall Study|Screen failure|1|||
126151678|NCT02493751|453842065|FG000|Overall Study|Withdrawal by Subject|2|||
126151679|NCT02493751|453842066|FG001|Overall Study|Withdrawal by Subject|8|||
126151680|NCT02493751|453842065|FG000|Overall Study|Death|6|||
126151681|NCT02493751|453842066|FG001|Overall Study|Death|13|||
126151682|NCT02493751|453842065|FG000|Overall Study|Lost to Follow-up|2|||
126151683|NCT02493751|453842066|FG001|Overall Study|Lost to Follow-up|3|||
126151684|NCT02493751|453842065|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
126151685|NCT02493751|453842066|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
126151686|NCT01824602|453842069|FG000|Overall Study|Withdrawal by Subject|0|||
126151687|NCT01824602|453842070|FG001|Overall Study|Withdrawal by Subject|0|||
126151688|NCT01824602|453842071|FG002|Overall Study|Withdrawal by Subject|1|||
126151689|NCT01824602|453842072|FG003|Overall Study|Withdrawal by Subject|2|||
126151690|NCT01824602|453842069|FG000|Overall Study|Patient non-compliance|0|||
126151691|NCT01824602|453842070|FG001|Overall Study|Patient non-compliance|0|||
126151692|NCT01824602|453842071|FG002|Overall Study|Patient non-compliance|1|||
126151693|NCT01824602|453842072|FG003|Overall Study|Patient non-compliance|0|||
126151694|NCT01824602|453842069|FG000|Overall Study|Adverse Event|1|||
126151695|NCT01824602|453842070|FG001|Overall Study|Adverse Event|0|||
126151696|NCT01824602|453842071|FG002|Overall Study|Adverse Event|2|||
126151697|NCT01824602|453842072|FG003|Overall Study|Adverse Event|2|||
126151698|NCT01824602|453842069|FG000|Overall Study|Treatment failure|0|||
126151699|NCT01824602|453842070|FG001|Overall Study|Treatment failure|0|||
126151700|NCT01824602|453842071|FG002|Overall Study|Treatment failure|0|||
126151701|NCT01824602|453842072|FG003|Overall Study|Treatment failure|1|||
126151702|NCT02485717|453842075|FG000|Overall Study|Lost to Follow-up|6|||
126151703|NCT02485717|453842076|FG001|Overall Study|Lost to Follow-up|0|||
126151704|NCT02485717|453842077|FG002|Overall Study|Lost to Follow-up|0|||
126151705|NCT02485717|453842075|FG000|Overall Study|Withdrawal by Subject|0|||
126151706|NCT02485717|453842076|FG001|Overall Study|Withdrawal by Subject|0|||
126151707|NCT02485717|453842077|FG002|Overall Study|Withdrawal by Subject|1|||
126151708|NCT02485717|453842075|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
126151709|NCT02485717|453842076|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
126151710|NCT02485717|453842077|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
126151711|NCT02485717|453842075|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
126151712|NCT02485717|453842076|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
126151713|NCT02485717|453842077|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
126151714|NCT03822468|453842080|FG000|Treatment Period|Progressive disease|98|||
126151715|NCT03822468|453842081|FG001|Treatment Period|Progressive disease|94|||
126151716|NCT03822468|453842080|FG000|Treatment Period|Adverse Event|21|||
126151717|NCT03822468|453842081|FG001|Treatment Period|Adverse Event|24|||
126151718|NCT03822468|453842080|FG000|Treatment Period|Withdrawal by Subject|9|||
126151719|NCT03822468|453842081|FG001|Treatment Period|Withdrawal by Subject|5|||
126151720|NCT03822468|453842080|FG000|Treatment Period|Physician Decision|9|||
126151721|NCT03822468|453842081|FG001|Treatment Period|Physician Decision|7|||
126151722|NCT03822468|453842080|FG000|Treatment Period|Protocol Violation|2|||
126151723|NCT03822468|453842081|FG001|Treatment Period|Protocol Violation|1|||
126151724|NCT03822468|453842080|FG000|Treatment Period|Death|2|||
126151725|NCT03822468|453842081|FG001|Treatment Period|Death|3|||
126151726|NCT03822468|453842080|FG000|Treatment Period|Lost to Follow-up|1|||
126151727|NCT03822468|453842081|FG001|Treatment Period|Lost to Follow-up|1|||
126151728|NCT03822468|453842080|FG000|Treatment Period|Sponsor decision|46|||
126151729|NCT03822468|453842081|FG001|Treatment Period|Sponsor decision|53|||
126151730|NCT03822468|453842080|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
126151731|NCT03822468|453842081|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
125971534|NCT04546581|453184736|FG001|Overall Study|Protocol Violation|2|||
126151732|NCT03822468|453842080|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
126151733|NCT03822468|453842081|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
126151734|NCT03822468|453842080|FG000|Post-treatment Efficacy Follow-up|Death|1|||
126151735|NCT03822468|453842081|FG001|Post-treatment Efficacy Follow-up|Death|0|||
126151736|NCT03822468|453842080|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125971535|NCT04546581|453184735|FG000|Overall Study|Withdrawal by Subject|3|||
126151737|NCT03822468|453842081|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
126151738|NCT03822468|453842080|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
126151739|NCT03822468|453842081|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125971536|NCT04546581|453184736|FG001|Overall Study|Withdrawal by Subject|7|||
126151740|NCT03822468|453842080|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
126151741|NCT03822468|453842081|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126151742|NCT03822468|453842080|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
126151743|NCT03822468|453842081|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
126151744|NCT01084252|453843716|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151745|NCT01084252|453843717|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151746|NCT01084252|453843718|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151747|NCT01084252|453843719|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151748|NCT01084252|453843720|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151749|NCT01084252|453843721|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151750|NCT01084252|453843722|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151751|NCT01084252|453843723|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151752|NCT01084252|453843724|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151753|NCT01084252|453843725|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151754|NCT01084252|453843726|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151755|NCT01084252|453843727|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151756|NCT01084252|453843728|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
126151757|NCT01084252|453843729|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126151758|NCT04909463|453843730|FG000|Overall Study|Withdrawal by Subject|0|||
126151759|NCT04909463|453843731|FG001|Overall Study|Withdrawal by Subject|1|||
126151760|NCT04909463|453843732|FG002|Overall Study|Withdrawal by Subject|0|||
126151761|NCT04909463|453843733|FG003|Overall Study|Withdrawal by Subject|0|||
126151762|NCT04909463|453843730|FG000|Overall Study|Lost to Follow-up|2|||
126151763|NCT04909463|453843731|FG001|Overall Study|Lost to Follow-up|1|||
126151764|NCT04909463|453843732|FG002|Overall Study|Lost to Follow-up|1|||
126151765|NCT04909463|453843733|FG003|Overall Study|Lost to Follow-up|0|||
126151766|NCT00955110|453843734|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
126151767|NCT00955110|453843734|FG000|Treatment Phase|Adverse Event|2|||
126151768|NCT00955110|453843734|FG000|Treatment Phase|Administrative reasons|2|||
126151769|NCT00955110|453843734|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
126151770|NCT00955110|453843734|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
126151771|NCT01416181|453843737|FG000|Part 1|Other|10|||
126151772|NCT01416181|453843738|FG001|Part 1|Other|24|||
126151773|NCT01416181|453843737|FG000|Part 1|Death|0|||
126151774|NCT01416181|453843738|FG001|Part 1|Death|1|||
126151775|NCT01416181|453843737|FG000|Part 1|Investigator Decision|7|||
126151776|NCT01416181|453843738|FG001|Part 1|Investigator Decision|6|||
126151777|NCT01416181|453843737|FG000|Part 1|Withdrawal by Subject|74|||
126151778|NCT01416181|453843738|FG001|Part 1|Withdrawal by Subject|48|||
126151779|NCT01416181|453843737|FG000|Part 1|Lack of Efficacy|16|||
126151780|NCT01416181|453843738|FG001|Part 1|Lack of Efficacy|8|||
126151781|NCT01416181|453843737|FG000|Part 1|Lost to Follow-up|1|||
126151782|NCT01416181|453843738|FG001|Part 1|Lost to Follow-up|1|||
126151783|NCT01416181|453843737|FG000|Part 1|Adverse Event|15|||
126151784|NCT01416181|453843738|FG001|Part 1|Adverse Event|18|||
126151785|NCT01416181|453843737|FG000|Part 1|Ongoing in Follow-Up|14|||
126151786|NCT01416181|453843738|FG001|Part 1|Ongoing in Follow-Up|8|||
126151787|NCT01416181|453843737|FG000|Part 2|Adverse Event|11|||
126151788|NCT01416181|453843738|FG001|Part 2|Adverse Event|4|||
126151789|NCT01416181|453843737|FG000|Part 2|Other|234|||
126151790|NCT01416181|453843738|FG001|Part 2|Other|267|||
126151791|NCT01416181|453843737|FG000|Part 2|Investigator Decision|6|||
126151792|NCT01416181|453843738|FG001|Part 2|Investigator Decision|7|||
126151793|NCT01416181|453843737|FG000|Part 2|Withdrawal by Subject|14|||
126151794|NCT01416181|453843738|FG001|Part 2|Withdrawal by Subject|5|||
126151795|NCT01416181|453843737|FG000|Part 2|Lack of Efficacy|4|||
126151796|NCT01416181|453843738|FG001|Part 2|Lack of Efficacy|1|||
126151797|NCT01416181|453843737|FG000|Part 2|Lost to Follow-up|2|||
126151798|NCT01416181|453843738|FG001|Part 2|Lost to Follow-up|2|||
126151799|NCT00698516|453843741|FG000|Overall Study|Study Termination|2|||
126151800|NCT00698516|453843741|FG000|Overall Study|Withdrawal by Subject|3|||
126151801|NCT02586207|453843746|FG000|Overall Study|Physician Decision|1|||
126151802|NCT02586207|453843746|FG000|Overall Study|Withdrawal by Subject|1|||
126151803|NCT02158533|453843754|FG000|Stage 1|Adverse Event|6|||
126151804|NCT02158533|453843755|FG001|Stage 1|Adverse Event|4|||
126151805|NCT02158533|453843756|FG002|Stage 1|Adverse Event|7|||
126151806|NCT02158533|453843757|FG003|Stage 1|Adverse Event|0|||
126151807|NCT02158533|453843758|FG004|Stage 1|Adverse Event|0|||
126151808|NCT02158533|453843759|FG005|Stage 1|Adverse Event|0|||
126151809|NCT02158533|453843754|FG000|Stage 1|Withdrawal by Subject|3|||
126151810|NCT02158533|453843755|FG001|Stage 1|Withdrawal by Subject|2|||
126151811|NCT02158533|453843756|FG002|Stage 1|Withdrawal by Subject|1|||
126151812|NCT02158533|453843757|FG003|Stage 1|Withdrawal by Subject|0|||
126151813|NCT02158533|453843758|FG004|Stage 1|Withdrawal by Subject|0|||
126151814|NCT02158533|453843759|FG005|Stage 1|Withdrawal by Subject|0|||
126151815|NCT02158533|453843754|FG000|Stage 1|Lack of Efficacy|1|||
126151816|NCT02158533|453843755|FG001|Stage 1|Lack of Efficacy|0|||
126151817|NCT02158533|453843756|FG002|Stage 1|Lack of Efficacy|0|||
126151818|NCT02158533|453843757|FG003|Stage 1|Lack of Efficacy|0|||
126151819|NCT02158533|453843758|FG004|Stage 1|Lack of Efficacy|0|||
126151820|NCT02158533|453843759|FG005|Stage 1|Lack of Efficacy|0|||
126151821|NCT02158533|453843754|FG000|Stage 1|Lost to Follow-up|3|||
126151822|NCT02158533|453843755|FG001|Stage 1|Lost to Follow-up|1|||
126151823|NCT02158533|453843756|FG002|Stage 1|Lost to Follow-up|0|||
126151824|NCT02158533|453843757|FG003|Stage 1|Lost to Follow-up|0|||
126151825|NCT02158533|453843758|FG004|Stage 1|Lost to Follow-up|0|||
126151826|NCT02158533|453843759|FG005|Stage 1|Lost to Follow-up|0|||
126151827|NCT02158533|453843754|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
126151828|NCT02158533|453843755|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
126151829|NCT02158533|453843756|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
126151830|NCT02158533|453843757|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
126151831|NCT02158533|453843758|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
126151832|NCT02158533|453843759|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
126151833|NCT02158533|453843754|FG000|Stage 1|Non-compliance with study visits|1|||
126151834|NCT02158533|453843755|FG001|Stage 1|Non-compliance with study visits|0|||
126151835|NCT02158533|453843756|FG002|Stage 1|Non-compliance with study visits|0|||
126151836|NCT02158533|453843757|FG003|Stage 1|Non-compliance with study visits|0|||
126151837|NCT02158533|453843758|FG004|Stage 1|Non-compliance with study visits|0|||
126151838|NCT02158533|453843759|FG005|Stage 1|Non-compliance with study visits|0|||
126151839|NCT02158533|453843754|FG000|Stage 2|Adverse Event|0|||
126151840|NCT02158533|453843755|FG001|Stage 2|Adverse Event|0|||
126151841|NCT02158533|453843756|FG002|Stage 2|Adverse Event|0|||
126151842|NCT02158533|453843757|FG003|Stage 2|Adverse Event|0|||
126151843|NCT02158533|453843758|FG004|Stage 2|Adverse Event|0|||
126151844|NCT02158533|453843759|FG005|Stage 2|Adverse Event|1|||
126151845|NCT02158533|453843754|FG000|Stage 2|Lack of Efficacy|0|||
126151846|NCT02158533|453843755|FG001|Stage 2|Lack of Efficacy|0|||
126151847|NCT02158533|453843756|FG002|Stage 2|Lack of Efficacy|0|||
126151848|NCT02158533|453843757|FG003|Stage 2|Lack of Efficacy|0|||
126151849|NCT02158533|453843758|FG004|Stage 2|Lack of Efficacy|1|||
126151850|NCT02158533|453843759|FG005|Stage 2|Lack of Efficacy|0|||
126151851|NCT02158533|453843754|FG000|Stage 2|Lost to Follow-up|0|||
126151852|NCT02158533|453843755|FG001|Stage 2|Lost to Follow-up|0|||
126151853|NCT02158533|453843756|FG002|Stage 2|Lost to Follow-up|0|||
126151854|NCT02158533|453843757|FG003|Stage 2|Lost to Follow-up|1|||
126151855|NCT02158533|453843758|FG004|Stage 2|Lost to Follow-up|1|||
126151856|NCT02158533|453843759|FG005|Stage 2|Lost to Follow-up|2|||
126151857|NCT02158533|453843754|FG000|Stage 2|Withdrawal by Subject|0|||
126151858|NCT02158533|453843755|FG001|Stage 2|Withdrawal by Subject|0|||
126151859|NCT02158533|453843756|FG002|Stage 2|Withdrawal by Subject|0|||
126151860|NCT02158533|453843757|FG003|Stage 2|Withdrawal by Subject|0|||
126151861|NCT02158533|453843758|FG004|Stage 2|Withdrawal by Subject|1|||
126151862|NCT02158533|453843759|FG005|Stage 2|Withdrawal by Subject|2|||
126151863|NCT02158533|453843754|FG000|Stage 2|Physician Decision|0|||
126151864|NCT02158533|453843755|FG001|Stage 2|Physician Decision|0|||
126151865|NCT02158533|453843756|FG002|Stage 2|Physician Decision|0|||
126151866|NCT02158533|453843757|FG003|Stage 2|Physician Decision|0|||
126151867|NCT02158533|453843758|FG004|Stage 2|Physician Decision|1|||
126151868|NCT02158533|453843759|FG005|Stage 2|Physician Decision|0|||
126151869|NCT02158533|453843754|FG000|Stage 2|Pregnancy|0|||
126151870|NCT02158533|453843755|FG001|Stage 2|Pregnancy|0|||
126151871|NCT02158533|453843756|FG002|Stage 2|Pregnancy|0|||
126151872|NCT02158533|453843757|FG003|Stage 2|Pregnancy|1|||
126151873|NCT02158533|453843758|FG004|Stage 2|Pregnancy|0|||
126151874|NCT02158533|453843759|FG005|Stage 2|Pregnancy|0|||
126151875|NCT02158533|453843754|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
126151876|NCT02158533|453843755|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
126151877|NCT02158533|453843756|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
126151878|NCT02158533|453843757|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
126151879|NCT02158533|453843758|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
126151880|NCT02158533|453843759|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
126151881|NCT02158533|453843754|FG000|Stage 2|Non-adherence with study visits|0|||
126151882|NCT02158533|453843755|FG001|Stage 2|Non-adherence with study visits|0|||
126151883|NCT02158533|453843756|FG002|Stage 2|Non-adherence with study visits|0|||
126151884|NCT02158533|453843757|FG003|Stage 2|Non-adherence with study visits|0|||
126151885|NCT02158533|453843758|FG004|Stage 2|Non-adherence with study visits|0|||
126151886|NCT02158533|453843759|FG005|Stage 2|Non-adherence with study visits|1|||
126151887|NCT00345605|453843766|FG000|Arm 1|Adverse Event|0|||
126151888|NCT00345605|453843767|FG001|Arm 1|Adverse Event|1|||
126151889|NCT00345605|453843766|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
126151890|NCT00345605|453843767|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
126151891|NCT01335971|453843768|FG000|Overall Study|Withdrawal by Subject|1|||
126151892|NCT01335971|453843769|FG001|Overall Study|Withdrawal by Subject|0|||
126151893|NCT01335971|453843770|FG002|Overall Study|Withdrawal by Subject|0|||
126151894|NCT01335971|453843768|FG000|Overall Study|Did not complete bronchoscopy|1|||
126151895|NCT01335971|453843769|FG001|Overall Study|Did not complete bronchoscopy|1|||
126151896|NCT01335971|453843770|FG002|Overall Study|Did not complete bronchoscopy|1|||
126151897|NCT00384956|453843771|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
126151898|NCT00917384|453843772|FG000|Overall Study|Lost to Follow-up|4|||
126151899|NCT00917384|453843773|FG001|Overall Study|Lost to Follow-up|2|||
126151900|NCT00917384|453843772|FG000|Overall Study|Withdrawal by Subject|10|||
126151901|NCT00917384|453843773|FG001|Overall Study|Withdrawal by Subject|2|||
126151902|NCT00149214|453843778|FG000|Overall Study|Adverse Event|12|||
125971537|NCT01983293|453184737|FG000|Overall Study|Withdrawal by Subject|29|||
125971538|NCT01983293|453184738|FG001|Overall Study|Withdrawal by Subject|15|||
125971539|NCT01983293|453184737|FG000|Overall Study|Missing 12-month visit|3|||
125971540|NCT01983293|453184738|FG001|Overall Study|Missing 12-month visit|3|||
125971541|NCT01983293|453184737|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
125971542|NCT01983293|453184738|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
125971543|NCT01747772|453184739|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
125971544|NCT02062632|453184740|FG000|Overall Study|No treatment data|1|||
125971545|NCT01944631|453184746|FG000|Overall Study|Adverse Event|1|||
125971546|NCT01944631|453184747|FG001|Overall Study|Adverse Event|0|||
125971547|NCT01944631|453184746|FG000|Overall Study|Lost to Follow-up|3|||
125971548|NCT01944631|453184747|FG001|Overall Study|Lost to Follow-up|1|||
125971549|NCT01944631|453184746|FG000|Overall Study|Withdrawal by Subject|0|||
125971550|NCT01944631|453184747|FG001|Overall Study|Withdrawal by Subject|1|||
125971551|NCT01412944|453184748|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
125971552|NCT01412944|453184749|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
125971553|NCT01412944|453184750|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
125971554|NCT01412944|453184751|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
126151903|NCT00149214|453843779|FG001|Overall Study|Adverse Event|9|||
126151904|NCT00149214|453843778|FG000|Overall Study|Withdrawal by Subject|4|||
126151905|NCT00149214|453843779|FG001|Overall Study|Withdrawal by Subject|1|||
126151906|NCT00149214|453843778|FG000|Overall Study|Physician Decision|3|||
126151907|NCT00149214|453843779|FG001|Overall Study|Physician Decision|3|||
126151908|NCT00149214|453843778|FG000|Overall Study|Sponsor Decision|0|||
126151909|NCT00149214|453843779|FG001|Overall Study|Sponsor Decision|1|||
126151910|NCT00149214|453843778|FG000|Overall Study|Progressive Disease|7|||
126151911|NCT00149214|453843779|FG001|Overall Study|Progressive Disease|3|||
126151912|NCT03126227|453843782|FG000|Overall Study|Adverse Event|43|||
126151913|NCT03126227|453843783|FG001|Overall Study|Adverse Event|4|||
126151914|NCT03126227|453843782|FG000|Overall Study|Death|0|||
126151915|NCT03126227|453843783|FG001|Overall Study|Death|1|||
126151916|NCT03126227|453843782|FG000|Overall Study|Lost to Follow-up|0|||
126151917|NCT03126227|453843783|FG001|Overall Study|Lost to Follow-up|1|||
126151918|NCT03126227|453843782|FG000|Overall Study|Physician Decision|2|||
126151919|NCT03126227|453843783|FG001|Overall Study|Physician Decision|0|||
126151920|NCT03126227|453843782|FG000|Overall Study|Protocol Violation|1|||
126151921|NCT03126227|453843783|FG001|Overall Study|Protocol Violation|0|||
126151922|NCT03126227|453843782|FG000|Overall Study|Withdrawal by Subject|19|||
126151923|NCT03126227|453843783|FG001|Overall Study|Withdrawal by Subject|3|||
126151924|NCT03126227|453843782|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
126151925|NCT03126227|453843783|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
126151926|NCT03126227|453843782|FG000|Overall Study|Lack of dosing compliance|2|||
126151927|NCT03126227|453843783|FG001|Overall Study|Lack of dosing compliance|0|||
126151928|NCT03126227|453843782|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
126151929|NCT03126227|453843783|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
126151930|NCT03126227|453843782|FG000|Overall Study|Scheduling conflict|1|||
126151931|NCT03126227|453843783|FG001|Overall Study|Scheduling conflict|0|||
126151932|NCT00900796|453843788|FG000|Phase 1|Lacked sufficient information|4|||
126151933|NCT00900796|453843788|FG000|Phase 1|Missing information at Week 16|7|||
126151934|NCT00900796|453843788|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
126151935|NCT00900796|453843788|FG000|Phase 2|Lost to Follow-up|5|||
126151936|NCT01859403|453843789|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
126151937|NCT01859403|453843790|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
126151938|NCT01859403|453843789|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
126151939|NCT01859403|453843790|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
126151940|NCT01859403|453843789|FG000|Primary Endpoint Measure|Physician Decision|0|||
126151941|NCT01859403|453843790|FG001|Primary Endpoint Measure|Physician Decision|1|||
126151942|NCT01859403|453843789|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
125971555|NCT01412944|453184752|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
126151943|NCT01859403|453843790|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
126151944|NCT01121406|453843798|FG000|Overall Study|Progressive disease RECIST|44|||
126151945|NCT01121406|453843799|FG001|Overall Study|Progressive disease RECIST|28|||
126151946|NCT01121406|453843798|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
126151947|NCT01121406|453843799|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
126151948|NCT01121406|453843798|FG000|Overall Study|Other AE|3|||
126151949|NCT01121406|453843799|FG001|Overall Study|Other AE|10|||
126151950|NCT01121406|453843798|FG000|Overall Study|Non-compliant with protocol|0|||
126151951|NCT01121406|453843799|FG001|Overall Study|Non-compliant with protocol|2|||
126151952|NCT01121406|453843798|FG000|Overall Study|Lost to Follow-up|0|||
126151953|NCT01121406|453843799|FG001|Overall Study|Lost to Follow-up|1|||
126151954|NCT01121406|453843798|FG000|Overall Study|Refused continuation of study med.|1|||
126151955|NCT01121406|453843799|FG001|Overall Study|Refused continuation of study med.|2|||
126151956|NCT01121406|453843798|FG000|Overall Study|Reason other than specified above|2|||
126151957|NCT01121406|453843799|FG001|Overall Study|Reason other than specified above|6|||
126151958|NCT01121406|453843798|FG000|Overall Study|Not treated|1|||
126151959|NCT01121406|453843799|FG001|Overall Study|Not treated|0|||
126151960|NCT00892437|453843800|FG000|Randomized Phase|Randomized but not treated|6|||
126151961|NCT00892437|453843801|FG001|Randomized Phase|Randomized but not treated|0|||
126151962|NCT00892437|453843800|FG000|Randomized Phase|Adverse Event|2|||
126151963|NCT00892437|453843801|FG001|Randomized Phase|Adverse Event|2|||
126151964|NCT00892437|453843800|FG000|Randomized Phase|Lost to Follow-up|1|||
126151965|NCT00892437|453843801|FG001|Randomized Phase|Lost to Follow-up|3|||
126151966|NCT00892437|453843800|FG000|Randomized Phase|Investigator's Discretion|1|||
126151967|NCT00892437|453843801|FG001|Randomized Phase|Investigator's Discretion|0|||
126151968|NCT00892437|453843800|FG000|Randomized Phase|Withdrew Consent|1|||
126151969|NCT00892437|453843801|FG001|Randomized Phase|Withdrew Consent|0|||
126151970|NCT00892437|453843800|FG000|Open-Label Extension Phase|Adverse Event|4|||
126151971|NCT00892437|453843801|FG001|Open-Label Extension Phase|Adverse Event|2|||
126151972|NCT00892437|453843800|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
126151973|NCT00892437|453843801|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
126151974|NCT00892437|453843800|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
126151975|NCT00892437|453843801|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
126151976|NCT00892437|453843800|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
126151977|NCT00892437|453843801|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
126151978|NCT00892437|453843800|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
126151979|NCT00892437|453843801|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
126151980|NCT03185130|453843803|FG000|Overall Study|Withdrawal by Subject|0|||
126151981|NCT03185130|453843804|FG001|Overall Study|Withdrawal by Subject|2|||
126151982|NCT02750410|453843805|FG000|Double-Blind Treatment Period|Adverse Event|2|||
126151983|NCT02750410|453843806|FG001|Double-Blind Treatment Period|Adverse Event|2|||
126151984|NCT02750410|453843805|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126151985|NCT02750410|453843806|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126151986|NCT02750410|453843805|FG000|Open-Label Extension Period|Adverse Event|5|||
126151987|NCT02750410|453843806|FG001|Open-Label Extension Period|Adverse Event|3|||
126151988|NCT02750410|453843805|FG000|Open-Label Extension Period|Protocol Violation|0|||
126151989|NCT02750410|453843806|FG001|Open-Label Extension Period|Protocol Violation|1|||
126151990|NCT02750410|453843805|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
126151991|NCT02750410|453843806|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
126151992|NCT01531725|453843810|FG000|Overall Study|Protocol Violation|5|||
126151993|NCT03596164|453843812|FG000|Overall Study|Adverse Event|0|||
126151994|NCT03596164|453843813|FG001|Overall Study|Adverse Event|1|||
126151995|NCT03596164|453843812|FG000|Overall Study|Death|1|||
126151996|NCT03596164|453843813|FG001|Overall Study|Death|0|||
126151997|NCT04112914|453843814|FG000|Overall Study|Lost to Follow-up|13|||
126151998|NCT04112914|453843815|FG001|Overall Study|Lost to Follow-up|9|||
126151999|NCT04112914|453843814|FG000|Overall Study|Withdrawal by Subject|1|||
126152000|NCT04112914|453843815|FG001|Overall Study|Withdrawal by Subject|0|||
126152001|NCT03427073|453843816|FG000|Overall Study|Disease Progression|1|||
126152002|NCT03427073|453843817|FG001|Overall Study|Disease Progression|1|||
126152003|NCT03427073|453843818|FG002|Overall Study|Disease Progression|1|||
126152004|NCT03427073|453843819|FG003|Overall Study|Disease Progression|3|||
126152005|NCT03427073|453843820|FG004|Overall Study|Disease Progression|3|||
126152006|NCT03427073|453843821|FG005|Overall Study|Disease Progression|4|||
126152007|NCT03427073|453843822|FG006|Overall Study|Disease Progression|2|||
126152008|NCT03427073|453843823|FG007|Overall Study|Disease Progression|3|||
126152009|NCT03427073|453843816|FG000|Overall Study|Physician Decision|0|||
126152010|NCT03427073|453843817|FG001|Overall Study|Physician Decision|0|||
126152011|NCT03427073|453843818|FG002|Overall Study|Physician Decision|0|||
126152012|NCT03427073|453843819|FG003|Overall Study|Physician Decision|0|||
126152013|NCT03427073|453843820|FG004|Overall Study|Physician Decision|0|||
126152014|NCT03427073|453843821|FG005|Overall Study|Physician Decision|0|||
125971556|NCT01412944|453184753|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
125971557|NCT01412944|453184748|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
125971558|NCT01412944|453184749|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
126152015|NCT03427073|453843822|FG006|Overall Study|Physician Decision|1|||
126152016|NCT03427073|453843823|FG007|Overall Study|Physician Decision|1|||
126152017|NCT02835495|453843826|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
126152018|NCT02835495|453843827|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
126152019|NCT02835495|453843826|FG000|Overall Study|Declined in-person follow-up visit|4|||
126152020|NCT02835495|453843827|FG001|Overall Study|Declined in-person follow-up visit|2|||
126152021|NCT05421754|453843828|FG000|Overall Study|Technical issue with sensor|1|||
126152022|NCT02580058|453843831|FG000|Overall Study|Adverse Event|16|||
126152023|NCT02580058|453843832|FG001|Overall Study|Adverse Event|30|||
126152024|NCT02580058|453843833|FG002|Overall Study|Adverse Event|20|||
126152025|NCT02580058|453843831|FG000|Overall Study|Death|4|||
126152026|NCT02580058|453843832|FG001|Overall Study|Death|4|||
126152027|NCT02580058|453843833|FG002|Overall Study|Death|5|||
126152028|NCT02580058|453843831|FG000|Overall Study|Physician Decision|1|||
126152029|NCT02580058|453843832|FG001|Overall Study|Physician Decision|3|||
126152030|NCT02580058|453843833|FG002|Overall Study|Physician Decision|11|||
126152031|NCT02580058|453843831|FG000|Overall Study|Other|5|||
126152032|NCT02580058|453843832|FG001|Overall Study|Other|1|||
126152033|NCT02580058|453843833|FG002|Overall Study|Other|3|||
126152034|NCT02580058|453843831|FG000|Overall Study|Withdrawal by Subject|4|||
126152035|NCT02580058|453843832|FG001|Overall Study|Withdrawal by Subject|7|||
126152036|NCT02580058|453843833|FG002|Overall Study|Withdrawal by Subject|31|||
126152037|NCT02580058|453843831|FG000|Overall Study|Global Deterioration of Health Status|19|||
126152038|NCT02580058|453843832|FG001|Overall Study|Global Deterioration of Health Status|18|||
126152039|NCT02580058|453843833|FG002|Overall Study|Global Deterioration of Health Status|24|||
126152040|NCT02580058|453843831|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
126152041|NCT02580058|453843832|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126152042|NCT02580058|453843833|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
126152043|NCT02580058|453843831|FG000|Overall Study|Progressive Disease|137|||
126152044|NCT02580058|453843832|FG001|Overall Study|Progressive Disease|125|||
126152045|NCT02580058|453843833|FG002|Overall Study|Progressive Disease|94|||
126152046|NCT02580058|453843831|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126152047|NCT02580058|453843832|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126152048|NCT02580058|453843833|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126152049|NCT05300087|453843834|FG000|Overall Study|Withdrawal by Subject|0|||
126152050|NCT05300087|453843835|FG001|Overall Study|Withdrawal by Subject|1|||
126152051|NCT03248128|453843836|FG000|Overall Study|Lost to Follow-up|1|||
126152052|NCT03248128|453843837|FG001|Overall Study|Lost to Follow-up|0|||
126152053|NCT03248128|453843836|FG000|Overall Study|Withdrawal by Subject|16|||
126152054|NCT03248128|453843837|FG001|Overall Study|Withdrawal by Subject|14|||
126152055|NCT03248128|453843836|FG000|Overall Study|Site Closed|4|||
126152056|NCT03248128|453843837|FG001|Overall Study|Site Closed|3|||
126152057|NCT03248128|453843836|FG000|Overall Study|Randomized, but did not receive treatment|1|||
126152058|NCT03248128|453843837|FG001|Overall Study|Randomized, but did not receive treatment|3|||
126152059|NCT01914679|453843838|FG000|Overall Study|Lack of Efficacy|1|||
126152060|NCT01914679|453843838|FG000|Overall Study|Sponsor terminated study|4|||
126152061|NCT00002850|453843840|FG000|Overall Study|Death|4|||
126152062|NCT00002850|453843841|FG001|Overall Study|Death|1|||
126152063|NCT00002850|453843842|FG002|Overall Study|Death|3|||
126152064|NCT00002850|453843840|FG000|Overall Study|Protocol Violation|1|||
126152065|NCT00002850|453843841|FG001|Overall Study|Protocol Violation|0|||
126152066|NCT00002850|453843842|FG002|Overall Study|Protocol Violation|1|||
126152067|NCT00002850|453843840|FG000|Overall Study|Withdrawal by Subject|0|||
126152068|NCT00002850|453843841|FG001|Overall Study|Withdrawal by Subject|1|||
126152069|NCT00002850|453843842|FG002|Overall Study|Withdrawal by Subject|0|||
126152070|NCT02452359|453843848|FG000|Overall Study|Adverse Event|1|||
126152071|NCT02452359|453843848|FG000|Overall Study|Lost to Follow-up|15|||
126152072|NCT02452359|453843848|FG000|Overall Study|Pregnancy|1|||
126152073|NCT02452359|453843848|FG000|Overall Study|Withdrawal by Subject|4|||
126152074|NCT01877655|453843851|FG000|Overall Study|Death|57|||
126152075|NCT01877655|453843852|FG001|Overall Study|Death|52|||
126152076|NCT01877655|453843851|FG000|Overall Study|Withdrawal by Subject|18|||
126152077|NCT01877655|453843852|FG001|Overall Study|Withdrawal by Subject|26|||
126152078|NCT01877655|453843851|FG000|Overall Study|Physician Decision|11|||
126152079|NCT01877655|453843852|FG001|Overall Study|Physician Decision|10|||
126152080|NCT01877655|453843851|FG000|Overall Study|Miscellaneous|4|||
126152081|NCT01877655|453843852|FG001|Overall Study|Miscellaneous|4|||
126152082|NCT01877655|453843851|FG000|Overall Study|Randomized but Never Received Drug|8|||
126152083|NCT01877655|453843852|FG001|Overall Study|Randomized but Never Received Drug|5|||
126152084|NCT05635838|453845301|FG000|16-Week DBVC Period|Adverse Event|2|||
126152085|NCT05635838|453845302|FG001|16-Week DBVC Period|Adverse Event|0|||
126152086|NCT05635838|453845303|FG002|16-Week DBVC Period|Adverse Event|0|||
125971559|NCT01412944|453184750|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
125971560|NCT01412944|453184751|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
125971561|NCT01412944|453184752|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
126152087|NCT05635838|453845304|FG003|16-Week DBVC Period|Adverse Event|0|||
126152088|NCT05635838|453845301|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
126152089|NCT05635838|453845302|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
126152090|NCT05635838|453845303|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
126152091|NCT05635838|453845304|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
126152092|NCT05635838|453845301|FG000|16-Week DBVC Period|Physician Decision|0|||
126152093|NCT05635838|453845302|FG001|16-Week DBVC Period|Physician Decision|1|||
126152094|NCT05635838|453845303|FG002|16-Week DBVC Period|Physician Decision|0|||
126152095|NCT05635838|453845304|FG003|16-Week DBVC Period|Physician Decision|0|||
126152096|NCT05635838|453845301|FG000|16-Week DBVC Period|Protocol Violation|1|||
126152097|NCT05635838|453845302|FG001|16-Week DBVC Period|Protocol Violation|0|||
126152098|NCT05635838|453845303|FG002|16-Week DBVC Period|Protocol Violation|0|||
126152099|NCT05635838|453845304|FG003|16-Week DBVC Period|Protocol Violation|0|||
126152100|NCT05635838|453845301|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
126152101|NCT05635838|453845302|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
126152102|NCT05635838|453845303|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
126152103|NCT05635838|453845304|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
126152104|NCT05635838|453845301|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
126152105|NCT05635838|453845302|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
126152106|NCT05635838|453845303|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
126152107|NCT05635838|453845304|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
126152108|NCT05635838|453845301|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
126152109|NCT05635838|453845302|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
126152110|NCT05635838|453845303|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
126152111|NCT05635838|453845304|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
126152112|NCT05635838|453845301|FG000|16-Week OLE Period|Adverse Event|0|||
126152113|NCT05635838|453845302|FG001|16-Week OLE Period|Adverse Event|0|||
126152114|NCT05635838|453845303|FG002|16-Week OLE Period|Adverse Event|0|||
126152115|NCT05635838|453845304|FG003|16-Week OLE Period|Adverse Event|2|||
126152116|NCT05635838|453845301|FG000|16-Week OLE Period|Lost to Follow-up|0|||
126152117|NCT05635838|453845302|FG001|16-Week OLE Period|Lost to Follow-up|0|||
126152118|NCT05635838|453845303|FG002|16-Week OLE Period|Lost to Follow-up|1|||
126152119|NCT05635838|453845304|FG003|16-Week OLE Period|Lost to Follow-up|3|||
126152120|NCT05635838|453845301|FG000|16-Week OLE Period|Physician Decision|0|||
126152121|NCT05635838|453845302|FG001|16-Week OLE Period|Physician Decision|0|||
126152122|NCT05635838|453845303|FG002|16-Week OLE Period|Physician Decision|0|||
126152123|NCT05635838|453845304|FG003|16-Week OLE Period|Physician Decision|1|||
126152124|NCT05635838|453845301|FG000|16-Week OLE Period|Protocol Violation|0|||
126152125|NCT05635838|453845302|FG001|16-Week OLE Period|Protocol Violation|0|||
126152126|NCT05635838|453845303|FG002|16-Week OLE Period|Protocol Violation|1|||
126152127|NCT05635838|453845304|FG003|16-Week OLE Period|Protocol Violation|1|||
126152128|NCT05635838|453845301|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
126152129|NCT05635838|453845302|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
126152130|NCT05635838|453845303|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
126152131|NCT05635838|453845304|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
126152132|NCT05635838|453845301|FG000|16-Week OLE Period|Pregnancy|0|||
126152133|NCT05635838|453845302|FG001|16-Week OLE Period|Pregnancy|0|||
126152134|NCT05635838|453845303|FG002|16-Week OLE Period|Pregnancy|1|||
126152135|NCT05635838|453845304|FG003|16-Week OLE Period|Pregnancy|0|||
126152136|NCT04493619|453845306|FG000|Overall Study|Death|4|||
126152137|NCT04493619|453845307|FG001|Overall Study|Death|3|||
126152138|NCT04493619|453845308|FG002|Overall Study|Death|3|||
126152139|NCT04493619|453845309|FG003|Overall Study|Death|4|||
126152140|NCT04493619|453845306|FG000|Overall Study|Study discontinued early|10|||
126152141|NCT04493619|453845307|FG001|Overall Study|Study discontinued early|0|||
126152142|NCT04493619|453845308|FG002|Overall Study|Study discontinued early|4|||
126152143|NCT04493619|453845309|FG003|Overall Study|Study discontinued early|8|||
126152144|NCT04493619|453845306|FG000|Overall Study|Lost to Follow-up|0|||
126152145|NCT04493619|453845307|FG001|Overall Study|Lost to Follow-up|0|||
126152146|NCT04493619|453845308|FG002|Overall Study|Lost to Follow-up|0|||
126152147|NCT04493619|453845309|FG003|Overall Study|Lost to Follow-up|1|||
126152148|NCT02128490|453845312|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126152149|NCT02128490|453845313|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
126152150|NCT02128490|453845314|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
126152151|NCT02128490|453845315|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
126152152|NCT02128490|453845316|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
126152153|NCT02128490|453845312|FG000|Overall Study|Major Protocol Deviation|1|||
126152154|NCT02128490|453845313|FG001|Overall Study|Major Protocol Deviation|2|||
125971562|NCT01412944|453184753|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
125971563|NCT01412944|453184748|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125971564|NCT01412944|453184749|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125971565|NCT01412944|453184750|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
126152155|NCT02128490|453845314|FG002|Overall Study|Major Protocol Deviation|0|||
126152156|NCT02128490|453845315|FG003|Overall Study|Major Protocol Deviation|2|||
126152157|NCT02128490|453845316|FG004|Overall Study|Major Protocol Deviation|2|||
126152158|NCT02128490|453845312|FG000|Overall Study|Lost to Follow-up|0|||
126152159|NCT02128490|453845313|FG001|Overall Study|Lost to Follow-up|0|||
126152160|NCT02128490|453845314|FG002|Overall Study|Lost to Follow-up|1|||
126152161|NCT02128490|453845315|FG003|Overall Study|Lost to Follow-up|1|||
126152162|NCT02128490|453845316|FG004|Overall Study|Lost to Follow-up|1|||
126152163|NCT02128490|453845312|FG000|Overall Study|Voluntary Withdrawal|3|||
126152164|NCT02128490|453845313|FG001|Overall Study|Voluntary Withdrawal|3|||
126152165|NCT02128490|453845314|FG002|Overall Study|Voluntary Withdrawal|1|||
126152166|NCT02128490|453845315|FG003|Overall Study|Voluntary Withdrawal|1|||
126152167|NCT02128490|453845316|FG004|Overall Study|Voluntary Withdrawal|2|||
126152168|NCT02128490|453845312|FG000|Overall Study|Lack of Efficacy|0|||
126152169|NCT02128490|453845313|FG001|Overall Study|Lack of Efficacy|1|||
126152170|NCT02128490|453845314|FG002|Overall Study|Lack of Efficacy|0|||
126152171|NCT02128490|453845315|FG003|Overall Study|Lack of Efficacy|0|||
126152172|NCT02128490|453845316|FG004|Overall Study|Lack of Efficacy|0|||
126152173|NCT02128490|453845312|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
126152174|NCT02128490|453845313|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
126152175|NCT02128490|453845314|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
126152176|NCT02128490|453845315|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
126152177|NCT02128490|453845316|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
126152178|NCT02128490|453845312|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126152179|NCT02128490|453845313|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126152180|NCT02128490|453845314|FG002|Overall Study|Other Miscellaneous Reasons|2|||
126152181|NCT02128490|453845315|FG003|Overall Study|Other Miscellaneous Reasons|1|||
126152182|NCT02128490|453845316|FG004|Overall Study|Other Miscellaneous Reasons|1|||
126152183|NCT02243176|453845317|FG000|Overall Study|Other reason|1|||
126152184|NCT02243176|453845318|FG001|Overall Study|Other reason|2|||
126152185|NCT02243176|453845317|FG000|Overall Study|protocol specified withdrawal critera|1|||
126152186|NCT02243176|453845318|FG001|Overall Study|protocol specified withdrawal critera|3|||
126152187|NCT02243176|453845317|FG000|Overall Study|Protocol Violation|2|||
126152188|NCT02243176|453845318|FG001|Overall Study|Protocol Violation|1|||
126152189|NCT02243176|453845317|FG000|Overall Study|Withdrawal by Subject|8|||
126152190|NCT02243176|453845318|FG001|Overall Study|Withdrawal by Subject|7|||
126152191|NCT02243176|453845317|FG000|Overall Study|Adverse Event|2|||
126152192|NCT02243176|453845318|FG001|Overall Study|Adverse Event|2|||
126152193|NCT03518840|453845322|FG000|Overall Study|Lost to Follow-up|6|||
126152194|NCT00875420|453845324|FG000|Overall Study|Adverse Event|0|||
126152195|NCT00875420|453845325|FG001|Overall Study|Adverse Event|1|||
126152196|NCT00875420|453845326|FG002|Overall Study|Adverse Event|1|||
126152197|NCT00875420|453845327|FG003|Overall Study|Adverse Event|0|||
126152198|NCT00875420|453845328|FG004|Overall Study|Adverse Event|0|||
126152199|NCT00875420|453845324|FG000|Overall Study|Inability to complete study procedures|1|||
126152200|NCT00875420|453845325|FG001|Overall Study|Inability to complete study procedures|0|||
126152201|NCT00875420|453845326|FG002|Overall Study|Inability to complete study procedures|1|||
126152202|NCT00875420|453845327|FG003|Overall Study|Inability to complete study procedures|1|||
126152203|NCT00875420|453845328|FG004|Overall Study|Inability to complete study procedures|1|||
126152204|NCT00875420|453845324|FG000|Overall Study|Lost to Follow-up|1|||
126152205|NCT00875420|453845325|FG001|Overall Study|Lost to Follow-up|0|||
126152206|NCT00875420|453845326|FG002|Overall Study|Lost to Follow-up|0|||
126152207|NCT00875420|453845327|FG003|Overall Study|Lost to Follow-up|0|||
126152208|NCT00875420|453845328|FG004|Overall Study|Lost to Follow-up|0|||
126152209|NCT00875420|453845324|FG000|Overall Study|Personal reason|0|||
126152210|NCT00875420|453845325|FG001|Overall Study|Personal reason|0|||
126152211|NCT00875420|453845326|FG002|Overall Study|Personal reason|0|||
126152212|NCT00875420|453845327|FG003|Overall Study|Personal reason|0|||
126152213|NCT00875420|453845328|FG004|Overall Study|Personal reason|1|||
126152214|NCT00875420|453845324|FG000|Overall Study|Prohibited medication|0|||
126152215|NCT00875420|453845325|FG001|Overall Study|Prohibited medication|0|||
126152216|NCT00875420|453845326|FG002|Overall Study|Prohibited medication|0|||
126152217|NCT00875420|453845327|FG003|Overall Study|Prohibited medication|1|||
126152218|NCT00875420|453845328|FG004|Overall Study|Prohibited medication|0|||
126152219|NCT00875420|453845324|FG000|Overall Study|Sponsor decision|0|||
126152220|NCT00875420|453845325|FG001|Overall Study|Sponsor decision|1|||
126152221|NCT00875420|453845326|FG002|Overall Study|Sponsor decision|0|||
125971566|NCT01412944|453184751|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125971567|NCT01412944|453184752|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125971568|NCT01412944|453184753|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
125971569|NCT01412944|453184748|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
125971570|NCT01412944|453184749|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
126152222|NCT00875420|453845327|FG003|Overall Study|Sponsor decision|0|||
126152223|NCT00875420|453845328|FG004|Overall Study|Sponsor decision|0|||
126152224|NCT00875420|453845324|FG000|Overall Study|Withdrawal by Subject|0|||
126152225|NCT00875420|453845325|FG001|Overall Study|Withdrawal by Subject|0|||
126152226|NCT00875420|453845326|FG002|Overall Study|Withdrawal by Subject|1|||
126152227|NCT00875420|453845327|FG003|Overall Study|Withdrawal by Subject|0|||
126152228|NCT00875420|453845328|FG004|Overall Study|Withdrawal by Subject|0|||
126152229|NCT00001259|453845329|FG000|Study 2|Adverse Event|0|||
126152230|NCT00001259|453845330|FG001|Study 2|Adverse Event|0|||
126152231|NCT00001259|453845331|FG002|Study 2|Adverse Event|0|||
126152232|NCT00001259|453845332|FG003|Study 2|Adverse Event|0|||
126152233|NCT00001259|453845333|FG004|Study 2|Adverse Event|2|||
126152234|NCT00001259|453845334|FG005|Study 2|Adverse Event|0|||
126152235|NCT00001259|453845335|FG006|Study 2|Adverse Event|0|||
126152236|NCT03704051|453845336|FG000|Overall Study|Withdrawal by Subject|4|||
126152237|NCT03704051|453845337|FG001|Overall Study|Withdrawal by Subject|0|||
126152238|NCT02629393|453845338|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
126152239|NCT02629393|453845338|FG000|Overall Study|Physician Decision|1|||
126152240|NCT03716726|453845341|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
126152241|NCT03716726|453845342|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
126152242|NCT03716726|453845341|FG000|12 Months Followup|Lost to Follow-up|10|||
126152243|NCT03716726|453845342|FG001|12 Months Followup|Lost to Follow-up|17|||
126152244|NCT01943539|453845346|FG000|Overall Study|Non-compliance with at-home intervention|4|||
126152245|NCT01943539|453845347|FG001|Overall Study|Non-compliance with at-home intervention|0|||
126152246|NCT03199911|453845348|FG000|Overall Study|Lost to Follow-up|5|||
126152247|NCT03199911|453845349|FG001|Overall Study|Lost to Follow-up|5|||
126152248|NCT03199911|453845348|FG000|Overall Study|Did not proceed with surgery|2|||
126152249|NCT03199911|453845349|FG001|Overall Study|Did not proceed with surgery|1|||
126152250|NCT00174941|453845354|FG000|Overall Study|Adverse Event|1|||
126152251|NCT00174941|453845355|FG001|Overall Study|Adverse Event|10|||
126152252|NCT00174941|453845356|FG002|Overall Study|Adverse Event|2|||
126152253|NCT00174941|453845357|FG003|Overall Study|Adverse Event|13|||
126152254|NCT00174941|453845354|FG000|Overall Study|Protocol Violation|0|||
126152255|NCT00174941|453845355|FG001|Overall Study|Protocol Violation|1|||
126152256|NCT00174941|453845356|FG002|Overall Study|Protocol Violation|0|||
126152257|NCT00174941|453845357|FG003|Overall Study|Protocol Violation|1|||
126152258|NCT00174941|453845354|FG000|Overall Study|Lost to Follow-up|0|||
126152259|NCT00174941|453845355|FG001|Overall Study|Lost to Follow-up|3|||
126152260|NCT00174941|453845356|FG002|Overall Study|Lost to Follow-up|2|||
126152261|NCT00174941|453845357|FG003|Overall Study|Lost to Follow-up|5|||
126152262|NCT00174941|453845354|FG000|Overall Study|Personal Reason(s)|0|||
126152263|NCT00174941|453845355|FG001|Overall Study|Personal Reason(s)|14|||
126152264|NCT00174941|453845356|FG002|Overall Study|Personal Reason(s)|8|||
126152265|NCT00174941|453845357|FG003|Overall Study|Personal Reason(s)|22|||
126152266|NCT00174941|453845354|FG000|Overall Study|Gout Flare|0|||
126152267|NCT00174941|453845355|FG001|Overall Study|Gout Flare|4|||
126152268|NCT00174941|453845356|FG002|Overall Study|Gout Flare|4|||
126152269|NCT00174941|453845357|FG003|Overall Study|Gout Flare|8|||
126152270|NCT00174941|453845354|FG000|Overall Study|Reason Not Specified|1|||
126152271|NCT00174941|453845355|FG001|Overall Study|Reason Not Specified|6|||
126152272|NCT00174941|453845356|FG002|Overall Study|Reason Not Specified|2|||
126152273|NCT00174941|453845357|FG003|Overall Study|Reason Not Specified|9|||
126152274|NCT03230097|453845361|FG000|Overall Study|Adverse Event|2|||
126152275|NCT03230097|453845362|FG001|Overall Study|Adverse Event|1|||
126152276|NCT03230097|453845361|FG000|Overall Study|non-compliance|0|||
126152277|NCT03230097|453845362|FG001|Overall Study|non-compliance|1|||
126152278|NCT03230097|453845361|FG000|Overall Study|Lost to Follow-up|2|||
126152279|NCT03230097|453845362|FG001|Overall Study|Lost to Follow-up|4|||
126152280|NCT03230097|453845361|FG000|Overall Study|Withdrawal by Subject|7|||
126152281|NCT03230097|453845362|FG001|Overall Study|Withdrawal by Subject|3|||
126152282|NCT03230097|453845361|FG000|Overall Study|Trial termination|4|||
126152283|NCT03230097|453845362|FG001|Overall Study|Trial termination|5|||
126152284|NCT03230097|453845361|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
126152285|NCT03230097|453845362|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
126152286|NCT03230097|453845361|FG000|Overall Study|outcome event|0|||
126152287|NCT03230097|453845362|FG001|Overall Study|outcome event|1|||
126152288|NCT01925703|453845365|FG000|Overall Study|Physician Decision|1|||
126152289|NCT01925703|453845365|FG000|Overall Study|Lost to Follow-up|2|||
126152290|NCT01925703|453845365|FG000|Overall Study|Discharge prior to full iron repletion|1|||
126152291|NCT03215277|453845367|FG000|Overall Study|Adverse Event|2|||
126152292|NCT03215277|453845368|FG001|Overall Study|Adverse Event|3|||
126152293|NCT03215277|453845367|FG000|Overall Study|Death|1|||
125971571|NCT01412944|453184750|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
125971572|NCT01412944|453184751|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
125971573|NCT01412944|453184752|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
125971574|NCT01412944|453184753|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
126152294|NCT03215277|453845368|FG001|Overall Study|Death|0|||
126152295|NCT03215277|453845367|FG000|Overall Study|Lost to Follow-up|0|||
126152296|NCT03215277|453845368|FG001|Overall Study|Lost to Follow-up|1|||
126152297|NCT03215277|453845367|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
126152298|NCT03215277|453845368|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
126152299|NCT03794986|453845369|FG000|Overall Study|0 Sessions Attended|34|||
126152300|NCT03794986|453845370|FG001|Overall Study|0 Sessions Attended|37|||
126152301|NCT03794986|453845369|FG000|Overall Study|Withdrawal by Subject|4|||
125971575|NCT01412944|453184748|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
125971576|NCT01412944|453184749|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
125971577|NCT01412944|453184750|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
125971578|NCT01412944|453184751|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
125971579|NCT01412944|453184752|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
126152302|NCT03794986|453845370|FG001|Overall Study|Withdrawal by Subject|6|||
126152303|NCT03794986|453845369|FG000|Overall Study|Protocol Violation|1|||
126152304|NCT03794986|453845370|FG001|Overall Study|Protocol Violation|0|||
126152305|NCT01238120|453845373|FG000|Overall Study|Withdrawal by Subject|4|||
126152306|NCT01238120|453845374|FG001|Overall Study|Withdrawal by Subject|1|||
126152307|NCT01238120|453845375|FG002|Overall Study|Withdrawal by Subject|2|||
126152308|NCT01238120|453845376|FG003|Overall Study|Withdrawal by Subject|5|||
126152309|NCT01238120|453845373|FG000|Overall Study|Lost to Follow-up|2|||
126152310|NCT01238120|453845374|FG001|Overall Study|Lost to Follow-up|0|||
126152311|NCT01238120|453845375|FG002|Overall Study|Lost to Follow-up|1|||
126152312|NCT01238120|453845376|FG003|Overall Study|Lost to Follow-up|1|||
126152313|NCT01238120|453845373|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
125971580|NCT01412944|453184753|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
125971581|NCT01412944|453184748|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
126152314|NCT01238120|453845374|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
126152315|NCT01238120|453845375|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
126152316|NCT01238120|453845376|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
126152317|NCT02498652|453845379|FG000|Overall Study|Protocol Violation|0|||
126152318|NCT02498652|453845380|FG001|Overall Study|Protocol Violation|1|||
126152319|NCT00465569|453845382|FG000|Overall Study|persistent eczema during dose escalation|1|||
126152320|NCT00465569|453845383|FG001|Overall Study|persistent eczema during dose escalation|0|||
126152321|NCT00922935|453845384|FG000|Overall Study|Protocol Violation|0|||
126152322|NCT00922935|453845385|FG001|Overall Study|Protocol Violation|3|||
126152323|NCT00922935|453845386|FG002|Overall Study|Protocol Violation|0|||
126152324|NCT00922935|453845384|FG000|Overall Study|Physician Decision|1|||
126152325|NCT00922935|453845385|FG001|Overall Study|Physician Decision|1|||
126152326|NCT00922935|453845386|FG002|Overall Study|Physician Decision|0|||
126152327|NCT00922935|453845384|FG000|Overall Study|Lost to Follow-up|0|||
126152328|NCT00922935|453845385|FG001|Overall Study|Lost to Follow-up|1|||
126152329|NCT00922935|453845386|FG002|Overall Study|Lost to Follow-up|0|||
126152330|NCT00849212|453845387|FG000|Overall Study|Lack of Efficacy|1|||
126152331|NCT00849212|453845387|FG000|Overall Study|Withdrawal by Subject|3|||
126152332|NCT00849212|453845387|FG000|Overall Study|Adverse Event|2|||
126152333|NCT00849212|453845387|FG000|Overall Study|Miscellaneous|1|||
126152334|NCT00095303|453845388|FG000|Main Study|Lost to Follow-up|91|||
126152335|NCT00095303|453845389|FG001|Main Study|Lost to Follow-up|87|||
126152336|NCT00095303|453845388|FG000|Follow Up Study|Lost to Follow-up|59|||
126152337|NCT00095303|453845389|FG001|Follow Up Study|Lost to Follow-up|58|||
126152338|NCT01499576|453845390|FG000|Overall Study|Physician Decision|12|||
126152339|NCT01499576|453845390|FG000|Overall Study|Withdrawal by Subject|9|||
126152340|NCT04283461|453845391|FG000|Overall Study|Enrolled in separate trial|0|||
126152341|NCT04283461|453845392|FG001|Overall Study|Enrolled in separate trial|0|||
126152342|NCT04283461|453845393|FG002|Overall Study|Enrolled in separate trial|8|||
126152343|NCT04283461|453845394|FG003|Overall Study|Enrolled in separate trial|13|||
126152344|NCT04283461|453845395|FG004|Overall Study|Enrolled in separate trial|12|||
126152345|NCT04283461|453845396|FG005|Overall Study|Enrolled in separate trial|0|||
126152346|NCT04283461|453845397|FG006|Overall Study|Enrolled in separate trial|0|||
126152347|NCT04283461|453845398|FG007|Overall Study|Enrolled in separate trial|8|||
126152348|NCT04283461|453845399|FG008|Overall Study|Enrolled in separate trial|0|||
126152349|NCT04283461|453845400|FG009|Overall Study|Enrolled in separate trial|0|||
126152350|NCT04283461|453845401|FG010|Overall Study|Enrolled in separate trial|0|||
126152351|NCT04283461|453845402|FG011|Overall Study|Enrolled in separate trial|7|||
126152352|NCT04283461|453845403|FG012|Overall Study|Enrolled in separate trial|0|||
126152353|NCT04375878|453845410|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
126152354|NCT04375878|453845411|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
126152355|NCT04375878|453845412|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
126152356|NCT04375878|453845413|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
126152357|NCT04375878|453845414|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
126152358|NCT04375878|453845415|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
126152359|NCT04375878|453845410|FG000|Crossover First and Second Interventions|Adverse Event|0|||
126152360|NCT04375878|453845411|FG001|Crossover First and Second Interventions|Adverse Event|0|||
126152361|NCT04375878|453845412|FG002|Crossover First and Second Interventions|Adverse Event|1|||
126152362|NCT04375878|453845413|FG003|Crossover First and Second Interventions|Adverse Event|0|||
126152363|NCT04375878|453845414|FG004|Crossover First and Second Interventions|Adverse Event|0|||
126152364|NCT04375878|453845415|FG005|Crossover First and Second Interventions|Adverse Event|0|||
126152365|NCT04375878|453845410|FG000|Extension Phase|Withdrawal by Subject|0|||
126152366|NCT04375878|453845411|FG001|Extension Phase|Withdrawal by Subject|0|||
126152367|NCT04375878|453845412|FG002|Extension Phase|Withdrawal by Subject|0|||
126152368|NCT04375878|453845413|FG003|Extension Phase|Withdrawal by Subject|0|||
126152369|NCT04375878|453845414|FG004|Extension Phase|Withdrawal by Subject|1|||
126152370|NCT04375878|453845415|FG005|Extension Phase|Withdrawal by Subject|0|||
126152371|NCT00195351|453845416|FG000|Overall Study|Lost to Follow-up|9|||
126152372|NCT00195351|453845417|FG001|Overall Study|Lost to Follow-up|9|||
125971582|NCT01412944|453184749|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
125971583|NCT01412944|453184750|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
126152373|NCT00195351|453845416|FG000|Overall Study|Withdrawal by Subject|6|||
126152374|NCT00195351|453845417|FG001|Overall Study|Withdrawal by Subject|3|||
126152375|NCT00195351|453845416|FG000|Overall Study|Protocol Deviation|3|||
126152376|NCT00195351|453845417|FG001|Overall Study|Protocol Deviation|2|||
126152377|NCT00195351|453845416|FG000|Overall Study|Death|3|||
126152378|NCT00195351|453845417|FG001|Overall Study|Death|1|||
126152379|NCT00195351|453845416|FG000|Overall Study|Lack of Efficacy|0|||
126152380|NCT00195351|453845417|FG001|Overall Study|Lack of Efficacy|1|||
125971584|NCT01412944|453184751|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
126152381|NCT02111369|453845418|FG000|Overall Study|Lost to Follow-up|2|||
126152382|NCT02111369|453845418|FG000|Overall Study|Withdrawal by Subject|1|||
126152383|NCT01259466|453845419|FG000|Overall Study|Withdrawal by Subject|1|||
126152384|NCT01259466|453845420|FG001|Overall Study|Withdrawal by Subject|9|||
126152385|NCT00519623|453845423|FG000|Overall Study|Adverse Event|1|||
126152386|NCT02296840|453845425|FG000|Overall Study|Adverse Event|1|||
126152387|NCT02296840|453845426|FG001|Overall Study|Adverse Event|1|||
126152388|NCT02296840|453845425|FG000|Overall Study|Protocol Violation|2|||
126152389|NCT02296840|453845426|FG001|Overall Study|Protocol Violation|1|||
126152390|NCT02296840|453845425|FG000|Overall Study|Lost to Follow-up|6|||
126152391|NCT02296840|453845426|FG001|Overall Study|Lost to Follow-up|17|||
126152392|NCT00104871|453845427|FG000|Overall Study|Not evaluable|1|||
126152393|NCT00761215|453845430|FG000|Overall Study|Randomized but didn't receive drug|1|||
126152394|NCT00761215|453845431|FG001|Overall Study|Randomized but didn't receive drug|1|||
126152395|NCT00761215|453845432|FG002|Overall Study|Randomized but didn't receive drug|2|||
126152396|NCT00761215|453845430|FG000|Overall Study|Lost to Follow-up|6|||
126152397|NCT00761215|453845431|FG001|Overall Study|Lost to Follow-up|3|||
126152398|NCT00761215|453845432|FG002|Overall Study|Lost to Follow-up|6|||
126152399|NCT00761215|453845430|FG000|Overall Study|Withdrawal by Subject|1|||
126152400|NCT00761215|453845431|FG001|Overall Study|Withdrawal by Subject|0|||
126152401|NCT00761215|453845432|FG002|Overall Study|Withdrawal by Subject|0|||
126152402|NCT00761215|453845430|FG000|Overall Study|Bacteremia|1|||
126152403|NCT00761215|453845431|FG001|Overall Study|Bacteremia|0|||
126152404|NCT00761215|453845432|FG002|Overall Study|Bacteremia|0|||
126152405|NCT05121103|453845433|FG000|Overall Study|Progressive disease|2|||
126152406|NCT05121103|453845434|FG001|Overall Study|Progressive disease|1|||
126152407|NCT05121103|453845435|FG002|Overall Study|Progressive disease|6|||
126152408|NCT05121103|453845433|FG000|Overall Study|Physician Decision|2|||
126152409|NCT05121103|453845434|FG001|Overall Study|Physician Decision|1|||
126152410|NCT05121103|453845435|FG002|Overall Study|Physician Decision|0|||
126152411|NCT05121103|453845433|FG000|Overall Study|Withdrawal by Subject|0|||
126152412|NCT05121103|453845434|FG001|Overall Study|Withdrawal by Subject|1|||
126152413|NCT05121103|453845435|FG002|Overall Study|Withdrawal by Subject|0|||
126152414|NCT01926886|453845436|FG000|Overall Study|Administrative/other|1|||
126152415|NCT01926886|453845437|FG001|Overall Study|Administrative/other|0|||
126152416|NCT01926886|453845436|FG000|Overall Study|Adverse event/intercurrent illness|4|||
126152417|NCT01926886|453845437|FG001|Overall Study|Adverse event/intercurrent illness|0|||
126152418|NCT01926886|453845436|FG000|Overall Study|Disease progression/recurrence|4|||
126152419|NCT01926886|453845437|FG001|Overall Study|Disease progression/recurrence|0|||
126152420|NCT01926886|453845436|FG000|Overall Study|Withdrawal by Subject|15|||
126152421|NCT01926886|453845437|FG001|Overall Study|Withdrawal by Subject|0|||
126152422|NCT01926886|453845436|FG000|Overall Study|Failure to return|3|||
126152423|NCT01926886|453845437|FG001|Overall Study|Failure to return|0|||
126152424|NCT01926886|453845436|FG000|Overall Study|Recurrence of disease|1|||
126152425|NCT01926886|453845437|FG001|Overall Study|Recurrence of disease|0|||
126152426|NCT01926886|453845436|FG000|Overall Study|Progression of disease|2|||
126152427|NCT01926886|453845437|FG001|Overall Study|Progression of disease|0|||
126152428|NCT01926886|453845436|FG000|Overall Study|Death|1|||
126152429|NCT01926886|453845437|FG001|Overall Study|Death|0|||
126152430|NCT01926886|453845436|FG000|Overall Study|Did not cooperate|1|||
126152431|NCT01926886|453845437|FG001|Overall Study|Did not cooperate|0|||
126152432|NCT01662999|453845441|FG000|Period 3|Withdrawal by Subject|0|||
126152433|NCT01662999|453845442|FG001|Period 3|Withdrawal by Subject|1|||
126152434|NCT01662999|453845443|FG002|Period 3|Withdrawal by Subject|0|||
126152435|NCT01662999|453845444|FG003|Period 3|Withdrawal by Subject|0|||
126152436|NCT01662999|453845445|FG004|Period 3|Withdrawal by Subject|0|||
126152437|NCT01662999|453845446|FG005|Period 3|Withdrawal by Subject|0|||
126152438|NCT03875235|453845454|FG000|Overall Study|Ongoing study treatment|63|||
126152439|NCT03875235|453845455|FG001|Overall Study|Ongoing study treatment|20|||
126152440|NCT03875235|453845454|FG000|Overall Study|Off treatment|77|||
125971585|NCT01412944|453184752|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
125971586|NCT01412944|453184753|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
125971587|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125971588|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125971589|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
125971590|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
126152441|NCT03875235|453845455|FG001|Overall Study|Off treatment|91|||
126152442|NCT03875235|453845454|FG000|Overall Study|Withdrawal by Subject|3|||
126152443|NCT03875235|453845455|FG001|Overall Study|Withdrawal by Subject|10|||
126152444|NCT03875235|453845454|FG000|Overall Study|Death|198|||
126152445|NCT03875235|453845455|FG001|Overall Study|Death|223|||
126152446|NCT01687673|453845456|FG000|Overall Study|Physician Decision|1|||
126152447|NCT02234622|453845457|FG000|Overall Study|Withdrawal by Subject|16|||
126152448|NCT02234622|453845458|FG001|Overall Study|Withdrawal by Subject|22|||
126152449|NCT02234622|453845457|FG000|Overall Study|Lost to Follow-up|27|||
126152450|NCT02234622|453845458|FG001|Overall Study|Lost to Follow-up|14|||
126152451|NCT02453841|453845459|FG000|Overall Study|Protocol Violation|1|||
126152452|NCT02453841|453845459|FG000|Overall Study|Unable to obtain blood samples|2|||
126152453|NCT00618956|453845460|FG000|Overall Study|Adverse Event|10|||
126152454|NCT00618956|453845461|FG001|Overall Study|Adverse Event|34|||
126152455|NCT00618956|453845460|FG000|Overall Study|Lack of Efficacy|2|||
126152456|NCT00618956|453845461|FG001|Overall Study|Lack of Efficacy|1|||
126152457|NCT00618956|453845460|FG000|Overall Study|Withdrawal by Subject|5|||
126152458|NCT00618956|453845461|FG001|Overall Study|Withdrawal by Subject|7|||
126152459|NCT00618956|453845460|FG000|Overall Study|Lost to Follow-up|4|||
126152460|NCT00618956|453845461|FG001|Overall Study|Lost to Follow-up|5|||
126152461|NCT00618956|453845460|FG000|Overall Study|Protocol Violation|2|||
126152462|NCT00618956|453845461|FG001|Overall Study|Protocol Violation|2|||
126152463|NCT00618956|453845460|FG000|Overall Study|did not meet criteria, non-compliance|2|||
126152464|NCT00618956|453845461|FG001|Overall Study|did not meet criteria, non-compliance|1|||
126152465|NCT01151137|453845462|FG000|Overall Study|Death|15|||
126152466|NCT01151137|453845463|FG001|Overall Study|Death|27|||
126152467|NCT01151137|453845462|FG000|Overall Study|Lost to Follow-up|1|||
126152468|NCT01151137|453845463|FG001|Overall Study|Lost to Follow-up|1|||
126152469|NCT02006576|453845464|FG000|Overall Study|Withdrawal by Subject|4|||
126152470|NCT02006576|453845465|FG001|Overall Study|Withdrawal by Subject|6|||
126152471|NCT02006576|453845466|FG002|Overall Study|Withdrawal by Subject|2|||
126152472|NCT02006576|453845464|FG000|Overall Study|Death|0|||
126152473|NCT02006576|453845465|FG001|Overall Study|Death|0|||
126152474|NCT02006576|453845466|FG002|Overall Study|Death|1|||
126152475|NCT02006576|453845464|FG000|Overall Study|Lost to Follow-up|1|||
126152476|NCT02006576|453845465|FG001|Overall Study|Lost to Follow-up|0|||
126152477|NCT02006576|453845466|FG002|Overall Study|Lost to Follow-up|1|||
126152478|NCT02006576|453845464|FG000|Overall Study|Screen Failure, too sick, other|13|||
126152479|NCT02006576|453845465|FG001|Overall Study|Screen Failure, too sick, other|1|||
126152480|NCT02006576|453845466|FG002|Overall Study|Screen Failure, too sick, other|13|||
126152481|NCT03478683|453845467|FG000|Overall Study|Adverse Event|5|||
126152482|NCT03478683|453845468|FG001|Overall Study|Adverse Event|3|||
126152483|NCT03478683|453845467|FG000|Overall Study|Lost to Follow-up|0|||
126152484|NCT03478683|453845468|FG001|Overall Study|Lost to Follow-up|5|||
126152485|NCT03478683|453845467|FG000|Overall Study|Physician Decision|1|||
126152486|NCT03478683|453845468|FG001|Overall Study|Physician Decision|3|||
126152487|NCT03478683|453845467|FG000|Overall Study|Withdrawal by Subject|7|||
126152488|NCT03478683|453845468|FG001|Overall Study|Withdrawal by Subject|7|||
126152489|NCT04090164|453845471|FG000|Overall Study|incomplete data on file|245|||
126152490|NCT04090164|453845472|FG001|Overall Study|incomplete data on file|0|||
126152491|NCT01650805|453845473|FG000|Overall Study|Withdrawal by Subject|1|||
126152492|NCT01650805|453845474|FG001|Overall Study|Withdrawal by Subject|0|||
126152493|NCT01887210|453845475|FG000|Overall Study|Withdrawal by Subject|1|||
126152494|NCT01887210|453845476|FG001|Overall Study|Withdrawal by Subject|3|||
126152495|NCT01887210|453845475|FG000|Overall Study|Lost to Follow-up|0|||
126152496|NCT01887210|453845476|FG001|Overall Study|Lost to Follow-up|1|||
126152497|NCT00630032|453845479|FG000|Overall Study|Death|55|||
126152498|NCT00630032|453845480|FG001|Overall Study|Death|49|||
126152499|NCT00630032|453845479|FG000|Overall Study|Withdrawal by Subject|3|||
126152500|NCT00630032|453845480|FG001|Overall Study|Withdrawal by Subject|2|||
126152501|NCT00630032|453845479|FG000|Overall Study|Lost to Follow-up|18|||
126152502|NCT00630032|453845480|FG001|Overall Study|Lost to Follow-up|31|||
126152503|NCT00630032|453845479|FG000|Overall Study|Protocol Violation|1|||
126152504|NCT00630032|453845480|FG001|Overall Study|Protocol Violation|0|||
126152505|NCT00630032|453845479|FG000|Overall Study|Patient has moved|1|||
126152506|NCT00630032|453845480|FG001|Overall Study|Patient has moved|1|||
126152507|NCT00630032|453845479|FG000|Overall Study|Disease progression|1|||
126152508|NCT00630032|453845480|FG001|Overall Study|Disease progression|1|||
126152509|NCT00630032|453845479|FG000|Overall Study|End of monitoring in US centers|11|||
126152510|NCT00630032|453845480|FG001|Overall Study|End of monitoring in US centers|11|||
126152511|NCT02332915|453845481|FG000|Overall Study|Moved out of region|3|||
126152512|NCT02332915|453845482|FG001|Overall Study|Moved out of region|0|||
126152513|NCT02332915|453845481|FG000|Overall Study|Unrelated illness|1|||
126152514|NCT02332915|453845482|FG001|Overall Study|Unrelated illness|1|||
126152515|NCT02332915|453845481|FG000|Overall Study|Travel distance prohibitive|0|||
126152516|NCT02332915|453845482|FG001|Overall Study|Travel distance prohibitive|1|||
126152517|NCT02332915|453845481|FG000|Overall Study|did not meet inclusion criteria|2|||
126152518|NCT02332915|453845482|FG001|Overall Study|did not meet inclusion criteria|4|||
126152519|NCT05847881|453845483|FG000|Overall Study|Principal Investigator Decision|8|||
126152520|NCT05847881|453845483|FG000|Overall Study|Withdrawal by Subject|2|||
126152521|NCT04513158|453845486|FG000|Overall Study|Screen Failure|1|||
126152522|NCT03439345|453847602|FG000|Overall Study|Lost to Follow-up|0|||
126152523|NCT03439345|453847603|FG001|Overall Study|Lost to Follow-up|1|||
126152524|NCT03439345|453847602|FG000|Overall Study|Consent withdrawn|0|||
126152525|NCT03439345|453847603|FG001|Overall Study|Consent withdrawn|1|||
126152526|NCT02342171|453847609|FG000|Overall Study|Death|4|||
126152527|NCT02342171|453847610|FG001|Overall Study|Death|87|||
126152528|NCT02342171|453847609|FG000|Overall Study|Received favipiravir|10|||
126152529|NCT02342171|453847610|FG001|Overall Study|Received favipiravir|0|||
126152530|NCT02342171|453847609|FG000|Overall Study|Missing cycle treshold value|1|||
126152531|NCT02342171|453847610|FG001|Overall Study|Missing cycle treshold value|0|||
126152532|NCT02342171|453847609|FG000|Overall Study|Unknown outcome|0|||
126152533|NCT02342171|453847610|FG001|Overall Study|Unknown outcome|1|||
126152534|NCT02342171|453847609|FG000|Overall Study|Missing age data|0|||
126152535|NCT02342171|453847610|FG001|Overall Study|Missing age data|1|||
126152536|NCT03705494|453847613|FG000|Overall Study|Lost to Follow-up|2|||
126152537|NCT03705494|453847614|FG001|Overall Study|Lost to Follow-up|1|||
126152538|NCT03705494|453847613|FG000|Overall Study|Withdrawal by Subject|5|||
126152539|NCT03705494|453847614|FG001|Overall Study|Withdrawal by Subject|2|||
126152540|NCT01981187|453847618|FG000|Overall Study|Participant/guardian decision|2|||
126152541|NCT01981187|453847618|FG000|Overall Study|Physician Decision|1|||
126152542|NCT01981187|453847618|FG000|Overall Study|Disease progression|2|||
126152543|NCT01981187|453847618|FG000|Overall Study|Adverse Event|7|||
126152544|NCT02413255|453847619|FG000|Overall Study|Voluntary Withdrawal|0|||
126152545|NCT02413255|453847620|FG001|Overall Study|Voluntary Withdrawal|0|||
126152546|NCT02413255|453847621|FG002|Overall Study|Voluntary Withdrawal|0|||
126152547|NCT02413255|453847622|FG003|Overall Study|Voluntary Withdrawal|0|||
126152548|NCT02413255|453847623|FG004|Overall Study|Voluntary Withdrawal|0|||
126152549|NCT02413255|453847624|FG005|Overall Study|Voluntary Withdrawal|0|||
126152550|NCT02413255|453847625|FG006|Overall Study|Voluntary Withdrawal|0|||
126152551|NCT02413255|453847626|FG007|Overall Study|Voluntary Withdrawal|0|||
126152552|NCT02413255|453847627|FG008|Overall Study|Voluntary Withdrawal|0|||
126152553|NCT02413255|453847628|FG009|Overall Study|Voluntary Withdrawal|0|||
126152554|NCT02413255|453847629|FG010|Overall Study|Voluntary Withdrawal|0|||
126152555|NCT02413255|453847630|FG011|Overall Study|Voluntary Withdrawal|0|||
126152556|NCT02413255|453847631|FG012|Overall Study|Voluntary Withdrawal|0|||
126152557|NCT02413255|453847632|FG013|Overall Study|Voluntary Withdrawal|0|||
126152558|NCT02413255|453847633|FG014|Overall Study|Voluntary Withdrawal|1|||
126152559|NCT02413255|453847634|FG015|Overall Study|Voluntary Withdrawal|0|||
126152560|NCT02413255|453847635|FG016|Overall Study|Voluntary Withdrawal|0|||
126152561|NCT02333331|453847636|FG000|Overall Study|Adverse Event|1|||
126152562|NCT02333331|453847637|FG001|Overall Study|Adverse Event|0|||
126152563|NCT02333331|453847638|FG002|Overall Study|Adverse Event|4|||
126152564|NCT02333331|453847639|FG003|Overall Study|Adverse Event|1|||
126152565|NCT02333331|453847636|FG000|Overall Study|Death|0|||
126152566|NCT02333331|453847637|FG001|Overall Study|Death|0|||
126152567|NCT02333331|453847638|FG002|Overall Study|Death|2|||
126152568|NCT02333331|453847639|FG003|Overall Study|Death|0|||
126152569|NCT02333331|453847636|FG000|Overall Study|Lost to Follow-up|0|||
126152570|NCT02333331|453847637|FG001|Overall Study|Lost to Follow-up|0|||
126152571|NCT02333331|453847638|FG002|Overall Study|Lost to Follow-up|1|||
126152572|NCT02333331|453847639|FG003|Overall Study|Lost to Follow-up|0|||
126152573|NCT02333331|453847636|FG000|Overall Study|Physician Decision|0|||
126152574|NCT02333331|453847637|FG001|Overall Study|Physician Decision|1|||
126152575|NCT02333331|453847638|FG002|Overall Study|Physician Decision|0|||
126152576|NCT02333331|453847639|FG003|Overall Study|Physician Decision|0|||
126152577|NCT02333331|453847636|FG000|Overall Study|Protocol Deviation|0|||
126152578|NCT02333331|453847637|FG001|Overall Study|Protocol Deviation|3|||
126152579|NCT02333331|453847638|FG002|Overall Study|Protocol Deviation|2|||
126152580|NCT02333331|453847639|FG003|Overall Study|Protocol Deviation|1|||
126152581|NCT02333331|453847636|FG000|Overall Study|Patient/Guardian Decision|1|||
126152582|NCT02333331|453847637|FG001|Overall Study|Patient/Guardian Decision|2|||
126152583|NCT02333331|453847638|FG002|Overall Study|Patient/Guardian Decision|9|||
126152584|NCT02333331|453847639|FG003|Overall Study|Patient/Guardian Decision|1|||
126152585|NCT05309668|453847640|FG000|Overall Study|Ongoing at data cut-off|14|||
126152586|NCT05309668|453847641|FG001|Overall Study|Ongoing at data cut-off|17|||
126152587|NCT05309668|453847642|FG002|Overall Study|Ongoing at data cut-off|4|||
126152588|NCT04329949|453847646|FG000|Overall Study|Death|36|||
126152589|NCT04329949|453847646|FG000|Overall Study|Withdrawal by Subject|4|||
126152590|NCT04329949|453847646|FG000|Overall Study|Termination of study by sponsor|3|||
126152591|NCT01451515|453847647|FG000|Overall Study|Death|0|||
126152592|NCT01451515|453847648|FG001|Overall Study|Death|1|||
126152593|NCT01451515|453847649|FG002|Overall Study|Death|0|||
126152594|NCT01451515|453847647|FG000|Overall Study|Withdrawal by Subject|0|||
126152595|NCT01451515|453847648|FG001|Overall Study|Withdrawal by Subject|1|||
126152596|NCT01451515|453847649|FG002|Overall Study|Withdrawal by Subject|0|||
126152597|NCT01451515|453847647|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
125971591|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
125971592|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
126152598|NCT01451515|453847648|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
126152599|NCT01451515|453847649|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
126152600|NCT01451515|453847647|FG000|Overall Study|Relapse (except CNS)|1|||
126152601|NCT01451515|453847648|FG001|Overall Study|Relapse (except CNS)|1|||
126152602|NCT01451515|453847649|FG002|Overall Study|Relapse (except CNS)|0|||
126152603|NCT01458340|453847650|FG000|Overall Study|Adverse Event|5|||
126152604|NCT01458340|453847651|FG001|Overall Study|Adverse Event|4|||
126152605|NCT01458340|453847652|FG002|Overall Study|Adverse Event|2|||
126152606|NCT01458340|453847650|FG000|Overall Study|Lost to Follow-up|3|||
126152607|NCT01458340|453847651|FG001|Overall Study|Lost to Follow-up|3|||
126152608|NCT01458340|453847652|FG002|Overall Study|Lost to Follow-up|10|||
126152609|NCT01458340|453847650|FG000|Overall Study|Miscellaneous|0|||
126152610|NCT01458340|453847651|FG001|Overall Study|Miscellaneous|1|||
126152611|NCT01458340|453847652|FG002|Overall Study|Miscellaneous|0|||
126152612|NCT01458340|453847650|FG000|Overall Study|Physician Decision|1|||
126152613|NCT01458340|453847651|FG001|Overall Study|Physician Decision|1|||
126152614|NCT01458340|453847652|FG002|Overall Study|Physician Decision|2|||
126152615|NCT01458340|453847650|FG000|Overall Study|Protocol Violation|6|||
126152616|NCT01458340|453847651|FG001|Overall Study|Protocol Violation|6|||
126152617|NCT01458340|453847652|FG002|Overall Study|Protocol Violation|5|||
126152618|NCT01458340|453847650|FG000|Overall Study|Withdrawal by Subject|12|||
126152619|NCT01458340|453847651|FG001|Overall Study|Withdrawal by Subject|6|||
126152620|NCT01458340|453847652|FG002|Overall Study|Withdrawal by Subject|4|||
126152621|NCT01126619|453847655|FG000|Overall Study|Not eligible for the study|2|||
126152622|NCT01126619|453847655|FG000|Overall Study|Investigator decision|4|||
126152623|NCT01126619|453847655|FG000|Overall Study|Serious adverse event|1|||
126152624|NCT01126619|453847655|FG000|Overall Study|Withdrawal by Subject|9|||
126152625|NCT01126619|453847655|FG000|Overall Study|Non-compliance|1|||
126152626|NCT03351244|453847656|FG000|Overall Study|Adverse Event|7|||
126152627|NCT03351244|453847657|FG001|Overall Study|Adverse Event|11|||
126152628|NCT03351244|453847658|FG002|Overall Study|Adverse Event|12|||
126152629|NCT03351244|453847656|FG000|Overall Study|Investigator's decision|0|||
126152630|NCT03351244|453847657|FG001|Overall Study|Investigator's decision|0|||
126152631|NCT03351244|453847658|FG002|Overall Study|Investigator's decision|2|||
126152632|NCT03351244|453847656|FG000|Overall Study|System error|0|||
126152633|NCT03351244|453847657|FG001|Overall Study|System error|0|||
126152634|NCT03351244|453847658|FG002|Overall Study|System error|2|||
126152635|NCT03351244|453847656|FG000|Overall Study|COVID-19 restrictions|3|||
126152636|NCT03351244|453847657|FG001|Overall Study|COVID-19 restrictions|0|||
126152637|NCT03351244|453847658|FG002|Overall Study|COVID-19 restrictions|1|||
126152638|NCT03351244|453847656|FG000|Overall Study|Non-compliance|2|||
126152639|NCT03351244|453847657|FG001|Overall Study|Non-compliance|5|||
126152640|NCT03351244|453847658|FG002|Overall Study|Non-compliance|0|||
126152641|NCT03351244|453847656|FG000|Overall Study|Withdrawal by Subject|11|||
126152642|NCT03351244|453847657|FG001|Overall Study|Withdrawal by Subject|16|||
126152643|NCT03351244|453847658|FG002|Overall Study|Withdrawal by Subject|13|||
126152644|NCT03351244|453847656|FG000|Overall Study|Lost to Follow-up|2|||
126152645|NCT03351244|453847657|FG001|Overall Study|Lost to Follow-up|6|||
126152646|NCT03351244|453847658|FG002|Overall Study|Lost to Follow-up|4|||
126152647|NCT03351244|453847656|FG000|Overall Study|Protocol Violation|2|||
126152648|NCT03351244|453847657|FG001|Overall Study|Protocol Violation|2|||
126152649|NCT03351244|453847658|FG002|Overall Study|Protocol Violation|0|||
126152650|NCT00091793|453847660|FG000|Overall Study|Adverse Event|1|||
126152651|NCT00091793|453847661|FG001|Overall Study|Adverse Event|2|||
126152652|NCT00091793|453847660|FG000|Overall Study|Withdrawal by Subject|10|||
126152653|NCT00091793|453847661|FG001|Overall Study|Withdrawal by Subject|15|||
126152654|NCT00091793|453847660|FG000|Overall Study|Ineligibility determined|2|||
126152655|NCT00091793|453847661|FG001|Overall Study|Ineligibility determined|0|||
126152656|NCT00091793|453847660|FG000|Overall Study|Lost to Follow-up|7|||
126152657|NCT00091793|453847661|FG001|Overall Study|Lost to Follow-up|5|||
126152658|NCT00091793|453847660|FG000|Overall Study|Noncompliance|2|||
126152659|NCT00091793|453847661|FG001|Overall Study|Noncompliance|0|||
126152660|NCT00091793|453847660|FG000|Overall Study|Other|2|||
126152661|NCT00091793|453847661|FG001|Overall Study|Other|0|||
126152662|NCT05309083|453847663|FG000|Overall Study|Withdrawal by Subject|2|||
126152663|NCT01165229|453847664|FG000|Overall Study|Serious Adverse Event|456|||
126152664|NCT01165229|453847665|FG001|Overall Study|Serious Adverse Event|487|||
126152665|NCT01165229|453847664|FG000|Overall Study|Non-Serious Adverse Event|47|||
126152666|NCT01165229|453847665|FG001|Overall Study|Non-Serious Adverse Event|15|||
126152667|NCT01165229|453847664|FG000|Overall Study|Protocol Violation|6|||
126152668|NCT01165229|453847665|FG001|Overall Study|Protocol Violation|8|||
126152669|NCT01165229|453847664|FG000|Overall Study|Withdrawal by Subject|387|||
126152670|NCT01165229|453847665|FG001|Overall Study|Withdrawal by Subject|396|||
126152671|NCT01165229|453847664|FG000|Overall Study|Migrated/moved from study area|51|||
126152672|NCT01165229|453847665|FG001|Overall Study|Migrated/moved from study area|46|||
126152673|NCT01165229|453847664|FG000|Overall Study|Lost to Follow-up|123|||
126152674|NCT01165229|453847665|FG001|Overall Study|Lost to Follow-up|133|||
126152675|NCT01165229|453847664|FG000|Overall Study|Suspected HZ Episode|2|||
126152676|NCT01165229|453847665|FG001|Overall Study|Suspected HZ Episode|2|||
126152677|NCT01165229|453847664|FG000|Overall Study|No reason from the subject|108|||
126152678|NCT01165229|453847665|FG001|Overall Study|No reason from the subject|102|||
126152679|NCT01165229|453847664|FG000|Overall Study|Unknown completion status|0|||
126152680|NCT01165229|453847665|FG001|Overall Study|Unknown completion status|1|||
126152681|NCT00779038|453847669|FG000|Overall Study|Study Prematurely Terminated|13|||
126152682|NCT00537745|453847670|FG000|Overall Study|Did not meet eligibility criteria|2|||
126152683|NCT00537745|453847670|FG000|Overall Study|Withdrawal by Subject|2|||
126152684|NCT00537745|453847670|FG000|Overall Study|Subject unable to provide Interlock info|1|||
126152685|NCT04786210|453847671|FG000|Overall Study|Lost to Follow-up|2|||
126152686|NCT04786210|453847671|FG000|Overall Study|Withdrawal by Subject|4|||
126152687|NCT05370157|453847672|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
126152688|NCT05370157|453847673|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
126152689|NCT05370157|453847672|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
126152690|NCT05370157|453847673|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
126152691|NCT03700892|453847674|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
126152692|NCT03700892|453847675|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
126152693|NCT03700892|453847676|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
126152694|NCT01364467|453847686|FG000|Overall Study|Lost to Follow-up|1|||
126152695|NCT01364467|453847687|FG001|Overall Study|Lost to Follow-up|2|||
126152696|NCT01634243|453847688|FG000|Overall Study|Adverse Event|5|||
126152697|NCT01634243|453847689|FG001|Overall Study|Adverse Event|5|||
126152698|NCT01634243|453847688|FG000|Overall Study|Lack of Efficacy|1|||
126152699|NCT01634243|453847689|FG001|Overall Study|Lack of Efficacy|0|||
126152700|NCT00587223|453847699|FG000|Overall Study|Adverse Event|1|||
126152701|NCT00883753|453847700|FG000|Overall Study|Adverse Event|37|||
126152702|NCT00883753|453847700|FG000|Overall Study|Death|2|||
126152703|NCT00883753|453847700|FG000|Overall Study|Insufficient therapeutic response|16|||
126152704|NCT00883753|453847700|FG000|Overall Study|Lost to Follow-up|4|||
126152705|NCT00883753|453847700|FG000|Overall Study|Violation of selection criteria at entry|7|||
126152706|NCT00883753|453847700|FG000|Overall Study|Protocol Violation|2|||
126152707|NCT00883753|453847700|FG000|Overall Study|Refused treatment|4|||
126152708|NCT00883753|453847700|FG000|Overall Study|Withdrew consent|10|||
126152709|NCT00883753|453847700|FG000|Overall Study|Investigator's decision|17|||
126152710|NCT00883753|453847700|FG000|Overall Study|Administrative/Other|8|||
126152711|NCT00971321|453847705|FG000|Up to Month 7|Withdrawal by Subject|1|||
126152712|NCT00971321|453847706|FG001|Up to Month 7|Withdrawal by Subject|0|||
126152713|NCT00971321|453847705|FG000|Up to Month 7|Migrated/moved from study area|3|||
126152714|NCT00971321|453847706|FG001|Up to Month 7|Migrated/moved from study area|2|||
126152715|NCT00971321|453847705|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
126152716|NCT00971321|453847706|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
126152717|NCT00971321|453847705|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
126152718|NCT00971321|453847706|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
126152719|NCT00971321|453847705|FG000|Up to Month 11-12|Lost to Follow-up|1|||
126152720|NCT00971321|453847706|FG001|Up to Month 11-12|Lost to Follow-up|0|||
126152721|NCT03885284|453847709|FG000|Overall Study|Disease Progression|1|||
126152722|NCT03885284|453847710|FG001|Overall Study|Disease Progression|3|||
126152723|NCT03885284|453847709|FG000|Overall Study|Physician Decision|0|||
126152724|NCT03885284|453847710|FG001|Overall Study|Physician Decision|1|||
126152725|NCT01476787|453847715|FG000|Treatment|Progression|64|||
126152726|NCT01476787|453847716|FG001|Treatment|Progression|71|||
126152727|NCT01476787|453847715|FG000|Treatment|Toxicity|44|||
126152728|NCT01476787|453847716|FG001|Treatment|Toxicity|16|||
126152729|NCT01476787|453847715|FG000|Treatment|Death|0|||
126152730|NCT01476787|453847716|FG001|Treatment|Death|1|||
126152731|NCT01476787|453847715|FG000|Treatment|Withdrawal by Subject|3|||
126152732|NCT01476787|453847716|FG001|Treatment|Withdrawal by Subject|14|||
126152733|NCT01476787|453847715|FG000|Treatment|Major protocol violation|1|||
126152734|NCT01476787|453847716|FG001|Treatment|Major protocol violation|6|||
126152735|NCT01476787|453847715|FG000|Treatment|Other reasons|10|||
126152736|NCT01476787|453847716|FG001|Treatment|Other reasons|22|||
126152737|NCT01476787|453847715|FG000|Treatment|Concurrent illness|12|||
126152738|NCT01476787|453847716|FG001|Treatment|Concurrent illness|9|||
126152739|NCT01476787|453847715|FG000|Treatment|Insufficient response|15|||
126152740|NCT01476787|453847716|FG001|Treatment|Insufficient response|3|||
126152741|NCT01476787|453847715|FG000|Treatment|Voluntary treatment discontinuation|8|||
126152742|NCT01476787|453847716|FG001|Treatment|Voluntary treatment discontinuation|4|||
126152743|NCT01591330|453847717|FG000|Period 1|Adverse Event|1|||
126152744|NCT01591330|453847718|FG001|Period 1|Adverse Event|0|||
126152745|NCT01591330|453847719|FG002|Period 1|Adverse Event|0|||
126152746|NCT01591330|453847720|FG003|Period 1|Adverse Event|0|||
126152747|NCT01591330|453847717|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
126152748|NCT01591330|453847718|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
125971593|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Adverse Event|0|||
125971594|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Adverse Event|0|||
126152749|NCT01591330|453847719|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
126152750|NCT01591330|453847720|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
126152751|NCT01591330|453847717|FG000|Period 2|Adverse Event|1|||
126152752|NCT01591330|453847718|FG001|Period 2|Adverse Event|0|||
126152753|NCT01591330|453847719|FG002|Period 2|Adverse Event|0|||
126152754|NCT01591330|453847720|FG003|Period 2|Adverse Event|0|||
126152755|NCT01450137|453847721|FG000|Up to Week 12|Adverse Event|2|||
126152756|NCT01450137|453847722|FG001|Up to Week 12|Adverse Event|1|||
126152757|NCT01450137|453847721|FG000|Up to Week 12|Withdrawal by Subject|0|||
126152758|NCT01450137|453847722|FG001|Up to Week 12|Withdrawal by Subject|2|||
126152759|NCT01450137|453847721|FG000|Week 12 to Study End|Death|0|||
126152760|NCT01450137|453847722|FG001|Week 12 to Study End|Death|1|||
126152761|NCT01450137|453847721|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
126152762|NCT01450137|453847722|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
126152763|NCT01450540|453847723|FG000|Overall Study|Withdrawal by Subject|19|||
126152764|NCT01450540|453847724|FG001|Overall Study|Withdrawal by Subject|13|||
126152765|NCT01450540|453847723|FG000|Overall Study|protocol deviation|3|||
126152766|NCT01450540|453847724|FG001|Overall Study|protocol deviation|23|||
126152767|NCT02932267|453847738|FG000|Overall Study|Withdrawal by Subject|3|||
126152768|NCT02932267|453847738|FG000|Overall Study|Lost to Follow-up|4|||
126152769|NCT02932267|453847738|FG000|Overall Study|Pregnancy|1|||
126152770|NCT03851510|453847741|FG000|Overall Study|Screen Fail|1|||
126152771|NCT03851510|453847741|FG000|Overall Study|Adverse Event|1|||
126152772|NCT03851510|453847741|FG000|Overall Study|Withdrawal by Subject|1|||
126152773|NCT01287117|453847746|FG000|Overall Study|Adverse Event|2|||
126152774|NCT01287117|453847747|FG001|Overall Study|Adverse Event|1|||
126152775|NCT01287117|453847748|FG002|Overall Study|Adverse Event|1|||
126152776|NCT01287117|453847749|FG003|Overall Study|Adverse Event|1|||
126152777|NCT01287117|453847746|FG000|Overall Study|Lost to Follow-up|1|||
126152778|NCT01287117|453847747|FG001|Overall Study|Lost to Follow-up|1|||
126152779|NCT01287117|453847748|FG002|Overall Study|Lost to Follow-up|0|||
126152780|NCT01287117|453847749|FG003|Overall Study|Lost to Follow-up|0|||
126152781|NCT01287117|453847746|FG000|Overall Study|Physician Decision|0|||
126152782|NCT01287117|453847747|FG001|Overall Study|Physician Decision|1|||
126152783|NCT01287117|453847748|FG002|Overall Study|Physician Decision|1|||
126152784|NCT01287117|453847749|FG003|Overall Study|Physician Decision|1|||
126152785|NCT01287117|453847746|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
126152786|NCT01287117|453847747|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
126152787|NCT01287117|453847748|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
126152788|NCT01287117|453847749|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
126152789|NCT01287117|453847746|FG000|Overall Study|Disease Progression|10|||
126152790|NCT01287117|453847747|FG001|Overall Study|Disease Progression|5|||
126152791|NCT01287117|453847748|FG002|Overall Study|Disease Progression|6|||
126152792|NCT01287117|453847749|FG003|Overall Study|Disease Progression|5|||
126152793|NCT02975349|453847754|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126152794|NCT02975349|453847755|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126152795|NCT02975349|453847756|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126152796|NCT02975349|453847757|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
126152797|NCT02975349|453847758|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
126152798|NCT02975349|453847759|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126152799|NCT02975349|453847760|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126152800|NCT02975349|453847754|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126152801|NCT02975349|453847755|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126152802|NCT02975349|453847756|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126152803|NCT02975349|453847757|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126152804|NCT02975349|453847758|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126152805|NCT02975349|453847759|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126152806|NCT02975349|453847760|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126152807|NCT02975349|453847754|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
126152808|NCT02975349|453847755|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
126152809|NCT02975349|453847756|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
126152810|NCT02975349|453847757|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
126152811|NCT02975349|453847758|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
126152812|NCT02975349|453847759|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
126152813|NCT02975349|453847760|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
126152814|NCT02975349|453847754|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
126152815|NCT02975349|453847755|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
125971595|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Adverse Event|0|||
125971596|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Adverse Event|0|||
126152816|NCT02975349|453847756|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
126152817|NCT02975349|453847757|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
126152818|NCT02975349|453847758|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
126152819|NCT02975349|453847759|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
125971597|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Adverse Event|1|||
125971598|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Adverse Event|0|||
125971599|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
126152820|NCT02975349|453847760|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
126152821|NCT02975349|453847754|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
126152822|NCT02975349|453847755|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
126152823|NCT02975349|453847756|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
126152824|NCT02975349|453847757|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
126152825|NCT02975349|453847758|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
126152826|NCT02975349|453847759|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
126152827|NCT02975349|453847760|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
126152828|NCT02975349|453847754|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126152829|NCT02975349|453847755|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126152830|NCT02975349|453847756|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126152831|NCT02975349|453847757|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
126152832|NCT02975349|453847758|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126152833|NCT02975349|453847759|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126152834|NCT02975349|453847760|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126152835|NCT02975349|453847754|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126152836|NCT02975349|453847755|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
126152837|NCT02975349|453847756|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126152838|NCT02975349|453847757|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126152839|NCT02975349|453847758|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126152840|NCT02975349|453847759|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126152841|NCT02975349|453847760|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126152842|NCT02975349|453847754|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
126152843|NCT02975349|453847755|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
126152844|NCT02975349|453847756|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
126152845|NCT02975349|453847757|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
126152846|NCT02975349|453847758|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
126152847|NCT02975349|453847759|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
126152848|NCT02975349|453847760|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
126152849|NCT02975349|453847754|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126152850|NCT02975349|453847755|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126152851|NCT02975349|453847756|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126152852|NCT02975349|453847757|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126152853|NCT02975349|453847758|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
126152854|NCT02975349|453847759|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126152855|NCT02975349|453847760|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126152856|NCT02975349|453847754|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126152857|NCT02975349|453847755|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126152858|NCT02975349|453847756|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126152859|NCT02975349|453847757|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126152860|NCT02975349|453847758|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
126152861|NCT02975349|453847759|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126152862|NCT02975349|453847760|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
126152863|NCT02975349|453847754|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
126152864|NCT02975349|453847755|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
126152865|NCT02975349|453847756|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
126152866|NCT02975349|453847757|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
126152867|NCT02975349|453847758|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
126152868|NCT02975349|453847759|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
126152869|NCT02975349|453847760|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
126152870|NCT02975349|453847754|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
126152871|NCT02975349|453847755|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
126152872|NCT02975349|453847756|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
126152873|NCT02975349|453847757|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
126152874|NCT02975349|453847758|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
126152875|NCT02975349|453847759|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
126152876|NCT02975349|453847760|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
126152877|NCT02975349|453847754|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126152878|NCT02975349|453847755|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126152879|NCT02975349|453847756|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
126152880|NCT02975349|453847757|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126152881|NCT02975349|453847758|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126152882|NCT02975349|453847759|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
126152883|NCT02975349|453847760|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126152884|NCT02975349|453847754|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
126152885|NCT02975349|453847755|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
126152886|NCT02975349|453847756|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
126152887|NCT02975349|453847757|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
126152888|NCT02975349|453847758|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
126152889|NCT02975349|453847759|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
126152890|NCT02975349|453847760|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
126152891|NCT02975349|453847754|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
126199951|NCT01117428|454017806|FG002|Overall Study|Physician Decision|0|||
126152892|NCT02975349|453847755|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
126152893|NCT02975349|453847756|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
126152894|NCT02975349|453847757|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
126152895|NCT02975349|453847758|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
126152896|NCT02975349|453847759|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
126152897|NCT02975349|453847760|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
126152898|NCT03497689|453847766|FG000|Overall Study|Adverse Event|2|||
126152899|NCT03497689|453847766|FG000|Overall Study|Death|1|||
126152900|NCT03497689|453847766|FG000|Overall Study|Physician Decision|1|||
126152901|NCT03497689|453847766|FG000|Overall Study|Withdrawal by Subject|1|||
126152902|NCT03497689|453847766|FG000|Overall Study|Protocol Violation|2|||
126152903|NCT03191786|453847767|FG000|Overall Study|Death|236|||
126152904|NCT03191786|453847768|FG001|Overall Study|Death|127|||
126152905|NCT03191786|453847767|FG000|Overall Study|Lost to Follow-up|9|||
126152906|NCT03191786|453847768|FG001|Overall Study|Lost to Follow-up|3|||
126152907|NCT03191786|453847767|FG000|Overall Study|Physician Decision|1|||
126152908|NCT03191786|453847768|FG001|Overall Study|Physician Decision|0|||
126152909|NCT03191786|453847767|FG000|Overall Study|Moved to Post Trial Access Program|30|||
126152910|NCT03191786|453847768|FG001|Overall Study|Moved to Post Trial Access Program|5|||
126152911|NCT03191786|453847767|FG000|Overall Study|Withdrawal by Subject|26|||
126152912|NCT03191786|453847768|FG001|Overall Study|Withdrawal by Subject|16|||
126152913|NCT05165394|453849335|FG000|Overall Study|Withdrawal by Subject|5|||
126152914|NCT05165394|453849336|FG001|Overall Study|Withdrawal by Subject|1|||
126152915|NCT05165394|453849335|FG000|Overall Study|Lost to Follow-up|1|||
126152916|NCT05165394|453849336|FG001|Overall Study|Lost to Follow-up|2|||
126152917|NCT05165394|453849335|FG000|Overall Study|Other Than Specified|0|||
126152918|NCT05165394|453849336|FG001|Overall Study|Other Than Specified|1|||
126152919|NCT02517515|453849342|FG000|Overall Study|Adverse Event|0|||
126152920|NCT02517515|453849343|FG001|Overall Study|Adverse Event|1|||
126152921|NCT02517515|453849342|FG000|Overall Study|Withdrew Consent|0|||
126152922|NCT02517515|453849343|FG001|Overall Study|Withdrew Consent|1|||
126152923|NCT02517515|453849342|FG000|Overall Study|Lost to Follow-up|1|||
126152924|NCT02517515|453849343|FG001|Overall Study|Lost to Follow-up|0|||
126152925|NCT02517515|453849342|FG000|Overall Study|Other|1|||
126152926|NCT02517515|453849343|FG001|Overall Study|Other|0|||
126152927|NCT02786537|453849344|FG000|As Randomized|Adverse Event|0|||
126152928|NCT02786537|453849345|FG001|As Randomized|Adverse Event|11|||
126152929|NCT02786537|453849346|FG002|As Randomized|Adverse Event|0|||
126152930|NCT02786537|453849347|FG003|As Randomized|Adverse Event|4|||
126152931|NCT02786537|453849348|FG004|As Randomized|Adverse Event|6|||
126152932|NCT02786537|453849349|FG005|As Randomized|Adverse Event|2|||
126152933|NCT02786537|453849344|FG000|As Randomized|Lack of Efficacy|0|||
126152934|NCT02786537|453849345|FG001|As Randomized|Lack of Efficacy|0|||
126152935|NCT02786537|453849346|FG002|As Randomized|Lack of Efficacy|0|||
126152936|NCT02786537|453849347|FG003|As Randomized|Lack of Efficacy|1|||
126152937|NCT02786537|453849348|FG004|As Randomized|Lack of Efficacy|0|||
126152938|NCT02786537|453849349|FG005|As Randomized|Lack of Efficacy|0|||
126152939|NCT02786537|453849344|FG000|As Randomized|Withdrawal by Subject|1|||
126152940|NCT02786537|453849345|FG001|As Randomized|Withdrawal by Subject|2|||
126152941|NCT02786537|453849346|FG002|As Randomized|Withdrawal by Subject|0|||
126152942|NCT02786537|453849347|FG003|As Randomized|Withdrawal by Subject|1|||
126152943|NCT02786537|453849348|FG004|As Randomized|Withdrawal by Subject|1|||
126152944|NCT02786537|453849349|FG005|As Randomized|Withdrawal by Subject|0|||
126152945|NCT02786537|453849344|FG000|As Randomized|Death|0|||
126152946|NCT02786537|453849345|FG001|As Randomized|Death|2|||
126152947|NCT02786537|453849346|FG002|As Randomized|Death|0|||
126152948|NCT02786537|453849347|FG003|As Randomized|Death|3|||
126152949|NCT02786537|453849348|FG004|As Randomized|Death|1|||
126152950|NCT02786537|453849349|FG005|As Randomized|Death|0|||
126152951|NCT02786537|453849344|FG000|As Randomized|Non-compliance with study drug|1|||
126152952|NCT02786537|453849345|FG001|As Randomized|Non-compliance with study drug|11|||
126152953|NCT02786537|453849346|FG002|As Randomized|Non-compliance with study drug|0|||
126152954|NCT02786537|453849347|FG003|As Randomized|Non-compliance with study drug|1|||
125971600|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
125971601|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
126152955|NCT02786537|453849348|FG004|As Randomized|Non-compliance with study drug|0|||
126152956|NCT02786537|453849349|FG005|As Randomized|Non-compliance with study drug|1|||
126152957|NCT02786537|453849344|FG000|As Randomized|Lost to treatment follow-up|4|||
126152958|NCT02786537|453849345|FG001|As Randomized|Lost to treatment follow-up|32|||
125971602|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
126152959|NCT02786537|453849346|FG002|As Randomized|Lost to treatment follow-up|0|||
126152960|NCT02786537|453849347|FG003|As Randomized|Lost to treatment follow-up|24|||
126152961|NCT02786537|453849348|FG004|As Randomized|Lost to treatment follow-up|4|||
126152962|NCT02786537|453849349|FG005|As Randomized|Lost to treatment follow-up|4|||
126152963|NCT02786537|453849344|FG000|As Randomized|Incarceration|0|||
126152964|NCT02786537|453849345|FG001|As Randomized|Incarceration|1|||
126152965|NCT02786537|453849346|FG002|As Randomized|Incarceration|0|||
126152966|NCT02786537|453849347|FG003|As Randomized|Incarceration|0|||
126152967|NCT02786537|453849348|FG004|As Randomized|Incarceration|0|||
126152968|NCT02786537|453849349|FG005|As Randomized|Incarceration|0|||
126152969|NCT02786537|453849344|FG000|As Randomized|Opiate Dependency Relapse|0|||
126152970|NCT02786537|453849345|FG001|As Randomized|Opiate Dependency Relapse|1|||
126152971|NCT02786537|453849346|FG002|As Randomized|Opiate Dependency Relapse|0|||
126152972|NCT02786537|453849347|FG003|As Randomized|Opiate Dependency Relapse|0|||
126152973|NCT02786537|453849348|FG004|As Randomized|Opiate Dependency Relapse|0|||
126152974|NCT02786537|453849349|FG005|As Randomized|Opiate Dependency Relapse|0|||
126152975|NCT02786537|453849344|FG000|As Randomized|HCV drugs stolen from pt|0|||
126152976|NCT02786537|453849345|FG001|As Randomized|HCV drugs stolen from pt|1|||
126152977|NCT02786537|453849346|FG002|As Randomized|HCV drugs stolen from pt|0|||
126152978|NCT02786537|453849347|FG003|As Randomized|HCV drugs stolen from pt|0|||
126152979|NCT02786537|453849348|FG004|As Randomized|HCV drugs stolen from pt|0|||
126152980|NCT02786537|453849349|FG005|As Randomized|HCV drugs stolen from pt|0|||
126152981|NCT02786537|453849344|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
126152982|NCT02786537|453849345|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
126152983|NCT02786537|453849346|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
126152984|NCT02786537|453849347|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
126152985|NCT02786537|453849348|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
126152986|NCT02786537|453849349|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
126152987|NCT02786537|453849344|FG000|As Randomized|Subject lost insurance|0|||
126152988|NCT02786537|453849345|FG001|As Randomized|Subject lost insurance|0|||
126152989|NCT02786537|453849346|FG002|As Randomized|Subject lost insurance|0|||
126152990|NCT02786537|453849347|FG003|As Randomized|Subject lost insurance|1|||
126152991|NCT02786537|453849348|FG004|As Randomized|Subject lost insurance|0|||
126152992|NCT02786537|453849349|FG005|As Randomized|Subject lost insurance|0|||
126152993|NCT02786537|453849344|FG000|As Treated|Adverse Event|0|||
126152994|NCT02786537|453849345|FG001|As Treated|Adverse Event|11|||
126152995|NCT02786537|453849346|FG002|As Treated|Adverse Event|0|||
126152996|NCT02786537|453849347|FG003|As Treated|Adverse Event|4|||
126152997|NCT02786537|453849348|FG004|As Treated|Adverse Event|6|||
126152998|NCT02786537|453849349|FG005|As Treated|Adverse Event|2|||
126152999|NCT02786537|453849344|FG000|As Treated|Death|0|||
126153000|NCT02786537|453849345|FG001|As Treated|Death|2|||
126153001|NCT02786537|453849346|FG002|As Treated|Death|0|||
126153002|NCT02786537|453849347|FG003|As Treated|Death|3|||
126153003|NCT02786537|453849348|FG004|As Treated|Death|1|||
126153004|NCT02786537|453849349|FG005|As Treated|Death|0|||
126153005|NCT02786537|453849344|FG000|As Treated|Lack of Efficacy|0|||
126153006|NCT02786537|453849345|FG001|As Treated|Lack of Efficacy|0|||
126153007|NCT02786537|453849346|FG002|As Treated|Lack of Efficacy|0|||
126153008|NCT02786537|453849347|FG003|As Treated|Lack of Efficacy|1|||
126153009|NCT02786537|453849348|FG004|As Treated|Lack of Efficacy|0|||
126153010|NCT02786537|453849349|FG005|As Treated|Lack of Efficacy|0|||
126153011|NCT02786537|453849344|FG000|As Treated|Lost to Follow-up|4|||
126153012|NCT02786537|453849345|FG001|As Treated|Lost to Follow-up|32|||
126153013|NCT02786537|453849346|FG002|As Treated|Lost to Follow-up|0|||
126153014|NCT02786537|453849347|FG003|As Treated|Lost to Follow-up|25|||
126153015|NCT02786537|453849348|FG004|As Treated|Lost to Follow-up|4|||
126153016|NCT02786537|453849349|FG005|As Treated|Lost to Follow-up|4|||
126153017|NCT02786537|453849344|FG000|As Treated|Non-compliance with study drug|1|||
126153018|NCT02786537|453849345|FG001|As Treated|Non-compliance with study drug|11|||
126153019|NCT02786537|453849346|FG002|As Treated|Non-compliance with study drug|0|||
126153020|NCT02786537|453849347|FG003|As Treated|Non-compliance with study drug|1|||
126153021|NCT02786537|453849348|FG004|As Treated|Non-compliance with study drug|0|||
126153022|NCT02786537|453849349|FG005|As Treated|Non-compliance with study drug|1|||
126153023|NCT02786537|453849344|FG000|As Treated|Lost insurance|0|||
126153024|NCT02786537|453849345|FG001|As Treated|Lost insurance|0|||
126153025|NCT02786537|453849346|FG002|As Treated|Lost insurance|0|||
126153026|NCT02786537|453849347|FG003|As Treated|Lost insurance|1|||
126153027|NCT02786537|453849348|FG004|As Treated|Lost insurance|0|||
126153028|NCT02786537|453849349|FG005|As Treated|Lost insurance|0|||
126153029|NCT02786537|453849344|FG000|As Treated|Withdrawal by Subject|1|||
126153030|NCT02786537|453849345|FG001|As Treated|Withdrawal by Subject|2|||
126153031|NCT02786537|453849346|FG002|As Treated|Withdrawal by Subject|0|||
125971603|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
125971604|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
126153032|NCT02786537|453849347|FG003|As Treated|Withdrawal by Subject|0|||
126153033|NCT02786537|453849348|FG004|As Treated|Withdrawal by Subject|1|||
125971605|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
126153034|NCT02786537|453849349|FG005|As Treated|Withdrawal by Subject|0|||
126153035|NCT02786537|453849344|FG000|As Treated|Incarceration|0|||
126153036|NCT02786537|453849345|FG001|As Treated|Incarceration|1|||
126153037|NCT02786537|453849346|FG002|As Treated|Incarceration|0|||
126153038|NCT02786537|453849347|FG003|As Treated|Incarceration|0|||
126153039|NCT02786537|453849348|FG004|As Treated|Incarceration|0|||
126153040|NCT02786537|453849349|FG005|As Treated|Incarceration|0|||
126153041|NCT02786537|453849344|FG000|As Treated|Opiate dependency relapse|0|||
126153042|NCT02786537|453849345|FG001|As Treated|Opiate dependency relapse|1|||
126153043|NCT02786537|453849346|FG002|As Treated|Opiate dependency relapse|0|||
126153044|NCT02786537|453849347|FG003|As Treated|Opiate dependency relapse|0|||
126153045|NCT02786537|453849348|FG004|As Treated|Opiate dependency relapse|0|||
126153046|NCT02786537|453849349|FG005|As Treated|Opiate dependency relapse|0|||
126153047|NCT02786537|453849344|FG000|As Treated|Drugs stolen from patient|0|||
126153048|NCT02786537|453849345|FG001|As Treated|Drugs stolen from patient|1|||
126153049|NCT02786537|453849346|FG002|As Treated|Drugs stolen from patient|0|||
126153050|NCT02786537|453849347|FG003|As Treated|Drugs stolen from patient|0|||
126153051|NCT02786537|453849348|FG004|As Treated|Drugs stolen from patient|0|||
126153052|NCT02786537|453849349|FG005|As Treated|Drugs stolen from patient|0|||
126153053|NCT02786537|453849344|FG000|As Treated|Advised to stop tx after loss of meds|0|||
126153054|NCT02786537|453849345|FG001|As Treated|Advised to stop tx after loss of meds|1|||
126153055|NCT02786537|453849346|FG002|As Treated|Advised to stop tx after loss of meds|0|||
126153056|NCT02786537|453849347|FG003|As Treated|Advised to stop tx after loss of meds|0|||
126153057|NCT02786537|453849348|FG004|As Treated|Advised to stop tx after loss of meds|0|||
126153058|NCT02786537|453849349|FG005|As Treated|Advised to stop tx after loss of meds|0|||
126153059|NCT02638012|453849350|FG000|Overall Study|Lost to Follow-up|1|||
126153060|NCT00443560|453849351|FG000|Overall Study|No intrathecal dose|58|||
126153061|NCT00443560|453849352|FG001|Overall Study|No intrathecal dose|26|||
126153062|NCT00443560|453849351|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
126153063|NCT00443560|453849352|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
126153064|NCT01009463|453849353|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
126153065|NCT01009463|453849354|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126153066|NCT01009463|453849355|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126153067|NCT01009463|453849356|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126153068|NCT01009463|453849357|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126153069|NCT01009463|453849353|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
126153070|NCT01009463|453849354|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
126153071|NCT01009463|453849355|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
125971606|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
125971607|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
126153072|NCT01009463|453849356|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
126153073|NCT01009463|453849357|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
126153074|NCT01009463|453849353|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
126153075|NCT01009463|453849354|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126153076|NCT01009463|453849355|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126153077|NCT01009463|453849356|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126153078|NCT01009463|453849357|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126153079|NCT01009463|453849353|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
125971608|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
125971609|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
125971610|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
125971611|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
125971612|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
125971613|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
125971614|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
125971615|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
125971616|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
125971617|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
125971618|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
125971619|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125971620|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125971621|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125971622|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125971623|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
125971624|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
125971625|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
125971626|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
126153080|NCT01009463|453849354|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
126153081|NCT01009463|453849355|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
126153082|NCT01009463|453849356|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
126153083|NCT01009463|453849357|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
126153084|NCT01009463|453849353|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
126153085|NCT01009463|453849354|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125971627|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
126153086|NCT01009463|453849355|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126153087|NCT01009463|453849356|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126153088|NCT01009463|453849357|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126153089|NCT01009463|453849353|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
126153090|NCT01009463|453849354|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
126153091|NCT01009463|453849355|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
126153092|NCT01009463|453849356|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
126153093|NCT01009463|453849357|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
126153094|NCT01009463|453849353|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126153095|NCT01009463|453849354|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
126153096|NCT01009463|453849355|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
126153097|NCT01009463|453849356|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
126153098|NCT01009463|453849357|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
126153099|NCT01009463|453849353|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
126153100|NCT01009463|453849354|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
126153101|NCT01009463|453849355|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
126153102|NCT01009463|453849356|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
126153103|NCT01009463|453849357|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
126153104|NCT01009463|453849353|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
126153105|NCT01009463|453849354|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
126153106|NCT01009463|453849355|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
126153107|NCT01009463|453849356|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
126153108|NCT01009463|453849357|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
126153109|NCT01009463|453849353|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126153110|NCT01009463|453849354|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
126153111|NCT01009463|453849355|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
126153112|NCT01009463|453849356|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
126153113|NCT01009463|453849357|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
126153114|NCT01009463|453849353|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126153115|NCT01009463|453849354|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
126153116|NCT01009463|453849355|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126153117|NCT01009463|453849356|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
126153118|NCT01009463|453849357|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126153119|NCT01009463|453849353|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126153120|NCT01009463|453849354|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
126153121|NCT01009463|453849355|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
126153122|NCT01009463|453849356|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
126153123|NCT01009463|453849357|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
126153124|NCT01009463|453849353|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
126153125|NCT01009463|453849354|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
126153126|NCT01009463|453849355|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
126153127|NCT01009463|453849356|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
126153128|NCT01009463|453849357|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
126153129|NCT01494038|453849358|FG000|Overall Study|Protocol Violation|1|||
126153130|NCT01494038|453849359|FG001|Overall Study|Protocol Violation|1|||
126153131|NCT01494038|453849358|FG000|Overall Study|Lost to Follow-up|18|||
126153132|NCT01494038|453849359|FG001|Overall Study|Lost to Follow-up|20|||
126153133|NCT01494038|453849358|FG000|Overall Study|Withdrawal by Subject|44|||
126153134|NCT01494038|453849359|FG001|Overall Study|Withdrawal by Subject|34|||
126153135|NCT01494038|453849358|FG000|Overall Study|Not able to get to clinic|21|||
126153136|NCT01494038|453849359|FG001|Overall Study|Not able to get to clinic|15|||
126153137|NCT01494038|453849358|FG000|Overall Study|Not willing to adhere to reqs|2|||
126153138|NCT01494038|453849359|FG001|Overall Study|Not willing to adhere to reqs|9|||
126153139|NCT01494038|453849358|FG000|Overall Study|Death|2|||
126153140|NCT01494038|453849359|FG001|Overall Study|Death|4|||
126153141|NCT02401256|453849360|FG000|Overall Study|Adverse Event|5|||
126153142|NCT02401256|453849360|FG000|Overall Study|Withdrawal by Subject|12|||
126153143|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
126153144|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
126153145|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
126153146|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
126153147|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
126153148|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
126153149|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
126153150|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
126153151|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
126153152|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
126153153|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
126153154|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
126153155|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
126153156|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
126153157|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
126153158|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
126153159|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
126153160|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
126153161|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Death|0|||
126153162|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Death|1|||
126153163|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Death|0|||
126153164|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
126153165|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
126153166|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
126153167|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
126153168|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
126153169|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
126153170|NCT00430781|453849361|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
126153171|NCT00430781|453849362|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
126153172|NCT00430781|453849363|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
126153173|NCT00430781|453849361|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
126153174|NCT00430781|453849362|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
126153175|NCT00430781|453849363|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
126153176|NCT00430781|453849361|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
126153177|NCT00430781|453849362|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
126153178|NCT00430781|453849363|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
126153179|NCT00430781|453849361|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
126153180|NCT00430781|453849362|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
126153181|NCT00430781|453849363|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
126153182|NCT00430781|453849361|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
126153183|NCT00430781|453849362|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
126153184|NCT00430781|453849363|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
126153185|NCT00430781|453849361|FG000|Final Analysis; 31 July 2008|Other|0|||
126153186|NCT00430781|453849362|FG001|Final Analysis; 31 July 2008|Other|1|||
126153187|NCT00430781|453849363|FG002|Final Analysis; 31 July 2008|Other|0|||
126153188|NCT00430781|453849361|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
126153189|NCT00430781|453849362|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
126153190|NCT00430781|453849363|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
126153191|NCT00430781|453849361|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
126153192|NCT00430781|453849362|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
126153193|NCT00430781|453849363|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
126153194|NCT00430781|453849361|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
126153195|NCT00430781|453849362|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
126153196|NCT00430781|453849363|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
126153197|NCT00430781|453849361|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
126153198|NCT00430781|453849362|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
126153199|NCT00430781|453849363|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
126153200|NCT00430781|453849361|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
126153201|NCT00430781|453849362|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
126153202|NCT00430781|453849363|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
126153203|NCT00430781|453849361|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
126153204|NCT00430781|453849362|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
126153205|NCT00430781|453849363|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
126153206|NCT00430781|453849361|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
126153207|NCT00430781|453849362|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
126153208|NCT00430781|453849363|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
126153209|NCT01389128|453849366|FG000|Overall Study|Fetal distress|1|||
126153210|NCT01389128|453849367|FG001|Overall Study|Fetal distress|0|||
126153211|NCT01389128|453849366|FG000|Overall Study|Cervix dilation stop|1|||
126153212|NCT01389128|453849367|FG001|Overall Study|Cervix dilation stop|2|||
126153213|NCT01389128|453849366|FG000|Overall Study|Rapid labor evolution|3|||
125971628|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
125971629|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
125971630|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
125971631|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
126153214|NCT01389128|453849367|FG001|Overall Study|Rapid labor evolution|2|||
126153215|NCT01389128|453849366|FG000|Overall Study|Intolerance to procedure|0|||
126153216|NCT01389128|453849367|FG001|Overall Study|Intolerance to procedure|2|||
126153217|NCT01059812|453849368|FG000|Overall Study|Adverse Event|9|||
126153218|NCT01059812|453849369|FG001|Overall Study|Adverse Event|5|||
126153219|NCT01059812|453849368|FG000|Overall Study|Lack of Efficacy|2|||
126153220|NCT01059812|453849369|FG001|Overall Study|Lack of Efficacy|2|||
126153221|NCT01059812|453849368|FG000|Overall Study|Protocol Violation|3|||
126153222|NCT01059812|453849369|FG001|Overall Study|Protocol Violation|1|||
126153223|NCT01059812|453849368|FG000|Overall Study|Withdrawal Criteria|9|||
126153224|NCT01059812|453849369|FG001|Overall Study|Withdrawal Criteria|4|||
126153225|NCT01059812|453849368|FG000|Overall Study|Unclassified|14|||
126153226|NCT01059812|453849369|FG001|Overall Study|Unclassified|4|||
126153227|NCT03180736|453849370|FG000|Overall Study|Adverse Event|3|||
126153228|NCT03180736|453849371|FG001|Overall Study|Adverse Event|4|||
126153229|NCT03180736|453849370|FG000|Overall Study|Death|10|||
126153230|NCT03180736|453849371|FG001|Overall Study|Death|7|||
126153231|NCT03180736|453849370|FG000|Overall Study|Withdrawal by Subject|5|||
126153232|NCT03180736|453849371|FG001|Overall Study|Withdrawal by Subject|12|||
126153233|NCT03180736|453849370|FG000|Overall Study|Lost to Follow-up|1|||
126153234|NCT03180736|453849371|FG001|Overall Study|Lost to Follow-up|0|||
126153235|NCT03180736|453849370|FG000|Overall Study|Lack of Efficacy|66|||
126153236|NCT03180736|453849371|FG001|Overall Study|Lack of Efficacy|87|||
126153237|NCT03180736|453849370|FG000|Overall Study|Physician Decision|4|||
126153238|NCT03180736|453849371|FG001|Overall Study|Physician Decision|7|||
126153239|NCT03180736|453849370|FG000|Overall Study|randomized but not treated|2|||
126153240|NCT03180736|453849371|FG001|Overall Study|randomized but not treated|3|||
126153241|NCT05299892|453849372|FG000|Overall Study|Withdrawal by Subject|2|||
126153242|NCT03056287|453849377|FG000|Overall Study|Withdrawal by Subject|0|||
126153243|NCT03056287|453849378|FG001|Overall Study|Withdrawal by Subject|1|||
126153244|NCT03056287|453849379|FG002|Overall Study|Withdrawal by Subject|0|||
126153245|NCT03056287|453849380|FG003|Overall Study|Withdrawal by Subject|0|||
126153246|NCT03056287|453849377|FG000|Overall Study|move out of area|0|||
126153247|NCT03056287|453849378|FG001|Overall Study|move out of area|0|||
126153248|NCT03056287|453849379|FG002|Overall Study|move out of area|1|||
126153249|NCT03056287|453849380|FG003|Overall Study|move out of area|1|||
126153250|NCT00881205|453849381|FG000|Overall Study|Adverse Event|8|||
126153251|NCT00881205|453849382|FG001|Overall Study|Adverse Event|3|||
126153252|NCT00881205|453849381|FG000|Overall Study|Withdrawal by Subject|1|||
126153253|NCT00881205|453849382|FG001|Overall Study|Withdrawal by Subject|2|||
126153254|NCT00881205|453849381|FG000|Overall Study|Lost to Follow-up|0|||
126153255|NCT00881205|453849382|FG001|Overall Study|Lost to Follow-up|1|||
126153256|NCT00881205|453849381|FG000|Overall Study|Administrative problems|1|||
126153257|NCT00881205|453849382|FG001|Overall Study|Administrative problems|1|||
126153258|NCT00881205|453849381|FG000|Overall Study|Condition no longer requires drug|1|||
126153259|NCT00881205|453849382|FG001|Overall Study|Condition no longer requires drug|0|||
126153260|NCT00550238|453849383|FG000|Overall Study|Adverse Event|88|||
126153261|NCT00550238|453849383|FG000|Overall Study|Death|34|||
126153262|NCT00550238|453849383|FG000|Overall Study|Disease progression|46|||
126153263|NCT00550238|453849383|FG000|Overall Study|Withdrawal by Subject|167|||
126153264|NCT00550238|453849383|FG000|Overall Study|Physician Decision|31|||
126153265|NCT00550238|453849383|FG000|Overall Study|Patient noncompliance|25|||
126153266|NCT00550238|453849383|FG000|Overall Study|Lost to Follow-up|13|||
126153267|NCT00550238|453849383|FG000|Overall Study|Sponsor decision|55|||
126153268|NCT00845429|453849384|FG000|Overall Study|Protocol Violation|5|||
126153269|NCT00845429|453849385|FG001|Overall Study|Protocol Violation|4|||
126153270|NCT00845429|453849386|FG002|Overall Study|Protocol Violation|7|||
126153271|NCT00845429|453849384|FG000|Overall Study|Lost to Follow-up|7|||
126153272|NCT00845429|453849385|FG001|Overall Study|Lost to Follow-up|9|||
126153273|NCT00845429|453849386|FG002|Overall Study|Lost to Follow-up|10|||
126153274|NCT00845429|453849384|FG000|Overall Study|Withdrawal by Subject|2|||
126153275|NCT00845429|453849385|FG001|Overall Study|Withdrawal by Subject|2|||
126153276|NCT00845429|453849386|FG002|Overall Study|Withdrawal by Subject|2|||
126153277|NCT00845429|453849384|FG000|Overall Study|Serious adverse event|0|||
126153278|NCT00845429|453849385|FG001|Overall Study|Serious adverse event|0|||
126153279|NCT00845429|453849386|FG002|Overall Study|Serious adverse event|1|||
126153280|NCT03240081|453849393|FG000|Overall Study|Withdrawal by Subject|0|||
126153281|NCT03240081|453849394|FG001|Overall Study|Withdrawal by Subject|2|||
126153282|NCT03240081|453849393|FG000|Overall Study|Lost to Follow-up|0|||
126153283|NCT03240081|453849394|FG001|Overall Study|Lost to Follow-up|1|||
126153284|NCT01480180|453849395|FG000|Main Phase|Withdrawal criteria|12|||
126153285|NCT01480180|453849396|FG001|Main Phase|Withdrawal criteria|1|||
126153286|NCT01480180|453849397|FG002|Main Phase|Withdrawal criteria|0|||
126153287|NCT01480180|453849398|FG003|Main Phase|Withdrawal criteria|0|||
126153288|NCT01480180|453849399|FG004|Main Phase|Withdrawal criteria|0|||
126153289|NCT01480180|453849400|FG005|Main Phase|Withdrawal criteria|0|||
126153290|NCT01480180|453849395|FG000|Main Phase|Lack of Efficacy|1|||
126153291|NCT01480180|453849396|FG001|Main Phase|Lack of Efficacy|0|||
126153292|NCT01480180|453849397|FG002|Main Phase|Lack of Efficacy|0|||
126153293|NCT01480180|453849398|FG003|Main Phase|Lack of Efficacy|0|||
126153294|NCT01480180|453849399|FG004|Main Phase|Lack of Efficacy|0|||
126153295|NCT01480180|453849400|FG005|Main Phase|Lack of Efficacy|0|||
126153296|NCT01480180|453849395|FG000|Main Phase|Non-compliance|3|||
126153297|NCT01480180|453849396|FG001|Main Phase|Non-compliance|0|||
126153298|NCT01480180|453849397|FG002|Main Phase|Non-compliance|0|||
126153299|NCT01480180|453849398|FG003|Main Phase|Non-compliance|0|||
126153300|NCT01480180|453849399|FG004|Main Phase|Non-compliance|0|||
126153301|NCT01480180|453849400|FG005|Main Phase|Non-compliance|0|||
126153302|NCT01480180|453849395|FG000|Main Phase|Unclassified|3|||
126153303|NCT01480180|453849396|FG001|Main Phase|Unclassified|0|||
126153304|NCT01480180|453849397|FG002|Main Phase|Unclassified|0|||
126153305|NCT01480180|453849398|FG003|Main Phase|Unclassified|0|||
126153306|NCT01480180|453849399|FG004|Main Phase|Unclassified|0|||
126153307|NCT01480180|453849400|FG005|Main Phase|Unclassified|0|||
126153308|NCT01480180|453849395|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
126153309|NCT01480180|453849396|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
126153310|NCT01480180|453849397|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
126153311|NCT01480180|453849398|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
126153312|NCT01480180|453849399|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
126153313|NCT01480180|453849400|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
126153314|NCT01480180|453849395|FG000|Extension Phase, Part 1|Unclassified|0|||
126153315|NCT01480180|453849396|FG001|Extension Phase, Part 1|Unclassified|0|||
126153316|NCT01480180|453849397|FG002|Extension Phase, Part 1|Unclassified|1|||
126153317|NCT01480180|453849398|FG003|Extension Phase, Part 1|Unclassified|0|||
126153318|NCT01480180|453849399|FG004|Extension Phase, Part 1|Unclassified|0|||
126153319|NCT01480180|453849400|FG005|Extension Phase, Part 1|Unclassified|0|||
126153320|NCT01480180|453849395|FG000|Extension Phase, Part 1|Adverse Event|0|||
126153321|NCT01480180|453849396|FG001|Extension Phase, Part 1|Adverse Event|0|||
126153322|NCT01480180|453849397|FG002|Extension Phase, Part 1|Adverse Event|4|||
126153323|NCT01480180|453849398|FG003|Extension Phase, Part 1|Adverse Event|1|||
126153324|NCT01480180|453849399|FG004|Extension Phase, Part 1|Adverse Event|0|||
126153325|NCT01480180|453849400|FG005|Extension Phase, Part 1|Adverse Event|0|||
126153326|NCT01480180|453849395|FG000|Extension Phase, Part 1|Change of treatment|0|||
126153327|NCT01480180|453849396|FG001|Extension Phase, Part 1|Change of treatment|0|||
126153328|NCT01480180|453849397|FG002|Extension Phase, Part 1|Change of treatment|0|||
126153329|NCT01480180|453849398|FG003|Extension Phase, Part 1|Change of treatment|9|||
126153330|NCT01480180|453849399|FG004|Extension Phase, Part 1|Change of treatment|0|||
126153331|NCT01480180|453849400|FG005|Extension Phase, Part 1|Change of treatment|0|||
126153332|NCT01480180|453849395|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
126153333|NCT01480180|453849396|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
126153334|NCT01480180|453849397|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
126153335|NCT01480180|453849398|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
126153336|NCT01480180|453849399|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
126153337|NCT01480180|453849400|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
126153338|NCT01480180|453849395|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
126153339|NCT01480180|453849396|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
126153340|NCT01480180|453849397|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
126153341|NCT01480180|453849398|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
126153342|NCT01480180|453849399|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
126153343|NCT01480180|453849400|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
126153344|NCT01480180|453849395|FG000|Extension Phase, Part 2|Unclassified|0|||
126153345|NCT01480180|453849396|FG001|Extension Phase, Part 2|Unclassified|0|||
126153346|NCT01480180|453849397|FG002|Extension Phase, Part 2|Unclassified|3|||
126153347|NCT01480180|453849398|FG003|Extension Phase, Part 2|Unclassified|1|||
126153348|NCT01480180|453849399|FG004|Extension Phase, Part 2|Unclassified|1|||
126153349|NCT01480180|453849400|FG005|Extension Phase, Part 2|Unclassified|0|||
126153350|NCT00184054|453849402|FG000|Overall Study|Adverse Event|1|||
126153351|NCT04925570|453849403|FG000|Overall Study|Protocol Violation|24|||
126153352|NCT04925570|453849404|FG001|Overall Study|Protocol Violation|30|||
126153353|NCT04925570|453849403|FG000|Overall Study|Withdrawal by Subject|0|||
126153354|NCT04925570|453849404|FG001|Overall Study|Withdrawal by Subject|2|||
126153355|NCT00828451|453849405|FG000|Overall Study|Death|2|||
126153356|NCT00828451|453849405|FG000|Overall Study|Lack of intravenous line|7|||
126153357|NCT00828451|453849405|FG000|Overall Study|Withdrawal by Subject|1|||
126153358|NCT00828451|453849405|FG000|Overall Study|Deterioration in clinical status|1|||
126153359|NCT00519532|453849409|FG000|Overall Study|Adverse Event|11|||
126153360|NCT00519532|453849409|FG000|Overall Study|Withdrawal by Subject|5|||
126153361|NCT00519532|453849409|FG000|Overall Study|Lost to Follow-up|2|||
125971632|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
125971633|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
126153362|NCT00667277|453849410|FG000|Overall Study|Withdrawal by Subject|2|||
126153363|NCT03138564|453849413|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
126153364|NCT03138564|453849414|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
126153365|NCT03138564|453849413|FG000|Overall Study|Lost to Follow-up|16|||
126153366|NCT03138564|453849414|FG001|Overall Study|Lost to Follow-up|2|||
126153367|NCT03138564|453849413|FG000|Overall Study|Withdrawal by Subject|48|||
126153368|NCT03138564|453849414|FG001|Overall Study|Withdrawal by Subject|4|||
126153369|NCT03138564|453849413|FG000|Overall Study|No longer met eligibility criteria|2|||
126153370|NCT03138564|453849414|FG001|Overall Study|No longer met eligibility criteria|0|||
126153371|NCT03138564|453849413|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
126153372|NCT03138564|453849414|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
126153373|NCT03138564|453849413|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
126153374|NCT03138564|453849414|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
126153375|NCT03138564|453849413|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
126153376|NCT03138564|453849414|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
126153377|NCT03138564|453849413|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
126153378|NCT03138564|453849414|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
126153379|NCT00814710|453849415|FG000|Overall Study|Adverse Event|1|||
126153380|NCT00814710|453849416|FG001|Overall Study|Adverse Event|0|||
126153381|NCT00814710|453849415|FG000|Overall Study|Lost to Follow-up|7|||
126153382|NCT00814710|453849416|FG001|Overall Study|Lost to Follow-up|3|||
126153383|NCT00624338|453849424|FG000|Overall Study|Adverse Event|14|||
126153384|NCT00624338|453849425|FG001|Overall Study|Adverse Event|14|||
126153385|NCT00624338|453849426|FG002|Overall Study|Adverse Event|18|||
126153386|NCT00624338|453849424|FG000|Overall Study|Lost to Follow-up|1|||
126153387|NCT00624338|453849425|FG001|Overall Study|Lost to Follow-up|0|||
126153388|NCT00624338|453849426|FG002|Overall Study|Lost to Follow-up|0|||
126153389|NCT00624338|453849424|FG000|Overall Study|Lack of Efficacy|11|||
126153390|NCT00624338|453849425|FG001|Overall Study|Lack of Efficacy|3|||
126153391|NCT00624338|453849426|FG002|Overall Study|Lack of Efficacy|14|||
126153392|NCT00624338|453849424|FG000|Overall Study|Protocol Violation|3|||
126153393|NCT00624338|453849425|FG001|Overall Study|Protocol Violation|3|||
126153394|NCT00624338|453849426|FG002|Overall Study|Protocol Violation|2|||
126153395|NCT00624338|453849424|FG000|Overall Study|Death|0|||
126153396|NCT00624338|453849425|FG001|Overall Study|Death|2|||
126153397|NCT00624338|453849426|FG002|Overall Study|Death|0|||
126153398|NCT00624338|453849424|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
126153399|NCT00624338|453849425|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
126153400|NCT00624338|453849426|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
126153401|NCT00624338|453849424|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
126153402|NCT00624338|453849425|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
126153403|NCT00624338|453849426|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
126153404|NCT00624338|453849424|FG000|Overall Study|Other|15|||
126153405|NCT00624338|453849425|FG001|Overall Study|Other|5|||
126153406|NCT00624338|453849426|FG002|Overall Study|Other|9|||
126153407|NCT00624338|453849424|FG000|Overall Study|Randomized but not treated|2|||
126153408|NCT00624338|453849425|FG001|Overall Study|Randomized but not treated|1|||
126153409|NCT00624338|453849426|FG002|Overall Study|Randomized but not treated|3|||
126153410|NCT01548638|453849427|FG000|Overall Study|Protocol Violation|3|||
126153411|NCT01548638|453849427|FG000|Overall Study|Withdrawal by Subject|1|||
126153412|NCT05593432|453849428|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
126153413|NCT05593432|453849429|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
126153414|NCT05593432|453849430|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
126153415|NCT05593432|453849431|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
126153416|NCT05593432|453849428|FG000|16-Week OLE Period|Lack of Efficacy|0|||
126153417|NCT05593432|453849429|FG001|16-Week OLE Period|Lack of Efficacy|0|||
126153418|NCT05593432|453849430|FG002|16-Week OLE Period|Lack of Efficacy|0|||
126153419|NCT05593432|453849431|FG003|16-Week OLE Period|Lack of Efficacy|1|||
126153420|NCT05593432|453849428|FG000|16-Week OLE Period|Lost to Follow-up|0|||
126153421|NCT05593432|453849429|FG001|16-Week OLE Period|Lost to Follow-up|0|||
126153422|NCT05593432|453849430|FG002|16-Week OLE Period|Lost to Follow-up|1|||
126153423|NCT05593432|453849431|FG003|16-Week OLE Period|Lost to Follow-up|2|||
126153424|NCT05593432|453849428|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
126153425|NCT05593432|453849429|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
126153426|NCT05593432|453849430|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
126153427|NCT05593432|453849431|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
126153428|NCT02609399|453849438|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
126153429|NCT02609399|453849439|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
126153430|NCT02609399|453849438|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
126153431|NCT02609399|453849439|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
126153432|NCT02609399|453849438|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
126153433|NCT02609399|453849439|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
126153434|NCT04800315|453849440|FG000|Randomization|Did not receive study treatment|1|||
126153435|NCT04800315|453849441|FG001|Randomization|Did not receive study treatment|0|||
126153436|NCT04800315|453849442|FG002|Randomization|Did not receive study treatment|0|||
126153437|NCT04800315|453849443|FG003|Randomization|Did not receive study treatment|0|||
126153438|NCT04800315|453849440|FG000|Treatment Period|Adverse Event|4|||
126153439|NCT04800315|453849441|FG001|Treatment Period|Adverse Event|2|||
126153440|NCT04800315|453849442|FG002|Treatment Period|Adverse Event|1|||
126153441|NCT04800315|453849443|FG003|Treatment Period|Adverse Event|2|||
126153442|NCT04800315|453849440|FG000|Treatment Period|Lack of Efficacy|1|||
126153443|NCT04800315|453849441|FG001|Treatment Period|Lack of Efficacy|0|||
126153444|NCT04800315|453849442|FG002|Treatment Period|Lack of Efficacy|0|||
126153445|NCT04800315|453849443|FG003|Treatment Period|Lack of Efficacy|3|||
126153446|NCT04800315|453849440|FG000|Treatment Period|Lost to Follow-up|0|||
126153447|NCT04800315|453849441|FG001|Treatment Period|Lost to Follow-up|1|||
126153448|NCT04800315|453849442|FG002|Treatment Period|Lost to Follow-up|2|||
126153449|NCT04800315|453849443|FG003|Treatment Period|Lost to Follow-up|2|||
126153450|NCT04800315|453849440|FG000|Treatment Period|Withdrawal by participant|0|||
126153451|NCT04800315|453849441|FG001|Treatment Period|Withdrawal by participant|0|||
126153452|NCT04800315|453849442|FG002|Treatment Period|Withdrawal by participant|0|||
126153453|NCT04800315|453849443|FG003|Treatment Period|Withdrawal by participant|4|||
126153454|NCT04800315|453849440|FG000|Treatment Period|Other Reasons|0|||
126153455|NCT04800315|453849441|FG001|Treatment Period|Other Reasons|2|||
126153456|NCT04800315|453849442|FG002|Treatment Period|Other Reasons|0|||
126153457|NCT04800315|453849443|FG003|Treatment Period|Other Reasons|1|||
126153458|NCT00753922|453849444|FG000|Overall Study|Lost to Follow-up|155|||
126153459|NCT00753922|453849445|FG001|Overall Study|Lost to Follow-up|24|||
126153460|NCT00753922|453849446|FG002|Overall Study|Lost to Follow-up|28|||
126153461|NCT00753922|453849447|FG003|Overall Study|Lost to Follow-up|5|||
126153462|NCT00753922|453849444|FG000|Overall Study|Withdrawal by Subject|9|||
126153463|NCT00753922|453849445|FG001|Overall Study|Withdrawal by Subject|11|||
126153464|NCT00753922|453849446|FG002|Overall Study|Withdrawal by Subject|4|||
126153465|NCT00753922|453849447|FG003|Overall Study|Withdrawal by Subject|2|||
126153466|NCT00753922|453849444|FG000|Overall Study|Patient Non-compliance|55|||
126153467|NCT00753922|453849445|FG001|Overall Study|Patient Non-compliance|22|||
126153468|NCT00753922|453849446|FG002|Overall Study|Patient Non-compliance|14|||
126153469|NCT00753922|453849447|FG003|Overall Study|Patient Non-compliance|11|||
126153470|NCT00753922|453849444|FG000|Overall Study|Patients Not Completing Visit|11|||
126153471|NCT00753922|453849445|FG001|Overall Study|Patients Not Completing Visit|0|||
126153472|NCT00753922|453849446|FG002|Overall Study|Patients Not Completing Visit|1|||
126153473|NCT00753922|453849447|FG003|Overall Study|Patients Not Completing Visit|0|||
126153474|NCT00753922|453849444|FG000|Overall Study|Death|2|||
126153475|NCT00753922|453849445|FG001|Overall Study|Death|23|||
126153476|NCT00753922|453849446|FG002|Overall Study|Death|2|||
126153477|NCT00753922|453849447|FG003|Overall Study|Death|1|||
126153478|NCT00753922|453849444|FG000|Overall Study|Discontinuation Due to Explantation|14|||
126153479|NCT00753922|453849445|FG001|Overall Study|Discontinuation Due to Explantation|14|||
126153480|NCT00753922|453849446|FG002|Overall Study|Discontinuation Due to Explantation|14|||
126153481|NCT00753922|453849447|FG003|Overall Study|Discontinuation Due to Explantation|4|||
126153482|NCT00840463|453849454|FG000|Overall Study|Adverse Event|1|||
126153483|NCT00840463|453849455|FG001|Overall Study|Adverse Event|0|||
126153484|NCT02515669|453849459|FG000|228 Week Open-Label Phase|Other|0|||
126153485|NCT02515669|453849460|FG001|228 Week Open-Label Phase|Other|0|||
126153486|NCT02515669|453849461|FG002|228 Week Open-Label Phase|Other|1|||
126153487|NCT02515669|453849462|FG003|228 Week Open-Label Phase|Other|4|||
126153488|NCT02515669|453849459|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
126153489|NCT02515669|453849460|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
126153490|NCT02515669|453849461|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
126153491|NCT02515669|453849462|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
126153492|NCT02515669|453849459|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
126153493|NCT02515669|453849460|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
126153494|NCT02515669|453849461|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
126153495|NCT02515669|453849462|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
126153496|NCT02515669|453849459|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
126153497|NCT02515669|453849460|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
126153498|NCT02515669|453849461|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
126153499|NCT02515669|453849462|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
126153500|NCT02515669|453849459|FG000|228 Week Open-Label Phase|Missing|0|||
126153501|NCT02515669|453849460|FG001|228 Week Open-Label Phase|Missing|2|||
126153502|NCT02515669|453849461|FG002|228 Week Open-Label Phase|Missing|2|||
125971634|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
125971635|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
126153503|NCT02515669|453849462|FG003|228 Week Open-Label Phase|Missing|2|||
126153504|NCT01739595|453849463|FG000|Overall Study|Adverse Event|3|||
126153505|NCT01739595|453849464|FG001|Overall Study|Adverse Event|0|||
126153506|NCT01739595|453849465|FG002|Overall Study|Adverse Event|0|||
126153507|NCT01739595|453849463|FG000|Overall Study|Lost to Follow-up|2|||
126153508|NCT01739595|453849464|FG001|Overall Study|Lost to Follow-up|0|||
126153509|NCT01739595|453849465|FG002|Overall Study|Lost to Follow-up|0|||
126153510|NCT01739595|453849463|FG000|Overall Study|Withdrawal by Subject|2|||
126153511|NCT01739595|453849464|FG001|Overall Study|Withdrawal by Subject|1|||
126153512|NCT01739595|453849465|FG002|Overall Study|Withdrawal by Subject|2|||
126153513|NCT01739595|453849463|FG000|Overall Study|Eligibility issue|3|||
126153514|NCT01739595|453849464|FG001|Overall Study|Eligibility issue|0|||
126153515|NCT01739595|453849465|FG002|Overall Study|Eligibility issue|0|||
126153516|NCT01739595|453849463|FG000|Overall Study|Protocol Violation|1|||
126153517|NCT01739595|453849464|FG001|Overall Study|Protocol Violation|0|||
126153518|NCT01739595|453849465|FG002|Overall Study|Protocol Violation|0|||
126153519|NCT01739595|453849463|FG000|Overall Study|Lab assessment|1|||
126153520|NCT01739595|453849464|FG001|Overall Study|Lab assessment|0|||
126153521|NCT01739595|453849465|FG002|Overall Study|Lab assessment|0|||
126153522|NCT01739595|453849463|FG000|Overall Study|Drug discrepancy|1|||
126153523|NCT01739595|453849464|FG001|Overall Study|Drug discrepancy|0|||
126153524|NCT01739595|453849465|FG002|Overall Study|Drug discrepancy|0|||
126153525|NCT01676116|453849469|FG000|Overall Study|Withdrawal criteria|2|||
126153526|NCT01676116|453849470|FG001|Overall Study|Withdrawal criteria|14|||
126153527|NCT01676116|453849469|FG000|Overall Study|Adverse Event|1|||
126153528|NCT01676116|453849470|FG001|Overall Study|Adverse Event|2|||
126153529|NCT01676116|453849469|FG000|Overall Study|Unclassified|4|||
126153530|NCT01676116|453849470|FG001|Overall Study|Unclassified|10|||
126153531|NCT01676116|453849469|FG000|Overall Study|Protocol Violation|9|||
126153532|NCT01676116|453849470|FG001|Overall Study|Protocol Violation|3|||
126153533|NCT00778999|453849473|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
126153534|NCT00778999|453849474|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
126153535|NCT00778999|453849473|FG000|Overall Study|Did not receive recFSH|14|||
126153536|NCT00778999|453849474|FG001|Overall Study|Did not receive recFSH|20|||
126153537|NCT02032524|453849475|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
126153538|NCT02032524|453849476|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
126153539|NCT02032524|453849477|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
126153540|NCT02032524|453849478|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
126153541|NCT02032524|453849479|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
126153542|NCT02032524|453849480|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
126153543|NCT02032524|453849475|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
126153544|NCT02032524|453849476|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
126153545|NCT02032524|453849477|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
126153546|NCT02032524|453849478|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
126153547|NCT02032524|453849479|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
126153548|NCT02032524|453849480|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
126153549|NCT02032524|453849475|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
126153550|NCT02032524|453849476|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
126153551|NCT02032524|453849477|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
126153552|NCT02032524|453849478|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
126153553|NCT02032524|453849479|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
126153554|NCT02032524|453849480|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
126153555|NCT02032524|453849475|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
126153556|NCT02032524|453849476|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
126153557|NCT02032524|453849477|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
126153558|NCT02032524|453849478|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
126153559|NCT02032524|453849479|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
126153560|NCT02032524|453849480|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
126153561|NCT02032524|453849475|FG000|Period 2: LTS13769 Study|Other|0|||
126153562|NCT02032524|453849476|FG001|Period 2: LTS13769 Study|Other|0|||
126153563|NCT02032524|453849477|FG002|Period 2: LTS13769 Study|Other|0|||
126153564|NCT02032524|453849478|FG003|Period 2: LTS13769 Study|Other|0|||
126153565|NCT02032524|453849479|FG004|Period 2: LTS13769 Study|Other|0|||
126153566|NCT02032524|453849480|FG005|Period 2: LTS13769 Study|Other|1|||
126153567|NCT02082184|453851281|FG000|Overall Study|Adverse Event|1|||
126153568|NCT02082184|453851282|FG001|Overall Study|Adverse Event|0|||
126153569|NCT02082184|453851281|FG000|Overall Study|Medical diagnosis|1|||
126153570|NCT02082184|453851282|FG001|Overall Study|Medical diagnosis|2|||
126153571|NCT02082184|453851281|FG000|Overall Study|Device associated symptoms|5|||
126153572|NCT02082184|453851282|FG001|Overall Study|Device associated symptoms|0|||
126153573|NCT02082184|453851281|FG000|Overall Study|Withdrawal by Subject|3|||
126153574|NCT02082184|453851282|FG001|Overall Study|Withdrawal by Subject|2|||
126153575|NCT02082184|453851281|FG000|Overall Study|Protocol Violation|0|||
126153576|NCT02082184|453851282|FG001|Overall Study|Protocol Violation|6|||
126153577|NCT02082184|453851281|FG000|Overall Study|Lost to Follow-up|0|||
126153578|NCT02082184|453851282|FG001|Overall Study|Lost to Follow-up|2|||
126153579|NCT02082184|453851281|FG000|Overall Study|Subject non-compliance|0|||
126153580|NCT02082184|453851282|FG001|Overall Study|Subject non-compliance|1|||
126153581|NCT01362322|453851289|FG000|Overall Study|Withdrawal by Subject|3|||
126153582|NCT01362322|453851290|FG001|Overall Study|Withdrawal by Subject|1|||
126153583|NCT01362322|453851289|FG000|Overall Study|Lost to Follow-up|2|||
126153584|NCT01362322|453851290|FG001|Overall Study|Lost to Follow-up|6|||
126153585|NCT02413398|453851293|FG000|Overall Study|Lost to Follow-up|2|||
126153586|NCT02413398|453851294|FG001|Overall Study|Lost to Follow-up|4|||
126153587|NCT02413398|453851293|FG000|Overall Study|Withdrawal by Subject|1|||
126153588|NCT02413398|453851294|FG001|Overall Study|Withdrawal by Subject|1|||
126153589|NCT02413398|453851293|FG000|Overall Study|Other Eligibility criteria|1|||
126153590|NCT02413398|453851294|FG001|Overall Study|Other Eligibility criteria|2|||
126153591|NCT02874794|453851297|FG000|Overall Study|Physician Decision|3|||
126153592|NCT02874794|453851298|FG001|Overall Study|Physician Decision|2|||
126153593|NCT02874794|453851297|FG000|Overall Study|Withdrawal by Subject|2|||
126153594|NCT02874794|453851298|FG001|Overall Study|Withdrawal by Subject|8|||
126153595|NCT02874794|453851297|FG000|Overall Study|Death|2|||
126153596|NCT02874794|453851298|FG001|Overall Study|Death|1|||
126153597|NCT00537940|453851299|FG000|Overall Study|Adverse Event|20|||
126153598|NCT00537940|453851300|FG001|Overall Study|Adverse Event|19|||
126153599|NCT00537940|453851299|FG000|Overall Study|Lack of Efficacy|8|||
126153600|NCT00537940|453851300|FG001|Overall Study|Lack of Efficacy|16|||
126153601|NCT00537940|453851299|FG000|Overall Study|Lost to Follow-up|23|||
126153602|NCT00537940|453851300|FG001|Overall Study|Lost to Follow-up|29|||
126153603|NCT00537940|453851299|FG000|Overall Study|Withdrawal by Subject|113|||
126153604|NCT00537940|453851300|FG001|Overall Study|Withdrawal by Subject|95|||
126153605|NCT00537940|453851299|FG000|Overall Study|Protocol Violation|6|||
126153606|NCT00537940|453851300|FG001|Overall Study|Protocol Violation|4|||
126153607|NCT00537940|453851299|FG000|Overall Study|Pregnancy|1|||
126153608|NCT00537940|453851300|FG001|Overall Study|Pregnancy|1|||
126153609|NCT00537940|453851299|FG000|Overall Study|Study terminated by sponsor|2|||
126153610|NCT00537940|453851300|FG001|Overall Study|Study terminated by sponsor|3|||
126153611|NCT00537940|453851299|FG000|Overall Study|Other|10|||
126153612|NCT00537940|453851300|FG001|Overall Study|Other|12|||
126153613|NCT00634543|453851303|FG000|Overall Study|Other|1|||
126153614|NCT00634543|453851304|FG001|Overall Study|Other|2|||
126153615|NCT00634543|453851303|FG000|Overall Study|Protocol Violation|3|||
126153616|NCT00634543|453851304|FG001|Overall Study|Protocol Violation|3|||
126153617|NCT00634543|453851303|FG000|Overall Study|Adverse Event|11|||
126153618|NCT00634543|453851304|FG001|Overall Study|Adverse Event|11|||
126153619|NCT00634543|453851303|FG000|Overall Study|Withdrawal by Subject|4|||
126153620|NCT00634543|453851304|FG001|Overall Study|Withdrawal by Subject|4|||
126153621|NCT00634543|453851303|FG000|Overall Study|Lost to Follow-up|0|||
126153622|NCT00634543|453851304|FG001|Overall Study|Lost to Follow-up|1|||
126153623|NCT02465034|453851305|FG000|Overall Study|Withdrawal by Subject|1|||
126153624|NCT02465034|453851306|FG001|Overall Study|Withdrawal by Subject|1|||
126153625|NCT02465034|453851305|FG000|Overall Study|Screen fail|2|||
126153626|NCT02465034|453851306|FG001|Overall Study|Screen fail|0|||
126153627|NCT02465034|453851305|FG000|Overall Study|Could not be scheduled for study visit|0|||
126153628|NCT02465034|453851306|FG001|Overall Study|Could not be scheduled for study visit|5|||
126153629|NCT02397655|453851312|FG000|Overall Study|data not completed|1301|||
126153630|NCT01736683|453851313|FG000|Overall Study|Disease Relapse|0|||
126153631|NCT01736683|453851314|FG001|Overall Study|Disease Relapse|0|||
126153632|NCT01736683|453851315|FG002|Overall Study|Disease Relapse|2|||
126153633|NCT01736683|453851316|FG003|Overall Study|Disease Relapse|1|||
126153634|NCT01736683|453851317|FG004|Overall Study|Disease Relapse|0|||
126153635|NCT01736683|453851313|FG000|Overall Study|Adverse Event|0|||
126153636|NCT01736683|453851314|FG001|Overall Study|Adverse Event|2|||
126153637|NCT01736683|453851315|FG002|Overall Study|Adverse Event|2|||
126153638|NCT01736683|453851316|FG003|Overall Study|Adverse Event|3|||
126153639|NCT01736683|453851317|FG004|Overall Study|Adverse Event|2|||
126153640|NCT01736683|453851313|FG000|Overall Study|Withdrawal by Subject|0|||
126153641|NCT01736683|453851314|FG001|Overall Study|Withdrawal by Subject|0|||
126153642|NCT01736683|453851315|FG002|Overall Study|Withdrawal by Subject|3|||
126153643|NCT01736683|453851316|FG003|Overall Study|Withdrawal by Subject|1|||
126153644|NCT01736683|453851317|FG004|Overall Study|Withdrawal by Subject|1|||
126153645|NCT01736683|453851313|FG000|Overall Study|Lack of Therapeutic Effect|7|||
126153646|NCT01736683|453851314|FG001|Overall Study|Lack of Therapeutic Effect|4|||
126153647|NCT01736683|453851315|FG002|Overall Study|Lack of Therapeutic Effect|13|||
126153648|NCT01736683|453851316|FG003|Overall Study|Lack of Therapeutic Effect|20|||
126153649|NCT01736683|453851317|FG004|Overall Study|Lack of Therapeutic Effect|1|||
126153650|NCT01736683|453851313|FG000|Overall Study|Progressive Disease|0|||
126153651|NCT01736683|453851314|FG001|Overall Study|Progressive Disease|0|||
126153652|NCT01736683|453851315|FG002|Overall Study|Progressive Disease|0|||
126153653|NCT01736683|453851316|FG003|Overall Study|Progressive Disease|1|||
126153654|NCT01736683|453851317|FG004|Overall Study|Progressive Disease|0|||
126153655|NCT01736683|453851313|FG000|Overall Study|Other|0|||
126153656|NCT01736683|453851314|FG001|Overall Study|Other|0|||
126153657|NCT01736683|453851315|FG002|Overall Study|Other|1|||
126153658|NCT01736683|453851316|FG003|Overall Study|Other|9|||
126153659|NCT01736683|453851317|FG004|Overall Study|Other|1|||
126153660|NCT00947154|453851321|FG000|Overall Study|Lost to Follow-up|1|||
125971636|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
126153661|NCT01588197|453851324|FG000|Overall Study|Lack of Efficacy|0|||
126153662|NCT01588197|453851325|FG001|Overall Study|Lack of Efficacy|1|||
126153663|NCT01588197|453851324|FG000|Overall Study|No MRI|1|||
126153664|NCT01588197|453851325|FG001|Overall Study|No MRI|0|||
126153665|NCT01844076|453851328|FG000|Overall Study|Adverse Event|1|||
126153666|NCT01844076|453851329|FG001|Overall Study|Adverse Event|0|||
125971637|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
126153667|NCT01844076|453851330|FG002|Overall Study|Adverse Event|0|||
126153668|NCT01844076|453851331|FG003|Overall Study|Adverse Event|0|||
126153669|NCT01844076|453851328|FG000|Overall Study|Withdrawal by Subject|1|||
126153670|NCT01844076|453851329|FG001|Overall Study|Withdrawal by Subject|0|||
126153671|NCT01844076|453851330|FG002|Overall Study|Withdrawal by Subject|0|||
126153672|NCT01844076|453851331|FG003|Overall Study|Withdrawal by Subject|0|||
126153673|NCT00440401|453851340|FG000|Overall Study|Adverse Event|2|||
126153674|NCT00440401|453851341|FG001|Overall Study|Adverse Event|1|||
126153675|NCT00440401|453851340|FG000|Overall Study|Other|2|||
126153676|NCT00440401|453851341|FG001|Overall Study|Other|5|||
126153677|NCT02286960|453851342|FG000|Overall Study|Lost to Follow-up|3|||
126153678|NCT02286960|453851343|FG001|Overall Study|Lost to Follow-up|3|||
126153679|NCT01937312|453851344|FG000|Overall Study|Adverse Event|10|||
126153680|NCT01937312|453851345|FG001|Overall Study|Adverse Event|1|||
126153681|NCT01937312|453851344|FG000|Overall Study|Lack of Efficacy|0|||
126153682|NCT01937312|453851345|FG001|Overall Study|Lack of Efficacy|1|||
126153683|NCT01937312|453851344|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
126153684|NCT01937312|453851345|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
126153685|NCT00474253|453851346|FG000|Overall Study|Withdrew consent|2|||
126153686|NCT00474253|453851347|FG001|Overall Study|Withdrew consent|0|||
126153687|NCT00474253|453851346|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
126153688|NCT00474253|453851347|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
126153689|NCT00474253|453851346|FG000|Overall Study|Lost to Follow-up|1|||
126153690|NCT00474253|453851347|FG001|Overall Study|Lost to Follow-up|0|||
126153691|NCT00474253|453851346|FG000|Overall Study|Discharged prior to study completion|0|||
126153692|NCT00474253|453851347|FG001|Overall Study|Discharged prior to study completion|1|||
126153693|NCT00593112|453851355|FG000|Overall Study|Scan Anxiety|3|||
126153694|NCT00593112|453851356|FG001|Overall Study|Scan Anxiety|0|||
126153695|NCT00593112|453851355|FG000|Overall Study|Abnormal Scan|1|||
126153696|NCT00593112|453851356|FG001|Overall Study|Abnormal Scan|0|||
126153697|NCT00593112|453851355|FG000|Overall Study|Unreadable Scan|1|||
126153698|NCT00593112|453851356|FG001|Overall Study|Unreadable Scan|0|||
126153699|NCT00593112|453851355|FG000|Overall Study|Withdrawal by Subject|5|||
126153700|NCT00593112|453851356|FG001|Overall Study|Withdrawal by Subject|0|||
126153701|NCT00482001|453851357|FG000|Overall Study|Protocol Violation|1|||
126153702|NCT00482001|453851358|FG001|Overall Study|Protocol Violation|1|||
126153703|NCT00258154|453851359|FG000|Overall Study|Adverse Event|1|||
126153704|NCT00258154|453851360|FG001|Overall Study|Adverse Event|0|||
126153705|NCT00258154|453851359|FG000|Overall Study|Lost to Follow-up|0|||
126153706|NCT00258154|453851360|FG001|Overall Study|Lost to Follow-up|1|||
126153707|NCT00258154|453851359|FG000|Overall Study|Protocol Violation|2|||
126153708|NCT00258154|453851360|FG001|Overall Study|Protocol Violation|1|||
126153709|NCT00258154|453851359|FG000|Overall Study|Withdrawal by Subject|3|||
126153710|NCT00258154|453851360|FG001|Overall Study|Withdrawal by Subject|4|||
126153711|NCT00258154|453851359|FG000|Overall Study|Patient Moved|3|||
126153712|NCT00258154|453851360|FG001|Overall Study|Patient Moved|1|||
126153713|NCT00847613|453851365|FG000|Overall Study|Ongoing at cut-off date|250|||
126153714|NCT00847613|453851366|FG001|Overall Study|Ongoing at cut-off date|265|||
126153715|NCT00847613|453851367|FG002|Overall Study|Ongoing at cut-off date|64|||
126153716|NCT00847613|453851368|FG003|Overall Study|Ongoing at cut-off date|64|||
126153717|NCT00847613|453851365|FG000|Overall Study|Death|1|||
126153718|NCT00847613|453851366|FG001|Overall Study|Death|1|||
126153719|NCT00847613|453851367|FG002|Overall Study|Death|0|||
126153720|NCT00847613|453851368|FG003|Overall Study|Death|0|||
126153721|NCT00847613|453851365|FG000|Overall Study|Adverse Event|36|||
126153722|NCT00847613|453851366|FG001|Overall Study|Adverse Event|26|||
126153723|NCT00847613|453851367|FG002|Overall Study|Adverse Event|5|||
126153724|NCT00847613|453851368|FG003|Overall Study|Adverse Event|6|||
126153725|NCT00847613|453851365|FG000|Overall Study|Lack of Efficacy|7|||
126153726|NCT00847613|453851366|FG001|Overall Study|Lack of Efficacy|3|||
126153727|NCT00847613|453851367|FG002|Overall Study|Lack of Efficacy|3|||
126153728|NCT00847613|453851368|FG003|Overall Study|Lack of Efficacy|1|||
126153729|NCT00847613|453851365|FG000|Overall Study|Study terminated by Sponsor|1|||
126153730|NCT00847613|453851366|FG001|Overall Study|Study terminated by Sponsor|0|||
126153731|NCT00847613|453851367|FG002|Overall Study|Study terminated by Sponsor|2|||
126153732|NCT00847613|453851368|FG003|Overall Study|Study terminated by Sponsor|1|||
126153733|NCT00847613|453851365|FG000|Overall Study|Lost to Follow-up|5|||
126153734|NCT00847613|453851366|FG001|Overall Study|Lost to Follow-up|0|||
126153735|NCT00847613|453851367|FG002|Overall Study|Lost to Follow-up|0|||
126153736|NCT00847613|453851368|FG003|Overall Study|Lost to Follow-up|3|||
126153737|NCT00847613|453851365|FG000|Overall Study|Protocol Violation|6|||
126153738|NCT00847613|453851366|FG001|Overall Study|Protocol Violation|6|||
126153739|NCT00847613|453851367|FG002|Overall Study|Protocol Violation|3|||
126153740|NCT00847613|453851368|FG003|Overall Study|Protocol Violation|1|||
126153741|NCT00847613|453851365|FG000|Overall Study|Pregnancy|1|||
126153742|NCT00847613|453851366|FG001|Overall Study|Pregnancy|1|||
126153743|NCT00847613|453851367|FG002|Overall Study|Pregnancy|0|||
126153744|NCT00847613|453851368|FG003|Overall Study|Pregnancy|0|||
125971638|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
126153745|NCT00847613|453851365|FG000|Overall Study|Site closure|1|||
126153746|NCT00847613|453851366|FG001|Overall Study|Site closure|0|||
126153747|NCT00847613|453851367|FG002|Overall Study|Site closure|0|||
126153748|NCT00847613|453851368|FG003|Overall Study|Site closure|1|||
126153749|NCT00847613|453851365|FG000|Overall Study|Withdrawal by Subject|8|||
126153750|NCT00847613|453851366|FG001|Overall Study|Withdrawal by Subject|11|||
126153751|NCT00847613|453851367|FG002|Overall Study|Withdrawal by Subject|2|||
126153752|NCT00847613|453851368|FG003|Overall Study|Withdrawal by Subject|2|||
126153753|NCT00847613|453851365|FG000|Overall Study|Participant moved|4|||
126153754|NCT00847613|453851366|FG001|Overall Study|Participant moved|1|||
126153755|NCT00847613|453851367|FG002|Overall Study|Participant moved|0|||
126153756|NCT00847613|453851368|FG003|Overall Study|Participant moved|0|||
126153757|NCT00847613|453851365|FG000|Overall Study|Sponsor request|0|||
126153758|NCT00847613|453851366|FG001|Overall Study|Sponsor request|1|||
126153759|NCT00847613|453851367|FG002|Overall Study|Sponsor request|0|||
126153760|NCT00847613|453851368|FG003|Overall Study|Sponsor request|0|||
126153761|NCT00847613|453851365|FG000|Overall Study|Randomized, but not treated|0|||
126153762|NCT00847613|453851366|FG001|Overall Study|Randomized, but not treated|3|||
126153763|NCT00847613|453851367|FG002|Overall Study|Randomized, but not treated|0|||
126153764|NCT00847613|453851368|FG003|Overall Study|Randomized, but not treated|0|||
126153765|NCT00847613|453851365|FG000|Overall Study|Other|1|||
126153766|NCT00847613|453851366|FG001|Overall Study|Other|1|||
126153767|NCT00847613|453851367|FG002|Overall Study|Other|2|||
126153768|NCT00847613|453851368|FG003|Overall Study|Other|0|||
126153769|NCT00754390|453851369|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
126153770|NCT00754390|453851369|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
126153771|NCT00754390|453851369|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
126153772|NCT00754390|453851369|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
126153773|NCT01009294|453851370|FG000|Overall Study|Study discontinued by Sponsor|6|||
126153774|NCT01856673|453851371|FG000|Overall Study|Withdrawal by Subject|44|||
126153775|NCT01856673|453851372|FG001|Overall Study|Withdrawal by Subject|50|||
126153776|NCT01856673|453851373|FG002|Overall Study|Withdrawal by Subject|33|||
126153777|NCT01856673|453851371|FG000|Overall Study|Lost to Follow-up|31|||
126153778|NCT01856673|453851372|FG001|Overall Study|Lost to Follow-up|34|||
126153779|NCT01856673|453851373|FG002|Overall Study|Lost to Follow-up|0|||
126153780|NCT01856673|453851371|FG000|Overall Study|Unknown reasons|9|||
126153781|NCT01856673|453851372|FG001|Overall Study|Unknown reasons|0|||
126153782|NCT01856673|453851373|FG002|Overall Study|Unknown reasons|0|||
126153783|NCT01856673|453851371|FG000|Overall Study|Psychologist decision|1|||
126153784|NCT01856673|453851372|FG001|Overall Study|Psychologist decision|0|||
126153785|NCT01856673|453851373|FG002|Overall Study|Psychologist decision|0|||
126153786|NCT01856673|453851371|FG000|Overall Study|Paperwork errors|8|||
126153787|NCT01856673|453851372|FG001|Overall Study|Paperwork errors|0|||
126153788|NCT01856673|453851373|FG002|Overall Study|Paperwork errors|0|||
126153789|NCT01856673|453851371|FG000|Overall Study|Death|1|||
126153790|NCT01856673|453851372|FG001|Overall Study|Death|1|||
126153791|NCT01856673|453851373|FG002|Overall Study|Death|0|||
126153792|NCT01856673|453851371|FG000|Overall Study|Protocol Violation|1|||
126153793|NCT01856673|453851372|FG001|Overall Study|Protocol Violation|0|||
126153794|NCT01856673|453851373|FG002|Overall Study|Protocol Violation|1|||
126153795|NCT04332419|453851374|FG000|Overall Study|Withdrawal by Subject|1|||
126153796|NCT02436239|453851375|FG000|Open-Lable Treatment Period|Adverse Event|12|||
126153797|NCT02436239|453851376|FG001|Open-Lable Treatment Period|Adverse Event|3|||
126153798|NCT02436239|453851377|FG002|Open-Lable Treatment Period|Adverse Event|4|||
126153799|NCT02436239|453851378|FG003|Open-Lable Treatment Period|Adverse Event|2|||
126153800|NCT02436239|453851375|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
126153801|NCT02436239|453851376|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
126153802|NCT02436239|453851377|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
126153803|NCT02436239|453851378|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
126153804|NCT02436239|453851375|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
126153805|NCT02436239|453851376|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
126153806|NCT02436239|453851377|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
126153807|NCT02436239|453851378|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
126153808|NCT02436239|453851375|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
126153809|NCT02436239|453851376|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
126153810|NCT02436239|453851377|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
126153811|NCT02436239|453851378|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
126153812|NCT02436239|453851375|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
126153813|NCT02436239|453851376|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
126153814|NCT02436239|453851377|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
126153815|NCT02436239|453851378|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
126153816|NCT02436239|453851375|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
126153817|NCT02436239|453851376|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
126153818|NCT02436239|453851377|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
126153819|NCT02436239|453851378|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
126153820|NCT02436239|453851375|FG000|Open-Lable Treatment Period|Other Reason|1|||
126153821|NCT02436239|453851376|FG001|Open-Lable Treatment Period|Other Reason|1|||
126153822|NCT02436239|453851377|FG002|Open-Lable Treatment Period|Other Reason|0|||
126153823|NCT02436239|453851378|FG003|Open-Lable Treatment Period|Other Reason|0|||
126153824|NCT02436239|453851375|FG000|Down-Taper Period|Withdrawal by Subject|4|||
126153825|NCT02436239|453851376|FG001|Down-Taper Period|Withdrawal by Subject|4|||
126153826|NCT02436239|453851377|FG002|Down-Taper Period|Withdrawal by Subject|1|||
126153827|NCT02436239|453851378|FG003|Down-Taper Period|Withdrawal by Subject|2|||
126153828|NCT00658333|453851379|FG000|Overall Study|Adverse Event|2|||
126153829|NCT00658333|453851380|FG001|Overall Study|Adverse Event|1|||
126153830|NCT03443024|453851385|FG000|Overall Study|Adverse Event|2|||
126153831|NCT03443024|453851386|FG001|Overall Study|Adverse Event|4|||
126153832|NCT03443024|453851387|FG002|Overall Study|Adverse Event|3|||
126153833|NCT03443024|453851388|FG003|Overall Study|Adverse Event|1|||
126153834|NCT03443024|453851385|FG000|Overall Study|Lost to Follow-up|9|||
126153835|NCT03443024|453851386|FG001|Overall Study|Lost to Follow-up|9|||
126153836|NCT03443024|453851387|FG002|Overall Study|Lost to Follow-up|7|||
126153837|NCT03443024|453851388|FG003|Overall Study|Lost to Follow-up|5|||
126153838|NCT03443024|453851385|FG000|Overall Study|Withdrawal by Subject|8|||
126153839|NCT03443024|453851386|FG001|Overall Study|Withdrawal by Subject|15|||
126153840|NCT03443024|453851387|FG002|Overall Study|Withdrawal by Subject|9|||
126153841|NCT03443024|453851388|FG003|Overall Study|Withdrawal by Subject|23|||
126153842|NCT03443024|453851385|FG000|Overall Study|Physician Decision|1|||
126153843|NCT03443024|453851386|FG001|Overall Study|Physician Decision|2|||
126153844|NCT03443024|453851387|FG002|Overall Study|Physician Decision|0|||
126153845|NCT03443024|453851388|FG003|Overall Study|Physician Decision|1|||
126153846|NCT03443024|453851385|FG000|Overall Study|Sponsor Decision|1|||
126153847|NCT03443024|453851386|FG001|Overall Study|Sponsor Decision|1|||
126153848|NCT03443024|453851387|FG002|Overall Study|Sponsor Decision|0|||
126153849|NCT03443024|453851388|FG003|Overall Study|Sponsor Decision|0|||
126153850|NCT03443024|453851385|FG000|Overall Study|Protocol Deviation|0|||
126153851|NCT03443024|453851386|FG001|Overall Study|Protocol Deviation|0|||
126153852|NCT03443024|453851387|FG002|Overall Study|Protocol Deviation|0|||
126153853|NCT03443024|453851388|FG003|Overall Study|Protocol Deviation|2|||
126153854|NCT03598777|453851389|FG000|Overall Study|Study Terminated by Sponsor|3|||
126153855|NCT03598777|453851390|FG001|Overall Study|Study Terminated by Sponsor|0|||
126153856|NCT03598777|453851391|FG002|Overall Study|Study Terminated by Sponsor|0|||
126153857|NCT03598777|453851392|FG003|Overall Study|Study Terminated by Sponsor|0|||
126153858|NCT03598777|453851393|FG004|Overall Study|Study Terminated by Sponsor|15|||
126153859|NCT03598777|453851389|FG000|Overall Study|Withdrawal by Subject|1|||
126153860|NCT03598777|453851390|FG001|Overall Study|Withdrawal by Subject|1|||
126153861|NCT03598777|453851391|FG002|Overall Study|Withdrawal by Subject|0|||
126153862|NCT03598777|453851392|FG003|Overall Study|Withdrawal by Subject|0|||
126153863|NCT03598777|453851393|FG004|Overall Study|Withdrawal by Subject|0|||
126153864|NCT03598777|453851389|FG000|Overall Study|Adverse Event|1|||
126153865|NCT03598777|453851390|FG001|Overall Study|Adverse Event|0|||
126153866|NCT03598777|453851391|FG002|Overall Study|Adverse Event|0|||
126153867|NCT03598777|453851392|FG003|Overall Study|Adverse Event|0|||
126153868|NCT03598777|453851393|FG004|Overall Study|Adverse Event|0|||
126153869|NCT03598777|453851389|FG000|Overall Study|Lost to Follow-up|1|||
126153870|NCT03598777|453851390|FG001|Overall Study|Lost to Follow-up|0|||
126153871|NCT03598777|453851391|FG002|Overall Study|Lost to Follow-up|0|||
126153872|NCT03598777|453851392|FG003|Overall Study|Lost to Follow-up|0|||
126153873|NCT03598777|453851393|FG004|Overall Study|Lost to Follow-up|0|||
126153874|NCT00072189|453851394|FG000|Overall Study|Withdrawal by Subject|1|||
126153875|NCT01919411|453851395|FG000|Overall Study|Lost to Follow-up|2|||
126153876|NCT01919411|453851396|FG001|Overall Study|Lost to Follow-up|4|||
126153877|NCT01919411|453851395|FG000|Overall Study|Physician Decision|1|||
126153878|NCT01919411|453851396|FG001|Overall Study|Physician Decision|0|||
126153879|NCT01919411|453851395|FG000|Overall Study|Protocol Violation|2|||
126153880|NCT01919411|453851396|FG001|Overall Study|Protocol Violation|1|||
126153881|NCT01933672|453851397|FG000|Metformin Run-in Period|Adverse Event|1|||
126153882|NCT01933672|453851398|FG001|Metformin Run-in Period|Adverse Event|0|||
126153883|NCT01933672|453851399|FG002|Metformin Run-in Period|Adverse Event|0|||
126153884|NCT01933672|453851400|FG003|Metformin Run-in Period|Adverse Event|0|||
126153885|NCT01933672|453851401|FG004|Metformin Run-in Period|Adverse Event|0|||
126153886|NCT01933672|453851402|FG005|Metformin Run-in Period|Adverse Event|0|||
126153887|NCT01933672|453851403|FG006|Metformin Run-in Period|Adverse Event|0|||
126153888|NCT01933672|453851397|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
126153889|NCT01933672|453851398|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126153890|NCT01933672|453851399|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126153891|NCT01933672|453851400|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126153892|NCT01933672|453851401|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126153893|NCT01933672|453851402|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126153894|NCT01933672|453851403|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126153895|NCT01933672|453851397|FG000|Metformin Run-in Period|Other|5|||
126153896|NCT01933672|453851398|FG001|Metformin Run-in Period|Other|0|||
126153897|NCT01933672|453851399|FG002|Metformin Run-in Period|Other|0|||
126153898|NCT01933672|453851400|FG003|Metformin Run-in Period|Other|0|||
126153899|NCT01933672|453851401|FG004|Metformin Run-in Period|Other|0|||
126153900|NCT01933672|453851402|FG005|Metformin Run-in Period|Other|0|||
126153901|NCT01933672|453851403|FG006|Metformin Run-in Period|Other|0|||
126153902|NCT01933672|453851397|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153903|NCT01933672|453851398|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126199952|NCT01117428|454017807|FG003|Overall Study|Physician Decision|0|||
126153904|NCT01933672|453851399|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153905|NCT01933672|453851400|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153906|NCT01933672|453851401|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
126153907|NCT01933672|453851402|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153908|NCT01933672|453851403|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153909|NCT01933672|453851397|FG000|First Intervention Period (12-16 Days)|Other|0|||
126153910|NCT01933672|453851398|FG001|First Intervention Period (12-16 Days)|Other|0|||
126153911|NCT01933672|453851399|FG002|First Intervention Period (12-16 Days)|Other|1|||
126153912|NCT01933672|453851400|FG003|First Intervention Period (12-16 Days)|Other|0|||
126153913|NCT01933672|453851401|FG004|First Intervention Period (12-16 Days)|Other|0|||
126153914|NCT01933672|453851402|FG005|First Intervention Period (12-16 Days)|Other|1|||
126153915|NCT01933672|453851403|FG006|First Intervention Period (12-16 Days)|Other|0|||
126153916|NCT01933672|453851397|FG000|Second Intervention Period (12-16 Days)|Other|0|||
126153917|NCT01933672|453851398|FG001|Second Intervention Period (12-16 Days)|Other|1|||
126153918|NCT01933672|453851399|FG002|Second Intervention Period (12-16 Days)|Other|1|||
126153919|NCT01933672|453851400|FG003|Second Intervention Period (12-16 Days)|Other|0|||
126153920|NCT01933672|453851401|FG004|Second Intervention Period (12-16 Days)|Other|0|||
126153921|NCT01933672|453851402|FG005|Second Intervention Period (12-16 Days)|Other|0|||
126153922|NCT01933672|453851403|FG006|Second Intervention Period (12-16 Days)|Other|0|||
126153923|NCT01933672|453851397|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153924|NCT01933672|453851398|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153925|NCT01933672|453851399|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153926|NCT01933672|453851400|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
126153927|NCT01933672|453851401|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153928|NCT01933672|453851402|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153929|NCT01933672|453851403|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126153930|NCT01933672|453851397|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126153931|NCT01933672|453851398|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
126153932|NCT01933672|453851399|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126153933|NCT01933672|453851400|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126153934|NCT01933672|453851401|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126153935|NCT01933672|453851402|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126153936|NCT01933672|453851403|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126153937|NCT02426086|453851404|FG000|Overall Study|Death|33|||
126153938|NCT02426086|453851405|FG001|Overall Study|Death|36|||
126153939|NCT02426086|453851404|FG000|Overall Study|Lost to Follow-up|2|||
126153940|NCT02426086|453851405|FG001|Overall Study|Lost to Follow-up|0|||
126153941|NCT02426086|453851404|FG000|Overall Study|Study Terminated by Sponsor|5|||
126153942|NCT02426086|453851405|FG001|Overall Study|Study Terminated by Sponsor|14|||
126153943|NCT02426086|453851404|FG000|Overall Study|Withdrawal by Subject|8|||
126153944|NCT02426086|453851405|FG001|Overall Study|Withdrawal by Subject|9|||
126153945|NCT00524303|453851406|FG000|Overall Study|Lost to Follow-up|6|||
126153946|NCT00524303|453851407|FG001|Overall Study|Lost to Follow-up|0|||
126153947|NCT00524303|453851408|FG002|Overall Study|Lost to Follow-up|3|||
126153948|NCT00524303|453851406|FG000|Overall Study|Protocol Violation|0|||
126153949|NCT00524303|453851407|FG001|Overall Study|Protocol Violation|1|||
126153950|NCT00524303|453851408|FG002|Overall Study|Protocol Violation|1|||
126153951|NCT00524303|453851406|FG000|Overall Study|Withdrawal by Subject|3|||
125971639|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
125971640|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
125971641|NCT01412944|453184748|FG000|Entire: IV + Maintenance|Adverse Event|0|||
125971642|NCT01412944|453184749|FG001|Entire: IV + Maintenance|Adverse Event|1|||
125971643|NCT01412944|453184750|FG002|Entire: IV + Maintenance|Adverse Event|0|||
125971644|NCT01412944|453184751|FG003|Entire: IV + Maintenance|Adverse Event|0|||
125971645|NCT01412944|453184752|FG004|Entire: IV + Maintenance|Adverse Event|0|||
125971646|NCT01412944|453184753|FG005|Entire: IV + Maintenance|Adverse Event|0|||
125971647|NCT01990950|453184754|FG000|Overall Study|Death|3|||
125971648|NCT01990950|453184754|FG000|Overall Study|Lost to Follow-up|2|||
125971649|NCT01990950|453184754|FG000|Overall Study|Withdrawal by Subject|6|||
125971650|NCT02388724|453184756|FG000|Overall Study|Reason not Specified|0|||
125971651|NCT02388724|453184757|FG001|Overall Study|Reason not Specified|1|||
126153952|NCT00524303|453851407|FG001|Overall Study|Withdrawal by Subject|0|||
126153953|NCT00524303|453851408|FG002|Overall Study|Withdrawal by Subject|4|||
126153954|NCT00524303|453851406|FG000|Overall Study|Death|0|||
126153955|NCT00524303|453851407|FG001|Overall Study|Death|2|||
126153956|NCT00524303|453851408|FG002|Overall Study|Death|3|||
126153957|NCT00524303|453851406|FG000|Overall Study|Adverse Event|1|||
126153958|NCT00524303|453851407|FG001|Overall Study|Adverse Event|2|||
126153959|NCT00524303|453851408|FG002|Overall Study|Adverse Event|3|||
126153960|NCT00524303|453851406|FG000|Overall Study|Did not Complete Study Dosing|1|||
126153961|NCT00524303|453851407|FG001|Overall Study|Did not Complete Study Dosing|0|||
126153962|NCT00524303|453851408|FG002|Overall Study|Did not Complete Study Dosing|0|||
126153963|NCT00524303|453851406|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
126153964|NCT00524303|453851407|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
126153965|NCT00524303|453851408|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
126153966|NCT00524303|453851406|FG000|Overall Study|Disease Progression|0|||
126153967|NCT00524303|453851407|FG001|Overall Study|Disease Progression|4|||
126153968|NCT00524303|453851408|FG002|Overall Study|Disease Progression|1|||
126153969|NCT00524303|453851406|FG000|Overall Study|Disease Recurrence|0|||
126153970|NCT00524303|453851407|FG001|Overall Study|Disease Recurrence|1|||
126153971|NCT00524303|453851408|FG002|Overall Study|Disease Recurrence|0|||
126153972|NCT00524303|453851406|FG000|Overall Study|Sponsor Request|0|||
126153973|NCT00524303|453851407|FG001|Overall Study|Sponsor Request|0|||
126153974|NCT00524303|453851408|FG002|Overall Study|Sponsor Request|1|||
126153975|NCT00524303|453851406|FG000|Overall Study|Physician Decision|0|||
126153976|NCT00524303|453851407|FG001|Overall Study|Physician Decision|0|||
126153977|NCT00524303|453851408|FG002|Overall Study|Physician Decision|1|||
126153978|NCT00524303|453851406|FG000|Overall Study|Completed 5 years|0|||
126153979|NCT00524303|453851407|FG001|Overall Study|Completed 5 years|0|||
126153980|NCT00524303|453851408|FG002|Overall Study|Completed 5 years|1|||
126153981|NCT03750838|453851409|FG000|Overall Study|Lost to Follow-up|10|||
126153982|NCT03750838|453851410|FG001|Overall Study|Lost to Follow-up|6|||
126153983|NCT01769404|453851415|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
126153984|NCT01769404|453851416|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
126153985|NCT01769404|453851415|FG000|Treatment Period 1|Withdrawal by Subject|3|||
126153986|NCT01769404|453851416|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126153987|NCT01769404|453851415|FG000|Treatment Period 1|Sponsor decision|1|||
126153988|NCT01769404|453851416|FG001|Treatment Period 1|Sponsor decision|0|||
126153989|NCT01769404|453851415|FG000|Treatment Period 2|Sponsor decision|7|||
126153990|NCT01769404|453851416|FG001|Treatment Period 2|Sponsor decision|0|||
126153991|NCT00538733|453851417|FG000|Overall Study|Adverse Event|8|||
126153992|NCT00538733|453851417|FG000|Overall Study|Death|1|||
126153993|NCT00538733|453851417|FG000|Overall Study|declined to participate|2|||
126153994|NCT00538733|453851417|FG000|Overall Study|still on therapy|1|||
126153995|NCT00095121|453851422|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
126153996|NCT00095121|453851423|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
126153997|NCT00095121|453851422|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
126153998|NCT00095121|453851423|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
126153999|NCT03567187|453851428|FG000|Overall Study|Lost to Follow-up|18|||
126154000|NCT02032875|453851431|FG000|Treatment Period|Adverse Event|1|||
126154001|NCT02032875|453851432|FG001|Treatment Period|Adverse Event|0|||
126154002|NCT02032875|453851431|FG000|Treatment Period|Liver transplant, No extension needed|0|||
126154003|NCT02032875|453851432|FG001|Treatment Period|Liver transplant, No extension needed|1|||
126154004|NCT02032875|453851431|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
126154005|NCT02032875|453851432|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
126154006|NCT02032875|453851431|FG000|Follow-up Period|Death|0|||
126154007|NCT02032875|453851432|FG001|Follow-up Period|Death|1|||
126154008|NCT02032875|453851431|FG000|Follow-up Period|Virologic Relapse|3|||
126154009|NCT02032875|453851432|FG001|Follow-up Period|Virologic Relapse|10|||
126154010|NCT04358458|453851433|FG000|Overall Study|Death|1|||
126154011|NCT04358458|453851434|FG001|Overall Study|Death|1|||
126154012|NCT04358458|453851435|FG002|Overall Study|Death|3|||
126154013|NCT04358458|453851436|FG003|Overall Study|Death|8|||
126154014|NCT04358458|453851437|FG004|Overall Study|Death|1|||
126154015|NCT04358458|453851438|FG005|Overall Study|Death|6|||
126154016|NCT04358458|453851439|FG006|Overall Study|Death|2|||
126154017|NCT04358458|453851440|FG007|Overall Study|Death|3|||
126154018|NCT04358458|453851433|FG000|Overall Study|Lost to Follow-up|0|||
126154019|NCT04358458|453851434|FG001|Overall Study|Lost to Follow-up|0|||
126154020|NCT04358458|453851435|FG002|Overall Study|Lost to Follow-up|0|||
126154021|NCT04358458|453851436|FG003|Overall Study|Lost to Follow-up|0|||
126154022|NCT04358458|453851437|FG004|Overall Study|Lost to Follow-up|0|||
126154023|NCT04358458|453851438|FG005|Overall Study|Lost to Follow-up|0|||
126154024|NCT04358458|453851439|FG006|Overall Study|Lost to Follow-up|0|||
126154025|NCT04358458|453851440|FG007|Overall Study|Lost to Follow-up|1|||
126154026|NCT04358458|453851433|FG000|Overall Study|Site is closing study participation|0|||
126154027|NCT04358458|453851434|FG001|Overall Study|Site is closing study participation|0|||
126154028|NCT04358458|453851435|FG002|Overall Study|Site is closing study participation|0|||
126154029|NCT04358458|453851436|FG003|Overall Study|Site is closing study participation|1|||
126154030|NCT04358458|453851437|FG004|Overall Study|Site is closing study participation|0|||
126154031|NCT04358458|453851438|FG005|Overall Study|Site is closing study participation|0|||
126154032|NCT04358458|453851439|FG006|Overall Study|Site is closing study participation|0|||
126154033|NCT04358458|453851440|FG007|Overall Study|Site is closing study participation|0|||
126154034|NCT04358458|453851433|FG000|Overall Study|Sponsor request|2|||
126154035|NCT04358458|453851434|FG001|Overall Study|Sponsor request|3|||
126154036|NCT04358458|453851435|FG002|Overall Study|Sponsor request|3|||
126154037|NCT04358458|453851436|FG003|Overall Study|Sponsor request|0|||
126154038|NCT04358458|453851437|FG004|Overall Study|Sponsor request|2|||
126154039|NCT04358458|453851438|FG005|Overall Study|Sponsor request|3|||
126154040|NCT04358458|453851439|FG006|Overall Study|Sponsor request|1|||
126154041|NCT04358458|453851440|FG007|Overall Study|Sponsor request|1|||
126154042|NCT04358458|453851433|FG000|Overall Study|Withdrawal by Subject|0|||
126154043|NCT04358458|453851434|FG001|Overall Study|Withdrawal by Subject|0|||
126154044|NCT04358458|453851435|FG002|Overall Study|Withdrawal by Subject|1|||
126154045|NCT04358458|453851436|FG003|Overall Study|Withdrawal by Subject|1|||
126154046|NCT04358458|453851437|FG004|Overall Study|Withdrawal by Subject|0|||
126154047|NCT04358458|453851438|FG005|Overall Study|Withdrawal by Subject|1|||
126154048|NCT04358458|453851439|FG006|Overall Study|Withdrawal by Subject|0|||
126154049|NCT04358458|453851440|FG007|Overall Study|Withdrawal by Subject|1|||
126154050|NCT02031146|453852653|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
126154051|NCT02031146|453852654|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
126154052|NCT02031146|453852655|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
126154053|NCT02031146|453852656|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
126154054|NCT02031146|453852657|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
126154055|NCT02031146|453852658|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
126154056|NCT02031146|453852659|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
126154057|NCT01266148|453852664|FG000|Overall Study|Adverse Event|2|||
126154058|NCT01266148|453852665|FG001|Overall Study|Adverse Event|0|||
126154059|NCT01266148|453852664|FG000|Overall Study|Ongoing rejection|1|||
126154060|NCT01266148|453852665|FG001|Overall Study|Ongoing rejection|0|||
126154061|NCT01266148|453852664|FG000|Overall Study|2 2R rejections|1|||
126154062|NCT01266148|453852665|FG001|Overall Study|2 2R rejections|0|||
126154063|NCT01266148|453852664|FG000|Overall Study|Death|2|||
126154064|NCT01266148|453852665|FG001|Overall Study|Death|3|||
126154065|NCT01266148|453852664|FG000|Overall Study|missing mGFR value + AE|1|||
126154066|NCT01266148|453852665|FG001|Overall Study|missing mGFR value + AE|0|||
126154067|NCT03937986|453852668|FG000|Overall Study|COVID-19 Pandemic|1|||
126154068|NCT01853228|453852671|FG000|Phase 1|Lack of Efficacy|8|||
126154069|NCT01853228|453852672|FG001|Phase 1|Lack of Efficacy|0|||
126154070|NCT01853228|453852671|FG000|Phase 1|Other|1|||
126154071|NCT01853228|453852672|FG001|Phase 1|Other|0|||
126154072|NCT01853228|453852671|FG000|Phase 2|Physician Decision|0|||
126154073|NCT01853228|453852672|FG001|Phase 2|Physician Decision|1|||
126154074|NCT01853228|453852671|FG000|Phase 2|Proceed To Transplant|0|||
126154075|NCT01853228|453852672|FG001|Phase 2|Proceed To Transplant|3|||
126154076|NCT01853228|453852671|FG000|Phase 2|Lack of Efficacy|0|||
126154077|NCT01853228|453852672|FG001|Phase 2|Lack of Efficacy|4|||
126154078|NCT03167619|453852673|FG000|Overall Study|Death|11|||
126154079|NCT03167619|453852674|FG001|Overall Study|Death|8|||
126154080|NCT03167619|453852673|FG000|Overall Study|Withdrawal by Subject|1|||
126154081|NCT03167619|453852674|FG001|Overall Study|Withdrawal by Subject|2|||
126154082|NCT03167619|453852673|FG000|Overall Study|Physician Decision|0|||
126154083|NCT03167619|453852674|FG001|Overall Study|Physician Decision|1|||
126154084|NCT01348919|453852678|FG000|Overall Study|Adverse Event|3|||
126154085|NCT01348919|453852679|FG001|Overall Study|Adverse Event|1|||
126154086|NCT01348919|453852680|FG002|Overall Study|Adverse Event|0|||
126154087|NCT01348919|453852678|FG000|Overall Study|Withdrawal by Subject|0|||
126154088|NCT01348919|453852679|FG001|Overall Study|Withdrawal by Subject|1|||
126154089|NCT01348919|453852680|FG002|Overall Study|Withdrawal by Subject|0|||
126154090|NCT01348919|453852678|FG000|Overall Study|Disease progression|0|||
126154091|NCT01348919|453852679|FG001|Overall Study|Disease progression|1|||
126154092|NCT01348919|453852680|FG002|Overall Study|Disease progression|1|||
126154093|NCT02114203|453852681|FG000|Overall Study|Adverse Event|0|||
126154094|NCT02114203|453852682|FG001|Overall Study|Adverse Event|1|||
126154095|NCT02114203|453852683|FG002|Overall Study|Adverse Event|0|||
126154096|NCT02114203|453852681|FG000|Overall Study|Withdrawal by Subject|0|||
126154097|NCT02114203|453852682|FG001|Overall Study|Withdrawal by Subject|1|||
126154098|NCT02114203|453852683|FG002|Overall Study|Withdrawal by Subject|0|||
126154099|NCT01518699|453852684|FG000|Period 2|Protocol Violation|1|||
126154100|NCT01518699|453852685|FG001|Period 2|Protocol Violation|1|||
126154101|NCT01518699|453852686|FG002|Period 2|Protocol Violation|0|||
126154102|NCT01518699|453852687|FG003|Period 2|Protocol Violation|0|||
126154103|NCT01518699|453852688|FG004|Period 2|Protocol Violation|0|||
126154104|NCT01518699|453852689|FG005|Period 2|Protocol Violation|0|||
126154105|NCT01518699|453852684|FG000|Period 2|Lost to Follow-up|0|||
126154106|NCT01518699|453852685|FG001|Period 2|Lost to Follow-up|1|||
126154107|NCT01518699|453852686|FG002|Period 2|Lost to Follow-up|0|||
126154108|NCT01518699|453852687|FG003|Period 2|Lost to Follow-up|0|||
126154109|NCT01518699|453852688|FG004|Period 2|Lost to Follow-up|0|||
126154110|NCT01518699|453852689|FG005|Period 2|Lost to Follow-up|0|||
126154111|NCT01518699|453852684|FG000|Period 2|Adverse Event|1|||
126154112|NCT01518699|453852685|FG001|Period 2|Adverse Event|0|||
126154113|NCT01518699|453852686|FG002|Period 2|Adverse Event|0|||
126154114|NCT01518699|453852687|FG003|Period 2|Adverse Event|0|||
126154115|NCT01518699|453852688|FG004|Period 2|Adverse Event|0|||
126154116|NCT01518699|453852689|FG005|Period 2|Adverse Event|0|||
126154117|NCT02839746|453852691|FG000|Overall Study|Not met selection criteria|12|||
126154118|NCT02089737|453852692|FG000|Overall Study|Survey form not completed|5|||
126154119|NCT02089737|453852692|FG000|Overall Study|Not treated|1|||
126154120|NCT00744055|453852693|FG000|Overall Study|Withdrawal by Subject|6|||
126154121|NCT00744055|453852694|FG001|Overall Study|Withdrawal by Subject|9|||
126154122|NCT00744055|453852693|FG000|Overall Study|Lack of Efficacy|0|||
126154123|NCT00744055|453852694|FG001|Overall Study|Lack of Efficacy|1|||
126154124|NCT00744055|453852693|FG000|Overall Study|Physician Decision|0|||
126154125|NCT00744055|453852694|FG001|Overall Study|Physician Decision|2|||
126154126|NCT00744055|453852693|FG000|Overall Study|Protocol Violation|1|||
126154127|NCT00744055|453852694|FG001|Overall Study|Protocol Violation|1|||
126154128|NCT00744055|453852693|FG000|Overall Study|Lost to Follow-up|0|||
126154129|NCT00744055|453852694|FG001|Overall Study|Lost to Follow-up|1|||
126154130|NCT02767570|453852695|FG000|Overall Study|Lost to Follow-up|3|||
126154131|NCT02767570|453852696|FG001|Overall Study|Lost to Follow-up|0|||
126154132|NCT02767570|453852695|FG000|Overall Study|COVID shutdown|2|||
126154133|NCT02767570|453852696|FG001|Overall Study|COVID shutdown|5|||
126154134|NCT02767570|453852695|FG000|Overall Study|Increased pain|2|||
126154135|NCT02767570|453852696|FG001|Overall Study|Increased pain|0|||
126154136|NCT02767570|453852695|FG000|Overall Study|Withdrawal by Subject|1|||
126154137|NCT02767570|453852696|FG001|Overall Study|Withdrawal by Subject|3|||
126154138|NCT02767570|453852695|FG000|Overall Study|Unrelated medical issue|1|||
126154139|NCT02767570|453852696|FG001|Overall Study|Unrelated medical issue|1|||
126154140|NCT02767570|453852695|FG000|Overall Study|Received intra-articular injection|0|||
126154141|NCT02767570|453852696|FG001|Overall Study|Received intra-articular injection|1|||
126154142|NCT00151411|453852697|FG000|Overall Study|Lost to Follow-up|15|||
126154143|NCT00151411|453852698|FG001|Overall Study|Lost to Follow-up|19|||
126154144|NCT00151411|453852697|FG000|Overall Study|Withdrawal by Subject|12|||
126154145|NCT00151411|453852698|FG001|Overall Study|Withdrawal by Subject|20|||
126154146|NCT00151411|453852697|FG000|Overall Study|Adverse Event|6|||
126154147|NCT00151411|453852698|FG001|Overall Study|Adverse Event|0|||
126154148|NCT00151411|453852697|FG000|Overall Study|Pregnancy|0|||
126154149|NCT00151411|453852698|FG001|Overall Study|Pregnancy|4|||
126154150|NCT01712438|453852699|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
126154151|NCT01712438|453852699|FG000|Overall Study|Ongoing ITI treatment|6|||
126154152|NCT01712438|453852699|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
126154153|NCT01712438|453852699|FG000|Overall Study|Prematurely Discontinued|25|||
126154154|NCT04426630|453852700|FG000|Overall Study|Death|4|||
126154155|NCT04426630|453852700|FG000|Overall Study|Lost to Follow-up|2|||
126154156|NCT01157169|453852703|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
126154157|NCT01157169|453852704|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
126154158|NCT01157169|453852703|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
126154159|NCT01157169|453852704|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
126154160|NCT01123889|453852705|FG000|Overall Study|Lost to Follow-up|3|||
126154161|NCT01123889|453852706|FG001|Overall Study|Lost to Follow-up|1|||
126154162|NCT03846947|453852711|FG000|Overall Study|technical issues with imaging sequence|2|||
126154163|NCT00849693|453852718|FG000|Acute Treatment Phase|Adverse Event|12|||
126154164|NCT00849693|453852719|FG001|Acute Treatment Phase|Adverse Event|7|||
126154165|NCT00849693|453852720|FG002|Acute Treatment Phase|Adverse Event|6|||
126154166|NCT00849693|453852721|FG003|Acute Treatment Phase|Adverse Event|4|||
126154167|NCT00849693|453852718|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
126154168|NCT00849693|453852719|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
126154169|NCT00849693|453852720|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
126154170|NCT00849693|453852721|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
126154171|NCT00849693|453852718|FG000|Acute Treatment Phase|Protocol Violation|1|||
126154172|NCT00849693|453852719|FG001|Acute Treatment Phase|Protocol Violation|5|||
126154173|NCT00849693|453852720|FG002|Acute Treatment Phase|Protocol Violation|2|||
126154174|NCT00849693|453852721|FG003|Acute Treatment Phase|Protocol Violation|6|||
126154175|NCT00849693|453852718|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
126154176|NCT00849693|453852719|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
126154177|NCT00849693|453852720|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
126154178|NCT00849693|453852721|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
126154179|NCT00849693|453852718|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
126154180|NCT00849693|453852719|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
126154181|NCT00849693|453852720|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
126154182|NCT00849693|453852721|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
126154183|NCT00849693|453852718|FG000|Acute Treatment Phase|Physician Decision|2|||
126154184|NCT00849693|453852719|FG001|Acute Treatment Phase|Physician Decision|1|||
126154185|NCT00849693|453852720|FG002|Acute Treatment Phase|Physician Decision|2|||
126154186|NCT00849693|453852721|FG003|Acute Treatment Phase|Physician Decision|1|||
126154187|NCT00849693|453852718|FG000|Acute Treatment Phase|Sponsor decision|0|||
126154188|NCT00849693|453852719|FG001|Acute Treatment Phase|Sponsor decision|0|||
126154189|NCT00849693|453852720|FG002|Acute Treatment Phase|Sponsor decision|1|||
126154190|NCT00849693|453852721|FG003|Acute Treatment Phase|Sponsor decision|0|||
126154191|NCT00849693|453852718|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
126154192|NCT00849693|453852719|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
126154193|NCT00849693|453852720|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
126154194|NCT00849693|453852721|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
126154195|NCT00849693|453852718|FG000|Extension Phase|Adverse Event|4|||
126154196|NCT00849693|453852719|FG001|Extension Phase|Adverse Event|6|||
126154197|NCT00849693|453852720|FG002|Extension Phase|Adverse Event|3|||
126154198|NCT00849693|453852721|FG003|Extension Phase|Adverse Event|7|||
126154199|NCT00849693|453852718|FG000|Extension Phase|Lost to Follow-up|7|||
126154200|NCT00849693|453852719|FG001|Extension Phase|Lost to Follow-up|5|||
126154201|NCT00849693|453852720|FG002|Extension Phase|Lost to Follow-up|6|||
126154202|NCT00849693|453852721|FG003|Extension Phase|Lost to Follow-up|6|||
126154203|NCT00849693|453852718|FG000|Extension Phase|Protocol Violation|0|||
126154204|NCT00849693|453852719|FG001|Extension Phase|Protocol Violation|3|||
126154205|NCT00849693|453852720|FG002|Extension Phase|Protocol Violation|2|||
126154206|NCT00849693|453852721|FG003|Extension Phase|Protocol Violation|3|||
126154207|NCT00849693|453852718|FG000|Extension Phase|Withdrawal by Subject|6|||
126154208|NCT00849693|453852719|FG001|Extension Phase|Withdrawal by Subject|9|||
126154209|NCT00849693|453852720|FG002|Extension Phase|Withdrawal by Subject|10|||
126154210|NCT00849693|453852721|FG003|Extension Phase|Withdrawal by Subject|15|||
126154211|NCT00849693|453852718|FG000|Extension Phase|Parent or caregiver decision|9|||
126154212|NCT00849693|453852719|FG001|Extension Phase|Parent or caregiver decision|4|||
126154213|NCT00849693|453852720|FG002|Extension Phase|Parent or caregiver decision|10|||
126154214|NCT00849693|453852721|FG003|Extension Phase|Parent or caregiver decision|5|||
126154215|NCT00849693|453852718|FG000|Extension Phase|Physician Decision|1|||
126154216|NCT00849693|453852719|FG001|Extension Phase|Physician Decision|1|||
126154217|NCT00849693|453852720|FG002|Extension Phase|Physician Decision|2|||
126154218|NCT00849693|453852721|FG003|Extension Phase|Physician Decision|0|||
126154219|NCT00849693|453852718|FG000|Extension Phase|Sponsor decision|1|||
126154220|NCT00849693|453852719|FG001|Extension Phase|Sponsor decision|0|||
126154221|NCT00849693|453852720|FG002|Extension Phase|Sponsor decision|0|||
126154222|NCT00849693|453852721|FG003|Extension Phase|Sponsor decision|1|||
126154223|NCT00849693|453852718|FG000|Extension Phase|Lack of Efficacy|2|||
126154224|NCT00849693|453852719|FG001|Extension Phase|Lack of Efficacy|2|||
126154225|NCT00849693|453852720|FG002|Extension Phase|Lack of Efficacy|2|||
126154226|NCT00849693|453852721|FG003|Extension Phase|Lack of Efficacy|1|||
126154227|NCT01062399|453852722|FG000|Overall Study|Protocol Violation|0|||
126154228|NCT01062399|453852723|FG001|Overall Study|Protocol Violation|1|||
126154229|NCT01062399|453852724|FG002|Overall Study|Protocol Violation|0|||
126154230|NCT01062399|453852725|FG003|Overall Study|Protocol Violation|6|||
126154231|NCT01062399|453852726|FG004|Overall Study|Protocol Violation|4|||
126154232|NCT03334214|453852734|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
126154233|NCT03334214|453852735|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
126154234|NCT03334214|453852734|FG000|Overall Study|Withdrawal by Subject|0|||
126154235|NCT03334214|453852735|FG001|Overall Study|Withdrawal by Subject|1|||
126154236|NCT03334214|453852734|FG000|Overall Study|Other|1|||
126154237|NCT03334214|453852735|FG001|Overall Study|Other|0|||
126154238|NCT01260181|453852738|FG000|Overall Study|Decision of Investigator|1|||
126154239|NCT00592683|453852744|FG000|Overall Study|Found ineligible|0|||
126154240|NCT00592683|453852745|FG001|Overall Study|Found ineligible|1|||
126154241|NCT00592683|453852744|FG000|Overall Study|Withdrawal by Subject|1|||
126154242|NCT00592683|453852745|FG001|Overall Study|Withdrawal by Subject|0|||
126154243|NCT00592683|453852744|FG000|Overall Study|Adverse Event|0|||
126154244|NCT00592683|453852745|FG001|Overall Study|Adverse Event|2|||
126154245|NCT00592683|453852744|FG000|Overall Study|Protocol Violation|1|||
126154246|NCT00592683|453852745|FG001|Overall Study|Protocol Violation|0|||
126154247|NCT00592683|453852744|FG000|Overall Study|Study drug expired|1|||
125971652|NCT02388724|453184756|FG000|Overall Study|Major Protocol Deviation|3|||
125971653|NCT02388724|453184757|FG001|Overall Study|Major Protocol Deviation|3|||
125971654|NCT02388724|453184756|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
125971655|NCT02388724|453184757|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125971656|NCT02388724|453184756|FG000|Overall Study|Voluntary Withdrawal|6|||
125971657|NCT02388724|453184757|FG001|Overall Study|Voluntary Withdrawal|5|||
126154248|NCT00592683|453852745|FG001|Overall Study|Study drug expired|0|||
126154249|NCT00592683|453852744|FG000|Overall Study|Other|1|||
126154250|NCT00592683|453852745|FG001|Overall Study|Other|0|||
126154251|NCT00592683|453852744|FG000|Overall Study|Lost to Follow-up|0|||
126154252|NCT00592683|453852745|FG001|Overall Study|Lost to Follow-up|1|||
126154253|NCT02723630|453852749|FG000|Intervention Period 1|Adverse Event|1|||
126154254|NCT02723630|453852750|FG001|Intervention Period 1|Adverse Event|0|||
126154255|NCT02723630|453852751|FG002|Intervention Period 1|Adverse Event|0|||
126154256|NCT02723630|453852752|FG003|Intervention Period 1|Adverse Event|0|||
126154257|NCT02723630|453852753|FG004|Intervention Period 1|Adverse Event|0|||
126154258|NCT02723630|453852754|FG005|Intervention Period 1|Adverse Event|0|||
126154259|NCT02723630|453852749|FG000|Intervention Period 3|consumption of restricted item|0|||
126154260|NCT02723630|453852750|FG001|Intervention Period 3|consumption of restricted item|1|||
126154261|NCT02723630|453852751|FG002|Intervention Period 3|consumption of restricted item|0|||
126154262|NCT02723630|453852752|FG003|Intervention Period 3|consumption of restricted item|0|||
126154263|NCT02723630|453852753|FG004|Intervention Period 3|consumption of restricted item|0|||
126154264|NCT02723630|453852754|FG005|Intervention Period 3|consumption of restricted item|0|||
126154265|NCT03633331|453852757|FG000|Overall Study|Withdrawal by Subject|1|||
126154266|NCT02986373|453852758|FG000|Overall Study|Adverse Event|4|||
126154267|NCT02986373|453852758|FG000|Overall Study|Lost to Follow-up|1|||
126154268|NCT02986373|453852758|FG000|Overall Study|Withdrawal by Subject|10|||
126154269|NCT02986373|453852758|FG000|Overall Study|Other|24|||
126154270|NCT00995371|453852764|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
126154271|NCT00995371|453852765|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
126154272|NCT04725682|453852766|FG000|Overall Study|Withdrawal by Subject|7|||
126154273|NCT04725682|453852767|FG001|Overall Study|Withdrawal by Subject|5|||
126154274|NCT04725682|453852766|FG000|Overall Study|Failed to comply with the requirements|2|||
126154275|NCT04725682|453852767|FG001|Overall Study|Failed to comply with the requirements|1|||
126154276|NCT04725682|453852766|FG000|Overall Study|Adverse Event|1|||
126154277|NCT04725682|453852767|FG001|Overall Study|Adverse Event|1|||
126154278|NCT04725682|453852766|FG000|Overall Study|Death|0|||
126154279|NCT04725682|453852767|FG001|Overall Study|Death|1|||
126154280|NCT02190591|453852768|FG000|Overall Study|Withdrawal by Subject|1|||
126154281|NCT02190591|453852769|FG001|Overall Study|Withdrawal by Subject|8|||
126154282|NCT02190591|453852768|FG000|Overall Study|Protocol Violation|1|||
126154283|NCT02190591|453852769|FG001|Overall Study|Protocol Violation|0|||
126154284|NCT02190591|453852768|FG000|Overall Study|did not use peanut ball as instructed|0|||
126154285|NCT02190591|453852769|FG001|Overall Study|did not use peanut ball as instructed|2|||
126154286|NCT02190591|453852768|FG000|Overall Study|face presentation so she was ineligible|0|||
126154287|NCT02190591|453852769|FG001|Overall Study|face presentation so she was ineligible|1|||
126154288|NCT00144300|453852770|FG000|Overall Study|Adverse Event|18|||
126154289|NCT00144300|453852771|FG001|Overall Study|Adverse Event|16|||
126154290|NCT00144300|453852770|FG000|Overall Study|Protocol Violation|1|||
126154291|NCT00144300|453852771|FG001|Overall Study|Protocol Violation|3|||
126154292|NCT00144300|453852770|FG000|Overall Study|Lost to Follow-up|3|||
126154293|NCT00144300|453852771|FG001|Overall Study|Lost to Follow-up|0|||
126154294|NCT00144300|453852770|FG000|Overall Study|Withdrawal by Subject|6|||
126154295|NCT00144300|453852771|FG001|Overall Study|Withdrawal by Subject|6|||
126154296|NCT00144300|453852770|FG000|Overall Study|Other reason (not specified)|1|||
126154297|NCT00144300|453852771|FG001|Overall Study|Other reason (not specified)|3|||
126154298|NCT01607892|453852772|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
126154299|NCT01607892|453852773|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
126154300|NCT01607892|453852774|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
126154301|NCT01607892|453852775|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
126154302|NCT01607892|453852776|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
126154303|NCT01607892|453852772|FG000|Overall Study|Death|4|||
126154304|NCT01607892|453852773|FG001|Overall Study|Death|2|||
126154305|NCT01607892|453852774|FG002|Overall Study|Death|8|||
126154306|NCT01607892|453852775|FG003|Overall Study|Death|10|||
126154307|NCT01607892|453852776|FG004|Overall Study|Death|3|||
126154308|NCT01607892|453852772|FG000|Overall Study|Investigator discretion|2|||
126154309|NCT01607892|453852773|FG001|Overall Study|Investigator discretion|4|||
126154310|NCT01607892|453852774|FG002|Overall Study|Investigator discretion|4|||
126154311|NCT01607892|453852775|FG003|Overall Study|Investigator discretion|8|||
126154312|NCT01607892|453852776|FG004|Overall Study|Investigator discretion|0|||
126154313|NCT01607892|453852772|FG000|Overall Study|Other treatments became available|1|||
126154314|NCT01607892|453852773|FG001|Overall Study|Other treatments became available|1|||
126154315|NCT01607892|453852774|FG002|Overall Study|Other treatments became available|0|||
126154316|NCT01607892|453852775|FG003|Overall Study|Other treatments became available|0|||
126154317|NCT01607892|453852776|FG004|Overall Study|Other treatments became available|2|||
126154318|NCT01607892|453852772|FG000|Overall Study|Intercurrent illness|1|||
126154319|NCT01607892|453852773|FG001|Overall Study|Intercurrent illness|0|||
126154320|NCT01607892|453852774|FG002|Overall Study|Intercurrent illness|0|||
126154321|NCT01607892|453852775|FG003|Overall Study|Intercurrent illness|3|||
126154322|NCT01607892|453852776|FG004|Overall Study|Intercurrent illness|0|||
126154323|NCT01607892|453852772|FG000|Overall Study|Non-Compliance with study procedures|0|||
126154324|NCT01607892|453852773|FG001|Overall Study|Non-Compliance with study procedures|0|||
126154325|NCT01607892|453852774|FG002|Overall Study|Non-Compliance with study procedures|1|||
126154326|NCT01607892|453852775|FG003|Overall Study|Non-Compliance with study procedures|0|||
126154327|NCT01607892|453852776|FG004|Overall Study|Non-Compliance with study procedures|0|||
126154328|NCT01607892|453852772|FG000|Overall Study|Consent withdrawn by participant|9|||
126154329|NCT01607892|453852773|FG001|Overall Study|Consent withdrawn by participant|4|||
126154330|NCT01607892|453852774|FG002|Overall Study|Consent withdrawn by participant|24|||
126154331|NCT01607892|453852775|FG003|Overall Study|Consent withdrawn by participant|14|||
126154332|NCT01607892|453852776|FG004|Overall Study|Consent withdrawn by participant|4|||
126154333|NCT01607892|453852772|FG000|Overall Study|Disease progression|38|||
126154334|NCT01607892|453852773|FG001|Overall Study|Disease progression|13|||
126154335|NCT01607892|453852774|FG002|Overall Study|Disease progression|37|||
126154336|NCT01607892|453852775|FG003|Overall Study|Disease progression|57|||
126154337|NCT01607892|453852776|FG004|Overall Study|Disease progression|9|||
126154338|NCT01607892|453852772|FG000|Overall Study|Incidence or severity of Adverse events|3|||
126154339|NCT01607892|453852773|FG001|Overall Study|Incidence or severity of Adverse events|3|||
126154340|NCT01607892|453852774|FG002|Overall Study|Incidence or severity of Adverse events|7|||
126154341|NCT01607892|453852775|FG003|Overall Study|Incidence or severity of Adverse events|2|||
126154342|NCT01607892|453852776|FG004|Overall Study|Incidence or severity of Adverse events|6|||
126154343|NCT03414359|453852780|FG000|Overall Study|Lack of Efficacy|1|||
126154344|NCT03414359|453852781|FG001|Overall Study|Lack of Efficacy|1|||
126154345|NCT03414359|453852780|FG000|Overall Study|Protocol Violation|0|||
126154346|NCT03414359|453852781|FG001|Overall Study|Protocol Violation|1|||
126154347|NCT02273973|453852782|FG000|Overall Study|Adverse Event|4|||
126154348|NCT02273973|453852783|FG001|Overall Study|Adverse Event|0|||
126154349|NCT02273973|453852782|FG000|Overall Study|Withdrawal by Subject|2|||
126154350|NCT02273973|453852783|FG001|Overall Study|Withdrawal by Subject|3|||
126154351|NCT02273973|453852782|FG000|Overall Study|Death|1|||
126154352|NCT02273973|453852783|FG001|Overall Study|Death|0|||
126154353|NCT02273973|453852782|FG000|Overall Study|Non-compliance|1|||
126154354|NCT02273973|453852783|FG001|Overall Study|Non-compliance|0|||
126154355|NCT02273973|453852782|FG000|Overall Study|Protocol Violation|1|||
126154356|NCT02273973|453852783|FG001|Overall Study|Protocol Violation|0|||
126154357|NCT02273973|453852782|FG000|Overall Study|Progression of disease|0|||
126154358|NCT02273973|453852783|FG001|Overall Study|Progression of disease|2|||
126154359|NCT02273973|453852782|FG000|Overall Study|Lost to Follow-up|0|||
126154360|NCT02273973|453852783|FG001|Overall Study|Lost to Follow-up|1|||
126154361|NCT02273973|453852782|FG000|Overall Study|Physician Decision|0|||
126154362|NCT02273973|453852783|FG001|Overall Study|Physician Decision|1|||
126154363|NCT02273973|453852782|FG000|Overall Study|Reason not specified|0|||
126154364|NCT02273973|453852783|FG001|Overall Study|Reason not specified|1|||
126154365|NCT02403206|453852785|FG000|Overall Study|Lost to Follow-up|4|||
126154366|NCT02403206|453852786|FG001|Overall Study|Lost to Follow-up|3|||
126154367|NCT02403206|453852785|FG000|Overall Study|Physician Decision|2|||
126154368|NCT02403206|453852786|FG001|Overall Study|Physician Decision|0|||
126154369|NCT02403206|453852785|FG000|Overall Study|Withdrawal by Subject|3|||
126154370|NCT02403206|453852786|FG001|Overall Study|Withdrawal by Subject|3|||
126154371|NCT02403206|453852785|FG000|Overall Study|Reason not given|2|||
126154372|NCT02403206|453852786|FG001|Overall Study|Reason not given|4|||
126154373|NCT02209597|453852787|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
126154374|NCT02209597|453852787|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
126154375|NCT02209597|453852787|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
126154376|NCT02209597|453852787|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
126154377|NCT00984659|453854411|FG000|2-week Run-in Period|Adverse Event|8|||
126154378|NCT00984659|453854412|FG001|2-week Run-in Period|Adverse Event|0|||
126154379|NCT00984659|453854413|FG002|2-week Run-in Period|Adverse Event|0|||
126154380|NCT00984659|453854414|FG003|2-week Run-in Period|Adverse Event|0|||
126154381|NCT00984659|453854411|FG000|2-week Run-in Period|Protocol Violation|5|||
126154382|NCT00984659|453854412|FG001|2-week Run-in Period|Protocol Violation|0|||
126154383|NCT00984659|453854413|FG002|2-week Run-in Period|Protocol Violation|0|||
126154384|NCT00984659|453854414|FG003|2-week Run-in Period|Protocol Violation|0|||
126154385|NCT00984659|453854411|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
126154386|NCT00984659|453854412|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
126154387|NCT00984659|453854413|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
126154388|NCT00984659|453854414|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
126154389|NCT00984659|453854411|FG000|2-week Run-in Period|Lost to Follow-up|3|||
126154390|NCT00984659|453854412|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126154391|NCT00984659|453854413|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126154392|NCT00984659|453854414|FG003|2-week Run-in Period|Lost to Follow-up|0|||
126154393|NCT00984659|453854411|FG000|2-week Run-in Period|Physician Decision|10|||
126154394|NCT00984659|453854412|FG001|2-week Run-in Period|Physician Decision|0|||
126154395|NCT00984659|453854413|FG002|2-week Run-in Period|Physician Decision|0|||
126154396|NCT00984659|453854414|FG003|2-week Run-in Period|Physician Decision|0|||
126154397|NCT00984659|453854411|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
126154398|NCT00984659|453854412|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126154399|NCT00984659|453854413|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126154400|NCT00984659|453854414|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
126154401|NCT00984659|453854411|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
126154402|NCT00984659|453854412|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126154403|NCT00984659|453854413|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126154404|NCT00984659|453854414|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126154405|NCT00984659|453854411|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
126154406|NCT00984659|453854412|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
126154407|NCT00984659|453854413|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
126154408|NCT00984659|453854414|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
126154409|NCT00984659|453854411|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
126154410|NCT00984659|453854412|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
126199953|NCT01117428|454017808|FG004|Overall Study|Physician Decision|0|||
126154411|NCT00984659|453854413|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
126154412|NCT00984659|453854414|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
126154413|NCT00984659|453854411|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
126154414|NCT00984659|453854412|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
126154415|NCT00984659|453854413|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
126154416|NCT00984659|453854414|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
126154417|NCT00984659|453854411|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
126154418|NCT00984659|453854412|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
126154419|NCT00984659|453854413|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
126154420|NCT00984659|453854414|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
126154421|NCT00984659|453854411|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126154422|NCT00984659|453854412|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
126154423|NCT00984659|453854413|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
126154424|NCT00984659|453854414|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
126154425|NCT00635102|453854417|FG000|Overall Study|Withdrawal by Subject|7|||
126154426|NCT00635102|453854418|FG001|Overall Study|Withdrawal by Subject|8|||
126154427|NCT01938625|453854419|FG000|Overall Study|Withdrawal by Subject|0|||
126154428|NCT01938625|453854420|FG001|Overall Study|Withdrawal by Subject|1|||
126154429|NCT01938625|453854419|FG000|Overall Study|Adverse Event|0|||
126154430|NCT01938625|453854420|FG001|Overall Study|Adverse Event|1|||
126154431|NCT02088034|453854421|FG000|Overall Study|Lost to Follow-up|1|||
126154432|NCT02088034|453854422|FG001|Overall Study|Lost to Follow-up|1|||
126154433|NCT02088034|453854423|FG002|Overall Study|Lost to Follow-up|0|||
126154434|NCT02088034|453854421|FG000|Overall Study|Pregnancy|2|||
126154435|NCT02088034|453854422|FG001|Overall Study|Pregnancy|1|||
126154436|NCT02088034|453854423|FG002|Overall Study|Pregnancy|2|||
126154437|NCT00308620|453854424|FG000|Overall Study|Death|1|||
126154438|NCT00308620|453854425|FG001|Overall Study|Death|1|||
126154439|NCT00308620|453854426|FG002|Overall Study|Death|0|||
126154440|NCT00308620|453854424|FG000|Overall Study|Lost to Follow-up|0|||
126154441|NCT00308620|453854425|FG001|Overall Study|Lost to Follow-up|0|||
126154442|NCT00308620|453854426|FG002|Overall Study|Lost to Follow-up|1|||
126154443|NCT00546351|453854427|FG000|Overall Study|Adverse Event|76|||
126154444|NCT00546351|453854427|FG000|Overall Study|Lack of Efficacy|15|||
126154445|NCT00546351|453854427|FG000|Overall Study|Withdrawal by Subject|109|||
126154446|NCT00546351|453854427|FG000|Overall Study|Lost to Follow-up|9|||
126154447|NCT00546351|453854427|FG000|Overall Study|Protocol Deviation|1|||
126154448|NCT00546351|453854427|FG000|Overall Study|Unsatisfactory compliance|9|||
126154449|NCT00546351|453854427|FG000|Overall Study|Other reasons for premature termination|17|||
126154450|NCT03952650|453854428|FG000|Overall Study|TRAVEL|0|||
126154451|NCT03952650|453854429|FG001|Overall Study|TRAVEL|4|||
126154452|NCT03952650|453854430|FG002|Overall Study|TRAVEL|0|||
126154453|NCT03952650|453854431|FG003|Overall Study|TRAVEL|4|||
126154454|NCT03952650|453854432|FG004|Overall Study|TRAVEL|0|||
126154455|NCT03952650|453854433|FG005|Overall Study|TRAVEL|3|||
126154456|NCT03952650|453854434|FG006|Overall Study|TRAVEL|2|||
126154457|NCT03952650|453854428|FG000|Overall Study|Withdrawal by Subject|0|||
126154458|NCT03952650|453854429|FG001|Overall Study|Withdrawal by Subject|2|||
126154459|NCT03952650|453854430|FG002|Overall Study|Withdrawal by Subject|0|||
126154460|NCT03952650|453854431|FG003|Overall Study|Withdrawal by Subject|3|||
126154461|NCT03952650|453854432|FG004|Overall Study|Withdrawal by Subject|0|||
126154462|NCT03952650|453854433|FG005|Overall Study|Withdrawal by Subject|1|||
126154463|NCT03952650|453854434|FG006|Overall Study|Withdrawal by Subject|1|||
126154464|NCT03952650|453854428|FG000|Overall Study|Lost to Follow-up|0|||
126154465|NCT03952650|453854429|FG001|Overall Study|Lost to Follow-up|1|||
126154466|NCT03952650|453854430|FG002|Overall Study|Lost to Follow-up|0|||
126154467|NCT03952650|453854431|FG003|Overall Study|Lost to Follow-up|0|||
126154468|NCT03952650|453854432|FG004|Overall Study|Lost to Follow-up|0|||
126154469|NCT03952650|453854433|FG005|Overall Study|Lost to Follow-up|1|||
126154470|NCT03952650|453854434|FG006|Overall Study|Lost to Follow-up|1|||
126154471|NCT03952650|453854428|FG000|Overall Study|Received wrong vaccine and travelled|0|||
126154472|NCT03952650|453854429|FG001|Overall Study|Received wrong vaccine and travelled|0|||
126154473|NCT03952650|453854430|FG002|Overall Study|Received wrong vaccine and travelled|0|||
126154474|NCT03952650|453854431|FG003|Overall Study|Received wrong vaccine and travelled|0|||
126154475|NCT03952650|453854432|FG004|Overall Study|Received wrong vaccine and travelled|0|||
126154476|NCT03952650|453854433|FG005|Overall Study|Received wrong vaccine and travelled|1|||
126154477|NCT03952650|453854434|FG006|Overall Study|Received wrong vaccine and travelled|0|||
126154478|NCT03952650|453854428|FG000|Overall Study|Unable to make study visit|0|||
126154479|NCT03952650|453854429|FG001|Overall Study|Unable to make study visit|0|||
126154480|NCT03952650|453854430|FG002|Overall Study|Unable to make study visit|0|||
126154481|NCT03952650|453854431|FG003|Overall Study|Unable to make study visit|0|||
126154482|NCT03952650|453854432|FG004|Overall Study|Unable to make study visit|0|||
126154483|NCT03952650|453854433|FG005|Overall Study|Unable to make study visit|1|||
126154484|NCT03952650|453854434|FG006|Overall Study|Unable to make study visit|0|||
126154485|NCT02424149|453854436|FG000|Overall Study|surgery cancelled|2|||
126154486|NCT02424149|453854437|FG001|Overall Study|surgery cancelled|0|||
126154487|NCT02424149|453854436|FG000|Overall Study|Withdrawal by Subject|0|||
126154488|NCT02424149|453854437|FG001|Overall Study|Withdrawal by Subject|1|||
126154489|NCT01025336|453854438|FG000|Overall Study|Protocol Violation|0|||
126154490|NCT01025336|453854439|FG001|Overall Study|Protocol Violation|0|||
126154491|NCT01025336|453854440|FG002|Overall Study|Protocol Violation|0|||
126154492|NCT01025336|453854441|FG003|Overall Study|Protocol Violation|2|||
126154493|NCT01025336|453854442|FG004|Overall Study|Protocol Violation|0|||
126154494|NCT01357239|453854447|FG000|Stratum: All Patients|Adverse Event|0|||
126154495|NCT01357239|453854448|FG001|Stratum: All Patients|Adverse Event|0|||
126154496|NCT01357239|453854449|FG002|Stratum: All Patients|Adverse Event|1|||
126154497|NCT01357239|453854450|FG003|Stratum: All Patients|Adverse Event|1|||
126154498|NCT01357239|453854447|FG000|Stratum: All Patients|Subject withdrew consent|0|||
126154499|NCT01357239|453854448|FG001|Stratum: All Patients|Subject withdrew consent|0|||
126154500|NCT01357239|453854449|FG002|Stratum: All Patients|Subject withdrew consent|1|||
126154501|NCT01357239|453854450|FG003|Stratum: All Patients|Subject withdrew consent|1|||
126154502|NCT01357239|453854447|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
126154503|NCT01357239|453854448|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
126154504|NCT01357239|453854449|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
126154505|NCT01357239|453854450|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
126154506|NCT01357239|453854447|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
126154507|NCT01357239|453854448|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
126154508|NCT01357239|453854449|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
126154509|NCT01357239|453854450|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
126154510|NCT01357239|453854447|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
126154511|NCT01357239|453854448|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
126154512|NCT01357239|453854449|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
126154513|NCT01357239|453854450|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
126154514|NCT03133481|453854454|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
126154515|NCT03133481|453854455|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
126154516|NCT00545818|453854459|FG000|Overall Study|Protocol Violation|1|||
126154517|NCT00545818|453854460|FG001|Overall Study|Protocol Violation|0|||
126154518|NCT00545818|453854459|FG000|Overall Study|Adverse Event|1|||
126154519|NCT00545818|453854460|FG001|Overall Study|Adverse Event|1|||
126154520|NCT00545818|453854459|FG000|Overall Study|Lost to Follow-up|1|||
126154521|NCT00545818|453854460|FG001|Overall Study|Lost to Follow-up|6|||
126154522|NCT00637728|453854461|FG000|Double-blind Phase|Adverse Event|1|||
126154523|NCT00637728|453854462|FG001|Double-blind Phase|Adverse Event|0|||
126154524|NCT00637728|453854463|FG002|Double-blind Phase|Adverse Event|0|||
126154525|NCT00637728|453854461|FG000|Double-blind Phase|Non-compliance|2|||
126154526|NCT00637728|453854462|FG001|Double-blind Phase|Non-compliance|0|||
126154527|NCT00637728|453854463|FG002|Double-blind Phase|Non-compliance|0|||
126154528|NCT00637728|453854461|FG000|Double-blind Phase|Study Discontinued|1|||
126154529|NCT00637728|453854462|FG001|Double-blind Phase|Study Discontinued|1|||
126154530|NCT00637728|453854463|FG002|Double-blind Phase|Study Discontinued|0|||
126154531|NCT01050062|453854466|FG000|Overall Study|Adverse Event|75|||
126154532|NCT01050062|453854467|FG001|Overall Study|Adverse Event|22|||
125971658|NCT02388724|453184756|FG000|Overall Study|Randomized but not Treated|0|||
125971659|NCT02388724|453184757|FG001|Overall Study|Randomized but not Treated|2|||
125971660|NCT02605954|453184759|FG000|Overall Study|Adverse Event|5|||
125971661|NCT02605954|453184760|FG001|Overall Study|Adverse Event|1|||
125971662|NCT02605954|453184759|FG000|Overall Study|Investigator's Discretion|1|||
125971663|NCT02605954|453184760|FG001|Overall Study|Investigator's Discretion|0|||
125971664|NCT02605954|453184759|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125971665|NCT02605954|453184760|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125971666|NCT02605954|453184759|FG000|Overall Study|Withdrew Consent|2|||
125971667|NCT02605954|453184760|FG001|Overall Study|Withdrew Consent|2|||
125971668|NCT02605954|453184759|FG000|Overall Study|Lost to Follow-up|3|||
125971669|NCT02605954|453184760|FG001|Overall Study|Lost to Follow-up|0|||
125971670|NCT02605954|453184759|FG000|Overall Study|Randomized but not treated|0|||
125971671|NCT02605954|453184760|FG001|Overall Study|Randomized but not treated|1|||
125971672|NCT00856856|453184764|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
125971673|NCT00856856|453184764|FG000|4-year Clinical Follow-up|Missed visit|1|||
125971674|NCT00922428|453184767|FG000|Overall Study|retrospective/extremely implausible data|2|||
125971675|NCT00922428|453184767|FG000|Overall Study|no medication use or questionable use|13|||
125971676|NCT02696317|453184768|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
126154533|NCT01050062|453854466|FG000|Overall Study|Lost to Follow-up|83|||
126154534|NCT01050062|453854467|FG001|Overall Study|Lost to Follow-up|35|||
126154535|NCT01050062|453854466|FG000|Overall Study|Lack of Efficacy|22|||
126154536|NCT01050062|453854467|FG001|Overall Study|Lack of Efficacy|35|||
125971677|NCT02696317|453184769|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
125971678|NCT02696317|453184768|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
125971679|NCT02696317|453184769|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
126154537|NCT01050062|453854466|FG000|Overall Study|Physician Decision|74|||
126154538|NCT01050062|453854467|FG001|Overall Study|Physician Decision|9|||
126154539|NCT01050062|453854466|FG000|Overall Study|Others|17|||
126154540|NCT01050062|453854467|FG001|Overall Study|Others|11|||
126154541|NCT00479466|453854470|FG000|Overall Study|Adverse Event|5|||
126154542|NCT00479466|453854471|FG001|Overall Study|Adverse Event|1|||
126154543|NCT00479466|453854472|FG002|Overall Study|Adverse Event|0|||
126154544|NCT00479466|453854473|FG003|Overall Study|Adverse Event|1|||
126154545|NCT00479466|453854474|FG004|Overall Study|Adverse Event|2|||
126154546|NCT00479466|453854475|FG005|Overall Study|Adverse Event|0|||
126154547|NCT00479466|453854470|FG000|Overall Study|Hyperglycemia|0|||
126154548|NCT00479466|453854471|FG001|Overall Study|Hyperglycemia|0|||
126154549|NCT00479466|453854472|FG002|Overall Study|Hyperglycemia|0|||
126154550|NCT00479466|453854473|FG003|Overall Study|Hyperglycemia|0|||
126154551|NCT00479466|453854474|FG004|Overall Study|Hyperglycemia|0|||
126154552|NCT00479466|453854475|FG005|Overall Study|Hyperglycemia|1|||
126154553|NCT00479466|453854470|FG000|Overall Study|Lack of Efficacy|2|||
126154554|NCT00479466|453854471|FG001|Overall Study|Lack of Efficacy|0|||
126154555|NCT00479466|453854472|FG002|Overall Study|Lack of Efficacy|1|||
126154556|NCT00479466|453854473|FG003|Overall Study|Lack of Efficacy|0|||
126154557|NCT00479466|453854474|FG004|Overall Study|Lack of Efficacy|0|||
126154558|NCT00479466|453854475|FG005|Overall Study|Lack of Efficacy|0|||
126154559|NCT00479466|453854470|FG000|Overall Study|Lost to Follow-up|0|||
126154560|NCT00479466|453854471|FG001|Overall Study|Lost to Follow-up|1|||
126154561|NCT00479466|453854472|FG002|Overall Study|Lost to Follow-up|1|||
126154562|NCT00479466|453854473|FG003|Overall Study|Lost to Follow-up|0|||
126154563|NCT00479466|453854474|FG004|Overall Study|Lost to Follow-up|2|||
126154564|NCT00479466|453854475|FG005|Overall Study|Lost to Follow-up|2|||
126154565|NCT00479466|453854470|FG000|Overall Study|Physician Decision|2|||
126154566|NCT00479466|453854471|FG001|Overall Study|Physician Decision|1|||
126154567|NCT00479466|453854472|FG002|Overall Study|Physician Decision|1|||
126154568|NCT00479466|453854473|FG003|Overall Study|Physician Decision|0|||
126154569|NCT00479466|453854474|FG004|Overall Study|Physician Decision|0|||
126154570|NCT00479466|453854475|FG005|Overall Study|Physician Decision|0|||
126154571|NCT00479466|453854470|FG000|Overall Study|Pregnancy|0|||
126154572|NCT00479466|453854471|FG001|Overall Study|Pregnancy|0|||
126154573|NCT00479466|453854472|FG002|Overall Study|Pregnancy|0|||
126154574|NCT00479466|453854473|FG003|Overall Study|Pregnancy|0|||
126154575|NCT00479466|453854474|FG004|Overall Study|Pregnancy|1|||
126154576|NCT00479466|453854475|FG005|Overall Study|Pregnancy|0|||
126154577|NCT00479466|453854470|FG000|Overall Study|Protocol Violation|1|||
126154578|NCT00479466|453854471|FG001|Overall Study|Protocol Violation|0|||
126154579|NCT00479466|453854472|FG002|Overall Study|Protocol Violation|0|||
126154580|NCT00479466|453854473|FG003|Overall Study|Protocol Violation|0|||
126154581|NCT00479466|453854474|FG004|Overall Study|Protocol Violation|0|||
126154582|NCT00479466|453854475|FG005|Overall Study|Protocol Violation|0|||
126154583|NCT00479466|453854470|FG000|Overall Study|Withdrawal by Subject|3|||
126154584|NCT00479466|453854471|FG001|Overall Study|Withdrawal by Subject|5|||
126154585|NCT00479466|453854472|FG002|Overall Study|Withdrawal by Subject|0|||
126154586|NCT00479466|453854473|FG003|Overall Study|Withdrawal by Subject|2|||
126154587|NCT00479466|453854474|FG004|Overall Study|Withdrawal by Subject|3|||
126154588|NCT00479466|453854475|FG005|Overall Study|Withdrawal by Subject|1|||
126154589|NCT01325493|453854476|FG000|Overall Study|Protocol Violation|0|||
126154590|NCT01325493|453854477|FG001|Overall Study|Protocol Violation|1|||
126154591|NCT01325493|453854476|FG000|Overall Study|loss of neuromonitoring signals|0|||
126154592|NCT01325493|453854477|FG001|Overall Study|loss of neuromonitoring signals|2|||
126154593|NCT01325493|453854476|FG000|Overall Study|Allergy|1|||
126154594|NCT01325493|453854477|FG001|Overall Study|Allergy|0|||
126154595|NCT05372315|453854480|FG000|Overall Study|Withdrawal by Subject|1|||
126154596|NCT05372315|453854481|FG001|Overall Study|Withdrawal by Subject|0|||
126154597|NCT01184989|453854482|FG000|Overall Study|Adverse Event|11|||
126154598|NCT01184989|453854482|FG000|Overall Study|Withdrawal by Subject|1|||
126154599|NCT01570491|453854483|FG000|Overall Study|Lost to Follow-up|3|||
126154600|NCT01570491|453854484|FG001|Overall Study|Lost to Follow-up|1|||
126154601|NCT01570491|453854483|FG000|Overall Study|treatment: not given or discontinued|2|||
126154602|NCT01570491|453854484|FG001|Overall Study|treatment: not given or discontinued|0|||
126154603|NCT03047213|453854485|FG000|Overall Study|Withdrawal by Subject|2|||
126154604|NCT03047213|453854486|FG001|Overall Study|Withdrawal by Subject|0|||
126154605|NCT03047213|453854485|FG000|Overall Study|Adverse Event|2|||
126154606|NCT03047213|453854486|FG001|Overall Study|Adverse Event|0|||
126154607|NCT00650585|453854491|FG000|Overall Study|Lost to Follow-up|505|||
126154608|NCT00650585|453854492|FG001|Overall Study|Lost to Follow-up|482|||
126154609|NCT00650585|453854491|FG000|Overall Study|No parental consent|935|||
126154610|NCT00650585|453854492|FG001|Overall Study|No parental consent|866|||
126154611|NCT00650585|453854491|FG000|Overall Study|Excluded/ruled ineligible|357|||
126154612|NCT00650585|453854492|FG001|Overall Study|Excluded/ruled ineligible|129|||
126154613|NCT04407507|453854494|FG000|Overall Study|Withdrawal by Subject|0|||
126154614|NCT04407507|453854495|FG001|Overall Study|Withdrawal by Subject|1|||
126154615|NCT00923091|453854496|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
126154616|NCT00923091|453854497|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
126154617|NCT00923091|453854498|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
126154618|NCT00923091|453854499|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
126154619|NCT00923091|453854500|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
126154620|NCT00923091|453854501|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
126154621|NCT00923091|453854502|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
126154622|NCT00923091|453854503|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
126154623|NCT00923091|453854504|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126154624|NCT00923091|453854505|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126154625|NCT00923091|453854506|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126154626|NCT00923091|453854507|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126154627|NCT00923091|453854508|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126154628|NCT00923091|453854496|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
126154629|NCT00923091|453854497|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
126154630|NCT00923091|453854498|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
126154631|NCT00923091|453854499|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
126154632|NCT00923091|453854500|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
126154633|NCT00923091|453854501|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
126154634|NCT00923091|453854502|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
126154635|NCT00923091|453854503|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
126154636|NCT00923091|453854504|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126154637|NCT00923091|453854505|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126154638|NCT00923091|453854506|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126154639|NCT00923091|453854507|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126154640|NCT00923091|453854508|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126154641|NCT00923091|453854496|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
126154642|NCT00923091|453854497|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
126154643|NCT00923091|453854498|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
126154644|NCT00923091|453854499|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
126154645|NCT00923091|453854500|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
126154646|NCT00923091|453854501|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
126154647|NCT00923091|453854502|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
126154648|NCT00923091|453854503|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
126154649|NCT00923091|453854504|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126154650|NCT00923091|453854505|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126154651|NCT00923091|453854506|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126154652|NCT00923091|453854507|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126154653|NCT00923091|453854508|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126154654|NCT00923091|453854496|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154655|NCT00923091|453854497|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154656|NCT00923091|453854498|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154657|NCT00923091|453854499|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154658|NCT00923091|453854500|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154659|NCT00923091|453854501|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
126154660|NCT00923091|453854502|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154661|NCT00923091|453854503|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154662|NCT00923091|453854504|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154663|NCT00923091|453854505|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154664|NCT00923091|453854506|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154665|NCT00923091|453854507|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154666|NCT00923091|453854508|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126154667|NCT00923091|453854496|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126154668|NCT00923091|453854497|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
126154669|NCT00923091|453854498|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126154670|NCT00923091|453854499|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
126154671|NCT00923091|453854500|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126154672|NCT00923091|453854501|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
126154673|NCT00923091|453854502|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126154674|NCT00923091|453854503|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125971680|NCT01343368|453184770|FG000|Overall Study|Death|1|||
125971681|NCT01343368|453184771|FG001|Overall Study|Death|0|||
125971682|NCT01343368|453184770|FG000|Overall Study|Lost to Follow-up|1|||
126154675|NCT00923091|453854504|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126154676|NCT00923091|453854505|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126199954|NCT01117428|454017809|FG005|Overall Study|Physician Decision|0|||
125971683|NCT01343368|453184771|FG001|Overall Study|Lost to Follow-up|0|||
125971684|NCT00321854|453184772|FG000|Overall Study|Adverse Event|41|||
125971685|NCT00321854|453184773|FG001|Overall Study|Adverse Event|43|||
126154677|NCT00923091|453854506|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126154678|NCT00923091|453854507|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126154679|NCT00923091|453854508|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126154680|NCT00923091|453854496|FG000|Period III (Single-Blind)|Adverse Event|5|||
126154681|NCT00923091|453854497|FG001|Period III (Single-Blind)|Adverse Event|0|||
126154682|NCT00923091|453854498|FG002|Period III (Single-Blind)|Adverse Event|0|||
126154683|NCT00923091|453854499|FG003|Period III (Single-Blind)|Adverse Event|0|||
126154684|NCT00923091|453854500|FG004|Period III (Single-Blind)|Adverse Event|0|||
126154685|NCT00923091|453854501|FG005|Period III (Single-Blind)|Adverse Event|0|||
126154686|NCT00923091|453854502|FG006|Period III (Single-Blind)|Adverse Event|0|||
126154687|NCT00923091|453854503|FG007|Period III (Single-Blind)|Adverse Event|0|||
126154688|NCT00923091|453854504|FG008|Period III (Single-Blind)|Adverse Event|0|||
126154689|NCT00923091|453854505|FG009|Period III (Single-Blind)|Adverse Event|0|||
126154690|NCT00923091|453854506|FG010|Period III (Single-Blind)|Adverse Event|0|||
126154691|NCT00923091|453854507|FG011|Period III (Single-Blind)|Adverse Event|0|||
126154692|NCT00923091|453854508|FG012|Period III (Single-Blind)|Adverse Event|0|||
126154693|NCT00923091|453854496|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
126154694|NCT00923091|453854497|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154695|NCT00923091|453854498|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154696|NCT00923091|453854499|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154697|NCT00923091|453854500|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154698|NCT00923091|453854501|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154699|NCT00923091|453854502|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154700|NCT00923091|453854503|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154701|NCT00923091|453854504|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154702|NCT00923091|453854505|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154703|NCT00923091|453854506|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154704|NCT00923091|453854507|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154705|NCT00923091|453854508|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
126154706|NCT00923091|453854496|FG000|Period III (Single-Blind)|Protocol Violation|3|||
126154707|NCT00923091|453854497|FG001|Period III (Single-Blind)|Protocol Violation|0|||
126154708|NCT00923091|453854498|FG002|Period III (Single-Blind)|Protocol Violation|0|||
126154709|NCT00923091|453854499|FG003|Period III (Single-Blind)|Protocol Violation|0|||
126154710|NCT00923091|453854500|FG004|Period III (Single-Blind)|Protocol Violation|0|||
126154711|NCT00923091|453854501|FG005|Period III (Single-Blind)|Protocol Violation|0|||
126154712|NCT00923091|453854502|FG006|Period III (Single-Blind)|Protocol Violation|0|||
126154713|NCT00923091|453854503|FG007|Period III (Single-Blind)|Protocol Violation|0|||
126154714|NCT00923091|453854504|FG008|Period III (Single-Blind)|Protocol Violation|0|||
126154715|NCT00923091|453854505|FG009|Period III (Single-Blind)|Protocol Violation|0|||
126154716|NCT00923091|453854506|FG010|Period III (Single-Blind)|Protocol Violation|0|||
126154717|NCT00923091|453854507|FG011|Period III (Single-Blind)|Protocol Violation|0|||
126154718|NCT00923091|453854508|FG012|Period III (Single-Blind)|Protocol Violation|0|||
126154719|NCT00923091|453854496|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
126154720|NCT00923091|453854497|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
126154721|NCT00923091|453854498|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
126154722|NCT00923091|453854499|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
126154723|NCT00923091|453854500|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
126154724|NCT00923091|453854501|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
126154725|NCT00923091|453854502|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
126154726|NCT00923091|453854503|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
126154727|NCT00923091|453854504|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
126154728|NCT00923091|453854505|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
126154729|NCT00923091|453854506|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
126154730|NCT00923091|453854507|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
126154731|NCT00923091|453854508|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
126154732|NCT00923091|453854496|FG000|Period IV (Double-Blind)|Adverse Event|2|||
126154733|NCT00923091|453854497|FG001|Period IV (Double-Blind)|Adverse Event|0|||
126154734|NCT00923091|453854498|FG002|Period IV (Double-Blind)|Adverse Event|0|||
126154735|NCT00923091|453854499|FG003|Period IV (Double-Blind)|Adverse Event|0|||
126154736|NCT00923091|453854500|FG004|Period IV (Double-Blind)|Adverse Event|0|||
126154737|NCT00923091|453854501|FG005|Period IV (Double-Blind)|Adverse Event|0|||
126154738|NCT00923091|453854502|FG006|Period IV (Double-Blind)|Adverse Event|0|||
126154739|NCT00923091|453854503|FG007|Period IV (Double-Blind)|Adverse Event|0|||
126154740|NCT00923091|453854504|FG008|Period IV (Double-Blind)|Adverse Event|0|||
125971686|NCT00321854|453184772|FG000|Overall Study|Lack of Efficacy|9|||
125971687|NCT00321854|453184773|FG001|Overall Study|Lack of Efficacy|14|||
125971688|NCT00321854|453184772|FG000|Overall Study|Protocol Violation|6|||
126154741|NCT00923091|453854505|FG009|Period IV (Double-Blind)|Adverse Event|0|||
126154742|NCT00923091|453854506|FG010|Period IV (Double-Blind)|Adverse Event|0|||
126154743|NCT00923091|453854507|FG011|Period IV (Double-Blind)|Adverse Event|0|||
126154744|NCT00923091|453854508|FG012|Period IV (Double-Blind)|Adverse Event|0|||
126154745|NCT00923091|453854496|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154746|NCT00923091|453854497|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
126154747|NCT00923091|453854498|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154748|NCT00923091|453854499|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154749|NCT00923091|453854500|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154750|NCT00923091|453854501|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154751|NCT00923091|453854502|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154752|NCT00923091|453854503|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154753|NCT00923091|453854504|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154754|NCT00923091|453854505|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154755|NCT00923091|453854506|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154756|NCT00923091|453854507|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154757|NCT00923091|453854508|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126154758|NCT00923091|453854496|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
126154759|NCT00923091|453854497|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
126154760|NCT00923091|453854498|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
126154761|NCT00923091|453854499|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
126154762|NCT00923091|453854500|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
126154763|NCT00923091|453854501|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
126154764|NCT00923091|453854502|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
126154765|NCT00923091|453854503|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
126154766|NCT00923091|453854504|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
126154767|NCT00923091|453854505|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
126154768|NCT00923091|453854506|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
126154769|NCT00923091|453854507|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
126154770|NCT00923091|453854508|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
126154771|NCT00923091|453854496|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154772|NCT00923091|453854497|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154773|NCT00923091|453854498|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154774|NCT00923091|453854499|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154775|NCT00923091|453854500|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154776|NCT00923091|453854501|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154777|NCT00923091|453854502|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154778|NCT00923091|453854503|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154779|NCT00923091|453854504|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
126154780|NCT00923091|453854505|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154781|NCT00923091|453854506|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154782|NCT00923091|453854507|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
126154783|NCT00923091|453854508|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
126154784|NCT00923091|453854496|FG000|Period V (Double -Blind)|Protocol Violation|0|||
126154785|NCT00923091|453854497|FG001|Period V (Double -Blind)|Protocol Violation|0|||
126154786|NCT00923091|453854498|FG002|Period V (Double -Blind)|Protocol Violation|0|||
126154787|NCT00923091|453854499|FG003|Period V (Double -Blind)|Protocol Violation|0|||
126154788|NCT00923091|453854500|FG004|Period V (Double -Blind)|Protocol Violation|0|||
126154789|NCT00923091|453854501|FG005|Period V (Double -Blind)|Protocol Violation|0|||
126154790|NCT00923091|453854502|FG006|Period V (Double -Blind)|Protocol Violation|0|||
126154791|NCT00923091|453854503|FG007|Period V (Double -Blind)|Protocol Violation|0|||
126154792|NCT00923091|453854504|FG008|Period V (Double -Blind)|Protocol Violation|0|||
126154793|NCT00923091|453854505|FG009|Period V (Double -Blind)|Protocol Violation|0|||
126154794|NCT00923091|453854506|FG010|Period V (Double -Blind)|Protocol Violation|0|||
126154795|NCT00923091|453854507|FG011|Period V (Double -Blind)|Protocol Violation|0|||
126154796|NCT00923091|453854508|FG012|Period V (Double -Blind)|Protocol Violation|1|||
126154797|NCT00923091|453854496|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
126154798|NCT00923091|453854497|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
126154799|NCT00923091|453854498|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
126154800|NCT00923091|453854499|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
126154801|NCT00923091|453854500|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
126154802|NCT00923091|453854501|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
126154803|NCT00923091|453854502|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
126154804|NCT00923091|453854503|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
126154805|NCT00923091|453854504|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
126154806|NCT00923091|453854505|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
126154807|NCT00923091|453854506|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
126154808|NCT00923091|453854507|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
126154809|NCT00923091|453854508|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
126154810|NCT00923091|453854496|FG000|Period VI (Open-Label)|Adverse Event|17|||
126154811|NCT00923091|453854497|FG001|Period VI (Open-Label)|Adverse Event|0|||
126154812|NCT00923091|453854498|FG002|Period VI (Open-Label)|Adverse Event|4|||
126154813|NCT00923091|453854499|FG003|Period VI (Open-Label)|Adverse Event|1|||
126154814|NCT00923091|453854500|FG004|Period VI (Open-Label)|Adverse Event|1|||
126154815|NCT00923091|453854501|FG005|Period VI (Open-Label)|Adverse Event|0|||
126154816|NCT00923091|453854502|FG006|Period VI (Open-Label)|Adverse Event|0|||
126154817|NCT00923091|453854503|FG007|Period VI (Open-Label)|Adverse Event|0|||
126154818|NCT00923091|453854504|FG008|Period VI (Open-Label)|Adverse Event|0|||
126154819|NCT00923091|453854505|FG009|Period VI (Open-Label)|Adverse Event|0|||
126154820|NCT00923091|453854506|FG010|Period VI (Open-Label)|Adverse Event|0|||
126154821|NCT00923091|453854507|FG011|Period VI (Open-Label)|Adverse Event|0|||
126154822|NCT00923091|453854508|FG012|Period VI (Open-Label)|Adverse Event|0|||
126154823|NCT00923091|453854496|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
126154824|NCT00923091|453854497|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
126154825|NCT00923091|453854498|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
126154826|NCT00923091|453854499|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154827|NCT00923091|453854500|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
126154828|NCT00923091|453854501|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154829|NCT00923091|453854502|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154830|NCT00923091|453854503|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154831|NCT00923091|453854504|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154832|NCT00923091|453854505|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154833|NCT00923091|453854506|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154834|NCT00923091|453854507|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154835|NCT00923091|453854508|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
126154836|NCT00923091|453854496|FG000|Period VI (Open-Label)|Protocol Violation|6|||
126154837|NCT00923091|453854497|FG001|Period VI (Open-Label)|Protocol Violation|1|||
126154838|NCT00923091|453854498|FG002|Period VI (Open-Label)|Protocol Violation|3|||
126154839|NCT00923091|453854499|FG003|Period VI (Open-Label)|Protocol Violation|1|||
126154840|NCT00923091|453854500|FG004|Period VI (Open-Label)|Protocol Violation|4|||
126154841|NCT00923091|453854501|FG005|Period VI (Open-Label)|Protocol Violation|0|||
126154842|NCT00923091|453854502|FG006|Period VI (Open-Label)|Protocol Violation|0|||
126154843|NCT00923091|453854503|FG007|Period VI (Open-Label)|Protocol Violation|0|||
126154844|NCT00923091|453854504|FG008|Period VI (Open-Label)|Protocol Violation|0|||
126154845|NCT00923091|453854505|FG009|Period VI (Open-Label)|Protocol Violation|0|||
126154846|NCT00923091|453854506|FG010|Period VI (Open-Label)|Protocol Violation|0|||
126154847|NCT00923091|453854507|FG011|Period VI (Open-Label)|Protocol Violation|0|||
126154848|NCT00923091|453854508|FG012|Period VI (Open-Label)|Protocol Violation|0|||
126154849|NCT00923091|453854496|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
126154850|NCT00923091|453854497|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
126154851|NCT00923091|453854498|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
126154852|NCT00923091|453854499|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
126154853|NCT00923091|453854500|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
126154854|NCT00923091|453854501|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
126154855|NCT00923091|453854502|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
126154856|NCT00923091|453854503|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
126154857|NCT00923091|453854504|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
126154858|NCT00923091|453854505|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
126154859|NCT00923091|453854506|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
126154860|NCT00923091|453854507|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
126154861|NCT00923091|453854508|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
126154862|NCT00923091|453854496|FG000|Period VI (Open-Label)|Other Reason|0|||
126154863|NCT00923091|453854497|FG001|Period VI (Open-Label)|Other Reason|0|||
126154864|NCT00923091|453854498|FG002|Period VI (Open-Label)|Other Reason|0|||
126154865|NCT00923091|453854499|FG003|Period VI (Open-Label)|Other Reason|1|||
126154866|NCT00923091|453854500|FG004|Period VI (Open-Label)|Other Reason|1|||
126154867|NCT00923091|453854501|FG005|Period VI (Open-Label)|Other Reason|0|||
126154868|NCT00923091|453854502|FG006|Period VI (Open-Label)|Other Reason|0|||
126154869|NCT00923091|453854503|FG007|Period VI (Open-Label)|Other Reason|0|||
126154870|NCT00923091|453854504|FG008|Period VI (Open-Label)|Other Reason|0|||
126154871|NCT00923091|453854505|FG009|Period VI (Open-Label)|Other Reason|0|||
126154872|NCT00923091|453854506|FG010|Period VI (Open-Label)|Other Reason|0|||
126154873|NCT00923091|453854507|FG011|Period VI (Open-Label)|Other Reason|0|||
126154874|NCT00923091|453854508|FG012|Period VI (Open-Label)|Other Reason|0|||
126154875|NCT00467649|453854509|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
126154876|NCT00467649|453854510|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
126154877|NCT00467649|453854511|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
126154878|NCT00467649|453854512|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
126154879|NCT00467649|453854513|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
126154880|NCT00467649|453854514|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
126154881|NCT00467649|453854509|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
125971689|NCT00321854|453184773|FG001|Overall Study|Protocol Violation|5|||
126154882|NCT00467649|453854510|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
126154883|NCT00467649|453854511|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
126154884|NCT00467649|453854512|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
126154885|NCT00467649|453854513|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
126154886|NCT00467649|453854514|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
126154887|NCT00467649|453854509|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
126154888|NCT00467649|453854510|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
126154889|NCT00467649|453854511|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
126154890|NCT00467649|453854512|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
126154891|NCT00467649|453854513|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
126154892|NCT00467649|453854514|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
126154893|NCT00467649|453854509|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
126154894|NCT00467649|453854510|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
126154895|NCT00467649|453854511|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
126154896|NCT00467649|453854512|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
126154897|NCT00467649|453854513|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
126154898|NCT00467649|453854514|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
126154899|NCT00467649|453854509|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126154900|NCT00467649|453854510|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126154901|NCT00467649|453854511|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126154902|NCT00467649|453854512|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
126154903|NCT00467649|453854513|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126154904|NCT00467649|453854514|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126154905|NCT00467649|453854509|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126154906|NCT00467649|453854510|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126154907|NCT00467649|453854511|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126154908|NCT00467649|453854512|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
126154909|NCT00467649|453854513|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126154910|NCT00467649|453854514|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126154911|NCT00467649|453854509|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126154912|NCT00467649|453854510|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126154913|NCT00467649|453854511|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126154914|NCT00467649|453854512|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126154915|NCT00467649|453854513|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126154916|NCT00467649|453854514|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
126154917|NCT03233048|453854517|FG000|Overall Study|Withdrawal by Subject|1|||
126154918|NCT04222725|453854522|FG000|Overall Study|Adverse Event|0|||
126154919|NCT04222725|453854523|FG001|Overall Study|Adverse Event|1|||
126154920|NCT04222725|453854524|FG002|Overall Study|Adverse Event|0|||
126154921|NCT04222725|453854525|FG003|Overall Study|Adverse Event|0|||
126154922|NCT01743027|453854530|FG000|Overall Study|Adverse Event|2|||
126154923|NCT01743027|453854531|FG001|Overall Study|Adverse Event|0|||
126154924|NCT01743027|453854532|FG002|Overall Study|Adverse Event|0|||
126154925|NCT01743027|453854533|FG003|Overall Study|Adverse Event|0|||
126154926|NCT01743027|453854530|FG000|Overall Study|Lost to Follow-up|0|||
126154927|NCT01743027|453854531|FG001|Overall Study|Lost to Follow-up|0|||
126154928|NCT01743027|453854532|FG002|Overall Study|Lost to Follow-up|2|||
126154929|NCT01743027|453854533|FG003|Overall Study|Lost to Follow-up|0|||
126154930|NCT01743027|453854530|FG000|Overall Study|Progressive Disease|1|||
126154931|NCT01743027|453854531|FG001|Overall Study|Progressive Disease|4|||
126154932|NCT01743027|453854532|FG002|Overall Study|Progressive Disease|3|||
126154933|NCT01743027|453854533|FG003|Overall Study|Progressive Disease|0|||
126154934|NCT01743027|453854530|FG000|Overall Study|Protocol Violation|1|||
126154935|NCT01743027|453854531|FG001|Overall Study|Protocol Violation|1|||
126154936|NCT01743027|453854532|FG002|Overall Study|Protocol Violation|1|||
126154937|NCT01743027|453854533|FG003|Overall Study|Protocol Violation|0|||
126154938|NCT01743027|453854530|FG000|Overall Study|Withdrawal by Subject|1|||
126154939|NCT01743027|453854531|FG001|Overall Study|Withdrawal by Subject|0|||
126154940|NCT01743027|453854532|FG002|Overall Study|Withdrawal by Subject|3|||
126154941|NCT01743027|453854533|FG003|Overall Study|Withdrawal by Subject|1|||
126154942|NCT05897853|453854540|FG000|Overall Study|Lost to Follow-up|2|||
126154943|NCT05897853|453854541|FG001|Overall Study|Lost to Follow-up|0|||
126154944|NCT05897853|453854540|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
126154945|NCT05897853|453854541|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
126154946|NCT02782715|453854546|FG000|Overall Study|Withdrawal by Subject|1|||
126154947|NCT04458857|453854547|FG000|Overall Study|Adverse Event|0|||
126154948|NCT04458857|453854548|FG001|Overall Study|Adverse Event|1|||
126154949|NCT04458857|453854549|FG002|Overall Study|Adverse Event|0|||
126154950|NCT04458857|453854547|FG000|Overall Study|Withdrawal by Subject|2|||
126154951|NCT04458857|453854548|FG001|Overall Study|Withdrawal by Subject|0|||
126154952|NCT04458857|453854549|FG002|Overall Study|Withdrawal by Subject|0|||
126154953|NCT04458857|453854547|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126154954|NCT04458857|453854548|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126154955|NCT04458857|453854549|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126154956|NCT04458857|453854547|FG000|Overall Study|Non-compliance with study drug|0|||
126154957|NCT04458857|453854548|FG001|Overall Study|Non-compliance with study drug|1|||
126154958|NCT04458857|453854549|FG002|Overall Study|Non-compliance with study drug|0|||
126154959|NCT04458857|453854547|FG000|Overall Study|Lost to Follow-up|4|||
126154960|NCT04458857|453854548|FG001|Overall Study|Lost to Follow-up|1|||
126154961|NCT04458857|453854549|FG002|Overall Study|Lost to Follow-up|0|||
126154962|NCT00069121|453854550|FG000|Overall Study|Death|286|||
126154963|NCT00069121|453854551|FG001|Overall Study|Death|242|||
126154964|NCT00069121|453854550|FG000|Overall Study|Withdrawal by Subject|18|||
126154965|NCT00069121|453854551|FG001|Overall Study|Withdrawal by Subject|20|||
126154966|NCT00069121|453854550|FG000|Overall Study|Lost to Follow-up|63|||
126154967|NCT00069121|453854551|FG001|Overall Study|Lost to Follow-up|63|||
126154968|NCT03368404|453854554|FG000|Overall Study|Adverse Event|2|||
126154969|NCT03368404|453854555|FG001|Overall Study|Adverse Event|1|||
126154970|NCT03368404|453854554|FG000|Overall Study|Withdrawal by Subject|1|||
126154971|NCT03368404|453854555|FG001|Overall Study|Withdrawal by Subject|1|||
126154972|NCT02983292|453854556|FG000|Overall Study|Participant unwell & cannot travel|2|||
126154973|NCT02983292|453854556|FG000|Overall Study|Lost to Follow-up|3|||
126154974|NCT02983292|453854556|FG000|Overall Study|Participant withdrew consent|2|||
126154975|NCT02983292|453854556|FG000|Overall Study|Revision|7|||
126154976|NCT02983292|453854556|FG000|Overall Study|Death|1|||
126154977|NCT02983292|453854556|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
126154978|NCT02983292|453854556|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
126154979|NCT02983292|453854556|FG000|Overall Study|Participant relocation|1|||
126154980|NCT00964795|453854557|FG000|Overall Study|Withdrawal by Subject|79|||
126154981|NCT00964795|453854557|FG000|Overall Study|Adverse Event|12|||
126154982|NCT00964795|453854557|FG000|Overall Study|Death|14|||
126154983|NCT00964795|453854557|FG000|Overall Study|Lost to Follow-up|7|||
126154984|NCT00964795|453854557|FG000|Overall Study|Termination of Study by Sponsor|169|||
126154985|NCT00964795|453854557|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
126154986|NCT00964795|453854557|FG000|Overall Study|Other|23|||
126154987|NCT00586690|453854562|FG000|Overall Study|Death|2|||
126154988|NCT00586690|453854563|FG001|Overall Study|Death|0|||
126154989|NCT00586690|453854562|FG000|Overall Study|Disease Progression|10|||
126154990|NCT00586690|453854563|FG001|Overall Study|Disease Progression|0|||
126154991|NCT00586690|453854562|FG000|Overall Study|Adverse Event|1|||
126154992|NCT00586690|453854563|FG001|Overall Study|Adverse Event|0|||
126154993|NCT00586690|453854562|FG000|Overall Study|Lack of Efficacy|2|||
126154994|NCT00586690|453854563|FG001|Overall Study|Lack of Efficacy|0|||
126154995|NCT00586690|453854562|FG000|Overall Study|Lab can't accommodate|1|||
126154996|NCT00586690|453854563|FG001|Overall Study|Lab can't accommodate|0|||
126154997|NCT00857246|453854564|FG000|Induction Regimen|Adverse Event|1|||
126154998|NCT00857246|453854564|FG000|Induction Regimen|disease-related complications|1|||
126154999|NCT00857246|453854564|FG000|Induction Regimen|Withdrawal by Subject|1|||
126155000|NCT00857246|453854564|FG000|Surgery (Curative)|disease progression|6|||
126155001|NCT00857246|453854564|FG000|ChemoRT|Withdrawal by Subject|1|||
126155002|NCT00857246|453854564|FG000|ChemoRT|Adverse Event|2|||
126155003|NCT03022422|453854570|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
126155004|NCT03022422|453854571|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
126155005|NCT03022422|453854572|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
126155006|NCT03022422|453854573|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
126155007|NCT03022422|453854574|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
126155008|NCT03022422|453854575|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
126155009|NCT01282814|453854576|FG000|First Intervention|Emesis During Dosing Interval|0|||
126155010|NCT01282814|453854577|FG001|First Intervention|Emesis During Dosing Interval|3|||
126155011|NCT01282814|453854576|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
126155012|NCT01282814|453854577|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126155013|NCT00957372|453854578|FG000|PART I|Lost to Follow-up|0|||
126155014|NCT00957372|453854579|FG001|PART I|Lost to Follow-up|0|||
126155015|NCT00957372|453854580|FG002|PART I|Lost to Follow-up|1|||
126155016|NCT00957372|453854581|FG003|PART I|Lost to Follow-up|0|||
126155017|NCT00957372|453854578|FG000|PART II|Withdrawal by Subject|0|||
126155018|NCT00957372|453854579|FG001|PART II|Withdrawal by Subject|0|||
126155019|NCT00957372|453854580|FG002|PART II|Withdrawal by Subject|0|||
126155020|NCT00957372|453854581|FG003|PART II|Withdrawal by Subject|8|||
126155021|NCT00957372|453854578|FG000|PART II|Physician Decision|0|||
126155022|NCT00957372|453854579|FG001|PART II|Physician Decision|0|||
126155023|NCT00957372|453854580|FG002|PART II|Physician Decision|0|||
126155024|NCT00957372|453854581|FG003|PART II|Physician Decision|1|||
126155025|NCT00957372|453854578|FG000|PART II|Pregnancy|0|||
126155026|NCT00957372|453854579|FG001|PART II|Pregnancy|0|||
126155027|NCT00957372|453854580|FG002|PART II|Pregnancy|0|||
125971690|NCT00321854|453184772|FG000|Overall Study|Lost to Follow-up|0|||
126155028|NCT00957372|453854581|FG003|PART II|Pregnancy|1|||
126155029|NCT00957372|453854578|FG000|PART II|Not Know|0|||
126155030|NCT00957372|453854579|FG001|PART II|Not Know|0|||
126155031|NCT00957372|453854580|FG002|PART II|Not Know|0|||
126155032|NCT00957372|453854581|FG003|PART II|Not Know|20|||
126155033|NCT00957372|453854578|FG000|PART II|Adverse Event|0|||
126155034|NCT00957372|453854579|FG001|PART II|Adverse Event|0|||
126155035|NCT00957372|453854580|FG002|PART II|Adverse Event|0|||
126155036|NCT00957372|453854581|FG003|PART II|Adverse Event|10|||
126155037|NCT00957372|453854578|FG000|PART II|Patient non-compliance|0|||
126155038|NCT00957372|453854579|FG001|PART II|Patient non-compliance|0|||
126155039|NCT00957372|453854580|FG002|PART II|Patient non-compliance|0|||
126155040|NCT00957372|453854581|FG003|PART II|Patient non-compliance|4|||
126155041|NCT02104180|453854582|FG000|Overall Study|Protocol Violation|1|||
126155042|NCT02104180|453854583|FG001|Overall Study|Protocol Violation|0|||
126155043|NCT01524289|453854584|FG000|Overall Study|Lost to Follow-up|0|||
126155044|NCT01524289|453854585|FG001|Overall Study|Lost to Follow-up|1|||
126155045|NCT01524289|453854584|FG000|Overall Study|Physician Decision|1|||
126155046|NCT01524289|453854585|FG001|Overall Study|Physician Decision|0|||
126155047|NCT01524289|453854584|FG000|Overall Study|Protocol Violation|5|||
126155048|NCT01524289|453854585|FG001|Overall Study|Protocol Violation|1|||
126155049|NCT01524289|453854584|FG000|Overall Study|Withdrawal by Subject|11|||
126155050|NCT01524289|453854585|FG001|Overall Study|Withdrawal by Subject|7|||
126155051|NCT01524289|453854584|FG000|Overall Study|Adverse Event|12|||
126155052|NCT01524289|453854585|FG001|Overall Study|Adverse Event|5|||
126155053|NCT01524289|453854584|FG000|Overall Study|Did not take study medication|1|||
126155054|NCT01524289|453854585|FG001|Overall Study|Did not take study medication|0|||
126155055|NCT01444391|453854586|FG000|Overall Study|Death|1|||
126155056|NCT01821677|453854587|FG000|Overall Study|Adverse Event|4|||
126155057|NCT01821677|453854588|FG001|Overall Study|Adverse Event|6|||
126155058|NCT01821677|453854589|FG002|Overall Study|Adverse Event|5|||
126155059|NCT01821677|453854587|FG000|Overall Study|Physician Decision|1|||
126155060|NCT01821677|453854588|FG001|Overall Study|Physician Decision|4|||
126155061|NCT01821677|453854589|FG002|Overall Study|Physician Decision|1|||
126155062|NCT01821677|453854587|FG000|Overall Study|Non-compliance|0|||
126155063|NCT01821677|453854588|FG001|Overall Study|Non-compliance|1|||
126155064|NCT01821677|453854589|FG002|Overall Study|Non-compliance|2|||
126155065|NCT01821677|453854587|FG000|Overall Study|Lost to Follow-up|2|||
126155066|NCT01821677|453854588|FG001|Overall Study|Lost to Follow-up|1|||
126155067|NCT01821677|453854589|FG002|Overall Study|Lost to Follow-up|3|||
126155068|NCT01821677|453854587|FG000|Overall Study|Protocol Violation|0|||
126155069|NCT01821677|453854588|FG001|Overall Study|Protocol Violation|0|||
126155070|NCT01821677|453854589|FG002|Overall Study|Protocol Violation|2|||
126155071|NCT01821677|453854587|FG000|Overall Study|Withdrawal by Subject|7|||
126155072|NCT01821677|453854588|FG001|Overall Study|Withdrawal by Subject|3|||
126155073|NCT01821677|453854589|FG002|Overall Study|Withdrawal by Subject|2|||
126155074|NCT01821677|453854587|FG000|Overall Study|Other|9|||
126155075|NCT01821677|453854588|FG001|Overall Study|Other|0|||
126155076|NCT01821677|453854589|FG002|Overall Study|Other|0|||
126155077|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Adverse Event|37|||
126155078|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Adverse Event|0|||
126155079|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Adverse Event|0|||
126155080|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Adverse Event|0|||
126155081|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Death|2|||
126155082|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Death|0|||
126155083|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Death|0|||
126155084|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Death|0|||
126155085|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
126155086|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
126155087|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
126155088|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
126155089|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
126155090|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
126155091|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
126155092|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
126155093|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
126155094|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
126155095|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
126155096|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
126155097|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
126155098|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
126155099|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
125971691|NCT00321854|453184773|FG001|Overall Study|Lost to Follow-up|2|||
126155100|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
126155101|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Physician Decision|4|||
126155102|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Physician Decision|0|||
126155103|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Physician Decision|0|||
126155104|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Physician Decision|0|||
126155105|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Pregnancy|1|||
126155106|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Pregnancy|0|||
126155107|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Pregnancy|0|||
125971692|NCT00321854|453184772|FG000|Overall Study|Withdrawal by Subject|6|||
126155108|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Pregnancy|0|||
126155109|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
126155110|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
126155111|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
126155112|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
126155113|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
126155114|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
126155115|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
126155116|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
126155117|NCT01855789|453854591|FG000|1) Baseline up to Week 24|Other|4|||
125971693|NCT00321854|453184773|FG001|Overall Study|Withdrawal by Subject|17|||
125971694|NCT00321854|453184772|FG000|Overall Study|Other|1|||
126155118|NCT01855789|453854592|FG001|1) Baseline up to Week 24|Other|0|||
126155119|NCT01855789|453854593|FG002|1) Baseline up to Week 24|Other|0|||
126155120|NCT01855789|453854594|FG003|1) Baseline up to Week 24|Other|0|||
126155121|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
126155122|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
125971695|NCT00321854|453184773|FG001|Overall Study|Other|1|||
125971696|NCT03204279|453184774|FG000|Overall Study|Withdrawal by Subject|0|||
125971697|NCT03204279|453184775|FG001|Overall Study|Withdrawal by Subject|1|||
125971698|NCT02277106|453184776|FG000|Stage 2|Adverse Event|0|||
125971699|NCT02277106|453184777|FG001|Stage 2|Adverse Event|0|||
126155123|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
126155124|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
126155125|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
126155126|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
126155127|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
126155128|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
126155129|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
126155130|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
126155131|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
126155132|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
126155133|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
126155134|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
126155135|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
126155136|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
126155137|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
126155138|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
126155139|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
126155140|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
126155141|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
126155142|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
126155143|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
126155144|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
126155145|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
126155146|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
126155147|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
126155148|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
126155149|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
126155150|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
126155151|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
126155152|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
126155153|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
126155154|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
126155155|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
126155156|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
126155157|NCT01855789|453854591|FG000|2) Week 24 up to End of Study|Other|0|||
126155158|NCT01855789|453854592|FG001|2) Week 24 up to End of Study|Other|0|||
126155159|NCT01855789|453854593|FG002|2) Week 24 up to End of Study|Other|0|||
126155160|NCT01855789|453854594|FG003|2) Week 24 up to End of Study|Other|1|||
126155161|NCT03067311|453854595|FG000|Overall Study|Lost to Follow-up|1|||
126155162|NCT03067311|453854596|FG001|Overall Study|Lost to Follow-up|1|||
126155163|NCT03067311|453854595|FG000|Overall Study|Moved away|1|||
126155164|NCT03067311|453854596|FG001|Overall Study|Moved away|1|||
125971700|NCT02277106|453184778|FG002|Stage 2|Adverse Event|1|||
125971701|NCT02384759|453184780|FG000|Overall Study|Patients not treated|3|||
125971702|NCT02384759|453184781|FG001|Overall Study|Patients not treated|2|||
126155165|NCT00907738|453854602|FG000|Overall Study|Adverse Event|2|||
126155166|NCT00907738|453854603|FG001|Overall Study|Adverse Event|0|||
126155167|NCT00907738|453854604|FG002|Overall Study|Adverse Event|1|||
126155168|NCT00907738|453854605|FG003|Overall Study|Adverse Event|0|||
126155169|NCT00907738|453854606|FG004|Overall Study|Adverse Event|0|||
126155170|NCT00907738|453854602|FG000|Overall Study|not specified or withdrew consent|3|||
126155171|NCT00907738|453854603|FG001|Overall Study|not specified or withdrew consent|0|||
126155172|NCT00907738|453854604|FG002|Overall Study|not specified or withdrew consent|0|||
126200102|NCT02394028|454017879|FG002|Induction Phase|Adverse Event|1|||
125971703|NCT03043664|453184782|FG000|Overall Study|Lost to Follow-up|1|||
125971704|NCT03759873|453184790|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
126155173|NCT00907738|453854605|FG003|Overall Study|not specified or withdrew consent|0|||
126155174|NCT00907738|453854606|FG004|Overall Study|not specified or withdrew consent|0|||
126155175|NCT00907738|453854602|FG000|Overall Study|Disease progression|8|||
126155176|NCT00907738|453854603|FG001|Overall Study|Disease progression|1|||
126155177|NCT00907738|453854604|FG002|Overall Study|Disease progression|6|||
126155178|NCT00907738|453854605|FG003|Overall Study|Disease progression|4|||
126155179|NCT00907738|453854606|FG004|Overall Study|Disease progression|2|||
126155180|NCT01089725|453854607|FG000|Overall Study|Adverse Event|1|||
126155181|NCT01089725|453854608|FG001|Overall Study|Adverse Event|1|||
126155182|NCT01089725|453854609|FG002|Overall Study|Adverse Event|0|||
126155183|NCT01089725|453854610|FG003|Overall Study|Adverse Event|0|||
126155184|NCT01089725|453854611|FG004|Overall Study|Adverse Event|2|||
126155185|NCT01089725|453854607|FG000|Overall Study|Lack of Efficacy|4|||
126155186|NCT01089725|453854608|FG001|Overall Study|Lack of Efficacy|3|||
126155187|NCT01089725|453854609|FG002|Overall Study|Lack of Efficacy|1|||
126155188|NCT01089725|453854610|FG003|Overall Study|Lack of Efficacy|0|||
126155189|NCT01089725|453854611|FG004|Overall Study|Lack of Efficacy|4|||
126155190|NCT01089725|453854607|FG000|Overall Study|Lost to Follow-up|2|||
126155191|NCT01089725|453854608|FG001|Overall Study|Lost to Follow-up|2|||
126155192|NCT01089725|453854609|FG002|Overall Study|Lost to Follow-up|0|||
126155193|NCT01089725|453854610|FG003|Overall Study|Lost to Follow-up|3|||
126155194|NCT01089725|453854611|FG004|Overall Study|Lost to Follow-up|0|||
126155195|NCT01089725|453854607|FG000|Overall Study|Protocol Violation|0|||
126155196|NCT01089725|453854608|FG001|Overall Study|Protocol Violation|0|||
126155197|NCT01089725|453854609|FG002|Overall Study|Protocol Violation|1|||
126155198|NCT01089725|453854610|FG003|Overall Study|Protocol Violation|1|||
126155199|NCT01089725|453854611|FG004|Overall Study|Protocol Violation|0|||
126155200|NCT01089725|453854607|FG000|Overall Study|Withdrawal by Subject|5|||
126155201|NCT01089725|453854608|FG001|Overall Study|Withdrawal by Subject|5|||
126155202|NCT01089725|453854609|FG002|Overall Study|Withdrawal by Subject|4|||
126155203|NCT01089725|453854610|FG003|Overall Study|Withdrawal by Subject|5|||
126155204|NCT01089725|453854611|FG004|Overall Study|Withdrawal by Subject|4|||
126155205|NCT01089725|453854607|FG000|Overall Study|Study Terminated by Sponsor|51|||
126155206|NCT01089725|453854608|FG001|Overall Study|Study Terminated by Sponsor|56|||
126155207|NCT01089725|453854609|FG002|Overall Study|Study Terminated by Sponsor|53|||
126155208|NCT01089725|453854610|FG003|Overall Study|Study Terminated by Sponsor|68|||
126155209|NCT01089725|453854611|FG004|Overall Study|Study Terminated by Sponsor|68|||
126155210|NCT01089725|453854607|FG000|Overall Study|Randomized, but not treated|0|||
126155211|NCT01089725|453854608|FG001|Overall Study|Randomized, but not treated|1|||
126155212|NCT01089725|453854609|FG002|Overall Study|Randomized, but not treated|2|||
126155213|NCT01089725|453854610|FG003|Overall Study|Randomized, but not treated|1|||
126155214|NCT01089725|453854611|FG004|Overall Study|Randomized, but not treated|2|||
126155215|NCT01089725|453854607|FG000|Overall Study|Other|3|||
126155216|NCT01089725|453854608|FG001|Overall Study|Other|0|||
126155217|NCT01089725|453854609|FG002|Overall Study|Other|0|||
126155218|NCT01089725|453854610|FG003|Overall Study|Other|1|||
126155219|NCT01089725|453854611|FG004|Overall Study|Other|0|||
126155220|NCT01582282|453856402|FG000|Overall Study|Adverse Event|1|||
126155221|NCT01582282|453856403|FG001|Overall Study|Adverse Event|1|||
126155222|NCT01582282|453856404|FG002|Overall Study|Adverse Event|0|||
126155223|NCT01582282|453856402|FG000|Overall Study|Lost to Follow-up|1|||
126155224|NCT01582282|453856403|FG001|Overall Study|Lost to Follow-up|0|||
126155225|NCT01582282|453856404|FG002|Overall Study|Lost to Follow-up|0|||
126155226|NCT01582282|453856402|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
126155227|NCT01582282|453856403|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
126155228|NCT01582282|453856404|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
126155229|NCT01486316|453856405|FG000|Overall Study|Device explanted with/without re-implant|3|||
126155230|NCT01486316|453856406|FG001|Overall Study|Device explanted with/without re-implant|2|||
126155231|NCT01486316|453856407|FG002|Overall Study|Device explanted with/without re-implant|0|||
126155232|NCT01486316|453856408|FG003|Overall Study|Device explanted with/without re-implant|2|||
126155233|NCT01486316|453856405|FG000|Overall Study|Not meeting eligibility criteria|0|||
126155234|NCT01486316|453856406|FG001|Overall Study|Not meeting eligibility criteria|0|||
126155235|NCT01486316|453856407|FG002|Overall Study|Not meeting eligibility criteria|1|||
126155236|NCT01486316|453856408|FG003|Overall Study|Not meeting eligibility criteria|0|||
126155237|NCT01486316|453856405|FG000|Overall Study|Withdrawal by Subject|1|||
126155238|NCT01486316|453856406|FG001|Overall Study|Withdrawal by Subject|0|||
126155239|NCT01486316|453856407|FG002|Overall Study|Withdrawal by Subject|3|||
126155240|NCT01486316|453856408|FG003|Overall Study|Withdrawal by Subject|0|||
126155241|NCT01486316|453856405|FG000|Overall Study|Physician Decision|0|||
126155242|NCT01486316|453856406|FG001|Overall Study|Physician Decision|0|||
126155243|NCT01486316|453856407|FG002|Overall Study|Physician Decision|1|||
126155244|NCT01486316|453856408|FG003|Overall Study|Physician Decision|0|||
126155245|NCT01486316|453856405|FG000|Overall Study|Death|0|||
126155246|NCT01486316|453856406|FG001|Overall Study|Death|1|||
126155247|NCT01486316|453856407|FG002|Overall Study|Death|0|||
126155248|NCT01486316|453856408|FG003|Overall Study|Death|0|||
126155249|NCT02495077|453856417|FG000|Overall Study|Adverse Event|0|||
126155250|NCT02495077|453856418|FG001|Overall Study|Adverse Event|1|||
126155251|NCT02495077|453856419|FG002|Overall Study|Adverse Event|1|||
126155252|NCT02495077|453856420|FG003|Overall Study|Adverse Event|0|||
126155253|NCT02495077|453856417|FG000|Overall Study|Death|3|||
126155254|NCT02495077|453856418|FG001|Overall Study|Death|5|||
126155255|NCT02495077|453856419|FG002|Overall Study|Death|0|||
126155256|NCT02495077|453856420|FG003|Overall Study|Death|0|||
126155257|NCT02495077|453856417|FG000|Overall Study|Lost to Follow-up|6|||
126155258|NCT02495077|453856418|FG001|Overall Study|Lost to Follow-up|4|||
126155259|NCT02495077|453856419|FG002|Overall Study|Lost to Follow-up|0|||
126155260|NCT02495077|453856420|FG003|Overall Study|Lost to Follow-up|0|||
126155261|NCT02495077|453856417|FG000|Overall Study|Physician Decision|2|||
126155262|NCT02495077|453856418|FG001|Overall Study|Physician Decision|1|||
126155263|NCT02495077|453856419|FG002|Overall Study|Physician Decision|4|||
126155264|NCT02495077|453856420|FG003|Overall Study|Physician Decision|0|||
126155265|NCT02495077|453856417|FG000|Overall Study|Protocol Violation|0|||
126155266|NCT02495077|453856418|FG001|Overall Study|Protocol Violation|1|||
126155267|NCT02495077|453856419|FG002|Overall Study|Protocol Violation|0|||
126155268|NCT02495077|453856420|FG003|Overall Study|Protocol Violation|0|||
126155269|NCT02495077|453856417|FG000|Overall Study|Screen Failure|0|||
126155270|NCT02495077|453856418|FG001|Overall Study|Screen Failure|0|||
126155271|NCT02495077|453856419|FG002|Overall Study|Screen Failure|0|||
126155272|NCT02495077|453856420|FG003|Overall Study|Screen Failure|48|||
126155273|NCT02495077|453856417|FG000|Overall Study|Withdrawal by Subject|7|||
126155274|NCT02495077|453856418|FG001|Overall Study|Withdrawal by Subject|7|||
126155275|NCT02495077|453856419|FG002|Overall Study|Withdrawal by Subject|7|||
126155276|NCT02495077|453856420|FG003|Overall Study|Withdrawal by Subject|0|||
126155277|NCT02495077|453856417|FG000|Overall Study|Covid-19 research restrictions|1|||
126155278|NCT02495077|453856418|FG001|Overall Study|Covid-19 research restrictions|0|||
126155279|NCT02495077|453856419|FG002|Overall Study|Covid-19 research restrictions|0|||
126155280|NCT02495077|453856420|FG003|Overall Study|Covid-19 research restrictions|0|||
126155281|NCT02495077|453856417|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
126155282|NCT02495077|453856418|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
126155283|NCT02495077|453856419|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
126155284|NCT02495077|453856420|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
126155285|NCT02495077|453856417|FG000|Overall Study|Incarcerated|0|||
126155286|NCT02495077|453856418|FG001|Overall Study|Incarcerated|1|||
126155287|NCT02495077|453856419|FG002|Overall Study|Incarcerated|0|||
126155288|NCT02495077|453856420|FG003|Overall Study|Incarcerated|0|||
126155289|NCT02495077|453856417|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
126155290|NCT02495077|453856418|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
126155291|NCT02495077|453856419|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
126155292|NCT02495077|453856420|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
126155293|NCT02495077|453856417|FG000|Overall Study|Timing of transplant and randomization|0|||
126155294|NCT02495077|453856418|FG001|Overall Study|Timing of transplant and randomization|0|||
126155295|NCT02495077|453856419|FG002|Overall Study|Timing of transplant and randomization|5|||
126155296|NCT02495077|453856420|FG003|Overall Study|Timing of transplant and randomization|0|||
126155297|NCT02742649|453856421|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
126155298|NCT02742649|453856422|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
126155299|NCT02742649|453856423|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
126155300|NCT02742649|453856424|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
126155301|NCT02742649|453856425|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
126155302|NCT02742649|453856421|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126155303|NCT02742649|453856422|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126155304|NCT02742649|453856423|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126155305|NCT02742649|453856424|FG003|Double-Blind Treatment Period|Adverse Event|0|||
126155306|NCT02742649|453856425|FG004|Double-Blind Treatment Period|Adverse Event|0|||
126155307|NCT02742649|453856421|FG000|Open-Label Period|Lost to Follow-up|0|||
125971705|NCT03759873|453184791|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
126155308|NCT02742649|453856422|FG001|Open-Label Period|Lost to Follow-up|0|||
126155309|NCT02742649|453856423|FG002|Open-Label Period|Lost to Follow-up|0|||
126155310|NCT02742649|453856424|FG003|Open-Label Period|Lost to Follow-up|0|||
126155311|NCT02742649|453856425|FG004|Open-Label Period|Lost to Follow-up|1|||
126155312|NCT03635190|453856435|FG000|Overall Study|Lost to Follow-up|4|||
126155313|NCT03635190|453856435|FG000|Overall Study|Death|3|||
126155314|NCT03635190|453856435|FG000|Overall Study|Withdrawal by Subject|1|||
126155315|NCT03635190|453856435|FG000|Overall Study|Patient moved and did not return for follow up|1|||
126155316|NCT03692910|453856438|FG000|Overall Study|Lost to Follow-up|4|||
125971706|NCT03759873|453184792|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
126155317|NCT03692910|453856439|FG001|Overall Study|Lost to Follow-up|0|||
126155318|NCT03692910|453856440|FG002|Overall Study|Lost to Follow-up|0|||
126155319|NCT03692910|453856438|FG000|Overall Study|Withdrawal by Subject|2|||
126155320|NCT03692910|453856439|FG001|Overall Study|Withdrawal by Subject|0|||
126155321|NCT03692910|453856440|FG002|Overall Study|Withdrawal by Subject|0|||
125971707|NCT03759873|453184793|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
126155322|NCT01981122|453856445|FG000|Overall Study|Withdrawal by Subject|0|||
126155323|NCT01981122|453856446|FG001|Overall Study|Withdrawal by Subject|2|||
126155324|NCT01981122|453856445|FG000|Overall Study|Protocol Violation|0|||
126155325|NCT01981122|453856446|FG001|Overall Study|Protocol Violation|1|||
126155326|NCT01981122|453856445|FG000|Overall Study|Lost to Follow-up|0|||
126155327|NCT01981122|453856446|FG001|Overall Study|Lost to Follow-up|1|||
126155328|NCT01981122|453856445|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
126155329|NCT01981122|453856446|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
126155330|NCT01981122|453856445|FG000|Overall Study|Death|14|||
126155331|NCT01981122|453856446|FG001|Overall Study|Death|15|||
126155332|NCT00092547|453856448|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
126155333|NCT00092547|453856449|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
126155334|NCT00092547|453856450|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
126155335|NCT00092547|453856448|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
126155336|NCT00092547|453856449|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
126155337|NCT00092547|453856450|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
126155338|NCT00092547|453856448|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
126155339|NCT00092547|453856449|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
126155340|NCT00092547|453856450|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
126155341|NCT00092547|453856448|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
126155342|NCT00092547|453856449|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
126155343|NCT00092547|453856450|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
126155344|NCT00092547|453856448|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
126155345|NCT00092547|453856449|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
126155346|NCT00092547|453856450|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
126155347|NCT00092547|453856448|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
126155348|NCT00092547|453856449|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
126155349|NCT00092547|453856450|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
126155350|NCT00092547|453856448|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
126155351|NCT00092547|453856449|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
126155352|NCT00092547|453856450|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
126155353|NCT00092547|453856448|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
126155354|NCT00092547|453856449|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
126155355|NCT00092547|453856450|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
126155356|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
126155357|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
126155358|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
126155359|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
126155360|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
126155361|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
126155362|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
126155363|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
126155364|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
126155365|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
126155366|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
126155367|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
126155368|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
126155369|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
126155370|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
126155371|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
126155372|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
126155373|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
126155374|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
126155375|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
126155376|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
126155377|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
126155378|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
126155379|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
126155380|NCT00092547|453856448|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
126155381|NCT00092547|453856449|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
126155382|NCT00092547|453856450|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
126155383|NCT00092547|453856448|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
126155384|NCT00092547|453856449|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
126155385|NCT00092547|453856450|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
126155386|NCT00092547|453856448|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
126155387|NCT00092547|453856449|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
126155388|NCT00092547|453856450|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
126155389|NCT00092547|453856448|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
126155390|NCT00092547|453856449|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
126155391|NCT00092547|453856450|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
126155392|NCT00092547|453856448|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
126155393|NCT00092547|453856449|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
126155394|NCT00092547|453856450|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
126155395|NCT04328623|453856451|FG000|Overall Study|Protocol Violation|0|||
126155396|NCT04328623|453856452|FG001|Overall Study|Protocol Violation|1|||
126155397|NCT01539837|453856453|FG000|Overall Study|reduce neutrophil level|0|||
126155398|NCT01539837|453856454|FG001|Overall Study|reduce neutrophil level|1|||
126155399|NCT01539837|453856455|FG002|Overall Study|reduce neutrophil level|1|||
126155400|NCT01539837|453856453|FG000|Overall Study|bad compliance|0|||
126155401|NCT01539837|453856454|FG001|Overall Study|bad compliance|0|||
126155402|NCT01539837|453856455|FG002|Overall Study|bad compliance|1|||
126155403|NCT01978912|453856456|FG000|Overall Study|Adverse Event|0|||
126155404|NCT01978912|453856457|FG001|Overall Study|Adverse Event|1|||
126155405|NCT01978912|453856458|FG002|Overall Study|Adverse Event|0|||
126155406|NCT01978912|453856459|FG003|Overall Study|Adverse Event|0|||
126155407|NCT01978912|453856456|FG000|Overall Study|Lost to Follow-up|1|||
126155408|NCT01978912|453856457|FG001|Overall Study|Lost to Follow-up|1|||
126155409|NCT01978912|453856458|FG002|Overall Study|Lost to Follow-up|0|||
126155410|NCT01978912|453856459|FG003|Overall Study|Lost to Follow-up|1|||
126155411|NCT01978912|453856456|FG000|Overall Study|Withdrawal by Subject|1|||
126155412|NCT01978912|453856457|FG001|Overall Study|Withdrawal by Subject|0|||
126155413|NCT01978912|453856458|FG002|Overall Study|Withdrawal by Subject|2|||
126155414|NCT01978912|453856459|FG003|Overall Study|Withdrawal by Subject|2|||
126155415|NCT01978912|453856456|FG000|Overall Study|Lumbar Surgery|1|||
126155416|NCT01978912|453856457|FG001|Overall Study|Lumbar Surgery|0|||
126155417|NCT01978912|453856458|FG002|Overall Study|Lumbar Surgery|1|||
126155418|NCT01978912|453856459|FG003|Overall Study|Lumbar Surgery|0|||
126155419|NCT01978912|453856456|FG000|Overall Study|Intradiscal Steroid Injection|0|||
126155420|NCT01978912|453856457|FG001|Overall Study|Intradiscal Steroid Injection|1|||
126155421|NCT01978912|453856458|FG002|Overall Study|Intradiscal Steroid Injection|0|||
126155422|NCT01978912|453856459|FG003|Overall Study|Intradiscal Steroid Injection|0|||
126155423|NCT04220866|453856460|FG000|Overall Study|Death|4|||
126155424|NCT04220866|453856461|FG001|Overall Study|Death|5|||
126155425|NCT04220866|453856460|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
126155426|NCT04220866|453856461|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
126155427|NCT04220866|453856460|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
126155428|NCT04220866|453856461|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
126155429|NCT04220866|453856460|FG000|Overall Study|Withdrawal by Subject|0|||
126155430|NCT04220866|453856461|FG001|Overall Study|Withdrawal by Subject|1|||
126155431|NCT02138110|453856462|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
126155432|NCT02138110|453856462|FG000|Overall Scaffold Implantation|Death|3|||
126155433|NCT01408537|453856466|FG000|Overall Study|Withdrawal by Subject|2|||
126155434|NCT01408537|453856466|FG000|Overall Study|Protocol Violation|3|||
126155435|NCT01408537|453856466|FG000|Overall Study|Lost to Follow-up|3|||
126155436|NCT02760602|453856469|FG000|Overall Study|Withdrawal by Subject|1|||
126155437|NCT02760602|453856470|FG001|Overall Study|Withdrawal by Subject|0|||
126155438|NCT02760602|453856469|FG000|Overall Study|Terminated by sponsor|12|||
126155439|NCT02760602|453856470|FG001|Overall Study|Terminated by sponsor|13|||
126155440|NCT02046564|453856476|FG000|Overall Study|Adverse Event|6|||
126155441|NCT02046564|453856477|FG001|Overall Study|Adverse Event|3|||
126155442|NCT02046564|453856476|FG000|Overall Study|Physician Decision|0|||
126155443|NCT02046564|453856477|FG001|Overall Study|Physician Decision|1|||
126155444|NCT02046564|453856476|FG000|Overall Study|Protocol Violation|3|||
126155445|NCT02046564|453856477|FG001|Overall Study|Protocol Violation|1|||
126155446|NCT02046564|453856476|FG000|Overall Study|Withdrawal by Subject|4|||
126155447|NCT02046564|453856477|FG001|Overall Study|Withdrawal by Subject|10|||
126155448|NCT02046564|453856476|FG000|Overall Study|Subject met withdrawal criteria|2|||
126155449|NCT02046564|453856477|FG001|Overall Study|Subject met withdrawal criteria|5|||
126155450|NCT01295905|453856480|FG000|Overall Study|Did not meet inclusion criteria|1|||
126155451|NCT01295905|453856481|FG001|Overall Study|Did not meet inclusion criteria|0|||
126155452|NCT01295905|453856480|FG000|Overall Study|Met exclusion criteria|1|||
126155453|NCT01295905|453856481|FG001|Overall Study|Met exclusion criteria|0|||
126155454|NCT00791128|453856483|FG000|Overall Study|Adverse Event|4|||
126155455|NCT00791128|453856483|FG000|Overall Study|Device migration|2|||
126155456|NCT00791128|453856483|FG000|Overall Study|non-compliance by subject|2|||
126155457|NCT00791128|453856483|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
126155458|NCT00670111|453856484|FG000|Enrollment to One Month|Testing Failure|0|||
126155459|NCT00670111|453856485|FG001|Enrollment to One Month|Testing Failure|0|||
126155460|NCT00670111|453856486|FG002|Enrollment to One Month|Testing Failure|13|||
126155461|NCT00670111|453856484|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
126155462|NCT00670111|453856485|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
126155463|NCT00670111|453856486|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
126155464|NCT00670111|453856484|FG000|Enrollment to One Month|Physician Decision|1|||
126155465|NCT00670111|453856485|FG001|Enrollment to One Month|Physician Decision|0|||
126155466|NCT00670111|453856486|FG002|Enrollment to One Month|Physician Decision|0|||
126155467|NCT03988751|453856487|FG000|Overall Study|Withdrawal by Subject|1|||
126155468|NCT03988751|453856488|FG001|Overall Study|Withdrawal by Subject|0|||
126155469|NCT03988751|453856487|FG000|Overall Study|Protocol Violation|0|||
126155470|NCT03988751|453856488|FG001|Overall Study|Protocol Violation|1|||
126155471|NCT02623361|453856489|FG000|Overall Study|Protocol Violation|0|||
126155472|NCT02623361|453856490|FG001|Overall Study|Protocol Violation|1|||
126155473|NCT02623361|453856489|FG000|Overall Study|Withdrawal by Subject|0|||
126155474|NCT02623361|453856490|FG001|Overall Study|Withdrawal by Subject|1|||
126155475|NCT00844883|453856491|FG000|Overall Study|Bridged to liver transplant|3|||
126155476|NCT00844883|453856491|FG000|Overall Study|Bridged to resection|1|||
126155477|NCT03894540|453856494|FG000|Overall Study|Adverse Event|0|||
126155478|NCT03894540|453856495|FG001|Overall Study|Adverse Event|0|||
126155479|NCT03894540|453856496|FG002|Overall Study|Adverse Event|0|||
126155480|NCT03894540|453856497|FG003|Overall Study|Adverse Event|0|||
126155481|NCT03894540|453856498|FG004|Overall Study|Adverse Event|1|||
126155482|NCT03894540|453856499|FG005|Overall Study|Adverse Event|0|||
126155483|NCT03894540|453856494|FG000|Overall Study|Withdrawal by Subject|0|||
126155484|NCT03894540|453856495|FG001|Overall Study|Withdrawal by Subject|0|||
126155485|NCT03894540|453856496|FG002|Overall Study|Withdrawal by Subject|0|||
126155486|NCT03894540|453856497|FG003|Overall Study|Withdrawal by Subject|0|||
126155487|NCT03894540|453856498|FG004|Overall Study|Withdrawal by Subject|1|||
126155488|NCT03894540|453856499|FG005|Overall Study|Withdrawal by Subject|0|||
126155489|NCT03894540|453856494|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
126155490|NCT03894540|453856495|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
126155491|NCT03894540|453856496|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
126155492|NCT03894540|453856497|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
126155493|NCT03894540|453856498|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
126155494|NCT03894540|453856499|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
126155495|NCT03894540|453856494|FG000|Overall Study|Progressive Disease Clinical|1|||
126155496|NCT03894540|453856495|FG001|Overall Study|Progressive Disease Clinical|1|||
126155497|NCT03894540|453856496|FG002|Overall Study|Progressive Disease Clinical|0|||
126155498|NCT03894540|453856497|FG003|Overall Study|Progressive Disease Clinical|1|||
126155499|NCT03894540|453856498|FG004|Overall Study|Progressive Disease Clinical|5|||
126155500|NCT03894540|453856499|FG005|Overall Study|Progressive Disease Clinical|1|||
126155501|NCT03894540|453856494|FG000|Overall Study|Study termination by sponsor|0|||
126155502|NCT03894540|453856495|FG001|Overall Study|Study termination by sponsor|0|||
126155503|NCT03894540|453856496|FG002|Overall Study|Study termination by sponsor|0|||
126155504|NCT03894540|453856497|FG003|Overall Study|Study termination by sponsor|0|||
126155505|NCT03894540|453856498|FG004|Overall Study|Study termination by sponsor|2|||
126155506|NCT03894540|453856499|FG005|Overall Study|Study termination by sponsor|0|||
126155507|NCT03000452|453856502|FG000|Treatment Period|Death|1|||
126155508|NCT03000452|453856502|FG000|Treatment Period|Progressive Disease (PD)|14|||
126155509|NCT03000452|453856502|FG000|Treatment Period|Physician Decision|1|||
126155510|NCT03000452|453856502|FG000|Treatment Period|Miscellaneous|2|||
126155511|NCT03000452|453856502|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
126155512|NCT03000452|453856502|FG000|Follow-Up Period|Death|3|||
126155513|NCT03000452|453856502|FG000|Follow-Up Period|Withdrawal by Subject|3|||
126155514|NCT03043365|453856503|FG000|Weeks 0 to Week 8|Adverse Event|1|||
126155515|NCT03043365|453856504|FG001|Weeks 0 to Week 8|Adverse Event|3|||
126155516|NCT03043365|453856503|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
126155517|NCT03043365|453856504|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
126155518|NCT03043365|453856503|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
126155519|NCT03043365|453856504|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
126155520|NCT03455543|453856505|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
126155521|NCT03455543|453856506|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
126155522|NCT03455543|453856507|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
126155523|NCT03455543|453856505|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
126155524|NCT03455543|453856506|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
126155525|NCT03455543|453856507|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
126155526|NCT03455543|453856505|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
126155527|NCT03455543|453856506|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
126155528|NCT03455543|453856507|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
125971708|NCT03759873|453184790|FG000|Overall Study|Moved outside eligible area|0|||
126200103|NCT02394028|454017880|FG003|Induction Phase|Adverse Event|2|||
125971709|NCT03759873|453184791|FG001|Overall Study|Moved outside eligible area|2|||
126155529|NCT03455543|453856505|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
126155530|NCT03455543|453856506|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
126155531|NCT03455543|453856507|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
126155532|NCT03455543|453856505|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
126155533|NCT03455543|453856506|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
126155534|NCT03455543|453856507|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
126155535|NCT03455543|453856505|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
126155536|NCT03455543|453856506|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
126155537|NCT03455543|453856507|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
126155538|NCT03455543|453856505|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
126155539|NCT03455543|453856506|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
126155540|NCT03455543|453856507|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
126155541|NCT03455543|453856505|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
126155542|NCT03455543|453856506|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
126155543|NCT03455543|453856507|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
126155544|NCT03455543|453856505|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
126155545|NCT03455543|453856506|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
126155546|NCT03455543|453856507|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
126155547|NCT02873221|453856508|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
126155548|NCT02873221|453856509|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
126155549|NCT02873221|453856510|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
126155550|NCT02873221|453856508|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
126155551|NCT02873221|453856509|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
126155552|NCT02873221|453856510|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
126155553|NCT02873221|453856508|FG000|Treatment Period|Protocol Violation|2|||
126155554|NCT02873221|453856509|FG001|Treatment Period|Protocol Violation|5|||
126155555|NCT02873221|453856510|FG002|Treatment Period|Protocol Violation|8|||
126155556|NCT02873221|453856508|FG000|Treatment Period|Pregnancy|4|||
126155557|NCT02873221|453856509|FG001|Treatment Period|Pregnancy|6|||
126155558|NCT02873221|453856510|FG002|Treatment Period|Pregnancy|3|||
126155559|NCT02873221|453856508|FG000|Treatment Period|Lack of Qualifying Event|0|||
126155560|NCT02873221|453856509|FG001|Treatment Period|Lack of Qualifying Event|3|||
126155561|NCT02873221|453856510|FG002|Treatment Period|Lack of Qualifying Event|1|||
126155562|NCT02873221|453856508|FG000|Treatment Period|Withdrawal of Consent|52|||
126155563|NCT02873221|453856509|FG001|Treatment Period|Withdrawal of Consent|51|||
126155564|NCT02873221|453856510|FG002|Treatment Period|Withdrawal of Consent|41|||
126155565|NCT02873221|453856508|FG000|Treatment Period|Lack of Efficacy|0|||
126155566|NCT02873221|453856509|FG001|Treatment Period|Lack of Efficacy|17|||
126155567|NCT02873221|453856510|FG002|Treatment Period|Lack of Efficacy|12|||
126155568|NCT02873221|453856508|FG000|Treatment Period|Adverse Event|4|||
126155569|NCT02873221|453856509|FG001|Treatment Period|Adverse Event|9|||
126155570|NCT02873221|453856510|FG002|Treatment Period|Adverse Event|11|||
126155571|NCT02873221|453856508|FG000|Treatment Period|Lost to Follow-up|26|||
126155572|NCT02873221|453856509|FG001|Treatment Period|Lost to Follow-up|30|||
126155573|NCT02873221|453856510|FG002|Treatment Period|Lost to Follow-up|26|||
126155574|NCT02873221|453856508|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
126155575|NCT02873221|453856509|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
126155576|NCT02873221|453856510|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
126155577|NCT02873221|453856508|FG000|Safety Follow-up Period|Protocol Violation|0|||
126155578|NCT02873221|453856509|FG001|Safety Follow-up Period|Protocol Violation|0|||
126155579|NCT02873221|453856510|FG002|Safety Follow-up Period|Protocol Violation|1|||
126155580|NCT02873221|453856508|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
126155581|NCT02873221|453856509|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
126155582|NCT02873221|453856510|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
126155583|NCT02873221|453856508|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
126155584|NCT02873221|453856509|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
126155585|NCT02873221|453856510|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
126155586|NCT01508676|453856511|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
126155587|NCT01508676|453856512|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
126155588|NCT01508676|453856511|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
126155589|NCT01508676|453856512|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
126155590|NCT01508676|453856511|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
126155591|NCT01508676|453856512|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
126155592|NCT01508676|453856511|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
126155593|NCT01508676|453856512|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
126155594|NCT01508676|453856511|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
126155595|NCT01508676|453856512|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
126155596|NCT02532543|453856513|FG000|Overall Study|Lost to Follow-up|0|||
126155597|NCT02532543|453856514|FG001|Overall Study|Lost to Follow-up|0|||
126155598|NCT02532543|453856515|FG002|Overall Study|Lost to Follow-up|1|||
125971710|NCT03759873|453184792|FG002|Overall Study|Moved outside eligible area|0|||
126155599|NCT02532543|453856516|FG003|Overall Study|Lost to Follow-up|0|||
126155600|NCT02614794|453856519|FG000|Overall Study|Death|258|||
126155601|NCT02614794|453856520|FG001|Overall Study|Death|151|||
126155602|NCT02614794|453856519|FG000|Overall Study|Study closure by Sponsor|119|||
126155603|NCT02614794|453856520|FG001|Overall Study|Study closure by Sponsor|45|||
126155604|NCT02614794|453856519|FG000|Overall Study|Withdrawal by Subject|24|||
126155605|NCT02614794|453856520|FG001|Overall Study|Withdrawal by Subject|5|||
126155606|NCT02614794|453856519|FG000|Overall Study|Lost to Follow-up|7|||
126155607|NCT02614794|453856520|FG001|Overall Study|Lost to Follow-up|0|||
126155608|NCT02614794|453856519|FG000|Overall Study|Physician Decision|1|||
126155609|NCT02614794|453856520|FG001|Overall Study|Physician Decision|1|||
126155610|NCT02614794|453856519|FG000|Overall Study|Hospital closure|1|||
126155611|NCT02614794|453856520|FG001|Overall Study|Hospital closure|0|||
126155612|NCT01633060|453856530|FG000|Randomization Phase|Protocol deviation|1|||
126155613|NCT01633060|453856531|FG001|Randomization Phase|Protocol deviation|2|||
126155614|NCT01633060|453856530|FG000|Randomization Phase|Technical problem|0|||
126155615|NCT01633060|453856531|FG001|Randomization Phase|Technical problem|1|||
126155616|NCT01633060|453856530|FG000|Treatment Phase|Adverse Event|24|||
126155617|NCT01633060|453856531|FG001|Treatment Phase|Adverse Event|3|||
126155618|NCT01633060|453856530|FG000|Treatment Phase|Lost to Follow-up|1|||
126155619|NCT01633060|453856531|FG001|Treatment Phase|Lost to Follow-up|0|||
126155620|NCT01633060|453856530|FG000|Treatment Phase|Physician Decision|16|||
126155621|NCT01633060|453856531|FG001|Treatment Phase|Physician Decision|7|||
126155622|NCT01633060|453856530|FG000|Treatment Phase|Progressive Disease|210|||
126155623|NCT01633060|453856531|FG001|Treatment Phase|Progressive Disease|120|||
126155624|NCT01633060|453856530|FG000|Treatment Phase|Protocol Deviation|1|||
126155625|NCT01633060|453856531|FG001|Treatment Phase|Protocol Deviation|0|||
126155626|NCT01633060|453856530|FG000|Treatment Phase|Study Terminated by sponsor|7|||
126155627|NCT01633060|453856531|FG001|Treatment Phase|Study Terminated by sponsor|3|||
126155628|NCT01633060|453856530|FG000|Treatment Phase|Subject/guardian decision|25|||
126155629|NCT01633060|453856531|FG001|Treatment Phase|Subject/guardian decision|4|||
126155630|NCT01633060|453856530|FG000|Treatment Phase|Death|4|||
126155631|NCT01633060|453856531|FG001|Treatment Phase|Death|3|||
126155632|NCT01633060|453856530|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
126155633|NCT01633060|453856531|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126155634|NCT01633060|453856530|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
126155635|NCT01633060|453856531|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
126155636|NCT01633060|453856530|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
126155637|NCT01633060|453856531|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
126155638|NCT01633060|453856530|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
126155639|NCT01633060|453856531|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
126155640|NCT01633060|453856530|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
126155641|NCT01633060|453856531|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
126155642|NCT01633060|453856530|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
126155643|NCT01633060|453856531|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
126155644|NCT01396525|453856534|FG000|Overall Study|Withdrawal by Subject|8|||
126155645|NCT01396525|453856534|FG000|Overall Study|Death|14|||
126155646|NCT01396525|453856534|FG000|Overall Study|Lost to Follow-up|4|||
126155647|NCT03114969|453856535|FG000|Overall Study|Lost to Follow-up|0|||
126155648|NCT03114969|453856536|FG001|Overall Study|Lost to Follow-up|0|||
126155649|NCT03114969|453856537|FG002|Overall Study|Lost to Follow-up|3|||
126155650|NCT03114969|453856538|FG003|Overall Study|Lost to Follow-up|2|||
126155651|NCT03114969|453856539|FG004|Overall Study|Lost to Follow-up|0|||
126155652|NCT03114969|453856540|FG005|Overall Study|Lost to Follow-up|0|||
126155653|NCT03114969|453856541|FG006|Overall Study|Lost to Follow-up|0|||
126155654|NCT03114969|453856542|FG007|Overall Study|Lost to Follow-up|0|||
126155655|NCT03114969|453856543|FG008|Overall Study|Lost to Follow-up|0|||
126155656|NCT03114969|453856535|FG000|Overall Study|Adverse Event|0|||
126155657|NCT03114969|453856536|FG001|Overall Study|Adverse Event|0|||
126155658|NCT03114969|453856537|FG002|Overall Study|Adverse Event|1|||
126155659|NCT03114969|453856538|FG003|Overall Study|Adverse Event|0|||
126155660|NCT03114969|453856539|FG004|Overall Study|Adverse Event|0|||
126155661|NCT03114969|453856540|FG005|Overall Study|Adverse Event|1|||
126155662|NCT03114969|453856541|FG006|Overall Study|Adverse Event|1|||
126155663|NCT03114969|453856542|FG007|Overall Study|Adverse Event|0|||
126155664|NCT03114969|453856543|FG008|Overall Study|Adverse Event|2|||
126155665|NCT00949650|453856544|FG000|Overall Study|Progressive disease|188|||
126155666|NCT00949650|453856545|FG001|Overall Study|Progressive disease|19|||
126155667|NCT00949650|453856544|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
126155668|NCT00949650|453856545|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
126155669|NCT00949650|453856544|FG000|Overall Study|Other Adverse Event (AE)|28|||
126155670|NCT00949650|453856545|FG001|Overall Study|Other Adverse Event (AE)|17|||
126155671|NCT00949650|453856544|FG000|Overall Study|Protocol Violation|1|||
126155672|NCT00949650|453856545|FG001|Overall Study|Protocol Violation|4|||
126155673|NCT00949650|453856544|FG000|Overall Study|Refusal to continue medication|7|||
126155674|NCT00949650|453856545|FG001|Overall Study|Refusal to continue medication|11|||
126155675|NCT00949650|453856544|FG000|Overall Study|Not treated|1|||
126155676|NCT00949650|453856545|FG001|Overall Study|Not treated|4|||
126155677|NCT00949650|453856544|FG000|Overall Study|Other not specified above|5|||
126155678|NCT00949650|453856545|FG001|Overall Study|Other not specified above|0|||
126155679|NCT04601272|453856546|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
126155680|NCT04601272|453856547|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
126155681|NCT04601272|453856548|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
126155682|NCT00414440|453856549|FG000|Core Period|Withdrawal by Subject|70|||
126155683|NCT00414440|453856550|FG001|Core Period|Withdrawal by Subject|32|||
126155684|NCT00414440|453856549|FG000|Extension Period|Lost to Follow-up|44|||
126155685|NCT00414440|453856550|FG001|Extension Period|Lost to Follow-up|52|||
126155686|NCT00414440|453856549|FG000|Extension Period|Did not consent to continue follow up|61|||
126155687|NCT00414440|453856550|FG001|Extension Period|Did not consent to continue follow up|54|||
126155688|NCT00414440|453856549|FG000|Extension Period|Other|1|||
126155689|NCT00414440|453856550|FG001|Extension Period|Other|1|||
126155690|NCT00414440|453856549|FG000|Extension Period|Administrative|16|||
126155691|NCT00414440|453856550|FG001|Extension Period|Administrative|16|||
126155692|NCT00414440|453856549|FG000|Extension Period|Death|1|||
126155693|NCT00414440|453856550|FG001|Extension Period|Death|2|||
126155694|NCT00414440|453856549|FG000|Extension Period|Withdrawal by Subject|9|||
126155695|NCT00414440|453856550|FG001|Extension Period|Withdrawal by Subject|7|||
126155696|NCT00414440|453856549|FG000|Extension Period|Not included in follow up period|18|||
126155697|NCT00414440|453856550|FG001|Extension Period|Not included in follow up period|8|||
126155698|NCT02168946|453856551|FG000|Overall Study|Adverse Event|8|||
126155699|NCT02168946|453856552|FG001|Overall Study|Adverse Event|5|||
126155700|NCT02168946|453856551|FG000|Overall Study|Lost to Follow-up|3|||
126155701|NCT02168946|453856552|FG001|Overall Study|Lost to Follow-up|0|||
126155702|NCT02168946|453856551|FG000|Overall Study|Subject unable to come back for visits|1|||
126155703|NCT02168946|453856552|FG001|Overall Study|Subject unable to come back for visits|0|||
126155704|NCT00231478|453856565|FG000|Overall Study|Protocol Violation|3|||
126155705|NCT00231478|453856566|FG001|Overall Study|Protocol Violation|2|||
126155706|NCT00231478|453856565|FG000|Overall Study|Refused Treatment|1|||
126155707|NCT00231478|453856566|FG001|Overall Study|Refused Treatment|1|||
126155708|NCT00231478|453856565|FG000|Overall Study|Withdrawal by Subject|1|||
126155709|NCT00231478|453856566|FG001|Overall Study|Withdrawal by Subject|0|||
126155710|NCT00231478|453856565|FG000|Overall Study|Adverse Event|0|||
126155711|NCT00231478|453856566|FG001|Overall Study|Adverse Event|1|||
126155712|NCT00231478|453856565|FG000|Overall Study|Administrative|3|||
126155713|NCT00231478|453856566|FG001|Overall Study|Administrative|2|||
126155714|NCT00393458|453856573|FG000|Overall Study|Adverse Event|35|||
126155715|NCT00393458|453856574|FG001|Overall Study|Adverse Event|24|||
126155716|NCT00393458|453856575|FG002|Overall Study|Adverse Event|40|||
126155717|NCT00393458|453856576|FG003|Overall Study|Adverse Event|35|||
126155718|NCT00393458|453856573|FG000|Overall Study|Subject withdrew consent|27|||
126155719|NCT00393458|453856574|FG001|Overall Study|Subject withdrew consent|40|||
126155720|NCT00393458|453856575|FG002|Overall Study|Subject withdrew consent|33|||
126155721|NCT00393458|453856576|FG003|Overall Study|Subject withdrew consent|50|||
126155722|NCT00393458|453856573|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
126155723|NCT00393458|453856574|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
126155724|NCT00393458|453856575|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
126155725|NCT00393458|453856576|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
126155726|NCT00393458|453856573|FG000|Overall Study|Protocol deviation|11|||
126155727|NCT00393458|453856574|FG001|Overall Study|Protocol deviation|11|||
126155728|NCT00393458|453856575|FG002|Overall Study|Protocol deviation|11|||
126155729|NCT00393458|453856576|FG003|Overall Study|Protocol deviation|10|||
126155730|NCT00393458|453856573|FG000|Overall Study|Administrative problems|7|||
126155731|NCT00393458|453856574|FG001|Overall Study|Administrative problems|8|||
126155732|NCT00393458|453856575|FG002|Overall Study|Administrative problems|5|||
125971711|NCT03759873|453184793|FG003|Overall Study|Moved outside eligible area|0|||
125971712|NCT03759873|453184790|FG000|Overall Study|Withdrawal by Subject|0|||
126155733|NCT00393458|453856576|FG003|Overall Study|Administrative problems|2|||
126155734|NCT00393458|453856573|FG000|Overall Study|Lost to Follow-up|5|||
126155735|NCT00393458|453856574|FG001|Overall Study|Lost to Follow-up|6|||
126155736|NCT00393458|453856575|FG002|Overall Study|Lost to Follow-up|5|||
125971713|NCT03759873|453184791|FG001|Overall Study|Withdrawal by Subject|0|||
125971714|NCT03759873|453184792|FG002|Overall Study|Withdrawal by Subject|1|||
126155737|NCT00393458|453856576|FG003|Overall Study|Lost to Follow-up|3|||
126155738|NCT00393458|453856573|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126155739|NCT00393458|453856574|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126155740|NCT00393458|453856575|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126155741|NCT00393458|453856576|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126155742|NCT00393458|453856573|FG000|Overall Study|Death|1|||
126155743|NCT00393458|453856574|FG001|Overall Study|Death|1|||
126155744|NCT00393458|453856575|FG002|Overall Study|Death|5|||
126155745|NCT00393458|453856576|FG003|Overall Study|Death|5|||
126155746|NCT00393458|453856573|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126155747|NCT00393458|453856574|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126155748|NCT00393458|453856575|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126155749|NCT00393458|453856576|FG003|Overall Study|Abnormal test procedure result(s)|2|||
126155750|NCT00393458|453856573|FG000|Overall Study|Subject no longer requires study drug|0|||
126155751|NCT00393458|453856574|FG001|Overall Study|Subject no longer requires study drug|1|||
126155752|NCT00393458|453856575|FG002|Overall Study|Subject no longer requires study drug|0|||
126155753|NCT00393458|453856576|FG003|Overall Study|Subject no longer requires study drug|0|||
126155754|NCT02704429|453856585|FG000|Part A: 24 Weeks|Adverse Event|3|||
126155755|NCT02704429|453856586|FG001|Part A: 24 Weeks|Adverse Event|0|||
126155756|NCT02704429|453856585|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
126155757|NCT02704429|453856586|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
126155758|NCT00104104|453856587|FG000|Overall Study|Adverse Event|8|||
126155759|NCT00104104|453856588|FG001|Overall Study|Adverse Event|8|||
126155760|NCT00104104|453856587|FG000|Overall Study|Abnormal laboratory value(s)|20|||
126155761|NCT00104104|453856588|FG001|Overall Study|Abnormal laboratory value(s)|14|||
126155762|NCT00104104|453856587|FG000|Overall Study|Lack of Efficacy|0|||
126155763|NCT00104104|453856588|FG001|Overall Study|Lack of Efficacy|3|||
126155764|NCT00104104|453856587|FG000|Overall Study|Condition no longer requires study drug|7|||
126155765|NCT00104104|453856588|FG001|Overall Study|Condition no longer requires study drug|4|||
126155766|NCT00104104|453856587|FG000|Overall Study|Protocol Violation|5|||
126155767|NCT00104104|453856588|FG001|Overall Study|Protocol Violation|2|||
126155768|NCT00104104|453856587|FG000|Overall Study|Withdrawal by Subject|11|||
126155769|NCT00104104|453856588|FG001|Overall Study|Withdrawal by Subject|15|||
126155770|NCT00104104|453856587|FG000|Overall Study|Lost to Follow-up|3|||
126155771|NCT00104104|453856588|FG001|Overall Study|Lost to Follow-up|7|||
126155772|NCT00104104|453856587|FG000|Overall Study|Administrative problems|12|||
126155773|NCT00104104|453856588|FG001|Overall Study|Administrative problems|13|||
126155774|NCT00104104|453856587|FG000|Overall Study|Death|9|||
126155775|NCT00104104|453856588|FG001|Overall Study|Death|6|||
126155776|NCT01894516|453858072|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
126155777|NCT01894516|453858073|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
126155778|NCT01894516|453858074|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
126155779|NCT01894516|453858075|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
126155780|NCT01894516|453858072|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
126155781|NCT01894516|453858073|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126155782|NCT01894516|453858074|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126155783|NCT01894516|453858075|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126155784|NCT01894516|453858072|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
126155785|NCT01894516|453858073|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
126155786|NCT01894516|453858074|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
126155787|NCT01894516|453858075|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
126155788|NCT01894516|453858072|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
126155789|NCT01894516|453858073|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
126155790|NCT01894516|453858074|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
126155791|NCT01894516|453858075|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
126155792|NCT01894516|453858072|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
126155793|NCT01894516|453858073|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
126155794|NCT01894516|453858074|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
126155795|NCT01894516|453858075|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
126155796|NCT01894516|453858072|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
126155797|NCT01894516|453858073|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
126155798|NCT01894516|453858074|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
126155799|NCT01894516|453858075|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
126155800|NCT01894516|453858072|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
126155801|NCT01894516|453858073|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
126155802|NCT01894516|453858074|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
126155803|NCT01894516|453858075|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
126155804|NCT01894516|453858072|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126155805|NCT01894516|453858073|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126155806|NCT01894516|453858074|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
126155807|NCT01894516|453858075|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125971715|NCT03759873|453184793|FG003|Overall Study|Withdrawal by Subject|0|||
125971716|NCT03579563|453184794|FG000|Overall Study|Lost to Follow-up|0|||
125971717|NCT03579563|453184795|FG001|Overall Study|Lost to Follow-up|0|||
126155808|NCT03191396|453858077|FG000|Overall Study|Lost to Follow-up|0|||
126155809|NCT03191396|453858078|FG001|Overall Study|Lost to Follow-up|3|||
126155810|NCT03191396|453858077|FG000|Overall Study|Withdrawal by Subject|3|||
126155811|NCT03191396|453858078|FG001|Overall Study|Withdrawal by Subject|2|||
125971718|NCT03579563|453184796|FG002|Overall Study|Lost to Follow-up|0|||
125971719|NCT03579563|453184797|FG003|Overall Study|Lost to Follow-up|0|||
126155812|NCT01300286|453858079|FG000|Overall Study|did not get dosed|1|||
126155813|NCT00417612|453858080|FG000|Overall Study|Errant diagnosis|0|||
126155814|NCT00417612|453858081|FG001|Overall Study|Errant diagnosis|1|||
126155815|NCT00417612|453858080|FG000|Overall Study|Adverse Event|2|||
126155816|NCT00417612|453858081|FG001|Overall Study|Adverse Event|0|||
126155817|NCT00417612|453858080|FG000|Overall Study|Protocol Violation|0|||
126155818|NCT00417612|453858081|FG001|Overall Study|Protocol Violation|2|||
126155819|NCT00417612|453858080|FG000|Overall Study|Lost to Follow-up|1|||
126155820|NCT00417612|453858081|FG001|Overall Study|Lost to Follow-up|0|||
126155821|NCT01330381|453858082|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
126155822|NCT01330381|453858083|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
126155823|NCT01330381|453858084|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
126155824|NCT01330381|453858082|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
126155825|NCT01330381|453858083|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
126155826|NCT01330381|453858084|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
126155827|NCT01330381|453858082|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
126155828|NCT01330381|453858083|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
126155829|NCT01330381|453858084|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
126155830|NCT01330381|453858082|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
126155831|NCT01330381|453858083|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
126155832|NCT01330381|453858084|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
126155833|NCT01330381|453858082|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
126155834|NCT01330381|453858083|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
126155835|NCT01330381|453858084|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
126155836|NCT01330381|453858082|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
126155837|NCT01330381|453858083|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
126155838|NCT01330381|453858084|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
126155839|NCT01330381|453858082|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
126155840|NCT01330381|453858083|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
126155841|NCT01330381|453858084|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
126155842|NCT01330381|453858082|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
126155843|NCT01330381|453858083|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
126155844|NCT01330381|453858084|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
126155845|NCT01330381|453858082|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
126155846|NCT01330381|453858083|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
126155847|NCT01330381|453858084|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
126155848|NCT01330381|453858082|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
126155849|NCT01330381|453858083|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
126155850|NCT01330381|453858084|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
126155851|NCT03060577|453858085|FG000|Overall Study|Withdrawal by Subject|25|||
126155852|NCT03060577|453858086|FG001|Overall Study|Withdrawal by Subject|5|||
126155853|NCT03060577|453858085|FG000|Overall Study|Physician Decision|4|||
126155854|NCT03060577|453858086|FG001|Overall Study|Physician Decision|3|||
126155855|NCT03060577|453858085|FG000|Overall Study|Lost to Follow-up|3|||
126155856|NCT03060577|453858086|FG001|Overall Study|Lost to Follow-up|0|||
126155857|NCT03060577|453858085|FG000|Overall Study|Death|7|||
126155858|NCT03060577|453858086|FG001|Overall Study|Death|1|||
126155859|NCT03060577|453858085|FG000|Overall Study|Adverse Event|9|||
126155860|NCT03060577|453858086|FG001|Overall Study|Adverse Event|1|||
126155861|NCT03060577|453858085|FG000|Overall Study|Inclusion/Exclusion|1|||
126155862|NCT03060577|453858086|FG001|Overall Study|Inclusion/Exclusion|0|||
126155863|NCT03060577|453858085|FG000|Overall Study|Other|8|||
126155864|NCT03060577|453858086|FG001|Overall Study|Other|2|||
126155865|NCT03216265|453858090|FG000|Overall Study|Adverse Event|2|||
126155866|NCT03216265|453858091|FG001|Overall Study|Adverse Event|0|||
126155867|NCT03216265|453858092|FG002|Overall Study|Adverse Event|2|||
126155868|NCT03216265|453858090|FG000|Overall Study|Lost to Follow-up|0|||
126155869|NCT03216265|453858091|FG001|Overall Study|Lost to Follow-up|1|||
126155870|NCT03216265|453858092|FG002|Overall Study|Lost to Follow-up|0|||
126155871|NCT03216265|453858090|FG000|Overall Study|Withdrawal by Subject|0|||
126155872|NCT03216265|453858091|FG001|Overall Study|Withdrawal by Subject|0|||
126155873|NCT03216265|453858092|FG002|Overall Study|Withdrawal by Subject|1|||
126155874|NCT01277289|453858093|FG000|Overall Study|fragile vein|1|||
126155875|NCT01277289|453858094|FG001|Overall Study|fragile vein|0|||
126155876|NCT01277289|453858093|FG000|Overall Study|Physician Decision|1|||
125971720|NCT03579563|453184798|FG004|Overall Study|Lost to Follow-up|1|||
126155877|NCT01277289|453858094|FG001|Overall Study|Physician Decision|0|||
125971721|NCT03579563|453184799|FG005|Overall Study|Lost to Follow-up|0|||
126155878|NCT01277289|453858093|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
126155879|NCT01277289|453858094|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
126155880|NCT01277289|453858093|FG000|Overall Study|Protocol Violation|1|||
125971722|NCT03579563|453184794|FG000|Overall Study|Lack of Efficacy|1|||
126155881|NCT01277289|453858094|FG001|Overall Study|Protocol Violation|1|||
126155882|NCT01277289|453858093|FG000|Overall Study|Adverse Event|2|||
126155883|NCT01277289|453858094|FG001|Overall Study|Adverse Event|1|||
126155884|NCT01277289|453858093|FG000|Overall Study|consent withdrawn|1|||
126155885|NCT01277289|453858094|FG001|Overall Study|consent withdrawn|1|||
126155886|NCT01277289|453858093|FG000|Overall Study|premature closure of the study|4|||
126155887|NCT01277289|453858094|FG001|Overall Study|premature closure of the study|2|||
126155888|NCT00224107|453858096|FG000|Overall Study|Adverse Event|20|||
126155889|NCT00224107|453858097|FG001|Overall Study|Adverse Event|6|||
126155890|NCT00224107|453858096|FG000|Overall Study|Protocol Violation|2|||
126155891|NCT00224107|453858097|FG001|Overall Study|Protocol Violation|3|||
126155892|NCT00224107|453858096|FG000|Overall Study|Withdrawal by Subject|1|||
126155893|NCT00224107|453858097|FG001|Overall Study|Withdrawal by Subject|4|||
126155894|NCT00224107|453858096|FG000|Overall Study|Lack of Efficacy|2|||
126155895|NCT00224107|453858097|FG001|Overall Study|Lack of Efficacy|0|||
126155896|NCT00224107|453858096|FG000|Overall Study|Lost to Follow-up|4|||
126155897|NCT00224107|453858097|FG001|Overall Study|Lost to Follow-up|0|||
126155898|NCT00224107|453858096|FG000|Overall Study|Physician Decision|1|||
126155899|NCT00224107|453858097|FG001|Overall Study|Physician Decision|0|||
126155900|NCT00224107|453858096|FG000|Overall Study|Other|1|||
126155901|NCT00224107|453858097|FG001|Overall Study|Other|1|||
126155902|NCT00685178|453858098|FG000|Overall Study|Adverse Event|1|||
126155903|NCT00685178|453858099|FG001|Overall Study|Adverse Event|5|||
126155904|NCT00685178|453858100|FG002|Overall Study|Adverse Event|2|||
126155905|NCT00685178|453858101|FG003|Overall Study|Adverse Event|4|||
126155906|NCT00685178|453858098|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
126155907|NCT00685178|453858099|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
126155908|NCT00685178|453858100|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
126155909|NCT00685178|453858101|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
126155910|NCT00685178|453858098|FG000|Overall Study|voluntary study discharge|4|||
126155911|NCT00685178|453858099|FG001|Overall Study|voluntary study discharge|5|||
126155912|NCT00685178|453858100|FG002|Overall Study|voluntary study discharge|1|||
126155913|NCT00685178|453858101|FG003|Overall Study|voluntary study discharge|1|||
126155914|NCT00685178|453858098|FG000|Overall Study|incarcerated|1|||
126155915|NCT00685178|453858099|FG001|Overall Study|incarcerated|3|||
126155916|NCT00685178|453858100|FG002|Overall Study|incarcerated|7|||
126155917|NCT00685178|453858101|FG003|Overall Study|incarcerated|0|||
126155918|NCT00685178|453858098|FG000|Overall Study|administrative (disciplinary) discharge|0|||
126155919|NCT00685178|453858099|FG001|Overall Study|administrative (disciplinary) discharge|1|||
126155920|NCT00685178|453858100|FG002|Overall Study|administrative (disciplinary) discharge|0|||
126155921|NCT00685178|453858101|FG003|Overall Study|administrative (disciplinary) discharge|2|||
126155922|NCT00685178|453858098|FG000|Overall Study|Pregnancy|0|||
126155923|NCT00685178|453858099|FG001|Overall Study|Pregnancy|0|||
126155924|NCT00685178|453858100|FG002|Overall Study|Pregnancy|0|||
126155925|NCT00685178|453858101|FG003|Overall Study|Pregnancy|1|||
126155926|NCT00077623|453858102|FG000|Overall Study|Adverse Event|1|||
126155927|NCT00077623|453858103|FG001|Overall Study|Adverse Event|0|||
126155928|NCT00077623|453858104|FG002|Overall Study|Adverse Event|1|||
126155929|NCT00077623|453858102|FG000|Overall Study|Withdrawal by Subject|2|||
126155930|NCT00077623|453858103|FG001|Overall Study|Withdrawal by Subject|10|||
126155931|NCT00077623|453858104|FG002|Overall Study|Withdrawal by Subject|1|||
126155932|NCT00077623|453858102|FG000|Overall Study|Other-Non safety reason|18|||
126155933|NCT00077623|453858103|FG001|Overall Study|Other-Non safety reason|15|||
126155934|NCT00077623|453858104|FG002|Overall Study|Other-Non safety reason|19|||
126155935|NCT00077623|453858102|FG000|Overall Study|Insufficient therapeutic response|2|||
126155936|NCT00077623|453858103|FG001|Overall Study|Insufficient therapeutic response|0|||
126155937|NCT00077623|453858104|FG002|Overall Study|Insufficient therapeutic response|0|||
126155938|NCT00077623|453858102|FG000|Overall Study|Death|12|||
126155939|NCT00077623|453858103|FG001|Overall Study|Death|18|||
126155940|NCT00077623|453858104|FG002|Overall Study|Death|11|||
126155941|NCT00077623|453858102|FG000|Overall Study|Failure to return|1|||
126155942|NCT00077623|453858103|FG001|Overall Study|Failure to return|0|||
126155943|NCT00077623|453858104|FG002|Overall Study|Failure to return|0|||
126155944|NCT00882713|453858107|FG000|Overall Study|Adverse Event|2|||
126155945|NCT00882713|453858107|FG000|Overall Study|Death|3|||
126155946|NCT00882713|453858107|FG000|Overall Study|Administrative reasons|4|||
126155947|NCT00882713|453858107|FG000|Overall Study|refused treatment/withdrew consent|4|||
126155948|NCT00882713|453858107|FG000|Overall Study|Blood transfusion|2|||
126155949|NCT00882713|453858107|FG000|Overall Study|Insufficient therapeutic response|3|||
126155950|NCT00882713|453858107|FG000|Overall Study|Failure to return|2|||
126155951|NCT00882713|453858107|FG000|Overall Study|Other - Reasons|2|||
126155952|NCT00401973|453858108|FG000|Overall Study|Adverse Event|2|||
126155953|NCT00401973|453858109|FG001|Overall Study|Adverse Event|8|||
126155954|NCT00401973|453858110|FG002|Overall Study|Adverse Event|4|||
125971723|NCT03579563|453184795|FG001|Overall Study|Lack of Efficacy|1|||
126155955|NCT00401973|453858108|FG000|Overall Study|Clinical Relapse|0|||
126155956|NCT00401973|453858109|FG001|Overall Study|Clinical Relapse|1|||
126155957|NCT00401973|453858110|FG002|Overall Study|Clinical Relapse|1|||
126155958|NCT00401973|453858108|FG000|Overall Study|Lack of Efficacy|0|||
126155959|NCT00401973|453858109|FG001|Overall Study|Lack of Efficacy|0|||
126155960|NCT00401973|453858110|FG002|Overall Study|Lack of Efficacy|3|||
126155961|NCT00401973|453858108|FG000|Overall Study|Lost to Follow-up|2|||
126155962|NCT00401973|453858109|FG001|Overall Study|Lost to Follow-up|2|||
126155963|NCT00401973|453858110|FG002|Overall Study|Lost to Follow-up|2|||
126155964|NCT00401973|453858108|FG000|Overall Study|Physician Decision|2|||
126155965|NCT00401973|453858109|FG001|Overall Study|Physician Decision|0|||
126155966|NCT00401973|453858110|FG002|Overall Study|Physician Decision|1|||
126155967|NCT00401973|453858108|FG000|Overall Study|Protocol Violation|1|||
126155968|NCT00401973|453858109|FG001|Overall Study|Protocol Violation|2|||
126155969|NCT00401973|453858110|FG002|Overall Study|Protocol Violation|3|||
126155970|NCT00401973|453858108|FG000|Overall Study|Sponsor Decision|0|||
126155971|NCT00401973|453858109|FG001|Overall Study|Sponsor Decision|1|||
126155972|NCT00401973|453858110|FG002|Overall Study|Sponsor Decision|0|||
126155973|NCT00401973|453858108|FG000|Overall Study|Withdrawal by Subject|4|||
126155974|NCT00401973|453858109|FG001|Overall Study|Withdrawal by Subject|12|||
126155975|NCT00401973|453858110|FG002|Overall Study|Withdrawal by Subject|9|||
126155976|NCT05523362|453858111|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
126155977|NCT05523362|453858111|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
126155978|NCT05523362|453858111|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
126155979|NCT05523362|453858111|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
126155980|NCT03515538|453858112|FG000|Overall Study|Lack of Efficacy|2|||
126155981|NCT03515538|453858113|FG001|Overall Study|Lack of Efficacy|0|||
126155982|NCT03515538|453858114|FG002|Overall Study|Lack of Efficacy|2|||
126155983|NCT03515538|453858115|FG003|Overall Study|Lack of Efficacy|0|||
126155984|NCT03515538|453858112|FG000|Overall Study|Death|0|||
126155985|NCT03515538|453858113|FG001|Overall Study|Death|0|||
126155986|NCT03515538|453858114|FG002|Overall Study|Death|1|||
126155987|NCT03515538|453858115|FG003|Overall Study|Death|0|||
126155988|NCT03515538|453858112|FG000|Overall Study|Protocol Violation|0|||
126155989|NCT03515538|453858113|FG001|Overall Study|Protocol Violation|0|||
126155990|NCT03515538|453858114|FG002|Overall Study|Protocol Violation|0|||
126155991|NCT03515538|453858115|FG003|Overall Study|Protocol Violation|1|||
126155992|NCT03515538|453858112|FG000|Overall Study|Screen failure (baseline dropout)|0|||
126155993|NCT03515538|453858113|FG001|Overall Study|Screen failure (baseline dropout)|1|||
126155994|NCT03515538|453858114|FG002|Overall Study|Screen failure (baseline dropout)|0|||
126155995|NCT03515538|453858115|FG003|Overall Study|Screen failure (baseline dropout)|0|||
126155996|NCT03515538|453858112|FG000|Overall Study|Withdrawal by Subject|2|||
126155997|NCT03515538|453858113|FG001|Overall Study|Withdrawal by Subject|2|||
126155998|NCT03515538|453858114|FG002|Overall Study|Withdrawal by Subject|1|||
126155999|NCT03515538|453858115|FG003|Overall Study|Withdrawal by Subject|3|||
126156000|NCT03515538|453858112|FG000|Overall Study|Physician Decision|1|||
126156001|NCT03515538|453858113|FG001|Overall Study|Physician Decision|0|||
126156002|NCT03515538|453858114|FG002|Overall Study|Physician Decision|0|||
126156003|NCT03515538|453858115|FG003|Overall Study|Physician Decision|1|||
126156004|NCT04075604|453858116|FG000|Overall Study|Adverse Event|0|||
126156005|NCT04075604|453858117|FG001|Overall Study|Adverse Event|0|||
126156006|NCT04075604|453858118|FG002|Overall Study|Adverse Event|3|||
126156007|NCT04075604|453858116|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126156008|NCT04075604|453858117|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126156009|NCT04075604|453858118|FG002|Overall Study|Participant request to discontinue study treatment|1|||
126156010|NCT04075604|453858116|FG000|Overall Study|Participant withdrew consent|0|||
126156011|NCT04075604|453858117|FG001|Overall Study|Participant withdrew consent|0|||
126156012|NCT04075604|453858118|FG002|Overall Study|Participant withdrew consent|1|||
126156013|NCT04075604|453858116|FG000|Overall Study|Other reasons|1|||
126156014|NCT04075604|453858117|FG001|Overall Study|Other reasons|0|||
126156015|NCT04075604|453858118|FG002|Overall Study|Other reasons|0|||
126156016|NCT04075604|453858116|FG000|Overall Study|Disease progression|0|||
125971724|NCT03579563|453184796|FG002|Overall Study|Lack of Efficacy|4|||
126156017|NCT04075604|453858117|FG001|Overall Study|Disease progression|1|||
126156018|NCT04075604|453858118|FG002|Overall Study|Disease progression|0|||
126156019|NCT04075604|453858116|FG000|Overall Study|Study drug toxicity|0|||
126156020|NCT04075604|453858117|FG001|Overall Study|Study drug toxicity|5|||
126156021|NCT04075604|453858118|FG002|Overall Study|Study drug toxicity|1|||
126156022|NCT01650779|453858125|FG000|Overall Study|Withdrawal by Subject|1|||
126156023|NCT03666143|453858126|FG000|Overall Study|Death|158|||
126156024|NCT03666143|453858126|FG000|Overall Study|Sponsor Decision|31|||
125971725|NCT03579563|453184797|FG003|Overall Study|Lack of Efficacy|1|||
126156025|NCT03666143|453858126|FG000|Overall Study|Withdrawal by Subject|11|||
126156026|NCT03666143|453858126|FG000|Overall Study|Lost to Follow-up|5|||
126156027|NCT03666143|453858126|FG000|Overall Study|Physician Decision|1|||
126156028|NCT03666143|453858126|FG000|Overall Study|Rolled into extension study|9|||
126156029|NCT03666143|453858126|FG000|Overall Study|Progressive Disease|1|||
126156030|NCT03707977|453858131|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
126156031|NCT03707977|453858132|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
125971726|NCT03579563|453184798|FG004|Overall Study|Lack of Efficacy|2|||
126156032|NCT03707977|453858133|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
126156033|NCT03707977|453858131|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
126156034|NCT03707977|453858132|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
126156035|NCT03707977|453858133|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
126156036|NCT02564120|453858134|FG000|Overall Study|Did not return release forms|160|||
126156037|NCT02564120|453858134|FG000|Overall Study|Death|58|||
126156038|NCT02564120|453858134|FG000|Overall Study|Withdrawal by Subject|204|||
126156039|NCT02564120|453858134|FG000|Overall Study|Other medical condition|24|||
126156040|NCT03842709|453858135|FG000|Overall Study|Withdrawal by Subject|3|||
126156041|NCT03842709|453858136|FG001|Overall Study|Withdrawal by Subject|3|||
126156042|NCT03842709|453858135|FG000|Overall Study|Lost to Follow-up|1|||
126156043|NCT03842709|453858136|FG001|Overall Study|Lost to Follow-up|0|||
126156044|NCT00609609|453858141|FG000|Overall Study|Withdrawal by Subject|2|||
126156045|NCT00609609|453858142|FG001|Overall Study|Withdrawal by Subject|0|||
126156046|NCT00609609|453858141|FG000|Overall Study|Progression|4|||
126156047|NCT00609609|453858142|FG001|Overall Study|Progression|2|||
126156048|NCT02441803|453858144|FG000|Overall Study|Physician Decision|0|||
126156049|NCT02441803|453858145|FG001|Overall Study|Physician Decision|2|||
126156050|NCT02441803|453858146|FG002|Overall Study|Physician Decision|2|||
126156051|NCT00537823|453858149|FG000|Overall Study|Adverse Event|2|||
126156052|NCT00537823|453858150|FG001|Overall Study|Adverse Event|0|||
126156053|NCT03065530|453858151|FG000|Overall Study|Lack of Efficacy|1|||
126156054|NCT03065530|453858152|FG001|Overall Study|Lack of Efficacy|1|||
126156055|NCT03065530|453858153|FG002|Overall Study|Lack of Efficacy|0|||
126156056|NCT03065530|453858154|FG003|Overall Study|Lack of Efficacy|1|||
126156057|NCT03065530|453858151|FG000|Overall Study|Protocol Violation|1|||
126156058|NCT03065530|453858152|FG001|Overall Study|Protocol Violation|0|||
126156059|NCT03065530|453858153|FG002|Overall Study|Protocol Violation|1|||
126156060|NCT03065530|453858154|FG003|Overall Study|Protocol Violation|1|||
126156061|NCT00852930|453858155|FG000|Overall Study|Withdrawal by Subject|1|||
126156062|NCT00852930|453858156|FG001|Overall Study|Withdrawal by Subject|1|||
126156063|NCT00852930|453858157|FG002|Overall Study|Withdrawal by Subject|1|||
126156064|NCT00852930|453858155|FG000|Overall Study|Physician Decision|0|||
126156065|NCT00852930|453858156|FG001|Overall Study|Physician Decision|0|||
126156066|NCT00852930|453858157|FG002|Overall Study|Physician Decision|1|||
126156067|NCT01512368|453858161|FG000|Overall Study|Protocol Violation|3|||
126156068|NCT02717546|453858166|FG000|Overall Study|Lost to Follow-up|12|||
126156069|NCT02460822|453858173|FG000|Overall Study|Withdrawal by Subject|1|||
126156070|NCT02498821|453858174|FG000|Overall Study|Screen failure|3|||
126156071|NCT02498821|453858175|FG001|Overall Study|Screen failure|5|||
126156072|NCT05258058|453858190|FG000|Overall Study|Withdrawal by Subject|2|||
126156073|NCT01333189|453858195|FG000|Overall Study|Time constraints|1|||
126156074|NCT01333189|453858196|FG001|Overall Study|Time constraints|0|||
126156075|NCT01333189|453858195|FG000|Overall Study|Adverse Event|1|||
126156076|NCT01333189|453858196|FG001|Overall Study|Adverse Event|0|||
126156077|NCT01333189|453858195|FG000|Overall Study|Transportation difficulties|0|||
126156078|NCT01333189|453858196|FG001|Overall Study|Transportation difficulties|1|||
126156079|NCT01333189|453858195|FG000|Overall Study|Moved from region|0|||
126156080|NCT01333189|453858196|FG001|Overall Study|Moved from region|1|||
126156081|NCT01787591|453858201|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
126156082|NCT01787591|453858202|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
126156083|NCT01787591|453858203|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
126156084|NCT01787591|453858204|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
126156085|NCT02725177|453858210|FG000|Overall Study|Physician Decision|4|||
126156086|NCT02725177|453858210|FG000|Overall Study|Adverse Event|1|||
126156087|NCT00793585|453858211|FG000|Overall Study|Adverse Event|1|||
126156088|NCT00793585|453858212|FG001|Overall Study|Adverse Event|1|||
126156089|NCT00793585|453858211|FG000|Overall Study|Protocol Violation|1|||
126156090|NCT00793585|453858212|FG001|Overall Study|Protocol Violation|2|||
126156091|NCT00377299|453858213|FG000|Overall Study|Lost to Follow-up|14|||
126156092|NCT00377299|453858214|FG001|Overall Study|Lost to Follow-up|19|||
126156093|NCT00377299|453858213|FG000|Overall Study|Adverse Event|0|||
126156094|NCT00377299|453858214|FG001|Overall Study|Adverse Event|1|||
126156095|NCT00377299|453858213|FG000|Overall Study|Withdrawal by Subject|5|||
125971727|NCT03579563|453184799|FG005|Overall Study|Lack of Efficacy|3|||
126156096|NCT00377299|453858214|FG001|Overall Study|Withdrawal by Subject|4|||
126156097|NCT00035815|453858216|FG000|Overall Study|Withdrawal by Subject|17|||
126156098|NCT00035815|453858217|FG001|Overall Study|Withdrawal by Subject|11|||
126156099|NCT00283712|453860006|FG000|Overall Study|Death|0|||
126156100|NCT00283712|453860007|FG001|Overall Study|Death|1|||
126156101|NCT04329923|453860008|FG000|Overall Study|Withdrawal by Subject|1|||
126156102|NCT04329923|453860009|FG001|Overall Study|Withdrawal by Subject|4|||
126156103|NCT04329923|453860010|FG002|Overall Study|Withdrawal by Subject|1|||
126156104|NCT04329923|453860011|FG003|Overall Study|Withdrawal by Subject|1|||
126156105|NCT04329923|453860012|FG004|Overall Study|Withdrawal by Subject|1|||
126156106|NCT04329923|453860013|FG005|Overall Study|Withdrawal by Subject|1|||
126156107|NCT04329923|453860008|FG000|Overall Study|early termination of study|0|||
126089037|NCT01371708|453620057|FG001|Overall Study|Insufficient clinical response|2|||
126089038|NCT01371708|453620058|FG002|Overall Study|Insufficient clinical response|0|||
126089039|NCT01371708|453620056|FG000|Overall Study|Lost to Follow-up|5|||
126089040|NCT01371708|453620057|FG001|Overall Study|Lost to Follow-up|9|||
126089041|NCT01371708|453620058|FG002|Overall Study|Lost to Follow-up|7|||
126089042|NCT01371708|453620056|FG000|Overall Study|Protocol Violation|2|||
126089043|NCT01371708|453620057|FG001|Overall Study|Protocol Violation|1|||
126089044|NCT01371708|453620058|FG002|Overall Study|Protocol Violation|2|||
126089045|NCT01371708|453620056|FG000|Overall Study|No longer willing to participate|7|||
126089046|NCT01371708|453620057|FG001|Overall Study|No longer willing to participate|7|||
126089047|NCT01371708|453620058|FG002|Overall Study|No longer willing to participate|13|||
126089048|NCT01371708|453620056|FG000|Overall Study|Medication error/not related to AE|0|||
126089049|NCT01371708|453620057|FG001|Overall Study|Medication error/not related to AE|1|||
126089050|NCT01371708|453620058|FG002|Overall Study|Medication error/not related to AE|0|||
126089051|NCT01371708|453620056|FG000|Overall Study|Other|3|||
126089052|NCT01371708|453620057|FG001|Overall Study|Other|2|||
126089053|NCT01371708|453620058|FG002|Overall Study|Other|4|||
126089054|NCT01371708|453620056|FG000|Overall Study|Adverse Event|5|||
126089055|NCT01371708|453620057|FG001|Overall Study|Adverse Event|8|||
126089056|NCT01371708|453620058|FG002|Overall Study|Adverse Event|12|||
126089057|NCT01371708|453620056|FG000|Overall Study|Started but did not receive treatment|1|||
126089058|NCT01371708|453620057|FG001|Overall Study|Started but did not receive treatment|0|||
126089059|NCT01371708|453620058|FG002|Overall Study|Started but did not receive treatment|1|||
126089060|NCT00694109|453620059|FG000|Overall Study|Physician Decision|3|||
126089061|NCT00694109|453620059|FG000|Overall Study|Adverse Event|74|||
126089062|NCT00694109|453620059|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
126089063|NCT00694109|453620059|FG000|Overall Study|Lack of Efficacy|2|||
126089064|NCT00694109|453620059|FG000|Overall Study|Withdrawal by Subject|13|||
126089065|NCT00694109|453620059|FG000|Overall Study|Pregnancy|1|||
126089066|NCT00694109|453620059|FG000|Overall Study|Enrolled but not treated|1|||
126089067|NCT00694109|453620059|FG000|Overall Study|Other|2|||
126089068|NCT00694109|453620059|FG000|Overall Study|Consented but no additional treatment|3|||
126089069|NCT00846807|453620060|FG000|Overall Study|Adverse Event|270|||
126089070|NCT00846807|453620060|FG000|Overall Study|Lost to Follow-up|94|||
126089071|NCT00846807|453620060|FG000|Overall Study|Withdrawal by Subject|56|||
126089072|NCT00846807|453620060|FG000|Overall Study|Non compliant with European label|7|||
126089073|NCT00846807|453620060|FG000|Overall Study|Switch to other anticoagulants|89|||
126089074|NCT00846807|453620060|FG000|Overall Study|No prescription after hospital discharge|56|||
126089075|NCT00846807|453620060|FG000|Overall Study|Other|60|||
126089076|NCT00737698|453620061|FG000|Overall Study|Withdrawal by Subject|6|||
126089077|NCT00737698|453620062|FG001|Overall Study|Withdrawal by Subject|5|||
126089078|NCT00737698|453620063|FG002|Overall Study|Withdrawal by Subject|3|||
126089079|NCT00737698|453620061|FG000|Overall Study|Death|0|||
126089080|NCT00737698|453620062|FG001|Overall Study|Death|0|||
126089081|NCT00737698|453620063|FG002|Overall Study|Death|1|||
126089082|NCT01067846|453620068|FG000|Overall Study|Lost to Follow-up|17|||
126089083|NCT01067846|453620069|FG001|Overall Study|Lost to Follow-up|19|||
126089084|NCT01067846|453620068|FG000|Overall Study|Withdrawal by Subject|1|||
126089085|NCT01067846|453620069|FG001|Overall Study|Withdrawal by Subject|0|||
126089086|NCT01067846|453620068|FG000|Overall Study|participation in other tx study|1|||
126089087|NCT01067846|453620069|FG001|Overall Study|participation in other tx study|0|||
126089088|NCT04608773|453620070|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
126089089|NCT04608773|453620071|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
126089090|NCT04608773|453620070|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
126089091|NCT04608773|453620071|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
126089092|NCT04608773|453620070|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
126089093|NCT04608773|453620071|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
126089094|NCT04608773|453620070|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
126089095|NCT04608773|453620071|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
126089096|NCT04608773|453620070|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
126089097|NCT04608773|453620071|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
126089098|NCT02387970|453620072|FG000|Overall Study|Did not complete 1-year follow up|1|||
126089099|NCT02387970|453620073|FG001|Overall Study|Did not complete 1-year follow up|2|||
126089100|NCT01436253|453620078|FG000|Overall Study|Lost to Follow-up|182|||
126089101|NCT01436253|453620078|FG000|Overall Study|Not meeting all eligibility criteria|117|||
126089102|NCT01217437|453620079|FG000|Overall Study|Adverse Event|0|||
126089103|NCT01217437|453620080|FG001|Overall Study|Adverse Event|8|||
126089104|NCT01217437|453620079|FG000|Overall Study|Death|5|||
126089105|NCT01217437|453620080|FG001|Overall Study|Death|0|||
126089106|NCT01217437|453620079|FG000|Overall Study|Lack of Efficacy|29|||
126089107|NCT01217437|453620080|FG001|Overall Study|Lack of Efficacy|25|||
126089108|NCT01217437|453620079|FG000|Overall Study|Physician Decision|8|||
126089109|NCT01217437|453620080|FG001|Overall Study|Physician Decision|5|||
126156108|NCT04329923|453860009|FG001|Overall Study|early termination of study|0|||
126156109|NCT04329923|453860010|FG002|Overall Study|early termination of study|0|||
126156110|NCT04329923|453860011|FG003|Overall Study|early termination of study|0|||
126156111|NCT04329923|453860012|FG004|Overall Study|early termination of study|1|||
126156112|NCT04329923|453860013|FG005|Overall Study|early termination of study|2|||
126156113|NCT04329923|453860008|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126156114|NCT04329923|453860009|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126156115|NCT04329923|453860010|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126156116|NCT04329923|453860011|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126156117|NCT04329923|453860012|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126156118|NCT04329923|453860013|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
126156119|NCT01272180|453860014|FG000|Overall Study|Adverse Event|0|||
126156120|NCT01272180|453860015|FG001|Overall Study|Adverse Event|0|||
126156121|NCT01272180|453860016|FG002|Overall Study|Adverse Event|1|||
126156122|NCT01272180|453860017|FG003|Overall Study|Adverse Event|0|||
126156123|NCT01272180|453860014|FG000|Overall Study|Withdrawal by Subject|2|||
126156124|NCT01272180|453860015|FG001|Overall Study|Withdrawal by Subject|6|||
126156125|NCT01272180|453860016|FG002|Overall Study|Withdrawal by Subject|3|||
126156126|NCT01272180|453860017|FG003|Overall Study|Withdrawal by Subject|2|||
126156127|NCT01272180|453860014|FG000|Overall Study|Lost to Follow-up|15|||
126156128|NCT01272180|453860015|FG001|Overall Study|Lost to Follow-up|14|||
126156129|NCT01272180|453860016|FG002|Overall Study|Lost to Follow-up|8|||
126156130|NCT01272180|453860017|FG003|Overall Study|Lost to Follow-up|10|||
126156131|NCT01272180|453860014|FG000|Overall Study|Inappropriate enrollment|0|||
126156132|NCT01272180|453860015|FG001|Overall Study|Inappropriate enrollment|0|||
126156133|NCT01272180|453860016|FG002|Overall Study|Inappropriate enrollment|1|||
126156134|NCT01272180|453860017|FG003|Overall Study|Inappropriate enrollment|1|||
126156135|NCT01272180|453860014|FG000|Overall Study|Protocol Violation|0|||
126156136|NCT01272180|453860015|FG001|Overall Study|Protocol Violation|1|||
126156137|NCT01272180|453860016|FG002|Overall Study|Protocol Violation|0|||
126156138|NCT01272180|453860017|FG003|Overall Study|Protocol Violation|1|||
126156139|NCT01183858|453860018|FG000|Overall Study|Death not related to Progressive Disease|5|||
126156140|NCT01183858|453860019|FG001|Overall Study|Death not related to Progressive Disease|6|||
126156141|NCT01183858|453860018|FG000|Overall Study|Adverse Event|14|||
126156142|NCT01183858|453860019|FG001|Overall Study|Adverse Event|11|||
126156143|NCT01183858|453860018|FG000|Overall Study|Investigator's Decision|0|||
126156144|NCT01183858|453860019|FG001|Overall Study|Investigator's Decision|3|||
126156145|NCT01183858|453860018|FG000|Overall Study|Insufficient Therapeutic Response|2|||
126156146|NCT01183858|453860019|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126156147|NCT01183858|453860018|FG000|Overall Study|Refused Treatment|1|||
126156148|NCT01183858|453860019|FG001|Overall Study|Refused Treatment|4|||
126156149|NCT01183858|453860018|FG000|Overall Study|Withdrew Consent|4|||
126156150|NCT01183858|453860019|FG001|Overall Study|Withdrew Consent|4|||
126156151|NCT01183858|453860018|FG000|Overall Study|Discontinued Smoking|3|||
126156152|NCT01183858|453860019|FG001|Overall Study|Discontinued Smoking|1|||
126156153|NCT01183858|453860018|FG000|Overall Study|Protocol Violation|1|||
126156154|NCT01183858|453860019|FG001|Overall Study|Protocol Violation|0|||
126156155|NCT01183858|453860018|FG000|Overall Study|Administrative/Other|6|||
126156156|NCT01183858|453860019|FG001|Overall Study|Administrative/Other|6|||
126156157|NCT01183858|453860018|FG000|Overall Study|Progressive Disease|112|||
126156158|NCT01183858|453860019|FG001|Overall Study|Progressive Disease|115|||
126156159|NCT01183858|453860018|FG000|Overall Study|Death related to Progressive Disease|4|||
126156160|NCT01183858|453860019|FG001|Overall Study|Death related to Progressive Disease|5|||
126156161|NCT01183858|453860018|FG000|Overall Study|Lost to Follow-up|1|||
126156162|NCT01183858|453860019|FG001|Overall Study|Lost to Follow-up|1|||
126156163|NCT02747043|453860022|FG000|Overall Study|Other|1|||
126156164|NCT02747043|453860023|FG001|Overall Study|Other|1|||
126156165|NCT02747043|453860022|FG000|Overall Study|Adverse Event|3|||
126156166|NCT02747043|453860023|FG001|Overall Study|Adverse Event|1|||
126156167|NCT02747043|453860022|FG000|Overall Study|Withdrawal by Subject|1|||
126156168|NCT02747043|453860023|FG001|Overall Study|Withdrawal by Subject|1|||
126156169|NCT02747043|453860022|FG000|Overall Study|Physician Decision|1|||
126156170|NCT02747043|453860023|FG001|Overall Study|Physician Decision|1|||
126156171|NCT02747043|453860022|FG000|Overall Study|Protocol Violation|0|||
126156172|NCT02747043|453860023|FG001|Overall Study|Protocol Violation|1|||
126156173|NCT02747043|453860022|FG000|Overall Study|Disease progression|4|||
126156174|NCT02747043|453860023|FG001|Overall Study|Disease progression|0|||
126156175|NCT00641147|453860028|FG000|Completed 4 Months.|Physician Decision|1|||
126156176|NCT00641147|453860029|FG001|Completed 4 Months.|Physician Decision|0|||
126156177|NCT00641147|453860028|FG000|Completed 4 Months.|Adverse Event|1|||
126156178|NCT00641147|453860029|FG001|Completed 4 Months.|Adverse Event|0|||
126156179|NCT00641147|453860028|FG000|Completed 8 Months.|Physician Decision|2|||
126156180|NCT00641147|453860029|FG001|Completed 8 Months.|Physician Decision|1|||
126156181|NCT00641147|453860028|FG000|Completed 8 Months.|non compliance|1|||
126156182|NCT00641147|453860029|FG001|Completed 8 Months.|non compliance|0|||
126156183|NCT00641147|453860028|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
126156184|NCT00641147|453860029|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
126156185|NCT00641147|453860028|FG000|Completed 12 Months.|Physician Decision|1|||
126156186|NCT00641147|453860029|FG001|Completed 12 Months.|Physician Decision|1|||
126156187|NCT00641147|453860028|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
126156188|NCT00641147|453860029|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
126156189|NCT00641147|453860028|FG000|Completed 16 Months.|Physician Decision|1|||
126156190|NCT00641147|453860029|FG001|Completed 16 Months.|Physician Decision|0|||
126156191|NCT00641147|453860028|FG000|Completed 16 Months.|Lost to Follow-up|1|||
126156192|NCT00641147|453860029|FG001|Completed 16 Months.|Lost to Follow-up|0|||
126156193|NCT01629667|453860030|FG000|Overall Study|Lost to Follow-up|0|||
126156194|NCT01629667|453860031|FG001|Overall Study|Lost to Follow-up|1|||
126156195|NCT01629667|453860032|FG002|Overall Study|Lost to Follow-up|1|||
126156196|NCT01629667|453860030|FG000|Overall Study|Withdrawal by Subject|31|||
126156197|NCT01629667|453860031|FG001|Overall Study|Withdrawal by Subject|20|||
126156198|NCT01629667|453860032|FG002|Overall Study|Withdrawal by Subject|28|||
126156199|NCT01629667|453860030|FG000|Overall Study|Death|1|||
126089110|NCT01217437|453620079|FG000|Overall Study|Withdrawal by Subject|0|||
126089111|NCT01217437|453620080|FG001|Overall Study|Withdrawal by Subject|2|||
126089112|NCT01217437|453620079|FG000|Overall Study|Ineligible|1|||
126089113|NCT01217437|453620080|FG001|Overall Study|Ineligible|1|||
126089114|NCT03682185|453620083|FG000|Overall Study|Lost to Follow-up|4|||
126089115|NCT03682185|453620084|FG001|Overall Study|Lost to Follow-up|7|||
126089116|NCT03682185|453620085|FG002|Overall Study|Lost to Follow-up|4|||
126089117|NCT03682185|453620086|FG003|Overall Study|Lost to Follow-up|7|||
126089118|NCT03682185|453620087|FG004|Overall Study|Lost to Follow-up|1|||
126089119|NCT03682185|453620083|FG000|Overall Study|Withdrawal by Subject|7|||
126089120|NCT03682185|453620084|FG001|Overall Study|Withdrawal by Subject|3|||
126089121|NCT03682185|453620085|FG002|Overall Study|Withdrawal by Subject|7|||
126089122|NCT03682185|453620086|FG003|Overall Study|Withdrawal by Subject|3|||
126089123|NCT03682185|453620087|FG004|Overall Study|Withdrawal by Subject|0|||
126089124|NCT04908631|453620088|FG000|Overall Study|Lost to Follow-up|1|||
126089125|NCT04908631|453620088|FG000|Overall Study|Physician Decision|1|||
126089126|NCT04908631|453620088|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
126089127|NCT04531982|453620089|FG000|Overall Study|Withdrawal by Subject|10|||
126089128|NCT04531982|453620090|FG001|Overall Study|Withdrawal by Subject|11|||
126089129|NCT04531982|453620089|FG000|Overall Study|Adverse Event|6|||
126089130|NCT04531982|453620090|FG001|Overall Study|Adverse Event|14|||
126089131|NCT04531982|453620089|FG000|Overall Study|Protocol Violation|6|||
126089132|NCT04531982|453620090|FG001|Overall Study|Protocol Violation|9|||
126089133|NCT04531982|453620089|FG000|Overall Study|Non-compliance with study drug|3|||
126089134|NCT04531982|453620090|FG001|Overall Study|Non-compliance with study drug|2|||
126089135|NCT04531982|453620089|FG000|Overall Study|Use of prohibited medication|2|||
126089136|NCT04531982|453620090|FG001|Overall Study|Use of prohibited medication|0|||
126089137|NCT04531982|453620089|FG000|Overall Study|Lost to Follow-up|0|||
126089138|NCT04531982|453620090|FG001|Overall Study|Lost to Follow-up|1|||
126089139|NCT04531982|453620089|FG000|Overall Study|Geopolitical conflict|2|||
126089140|NCT04531982|453620090|FG001|Overall Study|Geopolitical conflict|0|||
126089141|NCT04531982|453620089|FG000|Overall Study|Lack of Efficacy|3|||
126089142|NCT04531982|453620090|FG001|Overall Study|Lack of Efficacy|1|||
126089143|NCT03841526|453620094|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
126089144|NCT03841526|453620095|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
126089145|NCT03841526|453620096|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
126089146|NCT03841526|453620097|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
126089147|NCT03841526|453620098|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
126089148|NCT03841526|453620099|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
126089149|NCT03841526|453620094|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
126089150|NCT03841526|453620095|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
126089151|NCT03841526|453620096|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
126089152|NCT03841526|453620097|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
126089153|NCT03841526|453620098|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
126089154|NCT03841526|453620099|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
126089155|NCT03841526|453620094|FG000|Outpatient Phase Treatment|Physician Decision|0|||
126089156|NCT03841526|453620095|FG001|Outpatient Phase Treatment|Physician Decision|1|||
126089157|NCT03841526|453620096|FG002|Outpatient Phase Treatment|Physician Decision|0|||
126089158|NCT03841526|453620097|FG003|Outpatient Phase Treatment|Physician Decision|0|||
126089159|NCT03841526|453620098|FG004|Outpatient Phase Treatment|Physician Decision|0|||
126089160|NCT03841526|453620099|FG005|Outpatient Phase Treatment|Physician Decision|0|||
126089161|NCT03841526|453620094|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
126089162|NCT03841526|453620095|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
126089163|NCT03841526|453620096|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
126089164|NCT03841526|453620097|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
126089165|NCT03841526|453620098|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
126089166|NCT03841526|453620099|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
126089167|NCT04266795|453620100|FG000|Overall Study|Adverse Event|10|||
126156200|NCT01629667|453860031|FG001|Overall Study|Death|5|||
126156201|NCT01629667|453860032|FG002|Overall Study|Death|3|||
126156202|NCT01629667|453860030|FG000|Overall Study|Randomized, not treated|2|||
126156203|NCT01629667|453860031|FG001|Overall Study|Randomized, not treated|1|||
126156204|NCT01629667|453860032|FG002|Overall Study|Randomized, not treated|0|||
126156205|NCT01629667|453860030|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
126156206|NCT01629667|453860031|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
126156207|NCT01629667|453860032|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
126156208|NCT01629667|453860030|FG000|Overall Study|Requiring lung transplant|2|||
126156209|NCT01629667|453860031|FG001|Overall Study|Requiring lung transplant|1|||
126156210|NCT01629667|453860032|FG002|Overall Study|Requiring lung transplant|3|||
126156211|NCT01629667|453860030|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
126156212|NCT01629667|453860031|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
126156213|NCT01629667|453860032|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
126156214|NCT01629667|453860030|FG000|Overall Study|Started other medicine|1|||
126156215|NCT01629667|453860031|FG001|Overall Study|Started other medicine|0|||
126156216|NCT01629667|453860032|FG002|Overall Study|Started other medicine|1|||
126156217|NCT01629667|453860030|FG000|Overall Study|Site error in safety follow-up|0|||
126156218|NCT01629667|453860031|FG001|Overall Study|Site error in safety follow-up|0|||
126156219|NCT01629667|453860032|FG002|Overall Study|Site error in safety follow-up|1|||
126156220|NCT01629667|453860030|FG000|Overall Study|Enrolled in another clinical study|0|||
126156221|NCT01629667|453860031|FG001|Overall Study|Enrolled in another clinical study|1|||
126156222|NCT01629667|453860032|FG002|Overall Study|Enrolled in another clinical study|0|||
126156223|NCT01629667|453860030|FG000|Overall Study|Code break|1|||
126156224|NCT01629667|453860031|FG001|Overall Study|Code break|0|||
126156225|NCT01629667|453860032|FG002|Overall Study|Code break|0|||
126156226|NCT01966731|453860033|FG000|Overall Study|Death|2|||
126156227|NCT01966731|453860033|FG000|Overall Study|Lost to Follow-up|1|||
126156228|NCT01966731|453860033|FG000|Overall Study|Physician Decision|2|||
126156229|NCT01966731|453860033|FG000|Overall Study|Follow up is not complete|600|||
126156230|NCT01966731|453860033|FG000|Overall Study|Screening Failure|29|||
126156231|NCT01966731|453860033|FG000|Overall Study|Found to be ineligible|1|||
126156232|NCT01380093|453860035|FG000|Naloxone Challenge Phase|Screen failures|21|||
126156233|NCT01380093|453860036|FG001|Naloxone Challenge Phase|Screen failures|0|||
126156234|NCT01380093|453860037|FG002|Naloxone Challenge Phase|Screen failures|0|||
126156235|NCT01380093|453860038|FG003|Naloxone Challenge Phase|Screen failures|0|||
126156236|NCT01380093|453860039|FG004|Naloxone Challenge Phase|Screen failures|0|||
126156237|NCT01380093|453860040|FG005|Naloxone Challenge Phase|Screen failures|0|||
126156238|NCT01380093|453860041|FG006|Naloxone Challenge Phase|Screen failures|0|||
126156239|NCT01380093|453860042|FG007|Naloxone Challenge Phase|Screen failures|0|||
126156240|NCT01380093|453860043|FG008|Naloxone Challenge Phase|Screen failures|0|||
126156241|NCT01380093|453860035|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126156242|NCT01380093|453860036|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
126156243|NCT01380093|453860037|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126156244|NCT01380093|453860038|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126156245|NCT01380093|453860039|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126156246|NCT01380093|453860040|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126156247|NCT01380093|453860041|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126156248|NCT01380093|453860042|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126156249|NCT01380093|453860043|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126156250|NCT01380093|453860035|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126156251|NCT01380093|453860036|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
126156252|NCT01380093|453860037|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
126156253|NCT01380093|453860038|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126156254|NCT01380093|453860039|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125971728|NCT03579563|453184794|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
125971729|NCT03579563|453184795|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
125971730|NCT03579563|453184796|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
125971731|NCT03579563|453184797|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
125971732|NCT03579563|453184798|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
125971733|NCT03579563|453184799|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
125971734|NCT03579563|453184794|FG000|Overall Study|Time/distance concern|0|||
125971735|NCT03579563|453184795|FG001|Overall Study|Time/distance concern|0|||
126156255|NCT01380093|453860040|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126156256|NCT01380093|453860041|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126156257|NCT01380093|453860042|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126156258|NCT01380093|453860043|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126156259|NCT01380093|453860035|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126156260|NCT01380093|453860036|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
126156261|NCT01380093|453860037|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126156262|NCT01380093|453860038|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126156263|NCT01380093|453860039|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126156264|NCT01380093|453860040|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126156265|NCT01380093|453860041|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126156266|NCT01380093|453860042|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126156267|NCT01380093|453860043|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126156268|NCT01380093|453860035|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126156269|NCT01380093|453860036|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
126156270|NCT01380093|453860037|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
126156271|NCT01380093|453860038|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126156272|NCT01380093|453860039|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126156273|NCT01380093|453860040|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126156274|NCT01380093|453860041|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126156275|NCT01380093|453860042|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126156276|NCT01380093|453860043|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126156277|NCT01380093|453860035|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126156278|NCT01380093|453860036|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
126156279|NCT01380093|453860037|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
126156280|NCT01380093|453860038|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126156281|NCT01380093|453860039|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126156282|NCT01380093|453860040|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126156283|NCT01380093|453860041|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126156284|NCT01380093|453860042|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126156285|NCT01380093|453860043|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126156286|NCT01380093|453860035|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
126156287|NCT01380093|453860036|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
126156288|NCT01380093|453860037|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
126156289|NCT01380093|453860038|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
126156290|NCT01380093|453860039|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
126156291|NCT01380093|453860040|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
126156292|NCT01380093|453860041|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
126156293|NCT01380093|453860042|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
126156294|NCT01380093|453860043|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
126156295|NCT01380093|453860035|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126156296|NCT01380093|453860036|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126156297|NCT01380093|453860037|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
126156298|NCT01380093|453860038|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126156299|NCT01380093|453860039|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126156300|NCT01380093|453860040|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126156301|NCT01380093|453860041|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126156302|NCT01380093|453860042|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126156303|NCT01380093|453860043|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126156304|NCT01380093|453860035|FG000|Treatment Phase: Second Intervention|Other|0|||
126156305|NCT01380093|453860036|FG001|Treatment Phase: Second Intervention|Other|0|||
126156306|NCT01380093|453860037|FG002|Treatment Phase: Second Intervention|Other|0|||
126156307|NCT01380093|453860038|FG003|Treatment Phase: Second Intervention|Other|1|||
126156308|NCT01380093|453860039|FG004|Treatment Phase: Second Intervention|Other|0|||
126156309|NCT01380093|453860040|FG005|Treatment Phase: Second Intervention|Other|0|||
126156310|NCT01380093|453860041|FG006|Treatment Phase: Second Intervention|Other|0|||
126156311|NCT01380093|453860042|FG007|Treatment Phase: Second Intervention|Other|0|||
126156312|NCT01380093|453860043|FG008|Treatment Phase: Second Intervention|Other|0|||
126156313|NCT01380093|453860035|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
126156314|NCT01380093|453860036|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
126156315|NCT01380093|453860037|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
126156316|NCT01380093|453860038|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
126156317|NCT01380093|453860039|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
126156318|NCT01380093|453860040|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
126156319|NCT01380093|453860041|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
126156320|NCT01380093|453860042|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
126156321|NCT01380093|453860043|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
126156322|NCT01380093|453860035|FG000|Treatment Phase: Third Intervention|Other|0|||
126156323|NCT01380093|453860036|FG001|Treatment Phase: Third Intervention|Other|0|||
126156324|NCT01380093|453860037|FG002|Treatment Phase: Third Intervention|Other|0|||
126156325|NCT01380093|453860038|FG003|Treatment Phase: Third Intervention|Other|0|||
126156326|NCT01380093|453860039|FG004|Treatment Phase: Third Intervention|Other|0|||
125971736|NCT03579563|453184796|FG002|Overall Study|Time/distance concern|1|||
125971737|NCT03579563|453184797|FG003|Overall Study|Time/distance concern|0|||
126156327|NCT01380093|453860040|FG005|Treatment Phase: Third Intervention|Other|0|||
126156328|NCT01380093|453860041|FG006|Treatment Phase: Third Intervention|Other|0|||
126156329|NCT01380093|453860042|FG007|Treatment Phase: Third Intervention|Other|0|||
126156330|NCT01380093|453860043|FG008|Treatment Phase: Third Intervention|Other|1|||
126156331|NCT04734873|453860044|FG000|Overall Study|Lost to Follow-up|1|||
126156332|NCT04734873|453860045|FG001|Overall Study|Lost to Follow-up|3|||
126156333|NCT04734873|453860046|FG002|Overall Study|Lost to Follow-up|2|||
126156334|NCT04734873|453860044|FG000|Overall Study|Randomized but not dosed|1|||
126156335|NCT04734873|453860045|FG001|Overall Study|Randomized but not dosed|0|||
126156336|NCT04734873|453860046|FG002|Overall Study|Randomized but not dosed|1|||
126156337|NCT00328198|453860050|FG000|Treatment|Adverse Event|21|||
126156338|NCT00328198|453860050|FG000|Treatment|Death|1|||
126156339|NCT00328198|453860050|FG000|Treatment|Physician Decision|5|||
126156340|NCT00328198|453860050|FG000|Treatment|Withdrawal by Subject|5|||
126156341|NCT00328198|453860050|FG000|Treatment|Evidence of disease progression|2|||
126156342|NCT00328198|453860050|FG000|Treatment|Non-compliance|1|||
126156343|NCT00328198|453860050|FG000|Treatment|Confirmed complete response, MRD -|3|||
126156344|NCT00328198|453860050|FG000|Follow-up|Lost to Follow-up|4|||
126156345|NCT00328198|453860050|FG000|Follow-up|Death|31|||
126156346|NCT03396471|453860051|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
126156347|NCT03396471|453860051|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
126156348|NCT03396471|453860051|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
126156349|NCT03396471|453860051|FG000|Study Treatment - Up to 22 Months|Death|2|||
126156350|NCT03396471|453860051|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
126156351|NCT03396471|453860051|FG000|Follow up - Up to 2 Years|Death|9|||
126156352|NCT03396471|453860051|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
126156353|NCT03396471|453860051|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
126156354|NCT03396471|453860051|FG000|Follow up - Up to 2 Years|study terminated|1|||
126156355|NCT03396471|453860051|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
126156356|NCT03396471|453860051|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
126156357|NCT00718861|453860052|FG000|Overall Study|Withdrawal by Subject|15|||
126156358|NCT00718861|453860053|FG001|Overall Study|Withdrawal by Subject|10|||
126156359|NCT00718861|453860052|FG000|Overall Study|Adverse Event|2|||
126156360|NCT00718861|453860053|FG001|Overall Study|Adverse Event|1|||
126156361|NCT00718861|453860052|FG000|Overall Study|Lost to Follow-up|2|||
126156362|NCT00718861|453860053|FG001|Overall Study|Lost to Follow-up|1|||
126156363|NCT00718861|453860052|FG000|Overall Study|Administrative Problems|1|||
126156364|NCT00718861|453860053|FG001|Overall Study|Administrative Problems|1|||
126156365|NCT00718861|453860052|FG000|Overall Study|Death|1|||
126156366|NCT00718861|453860053|FG001|Overall Study|Death|5|||
126156367|NCT03237845|453860054|FG000|Overall Study|Adverse Event|0|||
126156368|NCT03237845|453860055|FG001|Overall Study|Adverse Event|1|||
126156369|NCT03237845|453860054|FG000|Overall Study|Lost to Follow-up|13|||
126156370|NCT03237845|453860055|FG001|Overall Study|Lost to Follow-up|10|||
126156371|NCT03237845|453860054|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
126156372|NCT03237845|453860055|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
126156373|NCT03237845|453860054|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
126156374|NCT03237845|453860055|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
126156375|NCT03237845|453860054|FG000|Overall Study|Physician Decision|1|||
126156376|NCT03237845|453860055|FG001|Overall Study|Physician Decision|2|||
126156377|NCT03237845|453860054|FG000|Overall Study|Pregnancy|1|||
126156378|NCT03237845|453860055|FG001|Overall Study|Pregnancy|0|||
126156379|NCT03237845|453860054|FG000|Overall Study|Protocol Deviation|0|||
126156380|NCT03237845|453860055|FG001|Overall Study|Protocol Deviation|1|||
126156381|NCT03237845|453860054|FG000|Overall Study|Technical Problems|8|||
126156382|NCT03237845|453860055|FG001|Overall Study|Technical Problems|1|||
126156383|NCT03237845|453860054|FG000|Overall Study|Withdrawal by Subject|3|||
126156384|NCT03237845|453860055|FG001|Overall Study|Withdrawal by Subject|3|||
126156385|NCT03237845|453860054|FG000|Overall Study|Other Reasons|4|||
126156386|NCT03237845|453860055|FG001|Overall Study|Other Reasons|0|||
126156387|NCT03865407|453860059|FG000|Overall Study|Adverse Event|1|||
126156388|NCT03865407|453860060|FG001|Overall Study|Adverse Event|0|||
126156389|NCT03865407|453860059|FG000|Overall Study|Withdrawal by Subject|1|||
126156390|NCT03865407|453860060|FG001|Overall Study|Withdrawal by Subject|0|||
126156391|NCT03865407|453860059|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
126156392|NCT03865407|453860060|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
126156393|NCT02117050|453860061|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
126156394|NCT01645280|453860062|FG000|Overall Study|Death|0|||
126156395|NCT01645280|453860063|FG001|Overall Study|Death|1|||
126156396|NCT01645280|453860064|FG002|Overall Study|Death|0|||
126156397|NCT01645280|453860065|FG003|Overall Study|Death|0|||
126156398|NCT01645280|453860066|FG004|Overall Study|Death|0|||
126156399|NCT01645280|453860062|FG000|Overall Study|Withdrawal by Subject|4|||
126156400|NCT01645280|453860063|FG001|Overall Study|Withdrawal by Subject|0|||
126156401|NCT01645280|453860064|FG002|Overall Study|Withdrawal by Subject|2|||
126156402|NCT01645280|453860065|FG003|Overall Study|Withdrawal by Subject|4|||
126156403|NCT01645280|453860066|FG004|Overall Study|Withdrawal by Subject|5|||
126156404|NCT01645280|453860062|FG000|Overall Study|Lost to Follow-up|0|||
126156405|NCT01645280|453860063|FG001|Overall Study|Lost to Follow-up|0|||
126156406|NCT01645280|453860064|FG002|Overall Study|Lost to Follow-up|0|||
126156407|NCT01645280|453860065|FG003|Overall Study|Lost to Follow-up|2|||
126156408|NCT01645280|453860066|FG004|Overall Study|Lost to Follow-up|1|||
126156409|NCT01645280|453860062|FG000|Overall Study|Other|1|||
126156410|NCT01645280|453860063|FG001|Overall Study|Other|1|||
126156411|NCT01645280|453860064|FG002|Overall Study|Other|2|||
126156412|NCT01645280|453860065|FG003|Overall Study|Other|0|||
126156413|NCT01645280|453860066|FG004|Overall Study|Other|0|||
126156414|NCT01645280|453860062|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
126156415|NCT01645280|453860063|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
126156416|NCT01645280|453860064|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
126156417|NCT01645280|453860065|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
126156418|NCT01645280|453860066|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
126156419|NCT00234104|453860071|FG000|Overall Study|Adverse Event|4|||
126156420|NCT00234104|453860072|FG001|Overall Study|Adverse Event|0|||
126156421|NCT00234104|453860073|FG002|Overall Study|Adverse Event|3|||
126156422|NCT00234104|453860074|FG003|Overall Study|Adverse Event|5|||
126156423|NCT00234104|453860071|FG000|Overall Study|Protocol Violation|0|||
126156424|NCT00234104|453860072|FG001|Overall Study|Protocol Violation|0|||
126156425|NCT00234104|453860073|FG002|Overall Study|Protocol Violation|0|||
126156426|NCT00234104|453860074|FG003|Overall Study|Protocol Violation|1|||
126156427|NCT00234104|453860071|FG000|Overall Study|Physician Decision|0|||
126156428|NCT00234104|453860072|FG001|Overall Study|Physician Decision|1|||
126156429|NCT00234104|453860073|FG002|Overall Study|Physician Decision|2|||
126156430|NCT00234104|453860074|FG003|Overall Study|Physician Decision|2|||
126156431|NCT01716169|453860076|FG000|Overall Study|Adverse Event|1|||
126156432|NCT01716169|453860076|FG000|Overall Study|Lost to Follow-up|1|||
126156433|NCT01716169|453860076|FG000|Overall Study|Withdrawal by Subject|1|||
126156434|NCT01716169|453860076|FG000|Overall Study|inconsistent dressing application|1|||
126156435|NCT01088412|453860077|FG000|Overall Study|Adverse Event|38|||
126156436|NCT01088412|453860078|FG001|Overall Study|Adverse Event|0|||
126156437|NCT01088412|453860079|FG002|Overall Study|Adverse Event|0|||
126156438|NCT01088412|453860077|FG000|Overall Study|Death|42|||
126156439|NCT01088412|453860078|FG001|Overall Study|Death|6|||
126156440|NCT01088412|453860079|FG002|Overall Study|Death|0|||
126156441|NCT01088412|453860077|FG000|Overall Study|Other Reason per Case Report Form|2089|||
126156442|NCT01088412|453860078|FG001|Overall Study|Other Reason per Case Report Form|103|||
126156443|NCT01088412|453860079|FG002|Overall Study|Other Reason per Case Report Form|9|||
126156444|NCT01088412|453860077|FG000|Overall Study|Withdrawal by Subject|1761|||
126156445|NCT01088412|453860078|FG001|Overall Study|Withdrawal by Subject|25|||
126156446|NCT01088412|453860079|FG002|Overall Study|Withdrawal by Subject|1|||
126156447|NCT01088412|453860077|FG000|Overall Study|Received Another GH Product|79|||
126156448|NCT01088412|453860078|FG001|Overall Study|Received Another GH Product|0|||
126156449|NCT01088412|453860079|FG002|Overall Study|Received Another GH Product|0|||
126156450|NCT01088412|453860077|FG000|Overall Study|Participant Moved|601|||
126156451|NCT01088412|453860078|FG001|Overall Study|Participant Moved|21|||
126156452|NCT01088412|453860079|FG002|Overall Study|Participant Moved|2|||
126156453|NCT01088412|453860077|FG000|Overall Study|Physician Decision|1041|||
126156454|NCT01088412|453860078|FG001|Overall Study|Physician Decision|8|||
126156455|NCT01088412|453860079|FG002|Overall Study|Physician Decision|4|||
126156456|NCT01088412|453860077|FG000|Overall Study|Sponsor Decision|4467|||
126156457|NCT01088412|453860078|FG001|Overall Study|Sponsor Decision|79|||
126156458|NCT01088412|453860079|FG002|Overall Study|Sponsor Decision|23|||
126156459|NCT01088412|453860077|FG000|Overall Study|Third Party Required to Change Brand|487|||
126156460|NCT01088412|453860078|FG001|Overall Study|Third Party Required to Change Brand|0|||
125971738|NCT03579563|453184798|FG004|Overall Study|Time/distance concern|0|||
126156461|NCT01088412|453860079|FG002|Overall Study|Third Party Required to Change Brand|0|||
126156462|NCT01088412|453860077|FG000|Overall Study|Lost to Follow-up|3052|||
126156463|NCT01088412|453860078|FG001|Overall Study|Lost to Follow-up|130|||
126156464|NCT01088412|453860079|FG002|Overall Study|Lost to Follow-up|11|||
126156465|NCT01088412|453860077|FG000|Overall Study|Study Summary Not Completed|4360|||
126156466|NCT01088412|453860078|FG001|Overall Study|Study Summary Not Completed|64|||
126156467|NCT01088412|453860079|FG002|Overall Study|Study Summary Not Completed|22|||
126156468|NCT02285010|453860080|FG000|Overall Study|not abdominal hysterectomy|2|||
126156469|NCT02285010|453860081|FG001|Overall Study|not abdominal hysterectomy|0|||
126156470|NCT02285010|453860080|FG000|Overall Study|Not spinal anesthesia|3|||
125971739|NCT03579563|453184799|FG005|Overall Study|Time/distance concern|1|||
126156471|NCT02285010|453860081|FG001|Overall Study|Not spinal anesthesia|1|||
126156472|NCT02111811|453860082|FG000|Treatment Phase|Lost to Follow-up|22|||
126156473|NCT02111811|453860083|FG001|Treatment Phase|Lost to Follow-up|18|||
126156474|NCT02111811|453860082|FG000|Treatment Phase|Death|2|||
126156475|NCT02111811|453860083|FG001|Treatment Phase|Death|0|||
126156476|NCT02111811|453860082|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
126156477|NCT02111811|453860083|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
126156478|NCT02111811|453860082|FG000|Follow up Period (Aim 2)|Death|2|||
126156479|NCT02111811|453860083|FG001|Follow up Period (Aim 2)|Death|0|||
126156480|NCT01478347|453860088|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
126156481|NCT01478347|453860088|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
126156482|NCT01478347|453860088|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
126156483|NCT00196937|453860089|FG000|Overall Study|Serious Adverse Event|1|||
126156484|NCT00196937|453860090|FG001|Overall Study|Serious Adverse Event|0|||
126156485|NCT00196937|453860091|FG002|Overall Study|Serious Adverse Event|0|||
126156486|NCT00196937|453860089|FG000|Overall Study|Non-serious adverse event|1|||
126156487|NCT00196937|453860090|FG001|Overall Study|Non-serious adverse event|1|||
126156488|NCT00196937|453860091|FG002|Overall Study|Non-serious adverse event|1|||
126156489|NCT00196937|453860089|FG000|Overall Study|Withdrawal by Subject|0|||
126156490|NCT00196937|453860090|FG001|Overall Study|Withdrawal by Subject|0|||
126156491|NCT00196937|453860091|FG002|Overall Study|Withdrawal by Subject|2|||
126156492|NCT00196937|453860089|FG000|Overall Study|Lost to Follow-up|4|||
126156493|NCT00196937|453860090|FG001|Overall Study|Lost to Follow-up|3|||
126156494|NCT00196937|453860091|FG002|Overall Study|Lost to Follow-up|3|||
126156495|NCT00196937|453860089|FG000|Overall Study|Other|3|||
126156496|NCT00196937|453860090|FG001|Overall Study|Other|1|||
126156497|NCT00196937|453860091|FG002|Overall Study|Other|1|||
126156498|NCT02973815|453860095|FG000|Post Intervention|Death|1|||
126156499|NCT02973815|453860096|FG001|Post Intervention|Death|0|||
126156500|NCT02973815|453860095|FG000|Post Intervention|Lost to Follow-up|7|||
126156501|NCT02973815|453860096|FG001|Post Intervention|Lost to Follow-up|24|||
126156502|NCT02973815|453860095|FG000|Follow-up|Lost to Follow-up|2|||
126156503|NCT02973815|453860096|FG001|Follow-up|Lost to Follow-up|0|||
126156504|NCT00853905|453860101|FG000|Overall Study|Lost to Follow-up|1|||
126156505|NCT00853905|453860102|FG001|Overall Study|Lost to Follow-up|3|||
126156506|NCT00853905|453860101|FG000|Overall Study|Withdrawal by Subject|0|||
126156507|NCT00853905|453860102|FG001|Overall Study|Withdrawal by Subject|1|||
126156508|NCT00853905|453860101|FG000|Overall Study|never had surgery|1|||
126156509|NCT00853905|453860102|FG001|Overall Study|never had surgery|0|||
126156510|NCT04579393|453860105|FG000|Overall Study|Withdrawal by Subject|2|||
126156511|NCT04579393|453860106|FG001|Overall Study|Withdrawal by Subject|2|||
126156512|NCT04579393|453860105|FG000|Overall Study|Death|1|||
126156513|NCT04579393|453860106|FG001|Overall Study|Death|3|||
126156514|NCT00465738|453860109|FG000|Overall Study|Lost to Follow-up|2|||
126156515|NCT00465738|453860110|FG001|Overall Study|Lost to Follow-up|0|||
126156516|NCT00465738|453860109|FG000|Overall Study|Adverse Event|0|||
126156517|NCT00465738|453860110|FG001|Overall Study|Adverse Event|1|||
126156518|NCT00465738|453860109|FG000|Overall Study|Withdrawal by Subject|2|||
126156519|NCT00465738|453860110|FG001|Overall Study|Withdrawal by Subject|0|||
126156520|NCT00465738|453860109|FG000|Overall Study|Other|2|||
126156521|NCT00465738|453860110|FG001|Overall Study|Other|5|||
126156522|NCT02489630|453860111|FG000|Overall Study|Oversedation|1|||
126156523|NCT02489630|453860112|FG001|Overall Study|Oversedation|1|||
126156524|NCT02489630|453860111|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
126156525|NCT02489630|453860112|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
126156526|NCT01326962|453860114|FG000|Overall Study|Adverse Event|1|||
126156527|NCT01326962|453860114|FG000|Overall Study|Withdrawal by Subject|1|||
126156528|NCT01326962|453860114|FG000|Overall Study|Lost to Follow-up|3|||
126156529|NCT01326962|453860114|FG000|Overall Study|Other|2|||
126156530|NCT01056523|453860115|FG000|Overall Study|Death|1|||
126156531|NCT01056523|453860116|FG001|Overall Study|Death|0|||
126156532|NCT01056523|453860117|FG002|Overall Study|Death|2|||
126156533|NCT01056523|453860118|FG003|Overall Study|Death|3|||
126156534|NCT01056523|453860119|FG004|Overall Study|Death|0|||
126156535|NCT01056523|453860120|FG005|Overall Study|Death|0|||
126156536|NCT01056523|453860121|FG006|Overall Study|Death|1|||
125971740|NCT03579563|453184794|FG000|Overall Study|COVID shutdown|2|||
125971741|NCT03579563|453184795|FG001|Overall Study|COVID shutdown|3|||
126156537|NCT03429556|453860122|FG000|Overall Study|Lost to Follow-up|0|||
126156538|NCT03429556|453860123|FG001|Overall Study|Lost to Follow-up|1|||
126156539|NCT03429556|453860124|FG002|Overall Study|Lost to Follow-up|0|||
126156540|NCT03429556|453860125|FG003|Overall Study|Lost to Follow-up|0|||
126156541|NCT01863758|453860132|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
125971742|NCT03579563|453184796|FG002|Overall Study|COVID shutdown|4|||
125971743|NCT03579563|453184797|FG003|Overall Study|COVID shutdown|3|||
126156542|NCT01863758|453860132|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
126156543|NCT02369510|453860133|FG000|Overall Study|Spilled Medication|1|||
126156544|NCT02369510|453860134|FG001|Overall Study|Spilled Medication|2|||
126156545|NCT02369510|453860135|FG002|Overall Study|Spilled Medication|1|||
126156546|NCT02369510|453860133|FG000|Overall Study|Epidural Activation|1|||
126156547|NCT02369510|453860134|FG001|Overall Study|Epidural Activation|1|||
126156548|NCT02369510|453860135|FG002|Overall Study|Epidural Activation|5|||
126156549|NCT04952389|453860136|FG000|Overall Study|Withdrawal by Subject|8|||
126156550|NCT04952389|453860137|FG001|Overall Study|Withdrawal by Subject|4|||
126156551|NCT02050048|453860138|FG000|Overall Study|Lost to Follow-up|0|||
126156552|NCT02050048|453860139|FG001|Overall Study|Lost to Follow-up|1|||
126156553|NCT02050048|453860138|FG000|Overall Study|Death|1|||
126156554|NCT02050048|453860139|FG001|Overall Study|Death|0|||
126156555|NCT02050048|453860138|FG000|Overall Study|Ineligible after ERCP|4|||
126156556|NCT02050048|453860139|FG001|Overall Study|Ineligible after ERCP|1|||
126156557|NCT04285723|453860143|FG000|Overall Study|Subject decision|1|||
126156558|NCT04285723|453860144|FG001|Overall Study|Subject decision|2|||
126156559|NCT04285723|453860143|FG000|Overall Study|Physician Decision|1|||
126156560|NCT04285723|453860144|FG001|Overall Study|Physician Decision|0|||
126156561|NCT04285723|453860143|FG000|Overall Study|No efficiency|1|||
126156562|NCT04285723|453860144|FG001|Overall Study|No efficiency|0|||
126156563|NCT01507246|453860146|FG000|Overall Study|Required different surgical procedures|2|||
126156564|NCT01507246|453860147|FG001|Overall Study|Required different surgical procedures|1|||
126156565|NCT02903511|453860153|FG000|Overall Study|Withdrawal by Subject|1|||
126156566|NCT02903511|453860154|FG001|Overall Study|Withdrawal by Subject|0|||
126156567|NCT02903511|453860153|FG000|Overall Study|Lost to Follow-up|3|||
126156568|NCT02903511|453860154|FG001|Overall Study|Lost to Follow-up|2|||
126156569|NCT00969618|453860155|FG000|Overall Study|Adverse Event|29|||
126156570|NCT00969618|453860155|FG000|Overall Study|Entry Criteria Not Met|3|||
126156571|NCT00969618|453860155|FG000|Overall Study|Lack of Efficacy|2|||
126156572|NCT00969618|453860155|FG000|Overall Study|Lost to Follow-up|7|||
126156573|NCT00969618|453860155|FG000|Overall Study|Physician Decision|1|||
126156574|NCT00969618|453860155|FG000|Overall Study|Protocol Violation|9|||
126156575|NCT00969618|453860155|FG000|Overall Study|Withdrawal by Subject|27|||
126156576|NCT05363293|453860160|FG000|Overall Study|Withdrawal by Subject|1|||
126156577|NCT05363293|453860161|FG001|Overall Study|Withdrawal by Subject|0|||
126156578|NCT05363293|453860162|FG002|Overall Study|Withdrawal by Subject|0|||
126156579|NCT05363293|453860163|FG003|Overall Study|Withdrawal by Subject|0|||
126156580|NCT05363293|453860164|FG004|Overall Study|Withdrawal by Subject|0|||
126156581|NCT05363293|453860165|FG005|Overall Study|Withdrawal by Subject|0|||
126156582|NCT05363293|453860166|FG006|Overall Study|Withdrawal by Subject|0|||
126156583|NCT05363293|453860167|FG007|Overall Study|Withdrawal by Subject|0|||
126156584|NCT05363293|453860168|FG008|Overall Study|Withdrawal by Subject|0|||
126156585|NCT05363293|453860169|FG009|Overall Study|Withdrawal by Subject|0|||
126156586|NCT01318902|453860170|FG000|Overall Study|Symptomatic Deterioration|0|||
126156587|NCT01318902|453860171|FG001|Overall Study|Symptomatic Deterioration|1|||
126156588|NCT01318902|453860172|FG002|Overall Study|Symptomatic Deterioration|1|||
126156589|NCT01318902|453860173|FG003|Overall Study|Symptomatic Deterioration|2|||
126156590|NCT01318902|453860170|FG000|Overall Study|Withdrawal by Patient|0|||
126156591|NCT01318902|453860171|FG001|Overall Study|Withdrawal by Patient|1|||
126156592|NCT01318902|453860172|FG002|Overall Study|Withdrawal by Patient|0|||
126156593|NCT01318902|453860173|FG003|Overall Study|Withdrawal by Patient|3|||
126156594|NCT01318902|453860170|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
126156595|NCT01318902|453860171|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
126156596|NCT01318902|453860172|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
126156597|NCT01318902|453860173|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
126156598|NCT01318902|453860170|FG000|Overall Study|Adverse Event|0|||
126156599|NCT01318902|453860171|FG001|Overall Study|Adverse Event|1|||
126156600|NCT01318902|453860172|FG002|Overall Study|Adverse Event|0|||
126156601|NCT01318902|453860173|FG003|Overall Study|Adverse Event|0|||
126156602|NCT01318902|453860170|FG000|Overall Study|Terminated by Sponsor|0|||
126156603|NCT01318902|453860171|FG001|Overall Study|Terminated by Sponsor|0|||
126156604|NCT01318902|453860172|FG002|Overall Study|Terminated by Sponsor|1|||
126156605|NCT01318902|453860173|FG003|Overall Study|Terminated by Sponsor|0|||
126156606|NCT02699515|453861808|FG000|Overall Study|Death|3|||
126156607|NCT02699515|453861809|FG001|Overall Study|Death|3|||
126156608|NCT02699515|453861810|FG002|Overall Study|Death|3|||
126156609|NCT02699515|453861811|FG003|Overall Study|Death|23|||
125971744|NCT03579563|453184798|FG004|Overall Study|COVID shutdown|1|||
125971745|NCT03579563|453184799|FG005|Overall Study|COVID shutdown|2|||
125971746|NCT03579563|453184794|FG000|Overall Study|Protocol administration error|1|||
126156610|NCT02699515|453861812|FG004|Overall Study|Death|22|||
126156611|NCT02699515|453861813|FG005|Overall Study|Death|23|||
126156612|NCT02699515|453861814|FG006|Overall Study|Death|3|||
126156613|NCT02699515|453861815|FG007|Overall Study|Death|5|||
126156614|NCT02699515|453861808|FG000|Overall Study|Withdrawal by Subject|0|||
126156615|NCT02699515|453861809|FG001|Overall Study|Withdrawal by Subject|0|||
126156616|NCT02699515|453861810|FG002|Overall Study|Withdrawal by Subject|3|||
126156617|NCT02699515|453861811|FG003|Overall Study|Withdrawal by Subject|1|||
126156618|NCT02699515|453861812|FG004|Overall Study|Withdrawal by Subject|5|||
126156619|NCT02699515|453861813|FG005|Overall Study|Withdrawal by Subject|3|||
126156620|NCT02699515|453861814|FG006|Overall Study|Withdrawal by Subject|0|||
126156621|NCT02699515|453861815|FG007|Overall Study|Withdrawal by Subject|1|||
126156622|NCT02699515|453861808|FG000|Overall Study|Other|1|||
126156623|NCT02699515|453861809|FG001|Overall Study|Other|0|||
126156624|NCT02699515|453861810|FG002|Overall Study|Other|1|||
126156625|NCT02699515|453861811|FG003|Overall Study|Other|6|||
126156626|NCT02699515|453861812|FG004|Overall Study|Other|4|||
126156627|NCT02699515|453861813|FG005|Overall Study|Other|3|||
126156628|NCT02699515|453861814|FG006|Overall Study|Other|0|||
126156629|NCT02699515|453861815|FG007|Overall Study|Other|0|||
126156630|NCT05243550|453861816|FG000|Overall Study|Ongoing in the Study|171|||
126156631|NCT05243550|453861816|FG000|Overall Study|Withdrawal by Subject|10|||
126156632|NCT05243550|453861816|FG000|Overall Study|Lost to Follow-up|7|||
126156633|NCT05243550|453861816|FG000|Overall Study|Adverse Event|3|||
126156634|NCT05243550|453861816|FG000|Overall Study|Noncompliance|1|||
126156635|NCT05243550|453861816|FG000|Overall Study|Physician Decision|1|||
126156636|NCT05243550|453861816|FG000|Overall Study|Other Reason|4|||
126156637|NCT00375934|453861823|FG000|Overall Study|Adverse Event|1|||
126156638|NCT00375934|453861824|FG001|Overall Study|Adverse Event|1|||
126156639|NCT00375934|453861823|FG000|Overall Study|Withdrawal by Subject|2|||
126156640|NCT00375934|453861824|FG001|Overall Study|Withdrawal by Subject|2|||
126156641|NCT00375934|453861823|FG000|Overall Study|Lack of Efficacy|0|||
126156642|NCT00375934|453861824|FG001|Overall Study|Lack of Efficacy|2|||
126156643|NCT00375934|453861823|FG000|Overall Study|Physician Decision|0|||
126156644|NCT00375934|453861824|FG001|Overall Study|Physician Decision|1|||
126156645|NCT02452970|453861827|FG000|Overall Study|Adverse Event|1|||
126156646|NCT00893113|453861828|FG000|Overall Study|Lost to Follow-up|4|||
126156647|NCT00893113|453861829|FG001|Overall Study|Lost to Follow-up|8|||
126156648|NCT00893113|453861828|FG000|Overall Study|Early Termination|1|||
126156649|NCT00893113|453861829|FG001|Overall Study|Early Termination|1|||
126156650|NCT00893113|453861828|FG000|Overall Study|Withdrew Consent|8|||
126156651|NCT00893113|453861829|FG001|Overall Study|Withdrew Consent|7|||
126156652|NCT00128206|453861838|FG000|Overall Study|Lost to Follow-up|137|||
126156653|NCT00128206|453861839|FG001|Overall Study|Lost to Follow-up|118|||
126156654|NCT00128206|453861838|FG000|Overall Study|Adverse Event|0|||
126156655|NCT00128206|453861839|FG001|Overall Study|Adverse Event|2|||
126156656|NCT03270085|453861840|FG000|Overall Study|Withdrawal by Subject|1|||
126156657|NCT03270085|453861841|FG001|Overall Study|Withdrawal by Subject|0|||
126156658|NCT02400346|453861842|FG000|Overall Study|Adverse Event|24|||
126156659|NCT02400346|453861842|FG000|Overall Study|Lack of Efficacy|9|||
126156660|NCT02400346|453861842|FG000|Overall Study|Non-compliance with IMP|1|||
126156661|NCT02400346|453861842|FG000|Overall Study|Withdrawal by Subject|7|||
126156662|NCT02400346|453861842|FG000|Overall Study|Administrative or other reason(s)|2|||
126156663|NCT02400346|453861842|FG000|Overall Study|Lost to Follow-up|1|||
126156664|NCT01269125|453861843|FG000|Overall Study|Adverse Event|3|||
126156665|NCT01269125|453861844|FG001|Overall Study|Adverse Event|5|||
126156666|NCT01269125|453861845|FG002|Overall Study|Adverse Event|0|||
126156667|NCT01269125|453861843|FG000|Overall Study|Lost to Follow-up|4|||
126156668|NCT01269125|453861844|FG001|Overall Study|Lost to Follow-up|0|||
126156669|NCT01269125|453861845|FG002|Overall Study|Lost to Follow-up|0|||
126156670|NCT01283581|453861848|FG000|Overall Study|Lost to Follow-up|8|||
126156671|NCT01283581|453861849|FG001|Overall Study|Lost to Follow-up|6|||
126156672|NCT01283581|453861850|FG002|Overall Study|Lost to Follow-up|8|||
126156673|NCT01283581|453861848|FG000|Overall Study|Withdrawal by Subject|2|||
126156674|NCT01283581|453861849|FG001|Overall Study|Withdrawal by Subject|5|||
126156675|NCT01283581|453861850|FG002|Overall Study|Withdrawal by Subject|2|||
126156676|NCT01283581|453861848|FG000|Overall Study|Adverse Event|1|||
126156677|NCT01283581|453861849|FG001|Overall Study|Adverse Event|1|||
126156678|NCT01283581|453861850|FG002|Overall Study|Adverse Event|4|||
126156679|NCT01283581|453861848|FG000|Overall Study|Physician Decision|0|||
126156680|NCT01283581|453861849|FG001|Overall Study|Physician Decision|1|||
126156681|NCT01283581|453861850|FG002|Overall Study|Physician Decision|2|||
126156682|NCT01283581|453861848|FG000|Overall Study|Protocol Violation|0|||
126156683|NCT01283581|453861849|FG001|Overall Study|Protocol Violation|1|||
126156684|NCT01283581|453861850|FG002|Overall Study|Protocol Violation|2|||
126156685|NCT01283581|453861848|FG000|Overall Study|Noncompliance|1|||
126156686|NCT01283581|453861849|FG001|Overall Study|Noncompliance|0|||
126156687|NCT01283581|453861850|FG002|Overall Study|Noncompliance|0|||
126156688|NCT01283581|453861848|FG000|Overall Study|Investigator unblinded|0|||
126156689|NCT01283581|453861849|FG001|Overall Study|Investigator unblinded|0|||
126156690|NCT01283581|453861850|FG002|Overall Study|Investigator unblinded|1|||
126156691|NCT01283581|453861848|FG000|Overall Study|"Early termination"|0|||
126156692|NCT01283581|453861849|FG001|Overall Study|"Early termination"|0|||
126156693|NCT01283581|453861850|FG002|Overall Study|"Early termination"|1|||
126156694|NCT00486226|453861851|FG000|Overall Study|Death|3|||
126156695|NCT00486226|453861851|FG000|Overall Study|Adverse Event|1|||
126156696|NCT00486226|453861851|FG000|Overall Study|Withdrawal by Subject|1|||
126156697|NCT00486226|453861851|FG000|Overall Study|Lost to Follow-up|8|||
126156698|NCT01259492|453861852|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
126156699|NCT01259492|453861853|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
126156700|NCT01259492|453861854|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
126156701|NCT01259492|453861855|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
126156702|NCT01259492|453861852|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
126156703|NCT01259492|453861853|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
126156704|NCT01259492|453861854|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
126156705|NCT01259492|453861855|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
126156706|NCT01259492|453861852|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
126156707|NCT01259492|453861853|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
126156708|NCT01259492|453861854|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
126156709|NCT01259492|453861855|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
126156710|NCT01259492|453861852|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
126156711|NCT01259492|453861853|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
126156712|NCT01259492|453861854|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
126156713|NCT01259492|453861855|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
126156714|NCT01259492|453861852|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
126156715|NCT01259492|453861853|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
126156716|NCT01259492|453861854|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
126156717|NCT01259492|453861855|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
126156718|NCT01259492|453861852|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
126156719|NCT01259492|453861853|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
126156720|NCT01259492|453861854|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
126156721|NCT01259492|453861855|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
126156722|NCT01259492|453861852|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
126156723|NCT01259492|453861853|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
126156724|NCT01259492|453861854|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
126156725|NCT01259492|453861855|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
126156726|NCT01259492|453861852|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
126156727|NCT01259492|453861853|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
126156728|NCT01259492|453861854|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
126156729|NCT01259492|453861855|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
126156730|NCT01259492|453861852|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
126156731|NCT01259492|453861853|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
126156732|NCT01259492|453861854|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
126156733|NCT01259492|453861855|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
126156734|NCT01259492|453861852|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
126156735|NCT01259492|453861853|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
126156736|NCT01259492|453861854|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
126156737|NCT01259492|453861855|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
126156738|NCT01259492|453861852|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
126156739|NCT01259492|453861853|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
126156740|NCT01259492|453861854|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
126156741|NCT01259492|453861855|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
126156742|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
126156743|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
126156744|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
126156745|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
126156746|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
126156747|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
126156748|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
125971747|NCT03579563|453184795|FG001|Overall Study|Protocol administration error|0|||
125971748|NCT03579563|453184796|FG002|Overall Study|Protocol administration error|1|||
125971749|NCT03579563|453184797|FG003|Overall Study|Protocol administration error|0|||
125971750|NCT03579563|453184798|FG004|Overall Study|Protocol administration error|1|||
125971751|NCT03579563|453184799|FG005|Overall Study|Protocol administration error|5|||
125971752|NCT02647359|453184800|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
125971753|NCT02647359|453184801|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
125971754|NCT02647359|453184800|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
125971755|NCT02647359|453184801|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
125971756|NCT02647359|453184800|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
125971757|NCT02647359|453184801|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
125971758|NCT02647359|453184800|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
125971759|NCT02647359|453184801|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
125971760|NCT02647359|453184800|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
125971761|NCT02647359|453184801|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
125971762|NCT02647359|453184800|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
125971763|NCT02647359|453184801|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
125971764|NCT02513563|453184802|FG000|Overall Study|Death|4|||
125971765|NCT02513563|453184802|FG000|Overall Study|Withdrawal by Subject|4|||
125971766|NCT02513563|453184802|FG000|Overall Study|Physician Decision|1|||
125971767|NCT01362140|453184806|FG000|Overall Study|Noncompliance|1|||
125971768|NCT01362140|453184807|FG001|Overall Study|Noncompliance|0|||
125971769|NCT01362140|453184806|FG000|Overall Study|Adverse Event|2|||
126156749|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
126156750|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
126156751|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
126156752|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
126200104|NCT02394028|454017881|FG004|Induction Phase|Adverse Event|5|||
126156753|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
126156754|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
126156755|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
126156756|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
126156757|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
126156758|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
126156759|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
126156760|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
126156761|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
126156762|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
126156763|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
126156764|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
126156765|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
126156766|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
126156767|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
126156768|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
126156769|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
126156770|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
126156771|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
126156772|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
126156773|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
126156774|NCT01259492|453861852|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
126156775|NCT01259492|453861853|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
126156776|NCT01259492|453861854|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
126156777|NCT01259492|453861855|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
126156778|NCT00663858|453861858|FG000|Overall Study|Adverse Event|9|||
126156779|NCT00663858|453861859|FG001|Overall Study|Adverse Event|1|||
126156780|NCT00663858|453861860|FG002|Overall Study|Adverse Event|6|||
126156781|NCT00663858|453861858|FG000|Overall Study|Lack of Efficacy|5|||
126156782|NCT00663858|453861859|FG001|Overall Study|Lack of Efficacy|1|||
126156783|NCT00663858|453861860|FG002|Overall Study|Lack of Efficacy|3|||
126156784|NCT00663858|453861858|FG000|Overall Study|Withdrawal by Subject|7|||
126156785|NCT00663858|453861859|FG001|Overall Study|Withdrawal by Subject|3|||
126156786|NCT00663858|453861860|FG002|Overall Study|Withdrawal by Subject|3|||
126156787|NCT00663858|453861858|FG000|Overall Study|Protocol Violation|5|||
126156788|NCT00663858|453861859|FG001|Overall Study|Protocol Violation|3|||
126156789|NCT00663858|453861860|FG002|Overall Study|Protocol Violation|4|||
126156790|NCT00663858|453861858|FG000|Overall Study|Other|8|||
126156791|NCT00663858|453861859|FG001|Overall Study|Other|2|||
126156792|NCT00663858|453861860|FG002|Overall Study|Other|4|||
126156793|NCT01166659|453861867|FG000|Overall Study|Subject Decision|8|||
126156794|NCT01166659|453861867|FG000|Overall Study|Investigator Decision|2|||
126156795|NCT01166659|453861867|FG000|Overall Study|Death|1|||
126156796|NCT01166659|453861867|FG000|Overall Study|Lost to Follow-up|1|||
126156797|NCT01166659|453861867|FG000|Overall Study|Study Closed at Site|1|||
126156798|NCT01371838|453861886|FG000|Overall Study|Withdrawal by Subject|27|||
126156799|NCT01371838|453861887|FG001|Overall Study|Withdrawal by Subject|33|||
126156800|NCT01371838|453861886|FG000|Overall Study|Lost to Follow-up|10|||
126156801|NCT01371838|453861887|FG001|Overall Study|Lost to Follow-up|20|||
126156802|NCT01371838|453861886|FG000|Overall Study|Death|3|||
126156803|NCT01371838|453861887|FG001|Overall Study|Death|4|||
126156804|NCT01371838|453861886|FG000|Overall Study|Protocol Violation|3|||
126156805|NCT01371838|453861887|FG001|Overall Study|Protocol Violation|0|||
126156806|NCT01371838|453861886|FG000|Overall Study|Investigator Decision|3|||
126156807|NCT01371838|453861887|FG001|Overall Study|Investigator Decision|8|||
126156808|NCT01371838|453861886|FG000|Overall Study|Last follow-up visit not conducted|2|||
126156809|NCT01371838|453861887|FG001|Overall Study|Last follow-up visit not conducted|0|||
126156810|NCT01371838|453861886|FG000|Overall Study|Lack of therapeutic response|0|||
126156811|NCT01371838|453861887|FG001|Overall Study|Lack of therapeutic response|1|||
126156812|NCT01371838|453861886|FG000|Overall Study|Surgery|1|||
126156813|NCT01371838|453861887|FG001|Overall Study|Surgery|0|||
126156814|NCT01334125|453861890|FG000|Overall Study|Lost to Follow-up|3|||
126156815|NCT01334125|453861891|FG001|Overall Study|Lost to Follow-up|3|||
126156816|NCT00641043|453861898|FG000|Overall Study|Adverse Event|6|||
126156817|NCT00641043|453861899|FG001|Overall Study|Adverse Event|4|||
126156818|NCT00641043|453861898|FG000|Overall Study|Protocol Violation|2|||
126156819|NCT00641043|453861899|FG001|Overall Study|Protocol Violation|3|||
126156820|NCT00641043|453861898|FG000|Overall Study|Lost to Follow-up|3|||
126156821|NCT00641043|453861899|FG001|Overall Study|Lost to Follow-up|2|||
126156822|NCT00641043|453861898|FG000|Overall Study|Withdrawal by Subject|4|||
126156823|NCT00641043|453861899|FG001|Overall Study|Withdrawal by Subject|4|||
125971770|NCT01362140|453184807|FG001|Overall Study|Adverse Event|2|||
126200105|NCT02394028|454017882|FG005|Induction Phase|Adverse Event|2|||
126156824|NCT00641043|453861898|FG000|Overall Study|Other incl. lack of efficacy|4|||
126156825|NCT00641043|453861899|FG001|Overall Study|Other incl. lack of efficacy|2|||
126156826|NCT02584634|453861900|FG000|Overall Study|Adverse Event|3|||
126156827|NCT02584634|453861901|FG001|Overall Study|Adverse Event|5|||
126156828|NCT02584634|453861900|FG000|Overall Study|Death|0|||
126156829|NCT02584634|453861901|FG001|Overall Study|Death|1|||
126156830|NCT02584634|453861900|FG000|Overall Study|Lost to Follow-up|0|||
125971771|NCT01362140|453184806|FG000|Overall Study|Withdrawal by Subject|3|||
125971772|NCT01362140|453184807|FG001|Overall Study|Withdrawal by Subject|3|||
125971773|NCT01362140|453184806|FG000|Overall Study|Administrative Decision|0|||
125971774|NCT01362140|453184807|FG001|Overall Study|Administrative Decision|1|||
125971775|NCT01362140|453184806|FG000|Overall Study|Death|2|||
125971776|NCT01362140|453184807|FG001|Overall Study|Death|1|||
125971777|NCT01362140|453184806|FG000|Overall Study|Other|1|||
125971778|NCT01362140|453184807|FG001|Overall Study|Other|1|||
126156831|NCT02584634|453861901|FG001|Overall Study|Lost to Follow-up|1|||
126156832|NCT02584634|453861900|FG000|Overall Study|Physician Decision|1|||
126156833|NCT02584634|453861901|FG001|Overall Study|Physician Decision|2|||
126156834|NCT02584634|453861900|FG000|Overall Study|Progressive disease|7|||
126156835|NCT02584634|453861901|FG001|Overall Study|Progressive disease|15|||
126156836|NCT02584634|453861900|FG000|Overall Study|Withdrawal by Subject|1|||
126156837|NCT02584634|453861901|FG001|Overall Study|Withdrawal by Subject|1|||
126156838|NCT02584634|453861900|FG000|Overall Study|Other|0|||
126156839|NCT02584634|453861901|FG001|Overall Study|Other|6|||
126156840|NCT04275310|453861902|FG000|Overall Study|Non-randomized due to running out of funding|4|||
126156841|NCT04275310|453861903|FG001|Overall Study|Non-randomized due to running out of funding|0|||
126156842|NCT03088605|453861904|FG000|Overall Study|Withdrawal by Subject|1|||
125971779|NCT01362140|453184806|FG000|Overall Study|Protocol-specified Criteria|1|||
125971780|NCT01362140|453184807|FG001|Overall Study|Protocol-specified Criteria|2|||
125971781|NCT01362140|453184806|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
126156843|NCT03088605|453861905|FG001|Overall Study|Withdrawal by Subject|0|||
126156844|NCT00098345|453861911|FG000|Overall Study|Adverse Event|7|||
126156845|NCT00098345|453861911|FG000|Overall Study|Withdrawal by Subject|2|||
126156846|NCT00098345|453861911|FG000|Overall Study|progression|4|||
126156847|NCT01936649|453861912|FG000|Overall Study|Withdrawal by Subject|4|||
126156848|NCT01936649|453861912|FG000|Overall Study|Physician Decision|2|||
126156849|NCT01936649|453861912|FG000|Overall Study|Protocol Violation|2|||
126156850|NCT01936649|453861912|FG000|Overall Study|Other than specified above|5|||
126156851|NCT04655586|453861919|FG000|Overall Study|Physician Decision|1|||
126156852|NCT04655586|453861920|FG001|Overall Study|Physician Decision|3|||
126156853|NCT04655586|453861921|FG002|Overall Study|Physician Decision|4|||
126156854|NCT04655586|453861919|FG000|Overall Study|Withdrawal by Subject|1|||
126156855|NCT04655586|453861920|FG001|Overall Study|Withdrawal by Subject|3|||
126156856|NCT04655586|453861921|FG002|Overall Study|Withdrawal by Subject|1|||
126156857|NCT00201201|453861924|FG000|Overall Study|Death|0|||
126156858|NCT00201201|453861925|FG001|Overall Study|Death|2|||
126156859|NCT00201201|453861924|FG000|Overall Study|Withdrawal by Subject|5|||
126156860|NCT00201201|453861925|FG001|Overall Study|Withdrawal by Subject|5|||
126156861|NCT01342640|453861927|FG000|Overall Study|Adverse Event|3|||
126156862|NCT01342640|453861927|FG000|Overall Study|Protocol Violation|16|||
126156863|NCT01342640|453861927|FG000|Overall Study|Lost to Follow-up|21|||
126156864|NCT01342640|453861927|FG000|Overall Study|Other|1|||
126156865|NCT04101422|453861929|FG000|Overall Study|Ineligible|1|||
126156866|NCT04101422|453861930|FG001|Overall Study|Ineligible|0|||
126156867|NCT04101422|453861931|FG002|Overall Study|Ineligible|9|||
126156868|NCT04101422|453861932|FG003|Overall Study|Ineligible|0|||
126156869|NCT04101422|453861929|FG000|Overall Study|Withdrawal by Subject|0|||
126156870|NCT04101422|453861930|FG001|Overall Study|Withdrawal by Subject|0|||
126156871|NCT04101422|453861931|FG002|Overall Study|Withdrawal by Subject|1|||
126156872|NCT04101422|453861932|FG003|Overall Study|Withdrawal by Subject|0|||
126156873|NCT04101422|453861929|FG000|Overall Study|Not attending to the stimuli|0|||
126156874|NCT04101422|453861930|FG001|Overall Study|Not attending to the stimuli|0|||
126156875|NCT04101422|453861931|FG002|Overall Study|Not attending to the stimuli|4|||
126156876|NCT04101422|453861932|FG003|Overall Study|Not attending to the stimuli|0|||
126156877|NCT04101422|453861929|FG000|Overall Study|Did not download app|0|||
126156878|NCT04101422|453861930|FG001|Overall Study|Did not download app|0|||
126156879|NCT04101422|453861931|FG002|Overall Study|Did not download app|0|||
125971782|NCT01362140|453184807|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
126156880|NCT04101422|453861932|FG003|Overall Study|Did not download app|17|||
126156881|NCT04101422|453861929|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
126156882|NCT04101422|453861930|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
126156883|NCT04101422|453861931|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
126156884|NCT04101422|453861932|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
126156885|NCT02640612|453861933|FG000|Overall Study|Adverse Event|6|||
126156886|NCT02640612|453861934|FG001|Overall Study|Adverse Event|7|||
126156887|NCT02640612|453861935|FG002|Overall Study|Adverse Event|2|||
126156888|NCT02640612|453861933|FG000|Overall Study|Death|1|||
126156889|NCT02640612|453861934|FG001|Overall Study|Death|0|||
126156890|NCT02640612|453861935|FG002|Overall Study|Death|0|||
126156891|NCT02640612|453861933|FG000|Overall Study|Withdrawal by Subject|10|||
126156892|NCT02640612|453861934|FG001|Overall Study|Withdrawal by Subject|3|||
126156893|NCT02640612|453861935|FG002|Overall Study|Withdrawal by Subject|3|||
126156894|NCT02640612|453861933|FG000|Overall Study|Lost to Follow-up|4|||
126156895|NCT02640612|453861934|FG001|Overall Study|Lost to Follow-up|1|||
126156896|NCT02640612|453861935|FG002|Overall Study|Lost to Follow-up|1|||
126156897|NCT02640612|453861933|FG000|Overall Study|Protocol Violation|0|||
126156898|NCT02640612|453861934|FG001|Overall Study|Protocol Violation|2|||
126156899|NCT02640612|453861935|FG002|Overall Study|Protocol Violation|0|||
126156900|NCT02640612|453861933|FG000|Overall Study|Lack of Efficacy|1|||
126156901|NCT02640612|453861934|FG001|Overall Study|Lack of Efficacy|1|||
126156902|NCT02640612|453861935|FG002|Overall Study|Lack of Efficacy|0|||
126156903|NCT03472534|453861936|FG000|Overall Study|Withdrawal by Subject|9|||
126156904|NCT03472534|453861936|FG000|Overall Study|Adverse Event|2|||
126156905|NCT00552305|453861937|FG000|Overall Study|Adverse Event|43|||
126156906|NCT00552305|453861937|FG000|Overall Study|Lack of Efficacy|120|||
126156907|NCT00552305|453861937|FG000|Overall Study|Lost to Follow-up|4|||
126156908|NCT00552305|453861937|FG000|Overall Study|Protocol Violation|3|||
126156909|NCT00552305|453861937|FG000|Overall Study|Withdrawal by Subject|44|||
126156910|NCT00552305|453861937|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
126156911|NCT00552305|453861937|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
126156912|NCT00552305|453861937|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
126156913|NCT00552305|453861937|FG000|Overall Study|Unsatisfactory compliance|11|||
126156914|NCT00552305|453861937|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
126156915|NCT00552305|453861937|FG000|Overall Study|AE/Other: prohibited drug required|1|||
126156916|NCT00552305|453861937|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
126156917|NCT00552305|453861937|FG000|Overall Study|Other: Site closed|4|||
126156918|NCT00552305|453861937|FG000|Overall Study|Other: Personal problems|1|||
126156919|NCT00552305|453861937|FG000|Overall Study|Other: Unable to attend visits|1|||
126156920|NCT00552305|453861937|FG000|Overall Study|Other: Subject underwent surgery|4|||
126156921|NCT00552305|453861937|FG000|Overall Study|Other: Subject became pregnant|1|||
126156922|NCT00552305|453861937|FG000|Overall Study|Other: Health problems, not drug related|1|||
126156923|NCT00552305|453861937|FG000|Overall Study|Other: Subject moved from area|2|||
126156924|NCT00552305|453861937|FG000|Overall Study|Other: Subject incarcerated|1|||
126156925|NCT00552305|453861937|FG000|Overall Study|Other: Subject went to rehab|1|||
126156926|NCT00546819|453861940|FG000|Overall Study|Adverse Event|2|||
126156927|NCT00546819|453861941|FG001|Overall Study|Adverse Event|3|||
126156928|NCT00546819|453861940|FG000|Overall Study|Lost to Follow-up|2|||
126156929|NCT00546819|453861941|FG001|Overall Study|Lost to Follow-up|1|||
126156930|NCT00546819|453861940|FG000|Overall Study|Withdrawal by Subject|4|||
126156931|NCT00546819|453861941|FG001|Overall Study|Withdrawal by Subject|2|||
126156932|NCT02052960|453861943|FG000|Overall Study|Adverse Event|19|||
126156933|NCT02052960|453861944|FG001|Overall Study|Adverse Event|17|||
126156934|NCT02052960|453861943|FG000|Overall Study|Protocol Violation|4|||
126156935|NCT02052960|453861944|FG001|Overall Study|Protocol Violation|3|||
126156936|NCT02052960|453861943|FG000|Overall Study|Withdrawal by Subject|6|||
126156937|NCT02052960|453861944|FG001|Overall Study|Withdrawal by Subject|11|||
126156938|NCT02052960|453861943|FG000|Overall Study|Other|25|||
126156939|NCT02052960|453861944|FG001|Overall Study|Other|15|||
126156940|NCT03849560|453861945|FG000|Overall Study|Withdrawal by Subject|1|||
126156941|NCT03849560|453861946|FG001|Overall Study|Withdrawal by Subject|0|||
126156942|NCT03849560|453861947|FG002|Overall Study|Withdrawal by Subject|0|||
126156943|NCT04045613|453861948|FG000|Overall Study|Adverse Event|2|||
126156944|NCT04045613|453861949|FG001|Overall Study|Adverse Event|2|||
126156945|NCT04045613|453861950|FG002|Overall Study|Adverse Event|1|||
126156946|NCT04045613|453861951|FG003|Overall Study|Adverse Event|1|||
126156947|NCT04045613|453861952|FG004|Overall Study|Adverse Event|0|||
126156948|NCT04045613|453861953|FG005|Overall Study|Adverse Event|0|||
126156949|NCT04045613|453861954|FG006|Overall Study|Adverse Event|1|||
126156950|NCT04045613|453861948|FG000|Overall Study|Withdrawal by Subject|0|||
126156951|NCT04045613|453861949|FG001|Overall Study|Withdrawal by Subject|5|||
126156952|NCT04045613|453861950|FG002|Overall Study|Withdrawal by Subject|0|||
126156953|NCT04045613|453861951|FG003|Overall Study|Withdrawal by Subject|0|||
126156954|NCT04045613|453861952|FG004|Overall Study|Withdrawal by Subject|0|||
126156955|NCT04045613|453861953|FG005|Overall Study|Withdrawal by Subject|1|||
126156956|NCT04045613|453861954|FG006|Overall Study|Withdrawal by Subject|0|||
126156957|NCT04045613|453861948|FG000|Overall Study|Physician Decision|2|||
126156958|NCT04045613|453861949|FG001|Overall Study|Physician Decision|0|||
126156959|NCT04045613|453861950|FG002|Overall Study|Physician Decision|0|||
126156960|NCT04045613|453861951|FG003|Overall Study|Physician Decision|0|||
126156961|NCT04045613|453861952|FG004|Overall Study|Physician Decision|1|||
126156962|NCT04045613|453861953|FG005|Overall Study|Physician Decision|0|||
126156963|NCT04045613|453861954|FG006|Overall Study|Physician Decision|0|||
126156964|NCT04045613|453861948|FG000|Overall Study|Death|3|||
126156965|NCT04045613|453861949|FG001|Overall Study|Death|0|||
126156966|NCT04045613|453861950|FG002|Overall Study|Death|0|||
126156967|NCT04045613|453861951|FG003|Overall Study|Death|0|||
126156968|NCT04045613|453861952|FG004|Overall Study|Death|0|||
126156969|NCT04045613|453861953|FG005|Overall Study|Death|0|||
126156970|NCT04045613|453861954|FG006|Overall Study|Death|1|||
126156971|NCT04045613|453861948|FG000|Overall Study|Other reasons|0|||
126156972|NCT04045613|453861949|FG001|Overall Study|Other reasons|1|||
126156973|NCT04045613|453861950|FG002|Overall Study|Other reasons|0|||
126156974|NCT04045613|453861951|FG003|Overall Study|Other reasons|0|||
126156975|NCT04045613|453861952|FG004|Overall Study|Other reasons|0|||
126156976|NCT04045613|453861953|FG005|Overall Study|Other reasons|0|||
126156977|NCT04045613|453861954|FG006|Overall Study|Other reasons|1|||
126156978|NCT04045613|453861948|FG000|Overall Study|Progressive disease: Clinical progression|1|||
126156979|NCT04045613|453861949|FG001|Overall Study|Progressive disease: Clinical progression|0|||
126156980|NCT04045613|453861950|FG002|Overall Study|Progressive disease: Clinical progression|3|||
126156981|NCT04045613|453861951|FG003|Overall Study|Progressive disease: Clinical progression|1|||
126156982|NCT04045613|453861952|FG004|Overall Study|Progressive disease: Clinical progression|1|||
126156983|NCT04045613|453861953|FG005|Overall Study|Progressive disease: Clinical progression|3|||
126156984|NCT04045613|453861954|FG006|Overall Study|Progressive disease: Clinical progression|3|||
126156985|NCT04045613|453861948|FG000|Overall Study|Progressive disease: Radiological progression|24|||
126156986|NCT04045613|453861949|FG001|Overall Study|Progressive disease: Radiological progression|6|||
126156987|NCT04045613|453861950|FG002|Overall Study|Progressive disease: Radiological progression|8|||
126156988|NCT04045613|453861951|FG003|Overall Study|Progressive disease: Radiological progression|0|||
126156989|NCT04045613|453861952|FG004|Overall Study|Progressive disease: Radiological progression|6|||
126156990|NCT04045613|453861953|FG005|Overall Study|Progressive disease: Radiological progression|6|||
126156991|NCT04045613|453861954|FG006|Overall Study|Progressive disease: Radiological progression|11|||
126156992|NCT04983901|453861955|FG000|Overall Study|Death|1|||
126156993|NCT04983901|453861956|FG001|Overall Study|Death|4|||
126156994|NCT04983901|453861955|FG000|Overall Study|Lost to Follow-up|3|||
126156995|NCT04983901|453861956|FG001|Overall Study|Lost to Follow-up|0|||
126156996|NCT04983901|453861955|FG000|Overall Study|Protocol Violation|1|||
126156997|NCT04983901|453861956|FG001|Overall Study|Protocol Violation|0|||
126156998|NCT04983901|453861955|FG000|Overall Study|Withdrawal by Subject|1|||
126156999|NCT04983901|453861956|FG001|Overall Study|Withdrawal by Subject|2|||
126157000|NCT02859415|453861964|FG000|Overall Study|Physician Decision|1|||
126157001|NCT02859415|453861965|FG001|Overall Study|Physician Decision|0|||
126157002|NCT02859415|453861964|FG000|Overall Study|Off treatment due to cardiac event|0|||
126157003|NCT02859415|453861965|FG001|Overall Study|Off treatment due to cardiac event|1|||
126157004|NCT01174784|453861966|FG000|Overall Study|Screen fails|4|||
126157005|NCT01507545|453861971|FG000|Overall Study|Withdrawal by Subject|6|||
126157006|NCT01507545|453861972|FG001|Overall Study|Withdrawal by Subject|2|||
126157007|NCT01507545|453861971|FG000|Overall Study|Lost to Follow-up|1|||
126157008|NCT01507545|453861972|FG001|Overall Study|Lost to Follow-up|0|||
126157009|NCT01507545|453861971|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
126157010|NCT01507545|453861972|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
126157011|NCT01507545|453861971|FG000|Overall Study|Progressive disease|60|||
126157012|NCT01507545|453861972|FG001|Overall Study|Progressive disease|27|||
126157013|NCT01507545|453861971|FG000|Overall Study|Other|6|||
126157014|NCT01507545|453861972|FG001|Overall Study|Other|4|||
126157015|NCT00450866|453861973|FG000|Overall Study|Adverse Event|0|||
126157016|NCT00450866|453861974|FG001|Overall Study|Adverse Event|1|||
126157017|NCT00450866|453861973|FG000|Overall Study|Withdrawal by Subject|5|||
126157018|NCT00450866|453861974|FG001|Overall Study|Withdrawal by Subject|2|||
126157019|NCT00450866|453861973|FG000|Overall Study|Death|1|||
126157020|NCT00450866|453861974|FG001|Overall Study|Death|0|||
126157021|NCT00450866|453861973|FG000|Overall Study|Physician Decision|1|||
126157022|NCT00450866|453861974|FG001|Overall Study|Physician Decision|0|||
126157023|NCT00553787|453861975|FG000|Overall Study|Adverse Event|34|||
126157024|NCT00553787|453861976|FG001|Overall Study|Adverse Event|21|||
126157025|NCT00553787|453861977|FG002|Overall Study|Adverse Event|67|||
126157026|NCT00553787|453861975|FG000|Overall Study|Lost to Follow-up|132|||
126157027|NCT00553787|453861976|FG001|Overall Study|Lost to Follow-up|44|||
125971783|NCT06476366|453184809|FG000|Overall Study|Lost to Follow-up|1|||
126157028|NCT00553787|453861977|FG002|Overall Study|Lost to Follow-up|78|||
126157029|NCT00553787|453861975|FG000|Overall Study|Withdrawal by Subject|151|||
126157030|NCT00553787|453861976|FG001|Overall Study|Withdrawal by Subject|40|||
126157031|NCT00553787|453861977|FG002|Overall Study|Withdrawal by Subject|83|||
126157032|NCT00553787|453861975|FG000|Overall Study|Lack of Efficacy|31|||
126157033|NCT00553787|453861976|FG001|Overall Study|Lack of Efficacy|1|||
126157034|NCT00553787|453861977|FG002|Overall Study|Lack of Efficacy|3|||
126157035|NCT00553787|453861975|FG000|Overall Study|Pregnancy|0|||
125971784|NCT06476366|453184810|FG001|Overall Study|Lost to Follow-up|3|||
126157036|NCT00553787|453861976|FG001|Overall Study|Pregnancy|1|||
126157037|NCT00553787|453861977|FG002|Overall Study|Pregnancy|2|||
126157038|NCT00553787|453861975|FG000|Overall Study|non compliance|4|||
126157039|NCT00553787|453861976|FG001|Overall Study|non compliance|0|||
125971785|NCT06476366|453184809|FG000|Overall Study|Adverse Event|1|||
126157040|NCT00553787|453861977|FG002|Overall Study|non compliance|11|||
126157041|NCT00553787|453861975|FG000|Overall Study|Requirement for restricted medication|8|||
126157042|NCT00553787|453861976|FG001|Overall Study|Requirement for restricted medication|7|||
126157043|NCT00553787|453861977|FG002|Overall Study|Requirement for restricted medication|5|||
126157044|NCT00553787|453861975|FG000|Overall Study|Other|18|||
126157045|NCT00553787|453861976|FG001|Overall Study|Other|10|||
126157046|NCT00553787|453861977|FG002|Overall Study|Other|13|||
126157047|NCT01426386|453861981|FG000|Overall Study|Adverse Event|0|||
126157048|NCT01426386|453861982|FG001|Overall Study|Adverse Event|1|||
126157049|NCT01426386|453861983|FG002|Overall Study|Adverse Event|0|||
126157050|NCT01426386|453861984|FG003|Overall Study|Adverse Event|0|||
126157051|NCT01426386|453861985|FG004|Overall Study|Adverse Event|0|||
126157052|NCT01426386|453861986|FG005|Overall Study|Adverse Event|0|||
126157053|NCT01426386|453861981|FG000|Overall Study|Did not attend scheduled visit|1|||
126157054|NCT01426386|453861982|FG001|Overall Study|Did not attend scheduled visit|4|||
126157055|NCT01426386|453861983|FG002|Overall Study|Did not attend scheduled visit|0|||
126157056|NCT01426386|453861984|FG003|Overall Study|Did not attend scheduled visit|0|||
126157057|NCT01426386|453861985|FG004|Overall Study|Did not attend scheduled visit|2|||
126157058|NCT01426386|453861986|FG005|Overall Study|Did not attend scheduled visit|1|||
126157059|NCT01426386|453861981|FG000|Overall Study|Poor response|2|||
126157060|NCT01426386|453861982|FG001|Overall Study|Poor response|1|||
126157061|NCT01426386|453861983|FG002|Overall Study|Poor response|2|||
126157062|NCT01426386|453861984|FG003|Overall Study|Poor response|0|||
126157063|NCT01426386|453861985|FG004|Overall Study|Poor response|1|||
126157064|NCT01426386|453861986|FG005|Overall Study|Poor response|0|||
126157065|NCT01426386|453861981|FG000|Overall Study|Personal reasons|0|||
126157066|NCT01426386|453861982|FG001|Overall Study|Personal reasons|0|||
126157067|NCT01426386|453861983|FG002|Overall Study|Personal reasons|0|||
126157068|NCT01426386|453861984|FG003|Overall Study|Personal reasons|0|||
126157069|NCT01426386|453861985|FG004|Overall Study|Personal reasons|1|||
126157070|NCT01426386|453861986|FG005|Overall Study|Personal reasons|0|||
126157071|NCT01096667|453861987|FG000|Overall Study|Lost to Follow-up|1|||
126157072|NCT01096667|453861988|FG001|Overall Study|Lost to Follow-up|1|||
126157073|NCT01096667|453861989|FG002|Overall Study|Lost to Follow-up|1|||
126157074|NCT01096667|453861990|FG003|Overall Study|Lost to Follow-up|0|||
126157075|NCT01096667|453861991|FG004|Overall Study|Lost to Follow-up|0|||
126157076|NCT01096667|453861987|FG000|Overall Study|Withdrawal by Subject|1|||
126157077|NCT01096667|453861988|FG001|Overall Study|Withdrawal by Subject|0|||
126157078|NCT01096667|453861989|FG002|Overall Study|Withdrawal by Subject|0|||
126157079|NCT01096667|453861990|FG003|Overall Study|Withdrawal by Subject|1|||
126157080|NCT01096667|453861991|FG004|Overall Study|Withdrawal by Subject|0|||
126157081|NCT01096667|453861987|FG000|Overall Study|Reason not available|0|||
126157082|NCT01096667|453861988|FG001|Overall Study|Reason not available|1|||
126157083|NCT01096667|453861989|FG002|Overall Study|Reason not available|1|||
126157084|NCT01096667|453861990|FG003|Overall Study|Reason not available|1|||
126157085|NCT01096667|453861991|FG004|Overall Study|Reason not available|0|||
126157086|NCT01096667|453861987|FG000|Overall Study|Protocol Violation|0|||
126157087|NCT01096667|453861988|FG001|Overall Study|Protocol Violation|0|||
126157088|NCT01096667|453861989|FG002|Overall Study|Protocol Violation|0|||
126157089|NCT01096667|453861990|FG003|Overall Study|Protocol Violation|1|||
126157090|NCT01096667|453861991|FG004|Overall Study|Protocol Violation|0|||
126157091|NCT01096667|453861987|FG000|Overall Study|Not treated|1|||
126157092|NCT01096667|453861988|FG001|Overall Study|Not treated|0|||
126157093|NCT01096667|453861989|FG002|Overall Study|Not treated|0|||
126157094|NCT01096667|453861990|FG003|Overall Study|Not treated|0|||
126157095|NCT01096667|453861991|FG004|Overall Study|Not treated|0|||
126157096|NCT01040832|453863941|FG000|Overall Study|Adverse Event|4|||
126157097|NCT01040832|453863942|FG001|Overall Study|Adverse Event|5|||
126157098|NCT01040832|453863941|FG000|Overall Study|Death|4|||
126157099|NCT01040832|453863942|FG001|Overall Study|Death|6|||
126157100|NCT01040832|453863941|FG000|Overall Study|Withdrawal by Subject|2|||
125971786|NCT06476366|453184810|FG001|Overall Study|Adverse Event|0|||
126157101|NCT01040832|453863942|FG001|Overall Study|Withdrawal by Subject|3|||
125971787|NCT01939028|453184815|FG000|Overall Study|Withdrawal by Subject|5|||
125971788|NCT01939028|453184815|FG000|Overall Study|Physician Decision|7|||
125971789|NCT00700401|453184820|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
125971790|NCT00700401|453184820|FG000|Overall Study|Adverse Event|5|||
125971791|NCT00700401|453184820|FG000|Overall Study|Refused Treatment|2|||
126157102|NCT01040832|453863941|FG000|Overall Study|Progressive disease|32|||
126157103|NCT01040832|453863942|FG001|Overall Study|Progressive disease|17|||
126157104|NCT01040832|453863941|FG000|Overall Study|Symptomatic deterioration|2|||
126157105|NCT01040832|453863942|FG001|Overall Study|Symptomatic deterioration|5|||
126157106|NCT01040832|453863941|FG000|Overall Study|Other|2|||
125971792|NCT00700401|453184820|FG000|Overall Study|Lost to Follow-up|1|||
125971793|NCT00700401|453184820|FG000|Overall Study|Treatment never started|1|||
126157107|NCT01040832|453863942|FG001|Overall Study|Other|1|||
126157108|NCT01058369|453863948|FG000|Overall Study|Adverse Event|1|||
126157109|NCT01058369|453863948|FG000|Overall Study|Early termination study|1|||
126157110|NCT02940886|453863949|FG000|Overall Study|Adverse Event|7|||
126157111|NCT02940886|453863950|FG001|Overall Study|Adverse Event|3|||
126157112|NCT02940886|453863949|FG000|Overall Study|Protocol Violation|0|||
126157113|NCT02940886|453863950|FG001|Overall Study|Protocol Violation|2|||
126157114|NCT02940886|453863949|FG000|Overall Study|Withdrawal by Subject|28|||
126157115|NCT02940886|453863950|FG001|Overall Study|Withdrawal by Subject|20|||
126157116|NCT02940886|453863949|FG000|Overall Study|Death|1|||
126157117|NCT02940886|453863950|FG001|Overall Study|Death|0|||
126157118|NCT02940886|453863949|FG000|Overall Study|Lack of Efficacy|1|||
126157119|NCT02940886|453863950|FG001|Overall Study|Lack of Efficacy|0|||
126157120|NCT02940886|453863949|FG000|Overall Study|Lost to Follow-up|49|||
126157121|NCT02940886|453863950|FG001|Overall Study|Lost to Follow-up|21|||
126157122|NCT02940886|453863949|FG000|Overall Study|Physician Decision|9|||
126157123|NCT02940886|453863950|FG001|Overall Study|Physician Decision|4|||
126157124|NCT02940886|453863949|FG000|Overall Study|Sponsor decision|0|||
126157125|NCT02940886|453863950|FG001|Overall Study|Sponsor decision|1|||
126157126|NCT02940886|453863949|FG000|Overall Study|No treatment|7|||
126157127|NCT02940886|453863950|FG001|Overall Study|No treatment|2|||
126157128|NCT02940886|453863949|FG000|Overall Study|Enrolment error|0|||
126157129|NCT02940886|453863950|FG001|Overall Study|Enrolment error|1|||
126157130|NCT01306058|453863952|FG000|Overall Study|Death|1|||
126157131|NCT01306058|453863952|FG000|Overall Study|Enrolled but did not get treatment|1|||
126157132|NCT01666444|453863953|FG000|Overall Study|Did not initiate treatment|2|||
126157133|NCT01666444|453863954|FG001|Overall Study|Did not initiate treatment|1|||
126157134|NCT00592358|453863957|FG000|Overall Study|Withdrawal by Subject|2|||
126157135|NCT00592358|453863957|FG000|Overall Study|Adverse Event|1|||
126157136|NCT00592358|453863957|FG000|Overall Study|Lack of Efficacy|2|||
126157137|NCT00592358|453863957|FG000|Overall Study|Inability to swallow pills|1|||
126157138|NCT00084682|453863958|FG000|Overall Study|Withdrawal by Subject|1|||
126157139|NCT03238248|453863966|FG000|Overall Study|Death|5|||
126157140|NCT03238248|453863966|FG000|Overall Study|Withdrawal by Subject|7|||
126157141|NCT03238248|453863966|FG000|Overall Study|Participant proceeding to transplant|10|||
126157142|NCT03238248|453863966|FG000|Overall Study|Lack of Efficacy|4|||
126157143|NCT03238248|453863966|FG000|Overall Study|Physician Decision|3|||
126157144|NCT03238248|453863966|FG000|Overall Study|Transitioning to another study|1|||
126157145|NCT03238248|453863966|FG000|Overall Study|No longer benefiting|1|||
126157146|NCT03238248|453863966|FG000|Overall Study|Other complicating disease|1|||
126157147|NCT03238248|453863966|FG000|Overall Study|Adverse Event|5|||
126157148|NCT03238248|453863966|FG000|Overall Study|Disease progression|26|||
126157149|NCT03238248|453863966|FG000|Overall Study|N/A participant is still on treatment|1|||
126157150|NCT03238248|453863966|FG000|Overall Study|Decline in condition|1|||
126157151|NCT03238248|453863966|FG000|Overall Study|Alternative therapy|2|||
126157152|NCT01013883|453863967|FG000|Overall Study|Lost to Follow-up|2|||
126157153|NCT01013883|453863968|FG001|Overall Study|Lost to Follow-up|2|||
126157154|NCT02241512|453863969|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
126157155|NCT02241512|453863970|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
126157156|NCT00474630|453863971|FG000|Overall Study|Adverse Event|98|||
126157157|NCT00474630|453863972|FG001|Overall Study|Adverse Event|26|||
126157158|NCT00474630|453863971|FG000|Overall Study|Lost to Follow-up|22|||
126157159|NCT00474630|453863972|FG001|Overall Study|Lost to Follow-up|15|||
126157160|NCT00474630|453863971|FG000|Overall Study|Withdrawal by Subject|21|||
126157161|NCT00474630|453863972|FG001|Overall Study|Withdrawal by Subject|15|||
126157162|NCT00474630|453863971|FG000|Overall Study|Protocol Violation|3|||
126157163|NCT00474630|453863972|FG001|Overall Study|Protocol Violation|4|||
126157164|NCT00474630|453863971|FG000|Overall Study|Lack of Efficacy|5|||
126157165|NCT00474630|453863972|FG001|Overall Study|Lack of Efficacy|6|||
126157166|NCT00474630|453863971|FG000|Overall Study|Drug noncompliance, other|11|||
126157167|NCT00474630|453863972|FG001|Overall Study|Drug noncompliance, other|4|||
126157168|NCT02225223|453863974|FG000|Overall Study|Death|10|||
126157169|NCT02225223|453863975|FG001|Overall Study|Death|1|||
126157170|NCT02225223|453863974|FG000|Overall Study|Lost to Follow-up|5|||
126157171|NCT02225223|453863975|FG001|Overall Study|Lost to Follow-up|0|||
126157172|NCT02225223|453863974|FG000|Overall Study|Other|1|||
126157173|NCT02225223|453863975|FG001|Overall Study|Other|2|||
126157174|NCT02225223|453863974|FG000|Overall Study|Physician Decision|1|||
126157175|NCT02225223|453863975|FG001|Overall Study|Physician Decision|0|||
126157176|NCT02225223|453863974|FG000|Overall Study|Withdrawal by Subject|2|||
126157177|NCT02225223|453863975|FG001|Overall Study|Withdrawal by Subject|2|||
126157178|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
126157179|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
126157180|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
126157181|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
126157182|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
126157183|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
126157184|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
126157185|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
126157186|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
126157187|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
126157188|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
126157189|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
126157190|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
126157191|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
126157192|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
126157193|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
126157194|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
126157195|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
126157196|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
126157197|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
126157198|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
126157199|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
126157200|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
126157201|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
126157202|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
126157203|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
126157204|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
126157205|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
126157206|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
126157207|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
126157208|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
126157209|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
126157210|NCT00958568|453863976|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
126157211|NCT00958568|453863977|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
126157212|NCT00958568|453863978|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
126157213|NCT00958568|453863979|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
126157214|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
126157215|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
126157216|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
126157217|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
126157218|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
126157219|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
126157220|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
126157221|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
126157222|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
126157223|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
126157224|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
126157225|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
126157226|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
126157227|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
126157228|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
126157229|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
126157230|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
126157231|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
126157232|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
126157233|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
126157234|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
126157235|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
126157236|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
126157237|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
126157238|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
126157239|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
126157240|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
126157241|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
126157242|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
126157243|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
126157244|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
126157245|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
126157246|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
126157247|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
126157248|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
126157249|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
126157250|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
126157251|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
125971794|NCT00700401|453184820|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
126089168|NCT04266795|453620101|FG001|Overall Study|Adverse Event|19|||
126089169|NCT04266795|453620100|FG000|Overall Study|Death|7|||
126089170|NCT04266795|453620101|FG001|Overall Study|Death|8|||
126089171|NCT04266795|453620100|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
126089172|NCT04266795|453620101|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
126089173|NCT04266795|453620100|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126089174|NCT04266795|453620101|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126089175|NCT04266795|453620100|FG000|Overall Study|Progressive Disease|12|||
126089176|NCT04266795|453620101|FG001|Overall Study|Progressive Disease|9|||
126089177|NCT04266795|453620100|FG000|Overall Study|Withdrawal by Patient|5|||
126089178|NCT04266795|453620101|FG001|Overall Study|Withdrawal by Patient|6|||
126089179|NCT04266795|453620100|FG000|Overall Study|Disease Relapse|3|||
126089180|NCT04266795|453620101|FG001|Overall Study|Disease Relapse|6|||
126089181|NCT04266795|453620100|FG000|Overall Study|Reason not Specified|12|||
126089182|NCT04266795|453620101|FG001|Overall Study|Reason not Specified|10|||
126089183|NCT04266795|453620100|FG000|Overall Study|Participants Ongoing on Treatment|25|||
126089184|NCT04266795|453620101|FG001|Overall Study|Participants Ongoing on Treatment|23|||
126089185|NCT04047862|453620102|FG000|Overall Study|Death|0|||
126089186|NCT04047862|453620103|FG001|Overall Study|Death|0|||
126089187|NCT04047862|453620104|FG002|Overall Study|Death|4|||
126089188|NCT04047862|453620105|FG003|Overall Study|Death|7|||
126089189|NCT04047862|453620106|FG004|Overall Study|Death|2|||
126089190|NCT04047862|453620107|FG005|Overall Study|Death|4|||
126089191|NCT04047862|453620108|FG006|Overall Study|Death|3|||
126089192|NCT04047862|453620109|FG007|Overall Study|Death|24|||
126089193|NCT04047862|453620110|FG008|Overall Study|Death|24|||
126089194|NCT04047862|453620111|FG009|Overall Study|Death|22|||
126089195|NCT04047862|453620112|FG010|Overall Study|Death|35|||
126089196|NCT04047862|453620113|FG011|Overall Study|Death|18|||
126089197|NCT04047862|453620114|FG012|Overall Study|Death|14|||
126089198|NCT04047862|453620115|FG013|Overall Study|Death|6|||
126089199|NCT04047862|453620116|FG014|Overall Study|Death|19|||
126089200|NCT04047862|453620117|FG015|Overall Study|Death|42|||
126089201|NCT04047862|453620118|FG016|Overall Study|Death|9|||
126089202|NCT04047862|453620119|FG017|Overall Study|Death|8|||
126089203|NCT04047862|453620120|FG018|Overall Study|Death|10|||
126089204|NCT04047862|453620102|FG000|Overall Study|Withdrawal by Subject|0|||
126089205|NCT04047862|453620103|FG001|Overall Study|Withdrawal by Subject|0|||
126089206|NCT04047862|453620104|FG002|Overall Study|Withdrawal by Subject|0|||
126089207|NCT04047862|453620105|FG003|Overall Study|Withdrawal by Subject|5|||
126089208|NCT04047862|453620106|FG004|Overall Study|Withdrawal by Subject|2|||
126089209|NCT04047862|453620107|FG005|Overall Study|Withdrawal by Subject|0|||
126089210|NCT04047862|453620108|FG006|Overall Study|Withdrawal by Subject|1|||
126089211|NCT04047862|453620109|FG007|Overall Study|Withdrawal by Subject|0|||
126089212|NCT04047862|453620110|FG008|Overall Study|Withdrawal by Subject|4|||
126089213|NCT04047862|453620111|FG009|Overall Study|Withdrawal by Subject|4|||
126089214|NCT04047862|453620112|FG010|Overall Study|Withdrawal by Subject|4|||
126089215|NCT04047862|453620113|FG011|Overall Study|Withdrawal by Subject|2|||
126089216|NCT04047862|453620114|FG012|Overall Study|Withdrawal by Subject|3|||
126089217|NCT04047862|453620115|FG013|Overall Study|Withdrawal by Subject|0|||
126089218|NCT04047862|453620116|FG014|Overall Study|Withdrawal by Subject|9|||
126089219|NCT04047862|453620117|FG015|Overall Study|Withdrawal by Subject|5|||
126089220|NCT04047862|453620118|FG016|Overall Study|Withdrawal by Subject|1|||
126089221|NCT04047862|453620119|FG017|Overall Study|Withdrawal by Subject|3|||
126089222|NCT04047862|453620120|FG018|Overall Study|Withdrawal by Subject|1|||
126089223|NCT04047862|453620102|FG000|Overall Study|Lost to Follow-up|0|||
126089224|NCT04047862|453620103|FG001|Overall Study|Lost to Follow-up|0|||
126089225|NCT04047862|453620104|FG002|Overall Study|Lost to Follow-up|1|||
126089226|NCT04047862|453620105|FG003|Overall Study|Lost to Follow-up|0|||
126089227|NCT04047862|453620106|FG004|Overall Study|Lost to Follow-up|0|||
126089228|NCT04047862|453620107|FG005|Overall Study|Lost to Follow-up|0|||
126089229|NCT04047862|453620108|FG006|Overall Study|Lost to Follow-up|0|||
126089230|NCT04047862|453620109|FG007|Overall Study|Lost to Follow-up|1|||
126089231|NCT04047862|453620110|FG008|Overall Study|Lost to Follow-up|0|||
126089232|NCT04047862|453620111|FG009|Overall Study|Lost to Follow-up|1|||
126089233|NCT04047862|453620112|FG010|Overall Study|Lost to Follow-up|0|||
126089234|NCT04047862|453620113|FG011|Overall Study|Lost to Follow-up|3|||
126089235|NCT04047862|453620114|FG012|Overall Study|Lost to Follow-up|0|||
126089236|NCT04047862|453620115|FG013|Overall Study|Lost to Follow-up|0|||
126089237|NCT04047862|453620116|FG014|Overall Study|Lost to Follow-up|2|||
126089238|NCT04047862|453620117|FG015|Overall Study|Lost to Follow-up|2|||
126089239|NCT04047862|453620118|FG016|Overall Study|Lost to Follow-up|1|||
126089240|NCT04047862|453620119|FG017|Overall Study|Lost to Follow-up|0|||
126089241|NCT04047862|453620120|FG018|Overall Study|Lost to Follow-up|0|||
126089242|NCT04047862|453620102|FG000|Overall Study|Physician Decision|0|||
126157252|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
126157253|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
126157254|NCT00958568|453863976|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
126157255|NCT00958568|453863977|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
126157256|NCT00958568|453863978|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
126157257|NCT00958568|453863979|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
126157258|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
126157259|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
126157260|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
126157261|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
126157262|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
126157263|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
126157264|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
126157265|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
126157266|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
126157267|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
126157268|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
126157269|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
126157270|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
126157271|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
126157272|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
126157273|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
126157274|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
126157275|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
126157276|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
126157277|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
126157278|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
126157279|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
126157280|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
126157281|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
126157282|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
126157283|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
126157284|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
126157285|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
126157286|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
126157287|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
126157288|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
126157289|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
126157290|NCT00958568|453863976|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
126157291|NCT00958568|453863977|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
126157292|NCT00958568|453863978|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
126157293|NCT00958568|453863979|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
126157294|NCT03268746|453863988|FG000|Overall Study|Withdrawal by Subject|1|||
126157295|NCT00891657|453863995|FG000|Overall Study|Withdrawal by Subject|1|||
126157296|NCT00891657|453863996|FG001|Overall Study|Withdrawal by Subject|1|||
126157297|NCT02927171|453863999|FG000|Overall Study|Lost to Follow-up|0|||
126157298|NCT02927171|453864000|FG001|Overall Study|Lost to Follow-up|1|||
126157299|NCT04530825|453864005|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
126157300|NCT04530825|453864006|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
126157301|NCT04530825|453864007|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
126157302|NCT04530825|453864008|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
126157303|NCT04530825|453864005|FG000|Overall Study|Did not complete follow-up|3|||
126157304|NCT04530825|453864006|FG001|Overall Study|Did not complete follow-up|0|||
126157305|NCT04530825|453864007|FG002|Overall Study|Did not complete follow-up|0|||
126157306|NCT04530825|453864008|FG003|Overall Study|Did not complete follow-up|0|||
126157307|NCT01720667|453864010|FG000|Overall Study|Adverse Event|1|||
126157308|NCT01720667|453864011|FG001|Overall Study|Adverse Event|1|||
126157309|NCT01720667|453864010|FG000|Overall Study|Withdrawal by Subject|3|||
126157310|NCT01720667|453864011|FG001|Overall Study|Withdrawal by Subject|0|||
126157311|NCT00850499|453864012|FG000|Overall Study|Adverse Event|3|||
126157312|NCT00850499|453864013|FG001|Overall Study|Adverse Event|1|||
126157313|NCT00850499|453864012|FG000|Overall Study|Lack of Efficacy|0|||
126157314|NCT00850499|453864013|FG001|Overall Study|Lack of Efficacy|1|||
126157315|NCT00909090|453864019|FG000|Overall Study|Lost to Follow-up|17|||
126157316|NCT00909090|453864020|FG001|Overall Study|Lost to Follow-up|17|||
126157317|NCT01319929|453864021|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
126157318|NCT01319929|453864022|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
126157319|NCT01319929|453864021|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
126157320|NCT01319929|453864022|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
126157321|NCT01319929|453864021|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
126157322|NCT01319929|453864022|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
126157323|NCT01319929|453864021|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
126157324|NCT01319929|453864022|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
126157325|NCT01319929|453864021|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
126157326|NCT01319929|453864022|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
126157327|NCT01749735|453864024|FG000|Overall Study|Withdrawal by Subject|1|||
126157328|NCT01749735|453864025|FG001|Overall Study|Withdrawal by Subject|0|||
126157329|NCT01221233|453864026|FG000|Overall Study|Withdrawal by Subject|3|||
126157330|NCT01221233|453864027|FG001|Overall Study|Withdrawal by Subject|1|||
126157331|NCT00611455|453864032|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
126157332|NCT00611455|453864033|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
126157333|NCT00611455|453864034|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126157334|NCT00611455|453864032|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
126157335|NCT00611455|453864033|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126157336|NCT00611455|453864034|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126157337|NCT00611455|453864032|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
126157338|NCT00611455|453864033|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
126157339|NCT00611455|453864034|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126157340|NCT00611455|453864032|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
126157341|NCT00611455|453864033|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
126157342|NCT00611455|453864034|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126157343|NCT00611455|453864032|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
126157344|NCT00611455|453864033|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
126157345|NCT00611455|453864034|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
126157346|NCT00611455|453864032|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
126157347|NCT00611455|453864033|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
126157348|NCT00611455|453864034|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
126157349|NCT00611455|453864032|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
126157350|NCT00611455|453864033|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
126157351|NCT00611455|453864034|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
126157352|NCT00611455|453864032|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
126157353|NCT00611455|453864033|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
126157354|NCT00611455|453864034|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
126157355|NCT00611455|453864032|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
126157356|NCT00611455|453864033|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
126157357|NCT00611455|453864034|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
126157358|NCT00611455|453864032|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
126157359|NCT00611455|453864033|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
126157360|NCT00611455|453864034|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
126157361|NCT00611455|453864032|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
126157362|NCT00611455|453864033|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
126157363|NCT00611455|453864034|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
126157364|NCT00611455|453864032|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
126157365|NCT00611455|453864033|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
126157366|NCT00611455|453864034|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
126157367|NCT00611455|453864032|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
126157368|NCT00611455|453864033|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
126157369|NCT00611455|453864034|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
126157370|NCT00611455|453864032|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
126157371|NCT00611455|453864033|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
126157372|NCT00611455|453864034|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
126157373|NCT00611455|453864032|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
126157374|NCT00611455|453864033|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
126157375|NCT00611455|453864034|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
126157376|NCT00611455|453864032|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
126157377|NCT00611455|453864033|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
126157378|NCT00611455|453864034|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
126157379|NCT00611455|453864032|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
126157380|NCT00611455|453864033|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
126157381|NCT00611455|453864034|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
126157382|NCT00611455|453864032|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
126157383|NCT00611455|453864033|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
126157384|NCT00611455|453864034|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
126157385|NCT00611455|453864032|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
126157386|NCT00611455|453864033|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
126157387|NCT00611455|453864034|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
126157388|NCT00611455|453864032|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
126157389|NCT00611455|453864033|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
126157390|NCT00611455|453864034|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
126157391|NCT00611455|453864032|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
126157392|NCT00611455|453864033|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
126157393|NCT00611455|453864034|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
126157394|NCT00858702|453864035|FG000|Overall Study|Lack of Efficacy|1|||
126157395|NCT00858702|453864036|FG001|Overall Study|Lack of Efficacy|0|||
126157396|NCT00858702|453864035|FG000|Overall Study|Protocol Violation|1|||
126157397|NCT00858702|453864036|FG001|Overall Study|Protocol Violation|1|||
126157398|NCT00858702|453864035|FG000|Overall Study|Other|2|||
126157399|NCT00858702|453864036|FG001|Overall Study|Other|1|||
126157400|NCT00858702|453864035|FG000|Overall Study|Withdrawal by Subject|1|||
126157401|NCT00858702|453864036|FG001|Overall Study|Withdrawal by Subject|0|||
126157402|NCT00491530|453864037|FG000|Overall Study|Adverse Event|6|||
126157403|NCT00491530|453864038|FG001|Overall Study|Adverse Event|1|||
126157404|NCT00491530|453864039|FG002|Overall Study|Adverse Event|2|||
126157405|NCT00491530|453864037|FG000|Overall Study|Withdrawal by Subject|3|||
126157406|NCT00491530|453864038|FG001|Overall Study|Withdrawal by Subject|0|||
126157407|NCT00491530|453864039|FG002|Overall Study|Withdrawal by Subject|0|||
126157408|NCT00491530|453864037|FG000|Overall Study|Lost to Follow-up|3|||
126157409|NCT00491530|453864038|FG001|Overall Study|Lost to Follow-up|2|||
126157410|NCT00491530|453864039|FG002|Overall Study|Lost to Follow-up|2|||
125971795|NCT00700401|453184820|FG000|Overall Study|Withdrawal by Subject|2|||
125971796|NCT01220557|453184822|FG000|Overall Study|Lost to Follow-up|5|||
125971797|NCT01220557|453184823|FG001|Overall Study|Lost to Follow-up|3|||
125971798|NCT01220557|453184822|FG000|Overall Study|attended less than 6 lessons|1|||
125971799|NCT01220557|453184823|FG001|Overall Study|attended less than 6 lessons|2|||
125971800|NCT01650259|453184824|FG000|Overall Study|Improvement|105|||
125971801|NCT01650259|453184825|FG001|Overall Study|Improvement|0|||
125971802|NCT01650259|453184824|FG000|Overall Study|Adverse Event|127|||
125971803|NCT01650259|453184825|FG001|Overall Study|Adverse Event|0|||
125971804|NCT01650259|453184824|FG000|Overall Study|Lack of Efficacy|143|||
125971805|NCT01650259|453184825|FG001|Overall Study|Lack of Efficacy|0|||
125971806|NCT01650259|453184824|FG000|Overall Study|Lost to Follow-up|435|||
125971807|NCT01650259|453184825|FG001|Overall Study|Lost to Follow-up|0|||
125971808|NCT01650259|453184824|FG000|Overall Study|Patients had no visit after entry|70|||
125971809|NCT01650259|453184825|FG001|Overall Study|Patients had no visit after entry|0|||
125971810|NCT01650259|453184824|FG000|Overall Study|CRF not collected|98|||
125971811|NCT01650259|453184825|FG001|Overall Study|CRF not collected|82|||
125971812|NCT01650259|453184824|FG000|Overall Study|Not treated|1|||
125971813|NCT01650259|453184825|FG001|Overall Study|Not treated|7|||
125971814|NCT01650259|453184824|FG000|Overall Study|Other than listed|64|||
125971815|NCT01650259|453184825|FG001|Overall Study|Other than listed|146|||
125971816|NCT00092131|453184826|FG000|Treatment Period I|Adverse Event|1|||
125971817|NCT00092131|453184827|FG001|Treatment Period I|Adverse Event|0|||
125971818|NCT00092131|453184826|FG000|Treatment Period II|Adverse Event|0|||
125971819|NCT00092131|453184827|FG001|Treatment Period II|Adverse Event|1|||
125971820|NCT03346759|453184828|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
125971821|NCT03346759|453184829|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
125971822|NCT03346759|453184828|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
125971823|NCT03346759|453184829|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
125971824|NCT03346759|453184828|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
125971825|NCT03346759|453184829|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
125971826|NCT02010060|453184830|FG000|Overall Study|Lost to Follow-up|1|||
125971827|NCT02010060|453184831|FG001|Overall Study|Lost to Follow-up|2|||
125971828|NCT02010060|453184832|FG002|Overall Study|Lost to Follow-up|2|||
125971829|NCT02010060|453184830|FG000|Overall Study|Injury|0|||
125971830|NCT02010060|453184831|FG001|Overall Study|Injury|1|||
125971831|NCT02010060|453184832|FG002|Overall Study|Injury|0|||
125971832|NCT05819749|453184833|FG000|Overall Study|Lost to Follow-up|1|||
126157411|NCT00491530|453864037|FG000|Overall Study|Lack of Efficacy|0|||
126157412|NCT00491530|453864038|FG001|Overall Study|Lack of Efficacy|1|||
126157413|NCT00491530|453864039|FG002|Overall Study|Lack of Efficacy|0|||
126157414|NCT00491530|453864037|FG000|Overall Study|Investigator Discretion|0|||
125971833|NCT00377234|453186685|FG000|Overall Study|Adverse Event|14|||
125971834|NCT00377234|453186686|FG001|Overall Study|Adverse Event|17|||
125971835|NCT00377234|453186685|FG000|Overall Study|Withdrawal by Subject|11|||
125971836|NCT00377234|453186686|FG001|Overall Study|Withdrawal by Subject|9|||
125971837|NCT00377234|453186685|FG000|Overall Study|Lost to Follow-up|4|||
126157415|NCT00491530|453864038|FG001|Overall Study|Investigator Discretion|1|||
125971838|NCT00377234|453186686|FG001|Overall Study|Lost to Follow-up|2|||
125971839|NCT00377234|453186685|FG000|Overall Study|Administrative|2|||
125971840|NCT00377234|453186686|FG001|Overall Study|Administrative|1|||
126157416|NCT00491530|453864039|FG002|Overall Study|Investigator Discretion|0|||
126157417|NCT00491530|453864037|FG000|Overall Study|Patient Request|0|||
126157418|NCT00491530|453864038|FG001|Overall Study|Patient Request|1|||
126157419|NCT00491530|453864039|FG002|Overall Study|Patient Request|0|||
126157420|NCT00491530|453864037|FG000|Overall Study|Use of Prohibited Medication|0|||
126157421|NCT00491530|453864038|FG001|Overall Study|Use of Prohibited Medication|0|||
126157422|NCT00491530|453864039|FG002|Overall Study|Use of Prohibited Medication|1|||
126157423|NCT03671369|453864042|FG000|Overall Study|Other|1|||
126157424|NCT03671369|453864042|FG000|Overall Study|Withdrawal by Subject|289|||
126157425|NCT03671369|453864042|FG000|Overall Study|Not willing to be vaccinated|1|||
126157426|NCT04382651|453864043|FG000|Overall Study|Death|26|||
126157427|NCT04382651|453864044|FG001|Overall Study|Death|23|||
126157428|NCT04382651|453864043|FG000|Overall Study|Lost to Follow-up|3|||
126157429|NCT04382651|453864044|FG001|Overall Study|Lost to Follow-up|4|||
126157430|NCT04382651|453864043|FG000|Overall Study|Withdrawal by Subject|2|||
126157431|NCT04382651|453864044|FG001|Overall Study|Withdrawal by Subject|0|||
126157432|NCT04382651|453864043|FG000|Overall Study|Physician Decision|0|||
126157433|NCT04382651|453864044|FG001|Overall Study|Physician Decision|1|||
126157434|NCT02732912|453864045|FG000|Overall Study|Discharged before night|2|||
126157435|NCT02732912|453864046|FG001|Overall Study|Discharged before night|6|||
126157436|NCT02732912|453864045|FG000|Overall Study|Incomplete completion of questionnaire|2|||
126157437|NCT02732912|453864046|FG001|Overall Study|Incomplete completion of questionnaire|3|||
126157438|NCT02732912|453864045|FG000|Overall Study|No outcome; discharged or refused|6|||
126157439|NCT02732912|453864046|FG001|Overall Study|No outcome; discharged or refused|9|||
126157440|NCT01873742|453864047|FG000|Overall Study|Lost to Follow-up|68|||
126157441|NCT01873742|453864048|FG001|Overall Study|Lost to Follow-up|76|||
126157442|NCT00790296|453864050|FG000|Overall Study|Did not meet study eligibility criteria|1|||
126157443|NCT00790296|453864051|FG001|Overall Study|Did not meet study eligibility criteria|1|||
126157444|NCT00790296|453864050|FG000|Overall Study|Adverse Event|0|||
126157445|NCT00790296|453864051|FG001|Overall Study|Adverse Event|1|||
126157446|NCT01671488|453864052|FG000|Overall Study|Withdrawal by Subject|1|||
126157447|NCT02612077|453864053|FG000|Overall Study|Adverse Event|3|||
126157448|NCT02612077|453864053|FG000|Overall Study|Withdrawal by Subject|9|||
126157449|NCT02612077|453864053|FG000|Overall Study|Protocol Violation|28|||
126157450|NCT02612077|453864053|FG000|Overall Study|Lost to Follow-up|20|||
126157451|NCT02612077|453864053|FG000|Overall Study|Death|377|||
126157452|NCT02612077|453864053|FG000|Overall Study|Moved or Changed Medical Team|23|||
126157453|NCT02612077|453864053|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
126157454|NCT02612077|453864053|FG000|Overall Study|Disease Progression|3|||
126157455|NCT02612077|453864053|FG000|Overall Study|Unknown reason|2|||
126157456|NCT01022853|453864054|FG000|Overall Study|Progressive disease|2|||
126157457|NCT01022853|453864055|FG001|Overall Study|Progressive disease|3|||
126157458|NCT01022853|453864056|FG002|Overall Study|Progressive disease|11|||
126157459|NCT01022853|453864057|FG003|Overall Study|Progressive disease|7|||
126157460|NCT01022853|453864058|FG004|Overall Study|Progressive disease|1|||
126157461|NCT01022853|453864054|FG000|Overall Study|Dose-limiting toxicity|0|||
126157462|NCT01022853|453864055|FG001|Overall Study|Dose-limiting toxicity|0|||
126157463|NCT01022853|453864056|FG002|Overall Study|Dose-limiting toxicity|0|||
126157464|NCT01022853|453864057|FG003|Overall Study|Dose-limiting toxicity|0|||
126157465|NCT01022853|453864058|FG004|Overall Study|Dose-limiting toxicity|1|||
126157466|NCT01022853|453864054|FG000|Overall Study|Withdrawal by Subject|0|||
126157467|NCT01022853|453864055|FG001|Overall Study|Withdrawal by Subject|1|||
126157468|NCT01022853|453864056|FG002|Overall Study|Withdrawal by Subject|1|||
126157469|NCT01022853|453864057|FG003|Overall Study|Withdrawal by Subject|1|||
126157470|NCT01022853|453864058|FG004|Overall Study|Withdrawal by Subject|0|||
126157471|NCT01022853|453864054|FG000|Overall Study|Other not stated above|1|||
126157472|NCT01022853|453864055|FG001|Overall Study|Other not stated above|0|||
126157473|NCT01022853|453864056|FG002|Overall Study|Other not stated above|1|||
126157474|NCT01022853|453864057|FG003|Overall Study|Other not stated above|0|||
126157475|NCT01022853|453864058|FG004|Overall Study|Other not stated above|0|||
126157476|NCT01753518|453864059|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
126157477|NCT01753518|453864060|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
126157478|NCT01753518|453864059|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
126157479|NCT01753518|453864060|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
126157480|NCT01753518|453864059|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
126157481|NCT01753518|453864060|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
126157482|NCT01753518|453864059|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
126157483|NCT01753518|453864060|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
126157484|NCT01971476|453864061|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
126157485|NCT01971476|453864062|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
126157486|NCT01971476|453864063|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
126157487|NCT01971476|453864061|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
126157488|NCT01971476|453864062|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
126157489|NCT01971476|453864063|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
126157490|NCT01971476|453864061|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
126157491|NCT01971476|453864062|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
126157492|NCT01971476|453864063|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
126157493|NCT02075255|453864064|FG000|Overall Study|Study specific withdrawal criteria|0|||
126157494|NCT02075255|453864065|FG001|Overall Study|Study specific withdrawal criteria|1|||
126157495|NCT02075255|453864066|FG002|Overall Study|Study specific withdrawal criteria|1|||
126157496|NCT02075255|453864064|FG000|Overall Study|Withdrawal by Subject|4|||
126157497|NCT02075255|453864065|FG001|Overall Study|Withdrawal by Subject|1|||
126157498|NCT02075255|453864066|FG002|Overall Study|Withdrawal by Subject|0|||
126157499|NCT02075255|453864064|FG000|Overall Study|Lost to Follow-up|0|||
126157500|NCT02075255|453864065|FG001|Overall Study|Lost to Follow-up|0|||
126157501|NCT02075255|453864066|FG002|Overall Study|Lost to Follow-up|1|||
126157502|NCT02075255|453864064|FG000|Overall Study|Adverse Event|0|||
126157503|NCT02075255|453864065|FG001|Overall Study|Adverse Event|0|||
126157504|NCT02075255|453864066|FG002|Overall Study|Adverse Event|1|||
126157505|NCT02075255|453864064|FG000|Overall Study|Death|0|||
126157506|NCT02075255|453864065|FG001|Overall Study|Death|2|||
126157507|NCT02075255|453864066|FG002|Overall Study|Death|0|||
126157508|NCT03503773|453864067|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
126157509|NCT03503773|453864068|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
126157510|NCT03503773|453864067|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
126157511|NCT03503773|453864068|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
126157512|NCT03503773|453864067|FG000|Overall Study|Not completing the primary ABPM|3|||
126157513|NCT03503773|453864068|FG001|Overall Study|Not completing the primary ABPM|1|||
126157514|NCT03503773|453864067|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126157515|NCT03503773|453864068|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126157516|NCT02675517|453864071|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
126157517|NCT02675517|453864071|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
126157518|NCT00425438|453864072|FG000|Overall Study|Termination by Sponsor|25|||
126157519|NCT00425438|453864073|FG001|Overall Study|Termination by Sponsor|27|||
126157520|NCT02619253|453864074|FG000|Overall Study|Adverse Event|0|||
126157521|NCT02619253|453864075|FG001|Overall Study|Adverse Event|0|||
126157522|NCT02619253|453864076|FG002|Overall Study|Adverse Event|1|||
126157523|NCT02619253|453864077|FG003|Overall Study|Adverse Event|1|||
126157524|NCT02619253|453864078|FG004|Overall Study|Adverse Event|3|||
126157525|NCT02619253|453864074|FG000|Overall Study|Alternative Therapy|0|||
126157526|NCT02619253|453864075|FG001|Overall Study|Alternative Therapy|0|||
126157527|NCT02619253|453864076|FG002|Overall Study|Alternative Therapy|1|||
126157528|NCT02619253|453864077|FG003|Overall Study|Alternative Therapy|0|||
126157529|NCT02619253|453864078|FG004|Overall Study|Alternative Therapy|0|||
126157530|NCT02619253|453864074|FG000|Overall Study|Death|0|||
126157531|NCT02619253|453864075|FG001|Overall Study|Death|0|||
126157532|NCT02619253|453864076|FG002|Overall Study|Death|0|||
126157533|NCT02619253|453864077|FG003|Overall Study|Death|1|||
126157534|NCT02619253|453864078|FG004|Overall Study|Death|0|||
126157535|NCT02619253|453864074|FG000|Overall Study|Disease Progression|4|||
126157536|NCT02619253|453864075|FG001|Overall Study|Disease Progression|2|||
126157537|NCT02619253|453864076|FG002|Overall Study|Disease Progression|8|||
126157538|NCT02619253|453864077|FG003|Overall Study|Disease Progression|9|||
126157539|NCT02619253|453864078|FG004|Overall Study|Disease Progression|10|||
126157540|NCT02619253|453864074|FG000|Overall Study|Needed a disqualifying therapy|0|||
126157541|NCT02619253|453864075|FG001|Overall Study|Needed a disqualifying therapy|0|||
126157542|NCT02619253|453864076|FG002|Overall Study|Needed a disqualifying therapy|1|||
126157543|NCT02619253|453864077|FG003|Overall Study|Needed a disqualifying therapy|0|||
126157544|NCT02619253|453864078|FG004|Overall Study|Needed a disqualifying therapy|0|||
126157545|NCT02619253|453864074|FG000|Overall Study|Transferred to hospice|0|||
126157546|NCT02619253|453864075|FG001|Overall Study|Transferred to hospice|0|||
126157547|NCT02619253|453864076|FG002|Overall Study|Transferred to hospice|1|||
126157548|NCT02619253|453864077|FG003|Overall Study|Transferred to hospice|0|||
126157549|NCT02619253|453864078|FG004|Overall Study|Transferred to hospice|0|||
126157550|NCT02619253|453864074|FG000|Overall Study|Physician Decision|0|||
126157551|NCT02619253|453864075|FG001|Overall Study|Physician Decision|1|||
126157552|NCT02619253|453864076|FG002|Overall Study|Physician Decision|2|||
126157553|NCT02619253|453864077|FG003|Overall Study|Physician Decision|3|||
126157554|NCT02619253|453864078|FG004|Overall Study|Physician Decision|0|||
126157555|NCT02619253|453864074|FG000|Overall Study|Withdrawal by Subject|0|||
126157556|NCT02619253|453864075|FG001|Overall Study|Withdrawal by Subject|1|||
126157557|NCT02619253|453864076|FG002|Overall Study|Withdrawal by Subject|0|||
126157558|NCT02619253|453864077|FG003|Overall Study|Withdrawal by Subject|0|||
126157559|NCT02619253|453864078|FG004|Overall Study|Withdrawal by Subject|2|||
126157560|NCT01208181|453864081|FG000|Part 1|Withdrawal by Subject|11|||
126157561|NCT01208181|453864082|FG001|Part 1|Withdrawal by Subject|10|||
126157562|NCT01208181|453864083|FG002|Part 1|Withdrawal by Subject|0|||
126157563|NCT01208181|453864084|FG003|Part 1|Withdrawal by Subject|0|||
126157564|NCT01208181|453864085|FG004|Part 1|Withdrawal by Subject|0|||
126157565|NCT01208181|453864081|FG000|Part 1|Technical problem|5|||
126157566|NCT01208181|453864082|FG001|Part 1|Technical problem|0|||
126157567|NCT01208181|453864083|FG002|Part 1|Technical problem|0|||
126157568|NCT01208181|453864084|FG003|Part 1|Technical problem|0|||
126157569|NCT01208181|453864085|FG004|Part 1|Technical problem|0|||
126157570|NCT01208181|453864081|FG000|Part 1|Protocol Violation|10|||
126157571|NCT01208181|453864082|FG001|Part 1|Protocol Violation|5|||
126157572|NCT01208181|453864083|FG002|Part 1|Protocol Violation|0|||
126157573|NCT01208181|453864084|FG003|Part 1|Protocol Violation|0|||
126157574|NCT01208181|453864085|FG004|Part 1|Protocol Violation|0|||
126157575|NCT01208181|453864081|FG000|Part 1|Physician Decision|4|||
126157576|NCT01208181|453864082|FG001|Part 1|Physician Decision|0|||
126157577|NCT01208181|453864083|FG002|Part 1|Physician Decision|0|||
126157578|NCT01208181|453864084|FG003|Part 1|Physician Decision|0|||
126157579|NCT01208181|453864085|FG004|Part 1|Physician Decision|0|||
126157580|NCT01208181|453864081|FG000|Part 1|Non-compliance with study drug|1|||
126157581|NCT01208181|453864082|FG001|Part 1|Non-compliance with study drug|1|||
126157582|NCT01208181|453864083|FG002|Part 1|Non-compliance with study drug|0|||
126157583|NCT01208181|453864084|FG003|Part 1|Non-compliance with study drug|0|||
126157584|NCT01208181|453864085|FG004|Part 1|Non-compliance with study drug|0|||
126157585|NCT01208181|453864081|FG000|Part 1|Lost to Follow-up|5|||
126157586|NCT01208181|453864082|FG001|Part 1|Lost to Follow-up|3|||
126157587|NCT01208181|453864083|FG002|Part 1|Lost to Follow-up|0|||
126157588|NCT01208181|453864084|FG003|Part 1|Lost to Follow-up|0|||
125971841|NCT00377234|453186685|FG000|Overall Study|Not assigned|3|||
125971842|NCT00377234|453186686|FG001|Overall Study|Not assigned|2|||
125971843|NCT01880424|453186687|FG000|Overall Study|Adverse Event|7|||
125971844|NCT01880424|453186688|FG001|Overall Study|Adverse Event|6|||
125971845|NCT01880424|453186687|FG000|Overall Study|Lack of Efficacy|1|||
125971846|NCT01880424|453186688|FG001|Overall Study|Lack of Efficacy|4|||
125971847|NCT01880424|453186687|FG000|Overall Study|Lost to Follow-up|3|||
125971848|NCT01880424|453186688|FG001|Overall Study|Lost to Follow-up|2|||
125971849|NCT01880424|453186687|FG000|Overall Study|Protocol Violation|11|||
125971850|NCT01880424|453186688|FG001|Overall Study|Protocol Violation|13|||
125971851|NCT01880424|453186687|FG000|Overall Study|Withdrawal by Subject|10|||
125971852|NCT01880424|453186688|FG001|Overall Study|Withdrawal by Subject|30|||
125971853|NCT01880424|453186687|FG000|Overall Study|Other|1|||
125971854|NCT01880424|453186688|FG001|Overall Study|Other|0|||
125971855|NCT00907153|453186689|FG000|Overall Study|Lost to Follow-up|1|||
125971856|NCT00907153|453186690|FG001|Overall Study|Lost to Follow-up|1|||
125971857|NCT00907153|453186689|FG000|Overall Study|Withdrawal by Subject|1|||
125971858|NCT00907153|453186690|FG001|Overall Study|Withdrawal by Subject|3|||
125971859|NCT03147248|453186691|FG000|Overall Study|Adverse Event|0|||
125971860|NCT03147248|453186692|FG001|Overall Study|Adverse Event|2|||
125971861|NCT03147248|453186693|FG002|Overall Study|Adverse Event|2|||
125971862|NCT03147248|453186694|FG003|Overall Study|Adverse Event|2|||
125971863|NCT03147248|453186695|FG004|Overall Study|Adverse Event|6|||
125971864|NCT03147248|453186696|FG005|Overall Study|Adverse Event|11|||
125971865|NCT03147248|453186691|FG000|Overall Study|Disease progression|1|||
125971866|NCT03147248|453186692|FG001|Overall Study|Disease progression|0|||
125971867|NCT03147248|453186693|FG002|Overall Study|Disease progression|0|||
125971868|NCT03147248|453186694|FG003|Overall Study|Disease progression|0|||
125971869|NCT03147248|453186695|FG004|Overall Study|Disease progression|0|||
125971870|NCT03147248|453186696|FG005|Overall Study|Disease progression|2|||
125971871|NCT03147248|453186691|FG000|Overall Study|Withdrawal by Subject|0|||
125971872|NCT03147248|453186692|FG001|Overall Study|Withdrawal by Subject|0|||
125971873|NCT03147248|453186693|FG002|Overall Study|Withdrawal by Subject|0|||
125971874|NCT03147248|453186694|FG003|Overall Study|Withdrawal by Subject|0|||
125971875|NCT03147248|453186695|FG004|Overall Study|Withdrawal by Subject|12|||
125971876|NCT03147248|453186696|FG005|Overall Study|Withdrawal by Subject|9|||
125971877|NCT03147248|453186691|FG000|Overall Study|Protocol Violation|0|||
125971878|NCT03147248|453186692|FG001|Overall Study|Protocol Violation|0|||
125971879|NCT03147248|453186693|FG002|Overall Study|Protocol Violation|0|||
126157589|NCT01208181|453864085|FG004|Part 1|Lost to Follow-up|1|||
125971880|NCT03147248|453186694|FG003|Overall Study|Protocol Violation|0|||
125971881|NCT03147248|453186695|FG004|Overall Study|Protocol Violation|2|||
125971882|NCT03147248|453186696|FG005|Overall Study|Protocol Violation|0|||
125971883|NCT03147248|453186691|FG000|Overall Study|Lost to Follow-up|0|||
125971884|NCT03147248|453186692|FG001|Overall Study|Lost to Follow-up|0|||
126157590|NCT01208181|453864081|FG000|Part 1|Lack of Efficacy|37|||
125971885|NCT03147248|453186693|FG002|Overall Study|Lost to Follow-up|0|||
125971886|NCT03147248|453186694|FG003|Overall Study|Lost to Follow-up|0|||
125971887|NCT03147248|453186695|FG004|Overall Study|Lost to Follow-up|2|||
126157591|NCT01208181|453864082|FG001|Part 1|Lack of Efficacy|12|||
126157592|NCT01208181|453864083|FG002|Part 1|Lack of Efficacy|0|||
126157593|NCT01208181|453864084|FG003|Part 1|Lack of Efficacy|0|||
126157594|NCT01208181|453864085|FG004|Part 1|Lack of Efficacy|17|||
125971888|NCT03147248|453186696|FG005|Overall Study|Lost to Follow-up|0|||
125971889|NCT03147248|453186691|FG000|Overall Study|Pregnancy|0|||
125971890|NCT03147248|453186692|FG001|Overall Study|Pregnancy|0|||
125971891|NCT03147248|453186693|FG002|Overall Study|Pregnancy|0|||
126157595|NCT01208181|453864081|FG000|Part 1|Adverse Event|26|||
126157596|NCT01208181|453864082|FG001|Part 1|Adverse Event|24|||
126157597|NCT01208181|453864083|FG002|Part 1|Adverse Event|0|||
126157598|NCT01208181|453864084|FG003|Part 1|Adverse Event|0|||
126157599|NCT01208181|453864085|FG004|Part 1|Adverse Event|4|||
126157600|NCT01208181|453864081|FG000|Part 2|Adverse Event|0|||
126157601|NCT01208181|453864082|FG001|Part 2|Adverse Event|0|||
126157602|NCT01208181|453864083|FG002|Part 2|Adverse Event|6|||
126157603|NCT01208181|453864084|FG003|Part 2|Adverse Event|7|||
126157604|NCT01208181|453864085|FG004|Part 2|Adverse Event|0|||
126157605|NCT01208181|453864081|FG000|Part 2|Withdrawal by Subject|0|||
126157606|NCT01208181|453864082|FG001|Part 2|Withdrawal by Subject|0|||
126157607|NCT01208181|453864083|FG002|Part 2|Withdrawal by Subject|1|||
126157608|NCT01208181|453864084|FG003|Part 2|Withdrawal by Subject|1|||
126157609|NCT01208181|453864085|FG004|Part 2|Withdrawal by Subject|0|||
126157610|NCT01208181|453864081|FG000|Part 2|Protocol Violation|0|||
126157611|NCT01208181|453864082|FG001|Part 2|Protocol Violation|0|||
126157612|NCT01208181|453864083|FG002|Part 2|Protocol Violation|1|||
126157613|NCT01208181|453864084|FG003|Part 2|Protocol Violation|0|||
126157614|NCT01208181|453864085|FG004|Part 2|Protocol Violation|0|||
126157615|NCT01208181|453864081|FG000|Part 2|Physician Decision|0|||
126157616|NCT01208181|453864082|FG001|Part 2|Physician Decision|0|||
126157617|NCT01208181|453864083|FG002|Part 2|Physician Decision|1|||
126157618|NCT01208181|453864084|FG003|Part 2|Physician Decision|2|||
126157619|NCT01208181|453864085|FG004|Part 2|Physician Decision|0|||
126157620|NCT01208181|453864081|FG000|Part 2|Non-compliance with study drug|0|||
126157621|NCT01208181|453864082|FG001|Part 2|Non-compliance with study drug|0|||
126157622|NCT01208181|453864083|FG002|Part 2|Non-compliance with study drug|1|||
126157623|NCT01208181|453864084|FG003|Part 2|Non-compliance with study drug|1|||
126157624|NCT01208181|453864085|FG004|Part 2|Non-compliance with study drug|0|||
125971892|NCT03147248|453186694|FG003|Overall Study|Pregnancy|0|||
125971893|NCT03147248|453186695|FG004|Overall Study|Pregnancy|1|||
125971894|NCT03147248|453186696|FG005|Overall Study|Pregnancy|0|||
125971895|NCT03147248|453186691|FG000|Overall Study|Death|0|||
125971896|NCT03147248|453186692|FG001|Overall Study|Death|0|||
125971897|NCT03147248|453186693|FG002|Overall Study|Death|0|||
125971898|NCT03147248|453186694|FG003|Overall Study|Death|0|||
125971899|NCT03147248|453186695|FG004|Overall Study|Death|0|||
125971900|NCT03147248|453186696|FG005|Overall Study|Death|4|||
125971901|NCT03147248|453186691|FG000|Overall Study|Physician Decision|0|||
125971902|NCT03147248|453186692|FG001|Overall Study|Physician Decision|0|||
125971903|NCT03147248|453186693|FG002|Overall Study|Physician Decision|0|||
125971904|NCT03147248|453186694|FG003|Overall Study|Physician Decision|0|||
125971905|NCT03147248|453186695|FG004|Overall Study|Physician Decision|2|||
125971906|NCT03147248|453186696|FG005|Overall Study|Physician Decision|4|||
125971907|NCT03147248|453186691|FG000|Overall Study|Prolonged Dosing Interval|0|||
125971908|NCT03147248|453186692|FG001|Overall Study|Prolonged Dosing Interval|0|||
125971909|NCT03147248|453186693|FG002|Overall Study|Prolonged Dosing Interval|0|||
125971910|NCT03147248|453186694|FG003|Overall Study|Prolonged Dosing Interval|0|||
125971911|NCT03147248|453186695|FG004|Overall Study|Prolonged Dosing Interval|1|||
125971912|NCT03147248|453186696|FG005|Overall Study|Prolonged Dosing Interval|1|||
125971913|NCT00448539|453186701|FG000|Overall Study|Medication non-compliance|4|||
125971914|NCT00448539|453186702|FG001|Overall Study|Medication non-compliance|1|||
125971915|NCT00448539|453186701|FG000|Overall Study|Protocol Violation|1|||
125971916|NCT00448539|453186702|FG001|Overall Study|Protocol Violation|0|||
125971917|NCT00448539|453186701|FG000|Overall Study|Request of the investigator or sponsor|67|||
125971918|NCT00448539|453186702|FG001|Overall Study|Request of the investigator or sponsor|54|||
125971919|NCT00448539|453186701|FG000|Overall Study|Withdrawal by Subject|20|||
125971920|NCT00448539|453186702|FG001|Overall Study|Withdrawal by Subject|24|||
125971921|NCT00448539|453186701|FG000|Overall Study|Diary non-compliance|1|||
125971922|NCT00448539|453186702|FG001|Overall Study|Diary non-compliance|0|||
125971923|NCT00448539|453186701|FG000|Overall Study|Adverse Event|9|||
125971924|NCT00448539|453186702|FG001|Overall Study|Adverse Event|26|||
125971925|NCT00448539|453186701|FG000|Overall Study|Lack of Efficacy|27|||
125971926|NCT00448539|453186702|FG001|Overall Study|Lack of Efficacy|40|||
125971927|NCT00448539|453186701|FG000|Overall Study|Miscellaneous|2|||
125971928|NCT00448539|453186702|FG001|Overall Study|Miscellaneous|1|||
125971929|NCT00448539|453186701|FG000|Overall Study|Change of meds|2|||
125971930|NCT00448539|453186702|FG001|Overall Study|Change of meds|3|||
125971931|NCT00448539|453186701|FG000|Overall Study|Lost to Follow-up|1|||
125971932|NCT00448539|453186702|FG001|Overall Study|Lost to Follow-up|3|||
125971933|NCT02103439|453186703|FG000|Overall Study|Adverse Event|0|||
125971934|NCT02103439|453186704|FG001|Overall Study|Adverse Event|2|||
125971935|NCT02103439|453186703|FG000|Overall Study|Withdrawal by Subject|3|||
125971936|NCT02103439|453186704|FG001|Overall Study|Withdrawal by Subject|1|||
125971937|NCT04955639|453186706|FG000|Overall Study|Withdrawal by Subject|2|||
126157625|NCT01208181|453864081|FG000|Part 2|Lost to Follow-up|0|||
126157626|NCT01208181|453864082|FG001|Part 2|Lost to Follow-up|0|||
125971938|NCT04955639|453186707|FG001|Overall Study|Withdrawal by Subject|2|||
126157627|NCT01208181|453864083|FG002|Part 2|Lost to Follow-up|1|||
125971939|NCT04955639|453186706|FG000|Overall Study|Week 26 survey not completed|2|||
125971940|NCT04955639|453186707|FG001|Overall Study|Week 26 survey not completed|2|||
126157628|NCT01208181|453864084|FG003|Part 2|Lost to Follow-up|2|||
125971941|NCT04447404|453186708|FG000|Overall Study|Death|2|||
126157629|NCT01208181|453864085|FG004|Part 2|Lost to Follow-up|0|||
126157630|NCT01208181|453864081|FG000|Part 2|Lack of Efficacy|0|||
126157631|NCT01208181|453864082|FG001|Part 2|Lack of Efficacy|0|||
125971942|NCT04447404|453186709|FG001|Overall Study|Death|0|||
125971943|NCT01369342|453186710|FG000|Overall Study|Withdrawal by Subject|7|||
125971944|NCT01369342|453186711|FG001|Overall Study|Withdrawal by Subject|7|||
125971945|NCT01369342|453186712|FG002|Overall Study|Withdrawal by Subject|2|||
126157632|NCT01208181|453864083|FG002|Part 2|Lack of Efficacy|5|||
126157633|NCT01208181|453864084|FG003|Part 2|Lack of Efficacy|7|||
126157634|NCT01208181|453864085|FG004|Part 2|Lack of Efficacy|0|||
126157635|NCT03694522|453864091|FG000|Overall Study|Withdrawal by Subject|8|||
126157636|NCT03694522|453864092|FG001|Overall Study|Withdrawal by Subject|10|||
126157637|NCT03694522|453864091|FG000|Overall Study|Physician Decision|53|||
126157638|NCT03694522|453864092|FG001|Overall Study|Physician Decision|54|||
126157639|NCT03694522|453864091|FG000|Overall Study|Other|1|||
126157640|NCT03694522|453864092|FG001|Overall Study|Other|1|||
126157641|NCT03694522|453864091|FG000|Overall Study|Lost to Follow-up|0|||
126157642|NCT03694522|453864092|FG001|Overall Study|Lost to Follow-up|1|||
126157643|NCT01748760|453864093|FG000|Overall Study|Withdrawal by Subject|1|||
126157644|NCT01748760|453864094|FG001|Overall Study|Withdrawal by Subject|1|||
126157645|NCT01748760|453864093|FG000|Overall Study|Lost to Follow-up|5|||
126157646|NCT01748760|453864094|FG001|Overall Study|Lost to Follow-up|1|||
126157647|NCT01164501|453864095|FG000|Overall Study|Not treated|2|||
126157648|NCT01164501|453864096|FG001|Overall Study|Not treated|0|||
126157649|NCT01164501|453864097|FG002|Overall Study|Not treated|1|||
126157650|NCT01164501|453864095|FG000|Overall Study|Adverse Event|18|||
126157651|NCT01164501|453864096|FG001|Overall Study|Adverse Event|4|||
126157652|NCT01164501|453864097|FG002|Overall Study|Adverse Event|21|||
126157653|NCT01164501|453864095|FG000|Overall Study|Lack of Efficacy|0|||
126157654|NCT01164501|453864096|FG001|Overall Study|Lack of Efficacy|0|||
126157655|NCT01164501|453864097|FG002|Overall Study|Lack of Efficacy|1|||
126157656|NCT01164501|453864095|FG000|Overall Study|Non compliant with protocol|1|||
126157657|NCT01164501|453864096|FG001|Overall Study|Non compliant with protocol|1|||
126157658|NCT01164501|453864097|FG002|Overall Study|Non compliant with protocol|4|||
126157659|NCT01164501|453864095|FG000|Overall Study|Lost to Follow-up|3|||
126157660|NCT01164501|453864096|FG001|Overall Study|Lost to Follow-up|0|||
126157661|NCT01164501|453864097|FG002|Overall Study|Lost to Follow-up|3|||
126157662|NCT01164501|453864095|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
126157663|NCT01164501|453864096|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
126157664|NCT01164501|453864097|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
126157665|NCT01164501|453864095|FG000|Overall Study|Other reason not defined above|9|||
126157666|NCT01164501|453864096|FG001|Overall Study|Other reason not defined above|1|||
126157667|NCT01164501|453864097|FG002|Overall Study|Other reason not defined above|4|||
126157668|NCT00306891|453864098|FG000|Part A|Withdrawal by Subject|1|||
126157669|NCT00306891|453864099|FG001|Part A|Withdrawal by Subject|1|||
126157670|NCT00306891|453864100|FG002|Part A|Withdrawal by Subject|0|||
126157671|NCT00306891|453864101|FG003|Part A|Withdrawal by Subject|0|||
126157672|NCT00306891|453864098|FG000|Part A|Condition under investigation worsened|2|||
126157673|NCT00306891|453864099|FG001|Part A|Condition under investigation worsened|2|||
126157674|NCT00306891|453864100|FG002|Part A|Condition under investigation worsened|0|||
126157675|NCT00306891|453864101|FG003|Part A|Condition under investigation worsened|0|||
126157676|NCT00306891|453864098|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
126157677|NCT00306891|453864099|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
126157678|NCT00306891|453864100|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
126157679|NCT00306891|453864101|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
126157680|NCT00306891|453864098|FG000|Part A|Partial bowel obstruction|1|||
126157681|NCT00306891|453864099|FG001|Part A|Partial bowel obstruction|0|||
126157682|NCT00306891|453864100|FG002|Part A|Partial bowel obstruction|0|||
126157683|NCT00306891|453864101|FG003|Part A|Partial bowel obstruction|0|||
126157684|NCT00306891|453864098|FG000|Part A|Reaccumul. of ascites following drainage|0|||
126157685|NCT00306891|453864099|FG001|Part A|Reaccumul. of ascites following drainage|1|||
126157686|NCT00306891|453864100|FG002|Part A|Reaccumul. of ascites following drainage|0|||
126157687|NCT00306891|453864101|FG003|Part A|Reaccumul. of ascites following drainage|0|||
126157688|NCT00306891|453864098|FG000|Part A|Suspicion of second malignancy|0|||
126157689|NCT00306891|453864099|FG001|Part A|Suspicion of second malignancy|1|||
126157690|NCT00306891|453864100|FG002|Part A|Suspicion of second malignancy|0|||
126157691|NCT00306891|453864101|FG003|Part A|Suspicion of second malignancy|0|||
125971946|NCT01369342|453186710|FG000|Overall Study|Lost to Follow-up|5|||
126157692|NCT00306891|453864098|FG000|Part A|QTC interval outwith elig. criteria|1|||
126157693|NCT00306891|453864099|FG001|Part A|QTC interval outwith elig. criteria|0|||
126157694|NCT00306891|453864100|FG002|Part A|QTC interval outwith elig. criteria|0|||
126157695|NCT00306891|453864101|FG003|Part A|QTC interval outwith elig. criteria|0|||
126157696|NCT00306891|453864098|FG000|Part B|Death|0|||
126157697|NCT00306891|453864099|FG001|Part B|Death|0|||
125971947|NCT01369342|453186711|FG001|Overall Study|Lost to Follow-up|2|||
126157698|NCT00306891|453864100|FG002|Part B|Death|1|||
126157699|NCT00306891|453864101|FG003|Part B|Death|2|||
126157700|NCT00306891|453864098|FG000|Part B|Adverse Event|0|||
126157701|NCT00306891|453864099|FG001|Part B|Adverse Event|0|||
126157702|NCT00306891|453864100|FG002|Part B|Adverse Event|5|||
126157703|NCT00306891|453864101|FG003|Part B|Adverse Event|5|||
126157704|NCT00306891|453864098|FG000|Part B|Withdrawal by Subject|0|||
126157705|NCT00306891|453864099|FG001|Part B|Withdrawal by Subject|0|||
126157706|NCT00306891|453864100|FG002|Part B|Withdrawal by Subject|3|||
126157707|NCT00306891|453864101|FG003|Part B|Withdrawal by Subject|1|||
126157708|NCT00306891|453864098|FG000|Part B|Condition under investigation worsened|0|||
126157709|NCT00306891|453864099|FG001|Part B|Condition under investigation worsened|0|||
126157710|NCT00306891|453864100|FG002|Part B|Condition under investigation worsened|2|||
126157711|NCT00306891|453864101|FG003|Part B|Condition under investigation worsened|8|||
126157712|NCT00306891|453864098|FG000|Part B|Development of study specific disc crit.|0|||
126157713|NCT00306891|453864099|FG001|Part B|Development of study specific disc crit.|0|||
126157714|NCT00306891|453864100|FG002|Part B|Development of study specific disc crit.|0|||
126157715|NCT00306891|453864101|FG003|Part B|Development of study specific disc crit.|1|||
126157716|NCT00673673|453864102|FG000|Overall Study|Progressive disease|27|||
126157717|NCT00673673|453864102|FG000|Overall Study|Adverse Event|4|||
126157718|NCT00673673|453864102|FG000|Overall Study|Withdrawal by Subject|3|||
126157719|NCT00673673|453864102|FG000|Overall Study|Investigators' discretion|2|||
126157720|NCT01751646|453864103|FG000|Overall Study|Lost to Follow-up|5|||
126157721|NCT01751646|453864104|FG001|Overall Study|Lost to Follow-up|1|||
126157722|NCT01751646|453864103|FG000|Overall Study|Withdrawal by Subject|0|||
126157723|NCT01751646|453864104|FG001|Overall Study|Withdrawal by Subject|4|||
126157724|NCT01751646|453864103|FG000|Overall Study|Starting hormone therapy|1|||
126157725|NCT01751646|453864104|FG001|Overall Study|Starting hormone therapy|0|||
126157726|NCT01751646|453864103|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
126157727|NCT01751646|453864104|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
126157728|NCT01751646|453864103|FG000|Overall Study|Inadvertent enrollment|1|||
126157729|NCT01751646|453864104|FG001|Overall Study|Inadvertent enrollment|1|||
126157730|NCT01751646|453864103|FG000|Overall Study|Moved out of the area|1|||
126157731|NCT01751646|453864104|FG001|Overall Study|Moved out of the area|5|||
126157732|NCT01751646|453864103|FG000|Overall Study|Inability to attend required visits|0|||
126157733|NCT01751646|453864104|FG001|Overall Study|Inability to attend required visits|1|||
126157734|NCT01751646|453864103|FG000|Overall Study|Off study due to multiple obligations|0|||
126157735|NCT01751646|453864104|FG001|Overall Study|Off study due to multiple obligations|1|||
126157736|NCT01751646|453864103|FG000|Overall Study|Fails to comply with study requirements|0|||
126157737|NCT01751646|453864104|FG001|Overall Study|Fails to comply with study requirements|1|||
126157738|NCT01751646|453864103|FG000|Overall Study|Childcare issues|1|||
126157739|NCT01751646|453864104|FG001|Overall Study|Childcare issues|1|||
126157740|NCT02335450|453864105|FG000|Overall Study|Pregnancy|1|||
126157741|NCT02613572|453864106|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
126157742|NCT02613572|453864107|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
126157743|NCT02613572|453864108|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
126157744|NCT02613572|453864106|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
126157745|NCT02613572|453864107|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
126157746|NCT02613572|453864108|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
126157747|NCT04542291|453864109|FG000|Overall Study|Adverse Event|1|||
126157748|NCT04542291|453864109|FG000|Overall Study|Physician Decision|2|||
126157749|NCT04538950|453864110|FG000|Overall Study|Pulmonary Issues|2|||
126157750|NCT04538950|453864110|FG000|Overall Study|illness|2|||
126157751|NCT01004146|453864111|FG000|Overall Study|Withdrawal by Subject|4|||
126157752|NCT01004146|453864112|FG001|Overall Study|Withdrawal by Subject|5|||
126157753|NCT00970294|453864115|FG000|Overall Study|Physician Decision|4|||
126157754|NCT00970294|453864115|FG000|Overall Study|Withdrawal by Subject|1|||
126157755|NCT00847561|453864116|FG000|Overall Study|Withdrawal by Subject|4|||
126157756|NCT00847561|453864117|FG001|Overall Study|Withdrawal by Subject|3|||
126157757|NCT00847561|453864116|FG000|Overall Study|Unable to schedule|9|||
126157758|NCT00847561|453864117|FG001|Overall Study|Unable to schedule|1|||
126157759|NCT00408681|453864118|FG000|Overall Study|Lack of Efficacy|2|||
126157760|NCT00408681|453864118|FG000|Overall Study|Adverse Event|7|||
126157761|NCT00447421|453864119|FG000|Overall Study|Lack of Efficacy|1|||
126157762|NCT00447421|453864119|FG000|Overall Study|Adverse Event|3|||
126157763|NCT00447421|453864119|FG000|Overall Study|Sponsor Decision|2|||
126157764|NCT01707147|453864120|FG000|Overall Study|Administered Trajenta prior to contract|5|||
126157765|NCT01707147|453864120|FG000|Overall Study|Patients who have not taken Trajenta|1|||
126157766|NCT01707147|453864120|FG000|Overall Study|Follow-up failure|17|||
126157767|NCT01707147|453864120|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
126157768|NCT02792777|453864121|FG000|Overall Study|Withdrawal by Subject|2|||
126157769|NCT02792777|453864122|FG001|Overall Study|Withdrawal by Subject|0|||
126157770|NCT02792777|453864121|FG000|Overall Study|Recording malfunction|2|||
126157771|NCT02792777|453864122|FG001|Overall Study|Recording malfunction|0|||
126157772|NCT02792777|453864121|FG000|Overall Study|Later determined to be ineligible|2|||
126157773|NCT02792777|453864122|FG001|Overall Study|Later determined to be ineligible|0|||
126157774|NCT02792777|453864121|FG000|Overall Study|Participant interviewed twice|1|||
126157775|NCT02792777|453864122|FG001|Overall Study|Participant interviewed twice|0|||
126157776|NCT02345434|453865586|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
126157777|NCT02345434|453865587|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
126157778|NCT01214434|453865594|FG000|Overall Study|Withdrawal by Subject|1|||
126157779|NCT01214434|453865595|FG001|Overall Study|Withdrawal by Subject|0|||
126157780|NCT01214434|453865594|FG000|Overall Study|Lost to Follow-up|2|||
126157781|NCT01214434|453865595|FG001|Overall Study|Lost to Follow-up|2|||
126157782|NCT01214434|453865594|FG000|Overall Study|Site error|1|||
126157783|NCT01214434|453865595|FG001|Overall Study|Site error|0|||
126157784|NCT03792750|453865597|FG000|Overall Study|Death|3|||
126157785|NCT00138151|453865598|FG000|Overall Study|Withdrawal by Subject|3|||
126157786|NCT00138151|453865598|FG000|Overall Study|Physician Decision|1|||
126157787|NCT02902809|453865602|FG000|Overall Study|Discontinuation of asthma program|28|||
126157788|NCT00532259|453865603|FG000|Overall Study|Withdrawal by Subject|2|||
126157789|NCT00532259|453865603|FG000|Overall Study|Adverse Event|1|||
126157790|NCT00532259|453865603|FG000|Overall Study|Death|1|||
126157791|NCT00532259|453865603|FG000|Overall Study|Lack of Efficacy|21|||
126157792|NCT00532259|453865603|FG000|Overall Study|Lost to Follow-up|3|||
126157793|NCT00532259|453865603|FG000|Overall Study|Physician Decision|3|||
126157794|NCT00532259|453865603|FG000|Overall Study|Protocol Violation|1|||
126157795|NCT00793104|453865604|FG000|Overall Study|Lost to Follow-up|1|||
126157796|NCT03494725|453865605|FG000|Overall Study|Withdrawal by Subject|0|||
126157797|NCT03494725|453865606|FG001|Overall Study|Withdrawal by Subject|2|||
126157798|NCT03494725|453865605|FG000|Overall Study|Antibiotic use|1|||
126157799|NCT03494725|453865606|FG001|Overall Study|Antibiotic use|0|||
126157800|NCT04983940|453865607|FG000|Overall Study|Lost to Follow-up|14|||
126157801|NCT04983940|453865607|FG000|Overall Study|Lack of Efficacy|2|||
126157802|NCT00514449|453865608|FG000|Overall Study|Withdrawal by Subject|1|||
126157803|NCT00514449|453865609|FG001|Overall Study|Withdrawal by Subject|2|||
126157804|NCT00514449|453865608|FG000|Overall Study|Protocol Violation|1|||
126157805|NCT00514449|453865609|FG001|Overall Study|Protocol Violation|2|||
126157806|NCT00514449|453865608|FG000|Overall Study|Lost to Follow-up|1|||
126157807|NCT00514449|453865609|FG001|Overall Study|Lost to Follow-up|0|||
126157808|NCT00301067|453865611|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
126157809|NCT00301067|453865612|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
126157810|NCT00301067|453865613|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
126157811|NCT00301067|453865614|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
126157812|NCT00301067|453865611|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
126157813|NCT00301067|453865612|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
126157814|NCT00301067|453865613|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
126157815|NCT00301067|453865614|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
126157816|NCT00301067|453865611|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
126157817|NCT00301067|453865612|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
126157818|NCT00301067|453865613|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
126157819|NCT00301067|453865614|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
126157820|NCT00301067|453865611|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
126157821|NCT00301067|453865612|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
126157822|NCT00301067|453865613|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
126157823|NCT00301067|453865614|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
126157824|NCT00301067|453865611|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
126157825|NCT00301067|453865612|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
126157826|NCT00301067|453865613|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
126157827|NCT00301067|453865614|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
126157828|NCT00301067|453865611|FG000|Follow up Until Death|Alive at last data cut point|1|||
126157829|NCT00301067|453865612|FG001|Follow up Until Death|Alive at last data cut point|0|||
126157830|NCT00301067|453865613|FG002|Follow up Until Death|Alive at last data cut point|0|||
126157831|NCT00301067|453865614|FG003|Follow up Until Death|Alive at last data cut point|1|||
126157832|NCT00149825|453865615|FG000|Overall Study|Intolerance to medication side effects|1|||
126157833|NCT00149825|453865616|FG001|Overall Study|Intolerance to medication side effects|2|||
126157834|NCT00149825|453865615|FG000|Overall Study|Time commitments|2|||
126157835|NCT00149825|453865616|FG001|Overall Study|Time commitments|1|||
126157836|NCT00149825|453865615|FG000|Overall Study|Not liking insomnia therapy|1|||
126157837|NCT00149825|453865616|FG001|Overall Study|Not liking insomnia therapy|0|||
126157838|NCT00149825|453865615|FG000|Overall Study|Other|1|||
126157839|NCT00149825|453865616|FG001|Overall Study|Other|0|||
126157840|NCT01359982|453865617|FG000|Overall Study|Adverse Event|2|||
126157841|NCT01359982|453865618|FG001|Overall Study|Adverse Event|0|||
126157842|NCT01359982|453865619|FG002|Overall Study|Adverse Event|0|||
126157843|NCT01359982|453865620|FG003|Overall Study|Adverse Event|1|||
126157844|NCT01359982|453865621|FG004|Overall Study|Adverse Event|0|||
126157845|NCT01359982|453865622|FG005|Overall Study|Adverse Event|0|||
126157846|NCT01359982|453865617|FG000|Overall Study|Death|1|||
126157847|NCT01359982|453865618|FG001|Overall Study|Death|0|||
126157848|NCT01359982|453865619|FG002|Overall Study|Death|0|||
126157849|NCT01359982|453865620|FG003|Overall Study|Death|0|||
126157850|NCT01359982|453865621|FG004|Overall Study|Death|0|||
126157851|NCT01359982|453865622|FG005|Overall Study|Death|0|||
126157852|NCT00942708|453865623|FG000|Overall Study|Withdrawal by Subject|1|||
126157853|NCT01457339|453865624|FG000|Period 3 (100 mg)|Adverse Event|0|||
126157854|NCT01457339|453865625|FG001|Period 3 (100 mg)|Adverse Event|1|||
126157855|NCT01457339|453865624|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
126157856|NCT01457339|453865625|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
126157857|NCT01457339|453865624|FG000|Period 6 (250 mg)|Family Emergency|1|||
126157858|NCT01457339|453865625|FG001|Period 6 (250 mg)|Family Emergency|0|||
126157859|NCT01457339|453865624|FG000|Period 6 (250 mg)|Personal appointment|0|||
126157860|NCT01457339|453865625|FG001|Period 6 (250 mg)|Personal appointment|1|||
126157861|NCT02760407|453865626|FG000|Overall Study|Death|2|||
126157862|NCT02760407|453865627|FG001|Overall Study|Death|3|||
126157863|NCT02760407|453865628|FG002|Overall Study|Death|1|||
126157864|NCT02760407|453865629|FG003|Overall Study|Death|1|||
126157865|NCT02760407|453865626|FG000|Overall Study|Lost to Follow-up|1|||
126157866|NCT02760407|453865627|FG001|Overall Study|Lost to Follow-up|7|||
126157867|NCT02760407|453865628|FG002|Overall Study|Lost to Follow-up|4|||
126157868|NCT02760407|453865629|FG003|Overall Study|Lost to Follow-up|6|||
126157869|NCT02760407|453865626|FG000|Overall Study|Withdrawal by Subject|25|||
126157870|NCT02760407|453865627|FG001|Overall Study|Withdrawal by Subject|31|||
126157871|NCT02760407|453865628|FG002|Overall Study|Withdrawal by Subject|37|||
126157872|NCT02760407|453865629|FG003|Overall Study|Withdrawal by Subject|25|||
126157873|NCT02760407|453865626|FG000|Overall Study|Violation of Eligibility criteria|0|||
126157874|NCT02760407|453865627|FG001|Overall Study|Violation of Eligibility criteria|0|||
126157875|NCT02760407|453865628|FG002|Overall Study|Violation of Eligibility criteria|1|||
126157876|NCT02760407|453865629|FG003|Overall Study|Violation of Eligibility criteria|1|||
126157877|NCT02760407|453865626|FG000|Overall Study|Personal reasons|0|||
126157878|NCT02760407|453865627|FG001|Overall Study|Personal reasons|0|||
126157879|NCT02760407|453865628|FG002|Overall Study|Personal reasons|0|||
126157880|NCT02760407|453865629|FG003|Overall Study|Personal reasons|1|||
126157881|NCT02760407|453865626|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
126157882|NCT02760407|453865627|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
126157883|NCT02760407|453865628|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
126157884|NCT02760407|453865629|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
126157885|NCT02760407|453865626|FG000|Overall Study|Use of prohibited Medication|0|||
126157886|NCT02760407|453865627|FG001|Overall Study|Use of prohibited Medication|0|||
126157887|NCT02760407|453865628|FG002|Overall Study|Use of prohibited Medication|1|||
126157888|NCT02760407|453865629|FG003|Overall Study|Use of prohibited Medication|0|||
126157889|NCT02760407|453865626|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
126157890|NCT02760407|453865627|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
126157891|NCT02760407|453865628|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
126157892|NCT02760407|453865629|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
126157893|NCT02760407|453865626|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
126157894|NCT02760407|453865627|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
126157895|NCT02760407|453865628|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
126157896|NCT02760407|453865629|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
126157897|NCT02760407|453865626|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
126157898|NCT02760407|453865627|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
126157899|NCT02760407|453865628|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
126157900|NCT02760407|453865629|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
126157901|NCT02760407|453865626|FG000|Overall Study|Inadequately Enrolled|0|||
126157902|NCT02760407|453865627|FG001|Overall Study|Inadequately Enrolled|0|||
126157903|NCT02760407|453865628|FG002|Overall Study|Inadequately Enrolled|0|||
126157904|NCT02760407|453865629|FG003|Overall Study|Inadequately Enrolled|1|||
126157905|NCT02760407|453865626|FG000|Overall Study|Withdrawal By PI's Decision|0|||
126157906|NCT02760407|453865627|FG001|Overall Study|Withdrawal By PI's Decision|1|||
126157907|NCT02760407|453865628|FG002|Overall Study|Withdrawal By PI's Decision|0|||
126157908|NCT02760407|453865629|FG003|Overall Study|Withdrawal By PI's Decision|0|||
126157909|NCT02760407|453865626|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
126157910|NCT02760407|453865627|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
126157911|NCT02760407|453865628|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
126157912|NCT02760407|453865629|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
126157913|NCT02760407|453865626|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
126157914|NCT02760407|453865627|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
126157915|NCT02760407|453865628|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
126157916|NCT02760407|453865629|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
126157917|NCT02760407|453865626|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
126157918|NCT02760407|453865627|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
126157919|NCT02760407|453865628|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
126157920|NCT02760407|453865629|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
126157921|NCT02760407|453865626|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
126157922|NCT02760407|453865627|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
126157923|NCT02760407|453865628|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
126157924|NCT02760407|453865629|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
126157925|NCT02760407|453865626|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
126157926|NCT02760407|453865627|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
126157927|NCT02760407|453865628|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
126157928|NCT02760407|453865629|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
126157929|NCT02760407|453865626|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
126157930|NCT02760407|453865627|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
126157931|NCT02760407|453865628|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
126157932|NCT02760407|453865629|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
126157933|NCT02760407|453865626|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
126157934|NCT02760407|453865627|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
126157935|NCT02760407|453865628|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
126157936|NCT02760407|453865629|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
126157937|NCT02760407|453865626|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
126157938|NCT02760407|453865627|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
126157939|NCT02760407|453865628|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
126157940|NCT02760407|453865629|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
126157941|NCT02760407|453865626|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
126157942|NCT02760407|453865627|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
126157943|NCT02760407|453865628|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
126157944|NCT02760407|453865629|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
126157945|NCT01645930|453865630|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
126157946|NCT01645930|453865630|FG000|Overall Study|Progressive Disease|12|||
126157947|NCT01645930|453865630|FG000|Overall Study|Adverse Event|4|||
126157948|NCT01645930|453865630|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
126157949|NCT01645930|453865630|FG000|Overall Study|Withdrawal by Participant|2|||
126157950|NCT01645930|453865630|FG000|Overall Study|Reason not Defined|1|||
126157951|NCT03245814|453865631|FG000|Overall Study|Lost to Follow-up|5|||
126157952|NCT03245814|453865632|FG001|Overall Study|Lost to Follow-up|8|||
126157953|NCT03245814|453865631|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
126157954|NCT03245814|453865632|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
126157955|NCT02522377|453865633|FG000|Overall Study|Withdrawal by Subject|1|||
126157956|NCT02522377|453865634|FG001|Overall Study|Withdrawal by Subject|0|||
126157957|NCT02522377|453865633|FG000|Overall Study|Remission Achieved|3|||
126157958|NCT02522377|453865634|FG001|Overall Study|Remission Achieved|0|||
126157959|NCT01158950|453865635|FG000|1st Intervention (1 Day)|Physician Decision|1|||
126157960|NCT01158950|453865636|FG001|1st Intervention (1 Day)|Physician Decision|2|||
126157961|NCT02263365|453865637|FG000|Overall Study|Physician Decision|22|||
126157962|NCT02263365|453865638|FG001|Overall Study|Physician Decision|18|||
126157963|NCT00945191|453865639|FG000|Overall Study|Did not achieve a complete response|18|||
126157964|NCT00945191|453865639|FG000|Overall Study|Participant relocated to another state|1|||
126157965|NCT00945191|453865639|FG000|Overall Study|Disease progression|3|||
126157966|NCT00945191|453865639|FG000|Overall Study|Serious adverse event or adverse event|1|||
126157967|NCT00945191|453865639|FG000|Overall Study|Investigator's discretion|1|||
126157968|NCT00206518|453865640|FG000|Overall Study|Lack of Efficacy|6|||
126157969|NCT00206518|453865641|FG001|Overall Study|Lack of Efficacy|4|||
126157970|NCT00206518|453865640|FG000|Overall Study|Adverse Event|2|||
126157971|NCT00206518|453865641|FG001|Overall Study|Adverse Event|1|||
126157972|NCT00206518|453865640|FG000|Overall Study|Physician Decision|1|||
126157973|NCT00206518|453865641|FG001|Overall Study|Physician Decision|0|||
126157974|NCT00206518|453865640|FG000|Overall Study|Protocol Violation|1|||
126157975|NCT00206518|453865641|FG001|Overall Study|Protocol Violation|1|||
126157976|NCT02053246|453865653|FG000|Overall Study|Withdrawal by Subject|3|||
126157977|NCT02053246|453865653|FG000|Overall Study|Physician Decision|1|||
126157978|NCT02707757|453865654|FG000|Overall Study|Protocol Violation|3|||
126157979|NCT02707757|453865655|FG001|Overall Study|Protocol Violation|2|||
126157980|NCT02707757|453865654|FG000|Overall Study|Withdrawal by Subject|2|||
126157981|NCT02707757|453865655|FG001|Overall Study|Withdrawal by Subject|0|||
126157982|NCT02707757|453865654|FG000|Overall Study|Death|0|||
126157983|NCT02707757|453865655|FG001|Overall Study|Death|1|||
126157984|NCT02707757|453865654|FG000|Overall Study|Adverse Event|6|||
126157985|NCT02707757|453865655|FG001|Overall Study|Adverse Event|4|||
126157986|NCT02707757|453865654|FG000|Overall Study|Renal transplant/elective operation|1|||
126157987|NCT02707757|453865655|FG001|Overall Study|Renal transplant/elective operation|5|||
126157988|NCT00638846|453865659|FG000|Overall Study|Adverse Event|0|||
126157989|NCT00638846|453865660|FG001|Overall Study|Adverse Event|1|||
126157990|NCT00638846|453865659|FG000|Overall Study|Lost to Follow-up|3|||
126157991|NCT00638846|453865660|FG001|Overall Study|Lost to Follow-up|2|||
126157992|NCT00638846|453865659|FG000|Overall Study|lens issue|1|||
126157993|NCT00638846|453865660|FG001|Overall Study|lens issue|3|||
126157994|NCT02746679|453865663|FG000|Overall Study|Lost to Follow-up|4|||
126157995|NCT02746679|453865664|FG001|Overall Study|Lost to Follow-up|6|||
126157996|NCT01171521|453865666|FG000|Overall Study|Lost to Follow-up|5|||
126157997|NCT01171521|453865666|FG000|Overall Study|screen failure|1|||
126157998|NCT00734929|453865671|FG000|Overall Study|Lost to Follow-up|1|||
126157999|NCT00734929|453865672|FG001|Overall Study|Lost to Follow-up|2|||
126158000|NCT00734929|453865671|FG000|Overall Study|No intervention/ screen fail|5|||
126158001|NCT00734929|453865672|FG001|Overall Study|No intervention/ screen fail|3|||
126158002|NCT01422304|453865673|FG000|Overall Study|Adverse Event|0|||
126158003|NCT01422304|453865674|FG001|Overall Study|Adverse Event|1|||
126158004|NCT01422304|453865673|FG000|Overall Study|Lost to Follow-up|14|||
126158005|NCT01422304|453865674|FG001|Overall Study|Lost to Follow-up|20|||
126158006|NCT01422304|453865673|FG000|Overall Study|Never Entered Follow-up|2|||
126158007|NCT01422304|453865674|FG001|Overall Study|Never Entered Follow-up|1|||
126158008|NCT01422304|453865673|FG000|Overall Study|Protocol Violation|1|||
126158009|NCT01422304|453865674|FG001|Overall Study|Protocol Violation|0|||
126158010|NCT01422304|453865673|FG000|Overall Study|Withdrawal by Subject|4|||
126158011|NCT01422304|453865674|FG001|Overall Study|Withdrawal by Subject|2|||
126158012|NCT01422304|453865673|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
126158013|NCT01422304|453865674|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
126158014|NCT01422304|453865673|FG000|Overall Study|Not Treated|3|||
126158015|NCT01422304|453865674|FG001|Overall Study|Not Treated|11|||
126158016|NCT04799782|453865675|FG000|Washout|Physician Decision|2|||
126158017|NCT04799782|453865676|FG001|Washout|Physician Decision|0|||
126158018|NCT04799782|453865675|FG000|Washout|Withdrawal by Subject|0|||
126158019|NCT04799782|453865676|FG001|Washout|Withdrawal by Subject|2|||
126158020|NCT04799782|453865675|FG000|Washout|Lost to Follow-up|0|||
126158021|NCT04799782|453865676|FG001|Washout|Lost to Follow-up|1|||
126158022|NCT02606877|453865677|FG000|Overall Study|Adverse Event|3|||
126158023|NCT02606877|453865678|FG001|Overall Study|Adverse Event|0|||
126158024|NCT02606877|453865677|FG000|Overall Study|Non-compliance with protocol|0|||
126158025|NCT02606877|453865678|FG001|Overall Study|Non-compliance with protocol|1|||
126158026|NCT02606877|453865677|FG000|Overall Study|Other than listed above|1|||
126158027|NCT02606877|453865678|FG001|Overall Study|Other than listed above|0|||
126158028|NCT00515463|453865690|FG000|Overall Study|Physician Decision|4|||
126158029|NCT00515463|453865691|FG001|Overall Study|Physician Decision|2|||
126158030|NCT00515463|453865690|FG000|Overall Study|Adverse Event|1|||
126158031|NCT00515463|453865691|FG001|Overall Study|Adverse Event|2|||
126158032|NCT00515463|453865690|FG000|Overall Study|Withdrawal by Subject|3|||
126158033|NCT00515463|453865691|FG001|Overall Study|Withdrawal by Subject|4|||
126158034|NCT00515463|453865690|FG000|Overall Study|Lost to Follow-up|6|||
126158035|NCT00515463|453865691|FG001|Overall Study|Lost to Follow-up|5|||
126158036|NCT00515463|453865690|FG000|Overall Study|Other|0|||
126158037|NCT00515463|453865691|FG001|Overall Study|Other|1|||
126158038|NCT01558089|453865692|FG000|Overall Study|Adverse Event|1|||
126158039|NCT01558089|453865692|FG000|Overall Study|Lack of Efficacy|1|||
125971948|NCT01369342|453186712|FG002|Overall Study|Lost to Follow-up|1|||
125971949|NCT01369342|453186710|FG000|Overall Study|Not Treated|1|||
125971950|NCT01369342|453186711|FG001|Overall Study|Not Treated|0|||
125971951|NCT01369342|453186712|FG002|Overall Study|Not Treated|0|||
125971952|NCT00413153|453186713|FG000|Overall Study|Withdrawal by Subject|1|||
125971953|NCT00413153|453186714|FG001|Overall Study|Withdrawal by Subject|1|||
125971954|NCT00413153|453186713|FG000|Overall Study|Adverse Event|1|||
126158040|NCT01558089|453865692|FG000|Overall Study|Lost to Follow-up|5|||
126158041|NCT01558089|453865692|FG000|Overall Study|Withdrawal by Subject|6|||
126158042|NCT01903434|453865695|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
126158043|NCT01903434|453865696|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
125971955|NCT00413153|453186714|FG001|Overall Study|Adverse Event|0|||
125971956|NCT01064739|453186715|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
125971957|NCT01669629|453186718|FG000|Period 1|protocol deviation|1|||
126158044|NCT01903434|453865695|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
126158045|NCT01903434|453865696|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
125971958|NCT01669629|453186719|FG001|Period 1|protocol deviation|2|||
125971959|NCT01221597|453186720|FG000|Overall Study|Adverse Event|4|||
126158046|NCT02190435|453865697|FG000|Overall Study|First 12 patients were lead-ins|12|||
126158047|NCT02190435|453865698|FG001|Overall Study|First 12 patients were lead-ins|0|||
126158048|NCT02190435|453865697|FG000|Overall Study|3 consented screen fails|3|||
126158049|NCT02190435|453865698|FG001|Overall Study|3 consented screen fails|0|||
126158050|NCT01781026|453865699|FG000|Overall Study|Lack of Efficacy|2|||
126158051|NCT02269319|453865700|FG000|Overall Study|Lost to Follow-up|4|||
126158052|NCT02269319|453865701|FG001|Overall Study|Lost to Follow-up|3|||
126158053|NCT02269319|453865700|FG000|Overall Study|Adverse Event|0|||
126158054|NCT02269319|453865701|FG001|Overall Study|Adverse Event|1|||
126158055|NCT02269319|453865700|FG000|Overall Study|Instructions not followed|1|||
126158056|NCT02269319|453865701|FG001|Overall Study|Instructions not followed|0|||
126158057|NCT01589094|453865702|FG000|Overall Study|Did not receive treatment|2|||
126158058|NCT03575468|453865703|FG000|Overall Study|Withdrawal by Subject|3|||
126158059|NCT03575468|453865704|FG001|Overall Study|Withdrawal by Subject|0|||
126158060|NCT03575468|453865703|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
126158061|NCT03575468|453865704|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
126158062|NCT03575468|453865703|FG000|Overall Study|Lost to Follow-up|13|||
126158063|NCT03575468|453865704|FG001|Overall Study|Lost to Follow-up|17|||
126158064|NCT03123939|453865707|FG000|Overall Study|Lack of Efficacy|6|||
126158065|NCT03123939|453865707|FG000|Overall Study|Death|5|||
126158066|NCT03123939|453865707|FG000|Overall Study|Physician Decision|2|||
126158067|NCT03123939|453865707|FG000|Overall Study|Subject/guardian decision|2|||
126158068|NCT03123939|453865707|FG000|Overall Study|Lost to Follow-up|1|||
126158069|NCT03123939|453865707|FG000|Overall Study|New therapy for study indication|1|||
126158070|NCT03123939|453865707|FG000|Overall Study|Protocol deviation|1|||
126158071|NCT03123939|453865707|FG000|Overall Study|Progressive disease|18|||
126158072|NCT03123939|453865707|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
126158073|NCT03123939|453865707|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
126158074|NCT01118143|453865708|FG000|Overall Study|Withdrawal by Subject|2|||
126158075|NCT01118143|453865709|FG001|Overall Study|Withdrawal by Subject|5|||
126158076|NCT02112448|453865710|FG000|Overall Study|lab values precluding use of ketorolac|2|||
126158077|NCT02112448|453865711|FG001|Overall Study|lab values precluding use of ketorolac|2|||
126158078|NCT02112448|453865710|FG000|Overall Study|Protocol Violation|1|||
126158079|NCT02112448|453865711|FG001|Overall Study|Protocol Violation|2|||
126158080|NCT02112448|453865710|FG000|Overall Study|Physician Decision|4|||
126158081|NCT02112448|453865711|FG001|Overall Study|Physician Decision|6|||
126158082|NCT02112448|453865710|FG000|Overall Study|required heparin so could not use ketoro|1|||
126158083|NCT02112448|453865711|FG001|Overall Study|required heparin so could not use ketoro|0|||
126158084|NCT05270694|453866831|FG000|Overall Study|Death|1|||
126158085|NCT05270694|453866831|FG000|Overall Study|Medical issues impacted ability to participate|2|||
126158086|NCT05270694|453866831|FG000|Overall Study|Lost to Follow-up|3|||
126158087|NCT05270694|453866831|FG000|Overall Study|Withdrawal by Subject|3|||
126158088|NCT01991977|453866834|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
126158089|NCT01991977|453866834|FG000|Overall Study|Withdrew after start of treatment|5|||
126158090|NCT02531035|453866841|FG000|Overall Study|Death|0|||
126158091|NCT02531035|453866842|FG001|Overall Study|Death|1|||
126158092|NCT02531035|453866841|FG000|Overall Study|Protocol Violation|1|||
126158093|NCT02531035|453866842|FG001|Overall Study|Protocol Violation|1|||
126158094|NCT02531035|453866841|FG000|Overall Study|Noncompliance with study drug|8|||
126158095|NCT02531035|453866842|FG001|Overall Study|Noncompliance with study drug|3|||
126158096|NCT02531035|453866841|FG000|Overall Study|Physician Decision|1|||
126158097|NCT02531035|453866842|FG001|Overall Study|Physician Decision|0|||
126158098|NCT02531035|453866841|FG000|Overall Study|Adverse Event|16|||
126158099|NCT02531035|453866842|FG001|Overall Study|Adverse Event|45|||
126158100|NCT02531035|453866841|FG000|Overall Study|Other|3|||
126158101|NCT02531035|453866842|FG001|Overall Study|Other|2|||
126158102|NCT02531035|453866841|FG000|Overall Study|Withdrawal by Subject|42|||
126158103|NCT02531035|453866842|FG001|Overall Study|Withdrawal by Subject|32|||
126158104|NCT02531035|453866841|FG000|Overall Study|Lost to Follow-up|8|||
126158105|NCT02531035|453866842|FG001|Overall Study|Lost to Follow-up|10|||
126158106|NCT02531035|453866841|FG000|Overall Study|Randomized, not treated|2|||
126158107|NCT02531035|453866842|FG001|Overall Study|Randomized, not treated|1|||
126158108|NCT03032068|453866852|FG000|Overall Study|Adverse Event|1|||
126158109|NCT01597622|453866853|FG000|Overall Study|Adverse Event|7|||
126158110|NCT01597622|453866853|FG000|Overall Study|Lack of Efficacy|3|||
126158111|NCT01597622|453866853|FG000|Overall Study|Protocol Violation|1|||
126158112|NCT01597622|453866853|FG000|Overall Study|Lost to Follow-up|1|||
126158113|NCT01597622|453866853|FG000|Overall Study|Investigator Discretion|5|||
126158114|NCT01597622|453866853|FG000|Overall Study|Withdrawal by Subject|20|||
126158115|NCT01597622|453866853|FG000|Overall Study|Death|1|||
126158116|NCT03567291|453866860|FG000|Period I|Adverse Event|14|||
126158117|NCT03567291|453866861|FG001|Period I|Adverse Event|0|||
126158118|NCT03567291|453866862|FG002|Period I|Adverse Event|0|||
126158119|NCT03567291|453866863|FG003|Period I|Adverse Event|0|||
126158120|NCT03567291|453866860|FG000|Period I|Protocol Violation|1|||
126158121|NCT03567291|453866861|FG001|Period I|Protocol Violation|0|||
126158122|NCT03567291|453866862|FG002|Period I|Protocol Violation|0|||
126158123|NCT03567291|453866863|FG003|Period I|Protocol Violation|0|||
126158124|NCT03567291|453866860|FG000|Period I|Withdrawal by Subject|23|||
126158125|NCT03567291|453866861|FG001|Period I|Withdrawal by Subject|0|||
126158126|NCT03567291|453866862|FG002|Period I|Withdrawal by Subject|0|||
126158127|NCT03567291|453866863|FG003|Period I|Withdrawal by Subject|0|||
126158128|NCT03567291|453866860|FG000|Period I|Lost to Follow-up|2|||
126158129|NCT03567291|453866861|FG001|Period I|Lost to Follow-up|0|||
126158130|NCT03567291|453866862|FG002|Period I|Lost to Follow-up|0|||
126158131|NCT03567291|453866863|FG003|Period I|Lost to Follow-up|0|||
126158132|NCT03567291|453866860|FG000|Period I|Terminated by sponsor|44|||
126158133|NCT03567291|453866861|FG001|Period I|Terminated by sponsor|0|||
126158134|NCT03567291|453866862|FG002|Period I|Terminated by sponsor|0|||
126158135|NCT03567291|453866863|FG003|Period I|Terminated by sponsor|0|||
126158136|NCT03567291|453866860|FG000|Period I|Missing or unknown|7|||
126158137|NCT03567291|453866861|FG001|Period I|Missing or unknown|0|||
126158138|NCT03567291|453866862|FG002|Period I|Missing or unknown|0|||
126158139|NCT03567291|453866863|FG003|Period I|Missing or unknown|0|||
126158140|NCT03567291|453866860|FG000|Period II|Adverse Event|0|||
126158141|NCT03567291|453866861|FG001|Period II|Adverse Event|1|||
126158142|NCT03567291|453866862|FG002|Period II|Adverse Event|0|||
126158143|NCT03567291|453866863|FG003|Period II|Adverse Event|0|||
126158144|NCT03567291|453866860|FG000|Period II|Missing or unknown|0|||
126158145|NCT03567291|453866861|FG001|Period II|Missing or unknown|2|||
126158146|NCT03567291|453866862|FG002|Period II|Missing or unknown|1|||
126158147|NCT03567291|453866863|FG003|Period II|Missing or unknown|0|||
126158148|NCT03567291|453866860|FG000|Period III|Adverse Event|0|||
126158149|NCT03567291|453866861|FG001|Period III|Adverse Event|0|||
126158150|NCT03567291|453866862|FG002|Period III|Adverse Event|0|||
126158151|NCT03567291|453866863|FG003|Period III|Adverse Event|4|||
126158152|NCT03567291|453866860|FG000|Period III|Withdrawal by Subject|0|||
126158153|NCT03567291|453866861|FG001|Period III|Withdrawal by Subject|0|||
126158154|NCT03567291|453866862|FG002|Period III|Withdrawal by Subject|0|||
126158155|NCT03567291|453866863|FG003|Period III|Withdrawal by Subject|4|||
126158156|NCT03567291|453866860|FG000|Period III|Lost to Follow-up|0|||
126158157|NCT03567291|453866861|FG001|Period III|Lost to Follow-up|0|||
126158158|NCT03567291|453866862|FG002|Period III|Lost to Follow-up|0|||
126158159|NCT03567291|453866863|FG003|Period III|Lost to Follow-up|1|||
126158160|NCT03567291|453866860|FG000|Period III|Terminated by sponsor|0|||
126158161|NCT03567291|453866861|FG001|Period III|Terminated by sponsor|0|||
126158162|NCT03567291|453866862|FG002|Period III|Terminated by sponsor|0|||
126158163|NCT03567291|453866863|FG003|Period III|Terminated by sponsor|68|||
126158164|NCT03567291|453866860|FG000|Period III|Missing or unknown|0|||
126158165|NCT03567291|453866861|FG001|Period III|Missing or unknown|0|||
126158166|NCT03567291|453866862|FG002|Period III|Missing or unknown|0|||
126158167|NCT03567291|453866863|FG003|Period III|Missing or unknown|8|||
126158168|NCT01103349|453866864|FG000|Overall Study|Adverse Event|8|||
126158169|NCT01103349|453866865|FG001|Overall Study|Adverse Event|5|||
126158170|NCT01103349|453866866|FG002|Overall Study|Adverse Event|3|||
126158171|NCT01103349|453866864|FG000|Overall Study|Consent withdrawn|1|||
126158172|NCT01103349|453866865|FG001|Overall Study|Consent withdrawn|0|||
126158173|NCT01103349|453866866|FG002|Overall Study|Consent withdrawn|0|||
126158174|NCT01103349|453866864|FG000|Overall Study|Incorrectly included in the trial|1|||
126158175|NCT01103349|453866865|FG001|Overall Study|Incorrectly included in the trial|0|||
126158176|NCT01103349|453866866|FG002|Overall Study|Incorrectly included in the trial|0|||
126158177|NCT01103349|453866864|FG000|Overall Study|Withdrawal by Subject|1|||
126158178|NCT01103349|453866865|FG001|Overall Study|Withdrawal by Subject|1|||
126158179|NCT01103349|453866866|FG002|Overall Study|Withdrawal by Subject|0|||
126158180|NCT01103349|453866864|FG000|Overall Study|did not want to take trial medication|0|||
126158181|NCT01103349|453866865|FG001|Overall Study|did not want to take trial medication|1|||
126158182|NCT01103349|453866866|FG002|Overall Study|did not want to take trial medication|0|||
126158183|NCT01103349|453866864|FG000|Overall Study|forgot to take medication|0|||
126158184|NCT01103349|453866865|FG001|Overall Study|forgot to take medication|0|||
126158185|NCT01103349|453866866|FG002|Overall Study|forgot to take medication|1|||
126158186|NCT00090285|453866867|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
126158187|NCT00090285|453866868|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
126158188|NCT00090285|453866869|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126158189|NCT00090285|453866870|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126158190|NCT00090285|453866871|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126158191|NCT00090285|453866872|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126158192|NCT00090285|453866867|FG000|Base Study Vaccination Period|Adverse Event|2|||
126158193|NCT00090285|453866868|FG001|Base Study Vaccination Period|Adverse Event|4|||
126158194|NCT00090285|453866869|FG002|Base Study Vaccination Period|Adverse Event|0|||
126158195|NCT00090285|453866870|FG003|Base Study Vaccination Period|Adverse Event|0|||
126158196|NCT00090285|453866871|FG004|Base Study Vaccination Period|Adverse Event|0|||
126158197|NCT00090285|453866872|FG005|Base Study Vaccination Period|Adverse Event|0|||
125971960|NCT01221597|453186721|FG001|Overall Study|Adverse Event|1|||
126158198|NCT00090285|453866867|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
126158199|NCT00090285|453866868|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
126158200|NCT00090285|453866869|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
126158201|NCT00090285|453866870|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
126158202|NCT00090285|453866871|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
126158203|NCT00090285|453866872|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
126158204|NCT00090285|453866867|FG000|Base Study Vaccination Period|Protocol Violation|2|||
126158205|NCT00090285|453866868|FG001|Base Study Vaccination Period|Protocol Violation|3|||
126158206|NCT00090285|453866869|FG002|Base Study Vaccination Period|Protocol Violation|0|||
126158207|NCT00090285|453866870|FG003|Base Study Vaccination Period|Protocol Violation|0|||
126158208|NCT00090285|453866871|FG004|Base Study Vaccination Period|Protocol Violation|0|||
126158209|NCT00090285|453866872|FG005|Base Study Vaccination Period|Protocol Violation|0|||
126158210|NCT00090285|453866867|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
126158211|NCT00090285|453866868|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
126158212|NCT00090285|453866869|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
126158213|NCT00090285|453866870|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
126158214|NCT00090285|453866871|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
126158215|NCT00090285|453866872|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
126158216|NCT00090285|453866867|FG000|Base Study Vaccination Period|Uncooperative|2|||
126158217|NCT00090285|453866868|FG001|Base Study Vaccination Period|Uncooperative|2|||
126158218|NCT00090285|453866869|FG002|Base Study Vaccination Period|Uncooperative|0|||
126158219|NCT00090285|453866870|FG003|Base Study Vaccination Period|Uncooperative|0|||
126158220|NCT00090285|453866871|FG004|Base Study Vaccination Period|Uncooperative|0|||
126158221|NCT00090285|453866872|FG005|Base Study Vaccination Period|Uncooperative|0|||
126158222|NCT00090285|453866867|FG000|Base Study Vaccination Period|Moved|20|||
126158223|NCT00090285|453866868|FG001|Base Study Vaccination Period|Moved|21|||
126158224|NCT00090285|453866869|FG002|Base Study Vaccination Period|Moved|0|||
126158225|NCT00090285|453866870|FG003|Base Study Vaccination Period|Moved|0|||
126158226|NCT00090285|453866871|FG004|Base Study Vaccination Period|Moved|0|||
126158227|NCT00090285|453866872|FG005|Base Study Vaccination Period|Moved|0|||
126158228|NCT00090285|453866867|FG000|Base Study Vaccination Period|Site Terminated|1|||
126158229|NCT00090285|453866868|FG001|Base Study Vaccination Period|Site Terminated|0|||
126158230|NCT00090285|453866869|FG002|Base Study Vaccination Period|Site Terminated|0|||
126158231|NCT00090285|453866870|FG003|Base Study Vaccination Period|Site Terminated|0|||
126158232|NCT00090285|453866871|FG004|Base Study Vaccination Period|Site Terminated|0|||
126158233|NCT00090285|453866872|FG005|Base Study Vaccination Period|Site Terminated|0|||
126158234|NCT00090285|453866867|FG000|Base Study Vaccination Period|Other|2|||
126158235|NCT00090285|453866868|FG001|Base Study Vaccination Period|Other|2|||
126158236|NCT00090285|453866869|FG002|Base Study Vaccination Period|Other|0|||
126158237|NCT00090285|453866870|FG003|Base Study Vaccination Period|Other|0|||
126158238|NCT00090285|453866871|FG004|Base Study Vaccination Period|Other|0|||
126158239|NCT00090285|453866872|FG005|Base Study Vaccination Period|Other|0|||
126158240|NCT00090285|453866867|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
126158241|NCT00090285|453866868|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
126158242|NCT00090285|453866869|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
126158243|NCT00090285|453866870|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
126158244|NCT00090285|453866871|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
126158245|NCT00090285|453866872|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
126158246|NCT00090285|453866867|FG000|Base Study Vaccination Period|HIV positive|1|||
126158247|NCT00090285|453866868|FG001|Base Study Vaccination Period|HIV positive|1|||
126158248|NCT00090285|453866869|FG002|Base Study Vaccination Period|HIV positive|0|||
126158249|NCT00090285|453866870|FG003|Base Study Vaccination Period|HIV positive|0|||
126158250|NCT00090285|453866871|FG004|Base Study Vaccination Period|HIV positive|0|||
126158251|NCT00090285|453866872|FG005|Base Study Vaccination Period|HIV positive|0|||
126158252|NCT00090285|453866867|FG000|Base Study Follow-up Period|Adverse Event|3|||
126158253|NCT00090285|453866868|FG001|Base Study Follow-up Period|Adverse Event|10|||
126158254|NCT00090285|453866869|FG002|Base Study Follow-up Period|Adverse Event|0|||
126158255|NCT00090285|453866870|FG003|Base Study Follow-up Period|Adverse Event|0|||
126158256|NCT00090285|453866871|FG004|Base Study Follow-up Period|Adverse Event|0|||
126158257|NCT00090285|453866872|FG005|Base Study Follow-up Period|Adverse Event|0|||
126158258|NCT00090285|453866867|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
126158259|NCT00090285|453866868|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
126158260|NCT00090285|453866869|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
126158261|NCT00090285|453866870|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
126158262|NCT00090285|453866871|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
126158263|NCT00090285|453866872|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
126158264|NCT00090285|453866867|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
126158265|NCT00090285|453866868|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
126158266|NCT00090285|453866869|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
126158267|NCT00090285|453866870|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
126158268|NCT00090285|453866871|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
126158269|NCT00090285|453866872|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
126158270|NCT00090285|453866867|FG000|Base Study Follow-up Period|Moved|41|||
126158271|NCT00090285|453866868|FG001|Base Study Follow-up Period|Moved|36|||
126158272|NCT00090285|453866869|FG002|Base Study Follow-up Period|Moved|0|||
126158273|NCT00090285|453866870|FG003|Base Study Follow-up Period|Moved|0|||
126158274|NCT00090285|453866871|FG004|Base Study Follow-up Period|Moved|0|||
126158275|NCT00090285|453866872|FG005|Base Study Follow-up Period|Moved|0|||
126158276|NCT00090285|453866867|FG000|Base Study Follow-up Period|Other|2|||
126158277|NCT00090285|453866868|FG001|Base Study Follow-up Period|Other|0|||
126158278|NCT00090285|453866869|FG002|Base Study Follow-up Period|Other|0|||
126158279|NCT00090285|453866870|FG003|Base Study Follow-up Period|Other|0|||
126158280|NCT00090285|453866871|FG004|Base Study Follow-up Period|Other|0|||
126158281|NCT00090285|453866872|FG005|Base Study Follow-up Period|Other|0|||
126158282|NCT00090285|453866867|FG000|Base Study Follow-up Period|Protocol Violation|1|||
126158283|NCT00090285|453866868|FG001|Base Study Follow-up Period|Protocol Violation|0|||
126158284|NCT00090285|453866869|FG002|Base Study Follow-up Period|Protocol Violation|0|||
126158285|NCT00090285|453866870|FG003|Base Study Follow-up Period|Protocol Violation|0|||
126158286|NCT00090285|453866871|FG004|Base Study Follow-up Period|Protocol Violation|0|||
126158287|NCT00090285|453866872|FG005|Base Study Follow-up Period|Protocol Violation|0|||
126158288|NCT00090285|453866867|FG000|Base Study Follow-up Period|Uncooperative|3|||
126158289|NCT00090285|453866868|FG001|Base Study Follow-up Period|Uncooperative|4|||
126158290|NCT00090285|453866869|FG002|Base Study Follow-up Period|Uncooperative|0|||
126158291|NCT00090285|453866870|FG003|Base Study Follow-up Period|Uncooperative|0|||
126158292|NCT00090285|453866871|FG004|Base Study Follow-up Period|Uncooperative|0|||
126158293|NCT00090285|453866872|FG005|Base Study Follow-up Period|Uncooperative|0|||
126158294|NCT00090285|453866867|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
126158295|NCT00090285|453866868|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
126158296|NCT00090285|453866869|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
126158297|NCT00090285|453866870|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
126158298|NCT00090285|453866871|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
126158299|NCT00090285|453866872|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
126158300|NCT00090285|453866867|FG000|Extension 1|Adverse Event|0|||
126158301|NCT00090285|453866868|FG001|Extension 1|Adverse Event|0|||
126158302|NCT00090285|453866869|FG002|Extension 1|Adverse Event|2|||
126158303|NCT00090285|453866870|FG003|Extension 1|Adverse Event|0|||
126158304|NCT00090285|453866871|FG004|Extension 1|Adverse Event|0|||
126158305|NCT00090285|453866872|FG005|Extension 1|Adverse Event|0|||
126158306|NCT00090285|453866867|FG000|Extension 1|Lost to Follow-up|0|||
126158307|NCT00090285|453866868|FG001|Extension 1|Lost to Follow-up|0|||
126158308|NCT00090285|453866869|FG002|Extension 1|Lost to Follow-up|35|||
126158309|NCT00090285|453866870|FG003|Extension 1|Lost to Follow-up|0|||
126158310|NCT00090285|453866871|FG004|Extension 1|Lost to Follow-up|0|||
126158311|NCT00090285|453866872|FG005|Extension 1|Lost to Follow-up|0|||
126158312|NCT00090285|453866867|FG000|Extension 1|Withdrawal by Subject|0|||
126158313|NCT00090285|453866868|FG001|Extension 1|Withdrawal by Subject|0|||
126158314|NCT00090285|453866869|FG002|Extension 1|Withdrawal by Subject|13|||
126158315|NCT00090285|453866870|FG003|Extension 1|Withdrawal by Subject|1|||
126158316|NCT00090285|453866871|FG004|Extension 1|Withdrawal by Subject|0|||
126158317|NCT00090285|453866872|FG005|Extension 1|Withdrawal by Subject|0|||
126158318|NCT00090285|453866867|FG000|Extension 1|Other|0|||
126158319|NCT00090285|453866868|FG001|Extension 1|Other|0|||
126158320|NCT00090285|453866869|FG002|Extension 1|Other|4|||
126158321|NCT00090285|453866870|FG003|Extension 1|Other|0|||
126158322|NCT00090285|453866871|FG004|Extension 1|Other|0|||
126158323|NCT00090285|453866872|FG005|Extension 1|Other|0|||
126158324|NCT00090285|453866867|FG000|Extension 1|Moved|0|||
126158325|NCT00090285|453866868|FG001|Extension 1|Moved|0|||
126158326|NCT00090285|453866869|FG002|Extension 1|Moved|3|||
126158327|NCT00090285|453866870|FG003|Extension 1|Moved|0|||
126158328|NCT00090285|453866871|FG004|Extension 1|Moved|0|||
126158329|NCT00090285|453866872|FG005|Extension 1|Moved|0|||
126158330|NCT00090285|453866867|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
126158331|NCT00090285|453866868|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
126158332|NCT00090285|453866869|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
126158333|NCT00090285|453866870|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
126158334|NCT00090285|453866871|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
126158335|NCT00090285|453866872|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
126158336|NCT00090285|453866867|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126158337|NCT00090285|453866868|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126158338|NCT00090285|453866869|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126158339|NCT00090285|453866870|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126158340|NCT00090285|453866871|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
126158341|NCT00090285|453866872|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
126158342|NCT00090285|453866867|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126158343|NCT00090285|453866868|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126158344|NCT00090285|453866869|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126158345|NCT00090285|453866870|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126158346|NCT00090285|453866871|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
126158347|NCT00090285|453866872|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
126158348|NCT00090285|453866867|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
126158349|NCT00090285|453866868|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
126158350|NCT00090285|453866869|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
126158351|NCT00090285|453866870|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
126158352|NCT00090285|453866871|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
126158353|NCT00090285|453866872|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
126158354|NCT00907478|453866873|FG000|Overall Study|Ineligibility determined|0|||
126158355|NCT00907478|453866874|FG001|Overall Study|Ineligibility determined|0|||
126158356|NCT00907478|453866875|FG002|Overall Study|Ineligibility determined|1|||
126158357|NCT00907478|453866873|FG000|Overall Study|Noncompliance|0|||
126158358|NCT00907478|453866874|FG001|Overall Study|Noncompliance|0|||
126158359|NCT00907478|453866875|FG002|Overall Study|Noncompliance|1|||
126158360|NCT00907478|453866873|FG000|Overall Study|Adverse Event|3|||
126158361|NCT00907478|453866874|FG001|Overall Study|Adverse Event|1|||
126158362|NCT00907478|453866875|FG002|Overall Study|Adverse Event|2|||
126158363|NCT00907478|453866873|FG000|Overall Study|Withdrawal by Subject|8|||
126158364|NCT00907478|453866874|FG001|Overall Study|Withdrawal by Subject|9|||
126158365|NCT00907478|453866875|FG002|Overall Study|Withdrawal by Subject|6|||
126158366|NCT00907478|453866873|FG000|Overall Study|Requirement for alternative therapy|1|||
126158367|NCT00907478|453866874|FG001|Overall Study|Requirement for alternative therapy|2|||
126158368|NCT00907478|453866875|FG002|Overall Study|Requirement for alternative therapy|3|||
126158369|NCT00907478|453866873|FG000|Overall Study|Physician Decision|2|||
126158370|NCT00907478|453866874|FG001|Overall Study|Physician Decision|0|||
126158371|NCT00907478|453866875|FG002|Overall Study|Physician Decision|3|||
126158372|NCT00907478|453866873|FG000|Overall Study|Death|4|||
126158373|NCT00907478|453866874|FG001|Overall Study|Death|2|||
126158374|NCT00907478|453866875|FG002|Overall Study|Death|1|||
126158375|NCT00907478|453866873|FG000|Overall Study|Protocol-specified criteria|5|||
126158376|NCT00907478|453866874|FG001|Overall Study|Protocol-specified criteria|2|||
126158377|NCT00907478|453866875|FG002|Overall Study|Protocol-specified criteria|3|||
126158378|NCT00907478|453866873|FG000|Overall Study|Pregnancy|0|||
126158379|NCT00907478|453866874|FG001|Overall Study|Pregnancy|1|||
126158380|NCT00907478|453866875|FG002|Overall Study|Pregnancy|1|||
126158381|NCT00907478|453866873|FG000|Overall Study|Lost to Follow-up|1|||
126158382|NCT00907478|453866874|FG001|Overall Study|Lost to Follow-up|0|||
126158383|NCT00907478|453866875|FG002|Overall Study|Lost to Follow-up|0|||
126158384|NCT00907478|453866873|FG000|Overall Study|Other|3|||
126158385|NCT00907478|453866874|FG001|Overall Study|Other|0|||
126158386|NCT00907478|453866875|FG002|Overall Study|Other|1|||
126158387|NCT02639182|453866876|FG000|Overall Study|Disease Progression|50|||
126158388|NCT02639182|453866877|FG001|Overall Study|Disease Progression|49|||
126158389|NCT02639182|453866876|FG000|Overall Study|Adverse Event|7|||
126158390|NCT02639182|453866877|FG001|Overall Study|Adverse Event|5|||
126158391|NCT02639182|453866876|FG000|Overall Study|Physician Decision|3|||
126158392|NCT02639182|453866877|FG001|Overall Study|Physician Decision|3|||
126158393|NCT02639182|453866876|FG000|Overall Study|Withdrew Consent|5|||
126158394|NCT02639182|453866877|FG001|Overall Study|Withdrew Consent|4|||
126158395|NCT02639182|453866876|FG000|Overall Study|Lost to Follow-up|0|||
126158396|NCT02639182|453866877|FG001|Overall Study|Lost to Follow-up|1|||
126158397|NCT02639182|453866876|FG000|Overall Study|Study Closure|1|||
126158398|NCT02639182|453866877|FG001|Overall Study|Study Closure|2|||
126158399|NCT02639182|453866876|FG000|Overall Study|Sponsor Ended Study|0|||
126158400|NCT02639182|453866877|FG001|Overall Study|Sponsor Ended Study|1|||
126158401|NCT02639182|453866876|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
126158402|NCT02639182|453866877|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
126158403|NCT03069690|453866878|FG000|Pregnancy Intervention|Pregnancy loss|9|||
126158404|NCT03069690|453866879|FG001|Pregnancy Intervention|Pregnancy loss|4|||
126158405|NCT03069690|453866880|FG002|Pregnancy Intervention|Pregnancy loss|0|||
126158406|NCT03069690|453866881|FG003|Pregnancy Intervention|Pregnancy loss|0|||
126158407|NCT03069690|453866882|FG004|Pregnancy Intervention|Pregnancy loss|0|||
126158408|NCT03069690|453866883|FG005|Pregnancy Intervention|Pregnancy loss|0|||
126158409|NCT03069690|453866878|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
126158410|NCT03069690|453866879|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
126158411|NCT03069690|453866880|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
126158412|NCT03069690|453866881|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
126158413|NCT03069690|453866882|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
126158414|NCT03069690|453866883|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
126158415|NCT03069690|453866878|FG000|Postpartum Intervention|Lost to Follow-up|0|||
126158416|NCT03069690|453866879|FG001|Postpartum Intervention|Lost to Follow-up|0|||
126158417|NCT03069690|453866880|FG002|Postpartum Intervention|Lost to Follow-up|5|||
126158418|NCT03069690|453866881|FG003|Postpartum Intervention|Lost to Follow-up|5|||
126158419|NCT03069690|453866882|FG004|Postpartum Intervention|Lost to Follow-up|2|||
126158420|NCT03069690|453866883|FG005|Postpartum Intervention|Lost to Follow-up|4|||
126158421|NCT01372878|453866884|FG000|Overall Study|Withdrawal by Subject|63|||
126158422|NCT01372878|453866884|FG000|Overall Study|Protocol Violation|17|||
126158423|NCT01372878|453866884|FG000|Overall Study|incomplete study procedure|104|||
126158424|NCT04498910|453866885|FG000|Overall Study|Lost to Follow-up|0|||
126158425|NCT04498910|453866886|FG001|Overall Study|Lost to Follow-up|1|||
126158426|NCT04498910|453866885|FG000|Overall Study|Withdrawal by Subject|2|||
126158427|NCT04498910|453866886|FG001|Overall Study|Withdrawal by Subject|1|||
126158428|NCT04498910|453866885|FG000|Overall Study|Adverse Event|1|||
126158429|NCT04498910|453866886|FG001|Overall Study|Adverse Event|0|||
126158430|NCT01849848|453866887|FG000|Overall Study|Physician Decision|1|||
126158431|NCT01849848|453866887|FG000|Overall Study|Progression of the primary disease|3|||
126158432|NCT01070303|453866888|FG000|Overall Study|Adverse Event|39|||
126158433|NCT01070303|453866888|FG000|Overall Study|Withdrawal by Subject|20|||
126158434|NCT01070303|453866888|FG000|Overall Study|Lost to Follow-up|9|||
126158435|NCT01070303|453866888|FG000|Overall Study|Protocol Violation|0|||
126158436|NCT01070303|453866888|FG000|Overall Study|Lack of Efficacy|2|||
126158437|NCT01070303|453866888|FG000|Overall Study|Administrative Reason|1|||
126158438|NCT01070303|453866888|FG000|Overall Study|Other|18|||
126158439|NCT02926573|453866890|FG000|Overall Study|Nausea|1|||
126158440|NCT02926573|453866891|FG001|Overall Study|Nausea|0|||
126158441|NCT02926573|453866890|FG000|Overall Study|Remain intubated|2|||
126158442|NCT02926573|453866891|FG001|Overall Study|Remain intubated|2|||
126158443|NCT02926573|453866890|FG000|Overall Study|Change in surgery plan|3|||
126158444|NCT02926573|453866891|FG001|Overall Study|Change in surgery plan|1|||
126158445|NCT02926573|453866890|FG000|Overall Study|Change to outpatient status|5|||
126158446|NCT02926573|453866891|FG001|Overall Study|Change to outpatient status|1|||
126158447|NCT02926573|453866890|FG000|Overall Study|Withdrawal by Subject|0|||
126158448|NCT02926573|453866891|FG001|Overall Study|Withdrawal by Subject|2|||
126158449|NCT02926573|453866890|FG000|Overall Study|Return to operating room|0|||
126158450|NCT02926573|453866891|FG001|Overall Study|Return to operating room|2|||
126158451|NCT02926573|453866890|FG000|Overall Study|Delirium|0|||
126158452|NCT02926573|453866891|FG001|Overall Study|Delirium|1|||
126158453|NCT01302769|453866900|FG000|Overall Study|Lost to Follow-up|1|||
126158454|NCT01302769|453866901|FG001|Overall Study|Lost to Follow-up|1|||
126158455|NCT00510692|453866908|FG000|Overall Study|Adverse Event|1|||
126158456|NCT00510692|453866909|FG001|Overall Study|Adverse Event|3|||
126158457|NCT00510692|453866908|FG000|Overall Study|Withdrawal by Subject|1|||
126158458|NCT00510692|453866909|FG001|Overall Study|Withdrawal by Subject|0|||
126158459|NCT01845077|453866912|FG000|Washout Period|Lost to Follow-up|0|||
126158460|NCT01845077|453866913|FG001|Washout Period|Lost to Follow-up|1|||
126158461|NCT01845077|453866914|FG002|Washout Period|Lost to Follow-up|0|||
126158462|NCT01845077|453866915|FG003|Washout Period|Lost to Follow-up|1|||
126158463|NCT01845077|453866916|FG004|Washout Period|Lost to Follow-up|0|||
126158464|NCT01845077|453866917|FG005|Washout Period|Lost to Follow-up|1|||
126158465|NCT01845077|453866912|FG000|Washout Period|Adverse Event|1|||
126158466|NCT01845077|453866913|FG001|Washout Period|Adverse Event|0|||
126158467|NCT01845077|453866914|FG002|Washout Period|Adverse Event|0|||
126158468|NCT01845077|453866915|FG003|Washout Period|Adverse Event|0|||
126158469|NCT01845077|453866916|FG004|Washout Period|Adverse Event|0|||
126158470|NCT01845077|453866917|FG005|Washout Period|Adverse Event|0|||
126158471|NCT01845077|453866912|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
126158472|NCT01845077|453866913|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
126158473|NCT01845077|453866914|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
126158474|NCT01845077|453866915|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
126158475|NCT01845077|453866916|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
126158476|NCT01845077|453866917|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
126158477|NCT01845077|453866912|FG000|Washout Period|Protocol Violation|0|||
126158478|NCT01845077|453866913|FG001|Washout Period|Protocol Violation|0|||
126158479|NCT01845077|453866914|FG002|Washout Period|Protocol Violation|0|||
126158480|NCT01845077|453866915|FG003|Washout Period|Protocol Violation|1|||
126158481|NCT01845077|453866916|FG004|Washout Period|Protocol Violation|1|||
126158482|NCT01845077|453866917|FG005|Washout Period|Protocol Violation|0|||
126158483|NCT00394914|453866918|FG000|Treatment Period|Adverse Event|0|||
126158484|NCT00394914|453866919|FG001|Treatment Period|Adverse Event|3|||
126158485|NCT00394914|453866920|FG002|Treatment Period|Adverse Event|1|||
126158486|NCT00394914|453866918|FG000|Treatment Period|Lost to Follow-up|0|||
125971961|NCT01221597|453186720|FG000|Overall Study|Withdrawal by Subject|20|||
125971962|NCT01221597|453186721|FG001|Overall Study|Withdrawal by Subject|6|||
125971963|NCT01221597|453186720|FG000|Overall Study|Lost to Follow-up|6|||
125971964|NCT01221597|453186721|FG001|Overall Study|Lost to Follow-up|5|||
126158487|NCT00394914|453866919|FG001|Treatment Period|Lost to Follow-up|1|||
126158488|NCT00394914|453866920|FG002|Treatment Period|Lost to Follow-up|0|||
125971965|NCT01221597|453186720|FG000|Overall Study|Protocol Violation|1|||
126158489|NCT00394914|453866918|FG000|Treatment Period|Withdrawal by Subject|0|||
126158490|NCT00394914|453866919|FG001|Treatment Period|Withdrawal by Subject|2|||
126158491|NCT00394914|453866920|FG002|Treatment Period|Withdrawal by Subject|2|||
126158492|NCT00394914|453866918|FG000|Treatment Period|Noncompliance with protocol|0|||
126158493|NCT00394914|453866919|FG001|Treatment Period|Noncompliance with protocol|3|||
126158494|NCT00394914|453866920|FG002|Treatment Period|Noncompliance with protocol|2|||
126158495|NCT00394914|453866918|FG000|Treatment Period|Did not meet protocol eligibility|0|||
126158496|NCT00394914|453866919|FG001|Treatment Period|Did not meet protocol eligibility|1|||
126158497|NCT00394914|453866920|FG002|Treatment Period|Did not meet protocol eligibility|1|||
126158498|NCT00312377|453866926|FG000|Overall Study|Death|403|||
125971966|NCT01221597|453186721|FG001|Overall Study|Protocol Violation|0|||
126158499|NCT00312377|453866927|FG001|Overall Study|Death|418|||
126158500|NCT00312377|453866926|FG000|Overall Study|Withdrawal by Subject|23|||
126158501|NCT00312377|453866927|FG001|Overall Study|Withdrawal by Subject|30|||
126158502|NCT00312377|453866926|FG000|Overall Study|Lost to Follow-up|9|||
126158503|NCT00312377|453866927|FG001|Overall Study|Lost to Follow-up|12|||
126158504|NCT00312377|453866926|FG000|Overall Study|Non-compliance|0|||
126158505|NCT00312377|453866927|FG001|Overall Study|Non-compliance|2|||
126158506|NCT00312377|453866926|FG000|Overall Study|Randomised but never received treatment|6|||
126158507|NCT00312377|453866927|FG001|Overall Study|Randomised but never received treatment|6|||
126158508|NCT00312377|453866926|FG000|Overall Study|Discontinue treatment survival follow up|202|||
126158509|NCT00312377|453866927|FG001|Overall Study|Discontinue treatment survival follow up|200|||
126158510|NCT00312377|453866926|FG000|Overall Study|Site ended participation in study|1|||
126158511|NCT00312377|453866927|FG001|Overall Study|Site ended participation in study|0|||
126158512|NCT00872898|453866928|FG000|Part Two - Double Blind|Adverse Event|4|||
126158513|NCT00872898|453866929|FG001|Part Two - Double Blind|Adverse Event|3|||
126158514|NCT00872898|453866928|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
126158515|NCT00872898|453866929|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
126158516|NCT00872898|453866928|FG000|Part Two - Double Blind|Protocol Violation|1|||
126158517|NCT00872898|453866929|FG001|Part Two - Double Blind|Protocol Violation|0|||
126158518|NCT00872898|453866928|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
126158519|NCT00872898|453866929|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
126158520|NCT00872898|453866928|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
126158521|NCT00872898|453866929|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
126158522|NCT00872898|453866928|FG000|Part Two - Double Blind|Other reasons|2|||
126158523|NCT00872898|453866929|FG001|Part Two - Double Blind|Other reasons|0|||
126158524|NCT01001494|453866940|FG000|Overall Study|Adverse Event|8|||
126158525|NCT01001494|453866941|FG001|Overall Study|Adverse Event|4|||
126158526|NCT01001494|453866942|FG002|Overall Study|Adverse Event|6|||
126158527|NCT01001494|453866940|FG000|Overall Study|Protocol Violation|0|||
126158528|NCT01001494|453866941|FG001|Overall Study|Protocol Violation|1|||
126158529|NCT01001494|453866942|FG002|Overall Study|Protocol Violation|1|||
126158530|NCT01001494|453866940|FG000|Overall Study|Lost to Follow-up|2|||
126158531|NCT01001494|453866941|FG001|Overall Study|Lost to Follow-up|0|||
126158532|NCT01001494|453866942|FG002|Overall Study|Lost to Follow-up|1|||
126158533|NCT01001494|453866940|FG000|Overall Study|Withdrawal by Subject|9|||
126158534|NCT01001494|453866941|FG001|Overall Study|Withdrawal by Subject|7|||
126158535|NCT01001494|453866942|FG002|Overall Study|Withdrawal by Subject|17|||
126158536|NCT01001494|453866940|FG000|Overall Study|COPD exacerbation|3|||
126158537|NCT01001494|453866941|FG001|Overall Study|COPD exacerbation|4|||
126158538|NCT01001494|453866942|FG002|Overall Study|COPD exacerbation|5|||
126158539|NCT01001494|453866940|FG000|Overall Study|Lack of Efficacy|2|||
126158540|NCT01001494|453866941|FG001|Overall Study|Lack of Efficacy|0|||
126158541|NCT01001494|453866942|FG002|Overall Study|Lack of Efficacy|8|||
125971967|NCT01221597|453186720|FG000|Overall Study|Other|3|||
125971968|NCT01221597|453186721|FG001|Overall Study|Other|4|||
125971969|NCT01221597|453186720|FG000|Overall Study|Death|2|||
125971970|NCT01221597|453186721|FG001|Overall Study|Death|0|||
125971971|NCT00487162|453186723|FG000|Overall Study|Adverse Event|0|||
125971972|NCT00487162|453186724|FG001|Overall Study|Adverse Event|1|||
125971973|NCT00487162|453186723|FG000|Overall Study|Physician Decision|0|||
125971974|NCT00487162|453186724|FG001|Overall Study|Physician Decision|1|||
125971975|NCT00487162|453186723|FG000|Overall Study|Withdrawal by Subject|2|||
125971976|NCT00487162|453186724|FG001|Overall Study|Withdrawal by Subject|3|||
125971977|NCT02278328|453186726|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
125971978|NCT02278328|453186727|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
125971979|NCT02278328|453186728|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
125971980|NCT02278328|453186726|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
125971981|NCT02278328|453186727|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
125971982|NCT02278328|453186728|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
125971983|NCT02278328|453186726|FG000|Neuropsych Screening|incomplete consent|0|||
125971984|NCT02278328|453186727|FG001|Neuropsych Screening|incomplete consent|0|||
125971985|NCT02278328|453186728|FG002|Neuropsych Screening|incomplete consent|2|||
125971986|NCT03834779|453186734|FG000|Overall Study|Death|1|||
125971987|NCT03834779|453186735|FG001|Overall Study|Death|2|||
125971988|NCT03834779|453186734|FG000|Overall Study|Lost to Follow-up|6|||
125971989|NCT03834779|453186735|FG001|Overall Study|Lost to Follow-up|4|||
125971990|NCT01292928|453186736|FG000|Overall Study|Death|8|||
126158542|NCT01001494|453866940|FG000|Overall Study|Other|0|||
126158543|NCT01001494|453866941|FG001|Overall Study|Other|1|||
126158544|NCT01001494|453866942|FG002|Overall Study|Other|3|||
126158545|NCT02179398|453866943|FG000|Overall Study|Lack of obligatory data|3|||
126158546|NCT02179398|453866944|FG001|Overall Study|Lack of obligatory data|3|||
126158547|NCT02179398|453866943|FG000|Overall Study|Lost to Follow-up|0|||
126158548|NCT02179398|453866944|FG001|Overall Study|Lost to Follow-up|1|||
126158549|NCT02519231|453866948|FG000|Overall Study|Lost to Follow-up|2|||
126158550|NCT02519231|453866949|FG001|Overall Study|Lost to Follow-up|5|||
126158551|NCT02519231|453866948|FG000|Overall Study|Withdrawal by Subject|0|||
126158552|NCT02519231|453866949|FG001|Overall Study|Withdrawal by Subject|1|||
126158553|NCT02124798|453866951|FG000|Overall Study|Adverse Event|3|||
126158554|NCT02124798|453866951|FG000|Overall Study|Lost to Follow-up|1|||
126158555|NCT01797432|453866954|FG000|Overall Study|Lost to Follow-up|1|||
126158556|NCT01797432|453866954|FG000|Overall Study|Adverse Event|1|||
126158557|NCT01797432|453866954|FG000|Overall Study|Withdrawal by Subject|1|||
126158558|NCT01797432|453866954|FG000|Overall Study|lived too far from study site|1|||
126158559|NCT02795156|453866956|FG000|Overall Study|Progressive Disease|22|||
126158560|NCT02795156|453866957|FG001|Overall Study|Progressive Disease|7|||
126158561|NCT02795156|453866958|FG002|Overall Study|Progressive Disease|34|||
126158562|NCT02795156|453866959|FG003|Overall Study|Progressive Disease|7|||
126158563|NCT02795156|453866956|FG000|Overall Study|Adverse Event|13|||
126158564|NCT02795156|453866957|FG001|Overall Study|Adverse Event|2|||
126158565|NCT02795156|453866958|FG002|Overall Study|Adverse Event|3|||
126158566|NCT02795156|453866959|FG003|Overall Study|Adverse Event|2|||
126158567|NCT02795156|453866956|FG000|Overall Study|Death|1|||
126089243|NCT04047862|453620103|FG001|Overall Study|Physician Decision|0|||
126089244|NCT04047862|453620104|FG002|Overall Study|Physician Decision|0|||
126089245|NCT04047862|453620105|FG003|Overall Study|Physician Decision|1|||
126089246|NCT04047862|453620106|FG004|Overall Study|Physician Decision|0|||
126089247|NCT04047862|453620107|FG005|Overall Study|Physician Decision|0|||
126089248|NCT04047862|453620108|FG006|Overall Study|Physician Decision|0|||
126089249|NCT04047862|453620109|FG007|Overall Study|Physician Decision|0|||
126089250|NCT04047862|453620110|FG008|Overall Study|Physician Decision|0|||
126089251|NCT04047862|453620111|FG009|Overall Study|Physician Decision|0|||
126089252|NCT04047862|453620112|FG010|Overall Study|Physician Decision|0|||
126089253|NCT04047862|453620113|FG011|Overall Study|Physician Decision|0|||
126089254|NCT04047862|453620114|FG012|Overall Study|Physician Decision|0|||
126089255|NCT04047862|453620115|FG013|Overall Study|Physician Decision|0|||
126089256|NCT04047862|453620116|FG014|Overall Study|Physician Decision|1|||
126089257|NCT04047862|453620117|FG015|Overall Study|Physician Decision|0|||
126089258|NCT04047862|453620118|FG016|Overall Study|Physician Decision|1|||
126089259|NCT04047862|453620119|FG017|Overall Study|Physician Decision|0|||
126089260|NCT04047862|453620120|FG018|Overall Study|Physician Decision|0|||
126089261|NCT04047862|453620102|FG000|Overall Study|Completed all Assessments|1|||
126089262|NCT04047862|453620103|FG001|Overall Study|Completed all Assessments|3|||
126089263|NCT04047862|453620104|FG002|Overall Study|Completed all Assessments|1|||
126089264|NCT04047862|453620105|FG003|Overall Study|Completed all Assessments|3|||
126089265|NCT04047862|453620106|FG004|Overall Study|Completed all Assessments|2|||
126089266|NCT04047862|453620107|FG005|Overall Study|Completed all Assessments|5|||
126089267|NCT04047862|453620108|FG006|Overall Study|Completed all Assessments|7|||
126089268|NCT04047862|453620109|FG007|Overall Study|Completed all Assessments|0|||
126089269|NCT04047862|453620110|FG008|Overall Study|Completed all Assessments|0|||
126089270|NCT04047862|453620111|FG009|Overall Study|Completed all Assessments|0|||
126089271|NCT04047862|453620112|FG010|Overall Study|Completed all Assessments|0|||
126089272|NCT04047862|453620113|FG011|Overall Study|Completed all Assessments|0|||
126089273|NCT04047862|453620114|FG012|Overall Study|Completed all Assessments|0|||
126089274|NCT04047862|453620115|FG013|Overall Study|Completed all Assessments|0|||
126089275|NCT04047862|453620116|FG014|Overall Study|Completed all Assessments|0|||
126089276|NCT04047862|453620117|FG015|Overall Study|Completed all Assessments|0|||
126089277|NCT04047862|453620118|FG016|Overall Study|Completed all Assessments|0|||
126089278|NCT04047862|453620119|FG017|Overall Study|Completed all Assessments|0|||
126089279|NCT04047862|453620120|FG018|Overall Study|Completed all Assessments|0|||
126089280|NCT04047862|453620102|FG000|Overall Study|Sponsor Decision|0|||
126089281|NCT04047862|453620103|FG001|Overall Study|Sponsor Decision|0|||
126089282|NCT04047862|453620104|FG002|Overall Study|Sponsor Decision|0|||
126089283|NCT04047862|453620105|FG003|Overall Study|Sponsor Decision|0|||
126089284|NCT04047862|453620106|FG004|Overall Study|Sponsor Decision|0|||
126089285|NCT04047862|453620107|FG005|Overall Study|Sponsor Decision|0|||
126089286|NCT04047862|453620108|FG006|Overall Study|Sponsor Decision|0|||
126089287|NCT04047862|453620109|FG007|Overall Study|Sponsor Decision|13|||
126089288|NCT04047862|453620110|FG008|Overall Study|Sponsor Decision|10|||
126089289|NCT04047862|453620111|FG009|Overall Study|Sponsor Decision|18|||
126089290|NCT04047862|453620112|FG010|Overall Study|Sponsor Decision|3|||
126089291|NCT04047862|453620113|FG011|Overall Study|Sponsor Decision|3|||
126089292|NCT04047862|453620114|FG012|Overall Study|Sponsor Decision|4|||
126089293|NCT04047862|453620115|FG013|Overall Study|Sponsor Decision|0|||
126089294|NCT04047862|453620116|FG014|Overall Study|Sponsor Decision|7|||
126089295|NCT04047862|453620117|FG015|Overall Study|Sponsor Decision|8|||
126089296|NCT04047862|453620118|FG016|Overall Study|Sponsor Decision|9|||
126089297|NCT04047862|453620119|FG017|Overall Study|Sponsor Decision|7|||
126089298|NCT04047862|453620120|FG018|Overall Study|Sponsor Decision|8|||
126089299|NCT04047862|453620102|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089300|NCT04047862|453620103|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089301|NCT04047862|453620104|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089302|NCT04047862|453620105|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089303|NCT04047862|453620106|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126158568|NCT02795156|453866957|FG001|Overall Study|Death|1|||
126158569|NCT02795156|453866958|FG002|Overall Study|Death|1|||
126158570|NCT02795156|453866959|FG003|Overall Study|Death|0|||
126158571|NCT02795156|453866956|FG000|Overall Study|Physician Decision|1|||
126158572|NCT02795156|453866957|FG001|Overall Study|Physician Decision|0|||
126158573|NCT02795156|453866958|FG002|Overall Study|Physician Decision|1|||
126158574|NCT02795156|453866959|FG003|Overall Study|Physician Decision|0|||
126158575|NCT02795156|453866956|FG000|Overall Study|Withdrawal by Subject|2|||
126158576|NCT02795156|453866957|FG001|Overall Study|Withdrawal by Subject|0|||
126158577|NCT02795156|453866958|FG002|Overall Study|Withdrawal by Subject|3|||
126158578|NCT02795156|453866959|FG003|Overall Study|Withdrawal by Subject|0|||
126158579|NCT00815308|453866960|FG000|Overall Study|Adverse Event|4|||
126158580|NCT00815308|453866960|FG000|Overall Study|Withdrawal by Subject|0|||
126158581|NCT00815308|453866960|FG000|Overall Study|Protocol Violation|6|||
126158582|NCT01137435|453866961|FG000|Overall Study|Lost to Follow-up|24|||
126158583|NCT01137435|453866961|FG000|Overall Study|Off label usage|4|||
126158584|NCT00487279|453866970|FG000|Overall Study|Death|1|||
126158585|NCT00487279|453866971|FG001|Overall Study|Death|0|||
126158586|NCT00487279|453866970|FG000|Overall Study|Withdrawal by Subject|0|||
126158587|NCT00487279|453866971|FG001|Overall Study|Withdrawal by Subject|2|||
126158588|NCT01416610|453866972|FG000|Overall Study|Adverse Event|4|||
126158589|NCT01416610|453866972|FG000|Overall Study|Adverse Event -Patient decision|3|||
126158590|NCT01416610|453866972|FG000|Overall Study|Lack of Efficacy|4|||
126158591|NCT01416610|453866972|FG000|Overall Study|No reason given|5|||
126158592|NCT01416610|453866972|FG000|Overall Study|Withdrawal by Subject|13|||
126158593|NCT01416610|453866972|FG000|Overall Study|Lost to Follow-up|7|||
126158594|NCT01416610|453866972|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
126158595|NCT01927562|453866973|FG000|Overall Study|Lost to Follow-up|30|||
126158596|NCT01927562|453866973|FG000|Overall Study|Withdrawal by Subject|3|||
126158597|NCT01927562|453866973|FG000|Overall Study|Physician Decision|5|||
126158598|NCT00642616|453866974|FG000|Overall Study|Adverse Event|2|||
126158599|NCT00642616|453866975|FG001|Overall Study|Adverse Event|0|||
126158600|NCT00642616|453866976|FG002|Overall Study|Adverse Event|1|||
126158601|NCT00642616|453866977|FG003|Overall Study|Adverse Event|0|||
126158602|NCT00642616|453866974|FG000|Overall Study|Study Terminated by Sponsor|7|||
126158603|NCT00642616|453866975|FG001|Overall Study|Study Terminated by Sponsor|6|||
126158604|NCT00642616|453866976|FG002|Overall Study|Study Terminated by Sponsor|4|||
126158605|NCT00642616|453866977|FG003|Overall Study|Study Terminated by Sponsor|5|||
126158606|NCT00642616|453866974|FG000|Overall Study|Withdrawal by Subject|0|||
126158607|NCT00642616|453866975|FG001|Overall Study|Withdrawal by Subject|1|||
126158608|NCT00642616|453866976|FG002|Overall Study|Withdrawal by Subject|1|||
126158609|NCT00642616|453866977|FG003|Overall Study|Withdrawal by Subject|1|||
126158610|NCT00642616|453866974|FG000|Overall Study|Protocol Violation|0|||
126158611|NCT00642616|453866975|FG001|Overall Study|Protocol Violation|0|||
126158612|NCT00642616|453866976|FG002|Overall Study|Protocol Violation|2|||
126158613|NCT00642616|453866977|FG003|Overall Study|Protocol Violation|0|||
126158614|NCT00642616|453866974|FG000|Overall Study|Physician Decision|0|||
126158615|NCT00642616|453866975|FG001|Overall Study|Physician Decision|0|||
126158616|NCT00642616|453866976|FG002|Overall Study|Physician Decision|1|||
126158617|NCT00642616|453866977|FG003|Overall Study|Physician Decision|1|||
126158618|NCT00492921|453866978|FG000|Overall Study|Death|1|||
126158619|NCT00492921|453866979|FG001|Overall Study|Death|0|||
126158620|NCT00492921|453866980|FG002|Overall Study|Death|1|||
126158621|NCT00399802|453866981|FG000|Overall Study|Adverse Event|0|||
126158622|NCT00399802|453866982|FG001|Overall Study|Adverse Event|2|||
126158623|NCT00399802|453866981|FG000|Overall Study|Participant discontinued by mistake|0|||
126158624|NCT00399802|453866982|FG001|Overall Study|Participant discontinued by mistake|1|||
126158625|NCT02955186|453866983|FG000|Overall Study|Withdrawal by Subject|6|||
126158626|NCT02955186|453866984|FG001|Overall Study|Withdrawal by Subject|2|||
126158627|NCT02955186|453866983|FG000|Overall Study|Protocol Violation|1|||
126158628|NCT02955186|453866984|FG001|Overall Study|Protocol Violation|0|||
126158629|NCT00866294|453866985|FG000|Overall Study|Adverse Event|12|||
126158630|NCT00866294|453866986|FG001|Overall Study|Adverse Event|13|||
125971991|NCT01292928|453186736|FG000|Overall Study|Withdrawal by Subject|8|||
126158631|NCT00866294|453866987|FG002|Overall Study|Adverse Event|9|||
126158632|NCT00866294|453866985|FG000|Overall Study|Lack of Efficacy|7|||
126158633|NCT00866294|453866986|FG001|Overall Study|Lack of Efficacy|1|||
126158634|NCT00866294|453866987|FG002|Overall Study|Lack of Efficacy|0|||
126158635|NCT00866294|453866985|FG000|Overall Study|Protocol Violation|2|||
126158636|NCT00866294|453866986|FG001|Overall Study|Protocol Violation|0|||
126158637|NCT00866294|453866987|FG002|Overall Study|Protocol Violation|0|||
126158638|NCT00866294|453866985|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
126158639|NCT00866294|453866986|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126158640|NCT00866294|453866987|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126158641|NCT00866294|453866985|FG000|Overall Study|Lost to Follow-up|1|||
126158642|NCT00866294|453866986|FG001|Overall Study|Lost to Follow-up|3|||
126158643|NCT00866294|453866987|FG002|Overall Study|Lost to Follow-up|0|||
126158644|NCT00866294|453866985|FG000|Overall Study|Physician Decision|6|||
126158645|NCT00866294|453866986|FG001|Overall Study|Physician Decision|2|||
126158646|NCT00866294|453866987|FG002|Overall Study|Physician Decision|1|||
126158647|NCT01937130|453868551|FG000|Overall Study|Withdrawal by Subject|0|||
126158648|NCT01937130|453868552|FG001|Overall Study|Withdrawal by Subject|0|||
126158649|NCT01937130|453868553|FG002|Overall Study|Withdrawal by Subject|0|||
126158650|NCT01937130|453868554|FG003|Overall Study|Withdrawal by Subject|1|||
126158651|NCT01937130|453868551|FG000|Overall Study|Adverse Event|0|||
126158652|NCT01937130|453868552|FG001|Overall Study|Adverse Event|1|||
126158653|NCT01937130|453868553|FG002|Overall Study|Adverse Event|0|||
126158654|NCT01937130|453868554|FG003|Overall Study|Adverse Event|1|||
126158655|NCT01937130|453868551|FG000|Overall Study|Death|1|||
126158656|NCT01937130|453868552|FG001|Overall Study|Death|1|||
125971992|NCT01292928|453186736|FG000|Overall Study|Lost to Follow-up|6|||
125971993|NCT01292928|453186736|FG000|Overall Study|Physician Decision|2|||
125971994|NCT00130533|453186737|FG000|Overall Study|Withdrawal by Subject|33|||
125971995|NCT00130533|453186738|FG001|Overall Study|Withdrawal by Subject|6|||
125971996|NCT00130533|453186737|FG000|Overall Study|Adverse Event|34|||
125971997|NCT00130533|453186738|FG001|Overall Study|Adverse Event|1|||
125971998|NCT00130533|453186737|FG000|Overall Study|Disease relapse|9|||
125971999|NCT00130533|453186738|FG001|Overall Study|Disease relapse|13|||
125972000|NCT00130533|453186737|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
125972001|NCT00130533|453186738|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
125972002|NCT00130533|453186737|FG000|Overall Study|Death|4|||
125972003|NCT00130533|453186738|FG001|Overall Study|Death|2|||
125972004|NCT00130533|453186737|FG000|Overall Study|Protocol Violation|5|||
125972005|NCT00130533|453186738|FG001|Overall Study|Protocol Violation|1|||
125972006|NCT00130533|453186737|FG000|Overall Study|Lost to Follow-up|1|||
125972007|NCT00130533|453186738|FG001|Overall Study|Lost to Follow-up|1|||
125972008|NCT00130533|453186737|FG000|Overall Study|Sponsor´s decision|2|||
125972009|NCT00130533|453186738|FG001|Overall Study|Sponsor´s decision|0|||
125972010|NCT00130533|453186737|FG000|Overall Study|Second Primary Malignancy|0|||
125972011|NCT00130533|453186738|FG001|Overall Study|Second Primary Malignancy|1|||
125972012|NCT00130533|453186737|FG000|Overall Study|Other|12|||
125972013|NCT00130533|453186738|FG001|Overall Study|Other|5|||
125972014|NCT03263429|453186739|FG000|Overall Study|Withdrawal by Subject|0|||
125972015|NCT03263429|453186740|FG001|Overall Study|Withdrawal by Subject|1|||
125972016|NCT03263429|453186741|FG002|Overall Study|Withdrawal by Subject|0|||
125972017|NCT03263429|453186739|FG000|Overall Study|Follow-Up Period Completed|0|||
125972018|NCT03263429|453186740|FG001|Overall Study|Follow-Up Period Completed|2|||
125972019|NCT03263429|453186741|FG002|Overall Study|Follow-Up Period Completed|0|||
125972020|NCT03263429|453186739|FG000|Overall Study|Death|3|||
125972021|NCT03263429|453186740|FG001|Overall Study|Death|5|||
125972022|NCT03263429|453186741|FG002|Overall Study|Death|16|||
125972023|NCT03263429|453186739|FG000|Overall Study|Participant unable to return|0|||
125972024|NCT03263429|453186740|FG001|Overall Study|Participant unable to return|0|||
125972025|NCT03263429|453186741|FG002|Overall Study|Participant unable to return|1|||
125972026|NCT03263429|453186739|FG000|Overall Study|Study Closed|0|||
125972027|NCT03263429|453186740|FG001|Overall Study|Study Closed|0|||
125972028|NCT03263429|453186741|FG002|Overall Study|Study Closed|1|||
125972029|NCT01314118|453186747|FG000|Overall Study|Adverse Event|9|||
125972030|NCT01314118|453186747|FG000|Overall Study|Progressive disease|27|||
125972031|NCT01314118|453186747|FG000|Overall Study|Physician Decision|11|||
125972032|NCT01314118|453186747|FG000|Overall Study|Death|4|||
125972033|NCT01314118|453186747|FG000|Overall Study|Protocol Violation|5|||
125972034|NCT01314118|453186747|FG000|Overall Study|Withdrawal by Subject|11|||
125972035|NCT01314118|453186747|FG000|Overall Study|Other|2|||
125972036|NCT01314118|453186747|FG000|Overall Study|Ongoing|62|||
125972037|NCT03638141|453186753|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
125972038|NCT05585307|453186756|FG000|Overall Study|Lost to Follow-up|0|||
125972039|NCT05585307|453186757|FG001|Overall Study|Lost to Follow-up|0|||
125972040|NCT05585307|453186758|FG002|Overall Study|Lost to Follow-up|0|||
125972041|NCT05585307|453186759|FG003|Overall Study|Lost to Follow-up|0|||
125972042|NCT05585307|453186760|FG004|Overall Study|Lost to Follow-up|0|||
125972043|NCT05585307|453186761|FG005|Overall Study|Lost to Follow-up|0|||
125972044|NCT05585307|453186762|FG006|Overall Study|Lost to Follow-up|1|||
125972045|NCT05585307|453186763|FG007|Overall Study|Lost to Follow-up|0|||
126158657|NCT01937130|453868553|FG002|Overall Study|Death|1|||
126158658|NCT01937130|453868554|FG003|Overall Study|Death|0|||
125972046|NCT03526250|453186764|FG000|Overall Study|Adverse Event|4|||
125972047|NCT03526250|453186764|FG000|Overall Study|Progressive Disease|16|||
125972048|NCT03526250|453186764|FG000|Overall Study|No Treatment|3|||
125972049|NCT01618864|453186765|FG000|Overall Study|Withdrawal by Subject|2|||
125972050|NCT01618864|453186765|FG000|Overall Study|Lost to Follow-up|2|||
125972051|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
125972052|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
125972053|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
126158659|NCT01937130|453868551|FG000|Overall Study|Lost to Follow-up|2|||
126158660|NCT01937130|453868552|FG001|Overall Study|Lost to Follow-up|0|||
126158661|NCT01937130|453868553|FG002|Overall Study|Lost to Follow-up|2|||
126158662|NCT01937130|453868554|FG003|Overall Study|Lost to Follow-up|0|||
126158663|NCT01937130|453868551|FG000|Overall Study|Physician Decision|0|||
126158664|NCT01937130|453868552|FG001|Overall Study|Physician Decision|1|||
126158665|NCT01937130|453868553|FG002|Overall Study|Physician Decision|0|||
126158666|NCT01937130|453868554|FG003|Overall Study|Physician Decision|0|||
126158667|NCT01937130|453868551|FG000|Overall Study|Patients unable to swallow|0|||
126158668|NCT01937130|453868552|FG001|Overall Study|Patients unable to swallow|1|||
126158669|NCT01937130|453868553|FG002|Overall Study|Patients unable to swallow|0|||
126158670|NCT01937130|453868554|FG003|Overall Study|Patients unable to swallow|0|||
126158671|NCT01937130|453868551|FG000|Overall Study|Patient lost to FU due to death|2|||
126158672|NCT01937130|453868552|FG001|Overall Study|Patient lost to FU due to death|0|||
126158673|NCT01937130|453868553|FG002|Overall Study|Patient lost to FU due to death|0|||
126158674|NCT01937130|453868554|FG003|Overall Study|Patient lost to FU due to death|0|||
126158675|NCT03825042|453868557|FG000|Overall Study|Adverse Event|1|||
126158676|NCT03825042|453868558|FG001|Overall Study|Adverse Event|0|||
126158677|NCT03825042|453868557|FG000|Overall Study|Withdrawal by Subject|1|||
126158678|NCT03825042|453868558|FG001|Overall Study|Withdrawal by Subject|0|||
126158679|NCT01988012|453868565|FG000|Overall Study|Adverse Event|5|||
126158680|NCT01988012|453868565|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126158681|NCT01988012|453868565|FG000|Overall Study|Patient Withdrawal of Consent|4|||
126158682|NCT01988012|453868565|FG000|Overall Study|Lost to Follow-up|1|||
126158683|NCT01988012|453868565|FG000|Overall Study|Physician Decision|1|||
126158684|NCT01988012|453868565|FG000|Overall Study|Protocol Violation|1|||
126158685|NCT00089843|453868566|FG000|Overall Study|Withdrawal by Subject|1|||
126158686|NCT00089843|453868567|FG001|Overall Study|Withdrawal by Subject|4|||
126158687|NCT00089843|453868568|FG002|Overall Study|Withdrawal by Subject|5|||
126158688|NCT00089843|453868569|FG003|Overall Study|Withdrawal by Subject|6|||
126158689|NCT00089843|453868566|FG000|Overall Study|Physician Decision|1|||
126158690|NCT00089843|453868567|FG001|Overall Study|Physician Decision|0|||
126158691|NCT00089843|453868568|FG002|Overall Study|Physician Decision|0|||
126158692|NCT00089843|453868569|FG003|Overall Study|Physician Decision|1|||
126158693|NCT03042611|453868570|FG000|Core Phase|Withdrawal by Subject|13|||
126158694|NCT03042611|453868571|FG001|Core Phase|Withdrawal by Subject|4|||
126158695|NCT03042611|453868572|FG002|Core Phase|Withdrawal by Subject|0|||
126158696|NCT03042611|453868573|FG003|Core Phase|Withdrawal by Subject|0|||
126158697|NCT03042611|453868570|FG000|Core Phase|Death|232|||
126158698|NCT03042611|453868571|FG001|Core Phase|Death|110|||
126158699|NCT03042611|453868572|FG002|Core Phase|Death|0|||
126158700|NCT03042611|453868573|FG003|Core Phase|Death|0|||
126158701|NCT03042611|453868570|FG000|Core Phase|Lost to Follow-up|4|||
126158702|NCT03042611|453868571|FG001|Core Phase|Lost to Follow-up|7|||
126158703|NCT03042611|453868572|FG002|Core Phase|Lost to Follow-up|0|||
126158704|NCT03042611|453868573|FG003|Core Phase|Lost to Follow-up|0|||
126158705|NCT03042611|453868570|FG000|Core Phase|Physician Decision|7|||
126158706|NCT03042611|453868571|FG001|Core Phase|Physician Decision|2|||
126158707|NCT03042611|453868572|FG002|Core Phase|Physician Decision|0|||
126158708|NCT03042611|453868573|FG003|Core Phase|Physician Decision|0|||
126158709|NCT03042611|453868570|FG000|Core Phase|Study Closed|0|||
126158710|NCT03042611|453868571|FG001|Core Phase|Study Closed|1|||
126158711|NCT03042611|453868572|FG002|Core Phase|Study Closed|0|||
126158712|NCT03042611|453868573|FG003|Core Phase|Study Closed|0|||
126158713|NCT03042611|453868570|FG000|Extension Phase|Death|0|||
126158714|NCT03042611|453868571|FG001|Extension Phase|Death|0|||
126158715|NCT03042611|453868572|FG002|Extension Phase|Death|34|||
126158716|NCT03042611|453868573|FG003|Extension Phase|Death|16|||
126158717|NCT03042611|453868570|FG000|Extension Phase|Lost to Follow-up|0|||
126158718|NCT03042611|453868571|FG001|Extension Phase|Lost to Follow-up|0|||
126158719|NCT03042611|453868572|FG002|Extension Phase|Lost to Follow-up|1|||
126158720|NCT03042611|453868573|FG003|Extension Phase|Lost to Follow-up|1|||
126158721|NCT03042611|453868570|FG000|Extension Phase|Study Closed|0|||
126158722|NCT03042611|453868571|FG001|Extension Phase|Study Closed|0|||
125972054|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
126158723|NCT03042611|453868572|FG002|Extension Phase|Study Closed|17|||
126158724|NCT03042611|453868573|FG003|Extension Phase|Study Closed|11|||
126158725|NCT02385123|453868576|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
126158726|NCT04504032|453868579|FG000|Overall Study|Adverse Event|1|||
126158727|NCT04504032|453868580|FG001|Overall Study|Adverse Event|2|||
126158728|NCT04504032|453868579|FG000|Overall Study|Lost to Follow-up|6|||
126158729|NCT04504032|453868580|FG001|Overall Study|Lost to Follow-up|9|||
126158730|NCT04504032|453868579|FG000|Overall Study|Protocol Violation|2|||
126158731|NCT04504032|453868580|FG001|Overall Study|Protocol Violation|0|||
126158732|NCT04504032|453868579|FG000|Overall Study|Study terminated by sponsor|1|||
126158733|NCT04504032|453868580|FG001|Overall Study|Study terminated by sponsor|2|||
126158734|NCT04504032|453868579|FG000|Overall Study|Withdrawal by Subject|9|||
126158735|NCT04504032|453868580|FG001|Overall Study|Withdrawal by Subject|11|||
126158736|NCT04504032|453868579|FG000|Overall Study|Disease progression prior to dosing|15|||
126158737|NCT04504032|453868580|FG001|Overall Study|Disease progression prior to dosing|3|||
126158738|NCT04504032|453868579|FG000|Overall Study|Drug supply issues|1|||
126158739|NCT04504032|453868580|FG001|Overall Study|Drug supply issues|1|||
126158740|NCT04504032|453868579|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
126158741|NCT04504032|453868580|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
126158742|NCT01839188|453868581|FG000|Overall Study|Withdrawal by Subject|1|||
126158743|NCT02416908|453868589|FG000|Dose Escalation Phase|Adverse Event|0|||
126158744|NCT02416908|453868590|FG001|Dose Escalation Phase|Adverse Event|0|||
126158745|NCT02416908|453868591|FG002|Dose Escalation Phase|Adverse Event|3|||
126158746|NCT02416908|453868592|FG003|Dose Escalation Phase|Adverse Event|0|||
126158747|NCT02416908|453868589|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126158748|NCT02416908|453868590|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126158749|NCT02416908|453868591|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
126158750|NCT02416908|453868592|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126158751|NCT01797783|453868593|FG000|Overall Study|Adverse Event|1|||
126158752|NCT01797783|453868594|FG001|Overall Study|Adverse Event|1|||
126158753|NCT01797783|453868593|FG000|Overall Study|Withdrawal by Subject|1|||
126158754|NCT01797783|453868594|FG001|Overall Study|Withdrawal by Subject|0|||
126158755|NCT00940342|453868595|FG000|Overall Study|Adverse Event|0|||
126158756|NCT00940342|453868596|FG001|Overall Study|Adverse Event|2|||
126158757|NCT00940342|453868597|FG002|Overall Study|Adverse Event|1|||
126158758|NCT01327339|453868598|FG000|Overall Study|Protocol Violation|8|||
126158759|NCT00700752|453868603|FG000|First Intervention|Withdrawal by Subject|0|||
126158760|NCT00700752|453868604|FG001|First Intervention|Withdrawal by Subject|2|||
126158761|NCT03662334|453868605|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
126158762|NCT03662334|453868606|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
126158763|NCT01097330|453868609|FG000|Overall Study|Study terminated early|7|||
126158764|NCT01097330|453868610|FG001|Overall Study|Study terminated early|5|||
126158765|NCT00501852|453868611|FG000|Overall Study|Adverse Event|3|||
126158766|NCT00501852|453868611|FG000|Overall Study|Withdrawal by Subject|2|||
126158767|NCT00652093|453868615|FG000|Overall Study|Withdrawal by Subject|0|||
126158768|NCT00652093|453868616|FG001|Overall Study|Withdrawal by Subject|0|||
126158769|NCT00652093|453868617|FG002|Overall Study|Withdrawal by Subject|1|||
126158770|NCT00652093|453868618|FG003|Overall Study|Withdrawal by Subject|0|||
126158771|NCT00652093|453868619|FG004|Overall Study|Withdrawal by Subject|1|||
126158772|NCT00652093|453868620|FG005|Overall Study|Withdrawal by Subject|0|||
126158773|NCT00652093|453868615|FG000|Overall Study|Physician Decision|0|||
126158774|NCT00652093|453868616|FG001|Overall Study|Physician Decision|0|||
126158775|NCT00652093|453868617|FG002|Overall Study|Physician Decision|0|||
126158776|NCT00652093|453868618|FG003|Overall Study|Physician Decision|0|||
126158777|NCT00652093|453868619|FG004|Overall Study|Physician Decision|1|||
126158778|NCT00652093|453868620|FG005|Overall Study|Physician Decision|0|||
126158779|NCT00542815|453868621|FG000|Overall Study|Adverse Event|19|||
126158780|NCT00542815|453868622|FG001|Overall Study|Adverse Event|6|||
126158781|NCT00542815|453868623|FG002|Overall Study|Adverse Event|9|||
126158782|NCT00542815|453868621|FG000|Overall Study|Death|10|||
126158783|NCT00542815|453868622|FG001|Overall Study|Death|7|||
126158784|NCT00542815|453868623|FG002|Overall Study|Death|3|||
126158785|NCT00542815|453868621|FG000|Overall Study|Lack of Efficacy|9|||
126158786|NCT00542815|453868622|FG001|Overall Study|Lack of Efficacy|2|||
126158787|NCT00542815|453868623|FG002|Overall Study|Lack of Efficacy|0|||
126158788|NCT00542815|453868621|FG000|Overall Study|Physician Decision|2|||
126158789|NCT00542815|453868622|FG001|Overall Study|Physician Decision|1|||
126158790|NCT00542815|453868623|FG002|Overall Study|Physician Decision|0|||
126158791|NCT00542815|453868621|FG000|Overall Study|Protocol Violation|1|||
126158792|NCT00542815|453868622|FG001|Overall Study|Protocol Violation|1|||
126158793|NCT00542815|453868623|FG002|Overall Study|Protocol Violation|2|||
126158794|NCT00542815|453868621|FG000|Overall Study|Withdrawal by Subject|41|||
126158795|NCT00542815|453868622|FG001|Overall Study|Withdrawal by Subject|5|||
126158796|NCT00542815|453868623|FG002|Overall Study|Withdrawal by Subject|8|||
126158797|NCT00542815|453868621|FG000|Overall Study|Other reasons|24|||
126158798|NCT00542815|453868622|FG001|Overall Study|Other reasons|10|||
126158799|NCT00542815|453868623|FG002|Overall Study|Other reasons|10|||
126158800|NCT03176966|453868624|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
126158801|NCT03176966|453868625|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
126158802|NCT03176966|453868624|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
125972055|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
125972056|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
126158803|NCT03176966|453868625|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
126158804|NCT03176966|453868624|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
126158805|NCT03176966|453868625|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
126158806|NCT03176966|453868624|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
126158807|NCT03176966|453868625|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
126158808|NCT03176966|453868624|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
126158809|NCT03176966|453868625|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
126158810|NCT03176966|453868624|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
125972057|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
126158811|NCT03176966|453868625|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
126200106|NCT02394028|454017883|FG006|Induction Phase|Adverse Event|0|||
126158812|NCT03176966|453868624|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
126158813|NCT03176966|453868625|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
126158814|NCT01520922|453868629|FG000|Treatment Phase|Physician Decision|2|||
126158815|NCT01520922|453868630|FG001|Treatment Phase|Physician Decision|1|||
126158816|NCT01520922|453868629|FG000|Treatment Phase|Progression|0|||
126158817|NCT01520922|453868630|FG001|Treatment Phase|Progression|2|||
126158818|NCT01520922|453868629|FG000|Treatment Phase|Adverse Event|3|||
126158819|NCT01520922|453868630|FG001|Treatment Phase|Adverse Event|5|||
126158820|NCT01520922|453868629|FG000|Follow up|Lost to Follow-up|0|||
126158821|NCT01520922|453868630|FG001|Follow up|Lost to Follow-up|1|||
126158822|NCT01520922|453868629|FG000|Survival Follow-up|Withdrawal by Subject|1|||
126158823|NCT01520922|453868630|FG001|Survival Follow-up|Withdrawal by Subject|0|||
126158824|NCT01696877|453868634|FG000|Overall Study|Adverse Event|0|||
126158825|NCT01696877|453868635|FG001|Overall Study|Adverse Event|1|||
126158826|NCT01618656|453868636|FG000|Overall Study|Withdrawal by Subject|7|||
126158827|NCT01618656|453868637|FG001|Overall Study|Withdrawal by Subject|3|||
126158828|NCT01618656|453868636|FG000|Overall Study|Physician Decision|1|||
126158829|NCT01618656|453868637|FG001|Overall Study|Physician Decision|1|||
126158830|NCT02961764|453868640|FG000|Overall Study|Protocol Violation|0|||
126158831|NCT02961764|453868641|FG001|Overall Study|Protocol Violation|1|||
126158832|NCT02961764|453868640|FG000|Overall Study|Death|2|||
126158833|NCT02961764|453868641|FG001|Overall Study|Death|0|||
126158834|NCT02961764|453868640|FG000|Overall Study|Lost to Follow-up|35|||
126158835|NCT02961764|453868641|FG001|Overall Study|Lost to Follow-up|24|||
126158836|NCT02961764|453868640|FG000|Overall Study|Withdrawal by Subject|2|||
126158837|NCT02961764|453868641|FG001|Overall Study|Withdrawal by Subject|0|||
126158838|NCT00469014|453868644|FG000|Initial Phase Randomization|Disease Progression|0|||
126158839|NCT00469014|453868645|FG001|Initial Phase Randomization|Disease Progression|1|||
126158840|NCT00469014|453868646|FG002|Initial Phase Randomization|Disease Progression|1|||
126158841|NCT00469014|453868647|FG003|Initial Phase Randomization|Disease Progression|0|||
126158842|NCT00469014|453868644|FG000|Initial Phase Randomization|No Response|1|||
126158843|NCT00469014|453868645|FG001|Initial Phase Randomization|No Response|0|||
126158844|NCT00469014|453868646|FG002|Initial Phase Randomization|No Response|0|||
126158845|NCT00469014|453868647|FG003|Initial Phase Randomization|No Response|1|||
126158846|NCT00469014|453868644|FG000|Adaptive Randomization|Not Evaluable|1|||
126158847|NCT00469014|453868645|FG001|Adaptive Randomization|Not Evaluable|0|||
126158848|NCT00469014|453868646|FG002|Adaptive Randomization|Not Evaluable|0|||
126158849|NCT00469014|453868647|FG003|Adaptive Randomization|Not Evaluable|1|||
126158850|NCT00469014|453868644|FG000|Adaptive Randomization|No Response|0|||
126158851|NCT00469014|453868645|FG001|Adaptive Randomization|No Response|1|||
126158852|NCT00469014|453868646|FG002|Adaptive Randomization|No Response|0|||
126158853|NCT00469014|453868647|FG003|Adaptive Randomization|No Response|0|||
126158854|NCT00469014|453868644|FG000|Adaptive Randomization|Death|0|||
126158855|NCT00469014|453868645|FG001|Adaptive Randomization|Death|0|||
126158856|NCT00469014|453868646|FG002|Adaptive Randomization|Death|1|||
126158857|NCT00469014|453868647|FG003|Adaptive Randomization|Death|0|||
126158858|NCT04770155|453868648|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126158859|NCT04770155|453868649|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126158860|NCT04770155|453868650|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126158861|NCT04770155|453868651|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126158862|NCT04770155|453868652|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126158863|NCT04770155|453868653|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126158864|NCT04770155|453868654|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126158865|NCT04770155|453868655|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126158866|NCT00864227|453868657|FG000|Overall Study|Withdrawal by Subject|1|||
126158867|NCT00864227|453868657|FG000|Overall Study|Disease Relapse/Progression|3|||
126158868|NCT03461289|453868658|FG000|Overall Study|Death|1|||
125972058|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
125972059|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
125972060|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
125972061|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
126158869|NCT03321929|453868659|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
126158870|NCT01632878|453868662|FG000|Screening|Physician Decision|268|||
126158871|NCT01632878|453868662|FG000|Treatment|Lost to Follow-up|41|||
126158872|NCT01632878|453868662|FG000|Treatment|Withdrawal by Subject|36|||
126158873|NCT01632878|453868662|FG000|Treatment|Physician Decision|34|||
126158874|NCT01632878|453868662|FG000|Treatment|missing information|4|||
126158875|NCT01632878|453868662|FG000|Treatment|no information on study completion|43|||
126158876|NCT00081289|453868663|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
126158877|NCT00081289|453868664|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
126158878|NCT00081289|453868663|FG000|Overall Study|Ineligible / no protocol treatment|3|||
126158879|NCT00081289|453868664|FG001|Overall Study|Ineligible / no protocol treatment|4|||
126158880|NCT00916721|453868667|FG000|Overall Study|Lost to Follow-up|0|||
126158881|NCT00916721|453868668|FG001|Overall Study|Lost to Follow-up|1|||
126158882|NCT00916721|453868667|FG000|Overall Study|Adverse Event|6|||
126158883|NCT00916721|453868668|FG001|Overall Study|Adverse Event|3|||
126158884|NCT00916721|453868667|FG000|Overall Study|Withdrawal by Subject|2|||
126158885|NCT00916721|453868668|FG001|Overall Study|Withdrawal by Subject|2|||
126158886|NCT00916721|453868667|FG000|Overall Study|Protocol Violation|2|||
126158887|NCT00916721|453868668|FG001|Overall Study|Protocol Violation|4|||
126158888|NCT01469052|453868676|FG000|Overall Study|Adverse Event|2|||
126158889|NCT01469052|453868677|FG001|Overall Study|Adverse Event|3|||
126158890|NCT01469052|453868678|FG002|Overall Study|Adverse Event|0|||
126158891|NCT01469052|453868679|FG003|Overall Study|Adverse Event|2|||
126158892|NCT01469052|453868680|FG004|Overall Study|Adverse Event|0|||
126158893|NCT01469052|453868681|FG005|Overall Study|Adverse Event|1|||
126158894|NCT01469052|453868676|FG000|Overall Study|Progressive disease|3|||
126158895|NCT01469052|453868677|FG001|Overall Study|Progressive disease|0|||
126158896|NCT01469052|453868678|FG002|Overall Study|Progressive disease|5|||
126158897|NCT01469052|453868679|FG003|Overall Study|Progressive disease|3|||
126158898|NCT01469052|453868680|FG004|Overall Study|Progressive disease|7|||
126158899|NCT01469052|453868681|FG005|Overall Study|Progressive disease|2|||
126158900|NCT01469052|453868676|FG000|Overall Study|Lack of Efficacy|0|||
126158901|NCT01469052|453868677|FG001|Overall Study|Lack of Efficacy|0|||
126158902|NCT01469052|453868678|FG002|Overall Study|Lack of Efficacy|0|||
126158903|NCT01469052|453868679|FG003|Overall Study|Lack of Efficacy|0|||
126158904|NCT01469052|453868680|FG004|Overall Study|Lack of Efficacy|0|||
126158905|NCT01469052|453868681|FG005|Overall Study|Lack of Efficacy|2|||
126158906|NCT01469052|453868676|FG000|Overall Study|Moved to rollover protocol|1|||
126158907|NCT01469052|453868677|FG001|Overall Study|Moved to rollover protocol|0|||
126158908|NCT01469052|453868678|FG002|Overall Study|Moved to rollover protocol|1|||
126158909|NCT01469052|453868679|FG003|Overall Study|Moved to rollover protocol|0|||
126158910|NCT01469052|453868680|FG004|Overall Study|Moved to rollover protocol|0|||
126158911|NCT01469052|453868681|FG005|Overall Study|Moved to rollover protocol|1|||
126158912|NCT01469052|453868676|FG000|Overall Study|Other|0|||
126158913|NCT01469052|453868677|FG001|Overall Study|Other|1|||
126158914|NCT01469052|453868678|FG002|Overall Study|Other|0|||
126158915|NCT01469052|453868679|FG003|Overall Study|Other|0|||
126158916|NCT01469052|453868680|FG004|Overall Study|Other|1|||
126158917|NCT01469052|453868681|FG005|Overall Study|Other|0|||
126158918|NCT02749370|453868685|FG000|Overall Study|Withdrawal by Subject|11|||
126158919|NCT02749370|453868685|FG000|Overall Study|Lost to Follow-up|3|||
126158920|NCT01519427|453868689|FG000|Overall Study|disease progression|2|||
126158921|NCT03894904|453868690|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
126158922|NCT03894904|453868691|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
126158923|NCT03894904|453868690|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
126158924|NCT03894904|453868691|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
126158925|NCT03242759|453868692|FG000|Overall Study|Adverse Event|5|||
126158926|NCT03242759|453868693|FG001|Overall Study|Adverse Event|1|||
126158927|NCT03242759|453868692|FG000|Overall Study|Withdrawal by Subject|4|||
126158928|NCT03242759|453868693|FG001|Overall Study|Withdrawal by Subject|3|||
126158929|NCT03242759|453868692|FG000|Overall Study|Lost to Follow-up|3|||
126158930|NCT03242759|453868693|FG001|Overall Study|Lost to Follow-up|1|||
126158931|NCT03242759|453868692|FG000|Overall Study|Administrative problems|1|||
126158932|NCT03242759|453868693|FG001|Overall Study|Administrative problems|1|||
126158933|NCT03242759|453868692|FG000|Overall Study|Death|22|||
126158934|NCT03242759|453868693|FG001|Overall Study|Death|0|||
126158935|NCT03242759|453868692|FG000|Overall Study|Change visit schedule|0|||
126158936|NCT03242759|453868693|FG001|Overall Study|Change visit schedule|1|||
126158937|NCT00336492|453868702|FG000|Overall Study|Adverse Event|4|||
126158938|NCT00336492|453868703|FG001|Overall Study|Adverse Event|3|||
126158939|NCT00336492|453868704|FG002|Overall Study|Adverse Event|6|||
126158940|NCT00336492|453868702|FG000|Overall Study|Lack of Efficacy|6|||
126158941|NCT00336492|453868703|FG001|Overall Study|Lack of Efficacy|1|||
126158942|NCT00336492|453868704|FG002|Overall Study|Lack of Efficacy|4|||
126158943|NCT00336492|453868702|FG000|Overall Study|Other|5|||
126158944|NCT00336492|453868703|FG001|Overall Study|Other|0|||
126158945|NCT00336492|453868704|FG002|Overall Study|Other|1|||
126158946|NCT00227877|453868705|FG000|Pre-visit Assessment|Technical difficulties|7|||
126158947|NCT00227877|453868706|FG001|Pre-visit Assessment|Technical difficulties|3|||
126158948|NCT00227877|453868707|FG002|Pre-visit Assessment|Technical difficulties|0|||
126158949|NCT00227877|453868708|FG003|Pre-visit Assessment|Technical difficulties|0|||
126158950|NCT00227877|453868705|FG000|Post-visit Checklist|Lost to Follow-up|24|||
126158951|NCT00227877|453868706|FG001|Post-visit Checklist|Lost to Follow-up|13|||
126158952|NCT00227877|453868707|FG002|Post-visit Checklist|Lost to Follow-up|1|||
126158953|NCT00227877|453868708|FG003|Post-visit Checklist|Lost to Follow-up|0|||
126158954|NCT00227877|453868705|FG000|3-months Follow-up|Completed late|135|||
126158955|NCT00227877|453868706|FG001|3-months Follow-up|Completed late|128|||
126158956|NCT00227877|453868707|FG002|3-months Follow-up|Completed late|34|||
126158957|NCT00227877|453868708|FG003|3-months Follow-up|Completed late|8|||
126158958|NCT00227877|453868705|FG000|3-months Follow-up|Lost to Follow-up|178|||
126158959|NCT00227877|453868706|FG001|3-months Follow-up|Lost to Follow-up|139|||
125972062|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
125972063|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
125972064|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
125972065|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
125972066|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
125972067|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
125972068|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
125972069|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
125972070|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
125972071|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
125972072|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
125972073|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
125972074|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
125972075|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
125972076|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
125972077|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
125972078|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
125972079|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
125972080|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
125972081|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
125972082|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
125972083|NCT04818346|453186771|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
125972084|NCT04818346|453186772|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
125972085|NCT04818346|453186773|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
125972086|NCT04818346|453186774|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
125972087|NCT04818346|453186771|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
125972088|NCT04818346|453186772|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
125972089|NCT04818346|453186773|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
125972090|NCT04818346|453186774|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
125972091|NCT04818346|453186771|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
125972092|NCT04818346|453186772|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
125972093|NCT04818346|453186773|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
125972094|NCT04818346|453186774|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
125972095|NCT04818346|453186771|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
125972096|NCT04818346|453186772|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
125972097|NCT04818346|453186773|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
125972098|NCT04818346|453186774|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
125972099|NCT04818346|453186771|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
125972100|NCT04818346|453186772|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
125972101|NCT04818346|453186773|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
125972102|NCT04818346|453186774|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
125972103|NCT04818346|453186771|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
125972104|NCT04818346|453186772|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
125972105|NCT04818346|453186773|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
125972106|NCT04818346|453186774|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
125972107|NCT04818346|453186771|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
125972108|NCT04818346|453186772|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
125972109|NCT04818346|453186773|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
125972110|NCT04818346|453186774|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
125972111|NCT01672801|453186775|FG000|Overall Study|Screen Failure|0|||
126158960|NCT00227877|453868707|FG002|3-months Follow-up|Lost to Follow-up|18|||
126158961|NCT00227877|453868708|FG003|3-months Follow-up|Lost to Follow-up|13|||
126158962|NCT00227877|453868705|FG000|12-months Follow-up|Completed late|78|||
126158963|NCT00227877|453868706|FG001|12-months Follow-up|Completed late|74|||
126158964|NCT00227877|453868707|FG002|12-months Follow-up|Completed late|1|||
126158965|NCT00227877|453868708|FG003|12-months Follow-up|Completed late|0|||
126158966|NCT00227877|453868705|FG000|12-months Follow-up|Lost to Follow-up|232|||
126158967|NCT00227877|453868706|FG001|12-months Follow-up|Lost to Follow-up|189|||
126158968|NCT00227877|453868707|FG002|12-months Follow-up|Lost to Follow-up|30|||
126158969|NCT00227877|453868708|FG003|12-months Follow-up|Lost to Follow-up|26|||
126158970|NCT02522481|453868711|FG000|Overall Study|discontinued|1|||
126158971|NCT02522481|453868711|FG000|Overall Study|Not dosed|2|||
126158972|NCT00404768|453868714|FG000|Part A and B|Withdrawn due to labor progression|1|||
126158973|NCT00404768|453868715|FG001|Part A and B|Withdrawn due to labor progression|0|||
126158974|NCT00404768|453868716|FG002|Part A and B|Withdrawn due to labor progression|0|||
126158975|NCT00404768|453868717|FG003|Part A and B|Withdrawn due to labor progression|0|||
126158976|NCT00404768|453868714|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
126158977|NCT00404768|453868715|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
126158978|NCT00404768|453868716|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
126158979|NCT00404768|453868717|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
126158980|NCT00404768|453868714|FG000|Part C|Adverse Event|0|||
126158981|NCT00404768|453868715|FG001|Part C|Adverse Event|0|||
126158982|NCT00404768|453868716|FG002|Part C|Adverse Event|0|||
126158983|NCT00404768|453868717|FG003|Part C|Adverse Event|3|||
126158984|NCT00404768|453868714|FG000|Part C|Lost to Follow-up|0|||
126158985|NCT00404768|453868715|FG001|Part C|Lost to Follow-up|0|||
126158986|NCT00404768|453868716|FG002|Part C|Lost to Follow-up|3|||
126158987|NCT00404768|453868717|FG003|Part C|Lost to Follow-up|1|||
126158988|NCT00404768|453868714|FG000|Part C|Withdrawal by Subject|0|||
126158989|NCT00404768|453868715|FG001|Part C|Withdrawal by Subject|0|||
125972112|NCT01672801|453186776|FG001|Overall Study|Screen Failure|1|||
125972113|NCT00492284|453186779|FG000|Overall Study|Adverse Event|0|||
125972114|NCT00492284|453186780|FG001|Overall Study|Adverse Event|1|||
125972115|NCT00492284|453186781|FG002|Overall Study|Adverse Event|1|||
125972116|NCT00492284|453186782|FG003|Overall Study|Adverse Event|2|||
125972117|NCT00492284|453186779|FG000|Overall Study|Lost to Follow-up|0|||
125972118|NCT00492284|453186780|FG001|Overall Study|Lost to Follow-up|0|||
125972119|NCT00492284|453186781|FG002|Overall Study|Lost to Follow-up|3|||
125972120|NCT00492284|453186782|FG003|Overall Study|Lost to Follow-up|1|||
125972121|NCT00492284|453186779|FG000|Overall Study|Death|0|||
125972122|NCT00492284|453186780|FG001|Overall Study|Death|3|||
125972123|NCT00492284|453186781|FG002|Overall Study|Death|2|||
125972124|NCT00492284|453186782|FG003|Overall Study|Death|5|||
125972125|NCT00492284|453186779|FG000|Overall Study|Withdrawal by Subject|1|||
125972126|NCT00492284|453186780|FG001|Overall Study|Withdrawal by Subject|0|||
125972127|NCT00492284|453186781|FG002|Overall Study|Withdrawal by Subject|0|||
125972128|NCT00492284|453186782|FG003|Overall Study|Withdrawal by Subject|2|||
125972129|NCT03150056|453186783|FG000|Overall Study|Withdrawal by Subject|0|||
125972130|NCT03150056|453186784|FG001|Overall Study|Withdrawal by Subject|0|||
125972131|NCT03150056|453186785|FG002|Overall Study|Withdrawal by Subject|0|||
125972132|NCT03150056|453186786|FG003|Overall Study|Withdrawal by Subject|0|||
125972133|NCT03150056|453186787|FG004|Overall Study|Withdrawal by Subject|0|||
125972134|NCT03150056|453186788|FG005|Overall Study|Withdrawal by Subject|2|||
125972135|NCT03150056|453186783|FG000|Overall Study|Study terminated by Sponsor|1|||
125972136|NCT03150056|453186784|FG001|Overall Study|Study terminated by Sponsor|3|||
125972137|NCT03150056|453186785|FG002|Overall Study|Study terminated by Sponsor|1|||
125972138|NCT03150056|453186786|FG003|Overall Study|Study terminated by Sponsor|1|||
125972139|NCT03150056|453186787|FG004|Overall Study|Study terminated by Sponsor|5|||
125972140|NCT03150056|453186788|FG005|Overall Study|Study terminated by Sponsor|6|||
125972141|NCT03150056|453186783|FG000|Overall Study|Death|9|||
125972142|NCT03150056|453186784|FG001|Overall Study|Death|2|||
125972143|NCT03150056|453186785|FG002|Overall Study|Death|2|||
126158990|NCT00404768|453868716|FG002|Part C|Withdrawal by Subject|2|||
126158991|NCT00404768|453868717|FG003|Part C|Withdrawal by Subject|1|||
126158992|NCT00404768|453868714|FG000|Part C|Early withdrawal from study medication|0|||
126158993|NCT00404768|453868715|FG001|Part C|Early withdrawal from study medication|0|||
126158994|NCT00404768|453868716|FG002|Part C|Early withdrawal from study medication|1|||
126158995|NCT00404768|453868717|FG003|Part C|Early withdrawal from study medication|0|||
126158996|NCT00404768|453868714|FG000|Part C|Participant did not respond to therapy|0|||
126158997|NCT00404768|453868715|FG001|Part C|Participant did not respond to therapy|0|||
126158998|NCT00404768|453868716|FG002|Part C|Participant did not respond to therapy|1|||
126158999|NCT00404768|453868717|FG003|Part C|Participant did not respond to therapy|1|||
125972144|NCT03150056|453186786|FG003|Overall Study|Death|7|||
125972145|NCT03150056|453186787|FG004|Overall Study|Death|8|||
125972146|NCT03150056|453186788|FG005|Overall Study|Death|10|||
125972147|NCT00965523|453186789|FG000|Study 221|Progressive Disease|4|||
125972148|NCT00965523|453186789|FG000|Study 221|Physician Decision|3|||
125972149|NCT00965523|453186789|FG000|Study 224|Progressive Disease|5|||
125972150|NCT00965523|453186789|FG000|Study 224|Physician Decision|1|||
125972151|NCT01581281|453186791|FG000|Overall Study|Early Study Closure|15|||
125972152|NCT01581281|453186792|FG001|Overall Study|Early Study Closure|6|||
125972153|NCT01581281|453186793|FG002|Overall Study|Early Study Closure|12|||
126159000|NCT00404768|453868714|FG000|Part C|Physician withdrew the study medication|0|||
126159001|NCT00404768|453868715|FG001|Part C|Physician withdrew the study medication|0|||
126159002|NCT00404768|453868716|FG002|Part C|Physician withdrew the study medication|1|||
126159003|NCT00404768|453868717|FG003|Part C|Physician withdrew the study medication|0|||
126159004|NCT00404768|453868714|FG000|Part C|Participant delivered baby|0|||
126159005|NCT00404768|453868715|FG001|Part C|Participant delivered baby|0|||
126159006|NCT00404768|453868716|FG002|Part C|Participant delivered baby|0|||
126159007|NCT00404768|453868717|FG003|Part C|Participant delivered baby|1|||
126159008|NCT00404768|453868714|FG000|Part C|Unsatisfactory uterine response to IP|0|||
126159009|NCT00404768|453868715|FG001|Part C|Unsatisfactory uterine response to IP|0|||
126159010|NCT00404768|453868716|FG002|Part C|Unsatisfactory uterine response to IP|0|||
126159011|NCT00404768|453868717|FG003|Part C|Unsatisfactory uterine response to IP|1|||
126159012|NCT00404768|453868714|FG000|Part C|Active labor|0|||
126159013|NCT00404768|453868715|FG001|Part C|Active labor|0|||
126159014|NCT00404768|453868716|FG002|Part C|Active labor|0|||
126159015|NCT00404768|453868717|FG003|Part C|Active labor|1|||
126159016|NCT00404768|453868714|FG000|Part C|Lack of Efficacy|0|||
126159017|NCT00404768|453868715|FG001|Part C|Lack of Efficacy|0|||
126159018|NCT00404768|453868716|FG002|Part C|Lack of Efficacy|0|||
126159019|NCT00404768|453868717|FG003|Part C|Lack of Efficacy|2|||
126159020|NCT00404768|453868714|FG000|Part C|Treatment failure|0|||
126159021|NCT00404768|453868715|FG001|Part C|Treatment failure|0|||
126159022|NCT00404768|453868716|FG002|Part C|Treatment failure|0|||
126159023|NCT00404768|453868717|FG003|Part C|Treatment failure|1|||
126159024|NCT00404768|453868714|FG000|Part C|Investigator discretion|0|||
126159025|NCT00404768|453868715|FG001|Part C|Investigator discretion|0|||
126159026|NCT00404768|453868716|FG002|Part C|Investigator discretion|0|||
126159027|NCT00404768|453868717|FG003|Part C|Investigator discretion|1|||
126159028|NCT00404768|453868714|FG000|Part C|Researcher suspended study medication|0|||
126159029|NCT00404768|453868715|FG001|Part C|Researcher suspended study medication|0|||
126159030|NCT00404768|453868716|FG002|Part C|Researcher suspended study medication|0|||
126159031|NCT00404768|453868717|FG003|Part C|Researcher suspended study medication|1|||
126159032|NCT05094154|453870201|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
125972154|NCT02187991|453186794|FG000|Overall Study|Adverse Event|13|||
125972155|NCT02187991|453186795|FG001|Overall Study|Adverse Event|14|||
125972156|NCT02187991|453186796|FG002|Overall Study|Adverse Event|3|||
125972157|NCT02187991|453186797|FG003|Overall Study|Adverse Event|2|||
125972158|NCT02187991|453186794|FG000|Overall Study|Withdrawal by Subject|9|||
125972159|NCT02187991|453186795|FG001|Overall Study|Withdrawal by Subject|6|||
125972160|NCT02187991|453186796|FG002|Overall Study|Withdrawal by Subject|3|||
125972161|NCT02187991|453186797|FG003|Overall Study|Withdrawal by Subject|2|||
125972162|NCT02187991|453186794|FG000|Overall Study|Physician Decision|4|||
125972163|NCT02187991|453186795|FG001|Overall Study|Physician Decision|4|||
125972164|NCT02187991|453186796|FG002|Overall Study|Physician Decision|0|||
125972165|NCT02187991|453186797|FG003|Overall Study|Physician Decision|2|||
125972166|NCT02187991|453186794|FG000|Overall Study|Other, unrelated complication|7|||
125972167|NCT02187991|453186795|FG001|Overall Study|Other, unrelated complication|1|||
125972168|NCT02187991|453186796|FG002|Overall Study|Other, unrelated complication|1|||
125972169|NCT02187991|453186797|FG003|Overall Study|Other, unrelated complication|2|||
125972170|NCT02187991|453186794|FG000|Overall Study|Death|1|||
125972171|NCT02187991|453186795|FG001|Overall Study|Death|3|||
125972172|NCT02187991|453186796|FG002|Overall Study|Death|0|||
125972173|NCT02187991|453186797|FG003|Overall Study|Death|0|||
125972174|NCT03273946|453186805|FG000|Overall Study|Withdrawal by Subject|5|||
125972175|NCT03273946|453186805|FG000|Overall Study|Unwillingness of the guardian|1|||
125972176|NCT03273946|453186805|FG000|Overall Study|Participant refused to use the drug|2|||
125972177|NCT03273946|453186805|FG000|Overall Study|Participant relative refused to use drug|1|||
125972178|NCT00522275|453186806|FG000|Overall Study|Adverse Event|35|||
125972179|NCT00522275|453186806|FG000|Overall Study|Lack of Efficacy|80|||
125972180|NCT00522275|453186806|FG000|Overall Study|Subject withdrew consent|16|||
125972181|NCT00522275|453186806|FG000|Overall Study|Protocol deviation|1|||
125972182|NCT00522275|453186806|FG000|Overall Study|Unsatisfactory compliance|11|||
125972183|NCT00522275|453186806|FG000|Overall Study|Lost to Follow-up|8|||
125972184|NCT00522275|453186806|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
125972185|NCT00522275|453186806|FG000|Overall Study|Other: Subject is pregnant|2|||
125972186|NCT00522275|453186806|FG000|Overall Study|Other: Subject relocated|2|||
126159033|NCT05094154|453870202|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
125972187|NCT00522275|453186806|FG000|Overall Study|Other: Subject arrested|1|||
126159034|NCT05094154|453870201|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
126159035|NCT05094154|453870202|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
126159036|NCT01240811|453870205|FG000|Overall Study|Physician Decision|0|||
125972188|NCT00522275|453186806|FG000|Overall Study|Other: Site / clinic closed|4|||
125972189|NCT00522275|453186806|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
125972190|NCT00522275|453186806|FG000|Overall Study|Other: Sponsor request|2|||
125972191|NCT00522275|453186806|FG000|Overall Study|Other: Subject ran out of medication|1|||
125972192|NCT00522275|453186806|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
126159037|NCT01240811|453870206|FG001|Overall Study|Physician Decision|1|||
126159038|NCT01240811|453870207|FG002|Overall Study|Physician Decision|0|||
126159039|NCT01240811|453870205|FG000|Overall Study|Withdrawal by Subject|0|||
126159040|NCT01240811|453870206|FG001|Overall Study|Withdrawal by Subject|0|||
126159041|NCT01240811|453870207|FG002|Overall Study|Withdrawal by Subject|1|||
126159042|NCT01543490|453870208|FG000|Overall Study|Adverse Event|4|||
126159043|NCT01543490|453870209|FG001|Overall Study|Adverse Event|0|||
126159044|NCT01543490|453870208|FG000|Overall Study|Physician Decision|1|||
126159045|NCT01543490|453870209|FG001|Overall Study|Physician Decision|0|||
126159046|NCT01543490|453870208|FG000|Overall Study|Lack of Efficacy|3|||
126159047|NCT01543490|453870209|FG001|Overall Study|Lack of Efficacy|3|||
126159048|NCT01543490|453870208|FG000|Overall Study|Lost to Follow-up|5|||
126159049|NCT01543490|453870209|FG001|Overall Study|Lost to Follow-up|0|||
126159050|NCT01543490|453870208|FG000|Overall Study|Withdrawal by Subject|2|||
126159051|NCT01543490|453870209|FG001|Overall Study|Withdrawal by Subject|0|||
126159052|NCT01543490|453870208|FG000|Overall Study|Other-Various Administrative Reasons|1|||
126159053|NCT01543490|453870209|FG001|Overall Study|Other-Various Administrative Reasons|2|||
126159054|NCT04168645|453870212|FG000|Overall Study|Lost to Follow-up|23|||
126159055|NCT04168645|453870213|FG001|Overall Study|Lost to Follow-up|28|||
126159056|NCT04168645|453870214|FG002|Overall Study|Lost to Follow-up|15|||
126159057|NCT04168645|453870215|FG003|Overall Study|Lost to Follow-up|12|||
126159058|NCT04168645|453870212|FG000|Overall Study|Death|1|||
126159059|NCT04168645|453870213|FG001|Overall Study|Death|1|||
126159060|NCT04168645|453870214|FG002|Overall Study|Death|0|||
126159061|NCT04168645|453870215|FG003|Overall Study|Death|0|||
126159062|NCT04168645|453870212|FG000|Overall Study|Withdrawal by Subject|5|||
126159063|NCT04168645|453870213|FG001|Overall Study|Withdrawal by Subject|2|||
126159064|NCT04168645|453870214|FG002|Overall Study|Withdrawal by Subject|2|||
126159065|NCT04168645|453870215|FG003|Overall Study|Withdrawal by Subject|2|||
126159066|NCT04168645|453870212|FG000|Overall Study|Administrative Withdrawal|3|||
126159067|NCT04168645|453870213|FG001|Overall Study|Administrative Withdrawal|1|||
126159068|NCT04168645|453870214|FG002|Overall Study|Administrative Withdrawal|1|||
126159069|NCT04168645|453870215|FG003|Overall Study|Administrative Withdrawal|3|||
126159070|NCT03132805|453870218|FG000|Overall Study|Lost to Follow-up|142|||
126159071|NCT03132805|453870219|FG001|Overall Study|Lost to Follow-up|141|||
126159072|NCT03132805|453870220|FG002|Overall Study|Lost to Follow-up|113|||
126159073|NCT00710034|453870221|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
126159074|NCT00710034|453870222|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
126159075|NCT00710034|453870221|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
126159076|NCT00710034|453870222|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
126159077|NCT00710034|453870221|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
126159078|NCT00710034|453870222|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
126159079|NCT00710034|453870221|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
126159080|NCT00710034|453870222|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
126159081|NCT00710034|453870221|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
126159082|NCT00710034|453870222|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
126159083|NCT00710034|453870221|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
126159084|NCT00710034|453870222|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
126159085|NCT00710034|453870221|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
126159086|NCT00710034|453870222|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
126159087|NCT00710034|453870221|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
126159088|NCT00710034|453870222|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
126159089|NCT00710034|453870221|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
126159090|NCT00710034|453870222|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
126159091|NCT00710034|453870221|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
126159092|NCT00710034|453870222|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
126159093|NCT00710034|453870221|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
126159094|NCT00710034|453870222|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
126159095|NCT03918642|453870223|FG000|Overall Study|Lost to Follow-up|12|||
126159096|NCT03918642|453870224|FG001|Overall Study|Lost to Follow-up|10|||
126159097|NCT02601001|453870225|FG000|Dosing Period 2|Adverse Event|0|||
126159098|NCT02601001|453870226|FG001|Dosing Period 2|Adverse Event|0|||
126159099|NCT02601001|453870227|FG002|Dosing Period 2|Adverse Event|0|||
126159100|NCT02601001|453870228|FG003|Dosing Period 2|Adverse Event|0|||
126159101|NCT02601001|453870229|FG004|Dosing Period 2|Adverse Event|0|||
126159102|NCT02601001|453870230|FG005|Dosing Period 2|Adverse Event|0|||
125972193|NCT02576067|453186807|FG000|Overall Study|Death|0|||
125972194|NCT02576067|453186808|FG001|Overall Study|Death|1|||
125972195|NCT02576067|453186807|FG000|Overall Study|Lack of Efficacy|1|||
125972196|NCT02576067|453186808|FG001|Overall Study|Lack of Efficacy|0|||
125972197|NCT02576067|453186807|FG000|Overall Study|Lost to Follow-up|11|||
125972198|NCT02576067|453186808|FG001|Overall Study|Lost to Follow-up|0|||
125972199|NCT02576067|453186807|FG000|Overall Study|Withdrawal by Subject|11|||
125972200|NCT02576067|453186808|FG001|Overall Study|Withdrawal by Subject|2|||
126159103|NCT02601001|453870231|FG006|Dosing Period 2|Adverse Event|1|||
126159104|NCT00500149|453870232|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
126159105|NCT00500149|453870233|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
126159106|NCT00500149|453870232|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
126159107|NCT00500149|453870233|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
126159108|NCT00500149|453870232|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
126159109|NCT00500149|453870233|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
126159110|NCT00500149|453870232|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
126159111|NCT00500149|453870233|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
126159112|NCT00500149|453870232|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
126159113|NCT00500149|453870233|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
126159114|NCT00500149|453870232|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
126159115|NCT00500149|453870233|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
126159116|NCT00500149|453870232|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
126159117|NCT00500149|453870233|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
126159118|NCT01158534|453870234|FG000|Overall Study|Withdrawal by Subject|1|||
126159119|NCT01158534|453870234|FG000|Overall Study|Death|1|||
126159120|NCT01158534|453870234|FG000|Overall Study|Other|1|||
126159121|NCT00521339|453870235|FG000|Treatment Phase|Adverse Event|2|||
126159122|NCT00521339|453870236|FG001|Treatment Phase|Adverse Event|0|||
126159123|NCT00521339|453870237|FG002|Treatment Phase|Adverse Event|0|||
126159124|NCT00521339|453870235|FG000|Treatment Phase|Intolerability to study drug|2|||
126159125|NCT00521339|453870236|FG001|Treatment Phase|Intolerability to study drug|0|||
126159126|NCT00521339|453870237|FG002|Treatment Phase|Intolerability to study drug|0|||
126159127|NCT00521339|453870235|FG000|Treatment Phase|Lack of Efficacy|3|||
126159128|NCT00521339|453870236|FG001|Treatment Phase|Lack of Efficacy|0|||
126159129|NCT00521339|453870237|FG002|Treatment Phase|Lack of Efficacy|0|||
126159130|NCT00521339|453870235|FG000|Treatment Phase|Withdrawal by Subject|3|||
126159131|NCT00521339|453870236|FG001|Treatment Phase|Withdrawal by Subject|0|||
126159132|NCT00521339|453870237|FG002|Treatment Phase|Withdrawal by Subject|0|||
126159133|NCT00521339|453870235|FG000|Treatment Phase|Lost to Follow-up|1|||
126159134|NCT00521339|453870236|FG001|Treatment Phase|Lost to Follow-up|0|||
126159135|NCT00521339|453870237|FG002|Treatment Phase|Lost to Follow-up|0|||
126159136|NCT00521339|453870235|FG000|Treatment Phase|Protocol Violation|1|||
126159137|NCT00521339|453870236|FG001|Treatment Phase|Protocol Violation|0|||
126159138|NCT00521339|453870237|FG002|Treatment Phase|Protocol Violation|0|||
126159139|NCT00521339|453870235|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
126159140|NCT00521339|453870236|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
126159141|NCT00521339|453870237|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
126159142|NCT00521339|453870235|FG000|Treatment Extension Phase|Death|0|||
126159143|NCT00521339|453870236|FG001|Treatment Extension Phase|Death|0|||
126159144|NCT00521339|453870237|FG002|Treatment Extension Phase|Death|1|||
126159145|NCT02115815|453870238|FG000|Overall Study|Withdrawal by Subject|2|||
126159146|NCT02115815|453870239|FG001|Overall Study|Withdrawal by Subject|0|||
126159147|NCT02115815|453870240|FG002|Overall Study|Withdrawal by Subject|0|||
126159148|NCT02115815|453870241|FG003|Overall Study|Withdrawal by Subject|0|||
126159149|NCT02115815|453870242|FG004|Overall Study|Withdrawal by Subject|0|||
126159150|NCT02115815|453870243|FG005|Overall Study|Withdrawal by Subject|0|||
126159151|NCT02115815|453870244|FG006|Overall Study|Withdrawal by Subject|0|||
126159152|NCT02115815|453870238|FG000|Overall Study|Not enough drug to dose participant|0|||
126159153|NCT02115815|453870239|FG001|Overall Study|Not enough drug to dose participant|0|||
126159154|NCT02115815|453870240|FG002|Overall Study|Not enough drug to dose participant|0|||
126159155|NCT02115815|453870241|FG003|Overall Study|Not enough drug to dose participant|0|||
126159156|NCT02115815|453870242|FG004|Overall Study|Not enough drug to dose participant|0|||
126159157|NCT02115815|453870243|FG005|Overall Study|Not enough drug to dose participant|1|||
126159158|NCT02115815|453870244|FG006|Overall Study|Not enough drug to dose participant|0|||
126159159|NCT02115815|453870238|FG000|Overall Study|Missed appointment, randomized in error|0|||
126159160|NCT02115815|453870239|FG001|Overall Study|Missed appointment, randomized in error|0|||
126159161|NCT02115815|453870240|FG002|Overall Study|Missed appointment, randomized in error|0|||
126159162|NCT02115815|453870241|FG003|Overall Study|Missed appointment, randomized in error|0|||
126159163|NCT02115815|453870242|FG004|Overall Study|Missed appointment, randomized in error|0|||
125972201|NCT02576067|453186807|FG000|Overall Study|study closure of main CIRT trial)|0|||
125972202|NCT02576067|453186808|FG001|Overall Study|study closure of main CIRT trial)|8|||
125972203|NCT02576067|453186807|FG000|Overall Study|not randomized, failed run-in|7|||
126159164|NCT02115815|453870243|FG005|Overall Study|Missed appointment, randomized in error|1|||
126159165|NCT02115815|453870244|FG006|Overall Study|Missed appointment, randomized in error|0|||
126159166|NCT01228071|453870245|FG000|Overall Study|Protocol Violation|1|||
126159167|NCT01228071|453870245|FG000|Overall Study|Withdrawal by Subject|1|||
125972204|NCT02576067|453186808|FG001|Overall Study|not randomized, failed run-in|0|||
125972205|NCT02576067|453186807|FG000|Overall Study|screen failure/ re-enrolled|0|||
125972206|NCT02576067|453186808|FG001|Overall Study|screen failure/ re-enrolled|25|||
126159168|NCT03314519|453870246|FG000|Overall Study|Protocol Violation|3|||
126159169|NCT03314519|453870247|FG001|Overall Study|Protocol Violation|2|||
126159170|NCT04003155|453870248|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
126159171|NCT04003155|453870249|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
126159172|NCT04003155|453870250|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
126159173|NCT04003155|453870251|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
126159174|NCT04003155|453870252|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
126159175|NCT04003155|453870248|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
126159176|NCT04003155|453870249|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
126159177|NCT04003155|453870250|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
126159178|NCT04003155|453870251|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
126159179|NCT04003155|453870252|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
126159180|NCT04003155|453870248|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
126159181|NCT04003155|453870249|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
126159182|NCT04003155|453870250|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
126159183|NCT04003155|453870251|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
126159184|NCT04003155|453870252|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
126159185|NCT04003155|453870248|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
126159186|NCT04003155|453870249|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
126159187|NCT04003155|453870250|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
126159188|NCT04003155|453870251|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
126159189|NCT04003155|453870252|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
126159190|NCT04003155|453870248|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
126159191|NCT04003155|453870249|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
126159192|NCT04003155|453870250|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
126159193|NCT04003155|453870251|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
126159194|NCT04003155|453870252|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
126159195|NCT04003155|453870248|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
126159196|NCT04003155|453870249|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
126159197|NCT04003155|453870250|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
126159198|NCT04003155|453870251|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
125972207|NCT02576067|453186807|FG000|Overall Study|Physician Decision|4|||
125972208|NCT02576067|453186808|FG001|Overall Study|Physician Decision|0|||
125972209|NCT04773587|453186809|FG000|Overall Study|Lost to Follow-up|11|||
125972210|NCT04773587|453186810|FG001|Overall Study|Lost to Follow-up|3|||
125972211|NCT04773587|453186809|FG000|Overall Study|Adverse Event|6|||
125972212|NCT04773587|453186810|FG001|Overall Study|Adverse Event|3|||
125972213|NCT04773587|453186809|FG000|Overall Study|Lack of Efficacy|5|||
125972214|NCT04773587|453186810|FG001|Overall Study|Lack of Efficacy|2|||
125972215|NCT04773587|453186809|FG000|Overall Study|Withdrawal by Subject|4|||
125972216|NCT04773587|453186810|FG001|Overall Study|Withdrawal by Subject|5|||
125972217|NCT04773587|453186809|FG000|Overall Study|Noncompliance|1|||
125972218|NCT04773587|453186810|FG001|Overall Study|Noncompliance|0|||
125972219|NCT04773587|453186809|FG000|Overall Study|Protocol Violation|1|||
125972220|NCT04773587|453186810|FG001|Overall Study|Protocol Violation|0|||
125972221|NCT04773587|453186809|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
125972222|NCT04773587|453186810|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
125972223|NCT02372409|453186811|FG000|Overall Study|Lost to Follow-up|1|||
125972224|NCT02372409|453186812|FG001|Overall Study|Lost to Follow-up|0|||
125972225|NCT02372409|453186811|FG000|Overall Study|Disease progression|1|||
125972226|NCT02372409|453186812|FG001|Overall Study|Disease progression|1|||
125972227|NCT01808313|453186813|FG000|Overall Study|Adverse Event|5|||
125972228|NCT01808313|453186813|FG000|Overall Study|Protocol Violation|2|||
125972229|NCT01808313|453186813|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125972230|NCT01808313|453186813|FG000|Overall Study|Lost to Follow-up|1|||
125972231|NCT01808313|453186813|FG000|Overall Study|Physician Decision|1|||
125972232|NCT00622167|453186815|FG000|Overall Study|Did not meet angiographic criteria|20|||
125972233|NCT04598152|453186817|FG000|Overall Study|Lost to Follow-up|0|||
125972234|NCT04598152|453186818|FG001|Overall Study|Lost to Follow-up|1|||
125972235|NCT01954017|453186819|FG000|Overall Study|Adverse Event|0|||
125972236|NCT01954017|453186820|FG001|Overall Study|Adverse Event|0|||
125972237|NCT01954017|453186821|FG002|Overall Study|Adverse Event|1|||
125972238|NCT01954017|453186819|FG000|Overall Study|Death|2|||
125972239|NCT01954017|453186820|FG001|Overall Study|Death|1|||
125972240|NCT01954017|453186821|FG002|Overall Study|Death|1|||
125972241|NCT01954017|453186819|FG000|Overall Study|Withdrawal by Subject|0|||
126159199|NCT04003155|453870252|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
126159200|NCT04003155|453870248|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
126159201|NCT04003155|453870249|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
126159202|NCT04003155|453870250|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
126159203|NCT04003155|453870251|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
126159204|NCT04003155|453870252|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
125972242|NCT01954017|453186820|FG001|Overall Study|Withdrawal by Subject|1|||
125972243|NCT01954017|453186821|FG002|Overall Study|Withdrawal by Subject|0|||
125972244|NCT01954017|453186819|FG000|Overall Study|Protocol Violation|0|||
125972245|NCT01954017|453186820|FG001|Overall Study|Protocol Violation|3|||
125972246|NCT01954017|453186821|FG002|Overall Study|Protocol Violation|2|||
125972247|NCT01954017|453186819|FG000|Overall Study|Necrotizing enterocolitis|1|||
126159205|NCT04003155|453870248|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
126159206|NCT04003155|453870249|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
126159207|NCT04003155|453870250|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
126159208|NCT04003155|453870251|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
126159209|NCT04003155|453870252|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
126159210|NCT04003155|453870248|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
126159211|NCT04003155|453870249|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
126159212|NCT04003155|453870250|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
126159213|NCT04003155|453870251|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
126159214|NCT04003155|453870252|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
126159215|NCT01912872|453870253|FG000|Overall Study|Lost to Follow-up|2|||
126159216|NCT01912872|453870254|FG001|Overall Study|Lost to Follow-up|3|||
126159217|NCT01912872|453870255|FG002|Overall Study|Lost to Follow-up|5|||
126159218|NCT01912872|453870256|FG003|Overall Study|Lost to Follow-up|5|||
126159219|NCT01912872|453870253|FG000|Overall Study|Other unspecified|3|||
126159220|NCT01912872|453870254|FG001|Overall Study|Other unspecified|1|||
126159221|NCT01912872|453870255|FG002|Overall Study|Other unspecified|3|||
126159222|NCT01912872|453870256|FG003|Overall Study|Other unspecified|0|||
126159223|NCT01912872|453870253|FG000|Overall Study|Informed consent withdrawn|0|||
126159224|NCT01912872|453870254|FG001|Overall Study|Informed consent withdrawn|0|||
126159225|NCT01912872|453870255|FG002|Overall Study|Informed consent withdrawn|1|||
126159226|NCT01912872|453870256|FG003|Overall Study|Informed consent withdrawn|1|||
126159227|NCT01912872|453870253|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
126159228|NCT01912872|453870254|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
126159229|NCT01912872|453870255|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
126159230|NCT01912872|453870256|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
126159231|NCT01912872|453870253|FG000|Overall Study|Protocol Violation|0|||
126159232|NCT01912872|453870254|FG001|Overall Study|Protocol Violation|0|||
126159233|NCT01912872|453870255|FG002|Overall Study|Protocol Violation|1|||
126159234|NCT01912872|453870256|FG003|Overall Study|Protocol Violation|0|||
126159235|NCT01912872|453870253|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126159236|NCT01912872|453870254|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126159237|NCT01912872|453870255|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126159238|NCT01912872|453870256|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
126159239|NCT01912872|453870253|FG000|Overall Study|Withdrawal of study medication|0|||
126159240|NCT01912872|453870254|FG001|Overall Study|Withdrawal of study medication|0|||
126159241|NCT01912872|453870255|FG002|Overall Study|Withdrawal of study medication|0|||
126159242|NCT01912872|453870256|FG003|Overall Study|Withdrawal of study medication|2|||
126159243|NCT01912872|453870253|FG000|Overall Study|Missing|0|||
126159244|NCT01912872|453870254|FG001|Overall Study|Missing|0|||
126159245|NCT01912872|453870255|FG002|Overall Study|Missing|0|||
126159246|NCT01912872|453870256|FG003|Overall Study|Missing|1|||
126159247|NCT00950690|453870257|FG000|Overall Study|Death|4|||
126159248|NCT00950690|453870257|FG000|Overall Study|Adverse Event|15|||
126159249|NCT00950690|453870257|FG000|Overall Study|Lack of Efficacy|22|||
126159250|NCT00950690|453870257|FG000|Overall Study|Lost to Follow-up|40|||
126159251|NCT00950690|453870257|FG000|Overall Study|Other|163|||
126159252|NCT01713036|453870258|FG000|Overall Study|Death|1|||
126159253|NCT02778867|453870259|FG000|Phase 1|Withdrawal by Subject|2|||
126159254|NCT02778867|453870260|FG001|Phase 1|Withdrawal by Subject|3|||
126159255|NCT02778867|453870261|FG002|Phase 1|Withdrawal by Subject|0|||
126159256|NCT02778867|453870262|FG003|Phase 1|Withdrawal by Subject|0|||
126159257|NCT02778867|453870259|FG000|Phase 2|Withdrawal by Subject|0|||
126159258|NCT02778867|453870260|FG001|Phase 2|Withdrawal by Subject|0|||
126159259|NCT02778867|453870261|FG002|Phase 2|Withdrawal by Subject|1|||
126159260|NCT02778867|453870262|FG003|Phase 2|Withdrawal by Subject|0|||
126159261|NCT02778867|453870259|FG000|Phase 2|Physician Decision|0|||
126159262|NCT02778867|453870260|FG001|Phase 2|Physician Decision|0|||
126159263|NCT02778867|453870261|FG002|Phase 2|Physician Decision|0|||
126159264|NCT02778867|453870262|FG003|Phase 2|Physician Decision|1|||
126159265|NCT02778867|453870259|FG000|Phase 2|Adverse Event|0|||
126159266|NCT02778867|453870260|FG001|Phase 2|Adverse Event|0|||
126159267|NCT02778867|453870261|FG002|Phase 2|Adverse Event|0|||
126159268|NCT02778867|453870262|FG003|Phase 2|Adverse Event|1|||
126159269|NCT03504774|453870263|FG000|Overall Study|Adverse Event|2|||
126159270|NCT03504774|453870264|FG001|Overall Study|Adverse Event|0|||
126159271|NCT03504774|453870263|FG000|Overall Study|Lost to Follow-up|0|||
126159272|NCT03504774|453870264|FG001|Overall Study|Lost to Follow-up|1|||
126159273|NCT03504774|453870263|FG000|Overall Study|Protocol Violation|11|||
126159274|NCT03504774|453870264|FG001|Overall Study|Protocol Violation|3|||
126159275|NCT03504774|453870263|FG000|Overall Study|failed wk 52 DBPCFC|1|||
126159276|NCT03504774|453870264|FG001|Overall Study|failed wk 52 DBPCFC|0|||
126159277|NCT00915005|453870270|FG000|Overall Study|Withdrawal by Subject|4|||
126159278|NCT00915005|453870271|FG001|Overall Study|Withdrawal by Subject|4|||
126159279|NCT00915005|453870270|FG000|Overall Study|Patient preferred protons therapy|6|||
126159280|NCT00915005|453870271|FG001|Overall Study|Patient preferred protons therapy|0|||
126159281|NCT00915005|453870270|FG000|Overall Study|Insurance denial|3|||
126159282|NCT00915005|453870271|FG001|Overall Study|Insurance denial|15|||
126159283|NCT00305006|453870276|FG000|Overall Study|Withdrawal by Subject|1|||
126159284|NCT00305006|453870277|FG001|Overall Study|Withdrawal by Subject|0|||
126159285|NCT00305006|453870276|FG000|Overall Study|Failure to complete pretest|0|||
126159286|NCT00305006|453870277|FG001|Overall Study|Failure to complete pretest|1|||
126159287|NCT00631488|453870278|FG000|Overall Study|Adverse Event|1|||
126159288|NCT00631488|453870279|FG001|Overall Study|Adverse Event|0|||
126159289|NCT00631488|453870280|FG002|Overall Study|Adverse Event|0|||
126159290|NCT00631488|453870278|FG000|Overall Study|Lost to Follow-up|2|||
126159291|NCT00631488|453870279|FG001|Overall Study|Lost to Follow-up|2|||
126159292|NCT00631488|453870280|FG002|Overall Study|Lost to Follow-up|0|||
126159293|NCT00631488|453870278|FG000|Overall Study|Physician Decision|1|||
126159294|NCT00631488|453870279|FG001|Overall Study|Physician Decision|0|||
126159295|NCT00631488|453870280|FG002|Overall Study|Physician Decision|1|||
126159296|NCT00631488|453870278|FG000|Overall Study|Protocol Violation|0|||
126159297|NCT00631488|453870279|FG001|Overall Study|Protocol Violation|0|||
126159298|NCT00631488|453870280|FG002|Overall Study|Protocol Violation|1|||
126159299|NCT03648476|453870282|FG000|Overall Study|Withdrawal by Subject|2|||
126159300|NCT03648476|453870283|FG001|Overall Study|Withdrawal by Subject|1|||
126159301|NCT02546856|453870288|FG000|4 Months Evaluation|Death|2|||
126159302|NCT02546856|453870289|FG001|4 Months Evaluation|Death|3|||
126159303|NCT02546856|453870288|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
126159304|NCT02546856|453870289|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
126159305|NCT02546856|453870288|FG000|4 Months Evaluation|Lost to Follow-up|3|||
126159306|NCT02546856|453870289|FG001|4 Months Evaluation|Lost to Follow-up|3|||
126159307|NCT02546856|453870288|FG000|4 Months Evaluation|Physician Decision|3|||
126159308|NCT02546856|453870289|FG001|4 Months Evaluation|Physician Decision|0|||
126159309|NCT02546856|453870288|FG000|4 Months Evaluation|Working or living abroad|5|||
126159310|NCT02546856|453870289|FG001|4 Months Evaluation|Working or living abroad|1|||
126159311|NCT02546856|453870288|FG000|4 Months Evaluation|reasons not due to titration|4|||
126159312|NCT02546856|453870289|FG001|4 Months Evaluation|reasons not due to titration|1|||
126159313|NCT02546856|453870288|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
126159314|NCT02546856|453870289|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
126159315|NCT02546856|453870288|FG000|6 Months Evaluation|Death|1|||
126159316|NCT02546856|453870289|FG001|6 Months Evaluation|Death|1|||
126159317|NCT02546856|453870288|FG000|6 Months Evaluation|Lost to Follow-up|1|||
126159318|NCT02546856|453870289|FG001|6 Months Evaluation|Lost to Follow-up|1|||
126159319|NCT02546856|453870288|FG000|6 Months Evaluation|Working or living abroad|6|||
126159320|NCT02546856|453870289|FG001|6 Months Evaluation|Working or living abroad|4|||
126159321|NCT02546856|453870288|FG000|6 Months Evaluation|reasons not due to titration|0|||
126159322|NCT02546856|453870289|FG001|6 Months Evaluation|reasons not due to titration|1|||
126159323|NCT01097616|453870291|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
126159324|NCT01097616|453870292|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
126159325|NCT01097616|453870293|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
126159326|NCT01097616|453870294|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126159327|NCT01097616|453870295|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126159328|NCT01097616|453870296|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126159329|NCT01097616|453870297|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126159330|NCT01097616|453870298|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126159331|NCT01097616|453870291|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
126159332|NCT01097616|453870292|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
126159333|NCT01097616|453870293|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
126159334|NCT01097616|453870294|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126159335|NCT01097616|453870295|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126159336|NCT01097616|453870296|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126159337|NCT01097616|453870297|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126159338|NCT01097616|453870298|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126159339|NCT01097616|453870291|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
126159340|NCT01097616|453870292|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
126159341|NCT01097616|453870293|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
126159342|NCT01097616|453870294|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126159343|NCT01097616|453870295|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126159344|NCT01097616|453870296|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126159345|NCT01097616|453870297|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126159346|NCT01097616|453870298|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126159347|NCT01097616|453870291|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
126159348|NCT01097616|453870292|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
126159349|NCT01097616|453870293|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126159350|NCT01097616|453870294|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126159351|NCT01097616|453870295|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126200107|NCT02394028|454017884|FG007|Induction Phase|Adverse Event|0|||
126159352|NCT01097616|453870296|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126159353|NCT01097616|453870297|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126159354|NCT01097616|453870298|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126159355|NCT01097616|453870291|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
126159356|NCT01097616|453870292|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
126159357|NCT01097616|453870293|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
126159358|NCT01097616|453870294|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126159359|NCT01097616|453870295|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126159360|NCT01097616|453870296|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126159361|NCT01097616|453870297|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126159362|NCT01097616|453870298|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126159363|NCT01097616|453870291|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
126159364|NCT01097616|453870292|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
126159365|NCT01097616|453870293|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126159366|NCT01097616|453870294|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126159367|NCT01097616|453870295|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126159368|NCT01097616|453870296|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126159369|NCT01097616|453870297|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126159370|NCT01097616|453870298|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126159371|NCT01097616|453870291|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
126159372|NCT01097616|453870292|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
126159373|NCT01097616|453870293|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126159374|NCT01097616|453870294|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126159375|NCT01097616|453870295|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126159376|NCT01097616|453870296|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126159377|NCT01097616|453870297|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126159378|NCT01097616|453870298|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126159379|NCT01097616|453870291|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126159380|NCT01097616|453870292|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126159381|NCT01097616|453870293|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
126159382|NCT01097616|453870294|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126159383|NCT01097616|453870295|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126159384|NCT01097616|453870296|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126159385|NCT01097616|453870297|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126159386|NCT01097616|453870298|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126159387|NCT01097616|453870291|FG000|Optional DB EXT Phase|Adverse Event|0|||
126159388|NCT01097616|453870292|FG001|Optional DB EXT Phase|Adverse Event|7|||
126159389|NCT01097616|453870293|FG002|Optional DB EXT Phase|Adverse Event|2|||
126159390|NCT01097616|453870294|FG003|Optional DB EXT Phase|Adverse Event|0|||
126159391|NCT01097616|453870295|FG004|Optional DB EXT Phase|Adverse Event|0|||
126159392|NCT01097616|453870296|FG005|Optional DB EXT Phase|Adverse Event|0|||
126159393|NCT01097616|453870297|FG006|Optional DB EXT Phase|Adverse Event|0|||
126159394|NCT01097616|453870298|FG007|Optional DB EXT Phase|Adverse Event|0|||
126159395|NCT01097616|453870291|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
126159396|NCT01097616|453870292|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
126159397|NCT01097616|453870293|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
126159398|NCT01097616|453870294|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
126159399|NCT01097616|453870295|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
126159400|NCT01097616|453870296|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
126159401|NCT01097616|453870297|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
126159402|NCT01097616|453870298|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
126159403|NCT01097616|453870291|FG000|Optional DB EXT Phase|Protocol Violation|0|||
126159404|NCT01097616|453870292|FG001|Optional DB EXT Phase|Protocol Violation|2|||
126159405|NCT01097616|453870293|FG002|Optional DB EXT Phase|Protocol Violation|3|||
126159406|NCT01097616|453870294|FG003|Optional DB EXT Phase|Protocol Violation|0|||
126159407|NCT01097616|453870295|FG004|Optional DB EXT Phase|Protocol Violation|0|||
126159408|NCT01097616|453870296|FG005|Optional DB EXT Phase|Protocol Violation|0|||
126159409|NCT01097616|453870297|FG006|Optional DB EXT Phase|Protocol Violation|0|||
126159410|NCT01097616|453870298|FG007|Optional DB EXT Phase|Protocol Violation|0|||
126159411|NCT01097616|453870291|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
126159412|NCT01097616|453870292|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
125972248|NCT01954017|453186820|FG001|Overall Study|Necrotizing enterocolitis|0|||
126159413|NCT01097616|453870293|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
126159414|NCT01097616|453870294|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
126159415|NCT01097616|453870295|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
125972249|NCT01954017|453186821|FG002|Overall Study|Necrotizing enterocolitis|1|||
125972250|NCT01954017|453186819|FG000|Overall Study|Enteral intake stopped >7 days|0|||
125972251|NCT01954017|453186820|FG001|Overall Study|Enteral intake stopped >7 days|1|||
125972252|NCT01954017|453186821|FG002|Overall Study|Enteral intake stopped >7 days|1|||
126159416|NCT01097616|453870296|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
126159417|NCT01097616|453870297|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
126159418|NCT01097616|453870298|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
126159419|NCT01097616|453870291|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
126159420|NCT01097616|453870292|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
126159421|NCT01097616|453870293|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
126159422|NCT01097616|453870294|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
126159423|NCT01097616|453870295|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
126159424|NCT01097616|453870296|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
126159425|NCT01097616|453870297|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
126159426|NCT01097616|453870298|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
126159427|NCT01097616|453870291|FG000|Optional DB EXT Phase|Physician Decision|1|||
126159428|NCT01097616|453870292|FG001|Optional DB EXT Phase|Physician Decision|0|||
126159429|NCT01097616|453870293|FG002|Optional DB EXT Phase|Physician Decision|0|||
126159430|NCT01097616|453870294|FG003|Optional DB EXT Phase|Physician Decision|0|||
126159431|NCT01097616|453870295|FG004|Optional DB EXT Phase|Physician Decision|0|||
126159432|NCT01097616|453870296|FG005|Optional DB EXT Phase|Physician Decision|0|||
126159433|NCT01097616|453870297|FG006|Optional DB EXT Phase|Physician Decision|0|||
126159434|NCT01097616|453870298|FG007|Optional DB EXT Phase|Physician Decision|0|||
126159435|NCT01097616|453870291|FG000|DB RO Phase|Adverse Event|0|||
126159436|NCT01097616|453870292|FG001|DB RO Phase|Adverse Event|0|||
126159437|NCT01097616|453870293|FG002|DB RO Phase|Adverse Event|0|||
126159438|NCT01097616|453870294|FG003|DB RO Phase|Adverse Event|0|||
126159439|NCT01097616|453870295|FG004|DB RO Phase|Adverse Event|0|||
126159440|NCT01097616|453870296|FG005|DB RO Phase|Adverse Event|0|||
126159441|NCT01097616|453870297|FG006|DB RO Phase|Adverse Event|1|||
126159442|NCT01097616|453870298|FG007|DB RO Phase|Adverse Event|0|||
126159443|NCT01097616|453870291|FG000|DB RO Phase|Withdrawal by Subject|0|||
126159444|NCT01097616|453870292|FG001|DB RO Phase|Withdrawal by Subject|0|||
126159445|NCT01097616|453870293|FG002|DB RO Phase|Withdrawal by Subject|0|||
126159446|NCT01097616|453870294|FG003|DB RO Phase|Withdrawal by Subject|0|||
126159447|NCT01097616|453870295|FG004|DB RO Phase|Withdrawal by Subject|0|||
126159448|NCT01097616|453870296|FG005|DB RO Phase|Withdrawal by Subject|1|||
126159449|NCT01097616|453870297|FG006|DB RO Phase|Withdrawal by Subject|0|||
126159450|NCT01097616|453870298|FG007|DB RO Phase|Withdrawal by Subject|0|||
126159451|NCT01097616|453870291|FG000|DB RO Phase|Lost to Follow-up|0|||
126159452|NCT01097616|453870292|FG001|DB RO Phase|Lost to Follow-up|0|||
126159453|NCT01097616|453870293|FG002|DB RO Phase|Lost to Follow-up|0|||
126159454|NCT01097616|453870294|FG003|DB RO Phase|Lost to Follow-up|1|||
126159455|NCT01097616|453870295|FG004|DB RO Phase|Lost to Follow-up|1|||
126159456|NCT01097616|453870296|FG005|DB RO Phase|Lost to Follow-up|0|||
126159457|NCT01097616|453870297|FG006|DB RO Phase|Lost to Follow-up|0|||
126159458|NCT01097616|453870298|FG007|DB RO Phase|Lost to Follow-up|1|||
126159459|NCT01097616|453870291|FG000|DB RO Phase|Not Treated in RO|0|||
126159460|NCT01097616|453870292|FG001|DB RO Phase|Not Treated in RO|0|||
126159461|NCT01097616|453870293|FG002|DB RO Phase|Not Treated in RO|0|||
126159462|NCT01097616|453870294|FG003|DB RO Phase|Not Treated in RO|0|||
126159463|NCT01097616|453870295|FG004|DB RO Phase|Not Treated in RO|0|||
126159464|NCT01097616|453870296|FG005|DB RO Phase|Not Treated in RO|1|||
126159465|NCT01097616|453870297|FG006|DB RO Phase|Not Treated in RO|0|||
126159466|NCT01097616|453870298|FG007|DB RO Phase|Not Treated in RO|0|||
126159467|NCT01996319|453870299|FG000|Overall Study|Protocol Violation|1|||
126159468|NCT01996319|453870300|FG001|Overall Study|Protocol Violation|0|||
126159469|NCT01996319|453870299|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
126159470|NCT01996319|453870300|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
126159471|NCT01996319|453870299|FG000|Overall Study|Adverse Event|2|||
126159472|NCT01996319|453870300|FG001|Overall Study|Adverse Event|2|||
126159473|NCT00117338|453870301|FG000|Overall Study|Adverse Event|0|||
126159474|NCT00117338|453870302|FG001|Overall Study|Adverse Event|1|||
126159475|NCT00117338|453870301|FG000|Overall Study|Protocol Violation|3|||
126159476|NCT00117338|453870302|FG001|Overall Study|Protocol Violation|2|||
126159477|NCT00117338|453870301|FG000|Overall Study|Withdrawal by Subject|1|||
126159478|NCT00117338|453870302|FG001|Overall Study|Withdrawal by Subject|0|||
126159479|NCT00117338|453870301|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
126159480|NCT00117338|453870302|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
126159481|NCT00117338|453870301|FG000|Overall Study|Lack of Efficacy|0|||
126159482|NCT00117338|453870302|FG001|Overall Study|Lack of Efficacy|1|||
126159483|NCT02240628|453870304|FG000|Overall Study|Physician Decision|6|||
126159484|NCT02240628|453870305|FG001|Overall Study|Physician Decision|5|||
126159485|NCT01703819|453870309|FG000|Overall Study|Adverse Event|0|||
126159486|NCT01703819|453870310|FG001|Overall Study|Adverse Event|1|||
126159487|NCT01703819|453870309|FG000|Overall Study|Withdrawal by Subject|0|||
126159488|NCT01703819|453870310|FG001|Overall Study|Withdrawal by Subject|1|||
126159489|NCT00859898|453870311|FG000|Overall Study|Lack of Efficacy|0|||
126159490|NCT00859898|453870312|FG001|Overall Study|Lack of Efficacy|1|||
126159491|NCT00859898|453870313|FG002|Overall Study|Lack of Efficacy|1|||
126159492|NCT00859898|453870311|FG000|Overall Study|Adverse Event|4|||
126159493|NCT00859898|453870312|FG001|Overall Study|Adverse Event|9|||
126159494|NCT00859898|453870313|FG002|Overall Study|Adverse Event|8|||
126159495|NCT00859898|453870311|FG000|Overall Study|Withdrawal by Subject|11|||
126159496|NCT00859898|453870312|FG001|Overall Study|Withdrawal by Subject|8|||
126159497|NCT00859898|453870313|FG002|Overall Study|Withdrawal by Subject|11|||
126159498|NCT00859898|453870311|FG000|Overall Study|Death|0|||
126159499|NCT00859898|453870312|FG001|Overall Study|Death|0|||
126159500|NCT00859898|453870313|FG002|Overall Study|Death|1|||
126159501|NCT00859898|453870311|FG000|Overall Study|Lost to Follow-up|10|||
126159502|NCT00859898|453870312|FG001|Overall Study|Lost to Follow-up|11|||
126159503|NCT00859898|453870313|FG002|Overall Study|Lost to Follow-up|5|||
126159504|NCT00859898|453870311|FG000|Overall Study|poor/non-compliance|2|||
126159505|NCT00859898|453870312|FG001|Overall Study|poor/non-compliance|0|||
126159506|NCT00859898|453870313|FG002|Overall Study|poor/non-compliance|0|||
126159507|NCT00859898|453870311|FG000|Overall Study|No longer meets criteria|0|||
126159508|NCT00859898|453870312|FG001|Overall Study|No longer meets criteria|1|||
126159509|NCT00859898|453870313|FG002|Overall Study|No longer meets criteria|0|||
126159510|NCT00859898|453870311|FG000|Overall Study|non-specified|1|||
126159511|NCT00859898|453870312|FG001|Overall Study|non-specified|1|||
126159512|NCT00859898|453870313|FG002|Overall Study|non-specified|1|||
126159513|NCT02145156|453870314|FG000|Overall Study|No match to vaccination records|60|||
126159514|NCT02145156|453870315|FG001|Overall Study|No match to vaccination records|52|||
126159515|NCT02145156|453870316|FG002|Overall Study|No match to vaccination records|41|||
126159516|NCT01302041|453870317|FG000|Overall Study|Death|5|||
126159517|NCT01302041|453870317|FG000|Overall Study|Withdrawal by Subject|4|||
126159518|NCT01302041|453870317|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
126159519|NCT01302041|453870317|FG000|Overall Study|Other-Miscellaneous Reason|2|||
126159520|NCT00771030|453870318|FG000|Overall Study|Adverse Event|0|||
126159521|NCT00771030|453870319|FG001|Overall Study|Adverse Event|1|||
126159522|NCT00771030|453870320|FG002|Overall Study|Adverse Event|0|||
126159523|NCT00771030|453870321|FG003|Overall Study|Adverse Event|0|||
126159524|NCT00771030|453870322|FG004|Overall Study|Adverse Event|0|||
126159525|NCT00771030|453870323|FG005|Overall Study|Adverse Event|0|||
126159526|NCT00771030|453870324|FG006|Overall Study|Adverse Event|0|||
126159527|NCT05232097|453870327|FG000|Overall Study|Physician Decision|1|||
126159528|NCT00871858|453870328|FG000|Overall Study|Protocol Violation|3|||
126159529|NCT00871858|453870329|FG001|Overall Study|Protocol Violation|4|||
126159530|NCT00871858|453870328|FG000|Overall Study|Adverse Event|1|||
126159531|NCT00871858|453870329|FG001|Overall Study|Adverse Event|1|||
126159532|NCT00871858|453870328|FG000|Overall Study|Withdrawal by Subject|1|||
126159533|NCT00871858|453870329|FG001|Overall Study|Withdrawal by Subject|1|||
126159534|NCT00871858|453870328|FG000|Overall Study|Lost to Follow-up|0|||
126159535|NCT00871858|453870329|FG001|Overall Study|Lost to Follow-up|1|||
126159536|NCT02853331|453870339|FG000|Overall Study|Death|59|||
126159537|NCT02853331|453870340|FG001|Overall Study|Death|95|||
126159538|NCT02853331|453870339|FG000|Overall Study|Withdrawal by Subject|5|||
126159539|NCT02853331|453870340|FG001|Overall Study|Withdrawal by Subject|9|||
126159540|NCT02853331|453870339|FG000|Overall Study|Ongoing in study|368|||
126159541|NCT02853331|453870340|FG001|Overall Study|Ongoing in study|325|||
126159542|NCT03290300|453870347|FG000|Overall Study|Lost to Follow-up|3|||
126159543|NCT04773041|453870352|FG000|Overall Study|Unable to data match|1|||
126159544|NCT04773041|453870353|FG001|Overall Study|Unable to data match|0|||
126159545|NCT04773041|453870354|FG002|Overall Study|Unable to data match|0|||
126159546|NCT02100657|453871590|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
126159547|NCT02100657|453871591|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
126159548|NCT02100657|453871592|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
126159549|NCT02100657|453871590|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
126159550|NCT02100657|453871591|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
126159551|NCT02100657|453871592|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
126159552|NCT02100657|453871590|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
125972253|NCT01954017|453186819|FG000|Overall Study|All other reasons|2|||
125972254|NCT01954017|453186820|FG001|Overall Study|All other reasons|2|||
125972255|NCT01954017|453186821|FG002|Overall Study|All other reasons|7|||
125972256|NCT03674177|453186829|FG000|Overall Study|Lost to Follow-up|2|||
125972257|NCT03674177|453186830|FG001|Overall Study|Lost to Follow-up|1|||
125972258|NCT03674177|453186831|FG002|Overall Study|Lost to Follow-up|0|||
125972259|NCT03674177|453186832|FG003|Overall Study|Lost to Follow-up|2|||
125972260|NCT00714168|453186833|FG000|Overall Study|Pregnancy|5|||
125972261|NCT00714168|453186834|FG001|Overall Study|Pregnancy|4|||
126159553|NCT02100657|453871591|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
126159554|NCT02100657|453871592|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
126159555|NCT02100657|453871590|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
126159556|NCT02100657|453871591|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
126159557|NCT02100657|453871592|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
126159558|NCT02100657|453871590|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
126159559|NCT02100657|453871591|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
126200108|NCT02394028|454017885|FG008|Induction Phase|Adverse Event|0|||
125972262|NCT00714168|453186833|FG000|Overall Study|Lost to Follow-up|32|||
125972263|NCT00714168|453186834|FG001|Overall Study|Lost to Follow-up|50|||
125972264|NCT00714168|453186833|FG000|Overall Study|Relocation|4|||
126159560|NCT02100657|453871592|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
126159561|NCT02100657|453871590|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
126159562|NCT02100657|453871591|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
126159563|NCT02100657|453871592|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
126159564|NCT02100657|453871590|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
126159565|NCT02100657|453871591|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
126159566|NCT02100657|453871592|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
126159567|NCT02100657|453871590|FG000|Cohort 3: Dose Level 3|Death|0|||
126159568|NCT02100657|453871591|FG001|Cohort 3: Dose Level 3|Death|0|||
126159569|NCT02100657|453871592|FG002|Cohort 3: Dose Level 3|Death|1|||
126159570|NCT02100657|453871590|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
126159571|NCT02100657|453871591|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
126159572|NCT02100657|453871592|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
126159573|NCT02100657|453871590|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
126159574|NCT02100657|453871591|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
126159575|NCT02100657|453871592|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
126159576|NCT02100657|453871590|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
126159577|NCT02100657|453871591|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
126159578|NCT02100657|453871592|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
126159579|NCT02100657|453871590|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
126159580|NCT02100657|453871591|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
126159581|NCT02100657|453871592|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
126159582|NCT02100657|453871590|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
126159583|NCT02100657|453871591|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
126159584|NCT02100657|453871592|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
126159585|NCT02322892|453871596|FG000|Overall Study|Surgery cancelled|1|||
126159586|NCT02322892|453871597|FG001|Overall Study|Surgery cancelled|2|||
126159587|NCT02322892|453871596|FG000|Overall Study|Met exclusion criteria|0|||
126159588|NCT02322892|453871597|FG001|Overall Study|Met exclusion criteria|1|||
126159589|NCT02322892|453871596|FG000|Overall Study|Protocol Violation|1|||
126159590|NCT02322892|453871597|FG001|Overall Study|Protocol Violation|0|||
125972265|NCT00714168|453186834|FG001|Overall Study|Relocation|3|||
125972266|NCT00714168|453186833|FG000|Overall Study|Non-study medical condition|3|||
125972267|NCT00714168|453186834|FG001|Overall Study|Non-study medical condition|2|||
125972268|NCT01128413|453186838|FG000|Overall Study|Withdrawal by Subject|1|||
125972269|NCT01128413|453186839|FG001|Overall Study|Withdrawal by Subject|0|||
125972270|NCT01128413|453186838|FG000|Overall Study|NICOM Monitor Problems|2|||
125972271|NCT01128413|453186839|FG001|Overall Study|NICOM Monitor Problems|1|||
125972272|NCT01128413|453186838|FG000|Overall Study|Pt made DNR|1|||
125972273|NCT01128413|453186839|FG001|Overall Study|Pt made DNR|0|||
125972274|NCT00722761|453186840|FG000|Overall Study|Lost to Follow-up|1|||
125972275|NCT00722761|453186841|FG001|Overall Study|Lost to Follow-up|4|||
125972276|NCT00722761|453186840|FG000|Overall Study|Withdrawal by Subject|5|||
125972277|NCT00722761|453186841|FG001|Overall Study|Withdrawal by Subject|2|||
125972278|NCT02075593|453186843|FG000|Overall Study|Withdrawal by Subject|1|||
125972279|NCT06167031|453186845|FG000|Overall Study|Lost to Follow-up|5|||
125972280|NCT06167031|453186846|FG001|Overall Study|Lost to Follow-up|1|||
125972281|NCT01588184|453188748|FG000|Overall Study|Death|1|||
125972282|NCT01588184|453188749|FG001|Overall Study|Death|0|||
125972283|NCT01588184|453188750|FG002|Overall Study|Death|0|||
125972284|NCT01588184|453188751|FG003|Overall Study|Death|1|||
125972285|NCT01588184|453188752|FG004|Overall Study|Death|1|||
125972286|NCT01588184|453188753|FG005|Overall Study|Death|1|||
125972287|NCT01588184|453188748|FG000|Overall Study|Withdrawal by Subject|2|||
125972288|NCT01588184|453188749|FG001|Overall Study|Withdrawal by Subject|4|||
125972289|NCT01588184|453188750|FG002|Overall Study|Withdrawal by Subject|0|||
125972290|NCT01588184|453188751|FG003|Overall Study|Withdrawal by Subject|1|||
125972291|NCT01588184|453188752|FG004|Overall Study|Withdrawal by Subject|0|||
125972292|NCT01588184|453188753|FG005|Overall Study|Withdrawal by Subject|0|||
125972293|NCT01588184|453188748|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
125972294|NCT01588184|453188749|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
125972295|NCT01588184|453188750|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
125972296|NCT01588184|453188751|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
125972297|NCT01588184|453188752|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
125972298|NCT01588184|453188753|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
125972299|NCT01588184|453188748|FG000|Overall Study|multiple reasons|0|||
125972300|NCT01588184|453188749|FG001|Overall Study|multiple reasons|3|||
125972301|NCT01588184|453188750|FG002|Overall Study|multiple reasons|0|||
125972302|NCT01588184|453188751|FG003|Overall Study|multiple reasons|1|||
125972303|NCT01588184|453188752|FG004|Overall Study|multiple reasons|0|||
125972304|NCT01588184|453188753|FG005|Overall Study|multiple reasons|0|||
125972305|NCT05912400|453188755|FG000|Overall Study|Lost to Follow-up|1|||
125972306|NCT05912400|453188756|FG001|Overall Study|Lost to Follow-up|0|||
125972307|NCT05912400|453188755|FG000|Overall Study|Physician Decision|6|||
125972308|NCT05912400|453188756|FG001|Overall Study|Physician Decision|0|||
126159591|NCT02125331|453871600|FG000|Overall Study|Protocol Violation|1|||
126159592|NCT02125331|453871601|FG001|Overall Study|Protocol Violation|0|||
126159593|NCT02125331|453871600|FG000|Overall Study|technical problem|2|||
126159594|NCT02125331|453871601|FG001|Overall Study|technical problem|0|||
126159595|NCT02125331|453871600|FG000|Overall Study|screen failure|2|||
126159596|NCT02125331|453871601|FG001|Overall Study|screen failure|0|||
126159597|NCT03123354|453871602|FG000|Overall Study|Physician Decision|6|||
126159598|NCT00130208|453871604|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
126159599|NCT00130208|453871605|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
126159600|NCT00130208|453871604|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
126159601|NCT00130208|453871605|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
126159602|NCT00130208|453871604|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
126159603|NCT00130208|453871605|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
126159604|NCT00130208|453871604|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
126159605|NCT00130208|453871605|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
126159606|NCT00130208|453871604|FG000|Maintenance Period (26 Weeks)|Other|1|||
126159607|NCT00130208|453871605|FG001|Maintenance Period (26 Weeks)|Other|1|||
126159608|NCT00130208|453871604|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
126159609|NCT00130208|453871605|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
126159610|NCT00130208|453871604|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
126159611|NCT00130208|453871605|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
126159612|NCT00130208|453871604|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
126159613|NCT00130208|453871605|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
126159614|NCT00130208|453871604|FG000|Washout Period (8 Weeks)|Other|1|||
126159615|NCT00130208|453871605|FG001|Washout Period (8 Weeks)|Other|1|||
126159616|NCT00589472|453871609|FG000|Overall Study|Adverse Event|1|||
126159617|NCT00553059|453871610|FG000|Overall Study|Deemed ineligible|1|||
126159618|NCT00553059|453871611|FG001|Overall Study|Deemed ineligible|1|||
126159619|NCT00553059|453871610|FG000|Overall Study|Drug supply not available|0|||
126159620|NCT00553059|453871611|FG001|Overall Study|Drug supply not available|1|||
126159621|NCT04230486|453871622|FG000|Overall Study|Screen Failure|1|||
126159622|NCT03215264|453871623|FG000|Dose Level 2|Adverse Event|0|||
126159623|NCT03215264|453871624|FG001|Dose Level 2|Adverse Event|1|||
126159624|NCT03215264|453871625|FG002|Dose Level 2|Adverse Event|0|||
126159625|NCT03215264|453871623|FG000|Dose Level 3|Withdrawal by Subject|0|||
126159626|NCT03215264|453871624|FG001|Dose Level 3|Withdrawal by Subject|0|||
126159627|NCT03215264|453871625|FG002|Dose Level 3|Withdrawal by Subject|1|||
126159628|NCT02234583|453871628|FG000|Overall Study|Adverse Event|172|||
126159629|NCT02234583|453871629|FG001|Overall Study|Adverse Event|156|||
126159630|NCT02234583|453871628|FG000|Overall Study|Withdrawal by Subject|109|||
126159631|NCT02234583|453871629|FG001|Overall Study|Withdrawal by Subject|157|||
126159632|NCT02234583|453871628|FG000|Overall Study|Lost to Follow-up|0|||
126159633|NCT02234583|453871629|FG001|Overall Study|Lost to Follow-up|1|||
126159634|NCT02234583|453871628|FG000|Overall Study|Lack of Efficacy|58|||
126159635|NCT02234583|453871629|FG001|Overall Study|Lack of Efficacy|103|||
126159636|NCT02234583|453871628|FG000|Overall Study|Protocol Violation|35|||
126159637|NCT02234583|453871629|FG001|Overall Study|Protocol Violation|42|||
126159638|NCT02234583|453871628|FG000|Overall Study|Other|39|||
126159639|NCT02234583|453871629|FG001|Overall Study|Other|97|||
126159640|NCT01740440|453871630|FG000|Overall Study|Lost to Follow-up|3|||
126159641|NCT02805907|453871631|FG000|Overall Study|Lost to Follow-up|3|||
126159642|NCT02805907|453871632|FG001|Overall Study|Lost to Follow-up|3|||
126159643|NCT01264965|453871633|FG000|Overall Study|Withdrawal by Subject|10|||
126159644|NCT00532883|453871634|FG000|Overall Study|Adverse Event|1|||
126159645|NCT00532883|453871635|FG001|Overall Study|Adverse Event|0|||
126159646|NCT00532883|453871636|FG002|Overall Study|Adverse Event|0|||
126159647|NCT00532883|453871637|FG003|Overall Study|Adverse Event|1|||
126159648|NCT00532883|453871634|FG000|Overall Study|Lost to Follow-up|1|||
126159649|NCT00532883|453871635|FG001|Overall Study|Lost to Follow-up|1|||
126159650|NCT00532883|453871636|FG002|Overall Study|Lost to Follow-up|1|||
126159651|NCT00532883|453871637|FG003|Overall Study|Lost to Follow-up|0|||
126159652|NCT00532883|453871634|FG000|Overall Study|Withdrawal by Subject|0|||
126159653|NCT00532883|453871635|FG001|Overall Study|Withdrawal by Subject|1|||
126159654|NCT00532883|453871636|FG002|Overall Study|Withdrawal by Subject|1|||
126159655|NCT00532883|453871637|FG003|Overall Study|Withdrawal by Subject|0|||
126159656|NCT00532883|453871634|FG000|Overall Study|Subject was Nonadherent|0|||
126159657|NCT00532883|453871635|FG001|Overall Study|Subject was Nonadherent|1|||
126159658|NCT00532883|453871636|FG002|Overall Study|Subject was Nonadherent|1|||
126159659|NCT00532883|453871637|FG003|Overall Study|Subject was Nonadherent|0|||
126159660|NCT00532883|453871634|FG000|Overall Study|Early Study Termination|4|||
126159661|NCT00532883|453871635|FG001|Overall Study|Early Study Termination|4|||
126159662|NCT00532883|453871636|FG002|Overall Study|Early Study Termination|1|||
126159663|NCT00532883|453871637|FG003|Overall Study|Early Study Termination|4|||
126159664|NCT02202031|453871638|FG000|Overall Study|Lost to Follow-up|1|||
126159665|NCT02202031|453871639|FG001|Overall Study|Lost to Follow-up|0|||
126159666|NCT02202031|453871638|FG000|Overall Study|Too Busy|1|||
126159667|NCT02202031|453871639|FG001|Overall Study|Too Busy|3|||
126200109|NCT02394028|454017886|FG009|Induction Phase|Adverse Event|0|||
126159668|NCT02202031|453871638|FG000|Overall Study|Illness/Medical Reason|0|||
126159669|NCT02202031|453871639|FG001|Overall Study|Illness/Medical Reason|2|||
126159670|NCT02202031|453871638|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
126159671|NCT02202031|453871639|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
126159672|NCT01172288|453871642|FG000|Overall Study|Adverse Event|1|||
126159673|NCT01172288|453871643|FG001|Overall Study|Adverse Event|0|||
126159674|NCT01172288|453871642|FG000|Overall Study|Protocol Violation|0|||
126159675|NCT01172288|453871643|FG001|Overall Study|Protocol Violation|1|||
126159676|NCT01276847|453871650|FG000|Overall Study|Withdrawal by Subject|1|||
126159677|NCT01276847|453871651|FG001|Overall Study|Withdrawal by Subject|0|||
126159678|NCT01276847|453871652|FG002|Overall Study|Withdrawal by Subject|0|||
126159679|NCT01899144|453871653|FG000|Treatment Period 2|Other|1|||
126159680|NCT01899144|453871653|FG000|Treatment Period 3|Other|2|||
126159681|NCT01899144|453871653|FG000|Treatment Period 5|Other|1|||
126159682|NCT00751881|453871656|FG000|Core Treatment Period|Not treated|1|||
126159683|NCT00751881|453871657|FG001|Core Treatment Period|Not treated|1|||
126159684|NCT00751881|453871658|FG002|Core Treatment Period|Not treated|2|||
126159685|NCT00751881|453871656|FG000|Core Treatment Period|Adverse Event|26|||
126159686|NCT00751881|453871657|FG001|Core Treatment Period|Adverse Event|54|||
126159687|NCT00751881|453871658|FG002|Core Treatment Period|Adverse Event|58|||
126159688|NCT00751881|453871656|FG000|Core Treatment Period|Lack of Efficacy|37|||
126159689|NCT00751881|453871657|FG001|Core Treatment Period|Lack of Efficacy|30|||
126159690|NCT00751881|453871658|FG002|Core Treatment Period|Lack of Efficacy|20|||
126159691|NCT00751881|453871656|FG000|Core Treatment Period|Poor compliance to protocol|15|||
126159692|NCT00751881|453871657|FG001|Core Treatment Period|Poor compliance to protocol|3|||
126159693|NCT00751881|453871658|FG002|Core Treatment Period|Poor compliance to protocol|4|||
126159694|NCT00751881|453871656|FG000|Core Treatment Period|Lost to Follow-up|6|||
126159695|NCT00751881|453871657|FG001|Core Treatment Period|Lost to Follow-up|4|||
126159696|NCT00751881|453871658|FG002|Core Treatment Period|Lost to Follow-up|3|||
126159697|NCT00751881|453871656|FG000|Core Treatment Period|Other: protocol deviation|3|||
126159698|NCT00751881|453871657|FG001|Core Treatment Period|Other: protocol deviation|3|||
126159699|NCT00751881|453871658|FG002|Core Treatment Period|Other: protocol deviation|7|||
126159700|NCT00751881|453871656|FG000|Core Treatment Period|Other: wish to parent|5|||
126159701|NCT00751881|453871657|FG001|Core Treatment Period|Other: wish to parent|7|||
126159702|NCT00751881|453871658|FG002|Core Treatment Period|Other: wish to parent|4|||
126159703|NCT00751881|453871656|FG000|Core Treatment Period|Other: personal/family constraints|6|||
126159704|NCT00751881|453871657|FG001|Core Treatment Period|Other: personal/family constraints|7|||
126159705|NCT00751881|453871658|FG002|Core Treatment Period|Other: personal/family constraints|10|||
126159706|NCT00751881|453871656|FG000|Core Treatment Period|Other: MS treatment change|6|||
126159707|NCT00751881|453871657|FG001|Core Treatment Period|Other: MS treatment change|4|||
126159708|NCT00751881|453871658|FG002|Core Treatment Period|Other: MS treatment change|4|||
126159709|NCT00751881|453871656|FG000|Core Treatment Period|Other: tolerability complaints|2|||
126159710|NCT00751881|453871657|FG001|Core Treatment Period|Other: tolerability complaints|0|||
126159711|NCT00751881|453871658|FG002|Core Treatment Period|Other: tolerability complaints|0|||
126159712|NCT00751881|453871656|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
126159713|NCT00751881|453871657|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
126159714|NCT00751881|453871658|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
126159715|NCT00751881|453871656|FG000|Extension Study Period|Adverse Event|18|||
126159716|NCT00751881|453871657|FG001|Extension Study Period|Adverse Event|20|||
126159717|NCT00751881|453871658|FG002|Extension Study Period|Adverse Event|21|||
126159718|NCT00751881|453871656|FG000|Extension Study Period|Lack of Efficacy|14|||
126159719|NCT00751881|453871657|FG001|Extension Study Period|Lack of Efficacy|10|||
126159720|NCT00751881|453871658|FG002|Extension Study Period|Lack of Efficacy|20|||
126159721|NCT00751881|453871656|FG000|Extension Study Period|Lost to Follow-up|4|||
126159722|NCT00751881|453871657|FG001|Extension Study Period|Lost to Follow-up|9|||
125972309|NCT05912400|453188755|FG000|Overall Study|Withdrawal by Subject|1|||
125972310|NCT05912400|453188756|FG001|Overall Study|Withdrawal by Subject|0|||
125972311|NCT02047045|453188761|FG000|Baseline|Withdrawal by Subject|3|||
125972312|NCT02047045|453188762|FG001|Baseline|Withdrawal by Subject|2|||
125972313|NCT02047045|453188761|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
125972314|NCT02047045|453188762|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
125972315|NCT02047045|453188761|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
126159723|NCT00751881|453871658|FG002|Extension Study Period|Lost to Follow-up|6|||
126159724|NCT00751881|453871656|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
126159725|NCT00751881|453871657|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
126159726|NCT00751881|453871658|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
126159727|NCT00751881|453871656|FG000|Extension Study Period|Other than specified above|26|||
126159728|NCT00751881|453871657|FG001|Extension Study Period|Other than specified above|30|||
126159729|NCT00751881|453871658|FG002|Extension Study Period|Other than specified above|18|||
126159730|NCT02119104|453871659|FG000|Overall Study|Protocol Violation|16|||
126159731|NCT00530712|453871662|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
126159732|NCT00530712|453871662|FG000|30 Day Follow-up Visit|Missed Visit|5|||
126159733|NCT00530712|453871662|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
126159734|NCT00530712|453871662|FG000|6 Month Follow-up Visit|Missed Visit|3|||
126159735|NCT00530712|453871662|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
126159736|NCT00530712|453871662|FG000|6 Month Follow-up Visit|Death|2|||
126159737|NCT00530712|453871662|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
126159738|NCT00530712|453871662|FG000|12 Month Follow-up Visit|Missed Visit|3|||
126159739|NCT00530712|453871662|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
126159740|NCT00530712|453871662|FG000|12 Month Follow-up Visit|Death|9|||
126159741|NCT00651118|453871670|FG000|Overall Study|Adverse Event|4|||
126159742|NCT00651118|453871671|FG001|Overall Study|Adverse Event|0|||
126159743|NCT00651118|453871672|FG002|Overall Study|Adverse Event|1|||
126159744|NCT00651118|453871673|FG003|Overall Study|Adverse Event|1|||
126159745|NCT00651118|453871670|FG000|Overall Study|Protocol Violation|2|||
126159746|NCT00651118|453871671|FG001|Overall Study|Protocol Violation|2|||
126159747|NCT00651118|453871672|FG002|Overall Study|Protocol Violation|6|||
126159748|NCT00651118|453871673|FG003|Overall Study|Protocol Violation|2|||
126159749|NCT00651118|453871670|FG000|Overall Study|Lost to Follow-up|2|||
126159750|NCT00651118|453871671|FG001|Overall Study|Lost to Follow-up|0|||
126159751|NCT00651118|453871672|FG002|Overall Study|Lost to Follow-up|1|||
126159752|NCT00651118|453871673|FG003|Overall Study|Lost to Follow-up|2|||
126159753|NCT00651118|453871670|FG000|Overall Study|administrative|1|||
126159754|NCT00651118|453871671|FG001|Overall Study|administrative|4|||
126159755|NCT00651118|453871672|FG002|Overall Study|administrative|2|||
126159756|NCT00651118|453871673|FG003|Overall Study|administrative|1|||
126159757|NCT00651118|453871670|FG000|Overall Study|Withdrawal by Subject|0|||
126159758|NCT00651118|453871671|FG001|Overall Study|Withdrawal by Subject|1|||
126159759|NCT00651118|453871672|FG002|Overall Study|Withdrawal by Subject|1|||
126159760|NCT00651118|453871673|FG003|Overall Study|Withdrawal by Subject|1|||
126159761|NCT03117049|453871674|FG000|Overall Study|Continued the follow-up period|109|||
126159762|NCT03117049|453871675|FG001|Overall Study|Continued the follow-up period|129|||
126159763|NCT03117049|453871674|FG000|Overall Study|Died|82|||
126159764|NCT03117049|453871675|FG001|Overall Study|Died|93|||
126159765|NCT03117049|453871674|FG000|Overall Study|Consent withdrawal|7|||
126159766|NCT03117049|453871675|FG001|Overall Study|Consent withdrawal|6|||
126159767|NCT03117049|453871674|FG000|Overall Study|Missing contact|3|||
126159768|NCT03117049|453871675|FG001|Overall Study|Missing contact|3|||
126159769|NCT00839098|453871676|FG000|Overall Study|Withdrawal by Subject|2|||
126159770|NCT00839098|453871677|FG001|Overall Study|Withdrawal by Subject|1|||
126159771|NCT00839098|453871678|FG002|Overall Study|Withdrawal by Subject|7|||
126159772|NCT00365976|453871681|FG000|Overall Study|Withdrawal by Subject|1|||
126159773|NCT00365976|453871682|FG001|Overall Study|Withdrawal by Subject|5|||
126159774|NCT02260193|453871683|FG000|Overall Study|Lack of Efficacy|0|||
126159775|NCT02260193|453871684|FG001|Overall Study|Lack of Efficacy|1|||
126159776|NCT02260193|453871685|FG002|Overall Study|Lack of Efficacy|6|||
126159777|NCT02260193|453871683|FG000|Overall Study|Adverse Event|3|||
126159778|NCT02260193|453871684|FG001|Overall Study|Adverse Event|4|||
126159779|NCT02260193|453871685|FG002|Overall Study|Adverse Event|1|||
126159780|NCT02260193|453871683|FG000|Overall Study|Protocol Violation|0|||
126159781|NCT02260193|453871684|FG001|Overall Study|Protocol Violation|4|||
126159782|NCT02260193|453871685|FG002|Overall Study|Protocol Violation|0|||
126159783|NCT02260193|453871683|FG000|Overall Study|Withdrawal by Subject|3|||
126159784|NCT02260193|453871684|FG001|Overall Study|Withdrawal by Subject|0|||
126159785|NCT02260193|453871685|FG002|Overall Study|Withdrawal by Subject|2|||
126159786|NCT02260193|453871683|FG000|Overall Study|Kidney Transplantation|0|||
126159787|NCT02260193|453871684|FG001|Overall Study|Kidney Transplantation|0|||
126159788|NCT02260193|453871685|FG002|Overall Study|Kidney Transplantation|1|||
126159789|NCT00633139|453871692|FG000|Overall Study|Non compliance|0|||
126159790|NCT00633139|453871693|FG001|Overall Study|Non compliance|0|||
126159791|NCT00633139|453871694|FG002|Overall Study|Non compliance|1|||
126159792|NCT00633139|453871692|FG000|Overall Study|Withdrawal by Subject|0|||
125972316|NCT02047045|453188762|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
125972317|NCT02047045|453188761|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
125972318|NCT02047045|453188762|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
125972319|NCT02047045|453188761|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
126159793|NCT00633139|453871693|FG001|Overall Study|Withdrawal by Subject|1|||
126159794|NCT00633139|453871694|FG002|Overall Study|Withdrawal by Subject|0|||
126159795|NCT04430582|453871695|FG000|Overall Study|Found to meet exclusionary criteria|1|||
126159796|NCT04430582|453871696|FG001|Overall Study|Found to meet exclusionary criteria|0|||
126159797|NCT04430582|453871695|FG000|Overall Study|Withdrawal by Subject|0|||
126159798|NCT04430582|453871696|FG001|Overall Study|Withdrawal by Subject|1|||
126159799|NCT01522651|453871699|FG000|Overall Study|Adverse Event|3|||
126159800|NCT01522651|453871700|FG001|Overall Study|Adverse Event|4|||
126159801|NCT01522651|453871701|FG002|Overall Study|Adverse Event|4|||
126159802|NCT01522651|453871702|FG003|Overall Study|Adverse Event|5|||
126159803|NCT01522651|453871703|FG004|Overall Study|Adverse Event|4|||
126159804|NCT01522651|453871699|FG000|Overall Study|Cardioversion|1|||
126159805|NCT01522651|453871700|FG001|Overall Study|Cardioversion|0|||
126159806|NCT01522651|453871701|FG002|Overall Study|Cardioversion|0|||
126159807|NCT01522651|453871702|FG003|Overall Study|Cardioversion|0|||
126159808|NCT01522651|453871703|FG004|Overall Study|Cardioversion|0|||
126159809|NCT01522651|453871699|FG000|Overall Study|Device Malfunction|0|||
126159810|NCT01522651|453871700|FG001|Overall Study|Device Malfunction|1|||
126159811|NCT01522651|453871701|FG002|Overall Study|Device Malfunction|0|||
126159812|NCT01522651|453871702|FG003|Overall Study|Device Malfunction|0|||
126159813|NCT01522651|453871703|FG004|Overall Study|Device Malfunction|0|||
126159814|NCT01522651|453871699|FG000|Overall Study|Investigator's Discretion|0|||
126159815|NCT01522651|453871700|FG001|Overall Study|Investigator's Discretion|1|||
126159816|NCT01522651|453871701|FG002|Overall Study|Investigator's Discretion|0|||
126159817|NCT01522651|453871702|FG003|Overall Study|Investigator's Discretion|0|||
125972320|NCT02047045|453188762|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
125972321|NCT02047045|453188761|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
125972322|NCT02047045|453188762|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
125972323|NCT02047045|453188761|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
125972324|NCT02047045|453188762|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
125972325|NCT02047045|453188761|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
125972326|NCT02047045|453188762|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
125972327|NCT02047045|453188761|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
125972328|NCT02047045|453188762|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
125972329|NCT03214367|453188763|FG000|Lead-in Period|Withdrawal by Subject|50|||
125972330|NCT03214367|453188764|FG001|Lead-in Period|Withdrawal by Subject|0|||
125972331|NCT03214367|453188765|FG002|Lead-in Period|Withdrawal by Subject|0|||
125972332|NCT03214367|453188766|FG003|Lead-in Period|Withdrawal by Subject|0|||
125972333|NCT03214367|453188767|FG004|Lead-in Period|Withdrawal by Subject|2|||
125972334|NCT03214367|453188768|FG005|Lead-in Period|Withdrawal by Subject|0|||
125972335|NCT03214367|453188769|FG006|Lead-in Period|Withdrawal by Subject|0|||
125972336|NCT03214367|453188770|FG007|Lead-in Period|Withdrawal by Subject|0|||
125972337|NCT03214367|453188763|FG000|Lead-in Period|Adverse Event|3|||
125972338|NCT03214367|453188764|FG001|Lead-in Period|Adverse Event|0|||
125972339|NCT03214367|453188765|FG002|Lead-in Period|Adverse Event|0|||
125972340|NCT03214367|453188766|FG003|Lead-in Period|Adverse Event|0|||
125972341|NCT03214367|453188767|FG004|Lead-in Period|Adverse Event|0|||
125972342|NCT03214367|453188768|FG005|Lead-in Period|Adverse Event|0|||
125972343|NCT03214367|453188769|FG006|Lead-in Period|Adverse Event|0|||
125972344|NCT03214367|453188770|FG007|Lead-in Period|Adverse Event|0|||
125972345|NCT03214367|453188763|FG000|Lead-in Period|Lost to Follow-up|12|||
125972346|NCT03214367|453188764|FG001|Lead-in Period|Lost to Follow-up|0|||
125972347|NCT03214367|453188765|FG002|Lead-in Period|Lost to Follow-up|0|||
125972348|NCT03214367|453188766|FG003|Lead-in Period|Lost to Follow-up|0|||
125972349|NCT03214367|453188767|FG004|Lead-in Period|Lost to Follow-up|0|||
125972350|NCT03214367|453188768|FG005|Lead-in Period|Lost to Follow-up|0|||
125972351|NCT03214367|453188769|FG006|Lead-in Period|Lost to Follow-up|0|||
125972352|NCT03214367|453188770|FG007|Lead-in Period|Lost to Follow-up|0|||
125972353|NCT03214367|453188763|FG000|Lead-in Period|Sponsor Decision|11|||
125972354|NCT03214367|453188764|FG001|Lead-in Period|Sponsor Decision|0|||
125972355|NCT03214367|453188765|FG002|Lead-in Period|Sponsor Decision|0|||
125972356|NCT03214367|453188766|FG003|Lead-in Period|Sponsor Decision|0|||
125972357|NCT03214367|453188767|FG004|Lead-in Period|Sponsor Decision|0|||
125972358|NCT03214367|453188768|FG005|Lead-in Period|Sponsor Decision|0|||
125972359|NCT03214367|453188769|FG006|Lead-in Period|Sponsor Decision|0|||
125972360|NCT03214367|453188770|FG007|Lead-in Period|Sponsor Decision|0|||
125972361|NCT03214367|453188763|FG000|Lead-in Period|Physician Decision|12|||
125972362|NCT03214367|453188764|FG001|Lead-in Period|Physician Decision|0|||
125972363|NCT03214367|453188765|FG002|Lead-in Period|Physician Decision|0|||
125972364|NCT03214367|453188766|FG003|Lead-in Period|Physician Decision|0|||
125972365|NCT03214367|453188767|FG004|Lead-in Period|Physician Decision|0|||
125972366|NCT03214367|453188768|FG005|Lead-in Period|Physician Decision|0|||
125972367|NCT03214367|453188769|FG006|Lead-in Period|Physician Decision|0|||
125972368|NCT03214367|453188770|FG007|Lead-in Period|Physician Decision|0|||
125972369|NCT03214367|453188763|FG000|Lead-in Period|Protocol Violation|5|||
125972370|NCT03214367|453188764|FG001|Lead-in Period|Protocol Violation|0|||
125972371|NCT03214367|453188765|FG002|Lead-in Period|Protocol Violation|0|||
125972372|NCT03214367|453188766|FG003|Lead-in Period|Protocol Violation|0|||
126159818|NCT01522651|453871703|FG004|Overall Study|Investigator's Discretion|0|||
125972373|NCT03214367|453188767|FG004|Lead-in Period|Protocol Violation|0|||
125972374|NCT03214367|453188768|FG005|Lead-in Period|Protocol Violation|0|||
125972375|NCT03214367|453188769|FG006|Lead-in Period|Protocol Violation|0|||
125972376|NCT03214367|453188770|FG007|Lead-in Period|Protocol Violation|0|||
125972377|NCT03214367|453188763|FG000|Lead-in Period|Treatment Interruption|1|||
125972378|NCT03214367|453188764|FG001|Lead-in Period|Treatment Interruption|0|||
125972379|NCT03214367|453188765|FG002|Lead-in Period|Treatment Interruption|0|||
125972380|NCT03214367|453188766|FG003|Lead-in Period|Treatment Interruption|0|||
126159819|NCT01522651|453871699|FG000|Overall Study|Protocol Violation|3|||
125972381|NCT03214367|453188767|FG004|Lead-in Period|Treatment Interruption|0|||
125972382|NCT03214367|453188768|FG005|Lead-in Period|Treatment Interruption|0|||
125972383|NCT03214367|453188769|FG006|Lead-in Period|Treatment Interruption|0|||
125972384|NCT03214367|453188770|FG007|Lead-in Period|Treatment Interruption|0|||
126159820|NCT01522651|453871700|FG001|Overall Study|Protocol Violation|0|||
126159821|NCT01522651|453871701|FG002|Overall Study|Protocol Violation|0|||
126159822|NCT01522651|453871702|FG003|Overall Study|Protocol Violation|0|||
126159823|NCT01522651|453871703|FG004|Overall Study|Protocol Violation|0|||
126159824|NCT01522651|453871699|FG000|Overall Study|Reason Not Specified|0|||
126159825|NCT01522651|453871700|FG001|Overall Study|Reason Not Specified|0|||
126159826|NCT01522651|453871701|FG002|Overall Study|Reason Not Specified|0|||
126159827|NCT01522651|453871702|FG003|Overall Study|Reason Not Specified|1|||
126159828|NCT01522651|453871703|FG004|Overall Study|Reason Not Specified|0|||
126159829|NCT01522651|453871699|FG000|Overall Study|Participant Non-Compliance|1|||
126159830|NCT01522651|453871700|FG001|Overall Study|Participant Non-Compliance|0|||
126159831|NCT01522651|453871701|FG002|Overall Study|Participant Non-Compliance|0|||
126159832|NCT01522651|453871702|FG003|Overall Study|Participant Non-Compliance|0|||
126159833|NCT01522651|453871703|FG004|Overall Study|Participant Non-Compliance|0|||
126159834|NCT01522651|453871699|FG000|Overall Study|Withdrew Consent|1|||
126159835|NCT01522651|453871700|FG001|Overall Study|Withdrew Consent|1|||
126159836|NCT01522651|453871701|FG002|Overall Study|Withdrew Consent|0|||
126159837|NCT01522651|453871702|FG003|Overall Study|Withdrew Consent|1|||
126159838|NCT01522651|453871703|FG004|Overall Study|Withdrew Consent|1|||
126159839|NCT01522651|453871699|FG000|Overall Study|Randomized but Never Treated|0|||
126159840|NCT01522651|453871700|FG001|Overall Study|Randomized but Never Treated|1|||
126159841|NCT01522651|453871701|FG002|Overall Study|Randomized but Never Treated|0|||
126159842|NCT01522651|453871702|FG003|Overall Study|Randomized but Never Treated|1|||
126159843|NCT01522651|453871703|FG004|Overall Study|Randomized but Never Treated|1|||
126159844|NCT02658656|453871704|FG000|Screening|Failed eligibility criteria|0|||
126159845|NCT02658656|453871705|FG001|Screening|Failed eligibility criteria|0|||
126159846|NCT02658656|453871706|FG002|Screening|Failed eligibility criteria|263|||
126159847|NCT02658656|453871704|FG000|Randomization|Withdrawal by Subject|8|||
126159848|NCT02658656|453871705|FG001|Randomization|Withdrawal by Subject|7|||
126159849|NCT02658656|453871706|FG002|Randomization|Withdrawal by Subject|0|||
126159850|NCT02658656|453871704|FG000|Randomization|Lost to Follow-up|1|||
126159851|NCT02658656|453871705|FG001|Randomization|Lost to Follow-up|3|||
126159852|NCT02658656|453871706|FG002|Randomization|Lost to Follow-up|0|||
126159853|NCT02658656|453871704|FG000|Randomization|Adverse Event|4|||
126159854|NCT02658656|453871705|FG001|Randomization|Adverse Event|0|||
126159855|NCT02658656|453871706|FG002|Randomization|Adverse Event|0|||
126159856|NCT02658656|453871704|FG000|Randomization|Administrative Termination|3|||
126159857|NCT02658656|453871705|FG001|Randomization|Administrative Termination|1|||
126159858|NCT02658656|453871706|FG002|Randomization|Administrative Termination|0|||
126159859|NCT02658656|453871704|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
126159860|NCT02658656|453871705|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
126159861|NCT02658656|453871706|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
126159862|NCT02658656|453871704|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
126159863|NCT02658656|453871705|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
126159864|NCT02658656|453871706|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
126159865|NCT02658656|453871704|FG000|Randomization|Not eligible for Randomization|1|||
126159866|NCT02658656|453871705|FG001|Randomization|Not eligible for Randomization|0|||
126159867|NCT02658656|453871706|FG002|Randomization|Not eligible for Randomization|0|||
126159868|NCT02658656|453871704|FG000|Randomization|Protocol Violation|1|||
126159869|NCT02658656|453871705|FG001|Randomization|Protocol Violation|0|||
126159870|NCT02658656|453871706|FG002|Randomization|Protocol Violation|0|||
126159871|NCT04359823|453873566|FG000|Overall Study|Lost to Follow-up|0|||
126159872|NCT04359823|453873567|FG001|Overall Study|Lost to Follow-up|1|||
126159873|NCT04359823|453873566|FG000|Overall Study|Withdrawal by Subject|0|||
126159874|NCT04359823|453873567|FG001|Overall Study|Withdrawal by Subject|1|||
126159875|NCT01850563|453873568|FG000|Overall Study|Not eligible|3|||
126159876|NCT01850563|453873569|FG001|Overall Study|Not eligible|0|||
126159877|NCT00408421|453873572|FG000|Treatment Initial Randomization|Adverse Event|5|||
126159878|NCT00408421|453873573|FG001|Treatment Initial Randomization|Adverse Event|9|||
126159879|NCT00408421|453873574|FG002|Treatment Initial Randomization|Adverse Event|0|||
126159880|NCT00408421|453873572|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
126159881|NCT00408421|453873573|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
125972385|NCT03214367|453188763|FG000|Treatment Period|Adverse Event|0|||
125972386|NCT03214367|453188764|FG001|Treatment Period|Adverse Event|1|||
126159882|NCT00408421|453873574|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
126159883|NCT00408421|453873572|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
126159884|NCT00408421|453873573|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
126159885|NCT00408421|453873574|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
126159886|NCT00408421|453873572|FG000|Treatment Initial Randomization|Physician Decision|1|||
126159887|NCT00408421|453873573|FG001|Treatment Initial Randomization|Physician Decision|0|||
126159888|NCT00408421|453873574|FG002|Treatment Initial Randomization|Physician Decision|0|||
126159889|NCT00408421|453873572|FG000|Treatment Initial Randomization|Protocol Violation|0|||
126159890|NCT00408421|453873573|FG001|Treatment Initial Randomization|Protocol Violation|1|||
126159891|NCT00408421|453873574|FG002|Treatment Initial Randomization|Protocol Violation|0|||
126089304|NCT04047862|453620107|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089305|NCT04047862|453620108|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089306|NCT04047862|453620109|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
126089307|NCT04047862|453620110|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
126089308|NCT04047862|453620111|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089309|NCT04047862|453620112|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
126089310|NCT04047862|453620113|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089311|NCT04047862|453620114|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089312|NCT04047862|453620115|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126089313|NCT04047862|453620116|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
126089314|NCT04047862|453620117|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
126089315|NCT04047862|453620118|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
126089316|NCT04047862|453620119|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
126089317|NCT04047862|453620120|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
126089318|NCT04047862|453620102|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089319|NCT04047862|453620103|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089320|NCT04047862|453620104|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089321|NCT04047862|453620105|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089322|NCT04047862|453620106|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089323|NCT04047862|453620107|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089324|NCT04047862|453620108|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089325|NCT04047862|453620109|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089326|NCT04047862|453620110|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089327|NCT04047862|453620111|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089328|NCT04047862|453620112|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089329|NCT04047862|453620113|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089330|NCT04047862|453620114|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089331|NCT04047862|453620115|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089332|NCT04047862|453620116|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089333|NCT04047862|453620117|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
126089334|NCT04047862|453620118|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089335|NCT04047862|453620119|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126089336|NCT04047862|453620120|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
126089337|NCT04047862|453620102|FG000|Overall Study|Other|0|||
126089338|NCT04047862|453620103|FG001|Overall Study|Other|0|||
126089339|NCT04047862|453620104|FG002|Overall Study|Other|0|||
126089340|NCT04047862|453620105|FG003|Overall Study|Other|0|||
126089341|NCT04047862|453620106|FG004|Overall Study|Other|0|||
126089342|NCT04047862|453620107|FG005|Overall Study|Other|0|||
126089343|NCT04047862|453620108|FG006|Overall Study|Other|0|||
126089344|NCT04047862|453620109|FG007|Overall Study|Other|0|||
126089345|NCT04047862|453620110|FG008|Overall Study|Other|0|||
126089346|NCT04047862|453620111|FG009|Overall Study|Other|0|||
126089347|NCT04047862|453620112|FG010|Overall Study|Other|0|||
126089348|NCT04047862|453620113|FG011|Overall Study|Other|0|||
126089349|NCT04047862|453620114|FG012|Overall Study|Other|0|||
126089350|NCT04047862|453620115|FG013|Overall Study|Other|0|||
126089351|NCT04047862|453620116|FG014|Overall Study|Other|2|||
126089352|NCT04047862|453620117|FG015|Overall Study|Other|1|||
126089353|NCT04047862|453620118|FG016|Overall Study|Other|1|||
126089354|NCT04047862|453620119|FG017|Overall Study|Other|1|||
126089355|NCT04047862|453620120|FG018|Overall Study|Other|0|||
126159892|NCT00408421|453873572|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
126159893|NCT00408421|453873573|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
126159894|NCT00408421|453873574|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
126159895|NCT00408421|453873572|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
126159896|NCT00408421|453873573|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
126159897|NCT00408421|453873574|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
126159898|NCT00408421|453873572|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
126159899|NCT00408421|453873573|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
126159900|NCT00408421|453873574|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
126159901|NCT00408421|453873572|FG000|Treatment Re-Randomization|Adverse Event|2|||
126159902|NCT00408421|453873573|FG001|Treatment Re-Randomization|Adverse Event|2|||
126159903|NCT00408421|453873574|FG002|Treatment Re-Randomization|Adverse Event|4|||
126159904|NCT00408421|453873572|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
126159905|NCT00408421|453873573|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
126159906|NCT00408421|453873574|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
126159907|NCT00408421|453873572|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
126159908|NCT00408421|453873573|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
126159909|NCT00408421|453873574|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
126159910|NCT00408421|453873572|FG000|Treatment Re-Randomization|Physician Decision|1|||
126159911|NCT00408421|453873573|FG001|Treatment Re-Randomization|Physician Decision|3|||
126159912|NCT00408421|453873574|FG002|Treatment Re-Randomization|Physician Decision|0|||
126159913|NCT00408421|453873572|FG000|Treatment Re-Randomization|Protocol Violation|1|||
126159914|NCT00408421|453873573|FG001|Treatment Re-Randomization|Protocol Violation|1|||
126159915|NCT00408421|453873574|FG002|Treatment Re-Randomization|Protocol Violation|0|||
126159916|NCT00408421|453873572|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
126159917|NCT00408421|453873573|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
126159918|NCT00408421|453873574|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
126159919|NCT01790438|453873579|FG000|Overall Study|Adverse Event|3|||
126159920|NCT01790438|453873580|FG001|Overall Study|Adverse Event|2|||
126159921|NCT01790438|453873579|FG000|Overall Study|Death|4|||
126159922|NCT01790438|453873580|FG001|Overall Study|Death|0|||
126159923|NCT01790438|453873579|FG000|Overall Study|Lost to Follow-up|5|||
126159924|NCT01790438|453873580|FG001|Overall Study|Lost to Follow-up|2|||
126159925|NCT01790438|453873579|FG000|Overall Study|Withdrawal by Subject|13|||
126159926|NCT01790438|453873580|FG001|Overall Study|Withdrawal by Subject|2|||
126159927|NCT01790438|453873579|FG000|Overall Study|Physician Decision|3|||
126159928|NCT01790438|453873580|FG001|Overall Study|Physician Decision|1|||
126159929|NCT01790438|453873579|FG000|Overall Study|Sponsor Decision|0|||
126159930|NCT01790438|453873580|FG001|Overall Study|Sponsor Decision|3|||
126159931|NCT01790438|453873579|FG000|Overall Study|Protocol Required Discontinuation|7|||
126159932|NCT01790438|453873580|FG001|Overall Study|Protocol Required Discontinuation|1|||
126159933|NCT01614769|453873586|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
126159934|NCT01614769|453873587|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
126159935|NCT01614769|453873588|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
126159936|NCT01614769|453873589|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
126159937|NCT01614769|453873590|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
126159938|NCT01614769|453873591|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
126159939|NCT01614769|453873586|FG000|Period 1|Protocol Violation|0|||
126159940|NCT01614769|453873587|FG001|Period 1|Protocol Violation|0|||
126159941|NCT01614769|453873588|FG002|Period 1|Protocol Violation|0|||
126159942|NCT01614769|453873589|FG003|Period 1|Protocol Violation|1|||
126159943|NCT01614769|453873590|FG004|Period 1|Protocol Violation|0|||
126159944|NCT01614769|453873591|FG005|Period 1|Protocol Violation|0|||
126159945|NCT01614769|453873586|FG000|Period 1|Withdrawal by Subject|1|||
126159946|NCT01614769|453873587|FG001|Period 1|Withdrawal by Subject|0|||
126159947|NCT01614769|453873588|FG002|Period 1|Withdrawal by Subject|0|||
126159948|NCT01614769|453873589|FG003|Period 1|Withdrawal by Subject|0|||
126159949|NCT01614769|453873590|FG004|Period 1|Withdrawal by Subject|0|||
126159950|NCT01614769|453873591|FG005|Period 1|Withdrawal by Subject|0|||
126159951|NCT01614769|453873586|FG000|Period 3|Withdrawal by Subject|0|||
126159952|NCT01614769|453873587|FG001|Period 3|Withdrawal by Subject|0|||
126159953|NCT01614769|453873588|FG002|Period 3|Withdrawal by Subject|1|||
126159954|NCT01614769|453873589|FG003|Period 3|Withdrawal by Subject|0|||
126159955|NCT01614769|453873590|FG004|Period 3|Withdrawal by Subject|0|||
126159956|NCT01614769|453873591|FG005|Period 3|Withdrawal by Subject|0|||
126159957|NCT04760314|453873594|FG000|Induction Period|Withdrawal by Subject|0|||
126159958|NCT04760314|453873595|FG001|Induction Period|Withdrawal by Subject|1|||
126159959|NCT04760314|453873596|FG002|Induction Period|Withdrawal by Subject|1|||
126159960|NCT04760314|453873597|FG003|Induction Period|Withdrawal by Subject|0|||
126159961|NCT04760314|453873598|FG004|Induction Period|Withdrawal by Subject|0|||
126159962|NCT04760314|453873599|FG005|Induction Period|Withdrawal by Subject|0|||
126159963|NCT04760314|453873600|FG006|Induction Period|Withdrawal by Subject|0|||
126159964|NCT04760314|453873601|FG007|Induction Period|Withdrawal by Subject|0|||
126159965|NCT04760314|453873602|FG008|Induction Period|Withdrawal by Subject|0|||
126159966|NCT04760314|453873603|FG009|Induction Period|Withdrawal by Subject|0|||
126159967|NCT04760314|453873604|FG010|Induction Period|Withdrawal by Subject|0|||
126159968|NCT04760314|453873594|FG000|Induction Period|Adverse Event|0|||
126159969|NCT04760314|453873595|FG001|Induction Period|Adverse Event|0|||
126159970|NCT04760314|453873596|FG002|Induction Period|Adverse Event|2|||
126159971|NCT04760314|453873597|FG003|Induction Period|Adverse Event|0|||
126159972|NCT04760314|453873598|FG004|Induction Period|Adverse Event|0|||
126159973|NCT04760314|453873599|FG005|Induction Period|Adverse Event|0|||
126159974|NCT04760314|453873600|FG006|Induction Period|Adverse Event|0|||
126159975|NCT04760314|453873601|FG007|Induction Period|Adverse Event|0|||
126159976|NCT04760314|453873602|FG008|Induction Period|Adverse Event|0|||
126159977|NCT04760314|453873603|FG009|Induction Period|Adverse Event|0|||
126159978|NCT04760314|453873604|FG010|Induction Period|Adverse Event|0|||
126159979|NCT04760314|453873594|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
126159980|NCT04760314|453873595|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
126159981|NCT04760314|453873596|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
126159982|NCT04760314|453873597|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
126159983|NCT04760314|453873598|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
126159984|NCT04760314|453873599|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
126159985|NCT04760314|453873600|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
126159986|NCT04760314|453873601|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
126159987|NCT04760314|453873602|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
126159988|NCT04760314|453873603|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
126159989|NCT04760314|453873604|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
126159990|NCT04760314|453873594|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126159991|NCT04760314|453873595|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126159992|NCT04760314|453873596|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126159993|NCT04760314|453873597|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
126159994|NCT04760314|453873598|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126159995|NCT04760314|453873599|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
126159996|NCT04760314|453873600|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
126159997|NCT04760314|453873601|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126159998|NCT04760314|453873602|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126159999|NCT04760314|453873603|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126160000|NCT04760314|453873604|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126160001|NCT04760314|453873594|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160002|NCT04760314|453873595|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160003|NCT04760314|453873596|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160004|NCT04760314|453873597|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160005|NCT04760314|453873598|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
126160006|NCT04760314|453873599|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160007|NCT04760314|453873600|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160008|NCT04760314|453873601|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160009|NCT04760314|453873602|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160010|NCT04760314|453873603|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160011|NCT04760314|453873604|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126160012|NCT04760314|453873594|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
126160013|NCT04760314|453873595|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
126160014|NCT04760314|453873596|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
126160015|NCT04760314|453873597|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
126160016|NCT04760314|453873598|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
126160017|NCT04760314|453873599|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
126160018|NCT04760314|453873600|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
126160019|NCT04760314|453873601|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
126160020|NCT04760314|453873602|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
126160021|NCT04760314|453873603|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
126160022|NCT04760314|453873604|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
126160023|NCT04760314|453873594|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126160024|NCT04760314|453873595|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126160025|NCT04760314|453873596|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126160026|NCT04760314|453873597|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126160027|NCT04760314|453873598|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126160028|NCT04760314|453873599|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126160029|NCT04760314|453873600|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126160030|NCT04760314|453873601|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
126160031|NCT04760314|453873602|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126160032|NCT04760314|453873603|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
126160033|NCT04760314|453873604|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
126160034|NCT04760314|453873594|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126160035|NCT04760314|453873595|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126160036|NCT04760314|453873596|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126160037|NCT04760314|453873597|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126160038|NCT04760314|453873598|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126160039|NCT04760314|453873599|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126160040|NCT04760314|453873600|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126160041|NCT04760314|453873601|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
126160042|NCT04760314|453873602|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
125972387|NCT03214367|453188765|FG002|Treatment Period|Adverse Event|4|||
126160043|NCT04760314|453873603|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
126160044|NCT04760314|453873604|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126160045|NCT04760314|453873594|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160046|NCT04760314|453873595|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160047|NCT04760314|453873596|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160048|NCT04760314|453873597|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160049|NCT04760314|453873598|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160050|NCT04760314|453873599|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125972388|NCT03214367|453188766|FG003|Treatment Period|Adverse Event|2|||
126160051|NCT04760314|453873600|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160052|NCT04760314|453873601|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
126160053|NCT04760314|453873602|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160054|NCT04760314|453873603|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160055|NCT04760314|453873604|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126160056|NCT04760314|453873594|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160057|NCT04760314|453873595|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160058|NCT04760314|453873596|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160059|NCT04760314|453873597|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160060|NCT04760314|453873598|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160061|NCT04760314|453873599|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160062|NCT04760314|453873600|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160063|NCT04760314|453873601|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160064|NCT04760314|453873602|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
126160065|NCT04760314|453873603|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
126160066|NCT04760314|453873604|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
126160067|NCT00960440|453873606|FG000|Overall Study|Death|0|||
126160068|NCT00960440|453873607|FG001|Overall Study|Death|0|||
126160069|NCT00960440|453873608|FG002|Overall Study|Death|0|||
126160070|NCT00960440|453873609|FG003|Overall Study|Death|1|||
126160071|NCT00960440|453873606|FG000|Overall Study|Adverse Event|12|||
126160072|NCT00960440|453873607|FG001|Overall Study|Adverse Event|12|||
126160073|NCT00960440|453873608|FG002|Overall Study|Adverse Event|4|||
126160074|NCT00960440|453873609|FG003|Overall Study|Adverse Event|4|||
126160075|NCT00960440|453873606|FG000|Overall Study|Lack of Efficacy|2|||
126160076|NCT00960440|453873607|FG001|Overall Study|Lack of Efficacy|5|||
126160077|NCT00960440|453873608|FG002|Overall Study|Lack of Efficacy|3|||
126160078|NCT00960440|453873609|FG003|Overall Study|Lack of Efficacy|8|||
126160079|NCT00960440|453873606|FG000|Overall Study|Protocol Violation|2|||
126160080|NCT00960440|453873607|FG001|Overall Study|Protocol Violation|8|||
126160081|NCT00960440|453873608|FG002|Overall Study|Protocol Violation|3|||
126160082|NCT00960440|453873609|FG003|Overall Study|Protocol Violation|4|||
126160083|NCT00960440|453873606|FG000|Overall Study|Withdrawal by Subject|9|||
126160084|NCT00960440|453873607|FG001|Overall Study|Withdrawal by Subject|5|||
126160085|NCT00960440|453873608|FG002|Overall Study|Withdrawal by Subject|2|||
126160086|NCT00960440|453873609|FG003|Overall Study|Withdrawal by Subject|1|||
126160087|NCT00960440|453873606|FG000|Overall Study|Other|1|||
126160088|NCT00960440|453873607|FG001|Overall Study|Other|1|||
126160089|NCT00960440|453873608|FG002|Overall Study|Other|1|||
126160090|NCT00960440|453873609|FG003|Overall Study|Other|0|||
126160091|NCT02421120|453873610|FG000|Overall Study|Adverse Event|1|||
126160092|NCT02207530|453873611|FG000|Overall Study|Worsening condition under investigation|78|||
126160093|NCT02207530|453873611|FG000|Overall Study|Patient decision to stop study treatment|5|||
126160094|NCT02207530|453873611|FG000|Overall Study|Adverse Event|8|||
126160095|NCT02345161|453873612|FG000|Overall Study|Withdrawal by Subject|25|||
126160096|NCT02345161|453873613|FG001|Overall Study|Withdrawal by Subject|33|||
126160097|NCT02345161|453873612|FG000|Overall Study|Adverse Event|16|||
126160098|NCT02345161|453873613|FG001|Overall Study|Adverse Event|19|||
126160099|NCT02345161|453873612|FG000|Overall Study|Physician Decision|4|||
126160100|NCT02345161|453873613|FG001|Overall Study|Physician Decision|4|||
126160101|NCT02345161|453873612|FG000|Overall Study|Lost to Follow-up|0|||
126160102|NCT02345161|453873613|FG001|Overall Study|Lost to Follow-up|1|||
126160103|NCT03554005|453873620|FG000|Overall Study|Not in participant's best interest|0|||
126160104|NCT03554005|453873621|FG001|Overall Study|Not in participant's best interest|0|||
126160105|NCT03554005|453873622|FG002|Overall Study|Not in participant's best interest|0|||
126160106|NCT03554005|453873623|FG003|Overall Study|Not in participant's best interest|0|||
126160107|NCT03554005|453873624|FG004|Overall Study|Not in participant's best interest|0|||
126160108|NCT03554005|453873625|FG005|Overall Study|Not in participant's best interest|1|||
126160109|NCT03554005|453873620|FG000|Overall Study|Disease Progression|1|||
126160110|NCT03554005|453873621|FG001|Overall Study|Disease Progression|1|||
126160111|NCT03554005|453873622|FG002|Overall Study|Disease Progression|1|||
126160112|NCT03554005|453873623|FG003|Overall Study|Disease Progression|1|||
126160113|NCT03554005|453873624|FG004|Overall Study|Disease Progression|5|||
126160114|NCT03554005|453873625|FG005|Overall Study|Disease Progression|6|||
126160115|NCT03554005|453873620|FG000|Overall Study|Adverse Event|0|||
126160116|NCT03554005|453873621|FG001|Overall Study|Adverse Event|0|||
126160117|NCT03554005|453873622|FG002|Overall Study|Adverse Event|0|||
126160118|NCT03554005|453873623|FG003|Overall Study|Adverse Event|0|||
126160119|NCT03554005|453873624|FG004|Overall Study|Adverse Event|0|||
126160120|NCT03554005|453873625|FG005|Overall Study|Adverse Event|3|||
126160121|NCT03554005|453873620|FG000|Overall Study|Physician Decision|0|||
126160122|NCT03554005|453873621|FG001|Overall Study|Physician Decision|0|||
126160123|NCT03554005|453873622|FG002|Overall Study|Physician Decision|0|||
126160124|NCT03554005|453873623|FG003|Overall Study|Physician Decision|0|||
126160125|NCT03554005|453873624|FG004|Overall Study|Physician Decision|1|||
126160126|NCT03554005|453873625|FG005|Overall Study|Physician Decision|0|||
126160127|NCT03554005|453873620|FG000|Overall Study|Other|0|||
126160128|NCT03554005|453873621|FG001|Overall Study|Other|0|||
126160129|NCT03554005|453873622|FG002|Overall Study|Other|0|||
126160130|NCT03554005|453873623|FG003|Overall Study|Other|0|||
126160131|NCT03554005|453873624|FG004|Overall Study|Other|0|||
126160132|NCT03554005|453873625|FG005|Overall Study|Other|1|||
126160133|NCT02855411|453873629|FG000|Overall Study|Study terminated by sponsor|21|||
126160134|NCT02855411|453873629|FG000|Overall Study|Does not meet entrance criteria|14|||
126160135|NCT02606045|453873630|FG000|Overall Study|Study closed before treament could begin|1|||
126160136|NCT02606045|453873631|FG001|Overall Study|Study closed before treament could begin|2|||
126160137|NCT00907881|453873632|FG000|Overall Study|Lost to Follow-up|59|||
126160138|NCT00907881|453873632|FG000|Overall Study|Noncompliance|5|||
126160139|NCT00907881|453873632|FG000|Overall Study|Withdrawal by Subject|5|||
126160140|NCT00907881|453873632|FG000|Overall Study|Protocol Violation|1|||
126160141|NCT00907881|453873632|FG000|Overall Study|Missing discontinuation information|15|||
126160142|NCT01671085|453873633|FG000|Overall Study|Withdrawal by Subject|1|||
126160143|NCT01671085|453873634|FG001|Overall Study|Withdrawal by Subject|0|||
126160144|NCT00637273|453873635|FG000|Overall Study|Adverse Event|11|||
126160145|NCT00637273|453873636|FG001|Overall Study|Adverse Event|5|||
126160146|NCT00637273|453873637|FG002|Overall Study|Adverse Event|7|||
126160147|NCT00637273|453873635|FG000|Overall Study|Lost to Follow-up|8|||
126160148|NCT00637273|453873636|FG001|Overall Study|Lost to Follow-up|9|||
126160149|NCT00637273|453873637|FG002|Overall Study|Lost to Follow-up|13|||
126160150|NCT00637273|453873635|FG000|Overall Study|Protocol Violation|2|||
126160151|NCT00637273|453873636|FG001|Overall Study|Protocol Violation|4|||
126160152|NCT00637273|453873637|FG002|Overall Study|Protocol Violation|1|||
126160153|NCT00637273|453873635|FG000|Overall Study|Withdrawal of Consent|18|||
126160154|NCT00637273|453873636|FG001|Overall Study|Withdrawal of Consent|6|||
126160155|NCT00637273|453873637|FG002|Overall Study|Withdrawal of Consent|18|||
126160156|NCT00637273|453873635|FG000|Overall Study|Investigator Decision|1|||
126160157|NCT00637273|453873636|FG001|Overall Study|Investigator Decision|3|||
126160158|NCT00637273|453873637|FG002|Overall Study|Investigator Decision|1|||
126160159|NCT00637273|453873635|FG000|Overall Study|Administrative|2|||
126160160|NCT00637273|453873636|FG001|Overall Study|Administrative|0|||
126160161|NCT00637273|453873637|FG002|Overall Study|Administrative|0|||
126160162|NCT00637273|453873635|FG000|Overall Study|Loss of Glucose Control|1|||
126160163|NCT00637273|453873636|FG001|Overall Study|Loss of Glucose Control|1|||
126160164|NCT00637273|453873637|FG002|Overall Study|Loss of Glucose Control|1|||
126160165|NCT00986258|453873638|FG000|Observation Period|Not eligible to be dosed|11|||
126160166|NCT00986258|453873638|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
126160167|NCT00986258|453873638|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
126160168|NCT00986258|453873638|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
126160169|NCT00986258|453873638|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
126160170|NCT00986258|453873638|FG000|Titration and Optimal Dose Period|Other|1|||
126160171|NCT00986258|453873638|FG000|Maintenance Period|Adverse Event|5|||
126160172|NCT00986258|453873638|FG000|Maintenance Period|Lack of Efficacy|2|||
126160173|NCT00986258|453873638|FG000|Maintenance Period|Withdrawal by Subject|2|||
126160174|NCT02616029|453873640|FG000|Overall Study|Adverse Event|1|||
126160175|NCT02616029|453873641|FG001|Overall Study|Adverse Event|0|||
126160176|NCT02616029|453873640|FG000|Overall Study|Death|0|||
126160177|NCT02616029|453873641|FG001|Overall Study|Death|1|||
126160178|NCT02616029|453873640|FG000|Overall Study|Protocol Violation|1|||
126160179|NCT02616029|453873641|FG001|Overall Study|Protocol Violation|0|||
126160180|NCT02616029|453873640|FG000|Overall Study|Withdrew Consent|1|||
126160181|NCT02616029|453873641|FG001|Overall Study|Withdrew Consent|0|||
126160182|NCT02616029|453873640|FG000|Overall Study|Enrolled and Never Treated|1|||
126160183|NCT02616029|453873641|FG001|Overall Study|Enrolled and Never Treated|1|||
126160184|NCT01188798|453873642|FG000|Overall Study|Death|0|||
126160185|NCT01188798|453873643|FG001|Overall Study|Death|1|||
126160186|NCT01188798|453873642|FG000|Overall Study|Required additional transplant|1|||
126160187|NCT01188798|453873643|FG001|Overall Study|Required additional transplant|1|||
126160188|NCT01188798|453873642|FG000|Overall Study|Protocol closure|1|||
126160189|NCT01188798|453873643|FG001|Overall Study|Protocol closure|1|||
126160190|NCT02795767|453873644|FG000|Overall Study|Received Commercial Emicizumab|1|||
126160191|NCT02795767|453873645|FG001|Overall Study|Received Commercial Emicizumab|0|||
126160192|NCT02795767|453873646|FG002|Overall Study|Received Commercial Emicizumab|0|||
126160193|NCT03078608|453873656|FG000|Overall Study|Death|1|||
125972389|NCT03214367|453188767|FG004|Treatment Period|Adverse Event|0|||
125972390|NCT03214367|453188768|FG005|Treatment Period|Adverse Event|0|||
125972391|NCT03214367|453188769|FG006|Treatment Period|Adverse Event|0|||
126160194|NCT03078608|453873657|FG001|Overall Study|Death|2|||
126160195|NCT03078608|453873658|FG002|Overall Study|Death|0|||
125972392|NCT03214367|453188770|FG007|Treatment Period|Adverse Event|0|||
125972393|NCT03214367|453188763|FG000|Treatment Period|Death|0|||
126160196|NCT03078608|453873659|FG003|Overall Study|Death|0|||
125972394|NCT03214367|453188764|FG001|Treatment Period|Death|1|||
126160197|NCT03078608|453873656|FG000|Overall Study|Withdrawal by Subject|8|||
126160198|NCT03078608|453873657|FG001|Overall Study|Withdrawal by Subject|1|||
126160199|NCT03078608|453873658|FG002|Overall Study|Withdrawal by Subject|0|||
126160200|NCT03078608|453873659|FG003|Overall Study|Withdrawal by Subject|0|||
126160201|NCT03078608|453873656|FG000|Overall Study|Lost to Follow-up|5|||
126160202|NCT03078608|453873657|FG001|Overall Study|Lost to Follow-up|8|||
126160203|NCT03078608|453873658|FG002|Overall Study|Lost to Follow-up|4|||
126160204|NCT03078608|453873659|FG003|Overall Study|Lost to Follow-up|1|||
126160205|NCT00723840|453873660|FG000|Overall Study|Lost to Follow-up|2|||
126160206|NCT00723840|453873660|FG000|Overall Study|Failure to return|18|||
126160207|NCT00723840|453873660|FG000|Overall Study|Withdrawal by Subject|55|||
126160208|NCT00723840|453873660|FG000|Overall Study|Serious Adverse Events|3|||
126160209|NCT00723840|453873660|FG000|Overall Study|Other Medical Event|2|||
126160210|NCT00723840|453873660|FG000|Overall Study|Unspecified reason|2|||
126160211|NCT04156646|453873661|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
126160212|NCT04156646|453873662|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
126160213|NCT00751101|453873663|FG000|Overall Study|Withdrawal by Subject|1|||
126160214|NCT00751101|453873664|FG001|Overall Study|Withdrawal by Subject|0|||
126160215|NCT00751101|453873663|FG000|Overall Study|No HFS / Never Started Patch/|0|||
126160216|NCT00751101|453873664|FG001|Overall Study|No HFS / Never Started Patch/|4|||
126160217|NCT00751101|453873663|FG000|Overall Study|Never began capecitabine|1|||
126160218|NCT00751101|453873664|FG001|Overall Study|Never began capecitabine|0|||
126160219|NCT00751101|453873663|FG000|Overall Study|Physician Decision|0|||
126160220|NCT00751101|453873664|FG001|Overall Study|Physician Decision|1|||
126160221|NCT00784784|453873665|FG000|Overall Study|Withdrawal by Subject|2|||
126160222|NCT00784784|453873666|FG001|Overall Study|Withdrawal by Subject|2|||
126160223|NCT01905397|453873667|FG000|Overall Study|Death|0|||
126160224|NCT01905397|453873668|FG001|Overall Study|Death|1|||
126160225|NCT01905397|453873667|FG000|Overall Study|Withdrawal by Subject|2|||
126160226|NCT01905397|453873668|FG001|Overall Study|Withdrawal by Subject|0|||
126160227|NCT01905397|453873667|FG000|Overall Study|Surgery canceled/aborted|9|||
126160228|NCT01905397|453873668|FG001|Overall Study|Surgery canceled/aborted|5|||
126160229|NCT01905397|453873667|FG000|Overall Study|Incision < 7 cm|2|||
126160230|NCT01905397|453873668|FG001|Overall Study|Incision < 7 cm|0|||
126160231|NCT01905397|453873667|FG000|Overall Study|Wrong treatment|1|||
126160232|NCT01905397|453873668|FG001|Overall Study|Wrong treatment|1|||
126160233|NCT01905397|453873667|FG000|Overall Study|Device not applied|3|||
126160234|NCT01905397|453873668|FG001|Overall Study|Device not applied|0|||
126160235|NCT01905397|453873667|FG000|Overall Study|Dressing not applied in operating room|1|||
126160236|NCT01905397|453873668|FG001|Overall Study|Dressing not applied in operating room|0|||
126160237|NCT01905397|453873667|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
126160238|NCT01905397|453873668|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
126160239|NCT00844428|453873669|FG000|Screening Period|Screen Failure|3|||
126160240|NCT00844428|453873669|FG000|Extension Treatment Period|Death|1|||
126160241|NCT00844428|453873669|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
126160242|NCT00863928|453873672|FG000|Overall Study|Protocol Violation|26|||
126160243|NCT00863928|453873673|FG001|Overall Study|Protocol Violation|0|||
126160244|NCT00863928|453873672|FG000|Overall Study|Withdrawal by Subject|3|||
126160245|NCT00863928|453873673|FG001|Overall Study|Withdrawal by Subject|0|||
126160246|NCT00863928|453873672|FG000|Overall Study|surgery cancellation|4|||
126160247|NCT00863928|453873673|FG001|Overall Study|surgery cancellation|0|||
126160248|NCT00863928|453873672|FG000|Overall Study|medication allergy|3|||
126160249|NCT00863928|453873673|FG001|Overall Study|medication allergy|0|||
126160250|NCT00772967|453873674|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
126160251|NCT00772967|453873675|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
126160252|NCT00772967|453873676|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
126160253|NCT00772967|453873677|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
126160254|NCT00772967|453873678|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
126160255|NCT00772967|453873679|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
126160256|NCT00772967|453873674|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126160257|NCT00772967|453873675|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
126160258|NCT00772967|453873676|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126160259|NCT00772967|453873677|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126160260|NCT00772967|453873678|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126160261|NCT00772967|453873679|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126160262|NCT00772967|453873674|FG000|Crossover Treatment 3|Adverse Event|0|||
126160263|NCT00772967|453873675|FG001|Crossover Treatment 3|Adverse Event|0|||
126160264|NCT00772967|453873676|FG002|Crossover Treatment 3|Adverse Event|0|||
126160265|NCT00772967|453873677|FG003|Crossover Treatment 3|Adverse Event|0|||
126160266|NCT00772967|453873678|FG004|Crossover Treatment 3|Adverse Event|1|||
126160267|NCT00772967|453873679|FG005|Crossover Treatment 3|Adverse Event|0|||
126160268|NCT01041573|453873681|FG000|Overall Study|Withdrawal by Subject|2|||
126160269|NCT01041573|453873682|FG001|Overall Study|Withdrawal by Subject|5|||
126160270|NCT01041573|453873683|FG002|Overall Study|Withdrawal by Subject|2|||
126160271|NCT01041573|453873684|FG003|Overall Study|Withdrawal by Subject|0|||
126160272|NCT01041573|453873681|FG000|Overall Study|Death|1|||
126160273|NCT01041573|453873682|FG001|Overall Study|Death|0|||
126160274|NCT01041573|453873683|FG002|Overall Study|Death|0|||
126160275|NCT01041573|453873684|FG003|Overall Study|Death|0|||
126160276|NCT01041573|453873681|FG000|Overall Study|Lost to Follow-up|0|||
126160277|NCT01041573|453873682|FG001|Overall Study|Lost to Follow-up|1|||
126160278|NCT01041573|453873683|FG002|Overall Study|Lost to Follow-up|2|||
126160279|NCT01041573|453873684|FG003|Overall Study|Lost to Follow-up|1|||
126160280|NCT01041573|453873681|FG000|Overall Study|Adverse Event|0|||
126160281|NCT01041573|453873682|FG001|Overall Study|Adverse Event|2|||
126160282|NCT01041573|453873683|FG002|Overall Study|Adverse Event|0|||
126160283|NCT01041573|453873684|FG003|Overall Study|Adverse Event|0|||
126160284|NCT01041573|453873681|FG000|Overall Study|relocation|1|||
126160285|NCT01041573|453873682|FG001|Overall Study|relocation|4|||
126160286|NCT01041573|453873683|FG002|Overall Study|relocation|3|||
126160287|NCT01041573|453873684|FG003|Overall Study|relocation|1|||
126160288|NCT01041573|453873681|FG000|Overall Study|further blood extraction|0|||
126160289|NCT01041573|453873682|FG001|Overall Study|further blood extraction|1|||
126160290|NCT01041573|453873683|FG002|Overall Study|further blood extraction|0|||
126160291|NCT01041573|453873684|FG003|Overall Study|further blood extraction|0|||
126160292|NCT01041573|453873681|FG000|Overall Study|positive to anti-HCV|1|||
126160293|NCT01041573|453873682|FG001|Overall Study|positive to anti-HCV|0|||
126160294|NCT01041573|453873683|FG002|Overall Study|positive to anti-HCV|0|||
126160295|NCT01041573|453873684|FG003|Overall Study|positive to anti-HCV|0|||
126160296|NCT04172831|453873685|FG000|Overall Study|Adverse Event|21|||
126160297|NCT04172831|453873686|FG001|Overall Study|Adverse Event|9|||
126160298|NCT04172831|453873685|FG000|Overall Study|Lack of Efficacy|2|||
126160299|NCT04172831|453873686|FG001|Overall Study|Lack of Efficacy|8|||
126160300|NCT04172831|453873685|FG000|Overall Study|Physician Decision|0|||
126160301|NCT04172831|453873686|FG001|Overall Study|Physician Decision|1|||
126160302|NCT04172831|453873685|FG000|Overall Study|Withdrawal by Subject|12|||
126160303|NCT04172831|453873686|FG001|Overall Study|Withdrawal by Subject|11|||
126160304|NCT04172831|453873685|FG000|Overall Study|Lost to Follow-up|4|||
126160305|NCT04172831|453873686|FG001|Overall Study|Lost to Follow-up|9|||
126160306|NCT04172831|453873685|FG000|Overall Study|COVID-19 related crisis|3|||
126160307|NCT04172831|453873686|FG001|Overall Study|COVID-19 related crisis|3|||
126160308|NCT04172831|453873685|FG000|Overall Study|Subject non-compliance|1|||
126160309|NCT04172831|453873686|FG001|Overall Study|Subject non-compliance|1|||
126160310|NCT04172831|453873685|FG000|Overall Study|Family emergency|1|||
126160311|NCT04172831|453873686|FG001|Overall Study|Family emergency|0|||
126160312|NCT01765764|453873691|FG000|Treatment Period|Adverse Event|1|||
126160313|NCT01765764|453873692|FG001|Treatment Period|Adverse Event|2|||
126160314|NCT01765764|453873693|FG002|Treatment Period|Adverse Event|1|||
126160315|NCT01765764|453873691|FG000|Treatment Period|Lost to Follow-up|0|||
126160316|NCT01765764|453873692|FG001|Treatment Period|Lost to Follow-up|3|||
126160317|NCT01765764|453873693|FG002|Treatment Period|Lost to Follow-up|2|||
126160318|NCT01765764|453873691|FG000|Treatment Period|Personal Reasons|1|||
126160319|NCT01765764|453873692|FG001|Treatment Period|Personal Reasons|2|||
126160320|NCT01765764|453873693|FG002|Treatment Period|Personal Reasons|1|||
126160321|NCT01765764|453873691|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
126160322|NCT01765764|453873692|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
126160323|NCT01765764|453873693|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
126160324|NCT01597193|453873695|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
126160325|NCT01597193|453873696|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
126160326|NCT01597193|453873697|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126160327|NCT01597193|453873698|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126160328|NCT01597193|453873699|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126160329|NCT01597193|453873700|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126160330|NCT01597193|453873701|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126160331|NCT01597193|453873695|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
126160332|NCT01597193|453873696|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
126160333|NCT01597193|453873697|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
126160334|NCT01597193|453873698|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
126160335|NCT01597193|453873699|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
126160336|NCT01597193|453873700|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
126160337|NCT01597193|453873701|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
126160338|NCT01597193|453873695|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
126160339|NCT01597193|453873696|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
126160340|NCT01597193|453873697|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
126160341|NCT01597193|453873698|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
125972395|NCT03214367|453188765|FG002|Treatment Period|Death|1|||
125972396|NCT03214367|453188766|FG003|Treatment Period|Death|1|||
125972397|NCT03214367|453188767|FG004|Treatment Period|Death|0|||
125972398|NCT03214367|453188768|FG005|Treatment Period|Death|0|||
125972399|NCT03214367|453188769|FG006|Treatment Period|Death|0|||
125972400|NCT03214367|453188770|FG007|Treatment Period|Death|0|||
125972401|NCT03214367|453188763|FG000|Treatment Period|Lost to Follow-up|0|||
126160342|NCT01597193|453873699|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
126160343|NCT01597193|453873700|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
125972402|NCT03214367|453188764|FG001|Treatment Period|Lost to Follow-up|5|||
126160344|NCT01597193|453873701|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
126160345|NCT01597193|453873695|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126160346|NCT01597193|453873696|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126160347|NCT01597193|453873697|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126160348|NCT01597193|453873698|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126160349|NCT01597193|453873699|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126160350|NCT01597193|453873700|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
126160351|NCT01597193|453873701|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126160352|NCT01597193|453873695|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126160353|NCT01597193|453873696|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126160354|NCT01597193|453873697|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126160355|NCT01597193|453873698|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
126160356|NCT01597193|453873699|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126160357|NCT01597193|453873700|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
126160358|NCT01597193|453873701|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126160359|NCT03184701|453873702|FG000|Overall Study|Death|3|||
126160360|NCT03184701|453873702|FG000|Overall Study|Physician Decision|3|||
126160361|NCT03184701|453873702|FG000|Overall Study|Withdrawal by Subject|6|||
126160362|NCT03184701|453873702|FG000|Overall Study|Lost to Follow-up|5|||
126160363|NCT00935220|453873713|FG000|Overall Study|Adverse Event|1|||
126160364|NCT00935220|453873713|FG000|Overall Study|Other reason (not specified)|1|||
126160365|NCT01000064|453873714|FG000|Overall Study|Withdrawal by Subject|1|||
126160366|NCT01000064|453873715|FG001|Overall Study|Withdrawal by Subject|1|||
126160367|NCT01518192|453873716|FG000|Overall Study|Lost to Follow-up|29|||
126160368|NCT01518192|453873717|FG001|Overall Study|Lost to Follow-up|26|||
126160369|NCT01518192|453873718|FG002|Overall Study|Lost to Follow-up|35|||
126160370|NCT00798967|453873719|FG000|Overall Study|Adverse Event|2|||
126160371|NCT00798967|453873720|FG001|Overall Study|Adverse Event|3|||
126160372|NCT00798967|453873719|FG000|Overall Study|Withdrawal by Subject|0|||
126160373|NCT00798967|453873720|FG001|Overall Study|Withdrawal by Subject|1|||
126160374|NCT00798967|453873719|FG000|Overall Study|Physician Decision|1|||
126160375|NCT00798967|453873720|FG001|Overall Study|Physician Decision|0|||
126160376|NCT00798967|453873719|FG000|Overall Study|Randomized in error by site|1|||
126160377|NCT00798967|453873720|FG001|Overall Study|Randomized in error by site|0|||
126160378|NCT01415440|453873721|FG000|Overall Study|Lost to Follow-up|0|||
126160379|NCT01415440|453873722|FG001|Overall Study|Lost to Follow-up|1|||
126160380|NCT01415440|453873723|FG002|Overall Study|Lost to Follow-up|2|||
126160381|NCT01415440|453873721|FG000|Overall Study|Physician Decision|3|||
126160382|NCT01415440|453873722|FG001|Overall Study|Physician Decision|0|||
126160383|NCT01415440|453873723|FG002|Overall Study|Physician Decision|0|||
126160384|NCT01415440|453873721|FG000|Overall Study|Withdrawal by Subject|1|||
126160385|NCT01415440|453873722|FG001|Overall Study|Withdrawal by Subject|0|||
126160386|NCT01415440|453873723|FG002|Overall Study|Withdrawal by Subject|0|||
126160387|NCT03141307|453873724|FG000|In-Hospital|Withdrawal by Subject|0|||
126160388|NCT03141307|453873725|FG001|In-Hospital|Withdrawal by Subject|2|||
126160389|NCT03141307|453873724|FG000|In-Hospital|Protocol Violation|4|||
126160390|NCT03141307|453873725|FG001|In-Hospital|Protocol Violation|0|||
126160391|NCT03141307|453873724|FG000|Follow-Up|Lost to Follow-up|97|||
126160392|NCT03141307|453873725|FG001|Follow-Up|Lost to Follow-up|54|||
126160393|NCT03090737|453873726|FG000|Overall Study|Other reasons|1|||
126160394|NCT03090737|453873726|FG000|Overall Study|Completed treatment as per protocol|17|||
126160395|NCT03090737|453873726|FG000|Overall Study|Maximum clinical benefit|2|||
126160396|NCT03090737|453873726|FG000|Overall Study|Adverse event unrelated to study drug|7|||
126160397|NCT03090737|453873726|FG000|Overall Study|Study drug toxicity|4|||
126160398|NCT03090737|453873726|FG000|Overall Study|Disease progression|98|||
126160399|NCT02160977|453873729|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
126160400|NCT02160977|453873730|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
126160401|NCT02160977|453873729|FG000|Three Months After Surgery|Lost to Follow-up|0|||
126160402|NCT02160977|453873730|FG001|Three Months After Surgery|Lost to Follow-up|2|||
126160403|NCT02160977|453873729|FG000|Six Months After Surgery|Lost to Follow-up|2|||
126160404|NCT02160977|453873730|FG001|Six Months After Surgery|Lost to Follow-up|1|||
126160405|NCT01505491|453875275|FG000|Overall Study|Other reason not listed|1|||
126160406|NCT01505491|453875276|FG001|Overall Study|Other reason not listed|0|||
126160407|NCT01505491|453875277|FG002|Overall Study|Other reason not listed|0|||
126160408|NCT01505491|453875275|FG000|Overall Study|Withdrawal by Subject|1|||
125972403|NCT03214367|453188765|FG002|Treatment Period|Lost to Follow-up|3|||
126160409|NCT01505491|453875276|FG001|Overall Study|Withdrawal by Subject|1|||
126160410|NCT01505491|453875277|FG002|Overall Study|Withdrawal by Subject|4|||
126160411|NCT01505491|453875275|FG000|Overall Study|Lost to Follow-up|0|||
125972404|NCT03214367|453188766|FG003|Treatment Period|Lost to Follow-up|2|||
126160412|NCT01505491|453875276|FG001|Overall Study|Lost to Follow-up|0|||
126160413|NCT01505491|453875277|FG002|Overall Study|Lost to Follow-up|1|||
126160414|NCT02433288|453875286|FG000|Overall Study|Severe non-compliance to protocol|13|||
126160415|NCT02433288|453875287|FG001|Overall Study|Severe non-compliance to protocol|7|||
126160416|NCT02433288|453875286|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
126160417|NCT02433288|453875287|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
126160418|NCT02433288|453875286|FG000|Overall Study|Withdrawal by Subject|101|||
126160419|NCT02433288|453875287|FG001|Overall Study|Withdrawal by Subject|99|||
126160420|NCT02433288|453875286|FG000|Overall Study|Lost to Follow-up|2|||
126160421|NCT02433288|453875287|FG001|Overall Study|Lost to Follow-up|14|||
126160422|NCT02433288|453875286|FG000|Overall Study|Death|0|||
126160423|NCT02433288|453875287|FG001|Overall Study|Death|3|||
126160424|NCT01063751|453875288|FG000|Overall Study|Censored from analyses|42|||
126160425|NCT01063751|453875288|FG000|Overall Study|Withdrawal by Subject|34|||
126160426|NCT01063751|453875288|FG000|Overall Study|Lost to Follow-up|30|||
126160427|NCT01063751|453875288|FG000|Overall Study|Death|13|||
126160428|NCT01063751|453875288|FG000|Overall Study|Sponsored Terminated Study|60|||
126160429|NCT01063751|453875288|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
126160430|NCT01063751|453875288|FG000|Overall Study|Investigator site closed|10|||
126160431|NCT01063751|453875288|FG000|Overall Study|Revision|6|||
126160432|NCT01063751|453875288|FG000|Overall Study|Physician Decision|4|||
126160433|NCT03408873|453875294|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
126160434|NCT03408873|453875294|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
126160435|NCT03408873|453875294|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
126160436|NCT03408873|453875294|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
126160437|NCT03408873|453875294|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
126160438|NCT03408873|453875294|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
126160439|NCT01312428|453875298|FG000|Overall Study|Study Termination|3|||
126160440|NCT01312428|453875299|FG001|Overall Study|Study Termination|4|||
126160441|NCT03799718|453875301|FG000|Overall Study|Adverse Event|2|||
126160442|NCT02214186|453875303|FG000|Overall Study|Lost to Follow-up|1|||
126160443|NCT02214186|453875304|FG001|Overall Study|Lost to Follow-up|1|||
126160444|NCT02214186|453875303|FG000|Overall Study|Protocol Violation|1|||
126160445|NCT02214186|453875304|FG001|Overall Study|Protocol Violation|1|||
126160446|NCT01651052|453875305|FG000|Overall Study|Death|21|||
126160447|NCT01651052|453875305|FG000|Overall Study|Explant|1|||
126160448|NCT01651052|453875305|FG000|Overall Study|Withdrawal by Subject|1|||
126160449|NCT01651052|453875305|FG000|Overall Study|Lost to Follow-up|3|||
126160450|NCT00611130|453875314|FG000|Overall Study|Lost to Follow-up|25|||
126160451|NCT00611130|453875315|FG001|Overall Study|Lost to Follow-up|29|||
126160452|NCT00611130|453875314|FG000|Overall Study|Protocol noncompliance|7|||
126160453|NCT00611130|453875315|FG001|Overall Study|Protocol noncompliance|6|||
126160454|NCT00611130|453875314|FG000|Overall Study|Withdrawal by Subject|6|||
126160455|NCT00611130|453875315|FG001|Overall Study|Withdrawal by Subject|5|||
126160456|NCT00611130|453875314|FG000|Overall Study|Other|5|||
126160457|NCT00611130|453875315|FG001|Overall Study|Other|4|||
126160458|NCT00611130|453875314|FG000|Overall Study|Incarceration|3|||
126160459|NCT00611130|453875315|FG001|Overall Study|Incarceration|2|||
126160460|NCT00611130|453875314|FG000|Overall Study|Administrative|1|||
126160461|NCT00611130|453875315|FG001|Overall Study|Administrative|1|||
126160462|NCT00611130|453875314|FG000|Overall Study|Adverse Event|1|||
126160463|NCT00611130|453875315|FG001|Overall Study|Adverse Event|0|||
126160464|NCT00611130|453875314|FG000|Overall Study|Death|1|||
126160465|NCT00611130|453875315|FG001|Overall Study|Death|0|||
126160466|NCT03964415|453875317|FG000|Overall Study|Sponsor's decision|1563|||
126160467|NCT03964415|453875318|FG001|Overall Study|Sponsor's decision|1528|||
126160468|NCT03964415|453875317|FG000|Overall Study|Lost to Follow-up|139|||
126160469|NCT03964415|453875318|FG001|Overall Study|Lost to Follow-up|146|||
126160470|NCT03964415|453875317|FG000|Overall Study|Withdrawal by Subject|68|||
126160471|NCT03964415|453875318|FG001|Overall Study|Withdrawal by Subject|72|||
126160472|NCT03964415|453875317|FG000|Overall Study|Physician Decision|34|||
126160473|NCT03964415|453875318|FG001|Overall Study|Physician Decision|48|||
126160474|NCT03964415|453875317|FG000|Overall Study|Adverse Event|3|||
126160475|NCT03964415|453875318|FG001|Overall Study|Adverse Event|0|||
126160476|NCT03964415|453875317|FG000|Overall Study|Death|4|||
126160477|NCT03964415|453875318|FG001|Overall Study|Death|6|||
126160478|NCT03964415|453875317|FG000|Overall Study|Protocol Violation|1|||
126160479|NCT03964415|453875318|FG001|Overall Study|Protocol Violation|4|||
126160480|NCT03964415|453875317|FG000|Overall Study|Other|35|||
126160481|NCT03964415|453875318|FG001|Overall Study|Other|38|||
126160482|NCT03964415|453875317|FG000|Overall Study|Randomized but not treated|6|||
126160483|NCT03964415|453875318|FG001|Overall Study|Randomized but not treated|7|||
126160484|NCT01734993|453875319|FG000|Overall Study|Adverse Event|1|||
126160485|NCT01734993|453875319|FG000|Overall Study|Lack of Efficacy|1|||
126160486|NCT01024465|453875320|FG000|Overall Study|Adverse Event|2|||
126160487|NCT01024465|453875320|FG000|Overall Study|Physician Decision|1|||
126160488|NCT01455428|453875321|FG000|Overall Study|Protocol Violation|2|||
126160489|NCT01455428|453875322|FG001|Overall Study|Protocol Violation|1|||
126160490|NCT01455428|453875321|FG000|Overall Study|Adverse Event|6|||
126160491|NCT01455428|453875322|FG001|Overall Study|Adverse Event|2|||
126160492|NCT01455428|453875321|FG000|Overall Study|Lost to Follow-up|1|||
126160493|NCT01455428|453875322|FG001|Overall Study|Lost to Follow-up|1|||
126160494|NCT01455428|453875321|FG000|Overall Study|Withdrawal by Subject|2|||
126160495|NCT01455428|453875322|FG001|Overall Study|Withdrawal by Subject|5|||
126160496|NCT01455428|453875321|FG000|Overall Study|Did not meet entrance criteria|0|||
126160497|NCT01455428|453875322|FG001|Overall Study|Did not meet entrance criteria|2|||
126160498|NCT01455428|453875321|FG000|Overall Study|Insufficient clinical response|0|||
126160499|NCT01455428|453875322|FG001|Overall Study|Insufficient clinical response|2|||
126160500|NCT01455428|453875321|FG000|Overall Study|Did not receive treatment|1|||
126160501|NCT01455428|453875322|FG001|Overall Study|Did not receive treatment|1|||
126160502|NCT01455428|453875321|FG000|Overall Study|Other|2|||
126160503|NCT01455428|453875322|FG001|Overall Study|Other|4|||
126160504|NCT03303339|453875323|FG000|Overall Study|Death|2|||
126160505|NCT03303339|453875324|FG001|Overall Study|Death|2|||
126160506|NCT03303339|453875325|FG002|Overall Study|Death|2|||
126160507|NCT03303339|453875326|FG003|Overall Study|Death|1|||
126160508|NCT03303339|453875327|FG004|Overall Study|Death|4|||
126160509|NCT03303339|453875328|FG005|Overall Study|Death|2|||
126160510|NCT03303339|453875329|FG006|Overall Study|Death|2|||
126160511|NCT03303339|453875330|FG007|Overall Study|Death|2|||
126160512|NCT03303339|453875331|FG008|Overall Study|Death|3|||
126160513|NCT03303339|453875332|FG009|Overall Study|Death|3|||
126160514|NCT03303339|453875333|FG010|Overall Study|Death|4|||
126160515|NCT03303339|453875334|FG011|Overall Study|Death|24|||
126160516|NCT03303339|453875323|FG000|Overall Study|Study Terminated by Sponsor|0|||
126160517|NCT03303339|453875324|FG001|Overall Study|Study Terminated by Sponsor|0|||
126160518|NCT03303339|453875325|FG002|Overall Study|Study Terminated by Sponsor|0|||
126160519|NCT03303339|453875326|FG003|Overall Study|Study Terminated by Sponsor|0|||
126160520|NCT03303339|453875327|FG004|Overall Study|Study Terminated by Sponsor|0|||
126160521|NCT03303339|453875328|FG005|Overall Study|Study Terminated by Sponsor|0|||
126160522|NCT03303339|453875329|FG006|Overall Study|Study Terminated by Sponsor|0|||
126160523|NCT03303339|453875330|FG007|Overall Study|Study Terminated by Sponsor|0|||
126160524|NCT03303339|453875331|FG008|Overall Study|Study Terminated by Sponsor|1|||
126160525|NCT03303339|453875332|FG009|Overall Study|Study Terminated by Sponsor|0|||
126160526|NCT03303339|453875333|FG010|Overall Study|Study Terminated by Sponsor|1|||
126160527|NCT03303339|453875334|FG011|Overall Study|Study Terminated by Sponsor|1|||
126160528|NCT03303339|453875323|FG000|Overall Study|Withdrawal by Subject|1|||
126160529|NCT03303339|453875324|FG001|Overall Study|Withdrawal by Subject|0|||
126160530|NCT03303339|453875325|FG002|Overall Study|Withdrawal by Subject|0|||
126160531|NCT03303339|453875326|FG003|Overall Study|Withdrawal by Subject|0|||
126160532|NCT03303339|453875327|FG004|Overall Study|Withdrawal by Subject|0|||
126160533|NCT03303339|453875328|FG005|Overall Study|Withdrawal by Subject|1|||
126160534|NCT03303339|453875329|FG006|Overall Study|Withdrawal by Subject|1|||
126160535|NCT03303339|453875330|FG007|Overall Study|Withdrawal by Subject|0|||
126160536|NCT03303339|453875331|FG008|Overall Study|Withdrawal by Subject|0|||
126160537|NCT03303339|453875332|FG009|Overall Study|Withdrawal by Subject|0|||
126160538|NCT03303339|453875333|FG010|Overall Study|Withdrawal by Subject|0|||
126160539|NCT03303339|453875334|FG011|Overall Study|Withdrawal by Subject|2|||
126160540|NCT03303339|453875323|FG000|Overall Study|Physician Decision|0|||
126160541|NCT03303339|453875324|FG001|Overall Study|Physician Decision|0|||
126160542|NCT03303339|453875325|FG002|Overall Study|Physician Decision|0|||
126160543|NCT03303339|453875326|FG003|Overall Study|Physician Decision|0|||
126160544|NCT03303339|453875327|FG004|Overall Study|Physician Decision|1|||
126160545|NCT03303339|453875328|FG005|Overall Study|Physician Decision|0|||
126160546|NCT03303339|453875329|FG006|Overall Study|Physician Decision|0|||
126160547|NCT03303339|453875330|FG007|Overall Study|Physician Decision|0|||
126160548|NCT03303339|453875331|FG008|Overall Study|Physician Decision|0|||
126160549|NCT03303339|453875332|FG009|Overall Study|Physician Decision|0|||
126160550|NCT03303339|453875333|FG010|Overall Study|Physician Decision|0|||
126160551|NCT03303339|453875334|FG011|Overall Study|Physician Decision|0|||
126160552|NCT03303339|453875323|FG000|Overall Study|Safety/Non-compliance|0|||
126160553|NCT03303339|453875324|FG001|Overall Study|Safety/Non-compliance|0|||
126160554|NCT03303339|453875325|FG002|Overall Study|Safety/Non-compliance|0|||
126160555|NCT03303339|453875326|FG003|Overall Study|Safety/Non-compliance|0|||
126160556|NCT03303339|453875327|FG004|Overall Study|Safety/Non-compliance|0|||
126160557|NCT03303339|453875328|FG005|Overall Study|Safety/Non-compliance|0|||
126160558|NCT03303339|453875329|FG006|Overall Study|Safety/Non-compliance|0|||
126160559|NCT03303339|453875330|FG007|Overall Study|Safety/Non-compliance|0|||
126160560|NCT03303339|453875331|FG008|Overall Study|Safety/Non-compliance|0|||
126160561|NCT03303339|453875332|FG009|Overall Study|Safety/Non-compliance|0|||
126160562|NCT03303339|453875333|FG010|Overall Study|Safety/Non-compliance|0|||
126160563|NCT03303339|453875334|FG011|Overall Study|Safety/Non-compliance|1|||
126160564|NCT02062151|453875337|FG000|Overall Study|screen failure|1|||
126160565|NCT00257192|453875340|FG000|Overall Study|Adverse Event|21|||
126160566|NCT00257192|453875341|FG001|Overall Study|Adverse Event|10|||
126160567|NCT00257192|453875340|FG000|Overall Study|Laboratory abnormality|1|||
125972405|NCT03214367|453188767|FG004|Treatment Period|Lost to Follow-up|0|||
126160568|NCT00257192|453875341|FG001|Overall Study|Laboratory abnormality|1|||
126160569|NCT00257192|453875340|FG000|Overall Study|Lost to Follow-up|3|||
126160570|NCT00257192|453875341|FG001|Overall Study|Lost to Follow-up|3|||
126160571|NCT00257192|453875340|FG000|Overall Study|Insufficient clinical response|18|||
126160572|NCT00257192|453875341|FG001|Overall Study|Insufficient clinical response|18|||
126160573|NCT00257192|453875340|FG000|Overall Study|Withdrawal by Subject|14|||
126160574|NCT00257192|453875341|FG001|Overall Study|Withdrawal by Subject|2|||
126160575|NCT00257192|453875340|FG000|Overall Study|Randomized but not treated|0|||
126160576|NCT00257192|453875341|FG001|Overall Study|Randomized but not treated|1|||
126160577|NCT00257192|453875340|FG000|Overall Study|Study terminated by sponsor|1|||
126160578|NCT00257192|453875341|FG001|Overall Study|Study terminated by sponsor|0|||
126160579|NCT00257192|453875340|FG000|Overall Study|Miscellaneous|0|||
126160580|NCT00257192|453875341|FG001|Overall Study|Miscellaneous|4|||
126160581|NCT00570739|453875342|FG000|Overall Study|Adverse Event|8|||
126160582|NCT00570739|453875343|FG001|Overall Study|Adverse Event|6|||
126160583|NCT00570739|453875344|FG002|Overall Study|Adverse Event|2|||
126160584|NCT00570739|453875345|FG003|Overall Study|Adverse Event|2|||
126160585|NCT00570739|453875342|FG000|Overall Study|Lost to Follow-up|4|||
126160586|NCT00570739|453875343|FG001|Overall Study|Lost to Follow-up|5|||
126160587|NCT00570739|453875344|FG002|Overall Study|Lost to Follow-up|4|||
126160588|NCT00570739|453875345|FG003|Overall Study|Lost to Follow-up|1|||
126160589|NCT00570739|453875342|FG000|Overall Study|Physician Decision|1|||
126160590|NCT00570739|453875343|FG001|Overall Study|Physician Decision|1|||
126160591|NCT00570739|453875344|FG002|Overall Study|Physician Decision|0|||
126160592|NCT00570739|453875345|FG003|Overall Study|Physician Decision|0|||
126160593|NCT00570739|453875342|FG000|Overall Study|Withdrawal by Subject|7|||
126160594|NCT00570739|453875343|FG001|Overall Study|Withdrawal by Subject|7|||
126160595|NCT00570739|453875344|FG002|Overall Study|Withdrawal by Subject|3|||
126160596|NCT00570739|453875345|FG003|Overall Study|Withdrawal by Subject|5|||
126160597|NCT00570739|453875342|FG000|Overall Study|Required restricted medication|0|||
126160598|NCT00570739|453875343|FG001|Overall Study|Required restricted medication|0|||
126160599|NCT00570739|453875344|FG002|Overall Study|Required restricted medication|1|||
126160600|NCT00570739|453875345|FG003|Overall Study|Required restricted medication|0|||
126160601|NCT00570739|453875342|FG000|Overall Study|Met discontinuation criteria|1|||
126160602|NCT00570739|453875343|FG001|Overall Study|Met discontinuation criteria|0|||
126160603|NCT00570739|453875344|FG002|Overall Study|Met discontinuation criteria|1|||
126160604|NCT00570739|453875345|FG003|Overall Study|Met discontinuation criteria|1|||
126160605|NCT00570739|453875342|FG000|Overall Study|Other|0|||
126160606|NCT00570739|453875343|FG001|Overall Study|Other|2|||
126160607|NCT00570739|453875344|FG002|Overall Study|Other|5|||
126160608|NCT00570739|453875345|FG003|Overall Study|Other|3|||
126160609|NCT02086565|453875347|FG000|Overall Study|Lost to Follow-up|9|||
126160610|NCT02086565|453875348|FG001|Overall Study|Lost to Follow-up|7|||
126160611|NCT02086565|453875347|FG000|Overall Study|Withdrawal by Subject|2|||
126160612|NCT02086565|453875348|FG001|Overall Study|Withdrawal by Subject|1|||
126160613|NCT02086565|453875347|FG000|Overall Study|Death|3|||
126160614|NCT02086565|453875348|FG001|Overall Study|Death|2|||
126160615|NCT02086565|453875347|FG000|Overall Study|withdrawn by research team|2|||
126160616|NCT02086565|453875348|FG001|Overall Study|withdrawn by research team|2|||
126160617|NCT02116972|453875349|FG000|Overall Study|Adverse Event|4|||
126160618|NCT02116972|453875350|FG001|Overall Study|Adverse Event|4|||
126160619|NCT02116972|453875351|FG002|Overall Study|Adverse Event|1|||
126160620|NCT02116972|453875349|FG000|Overall Study|Withdrawal by Subject|1|||
126160621|NCT02116972|453875350|FG001|Overall Study|Withdrawal by Subject|1|||
126160622|NCT02116972|453875351|FG002|Overall Study|Withdrawal by Subject|5|||
126160623|NCT02116972|453875349|FG000|Overall Study|Protocol Violation|1|||
126160624|NCT02116972|453875350|FG001|Overall Study|Protocol Violation|0|||
126160625|NCT02116972|453875351|FG002|Overall Study|Protocol Violation|1|||
126160626|NCT02116972|453875349|FG000|Overall Study|Lost to Follow-up|4|||
126160627|NCT02116972|453875350|FG001|Overall Study|Lost to Follow-up|3|||
126160628|NCT02116972|453875351|FG002|Overall Study|Lost to Follow-up|1|||
126160629|NCT02116972|453875349|FG000|Overall Study|Lack of Efficacy|6|||
126160630|NCT02116972|453875350|FG001|Overall Study|Lack of Efficacy|6|||
126160631|NCT02116972|453875351|FG002|Overall Study|Lack of Efficacy|5|||
126160632|NCT02116972|453875349|FG000|Overall Study|scheduling conflicts and relocation|3|||
126160633|NCT02116972|453875350|FG001|Overall Study|scheduling conflicts and relocation|3|||
126160634|NCT02116972|453875351|FG002|Overall Study|scheduling conflicts and relocation|6|||
126160635|NCT01400971|453875352|FG000|Overall Study|Death|82|||
126160636|NCT01400971|453875352|FG000|Overall Study|Lost to Follow-up|196|||
126160637|NCT01400971|453875352|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
126160638|NCT01400971|453875352|FG000|Overall Study|Physician Decision|57|||
126160639|NCT01400971|453875352|FG000|Overall Study|Withdrawal by Subject|158|||
126160640|NCT01400971|453875352|FG000|Overall Study|Other|422|||
126160641|NCT01921270|453875357|FG000|Overall Study|Withdrawal by Subject|1|||
126160642|NCT00789477|453875358|FG000|Overall Study|Withdrawal by Subject|2|||
126160643|NCT00789477|453875359|FG001|Overall Study|Withdrawal by Subject|1|||
126160644|NCT00789477|453875360|FG002|Overall Study|Withdrawal by Subject|3|||
126160645|NCT00789477|453875361|FG003|Overall Study|Withdrawal by Subject|2|||
126160646|NCT00789477|453875362|FG004|Overall Study|Withdrawal by Subject|3|||
126160647|NCT00789477|453875358|FG000|Overall Study|Protocol Violation|1|||
126160648|NCT00789477|453875359|FG001|Overall Study|Protocol Violation|0|||
126160649|NCT00789477|453875360|FG002|Overall Study|Protocol Violation|0|||
126160650|NCT00789477|453875361|FG003|Overall Study|Protocol Violation|1|||
126160651|NCT00789477|453875362|FG004|Overall Study|Protocol Violation|0|||
126160652|NCT00789477|453875358|FG000|Overall Study|Adverse Event|3|||
126160653|NCT00789477|453875359|FG001|Overall Study|Adverse Event|3|||
126160654|NCT00789477|453875360|FG002|Overall Study|Adverse Event|1|||
126160655|NCT00789477|453875361|FG003|Overall Study|Adverse Event|0|||
126160656|NCT00789477|453875362|FG004|Overall Study|Adverse Event|0|||
126160657|NCT00789477|453875358|FG000|Overall Study|Death|1|||
126160658|NCT00789477|453875359|FG001|Overall Study|Death|1|||
126160659|NCT00789477|453875360|FG002|Overall Study|Death|2|||
126160660|NCT00789477|453875361|FG003|Overall Study|Death|2|||
126160661|NCT00789477|453875362|FG004|Overall Study|Death|0|||
126160662|NCT00789477|453875358|FG000|Overall Study|Lost to Follow-up|0|||
126160663|NCT00789477|453875359|FG001|Overall Study|Lost to Follow-up|1|||
126160664|NCT00789477|453875360|FG002|Overall Study|Lost to Follow-up|4|||
125972406|NCT03214367|453188768|FG005|Treatment Period|Lost to Follow-up|2|||
125972407|NCT03214367|453188769|FG006|Treatment Period|Lost to Follow-up|1|||
125972408|NCT03214367|453188770|FG007|Treatment Period|Lost to Follow-up|0|||
125972409|NCT03214367|453188763|FG000|Treatment Period|Sponsor Decision|0|||
125972410|NCT03214367|453188764|FG001|Treatment Period|Sponsor Decision|3|||
126160665|NCT00789477|453875361|FG003|Overall Study|Lost to Follow-up|2|||
126160666|NCT00789477|453875362|FG004|Overall Study|Lost to Follow-up|4|||
126160667|NCT00789477|453875358|FG000|Overall Study|Lack of Efficacy|2|||
126160668|NCT00789477|453875359|FG001|Overall Study|Lack of Efficacy|0|||
126160669|NCT00789477|453875360|FG002|Overall Study|Lack of Efficacy|0|||
126160670|NCT00789477|453875361|FG003|Overall Study|Lack of Efficacy|0|||
126160671|NCT00789477|453875362|FG004|Overall Study|Lack of Efficacy|0|||
126160672|NCT00789477|453875358|FG000|Overall Study|Other|2|||
126160673|NCT00789477|453875359|FG001|Overall Study|Other|0|||
126160674|NCT00789477|453875360|FG002|Overall Study|Other|1|||
126160675|NCT00789477|453875361|FG003|Overall Study|Other|3|||
126160676|NCT00789477|453875362|FG004|Overall Study|Other|0|||
126160677|NCT00455858|453875363|FG000|Overall Study|Lost to Follow-up|2|||
126160678|NCT00455858|453875363|FG000|Overall Study|Protocol Violation|1|||
126160679|NCT00455858|453875363|FG000|Overall Study|Lack of Efficacy|1|||
126160680|NCT00455858|453875363|FG000|Overall Study|Well controlled FPG without insulin|1|||
126160681|NCT00455858|453875363|FG000|Overall Study|Withdrawal|1|||
126160682|NCT02092389|453875365|FG000|Overall Study|Adverse Event|1|||
126160683|NCT02092389|453875365|FG000|Overall Study|Other|5|||
126160684|NCT01242020|453875366|FG000|Overall Study|Withdrawal by Subject|2|||
126160685|NCT01242020|453875367|FG001|Overall Study|Withdrawal by Subject|0|||
126160686|NCT01242020|453875366|FG000|Overall Study|Failed screening|1|||
126160687|NCT01242020|453875367|FG001|Overall Study|Failed screening|0|||
126160688|NCT01595646|453875368|FG000|Overall Study|Withdrawal by Subject|1|||
126160689|NCT01595646|453875369|FG001|Overall Study|Withdrawal by Subject|0|||
126160690|NCT01595646|453875370|FG002|Overall Study|Withdrawal by Subject|0|||
126160691|NCT01161524|453875372|FG000|Core Study (23 Weeks)|Adverse Event|3|||
126160692|NCT01161524|453875373|FG001|Core Study (23 Weeks)|Adverse Event|0|||
126160693|NCT01161524|453875374|FG002|Core Study (23 Weeks)|Adverse Event|0|||
126160694|NCT01161524|453875372|FG000|Core Study (23 Weeks)|Other|1|||
126160695|NCT01161524|453875373|FG001|Core Study (23 Weeks)|Other|0|||
126160696|NCT01161524|453875374|FG002|Core Study (23 Weeks)|Other|0|||
126160697|NCT01161524|453875372|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
126160698|NCT01161524|453875373|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
126160699|NCT01161524|453875374|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
126160700|NCT01161524|453875372|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
126160701|NCT01161524|453875373|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
126160702|NCT01161524|453875374|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
126160703|NCT01161524|453875372|FG000|Core Study (23 Weeks)|Subject Choice|3|||
126160704|NCT01161524|453875373|FG001|Core Study (23 Weeks)|Subject Choice|2|||
126160705|NCT01161524|453875374|FG002|Core Study (23 Weeks)|Subject Choice|0|||
126160706|NCT01161524|453875372|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
126160707|NCT01161524|453875373|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
126160708|NCT01161524|453875374|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
126160709|NCT01161524|453875372|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
126160710|NCT01161524|453875373|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
126160711|NCT01161524|453875374|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
126160712|NCT01161524|453875372|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
126160713|NCT01161524|453875373|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
126160714|NCT01161524|453875374|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
126160715|NCT01161524|453875372|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
126160716|NCT01161524|453875373|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
126160717|NCT01161524|453875374|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
126160718|NCT01161524|453875372|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
126160719|NCT01161524|453875373|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
126160720|NCT01161524|453875374|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
126160721|NCT00231062|453875383|FG000|Overall Study|Physician Decision|6|||
126160722|NCT00616239|453875384|FG000|Overall Study|Withdrawal by Subject|2|||
126160723|NCT01052012|453875385|FG000|Overall Study|Not treated|2|||
126160724|NCT01052012|453875386|FG001|Overall Study|Not treated|5|||
126160725|NCT01052012|453875387|FG002|Overall Study|Not treated|0|||
126160726|NCT01052012|453875388|FG003|Overall Study|Not treated|0|||
126160727|NCT01052012|453875389|FG004|Overall Study|Not treated|11|||
126160728|NCT01052012|453875390|FG005|Overall Study|Not treated|8|||
126160729|NCT01052012|453875385|FG000|Overall Study|Adverse Event|1|||
126160730|NCT01052012|453875386|FG001|Overall Study|Adverse Event|0|||
126160731|NCT01052012|453875387|FG002|Overall Study|Adverse Event|0|||
126160732|NCT01052012|453875388|FG003|Overall Study|Adverse Event|1|||
126160733|NCT01052012|453875389|FG004|Overall Study|Adverse Event|0|||
126160734|NCT01052012|453875390|FG005|Overall Study|Adverse Event|0|||
126160735|NCT01052012|453875385|FG000|Overall Study|Lost to Follow-up|0|||
126160736|NCT01052012|453875386|FG001|Overall Study|Lost to Follow-up|0|||
126160737|NCT01052012|453875387|FG002|Overall Study|Lost to Follow-up|0|||
126160738|NCT01052012|453875388|FG003|Overall Study|Lost to Follow-up|0|||
126160739|NCT01052012|453875389|FG004|Overall Study|Lost to Follow-up|1|||
126160740|NCT01052012|453875390|FG005|Overall Study|Lost to Follow-up|0|||
126160741|NCT01052012|453875385|FG000|Overall Study|Withdrawal by Subject|1|||
126160742|NCT01052012|453875386|FG001|Overall Study|Withdrawal by Subject|1|||
126160743|NCT01052012|453875387|FG002|Overall Study|Withdrawal by Subject|0|||
126160744|NCT01052012|453875388|FG003|Overall Study|Withdrawal by Subject|0|||
126160745|NCT01052012|453875389|FG004|Overall Study|Withdrawal by Subject|3|||
126160746|NCT01052012|453875390|FG005|Overall Study|Withdrawal by Subject|1|||
126160747|NCT01052012|453875385|FG000|Overall Study|Physician Decision|0|||
126160748|NCT01052012|453875386|FG001|Overall Study|Physician Decision|0|||
126160749|NCT01052012|453875387|FG002|Overall Study|Physician Decision|0|||
126160750|NCT01052012|453875388|FG003|Overall Study|Physician Decision|0|||
126160751|NCT01052012|453875389|FG004|Overall Study|Physician Decision|0|||
126160752|NCT01052012|453875390|FG005|Overall Study|Physician Decision|1|||
126160753|NCT01052012|453875385|FG000|Overall Study|Other|0|||
126160754|NCT01052012|453875386|FG001|Overall Study|Other|0|||
126160755|NCT01052012|453875387|FG002|Overall Study|Other|0|||
126160756|NCT01052012|453875388|FG003|Overall Study|Other|0|||
126160757|NCT01052012|453875389|FG004|Overall Study|Other|1|||
126160758|NCT01052012|453875390|FG005|Overall Study|Other|0|||
126160759|NCT02873715|453875391|FG000|Overall Study|Lost to Follow-up|84|||
126160760|NCT02873715|453875392|FG001|Overall Study|Lost to Follow-up|94|||
126160761|NCT02873715|453875391|FG000|Overall Study|Withdrawal by Subject|7|||
126160762|NCT02873715|453875392|FG001|Overall Study|Withdrawal by Subject|26|||
126160763|NCT02021812|453875398|FG000|Overall Study|Death|8|||
126160764|NCT02021812|453875398|FG000|Overall Study|Withdrawal by Subject|3|||
126160765|NCT02021812|453875398|FG000|Overall Study|Lost to Follow-up|2|||
126160766|NCT02021812|453875398|FG000|Overall Study|Refuse to return, COVD 19|2|||
126160767|NCT00564629|453875399|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
126160768|NCT00564629|453875400|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
126160769|NCT02698423|453875401|FG000|Overall Study|Lost to Follow-up|19|||
126160770|NCT02698423|453875402|FG001|Overall Study|Lost to Follow-up|24|||
126160771|NCT03634072|453875403|FG000|Overall Study|Early termination of overall study|1|||
126160772|NCT03634072|453875404|FG001|Overall Study|Early termination of overall study|0|||
126160773|NCT01651260|453875405|FG000|Overall Study|unable to apply product|3|||
126160774|NCT01952015|453875408|FG000|Induction|Protocol Violation|1|||
126160775|NCT01952015|453875408|FG000|Maintenance|Adverse Event|2|||
126160776|NCT01952015|453875408|FG000|Treatment Period 3|Physician Decision|9|||
126160777|NCT02239094|453875409|FG000|Overall Study|Withdrawal by Subject|1|||
126160778|NCT02239094|453875409|FG000|Overall Study|Remitted before started|1|||
126160779|NCT02508701|453875410|FG000|Overall Study|Lost to Follow-up|9|||
126160780|NCT02508701|453875411|FG001|Overall Study|Lost to Follow-up|5|||
126160781|NCT02508701|453875412|FG002|Overall Study|Lost to Follow-up|5|||
126160782|NCT02508701|453875413|FG003|Overall Study|Lost to Follow-up|3|||
126160783|NCT01259297|453875414|FG000|Double Blind Randomized Period|Death|1|||
126160784|NCT01259297|453875415|FG001|Double Blind Randomized Period|Death|1|||
126160785|NCT01259297|453875416|FG002|Double Blind Randomized Period|Death|1|||
125972411|NCT03214367|453188765|FG002|Treatment Period|Sponsor Decision|0|||
125972412|NCT03214367|453188766|FG003|Treatment Period|Sponsor Decision|0|||
126160786|NCT01259297|453875417|FG003|Double Blind Randomized Period|Death|2|||
126160787|NCT01259297|453875418|FG004|Double Blind Randomized Period|Death|1|||
126160788|NCT01259297|453875419|FG005|Double Blind Randomized Period|Death|5|||
126160789|NCT01259297|453875420|FG006|Double Blind Randomized Period|Death|2|||
125972413|NCT03214367|453188767|FG004|Treatment Period|Sponsor Decision|0|||
126160790|NCT01259297|453875421|FG007|Double Blind Randomized Period|Death|1|||
126160791|NCT01259297|453875414|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126160792|NCT01259297|453875415|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126160793|NCT01259297|453875416|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
126160794|NCT01259297|453875417|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
126160795|NCT01259297|453875418|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
126200110|NCT02394028|454017887|FG010|Induction Phase|Adverse Event|0|||
125972414|NCT03214367|453188768|FG005|Treatment Period|Sponsor Decision|0|||
126160796|NCT01259297|453875419|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126160797|NCT01259297|453875420|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126160798|NCT01259297|453875421|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126160799|NCT01259297|453875414|FG000|Double Blind Randomized Period|Other reasons|0|||
126160800|NCT01259297|453875415|FG001|Double Blind Randomized Period|Other reasons|1|||
126160801|NCT01259297|453875416|FG002|Double Blind Randomized Period|Other reasons|0|||
126160802|NCT01259297|453875417|FG003|Double Blind Randomized Period|Other reasons|0|||
126160803|NCT01259297|453875418|FG004|Double Blind Randomized Period|Other reasons|1|||
126160804|NCT01259297|453875419|FG005|Double Blind Randomized Period|Other reasons|2|||
126160805|NCT01259297|453875420|FG006|Double Blind Randomized Period|Other reasons|3|||
126160806|NCT01259297|453875421|FG007|Double Blind Randomized Period|Other reasons|1|||
126160807|NCT00592501|453875422|FG000|Overall Study|Withdrawal by Subject|1|||
126160808|NCT00592501|453875422|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
126160809|NCT03880227|453875426|FG000|First Visit|Withdrawal by Subject|1|||
126160810|NCT03880227|453875427|FG001|First Visit|Withdrawal by Subject|0|||
126160811|NCT03880227|453875428|FG002|First Visit|Withdrawal by Subject|0|||
126160812|NCT03880227|453875429|FG003|First Visit|Withdrawal by Subject|0|||
126160813|NCT03880227|453875426|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
126160814|NCT03880227|453875427|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
126160815|NCT03880227|453875428|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
126160816|NCT03880227|453875429|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
126160817|NCT03880227|453875426|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
126160818|NCT03880227|453875427|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
126160819|NCT03880227|453875428|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
126160820|NCT03880227|453875429|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
126160821|NCT03880227|453875426|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
126160822|NCT03880227|453875427|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
126160823|NCT03880227|453875428|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
126160824|NCT03880227|453875429|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
126160825|NCT02399475|453875432|FG000|Overall Study|Physician Decision|1|||
126160826|NCT02399475|453875433|FG001|Overall Study|Physician Decision|0|||
126160827|NCT01963117|453875434|FG000|Overall Study|Death|1|||
126160828|NCT01605396|453875435|FG000|Overall Study|Adverse Event|5|||
126160829|NCT01605396|453875436|FG001|Overall Study|Adverse Event|3|||
126160830|NCT01605396|453875435|FG000|Overall Study|Lost to Follow-up|1|||
126160831|NCT01605396|453875436|FG001|Overall Study|Lost to Follow-up|0|||
126160832|NCT01605396|453875435|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126160833|NCT01605396|453875436|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126160834|NCT01605396|453875435|FG000|Overall Study|Physician Decision|2|||
126160835|NCT01605396|453875436|FG001|Overall Study|Physician Decision|2|||
126160836|NCT01605396|453875435|FG000|Overall Study|Progressive Disease|23|||
126160837|NCT01605396|453875436|FG001|Overall Study|Progressive Disease|27|||
126160838|NCT01605396|453875435|FG000|Overall Study|Withdrawal by Subject|4|||
126160839|NCT01605396|453875436|FG001|Overall Study|Withdrawal by Subject|2|||
126160840|NCT01605396|453875435|FG000|Overall Study|Transfer Off Study|4|||
126160841|NCT01605396|453875436|FG001|Overall Study|Transfer Off Study|5|||
126160842|NCT03009539|453877151|FG000|Overall Study|Lost to Follow-up|132|||
126160843|NCT03009539|453877152|FG001|Overall Study|Lost to Follow-up|113|||
126160844|NCT03009539|453877153|FG002|Overall Study|Lost to Follow-up|132|||
126160845|NCT03009539|453877154|FG003|Overall Study|Lost to Follow-up|113|||
126160846|NCT03151148|453877155|FG000|Overall Study|Lost to Follow-up|1|||
126160847|NCT03151148|453877156|FG001|Overall Study|Lost to Follow-up|0|||
126160848|NCT03151148|453877155|FG000|Overall Study|Withdrawal by Subject|1|||
126160849|NCT03151148|453877156|FG001|Overall Study|Withdrawal by Subject|0|||
126160850|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
126160851|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
126160852|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
126160853|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
126160854|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Death|8|||
126160855|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Death|3|||
126160856|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
126160857|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
126160858|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
126160859|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
126160860|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
126160861|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
126160862|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
126160863|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
126160864|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
126160865|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
126200111|NCT02394028|454017877|FG000|Induction Phase|Lack of Efficacy|3|||
126160866|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
126160867|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
126160868|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
126160869|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
126160870|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
126160871|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
126160872|NCT00494871|453877157|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
126160873|NCT00494871|453877158|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
126160874|NCT00494871|453877157|FG000|Follow-up (FU) Period|Adverse Event|1|||
126160875|NCT00494871|453877158|FG001|Follow-up (FU) Period|Adverse Event|1|||
126160876|NCT00494871|453877157|FG000|Follow-up (FU) Period|Death|13|||
126160877|NCT00494871|453877158|FG001|Follow-up (FU) Period|Death|12|||
126160878|NCT00494871|453877157|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
126160879|NCT00494871|453877158|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
126160880|NCT00494871|453877157|FG000|Follow-up (FU) Period|Physician Decision|0|||
126160881|NCT00494871|453877158|FG001|Follow-up (FU) Period|Physician Decision|1|||
126160882|NCT00494871|453877157|FG000|Follow-up (FU) Period|Protocol Violation|1|||
126160883|NCT00494871|453877158|FG001|Follow-up (FU) Period|Protocol Violation|0|||
126160884|NCT00494871|453877157|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
126160885|NCT00494871|453877158|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
126160886|NCT00494871|453877157|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
126160887|NCT00494871|453877158|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
126160888|NCT04543955|453877159|FG000|Overall Study|Company cancelled study|1|||
126160889|NCT04543955|453877160|FG001|Overall Study|Company cancelled study|0|||
126160890|NCT02433210|453877164|FG000|Overall Study|Physician Decision|1|||
126160891|NCT02433210|453877165|FG001|Overall Study|Physician Decision|0|||
126160892|NCT02433210|453877166|FG002|Overall Study|Physician Decision|0|||
126160893|NCT01958671|453877171|FG000|Overall Study|Adverse Event|1|||
126160894|NCT01958671|453877172|FG001|Overall Study|Adverse Event|1|||
126160895|NCT01958671|453877173|FG002|Overall Study|Adverse Event|5|||
126160896|NCT01958671|453877171|FG000|Overall Study|Death|1|||
126160897|NCT01958671|453877172|FG001|Overall Study|Death|0|||
126160898|NCT01958671|453877173|FG002|Overall Study|Death|0|||
126160899|NCT01958671|453877171|FG000|Overall Study|Excluded medication|0|||
126160900|NCT01958671|453877172|FG001|Overall Study|Excluded medication|0|||
126160901|NCT01958671|453877173|FG002|Overall Study|Excluded medication|1|||
126160902|NCT01958671|453877171|FG000|Overall Study|Hyperglycemia|0|||
126160903|NCT01958671|453877172|FG001|Overall Study|Hyperglycemia|0|||
126160904|NCT01958671|453877173|FG002|Overall Study|Hyperglycemia|2|||
126160905|NCT01958671|453877171|FG000|Overall Study|Lost to Follow-up|7|||
126160906|NCT01958671|453877172|FG001|Overall Study|Lost to Follow-up|11|||
126160907|NCT01958671|453877173|FG002|Overall Study|Lost to Follow-up|7|||
126160908|NCT01958671|453877171|FG000|Overall Study|Non-compliance with study drug|1|||
126160909|NCT01958671|453877172|FG001|Overall Study|Non-compliance with study drug|1|||
126160910|NCT01958671|453877173|FG002|Overall Study|Non-compliance with study drug|1|||
126160911|NCT01958671|453877171|FG000|Overall Study|Pregnancy|0|||
126160912|NCT01958671|453877172|FG001|Overall Study|Pregnancy|0|||
126160913|NCT01958671|453877173|FG002|Overall Study|Pregnancy|1|||
126160914|NCT01958671|453877171|FG000|Overall Study|Protocol Violation|0|||
126160915|NCT01958671|453877172|FG001|Overall Study|Protocol Violation|1|||
126160916|NCT01958671|453877173|FG002|Overall Study|Protocol Violation|0|||
126160917|NCT01958671|453877171|FG000|Overall Study|Study site terminated by sponsor|1|||
126160918|NCT01958671|453877172|FG001|Overall Study|Study site terminated by sponsor|0|||
126160919|NCT01958671|453877173|FG002|Overall Study|Study site terminated by sponsor|1|||
126160920|NCT01958671|453877171|FG000|Overall Study|Participant moved|0|||
126160921|NCT01958671|453877172|FG001|Overall Study|Participant moved|0|||
126160922|NCT01958671|453877173|FG002|Overall Study|Participant moved|1|||
126160923|NCT01958671|453877171|FG000|Overall Study|Withdrawal by Subject|8|||
126160924|NCT01958671|453877172|FG001|Overall Study|Withdrawal by Subject|10|||
125972415|NCT03214367|453188769|FG006|Treatment Period|Sponsor Decision|0|||
125972416|NCT03214367|453188770|FG007|Treatment Period|Sponsor Decision|0|||
126160925|NCT01958671|453877173|FG002|Overall Study|Withdrawal by Subject|13|||
126160926|NCT02948777|453877174|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
126160927|NCT02311478|453877175|FG000|Overall Study|Withdrawal by Subject|1|||
126160928|NCT02311478|453877175|FG000|Overall Study|Lost to Follow-up|5|||
126160929|NCT02311478|453877175|FG000|Overall Study|Failed IUD Insertion|1|||
126160930|NCT03242928|453877176|FG000|Overall Study|Adverse Event|2|||
126160931|NCT03242928|453877177|FG001|Overall Study|Adverse Event|1|||
126160932|NCT03242928|453877176|FG000|Overall Study|Lost to Follow-up|2|||
126160933|NCT03242928|453877177|FG001|Overall Study|Lost to Follow-up|0|||
126160934|NCT03242928|453877176|FG000|Overall Study|Physician Decision|0|||
126160935|NCT03242928|453877177|FG001|Overall Study|Physician Decision|1|||
126160936|NCT03242928|453877176|FG000|Overall Study|Withdrawal by Subject|5|||
126160937|NCT03242928|453877177|FG001|Overall Study|Withdrawal by Subject|3|||
126160938|NCT00390780|453877181|FG000|Overall Study|Not completed|10|||
126160939|NCT00390780|453877182|FG001|Overall Study|Not completed|4|||
126160940|NCT00390780|453877181|FG000|Overall Study|Protocol Violation|6|||
126160941|NCT00390780|453877182|FG001|Overall Study|Protocol Violation|4|||
126160942|NCT00390780|453877181|FG000|Overall Study|Lost to Follow-up|3|||
126160943|NCT00390780|453877182|FG001|Overall Study|Lost to Follow-up|6|||
126160944|NCT00390780|453877181|FG000|Overall Study|Adverse Event|2|||
126160945|NCT00390780|453877182|FG001|Overall Study|Adverse Event|3|||
126160946|NCT00390780|453877181|FG000|Overall Study|Death|1|||
126160947|NCT00390780|453877182|FG001|Overall Study|Death|3|||
126160948|NCT00390780|453877181|FG000|Overall Study|Withdrawal by Subject|1|||
126160949|NCT00390780|453877182|FG001|Overall Study|Withdrawal by Subject|2|||
126160950|NCT00390780|453877181|FG000|Overall Study|Inclusion criteria not satisfied|0|||
126160951|NCT00390780|453877182|FG001|Overall Study|Inclusion criteria not satisfied|2|||
126160952|NCT00390780|453877181|FG000|Overall Study|Lost to follow up and other reasons|0|||
126160953|NCT00390780|453877182|FG001|Overall Study|Lost to follow up and other reasons|1|||
126160954|NCT00390780|453877181|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
126160955|NCT00390780|453877182|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
126160956|NCT00390780|453877181|FG000|Overall Study|SAE, death|0|||
126160957|NCT00390780|453877182|FG001|Overall Study|SAE, death|1|||
126160958|NCT01070550|453877183|FG000|Overall Study|Adverse Event|43|||
126160959|NCT01070550|453877184|FG001|Overall Study|Adverse Event|1|||
126160960|NCT01070550|453877185|FG002|Overall Study|Adverse Event|3|||
126160961|NCT01070550|453877186|FG003|Overall Study|Adverse Event|0|||
126160962|NCT01070550|453877187|FG004|Overall Study|Adverse Event|0|||
126160963|NCT01070550|453877188|FG005|Overall Study|Adverse Event|0|||
126160964|NCT01070550|453877183|FG000|Overall Study|Death|20|||
126160965|NCT01070550|453877184|FG001|Overall Study|Death|4|||
126160966|NCT01070550|453877185|FG002|Overall Study|Death|3|||
126160967|NCT01070550|453877186|FG003|Overall Study|Death|0|||
126160968|NCT01070550|453877187|FG004|Overall Study|Death|0|||
126160969|NCT01070550|453877188|FG005|Overall Study|Death|0|||
126160970|NCT01070550|453877183|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
126160971|NCT01070550|453877184|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126160972|NCT01070550|453877185|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126160973|NCT01070550|453877186|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126160974|NCT01070550|453877187|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126160975|NCT01070550|453877188|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126160976|NCT01070550|453877183|FG000|Overall Study|Early termination|3|||
126160977|NCT01070550|453877184|FG001|Overall Study|Early termination|0|||
126160978|NCT01070550|453877185|FG002|Overall Study|Early termination|0|||
126160979|NCT01070550|453877186|FG003|Overall Study|Early termination|0|||
126160980|NCT01070550|453877187|FG004|Overall Study|Early termination|0|||
126160981|NCT01070550|453877188|FG005|Overall Study|Early termination|0|||
126160982|NCT01070550|453877183|FG000|Overall Study|Failed to return|450|||
126160983|NCT01070550|453877184|FG001|Overall Study|Failed to return|33|||
126160984|NCT01070550|453877185|FG002|Overall Study|Failed to return|144|||
126160985|NCT01070550|453877186|FG003|Overall Study|Failed to return|40|||
126160986|NCT01070550|453877187|FG004|Overall Study|Failed to return|1|||
126160987|NCT01070550|453877188|FG005|Overall Study|Failed to return|2|||
126160988|NCT01070550|453877183|FG000|Overall Study|Incomplete treatment|2|||
126160989|NCT01070550|453877184|FG001|Overall Study|Incomplete treatment|0|||
126160990|NCT01070550|453877185|FG002|Overall Study|Incomplete treatment|0|||
126160991|NCT01070550|453877186|FG003|Overall Study|Incomplete treatment|0|||
126160992|NCT01070550|453877187|FG004|Overall Study|Incomplete treatment|0|||
126160993|NCT01070550|453877188|FG005|Overall Study|Incomplete treatment|0|||
126160994|NCT01070550|453877183|FG000|Overall Study|Lab test not done|22|||
126160995|NCT01070550|453877184|FG001|Overall Study|Lab test not done|3|||
126160996|NCT01070550|453877185|FG002|Overall Study|Lab test not done|4|||
126160997|NCT01070550|453877186|FG003|Overall Study|Lab test not done|1|||
126160998|NCT01070550|453877187|FG004|Overall Study|Lab test not done|0|||
126160999|NCT01070550|453877188|FG005|Overall Study|Lab test not done|1|||
126161000|NCT01070550|453877183|FG000|Overall Study|Lack of Efficacy|65|||
126161001|NCT01070550|453877184|FG001|Overall Study|Lack of Efficacy|1|||
126161002|NCT01070550|453877185|FG002|Overall Study|Lack of Efficacy|5|||
126161003|NCT01070550|453877186|FG003|Overall Study|Lack of Efficacy|5|||
126161004|NCT01070550|453877187|FG004|Overall Study|Lack of Efficacy|0|||
126161005|NCT01070550|453877188|FG005|Overall Study|Lack of Efficacy|1|||
125972417|NCT03214367|453188763|FG000|Treatment Period|Physician Decision|0|||
126161006|NCT01070550|453877183|FG000|Overall Study|Miscellaneous|12|||
126161007|NCT01070550|453877184|FG001|Overall Study|Miscellaneous|2|||
126161008|NCT01070550|453877185|FG002|Overall Study|Miscellaneous|3|||
126161009|NCT01070550|453877186|FG003|Overall Study|Miscellaneous|1|||
126161010|NCT01070550|453877187|FG004|Overall Study|Miscellaneous|0|||
126161011|NCT01070550|453877188|FG005|Overall Study|Miscellaneous|0|||
126161012|NCT01070550|453877183|FG000|Overall Study|New treatment started|3|||
125972418|NCT03214367|453188764|FG001|Treatment Period|Physician Decision|1|||
126161013|NCT01070550|453877184|FG001|Overall Study|New treatment started|1|||
126161014|NCT01070550|453877185|FG002|Overall Study|New treatment started|0|||
125972419|NCT03214367|453188765|FG002|Treatment Period|Physician Decision|2|||
126161015|NCT01070550|453877186|FG003|Overall Study|New treatment started|2|||
126161016|NCT01070550|453877187|FG004|Overall Study|New treatment started|0|||
126161017|NCT01070550|453877188|FG005|Overall Study|New treatment started|0|||
126161018|NCT01070550|453877183|FG000|Overall Study|Non-responders|493|||
126161019|NCT01070550|453877184|FG001|Overall Study|Non-responders|4|||
126161020|NCT01070550|453877185|FG002|Overall Study|Non-responders|21|||
126161021|NCT01070550|453877186|FG003|Overall Study|Non-responders|20|||
126161022|NCT01070550|453877187|FG004|Overall Study|Non-responders|0|||
126161023|NCT01070550|453877188|FG005|Overall Study|Non-responders|2|||
126161024|NCT01070550|453877183|FG000|Overall Study|Not categorized|33|||
126161025|NCT01070550|453877184|FG001|Overall Study|Not categorized|2|||
126161026|NCT01070550|453877185|FG002|Overall Study|Not categorized|6|||
126161027|NCT01070550|453877186|FG003|Overall Study|Not categorized|1|||
126161028|NCT01070550|453877187|FG004|Overall Study|Not categorized|0|||
126161029|NCT01070550|453877188|FG005|Overall Study|Not categorized|1|||
126161030|NCT01070550|453877183|FG000|Overall Study|Protocol Violation|15|||
126161031|NCT01070550|453877184|FG001|Overall Study|Protocol Violation|1|||
126161032|NCT01070550|453877185|FG002|Overall Study|Protocol Violation|1|||
126161033|NCT01070550|453877186|FG003|Overall Study|Protocol Violation|1|||
126161034|NCT01070550|453877187|FG004|Overall Study|Protocol Violation|0|||
126161035|NCT01070550|453877188|FG005|Overall Study|Protocol Violation|0|||
126161036|NCT01070550|453877183|FG000|Overall Study|Relapse|44|||
126161037|NCT01070550|453877184|FG001|Overall Study|Relapse|5|||
126161038|NCT01070550|453877185|FG002|Overall Study|Relapse|14|||
126161039|NCT01070550|453877186|FG003|Overall Study|Relapse|4|||
126161040|NCT01070550|453877187|FG004|Overall Study|Relapse|0|||
126161041|NCT01070550|453877188|FG005|Overall Study|Relapse|0|||
126161042|NCT01070550|453877183|FG000|Overall Study|Result not available|3|||
126161043|NCT01070550|453877184|FG001|Overall Study|Result not available|1|||
126161044|NCT01070550|453877185|FG002|Overall Study|Result not available|3|||
126161045|NCT01070550|453877186|FG003|Overall Study|Result not available|0|||
126161046|NCT01070550|453877187|FG004|Overall Study|Result not available|0|||
126161047|NCT01070550|453877188|FG005|Overall Study|Result not available|0|||
126161048|NCT01070550|453877183|FG000|Overall Study|Screen failure|1|||
126161049|NCT01070550|453877184|FG001|Overall Study|Screen failure|0|||
126161050|NCT01070550|453877185|FG002|Overall Study|Screen failure|0|||
126161051|NCT01070550|453877186|FG003|Overall Study|Screen failure|0|||
126161052|NCT01070550|453877187|FG004|Overall Study|Screen failure|0|||
126161053|NCT01070550|453877188|FG005|Overall Study|Screen failure|0|||
126161054|NCT01070550|453877183|FG000|Overall Study|Sponsor decision|1|||
126161055|NCT01070550|453877184|FG001|Overall Study|Sponsor decision|0|||
126161056|NCT01070550|453877185|FG002|Overall Study|Sponsor decision|0|||
126161057|NCT01070550|453877186|FG003|Overall Study|Sponsor decision|0|||
126161058|NCT01070550|453877187|FG004|Overall Study|Sponsor decision|0|||
126161059|NCT01070550|453877188|FG005|Overall Study|Sponsor decision|0|||
126161060|NCT01070550|453877183|FG000|Overall Study|Treatment duration shortened|1|||
126161061|NCT01070550|453877184|FG001|Overall Study|Treatment duration shortened|0|||
126161062|NCT01070550|453877185|FG002|Overall Study|Treatment duration shortened|0|||
126161063|NCT01070550|453877186|FG003|Overall Study|Treatment duration shortened|0|||
126161064|NCT01070550|453877187|FG004|Overall Study|Treatment duration shortened|0|||
126161065|NCT01070550|453877188|FG005|Overall Study|Treatment duration shortened|0|||
126161066|NCT01070550|453877183|FG000|Overall Study|Treatment interrupted|7|||
126161067|NCT01070550|453877184|FG001|Overall Study|Treatment interrupted|0|||
126161068|NCT01070550|453877185|FG002|Overall Study|Treatment interrupted|1|||
126161069|NCT01070550|453877186|FG003|Overall Study|Treatment interrupted|1|||
126161070|NCT01070550|453877187|FG004|Overall Study|Treatment interrupted|0|||
126161071|NCT01070550|453877188|FG005|Overall Study|Treatment interrupted|0|||
126161072|NCT01070550|453877183|FG000|Overall Study|Treatment not started|14|||
126161073|NCT01070550|453877184|FG001|Overall Study|Treatment not started|2|||
126161074|NCT01070550|453877185|FG002|Overall Study|Treatment not started|4|||
126161075|NCT01070550|453877186|FG003|Overall Study|Treatment not started|0|||
126161076|NCT01070550|453877187|FG004|Overall Study|Treatment not started|0|||
126161077|NCT01070550|453877188|FG005|Overall Study|Treatment not started|0|||
126161078|NCT01070550|453877183|FG000|Overall Study|Treatment restarted|0|||
125972420|NCT03214367|453188766|FG003|Treatment Period|Physician Decision|0|||
125972421|NCT03214367|453188767|FG004|Treatment Period|Physician Decision|0|||
125972422|NCT03214367|453188768|FG005|Treatment Period|Physician Decision|0|||
125972423|NCT03214367|453188769|FG006|Treatment Period|Physician Decision|0|||
125972424|NCT03214367|453188770|FG007|Treatment Period|Physician Decision|0|||
125972425|NCT03214367|453188763|FG000|Treatment Period|Protocol Violation|0|||
126161079|NCT01070550|453877184|FG001|Overall Study|Treatment restarted|1|||
126161080|NCT01070550|453877185|FG002|Overall Study|Treatment restarted|0|||
126161081|NCT01070550|453877186|FG003|Overall Study|Treatment restarted|0|||
125972426|NCT03214367|453188764|FG001|Treatment Period|Protocol Violation|3|||
126161082|NCT01070550|453877187|FG004|Overall Study|Treatment restarted|0|||
126161083|NCT01070550|453877188|FG005|Overall Study|Treatment restarted|0|||
126161084|NCT01070550|453877183|FG000|Overall Study|Treatment stopped|3|||
126161085|NCT01070550|453877184|FG001|Overall Study|Treatment stopped|0|||
126161086|NCT01070550|453877185|FG002|Overall Study|Treatment stopped|0|||
126161087|NCT01070550|453877186|FG003|Overall Study|Treatment stopped|0|||
126161088|NCT01070550|453877187|FG004|Overall Study|Treatment stopped|0|||
126161089|NCT01070550|453877188|FG005|Overall Study|Treatment stopped|0|||
126161090|NCT01070550|453877183|FG000|Overall Study|Treatment unavailable|1|||
126161091|NCT01070550|453877184|FG001|Overall Study|Treatment unavailable|0|||
126161092|NCT01070550|453877185|FG002|Overall Study|Treatment unavailable|0|||
126161093|NCT01070550|453877186|FG003|Overall Study|Treatment unavailable|0|||
126161094|NCT01070550|453877187|FG004|Overall Study|Treatment unavailable|0|||
126161095|NCT01070550|453877188|FG005|Overall Study|Treatment unavailable|0|||
126161096|NCT01070550|453877183|FG000|Overall Study|Treatment was stopped early|7|||
126161097|NCT01070550|453877184|FG001|Overall Study|Treatment was stopped early|0|||
126161098|NCT01070550|453877185|FG002|Overall Study|Treatment was stopped early|0|||
126161099|NCT01070550|453877186|FG003|Overall Study|Treatment was stopped early|0|||
126161100|NCT01070550|453877187|FG004|Overall Study|Treatment was stopped early|0|||
126161101|NCT01070550|453877188|FG005|Overall Study|Treatment was stopped early|0|||
126161102|NCT01070550|453877183|FG000|Overall Study|Other|5|||
126161103|NCT01070550|453877184|FG001|Overall Study|Other|0|||
126161104|NCT01070550|453877185|FG002|Overall Study|Other|0|||
126161105|NCT01070550|453877186|FG003|Overall Study|Other|1|||
126161106|NCT01070550|453877187|FG004|Overall Study|Other|0|||
126161107|NCT01070550|453877188|FG005|Overall Study|Other|0|||
126161108|NCT01070550|453877183|FG000|Overall Study|Withdrawal by Subject|35|||
126161109|NCT01070550|453877184|FG001|Overall Study|Withdrawal by Subject|0|||
126161110|NCT01070550|453877185|FG002|Overall Study|Withdrawal by Subject|3|||
126161111|NCT01070550|453877186|FG003|Overall Study|Withdrawal by Subject|0|||
126161112|NCT01070550|453877187|FG004|Overall Study|Withdrawal by Subject|0|||
126161113|NCT01070550|453877188|FG005|Overall Study|Withdrawal by Subject|0|||
126161114|NCT01258348|453877189|FG000|Overall Study|Adverse Event|1|||
126161115|NCT01258348|453877190|FG001|Overall Study|Adverse Event|1|||
126161116|NCT01258348|453877191|FG002|Overall Study|Adverse Event|3|||
126161117|NCT01258348|453877192|FG003|Overall Study|Adverse Event|2|||
126161118|NCT01258348|453877193|FG004|Overall Study|Adverse Event|4|||
126161119|NCT01258348|453877189|FG000|Overall Study|Progressive Disease|0|||
126161120|NCT01258348|453877190|FG001|Overall Study|Progressive Disease|3|||
126161121|NCT01258348|453877191|FG002|Overall Study|Progressive Disease|0|||
126161122|NCT01258348|453877192|FG003|Overall Study|Progressive Disease|2|||
126161123|NCT01258348|453877193|FG004|Overall Study|Progressive Disease|2|||
126161124|NCT01258348|453877189|FG000|Overall Study|Physician Decision|0|||
126161125|NCT01258348|453877190|FG001|Overall Study|Physician Decision|0|||
126161126|NCT01258348|453877191|FG002|Overall Study|Physician Decision|0|||
126161127|NCT01258348|453877192|FG003|Overall Study|Physician Decision|2|||
126161128|NCT01258348|453877193|FG004|Overall Study|Physician Decision|0|||
126161129|NCT01258348|453877189|FG000|Overall Study|Withdrawal by Subject|0|||
126161130|NCT01258348|453877190|FG001|Overall Study|Withdrawal by Subject|1|||
126161131|NCT01258348|453877191|FG002|Overall Study|Withdrawal by Subject|0|||
126161132|NCT01258348|453877192|FG003|Overall Study|Withdrawal by Subject|0|||
126161133|NCT01258348|453877193|FG004|Overall Study|Withdrawal by Subject|0|||
126161134|NCT00109733|453877194|FG000|Overall Study|Protocol Violation|0|||
126161135|NCT00109733|453877195|FG001|Overall Study|Protocol Violation|1|||
126161136|NCT00109733|453877194|FG000|Overall Study|Stopped taking study drug|1|||
126161137|NCT00109733|453877195|FG001|Overall Study|Stopped taking study drug|1|||
126161138|NCT00109733|453877194|FG000|Overall Study|Non-compliant|0|||
126161139|NCT00109733|453877195|FG001|Overall Study|Non-compliant|1|||
126161140|NCT00109733|453877194|FG000|Overall Study|Could not commit time for study|1|||
126161141|NCT00109733|453877195|FG001|Overall Study|Could not commit time for study|1|||
126161142|NCT00367640|453877200|FG000|Overall Study|Adverse Event|3|||
126161143|NCT00367640|453877201|FG001|Overall Study|Adverse Event|6|||
126161144|NCT00367640|453877202|FG002|Overall Study|Adverse Event|8|||
125972427|NCT03214367|453188765|FG002|Treatment Period|Protocol Violation|0|||
125972428|NCT03214367|453188766|FG003|Treatment Period|Protocol Violation|0|||
126161145|NCT00367640|453877203|FG003|Overall Study|Adverse Event|0|||
126161146|NCT00367640|453877200|FG000|Overall Study|Withdrawal by Subject|8|||
126161147|NCT00367640|453877201|FG001|Overall Study|Withdrawal by Subject|11|||
126161148|NCT00367640|453877202|FG002|Overall Study|Withdrawal by Subject|8|||
126161149|NCT00367640|453877203|FG003|Overall Study|Withdrawal by Subject|6|||
126161150|NCT00367640|453877200|FG000|Overall Study|Any other reason not above-mentioned|7|||
126161151|NCT00367640|453877201|FG001|Overall Study|Any other reason not above-mentioned|5|||
126161152|NCT00367640|453877202|FG002|Overall Study|Any other reason not above-mentioned|3|||
126161153|NCT00367640|453877203|FG003|Overall Study|Any other reason not above-mentioned|4|||
126161154|NCT00406315|453877205|FG000|Overall Study|Death|1|||
126161155|NCT00406315|453877205|FG000|Overall Study|Adverse Event|39|||
126161156|NCT00406315|453877205|FG000|Overall Study|Laboratory Abnormality|4|||
126161157|NCT00406315|453877205|FG000|Overall Study|Lack of Efficacy|13|||
125972429|NCT03214367|453188767|FG004|Treatment Period|Protocol Violation|0|||
126161158|NCT00406315|453877205|FG000|Overall Study|Other|33|||
126161159|NCT00406315|453877205|FG000|Overall Study|Lost to Follow-up|21|||
126161160|NCT00406315|453877205|FG000|Overall Study|Withdrawal by Subject|30|||
126161161|NCT01525849|453877208|FG000|Overall Study|Lost to Follow-up|3|||
126161162|NCT01525849|453877209|FG001|Overall Study|Lost to Follow-up|2|||
126161163|NCT01525849|453877208|FG000|Overall Study|Withdrawal by Subject|1|||
126161164|NCT01525849|453877209|FG001|Overall Study|Withdrawal by Subject|9|||
126161165|NCT01525849|453877208|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
126161166|NCT01525849|453877209|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
126161167|NCT01525849|453877208|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
126161168|NCT01525849|453877209|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
126161169|NCT00339183|453877210|FG000|Overall Study|Adverse Event|5|||
126161170|NCT00339183|453877211|FG001|Overall Study|Adverse Event|3|||
126161171|NCT00339183|453877210|FG000|Overall Study|Withdrawal by Subject|16|||
126161172|NCT00339183|453877211|FG001|Overall Study|Withdrawal by Subject|19|||
126161173|NCT00339183|453877210|FG000|Overall Study|Physician Decision|2|||
126161174|NCT00339183|453877211|FG001|Overall Study|Physician Decision|4|||
126161175|NCT00339183|453877210|FG000|Overall Study|Lost to Follow-up|17|||
126161176|NCT00339183|453877211|FG001|Overall Study|Lost to Follow-up|17|||
126161177|NCT00339183|453877210|FG000|Overall Study|Protocol-specified criteria|12|||
126161178|NCT00339183|453877211|FG001|Overall Study|Protocol-specified criteria|8|||
126161179|NCT00339183|453877210|FG000|Overall Study|Missing reason|3|||
126161180|NCT00339183|453877211|FG001|Overall Study|Missing reason|1|||
126161181|NCT00339183|453877210|FG000|Overall Study|Other|46|||
126161182|NCT00339183|453877211|FG001|Overall Study|Other|40|||
126161183|NCT00339183|453877210|FG000|Overall Study|Ongoing|20|||
126161184|NCT00339183|453877211|FG001|Overall Study|Ongoing|13|||
126161185|NCT02142894|453877212|FG000|Overall Study|Protocol Violation|8|||
126161186|NCT01844700|453877225|FG000|Overall Study|Lack of Efficacy|1|||
126161187|NCT01844700|453877226|FG001|Overall Study|Lack of Efficacy|0|||
126161188|NCT01844700|453877225|FG000|Overall Study|refused medication switch|1|||
126161189|NCT01844700|453877226|FG001|Overall Study|refused medication switch|0|||
126161190|NCT01844700|453877225|FG000|Overall Study|Withdrawal by Subject|1|||
126161191|NCT01844700|453877226|FG001|Overall Study|Withdrawal by Subject|0|||
126161192|NCT01844700|453877225|FG000|Overall Study|stopped taking meds|0|||
126161193|NCT01844700|453877226|FG001|Overall Study|stopped taking meds|1|||
126161194|NCT02375698|453877227|FG000|Overall Study|Withdrawal by Subject|0|||
126161195|NCT02375698|453877228|FG001|Overall Study|Withdrawal by Subject|2|||
126161196|NCT02375698|453877227|FG000|Overall Study|Physician Decision|2|||
126161197|NCT02375698|453877228|FG001|Overall Study|Physician Decision|0|||
126161198|NCT02680847|453877229|FG000|Overall Study|Other|2|||
126161199|NCT02680847|453877230|FG001|Overall Study|Other|0|||
126161200|NCT02680847|453877231|FG002|Overall Study|Other|0|||
126161201|NCT02680847|453877229|FG000|Overall Study|No longer met eligibility criteria|2|||
126161202|NCT02680847|453877230|FG001|Overall Study|No longer met eligibility criteria|2|||
126161203|NCT02680847|453877231|FG002|Overall Study|No longer met eligibility criteria|0|||
126161204|NCT02680847|453877229|FG000|Overall Study|Unwilling to participate in study|1|||
126161205|NCT02680847|453877230|FG001|Overall Study|Unwilling to participate in study|1|||
126161206|NCT02680847|453877231|FG002|Overall Study|Unwilling to participate in study|0|||
126161207|NCT02680847|453877229|FG000|Overall Study|Lack of Efficacy|0|||
126161208|NCT02680847|453877230|FG001|Overall Study|Lack of Efficacy|0|||
126161209|NCT02680847|453877231|FG002|Overall Study|Lack of Efficacy|2|||
126161210|NCT02680847|453877229|FG000|Overall Study|Adverse Event|0|||
126161211|NCT02680847|453877230|FG001|Overall Study|Adverse Event|0|||
126161212|NCT02680847|453877231|FG002|Overall Study|Adverse Event|1|||
126161213|NCT00803244|453877234|FG000|Overall Study|Adverse Event|1|||
126161214|NCT00803244|453877235|FG001|Overall Study|Adverse Event|2|||
126161215|NCT00803244|453877234|FG000|Overall Study|Withdrawal by Subject|2|||
126161216|NCT00803244|453877235|FG001|Overall Study|Withdrawal by Subject|3|||
126161217|NCT00803244|453877234|FG000|Overall Study|Any other reason not above-mentioned|4|||
126161218|NCT00803244|453877235|FG001|Overall Study|Any other reason not above-mentioned|10|||
126161219|NCT03241173|453877236|FG000|Overall Study|Death|3|||
126161220|NCT03241173|453877237|FG001|Overall Study|Death|2|||
126161221|NCT03241173|453877238|FG002|Overall Study|Death|4|||
125972430|NCT03214367|453188768|FG005|Treatment Period|Protocol Violation|0|||
125972431|NCT03214367|453188769|FG006|Treatment Period|Protocol Violation|0|||
125972432|NCT03214367|453188770|FG007|Treatment Period|Protocol Violation|0|||
126161222|NCT03241173|453877239|FG003|Overall Study|Death|4|||
125972433|NCT03214367|453188763|FG000|Treatment Period|Withdrawal by Subject|0|||
125972434|NCT03214367|453188764|FG001|Treatment Period|Withdrawal by Subject|20|||
126161223|NCT03241173|453877240|FG004|Overall Study|Death|2|||
126161224|NCT03241173|453877241|FG005|Overall Study|Death|2|||
126161225|NCT03241173|453877242|FG006|Overall Study|Death|3|||
126161226|NCT03241173|453877243|FG007|Overall Study|Death|1|||
126161227|NCT03241173|453877244|FG008|Overall Study|Death|0|||
126161228|NCT03241173|453877245|FG009|Overall Study|Death|5|||
126161229|NCT03241173|453877246|FG010|Overall Study|Death|4|||
126161230|NCT03241173|453877247|FG011|Overall Study|Death|3|||
126161231|NCT03241173|453877248|FG012|Overall Study|Death|0|||
126161232|NCT03241173|453877249|FG013|Overall Study|Death|0|||
126161233|NCT03241173|453877250|FG014|Overall Study|Death|0|||
126161234|NCT03241173|453877236|FG000|Overall Study|Withdrawal by Subject|0|||
126161235|NCT03241173|453877237|FG001|Overall Study|Withdrawal by Subject|0|||
126161236|NCT03241173|453877238|FG002|Overall Study|Withdrawal by Subject|1|||
126161237|NCT03241173|453877239|FG003|Overall Study|Withdrawal by Subject|0|||
126161238|NCT03241173|453877240|FG004|Overall Study|Withdrawal by Subject|0|||
126161239|NCT03241173|453877241|FG005|Overall Study|Withdrawal by Subject|1|||
126161240|NCT03241173|453877242|FG006|Overall Study|Withdrawal by Subject|0|||
126161241|NCT03241173|453877243|FG007|Overall Study|Withdrawal by Subject|0|||
126161242|NCT03241173|453877244|FG008|Overall Study|Withdrawal by Subject|0|||
126161243|NCT03241173|453877245|FG009|Overall Study|Withdrawal by Subject|0|||
126161244|NCT03241173|453877246|FG010|Overall Study|Withdrawal by Subject|0|||
126161245|NCT03241173|453877247|FG011|Overall Study|Withdrawal by Subject|0|||
126161246|NCT03241173|453877248|FG012|Overall Study|Withdrawal by Subject|0|||
126161247|NCT03241173|453877249|FG013|Overall Study|Withdrawal by Subject|0|||
126161248|NCT03241173|453877250|FG014|Overall Study|Withdrawal by Subject|0|||
126161249|NCT03241173|453877236|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
126161250|NCT03241173|453877237|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
126161251|NCT03241173|453877238|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126161252|NCT03241173|453877239|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
126161253|NCT03241173|453877240|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
126161254|NCT03241173|453877241|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
126161255|NCT03241173|453877242|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
126161256|NCT03241173|453877243|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
126161257|NCT03241173|453877244|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126161258|NCT03241173|453877245|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126161259|NCT03241173|453877246|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
126161260|NCT03241173|453877247|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
126161261|NCT03241173|453877248|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126161262|NCT03241173|453877249|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126161263|NCT03241173|453877250|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126161264|NCT03241173|453877236|FG000|Overall Study|Lost to Follow-up|0|||
126161265|NCT03241173|453877237|FG001|Overall Study|Lost to Follow-up|0|||
126161266|NCT03241173|453877238|FG002|Overall Study|Lost to Follow-up|0|||
126161267|NCT03241173|453877239|FG003|Overall Study|Lost to Follow-up|0|||
126161268|NCT03241173|453877240|FG004|Overall Study|Lost to Follow-up|1|||
126161269|NCT03241173|453877241|FG005|Overall Study|Lost to Follow-up|0|||
126161270|NCT03241173|453877242|FG006|Overall Study|Lost to Follow-up|0|||
126161271|NCT03241173|453877243|FG007|Overall Study|Lost to Follow-up|0|||
126161272|NCT03241173|453877244|FG008|Overall Study|Lost to Follow-up|0|||
126161273|NCT03241173|453877245|FG009|Overall Study|Lost to Follow-up|1|||
126161274|NCT03241173|453877246|FG010|Overall Study|Lost to Follow-up|0|||
126161275|NCT03241173|453877247|FG011|Overall Study|Lost to Follow-up|0|||
126161276|NCT03241173|453877248|FG012|Overall Study|Lost to Follow-up|0|||
126161277|NCT03241173|453877249|FG013|Overall Study|Lost to Follow-up|0|||
126161278|NCT03241173|453877250|FG014|Overall Study|Lost to Follow-up|0|||
126161279|NCT02144220|453877252|FG000|Overall Study|technology incompatibility|9|||
126161280|NCT02144220|453877252|FG000|Overall Study|Lack of Efficacy|4|||
126161281|NCT02144220|453877252|FG000|Overall Study|Physician Decision|3|||
126161282|NCT02144220|453877252|FG000|Overall Study|Withdrawal by Subject|2|||
126161283|NCT02144220|453877252|FG000|Overall Study|Protocol Violation|1|||
126161284|NCT00053846|453877258|FG000|Overall Study|Changed mind|8|||
126161285|NCT00053846|453877259|FG001|Overall Study|Changed mind|13|||
126161286|NCT00053846|453877258|FG000|Overall Study|Became too ill|8|||
126161287|NCT00053846|453877259|FG001|Overall Study|Became too ill|7|||
126161288|NCT00053846|453877258|FG000|Overall Study|Expired|5|||
126161289|NCT00053846|453877259|FG001|Overall Study|Expired|0|||
126161290|NCT00053846|453877258|FG000|Overall Study|Became ineligible|3|||
126161291|NCT00053846|453877259|FG001|Overall Study|Became ineligible|1|||
126161292|NCT00053846|453877258|FG000|Overall Study|Did not return data|1|||
126161293|NCT00053846|453877259|FG001|Overall Study|Did not return data|2|||
126161294|NCT00053846|453877258|FG000|Overall Study|Quit due to side effects|1|||
126161295|NCT00053846|453877259|FG001|Overall Study|Quit due to side effects|3|||
126161296|NCT00053846|453877258|FG000|Overall Study|Pills too large|0|||
126161297|NCT00053846|453877259|FG001|Overall Study|Pills too large|1|||
126161298|NCT00064662|453877260|FG000|Overall Study|Death|1|||
126161299|NCT00064662|453877261|FG001|Overall Study|Death|1|||
126161300|NCT00064662|453877260|FG000|Overall Study|Lost to Follow-up|57|||
126161301|NCT00064662|453877261|FG001|Overall Study|Lost to Follow-up|44|||
126161302|NCT00064662|453877260|FG000|Overall Study|Withdrawal by Subject|14|||
126161303|NCT00064662|453877261|FG001|Overall Study|Withdrawal by Subject|14|||
126161304|NCT00064662|453877260|FG000|Overall Study|Administratively withdrawn|2|||
126161305|NCT00064662|453877261|FG001|Overall Study|Administratively withdrawn|2|||
126161306|NCT02229864|453877264|FG000|Overall Study|Death|2|||
126161307|NCT02229864|453877264|FG000|Overall Study|Lost to Follow-up|1|||
126161308|NCT01345786|453877272|FG000|Overall Study|Adverse Event|0|||
126161309|NCT01345786|453877273|FG001|Overall Study|Adverse Event|1|||
126161310|NCT01345786|453877274|FG002|Overall Study|Adverse Event|3|||
126161311|NCT01345786|453877275|FG003|Overall Study|Adverse Event|1|||
126161312|NCT01345786|453877272|FG000|Overall Study|Subject withdrew consent|2|||
126161313|NCT01345786|453877273|FG001|Overall Study|Subject withdrew consent|2|||
126161314|NCT01345786|453877274|FG002|Overall Study|Subject withdrew consent|1|||
126161315|NCT01345786|453877275|FG003|Overall Study|Subject withdrew consent|0|||
126161316|NCT01345786|453877272|FG000|Overall Study|Noncompliance with protocol|1|||
126161317|NCT01345786|453877273|FG001|Overall Study|Noncompliance with protocol|0|||
126161318|NCT01345786|453877274|FG002|Overall Study|Noncompliance with protocol|1|||
126161319|NCT01345786|453877275|FG003|Overall Study|Noncompliance with protocol|0|||
126161320|NCT01345786|453877272|FG000|Overall Study|Administrative|3|||
126161321|NCT01345786|453877273|FG001|Overall Study|Administrative|5|||
126161322|NCT01345786|453877274|FG002|Overall Study|Administrative|0|||
126161323|NCT01345786|453877275|FG003|Overall Study|Administrative|0|||
126161324|NCT01345786|453877272|FG000|Overall Study|Lost to Follow-up|0|||
126161325|NCT01345786|453877273|FG001|Overall Study|Lost to Follow-up|0|||
126161326|NCT01345786|453877274|FG002|Overall Study|Lost to Follow-up|0|||
126161327|NCT01345786|453877275|FG003|Overall Study|Lost to Follow-up|2|||
126161328|NCT01929044|453877276|FG000|Overall Study|Adverse Event|1|||
126161329|NCT01929044|453877277|FG001|Overall Study|Adverse Event|0|||
126161330|NCT01929044|453877276|FG000|Overall Study|Protocol Violation|9|||
126161331|NCT01929044|453877277|FG001|Overall Study|Protocol Violation|14|||
126161332|NCT01929044|453877276|FG000|Overall Study|Not Treated|1|||
126161333|NCT01929044|453877277|FG001|Overall Study|Not Treated|3|||
126161334|NCT02807454|453877280|FG000|Overall Study|Adverse Event|1|||
126161335|NCT02807454|453877281|FG001|Overall Study|Adverse Event|0|||
126161336|NCT02807454|453877280|FG000|Overall Study|Withdrawal by Subject|0|||
126161337|NCT02807454|453877281|FG001|Overall Study|Withdrawal by Subject|1|||
126161338|NCT02807454|453877280|FG000|Overall Study|Progressive Disease|30|||
126161339|NCT02807454|453877281|FG001|Overall Study|Progressive Disease|3|||
126161340|NCT02807454|453877280|FG000|Overall Study|Other Reasons|1|||
126161341|NCT02807454|453877281|FG001|Overall Study|Other Reasons|1|||
126161342|NCT01165203|453877282|FG000|Active Phase|Serious Adverse Event|1|||
126161343|NCT01165203|453877283|FG001|Active Phase|Serious Adverse Event|0|||
126161344|NCT01165203|453877282|FG000|Active Phase|Withdrawal by Subject|2|||
126161345|NCT01165203|453877283|FG001|Active Phase|Withdrawal by Subject|1|||
126161346|NCT01165203|453877282|FG000|Active Phase|Migrated/moved from study area|0|||
126161347|NCT01165203|453877283|FG001|Active Phase|Migrated/moved from study area|1|||
126161348|NCT01165203|453877282|FG000|Active Phase|Lost to Follow-up|2|||
126161349|NCT01165203|453877283|FG001|Active Phase|Lost to Follow-up|0|||
126161350|NCT01165203|453877282|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
126161351|NCT01165203|453877283|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
126161352|NCT01165203|453877282|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
126161353|NCT01165203|453877283|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
126161354|NCT01165203|453877282|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
126161355|NCT01165203|453877283|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
126161356|NCT01165203|453877282|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
126161357|NCT01165203|453877283|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
126161358|NCT01165203|453877282|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
126161359|NCT01165203|453877283|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
126161360|NCT01070784|453877284|FG000|Overall Study|Withdrawal by Subject|6|||
126161361|NCT01070784|453877285|FG001|Overall Study|Withdrawal by Subject|9|||
126161362|NCT01070784|453877284|FG000|Overall Study|Adverse Event|14|||
126161363|NCT01070784|453877285|FG001|Overall Study|Adverse Event|9|||
126161364|NCT02582749|453877286|FG000|Overall Study|Study terminated by funder|5|||
126161365|NCT02582749|453877287|FG001|Overall Study|Study terminated by funder|10|||
126161366|NCT02582749|453877286|FG000|Overall Study|Withdrawal by Subject|0|||
126161367|NCT02582749|453877287|FG001|Overall Study|Withdrawal by Subject|1|||
126161368|NCT02815397|453877288|FG000|Overall Study|Physician Decision|2|||
126161369|NCT02518620|453877289|FG000|Overall Study|Adverse Event|23|||
126161370|NCT02518620|453877290|FG001|Overall Study|Adverse Event|11|||
126161371|NCT02518620|453877289|FG000|Overall Study|Lack of Efficacy|2|||
126161372|NCT02518620|453877290|FG001|Overall Study|Lack of Efficacy|0|||
126161373|NCT02518620|453877289|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126161374|NCT02518620|453877290|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126161375|NCT02518620|453877289|FG000|Overall Study|Physician Decision|1|||
126161376|NCT02518620|453877290|FG001|Overall Study|Physician Decision|1|||
126161377|NCT02518620|453877289|FG000|Overall Study|Sponsor's Decision|0|||
126161378|NCT02518620|453877290|FG001|Overall Study|Sponsor's Decision|3|||
126161379|NCT02518620|453877289|FG000|Overall Study|Lost to Follow-up|1|||
126161380|NCT02518620|453877290|FG001|Overall Study|Lost to Follow-up|1|||
126161381|NCT02518620|453877289|FG000|Overall Study|Withdrawal by Subject|17|||
126161382|NCT02518620|453877290|FG001|Overall Study|Withdrawal by Subject|9|||
126161383|NCT02518620|453877289|FG000|Overall Study|Death|1|||
126161384|NCT02518620|453877290|FG001|Overall Study|Death|0|||
126161385|NCT02518620|453877289|FG000|Overall Study|Pregnancy Wish|3|||
126161386|NCT02518620|453877290|FG001|Overall Study|Pregnancy Wish|0|||
126161387|NCT02518620|453877289|FG000|Overall Study|Pregnancy|1|||
126161388|NCT02518620|453877290|FG001|Overall Study|Pregnancy|0|||
126161389|NCT02518620|453877289|FG000|Overall Study|Relocation|2|||
126161390|NCT02518620|453877290|FG001|Overall Study|Relocation|1|||
126161391|NCT00085540|453877291|FG000|Overall Study|Withdrawal by Subject|0|||
126161392|NCT00085540|453877292|FG001|Overall Study|Withdrawal by Subject|1|||
126161393|NCT00085540|453877291|FG000|Overall Study|Protocol Violation|0|||
126161394|NCT00085540|453877292|FG001|Overall Study|Protocol Violation|1|||
126161395|NCT01663740|453877295|FG000|Overall Study|Lost to Follow-up|1|||
126161396|NCT01663740|453877296|FG001|Overall Study|Lost to Follow-up|4|||
126161397|NCT01663740|453877295|FG000|Overall Study|Other|9|||
126161398|NCT01663740|453877296|FG001|Overall Study|Other|2|||
126161399|NCT01663740|453877295|FG000|Overall Study|Inclusion/Exclusion not met|1|||
126161400|NCT01663740|453877296|FG001|Overall Study|Inclusion/Exclusion not met|0|||
126161401|NCT01663740|453877295|FG000|Overall Study|Death|0|||
126161402|NCT01663740|453877296|FG001|Overall Study|Death|1|||
126161403|NCT01663740|453877295|FG000|Overall Study|Withdrawal by Subject|2|||
126161404|NCT01663740|453877296|FG001|Overall Study|Withdrawal by Subject|1|||
126161405|NCT01663740|453877295|FG000|Overall Study|No end of study status|3|||
126161406|NCT01663740|453877296|FG001|Overall Study|No end of study status|0|||
126161407|NCT03607682|453877297|FG000|Overall Study|Withdrawal by Subject|1|||
126161408|NCT03607682|453877297|FG000|Overall Study|Disease progression|1|||
126161409|NCT01770353|453877298|FG000|Overall Study|Progressive disease|2|||
126161410|NCT01770353|453877299|FG001|Overall Study|Progressive disease|1|||
126161411|NCT01770353|453877298|FG000|Overall Study|Adverse Event|0|||
126161412|NCT01770353|453877299|FG001|Overall Study|Adverse Event|1|||
126161413|NCT01770353|453877298|FG000|Overall Study|Protocol Violation|1|||
126161414|NCT01770353|453877299|FG001|Overall Study|Protocol Violation|0|||
126161415|NCT01770353|453877298|FG000|Overall Study|Physician Decision|0|||
126161416|NCT01770353|453877299|FG001|Overall Study|Physician Decision|3|||
126161417|NCT01770353|453877298|FG000|Overall Study|Clinical deterioration|3|||
126161418|NCT01770353|453877299|FG001|Overall Study|Clinical deterioration|6|||
126161419|NCT01770353|453877298|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
126161420|NCT01770353|453877299|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
126161421|NCT00376688|453877300|FG000|Overall Study|Adverse Event|3|||
126161422|NCT00376688|453877300|FG000|Overall Study|Death|1|||
126161423|NCT02574312|453877301|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
126161424|NCT02574312|453877302|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
126161425|NCT04267562|453879494|FG000|Assessed for Eligibility|Screen Failure|64|||
126161426|NCT04267562|453879494|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
126161427|NCT04267562|453879494|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
126161428|NCT04267562|453879494|FG000|Assessed for Eligibility|Site closure|6|||
126161429|NCT04267562|453879494|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
126161430|NCT04267562|453879494|FG000|Assessed for Eligibility|Physician Decision|1|||
126161431|NCT04267562|453879494|FG000|Month 24|Elective hysterectomy|1|||
126161432|NCT04267562|453879494|FG000|Month 24|Lost to Follow-up|1|||
126161433|NCT04267562|453879494|FG000|Month 36|Elective hysterectomy|2|||
126161434|NCT04267562|453879494|FG000|Month 36|Lost to Follow-up|3|||
126161435|NCT02078713|453879495|FG000|Overall Study|Lost to Follow-up|49|||
126161436|NCT02078713|453879496|FG001|Overall Study|Lost to Follow-up|55|||
126161437|NCT02078713|453879497|FG002|Overall Study|Lost to Follow-up|0|||
126161438|NCT02078713|453879498|FG003|Overall Study|Lost to Follow-up|0|||
126161439|NCT02078713|453879495|FG000|Overall Study|Pregnant at baseline|3|||
126161440|NCT02078713|453879496|FG001|Overall Study|Pregnant at baseline|5|||
126161441|NCT02078713|453879497|FG002|Overall Study|Pregnant at baseline|0|||
126161442|NCT02078713|453879498|FG003|Overall Study|Pregnant at baseline|0|||
126161443|NCT02078713|453879495|FG000|Overall Study|Enrolled twice|0|||
126161444|NCT02078713|453879496|FG001|Overall Study|Enrolled twice|1|||
126161445|NCT02078713|453879497|FG002|Overall Study|Enrolled twice|0|||
126161446|NCT02078713|453879498|FG003|Overall Study|Enrolled twice|0|||
126161447|NCT00696657|453879503|FG000|Overall Study|Protocol Violation|0|||
126161448|NCT00696657|453879504|FG001|Overall Study|Protocol Violation|0|||
126161449|NCT00696657|453879505|FG002|Overall Study|Protocol Violation|0|||
126161450|NCT00696657|453879506|FG003|Overall Study|Protocol Violation|0|||
126161451|NCT00696657|453879507|FG004|Overall Study|Protocol Violation|0|||
126161452|NCT00696657|453879508|FG005|Overall Study|Protocol Violation|1|||
126161453|NCT00696657|453879509|FG006|Overall Study|Protocol Violation|0|||
126161454|NCT00696657|453879510|FG007|Overall Study|Protocol Violation|0|||
126161455|NCT00696657|453879511|FG008|Overall Study|Protocol Violation|1|||
126161456|NCT00696657|453879503|FG000|Overall Study|Lack of Efficacy|0|||
126161457|NCT00696657|453879504|FG001|Overall Study|Lack of Efficacy|1|||
126161458|NCT00696657|453879505|FG002|Overall Study|Lack of Efficacy|0|||
126161459|NCT00696657|453879506|FG003|Overall Study|Lack of Efficacy|0|||
126161460|NCT00696657|453879507|FG004|Overall Study|Lack of Efficacy|0|||
126161461|NCT00696657|453879508|FG005|Overall Study|Lack of Efficacy|0|||
126161462|NCT00696657|453879509|FG006|Overall Study|Lack of Efficacy|0|||
126161463|NCT00696657|453879510|FG007|Overall Study|Lack of Efficacy|0|||
126161464|NCT00696657|453879511|FG008|Overall Study|Lack of Efficacy|0|||
126161465|NCT00696657|453879503|FG000|Overall Study|Withdrawal criteria|1|||
126161466|NCT00696657|453879504|FG001|Overall Study|Withdrawal criteria|3|||
126161467|NCT00696657|453879505|FG002|Overall Study|Withdrawal criteria|2|||
126161468|NCT00696657|453879506|FG003|Overall Study|Withdrawal criteria|2|||
126161469|NCT00696657|453879507|FG004|Overall Study|Withdrawal criteria|0|||
126161470|NCT00696657|453879508|FG005|Overall Study|Withdrawal criteria|0|||
126161471|NCT00696657|453879509|FG006|Overall Study|Withdrawal criteria|1|||
126161472|NCT00696657|453879510|FG007|Overall Study|Withdrawal criteria|1|||
126161473|NCT00696657|453879511|FG008|Overall Study|Withdrawal criteria|2|||
126161474|NCT00696657|453879503|FG000|Overall Study|Unclassified|0|||
126161475|NCT00696657|453879504|FG001|Overall Study|Unclassified|1|||
126161476|NCT00696657|453879505|FG002|Overall Study|Unclassified|3|||
126161477|NCT00696657|453879506|FG003|Overall Study|Unclassified|2|||
126161478|NCT00696657|453879507|FG004|Overall Study|Unclassified|4|||
126161479|NCT00696657|453879508|FG005|Overall Study|Unclassified|2|||
126161480|NCT00696657|453879509|FG006|Overall Study|Unclassified|0|||
126161481|NCT00696657|453879510|FG007|Overall Study|Unclassified|0|||
126161482|NCT00696657|453879511|FG008|Overall Study|Unclassified|1|||
126161483|NCT00696657|453879503|FG000|Overall Study|Adverse Event|0|||
126161484|NCT00696657|453879504|FG001|Overall Study|Adverse Event|0|||
126161485|NCT00696657|453879505|FG002|Overall Study|Adverse Event|3|||
126161486|NCT00696657|453879506|FG003|Overall Study|Adverse Event|7|||
126161487|NCT00696657|453879507|FG004|Overall Study|Adverse Event|6|||
126161488|NCT00696657|453879508|FG005|Overall Study|Adverse Event|9|||
126161489|NCT00696657|453879509|FG006|Overall Study|Adverse Event|14|||
126161490|NCT00696657|453879510|FG007|Overall Study|Adverse Event|2|||
126161491|NCT00696657|453879511|FG008|Overall Study|Adverse Event|5|||
126161492|NCT02090114|453879512|FG000|Overall Study|Withdrawal by Subject|3|||
126161493|NCT02090114|453879513|FG001|Overall Study|Withdrawal by Subject|6|||
126161494|NCT02090114|453879514|FG002|Overall Study|Withdrawal by Subject|2|||
126161495|NCT02090114|453879515|FG003|Overall Study|Withdrawal by Subject|1|||
126161496|NCT02090114|453879512|FG000|Overall Study|Physician Decision|5|||
126161497|NCT02090114|453879513|FG001|Overall Study|Physician Decision|0|||
126161498|NCT02090114|453879514|FG002|Overall Study|Physician Decision|1|||
126161499|NCT02090114|453879515|FG003|Overall Study|Physician Decision|1|||
126161500|NCT02090114|453879512|FG000|Overall Study|Adverse Event|1|||
126161501|NCT02090114|453879513|FG001|Overall Study|Adverse Event|2|||
126161502|NCT02090114|453879514|FG002|Overall Study|Adverse Event|2|||
126161503|NCT02090114|453879515|FG003|Overall Study|Adverse Event|0|||
126161504|NCT02090114|453879512|FG000|Overall Study|Progressive Disease|20|||
126161505|NCT02090114|453879513|FG001|Overall Study|Progressive Disease|21|||
126161506|NCT02090114|453879514|FG002|Overall Study|Progressive Disease|23|||
126161507|NCT02090114|453879515|FG003|Overall Study|Progressive Disease|6|||
126161508|NCT02090114|453879512|FG000|Overall Study|Death|1|||
126161509|NCT02090114|453879513|FG001|Overall Study|Death|0|||
126161510|NCT02090114|453879514|FG002|Overall Study|Death|1|||
126161511|NCT02090114|453879515|FG003|Overall Study|Death|0|||
126161512|NCT01989546|453879516|FG000|Overall Study|Clinical Progression|1|||
126161513|NCT01989546|453879516|FG000|Overall Study|Disease progression on study|8|||
126161514|NCT00059215|453879520|FG000|Overall Study|Adverse Event|5|||
126161515|NCT00059215|453879521|FG001|Overall Study|Adverse Event|5|||
126161516|NCT00059215|453879522|FG002|Overall Study|Adverse Event|9|||
126161517|NCT00059215|453879523|FG003|Overall Study|Adverse Event|9|||
126161518|NCT00059215|453879520|FG000|Overall Study|Death|0|||
126161519|NCT00059215|453879521|FG001|Overall Study|Death|0|||
126161520|NCT00059215|453879522|FG002|Overall Study|Death|3|||
126161521|NCT00059215|453879523|FG003|Overall Study|Death|0|||
126161522|NCT00059215|453879520|FG000|Overall Study|Lost to Follow-up|1|||
126161523|NCT00059215|453879521|FG001|Overall Study|Lost to Follow-up|2|||
126161524|NCT00059215|453879522|FG002|Overall Study|Lost to Follow-up|0|||
126161525|NCT00059215|453879523|FG003|Overall Study|Lost to Follow-up|0|||
126161526|NCT00059215|453879520|FG000|Overall Study|Withdrawal by Subject|4|||
126161527|NCT00059215|453879521|FG001|Overall Study|Withdrawal by Subject|4|||
126161528|NCT00059215|453879522|FG002|Overall Study|Withdrawal by Subject|1|||
126161529|NCT00059215|453879523|FG003|Overall Study|Withdrawal by Subject|3|||
126161530|NCT00059215|453879520|FG000|Overall Study|Protocol Violation|1|||
126161531|NCT00059215|453879521|FG001|Overall Study|Protocol Violation|0|||
126161532|NCT00059215|453879522|FG002|Overall Study|Protocol Violation|1|||
126161533|NCT00059215|453879523|FG003|Overall Study|Protocol Violation|0|||
126161534|NCT00059215|453879520|FG000|Overall Study|Protocol entry criteria not met|1|||
126161535|NCT00059215|453879521|FG001|Overall Study|Protocol entry criteria not met|1|||
126161536|NCT00059215|453879522|FG002|Overall Study|Protocol entry criteria not met|0|||
126161537|NCT00059215|453879523|FG003|Overall Study|Protocol entry criteria not met|2|||
126161538|NCT00059215|453879520|FG000|Overall Study|Physician Decision|1|||
126161539|NCT00059215|453879521|FG001|Overall Study|Physician Decision|2|||
126161540|NCT00059215|453879522|FG002|Overall Study|Physician Decision|1|||
126161541|NCT00059215|453879523|FG003|Overall Study|Physician Decision|1|||
126161542|NCT04439838|453879524|FG000|Overall Study|Withdrawal by Subject|0|||
126161543|NCT04439838|453879525|FG001|Overall Study|Withdrawal by Subject|0|||
126161544|NCT04439838|453879526|FG002|Overall Study|Withdrawal by Subject|0|||
126161545|NCT04439838|453879527|FG003|Overall Study|Withdrawal by Subject|0|||
126161546|NCT04439838|453879528|FG004|Overall Study|Withdrawal by Subject|0|||
126161547|NCT04439838|453879529|FG005|Overall Study|Withdrawal by Subject|0|||
126161548|NCT04439838|453879530|FG006|Overall Study|Withdrawal by Subject|0|||
126161549|NCT04439838|453879531|FG007|Overall Study|Withdrawal by Subject|0|||
126161550|NCT04439838|453879532|FG008|Overall Study|Withdrawal by Subject|1|||
126161551|NCT04494633|453879535|FG000|Overall Study|Lost to Follow-up|5|||
126161552|NCT04494633|453879536|FG001|Overall Study|Lost to Follow-up|3|||
126161553|NCT04494633|453879535|FG000|Overall Study|Protocol Violation|1|||
126161554|NCT04494633|453879536|FG001|Overall Study|Protocol Violation|1|||
126161555|NCT00414310|453879537|FG000|Overall Study|Not treated|1|||
126161556|NCT00414310|453879538|FG001|Overall Study|Not treated|0|||
126161557|NCT01254604|453879539|FG000|Overall Study|Lost to Follow-up|1|||
126161558|NCT01254604|453879540|FG001|Overall Study|Lost to Follow-up|1|||
126161559|NCT01254604|453879539|FG000|Overall Study|Protocol Violation|2|||
126161560|NCT01254604|453879540|FG001|Overall Study|Protocol Violation|2|||
126161561|NCT01254604|453879539|FG000|Overall Study|Withdrawal by Subject|2|||
126161562|NCT01254604|453879540|FG001|Overall Study|Withdrawal by Subject|4|||
126161563|NCT01254604|453879539|FG000|Overall Study|Adverse Event|3|||
126161564|NCT01254604|453879540|FG001|Overall Study|Adverse Event|2|||
126161565|NCT03074162|453879541|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126161566|NCT03074162|453879542|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126161567|NCT03074162|453879543|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
126161568|NCT03074162|453879544|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126161569|NCT03074162|453879545|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126161570|NCT03074162|453879546|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126161571|NCT03074162|453879541|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
126161572|NCT03074162|453879542|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
126161573|NCT03074162|453879543|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
126161574|NCT03074162|453879544|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
126161575|NCT03074162|453879545|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
126161576|NCT03074162|453879546|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
126161577|NCT03074162|453879541|FG000|Period 3|Withdrawal by Subject|1|||
126161578|NCT03074162|453879542|FG001|Period 3|Withdrawal by Subject|0|||
126161579|NCT03074162|453879543|FG002|Period 3|Withdrawal by Subject|0|||
126161580|NCT03074162|453879544|FG003|Period 3|Withdrawal by Subject|0|||
126161581|NCT03074162|453879545|FG004|Period 3|Withdrawal by Subject|1|||
126161582|NCT03074162|453879546|FG005|Period 3|Withdrawal by Subject|0|||
126161583|NCT01993329|453879547|FG000|Period 2|Adverse Event|0|||
126161584|NCT01993329|453879548|FG001|Period 2|Adverse Event|0|||
126161585|NCT01993329|453879549|FG002|Period 2|Adverse Event|0|||
126161586|NCT01993329|453879550|FG003|Period 2|Adverse Event|0|||
126161587|NCT01993329|453879551|FG004|Period 2|Adverse Event|0|||
126161588|NCT01993329|453879552|FG005|Period 2|Adverse Event|1|||
126161589|NCT01993329|453879547|FG000|Wash-out|Personal reasons|0|||
126161590|NCT01993329|453879548|FG001|Wash-out|Personal reasons|1|||
126161591|NCT01993329|453879549|FG002|Wash-out|Personal reasons|0|||
126161592|NCT01993329|453879550|FG003|Wash-out|Personal reasons|0|||
126161593|NCT01993329|453879551|FG004|Wash-out|Personal reasons|0|||
126161594|NCT01993329|453879552|FG005|Wash-out|Personal reasons|0|||
126161595|NCT03041116|453879553|FG000|Double-blind|Death|0|||
126161596|NCT03041116|453879554|FG001|Double-blind|Death|2|||
126161597|NCT03041116|453879553|FG000|Double-blind|Withdrawal by Subject|0|||
126161598|NCT03041116|453879554|FG001|Double-blind|Withdrawal by Subject|4|||
126161599|NCT03041116|453879553|FG000|Open-label|Death|1|||
126161600|NCT03041116|453879554|FG001|Open-label|Death|0|||
126161601|NCT03041116|453879553|FG000|Open-label|Termination of the study by Sponsor|39|||
126161602|NCT03041116|453879554|FG001|Open-label|Termination of the study by Sponsor|37|||
126161603|NCT03041116|453879553|FG000|Open-label|Withdrawal by Subject|1|||
126161604|NCT03041116|453879554|FG001|Open-label|Withdrawal by Subject|0|||
125972435|NCT03214367|453188765|FG002|Treatment Period|Withdrawal by Subject|23|||
125972436|NCT03214367|453188766|FG003|Treatment Period|Withdrawal by Subject|14|||
125972437|NCT03214367|453188767|FG004|Treatment Period|Withdrawal by Subject|0|||
125972438|NCT03214367|453188768|FG005|Treatment Period|Withdrawal by Subject|1|||
126161605|NCT03097328|453879555|FG000|Overall Study|Still on Therapy|2|||
126161606|NCT03097328|453879555|FG000|Overall Study|Progressive Disease|29|||
126161607|NCT03097328|453879555|FG000|Overall Study|Adverse Event|4|||
126161608|NCT03097328|453879555|FG000|Overall Study|Withdrawal by Subject|1|||
126161609|NCT03097328|453879555|FG000|Overall Study|Physician Decision|1|||
126161610|NCT03097328|453879555|FG000|Overall Study|Patient Decision|1|||
126161611|NCT03097328|453879555|FG000|Overall Study|Ineligible for Study Drug|1|||
126161612|NCT02436577|453879556|FG000|Overall Study|Protocol Deviation|0|||
126161613|NCT02436577|453879557|FG001|Overall Study|Protocol Deviation|1|||
126161614|NCT02436577|453879558|FG002|Overall Study|Protocol Deviation|0|||
126161615|NCT02436577|453879559|FG003|Overall Study|Protocol Deviation|0|||
126161616|NCT02436577|453879560|FG004|Overall Study|Protocol Deviation|0|||
126161617|NCT02436577|453879561|FG005|Overall Study|Protocol Deviation|0|||
126161618|NCT01675011|453879565|FG000|Overall Study|Trial terminated by Sponsor|3|||
126161619|NCT01675011|453879566|FG001|Overall Study|Trial terminated by Sponsor|1|||
126161620|NCT00931892|453879570|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
126161621|NCT00931892|453879571|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
125972439|NCT03214367|453188769|FG006|Treatment Period|Withdrawal by Subject|1|||
125972440|NCT03214367|453188770|FG007|Treatment Period|Withdrawal by Subject|1|||
125972441|NCT03508843|453188771|FG000|Overall Study|Withdrawal by Subject|1|||
125972442|NCT03508843|453188771|FG000|Overall Study|technical difficulties|2|||
125972443|NCT00765843|453188772|FG000|Overall Study|Lost to Follow-up|1|||
125972444|NCT00765843|453188773|FG001|Overall Study|Lost to Follow-up|3|||
125972445|NCT00765843|453188774|FG002|Overall Study|Lost to Follow-up|2|||
125972446|NCT00765843|453188772|FG000|Overall Study|did not return to receive intervention|0|||
125972447|NCT00765843|453188773|FG001|Overall Study|did not return to receive intervention|1|||
125972448|NCT00765843|453188774|FG002|Overall Study|did not return to receive intervention|0|||
125972449|NCT00765843|453188772|FG000|Overall Study|Adverse Event|0|||
125972450|NCT00765843|453188773|FG001|Overall Study|Adverse Event|0|||
125972451|NCT00765843|453188774|FG002|Overall Study|Adverse Event|1|||
125972452|NCT03555396|453188775|FG000|Overall Study|Death|3|||
125972453|NCT03555396|453188776|FG001|Overall Study|Death|1|||
125972454|NCT03555396|453188775|FG000|Overall Study|Lost to Follow-up|0|||
125972455|NCT03555396|453188776|FG001|Overall Study|Lost to Follow-up|2|||
125972456|NCT01816594|453188784|FG000|Overall Study|Local Progress|0|||
125972457|NCT01816594|453188785|FG001|Overall Study|Local Progress|2|||
125972458|NCT01816594|453188784|FG000|Overall Study|Adverse Event|9|||
125972459|NCT01816594|453188785|FG001|Overall Study|Adverse Event|0|||
125972460|NCT01816594|453188784|FG000|Overall Study|Withdrawal by Subject|1|||
125972461|NCT01816594|453188785|FG001|Overall Study|Withdrawal by Subject|0|||
125972462|NCT01816594|453188784|FG000|Overall Study|Physician Decision|1|||
125972463|NCT01816594|453188785|FG001|Overall Study|Physician Decision|0|||
125972464|NCT03905655|453188786|FG000|Overall Study|Adverse Event|1|||
125972465|NCT03905655|453188787|FG001|Overall Study|Adverse Event|0|||
125972466|NCT03905655|453188788|FG002|Overall Study|Adverse Event|1|||
125972467|NCT03905655|453188789|FG003|Overall Study|Adverse Event|1|||
125972468|NCT02566031|453188790|FG000|Overall Study|Patient/guardian decision|14|||
125972469|NCT02566031|453188791|FG001|Overall Study|Patient/guardian decision|7|||
125972470|NCT02566031|453188790|FG000|Overall Study|Protocol deviation|2|||
125972471|NCT02566031|453188791|FG001|Overall Study|Protocol deviation|3|||
125972472|NCT02566031|453188790|FG000|Overall Study|Adverse Event|3|||
125972473|NCT02566031|453188791|FG001|Overall Study|Adverse Event|1|||
125972474|NCT02566031|453188790|FG000|Overall Study|Lost to Follow-up|1|||
125972475|NCT02566031|453188791|FG001|Overall Study|Lost to Follow-up|1|||
125972476|NCT02479412|453188794|FG000|Overall Study|Adverse Event|0|||
125972477|NCT02479412|453188795|FG001|Overall Study|Adverse Event|0|||
125972478|NCT02479412|453188796|FG002|Overall Study|Adverse Event|1|||
125972479|NCT02479412|453188797|FG003|Overall Study|Adverse Event|0|||
125972480|NCT02479412|453188798|FG004|Overall Study|Adverse Event|0|||
125972481|NCT02479412|453188799|FG005|Overall Study|Adverse Event|0|||
125972482|NCT02479412|453188800|FG006|Overall Study|Adverse Event|0|||
125972483|NCT02479412|453188801|FG007|Overall Study|Adverse Event|0|||
125972484|NCT02479412|453188802|FG008|Overall Study|Adverse Event|0|||
125972485|NCT02479412|453188794|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125972486|NCT02479412|453188795|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125972487|NCT02479412|453188796|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125972488|NCT02479412|453188797|FG003|Overall Study|Study-specific withdrawal criteria|1|||
125972489|NCT02479412|453188798|FG004|Overall Study|Study-specific withdrawal criteria|0|||
125972490|NCT02479412|453188799|FG005|Overall Study|Study-specific withdrawal criteria|0|||
126161622|NCT01876732|453879572|FG000|Overall Study|MMA was not over 800mg/dL|75|||
126161623|NCT02531373|453879575|FG000|Overall Study|Lack of Efficacy|0|||
126161624|NCT02531373|453879576|FG001|Overall Study|Lack of Efficacy|0|||
126161625|NCT02531373|453879577|FG002|Overall Study|Lack of Efficacy|0|||
126161626|NCT02531373|453879578|FG003|Overall Study|Lack of Efficacy|0|||
126161627|NCT02531373|453879579|FG004|Overall Study|Lack of Efficacy|3|||
126161628|NCT02531373|453879580|FG005|Overall Study|Lack of Efficacy|2|||
126161629|NCT02531373|453879581|FG006|Overall Study|Lack of Efficacy|4|||
126161630|NCT02531373|453879582|FG007|Overall Study|Lack of Efficacy|8|||
126161631|NCT02531373|453879583|FG008|Overall Study|Lack of Efficacy|5|||
125972491|NCT02479412|453188800|FG006|Overall Study|Study-specific withdrawal criteria|0|||
125972492|NCT02479412|453188801|FG007|Overall Study|Study-specific withdrawal criteria|1|||
125972493|NCT02479412|453188802|FG008|Overall Study|Study-specific withdrawal criteria|1|||
125972494|NCT02479412|453188794|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
125972495|NCT02479412|453188795|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
125972496|NCT02479412|453188796|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
125972497|NCT02479412|453188797|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
125972498|NCT02479412|453188798|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
125972499|NCT02479412|453188799|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
125972500|NCT02479412|453188800|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
126161632|NCT02531373|453879575|FG000|Overall Study|Lost to Follow-up|0|||
126161633|NCT02531373|453879576|FG001|Overall Study|Lost to Follow-up|0|||
126161634|NCT02531373|453879577|FG002|Overall Study|Lost to Follow-up|0|||
126161635|NCT02531373|453879578|FG003|Overall Study|Lost to Follow-up|0|||
126161636|NCT02531373|453879579|FG004|Overall Study|Lost to Follow-up|0|||
126161637|NCT02531373|453879580|FG005|Overall Study|Lost to Follow-up|2|||
126161638|NCT02531373|453879581|FG006|Overall Study|Lost to Follow-up|2|||
126161639|NCT02531373|453879582|FG007|Overall Study|Lost to Follow-up|0|||
126161640|NCT02531373|453879583|FG008|Overall Study|Lost to Follow-up|0|||
126161641|NCT02531373|453879575|FG000|Overall Study|Physician Decision|0|||
126161642|NCT02531373|453879576|FG001|Overall Study|Physician Decision|0|||
126161643|NCT02531373|453879577|FG002|Overall Study|Physician Decision|0|||
126161644|NCT02531373|453879578|FG003|Overall Study|Physician Decision|0|||
126161645|NCT02531373|453879579|FG004|Overall Study|Physician Decision|2|||
126161646|NCT02531373|453879580|FG005|Overall Study|Physician Decision|1|||
126161647|NCT02531373|453879581|FG006|Overall Study|Physician Decision|0|||
126161648|NCT02531373|453879582|FG007|Overall Study|Physician Decision|0|||
126161649|NCT02531373|453879583|FG008|Overall Study|Physician Decision|0|||
126161650|NCT02531373|453879575|FG000|Overall Study|Protocol Violation|0|||
126161651|NCT02531373|453879576|FG001|Overall Study|Protocol Violation|0|||
126161652|NCT02531373|453879577|FG002|Overall Study|Protocol Violation|0|||
126161653|NCT02531373|453879578|FG003|Overall Study|Protocol Violation|0|||
126161654|NCT02531373|453879579|FG004|Overall Study|Protocol Violation|0|||
126161655|NCT02531373|453879580|FG005|Overall Study|Protocol Violation|1|||
126161656|NCT02531373|453879581|FG006|Overall Study|Protocol Violation|1|||
126161657|NCT02531373|453879582|FG007|Overall Study|Protocol Violation|0|||
126161658|NCT02531373|453879583|FG008|Overall Study|Protocol Violation|1|||
126161659|NCT02531373|453879575|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126161660|NCT02531373|453879576|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126161661|NCT02531373|453879577|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126161662|NCT02531373|453879578|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126161663|NCT02531373|453879579|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126161664|NCT02531373|453879580|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
126161665|NCT02531373|453879581|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
126161666|NCT02531373|453879582|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
126161667|NCT02531373|453879583|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
126161668|NCT02531373|453879575|FG000|Overall Study|Withdrawal by Subject|0|||
126161669|NCT02531373|453879576|FG001|Overall Study|Withdrawal by Subject|0|||
126161670|NCT02531373|453879577|FG002|Overall Study|Withdrawal by Subject|0|||
126161671|NCT02531373|453879578|FG003|Overall Study|Withdrawal by Subject|0|||
126161672|NCT02531373|453879579|FG004|Overall Study|Withdrawal by Subject|3|||
126161673|NCT02531373|453879580|FG005|Overall Study|Withdrawal by Subject|0|||
126161674|NCT02531373|453879581|FG006|Overall Study|Withdrawal by Subject|0|||
126161675|NCT02531373|453879582|FG007|Overall Study|Withdrawal by Subject|0|||
126161676|NCT02531373|453879583|FG008|Overall Study|Withdrawal by Subject|0|||
126161677|NCT00536731|453879584|FG000|Overall Study|Adverse Event|3|||
126161678|NCT00536731|453879585|FG001|Overall Study|Adverse Event|2|||
126161679|NCT00536731|453879586|FG002|Overall Study|Adverse Event|3|||
126161680|NCT00536731|453879584|FG000|Overall Study|Withdrawal by Subject|0|||
126161681|NCT00536731|453879585|FG001|Overall Study|Withdrawal by Subject|2|||
126161682|NCT00536731|453879586|FG002|Overall Study|Withdrawal by Subject|0|||
126161683|NCT00536731|453879584|FG000|Overall Study|Intake of prohibited conc. medication|0|||
126161684|NCT00536731|453879585|FG001|Overall Study|Intake of prohibited conc. medication|0|||
126161685|NCT00536731|453879586|FG002|Overall Study|Intake of prohibited conc. medication|1|||
126161686|NCT00536731|453879584|FG000|Overall Study|Safety reasons|0|||
126161687|NCT00536731|453879585|FG001|Overall Study|Safety reasons|0|||
126161688|NCT00536731|453879586|FG002|Overall Study|Safety reasons|1|||
126161689|NCT00536731|453879584|FG000|Overall Study|Other|1|||
126161690|NCT00536731|453879585|FG001|Overall Study|Other|1|||
126161691|NCT00536731|453879586|FG002|Overall Study|Other|0|||
126161692|NCT01675531|453879587|FG000|Overall Study|Adverse Event|9|||
126161693|NCT01675531|453879587|FG000|Overall Study|Withdrawal by Subject|7|||
126161694|NCT01675531|453879587|FG000|Overall Study|Lack of Efficacy|1|||
126161695|NCT01675531|453879587|FG000|Overall Study|Protocol Violation|8|||
126161696|NCT00623467|453879588|FG000|Overall Study|Lost to Follow-up|1|||
126161697|NCT00623467|453879588|FG000|Overall Study|Protocol Violation|4|||
126161698|NCT00623467|453879588|FG000|Overall Study|Withdrawal by Subject|2|||
126161699|NCT02795988|453879597|FG000|Phase 1b|Withdrawal by Subject|0|||
126161700|NCT02795988|453879598|FG001|Phase 1b|Withdrawal by Subject|1|||
126161701|NCT02795988|453879599|FG002|Phase 1b|Withdrawal by Subject|0|||
126161702|NCT02795988|453879600|FG003|Phase 1b|Withdrawal by Subject|0|||
126161703|NCT02795988|453879601|FG004|Phase 1b|Withdrawal by Subject|0|||
126161704|NCT02795988|453879602|FG005|Phase 1b|Withdrawal by Subject|0|||
126161705|NCT02795988|453879603|FG006|Phase 1b|Withdrawal by Subject|0|||
126161706|NCT02795988|453879597|FG000|Phase 1b|Death|1|||
126161707|NCT02795988|453879598|FG001|Phase 1b|Death|2|||
126161708|NCT02795988|453879599|FG002|Phase 1b|Death|1|||
126161709|NCT02795988|453879600|FG003|Phase 1b|Death|0|||
126161710|NCT02795988|453879601|FG004|Phase 1b|Death|0|||
126161711|NCT02795988|453879602|FG005|Phase 1b|Death|0|||
126161712|NCT02795988|453879603|FG006|Phase 1b|Death|0|||
126161713|NCT02795988|453879597|FG000|Phase 1b|Physician Decision|0|||
126161714|NCT02795988|453879598|FG001|Phase 1b|Physician Decision|0|||
126161715|NCT02795988|453879599|FG002|Phase 1b|Physician Decision|1|||
126161716|NCT02795988|453879600|FG003|Phase 1b|Physician Decision|0|||
126161717|NCT02795988|453879601|FG004|Phase 1b|Physician Decision|0|||
126161718|NCT02795988|453879602|FG005|Phase 1b|Physician Decision|0|||
126161719|NCT02795988|453879603|FG006|Phase 1b|Physician Decision|0|||
126161720|NCT02795988|453879597|FG000|Phase 1b|Progressive Disease|2|||
126161721|NCT02795988|453879598|FG001|Phase 1b|Progressive Disease|2|||
126161722|NCT02795988|453879599|FG002|Phase 1b|Progressive Disease|0|||
126161723|NCT02795988|453879600|FG003|Phase 1b|Progressive Disease|0|||
126161724|NCT02795988|453879601|FG004|Phase 1b|Progressive Disease|0|||
126161725|NCT02795988|453879602|FG005|Phase 1b|Progressive Disease|0|||
126161726|NCT02795988|453879603|FG006|Phase 1b|Progressive Disease|0|||
126161727|NCT02795988|453879597|FG000|Phase 2|Withdrawal by Subject|0|||
126161728|NCT02795988|453879598|FG001|Phase 2|Withdrawal by Subject|0|||
126161729|NCT02795988|453879599|FG002|Phase 2|Withdrawal by Subject|0|||
126161730|NCT02795988|453879600|FG003|Phase 2|Withdrawal by Subject|1|||
126161731|NCT02795988|453879601|FG004|Phase 2|Withdrawal by Subject|0|||
126161732|NCT02795988|453879602|FG005|Phase 2|Withdrawal by Subject|0|||
126161733|NCT02795988|453879603|FG006|Phase 2|Withdrawal by Subject|0|||
126161734|NCT02795988|453879597|FG000|Phase 2|Death|0|||
126161735|NCT02795988|453879598|FG001|Phase 2|Death|0|||
126161736|NCT02795988|453879599|FG002|Phase 2|Death|0|||
126161737|NCT02795988|453879600|FG003|Phase 2|Death|17|||
126161738|NCT02795988|453879601|FG004|Phase 2|Death|17|||
126161739|NCT02795988|453879602|FG005|Phase 2|Death|0|||
126161740|NCT02795988|453879603|FG006|Phase 2|Death|0|||
126161741|NCT02795988|453879597|FG000|Phase 2|Other|0|||
126161742|NCT02795988|453879598|FG001|Phase 2|Other|0|||
126161743|NCT02795988|453879599|FG002|Phase 2|Other|0|||
126161744|NCT02795988|453879600|FG003|Phase 2|Other|1|||
126161745|NCT02795988|453879601|FG004|Phase 2|Other|0|||
126161746|NCT02795988|453879602|FG005|Phase 2|Other|0|||
126161747|NCT02795988|453879603|FG006|Phase 2|Other|0|||
126161748|NCT02795988|453879597|FG000|Phase 2 Extension|Death|0|||
126161749|NCT02795988|453879598|FG001|Phase 2 Extension|Death|0|||
126161750|NCT02795988|453879599|FG002|Phase 2 Extension|Death|0|||
126161751|NCT02795988|453879600|FG003|Phase 2 Extension|Death|0|||
126161752|NCT02795988|453879601|FG004|Phase 2 Extension|Death|0|||
126161753|NCT02795988|453879602|FG005|Phase 2 Extension|Death|5|||
126161754|NCT02795988|453879603|FG006|Phase 2 Extension|Death|6|||
126161755|NCT02795988|453879597|FG000|Phase 2 Extension|Other reasons|0|||
126161756|NCT02795988|453879598|FG001|Phase 2 Extension|Other reasons|0|||
126161757|NCT02795988|453879599|FG002|Phase 2 Extension|Other reasons|0|||
126161758|NCT02795988|453879600|FG003|Phase 2 Extension|Other reasons|0|||
126161759|NCT02795988|453879601|FG004|Phase 2 Extension|Other reasons|0|||
126161760|NCT02795988|453879602|FG005|Phase 2 Extension|Other reasons|2|||
126161761|NCT02795988|453879603|FG006|Phase 2 Extension|Other reasons|1|||
126161762|NCT02834403|453879604|FG000|Overall Study|Physician Decision|2|||
126161763|NCT02834403|453879605|FG001|Overall Study|Physician Decision|1|||
126161764|NCT02834403|453879606|FG002|Overall Study|Physician Decision|2|||
126161765|NCT02834403|453879607|FG003|Overall Study|Physician Decision|1|||
126161766|NCT02834403|453879608|FG004|Overall Study|Physician Decision|1|||
126161767|NCT02834403|453879609|FG005|Overall Study|Physician Decision|2|||
126161768|NCT02834403|453879610|FG006|Overall Study|Physician Decision|12|||
126161769|NCT02834403|453879604|FG000|Overall Study|Adverse Event|0|||
126161770|NCT02834403|453879605|FG001|Overall Study|Adverse Event|0|||
126161771|NCT02834403|453879606|FG002|Overall Study|Adverse Event|0|||
126161772|NCT02834403|453879607|FG003|Overall Study|Adverse Event|0|||
126161773|NCT02834403|453879608|FG004|Overall Study|Adverse Event|1|||
126161774|NCT02834403|453879609|FG005|Overall Study|Adverse Event|1|||
126161775|NCT02834403|453879610|FG006|Overall Study|Adverse Event|3|||
126161776|NCT02834403|453879604|FG000|Overall Study|Withdrawal by Subject|0|||
126161777|NCT02834403|453879605|FG001|Overall Study|Withdrawal by Subject|1|||
126161778|NCT02834403|453879606|FG002|Overall Study|Withdrawal by Subject|0|||
126161779|NCT02834403|453879607|FG003|Overall Study|Withdrawal by Subject|0|||
126161780|NCT02834403|453879608|FG004|Overall Study|Withdrawal by Subject|1|||
126161781|NCT02834403|453879609|FG005|Overall Study|Withdrawal by Subject|0|||
126161782|NCT02834403|453879610|FG006|Overall Study|Withdrawal by Subject|0|||
126161783|NCT02834403|453879604|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
126161784|NCT02834403|453879605|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
126161785|NCT02834403|453879606|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
126161786|NCT02834403|453879607|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
126161787|NCT02834403|453879608|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
126161788|NCT02834403|453879609|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
126161789|NCT02834403|453879610|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
126161790|NCT02341014|453879611|FG000|Overall Study|Adverse Event|0|||
126161791|NCT02341014|453879612|FG001|Overall Study|Adverse Event|1|||
126161792|NCT02341014|453879613|FG002|Overall Study|Adverse Event|0|||
126161793|NCT02341014|453879614|FG003|Overall Study|Adverse Event|0|||
126161794|NCT02341014|453879615|FG004|Overall Study|Adverse Event|2|||
126161795|NCT04705597|453879616|FG000|Overall Study|Death|16|||
126161796|NCT04705597|453879617|FG001|Overall Study|Death|9|||
126161797|NCT04705597|453879616|FG000|Overall Study|Lost to Follow-up|1|||
126161798|NCT04705597|453879617|FG001|Overall Study|Lost to Follow-up|0|||
126161799|NCT04705597|453879616|FG000|Overall Study|Withdrawal by Subject|1|||
126161800|NCT04705597|453879617|FG001|Overall Study|Withdrawal by Subject|2|||
126161801|NCT00273858|453879626|FG000|Overall Study|Not completed 24 month observation time|334|||
126161802|NCT00273858|453879626|FG000|Overall Study|Lost to Follow-up|101|||
126161803|NCT00273858|453879626|FG000|Overall Study|Withdrawal by Subject|21|||
126161804|NCT00273858|453879626|FG000|Overall Study|Adverse Event|81|||
126161805|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
126161806|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
126161807|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
126161808|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
126161809|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
126161810|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
126161811|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
126161812|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
126161813|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
126161814|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
126161815|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
126161816|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
126161817|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
126161818|NCT02232516|453879627|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
126161819|NCT02232516|453879627|FG000|Survival Follow-up|Death|15|||
126161820|NCT02232516|453879627|FG000|Survival Follow-up|Withdrawal by Subject|3|||
126161821|NCT02232516|453879627|FG000|Survival Follow-up|Lost to Follow-up|1|||
126161822|NCT02232516|453879627|FG000|Survival Follow-up|Still in follow-up|5|||
126161823|NCT01585961|453879628|FG000|Overall Study|Death|6|||
126161824|NCT01585961|453879628|FG000|Overall Study|Physician Decision|1|||
126161825|NCT01585961|453879628|FG000|Overall Study|Decision to use non-study catheter|1|||
126161826|NCT01585961|453879628|FG000|Overall Study|Withdrawal by Subject|1|||
126161827|NCT01585961|453879628|FG000|Overall Study|Lost to Follow-up|23|||
126161828|NCT01585961|453879628|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
126161829|NCT06094296|453879629|FG000|Overall Study|Progressive Disease|1|||
126161830|NCT06094296|453879630|FG001|Overall Study|Progressive Disease|0|||
126161831|NCT06094296|453879631|FG002|Overall Study|Progressive Disease|0|||
126161832|NCT06094296|453879632|FG003|Overall Study|Progressive Disease|0|||
126161833|NCT03332667|453879633|FG000|Overall Study|Adverse Event|0|||
126161834|NCT03332667|453879634|FG001|Overall Study|Adverse Event|0|||
126161835|NCT03332667|453879635|FG002|Overall Study|Adverse Event|2|||
126161836|NCT03332667|453879636|FG003|Overall Study|Adverse Event|1|||
126161837|NCT03332667|453879633|FG000|Overall Study|Withdrawal by Subject|2|||
126161838|NCT03332667|453879634|FG001|Overall Study|Withdrawal by Subject|1|||
126161839|NCT03332667|453879635|FG002|Overall Study|Withdrawal by Subject|5|||
126161840|NCT03332667|453879636|FG003|Overall Study|Withdrawal by Subject|1|||
126161841|NCT03332667|453879633|FG000|Overall Study|Disease Progression or Relapse|2|||
126161842|NCT03332667|453879634|FG001|Overall Study|Disease Progression or Relapse|1|||
126161843|NCT03332667|453879635|FG002|Overall Study|Disease Progression or Relapse|3|||
126161844|NCT03332667|453879636|FG003|Overall Study|Disease Progression or Relapse|0|||
126161845|NCT03332667|453879633|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
126161846|NCT03332667|453879634|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
126161847|NCT03332667|453879635|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
126161848|NCT03332667|453879636|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
126161849|NCT03332667|453879633|FG000|Overall Study|No Treatment Received|0|||
126161850|NCT03332667|453879634|FG001|Overall Study|No Treatment Received|0|||
126161851|NCT03332667|453879635|FG002|Overall Study|No Treatment Received|1|||
126161852|NCT03332667|453879636|FG003|Overall Study|No Treatment Received|0|||
126161853|NCT04964063|453879637|FG000|Overall Study|Adverse Event|4|||
126161854|NCT04964063|453879637|FG000|Overall Study|Lost to Follow-up|47|||
126161855|NCT04964063|453879637|FG000|Overall Study|Withdrawal by Subject|5|||
126161856|NCT04964063|453879637|FG000|Overall Study|Baseline Tasks Expired|41|||
126161857|NCT04964063|453879637|FG000|Overall Study|Participant withdrawn in error|1|||
126161858|NCT01035606|453879638|FG000|Overall Study|change in health, job demands,family|3|||
126161859|NCT01035606|453879639|FG001|Overall Study|change in health, job demands,family|3|||
126161860|NCT01035606|453879640|FG002|Overall Study|change in health, job demands,family|4|||
126161861|NCT03350750|453879641|FG000|Overall Study|Death|1|||
126161862|NCT03350750|453879642|FG001|Overall Study|Death|1|||
126161863|NCT01849250|453879643|FG000|Overall Study|Withdrawal by Subject|1|||
126161864|NCT01849250|453879644|FG001|Overall Study|Withdrawal by Subject|0|||
126161865|NCT01849250|453879643|FG000|Overall Study|Not Evaluable|5|||
126161866|NCT01849250|453879644|FG001|Overall Study|Not Evaluable|3|||
126161867|NCT01849250|453879643|FG000|Overall Study|Screen Failure|1|||
126161868|NCT01849250|453879644|FG001|Overall Study|Screen Failure|0|||
126161869|NCT00793819|453879648|FG000|Overall Study|Adverse Event|8|||
126161870|NCT00793819|453879649|FG001|Overall Study|Adverse Event|4|||
126161871|NCT00793819|453879648|FG000|Overall Study|Lack of Efficacy|1|||
126161872|NCT00793819|453879649|FG001|Overall Study|Lack of Efficacy|1|||
126161873|NCT00793819|453879648|FG000|Overall Study|Withdrawal by Subject|4|||
126161874|NCT00793819|453879649|FG001|Overall Study|Withdrawal by Subject|3|||
126161875|NCT00793819|453879648|FG000|Overall Study|Lost to Follow-up|1|||
126161876|NCT00793819|453879649|FG001|Overall Study|Lost to Follow-up|1|||
126161877|NCT00446446|453879650|FG000|Overall Study|Death|10|||
126161878|NCT00446446|453879650|FG000|Overall Study|Withdrawal by Subject|6|||
126161879|NCT00446446|453879650|FG000|Overall Study|Other|4|||
126161880|NCT00446446|453879650|FG000|Overall Study|Disease Progession|2|||
126161881|NCT00446446|453879650|FG000|Overall Study|Adverse Event|1|||
126161882|NCT00446446|453879650|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
126161883|NCT03648996|453879652|FG000|Overall Study|Withdrawal by Subject|0|||
125972501|NCT02479412|453188801|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
125972502|NCT02479412|453188802|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
125972503|NCT04969250|453188804|FG000|Overall Study|Protocol Violation|0|||
125972504|NCT04969250|453188805|FG001|Overall Study|Protocol Violation|2|||
125972505|NCT04969250|453188806|FG002|Overall Study|Protocol Violation|3|||
125972506|NCT04969250|453188807|FG003|Overall Study|Protocol Violation|8|||
125972507|NCT04969250|453188804|FG000|Overall Study|Withdrawal by Subject|0|||
125972508|NCT04969250|453188805|FG001|Overall Study|Withdrawal by Subject|1|||
125972509|NCT04969250|453188806|FG002|Overall Study|Withdrawal by Subject|0|||
125972510|NCT04969250|453188807|FG003|Overall Study|Withdrawal by Subject|0|||
125972511|NCT03667053|453188808|FG000|Overall Study|Withdrawal by Subject|1|||
125972512|NCT03667053|453188809|FG001|Overall Study|Withdrawal by Subject|0|||
125972513|NCT03667053|453188810|FG002|Overall Study|Withdrawal by Subject|0|||
125972514|NCT01059565|453188811|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
125972515|NCT01059565|453188812|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
125972516|NCT01059565|453188811|FG000|24-Week Randomized Phase|Adverse Event|5|||
125972517|NCT01059565|453188812|FG001|24-Week Randomized Phase|Adverse Event|0|||
125972518|NCT01059565|453188811|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
125972519|NCT01059565|453188812|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
125972520|NCT01059565|453188811|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
125972521|NCT01059565|453188812|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
125972522|NCT01059565|453188811|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
125972523|NCT01059565|453188812|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
125972524|NCT01059565|453188811|FG000|24-Week Open-Label Phase|Adverse Event|2|||
125972525|NCT01059565|453188812|FG001|24-Week Open-Label Phase|Adverse Event|0|||
125972526|NCT01059565|453188811|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
125972527|NCT01059565|453188812|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
125972528|NCT01059565|453188811|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
125972529|NCT01059565|453188812|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
125972530|NCT01059565|453188811|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
125972531|NCT01059565|453188812|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
125972532|NCT01059565|453188811|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
125972533|NCT01059565|453188812|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
125972534|NCT01059565|453188811|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
125972535|NCT01059565|453188812|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
125972536|NCT01605617|453188818|FG000|First Intervention|Adverse Event|0|||
125972537|NCT01605617|453188819|FG001|First Intervention|Adverse Event|1|||
125972538|NCT01605617|453188818|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
125972539|NCT01605617|453188819|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
125972540|NCT05545072|453188820|FG000|Overall Study|Lost to Follow-up|1|||
125972541|NCT05545072|453188821|FG001|Overall Study|Lost to Follow-up|0|||
125972542|NCT05545072|453188820|FG000|Overall Study|Study ended prematurely due to funding|2|||
125972543|NCT05545072|453188821|FG001|Overall Study|Study ended prematurely due to funding|2|||
125972544|NCT04420221|453188827|FG000|Overall Study|Withdrawal by Subject|0|||
125972545|NCT04420221|453188828|FG001|Overall Study|Withdrawal by Subject|0|||
126161884|NCT03648996|453879653|FG001|Overall Study|Withdrawal by Subject|2|||
126161885|NCT03648996|453879654|FG002|Overall Study|Withdrawal by Subject|2|||
126161886|NCT03648996|453879652|FG000|Overall Study|Physician Decision|2|||
125972546|NCT04420221|453188829|FG002|Overall Study|Withdrawal by Subject|0|||
125972547|NCT04420221|453188830|FG003|Overall Study|Withdrawal by Subject|0|||
125972548|NCT04420221|453188831|FG004|Overall Study|Withdrawal by Subject|0|||
125972549|NCT04420221|453188832|FG005|Overall Study|Withdrawal by Subject|20|||
126161887|NCT03648996|453879653|FG001|Overall Study|Physician Decision|0|||
126161888|NCT03648996|453879654|FG002|Overall Study|Physician Decision|0|||
126161889|NCT00590681|453879655|FG000|Overall Study|Withdrawal by Subject|7|||
126161890|NCT00590681|453879655|FG000|Overall Study|Adverse Event|8|||
126161891|NCT00590681|453879655|FG000|Overall Study|Death|3|||
126161892|NCT00590681|453879655|FG000|Overall Study|Lost to Follow-up|1|||
126161893|NCT00590681|453879655|FG000|Overall Study|disease progression|1|||
126161894|NCT00504166|453879656|FG000|Overall Study|Adverse Event|1|||
126161895|NCT00504166|453879657|FG001|Overall Study|Adverse Event|4|||
126161896|NCT00504166|453879656|FG000|Overall Study|Withdrawal by Subject|3|||
126161897|NCT00504166|453879657|FG001|Overall Study|Withdrawal by Subject|6|||
126161898|NCT00504166|453879656|FG000|Overall Study|Physician Decision|1|||
126161899|NCT00504166|453879657|FG001|Overall Study|Physician Decision|1|||
126161900|NCT00504166|453879656|FG000|Overall Study|Lost to Follow-up|1|||
126161901|NCT00504166|453879657|FG001|Overall Study|Lost to Follow-up|3|||
126161902|NCT02650284|453879658|FG000|Overall Study|Lost to Follow-up|3|||
126161903|NCT02650284|453879659|FG001|Overall Study|Lost to Follow-up|3|||
126161904|NCT02650284|453879658|FG000|Overall Study|Consent incorrectly taken|0|||
126161905|NCT02650284|453879659|FG001|Overall Study|Consent incorrectly taken|1|||
126161906|NCT01780389|453879665|FG000|Overall Study|Adverse Event|1|||
126161907|NCT02566525|453879670|FG000|Overall Study|Protocol Violation|3|||
126161908|NCT02566525|453879671|FG001|Overall Study|Protocol Violation|5|||
126161909|NCT00337467|453879672|FG000|Overall Study|Adverse Event|3|||
126161910|NCT00337467|453879672|FG000|Overall Study|Subject Withdrew Consent|2|||
126161911|NCT00337467|453879672|FG000|Overall Study|Pregnancy|1|||
126161912|NCT00337467|453879672|FG000|Overall Study|Lost to Follow-up|2|||
126161913|NCT00337467|453879672|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
126161914|NCT02488759|453879673|FG000|Overall Study|Disease progression|73|||
126161915|NCT02488759|453879674|FG001|Overall Study|Disease progression|111|||
126161916|NCT02488759|453879675|FG002|Overall Study|Disease progression|62|||
126161917|NCT02488759|453879676|FG003|Overall Study|Disease progression|7|||
126161918|NCT02488759|453879677|FG004|Overall Study|Disease progression|4|||
126161919|NCT02488759|453879678|FG005|Overall Study|Disease progression|2|||
126161920|NCT02488759|453879673|FG000|Overall Study|Study drug toxicity|11|||
126161921|NCT02488759|453879674|FG001|Overall Study|Study drug toxicity|33|||
126161922|NCT02488759|453879675|FG002|Overall Study|Study drug toxicity|31|||
126161923|NCT02488759|453879676|FG003|Overall Study|Study drug toxicity|0|||
126161924|NCT02488759|453879677|FG004|Overall Study|Study drug toxicity|0|||
126161925|NCT02488759|453879678|FG005|Overall Study|Study drug toxicity|2|||
126161926|NCT02488759|453879673|FG000|Overall Study|Adverse event unrelated to study drug|9|||
126161927|NCT02488759|453879674|FG001|Overall Study|Adverse event unrelated to study drug|11|||
126161928|NCT02488759|453879675|FG002|Overall Study|Adverse event unrelated to study drug|7|||
126161929|NCT02488759|453879676|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126161930|NCT02488759|453879677|FG004|Overall Study|Adverse event unrelated to study drug|1|||
126161931|NCT02488759|453879678|FG005|Overall Study|Adverse event unrelated to study drug|0|||
126161932|NCT02488759|453879673|FG000|Overall Study|Participant request to discontinue study treatment|6|||
126161933|NCT02488759|453879674|FG001|Overall Study|Participant request to discontinue study treatment|8|||
126161934|NCT02488759|453879675|FG002|Overall Study|Participant request to discontinue study treatment|4|||
126161935|NCT02488759|453879676|FG003|Overall Study|Participant request to discontinue study treatment|0|||
126161936|NCT02488759|453879677|FG004|Overall Study|Participant request to discontinue study treatment|0|||
126161937|NCT02488759|453879678|FG005|Overall Study|Participant request to discontinue study treatment|0|||
126161938|NCT02488759|453879673|FG000|Overall Study|Withdrawal by Subject|4|||
126161939|NCT02488759|453879674|FG001|Overall Study|Withdrawal by Subject|0|||
126161940|NCT02488759|453879675|FG002|Overall Study|Withdrawal by Subject|3|||
126161941|NCT02488759|453879676|FG003|Overall Study|Withdrawal by Subject|0|||
126161942|NCT02488759|453879677|FG004|Overall Study|Withdrawal by Subject|0|||
126161943|NCT02488759|453879678|FG005|Overall Study|Withdrawal by Subject|2|||
126161944|NCT02488759|453879673|FG000|Overall Study|Lost to Follow-up|0|||
126161945|NCT02488759|453879674|FG001|Overall Study|Lost to Follow-up|0|||
126161946|NCT02488759|453879675|FG002|Overall Study|Lost to Follow-up|2|||
126161947|NCT02488759|453879676|FG003|Overall Study|Lost to Follow-up|0|||
126161948|NCT02488759|453879677|FG004|Overall Study|Lost to Follow-up|0|||
126161949|NCT02488759|453879678|FG005|Overall Study|Lost to Follow-up|0|||
126161950|NCT02488759|453879673|FG000|Overall Study|Maximum clinical benefit|3|||
126161951|NCT02488759|453879674|FG001|Overall Study|Maximum clinical benefit|0|||
126161952|NCT02488759|453879675|FG002|Overall Study|Maximum clinical benefit|1|||
126161953|NCT02488759|453879676|FG003|Overall Study|Maximum clinical benefit|0|||
126161954|NCT02488759|453879677|FG004|Overall Study|Maximum clinical benefit|0|||
126161955|NCT02488759|453879678|FG005|Overall Study|Maximum clinical benefit|0|||
126161956|NCT02488759|453879673|FG000|Overall Study|Other reasons|7|||
126161957|NCT02488759|453879674|FG001|Overall Study|Other reasons|32|||
126161958|NCT02488759|453879675|FG002|Overall Study|Other reasons|23|||
126161959|NCT02488759|453879676|FG003|Overall Study|Other reasons|1|||
126161960|NCT02488759|453879677|FG004|Overall Study|Other reasons|1|||
126161961|NCT02488759|453879678|FG005|Overall Study|Other reasons|1|||
126161962|NCT04083222|453879679|FG000|Overall Study|Voluntary Withdrawal|0|||
126161963|NCT04083222|453879680|FG001|Overall Study|Voluntary Withdrawal|1|||
126161964|NCT04083222|453879679|FG000|Overall Study|Reason not Specified|0|||
126161965|NCT04083222|453879680|FG001|Overall Study|Reason not Specified|1|||
126161966|NCT03103750|453879681|FG000|Overall Study|Adverse Event|1|||
126161967|NCT03103750|453879682|FG001|Overall Study|Adverse Event|0|||
126161968|NCT03103750|453879681|FG000|Overall Study|Lost to Follow-up|1|||
126161969|NCT03103750|453879682|FG001|Overall Study|Lost to Follow-up|0|||
126161970|NCT03103750|453879681|FG000|Overall Study|PET Equipment Related|2|||
126161971|NCT03103750|453879682|FG001|Overall Study|PET Equipment Related|2|||
126161972|NCT02429427|453879690|FG000|Overall Study|Adverse Event|220|||
126161973|NCT02429427|453879691|FG001|Overall Study|Adverse Event|92|||
126161974|NCT02429427|453879690|FG000|Overall Study|Protocol Violation|10|||
126161975|NCT02429427|453879691|FG001|Overall Study|Protocol Violation|6|||
126161976|NCT02429427|453879690|FG000|Overall Study|Lost to Follow-up|15|||
126161977|NCT02429427|453879691|FG001|Overall Study|Lost to Follow-up|6|||
126161978|NCT02429427|453879690|FG000|Overall Study|Withdrawal by Subject|64|||
126161979|NCT02429427|453879691|FG001|Overall Study|Withdrawal by Subject|34|||
126161980|NCT02429427|453879690|FG000|Overall Study|Other|62|||
126161981|NCT02429427|453879691|FG001|Overall Study|Other|41|||
126161982|NCT00747617|453881349|FG000|Overall Study|Lost to Follow-up|3|||
126161983|NCT00747617|453881350|FG001|Overall Study|Lost to Follow-up|1|||
126161984|NCT01746732|453881351|FG000|Lead-In Period|Withdrawal by Subject|1|||
126161985|NCT01746732|453881352|FG001|Lead-In Period|Withdrawal by Subject|0|||
126161986|NCT01746732|453881353|FG002|Lead-In Period|Withdrawal by Subject|0|||
126161987|NCT01746732|453881351|FG000|Period 1|Physician Decision|0|||
126161988|NCT01746732|453881352|FG001|Period 1|Physician Decision|1|||
126161989|NCT01746732|453881353|FG002|Period 1|Physician Decision|0|||
126161990|NCT01746732|453881351|FG000|Period 2|Withdrawal by Subject|0|||
126161991|NCT01746732|453881352|FG001|Period 2|Withdrawal by Subject|0|||
126161992|NCT01746732|453881353|FG002|Period 2|Withdrawal by Subject|2|||
126161993|NCT01746732|453881351|FG000|Period 2|Adverse Event|0|||
126161994|NCT01746732|453881352|FG001|Period 2|Adverse Event|0|||
126161995|NCT01746732|453881353|FG002|Period 2|Adverse Event|1|||
126161996|NCT01746732|453881351|FG000|Period 2|Lost to Follow-up|0|||
126161997|NCT01746732|453881352|FG001|Period 2|Lost to Follow-up|0|||
126161998|NCT01746732|453881353|FG002|Period 2|Lost to Follow-up|1|||
126161999|NCT02279524|453881354|FG000|Overall Study|Withdrawal by Subject|3|||
126162000|NCT02279524|453881355|FG001|Overall Study|Withdrawal by Subject|6|||
126162001|NCT02279524|453881356|FG002|Overall Study|Withdrawal by Subject|3|||
126162002|NCT02279524|453881354|FG000|Overall Study|Adverse Event|4|||
126162003|NCT02279524|453881355|FG001|Overall Study|Adverse Event|3|||
125972550|NCT04420221|453188833|FG006|Overall Study|Withdrawal by Subject|5|||
125972551|NCT04420221|453188827|FG000|Overall Study|Other|0|||
125972552|NCT04420221|453188828|FG001|Overall Study|Other|0|||
125972553|NCT04420221|453188829|FG002|Overall Study|Other|0|||
125972554|NCT04420221|453188830|FG003|Overall Study|Other|0|||
125972555|NCT04420221|453188831|FG004|Overall Study|Other|0|||
125972556|NCT04420221|453188832|FG005|Overall Study|Other|1|||
125972557|NCT04420221|453188833|FG006|Overall Study|Other|1|||
125972558|NCT04420221|453188827|FG000|Overall Study|Lost to Follow-up|0|||
125972559|NCT04420221|453188828|FG001|Overall Study|Lost to Follow-up|0|||
125972560|NCT04420221|453188829|FG002|Overall Study|Lost to Follow-up|0|||
125972561|NCT04420221|453188830|FG003|Overall Study|Lost to Follow-up|0|||
125972562|NCT04420221|453188831|FG004|Overall Study|Lost to Follow-up|0|||
125972563|NCT04420221|453188832|FG005|Overall Study|Lost to Follow-up|3|||
125972564|NCT04420221|453188833|FG006|Overall Study|Lost to Follow-up|2|||
125972565|NCT04420221|453188827|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
125972566|NCT04420221|453188828|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
125972567|NCT04420221|453188829|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
125972568|NCT04420221|453188830|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
125972569|NCT04420221|453188831|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
125972570|NCT04420221|453188832|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
125972571|NCT04420221|453188833|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
125972572|NCT00511004|453188834|FG000|Overall Study|Lost to Follow-up|0|||
125972573|NCT00511004|453188835|FG001|Overall Study|Lost to Follow-up|0|||
125972574|NCT00511004|453188836|FG002|Overall Study|Lost to Follow-up|4|||
125972575|NCT04642638|453188837|FG000|Overall Study|Withdrawal by Subject|23|||
125972576|NCT04642638|453188838|FG001|Overall Study|Withdrawal by Subject|29|||
125972577|NCT04642638|453188839|FG002|Overall Study|Withdrawal by Subject|9|||
126162004|NCT02279524|453881356|FG002|Overall Study|Adverse Event|2|||
126162005|NCT02279524|453881354|FG000|Overall Study|Lost to Follow-up|1|||
125972578|NCT04642638|453188840|FG003|Overall Study|Withdrawal by Subject|7|||
125972579|NCT04642638|453188841|FG004|Overall Study|Withdrawal by Subject|61|||
125972580|NCT04642638|453188842|FG005|Overall Study|Withdrawal by Subject|27|||
125972581|NCT04642638|453188837|FG000|Overall Study|Lost to Follow-up|17|||
126162006|NCT02279524|453881355|FG001|Overall Study|Lost to Follow-up|1|||
126162007|NCT02279524|453881356|FG002|Overall Study|Lost to Follow-up|0|||
126162008|NCT02279524|453881354|FG000|Overall Study|Disallowed medication|1|||
126162009|NCT02279524|453881355|FG001|Overall Study|Disallowed medication|1|||
126162010|NCT02279524|453881356|FG002|Overall Study|Disallowed medication|2|||
126162011|NCT02279524|453881354|FG000|Overall Study|Bariatric surgery|1|||
126162012|NCT02279524|453881355|FG001|Overall Study|Bariatric surgery|0|||
126162013|NCT02279524|453881356|FG002|Overall Study|Bariatric surgery|0|||
126162014|NCT03509207|453881357|FG000|Overall Study|Death|2|||
126162015|NCT02817555|453881358|FG000|Overall Study|Death|1|||
126162016|NCT02817555|453881359|FG001|Overall Study|Death|3|||
126162017|NCT02817555|453881358|FG000|Overall Study|moved away|1|||
126162018|NCT02817555|453881359|FG001|Overall Study|moved away|0|||
126162019|NCT02817555|453881358|FG000|Overall Study|transplant|1|||
126162020|NCT02817555|453881359|FG001|Overall Study|transplant|1|||
126162021|NCT02817555|453881358|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
126162022|NCT02817555|453881359|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
126162023|NCT00137436|453881360|FG000|Overall Study|Adverse Event|13|||
126162024|NCT00137436|453881360|FG000|Overall Study|Death|2|||
126162025|NCT00137436|453881360|FG000|Overall Study|Lack of Efficacy|17|||
126162026|NCT00137436|453881360|FG000|Overall Study|Withdrawal by Subject|6|||
126162027|NCT00137436|453881360|FG000|Overall Study|Other|5|||
126162028|NCT00165646|453881361|FG000|Overall Study|Adverse Event|1|||
126162029|NCT00165646|453881362|FG001|Overall Study|Adverse Event|1|||
126162030|NCT00165646|453881363|FG002|Overall Study|Adverse Event|1|||
126162031|NCT00165646|453881361|FG000|Overall Study|Lack of Efficacy|1|||
126162032|NCT00165646|453881362|FG001|Overall Study|Lack of Efficacy|2|||
126162033|NCT00165646|453881363|FG002|Overall Study|Lack of Efficacy|0|||
126162034|NCT00165646|453881361|FG000|Overall Study|Withdrawal by Subject|0|||
126162035|NCT00165646|453881362|FG001|Overall Study|Withdrawal by Subject|2|||
126162036|NCT00165646|453881363|FG002|Overall Study|Withdrawal by Subject|1|||
126162037|NCT00165646|453881361|FG000|Overall Study|Physician Decision|2|||
126162038|NCT00165646|453881362|FG001|Overall Study|Physician Decision|0|||
126162039|NCT00165646|453881363|FG002|Overall Study|Physician Decision|2|||
126162040|NCT00165646|453881361|FG000|Overall Study|Protocol Violation|1|||
126162041|NCT00165646|453881362|FG001|Overall Study|Protocol Violation|0|||
126162042|NCT00165646|453881363|FG002|Overall Study|Protocol Violation|0|||
126162043|NCT00912015|453881367|FG000|Overall Study|Lack of Efficacy|1|||
126162044|NCT00912015|453881368|FG001|Overall Study|Lack of Efficacy|0|||
126162045|NCT00912015|453881369|FG002|Overall Study|Lack of Efficacy|0|||
126162046|NCT00912015|453881370|FG003|Overall Study|Lack of Efficacy|0|||
126162047|NCT00912015|453881367|FG000|Overall Study|Withdrawal by Subject|8|||
126162048|NCT00912015|453881368|FG001|Overall Study|Withdrawal by Subject|8|||
126162049|NCT00912015|453881369|FG002|Overall Study|Withdrawal by Subject|3|||
126162050|NCT00912015|453881370|FG003|Overall Study|Withdrawal by Subject|0|||
126162051|NCT00912015|453881367|FG000|Overall Study|Protocol Violation|1|||
126162052|NCT00912015|453881368|FG001|Overall Study|Protocol Violation|0|||
126162053|NCT00912015|453881369|FG002|Overall Study|Protocol Violation|0|||
126162054|NCT00912015|453881370|FG003|Overall Study|Protocol Violation|1|||
126162055|NCT00912015|453881367|FG000|Overall Study|Adverse Event|6|||
126162056|NCT00912015|453881368|FG001|Overall Study|Adverse Event|0|||
126162057|NCT00912015|453881369|FG002|Overall Study|Adverse Event|0|||
126162058|NCT00912015|453881370|FG003|Overall Study|Adverse Event|1|||
126162059|NCT01356602|453881371|FG000|Overall Study|Protocol Deviation|0|||
126162060|NCT01356602|453881372|FG001|Overall Study|Protocol Deviation|1|||
126162061|NCT01356602|453881373|FG002|Overall Study|Protocol Deviation|1|||
126162062|NCT01356602|453881371|FG000|Overall Study|Administrative Problems|1|||
126162063|NCT01356602|453881372|FG001|Overall Study|Administrative Problems|4|||
126162064|NCT01356602|453881373|FG002|Overall Study|Administrative Problems|5|||
126162065|NCT01356602|453881371|FG000|Overall Study|Lost to Follow-up|4|||
126162066|NCT01356602|453881372|FG001|Overall Study|Lost to Follow-up|5|||
126162067|NCT01356602|453881373|FG002|Overall Study|Lost to Follow-up|6|||
126162068|NCT01356602|453881371|FG000|Overall Study|Withdrawal by Subject|4|||
126162069|NCT01356602|453881372|FG001|Overall Study|Withdrawal by Subject|3|||
126162070|NCT01356602|453881373|FG002|Overall Study|Withdrawal by Subject|7|||
126162071|NCT01356602|453881371|FG000|Overall Study|Lack of Efficacy|0|||
126162072|NCT01356602|453881372|FG001|Overall Study|Lack of Efficacy|1|||
126162073|NCT01356602|453881373|FG002|Overall Study|Lack of Efficacy|4|||
126162074|NCT01356602|453881371|FG000|Overall Study|Adverse Event|0|||
125972582|NCT04642638|453188838|FG001|Overall Study|Lost to Follow-up|18|||
125972583|NCT04642638|453188839|FG002|Overall Study|Lost to Follow-up|5|||
126162075|NCT01356602|453881372|FG001|Overall Study|Adverse Event|1|||
126162076|NCT01356602|453881373|FG002|Overall Study|Adverse Event|1|||
126162077|NCT01115569|453881374|FG000|Conversion/Titration Phase|Adverse Event|59|||
126162078|NCT01115569|453881375|FG001|Conversion/Titration Phase|Adverse Event|0|||
126162079|NCT01115569|453881374|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
126162080|NCT01115569|453881375|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
126162081|NCT01115569|453881374|FG000|Conversion/Titration Phase|Physician Decision|5|||
126162082|NCT01115569|453881375|FG001|Conversion/Titration Phase|Physician Decision|0|||
126162083|NCT01115569|453881374|FG000|Conversion/Titration Phase|Protocol Violation|68|||
126162084|NCT01115569|453881375|FG001|Conversion/Titration Phase|Protocol Violation|0|||
126162085|NCT01115569|453881374|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
126162086|NCT01115569|453881375|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
126162087|NCT01115569|453881374|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
126162088|NCT01115569|453881375|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
126162089|NCT01115569|453881374|FG000|Maintenance Phase|Adverse Event|0|||
126162090|NCT01115569|453881375|FG001|Maintenance Phase|Adverse Event|43|||
126162091|NCT01115569|453881374|FG000|Maintenance Phase|Lost to Follow-up|0|||
126162092|NCT01115569|453881375|FG001|Maintenance Phase|Lost to Follow-up|8|||
126162093|NCT01115569|453881374|FG000|Maintenance Phase|Physician Decision|0|||
126162094|NCT01115569|453881375|FG001|Maintenance Phase|Physician Decision|3|||
126162095|NCT01115569|453881374|FG000|Maintenance Phase|Protocol Violation|0|||
126162096|NCT01115569|453881375|FG001|Maintenance Phase|Protocol Violation|9|||
126162097|NCT01115569|453881374|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126162098|NCT01115569|453881375|FG001|Maintenance Phase|Withdrawal by Subject|27|||
126162099|NCT01115569|453881374|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
126162100|NCT01115569|453881375|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
126162101|NCT01115569|453881374|FG000|Maintenance Phase|Administrative|0|||
126162102|NCT01115569|453881375|FG001|Maintenance Phase|Administrative|1|||
126162103|NCT01931462|453881376|FG000|Overall Study|Withdrawal by Subject|1|||
126162104|NCT02819310|453881377|FG000|Overall Study|Withdrawal by Subject|37|||
126162105|NCT02819310|453881377|FG000|Overall Study|Lost to Follow-up|16|||
126162106|NCT02819310|453881377|FG000|Overall Study|Adverse Event|13|||
126162107|NCT02819310|453881377|FG000|Overall Study|Lack of Efficacy|5|||
126162108|NCT02819310|453881377|FG000|Overall Study|Physician Decision|8|||
126162109|NCT02819310|453881377|FG000|Overall Study|Protocol Violation|30|||
126162110|NCT05070429|453881383|FG000|Overall Study|Death|0|||
126162111|NCT05070429|453881384|FG001|Overall Study|Death|4|||
126162112|NCT05070429|453881383|FG000|Overall Study|Withdrawal by Subject|2|||
126162113|NCT05070429|453881384|FG001|Overall Study|Withdrawal by Subject|1|||
126162114|NCT05070429|453881383|FG000|Overall Study|Other|15|||
126162115|NCT05070429|453881384|FG001|Overall Study|Other|5|||
126162116|NCT00943319|453881385|FG000|Overall Study|Death|1|||
126162117|NCT02043301|453881386|FG000|Overall Study|Discontinued|0|||
126162118|NCT02043301|453881387|FG001|Overall Study|Discontinued|1|||
126162119|NCT02043301|453881388|FG002|Overall Study|Discontinued|0|||
126162120|NCT02653976|453881389|FG000|Overall Study|Withdrawal by Subject|5|||
126162121|NCT02653976|453881389|FG000|Overall Study|Death|4|||
126162122|NCT02023164|453881390|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
126162123|NCT02023164|453881391|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
126162124|NCT00883558|453881392|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
126162125|NCT00883558|453881393|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
126162126|NCT00883558|453881394|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
126162127|NCT00883558|453881392|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
126162128|NCT00883558|453881393|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
126162129|NCT00883558|453881394|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
126162130|NCT00883558|453881392|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
126162131|NCT00883558|453881393|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
126162132|NCT00883558|453881394|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
126162133|NCT00883558|453881392|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
126162134|NCT00883558|453881393|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
126162135|NCT00883558|453881394|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
126162136|NCT00883558|453881392|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
126162137|NCT00883558|453881393|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
126162138|NCT00883558|453881394|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
126162139|NCT03703375|453881395|FG000|Randomization Period|Withdrawal by Subject|0|||
126162140|NCT03703375|453881396|FG001|Randomization Period|Withdrawal by Subject|0|||
126162141|NCT03703375|453881397|FG002|Randomization Period|Withdrawal by Subject|0|||
126162142|NCT03703375|453881398|FG003|Randomization Period|Withdrawal by Subject|1|||
126162143|NCT03703375|453881395|FG000|Randomization Period|Completed safety run-in treatment|7|||
126162144|NCT03703375|453881396|FG001|Randomization Period|Completed safety run-in treatment|0|||
126162145|NCT03703375|453881397|FG002|Randomization Period|Completed safety run-in treatment|0|||
126162146|NCT03703375|453881398|FG003|Randomization Period|Completed safety run-in treatment|0|||
126162147|NCT03703375|453881395|FG000|Treatment Period|Other Reasons|0|||
126162148|NCT03703375|453881396|FG001|Treatment Period|Other Reasons|1|||
126162149|NCT03703375|453881397|FG002|Treatment Period|Other Reasons|0|||
126162150|NCT03703375|453881398|FG003|Treatment Period|Other Reasons|3|||
126162151|NCT03703375|453881395|FG000|Treatment Period|Consent Withdrawal|0|||
126162152|NCT03703375|453881396|FG001|Treatment Period|Consent Withdrawal|0|||
126162153|NCT03703375|453881397|FG002|Treatment Period|Consent Withdrawal|0|||
126162154|NCT03703375|453881398|FG003|Treatment Period|Consent Withdrawal|1|||
126162155|NCT03703375|453881395|FG000|Treatment Period|Death|1|||
126162156|NCT03703375|453881396|FG001|Treatment Period|Death|0|||
126162157|NCT03703375|453881397|FG002|Treatment Period|Death|1|||
126162158|NCT03703375|453881398|FG003|Treatment Period|Death|2|||
126162159|NCT03703375|453881395|FG000|Treatment Period|Toxicity of Study Treatment|2|||
126162160|NCT03703375|453881396|FG001|Treatment Period|Toxicity of Study Treatment|0|||
126162161|NCT03703375|453881397|FG002|Treatment Period|Toxicity of Study Treatment|4|||
126162162|NCT03703375|453881398|FG003|Treatment Period|Toxicity of Study Treatment|1|||
126162163|NCT03703375|453881395|FG000|Treatment Period|Progression|32|||
126162164|NCT03703375|453881396|FG001|Treatment Period|Progression|1|||
126162165|NCT03703375|453881397|FG002|Treatment Period|Progression|7|||
126162166|NCT03703375|453881398|FG003|Treatment Period|Progression|11|||
126162167|NCT03703375|453881395|FG000|Treatment Period|Completed treatment|7|||
126162168|NCT03703375|453881396|FG001|Treatment Period|Completed treatment|2|||
126162169|NCT03703375|453881397|FG002|Treatment Period|Completed treatment|0|||
126162170|NCT03703375|453881398|FG003|Treatment Period|Completed treatment|0|||
126162171|NCT01781429|453881400|FG000|Overall Study|Death|0|||
126162172|NCT01781429|453881401|FG001|Overall Study|Death|0|||
126162173|NCT01781429|453881402|FG002|Overall Study|Death|0|||
126162174|NCT01781429|453881403|FG003|Overall Study|Death|0|||
126162175|NCT01781429|453881404|FG004|Overall Study|Death|0|||
126162176|NCT01781429|453881405|FG005|Overall Study|Death|0|||
126162177|NCT01781429|453881406|FG006|Overall Study|Death|0|||
126162178|NCT01781429|453881407|FG007|Overall Study|Death|0|||
126162179|NCT01781429|453881408|FG008|Overall Study|Death|0|||
126162180|NCT01781429|453881409|FG009|Overall Study|Death|1|||
126162181|NCT01781429|453881410|FG010|Overall Study|Death|0|||
126162182|NCT01781429|453881411|FG011|Overall Study|Death|0|||
126162183|NCT01781429|453881412|FG012|Overall Study|Death|1|||
126162184|NCT01781429|453881413|FG013|Overall Study|Death|0|||
126162185|NCT01781429|453881414|FG014|Overall Study|Death|1|||
126162186|NCT01781429|453881415|FG015|Overall Study|Death|0|||
126162187|NCT01781429|453881400|FG000|Overall Study|Withdrawal by Subject|0|||
126162188|NCT01781429|453881401|FG001|Overall Study|Withdrawal by Subject|0|||
126162189|NCT01781429|453881402|FG002|Overall Study|Withdrawal by Subject|0|||
126162190|NCT01781429|453881403|FG003|Overall Study|Withdrawal by Subject|0|||
126162191|NCT01781429|453881404|FG004|Overall Study|Withdrawal by Subject|0|||
126162192|NCT01781429|453881405|FG005|Overall Study|Withdrawal by Subject|0|||
126162193|NCT01781429|453881406|FG006|Overall Study|Withdrawal by Subject|0|||
126162194|NCT01781429|453881407|FG007|Overall Study|Withdrawal by Subject|0|||
126162195|NCT01781429|453881408|FG008|Overall Study|Withdrawal by Subject|1|||
126162196|NCT01781429|453881409|FG009|Overall Study|Withdrawal by Subject|3|||
126162197|NCT01781429|453881410|FG010|Overall Study|Withdrawal by Subject|1|||
126162198|NCT01781429|453881411|FG011|Overall Study|Withdrawal by Subject|1|||
126162199|NCT01781429|453881412|FG012|Overall Study|Withdrawal by Subject|5|||
126162200|NCT01781429|453881413|FG013|Overall Study|Withdrawal by Subject|2|||
126162201|NCT01781429|453881414|FG014|Overall Study|Withdrawal by Subject|3|||
126162202|NCT01781429|453881415|FG015|Overall Study|Withdrawal by Subject|0|||
126162203|NCT01781429|453881400|FG000|Overall Study|Disease Progression|1|||
126162204|NCT01781429|453881401|FG001|Overall Study|Disease Progression|0|||
126162205|NCT01781429|453881402|FG002|Overall Study|Disease Progression|1|||
126162206|NCT01781429|453881403|FG003|Overall Study|Disease Progression|1|||
126162207|NCT01781429|453881404|FG004|Overall Study|Disease Progression|1|||
126162208|NCT01781429|453881405|FG005|Overall Study|Disease Progression|4|||
126162209|NCT01781429|453881406|FG006|Overall Study|Disease Progression|7|||
126162210|NCT01781429|453881407|FG007|Overall Study|Disease Progression|4|||
126162211|NCT01781429|453881408|FG008|Overall Study|Disease Progression|6|||
126162212|NCT01781429|453881409|FG009|Overall Study|Disease Progression|15|||
126162213|NCT01781429|453881410|FG010|Overall Study|Disease Progression|15|||
126162214|NCT01781429|453881411|FG011|Overall Study|Disease Progression|15|||
126162215|NCT01781429|453881412|FG012|Overall Study|Disease Progression|15|||
126162216|NCT01781429|453881413|FG013|Overall Study|Disease Progression|4|||
126162217|NCT01781429|453881414|FG014|Overall Study|Disease Progression|11|||
126162218|NCT01781429|453881415|FG015|Overall Study|Disease Progression|0|||
126162219|NCT01781429|453881400|FG000|Overall Study|Unacceptable Toxicity|0|||
126162220|NCT01781429|453881401|FG001|Overall Study|Unacceptable Toxicity|0|||
126162221|NCT01781429|453881402|FG002|Overall Study|Unacceptable Toxicity|0|||
126162222|NCT01781429|453881403|FG003|Overall Study|Unacceptable Toxicity|0|||
126162223|NCT01781429|453881404|FG004|Overall Study|Unacceptable Toxicity|0|||
126162224|NCT01781429|453881405|FG005|Overall Study|Unacceptable Toxicity|0|||
126162225|NCT01781429|453881406|FG006|Overall Study|Unacceptable Toxicity|0|||
126162226|NCT01781429|453881407|FG007|Overall Study|Unacceptable Toxicity|0|||
126162227|NCT01781429|453881408|FG008|Overall Study|Unacceptable Toxicity|0|||
126162228|NCT01781429|453881409|FG009|Overall Study|Unacceptable Toxicity|0|||
126162229|NCT01781429|453881410|FG010|Overall Study|Unacceptable Toxicity|0|||
126162230|NCT01781429|453881411|FG011|Overall Study|Unacceptable Toxicity|2|||
126162231|NCT01781429|453881412|FG012|Overall Study|Unacceptable Toxicity|0|||
126162232|NCT01781429|453881413|FG013|Overall Study|Unacceptable Toxicity|0|||
126162233|NCT01781429|453881414|FG014|Overall Study|Unacceptable Toxicity|0|||
126162234|NCT01781429|453881415|FG015|Overall Study|Unacceptable Toxicity|0|||
126162235|NCT01781429|453881400|FG000|Overall Study|Patient Condition Changed|0|||
126162236|NCT01781429|453881401|FG001|Overall Study|Patient Condition Changed|0|||
126162237|NCT01781429|453881402|FG002|Overall Study|Patient Condition Changed|0|||
126162238|NCT01781429|453881403|FG003|Overall Study|Patient Condition Changed|0|||
126162239|NCT01781429|453881404|FG004|Overall Study|Patient Condition Changed|0|||
126162240|NCT01781429|453881405|FG005|Overall Study|Patient Condition Changed|0|||
126162241|NCT01781429|453881406|FG006|Overall Study|Patient Condition Changed|0|||
126162242|NCT01781429|453881407|FG007|Overall Study|Patient Condition Changed|0|||
126162243|NCT01781429|453881408|FG008|Overall Study|Patient Condition Changed|0|||
126162244|NCT01781429|453881409|FG009|Overall Study|Patient Condition Changed|4|||
126162245|NCT01781429|453881410|FG010|Overall Study|Patient Condition Changed|0|||
126162246|NCT01781429|453881411|FG011|Overall Study|Patient Condition Changed|1|||
126162247|NCT01781429|453881412|FG012|Overall Study|Patient Condition Changed|0|||
126162248|NCT01781429|453881413|FG013|Overall Study|Patient Condition Changed|1|||
126162249|NCT01781429|453881414|FG014|Overall Study|Patient Condition Changed|0|||
126162250|NCT01781429|453881415|FG015|Overall Study|Patient Condition Changed|0|||
126162251|NCT01781429|453881400|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
126162252|NCT01781429|453881401|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
126162253|NCT01781429|453881402|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
126162254|NCT01781429|453881403|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
126162255|NCT01781429|453881404|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
126162256|NCT01781429|453881405|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
126162257|NCT01781429|453881406|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
126162258|NCT01781429|453881407|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
126162259|NCT01781429|453881408|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
126162260|NCT01781429|453881409|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
126162261|NCT01781429|453881410|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
126162262|NCT01781429|453881411|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
126162263|NCT01781429|453881412|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
126162264|NCT01781429|453881413|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
126162265|NCT01781429|453881414|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
126162266|NCT01781429|453881415|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
126162267|NCT01781429|453881400|FG000|Overall Study|Enrolled, but not treated|0|||
126162268|NCT01781429|453881401|FG001|Overall Study|Enrolled, but not treated|0|||
126162269|NCT01781429|453881402|FG002|Overall Study|Enrolled, but not treated|0|||
126162270|NCT01781429|453881403|FG003|Overall Study|Enrolled, but not treated|0|||
126162271|NCT01781429|453881404|FG004|Overall Study|Enrolled, but not treated|0|||
126162272|NCT01781429|453881405|FG005|Overall Study|Enrolled, but not treated|0|||
126162273|NCT01781429|453881406|FG006|Overall Study|Enrolled, but not treated|0|||
126162274|NCT01781429|453881407|FG007|Overall Study|Enrolled, but not treated|0|||
126162275|NCT01781429|453881408|FG008|Overall Study|Enrolled, but not treated|0|||
126162276|NCT01781429|453881409|FG009|Overall Study|Enrolled, but not treated|0|||
126162277|NCT01781429|453881410|FG010|Overall Study|Enrolled, but not treated|1|||
126162278|NCT01781429|453881411|FG011|Overall Study|Enrolled, but not treated|0|||
126162279|NCT01781429|453881412|FG012|Overall Study|Enrolled, but not treated|0|||
126162280|NCT01781429|453881413|FG013|Overall Study|Enrolled, but not treated|0|||
126162281|NCT01781429|453881414|FG014|Overall Study|Enrolled, but not treated|0|||
126162282|NCT01781429|453881415|FG015|Overall Study|Enrolled, but not treated|0|||
126162283|NCT02678741|453881416|FG000|Overall Study|Death|4|||
126162284|NCT02678741|453881416|FG000|Overall Study|Withdrawal by Subject|1|||
126162285|NCT02678741|453881416|FG000|Overall Study|ineligible|3|||
126162286|NCT02678741|453881416|FG000|Overall Study|Not RECIST Measurable|2|||
126162287|NCT02678741|453881416|FG000|Overall Study|Lack of Efficacy|10|||
126162288|NCT00903032|453881417|FG000|Overall Study|Withdrawal by Subject|5|||
126162289|NCT00903032|453881418|FG001|Overall Study|Withdrawal by Subject|3|||
126162290|NCT00903032|453881417|FG000|Overall Study|Lost to Follow-up|2|||
126162291|NCT00903032|453881418|FG001|Overall Study|Lost to Follow-up|2|||
126162292|NCT01809262|453881430|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162293|NCT01809262|453881431|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162294|NCT01809262|453881432|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162295|NCT01809262|453881433|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162296|NCT01809262|453881434|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
126162297|NCT01809262|453881435|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162298|NCT01809262|453881436|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162299|NCT01809262|453881437|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162300|NCT01809262|453881438|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162301|NCT01809262|453881439|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
126162302|NCT01809262|453881430|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126162303|NCT01809262|453881431|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
126162304|NCT01809262|453881432|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125972584|NCT04642638|453188840|FG003|Overall Study|Lost to Follow-up|5|||
125972585|NCT04642638|453188841|FG004|Overall Study|Lost to Follow-up|6|||
125972586|NCT04642638|453188842|FG005|Overall Study|Lost to Follow-up|3|||
125972587|NCT04642638|453188837|FG000|Overall Study|Adverse Event|0|||
126162305|NCT01809262|453881433|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125972588|NCT04642638|453188838|FG001|Overall Study|Adverse Event|0|||
126162306|NCT01809262|453881434|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126162307|NCT01809262|453881435|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126162308|NCT01809262|453881436|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126162309|NCT01809262|453881437|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126162310|NCT01809262|453881438|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125972589|NCT04642638|453188839|FG002|Overall Study|Adverse Event|1|||
125972590|NCT04642638|453188840|FG003|Overall Study|Adverse Event|0|||
126162311|NCT01809262|453881439|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126162312|NCT02064439|453881441|FG000|Overall Study|Adverse Event|51|||
126162313|NCT02064439|453881442|FG001|Overall Study|Adverse Event|47|||
126162314|NCT02064439|453881443|FG002|Overall Study|Adverse Event|46|||
126162315|NCT02064439|453881441|FG000|Overall Study|Death|0|||
126162316|NCT02064439|453881442|FG001|Overall Study|Death|2|||
126162317|NCT02064439|453881443|FG002|Overall Study|Death|3|||
126162318|NCT02064439|453881441|FG000|Overall Study|Withdrawal by Subject|29|||
126162319|NCT02064439|453881442|FG001|Overall Study|Withdrawal by Subject|18|||
126162320|NCT02064439|453881443|FG002|Overall Study|Withdrawal by Subject|26|||
126162321|NCT02064439|453881441|FG000|Overall Study|Protocol Violation|3|||
126162322|NCT02064439|453881442|FG001|Overall Study|Protocol Violation|5|||
126162323|NCT02064439|453881443|FG002|Overall Study|Protocol Violation|3|||
126162324|NCT02064439|453881441|FG000|Overall Study|Lost to Follow-up|1|||
126162325|NCT02064439|453881442|FG001|Overall Study|Lost to Follow-up|3|||
126162326|NCT02064439|453881443|FG002|Overall Study|Lost to Follow-up|4|||
126162327|NCT02064439|453881441|FG000|Overall Study|Non-compliance with study medication|21|||
126162328|NCT02064439|453881442|FG001|Overall Study|Non-compliance with study medication|19|||
126162329|NCT02064439|453881443|FG002|Overall Study|Non-compliance with study medication|23|||
126162330|NCT02064439|453881441|FG000|Overall Study|Physician Decision|0|||
126162331|NCT02064439|453881442|FG001|Overall Study|Physician Decision|1|||
126162332|NCT02064439|453881443|FG002|Overall Study|Physician Decision|1|||
126162333|NCT02064439|453881441|FG000|Overall Study|Logistical difficulties|6|||
126162334|NCT02064439|453881442|FG001|Overall Study|Logistical difficulties|5|||
126162335|NCT02064439|453881443|FG002|Overall Study|Logistical difficulties|2|||
126162336|NCT02064439|453881441|FG000|Overall Study|Efficacy outcome reached|18|||
126162337|NCT02064439|453881442|FG001|Overall Study|Efficacy outcome reached|16|||
126162338|NCT02064439|453881443|FG002|Overall Study|Efficacy outcome reached|57|||
126162339|NCT02064439|453881441|FG000|Overall Study|Safety outcome reached|12|||
126162340|NCT02064439|453881442|FG001|Overall Study|Safety outcome reached|20|||
126162341|NCT02064439|453881443|FG002|Overall Study|Safety outcome reached|10|||
126162342|NCT02064439|453881441|FG000|Overall Study|Other|2|||
126162343|NCT02064439|453881442|FG001|Overall Study|Other|2|||
126162344|NCT02064439|453881443|FG002|Overall Study|Other|7|||
126162345|NCT01120093|453881448|FG000|Treatment Period 1|Adverse Event|0|||
126162346|NCT01120093|453881449|FG001|Treatment Period 1|Adverse Event|0|||
126162347|NCT01120093|453881450|FG002|Treatment Period 1|Adverse Event|1|||
126162348|NCT01120093|453881451|FG003|Treatment Period 1|Adverse Event|0|||
126162349|NCT01120093|453881452|FG004|Treatment Period 1|Adverse Event|1|||
126162350|NCT01120093|453881448|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126162351|NCT01120093|453881449|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126162352|NCT01120093|453881450|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126162353|NCT01120093|453881451|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126162354|NCT01120093|453881452|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126162355|NCT01120093|453881448|FG000|Treatment Period 2|Adverse Event|0|||
126162356|NCT01120093|453881449|FG001|Treatment Period 2|Adverse Event|0|||
126162357|NCT01120093|453881450|FG002|Treatment Period 2|Adverse Event|0|||
126162358|NCT01120093|453881451|FG003|Treatment Period 2|Adverse Event|1|||
126162359|NCT01120093|453881452|FG004|Treatment Period 2|Adverse Event|0|||
126162360|NCT01120093|453881448|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126162361|NCT01120093|453881449|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126162362|NCT01120093|453881450|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126162363|NCT01120093|453881451|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126162364|NCT01120093|453881452|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126162365|NCT01120093|453881448|FG000|Treatment Period 3|Lack of Efficacy|0|||
126162366|NCT01120093|453881449|FG001|Treatment Period 3|Lack of Efficacy|0|||
126162367|NCT01120093|453881450|FG002|Treatment Period 3|Lack of Efficacy|0|||
126162368|NCT01120093|453881451|FG003|Treatment Period 3|Lack of Efficacy|1|||
126162369|NCT01120093|453881452|FG004|Treatment Period 3|Lack of Efficacy|0|||
126162370|NCT01120093|453881448|FG000|Treatment Period 3|Adverse Event|0|||
126162371|NCT01120093|453881449|FG001|Treatment Period 3|Adverse Event|0|||
126162372|NCT01120093|453881450|FG002|Treatment Period 3|Adverse Event|0|||
126162373|NCT01120093|453881451|FG003|Treatment Period 3|Adverse Event|0|||
126162374|NCT01120093|453881452|FG004|Treatment Period 3|Adverse Event|1|||
126162375|NCT01120093|453881448|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126162376|NCT01120093|453881449|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126162377|NCT01120093|453881450|FG002|Treatment Period 3|Withdrawal by Subject|1|||
126162378|NCT01120093|453881451|FG003|Treatment Period 3|Withdrawal by Subject|0|||
126162379|NCT01120093|453881452|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126162380|NCT01120093|453881448|FG000|Treatment Period 4|Adverse Event|1|||
126162381|NCT01120093|453881449|FG001|Treatment Period 4|Adverse Event|0|||
126162382|NCT01120093|453881450|FG002|Treatment Period 4|Adverse Event|0|||
126162383|NCT01120093|453881451|FG003|Treatment Period 4|Adverse Event|0|||
126162384|NCT01120093|453881452|FG004|Treatment Period 4|Adverse Event|0|||
126162385|NCT01120093|453881448|FG000|Treatment Period 5|Adverse Event|0|||
126162386|NCT01120093|453881449|FG001|Treatment Period 5|Adverse Event|1|||
126162387|NCT01120093|453881450|FG002|Treatment Period 5|Adverse Event|0|||
126162388|NCT01120093|453881451|FG003|Treatment Period 5|Adverse Event|1|||
126162389|NCT01120093|453881452|FG004|Treatment Period 5|Adverse Event|0|||
126162390|NCT02389816|453881457|FG000|Overall Study|Randomized but Not Treated|1|||
126162391|NCT02389816|453881458|FG001|Overall Study|Randomized but Not Treated|0|||
126162392|NCT02389816|453881459|FG002|Overall Study|Randomized but Not Treated|0|||
126162393|NCT02389816|453881457|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
126162394|NCT02389816|453881458|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
126162395|NCT02389816|453881459|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
126162396|NCT02389816|453881457|FG000|Overall Study|Major Protocol Deviation|1|||
126162397|NCT02389816|453881458|FG001|Overall Study|Major Protocol Deviation|0|||
126162398|NCT02389816|453881459|FG002|Overall Study|Major Protocol Deviation|0|||
126162399|NCT02389816|453881457|FG000|Overall Study|Lost to Follow-up|1|||
126162400|NCT02389816|453881458|FG001|Overall Study|Lost to Follow-up|0|||
126162401|NCT02389816|453881459|FG002|Overall Study|Lost to Follow-up|0|||
126162402|NCT02389816|453881457|FG000|Overall Study|Withdrawal of Consent|6|||
126162403|NCT02389816|453881458|FG001|Overall Study|Withdrawal of Consent|4|||
126162404|NCT02389816|453881459|FG002|Overall Study|Withdrawal of Consent|4|||
126162405|NCT02389816|453881457|FG000|Overall Study|Lack of Efficacy|1|||
126162406|NCT02389816|453881458|FG001|Overall Study|Lack of Efficacy|0|||
126162407|NCT02389816|453881459|FG002|Overall Study|Lack of Efficacy|0|||
126162408|NCT02389816|453881457|FG000|Overall Study|Non Compliance with Study Drug|1|||
126162409|NCT02389816|453881458|FG001|Overall Study|Non Compliance with Study Drug|1|||
126162410|NCT02389816|453881459|FG002|Overall Study|Non Compliance with Study Drug|1|||
126162411|NCT02389816|453881457|FG000|Overall Study|Reason not Specified|0|||
126162412|NCT02389816|453881458|FG001|Overall Study|Reason not Specified|2|||
126162413|NCT02389816|453881459|FG002|Overall Study|Reason not Specified|0|||
126162414|NCT02417233|453881460|FG000|Overall Study|Death|4|||
126162415|NCT02417233|453881461|FG001|Overall Study|Death|10|||
126162416|NCT02417233|453881462|FG002|Overall Study|Death|14|||
126162417|NCT02417233|453881460|FG000|Overall Study|Lost to Follow-up|27|||
126162418|NCT02417233|453881461|FG001|Overall Study|Lost to Follow-up|39|||
126162419|NCT02417233|453881462|FG002|Overall Study|Lost to Follow-up|34|||
126162420|NCT02417233|453881460|FG000|Overall Study|Protocol Violation|2|||
126162421|NCT02417233|453881461|FG001|Overall Study|Protocol Violation|0|||
126162422|NCT02417233|453881462|FG002|Overall Study|Protocol Violation|2|||
126162423|NCT02417233|453881460|FG000|Overall Study|Withdrawal by Subject|2|||
126162424|NCT02417233|453881461|FG001|Overall Study|Withdrawal by Subject|1|||
126162425|NCT02417233|453881462|FG002|Overall Study|Withdrawal by Subject|8|||
126162426|NCT02417233|453881460|FG000|Overall Study|Relocation out of study area|1|||
126162427|NCT02417233|453881461|FG001|Overall Study|Relocation out of study area|0|||
126162428|NCT02417233|453881462|FG002|Overall Study|Relocation out of study area|1|||
126162429|NCT02417233|453881460|FG000|Overall Study|Mentally unstable|0|||
126162430|NCT02417233|453881461|FG001|Overall Study|Mentally unstable|1|||
126162431|NCT02417233|453881462|FG002|Overall Study|Mentally unstable|0|||
126162432|NCT03649321|453881463|FG000|Overall Study|Withdrawal by Subject|1|||
126162433|NCT03649321|453881464|FG001|Overall Study|Withdrawal by Subject|0|||
126162434|NCT03649321|453881463|FG000|Overall Study|Death|1|||
126162435|NCT03649321|453881464|FG001|Overall Study|Death|0|||
126162436|NCT01702363|453881465|FG000|Overall Study|Adverse Event|14|||
126162437|NCT01702363|453881465|FG000|Overall Study|Lack of Efficacy|4|||
126162438|NCT01702363|453881465|FG000|Overall Study|Withdrawal by Subject|2|||
126162439|NCT01293032|453881466|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
126162440|NCT01293032|453881467|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
126162441|NCT01293032|453881468|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
126162442|NCT01293032|453881469|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
126162443|NCT01293032|453881466|FG000|Treatment|Adverse Event|0|||
126162444|NCT01293032|453881467|FG001|Treatment|Adverse Event|0|||
125972591|NCT04642638|453188841|FG004|Overall Study|Adverse Event|10|||
125972592|NCT04642638|453188842|FG005|Overall Study|Adverse Event|3|||
125972593|NCT04642638|453188837|FG000|Overall Study|Reason Not Specified|1|||
126162445|NCT01293032|453881468|FG002|Treatment|Adverse Event|1|||
126162446|NCT01293032|453881469|FG003|Treatment|Adverse Event|1|||
126162447|NCT01293032|453881466|FG000|Treatment|Withdrawal by Subject|2|||
126162448|NCT01293032|453881467|FG001|Treatment|Withdrawal by Subject|4|||
126162449|NCT01293032|453881468|FG002|Treatment|Withdrawal by Subject|0|||
126162450|NCT01293032|453881469|FG003|Treatment|Withdrawal by Subject|0|||
126162451|NCT01293032|453881466|FG000|Treatment|Disease Progression, relapse|0|||
126162452|NCT01293032|453881467|FG001|Treatment|Disease Progression, relapse|1|||
126162453|NCT01293032|453881468|FG002|Treatment|Disease Progression, relapse|0|||
126162454|NCT01293032|453881469|FG003|Treatment|Disease Progression, relapse|0|||
126162455|NCT02184143|453881476|FG000|Overall Study|Withdrawal by Subject|4|||
126162456|NCT02184143|453881477|FG001|Overall Study|Withdrawal by Subject|4|||
126162457|NCT02184143|453881476|FG000|Overall Study|Lost to Follow-up|5|||
126162458|NCT02184143|453881477|FG001|Overall Study|Lost to Follow-up|3|||
126162459|NCT02184143|453881476|FG000|Overall Study|Death|1|||
126162460|NCT02184143|453881477|FG001|Overall Study|Death|0|||
126162461|NCT00321984|453881478|FG000|Overall Study|Adverse Event|9|||
126162462|NCT00321984|453881479|FG001|Overall Study|Adverse Event|6|||
126162463|NCT00321984|453881480|FG002|Overall Study|Adverse Event|8|||
126162464|NCT00321984|453881478|FG000|Overall Study|Protocol Violation|0|||
126162465|NCT00321984|453881479|FG001|Overall Study|Protocol Violation|1|||
126162466|NCT00321984|453881480|FG002|Overall Study|Protocol Violation|1|||
125972594|NCT04642638|453188838|FG001|Overall Study|Reason Not Specified|4|||
125972595|NCT04642638|453188839|FG002|Overall Study|Reason Not Specified|0|||
125972596|NCT04642638|453188840|FG003|Overall Study|Reason Not Specified|0|||
125972597|NCT04642638|453188841|FG004|Overall Study|Reason Not Specified|38|||
125972598|NCT04642638|453188842|FG005|Overall Study|Reason Not Specified|16|||
125972599|NCT04642638|453188837|FG000|Overall Study|Physician Decision|0|||
125972600|NCT04642638|453188838|FG001|Overall Study|Physician Decision|0|||
125972601|NCT04642638|453188839|FG002|Overall Study|Physician Decision|0|||
125972602|NCT04642638|453188840|FG003|Overall Study|Physician Decision|0|||
125972603|NCT04642638|453188841|FG004|Overall Study|Physician Decision|2|||
125972604|NCT04642638|453188842|FG005|Overall Study|Physician Decision|1|||
125972605|NCT04642638|453188837|FG000|Overall Study|Protocol Deviation|0|||
125972606|NCT04642638|453188838|FG001|Overall Study|Protocol Deviation|0|||
125972607|NCT04642638|453188839|FG002|Overall Study|Protocol Deviation|0|||
125972608|NCT04642638|453188840|FG003|Overall Study|Protocol Deviation|0|||
125972609|NCT04642638|453188841|FG004|Overall Study|Protocol Deviation|1|||
125972610|NCT04642638|453188842|FG005|Overall Study|Protocol Deviation|3|||
125972611|NCT04642638|453188837|FG000|Overall Study|Study Terminated|0|||
125972612|NCT04642638|453188838|FG001|Overall Study|Study Terminated|0|||
125972613|NCT04642638|453188839|FG002|Overall Study|Study Terminated|0|||
125972614|NCT04642638|453188840|FG003|Overall Study|Study Terminated|0|||
125972615|NCT04642638|453188841|FG004|Overall Study|Study Terminated|484|||
125972616|NCT04642638|453188842|FG005|Overall Study|Study Terminated|250|||
125972617|NCT04642638|453188837|FG000|Overall Study|Pregnancy|0|||
125972618|NCT04642638|453188838|FG001|Overall Study|Pregnancy|0|||
125972619|NCT04642638|453188839|FG002|Overall Study|Pregnancy|0|||
125972620|NCT04642638|453188840|FG003|Overall Study|Pregnancy|0|||
125972621|NCT04642638|453188841|FG004|Overall Study|Pregnancy|1|||
125972622|NCT04642638|453188842|FG005|Overall Study|Pregnancy|0|||
125972623|NCT02085408|453188846|FG000|Step 1: Induction|Disease Progression|19|||
125972624|NCT02085408|453188847|FG001|Step 1: Induction|Disease Progression|19|||
125972625|NCT02085408|453188846|FG000|Step 1: Induction|Adverse Event|18|||
125972626|NCT02085408|453188847|FG001|Step 1: Induction|Adverse Event|17|||
125972627|NCT02085408|453188846|FG000|Step 1: Induction|Death|33|||
125972628|NCT02085408|453188847|FG001|Step 1: Induction|Death|30|||
125972629|NCT02085408|453188846|FG000|Step 1: Induction|Withdrawal by Subject|16|||
125972630|NCT02085408|453188847|FG001|Step 1: Induction|Withdrawal by Subject|8|||
125972631|NCT02085408|453188846|FG000|Step 1: Induction|Alternative Therapy|15|||
125972632|NCT02085408|453188847|FG001|Step 1: Induction|Alternative Therapy|19|||
125972633|NCT02085408|453188846|FG000|Step 1: Induction|Complicating Disease|2|||
125972634|NCT02085408|453188847|FG001|Step 1: Induction|Complicating Disease|3|||
125972635|NCT02085408|453188846|FG000|Step 1: Induction|Other|27|||
125972636|NCT02085408|453188847|FG001|Step 1: Induction|Other|39|||
125972637|NCT02085408|453188846|FG000|Step 1: Induction|Never started treatment|6|||
125972638|NCT02085408|453188847|FG001|Step 1: Induction|Never started treatment|4|||
125972639|NCT02085408|453188846|FG000|Step 2: Consolidation|Disease Progression|5|||
125972640|NCT02085408|453188847|FG001|Step 2: Consolidation|Disease Progression|20|||
125972641|NCT02085408|453188846|FG000|Step 2: Consolidation|Adverse Event|9|||
125972642|NCT02085408|453188847|FG001|Step 2: Consolidation|Adverse Event|8|||
125972643|NCT02085408|453188846|FG000|Step 2: Consolidation|Death|4|||
125972644|NCT02085408|453188847|FG001|Step 2: Consolidation|Death|3|||
125972645|NCT02085408|453188846|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
125972646|NCT02085408|453188847|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
125972647|NCT02085408|453188846|FG000|Step 2: Consolidation|Alternative Therapy|9|||
125972648|NCT02085408|453188847|FG001|Step 2: Consolidation|Alternative Therapy|3|||
125972649|NCT02085408|453188846|FG000|Step 2: Consolidation|Complicating Disease|0|||
125972650|NCT02085408|453188847|FG001|Step 2: Consolidation|Complicating Disease|2|||
125972651|NCT02085408|453188846|FG000|Step 2: Consolidation|Other|6|||
125972652|NCT02085408|453188847|FG001|Step 2: Consolidation|Other|6|||
125972653|NCT02085408|453188846|FG000|Step 2: Consolidation|Never started treatment|4|||
125972654|NCT02085408|453188847|FG001|Step 2: Consolidation|Never started treatment|3|||
125972655|NCT02085408|453188846|FG000|Step 3: Maintenance|Disease Progression|13|||
125972656|NCT02085408|453188847|FG001|Step 3: Maintenance|Disease Progression|11|||
125972657|NCT02085408|453188846|FG000|Step 3: Maintenance|Adverse Event|2|||
125972658|NCT02085408|453188847|FG001|Step 3: Maintenance|Adverse Event|4|||
125972659|NCT02085408|453188846|FG000|Step 3: Maintenance|Death|1|||
125972660|NCT02085408|453188847|FG001|Step 3: Maintenance|Death|2|||
125972661|NCT02085408|453188846|FG000|Step 3: Maintenance|Alternative Therapy|1|||
125972662|NCT02085408|453188847|FG001|Step 3: Maintenance|Alternative Therapy|1|||
125972663|NCT02085408|453188846|FG000|Step 3: Maintenance|Complicating Disease|0|||
125972664|NCT02085408|453188847|FG001|Step 3: Maintenance|Complicating Disease|1|||
125972665|NCT02085408|453188846|FG000|Step 3: Maintenance|Other|3|||
125972666|NCT02085408|453188847|FG001|Step 3: Maintenance|Other|2|||
125972667|NCT02085408|453188846|FG000|Step 3: Maintenance|Never started treatment|5|||
126162467|NCT00321984|453881478|FG000|Overall Study|Lost to Follow-up|2|||
126162468|NCT00321984|453881479|FG001|Overall Study|Lost to Follow-up|4|||
126162469|NCT00321984|453881480|FG002|Overall Study|Lost to Follow-up|2|||
126162470|NCT00321984|453881478|FG000|Overall Study|Withdrawal by Subject|8|||
126162471|NCT00321984|453881479|FG001|Overall Study|Withdrawal by Subject|6|||
126162472|NCT00321984|453881480|FG002|Overall Study|Withdrawal by Subject|5|||
126162473|NCT00321984|453881478|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
126162474|NCT00321984|453881479|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
126162475|NCT00321984|453881480|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
126162476|NCT00321984|453881478|FG000|Overall Study|Lack of Efficacy|3|||
126162477|NCT00321984|453881479|FG001|Overall Study|Lack of Efficacy|1|||
126162478|NCT00321984|453881480|FG002|Overall Study|Lack of Efficacy|3|||
126162479|NCT00321984|453881478|FG000|Overall Study|Noncompliant|0|||
126162480|NCT00321984|453881479|FG001|Overall Study|Noncompliant|0|||
126162481|NCT00321984|453881480|FG002|Overall Study|Noncompliant|2|||
126162482|NCT00321984|453881478|FG000|Overall Study|Pregnancy|0|||
126162483|NCT00321984|453881479|FG001|Overall Study|Pregnancy|1|||
126162484|NCT00321984|453881480|FG002|Overall Study|Pregnancy|0|||
126162485|NCT00321984|453881478|FG000|Overall Study|Per Subject Request|1|||
126162486|NCT00321984|453881479|FG001|Overall Study|Per Subject Request|0|||
126162487|NCT00321984|453881480|FG002|Overall Study|Per Subject Request|0|||
126162488|NCT00321984|453881478|FG000|Overall Study|Per Investigator Request|1|||
126162489|NCT00321984|453881479|FG001|Overall Study|Per Investigator Request|0|||
126162490|NCT00321984|453881480|FG002|Overall Study|Per Investigator Request|0|||
126162491|NCT00321984|453881478|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
126162492|NCT00321984|453881479|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
126162493|NCT00321984|453881480|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
126162494|NCT02985450|453881487|FG000|Overall Study|Lost to Follow-up|7|||
126162495|NCT00431847|453881490|FG000|Overall Study|completion of less than two study visits|6|||
126162496|NCT00431847|453881491|FG001|Overall Study|completion of less than two study visits|3|||
126162497|NCT00431847|453881492|FG002|Overall Study|completion of less than two study visits|4|||
126162498|NCT00431847|453881493|FG003|Overall Study|completion of less than two study visits|14|||
126162499|NCT00431847|453881494|FG004|Overall Study|completion of less than two study visits|0|||
126162500|NCT00431847|453881490|FG000|Overall Study|Protocol Violation|0|||
126162501|NCT00431847|453881491|FG001|Overall Study|Protocol Violation|0|||
126162502|NCT00431847|453881492|FG002|Overall Study|Protocol Violation|0|||
126162503|NCT00431847|453881493|FG003|Overall Study|Protocol Violation|0|||
126162504|NCT00431847|453881494|FG004|Overall Study|Protocol Violation|1|||
126162505|NCT01469013|453881495|FG000|Part A (Treatment Period)|Adverse Event|1|||
126162506|NCT01469013|453881496|FG001|Part A (Treatment Period)|Adverse Event|0|||
126162507|NCT01469013|453881497|FG002|Part A (Treatment Period)|Adverse Event|0|||
126162508|NCT01469013|453881498|FG003|Part A (Treatment Period)|Adverse Event|0|||
126162509|NCT01469013|453881499|FG004|Part A (Treatment Period)|Adverse Event|1|||
126162510|NCT01469013|453881500|FG005|Part A (Treatment Period)|Adverse Event|0|||
126162511|NCT01469013|453881501|FG006|Part A (Treatment Period)|Adverse Event|0|||
126162512|NCT01469013|453881502|FG007|Part A (Treatment Period)|Adverse Event|0|||
126162513|NCT01469013|453881503|FG008|Part A (Treatment Period)|Adverse Event|0|||
126162514|NCT01469013|453881504|FG009|Part A (Treatment Period)|Adverse Event|0|||
126162515|NCT01469013|453881505|FG010|Part A (Treatment Period)|Adverse Event|0|||
126162516|NCT01469013|453881506|FG011|Part A (Treatment Period)|Adverse Event|0|||
126162517|NCT01469013|453881507|FG012|Part A (Treatment Period)|Adverse Event|0|||
126162518|NCT01469013|453881495|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162519|NCT01469013|453881496|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162520|NCT01469013|453881497|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
126162521|NCT01469013|453881498|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162522|NCT01469013|453881499|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162523|NCT01469013|453881500|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162524|NCT01469013|453881501|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162525|NCT01469013|453881502|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162526|NCT01469013|453881503|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162527|NCT01469013|453881504|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162528|NCT01469013|453881505|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162529|NCT01469013|453881506|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162530|NCT01469013|453881507|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
126162531|NCT01469013|453881495|FG000|Part B (Extension Period)|Adverse Event|0|||
126162532|NCT01469013|453881496|FG001|Part B (Extension Period)|Adverse Event|0|||
126162533|NCT01469013|453881497|FG002|Part B (Extension Period)|Adverse Event|0|||
125972668|NCT02085408|453188847|FG001|Step 3: Maintenance|Never started treatment|1|||
125972669|NCT02273141|453188848|FG000|Overall Study|Adverse Event|0|||
125972670|NCT02273141|453188849|FG001|Overall Study|Adverse Event|1|||
126162534|NCT01469013|453881498|FG003|Part B (Extension Period)|Adverse Event|0|||
126162535|NCT01469013|453881499|FG004|Part B (Extension Period)|Adverse Event|0|||
126162536|NCT01469013|453881500|FG005|Part B (Extension Period)|Adverse Event|2|||
126162537|NCT01469013|453881501|FG006|Part B (Extension Period)|Adverse Event|5|||
126162538|NCT01469013|453881502|FG007|Part B (Extension Period)|Adverse Event|5|||
126162539|NCT01469013|453881503|FG008|Part B (Extension Period)|Adverse Event|3|||
126162540|NCT01469013|453881504|FG009|Part B (Extension Period)|Adverse Event|3|||
126162541|NCT01469013|453881505|FG010|Part B (Extension Period)|Adverse Event|1|||
126162542|NCT01469013|453881506|FG011|Part B (Extension Period)|Adverse Event|6|||
126162543|NCT01469013|453881507|FG012|Part B (Extension Period)|Adverse Event|3|||
126162544|NCT01469013|453881495|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
126162545|NCT01469013|453881496|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
126162546|NCT01469013|453881497|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
126162547|NCT01469013|453881498|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
126162548|NCT01469013|453881499|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
126162549|NCT01469013|453881500|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
126162550|NCT01469013|453881501|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
126162551|NCT01469013|453881502|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
126162552|NCT01469013|453881503|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
126162553|NCT01469013|453881504|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
126162554|NCT01469013|453881505|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
126162555|NCT01469013|453881506|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
126162556|NCT01469013|453881507|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
126162557|NCT00002663|453881508|FG000|Overall Study|Death|4|||
126162558|NCT00002663|453881509|FG001|Overall Study|Death|1|||
126162559|NCT00002663|453881510|FG002|Overall Study|Death|1|||
126162560|NCT00002663|453881511|FG003|Overall Study|Death|0|||
126162561|NCT00002663|453881512|FG004|Overall Study|Death|0|||
126162562|NCT00002663|453881513|FG005|Overall Study|Death|13|||
126162563|NCT00002663|453881514|FG006|Overall Study|Death|0|||
126162564|NCT00002663|453881515|FG007|Overall Study|Death|1|||
126162565|NCT00002663|453881516|FG008|Overall Study|Death|1|||
126162566|NCT00002663|453881517|FG009|Overall Study|Death|1|||
126162567|NCT00002663|453881508|FG000|Overall Study|Lost to Follow-up|3|||
126162568|NCT00002663|453881509|FG001|Overall Study|Lost to Follow-up|0|||
126162569|NCT00002663|453881510|FG002|Overall Study|Lost to Follow-up|0|||
126162570|NCT00002663|453881511|FG003|Overall Study|Lost to Follow-up|1|||
126162571|NCT00002663|453881512|FG004|Overall Study|Lost to Follow-up|0|||
126162572|NCT00002663|453881513|FG005|Overall Study|Lost to Follow-up|1|||
126162573|NCT00002663|453881514|FG006|Overall Study|Lost to Follow-up|0|||
126162574|NCT00002663|453881515|FG007|Overall Study|Lost to Follow-up|0|||
126162575|NCT00002663|453881516|FG008|Overall Study|Lost to Follow-up|0|||
126162576|NCT00002663|453881517|FG009|Overall Study|Lost to Follow-up|0|||
126162577|NCT00002663|453881508|FG000|Overall Study|Other|0|||
126162578|NCT00002663|453881509|FG001|Overall Study|Other|1|||
126162579|NCT00002663|453881510|FG002|Overall Study|Other|0|||
126162580|NCT00002663|453881511|FG003|Overall Study|Other|0|||
126162581|NCT00002663|453881512|FG004|Overall Study|Other|0|||
126162582|NCT00002663|453881513|FG005|Overall Study|Other|1|||
126162583|NCT00002663|453881514|FG006|Overall Study|Other|1|||
126162584|NCT00002663|453881515|FG007|Overall Study|Other|0|||
126162585|NCT00002663|453881516|FG008|Overall Study|Other|0|||
126162586|NCT00002663|453881517|FG009|Overall Study|Other|0|||
126162587|NCT00002663|453881508|FG000|Overall Study|Physician Decision|0|||
126162588|NCT00002663|453881509|FG001|Overall Study|Physician Decision|0|||
126162589|NCT00002663|453881510|FG002|Overall Study|Physician Decision|0|||
126162590|NCT00002663|453881511|FG003|Overall Study|Physician Decision|0|||
126162591|NCT00002663|453881512|FG004|Overall Study|Physician Decision|1|||
126162592|NCT00002663|453881513|FG005|Overall Study|Physician Decision|0|||
126162593|NCT00002663|453881514|FG006|Overall Study|Physician Decision|0|||
126162594|NCT00002663|453881515|FG007|Overall Study|Physician Decision|0|||
126162595|NCT00002663|453881516|FG008|Overall Study|Physician Decision|1|||
126162596|NCT00002663|453881517|FG009|Overall Study|Physician Decision|1|||
126162597|NCT00002663|453881508|FG000|Overall Study|Adverse Event|0|||
126162598|NCT00002663|453881509|FG001|Overall Study|Adverse Event|0|||
126162599|NCT00002663|453881510|FG002|Overall Study|Adverse Event|0|||
126162600|NCT00002663|453881511|FG003|Overall Study|Adverse Event|1|||
126162601|NCT00002663|453881512|FG004|Overall Study|Adverse Event|0|||
126162602|NCT00002663|453881513|FG005|Overall Study|Adverse Event|0|||
126162603|NCT00002663|453881514|FG006|Overall Study|Adverse Event|0|||
126162604|NCT00002663|453881515|FG007|Overall Study|Adverse Event|1|||
126162605|NCT00002663|453881516|FG008|Overall Study|Adverse Event|0|||
126162606|NCT00002663|453881517|FG009|Overall Study|Adverse Event|0|||
126162607|NCT01603641|453881521|FG000|Overall Study|Did not Receive Treatment|3|||
126162608|NCT01603641|453881521|FG000|Overall Study|Adverse Event|1|||
126162609|NCT01603641|453881521|FG000|Overall Study|Lack of Efficacy|1|||
126162610|NCT01603641|453881521|FG000|Overall Study|Lost to Follow-up|6|||
126162611|NCT01603641|453881521|FG000|Overall Study|Personal Reasons|18|||
126162612|NCT01603641|453881521|FG000|Overall Study|Other Miscellaneous Reasons|6|||
126162613|NCT03161678|453881522|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
126162614|NCT03161678|453881523|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
126162615|NCT03161678|453881524|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
126162616|NCT03161678|453881525|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
126162617|NCT03161678|453881526|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
126162618|NCT03161678|453881527|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
126162619|NCT03161678|453881522|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
126162620|NCT03161678|453881523|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
126162621|NCT03161678|453881524|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
126162622|NCT03161678|453881525|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
126162623|NCT03161678|453881526|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
126162624|NCT03161678|453881527|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
126162625|NCT03161678|453881522|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
126162626|NCT03161678|453881523|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
126162627|NCT03161678|453881524|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
126162628|NCT03161678|453881525|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
126162629|NCT03161678|453881526|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
126162630|NCT03161678|453881527|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
126162631|NCT03161678|453881522|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126162632|NCT03161678|453881523|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126162633|NCT03161678|453881524|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126162634|NCT03161678|453881525|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
126162635|NCT03161678|453881526|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126162636|NCT03161678|453881527|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126162637|NCT00739297|453881528|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
126162638|NCT00739297|453881529|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
126162639|NCT00739297|453881530|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
126162640|NCT00739297|453881531|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
126162641|NCT00739297|453881532|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
126162642|NCT00739297|453881533|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
126162643|NCT00739297|453881534|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
126162644|NCT00739297|453881528|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126162645|NCT00739297|453881529|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126162646|NCT00739297|453881530|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126162647|NCT00739297|453881531|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126162648|NCT00739297|453881532|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126162649|NCT00739297|453881533|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
126162650|NCT00739297|453881534|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
126162651|NCT01757704|453881535|FG000|Overall Study|Protocol Violation|1|||
126162652|NCT01757704|453881536|FG001|Overall Study|Protocol Violation|3|||
126162653|NCT02749721|453881542|FG000|Screening|Withdrawal by Subject|1|||
126162654|NCT02749721|453881542|FG000|Screening|Lost to Follow-up|2|||
126162655|NCT02749721|453881542|FG000|Screening|Protocol Violation|3|||
126162656|NCT02749721|453881542|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
126162657|NCT02749721|453881542|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
126162658|NCT02137772|453881543|FG000|Overall Study|Adverse Event|6|||
126162659|NCT02137772|453881544|FG001|Overall Study|Adverse Event|3|||
126162660|NCT02137772|453881543|FG000|Overall Study|Death|71|||
126162661|NCT02137772|453881544|FG001|Overall Study|Death|44|||
126162662|NCT02137772|453881543|FG000|Overall Study|Lost to Follow-up|8|||
126162663|NCT02137772|453881544|FG001|Overall Study|Lost to Follow-up|4|||
126162664|NCT02137772|453881543|FG000|Overall Study|Physician Decision|15|||
126162665|NCT02137772|453881544|FG001|Overall Study|Physician Decision|5|||
126162666|NCT02137772|453881543|FG000|Overall Study|Withdrawal by Subject|28|||
126162667|NCT02137772|453881544|FG001|Overall Study|Withdrawal by Subject|17|||
126162668|NCT02137772|453881543|FG000|Overall Study|Non-compliance with study drug|1|||
126162669|NCT02137772|453881544|FG001|Overall Study|Non-compliance with study drug|0|||
126162670|NCT02137772|453881543|FG000|Overall Study|Not treated|3|||
126162671|NCT02137772|453881544|FG001|Overall Study|Not treated|2|||
126162672|NCT02691247|453881545|FG000|Overall Study|Withdrawal by Subject|1|||
126162673|NCT02691247|453881546|FG001|Overall Study|Withdrawal by Subject|2|||
126162674|NCT02691247|453881547|FG002|Overall Study|Withdrawal by Subject|2|||
126162675|NCT02691247|453881545|FG000|Overall Study|Lost to Follow-up|2|||
126162676|NCT02691247|453881546|FG001|Overall Study|Lost to Follow-up|0|||
126162677|NCT02691247|453881547|FG002|Overall Study|Lost to Follow-up|1|||
126162678|NCT00443430|453881549|FG000|Overall Study|Lack of Efficacy|3|||
126162679|NCT00443430|453881550|FG001|Overall Study|Lack of Efficacy|3|||
125972671|NCT02273141|453188848|FG000|Overall Study|Lost to Follow-up|1|||
125972672|NCT02273141|453188849|FG001|Overall Study|Lost to Follow-up|3|||
125972673|NCT02273141|453188848|FG000|Overall Study|Withdrawal by Subject|10|||
126162680|NCT00443430|453881549|FG000|Overall Study|Adverse Event|1|||
126162681|NCT00443430|453881550|FG001|Overall Study|Adverse Event|1|||
126162682|NCT00933335|453881552|FG000|Overall Study|Lost to Follow-up|1|||
126162683|NCT00933335|453881553|FG001|Overall Study|Lost to Follow-up|3|||
126162684|NCT00933335|453881552|FG000|Overall Study|Withdrawal by Subject|0|||
125972674|NCT02273141|453188849|FG001|Overall Study|Withdrawal by Subject|15|||
126162685|NCT00933335|453881553|FG001|Overall Study|Withdrawal by Subject|1|||
126162686|NCT00933335|453881552|FG000|Overall Study|Progressive Disease|0|||
126162687|NCT00933335|453881553|FG001|Overall Study|Progressive Disease|11|||
125972675|NCT02273141|453188848|FG000|Overall Study|Various|6|||
126162688|NCT00933335|453881552|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
126162689|NCT00933335|453881553|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
126162690|NCT00933335|453881552|FG000|Overall Study|Co-morbid Illness|1|||
126162691|NCT00933335|453881553|FG001|Overall Study|Co-morbid Illness|0|||
126162692|NCT02084134|453881560|FG000|Overall Study|Protocol Violation|4|||
126162693|NCT02084134|453881561|FG001|Overall Study|Protocol Violation|2|||
126162694|NCT02084134|453881560|FG000|Overall Study|Death|0|||
126162695|NCT02084134|453881561|FG001|Overall Study|Death|1|||
126162696|NCT01095250|453881567|FG000|Overall Study|administrative reasons|8|||
126162697|NCT01095250|453881568|FG001|Overall Study|administrative reasons|10|||
126162698|NCT01095250|453881569|FG002|Overall Study|administrative reasons|7|||
126162699|NCT01095250|453881570|FG003|Overall Study|administrative reasons|5|||
126162700|NCT01095250|453881567|FG000|Overall Study|Withdrawal by Subject|0|||
126162701|NCT01095250|453881568|FG001|Overall Study|Withdrawal by Subject|0|||
126162702|NCT01095250|453881569|FG002|Overall Study|Withdrawal by Subject|1|||
126162703|NCT01095250|453881570|FG003|Overall Study|Withdrawal by Subject|0|||
126162704|NCT04598165|453881571|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
126162705|NCT04598165|453881572|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
126162706|NCT04598165|453881571|FG000|Completed 6-week Follow-up|Death|2|||
126162707|NCT04598165|453881572|FG001|Completed 6-week Follow-up|Death|1|||
126162708|NCT04598165|453881571|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
126162709|NCT04598165|453881572|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
126162710|NCT04598165|453881571|FG000|Completed 6-week Follow-up|Ineligible|4|||
126162711|NCT04598165|453881572|FG001|Completed 6-week Follow-up|Ineligible|3|||
126162712|NCT04598165|453881571|FG000|Completed 6-week Follow-up|Partner refusal|0|||
126162713|NCT04598165|453881572|FG001|Completed 6-week Follow-up|Partner refusal|1|||
126162714|NCT04598165|453881571|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
126162715|NCT04598165|453881572|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
126162716|NCT01323673|453881573|FG000|Overall Study|Adverse Event|0|||
126162717|NCT01323673|453881574|FG001|Overall Study|Adverse Event|1|||
126162718|NCT01323673|453881573|FG000|Overall Study|Lost to Follow-up|0|||
126162719|NCT01323673|453881574|FG001|Overall Study|Lost to Follow-up|1|||
126162720|NCT01323673|453881573|FG000|Overall Study|Protocol Violation|1|||
126162721|NCT01323673|453881574|FG001|Overall Study|Protocol Violation|0|||
126162722|NCT01323673|453881573|FG000|Overall Study|Withdrawal by Subject|2|||
126162723|NCT01323673|453881574|FG001|Overall Study|Withdrawal by Subject|3|||
126162724|NCT00426751|453881575|FG000|Overall Study|Adverse Event|8|||
126162725|NCT00426751|453881576|FG001|Overall Study|Adverse Event|1|||
126162726|NCT00426751|453881575|FG000|Overall Study|Lost to Follow-up|7|||
126162727|NCT00426751|453881576|FG001|Overall Study|Lost to Follow-up|6|||
126162728|NCT00426751|453881575|FG000|Overall Study|Consent Withdrawn|0|||
126162729|NCT00426751|453881576|FG001|Overall Study|Consent Withdrawn|1|||
126162730|NCT00426751|453881575|FG000|Overall Study|Other Reasons|7|||
126162731|NCT00426751|453881576|FG001|Overall Study|Other Reasons|12|||
126162732|NCT01432262|453882670|FG000|Overall Study|Withdrawal by Subject|2|||
126162733|NCT01432262|453882671|FG001|Overall Study|Withdrawal by Subject|1|||
126162734|NCT04657016|453882672|FG000|Overall Study|Adverse Event|2|||
126162735|NCT04657016|453882673|FG001|Overall Study|Adverse Event|4|||
126162736|NCT04657016|453882672|FG000|Overall Study|Death|1|||
126162737|NCT04657016|453882673|FG001|Overall Study|Death|1|||
126162738|NCT04657016|453882672|FG000|Overall Study|Lost to Follow-up|24|||
126162739|NCT04657016|453882673|FG001|Overall Study|Lost to Follow-up|12|||
126162740|NCT04657016|453882672|FG000|Overall Study|Physician Decision|1|||
126162741|NCT04657016|453882673|FG001|Overall Study|Physician Decision|2|||
126162742|NCT04657016|453882672|FG000|Overall Study|Pregnancy|2|||
126162743|NCT04657016|453882673|FG001|Overall Study|Pregnancy|2|||
126162744|NCT04657016|453882672|FG000|Overall Study|Protocol Deviation|1|||
126162745|NCT04657016|453882673|FG001|Overall Study|Protocol Deviation|0|||
126162746|NCT04657016|453882672|FG000|Overall Study|Withdrawal by Subject|28|||
126162747|NCT04657016|453882673|FG001|Overall Study|Withdrawal by Subject|14|||
126162748|NCT04657016|453882672|FG000|Overall Study|Other - as reported by the investigator|6|||
126162749|NCT04657016|453882673|FG001|Overall Study|Other - as reported by the investigator|0|||
126162750|NCT01755195|453882674|FG000|Overall Study|Participant noncompliance|2|||
126162751|NCT01755195|453882674|FG000|Overall Study|Switched to alternative treatment|4|||
126162752|NCT01755195|453882674|FG000|Overall Study|Withdrawal by Subject|1|||
126162753|NCT01755195|453882674|FG000|Overall Study|Participant refused to start treatment|1|||
126162754|NCT01755195|453882674|FG000|Overall Study|Participant has been consented for another trial|1|||
126162755|NCT01755195|453882674|FG000|Overall Study|Refused further treatment|3|||
126162756|NCT01755195|453882674|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
126162757|NCT03470922|453882675|FG000|Overall Study|Death|107|||
126162758|NCT03470922|453882676|FG001|Overall Study|Death|118|||
126162759|NCT03470922|453882675|FG000|Overall Study|Lost to Follow-up|5|||
126162760|NCT03470922|453882676|FG001|Overall Study|Lost to Follow-up|5|||
126162761|NCT03470922|453882675|FG000|Overall Study|Participant Withdrew Consent|4|||
126162762|NCT03470922|453882676|FG001|Overall Study|Participant Withdrew Consent|9|||
125972676|NCT02273141|453188849|FG001|Overall Study|Various|6|||
126162763|NCT03470922|453882675|FG000|Overall Study|Other reasons|1|||
126162764|NCT03470922|453882676|FG001|Overall Study|Other reasons|0|||
126162765|NCT03470922|453882675|FG000|Overall Study|Not reported|1|||
126162766|NCT03470922|453882676|FG001|Overall Study|Not reported|0|||
126162767|NCT02340819|453882677|FG000|Overall Study|Adverse Event|1|||
126162768|NCT02340819|453882677|FG000|Overall Study|Withdrawal by Subject|2|||
126162769|NCT02340819|453882677|FG000|Overall Study|Discontinued with other reason|1|||
126162770|NCT02361762|453882678|FG000|Overall Study|Withdrawal by Subject|0|||
126162771|NCT02361762|453882679|FG001|Overall Study|Withdrawal by Subject|1|||
126162772|NCT02361762|453882678|FG000|Overall Study|Lost to Follow-up|0|||
126162773|NCT02361762|453882679|FG001|Overall Study|Lost to Follow-up|1|||
126162774|NCT00028002|453882680|FG000|Overall Study|Withdrawal by Subject|3|||
126162775|NCT00028002|453882680|FG000|Overall Study|Ineligible|8|||
126162776|NCT01793051|453882681|FG000|Overall Study|Withdrawal by Subject|6|||
126162777|NCT01793051|453882682|FG001|Overall Study|Withdrawal by Subject|4|||
126162778|NCT01793051|453882681|FG000|Overall Study|Adverse Event|0|||
126162779|NCT01793051|453882682|FG001|Overall Study|Adverse Event|2|||
126162780|NCT01793051|453882681|FG000|Overall Study|Too ill to continue|1|||
126162781|NCT01793051|453882682|FG001|Overall Study|Too ill to continue|0|||
126162782|NCT01793051|453882681|FG000|Overall Study|Switched chemo|1|||
126162783|NCT01793051|453882682|FG001|Overall Study|Switched chemo|1|||
126162784|NCT01793051|453882681|FG000|Overall Study|Lack of compliance|1|||
126162785|NCT01793051|453882682|FG001|Overall Study|Lack of compliance|0|||
126162786|NCT01793051|453882681|FG000|Overall Study|Requested to be removed from the study|1|||
126162787|NCT01793051|453882682|FG001|Overall Study|Requested to be removed from the study|1|||
126162788|NCT04467164|453882686|FG000|Washout (1 Week)|Lost to Follow-up|2|||
126162789|NCT04467164|453882687|FG001|Washout (1 Week)|Lost to Follow-up|0|||
126162790|NCT03276936|453882690|FG000|Overall Study|Adverse Event|4|||
126162791|NCT03276936|453882691|FG001|Overall Study|Adverse Event|2|||
126162792|NCT03276936|453882690|FG000|Overall Study|Lost to Follow-up|16|||
126162793|NCT03276936|453882691|FG001|Overall Study|Lost to Follow-up|13|||
126162794|NCT03276936|453882690|FG000|Overall Study|Withdrawal by Subject|30|||
126162795|NCT03276936|453882691|FG001|Overall Study|Withdrawal by Subject|20|||
126162796|NCT03276936|453882690|FG000|Overall Study|Not mentioned|6|||
126162797|NCT03276936|453882691|FG001|Overall Study|Not mentioned|3|||
126162798|NCT01798134|453882692|FG000|Overall Study|Lost to Follow-up|1|||
126162799|NCT01798134|453882692|FG000|Overall Study|Withdrawal by Subject|3|||
126162800|NCT01798134|453882692|FG000|Overall Study|Death|2|||
126162801|NCT01798134|453882692|FG000|Overall Study|Adverse Event|3|||
126162802|NCT01798134|453882692|FG000|Overall Study|Physician Decision|3|||
126162803|NCT01798134|453882692|FG000|Overall Study|Liver transplant/surgery|4|||
126162804|NCT00625365|453882693|FG000|Overall Study|Withdrawal by Subject|1|||
126162805|NCT00625365|453882693|FG000|Overall Study|No IV access|5|||
126162806|NCT00625365|453882693|FG000|Overall Study|VSD|1|||
126162807|NCT01703286|453882695|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
126162808|NCT01703286|453882696|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
126162809|NCT01703286|453882697|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
126162810|NCT01703286|453882698|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
126162811|NCT01703286|453882699|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
126162812|NCT01703286|453882700|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
126162813|NCT01703286|453882695|FG000|Period 2 Including Washout|Adverse Event|0|||
126162814|NCT01703286|453882696|FG001|Period 2 Including Washout|Adverse Event|0|||
126162815|NCT01703286|453882697|FG002|Period 2 Including Washout|Adverse Event|0|||
126162816|NCT01703286|453882698|FG003|Period 2 Including Washout|Adverse Event|1|||
126162817|NCT01703286|453882699|FG004|Period 2 Including Washout|Adverse Event|0|||
126162818|NCT01703286|453882700|FG005|Period 2 Including Washout|Adverse Event|0|||
126162819|NCT01984346|453882701|FG000|Overall Study|Physician Decision|4|||
126162820|NCT01984346|453882702|FG001|Overall Study|Physician Decision|2|||
126162821|NCT01984346|453882701|FG000|Overall Study|Withdrawal by Subject|2|||
126162822|NCT01984346|453882702|FG001|Overall Study|Withdrawal by Subject|2|||
126162823|NCT01984346|453882701|FG000|Overall Study|Enrollment Closed|8|||
126162824|NCT01984346|453882702|FG001|Overall Study|Enrollment Closed|1|||
126162825|NCT01984346|453882701|FG000|Overall Study|Insurance Coverage|1|||
126162826|NCT01984346|453882702|FG001|Overall Study|Insurance Coverage|0|||
126162827|NCT01984346|453882701|FG000|Overall Study|Intra-operative Exclusion|2|||
126162828|NCT01984346|453882702|FG001|Overall Study|Intra-operative Exclusion|0|||
126162829|NCT01234402|453882704|FG000|Overall Study|Lost to Follow-up|0|||
126162830|NCT01234402|453882705|FG001|Overall Study|Lost to Follow-up|1|||
126162831|NCT01234402|453882706|FG002|Overall Study|Lost to Follow-up|3|||
126162832|NCT01234402|453882704|FG000|Overall Study|Withdrawal by Subject|1|||
126162833|NCT01234402|453882705|FG001|Overall Study|Withdrawal by Subject|3|||
126162834|NCT01234402|453882706|FG002|Overall Study|Withdrawal by Subject|4|||
126162835|NCT01234402|453882704|FG000|Overall Study|Never treated: Death|0|||
126162836|NCT01234402|453882705|FG001|Overall Study|Never treated: Death|0|||
126162837|NCT01234402|453882706|FG002|Overall Study|Never treated: Death|1|||
126162838|NCT01234402|453882704|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
126162839|NCT01234402|453882705|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
126162840|NCT01234402|453882706|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
126162841|NCT01234402|453882704|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
126162842|NCT01234402|453882705|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
126162843|NCT01234402|453882706|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
126162844|NCT01594476|453882707|FG000|Overall Study|Protocol Violation|1|||
126162845|NCT01594476|453882708|FG001|Overall Study|Protocol Violation|3|||
126162846|NCT02890329|453882709|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126162847|NCT02890329|453882710|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
126162848|NCT02890329|453882711|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126162849|NCT02890329|453882712|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126162850|NCT02890329|453882713|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126162851|NCT02890329|453882714|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126162852|NCT02890329|453882709|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
126162853|NCT02890329|453882710|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
126162854|NCT02890329|453882711|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
126162855|NCT02890329|453882712|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
126162856|NCT02890329|453882713|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
126162857|NCT02890329|453882714|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
126162858|NCT02890329|453882709|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126162859|NCT02890329|453882710|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126162860|NCT02890329|453882711|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126162861|NCT02890329|453882712|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
126162862|NCT02890329|453882713|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126162863|NCT02890329|453882714|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126162864|NCT02890329|453882709|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126162865|NCT02890329|453882710|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126162866|NCT02890329|453882711|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
126162867|NCT02890329|453882712|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126162868|NCT02890329|453882713|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126162869|NCT02890329|453882714|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126162870|NCT05468086|453882715|FG000|Overall Study|Withdrawal by Subject|3|||
126162871|NCT05468086|453882715|FG000|Overall Study|Subject was found ineligible after consent|1|||
126162872|NCT00374907|453882716|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
126162873|NCT00374907|453882717|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
126162874|NCT00374907|453882716|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
126162875|NCT00374907|453882717|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
126162876|NCT00374907|453882716|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
126162877|NCT00374907|453882717|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
126162878|NCT00374907|453882716|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
126162879|NCT00374907|453882717|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
126162880|NCT00374907|453882716|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
126162881|NCT00374907|453882717|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
126162882|NCT01108809|453882718|FG000|Overall Study|Adverse Event|3|||
126162883|NCT01108809|453882718|FG000|Overall Study|Lost to Follow-up|1|||
126162884|NCT00783705|453882721|FG000|Overall Study|Adverse Event|2|||
126162885|NCT00783705|453882722|FG001|Overall Study|Adverse Event|0|||
126162886|NCT00783705|453882721|FG000|Overall Study|Withdrawal by Subject|3|||
126162887|NCT00783705|453882722|FG001|Overall Study|Withdrawal by Subject|2|||
126162888|NCT00783705|453882721|FG000|Overall Study|Lost to Follow-up|1|||
126162889|NCT00783705|453882722|FG001|Overall Study|Lost to Follow-up|3|||
126162890|NCT02379923|453882724|FG000|Overall Study|Death|5|||
126162891|NCT01200511|453882725|FG000|Overall Study|Lost to Follow-up|3|||
126162892|NCT01200511|453882725|FG000|Overall Study|Withdrawal by Subject|1|||
126162893|NCT01200511|453882725|FG000|Overall Study|Adverse Event|1|||
126162894|NCT02504892|453882732|FG000|Overall Study|Adverse event-pneumonitis|2|||
126162895|NCT04229446|453882733|FG000|Overall Study|Death|12|||
126162896|NCT04229446|453882734|FG001|Overall Study|Death|10|||
126162897|NCT04229446|453882733|FG000|Overall Study|Lost to Follow-up|5|||
125972677|NCT01556438|453188850|FG000|Overall Study|Adverse Event|4|||
125972678|NCT01556438|453188851|FG001|Overall Study|Adverse Event|2|||
126162898|NCT04229446|453882734|FG001|Overall Study|Lost to Follow-up|8|||
126162899|NCT01413178|453882735|FG000|Overall Study|Toxicity|1|||
126162900|NCT01413178|453882736|FG001|Overall Study|Toxicity|0|||
126162901|NCT01413178|453882735|FG000|Overall Study|Ineligible|0|||
126162902|NCT01413178|453882736|FG001|Overall Study|Ineligible|2|||
126162903|NCT00576693|453882737|FG000|Overall Study|Lost to Follow-up|7|||
126162904|NCT00576693|453882738|FG001|Overall Study|Lost to Follow-up|11|||
126162905|NCT00576693|453882737|FG000|Overall Study|Withdrawal by Subject|3|||
125972679|NCT01556438|453188850|FG000|Overall Study|Sponsor Decision|0|||
126162906|NCT00576693|453882738|FG001|Overall Study|Withdrawal by Subject|13|||
126162907|NCT00804193|453882739|FG000|Overall Study|Lack of baseline fungus|32|||
126162908|NCT00804193|453882740|FG001|Overall Study|Lack of baseline fungus|31|||
126162909|NCT00804193|453882741|FG002|Overall Study|Lack of baseline fungus|19|||
126162910|NCT00804193|453882739|FG000|Overall Study|Adverse Event|0|||
126162911|NCT00804193|453882740|FG001|Overall Study|Adverse Event|0|||
126162912|NCT00804193|453882741|FG002|Overall Study|Adverse Event|2|||
126162913|NCT00804193|453882739|FG000|Overall Study|Lack of Efficacy|1|||
126162914|NCT00804193|453882740|FG001|Overall Study|Lack of Efficacy|1|||
126162915|NCT00804193|453882741|FG002|Overall Study|Lack of Efficacy|3|||
126162916|NCT00804193|453882739|FG000|Overall Study|Protocol Violation|0|||
126162917|NCT00804193|453882740|FG001|Overall Study|Protocol Violation|8|||
126162918|NCT00804193|453882741|FG002|Overall Study|Protocol Violation|2|||
126162919|NCT00804193|453882739|FG000|Overall Study|Lost to Follow-up|3|||
126162920|NCT00804193|453882740|FG001|Overall Study|Lost to Follow-up|3|||
126162921|NCT00804193|453882741|FG002|Overall Study|Lost to Follow-up|4|||
126162922|NCT00804193|453882739|FG000|Overall Study|Withdrawal by Subject|3|||
126162923|NCT00804193|453882740|FG001|Overall Study|Withdrawal by Subject|1|||
126162924|NCT00804193|453882741|FG002|Overall Study|Withdrawal by Subject|2|||
126162925|NCT00705224|453882742|FG000|Overall Study|Adverse Event|1|||
126162926|NCT00705224|453882742|FG000|Overall Study|Lack of Efficacy|2|||
126162927|NCT00705224|453882742|FG000|Overall Study|Withdrawal by Subject|3|||
126162928|NCT00705224|453882742|FG000|Overall Study|Lost to Follow-up|5|||
126162929|NCT01987986|453882743|FG000|Overall Study|Lost to Follow-up|1|||
126162930|NCT01987986|453882744|FG001|Overall Study|Lost to Follow-up|0|||
126162931|NCT01987986|453882745|FG002|Overall Study|Lost to Follow-up|0|||
126162932|NCT01987986|453882746|FG003|Overall Study|Lost to Follow-up|0|||
126162933|NCT01987986|453882743|FG000|Overall Study|Adverse Event|1|||
126162934|NCT01987986|453882744|FG001|Overall Study|Adverse Event|0|||
126162935|NCT01987986|453882745|FG002|Overall Study|Adverse Event|2|||
126162936|NCT01987986|453882746|FG003|Overall Study|Adverse Event|0|||
126162937|NCT01617434|453882747|FG000|Overall Study|Adverse Event|12|||
126162938|NCT01617434|453882748|FG001|Overall Study|Adverse Event|3|||
126162939|NCT01617434|453882747|FG000|Overall Study|Protocol Violation|8|||
126162940|NCT01617434|453882748|FG001|Overall Study|Protocol Violation|7|||
126162941|NCT01617434|453882747|FG000|Overall Study|Withdrawal Criteria|12|||
126162942|NCT01617434|453882748|FG001|Overall Study|Withdrawal Criteria|37|||
126162943|NCT01617434|453882747|FG000|Overall Study|Unclassified|3|||
126162944|NCT01617434|453882748|FG001|Overall Study|Unclassified|4|||
126162945|NCT03283163|453882749|FG000|Overall Study|Lost to Follow-up|1|||
126162946|NCT03283163|453882749|FG000|Overall Study|other life commitments|6|||
126162947|NCT03283163|453882749|FG000|Overall Study|COVID-19 institution wide halting|1|||
126162948|NCT03283163|453882749|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
126162949|NCT03283163|453882749|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
126162950|NCT00237796|453882750|FG000|Overall Study|Baseline and one other ILSS required|10|||
126162951|NCT00237796|453882751|FG001|Overall Study|Baseline and one other ILSS required|5|||
126162952|NCT04238663|453882752|FG000|Overall Study|Lost to Follow-up|0|||
126162953|NCT04238663|453882753|FG001|Overall Study|Lost to Follow-up|1|||
126162954|NCT04238663|453882754|FG002|Overall Study|Lost to Follow-up|0|||
126162955|NCT03596177|453882756|FG000|Single Blind Period|Withdrawal by Subject|1|||
126162956|NCT03596177|453882757|FG001|Single Blind Period|Withdrawal by Subject|1|||
126162957|NCT03596177|453882756|FG000|Single Blind Period|Other|1|||
126162958|NCT03596177|453882757|FG001|Single Blind Period|Other|0|||
126162959|NCT03596177|453882756|FG000|Double Blind Period|Withdrawal by Subject|0|||
126162960|NCT03596177|453882757|FG001|Double Blind Period|Withdrawal by Subject|1|||
126162961|NCT03596177|453882756|FG000|Double Blind Period|Other|0|||
126162962|NCT03596177|453882757|FG001|Double Blind Period|Other|4|||
126162963|NCT03596177|453882756|FG000|Double Blind Period|Death during safety follow-up|0|||
126162964|NCT03596177|453882757|FG001|Double Blind Period|Death during safety follow-up|1|||
126162965|NCT00968253|453882758|FG000|Overall Study|Death|0|||
126162966|NCT00968253|453882759|FG001|Overall Study|Death|0|||
125972680|NCT01556438|453188851|FG001|Overall Study|Sponsor Decision|2|||
126162967|NCT00968253|453882760|FG002|Overall Study|Death|2|||
126162968|NCT00968253|453882758|FG000|Overall Study|Withdrawal by Subject|0|||
126162969|NCT00968253|453882759|FG001|Overall Study|Withdrawal by Subject|0|||
126162970|NCT00968253|453882760|FG002|Overall Study|Withdrawal by Subject|1|||
125972681|NCT01556438|453188850|FG000|Overall Study|Progressive Disease|0|||
126162971|NCT00968253|453882758|FG000|Overall Study|Disease Progression|0|||
126162972|NCT00968253|453882759|FG001|Overall Study|Disease Progression|3|||
126162973|NCT00968253|453882760|FG002|Overall Study|Disease Progression|3|||
126162974|NCT00968253|453882758|FG000|Overall Study|Adverse Event|0|||
126162975|NCT00968253|453882759|FG001|Overall Study|Adverse Event|0|||
126162976|NCT00968253|453882760|FG002|Overall Study|Adverse Event|1|||
126162977|NCT04400318|453884173|FG000|Overall Study|Adverse Event|1|||
125972682|NCT01556438|453188851|FG001|Overall Study|Progressive Disease|6|||
126162978|NCT04400318|453884174|FG001|Overall Study|Adverse Event|0|||
126162979|NCT04400318|453884173|FG000|Overall Study|Withdrawal by Subject|1|||
125972683|NCT01556438|453188850|FG000|Overall Study|Death|0|||
126162980|NCT04400318|453884174|FG001|Overall Study|Withdrawal by Subject|1|||
126162981|NCT04400318|453884173|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
126162982|NCT04400318|453884174|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
126162983|NCT01096446|453884175|FG000|Overall Study|Death|1|||
126162984|NCT01096446|453884176|FG001|Overall Study|Death|0|||
126162985|NCT01096446|453884175|FG000|Overall Study|Protocol Violation|2|||
126162986|NCT01096446|453884176|FG001|Overall Study|Protocol Violation|0|||
126162987|NCT01043185|453884177|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
126162988|NCT01043185|453884178|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
126162989|NCT01043185|453884179|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
126162990|NCT01043185|453884180|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
126162991|NCT01043185|453884181|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
126162992|NCT01043185|453884182|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
126162993|NCT01043185|453884183|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
126162994|NCT01043185|453884184|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
126162995|NCT01043185|453884185|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
126162996|NCT01043185|453884186|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
126162997|NCT01104558|453884187|FG000|Overall Study|Protocol Violation|6|||
126162998|NCT01104558|453884187|FG000|Overall Study|Missing of primary efficacy assessment|10|||
126162999|NCT01104558|453884187|FG000|Overall Study|Missing of genetic analysis results|1|||
126163000|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126163001|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126163002|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126163003|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
126163004|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126163005|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126163006|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
126163007|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
126163008|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
126163009|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
126163010|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
126163011|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
126163012|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126163013|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126163014|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
126163015|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126163016|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126163017|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126163018|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
126163019|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
126163020|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
126163021|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
126163022|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
126163023|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
126163024|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
126163025|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
126163026|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
126163027|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
126163028|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
126163029|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
126163030|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
126163031|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
126163032|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
126163033|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
126163034|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
126163035|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
126163036|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
126163037|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
126163038|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
126163039|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
126163040|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
126163041|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
126163042|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
126163043|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
125972684|NCT01556438|453188851|FG001|Overall Study|Death|1|||
125972685|NCT00529399|453188852|FG000|Overall Study|Lost to Follow-up|1|||
125972686|NCT00529399|453188853|FG001|Overall Study|Lost to Follow-up|0|||
125972687|NCT00529399|453188854|FG002|Overall Study|Lost to Follow-up|1|||
125972688|NCT00529399|453188852|FG000|Overall Study|Withdrawal by Subject|1|||
125972689|NCT00529399|453188853|FG001|Overall Study|Withdrawal by Subject|0|||
125972690|NCT00529399|453188854|FG002|Overall Study|Withdrawal by Subject|1|||
125972691|NCT00529399|453188852|FG000|Overall Study|Non-compliant|0|||
125972692|NCT00529399|453188853|FG001|Overall Study|Non-compliant|1|||
125972693|NCT00529399|453188854|FG002|Overall Study|Non-compliant|0|||
125972694|NCT03695172|453188855|FG000|Overall Study|Withdrawal by Subject|1|||
125972695|NCT03695172|453188856|FG001|Overall Study|Withdrawal by Subject|1|||
125972696|NCT03695172|453188857|FG002|Overall Study|Withdrawal by Subject|0|||
125972697|NCT02734212|453188861|FG000|Overall Study|Lost to Follow-up|5|||
125972698|NCT02734212|453188862|FG001|Overall Study|Lost to Follow-up|10|||
125972699|NCT04313881|453188863|FG000|Overall Study|Death|138|||
125972700|NCT04313881|453188864|FG001|Overall Study|Death|126|||
125972701|NCT04313881|453188863|FG000|Overall Study|Study terminated by sponsor|108|||
125972702|NCT04313881|453188864|FG001|Overall Study|Study terminated by sponsor|129|||
125972703|NCT04313881|453188863|FG000|Overall Study|Consent withdrawn|19|||
125972704|NCT04313881|453188864|FG001|Overall Study|Consent withdrawn|15|||
125972705|NCT04313881|453188863|FG000|Overall Study|Reason not Specified|3|||
125972706|NCT04313881|453188864|FG001|Overall Study|Reason not Specified|1|||
125972707|NCT00688636|453188867|FG000|Overall Study|Adverse Event|2|||
125972708|NCT00688636|453188868|FG001|Overall Study|Adverse Event|1|||
125972709|NCT01572727|453188869|FG000|Overall Study|Adverse Event|43|||
125972710|NCT01572727|453188870|FG001|Overall Study|Adverse Event|15|||
125972711|NCT01572727|453188869|FG000|Overall Study|Lost to Follow-up|1|||
125972712|NCT01572727|453188870|FG001|Overall Study|Lost to Follow-up|1|||
125972713|NCT01572727|453188869|FG000|Overall Study|Physician Decision|23|||
125972714|NCT01572727|453188870|FG001|Overall Study|Physician Decision|9|||
125972715|NCT01572727|453188869|FG000|Overall Study|Progressive disease|59|||
125972716|NCT01572727|453188870|FG001|Overall Study|Progressive disease|82|||
125972717|NCT01572727|453188869|FG000|Overall Study|Protocol Violation|0|||
125972718|NCT01572727|453188870|FG001|Overall Study|Protocol Violation|1|||
125972719|NCT01572727|453188869|FG000|Overall Study|Study terminated by sponsor|61|||
125972720|NCT01572727|453188870|FG001|Overall Study|Study terminated by sponsor|83|||
125972721|NCT01572727|453188869|FG000|Overall Study|Parent/guardian decision|14|||
125972722|NCT01572727|453188870|FG001|Overall Study|Parent/guardian decision|9|||
125972723|NCT01572727|453188869|FG000|Overall Study|Death|2|||
125972724|NCT01572727|453188870|FG001|Overall Study|Death|2|||
125972725|NCT01572727|453188869|FG000|Overall Study|Untreated|4|||
125972726|NCT01572727|453188870|FG001|Overall Study|Untreated|7|||
125972727|NCT04053764|453188871|FG000|Overall Study|Withdrawal by Subject|6|||
125972728|NCT04053764|453188872|FG001|Overall Study|Withdrawal by Subject|2|||
125972729|NCT04053764|453188871|FG000|Overall Study|Physician Decision|2|||
125972730|NCT04053764|453188872|FG001|Overall Study|Physician Decision|1|||
125972731|NCT04053764|453188871|FG000|Overall Study|Adverse Event|1|||
125972732|NCT04053764|453188872|FG001|Overall Study|Adverse Event|0|||
125972733|NCT04053764|453188871|FG000|Overall Study|Pregnancy|1|||
125972734|NCT04053764|453188872|FG001|Overall Study|Pregnancy|0|||
125972735|NCT04732286|453188876|FG000|Overall Study|Progressive Disease|2|||
125972736|NCT04732286|453188876|FG000|Overall Study|Physician Decision|1|||
125972737|NCT04732286|453188876|FG000|Overall Study|Study Terminated by Sponsor|31|||
125972738|NCT04732286|453188876|FG000|Overall Study|Withdrawal by Subject|10|||
125972739|NCT04732286|453188876|FG000|Overall Study|Non-compliance With Study Drug|1|||
125972740|NCT04732286|453188876|FG000|Overall Study|Lost to Follow-up|4|||
125972741|NCT04732286|453188876|FG000|Overall Study|Death|51|||
125972742|NCT01474681|453188880|FG000|Overall Study|Death|0|||
125972743|NCT01474681|453188881|FG001|Overall Study|Death|3|||
125972744|NCT01474681|453188882|FG002|Overall Study|Death|2|||
125972745|NCT01474681|453188883|FG003|Overall Study|Death|6|||
125972746|NCT01910129|453188888|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
125972747|NCT01910129|453188889|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
125972748|NCT01910129|453188890|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
125972749|NCT01910129|453188888|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
125972750|NCT01910129|453188889|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
125972751|NCT01910129|453188890|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
125972752|NCT00319098|453188891|FG000|Overall Study|Serious adverse event|3|||
125972753|NCT00319098|453188892|FG001|Overall Study|Serious adverse event|0|||
125972754|NCT00319098|453188891|FG000|Overall Study|Adverse Event|20|||
125972755|NCT00319098|453188892|FG001|Overall Study|Adverse Event|1|||
125972756|NCT00319098|453188891|FG000|Overall Study|Withdrawal by Subject|37|||
125972757|NCT00319098|453188892|FG001|Overall Study|Withdrawal by Subject|8|||
125972758|NCT00319098|453188891|FG000|Overall Study|Migrated/moved from study area|2|||
125972759|NCT00319098|453188892|FG001|Overall Study|Migrated/moved from study area|1|||
125972760|NCT00319098|453188891|FG000|Overall Study|Lost to Follow-up|37|||
125972761|NCT00319098|453188892|FG001|Overall Study|Lost to Follow-up|13|||
125972762|NCT00319098|453188891|FG000|Overall Study|Others|33|||
125972763|NCT00319098|453188892|FG001|Overall Study|Others|8|||
126163044|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
126163045|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
126163046|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
126163047|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
126163048|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
126163049|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
126163050|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
126163051|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
126163052|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
126163053|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
126163054|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
126163055|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
126163056|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
126163057|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
126163058|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
126163059|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
125972764|NCT00319098|453188891|FG000|Overall Study|Protocol Violation|3|||
125972765|NCT00319098|453188892|FG001|Overall Study|Protocol Violation|1|||
125972766|NCT03595904|453188895|FG000|Overall Study|Protocol Violation|3|||
125972767|NCT03595904|453188896|FG001|Overall Study|Protocol Violation|1|||
125972768|NCT03595904|453188895|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
125972769|NCT03595904|453188896|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
125972770|NCT03595904|453188895|FG000|Overall Study|Insurance complications|1|||
125972771|NCT03595904|453188896|FG001|Overall Study|Insurance complications|0|||
125972772|NCT03595904|453188895|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
125972773|NCT03595904|453188896|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
125972774|NCT01392560|453188897|FG000|Overall Study|Adverse Event|2|||
125972775|NCT01392560|453188897|FG000|Overall Study|not entered|8|||
125972776|NCT01392560|453188897|FG000|Overall Study|discontinued during placebo run-in|2|||
125972777|NCT02199028|453188907|FG000|Week 1|Adverse Event|1|||
125972778|NCT02199028|453188908|FG001|Week 1|Adverse Event|0|||
125972779|NCT02199028|453188907|FG000|Week 3|Adverse Event|1|||
125972780|NCT02199028|453188908|FG001|Week 3|Adverse Event|0|||
125972781|NCT01881126|453188909|FG000|Overall Study|Non-compliance|1|||
125972782|NCT01881126|453188910|FG001|Overall Study|Non-compliance|1|||
125972783|NCT01881126|453188909|FG000|Overall Study|Adverse Event|0|||
125972784|NCT01881126|453188910|FG001|Overall Study|Adverse Event|1|||
125972785|NCT02341417|453188911|FG000|Overall Study|Withdrawal by Subject|0|||
125972786|NCT02341417|453188912|FG001|Overall Study|Withdrawal by Subject|2|||
125972787|NCT02341417|453188913|FG002|Overall Study|Withdrawal by Subject|0|||
125972788|NCT02341417|453188911|FG000|Overall Study|Decision by sponsor|2|||
125972789|NCT02341417|453188912|FG001|Overall Study|Decision by sponsor|0|||
125972790|NCT02341417|453188913|FG002|Overall Study|Decision by sponsor|0|||
125972791|NCT02341417|453188911|FG000|Overall Study|Death|0|||
125972792|NCT02341417|453188912|FG001|Overall Study|Death|0|||
125972793|NCT02341417|453188913|FG002|Overall Study|Death|1|||
125972794|NCT04764396|453188921|FG000|Overall Study|Physician Decision|1|||
125972795|NCT04764396|453188922|FG001|Overall Study|Physician Decision|0|||
125972796|NCT02653482|453188924|FG000|Overall Study|Death|1|||
125972797|NCT02653482|453188925|FG001|Overall Study|Death|1|||
125972798|NCT03230916|453188928|FG000|Overall Study|Withdrawal by Subject|0|||
125972799|NCT03230916|453188929|FG001|Overall Study|Withdrawal by Subject|0|||
125972800|NCT03230916|453188930|FG002|Overall Study|Withdrawal by Subject|0|||
125972801|NCT03230916|453188931|FG003|Overall Study|Withdrawal by Subject|0|||
125972802|NCT03230916|453188932|FG004|Overall Study|Withdrawal by Subject|0|||
125972803|NCT03230916|453188933|FG005|Overall Study|Withdrawal by Subject|1|||
125972804|NCT03230916|453188934|FG006|Overall Study|Withdrawal by Subject|0|||
125972805|NCT03230916|453188935|FG007|Overall Study|Withdrawal by Subject|0|||
125972806|NCT03230916|453188936|FG008|Overall Study|Withdrawal by Subject|0|||
125972807|NCT03230916|453188937|FG009|Overall Study|Withdrawal by Subject|0|||
125972808|NCT03230916|453188938|FG010|Overall Study|Withdrawal by Subject|0|||
125972809|NCT03077724|453188941|FG000|Overall Study|Lost to Follow-up|5|||
125972810|NCT03077724|453188942|FG001|Overall Study|Lost to Follow-up|1|||
125972811|NCT03077724|453188941|FG000|Overall Study|Withdrawal by Subject|3|||
125972812|NCT03077724|453188942|FG001|Overall Study|Withdrawal by Subject|1|||
125972813|NCT04370054|453188945|FG000|Treatment Phase|Lost to Follow-up|1|||
125972814|NCT04370054|453188945|FG000|Treatment Phase|Withdrawal by Subject|1|||
125972815|NCT04370054|453188945|FG000|Follow-Up Phase|Ongoing|75|||
125972816|NCT00680407|453188949|FG000|Overall Study|Lost to Follow-up|3|||
125972817|NCT00680407|453188950|FG001|Overall Study|Lost to Follow-up|3|||
125972818|NCT00680407|453188951|FG002|Overall Study|Lost to Follow-up|1|||
125972819|NCT00680407|453188949|FG000|Overall Study|Withdrawal by Subject|5|||
125972820|NCT00680407|453188950|FG001|Overall Study|Withdrawal by Subject|2|||
126163060|NCT03395197|453884190|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
126163061|NCT03395197|453884191|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
126163062|NCT03395197|453884192|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
126163063|NCT03395197|453884193|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
126163064|NCT03395197|453884194|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
126163065|NCT03395197|453884195|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
126163066|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|Death|0|||
126163067|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|Death|0|||
126163068|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|Death|0|||
126163069|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|Death|0|||
126163070|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|Death|1|||
126163071|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|Death|4|||
126163072|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
126163073|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
126163074|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
126163075|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
126163076|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
126163077|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
126163078|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126163079|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126163080|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126163081|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126163082|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
126163083|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126163084|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
126163085|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
126163086|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
126163087|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
126163088|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
126163089|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
126163090|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
126163091|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
126163092|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
126163093|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
126163094|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
126163095|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
126163096|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
126163097|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
126163098|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
126163099|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
126163100|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
126163101|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
126163102|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
126163103|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
126163104|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
126163105|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
126163106|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
126163107|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
126163108|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|Other|0|||
126163109|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|Other|0|||
126163110|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|Other|0|||
126163111|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|Other|0|||
126163112|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|Other|3|||
126163113|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|Other|3|||
126163114|NCT03395197|453884190|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
126163115|NCT03395197|453884191|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
126163116|NCT03395197|453884192|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
126163117|NCT03395197|453884193|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
126163118|NCT03395197|453884194|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
126163119|NCT03395197|453884195|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
126163120|NCT01605071|453884196|FG000|Overall Study|Withdrawal by Subject|3|||
126163121|NCT01605071|453884197|FG001|Overall Study|Withdrawal by Subject|2|||
126163122|NCT00392171|453884198|FG000|Overall Study|Did not meet inclusion criteria|4|||
126163123|NCT00392171|453884198|FG000|Overall Study|Disease progression|101|||
126163124|NCT04907539|453884204|FG000|Overall Study|Consent withdrawn|1|||
126163125|NCT04907539|453884205|FG001|Overall Study|Consent withdrawn|0|||
126163126|NCT04907539|453884204|FG000|Overall Study|Death|14|||
126163127|NCT04907539|453884205|FG001|Overall Study|Death|3|||
126163128|NCT01881620|453884207|FG000|Overall Study|Protocol Violation|4|||
126163129|NCT01808118|453884208|FG000|Period 1|Adverse Event|15|||
126163130|NCT01808118|453884209|FG001|Period 1|Adverse Event|0|||
126163131|NCT01808118|453884210|FG002|Period 1|Adverse Event|0|||
126163132|NCT01808118|453884208|FG000|Period 1|Withdrew consent|24|||
126163133|NCT01808118|453884209|FG001|Period 1|Withdrew consent|0|||
126163134|NCT01808118|453884210|FG002|Period 1|Withdrew consent|0|||
126163135|NCT01808118|453884208|FG000|Period 1|Lost to Follow-up|9|||
126163136|NCT01808118|453884209|FG001|Period 1|Lost to Follow-up|0|||
126163137|NCT01808118|453884210|FG002|Period 1|Lost to Follow-up|0|||
126163138|NCT01808118|453884208|FG000|Period 1|Did not meet criteria for remission|303|||
126163139|NCT01808118|453884209|FG001|Period 1|Did not meet criteria for remission|0|||
126163140|NCT01808118|453884210|FG002|Period 1|Did not meet criteria for remission|0|||
126163141|NCT01808118|453884208|FG000|Period 1|Enrolled in error|7|||
126163142|NCT01808118|453884209|FG001|Period 1|Enrolled in error|0|||
126163143|NCT01808118|453884210|FG002|Period 1|Enrolled in error|0|||
126163144|NCT01808118|453884208|FG000|Period 1|Did not meet inclusion criteria|3|||
126163145|NCT01808118|453884209|FG001|Period 1|Did not meet inclusion criteria|0|||
126163146|NCT01808118|453884210|FG002|Period 1|Did not meet inclusion criteria|0|||
126163147|NCT01808118|453884208|FG000|Period 1|Non-conformance with inclusion criteria|3|||
126163148|NCT01808118|453884209|FG001|Period 1|Non-conformance with inclusion criteria|0|||
126163149|NCT01808118|453884210|FG002|Period 1|Non-conformance with inclusion criteria|0|||
126163150|NCT01808118|453884208|FG000|Period 1|Investigator decision: site closure|2|||
126163151|NCT01808118|453884209|FG001|Period 1|Investigator decision: site closure|0|||
126163152|NCT01808118|453884210|FG002|Period 1|Investigator decision: site closure|0|||
126163153|NCT01808118|453884208|FG000|Period 1|Non-compliance per sponsor|1|||
126163154|NCT01808118|453884209|FG001|Period 1|Non-compliance per sponsor|0|||
126163155|NCT01808118|453884210|FG002|Period 1|Non-compliance per sponsor|0|||
126163156|NCT01808118|453884208|FG000|Period 1|Lack of Efficacy|1|||
126163157|NCT01808118|453884209|FG001|Period 1|Lack of Efficacy|0|||
126163158|NCT01808118|453884210|FG002|Period 1|Lack of Efficacy|0|||
126163159|NCT01808118|453884208|FG000|Period 2|Adverse Event|0|||
126163160|NCT01808118|453884209|FG001|Period 2|Adverse Event|4|||
126163161|NCT01808118|453884210|FG002|Period 2|Adverse Event|0|||
126163162|NCT01808118|453884208|FG000|Period 2|Withdrew consent|0|||
126163163|NCT01808118|453884209|FG001|Period 2|Withdrew consent|7|||
126163164|NCT01808118|453884210|FG002|Period 2|Withdrew consent|6|||
126163165|NCT01808118|453884208|FG000|Period 2|Lost to Follow-up|0|||
126163166|NCT01808118|453884209|FG001|Period 2|Lost to Follow-up|0|||
126163167|NCT01808118|453884210|FG002|Period 2|Lost to Follow-up|2|||
126163168|NCT01808118|453884208|FG000|Period 2|Investigator no longer conducting trials|0|||
126163169|NCT01808118|453884209|FG001|Period 2|Investigator no longer conducting trials|1|||
126163170|NCT01808118|453884210|FG002|Period 2|Investigator no longer conducting trials|0|||
126163171|NCT01808118|453884208|FG000|Period 2|Switched to other therapy|0|||
126163172|NCT01808118|453884209|FG001|Period 2|Switched to other therapy|1|||
126163173|NCT01808118|453884210|FG002|Period 2|Switched to other therapy|0|||
126163174|NCT01701583|453884211|FG000|Overall Study|Withdrawal by Subject|2|||
126163175|NCT01701583|453884212|FG001|Overall Study|Withdrawal by Subject|0|||
126163176|NCT01441440|453884213|FG000|Overall Study|Death|1|||
126163177|NCT01441440|453884214|FG001|Overall Study|Death|0|||
126163178|NCT01441440|453884215|FG002|Overall Study|Death|1|||
126163179|NCT01441440|453884213|FG000|Overall Study|Adverse Event|2|||
126163180|NCT01441440|453884214|FG001|Overall Study|Adverse Event|9|||
126163181|NCT01441440|453884215|FG002|Overall Study|Adverse Event|9|||
126163182|NCT01441440|453884213|FG000|Overall Study|Lost to Follow-up|0|||
126163183|NCT01441440|453884214|FG001|Overall Study|Lost to Follow-up|2|||
126163184|NCT01441440|453884215|FG002|Overall Study|Lost to Follow-up|1|||
126163185|NCT01441440|453884213|FG000|Overall Study|Withdrawal by Subject|11|||
126163186|NCT01441440|453884214|FG001|Overall Study|Withdrawal by Subject|9|||
126163187|NCT01441440|453884215|FG002|Overall Study|Withdrawal by Subject|9|||
126163188|NCT01441440|453884213|FG000|Overall Study|Pregnancy|1|||
126163189|NCT01441440|453884214|FG001|Overall Study|Pregnancy|0|||
126163190|NCT01441440|453884215|FG002|Overall Study|Pregnancy|0|||
126163191|NCT01441440|453884213|FG000|Overall Study|Lack of Efficacy|1|||
126163192|NCT01441440|453884214|FG001|Overall Study|Lack of Efficacy|0|||
125972821|NCT00680407|453188951|FG002|Overall Study|Withdrawal by Subject|2|||
125972822|NCT00924287|453191353|FG000|Overall Study|Death|1|||
126163193|NCT01441440|453884215|FG002|Overall Study|Lack of Efficacy|1|||
126163194|NCT01441440|453884213|FG000|Overall Study|Moving|0|||
126163195|NCT01441440|453884214|FG001|Overall Study|Moving|1|||
126163196|NCT01441440|453884215|FG002|Overall Study|Moving|1|||
126163197|NCT01441440|453884213|FG000|Overall Study|Work-related matter|0|||
126163198|NCT01441440|453884214|FG001|Overall Study|Work-related matter|1|||
126163199|NCT01441440|453884215|FG002|Overall Study|Work-related matter|0|||
126163200|NCT01441440|453884213|FG000|Overall Study|Difficllty in keeping the schedule|1|||
126163201|NCT01441440|453884214|FG001|Overall Study|Difficllty in keeping the schedule|1|||
126163202|NCT01441440|453884215|FG002|Overall Study|Difficllty in keeping the schedule|0|||
126163203|NCT02750813|453884221|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
126163204|NCT02750813|453884222|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
126163205|NCT02750813|453884221|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
126163206|NCT02750813|453884222|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
126163207|NCT00615290|453884223|FG000|Overall Study|Adverse Event|2|||
126163208|NCT00615290|453884223|FG000|Overall Study|Lost to Follow-up|3|||
126163209|NCT00615290|453884223|FG000|Overall Study|Withdrawal by Subject|1|||
126163210|NCT00615290|453884223|FG000|Overall Study|Other|2|||
126163211|NCT02245568|453884224|FG000|Overall Study|Study terminated by Sponsor|346|||
126163212|NCT02245568|453884224|FG000|Overall Study|Adverse Event|144|||
126163213|NCT02245568|453884224|FG000|Overall Study|Lack of Efficacy|98|||
126163214|NCT02245568|453884224|FG000|Overall Study|Withdrawal by Caregiver|85|||
126163215|NCT02245568|453884224|FG000|Overall Study|Withdrawal by Subject|77|||
126163216|NCT02245568|453884224|FG000|Overall Study|Withdrawal by Legal Representative|31|||
126163217|NCT02245568|453884224|FG000|Overall Study|Missing (Site closure)|16|||
126163218|NCT02245568|453884224|FG000|Overall Study|Physician Decision|14|||
126163219|NCT02245568|453884224|FG000|Overall Study|Non-compliance with study drug|11|||
126163220|NCT02245568|453884224|FG000|Overall Study|Death|9|||
126163221|NCT02245568|453884224|FG000|Overall Study|Blue staining|6|||
126163222|NCT02245568|453884224|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
126163223|NCT02245568|453884224|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
126163224|NCT02245568|453884224|FG000|Overall Study|Lost to Follow-up|5|||
126163225|NCT00366548|453884225|FG000|Infant Series|Adverse Event|1|||
126163226|NCT00366548|453884226|FG001|Infant Series|Adverse Event|3|||
126163227|NCT00366548|453884225|FG000|Infant Series|Protocol Violation|0|||
126163228|NCT00366548|453884226|FG001|Infant Series|Protocol Violation|1|||
126163229|NCT00366548|453884225|FG000|Infant Series|Withdrawal by Subject|3|||
126163230|NCT00366548|453884226|FG001|Infant Series|Withdrawal by Subject|1|||
126163231|NCT00366548|453884225|FG000|After Infant Series|Withdrawal by Subject|3|||
126163232|NCT00366548|453884226|FG001|After Infant Series|Withdrawal by Subject|1|||
126163233|NCT00366548|453884225|FG000|After Infant Series|Adverse Event|2|||
126163234|NCT00366548|453884226|FG001|After Infant Series|Adverse Event|0|||
126163235|NCT00366548|453884225|FG000|After Infant Series|Lost to Follow-up|1|||
126163236|NCT00366548|453884226|FG001|After Infant Series|Lost to Follow-up|0|||
126163237|NCT01252134|453884227|FG000|Period 1, 8 Hours|Personal Reasons|0|||
126163238|NCT01252134|453884228|FG001|Period 1, 8 Hours|Personal Reasons|1|||
126163239|NCT01252134|453884229|FG002|Period 1, 8 Hours|Personal Reasons|1|||
126163240|NCT01252134|453884230|FG003|Period 1, 8 Hours|Personal Reasons|0|||
126163241|NCT01252134|453884231|FG004|Period 1, 8 Hours|Personal Reasons|0|||
126163242|NCT01252134|453884232|FG005|Period 1, 8 Hours|Personal Reasons|0|||
126163243|NCT03650452|453884234|FG000|Overall Study|Physician Decision|1|||
126163244|NCT03650452|453884235|FG001|Overall Study|Physician Decision|0|||
126163245|NCT03650452|453884234|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
126163246|NCT03650452|453884235|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126163247|NCT03650452|453884234|FG000|Overall Study|Adverse Event|3|||
126163248|NCT03650452|453884235|FG001|Overall Study|Adverse Event|4|||
126163249|NCT03650452|453884234|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
126163250|NCT03650452|453884235|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
126163251|NCT02273050|453884236|FG000|Overall Study|Adverse Event|4|||
126163252|NCT02273050|453884237|FG001|Overall Study|Adverse Event|3|||
126163253|NCT02273050|453884238|FG002|Overall Study|Adverse Event|3|||
126163254|NCT02273050|453884236|FG000|Overall Study|Death|0|||
126163255|NCT02273050|453884237|FG001|Overall Study|Death|0|||
126163256|NCT02273050|453884238|FG002|Overall Study|Death|1|||
126163257|NCT02273050|453884236|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
126163258|NCT02273050|453884237|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
126163259|NCT02273050|453884238|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
126163260|NCT02273050|453884236|FG000|Overall Study|Lack of Efficacy|0|||
126163261|NCT02273050|453884237|FG001|Overall Study|Lack of Efficacy|1|||
126163262|NCT02273050|453884238|FG002|Overall Study|Lack of Efficacy|1|||
126163263|NCT02273050|453884236|FG000|Overall Study|Withdrawal by Subject|17|||
126163264|NCT02273050|453884237|FG001|Overall Study|Withdrawal by Subject|14|||
126163265|NCT02273050|453884238|FG002|Overall Study|Withdrawal by Subject|16|||
125972823|NCT01625897|453191354|FG000|Overall Study|Adverse Event|27|||
126163266|NCT02273050|453884236|FG000|Overall Study|Lost to Follow-up|0|||
126163267|NCT02273050|453884237|FG001|Overall Study|Lost to Follow-up|2|||
126163268|NCT02273050|453884238|FG002|Overall Study|Lost to Follow-up|3|||
126163269|NCT02273050|453884236|FG000|Overall Study|Protocol Violation|3|||
126163270|NCT02273050|453884237|FG001|Overall Study|Protocol Violation|1|||
126163271|NCT02273050|453884238|FG002|Overall Study|Protocol Violation|4|||
126163272|NCT02297438|453884239|FG000|Overall Study|Death|79|||
126163273|NCT02297438|453884240|FG001|Overall Study|Death|86|||
126163274|NCT02297438|453884239|FG000|Overall Study|Lost to Follow-up|9|||
126163275|NCT02297438|453884240|FG001|Overall Study|Lost to Follow-up|7|||
126163276|NCT02297438|453884239|FG000|Overall Study|Withdrawal by Subject|7|||
126163277|NCT02297438|453884240|FG001|Overall Study|Withdrawal by Subject|0|||
126163278|NCT02297438|453884239|FG000|Overall Study|Other|9|||
126163279|NCT02297438|453884240|FG001|Overall Study|Other|5|||
126163280|NCT02297438|453884239|FG000|Overall Study|Ongoing|65|||
126163281|NCT02297438|453884240|FG001|Overall Study|Ongoing|73|||
126163282|NCT02042404|453884241|FG000|Overall Study|Death|1|||
126163283|NCT02042404|453884242|FG001|Overall Study|Death|0|||
126163284|NCT02042404|453884241|FG000|Overall Study|Unrelated Adverse Event|3|||
126163285|NCT02042404|453884242|FG001|Overall Study|Unrelated Adverse Event|0|||
126163286|NCT02042404|453884241|FG000|Overall Study|Inability to meet time requirements|1|||
126163287|NCT02042404|453884242|FG001|Overall Study|Inability to meet time requirements|0|||
126163288|NCT05058664|453884249|FG000|Overall Study|No follow-up data provided|4|||
126163289|NCT05058664|453884250|FG001|Overall Study|No follow-up data provided|0|||
126163290|NCT05058664|453884251|FG002|Overall Study|No follow-up data provided|2|||
126163291|NCT05058664|453884249|FG000|Overall Study|Withdrawal by Subject|0|||
126163292|NCT05058664|453884250|FG001|Overall Study|Withdrawal by Subject|0|||
126163293|NCT05058664|453884251|FG002|Overall Study|Withdrawal by Subject|1|||
126163294|NCT00972244|453884252|FG000|Overall Study|Incorrect Enrolment|1|||
126163295|NCT00972244|453884253|FG001|Overall Study|Incorrect Enrolment|0|||
126163296|NCT00972244|453884254|FG002|Overall Study|Incorrect Enrolment|0|||
126163297|NCT00972244|453884255|FG003|Overall Study|Incorrect Enrolment|0|||
126163298|NCT00972244|453884256|FG004|Overall Study|Incorrect Enrolment|0|||
126163299|NCT00972244|453884252|FG000|Overall Study|Adverse Event|0|||
126163300|NCT00972244|453884253|FG001|Overall Study|Adverse Event|1|||
126163301|NCT00972244|453884254|FG002|Overall Study|Adverse Event|1|||
126163302|NCT00972244|453884255|FG003|Overall Study|Adverse Event|0|||
126163303|NCT00972244|453884256|FG004|Overall Study|Adverse Event|0|||
126163304|NCT00972244|453884252|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
126163305|NCT00972244|453884253|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
126163306|NCT00972244|453884254|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
126163307|NCT00972244|453884255|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
126163308|NCT00972244|453884256|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
126163309|NCT00972244|453884252|FG000|Overall Study|Withdrawal by Subject|1|||
126163310|NCT00972244|453884253|FG001|Overall Study|Withdrawal by Subject|2|||
126163311|NCT00972244|453884254|FG002|Overall Study|Withdrawal by Subject|1|||
126163312|NCT00972244|453884255|FG003|Overall Study|Withdrawal by Subject|0|||
126163313|NCT00972244|453884256|FG004|Overall Study|Withdrawal by Subject|1|||
126163314|NCT00972244|453884252|FG000|Overall Study|Safety|0|||
126163315|NCT00972244|453884253|FG001|Overall Study|Safety|0|||
126163316|NCT00972244|453884254|FG002|Overall Study|Safety|0|||
126163317|NCT00972244|453884255|FG003|Overall Study|Safety|0|||
126163318|NCT00972244|453884256|FG004|Overall Study|Safety|1|||
126163319|NCT00972244|453884252|FG000|Overall Study|Death|1|||
126163320|NCT00972244|453884253|FG001|Overall Study|Death|0|||
126163321|NCT00972244|453884254|FG002|Overall Study|Death|0|||
126163322|NCT00972244|453884255|FG003|Overall Study|Death|0|||
126163323|NCT00972244|453884256|FG004|Overall Study|Death|0|||
126163324|NCT00972244|453884252|FG000|Overall Study|Various|0|||
126163325|NCT00972244|453884253|FG001|Overall Study|Various|0|||
126163326|NCT00972244|453884254|FG002|Overall Study|Various|0|||
126163327|NCT00972244|453884255|FG003|Overall Study|Various|0|||
126163328|NCT00972244|453884256|FG004|Overall Study|Various|2|||
126163329|NCT01597557|453884257|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
126163330|NCT01597557|453884258|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
126163331|NCT02561000|453884261|FG000|Overall Study|Withdrawal by Subject|2|||
126163332|NCT02561000|453884262|FG001|Overall Study|Withdrawal by Subject|3|||
126163333|NCT02561000|453884263|FG002|Overall Study|Withdrawal by Subject|0|||
126163334|NCT02561000|453884261|FG000|Overall Study|Adverse Event|0|||
126163335|NCT02561000|453884262|FG001|Overall Study|Adverse Event|1|||
126163336|NCT02561000|453884263|FG002|Overall Study|Adverse Event|0|||
126163337|NCT03952468|453884264|FG000|Overall Study|Death|0|||
126163338|NCT03952468|453884265|FG001|Overall Study|Death|1|||
126163339|NCT03952468|453884264|FG000|Overall Study|Adverse Event|0|||
126163340|NCT03952468|453884265|FG001|Overall Study|Adverse Event|1|||
126163341|NCT03952468|453884264|FG000|Overall Study|Physician Decision|1|||
126163342|NCT03952468|453884265|FG001|Overall Study|Physician Decision|0|||
126163343|NCT03952468|453884264|FG000|Overall Study|Lost to Follow-up|3|||
126163344|NCT03952468|453884265|FG001|Overall Study|Lost to Follow-up|4|||
126163345|NCT03952468|453884264|FG000|Overall Study|Withdrawal by Subject|2|||
126163346|NCT03952468|453884265|FG001|Overall Study|Withdrawal by Subject|1|||
126163347|NCT05761444|453884267|FG000|Overall Study|Protocol Violation|2|||
126163348|NCT05761444|453884268|FG001|Overall Study|Protocol Violation|1|||
126163349|NCT05761444|453884267|FG000|Overall Study|Adverse Event|2|||
126163350|NCT05761444|453884268|FG001|Overall Study|Adverse Event|2|||
126163351|NCT05761444|453884267|FG000|Overall Study|Withdrawal by Subject|3|||
126163352|NCT05761444|453884268|FG001|Overall Study|Withdrawal by Subject|2|||
126163353|NCT05761444|453884267|FG000|Overall Study|Other|1|||
126163354|NCT05761444|453884268|FG001|Overall Study|Other|0|||
126163355|NCT04716933|453884269|FG000|Overall Study|Sponsor Decision|36|||
126163356|NCT04716933|453884270|FG001|Overall Study|Sponsor Decision|33|||
126163357|NCT04716933|453884269|FG000|Overall Study|Death|65|||
126163358|NCT04716933|453884270|FG001|Overall Study|Death|67|||
126163359|NCT01005719|453884273|FG000|Period 1|Adverse Event|0|||
126163360|NCT01005719|453884274|FG001|Period 1|Adverse Event|0|||
126163361|NCT01005719|453884275|FG002|Period 1|Adverse Event|0|||
126163362|NCT01005719|453884276|FG003|Period 1|Adverse Event|1|||
126163363|NCT01005719|453884277|FG004|Period 1|Adverse Event|0|||
126163364|NCT01005719|453884278|FG005|Period 1|Adverse Event|0|||
126163365|NCT01005719|453884273|FG000|Period 1|Delay in completing study procedures|0|||
126163366|NCT01005719|453884274|FG001|Period 1|Delay in completing study procedures|0|||
126163367|NCT01005719|453884275|FG002|Period 1|Delay in completing study procedures|0|||
126163368|NCT01005719|453884276|FG003|Period 1|Delay in completing study procedures|0|||
126163369|NCT01005719|453884277|FG004|Period 1|Delay in completing study procedures|0|||
126163370|NCT01005719|453884278|FG005|Period 1|Delay in completing study procedures|1|||
126163371|NCT01005719|453884273|FG000|Period 2|Adverse Event|0|||
126163372|NCT01005719|453884274|FG001|Period 2|Adverse Event|0|||
126163373|NCT01005719|453884275|FG002|Period 2|Adverse Event|0|||
126163374|NCT01005719|453884276|FG003|Period 2|Adverse Event|0|||
126163375|NCT01005719|453884277|FG004|Period 2|Adverse Event|1|||
126163376|NCT01005719|453884278|FG005|Period 2|Adverse Event|1|||
126163377|NCT01106534|453884279|FG000|Overall Study|Withdrawal by Subject|18|||
126163378|NCT01106534|453884279|FG000|Overall Study|Lost to Follow-up|2|||
126163379|NCT01106534|453884279|FG000|Overall Study|Death|16|||
126163380|NCT01106534|453884279|FG000|Overall Study|Physician Decision|1|||
126163381|NCT04430738|453884280|FG000|Phase 1: Dose Escalation|Death|1|||
126163382|NCT04430738|453884281|FG001|Phase 1: Dose Escalation|Death|4|||
126163383|NCT04430738|453884282|FG002|Phase 1: Dose Escalation|Death|4|||
126163384|NCT04430738|453884283|FG003|Phase 1: Dose Escalation|Death|1|||
126163385|NCT04430738|453884284|FG004|Phase 1: Dose Escalation|Death|6|||
126163386|NCT04430738|453884285|FG005|Phase 1: Dose Escalation|Death|0|||
126163387|NCT04430738|453884280|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
126163388|NCT04430738|453884281|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
126163389|NCT04430738|453884282|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
126163390|NCT04430738|453884283|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
126163391|NCT04430738|453884284|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
126163392|NCT04430738|453884285|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
126163393|NCT04430738|453884280|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
126163394|NCT04430738|453884281|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
126163395|NCT04430738|453884282|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
126163396|NCT04430738|453884283|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
126163397|NCT04430738|453884284|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
126163398|NCT04430738|453884285|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
126163399|NCT04430738|453884280|FG000|Phase 1: Dose Escalation|Other|1|||
126163400|NCT04430738|453884281|FG001|Phase 1: Dose Escalation|Other|0|||
126163401|NCT04430738|453884282|FG002|Phase 1: Dose Escalation|Other|0|||
126163402|NCT04430738|453884283|FG003|Phase 1: Dose Escalation|Other|0|||
126163403|NCT04430738|453884284|FG004|Phase 1: Dose Escalation|Other|0|||
126163404|NCT04430738|453884285|FG005|Phase 1: Dose Escalation|Other|0|||
126163405|NCT04430738|453884280|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126163406|NCT04430738|453884281|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126163407|NCT04430738|453884282|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126163408|NCT04430738|453884283|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126163409|NCT04430738|453884284|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126163410|NCT04430738|453884285|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
126163411|NCT04430738|453884280|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126163412|NCT04430738|453884281|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126163413|NCT04430738|453884282|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126163414|NCT04430738|453884283|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126163415|NCT04430738|453884284|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126163416|NCT04430738|453884285|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
126163417|NCT05187013|453884286|FG000|Overall Study|Withdrawal by Subject|1|||
126163418|NCT05187013|453884287|FG001|Overall Study|Withdrawal by Subject|1|||
126163419|NCT05187013|453884288|FG002|Overall Study|Withdrawal by Subject|0|||
126163420|NCT05187013|453884286|FG000|Overall Study|Death|0|||
126163421|NCT05187013|453884287|FG001|Overall Study|Death|1|||
126163422|NCT05187013|453884288|FG002|Overall Study|Death|0|||
126163423|NCT05187013|453884286|FG000|Overall Study|Lost to Follow-up|20|||
126163424|NCT05187013|453884287|FG001|Overall Study|Lost to Follow-up|17|||
126163425|NCT05187013|453884288|FG002|Overall Study|Lost to Follow-up|0|||
126163426|NCT05187013|453884286|FG000|Overall Study|Ongoing Participants|3|||
126163427|NCT05187013|453884287|FG001|Overall Study|Ongoing Participants|5|||
126163428|NCT05187013|453884288|FG002|Overall Study|Ongoing Participants|0|||
126163429|NCT04488822|453884289|FG000|Overall Study|Adverse Event|8|||
126163430|NCT04488822|453884289|FG000|Overall Study|Withdrawal by Subject|1|||
126163431|NCT03838367|453884290|FG000|Overall Study|Early termination of study|3|||
126163432|NCT03838367|453884291|FG001|Overall Study|Early termination of study|4|||
126163433|NCT03838367|453884292|FG002|Overall Study|Early termination of study|3|||
126163434|NCT03838367|453884293|FG003|Overall Study|Early termination of study|0|||
126163435|NCT03406104|453884294|FG000|Overall Study|Lost to Follow-up|2|||
126163436|NCT03406104|453884294|FG000|Overall Study|Withdrawal by Subject|2|||
126163437|NCT03406104|453884294|FG000|Overall Study|due to Covid patient did not want to travel|1|||
126163438|NCT03406104|453884294|FG000|Overall Study|Death|2|||
126163439|NCT02499146|453884308|FG000|Overall Study|Lost to Follow-up|1|||
126163440|NCT02499146|453884308|FG000|Overall Study|Withdrawal by Subject|1|||
126163441|NCT02499146|453884308|FG000|Overall Study|Other|2|||
126163442|NCT02499146|453884308|FG000|Overall Study|Ongoing at date of cut-off|9|||
126163443|NCT02499146|453884308|FG000|Overall Study|Began other treatment/therapy|13|||
126163444|NCT05692154|453884309|FG000|Overall Study|Adverse Event|0|||
126163445|NCT05692154|453884310|FG001|Overall Study|Adverse Event|1|||
126163446|NCT01879618|453884311|FG000|Overall Study|Does not meet entrance criteria|1|||
126163447|NCT01879618|453884311|FG000|Overall Study|Withdrawal by Subject|1|||
126163448|NCT01879618|453884311|FG000|Overall Study|Surgery;changed schedule; not available|8|||
126163449|NCT01879618|453884311|FG000|Overall Study|Protocol Violation|6|||
126163450|NCT01879618|453884311|FG000|Overall Study|Adverse Event|5|||
126163451|NCT01519245|453884312|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
126163452|NCT01519245|453884313|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
126163453|NCT02275026|453884316|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
126163454|NCT02275026|453884316|FG000|Overall Study|Withdrawal by Subject|4|||
126163455|NCT02275026|453884316|FG000|Overall Study|Ineligible due to medical history|13|||
126163456|NCT02275026|453884316|FG000|Overall Study|MRI malfunction precluded testing|1|||
126163457|NCT02275026|453884316|FG000|Overall Study|Ineligible after MRI findings|1|||
126163458|NCT02275026|453884316|FG000|Overall Study|Lost to Follow-up|2|||
126163459|NCT02275026|453884316|FG000|Overall Study|Scanner failure|1|||
126163460|NCT00001262|453884317|FG000|Overall Study|Death|10|||
126163461|NCT00001262|453884318|FG001|Overall Study|Death|11|||
126163462|NCT00001262|453884319|FG002|Overall Study|Death|0|||
126163463|NCT00001262|453884317|FG000|Overall Study|Withdrawal by Subject|0|||
126163464|NCT00001262|453884318|FG001|Overall Study|Withdrawal by Subject|3|||
126163465|NCT00001262|453884319|FG002|Overall Study|Withdrawal by Subject|0|||
126163466|NCT00878072|453884320|FG000|Overall Study|Withdrew consent|2|||
126163467|NCT01954121|453884321|FG000|Overall Study|Lack of Efficacy|94|||
126163468|NCT01954121|453884322|FG001|Overall Study|Lack of Efficacy|41|||
126163469|NCT01954121|453884321|FG000|Overall Study|Protocol Violation|0|||
126163470|NCT01954121|453884322|FG001|Overall Study|Protocol Violation|2|||
126163471|NCT01954121|453884321|FG000|Overall Study|Lost to Follow-up|5|||
126163472|NCT01954121|453884322|FG001|Overall Study|Lost to Follow-up|6|||
126163473|NCT01954121|453884321|FG000|Overall Study|Withdrawal by Subject|18|||
126163474|NCT01954121|453884322|FG001|Overall Study|Withdrawal by Subject|12|||
126163475|NCT01954121|453884321|FG000|Overall Study|Pregnancy|1|||
126163476|NCT01954121|453884322|FG001|Overall Study|Pregnancy|1|||
126163477|NCT01954121|453884321|FG000|Overall Study|AE, serious fatal|1|||
126163478|NCT01954121|453884322|FG001|Overall Study|AE, serious fatal|0|||
126163479|NCT01954121|453884321|FG000|Overall Study|AE, non-serious non-fatal|5|||
126163480|NCT01954121|453884322|FG001|Overall Study|AE, non-serious non-fatal|22|||
126163481|NCT01954121|453884321|FG000|Overall Study|SAE, non-fatal|1|||
126163482|NCT01954121|453884322|FG001|Overall Study|SAE, non-fatal|4|||
126163483|NCT01954121|453884321|FG000|Overall Study|Non-compliant with study procedures|1|||
126163484|NCT01954121|453884322|FG001|Overall Study|Non-compliant with study procedures|0|||
126163485|NCT01954121|453884321|FG000|Overall Study|Non-compliant patient|1|||
126163486|NCT01954121|453884322|FG001|Overall Study|Non-compliant patient|1|||
126163487|NCT01954121|453884321|FG000|Overall Study|Subject did not follow instructions|0|||
126163488|NCT01954121|453884322|FG001|Overall Study|Subject did not follow instructions|2|||
126163489|NCT03844633|453884323|FG000|1 Week FU|Lost to Follow-up|0|||
126163490|NCT03844633|453884324|FG001|1 Week FU|Lost to Follow-up|1|||
126163491|NCT03844633|453884325|FG002|1 Week FU|Lost to Follow-up|4|||
126163492|NCT03844633|453884323|FG000|12-month Follow-up|Lost to Follow-up|7|||
126163493|NCT03844633|453884324|FG001|12-month Follow-up|Lost to Follow-up|5|||
126163494|NCT03844633|453884325|FG002|12-month Follow-up|Lost to Follow-up|8|||
126163495|NCT02588248|453884326|FG000|Overall Study|Physician Decision|4|||
126163496|NCT02588248|453884327|FG001|Overall Study|Physician Decision|3|||
126163497|NCT03141086|453884328|FG000|Overall Study|Study Terminated By Sponsor|1|||
126163498|NCT03141086|453884329|FG001|Overall Study|Study Terminated By Sponsor|1|||
126163499|NCT03141086|453884328|FG000|Overall Study|Withdrawal by Subject|0|||
126163500|NCT03141086|453884329|FG001|Overall Study|Withdrawal by Subject|1|||
126163501|NCT03141086|453884328|FG000|Overall Study|Protocol Violation|0|||
126163502|NCT03141086|453884329|FG001|Overall Study|Protocol Violation|1|||
126163503|NCT03141086|453884328|FG000|Overall Study|Adverse Event|0|||
126163504|NCT03141086|453884329|FG001|Overall Study|Adverse Event|2|||
126163505|NCT03860844|453884330|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
126163506|NCT03860844|453884331|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
126163507|NCT03860844|453884332|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
126163508|NCT03860844|453884330|FG000|Overall Study|Progressive disease|5|||
126163509|NCT03860844|453884331|FG001|Overall Study|Progressive disease|3|||
126163510|NCT03860844|453884332|FG002|Overall Study|Progressive disease|4|||
126163511|NCT03860844|453884330|FG000|Overall Study|Other, Not related to COVID-19|0|||
126163512|NCT03860844|453884331|FG001|Overall Study|Other, Not related to COVID-19|1|||
126163513|NCT03860844|453884332|FG002|Overall Study|Other, Not related to COVID-19|0|||
126163514|NCT01678807|453884333|FG000|Overall Study|Adverse Event|4|||
126163515|NCT01678807|453884334|FG001|Overall Study|Adverse Event|4|||
126163516|NCT01678807|453884335|FG002|Overall Study|Adverse Event|0|||
126163517|NCT01678807|453884333|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
126163518|NCT01678807|453884334|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
126163519|NCT01678807|453884335|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
126163520|NCT00370149|453884336|FG000|Overall Study|Physician Decision|16|||
126163521|NCT00370149|453884337|FG001|Overall Study|Physician Decision|16|||
126163522|NCT00370149|453884336|FG000|Overall Study|Protocol Violation|1|||
126163523|NCT00370149|453884337|FG001|Overall Study|Protocol Violation|0|||
126163524|NCT00370149|453884336|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
126163525|NCT00370149|453884337|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
126163526|NCT00370149|453884336|FG000|Overall Study|Pre-existing infection|0|||
126163527|NCT00370149|453884337|FG001|Overall Study|Pre-existing infection|1|||
126163528|NCT00370149|453884336|FG000|Overall Study|Antibiotic coated dressing placed|0|||
126163529|NCT00370149|453884337|FG001|Overall Study|Antibiotic coated dressing placed|1|||
126163530|NCT00719732|453884338|FG000|Overall Study|Lost to Follow-up|20|||
126163531|NCT00719732|453884338|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
126163532|NCT00719732|453884338|FG000|Overall Study|Illness not associated with device|1|||
126163533|NCT03625986|453885738|FG000|Randomization Period|Lost to Follow-up|7|||
126163534|NCT03625986|453885739|FG001|Randomization Period|Lost to Follow-up|12|||
126163535|NCT03625986|453885738|FG000|Randomization Period|Withdrawal by Subject|10|||
126163536|NCT03625986|453885739|FG001|Randomization Period|Withdrawal by Subject|6|||
126163537|NCT04920084|453885741|FG000|Overall Study|Adverse Event|1|||
126163538|NCT04920084|453885741|FG000|Overall Study|Lost to Follow-up|2|||
126163539|NCT04920084|453885741|FG000|Overall Study|Withdrawal by Subject|2|||
126163540|NCT00620321|453885742|FG000|Overall Study|Adverse Event|1|||
126163541|NCT00620321|453885743|FG001|Overall Study|Adverse Event|1|||
126163542|NCT00620321|453885742|FG000|Overall Study|Death|1|||
126163543|NCT00620321|453885743|FG001|Overall Study|Death|1|||
126163544|NCT00620321|453885742|FG000|Overall Study|Physician Decision|0|||
126163545|NCT00620321|453885743|FG001|Overall Study|Physician Decision|7|||
126163546|NCT00620321|453885742|FG000|Overall Study|Progressive Disease|5|||
126163547|NCT00620321|453885743|FG001|Overall Study|Progressive Disease|5|||
126163548|NCT00620321|453885742|FG000|Overall Study|Sponsor Decision|0|||
126163549|NCT00620321|453885743|FG001|Overall Study|Sponsor Decision|1|||
126163550|NCT00620321|453885742|FG000|Overall Study|Withdrawal by Subject|1|||
126163551|NCT00620321|453885743|FG001|Overall Study|Withdrawal by Subject|1|||
126163552|NCT04191967|453885744|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
126163553|NCT04191967|453885744|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
126163554|NCT01431144|453885745|FG000|Overall Study|Implant mobility and removal|2|||
126163555|NCT01431144|453885746|FG001|Overall Study|Implant mobility and removal|0|||
126163556|NCT02410902|453885755|FG000|Overall Study|Adverse Event|2|||
126163557|NCT02410902|453885756|FG001|Overall Study|Adverse Event|3|||
126163558|NCT02410902|453885755|FG000|Overall Study|Lost to Follow-up|4|||
126163559|NCT02410902|453885756|FG001|Overall Study|Lost to Follow-up|1|||
126163560|NCT02410902|453885755|FG000|Overall Study|Protocol Violation|1|||
126163561|NCT02410902|453885756|FG001|Overall Study|Protocol Violation|4|||
126163562|NCT02410902|453885755|FG000|Overall Study|Withdrawal by Subject|6|||
126163563|NCT02410902|453885756|FG001|Overall Study|Withdrawal by Subject|8|||
126163564|NCT02410902|453885755|FG000|Overall Study|Non-Compliance|8|||
126163565|NCT02410902|453885756|FG001|Overall Study|Non-Compliance|2|||
126163566|NCT00953043|453885757|FG000|Overall Study|Withdrawal by Subject|4|||
126163567|NCT00953043|453885758|FG001|Overall Study|Withdrawal by Subject|0|||
125972824|NCT01625897|453191355|FG001|Overall Study|Adverse Event|10|||
125972825|NCT01625897|453191354|FG000|Overall Study|Physician Decision|0|||
125972826|NCT01625897|453191355|FG001|Overall Study|Physician Decision|1|||
125972827|NCT01625897|453191354|FG000|Overall Study|Withdrawal by Subject|25|||
125972828|NCT01625897|453191355|FG001|Overall Study|Withdrawal by Subject|3|||
125972829|NCT02621931|453191356|FG000|Overall Study|Death|0|||
125972830|NCT02621931|453191357|FG001|Overall Study|Death|1|||
125972831|NCT02621931|453191358|FG002|Overall Study|Death|0|||
125972832|NCT02621931|453191356|FG000|Overall Study|Adverse Event|8|||
125972833|NCT02621931|453191357|FG001|Overall Study|Adverse Event|5|||
125972834|NCT02621931|453191358|FG002|Overall Study|Adverse Event|7|||
126163568|NCT00953043|453885757|FG000|Overall Study|Physician Decision|0|||
126163569|NCT00953043|453885758|FG001|Overall Study|Physician Decision|2|||
126163570|NCT00701727|453885760|FG000|First Treatment Period|Adverse Event|0|||
126163571|NCT00701727|453885761|FG001|First Treatment Period|Adverse Event|0|||
125972835|NCT02621931|453191356|FG000|Overall Study|Withdrawal by Subject|12|||
126163572|NCT00701727|453885760|FG000|First Treatment Period|Withdrawal by Subject|1|||
126163573|NCT00701727|453885761|FG001|First Treatment Period|Withdrawal by Subject|0|||
126163574|NCT00701727|453885760|FG000|First Treatment Period|sponsor decision|0|||
126163575|NCT00701727|453885761|FG001|First Treatment Period|sponsor decision|1|||
126163576|NCT00701727|453885760|FG000|First Treatment Period|Lost to Follow-up|0|||
126163577|NCT00701727|453885761|FG001|First Treatment Period|Lost to Follow-up|1|||
126163578|NCT00701727|453885760|FG000|Second Treatment Period|Withdrawal by Subject|2|||
126163579|NCT00701727|453885761|FG001|Second Treatment Period|Withdrawal by Subject|0|||
126163580|NCT05113953|453885764|FG000|Overall Study|Adverse Event|5|||
126163581|NCT05113953|453885765|FG001|Overall Study|Adverse Event|0|||
126163582|NCT05113953|453885766|FG002|Overall Study|Adverse Event|3|||
126163583|NCT05113953|453885764|FG000|Overall Study|Lost to Follow-up|3|||
126163584|NCT05113953|453885765|FG001|Overall Study|Lost to Follow-up|4|||
126163585|NCT05113953|453885766|FG002|Overall Study|Lost to Follow-up|2|||
126163586|NCT05113953|453885764|FG000|Overall Study|Non-compliance with Study Drug|1|||
126163587|NCT05113953|453885765|FG001|Overall Study|Non-compliance with Study Drug|0|||
126163588|NCT05113953|453885766|FG002|Overall Study|Non-compliance with Study Drug|0|||
126163589|NCT05113953|453885764|FG000|Overall Study|Withdrawal by Subject|2|||
126163590|NCT05113953|453885765|FG001|Overall Study|Withdrawal by Subject|6|||
126163591|NCT05113953|453885766|FG002|Overall Study|Withdrawal by Subject|4|||
126163592|NCT05113953|453885764|FG000|Overall Study|Reason not Specified|2|||
126163593|NCT05113953|453885765|FG001|Overall Study|Reason not Specified|0|||
126163594|NCT05113953|453885766|FG002|Overall Study|Reason not Specified|0|||
126163595|NCT00523341|453885767|FG000|Overall Study|Withdrawal by Subject|399|||
126163596|NCT00523341|453885768|FG001|Overall Study|Withdrawal by Subject|427|||
126163597|NCT00523341|453885767|FG000|Overall Study|Other|181|||
126163598|NCT00523341|453885768|FG001|Overall Study|Other|198|||
126163599|NCT00523341|453885767|FG000|Overall Study|Adverse Event|122|||
126163600|NCT00523341|453885768|FG001|Overall Study|Adverse Event|155|||
126163601|NCT00523341|453885767|FG000|Overall Study|Death|101|||
126163602|NCT00523341|453885768|FG001|Overall Study|Death|110|||
126163603|NCT00523341|453885767|FG000|Overall Study|Lost to Follow-up|73|||
126163604|NCT00523341|453885768|FG001|Overall Study|Lost to Follow-up|61|||
126163605|NCT00523341|453885767|FG000|Overall Study|Non-compliance|20|||
126163606|NCT00523341|453885768|FG001|Overall Study|Non-compliance|13|||
126163607|NCT00523341|453885767|FG000|Overall Study|Physician Decision|14|||
126163608|NCT00523341|453885768|FG001|Overall Study|Physician Decision|13|||
126163609|NCT00523341|453885767|FG000|Overall Study|Requirement for Alternative Therapy|4|||
126163610|NCT00523341|453885768|FG001|Overall Study|Requirement for Alternative Therapy|14|||
126163611|NCT00523341|453885767|FG000|Overall Study|Protocol Deviation|6|||
126163612|NCT00523341|453885768|FG001|Overall Study|Protocol Deviation|5|||
126163613|NCT00523341|453885767|FG000|Overall Study|Ineligibility Determined|3|||
126163614|NCT00523341|453885768|FG001|Overall Study|Ineligibility Determined|4|||
126163615|NCT00523341|453885767|FG000|Overall Study|Disease Progression|1|||
126163616|NCT00523341|453885768|FG001|Overall Study|Disease Progression|0|||
126163617|NCT05137041|453885769|FG000|Overall Study|Lost to Follow-up|1|||
126163618|NCT05137041|453885770|FG001|Overall Study|Lost to Follow-up|1|||
126163619|NCT05137041|453885769|FG000|Overall Study|Withdrawal by Subject|0|||
126163620|NCT05137041|453885770|FG001|Overall Study|Withdrawal by Subject|2|||
126163621|NCT05137041|453885769|FG000|Overall Study|Reason not Specified|0|||
126163622|NCT05137041|453885770|FG001|Overall Study|Reason not Specified|1|||
126163623|NCT02626819|453885771|FG000|Overall Study|Lost to Follow-up|3|||
126163624|NCT02626819|453885772|FG001|Overall Study|Lost to Follow-up|2|||
126163625|NCT02626819|453885771|FG000|Overall Study|Withdrawal by Subject|1|||
126163626|NCT02626819|453885772|FG001|Overall Study|Withdrawal by Subject|0|||
126163627|NCT02626819|453885771|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
126163628|NCT02626819|453885772|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
126163629|NCT00502307|453885775|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
126163630|NCT00502307|453885776|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
126163631|NCT00502307|453885777|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
126163632|NCT00502307|453885775|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
126163633|NCT00502307|453885776|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
126163634|NCT00502307|453885777|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
126163635|NCT00502307|453885775|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
126163636|NCT00502307|453885776|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
126163637|NCT00502307|453885777|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
126163638|NCT00502307|453885775|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
126163639|NCT00502307|453885776|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
126163640|NCT00502307|453885777|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
126163641|NCT00502307|453885775|FG000|Maintenance Period|Progressive disease|80|||
126163642|NCT00502307|453885776|FG001|Maintenance Period|Progressive disease|0|||
126163643|NCT00502307|453885777|FG002|Maintenance Period|Progressive disease|0|||
126163644|NCT00502307|453885775|FG000|Maintenance Period|Discontinued due to other reasons|68|||
126163645|NCT00502307|453885776|FG001|Maintenance Period|Discontinued due to other reasons|0|||
126163646|NCT00502307|453885777|FG002|Maintenance Period|Discontinued due to other reasons|0|||
126163647|NCT00051558|453885778|FG000|Overall Study|Adverse Event|30|||
126163648|NCT00051558|453885779|FG001|Overall Study|Adverse Event|18|||
126163649|NCT00051558|453885778|FG000|Overall Study|Withdrawal by Subject|29|||
126163650|NCT00051558|453885779|FG001|Overall Study|Withdrawal by Subject|42|||
126163651|NCT00051558|453885778|FG000|Overall Study|Death|9|||
126163652|NCT00051558|453885779|FG001|Overall Study|Death|15|||
126163653|NCT00051558|453885778|FG000|Overall Study|Lost to Follow-up|4|||
126163654|NCT00051558|453885779|FG001|Overall Study|Lost to Follow-up|13|||
126163655|NCT00051558|453885778|FG000|Overall Study|Protocol Violation|3|||
126163656|NCT00051558|453885779|FG001|Overall Study|Protocol Violation|4|||
126163657|NCT00051558|453885778|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
126163658|NCT00051558|453885779|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
126163659|NCT00051558|453885778|FG000|Overall Study|Sponsor Decision|6|||
126163660|NCT00051558|453885779|FG001|Overall Study|Sponsor Decision|1|||
126163661|NCT00051558|453885778|FG000|Overall Study|Other|2|||
126163662|NCT00051558|453885779|FG001|Overall Study|Other|1|||
126163663|NCT00051558|453885778|FG000|Overall Study|Significant Lab Value|2|||
126163664|NCT00051558|453885779|FG001|Overall Study|Significant Lab Value|0|||
126163665|NCT00051558|453885778|FG000|Overall Study|Physician Decision|5|||
126163666|NCT00051558|453885779|FG001|Overall Study|Physician Decision|0|||
126163667|NCT02849990|453885787|FG000|Overall Study|Adverse Event|1|||
126163668|NCT02849990|453885787|FG000|Overall Study|Withdrawal by Subject|1|||
126163669|NCT01051986|453885788|FG000|Overall Study|Death|1|||
126163670|NCT01051986|453885789|FG001|Overall Study|Death|0|||
126163671|NCT01051986|453885788|FG000|Overall Study|Withdrawal by Subject|2|||
126163672|NCT01051986|453885789|FG001|Overall Study|Withdrawal by Subject|1|||
126163673|NCT01051986|453885788|FG000|Overall Study|Protocol Violation|2|||
126163674|NCT01051986|453885789|FG001|Overall Study|Protocol Violation|3|||
126163675|NCT02044159|453885791|FG000|Overall Study|Consent declined (deferred consent)|2|||
126163676|NCT02044159|453885792|FG001|Overall Study|Consent declined (deferred consent)|4|||
126163677|NCT02044159|453885791|FG000|Overall Study|No longer eligible, drug not given|1|||
126163678|NCT02044159|453885792|FG001|Overall Study|No longer eligible, drug not given|0|||
126163679|NCT02044159|453885791|FG000|Overall Study|Nurse declined to give study drug|1|||
126163680|NCT02044159|453885792|FG001|Overall Study|Nurse declined to give study drug|0|||
126163681|NCT01111539|453885794|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
126163682|NCT01111539|453885795|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126163683|NCT01111539|453885796|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126163684|NCT01111539|453885797|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126163685|NCT01111539|453885798|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126163686|NCT01111539|453885794|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
126163687|NCT01111539|453885795|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126163688|NCT01111539|453885796|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126163689|NCT01111539|453885797|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126163690|NCT01111539|453885798|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126163691|NCT01111539|453885794|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
126163692|NCT01111539|453885795|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126163693|NCT01111539|453885796|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126163694|NCT01111539|453885797|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126163695|NCT01111539|453885798|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126163696|NCT01111539|453885794|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
126163697|NCT01111539|453885795|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
126163698|NCT01111539|453885796|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
126163699|NCT01111539|453885797|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
126163700|NCT01111539|453885798|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
126163701|NCT01111539|453885794|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
126163702|NCT01111539|453885795|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
126163703|NCT01111539|453885796|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
126163704|NCT01111539|453885797|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
126163705|NCT01111539|453885798|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
126163706|NCT01111539|453885794|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
126163707|NCT01111539|453885795|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126163708|NCT01111539|453885796|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126163709|NCT01111539|453885797|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126163710|NCT01111539|453885798|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126163711|NCT01111539|453885794|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
126163712|NCT01111539|453885795|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
126163713|NCT01111539|453885796|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
126163714|NCT01111539|453885797|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
126163715|NCT01111539|453885798|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
126163716|NCT01111539|453885794|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126163717|NCT01111539|453885795|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126163718|NCT01111539|453885796|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
126163719|NCT01111539|453885797|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126163720|NCT01111539|453885798|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
126163721|NCT01111539|453885794|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126163722|NCT01111539|453885795|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126163723|NCT01111539|453885796|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
126163724|NCT01111539|453885797|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126163725|NCT01111539|453885798|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
126163726|NCT01111539|453885794|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
126163727|NCT01111539|453885795|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
126163728|NCT01111539|453885796|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
126163729|NCT01111539|453885797|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
126163730|NCT01111539|453885798|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
126163731|NCT01111539|453885794|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
126163732|NCT01111539|453885795|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
126163733|NCT01111539|453885796|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
126163734|NCT01111539|453885797|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
126163735|NCT01111539|453885798|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
126163736|NCT01111539|453885794|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
126163737|NCT01111539|453885795|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
126163738|NCT01111539|453885796|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
126163739|NCT01111539|453885797|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
126163740|NCT01111539|453885798|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
126163741|NCT01111539|453885794|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
126163742|NCT01111539|453885795|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
126163743|NCT01111539|453885796|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
126163744|NCT01111539|453885797|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
126163745|NCT01111539|453885798|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
126163746|NCT01111539|453885794|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126163747|NCT01111539|453885795|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126163748|NCT01111539|453885796|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126163749|NCT01111539|453885797|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126163750|NCT01111539|453885798|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
126163751|NCT01795898|453885799|FG000|Overall Study|Adverse Event|27|||
126163752|NCT01795898|453885799|FG000|Overall Study|Lost to Follow-up|20|||
126163753|NCT01795898|453885799|FG000|Overall Study|Withdrawal of consent|6|||
126163754|NCT01795898|453885799|FG000|Overall Study|Diagnosed with metastasis|1|||
126163755|NCT01795898|453885799|FG000|Overall Study|No pain|1|||
126163756|NCT01795898|453885799|FG000|Overall Study|Death|1|||
126163757|NCT01795898|453885799|FG000|Overall Study|Withdrew consent & had adverse events|3|||
126163758|NCT01795898|453885799|FG000|Overall Study|Physician Decision|1|||
126163759|NCT03628417|453885800|FG000|Overall Study|Death|1|||
126163760|NCT03628417|453885801|FG001|Overall Study|Death|1|||
126163761|NCT03539458|453885802|FG000|Overall Study|Death|1|||
126163762|NCT00718419|453885803|FG000|Overall Study|Adverse Event|2|||
126163763|NCT00718419|453885804|FG001|Overall Study|Adverse Event|1|||
126163764|NCT00718419|453885803|FG000|Overall Study|Physician Decision|1|||
126163765|NCT00718419|453885804|FG001|Overall Study|Physician Decision|6|||
126163766|NCT00718419|453885803|FG000|Overall Study|Sponsor decision|0|||
126163767|NCT00718419|453885804|FG001|Overall Study|Sponsor decision|1|||
126163768|NCT00718419|453885803|FG000|Overall Study|Withdrawal by Subject|0|||
126163769|NCT00718419|453885804|FG001|Overall Study|Withdrawal by Subject|5|||
126163770|NCT00718419|453885803|FG000|Overall Study|Progressive Disease|7|||
126163771|NCT00718419|453885804|FG001|Overall Study|Progressive Disease|25|||
126163772|NCT00718419|453885803|FG000|Overall Study|Death Due to Progressive Disease|2|||
126163773|NCT00718419|453885804|FG001|Overall Study|Death Due to Progressive Disease|0|||
126163774|NCT00718419|453885803|FG000|Overall Study|Death Due to Study Drug Related|0|||
126163775|NCT00718419|453885804|FG001|Overall Study|Death Due to Study Drug Related|1|||
126163776|NCT00718419|453885803|FG000|Overall Study|Death Due to Adverse Events|1|||
126163777|NCT00718419|453885804|FG001|Overall Study|Death Due to Adverse Events|0|||
126163778|NCT00726323|453885807|FG000|Overall Study|Withdrawal by Subject|3|||
126163779|NCT00726323|453885808|FG001|Overall Study|Withdrawal by Subject|1|||
126163780|NCT00726323|453885807|FG000|Overall Study|Physician Decision|1|||
126163781|NCT00726323|453885808|FG001|Overall Study|Physician Decision|0|||
126163782|NCT00726323|453885807|FG000|Overall Study|Progressive disease|23|||
126163783|NCT00726323|453885808|FG001|Overall Study|Progressive disease|16|||
126163784|NCT00726323|453885807|FG000|Overall Study|Clinical progression|0|||
126163785|NCT00726323|453885808|FG001|Overall Study|Clinical progression|3|||
126163786|NCT00726323|453885807|FG000|Overall Study|Adverse Event|9|||
126163787|NCT00726323|453885808|FG001|Overall Study|Adverse Event|9|||
126163788|NCT00726323|453885807|FG000|Overall Study|Death|1|||
126163789|NCT00726323|453885808|FG001|Overall Study|Death|0|||
126163790|NCT00726323|453885807|FG000|Overall Study|Participant wished to discontinue|0|||
126163791|NCT00726323|453885808|FG001|Overall Study|Participant wished to discontinue|1|||
126163792|NCT00726323|453885807|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
126163793|NCT00726323|453885808|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
126163794|NCT00972478|453885817|FG000|Overall Study|Adverse Event|3|||
126163795|NCT00972478|453885818|FG001|Overall Study|Adverse Event|16|||
126163796|NCT00972478|453885817|FG000|Overall Study|Withdrawal by Subject|1|||
126163797|NCT00972478|453885818|FG001|Overall Study|Withdrawal by Subject|8|||
126163798|NCT00972478|453885817|FG000|Overall Study|Progression/Relapse|0|||
126163799|NCT00972478|453885818|FG001|Overall Study|Progression/Relapse|2|||
126163800|NCT00972478|453885817|FG000|Overall Study|Death|0|||
126163801|NCT00972478|453885818|FG001|Overall Study|Death|2|||
126163802|NCT00972478|453885817|FG000|Overall Study|Not protocol specified|1|||
126163803|NCT00972478|453885818|FG001|Overall Study|Not protocol specified|1|||
126163804|NCT00972478|453885817|FG000|Overall Study|Ineligible|1|||
126163805|NCT00972478|453885818|FG001|Overall Study|Ineligible|7|||
126163806|NCT00972478|453885817|FG000|Overall Study|Not start protocol treatment|1|||
126163807|NCT00972478|453885818|FG001|Overall Study|Not start protocol treatment|2|||
126163808|NCT01522976|453885819|FG000|Overall Study|Ineligible|4|||
126163809|NCT01522976|453885820|FG001|Overall Study|Ineligible|0|||
126163810|NCT01522976|453885821|FG002|Overall Study|Ineligible|1|||
126163811|NCT01522976|453885819|FG000|Overall Study|Death|7|||
126163812|NCT01522976|453885820|FG001|Overall Study|Death|6|||
126163813|NCT01522976|453885821|FG002|Overall Study|Death|2|||
126163814|NCT01522976|453885819|FG000|Overall Study|Still on treatment|9|||
126163815|NCT01522976|453885820|FG001|Overall Study|Still on treatment|9|||
126163816|NCT01522976|453885821|FG002|Overall Study|Still on treatment|6|||
126163817|NCT01522976|453885819|FG000|Overall Study|Disease progression|28|||
126163818|NCT01522976|453885820|FG001|Overall Study|Disease progression|30|||
126163819|NCT01522976|453885821|FG002|Overall Study|Disease progression|25|||
126163820|NCT01522976|453885819|FG000|Overall Study|Adverse Event|17|||
126163821|NCT01522976|453885820|FG001|Overall Study|Adverse Event|7|||
126163822|NCT01522976|453885821|FG002|Overall Study|Adverse Event|18|||
126163823|NCT01522976|453885819|FG000|Overall Study|Refusal unrelated to adverse event|10|||
126163824|NCT01522976|453885820|FG001|Overall Study|Refusal unrelated to adverse event|13|||
126163825|NCT01522976|453885821|FG002|Overall Study|Refusal unrelated to adverse event|14|||
126163826|NCT01522976|453885819|FG000|Overall Study|Not protocol specified|22|||
126163827|NCT01522976|453885820|FG001|Overall Study|Not protocol specified|27|||
126163828|NCT01522976|453885821|FG002|Overall Study|Not protocol specified|27|||
126163829|NCT04075266|453885822|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
126163830|NCT04075266|453885823|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
126163831|NCT04075266|453885822|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
126163832|NCT04075266|453885823|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
126163833|NCT05132569|453885824|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
126163834|NCT05132569|453885825|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
126163835|NCT05132569|453885824|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
126163836|NCT05132569|453885825|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
126163837|NCT05132569|453885824|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
126163838|NCT05132569|453885825|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
126163839|NCT04102098|453885826|FG000|Main Study Period|Ongoing in study|302|||
126163840|NCT04102098|453885827|FG001|Main Study Period|Ongoing in study|291|||
126163841|NCT04102098|453885826|FG000|Main Study Period|Death|20|||
126163842|NCT04102098|453885827|FG001|Main Study Period|Death|27|||
126163843|NCT04102098|453885826|FG000|Main Study Period|Lost to Follow-up|1|||
126163844|NCT04102098|453885827|FG001|Main Study Period|Lost to Follow-up|1|||
126163845|NCT04102098|453885826|FG000|Main Study Period|Physician Decision|0|||
126163846|NCT04102098|453885827|FG001|Main Study Period|Physician Decision|1|||
126163847|NCT04102098|453885826|FG000|Main Study Period|Withdrawal by Subject|11|||
126163848|NCT04102098|453885827|FG001|Main Study Period|Withdrawal by Subject|14|||
126163849|NCT04102098|453885826|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
126163850|NCT04102098|453885827|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
126163851|NCT04102098|453885826|FG000|Crossover: AS Who Crossed Over|Death|11|||
126163852|NCT04102098|453885827|FG001|Crossover: AS Who Crossed Over|Death|0|||
126163853|NCT04102098|453885826|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
126163854|NCT04102098|453885827|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
126163855|NCT04742907|453885828|FG000|Overall Study|Adverse Event|1|||
126163856|NCT04742907|453885829|FG001|Overall Study|Adverse Event|0|||
126163857|NCT04742907|453885830|FG002|Overall Study|Adverse Event|1|||
126163858|NCT04742907|453885828|FG000|Overall Study|Lost to Follow-up|3|||
126163859|NCT04742907|453885829|FG001|Overall Study|Lost to Follow-up|3|||
126163860|NCT04742907|453885830|FG002|Overall Study|Lost to Follow-up|2|||
126163861|NCT04742907|453885828|FG000|Overall Study|Physician Decision|0|||
126163862|NCT04742907|453885829|FG001|Overall Study|Physician Decision|1|||
126163863|NCT04742907|453885830|FG002|Overall Study|Physician Decision|0|||
126163864|NCT04742907|453885828|FG000|Overall Study|Protocol Violation|1|||
126163865|NCT04742907|453885829|FG001|Overall Study|Protocol Violation|1|||
126163866|NCT04742907|453885830|FG002|Overall Study|Protocol Violation|1|||
126163867|NCT04742907|453885828|FG000|Overall Study|Withdrawal by Subject|5|||
126163868|NCT04742907|453885829|FG001|Overall Study|Withdrawal by Subject|6|||
126163869|NCT04742907|453885830|FG002|Overall Study|Withdrawal by Subject|4|||
126163870|NCT04742907|453885828|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
126163871|NCT04742907|453885829|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
126163872|NCT04742907|453885830|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
126163873|NCT04742907|453885828|FG000|Overall Study|Did Not Receive the Study Drug|2|||
126163874|NCT04742907|453885829|FG001|Overall Study|Did Not Receive the Study Drug|4|||
126163875|NCT04742907|453885830|FG002|Overall Study|Did Not Receive the Study Drug|4|||
126163876|NCT02280291|453885831|FG000|Overall Study|Lost to Follow-up|2|||
126163877|NCT02280291|453885832|FG001|Overall Study|Lost to Follow-up|1|||
126163878|NCT02280291|453885833|FG002|Overall Study|Lost to Follow-up|3|||
126163879|NCT02280291|453885834|FG003|Overall Study|Lost to Follow-up|8|||
126163880|NCT02280291|453885831|FG000|Overall Study|Protocol Violation|1|||
126163881|NCT02280291|453885832|FG001|Overall Study|Protocol Violation|0|||
126163882|NCT02280291|453885833|FG002|Overall Study|Protocol Violation|0|||
126163883|NCT02280291|453885834|FG003|Overall Study|Protocol Violation|0|||
126163884|NCT02280291|453885831|FG000|Overall Study|Other|1|||
126163885|NCT02280291|453885832|FG001|Overall Study|Other|1|||
126163886|NCT02280291|453885833|FG002|Overall Study|Other|0|||
126163887|NCT02280291|453885834|FG003|Overall Study|Other|0|||
126163888|NCT03508622|453885835|FG000|Overall Study|Protocol Violation|1|||
126163889|NCT03508622|453885836|FG001|Overall Study|Protocol Violation|0|||
126163890|NCT03508622|453885835|FG000|Overall Study|Withdrawal by Subject|1|||
126163891|NCT03508622|453885836|FG001|Overall Study|Withdrawal by Subject|0|||
126163892|NCT03508622|453885835|FG000|Overall Study|Lost to Follow-up|16|||
126163893|NCT03508622|453885836|FG001|Overall Study|Lost to Follow-up|0|||
126163894|NCT03508622|453885835|FG000|Overall Study|Incomplete data|0|||
126163895|NCT03508622|453885836|FG001|Overall Study|Incomplete data|24|||
126163896|NCT00210158|453885838|FG000|Overall Study|Protocol Violation|0|||
126163897|NCT00210158|453885839|FG001|Overall Study|Protocol Violation|2|||
126163898|NCT03196505|453885841|FG000|Overall Study|Physician Decision|26|||
126163899|NCT03196505|453885842|FG001|Overall Study|Physician Decision|26|||
126163900|NCT05590793|453885844|FG000|Overall Study|Withdrawal by Subject|6|||
126163901|NCT05590793|453885844|FG000|Overall Study|Physician Decision|1|||
126163902|NCT03015610|453885849|FG000|Overall Study|Lost to Follow-up|1|||
126163903|NCT03015610|453885850|FG001|Overall Study|Lost to Follow-up|5|||
126163904|NCT00938327|453885857|FG000|Overall Study|Adverse Event|2|||
126163905|NCT00938327|453885857|FG000|Overall Study|Protocol Violation|1|||
126163906|NCT00938327|453885857|FG000|Overall Study|Withdrawal by Subject|4|||
126163907|NCT00938327|453885857|FG000|Overall Study|Lost to Follow-up|37|||
126163908|NCT00938327|453885857|FG000|Overall Study|2nd dose received outside of the study|7|||
126163909|NCT00938327|453885857|FG000|Overall Study|Vaccine not received as out of stock|9|||
126163910|NCT02552355|453885858|FG000|Overall Study|Adverse Event|0|||
126163911|NCT02552355|453885859|FG001|Overall Study|Adverse Event|2|||
126163912|NCT02552355|453885860|FG002|Overall Study|Adverse Event|2|||
126163913|NCT02552355|453885861|FG003|Overall Study|Adverse Event|0|||
126163914|NCT02552355|453885858|FG000|Overall Study|Withdrawal by Subject|0|||
126163915|NCT02552355|453885859|FG001|Overall Study|Withdrawal by Subject|0|||
126163916|NCT02552355|453885860|FG002|Overall Study|Withdrawal by Subject|0|||
126163917|NCT02552355|453885861|FG003|Overall Study|Withdrawal by Subject|1|||
126163918|NCT04072146|453885864|FG000|Overall Study|Adverse Event|0|||
126163919|NCT04072146|453885865|FG001|Overall Study|Adverse Event|1|||
126163920|NCT01193348|453885869|FG000|Screening Period|Screen Failure|5|||
126163921|NCT01193348|453885869|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
126163922|NCT01193348|453885869|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
126163923|NCT01193348|453885869|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
126163924|NCT01193348|453885869|FG000|Extension Treatment Period|Physician Decision|1|||
126163925|NCT01193348|453885869|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
126163926|NCT04070378|453885870|FG000|Overall Study|Withdrawal by Subject|2|||
126163927|NCT04070378|453885870|FG000|Overall Study|Screen Failure|6|||
126163928|NCT04070378|453885870|FG000|Overall Study|Physician Decision|1|||
126163929|NCT04070378|453885870|FG000|Overall Study|Adverse Event|1|||
126163930|NCT03259334|453885871|FG000|Overall Study|Adverse Event|3|||
126163931|NCT03259334|453885872|FG001|Overall Study|Adverse Event|8|||
126163932|NCT03259334|453885873|FG002|Overall Study|Adverse Event|5|||
126163933|NCT03259334|453885871|FG000|Overall Study|Withdrawal by Subject|4|||
126163934|NCT03259334|453885872|FG001|Overall Study|Withdrawal by Subject|2|||
126163935|NCT03259334|453885873|FG002|Overall Study|Withdrawal by Subject|4|||
126163936|NCT03259334|453885871|FG000|Overall Study|Physician Decision|1|||
126163937|NCT03259334|453885872|FG001|Overall Study|Physician Decision|0|||
126163938|NCT03259334|453885873|FG002|Overall Study|Physician Decision|0|||
126163939|NCT03259334|453885871|FG000|Overall Study|Lost to Follow-up|0|||
126163940|NCT03259334|453885872|FG001|Overall Study|Lost to Follow-up|2|||
126163941|NCT03259334|453885873|FG002|Overall Study|Lost to Follow-up|1|||
126163942|NCT03259334|453885871|FG000|Overall Study|Protocol Deviation|0|||
126163943|NCT03259334|453885872|FG001|Overall Study|Protocol Deviation|3|||
126163944|NCT03259334|453885873|FG002|Overall Study|Protocol Deviation|2|||
126163945|NCT03259334|453885871|FG000|Overall Study|Lack of Efficacy|2|||
126163946|NCT03259334|453885872|FG001|Overall Study|Lack of Efficacy|0|||
126163947|NCT03259334|453885873|FG002|Overall Study|Lack of Efficacy|1|||
126163948|NCT03259334|453885871|FG000|Overall Study|Randomized but never treated|0|||
126163949|NCT03259334|453885872|FG001|Overall Study|Randomized but never treated|2|||
126163950|NCT03259334|453885873|FG002|Overall Study|Randomized but never treated|0|||
126163951|NCT05306873|453886826|FG000|Stage 2|Study stopped|1|||
126163952|NCT05306873|453886827|FG001|Stage 2|Study stopped|1|||
126163953|NCT05306873|453886828|FG002|Stage 2|Study stopped|0|||
126163954|NCT05306873|453886829|FG003|Stage 2|Study stopped|0|||
126163955|NCT05306873|453886826|FG000|Stage 2|Stage 2 Treatment Failure|2|||
126163956|NCT05306873|453886827|FG001|Stage 2|Stage 2 Treatment Failure|3|||
126163957|NCT05306873|453886828|FG002|Stage 2|Stage 2 Treatment Failure|0|||
126163958|NCT05306873|453886829|FG003|Stage 2|Stage 2 Treatment Failure|0|||
126163959|NCT05306873|453886826|FG000|Stage 2|Logistical issues due to participant moving|1|||
126163960|NCT05306873|453886827|FG001|Stage 2|Logistical issues due to participant moving|0|||
126163961|NCT05306873|453886828|FG002|Stage 2|Logistical issues due to participant moving|0|||
126163962|NCT05306873|453886829|FG003|Stage 2|Logistical issues due to participant moving|0|||
126163963|NCT05306873|453886826|FG000|Stage 3|Stage 3 Treatment Failure|0|||
126163964|NCT05306873|453886827|FG001|Stage 3|Stage 3 Treatment Failure|0|||
126163965|NCT05306873|453886828|FG002|Stage 3|Stage 3 Treatment Failure|0|||
126163966|NCT05306873|453886829|FG003|Stage 3|Stage 3 Treatment Failure|1|||
126163967|NCT05306873|453886826|FG000|Stage 3|Study Stopped|0|||
126163968|NCT05306873|453886827|FG001|Stage 3|Study Stopped|0|||
126163969|NCT05306873|453886828|FG002|Stage 3|Study Stopped|1|||
126163970|NCT05306873|453886829|FG003|Stage 3|Study Stopped|0|||
126163971|NCT01725152|453886830|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
126163972|NCT01725152|453886831|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
126163973|NCT01725152|453886830|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
126163974|NCT01725152|453886831|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
126163975|NCT01725152|453886830|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
126163976|NCT01725152|453886831|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
126163977|NCT01725152|453886830|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
126163978|NCT01725152|453886831|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
126163979|NCT00372190|453886832|FG000|Overall Study|Lost to Follow-up|3|||
126163980|NCT00372190|453886833|FG001|Overall Study|Lost to Follow-up|1|||
126163981|NCT03521154|453886842|FG000|Overall Study|Ongoing study at data cut-off|111|||
126163982|NCT03521154|453886843|FG001|Overall Study|Ongoing study at data cut-off|52|||
126163983|NCT01554956|453886846|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
126163984|NCT01554956|453886847|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
126163985|NCT01554956|453886848|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
126163986|NCT01554956|453886846|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
126163987|NCT01554956|453886847|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
126163988|NCT01554956|453886848|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
126163989|NCT01554956|453886846|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
126163990|NCT01554956|453886847|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
126163991|NCT01554956|453886848|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
126163992|NCT00365716|453886849|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
126163993|NCT00365716|453886850|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
126163994|NCT00365716|453886851|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126163995|NCT00365716|453886852|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126163996|NCT00365716|453886853|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126163997|NCT00365716|453886854|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126163998|NCT00365716|453886855|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126163999|NCT00365716|453886849|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125972836|NCT02621931|453191357|FG001|Overall Study|Withdrawal by Subject|10|||
125972837|NCT02621931|453191358|FG002|Overall Study|Withdrawal by Subject|11|||
125972838|NCT02621931|453191356|FG000|Overall Study|Protocol Violation|2|||
126164000|NCT00365716|453886850|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
125972839|NCT02621931|453191357|FG001|Overall Study|Protocol Violation|2|||
126164001|NCT00365716|453886851|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126164002|NCT00365716|453886852|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126164003|NCT00365716|453886853|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
126164004|NCT00365716|453886854|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126164005|NCT00365716|453886855|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126200112|NCT02394028|454017878|FG001|Induction Phase|Lack of Efficacy|6|||
126164006|NCT00365716|453886849|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
126164007|NCT00365716|453886850|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
126164008|NCT00365716|453886851|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
126164009|NCT00365716|453886852|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
126164010|NCT00365716|453886853|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
126164011|NCT00365716|453886854|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
126164012|NCT00365716|453886855|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
126164013|NCT00365716|453886849|FG000|Base Study (Day 1 to Month 7)|Other|0|||
126164014|NCT00365716|453886850|FG001|Base Study (Day 1 to Month 7)|Other|1|||
126164015|NCT00365716|453886851|FG002|Base Study (Day 1 to Month 7)|Other|0|||
126164016|NCT00365716|453886852|FG003|Base Study (Day 1 to Month 7)|Other|0|||
126164017|NCT00365716|453886853|FG004|Base Study (Day 1 to Month 7)|Other|0|||
126164018|NCT00365716|453886854|FG005|Base Study (Day 1 to Month 7)|Other|0|||
126164019|NCT00365716|453886855|FG006|Base Study (Day 1 to Month 7)|Other|0|||
126164020|NCT00365716|453886849|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
126164021|NCT00365716|453886850|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
126164022|NCT00365716|453886851|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
126164023|NCT00365716|453886852|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
126164024|NCT00365716|453886853|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
126164025|NCT00365716|453886854|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
126164026|NCT00365716|453886855|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
126164027|NCT00365716|453886849|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
126164028|NCT00365716|453886850|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
126164029|NCT00365716|453886851|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
126164030|NCT00365716|453886852|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
126164031|NCT00365716|453886853|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
126164032|NCT00365716|453886854|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
126164033|NCT00365716|453886855|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
126164034|NCT00365716|453886849|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
126164035|NCT00365716|453886850|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
126164036|NCT00365716|453886851|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
126164037|NCT00365716|453886852|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
126164038|NCT00365716|453886853|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
126164039|NCT00365716|453886854|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
126164040|NCT00365716|453886855|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
126164041|NCT00365716|453886849|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
126164042|NCT00365716|453886850|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
126164043|NCT00365716|453886851|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
126164044|NCT00365716|453886852|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
126164045|NCT00365716|453886853|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
126164046|NCT00365716|453886854|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
126164047|NCT00365716|453886855|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
126164048|NCT00365716|453886849|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
126164049|NCT00365716|453886850|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
126164050|NCT00365716|453886851|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
126164051|NCT00365716|453886852|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
126164052|NCT00365716|453886853|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
126164053|NCT00365716|453886854|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
126164054|NCT00365716|453886855|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
126164055|NCT00365716|453886849|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
126164056|NCT00365716|453886850|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
126164057|NCT00365716|453886851|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
126164058|NCT00365716|453886852|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
126164059|NCT00365716|453886853|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
126164060|NCT00365716|453886854|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
126164061|NCT00365716|453886855|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
126164062|NCT00365716|453886849|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
126164063|NCT00365716|453886850|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126164064|NCT00365716|453886851|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126164065|NCT00365716|453886852|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126164066|NCT00365716|453886853|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
126164067|NCT00365716|453886854|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126164068|NCT00365716|453886855|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126164069|NCT00365716|453886849|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126164070|NCT00365716|453886850|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
126164071|NCT00365716|453886851|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
126164072|NCT00365716|453886852|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125972840|NCT02621931|453191358|FG002|Overall Study|Protocol Violation|2|||
126164073|NCT00365716|453886853|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126164074|NCT00365716|453886854|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126164075|NCT00365716|453886855|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126164076|NCT00365716|453886849|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
126164077|NCT00365716|453886850|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
126164078|NCT00365716|453886851|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
126164079|NCT00365716|453886852|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
126164080|NCT00365716|453886853|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
126164081|NCT00365716|453886854|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
126164082|NCT00365716|453886855|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
126164083|NCT00365716|453886849|FG000|Extension 1|Lost to Follow-up|0|||
126164084|NCT00365716|453886850|FG001|Extension 1|Lost to Follow-up|0|||
126164085|NCT00365716|453886851|FG002|Extension 1|Lost to Follow-up|0|||
126164086|NCT00365716|453886852|FG003|Extension 1|Lost to Follow-up|0|||
126164087|NCT00365716|453886853|FG004|Extension 1|Lost to Follow-up|0|||
126164088|NCT00365716|453886854|FG005|Extension 1|Lost to Follow-up|1|||
126164089|NCT00365716|453886855|FG006|Extension 1|Lost to Follow-up|0|||
126164090|NCT00365716|453886849|FG000|Extension 1|Other|0|||
126164091|NCT00365716|453886850|FG001|Extension 1|Other|0|||
126164092|NCT00365716|453886851|FG002|Extension 1|Other|0|||
126164093|NCT00365716|453886852|FG003|Extension 1|Other|0|||
126164094|NCT00365716|453886853|FG004|Extension 1|Other|0|||
126164095|NCT00365716|453886854|FG005|Extension 1|Other|9|||
126164096|NCT00365716|453886855|FG006|Extension 1|Other|0|||
126164097|NCT00365716|453886849|FG000|Extension 1|Moved|0|||
126164098|NCT00365716|453886850|FG001|Extension 1|Moved|0|||
126164099|NCT00365716|453886851|FG002|Extension 1|Moved|0|||
126164100|NCT00365716|453886852|FG003|Extension 1|Moved|0|||
126164101|NCT00365716|453886853|FG004|Extension 1|Moved|0|||
126164102|NCT00365716|453886854|FG005|Extension 1|Moved|4|||
126164103|NCT00365716|453886855|FG006|Extension 1|Moved|0|||
126164104|NCT00365716|453886849|FG000|Extension 1|Withdrawal by Subject|0|||
126164105|NCT00365716|453886850|FG001|Extension 1|Withdrawal by Subject|0|||
126164106|NCT00365716|453886851|FG002|Extension 1|Withdrawal by Subject|0|||
126164107|NCT00365716|453886852|FG003|Extension 1|Withdrawal by Subject|0|||
126164108|NCT00365716|453886853|FG004|Extension 1|Withdrawal by Subject|0|||
126164109|NCT00365716|453886854|FG005|Extension 1|Withdrawal by Subject|3|||
126164110|NCT00365716|453886855|FG006|Extension 1|Withdrawal by Subject|0|||
126164111|NCT00365716|453886849|FG000|Extension 1|Pregnancy|0|||
126164112|NCT00365716|453886850|FG001|Extension 1|Pregnancy|0|||
126164113|NCT00365716|453886851|FG002|Extension 1|Pregnancy|0|||
126164114|NCT00365716|453886852|FG003|Extension 1|Pregnancy|0|||
126164115|NCT00365716|453886853|FG004|Extension 1|Pregnancy|0|||
126164116|NCT00365716|453886854|FG005|Extension 1|Pregnancy|4|||
126164117|NCT00365716|453886855|FG006|Extension 1|Pregnancy|0|||
126164118|NCT00365716|453886849|FG000|Extension 1|Protocol Violation|0|||
126164119|NCT00365716|453886850|FG001|Extension 1|Protocol Violation|0|||
126164120|NCT00365716|453886851|FG002|Extension 1|Protocol Violation|0|||
126164121|NCT00365716|453886852|FG003|Extension 1|Protocol Violation|0|||
126164122|NCT00365716|453886853|FG004|Extension 1|Protocol Violation|0|||
126164123|NCT00365716|453886854|FG005|Extension 1|Protocol Violation|1|||
126164124|NCT00365716|453886855|FG006|Extension 1|Protocol Violation|0|||
126164125|NCT00365716|453886849|FG000|Extension 2|Lost to Follow-up|0|||
126164126|NCT00365716|453886850|FG001|Extension 2|Lost to Follow-up|0|||
126164127|NCT00365716|453886851|FG002|Extension 2|Lost to Follow-up|0|||
126164128|NCT00365716|453886852|FG003|Extension 2|Lost to Follow-up|0|||
126164129|NCT00365716|453886853|FG004|Extension 2|Lost to Follow-up|0|||
126164130|NCT00365716|453886854|FG005|Extension 2|Lost to Follow-up|0|||
126164131|NCT00365716|453886855|FG006|Extension 2|Lost to Follow-up|2|||
126164132|NCT00365716|453886849|FG000|Extension 2|Other|0|||
126164133|NCT00365716|453886850|FG001|Extension 2|Other|0|||
126164134|NCT00365716|453886851|FG002|Extension 2|Other|0|||
126164135|NCT00365716|453886852|FG003|Extension 2|Other|0|||
126164136|NCT00365716|453886853|FG004|Extension 2|Other|0|||
126164137|NCT00365716|453886854|FG005|Extension 2|Other|0|||
126164138|NCT00365716|453886855|FG006|Extension 2|Other|3|||
126164139|NCT00365716|453886849|FG000|Extension 2|Withdrawal by Subject|0|||
126164140|NCT00365716|453886850|FG001|Extension 2|Withdrawal by Subject|0|||
126164141|NCT00365716|453886851|FG002|Extension 2|Withdrawal by Subject|0|||
126164142|NCT00365716|453886852|FG003|Extension 2|Withdrawal by Subject|0|||
126164143|NCT00365716|453886853|FG004|Extension 2|Withdrawal by Subject|0|||
126164144|NCT00365716|453886854|FG005|Extension 2|Withdrawal by Subject|0|||
126164145|NCT00365716|453886855|FG006|Extension 2|Withdrawal by Subject|5|||
126164146|NCT06150573|453886856|FG000|Overall Study|Did not meet study criteria|1|||
126164147|NCT06150573|453886857|FG001|Overall Study|Did not meet study criteria|0|||
126164148|NCT06150573|453886856|FG000|Overall Study|Adverse Event|1|||
126164149|NCT06150573|453886857|FG001|Overall Study|Adverse Event|0|||
125972841|NCT02621931|453191356|FG000|Overall Study|Pregnancy|2|||
126164150|NCT06150573|453886856|FG000|Overall Study|Lost to Follow-up|0|||
126164151|NCT06150573|453886857|FG001|Overall Study|Lost to Follow-up|1|||
126164152|NCT06150573|453886856|FG000|Overall Study|Protocol Violation|0|||
126164153|NCT06150573|453886857|FG001|Overall Study|Protocol Violation|1|||
126164154|NCT06150573|453886856|FG000|Overall Study|Withdrawal by Subject|2|||
126164155|NCT06150573|453886857|FG001|Overall Study|Withdrawal by Subject|0|||
126164156|NCT00069095|453886858|FG000|Primary Treatment Phase|Ongoing|0|||
126164157|NCT00069095|453886859|FG001|Primary Treatment Phase|Ongoing|0|||
126164158|NCT00069095|453886860|FG002|Primary Treatment Phase|Ongoing|5|||
126164159|NCT00069095|453886861|FG003|Primary Treatment Phase|Ongoing|7|||
126164160|NCT00069095|453886862|FG004|Primary Treatment Phase|Ongoing|7|||
126164161|NCT00069095|453886863|FG005|Primary Treatment Phase|Ongoing|4|||
126164162|NCT00069095|453886858|FG000|Primary Treatment Phase|Admin/Other|29|||
126164163|NCT00069095|453886859|FG001|Primary Treatment Phase|Admin/Other|38|||
126164164|NCT00069095|453886860|FG002|Primary Treatment Phase|Admin/Other|31|||
126164165|NCT00069095|453886861|FG003|Primary Treatment Phase|Admin/Other|45|||
126164166|NCT00069095|453886862|FG004|Primary Treatment Phase|Admin/Other|48|||
126164167|NCT00069095|453886863|FG005|Primary Treatment Phase|Admin/Other|42|||
126164168|NCT00069095|453886858|FG000|Primary Treatment Phase|Adverse Event|99|||
126164169|NCT00069095|453886859|FG001|Primary Treatment Phase|Adverse Event|92|||
126164170|NCT00069095|453886860|FG002|Primary Treatment Phase|Adverse Event|71|||
126164171|NCT00069095|453886861|FG003|Primary Treatment Phase|Adverse Event|72|||
126164172|NCT00069095|453886862|FG004|Primary Treatment Phase|Adverse Event|109|||
126164173|NCT00069095|453886863|FG005|Primary Treatment Phase|Adverse Event|101|||
126164174|NCT00069095|453886858|FG000|Primary Treatment Phase|Death|14|||
126164175|NCT00069095|453886859|FG001|Primary Treatment Phase|Death|8|||
126164176|NCT00069095|453886860|FG002|Primary Treatment Phase|Death|2|||
126164177|NCT00069095|453886861|FG003|Primary Treatment Phase|Death|5|||
126164178|NCT00069095|453886862|FG004|Primary Treatment Phase|Death|8|||
126164179|NCT00069095|453886863|FG005|Primary Treatment Phase|Death|8|||
126164180|NCT00069095|453886858|FG000|Primary Treatment Phase|Failure to return|5|||
126164181|NCT00069095|453886859|FG001|Primary Treatment Phase|Failure to return|5|||
126164182|NCT00069095|453886860|FG002|Primary Treatment Phase|Failure to return|0|||
126164183|NCT00069095|453886861|FG003|Primary Treatment Phase|Failure to return|0|||
126164184|NCT00069095|453886862|FG004|Primary Treatment Phase|Failure to return|0|||
126164185|NCT00069095|453886863|FG005|Primary Treatment Phase|Failure to return|2|||
126164186|NCT00069095|453886858|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
126164187|NCT00069095|453886859|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
126164188|NCT00069095|453886860|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
126164189|NCT00069095|453886861|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
126164190|NCT00069095|453886862|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
126164191|NCT00069095|453886863|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
126164192|NCT00069095|453886858|FG000|Primary Treatment Phase|Refused treatment|15|||
126164193|NCT00069095|453886859|FG001|Primary Treatment Phase|Refused treatment|26|||
126164194|NCT00069095|453886860|FG002|Primary Treatment Phase|Refused treatment|17|||
126164195|NCT00069095|453886861|FG003|Primary Treatment Phase|Refused treatment|31|||
126164196|NCT00069095|453886862|FG004|Primary Treatment Phase|Refused treatment|24|||
126164197|NCT00069095|453886863|FG005|Primary Treatment Phase|Refused treatment|27|||
126164198|NCT00069095|453886858|FG000|Primary Treatment Phase|Withdrew|2|||
126164199|NCT00069095|453886859|FG001|Primary Treatment Phase|Withdrew|3|||
126164200|NCT00069095|453886860|FG002|Primary Treatment Phase|Withdrew|8|||
126164201|NCT00069095|453886861|FG003|Primary Treatment Phase|Withdrew|2|||
126164202|NCT00069095|453886862|FG004|Primary Treatment Phase|Withdrew|4|||
126164203|NCT00069095|453886863|FG005|Primary Treatment Phase|Withdrew|9|||
126164204|NCT00069095|453886858|FG000|Primary Treatment Phase|Other Violation|0|||
126164205|NCT00069095|453886859|FG001|Primary Treatment Phase|Other Violation|1|||
126164206|NCT00069095|453886860|FG002|Primary Treatment Phase|Other Violation|1|||
126164207|NCT00069095|453886861|FG003|Primary Treatment Phase|Other Violation|1|||
126164208|NCT00069095|453886862|FG004|Primary Treatment Phase|Other Violation|0|||
126164209|NCT00069095|453886863|FG005|Primary Treatment Phase|Other Violation|1|||
125972842|NCT02621931|453191357|FG001|Overall Study|Pregnancy|0|||
125972843|NCT02621931|453191358|FG002|Overall Study|Pregnancy|0|||
125972844|NCT02621931|453191356|FG000|Overall Study|Noncompliance to study procedures|0|||
125972845|NCT02621931|453191357|FG001|Overall Study|Noncompliance to study procedures|1|||
126164210|NCT00069095|453886858|FG000|Primary Treatment Phase|Violation criteria|0|||
126164211|NCT00069095|453886859|FG001|Primary Treatment Phase|Violation criteria|2|||
126164212|NCT00069095|453886860|FG002|Primary Treatment Phase|Violation criteria|4|||
126164213|NCT00069095|453886861|FG003|Primary Treatment Phase|Violation criteria|3|||
126164214|NCT00069095|453886862|FG004|Primary Treatment Phase|Violation criteria|1|||
126164215|NCT00069095|453886863|FG005|Primary Treatment Phase|Violation criteria|5|||
126164216|NCT00069095|453886858|FG000|Post-study Treatment Phase|Missing reason|1|||
126164217|NCT00069095|453886859|FG001|Post-study Treatment Phase|Missing reason|3|||
126164218|NCT00069095|453886860|FG002|Post-study Treatment Phase|Missing reason|12|||
126164219|NCT00069095|453886861|FG003|Post-study Treatment Phase|Missing reason|8|||
126164220|NCT00069095|453886862|FG004|Post-study Treatment Phase|Missing reason|18|||
126164221|NCT00069095|453886863|FG005|Post-study Treatment Phase|Missing reason|17|||
126164222|NCT00069095|453886858|FG000|Post-study Treatment Phase|Adverse Event|2|||
125972846|NCT02621931|453191358|FG002|Overall Study|Noncompliance to study procedures|2|||
125972847|NCT02621931|453191356|FG000|Overall Study|Lost to Follow-up|8|||
126164223|NCT00069095|453886859|FG001|Post-study Treatment Phase|Adverse Event|3|||
126164224|NCT00069095|453886860|FG002|Post-study Treatment Phase|Adverse Event|1|||
126164225|NCT00069095|453886861|FG003|Post-study Treatment Phase|Adverse Event|0|||
126164226|NCT00069095|453886862|FG004|Post-study Treatment Phase|Adverse Event|5|||
126164227|NCT00069095|453886863|FG005|Post-study Treatment Phase|Adverse Event|1|||
126164228|NCT00069095|453886858|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
126164229|NCT00069095|453886859|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
126164230|NCT00069095|453886860|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
126164231|NCT00069095|453886861|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
126164232|NCT00069095|453886862|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
126164233|NCT00069095|453886863|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
126164234|NCT00069095|453886858|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
126164235|NCT00069095|453886859|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
126164236|NCT00069095|453886860|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
126164237|NCT00069095|453886861|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
126164238|NCT00069095|453886862|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
126164239|NCT00069095|453886863|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
126164240|NCT00069095|453886858|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
126164241|NCT00069095|453886859|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
126164242|NCT00069095|453886860|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
126164243|NCT00069095|453886861|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
126164244|NCT00069095|453886862|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
126164245|NCT00069095|453886863|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
126164246|NCT00069095|453886858|FG000|Post-study Treatment Phase|Participant had complete response|1|||
126164247|NCT00069095|453886859|FG001|Post-study Treatment Phase|Participant had complete response|1|||
126164248|NCT00069095|453886860|FG002|Post-study Treatment Phase|Participant had complete response|0|||
126164249|NCT00069095|453886861|FG003|Post-study Treatment Phase|Participant had complete response|0|||
126164250|NCT00069095|453886862|FG004|Post-study Treatment Phase|Participant had complete response|0|||
126164251|NCT00069095|453886863|FG005|Post-study Treatment Phase|Participant had complete response|0|||
126164252|NCT00069095|453886858|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126164253|NCT00069095|453886859|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
126164254|NCT00069095|453886860|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126164255|NCT00069095|453886861|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126164256|NCT00069095|453886862|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126164257|NCT00069095|453886863|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126164258|NCT00069095|453886858|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
126164259|NCT00069095|453886859|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
126164260|NCT00069095|453886860|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
126164261|NCT00069095|453886861|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
126164262|NCT00069095|453886862|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
126164263|NCT00069095|453886863|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
126164264|NCT00069095|453886858|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
126164265|NCT00069095|453886859|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
126164266|NCT00069095|453886860|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
126164267|NCT00069095|453886861|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
126164268|NCT00069095|453886862|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
126164269|NCT00069095|453886863|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
126164270|NCT00069095|453886858|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
126164271|NCT00069095|453886859|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
126164272|NCT00069095|453886860|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
126164273|NCT00069095|453886861|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
126164274|NCT00069095|453886862|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
126164275|NCT00069095|453886863|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
126164276|NCT00069095|453886858|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126164277|NCT00069095|453886859|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125972848|NCT02621931|453191357|FG001|Overall Study|Lost to Follow-up|7|||
125972849|NCT02621931|453191358|FG002|Overall Study|Lost to Follow-up|10|||
125972850|NCT02621931|453191356|FG000|Overall Study|Lack of Efficacy|0|||
125972851|NCT02621931|453191357|FG001|Overall Study|Lack of Efficacy|0|||
125972852|NCT02621931|453191358|FG002|Overall Study|Lack of Efficacy|1|||
125972853|NCT02621931|453191356|FG000|Overall Study|Other|1|||
125972854|NCT02621931|453191357|FG001|Overall Study|Other|1|||
125972855|NCT02621931|453191358|FG002|Overall Study|Other|3|||
125972856|NCT01912612|453191361|FG000|Overall Study|Adverse Event|4|||
125972857|NCT01912612|453191362|FG001|Overall Study|Adverse Event|0|||
126164278|NCT00069095|453886860|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126164279|NCT00069095|453886861|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
126164280|NCT00069095|453886862|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126164281|NCT00069095|453886863|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126164282|NCT00069095|453886858|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
126164283|NCT00069095|453886859|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
126164284|NCT00069095|453886860|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
126164285|NCT00069095|453886861|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
126164286|NCT00069095|453886862|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
126164287|NCT00069095|453886863|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
126164288|NCT00069095|453886858|FG000|Post-study Treatment Phase|Surgery|0|||
126164289|NCT00069095|453886859|FG001|Post-study Treatment Phase|Surgery|0|||
126164290|NCT00069095|453886860|FG002|Post-study Treatment Phase|Surgery|0|||
126164291|NCT00069095|453886861|FG003|Post-study Treatment Phase|Surgery|1|||
126164292|NCT00069095|453886862|FG004|Post-study Treatment Phase|Surgery|1|||
126164293|NCT00069095|453886863|FG005|Post-study Treatment Phase|Surgery|0|||
126164294|NCT00069095|453886858|FG000|Post-study Treatment Phase|Death|0|||
126164295|NCT00069095|453886859|FG001|Post-study Treatment Phase|Death|0|||
126164296|NCT00069095|453886860|FG002|Post-study Treatment Phase|Death|0|||
126164297|NCT00069095|453886861|FG003|Post-study Treatment Phase|Death|0|||
126164298|NCT00069095|453886862|FG004|Post-study Treatment Phase|Death|1|||
126164299|NCT00069095|453886863|FG005|Post-study Treatment Phase|Death|0|||
126164300|NCT00069095|453886858|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
126164301|NCT00069095|453886859|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
126164302|NCT00069095|453886860|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
126164303|NCT00069095|453886861|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
126164304|NCT00069095|453886862|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
126164305|NCT00069095|453886863|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
126164306|NCT00069095|453886858|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126164307|NCT00069095|453886859|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126164308|NCT00069095|453886860|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126164309|NCT00069095|453886861|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126164310|NCT00069095|453886862|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
126164311|NCT00069095|453886863|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126164312|NCT00069095|453886858|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126164313|NCT00069095|453886859|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126164314|NCT00069095|453886860|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126164315|NCT00069095|453886861|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126164316|NCT00069095|453886862|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
126164317|NCT00069095|453886863|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126164318|NCT00069095|453886858|FG000|Post-study Treatment Phase|Investigator decision|0|||
126164319|NCT00069095|453886859|FG001|Post-study Treatment Phase|Investigator decision|0|||
126164320|NCT00069095|453886860|FG002|Post-study Treatment Phase|Investigator decision|0|||
126164321|NCT00069095|453886861|FG003|Post-study Treatment Phase|Investigator decision|0|||
126164322|NCT00069095|453886862|FG004|Post-study Treatment Phase|Investigator decision|0|||
126164323|NCT00069095|453886863|FG005|Post-study Treatment Phase|Investigator decision|1|||
126164324|NCT00069095|453886858|FG000|Follow-up Phase|Death|174|||
126164325|NCT00069095|453886859|FG001|Follow-up Phase|Death|206|||
126164326|NCT00069095|453886860|FG002|Follow-up Phase|Death|120|||
126164327|NCT00069095|453886861|FG003|Follow-up Phase|Death|112|||
126164328|NCT00069095|453886862|FG004|Follow-up Phase|Death|92|||
126164329|NCT00069095|453886863|FG005|Follow-up Phase|Death|101|||
126164330|NCT00913978|453886864|FG000|Overall Study|Surgeon choice|1|||
126164331|NCT00913978|453886865|FG001|Overall Study|Surgeon choice|3|||
126164332|NCT05100199|453886869|FG000|Overall Study|Lost to Follow-up|5|||
126164333|NCT05100199|453886870|FG001|Overall Study|Lost to Follow-up|8|||
126164334|NCT05100199|453886871|FG002|Overall Study|Lost to Follow-up|3|||
126164335|NCT05100199|453886872|FG003|Overall Study|Lost to Follow-up|6|||
126164336|NCT05100199|453886869|FG000|Overall Study|Withdrawal by Subject|3|||
125972858|NCT01912612|453191363|FG002|Overall Study|Adverse Event|0|||
125972859|NCT01912612|453191361|FG000|Overall Study|Withdrew consent|1|||
125972860|NCT01912612|453191362|FG001|Overall Study|Withdrew consent|0|||
126164337|NCT05100199|453886870|FG001|Overall Study|Withdrawal by Subject|3|||
126164338|NCT05100199|453886871|FG002|Overall Study|Withdrawal by Subject|9|||
126164339|NCT05100199|453886872|FG003|Overall Study|Withdrawal by Subject|7|||
126164340|NCT05100199|453886869|FG000|Overall Study|Other|0|||
126164341|NCT05100199|453886870|FG001|Overall Study|Other|0|||
126164342|NCT05100199|453886871|FG002|Overall Study|Other|1|||
126164343|NCT05100199|453886872|FG003|Overall Study|Other|1|||
126164344|NCT00830037|453886873|FG000|Overall Study|Withdrawal by Subject|2|||
126164345|NCT00830037|453886874|FG001|Overall Study|Withdrawal by Subject|3|||
126164346|NCT00830037|453886873|FG000|Overall Study|Lost to Follow-up|1|||
126164347|NCT00830037|453886874|FG001|Overall Study|Lost to Follow-up|2|||
126164348|NCT00830037|453886873|FG000|Overall Study|Active when terminated by DSMB|15|||
126164349|NCT00830037|453886874|FG001|Overall Study|Active when terminated by DSMB|14|||
126164350|NCT00752609|453886875|FG000|Overall Study|Adverse Event|2|||
126164351|NCT00752609|453886876|FG001|Overall Study|Adverse Event|2|||
126164352|NCT00752609|453886875|FG000|Overall Study|Withdrawal by Subject|3|||
126164353|NCT00752609|453886876|FG001|Overall Study|Withdrawal by Subject|0|||
126164354|NCT00752609|453886875|FG000|Overall Study|Physician Decision|1|||
126164355|NCT00752609|453886876|FG001|Overall Study|Physician Decision|0|||
126164356|NCT00752609|453886875|FG000|Overall Study|Death|1|||
126164357|NCT00752609|453886876|FG001|Overall Study|Death|0|||
126164358|NCT00752609|453886875|FG000|Overall Study|Met exclusion criteria|1|||
126164359|NCT00752609|453886876|FG001|Overall Study|Met exclusion criteria|0|||
126164360|NCT00752609|453886875|FG000|Overall Study|Received Aranesp in error|1|||
126164361|NCT00752609|453886876|FG001|Overall Study|Received Aranesp in error|0|||
126164362|NCT05114590|453886877|FG000|Overall Study|Adverse Event|1|||
126164363|NCT05114590|453886877|FG000|Overall Study|Investigator decision|1|||
126164364|NCT05114590|453886877|FG000|Overall Study|Lost to Follow-up|5|||
126164365|NCT05114590|453886877|FG000|Overall Study|Withdrawal by Subject|5|||
126164366|NCT05114590|453886877|FG000|Overall Study|Other|2|||
126164367|NCT00358917|453886880|FG000|Overall Study|Adverse Event|14|||
126164368|NCT00358917|453886881|FG001|Overall Study|Adverse Event|21|||
126164369|NCT00358917|453886880|FG000|Overall Study|Withdrawal by Subject|5|||
126164370|NCT00358917|453886881|FG001|Overall Study|Withdrawal by Subject|7|||
126164371|NCT00358917|453886880|FG000|Overall Study|Lost to Follow-up|20|||
126164372|NCT00358917|453886881|FG001|Overall Study|Lost to Follow-up|17|||
126164373|NCT00358917|453886880|FG000|Overall Study|Noncompliance|12|||
126164374|NCT00358917|453886881|FG001|Overall Study|Noncompliance|11|||
126164375|NCT00358917|453886880|FG000|Overall Study|Death|2|||
126164376|NCT00358917|453886881|FG001|Overall Study|Death|3|||
126164377|NCT00358917|453886880|FG000|Overall Study|Virologic failure|11|||
126164378|NCT00358917|453886881|FG001|Overall Study|Virologic failure|8|||
126164379|NCT00358917|453886880|FG000|Overall Study|Unable to Continue Participation|2|||
126164380|NCT00358917|453886881|FG001|Overall Study|Unable to Continue Participation|2|||
126164381|NCT01379534|453886886|FG000|Treatment Phase|Withdrawal by Subject|2|||
126164382|NCT01379534|453886887|FG001|Treatment Phase|Withdrawal by Subject|2|||
126164383|NCT01379534|453886886|FG000|Treatment Phase|Progressive disease|13|||
126164384|NCT01379534|453886887|FG001|Treatment Phase|Progressive disease|22|||
126164385|NCT01379534|453886886|FG000|Treatment Phase|Adverse Event|7|||
126164386|NCT01379534|453886887|FG001|Treatment Phase|Adverse Event|7|||
126164387|NCT01379534|453886886|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
126164388|NCT01379534|453886887|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
126164389|NCT01379534|453886886|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
126164390|NCT01379534|453886887|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
126164391|NCT01379534|453886886|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
126164392|NCT01379534|453886887|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
126164393|NCT01379534|453886886|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
126164394|NCT01379534|453886887|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
126164395|NCT05372575|453886894|FG000|Overall Study|Protocol Violation|7|||
126164396|NCT05372575|453886895|FG001|Overall Study|Protocol Violation|16|||
126164397|NCT01096550|453886896|FG000|Overall Study|discontinued site|10|||
126164398|NCT01096550|453886897|FG001|Overall Study|discontinued site|11|||
126164399|NCT01096550|453886896|FG000|Overall Study|non-regular treatment track at clinic|1|||
126164400|NCT01096550|453886897|FG001|Overall Study|non-regular treatment track at clinic|1|||
126164401|NCT01096550|453886896|FG000|Overall Study|clinic readmission|1|||
126164402|NCT01096550|453886897|FG001|Overall Study|clinic readmission|1|||
126164403|NCT01096550|453886896|FG000|Overall Study|Withdrawal by Subject|0|||
126164404|NCT01096550|453886897|FG001|Overall Study|Withdrawal by Subject|1|||
126164405|NCT01096550|453886896|FG000|Overall Study|non-African American participant|13|||
126164406|NCT01096550|453886897|FG001|Overall Study|non-African American participant|6|||
126164407|NCT01096550|453886896|FG000|Overall Study|Lost to Follow-up|12|||
126164408|NCT01096550|453886897|FG001|Overall Study|Lost to Follow-up|9|||
126164409|NCT01544595|453886900|FG000|Status at Week 68|Adverse Event|3|||
126164410|NCT01544595|453886901|FG001|Status at Week 68|Adverse Event|2|||
126164411|NCT01544595|453886902|FG002|Status at Week 68|Adverse Event|1|||
126164412|NCT01544595|453886903|FG003|Status at Week 68|Adverse Event|0|||
126164413|NCT01544595|453886904|FG004|Status at Week 68|Adverse Event|0|||
126164414|NCT01544595|453886905|FG005|Status at Week 68|Adverse Event|0|||
126164415|NCT01544595|453886900|FG000|Status at Week 68|Lack of Efficacy|1|||
126164416|NCT01544595|453886901|FG001|Status at Week 68|Lack of Efficacy|0|||
126164417|NCT01544595|453886902|FG002|Status at Week 68|Lack of Efficacy|0|||
126164418|NCT01544595|453886903|FG003|Status at Week 68|Lack of Efficacy|0|||
126164419|NCT01544595|453886904|FG004|Status at Week 68|Lack of Efficacy|0|||
126164420|NCT01544595|453886905|FG005|Status at Week 68|Lack of Efficacy|0|||
126164421|NCT01544595|453886900|FG000|Status at Week 68|Lost to Follow-up|1|||
126164422|NCT01544595|453886901|FG001|Status at Week 68|Lost to Follow-up|1|||
126164423|NCT01544595|453886902|FG002|Status at Week 68|Lost to Follow-up|0|||
126164424|NCT01544595|453886903|FG003|Status at Week 68|Lost to Follow-up|0|||
126164425|NCT01544595|453886904|FG004|Status at Week 68|Lost to Follow-up|0|||
126164426|NCT01544595|453886905|FG005|Status at Week 68|Lost to Follow-up|0|||
126164427|NCT01544595|453886900|FG000|Status at Week 68|Non-compliance with study treatment|1|||
126164428|NCT01544595|453886901|FG001|Status at Week 68|Non-compliance with study treatment|0|||
126164429|NCT01544595|453886902|FG002|Status at Week 68|Non-compliance with study treatment|0|||
126164430|NCT01544595|453886903|FG003|Status at Week 68|Non-compliance with study treatment|1|||
126164431|NCT01544595|453886904|FG004|Status at Week 68|Non-compliance with study treatment|0|||
126164432|NCT01544595|453886905|FG005|Status at Week 68|Non-compliance with study treatment|0|||
126164433|NCT01544595|453886900|FG000|Status at Week 68|Protocol Violation|2|||
126164434|NCT01544595|453886901|FG001|Status at Week 68|Protocol Violation|0|||
126164435|NCT01544595|453886902|FG002|Status at Week 68|Protocol Violation|1|||
126164436|NCT01544595|453886903|FG003|Status at Week 68|Protocol Violation|1|||
126164437|NCT01544595|453886904|FG004|Status at Week 68|Protocol Violation|0|||
126164438|NCT01544595|453886905|FG005|Status at Week 68|Protocol Violation|0|||
126164439|NCT01544595|453886900|FG000|Status at Week 68|Technical problems|1|||
126164440|NCT01544595|453886901|FG001|Status at Week 68|Technical problems|0|||
126164441|NCT01544595|453886902|FG002|Status at Week 68|Technical problems|0|||
126164442|NCT01544595|453886903|FG003|Status at Week 68|Technical problems|1|||
126164443|NCT01544595|453886904|FG004|Status at Week 68|Technical problems|0|||
126164444|NCT01544595|453886905|FG005|Status at Week 68|Technical problems|0|||
126164445|NCT01544595|453886900|FG000|Status at Week 68|Withdrawal by Subject|0|||
126164446|NCT01544595|453886901|FG001|Status at Week 68|Withdrawal by Subject|1|||
126164447|NCT01544595|453886902|FG002|Status at Week 68|Withdrawal by Subject|1|||
126164448|NCT01544595|453886903|FG003|Status at Week 68|Withdrawal by Subject|2|||
126164449|NCT01544595|453886904|FG004|Status at Week 68|Withdrawal by Subject|0|||
126164450|NCT01544595|453886905|FG005|Status at Week 68|Withdrawal by Subject|0|||
126164451|NCT01544595|453886900|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
126164452|NCT01544595|453886901|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
126164453|NCT01544595|453886902|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
126164454|NCT01544595|453886903|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
126164455|NCT01544595|453886904|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
126164456|NCT01544595|453886905|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
126164457|NCT01544595|453886900|FG000|Status at Week 156|Withdrawal by Subject|9|||
126164458|NCT01544595|453886901|FG001|Status at Week 156|Withdrawal by Subject|10|||
126164459|NCT01544595|453886902|FG002|Status at Week 156|Withdrawal by Subject|4|||
126164460|NCT01544595|453886903|FG003|Status at Week 156|Withdrawal by Subject|9|||
126164461|NCT01544595|453886904|FG004|Status at Week 156|Withdrawal by Subject|20|||
126164462|NCT01544595|453886905|FG005|Status at Week 156|Withdrawal by Subject|6|||
126164463|NCT01544595|453886900|FG000|Status at Week 156|Adverse Event|9|||
126164464|NCT01544595|453886901|FG001|Status at Week 156|Adverse Event|11|||
126164465|NCT01544595|453886902|FG002|Status at Week 156|Adverse Event|1|||
126164466|NCT01544595|453886903|FG003|Status at Week 156|Adverse Event|3|||
126164467|NCT01544595|453886904|FG004|Status at Week 156|Adverse Event|4|||
126164468|NCT01544595|453886905|FG005|Status at Week 156|Adverse Event|2|||
126164469|NCT01544595|453886900|FG000|Status at Week 156|Lost to Follow-up|4|||
126164470|NCT01544595|453886901|FG001|Status at Week 156|Lost to Follow-up|4|||
126164471|NCT01544595|453886902|FG002|Status at Week 156|Lost to Follow-up|0|||
126164472|NCT01544595|453886903|FG003|Status at Week 156|Lost to Follow-up|1|||
126164473|NCT01544595|453886904|FG004|Status at Week 156|Lost to Follow-up|4|||
126164474|NCT01544595|453886905|FG005|Status at Week 156|Lost to Follow-up|1|||
126164475|NCT01544595|453886900|FG000|Status at Week 156|Non-compliance with study treatement|0|||
126164476|NCT01544595|453886901|FG001|Status at Week 156|Non-compliance with study treatement|1|||
126164477|NCT01544595|453886902|FG002|Status at Week 156|Non-compliance with study treatement|0|||
126164478|NCT01544595|453886903|FG003|Status at Week 156|Non-compliance with study treatement|1|||
126164479|NCT01544595|453886904|FG004|Status at Week 156|Non-compliance with study treatement|0|||
126164480|NCT01544595|453886905|FG005|Status at Week 156|Non-compliance with study treatement|1|||
126164481|NCT01544595|453886900|FG000|Status at Week 156|Physician Decision|0|||
126164482|NCT01544595|453886901|FG001|Status at Week 156|Physician Decision|3|||
126164483|NCT01544595|453886902|FG002|Status at Week 156|Physician Decision|1|||
126164484|NCT01544595|453886903|FG003|Status at Week 156|Physician Decision|0|||
126164485|NCT01544595|453886904|FG004|Status at Week 156|Physician Decision|0|||
126164486|NCT01544595|453886905|FG005|Status at Week 156|Physician Decision|0|||
126164487|NCT01544595|453886900|FG000|Status at Week 156|Pregnancy|2|||
126164488|NCT01544595|453886901|FG001|Status at Week 156|Pregnancy|3|||
126164489|NCT01544595|453886902|FG002|Status at Week 156|Pregnancy|0|||
126164490|NCT01544595|453886903|FG003|Status at Week 156|Pregnancy|0|||
126164491|NCT01544595|453886904|FG004|Status at Week 156|Pregnancy|0|||
126164492|NCT01544595|453886905|FG005|Status at Week 156|Pregnancy|0|||
126164493|NCT01544595|453886900|FG000|Status at Week 156|Protocol Violation|3|||
126164494|NCT01544595|453886901|FG001|Status at Week 156|Protocol Violation|1|||
126164495|NCT01544595|453886902|FG002|Status at Week 156|Protocol Violation|2|||
126164496|NCT01544595|453886903|FG003|Status at Week 156|Protocol Violation|2|||
126164497|NCT01544595|453886904|FG004|Status at Week 156|Protocol Violation|0|||
126164498|NCT01544595|453886905|FG005|Status at Week 156|Protocol Violation|0|||
126164499|NCT01544595|453886900|FG000|Status at Week 156|Technical problems|3|||
126164500|NCT01544595|453886901|FG001|Status at Week 156|Technical problems|1|||
126164501|NCT01544595|453886902|FG002|Status at Week 156|Technical problems|0|||
126164502|NCT01544595|453886903|FG003|Status at Week 156|Technical problems|1|||
126164503|NCT01544595|453886904|FG004|Status at Week 156|Technical problems|0|||
126164504|NCT01544595|453886905|FG005|Status at Week 156|Technical problems|0|||
126164505|NCT01544595|453886900|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
126164506|NCT01544595|453886901|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
126164507|NCT01544595|453886902|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
126164508|NCT01544595|453886903|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
126164509|NCT01544595|453886904|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
125972861|NCT01912612|453191363|FG002|Overall Study|Withdrew consent|0|||
125972862|NCT01912612|453191361|FG000|Overall Study|Study design change|0|||
125972863|NCT01912612|453191362|FG001|Overall Study|Study design change|0|||
125972864|NCT01912612|453191363|FG002|Overall Study|Study design change|3|||
125972865|NCT02008890|453191364|FG000|Period 1|Withdrawal by Subject|7|||
125972866|NCT02008890|453191365|FG001|Period 1|Withdrawal by Subject|7|||
125972867|NCT02008890|453191366|FG002|Period 1|Withdrawal by Subject|5|||
125972868|NCT02008890|453191367|FG003|Period 1|Withdrawal by Subject|0|||
125972869|NCT02008890|453191368|FG004|Period 1|Withdrawal by Subject|0|||
125972870|NCT02008890|453191364|FG000|Period 1|Pregnancy|1|||
125972871|NCT02008890|453191365|FG001|Period 1|Pregnancy|0|||
125972872|NCT02008890|453191366|FG002|Period 1|Pregnancy|0|||
125972873|NCT02008890|453191367|FG003|Period 1|Pregnancy|0|||
125972874|NCT02008890|453191368|FG004|Period 1|Pregnancy|0|||
125972875|NCT02008890|453191364|FG000|Period 1|Physician Decision|1|||
125972876|NCT02008890|453191365|FG001|Period 1|Physician Decision|0|||
125972877|NCT02008890|453191366|FG002|Period 1|Physician Decision|1|||
125972878|NCT02008890|453191367|FG003|Period 1|Physician Decision|0|||
125972879|NCT02008890|453191368|FG004|Period 1|Physician Decision|0|||
125972880|NCT02008890|453191364|FG000|Period 1|Adverse Event|6|||
125972881|NCT02008890|453191365|FG001|Period 1|Adverse Event|8|||
126164510|NCT01544595|453886905|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
126164511|NCT01544595|453886900|FG000|Status at Week 156|Lack of Efficacy|1|||
126164512|NCT01544595|453886901|FG001|Status at Week 156|Lack of Efficacy|0|||
126164513|NCT01544595|453886902|FG002|Status at Week 156|Lack of Efficacy|1|||
126164514|NCT01544595|453886903|FG003|Status at Week 156|Lack of Efficacy|4|||
126164515|NCT01544595|453886904|FG004|Status at Week 156|Lack of Efficacy|10|||
126164516|NCT01544595|453886905|FG005|Status at Week 156|Lack of Efficacy|5|||
126164517|NCT03288779|453886913|FG000|Overall Study|Withdrawal by Subject|3|||
126164518|NCT00601523|453886914|FG000|Overall Study|Adverse Event|42|||
126164519|NCT00601523|453886915|FG001|Overall Study|Adverse Event|14|||
126164520|NCT00601523|453886914|FG000|Overall Study|Lack of Efficacy|3|||
126164521|NCT00601523|453886915|FG001|Overall Study|Lack of Efficacy|0|||
126164522|NCT00601523|453886914|FG000|Overall Study|Protocol Violation|5|||
126164523|NCT00601523|453886915|FG001|Overall Study|Protocol Violation|1|||
126164524|NCT00601523|453886914|FG000|Overall Study|Lost to Follow-up|0|||
126164525|NCT00601523|453886915|FG001|Overall Study|Lost to Follow-up|1|||
126164526|NCT00601523|453886914|FG000|Overall Study|Withdrawal by Subject|18|||
126164527|NCT00601523|453886915|FG001|Overall Study|Withdrawal by Subject|9|||
126164528|NCT00601523|453886914|FG000|Overall Study|Other|9|||
126164529|NCT00601523|453886915|FG001|Overall Study|Other|1|||
126164530|NCT03643432|453886916|FG000|Overall Study|Lost to Follow-up|1|||
126164531|NCT03643432|453886917|FG001|Overall Study|Lost to Follow-up|0|||
126164532|NCT01064648|453886926|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
126164533|NCT01064648|453886927|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
126164534|NCT01064648|453886928|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
126164535|NCT01064648|453886929|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
126164536|NCT01064648|453886926|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
126164537|NCT01064648|453886927|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
126164538|NCT01064648|453886928|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
126164539|NCT01064648|453886929|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
126164540|NCT01064648|453886926|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
125972882|NCT02008890|453191366|FG002|Period 1|Adverse Event|6|||
125972883|NCT02008890|453191367|FG003|Period 1|Adverse Event|0|||
125972884|NCT02008890|453191368|FG004|Period 1|Adverse Event|0|||
125972885|NCT02008890|453191364|FG000|Period 2|Adverse Event|12|||
125972886|NCT02008890|453191365|FG001|Period 2|Adverse Event|7|||
125972887|NCT02008890|453191366|FG002|Period 2|Adverse Event|0|||
126164541|NCT01064648|453886927|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
126164542|NCT01064648|453886928|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
126164543|NCT01064648|453886929|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
125972888|NCT02008890|453191367|FG003|Period 2|Adverse Event|5|||
125972889|NCT02008890|453191368|FG004|Period 2|Adverse Event|5|||
126164544|NCT01064648|453886926|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
126164545|NCT01064648|453886927|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
126164546|NCT01064648|453886928|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
126164547|NCT01064648|453886929|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
126164548|NCT01064648|453886926|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
126164549|NCT01064648|453886927|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
126164550|NCT01064648|453886928|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
126164551|NCT01064648|453886929|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
126164552|NCT01064648|453886926|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
126164553|NCT01064648|453886927|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
126164554|NCT01064648|453886928|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
126164555|NCT01064648|453886929|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
126164556|NCT01064648|453886926|FG000|Phase II|Adverse Event|0|||
126164557|NCT01064648|453886927|FG001|Phase II|Adverse Event|0|||
126164558|NCT01064648|453886928|FG002|Phase II|Adverse Event|15|||
126164559|NCT01064648|453886929|FG003|Phase II|Adverse Event|8|||
126164560|NCT01064648|453886926|FG000|Phase II|Death|0|||
126164561|NCT01064648|453886927|FG001|Phase II|Death|0|||
126164562|NCT01064648|453886928|FG002|Phase II|Death|4|||
126164563|NCT01064648|453886929|FG003|Phase II|Death|5|||
126164564|NCT01064648|453886926|FG000|Phase II|Withdrawal by Subject|0|||
126164565|NCT01064648|453886927|FG001|Phase II|Withdrawal by Subject|0|||
126164566|NCT01064648|453886928|FG002|Phase II|Withdrawal by Subject|2|||
126164567|NCT01064648|453886929|FG003|Phase II|Withdrawal by Subject|5|||
126164568|NCT01064648|453886926|FG000|Phase II|Progression|0|||
126164569|NCT01064648|453886927|FG001|Phase II|Progression|0|||
126164570|NCT01064648|453886928|FG002|Phase II|Progression|21|||
126164571|NCT01064648|453886929|FG003|Phase II|Progression|27|||
126164572|NCT01064648|453886926|FG000|Phase II|Non-protocol specified|0|||
126164573|NCT01064648|453886927|FG001|Phase II|Non-protocol specified|0|||
126164574|NCT01064648|453886928|FG002|Phase II|Non-protocol specified|5|||
126164575|NCT01064648|453886929|FG003|Phase II|Non-protocol specified|3|||
126164576|NCT01064648|453886926|FG000|Phase II|Under Review|0|||
126164577|NCT01064648|453886927|FG001|Phase II|Under Review|0|||
126164578|NCT01064648|453886928|FG002|Phase II|Under Review|2|||
126164579|NCT01064648|453886929|FG003|Phase II|Under Review|0|||
126164580|NCT00977574|453886930|FG000|Overall Study|Never Treated|4|||
126164581|NCT00977574|453886931|FG001|Overall Study|Never Treated|2|||
126164582|NCT00977574|453886932|FG002|Overall Study|Never Treated|4|||
126164583|NCT04038255|453889651|FG000|Overall Study|Lost to Follow-up|0|||
126164584|NCT04038255|453889652|FG001|Overall Study|Lost to Follow-up|9|||
126164585|NCT04038255|453889653|FG002|Overall Study|Lost to Follow-up|5|||
126164586|NCT04038255|453889651|FG000|Overall Study|Withdrawal by Subject|0|||
126164587|NCT04038255|453889652|FG001|Overall Study|Withdrawal by Subject|0|||
126164588|NCT04038255|453889653|FG002|Overall Study|Withdrawal by Subject|1|||
126164589|NCT05183867|453889656|FG000|Overall Study|Withdrawal by Subject|3|||
126164590|NCT05183867|453889657|FG001|Overall Study|Withdrawal by Subject|2|||
126164591|NCT05183867|453889658|FG002|Overall Study|Withdrawal by Subject|0|||
126164592|NCT04491877|453889661|FG000|Overall Study|Protocol Deviation|1|||
126164593|NCT04491877|453889662|FG001|Overall Study|Protocol Deviation|0|||
126164594|NCT04491877|453889663|FG002|Overall Study|Protocol Deviation|2|||
126164595|NCT04491877|453889664|FG003|Overall Study|Protocol Deviation|0|||
126164596|NCT04491877|453889665|FG004|Overall Study|Protocol Deviation|0|||
126164597|NCT04491877|453889666|FG005|Overall Study|Protocol Deviation|0|||
126164598|NCT04491877|453889667|FG006|Overall Study|Protocol Deviation|1|||
126164599|NCT04491877|453889668|FG007|Overall Study|Protocol Deviation|1|||
126164600|NCT04491877|453889669|FG008|Overall Study|Protocol Deviation|0|||
126164601|NCT04491877|453889661|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126164602|NCT04491877|453889662|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125972890|NCT02008890|453191364|FG000|Period 2|Withdrawal by Subject|11|||
125972891|NCT02008890|453191365|FG001|Period 2|Withdrawal by Subject|8|||
125972892|NCT02008890|453191366|FG002|Period 2|Withdrawal by Subject|0|||
125972893|NCT02008890|453191367|FG003|Period 2|Withdrawal by Subject|7|||
125972894|NCT02008890|453191368|FG004|Period 2|Withdrawal by Subject|2|||
125972895|NCT02008890|453191364|FG000|Period 2|Physician Decision|4|||
125972896|NCT02008890|453191365|FG001|Period 2|Physician Decision|0|||
125972897|NCT02008890|453191366|FG002|Period 2|Physician Decision|0|||
126164603|NCT04491877|453889663|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126164604|NCT04491877|453889664|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
125972898|NCT02008890|453191367|FG003|Period 2|Physician Decision|2|||
126164605|NCT04491877|453889665|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126164606|NCT04491877|453889666|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
126164607|NCT04491877|453889667|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
126164608|NCT04491877|453889668|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
126164609|NCT04491877|453889669|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
126164610|NCT04491877|453889661|FG000|Overall Study|Lost to Follow-up|0|||
125972899|NCT02008890|453191368|FG004|Period 2|Physician Decision|1|||
125972900|NCT02008890|453191364|FG000|Period 2|Lost to Follow-up|0|||
126164611|NCT04491877|453889662|FG001|Overall Study|Lost to Follow-up|2|||
126164612|NCT04491877|453889663|FG002|Overall Study|Lost to Follow-up|0|||
126164613|NCT04491877|453889664|FG003|Overall Study|Lost to Follow-up|0|||
126164614|NCT04491877|453889665|FG004|Overall Study|Lost to Follow-up|0|||
126164615|NCT04491877|453889666|FG005|Overall Study|Lost to Follow-up|0|||
126164616|NCT04491877|453889667|FG006|Overall Study|Lost to Follow-up|2|||
126164617|NCT04491877|453889668|FG007|Overall Study|Lost to Follow-up|1|||
126164618|NCT04491877|453889669|FG008|Overall Study|Lost to Follow-up|1|||
126164619|NCT01286272|453889673|FG000|Overall Study|Ineligible after beginning treatment|1|||
126164620|NCT01286272|453889674|FG001|Overall Study|Ineligible after beginning treatment|3|||
126164621|NCT00418834|453889679|FG000|Overall Study|Adverse Event|16|||
126164622|NCT00418834|453889680|FG001|Overall Study|Adverse Event|9|||
126164623|NCT00418834|453889679|FG000|Overall Study|Lost to Follow-up|0|||
126164624|NCT00418834|453889680|FG001|Overall Study|Lost to Follow-up|1|||
126164625|NCT00418834|453889679|FG000|Overall Study|Protocol Violation|4|||
126164626|NCT00418834|453889680|FG001|Overall Study|Protocol Violation|3|||
126164627|NCT00418834|453889679|FG000|Overall Study|Withdrawal by Subject|3|||
126164628|NCT00418834|453889680|FG001|Overall Study|Withdrawal by Subject|7|||
126164629|NCT01953328|453889681|FG000|Overall Study|Withdrawal by Subject|0|||
126164630|NCT01953328|453889682|FG001|Overall Study|Withdrawal by Subject|0|||
126164631|NCT01953328|453889683|FG002|Overall Study|Withdrawal by Subject|0|||
126164632|NCT01953328|453889684|FG003|Overall Study|Withdrawal by Subject|0|||
126164633|NCT01953328|453889685|FG004|Overall Study|Withdrawal by Subject|1|||
126164634|NCT01953328|453889686|FG005|Overall Study|Withdrawal by Subject|0|||
126164635|NCT01953328|453889687|FG006|Overall Study|Withdrawal by Subject|0|||
126164636|NCT01953328|453889688|FG007|Overall Study|Withdrawal by Subject|0|||
126164637|NCT01953328|453889681|FG000|Overall Study|Lost to Follow-up|0|||
126164638|NCT01953328|453889682|FG001|Overall Study|Lost to Follow-up|0|||
126164639|NCT01953328|453889683|FG002|Overall Study|Lost to Follow-up|0|||
126164640|NCT01953328|453889684|FG003|Overall Study|Lost to Follow-up|0|||
126164641|NCT01953328|453889685|FG004|Overall Study|Lost to Follow-up|1|||
126164642|NCT01953328|453889686|FG005|Overall Study|Lost to Follow-up|0|||
126164643|NCT01953328|453889687|FG006|Overall Study|Lost to Follow-up|0|||
126164644|NCT01953328|453889688|FG007|Overall Study|Lost to Follow-up|0|||
126164645|NCT02364947|453889693|FG000|Overall Study|Withdrawal by Subject|10|||
126164646|NCT02364947|453889694|FG001|Overall Study|Withdrawal by Subject|8|||
126164647|NCT02364947|453889695|FG002|Overall Study|Withdrawal by Subject|9|||
126164648|NCT02364947|453889693|FG000|Overall Study|Adverse Event|45|||
126164649|NCT02364947|453889694|FG001|Overall Study|Adverse Event|33|||
126164650|NCT02364947|453889695|FG002|Overall Study|Adverse Event|11|||
126164651|NCT02364947|453889693|FG000|Overall Study|Protocol Violation|1|||
126164652|NCT02364947|453889694|FG001|Overall Study|Protocol Violation|1|||
126164653|NCT02364947|453889695|FG002|Overall Study|Protocol Violation|1|||
126164654|NCT02364947|453889693|FG000|Overall Study|Physician Decision|3|||
126164655|NCT02364947|453889694|FG001|Overall Study|Physician Decision|2|||
126164656|NCT02364947|453889695|FG002|Overall Study|Physician Decision|5|||
126164657|NCT02364947|453889693|FG000|Overall Study|Death|0|||
126164658|NCT02364947|453889694|FG001|Overall Study|Death|1|||
126164659|NCT02364947|453889695|FG002|Overall Study|Death|0|||
126164660|NCT05525975|453889696|FG000|Overall Study|Surgery cancellation|4|||
126164661|NCT05525975|453889697|FG001|Overall Study|Surgery cancellation|5|||
126164662|NCT05525975|453889696|FG000|Overall Study|didn't fill prescription|1|||
126164663|NCT05525975|453889697|FG001|Overall Study|didn't fill prescription|0|||
126164664|NCT05525975|453889696|FG000|Overall Study|Withdrawal by Subject|0|||
126164665|NCT05525975|453889697|FG001|Overall Study|Withdrawal by Subject|3|||
126164666|NCT00262080|453889698|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
126164667|NCT00262080|453889699|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126164668|NCT00262080|453889700|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
126164669|NCT00262080|453889698|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
126164670|NCT00262080|453889699|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
126164671|NCT00262080|453889700|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
126164672|NCT00262080|453889698|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
126164673|NCT00262080|453889699|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
126164674|NCT00262080|453889700|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
126164675|NCT00262080|453889698|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
126164676|NCT00262080|453889699|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
126164677|NCT00262080|453889700|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
126164678|NCT00262080|453889698|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
126164679|NCT00262080|453889699|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
126164680|NCT00262080|453889700|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
126164681|NCT00262080|453889698|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
126164682|NCT00262080|453889699|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
126164683|NCT00262080|453889700|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
126164684|NCT02273752|453889701|FG000|Overall Study|Trial was terminated early|2|||
126164685|NCT02808312|453889702|FG000|Overall Study|Enrolled but Never Treated|0|||
126164686|NCT02808312|453889703|FG001|Overall Study|Enrolled but Never Treated|0|||
126164687|NCT02808312|453889704|FG002|Overall Study|Enrolled but Never Treated|1|||
126164688|NCT02808312|453889705|FG003|Overall Study|Enrolled but Never Treated|0|||
126164689|NCT02808312|453889706|FG004|Overall Study|Enrolled but Never Treated|0|||
126164690|NCT03100942|453889710|FG000|Randomized Treatment Period|Withdrew Consent|4|||
126164691|NCT03100942|453889711|FG001|Randomized Treatment Period|Withdrew Consent|5|||
126164692|NCT03100942|453889712|FG002|Randomized Treatment Period|Withdrew Consent|3|||
126164693|NCT03100942|453889713|FG003|Randomized Treatment Period|Withdrew Consent|3|||
126164694|NCT03100942|453889714|FG004|Randomized Treatment Period|Withdrew Consent|0|||
126164695|NCT03100942|453889715|FG005|Randomized Treatment Period|Withdrew Consent|0|||
126164696|NCT03100942|453889716|FG006|Randomized Treatment Period|Withdrew Consent|0|||
126164697|NCT03100942|453889710|FG000|Randomized Treatment Period|Adverse Event|5|||
126164698|NCT03100942|453889711|FG001|Randomized Treatment Period|Adverse Event|2|||
126164699|NCT03100942|453889712|FG002|Randomized Treatment Period|Adverse Event|1|||
126164700|NCT03100942|453889713|FG003|Randomized Treatment Period|Adverse Event|0|||
126164701|NCT03100942|453889714|FG004|Randomized Treatment Period|Adverse Event|0|||
126164702|NCT03100942|453889715|FG005|Randomized Treatment Period|Adverse Event|0|||
126164703|NCT03100942|453889716|FG006|Randomized Treatment Period|Adverse Event|0|||
126164704|NCT03100942|453889710|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
126164705|NCT03100942|453889711|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
126164706|NCT03100942|453889712|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
126164707|NCT03100942|453889713|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
126164708|NCT03100942|453889714|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
126164709|NCT03100942|453889715|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
126164710|NCT03100942|453889716|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
126164711|NCT03100942|453889710|FG000|Randomized Treatment Period|Protocol Violation|0|||
126164712|NCT03100942|453889711|FG001|Randomized Treatment Period|Protocol Violation|1|||
126164713|NCT03100942|453889712|FG002|Randomized Treatment Period|Protocol Violation|1|||
126164714|NCT03100942|453889713|FG003|Randomized Treatment Period|Protocol Violation|1|||
126164715|NCT03100942|453889714|FG004|Randomized Treatment Period|Protocol Violation|0|||
126164716|NCT03100942|453889715|FG005|Randomized Treatment Period|Protocol Violation|0|||
126164717|NCT03100942|453889716|FG006|Randomized Treatment Period|Protocol Violation|0|||
126164718|NCT03100942|453889710|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
126164719|NCT03100942|453889711|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
126164720|NCT03100942|453889712|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
126164721|NCT03100942|453889713|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
126164722|NCT03100942|453889714|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
126164723|NCT03100942|453889715|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
126164724|NCT03100942|453889716|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
126164725|NCT03100942|453889710|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
126164726|NCT03100942|453889711|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126164727|NCT03100942|453889712|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126164728|NCT03100942|453889713|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
126164729|NCT03100942|453889714|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126164730|NCT03100942|453889715|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126164731|NCT03100942|453889716|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126164732|NCT03100942|453889710|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126164733|NCT03100942|453889711|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126164734|NCT03100942|453889712|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126164735|NCT03100942|453889713|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126164736|NCT03100942|453889714|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126164737|NCT03100942|453889715|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126164738|NCT03100942|453889716|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
126164739|NCT04009096|453889717|FG000|Overall Study|Withdrawal by Subject|0|||
126164740|NCT04009096|453889718|FG001|Overall Study|Withdrawal by Subject|7|||
126164741|NCT04009096|453889719|FG002|Overall Study|Withdrawal by Subject|0|||
126164742|NCT04009096|453889717|FG000|Overall Study|Physician Decision|0|||
126164743|NCT04009096|453889718|FG001|Overall Study|Physician Decision|1|||
126164744|NCT04009096|453889719|FG002|Overall Study|Physician Decision|0|||
126164745|NCT05151471|453889720|FG000|Overall Study|Adverse Event|21|||
126164746|NCT05151471|453889721|FG001|Overall Study|Adverse Event|16|||
126164747|NCT05151471|453889720|FG000|Overall Study|Death|1|||
126164748|NCT05151471|453889721|FG001|Overall Study|Death|0|||
126164749|NCT05151471|453889720|FG000|Overall Study|Lost to Follow-up|0|||
126164750|NCT05151471|453889721|FG001|Overall Study|Lost to Follow-up|1|||
126164751|NCT05151471|453889720|FG000|Overall Study|Withdrawal by Subject|7|||
126164752|NCT05151471|453889721|FG001|Overall Study|Withdrawal by Subject|9|||
126164753|NCT05151471|453889720|FG000|Overall Study|Study terminated by sponsor|49|||
126164754|NCT05151471|453889721|FG001|Overall Study|Study terminated by sponsor|47|||
126164755|NCT05151471|453889720|FG000|Overall Study|Other|2|||
126164756|NCT05151471|453889721|FG001|Overall Study|Other|1|||
126164757|NCT04263142|453889722|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
126164758|NCT04263142|453889723|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
126164759|NCT04263142|453889724|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
126164760|NCT04263142|453889725|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
126164761|NCT04263142|453889726|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
126164762|NCT04263142|453889722|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
126164763|NCT04263142|453889723|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
126164764|NCT04263142|453889724|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
126164765|NCT04263142|453889725|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
126164766|NCT04263142|453889726|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
126164767|NCT01623531|453889727|FG000|Overall Study|Death|1|||
126164768|NCT01623531|453889728|FG001|Overall Study|Death|0|||
126164769|NCT01623531|453889727|FG000|Overall Study|Protocol Violation|2|||
126164770|NCT01623531|453889728|FG001|Overall Study|Protocol Violation|1|||
126164771|NCT01623531|453889727|FG000|Overall Study|Missing data at primary outcome time poi|1|||
126164772|NCT01623531|453889728|FG001|Overall Study|Missing data at primary outcome time poi|1|||
126164773|NCT01429792|453889729|FG000|Overall Study|Other Reasons|67|||
126164774|NCT01429792|453889729|FG000|Overall Study|Unknown Disposition|94|||
126164775|NCT01429792|453889729|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
126164776|NCT01429792|453889729|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
126164777|NCT01429792|453889729|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
126164778|NCT01429792|453889729|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
126164779|NCT01429792|453889729|FG000|Overall Study|Withdrawal by Subject|70|||
126164780|NCT01429792|453889729|FG000|Overall Study|Lost to Follow-up|88|||
126164781|NCT04184622|453889731|FG000|Primary Treatment Period|Adverse Event|6|||
126164782|NCT04184622|453889732|FG001|Primary Treatment Period|Adverse Event|4|||
126164783|NCT04184622|453889733|FG002|Primary Treatment Period|Adverse Event|8|||
126164784|NCT04184622|453889734|FG003|Primary Treatment Period|Adverse Event|6|||
126164785|NCT04184622|453889731|FG000|Primary Treatment Period|Death|4|||
126164786|NCT04184622|453889732|FG001|Primary Treatment Period|Death|4|||
126164787|NCT04184622|453889733|FG002|Primary Treatment Period|Death|2|||
126164788|NCT04184622|453889734|FG003|Primary Treatment Period|Death|1|||
126164789|NCT04184622|453889731|FG000|Primary Treatment Period|Lost to Follow-up|41|||
126164790|NCT04184622|453889732|FG001|Primary Treatment Period|Lost to Follow-up|17|||
126164791|NCT04184622|453889733|FG002|Primary Treatment Period|Lost to Follow-up|15|||
126164792|NCT04184622|453889734|FG003|Primary Treatment Period|Lost to Follow-up|13|||
126164793|NCT04184622|453889731|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
126164794|NCT04184622|453889732|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
126164795|NCT04184622|453889733|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
126164796|NCT04184622|453889734|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
126164797|NCT04184622|453889731|FG000|Primary Treatment Period|Physician Decision|0|||
126164798|NCT04184622|453889732|FG001|Primary Treatment Period|Physician Decision|0|||
126164799|NCT04184622|453889733|FG002|Primary Treatment Period|Physician Decision|3|||
126164800|NCT04184622|453889734|FG003|Primary Treatment Period|Physician Decision|1|||
126164801|NCT04184622|453889731|FG000|Primary Treatment Period|Pregnancy|4|||
126164802|NCT04184622|453889732|FG001|Primary Treatment Period|Pregnancy|3|||
126164803|NCT04184622|453889733|FG002|Primary Treatment Period|Pregnancy|4|||
126164804|NCT04184622|453889734|FG003|Primary Treatment Period|Pregnancy|1|||
126164805|NCT04184622|453889731|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
126164806|NCT04184622|453889732|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
126164807|NCT04184622|453889733|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
126164808|NCT04184622|453889734|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
126164809|NCT04184622|453889731|FG000|Additional Treatment Period|Adverse Event|1|||
126164810|NCT04184622|453889732|FG001|Additional Treatment Period|Adverse Event|2|||
126164811|NCT04184622|453889733|FG002|Additional Treatment Period|Adverse Event|1|||
126164812|NCT04184622|453889734|FG003|Additional Treatment Period|Adverse Event|0|||
126164813|NCT04184622|453889731|FG000|Additional Treatment Period|Death|0|||
126164814|NCT04184622|453889732|FG001|Additional Treatment Period|Death|0|||
126164815|NCT04184622|453889733|FG002|Additional Treatment Period|Death|1|||
126164816|NCT04184622|453889734|FG003|Additional Treatment Period|Death|1|||
126164817|NCT04184622|453889731|FG000|Additional Treatment Period|Lost to Follow-up|6|||
126164818|NCT04184622|453889732|FG001|Additional Treatment Period|Lost to Follow-up|4|||
126164819|NCT04184622|453889733|FG002|Additional Treatment Period|Lost to Follow-up|8|||
126164820|NCT04184622|453889734|FG003|Additional Treatment Period|Lost to Follow-up|6|||
126164821|NCT04184622|453889731|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
126164822|NCT04184622|453889732|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
126164823|NCT04184622|453889733|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
126164824|NCT04184622|453889734|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
126164825|NCT04184622|453889731|FG000|Additional Treatment Period|Physician Decision|0|||
126164826|NCT04184622|453889732|FG001|Additional Treatment Period|Physician Decision|0|||
126164827|NCT04184622|453889733|FG002|Additional Treatment Period|Physician Decision|1|||
126164828|NCT04184622|453889734|FG003|Additional Treatment Period|Physician Decision|0|||
126164829|NCT04184622|453889731|FG000|Additional Treatment Period|Pregnancy|0|||
126164830|NCT04184622|453889732|FG001|Additional Treatment Period|Pregnancy|0|||
126164831|NCT04184622|453889733|FG002|Additional Treatment Period|Pregnancy|0|||
126164832|NCT04184622|453889734|FG003|Additional Treatment Period|Pregnancy|1|||
126164833|NCT04184622|453889731|FG000|Additional Treatment Period|Protocol deviation|0|||
126164834|NCT04184622|453889732|FG001|Additional Treatment Period|Protocol deviation|0|||
126164835|NCT04184622|453889733|FG002|Additional Treatment Period|Protocol deviation|1|||
126164836|NCT04184622|453889734|FG003|Additional Treatment Period|Protocol deviation|0|||
126164837|NCT04184622|453889731|FG000|Additional Treatment Period|Site closed|1|||
126164838|NCT04184622|453889732|FG001|Additional Treatment Period|Site closed|0|||
126164839|NCT04184622|453889733|FG002|Additional Treatment Period|Site closed|1|||
126164840|NCT04184622|453889734|FG003|Additional Treatment Period|Site closed|0|||
126164841|NCT04184622|453889731|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
126164842|NCT04184622|453889732|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
126164843|NCT04184622|453889733|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
126164844|NCT04184622|453889734|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
126164845|NCT04184622|453889731|FG000|Safety Follow-up Period|Adverse Event|6|||
126164846|NCT04184622|453889732|FG001|Safety Follow-up Period|Adverse Event|8|||
126164847|NCT04184622|453889733|FG002|Safety Follow-up Period|Adverse Event|9|||
126164848|NCT04184622|453889734|FG003|Safety Follow-up Period|Adverse Event|16|||
126164849|NCT04184622|453889731|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
126164850|NCT04184622|453889732|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
126164851|NCT04184622|453889733|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
126164852|NCT04184622|453889734|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
126164853|NCT04184622|453889731|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
126164854|NCT04184622|453889732|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
126164855|NCT04184622|453889733|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
126164856|NCT04184622|453889734|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
126164857|NCT04184622|453889731|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
126164858|NCT04184622|453889732|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
126164859|NCT04184622|453889733|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
126164860|NCT04184622|453889734|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
126164861|NCT04184622|453889731|FG000|Safety Follow-up Period|Physician Decision|1|||
126164862|NCT04184622|453889732|FG001|Safety Follow-up Period|Physician Decision|0|||
126164863|NCT04184622|453889733|FG002|Safety Follow-up Period|Physician Decision|0|||
126164864|NCT04184622|453889734|FG003|Safety Follow-up Period|Physician Decision|1|||
126164865|NCT04184622|453889731|FG000|Safety Follow-up Period|Pregnancy|1|||
126164866|NCT04184622|453889732|FG001|Safety Follow-up Period|Pregnancy|3|||
126164867|NCT04184622|453889733|FG002|Safety Follow-up Period|Pregnancy|0|||
126164868|NCT04184622|453889734|FG003|Safety Follow-up Period|Pregnancy|6|||
126164869|NCT04184622|453889731|FG000|Safety Follow-up Period|Protocol deviation|1|||
126164870|NCT04184622|453889732|FG001|Safety Follow-up Period|Protocol deviation|0|||
126164871|NCT04184622|453889733|FG002|Safety Follow-up Period|Protocol deviation|0|||
126164872|NCT04184622|453889734|FG003|Safety Follow-up Period|Protocol deviation|0|||
126164873|NCT04184622|453889731|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
126164874|NCT04184622|453889732|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
126164875|NCT04184622|453889733|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
126164876|NCT04184622|453889734|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
126164877|NCT00769704|453889735|FG000|Overall Study|Lost to Follow-up|3|||
126164878|NCT00769704|453889736|FG001|Overall Study|Lost to Follow-up|2|||
126164879|NCT00769704|453889735|FG000|Overall Study|Death|95|||
126164880|NCT00769704|453889736|FG001|Overall Study|Death|190|||
126164881|NCT00769704|453889735|FG000|Overall Study|Withdrawal by Subject|12|||
126164882|NCT00769704|453889736|FG001|Overall Study|Withdrawal by Subject|5|||
126164883|NCT00769704|453889735|FG000|Overall Study|Other|1|||
126164884|NCT00769704|453889736|FG001|Overall Study|Other|2|||
126164885|NCT01617681|453889739|FG000|Period 1 Double Blind|Adverse Event|2|||
126164886|NCT01617681|453889740|FG001|Period 1 Double Blind|Adverse Event|0|||
126164887|NCT01617681|453889741|FG002|Period 1 Double Blind|Adverse Event|0|||
126164888|NCT01617681|453889742|FG003|Period 1 Double Blind|Adverse Event|2|||
126164889|NCT01617681|453889743|FG004|Period 1 Double Blind|Adverse Event|0|||
125972901|NCT02008890|453191365|FG001|Period 2|Lost to Follow-up|0|||
125972902|NCT02008890|453191366|FG002|Period 2|Lost to Follow-up|1|||
126164890|NCT01617681|453889739|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
125972903|NCT02008890|453191367|FG003|Period 2|Lost to Follow-up|0|||
125972904|NCT02008890|453191368|FG004|Period 2|Lost to Follow-up|0|||
126164891|NCT01617681|453889740|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
126164892|NCT01617681|453889741|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
126164893|NCT01617681|453889742|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
126164894|NCT01617681|453889743|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
126164895|NCT01617681|453889739|FG000|Period 2 Open Label|Adverse Event|0|||
126164896|NCT01617681|453889740|FG001|Period 2 Open Label|Adverse Event|0|||
126164897|NCT01617681|453889741|FG002|Period 2 Open Label|Adverse Event|0|||
126164898|NCT01617681|453889742|FG003|Period 2 Open Label|Adverse Event|0|||
126164899|NCT01617681|453889743|FG004|Period 2 Open Label|Adverse Event|3|||
126164900|NCT01617681|453889739|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
126164901|NCT01617681|453889740|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
126164902|NCT01617681|453889741|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
126164903|NCT01617681|453889742|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
126164904|NCT01617681|453889743|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
126164905|NCT01856595|453889750|FG000|Overall Study|Withdrawal by Subject|0|||
126164906|NCT01856595|453889751|FG001|Overall Study|Withdrawal by Subject|1|||
126164907|NCT01856595|453889752|FG002|Overall Study|Withdrawal by Subject|0|||
126164908|NCT01856595|453889753|FG003|Overall Study|Withdrawal by Subject|0|||
126164909|NCT01856595|453889754|FG004|Overall Study|Withdrawal by Subject|0|||
126164910|NCT01856595|453889755|FG005|Overall Study|Withdrawal by Subject|0|||
126164911|NCT01856595|453889756|FG006|Overall Study|Withdrawal by Subject|1|||
126164912|NCT01856595|453889757|FG007|Overall Study|Withdrawal by Subject|0|||
126164913|NCT01856595|453889758|FG008|Overall Study|Withdrawal by Subject|0|||
126164914|NCT04426825|453889759|FG000|Overall Study|Death|17|||
126164915|NCT04426825|453889759|FG000|Overall Study|Lost to Follow-up|1|||
126164916|NCT04426825|453889759|FG000|Overall Study|Study terminated by sponsor|5|||
126164917|NCT01028651|453889764|FG000|Overall Study|Death|2|||
126164918|NCT01028651|453889764|FG000|Overall Study|Adverse Event|1|||
126164919|NCT01327651|453889767|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
126164920|NCT01327651|453889768|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
126164921|NCT01327651|453889769|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
126164922|NCT01327651|453889770|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
126164923|NCT01327651|453889771|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
126164924|NCT01327651|453889772|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
126164925|NCT01327651|453889773|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
126164926|NCT01327651|453889774|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
126164927|NCT01327651|453889775|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
126164928|NCT01327651|453889767|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
126164929|NCT01327651|453889768|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126164930|NCT01327651|453889769|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126164931|NCT01327651|453889770|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126164932|NCT01327651|453889771|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126164933|NCT01327651|453889772|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126164934|NCT01327651|453889773|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126164935|NCT01327651|453889774|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126164936|NCT01327651|453889775|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126164937|NCT01327651|453889767|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
126164938|NCT01327651|453889768|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
126164939|NCT01327651|453889769|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
126164940|NCT01327651|453889770|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
126164941|NCT01327651|453889771|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
126164942|NCT01327651|453889772|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
126164943|NCT01327651|453889773|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
126164944|NCT01327651|453889774|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
126164945|NCT01327651|453889775|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
126164946|NCT01327651|453889767|FG000|Post Study Follow-up|Lost to Follow-up|0|||
126164947|NCT01327651|453889768|FG001|Post Study Follow-up|Lost to Follow-up|1|||
126164948|NCT01327651|453889769|FG002|Post Study Follow-up|Lost to Follow-up|1|||
126164949|NCT01327651|453889770|FG003|Post Study Follow-up|Lost to Follow-up|0|||
126164950|NCT01327651|453889771|FG004|Post Study Follow-up|Lost to Follow-up|0|||
126164951|NCT01327651|453889772|FG005|Post Study Follow-up|Lost to Follow-up|0|||
126164952|NCT01327651|453889773|FG006|Post Study Follow-up|Lost to Follow-up|4|||
126164953|NCT01327651|453889774|FG007|Post Study Follow-up|Lost to Follow-up|1|||
126164954|NCT01327651|453889775|FG008|Post Study Follow-up|Lost to Follow-up|2|||
126164955|NCT03249792|453889780|FG000|Arms 1, 2, and 4|Death|1|||
126164956|NCT03249792|453889781|FG001|Arms 1, 2, and 4|Death|1|||
126164957|NCT03249792|453889782|FG002|Arms 1, 2, and 4|Death|0|||
126164958|NCT03249792|453889783|FG003|Arms 1, 2, and 4|Death|2|||
126164959|NCT03249792|453889784|FG004|Arms 1, 2, and 4|Death|3|||
126164960|NCT03249792|453889785|FG005|Arms 1, 2, and 4|Death|2|||
126164961|NCT03249792|453889786|FG006|Arms 1, 2, and 4|Death|2|||
126164962|NCT03249792|453889787|FG007|Arms 1, 2, and 4|Death|4|||
126164963|NCT03249792|453889788|FG008|Arms 1, 2, and 4|Death|2|||
126164964|NCT03249792|453889789|FG009|Arms 1, 2, and 4|Death|1|||
126164965|NCT03249792|453889790|FG010|Arms 1, 2, and 4|Death|7|||
126164966|NCT03249792|453889791|FG011|Arms 1, 2, and 4|Death|7|||
126164967|NCT03249792|453889792|FG012|Arms 1, 2, and 4|Death|12|||
126164968|NCT03249792|453889793|FG013|Arms 1, 2, and 4|Death|7|||
126164969|NCT03249792|453889794|FG014|Arms 1, 2, and 4|Death|0|||
126164970|NCT03249792|453889795|FG015|Arms 1, 2, and 4|Death|4|||
126164971|NCT03249792|453889796|FG016|Arms 1, 2, and 4|Death|4|||
126164972|NCT03249792|453889797|FG017|Arms 1, 2, and 4|Death|12|||
126164973|NCT03249792|453889798|FG018|Arms 1, 2, and 4|Death|6|||
126164974|NCT03249792|453889799|FG019|Arms 1, 2, and 4|Death|4|||
126164975|NCT03249792|453889800|FG020|Arms 1, 2, and 4|Death|2|||
126164976|NCT03249792|453889801|FG021|Arms 1, 2, and 4|Death|3|||
126164977|NCT03249792|453889802|FG022|Arms 1, 2, and 4|Death|1|||
126164978|NCT03249792|453889803|FG023|Arms 1, 2, and 4|Death|1|||
126164979|NCT03249792|453889804|FG024|Arms 1, 2, and 4|Death|4|||
126164980|NCT03249792|453889805|FG025|Arms 1, 2, and 4|Death|0|||
126164981|NCT03249792|453889806|FG026|Arms 1, 2, and 4|Death|0|||
126164982|NCT03249792|453889807|FG027|Arms 1, 2, and 4|Death|0|||
126164983|NCT03249792|453889808|FG028|Arms 1, 2, and 4|Death|0|||
126164984|NCT03249792|453889809|FG029|Arms 1, 2, and 4|Death|0|||
126164985|NCT03249792|453889810|FG030|Arms 1, 2, and 4|Death|0|||
126164986|NCT03249792|453889811|FG031|Arms 1, 2, and 4|Death|0|||
126164987|NCT03249792|453889812|FG032|Arms 1, 2, and 4|Death|0|||
126164988|NCT03249792|453889780|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126164989|NCT03249792|453889781|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126164990|NCT03249792|453889782|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126164991|NCT03249792|453889783|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126164992|NCT03249792|453889784|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126164993|NCT03249792|453889785|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126164994|NCT03249792|453889786|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
126164995|NCT03249792|453889787|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126164996|NCT03249792|453889788|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
126164997|NCT03249792|453889789|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126164998|NCT03249792|453889790|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
126164999|NCT03249792|453889791|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
126165000|NCT03249792|453889792|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
126165001|NCT03249792|453889793|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
126165002|NCT03249792|453889794|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165003|NCT03249792|453889795|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165004|NCT03249792|453889796|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
126165005|NCT03249792|453889797|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165006|NCT03249792|453889798|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126165007|NCT03249792|453889799|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165008|NCT03249792|453889800|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165009|NCT03249792|453889801|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165010|NCT03249792|453889802|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126165011|NCT03249792|453889803|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126165012|NCT03249792|453889804|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165013|NCT03249792|453889805|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165014|NCT03249792|453889806|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165015|NCT03249792|453889807|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165016|NCT03249792|453889808|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165017|NCT03249792|453889809|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165018|NCT03249792|453889810|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165019|NCT03249792|453889811|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165020|NCT03249792|453889812|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126165021|NCT03249792|453889780|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
126165022|NCT03249792|453889781|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
126165023|NCT03249792|453889782|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
126165024|NCT03249792|453889783|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
126165025|NCT03249792|453889784|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
126165026|NCT03249792|453889785|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
126165027|NCT03249792|453889786|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
126165028|NCT03249792|453889787|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
126165029|NCT03249792|453889788|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
126165030|NCT03249792|453889789|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
126165031|NCT03249792|453889790|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
126165032|NCT03249792|453889791|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
126165033|NCT03249792|453889792|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
126165034|NCT03249792|453889793|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
126165035|NCT03249792|453889794|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
126165036|NCT03249792|453889795|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
126165037|NCT03249792|453889796|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
126165038|NCT03249792|453889797|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
126165039|NCT03249792|453889798|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
126165040|NCT03249792|453889799|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
126165041|NCT03249792|453889800|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
126165042|NCT03249792|453889801|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
126165043|NCT03249792|453889802|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
126165044|NCT03249792|453889803|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
126165045|NCT03249792|453889804|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
126165046|NCT03249792|453889805|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
126165047|NCT03249792|453889806|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
126165048|NCT03249792|453889807|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
126165049|NCT03249792|453889808|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
126165050|NCT03249792|453889809|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
126165051|NCT03249792|453889810|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
126165052|NCT03249792|453889811|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
126165053|NCT03249792|453889812|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
126165054|NCT03249792|453889780|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165055|NCT03249792|453889781|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165056|NCT03249792|453889782|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165057|NCT03249792|453889783|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165058|NCT03249792|453889784|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165059|NCT03249792|453889785|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165060|NCT03249792|453889786|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165061|NCT03249792|453889787|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165062|NCT03249792|453889788|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
126165063|NCT03249792|453889789|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165064|NCT03249792|453889790|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165065|NCT03249792|453889791|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165066|NCT03249792|453889792|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165067|NCT03249792|453889793|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165068|NCT03249792|453889794|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165069|NCT03249792|453889795|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165070|NCT03249792|453889796|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
126165071|NCT03249792|453889797|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
126165072|NCT03249792|453889798|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165073|NCT03249792|453889799|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
126165074|NCT03249792|453889800|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165075|NCT03249792|453889801|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165076|NCT03249792|453889802|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165077|NCT03249792|453889803|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165078|NCT03249792|453889804|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165079|NCT03249792|453889805|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165080|NCT03249792|453889806|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165081|NCT03249792|453889807|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165082|NCT03249792|453889808|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165083|NCT03249792|453889809|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165084|NCT03249792|453889810|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165085|NCT03249792|453889811|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165086|NCT03249792|453889812|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
126165087|NCT03249792|453889780|FG000|Switch Over Period|Withdrawal by Subject|0|||
126165088|NCT03249792|453889781|FG001|Switch Over Period|Withdrawal by Subject|0|||
126165089|NCT03249792|453889782|FG002|Switch Over Period|Withdrawal by Subject|0|||
126165090|NCT03249792|453889783|FG003|Switch Over Period|Withdrawal by Subject|0|||
126165091|NCT03249792|453889784|FG004|Switch Over Period|Withdrawal by Subject|0|||
126165092|NCT03249792|453889785|FG005|Switch Over Period|Withdrawal by Subject|0|||
126165093|NCT03249792|453889786|FG006|Switch Over Period|Withdrawal by Subject|0|||
126165094|NCT03249792|453889787|FG007|Switch Over Period|Withdrawal by Subject|0|||
126165095|NCT03249792|453889788|FG008|Switch Over Period|Withdrawal by Subject|0|||
126165096|NCT03249792|453889789|FG009|Switch Over Period|Withdrawal by Subject|0|||
126165097|NCT03249792|453889790|FG010|Switch Over Period|Withdrawal by Subject|0|||
126165098|NCT03249792|453889791|FG011|Switch Over Period|Withdrawal by Subject|0|||
126165099|NCT03249792|453889792|FG012|Switch Over Period|Withdrawal by Subject|0|||
126165100|NCT03249792|453889793|FG013|Switch Over Period|Withdrawal by Subject|0|||
126165101|NCT03249792|453889794|FG014|Switch Over Period|Withdrawal by Subject|0|||
126165102|NCT03249792|453889795|FG015|Switch Over Period|Withdrawal by Subject|0|||
126165103|NCT03249792|453889796|FG016|Switch Over Period|Withdrawal by Subject|0|||
126165104|NCT03249792|453889797|FG017|Switch Over Period|Withdrawal by Subject|0|||
126165105|NCT03249792|453889798|FG018|Switch Over Period|Withdrawal by Subject|0|||
126165106|NCT03249792|453889799|FG019|Switch Over Period|Withdrawal by Subject|0|||
126165107|NCT03249792|453889800|FG020|Switch Over Period|Withdrawal by Subject|0|||
126165108|NCT03249792|453889801|FG021|Switch Over Period|Withdrawal by Subject|0|||
126165109|NCT03249792|453889802|FG022|Switch Over Period|Withdrawal by Subject|0|||
126165110|NCT03249792|453889803|FG023|Switch Over Period|Withdrawal by Subject|0|||
126165111|NCT03249792|453889804|FG024|Switch Over Period|Withdrawal by Subject|0|||
126165112|NCT03249792|453889805|FG025|Switch Over Period|Withdrawal by Subject|0|||
126165113|NCT03249792|453889806|FG026|Switch Over Period|Withdrawal by Subject|0|||
126165114|NCT03249792|453889807|FG027|Switch Over Period|Withdrawal by Subject|0|||
126165115|NCT03249792|453889808|FG028|Switch Over Period|Withdrawal by Subject|0|||
126165116|NCT03249792|453889809|FG029|Switch Over Period|Withdrawal by Subject|0|||
126165117|NCT03249792|453889810|FG030|Switch Over Period|Withdrawal by Subject|0|||
126165118|NCT03249792|453889811|FG031|Switch Over Period|Withdrawal by Subject|1|||
126165119|NCT03249792|453889812|FG032|Switch Over Period|Withdrawal by Subject|0|||
126165120|NCT03249792|453889780|FG000|Switch Over Period|Progressive Disease|0|||
126165121|NCT03249792|453889781|FG001|Switch Over Period|Progressive Disease|0|||
126165122|NCT03249792|453889782|FG002|Switch Over Period|Progressive Disease|0|||
126165123|NCT03249792|453889783|FG003|Switch Over Period|Progressive Disease|0|||
126165124|NCT03249792|453889784|FG004|Switch Over Period|Progressive Disease|0|||
126165125|NCT03249792|453889785|FG005|Switch Over Period|Progressive Disease|0|||
126165126|NCT03249792|453889786|FG006|Switch Over Period|Progressive Disease|0|||
126165127|NCT03249792|453889787|FG007|Switch Over Period|Progressive Disease|0|||
126165128|NCT03249792|453889788|FG008|Switch Over Period|Progressive Disease|0|||
126165129|NCT03249792|453889789|FG009|Switch Over Period|Progressive Disease|0|||
126165130|NCT03249792|453889790|FG010|Switch Over Period|Progressive Disease|0|||
126165131|NCT03249792|453889791|FG011|Switch Over Period|Progressive Disease|0|||
126165132|NCT03249792|453889792|FG012|Switch Over Period|Progressive Disease|0|||
126165133|NCT03249792|453889793|FG013|Switch Over Period|Progressive Disease|0|||
126165134|NCT03249792|453889794|FG014|Switch Over Period|Progressive Disease|0|||
126165135|NCT03249792|453889795|FG015|Switch Over Period|Progressive Disease|0|||
126165136|NCT03249792|453889796|FG016|Switch Over Period|Progressive Disease|0|||
126165137|NCT03249792|453889797|FG017|Switch Over Period|Progressive Disease|0|||
126165138|NCT03249792|453889798|FG018|Switch Over Period|Progressive Disease|0|||
126165139|NCT03249792|453889799|FG019|Switch Over Period|Progressive Disease|0|||
126165140|NCT03249792|453889800|FG020|Switch Over Period|Progressive Disease|0|||
126165141|NCT03249792|453889801|FG021|Switch Over Period|Progressive Disease|0|||
126165142|NCT03249792|453889802|FG022|Switch Over Period|Progressive Disease|0|||
126165143|NCT03249792|453889803|FG023|Switch Over Period|Progressive Disease|0|||
126165144|NCT03249792|453889804|FG024|Switch Over Period|Progressive Disease|0|||
126165145|NCT03249792|453889805|FG025|Switch Over Period|Progressive Disease|0|||
126165146|NCT03249792|453889806|FG026|Switch Over Period|Progressive Disease|1|||
126165147|NCT03249792|453889807|FG027|Switch Over Period|Progressive Disease|0|||
126165148|NCT03249792|453889808|FG028|Switch Over Period|Progressive Disease|1|||
126165149|NCT03249792|453889809|FG029|Switch Over Period|Progressive Disease|2|||
126165150|NCT03249792|453889810|FG030|Switch Over Period|Progressive Disease|1|||
126165151|NCT03249792|453889811|FG031|Switch Over Period|Progressive Disease|0|||
126165152|NCT03249792|453889812|FG032|Switch Over Period|Progressive Disease|1|||
126165153|NCT03249792|453889780|FG000|Switch Over Period|Adverse Event|0|||
126165154|NCT03249792|453889781|FG001|Switch Over Period|Adverse Event|0|||
126165155|NCT03249792|453889782|FG002|Switch Over Period|Adverse Event|0|||
126165156|NCT03249792|453889783|FG003|Switch Over Period|Adverse Event|0|||
126165157|NCT03249792|453889784|FG004|Switch Over Period|Adverse Event|0|||
126165158|NCT03249792|453889785|FG005|Switch Over Period|Adverse Event|0|||
126165159|NCT03249792|453889786|FG006|Switch Over Period|Adverse Event|0|||
126165160|NCT03249792|453889787|FG007|Switch Over Period|Adverse Event|0|||
126165161|NCT03249792|453889788|FG008|Switch Over Period|Adverse Event|0|||
126165162|NCT03249792|453889789|FG009|Switch Over Period|Adverse Event|0|||
126165163|NCT03249792|453889790|FG010|Switch Over Period|Adverse Event|0|||
126165164|NCT03249792|453889791|FG011|Switch Over Period|Adverse Event|0|||
126165165|NCT03249792|453889792|FG012|Switch Over Period|Adverse Event|0|||
126165166|NCT03249792|453889793|FG013|Switch Over Period|Adverse Event|0|||
126165167|NCT03249792|453889794|FG014|Switch Over Period|Adverse Event|0|||
126165168|NCT03249792|453889795|FG015|Switch Over Period|Adverse Event|0|||
126165169|NCT03249792|453889796|FG016|Switch Over Period|Adverse Event|0|||
126165170|NCT03249792|453889797|FG017|Switch Over Period|Adverse Event|0|||
126165171|NCT03249792|453889798|FG018|Switch Over Period|Adverse Event|0|||
126165172|NCT03249792|453889799|FG019|Switch Over Period|Adverse Event|0|||
126165173|NCT03249792|453889800|FG020|Switch Over Period|Adverse Event|0|||
126165174|NCT03249792|453889801|FG021|Switch Over Period|Adverse Event|0|||
126165175|NCT03249792|453889802|FG022|Switch Over Period|Adverse Event|0|||
126165176|NCT03249792|453889803|FG023|Switch Over Period|Adverse Event|0|||
126165177|NCT03249792|453889804|FG024|Switch Over Period|Adverse Event|0|||
126165178|NCT03249792|453889805|FG025|Switch Over Period|Adverse Event|1|||
126165179|NCT03249792|453889806|FG026|Switch Over Period|Adverse Event|0|||
126165180|NCT03249792|453889807|FG027|Switch Over Period|Adverse Event|1|||
126165181|NCT03249792|453889808|FG028|Switch Over Period|Adverse Event|0|||
126165182|NCT03249792|453889809|FG029|Switch Over Period|Adverse Event|0|||
126165183|NCT03249792|453889810|FG030|Switch Over Period|Adverse Event|0|||
126165184|NCT03249792|453889811|FG031|Switch Over Period|Adverse Event|0|||
126165185|NCT03249792|453889812|FG032|Switch Over Period|Adverse Event|0|||
126165186|NCT02284906|453889815|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126165187|NCT02284906|453889816|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
126165188|NCT02284906|453889817|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126165189|NCT02284906|453889815|FG000|Overall Study|Major Protocol Deviation|0|||
126165190|NCT02284906|453889816|FG001|Overall Study|Major Protocol Deviation|1|||
126165191|NCT02284906|453889817|FG002|Overall Study|Major Protocol Deviation|0|||
125972905|NCT02008890|453191364|FG000|Extension Period|Withdrawal by Subject|3|||
126165192|NCT02284906|453889815|FG000|Overall Study|Voluntary Withdrawal|2|||
126165193|NCT02284906|453889816|FG001|Overall Study|Voluntary Withdrawal|4|||
126165194|NCT02284906|453889817|FG002|Overall Study|Voluntary Withdrawal|5|||
126165195|NCT02284906|453889815|FG000|Overall Study|Study Termination|0|||
126165196|NCT02284906|453889816|FG001|Overall Study|Study Termination|11|||
126165197|NCT02284906|453889817|FG002|Overall Study|Study Termination|14|||
126165198|NCT02284906|453889815|FG000|Overall Study|Reason not Specified|1|||
126165199|NCT02284906|453889816|FG001|Overall Study|Reason not Specified|1|||
126165200|NCT02284906|453889817|FG002|Overall Study|Reason not Specified|0|||
126165201|NCT00069576|453889819|FG000|Original Trial|Lost to Follow-up|25|||
126165202|NCT00069576|453889820|FG001|Original Trial|Lost to Follow-up|33|||
126165203|NCT00069576|453889819|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
126165204|NCT00069576|453889820|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
126165205|NCT04060667|453889821|FG000|Overall Study|Lost to Follow-up|75|||
126165206|NCT04060667|453889822|FG001|Overall Study|Lost to Follow-up|10|||
126165207|NCT00525148|453889823|FG000|Overall Study|Other Adverse Event|3|||
126165208|NCT00525148|453889824|FG001|Overall Study|Other Adverse Event|5|||
126165209|NCT00525148|453889825|FG002|Overall Study|Other Adverse Event|1|||
126165210|NCT00525148|453889826|FG003|Overall Study|Other Adverse Event|8|||
126165211|NCT00525148|453889823|FG000|Overall Study|Progressive disease|18|||
126165212|NCT00525148|453889824|FG001|Overall Study|Progressive disease|30|||
126165213|NCT00525148|453889825|FG002|Overall Study|Progressive disease|6|||
126165214|NCT00525148|453889826|FG003|Overall Study|Progressive disease|49|||
126165215|NCT00525148|453889823|FG000|Overall Study|Refused continuation of study medication|0|||
126165216|NCT00525148|453889824|FG001|Overall Study|Refused continuation of study medication|2|||
126165217|NCT00525148|453889825|FG002|Overall Study|Refused continuation of study medication|0|||
126165218|NCT00525148|453889826|FG003|Overall Study|Refused continuation of study medication|1|||
126165219|NCT00525148|453889823|FG000|Overall Study|Other than stated|2|||
126165220|NCT00525148|453889824|FG001|Overall Study|Other than stated|1|||
126165221|NCT00525148|453889825|FG002|Overall Study|Other than stated|0|||
126165222|NCT00525148|453889826|FG003|Overall Study|Other than stated|3|||
126165223|NCT04333433|453889834|FG000|Overall Study|Withdrawal by Subject|6|||
126165224|NCT04333433|453889835|FG001|Overall Study|Withdrawal by Subject|3|||
126165225|NCT04333433|453889834|FG000|Overall Study|Death|3|||
126165226|NCT04333433|453889835|FG001|Overall Study|Death|0|||
126165227|NCT04333433|453889834|FG000|Overall Study|Lost to Follow-up|6|||
126165228|NCT04333433|453889835|FG001|Overall Study|Lost to Follow-up|1|||
126165229|NCT04333433|453889834|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
126165230|NCT04333433|453889835|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
126165231|NCT00320385|453889836|FG000|Overall Study|Lost to Follow-up|7|||
126165232|NCT00320385|453889837|FG001|Overall Study|Lost to Follow-up|10|||
126165233|NCT00320385|453889836|FG000|Overall Study|Withdrawal by Subject|6|||
126165234|NCT00320385|453889837|FG001|Overall Study|Withdrawal by Subject|7|||
126165235|NCT00320385|453889836|FG000|Overall Study|Sponsor Terminated Study|2|||
126165236|NCT00320385|453889837|FG001|Overall Study|Sponsor Terminated Study|1|||
126165237|NCT00320385|453889836|FG000|Overall Study|Investigator Decision|0|||
126165238|NCT00320385|453889837|FG001|Overall Study|Investigator Decision|1|||
126165239|NCT00320385|453889836|FG000|Overall Study|Death|1|||
126165240|NCT00320385|453889837|FG001|Overall Study|Death|2|||
126165241|NCT00320385|453889836|FG000|Overall Study|Serious Adverse Event|1|||
126165242|NCT00320385|453889837|FG001|Overall Study|Serious Adverse Event|0|||
126165243|NCT00320385|453889836|FG000|Overall Study|Withdrew Consent|1|||
126165244|NCT00320385|453889837|FG001|Overall Study|Withdrew Consent|0|||
126165245|NCT00320385|453889836|FG000|Overall Study|Adverse Event|0|||
126165246|NCT00320385|453889837|FG001|Overall Study|Adverse Event|1|||
126165247|NCT04743635|453889838|FG000|Overall Study|Lost to Follow-up|2|||
126165248|NCT04743635|453889839|FG001|Overall Study|Lost to Follow-up|0|||
126165249|NCT03382899|453889845|FG000|Overall Study|Ineligibility Determined|0|||
126165250|NCT03382899|453889846|FG001|Overall Study|Ineligibility Determined|1|||
126165251|NCT03382899|453889845|FG000|Overall Study|Lost to Follow-up|0|||
126165252|NCT03382899|453889846|FG001|Overall Study|Lost to Follow-up|1|||
126165253|NCT03382899|453889845|FG000|Overall Study|Sponsor's decision|31|||
126165254|NCT03382899|453889846|FG001|Overall Study|Sponsor's decision|28|||
126165255|NCT03382899|453889845|FG000|Overall Study|Withdrawal by Subject|0|||
126165256|NCT03382899|453889846|FG001|Overall Study|Withdrawal by Subject|5|||
126165257|NCT01355068|453889847|FG000|First Intervention Period|Adverse Event|0|||
126165258|NCT01355068|453889848|FG001|First Intervention Period|Adverse Event|1|||
126165259|NCT01355068|453889847|FG000|First Intervention Period|Withdrawal by Subject|0|||
126165260|NCT01355068|453889848|FG001|First Intervention Period|Withdrawal by Subject|1|||
126165261|NCT00524745|453889849|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
126165262|NCT00524745|453889850|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
126165263|NCT00524745|453889851|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
126165264|NCT00524745|453889852|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
126165265|NCT00540449|453889853|FG000|Overall Study|Adverse Event|12|||
126165266|NCT00540449|453889854|FG001|Overall Study|Adverse Event|32|||
126165267|NCT00540449|453889853|FG000|Overall Study|Sponsor's Decision|1|||
126165268|NCT00540449|453889854|FG001|Overall Study|Sponsor's Decision|1|||
126165269|NCT00540449|453889853|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
126165270|NCT00540449|453889854|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
126165271|NCT00540449|453889853|FG000|Overall Study|Lost to Follow-up|19|||
126165272|NCT00540449|453889854|FG001|Overall Study|Lost to Follow-up|17|||
126165273|NCT00540449|453889853|FG000|Overall Study|Subject Non-Compliant|7|||
126165274|NCT00540449|453889854|FG001|Overall Study|Subject Non-Compliant|5|||
126165275|NCT00540449|453889853|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
126165276|NCT00540449|453889854|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
126165277|NCT00540449|453889853|FG000|Overall Study|Withdrawal by Subject|10|||
126165278|NCT00540449|453889854|FG001|Overall Study|Withdrawal by Subject|10|||
126165279|NCT00540449|453889853|FG000|Overall Study|Other|1|||
126165280|NCT00540449|453889854|FG001|Overall Study|Other|4|||
126165281|NCT00872170|453889855|FG000|Overall Study|Adverse Event|1|||
126165282|NCT00872170|453889856|FG001|Overall Study|Adverse Event|0|||
126165283|NCT01721408|453889857|FG000|Overall Study|Adverse Event|6|||
126165284|NCT01721408|453889858|FG001|Overall Study|Adverse Event|1|||
126165285|NCT01721408|453889857|FG000|Overall Study|Death|1|||
126165286|NCT01721408|453889858|FG001|Overall Study|Death|0|||
126165287|NCT01721408|453889857|FG000|Overall Study|Insufficient clinical response|15|||
126165288|NCT01721408|453889858|FG001|Overall Study|Insufficient clinical response|6|||
126165289|NCT01721408|453889857|FG000|Overall Study|No longer willing to participate study|9|||
126165290|NCT01721408|453889858|FG001|Overall Study|No longer willing to participate study|10|||
126165291|NCT01721408|453889857|FG000|Overall Study|Protocol Violation|0|||
126165292|NCT01721408|453889858|FG001|Overall Study|Protocol Violation|2|||
126165293|NCT01721408|453889857|FG000|Overall Study|Other|3|||
126165294|NCT01721408|453889858|FG001|Overall Study|Other|3|||
126165295|NCT01721408|453889857|FG000|Overall Study|Lost to Follow-up|1|||
126165296|NCT01721408|453889858|FG001|Overall Study|Lost to Follow-up|2|||
126165297|NCT01721408|453889857|FG000|Overall Study|Does not meet entrance criteria|1|||
126165298|NCT01721408|453889858|FG001|Overall Study|Does not meet entrance criteria|0|||
126165299|NCT02426658|453889859|FG000|Overall Study|Withdrawal by Subject|1|||
126165300|NCT02426658|453889859|FG000|Overall Study|Patient expired before treatment|2|||
126165301|NCT00524316|453889860|FG000|Overall Study|Withdrawal by Subject|2|||
126165302|NCT00524316|453889860|FG000|Overall Study|Adverse Event|7|||
126165303|NCT00524316|453889860|FG000|Overall Study|Disease Progression|7|||
126165304|NCT01199263|453889861|FG000|Overall Study|Ineligible|0|||
126165305|NCT01199263|453889862|FG001|Overall Study|Ineligible|2|||
126165306|NCT01199263|453889861|FG000|Overall Study|Never Treated|6|||
126165307|NCT01199263|453889862|FG001|Overall Study|Never Treated|0|||
126165308|NCT01402284|453889863|FG000|Overall Study|Withdrawal consent|2|||
126165309|NCT01402284|453889863|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
126165310|NCT01402284|453889863|FG000|Overall Study|Physician Decision|1|||
126165311|NCT01402284|453889863|FG000|Overall Study|Disease progression on study|10|||
126165312|NCT02928406|453889866|FG000|Overall Study|Death|780|||
126165313|NCT02928406|453889866|FG000|Overall Study|Progressive disease|3|||
126165314|NCT02928406|453889866|FG000|Overall Study|Lost to Follow-up|49|||
126165315|NCT02928406|453889866|FG000|Overall Study|Non-compliance|2|||
126165316|NCT02928406|453889866|FG000|Overall Study|Withdrawal by Subject|40|||
126165317|NCT02928406|453889866|FG000|Overall Study|Study terminated by sponsor|57|||
126165318|NCT02928406|453889866|FG000|Overall Study|Physician Decision|1|||
126165319|NCT02928406|453889866|FG000|Overall Study|Various reasons|72|||
126165320|NCT02149836|453889867|FG000|Overall Study|Withdrawal by Subject|1|||
126165321|NCT04937816|453889868|FG000|Overall Study|Study drug stopped, reason missing|5|||
126165322|NCT04937816|453889869|FG001|Overall Study|Study drug stopped, reason missing|3|||
126165323|NCT04937816|453889870|FG002|Overall Study|Study drug stopped, reason missing|4|||
126165324|NCT04937816|453889871|FG003|Overall Study|Study drug stopped, reason missing|6|||
126165325|NCT04937816|453889872|FG004|Overall Study|Study drug stopped, reason missing|1|||
126165326|NCT04937816|453889873|FG005|Overall Study|Study drug stopped, reason missing|0|||
126165327|NCT04937816|453889874|FG006|Overall Study|Study drug stopped, reason missing|0|||
126165328|NCT04937816|453889868|FG000|Overall Study|Other than stated below|173|||
126165329|NCT04937816|453889869|FG001|Overall Study|Other than stated below|143|||
126165330|NCT04937816|453889870|FG002|Overall Study|Other than stated below|125|||
126165331|NCT04937816|453889871|FG003|Overall Study|Other than stated below|44|||
126165332|NCT04937816|453889872|FG004|Overall Study|Other than stated below|45|||
126165333|NCT04937816|453889873|FG005|Overall Study|Other than stated below|28|||
126165334|NCT04937816|453889874|FG006|Overall Study|Other than stated below|31|||
126165335|NCT04937816|453889868|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
126165336|NCT04937816|453889869|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
126165337|NCT04937816|453889870|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
126165338|NCT04937816|453889871|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
126165339|NCT04937816|453889872|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
126165340|NCT04937816|453889873|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
126165341|NCT04937816|453889874|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
126165342|NCT04937816|453889868|FG000|Overall Study|Lost to Follow-up|15|||
126165343|NCT04937816|453889869|FG001|Overall Study|Lost to Follow-up|9|||
126165344|NCT04937816|453889870|FG002|Overall Study|Lost to Follow-up|6|||
126165345|NCT04937816|453889871|FG003|Overall Study|Lost to Follow-up|6|||
126165346|NCT04937816|453889872|FG004|Overall Study|Lost to Follow-up|16|||
126165347|NCT04937816|453889873|FG005|Overall Study|Lost to Follow-up|11|||
125972906|NCT02008890|453191365|FG001|Extension Period|Withdrawal by Subject|2|||
126165348|NCT04937816|453889874|FG006|Overall Study|Lost to Follow-up|17|||
125972907|NCT02008890|453191366|FG002|Extension Period|Withdrawal by Subject|0|||
126165349|NCT04937816|453889868|FG000|Overall Study|Protocol Violation|15|||
126165350|NCT04937816|453889869|FG001|Overall Study|Protocol Violation|15|||
126165351|NCT04937816|453889870|FG002|Overall Study|Protocol Violation|12|||
125972908|NCT02008890|453191367|FG003|Extension Period|Withdrawal by Subject|4|||
126165352|NCT04937816|453889871|FG003|Overall Study|Protocol Violation|30|||
126165353|NCT04937816|453889872|FG004|Overall Study|Protocol Violation|24|||
126165354|NCT04937816|453889873|FG005|Overall Study|Protocol Violation|5|||
126165355|NCT04937816|453889874|FG006|Overall Study|Protocol Violation|5|||
126165356|NCT04937816|453889868|FG000|Overall Study|Adverse Event|303|||
126165357|NCT04937816|453889869|FG001|Overall Study|Adverse Event|267|||
126165358|NCT04937816|453889870|FG002|Overall Study|Adverse Event|273|||
126165359|NCT04937816|453889871|FG003|Overall Study|Adverse Event|553|||
126165360|NCT04937816|453889872|FG004|Overall Study|Adverse Event|575|||
126165361|NCT04937816|453889873|FG005|Overall Study|Adverse Event|343|||
126165362|NCT04937816|453889874|FG006|Overall Study|Adverse Event|337|||
126165363|NCT04937816|453889868|FG000|Overall Study|Not treated|4|||
126165364|NCT04937816|453889869|FG001|Overall Study|Not treated|2|||
126165365|NCT04937816|453889870|FG002|Overall Study|Not treated|2|||
126165366|NCT04937816|453889871|FG003|Overall Study|Not treated|2|||
126165367|NCT04937816|453889872|FG004|Overall Study|Not treated|1|||
126165368|NCT04937816|453889873|FG005|Overall Study|Not treated|4|||
126165369|NCT04937816|453889874|FG006|Overall Study|Not treated|0|||
126165370|NCT05281523|453889879|FG000|Overall Study|Adverse Event|1|||
126165371|NCT05281523|453889880|FG001|Overall Study|Adverse Event|1|||
126165372|NCT05281523|453889879|FG000|Overall Study|Physician Decision|1|||
126165373|NCT05281523|453889880|FG001|Overall Study|Physician Decision|1|||
126165374|NCT05281523|453889879|FG000|Overall Study|Withdrawal by Subject|5|||
126165375|NCT05281523|453889880|FG001|Overall Study|Withdrawal by Subject|15|||
126165376|NCT05281523|453889879|FG000|Overall Study|GCP violations|3|||
126165377|NCT05281523|453889880|FG001|Overall Study|GCP violations|4|||
126165378|NCT05513391|453889881|FG000|Overall Study|Adverse Event|1|||
126165379|NCT05513391|453889882|FG001|Overall Study|Adverse Event|0|||
126165380|NCT05513391|453889881|FG000|Overall Study|Protocol Deviation|0|||
126165381|NCT05513391|453889882|FG001|Overall Study|Protocol Deviation|1|||
126165382|NCT05513391|453889881|FG000|Overall Study|Withdrawal by Subject|3|||
126165383|NCT05513391|453889882|FG001|Overall Study|Withdrawal by Subject|1|||
126165384|NCT05513391|453889881|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126165385|NCT05513391|453889882|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126165386|NCT05513391|453889881|FG000|Overall Study|Lost to Follow-up|0|||
126165387|NCT05513391|453889882|FG001|Overall Study|Lost to Follow-up|2|||
126165388|NCT05128162|453889883|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
126165389|NCT05128162|453889883|FG000|Overall Study|Physician Decision|1|||
126165390|NCT05513053|453889884|FG000|Overall Study|Lost to Follow-up|9|||
126165391|NCT05513053|453889885|FG001|Overall Study|Lost to Follow-up|11|||
126165392|NCT05513053|453889884|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126165393|NCT05513053|453889885|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126165394|NCT05513053|453889884|FG000|Overall Study|Withdrawal by Subject|2|||
126165395|NCT05513053|453889885|FG001|Overall Study|Withdrawal by Subject|9|||
126165396|NCT05513053|453889884|FG000|Overall Study|Protocol Violation|6|||
126165397|NCT05513053|453889885|FG001|Overall Study|Protocol Violation|3|||
126165398|NCT05513053|453889884|FG000|Overall Study|Adverse Event|0|||
126165399|NCT05513053|453889885|FG001|Overall Study|Adverse Event|2|||
126165400|NCT00074412|453891449|FG000|Overall Study|Death|30|||
126165401|NCT00074412|453891450|FG001|Overall Study|Death|26|||
126165402|NCT00074412|453891449|FG000|Overall Study|Lost to Follow-up|52|||
126165403|NCT00074412|453891450|FG001|Overall Study|Lost to Follow-up|58|||
126165404|NCT01520324|453891454|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
126165405|NCT00423085|453891456|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
126165406|NCT00423085|453891457|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
126165407|NCT00423085|453891458|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
126165408|NCT00423085|453891459|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
126165409|NCT00423085|453891456|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
126165410|NCT00423085|453891457|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
126165411|NCT00423085|453891458|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
126165412|NCT00423085|453891459|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126165413|NCT00423085|453891456|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
126165414|NCT00423085|453891457|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
126165415|NCT00423085|453891458|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
126165416|NCT00423085|453891459|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
126165417|NCT00423085|453891456|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
125972909|NCT02008890|453191368|FG004|Extension Period|Withdrawal by Subject|2|||
126165418|NCT00423085|453891457|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
126165419|NCT00423085|453891458|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
126165420|NCT00423085|453891459|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
126165421|NCT00423085|453891456|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
126165422|NCT00423085|453891457|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
126165423|NCT00423085|453891458|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
126165424|NCT00423085|453891459|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
126165425|NCT00423085|453891456|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
126165426|NCT00423085|453891457|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
126165427|NCT00423085|453891458|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
126165428|NCT00423085|453891459|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
126165429|NCT00423085|453891456|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
126165430|NCT00423085|453891457|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
126165431|NCT00423085|453891458|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
126165432|NCT00423085|453891459|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
126165433|NCT00423085|453891456|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
126165434|NCT00423085|453891457|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
126165435|NCT00423085|453891458|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
126165436|NCT00423085|453891459|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
126165437|NCT00423085|453891456|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
126165438|NCT00423085|453891457|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
126165439|NCT00423085|453891458|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
126165440|NCT00423085|453891459|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
126165441|NCT00423085|453891456|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
126165442|NCT00423085|453891457|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
126165443|NCT00423085|453891458|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
126165444|NCT00423085|453891459|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
126165445|NCT00423085|453891456|FG000|52-Week Open-Label Extension Phase|Death|0|||
126165446|NCT00423085|453891457|FG001|52-Week Open-Label Extension Phase|Death|0|||
126165447|NCT00423085|453891458|FG002|52-Week Open-Label Extension Phase|Death|0|||
126165448|NCT00423085|453891459|FG003|52-Week Open-Label Extension Phase|Death|2|||
126165449|NCT02163993|453891460|FG000|Treatment Period|Adverse Event|0|||
126165450|NCT02163993|453891461|FG001|Treatment Period|Adverse Event|1|||
126165451|NCT02163993|453891462|FG002|Treatment Period|Adverse Event|0|||
126165452|NCT02163993|453891463|FG003|Treatment Period|Adverse Event|0|||
126165453|NCT02163993|453891464|FG004|Treatment Period|Adverse Event|1|||
126165454|NCT02163993|453891460|FG000|Treatment Period|Lost to Follow-up|2|||
126165455|NCT02163993|453891461|FG001|Treatment Period|Lost to Follow-up|3|||
126165456|NCT02163993|453891462|FG002|Treatment Period|Lost to Follow-up|1|||
126165457|NCT02163993|453891463|FG003|Treatment Period|Lost to Follow-up|3|||
126165458|NCT02163993|453891464|FG004|Treatment Period|Lost to Follow-up|1|||
126165459|NCT02163993|453891460|FG000|Treatment Period|Physician Decision|1|||
126165460|NCT02163993|453891461|FG001|Treatment Period|Physician Decision|0|||
126165461|NCT02163993|453891462|FG002|Treatment Period|Physician Decision|0|||
126165462|NCT02163993|453891463|FG003|Treatment Period|Physician Decision|0|||
126165463|NCT02163993|453891464|FG004|Treatment Period|Physician Decision|0|||
126165464|NCT02163993|453891460|FG000|Treatment Period|Protocol Violation|2|||
126165465|NCT02163993|453891461|FG001|Treatment Period|Protocol Violation|1|||
126165466|NCT02163993|453891462|FG002|Treatment Period|Protocol Violation|0|||
126165467|NCT02163993|453891463|FG003|Treatment Period|Protocol Violation|1|||
126165468|NCT02163993|453891464|FG004|Treatment Period|Protocol Violation|2|||
126165469|NCT02163993|453891460|FG000|Treatment Period|Withdrawal by Subject|6|||
126165470|NCT02163993|453891461|FG001|Treatment Period|Withdrawal by Subject|4|||
126165471|NCT02163993|453891462|FG002|Treatment Period|Withdrawal by Subject|1|||
126165472|NCT02163993|453891463|FG003|Treatment Period|Withdrawal by Subject|4|||
126165473|NCT02163993|453891464|FG004|Treatment Period|Withdrawal by Subject|1|||
126165474|NCT02163993|453891460|FG000|Treatment Period|Not treated|1|||
126165475|NCT02163993|453891461|FG001|Treatment Period|Not treated|0|||
126165476|NCT02163993|453891462|FG002|Treatment Period|Not treated|0|||
126165477|NCT02163993|453891463|FG003|Treatment Period|Not treated|1|||
126165478|NCT02163993|453891464|FG004|Treatment Period|Not treated|2|||
126165479|NCT02163993|453891460|FG000|Post-treatment Period|Adverse Event|0|||
126165480|NCT02163993|453891461|FG001|Post-treatment Period|Adverse Event|0|||
126165481|NCT02163993|453891462|FG002|Post-treatment Period|Adverse Event|1|||
126165482|NCT02163993|453891463|FG003|Post-treatment Period|Adverse Event|0|||
126165483|NCT02163993|453891464|FG004|Post-treatment Period|Adverse Event|0|||
126165484|NCT02163993|453891460|FG000|Post-treatment Period|Lost to Follow-up|2|||
126165485|NCT02163993|453891461|FG001|Post-treatment Period|Lost to Follow-up|2|||
126165486|NCT02163993|453891462|FG002|Post-treatment Period|Lost to Follow-up|3|||
126165487|NCT02163993|453891463|FG003|Post-treatment Period|Lost to Follow-up|1|||
126165488|NCT02163993|453891464|FG004|Post-treatment Period|Lost to Follow-up|0|||
126165489|NCT02163993|453891460|FG000|Post-treatment Period|Protocol Violation|0|||
126165490|NCT02163993|453891461|FG001|Post-treatment Period|Protocol Violation|0|||
126165491|NCT02163993|453891462|FG002|Post-treatment Period|Protocol Violation|0|||
126165492|NCT02163993|453891463|FG003|Post-treatment Period|Protocol Violation|0|||
126165493|NCT02163993|453891464|FG004|Post-treatment Period|Protocol Violation|1|||
126165494|NCT02163993|453891460|FG000|Post-treatment Period|Withdrawal by Subject|2|||
126165495|NCT02163993|453891461|FG001|Post-treatment Period|Withdrawal by Subject|4|||
126165496|NCT02163993|453891462|FG002|Post-treatment Period|Withdrawal by Subject|0|||
126165497|NCT02163993|453891463|FG003|Post-treatment Period|Withdrawal by Subject|1|||
126165498|NCT02163993|453891464|FG004|Post-treatment Period|Withdrawal by Subject|2|||
126165499|NCT00853489|453891465|FG000|Overall Study|Lost to Follow-up|5|||
126165500|NCT00853489|453891466|FG001|Overall Study|Lost to Follow-up|2|||
126165501|NCT01998581|453891468|FG000|Overall Study|Refused repeat treatment|20|||
126165502|NCT01998581|453891469|FG001|Overall Study|Refused repeat treatment|4|||
126165503|NCT01998581|453891468|FG000|Overall Study|Protocol Violation|1|||
126165504|NCT01998581|453891469|FG001|Overall Study|Protocol Violation|0|||
126165505|NCT01998581|453891468|FG000|Overall Study|Withdrawal by Subject|8|||
126165506|NCT01998581|453891469|FG001|Overall Study|Withdrawal by Subject|1|||
126165507|NCT01998581|453891468|FG000|Overall Study|Lost to Follow-up|12|||
126165508|NCT01998581|453891469|FG001|Overall Study|Lost to Follow-up|4|||
126165509|NCT01998581|453891468|FG000|Overall Study|Adverse Event|1|||
126165510|NCT01998581|453891469|FG001|Overall Study|Adverse Event|1|||
126165511|NCT01998581|453891468|FG000|Overall Study|Other reasons|3|||
126165512|NCT01998581|453891469|FG001|Overall Study|Other reasons|2|||
126165513|NCT01998581|453891468|FG000|Overall Study|Randomized but withdrew before treatment|1|||
126165514|NCT01998581|453891469|FG001|Overall Study|Randomized but withdrew before treatment|0|||
126165515|NCT01251276|453891470|FG000|Overall Study|Protocol Violation|1|||
126165516|NCT01251276|453891471|FG001|Overall Study|Protocol Violation|0|||
126165517|NCT01251276|453891470|FG000|Overall Study|Lost to Follow-up|0|||
126165518|NCT01251276|453891471|FG001|Overall Study|Lost to Follow-up|1|||
126165519|NCT01345123|453891472|FG000|Overall Study|participants no longer with health plan|79|||
126165520|NCT01345123|453891473|FG001|Overall Study|participants no longer with health plan|85|||
126165521|NCT01345123|453891474|FG002|Overall Study|participants no longer with health plan|88|||
126165522|NCT00441441|453891478|FG000|Overall Study|Adverse Event|2|||
126165523|NCT00441441|453891479|FG001|Overall Study|Adverse Event|1|||
126165524|NCT00441441|453891478|FG000|Overall Study|Protocol Violation|4|||
126165525|NCT00441441|453891479|FG001|Overall Study|Protocol Violation|6|||
126165526|NCT00441441|453891478|FG000|Overall Study|Exacerbation of asthma|1|||
126165527|NCT00441441|453891479|FG001|Overall Study|Exacerbation of asthma|2|||
126165528|NCT00441441|453891478|FG000|Overall Study|Withdrawal by Subject|1|||
126165529|NCT00441441|453891479|FG001|Overall Study|Withdrawal by Subject|2|||
126165530|NCT00441441|453891478|FG000|Overall Study|Other|3|||
126165531|NCT00441441|453891479|FG001|Overall Study|Other|3|||
126165532|NCT01763905|453891482|FG000|Overall Study|Withdrawal by Subject|1|||
126165533|NCT01763905|453891483|FG001|Overall Study|Withdrawal by Subject|1|||
126165534|NCT01763905|453891484|FG002|Overall Study|Withdrawal by Subject|0|||
126165535|NCT01763905|453891485|FG003|Overall Study|Withdrawal by Subject|1|||
126165536|NCT01763905|453891482|FG000|Overall Study|Decision by sponsor|5|||
126165537|NCT01763905|453891483|FG001|Overall Study|Decision by sponsor|0|||
126165538|NCT01763905|453891484|FG002|Overall Study|Decision by sponsor|8|||
126165539|NCT01763905|453891485|FG003|Overall Study|Decision by sponsor|0|||
126165540|NCT01763905|453891482|FG000|Overall Study|Lost to Follow-up|0|||
126165541|NCT01763905|453891483|FG001|Overall Study|Lost to Follow-up|0|||
126165542|NCT01763905|453891484|FG002|Overall Study|Lost to Follow-up|1|||
126165543|NCT01763905|453891485|FG003|Overall Study|Lost to Follow-up|0|||
126165544|NCT04346628|453891486|FG000|Overall Study|Lost to Follow-up|4|||
126165545|NCT04346628|453891487|FG001|Overall Study|Lost to Follow-up|4|||
126165546|NCT04346628|453891486|FG000|Overall Study|Withdrew (had personal reasons)|2|||
126165547|NCT04346628|453891487|FG001|Overall Study|Withdrew (had personal reasons)|5|||
126165548|NCT04346628|453891486|FG000|Overall Study|Withdrew (medication intolerant)|0|||
126165549|NCT04346628|453891487|FG001|Overall Study|Withdrew (medication intolerant)|3|||
126165550|NCT04346628|453891486|FG000|Overall Study|Withdrew (declined intervention)|0|||
126165551|NCT04346628|453891487|FG001|Overall Study|Withdrew (declined intervention)|1|||
126165552|NCT01428063|453891489|FG000|Overall Study|Lack of Efficacy|8|||
126165553|NCT01428063|453891490|FG001|Overall Study|Lack of Efficacy|4|||
126165554|NCT01428063|453891491|FG002|Overall Study|Lack of Efficacy|1|||
126165555|NCT01428063|453891489|FG000|Overall Study|Adverse Event|2|||
126165556|NCT01428063|453891490|FG001|Overall Study|Adverse Event|3|||
126165557|NCT01428063|453891491|FG002|Overall Study|Adverse Event|0|||
126165558|NCT01428063|453891489|FG000|Overall Study|Lost to Follow-up|0|||
126165559|NCT01428063|453891490|FG001|Overall Study|Lost to Follow-up|2|||
126165560|NCT01428063|453891491|FG002|Overall Study|Lost to Follow-up|0|||
126165561|NCT01428063|453891489|FG000|Overall Study|No longer meets study criteria|0|||
126165562|NCT01428063|453891490|FG001|Overall Study|No longer meets study criteria|1|||
126165563|NCT01428063|453891491|FG002|Overall Study|No longer meets study criteria|0|||
126165564|NCT00850759|453891492|FG000|Overall Study|Lost to Follow-up|7|||
126165565|NCT00850759|453891493|FG001|Overall Study|Lost to Follow-up|5|||
126165566|NCT00850759|453891494|FG002|Overall Study|Lost to Follow-up|5|||
126165567|NCT00850759|453891495|FG003|Overall Study|Lost to Follow-up|3|||
126165568|NCT02575079|453891496|FG000|Overall Study|Death|3|||
126165569|NCT02575079|453891497|FG001|Overall Study|Death|0|||
126165570|NCT02575079|453891496|FG000|Overall Study|Withdrawal by Subject|3|||
126165571|NCT02575079|453891497|FG001|Overall Study|Withdrawal by Subject|0|||
126165572|NCT02918266|453891498|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
126165573|NCT02918266|453891499|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125972910|NCT02008890|453191364|FG000|Extension Period|Lost to Follow-up|1|||
126165574|NCT02918266|453891500|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126165575|NCT02918266|453891501|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125972911|NCT02008890|453191365|FG001|Extension Period|Lost to Follow-up|0|||
126165576|NCT02918266|453891502|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126165577|NCT02918266|453891503|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126165578|NCT02918266|453891504|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
126165579|NCT02918266|453891505|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126165580|NCT02918266|453891506|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
126165581|NCT02918266|453891507|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126165582|NCT02918266|453891508|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126165583|NCT01259856|453891515|FG000|Overall Study|Adverse Event|12|||
126165584|NCT01259856|453891516|FG001|Overall Study|Adverse Event|9|||
126165585|NCT01259856|453891515|FG000|Overall Study|Death|0|||
126165586|NCT01259856|453891516|FG001|Overall Study|Death|1|||
126165587|NCT01259856|453891515|FG000|Overall Study|Lack of Efficacy|3|||
126165588|NCT01259856|453891516|FG001|Overall Study|Lack of Efficacy|1|||
126165589|NCT01259856|453891515|FG000|Overall Study|Lost to Follow-up|1|||
126165590|NCT01259856|453891516|FG001|Overall Study|Lost to Follow-up|1|||
126165591|NCT01259856|453891515|FG000|Overall Study|Physician Decision|2|||
126165592|NCT01259856|453891516|FG001|Overall Study|Physician Decision|1|||
126165593|NCT01259856|453891515|FG000|Overall Study|Withdrawal by Subject|9|||
126165594|NCT01259856|453891516|FG001|Overall Study|Withdrawal by Subject|10|||
126165595|NCT01259856|453891515|FG000|Overall Study|Treatment never started|0|||
126165596|NCT01259856|453891516|FG001|Overall Study|Treatment never started|6|||
126165597|NCT01259856|453891515|FG000|Overall Study|Study closure by sponsor|40|||
126165598|NCT01259856|453891516|FG001|Overall Study|Study closure by sponsor|41|||
126165599|NCT01259856|453891515|FG000|Overall Study|Patient developed other disease|0|||
126165600|NCT01259856|453891516|FG001|Overall Study|Patient developed other disease|1|||
126165601|NCT01259856|453891515|FG000|Overall Study|Transfer to another study|0|||
126165602|NCT01259856|453891516|FG001|Overall Study|Transfer to another study|1|||
126165603|NCT01259856|453891515|FG000|Overall Study|Unknown/missing|2|||
126165604|NCT01259856|453891516|FG001|Overall Study|Unknown/missing|2|||
126165605|NCT00788775|453891517|FG000|Overall Study|Progressive Disease|8|||
126165606|NCT00788775|453891518|FG001|Overall Study|Progressive Disease|6|||
126165607|NCT00788775|453891517|FG000|Overall Study|Withdrawal by Subject|0|||
126165608|NCT00788775|453891518|FG001|Overall Study|Withdrawal by Subject|2|||
126165609|NCT00788775|453891517|FG000|Overall Study|Patient Non-Compliance|1|||
126165610|NCT00788775|453891518|FG001|Overall Study|Patient Non-Compliance|0|||
126165611|NCT00788775|453891517|FG000|Overall Study|Patient's measurable disease resected.|1|||
126165612|NCT00788775|453891518|FG001|Overall Study|Patient's measurable disease resected.|0|||
126165613|NCT00578864|453891519|FG000|Overall Study|Death|1|||
126165614|NCT00578864|453891520|FG001|Overall Study|Death|0|||
126165615|NCT01087528|453891521|FG000|Overall Study|Withdrawal by Subject|1|||
126165616|NCT01087528|453891521|FG000|Overall Study|Incomplete CE procedure|6|||
126165617|NCT02702193|453891532|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
126165618|NCT02702193|453891533|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
126165619|NCT02702193|453891532|FG000|4 Month Follow up|Withdrawal by Subject|1|||
126165620|NCT02702193|453891533|FG001|4 Month Follow up|Withdrawal by Subject|0|||
126165621|NCT02702193|453891532|FG000|4 Month Follow up|Lost to Follow-up|17|||
126165622|NCT02702193|453891533|FG001|4 Month Follow up|Lost to Follow-up|18|||
126165623|NCT02702193|453891532|FG000|8 Month Follow up|Withdrawal by Subject|1|||
126165624|NCT02702193|453891533|FG001|8 Month Follow up|Withdrawal by Subject|0|||
126165625|NCT02702193|453891532|FG000|8 Month Follow up|Lost to Follow-up|14|||
126165626|NCT02702193|453891533|FG001|8 Month Follow up|Lost to Follow-up|18|||
126165627|NCT02702193|453891532|FG000|12 Month Follow up|Withdrawal by Subject|1|||
126165628|NCT02702193|453891533|FG001|12 Month Follow up|Withdrawal by Subject|0|||
126165629|NCT02702193|453891532|FG000|12 Month Follow up|Lost to Follow-up|16|||
126165630|NCT02702193|453891533|FG001|12 Month Follow up|Lost to Follow-up|18|||
126165631|NCT01201798|453891536|FG000|Overall Study|Adverse Event|2|||
126165632|NCT01201798|453891537|FG001|Overall Study|Adverse Event|0|||
126165633|NCT01201798|453891536|FG000|Overall Study|Lost to Follow-up|3|||
126165634|NCT01201798|453891537|FG001|Overall Study|Lost to Follow-up|5|||
126165635|NCT01201798|453891536|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
126165636|NCT01201798|453891537|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
126165637|NCT01201798|453891536|FG000|Overall Study|Noncompliance|1|||
126165638|NCT01201798|453891537|FG001|Overall Study|Noncompliance|0|||
126165639|NCT01201798|453891536|FG000|Overall Study|Protocol Violation|1|||
126165640|NCT01201798|453891537|FG001|Overall Study|Protocol Violation|1|||
126165641|NCT01201798|453891536|FG000|Overall Study|Treatment Failure|1|||
126165642|NCT01201798|453891537|FG001|Overall Study|Treatment Failure|8|||
126165643|NCT00114972|453891539|FG000|Overall Study|Withdrawal by Subject|40|||
126165644|NCT00114972|453891540|FG001|Overall Study|Withdrawal by Subject|7|||
126165645|NCT00114972|453891539|FG000|Overall Study|Lost to Follow-up|8|||
126165646|NCT00114972|453891540|FG001|Overall Study|Lost to Follow-up|5|||
126165647|NCT03609359|453891541|FG000|Overall Study|Progression of primary disease (PD)|25|||
126165648|NCT03609359|453891541|FG000|Overall Study|Patient's refusal|1|||
126165649|NCT03609359|453891541|FG000|Overall Study|Physician Decision|1|||
126165650|NCT03609359|453891541|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
126165651|NCT01425190|453891543|FG000|Overall Study|Full dose not consumed.|1|||
126165652|NCT01425190|453891544|FG001|Overall Study|Full dose not consumed.|0|||
126165653|NCT01425190|453891545|FG002|Overall Study|Full dose not consumed.|0|||
126165654|NCT01035255|453891546|FG000|Overall Study|Death|724|||
126165655|NCT01035255|453891547|FG001|Overall Study|Death|844|||
126165656|NCT01035255|453891546|FG000|Overall Study|Lost to Follow-up|2|||
126165657|NCT01035255|453891547|FG001|Overall Study|Lost to Follow-up|5|||
126165658|NCT01035255|453891546|FG000|Overall Study|patient's request|15|||
126165659|NCT01035255|453891547|FG001|Overall Study|patient's request|13|||
126165660|NCT01952834|453891550|FG000|Overall Study|Adverse Event|1|||
126165661|NCT04285346|453891551|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
126165662|NCT04285346|453891552|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
126165663|NCT04285346|453891551|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
126165664|NCT04285346|453891552|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126165665|NCT04285346|453891551|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
126165666|NCT04285346|453891552|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126165667|NCT00610935|453891553|FG000|Overall Study|Lost to Follow-up|0|||
126165668|NCT00610935|453891554|FG001|Overall Study|Lost to Follow-up|1|||
126165669|NCT00610935|453891553|FG000|Overall Study|Withdrawal by Subject|0|||
126165670|NCT00610935|453891554|FG001|Overall Study|Withdrawal by Subject|2|||
126165671|NCT00610935|453891553|FG000|Overall Study|Sponsor Discontinuation|1|||
126165672|NCT00610935|453891554|FG001|Overall Study|Sponsor Discontinuation|0|||
126165673|NCT03007953|453891555|FG000|Overall Study|Withdrawal by Subject|5|||
126165674|NCT03007953|453891556|FG001|Overall Study|Withdrawal by Subject|2|||
126165675|NCT03007953|453891555|FG000|Overall Study|Death|5|||
126165676|NCT03007953|453891556|FG001|Overall Study|Death|7|||
126165677|NCT03007953|453891555|FG000|Overall Study|Lost to Follow-up|3|||
126165678|NCT03007953|453891556|FG001|Overall Study|Lost to Follow-up|2|||
126165679|NCT03007953|453891555|FG000|Overall Study|Enrolled in Hospice|3|||
126165680|NCT03007953|453891556|FG001|Overall Study|Enrolled in Hospice|2|||
126165681|NCT02203838|453891557|FG000|Overall Study|Lack of Efficacy|7|||
126165682|NCT02203838|453891558|FG001|Overall Study|Lack of Efficacy|0|||
126165683|NCT02203838|453891559|FG002|Overall Study|Lack of Efficacy|1|||
126165684|NCT02203838|453891560|FG003|Overall Study|Lack of Efficacy|1|||
126165685|NCT02203838|453891557|FG000|Overall Study|Adverse Event|46|||
126165686|NCT02203838|453891558|FG001|Overall Study|Adverse Event|6|||
126165687|NCT02203838|453891559|FG002|Overall Study|Adverse Event|3|||
126165688|NCT02203838|453891560|FG003|Overall Study|Adverse Event|2|||
126165689|NCT02203838|453891557|FG000|Overall Study|Lost to Follow-up|39|||
126165690|NCT02203838|453891558|FG001|Overall Study|Lost to Follow-up|3|||
126165691|NCT02203838|453891559|FG002|Overall Study|Lost to Follow-up|2|||
126165692|NCT02203838|453891560|FG003|Overall Study|Lost to Follow-up|1|||
126165693|NCT02203838|453891557|FG000|Overall Study|Protocol Violation|7|||
126165694|NCT02203838|453891558|FG001|Overall Study|Protocol Violation|3|||
126165695|NCT02203838|453891559|FG002|Overall Study|Protocol Violation|0|||
126165696|NCT02203838|453891560|FG003|Overall Study|Protocol Violation|0|||
126165697|NCT02203838|453891557|FG000|Overall Study|Withdrawal by Subject|83|||
126165698|NCT02203838|453891558|FG001|Overall Study|Withdrawal by Subject|10|||
126165699|NCT02203838|453891559|FG002|Overall Study|Withdrawal by Subject|8|||
126165700|NCT02203838|453891560|FG003|Overall Study|Withdrawal by Subject|11|||
126165701|NCT02203838|453891557|FG000|Overall Study|Physician Decision|27|||
126165702|NCT02203838|453891558|FG001|Overall Study|Physician Decision|0|||
126165703|NCT02203838|453891559|FG002|Overall Study|Physician Decision|2|||
126165704|NCT02203838|453891560|FG003|Overall Study|Physician Decision|3|||
126165705|NCT02203838|453891557|FG000|Overall Study|Other|1|||
126165706|NCT02203838|453891558|FG001|Overall Study|Other|0|||
126165707|NCT02203838|453891559|FG002|Overall Study|Other|0|||
126165708|NCT02203838|453891560|FG003|Overall Study|Other|0|||
126165709|NCT03196297|453891561|FG000|Main Period|Withdrawal by Subject|4|||
126165710|NCT03196297|453891561|FG000|Extension Period|Withdrawal by Subject|1|||
125972912|NCT02008890|453191366|FG002|Extension Period|Lost to Follow-up|0|||
125972913|NCT02008890|453191367|FG003|Extension Period|Lost to Follow-up|0|||
126165711|NCT03196297|453891561|FG000|Extension Period|Lack of Efficacy|2|||
126165712|NCT00829166|453891562|FG000|Overall Study|Death|305|||
126165713|NCT00829166|453891563|FG001|Overall Study|Death|333|||
126165714|NCT00829166|453891562|FG000|Overall Study|Lost to Follow-up|5|||
126165715|NCT00829166|453891563|FG001|Overall Study|Lost to Follow-up|4|||
126165716|NCT00829166|453891562|FG000|Overall Study|Physician's Decision|4|||
125972914|NCT02008890|453191368|FG004|Extension Period|Lost to Follow-up|0|||
126165717|NCT00829166|453891563|FG001|Overall Study|Physician's Decision|3|||
126165718|NCT00829166|453891562|FG000|Overall Study|Subject's Decision|41|||
126165719|NCT00829166|453891563|FG001|Overall Study|Subject's Decision|55|||
126165720|NCT00829166|453891562|FG000|Overall Study|Sponsor's Decision|137|||
126165721|NCT00829166|453891563|FG001|Overall Study|Sponsor's Decision|98|||
126165722|NCT00829166|453891562|FG000|Overall Study|Reason Not Specified|3|||
126165723|NCT00829166|453891563|FG001|Overall Study|Reason Not Specified|3|||
126165724|NCT04590937|453891564|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
126165725|NCT01635933|453891565|FG000|Overall Study|Adverse Event|1|||
126165726|NCT01635933|453891566|FG001|Overall Study|Adverse Event|0|||
126165727|NCT01635933|453891565|FG000|Overall Study|Lost to Follow-up|0|||
126165728|NCT01635933|453891566|FG001|Overall Study|Lost to Follow-up|5|||
126165729|NCT01635933|453891565|FG000|Overall Study|Subject decision|1|||
126165730|NCT01635933|453891566|FG001|Overall Study|Subject decision|1|||
126165731|NCT01635933|453891565|FG000|Overall Study|Noncompliance|0|||
126165732|NCT01635933|453891566|FG001|Overall Study|Noncompliance|1|||
126165733|NCT01635933|453891565|FG000|Overall Study|No longer had transportation|0|||
126165734|NCT01635933|453891566|FG001|Overall Study|No longer had transportation|1|||
126165735|NCT03987620|453891567|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
126165736|NCT03987620|453891568|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
126165737|NCT03987620|453891567|FG000|Overall Study|Adverse Event|3|||
126165738|NCT03987620|453891568|FG001|Overall Study|Adverse Event|0|||
126165739|NCT03987620|453891567|FG000|Overall Study|Lost to Follow-up|1|||
126165740|NCT03987620|453891568|FG001|Overall Study|Lost to Follow-up|2|||
126165741|NCT03987620|453891567|FG000|Overall Study|Physician Decision|0|||
126165742|NCT03987620|453891568|FG001|Overall Study|Physician Decision|1|||
126165743|NCT03987620|453891567|FG000|Overall Study|Pregnancy|1|||
126165744|NCT03987620|453891568|FG001|Overall Study|Pregnancy|0|||
126165745|NCT03987620|453891567|FG000|Overall Study|Withdrawal by Subject|7|||
126165746|NCT03987620|453891568|FG001|Overall Study|Withdrawal by Subject|1|||
126165747|NCT03987620|453891567|FG000|Overall Study|Other|2|||
126165748|NCT03987620|453891568|FG001|Overall Study|Other|5|||
126165749|NCT01204658|453891572|FG000|Primary Phase|Adverse Event|0|||
126165750|NCT01204658|453891573|FG001|Primary Phase|Adverse Event|0|||
126165751|NCT01204658|453891574|FG002|Primary Phase|Adverse Event|1|||
126165752|NCT01204658|453891575|FG003|Primary Phase|Adverse Event|0|||
126165753|NCT00436215|453891576|FG000|Overall Study|Refused further treatment|3|||
126165754|NCT00436215|453891576|FG000|Overall Study|Small bowel obstruction|1|||
126165755|NCT00309777|453891577|FG000|Overall Study|Adverse Event|13|||
126165756|NCT00309777|453891578|FG001|Overall Study|Adverse Event|2|||
126165757|NCT00309777|453891579|FG002|Overall Study|Adverse Event|8|||
126165758|NCT00309777|453891580|FG003|Overall Study|Adverse Event|1|||
126165759|NCT00309777|453891577|FG000|Overall Study|Protocol Violation|4|||
126165760|NCT00309777|453891578|FG001|Overall Study|Protocol Violation|1|||
126165761|NCT00309777|453891579|FG002|Overall Study|Protocol Violation|3|||
126165762|NCT00309777|453891580|FG003|Overall Study|Protocol Violation|1|||
126165763|NCT00309777|453891577|FG000|Overall Study|Withdrawal by Subject|6|||
126165764|NCT00309777|453891578|FG001|Overall Study|Withdrawal by Subject|5|||
126165765|NCT00309777|453891579|FG002|Overall Study|Withdrawal by Subject|7|||
126165766|NCT00309777|453891580|FG003|Overall Study|Withdrawal by Subject|2|||
126165767|NCT00309777|453891577|FG000|Overall Study|Lost to Follow-up|0|||
126165768|NCT00309777|453891578|FG001|Overall Study|Lost to Follow-up|0|||
126165769|NCT00309777|453891579|FG002|Overall Study|Lost to Follow-up|1|||
126165770|NCT00309777|453891580|FG003|Overall Study|Lost to Follow-up|0|||
126165771|NCT00309777|453891577|FG000|Overall Study|Death|0|||
126165772|NCT00309777|453891578|FG001|Overall Study|Death|1|||
126165773|NCT00309777|453891579|FG002|Overall Study|Death|0|||
126165774|NCT00309777|453891580|FG003|Overall Study|Death|0|||
126165775|NCT00492856|453893194|FG000|Induction|Adverse Event|2|||
126165776|NCT00492856|453893195|FG001|Induction|Adverse Event|0|||
126165777|NCT00492856|453893196|FG002|Induction|Adverse Event|0|||
126165778|NCT00492856|453893197|FG003|Induction|Adverse Event|0|||
126165779|NCT00492856|453893194|FG000|Induction|Withdrawal by Subject|1|||
126165780|NCT00492856|453893195|FG001|Induction|Withdrawal by Subject|0|||
126165781|NCT00492856|453893196|FG002|Induction|Withdrawal by Subject|0|||
126165782|NCT00492856|453893197|FG003|Induction|Withdrawal by Subject|0|||
126165783|NCT00492856|453893194|FG000|Induction|Death|3|||
126165784|NCT00492856|453893195|FG001|Induction|Death|0|||
126165785|NCT00492856|453893196|FG002|Induction|Death|0|||
126165786|NCT00492856|453893197|FG003|Induction|Death|0|||
126165787|NCT00492856|453893194|FG000|Consolidation|Adverse Event|6|||
126165788|NCT00492856|453893195|FG001|Consolidation|Adverse Event|0|||
126165789|NCT00492856|453893196|FG002|Consolidation|Adverse Event|0|||
126165790|NCT00492856|453893197|FG003|Consolidation|Adverse Event|0|||
126165791|NCT00492856|453893194|FG000|Consolidation|Not protocol specified|2|||
126165792|NCT00492856|453893195|FG001|Consolidation|Not protocol specified|0|||
126165793|NCT00492856|453893196|FG002|Consolidation|Not protocol specified|0|||
126165794|NCT00492856|453893197|FG003|Consolidation|Not protocol specified|0|||
126165795|NCT00492856|453893194|FG000|Consolidation|Lost to Follow-up|1|||
126165796|NCT00492856|453893195|FG001|Consolidation|Lost to Follow-up|0|||
126165797|NCT00492856|453893196|FG002|Consolidation|Lost to Follow-up|0|||
126165798|NCT00492856|453893197|FG003|Consolidation|Lost to Follow-up|0|||
126165799|NCT00492856|453893194|FG000|Post-consolidation|Adverse Event|0|||
126165800|NCT00492856|453893195|FG001|Post-consolidation|Adverse Event|4|||
126165801|NCT00492856|453893196|FG002|Post-consolidation|Adverse Event|0|||
126165802|NCT00492856|453893197|FG003|Post-consolidation|Adverse Event|1|||
125972915|NCT02008890|453191364|FG000|Extension Period|Adverse Event|1|||
126165803|NCT00492856|453893194|FG000|Post-consolidation|Withdrawal by Subject|0|||
126165804|NCT00492856|453893195|FG001|Post-consolidation|Withdrawal by Subject|4|||
126165805|NCT00492856|453893196|FG002|Post-consolidation|Withdrawal by Subject|0|||
126165806|NCT00492856|453893197|FG003|Post-consolidation|Withdrawal by Subject|0|||
126165807|NCT00492856|453893194|FG000|Post-consolidation|Death|0|||
126165808|NCT00492856|453893195|FG001|Post-consolidation|Death|1|||
126165809|NCT00492856|453893196|FG002|Post-consolidation|Death|0|||
126165810|NCT00492856|453893197|FG003|Post-consolidation|Death|0|||
126165811|NCT00492856|453893194|FG000|Post-consolidation|Not protocol specified|0|||
126165812|NCT00492856|453893195|FG001|Post-consolidation|Not protocol specified|1|||
126165813|NCT00492856|453893196|FG002|Post-consolidation|Not protocol specified|0|||
126165814|NCT00492856|453893197|FG003|Post-consolidation|Not protocol specified|0|||
126165815|NCT00492856|453893194|FG000|Post-consolidation|Lost to Follow-up|0|||
126165816|NCT00492856|453893195|FG001|Post-consolidation|Lost to Follow-up|2|||
126165817|NCT00492856|453893196|FG002|Post-consolidation|Lost to Follow-up|0|||
126165818|NCT00492856|453893197|FG003|Post-consolidation|Lost to Follow-up|0|||
126165819|NCT00492856|453893194|FG000|Post-consolidation|Observation Arm|0|||
126165820|NCT00492856|453893195|FG001|Post-consolidation|Observation Arm|0|||
126165821|NCT00492856|453893196|FG002|Post-consolidation|Observation Arm|27|||
126165822|NCT00492856|453893197|FG003|Post-consolidation|Observation Arm|0|||
126165823|NCT03488472|453893198|FG000|Overall Study|disease progression additional mets|1|||
126165824|NCT03010423|453893200|FG000|Overall Study|Study termination|8|||
126165825|NCT03484923|453893201|FG000|Overall Study|Adverse Event|3|||
126165826|NCT03484923|453893202|FG001|Overall Study|Adverse Event|3|||
126165827|NCT03484923|453893203|FG002|Overall Study|Adverse Event|5|||
126165828|NCT03484923|453893204|FG003|Overall Study|Adverse Event|11|||
126165829|NCT03484923|453893205|FG004|Overall Study|Adverse Event|1|||
126165830|NCT03484923|453893201|FG000|Overall Study|Death|2|||
126165831|NCT03484923|453893202|FG001|Overall Study|Death|2|||
126165832|NCT03484923|453893203|FG002|Overall Study|Death|3|||
126165833|NCT03484923|453893204|FG003|Overall Study|Death|0|||
126165834|NCT03484923|453893205|FG004|Overall Study|Death|1|||
126165835|NCT03484923|453893201|FG000|Overall Study|Physician Decision|6|||
126165836|NCT03484923|453893202|FG001|Overall Study|Physician Decision|7|||
126165837|NCT03484923|453893203|FG002|Overall Study|Physician Decision|6|||
126165838|NCT03484923|453893204|FG003|Overall Study|Physician Decision|3|||
126165839|NCT03484923|453893205|FG004|Overall Study|Physician Decision|2|||
126165840|NCT03484923|453893201|FG000|Overall Study|Progressive disease|33|||
126165841|NCT03484923|453893202|FG001|Overall Study|Progressive disease|28|||
126165842|NCT03484923|453893203|FG002|Overall Study|Progressive disease|26|||
126165843|NCT03484923|453893204|FG003|Overall Study|Progressive disease|30|||
126165844|NCT03484923|453893205|FG004|Overall Study|Progressive disease|16|||
126165845|NCT03484923|453893201|FG000|Overall Study|Subject Decision|1|||
126165846|NCT03484923|453893202|FG001|Overall Study|Subject Decision|3|||
126165847|NCT03484923|453893203|FG002|Overall Study|Subject Decision|3|||
126165848|NCT03484923|453893204|FG003|Overall Study|Subject Decision|0|||
126165849|NCT03484923|453893205|FG004|Overall Study|Subject Decision|1|||
126165850|NCT03165721|453893211|FG000|Overall Study|Refused further treatment|3|||
126165851|NCT03165721|453893212|FG001|Overall Study|Refused further treatment|0|||
126165852|NCT03165721|453893213|FG002|Overall Study|Refused further treatment|0|||
126165853|NCT03165721|453893211|FG000|Overall Study|Physician Decision|1|||
126165854|NCT03165721|453893212|FG001|Overall Study|Physician Decision|0|||
126165855|NCT03165721|453893213|FG002|Overall Study|Physician Decision|0|||
126165856|NCT01863849|453893214|FG000|Overall Study|Lost to Follow-up|1|||
126165857|NCT01863849|453893215|FG001|Overall Study|Lost to Follow-up|0|||
126165858|NCT01457118|453893216|FG000|Overall Study|Adverse Event|1|||
126165859|NCT01457118|453893217|FG001|Overall Study|Adverse Event|0|||
126165860|NCT01457118|453893218|FG002|Overall Study|Adverse Event|0|||
126165861|NCT01457118|453893219|FG003|Overall Study|Adverse Event|1|||
126165862|NCT01457118|453893216|FG000|Overall Study|Clinical Progression|0|||
126165863|NCT01457118|453893217|FG001|Overall Study|Clinical Progression|1|||
126165864|NCT01457118|453893218|FG002|Overall Study|Clinical Progression|0|||
126165865|NCT01457118|453893219|FG003|Overall Study|Clinical Progression|1|||
126165866|NCT01457118|453893216|FG000|Overall Study|Physician Decision|2|||
126165867|NCT01457118|453893217|FG001|Overall Study|Physician Decision|0|||
126165868|NCT01457118|453893218|FG002|Overall Study|Physician Decision|0|||
126165869|NCT01457118|453893219|FG003|Overall Study|Physician Decision|0|||
126165870|NCT01457118|453893216|FG000|Overall Study|Progressive Disease by RECIST|12|||
126165871|NCT01457118|453893217|FG001|Overall Study|Progressive Disease by RECIST|3|||
126165872|NCT01457118|453893218|FG002|Overall Study|Progressive Disease by RECIST|1|||
126165873|NCT01457118|453893219|FG003|Overall Study|Progressive Disease by RECIST|0|||
126165874|NCT01457118|453893216|FG000|Overall Study|Withdrawal by Subject|5|||
126165875|NCT01457118|453893217|FG001|Overall Study|Withdrawal by Subject|0|||
126165876|NCT01457118|453893218|FG002|Overall Study|Withdrawal by Subject|0|||
126165877|NCT01457118|453893219|FG003|Overall Study|Withdrawal by Subject|0|||
126165878|NCT03456713|453893224|FG000|Overall Study|Lost to Follow-up|1|||
126165879|NCT03456713|453893225|FG001|Overall Study|Lost to Follow-up|0|||
126165880|NCT03456713|453893226|FG002|Overall Study|Lost to Follow-up|0|||
126165881|NCT03456713|453893227|FG003|Overall Study|Lost to Follow-up|0|||
126165882|NCT01263691|453893228|FG000|Overall Study|Lost to Follow-up|1|||
126165883|NCT01263691|453893229|FG001|Overall Study|Lost to Follow-up|0|||
126165884|NCT01263691|453893230|FG002|Overall Study|Lost to Follow-up|1|||
126165885|NCT01263691|453893231|FG003|Overall Study|Lost to Follow-up|1|||
126165886|NCT01263691|453893232|FG004|Overall Study|Lost to Follow-up|0|||
126165887|NCT01263691|453893233|FG005|Overall Study|Lost to Follow-up|0|||
126165888|NCT01263691|453893228|FG000|Overall Study|Withdrawal by Subject|1|||
126165889|NCT01263691|453893229|FG001|Overall Study|Withdrawal by Subject|0|||
126165890|NCT01263691|453893230|FG002|Overall Study|Withdrawal by Subject|0|||
126165891|NCT01263691|453893231|FG003|Overall Study|Withdrawal by Subject|0|||
126165892|NCT01263691|453893232|FG004|Overall Study|Withdrawal by Subject|0|||
126165893|NCT01263691|453893233|FG005|Overall Study|Withdrawal by Subject|0|||
126165894|NCT01263691|453893228|FG000|Overall Study|Adverse Event|1|||
126165895|NCT01263691|453893229|FG001|Overall Study|Adverse Event|0|||
126165896|NCT01263691|453893230|FG002|Overall Study|Adverse Event|0|||
126165897|NCT01263691|453893231|FG003|Overall Study|Adverse Event|0|||
126165898|NCT01263691|453893232|FG004|Overall Study|Adverse Event|0|||
126165899|NCT01263691|453893233|FG005|Overall Study|Adverse Event|0|||
126165900|NCT01202227|453893236|FG000|Overall Study|Adverse Event|16|||
126165901|NCT01202227|453893236|FG000|Overall Study|Withdrawal by Subject|2|||
126165902|NCT01202227|453893236|FG000|Overall Study|Lack of Efficacy|1|||
126165903|NCT04402008|453893239|FG000|Overall Study|Adverse Event|0|||
126165904|NCT04402008|453893240|FG001|Overall Study|Adverse Event|0|||
126165905|NCT04402008|453893241|FG002|Overall Study|Adverse Event|0|||
126165906|NCT04402008|453893242|FG003|Overall Study|Adverse Event|1|||
126165907|NCT04402008|453893243|FG004|Overall Study|Adverse Event|0|||
126165908|NCT04402008|453893244|FG005|Overall Study|Adverse Event|0|||
126165909|NCT04402008|453893245|FG006|Overall Study|Adverse Event|0|||
126165910|NCT04402008|453893239|FG000|Overall Study|Disease Progression|3|||
126165911|NCT04402008|453893240|FG001|Overall Study|Disease Progression|2|||
126165912|NCT04402008|453893241|FG002|Overall Study|Disease Progression|3|||
126165913|NCT04402008|453893242|FG003|Overall Study|Disease Progression|3|||
126165914|NCT04402008|453893243|FG004|Overall Study|Disease Progression|4|||
126165915|NCT04402008|453893244|FG005|Overall Study|Disease Progression|3|||
126165916|NCT04402008|453893245|FG006|Overall Study|Disease Progression|10|||
126165917|NCT04402008|453893239|FG000|Overall Study|Withdrawal by Subject|0|||
126165918|NCT04402008|453893240|FG001|Overall Study|Withdrawal by Subject|1|||
126165919|NCT04402008|453893241|FG002|Overall Study|Withdrawal by Subject|0|||
126165920|NCT04402008|453893242|FG003|Overall Study|Withdrawal by Subject|0|||
126165921|NCT04402008|453893243|FG004|Overall Study|Withdrawal by Subject|1|||
126165922|NCT04402008|453893244|FG005|Overall Study|Withdrawal by Subject|0|||
126165923|NCT04402008|453893245|FG006|Overall Study|Withdrawal by Subject|0|||
126165924|NCT04402008|453893239|FG000|Overall Study|Sponsor Decision|0|||
126165925|NCT04402008|453893240|FG001|Overall Study|Sponsor Decision|0|||
126165926|NCT04402008|453893241|FG002|Overall Study|Sponsor Decision|0|||
126165927|NCT04402008|453893242|FG003|Overall Study|Sponsor Decision|0|||
126165928|NCT04402008|453893243|FG004|Overall Study|Sponsor Decision|0|||
126165929|NCT04402008|453893244|FG005|Overall Study|Sponsor Decision|0|||
126165930|NCT04402008|453893245|FG006|Overall Study|Sponsor Decision|3|||
126165931|NCT04402008|453893239|FG000|Overall Study|Death|0|||
126165932|NCT04402008|453893240|FG001|Overall Study|Death|0|||
126165933|NCT04402008|453893241|FG002|Overall Study|Death|0|||
126165934|NCT04402008|453893242|FG003|Overall Study|Death|0|||
126165935|NCT04402008|453893243|FG004|Overall Study|Death|1|||
126165936|NCT04402008|453893244|FG005|Overall Study|Death|0|||
126165937|NCT04402008|453893245|FG006|Overall Study|Death|2|||
126165938|NCT04402008|453893239|FG000|Overall Study|Other|0|||
126165939|NCT04402008|453893240|FG001|Overall Study|Other|0|||
126165940|NCT04402008|453893241|FG002|Overall Study|Other|0|||
126165941|NCT04402008|453893242|FG003|Overall Study|Other|0|||
126165942|NCT04402008|453893243|FG004|Overall Study|Other|0|||
126165943|NCT04402008|453893244|FG005|Overall Study|Other|0|||
126165944|NCT04402008|453893245|FG006|Overall Study|Other|5|||
126165945|NCT00411788|453893246|FG000|Overall Study|Protocol Violation|1|||
126165946|NCT00411788|453893246|FG000|Overall Study|Adverse Event|1|||
126165947|NCT01533935|453893247|FG000|Overall Study|Adverse Event|5|||
126165948|NCT01533935|453893248|FG001|Overall Study|Adverse Event|7|||
126165949|NCT01533935|453893249|FG002|Overall Study|Adverse Event|1|||
126165950|NCT01533935|453893250|FG003|Overall Study|Adverse Event|5|||
126165951|NCT01533935|453893251|FG004|Overall Study|Adverse Event|3|||
126165952|NCT01533935|453893247|FG000|Overall Study|Protocol Violation|0|||
126165953|NCT01533935|453893248|FG001|Overall Study|Protocol Violation|2|||
126165954|NCT01533935|453893249|FG002|Overall Study|Protocol Violation|0|||
126165955|NCT01533935|453893250|FG003|Overall Study|Protocol Violation|0|||
126165956|NCT01533935|453893251|FG004|Overall Study|Protocol Violation|0|||
126165957|NCT01533935|453893247|FG000|Overall Study|Lost to Follow-up|0|||
126165958|NCT01533935|453893248|FG001|Overall Study|Lost to Follow-up|0|||
126165959|NCT01533935|453893249|FG002|Overall Study|Lost to Follow-up|1|||
126165960|NCT01533935|453893250|FG003|Overall Study|Lost to Follow-up|0|||
126165961|NCT01533935|453893251|FG004|Overall Study|Lost to Follow-up|0|||
126165962|NCT01533935|453893247|FG000|Overall Study|Withdrawal by Subject|0|||
126165963|NCT01533935|453893248|FG001|Overall Study|Withdrawal by Subject|4|||
125972916|NCT02008890|453191365|FG001|Extension Period|Adverse Event|3|||
126165964|NCT01533935|453893249|FG002|Overall Study|Withdrawal by Subject|5|||
126165965|NCT01533935|453893250|FG003|Overall Study|Withdrawal by Subject|2|||
126165966|NCT01533935|453893251|FG004|Overall Study|Withdrawal by Subject|4|||
126165967|NCT01533935|453893247|FG000|Overall Study|Other reason not defined above|1|||
126165968|NCT01533935|453893248|FG001|Overall Study|Other reason not defined above|0|||
126165969|NCT01533935|453893249|FG002|Overall Study|Other reason not defined above|1|||
126165970|NCT01533935|453893250|FG003|Overall Study|Other reason not defined above|0|||
126165971|NCT01533935|453893251|FG004|Overall Study|Other reason not defined above|1|||
126165972|NCT00630812|453893254|FG000|Randomisation to First Dose|Adverse Event|1|||
126165973|NCT00630812|453893255|FG001|Randomisation to First Dose|Adverse Event|1|||
126165974|NCT00630812|453893254|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
126165975|NCT00630812|453893255|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
126165976|NCT00630812|453893254|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
126165977|NCT00630812|453893255|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
126165978|NCT00630812|453893254|FG000|Randomisation to First Dose|Protocol Violation|4|||
126165979|NCT00630812|453893255|FG001|Randomisation to First Dose|Protocol Violation|1|||
126165980|NCT00630812|453893254|FG000|Double Blind Treatment Period|Adverse Event|13|||
126165981|NCT00630812|453893255|FG001|Double Blind Treatment Period|Adverse Event|5|||
126165982|NCT00630812|453893254|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
126165983|NCT00630812|453893255|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126165984|NCT00630812|453893254|FG000|Double Blind Treatment Period|Physician Decision|2|||
126165985|NCT00630812|453893255|FG001|Double Blind Treatment Period|Physician Decision|1|||
126165986|NCT00630812|453893254|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126165987|NCT00630812|453893255|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126165988|NCT00630812|453893254|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
126165989|NCT00630812|453893255|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
126165990|NCT00630812|453893254|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
126165991|NCT00630812|453893255|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
126165992|NCT00630812|453893254|FG000|Double Blind Treatment Period|Non-compliance|0|||
126165993|NCT00630812|453893255|FG001|Double Blind Treatment Period|Non-compliance|1|||
126165994|NCT03430245|453893256|FG000|Overall Study|Withdrawal by Subject|6|||
126165995|NCT03430245|453893256|FG000|Overall Study|Lost to Follow-up|1|||
126165996|NCT05628181|453893257|FG000|Overall Study|Death|2|||
126165997|NCT05628181|453893258|FG001|Overall Study|Death|4|||
126165998|NCT05628181|453893259|FG002|Overall Study|Death|0|||
126165999|NCT00316303|453893260|FG000|Overall Study|Lost to Follow-up|11|||
126166000|NCT00316303|453893261|FG001|Overall Study|Lost to Follow-up|16|||
126166001|NCT00532948|453893262|FG000|Overall Study|Protocol Violation|1|||
126166002|NCT00532948|453893263|FG001|Overall Study|Protocol Violation|0|||
126166003|NCT00532948|453893264|FG002|Overall Study|Protocol Violation|0|||
126166004|NCT00532948|453893262|FG000|Overall Study|Death|3|||
126166005|NCT00532948|453893263|FG001|Overall Study|Death|3|||
126166006|NCT00532948|453893264|FG002|Overall Study|Death|4|||
126166007|NCT00532948|453893262|FG000|Overall Study|Violation of selection criteria at entry|0|||
126166008|NCT00532948|453893263|FG001|Overall Study|Violation of selection criteria at entry|1|||
126166009|NCT00532948|453893264|FG002|Overall Study|Violation of selection criteria at entry|0|||
126166010|NCT00532948|453893262|FG000|Overall Study|Failure to return|0|||
126166011|NCT00532948|453893263|FG001|Overall Study|Failure to return|1|||
126166012|NCT00532948|453893264|FG002|Overall Study|Failure to return|0|||
126166013|NCT01753076|453893265|FG000|Overall Study|Adverse Event|17|||
126166014|NCT01753076|453893266|FG001|Overall Study|Adverse Event|18|||
126166015|NCT01753076|453893265|FG000|Overall Study|Lack of Efficacy|3|||
126166016|NCT01753076|453893266|FG001|Overall Study|Lack of Efficacy|1|||
126166017|NCT01753076|453893265|FG000|Overall Study|Lost to Follow-up|2|||
126166018|NCT01753076|453893266|FG001|Overall Study|Lost to Follow-up|1|||
126166019|NCT01753076|453893265|FG000|Overall Study|Physician Decision|4|||
126166020|NCT01753076|453893266|FG001|Overall Study|Physician Decision|2|||
126166021|NCT01753076|453893265|FG000|Overall Study|Withdrawal by Subject|14|||
126166022|NCT01753076|453893266|FG001|Overall Study|Withdrawal by Subject|24|||
126166023|NCT01753076|453893265|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
126166024|NCT01753076|453893266|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
126166025|NCT01253044|453893271|FG000|Overall Study|Lost to Follow-up|38|||
126166026|NCT01253044|453893272|FG001|Overall Study|Lost to Follow-up|29|||
126166027|NCT00905307|453893273|FG000|Overall Study|Switched to Open Label Rescue|7|||
126166028|NCT00905307|453893274|FG001|Overall Study|Switched to Open Label Rescue|17|||
126166029|NCT00905307|453893275|FG002|Overall Study|Switched to Open Label Rescue|11|||
126166030|NCT00905307|453893276|FG003|Overall Study|Switched to Open Label Rescue|11|||
126166031|NCT00905307|453893277|FG004|Overall Study|Switched to Open Label Rescue|4|||
126166032|NCT00905307|453893278|FG005|Overall Study|Switched to Open Label Rescue|15|||
125972917|NCT02008890|453191366|FG002|Extension Period|Adverse Event|0|||
126166033|NCT00905307|453893273|FG000|Overall Study|Lost to Follow-up|0|||
126166034|NCT00905307|453893274|FG001|Overall Study|Lost to Follow-up|0|||
126166035|NCT00905307|453893275|FG002|Overall Study|Lost to Follow-up|0|||
125972918|NCT02008890|453191367|FG003|Extension Period|Adverse Event|0|||
125972919|NCT02008890|453191368|FG004|Extension Period|Adverse Event|2|||
125972920|NCT02207816|453191369|FG000|Overall Study|Serious Adverse Event|0|||
125972921|NCT02207816|453191370|FG001|Overall Study|Serious Adverse Event|5|||
125972922|NCT02207816|453191371|FG002|Overall Study|Serious Adverse Event|2|||
125972923|NCT02207816|453191369|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
125972924|NCT02207816|453191370|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
125972925|NCT02207816|453191371|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
125972926|NCT02207816|453191369|FG000|Overall Study|Withdrawal by Subject|4|||
125972927|NCT02207816|453191370|FG001|Overall Study|Withdrawal by Subject|9|||
125972928|NCT02207816|453191371|FG002|Overall Study|Withdrawal by Subject|7|||
125972929|NCT02207816|453191369|FG000|Overall Study|Migrated/Moved From Study Area|41|||
125972930|NCT02207816|453191370|FG001|Overall Study|Migrated/Moved From Study Area|60|||
125972931|NCT02207816|453191371|FG002|Overall Study|Migrated/Moved From Study Area|51|||
125972932|NCT02207816|453191369|FG000|Overall Study|Lost to Follow-up|3|||
125972933|NCT02207816|453191370|FG001|Overall Study|Lost to Follow-up|9|||
125972934|NCT02207816|453191371|FG002|Overall Study|Lost to Follow-up|1|||
125972935|NCT02207816|453191369|FG000|Overall Study|Other|1|||
125972936|NCT02207816|453191370|FG001|Overall Study|Other|2|||
125972937|NCT02207816|453191371|FG002|Overall Study|Other|4|||
125972938|NCT02522494|453191372|FG000|Overall Study|Lost to Follow-up|6|||
125972939|NCT02522494|453191373|FG001|Overall Study|Lost to Follow-up|2|||
125972940|NCT02522494|453191372|FG000|Overall Study|Withdrawal by Subject|1|||
125972941|NCT02522494|453191373|FG001|Overall Study|Withdrawal by Subject|0|||
125972942|NCT02522494|453191372|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
125972943|NCT02522494|453191373|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
125972944|NCT02522494|453191372|FG000|Overall Study|Participant did not watch the video|1|||
125972945|NCT02522494|453191373|FG001|Overall Study|Participant did not watch the video|0|||
125972946|NCT02522494|453191372|FG000|Overall Study|Death|0|||
125972947|NCT02522494|453191373|FG001|Overall Study|Death|1|||
125972948|NCT03461003|453191374|FG000|Overall Study|Lost to Follow-up|2|||
125972949|NCT03461003|453191375|FG001|Overall Study|Lost to Follow-up|2|||
125972950|NCT03461003|453191374|FG000|Overall Study|Withdrawal by Subject|3|||
125972951|NCT03461003|453191375|FG001|Overall Study|Withdrawal by Subject|1|||
125972952|NCT03489304|453191376|FG000|Overall Study|Lost to Follow-up|4|||
125972953|NCT02239679|453191380|FG000|Overall Study|Lost to Follow-up|1|||
125972954|NCT02239679|453191381|FG001|Overall Study|Lost to Follow-up|0|||
125972955|NCT02239679|453191382|FG002|Overall Study|Lost to Follow-up|0|||
125972956|NCT02239679|453191380|FG000|Overall Study|Withdrawal by Subject|2|||
125972957|NCT02239679|453191381|FG001|Overall Study|Withdrawal by Subject|3|||
125972958|NCT02239679|453191382|FG002|Overall Study|Withdrawal by Subject|1|||
125972959|NCT01217073|453191383|FG000|Base Period|Adverse Event|1|||
125972960|NCT01217073|453191384|FG001|Base Period|Adverse Event|0|||
125972961|NCT01217073|453191385|FG002|Base Period|Adverse Event|1|||
125972962|NCT01217073|453191386|FG003|Base Period|Adverse Event|0|||
125972963|NCT01217073|453191387|FG004|Base Period|Adverse Event|4|||
125972964|NCT01217073|453191388|FG005|Base Period|Adverse Event|1|||
125972965|NCT01217073|453191389|FG006|Base Period|Adverse Event|0|||
125972966|NCT01217073|453191390|FG007|Base Period|Adverse Event|0|||
125972967|NCT01217073|453191383|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
125972968|NCT01217073|453191384|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125972969|NCT01217073|453191385|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125972970|NCT01217073|453191386|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125972971|NCT01217073|453191387|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125972972|NCT01217073|453191388|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125972973|NCT01217073|453191389|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125972974|NCT01217073|453191390|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125972975|NCT01217073|453191383|FG000|Base Period|Excluded medication|0|||
125972976|NCT01217073|453191384|FG001|Base Period|Excluded medication|0|||
125972977|NCT01217073|453191385|FG002|Base Period|Excluded medication|0|||
125972978|NCT01217073|453191386|FG003|Base Period|Excluded medication|0|||
125972979|NCT01217073|453191387|FG004|Base Period|Excluded medication|1|||
125972980|NCT01217073|453191388|FG005|Base Period|Excluded medication|0|||
125972981|NCT01217073|453191389|FG006|Base Period|Excluded medication|0|||
125972982|NCT01217073|453191390|FG007|Base Period|Excluded medication|0|||
125972983|NCT01217073|453191383|FG000|Base Period|Lack of Efficacy|0|||
125972984|NCT01217073|453191384|FG001|Base Period|Lack of Efficacy|0|||
125972985|NCT01217073|453191385|FG002|Base Period|Lack of Efficacy|0|||
125972986|NCT01217073|453191386|FG003|Base Period|Lack of Efficacy|0|||
125972987|NCT01217073|453191387|FG004|Base Period|Lack of Efficacy|0|||
125972988|NCT01217073|453191388|FG005|Base Period|Lack of Efficacy|1|||
125972989|NCT01217073|453191389|FG006|Base Period|Lack of Efficacy|0|||
125972990|NCT01217073|453191390|FG007|Base Period|Lack of Efficacy|0|||
125972991|NCT01217073|453191383|FG000|Base Period|Lost to Follow-up|0|||
125972992|NCT01217073|453191384|FG001|Base Period|Lost to Follow-up|0|||
125972993|NCT01217073|453191385|FG002|Base Period|Lost to Follow-up|1|||
125972994|NCT01217073|453191386|FG003|Base Period|Lost to Follow-up|1|||
125972995|NCT01217073|453191387|FG004|Base Period|Lost to Follow-up|3|||
125972996|NCT01217073|453191388|FG005|Base Period|Lost to Follow-up|0|||
126166036|NCT00905307|453893276|FG003|Overall Study|Lost to Follow-up|0|||
125972997|NCT01217073|453191389|FG006|Base Period|Lost to Follow-up|0|||
125972998|NCT01217073|453191390|FG007|Base Period|Lost to Follow-up|0|||
125972999|NCT01217073|453191383|FG000|Base Period|Physician Decision|0|||
125973000|NCT01217073|453191384|FG001|Base Period|Physician Decision|0|||
125973001|NCT01217073|453191385|FG002|Base Period|Physician Decision|0|||
125973002|NCT01217073|453191386|FG003|Base Period|Physician Decision|0|||
125973003|NCT01217073|453191387|FG004|Base Period|Physician Decision|1|||
125973004|NCT01217073|453191388|FG005|Base Period|Physician Decision|0|||
125973005|NCT01217073|453191389|FG006|Base Period|Physician Decision|0|||
125973006|NCT01217073|453191390|FG007|Base Period|Physician Decision|0|||
125973007|NCT01217073|453191383|FG000|Base Period|Protocol Violation|1|||
125973008|NCT01217073|453191384|FG001|Base Period|Protocol Violation|0|||
125973009|NCT01217073|453191385|FG002|Base Period|Protocol Violation|0|||
125973010|NCT01217073|453191386|FG003|Base Period|Protocol Violation|0|||
125973011|NCT01217073|453191387|FG004|Base Period|Protocol Violation|1|||
125973012|NCT01217073|453191388|FG005|Base Period|Protocol Violation|2|||
125973013|NCT01217073|453191389|FG006|Base Period|Protocol Violation|0|||
125973014|NCT01217073|453191390|FG007|Base Period|Protocol Violation|0|||
125973015|NCT01217073|453191383|FG000|Base Period|Withdrawal by Subject|4|||
125973016|NCT01217073|453191384|FG001|Base Period|Withdrawal by Subject|5|||
125973017|NCT01217073|453191385|FG002|Base Period|Withdrawal by Subject|5|||
125973018|NCT01217073|453191386|FG003|Base Period|Withdrawal by Subject|1|||
125973019|NCT01217073|453191387|FG004|Base Period|Withdrawal by Subject|5|||
125973020|NCT01217073|453191388|FG005|Base Period|Withdrawal by Subject|5|||
125973021|NCT01217073|453191389|FG006|Base Period|Withdrawal by Subject|0|||
125973022|NCT01217073|453191390|FG007|Base Period|Withdrawal by Subject|0|||
125973023|NCT01217073|453191383|FG000|Extension Period|Adverse Event|0|||
125973024|NCT01217073|453191384|FG001|Extension Period|Adverse Event|0|||
125973025|NCT01217073|453191385|FG002|Extension Period|Adverse Event|0|||
125973026|NCT01217073|453191386|FG003|Extension Period|Adverse Event|0|||
125973027|NCT01217073|453191387|FG004|Extension Period|Adverse Event|0|||
125973028|NCT01217073|453191388|FG005|Extension Period|Adverse Event|0|||
125973029|NCT01217073|453191389|FG006|Extension Period|Adverse Event|19|||
125973030|NCT01217073|453191390|FG007|Extension Period|Adverse Event|5|||
125973031|NCT01217073|453191383|FG000|Extension Period|ALT/AST|0|||
125973032|NCT01217073|453191384|FG001|Extension Period|ALT/AST|0|||
126166037|NCT00905307|453893277|FG004|Overall Study|Lost to Follow-up|1|||
126166038|NCT00905307|453893278|FG005|Overall Study|Lost to Follow-up|1|||
126166039|NCT00905307|453893273|FG000|Overall Study|Adverse Event|3|||
126166040|NCT00905307|453893274|FG001|Overall Study|Adverse Event|4|||
126166041|NCT00905307|453893275|FG002|Overall Study|Adverse Event|5|||
126166042|NCT00905307|453893276|FG003|Overall Study|Adverse Event|11|||
126166043|NCT00905307|453893277|FG004|Overall Study|Adverse Event|3|||
126166044|NCT00905307|453893278|FG005|Overall Study|Adverse Event|5|||
126166045|NCT00905307|453893273|FG000|Overall Study|Withdrawal by Subject|5|||
126166046|NCT00905307|453893274|FG001|Overall Study|Withdrawal by Subject|13|||
126166047|NCT00905307|453893275|FG002|Overall Study|Withdrawal by Subject|15|||
126166048|NCT00905307|453893276|FG003|Overall Study|Withdrawal by Subject|11|||
126166049|NCT00905307|453893277|FG004|Overall Study|Withdrawal by Subject|4|||
126166050|NCT00905307|453893278|FG005|Overall Study|Withdrawal by Subject|13|||
126166051|NCT00905307|453893273|FG000|Overall Study|Protocol Violation|1|||
126166052|NCT00905307|453893274|FG001|Overall Study|Protocol Violation|0|||
126166053|NCT00905307|453893275|FG002|Overall Study|Protocol Violation|1|||
126166054|NCT00905307|453893276|FG003|Overall Study|Protocol Violation|0|||
126166055|NCT00905307|453893277|FG004|Overall Study|Protocol Violation|0|||
126166056|NCT00905307|453893278|FG005|Overall Study|Protocol Violation|0|||
126166057|NCT00905307|453893273|FG000|Overall Study|Lack of Efficacy|6|||
126166058|NCT00905307|453893274|FG001|Overall Study|Lack of Efficacy|3|||
126166059|NCT00905307|453893275|FG002|Overall Study|Lack of Efficacy|5|||
126166060|NCT00905307|453893276|FG003|Overall Study|Lack of Efficacy|4|||
126166061|NCT00905307|453893277|FG004|Overall Study|Lack of Efficacy|4|||
126166062|NCT00905307|453893278|FG005|Overall Study|Lack of Efficacy|8|||
126166063|NCT01864018|453893279|FG000|Overall Study|Ineligible|3|||
126166064|NCT01864018|453893280|FG001|Overall Study|Ineligible|1|||
126166065|NCT01912729|453893281|FG000|Overall Study|Withdrawal by Subject|0|||
125973033|NCT01217073|453191385|FG002|Extension Period|ALT/AST|0|||
125973034|NCT01217073|453191386|FG003|Extension Period|ALT/AST|0|||
125973035|NCT01217073|453191387|FG004|Extension Period|ALT/AST|0|||
125973036|NCT01217073|453191388|FG005|Extension Period|ALT/AST|0|||
125973037|NCT01217073|453191389|FG006|Extension Period|ALT/AST|2|||
125973038|NCT01217073|453191390|FG007|Extension Period|ALT/AST|0|||
126166066|NCT01912729|453893282|FG001|Overall Study|Withdrawal by Subject|1|||
126166067|NCT00740779|453893283|FG000|Overall Study|Adverse Event|4|||
126166068|NCT00740779|453893284|FG001|Overall Study|Adverse Event|6|||
126166069|NCT00740779|453893285|FG002|Overall Study|Adverse Event|3|||
125973039|NCT01217073|453191383|FG000|Extension Period|Contraindication to study medication|0|||
125973040|NCT01217073|453191384|FG001|Extension Period|Contraindication to study medication|0|||
125973041|NCT01217073|453191385|FG002|Extension Period|Contraindication to study medication|0|||
125973042|NCT01217073|453191386|FG003|Extension Period|Contraindication to study medication|0|||
125973043|NCT01217073|453191387|FG004|Extension Period|Contraindication to study medication|0|||
126166070|NCT00740779|453893283|FG000|Overall Study|Protocol Violation|1|||
126166071|NCT00740779|453893284|FG001|Overall Study|Protocol Violation|1|||
126166072|NCT00740779|453893285|FG002|Overall Study|Protocol Violation|1|||
126166073|NCT00740779|453893283|FG000|Overall Study|Lack of Efficacy|0|||
126166074|NCT00740779|453893284|FG001|Overall Study|Lack of Efficacy|0|||
126166075|NCT00740779|453893285|FG002|Overall Study|Lack of Efficacy|2|||
126166076|NCT00740779|453893283|FG000|Overall Study|Withdrawal by Subject|2|||
126166077|NCT00740779|453893284|FG001|Overall Study|Withdrawal by Subject|4|||
126166078|NCT00740779|453893285|FG002|Overall Study|Withdrawal by Subject|2|||
126166079|NCT00740779|453893283|FG000|Overall Study|Lost to Follow-up|2|||
126166080|NCT00740779|453893284|FG001|Overall Study|Lost to Follow-up|3|||
126166081|NCT00740779|453893285|FG002|Overall Study|Lost to Follow-up|5|||
126166082|NCT00850460|453893286|FG000|Overall Study|Lost to Follow-up|4|||
126166083|NCT00850460|453893287|FG001|Overall Study|Lost to Follow-up|4|||
126166084|NCT02399813|453893290|FG000|Overall Study|Progressive Disease-Radiographic|2|||
126166085|NCT02399813|453893290|FG000|Overall Study|Death|20|||
126166086|NCT02399813|453893290|FG000|Overall Study|Withdrawal by Subject|3|||
126166087|NCT02399813|453893290|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
126166088|NCT02399813|453893290|FG000|Overall Study|Lost to Follow-up|2|||
126166089|NCT02399813|453893290|FG000|Overall Study|Other than specified|5|||
126166090|NCT00988559|453893291|FG000|Overall Study|Withdrawal by Subject|1|||
126166091|NCT00988559|453893292|FG001|Overall Study|Withdrawal by Subject|1|||
126166092|NCT00988559|453893293|FG002|Overall Study|Withdrawal by Subject|0|||
126166093|NCT00988559|453893294|FG003|Overall Study|Withdrawal by Subject|1|||
126166094|NCT00988559|453893291|FG000|Overall Study|Pregnancy|0|||
126166095|NCT00988559|453893292|FG001|Overall Study|Pregnancy|1|||
126166096|NCT00988559|453893293|FG002|Overall Study|Pregnancy|1|||
126166097|NCT00988559|453893294|FG003|Overall Study|Pregnancy|0|||
126166098|NCT00988559|453893291|FG000|Overall Study|Lost to Follow-up|0|||
126166099|NCT00988559|453893292|FG001|Overall Study|Lost to Follow-up|0|||
126166100|NCT00988559|453893293|FG002|Overall Study|Lost to Follow-up|1|||
126166101|NCT00988559|453893294|FG003|Overall Study|Lost to Follow-up|0|||
126166102|NCT02224846|453893295|FG000|Period 1 (Month 3)|Adverse Event|2|||
126166103|NCT02224846|453893296|FG001|Period 1 (Month 3)|Adverse Event|1|||
126166104|NCT02224846|453893295|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
126166105|NCT02224846|453893296|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
126166106|NCT02224846|453893295|FG000|Period 1 (Month 3)|Protocol Violation|4|||
126166107|NCT02224846|453893296|FG001|Period 1 (Month 3)|Protocol Violation|8|||
126166108|NCT02224846|453893295|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
126166109|NCT02224846|453893296|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
126166110|NCT02224846|453893295|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
126166111|NCT02224846|453893296|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
126166112|NCT02224846|453893295|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
126166113|NCT02224846|453893296|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
126166114|NCT02224846|453893295|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
126166115|NCT02224846|453893296|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
126166116|NCT02224846|453893295|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
126166117|NCT02224846|453893296|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
126166118|NCT02224846|453893295|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
126166119|NCT02224846|453893296|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
126166120|NCT02224846|453893295|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
126166121|NCT02224846|453893296|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
126166122|NCT02224846|453893295|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
126166123|NCT02224846|453893296|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
126166124|NCT02224846|453893295|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
126166125|NCT02224846|453893296|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
126166126|NCT02224846|453893295|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
126166127|NCT02224846|453893296|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
126166128|NCT02224846|453893295|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
126166129|NCT02224846|453893296|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
126166130|NCT02224846|453893295|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
126166131|NCT02224846|453893296|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
126166132|NCT02224846|453893295|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
126166133|NCT02224846|453893296|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
126166134|NCT02224846|453893295|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
126166135|NCT02224846|453893296|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
126166136|NCT03280550|453893297|FG000|Overall Study|Withdrawal by Subject|2|||
125973044|NCT01217073|453191388|FG005|Extension Period|Contraindication to study medication|0|||
126166137|NCT03280550|453893298|FG001|Overall Study|Withdrawal by Subject|2|||
125973045|NCT01217073|453191389|FG006|Extension Period|Contraindication to study medication|1|||
125973046|NCT01217073|453191390|FG007|Extension Period|Contraindication to study medication|0|||
126166138|NCT03280550|453893297|FG000|Overall Study|Physician Decision|0|||
126166139|NCT03280550|453893298|FG001|Overall Study|Physician Decision|1|||
126166140|NCT02538666|453893301|FG000|Pre-Treatment|Disease progression|1|||
126166141|NCT02538666|453893302|FG001|Pre-Treatment|Disease progression|0|||
126166142|NCT02538666|453893303|FG002|Pre-Treatment|Disease progression|0|||
126166143|NCT02538666|453893301|FG000|Pre-Treatment|no longer meets study criteria|1|||
126166144|NCT02538666|453893302|FG001|Pre-Treatment|no longer meets study criteria|0|||
126166145|NCT02538666|453893303|FG002|Pre-Treatment|no longer meets study criteria|0|||
126166146|NCT02538666|453893301|FG000|Pre-Treatment|Withdrew Consent|0|||
126166147|NCT02538666|453893302|FG001|Pre-Treatment|Withdrew Consent|1|||
126166148|NCT02538666|453893303|FG002|Pre-Treatment|Withdrew Consent|1|||
126166149|NCT02538666|453893301|FG000|Treatment|Disease progression|270|||
126166150|NCT02538666|453893302|FG001|Treatment|Disease progression|227|||
126166151|NCT02538666|453893303|FG002|Treatment|Disease progression|165|||
126166152|NCT02538666|453893301|FG000|Treatment|Study drug toxicity|1|||
126166153|NCT02538666|453893302|FG001|Treatment|Study drug toxicity|29|||
126166154|NCT02538666|453893303|FG002|Treatment|Study drug toxicity|92|||
126166155|NCT02538666|453893301|FG000|Treatment|Death|0|||
126166156|NCT02538666|453893302|FG001|Treatment|Death|2|||
126166157|NCT02538666|453893303|FG002|Treatment|Death|3|||
126166158|NCT02538666|453893301|FG000|Treatment|Adverse event unrelated to study drug|8|||
126166159|NCT02538666|453893302|FG001|Treatment|Adverse event unrelated to study drug|10|||
126166160|NCT02538666|453893303|FG002|Treatment|Adverse event unrelated to study drug|15|||
126166161|NCT02538666|453893301|FG000|Treatment|Participant request to discontinue study treatment|3|||
126166162|NCT02538666|453893302|FG001|Treatment|Participant request to discontinue study treatment|6|||
126166163|NCT02538666|453893303|FG002|Treatment|Participant request to discontinue study treatment|11|||
126166164|NCT02538666|453893301|FG000|Treatment|Participant withdrew consent|2|||
126166165|NCT02538666|453893302|FG001|Treatment|Participant withdrew consent|5|||
126166166|NCT02538666|453893303|FG002|Treatment|Participant withdrew consent|3|||
126166167|NCT02538666|453893301|FG000|Treatment|Lost to Follow-up|0|||
126166168|NCT02538666|453893302|FG001|Treatment|Lost to Follow-up|1|||
126166169|NCT02538666|453893303|FG002|Treatment|Lost to Follow-up|1|||
126166170|NCT02538666|453893301|FG000|Treatment|Maximum clinical benefit|4|||
126166171|NCT02538666|453893302|FG001|Treatment|Maximum clinical benefit|3|||
126166172|NCT02538666|453893303|FG002|Treatment|Maximum clinical benefit|4|||
126166173|NCT02538666|453893301|FG000|Treatment|Poor/non-compliance|0|||
126166174|NCT02538666|453893302|FG001|Treatment|Poor/non-compliance|1|||
126166175|NCT02538666|453893303|FG002|Treatment|Poor/non-compliance|0|||
126166176|NCT02538666|453893301|FG000|Treatment|Participant no longer meets study criteria|0|||
126166177|NCT02538666|453893302|FG001|Treatment|Participant no longer meets study criteria|2|||
126166178|NCT02538666|453893303|FG002|Treatment|Participant no longer meets study criteria|0|||
126166179|NCT02538666|453893301|FG000|Treatment|Administrative reason by sponsor|0|||
126166180|NCT02538666|453893302|FG001|Treatment|Administrative reason by sponsor|0|||
126166181|NCT02538666|453893303|FG002|Treatment|Administrative reason by sponsor|1|||
126166182|NCT02538666|453893301|FG000|Treatment|Other reasons|8|||
126166183|NCT02538666|453893302|FG001|Treatment|Other reasons|15|||
126166184|NCT02538666|453893303|FG002|Treatment|Other reasons|5|||
126166185|NCT02538666|453893301|FG000|Treatment|Not reported|2|||
126166186|NCT02538666|453893302|FG001|Treatment|Not reported|2|||
126166187|NCT02538666|453893303|FG002|Treatment|Not reported|2|||
126166188|NCT03345836|453893304|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
126166189|NCT03345836|453893305|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
126166190|NCT03345836|453893306|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
126166191|NCT03345836|453893307|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
126166192|NCT03345836|453893308|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
126166193|NCT03345836|453893309|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
126166194|NCT03345836|453893304|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
126166195|NCT03345836|453893305|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
126166196|NCT03345836|453893306|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
126166197|NCT03345836|453893307|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
126166198|NCT03345836|453893308|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
126166199|NCT03345836|453893309|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
126166200|NCT03345836|453893304|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126166201|NCT03345836|453893305|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
126166202|NCT03345836|453893306|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126166203|NCT03345836|453893307|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125973047|NCT01217073|453191383|FG000|Extension Period|Creatinine/eGFR|0|||
125973048|NCT01217073|453191384|FG001|Extension Period|Creatinine/eGFR|0|||
126166204|NCT03345836|453893308|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126166205|NCT03345836|453893309|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126166206|NCT03345836|453893304|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
126166207|NCT03345836|453893305|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
126166208|NCT03345836|453893306|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
126166209|NCT03345836|453893307|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
126166210|NCT03345836|453893308|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
126166211|NCT03345836|453893309|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
126166212|NCT03345836|453893304|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
126166213|NCT03345836|453893305|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
126166214|NCT03345836|453893306|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
126166215|NCT03345836|453893307|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
126166216|NCT03345836|453893308|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
126166217|NCT03345836|453893309|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
126166218|NCT03345836|453893304|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
126166219|NCT03345836|453893305|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
126166220|NCT03345836|453893306|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
126166221|NCT03345836|453893307|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
126166222|NCT03345836|453893308|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
126166223|NCT03345836|453893309|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
126166224|NCT03345836|453893304|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
126166225|NCT03345836|453893305|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
126166226|NCT03345836|453893306|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
126166227|NCT03345836|453893307|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
126166228|NCT03345836|453893308|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
126166229|NCT03345836|453893309|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
126166230|NCT03345836|453893304|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126166231|NCT03345836|453893305|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126166232|NCT03345836|453893306|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126166233|NCT03345836|453893307|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126166234|NCT03345836|453893308|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126166235|NCT03345836|453893309|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
126166236|NCT03345836|453893304|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
126166237|NCT03345836|453893305|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
126166238|NCT03345836|453893306|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
126166239|NCT03345836|453893307|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
126166240|NCT03345836|453893308|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
126166241|NCT03345836|453893309|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
126166242|NCT03345836|453893304|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126166243|NCT03345836|453893305|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126166244|NCT03345836|453893306|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126166245|NCT03345836|453893307|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126166246|NCT03345836|453893308|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
126166247|NCT03345836|453893309|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126166248|NCT03345836|453893304|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
126166249|NCT03345836|453893305|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
126166250|NCT03345836|453893306|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
126166251|NCT03345836|453893307|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
126166252|NCT03345836|453893308|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
126166253|NCT03345836|453893309|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
126166254|NCT03510663|453893312|FG000|Overall Study|Withdrawal by Subject|0|||
126166255|NCT03510663|453893313|FG001|Overall Study|Withdrawal by Subject|1|||
126166256|NCT03510663|453893314|FG002|Overall Study|Withdrawal by Subject|0|||
126166257|NCT03510663|453893315|FG003|Overall Study|Withdrawal by Subject|0|||
126166258|NCT03510663|453893316|FG004|Overall Study|Withdrawal by Subject|0|||
126166259|NCT03510663|453893317|FG005|Overall Study|Withdrawal by Subject|0|||
126166260|NCT03510663|453893318|FG006|Overall Study|Withdrawal by Subject|0|||
126166261|NCT03510663|453893319|FG007|Overall Study|Withdrawal by Subject|0|||
126166262|NCT01555463|453893322|FG000|Treatment|Adverse Event|6|||
126166263|NCT01555463|453893323|FG001|Treatment|Adverse Event|12|||
126166264|NCT01555463|453893322|FG000|Treatment|Withdrawal by Subject|24|||
126166265|NCT01555463|453893323|FG001|Treatment|Withdrawal by Subject|36|||
126166266|NCT01555463|453893322|FG000|Treatment|Lost to Follow-up|28|||
126166267|NCT01555463|453893323|FG001|Treatment|Lost to Follow-up|23|||
126166268|NCT01555463|453893322|FG000|Treatment|Protocol Violation|4|||
126166269|NCT01555463|453893323|FG001|Treatment|Protocol Violation|5|||
126166270|NCT01555463|453893322|FG000|Treatment|Other reason|2|||
126166271|NCT01555463|453893323|FG001|Treatment|Other reason|3|||
126166272|NCT01555463|453893322|FG000|Follow up|Adverse Event|2|||
126166273|NCT01555463|453893323|FG001|Follow up|Adverse Event|5|||
126166274|NCT01555463|453893322|FG000|Follow up|Death|0|||
126166275|NCT01555463|453893323|FG001|Follow up|Death|1|||
125973049|NCT01217073|453191385|FG002|Extension Period|Creatinine/eGFR|0|||
125973050|NCT01217073|453191386|FG003|Extension Period|Creatinine/eGFR|0|||
125973051|NCT01217073|453191387|FG004|Extension Period|Creatinine/eGFR|0|||
126166276|NCT01555463|453893322|FG000|Follow up|Withdrawal by Subject|22|||
126166277|NCT01555463|453893323|FG001|Follow up|Withdrawal by Subject|22|||
125973052|NCT01217073|453191388|FG005|Extension Period|Creatinine/eGFR|0|||
126166278|NCT01555463|453893322|FG000|Follow up|Lost to Follow-up|9|||
126166279|NCT01555463|453893323|FG001|Follow up|Lost to Follow-up|10|||
126166280|NCT01555463|453893322|FG000|Follow up|Protocol Violation|2|||
126166281|NCT01555463|453893323|FG001|Follow up|Protocol Violation|4|||
126166282|NCT01555463|453893322|FG000|Follow up|Other reason|3|||
126166283|NCT01555463|453893323|FG001|Follow up|Other reason|3|||
126166284|NCT02026271|453893324|FG000|Overall Study|Adverse Event|2|||
126166285|NCT02026271|453893325|FG001|Overall Study|Adverse Event|3|||
126166286|NCT02026271|453893326|FG002|Overall Study|Adverse Event|2|||
126166287|NCT02026271|453893327|FG003|Overall Study|Adverse Event|3|||
126166288|NCT02026271|453893328|FG004|Overall Study|Adverse Event|0|||
126166289|NCT02026271|453893324|FG000|Overall Study|Withdrawal by Subject|0|||
126166290|NCT02026271|453893325|FG001|Overall Study|Withdrawal by Subject|0|||
126166291|NCT02026271|453893326|FG002|Overall Study|Withdrawal by Subject|0|||
126166292|NCT02026271|453893327|FG003|Overall Study|Withdrawal by Subject|0|||
126166293|NCT02026271|453893328|FG004|Overall Study|Withdrawal by Subject|1|||
126166294|NCT04370028|453893331|FG000|Overall Study|Withdrawal by Subject|695|||
126166295|NCT04370028|453893331|FG000|Overall Study|Protocol Violation|9|||
126166296|NCT04370028|453893331|FG000|Overall Study|Adverse Event|3|||
126166297|NCT02213198|453893334|FG000|Baseline|No show for intake|7|||
126166298|NCT02213198|453893335|FG001|Baseline|No show for intake|9|||
126166299|NCT02213198|453893334|FG000|Baseline|Withdrawal by Subject|34|||
126166300|NCT02213198|453893335|FG001|Baseline|Withdrawal by Subject|11|||
126166301|NCT02213198|453893334|FG000|Baseline|transferred out of clinic|7|||
126166302|NCT02213198|453893335|FG001|Baseline|transferred out of clinic|9|||
126166303|NCT02213198|453893334|FG000|Baseline|Lost to Follow-up|40|||
126166304|NCT02213198|453893335|FG001|Baseline|Lost to Follow-up|21|||
126166305|NCT02213198|453893334|FG000|Baseline|incarcerated,violent|0|||
126166306|NCT02213198|453893335|FG001|Baseline|incarcerated,violent|1|||
126166307|NCT02213198|453893334|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
126166308|NCT02213198|453893335|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
126166309|NCT02213198|453893334|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
126166310|NCT02213198|453893335|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
126166311|NCT02213198|453893334|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
126166312|NCT02213198|453893335|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
126166313|NCT02213198|453893334|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
126166314|NCT02213198|453893335|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
126166315|NCT02213198|453893334|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
126166316|NCT02213198|453893335|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
126166317|NCT02213198|453893334|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
126166318|NCT02213198|453893335|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
126166319|NCT05091060|453893336|FG000|Overall Study|Lost to Follow-up|1|||
126166320|NCT00496873|453893337|FG000|Overall Study|Ineligible|2|||
126166321|NCT00496873|453893337|FG000|Overall Study|Death|2|||
126166322|NCT00496873|453893337|FG000|Overall Study|Withdrawal by Subject|3|||
126166323|NCT03552549|453893341|FG000|Overall Study|Disease progression|25|||
126166324|NCT03552549|453893342|FG001|Overall Study|Disease progression|17|||
126166325|NCT03552549|453893341|FG000|Overall Study|Adverse event in first 12 months|12|||
126166326|NCT03552549|453893342|FG001|Overall Study|Adverse event in first 12 months|8|||
126166327|NCT03552549|453893341|FG000|Overall Study|Withdrawal by Subject|7|||
126166328|NCT03552549|453893342|FG001|Overall Study|Withdrawal by Subject|7|||
126166329|NCT03552549|453893341|FG000|Overall Study|Unknown (no reason provided)|4|||
126166330|NCT03552549|453893342|FG001|Overall Study|Unknown (no reason provided)|2|||
126166331|NCT03552549|453893341|FG000|Overall Study|Not in participant's best interest|2|||
126166332|NCT03552549|453893342|FG001|Overall Study|Not in participant's best interest|1|||
126166333|NCT03552549|453893341|FG000|Overall Study|Did not complete study treatment|2|||
126166334|NCT03552549|453893342|FG001|Overall Study|Did not complete study treatment|3|||
126166335|NCT03552549|453893341|FG000|Overall Study|Did not meet eligibility criteria|1|||
126166336|NCT03552549|453893342|FG001|Overall Study|Did not meet eligibility criteria|0|||
126166337|NCT03552549|453893341|FG000|Overall Study|Administrative|0|||
126166338|NCT03552549|453893342|FG001|Overall Study|Administrative|14|||
126166339|NCT01465178|453893348|FG000|Overall Study|Withdrawal by Subject|1|||
126166340|NCT01465178|453893349|FG001|Overall Study|Withdrawal by Subject|0|||
126166341|NCT00527111|453893350|FG000|Overall Study|Adverse Event|14|||
126166342|NCT00527111|453893351|FG001|Overall Study|Adverse Event|13|||
126166343|NCT00527111|453893350|FG000|Overall Study|Death|0|||
126166344|NCT00527111|453893351|FG001|Overall Study|Death|1|||
126166345|NCT00527111|453893350|FG000|Overall Study|Investigator Request|2|||
126166346|NCT00527111|453893351|FG001|Overall Study|Investigator Request|1|||
126166347|NCT00527111|453893350|FG000|Overall Study|Patient Request|2|||
126166348|NCT00527111|453893351|FG001|Overall Study|Patient Request|5|||
126166349|NCT00527111|453893350|FG000|Overall Study|Other|2|||
126166350|NCT00527111|453893351|FG001|Overall Study|Other|2|||
126166351|NCT02689219|453893354|FG000|Overall Study|Death|1|||
126166352|NCT02689219|453893355|FG001|Overall Study|Death|1|||
126166353|NCT02689219|453893354|FG000|Overall Study|Disease Progression|10|||
126166354|NCT02689219|453893355|FG001|Overall Study|Disease Progression|6|||
126166355|NCT01477892|453893356|FG000|Overall Study|Withdrawal by Subject|0|||
126166356|NCT01477892|453893357|FG001|Overall Study|Withdrawal by Subject|2|||
126166357|NCT01921257|453893358|FG000|Overall Study|Adverse Event|1|||
126166358|NCT01921257|453893358|FG000|Overall Study|Protocol Violation|1|||
126166359|NCT01921257|453893358|FG000|Overall Study|Withdrawal by Subject|1|||
126166360|NCT00777491|453893359|FG000|Overall Study|Protocol Violation|0|||
126166361|NCT00777491|453893360|FG001|Overall Study|Protocol Violation|2|||
126166362|NCT00777491|453893359|FG000|Overall Study|Did not receive any protocol treatment|2|||
126166363|NCT00777491|453893360|FG001|Overall Study|Did not receive any protocol treatment|0|||
126166364|NCT01745393|453893362|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
126166365|NCT01745393|453893363|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
126166366|NCT01745393|453893362|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
126166367|NCT01745393|453893363|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
126166368|NCT01745393|453893362|FG000|12-month Follow-up|Lost to Follow-up|6|||
126166369|NCT01745393|453893363|FG001|12-month Follow-up|Lost to Follow-up|5|||
126166370|NCT00471445|453893364|FG000|Overall Study|Withdrawal by Subject|1|||
126166371|NCT00471445|453893365|FG001|Overall Study|Withdrawal by Subject|1|||
126166372|NCT00471445|453893364|FG000|Overall Study|Ineligible|1|||
126166373|NCT00471445|453893365|FG001|Overall Study|Ineligible|0|||
126166374|NCT00471445|453893364|FG000|Overall Study|Protocol Violation|0|||
126166375|NCT00471445|453893365|FG001|Overall Study|Protocol Violation|1|||
126166376|NCT03591146|453893366|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
126166377|NCT03591146|453893367|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
126166378|NCT03591146|453893368|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
126166379|NCT03591146|453893369|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
126166380|NCT03591146|453893370|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
126166381|NCT03591146|453893366|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
126166382|NCT03591146|453893367|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
126166383|NCT03591146|453893368|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
126166384|NCT03591146|453893369|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
126166385|NCT03591146|453893370|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
126166386|NCT03591146|453893366|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
126166387|NCT03591146|453893367|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
126166388|NCT03591146|453893368|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
126166389|NCT03591146|453893369|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
126166390|NCT03591146|453893370|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
126166391|NCT03591146|453893366|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
126166392|NCT03591146|453893367|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
126166393|NCT03591146|453893368|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
126166394|NCT03591146|453893369|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
126166395|NCT03591146|453893370|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
126166396|NCT04737031|453893373|FG000|Overall Study|Patients who did not have a treatment visit|0|||
126166397|NCT04737031|453893374|FG001|Overall Study|Patients who did not have a treatment visit|31|||
126166398|NCT04737031|453893375|FG002|Overall Study|Patients who did not have a treatment visit|93|||
126166399|NCT04737031|453893376|FG003|Overall Study|Patients who did not have a treatment visit|227|||
126166400|NCT01468909|453893377|FG000|Overall Study|Never Treated|2|||
126166401|NCT01468909|453893378|FG001|Overall Study|Never Treated|2|||
126166402|NCT00905021|453893379|FG000|Overall Study|Adverse Event|2|||
126166403|NCT01511419|453893380|FG000|Dose 2|Physician Decision|1|||
126166404|NCT01511419|453893381|FG001|Dose 2|Physician Decision|0|||
126166405|NCT00786838|453893382|FG000|Overall Study|Physician Decision|4|||
126166406|NCT00786838|453893382|FG000|Overall Study|Death|4|||
126166407|NCT00786838|453893382|FG000|Overall Study|Adverse Event|6|||
126166408|NCT00786838|453893382|FG000|Overall Study|Progressive disease|31|||
126166409|NCT00786838|453893382|FG000|Overall Study|Withdrawal by Subject|4|||
126166410|NCT04594239|453893383|FG000|Overall Study|Withdrawal by Subject|3|||
126166411|NCT04594239|453893384|FG001|Overall Study|Withdrawal by Subject|4|||
126166412|NCT04594239|453893385|FG002|Overall Study|Withdrawal by Subject|2|||
126166413|NCT04594239|453893386|FG003|Overall Study|Withdrawal by Subject|4|||
126166414|NCT04594239|453893383|FG000|Overall Study|Lost to Follow-up|8|||
126166415|NCT04594239|453893384|FG001|Overall Study|Lost to Follow-up|5|||
126166416|NCT04594239|453893385|FG002|Overall Study|Lost to Follow-up|4|||
126166417|NCT04594239|453893386|FG003|Overall Study|Lost to Follow-up|6|||
126166418|NCT04594239|453893383|FG000|Overall Study|Subject relocated|0|||
126166419|NCT04594239|453893384|FG001|Overall Study|Subject relocated|0|||
126166420|NCT04594239|453893385|FG002|Overall Study|Subject relocated|0|||
126166421|NCT04594239|453893386|FG003|Overall Study|Subject relocated|1|||
126166422|NCT00833248|453894950|FG000|Overall Study|Adverse Event|3|||
126166423|NCT00833248|453894951|FG001|Overall Study|Adverse Event|0|||
126166424|NCT00833248|453894950|FG000|Overall Study|Protocol Violation|1|||
126166425|NCT00833248|453894951|FG001|Overall Study|Protocol Violation|2|||
126166426|NCT00833248|453894950|FG000|Overall Study|Withdrawal by Subject|0|||
125973053|NCT01217073|453191389|FG006|Extension Period|Creatinine/eGFR|11|||
126166427|NCT00833248|453894951|FG001|Overall Study|Withdrawal by Subject|1|||
126166428|NCT01718509|453894952|FG000|Overall Study|Lost to Follow-up|18|||
126166429|NCT01718509|453894953|FG001|Overall Study|Lost to Follow-up|15|||
126166430|NCT01718509|453894952|FG000|Overall Study|Withdrawal by Subject|7|||
126166431|NCT01718509|453894953|FG001|Overall Study|Withdrawal by Subject|13|||
126166432|NCT01718509|453894952|FG000|Overall Study|Adverse Event|5|||
126166433|NCT01718509|453894953|FG001|Overall Study|Adverse Event|7|||
126166434|NCT01718509|453894952|FG000|Overall Study|Other|13|||
126166435|NCT01718509|453894953|FG001|Overall Study|Other|11|||
126166436|NCT01718509|453894952|FG000|Overall Study|Protocol Violation|4|||
126166437|NCT01718509|453894953|FG001|Overall Study|Protocol Violation|2|||
126166438|NCT01718509|453894952|FG000|Overall Study|Lack of Efficacy|1|||
126166439|NCT01718509|453894953|FG001|Overall Study|Lack of Efficacy|0|||
126166440|NCT00643487|453894959|FG000|Overall Study|Technical difficulty|3|||
126166441|NCT00879814|453894961|FG000|Overall Study|Adverse Event|0|||
126166442|NCT00879814|453894962|FG001|Overall Study|Adverse Event|1|||
126166443|NCT00879814|453894963|FG002|Overall Study|Adverse Event|0|||
126166444|NCT00879814|453894964|FG003|Overall Study|Adverse Event|0|||
126166445|NCT00879814|453894961|FG000|Overall Study|Lost to Follow-up|1|||
126166446|NCT00879814|453894962|FG001|Overall Study|Lost to Follow-up|0|||
126166447|NCT00879814|453894963|FG002|Overall Study|Lost to Follow-up|0|||
126166448|NCT00879814|453894964|FG003|Overall Study|Lost to Follow-up|2|||
126166449|NCT00879814|453894961|FG000|Overall Study|Participant Failed to Return|0|||
126166450|NCT00879814|453894962|FG001|Overall Study|Participant Failed to Return|0|||
126166451|NCT00879814|453894963|FG002|Overall Study|Participant Failed to Return|0|||
126166452|NCT00879814|453894964|FG003|Overall Study|Participant Failed to Return|1|||
126166453|NCT00879814|453894961|FG000|Overall Study|Withdrawal by Subject|3|||
126166454|NCT00879814|453894962|FG001|Overall Study|Withdrawal by Subject|1|||
126166455|NCT00879814|453894963|FG002|Overall Study|Withdrawal by Subject|1|||
126166456|NCT00879814|453894964|FG003|Overall Study|Withdrawal by Subject|2|||
126166457|NCT00879814|453894961|FG000|Overall Study|Physician Decision|0|||
126166458|NCT00879814|453894962|FG001|Overall Study|Physician Decision|0|||
126166459|NCT00879814|453894963|FG002|Overall Study|Physician Decision|1|||
126166460|NCT00879814|453894964|FG003|Overall Study|Physician Decision|0|||
126166461|NCT00879814|453894961|FG000|Overall Study|Other|0|||
126166462|NCT00879814|453894962|FG001|Overall Study|Other|0|||
126166463|NCT00879814|453894963|FG002|Overall Study|Other|1|||
126166464|NCT00879814|453894964|FG003|Overall Study|Other|0|||
126166465|NCT01219959|453894975|FG000|Overall Study|Adverse Event|6|||
126166466|NCT01219959|453894976|FG001|Overall Study|Adverse Event|14|||
126166467|NCT01219959|453894975|FG000|Overall Study|Physician Decision|0|||
126166468|NCT01219959|453894976|FG001|Overall Study|Physician Decision|4|||
126166469|NCT01219959|453894975|FG000|Overall Study|Withdrawal by Subject|0|||
126166470|NCT01219959|453894976|FG001|Overall Study|Withdrawal by Subject|2|||
126166471|NCT01219959|453894975|FG000|Overall Study|Renal Transplantation|0|||
126166472|NCT01219959|453894976|FG001|Overall Study|Renal Transplantation|3|||
126166473|NCT01219959|453894975|FG000|Overall Study|Other|1|||
126166474|NCT01219959|453894976|FG001|Overall Study|Other|0|||
126166475|NCT01728584|453894977|FG000|Overall Study|Adverse Event|1|||
126166476|NCT01728584|453894978|FG001|Overall Study|Adverse Event|0|||
126166477|NCT01728584|453894979|FG002|Overall Study|Adverse Event|0|||
126166478|NCT01728584|453894980|FG003|Overall Study|Adverse Event|0|||
126166479|NCT01728584|453894977|FG000|Overall Study|Physician Decision|4|||
126166480|NCT01728584|453894978|FG001|Overall Study|Physician Decision|0|||
126166481|NCT01728584|453894979|FG002|Overall Study|Physician Decision|1|||
126166482|NCT01728584|453894980|FG003|Overall Study|Physician Decision|0|||
126166483|NCT01728584|453894977|FG000|Overall Study|Withdrawal by Subject|1|||
126166484|NCT01728584|453894978|FG001|Overall Study|Withdrawal by Subject|0|||
126166485|NCT01728584|453894979|FG002|Overall Study|Withdrawal by Subject|0|||
126166486|NCT01728584|453894980|FG003|Overall Study|Withdrawal by Subject|0|||
125973054|NCT01217073|453191390|FG007|Extension Period|Creatinine/eGFR|1|||
126166487|NCT01728584|453894977|FG000|Overall Study|Screen failure|1|||
125973055|NCT01217073|453191383|FG000|Extension Period|Death|0|||
126166488|NCT01728584|453894978|FG001|Overall Study|Screen failure|0|||
126166489|NCT01728584|453894979|FG002|Overall Study|Screen failure|0|||
126166490|NCT01728584|453894980|FG003|Overall Study|Screen failure|0|||
126166491|NCT01728584|453894977|FG000|Overall Study|Other reason (not specified)|1|||
126166492|NCT01728584|453894978|FG001|Overall Study|Other reason (not specified)|0|||
126166493|NCT01728584|453894979|FG002|Overall Study|Other reason (not specified)|0|||
126166494|NCT01728584|453894980|FG003|Overall Study|Other reason (not specified)|1|||
126166495|NCT02935634|453894981|FG000|Randomization|Participant withdrew consent|0|||
126166496|NCT02935634|453894982|FG001|Randomization|Participant withdrew consent|1|||
126166497|NCT02935634|453894983|FG002|Randomization|Participant withdrew consent|0|||
126166498|NCT02935634|453894984|FG003|Randomization|Participant withdrew consent|0|||
126166499|NCT02935634|453894985|FG004|Randomization|Participant withdrew consent|0|||
126166500|NCT02935634|453894986|FG005|Randomization|Participant withdrew consent|0|||
126166501|NCT02935634|453894981|FG000|Randomization|Death|2|||
126166502|NCT02935634|453894982|FG001|Randomization|Death|1|||
126166503|NCT02935634|453894983|FG002|Randomization|Death|1|||
126166504|NCT02935634|453894984|FG003|Randomization|Death|0|||
126166505|NCT02935634|453894985|FG004|Randomization|Death|0|||
126166506|NCT02935634|453894986|FG005|Randomization|Death|0|||
126166507|NCT02935634|453894981|FG000|Randomization|Other reasons|0|||
126166508|NCT02935634|453894982|FG001|Randomization|Other reasons|2|||
126166509|NCT02935634|453894983|FG002|Randomization|Other reasons|2|||
126166510|NCT02935634|453894984|FG003|Randomization|Other reasons|0|||
126166511|NCT02935634|453894985|FG004|Randomization|Other reasons|0|||
126166512|NCT02935634|453894986|FG005|Randomization|Other reasons|0|||
126166513|NCT02935634|453894981|FG000|Treatment: Track 1|Disease progression|15|||
126166514|NCT02935634|453894982|FG001|Treatment: Track 1|Disease progression|17|||
126166515|NCT02935634|453894983|FG002|Treatment: Track 1|Disease progression|28|||
126166516|NCT02935634|453894984|FG003|Treatment: Track 1|Disease progression|4|||
126166517|NCT02935634|453894985|FG004|Treatment: Track 1|Disease progression|6|||
126166518|NCT02935634|453894986|FG005|Treatment: Track 1|Disease progression|2|||
126166519|NCT02935634|453894981|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
126166520|NCT02935634|453894982|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
126166521|NCT02935634|453894983|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
126166522|NCT02935634|453894984|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
126166523|NCT02935634|453894985|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
126166524|NCT02935634|453894986|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
126166525|NCT02935634|453894981|FG000|Treatment: Track 1|Lost to Follow-up|1|||
126166526|NCT02935634|453894982|FG001|Treatment: Track 1|Lost to Follow-up|0|||
126166527|NCT02935634|453894983|FG002|Treatment: Track 1|Lost to Follow-up|0|||
126166528|NCT02935634|453894984|FG003|Treatment: Track 1|Lost to Follow-up|0|||
126166529|NCT02935634|453894985|FG004|Treatment: Track 1|Lost to Follow-up|0|||
126166530|NCT02935634|453894986|FG005|Treatment: Track 1|Lost to Follow-up|0|||
126166531|NCT02935634|453894981|FG000|Treatment: Track 1|Study drug toxicity|2|||
126166532|NCT02935634|453894982|FG001|Treatment: Track 1|Study drug toxicity|1|||
126166533|NCT02935634|453894983|FG002|Treatment: Track 1|Study drug toxicity|3|||
126166534|NCT02935634|453894984|FG003|Treatment: Track 1|Study drug toxicity|0|||
126166535|NCT02935634|453894985|FG004|Treatment: Track 1|Study drug toxicity|0|||
126166536|NCT02935634|453894986|FG005|Treatment: Track 1|Study drug toxicity|1|||
126166537|NCT02935634|453894981|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
126166538|NCT02935634|453894982|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
126166539|NCT02935634|453894983|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
126166540|NCT02935634|453894984|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
126166541|NCT02935634|453894985|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
126166542|NCT02935634|453894986|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
126166543|NCT02935634|453894981|FG000|Treatment: Track 1|Participant withdrew consent|2|||
126166544|NCT02935634|453894982|FG001|Treatment: Track 1|Participant withdrew consent|0|||
126166545|NCT02935634|453894983|FG002|Treatment: Track 1|Participant withdrew consent|1|||
126166546|NCT02935634|453894984|FG003|Treatment: Track 1|Participant withdrew consent|0|||
126166547|NCT02935634|453894985|FG004|Treatment: Track 1|Participant withdrew consent|1|||
126166548|NCT02935634|453894986|FG005|Treatment: Track 1|Participant withdrew consent|0|||
126166549|NCT02935634|453894981|FG000|Treatment: Track 1|Other reasons|0|||
126166550|NCT02935634|453894982|FG001|Treatment: Track 1|Other reasons|0|||
126166551|NCT02935634|453894983|FG002|Treatment: Track 1|Other reasons|2|||
126166552|NCT02935634|453894984|FG003|Treatment: Track 1|Other reasons|0|||
126166553|NCT02935634|453894985|FG004|Treatment: Track 1|Other reasons|0|||
126166554|NCT02935634|453894986|FG005|Treatment: Track 1|Other reasons|0|||
126166555|NCT02935634|453894981|FG000|Treatment: Track 2|Disease progression|13|||
126166556|NCT02935634|453894982|FG001|Treatment: Track 2|Disease progression|26|||
126166557|NCT02935634|453894983|FG002|Treatment: Track 2|Disease progression|20|||
126166558|NCT02935634|453894984|FG003|Treatment: Track 2|Disease progression|5|||
126166559|NCT02935634|453894985|FG004|Treatment: Track 2|Disease progression|1|||
126166560|NCT02935634|453894986|FG005|Treatment: Track 2|Disease progression|4|||
126166561|NCT02935634|453894981|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
126166562|NCT02935634|453894982|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
126166563|NCT02935634|453894983|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
126166564|NCT02935634|453894984|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
126166565|NCT02935634|453894985|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
126166566|NCT02935634|453894986|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
126166567|NCT02935634|453894981|FG000|Treatment: Track 2|Study drug toxicity|7|||
126166568|NCT02935634|453894982|FG001|Treatment: Track 2|Study drug toxicity|3|||
126166569|NCT02935634|453894983|FG002|Treatment: Track 2|Study drug toxicity|0|||
126166570|NCT02935634|453894984|FG003|Treatment: Track 2|Study drug toxicity|0|||
126166571|NCT02935634|453894985|FG004|Treatment: Track 2|Study drug toxicity|0|||
126166572|NCT02935634|453894986|FG005|Treatment: Track 2|Study drug toxicity|0|||
126166573|NCT02935634|453894981|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
126166574|NCT02935634|453894982|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
126166575|NCT02935634|453894983|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
126166576|NCT02935634|453894984|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
126166577|NCT02935634|453894985|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
126166578|NCT02935634|453894986|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
126166579|NCT02935634|453894981|FG000|Treatment: Track 2|Participant withdrew consent|0|||
126166580|NCT02935634|453894982|FG001|Treatment: Track 2|Participant withdrew consent|1|||
126166581|NCT02935634|453894983|FG002|Treatment: Track 2|Participant withdrew consent|1|||
126166582|NCT02935634|453894984|FG003|Treatment: Track 2|Participant withdrew consent|0|||
126166583|NCT02935634|453894985|FG004|Treatment: Track 2|Participant withdrew consent|1|||
126166584|NCT02935634|453894986|FG005|Treatment: Track 2|Participant withdrew consent|0|||
126166585|NCT05906732|453894987|FG000|Overall Study|Withdrawal by Subject|1|||
126166586|NCT05906732|453894988|FG001|Overall Study|Withdrawal by Subject|0|||
126166587|NCT05906732|453894989|FG002|Overall Study|Withdrawal by Subject|0|||
126166588|NCT05906732|453894990|FG003|Overall Study|Withdrawal by Subject|0|||
126166589|NCT05906732|453894987|FG000|Overall Study|Physician Decision|2|||
126166590|NCT05906732|453894988|FG001|Overall Study|Physician Decision|4|||
126166591|NCT05906732|453894989|FG002|Overall Study|Physician Decision|0|||
126166592|NCT05906732|453894990|FG003|Overall Study|Physician Decision|0|||
126166593|NCT03656926|453895000|FG000|Overall Study|Adverse Event|5|||
126166594|NCT03656926|453895001|FG001|Overall Study|Adverse Event|4|||
126166595|NCT03656926|453895000|FG000|Overall Study|Withdrawal by Subject|7|||
126166596|NCT03656926|453895001|FG001|Overall Study|Withdrawal by Subject|2|||
126166597|NCT03656926|453895000|FG000|Overall Study|Screen fail after randomization|1|||
126166598|NCT03656926|453895001|FG001|Overall Study|Screen fail after randomization|0|||
126166599|NCT03656926|453895000|FG000|Overall Study|PI decision due to patient condition|1|||
126166600|NCT03656926|453895001|FG001|Overall Study|PI decision due to patient condition|0|||
126166601|NCT03656926|453895000|FG000|Overall Study|Patient unresponsiveness|1|||
126166602|NCT03656926|453895001|FG001|Overall Study|Patient unresponsiveness|0|||
126166603|NCT05610176|453895002|FG000|Overall Study|Death|6|||
126166604|NCT00506077|453895003|FG000|Treatment Period 1|Adverse Event|2|||
126166605|NCT00506077|453895004|FG001|Treatment Period 1|Adverse Event|1|||
126166606|NCT00506077|453895003|FG000|Treatment Period 1|Lost to Follow-up|0|||
126166607|NCT00506077|453895004|FG001|Treatment Period 1|Lost to Follow-up|2|||
126166608|NCT00506077|453895003|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126166609|NCT00506077|453895004|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126166610|NCT00506077|453895003|FG000|Treatment Period 2|Adverse Event|0|||
126166611|NCT00506077|453895004|FG001|Treatment Period 2|Adverse Event|1|||
126166612|NCT00506077|453895003|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126166613|NCT00506077|453895004|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126166614|NCT01727713|453895008|FG000|Overall Study|Lost to Follow-up|5|||
126166615|NCT01727713|453895008|FG000|Overall Study|Adverse Event|10|||
126166616|NCT01727713|453895008|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
126166617|NCT01727713|453895008|FG000|Overall Study|Withdrawal by Subject|13|||
126166618|NCT01727713|453895008|FG000|Overall Study|Protocol Deviation|2|||
126166619|NCT00471536|453895009|FG000|Overall Study|Withdrawal by Subject|1|||
126166620|NCT00515008|453895014|FG000|Overall Study|Lost to Follow-up|1|||
126166621|NCT00515008|453895015|FG001|Overall Study|Lost to Follow-up|0|||
126166622|NCT00515008|453895014|FG000|Overall Study|Declined|0|||
126166623|NCT00515008|453895015|FG001|Overall Study|Declined|3|||
126166624|NCT00515008|453895014|FG000|Overall Study|Left the Boston Area|1|||
126166625|NCT00515008|453895015|FG001|Overall Study|Left the Boston Area|1|||
126166626|NCT00515008|453895014|FG000|Overall Study|Scheduling conflict|1|||
126166627|NCT00515008|453895015|FG001|Overall Study|Scheduling conflict|0|||
126166628|NCT01915849|453895018|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
126166629|NCT01915849|453895019|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
126166630|NCT01915849|453895020|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
126166631|NCT01915849|453895021|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
126166632|NCT01915849|453895018|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
126166633|NCT01915849|453895019|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126166634|NCT01915849|453895020|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126166635|NCT01915849|453895021|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126166636|NCT01798706|453895022|FG000|Overall Study|Adverse Event|15|||
126166637|NCT01798706|453895023|FG001|Overall Study|Adverse Event|10|||
126166638|NCT01798706|453895022|FG000|Overall Study|Lack of Efficacy|0|||
125973056|NCT01217073|453191384|FG001|Extension Period|Death|0|||
125973057|NCT01217073|453191385|FG002|Extension Period|Death|0|||
125973058|NCT01217073|453191386|FG003|Extension Period|Death|0|||
126166639|NCT01798706|453895023|FG001|Overall Study|Lack of Efficacy|2|||
126166640|NCT01798706|453895022|FG000|Overall Study|Poor compliance to protocol|1|||
126166641|NCT01798706|453895023|FG001|Overall Study|Poor compliance to protocol|0|||
126166642|NCT01798706|453895022|FG000|Overall Study|Other than specified above|5|||
126166643|NCT01798706|453895023|FG001|Overall Study|Other than specified above|9|||
126166644|NCT02775864|453895024|FG000|Overall Study|Data ended end of 2010|1764|||
126166645|NCT02775864|453895025|FG001|Overall Study|Data ended end of 2010|2880|||
126200113|NCT02394028|454017879|FG002|Induction Phase|Lack of Efficacy|2|||
125973059|NCT01217073|453191387|FG004|Extension Period|Death|0|||
125973060|NCT01217073|453191388|FG005|Extension Period|Death|0|||
126166646|NCT02775864|453895026|FG002|Overall Study|Data ended end of 2010|1140|||
126166647|NCT02775864|453895027|FG003|Overall Study|Data ended end of 2010|1194|||
126166648|NCT02775864|453895024|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
126166649|NCT02775864|453895025|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
126166650|NCT02775864|453895026|FG002|Overall Study|Medicaid eligibility discontinued|720|||
126166651|NCT02775864|453895027|FG003|Overall Study|Medicaid eligibility discontinued|890|||
126166652|NCT03238235|453895028|FG000|Overall Study|Adverse Event|2|||
126166653|NCT03238235|453895029|FG001|Overall Study|Adverse Event|0|||
126166654|NCT03238235|453895028|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
126166655|NCT03238235|453895029|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
126166656|NCT05896761|453895030|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
126166657|NCT05896761|453895031|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
126166658|NCT05896761|453895030|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
126166659|NCT05896761|453895031|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
126166660|NCT02739594|453895032|FG000|Overall Study|Undesired Event|3|||
126166661|NCT02739594|453895033|FG001|Overall Study|Undesired Event|4|||
126166662|NCT02739594|453895032|FG000|Overall Study|Violation of Eligibility Criteria|1|||
126166663|NCT02739594|453895033|FG001|Overall Study|Violation of Eligibility Criteria|2|||
126166664|NCT02739594|453895032|FG000|Overall Study|Protocol Violation|5|||
126166665|NCT02739594|453895033|FG001|Overall Study|Protocol Violation|6|||
126166666|NCT02739594|453895032|FG000|Overall Study|Death|4|||
126166667|NCT02739594|453895033|FG001|Overall Study|Death|2|||
126166668|NCT02739594|453895032|FG000|Overall Study|Renal Insufficiency|4|||
126166669|NCT02739594|453895033|FG001|Overall Study|Renal Insufficiency|6|||
126166670|NCT02739594|453895032|FG000|Overall Study|Administrative Reasons|1|||
126166671|NCT02739594|453895033|FG001|Overall Study|Administrative Reasons|3|||
126166672|NCT02739594|453895032|FG000|Overall Study|Withdrawal by Subject|1|||
126166673|NCT02739594|453895033|FG001|Overall Study|Withdrawal by Subject|1|||
126166674|NCT02739594|453895032|FG000|Overall Study|Lost to Follow-up|0|||
126166675|NCT02739594|453895033|FG001|Overall Study|Lost to Follow-up|1|||
126166676|NCT02739594|453895032|FG000|Overall Study|Elevated Serum Creatinine|0|||
126166677|NCT02739594|453895033|FG001|Overall Study|Elevated Serum Creatinine|1|||
126166678|NCT02739594|453895032|FG000|Overall Study|Other|6|||
126166679|NCT02739594|453895033|FG001|Overall Study|Other|2|||
126166680|NCT03827473|453895036|FG000|Overall Study|Withdrawal by Subject|1|||
126166681|NCT03827473|453895037|FG001|Overall Study|Withdrawal by Subject|0|||
126166682|NCT00875017|453895038|FG000|First Intervention|Withdrawal by Subject|1|||
126166683|NCT00875017|453895039|FG001|First Intervention|Withdrawal by Subject|0|||
126166684|NCT00875017|453895040|FG002|First Intervention|Withdrawal by Subject|1|||
126166685|NCT00875017|453895041|FG003|First Intervention|Withdrawal by Subject|0|||
126166686|NCT00875017|453895042|FG004|First Intervention|Withdrawal by Subject|0|||
126166687|NCT00875017|453895043|FG005|First Intervention|Withdrawal by Subject|0|||
126166688|NCT00875017|453895038|FG000|First Intervention|Adverse Event|0|||
126166689|NCT00875017|453895039|FG001|First Intervention|Adverse Event|0|||
126166690|NCT00875017|453895040|FG002|First Intervention|Adverse Event|0|||
126166691|NCT00875017|453895041|FG003|First Intervention|Adverse Event|1|||
126166692|NCT00875017|453895042|FG004|First Intervention|Adverse Event|0|||
126166693|NCT00875017|453895043|FG005|First Intervention|Adverse Event|0|||
126166694|NCT00875017|453895038|FG000|First Intervention|Problems collecting rectal effluent|1|||
126166695|NCT00875017|453895039|FG001|First Intervention|Problems collecting rectal effluent|0|||
126166696|NCT00875017|453895040|FG002|First Intervention|Problems collecting rectal effluent|0|||
126166697|NCT00875017|453895041|FG003|First Intervention|Problems collecting rectal effluent|0|||
126166698|NCT00875017|453895042|FG004|First Intervention|Problems collecting rectal effluent|0|||
126166699|NCT00875017|453895043|FG005|First Intervention|Problems collecting rectal effluent|0|||
126166700|NCT00875017|453895038|FG000|First Intervention|Intolerance to nasogastric tube|0|||
126166701|NCT00875017|453895039|FG001|First Intervention|Intolerance to nasogastric tube|0|||
126166702|NCT00875017|453895040|FG002|First Intervention|Intolerance to nasogastric tube|0|||
126166703|NCT00875017|453895041|FG003|First Intervention|Intolerance to nasogastric tube|0|||
126166704|NCT00875017|453895042|FG004|First Intervention|Intolerance to nasogastric tube|1|||
126166705|NCT00875017|453895043|FG005|First Intervention|Intolerance to nasogastric tube|0|||
126166706|NCT00875017|453895038|FG000|Washout|Problem collecting rectal effluent|0|||
125973061|NCT01217073|453191389|FG006|Extension Period|Death|1|||
125973062|NCT01217073|453191390|FG007|Extension Period|Death|0|||
125973063|NCT01217073|453191383|FG000|Extension Period|Excluded medication|0|||
125973064|NCT01217073|453191384|FG001|Extension Period|Excluded medication|0|||
126166707|NCT00875017|453895039|FG001|Washout|Problem collecting rectal effluent|0|||
126166708|NCT00875017|453895040|FG002|Washout|Problem collecting rectal effluent|1|||
126166709|NCT00875017|453895041|FG003|Washout|Problem collecting rectal effluent|0|||
126166710|NCT00875017|453895042|FG004|Washout|Problem collecting rectal effluent|0|||
126166711|NCT00875017|453895043|FG005|Washout|Problem collecting rectal effluent|0|||
126166712|NCT00875017|453895038|FG000|Second Intervention|Adverse Event|0|||
126166713|NCT00875017|453895039|FG001|Second Intervention|Adverse Event|0|||
126166714|NCT00875017|453895040|FG002|Second Intervention|Adverse Event|0|||
126166715|NCT00875017|453895041|FG003|Second Intervention|Adverse Event|1|||
126166716|NCT00875017|453895042|FG004|Second Intervention|Adverse Event|0|||
126166717|NCT00875017|453895043|FG005|Second Intervention|Adverse Event|0|||
126166718|NCT00875017|453895038|FG000|Washout|Problems collecting rectal effluent|0|||
126166719|NCT00875017|453895039|FG001|Washout|Problems collecting rectal effluent|1|||
126166720|NCT00875017|453895040|FG002|Washout|Problems collecting rectal effluent|0|||
126166721|NCT00875017|453895041|FG003|Washout|Problems collecting rectal effluent|0|||
126166722|NCT00875017|453895042|FG004|Washout|Problems collecting rectal effluent|0|||
126166723|NCT00875017|453895043|FG005|Washout|Problems collecting rectal effluent|0|||
126166724|NCT00875017|453895038|FG000|Third Intervention|Adverse Event|0|||
126166725|NCT00875017|453895039|FG001|Third Intervention|Adverse Event|1|||
126166726|NCT00875017|453895040|FG002|Third Intervention|Adverse Event|1|||
126166727|NCT00875017|453895041|FG003|Third Intervention|Adverse Event|0|||
126166728|NCT00875017|453895042|FG004|Third Intervention|Adverse Event|0|||
126166729|NCT00875017|453895043|FG005|Third Intervention|Adverse Event|0|||
126166730|NCT00875017|453895038|FG000|Washout|Withdrawal by Subject|0|||
126166731|NCT00875017|453895039|FG001|Washout|Withdrawal by Subject|0|||
126166732|NCT00875017|453895040|FG002|Washout|Withdrawal by Subject|0|||
126166733|NCT00875017|453895041|FG003|Washout|Withdrawal by Subject|0|||
126166734|NCT00875017|453895042|FG004|Washout|Withdrawal by Subject|1|||
126166735|NCT00875017|453895043|FG005|Washout|Withdrawal by Subject|0|||
126166736|NCT00875017|453895038|FG000|Fourth Intervention|Inability to comply with fasting|0|||
126166737|NCT00875017|453895039|FG001|Fourth Intervention|Inability to comply with fasting|0|||
126166738|NCT00875017|453895040|FG002|Fourth Intervention|Inability to comply with fasting|0|||
126166739|NCT00875017|453895041|FG003|Fourth Intervention|Inability to comply with fasting|0|||
126166740|NCT00875017|453895042|FG004|Fourth Intervention|Inability to comply with fasting|0|||
126166741|NCT00875017|453895043|FG005|Fourth Intervention|Inability to comply with fasting|1|||
126166742|NCT05515601|453895047|FG000|Overall Study|Withdrawal by Subject|1|||
126166743|NCT05515601|453895048|FG001|Overall Study|Withdrawal by Subject|3|||
126166744|NCT05515601|453895049|FG002|Overall Study|Withdrawal by Subject|2|||
126166745|NCT05515601|453895050|FG003|Overall Study|Withdrawal by Subject|1|||
126166746|NCT05515601|453895051|FG004|Overall Study|Withdrawal by Subject|1|||
126166747|NCT05515601|453895052|FG005|Overall Study|Withdrawal by Subject|1|||
126166748|NCT05515601|453895047|FG000|Overall Study|Lost to Follow-up|0|||
126166749|NCT05515601|453895048|FG001|Overall Study|Lost to Follow-up|0|||
126166750|NCT05515601|453895049|FG002|Overall Study|Lost to Follow-up|0|||
126166751|NCT05515601|453895050|FG003|Overall Study|Lost to Follow-up|0|||
126166752|NCT05515601|453895051|FG004|Overall Study|Lost to Follow-up|1|||
126166753|NCT05515601|453895052|FG005|Overall Study|Lost to Follow-up|0|||
126166754|NCT00364845|453895053|FG000|Overall Study|Adverse Event|1|||
126166755|NCT00364845|453895054|FG001|Overall Study|Adverse Event|0|||
126166756|NCT00364845|453895053|FG000|Overall Study|Withdrawal by Subject|2|||
126166757|NCT00364845|453895054|FG001|Overall Study|Withdrawal by Subject|1|||
126166758|NCT00364845|453895053|FG000|Overall Study|Physician Decision|8|||
126166759|NCT00364845|453895054|FG001|Overall Study|Physician Decision|8|||
126166760|NCT00364845|453895053|FG000|Overall Study|Lost to Follow-up|0|||
126166761|NCT00364845|453895054|FG001|Overall Study|Lost to Follow-up|1|||
126166762|NCT00364845|453895053|FG000|Overall Study|Death|0|||
126166763|NCT00364845|453895054|FG001|Overall Study|Death|1|||
126166764|NCT04160468|453895055|FG000|Overall Study|Lost to Follow-up|19|||
126166765|NCT04160468|453895056|FG001|Overall Study|Lost to Follow-up|4|||
126166766|NCT04160468|453895055|FG000|Overall Study|Randomized but not dosed|6|||
126166767|NCT04160468|453895056|FG001|Overall Study|Randomized but not dosed|0|||
126166768|NCT04160468|453895055|FG000|Overall Study|Withdrawal by Subject|4|||
126166769|NCT04160468|453895056|FG001|Overall Study|Withdrawal by Subject|1|||
126166770|NCT04160468|453895055|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
126166771|NCT04160468|453895056|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
126166772|NCT04160468|453895055|FG000|Overall Study|Participant incarcerated|1|||
126166773|NCT04160468|453895056|FG001|Overall Study|Participant incarcerated|0|||
126166774|NCT01187901|453895057|FG000|Overall Study|Protocol Violation|1|||
126166775|NCT01187901|453895058|FG001|Overall Study|Protocol Violation|0|||
126166776|NCT01187901|453895057|FG000|Overall Study|Lost to Follow-up|1|||
126166777|NCT01187901|453895058|FG001|Overall Study|Lost to Follow-up|2|||
126166778|NCT01187901|453895057|FG000|Overall Study|Unrelated Health Reasons|1|||
126166779|NCT01187901|453895058|FG001|Overall Study|Unrelated Health Reasons|2|||
126166780|NCT01187901|453895057|FG000|Overall Study|Suspected Allergic Reaction|1|||
126166781|NCT01187901|453895058|FG001|Overall Study|Suspected Allergic Reaction|1|||
126166782|NCT01187901|453895057|FG000|Overall Study|Adverse Event|3|||
126166783|NCT01187901|453895058|FG001|Overall Study|Adverse Event|0|||
126166784|NCT01187901|453895057|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
126166785|NCT01187901|453895058|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
126166786|NCT01187901|453895057|FG000|Overall Study|Pregnancy|0|||
126166787|NCT01187901|453895058|FG001|Overall Study|Pregnancy|2|||
126166788|NCT01912768|453895059|FG000|Overall Study|Adverse Event|2|||
126166789|NCT01912768|453895060|FG001|Overall Study|Adverse Event|0|||
126166790|NCT01912768|453895059|FG000|Overall Study|Lost to Follow-up|2|||
126166791|NCT01912768|453895060|FG001|Overall Study|Lost to Follow-up|1|||
126166792|NCT01912768|453895059|FG000|Overall Study|Withdrawal by Subject|5|||
126166793|NCT01912768|453895060|FG001|Overall Study|Withdrawal by Subject|3|||
126166794|NCT01912768|453895059|FG000|Overall Study|Randomized in error|1|||
126166795|NCT01912768|453895060|FG001|Overall Study|Randomized in error|0|||
126166796|NCT00540436|453895063|FG000|First 12-Week Treatment Period|Adverse Event|1|||
126166797|NCT00540436|453895063|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
126166798|NCT00540436|453895063|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
126166799|NCT00540436|453895063|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
126166800|NCT03255291|453895064|FG000|Overall Study|Determined to be ineligible|10|||
126166801|NCT03255291|453895065|FG001|Overall Study|Determined to be ineligible|12|||
126166802|NCT03255291|453895066|FG002|Overall Study|Determined to be ineligible|6|||
126166803|NCT03255291|453895067|FG003|Overall Study|Determined to be ineligible|6|||
126166804|NCT03255291|453895068|FG004|Overall Study|Determined to be ineligible|5|||
126166805|NCT03255291|453895069|FG005|Overall Study|Determined to be ineligible|10|||
126166806|NCT03255291|453895064|FG000|Overall Study|Baseline data collection issues|3|||
126166807|NCT03255291|453895065|FG001|Overall Study|Baseline data collection issues|0|||
126166808|NCT03255291|453895066|FG002|Overall Study|Baseline data collection issues|0|||
126166809|NCT03255291|453895067|FG003|Overall Study|Baseline data collection issues|0|||
126166810|NCT03255291|453895068|FG004|Overall Study|Baseline data collection issues|2|||
126166811|NCT03255291|453895069|FG005|Overall Study|Baseline data collection issues|0|||
126166812|NCT01067508|453895075|FG000|Overall Study|Physician Decision|0|||
126166813|NCT01067508|453895076|FG001|Overall Study|Physician Decision|1|||
126166814|NCT01067508|453895075|FG000|Overall Study|Withdrawal by Subject|0|||
126166815|NCT01067508|453895076|FG001|Overall Study|Withdrawal by Subject|1|||
126166816|NCT00444626|453895079|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
126166817|NCT00444626|453895079|FG000|Initial Treatment Period|Adverse Event|1|||
126166818|NCT00444626|453895079|FG000|Initial Treatment Period|Lost to Follow-up|9|||
126166819|NCT00091390|453895082|FG000|Overall Study|Protocol Violation|1|||
126166820|NCT00091390|453895082|FG000|Overall Study|No protocol treatment|3|||
126166821|NCT03229759|453895083|FG000|Overall Study|Screen Failure|30|||
126166822|NCT03050359|453896429|FG000|Overall Study|Randomized But Not Treated|2|||
126166823|NCT03050359|453896430|FG001|Overall Study|Randomized But Not Treated|0|||
126166824|NCT03050359|453896429|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
126166825|NCT03050359|453896430|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
126166826|NCT03050359|453896429|FG000|Overall Study|Significant Protocol Deviation|2|||
126166827|NCT03050359|453896430|FG001|Overall Study|Significant Protocol Deviation|3|||
126166828|NCT03050359|453896429|FG000|Overall Study|Lost to Follow-up|2|||
126166829|NCT03050359|453896430|FG001|Overall Study|Lost to Follow-up|1|||
126166830|NCT03050359|453896429|FG000|Overall Study|Voluntary Withdrawal|4|||
126166831|NCT03050359|453896430|FG001|Overall Study|Voluntary Withdrawal|6|||
126166832|NCT03050359|453896429|FG000|Overall Study|Pregnancy|1|||
126166833|NCT03050359|453896430|FG001|Overall Study|Pregnancy|0|||
126166834|NCT03050359|453896429|FG000|Overall Study|Reason Not Specified|1|||
126166835|NCT03050359|453896430|FG001|Overall Study|Reason Not Specified|0|||
126166836|NCT02614287|453896433|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
126166837|NCT02614287|453896434|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
126166838|NCT02614287|453896433|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
126166839|NCT02614287|453896434|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
126166840|NCT02614287|453896433|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
126166841|NCT02614287|453896434|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
126166842|NCT02614287|453896433|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
126166843|NCT02614287|453896434|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
126166844|NCT02614287|453896433|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
126166845|NCT02614287|453896434|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
126166846|NCT02614287|453896433|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
126166847|NCT02614287|453896434|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
126166848|NCT02614287|453896433|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
126166849|NCT02614287|453896434|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
126166850|NCT02614287|453896433|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
126166851|NCT02614287|453896434|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
126166852|NCT02006667|453896440|FG000|Overall Study|Adverse Event|3|||
126166853|NCT02006667|453896440|FG000|Overall Study|Death|2|||
126166854|NCT02006667|453896440|FG000|Overall Study|Withdrawal by Subject|1|||
126166855|NCT02939937|453896441|FG000|Overall Study|Adverse Event|5|||
126166856|NCT02939937|453896442|FG001|Overall Study|Adverse Event|0|||
126166857|NCT02939937|453896441|FG000|Overall Study|Lost to Follow-up|1|||
126166858|NCT02939937|453896442|FG001|Overall Study|Lost to Follow-up|3|||
126166859|NCT03580382|453896443|FG000|Overall Study|Early Termination of Study|0|||
126166860|NCT03580382|453896444|FG001|Overall Study|Early Termination of Study|3|||
126166861|NCT05619172|453896448|FG000|Safety Cohort 1|Death|7|||
126166862|NCT05619172|453896449|FG001|Safety Cohort 1|Death|0|||
126166863|NCT05619172|453896448|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
126166864|NCT05619172|453896449|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
126166865|NCT05619172|453896448|FG000|Safety Cohort 2|Death|0|||
126166866|NCT05619172|453896449|FG001|Safety Cohort 2|Death|1|||
126166867|NCT05619172|453896448|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
126166868|NCT05619172|453896449|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
126166869|NCT00450372|453896452|FG000|Overall Study|Physician Decision|1|||
126166870|NCT00520676|453896454|FG000|Overall Study|Death|84|||
126166871|NCT00520676|453896455|FG001|Overall Study|Death|81|||
126166872|NCT00520676|453896454|FG000|Overall Study|Lost to Follow-up|6|||
126166873|NCT00520676|453896455|FG001|Overall Study|Lost to Follow-up|10|||
126166874|NCT00520676|453896454|FG000|Overall Study|Physician Decision|4|||
126166875|NCT00520676|453896455|FG001|Overall Study|Physician Decision|1|||
126166876|NCT00520676|453896454|FG000|Overall Study|Withdrawal by Subject|7|||
126166877|NCT00520676|453896455|FG001|Overall Study|Withdrawal by Subject|11|||
126166878|NCT02179515|453896456|FG000|Overall Study|switched to alternative treatment|0|||
126166879|NCT02179515|453896457|FG001|Overall Study|switched to alternative treatment|1|||
126166880|NCT02179515|453896458|FG002|Overall Study|switched to alternative treatment|1|||
126166881|NCT02179515|453896456|FG000|Overall Study|Death|0|||
126166882|NCT02179515|453896457|FG001|Overall Study|Death|1|||
126166883|NCT02179515|453896458|FG002|Overall Study|Death|1|||
126166884|NCT02179515|453896456|FG000|Overall Study|refused further treatment|0|||
126166885|NCT02179515|453896457|FG001|Overall Study|refused further treatment|3|||
126166886|NCT02179515|453896458|FG002|Overall Study|refused further treatment|4|||
126166887|NCT02179515|453896456|FG000|Overall Study|Disease progression on study|2|||
126166888|NCT02179515|453896457|FG001|Overall Study|Disease progression on study|11|||
126166889|NCT02179515|453896458|FG002|Overall Study|Disease progression on study|8|||
126166890|NCT03439748|453896459|FG000|Overall Study|Withdrawal by Subject|11|||
126166891|NCT03439748|453896460|FG001|Overall Study|Withdrawal by Subject|17|||
126166892|NCT05131451|453896461|FG000|Overall Study|Protocol Violation|1|||
126166893|NCT05131451|453896462|FG001|Overall Study|Protocol Violation|0|||
126166894|NCT00782418|453896463|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
126166895|NCT00782418|453896464|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126166896|NCT00782418|453896465|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126166897|NCT00782418|453896466|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126166898|NCT00782418|453896467|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126166899|NCT00782418|453896468|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126166900|NCT00782418|453896469|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126166901|NCT00782418|453896463|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
126166902|NCT00782418|453896464|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
126166903|NCT00782418|453896465|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
126166904|NCT00782418|453896466|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
126166905|NCT00782418|453896467|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
126166906|NCT00782418|453896468|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
126166907|NCT00782418|453896469|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
126166908|NCT00115349|453896470|FG000|Overall Study|Study closed due to low enrollment.|11|||
126166909|NCT00115349|453896471|FG001|Overall Study|Study closed due to low enrollment.|9|||
126166910|NCT02116660|453896472|FG000|Overall Study|Deteriorating renal function|0|||
126166911|NCT02116660|453896473|FG001|Overall Study|Deteriorating renal function|1|||
126166912|NCT02116660|453896472|FG000|Overall Study|Adverse Event|1|||
126166913|NCT02116660|453896473|FG001|Overall Study|Adverse Event|1|||
126166914|NCT02116660|453896472|FG000|Overall Study|Withdrawal by Subject|0|||
126166915|NCT02116660|453896473|FG001|Overall Study|Withdrawal by Subject|2|||
126166916|NCT02116660|453896472|FG000|Overall Study|Organization reason|1|||
126166917|NCT02116660|453896473|FG001|Overall Study|Organization reason|0|||
126166918|NCT02750800|453896474|FG000|Overall Study|Adverse Event|18|||
126166919|NCT02750800|453896474|FG000|Overall Study|Lost to Follow-up|12|||
126166920|NCT02750800|453896474|FG000|Overall Study|Investigator decision|53|||
126166921|NCT02750800|453896474|FG000|Overall Study|Patient request|12|||
126166922|NCT02750800|453896474|FG000|Overall Study|Other, not specified|3|||
126166923|NCT05631548|453896476|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
126166924|NCT05631548|453896477|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
126166925|NCT00390416|453896478|FG000|Overall Study|Withdrawal by Subject|1|||
126166926|NCT00390416|453896478|FG000|Overall Study|Not treated|3|||
126166927|NCT02651194|453896483|FG000|Overall Study|Lost to Follow-up|3|||
126166928|NCT02651194|453896483|FG000|Overall Study|Other|2|||
126166929|NCT03885726|453896486|FG000|Overall Study|Staffing issues/lost interest|1|||
126166930|NCT03885726|453896486|FG000|Overall Study|Early discharge from hospital|3|||
126166931|NCT01217190|453896487|FG000|Second Dosing|Withdrawal by Subject|0|||
126166932|NCT01217190|453896488|FG001|Second Dosing|Withdrawal by Subject|2|||
126166933|NCT03116399|453896489|FG000|Overall Study|Death|8|||
126166934|NCT03116399|453896490|FG001|Overall Study|Death|3|||
126166935|NCT03116399|453896489|FG000|Overall Study|Lost to Follow-up|7|||
126166936|NCT03116399|453896490|FG001|Overall Study|Lost to Follow-up|11|||
126166937|NCT03116399|453896489|FG000|Overall Study|Investigator Decision|1|||
126166938|NCT03116399|453896490|FG001|Overall Study|Investigator Decision|1|||
126166939|NCT03116399|453896489|FG000|Overall Study|Withdrawal by Subject|24|||
126166940|NCT03116399|453896490|FG001|Overall Study|Withdrawal by Subject|9|||
126166941|NCT02868216|453896491|FG000|Overall Study|Death|0|||
126166942|NCT02868216|453896492|FG001|Overall Study|Death|1|||
126166943|NCT02868216|453896491|FG000|Overall Study|coronary artery bypass|1|||
126166944|NCT02868216|453896492|FG001|Overall Study|coronary artery bypass|0|||
126166945|NCT02868216|453896491|FG000|Overall Study|Withdrawal by Subject|7|||
126166946|NCT02868216|453896492|FG001|Overall Study|Withdrawal by Subject|5|||
126166947|NCT02496585|453896493|FG000|Overall Study|Death|3|||
126166948|NCT02496585|453896494|FG001|Overall Study|Death|0|||
126166949|NCT02496585|453896493|FG000|Overall Study|Lost to Follow-up|2|||
126166950|NCT02496585|453896494|FG001|Overall Study|Lost to Follow-up|0|||
126166951|NCT02496585|453896493|FG000|Overall Study|Withdrawal by Subject|1|||
126166952|NCT02496585|453896494|FG001|Overall Study|Withdrawal by Subject|2|||
126166953|NCT02496585|453896493|FG000|Overall Study|Progression of Malignancy|4|||
126166954|NCT02496585|453896494|FG001|Overall Study|Progression of Malignancy|1|||
126166955|NCT04891770|453896496|FG000|Overall Study|Withdrew consent|1|||
126166956|NCT04891770|453896497|FG001|Overall Study|Withdrew consent|3|||
126166957|NCT04891770|453896498|FG002|Overall Study|Withdrew consent|0|||
126166958|NCT04891770|453896496|FG000|Overall Study|Enrolled but never treated|0|||
126166959|NCT04891770|453896497|FG001|Overall Study|Enrolled but never treated|0|||
126166960|NCT04891770|453896498|FG002|Overall Study|Enrolled but never treated|1|||
126166961|NCT04891770|453896496|FG000|Overall Study|Investigator's discretion|0|||
126166962|NCT04891770|453896497|FG001|Overall Study|Investigator's discretion|1|||
126166963|NCT04891770|453896498|FG002|Overall Study|Investigator's discretion|0|||
126166964|NCT01401010|453896502|FG000|Overall Study|Could not interpret assay results|1|||
126166965|NCT01401010|453896503|FG001|Overall Study|Could not interpret assay results|0|||
126166966|NCT00195260|453896507|FG000|Part 1: Dose Escalation|Adverse Event|0|||
126166967|NCT00195260|453896508|FG001|Part 1: Dose Escalation|Adverse Event|1|||
126166968|NCT00195260|453896509|FG002|Part 1: Dose Escalation|Adverse Event|0|||
126166969|NCT00195260|453896510|FG003|Part 1: Dose Escalation|Adverse Event|1|||
126166970|NCT00195260|453896511|FG004|Part 1: Dose Escalation|Adverse Event|1|||
126166971|NCT00195260|453896512|FG005|Part 1: Dose Escalation|Adverse Event|0|||
126166972|NCT00195260|453896513|FG006|Part 1: Dose Escalation|Adverse Event|3|||
126166973|NCT00195260|453896514|FG007|Part 1: Dose Escalation|Adverse Event|0|||
126166974|NCT00195260|453896515|FG008|Part 1: Dose Escalation|Adverse Event|0|||
126166975|NCT00195260|453896516|FG009|Part 1: Dose Escalation|Adverse Event|0|||
126166976|NCT00195260|453896517|FG010|Part 1: Dose Escalation|Adverse Event|0|||
126166977|NCT00195260|453896507|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166978|NCT00195260|453896508|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166979|NCT00195260|453896509|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166980|NCT00195260|453896510|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166981|NCT00195260|453896511|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
126166982|NCT00195260|453896512|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166983|NCT00195260|453896513|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166984|NCT00195260|453896514|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
126166985|NCT00195260|453896515|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166986|NCT00195260|453896516|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166987|NCT00195260|453896517|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126166988|NCT00195260|453896507|FG000|Part 1: Dose Escalation|Death|0|||
126166989|NCT00195260|453896508|FG001|Part 1: Dose Escalation|Death|0|||
126166990|NCT00195260|453896509|FG002|Part 1: Dose Escalation|Death|0|||
126166991|NCT00195260|453896510|FG003|Part 1: Dose Escalation|Death|0|||
126166992|NCT00195260|453896511|FG004|Part 1: Dose Escalation|Death|0|||
126166993|NCT00195260|453896512|FG005|Part 1: Dose Escalation|Death|0|||
126166994|NCT00195260|453896513|FG006|Part 1: Dose Escalation|Death|0|||
126166995|NCT00195260|453896514|FG007|Part 1: Dose Escalation|Death|1|||
126166996|NCT00195260|453896515|FG008|Part 1: Dose Escalation|Death|0|||
126166997|NCT00195260|453896516|FG009|Part 1: Dose Escalation|Death|0|||
126166998|NCT00195260|453896517|FG010|Part 1: Dose Escalation|Death|0|||
126166999|NCT00195260|453896507|FG000|Part 1: Dose Escalation|Disease Progression|3|||
126167000|NCT00195260|453896508|FG001|Part 1: Dose Escalation|Disease Progression|2|||
126167001|NCT00195260|453896509|FG002|Part 1: Dose Escalation|Disease Progression|5|||
126167002|NCT00195260|453896510|FG003|Part 1: Dose Escalation|Disease Progression|6|||
126167003|NCT00195260|453896511|FG004|Part 1: Dose Escalation|Disease Progression|4|||
126167004|NCT00195260|453896512|FG005|Part 1: Dose Escalation|Disease Progression|6|||
126167005|NCT00195260|453896513|FG006|Part 1: Dose Escalation|Disease Progression|7|||
126167006|NCT00195260|453896514|FG007|Part 1: Dose Escalation|Disease Progression|4|||
126167007|NCT00195260|453896515|FG008|Part 1: Dose Escalation|Disease Progression|0|||
126167008|NCT00195260|453896516|FG009|Part 1: Dose Escalation|Disease Progression|0|||
126167009|NCT00195260|453896517|FG010|Part 1: Dose Escalation|Disease Progression|0|||
126167010|NCT00195260|453896507|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
126167011|NCT00195260|453896508|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
126167012|NCT00195260|453896509|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
126167013|NCT00195260|453896510|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126167014|NCT00195260|453896511|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126167015|NCT00195260|453896512|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
126167016|NCT00195260|453896513|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126167017|NCT00195260|453896514|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126167018|NCT00195260|453896515|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126167019|NCT00195260|453896516|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126167020|NCT00195260|453896517|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126167021|NCT00195260|453896507|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126167022|NCT00195260|453896508|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126167023|NCT00195260|453896509|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126167024|NCT00195260|453896510|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126167025|NCT00195260|453896511|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126167026|NCT00195260|453896512|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126167027|NCT00195260|453896513|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126167028|NCT00195260|453896514|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126167029|NCT00195260|453896515|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
126167030|NCT00195260|453896516|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
126167031|NCT00195260|453896517|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
126167032|NCT00195260|453896507|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126167033|NCT00195260|453896508|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126167034|NCT00195260|453896509|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126167035|NCT00195260|453896510|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126167036|NCT00195260|453896511|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126167037|NCT00195260|453896512|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126167038|NCT00195260|453896513|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126167039|NCT00195260|453896514|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126167040|NCT00195260|453896515|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
126167041|NCT00195260|453896516|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
126167042|NCT00195260|453896517|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
126167043|NCT00195260|453896507|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126167044|NCT00195260|453896508|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126167045|NCT00195260|453896509|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126167046|NCT00195260|453896510|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126167047|NCT00195260|453896511|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126167048|NCT00195260|453896512|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126167049|NCT00195260|453896513|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126167050|NCT00195260|453896514|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126167051|NCT00195260|453896515|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
126167052|NCT00195260|453896516|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
126167053|NCT00195260|453896517|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
126167054|NCT00195260|453896507|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126167055|NCT00195260|453896508|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126167056|NCT00195260|453896509|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126167057|NCT00195260|453896510|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126167058|NCT00195260|453896511|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126167059|NCT00195260|453896512|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126167060|NCT00195260|453896513|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126167061|NCT00195260|453896514|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126167062|NCT00195260|453896515|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
126167063|NCT00195260|453896516|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
126167064|NCT00195260|453896517|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
126167065|NCT01975272|453896520|FG000|Overall Study|Excluded after protocol amendment|1|||
126167066|NCT01975272|453896521|FG001|Overall Study|Excluded after protocol amendment|1|||
126167067|NCT01975272|453896522|FG002|Overall Study|Excluded after protocol amendment|2|||
126167068|NCT02028338|453896525|FG000|Overall Study|Withdrawal by Subject|3|||
126167069|NCT02028338|453896526|FG001|Overall Study|Withdrawal by Subject|1|||
126167070|NCT02028338|453896525|FG000|Overall Study|Unable to contact participant|1|||
126167071|NCT02028338|453896526|FG001|Overall Study|Unable to contact participant|0|||
126167072|NCT02761993|453896532|FG000|Overall Study|Adverse Event|0|||
126167073|NCT02761993|453896533|FG001|Overall Study|Adverse Event|2|||
126167074|NCT02761993|453896534|FG002|Overall Study|Adverse Event|0|||
126167075|NCT02761993|453896532|FG000|Overall Study|Lost to Follow-up|1|||
126167076|NCT02761993|453896533|FG001|Overall Study|Lost to Follow-up|3|||
126167077|NCT02761993|453896534|FG002|Overall Study|Lost to Follow-up|2|||
126167078|NCT02761993|453896532|FG000|Overall Study|Withdrawal by Subject|1|||
126167079|NCT02761993|453896533|FG001|Overall Study|Withdrawal by Subject|1|||
126167080|NCT02761993|453896534|FG002|Overall Study|Withdrawal by Subject|2|||
126167081|NCT01842620|453896535|FG000|Period 1|Withdrawal by Subject|1|||
125973065|NCT01217073|453191385|FG002|Extension Period|Excluded medication|0|||
126167082|NCT01842620|453896536|FG001|Period 1|Withdrawal by Subject|0|||
126167083|NCT03342469|453896543|FG000|Overall Study|Withdrawal by Subject|0|||
126167084|NCT03342469|453896544|FG001|Overall Study|Withdrawal by Subject|1|||
126167085|NCT03342469|453896545|FG002|Overall Study|Withdrawal by Subject|0|||
126167086|NCT03342469|453896546|FG003|Overall Study|Withdrawal by Subject|0|||
126167087|NCT03136185|453896554|FG000|Overall Study|Adverse Event|0|||
126167088|NCT03136185|453896555|FG001|Overall Study|Adverse Event|1|||
126167089|NCT03136185|453896556|FG002|Overall Study|Adverse Event|3|||
126167090|NCT03136185|453896557|FG003|Overall Study|Adverse Event|1|||
126167091|NCT03136185|453896558|FG004|Overall Study|Adverse Event|2|||
126167092|NCT03136185|453896559|FG005|Overall Study|Adverse Event|2|||
126167093|NCT03136185|453896560|FG006|Overall Study|Adverse Event|5|||
126167094|NCT03136185|453896561|FG007|Overall Study|Adverse Event|1|||
126167095|NCT03136185|453896562|FG008|Overall Study|Adverse Event|1|||
126167096|NCT03136185|453896554|FG000|Overall Study|Death|0|||
126167097|NCT03136185|453896555|FG001|Overall Study|Death|0|||
126167098|NCT03136185|453896556|FG002|Overall Study|Death|0|||
126167099|NCT03136185|453896557|FG003|Overall Study|Death|1|||
126167100|NCT03136185|453896558|FG004|Overall Study|Death|1|||
126167101|NCT03136185|453896559|FG005|Overall Study|Death|0|||
126167102|NCT03136185|453896560|FG006|Overall Study|Death|1|||
126167103|NCT03136185|453896561|FG007|Overall Study|Death|0|||
126167104|NCT03136185|453896562|FG008|Overall Study|Death|0|||
126167105|NCT03136185|453896554|FG000|Overall Study|Physician Decision|3|||
126167106|NCT03136185|453896555|FG001|Overall Study|Physician Decision|1|||
126167107|NCT03136185|453896556|FG002|Overall Study|Physician Decision|1|||
126167108|NCT03136185|453896557|FG003|Overall Study|Physician Decision|2|||
126167109|NCT03136185|453896558|FG004|Overall Study|Physician Decision|1|||
126167110|NCT03136185|453896559|FG005|Overall Study|Physician Decision|2|||
126167111|NCT03136185|453896560|FG006|Overall Study|Physician Decision|1|||
126167112|NCT03136185|453896561|FG007|Overall Study|Physician Decision|0|||
126167113|NCT03136185|453896562|FG008|Overall Study|Physician Decision|1|||
126167114|NCT03136185|453896554|FG000|Overall Study|Protocol Defined Disease Progression|0|||
126167115|NCT03136185|453896555|FG001|Overall Study|Protocol Defined Disease Progression|0|||
126167116|NCT03136185|453896556|FG002|Overall Study|Protocol Defined Disease Progression|1|||
126167117|NCT03136185|453896557|FG003|Overall Study|Protocol Defined Disease Progression|0|||
126167118|NCT03136185|453896558|FG004|Overall Study|Protocol Defined Disease Progression|0|||
126167119|NCT03136185|453896559|FG005|Overall Study|Protocol Defined Disease Progression|1|||
126167120|NCT03136185|453896560|FG006|Overall Study|Protocol Defined Disease Progression|0|||
126167121|NCT03136185|453896561|FG007|Overall Study|Protocol Defined Disease Progression|1|||
126167122|NCT03136185|453896562|FG008|Overall Study|Protocol Defined Disease Progression|1|||
126167123|NCT03136185|453896554|FG000|Overall Study|Withdrawal by Subject|1|||
126167124|NCT03136185|453896555|FG001|Overall Study|Withdrawal by Subject|0|||
126167125|NCT03136185|453896556|FG002|Overall Study|Withdrawal by Subject|1|||
126167126|NCT03136185|453896557|FG003|Overall Study|Withdrawal by Subject|1|||
126167127|NCT03136185|453896558|FG004|Overall Study|Withdrawal by Subject|1|||
126167128|NCT03136185|453896559|FG005|Overall Study|Withdrawal by Subject|1|||
126167129|NCT03136185|453896560|FG006|Overall Study|Withdrawal by Subject|2|||
126167130|NCT03136185|453896561|FG007|Overall Study|Withdrawal by Subject|3|||
126167131|NCT03136185|453896562|FG008|Overall Study|Withdrawal by Subject|3|||
126167132|NCT03136185|453896554|FG000|Overall Study|Not Reported|4|||
126167133|NCT03136185|453896555|FG001|Overall Study|Not Reported|1|||
126167134|NCT03136185|453896556|FG002|Overall Study|Not Reported|0|||
126167135|NCT03136185|453896557|FG003|Overall Study|Not Reported|1|||
126167136|NCT03136185|453896558|FG004|Overall Study|Not Reported|0|||
126167137|NCT03136185|453896559|FG005|Overall Study|Not Reported|2|||
126167138|NCT03136185|453896560|FG006|Overall Study|Not Reported|1|||
126167139|NCT03136185|453896561|FG007|Overall Study|Not Reported|1|||
126167140|NCT03136185|453896562|FG008|Overall Study|Not Reported|0|||
126167141|NCT00488033|453896568|FG000|Overall Study|Withdrawal by Subject|1|||
126167142|NCT00488033|453896569|FG001|Overall Study|Withdrawal by Subject|0|||
126167143|NCT04715230|453896572|FG000|Overall Study|Withdrawal by Subject|1|||
126167144|NCT04715230|453896573|FG001|Overall Study|Withdrawal by Subject|0|||
126167145|NCT04715230|453896574|FG002|Overall Study|Withdrawal by Subject|0|||
126167146|NCT04715230|453896572|FG000|Overall Study|Lost to Follow-up|0|||
126167147|NCT04715230|453896573|FG001|Overall Study|Lost to Follow-up|5|||
126167148|NCT04715230|453896574|FG002|Overall Study|Lost to Follow-up|1|||
126167149|NCT03453151|453896575|FG000|Overall Study|Withdrawal by Subject|1|||
126167150|NCT03453151|453896575|FG000|Overall Study|Physician Decision|3|||
126167151|NCT04281030|453897793|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
126167152|NCT04281030|453897794|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
126167153|NCT04281030|453897793|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
126167154|NCT04281030|453897794|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
126167155|NCT01361009|453897795|FG000|Overall Study|Protocol Violation|116|||
126167156|NCT01826422|453897796|FG000|Overall Study|Withdrawal by Subject|1|||
126167157|NCT01826422|453897797|FG001|Overall Study|Withdrawal by Subject|3|||
126167158|NCT02324842|453897800|FG000|Overall Study|Lost to Follow-up|1|||
126167159|NCT02324842|453897801|FG001|Overall Study|Lost to Follow-up|1|||
126167160|NCT02324842|453897802|FG002|Overall Study|Lost to Follow-up|2|||
126167161|NCT03298412|453897803|FG000|Run-in Period|Other, Not Specified|1|||
126167162|NCT03298412|453897803|FG000|Run-in Period|Disease Progression|1|||
126167163|NCT03298412|453897803|FG000|Run-in Period|Ineligibility Determined|1|||
126167164|NCT03298412|453897803|FG000|Run-in Period|Decision by Sponsor|6|||
126167165|NCT00995345|453897808|FG000|Overall Study|Withdrawal by Subject|4|||
126167166|NCT00995345|453897809|FG001|Overall Study|Withdrawal by Subject|2|||
126167167|NCT00995345|453897810|FG002|Overall Study|Withdrawal by Subject|1|||
126167168|NCT00995345|453897811|FG003|Overall Study|Withdrawal by Subject|3|||
126167169|NCT00995345|453897812|FG004|Overall Study|Withdrawal by Subject|1|||
126167170|NCT00995345|453897808|FG000|Overall Study|Adverse Event|3|||
126167171|NCT00995345|453897809|FG001|Overall Study|Adverse Event|1|||
126167172|NCT00995345|453897810|FG002|Overall Study|Adverse Event|2|||
126167173|NCT00995345|453897811|FG003|Overall Study|Adverse Event|0|||
126167174|NCT00995345|453897812|FG004|Overall Study|Adverse Event|1|||
126167175|NCT00995345|453897808|FG000|Overall Study|Lost to Follow-up|2|||
126167176|NCT00995345|453897809|FG001|Overall Study|Lost to Follow-up|2|||
126167177|NCT00995345|453897810|FG002|Overall Study|Lost to Follow-up|2|||
126167178|NCT00995345|453897811|FG003|Overall Study|Lost to Follow-up|1|||
126167179|NCT00995345|453897812|FG004|Overall Study|Lost to Follow-up|0|||
126167180|NCT00995345|453897808|FG000|Overall Study|all other reasons combined|2|||
126167181|NCT00995345|453897809|FG001|Overall Study|all other reasons combined|2|||
126167182|NCT00995345|453897810|FG002|Overall Study|all other reasons combined|2|||
126167183|NCT00995345|453897811|FG003|Overall Study|all other reasons combined|1|||
126167184|NCT00995345|453897812|FG004|Overall Study|all other reasons combined|3|||
126167185|NCT01860534|453897813|FG000|ROP #1|Needed treatment for ROP|0|||
126167186|NCT01860534|453897814|FG001|ROP #1|Needed treatment for ROP|1|||
126167187|NCT01860534|453897813|FG000|ROP #2|discharged prior to ROP #2|1|||
126167188|NCT01860534|453897814|FG001|ROP #2|discharged prior to ROP #2|0|||
126167189|NCT05122650|453897817|FG000|Overall Study|Adverse Event|4|||
126167190|NCT05122650|453897818|FG001|Overall Study|Adverse Event|16|||
126167191|NCT05122650|453897819|FG002|Overall Study|Adverse Event|11|||
126167192|NCT05122650|453897820|FG003|Overall Study|Adverse Event|12|||
126167193|NCT05122650|453897817|FG000|Overall Study|Lack of Efficacy|0|||
126167194|NCT05122650|453897818|FG001|Overall Study|Lack of Efficacy|1|||
126167195|NCT05122650|453897819|FG002|Overall Study|Lack of Efficacy|1|||
126167196|NCT05122650|453897820|FG003|Overall Study|Lack of Efficacy|2|||
126167197|NCT05122650|453897817|FG000|Overall Study|Lost to Follow-up|1|||
126167198|NCT05122650|453897818|FG001|Overall Study|Lost to Follow-up|1|||
126167199|NCT05122650|453897819|FG002|Overall Study|Lost to Follow-up|3|||
126167200|NCT05122650|453897820|FG003|Overall Study|Lost to Follow-up|0|||
126167201|NCT05122650|453897817|FG000|Overall Study|Non-compliance with study intervention|0|||
126167202|NCT05122650|453897818|FG001|Overall Study|Non-compliance with study intervention|0|||
126167203|NCT05122650|453897819|FG002|Overall Study|Non-compliance with study intervention|0|||
126167204|NCT05122650|453897820|FG003|Overall Study|Non-compliance with study intervention|2|||
126167205|NCT05122650|453897817|FG000|Overall Study|Protocol Violation|0|||
126167206|NCT05122650|453897818|FG001|Overall Study|Protocol Violation|1|||
126167207|NCT05122650|453897819|FG002|Overall Study|Protocol Violation|0|||
126167208|NCT05122650|453897820|FG003|Overall Study|Protocol Violation|1|||
125973066|NCT01217073|453191386|FG003|Extension Period|Excluded medication|0|||
125973067|NCT01217073|453191387|FG004|Extension Period|Excluded medication|0|||
125973068|NCT01217073|453191388|FG005|Extension Period|Excluded medication|0|||
125973069|NCT01217073|453191389|FG006|Extension Period|Excluded medication|2|||
125973070|NCT01217073|453191390|FG007|Extension Period|Excluded medication|0|||
125973071|NCT01217073|453191383|FG000|Extension Period|Lack of Efficacy|0|||
125973072|NCT01217073|453191384|FG001|Extension Period|Lack of Efficacy|0|||
125973073|NCT01217073|453191385|FG002|Extension Period|Lack of Efficacy|0|||
125973074|NCT01217073|453191386|FG003|Extension Period|Lack of Efficacy|0|||
125973075|NCT01217073|453191387|FG004|Extension Period|Lack of Efficacy|0|||
125973076|NCT01217073|453191388|FG005|Extension Period|Lack of Efficacy|0|||
125973077|NCT01217073|453191389|FG006|Extension Period|Lack of Efficacy|3|||
125973078|NCT01217073|453191390|FG007|Extension Period|Lack of Efficacy|0|||
125973079|NCT01217073|453191383|FG000|Extension Period|Lost to Follow-up|0|||
125973080|NCT01217073|453191384|FG001|Extension Period|Lost to Follow-up|0|||
125973081|NCT01217073|453191385|FG002|Extension Period|Lost to Follow-up|0|||
125973082|NCT01217073|453191386|FG003|Extension Period|Lost to Follow-up|0|||
126167209|NCT05122650|453897817|FG000|Overall Study|Randomized by mistake|0|||
126167210|NCT05122650|453897818|FG001|Overall Study|Randomized by mistake|0|||
126167211|NCT05122650|453897819|FG002|Overall Study|Randomized by mistake|3|||
125973083|NCT01217073|453191387|FG004|Extension Period|Lost to Follow-up|0|||
125973084|NCT01217073|453191388|FG005|Extension Period|Lost to Follow-up|0|||
125973085|NCT01217073|453191389|FG006|Extension Period|Lost to Follow-up|9|||
125973086|NCT01217073|453191390|FG007|Extension Period|Lost to Follow-up|1|||
125973087|NCT01217073|453191383|FG000|Extension Period|Non-compliance with study drug|0|||
126167212|NCT05122650|453897820|FG003|Overall Study|Randomized by mistake|2|||
126167213|NCT05122650|453897817|FG000|Overall Study|Sponsor request|0|||
125973088|NCT01217073|453191384|FG001|Extension Period|Non-compliance with study drug|0|||
125973089|NCT01217073|453191385|FG002|Extension Period|Non-compliance with study drug|0|||
125973090|NCT01217073|453191386|FG003|Extension Period|Non-compliance with study drug|0|||
125973091|NCT01217073|453191387|FG004|Extension Period|Non-compliance with study drug|0|||
125973092|NCT01217073|453191388|FG005|Extension Period|Non-compliance with study drug|0|||
125973093|NCT01217073|453191389|FG006|Extension Period|Non-compliance with study drug|0|||
125973094|NCT01217073|453191390|FG007|Extension Period|Non-compliance with study drug|1|||
125973095|NCT01217073|453191383|FG000|Extension Period|Physician Decision|0|||
125973096|NCT01217073|453191384|FG001|Extension Period|Physician Decision|0|||
125973097|NCT01217073|453191385|FG002|Extension Period|Physician Decision|0|||
125973098|NCT01217073|453191386|FG003|Extension Period|Physician Decision|0|||
125973099|NCT01217073|453191387|FG004|Extension Period|Physician Decision|0|||
125973100|NCT01217073|453191388|FG005|Extension Period|Physician Decision|0|||
125973101|NCT01217073|453191389|FG006|Extension Period|Physician Decision|4|||
125973102|NCT01217073|453191390|FG007|Extension Period|Physician Decision|1|||
125973103|NCT01217073|453191383|FG000|Extension Period|Protocol Violation|0|||
125973104|NCT01217073|453191384|FG001|Extension Period|Protocol Violation|0|||
125973105|NCT01217073|453191385|FG002|Extension Period|Protocol Violation|0|||
125973106|NCT01217073|453191386|FG003|Extension Period|Protocol Violation|0|||
125973107|NCT01217073|453191387|FG004|Extension Period|Protocol Violation|0|||
125973108|NCT01217073|453191388|FG005|Extension Period|Protocol Violation|0|||
125973109|NCT01217073|453191389|FG006|Extension Period|Protocol Violation|2|||
125973110|NCT01217073|453191390|FG007|Extension Period|Protocol Violation|1|||
125973111|NCT01217073|453191383|FG000|Extension Period|Site discontinued study participation|0|||
125973112|NCT01217073|453191384|FG001|Extension Period|Site discontinued study participation|0|||
125973113|NCT01217073|453191385|FG002|Extension Period|Site discontinued study participation|0|||
125973114|NCT01217073|453191386|FG003|Extension Period|Site discontinued study participation|0|||
125973115|NCT01217073|453191387|FG004|Extension Period|Site discontinued study participation|0|||
125973116|NCT01217073|453191388|FG005|Extension Period|Site discontinued study participation|0|||
125973117|NCT01217073|453191389|FG006|Extension Period|Site discontinued study participation|7|||
125973118|NCT01217073|453191390|FG007|Extension Period|Site discontinued study participation|2|||
125973119|NCT01217073|453191383|FG000|Extension Period|Withdrawal by Subject|0|||
125973120|NCT01217073|453191384|FG001|Extension Period|Withdrawal by Subject|0|||
125973121|NCT01217073|453191385|FG002|Extension Period|Withdrawal by Subject|0|||
125973122|NCT01217073|453191386|FG003|Extension Period|Withdrawal by Subject|0|||
125973123|NCT01217073|453191387|FG004|Extension Period|Withdrawal by Subject|0|||
125973124|NCT01217073|453191388|FG005|Extension Period|Withdrawal by Subject|0|||
125973125|NCT01217073|453191389|FG006|Extension Period|Withdrawal by Subject|30|||
125973126|NCT01217073|453191390|FG007|Extension Period|Withdrawal by Subject|8|||
125973127|NCT02564523|453191391|FG000|Overall Study|Withdrawal by Subject|3|||
125973128|NCT02564523|453191392|FG001|Overall Study|Withdrawal by Subject|0|||
125973129|NCT02564523|453191393|FG002|Overall Study|Withdrawal by Subject|1|||
125973130|NCT02564523|453191394|FG003|Overall Study|Withdrawal by Subject|0|||
125973131|NCT02564523|453191395|FG004|Overall Study|Withdrawal by Subject|1|||
125973132|NCT02564523|453191396|FG005|Overall Study|Withdrawal by Subject|0|||
125973133|NCT02564523|453191397|FG006|Overall Study|Withdrawal by Subject|1|||
125973134|NCT02564523|453191398|FG007|Overall Study|Withdrawal by Subject|0|||
125973135|NCT02564523|453191399|FG008|Overall Study|Withdrawal by Subject|0|||
125973136|NCT02564523|453191400|FG009|Overall Study|Withdrawal by Subject|0|||
125973137|NCT02564523|453191401|FG010|Overall Study|Withdrawal by Subject|1|||
125973138|NCT02564523|453191402|FG011|Overall Study|Withdrawal by Subject|0|||
125973139|NCT02564523|453191403|FG012|Overall Study|Withdrawal by Subject|1|||
125973140|NCT02564523|453191404|FG013|Overall Study|Withdrawal by Subject|0|||
125973141|NCT02564523|453191405|FG014|Overall Study|Withdrawal by Subject|0|||
125973142|NCT02564523|453191406|FG015|Overall Study|Withdrawal by Subject|0|||
125973143|NCT02564523|453191407|FG016|Overall Study|Withdrawal by Subject|0|||
125973144|NCT02564523|453191408|FG017|Overall Study|Withdrawal by Subject|0|||
125973145|NCT02564523|453191391|FG000|Overall Study|Adverse Event|0|||
125973146|NCT02564523|453191392|FG001|Overall Study|Adverse Event|0|||
125973147|NCT02564523|453191393|FG002|Overall Study|Adverse Event|0|||
125973148|NCT02564523|453191394|FG003|Overall Study|Adverse Event|0|||
125973149|NCT02564523|453191395|FG004|Overall Study|Adverse Event|0|||
125973150|NCT02564523|453191396|FG005|Overall Study|Adverse Event|0|||
125973151|NCT02564523|453191397|FG006|Overall Study|Adverse Event|0|||
125973152|NCT02564523|453191398|FG007|Overall Study|Adverse Event|0|||
125973153|NCT02564523|453191399|FG008|Overall Study|Adverse Event|0|||
125973154|NCT02564523|453191400|FG009|Overall Study|Adverse Event|0|||
125973155|NCT02564523|453191401|FG010|Overall Study|Adverse Event|0|||
125973156|NCT02564523|453191402|FG011|Overall Study|Adverse Event|0|||
125973157|NCT02564523|453191403|FG012|Overall Study|Adverse Event|0|||
125973158|NCT02564523|453191404|FG013|Overall Study|Adverse Event|0|||
125973159|NCT02564523|453191405|FG014|Overall Study|Adverse Event|0|||
125973160|NCT02564523|453191406|FG015|Overall Study|Adverse Event|0|||
125973161|NCT02564523|453191407|FG016|Overall Study|Adverse Event|0|||
125973162|NCT02564523|453191408|FG017|Overall Study|Adverse Event|1|||
125973163|NCT02564523|453191391|FG000|Overall Study|Death|0|||
125973164|NCT02564523|453191392|FG001|Overall Study|Death|0|||
125973165|NCT02564523|453191393|FG002|Overall Study|Death|0|||
125973166|NCT02564523|453191394|FG003|Overall Study|Death|0|||
125973167|NCT02564523|453191395|FG004|Overall Study|Death|0|||
125973168|NCT02564523|453191396|FG005|Overall Study|Death|0|||
125973169|NCT02564523|453191397|FG006|Overall Study|Death|1|||
125973170|NCT02564523|453191398|FG007|Overall Study|Death|0|||
125973171|NCT02564523|453191399|FG008|Overall Study|Death|0|||
125973172|NCT02564523|453191400|FG009|Overall Study|Death|0|||
125973173|NCT02564523|453191401|FG010|Overall Study|Death|1|||
125973174|NCT02564523|453191402|FG011|Overall Study|Death|0|||
125973175|NCT02564523|453191403|FG012|Overall Study|Death|0|||
125973176|NCT02564523|453191404|FG013|Overall Study|Death|0|||
125973177|NCT02564523|453191405|FG014|Overall Study|Death|0|||
125973178|NCT02564523|453191406|FG015|Overall Study|Death|0|||
125973179|NCT02564523|453191407|FG016|Overall Study|Death|0|||
125973180|NCT02564523|453191408|FG017|Overall Study|Death|0|||
126167214|NCT05122650|453897818|FG001|Overall Study|Sponsor request|1|||
126167215|NCT05122650|453897819|FG002|Overall Study|Sponsor request|1|||
126167216|NCT05122650|453897820|FG003|Overall Study|Sponsor request|2|||
126167217|NCT05122650|453897817|FG000|Overall Study|Withdrawal by Subject|3|||
126167218|NCT05122650|453897818|FG001|Overall Study|Withdrawal by Subject|7|||
126167219|NCT05122650|453897819|FG002|Overall Study|Withdrawal by Subject|4|||
126167220|NCT05122650|453897820|FG003|Overall Study|Withdrawal by Subject|8|||
126167221|NCT05122650|453897817|FG000|Overall Study|Other|5|||
126167222|NCT05122650|453897818|FG001|Overall Study|Other|0|||
126167223|NCT05122650|453897819|FG002|Overall Study|Other|0|||
126167224|NCT05122650|453897820|FG003|Overall Study|Other|0|||
126167225|NCT04360187|453897831|FG000|Double-Blind Treatment|Adverse Event|9|||
126167226|NCT04360187|453897832|FG001|Double-Blind Treatment|Adverse Event|11|||
126167227|NCT04360187|453897831|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
126167228|NCT04360187|453897832|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
126167229|NCT04360187|453897831|FG000|Double-Blind Treatment|Physician Decision|1|||
126167230|NCT04360187|453897832|FG001|Double-Blind Treatment|Physician Decision|0|||
126167231|NCT04360187|453897831|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
126167232|NCT04360187|453897832|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
126167233|NCT04360187|453897831|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
126167234|NCT04360187|453897832|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
126167235|NCT04360187|453897831|FG000|Follow-Up|Lost to Follow-up|1|||
126167236|NCT04360187|453897832|FG001|Follow-Up|Lost to Follow-up|0|||
126167237|NCT00222729|453897836|FG000|Overall Study|Adverse Event|3|||
126167238|NCT01318083|453897837|FG000|Overall Study|Adverse Event|4|||
126167239|NCT01318083|453897838|FG001|Overall Study|Adverse Event|1|||
126167240|NCT01318083|453897839|FG002|Overall Study|Adverse Event|2|||
126167241|NCT01318083|453897837|FG000|Overall Study|Withdrawal by Subject|1|||
126167242|NCT01318083|453897838|FG001|Overall Study|Withdrawal by Subject|0|||
126167243|NCT01318083|453897839|FG002|Overall Study|Withdrawal by Subject|2|||
126167244|NCT01318083|453897837|FG000|Overall Study|Lack of Efficacy|0|||
126167245|NCT01318083|453897838|FG001|Overall Study|Lack of Efficacy|0|||
126167246|NCT01318083|453897839|FG002|Overall Study|Lack of Efficacy|1|||
126167247|NCT01318083|453897837|FG000|Overall Study|Treatment Complications|1|||
126167248|NCT01318083|453897838|FG001|Overall Study|Treatment Complications|0|||
126167249|NCT01318083|453897839|FG002|Overall Study|Treatment Complications|0|||
126167250|NCT01318083|453897837|FG000|Overall Study|Lack of Study Medication Compliance|0|||
126167251|NCT01318083|453897838|FG001|Overall Study|Lack of Study Medication Compliance|1|||
126167252|NCT01318083|453897839|FG002|Overall Study|Lack of Study Medication Compliance|0|||
126167253|NCT00256867|453897840|FG000|Overall Study|Adverse Event|0|||
126167254|NCT00256867|453897841|FG001|Overall Study|Adverse Event|1|||
125973181|NCT02564523|453191391|FG000|Overall Study|Lost to Follow-up|2|||
125973182|NCT02564523|453191392|FG001|Overall Study|Lost to Follow-up|1|||
125973183|NCT02564523|453191393|FG002|Overall Study|Lost to Follow-up|4|||
126167255|NCT00256867|453897842|FG002|Overall Study|Adverse Event|1|||
126167256|NCT00256867|453897843|FG003|Overall Study|Adverse Event|1|||
126167257|NCT00256867|453897844|FG004|Overall Study|Adverse Event|2|||
126167258|NCT00256867|453897845|FG005|Overall Study|Adverse Event|2|||
126167259|NCT00256867|453897846|FG006|Overall Study|Adverse Event|1|||
126167260|NCT00256867|453897847|FG007|Overall Study|Adverse Event|4|||
125973184|NCT02564523|453191394|FG003|Overall Study|Lost to Follow-up|0|||
125973185|NCT02564523|453191395|FG004|Overall Study|Lost to Follow-up|1|||
125973186|NCT02564523|453191396|FG005|Overall Study|Lost to Follow-up|0|||
125973187|NCT02564523|453191397|FG006|Overall Study|Lost to Follow-up|1|||
125973188|NCT02564523|453191398|FG007|Overall Study|Lost to Follow-up|0|||
126167261|NCT00256867|453897840|FG000|Overall Study|Lost to Follow-up|2|||
126167262|NCT00256867|453897841|FG001|Overall Study|Lost to Follow-up|2|||
126167263|NCT00256867|453897842|FG002|Overall Study|Lost to Follow-up|2|||
125973189|NCT02564523|453191399|FG008|Overall Study|Lost to Follow-up|0|||
126167264|NCT00256867|453897843|FG003|Overall Study|Lost to Follow-up|3|||
126167265|NCT00256867|453897844|FG004|Overall Study|Lost to Follow-up|2|||
125973190|NCT02564523|453191400|FG009|Overall Study|Lost to Follow-up|0|||
126167266|NCT00256867|453897845|FG005|Overall Study|Lost to Follow-up|0|||
126167267|NCT00256867|453897846|FG006|Overall Study|Lost to Follow-up|1|||
126167268|NCT00256867|453897847|FG007|Overall Study|Lost to Follow-up|2|||
126167269|NCT00256867|453897840|FG000|Overall Study|Protocol Violation|0|||
126167270|NCT00256867|453897841|FG001|Overall Study|Protocol Violation|0|||
126167271|NCT00256867|453897842|FG002|Overall Study|Protocol Violation|0|||
126167272|NCT00256867|453897843|FG003|Overall Study|Protocol Violation|1|||
126167273|NCT00256867|453897844|FG004|Overall Study|Protocol Violation|0|||
126167274|NCT00256867|453897845|FG005|Overall Study|Protocol Violation|1|||
126167275|NCT00256867|453897846|FG006|Overall Study|Protocol Violation|0|||
126167276|NCT00256867|453897847|FG007|Overall Study|Protocol Violation|1|||
126167277|NCT00256867|453897840|FG000|Overall Study|Withdrawal by Subject|0|||
126167278|NCT00256867|453897841|FG001|Overall Study|Withdrawal by Subject|0|||
126167279|NCT00256867|453897842|FG002|Overall Study|Withdrawal by Subject|1|||
126167280|NCT00256867|453897843|FG003|Overall Study|Withdrawal by Subject|1|||
126167281|NCT00256867|453897844|FG004|Overall Study|Withdrawal by Subject|2|||
126167282|NCT00256867|453897845|FG005|Overall Study|Withdrawal by Subject|2|||
126167283|NCT00256867|453897846|FG006|Overall Study|Withdrawal by Subject|3|||
126167284|NCT00256867|453897847|FG007|Overall Study|Withdrawal by Subject|2|||
126167285|NCT00256867|453897840|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126167286|NCT00256867|453897841|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
126167287|NCT00256867|453897842|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126167288|NCT00256867|453897843|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126167289|NCT00256867|453897844|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126167290|NCT00256867|453897845|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126167291|NCT00256867|453897846|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126167292|NCT00256867|453897847|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126167293|NCT00256867|453897840|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126167294|NCT00256867|453897841|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126167295|NCT00256867|453897842|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126167296|NCT00256867|453897843|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126167297|NCT00256867|453897844|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126167298|NCT00256867|453897845|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126167299|NCT00256867|453897846|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126167300|NCT00256867|453897847|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
126167301|NCT00256867|453897840|FG000|Overall Study|Investigator's Decision|0|||
126167302|NCT00256867|453897841|FG001|Overall Study|Investigator's Decision|0|||
126167303|NCT00256867|453897842|FG002|Overall Study|Investigator's Decision|0|||
126167304|NCT00256867|453897843|FG003|Overall Study|Investigator's Decision|0|||
126167305|NCT00256867|453897844|FG004|Overall Study|Investigator's Decision|1|||
126167306|NCT00256867|453897845|FG005|Overall Study|Investigator's Decision|0|||
126167307|NCT00256867|453897846|FG006|Overall Study|Investigator's Decision|0|||
126167308|NCT00256867|453897847|FG007|Overall Study|Investigator's Decision|0|||
126167309|NCT00256867|453897840|FG000|Overall Study|Non-compliance with study medication|0|||
126167310|NCT00256867|453897841|FG001|Overall Study|Non-compliance with study medication|0|||
126167311|NCT00256867|453897842|FG002|Overall Study|Non-compliance with study medication|0|||
126167312|NCT00256867|453897843|FG003|Overall Study|Non-compliance with study medication|0|||
126167313|NCT00256867|453897844|FG004|Overall Study|Non-compliance with study medication|0|||
126167314|NCT00256867|453897845|FG005|Overall Study|Non-compliance with study medication|0|||
126167315|NCT00256867|453897846|FG006|Overall Study|Non-compliance with study medication|0|||
126167316|NCT00256867|453897847|FG007|Overall Study|Non-compliance with study medication|1|||
126167317|NCT00256867|453897840|FG000|Overall Study|Participant travelled Overseas|0|||
126167318|NCT00256867|453897841|FG001|Overall Study|Participant travelled Overseas|1|||
126167319|NCT00256867|453897842|FG002|Overall Study|Participant travelled Overseas|0|||
126167320|NCT00256867|453897843|FG003|Overall Study|Participant travelled Overseas|0|||
126167321|NCT00256867|453897844|FG004|Overall Study|Participant travelled Overseas|0|||
126167322|NCT00256867|453897845|FG005|Overall Study|Participant travelled Overseas|0|||
126167323|NCT00256867|453897846|FG006|Overall Study|Participant travelled Overseas|0|||
126167324|NCT00256867|453897847|FG007|Overall Study|Participant travelled Overseas|0|||
126167325|NCT00256867|453897840|FG000|Overall Study|Participant out of assessment window|0|||
125973191|NCT02564523|453191401|FG010|Overall Study|Lost to Follow-up|0|||
126167326|NCT00256867|453897841|FG001|Overall Study|Participant out of assessment window|0|||
126167327|NCT00256867|453897842|FG002|Overall Study|Participant out of assessment window|1|||
126167328|NCT00256867|453897843|FG003|Overall Study|Participant out of assessment window|0|||
126167329|NCT00256867|453897844|FG004|Overall Study|Participant out of assessment window|0|||
126167330|NCT00256867|453897845|FG005|Overall Study|Participant out of assessment window|0|||
126167331|NCT00256867|453897846|FG006|Overall Study|Participant out of assessment window|0|||
126167332|NCT00256867|453897847|FG007|Overall Study|Participant out of assessment window|0|||
126167333|NCT00256867|453897840|FG000|Overall Study|Withdrawal by participant|0|||
126167334|NCT00256867|453897841|FG001|Overall Study|Withdrawal by participant|0|||
126167335|NCT00256867|453897842|FG002|Overall Study|Withdrawal by participant|0|||
126167336|NCT00256867|453897843|FG003|Overall Study|Withdrawal by participant|0|||
126167337|NCT00256867|453897844|FG004|Overall Study|Withdrawal by participant|0|||
126167338|NCT00256867|453897845|FG005|Overall Study|Withdrawal by participant|1|||
126167339|NCT00256867|453897846|FG006|Overall Study|Withdrawal by participant|0|||
126167340|NCT00256867|453897847|FG007|Overall Study|Withdrawal by participant|0|||
126167341|NCT02993224|453897848|FG000|Core Phase - Period 1|Adverse Event|4|||
126167342|NCT02993224|453897848|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
126167343|NCT02993224|453897848|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
126167344|NCT02993224|453897848|FG000|Core Phase- Period 2|Adverse Event|1|||
126167345|NCT02993224|453897848|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
126167346|NCT02993224|453897848|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
126167347|NCT02993224|453897848|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
126167348|NCT02993224|453897848|FG000|Extension Phase|Adverse Event|3|||
126167349|NCT02993224|453897848|FG000|Extension Phase|Withdrawal by Subject|3|||
126167350|NCT02993224|453897848|FG000|Extension Phase|Lost to Follow-up|2|||
126167351|NCT02993224|453897848|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
126167352|NCT01930799|453897850|FG000|Overall Study|Withdrawal by Subject|3|||
126167353|NCT01930799|453897850|FG000|Overall Study|Lost to Follow-up|5|||
126167354|NCT00952289|453897854|FG000|All Participants|Death|9|||
126167355|NCT00952289|453897855|FG001|All Participants|Death|9|||
126167356|NCT00952289|453897854|FG000|All Participants|Adverse Event|8|||
126167357|NCT00952289|453897855|FG001|All Participants|Adverse Event|8|||
126167358|NCT00952289|453897854|FG000|All Participants|Disease progression|3|||
126167359|NCT00952289|453897855|FG001|All Participants|Disease progression|12|||
126167360|NCT00952289|453897854|FG000|All Participants|Withdrawal by Subject|1|||
126167361|NCT00952289|453897855|FG001|All Participants|Withdrawal by Subject|10|||
126167362|NCT00952289|453897854|FG000|All Participants|Data lost during site relocation|0|||
126167363|NCT00952289|453897855|FG001|All Participants|Data lost during site relocation|1|||
126167364|NCT00952289|453897854|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
126167365|NCT00952289|453897855|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
126167366|NCT00952289|453897854|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
126167367|NCT00952289|453897855|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
126167368|NCT00952289|453897854|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
126167369|NCT00952289|453897855|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
126167370|NCT00952289|453897854|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
126167371|NCT00952289|453897855|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
126167372|NCT00952289|453897854|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
126167373|NCT00952289|453897855|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
126167374|NCT00634244|453897859|FG000|Overall Study|Never started treatment|0|||
126167375|NCT00634244|453897860|FG001|Overall Study|Never started treatment|1|||
126167376|NCT00634244|453897861|FG002|Overall Study|Never started treatment|0|||
126167377|NCT00634244|453897859|FG000|Overall Study|Death|1|||
126167378|NCT00634244|453897860|FG001|Overall Study|Death|6|||
126167379|NCT00634244|453897861|FG002|Overall Study|Death|0|||
126167380|NCT00634244|453897859|FG000|Overall Study|Adverse Event|0|||
126167381|NCT00634244|453897860|FG001|Overall Study|Adverse Event|2|||
126167382|NCT00634244|453897861|FG002|Overall Study|Adverse Event|0|||
126167383|NCT00634244|453897859|FG000|Overall Study|Withdrawal by Subject|0|||
126167384|NCT00634244|453897860|FG001|Overall Study|Withdrawal by Subject|1|||
126167385|NCT00634244|453897861|FG002|Overall Study|Withdrawal by Subject|0|||
126167386|NCT00634244|453897859|FG000|Overall Study|Physician Decision|0|||
126167387|NCT00634244|453897860|FG001|Overall Study|Physician Decision|1|||
126167388|NCT00634244|453897861|FG002|Overall Study|Physician Decision|0|||
126167389|NCT00634244|453897859|FG000|Overall Study|Disease progression/relapse|0|||
126167390|NCT00634244|453897860|FG001|Overall Study|Disease progression/relapse|1|||
126167391|NCT00634244|453897861|FG002|Overall Study|Disease progression/relapse|0|||
126167392|NCT00634244|453897859|FG000|Overall Study|Other complicating disease|0|||
126167393|NCT00634244|453897860|FG001|Overall Study|Other complicating disease|1|||
126167394|NCT00634244|453897861|FG002|Overall Study|Other complicating disease|0|||
126167395|NCT02427477|453897862|FG000|Period 1|Adverse Event|1|||
125973192|NCT02564523|453191402|FG011|Overall Study|Lost to Follow-up|1|||
125973193|NCT02564523|453191403|FG012|Overall Study|Lost to Follow-up|1|||
125973194|NCT02564523|453191404|FG013|Overall Study|Lost to Follow-up|0|||
126167396|NCT02427477|453897863|FG001|Period 1|Adverse Event|0|||
126167397|NCT04369430|453897864|FG000|Overall Study|Adverse Event|2|||
126167398|NCT04369430|453897865|FG001|Overall Study|Adverse Event|3|||
126167399|NCT04369430|453897864|FG000|Overall Study|Death|1|||
126167400|NCT04369430|453897865|FG001|Overall Study|Death|0|||
126167401|NCT04369430|453897864|FG000|Overall Study|Withdrawal by Subject|4|||
126167402|NCT04369430|453897865|FG001|Overall Study|Withdrawal by Subject|3|||
126167403|NCT04369430|453897864|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
126167404|NCT04369430|453897865|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
126167405|NCT04369430|453897864|FG000|Overall Study|Lost to Follow-up|0|||
126167406|NCT04369430|453897865|FG001|Overall Study|Lost to Follow-up|1|||
126167407|NCT02635737|453897875|FG000|Overall Study|Protocol Violation|1|||
126167408|NCT00937768|453897876|FG000|Overall Study|Refused Further Treatment|3|||
126167409|NCT00937768|453897877|FG001|Overall Study|Refused Further Treatment|2|||
126167410|NCT00937768|453897876|FG000|Overall Study|Disease Progression|1|||
126167411|NCT00937768|453897877|FG001|Overall Study|Disease Progression|1|||
126167412|NCT00937768|453897876|FG000|Overall Study|Alternate Treatment|0|||
126167413|NCT00937768|453897877|FG001|Overall Study|Alternate Treatment|1|||
126167414|NCT00937768|453897876|FG000|Overall Study|No Further Funding|4|||
126167415|NCT00937768|453897877|FG001|Overall Study|No Further Funding|4|||
126167416|NCT02065622|453897878|FG000|Induction Study|Adverse Event|13|||
126167417|NCT02065622|453897879|FG001|Induction Study|Adverse Event|19|||
126167418|NCT02065622|453897880|FG002|Induction Study|Adverse Event|0|||
126167419|NCT02065622|453897881|FG003|Induction Study|Adverse Event|0|||
126167420|NCT02065622|453897882|FG004|Induction Study|Adverse Event|0|||
126167421|NCT02065622|453897878|FG000|Induction Study|Withdrawal by Subject|3|||
126167422|NCT02065622|453897879|FG001|Induction Study|Withdrawal by Subject|5|||
126167423|NCT02065622|453897880|FG002|Induction Study|Withdrawal by Subject|0|||
126167424|NCT02065622|453897881|FG003|Induction Study|Withdrawal by Subject|0|||
126167425|NCT02065622|453897882|FG004|Induction Study|Withdrawal by Subject|0|||
126167426|NCT02065622|453897878|FG000|Induction Study|Lost to Follow-up|1|||
126167427|NCT02065622|453897879|FG001|Induction Study|Lost to Follow-up|0|||
126167428|NCT02065622|453897880|FG002|Induction Study|Lost to Follow-up|0|||
126167429|NCT02065622|453897881|FG003|Induction Study|Lost to Follow-up|0|||
126167430|NCT02065622|453897882|FG004|Induction Study|Lost to Follow-up|0|||
126167431|NCT02065622|453897878|FG000|Induction Study|Lack of Efficacy|22|||
126167432|NCT02065622|453897879|FG001|Induction Study|Lack of Efficacy|27|||
126167433|NCT02065622|453897880|FG002|Induction Study|Lack of Efficacy|0|||
126167434|NCT02065622|453897881|FG003|Induction Study|Lack of Efficacy|0|||
126167435|NCT02065622|453897882|FG004|Induction Study|Lack of Efficacy|0|||
126167436|NCT02065622|453897878|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
126167437|NCT02065622|453897879|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
126167438|NCT02065622|453897880|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
126167439|NCT02065622|453897881|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
126167440|NCT02065622|453897882|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
126167441|NCT02065622|453897878|FG000|Induction Study|Subject Noncompliance|1|||
126167442|NCT02065622|453897879|FG001|Induction Study|Subject Noncompliance|1|||
126167443|NCT02065622|453897880|FG002|Induction Study|Subject Noncompliance|0|||
126167444|NCT02065622|453897881|FG003|Induction Study|Subject Noncompliance|0|||
126167445|NCT02065622|453897882|FG004|Induction Study|Subject Noncompliance|0|||
126167446|NCT02065622|453897878|FG000|Induction Study|Other, Not Specified|3|||
126167447|NCT02065622|453897879|FG001|Induction Study|Other, Not Specified|2|||
126167448|NCT02065622|453897880|FG002|Induction Study|Other, Not Specified|0|||
126167449|NCT02065622|453897881|FG003|Induction Study|Other, Not Specified|0|||
126167450|NCT02065622|453897882|FG004|Induction Study|Other, Not Specified|0|||
126167451|NCT02065622|453897878|FG000|Maintenance Study|Adverse Event|0|||
126167452|NCT02065622|453897879|FG001|Maintenance Study|Adverse Event|0|||
126167453|NCT02065622|453897880|FG002|Maintenance Study|Adverse Event|25|||
126167454|NCT02065622|453897881|FG003|Maintenance Study|Adverse Event|22|||
126167455|NCT02065622|453897882|FG004|Maintenance Study|Adverse Event|11|||
126167456|NCT02065622|453897878|FG000|Maintenance Study|Withdrawal by Subject|0|||
126167457|NCT02065622|453897879|FG001|Maintenance Study|Withdrawal by Subject|0|||
126167458|NCT02065622|453897880|FG002|Maintenance Study|Withdrawal by Subject|11|||
126167459|NCT02065622|453897881|FG003|Maintenance Study|Withdrawal by Subject|5|||
126167460|NCT02065622|453897882|FG004|Maintenance Study|Withdrawal by Subject|7|||
126167461|NCT02065622|453897878|FG000|Maintenance Study|Lost to Follow-up|0|||
126167462|NCT02065622|453897879|FG001|Maintenance Study|Lost to Follow-up|0|||
126167463|NCT02065622|453897880|FG002|Maintenance Study|Lost to Follow-up|4|||
126167464|NCT02065622|453897881|FG003|Maintenance Study|Lost to Follow-up|1|||
126167465|NCT02065622|453897882|FG004|Maintenance Study|Lost to Follow-up|1|||
126167466|NCT02065622|453897878|FG000|Maintenance Study|Lack of Efficacy|0|||
126167467|NCT02065622|453897879|FG001|Maintenance Study|Lack of Efficacy|0|||
126167468|NCT02065622|453897880|FG002|Maintenance Study|Lack of Efficacy|70|||
126167469|NCT02065622|453897881|FG003|Maintenance Study|Lack of Efficacy|55|||
125973195|NCT02564523|453191405|FG014|Overall Study|Lost to Follow-up|0|||
126167470|NCT02065622|453897882|FG004|Maintenance Study|Lack of Efficacy|19|||
126167471|NCT02065622|453897878|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
126167472|NCT02065622|453897879|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
126167473|NCT02065622|453897880|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
126167474|NCT02065622|453897881|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
126167475|NCT02065622|453897882|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
126167476|NCT02065622|453897878|FG000|Maintenance Study|Subject Non-Compliance|0|||
126167477|NCT02065622|453897879|FG001|Maintenance Study|Subject Non-Compliance|0|||
126167478|NCT02065622|453897880|FG002|Maintenance Study|Subject Non-Compliance|1|||
126167479|NCT02065622|453897881|FG003|Maintenance Study|Subject Non-Compliance|3|||
126167480|NCT02065622|453897882|FG004|Maintenance Study|Subject Non-Compliance|2|||
125973196|NCT02564523|453191406|FG015|Overall Study|Lost to Follow-up|0|||
126167481|NCT02065622|453897878|FG000|Maintenance Study|Other, Not Specified|0|||
126167482|NCT02065622|453897879|FG001|Maintenance Study|Other, Not Specified|0|||
126167483|NCT02065622|453897880|FG002|Maintenance Study|Other, Not Specified|6|||
126167484|NCT02065622|453897881|FG003|Maintenance Study|Other, Not Specified|14|||
126167485|NCT02065622|453897882|FG004|Maintenance Study|Other, Not Specified|2|||
126167486|NCT02065622|453897878|FG000|Maintenance Study|Unknown Reason|0|||
126167487|NCT02065622|453897879|FG001|Maintenance Study|Unknown Reason|0|||
126167488|NCT02065622|453897880|FG002|Maintenance Study|Unknown Reason|0|||
126167489|NCT02065622|453897881|FG003|Maintenance Study|Unknown Reason|1|||
126167490|NCT02065622|453897882|FG004|Maintenance Study|Unknown Reason|0|||
126167491|NCT01687413|453897883|FG000|Overall Study|Withdrawal by Subject|0|||
126167492|NCT01687413|453897884|FG001|Overall Study|Withdrawal by Subject|2|||
126167493|NCT01687413|453897883|FG000|Overall Study|Not eligible|0|||
126167494|NCT01687413|453897884|FG001|Overall Study|Not eligible|2|||
126167495|NCT01687413|453897883|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
126167496|NCT01687413|453897884|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
126167497|NCT01767194|453897885|FG000|Overall Study|Adverse Event|1|||
126167498|NCT01767194|453897886|FG001|Overall Study|Adverse Event|1|||
126167499|NCT01767194|453897885|FG000|Overall Study|Death|0|||
126167500|NCT01767194|453897886|FG001|Overall Study|Death|1|||
126167501|NCT01767194|453897885|FG000|Overall Study|Lack of Efficacy|12|||
126167502|NCT01767194|453897886|FG001|Overall Study|Lack of Efficacy|11|||
126167503|NCT01767194|453897885|FG000|Overall Study|Physician Decision|2|||
126167504|NCT01767194|453897886|FG001|Overall Study|Physician Decision|23|||
126167505|NCT01767194|453897885|FG000|Overall Study|Withdrawal by Subject|0|||
126167506|NCT01767194|453897886|FG001|Overall Study|Withdrawal by Subject|1|||
126167507|NCT01767194|453897885|FG000|Overall Study|Ineligible|1|||
126167508|NCT01767194|453897886|FG001|Overall Study|Ineligible|1|||
126167509|NCT01767194|453897885|FG000|Overall Study|Refusal by patient/parent|2|||
126167510|NCT01767194|453897886|FG001|Overall Study|Refusal by patient/parent|4|||
126167511|NCT01767194|453897885|FG000|Overall Study|Criteria not met on time for next cycle|0|||
126167512|NCT01767194|453897886|FG001|Overall Study|Criteria not met on time for next cycle|1|||
126167513|NCT00488618|453897896|FG000|Overall Study|Adverse Event|13|||
126167514|NCT00488618|453897897|FG001|Overall Study|Adverse Event|17|||
126167515|NCT00488618|453897896|FG000|Overall Study|Insufficient Therapeutic Response|18|||
126167516|NCT00488618|453897897|FG001|Overall Study|Insufficient Therapeutic Response|11|||
126167517|NCT00488618|453897896|FG000|Overall Study|Protocol Violation|0|||
126167518|NCT00488618|453897897|FG001|Overall Study|Protocol Violation|2|||
126167519|NCT00488618|453897896|FG000|Overall Study|Withdrawal of Consent|15|||
126167520|NCT00488618|453897897|FG001|Overall Study|Withdrawal of Consent|13|||
126167521|NCT00488618|453897896|FG000|Overall Study|Lost to Follow-up|1|||
126167522|NCT00488618|453897897|FG001|Overall Study|Lost to Follow-up|0|||
126167523|NCT03675737|453897899|FG000|Overall Study|Death|593|||
126167524|NCT03675737|453897900|FG001|Overall Study|Death|660|||
126167525|NCT03675737|453897899|FG000|Overall Study|Lost to Follow-up|1|||
126167526|NCT03675737|453897900|FG001|Overall Study|Lost to Follow-up|5|||
126167527|NCT03675737|453897899|FG000|Overall Study|Physician Decision|1|||
126167528|NCT03675737|453897900|FG001|Overall Study|Physician Decision|0|||
126167529|NCT03675737|453897899|FG000|Overall Study|Withdrawal by Subject|14|||
126167530|NCT03675737|453897900|FG001|Overall Study|Withdrawal by Subject|12|||
126167531|NCT03675737|453897899|FG000|Overall Study|Ongoing in Study|181|||
126167532|NCT03675737|453897900|FG001|Overall Study|Ongoing in Study|112|||
126167533|NCT02349789|453899567|FG000|Overall Study|Withdrawal by Subject|2|||
126167534|NCT00683475|453899570|FG000|Overall Study|Withdrawal by Subject|1|||
126167535|NCT00683475|453899571|FG001|Overall Study|Withdrawal by Subject|0|||
126167536|NCT00683475|453899570|FG000|Overall Study|Never Treated: Adverse Event|2|||
126167537|NCT00683475|453899571|FG001|Overall Study|Never Treated: Adverse Event|3|||
126167538|NCT00683475|453899570|FG000|Overall Study|Never Treated: Progressive Disease|1|||
126167539|NCT00683475|453899571|FG001|Overall Study|Never Treated: Progressive Disease|0|||
126167540|NCT02922634|453899572|FG000|Overall Study|Withdrawal by Subject|5|||
126167541|NCT02922634|453899572|FG000|Overall Study|Did not have their surgery|5|||
126167542|NCT02723604|453899573|FG000|Overall Study|ineligible|1|||
126167543|NCT02723604|453899573|FG000|Overall Study|never received treatment|1|||
126167544|NCT00352755|453899576|FG000|Overall Study|Physician Decision|1|||
126167545|NCT00352755|453899576|FG000|Overall Study|Adverse Event|1|||
126167546|NCT01694420|453899578|FG000|Overall Study|Lost to Follow-up|3|||
126167547|NCT03987919|453899579|FG000|Overall Study|Adverse Event|1|||
126167548|NCT03987919|453899580|FG001|Overall Study|Adverse Event|4|||
125973197|NCT02564523|453191407|FG016|Overall Study|Lost to Follow-up|0|||
125973198|NCT02564523|453191408|FG017|Overall Study|Lost to Follow-up|0|||
125973199|NCT02564523|453191391|FG000|Overall Study|Physician Decision|0|||
126167549|NCT03987919|453899581|FG002|Overall Study|Adverse Event|1|||
126167550|NCT03987919|453899582|FG003|Overall Study|Adverse Event|3|||
126167551|NCT03987919|453899579|FG000|Overall Study|Death|4|||
126167552|NCT03987919|453899580|FG001|Overall Study|Death|4|||
126167553|NCT03987919|453899581|FG002|Overall Study|Death|4|||
126167554|NCT03987919|453899582|FG003|Overall Study|Death|1|||
126167555|NCT03987919|453899579|FG000|Overall Study|Lost to Follow-up|5|||
126167556|NCT03987919|453899580|FG001|Overall Study|Lost to Follow-up|6|||
126167557|NCT03987919|453899581|FG002|Overall Study|Lost to Follow-up|8|||
126167558|NCT03987919|453899582|FG003|Overall Study|Lost to Follow-up|12|||
126167559|NCT03987919|453899579|FG000|Overall Study|Physician Decision|0|||
126167560|NCT03987919|453899580|FG001|Overall Study|Physician Decision|2|||
126167561|NCT03987919|453899581|FG002|Overall Study|Physician Decision|0|||
126167562|NCT03987919|453899582|FG003|Overall Study|Physician Decision|4|||
126167563|NCT03987919|453899579|FG000|Overall Study|Pregnancy|1|||
126167564|NCT03987919|453899580|FG001|Overall Study|Pregnancy|0|||
126167565|NCT03987919|453899581|FG002|Overall Study|Pregnancy|1|||
126167566|NCT03987919|453899582|FG003|Overall Study|Pregnancy|1|||
126167567|NCT03987919|453899579|FG000|Overall Study|Protocol Violation|0|||
126167568|NCT03987919|453899580|FG001|Overall Study|Protocol Violation|1|||
126167569|NCT03987919|453899581|FG002|Overall Study|Protocol Violation|0|||
126167570|NCT03987919|453899582|FG003|Overall Study|Protocol Violation|0|||
126167571|NCT03987919|453899579|FG000|Overall Study|Site terminated by Sponsor|0|||
126167572|NCT03987919|453899580|FG001|Overall Study|Site terminated by Sponsor|0|||
126167573|NCT03987919|453899581|FG002|Overall Study|Site terminated by Sponsor|0|||
126167574|NCT03987919|453899582|FG003|Overall Study|Site terminated by Sponsor|1|||
126167575|NCT03987919|453899579|FG000|Overall Study|Withdrawal by Subject|7|||
126167576|NCT03987919|453899580|FG001|Overall Study|Withdrawal by Subject|7|||
126167577|NCT03987919|453899581|FG002|Overall Study|Withdrawal by Subject|8|||
126167578|NCT03987919|453899582|FG003|Overall Study|Withdrawal by Subject|4|||
126167579|NCT03987919|453899579|FG000|Overall Study|Other - as reported by the investigator|1|||
126167580|NCT03987919|453899580|FG001|Overall Study|Other - as reported by the investigator|3|||
126167581|NCT03987919|453899581|FG002|Overall Study|Other - as reported by the investigator|2|||
126167582|NCT03987919|453899582|FG003|Overall Study|Other - as reported by the investigator|0|||
126167583|NCT01194804|453899583|FG000|Overall Study|Withdrawal by Subject|1|||
126167584|NCT03621943|453899584|FG000|First Randomized Intervention|Lost to Follow-up|51|||
126167585|NCT03621943|453899585|FG001|First Randomized Intervention|Lost to Follow-up|54|||
126167586|NCT03621943|453899584|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
126167587|NCT03621943|453899585|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
126167588|NCT03621943|453899584|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
126167589|NCT03621943|453899585|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
125973200|NCT02564523|453191392|FG001|Overall Study|Physician Decision|0|||
125973201|NCT02564523|453191393|FG002|Overall Study|Physician Decision|0|||
125973202|NCT02564523|453191394|FG003|Overall Study|Physician Decision|0|||
125973203|NCT02564523|453191395|FG004|Overall Study|Physician Decision|1|||
125973204|NCT02564523|453191396|FG005|Overall Study|Physician Decision|0|||
125973205|NCT02564523|453191397|FG006|Overall Study|Physician Decision|0|||
125973206|NCT02564523|453191398|FG007|Overall Study|Physician Decision|0|||
125973207|NCT02564523|453191399|FG008|Overall Study|Physician Decision|0|||
125973208|NCT02564523|453191400|FG009|Overall Study|Physician Decision|0|||
125973209|NCT02564523|453191401|FG010|Overall Study|Physician Decision|1|||
125973210|NCT02564523|453191402|FG011|Overall Study|Physician Decision|0|||
125973211|NCT02564523|453191403|FG012|Overall Study|Physician Decision|0|||
125973212|NCT02564523|453191404|FG013|Overall Study|Physician Decision|0|||
125973213|NCT02564523|453191405|FG014|Overall Study|Physician Decision|0|||
126167590|NCT03621943|453899584|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
126167591|NCT03621943|453899585|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
126167592|NCT00748553|453899586|FG000|Overall Study|Adverse Event|0|||
126167593|NCT00748553|453899587|FG001|Overall Study|Adverse Event|1|||
126167594|NCT00748553|453899586|FG000|Overall Study|disease progression|2|||
126167595|NCT00748553|453899587|FG001|Overall Study|disease progression|0|||
125973214|NCT02564523|453191406|FG015|Overall Study|Physician Decision|0|||
126167596|NCT00748553|453899586|FG000|Overall Study|noncompliance|1|||
126167597|NCT00748553|453899587|FG001|Overall Study|noncompliance|0|||
126167598|NCT00315705|453899588|FG000|Phase 1|Refused further treatment|1|||
126167599|NCT00315705|453899588|FG000|Phase 1|Failure to achieve response|8|||
126167600|NCT00315705|453899588|FG000|Phase 1|Disease relapse|4|||
126167601|NCT00315705|453899588|FG000|Phase 1|Scheduled for transplant|9|||
125973215|NCT02564523|453191407|FG016|Overall Study|Physician Decision|0|||
125973216|NCT02564523|453191408|FG017|Overall Study|Physician Decision|0|||
125973217|NCT02564523|453191391|FG000|Overall Study|Protocol Violation|2|||
125973218|NCT02564523|453191392|FG001|Overall Study|Protocol Violation|2|||
125973219|NCT02564523|453191393|FG002|Overall Study|Protocol Violation|5|||
125973220|NCT02564523|453191394|FG003|Overall Study|Protocol Violation|0|||
126167602|NCT00315705|453899588|FG000|Phase 1|Death|3|||
126167603|NCT00315705|453899588|FG000|Phase 2|Physician Decision|4|||
125973221|NCT02564523|453191395|FG004|Overall Study|Protocol Violation|1|||
126167604|NCT00315705|453899588|FG000|Phase 2|Adverse Event|1|||
126167605|NCT00315705|453899588|FG000|Phase 2|Failure to achieve response|3|||
125973222|NCT02564523|453191396|FG005|Overall Study|Protocol Violation|0|||
125973223|NCT02564523|453191397|FG006|Overall Study|Protocol Violation|0|||
125973224|NCT02564523|453191398|FG007|Overall Study|Protocol Violation|0|||
125973225|NCT02564523|453191399|FG008|Overall Study|Protocol Violation|0|||
126167606|NCT00315705|453899588|FG000|Phase 2|Disease relapse|1|||
126167607|NCT00315705|453899588|FG000|Phase 2|Scheduled for transplant|8|||
126167608|NCT00315705|453899588|FG000|Phase 2|Other|1|||
126167609|NCT00315705|453899588|FG000|Phase 2|Death|7|||
126167610|NCT00948818|453899590|FG000|Overall Study|Adverse Event|10|||
126167611|NCT00948818|453899591|FG001|Overall Study|Adverse Event|32|||
126167612|NCT00948818|453899590|FG000|Overall Study|Protocol Violation|9|||
126167613|NCT00948818|453899591|FG001|Overall Study|Protocol Violation|10|||
126167614|NCT00948818|453899590|FG000|Overall Study|Withdrawal by Subject|25|||
126167615|NCT00948818|453899591|FG001|Overall Study|Withdrawal by Subject|25|||
126167616|NCT00948818|453899590|FG000|Overall Study|Lost to Follow-up|10|||
126167617|NCT00948818|453899591|FG001|Overall Study|Lost to Follow-up|17|||
126167618|NCT00948818|453899590|FG000|Overall Study|Lack of Efficacy|4|||
126167619|NCT00948818|453899591|FG001|Overall Study|Lack of Efficacy|5|||
126167620|NCT00948818|453899590|FG000|Overall Study|Other Reason|4|||
126167621|NCT00948818|453899591|FG001|Overall Study|Other Reason|5|||
126167622|NCT02330549|453899592|FG000|Overall Study|Adverse Event|1|||
126167623|NCT02330549|453899593|FG001|Overall Study|Adverse Event|0|||
126167624|NCT02330549|453899592|FG000|Overall Study|Subject withdrew consent|2|||
126167625|NCT02330549|453899593|FG001|Overall Study|Subject withdrew consent|1|||
126167626|NCT02330549|453899592|FG000|Overall Study|Failure to meet randomization criteria|1|||
126167627|NCT02330549|453899593|FG001|Overall Study|Failure to meet randomization criteria|0|||
126167628|NCT02326467|453899597|FG000|Overall Study|Withdrawal by Subject|1|||
126167629|NCT00434512|453899598|FG000|Overall Study|Migrated/moved from study area|0|||
126167630|NCT00434512|453899599|FG001|Overall Study|Migrated/moved from study area|0|||
126167631|NCT00434512|453899600|FG002|Overall Study|Migrated/moved from study area|0|||
126167632|NCT00434512|453899601|FG003|Overall Study|Migrated/moved from study area|1|||
126167633|NCT00434512|453899602|FG004|Overall Study|Migrated/moved from study area|1|||
126167634|NCT00434512|453899603|FG005|Overall Study|Migrated/moved from study area|1|||
126167635|NCT00434512|453899598|FG000|Overall Study|Other|0|||
126167636|NCT00434512|453899599|FG001|Overall Study|Other|1|||
126167637|NCT00434512|453899600|FG002|Overall Study|Other|0|||
126167638|NCT00434512|453899601|FG003|Overall Study|Other|0|||
126167639|NCT00434512|453899602|FG004|Overall Study|Other|0|||
126167640|NCT00434512|453899603|FG005|Overall Study|Other|0|||
126167641|NCT01575197|453899606|FG000|Overall Study|Migration out of study area|1|||
126167642|NCT01575197|453899607|FG001|Overall Study|Migration out of study area|5|||
126167643|NCT01575197|453899608|FG002|Overall Study|Migration out of study area|4|||
126167644|NCT01575197|453899606|FG000|Overall Study|SAE|0|||
126167645|NCT01575197|453899607|FG001|Overall Study|SAE|1|||
126167646|NCT01575197|453899608|FG002|Overall Study|SAE|0|||
126167647|NCT01575197|453899606|FG000|Overall Study|Lost to Follow-up|0|||
126167648|NCT01575197|453899607|FG001|Overall Study|Lost to Follow-up|1|||
126167649|NCT01575197|453899608|FG002|Overall Study|Lost to Follow-up|0|||
126167650|NCT01575197|453899606|FG000|Overall Study|Withdrawal by Subject|0|||
126167651|NCT01575197|453899607|FG001|Overall Study|Withdrawal by Subject|1|||
126167652|NCT01575197|453899608|FG002|Overall Study|Withdrawal by Subject|1|||
126167653|NCT01575197|453899606|FG000|Overall Study|Protocol Violation|2|||
126167654|NCT01575197|453899607|FG001|Overall Study|Protocol Violation|1|||
126167655|NCT01575197|453899608|FG002|Overall Study|Protocol Violation|1|||
126167656|NCT00111475|453899612|FG000|Overall Study|Lost to Follow-up|0|||
126167657|NCT00111475|453899613|FG001|Overall Study|Lost to Follow-up|0|||
126167658|NCT00111475|453899614|FG002|Overall Study|Lost to Follow-up|0|||
126167659|NCT00111475|453899615|FG003|Overall Study|Lost to Follow-up|0|||
126167660|NCT00111475|453899616|FG004|Overall Study|Lost to Follow-up|0|||
126167661|NCT00111475|453899617|FG005|Overall Study|Lost to Follow-up|1|||
126167662|NCT00111475|453899618|FG006|Overall Study|Lost to Follow-up|0|||
126167663|NCT00111475|453899619|FG007|Overall Study|Lost to Follow-up|0|||
126167664|NCT00111475|453899620|FG008|Overall Study|Lost to Follow-up|0|||
126167665|NCT00111475|453899621|FG009|Overall Study|Lost to Follow-up|0|||
126167666|NCT03303092|453899622|FG000|Overall Study|Adverse Event|1|||
126167667|NCT03303092|453899623|FG001|Overall Study|Adverse Event|0|||
126167668|NCT03303092|453899624|FG002|Overall Study|Adverse Event|1|||
125973226|NCT02564523|453191400|FG009|Overall Study|Protocol Violation|0|||
125973227|NCT02564523|453191401|FG010|Overall Study|Protocol Violation|0|||
126167669|NCT03303092|453899622|FG000|Overall Study|Protocol Violation|1|||
126167670|NCT03303092|453899623|FG001|Overall Study|Protocol Violation|5|||
126167671|NCT03303092|453899624|FG002|Overall Study|Protocol Violation|1|||
126167672|NCT03303092|453899622|FG000|Overall Study|Withdrawal by Subject|1|||
126167673|NCT03303092|453899623|FG001|Overall Study|Withdrawal by Subject|1|||
126167674|NCT03303092|453899624|FG002|Overall Study|Withdrawal by Subject|3|||
126167675|NCT01995136|453899627|FG000|Overall Study|Change in residence|1|||
126167676|NCT00748540|453899628|FG000|Overall Study|Physician Decision|1|||
126167677|NCT01814800|453899629|FG000|Overall Study|Adverse Event|2|||
126167678|NCT01814800|453899629|FG000|Overall Study|Pregnancy|1|||
126167679|NCT01814800|453899629|FG000|Overall Study|Sponsor decision|1|||
126167680|NCT01814800|453899629|FG000|Overall Study|Subject relocation|1|||
126167681|NCT02371759|453899632|FG000|Overall Study|Protocol Violation|3|||
126167682|NCT02371759|453899633|FG001|Overall Study|Protocol Violation|1|||
126167683|NCT02371759|453899634|FG002|Overall Study|Protocol Violation|1|||
126167684|NCT02371759|453899635|FG003|Overall Study|Protocol Violation|0|||
126167685|NCT02371759|453899636|FG004|Overall Study|Protocol Violation|3|||
126167686|NCT02371759|453899637|FG005|Overall Study|Protocol Violation|1|||
126167687|NCT02371759|453899638|FG006|Overall Study|Protocol Violation|0|||
126167688|NCT02371759|453899639|FG007|Overall Study|Protocol Violation|3|||
126167689|NCT02371759|453899632|FG000|Overall Study|Withdrawal by Subject|0|||
126167690|NCT02371759|453899633|FG001|Overall Study|Withdrawal by Subject|0|||
126167691|NCT02371759|453899634|FG002|Overall Study|Withdrawal by Subject|0|||
126167692|NCT02371759|453899635|FG003|Overall Study|Withdrawal by Subject|0|||
126167693|NCT02371759|453899636|FG004|Overall Study|Withdrawal by Subject|0|||
126167694|NCT02371759|453899637|FG005|Overall Study|Withdrawal by Subject|0|||
126167695|NCT02371759|453899638|FG006|Overall Study|Withdrawal by Subject|0|||
126167696|NCT02371759|453899639|FG007|Overall Study|Withdrawal by Subject|1|||
126167697|NCT00243230|453899642|FG000|Double-Blind Period|Adverse Event|0|||
126167698|NCT00243230|453899643|FG001|Double-Blind Period|Adverse Event|2|||
126167699|NCT00243230|453899644|FG002|Double-Blind Period|Adverse Event|2|||
126167700|NCT00243230|453899645|FG003|Double-Blind Period|Adverse Event|0|||
126167701|NCT00243230|453899642|FG000|Double-Blind Period|Withdrawal by Subject|1|||
126167702|NCT00243230|453899643|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126167703|NCT00243230|453899644|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126167704|NCT00243230|453899645|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126167705|NCT00243230|453899642|FG000|Double-Blind Period|Protocol Violation|0|||
126167706|NCT00243230|453899643|FG001|Double-Blind Period|Protocol Violation|0|||
126167707|NCT00243230|453899644|FG002|Double-Blind Period|Protocol Violation|1|||
126167708|NCT00243230|453899645|FG003|Double-Blind Period|Protocol Violation|0|||
126167709|NCT00243230|453899642|FG000|Double-Blind Period|Randomized but Not Treated|0|||
126167710|NCT00243230|453899643|FG001|Double-Blind Period|Randomized but Not Treated|0|||
126167711|NCT00243230|453899644|FG002|Double-Blind Period|Randomized but Not Treated|2|||
126167712|NCT00243230|453899645|FG003|Double-Blind Period|Randomized but Not Treated|0|||
126167713|NCT00243230|453899642|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
126167714|NCT00243230|453899643|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
126167715|NCT00243230|453899644|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
126167716|NCT00243230|453899645|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
126167717|NCT00243230|453899642|FG000|Open Label Period|Adverse Event|0|||
126167718|NCT00243230|453899643|FG001|Open Label Period|Adverse Event|0|||
126167719|NCT00243230|453899644|FG002|Open Label Period|Adverse Event|0|||
126167720|NCT00243230|453899645|FG003|Open Label Period|Adverse Event|2|||
126167721|NCT00243230|453899642|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
126167722|NCT00243230|453899643|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
126167723|NCT00243230|453899644|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
126167724|NCT00243230|453899645|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
126167725|NCT00243230|453899642|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
126167726|NCT00243230|453899643|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
126167727|NCT00243230|453899644|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
126167728|NCT00243230|453899645|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
126167729|NCT00243230|453899642|FG000|Open Label Period|Lost to Follow-up|0|||
126167730|NCT00243230|453899643|FG001|Open Label Period|Lost to Follow-up|0|||
126167731|NCT00243230|453899644|FG002|Open Label Period|Lost to Follow-up|0|||
126167732|NCT00243230|453899645|FG003|Open Label Period|Lost to Follow-up|2|||
126167733|NCT00243230|453899642|FG000|Open Label Period|Withdrawal by Subject|0|||
126167734|NCT00243230|453899643|FG001|Open Label Period|Withdrawal by Subject|0|||
126167735|NCT00243230|453899644|FG002|Open Label Period|Withdrawal by Subject|0|||
126167736|NCT00243230|453899645|FG003|Open Label Period|Withdrawal by Subject|2|||
126167737|NCT00243230|453899642|FG000|Open Label Period|Protocol Violation|0|||
126167738|NCT00243230|453899643|FG001|Open Label Period|Protocol Violation|0|||
126167739|NCT00243230|453899644|FG002|Open Label Period|Protocol Violation|0|||
126167740|NCT00243230|453899645|FG003|Open Label Period|Protocol Violation|2|||
126167741|NCT00243230|453899642|FG000|Open Label Period|Administrative Reason|0|||
126167742|NCT00243230|453899643|FG001|Open Label Period|Administrative Reason|0|||
126167743|NCT00243230|453899644|FG002|Open Label Period|Administrative Reason|0|||
126167744|NCT00243230|453899645|FG003|Open Label Period|Administrative Reason|63|||
126167745|NCT01689207|453899646|FG000|Overall Study|Adverse Event|0|||
126167746|NCT01689207|453899647|FG001|Overall Study|Adverse Event|1|||
126167747|NCT01689207|453899648|FG002|Overall Study|Adverse Event|0|||
126167748|NCT01689207|453899649|FG003|Overall Study|Adverse Event|0|||
126167749|NCT01689207|453899650|FG004|Overall Study|Adverse Event|2|||
126167750|NCT01689207|453899651|FG005|Overall Study|Adverse Event|1|||
126167751|NCT01689207|453899652|FG006|Overall Study|Adverse Event|0|||
125973228|NCT02564523|453191402|FG011|Overall Study|Protocol Violation|0|||
125973229|NCT02564523|453191403|FG012|Overall Study|Protocol Violation|0|||
126167752|NCT01689207|453899653|FG007|Overall Study|Adverse Event|0|||
126167753|NCT01689207|453899654|FG008|Overall Study|Adverse Event|1|||
126167754|NCT01689207|453899655|FG009|Overall Study|Adverse Event|0|||
126167755|NCT01689207|453899656|FG010|Overall Study|Adverse Event|0|||
126167756|NCT05118386|453899660|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126167757|NCT05118386|453899661|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126167758|NCT05118386|453899662|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126167759|NCT05118386|453899663|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
126167760|NCT05118386|453899664|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126167761|NCT05118386|453899665|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126167762|NCT05118386|453899660|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126167763|NCT05118386|453899661|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126167764|NCT05118386|453899662|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126167765|NCT05118386|453899663|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126167766|NCT05118386|453899664|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
126167767|NCT05118386|453899665|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126167768|NCT01423617|453899666|FG000|Overall Study|Lost to Follow-up|0|||
126167769|NCT01423617|453899667|FG001|Overall Study|Lost to Follow-up|1|||
126167770|NCT01515306|453899668|FG000|Overall Study|Adverse Event|3|||
126167771|NCT01515306|453899669|FG001|Overall Study|Adverse Event|2|||
126167772|NCT01515306|453899668|FG000|Overall Study|Progressive Disease|19|||
126167773|NCT01515306|453899669|FG001|Overall Study|Progressive Disease|9|||
126167774|NCT01515306|453899668|FG000|Overall Study|Withdrawal by Subject|1|||
126167775|NCT01515306|453899669|FG001|Overall Study|Withdrawal by Subject|2|||
126167776|NCT01515306|453899668|FG000|Overall Study|Physician Decision|1|||
126167777|NCT01515306|453899669|FG001|Overall Study|Physician Decision|1|||
126167778|NCT00303108|453899670|FG000|Overall Study|Adverse Event|5|||
126167779|NCT00303108|453899671|FG001|Overall Study|Adverse Event|6|||
126167780|NCT00303108|453899672|FG002|Overall Study|Adverse Event|7|||
126167781|NCT00303108|453899670|FG000|Overall Study|Patient Request|4|||
126167782|NCT00303108|453899671|FG001|Overall Study|Patient Request|2|||
126167783|NCT00303108|453899672|FG002|Overall Study|Patient Request|8|||
126167784|NCT00303108|453899670|FG000|Overall Study|Failed Entry|1|||
126167785|NCT00303108|453899671|FG001|Overall Study|Failed Entry|0|||
126167786|NCT00303108|453899672|FG002|Overall Study|Failed Entry|1|||
126167787|NCT00303108|453899670|FG000|Overall Study|ineligible|2|||
126167788|NCT00303108|453899671|FG001|Overall Study|ineligible|1|||
126167789|NCT00303108|453899672|FG002|Overall Study|ineligible|0|||
126167790|NCT03201198|453899675|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
126167791|NCT03201198|453899676|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
126167792|NCT03201198|453899675|FG000|Overall Study|Withdrawal by Subject|2|||
126167793|NCT03201198|453899676|FG001|Overall Study|Withdrawal by Subject|3|||
126167794|NCT03855137|453899677|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
126167795|NCT03855137|453899678|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
126167796|NCT03855137|453899679|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
126167797|NCT03855137|453899677|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
126167798|NCT03855137|453899678|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
126167799|NCT03855137|453899679|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
126167800|NCT03855137|453899677|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
126167801|NCT03855137|453899678|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
126167802|NCT03855137|453899679|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
126167803|NCT03855137|453899677|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
126167804|NCT03855137|453899678|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
126167805|NCT03855137|453899679|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
126167806|NCT03855137|453899677|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
126167807|NCT03855137|453899678|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
126167808|NCT03855137|453899679|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
126167809|NCT03855137|453899677|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
126167810|NCT03855137|453899678|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
126167811|NCT03855137|453899679|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
126167812|NCT03855137|453899677|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
126167813|NCT03855137|453899678|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
126167814|NCT03855137|453899679|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
126167815|NCT03855137|453899677|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
126167816|NCT03855137|453899678|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
126167817|NCT03855137|453899679|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
126167818|NCT03855137|453899677|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
126167819|NCT03855137|453899678|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
126167820|NCT03855137|453899679|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
126167821|NCT03855137|453899677|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
126167822|NCT03855137|453899678|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
126167823|NCT03855137|453899679|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
126167824|NCT02435277|453899686|FG000|Overall Study|Adverse Event|1|||
126167825|NCT02435277|453899687|FG001|Overall Study|Adverse Event|1|||
126167826|NCT02435277|453899688|FG002|Overall Study|Adverse Event|0|||
126167827|NCT02435277|453899689|FG003|Overall Study|Adverse Event|0|||
126167828|NCT02435277|453899686|FG000|Overall Study|Withdrawal by Subject|1|||
126167829|NCT02435277|453899687|FG001|Overall Study|Withdrawal by Subject|0|||
126167830|NCT02435277|453899688|FG002|Overall Study|Withdrawal by Subject|0|||
126167831|NCT02435277|453899689|FG003|Overall Study|Withdrawal by Subject|0|||
126167832|NCT00008138|453899690|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
126167833|NCT00008138|453899690|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
126167834|NCT00008138|453899690|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
126167835|NCT00008138|453899690|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
126167836|NCT00008138|453899690|FG000|Interval Debulking|Withdrawal by Subject|2|||
126167837|NCT00008138|453899690|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
126167838|NCT00008138|453899690|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
126167839|NCT00008138|453899690|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
126167840|NCT04973228|453899691|FG000|Overall Study|Adverse Event|2|||
126167841|NCT04973228|453899692|FG001|Overall Study|Adverse Event|3|||
126167842|NCT04973228|453899691|FG000|Overall Study|Lack of Efficacy|1|||
126167843|NCT04973228|453899692|FG001|Overall Study|Lack of Efficacy|3|||
126167844|NCT04973228|453899691|FG000|Overall Study|Lost to Follow-up|12|||
126167845|NCT04973228|453899692|FG001|Overall Study|Lost to Follow-up|4|||
126167846|NCT04973228|453899691|FG000|Overall Study|Withdrawal by Subject|11|||
126167847|NCT04973228|453899692|FG001|Overall Study|Withdrawal by Subject|4|||
126167848|NCT04973228|453899691|FG000|Overall Study|Did not tolerate application|1|||
126167849|NCT04973228|453899692|FG001|Overall Study|Did not tolerate application|0|||
126167850|NCT04973228|453899691|FG000|Overall Study|Wanted to early terminate and use own product|0|||
126167851|NCT04973228|453899692|FG001|Overall Study|Wanted to early terminate and use own product|1|||
126167852|NCT04973228|453899691|FG000|Overall Study|Missed visits due to new work schedule|1|||
126167853|NCT04973228|453899692|FG001|Overall Study|Missed visits due to new work schedule|0|||
126167854|NCT02678780|453899696|FG000|Overall Study|Adverse Event|11|||
126167855|NCT02678780|453899697|FG001|Overall Study|Adverse Event|14|||
126167856|NCT02678780|453899696|FG000|Overall Study|Withdrawal by Subject|2|||
126167857|NCT02678780|453899697|FG001|Overall Study|Withdrawal by Subject|1|||
126167858|NCT02678780|453899696|FG000|Overall Study|Sponsor discontinuation|7|||
126167859|NCT02678780|453899697|FG001|Overall Study|Sponsor discontinuation|4|||
126167860|NCT02678780|453899696|FG000|Overall Study|Death|1|||
126167861|NCT02678780|453899697|FG001|Overall Study|Death|1|||
126167862|NCT02678780|453899696|FG000|Overall Study|Other|6|||
126167863|NCT02678780|453899697|FG001|Overall Study|Other|8|||
126167864|NCT01454401|453899712|FG000|Overall Study|Death|1|||
126167865|NCT01454401|453899712|FG000|Overall Study|hospitalised|1|||
126167866|NCT01454401|453899712|FG000|Overall Study|osteomyelitis|2|||
126167867|NCT01454401|453899712|FG000|Overall Study|non-adherence|1|||
126167868|NCT00992446|453899719|FG000|Overall Study|Disease Progression|1|||
126167869|NCT00992446|453899719|FG000|Overall Study|Withdrawal by Subject|2|||
126167870|NCT00992446|453899719|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
126167871|NCT02294318|453900840|FG000|Overall Study|Worsening of drinking|3|||
126167872|NCT02294318|453900841|FG001|Overall Study|Worsening of drinking|0|||
126167873|NCT02294318|453900840|FG000|Overall Study|Not exposed to intervention|0|||
126167874|NCT02294318|453900841|FG001|Overall Study|Not exposed to intervention|2|||
126167875|NCT03725202|453900843|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
126167876|NCT03725202|453900844|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
126167877|NCT03725202|453900845|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
126167878|NCT03725202|453900846|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126167879|NCT03725202|453900847|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126167880|NCT03725202|453900848|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126167881|NCT03725202|453900849|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126167882|NCT03725202|453900850|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126167883|NCT03725202|453900843|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
126167884|NCT03725202|453900844|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
126167885|NCT03725202|453900845|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
126167886|NCT03725202|453900846|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126167887|NCT03725202|453900847|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126167888|NCT03725202|453900848|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126167889|NCT03725202|453900849|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126167890|NCT03725202|453900850|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126167891|NCT03725202|453900843|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
126167892|NCT03725202|453900844|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126167893|NCT03725202|453900845|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126167894|NCT03725202|453900846|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126167895|NCT03725202|453900847|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126167896|NCT03725202|453900848|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126167897|NCT03725202|453900849|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126167898|NCT03725202|453900850|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126167899|NCT03725202|453900843|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
126167900|NCT03725202|453900844|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126167901|NCT03725202|453900845|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126167902|NCT03725202|453900846|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126167903|NCT03725202|453900847|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126167904|NCT03725202|453900848|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126167905|NCT03725202|453900849|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126167906|NCT03725202|453900850|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126167907|NCT03725202|453900843|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
126167908|NCT03725202|453900844|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
126167909|NCT03725202|453900845|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
126167910|NCT03725202|453900846|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126167911|NCT03725202|453900847|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126167912|NCT03725202|453900848|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126167913|NCT03725202|453900849|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126167914|NCT03725202|453900850|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126167915|NCT03725202|453900843|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126167916|NCT03725202|453900844|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126167917|NCT03725202|453900845|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
126167918|NCT03725202|453900846|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126167919|NCT03725202|453900847|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126167920|NCT03725202|453900848|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126167921|NCT03725202|453900849|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126167922|NCT03725202|453900850|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126167923|NCT03725202|453900843|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
126167924|NCT03725202|453900844|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
126167925|NCT03725202|453900845|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
126167926|NCT03725202|453900846|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
126167927|NCT03725202|453900847|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
126167928|NCT03725202|453900848|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
126167929|NCT03725202|453900849|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
126167930|NCT03725202|453900850|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
126167931|NCT03725202|453900843|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
126167932|NCT03725202|453900844|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
126167933|NCT03725202|453900845|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
126167934|NCT03725202|453900846|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
126167935|NCT03725202|453900847|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
126167936|NCT03725202|453900848|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
126167937|NCT03725202|453900849|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
126167938|NCT03725202|453900850|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
126167939|NCT03725202|453900843|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126167940|NCT03725202|453900844|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126167941|NCT03725202|453900845|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126167942|NCT03725202|453900846|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
126167943|NCT03725202|453900847|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126167944|NCT03725202|453900848|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126167945|NCT03725202|453900849|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
126167946|NCT03725202|453900850|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
126167947|NCT03725202|453900843|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126167948|NCT03725202|453900844|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126167949|NCT03725202|453900845|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126167950|NCT03725202|453900846|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126167951|NCT03725202|453900847|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126167952|NCT03725202|453900848|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126167953|NCT03725202|453900849|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
126167954|NCT03725202|453900850|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126167955|NCT03725202|453900843|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126167956|NCT03725202|453900844|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126167957|NCT03725202|453900845|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126167958|NCT03725202|453900846|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126167959|NCT03725202|453900847|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126167960|NCT03725202|453900848|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
126167961|NCT03725202|453900849|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126167962|NCT03725202|453900850|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126200114|NCT02394028|454017880|FG003|Induction Phase|Lack of Efficacy|17|||
126167963|NCT03725202|453900843|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126167964|NCT03725202|453900844|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126167965|NCT03725202|453900845|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126167966|NCT03725202|453900846|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
126167967|NCT03725202|453900847|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126167968|NCT03725202|453900848|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126167969|NCT03725202|453900849|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
126167970|NCT03725202|453900850|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
126167971|NCT01328249|453900853|FG000|Overall Study|Adverse Event|3|||
126167972|NCT01328249|453900854|FG001|Overall Study|Adverse Event|0|||
126167973|NCT01328249|453900853|FG000|Overall Study|Disease progression|1|||
126167974|NCT01328249|453900854|FG001|Overall Study|Disease progression|0|||
126167975|NCT01328249|453900853|FG000|Overall Study|Withdrawal by Subject|1|||
126167976|NCT01328249|453900854|FG001|Overall Study|Withdrawal by Subject|1|||
126167977|NCT01328249|453900853|FG000|Overall Study|Moved before end of treatment visit|1|||
126167978|NCT01328249|453900854|FG001|Overall Study|Moved before end of treatment visit|0|||
126167979|NCT01328249|453900853|FG000|Overall Study|Subject choice|1|||
126167980|NCT01328249|453900854|FG001|Overall Study|Subject choice|1|||
126167981|NCT01328249|453900853|FG000|Overall Study|Protocol Violation|0|||
126167982|NCT01328249|453900854|FG001|Overall Study|Protocol Violation|1|||
126167983|NCT01215734|453900855|FG000|Overall Study|Death|0|||
126167984|NCT01215734|453900856|FG001|Overall Study|Death|1|||
126167985|NCT01716533|453900857|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
126167986|NCT01716533|453900858|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
126167987|NCT01716533|453900859|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
126167988|NCT01716533|453900860|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
126167989|NCT01716533|453900857|FG000|Overall Study|Withdrawal by Subject|0|||
126167990|NCT01716533|453900858|FG001|Overall Study|Withdrawal by Subject|0|||
126167991|NCT01716533|453900859|FG002|Overall Study|Withdrawal by Subject|0|||
126167992|NCT01716533|453900860|FG003|Overall Study|Withdrawal by Subject|5|||
126167993|NCT01716533|453900857|FG000|Overall Study|Death|0|||
126167994|NCT01716533|453900858|FG001|Overall Study|Death|0|||
126167995|NCT01716533|453900859|FG002|Overall Study|Death|0|||
126167996|NCT01716533|453900860|FG003|Overall Study|Death|2|||
126167997|NCT01716533|453900857|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
126167998|NCT01716533|453900858|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
126167999|NCT01716533|453900859|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
126168000|NCT01716533|453900860|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
126168001|NCT00745368|453900863|FG000|Overall Study|Unable to provide sample|3|||
126168002|NCT00495495|453900864|FG000|Overall Study|Protocol Violation|99|||
126168003|NCT03331666|453900868|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
126168004|NCT03331666|453900869|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
126168005|NCT03137121|453900870|FG000|Overall Study|Withdrawal by Subject|0|||
126168006|NCT03137121|453900871|FG001|Overall Study|Withdrawal by Subject|1|||
126168007|NCT01026389|453900877|FG000|Overall Study|Withdrawal by Subject|1|||
126168008|NCT01026389|453900878|FG001|Overall Study|Withdrawal by Subject|3|||
126168009|NCT01026389|453900877|FG000|Overall Study|change of treatment, patient moved|4|||
126168010|NCT01026389|453900878|FG001|Overall Study|change of treatment, patient moved|2|||
126168011|NCT00836277|453900879|FG000|Overall Study|Not evaluable for response|6|||
126168012|NCT04410198|453900880|FG000|Overall Study|Death|10|||
126168013|NCT04410198|453900880|FG000|Overall Study|Withdrawal by Subject|7|||
126168014|NCT04410198|453900880|FG000|Overall Study|Transferred/Relocation|4|||
126168015|NCT04410198|453900880|FG000|Overall Study|Kidney Transplant|9|||
126168016|NCT04410198|453900880|FG000|Overall Study|Adverse Event|4|||
126168017|NCT04410198|453900880|FG000|Overall Study|Physician Decision|2|||
126168018|NCT04410198|453900880|FG000|Overall Study|Other than specified|1|||
126168019|NCT01830543|453900886|FG000|Overall Study|Subject Decision|19|||
126168020|NCT01830543|453900887|FG001|Overall Study|Subject Decision|21|||
126168021|NCT01830543|453900888|FG002|Overall Study|Subject Decision|57|||
126168022|NCT01830543|453900886|FG000|Overall Study|Adverse Event|91|||
126168023|NCT01830543|453900887|FG001|Overall Study|Adverse Event|77|||
126168024|NCT01830543|453900888|FG002|Overall Study|Adverse Event|76|||
126168025|NCT01830543|453900886|FG000|Overall Study|Death|20|||
126168026|NCT01830543|453900887|FG001|Overall Study|Death|22|||
126168027|NCT01830543|453900888|FG002|Overall Study|Death|22|||
126168028|NCT01830543|453900886|FG000|Overall Study|Protocol Violation|3|||
126168029|NCT01830543|453900887|FG001|Overall Study|Protocol Violation|7|||
126168030|NCT01830543|453900888|FG002|Overall Study|Protocol Violation|7|||
126168031|NCT01830543|453900886|FG000|Overall Study|Physician Decision|11|||
126168032|NCT01830543|453900887|FG001|Overall Study|Physician Decision|5|||
126168033|NCT01830543|453900888|FG002|Overall Study|Physician Decision|12|||
126168034|NCT01830543|453900886|FG000|Overall Study|Withdrawal by consent|3|||
126168035|NCT01830543|453900887|FG001|Overall Study|Withdrawal by consent|3|||
126168036|NCT01830543|453900888|FG002|Overall Study|Withdrawal by consent|3|||
126168037|NCT01830543|453900886|FG000|Overall Study|Other|12|||
126168038|NCT01830543|453900887|FG001|Overall Study|Other|17|||
126168039|NCT01830543|453900888|FG002|Overall Study|Other|37|||
126168040|NCT03583372|453900893|FG000|Overall Study|Withdrawal by Subject|6|||
126168041|NCT03583372|453900894|FG001|Overall Study|Withdrawal by Subject|11|||
126168042|NCT03583372|453900895|FG002|Overall Study|Withdrawal by Subject|7|||
126168043|NCT03583372|453900896|FG003|Overall Study|Withdrawal by Subject|8|||
126168044|NCT03583372|453900893|FG000|Overall Study|Lost to Follow-up|4|||
126168045|NCT03583372|453900894|FG001|Overall Study|Lost to Follow-up|6|||
126168046|NCT03583372|453900895|FG002|Overall Study|Lost to Follow-up|3|||
126168047|NCT03583372|453900896|FG003|Overall Study|Lost to Follow-up|2|||
126168048|NCT03583372|453900893|FG000|Overall Study|Adverse Event|1|||
126168049|NCT03583372|453900894|FG001|Overall Study|Adverse Event|3|||
126168050|NCT03583372|453900895|FG002|Overall Study|Adverse Event|4|||
126168051|NCT03583372|453900896|FG003|Overall Study|Adverse Event|4|||
126168052|NCT03583372|453900893|FG000|Overall Study|Physician Decision|0|||
126168053|NCT03583372|453900894|FG001|Overall Study|Physician Decision|1|||
126168054|NCT03583372|453900895|FG002|Overall Study|Physician Decision|1|||
126168055|NCT03583372|453900896|FG003|Overall Study|Physician Decision|1|||
126168056|NCT03583372|453900893|FG000|Overall Study|Lack of Efficacy|0|||
126168057|NCT03583372|453900894|FG001|Overall Study|Lack of Efficacy|1|||
126168058|NCT03583372|453900895|FG002|Overall Study|Lack of Efficacy|0|||
126168059|NCT03583372|453900896|FG003|Overall Study|Lack of Efficacy|1|||
126168060|NCT03583372|453900893|FG000|Overall Study|Death|1|||
126168061|NCT03583372|453900894|FG001|Overall Study|Death|0|||
126168062|NCT03583372|453900895|FG002|Overall Study|Death|0|||
126168063|NCT03583372|453900896|FG003|Overall Study|Death|0|||
126168064|NCT03583372|453900893|FG000|Overall Study|Protocol Violation|0|||
126168065|NCT03583372|453900894|FG001|Overall Study|Protocol Violation|1|||
126168066|NCT03583372|453900895|FG002|Overall Study|Protocol Violation|0|||
126168067|NCT03583372|453900896|FG003|Overall Study|Protocol Violation|0|||
126168068|NCT03583372|453900893|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
126168069|NCT03583372|453900894|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
126168070|NCT03583372|453900895|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
126168071|NCT03583372|453900896|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
126168072|NCT03583372|453900893|FG000|Overall Study|Did Not Receive Study Drug|0|||
126168073|NCT03583372|453900894|FG001|Overall Study|Did Not Receive Study Drug|1|||
126168074|NCT03583372|453900895|FG002|Overall Study|Did Not Receive Study Drug|0|||
126168075|NCT03583372|453900896|FG003|Overall Study|Did Not Receive Study Drug|0|||
126168076|NCT03583372|453900893|FG000|Overall Study|Captured as Other in the Database|1|||
126168077|NCT03583372|453900894|FG001|Overall Study|Captured as Other in the Database|2|||
126168078|NCT03583372|453900895|FG002|Overall Study|Captured as Other in the Database|4|||
126168079|NCT03583372|453900896|FG003|Overall Study|Captured as Other in the Database|1|||
126168080|NCT03446651|453900904|FG000|Overall Study|Lost to Follow-up|4|||
126168081|NCT03446651|453900905|FG001|Overall Study|Lost to Follow-up|0|||
126168082|NCT03446651|453900904|FG000|Overall Study|Open Label Participants|5|||
126168083|NCT03446651|453900905|FG001|Overall Study|Open Label Participants|0|||
126168084|NCT02420223|453900906|FG000|Overall Study|Adverse Event|1|||
126168085|NCT02420223|453900907|FG001|Overall Study|Adverse Event|0|||
126168086|NCT02420223|453900906|FG000|Overall Study|Physician Decision|0|||
126168087|NCT02420223|453900907|FG001|Overall Study|Physician Decision|2|||
126168088|NCT05142332|453900920|FG000|Overall Study|Withdrawal by Subject|0|||
126168089|NCT05142332|453900921|FG001|Overall Study|Withdrawal by Subject|1|||
126168090|NCT05142332|453900922|FG002|Overall Study|Withdrawal by Subject|2|||
126168091|NCT05142332|453900923|FG003|Overall Study|Withdrawal by Subject|0|||
126168092|NCT05142332|453900924|FG004|Overall Study|Withdrawal by Subject|0|||
126168093|NCT05142332|453900925|FG005|Overall Study|Withdrawal by Subject|2|||
126168094|NCT05142332|453900926|FG006|Overall Study|Withdrawal by Subject|6|||
126168095|NCT05142332|453900920|FG000|Overall Study|Left ED|3|||
126168096|NCT05142332|453900921|FG001|Overall Study|Left ED|0|||
126168097|NCT05142332|453900922|FG002|Overall Study|Left ED|4|||
126168098|NCT05142332|453900923|FG003|Overall Study|Left ED|6|||
126168099|NCT05142332|453900924|FG004|Overall Study|Left ED|1|||
126168100|NCT05142332|453900925|FG005|Overall Study|Left ED|2|||
126168101|NCT05142332|453900926|FG006|Overall Study|Left ED|6|||
126168102|NCT05142332|453900920|FG000|Overall Study|Physician Decision|0|||
126168103|NCT05142332|453900921|FG001|Overall Study|Physician Decision|0|||
126168104|NCT05142332|453900922|FG002|Overall Study|Physician Decision|2|||
126168105|NCT05142332|453900923|FG003|Overall Study|Physician Decision|1|||
126168106|NCT05142332|453900924|FG004|Overall Study|Physician Decision|0|||
126168107|NCT05142332|453900925|FG005|Overall Study|Physician Decision|0|||
126168108|NCT05142332|453900926|FG006|Overall Study|Physician Decision|3|||
126168109|NCT05142332|453900920|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
126168110|NCT05142332|453900921|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
126168111|NCT05142332|453900922|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
126168112|NCT05142332|453900923|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
126168113|NCT05142332|453900924|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
126168114|NCT05142332|453900925|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
126168115|NCT05142332|453900926|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
126168116|NCT01894477|453900931|FG000|Overall Study|Protocol Violation|0|||
126168117|NCT01894477|453900932|FG001|Overall Study|Protocol Violation|1|||
126168118|NCT01894477|453900931|FG000|Overall Study|protocol changed due SC changed to cord|0|||
126168119|NCT01894477|453900932|FG001|Overall Study|protocol changed due SC changed to cord|1|||
126168120|NCT01592409|453900933|FG000|Overall Study|Withdrawal by Subject|0|||
126168121|NCT01592409|453900934|FG001|Overall Study|Withdrawal by Subject|1|||
126168122|NCT02052778|453900935|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
126168123|NCT02052778|453900936|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
126168124|NCT02052778|453900937|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
126168125|NCT02052778|453900938|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
126168126|NCT02052778|453900939|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
126168127|NCT02052778|453900940|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
126168128|NCT02052778|453900941|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168129|NCT02052778|453900942|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
126168130|NCT02052778|453900943|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
126168131|NCT02052778|453900944|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
126168132|NCT02052778|453900945|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
126168133|NCT02052778|453900946|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
126168134|NCT02052778|453900947|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
126168135|NCT02052778|453900948|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
126168136|NCT02052778|453900949|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168137|NCT02052778|453900950|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168138|NCT02052778|453900951|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168139|NCT02052778|453900952|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168140|NCT02052778|453900953|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168141|NCT02052778|453900954|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168142|NCT02052778|453900955|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168143|NCT02052778|453900956|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168144|NCT02052778|453900957|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126168145|NCT02052778|453900935|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126168146|NCT02052778|453900936|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126168147|NCT02052778|453900937|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126168148|NCT02052778|453900938|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126168149|NCT02052778|453900939|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126168150|NCT02052778|453900940|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126168151|NCT02052778|453900941|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
126168152|NCT02052778|453900942|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126168153|NCT02052778|453900943|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126168154|NCT02052778|453900944|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168155|NCT02052778|453900945|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168156|NCT02052778|453900946|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126168157|NCT02052778|453900947|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126168158|NCT02052778|453900948|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
126168159|NCT02052778|453900949|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168160|NCT02052778|453900950|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168161|NCT02052778|453900951|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168162|NCT02052778|453900952|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168163|NCT02052778|453900953|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168164|NCT02052778|453900954|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168165|NCT02052778|453900955|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168166|NCT02052778|453900956|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168167|NCT02052778|453900957|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126168168|NCT02052778|453900935|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168169|NCT02052778|453900936|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168170|NCT02052778|453900937|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168171|NCT02052778|453900938|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168172|NCT02052778|453900939|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168173|NCT02052778|453900940|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168174|NCT02052778|453900941|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168175|NCT02052778|453900942|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126200115|NCT02394028|454017881|FG004|Induction Phase|Lack of Efficacy|14|||
126168176|NCT02052778|453900943|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168177|NCT02052778|453900944|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168178|NCT02052778|453900945|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168179|NCT02052778|453900946|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168180|NCT02052778|453900947|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168181|NCT02052778|453900948|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
126168182|NCT02052778|453900949|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168183|NCT02052778|453900950|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168184|NCT02052778|453900951|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168185|NCT02052778|453900952|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168186|NCT02052778|453900953|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168187|NCT02052778|453900954|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168188|NCT02052778|453900955|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168189|NCT02052778|453900956|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168190|NCT02052778|453900957|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126168191|NCT02052778|453900935|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
126168192|NCT02052778|453900936|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
126168193|NCT02052778|453900937|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
126168194|NCT02052778|453900938|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
126168195|NCT02052778|453900939|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
126168196|NCT02052778|453900940|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
126168197|NCT02052778|453900941|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
126168198|NCT02052778|453900942|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
126168199|NCT02052778|453900943|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
126168200|NCT02052778|453900944|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
126168201|NCT02052778|453900945|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
126168202|NCT02052778|453900946|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
126168203|NCT02052778|453900947|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
126168204|NCT02052778|453900948|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
126168205|NCT02052778|453900949|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
126168206|NCT02052778|453900950|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
126168207|NCT02052778|453900951|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
126168208|NCT02052778|453900952|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
126168209|NCT02052778|453900953|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
126168210|NCT02052778|453900954|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
126168211|NCT02052778|453900955|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
126168212|NCT02052778|453900956|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
126168213|NCT02052778|453900957|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
126168214|NCT02052778|453900935|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168215|NCT02052778|453900936|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168216|NCT02052778|453900937|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168217|NCT02052778|453900938|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168218|NCT02052778|453900939|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168219|NCT02052778|453900940|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168220|NCT02052778|453900941|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168221|NCT02052778|453900942|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168222|NCT02052778|453900943|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
126168223|NCT02052778|453900944|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168224|NCT02052778|453900945|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168225|NCT02052778|453900946|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168226|NCT02052778|453900947|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168227|NCT02052778|453900948|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
126168228|NCT02052778|453900949|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168229|NCT02052778|453900950|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168230|NCT02052778|453900951|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168231|NCT02052778|453900952|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168232|NCT02052778|453900953|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168233|NCT02052778|453900954|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168234|NCT02052778|453900955|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168235|NCT02052778|453900956|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168236|NCT02052778|453900957|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126168237|NCT02052778|453900935|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168238|NCT02052778|453900936|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125973230|NCT02564523|453191404|FG013|Overall Study|Protocol Violation|0|||
126168239|NCT02052778|453900937|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168240|NCT02052778|453900938|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168241|NCT02052778|453900939|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168242|NCT02052778|453900940|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
126168243|NCT02052778|453900941|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168244|NCT02052778|453900942|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168245|NCT02052778|453900943|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168246|NCT02052778|453900944|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168247|NCT02052778|453900945|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168248|NCT02052778|453900946|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168249|NCT02052778|453900947|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
126168250|NCT02052778|453900948|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168251|NCT02052778|453900949|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168252|NCT02052778|453900950|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168253|NCT02052778|453900951|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168254|NCT02052778|453900952|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168255|NCT02052778|453900953|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168256|NCT02052778|453900954|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168257|NCT02052778|453900955|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168258|NCT02052778|453900956|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168259|NCT02052778|453900957|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126168260|NCT02052778|453900935|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168261|NCT02052778|453900936|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168262|NCT02052778|453900937|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168263|NCT02052778|453900938|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168264|NCT02052778|453900939|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168265|NCT02052778|453900940|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168266|NCT02052778|453900941|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168267|NCT02052778|453900942|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168268|NCT02052778|453900943|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168269|NCT02052778|453900944|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168270|NCT02052778|453900945|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168271|NCT02052778|453900946|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168272|NCT02052778|453900947|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168273|NCT02052778|453900948|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168274|NCT02052778|453900949|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
126168275|NCT02052778|453900950|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
126168276|NCT02052778|453900951|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
126168277|NCT02052778|453900952|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
126168278|NCT02052778|453900953|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
126168279|NCT02052778|453900954|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
126168280|NCT02052778|453900955|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
126168281|NCT02052778|453900956|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
126168282|NCT02052778|453900957|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126168283|NCT02052778|453900935|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168284|NCT02052778|453900936|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168285|NCT02052778|453900937|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168286|NCT02052778|453900938|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168287|NCT02052778|453900939|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168288|NCT02052778|453900940|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168289|NCT02052778|453900941|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168290|NCT02052778|453900942|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168291|NCT02052778|453900943|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168292|NCT02052778|453900944|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168293|NCT02052778|453900945|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168294|NCT02052778|453900946|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168295|NCT02052778|453900947|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168296|NCT02052778|453900948|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168297|NCT02052778|453900949|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
126168298|NCT02052778|453900950|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
126200116|NCT02394028|454017882|FG005|Induction Phase|Lack of Efficacy|8|||
126168299|NCT02052778|453900951|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168300|NCT02052778|453900952|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
126168301|NCT02052778|453900953|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
126168302|NCT02052778|453900954|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
126168303|NCT02052778|453900955|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
126168304|NCT02052778|453900956|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
126168305|NCT02052778|453900957|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126168306|NCT02052778|453900935|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125973231|NCT02564523|453191405|FG014|Overall Study|Protocol Violation|0|||
125973232|NCT02564523|453191406|FG015|Overall Study|Protocol Violation|0|||
125973233|NCT02564523|453191407|FG016|Overall Study|Protocol Violation|0|||
125973234|NCT02564523|453191408|FG017|Overall Study|Protocol Violation|0|||
125973235|NCT02564523|453191391|FG000|Overall Study|Other|3|||
125973236|NCT02564523|453191392|FG001|Overall Study|Other|0|||
125973237|NCT02564523|453191393|FG002|Overall Study|Other|0|||
125973238|NCT02564523|453191394|FG003|Overall Study|Other|1|||
125973239|NCT02564523|453191395|FG004|Overall Study|Other|0|||
125973240|NCT02564523|453191396|FG005|Overall Study|Other|0|||
125973241|NCT02564523|453191397|FG006|Overall Study|Other|0|||
125973242|NCT02564523|453191398|FG007|Overall Study|Other|0|||
125973243|NCT02564523|453191399|FG008|Overall Study|Other|0|||
125973244|NCT02564523|453191400|FG009|Overall Study|Other|0|||
125973245|NCT02564523|453191401|FG010|Overall Study|Other|0|||
125973246|NCT02564523|453191402|FG011|Overall Study|Other|0|||
125973247|NCT02564523|453191403|FG012|Overall Study|Other|0|||
125973248|NCT02564523|453191404|FG013|Overall Study|Other|0|||
125973249|NCT02564523|453191405|FG014|Overall Study|Other|0|||
125973250|NCT02564523|453191406|FG015|Overall Study|Other|0|||
125973251|NCT02564523|453191407|FG016|Overall Study|Other|0|||
125973252|NCT02564523|453191408|FG017|Overall Study|Other|0|||
125973253|NCT04862143|453191423|FG000|Overall Study|Adverse Event|1|||
125973254|NCT04862143|453191423|FG000|Overall Study|Study terminated by sponsor|1|||
125973255|NCT03031938|453191424|FG000|Overall Study|Death|1|||
125973256|NCT03031938|453191425|FG001|Overall Study|Death|0|||
125973257|NCT00454051|453191426|FG000|Overall Study|Adverse Event|1|||
125973258|NCT00454051|453191427|FG001|Overall Study|Adverse Event|2|||
125973259|NCT00454051|453191426|FG000|Overall Study|Withdrawal by Subject|1|||
125973260|NCT00454051|453191427|FG001|Overall Study|Withdrawal by Subject|0|||
125973261|NCT00454051|453191426|FG000|Overall Study|Protocol Violation|1|||
125973262|NCT00454051|453191427|FG001|Overall Study|Protocol Violation|1|||
125973263|NCT01571362|453191428|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
125973264|NCT01571362|453191429|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
125973265|NCT01571362|453191430|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
125973266|NCT01571362|453191428|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
125973267|NCT01571362|453191429|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
125973268|NCT01571362|453191430|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
125973269|NCT01571362|453191428|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
125973270|NCT01571362|453191429|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
125973271|NCT01571362|453191430|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
125973272|NCT01571362|453191428|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
125973273|NCT01571362|453191429|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
125973274|NCT01571362|453191430|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
125973275|NCT01571362|453191428|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
125973276|NCT01571362|453191429|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
125973277|NCT01571362|453191430|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
125973278|NCT01571362|453191428|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
125973279|NCT01571362|453191429|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
125973280|NCT01571362|453191430|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
125973281|NCT01571362|453191428|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125973282|NCT01571362|453191429|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
125973283|NCT01571362|453191430|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
125973284|NCT01571362|453191428|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125973285|NCT01571362|453191429|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
125973286|NCT01571362|453191430|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
125973287|NCT01571362|453191428|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125973288|NCT01571362|453191429|FG001|Double-Blind Treatment Period|Adverse Event|9|||
125973289|NCT01571362|453191430|FG002|Double-Blind Treatment Period|Adverse Event|14|||
125973290|NCT01571362|453191428|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125973291|NCT01571362|453191429|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
125973292|NCT01571362|453191430|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
125973293|NCT01571362|453191428|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
126168307|NCT02052778|453900936|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168308|NCT02052778|453900937|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168309|NCT02052778|453900938|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168310|NCT02052778|453900939|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168311|NCT02052778|453900940|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168312|NCT02052778|453900941|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168313|NCT02052778|453900942|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168314|NCT02052778|453900943|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168315|NCT02052778|453900944|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168316|NCT02052778|453900945|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168317|NCT02052778|453900946|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168318|NCT02052778|453900947|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168319|NCT02052778|453900948|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168320|NCT02052778|453900949|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
126168321|NCT02052778|453900950|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
126168322|NCT02052778|453900951|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
126168323|NCT02052778|453900952|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168324|NCT02052778|453900953|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
126168325|NCT02052778|453900954|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
126168326|NCT02052778|453900955|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168327|NCT02052778|453900956|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168328|NCT02052778|453900957|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126168329|NCT02052778|453900935|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168330|NCT02052778|453900936|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168331|NCT02052778|453900937|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168332|NCT02052778|453900938|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168333|NCT02052778|453900939|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168334|NCT02052778|453900940|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168335|NCT02052778|453900941|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168336|NCT02052778|453900942|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168337|NCT02052778|453900943|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168338|NCT02052778|453900944|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168339|NCT02052778|453900945|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168340|NCT02052778|453900946|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168341|NCT02052778|453900947|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168342|NCT02052778|453900948|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168343|NCT02052778|453900949|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
126168344|NCT02052778|453900950|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
126168345|NCT02052778|453900951|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168346|NCT02052778|453900952|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168347|NCT02052778|453900953|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168348|NCT02052778|453900954|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168349|NCT02052778|453900955|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168350|NCT02052778|453900956|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168351|NCT02052778|453900957|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126168352|NCT02052778|453900935|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168353|NCT02052778|453900936|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168354|NCT02052778|453900937|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168355|NCT02052778|453900938|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168356|NCT02052778|453900939|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168357|NCT02052778|453900940|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168358|NCT02052778|453900941|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168359|NCT02052778|453900942|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168360|NCT02052778|453900943|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168361|NCT02052778|453900944|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168362|NCT02052778|453900945|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168363|NCT02052778|453900946|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168364|NCT02052778|453900947|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168365|NCT02052778|453900948|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168366|NCT02052778|453900949|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
126168367|NCT02052778|453900950|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
126168368|NCT02052778|453900951|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168369|NCT02052778|453900952|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168370|NCT02052778|453900953|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168371|NCT02052778|453900954|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
126168372|NCT02052778|453900955|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168373|NCT02052778|453900956|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168374|NCT02052778|453900957|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126168375|NCT02052778|453900935|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
126168376|NCT02052778|453900936|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
126168377|NCT02052778|453900937|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
126168378|NCT02052778|453900938|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
126168379|NCT02052778|453900939|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
126168380|NCT02052778|453900940|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
126168381|NCT02052778|453900941|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
126168382|NCT02052778|453900942|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
126168383|NCT02052778|453900943|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
126168384|NCT02052778|453900944|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
126168385|NCT02052778|453900945|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
126168386|NCT02052778|453900946|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
126168387|NCT02052778|453900947|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
126168388|NCT02052778|453900948|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
126168389|NCT02052778|453900949|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
126168390|NCT02052778|453900950|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
126168391|NCT02052778|453900951|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
126168392|NCT02052778|453900952|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
126168393|NCT02052778|453900953|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
126168394|NCT02052778|453900954|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
126168395|NCT02052778|453900955|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
126168396|NCT02052778|453900956|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
126168397|NCT02052778|453900957|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
126168398|NCT02052778|453900935|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168399|NCT02052778|453900936|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168400|NCT02052778|453900937|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168401|NCT02052778|453900938|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168402|NCT02052778|453900939|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168403|NCT02052778|453900940|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168404|NCT02052778|453900941|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168405|NCT02052778|453900942|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168406|NCT02052778|453900943|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168407|NCT02052778|453900944|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168408|NCT02052778|453900945|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168409|NCT02052778|453900946|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168410|NCT02052778|453900947|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168411|NCT02052778|453900948|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168412|NCT02052778|453900949|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
126168413|NCT02052778|453900950|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
126168414|NCT02052778|453900951|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
126168415|NCT02052778|453900952|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168416|NCT02052778|453900953|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
126168417|NCT02052778|453900954|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168418|NCT02052778|453900955|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168419|NCT02052778|453900956|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168420|NCT02052778|453900957|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126168421|NCT02052778|453900935|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168422|NCT02052778|453900936|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168423|NCT02052778|453900937|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168424|NCT02052778|453900938|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168425|NCT02052778|453900939|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168426|NCT02052778|453900940|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168427|NCT02052778|453900941|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168428|NCT02052778|453900942|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168429|NCT02052778|453900943|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168430|NCT02052778|453900944|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168431|NCT02052778|453900945|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168432|NCT02052778|453900946|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168433|NCT02052778|453900947|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168434|NCT02052778|453900948|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168435|NCT02052778|453900949|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168436|NCT02052778|453900950|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168437|NCT02052778|453900951|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168438|NCT02052778|453900952|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168439|NCT02052778|453900953|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168440|NCT02052778|453900954|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168441|NCT02052778|453900955|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168442|NCT02052778|453900956|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126168443|NCT02052778|453900957|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
126168444|NCT02052778|453900935|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168445|NCT02052778|453900936|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168446|NCT02052778|453900937|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168447|NCT02052778|453900938|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168448|NCT02052778|453900939|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168449|NCT02052778|453900940|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168450|NCT02052778|453900941|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168451|NCT02052778|453900942|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168452|NCT02052778|453900943|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168453|NCT02052778|453900944|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168454|NCT02052778|453900945|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168455|NCT02052778|453900946|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168456|NCT02052778|453900947|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168457|NCT02052778|453900948|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168458|NCT02052778|453900949|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168459|NCT02052778|453900950|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168460|NCT02052778|453900951|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168461|NCT02052778|453900952|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168462|NCT02052778|453900953|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168463|NCT02052778|453900954|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168464|NCT02052778|453900955|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168465|NCT02052778|453900956|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126168466|NCT02052778|453900957|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
126168467|NCT02052778|453900935|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168468|NCT02052778|453900936|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168469|NCT02052778|453900937|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168470|NCT02052778|453900938|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168471|NCT02052778|453900939|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168472|NCT02052778|453900940|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168473|NCT02052778|453900941|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168474|NCT02052778|453900942|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168475|NCT02052778|453900943|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168476|NCT02052778|453900944|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168477|NCT02052778|453900945|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168478|NCT02052778|453900946|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168479|NCT02052778|453900947|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168480|NCT02052778|453900948|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168481|NCT02052778|453900949|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168482|NCT02052778|453900950|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168483|NCT02052778|453900951|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168484|NCT02052778|453900952|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168485|NCT02052778|453900953|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168486|NCT02052778|453900954|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168487|NCT02052778|453900955|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168488|NCT02052778|453900956|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126168489|NCT02052778|453900957|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
126168490|NCT02052778|453900935|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168491|NCT02052778|453900936|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168492|NCT02052778|453900937|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168493|NCT02052778|453900938|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168494|NCT02052778|453900939|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168495|NCT02052778|453900940|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168496|NCT02052778|453900941|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168497|NCT02052778|453900942|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168498|NCT02052778|453900943|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168499|NCT02052778|453900944|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168500|NCT02052778|453900945|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168501|NCT02052778|453900946|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168502|NCT02052778|453900947|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168503|NCT02052778|453900948|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168504|NCT02052778|453900949|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168505|NCT02052778|453900950|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168506|NCT02052778|453900951|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168507|NCT02052778|453900952|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168508|NCT02052778|453900953|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168509|NCT02052778|453900954|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168510|NCT02052778|453900955|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168511|NCT02052778|453900956|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126168512|NCT02052778|453900957|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
126168513|NCT02052778|453900935|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168514|NCT02052778|453900936|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168515|NCT02052778|453900937|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168516|NCT02052778|453900938|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168517|NCT02052778|453900939|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168518|NCT02052778|453900940|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168519|NCT02052778|453900941|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168520|NCT02052778|453900942|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168521|NCT02052778|453900943|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168522|NCT02052778|453900944|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168523|NCT02052778|453900945|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168524|NCT02052778|453900946|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168525|NCT02052778|453900947|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168526|NCT02052778|453900948|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168527|NCT02052778|453900949|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168528|NCT02052778|453900950|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168529|NCT02052778|453900951|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168530|NCT02052778|453900952|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168531|NCT02052778|453900953|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168532|NCT02052778|453900954|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168533|NCT02052778|453900955|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168534|NCT02052778|453900956|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126168535|NCT02052778|453900957|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
126168536|NCT02052778|453900935|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
126168537|NCT02052778|453900936|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
126168538|NCT02052778|453900937|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
126168539|NCT02052778|453900938|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
126168540|NCT02052778|453900939|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
126168541|NCT02052778|453900940|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
126168542|NCT02052778|453900941|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
126168543|NCT02052778|453900942|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
126168544|NCT02052778|453900943|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
126168545|NCT02052778|453900944|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
126168546|NCT02052778|453900945|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
126168547|NCT02052778|453900946|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
126168548|NCT02052778|453900947|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
126168549|NCT02052778|453900948|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
126168550|NCT02052778|453900949|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
126168551|NCT02052778|453900950|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
126168552|NCT02052778|453900951|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
126168553|NCT02052778|453900952|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
126168554|NCT02052778|453900953|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
126168555|NCT02052778|453900954|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
126168556|NCT02052778|453900955|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
126168557|NCT02052778|453900956|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
126168558|NCT02052778|453900957|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
126168559|NCT02052778|453900935|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168560|NCT02052778|453900936|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168561|NCT02052778|453900937|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168562|NCT02052778|453900938|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168563|NCT02052778|453900939|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168564|NCT02052778|453900940|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168565|NCT02052778|453900941|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168566|NCT02052778|453900942|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
125973294|NCT01571362|453191429|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
126168567|NCT02052778|453900943|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168568|NCT02052778|453900944|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168569|NCT02052778|453900945|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168570|NCT02052778|453900946|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168571|NCT02052778|453900947|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168572|NCT02052778|453900948|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168573|NCT02052778|453900949|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168574|NCT02052778|453900950|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168575|NCT02052778|453900951|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168576|NCT02052778|453900952|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168577|NCT02052778|453900953|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168578|NCT02052778|453900954|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168579|NCT02052778|453900955|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168580|NCT02052778|453900956|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
126168581|NCT02052778|453900957|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
126168582|NCT01409031|453900964|FG000|Overall Study|transferred to other hosp|1|||
126168583|NCT01409031|453900965|FG001|Overall Study|transferred to other hosp|0|||
126168584|NCT02345252|453900970|FG000|Double-Blind Phase|Adverse Event|2|||
126168585|NCT02345252|453900971|FG001|Double-Blind Phase|Adverse Event|3|||
126168586|NCT02345252|453900970|FG000|Double-Blind Phase|Death|1|||
126168587|NCT02345252|453900971|FG001|Double-Blind Phase|Death|2|||
126168588|NCT02345252|453900970|FG000|Double-Blind Phase|Lack of Efficacy|1|||
126168589|NCT02345252|453900971|FG001|Double-Blind Phase|Lack of Efficacy|0|||
126168590|NCT02345252|453900970|FG000|Double-Blind Phase|Investigator's Discretion|4|||
126168591|NCT02345252|453900971|FG001|Double-Blind Phase|Investigator's Discretion|6|||
126168592|NCT02345252|453900970|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
126168593|NCT02345252|453900971|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
126168594|NCT02345252|453900970|FG000|Double-Blind Phase|Protocol Violation|2|||
126168595|NCT02345252|453900971|FG001|Double-Blind Phase|Protocol Violation|1|||
126168596|NCT02345252|453900970|FG000|Double-Blind Phase|Withdrew Consent|21|||
126168597|NCT02345252|453900971|FG001|Double-Blind Phase|Withdrew Consent|23|||
126168598|NCT02345252|453900970|FG000|Double-Blind Phase|Lost to Follow-up|8|||
126168599|NCT02345252|453900971|FG001|Double-Blind Phase|Lost to Follow-up|10|||
126168600|NCT02345252|453900970|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
126168601|NCT02345252|453900971|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
126168602|NCT01094730|453900972|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
126168603|NCT01094730|453900973|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
126168604|NCT01094730|453900972|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
126168605|NCT01094730|453900973|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
126168606|NCT01094730|453900972|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
126168607|NCT01094730|453900973|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
126168608|NCT01094730|453900972|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
126168609|NCT01094730|453900973|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
126168610|NCT01094730|453900972|FG000|Period 2 (14 Days)|Protocol Violation|2|||
126168611|NCT01094730|453900973|FG001|Period 2 (14 Days)|Protocol Violation|0|||
126168612|NCT01094730|453900972|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
126168613|NCT01094730|453900973|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
126168614|NCT01094730|453900972|FG000|Period 2 (14 Days)|Adverse Event|0|||
126168615|NCT01094730|453900973|FG001|Period 2 (14 Days)|Adverse Event|1|||
126168616|NCT01094730|453900972|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
126168617|NCT01094730|453900973|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
126168618|NCT04171037|453900974|FG000|Overall Study|Lost to Follow-up|1|||
126168619|NCT04171037|453900975|FG001|Overall Study|Lost to Follow-up|0|||
126168620|NCT04171037|453900974|FG000|Overall Study|Physician Decision|3|||
126168621|NCT04171037|453900975|FG001|Overall Study|Physician Decision|3|||
126168622|NCT00779324|453900976|FG000|Overall Study|Lost to Follow-up|2|||
126168623|NCT00779324|453900977|FG001|Overall Study|Lost to Follow-up|1|||
126168624|NCT00779324|453900976|FG000|Overall Study|Withdrawal by Subject|4|||
126168625|NCT00779324|453900977|FG001|Overall Study|Withdrawal by Subject|2|||
126168626|NCT00779324|453900976|FG000|Overall Study|Missed visit|1|||
126168627|NCT00779324|453900977|FG001|Overall Study|Missed visit|1|||
126168628|NCT00617409|453900978|FG000|Overall Study|Withdrawal by Subject|4|||
126168629|NCT00617409|453900979|FG001|Overall Study|Withdrawal by Subject|1|||
126168630|NCT00617409|453900980|FG002|Overall Study|Withdrawal by Subject|2|||
126168631|NCT00617409|453900978|FG000|Overall Study|Adverse Event|0|||
126168632|NCT00617409|453900979|FG001|Overall Study|Adverse Event|2|||
126168633|NCT00617409|453900980|FG002|Overall Study|Adverse Event|3|||
126168634|NCT00617409|453900978|FG000|Overall Study|Disease Progression|8|||
126168635|NCT00617409|453900979|FG001|Overall Study|Disease Progression|8|||
126168636|NCT00617409|453900980|FG002|Overall Study|Disease Progression|18|||
126168637|NCT00617409|453900978|FG000|Overall Study|Death|3|||
126168638|NCT00617409|453900979|FG001|Overall Study|Death|5|||
126168639|NCT00617409|453900980|FG002|Overall Study|Death|4|||
126168640|NCT00617409|453900978|FG000|Overall Study|Alternative Therapy|1|||
126168641|NCT00617409|453900979|FG001|Overall Study|Alternative Therapy|2|||
126168642|NCT00617409|453900980|FG002|Overall Study|Alternative Therapy|0|||
126168643|NCT00987623|453900985|FG000|Overall Study|Lost to Follow-up|2|||
126168644|NCT00987623|453900986|FG001|Overall Study|Lost to Follow-up|1|||
126168645|NCT00987623|453900985|FG000|Overall Study|Time/job conflict|2|||
126168646|NCT00987623|453900986|FG001|Overall Study|Time/job conflict|0|||
126168647|NCT00987623|453900985|FG000|Overall Study|Discomfort|1|||
126168648|NCT00987623|453900986|FG001|Overall Study|Discomfort|0|||
126168649|NCT00987623|453900985|FG000|Overall Study|Biomicroscopy|0|||
126168650|NCT00987623|453900986|FG001|Overall Study|Biomicroscopy|1|||
126168651|NCT00987623|453900985|FG000|Overall Study|Influenza|0|||
126168652|NCT00987623|453900986|FG001|Overall Study|Influenza|1|||
126168653|NCT01100307|453900988|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
126168654|NCT01100307|453900989|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
126168655|NCT01100307|453900988|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
126168656|NCT01100307|453900989|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
126168657|NCT01100307|453900988|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
126168658|NCT01100307|453900989|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
126168659|NCT01100307|453900988|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
126168660|NCT01100307|453900989|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
126168661|NCT01100307|453900988|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
126168662|NCT01100307|453900989|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
126168663|NCT01100307|453900988|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
126168664|NCT01100307|453900989|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
126168665|NCT00406640|453900990|FG000|Acute Phase|Adverse Event|18|||
126168666|NCT00406640|453900991|FG001|Acute Phase|Adverse Event|13|||
126168667|NCT00406640|453900990|FG000|Acute Phase|Failed to Return|5|||
126168668|NCT00406640|453900991|FG001|Acute Phase|Failed to Return|1|||
126168669|NCT00406640|453900990|FG000|Acute Phase|Physician Decision|0|||
126168670|NCT00406640|453900991|FG001|Acute Phase|Physician Decision|1|||
126168671|NCT00406640|453900990|FG000|Acute Phase|Lost to Follow-up|7|||
126168672|NCT00406640|453900991|FG001|Acute Phase|Lost to Follow-up|4|||
126168673|NCT00406640|453900990|FG000|Acute Phase|Protocol deviation|4|||
126168674|NCT00406640|453900991|FG001|Acute Phase|Protocol deviation|10|||
126168675|NCT00406640|453900990|FG000|Acute Phase|Protocol Violation|3|||
126168676|NCT00406640|453900991|FG001|Acute Phase|Protocol Violation|2|||
126168677|NCT00406640|453900990|FG000|Acute Phase|Withdrawal by Subject|11|||
126168678|NCT00406640|453900991|FG001|Acute Phase|Withdrawal by Subject|9|||
126168679|NCT00406640|453900990|FG000|Acute Phase|Lack of Efficacy|3|||
126168680|NCT00406640|453900991|FG001|Acute Phase|Lack of Efficacy|3|||
126168681|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
126168682|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
126168683|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|Death|1|||
126168684|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|Death|0|||
126168685|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
126168686|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
126168687|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
126168688|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
126168689|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
126168690|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
126168691|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|non-compliance|7|||
126168692|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|non-compliance|5|||
126168693|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
126168694|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
126168695|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
126168696|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
126168697|NCT00406640|453900990|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
126168698|NCT00406640|453900991|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
126168699|NCT00406640|453900990|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
126168700|NCT00406640|453900991|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
126168701|NCT00406640|453900990|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
126168702|NCT00406640|453900991|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
126168703|NCT00406640|453900990|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
126168704|NCT00406640|453900991|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
126168705|NCT00406640|453900990|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
126168706|NCT00406640|453900991|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
126168707|NCT00406640|453900990|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
126168708|NCT00406640|453900991|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
125973295|NCT01571362|453191430|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
126168709|NCT00406640|453900990|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
126168710|NCT00406640|453900991|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
126168711|NCT00406640|453900990|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
126168712|NCT00406640|453900991|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
126168713|NCT00755846|453902615|FG000|Overall Study|Adverse Event|0|||
126168714|NCT00755846|453902616|FG001|Overall Study|Adverse Event|0|||
126168715|NCT00755846|453902617|FG002|Overall Study|Adverse Event|0|||
126168716|NCT00755846|453902618|FG003|Overall Study|Adverse Event|1|||
126168717|NCT00755846|453902619|FG004|Overall Study|Adverse Event|3|||
126168718|NCT00755846|453902620|FG005|Overall Study|Adverse Event|2|||
126168719|NCT00755846|453902615|FG000|Overall Study|Protocol Violation|1|||
126168720|NCT00755846|453902616|FG001|Overall Study|Protocol Violation|1|||
126168721|NCT00755846|453902617|FG002|Overall Study|Protocol Violation|1|||
126168722|NCT00755846|453902618|FG003|Overall Study|Protocol Violation|1|||
126168723|NCT00755846|453902619|FG004|Overall Study|Protocol Violation|1|||
126168724|NCT00755846|453902620|FG005|Overall Study|Protocol Violation|1|||
126168725|NCT00755846|453902615|FG000|Overall Study|Lost to Follow-up|0|||
126168726|NCT00755846|453902616|FG001|Overall Study|Lost to Follow-up|2|||
126168727|NCT00755846|453902617|FG002|Overall Study|Lost to Follow-up|1|||
126168728|NCT00755846|453902618|FG003|Overall Study|Lost to Follow-up|0|||
126168729|NCT00755846|453902619|FG004|Overall Study|Lost to Follow-up|4|||
126168730|NCT00755846|453902620|FG005|Overall Study|Lost to Follow-up|2|||
126168731|NCT00755846|453902615|FG000|Overall Study|Withdrawal by Subject|2|||
126168732|NCT00755846|453902616|FG001|Overall Study|Withdrawal by Subject|3|||
126168733|NCT00755846|453902617|FG002|Overall Study|Withdrawal by Subject|5|||
126168734|NCT00755846|453902618|FG003|Overall Study|Withdrawal by Subject|2|||
126168735|NCT00755846|453902619|FG004|Overall Study|Withdrawal by Subject|0|||
126168736|NCT00755846|453902620|FG005|Overall Study|Withdrawal by Subject|1|||
126168737|NCT00755846|453902615|FG000|Overall Study|Hyperglycemic Rescue|21|||
126168738|NCT00755846|453902616|FG001|Overall Study|Hyperglycemic Rescue|7|||
126168739|NCT00755846|453902617|FG002|Overall Study|Hyperglycemic Rescue|5|||
126168740|NCT00755846|453902618|FG003|Overall Study|Hyperglycemic Rescue|8|||
126168741|NCT00755846|453902619|FG004|Overall Study|Hyperglycemic Rescue|8|||
126168742|NCT00755846|453902620|FG005|Overall Study|Hyperglycemic Rescue|7|||
126168743|NCT00755846|453902615|FG000|Overall Study|Physician Decision|1|||
126168744|NCT00755846|453902616|FG001|Overall Study|Physician Decision|3|||
126168745|NCT00755846|453902617|FG002|Overall Study|Physician Decision|0|||
126168746|NCT00755846|453902618|FG003|Overall Study|Physician Decision|1|||
126168747|NCT00755846|453902619|FG004|Overall Study|Physician Decision|0|||
126168748|NCT00755846|453902620|FG005|Overall Study|Physician Decision|1|||
126168749|NCT00755846|453902615|FG000|Overall Study|Administrative Error|0|||
126168750|NCT00755846|453902616|FG001|Overall Study|Administrative Error|1|||
126168751|NCT00755846|453902617|FG002|Overall Study|Administrative Error|0|||
126168752|NCT00755846|453902618|FG003|Overall Study|Administrative Error|0|||
126168753|NCT00755846|453902619|FG004|Overall Study|Administrative Error|0|||
126168754|NCT00755846|453902620|FG005|Overall Study|Administrative Error|0|||
126168755|NCT00755846|453902615|FG000|Overall Study|Participant Non-compliance|0|||
126168756|NCT00755846|453902616|FG001|Overall Study|Participant Non-compliance|0|||
126168757|NCT00755846|453902617|FG002|Overall Study|Participant Non-compliance|0|||
126168758|NCT00755846|453902618|FG003|Overall Study|Participant Non-compliance|0|||
126168759|NCT00755846|453902619|FG004|Overall Study|Participant Non-compliance|1|||
126168760|NCT00755846|453902620|FG005|Overall Study|Participant Non-compliance|0|||
126168761|NCT00786032|453902621|FG000|Overall Study|Death|4|||
126168762|NCT00786032|453902621|FG000|Overall Study|Withdrawal by Subject|14|||
126168763|NCT00786032|453902621|FG000|Overall Study|Did not complete in the timeframe|6|||
126168764|NCT02669862|453902622|FG000|Overall Study|Lost to Follow-up|0|||
126168765|NCT02669862|453902623|FG001|Overall Study|Lost to Follow-up|2|||
126168766|NCT02669862|453902624|FG002|Overall Study|Lost to Follow-up|1|||
126168767|NCT02669862|453902622|FG000|Overall Study|Withdrawal by Subject|2|||
126168768|NCT02669862|453902623|FG001|Overall Study|Withdrawal by Subject|2|||
126168769|NCT02669862|453902624|FG002|Overall Study|Withdrawal by Subject|3|||
125973296|NCT01571362|453191428|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
125973297|NCT01571362|453191429|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
125973298|NCT01571362|453191430|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
125973299|NCT01491854|453191441|FG000|Overall Study|mainly due to premature termination|93|||
125973300|NCT01491854|453191441|FG000|Overall Study|Death|1|||
125973301|NCT01491854|453191441|FG000|Overall Study|Withdrawal by Subject|3|||
125973302|NCT01491854|453191441|FG000|Overall Study|Lost to Follow-up|33|||
125973303|NCT00121238|453191443|FG000|Overall Study|disease progression before intervention|1|||
125973304|NCT00121238|453191443|FG000|Overall Study|Protocol Violation|2|||
125973305|NCT01026974|453191455|FG000|Overall Study|Withdrawal by Subject|0|||
125973306|NCT01026974|453191456|FG001|Overall Study|Withdrawal by Subject|1|||
125973307|NCT01026974|453191457|FG002|Overall Study|Withdrawal by Subject|7|||
126168770|NCT02669862|453902622|FG000|Overall Study|moved|0|||
126168771|NCT02669862|453902623|FG001|Overall Study|moved|1|||
126168772|NCT02669862|453902624|FG002|Overall Study|moved|0|||
126168773|NCT02669862|453902622|FG000|Overall Study|Protocol Violation|0|||
126168774|NCT02669862|453902623|FG001|Overall Study|Protocol Violation|0|||
126168775|NCT02669862|453902624|FG002|Overall Study|Protocol Violation|1|||
126168776|NCT00311181|453902625|FG000|Overall Study|Final DFTs were not obtained|96|||
126168777|NCT02429258|453902626|FG000|Overall Study|Withdrawal by Subject|2|||
126168778|NCT02429258|453902627|FG001|Overall Study|Withdrawal by Subject|0|||
126168779|NCT02429258|453902626|FG000|Overall Study|Protocol Violation|0|||
126168780|NCT02429258|453902627|FG001|Overall Study|Protocol Violation|1|||
126168781|NCT02397694|453902628|FG000|Double-Blinded Phase|Adverse Event|1|||
126168782|NCT02397694|453902629|FG001|Double-Blinded Phase|Adverse Event|0|||
126168783|NCT02397694|453902628|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
126168784|NCT02397694|453902629|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
126168785|NCT02397694|453902628|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
126168786|NCT02397694|453902629|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
126168787|NCT02397694|453902628|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
126168788|NCT02397694|453902629|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
126168789|NCT02397694|453902628|FG000|Open Label Extension Phase|Protocol Violation|1|||
126168790|NCT02397694|453902629|FG001|Open Label Extension Phase|Protocol Violation|0|||
126168791|NCT02397694|453902628|FG000|Open Label Extension Phase|Withdrew Consent|3|||
126168792|NCT02397694|453902629|FG001|Open Label Extension Phase|Withdrew Consent|1|||
126168793|NCT02397694|453902628|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
126168794|NCT02397694|453902629|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
126168795|NCT02616185|453902631|FG000|Overall Study|Death|0|||
126168796|NCT02616185|453902632|FG001|Overall Study|Death|0|||
126168797|NCT02616185|453902633|FG002|Overall Study|Death|0|||
126168798|NCT02616185|453902634|FG003|Overall Study|Death|1|||
126168799|NCT02616185|453902635|FG004|Overall Study|Death|2|||
126168800|NCT02616185|453902636|FG005|Overall Study|Death|0|||
126168801|NCT02616185|453902637|FG006|Overall Study|Death|0|||
126168802|NCT02616185|453902638|FG007|Overall Study|Death|2|||
126168803|NCT02616185|453902639|FG008|Overall Study|Death|1|||
126168804|NCT02616185|453902631|FG000|Overall Study|Study terminated by sponsor|0|||
126168805|NCT02616185|453902632|FG001|Overall Study|Study terminated by sponsor|0|||
126168806|NCT02616185|453902633|FG002|Overall Study|Study terminated by sponsor|1|||
126168807|NCT02616185|453902634|FG003|Overall Study|Study terminated by sponsor|0|||
126168808|NCT02616185|453902635|FG004|Overall Study|Study terminated by sponsor|0|||
126168809|NCT02616185|453902636|FG005|Overall Study|Study terminated by sponsor|0|||
126168810|NCT02616185|453902637|FG006|Overall Study|Study terminated by sponsor|5|||
126168811|NCT02616185|453902638|FG007|Overall Study|Study terminated by sponsor|2|||
126168812|NCT02616185|453902639|FG008|Overall Study|Study terminated by sponsor|0|||
126168813|NCT02616185|453902631|FG000|Overall Study|Participant refused further follow-up|1|||
126168814|NCT02616185|453902632|FG001|Overall Study|Participant refused further follow-up|1|||
126168815|NCT02616185|453902633|FG002|Overall Study|Participant refused further follow-up|2|||
126168816|NCT02616185|453902634|FG003|Overall Study|Participant refused further follow-up|3|||
126168817|NCT02616185|453902635|FG004|Overall Study|Participant refused further follow-up|4|||
126168818|NCT02616185|453902636|FG005|Overall Study|Participant refused further follow-up|0|||
126168819|NCT02616185|453902637|FG006|Overall Study|Participant refused further follow-up|3|||
126168820|NCT02616185|453902638|FG007|Overall Study|Participant refused further follow-up|4|||
126168821|NCT02616185|453902639|FG008|Overall Study|Participant refused further follow-up|3|||
126168822|NCT02616185|453902631|FG000|Overall Study|Not reported|0|||
126168823|NCT02616185|453902632|FG001|Overall Study|Not reported|0|||
126168824|NCT02616185|453902633|FG002|Overall Study|Not reported|0|||
126168825|NCT02616185|453902634|FG003|Overall Study|Not reported|1|||
126168826|NCT02616185|453902635|FG004|Overall Study|Not reported|3|||
126168827|NCT02616185|453902636|FG005|Overall Study|Not reported|1|||
126168828|NCT02616185|453902637|FG006|Overall Study|Not reported|0|||
126168829|NCT02616185|453902638|FG007|Overall Study|Not reported|5|||
126168830|NCT02616185|453902639|FG008|Overall Study|Not reported|2|||
126168831|NCT01303380|453902640|FG000|Overall Study|Lack of compliance to study procedures|1|||
126168832|NCT01346371|453902641|FG000|Overall Study|Lost to Follow-up|2|||
126168833|NCT01346371|453902642|FG001|Overall Study|Lost to Follow-up|0|||
126168834|NCT01670656|453902644|FG000|Overall Study|Non-compliance with study drug|0|||
126168835|NCT01670656|453902645|FG001|Overall Study|Non-compliance with study drug|0|||
126168836|NCT01670656|453902646|FG002|Overall Study|Non-compliance with study drug|3|||
126168837|NCT01670656|453902647|FG003|Overall Study|Non-compliance with study drug|0|||
126168838|NCT01670656|453902648|FG004|Overall Study|Non-compliance with study drug|1|||
126168839|NCT01670656|453902644|FG000|Overall Study|Pregnancy|0|||
126168840|NCT01670656|453902645|FG001|Overall Study|Pregnancy|0|||
126168841|NCT01670656|453902646|FG002|Overall Study|Pregnancy|0|||
126168842|NCT01670656|453902647|FG003|Overall Study|Pregnancy|0|||
126168843|NCT01670656|453902648|FG004|Overall Study|Pregnancy|1|||
126168844|NCT01670656|453902644|FG000|Overall Study|Withdrawal by Subject|1|||
126168845|NCT01670656|453902645|FG001|Overall Study|Withdrawal by Subject|1|||
126168846|NCT01670656|453902646|FG002|Overall Study|Withdrawal by Subject|0|||
126168847|NCT01670656|453902647|FG003|Overall Study|Withdrawal by Subject|0|||
126168848|NCT01670656|453902648|FG004|Overall Study|Withdrawal by Subject|0|||
126168849|NCT01670656|453902644|FG000|Overall Study|Non-compliance with protocol|0|||
126168850|NCT01670656|453902645|FG001|Overall Study|Non-compliance with protocol|3|||
126168851|NCT01670656|453902646|FG002|Overall Study|Non-compliance with protocol|1|||
126168852|NCT01670656|453902647|FG003|Overall Study|Non-compliance with protocol|1|||
126168853|NCT01670656|453902648|FG004|Overall Study|Non-compliance with protocol|2|||
126168854|NCT01670656|453902644|FG000|Overall Study|Adverse Event|2|||
126168855|NCT01670656|453902645|FG001|Overall Study|Adverse Event|2|||
126168856|NCT01670656|453902646|FG002|Overall Study|Adverse Event|2|||
126168857|NCT01670656|453902647|FG003|Overall Study|Adverse Event|3|||
126168858|NCT01670656|453902648|FG004|Overall Study|Adverse Event|3|||
126168859|NCT01670656|453902644|FG000|Overall Study|Subject withdrew consent|0|||
126168860|NCT01670656|453902645|FG001|Overall Study|Subject withdrew consent|1|||
126168861|NCT01670656|453902646|FG002|Overall Study|Subject withdrew consent|2|||
126168862|NCT01670656|453902647|FG003|Overall Study|Subject withdrew consent|1|||
126168863|NCT01670656|453902648|FG004|Overall Study|Subject withdrew consent|1|||
126168864|NCT01670656|453902644|FG000|Overall Study|Lost to Follow-up|0|||
126168865|NCT01670656|453902645|FG001|Overall Study|Lost to Follow-up|0|||
126168866|NCT01670656|453902646|FG002|Overall Study|Lost to Follow-up|0|||
126168867|NCT01670656|453902647|FG003|Overall Study|Lost to Follow-up|0|||
126168868|NCT01670656|453902648|FG004|Overall Study|Lost to Follow-up|3|||
126168869|NCT01670656|453902644|FG000|Overall Study|Subject moved|0|||
126168870|NCT01670656|453902645|FG001|Overall Study|Subject moved|0|||
126168871|NCT01670656|453902646|FG002|Overall Study|Subject moved|0|||
126168872|NCT01670656|453902647|FG003|Overall Study|Subject moved|1|||
126168873|NCT01670656|453902648|FG004|Overall Study|Subject moved|0|||
126168874|NCT00789958|453902649|FG000|Overall Study|Adverse Event|3|||
126168875|NCT00789958|453902649|FG000|Overall Study|Withdrawal by Subject|4|||
126168876|NCT00789958|453902649|FG000|Overall Study|Progression|3|||
126168877|NCT00789958|453902649|FG000|Overall Study|not protocol specified|1|||
126168878|NCT00789958|453902649|FG000|Overall Study|Not eligible/not analyzable|26|||
126168879|NCT01000727|453902653|FG000|Overall Study|Lost to Follow-up|41|||
126168880|NCT01000727|453902654|FG001|Overall Study|Lost to Follow-up|43|||
126168881|NCT01000727|453902653|FG000|Overall Study|Withdrawal by Subject|111|||
126168882|NCT01000727|453902654|FG001|Overall Study|Withdrawal by Subject|109|||
126168883|NCT01000727|453902653|FG000|Overall Study|Study closed/terminated|23|||
126168884|NCT01000727|453902654|FG001|Overall Study|Study closed/terminated|24|||
126168885|NCT00568958|453902658|FG000|Allocation|Withdrawal by Subject|7|||
126168886|NCT00568958|453902659|FG001|Allocation|Withdrawal by Subject|3|||
126168887|NCT00568958|453902658|FG000|Allocation|Physician Decision|2|||
126168888|NCT00568958|453902659|FG001|Allocation|Physician Decision|0|||
126168889|NCT00568958|453902658|FG000|Follow-Up|Withdrawal by Subject|6|||
126168890|NCT00568958|453902659|FG001|Follow-Up|Withdrawal by Subject|6|||
126168891|NCT00568958|453902658|FG000|Follow-Up|Physician Decision|1|||
126168892|NCT00568958|453902659|FG001|Follow-Up|Physician Decision|1|||
126168893|NCT00568958|453902658|FG000|Follow-Up|Family Emergency|1|||
126168894|NCT00568958|453902659|FG001|Follow-Up|Family Emergency|0|||
126168895|NCT00568958|453902658|FG000|Follow-Up|Adverse Event|1|||
126168896|NCT00568958|453902659|FG001|Follow-Up|Adverse Event|0|||
126168897|NCT01354353|453902664|FG000|Overall Study|Adverse Event|1|||
126168898|NCT01354353|453902665|FG001|Overall Study|Adverse Event|0|||
126168899|NCT01354353|453902666|FG002|Overall Study|Adverse Event|0|||
126168900|NCT01354353|453902667|FG003|Overall Study|Adverse Event|4|||
126168901|NCT01354353|453902668|FG004|Overall Study|Adverse Event|0|||
126168902|NCT01354353|453902669|FG005|Overall Study|Adverse Event|5|||
126168903|NCT01354353|453902664|FG000|Overall Study|Entry Criteria Not Met|0|||
126168904|NCT01354353|453902665|FG001|Overall Study|Entry Criteria Not Met|0|||
126168905|NCT01354353|453902666|FG002|Overall Study|Entry Criteria Not Met|0|||
126168906|NCT01354353|453902667|FG003|Overall Study|Entry Criteria Not Met|1|||
126168907|NCT01354353|453902668|FG004|Overall Study|Entry Criteria Not Met|1|||
126168908|NCT01354353|453902669|FG005|Overall Study|Entry Criteria Not Met|0|||
126168909|NCT01354353|453902664|FG000|Overall Study|Physician Decision|0|||
126168910|NCT01354353|453902665|FG001|Overall Study|Physician Decision|1|||
126168911|NCT01354353|453902666|FG002|Overall Study|Physician Decision|1|||
126168912|NCT01354353|453902667|FG003|Overall Study|Physician Decision|0|||
126168913|NCT01354353|453902668|FG004|Overall Study|Physician Decision|0|||
126168914|NCT01354353|453902669|FG005|Overall Study|Physician Decision|0|||
126168915|NCT01354353|453902664|FG000|Overall Study|Withdrawal by Subject|2|||
126168916|NCT01354353|453902665|FG001|Overall Study|Withdrawal by Subject|0|||
125973308|NCT01026974|453191458|FG003|Overall Study|Withdrawal by Subject|2|||
126168917|NCT01354353|453902666|FG002|Overall Study|Withdrawal by Subject|1|||
126168918|NCT01354353|453902667|FG003|Overall Study|Withdrawal by Subject|0|||
126168919|NCT01354353|453902668|FG004|Overall Study|Withdrawal by Subject|0|||
126168920|NCT01354353|453902669|FG005|Overall Study|Withdrawal by Subject|1|||
126168921|NCT00377611|453902672|FG000|Overall Study|Adverse Event|2|||
126168922|NCT00377611|453902673|FG001|Overall Study|Adverse Event|9|||
126168923|NCT00377611|453902672|FG000|Overall Study|Protocol Violation|2|||
126168924|NCT00377611|453902673|FG001|Overall Study|Protocol Violation|0|||
126168925|NCT00377611|453902672|FG000|Overall Study|Withdrawal by Subject|0|||
126168926|NCT00377611|453902673|FG001|Overall Study|Withdrawal by Subject|5|||
126168927|NCT00377611|453902672|FG000|Overall Study|Lost to Follow-up|18|||
126168928|NCT00377611|453902673|FG001|Overall Study|Lost to Follow-up|16|||
126168929|NCT00377611|453902672|FG000|Overall Study|Other|0|||
126168930|NCT00377611|453902673|FG001|Overall Study|Other|3|||
126168931|NCT04831515|453902674|FG000|First Intervention|Adverse Event|0|||
126168932|NCT04831515|453902675|FG001|First Intervention|Adverse Event|1|||
126168933|NCT01640925|453902680|FG000|Overall Study|Withdrawal by Subject|1|||
126168934|NCT01640925|453902681|FG001|Overall Study|Withdrawal by Subject|0|||
126168935|NCT01640925|453902680|FG000|Overall Study|Previously enrolled in this trial|13|||
126168936|NCT01640925|453902681|FG001|Overall Study|Previously enrolled in this trial|11|||
126168937|NCT01030458|453902695|FG000|Overall Study|Lost to Follow-up|9|||
126168938|NCT01030458|453902696|FG001|Overall Study|Lost to Follow-up|10|||
126168939|NCT01030458|453902695|FG000|Overall Study|Withdrawal by Subject|2|||
126168940|NCT01030458|453902696|FG001|Overall Study|Withdrawal by Subject|3|||
126168941|NCT01030458|453902695|FG000|Overall Study|Logistical reasons|9|||
126168942|NCT01030458|453902696|FG001|Overall Study|Logistical reasons|5|||
126168943|NCT01030458|453902695|FG000|Overall Study|Moved or changed job|6|||
126168944|NCT01030458|453902696|FG001|Overall Study|Moved or changed job|13|||
126168945|NCT01030458|453902695|FG000|Overall Study|Side effect of medication|1|||
126168946|NCT01030458|453902696|FG001|Overall Study|Side effect of medication|1|||
126168947|NCT01332019|453902697|FG000|Overall Study|Was Not Dosed|1|||
126168948|NCT01332019|453902698|FG001|Overall Study|Was Not Dosed|0|||
126168949|NCT01332019|453902697|FG000|Overall Study|Other|16|||
126168950|NCT01332019|453902698|FG001|Overall Study|Other|18|||
126168951|NCT01332019|453902697|FG000|Overall Study|Death|2|||
126168952|NCT01332019|453902698|FG001|Overall Study|Death|1|||
126168953|NCT01332019|453902697|FG000|Overall Study|Physician Decision|4|||
126168954|NCT01332019|453902698|FG001|Overall Study|Physician Decision|3|||
126168955|NCT01332019|453902697|FG000|Overall Study|Withdrawal by Subject|73|||
126168956|NCT01332019|453902698|FG001|Overall Study|Withdrawal by Subject|71|||
126168957|NCT01332019|453902697|FG000|Overall Study|Lost to Follow-up|4|||
126168958|NCT01332019|453902698|FG001|Overall Study|Lost to Follow-up|7|||
126168959|NCT01332019|453902697|FG000|Overall Study|Adverse Event|13|||
126168960|NCT01332019|453902698|FG001|Overall Study|Adverse Event|22|||
126168961|NCT01358877|453902701|FG000|Overall Study|Death|80|||
126168962|NCT01358877|453902702|FG001|Overall Study|Death|89|||
126168963|NCT01358877|453902701|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
126168964|NCT01358877|453902702|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
126168965|NCT01358877|453902701|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
126168966|NCT01358877|453902702|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
126168967|NCT01358877|453902701|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
126168968|NCT01358877|453902702|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
126168969|NCT01358877|453902701|FG000|Overall Study|Other|142|||
126168970|NCT01358877|453902702|FG001|Overall Study|Other|129|||
126168971|NCT01911845|453902707|FG000|Overall Study|Adverse Event|2|||
126168972|NCT01911845|453902707|FG000|Overall Study|Lost to Follow-up|1|||
126168973|NCT01911845|453902707|FG000|Overall Study|Other (not specified)|3|||
126168974|NCT01994226|453902708|FG000|Overall Study|Protocol Violation|13|||
126168975|NCT01994226|453902709|FG001|Overall Study|Protocol Violation|10|||
126168976|NCT01994226|453902708|FG000|Overall Study|Early Cessation of treatment|6|||
126168977|NCT01994226|453902709|FG001|Overall Study|Early Cessation of treatment|11|||
126168978|NCT00501046|453902714|FG000|Overall Study|Adverse Event|21|||
126168979|NCT00501046|453902715|FG001|Overall Study|Adverse Event|25|||
126168980|NCT00501046|453902714|FG000|Overall Study|Death|23|||
126168981|NCT00501046|453902715|FG001|Overall Study|Death|30|||
126168982|NCT00501046|453902714|FG000|Overall Study|Lost to Follow-up|14|||
126168983|NCT00501046|453902715|FG001|Overall Study|Lost to Follow-up|13|||
126168984|NCT00501046|453902714|FG000|Overall Study|Physician Decision|7|||
126168985|NCT00501046|453902715|FG001|Overall Study|Physician Decision|2|||
126168986|NCT00501046|453902714|FG000|Overall Study|Pregnancy|0|||
126168987|NCT00501046|453902715|FG001|Overall Study|Pregnancy|3|||
126168988|NCT00501046|453902714|FG000|Overall Study|Protocol Violation|2|||
126168989|NCT00501046|453902715|FG001|Overall Study|Protocol Violation|1|||
126168990|NCT00501046|453902714|FG000|Overall Study|Withdrawal by Subject|84|||
126168991|NCT00501046|453902715|FG001|Overall Study|Withdrawal by Subject|83|||
126168992|NCT00501046|453902714|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
126168993|NCT00501046|453902715|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
126168994|NCT01980706|453902718|FG000|Overall Study|Withdrawal by Subject|9|||
126168995|NCT01980706|453902719|FG001|Overall Study|Withdrawal by Subject|6|||
126168996|NCT01980706|453902720|FG002|Overall Study|Withdrawal by Subject|2|||
126168997|NCT01980706|453902718|FG000|Overall Study|Adverse Event|1|||
126168998|NCT01980706|453902719|FG001|Overall Study|Adverse Event|2|||
126168999|NCT01980706|453902720|FG002|Overall Study|Adverse Event|5|||
126169000|NCT01980706|453902718|FG000|Overall Study|Lost to Follow-up|3|||
126169001|NCT01980706|453902719|FG001|Overall Study|Lost to Follow-up|4|||
126169002|NCT01980706|453902720|FG002|Overall Study|Lost to Follow-up|3|||
126169003|NCT01980706|453902718|FG000|Overall Study|miscellaneous|4|||
126169004|NCT01980706|453902719|FG001|Overall Study|miscellaneous|5|||
126169005|NCT01980706|453902720|FG002|Overall Study|miscellaneous|3|||
126169006|NCT01934894|453902723|FG000|Overall Study|Adverse Event|1|||
126169007|NCT01934894|453902724|FG001|Overall Study|Adverse Event|2|||
126169008|NCT01934894|453902723|FG000|Overall Study|Death|2|||
126169009|NCT01934894|453902724|FG001|Overall Study|Death|0|||
126169010|NCT01934894|453902723|FG000|Overall Study|Withdrawal by Subject|0|||
126200117|NCT02394028|454017883|FG006|Induction Phase|Lack of Efficacy|17|||
125973309|NCT01026974|453191455|FG000|Overall Study|Lost to Follow-up|1|||
125973310|NCT01026974|453191456|FG001|Overall Study|Lost to Follow-up|1|||
126169011|NCT01934894|453902724|FG001|Overall Study|Withdrawal by Subject|1|||
126169012|NCT01934894|453902723|FG000|Overall Study|Progressive Disease|3|||
126169013|NCT01934894|453902724|FG001|Overall Study|Progressive Disease|2|||
126169014|NCT01842308|453902725|FG000|Overall Study|Withdrawal by Subject|0|||
126169015|NCT01842308|453902726|FG001|Overall Study|Withdrawal by Subject|0|||
126169016|NCT01842308|453902727|FG002|Overall Study|Withdrawal by Subject|0|||
126169017|NCT01842308|453902728|FG003|Overall Study|Withdrawal by Subject|0|||
126169018|NCT01842308|453902729|FG004|Overall Study|Withdrawal by Subject|1|||
126169019|NCT02509598|453902730|FG000|Overall Study|Withdrawal by Subject|1|||
126169020|NCT02196038|453902731|FG000|Overall Study|Death|16|||
126169021|NCT02196038|453902732|FG001|Overall Study|Death|21|||
126169022|NCT02196038|453902731|FG000|Overall Study|Withdrawal by Subject|0|||
126169023|NCT02196038|453902732|FG001|Overall Study|Withdrawal by Subject|1|||
126169024|NCT02196038|453902731|FG000|Overall Study|Lost to Follow-up|1|||
126169025|NCT02196038|453902732|FG001|Overall Study|Lost to Follow-up|0|||
126169026|NCT04056455|453902733|FG000|Overall Study|Adverse Event|1|||
126169027|NCT04056455|453902734|FG001|Overall Study|Adverse Event|0|||
126169028|NCT03135028|453902741|FG000|Overall Study|Death|6|||
126169029|NCT03135028|453902741|FG000|Overall Study|Study Terminated by Sponsor|2|||
126169030|NCT03135028|453902741|FG000|Overall Study|Withdrew Consent|1|||
126169031|NCT02065869|453902743|FG000|Overall Study|Death|7|||
126169032|NCT02065869|453902743|FG000|Overall Study|Disease relapse|16|||
126169033|NCT02065869|453902743|FG000|Overall Study|Lost to Follow-up|4|||
126169034|NCT02065869|453902743|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
126169035|NCT02065869|453902743|FG000|Overall Study|Withdrawal by Subject|1|||
126169036|NCT04436822|453902744|FG000|Overall Study|Physician Decision|2|||
126169037|NCT04436822|453902745|FG001|Overall Study|Physician Decision|0|||
126169038|NCT04436822|453902744|FG000|Overall Study|Sponsor request|1|||
126169039|NCT04436822|453902745|FG001|Overall Study|Sponsor request|0|||
126169040|NCT04436822|453902744|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126169041|NCT04436822|453902745|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126169042|NCT04436822|453902744|FG000|Overall Study|Unsuccessful procedure|0|||
126169043|NCT04436822|453902745|FG001|Overall Study|Unsuccessful procedure|1|||
126169044|NCT04436822|453902744|FG000|Overall Study|Withdrawal due to Covid-19|8|||
126169045|NCT04436822|453902745|FG001|Overall Study|Withdrawal due to Covid-19|1|||
126169046|NCT04436822|453902744|FG000|Overall Study|Withdrawal by Subject|1|||
126169047|NCT04436822|453902745|FG001|Overall Study|Withdrawal by Subject|0|||
126169048|NCT04436822|453902744|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
126169049|NCT04436822|453902745|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
126169050|NCT03375112|453902746|FG000|Overall Study|Withdrawal by Subject|3|||
126169051|NCT03375112|453902747|FG001|Overall Study|Withdrawal by Subject|0|||
126169052|NCT00369668|453902748|FG000|Overall Study|Lack of Efficacy|4|||
126169053|NCT00369668|453902749|FG001|Overall Study|Lack of Efficacy|5|||
126169054|NCT00369668|453902750|FG002|Overall Study|Lack of Efficacy|7|||
126169055|NCT00894413|453902753|FG000|Overall Study|Physician Decision|0|||
126169056|NCT00894413|453902754|FG001|Overall Study|Physician Decision|2|||
126169057|NCT00894413|453902753|FG000|Overall Study|Adverse Event|0|||
126169058|NCT00894413|453902754|FG001|Overall Study|Adverse Event|2|||
126169059|NCT00894413|453902753|FG000|Overall Study|Withdrawal by Subject|0|||
126169060|NCT00894413|453902754|FG001|Overall Study|Withdrawal by Subject|4|||
126169061|NCT03213626|453902757|FG000|Overall Study|Adverse Event|1|||
126169062|NCT03213626|453902757|FG000|Overall Study|Progressive Disease|6|||
126169063|NCT01079962|453902770|FG000|Overall Study|Adverse Event|2|||
126169064|NCT01079962|453902771|FG001|Overall Study|Adverse Event|2|||
126169065|NCT01079962|453902770|FG000|Overall Study|Withdrawal by Subject|5|||
126169066|NCT01079962|453902771|FG001|Overall Study|Withdrawal by Subject|7|||
126169067|NCT01079962|453902770|FG000|Overall Study|Protocol Violation|2|||
126169068|NCT01079962|453902771|FG001|Overall Study|Protocol Violation|2|||
126169069|NCT01079962|453902770|FG000|Overall Study|No blood pressure (BP) control|3|||
126169070|NCT01079962|453902771|FG001|Overall Study|No blood pressure (BP) control|0|||
126169071|NCT01079962|453902770|FG000|Overall Study|Inclusion/exclusion criteria|1|||
126169072|NCT01079962|453902771|FG001|Overall Study|Inclusion/exclusion criteria|3|||
126169073|NCT01079962|453902770|FG000|Overall Study|Participant not returning for next visit|1|||
126169074|NCT01079962|453902771|FG001|Overall Study|Participant not returning for next visit|0|||
126169075|NCT01079962|453902770|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
126169076|NCT01079962|453902771|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
126169077|NCT01331239|453902772|FG000|Part II: Core Study|Adverse Event|0|||
126169078|NCT01331239|453902773|FG001|Part II: Core Study|Adverse Event|3|||
126169079|NCT01331239|453902774|FG002|Part II: Core Study|Adverse Event|0|||
126169080|NCT01331239|453902772|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
126169081|NCT01331239|453902773|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
126169082|NCT01331239|453902774|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
126169083|NCT01331239|453902772|FG000|Part II: Core Study|Withdrawal by Subject|0|||
126169084|NCT01331239|453902773|FG001|Part II: Core Study|Withdrawal by Subject|2|||
125973311|NCT01026974|453191457|FG002|Overall Study|Lost to Follow-up|4|||
125973312|NCT01026974|453191458|FG003|Overall Study|Lost to Follow-up|0|||
125973313|NCT01026974|453191455|FG000|Overall Study|Adverse Event|0|||
125973314|NCT01026974|453191456|FG001|Overall Study|Adverse Event|0|||
125973315|NCT01026974|453191457|FG002|Overall Study|Adverse Event|0|||
125973316|NCT01026974|453191458|FG003|Overall Study|Adverse Event|1|||
126169085|NCT01331239|453902774|FG002|Part II: Core Study|Withdrawal by Subject|0|||
126169086|NCT01331239|453902772|FG000|Part II: Core Study|Administrative problems|0|||
126169087|NCT01331239|453902773|FG001|Part II: Core Study|Administrative problems|1|||
126169088|NCT01331239|453902774|FG002|Part II: Core Study|Administrative problems|0|||
126169089|NCT00946530|453902777|FG000|Overall Study|Withdrawal by Subject|0|||
126169090|NCT00946530|453902778|FG001|Overall Study|Withdrawal by Subject|3|||
126169091|NCT00946530|453902779|FG002|Overall Study|Withdrawal by Subject|0|||
126169092|NCT00946530|453902780|FG003|Overall Study|Withdrawal by Subject|3|||
126169093|NCT00946530|453902777|FG000|Overall Study|Physician Decision|1|||
126169094|NCT00946530|453902778|FG001|Overall Study|Physician Decision|1|||
126169095|NCT00946530|453902779|FG002|Overall Study|Physician Decision|1|||
126169096|NCT00946530|453902780|FG003|Overall Study|Physician Decision|1|||
126169097|NCT01008995|453902781|FG000|Controlled Period|Adverse Event|1|||
126169098|NCT01008995|453902782|FG001|Controlled Period|Adverse Event|2|||
126169099|NCT01008995|453902783|FG002|Controlled Period|Adverse Event|0|||
126169100|NCT01008995|453902784|FG003|Controlled Period|Adverse Event|0|||
126169101|NCT01008995|453902781|FG000|Controlled Period|Other|2|||
126169102|NCT01008995|453902782|FG001|Controlled Period|Other|1|||
126169103|NCT01008995|453902783|FG002|Controlled Period|Other|0|||
126169104|NCT01008995|453902784|FG003|Controlled Period|Other|0|||
126169105|NCT01008995|453902781|FG000|After Controlled Period|Adverse Event|0|||
126169106|NCT01008995|453902782|FG001|After Controlled Period|Adverse Event|0|||
126169107|NCT01008995|453902783|FG002|After Controlled Period|Adverse Event|1|||
126169108|NCT01008995|453902784|FG003|After Controlled Period|Adverse Event|1|||
126169109|NCT01008995|453902781|FG000|After Controlled Period|Other|0|||
126169110|NCT01008995|453902782|FG001|After Controlled Period|Other|0|||
126169111|NCT01008995|453902783|FG002|After Controlled Period|Other|1|||
126169112|NCT01008995|453902784|FG003|After Controlled Period|Other|0|||
126169113|NCT02457182|453905104|FG000|Overall Study|Lost to Follow-up|1|||
126169114|NCT02457182|453905105|FG001|Overall Study|Lost to Follow-up|0|||
126169115|NCT00789191|453905110|FG000|Overall Study|Adverse Event|2|||
126169116|NCT00789191|453905111|FG001|Overall Study|Adverse Event|4|||
126169117|NCT00789191|453905110|FG000|Overall Study|Lack of Efficacy|0|||
126169118|NCT00789191|453905111|FG001|Overall Study|Lack of Efficacy|5|||
126169119|NCT00789191|453905110|FG000|Overall Study|Protocol Violation|5|||
126169120|NCT00789191|453905111|FG001|Overall Study|Protocol Violation|3|||
126169121|NCT00789191|453905110|FG000|Overall Study|Withdrawal Criteria|2|||
126169122|NCT00789191|453905111|FG001|Overall Study|Withdrawal Criteria|4|||
126169123|NCT00789191|453905110|FG000|Overall Study|Unclassified|5|||
126169124|NCT00789191|453905111|FG001|Overall Study|Unclassified|3|||
126169125|NCT01009983|453905112|FG000|Overall Study|necessary scans not completed|1|||
126169126|NCT03497429|453905113|FG000|Overall Study|Progressive disease|3|||
126169127|NCT03497429|453905114|FG001|Overall Study|Progressive disease|4|||
126169128|NCT03497429|453905113|FG000|Overall Study|Adverse Event|0|||
126169129|NCT03497429|453905114|FG001|Overall Study|Adverse Event|2|||
126169130|NCT00506948|453905115|FG000|Overall Study|Death|4|||
126169131|NCT00506948|453905115|FG000|Overall Study|Adverse Event|5|||
126169132|NCT00506948|453905115|FG000|Overall Study|Physician Decision|1|||
126169133|NCT00762372|453905117|FG000|Overall Study|Adverse Event|1|||
126169134|NCT00762372|453905118|FG001|Overall Study|Adverse Event|0|||
126169135|NCT00762372|453905119|FG002|Overall Study|Adverse Event|0|||
126169136|NCT03364335|453905120|FG000|Overall Study|Adverse Event|3|||
126169137|NCT03364335|453905121|FG001|Overall Study|Adverse Event|4|||
126169138|NCT03364335|453905122|FG002|Overall Study|Adverse Event|1|||
126169139|NCT03364335|453905123|FG003|Overall Study|Adverse Event|2|||
126169140|NCT03364335|453905124|FG004|Overall Study|Adverse Event|0|||
126169141|NCT03364335|453905120|FG000|Overall Study|Lost to Follow-up|7|||
126169142|NCT03364335|453905121|FG001|Overall Study|Lost to Follow-up|7|||
126169143|NCT03364335|453905122|FG002|Overall Study|Lost to Follow-up|10|||
126169144|NCT03364335|453905123|FG003|Overall Study|Lost to Follow-up|11|||
126169145|NCT03364335|453905124|FG004|Overall Study|Lost to Follow-up|11|||
126169146|NCT02670915|453905125|FG000|Overall Study|Withdrawal by Subject|0|||
126169147|NCT02670915|453905126|FG001|Overall Study|Withdrawal by Subject|1|||
126169148|NCT02670915|453905127|FG002|Overall Study|Withdrawal by Subject|4|||
126169149|NCT02670915|453905125|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126169150|NCT02670915|453905126|FG001|Overall Study|Withdrawal by parent/guardian|4|||
126169151|NCT02670915|453905127|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125973317|NCT01026974|453191455|FG000|Overall Study|Inappropriate enrollment|0|||
126169152|NCT02670915|453905125|FG000|Overall Study|Unclassified|0|||
126169153|NCT02670915|453905126|FG001|Overall Study|Unclassified|3|||
126169154|NCT02670915|453905127|FG002|Overall Study|Unclassified|0|||
126169155|NCT00818207|453905128|FG000|Overall Study|Adverse Event|6|||
126169156|NCT00818207|453905129|FG001|Overall Study|Adverse Event|0|||
126169157|NCT00818207|453905128|FG000|Overall Study|Lost to Follow-up|160|||
126169158|NCT00818207|453905129|FG001|Overall Study|Lost to Follow-up|146|||
126169159|NCT00818207|453905128|FG000|Overall Study|Multiple reasons|11|||
126169160|NCT00818207|453905129|FG001|Overall Study|Multiple reasons|12|||
126169161|NCT00818207|453905128|FG000|Overall Study|Withdrawal by Subject|42|||
126169162|NCT00818207|453905129|FG001|Overall Study|Withdrawal by Subject|104|||
126169163|NCT00818207|453905128|FG000|Overall Study|Death|3|||
126169164|NCT00818207|453905129|FG001|Overall Study|Death|5|||
126169165|NCT02494778|453905130|FG000|Overall Study|Death|3|||
126169166|NCT02494778|453905130|FG000|Overall Study|Other|173|||
126169167|NCT02494778|453905130|FG000|Overall Study|Lack of Efficacy|4|||
126169168|NCT02494778|453905130|FG000|Overall Study|Adverse Event|18|||
126169169|NCT02494778|453905130|FG000|Overall Study|Withdrawal by Subject|20|||
126169170|NCT02494778|453905130|FG000|Overall Study|Lost to Follow-up|2|||
126169171|NCT02494778|453905130|FG000|Overall Study|Noncompliant with study drug admin.|1|||
126169172|NCT02174861|453905131|FG000|Overall Study|Decision by sponsor|8|||
126169173|NCT02174861|453905131|FG000|Overall Study|Withdrawal by Subject|124|||
126169174|NCT02174861|453905131|FG000|Overall Study|Lost to Follow-up|26|||
126169175|NCT03544268|453905136|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
126169176|NCT03544268|453905137|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
126169177|NCT00871377|453905138|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126169178|NCT00871377|453905139|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126169179|NCT00871377|453905140|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
126169180|NCT00871377|453905141|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126169181|NCT00871377|453905142|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126169182|NCT00871377|453905143|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126169183|NCT00871377|453905138|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126169184|NCT00871377|453905139|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126169185|NCT00871377|453905140|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126169186|NCT00871377|453905141|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126169187|NCT00871377|453905142|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126169188|NCT00871377|453905143|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
126169189|NCT00871377|453905138|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
126169190|NCT00871377|453905139|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169191|NCT00871377|453905140|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169192|NCT00871377|453905141|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169193|NCT00871377|453905142|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169194|NCT00871377|453905143|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169195|NCT00871377|453905138|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169196|NCT00871377|453905139|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169197|NCT00871377|453905140|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169198|NCT00871377|453905141|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169199|NCT00871377|453905142|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
126169200|NCT00871377|453905143|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
126169201|NCT00871377|453905138|FG000|Third Intervention (10 Weeks)|Death|0|||
126169202|NCT00871377|453905139|FG001|Third Intervention (10 Weeks)|Death|0|||
126169203|NCT00871377|453905140|FG002|Third Intervention (10 Weeks)|Death|0|||
126169204|NCT00871377|453905141|FG003|Third Intervention (10 Weeks)|Death|1|||
126169205|NCT00871377|453905142|FG004|Third Intervention (10 Weeks)|Death|0|||
126169206|NCT00871377|453905143|FG005|Third Intervention (10 Weeks)|Death|0|||
126169207|NCT01395368|453905145|FG000|Overall Study|Physician Decision|14|||
126169208|NCT01395368|453905145|FG000|Overall Study|Withdrawal by Subject|2|||
126169209|NCT00288860|453905148|FG000|Overall Study|Did not complete intake|4|||
126169210|NCT00288860|453905149|FG001|Overall Study|Did not complete intake|8|||
126169211|NCT00288860|453905148|FG000|Overall Study|Death|4|||
126169212|NCT00288860|453905149|FG001|Overall Study|Death|3|||
126169213|NCT00288860|453905148|FG000|Overall Study|Withdrawal by Subject|20|||
126169214|NCT00288860|453905149|FG001|Overall Study|Withdrawal by Subject|15|||
126169215|NCT00288860|453905148|FG000|Overall Study|Lost to Follow-up|74|||
126169216|NCT00288860|453905149|FG001|Overall Study|Lost to Follow-up|71|||
126169217|NCT03072719|453905154|FG000|Overall Study|Adverse Event|1|||
126169218|NCT03072719|453905155|FG001|Overall Study|Adverse Event|1|||
126169219|NCT00882999|453905157|FG000|Overall Study|Adverse Event|0|||
126169220|NCT00882999|453905158|FG001|Overall Study|Adverse Event|0|||
126169221|NCT00882999|453905159|FG002|Overall Study|Adverse Event|0|||
126169222|NCT00882999|453905160|FG003|Overall Study|Adverse Event|0|||
126169223|NCT00882999|453905161|FG004|Overall Study|Adverse Event|1|||
126169224|NCT00882999|453905162|FG005|Overall Study|Adverse Event|0|||
126169225|NCT00882999|453905163|FG006|Overall Study|Adverse Event|0|||
126169226|NCT00882999|453905157|FG000|Overall Study|Death|0|||
126169227|NCT00882999|453905158|FG001|Overall Study|Death|1|||
126169228|NCT00882999|453905159|FG002|Overall Study|Death|0|||
126169229|NCT00882999|453905160|FG003|Overall Study|Death|0|||
126169230|NCT00882999|453905161|FG004|Overall Study|Death|0|||
126169231|NCT00882999|453905162|FG005|Overall Study|Death|0|||
126169232|NCT00882999|453905163|FG006|Overall Study|Death|0|||
126169233|NCT00882999|453905157|FG000|Overall Study|Withdrawal by Subject|7|||
126169234|NCT00882999|453905158|FG001|Overall Study|Withdrawal by Subject|6|||
126169235|NCT00882999|453905159|FG002|Overall Study|Withdrawal by Subject|3|||
126169236|NCT00882999|453905160|FG003|Overall Study|Withdrawal by Subject|3|||
126169237|NCT00882999|453905161|FG004|Overall Study|Withdrawal by Subject|6|||
126169238|NCT00882999|453905162|FG005|Overall Study|Withdrawal by Subject|5|||
126169239|NCT00882999|453905163|FG006|Overall Study|Withdrawal by Subject|5|||
126169240|NCT00882999|453905157|FG000|Overall Study|Lost to Follow-up|0|||
126169241|NCT00882999|453905158|FG001|Overall Study|Lost to Follow-up|1|||
126169242|NCT00882999|453905159|FG002|Overall Study|Lost to Follow-up|1|||
126169243|NCT00882999|453905160|FG003|Overall Study|Lost to Follow-up|2|||
126169244|NCT00882999|453905161|FG004|Overall Study|Lost to Follow-up|1|||
126169245|NCT00882999|453905162|FG005|Overall Study|Lost to Follow-up|1|||
126169246|NCT00882999|453905163|FG006|Overall Study|Lost to Follow-up|2|||
126169247|NCT00882999|453905157|FG000|Overall Study|Physician Decision|1|||
126169248|NCT00882999|453905158|FG001|Overall Study|Physician Decision|0|||
126169249|NCT00882999|453905159|FG002|Overall Study|Physician Decision|0|||
126169250|NCT00882999|453905160|FG003|Overall Study|Physician Decision|0|||
126169251|NCT00882999|453905161|FG004|Overall Study|Physician Decision|0|||
126169252|NCT00882999|453905162|FG005|Overall Study|Physician Decision|1|||
126169253|NCT00882999|453905163|FG006|Overall Study|Physician Decision|1|||
126169254|NCT01104584|453905164|FG000|Overall Study|Study drug never administered|21|||
126169255|NCT01104584|453905164|FG000|Overall Study|Study prematurely discontinued|2|||
126169256|NCT04017442|453905165|FG000|Overall Study|Withdrawal by Subject|0|||
126169257|NCT04017442|453905166|FG001|Overall Study|Withdrawal by Subject|3|||
126169258|NCT04017442|453905165|FG000|Overall Study|Lost to Follow-up|21|||
126169259|NCT04017442|453905166|FG001|Overall Study|Lost to Follow-up|19|||
126169260|NCT02586233|453905169|FG000|Overall Study|Randomized but did not receive treatment|0|||
126169261|NCT02586233|453905170|FG001|Overall Study|Randomized but did not receive treatment|1|||
126169262|NCT02586233|453905171|FG002|Overall Study|Randomized but did not receive treatment|0|||
126169263|NCT02586233|453905172|FG003|Overall Study|Randomized but did not receive treatment|0|||
126169264|NCT02586233|453905173|FG004|Overall Study|Randomized but did not receive treatment|0|||
126169265|NCT02586233|453905174|FG005|Overall Study|Randomized but did not receive treatment|2|||
126169266|NCT02586233|453905175|FG006|Overall Study|Randomized but did not receive treatment|2|||
126169267|NCT02586233|453905169|FG000|Overall Study|Death|0|||
126169268|NCT02586233|453905170|FG001|Overall Study|Death|1|||
126169269|NCT02586233|453905171|FG002|Overall Study|Death|0|||
126169270|NCT02586233|453905172|FG003|Overall Study|Death|0|||
126169271|NCT02586233|453905173|FG004|Overall Study|Death|2|||
126169272|NCT02586233|453905174|FG005|Overall Study|Death|0|||
126169273|NCT02586233|453905175|FG006|Overall Study|Death|0|||
126169274|NCT01757405|453905176|FG000|Overall Study|Lost to Follow-up|1|||
126169275|NCT01757405|453905177|FG001|Overall Study|Lost to Follow-up|1|||
126169276|NCT01757405|453905176|FG000|Overall Study|Withdrawal by Subject|0|||
126169277|NCT01757405|453905177|FG001|Overall Study|Withdrawal by Subject|1|||
126169278|NCT00082758|453905178|FG000|Overall Study|Adverse Event|0|||
126169279|NCT00082758|453905179|FG001|Overall Study|Adverse Event|2|||
126169280|NCT00082758|453905180|FG002|Overall Study|Adverse Event|0|||
126169281|NCT00082758|453905178|FG000|Overall Study|Lack of Efficacy|12|||
126169282|NCT00082758|453905179|FG001|Overall Study|Lack of Efficacy|13|||
126169283|NCT00082758|453905180|FG002|Overall Study|Lack of Efficacy|0|||
126169284|NCT00082758|453905178|FG000|Overall Study|Physician Decision|0|||
126169285|NCT00082758|453905179|FG001|Overall Study|Physician Decision|1|||
126169286|NCT00082758|453905180|FG002|Overall Study|Physician Decision|0|||
126169287|NCT00082758|453905178|FG000|Overall Study|Withdrawal by Subject|3|||
126169288|NCT00082758|453905179|FG001|Overall Study|Withdrawal by Subject|0|||
126169289|NCT00082758|453905180|FG002|Overall Study|Withdrawal by Subject|0|||
125973318|NCT01026974|453191456|FG001|Overall Study|Inappropriate enrollment|0|||
125973319|NCT01026974|453191457|FG002|Overall Study|Inappropriate enrollment|1|||
125973320|NCT01026974|453191458|FG003|Overall Study|Inappropriate enrollment|0|||
125973321|NCT00325468|453191460|FG000|Overall Study|Adverse Event|1|||
125973322|NCT00325468|453191461|FG001|Overall Study|Adverse Event|1|||
125973323|NCT00325468|453191462|FG002|Overall Study|Adverse Event|0|||
126169290|NCT00082758|453905178|FG000|Overall Study|Protocol Violation|0|||
126169291|NCT00082758|453905179|FG001|Overall Study|Protocol Violation|1|||
126169292|NCT00082758|453905180|FG002|Overall Study|Protocol Violation|0|||
125973324|NCT00325468|453191463|FG003|Overall Study|Adverse Event|5|||
125973325|NCT00325468|453191464|FG004|Overall Study|Adverse Event|1|||
125973326|NCT00325468|453191460|FG000|Overall Study|Death|2|||
126169293|NCT00238303|453905181|FG000|Overall Study|Withdrawal by Subject|11|||
126169294|NCT00238303|453905182|FG001|Overall Study|Withdrawal by Subject|1|||
126169295|NCT00238303|453905183|FG002|Overall Study|Withdrawal by Subject|2|||
126169296|NCT00238303|453905181|FG000|Overall Study|Death|1|||
126169297|NCT00238303|453905182|FG001|Overall Study|Death|0|||
126169298|NCT00238303|453905183|FG002|Overall Study|Death|1|||
126169299|NCT00238303|453905181|FG000|Overall Study|Other Medical Problems|2|||
126169300|NCT00238303|453905182|FG001|Overall Study|Other Medical Problems|0|||
126169301|NCT00238303|453905183|FG002|Overall Study|Other Medical Problems|2|||
126169302|NCT00238303|453905181|FG000|Overall Study|Poor tolerance of study treatment|1|||
126169303|NCT00238303|453905182|FG001|Overall Study|Poor tolerance of study treatment|0|||
126169304|NCT00238303|453905183|FG002|Overall Study|Poor tolerance of study treatment|1|||
126169305|NCT00238303|453905181|FG000|Overall Study|Adverse Event|0|||
126169306|NCT00238303|453905182|FG001|Overall Study|Adverse Event|1|||
126169307|NCT00238303|453905183|FG002|Overall Study|Adverse Event|3|||
126169308|NCT02561299|453905187|FG000|Overall Study|Death|2|||
126169309|NCT02561299|453905188|FG001|Overall Study|Death|4|||
126169310|NCT02561299|453905187|FG000|Overall Study|Lost to Follow-up|1|||
126169311|NCT02561299|453905188|FG001|Overall Study|Lost to Follow-up|0|||
126169312|NCT02561299|453905187|FG000|Overall Study|Withdrawal by Subject|2|||
126169313|NCT02561299|453905188|FG001|Overall Study|Withdrawal by Subject|2|||
126169314|NCT00436566|453905189|FG000|Overall Study|Withdrawal by Subject|2|||
126169315|NCT00436566|453905189|FG000|Overall Study|Protocol Violation|1|||
126169316|NCT04507867|453905190|FG000|Overall Study|Death|7|||
126169317|NCT04507867|453905191|FG001|Overall Study|Death|1|||
126169318|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
126169319|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
126169320|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
126169321|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
126169322|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
126169323|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
126169324|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
126169325|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
126169326|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
126169327|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
126169328|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
126169329|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
126169330|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
126169331|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
126169332|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
126169333|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
126169334|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
126169335|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126169336|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
126169337|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
126169338|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
126169339|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126169340|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126169341|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126169342|NCT01106625|453905197|FG000|Core Period: Baseline to Week 26|Other|8|||
126169343|NCT01106625|453905198|FG001|Core Period: Baseline to Week 26|Other|7|||
126169344|NCT01106625|453905199|FG002|Core Period: Baseline to Week 26|Other|4|||
126169345|NCT01106625|453905197|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
126169346|NCT01106625|453905198|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
126169347|NCT01106625|453905199|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
126169348|NCT01106625|453905197|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
126169349|NCT01106625|453905198|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
126169350|NCT01106625|453905199|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
126169351|NCT01106625|453905197|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
126169352|NCT01106625|453905198|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126169353|NCT01106625|453905199|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
126169354|NCT01106625|453905197|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126169355|NCT01106625|453905198|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126169356|NCT01106625|453905199|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126169357|NCT01106625|453905197|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
126169358|NCT01106625|453905198|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126169359|NCT01106625|453905199|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126169360|NCT01106625|453905197|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
126169361|NCT01106625|453905198|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
126169362|NCT01106625|453905199|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
126169363|NCT01106625|453905197|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
126169364|NCT01106625|453905198|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
126169365|NCT01106625|453905199|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
126169366|NCT01106625|453905197|FG000|Extension Period: Week 26 to Week 52|Other|5|||
126169367|NCT01106625|453905198|FG001|Extension Period: Week 26 to Week 52|Other|5|||
126169368|NCT01106625|453905199|FG002|Extension Period: Week 26 to Week 52|Other|4|||
126169369|NCT01088438|453905208|FG000|Overall Study|Withdrawal by Subject|11|||
126169370|NCT01088438|453905209|FG001|Overall Study|Withdrawal by Subject|6|||
126169371|NCT01088438|453905208|FG000|Overall Study|Lost to Follow-up|18|||
126169372|NCT01088438|453905209|FG001|Overall Study|Lost to Follow-up|30|||
126169373|NCT00511342|453905210|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
126169374|NCT00511342|453905211|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
126169375|NCT00511342|453905210|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
126169376|NCT00511342|453905211|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
126169377|NCT00511342|453905210|FG000|Overall Study|Pregnancy|0|||
126169378|NCT00511342|453905211|FG001|Overall Study|Pregnancy|1|||
126169379|NCT00511342|453905210|FG000|Overall Study|Pregnancy wish|0|||
126169380|NCT00511342|453905211|FG001|Overall Study|Pregnancy wish|1|||
126169381|NCT00511342|453905210|FG000|Overall Study|Lost to Follow-up|1|||
126169382|NCT00511342|453905211|FG001|Overall Study|Lost to Follow-up|5|||
126169383|NCT00511342|453905210|FG000|Overall Study|Other Reason|2|||
126169384|NCT00511342|453905211|FG001|Overall Study|Other Reason|2|||
126169385|NCT01496430|453905212|FG000|Overall Study|Adverse Event|0|||
126169386|NCT01496430|453905213|FG001|Overall Study|Adverse Event|0|||
126169387|NCT01496430|453905214|FG002|Overall Study|Adverse Event|1|||
126169388|NCT01496430|453905212|FG000|Overall Study|Major Protocol Deviation|0|||
126169389|NCT01496430|453905213|FG001|Overall Study|Major Protocol Deviation|0|||
126169390|NCT01496430|453905214|FG002|Overall Study|Major Protocol Deviation|1|||
126169391|NCT01496430|453905212|FG000|Overall Study|Lost to Follow-up|2|||
126169392|NCT01496430|453905213|FG001|Overall Study|Lost to Follow-up|3|||
126169393|NCT01496430|453905214|FG002|Overall Study|Lost to Follow-up|1|||
126169394|NCT01496430|453905212|FG000|Overall Study|Voluntary Withdrawal|2|||
126169395|NCT01496430|453905213|FG001|Overall Study|Voluntary Withdrawal|1|||
126169396|NCT01496430|453905214|FG002|Overall Study|Voluntary Withdrawal|6|||
126169397|NCT01496430|453905212|FG000|Overall Study|Principal Investigator Discretion|0|||
126169398|NCT01496430|453905213|FG001|Overall Study|Principal Investigator Discretion|1|||
126169399|NCT01496430|453905214|FG002|Overall Study|Principal Investigator Discretion|1|||
126169400|NCT01496430|453905212|FG000|Overall Study|Other|2|||
126169401|NCT01496430|453905213|FG001|Overall Study|Other|0|||
126169402|NCT01496430|453905214|FG002|Overall Study|Other|0|||
126169403|NCT00997321|453905215|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
126169404|NCT00997321|453905216|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
126169405|NCT01276457|453905228|FG000|Core Study|Adverse Event|6|||
126169406|NCT01276457|453905229|FG001|Core Study|Adverse Event|3|||
126169407|NCT01276457|453905228|FG000|Core Study|Lost to Follow-up|1|||
126169408|NCT01276457|453905229|FG001|Core Study|Lost to Follow-up|2|||
126169409|NCT01276457|453905228|FG000|Core Study|Administrative problems|1|||
126169410|NCT01276457|453905229|FG001|Core Study|Administrative problems|1|||
126169411|NCT01276457|453905228|FG000|Core Study|Death|2|||
126169412|NCT01276457|453905229|FG001|Core Study|Death|2|||
126169413|NCT01276457|453905228|FG000|Core Study|Lack of Efficacy|3|||
126169414|NCT01276457|453905229|FG001|Core Study|Lack of Efficacy|12|||
126169415|NCT01276457|453905228|FG000|Extension Study|Lost to Follow-up|3|||
126169416|NCT01276457|453905229|FG001|Extension Study|Lost to Follow-up|0|||
126169417|NCT01276457|453905228|FG000|Extension Study|Death|0|||
126169418|NCT01276457|453905229|FG001|Extension Study|Death|1|||
126169419|NCT01276457|453905228|FG000|Extension Study|Lack of Efficacy|3|||
126169420|NCT01276457|453905229|FG001|Extension Study|Lack of Efficacy|1|||
126169421|NCT01474746|453905235|FG000|Overall Study|Lost to Follow-up|1|||
126169422|NCT01474746|453905236|FG001|Overall Study|Lost to Follow-up|1|||
126169423|NCT01474746|453905235|FG000|Overall Study|Withdrawal by Subject|2|||
126169424|NCT01474746|453905236|FG001|Overall Study|Withdrawal by Subject|1|||
126169425|NCT02605447|453905237|FG000|Overall Study|Death|66|||
126169426|NCT02605447|453905237|FG000|Overall Study|Physician Decision|1|||
126169427|NCT02605447|453905237|FG000|Overall Study|Lost to Follow-up|24|||
126169428|NCT02605447|453905237|FG000|Overall Study|Withdrawal by Subject|10|||
126169429|NCT02605447|453905237|FG000|Overall Study|Not disclosed|1|||
126169430|NCT02402218|453905241|FG000|Overall Study|Did not pickup study medication|12|||
126169431|NCT02402218|453905242|FG001|Overall Study|Did not pickup study medication|9|||
126169432|NCT02402218|453905243|FG002|Overall Study|Did not pickup study medication|13|||
126169433|NCT02402218|453905241|FG000|Overall Study|Lack of Efficacy|0|||
126169434|NCT02402218|453905242|FG001|Overall Study|Lack of Efficacy|1|||
126169435|NCT02402218|453905243|FG002|Overall Study|Lack of Efficacy|1|||
126169436|NCT02402218|453905241|FG000|Overall Study|Death|1|||
126169437|NCT02402218|453905242|FG001|Overall Study|Death|0|||
126169438|NCT02402218|453905243|FG002|Overall Study|Death|0|||
126169439|NCT02402218|453905241|FG000|Overall Study|Reinfection|0|||
126169440|NCT02402218|453905242|FG001|Overall Study|Reinfection|0|||
126169441|NCT02402218|453905243|FG002|Overall Study|Reinfection|1|||
126169442|NCT02402218|453905241|FG000|Overall Study|Adverse Event|0|||
126169443|NCT02402218|453905242|FG001|Overall Study|Adverse Event|2|||
126169444|NCT02402218|453905243|FG002|Overall Study|Adverse Event|1|||
126169445|NCT02402218|453905241|FG000|Overall Study|Withdrawal by Subject|1|||
126169446|NCT02402218|453905242|FG001|Overall Study|Withdrawal by Subject|1|||
126169447|NCT02402218|453905243|FG002|Overall Study|Withdrawal by Subject|1|||
126169448|NCT03807739|453905244|FG000|Overall Study|Adverse Event|1|||
126169449|NCT03807739|453905245|FG001|Overall Study|Adverse Event|0|||
126169450|NCT03807739|453905246|FG002|Overall Study|Adverse Event|0|||
126169451|NCT03807739|453905247|FG003|Overall Study|Adverse Event|0|||
126169452|NCT03807739|453905244|FG000|Overall Study|Withdrawal by Subject|1|||
126169453|NCT03807739|453905245|FG001|Overall Study|Withdrawal by Subject|0|||
126169454|NCT03807739|453905246|FG002|Overall Study|Withdrawal by Subject|0|||
126169455|NCT03807739|453905247|FG003|Overall Study|Withdrawal by Subject|0|||
126169456|NCT03126539|453905258|FG000|Overall Study|Lost to Follow-up|1|||
126169457|NCT03126539|453905259|FG001|Overall Study|Lost to Follow-up|1|||
126169458|NCT03126539|453905260|FG002|Overall Study|Lost to Follow-up|1|||
126169459|NCT03126539|453905261|FG003|Overall Study|Lost to Follow-up|0|||
126169460|NCT03126539|453905262|FG004|Overall Study|Lost to Follow-up|0|||
126169461|NCT02632110|453905263|FG000|Overall Study|Withdrawal by Subject|1|||
126169462|NCT02632110|453905264|FG001|Overall Study|Withdrawal by Subject|1|||
126169463|NCT02632110|453905265|FG002|Overall Study|Withdrawal by Subject|0|||
126169464|NCT02632110|453905266|FG003|Overall Study|Withdrawal by Subject|0|||
126169465|NCT02632110|453905267|FG004|Overall Study|Withdrawal by Subject|1|||
126169466|NCT02632110|453905268|FG005|Overall Study|Withdrawal by Subject|1|||
126169467|NCT02632110|453905269|FG006|Overall Study|Withdrawal by Subject|3|||
126169468|NCT02632110|453905270|FG007|Overall Study|Withdrawal by Subject|3|||
126169469|NCT02632110|453905271|FG008|Overall Study|Withdrawal by Subject|1|||
126169470|NCT02632110|453905272|FG009|Overall Study|Withdrawal by Subject|1|||
126169471|NCT03352414|453905273|FG000|Overall Study|Ineligible by operative criteria|12|||
126169472|NCT03352414|453905274|FG001|Overall Study|Ineligible by operative criteria|10|||
126169473|NCT00516269|453905277|FG000|Overall Study|Adverse Event|2|||
126169474|NCT00516269|453905278|FG001|Overall Study|Adverse Event|1|||
126169475|NCT00516269|453905277|FG000|Overall Study|Lost to Follow-up|0|||
126169476|NCT00516269|453905278|FG001|Overall Study|Lost to Follow-up|1|||
126169477|NCT00516269|453905277|FG000|Overall Study|Protocol Violation|0|||
126169478|NCT00516269|453905278|FG001|Overall Study|Protocol Violation|1|||
126169479|NCT00142519|453905279|FG000|Overall Study|Not Treated|7|||
126169480|NCT00142519|453905280|FG001|Overall Study|Not Treated|9|||
126169481|NCT00142519|453905279|FG000|Overall Study|Protocol Violation|1|||
126169482|NCT00142519|453905280|FG001|Overall Study|Protocol Violation|0|||
126169483|NCT00142519|453905279|FG000|Overall Study|Withdrawal by Subject|10|||
126169484|NCT00142519|453905280|FG001|Overall Study|Withdrawal by Subject|7|||
126169485|NCT01005732|453905281|FG000|Overall Study|Lost to Follow-up|10|||
126169486|NCT01005732|453905281|FG000|Overall Study|Death|1|||
126169487|NCT02596711|453905282|FG000|Overall Study|Lost to Follow-up|1|||
126169488|NCT02596711|453905283|FG001|Overall Study|Lost to Follow-up|2|||
126169489|NCT02596711|453905284|FG002|Overall Study|Lost to Follow-up|3|||
126169490|NCT01552928|453905285|FG000|Period 3|Adverse Event|0|||
126169491|NCT01552928|453905286|FG001|Period 3|Adverse Event|0|||
126169492|NCT01552928|453905287|FG002|Period 3|Adverse Event|1|||
126169493|NCT01552928|453905288|FG003|Period 3|Adverse Event|0|||
126169494|NCT02702518|453906691|FG000|Overall Study|Lost to Follow-up|3|||
126169495|NCT02702518|453906692|FG001|Overall Study|Lost to Follow-up|4|||
126169496|NCT00165841|453906693|FG000|Overall Study|Adverse Event|2|||
126169497|NCT00165841|453906694|FG001|Overall Study|Adverse Event|3|||
126169498|NCT00165841|453906693|FG000|Overall Study|Lack of Efficacy|6|||
126169499|NCT00165841|453906694|FG001|Overall Study|Lack of Efficacy|33|||
126169500|NCT00165841|453906693|FG000|Overall Study|Lost to Follow-up|4|||
126169501|NCT00165841|453906694|FG001|Overall Study|Lost to Follow-up|4|||
126169502|NCT00165841|453906693|FG000|Overall Study|Withdrawal by Subject|7|||
126169503|NCT00165841|453906694|FG001|Overall Study|Withdrawal by Subject|8|||
126169504|NCT00165841|453906693|FG000|Overall Study|Physician Decision|1|||
126169505|NCT00165841|453906694|FG001|Overall Study|Physician Decision|0|||
126169506|NCT00165841|453906693|FG000|Overall Study|Protocol Violation|6|||
126169507|NCT00165841|453906694|FG001|Overall Study|Protocol Violation|8|||
126169508|NCT00165841|453906693|FG000|Overall Study|Other|3|||
126169509|NCT00165841|453906694|FG001|Overall Study|Other|5|||
126169510|NCT00165841|453906693|FG000|Overall Study|Medication Noncompliance|1|||
126169511|NCT00165841|453906694|FG001|Overall Study|Medication Noncompliance|1|||
126169512|NCT03196193|453906701|FG000|Overall Study|Adverse Event|1|||
126169513|NCT03196193|453906702|FG001|Overall Study|Adverse Event|0|||
126169514|NCT03196193|453906701|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
126169515|NCT03196193|453906702|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
126169516|NCT02709083|453906703|FG000|Overall Study|Original PI left institution|7|||
126169517|NCT01697267|453906704|FG000|Overall Study|Death|3|||
126169518|NCT01697267|453906705|FG001|Overall Study|Death|1|||
126169519|NCT01697267|453906704|FG000|Overall Study|Withdrawal by Subject|5|||
126169520|NCT01697267|453906705|FG001|Overall Study|Withdrawal by Subject|5|||
126169521|NCT01697267|453906704|FG000|Overall Study|Adverse Event|2|||
126169522|NCT01697267|453906705|FG001|Overall Study|Adverse Event|1|||
126169523|NCT01697267|453906704|FG000|Overall Study|Lost to Follow-up|2|||
126169524|NCT01697267|453906705|FG001|Overall Study|Lost to Follow-up|4|||
126169525|NCT01697267|453906704|FG000|Overall Study|Physician Decision|2|||
126169526|NCT01697267|453906705|FG001|Overall Study|Physician Decision|4|||
126169527|NCT00333619|453906706|FG000|Overall Study|Death|12|||
126169528|NCT00333619|453906707|FG001|Overall Study|Death|6|||
126169529|NCT00333619|453906706|FG000|Overall Study|Withdrawal by Subject|6|||
126169530|NCT00333619|453906707|FG001|Overall Study|Withdrawal by Subject|1|||
126169531|NCT00333619|453906706|FG000|Overall Study|Lost to Follow-up|3|||
126169532|NCT00333619|453906707|FG001|Overall Study|Lost to Follow-up|3|||
126169533|NCT04031404|453906708|FG000|Baseline|Lost to Follow-up|0|||
126169534|NCT04031404|453906709|FG001|Baseline|Lost to Follow-up|1|||
126169535|NCT04031404|453906708|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
126169536|NCT04031404|453906709|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
126169537|NCT04031404|453906708|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
126169538|NCT04031404|453906709|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
126169539|NCT04031404|453906708|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
126169540|NCT04031404|453906709|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
126169541|NCT04031404|453906708|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
126169542|NCT04031404|453906709|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
126169543|NCT02796391|453906712|FG000|Overall Study|Lost to Follow-up|2|||
126169544|NCT02796391|453906713|FG001|Overall Study|Lost to Follow-up|2|||
126169545|NCT02796391|453906714|FG002|Overall Study|Lost to Follow-up|13|||
126169546|NCT02796391|453906715|FG003|Overall Study|Lost to Follow-up|8|||
126169547|NCT02796391|453906716|FG004|Overall Study|Lost to Follow-up|14|||
126169548|NCT02796391|453906717|FG005|Overall Study|Lost to Follow-up|13|||
126169549|NCT02796391|453906712|FG000|Overall Study|COVID|0|||
126169550|NCT02796391|453906713|FG001|Overall Study|COVID|0|||
126169551|NCT02796391|453906714|FG002|Overall Study|COVID|5|||
126169552|NCT02796391|453906715|FG003|Overall Study|COVID|5|||
126169553|NCT02796391|453906716|FG004|Overall Study|COVID|2|||
126169554|NCT02796391|453906717|FG005|Overall Study|COVID|4|||
126169555|NCT02796391|453906712|FG000|Overall Study|Participant did not like study cigarettes|0|||
126169556|NCT02796391|453906713|FG001|Overall Study|Participant did not like study cigarettes|0|||
126169557|NCT02796391|453906714|FG002|Overall Study|Participant did not like study cigarettes|3|||
126169558|NCT02796391|453906715|FG003|Overall Study|Participant did not like study cigarettes|0|||
126169559|NCT02796391|453906716|FG004|Overall Study|Participant did not like study cigarettes|0|||
126169560|NCT02796391|453906717|FG005|Overall Study|Participant did not like study cigarettes|0|||
126169561|NCT02796391|453906712|FG000|Overall Study|Withdrawal by Subject|1|||
126169562|NCT02796391|453906713|FG001|Overall Study|Withdrawal by Subject|1|||
126169563|NCT02796391|453906714|FG002|Overall Study|Withdrawal by Subject|4|||
126169564|NCT02796391|453906715|FG003|Overall Study|Withdrawal by Subject|3|||
126169565|NCT02796391|453906716|FG004|Overall Study|Withdrawal by Subject|4|||
126169566|NCT02796391|453906717|FG005|Overall Study|Withdrawal by Subject|3|||
126169567|NCT02796391|453906712|FG000|Overall Study|Adverse Event|0|||
126169568|NCT02796391|453906713|FG001|Overall Study|Adverse Event|0|||
126169569|NCT02796391|453906714|FG002|Overall Study|Adverse Event|0|||
126169570|NCT02796391|453906715|FG003|Overall Study|Adverse Event|1|||
126169571|NCT02796391|453906716|FG004|Overall Study|Adverse Event|0|||
126169572|NCT02796391|453906717|FG005|Overall Study|Adverse Event|0|||
126169573|NCT02796391|453906712|FG000|Overall Study|Protocol Violation|0|||
126169574|NCT02796391|453906713|FG001|Overall Study|Protocol Violation|0|||
126169575|NCT02796391|453906714|FG002|Overall Study|Protocol Violation|0|||
126169576|NCT02796391|453906715|FG003|Overall Study|Protocol Violation|1|||
126169577|NCT02796391|453906716|FG004|Overall Study|Protocol Violation|0|||
126169578|NCT02796391|453906717|FG005|Overall Study|Protocol Violation|0|||
126169579|NCT02681055|453906718|FG000|Weeks 5-12|Adverse Event|1|||
126169580|NCT02695524|453906719|FG000|Overall Study|Lost to Follow-up|3|||
126169581|NCT02695524|453906720|FG001|Overall Study|Lost to Follow-up|2|||
126169582|NCT02695524|453906719|FG000|Overall Study|Death|0|||
126169583|NCT02695524|453906720|FG001|Overall Study|Death|1|||
126169584|NCT00831441|453906721|FG000|Randomized|Death|82|||
126169585|NCT00831441|453906722|FG001|Randomized|Death|81|||
126169586|NCT00831441|453906721|FG000|Randomized|Adverse Event|248|||
126169587|NCT00831441|453906722|FG001|Randomized|Adverse Event|321|||
126169588|NCT00831441|453906721|FG000|Randomized|Emergency procedure|2|||
126169589|NCT00831441|453906722|FG001|Randomized|Emergency procedure|2|||
126169590|NCT00831441|453906721|FG000|Randomized|Elective procedure|26|||
126169591|NCT00831441|453906722|FG001|Randomized|Elective procedure|25|||
126169592|NCT00831441|453906721|FG000|Randomized|Physician Decision|26|||
126169593|NCT00831441|453906722|FG001|Randomized|Physician Decision|35|||
126169594|NCT00831441|453906721|FG000|Randomized|No longer met criteria|13|||
125973327|NCT00325468|453191461|FG001|Overall Study|Death|0|||
125973328|NCT00325468|453191462|FG002|Overall Study|Death|2|||
126169595|NCT00831441|453906722|FG001|Randomized|No longer met criteria|19|||
126169596|NCT00831441|453906721|FG000|Randomized|Withdrawal by Subject|178|||
126169597|NCT00831441|453906722|FG001|Randomized|Withdrawal by Subject|212|||
126169598|NCT00831441|453906721|FG000|Randomized|Lost to Follow-up|26|||
126169599|NCT00831441|453906722|FG001|Randomized|Lost to Follow-up|35|||
126169600|NCT00831441|453906721|FG000|Randomized|Administrative reason by sponsor|2780|||
126169601|NCT00831441|453906722|FG001|Randomized|Administrative reason by sponsor|2671|||
126169602|NCT00831441|453906721|FG000|Randomized|poor/non-compliance|30|||
126169603|NCT00831441|453906722|FG001|Randomized|poor/non-compliance|38|||
126169604|NCT00831441|453906721|FG000|Randomized|non-specified|276|||
126169605|NCT00831441|453906722|FG001|Randomized|non-specified|266|||
126169606|NCT00831441|453906721|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
126169607|NCT00831441|453906722|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
126169608|NCT00831441|453906721|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
126169609|NCT00831441|453906722|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
126169610|NCT00831441|453906721|FG000|Follow Up (30 Days)|Death|63|||
126169611|NCT00831441|453906722|FG001|Follow Up (30 Days)|Death|86|||
126169612|NCT00831441|453906721|FG000|Follow Up (30 Days)|non-specified|16|||
126169613|NCT00831441|453906722|FG001|Follow Up (30 Days)|non-specified|26|||
126169614|NCT00831441|453906721|FG000|Follow Up (30 Days)|missing end of study status|0|||
126169615|NCT00831441|453906722|FG001|Follow Up (30 Days)|missing end of study status|1|||
126169616|NCT05674344|453906723|FG000|Overall Study|Screen Fail|21|||
126169617|NCT05674344|453906723|FG000|Overall Study|Incomplete study procedures|3|||
126169618|NCT00111917|453906724|FG000|Overall Study|Withdrawal by Subject|1|||
126169619|NCT00111917|453906725|FG001|Overall Study|Withdrawal by Subject|1|||
126169620|NCT00798655|453906726|FG000|Overall Study|Did not receive at least one dose of pan|2|||
126169621|NCT00960934|453906727|FG000|Overall Study|Adverse Event|2|||
126169622|NCT00960934|453906728|FG001|Overall Study|Adverse Event|3|||
126169623|NCT00960934|453906729|FG002|Overall Study|Adverse Event|3|||
126169624|NCT00960934|453906730|FG003|Overall Study|Adverse Event|2|||
126169625|NCT00960934|453906731|FG004|Overall Study|Adverse Event|4|||
126169626|NCT00960934|453906732|FG005|Overall Study|Adverse Event|3|||
126169627|NCT00960934|453906727|FG000|Overall Study|Lack of Efficacy|1|||
126169628|NCT00960934|453906728|FG001|Overall Study|Lack of Efficacy|0|||
126169629|NCT00960934|453906729|FG002|Overall Study|Lack of Efficacy|0|||
126169630|NCT00960934|453906730|FG003|Overall Study|Lack of Efficacy|0|||
126169631|NCT00960934|453906731|FG004|Overall Study|Lack of Efficacy|0|||
126169632|NCT00960934|453906732|FG005|Overall Study|Lack of Efficacy|0|||
126169633|NCT00960934|453906727|FG000|Overall Study|Lost to Follow-up|0|||
126169634|NCT00960934|453906728|FG001|Overall Study|Lost to Follow-up|1|||
126169635|NCT00960934|453906729|FG002|Overall Study|Lost to Follow-up|0|||
126169636|NCT00960934|453906730|FG003|Overall Study|Lost to Follow-up|0|||
126169637|NCT00960934|453906731|FG004|Overall Study|Lost to Follow-up|0|||
126169638|NCT00960934|453906732|FG005|Overall Study|Lost to Follow-up|0|||
126169639|NCT00960934|453906727|FG000|Overall Study|Other|2|||
126169640|NCT00960934|453906728|FG001|Overall Study|Other|1|||
126169641|NCT00960934|453906729|FG002|Overall Study|Other|5|||
126169642|NCT00960934|453906730|FG003|Overall Study|Other|4|||
126169643|NCT00960934|453906731|FG004|Overall Study|Other|2|||
126169644|NCT00960934|453906732|FG005|Overall Study|Other|2|||
126169645|NCT00960934|453906727|FG000|Overall Study|Physician Decision|0|||
126169646|NCT00960934|453906728|FG001|Overall Study|Physician Decision|1|||
126169647|NCT00960934|453906729|FG002|Overall Study|Physician Decision|0|||
125973329|NCT00325468|453191463|FG003|Overall Study|Death|4|||
125973330|NCT00325468|453191464|FG004|Overall Study|Death|0|||
125973331|NCT00325468|453191460|FG000|Overall Study|Lost to Follow-up|0|||
125973332|NCT00325468|453191461|FG001|Overall Study|Lost to Follow-up|0|||
125973333|NCT00325468|453191462|FG002|Overall Study|Lost to Follow-up|1|||
125973334|NCT00325468|453191463|FG003|Overall Study|Lost to Follow-up|2|||
125973335|NCT00325468|453191464|FG004|Overall Study|Lost to Follow-up|2|||
125973336|NCT00325468|453191460|FG000|Overall Study|Physician Decision|1|||
125973337|NCT00325468|453191461|FG001|Overall Study|Physician Decision|1|||
125973338|NCT00325468|453191462|FG002|Overall Study|Physician Decision|0|||
125973339|NCT00325468|453191463|FG003|Overall Study|Physician Decision|1|||
125973340|NCT00325468|453191464|FG004|Overall Study|Physician Decision|0|||
125973341|NCT00325468|453191460|FG000|Overall Study|Withdrawal by Subject|3|||
125973342|NCT00325468|453191461|FG001|Overall Study|Withdrawal by Subject|1|||
125973343|NCT00325468|453191462|FG002|Overall Study|Withdrawal by Subject|0|||
125973344|NCT00325468|453191463|FG003|Overall Study|Withdrawal by Subject|14|||
125973345|NCT00325468|453191464|FG004|Overall Study|Withdrawal by Subject|4|||
125973346|NCT00325468|453191460|FG000|Overall Study|site closure etc|4|||
125973347|NCT00325468|453191461|FG001|Overall Study|site closure etc|2|||
125973348|NCT00325468|453191462|FG002|Overall Study|site closure etc|1|||
125973349|NCT00325468|453191463|FG003|Overall Study|site closure etc|8|||
125973350|NCT00325468|453191464|FG004|Overall Study|site closure etc|1|||
125973351|NCT03280121|453191465|FG000|Overall Study|Physician Decision|1|||
125973352|NCT03280121|453191465|FG000|Overall Study|Lost to Follow-up|1|||
125973353|NCT03280121|453191465|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
125973354|NCT00990652|453191466|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
125973355|NCT00990652|453191466|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
125973356|NCT02384954|453191474|FG000|Phase 1|Progressive Disease|2|||
125973357|NCT02384954|453191475|FG001|Phase 1|Progressive Disease|0|||
125973358|NCT02384954|453191476|FG002|Phase 1|Progressive Disease|1|||
125973359|NCT02384954|453191477|FG003|Phase 1|Progressive Disease|1|||
125973360|NCT02384954|453191478|FG004|Phase 1|Progressive Disease|0|||
125973361|NCT02384954|453191479|FG005|Phase 1|Progressive Disease|0|||
126169648|NCT00960934|453906730|FG003|Overall Study|Physician Decision|0|||
126169649|NCT00960934|453906731|FG004|Overall Study|Physician Decision|0|||
126169650|NCT00960934|453906732|FG005|Overall Study|Physician Decision|0|||
126169651|NCT00960934|453906727|FG000|Overall Study|Progressive Disease|1|||
126169652|NCT00960934|453906728|FG001|Overall Study|Progressive Disease|1|||
126169653|NCT00960934|453906729|FG002|Overall Study|Progressive Disease|0|||
126169654|NCT00960934|453906730|FG003|Overall Study|Progressive Disease|0|||
126169655|NCT00960934|453906731|FG004|Overall Study|Progressive Disease|1|||
126169656|NCT00960934|453906732|FG005|Overall Study|Progressive Disease|1|||
126169657|NCT00960934|453906727|FG000|Overall Study|Protocol Violation|3|||
126169658|NCT00960934|453906728|FG001|Overall Study|Protocol Violation|4|||
126169659|NCT00960934|453906729|FG002|Overall Study|Protocol Violation|0|||
126169660|NCT00960934|453906730|FG003|Overall Study|Protocol Violation|3|||
126169661|NCT00960934|453906731|FG004|Overall Study|Protocol Violation|3|||
126169662|NCT00960934|453906732|FG005|Overall Study|Protocol Violation|2|||
126169663|NCT00960934|453906727|FG000|Overall Study|Withdrawal by Subject|5|||
126169664|NCT00960934|453906728|FG001|Overall Study|Withdrawal by Subject|6|||
126169665|NCT00960934|453906729|FG002|Overall Study|Withdrawal by Subject|4|||
126169666|NCT00960934|453906730|FG003|Overall Study|Withdrawal by Subject|5|||
126169667|NCT00960934|453906731|FG004|Overall Study|Withdrawal by Subject|5|||
126169668|NCT00960934|453906732|FG005|Overall Study|Withdrawal by Subject|7|||
126169669|NCT00960934|453906727|FG000|Overall Study|Study Terminated by Sponsor|50|||
126169670|NCT00960934|453906728|FG001|Overall Study|Study Terminated by Sponsor|46|||
126169671|NCT00960934|453906729|FG002|Overall Study|Study Terminated by Sponsor|52|||
126169672|NCT00960934|453906730|FG003|Overall Study|Study Terminated by Sponsor|50|||
126169673|NCT00960934|453906731|FG004|Overall Study|Study Terminated by Sponsor|49|||
126169674|NCT00960934|453906732|FG005|Overall Study|Study Terminated by Sponsor|49|||
126169675|NCT02156492|453906733|FG000|Period 1|No Reason Given|0|||
126169676|NCT02156492|453906734|FG001|Period 1|No Reason Given|1|||
126169677|NCT02156492|453906735|FG002|Period 1|No Reason Given|0|||
126169678|NCT02156492|453906733|FG000|Period 3|Adverse Event|0|||
126169679|NCT02156492|453906734|FG001|Period 3|Adverse Event|1|||
126169680|NCT02156492|453906735|FG002|Period 3|Adverse Event|0|||
126169681|NCT05254613|453906742|FG000|Overall Study|Lost to Follow-up|0|||
126169682|NCT05254613|453906743|FG001|Overall Study|Lost to Follow-up|0|||
126169683|NCT05254613|453906744|FG002|Overall Study|Lost to Follow-up|1|||
126169684|NCT02338492|453906745|FG000|Overall Study|Death|32|||
126169685|NCT02338492|453906745|FG000|Overall Study|Adverse Event|3|||
126169686|NCT02338492|453906745|FG000|Overall Study|Lost to Follow-up|4|||
126169687|NCT02338492|453906745|FG000|Overall Study|Reason not captured above|6|||
126169688|NCT02387372|453906746|FG000|Overall Study|Not Treated|1|||
126169689|NCT02387372|453906747|FG001|Overall Study|Not Treated|0|||
126169690|NCT00848549|453906749|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
126169691|NCT00848549|453906750|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
126169692|NCT00848549|453906749|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
126169693|NCT00848549|453906750|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
126169694|NCT00848549|453906749|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
126169695|NCT00848549|453906750|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
126169696|NCT00848549|453906749|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
126169697|NCT00848549|453906750|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
126169698|NCT00848549|453906749|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
126169699|NCT00848549|453906750|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
126169700|NCT00848549|453906749|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
126169701|NCT00848549|453906750|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
126169702|NCT00848549|453906749|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
126169703|NCT00848549|453906750|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
126169704|NCT00848549|453906749|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
126169705|NCT00848549|453906750|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
126169706|NCT00848549|453906749|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
126169707|NCT00848549|453906750|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
126169708|NCT00848549|453906749|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
126169709|NCT00848549|453906750|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
126169710|NCT00848549|453906749|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
126169711|NCT00848549|453906750|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
126169712|NCT00848549|453906749|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
126169713|NCT00848549|453906750|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
126169714|NCT00848549|453906749|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
126169715|NCT00848549|453906750|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
126169716|NCT00848549|453906749|FG000|E2090-E044-314 (Extension Study)|Other|5|||
126169717|NCT00848549|453906750|FG001|E2090-E044-314 (Extension Study)|Other|6|||
126169718|NCT01248130|453906753|FG000|Overall Study|Protocol Violation|1|||
126169719|NCT01248130|453906754|FG001|Overall Study|Protocol Violation|0|||
126169720|NCT01248130|453906753|FG000|Overall Study|Ineligible|1|||
126169721|NCT01248130|453906754|FG001|Overall Study|Ineligible|0|||
126169722|NCT00229203|453906759|FG000|Overall Study|Progressive disease|18|||
126169723|NCT00229203|453906760|FG001|Overall Study|Progressive disease|9|||
126169724|NCT00229203|453906759|FG000|Overall Study|Toxicity|6|||
126169725|NCT00229203|453906760|FG001|Overall Study|Toxicity|1|||
126169726|NCT00229203|453906759|FG000|Overall Study|Death|4|||
126169727|NCT00229203|453906760|FG001|Overall Study|Death|2|||
126169728|NCT00229203|453906759|FG000|Overall Study|Other|3|||
126169729|NCT00229203|453906760|FG001|Overall Study|Other|3|||
126169730|NCT00229203|453906759|FG000|Overall Study|Withdrawal by Subject|1|||
126169731|NCT00229203|453906760|FG001|Overall Study|Withdrawal by Subject|4|||
126169732|NCT02106455|453906761|FG000|Overall Study|Case Report Form Uncollected|6|||
126169733|NCT02106455|453906761|FG000|Overall Study|Protocol Deviation|2|||
126169734|NCT01188564|453906769|FG000|Double-blind Phase|randomized not treated|1|||
126169735|NCT01188564|453906770|FG001|Double-blind Phase|randomized not treated|0|||
126169736|NCT04096326|453906771|FG000|Overall Study|Withdrawal by Subject|0|||
126169737|NCT04096326|453906772|FG001|Overall Study|Withdrawal by Subject|0|||
126169738|NCT04096326|453906773|FG002|Overall Study|Withdrawal by Subject|0|||
126169739|NCT04096326|453906774|FG003|Overall Study|Withdrawal by Subject|0|||
126169740|NCT04096326|453906775|FG004|Overall Study|Withdrawal by Subject|0|||
126169741|NCT04096326|453906776|FG005|Overall Study|Withdrawal by Subject|0|||
126169742|NCT04096326|453906777|FG006|Overall Study|Withdrawal by Subject|1|||
126169743|NCT04096326|453906778|FG007|Overall Study|Withdrawal by Subject|0|||
126169744|NCT04096326|453906779|FG008|Overall Study|Withdrawal by Subject|0|||
126169745|NCT04096326|453906780|FG009|Overall Study|Withdrawal by Subject|0|||
126169746|NCT04096326|453906771|FG000|Overall Study|Lost to Follow-up|0|||
126169747|NCT04096326|453906772|FG001|Overall Study|Lost to Follow-up|1|||
126169748|NCT04096326|453906773|FG002|Overall Study|Lost to Follow-up|0|||
126169749|NCT04096326|453906774|FG003|Overall Study|Lost to Follow-up|0|||
126169750|NCT04096326|453906775|FG004|Overall Study|Lost to Follow-up|0|||
126169751|NCT04096326|453906776|FG005|Overall Study|Lost to Follow-up|0|||
126169752|NCT04096326|453906777|FG006|Overall Study|Lost to Follow-up|0|||
126169753|NCT04096326|453906778|FG007|Overall Study|Lost to Follow-up|0|||
126169754|NCT04096326|453906779|FG008|Overall Study|Lost to Follow-up|0|||
126169755|NCT04096326|453906780|FG009|Overall Study|Lost to Follow-up|0|||
126169756|NCT04096326|453906771|FG000|Overall Study|COVID-19-related reasons|0|||
126169757|NCT04096326|453906772|FG001|Overall Study|COVID-19-related reasons|0|||
126169758|NCT04096326|453906773|FG002|Overall Study|COVID-19-related reasons|0|||
126169759|NCT04096326|453906774|FG003|Overall Study|COVID-19-related reasons|0|||
126169760|NCT04096326|453906775|FG004|Overall Study|COVID-19-related reasons|1|||
126169761|NCT04096326|453906776|FG005|Overall Study|COVID-19-related reasons|5|||
126169762|NCT04096326|453906777|FG006|Overall Study|COVID-19-related reasons|0|||
126169763|NCT04096326|453906778|FG007|Overall Study|COVID-19-related reasons|0|||
126169764|NCT04096326|453906779|FG008|Overall Study|COVID-19-related reasons|0|||
126169765|NCT04096326|453906780|FG009|Overall Study|COVID-19-related reasons|0|||
126169766|NCT00781599|453906792|FG000|Overall Study|Lost to Follow-up|7|||
126169767|NCT00781599|453906793|FG001|Overall Study|Lost to Follow-up|4|||
126169768|NCT00089479|453906799|FG000|Overall Study|Death|108|||
126169769|NCT00089479|453906800|FG001|Overall Study|Death|75|||
126169770|NCT00089479|453906799|FG000|Overall Study|Withdrawal by Subject|86|||
126169771|NCT00089479|453906800|FG001|Overall Study|Withdrawal by Subject|107|||
126169772|NCT00089479|453906799|FG000|Overall Study|Lost to Follow-up|137|||
126169773|NCT00089479|453906800|FG001|Overall Study|Lost to Follow-up|107|||
126169774|NCT01124448|453906803|FG000|Overall Study|Lost to Follow-up|0|||
126169775|NCT01124448|453906804|FG001|Overall Study|Lost to Follow-up|3|||
126169776|NCT01124448|453906803|FG000|Overall Study|Protocol Violation|2|||
126169777|NCT01124448|453906804|FG001|Overall Study|Protocol Violation|0|||
126169778|NCT03198754|453906805|FG000|Overall Study|Withdrawal by Subject|5|||
126169779|NCT03198754|453906806|FG001|Overall Study|Withdrawal by Subject|4|||
126169780|NCT03198754|453906805|FG000|Overall Study|Lost to Follow-up|4|||
126169781|NCT03198754|453906806|FG001|Overall Study|Lost to Follow-up|3|||
126169782|NCT03198754|453906805|FG000|Overall Study|Ineligible|2|||
126169783|NCT03198754|453906806|FG001|Overall Study|Ineligible|1|||
126169784|NCT02512068|453906812|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
126169785|NCT02512068|453906813|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
126169786|NCT02512068|453906812|FG000|Overall Study|Major Protocol Deviation|1|||
126169787|NCT02512068|453906813|FG001|Overall Study|Major Protocol Deviation|0|||
126169788|NCT02512068|453906812|FG000|Overall Study|Voluntary Withdrawal|0|||
126169789|NCT02512068|453906813|FG001|Overall Study|Voluntary Withdrawal|1|||
126169790|NCT02512068|453906812|FG000|Overall Study|Lack of Efficacy|0|||
126169791|NCT02512068|453906813|FG001|Overall Study|Lack of Efficacy|1|||
126169792|NCT02512068|453906812|FG000|Overall Study|Reason Not Specified|3|||
126169793|NCT02512068|453906813|FG001|Overall Study|Reason Not Specified|5|||
126169794|NCT03521687|453906816|FG000|Overall Study|Adverse Event|4|||
126169795|NCT03521687|453906816|FG000|Overall Study|Physician Decision|1|||
126169796|NCT01151579|453906817|FG000|Overall Study|Physician Decision|3|||
126169797|NCT01151579|453906818|FG001|Overall Study|Physician Decision|1|||
126169798|NCT01151579|453906817|FG000|Overall Study|Withdrawal by Subject|3|||
126169799|NCT01151579|453906818|FG001|Overall Study|Withdrawal by Subject|2|||
126169800|NCT01151579|453906817|FG000|Overall Study|Not meet inclusion criteria|6|||
126169801|NCT01151579|453906818|FG001|Overall Study|Not meet inclusion criteria|4|||
126169802|NCT01098461|453906820|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
126169803|NCT01098461|453906821|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
126169804|NCT01098461|453906822|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
126169805|NCT01098461|453906823|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
126169806|NCT01098461|453906820|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
126169807|NCT01098461|453906821|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
126169808|NCT01098461|453906822|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
126169809|NCT01098461|453906823|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
126169810|NCT01098461|453906820|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
126169811|NCT01098461|453906821|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
126169812|NCT01098461|453906822|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
126169813|NCT01098461|453906823|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
126169814|NCT01098461|453906820|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
126169815|NCT01098461|453906821|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
126169816|NCT01098461|453906822|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
126169817|NCT01098461|453906823|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
126169818|NCT01098461|453906820|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
126169819|NCT01098461|453906821|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
126169820|NCT01098461|453906822|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
126169821|NCT01098461|453906823|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
126169822|NCT01098461|453906820|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
126169823|NCT01098461|453906821|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
126169824|NCT01098461|453906822|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
126169825|NCT01098461|453906823|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
126169826|NCT01098461|453906820|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
126169827|NCT01098461|453906821|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
126169828|NCT01098461|453906822|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
126169829|NCT01098461|453906823|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
126169830|NCT01153763|453906824|FG000|Overall Study|Study Closed|16|||
126169831|NCT01153763|453906824|FG000|Overall Study|Lost to Follow-up|1|||
126169832|NCT01153763|453906824|FG000|Overall Study|Physician Decision|2|||
126169833|NCT01153763|453906824|FG000|Overall Study|Withdrawal by Subject|2|||
126169834|NCT01766336|453906826|FG000|Overall Study|Adverse Event|11|||
126169835|NCT01766336|453906827|FG001|Overall Study|Adverse Event|8|||
126169836|NCT01766336|453906826|FG000|Overall Study|Death|4|||
126169837|NCT01766336|453906827|FG001|Overall Study|Death|3|||
126169838|NCT01766336|453906826|FG000|Overall Study|Lost to Follow-up|1|||
126169839|NCT01766336|453906827|FG001|Overall Study|Lost to Follow-up|3|||
126169840|NCT01766336|453906826|FG000|Overall Study|Physician Decision|4|||
126169841|NCT01766336|453906827|FG001|Overall Study|Physician Decision|2|||
126169842|NCT01766336|453906826|FG000|Overall Study|Protocol Violation|0|||
126169843|NCT01766336|453906827|FG001|Overall Study|Protocol Violation|1|||
126169844|NCT01766336|453906826|FG000|Overall Study|Sponsor Decision|52|||
126169845|NCT01766336|453906827|FG001|Overall Study|Sponsor Decision|43|||
126169846|NCT01766336|453906826|FG000|Overall Study|Withdrawal by Subject|18|||
126169847|NCT01766336|453906827|FG001|Overall Study|Withdrawal by Subject|15|||
126169848|NCT04544709|453906828|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
126169849|NCT03628508|453906829|FG000|Overall Study|Lost to Follow-up|1|||
126169850|NCT02045212|453906830|FG000|Overall Study|Adverse Event|0|||
126169851|NCT02045212|453906831|FG001|Overall Study|Adverse Event|1|||
126169852|NCT02045212|453906830|FG000|Overall Study|Withdrawal by Subject|1|||
126169853|NCT02045212|453906831|FG001|Overall Study|Withdrawal by Subject|0|||
126169854|NCT02045212|453906830|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
126169855|NCT02045212|453906831|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
126169856|NCT04570657|453906835|FG000|Overall Study|Adverse Event|0|||
126169857|NCT04570657|453906836|FG001|Overall Study|Adverse Event|0|||
126169858|NCT04570657|453906837|FG002|Overall Study|Adverse Event|1|||
126169859|NCT04570657|453906835|FG000|Overall Study|Lost to Follow-up|0|||
126169860|NCT04570657|453906836|FG001|Overall Study|Lost to Follow-up|0|||
126169861|NCT04570657|453906837|FG002|Overall Study|Lost to Follow-up|1|||
126169862|NCT04570657|453906835|FG000|Overall Study|Physician Decision|0|||
126169863|NCT04570657|453906836|FG001|Overall Study|Physician Decision|1|||
126169864|NCT04570657|453906837|FG002|Overall Study|Physician Decision|0|||
126169865|NCT04570657|453906835|FG000|Overall Study|Withdrawal by Subject|1|||
126169866|NCT04570657|453906836|FG001|Overall Study|Withdrawal by Subject|2|||
126169867|NCT04570657|453906837|FG002|Overall Study|Withdrawal by Subject|2|||
126169868|NCT01072539|453906838|FG000|Overall Study|Treated prior to the Site Initiation|1|||
126169869|NCT01072539|453906838|FG000|Overall Study|Protocol Violation|2|||
126169870|NCT00115804|453906841|FG000|Overall Study|Adverse Event|2|||
126169871|NCT01752842|453906842|FG000|Overall Study|Adverse Event|3|||
126169872|NCT01752842|453906843|FG001|Overall Study|Adverse Event|0|||
126169873|NCT01752842|453906842|FG000|Overall Study|Withdrawal by Subject|0|||
126169874|NCT01752842|453906843|FG001|Overall Study|Withdrawal by Subject|2|||
126169875|NCT01683071|453906844|FG000|Part 1|Lack of Efficacy|1|||
126169876|NCT01683071|453906845|FG001|Part 1|Lack of Efficacy|0|||
126169877|NCT01683071|453906846|FG002|Part 1|Lack of Efficacy|0|||
126169878|NCT01683071|453906847|FG003|Part 1|Lack of Efficacy|3|||
126169879|NCT01683071|453906848|FG004|Part 1|Lack of Efficacy|0|||
126169880|NCT01683071|453906849|FG005|Part 1|Lack of Efficacy|0|||
126169881|NCT01683071|453906844|FG000|Part 1|Withdrawal by Subject|1|||
126169882|NCT01683071|453906845|FG001|Part 1|Withdrawal by Subject|2|||
126169883|NCT01683071|453906846|FG002|Part 1|Withdrawal by Subject|2|||
126169884|NCT01683071|453906847|FG003|Part 1|Withdrawal by Subject|1|||
126169885|NCT01683071|453906848|FG004|Part 1|Withdrawal by Subject|0|||
126169886|NCT01683071|453906849|FG005|Part 1|Withdrawal by Subject|0|||
126169887|NCT01683071|453906844|FG000|Part 1|Surgery Cancelled|1|||
126169888|NCT01683071|453906845|FG001|Part 1|Surgery Cancelled|0|||
126169889|NCT01683071|453906846|FG002|Part 1|Surgery Cancelled|0|||
126169890|NCT01683071|453906847|FG003|Part 1|Surgery Cancelled|0|||
126169891|NCT01683071|453906848|FG004|Part 1|Surgery Cancelled|0|||
126169892|NCT01683071|453906849|FG005|Part 1|Surgery Cancelled|0|||
126169893|NCT01683071|453906844|FG000|Part 1|Did not receive study drug|1|||
126169894|NCT01683071|453906845|FG001|Part 1|Did not receive study drug|0|||
126169895|NCT01683071|453906846|FG002|Part 1|Did not receive study drug|0|||
126169896|NCT01683071|453906847|FG003|Part 1|Did not receive study drug|1|||
126169897|NCT01683071|453906848|FG004|Part 1|Did not receive study drug|0|||
126169898|NCT01683071|453906849|FG005|Part 1|Did not receive study drug|0|||
126169899|NCT01683071|453906844|FG000|Part 1|Early termination; met exclusion criteria|0|||
126169900|NCT01683071|453906845|FG001|Part 1|Early termination; met exclusion criteria|2|||
126169901|NCT01683071|453906846|FG002|Part 1|Early termination; met exclusion criteria|1|||
126169902|NCT01683071|453906847|FG003|Part 1|Early termination; met exclusion criteria|0|||
126169903|NCT01683071|453906848|FG004|Part 1|Early termination; met exclusion criteria|0|||
126169904|NCT01683071|453906849|FG005|Part 1|Early termination; met exclusion criteria|0|||
126169905|NCT01683071|453906844|FG000|Part 2|Lack of Efficacy|0|||
126169906|NCT01683071|453906845|FG001|Part 2|Lack of Efficacy|0|||
126169907|NCT01683071|453906846|FG002|Part 2|Lack of Efficacy|0|||
126169908|NCT01683071|453906847|FG003|Part 2|Lack of Efficacy|0|||
126169909|NCT01683071|453906848|FG004|Part 2|Lack of Efficacy|3|||
126169910|NCT01683071|453906849|FG005|Part 2|Lack of Efficacy|4|||
126169911|NCT01683071|453906844|FG000|Part 2|Lost to Follow-up|0|||
126169912|NCT01683071|453906845|FG001|Part 2|Lost to Follow-up|0|||
126169913|NCT01683071|453906846|FG002|Part 2|Lost to Follow-up|0|||
126169914|NCT01683071|453906847|FG003|Part 2|Lost to Follow-up|0|||
126169915|NCT01683071|453906848|FG004|Part 2|Lost to Follow-up|2|||
126169916|NCT01683071|453906849|FG005|Part 2|Lost to Follow-up|0|||
126169917|NCT01683071|453906844|FG000|Part 2|Withdrawal by Subject|0|||
126169918|NCT01683071|453906845|FG001|Part 2|Withdrawal by Subject|0|||
126169919|NCT01683071|453906846|FG002|Part 2|Withdrawal by Subject|0|||
126169920|NCT01683071|453906847|FG003|Part 2|Withdrawal by Subject|0|||
126169921|NCT01683071|453906848|FG004|Part 2|Withdrawal by Subject|3|||
126169922|NCT01683071|453906849|FG005|Part 2|Withdrawal by Subject|3|||
126169923|NCT01683071|453906844|FG000|Part 2|Surgery cancelled|0|||
126169924|NCT01683071|453906845|FG001|Part 2|Surgery cancelled|0|||
126169925|NCT01683071|453906846|FG002|Part 2|Surgery cancelled|0|||
126169926|NCT01683071|453906847|FG003|Part 2|Surgery cancelled|0|||
126169927|NCT01683071|453906848|FG004|Part 2|Surgery cancelled|4|||
126169928|NCT01683071|453906849|FG005|Part 2|Surgery cancelled|2|||
126169929|NCT01683071|453906844|FG000|Part 2|Did not receive study drug|0|||
126169930|NCT01683071|453906845|FG001|Part 2|Did not receive study drug|0|||
126169931|NCT01683071|453906846|FG002|Part 2|Did not receive study drug|0|||
126169932|NCT01683071|453906847|FG003|Part 2|Did not receive study drug|0|||
126169933|NCT01683071|453906848|FG004|Part 2|Did not receive study drug|2|||
126169934|NCT01683071|453906849|FG005|Part 2|Did not receive study drug|1|||
126169935|NCT01683071|453906844|FG000|Part 2|Met exclusion criterion|0|||
126169936|NCT01683071|453906845|FG001|Part 2|Met exclusion criterion|0|||
126169937|NCT01683071|453906846|FG002|Part 2|Met exclusion criterion|0|||
126169938|NCT01683071|453906847|FG003|Part 2|Met exclusion criterion|0|||
126169939|NCT01683071|453906848|FG004|Part 2|Met exclusion criterion|1|||
126169940|NCT01683071|453906849|FG005|Part 2|Met exclusion criterion|1|||
126169941|NCT01683071|453906844|FG000|Part 2|Protocol deviation|0|||
126169942|NCT01683071|453906845|FG001|Part 2|Protocol deviation|0|||
126169943|NCT01683071|453906846|FG002|Part 2|Protocol deviation|0|||
126169944|NCT01683071|453906847|FG003|Part 2|Protocol deviation|0|||
126169945|NCT01683071|453906848|FG004|Part 2|Protocol deviation|1|||
126169946|NCT01683071|453906849|FG005|Part 2|Protocol deviation|2|||
126169947|NCT01683071|453906844|FG000|Part 2|Withdrawal by investigator decision|0|||
126169948|NCT01683071|453906845|FG001|Part 2|Withdrawal by investigator decision|0|||
126169949|NCT01683071|453906846|FG002|Part 2|Withdrawal by investigator decision|0|||
126169950|NCT01683071|453906847|FG003|Part 2|Withdrawal by investigator decision|0|||
126169951|NCT01683071|453906848|FG004|Part 2|Withdrawal by investigator decision|1|||
126169952|NCT01683071|453906849|FG005|Part 2|Withdrawal by investigator decision|2|||
126169953|NCT02020031|453908829|FG000|Overall Study|Physician Decision|1|||
126169954|NCT02020031|453908830|FG001|Overall Study|Physician Decision|1|||
126169955|NCT02625324|453908843|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
126169956|NCT02625324|453908843|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
126169957|NCT02625324|453908843|FG000|6-Month Follow-up Subject Accountability|Death|5|||
126169958|NCT02625324|453908843|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
126169959|NCT02625324|453908843|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
126169960|NCT02625324|453908843|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
126169961|NCT02625324|453908843|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
126169962|NCT02625324|453908843|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
126169963|NCT02625324|453908843|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
126169964|NCT02625324|453908843|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
126169965|NCT02625324|453908843|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
126169966|NCT02625324|453908843|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
126169967|NCT02625324|453908843|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
126169968|NCT02625324|453908843|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
126169969|NCT02625324|453908843|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
126169970|NCT02625324|453908843|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
126169971|NCT02625324|453908843|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
126169972|NCT04092816|453908844|FG000|Overall Study|Lost to Follow-up|1|||
126169973|NCT04092816|453908845|FG001|Overall Study|Lost to Follow-up|2|||
126169974|NCT01116687|453908846|FG000|Overall Study|Withdrawal by Subject|4|||
126169975|NCT00424528|453908847|FG000|Overall Study|Adverse Event|2|||
126169976|NCT00424528|453908848|FG001|Overall Study|Adverse Event|1|||
126169977|NCT00424528|453908849|FG002|Overall Study|Adverse Event|2|||
126169978|NCT00424528|453908847|FG000|Overall Study|Protocol Violation|1|||
126169979|NCT00424528|453908848|FG001|Overall Study|Protocol Violation|1|||
126169980|NCT00424528|453908849|FG002|Overall Study|Protocol Violation|0|||
126169981|NCT00424528|453908847|FG000|Overall Study|Lost to Follow-up|0|||
126169982|NCT00424528|453908848|FG001|Overall Study|Lost to Follow-up|1|||
126169983|NCT00424528|453908849|FG002|Overall Study|Lost to Follow-up|0|||
126169984|NCT00424528|453908847|FG000|Overall Study|noncompliance with study requirements|2|||
126169985|NCT00424528|453908848|FG001|Overall Study|noncompliance with study requirements|1|||
126169986|NCT00424528|453908849|FG002|Overall Study|noncompliance with study requirements|2|||
126169987|NCT02395653|453908853|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
126169988|NCT02395653|453908853|FG000|Overall Study|Consent Withdrawn at Screening|1|||
126169989|NCT02395653|453908853|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
126169990|NCT02395653|453908853|FG000|Overall Study|Investigator Decision at Screening|1|||
126169991|NCT02395653|453908853|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
126169992|NCT02395653|453908853|FG000|Overall Study|Withdrawal by Subject|1|||
126169993|NCT02395653|453908853|FG000|Overall Study|Lost to Follow-up|1|||
126169994|NCT00967226|453908857|FG000|Overall Study|Adverse Event|0|||
126169995|NCT00967226|453908858|FG001|Overall Study|Adverse Event|5|||
126169996|NCT00967226|453908857|FG000|Overall Study|Protocol Violation|2|||
126169997|NCT00967226|453908858|FG001|Overall Study|Protocol Violation|0|||
126169998|NCT00967226|453908857|FG000|Overall Study|Physician Decision|0|||
126169999|NCT00967226|453908858|FG001|Overall Study|Physician Decision|1|||
126170000|NCT00605722|453908859|FG000|Overall Study|Adverse Event|6|||
126170001|NCT00605722|453908859|FG000|Overall Study|Insufficient therapeutic response|44|||
126170002|NCT00605722|453908859|FG000|Overall Study|Failure to return|1|||
126170003|NCT00487084|453908862|FG000|Overall Study|Did not receive intervention|4|||
126170004|NCT00487084|453908863|FG001|Overall Study|Did not receive intervention|3|||
126170005|NCT00487084|453908864|FG002|Overall Study|Did not receive intervention|5|||
126170006|NCT00254293|453908865|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126170007|NCT00254293|453908866|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
126170008|NCT00254293|453908867|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126170009|NCT00254293|453908868|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
126170010|NCT00254293|453908869|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126170011|NCT00254293|453908870|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126170012|NCT00254293|453908871|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126170013|NCT00254293|453908865|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126170014|NCT00254293|453908866|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126170015|NCT00254293|453908867|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
126170016|NCT00254293|453908868|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126170017|NCT00254293|453908869|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126170018|NCT00254293|453908870|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126170019|NCT00254293|453908871|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126170020|NCT00254293|453908865|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126170021|NCT00254293|453908866|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126170022|NCT00254293|453908867|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
126170023|NCT00254293|453908868|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126170024|NCT00254293|453908869|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126170025|NCT00254293|453908870|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126170026|NCT00254293|453908871|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126170027|NCT00254293|453908865|FG000|LTE Open Label Variable SC Dosing|Death|0|||
126170028|NCT00254293|453908866|FG001|LTE Open Label Variable SC Dosing|Death|0|||
126170029|NCT00254293|453908867|FG002|LTE Open Label Variable SC Dosing|Death|1|||
126170030|NCT00254293|453908868|FG003|LTE Open Label Variable SC Dosing|Death|0|||
126170031|NCT00254293|453908869|FG004|LTE Open Label Variable SC Dosing|Death|0|||
126170032|NCT00254293|453908870|FG005|LTE Open Label Variable SC Dosing|Death|0|||
126170033|NCT00254293|453908871|FG006|LTE Open Label Variable SC Dosing|Death|0|||
126170034|NCT00254293|453908865|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
126170035|NCT00254293|453908866|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
126170036|NCT00254293|453908867|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
126170037|NCT00254293|453908868|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
126170038|NCT00254293|453908869|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
126170039|NCT00254293|453908870|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
126170040|NCT00254293|453908871|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
126170041|NCT00254293|453908865|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
126170042|NCT00254293|453908866|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
126170043|NCT00254293|453908867|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
126170044|NCT00254293|453908868|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
126170045|NCT00254293|453908869|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
126170046|NCT00254293|453908870|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
126170047|NCT00254293|453908871|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
126170048|NCT00254293|453908865|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126170049|NCT00254293|453908866|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126170050|NCT00254293|453908867|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
126170051|NCT00254293|453908868|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126170052|NCT00254293|453908869|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126170053|NCT00254293|453908870|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126170054|NCT00254293|453908871|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126170055|NCT00254293|453908865|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126170056|NCT00254293|453908866|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126170057|NCT00254293|453908867|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
126170058|NCT00254293|453908868|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126170059|NCT00254293|453908869|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126170060|NCT00254293|453908870|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126170061|NCT00254293|453908871|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126170062|NCT00254293|453908865|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126170063|NCT00254293|453908866|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126170064|NCT00254293|453908867|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
126170065|NCT00254293|453908868|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126170066|NCT00254293|453908869|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126170067|NCT00254293|453908870|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126170068|NCT00254293|453908871|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126170069|NCT00254293|453908865|FG000|LTE Open Label Variable SC Dosing|Other|0|||
126170070|NCT00254293|453908866|FG001|LTE Open Label Variable SC Dosing|Other|0|||
126170071|NCT00254293|453908867|FG002|LTE Open Label Variable SC Dosing|Other|2|||
126170072|NCT00254293|453908868|FG003|LTE Open Label Variable SC Dosing|Other|0|||
126170073|NCT00254293|453908869|FG004|LTE Open Label Variable SC Dosing|Other|0|||
126170074|NCT00254293|453908870|FG005|LTE Open Label Variable SC Dosing|Other|0|||
126170075|NCT00254293|453908871|FG006|LTE Open Label Variable SC Dosing|Other|0|||
126170076|NCT00254293|453908865|FG000|LTE Open Label Fixed Dosing|Death|0|||
126170077|NCT00254293|453908866|FG001|LTE Open Label Fixed Dosing|Death|0|||
126170078|NCT00254293|453908867|FG002|LTE Open Label Fixed Dosing|Death|0|||
126170079|NCT00254293|453908868|FG003|LTE Open Label Fixed Dosing|Death|0|||
126170080|NCT00254293|453908869|FG004|LTE Open Label Fixed Dosing|Death|0|||
126170081|NCT00254293|453908870|FG005|LTE Open Label Fixed Dosing|Death|0|||
126170082|NCT00254293|453908871|FG006|LTE Open Label Fixed Dosing|Death|3|||
126170083|NCT00254293|453908865|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
126170084|NCT00254293|453908866|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
126170085|NCT00254293|453908867|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
126170086|NCT00254293|453908868|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
126170087|NCT00254293|453908869|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
125973362|NCT02384954|453191480|FG006|Phase 1|Progressive Disease|0|||
125973363|NCT02384954|453191481|FG007|Phase 1|Progressive Disease|0|||
125973364|NCT02384954|453191482|FG008|Phase 1|Progressive Disease|0|||
125973365|NCT02384954|453191474|FG000|Phase 1|Adverse Event|0|||
125973366|NCT02384954|453191475|FG001|Phase 1|Adverse Event|0|||
125973367|NCT02384954|453191476|FG002|Phase 1|Adverse Event|1|||
125973368|NCT02384954|453191477|FG003|Phase 1|Adverse Event|0|||
126170088|NCT00254293|453908870|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
126170089|NCT00254293|453908871|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
126170090|NCT00254293|453908865|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125973369|NCT02384954|453191478|FG004|Phase 1|Adverse Event|0|||
125973370|NCT02384954|453191479|FG005|Phase 1|Adverse Event|0|||
126170091|NCT00254293|453908866|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126170092|NCT00254293|453908867|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126170093|NCT00254293|453908868|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126170094|NCT00254293|453908869|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126170095|NCT00254293|453908870|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126170096|NCT00254293|453908871|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
126170097|NCT00254293|453908865|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126170098|NCT00254293|453908866|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126170099|NCT00254293|453908867|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126170100|NCT00254293|453908868|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126170101|NCT00254293|453908869|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126170102|NCT00254293|453908870|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126170103|NCT00254293|453908871|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
126170104|NCT00254293|453908865|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126170105|NCT00254293|453908866|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126170106|NCT00254293|453908867|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126170107|NCT00254293|453908868|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126170108|NCT00254293|453908869|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126170109|NCT00254293|453908870|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126170110|NCT00254293|453908871|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
126170111|NCT00254293|453908865|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126170112|NCT00254293|453908866|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126170113|NCT00254293|453908867|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126170114|NCT00254293|453908868|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126170115|NCT00254293|453908869|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126170116|NCT00254293|453908870|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126170117|NCT00254293|453908871|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
126170118|NCT00254293|453908865|FG000|LTE Open Label Fixed Dosing|Other|0|||
126170119|NCT00254293|453908866|FG001|LTE Open Label Fixed Dosing|Other|0|||
126170120|NCT00254293|453908867|FG002|LTE Open Label Fixed Dosing|Other|0|||
126170121|NCT00254293|453908868|FG003|LTE Open Label Fixed Dosing|Other|0|||
126170122|NCT00254293|453908869|FG004|LTE Open Label Fixed Dosing|Other|0|||
126170123|NCT00254293|453908870|FG005|LTE Open Label Fixed Dosing|Other|0|||
126170124|NCT00254293|453908871|FG006|LTE Open Label Fixed Dosing|Other|1|||
126170125|NCT02690207|453908879|FG000|Overall Study|Lost to Follow-up|48|||
126170126|NCT02690207|453908879|FG000|Overall Study|Withdrawal by Subject|46|||
126170127|NCT02690207|453908879|FG000|Overall Study|Protocol Violation|2|||
126170128|NCT02690207|453908879|FG000|Overall Study|Serious adverse event|110|||
126170129|NCT02690207|453908879|FG000|Overall Study|Non-serious Adverse Event|18|||
126170130|NCT02690207|453908879|FG000|Overall Study|Migrated/moved from study area|5|||
126170131|NCT02690207|453908879|FG000|Overall Study|Suspected HZ Episode|1|||
126170132|NCT02690207|453908879|FG000|Overall Study|Other reasons for withdrawal|23|||
126170133|NCT01626352|453908880|FG000|Overall Study|Disease Progression|3|||
126170134|NCT01626352|453908880|FG000|Overall Study|Intercurrent Illness|2|||
126170135|NCT01626352|453908880|FG000|Overall Study|Death|2|||
126170136|NCT01626352|453908880|FG000|Overall Study|Withdrawal by Subject|1|||
126170137|NCT01626352|453908880|FG000|Overall Study|Non-Compliance|1|||
126170138|NCT01626352|453908880|FG000|Overall Study|Never Treated|1|||
126170139|NCT04348656|453908883|FG000|Overall Study|Withdrawal by Subject|2|||
126170140|NCT04348656|453908884|FG001|Overall Study|Withdrawal by Subject|0|||
126170141|NCT04348656|453908883|FG000|Overall Study|Lost to Follow-up|11|||
126170142|NCT04348656|453908884|FG001|Overall Study|Lost to Follow-up|6|||
126170143|NCT00937560|453908891|FG000|Initial Treatment|Death|6|||
126170144|NCT00937560|453908891|FG000|Initial Treatment|Withdraw consent|3|||
126170145|NCT00937560|453908891|FG000|Initial Treatment|Adverse Event|1|||
126170146|NCT00937560|453908891|FG000|Initial Treatment|Lost to Follow-up|1|||
126170147|NCT00937560|453908891|FG000|Initial Treatment|No end of study page|10|||
126170148|NCT00937560|453908891|FG000|Maintenance Treatment|Death|12|||
126170149|NCT00937560|453908891|FG000|Maintenance Treatment|Withdraw consent|5|||
126170150|NCT00937560|453908891|FG000|Maintenance Treatment|According to protocol|1|||
126170151|NCT03607838|453908894|FG000|Overall Study|Lack of Efficacy|14|||
126170152|NCT03607838|453908895|FG001|Overall Study|Lack of Efficacy|20|||
126170153|NCT03607838|453908894|FG000|Overall Study|Withdrawal by Subject|13|||
126170154|NCT03607838|453908895|FG001|Overall Study|Withdrawal by Subject|8|||
126170155|NCT03607838|453908894|FG000|Overall Study|Lost to Follow-up|6|||
126170156|NCT03607838|453908895|FG001|Overall Study|Lost to Follow-up|11|||
126170157|NCT03607838|453908894|FG000|Overall Study|Adverse Event|2|||
126170158|NCT03607838|453908895|FG001|Overall Study|Adverse Event|2|||
126170159|NCT03607838|453908894|FG000|Overall Study|Physician Decision|2|||
126170160|NCT03607838|453908895|FG001|Overall Study|Physician Decision|0|||
126170161|NCT03607838|453908894|FG000|Overall Study|Failure to meet randomization criteria|1|||
126170162|NCT03607838|453908895|FG001|Overall Study|Failure to meet randomization criteria|2|||
126170163|NCT03607838|453908894|FG000|Overall Study|Pregnancy|1|||
126170164|NCT03607838|453908895|FG001|Overall Study|Pregnancy|0|||
126170165|NCT03607838|453908894|FG000|Overall Study|Protocol Violation|1|||
126170166|NCT03607838|453908895|FG001|Overall Study|Protocol Violation|0|||
126170167|NCT03607838|453908894|FG000|Overall Study|Due to work|1|||
126170168|NCT03607838|453908895|FG001|Overall Study|Due to work|0|||
126170169|NCT03607838|453908894|FG000|Overall Study|Litigation|0|||
126170170|NCT03607838|453908895|FG001|Overall Study|Litigation|1|||
126170171|NCT03607838|453908894|FG000|Overall Study|Temperature excursion for study drug|0|||
126170172|NCT03607838|453908895|FG001|Overall Study|Temperature excursion for study drug|1|||
126170173|NCT03607838|453908894|FG000|Overall Study|Change of mind|0|||
126170174|NCT03607838|453908895|FG001|Overall Study|Change of mind|1|||
126170175|NCT01576016|453908896|FG000|Lead Safety|Death|132|||
126170176|NCT01576016|453908897|FG001|Lead Safety|Death|0|||
126170177|NCT01576016|453908896|FG000|Lead Safety|Withdrawal by Subject|81|||
126170178|NCT01576016|453908897|FG001|Lead Safety|Withdrawal by Subject|0|||
126170179|NCT01576016|453908896|FG000|Lead Safety|System Explanted without Replacement|24|||
126170180|NCT01576016|453908897|FG001|Lead Safety|System Explanted without Replacement|0|||
126170181|NCT01576016|453908896|FG000|Lead Safety|Physician Decision|14|||
126170182|NCT01576016|453908897|FG001|Lead Safety|Physician Decision|0|||
126170183|NCT01576016|453908896|FG000|Lead Safety|Lost to Follow-up|13|||
126170184|NCT01576016|453908897|FG001|Lead Safety|Lost to Follow-up|0|||
126170185|NCT01576016|453908896|FG000|Lead Safety|Unsuccessful implant|2|||
126170186|NCT01576016|453908897|FG001|Lead Safety|Unsuccessful implant|0|||
126170187|NCT01576016|453908896|FG000|Lead Safety|Sponsor request|1|||
126170188|NCT01576016|453908897|FG001|Lead Safety|Sponsor request|0|||
126170189|NCT01576016|453908896|FG000|Lead Safety|Device replaced with CRT-D|1|||
126170190|NCT01576016|453908897|FG001|Lead Safety|Device replaced with CRT-D|0|||
126170191|NCT01576016|453908896|FG000|Lead Safety|Patient on Palliative Care|1|||
126170192|NCT01576016|453908897|FG001|Lead Safety|Patient on Palliative Care|0|||
126170193|NCT01576016|453908896|FG000|Lead Safety|Patient noncompliance|1|||
126170194|NCT01576016|453908897|FG001|Lead Safety|Patient noncompliance|0|||
126170195|NCT01576016|453908896|FG000|Lead Safety|Too far from study site|1|||
126170196|NCT01576016|453908897|FG001|Lead Safety|Too far from study site|0|||
126170197|NCT01576016|453908896|FG000|Lead Safety|System deactivated|1|||
126170198|NCT01576016|453908897|FG001|Lead Safety|System deactivated|0|||
126170199|NCT01576016|453908896|FG000|Lead Safety|Patient no longer followed by study PI|1|||
126170200|NCT01576016|453908897|FG001|Lead Safety|Patient no longer followed by study PI|0|||
126170201|NCT01576016|453908896|FG000|MRI Safety|Withdrawal by Subject|0|||
126170202|NCT01576016|453908897|FG001|MRI Safety|Withdrawal by Subject|10|||
126170203|NCT01576016|453908896|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
126170204|NCT01576016|453908897|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
126170205|NCT01576016|453908896|FG000|MRI Safety|Has not yet completed MRI scan|0|||
126170206|NCT01576016|453908897|FG001|MRI Safety|Has not yet completed MRI scan|56|||
126170207|NCT01576016|453908896|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
126170208|NCT01576016|453908897|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
126170209|NCT02488551|453908900|FG000|Overall Study|Lost to Follow-up|4|||
126170210|NCT02488551|453908901|FG001|Overall Study|Lost to Follow-up|7|||
125973371|NCT02384954|453191480|FG006|Phase 1|Adverse Event|0|||
125973372|NCT02384954|453191481|FG007|Phase 1|Adverse Event|0|||
125973373|NCT02384954|453191482|FG008|Phase 1|Adverse Event|0|||
125973374|NCT02384954|453191474|FG000|Phase 2|Progressive Disease|0|||
125973375|NCT02384954|453191475|FG001|Phase 2|Progressive Disease|0|||
125973376|NCT02384954|453191476|FG002|Phase 2|Progressive Disease|0|||
125973377|NCT02384954|453191477|FG003|Phase 2|Progressive Disease|0|||
125973378|NCT02384954|453191478|FG004|Phase 2|Progressive Disease|0|||
125973379|NCT02384954|453191479|FG005|Phase 2|Progressive Disease|0|||
125973380|NCT02384954|453191480|FG006|Phase 2|Progressive Disease|0|||
125973381|NCT02384954|453191481|FG007|Phase 2|Progressive Disease|1|||
125973382|NCT02384954|453191482|FG008|Phase 2|Progressive Disease|2|||
125973383|NCT02384954|453191474|FG000|Phase 2|Adverse Event|0|||
125973384|NCT02384954|453191475|FG001|Phase 2|Adverse Event|0|||
125973385|NCT02384954|453191476|FG002|Phase 2|Adverse Event|0|||
125973386|NCT02384954|453191477|FG003|Phase 2|Adverse Event|0|||
125973387|NCT02384954|453191478|FG004|Phase 2|Adverse Event|0|||
125973388|NCT02384954|453191479|FG005|Phase 2|Adverse Event|0|||
126170211|NCT02488551|453908902|FG002|Overall Study|Lost to Follow-up|0|||
126170212|NCT02488551|453908903|FG003|Overall Study|Lost to Follow-up|0|||
126170213|NCT02488551|453908900|FG000|Overall Study|Military Deployment|1|||
126170214|NCT02488551|453908901|FG001|Overall Study|Military Deployment|1|||
126170215|NCT02488551|453908902|FG002|Overall Study|Military Deployment|0|||
126170216|NCT02488551|453908903|FG003|Overall Study|Military Deployment|0|||
126170217|NCT03364608|453908904|FG000|Overall Study|Withdrawal by Subject|4|||
126170218|NCT03364608|453908904|FG000|Overall Study|Protocol Violation|2|||
126170219|NCT03364608|453908904|FG000|Overall Study|Lost to Follow-up|2|||
126170220|NCT02546674|453908911|FG000|Overall Study|Adverse Event|19|||
126170221|NCT02546674|453908911|FG000|Overall Study|Death|1|||
125973389|NCT02384954|453191480|FG006|Phase 2|Adverse Event|0|||
125973390|NCT02384954|453191481|FG007|Phase 2|Adverse Event|1|||
125973391|NCT02384954|453191482|FG008|Phase 2|Adverse Event|1|||
125973392|NCT02384954|453191474|FG000|Phase 2|Failure to meet continuation criteria|0|||
125973393|NCT02384954|453191475|FG001|Phase 2|Failure to meet continuation criteria|0|||
125973394|NCT02384954|453191476|FG002|Phase 2|Failure to meet continuation criteria|0|||
126170222|NCT02546674|453908911|FG000|Overall Study|Lost to Follow-up|1|||
126170223|NCT02546674|453908911|FG000|Overall Study|Physician Decision|13|||
126170224|NCT02546674|453908911|FG000|Overall Study|Pregnancy|1|||
126170225|NCT02546674|453908911|FG000|Overall Study|Progressive Disease|2|||
126170226|NCT02546674|453908911|FG000|Overall Study|Protocol Deviation|2|||
126170227|NCT02546674|453908911|FG000|Overall Study|Subject/Guardian Decision|6|||
126170228|NCT02546674|453908911|FG000|Overall Study|Withdrawal of Informed Consent|3|||
126170229|NCT01163253|453908912|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
126170230|NCT01163253|453908913|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
126170231|NCT01163253|453908912|FG000|Overall Study|Study Terminated by Sponsor|978|||
126170232|NCT01163253|453908913|FG001|Overall Study|Study Terminated by Sponsor|349|||
126170233|NCT01163253|453908912|FG000|Overall Study|Protocol Violation|43|||
126170234|NCT01163253|453908913|FG001|Overall Study|Protocol Violation|12|||
126170235|NCT01163253|453908912|FG000|Overall Study|Withdrawal by Subject|199|||
126170236|NCT01163253|453908913|FG001|Overall Study|Withdrawal by Subject|50|||
126170237|NCT01163253|453908912|FG000|Overall Study|Medication Error|1|||
126170238|NCT01163253|453908913|FG001|Overall Study|Medication Error|0|||
126170239|NCT01163253|453908912|FG000|Overall Study|Lost to Follow-up|125|||
126170240|NCT01163253|453908913|FG001|Overall Study|Lost to Follow-up|23|||
126170241|NCT01163253|453908912|FG000|Overall Study|Insufficient Clinical Response|423|||
126170242|NCT01163253|453908913|FG001|Overall Study|Insufficient Clinical Response|29|||
126170243|NCT01163253|453908912|FG000|Overall Study|Adverse Event|300|||
126170244|NCT01163253|453908913|FG001|Overall Study|Adverse Event|78|||
126170245|NCT01163253|453908912|FG000|Overall Study|Death|17|||
126170246|NCT01163253|453908913|FG001|Overall Study|Death|5|||
126170247|NCT01163253|453908912|FG000|Overall Study|Ongoing|13|||
126170248|NCT01163253|453908913|FG001|Overall Study|Ongoing|4|||
126170249|NCT01163253|453908912|FG000|Overall Study|Other Unspecified|170|||
126170250|NCT01163253|453908913|FG001|Overall Study|Other Unspecified|34|||
126170251|NCT02492997|453908914|FG000|Overall Study|Withdrawal by Subject|1|||
125973395|NCT02384954|453191477|FG003|Phase 2|Failure to meet continuation criteria|0|||
125973396|NCT02384954|453191478|FG004|Phase 2|Failure to meet continuation criteria|0|||
125973397|NCT02384954|453191479|FG005|Phase 2|Failure to meet continuation criteria|0|||
125973398|NCT02384954|453191480|FG006|Phase 2|Failure to meet continuation criteria|0|||
125973399|NCT02384954|453191481|FG007|Phase 2|Failure to meet continuation criteria|1|||
125973400|NCT02384954|453191482|FG008|Phase 2|Failure to meet continuation criteria|0|||
125973401|NCT03998618|453191483|FG000|Overall Study|Death|7|||
125973402|NCT03998618|453191484|FG001|Overall Study|Death|11|||
125973403|NCT03998618|453191483|FG000|Overall Study|hospice enrollment|3|||
125973404|NCT03998618|453191484|FG001|Overall Study|hospice enrollment|3|||
125973405|NCT03998618|453191483|FG000|Overall Study|Not feeling well/health problems|3|||
125973406|NCT03998618|453191484|FG001|Overall Study|Not feeling well/health problems|5|||
125973407|NCT03998618|453191483|FG000|Overall Study|Lost to Follow-up|6|||
125973408|NCT03998618|453191484|FG001|Overall Study|Lost to Follow-up|6|||
125973409|NCT03998618|453191483|FG000|Overall Study|Withdrawal by Subject|0|||
125973410|NCT03998618|453191484|FG001|Overall Study|Withdrawal by Subject|4|||
125973411|NCT00295750|453191485|FG000|Overall Study|Adverse Event|19|||
125973412|NCT00295750|453191486|FG001|Overall Study|Adverse Event|15|||
125973413|NCT00295750|453191487|FG002|Overall Study|Adverse Event|12|||
125973414|NCT00295750|453191485|FG000|Overall Study|Lack of Efficacy|1|||
125973415|NCT00295750|453191486|FG001|Overall Study|Lack of Efficacy|1|||
125973416|NCT00295750|453191487|FG002|Overall Study|Lack of Efficacy|0|||
125973417|NCT00295750|453191485|FG000|Overall Study|Lost to Follow-up|1|||
125973418|NCT00295750|453191486|FG001|Overall Study|Lost to Follow-up|4|||
125973419|NCT00295750|453191487|FG002|Overall Study|Lost to Follow-up|1|||
125973420|NCT00295750|453191485|FG000|Overall Study|Taking prohibited therapy|2|||
125973421|NCT00295750|453191486|FG001|Overall Study|Taking prohibited therapy|3|||
125973422|NCT00295750|453191487|FG002|Overall Study|Taking prohibited therapy|2|||
125973423|NCT00295750|453191485|FG000|Overall Study|Administrative errors|2|||
125973424|NCT00295750|453191486|FG001|Overall Study|Administrative errors|4|||
125973425|NCT00295750|453191487|FG002|Overall Study|Administrative errors|5|||
125973426|NCT00295750|453191485|FG000|Overall Study|Trial drug errors|1|||
125973427|NCT00295750|453191486|FG001|Overall Study|Trial drug errors|1|||
126170252|NCT02492997|453908915|FG001|Overall Study|Withdrawal by Subject|0|||
126170253|NCT02492997|453908914|FG000|Overall Study|Gained Weight|1|||
126170254|NCT02492997|453908915|FG001|Overall Study|Gained Weight|0|||
126170255|NCT02492997|453908914|FG000|Overall Study|Lost to Follow-up|0|||
126170256|NCT02492997|453908915|FG001|Overall Study|Lost to Follow-up|1|||
126170257|NCT03888391|453908922|FG000|Overall Study|Lost to Follow-up|15|||
125973428|NCT00295750|453191487|FG002|Overall Study|Trial drug errors|0|||
125973429|NCT00295750|453191485|FG000|Overall Study|Disease progression|2|||
125973430|NCT00295750|453191486|FG001|Overall Study|Disease progression|1|||
125973431|NCT00295750|453191487|FG002|Overall Study|Disease progression|0|||
125973432|NCT00295750|453191485|FG000|Overall Study|Personal reasons|0|||
125973433|NCT00295750|453191486|FG001|Overall Study|Personal reasons|1|||
125973434|NCT00295750|453191487|FG002|Overall Study|Personal reasons|0|||
126170258|NCT00423735|453908924|FG000|Overall Study|Ineligible / No protocol treatment|8|||
126170259|NCT00423735|453908925|FG001|Overall Study|Ineligible / No protocol treatment|6|||
125973435|NCT00295750|453191485|FG000|Overall Study|Randomized but never received trial drug|4|||
125973436|NCT00295750|453191486|FG001|Overall Study|Randomized but never received trial drug|3|||
125973437|NCT00295750|453191487|FG002|Overall Study|Randomized but never received trial drug|3|||
125973438|NCT00295750|453191485|FG000|Overall Study|Withdrawal by Subject|9|||
125973439|NCT00295750|453191486|FG001|Overall Study|Withdrawal by Subject|4|||
125973440|NCT00295750|453191487|FG002|Overall Study|Withdrawal by Subject|7|||
125973441|NCT00295750|453191485|FG000|Overall Study|Protocol Violation|2|||
125973442|NCT00295750|453191486|FG001|Overall Study|Protocol Violation|4|||
125973443|NCT00295750|453191487|FG002|Overall Study|Protocol Violation|2|||
125973444|NCT00936858|453191488|FG000|Overall Study|Death|3|||
125973445|NCT00936858|453191488|FG000|Overall Study|Progression|29|||
125973446|NCT00936858|453191488|FG000|Overall Study|Withdrawal by Subject|5|||
125973447|NCT00936858|453191488|FG000|Overall Study|Adverse Event|1|||
125973448|NCT00936858|453191488|FG000|Overall Study|Physician Decision|7|||
125973449|NCT00936858|453191488|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
125973450|NCT00936858|453191488|FG000|Overall Study|Lost to Follow-up|1|||
125973451|NCT04899349|453191495|FG000|Overall Study|Study terminated by Sponsor|2|||
125973452|NCT04899349|453191496|FG001|Overall Study|Study terminated by Sponsor|0|||
125973453|NCT01857531|453191497|FG000|Overall Study|Withdrawal by Subject|4|||
125973454|NCT04656847|453191501|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
125973455|NCT03301051|453191502|FG000|Overall Study|Adverse Event|0|||
125973456|NCT03301051|453191503|FG001|Overall Study|Adverse Event|4|||
125973457|NCT03301051|453191502|FG000|Overall Study|Withdrawal by Subject|59|||
125973458|NCT03301051|453191503|FG001|Overall Study|Withdrawal by Subject|65|||
125973459|NCT03301051|453191502|FG000|Overall Study|Lost to Follow-up|263|||
125973460|NCT03301051|453191503|FG001|Overall Study|Lost to Follow-up|282|||
125973461|NCT03301051|453191502|FG000|Overall Study|Protocol Violation|1|||
125973462|NCT03301051|453191503|FG001|Overall Study|Protocol Violation|3|||
125973463|NCT03301051|453191502|FG000|Overall Study|Physician Decision|1|||
125973464|NCT03301051|453191503|FG001|Overall Study|Physician Decision|3|||
125973465|NCT03301051|453191502|FG000|Overall Study|Death|1|||
125973466|NCT03301051|453191503|FG001|Overall Study|Death|1|||
125973467|NCT03301051|453191502|FG000|Overall Study|Miscellaneous|8|||
125973468|NCT03301051|453191503|FG001|Overall Study|Miscellaneous|4|||
125973469|NCT03301051|453191502|FG000|Overall Study|Randomized, not vaccinated|13|||
125973470|NCT03301051|453191503|FG001|Overall Study|Randomized, not vaccinated|10|||
125973471|NCT00047879|453191504|FG000|Overall Study|Progressive disease|4|||
125973472|NCT00047879|453191505|FG001|Overall Study|Progressive disease|3|||
125973473|NCT00435370|453191508|FG000|Overall Study|Adverse Event|8|||
125973474|NCT00435370|453191509|FG001|Overall Study|Adverse Event|8|||
125973475|NCT00435370|453191508|FG000|Overall Study|Withdrawal by Subject|10|||
125973476|NCT00435370|453191509|FG001|Overall Study|Withdrawal by Subject|10|||
125973477|NCT00435370|453191508|FG000|Overall Study|Antipsychotic medication changed|4|||
125973478|NCT00435370|453191509|FG001|Overall Study|Antipsychotic medication changed|2|||
125973479|NCT00617344|453191514|FG000|Overall Study|Serious adverse event|1|||
125973480|NCT00617344|453191515|FG001|Overall Study|Serious adverse event|0|||
125973481|NCT00617344|453191516|FG002|Overall Study|Serious adverse event|0|||
125973482|NCT00617344|453191514|FG000|Overall Study|Other Adverse Event|1|||
125973483|NCT00617344|453191515|FG001|Overall Study|Other Adverse Event|1|||
125973484|NCT00617344|453191516|FG002|Overall Study|Other Adverse Event|0|||
125973485|NCT00617344|453191514|FG000|Overall Study|Protocol Violation|10|||
125973486|NCT00617344|453191515|FG001|Overall Study|Protocol Violation|8|||
125973487|NCT00617344|453191516|FG002|Overall Study|Protocol Violation|5|||
125973488|NCT00617344|453191514|FG000|Overall Study|Lost to Follow-up|5|||
125973489|NCT00617344|453191515|FG001|Overall Study|Lost to Follow-up|4|||
125973490|NCT00617344|453191516|FG002|Overall Study|Lost to Follow-up|1|||
125973491|NCT00617344|453191514|FG000|Overall Study|Withdrawal by Subject|8|||
125973492|NCT00617344|453191515|FG001|Overall Study|Withdrawal by Subject|9|||
125973493|NCT00617344|453191516|FG002|Overall Study|Withdrawal by Subject|2|||
125973494|NCT00941330|453191518|FG000|Overall Study|Other|1|||
125973495|NCT00941330|453191519|FG001|Overall Study|Other|0|||
125973496|NCT00941330|453191518|FG000|Overall Study|Physician Decision|0|||
125973497|NCT00941330|453191519|FG001|Overall Study|Physician Decision|2|||
125973498|NCT04657211|453191520|FG000|Overall Study|Withdrawal by Subject|21|||
125973499|NCT04657211|453191520|FG000|Overall Study|Lost to Follow-up|113|||
125973500|NCT04657211|453191520|FG000|Overall Study|Death|47|||
125973501|NCT04657211|453191520|FG000|Overall Study|Transfer to another institution|21|||
125973502|NCT04657211|453191520|FG000|Overall Study|Other|29|||
125973503|NCT01962493|453191521|FG000|Overall Study|Adverse Event|1|||
125973504|NCT01962493|453191522|FG001|Overall Study|Adverse Event|2|||
125973505|NCT01962493|453191521|FG000|Overall Study|Protocol Violation|0|||
125973506|NCT01962493|453191522|FG001|Overall Study|Protocol Violation|1|||
125973507|NCT01962493|453191521|FG000|Overall Study|Withdrawal by Subject|4|||
125973508|NCT01962493|453191522|FG001|Overall Study|Withdrawal by Subject|2|||
125973509|NCT03776136|453191523|FG000|Overall Study|Death|85|||
125973510|NCT03776136|453191523|FG000|Overall Study|Withdrawal by Subject|3|||
125973511|NCT03776136|453191523|FG000|Overall Study|Sponsor Decision|15|||
125973512|NCT06273774|453191524|FG000|Overall Study|Participant was out of state.|0|||
125973513|NCT06273774|453191525|FG001|Overall Study|Participant was out of state.|0|||
125973514|NCT06273774|453191526|FG002|Overall Study|Participant was out of state.|0|||
125973515|NCT06273774|453191527|FG003|Overall Study|Participant was out of state.|0|||
125973516|NCT06273774|453191528|FG004|Overall Study|Participant was out of state.|0|||
125973517|NCT06273774|453191529|FG005|Overall Study|Participant was out of state.|1|||
125973518|NCT06273774|453191524|FG000|Overall Study|Lost to Follow-up|0|||
125973519|NCT06273774|453191525|FG001|Overall Study|Lost to Follow-up|0|||
125973520|NCT06273774|453191526|FG002|Overall Study|Lost to Follow-up|0|||
125973521|NCT06273774|453191527|FG003|Overall Study|Lost to Follow-up|0|||
125973522|NCT06273774|453191528|FG004|Overall Study|Lost to Follow-up|1|||
125973523|NCT06273774|453191529|FG005|Overall Study|Lost to Follow-up|0|||
125973524|NCT00613951|453191534|FG000|Overall Study|Adverse Event|1|||
125973525|NCT00613951|453191535|FG001|Overall Study|Adverse Event|0|||
125973526|NCT00613951|453191536|FG002|Overall Study|Adverse Event|1|||
125973527|NCT00613951|453191534|FG000|Overall Study|Lack of Efficacy|0|||
125973528|NCT00613951|453191535|FG001|Overall Study|Lack of Efficacy|1|||
125973529|NCT00613951|453191536|FG002|Overall Study|Lack of Efficacy|1|||
125973530|NCT00613951|453191534|FG000|Overall Study|Protocol Violation|1|||
125973531|NCT00613951|453191535|FG001|Overall Study|Protocol Violation|1|||
125973532|NCT00613951|453191536|FG002|Overall Study|Protocol Violation|1|||
125973533|NCT00613951|453191534|FG000|Overall Study|Unclassified|5|||
125973534|NCT00613951|453191535|FG001|Overall Study|Unclassified|3|||
125973535|NCT00613951|453191536|FG002|Overall Study|Unclassified|2|||
125973536|NCT04414696|453191537|FG000|3-month Follow up|Withdrawal by Subject|1|||
125973537|NCT04414696|453191538|FG001|3-month Follow up|Withdrawal by Subject|0|||
125973538|NCT04414696|453191537|FG000|3-month Follow up|Lost to Follow-up|22|||
125973539|NCT04414696|453191538|FG001|3-month Follow up|Lost to Follow-up|23|||
125973540|NCT04414696|453191537|FG000|6-month Follow up|Withdrawal by Subject|1|||
125973541|NCT04414696|453191538|FG001|6-month Follow up|Withdrawal by Subject|2|||
125973542|NCT04414696|453191537|FG000|6-month Follow up|Lost to Follow-up|5|||
125973543|NCT04414696|453191538|FG001|6-month Follow up|Lost to Follow-up|2|||
125973544|NCT01329029|453191545|FG000|Overall Study|Withdrawal by Subject|117|||
125973545|NCT01329029|453191546|FG001|Overall Study|Withdrawal by Subject|87|||
125973546|NCT01329029|453191545|FG000|Overall Study|Adverse Event|82|||
125973547|NCT01329029|453191546|FG001|Overall Study|Adverse Event|29|||
125973548|NCT01329029|453191545|FG000|Overall Study|Death|16|||
125973549|NCT01329029|453191546|FG001|Overall Study|Death|19|||
125973550|NCT01329029|453191545|FG000|Overall Study|Other|14|||
125973551|NCT01329029|453191546|FG001|Overall Study|Other|20|||
125973552|NCT01329029|453191545|FG000|Overall Study|COPD Exacerbation|11|||
125973553|NCT01329029|453191546|FG001|Overall Study|COPD Exacerbation|18|||
125973554|NCT01329029|453191545|FG000|Overall Study|Physician Decision|16|||
125973555|NCT01329029|453191546|FG001|Overall Study|Physician Decision|13|||
125973556|NCT01329029|453191545|FG000|Overall Study|Lost to Follow-up|8|||
125973557|NCT01329029|453191546|FG001|Overall Study|Lost to Follow-up|5|||
125973558|NCT01329029|453191545|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
125973559|NCT01329029|453191546|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
125973560|NCT01266642|453191547|FG000|Overall Study|Protocol Violation|0|||
125973561|NCT01266642|453191548|FG001|Overall Study|Protocol Violation|1|||
126170260|NCT00423735|453908926|FG002|Overall Study|Ineligible / No protocol treatment|0|||
126170261|NCT01954251|453908929|FG000|Overall Study|Adverse Event|5|||
126170262|NCT01954251|453908930|FG001|Overall Study|Adverse Event|7|||
126170263|NCT01954251|453908929|FG000|Overall Study|Lost to Follow-up|6|||
126170264|NCT01954251|453908930|FG001|Overall Study|Lost to Follow-up|6|||
126170265|NCT01954251|453908929|FG000|Overall Study|Withdrawal by Subject|2|||
126170266|NCT01954251|453908930|FG001|Overall Study|Withdrawal by Subject|6|||
126170267|NCT02864940|453908931|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
125973562|NCT02985866|453193118|FG000|Overall Study|Poor CGM data|1|||
125973563|NCT02985866|453193119|FG001|Overall Study|Poor CGM data|1|||
125973564|NCT02811861|453193120|FG000|Overall Study|Radiological Disease Progression|123|||
125973565|NCT02811861|453193121|FG001|Overall Study|Radiological Disease Progression|97|||
125973566|NCT02811861|453193122|FG002|Overall Study|Radiological Disease Progression|174|||
125973567|NCT02811861|453193120|FG000|Overall Study|Clinical Disease Progression|20|||
125973568|NCT02811861|453193121|FG001|Overall Study|Clinical Disease Progression|19|||
126170268|NCT02864940|453908932|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
125973569|NCT02811861|453193122|FG002|Overall Study|Clinical Disease Progression|22|||
125973570|NCT02811861|453193120|FG000|Overall Study|Adverse Event|63|||
125973571|NCT02811861|453193121|FG001|Overall Study|Adverse Event|60|||
125973572|NCT02811861|453193122|FG002|Overall Study|Adverse Event|41|||
125973573|NCT02811861|453193120|FG000|Overall Study|Lost to Follow-up|0|||
125973574|NCT02811861|453193121|FG001|Overall Study|Lost to Follow-up|0|||
125973575|NCT02811861|453193122|FG002|Overall Study|Lost to Follow-up|1|||
125973576|NCT02811861|453193120|FG000|Overall Study|Subject Choice|29|||
125973577|NCT02811861|453193121|FG001|Overall Study|Subject Choice|17|||
126200118|NCT02394028|454017884|FG007|Induction Phase|Lack of Efficacy|23|||
125973578|NCT02811861|453193122|FG002|Overall Study|Subject Choice|23|||
125973579|NCT02811861|453193120|FG000|Overall Study|Withdrawal by Subject|4|||
126170269|NCT02175771|453908933|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
126170270|NCT02175771|453908934|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126170271|NCT02175771|453908935|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126170272|NCT02175771|453908936|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126170273|NCT02175771|453908937|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126170274|NCT02175771|453908938|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126170275|NCT02175771|453908939|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126170276|NCT02175771|453908940|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126170277|NCT02175771|453908941|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126170278|NCT02175771|453908933|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
126170279|NCT02175771|453908934|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126170280|NCT02175771|453908935|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126170281|NCT02175771|453908936|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126170282|NCT02175771|453908937|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126170283|NCT02175771|453908938|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126170284|NCT02175771|453908939|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126170285|NCT02175771|453908940|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126170286|NCT02175771|453908941|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126170287|NCT02175771|453908933|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
126170288|NCT02175771|453908934|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126170289|NCT02175771|453908935|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126170290|NCT02175771|453908936|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126170291|NCT02175771|453908937|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126170292|NCT02175771|453908938|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126170293|NCT02175771|453908939|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126170294|NCT02175771|453908940|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126170295|NCT02175771|453908941|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126170296|NCT02175771|453908933|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
126170297|NCT02175771|453908934|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
126170298|NCT02175771|453908935|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
126170299|NCT02175771|453908936|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
126170300|NCT02175771|453908937|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
126170301|NCT02175771|453908938|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
126170302|NCT02175771|453908939|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
126170303|NCT02175771|453908940|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
126170304|NCT02175771|453908941|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
126170305|NCT02175771|453908933|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
126170306|NCT02175771|453908934|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126170307|NCT02175771|453908935|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126170308|NCT02175771|453908936|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126170309|NCT02175771|453908937|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126170310|NCT02175771|453908938|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126170311|NCT02175771|453908939|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126170312|NCT02175771|453908940|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126170313|NCT02175771|453908941|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126170314|NCT02175771|453908933|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
126170315|NCT02175771|453908934|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126170316|NCT02175771|453908935|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126170317|NCT02175771|453908936|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126170318|NCT02175771|453908937|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126170319|NCT02175771|453908938|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126170320|NCT02175771|453908939|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126170321|NCT02175771|453908940|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126170322|NCT02175771|453908941|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126170323|NCT02175771|453908933|FG000|Run-In Period (Pre-assignment)|Other|8|||
126170324|NCT02175771|453908934|FG001|Run-In Period (Pre-assignment)|Other|0|||
126170325|NCT02175771|453908935|FG002|Run-In Period (Pre-assignment)|Other|0|||
126170326|NCT02175771|453908936|FG003|Run-In Period (Pre-assignment)|Other|0|||
126170327|NCT02175771|453908937|FG004|Run-In Period (Pre-assignment)|Other|0|||
126170328|NCT02175771|453908938|FG005|Run-In Period (Pre-assignment)|Other|0|||
126170329|NCT02175771|453908939|FG006|Run-In Period (Pre-assignment)|Other|0|||
126170330|NCT02175771|453908940|FG007|Run-In Period (Pre-assignment)|Other|0|||
126170331|NCT02175771|453908941|FG008|Run-In Period (Pre-assignment)|Other|0|||
126170332|NCT02175771|453908933|FG000|Treatment Period|Adverse Event|0|||
126170333|NCT02175771|453908934|FG001|Treatment Period|Adverse Event|2|||
126170334|NCT02175771|453908935|FG002|Treatment Period|Adverse Event|1|||
126170335|NCT02175771|453908936|FG003|Treatment Period|Adverse Event|1|||
126170336|NCT02175771|453908937|FG004|Treatment Period|Adverse Event|1|||
126170337|NCT02175771|453908938|FG005|Treatment Period|Adverse Event|3|||
126170338|NCT02175771|453908939|FG006|Treatment Period|Adverse Event|2|||
126170339|NCT02175771|453908940|FG007|Treatment Period|Adverse Event|0|||
126170340|NCT02175771|453908941|FG008|Treatment Period|Adverse Event|1|||
126170341|NCT02175771|453908933|FG000|Treatment Period|Withdrawal by Subject|0|||
126170342|NCT02175771|453908934|FG001|Treatment Period|Withdrawal by Subject|9|||
126170343|NCT02175771|453908935|FG002|Treatment Period|Withdrawal by Subject|3|||
126170344|NCT02175771|453908936|FG003|Treatment Period|Withdrawal by Subject|6|||
126170345|NCT02175771|453908937|FG004|Treatment Period|Withdrawal by Subject|2|||
126170346|NCT02175771|453908938|FG005|Treatment Period|Withdrawal by Subject|4|||
126170347|NCT02175771|453908939|FG006|Treatment Period|Withdrawal by Subject|2|||
126170348|NCT02175771|453908940|FG007|Treatment Period|Withdrawal by Subject|9|||
126170349|NCT02175771|453908941|FG008|Treatment Period|Withdrawal by Subject|2|||
126170350|NCT02175771|453908933|FG000|Treatment Period|Noncompliance|0|||
126170351|NCT02175771|453908934|FG001|Treatment Period|Noncompliance|1|||
126170352|NCT02175771|453908935|FG002|Treatment Period|Noncompliance|2|||
126170353|NCT02175771|453908936|FG003|Treatment Period|Noncompliance|0|||
126170354|NCT02175771|453908937|FG004|Treatment Period|Noncompliance|0|||
126170355|NCT02175771|453908938|FG005|Treatment Period|Noncompliance|0|||
126170356|NCT02175771|453908939|FG006|Treatment Period|Noncompliance|0|||
126170357|NCT02175771|453908940|FG007|Treatment Period|Noncompliance|0|||
126170358|NCT02175771|453908941|FG008|Treatment Period|Noncompliance|1|||
126170359|NCT02175771|453908933|FG000|Treatment Period|Protocol Violation|0|||
126170360|NCT02175771|453908934|FG001|Treatment Period|Protocol Violation|0|||
126170361|NCT02175771|453908935|FG002|Treatment Period|Protocol Violation|0|||
126170362|NCT02175771|453908936|FG003|Treatment Period|Protocol Violation|0|||
126170363|NCT02175771|453908937|FG004|Treatment Period|Protocol Violation|0|||
126170364|NCT02175771|453908938|FG005|Treatment Period|Protocol Violation|0|||
126170365|NCT02175771|453908939|FG006|Treatment Period|Protocol Violation|0|||
126170366|NCT02175771|453908940|FG007|Treatment Period|Protocol Violation|1|||
126170367|NCT02175771|453908941|FG008|Treatment Period|Protocol Violation|0|||
126170368|NCT02175771|453908933|FG000|Treatment Period|Disease progression|0|||
126170369|NCT02175771|453908934|FG001|Treatment Period|Disease progression|0|||
126170370|NCT02175771|453908935|FG002|Treatment Period|Disease progression|0|||
126170371|NCT02175771|453908936|FG003|Treatment Period|Disease progression|0|||
126170372|NCT02175771|453908937|FG004|Treatment Period|Disease progression|0|||
126170373|NCT02175771|453908938|FG005|Treatment Period|Disease progression|0|||
126170374|NCT02175771|453908939|FG006|Treatment Period|Disease progression|0|||
126170375|NCT02175771|453908940|FG007|Treatment Period|Disease progression|2|||
126170376|NCT02175771|453908941|FG008|Treatment Period|Disease progression|0|||
126170377|NCT02175771|453908933|FG000|Treatment Period|Lost to Follow-up|0|||
126170378|NCT02175771|453908934|FG001|Treatment Period|Lost to Follow-up|3|||
126170379|NCT02175771|453908935|FG002|Treatment Period|Lost to Follow-up|1|||
126170380|NCT02175771|453908936|FG003|Treatment Period|Lost to Follow-up|3|||
126170381|NCT02175771|453908937|FG004|Treatment Period|Lost to Follow-up|1|||
126170382|NCT02175771|453908938|FG005|Treatment Period|Lost to Follow-up|2|||
126170383|NCT02175771|453908939|FG006|Treatment Period|Lost to Follow-up|1|||
126170384|NCT02175771|453908940|FG007|Treatment Period|Lost to Follow-up|2|||
126170385|NCT02175771|453908941|FG008|Treatment Period|Lost to Follow-up|2|||
126170386|NCT02175771|453908933|FG000|Treatment Period|Lack of Efficacy|0|||
126170387|NCT02175771|453908934|FG001|Treatment Period|Lack of Efficacy|0|||
126170388|NCT02175771|453908935|FG002|Treatment Period|Lack of Efficacy|0|||
126170389|NCT02175771|453908936|FG003|Treatment Period|Lack of Efficacy|0|||
126170390|NCT02175771|453908937|FG004|Treatment Period|Lack of Efficacy|0|||
125973580|NCT02811861|453193121|FG001|Overall Study|Withdrawal by Subject|4|||
125973581|NCT02811861|453193122|FG002|Overall Study|Withdrawal by Subject|9|||
125973582|NCT02811861|453193120|FG000|Overall Study|Other|4|||
125973583|NCT02811861|453193121|FG001|Overall Study|Other|13|||
125973584|NCT02811861|453193122|FG002|Overall Study|Other|3|||
125973585|NCT02811861|453193120|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
125973586|NCT02811861|453193121|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
125973587|NCT02811861|453193122|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
125973588|NCT02811861|453193120|FG000|Overall Study|Randomized but not treated|2|||
125973589|NCT02811861|453193121|FG001|Overall Study|Randomized but not treated|3|||
125973590|NCT02811861|453193122|FG002|Overall Study|Randomized but not treated|17|||
125973591|NCT02925455|453193123|FG000|Overall Study|Withdrawal by Subject|2|||
125973592|NCT02925455|453193124|FG001|Overall Study|Withdrawal by Subject|0|||
125973593|NCT00360308|453193125|FG000|Overall Study|Adverse Event|15|||
126170391|NCT02175771|453908938|FG005|Treatment Period|Lack of Efficacy|1|||
126170392|NCT02175771|453908939|FG006|Treatment Period|Lack of Efficacy|0|||
126170393|NCT02175771|453908940|FG007|Treatment Period|Lack of Efficacy|1|||
126170394|NCT02175771|453908941|FG008|Treatment Period|Lack of Efficacy|0|||
126170395|NCT02175771|453908933|FG000|Treatment Period|Other|0|||
126170396|NCT02175771|453908934|FG001|Treatment Period|Other|1|||
126170397|NCT02175771|453908935|FG002|Treatment Period|Other|0|||
126170398|NCT02175771|453908936|FG003|Treatment Period|Other|3|||
126170399|NCT02175771|453908937|FG004|Treatment Period|Other|1|||
126170400|NCT02175771|453908938|FG005|Treatment Period|Other|0|||
126170401|NCT02175771|453908939|FG006|Treatment Period|Other|0|||
126170402|NCT02175771|453908940|FG007|Treatment Period|Other|2|||
126170403|NCT02175771|453908941|FG008|Treatment Period|Other|0|||
126170404|NCT00579501|453908946|FG000|Overall Study|Death|1|||
126170405|NCT00579501|453908946|FG000|Overall Study|End of neoadjuvant therapy|25|||
126170406|NCT00579501|453908946|FG000|Overall Study|toxicity|1|||
126170407|NCT00579501|453908946|FG000|Overall Study|Secondary lesion|1|||
126170408|NCT00579501|453908946|FG000|Overall Study|Radiation therapy before surgery|1|||
126170409|NCT03364673|453908947|FG000|Overall Study|Withdrawal by Subject|2|||
126170410|NCT03364673|453908947|FG000|Overall Study|Injury unrelated to study|3|||
126170411|NCT02232087|453908948|FG000|Overall Study|Withdrawal by Subject|2|||
126170412|NCT02232087|453908949|FG001|Overall Study|Withdrawal by Subject|0|||
126170413|NCT02232087|453908950|FG002|Overall Study|Withdrawal by Subject|0|||
126170414|NCT02232087|453908951|FG003|Overall Study|Withdrawal by Subject|0|||
126170415|NCT02232087|453908952|FG004|Overall Study|Withdrawal by Subject|0|||
126170416|NCT02232087|453908953|FG005|Overall Study|Withdrawal by Subject|1|||
126170417|NCT02232087|453908948|FG000|Overall Study|poor inhalation technique|0|||
126170418|NCT02232087|453908949|FG001|Overall Study|poor inhalation technique|1|||
126170419|NCT02232087|453908950|FG002|Overall Study|poor inhalation technique|0|||
125973594|NCT00360308|453193126|FG001|Overall Study|Adverse Event|14|||
125973595|NCT00360308|453193127|FG002|Overall Study|Adverse Event|25|||
125973596|NCT00360308|453193125|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
125973597|NCT00360308|453193126|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
125973598|NCT00360308|453193127|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
125973599|NCT00360308|453193125|FG000|Overall Study|Protocol Violation|2|||
125973600|NCT00360308|453193126|FG001|Overall Study|Protocol Violation|1|||
125973601|NCT00360308|453193127|FG002|Overall Study|Protocol Violation|2|||
125973602|NCT00360308|453193125|FG000|Overall Study|Withdrawal by Subject|11|||
125973603|NCT00360308|453193126|FG001|Overall Study|Withdrawal by Subject|7|||
125973604|NCT00360308|453193127|FG002|Overall Study|Withdrawal by Subject|14|||
125973605|NCT00360308|453193125|FG000|Overall Study|Lack of Efficacy|3|||
125973606|NCT00360308|453193126|FG001|Overall Study|Lack of Efficacy|0|||
125973607|NCT00360308|453193127|FG002|Overall Study|Lack of Efficacy|2|||
125973608|NCT00360308|453193125|FG000|Overall Study|Other|2|||
125973609|NCT00360308|453193126|FG001|Overall Study|Other|1|||
125973610|NCT00360308|453193127|FG002|Overall Study|Other|1|||
125973611|NCT00360308|453193125|FG000|Overall Study|Study termination by sponsor|43|||
125973612|NCT00360308|453193126|FG001|Overall Study|Study termination by sponsor|55|||
125973613|NCT00360308|453193127|FG002|Overall Study|Study termination by sponsor|44|||
125973614|NCT02732938|453193128|FG000|Overall Study|Death|0|||
125973615|NCT02732938|453193129|FG001|Overall Study|Death|11|||
125973616|NCT02732938|453193130|FG002|Overall Study|Death|0|||
125973617|NCT02732938|453193128|FG000|Overall Study|Randomized but did not receive treatment|0|||
125973618|NCT02732938|453193129|FG001|Overall Study|Randomized but did not receive treatment|1|||
125973619|NCT02732938|453193130|FG002|Overall Study|Randomized but did not receive treatment|0|||
125973620|NCT02732938|453193128|FG000|Overall Study|Refused further follow-up|1|||
125973621|NCT02732938|453193129|FG001|Overall Study|Refused further follow-up|0|||
125973622|NCT02732938|453193130|FG002|Overall Study|Refused further follow-up|0|||
125973623|NCT02732938|453193128|FG000|Overall Study|Study terminated by sponsor|3|||
125973624|NCT02732938|453193129|FG001|Overall Study|Study terminated by sponsor|6|||
125973625|NCT02732938|453193130|FG002|Overall Study|Study terminated by sponsor|0|||
125973626|NCT03927950|453193131|FG000|Overall Study|Adverse Event|9|||
125973627|NCT04530448|453193132|FG000|Overall Study|Physician Decision|3|||
125973628|NCT04530448|453193133|FG001|Overall Study|Physician Decision|0|||
125973629|NCT02015676|453193134|FG000|Overall Study|Adverse Event|2|||
125973630|NCT02015676|453193135|FG001|Overall Study|Adverse Event|18|||
125973631|NCT02015676|453193136|FG002|Overall Study|Adverse Event|0|||
125973632|NCT02015676|453193134|FG000|Overall Study|Lack of Efficacy|2|||
125973633|NCT02015676|453193135|FG001|Overall Study|Lack of Efficacy|4|||
125973634|NCT02015676|453193136|FG002|Overall Study|Lack of Efficacy|0|||
125973635|NCT02015676|453193134|FG000|Overall Study|Protocol Violation|1|||
125973636|NCT02015676|453193135|FG001|Overall Study|Protocol Violation|0|||
126170420|NCT02232087|453908951|FG003|Overall Study|poor inhalation technique|0|||
126170421|NCT02232087|453908952|FG004|Overall Study|poor inhalation technique|0|||
125973637|NCT02015676|453193136|FG002|Overall Study|Protocol Violation|0|||
125973638|NCT02015676|453193134|FG000|Overall Study|Withdrawal by Subject|1|||
125973639|NCT02015676|453193135|FG001|Overall Study|Withdrawal by Subject|7|||
125973640|NCT02015676|453193136|FG002|Overall Study|Withdrawal by Subject|1|||
125973641|NCT02015676|453193134|FG000|Overall Study|Administrative reasons|0|||
125973642|NCT02015676|453193135|FG001|Overall Study|Administrative reasons|3|||
125973643|NCT02015676|453193136|FG002|Overall Study|Administrative reasons|1|||
125973644|NCT02015676|453193134|FG000|Overall Study|Death|0|||
125973645|NCT02015676|453193135|FG001|Overall Study|Death|1|||
125973646|NCT02015676|453193136|FG002|Overall Study|Death|0|||
125973647|NCT02015676|453193134|FG000|Overall Study|Disease progression|3|||
126170422|NCT02232087|453908953|FG005|Overall Study|poor inhalation technique|2|||
126170423|NCT02232087|453908948|FG000|Overall Study|protocol stop criteria|0|||
126170424|NCT02232087|453908949|FG001|Overall Study|protocol stop criteria|1|||
126170425|NCT02232087|453908950|FG002|Overall Study|protocol stop criteria|0|||
126170426|NCT02232087|453908951|FG003|Overall Study|protocol stop criteria|1|||
126170427|NCT02232087|453908952|FG004|Overall Study|protocol stop criteria|0|||
126170428|NCT02232087|453908953|FG005|Overall Study|protocol stop criteria|0|||
126170429|NCT02232087|453908948|FG000|Overall Study|Adverse Event|0|||
126170430|NCT02232087|453908949|FG001|Overall Study|Adverse Event|0|||
126170431|NCT02232087|453908950|FG002|Overall Study|Adverse Event|0|||
126170432|NCT02232087|453908951|FG003|Overall Study|Adverse Event|0|||
126170433|NCT02232087|453908952|FG004|Overall Study|Adverse Event|1|||
126170434|NCT02232087|453908953|FG005|Overall Study|Adverse Event|0|||
126170435|NCT02504268|453908955|FG000|Overall Study|Adverse Event|18|||
126170436|NCT02504268|453908956|FG001|Overall Study|Adverse Event|8|||
126170437|NCT02504268|453908957|FG002|Overall Study|Adverse Event|14|||
126170438|NCT02504268|453908958|FG003|Overall Study|Adverse Event|0|||
126170439|NCT02504268|453908959|FG004|Overall Study|Adverse Event|0|||
126170440|NCT02504268|453908960|FG005|Overall Study|Adverse Event|0|||
126170441|NCT02504268|453908961|FG006|Overall Study|Adverse Event|0|||
126170442|NCT02504268|453908962|FG007|Overall Study|Adverse Event|0|||
126170443|NCT02504268|453908963|FG008|Overall Study|Adverse Event|0|||
126170444|NCT02504268|453908955|FG000|Overall Study|Withdrawal of Consent|11|||
126170445|NCT02504268|453908956|FG001|Overall Study|Withdrawal of Consent|10|||
126170446|NCT02504268|453908957|FG002|Overall Study|Withdrawal of Consent|3|||
126170447|NCT02504268|453908958|FG003|Overall Study|Withdrawal of Consent|0|||
126170448|NCT02504268|453908959|FG004|Overall Study|Withdrawal of Consent|0|||
126170449|NCT02504268|453908960|FG005|Overall Study|Withdrawal of Consent|0|||
126170450|NCT02504268|453908961|FG006|Overall Study|Withdrawal of Consent|0|||
126170451|NCT02504268|453908962|FG007|Overall Study|Withdrawal of Consent|0|||
126170452|NCT02504268|453908963|FG008|Overall Study|Withdrawal of Consent|0|||
126170453|NCT02504268|453908955|FG000|Overall Study|Pregnancy|2|||
126170454|NCT02504268|453908956|FG001|Overall Study|Pregnancy|0|||
126170455|NCT02504268|453908957|FG002|Overall Study|Pregnancy|0|||
126170456|NCT02504268|453908958|FG003|Overall Study|Pregnancy|0|||
126170457|NCT02504268|453908959|FG004|Overall Study|Pregnancy|0|||
126170458|NCT02504268|453908960|FG005|Overall Study|Pregnancy|0|||
126170459|NCT02504268|453908961|FG006|Overall Study|Pregnancy|0|||
126170460|NCT02504268|453908962|FG007|Overall Study|Pregnancy|0|||
126170461|NCT02504268|453908963|FG008|Overall Study|Pregnancy|0|||
126170462|NCT02504268|453908955|FG000|Overall Study|Lost to Follow-up|3|||
126170463|NCT02504268|453908956|FG001|Overall Study|Lost to Follow-up|6|||
126170464|NCT02504268|453908957|FG002|Overall Study|Lost to Follow-up|4|||
126170465|NCT02504268|453908958|FG003|Overall Study|Lost to Follow-up|0|||
126170466|NCT02504268|453908959|FG004|Overall Study|Lost to Follow-up|0|||
126170467|NCT02504268|453908960|FG005|Overall Study|Lost to Follow-up|0|||
126170468|NCT02504268|453908961|FG006|Overall Study|Lost to Follow-up|0|||
126170469|NCT02504268|453908962|FG007|Overall Study|Lost to Follow-up|0|||
126170470|NCT02504268|453908963|FG008|Overall Study|Lost to Follow-up|0|||
126170471|NCT02504268|453908955|FG000|Overall Study|Death|1|||
126170472|NCT02504268|453908956|FG001|Overall Study|Death|1|||
125973648|NCT02015676|453193135|FG001|Overall Study|Disease progression|1|||
125973649|NCT02015676|453193136|FG002|Overall Study|Disease progression|1|||
125973650|NCT02701985|453193137|FG000|Overall Study|Withdrawal by Subject|1|||
125973651|NCT02701985|453193138|FG001|Overall Study|Withdrawal by Subject|1|||
125973652|NCT02701985|453193137|FG000|Overall Study|Lost to Follow-up|1|||
125973653|NCT02701985|453193138|FG001|Overall Study|Lost to Follow-up|0|||
125973654|NCT02701985|453193137|FG000|Overall Study|Death|1|||
125973655|NCT02701985|453193138|FG001|Overall Study|Death|0|||
125973656|NCT02701985|453193137|FG000|Overall Study|Adverse Event|0|||
125973657|NCT02701985|453193138|FG001|Overall Study|Adverse Event|5|||
125973658|NCT01640808|453193139|FG000|Overall Study|Unable to continue dynamic CT|14|||
125973659|NCT01640808|453193140|FG001|Overall Study|Unable to continue dynamic CT|4|||
125973660|NCT01640808|453193139|FG000|Overall Study|Withdrawal by Subject|12|||
125973661|NCT01640808|453193140|FG001|Overall Study|Withdrawal by Subject|4|||
125973662|NCT01640808|453193139|FG000|Overall Study|Lost to Follow-up|4|||
125973663|NCT01640808|453193140|FG001|Overall Study|Lost to Follow-up|0|||
125973664|NCT01640808|453193139|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
125973665|NCT01640808|453193140|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
126170473|NCT02504268|453908957|FG002|Overall Study|Death|0|||
126170474|NCT02504268|453908958|FG003|Overall Study|Death|0|||
126170475|NCT02504268|453908959|FG004|Overall Study|Death|0|||
126170476|NCT02504268|453908960|FG005|Overall Study|Death|0|||
126170477|NCT02504268|453908961|FG006|Overall Study|Death|0|||
126170478|NCT02504268|453908962|FG007|Overall Study|Death|0|||
125973666|NCT01640808|453193139|FG000|Overall Study|Administration of anticancer drugs|2|||
125973667|NCT01640808|453193140|FG001|Overall Study|Administration of anticancer drugs|1|||
126170479|NCT02504268|453908963|FG008|Overall Study|Death|0|||
126170480|NCT02504268|453908955|FG000|Overall Study|Subject Request to Discontinue|11|||
126170481|NCT02504268|453908956|FG001|Overall Study|Subject Request to Discontinue|3|||
126170482|NCT02504268|453908957|FG002|Overall Study|Subject Request to Discontinue|6|||
126170483|NCT02504268|453908958|FG003|Overall Study|Subject Request to Discontinue|0|||
126170484|NCT02504268|453908959|FG004|Overall Study|Subject Request to Discontinue|0|||
126170485|NCT02504268|453908960|FG005|Overall Study|Subject Request to Discontinue|0|||
126170486|NCT02504268|453908961|FG006|Overall Study|Subject Request to Discontinue|0|||
126170487|NCT02504268|453908962|FG007|Overall Study|Subject Request to Discontinue|0|||
126170488|NCT02504268|453908963|FG008|Overall Study|Subject Request to Discontinue|0|||
126170489|NCT02504268|453908955|FG000|Overall Study|No Longer Meets Study Criteria|2|||
126170490|NCT02504268|453908956|FG001|Overall Study|No Longer Meets Study Criteria|3|||
126170491|NCT02504268|453908957|FG002|Overall Study|No Longer Meets Study Criteria|0|||
126170492|NCT02504268|453908958|FG003|Overall Study|No Longer Meets Study Criteria|0|||
126170493|NCT02504268|453908959|FG004|Overall Study|No Longer Meets Study Criteria|0|||
126170494|NCT02504268|453908960|FG005|Overall Study|No Longer Meets Study Criteria|0|||
126170495|NCT02504268|453908961|FG006|Overall Study|No Longer Meets Study Criteria|0|||
126170496|NCT02504268|453908962|FG007|Overall Study|No Longer Meets Study Criteria|0|||
126170497|NCT02504268|453908963|FG008|Overall Study|No Longer Meets Study Criteria|0|||
126170498|NCT02504268|453908955|FG000|Overall Study|Lack of Efficacy|11|||
126170499|NCT02504268|453908956|FG001|Overall Study|Lack of Efficacy|35|||
126170500|NCT02504268|453908957|FG002|Overall Study|Lack of Efficacy|9|||
126170501|NCT02504268|453908958|FG003|Overall Study|Lack of Efficacy|0|||
126170502|NCT02504268|453908959|FG004|Overall Study|Lack of Efficacy|0|||
126170503|NCT02504268|453908960|FG005|Overall Study|Lack of Efficacy|0|||
126170504|NCT02504268|453908961|FG006|Overall Study|Lack of Efficacy|0|||
126170505|NCT02504268|453908962|FG007|Overall Study|Lack of Efficacy|0|||
126170506|NCT02504268|453908963|FG008|Overall Study|Lack of Efficacy|0|||
126170507|NCT02504268|453908955|FG000|Overall Study|Poor/Non-Compliance|3|||
126170508|NCT02504268|453908956|FG001|Overall Study|Poor/Non-Compliance|2|||
126170509|NCT02504268|453908957|FG002|Overall Study|Poor/Non-Compliance|3|||
126170510|NCT02504268|453908958|FG003|Overall Study|Poor/Non-Compliance|0|||
126170511|NCT02504268|453908959|FG004|Overall Study|Poor/Non-Compliance|0|||
126170512|NCT02504268|453908960|FG005|Overall Study|Poor/Non-Compliance|0|||
126170513|NCT02504268|453908961|FG006|Overall Study|Poor/Non-Compliance|0|||
126170514|NCT02504268|453908962|FG007|Overall Study|Poor/Non-Compliance|0|||
126170515|NCT02504268|453908963|FG008|Overall Study|Poor/Non-Compliance|0|||
126170516|NCT02504268|453908955|FG000|Overall Study|Not Disclosed|1|||
126170517|NCT02504268|453908956|FG001|Overall Study|Not Disclosed|0|||
126170518|NCT02504268|453908957|FG002|Overall Study|Not Disclosed|2|||
126170519|NCT02504268|453908958|FG003|Overall Study|Not Disclosed|0|||
126170520|NCT02504268|453908959|FG004|Overall Study|Not Disclosed|0|||
126170521|NCT02504268|453908960|FG005|Overall Study|Not Disclosed|0|||
126170522|NCT02504268|453908961|FG006|Overall Study|Not Disclosed|0|||
126170523|NCT02504268|453908962|FG007|Overall Study|Not Disclosed|0|||
126170524|NCT02504268|453908963|FG008|Overall Study|Not Disclosed|0|||
126170525|NCT03025217|453908964|FG000|Overall Study|Pregnancy|1|||
126170526|NCT03025217|453908964|FG000|Overall Study|Lost to Follow-up|1|||
126170527|NCT03025217|453908964|FG000|Overall Study|Not eligible, poor English|2|||
126170528|NCT04069156|453908965|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
126170529|NCT04069156|453908966|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
126170530|NCT04069156|453908965|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
126170531|NCT04069156|453908966|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
126170532|NCT04069156|453908965|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
126170533|NCT04069156|453908966|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
126170534|NCT04069156|453908965|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
126170535|NCT04069156|453908966|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
126170536|NCT02208024|453908967|FG000|Overall Study|Withdrawal by Subject|1|||
126170537|NCT02207556|453908968|FG000|Overall Study|Physician Decision|1|||
126170538|NCT02207556|453908969|FG001|Overall Study|Physician Decision|0|||
126170539|NCT02207556|453908968|FG000|Overall Study|Withdrawal by Subject|1|||
126170540|NCT02207556|453908969|FG001|Overall Study|Withdrawal by Subject|0|||
126170541|NCT02207556|453908968|FG000|Overall Study|Death|0|||
126170542|NCT02207556|453908969|FG001|Overall Study|Death|5|||
126170543|NCT03558555|453908970|FG000|Overall Study|Lost to Follow-up|2|||
126170544|NCT03558555|453908971|FG001|Overall Study|Lost to Follow-up|1|||
126170545|NCT01958125|453908972|FG000|Overall Study|Missing diary data|2|||
126170546|NCT01958125|453908973|FG001|Overall Study|Missing diary data|6|||
126170547|NCT01958125|453908972|FG000|Overall Study|No headache attacks|0|||
125973668|NCT01640808|453193139|FG000|Overall Study|Physician Decision|19|||
125973669|NCT01640808|453193140|FG001|Overall Study|Physician Decision|5|||
126170548|NCT01958125|453908973|FG001|Overall Study|No headache attacks|2|||
126170549|NCT00194025|453908974|FG000|Overall Study|Adverse Event|1|||
126170550|NCT00194025|453908974|FG000|Overall Study|non-adherence with study medication|4|||
126170551|NCT04804033|453908978|FG000|Period 1: DBT Phase|Adverse Event|1|||
126170552|NCT04804033|453908979|FG001|Period 1: DBT Phase|Adverse Event|5|||
126170553|NCT04804033|453908980|FG002|Period 1: DBT Phase|Adverse Event|3|||
126170554|NCT04804033|453908981|FG003|Period 1: DBT Phase|Adverse Event|4|||
126170555|NCT04804033|453908978|FG000|Period 1: DBT Phase|Death|1|||
126170556|NCT04804033|453908979|FG001|Period 1: DBT Phase|Death|0|||
126170557|NCT04804033|453908980|FG002|Period 1: DBT Phase|Death|0|||
125973670|NCT01640808|453193139|FG000|Overall Study|Randomized but not treated|4|||
126170558|NCT04804033|453908981|FG003|Period 1: DBT Phase|Death|0|||
126170559|NCT04804033|453908978|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
126170560|NCT04804033|453908979|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
126170561|NCT04804033|453908980|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
126170562|NCT04804033|453908981|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
126170563|NCT04804033|453908978|FG000|Period 1: DBT Phase|Non-compliance|1|||
126170564|NCT04804033|453908979|FG001|Period 1: DBT Phase|Non-compliance|0|||
126170565|NCT04804033|453908980|FG002|Period 1: DBT Phase|Non-compliance|1|||
126170566|NCT04804033|453908981|FG003|Period 1: DBT Phase|Non-compliance|2|||
126170567|NCT04804033|453908978|FG000|Period 1: DBT Phase|Other|0|||
126170568|NCT04804033|453908979|FG001|Period 1: DBT Phase|Other|1|||
126170569|NCT04804033|453908980|FG002|Period 1: DBT Phase|Other|0|||
126170570|NCT04804033|453908981|FG003|Period 1: DBT Phase|Other|0|||
126170571|NCT04804033|453908978|FG000|Period 1: DBT Phase|Pregnancy|2|||
126170572|NCT04804033|453908979|FG001|Period 1: DBT Phase|Pregnancy|0|||
126170573|NCT04804033|453908980|FG002|Period 1: DBT Phase|Pregnancy|0|||
126170574|NCT04804033|453908981|FG003|Period 1: DBT Phase|Pregnancy|0|||
126170575|NCT04804033|453908978|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
126170576|NCT04804033|453908979|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
126170577|NCT04804033|453908980|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
126170578|NCT04804033|453908981|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
126170579|NCT04804033|453908978|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
126170580|NCT04804033|453908979|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
126170581|NCT04804033|453908980|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
126170582|NCT04804033|453908981|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
126170583|NCT04804033|453908978|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
126170584|NCT04804033|453908979|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
126170585|NCT04804033|453908980|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
126170586|NCT04804033|453908981|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
126170587|NCT04804033|453908978|FG000|Period 2: OLE Phase|Adverse Event|3|||
126170588|NCT04804033|453908979|FG001|Period 2: OLE Phase|Adverse Event|4|||
126170589|NCT04804033|453908980|FG002|Period 2: OLE Phase|Adverse Event|2|||
126170590|NCT04804033|453908981|FG003|Period 2: OLE Phase|Adverse Event|0|||
126170591|NCT04804033|453908978|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
126170592|NCT04804033|453908979|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
126170593|NCT04804033|453908980|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
126170594|NCT04804033|453908981|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
126170595|NCT04804033|453908978|FG000|Period 2: OLE Phase|Non-compliance|2|||
126170596|NCT04804033|453908979|FG001|Period 2: OLE Phase|Non-compliance|2|||
126170597|NCT04804033|453908980|FG002|Period 2: OLE Phase|Non-compliance|0|||
126170598|NCT04804033|453908981|FG003|Period 2: OLE Phase|Non-compliance|1|||
126170599|NCT04804033|453908978|FG000|Period 2: OLE Phase|Other|0|||
126170600|NCT04804033|453908979|FG001|Period 2: OLE Phase|Other|2|||
126170601|NCT04804033|453908980|FG002|Period 2: OLE Phase|Other|0|||
126170602|NCT04804033|453908981|FG003|Period 2: OLE Phase|Other|0|||
126170603|NCT04804033|453908978|FG000|Period 2: OLE Phase|Physician Decision|1|||
126170604|NCT04804033|453908979|FG001|Period 2: OLE Phase|Physician Decision|1|||
126170605|NCT04804033|453908980|FG002|Period 2: OLE Phase|Physician Decision|0|||
126170606|NCT04804033|453908981|FG003|Period 2: OLE Phase|Physician Decision|0|||
126170607|NCT04804033|453908978|FG000|Period 2: OLE Phase|Pregnancy|0|||
126170608|NCT04804033|453908979|FG001|Period 2: OLE Phase|Pregnancy|0|||
126170609|NCT04804033|453908980|FG002|Period 2: OLE Phase|Pregnancy|2|||
126170610|NCT04804033|453908981|FG003|Period 2: OLE Phase|Pregnancy|0|||
126170611|NCT04804033|453908978|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
126170612|NCT04804033|453908979|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
126170613|NCT04804033|453908980|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
126170614|NCT04804033|453908981|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
126170615|NCT04804033|453908978|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
126170616|NCT04804033|453908979|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
126170617|NCT04804033|453908980|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
126170618|NCT04804033|453908981|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
126170619|NCT04804033|453908978|FG000|Period 2: OLE Phase|Not reported|0|||
126170620|NCT04804033|453908979|FG001|Period 2: OLE Phase|Not reported|2|||
126170621|NCT04804033|453908980|FG002|Period 2: OLE Phase|Not reported|0|||
126170622|NCT04804033|453908981|FG003|Period 2: OLE Phase|Not reported|0|||
126170623|NCT04804033|453908978|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
126170624|NCT04804033|453908979|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
126170625|NCT04804033|453908980|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
126170626|NCT04804033|453908981|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
126170627|NCT04804033|453908978|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
126170628|NCT04804033|453908979|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
126170629|NCT04804033|453908980|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
126170630|NCT04804033|453908981|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
126170631|NCT04804033|453908978|FG000|Period 3: Follow-up Phase|Other|0|||
126170632|NCT04804033|453908979|FG001|Period 3: Follow-up Phase|Other|1|||
126170633|NCT04804033|453908980|FG002|Period 3: Follow-up Phase|Other|2|||
126170634|NCT04804033|453908981|FG003|Period 3: Follow-up Phase|Other|1|||
126170635|NCT04804033|453908978|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
126170636|NCT04804033|453908979|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
126170637|NCT04804033|453908980|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
126170638|NCT04804033|453908981|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
126170639|NCT04804033|453908978|FG000|Period 3: Follow-up Phase|Not reported|18|||
126170640|NCT04804033|453908979|FG001|Period 3: Follow-up Phase|Not reported|15|||
126170641|NCT04804033|453908980|FG002|Period 3: Follow-up Phase|Not reported|1|||
126170642|NCT04804033|453908981|FG003|Period 3: Follow-up Phase|Not reported|4|||
126170643|NCT00209170|453908982|FG000|Overall Study|Adverse Event|0|||
126170644|NCT00209170|453908983|FG001|Overall Study|Adverse Event|1|||
126170645|NCT00209170|453908982|FG000|Overall Study|Withdrawal by Subject|2|||
126170646|NCT00209170|453908983|FG001|Overall Study|Withdrawal by Subject|1|||
126170647|NCT00209170|453908982|FG000|Overall Study|Lack of Efficacy|0|||
126170648|NCT00209170|453908983|FG001|Overall Study|Lack of Efficacy|1|||
126170649|NCT02130427|453908984|FG000|Overall Study|Imaging results not interpretable|30|||
126170650|NCT00543569|453908989|FG000|Overall Study|Death|2|||
126170651|NCT00543569|453908990|FG001|Overall Study|Death|2|||
126170652|NCT00543569|453908991|FG002|Overall Study|Death|3|||
126170653|NCT00543569|453908992|FG003|Overall Study|Death|1|||
126170654|NCT00543569|453908989|FG000|Overall Study|Lost to Follow-up|0|||
126170655|NCT00543569|453908990|FG001|Overall Study|Lost to Follow-up|0|||
126170656|NCT00543569|453908991|FG002|Overall Study|Lost to Follow-up|1|||
126170657|NCT00543569|453908992|FG003|Overall Study|Lost to Follow-up|1|||
126170658|NCT00543569|453908989|FG000|Overall Study|Miscellaneous Reasons|7|||
126170659|NCT00543569|453908990|FG001|Overall Study|Miscellaneous Reasons|3|||
126170660|NCT00543569|453908991|FG002|Overall Study|Miscellaneous Reasons|11|||
126170661|NCT00543569|453908992|FG003|Overall Study|Miscellaneous Reasons|4|||
126170662|NCT00543569|453908989|FG000|Overall Study|Randomized but never received study drug|3|||
126170663|NCT00543569|453908990|FG001|Overall Study|Randomized but never received study drug|3|||
126170664|NCT00543569|453908991|FG002|Overall Study|Randomized but never received study drug|5|||
126170665|NCT00543569|453908992|FG003|Overall Study|Randomized but never received study drug|3|||
126170666|NCT02108600|453908993|FG000|Overall Study|Withdrawal by Subject|2|||
126170667|NCT02108600|453908994|FG001|Overall Study|Withdrawal by Subject|0|||
126170668|NCT02108600|453908993|FG000|Overall Study|Lost to Follow-up|1|||
126170669|NCT02108600|453908994|FG001|Overall Study|Lost to Follow-up|1|||
126170670|NCT03150095|453908995|FG000|Overall Study|Death|0|||
126170671|NCT03150095|453908996|FG001|Overall Study|Death|1|||
126170672|NCT03150095|453908995|FG000|Overall Study|Lost to Follow-up|1|||
126170673|NCT03150095|453908996|FG001|Overall Study|Lost to Follow-up|1|||
126170674|NCT03150095|453908995|FG000|Overall Study|Withdrawal by Subject|4|||
126170675|NCT03150095|453908996|FG001|Overall Study|Withdrawal by Subject|0|||
126170676|NCT03150095|453908995|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
126170677|NCT03150095|453908996|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
126170678|NCT04032171|453908997|FG000|Overall Study|Study Termination|1|||
126170679|NCT04032171|453908998|FG001|Overall Study|Study Termination|0|||
126170680|NCT02124707|453908999|FG000|Overall Study|Adverse Event|5|||
126170681|NCT02124707|453908999|FG000|Overall Study|Physician Decision|1|||
126170682|NCT02124707|453908999|FG000|Overall Study|Death|1|||
126170683|NCT00668200|453909006|FG000|Overall Study|Withdrawal by Subject|2|||
126170684|NCT00668200|453909006|FG000|Overall Study|Lost to Follow-up|1|||
126170685|NCT01968187|453909008|FG000|Overall Study|Adverse Event|0|||
126170686|NCT01968187|453909009|FG001|Overall Study|Adverse Event|1|||
126170687|NCT01968187|453909008|FG000|Overall Study|Randomized but not treated|1|||
126170688|NCT01968187|453909009|FG001|Overall Study|Randomized but not treated|0|||
126170689|NCT04095286|453909010|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170690|NCT04095286|453909011|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
126170691|NCT04095286|453909012|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170692|NCT04095286|453909013|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170693|NCT04095286|453909014|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170694|NCT04095286|453909015|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170695|NCT04095286|453909010|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
126170696|NCT04095286|453909011|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126170697|NCT04095286|453909012|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126170698|NCT04095286|453909013|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126170699|NCT04095286|453909014|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126170700|NCT04095286|453909015|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126170701|NCT04095286|453909010|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126170702|NCT04095286|453909011|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126170703|NCT04095286|453909012|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
126170704|NCT04095286|453909013|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126170705|NCT04095286|453909014|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126170706|NCT04095286|453909015|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126200119|NCT02394028|454017885|FG008|Induction Phase|Lack of Efficacy|0|||
126170707|NCT04095286|453909010|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170708|NCT04095286|453909011|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170709|NCT04095286|453909012|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
126170710|NCT04095286|453909013|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170711|NCT04095286|453909014|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170712|NCT04095286|453909015|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126170713|NCT04095286|453909010|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126170714|NCT04095286|453909011|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126170715|NCT04095286|453909012|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126170716|NCT04095286|453909013|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126170717|NCT04095286|453909014|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
126170718|NCT04095286|453909015|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126170719|NCT00839423|453911050|FG000|Overall Study|Adverse Event|4|||
126170720|NCT00839423|453911051|FG001|Overall Study|Adverse Event|3|||
126170721|NCT00839423|453911052|FG002|Overall Study|Adverse Event|7|||
126170722|NCT00839423|453911053|FG003|Overall Study|Adverse Event|16|||
126170723|NCT00839423|453911050|FG000|Overall Study|Lack of Efficacy|6|||
126170724|NCT00839423|453911051|FG001|Overall Study|Lack of Efficacy|6|||
126170725|NCT00839423|453911052|FG002|Overall Study|Lack of Efficacy|3|||
126170726|NCT00839423|453911053|FG003|Overall Study|Lack of Efficacy|2|||
126170727|NCT00839423|453911050|FG000|Overall Study|Non-compliance|0|||
126170728|NCT00839423|453911051|FG001|Overall Study|Non-compliance|0|||
126170729|NCT00839423|453911052|FG002|Overall Study|Non-compliance|0|||
126170730|NCT00839423|453911053|FG003|Overall Study|Non-compliance|1|||
126170731|NCT00839423|453911050|FG000|Overall Study|Protocol Violation|0|||
126170732|NCT00839423|453911051|FG001|Overall Study|Protocol Violation|1|||
126170733|NCT00839423|453911052|FG002|Overall Study|Protocol Violation|2|||
126170734|NCT00839423|453911053|FG003|Overall Study|Protocol Violation|0|||
126170735|NCT00839423|453911050|FG000|Overall Study|Withdrawal of consent|4|||
126170736|NCT00839423|453911051|FG001|Overall Study|Withdrawal of consent|0|||
126170737|NCT00839423|453911052|FG002|Overall Study|Withdrawal of consent|4|||
126170738|NCT00839423|453911053|FG003|Overall Study|Withdrawal of consent|1|||
126170739|NCT00839423|453911050|FG000|Overall Study|Lost to Follow-up|1|||
126170740|NCT00839423|453911051|FG001|Overall Study|Lost to Follow-up|0|||
126170741|NCT00839423|453911052|FG002|Overall Study|Lost to Follow-up|1|||
126170742|NCT00839423|453911053|FG003|Overall Study|Lost to Follow-up|0|||
126170743|NCT00839423|453911050|FG000|Overall Study|Administrative or other reasons|3|||
126170744|NCT00839423|453911051|FG001|Overall Study|Administrative or other reasons|0|||
126170745|NCT00839423|453911052|FG002|Overall Study|Administrative or other reasons|1|||
126170746|NCT00839423|453911053|FG003|Overall Study|Administrative or other reasons|0|||
126170747|NCT01071096|453911054|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
126170748|NCT01071096|453911055|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
126170749|NCT00756886|453911059|FG000|Overall Study|Lost to Follow-up|1|||
126170750|NCT00756886|453911060|FG001|Overall Study|Lost to Follow-up|0|||
126170751|NCT00756886|453911059|FG000|Overall Study|Adverse Event|0|||
126170752|NCT00756886|453911060|FG001|Overall Study|Adverse Event|3|||
126170753|NCT00756886|453911059|FG000|Overall Study|Lack of Efficacy|1|||
126170754|NCT00756886|453911060|FG001|Overall Study|Lack of Efficacy|0|||
126170755|NCT00756886|453911059|FG000|Overall Study|Ineligible|9|||
126170756|NCT00756886|453911060|FG001|Overall Study|Ineligible|4|||
126170757|NCT03421964|453911061|FG000|Overall Study|Lost to Follow-up|11|||
126170758|NCT03421964|453911062|FG001|Overall Study|Lost to Follow-up|21|||
126170759|NCT03421964|453911061|FG000|Overall Study|Withdrawal by Subject|9|||
126170760|NCT03421964|453911062|FG001|Overall Study|Withdrawal by Subject|3|||
126170761|NCT03421964|453911061|FG000|Overall Study|Incarcerated|1|||
126170762|NCT03421964|453911062|FG001|Overall Study|Incarcerated|0|||
126170763|NCT03421964|453911061|FG000|Overall Study|Inpt Treatment Facility|1|||
126170764|NCT03421964|453911062|FG001|Overall Study|Inpt Treatment Facility|1|||
126170765|NCT03421964|453911061|FG000|Overall Study|Virtual Platform Issues|1|||
126170766|NCT03421964|453911062|FG001|Overall Study|Virtual Platform Issues|1|||
126170767|NCT00992784|453911063|FG000|Overall Study|Adverse Event|2|||
126170768|NCT00992784|453911064|FG001|Overall Study|Adverse Event|1|||
126170769|NCT00992784|453911065|FG002|Overall Study|Adverse Event|0|||
126170770|NCT00992784|453911063|FG000|Overall Study|Withdrawal by Subject|1|||
126170771|NCT00992784|453911064|FG001|Overall Study|Withdrawal by Subject|1|||
126170772|NCT00992784|453911065|FG002|Overall Study|Withdrawal by Subject|1|||
126170773|NCT02108951|453911069|FG000|Overall Study|Lost to Follow-up|1|||
126170774|NCT02108951|453911069|FG000|Overall Study|Patient's/guardian's decision|1|||
126170775|NCT02108951|453911069|FG000|Overall Study|Study Terminated by Sponsor|14|||
126170776|NCT00718666|453911070|FG000|Booster Phase Year 5|No active participation request|0|||
126170777|NCT00718666|453911071|FG001|Booster Phase Year 5|No active participation request|0|||
126170778|NCT00718666|453911072|FG002|Booster Phase Year 5|No active participation request|1|||
126170779|NCT00718666|453911070|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
126170780|NCT00718666|453911071|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
126170781|NCT00718666|453911072|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
126170782|NCT00718666|453911070|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
126170783|NCT00718666|453911071|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
126170784|NCT00718666|453911072|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
126170785|NCT00718666|453911070|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
126170786|NCT00718666|453911071|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
126170787|NCT00718666|453911072|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
126170788|NCT00421343|453911075|FG000|Overall Study|Death|1|||
126170789|NCT00421343|453911075|FG000|Overall Study|Withdrawal by Subject|2|||
126170790|NCT00421343|453911075|FG000|Overall Study|Lost to Follow-up|3|||
126170791|NCT03471767|453911081|FG000|Overall Study|Withdrawal by Subject|3|||
126170792|NCT03471767|453911082|FG001|Overall Study|Withdrawal by Subject|1|||
126170793|NCT03471767|453911081|FG000|Overall Study|Adverse Event|1|||
126170794|NCT03471767|453911082|FG001|Overall Study|Adverse Event|0|||
126170795|NCT03471767|453911081|FG000|Overall Study|Lost to Follow-up|1|||
126170796|NCT03471767|453911082|FG001|Overall Study|Lost to Follow-up|0|||
126170797|NCT03471767|453911081|FG000|Overall Study|PI Withdrawal|1|||
126170798|NCT03471767|453911082|FG001|Overall Study|PI Withdrawal|3|||
126170799|NCT00678587|453911083|FG000|Overall Study|Adverse Event|3|||
126170800|NCT00678587|453911084|FG001|Overall Study|Adverse Event|3|||
126170801|NCT00678587|453911083|FG000|Overall Study|Lack of Efficacy|1|||
126170802|NCT00678587|453911084|FG001|Overall Study|Lack of Efficacy|0|||
126170803|NCT00678587|453911083|FG000|Overall Study|Protocol Violation|2|||
126170804|NCT00678587|453911084|FG001|Overall Study|Protocol Violation|1|||
126170805|NCT00678587|453911083|FG000|Overall Study|Study Closed/Terminated|1|||
126170806|NCT00678587|453911084|FG001|Overall Study|Study Closed/Terminated|0|||
126170807|NCT00678587|453911083|FG000|Overall Study|Lost to Follow-up|3|||
126170808|NCT00678587|453911084|FG001|Overall Study|Lost to Follow-up|5|||
126170809|NCT00678587|453911083|FG000|Overall Study|Investigator Discretion|2|||
126170810|NCT00678587|453911084|FG001|Overall Study|Investigator Discretion|6|||
126170811|NCT00678587|453911083|FG000|Overall Study|Withdrew Consent|8|||
126170812|NCT00678587|453911084|FG001|Overall Study|Withdrew Consent|3|||
126170813|NCT03806179|453911085|FG000|Overall Study|Progressive disease|0|||
126170814|NCT03806179|453911086|FG001|Overall Study|Progressive disease|2|||
126170815|NCT01952730|453911089|FG000|Overall Study|FDA shut down core lab used by study|1|||
126170816|NCT01357915|453911094|FG000|Overall Study|Lost to Follow-up|3|||
126170817|NCT01357915|453911095|FG001|Overall Study|Lost to Follow-up|0|||
126170818|NCT00305253|453911096|FG000|Overall Study|Withdrawal by Subject|0|||
126170819|NCT00305253|453911097|FG001|Overall Study|Withdrawal by Subject|1|||
126170820|NCT05373706|453911101|FG000|Overall Study|Lost to Follow-up|2|||
126170821|NCT05373706|453911102|FG001|Overall Study|Lost to Follow-up|2|||
126170822|NCT01479374|453911107|FG000|Overall Study|Adverse Event|2|||
126170823|NCT01479374|453911108|FG001|Overall Study|Adverse Event|1|||
126170824|NCT01479374|453911109|FG002|Overall Study|Adverse Event|0|||
126170825|NCT01479374|453911107|FG000|Overall Study|Lost to Follow-up|1|||
126170826|NCT01479374|453911108|FG001|Overall Study|Lost to Follow-up|2|||
126170827|NCT01479374|453911109|FG002|Overall Study|Lost to Follow-up|0|||
126170828|NCT01479374|453911107|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
126170829|NCT01479374|453911108|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
126170830|NCT01479374|453911109|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
126170831|NCT01479374|453911107|FG000|Overall Study|Other|0|||
126170832|NCT01479374|453911108|FG001|Overall Study|Other|4|||
126170833|NCT01479374|453911109|FG002|Overall Study|Other|5|||
126170834|NCT01606761|453911110|FG000|Prior to Week 24|Lost to Follow-up|0|||
126170835|NCT01606761|453911111|FG001|Prior to Week 24|Lost to Follow-up|3|||
126170836|NCT01606761|453911112|FG002|Prior to Week 24|Lost to Follow-up|2|||
126170837|NCT01606761|453911113|FG003|Prior to Week 24|Lost to Follow-up|0|||
126170838|NCT01606761|453911114|FG004|Prior to Week 24|Lost to Follow-up|0|||
126170839|NCT01606761|453911110|FG000|Prior to Week 24|Withdrawal by Subject|12|||
126170840|NCT01606761|453911111|FG001|Prior to Week 24|Withdrawal by Subject|10|||
126170841|NCT01606761|453911112|FG002|Prior to Week 24|Withdrawal by Subject|9|||
126170842|NCT01606761|453911113|FG003|Prior to Week 24|Withdrawal by Subject|0|||
126170843|NCT01606761|453911114|FG004|Prior to Week 24|Withdrawal by Subject|0|||
126170844|NCT01606761|453911110|FG000|Prior to Week 24|Adverse Event|11|||
126170845|NCT01606761|453911111|FG001|Prior to Week 24|Adverse Event|18|||
126170846|NCT01606761|453911112|FG002|Prior to Week 24|Adverse Event|22|||
126170847|NCT01606761|453911113|FG003|Prior to Week 24|Adverse Event|0|||
126170848|NCT01606761|453911114|FG004|Prior to Week 24|Adverse Event|0|||
126170849|NCT01606761|453911110|FG000|Prior to Week 24|Lack of Efficacy|15|||
126170850|NCT01606761|453911111|FG001|Prior to Week 24|Lack of Efficacy|14|||
126170851|NCT01606761|453911112|FG002|Prior to Week 24|Lack of Efficacy|8|||
126170852|NCT01606761|453911113|FG003|Prior to Week 24|Lack of Efficacy|0|||
126170853|NCT01606761|453911114|FG004|Prior to Week 24|Lack of Efficacy|0|||
126170854|NCT01606761|453911110|FG000|Prior to Week 24|Physician Decision|0|||
126170855|NCT01606761|453911111|FG001|Prior to Week 24|Physician Decision|3|||
126170856|NCT01606761|453911112|FG002|Prior to Week 24|Physician Decision|1|||
126170857|NCT01606761|453911113|FG003|Prior to Week 24|Physician Decision|0|||
126170858|NCT01606761|453911114|FG004|Prior to Week 24|Physician Decision|0|||
126170859|NCT01606761|453911110|FG000|Prior to Week 24|Other|4|||
126170860|NCT01606761|453911111|FG001|Prior to Week 24|Other|7|||
126170861|NCT01606761|453911112|FG002|Prior to Week 24|Other|5|||
126170862|NCT01606761|453911113|FG003|Prior to Week 24|Other|0|||
126170863|NCT01606761|453911114|FG004|Prior to Week 24|Other|0|||
126170864|NCT01606761|453911110|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
126170865|NCT01606761|453911111|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
126170866|NCT01606761|453911112|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
126170867|NCT01606761|453911113|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
126170868|NCT01606761|453911114|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
126170869|NCT01606761|453911110|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
126170870|NCT01606761|453911111|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
126170871|NCT01606761|453911112|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
126170872|NCT01606761|453911113|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
126170873|NCT01606761|453911114|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
126170874|NCT01606761|453911110|FG000|Week 24 to Week 52|Adverse Event|0|||
126170875|NCT01606761|453911111|FG001|Week 24 to Week 52|Adverse Event|11|||
126170876|NCT01606761|453911112|FG002|Week 24 to Week 52|Adverse Event|14|||
126170877|NCT01606761|453911113|FG003|Week 24 to Week 52|Adverse Event|3|||
126170878|NCT01606761|453911114|FG004|Week 24 to Week 52|Adverse Event|15|||
126170879|NCT01606761|453911110|FG000|Week 24 to Week 52|Death|0|||
126170880|NCT01606761|453911111|FG001|Week 24 to Week 52|Death|0|||
126170881|NCT01606761|453911112|FG002|Week 24 to Week 52|Death|2|||
126170882|NCT01606761|453911113|FG003|Week 24 to Week 52|Death|1|||
126170883|NCT01606761|453911114|FG004|Week 24 to Week 52|Death|0|||
126170884|NCT01606761|453911110|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
126170885|NCT01606761|453911111|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
126170886|NCT01606761|453911112|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
126170887|NCT01606761|453911113|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
126170888|NCT01606761|453911114|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
126170889|NCT01606761|453911110|FG000|Week 24 to Week 52|Physician Decision|0|||
126170890|NCT01606761|453911111|FG001|Week 24 to Week 52|Physician Decision|1|||
126170891|NCT01606761|453911112|FG002|Week 24 to Week 52|Physician Decision|1|||
126170892|NCT01606761|453911113|FG003|Week 24 to Week 52|Physician Decision|0|||
126170893|NCT01606761|453911114|FG004|Week 24 to Week 52|Physician Decision|0|||
126170894|NCT01606761|453911110|FG000|Week 24 to Week 52|Other|0|||
126170895|NCT01606761|453911111|FG001|Week 24 to Week 52|Other|1|||
126170896|NCT01606761|453911112|FG002|Week 24 to Week 52|Other|5|||
126170897|NCT01606761|453911113|FG003|Week 24 to Week 52|Other|2|||
126170898|NCT01606761|453911114|FG004|Week 24 to Week 52|Other|2|||
126170899|NCT01606761|453911110|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
126170900|NCT01606761|453911111|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
126170901|NCT01606761|453911112|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
126170902|NCT01606761|453911113|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
126170903|NCT01606761|453911114|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
126170904|NCT01606761|453911110|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
126170905|NCT01606761|453911111|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
126170906|NCT01606761|453911112|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
126170907|NCT01606761|453911113|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
126170908|NCT01606761|453911114|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
126170909|NCT01606761|453911110|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
126170910|NCT01606761|453911111|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
126170911|NCT01606761|453911112|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
126170912|NCT01606761|453911113|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
126170913|NCT01606761|453911114|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
126170914|NCT01606761|453911110|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
126170915|NCT01606761|453911111|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
126170916|NCT01606761|453911112|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
126170917|NCT01606761|453911113|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
126170918|NCT01606761|453911114|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
125973671|NCT01640808|453193140|FG001|Overall Study|Randomized but not treated|2|||
126170919|NCT05086289|453911115|FG000|Overall Study|Adverse Event|4|||
126170920|NCT05086289|453911116|FG001|Overall Study|Adverse Event|2|||
126170921|NCT05086289|453911115|FG000|Overall Study|Lost to Follow-up|2|||
126170922|NCT05086289|453911116|FG001|Overall Study|Lost to Follow-up|0|||
126170923|NCT05086289|453911115|FG000|Overall Study|Non-compliance with study drug|2|||
126170924|NCT05086289|453911116|FG001|Overall Study|Non-compliance with study drug|1|||
125973672|NCT04391023|453193141|FG000|Overall Study|Withdrawal by Subject|2|||
126170925|NCT05086289|453911115|FG000|Overall Study|Physician Decision|2|||
126170926|NCT05086289|453911116|FG001|Overall Study|Physician Decision|0|||
126170927|NCT05086289|453911115|FG000|Overall Study|Withdrawal by Subject|5|||
126170928|NCT05086289|453911116|FG001|Overall Study|Withdrawal by Subject|2|||
126170929|NCT02237157|453911117|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
126170930|NCT02237157|453911118|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
126170931|NCT02237157|453911119|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
126170932|NCT02237157|453911120|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
126170933|NCT02237157|453911117|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
126170934|NCT02237157|453911118|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
126170935|NCT02237157|453911119|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
126170936|NCT02237157|453911120|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
126170937|NCT01996748|453911121|FG000|Overall Study|Personal reason|1|||
126170938|NCT01996748|453911122|FG001|Overall Study|Personal reason|0|||
126170939|NCT01996748|453911121|FG000|Overall Study|Physician Decision|2|||
126170940|NCT01996748|453911122|FG001|Overall Study|Physician Decision|0|||
126170941|NCT01996748|453911121|FG000|Overall Study|Adverse Event|1|||
126170942|NCT01996748|453911122|FG001|Overall Study|Adverse Event|4|||
126170943|NCT01996748|453911121|FG000|Overall Study|Withdrawal by Subject|0|||
126170944|NCT01996748|453911122|FG001|Overall Study|Withdrawal by Subject|1|||
126170945|NCT01996748|453911121|FG000|Overall Study|Lost to Follow-up|4|||
126170946|NCT01996748|453911122|FG001|Overall Study|Lost to Follow-up|1|||
126170947|NCT04533815|453911124|FG000|Overall Study|Adverse Event|2|||
126170948|NCT04533815|453911124|FG000|Overall Study|Site withdrew|5|||
126170949|NCT03599141|453911129|FG000|Overall Study|Lost to Follow-up|3|||
126170950|NCT03599141|453911130|FG001|Overall Study|Lost to Follow-up|1|||
126170951|NCT00807846|453911131|FG000|Overall Study|Adverse Event|5|||
126170952|NCT00807846|453911132|FG001|Overall Study|Adverse Event|0|||
126170953|NCT00807846|453911131|FG000|Overall Study|Lack of Efficacy|2|||
126170954|NCT00807846|453911132|FG001|Overall Study|Lack of Efficacy|0|||
126170955|NCT00807846|453911131|FG000|Overall Study|Protocol Violation|2|||
126170956|NCT00807846|453911132|FG001|Overall Study|Protocol Violation|1|||
126170957|NCT00807846|453911131|FG000|Overall Study|Withdrawal by Subject|2|||
126170958|NCT00807846|453911132|FG001|Overall Study|Withdrawal by Subject|1|||
126170959|NCT00807846|453911131|FG000|Overall Study|Other|1|||
126170960|NCT00807846|453911132|FG001|Overall Study|Other|2|||
126170961|NCT01081873|453911133|FG000|Overall Study|Death|86|||
126170962|NCT01081873|453911133|FG000|Overall Study|Withdrawal by Subject|10|||
126170963|NCT01081873|453911133|FG000|Overall Study|Lost to Follow-up|142|||
126170964|NCT01081873|453911133|FG000|Overall Study|Progression of prostate cancer|13|||
126170965|NCT01081873|453911133|FG000|Overall Study|Other|47|||
126170966|NCT03011840|453911134|FG000|Overall Study|Not received PIL in post PIL phase|0|||
126170967|NCT03011840|453911135|FG001|Overall Study|Not received PIL in post PIL phase|21|||
126170968|NCT01165021|453911137|FG000|Overall Study|Death|1|||
126170969|NCT02491073|453911138|FG000|Overall Study|screen failure|1|||
126170970|NCT02491073|453911139|FG001|Overall Study|screen failure|0|||
126170971|NCT01419665|453911140|FG000|Combination Treatment|Adverse Event|7|||
126170972|NCT01419665|453911141|FG001|Combination Treatment|Adverse Event|10|||
126170973|NCT01419665|453911140|FG000|Combination Treatment|Physician Decision|5|||
126170974|NCT01419665|453911141|FG001|Combination Treatment|Physician Decision|8|||
126170975|NCT01419665|453911140|FG000|Combination Treatment|Protocol Violation|6|||
126170976|NCT01419665|453911141|FG001|Combination Treatment|Protocol Violation|2|||
126170977|NCT01419665|453911140|FG000|Combination Treatment|disease progression|10|||
126170978|NCT01419665|453911141|FG001|Combination Treatment|disease progression|9|||
126170979|NCT01419665|453911140|FG000|Combination Treatment|Death|5|||
126170980|NCT01419665|453911141|FG001|Combination Treatment|Death|7|||
126170981|NCT01419665|453911140|FG000|Combination Treatment|administrative problems|0|||
126170982|NCT01419665|453911141|FG001|Combination Treatment|administrative problems|1|||
126170983|NCT01419665|453911140|FG000|Combination Treatment|Withdrawal by Subject|5|||
126170984|NCT01419665|453911141|FG001|Combination Treatment|Withdrawal by Subject|4|||
126170985|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
126170986|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
126170987|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
126170988|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
126170989|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
126170990|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
126170991|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
126170992|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
125973673|NCT04391023|453193142|FG001|Overall Study|Withdrawal by Subject|2|||
126170993|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
126170994|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
126170995|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
126170996|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
126170997|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|Death|1|||
126170998|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|Death|2|||
126170999|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
126171000|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
126171001|NCT01419665|453911140|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
125973674|NCT02189798|453193143|FG000|Extended Use Phase|Withdrawal by Subject|0|||
125973675|NCT02189798|453193144|FG001|Extended Use Phase|Withdrawal by Subject|4|||
126171002|NCT01419665|453911141|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
126171003|NCT01419665|453911140|FG000|Open Label Phase|Death|1|||
126171004|NCT01419665|453911141|FG001|Open Label Phase|Death|0|||
126171005|NCT01419665|453911140|FG000|Open Label Phase|disease progression|0|||
126171006|NCT01419665|453911141|FG001|Open Label Phase|disease progression|1|||
126171007|NCT03738566|453911142|FG000|Initial Study Phase|Withdrawal by Subject|1|||
126171008|NCT03738566|453911143|FG001|Initial Study Phase|Withdrawal by Subject|1|||
126171009|NCT03738566|453911144|FG002|Initial Study Phase|Withdrawal by Subject|2|||
126171010|NCT03738566|453911145|FG003|Initial Study Phase|Withdrawal by Subject|0|||
126171011|NCT03738566|453911142|FG000|Initial Study Phase|Death|0|||
126171012|NCT03738566|453911143|FG001|Initial Study Phase|Death|1|||
126171013|NCT03738566|453911144|FG002|Initial Study Phase|Death|0|||
126171014|NCT03738566|453911145|FG003|Initial Study Phase|Death|0|||
126171015|NCT03738566|453911142|FG000|Initial Study Phase|Treatment failure|5|||
126171016|NCT03738566|453911143|FG001|Initial Study Phase|Treatment failure|0|||
126171017|NCT03738566|453911144|FG002|Initial Study Phase|Treatment failure|0|||
126171018|NCT03738566|453911145|FG003|Initial Study Phase|Treatment failure|0|||
126171019|NCT03738566|453911142|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
126171020|NCT03738566|453911143|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
126171021|NCT03738566|453911144|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
126171022|NCT03738566|453911145|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
126171023|NCT01655823|453911146|FG000|Overall Study|Lost to Follow-up|0|||
126171024|NCT01655823|453911147|FG001|Overall Study|Lost to Follow-up|1|||
126171025|NCT01655823|453911148|FG002|Overall Study|Lost to Follow-up|0|||
126171026|NCT01655823|453911149|FG003|Overall Study|Lost to Follow-up|0|||
126171027|NCT01655823|453911150|FG004|Overall Study|Lost to Follow-up|1|||
126171028|NCT01655823|453911146|FG000|Overall Study|Withdrawal by Subject|0|||
126171029|NCT01655823|453911147|FG001|Overall Study|Withdrawal by Subject|1|||
126171030|NCT01655823|453911148|FG002|Overall Study|Withdrawal by Subject|0|||
126171031|NCT01655823|453911149|FG003|Overall Study|Withdrawal by Subject|1|||
126171032|NCT01655823|453911150|FG004|Overall Study|Withdrawal by Subject|0|||
126171033|NCT04799405|453911153|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
126171034|NCT00632463|453911154|FG000|Overall Study|Adverse Event|0|||
126171035|NCT00632463|453911155|FG001|Overall Study|Adverse Event|1|||
126171036|NCT00632463|453911156|FG002|Overall Study|Adverse Event|0|||
126171037|NCT02998554|453911159|FG000|Overall Study|Adverse Event|8|||
126171038|NCT02998554|453911160|FG001|Overall Study|Adverse Event|3|||
126171039|NCT02998554|453911159|FG000|Overall Study|Protocol deviation|1|||
126171040|NCT02998554|453911160|FG001|Overall Study|Protocol deviation|0|||
126171041|NCT02998554|453911159|FG000|Overall Study|Withdrawal by Subject|2|||
126171042|NCT02998554|453911160|FG001|Overall Study|Withdrawal by Subject|6|||
126171043|NCT02998554|453911159|FG000|Overall Study|Lost to Follow-up|0|||
126171044|NCT02998554|453911160|FG001|Overall Study|Lost to Follow-up|1|||
126171045|NCT02998554|453911159|FG000|Overall Study|Lack of Efficacy|0|||
126171046|NCT02998554|453911160|FG001|Overall Study|Lack of Efficacy|1|||
126171047|NCT03731364|453911165|FG000|Overall Study|Adverse Event|0|||
126171048|NCT03731364|453911166|FG001|Overall Study|Adverse Event|0|||
126171049|NCT03731364|453911167|FG002|Overall Study|Adverse Event|1|||
126171050|NCT03731364|453911168|FG003|Overall Study|Adverse Event|2|||
126171051|NCT03731364|453911169|FG004|Overall Study|Adverse Event|1|||
126171052|NCT02953782|453911170|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
126171053|NCT02953782|453911171|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
126171054|NCT02953782|453911172|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
126171055|NCT02953782|453911173|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
126171056|NCT02953782|453911174|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
126171057|NCT02953782|453911175|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
126171058|NCT02953782|453911176|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
126171059|NCT02953782|453911177|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
126171060|NCT02953782|453911170|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
126171061|NCT02953782|453911171|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126171062|NCT02953782|453911172|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
126171063|NCT02953782|453911173|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126171064|NCT02953782|453911174|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
126171065|NCT02953782|453911175|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126171066|NCT02953782|453911176|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126171067|NCT02953782|453911177|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126171068|NCT02953782|453911170|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126171069|NCT02953782|453911171|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
126171070|NCT02953782|453911172|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126171071|NCT02953782|453911173|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
126171072|NCT02953782|453911174|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
126171073|NCT02953782|453911175|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126171074|NCT02953782|453911176|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126171075|NCT02953782|453911177|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126171076|NCT02953782|453911170|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126171077|NCT02953782|453911171|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126171078|NCT02953782|453911172|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
126171079|NCT02953782|453911173|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
126171080|NCT02953782|453911174|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126171081|NCT02953782|453911175|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126171082|NCT02953782|453911176|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126171083|NCT02953782|453911177|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126171084|NCT02953782|453911170|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126171085|NCT02953782|453911171|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125973676|NCT02189798|453193143|FG000|Extended Use Phase|Physician Decision|1|||
125973677|NCT02189798|453193144|FG001|Extended Use Phase|Physician Decision|0|||
126171086|NCT02953782|453911172|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126171087|NCT02953782|453911173|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126171088|NCT02953782|453911174|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126171089|NCT02953782|453911175|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
126171090|NCT02953782|453911176|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
126171091|NCT02953782|453911177|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
126171092|NCT02953782|453911170|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126171093|NCT02953782|453911171|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126171094|NCT02953782|453911172|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126171095|NCT02953782|453911173|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126171096|NCT02953782|453911174|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126171097|NCT02953782|453911175|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
126171098|NCT02953782|453911176|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
126171099|NCT02953782|453911177|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
126171100|NCT02953782|453911170|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126171101|NCT02953782|453911171|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126171102|NCT02953782|453911172|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126171103|NCT02953782|453911173|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126171104|NCT02953782|453911174|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126171105|NCT02953782|453911175|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
126171106|NCT02953782|453911176|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
126171107|NCT02953782|453911177|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
126171108|NCT02953782|453911170|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126171109|NCT02953782|453911171|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126171110|NCT02953782|453911172|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126171111|NCT02953782|453911173|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126171112|NCT02953782|453911174|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126171113|NCT02953782|453911175|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126171114|NCT02953782|453911176|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
126171115|NCT02953782|453911177|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126171116|NCT01934192|453911178|FG000|Overall Study|Protocol Violation|0|||
126171117|NCT01934192|453911179|FG001|Overall Study|Protocol Violation|0|||
126171118|NCT01934192|453911180|FG002|Overall Study|Protocol Violation|0|||
126171119|NCT01934192|453911181|FG003|Overall Study|Protocol Violation|1|||
126171120|NCT01934192|453911178|FG000|Overall Study|Other: reached stopping criteria|6|||
126171121|NCT01934192|453911179|FG001|Overall Study|Other: reached stopping criteria|5|||
126171122|NCT01934192|453911180|FG002|Overall Study|Other: reached stopping criteria|1|||
126171123|NCT01934192|453911181|FG003|Overall Study|Other: reached stopping criteria|0|||
126171124|NCT01934192|453911178|FG000|Overall Study|Physician Decision|3|||
126171125|NCT01934192|453911179|FG001|Overall Study|Physician Decision|2|||
126171126|NCT01934192|453911180|FG002|Overall Study|Physician Decision|0|||
126171127|NCT01934192|453911181|FG003|Overall Study|Physician Decision|0|||
126171128|NCT02357849|453911182|FG000|Overall Study|Withdrawal by Subject|2|||
126171129|NCT02357849|453911183|FG001|Overall Study|Withdrawal by Subject|3|||
126171130|NCT03095521|453911184|FG000|Overall Study|Withdrawal by Subject|0|||
126171131|NCT03095521|453911185|FG001|Overall Study|Withdrawal by Subject|1|||
126171132|NCT03095521|453911184|FG000|Overall Study|Lost to Follow-up|0|||
126171133|NCT03095521|453911185|FG001|Overall Study|Lost to Follow-up|1|||
126171134|NCT01536119|453911186|FG000|Overall Study|Lost to Follow-up|17|||
126171135|NCT01536119|453911187|FG001|Overall Study|Lost to Follow-up|14|||
126171136|NCT01810042|453911188|FG000|Overall Study|Lost to Follow-up|10|||
126171137|NCT02773238|453911190|FG000|Overall Study|Lack of Efficacy|4|||
126171138|NCT05301322|453911193|FG000|Overall Study|Adverse Event|7|||
126171139|NCT05301322|453911194|FG001|Overall Study|Adverse Event|3|||
126171140|NCT05301322|453911193|FG000|Overall Study|Death|0|||
126171141|NCT05301322|453911194|FG001|Overall Study|Death|1|||
126171142|NCT05301322|453911193|FG000|Overall Study|Lost to Follow-up|2|||
126171143|NCT05301322|453911194|FG001|Overall Study|Lost to Follow-up|1|||
126171144|NCT05301322|453911193|FG000|Overall Study|Protocol Violation|3|||
126171145|NCT05301322|453911194|FG001|Overall Study|Protocol Violation|1|||
126171146|NCT05301322|453911193|FG000|Overall Study|Withdrawal by Subject|3|||
126171147|NCT05301322|453911194|FG001|Overall Study|Withdrawal by Subject|0|||
126171148|NCT05301322|453911193|FG000|Overall Study|Other|4|||
126171149|NCT05301322|453911194|FG001|Overall Study|Other|0|||
126171150|NCT01877382|453911198|FG000|Dose Escalation|Progressive disease|2|||
126171151|NCT01877382|453911199|FG001|Dose Escalation|Progressive disease|0|||
126171152|NCT01877382|453911200|FG002|Dose Escalation|Progressive disease|1|||
126171153|NCT01877382|453911201|FG003|Dose Escalation|Progressive disease|6|||
126171154|NCT01877382|453911202|FG004|Dose Escalation|Progressive disease|1|||
126171155|NCT01877382|453911203|FG005|Dose Escalation|Progressive disease|0|||
126171156|NCT01877382|453911204|FG006|Dose Escalation|Progressive disease|3|||
126171157|NCT01877382|453911205|FG007|Dose Escalation|Progressive disease|10|||
126171158|NCT01877382|453911206|FG008|Dose Escalation|Progressive disease|4|||
126171159|NCT01877382|453911207|FG009|Dose Escalation|Progressive disease|2|||
126171160|NCT01877382|453911208|FG010|Dose Escalation|Progressive disease|3|||
126171161|NCT01877382|453911209|FG011|Dose Escalation|Progressive disease|3|||
126171162|NCT01877382|453911210|FG012|Dose Escalation|Progressive disease|13|||
126171163|NCT01877382|453911211|FG013|Dose Escalation|Progressive disease|1|||
126171164|NCT01877382|453911212|FG014|Dose Escalation|Progressive disease|0|||
126171165|NCT01877382|453911198|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
126171166|NCT01877382|453911199|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171167|NCT01877382|453911200|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171168|NCT01877382|453911201|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
126171169|NCT01877382|453911202|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171170|NCT01877382|453911203|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171171|NCT01877382|453911204|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
126171172|NCT01877382|453911205|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171173|NCT01877382|453911206|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171174|NCT01877382|453911207|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171175|NCT01877382|453911208|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171176|NCT01877382|453911209|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171177|NCT01877382|453911210|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171178|NCT01877382|453911211|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171179|NCT01877382|453911212|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171180|NCT01877382|453911198|FG000|Dose Escalation|Clinical progression|0|||
126171181|NCT01877382|453911199|FG001|Dose Escalation|Clinical progression|1|||
126171182|NCT01877382|453911200|FG002|Dose Escalation|Clinical progression|0|||
126171183|NCT01877382|453911201|FG003|Dose Escalation|Clinical progression|2|||
126171184|NCT01877382|453911202|FG004|Dose Escalation|Clinical progression|0|||
126171185|NCT01877382|453911203|FG005|Dose Escalation|Clinical progression|0|||
126171186|NCT01877382|453911204|FG006|Dose Escalation|Clinical progression|1|||
126171187|NCT01877382|453911205|FG007|Dose Escalation|Clinical progression|0|||
126171188|NCT01877382|453911206|FG008|Dose Escalation|Clinical progression|0|||
126171189|NCT01877382|453911207|FG009|Dose Escalation|Clinical progression|1|||
126171190|NCT01877382|453911208|FG010|Dose Escalation|Clinical progression|0|||
126171191|NCT01877382|453911209|FG011|Dose Escalation|Clinical progression|0|||
126171192|NCT01877382|453911210|FG012|Dose Escalation|Clinical progression|2|||
126171193|NCT01877382|453911211|FG013|Dose Escalation|Clinical progression|1|||
126171194|NCT01877382|453911212|FG014|Dose Escalation|Clinical progression|0|||
126171195|NCT01877382|453911198|FG000|Dose Escalation|Adverse Event|0|||
126171196|NCT01877382|453911199|FG001|Dose Escalation|Adverse Event|0|||
126171197|NCT01877382|453911200|FG002|Dose Escalation|Adverse Event|0|||
126171198|NCT01877382|453911201|FG003|Dose Escalation|Adverse Event|4|||
126171199|NCT01877382|453911202|FG004|Dose Escalation|Adverse Event|1|||
126171200|NCT01877382|453911203|FG005|Dose Escalation|Adverse Event|2|||
126171201|NCT01877382|453911204|FG006|Dose Escalation|Adverse Event|1|||
126171202|NCT01877382|453911205|FG007|Dose Escalation|Adverse Event|2|||
126171203|NCT01877382|453911206|FG008|Dose Escalation|Adverse Event|0|||
126171204|NCT01877382|453911207|FG009|Dose Escalation|Adverse Event|0|||
126171205|NCT01877382|453911208|FG010|Dose Escalation|Adverse Event|0|||
126171206|NCT01877382|453911209|FG011|Dose Escalation|Adverse Event|0|||
126171207|NCT01877382|453911210|FG012|Dose Escalation|Adverse Event|1|||
126171208|NCT01877382|453911211|FG013|Dose Escalation|Adverse Event|0|||
126171209|NCT01877382|453911212|FG014|Dose Escalation|Adverse Event|0|||
126171210|NCT01877382|453911198|FG000|Dose Escalation|Withdrawal by Subject|0|||
126171211|NCT01877382|453911199|FG001|Dose Escalation|Withdrawal by Subject|0|||
126200120|NCT02394028|454017886|FG009|Induction Phase|Lack of Efficacy|0|||
126171212|NCT01877382|453911200|FG002|Dose Escalation|Withdrawal by Subject|0|||
126171213|NCT01877382|453911201|FG003|Dose Escalation|Withdrawal by Subject|0|||
126171214|NCT01877382|453911202|FG004|Dose Escalation|Withdrawal by Subject|0|||
126171215|NCT01877382|453911203|FG005|Dose Escalation|Withdrawal by Subject|3|||
126171216|NCT01877382|453911204|FG006|Dose Escalation|Withdrawal by Subject|2|||
126171217|NCT01877382|453911205|FG007|Dose Escalation|Withdrawal by Subject|1|||
126171218|NCT01877382|453911206|FG008|Dose Escalation|Withdrawal by Subject|1|||
126171219|NCT01877382|453911207|FG009|Dose Escalation|Withdrawal by Subject|0|||
126171220|NCT01877382|453911208|FG010|Dose Escalation|Withdrawal by Subject|0|||
126171221|NCT01877382|453911209|FG011|Dose Escalation|Withdrawal by Subject|0|||
126171222|NCT01877382|453911210|FG012|Dose Escalation|Withdrawal by Subject|0|||
126171223|NCT01877382|453911211|FG013|Dose Escalation|Withdrawal by Subject|0|||
126171224|NCT01877382|453911212|FG014|Dose Escalation|Withdrawal by Subject|0|||
126171225|NCT01877382|453911198|FG000|Dose Escalation|Protocol Violation|0|||
126171226|NCT01877382|453911199|FG001|Dose Escalation|Protocol Violation|0|||
126171227|NCT01877382|453911200|FG002|Dose Escalation|Protocol Violation|0|||
126171228|NCT01877382|453911201|FG003|Dose Escalation|Protocol Violation|0|||
126171229|NCT01877382|453911202|FG004|Dose Escalation|Protocol Violation|0|||
126171230|NCT01877382|453911203|FG005|Dose Escalation|Protocol Violation|0|||
125973678|NCT02189798|453193143|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
125973679|NCT02189798|453193144|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
125973680|NCT02189798|453193143|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
125973681|NCT02189798|453193144|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
125973682|NCT02189798|453193143|FG000|Extended Use Phase|Travel Issues|2|||
125973683|NCT02189798|453193144|FG001|Extended Use Phase|Travel Issues|1|||
125973684|NCT02189798|453193143|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
125973685|NCT02189798|453193144|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
125973686|NCT00727272|453193151|FG000|Washout Period A|Adverse Event|0|||
125973687|NCT00727272|453193152|FG001|Washout Period A|Adverse Event|0|||
125973688|NCT00727272|453193153|FG002|Washout Period A|Adverse Event|1|||
125973689|NCT00727272|453193151|FG000|Washout Period B|Withdrawal by Subject|0|||
125973690|NCT00727272|453193152|FG001|Washout Period B|Withdrawal by Subject|0|||
125973691|NCT00727272|453193153|FG002|Washout Period B|Withdrawal by Subject|1|||
125973692|NCT00651664|453193154|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
125973693|NCT00651664|453193155|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
125973694|NCT00651664|453193156|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
125973695|NCT00651664|453193157|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
125973696|NCT00651664|453193158|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
125973697|NCT00651664|453193159|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
125973698|NCT00651664|453193160|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
125973699|NCT00651664|453193161|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
125973700|NCT00651664|453193162|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
125973701|NCT00651664|453193163|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
125973702|NCT00651664|453193154|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
125973703|NCT00651664|453193155|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125973704|NCT00651664|453193156|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125973705|NCT00651664|453193157|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
125973706|NCT00651664|453193158|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
125973707|NCT00651664|453193159|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
125973708|NCT00651664|453193160|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
125973709|NCT00651664|453193161|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
125973710|NCT00651664|453193162|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
125973711|NCT00651664|453193163|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
125973712|NCT00651664|453193154|FG000|Overall Study|Progressive Disease|3|||
125973713|NCT00651664|453193155|FG001|Overall Study|Progressive Disease|3|||
125973714|NCT00651664|453193156|FG002|Overall Study|Progressive Disease|3|||
125973715|NCT00651664|453193157|FG003|Overall Study|Progressive Disease|12|||
125973716|NCT00651664|453193158|FG004|Overall Study|Progressive Disease|4|||
125973717|NCT00651664|453193159|FG005|Overall Study|Progressive Disease|1|||
125973718|NCT00651664|453193160|FG006|Overall Study|Progressive Disease|3|||
125973719|NCT00651664|453193161|FG007|Overall Study|Progressive Disease|6|||
125973720|NCT00651664|453193162|FG008|Overall Study|Progressive Disease|5|||
125973721|NCT00651664|453193163|FG009|Overall Study|Progressive Disease|5|||
125973722|NCT00651664|453193154|FG000|Overall Study|Patient Declined Further Treatment|0|||
125973723|NCT00651664|453193155|FG001|Overall Study|Patient Declined Further Treatment|0|||
125973724|NCT00651664|453193156|FG002|Overall Study|Patient Declined Further Treatment|0|||
125973725|NCT00651664|453193157|FG003|Overall Study|Patient Declined Further Treatment|1|||
125973726|NCT00651664|453193158|FG004|Overall Study|Patient Declined Further Treatment|1|||
125973727|NCT00651664|453193159|FG005|Overall Study|Patient Declined Further Treatment|1|||
125973728|NCT00651664|453193160|FG006|Overall Study|Patient Declined Further Treatment|0|||
125973729|NCT00651664|453193161|FG007|Overall Study|Patient Declined Further Treatment|0|||
125973730|NCT00651664|453193162|FG008|Overall Study|Patient Declined Further Treatment|0|||
126171231|NCT01877382|453911204|FG006|Dose Escalation|Protocol Violation|1|||
126171232|NCT01877382|453911205|FG007|Dose Escalation|Protocol Violation|0|||
126171233|NCT01877382|453911206|FG008|Dose Escalation|Protocol Violation|0|||
126171234|NCT01877382|453911207|FG009|Dose Escalation|Protocol Violation|0|||
126171235|NCT01877382|453911208|FG010|Dose Escalation|Protocol Violation|0|||
126171236|NCT01877382|453911209|FG011|Dose Escalation|Protocol Violation|0|||
126171237|NCT01877382|453911210|FG012|Dose Escalation|Protocol Violation|0|||
126171238|NCT01877382|453911211|FG013|Dose Escalation|Protocol Violation|0|||
126171239|NCT01877382|453911212|FG014|Dose Escalation|Protocol Violation|0|||
126171240|NCT01877382|453911198|FG000|Dose Escalation|Study terminated by sponsor|0|||
126171241|NCT01877382|453911199|FG001|Dose Escalation|Study terminated by sponsor|0|||
126171242|NCT01877382|453911200|FG002|Dose Escalation|Study terminated by sponsor|0|||
126171243|NCT01877382|453911201|FG003|Dose Escalation|Study terminated by sponsor|0|||
126171244|NCT01877382|453911202|FG004|Dose Escalation|Study terminated by sponsor|0|||
126171245|NCT01877382|453911203|FG005|Dose Escalation|Study terminated by sponsor|0|||
126171246|NCT01877382|453911204|FG006|Dose Escalation|Study terminated by sponsor|0|||
126171247|NCT01877382|453911205|FG007|Dose Escalation|Study terminated by sponsor|1|||
126171248|NCT01877382|453911206|FG008|Dose Escalation|Study terminated by sponsor|1|||
126171249|NCT01877382|453911207|FG009|Dose Escalation|Study terminated by sponsor|0|||
126171250|NCT01877382|453911208|FG010|Dose Escalation|Study terminated by sponsor|0|||
126171251|NCT01877382|453911209|FG011|Dose Escalation|Study terminated by sponsor|0|||
126171252|NCT01877382|453911210|FG012|Dose Escalation|Study terminated by sponsor|3|||
126171253|NCT01877382|453911211|FG013|Dose Escalation|Study terminated by sponsor|0|||
126171254|NCT01877382|453911212|FG014|Dose Escalation|Study terminated by sponsor|0|||
126171255|NCT01877382|453911198|FG000|Dose Escalation|Death|0|||
126171256|NCT01877382|453911199|FG001|Dose Escalation|Death|0|||
126171257|NCT01877382|453911200|FG002|Dose Escalation|Death|0|||
126171258|NCT01877382|453911201|FG003|Dose Escalation|Death|0|||
126171259|NCT01877382|453911202|FG004|Dose Escalation|Death|0|||
126171260|NCT01877382|453911203|FG005|Dose Escalation|Death|0|||
126171261|NCT01877382|453911204|FG006|Dose Escalation|Death|0|||
126171262|NCT01877382|453911205|FG007|Dose Escalation|Death|1|||
126171263|NCT01877382|453911206|FG008|Dose Escalation|Death|0|||
126171264|NCT01877382|453911207|FG009|Dose Escalation|Death|0|||
126171265|NCT01877382|453911208|FG010|Dose Escalation|Death|0|||
126171266|NCT01877382|453911209|FG011|Dose Escalation|Death|0|||
126171267|NCT01877382|453911210|FG012|Dose Escalation|Death|1|||
126171268|NCT01877382|453911211|FG013|Dose Escalation|Death|1|||
126171269|NCT01877382|453911212|FG014|Dose Escalation|Death|0|||
126171270|NCT01877382|453911198|FG000|Dose Expansion|Progressive disease|0|||
126171271|NCT01877382|453911199|FG001|Dose Expansion|Progressive disease|0|||
126171272|NCT01877382|453911200|FG002|Dose Expansion|Progressive disease|0|||
126171273|NCT01877382|453911201|FG003|Dose Expansion|Progressive disease|0|||
126171274|NCT01877382|453911202|FG004|Dose Expansion|Progressive disease|0|||
126171275|NCT01877382|453911203|FG005|Dose Expansion|Progressive disease|0|||
126171276|NCT01877382|453911204|FG006|Dose Expansion|Progressive disease|0|||
126171277|NCT01877382|453911205|FG007|Dose Expansion|Progressive disease|0|||
126171278|NCT01877382|453911206|FG008|Dose Expansion|Progressive disease|0|||
126171279|NCT01877382|453911207|FG009|Dose Expansion|Progressive disease|0|||
126171280|NCT01877382|453911208|FG010|Dose Expansion|Progressive disease|0|||
126171281|NCT01877382|453911209|FG011|Dose Expansion|Progressive disease|0|||
126171282|NCT01877382|453911210|FG012|Dose Expansion|Progressive disease|0|||
126171283|NCT01877382|453911211|FG013|Dose Expansion|Progressive disease|0|||
126171284|NCT01877382|453911212|FG014|Dose Expansion|Progressive disease|11|||
126171285|NCT01877382|453911198|FG000|Dose Expansion|Clinical progression|0|||
126171286|NCT01877382|453911199|FG001|Dose Expansion|Clinical progression|0|||
126171287|NCT01877382|453911200|FG002|Dose Expansion|Clinical progression|0|||
126171288|NCT01877382|453911201|FG003|Dose Expansion|Clinical progression|0|||
126171289|NCT01877382|453911202|FG004|Dose Expansion|Clinical progression|0|||
126171290|NCT01877382|453911203|FG005|Dose Expansion|Clinical progression|0|||
126171291|NCT01877382|453911204|FG006|Dose Expansion|Clinical progression|0|||
126171292|NCT01877382|453911205|FG007|Dose Expansion|Clinical progression|0|||
126171293|NCT01877382|453911206|FG008|Dose Expansion|Clinical progression|0|||
126171294|NCT01877382|453911207|FG009|Dose Expansion|Clinical progression|0|||
126171295|NCT01877382|453911208|FG010|Dose Expansion|Clinical progression|0|||
126171296|NCT01877382|453911209|FG011|Dose Expansion|Clinical progression|0|||
126171297|NCT01877382|453911210|FG012|Dose Expansion|Clinical progression|0|||
126171298|NCT01877382|453911211|FG013|Dose Expansion|Clinical progression|0|||
126171299|NCT01877382|453911212|FG014|Dose Expansion|Clinical progression|6|||
126171300|NCT01877382|453911198|FG000|Dose Expansion|Adverse Event|0|||
126171301|NCT01877382|453911199|FG001|Dose Expansion|Adverse Event|0|||
126171302|NCT01877382|453911200|FG002|Dose Expansion|Adverse Event|0|||
126171303|NCT01877382|453911201|FG003|Dose Expansion|Adverse Event|0|||
126171304|NCT01877382|453911202|FG004|Dose Expansion|Adverse Event|0|||
126171305|NCT01877382|453911203|FG005|Dose Expansion|Adverse Event|0|||
126171306|NCT01877382|453911204|FG006|Dose Expansion|Adverse Event|0|||
126171307|NCT01877382|453911205|FG007|Dose Expansion|Adverse Event|0|||
126171308|NCT01877382|453911206|FG008|Dose Expansion|Adverse Event|0|||
126171309|NCT01877382|453911207|FG009|Dose Expansion|Adverse Event|0|||
126171310|NCT01877382|453911208|FG010|Dose Expansion|Adverse Event|0|||
126171311|NCT01877382|453911209|FG011|Dose Expansion|Adverse Event|0|||
126171312|NCT01877382|453911210|FG012|Dose Expansion|Adverse Event|0|||
125973731|NCT00651664|453193163|FG009|Overall Study|Patient Declined Further Treatment|1|||
125973732|NCT00651664|453193154|FG000|Overall Study|Symptomatic Deterioration|0|||
125973733|NCT00651664|453193155|FG001|Overall Study|Symptomatic Deterioration|0|||
125973734|NCT00651664|453193156|FG002|Overall Study|Symptomatic Deterioration|0|||
125973735|NCT00651664|453193157|FG003|Overall Study|Symptomatic Deterioration|1|||
125973736|NCT00651664|453193158|FG004|Overall Study|Symptomatic Deterioration|0|||
125973737|NCT00651664|453193159|FG005|Overall Study|Symptomatic Deterioration|0|||
125973738|NCT00651664|453193160|FG006|Overall Study|Symptomatic Deterioration|1|||
125973739|NCT00651664|453193161|FG007|Overall Study|Symptomatic Deterioration|0|||
125973740|NCT00651664|453193162|FG008|Overall Study|Symptomatic Deterioration|1|||
125973741|NCT00651664|453193163|FG009|Overall Study|Symptomatic Deterioration|0|||
125973742|NCT00651664|453193154|FG000|Overall Study|Reason not Specified|0|||
125973743|NCT00651664|453193155|FG001|Overall Study|Reason not Specified|0|||
125973744|NCT00651664|453193156|FG002|Overall Study|Reason not Specified|0|||
125973745|NCT00651664|453193157|FG003|Overall Study|Reason not Specified|0|||
125973746|NCT00651664|453193158|FG004|Overall Study|Reason not Specified|0|||
125973747|NCT00651664|453193159|FG005|Overall Study|Reason not Specified|0|||
125973748|NCT00651664|453193160|FG006|Overall Study|Reason not Specified|1|||
125973749|NCT00651664|453193161|FG007|Overall Study|Reason not Specified|0|||
125973750|NCT00651664|453193162|FG008|Overall Study|Reason not Specified|0|||
125973751|NCT00651664|453193163|FG009|Overall Study|Reason not Specified|0|||
125973752|NCT02415400|453193164|FG000|Overall Study|Adverse Event|0|||
125973753|NCT02415400|453193165|FG001|Overall Study|Adverse Event|1|||
125973754|NCT02415400|453193166|FG002|Overall Study|Adverse Event|1|||
125973755|NCT02415400|453193167|FG003|Overall Study|Adverse Event|2|||
125973756|NCT02415400|453193164|FG000|Overall Study|Participant request to stop therapy|4|||
125973757|NCT02415400|453193165|FG001|Overall Study|Participant request to stop therapy|3|||
125973758|NCT02415400|453193166|FG002|Overall Study|Participant request to stop therapy|8|||
125973759|NCT02415400|453193167|FG003|Overall Study|Participant request to stop therapy|6|||
125973760|NCT02415400|453193164|FG000|Overall Study|Participant withdrew consent|14|||
125973761|NCT02415400|453193165|FG001|Overall Study|Participant withdrew consent|12|||
125973762|NCT02415400|453193166|FG002|Overall Study|Participant withdrew consent|30|||
125973763|NCT02415400|453193167|FG003|Overall Study|Participant withdrew consent|21|||
125973764|NCT02415400|453193164|FG000|Overall Study|Death|39|||
125973765|NCT02415400|453193165|FG001|Overall Study|Death|41|||
125973766|NCT02415400|453193166|FG002|Overall Study|Death|35|||
125973767|NCT02415400|453193167|FG003|Overall Study|Death|42|||
125973768|NCT02415400|453193164|FG000|Overall Study|Lost to Follow-up|3|||
125973769|NCT02415400|453193165|FG001|Overall Study|Lost to Follow-up|3|||
125973770|NCT02415400|453193166|FG002|Overall Study|Lost to Follow-up|2|||
125973771|NCT02415400|453193167|FG003|Overall Study|Lost to Follow-up|5|||
125973772|NCT02415400|453193164|FG000|Overall Study|Poor/Non-Compliance|0|||
125973773|NCT02415400|453193165|FG001|Overall Study|Poor/Non-Compliance|1|||
125973774|NCT02415400|453193166|FG002|Overall Study|Poor/Non-Compliance|3|||
125973775|NCT02415400|453193167|FG003|Overall Study|Poor/Non-Compliance|4|||
125973776|NCT02415400|453193164|FG000|Overall Study|Participant no longer meets criteria|2|||
125973777|NCT02415400|453193165|FG001|Overall Study|Participant no longer meets criteria|0|||
125973778|NCT02415400|453193166|FG002|Overall Study|Participant no longer meets criteria|0|||
125973779|NCT02415400|453193167|FG003|Overall Study|Participant no longer meets criteria|1|||
125973780|NCT02415400|453193164|FG000|Overall Study|Participant doesn't answer phone|1|||
125973781|NCT02415400|453193165|FG001|Overall Study|Participant doesn't answer phone|0|||
125973782|NCT02415400|453193166|FG002|Overall Study|Participant doesn't answer phone|0|||
125973783|NCT02415400|453193167|FG003|Overall Study|Participant doesn't answer phone|0|||
125973784|NCT02415400|453193164|FG000|Overall Study|Participant wanted home visits|1|||
125973785|NCT02415400|453193165|FG001|Overall Study|Participant wanted home visits|0|||
125973786|NCT02415400|453193166|FG002|Overall Study|Participant wanted home visits|0|||
125973787|NCT02415400|453193167|FG003|Overall Study|Participant wanted home visits|0|||
125973788|NCT02415400|453193164|FG000|Overall Study|Randomized in error|2|||
125973789|NCT02415400|453193165|FG001|Overall Study|Randomized in error|0|||
125973790|NCT02415400|453193166|FG002|Overall Study|Randomized in error|0|||
125973791|NCT02415400|453193167|FG003|Overall Study|Randomized in error|0|||
125973792|NCT02415400|453193164|FG000|Overall Study|No study drug on site|0|||
126171313|NCT01877382|453911211|FG013|Dose Expansion|Adverse Event|0|||
125973793|NCT02415400|453193165|FG001|Overall Study|No study drug on site|1|||
125973794|NCT02415400|453193166|FG002|Overall Study|No study drug on site|0|||
125973795|NCT02415400|453193167|FG003|Overall Study|No study drug on site|0|||
125973796|NCT02415400|453193164|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
125973797|NCT02415400|453193165|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
125973798|NCT02415400|453193166|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
125973799|NCT02415400|453193167|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
126171314|NCT01877382|453911212|FG014|Dose Expansion|Adverse Event|1|||
126171315|NCT01877382|453911198|FG000|Dose Expansion|Death|0|||
126171316|NCT01877382|453911199|FG001|Dose Expansion|Death|0|||
126171317|NCT01877382|453911200|FG002|Dose Expansion|Death|0|||
126171318|NCT01877382|453911201|FG003|Dose Expansion|Death|0|||
126171319|NCT01877382|453911202|FG004|Dose Expansion|Death|0|||
126171320|NCT01877382|453911203|FG005|Dose Expansion|Death|0|||
126171321|NCT01877382|453911204|FG006|Dose Expansion|Death|0|||
126171322|NCT01877382|453911205|FG007|Dose Expansion|Death|0|||
126171323|NCT01877382|453911206|FG008|Dose Expansion|Death|0|||
126171324|NCT01877382|453911207|FG009|Dose Expansion|Death|0|||
126171325|NCT01877382|453911208|FG010|Dose Expansion|Death|0|||
126171326|NCT01877382|453911209|FG011|Dose Expansion|Death|0|||
126171327|NCT01877382|453911210|FG012|Dose Expansion|Death|0|||
126171328|NCT01877382|453911211|FG013|Dose Expansion|Death|0|||
126171329|NCT01877382|453911212|FG014|Dose Expansion|Death|1|||
126171330|NCT01877382|453911198|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171331|NCT01877382|453911199|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171332|NCT01877382|453911200|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171333|NCT01877382|453911201|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171334|NCT01877382|453911202|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171335|NCT01877382|453911203|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171336|NCT01877382|453911204|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171337|NCT01877382|453911205|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171338|NCT01877382|453911206|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171339|NCT01877382|453911207|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171340|NCT01877382|453911208|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171341|NCT01877382|453911209|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171342|NCT01877382|453911210|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171343|NCT01877382|453911211|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126171344|NCT01877382|453911212|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
126171345|NCT03829332|453911213|FG000|Overall Study|Death|225|||
126171346|NCT03829332|453911214|FG001|Overall Study|Death|230|||
126171347|NCT03829332|453911213|FG000|Overall Study|Lost to Follow-up|1|||
126171348|NCT03829332|453911214|FG001|Overall Study|Lost to Follow-up|3|||
126171349|NCT03829332|453911213|FG000|Overall Study|Physician Decision|1|||
126171350|NCT03829332|453911214|FG001|Overall Study|Physician Decision|0|||
126171351|NCT03829332|453911213|FG000|Overall Study|Sponsor Decision|71|||
126171352|NCT03829332|453911214|FG001|Overall Study|Sponsor Decision|72|||
126171353|NCT03829332|453911213|FG000|Overall Study|Withdrawal by Subject|11|||
126171354|NCT03829332|453911214|FG001|Overall Study|Withdrawal by Subject|9|||
126171355|NCT00430521|453911215|FG000|Overall Study|Adverse Event|0|||
126171356|NCT00430521|453911216|FG001|Overall Study|Adverse Event|0|||
126171357|NCT00430521|453911217|FG002|Overall Study|Adverse Event|0|||
126171358|NCT00430521|453911218|FG003|Overall Study|Adverse Event|0|||
126171359|NCT00430521|453911219|FG004|Overall Study|Adverse Event|0|||
126171360|NCT00430521|453911220|FG005|Overall Study|Adverse Event|2|||
126171361|NCT00430521|453911221|FG006|Overall Study|Adverse Event|1|||
126171362|NCT00430521|453911222|FG007|Overall Study|Adverse Event|0|||
126171363|NCT00430521|453911215|FG000|Overall Study|Lost to Follow-up|7|||
126171364|NCT00430521|453911216|FG001|Overall Study|Lost to Follow-up|8|||
126171365|NCT00430521|453911217|FG002|Overall Study|Lost to Follow-up|3|||
126171366|NCT00430521|453911218|FG003|Overall Study|Lost to Follow-up|5|||
126171367|NCT00430521|453911219|FG004|Overall Study|Lost to Follow-up|5|||
126171368|NCT00430521|453911220|FG005|Overall Study|Lost to Follow-up|2|||
126171369|NCT00430521|453911221|FG006|Overall Study|Lost to Follow-up|8|||
126171370|NCT00430521|453911222|FG007|Overall Study|Lost to Follow-up|10|||
126171371|NCT00430521|453911215|FG000|Overall Study|Pregnancy|0|||
126171372|NCT00430521|453911216|FG001|Overall Study|Pregnancy|0|||
126171373|NCT00430521|453911217|FG002|Overall Study|Pregnancy|0|||
126171374|NCT00430521|453911218|FG003|Overall Study|Pregnancy|0|||
126171375|NCT00430521|453911219|FG004|Overall Study|Pregnancy|0|||
126171376|NCT00430521|453911220|FG005|Overall Study|Pregnancy|0|||
126171377|NCT00430521|453911221|FG006|Overall Study|Pregnancy|1|||
126171378|NCT00430521|453911222|FG007|Overall Study|Pregnancy|0|||
126171379|NCT00430521|453911215|FG000|Overall Study|Vaccine Expired|0|||
126171380|NCT00430521|453911216|FG001|Overall Study|Vaccine Expired|0|||
126171381|NCT00430521|453911217|FG002|Overall Study|Vaccine Expired|0|||
126171382|NCT00430521|453911218|FG003|Overall Study|Vaccine Expired|0|||
125973800|NCT02415400|453193164|FG000|Overall Study|Coagulation values cannot be set|0|||
126171383|NCT00430521|453911219|FG004|Overall Study|Vaccine Expired|0|||
126171384|NCT00430521|453911220|FG005|Overall Study|Vaccine Expired|1|||
126171385|NCT00430521|453911221|FG006|Overall Study|Vaccine Expired|0|||
126171386|NCT00430521|453911222|FG007|Overall Study|Vaccine Expired|0|||
126171387|NCT00430521|453911215|FG000|Overall Study|Protocol Violation|1|||
126171388|NCT00430521|453911216|FG001|Overall Study|Protocol Violation|0|||
126171389|NCT00430521|453911217|FG002|Overall Study|Protocol Violation|0|||
126171390|NCT00430521|453911218|FG003|Overall Study|Protocol Violation|0|||
126171391|NCT00430521|453911219|FG004|Overall Study|Protocol Violation|0|||
126171392|NCT00430521|453911220|FG005|Overall Study|Protocol Violation|0|||
126171393|NCT00430521|453911221|FG006|Overall Study|Protocol Violation|0|||
126171394|NCT00430521|453911222|FG007|Overall Study|Protocol Violation|0|||
126171395|NCT00430521|453911215|FG000|Overall Study|Withdrawal by Subject|3|||
126171396|NCT00430521|453911216|FG001|Overall Study|Withdrawal by Subject|1|||
126171397|NCT00430521|453911217|FG002|Overall Study|Withdrawal by Subject|0|||
126171398|NCT00430521|453911218|FG003|Overall Study|Withdrawal by Subject|3|||
126171399|NCT00430521|453911219|FG004|Overall Study|Withdrawal by Subject|0|||
126171400|NCT00430521|453911220|FG005|Overall Study|Withdrawal by Subject|0|||
126171401|NCT00430521|453911221|FG006|Overall Study|Withdrawal by Subject|0|||
126171402|NCT00430521|453911222|FG007|Overall Study|Withdrawal by Subject|2|||
126171403|NCT02115113|453913050|FG000|Participants in Run-in Period|Death|0|||
126171404|NCT02115113|453913051|FG001|Participants in Run-in Period|Death|0|||
126171405|NCT02115113|453913052|FG002|Participants in Run-in Period|Death|1|||
126171406|NCT02115113|453913050|FG000|Participants in Run-in Period|Administrative problems|0|||
126171407|NCT02115113|453913051|FG001|Participants in Run-in Period|Administrative problems|0|||
126171408|NCT02115113|453913052|FG002|Participants in Run-in Period|Administrative problems|1|||
126171409|NCT02115113|453913050|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
126171410|NCT02115113|453913051|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
126171411|NCT02115113|453913052|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
126171412|NCT02115113|453913050|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
126171413|NCT02115113|453913051|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
126171414|NCT02115113|453913052|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
126171415|NCT02115113|453913050|FG000|Participants Randomized|Lost to Follow-up|1|||
126171416|NCT02115113|453913051|FG001|Participants Randomized|Lost to Follow-up|0|||
126171417|NCT02115113|453913052|FG002|Participants Randomized|Lost to Follow-up|0|||
126171418|NCT02115113|453913050|FG000|Participants Randomized|Death|1|||
126171419|NCT02115113|453913051|FG001|Participants Randomized|Death|0|||
126171420|NCT02115113|453913052|FG002|Participants Randomized|Death|0|||
126171421|NCT00296725|453913053|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
126171422|NCT00296725|453913053|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
126171423|NCT00296725|453913053|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
126171424|NCT02622724|453913054|FG000|Overall Study|Death|51|||
126171425|NCT02622724|453913055|FG001|Overall Study|Death|53|||
126171426|NCT02622724|453913054|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
126171427|NCT02622724|453913055|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
126171428|NCT02622724|453913054|FG000|Overall Study|Early termination of study|38|||
126171429|NCT02622724|453913055|FG001|Overall Study|Early termination of study|43|||
126171430|NCT00356863|453913056|FG000|Overall Study|Death|16|||
126171431|NCT00356863|453913057|FG001|Overall Study|Death|32|||
126171432|NCT00356863|453913056|FG000|Overall Study|Lost to Follow-up|76|||
126171433|NCT00356863|453913057|FG001|Overall Study|Lost to Follow-up|43|||
126171434|NCT00343291|453913060|FG000|Overall Study|Adverse Event|13|||
126171435|NCT00343291|453913061|FG001|Overall Study|Adverse Event|13|||
126171436|NCT00343291|453913060|FG000|Overall Study|Death|3|||
126171437|NCT00343291|453913061|FG001|Overall Study|Death|2|||
126171438|NCT00343291|453913060|FG000|Overall Study|Progressive disease|33|||
126171439|NCT00343291|453913061|FG001|Overall Study|Progressive disease|34|||
125973801|NCT02415400|453193165|FG001|Overall Study|Coagulation values cannot be set|0|||
125973802|NCT02415400|453193166|FG002|Overall Study|Coagulation values cannot be set|1|||
125973803|NCT02415400|453193167|FG003|Overall Study|Coagulation values cannot be set|0|||
125973804|NCT02415400|453193164|FG000|Overall Study|State regulations prevent participation|0|||
125973805|NCT02415400|453193165|FG001|Overall Study|State regulations prevent participation|0|||
125973806|NCT02415400|453193166|FG002|Overall Study|State regulations prevent participation|1|||
125973807|NCT02415400|453193167|FG003|Overall Study|State regulations prevent participation|0|||
125973808|NCT02415400|453193164|FG000|Overall Study|Poor treatment monitoring|0|||
125973809|NCT02415400|453193165|FG001|Overall Study|Poor treatment monitoring|0|||
126171440|NCT00343291|453913060|FG000|Overall Study|Withdrawal by Subject|0|||
126171441|NCT00343291|453913061|FG001|Overall Study|Withdrawal by Subject|2|||
126171442|NCT00343291|453913060|FG000|Overall Study|Other|8|||
126171443|NCT00343291|453913061|FG001|Overall Study|Other|5|||
126171444|NCT03712345|453913062|FG000|Overall Study|Failure to meet randomization criteria|0|||
126171445|NCT03712345|453913063|FG001|Overall Study|Failure to meet randomization criteria|0|||
126171446|NCT03712345|453913064|FG002|Overall Study|Failure to meet randomization criteria|1|||
126171447|NCT00485589|453913068|FG000|Overall Study|Death|2|||
126171448|NCT00485589|453913069|FG001|Overall Study|Death|2|||
126171449|NCT00485589|453913070|FG002|Overall Study|Death|0|||
126171450|NCT00485589|453913068|FG000|Overall Study|Failure to return|6|||
126171451|NCT00485589|453913069|FG001|Overall Study|Failure to return|5|||
126171452|NCT00485589|453913070|FG002|Overall Study|Failure to return|1|||
126171453|NCT00485589|453913068|FG000|Overall Study|Protocol Violation|1|||
125973810|NCT02415400|453193166|FG002|Overall Study|Poor treatment monitoring|1|||
126171454|NCT00485589|453913069|FG001|Overall Study|Protocol Violation|0|||
126171455|NCT00485589|453913070|FG002|Overall Study|Protocol Violation|0|||
126171456|NCT00485589|453913068|FG000|Overall Study|Violation of selection criteria at entry|0|||
126171457|NCT00485589|453913069|FG001|Overall Study|Violation of selection criteria at entry|3|||
126171458|NCT00485589|453913070|FG002|Overall Study|Violation of selection criteria at entry|1|||
126171459|NCT00485589|453913068|FG000|Overall Study|Administrative/Other|1|||
126171460|NCT00485589|453913069|FG001|Overall Study|Administrative/Other|2|||
126171461|NCT00485589|453913070|FG002|Overall Study|Administrative/Other|1|||
126171462|NCT00485589|453913068|FG000|Overall Study|Insufficient therapeutic response|10|||
126171463|NCT00485589|453913069|FG001|Overall Study|Insufficient therapeutic response|3|||
126171464|NCT00485589|453913070|FG002|Overall Study|Insufficient therapeutic response|1|||
126171465|NCT00485589|453913068|FG000|Overall Study|Refused treatment/did not cooperate|1|||
126171466|NCT00485589|453913069|FG001|Overall Study|Refused treatment/did not cooperate|0|||
126171467|NCT00485589|453913070|FG002|Overall Study|Refused treatment/did not cooperate|2|||
126171468|NCT00485589|453913068|FG000|Overall Study|Withdrawal by Subject|3|||
126171469|NCT00485589|453913069|FG001|Overall Study|Withdrawal by Subject|2|||
126171470|NCT00485589|453913070|FG002|Overall Study|Withdrawal by Subject|2|||
126171471|NCT00485589|453913068|FG000|Overall Study|Adverse Event|3|||
126171472|NCT00485589|453913069|FG001|Overall Study|Adverse Event|3|||
126171473|NCT00485589|453913070|FG002|Overall Study|Adverse Event|10|||
126171474|NCT02585999|453913071|FG000|Overall Study|Lost to Follow-up|1|||
126171475|NCT02585999|453913071|FG000|Overall Study|Protocol Violation|1|||
126171476|NCT01369849|453913072|FG000|Overall Study|Ineligible prior to treatment|0|||
126171477|NCT01369849|453913073|FG001|Overall Study|Ineligible prior to treatment|0|||
126171478|NCT01369849|453913074|FG002|Overall Study|Ineligible prior to treatment|1|||
126171479|NCT01369849|453913072|FG000|Overall Study|Ineligible after receiving treatment|0|||
126171480|NCT01369849|453913073|FG001|Overall Study|Ineligible after receiving treatment|1|||
126171481|NCT01369849|453913074|FG002|Overall Study|Ineligible after receiving treatment|0|||
126171482|NCT02924688|453913075|FG000|Overall Study|Adverse Event|9|||
126171483|NCT02924688|453913076|FG001|Overall Study|Adverse Event|3|||
126171484|NCT02924688|453913077|FG002|Overall Study|Adverse Event|2|||
126171485|NCT02924688|453913078|FG003|Overall Study|Adverse Event|2|||
126171486|NCT02924688|453913079|FG004|Overall Study|Adverse Event|3|||
126171487|NCT02924688|453913080|FG005|Overall Study|Adverse Event|2|||
126171488|NCT02924688|453913075|FG000|Overall Study|Lack of Efficacy|2|||
126171489|NCT02924688|453913076|FG001|Overall Study|Lack of Efficacy|3|||
126171490|NCT02924688|453913077|FG002|Overall Study|Lack of Efficacy|4|||
126171491|NCT02924688|453913078|FG003|Overall Study|Lack of Efficacy|2|||
126171492|NCT02924688|453913079|FG004|Overall Study|Lack of Efficacy|1|||
126171493|NCT02924688|453913080|FG005|Overall Study|Lack of Efficacy|1|||
126171494|NCT02924688|453913075|FG000|Overall Study|Protocol Violation|3|||
126171495|NCT02924688|453913076|FG001|Overall Study|Protocol Violation|7|||
126171496|NCT02924688|453913077|FG002|Overall Study|Protocol Violation|5|||
126171497|NCT02924688|453913078|FG003|Overall Study|Protocol Violation|6|||
126171498|NCT02924688|453913079|FG004|Overall Study|Protocol Violation|2|||
126171499|NCT02924688|453913080|FG005|Overall Study|Protocol Violation|2|||
126171500|NCT02924688|453913075|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
126171501|NCT02924688|453913076|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
126171502|NCT02924688|453913077|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
126171503|NCT02924688|453913078|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
126171504|NCT02924688|453913079|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
126171505|NCT02924688|453913080|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
126171506|NCT02924688|453913075|FG000|Overall Study|Lost to Follow-up|2|||
126171507|NCT02924688|453913076|FG001|Overall Study|Lost to Follow-up|4|||
126171508|NCT02924688|453913077|FG002|Overall Study|Lost to Follow-up|2|||
126171509|NCT02924688|453913078|FG003|Overall Study|Lost to Follow-up|4|||
126171510|NCT02924688|453913079|FG004|Overall Study|Lost to Follow-up|2|||
126171511|NCT02924688|453913080|FG005|Overall Study|Lost to Follow-up|4|||
125973811|NCT02415400|453193167|FG003|Overall Study|Poor treatment monitoring|0|||
125973812|NCT02415400|453193164|FG000|Overall Study|Participant in jail|0|||
125973813|NCT02415400|453193165|FG001|Overall Study|Participant in jail|0|||
125973814|NCT02415400|453193166|FG002|Overall Study|Participant in jail|1|||
126171512|NCT02924688|453913075|FG000|Overall Study|Physician Decision|2|||
126171513|NCT02924688|453913076|FG001|Overall Study|Physician Decision|1|||
126171514|NCT02924688|453913077|FG002|Overall Study|Physician Decision|0|||
126171515|NCT02924688|453913078|FG003|Overall Study|Physician Decision|1|||
126171516|NCT02924688|453913079|FG004|Overall Study|Physician Decision|1|||
126171517|NCT02924688|453913080|FG005|Overall Study|Physician Decision|1|||
126171518|NCT02924688|453913075|FG000|Overall Study|Withdrawal by Subject|14|||
126171519|NCT02924688|453913076|FG001|Overall Study|Withdrawal by Subject|13|||
126171520|NCT02924688|453913077|FG002|Overall Study|Withdrawal by Subject|9|||
126171521|NCT02924688|453913078|FG003|Overall Study|Withdrawal by Subject|12|||
126171522|NCT02924688|453913079|FG004|Overall Study|Withdrawal by Subject|13|||
126171523|NCT02924688|453913080|FG005|Overall Study|Withdrawal by Subject|14|||
126171524|NCT00174785|453913081|FG000|Overall Study|Adverse Event|293|||
126171525|NCT00174785|453913082|FG001|Overall Study|Adverse Event|191|||
125973815|NCT02415400|453193167|FG003|Overall Study|Participant in jail|0|||
126171526|NCT00174785|453913081|FG000|Overall Study|Protocol Violation|14|||
126171527|NCT00174785|453913082|FG001|Overall Study|Protocol Violation|14|||
126171528|NCT00174785|453913081|FG000|Overall Study|Withdrawal by Subject|173|||
126171529|NCT00174785|453913082|FG001|Overall Study|Withdrawal by Subject|175|||
126171530|NCT00174785|453913081|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
126171531|NCT00174785|453913082|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
126171532|NCT00174785|453913081|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
126171533|NCT00174785|453913082|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
126171534|NCT00174785|453913081|FG000|Overall Study|Other prohibited medication|5|||
126171535|NCT00174785|453913082|FG001|Overall Study|Other prohibited medication|3|||
126171536|NCT00174785|453913081|FG000|Overall Study|Family request|6|||
126171537|NCT00174785|453913082|FG001|Overall Study|Family request|8|||
126171538|NCT00174785|453913081|FG000|Overall Study|Not pre-specified/Not coded|56|||
126171539|NCT00174785|453913082|FG001|Overall Study|Not pre-specified/Not coded|70|||
126171540|NCT00120289|453913084|FG000|Overall Study|Death|96|||
126171541|NCT00120289|453913085|FG001|Overall Study|Death|82|||
126171542|NCT00120289|453913084|FG000|Overall Study|Lost to Follow-up|11|||
126171543|NCT00120289|453913085|FG001|Overall Study|Lost to Follow-up|14|||
126171544|NCT00120289|453913084|FG000|Overall Study|Withdrawal by Subject|14|||
126171545|NCT00120289|453913085|FG001|Overall Study|Withdrawal by Subject|13|||
126171546|NCT01944969|453913086|FG000|Overall Study|Adverse Event|1|||
126171547|NCT01944969|453913086|FG000|Overall Study|Lack of Efficacy|1|||
126171548|NCT01944969|453913086|FG000|Overall Study|Non-compliance with IMP|1|||
126171549|NCT01944969|453913086|FG000|Overall Study|Administrative or other reasons|23|||
126171550|NCT00848250|453913088|FG000|Overall Study|surgery was completed without cardiopulm|0|||
126171551|NCT00848250|453913089|FG001|Overall Study|surgery was completed without cardiopulm|1|||
126171552|NCT02938585|453913095|FG000|Overall Study|Withdrawal by parent or guardian|0|||
126171553|NCT02938585|453913096|FG001|Overall Study|Withdrawal by parent or guardian|1|||
126171554|NCT02938585|453913097|FG002|Overall Study|Withdrawal by parent or guardian|0|||
126171555|NCT02938585|453913098|FG003|Overall Study|Withdrawal by parent or guardian|0|||
126171556|NCT02938585|453913095|FG000|Overall Study|Withdrawal by Subject|0|||
126171557|NCT02938585|453913096|FG001|Overall Study|Withdrawal by Subject|0|||
126171558|NCT02938585|453913097|FG002|Overall Study|Withdrawal by Subject|0|||
126171559|NCT02938585|453913098|FG003|Overall Study|Withdrawal by Subject|5|||
126171560|NCT02411201|453913102|FG000|Overall Study|Adverse Event|2|||
126171561|NCT02411201|453913102|FG000|Overall Study|Withdrawal by Subject|2|||
126171562|NCT02411201|453913102|FG000|Overall Study|Age group completed|2|||
126171563|NCT01260467|453913103|FG000|Overall Study|Withdrawal by Subject|2|||
126171564|NCT01774344|453913104|FG000|Overall Study|Withdrawal by Subject|3|||
126171565|NCT01774344|453913105|FG001|Overall Study|Withdrawal by Subject|10|||
126171566|NCT01774344|453913104|FG000|Overall Study|Protocol Violation|0|||
126171567|NCT01774344|453913105|FG001|Overall Study|Protocol Violation|1|||
126171568|NCT01774344|453913104|FG000|Overall Study|Lost to Follow-up|4|||
126171569|NCT01774344|453913105|FG001|Overall Study|Lost to Follow-up|10|||
126171570|NCT01774344|453913104|FG000|Overall Study|End of survival follow-up not available|2|||
126171571|NCT01774344|453913105|FG001|Overall Study|End of survival follow-up not available|2|||
126171572|NCT01774344|453913104|FG000|Overall Study|Data collection finished|4|||
126171573|NCT01774344|453913105|FG001|Overall Study|Data collection finished|14|||
126171574|NCT01774344|453913104|FG000|Overall Study|Other|0|||
126171575|NCT01774344|453913105|FG001|Overall Study|Other|1|||
126171576|NCT01774344|453913104|FG000|Overall Study|Did not enter Survival Follow up|49|||
126171577|NCT01774344|453913105|FG001|Overall Study|Did not enter Survival Follow up|83|||
126171578|NCT01397552|453913106|FG000|Overall Study|Adverse Event|1|||
126171579|NCT01397552|453913107|FG001|Overall Study|Adverse Event|0|||
126171580|NCT01397552|453913106|FG000|Overall Study|Withdrawal by Subject|2|||
126171581|NCT01397552|453913107|FG001|Overall Study|Withdrawal by Subject|1|||
126171582|NCT01363713|453913114|FG000|Overall Study|Adverse Event|1|||
126171583|NCT01363713|453913114|FG000|Overall Study|Protocol Violation|3|||
126171584|NCT01363713|453913114|FG000|Overall Study|Withdrawal by Subject|2|||
126171585|NCT01658579|453913115|FG000|Treatment Period A|Other|0|||
126171586|NCT01658579|453913116|FG001|Treatment Period A|Other|0|||
126171587|NCT01658579|453913117|FG002|Treatment Period A|Other|1|||
126171588|NCT01658579|453913118|FG003|Treatment Period A|Other|1|||
126171589|NCT01658579|453913115|FG000|Treatment Period A|Adverse Event|1|||
126171590|NCT01658579|453913116|FG001|Treatment Period A|Adverse Event|0|||
126171591|NCT01658579|453913117|FG002|Treatment Period A|Adverse Event|0|||
126171592|NCT01658579|453913118|FG003|Treatment Period A|Adverse Event|0|||
126171593|NCT01658579|453913115|FG000|Treatment Period B|Other|0|||
126171594|NCT01658579|453913116|FG001|Treatment Period B|Other|0|||
126171595|NCT01658579|453913117|FG002|Treatment Period B|Other|0|||
126171596|NCT01658579|453913118|FG003|Treatment Period B|Other|1|||
126171597|NCT00608530|453913121|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
126171598|NCT00608530|453913122|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
126171599|NCT00608530|453913123|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
125973816|NCT02415400|453193164|FG000|Overall Study|Investigator decision|0|||
126171600|NCT00608530|453913124|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
126171601|NCT00608530|453913121|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
126171602|NCT00608530|453913122|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
126171603|NCT00608530|453913123|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
126171604|NCT00608530|453913124|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
126171605|NCT00608530|453913121|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
126171606|NCT00608530|453913122|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
126171607|NCT00608530|453913123|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
126171608|NCT00608530|453913124|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
126171609|NCT00608530|453913121|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
126171610|NCT00608530|453913122|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
126171611|NCT00608530|453913123|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
126171612|NCT00608530|453913124|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
126171613|NCT00608530|453913121|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
126171614|NCT00608530|453913122|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
126171615|NCT00608530|453913123|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
126171616|NCT00608530|453913124|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
126171617|NCT00608530|453913121|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
126171618|NCT00608530|453913122|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
126171619|NCT00608530|453913123|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
126171620|NCT00608530|453913124|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
126171621|NCT01514188|453913125|FG000|Overall Study|Adverse Event|3|||
126171622|NCT01514188|453913126|FG001|Overall Study|Adverse Event|5|||
126171623|NCT01514188|453913125|FG000|Overall Study|Withdrawal by Subject|2|||
126171624|NCT01514188|453913126|FG001|Overall Study|Withdrawal by Subject|4|||
126171625|NCT01514188|453913125|FG000|Overall Study|Protocol Violation|2|||
126171626|NCT01514188|453913126|FG001|Overall Study|Protocol Violation|4|||
126171627|NCT01514188|453913125|FG000|Overall Study|Physician Decision|0|||
126171628|NCT01514188|453913126|FG001|Overall Study|Physician Decision|2|||
126171629|NCT01514188|453913125|FG000|Overall Study|Disease Progression|13|||
126171630|NCT01514188|453913126|FG001|Overall Study|Disease Progression|14|||
126171631|NCT01514188|453913125|FG000|Overall Study|Death|1|||
126171632|NCT01514188|453913126|FG001|Overall Study|Death|3|||
126171633|NCT01514188|453913125|FG000|Overall Study|Other|2|||
126171634|NCT01514188|453913126|FG001|Overall Study|Other|1|||
126171635|NCT01019486|453913127|FG000|Overall Study|Withdrawal by Subject|1|||
126171636|NCT01019486|453913128|FG001|Overall Study|Withdrawal by Subject|1|||
126171637|NCT01019486|453913129|FG002|Overall Study|Withdrawal by Subject|1|||
126171638|NCT02932332|453913134|FG000|Overall Study|Withdrawal by Subject|1|||
126171639|NCT02932332|453913135|FG001|Overall Study|Withdrawal by Subject|1|||
126171640|NCT02932332|453913136|FG002|Overall Study|Withdrawal by Subject|0|||
126171641|NCT02932332|453913137|FG003|Overall Study|Withdrawal by Subject|1|||
126171642|NCT02932332|453913134|FG000|Overall Study|Chest pain|0|||
126171643|NCT02932332|453913135|FG001|Overall Study|Chest pain|0|||
126171644|NCT02932332|453913136|FG002|Overall Study|Chest pain|0|||
126171645|NCT02932332|453913137|FG003|Overall Study|Chest pain|1|||
126171646|NCT02932332|453913134|FG000|Overall Study|Not Dyspneic cough|1|||
126171647|NCT02932332|453913135|FG001|Overall Study|Not Dyspneic cough|2|||
126171648|NCT02932332|453913136|FG002|Overall Study|Not Dyspneic cough|1|||
126171649|NCT02932332|453913137|FG003|Overall Study|Not Dyspneic cough|0|||
126171650|NCT02841787|453913138|FG000|Overall Study|Lost to Follow-up|1|||
126171651|NCT02841787|453913139|FG001|Overall Study|Lost to Follow-up|0|||
126171652|NCT02841787|453913140|FG002|Overall Study|Lost to Follow-up|0|||
126171653|NCT02841787|453913138|FG000|Overall Study|Symptoms dropped below threshold|1|||
126171654|NCT02841787|453913139|FG001|Overall Study|Symptoms dropped below threshold|0|||
126171655|NCT02841787|453913140|FG002|Overall Study|Symptoms dropped below threshold|0|||
126171656|NCT02841787|453913138|FG000|Overall Study|Withdrawal by Subject|1|||
126171657|NCT02841787|453913139|FG001|Overall Study|Withdrawal by Subject|4|||
126171658|NCT02841787|453913140|FG002|Overall Study|Withdrawal by Subject|0|||
125973817|NCT02415400|453193165|FG001|Overall Study|Investigator decision|0|||
126171659|NCT03029650|453913141|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
126171660|NCT03029650|453913142|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
126171661|NCT03029650|453913141|FG000|Washout (1 Week)|Physician Decision|0|||
126171662|NCT03029650|453913142|FG001|Washout (1 Week)|Physician Decision|1|||
126171663|NCT01875367|453913143|FG000|Overall Study|Not complete at least 2 questionaries|4|||
126171664|NCT01875367|453913144|FG001|Overall Study|Not complete at least 2 questionaries|2|||
125973818|NCT02415400|453193166|FG002|Overall Study|Investigator decision|1|||
125973819|NCT02415400|453193167|FG003|Overall Study|Investigator decision|1|||
125973820|NCT02415400|453193164|FG000|Overall Study|Site closure; participant won't transfer|0|||
126171665|NCT01875367|453913143|FG000|Overall Study|Not receive study treatment|1|||
126171666|NCT01875367|453913144|FG001|Overall Study|Not receive study treatment|0|||
126171667|NCT02951988|453913157|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
126171668|NCT02951988|453913158|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
126200121|NCT02394028|454017887|FG010|Induction Phase|Lack of Efficacy|0|||
126171669|NCT02951988|453913159|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
126171670|NCT02951988|453913160|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
126171671|NCT02951988|453913157|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
126171672|NCT02951988|453913158|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
126171673|NCT02951988|453913159|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
126171674|NCT02951988|453913160|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
126171675|NCT02951988|453913157|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
126171676|NCT02951988|453913158|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
126171677|NCT02951988|453913159|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
126171678|NCT02951988|453913160|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
126171679|NCT02951988|453913157|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
126171680|NCT02951988|453913158|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
126171681|NCT02951988|453913159|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
126171682|NCT02951988|453913160|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
126171683|NCT02951988|453913157|FG000|Open-Label Treatment Period|Protocol Violation|22|||
126171684|NCT02951988|453913158|FG001|Open-Label Treatment Period|Protocol Violation|0|||
126171685|NCT02951988|453913159|FG002|Open-Label Treatment Period|Protocol Violation|0|||
126171686|NCT02951988|453913160|FG003|Open-Label Treatment Period|Protocol Violation|0|||
126171687|NCT02951988|453913157|FG000|Open-Label Treatment Period|Pregnancy|2|||
126171688|NCT02951988|453913158|FG001|Open-Label Treatment Period|Pregnancy|0|||
126171689|NCT02951988|453913159|FG002|Open-Label Treatment Period|Pregnancy|0|||
126171690|NCT02951988|453913160|FG003|Open-Label Treatment Period|Pregnancy|0|||
126171691|NCT02951988|453913157|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
126171692|NCT02951988|453913158|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
126171693|NCT02951988|453913159|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
126171694|NCT02951988|453913160|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
126171695|NCT02951988|453913157|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
126171696|NCT02951988|453913158|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
126171697|NCT02951988|453913159|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
126171698|NCT02951988|453913160|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
126171699|NCT02951988|453913157|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
126171700|NCT02951988|453913158|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
126171701|NCT02951988|453913159|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
126171702|NCT02951988|453913160|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
126171703|NCT02951988|453913157|FG000|Open-Label Treatment Period|Adverse Event|45|||
126171704|NCT02951988|453913158|FG001|Open-Label Treatment Period|Adverse Event|0|||
126171705|NCT02951988|453913159|FG002|Open-Label Treatment Period|Adverse Event|0|||
126171706|NCT02951988|453913160|FG003|Open-Label Treatment Period|Adverse Event|0|||
126171707|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
126171708|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
126171709|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
126171710|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
126171711|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
126171712|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
126171713|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
126171714|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
126171715|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
126171716|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
126171717|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
126171718|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
126171719|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126171720|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
126171721|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
126171722|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
126171723|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Pregnancy|0|||
126171724|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Pregnancy|1|||
126171725|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Pregnancy|1|||
126200122|NCT02394028|454017877|FG000|Induction Phase|Lost to Follow-up|1|||
125973821|NCT02415400|453193165|FG001|Overall Study|Site closure; participant won't transfer|0|||
125973822|NCT02415400|453193166|FG002|Overall Study|Site closure; participant won't transfer|0|||
125973823|NCT02415400|453193167|FG003|Overall Study|Site closure; participant won't transfer|1|||
125973824|NCT02270450|453193168|FG000|Overall Study|Refusal unrelated to adverse event|3|||
125973825|NCT02270450|453193169|FG001|Overall Study|Refusal unrelated to adverse event|1|||
125973826|NCT02270450|453193170|FG002|Overall Study|Refusal unrelated to adverse event|5|||
125973827|NCT02270450|453193171|FG003|Overall Study|Refusal unrelated to adverse event|14|||
125973828|NCT02270450|453193168|FG000|Overall Study|Progression/relapse|1|||
125973829|NCT02270450|453193169|FG001|Overall Study|Progression/relapse|2|||
125973830|NCT02270450|453193170|FG002|Overall Study|Progression/relapse|4|||
125973831|NCT02270450|453193171|FG003|Overall Study|Progression/relapse|9|||
126171726|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Pregnancy|0|||
126171727|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126171728|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
126171729|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
126171730|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
126171731|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126171732|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
126171733|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
126171734|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
126171735|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126171736|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Adverse Event|8|||
126171737|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Adverse Event|3|||
126171738|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Adverse Event|6|||
126171739|NCT02951988|453913157|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
126171740|NCT02951988|453913158|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
126171741|NCT02951988|453913159|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
126171742|NCT02951988|453913160|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
126171743|NCT05836818|453913161|FG000|Overall Study|Physician Decision|1|||
126171744|NCT05836818|453913162|FG001|Overall Study|Physician Decision|1|||
126171745|NCT05836818|453913163|FG002|Overall Study|Physician Decision|0|||
126171746|NCT05836818|453913161|FG000|Overall Study|Withdrawal by Subject|0|||
126171747|NCT05836818|453913162|FG001|Overall Study|Withdrawal by Subject|0|||
126171748|NCT05836818|453913163|FG002|Overall Study|Withdrawal by Subject|1|||
126171749|NCT05836818|453913161|FG000|Overall Study|Later found to be previously vaccinated|0|||
126171750|NCT05836818|453913162|FG001|Overall Study|Later found to be previously vaccinated|1|||
126171751|NCT05836818|453913163|FG002|Overall Study|Later found to be previously vaccinated|3|||
126171752|NCT05836818|453913161|FG000|Overall Study|Pregnancy|0|||
126171753|NCT05836818|453913162|FG001|Overall Study|Pregnancy|1|||
126171754|NCT05836818|453913163|FG002|Overall Study|Pregnancy|0|||
126171755|NCT05836818|453913161|FG000|Overall Study|Allergic to vaccines|0|||
126171756|NCT05836818|453913162|FG001|Overall Study|Allergic to vaccines|1|||
126171757|NCT05836818|453913163|FG002|Overall Study|Allergic to vaccines|0|||
126171758|NCT03977727|453913164|FG000|Second Treatment|Lost to Follow-up|0|||
126171759|NCT03977727|453913165|FG001|Second Treatment|Lost to Follow-up|3|||
126171760|NCT00603980|453913171|FG000|Study Qualification|Protocol Violation|3|||
126171761|NCT00603980|453913171|FG000|Study Qualification|Inconsistent data reporting|13|||
126171762|NCT00603980|453913171|FG000|Main Study|14th subject completed trial|1|||
126171763|NCT02683525|453913172|FG000|Overall Study|Lost to Follow-up|1|||
126171764|NCT02683525|453913172|FG000|Overall Study|Physician Decision|1|||
126171765|NCT02683525|453913172|FG000|Overall Study|Disease Progression|6|||
126171766|NCT01627067|453913173|FG000|Overall Study|Screen Failure|1|||
126171767|NCT00926796|453913181|FG000|Overall Study|Did not receive randomized treatment|4|||
126171768|NCT00926796|453913182|FG001|Overall Study|Did not receive randomized treatment|7|||
126171769|NCT00926796|453913181|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
126171770|NCT00926796|453913182|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
126171771|NCT00926796|453913181|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
126171772|NCT00926796|453913182|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
126171773|NCT00926796|453913181|FG000|Overall Study|Adverse Event|7|||
126171774|NCT00926796|453913182|FG001|Overall Study|Adverse Event|14|||
126171775|NCT00926796|453913181|FG000|Overall Study|Lost to Follow-up|22|||
126171776|NCT00926796|453913182|FG001|Overall Study|Lost to Follow-up|13|||
126171777|NCT00926796|453913181|FG000|Overall Study|Protocol Violation|15|||
126171778|NCT00926796|453913182|FG001|Overall Study|Protocol Violation|11|||
126171779|NCT00926796|453913181|FG000|Overall Study|Withdrawal by Subject|1|||
126171780|NCT00926796|453913182|FG001|Overall Study|Withdrawal by Subject|0|||
126171781|NCT01341652|453913186|FG000|Overall Study|Incorrect Random Assignment|0|||
126171782|NCT01341652|453913187|FG001|Overall Study|Incorrect Random Assignment|1|||
126171783|NCT01341652|453913186|FG000|Overall Study|ineligible; presence metastatic disease|0|||
126171784|NCT01341652|453913187|FG001|Overall Study|ineligible; presence metastatic disease|1|||
126171785|NCT00586924|453913189|FG000|Overall Study|Adverse event/serious adverse event|0|||
126171786|NCT00586924|453913190|FG001|Overall Study|Adverse event/serious adverse event|0|||
126171787|NCT00586924|453913191|FG002|Overall Study|Adverse event/serious adverse event|0|||
126171788|NCT00586924|453913192|FG003|Overall Study|Adverse event/serious adverse event|1|||
126171789|NCT00586924|453913193|FG004|Overall Study|Adverse event/serious adverse event|0|||
126171790|NCT00586924|453913194|FG005|Overall Study|Adverse event/serious adverse event|2|||
126171791|NCT00586924|453913189|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
126171792|NCT00586924|453913190|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
126171793|NCT00586924|453913191|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
126171794|NCT00586924|453913192|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
126171795|NCT00586924|453913193|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
126171796|NCT00586924|453913194|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
126171797|NCT00586924|453913189|FG000|Overall Study|Disease progression|0|||
126171798|NCT00586924|453913190|FG001|Overall Study|Disease progression|0|||
126171799|NCT00586924|453913191|FG002|Overall Study|Disease progression|0|||
126171800|NCT00586924|453913192|FG003|Overall Study|Disease progression|1|||
126171801|NCT00586924|453913193|FG004|Overall Study|Disease progression|1|||
126171802|NCT00586924|453913194|FG005|Overall Study|Disease progression|0|||
126171803|NCT00586924|453913189|FG000|Overall Study|Development of neutralizing antibodies|2|||
126171804|NCT00586924|453913190|FG001|Overall Study|Development of neutralizing antibodies|2|||
126171805|NCT00586924|453913191|FG002|Overall Study|Development of neutralizing antibodies|2|||
126171806|NCT00586924|453913192|FG003|Overall Study|Development of neutralizing antibodies|0|||
126171807|NCT00586924|453913193|FG004|Overall Study|Development of neutralizing antibodies|0|||
126171808|NCT00586924|453913194|FG005|Overall Study|Development of neutralizing antibodies|22|||
126171809|NCT00586924|453913189|FG000|Overall Study|Complete response|0|||
126171810|NCT00586924|453913190|FG001|Overall Study|Complete response|1|||
126171811|NCT00586924|453913191|FG002|Overall Study|Complete response|0|||
126171812|NCT00586924|453913192|FG003|Overall Study|Complete response|0|||
126171813|NCT00586924|453913193|FG004|Overall Study|Complete response|2|||
126171814|NCT00586924|453913194|FG005|Overall Study|Complete response|2|||
126171815|NCT00586924|453913189|FG000|Overall Study|Other|1|||
126171816|NCT00586924|453913190|FG001|Overall Study|Other|0|||
126171817|NCT00586924|453913191|FG002|Overall Study|Other|1|||
126171818|NCT00586924|453913192|FG003|Overall Study|Other|1|||
126171819|NCT00586924|453913193|FG004|Overall Study|Other|1|||
126171820|NCT00586924|453913194|FG005|Overall Study|Other|6|||
126171821|NCT04167306|453913199|FG000|Overall Study|Lost to Follow-up|2|||
126171822|NCT04167306|453913200|FG001|Overall Study|Lost to Follow-up|2|||
126171823|NCT04167306|453913201|FG002|Overall Study|Lost to Follow-up|5|||
126171824|NCT04167306|453913202|FG003|Overall Study|Lost to Follow-up|5|||
126171825|NCT04167306|453913199|FG000|Overall Study|Adverse Event|13|||
126171826|NCT04167306|453913200|FG001|Overall Study|Adverse Event|14|||
126171827|NCT04167306|453913201|FG002|Overall Study|Adverse Event|5|||
126171828|NCT04167306|453913202|FG003|Overall Study|Adverse Event|4|||
126171829|NCT04167306|453913199|FG000|Overall Study|Withdrawal by Subject|4|||
126171830|NCT04167306|453913200|FG001|Overall Study|Withdrawal by Subject|6|||
126171831|NCT04167306|453913201|FG002|Overall Study|Withdrawal by Subject|8|||
126171832|NCT04167306|453913202|FG003|Overall Study|Withdrawal by Subject|3|||
126171833|NCT04167306|453913199|FG000|Overall Study|covid|1|||
126171834|NCT04167306|453913200|FG001|Overall Study|covid|1|||
126171835|NCT04167306|453913201|FG002|Overall Study|covid|2|||
126171836|NCT04167306|453913202|FG003|Overall Study|covid|1|||
126171837|NCT04167306|453913199|FG000|Overall Study|concomitant medication|0|||
126171838|NCT04167306|453913200|FG001|Overall Study|concomitant medication|0|||
126171839|NCT04167306|453913201|FG002|Overall Study|concomitant medication|0|||
126171840|NCT04167306|453913202|FG003|Overall Study|concomitant medication|1|||
126171841|NCT04167306|453913199|FG000|Overall Study|Alcohol treatment|0|||
126171842|NCT04167306|453913200|FG001|Overall Study|Alcohol treatment|4|||
126171843|NCT04167306|453913201|FG002|Overall Study|Alcohol treatment|3|||
126171844|NCT04167306|453913202|FG003|Overall Study|Alcohol treatment|2|||
126171845|NCT04167306|453913199|FG000|Overall Study|non-compliance|0|||
126171846|NCT04167306|453913200|FG001|Overall Study|non-compliance|0|||
126171847|NCT04167306|453913201|FG002|Overall Study|non-compliance|1|||
126171848|NCT04167306|453913202|FG003|Overall Study|non-compliance|0|||
126171849|NCT04167306|453913199|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
126171850|NCT04167306|453913200|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
126171851|NCT04167306|453913201|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
126171852|NCT04167306|453913202|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
126171853|NCT04146467|453913204|FG000|Overall Study|Adverse Event|0|||
126171854|NCT04146467|453913205|FG001|Overall Study|Adverse Event|1|||
126171855|NCT04146467|453913204|FG000|Overall Study|Lost to Follow-up|0|||
126171856|NCT04146467|453913205|FG001|Overall Study|Lost to Follow-up|2|||
126171857|NCT00621855|453913206|FG000|Overall Study|Adverse Event|32|||
126171858|NCT00621855|453913207|FG001|Overall Study|Adverse Event|31|||
126171859|NCT00621855|453913208|FG002|Overall Study|Adverse Event|48|||
126171860|NCT00621855|453913209|FG003|Overall Study|Adverse Event|34|||
126171861|NCT00621855|453913210|FG004|Overall Study|Adverse Event|31|||
126171862|NCT00621855|453913206|FG000|Overall Study|Lost to Follow-up|0|||
126171863|NCT00621855|453913207|FG001|Overall Study|Lost to Follow-up|1|||
126171864|NCT00621855|453913208|FG002|Overall Study|Lost to Follow-up|3|||
126171865|NCT00621855|453913209|FG003|Overall Study|Lost to Follow-up|4|||
126171866|NCT00621855|453913210|FG004|Overall Study|Lost to Follow-up|1|||
126171867|NCT00621855|453913206|FG000|Overall Study|Protocol Violation|16|||
126171868|NCT00621855|453913207|FG001|Overall Study|Protocol Violation|8|||
126171869|NCT00621855|453913208|FG002|Overall Study|Protocol Violation|6|||
126171870|NCT00621855|453913209|FG003|Overall Study|Protocol Violation|7|||
126171871|NCT00621855|453913210|FG004|Overall Study|Protocol Violation|8|||
126171872|NCT00621855|453913206|FG000|Overall Study|Withdrawal by Subject|16|||
126171873|NCT00621855|453913207|FG001|Overall Study|Withdrawal by Subject|11|||
126171874|NCT00621855|453913208|FG002|Overall Study|Withdrawal by Subject|13|||
126171875|NCT00621855|453913209|FG003|Overall Study|Withdrawal by Subject|13|||
126171876|NCT00621855|453913210|FG004|Overall Study|Withdrawal by Subject|9|||
126171877|NCT00621855|453913206|FG000|Overall Study|Other|9|||
126171878|NCT00621855|453913207|FG001|Overall Study|Other|7|||
126171879|NCT00621855|453913208|FG002|Overall Study|Other|6|||
126171880|NCT00621855|453913209|FG003|Overall Study|Other|5|||
126171881|NCT00621855|453913210|FG004|Overall Study|Other|4|||
126171882|NCT00621855|453913206|FG000|Overall Study|Patients did not receive study drug|3|||
126171883|NCT00621855|453913207|FG001|Overall Study|Patients did not receive study drug|3|||
126171884|NCT00621855|453913208|FG002|Overall Study|Patients did not receive study drug|5|||
126171885|NCT00621855|453913209|FG003|Overall Study|Patients did not receive study drug|4|||
126171886|NCT00621855|453913210|FG004|Overall Study|Patients did not receive study drug|2|||
126171887|NCT01737840|453913211|FG000|Overall Study|Diagnosed with an other pathology|2|||
126171888|NCT01737840|453913212|FG001|Overall Study|Diagnosed with an other pathology|2|||
126171889|NCT01189435|453913213|FG000|Overall Study|Withdrawal by Subject|1|||
126171890|NCT01189435|453913213|FG000|Overall Study|Physician Decision|1|||
126171891|NCT03259490|453913216|FG000|Period 1|Withdrawal by Subject|0|||
126171892|NCT03259490|453913217|FG001|Period 1|Withdrawal by Subject|1|||
126171893|NCT03259490|453913216|FG000|Period 2|Protocol Violation|1|||
126171894|NCT03259490|453913217|FG001|Period 2|Protocol Violation|0|||
126171895|NCT01963208|453913218|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
126171896|NCT01963208|453913219|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
126171897|NCT01963208|453913220|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
126171898|NCT01963208|453913221|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
126171899|NCT01963208|453913222|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
126171900|NCT01963208|453913223|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
126171901|NCT01963208|453913218|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
126171902|NCT01963208|453913219|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
126171903|NCT01963208|453913220|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
126171904|NCT01963208|453913221|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
126171905|NCT01963208|453913222|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
126171906|NCT01963208|453913223|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
126171907|NCT01963208|453913218|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126171908|NCT01963208|453913219|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126171909|NCT01963208|453913220|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
126171910|NCT01963208|453913221|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126171911|NCT01963208|453913222|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126171912|NCT01963208|453913223|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126171913|NCT01963208|453913218|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
126171914|NCT01963208|453913219|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
126171915|NCT01963208|453913220|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
126171916|NCT01963208|453913221|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
126171917|NCT01963208|453913222|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
126171918|NCT01963208|453913223|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
126171919|NCT01963208|453913218|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
126171920|NCT01963208|453913219|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
126171921|NCT01963208|453913220|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
126171922|NCT01963208|453913221|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
126171923|NCT01963208|453913222|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
126171924|NCT01963208|453913223|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
126171925|NCT01963208|453913218|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126171926|NCT01963208|453913219|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126171927|NCT01963208|453913220|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126171928|NCT01963208|453913221|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
126171929|NCT01963208|453913222|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126171930|NCT01963208|453913223|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126171931|NCT01963208|453913218|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126171932|NCT01963208|453913219|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126171933|NCT01963208|453913220|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126171934|NCT01963208|453913221|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
126171935|NCT01963208|453913222|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126171936|NCT01963208|453913223|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126171937|NCT01963208|453913218|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
126171938|NCT01963208|453913219|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
126171939|NCT01963208|453913220|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
126171940|NCT01963208|453913221|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
126171941|NCT01963208|453913222|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
126171942|NCT01963208|453913223|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
126171943|NCT01963208|453913218|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
126171944|NCT01963208|453913219|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
126171945|NCT01963208|453913220|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
126171946|NCT01963208|453913221|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
126171947|NCT01963208|453913222|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
126171948|NCT01963208|453913223|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
126171949|NCT01963208|453913218|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126171950|NCT01963208|453913219|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126171951|NCT01963208|453913220|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126171952|NCT01963208|453913221|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126171953|NCT01963208|453913222|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126171954|NCT01963208|453913223|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
126171955|NCT01963208|453913218|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126171956|NCT01963208|453913219|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126171957|NCT01963208|453913220|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126171958|NCT01963208|453913221|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126171959|NCT01963208|453913222|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126171960|NCT01963208|453913223|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
126171961|NCT01963208|453913218|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
126171962|NCT01963208|453913219|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
126171963|NCT01963208|453913220|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
126171964|NCT01963208|453913221|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
126171965|NCT01963208|453913222|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
126171966|NCT01963208|453913223|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
126171967|NCT01963208|453913218|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
126171968|NCT01963208|453913219|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
126171969|NCT01963208|453913220|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
126171970|NCT01963208|453913221|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
126171971|NCT01963208|453913222|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
126171972|NCT01963208|453913223|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
126171973|NCT01963208|453913218|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
126171974|NCT01963208|453913219|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
126171975|NCT01963208|453913220|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
126171976|NCT01963208|453913221|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
126171977|NCT01963208|453913222|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
126171978|NCT01963208|453913223|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
126171979|NCT00448916|453913224|FG000|Overall Study|Adverse Event|2|||
126171980|NCT00448916|453913225|FG001|Overall Study|Adverse Event|2|||
126171981|NCT00448916|453913226|FG002|Overall Study|Adverse Event|3|||
126171982|NCT00448916|453913227|FG003|Overall Study|Adverse Event|2|||
126171983|NCT00448916|453913224|FG000|Overall Study|Lack of Efficacy|1|||
126171984|NCT00448916|453913225|FG001|Overall Study|Lack of Efficacy|0|||
126171985|NCT00448916|453913226|FG002|Overall Study|Lack of Efficacy|2|||
126171986|NCT00448916|453913227|FG003|Overall Study|Lack of Efficacy|1|||
126171987|NCT00448916|453913224|FG000|Overall Study|Withdrawal by Subject|3|||
126171988|NCT00448916|453913225|FG001|Overall Study|Withdrawal by Subject|3|||
126171989|NCT00448916|453913226|FG002|Overall Study|Withdrawal by Subject|1|||
126171990|NCT00448916|453913227|FG003|Overall Study|Withdrawal by Subject|1|||
126171991|NCT00448916|453913224|FG000|Overall Study|Other|1|||
126171992|NCT00448916|453913225|FG001|Overall Study|Other|0|||
126171993|NCT00448916|453913226|FG002|Overall Study|Other|0|||
126171994|NCT00448916|453913227|FG003|Overall Study|Other|0|||
126171995|NCT00448916|453913224|FG000|Overall Study|Lost to Follow-up|0|||
126171996|NCT00448916|453913225|FG001|Overall Study|Lost to Follow-up|1|||
126171997|NCT00448916|453913226|FG002|Overall Study|Lost to Follow-up|0|||
126171998|NCT00448916|453913227|FG003|Overall Study|Lost to Follow-up|1|||
126171999|NCT00448916|453913224|FG000|Overall Study|Protocol Violation|0|||
126172000|NCT00448916|453913225|FG001|Overall Study|Protocol Violation|0|||
126172001|NCT00448916|453913226|FG002|Overall Study|Protocol Violation|0|||
126172002|NCT00448916|453913227|FG003|Overall Study|Protocol Violation|1|||
126172003|NCT03521193|453913228|FG000|Overall Study|Withdrawal by Subject|8|||
126172004|NCT03521193|453913229|FG001|Overall Study|Withdrawal by Subject|0|||
126172005|NCT03521193|453913228|FG000|Overall Study|non compliant to ASA treatment|8|||
126172006|NCT03521193|453913229|FG001|Overall Study|non compliant to ASA treatment|0|||
126172007|NCT03707158|453913230|FG000|Midtreatment|Lost to Follow-up|16|||
126172008|NCT03707158|453913231|FG001|Midtreatment|Lost to Follow-up|7|||
126172009|NCT03707158|453913230|FG000|Midtreatment|Withdrawal by Subject|28|||
126172010|NCT03707158|453913231|FG001|Midtreatment|Withdrawal by Subject|19|||
126172011|NCT03707158|453913230|FG000|Posttreatment|Lost to Follow-up|0|||
126172012|NCT03707158|453913231|FG001|Posttreatment|Lost to Follow-up|5|||
126172013|NCT03707158|453913230|FG000|Follow-up|Lost to Follow-up|19|||
126172014|NCT03707158|453913231|FG001|Follow-up|Lost to Follow-up|18|||
126172015|NCT03707158|453913230|FG000|Follow-up|Withdrawal by Subject|13|||
126172016|NCT03707158|453913231|FG001|Follow-up|Withdrawal by Subject|6|||
126172017|NCT05108805|453913232|FG000|Overall Study|T-cell expansion was not successful.|5|||
126172018|NCT02198651|453915504|FG000|Lead-in Period|Withdrew consent|13|||
126172019|NCT02198651|453915505|FG001|Lead-in Period|Withdrew consent|0|||
126172020|NCT02198651|453915506|FG002|Lead-in Period|Withdrew consent|0|||
126172021|NCT02198651|453915507|FG003|Lead-in Period|Withdrew consent|0|||
126172022|NCT02198651|453915508|FG004|Lead-in Period|Withdrew consent|0|||
126172023|NCT02198651|453915504|FG000|Lead-in Period|Adverse Event|2|||
126172024|NCT02198651|453915505|FG001|Lead-in Period|Adverse Event|0|||
126172025|NCT02198651|453915506|FG002|Lead-in Period|Adverse Event|0|||
126172026|NCT02198651|453915507|FG003|Lead-in Period|Adverse Event|0|||
126172027|NCT02198651|453915508|FG004|Lead-in Period|Adverse Event|0|||
126172028|NCT02198651|453915504|FG000|Lead-in Period|Other, not specified|22|||
126172029|NCT02198651|453915505|FG001|Lead-in Period|Other, not specified|0|||
126172030|NCT02198651|453915506|FG002|Lead-in Period|Other, not specified|0|||
126172031|NCT02198651|453915507|FG003|Lead-in Period|Other, not specified|0|||
126172032|NCT02198651|453915508|FG004|Lead-in Period|Other, not specified|0|||
126172033|NCT02198651|453915504|FG000|Double-blind Period|Withdrew consent|0|||
126172034|NCT02198651|453915505|FG001|Double-blind Period|Withdrew consent|4|||
126172035|NCT02198651|453915506|FG002|Double-blind Period|Withdrew consent|0|||
126172036|NCT02198651|453915507|FG003|Double-blind Period|Withdrew consent|0|||
126172037|NCT02198651|453915508|FG004|Double-blind Period|Withdrew consent|0|||
126172038|NCT02198651|453915504|FG000|Double-blind Period|Adverse Event|0|||
126172039|NCT02198651|453915505|FG001|Double-blind Period|Adverse Event|1|||
126172040|NCT02198651|453915506|FG002|Double-blind Period|Adverse Event|0|||
126172041|NCT02198651|453915507|FG003|Double-blind Period|Adverse Event|0|||
126172042|NCT02198651|453915508|FG004|Double-blind Period|Adverse Event|0|||
126172043|NCT02198651|453915504|FG000|Double-blind Period|Other, not specified|0|||
126172044|NCT02198651|453915505|FG001|Double-blind Period|Other, not specified|4|||
126172045|NCT02198651|453915506|FG002|Double-blind Period|Other, not specified|1|||
126172046|NCT02198651|453915507|FG003|Double-blind Period|Other, not specified|0|||
126172047|NCT02198651|453915508|FG004|Double-blind Period|Other, not specified|0|||
126172048|NCT02198651|453915504|FG000|Open-label Rescue Period|Withdrew consent|0|||
126172049|NCT02198651|453915505|FG001|Open-label Rescue Period|Withdrew consent|0|||
126172050|NCT02198651|453915506|FG002|Open-label Rescue Period|Withdrew consent|0|||
126172051|NCT02198651|453915507|FG003|Open-label Rescue Period|Withdrew consent|2|||
126172052|NCT02198651|453915508|FG004|Open-label Rescue Period|Withdrew consent|0|||
126172053|NCT02198651|453915504|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
126172054|NCT02198651|453915505|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
126172055|NCT02198651|453915506|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
126172056|NCT02198651|453915507|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
126172057|NCT02198651|453915508|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
126172058|NCT01754922|453915509|FG000|Overall Study|Adverse Event|0|||
126172059|NCT01754922|453915510|FG001|Overall Study|Adverse Event|1|||
126172060|NCT00310388|453915512|FG000|Primary Reporting Phase|Adverse Event|101|||
126172061|NCT00310388|453915513|FG001|Primary Reporting Phase|Adverse Event|0|||
126172062|NCT00310388|453915512|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
126172063|NCT00310388|453915513|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
126172064|NCT00310388|453915512|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
126172065|NCT00310388|453915513|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
126172066|NCT00310388|453915512|FG000|Primary Reporting Phase|Protocol Violation|10|||
126172067|NCT00310388|453915513|FG001|Primary Reporting Phase|Protocol Violation|0|||
126172068|NCT00310388|453915512|FG000|Primary Reporting Phase|Pregnancy|3|||
126172069|NCT00310388|453915513|FG001|Primary Reporting Phase|Pregnancy|0|||
126172070|NCT00310388|453915512|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
126172071|NCT00310388|453915513|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
126172072|NCT00310388|453915512|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
126172073|NCT00310388|453915513|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
126172074|NCT00310388|453915512|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
126172075|NCT00310388|453915513|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
126172076|NCT00310388|453915512|FG000|Primary Reporting Phase|Physician Decision|2|||
125973832|NCT02270450|453193168|FG000|Overall Study|Death|19|||
125973833|NCT02270450|453193169|FG001|Overall Study|Death|19|||
125973834|NCT02270450|453193170|FG002|Overall Study|Death|31|||
125973835|NCT02270450|453193171|FG003|Overall Study|Death|59|||
125973836|NCT02363738|453193172|FG000|Overall Study|Adverse Event|5|||
125973837|NCT02363738|453193173|FG001|Overall Study|Adverse Event|2|||
125973838|NCT02363738|453193172|FG000|Overall Study|Lack of Efficacy|1|||
125973839|NCT02363738|453193173|FG001|Overall Study|Lack of Efficacy|2|||
125973840|NCT02363738|453193172|FG000|Overall Study|Lost to Follow-up|2|||
126172077|NCT00310388|453915513|FG001|Primary Reporting Phase|Physician Decision|0|||
126172078|NCT00310388|453915512|FG000|Primary Reporting Phase|Request of the sponsor|19|||
126172079|NCT00310388|453915513|FG001|Primary Reporting Phase|Request of the sponsor|0|||
126172080|NCT00310388|453915512|FG000|Primary Reporting Phase|Failed to return|8|||
125973841|NCT02363738|453193173|FG001|Overall Study|Lost to Follow-up|1|||
125973842|NCT02081846|453193176|FG000|Overall Study|Withdrawal by Subject|1|||
125973843|NCT02081846|453193177|FG001|Overall Study|Withdrawal by Subject|0|||
126172081|NCT00310388|453915513|FG001|Primary Reporting Phase|Failed to return|0|||
125973844|NCT02081846|453193176|FG000|Overall Study|invalid consent|1|||
125973845|NCT02081846|453193177|FG001|Overall Study|invalid consent|0|||
125973846|NCT03282227|453193178|FG000|Overall Study|Exposure Goals Achieved|60|||
125973847|NCT03282227|453193178|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
125973848|NCT03282227|453193178|FG000|Overall Study|Adverse Event|15|||
125973849|NCT03282227|453193178|FG000|Overall Study|Lost to Follow-up|21|||
125973850|NCT03282227|453193178|FG000|Overall Study|Withdrawal by Subject|20|||
125973851|NCT03282227|453193178|FG000|Overall Study|Lack of Efficacy|12|||
125973852|NCT03282227|453193178|FG000|Overall Study|Sponsor decision|3|||
125973853|NCT03282227|453193178|FG000|Overall Study|Physician Decision|2|||
125973854|NCT03282227|453193178|FG000|Overall Study|Pregnancy|2|||
125973855|NCT03282227|453193178|FG000|Overall Study|Other|1|||
125973856|NCT02576678|453193179|FG000|Overall Study|Adverse Event|0|||
126172082|NCT00310388|453915512|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
126172083|NCT00310388|453915513|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
126172084|NCT00310388|453915512|FG000|Primary Reporting Phase|Participant request|2|||
126172085|NCT00310388|453915513|FG001|Primary Reporting Phase|Participant request|0|||
126172086|NCT00310388|453915512|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
126172087|NCT00310388|453915513|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
126172088|NCT00310388|453915512|FG000|Primary Reporting Phase|Discontinuation of study|1|||
126172089|NCT00310388|453915513|FG001|Primary Reporting Phase|Discontinuation of study|0|||
126172090|NCT00310388|453915512|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
126172091|NCT00310388|453915513|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
126172092|NCT00310388|453915512|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
126172093|NCT00310388|453915513|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
126172094|NCT00310388|453915512|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
126172095|NCT00310388|453915513|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
126172096|NCT00310388|453915512|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
126172097|NCT00310388|453915513|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
126172098|NCT00310388|453915512|FG000|Primary Reporting Phase|Participant passed away|1|||
126172099|NCT00310388|453915513|FG001|Primary Reporting Phase|Participant passed away|0|||
126172100|NCT00310388|453915512|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
126172101|NCT00310388|453915513|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
126172102|NCT00310388|453915512|FG000|Primary Reporting Phase|Missing|1|||
126172103|NCT00310388|453915513|FG001|Primary Reporting Phase|Missing|0|||
126172104|NCT00310388|453915512|FG000|Primary Reporting Phase|Other|1|||
126172105|NCT00310388|453915513|FG001|Primary Reporting Phase|Other|0|||
126172106|NCT00310388|453915512|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
126172107|NCT00310388|453915513|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
126172108|NCT00310388|453915512|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
126172109|NCT00310388|453915513|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
126172110|NCT00310388|453915512|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
126172111|NCT00310388|453915513|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
126172112|NCT00310388|453915512|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
126172113|NCT00310388|453915513|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
126172114|NCT03457103|453915514|FG000|Overall Study|illness/hospitalization|4|||
126172115|NCT03457103|453915515|FG001|Overall Study|illness/hospitalization|2|||
126172116|NCT03457103|453915514|FG000|Overall Study|Lost to Follow-up|2|||
126172117|NCT03457103|453915515|FG001|Overall Study|Lost to Follow-up|1|||
126172118|NCT03457103|453915514|FG000|Overall Study|Withdrawal by Subject|1|||
126172119|NCT03457103|453915515|FG001|Overall Study|Withdrawal by Subject|2|||
126172120|NCT03457103|453915514|FG000|Overall Study|financial/ insurance issues|1|||
126172121|NCT03457103|453915515|FG001|Overall Study|financial/ insurance issues|1|||
126172122|NCT00213980|453915516|FG000|Overall Study|Withdrawal by Subject|3|||
126172123|NCT00213980|453915517|FG001|Overall Study|Withdrawal by Subject|1|||
126172124|NCT00213980|453915516|FG000|Overall Study|Adverse Event|1|||
126172125|NCT00213980|453915517|FG001|Overall Study|Adverse Event|1|||
126172126|NCT00213980|453915516|FG000|Overall Study|Disease progression|0|||
126172127|NCT00213980|453915517|FG001|Overall Study|Disease progression|2|||
126172128|NCT00213980|453915516|FG000|Overall Study|Developed ovarian cancer|1|||
126172129|NCT00213980|453915517|FG001|Overall Study|Developed ovarian cancer|0|||
126172130|NCT00213980|453915516|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
126172131|NCT00213980|453915517|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
126172132|NCT00798694|453915518|FG000|Overall Study|Lost to Follow-up|1|||
126172133|NCT00798694|453915519|FG001|Overall Study|Lost to Follow-up|1|||
126172134|NCT00798694|453915518|FG000|Overall Study|Physician Decision|1|||
126172135|NCT00798694|453915519|FG001|Overall Study|Physician Decision|0|||
125973857|NCT02576678|453193180|FG001|Overall Study|Adverse Event|0|||
125973858|NCT02576678|453193181|FG002|Overall Study|Adverse Event|2|||
125973859|NCT02576678|453193179|FG000|Overall Study|Withdrawal by Subject|3|||
125973860|NCT02576678|453193180|FG001|Overall Study|Withdrawal by Subject|1|||
126172136|NCT01089582|453915533|FG000|Overall Study|Death|2|||
126172137|NCT01089582|453915533|FG000|Overall Study|Adverse Event|15|||
126172138|NCT01089582|453915533|FG000|Overall Study|Lost to Follow-up|8|||
126172139|NCT01089582|453915533|FG000|Overall Study|Other|4|||
126172140|NCT01089582|453915533|FG000|Overall Study|Withdrawal by Subject|1|||
126172141|NCT00862849|453915534|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126172142|NCT00862849|453915535|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
126172143|NCT00862849|453915536|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126172144|NCT00862849|453915537|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126172145|NCT00862849|453915538|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126172146|NCT00862849|453915539|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126172147|NCT00862849|453915534|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126172148|NCT00862849|453915535|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
126172149|NCT00862849|453915536|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126172150|NCT00862849|453915537|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126172151|NCT00862849|453915538|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126172152|NCT00862849|453915539|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126172153|NCT03943953|453915542|FG000|Trial of ITG 1|Lost to Follow-up|19|||
126172154|NCT03943953|453915543|FG001|Trial of ITG 1|Lost to Follow-up|1|||
126172155|NCT03943953|453915542|FG000|Trial of ITG 2|Lost to Follow-up|8|||
126172156|NCT03943953|453915543|FG001|Trial of ITG 2|Lost to Follow-up|0|||
126172157|NCT03943953|453915542|FG000|Trial of ITG 3|Lost to Follow-up|2|||
126172158|NCT03943953|453915543|FG001|Trial of ITG 3|Lost to Follow-up|0|||
126172159|NCT03943953|453915542|FG000|Trial of ITG 4|Lost to Follow-up|2|||
126172160|NCT03943953|453915543|FG001|Trial of ITG 4|Lost to Follow-up|0|||
126172161|NCT00289185|453915548|FG000|Overall Study|Withdrawal by Subject|4|||
126172162|NCT00289185|453915549|FG001|Overall Study|Withdrawal by Subject|8|||
126172163|NCT00289185|453915548|FG000|Overall Study|Lost to Follow-up|23|||
126172164|NCT00289185|453915549|FG001|Overall Study|Lost to Follow-up|17|||
126172165|NCT00289185|453915548|FG000|Overall Study|Death|1|||
126172166|NCT00289185|453915549|FG001|Overall Study|Death|1|||
126172167|NCT01199055|453915550|FG000|Overall Study|Death|0|||
126172168|NCT01199055|453915551|FG001|Overall Study|Death|1|||
126172169|NCT01199055|453915552|FG002|Overall Study|Death|0|||
126172170|NCT01199055|453915550|FG000|Overall Study|Physician Decision|0|||
126172171|NCT01199055|453915551|FG001|Overall Study|Physician Decision|1|||
126172172|NCT01199055|453915552|FG002|Overall Study|Physician Decision|1|||
126172173|NCT01199055|453915550|FG000|Overall Study|Progressive disease|2|||
126172174|NCT01199055|453915551|FG001|Overall Study|Progressive disease|1|||
126172175|NCT01199055|453915552|FG002|Overall Study|Progressive disease|2|||
126172176|NCT01199055|453915550|FG000|Overall Study|Withdrawal by Subject|0|||
126172177|NCT01199055|453915551|FG001|Overall Study|Withdrawal by Subject|0|||
126172178|NCT01199055|453915552|FG002|Overall Study|Withdrawal by Subject|1|||
126172179|NCT02432040|453915553|FG000|Overall Study|Lack of Efficacy|3|||
126172180|NCT02432040|453915554|FG001|Overall Study|Lack of Efficacy|0|||
126172181|NCT02432040|453915553|FG000|Overall Study|Lost to Follow-up|4|||
126172182|NCT02432040|453915554|FG001|Overall Study|Lost to Follow-up|5|||
126172183|NCT02432040|453915553|FG000|Overall Study|Physician Decision|1|||
126172184|NCT02432040|453915554|FG001|Overall Study|Physician Decision|1|||
126172185|NCT03633227|453915555|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
126172186|NCT03633227|453915556|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
126172187|NCT03633227|453915555|FG000|Double Blind (DB), up to Week 48|Death|2|||
126172188|NCT03633227|453915556|FG001|Double Blind (DB), up to Week 48|Death|1|||
126172189|NCT03633227|453915555|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
126172190|NCT03633227|453915556|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
126172191|NCT03633227|453915555|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
126172192|NCT03633227|453915556|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
126172193|NCT03633227|453915555|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
126172194|NCT03633227|453915556|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
126172195|NCT03633227|453915555|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
126172196|NCT03633227|453915556|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
126172197|NCT03633227|453915555|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
126172198|NCT03633227|453915556|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
126172199|NCT03633227|453915555|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
126172200|NCT03633227|453915556|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
126172201|NCT03633227|453915555|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
126172202|NCT03633227|453915556|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
126172203|NCT03633227|453915555|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
126172204|NCT03633227|453915556|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
126172205|NCT03633227|453915555|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
126172206|NCT03633227|453915556|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
126172207|NCT03633227|453915555|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
126172208|NCT03633227|453915556|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
126172209|NCT01069523|453915557|FG000|Overall Study|Withdrawal by Subject|4|||
126172210|NCT01069523|453915558|FG001|Overall Study|Withdrawal by Subject|7|||
126172211|NCT00403559|453915567|FG000|Overall Study|Adverse Event|0|||
126172212|NCT00403559|453915568|FG001|Overall Study|Adverse Event|1|||
126172213|NCT00403559|453915567|FG000|Overall Study|Lost to Follow-up|3|||
126172214|NCT00403559|453915568|FG001|Overall Study|Lost to Follow-up|3|||
126172215|NCT00403559|453915567|FG000|Overall Study|Withdrawal by Subject|1|||
126172216|NCT00403559|453915568|FG001|Overall Study|Withdrawal by Subject|0|||
126172217|NCT03105700|453915569|FG000|Overall Study|screen fail|3|||
126172218|NCT03105700|453915569|FG000|Overall Study|Lost to Follow-up|4|||
126172219|NCT00929734|453915572|FG000|Overall Study|Lost to Follow-up|2|||
126172220|NCT00929734|453915573|FG001|Overall Study|Lost to Follow-up|1|||
126172221|NCT00929734|453915572|FG000|Overall Study|Withdrawal by Subject|0|||
126172222|NCT00929734|453915573|FG001|Overall Study|Withdrawal by Subject|2|||
126172223|NCT01253421|453915574|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
126172224|NCT01253421|453915575|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
126172225|NCT01253421|453915576|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
126172226|NCT01253421|453915577|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
126172227|NCT01253421|453915578|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
126172228|NCT01253421|453915574|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
126172229|NCT01253421|453915575|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
126172230|NCT01253421|453915576|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
126172231|NCT01253421|453915577|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
126172232|NCT01253421|453915578|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
126172233|NCT01253421|453915574|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
126172234|NCT01253421|453915575|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
126172235|NCT01253421|453915576|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
126172236|NCT01253421|453915577|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
126172237|NCT01253421|453915578|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
126172238|NCT01253421|453915574|FG000|Assessment and Scheduling|Physician Decision|1|||
126172239|NCT01253421|453915575|FG001|Assessment and Scheduling|Physician Decision|0|||
126172240|NCT01253421|453915576|FG002|Assessment and Scheduling|Physician Decision|0|||
126172241|NCT01253421|453915577|FG003|Assessment and Scheduling|Physician Decision|0|||
126172242|NCT01253421|453915578|FG004|Assessment and Scheduling|Physician Decision|0|||
126172243|NCT01253421|453915574|FG000|Drug+Scanning Visit|Physician Decision|0|||
126172244|NCT01253421|453915575|FG001|Drug+Scanning Visit|Physician Decision|0|||
126172245|NCT01253421|453915576|FG002|Drug+Scanning Visit|Physician Decision|0|||
126172246|NCT01253421|453915577|FG003|Drug+Scanning Visit|Physician Decision|0|||
126172247|NCT01253421|453915578|FG004|Drug+Scanning Visit|Physician Decision|1|||
126172248|NCT00980980|453915579|FG000|Overall Study|Withdrawal by Hospital|0|||
126172249|NCT00980980|453915580|FG001|Overall Study|Withdrawal by Hospital|1|||
126172250|NCT00980980|453915581|FG002|Overall Study|Withdrawal by Hospital|0|||
126172251|NCT00121992|453915583|FG000|Overall Study|Treatment not received|2|||
126172252|NCT00121992|453915584|FG001|Overall Study|Treatment not received|11|||
126172253|NCT01449682|453915585|FG000|Overall Study|Death|0|||
126172254|NCT01449682|453915586|FG001|Overall Study|Death|1|||
126172255|NCT01449682|453915585|FG000|Overall Study|Adverse Event|1|||
126172256|NCT01449682|453915586|FG001|Overall Study|Adverse Event|0|||
126172257|NCT00414960|453915587|FG000|Overall Study|Adverse Event|4|||
126172258|NCT00414960|453915588|FG001|Overall Study|Adverse Event|0|||
126172259|NCT00414960|453915587|FG000|Overall Study|Withdrawal by Subject|3|||
126172260|NCT00414960|453915588|FG001|Overall Study|Withdrawal by Subject|0|||
126172261|NCT00414960|453915587|FG000|Overall Study|Physician Decision|0|||
126172262|NCT00414960|453915588|FG001|Overall Study|Physician Decision|1|||
126172263|NCT04863014|453915589|FG000|Overall Study|Lost to Follow-up|3|||
126172264|NCT04863014|453915590|FG001|Overall Study|Lost to Follow-up|2|||
126172265|NCT04863014|453915589|FG000|Overall Study|Subject Decision|0|||
126172266|NCT04863014|453915590|FG001|Overall Study|Subject Decision|4|||
126172267|NCT04633473|453915594|FG000|Overall Study|Withdrawal by Subject|6|||
126172268|NCT04387136|453915596|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
126172269|NCT04387136|453915597|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
126172270|NCT00264849|453915598|FG000|Overall Study|Adverse Event|7|||
126172271|NCT00264849|453915599|FG001|Overall Study|Adverse Event|2|||
126172272|NCT00264849|453915598|FG000|Overall Study|Withdrawal by Subject|7|||
126172273|NCT00264849|453915599|FG001|Overall Study|Withdrawal by Subject|11|||
126172274|NCT00264849|453915598|FG000|Overall Study|Protocol Violation|5|||
126172275|NCT00264849|453915599|FG001|Overall Study|Protocol Violation|3|||
125973861|NCT02576678|453193181|FG002|Overall Study|Withdrawal by Subject|2|||
126172276|NCT00264849|453915598|FG000|Overall Study|Lack of Efficacy|1|||
126172277|NCT00264849|453915599|FG001|Overall Study|Lack of Efficacy|6|||
126172278|NCT00264849|453915598|FG000|Overall Study|Lost to Follow-up|0|||
126172279|NCT00264849|453915599|FG001|Overall Study|Lost to Follow-up|2|||
126172280|NCT00264849|453915598|FG000|Overall Study|Death|0|||
126172281|NCT00264849|453915599|FG001|Overall Study|Death|1|||
126172282|NCT00264849|453915598|FG000|Overall Study|Administrative Problems|2|||
125973862|NCT02576678|453193179|FG000|Overall Study|Lost to Follow-up|0|||
125973863|NCT02576678|453193180|FG001|Overall Study|Lost to Follow-up|0|||
125973864|NCT02576678|453193181|FG002|Overall Study|Lost to Follow-up|1|||
126172283|NCT00264849|453915599|FG001|Overall Study|Administrative Problems|0|||
126172284|NCT01982773|453915602|FG000|Overall Study|Withdrawal by Subject|1|||
126172285|NCT01982773|453915603|FG001|Overall Study|Withdrawal by Subject|3|||
126172286|NCT01982773|453915602|FG000|Overall Study|Lost to Follow-up|7|||
126172287|NCT01982773|453915603|FG001|Overall Study|Lost to Follow-up|1|||
126172288|NCT01029886|453915606|FG000|Overall Study|Adverse Event|12|||
126172289|NCT01029886|453915607|FG001|Overall Study|Adverse Event|25|||
126172290|NCT01029886|453915606|FG000|Overall Study|Lost to Follow-up|1|||
126172291|NCT01029886|453915607|FG001|Overall Study|Lost to Follow-up|0|||
126172292|NCT01029886|453915606|FG000|Overall Study|Physician Decision|2|||
126172293|NCT01029886|453915607|FG001|Overall Study|Physician Decision|6|||
126172294|NCT01029886|453915606|FG000|Overall Study|Protocol Violation|17|||
126172295|NCT01029886|453915607|FG001|Overall Study|Protocol Violation|5|||
126172296|NCT01029886|453915606|FG000|Overall Study|Withdrawal by Subject|8|||
126172297|NCT01029886|453915607|FG001|Overall Study|Withdrawal by Subject|18|||
126172298|NCT01029886|453915606|FG000|Overall Study|Entry Criteria Not Met|13|||
126172299|NCT01029886|453915607|FG001|Overall Study|Entry Criteria Not Met|5|||
126172300|NCT01029886|453915606|FG000|Overall Study|Sponsor Decision|1|||
126172301|NCT01029886|453915607|FG001|Overall Study|Sponsor Decision|0|||
126172302|NCT01029886|453915606|FG000|Overall Study|Loss Glucose Control|7|||
126172303|NCT01029886|453915607|FG001|Overall Study|Loss Glucose Control|1|||
126172304|NCT01553916|453915608|FG000|Overall Study|Withdrawal by Subject|2|||
126172305|NCT01553916|453915608|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
126172306|NCT03294681|453915609|FG000|Overall Study|Withdrawal by Subject|1|||
126172307|NCT03089216|453915612|FG000|Overall Study|Adverse Event|0|||
126172308|NCT03089216|453915613|FG001|Overall Study|Adverse Event|0|||
126172309|NCT03089216|453915614|FG002|Overall Study|Adverse Event|0|||
126172310|NCT03089216|453915615|FG003|Overall Study|Adverse Event|1|||
126172311|NCT00417976|453915618|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
126172312|NCT00417976|453915618|FG000|Overall Study|Treatment -related toxicity|2|||
126172313|NCT04348591|453915619|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
126172314|NCT04348591|453915620|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
126172315|NCT04348591|453915619|FG000|Imaging Session (120 Min)|Physician Decision|0|||
126172316|NCT04348591|453915620|FG001|Imaging Session (120 Min)|Physician Decision|1|||
126172317|NCT04348591|453915619|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
126172318|NCT04348591|453915620|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
126172319|NCT01778127|453915621|FG000|Overall Study|Lost to Follow-up|5|||
126172320|NCT01778127|453915622|FG001|Overall Study|Lost to Follow-up|1|||
126172321|NCT01778127|453915623|FG002|Overall Study|Lost to Follow-up|2|||
126172322|NCT01778127|453915621|FG000|Overall Study|Withdrawal by Subject|3|||
126172323|NCT01778127|453915622|FG001|Overall Study|Withdrawal by Subject|1|||
126172324|NCT01778127|453915623|FG002|Overall Study|Withdrawal by Subject|4|||
126172325|NCT02104804|453915626|FG000|Overall Study|Did not take study medication|0|||
126172326|NCT02104804|453915627|FG001|Overall Study|Did not take study medication|1|||
126172327|NCT02104804|453915626|FG000|Overall Study|Study specific discontinuation criteria|6|||
126172328|NCT02104804|453915627|FG001|Overall Study|Study specific discontinuation criteria|1|||
126172329|NCT02104804|453915626|FG000|Overall Study|Other listed|2|||
126172330|NCT02104804|453915627|FG001|Overall Study|Other listed|1|||
126172331|NCT02104804|453915626|FG000|Overall Study|Protocol Violation|0|||
126172332|NCT02104804|453915627|FG001|Overall Study|Protocol Violation|1|||
126172333|NCT02104804|453915626|FG000|Overall Study|Adverse Event|4|||
126172334|NCT02104804|453915627|FG001|Overall Study|Adverse Event|3|||
126172335|NCT02104804|453915626|FG000|Overall Study|Withdrawal by Subject|4|||
126172336|NCT02104804|453915627|FG001|Overall Study|Withdrawal by Subject|12|||
126172337|NCT01348425|453915628|FG000|Overall Study|Imaging was not taken.|1|||
126172338|NCT01348425|453915629|FG001|Overall Study|Imaging was not taken.|1|||
126172339|NCT03722784|453915632|FG000|Overall Study|Withdrawal by Subject|1|||
126172340|NCT03722784|453915633|FG001|Overall Study|Withdrawal by Subject|0|||
126172341|NCT03722784|453915632|FG000|Overall Study|Physician Decision|1|||
126172342|NCT03722784|453915633|FG001|Overall Study|Physician Decision|1|||
126172343|NCT03722784|453915632|FG000|Overall Study|Protocol Violation|0|||
126172344|NCT03722784|453915633|FG001|Overall Study|Protocol Violation|1|||
126172345|NCT01968954|453915637|FG000|Overall Study|Adverse Event|6|||
126172346|NCT01968954|453915638|FG001|Overall Study|Adverse Event|3|||
125973865|NCT02576678|453193179|FG000|Overall Study|Miscellaneous|2|||
125973866|NCT02576678|453193180|FG001|Overall Study|Miscellaneous|0|||
126172347|NCT01968954|453915637|FG000|Overall Study|Death|1|||
126172348|NCT01968954|453915638|FG001|Overall Study|Death|2|||
126172349|NCT01968954|453915637|FG000|Overall Study|Lost to Follow-up|6|||
125973867|NCT02576678|453193181|FG002|Overall Study|Miscellaneous|0|||
125973868|NCT02251990|453193185|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
126172350|NCT01968954|453915638|FG001|Overall Study|Lost to Follow-up|4|||
126172351|NCT01968954|453915637|FG000|Overall Study|Withdrawal by Subject|20|||
126172352|NCT01968954|453915638|FG001|Overall Study|Withdrawal by Subject|23|||
126172353|NCT01968954|453915637|FG000|Overall Study|Other|7|||
126172354|NCT01968954|453915638|FG001|Overall Study|Other|8|||
126172355|NCT01968954|453915637|FG000|Overall Study|Protocol Violation|0|||
126172356|NCT01968954|453915638|FG001|Overall Study|Protocol Violation|1|||
126172357|NCT01968954|453915637|FG000|Overall Study|Did not met inclusion criteria|0|||
126172358|NCT01968954|453915638|FG001|Overall Study|Did not met inclusion criteria|2|||
126172359|NCT00751114|453915640|FG000|Overall Study|Adverse Event|2|||
126172360|NCT00751114|453915641|FG001|Overall Study|Adverse Event|4|||
126172361|NCT00751114|453915640|FG000|Overall Study|Protocol Violation|8|||
126172362|NCT00751114|453915641|FG001|Overall Study|Protocol Violation|9|||
126172363|NCT00751114|453915640|FG000|Overall Study|Withdrawal by Subject|9|||
126172364|NCT00751114|453915641|FG001|Overall Study|Withdrawal by Subject|4|||
126172365|NCT00751114|453915640|FG000|Overall Study|Lost to Follow-up|4|||
126172366|NCT00751114|453915641|FG001|Overall Study|Lost to Follow-up|7|||
126172367|NCT00751114|453915640|FG000|Overall Study|Lack of Efficacy|0|||
126172368|NCT00751114|453915641|FG001|Overall Study|Lack of Efficacy|7|||
126172369|NCT00751114|453915640|FG000|Overall Study|Not Treated|13|||
126172370|NCT00751114|453915641|FG001|Overall Study|Not Treated|1|||
126172371|NCT00751114|453915640|FG000|Overall Study|Out of country for 2 months|1|||
126172372|NCT00751114|453915641|FG001|Overall Study|Out of country for 2 months|0|||
126172373|NCT00751114|453915640|FG000|Overall Study|Move to another city|1|||
126172374|NCT00751114|453915641|FG001|Overall Study|Move to another city|0|||
126172375|NCT05319080|453915642|FG000|Overall Study|Withdrawal by Subject|2|||
126172376|NCT05319080|453915642|FG000|Overall Study|Physician Decision|4|||
126172377|NCT02648724|453915645|FG000|Overall Study|Withdrawal by Subject|0|||
126172378|NCT02648724|453915646|FG001|Overall Study|Withdrawal by Subject|1|||
126172379|NCT02648724|453915647|FG002|Overall Study|Withdrawal by Subject|1|||
126172380|NCT02648724|453915648|FG003|Overall Study|Withdrawal by Subject|0|||
126172381|NCT02648724|453915649|FG004|Overall Study|Withdrawal by Subject|1|||
126172382|NCT02648724|453915650|FG005|Overall Study|Withdrawal by Subject|0|||
126172383|NCT02648724|453915651|FG006|Overall Study|Withdrawal by Subject|0|||
126172384|NCT02648724|453915645|FG000|Overall Study|Progressive disease|2|||
126172385|NCT02648724|453915646|FG001|Overall Study|Progressive disease|2|||
126172386|NCT02648724|453915647|FG002|Overall Study|Progressive disease|2|||
126172387|NCT02648724|453915648|FG003|Overall Study|Progressive disease|3|||
126172388|NCT02648724|453915649|FG004|Overall Study|Progressive disease|22|||
126172389|NCT02648724|453915650|FG005|Overall Study|Progressive disease|7|||
126172390|NCT02648724|453915651|FG006|Overall Study|Progressive disease|8|||
126172391|NCT02648724|453915645|FG000|Overall Study|Other reason (unknown)|1|||
126172392|NCT02648724|453915646|FG001|Overall Study|Other reason (unknown)|0|||
126172393|NCT02648724|453915647|FG002|Overall Study|Other reason (unknown)|0|||
126172394|NCT02648724|453915648|FG003|Overall Study|Other reason (unknown)|0|||
126172395|NCT02648724|453915649|FG004|Overall Study|Other reason (unknown)|0|||
126172396|NCT02648724|453915650|FG005|Overall Study|Other reason (unknown)|0|||
126172397|NCT02648724|453915651|FG006|Overall Study|Other reason (unknown)|0|||
126172398|NCT02648724|453915645|FG000|Overall Study|Protocol Violation|0|||
126172399|NCT02648724|453915646|FG001|Overall Study|Protocol Violation|0|||
126172400|NCT02648724|453915647|FG002|Overall Study|Protocol Violation|0|||
126172401|NCT02648724|453915648|FG003|Overall Study|Protocol Violation|0|||
126172402|NCT02648724|453915649|FG004|Overall Study|Protocol Violation|1|||
126172403|NCT02648724|453915650|FG005|Overall Study|Protocol Violation|0|||
126172404|NCT02648724|453915651|FG006|Overall Study|Protocol Violation|0|||
126172405|NCT02648724|453915645|FG000|Overall Study|Death|0|||
126172406|NCT02648724|453915646|FG001|Overall Study|Death|0|||
126172407|NCT02648724|453915647|FG002|Overall Study|Death|0|||
126172408|NCT02648724|453915648|FG003|Overall Study|Death|0|||
126172409|NCT02648724|453915649|FG004|Overall Study|Death|0|||
126172410|NCT02648724|453915650|FG005|Overall Study|Death|0|||
126172411|NCT02648724|453915651|FG006|Overall Study|Death|3|||
126172412|NCT02648724|453915645|FG000|Overall Study|Physician Decision|0|||
126172413|NCT02648724|453915646|FG001|Overall Study|Physician Decision|0|||
126172414|NCT02648724|453915647|FG002|Overall Study|Physician Decision|0|||
126172415|NCT02648724|453915648|FG003|Overall Study|Physician Decision|0|||
126172416|NCT02648724|453915649|FG004|Overall Study|Physician Decision|1|||
126172417|NCT02648724|453915650|FG005|Overall Study|Physician Decision|0|||
126172418|NCT02648724|453915651|FG006|Overall Study|Physician Decision|1|||
126172419|NCT02648724|453915645|FG000|Overall Study|Transferred to named patient program|0|||
126172420|NCT02648724|453915646|FG001|Overall Study|Transferred to named patient program|0|||
125973869|NCT02251990|453193186|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
125973870|NCT02251990|453193185|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
126172421|NCT02648724|453915647|FG002|Overall Study|Transferred to named patient program|0|||
126172422|NCT02648724|453915648|FG003|Overall Study|Transferred to named patient program|0|||
125973871|NCT02251990|453193186|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
125973872|NCT02251990|453193185|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
126172423|NCT02648724|453915649|FG004|Overall Study|Transferred to named patient program|0|||
126172424|NCT02648724|453915650|FG005|Overall Study|Transferred to named patient program|1|||
126172425|NCT02648724|453915651|FG006|Overall Study|Transferred to named patient program|0|||
126172426|NCT03076190|453915652|FG000|Overall Study|Lost to Follow-up|9|||
126172427|NCT03076190|453915653|FG001|Overall Study|Lost to Follow-up|34|||
126172428|NCT03076190|453915652|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
126172429|NCT03076190|453915653|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
126172430|NCT00434122|453915654|FG000|Overall Study|Non-compliance with protocol|0|||
126172431|NCT00434122|453915655|FG001|Overall Study|Non-compliance with protocol|1|||
126172432|NCT00434122|453915654|FG000|Overall Study|loss of subject contact|1|||
126172433|NCT00434122|453915655|FG001|Overall Study|loss of subject contact|1|||
126172434|NCT00434122|453915654|FG000|Overall Study|Personal reasons|1|||
126172435|NCT00434122|453915655|FG001|Overall Study|Personal reasons|1|||
126172436|NCT00434122|453915654|FG000|Overall Study|Large follicle size|2|||
126172437|NCT00434122|453915655|FG001|Overall Study|Large follicle size|2|||
126172438|NCT00434122|453915654|FG000|Overall Study|Low follicular response.|1|||
126172439|NCT00434122|453915655|FG001|Overall Study|Low follicular response.|2|||
126172440|NCT00434122|453915654|FG000|Overall Study|Travelling of subject.|1|||
126172441|NCT00434122|453915655|FG001|Overall Study|Travelling of subject.|0|||
126172442|NCT04191577|453915656|FG000|Overall Study|Withdrawal by Subject|2|||
126172443|NCT04191577|453915657|FG001|Overall Study|Withdrawal by Subject|2|||
126172444|NCT04191577|453915658|FG002|Overall Study|Withdrawal by Subject|1|||
126172445|NCT04191577|453915656|FG000|Overall Study|Physician Decision|1|||
126172446|NCT04191577|453915657|FG001|Overall Study|Physician Decision|1|||
126172447|NCT04191577|453915658|FG002|Overall Study|Physician Decision|0|||
126172448|NCT04191577|453915656|FG000|Overall Study|Adverse Event|0|||
126172449|NCT04191577|453915657|FG001|Overall Study|Adverse Event|0|||
126172450|NCT04191577|453915658|FG002|Overall Study|Adverse Event|1|||
126172451|NCT04191577|453915656|FG000|Overall Study|Death|0|||
126172452|NCT04191577|453915657|FG001|Overall Study|Death|0|||
126172453|NCT04191577|453915658|FG002|Overall Study|Death|1|||
126172454|NCT03655717|453915659|FG000|Overall Study|Withdrawal by Subject|4|||
126172455|NCT03655717|453915660|FG001|Overall Study|Withdrawal by Subject|8|||
126172456|NCT03655717|453915661|FG002|Overall Study|Withdrawal by Subject|1|||
126172457|NCT03655717|453915662|FG003|Overall Study|Withdrawal by Subject|0|||
126172458|NCT03655717|453915663|FG004|Overall Study|Withdrawal by Subject|0|||
126172459|NCT03655717|453915664|FG005|Overall Study|Withdrawal by Subject|1|||
126172460|NCT03655717|453915665|FG006|Overall Study|Withdrawal by Subject|3|||
126172461|NCT03655717|453915666|FG007|Overall Study|Withdrawal by Subject|1|||
126172462|NCT03655717|453915667|FG008|Overall Study|Withdrawal by Subject|2|||
126172463|NCT03655717|453915668|FG009|Overall Study|Withdrawal by Subject|0|||
126172464|NCT03655717|453915669|FG010|Overall Study|Withdrawal by Subject|0|||
126172465|NCT03655717|453915670|FG011|Overall Study|Withdrawal by Subject|1|||
126172466|NCT03655717|453915671|FG012|Overall Study|Withdrawal by Subject|0|||
126172467|NCT03655717|453915672|FG013|Overall Study|Withdrawal by Subject|3|||
126172468|NCT03655717|453915673|FG014|Overall Study|Withdrawal by Subject|0|||
126172469|NCT03655717|453915674|FG015|Overall Study|Withdrawal by Subject|1|||
126172470|NCT03655717|453915675|FG016|Overall Study|Withdrawal by Subject|0|||
126172471|NCT03655717|453915676|FG017|Overall Study|Withdrawal by Subject|0|||
126172472|NCT03655717|453915677|FG018|Overall Study|Withdrawal by Subject|1|||
126172473|NCT03655717|453915678|FG019|Overall Study|Withdrawal by Subject|0|||
126172474|NCT03655717|453915679|FG020|Overall Study|Withdrawal by Subject|0|||
126172475|NCT03655717|453915680|FG021|Overall Study|Withdrawal by Subject|1|||
126172476|NCT03655717|453915681|FG022|Overall Study|Withdrawal by Subject|2|||
126172477|NCT03655717|453915682|FG023|Overall Study|Withdrawal by Subject|1|||
126172478|NCT03655717|453915683|FG024|Overall Study|Withdrawal by Subject|1|||
126172479|NCT03655717|453915684|FG025|Overall Study|Withdrawal by Subject|0|||
126172480|NCT03655717|453915659|FG000|Overall Study|Physician Decision|3|||
126172481|NCT03655717|453915660|FG001|Overall Study|Physician Decision|3|||
126172482|NCT03655717|453915661|FG002|Overall Study|Physician Decision|0|||
126172483|NCT03655717|453915662|FG003|Overall Study|Physician Decision|0|||
126172484|NCT03655717|453915663|FG004|Overall Study|Physician Decision|0|||
126172485|NCT03655717|453915664|FG005|Overall Study|Physician Decision|0|||
126172486|NCT03655717|453915665|FG006|Overall Study|Physician Decision|0|||
126172487|NCT03655717|453915666|FG007|Overall Study|Physician Decision|0|||
126172488|NCT03655717|453915667|FG008|Overall Study|Physician Decision|0|||
126172489|NCT03655717|453915668|FG009|Overall Study|Physician Decision|1|||
126172490|NCT03655717|453915669|FG010|Overall Study|Physician Decision|0|||
126172491|NCT03655717|453915670|FG011|Overall Study|Physician Decision|0|||
126172492|NCT03655717|453915671|FG012|Overall Study|Physician Decision|0|||
126172493|NCT03655717|453915672|FG013|Overall Study|Physician Decision|0|||
126172494|NCT03655717|453915673|FG014|Overall Study|Physician Decision|0|||
126172495|NCT03655717|453915674|FG015|Overall Study|Physician Decision|0|||
126172496|NCT03655717|453915675|FG016|Overall Study|Physician Decision|0|||
126172497|NCT03655717|453915676|FG017|Overall Study|Physician Decision|0|||
126172498|NCT03655717|453915677|FG018|Overall Study|Physician Decision|0|||
126172499|NCT03655717|453915678|FG019|Overall Study|Physician Decision|1|||
126172500|NCT03655717|453915679|FG020|Overall Study|Physician Decision|0|||
126172501|NCT03655717|453915680|FG021|Overall Study|Physician Decision|0|||
126172502|NCT03655717|453915681|FG022|Overall Study|Physician Decision|0|||
126172503|NCT03655717|453915682|FG023|Overall Study|Physician Decision|1|||
126172504|NCT03655717|453915683|FG024|Overall Study|Physician Decision|0|||
126172505|NCT03655717|453915684|FG025|Overall Study|Physician Decision|0|||
126172506|NCT03655717|453915659|FG000|Overall Study|Lost to Follow-up|3|||
126172507|NCT03655717|453915660|FG001|Overall Study|Lost to Follow-up|1|||
126172508|NCT03655717|453915661|FG002|Overall Study|Lost to Follow-up|0|||
126172509|NCT03655717|453915662|FG003|Overall Study|Lost to Follow-up|1|||
126172510|NCT03655717|453915663|FG004|Overall Study|Lost to Follow-up|0|||
126172511|NCT03655717|453915664|FG005|Overall Study|Lost to Follow-up|1|||
126172512|NCT03655717|453915665|FG006|Overall Study|Lost to Follow-up|0|||
126172513|NCT03655717|453915666|FG007|Overall Study|Lost to Follow-up|0|||
126172514|NCT03655717|453915667|FG008|Overall Study|Lost to Follow-up|0|||
126172515|NCT03655717|453915668|FG009|Overall Study|Lost to Follow-up|0|||
126172516|NCT03655717|453915669|FG010|Overall Study|Lost to Follow-up|0|||
126172517|NCT03655717|453915670|FG011|Overall Study|Lost to Follow-up|1|||
126172518|NCT03655717|453915671|FG012|Overall Study|Lost to Follow-up|0|||
126172519|NCT03655717|453915672|FG013|Overall Study|Lost to Follow-up|0|||
126172520|NCT03655717|453915673|FG014|Overall Study|Lost to Follow-up|0|||
126172521|NCT03655717|453915674|FG015|Overall Study|Lost to Follow-up|0|||
126172522|NCT03655717|453915675|FG016|Overall Study|Lost to Follow-up|0|||
126172523|NCT03655717|453915676|FG017|Overall Study|Lost to Follow-up|0|||
126172524|NCT03655717|453915677|FG018|Overall Study|Lost to Follow-up|0|||
126172525|NCT03655717|453915678|FG019|Overall Study|Lost to Follow-up|0|||
126172526|NCT03655717|453915679|FG020|Overall Study|Lost to Follow-up|0|||
126172527|NCT03655717|453915680|FG021|Overall Study|Lost to Follow-up|0|||
126172528|NCT03655717|453915681|FG022|Overall Study|Lost to Follow-up|0|||
126172529|NCT03655717|453915682|FG023|Overall Study|Lost to Follow-up|0|||
126172530|NCT03655717|453915683|FG024|Overall Study|Lost to Follow-up|0|||
126172531|NCT03655717|453915684|FG025|Overall Study|Lost to Follow-up|0|||
126172532|NCT01185249|453915685|FG000|Overall Study|Patients discharged or change in status|42|||
126172533|NCT00406783|453915688|FG000|Overall Study|Adverse Event|4|||
126172534|NCT00406783|453915689|FG001|Overall Study|Adverse Event|4|||
126172535|NCT00406783|453915688|FG000|Overall Study|Treatment Failure|2|||
126172536|NCT00406783|453915689|FG001|Overall Study|Treatment Failure|3|||
126172537|NCT00406783|453915688|FG000|Overall Study|Lost to Follow-up|3|||
126172538|NCT00406783|453915689|FG001|Overall Study|Lost to Follow-up|0|||
126172539|NCT00406783|453915688|FG000|Overall Study|Withdrawal by Subject|1|||
126172540|NCT00406783|453915689|FG001|Overall Study|Withdrawal by Subject|4|||
126172541|NCT00406783|453915688|FG000|Overall Study|Protocol Violation|4|||
126172542|NCT00406783|453915689|FG001|Overall Study|Protocol Violation|4|||
126172543|NCT00012012|453915690|FG000|Overall Study|Protocol Violation|1|||
126172544|NCT00012012|453915691|FG001|Overall Study|Protocol Violation|1|||
126172545|NCT00012012|453915690|FG000|Overall Study|Withdrawal by Subject|0|||
126172546|NCT00012012|453915691|FG001|Overall Study|Withdrawal by Subject|2|||
126172547|NCT01391819|453915692|FG000|Overall Study|Withdrawal by Subject|56|||
126172548|NCT01391819|453915692|FG000|Overall Study|Migrated/moved from study area|82|||
126172549|NCT01391819|453915692|FG000|Overall Study|Lost to Follow-up|252|||
126172550|NCT01391819|453915692|FG000|Overall Study|Death|3|||
126172551|NCT01391819|453915692|FG000|Overall Study|Other|9|||
126172552|NCT01208038|453915695|FG000|Overall Study|Withdrawal by Subject|1|||
126172553|NCT03260205|453915701|FG000|Overall Study|Adverse Event|2|||
126172554|NCT03260205|453915702|FG001|Overall Study|Adverse Event|0|||
126172555|NCT03260205|453915703|FG002|Overall Study|Adverse Event|2|||
126172556|NCT03260205|453915704|FG003|Overall Study|Adverse Event|2|||
126172557|NCT03260205|453915705|FG004|Overall Study|Adverse Event|4|||
126172558|NCT03260205|453915701|FG000|Overall Study|Lost to Follow-up|2|||
126172559|NCT03260205|453915702|FG001|Overall Study|Lost to Follow-up|2|||
126172560|NCT03260205|453915703|FG002|Overall Study|Lost to Follow-up|1|||
126172561|NCT03260205|453915704|FG003|Overall Study|Lost to Follow-up|1|||
126172562|NCT03260205|453915705|FG004|Overall Study|Lost to Follow-up|5|||
126172563|NCT03260205|453915701|FG000|Overall Study|Protocol Violation|0|||
126172564|NCT03260205|453915702|FG001|Overall Study|Protocol Violation|0|||
126172565|NCT03260205|453915703|FG002|Overall Study|Protocol Violation|2|||
126172566|NCT03260205|453915704|FG003|Overall Study|Protocol Violation|0|||
126172567|NCT03260205|453915705|FG004|Overall Study|Protocol Violation|1|||
126172568|NCT03260205|453915701|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
126172569|NCT03260205|453915702|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
126172570|NCT03260205|453915703|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
126172571|NCT03260205|453915704|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
126172572|NCT03260205|453915705|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
126172573|NCT03260205|453915701|FG000|Overall Study|Other: Unspecified|0|||
126172574|NCT03260205|453915702|FG001|Overall Study|Other: Unspecified|0|||
126172575|NCT03260205|453915703|FG002|Overall Study|Other: Unspecified|3|||
126172576|NCT03260205|453915704|FG003|Overall Study|Other: Unspecified|1|||
126172577|NCT03260205|453915705|FG004|Overall Study|Other: Unspecified|1|||
126172578|NCT03260205|453915701|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
126172579|NCT03260205|453915702|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
126172580|NCT03260205|453915703|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
126172581|NCT03260205|453915704|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
126172582|NCT03260205|453915705|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
126172583|NCT04752189|453915708|FG000|Overall Study|Withdrawal by Subject|0|||
126172584|NCT04752189|453915709|FG001|Overall Study|Withdrawal by Subject|150|||
126172585|NCT04752189|453915708|FG000|Overall Study|Lost to Follow-up|261|||
126172586|NCT04752189|453915709|FG001|Overall Study|Lost to Follow-up|126|||
126172587|NCT03422133|453915710|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
126172588|NCT03422133|453915711|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
126172589|NCT04124692|453917639|FG000|Overall Study|Medical reason|0|||
126172590|NCT04124692|453917640|FG001|Overall Study|Medical reason|1|||
126172591|NCT04124692|453917639|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
126172592|NCT04124692|453917640|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
126172593|NCT04124692|453917639|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
126172594|NCT04124692|453917640|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
126172595|NCT04124692|453917639|FG000|Overall Study|Lost to Follow-up|2|||
126172596|NCT04124692|453917640|FG001|Overall Study|Lost to Follow-up|4|||
126172597|NCT04124692|453917639|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
126172598|NCT04124692|453917640|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
126172599|NCT02370498|453917641|FG000|Overall Study|Adverse Event|10|||
126172600|NCT02370498|453917642|FG001|Overall Study|Adverse Event|8|||
126172601|NCT02370498|453917641|FG000|Overall Study|Death|263|||
126172602|NCT02370498|453917642|FG001|Overall Study|Death|265|||
126172603|NCT02370498|453917641|FG000|Overall Study|Protocol Violation|1|||
126172604|NCT02370498|453917642|FG001|Overall Study|Protocol Violation|2|||
126172605|NCT02370498|453917641|FG000|Overall Study|Withdrawal by Subject|7|||
126172606|NCT02370498|453917642|FG001|Overall Study|Withdrawal by Subject|12|||
126172607|NCT02370498|453917641|FG000|Overall Study|Sponsor's decision|15|||
126172608|NCT02370498|453917642|FG001|Overall Study|Sponsor's decision|9|||
126172609|NCT01453998|453917653|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
126172610|NCT01453998|453917654|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
126172611|NCT01453998|453917655|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
126172612|NCT01486784|453917656|FG000|Overall Study|Withdrawal by Subject|0|||
126172613|NCT01486784|453917657|FG001|Overall Study|Withdrawal by Subject|0|||
126172614|NCT01486784|453917658|FG002|Overall Study|Withdrawal by Subject|1|||
126172615|NCT01486784|453917659|FG003|Overall Study|Withdrawal by Subject|0|||
126172616|NCT01486784|453917660|FG004|Overall Study|Withdrawal by Subject|1|||
126172617|NCT01486784|453917661|FG005|Overall Study|Withdrawal by Subject|2|||
126172618|NCT01486784|453917656|FG000|Overall Study|Subject did not meet entry criteria|0|||
126172619|NCT01486784|453917657|FG001|Overall Study|Subject did not meet entry criteria|0|||
126172620|NCT01486784|453917658|FG002|Overall Study|Subject did not meet entry criteria|0|||
126172621|NCT01486784|453917659|FG003|Overall Study|Subject did not meet entry criteria|0|||
126172622|NCT01486784|453917660|FG004|Overall Study|Subject did not meet entry criteria|1|||
126172623|NCT01486784|453917661|FG005|Overall Study|Subject did not meet entry criteria|0|||
126172624|NCT01486784|453917656|FG000|Overall Study|Death|0|||
126172625|NCT01486784|453917657|FG001|Overall Study|Death|0|||
126172626|NCT01486784|453917658|FG002|Overall Study|Death|0|||
126172627|NCT01486784|453917659|FG003|Overall Study|Death|0|||
126172628|NCT01486784|453917660|FG004|Overall Study|Death|0|||
126172629|NCT01486784|453917661|FG005|Overall Study|Death|1|||
126172630|NCT03491553|453917662|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
126172631|NCT03491553|453917663|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
126172632|NCT03491553|453917664|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
126172633|NCT03491553|453917665|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
126172634|NCT03491553|453917666|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
126172635|NCT03491553|453917667|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
126172636|NCT03491553|453917662|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
126172637|NCT03491553|453917663|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
126172638|NCT03491553|453917664|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
126172639|NCT03491553|453917665|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
126172640|NCT03491553|453917666|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
126172641|NCT03491553|453917667|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
126172642|NCT00973921|453917668|FG000|Overall Study|IVUS results were not available|9|||
126172643|NCT00488592|453917669|FG000|Overall Study|Withdrawal by Subject|1|||
126172644|NCT00488592|453917669|FG000|Overall Study|Disease progression|1|||
126172645|NCT00488592|453917669|FG000|Overall Study|Enrolled but not treated|1|||
126172646|NCT03670641|453917674|FG000|Overall Study|Lost to Follow-up|3|||
126172647|NCT01096849|453917675|FG000|Overall Study|Consent Withdrawn|1|||
126172648|NCT01096849|453917676|FG001|Overall Study|Consent Withdrawn|4|||
126172649|NCT01096849|453917677|FG002|Overall Study|Consent Withdrawn|2|||
126172650|NCT01096849|453917675|FG000|Overall Study|Lack of Efficacy|0|||
126172651|NCT01096849|453917676|FG001|Overall Study|Lack of Efficacy|2|||
126172652|NCT01096849|453917677|FG002|Overall Study|Lack of Efficacy|0|||
126172653|NCT01096849|453917675|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
126172654|NCT01096849|453917676|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
126172655|NCT01096849|453917677|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
126172656|NCT01096849|453917675|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
126172657|NCT01096849|453917676|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
126172658|NCT01096849|453917677|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
126172659|NCT01096849|453917675|FG000|Overall Study|Administrative Reasons|0|||
126172660|NCT01096849|453917676|FG001|Overall Study|Administrative Reasons|1|||
126172661|NCT01096849|453917677|FG002|Overall Study|Administrative Reasons|2|||
126172662|NCT01096849|453917675|FG000|Overall Study|Lost to Follow-up|1|||
126172663|NCT01096849|453917676|FG001|Overall Study|Lost to Follow-up|3|||
126172664|NCT01096849|453917677|FG002|Overall Study|Lost to Follow-up|1|||
126172665|NCT00118482|453917679|FG000|Overall Study|Lost to Follow-up|7|||
126172666|NCT00118482|453917680|FG001|Overall Study|Lost to Follow-up|7|||
126172667|NCT00118482|453917679|FG000|Overall Study|Withdrawal by Subject|23|||
126172668|NCT00118482|453917680|FG001|Overall Study|Withdrawal by Subject|22|||
126172669|NCT00242580|453917681|FG000|Overall Study|Adverse Event|3|||
126172670|NCT00242580|453917682|FG001|Overall Study|Adverse Event|0|||
126172671|NCT00242580|453917683|FG002|Overall Study|Adverse Event|2|||
126172672|NCT00242580|453917681|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126172673|NCT00242580|453917682|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
126172674|NCT00242580|453917683|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
126172675|NCT00242580|453917681|FG000|Overall Study|Protocol Violation|0|||
126172676|NCT00242580|453917682|FG001|Overall Study|Protocol Violation|0|||
126172677|NCT00242580|453917683|FG002|Overall Study|Protocol Violation|1|||
126172678|NCT00242580|453917681|FG000|Overall Study|Subject withdrew consent|2|||
126172679|NCT00242580|453917682|FG001|Overall Study|Subject withdrew consent|2|||
126172680|NCT00242580|453917683|FG002|Overall Study|Subject withdrew consent|5|||
126172681|NCT00242580|453917681|FG000|Overall Study|Lost to Follow-up|0|||
126172682|NCT00242580|453917682|FG001|Overall Study|Lost to Follow-up|3|||
126172683|NCT00242580|453917683|FG002|Overall Study|Lost to Follow-up|0|||
126172684|NCT00242580|453917681|FG000|Overall Study|Death|1|||
126172685|NCT00242580|453917682|FG001|Overall Study|Death|2|||
126172686|NCT00242580|453917683|FG002|Overall Study|Death|1|||
126172687|NCT01232894|453917684|FG000|Overall Study|Lost to Follow-up|0|||
126172688|NCT01232894|453917685|FG001|Overall Study|Lost to Follow-up|1|||
126172689|NCT01232894|453917684|FG000|Overall Study|Death|1|||
126172690|NCT01232894|453917685|FG001|Overall Study|Death|0|||
126172691|NCT01232894|453917684|FG000|Overall Study|Protocol Violation|1|||
126172692|NCT01232894|453917685|FG001|Overall Study|Protocol Violation|1|||
126172693|NCT01232894|453917684|FG000|Overall Study|Withdrawal by Subject|8|||
126172694|NCT01232894|453917685|FG001|Overall Study|Withdrawal by Subject|5|||
126172695|NCT01232894|453917684|FG000|Overall Study|Physician Decision|2|||
126172696|NCT01232894|453917685|FG001|Overall Study|Physician Decision|1|||
126172697|NCT03970395|453917686|FG000|Overall Study|Withdrawal by Subject|3|||
126172698|NCT03970395|453917687|FG001|Overall Study|Withdrawal by Subject|4|||
126172699|NCT03970395|453917686|FG000|Overall Study|Lost to Follow-up|4|||
126172700|NCT03970395|453917687|FG001|Overall Study|Lost to Follow-up|8|||
126172701|NCT00125190|453917689|FG000|Overall Study|Subject/Parent Decision|7|||
126172702|NCT00125190|453917689|FG000|Overall Study|Non-compliance|2|||
126172703|NCT00125190|453917689|FG000|Overall Study|Adverse Event|1|||
126172704|NCT00125190|453917689|FG000|Overall Study|Other|1|||
126172705|NCT00125190|453917689|FG000|Overall Study|Lost to Follow-up|4|||
126172706|NCT02128763|453917690|FG000|Overall Study|Death|1|||
126172707|NCT02128763|453917691|FG001|Overall Study|Death|0|||
126172708|NCT02128763|453917690|FG000|Overall Study|Lost to Follow-up|19|||
126172709|NCT02128763|453917691|FG001|Overall Study|Lost to Follow-up|16|||
126172710|NCT02921919|453917692|FG000|Overall Study|Other|5|||
126172711|NCT02921919|453917693|FG001|Overall Study|Other|6|||
126172712|NCT02921919|453917692|FG000|Overall Study|Lost to Follow-up|0|||
126172713|NCT02921919|453917693|FG001|Overall Study|Lost to Follow-up|1|||
126172714|NCT02921919|453917692|FG000|Overall Study|Withdrawal by Subject|5|||
126172715|NCT02921919|453917693|FG001|Overall Study|Withdrawal by Subject|1|||
126172716|NCT02921919|453917692|FG000|Overall Study|Disease Progression|47|||
126172717|NCT02921919|453917693|FG001|Overall Study|Disease Progression|38|||
126172718|NCT02921919|453917692|FG000|Overall Study|Physician Decision|3|||
126172719|NCT02921919|453917693|FG001|Overall Study|Physician Decision|2|||
126172720|NCT02921919|453917692|FG000|Overall Study|Adverse Event|6|||
126172721|NCT02921919|453917693|FG001|Overall Study|Adverse Event|4|||
126172722|NCT03666858|453917694|FG000|Cohort 1|Adverse Event|1|||
126172723|NCT03666858|453917695|FG001|Cohort 1|Adverse Event|0|||
126172724|NCT03666858|453917694|FG000|Cohort 2|Adverse Event|0|||
126172725|NCT03666858|453917695|FG001|Cohort 2|Adverse Event|1|||
126172726|NCT00547378|453917696|FG000|Randomized Cohort|Withdrawal by Subject|7|||
126172727|NCT00547378|453917697|FG001|Randomized Cohort|Withdrawal by Subject|5|||
125973873|NCT02251990|453193186|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
125973874|NCT02251990|453193185|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
126172728|NCT00547378|453917698|FG002|Randomized Cohort|Withdrawal by Subject|0|||
126172729|NCT00547378|453917696|FG000|Randomized Cohort|Death|0|||
126172730|NCT00547378|453917697|FG001|Randomized Cohort|Death|1|||
126172731|NCT00547378|453917698|FG002|Randomized Cohort|Death|0|||
126172732|NCT00547378|453917696|FG000|Randomized Cohort|Lost to Follow-up|1|||
126172733|NCT00547378|453917697|FG001|Randomized Cohort|Lost to Follow-up|0|||
126172734|NCT00547378|453917698|FG002|Randomized Cohort|Lost to Follow-up|0|||
126172735|NCT00547378|453917696|FG000|Randomized Cohort|Adverse Event|1|||
126172736|NCT00547378|453917697|FG001|Randomized Cohort|Adverse Event|0|||
126172737|NCT00547378|453917698|FG002|Randomized Cohort|Adverse Event|0|||
126172738|NCT00547378|453917696|FG000|Randomized Cohort|Other reasons|2|||
126172739|NCT00547378|453917697|FG001|Randomized Cohort|Other reasons|0|||
126172740|NCT00547378|453917698|FG002|Randomized Cohort|Other reasons|0|||
126172741|NCT00547378|453917696|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
126172742|NCT00547378|453917697|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
126172743|NCT00547378|453917698|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
126172744|NCT00547378|453917696|FG000|All Implanted Cohort|Adverse Event|4|||
126172745|NCT00547378|453917697|FG001|All Implanted Cohort|Adverse Event|10|||
126172746|NCT00547378|453917698|FG002|All Implanted Cohort|Adverse Event|17|||
126172747|NCT00547378|453917696|FG000|All Implanted Cohort|Lost to Follow-up|0|||
126172748|NCT00547378|453917697|FG001|All Implanted Cohort|Lost to Follow-up|1|||
126172749|NCT00547378|453917698|FG002|All Implanted Cohort|Lost to Follow-up|14|||
126172750|NCT00547378|453917696|FG000|All Implanted Cohort|Death|3|||
126172751|NCT00547378|453917697|FG001|All Implanted Cohort|Death|1|||
126172752|NCT00547378|453917698|FG002|All Implanted Cohort|Death|4|||
126172753|NCT00547378|453917696|FG000|All Implanted Cohort|Physician Decision|0|||
126172754|NCT00547378|453917697|FG001|All Implanted Cohort|Physician Decision|2|||
126172755|NCT00547378|453917698|FG002|All Implanted Cohort|Physician Decision|6|||
126172756|NCT00547378|453917696|FG000|All Implanted Cohort|Site closure|2|||
126172757|NCT00547378|453917697|FG001|All Implanted Cohort|Site closure|0|||
126172758|NCT00547378|453917698|FG002|All Implanted Cohort|Site closure|1|||
126172759|NCT00547378|453917696|FG000|All Implanted Cohort|Other reasons|1|||
126172760|NCT00547378|453917697|FG001|All Implanted Cohort|Other reasons|0|||
126172761|NCT00547378|453917698|FG002|All Implanted Cohort|Other reasons|1|||
126172762|NCT02112994|453917699|FG000|Overall Study|Progressive Disease|0|||
126172763|NCT02112994|453917700|FG001|Overall Study|Progressive Disease|0|||
126172764|NCT02112994|453917701|FG002|Overall Study|Progressive Disease|1|||
126172765|NCT02112994|453917699|FG000|Overall Study|Pregnancy|0|||
126172766|NCT02112994|453917700|FG001|Overall Study|Pregnancy|1|||
126172767|NCT02112994|453917701|FG002|Overall Study|Pregnancy|1|||
126172768|NCT02112994|453917699|FG000|Overall Study|Liver Transplant|0|||
126172769|NCT02112994|453917700|FG001|Overall Study|Liver Transplant|1|||
126172770|NCT02112994|453917701|FG002|Overall Study|Liver Transplant|0|||
126172771|NCT02112994|453917699|FG000|Overall Study|Withdrawal by Subject|0|||
126172772|NCT02112994|453917700|FG001|Overall Study|Withdrawal by Subject|0|||
126172773|NCT02112994|453917701|FG002|Overall Study|Withdrawal by Subject|1|||
126172774|NCT04105244|453917703|FG000|Overall Study|Withdrawal by Subject|10|||
126172775|NCT04105244|453917704|FG001|Overall Study|Withdrawal by Subject|12|||
126172776|NCT04105244|453917703|FG000|Overall Study|Lost to Follow-up|20|||
126172777|NCT04105244|453917704|FG001|Overall Study|Lost to Follow-up|15|||
126172778|NCT04105244|453917703|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
126172779|NCT04105244|453917704|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
126172780|NCT04105244|453917703|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
126172781|NCT04105244|453917704|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
126172782|NCT02768194|453917705|FG000|Period 1|Adverse Event|0|||
126172783|NCT02768194|453917706|FG001|Period 1|Adverse Event|0|||
126172784|NCT02768194|453917707|FG002|Period 1|Adverse Event|0|||
126172785|NCT02768194|453917708|FG003|Period 1|Adverse Event|1|||
126172786|NCT02768194|453917709|FG004|Period 1|Adverse Event|0|||
126172787|NCT02768194|453917710|FG005|Period 1|Adverse Event|0|||
126172788|NCT02768194|453917705|FG000|Period 2|Other (Reason not specified)|1|||
126172789|NCT02768194|453917706|FG001|Period 2|Other (Reason not specified)|0|||
126172790|NCT02768194|453917707|FG002|Period 2|Other (Reason not specified)|0|||
126172791|NCT02768194|453917708|FG003|Period 2|Other (Reason not specified)|0|||
126172792|NCT02768194|453917709|FG004|Period 2|Other (Reason not specified)|0|||
126172793|NCT02768194|453917710|FG005|Period 2|Other (Reason not specified)|0|||
126172794|NCT02768194|453917705|FG000|Period 3|Other (Reason not specified)|0|||
126172795|NCT02768194|453917706|FG001|Period 3|Other (Reason not specified)|1|||
126172796|NCT02768194|453917707|FG002|Period 3|Other (Reason not specified)|0|||
126172797|NCT02768194|453917708|FG003|Period 3|Other (Reason not specified)|0|||
126172798|NCT02768194|453917709|FG004|Period 3|Other (Reason not specified)|0|||
126172799|NCT02768194|453917710|FG005|Period 3|Other (Reason not specified)|0|||
126172800|NCT00975195|453917711|FG000|Overall Study|Adverse Event|108|||
126172801|NCT00975195|453917712|FG001|Overall Study|Adverse Event|101|||
126172802|NCT00975195|453917711|FG000|Overall Study|Lack of Efficacy|6|||
126172803|NCT00975195|453917712|FG001|Overall Study|Lack of Efficacy|6|||
126172804|NCT00975195|453917711|FG000|Overall Study|Protocol Violation|27|||
126172805|NCT00975195|453917712|FG001|Overall Study|Protocol Violation|23|||
126172806|NCT00975195|453917711|FG000|Overall Study|Lost to Follow-up|9|||
126172807|NCT00975195|453917712|FG001|Overall Study|Lost to Follow-up|7|||
126172808|NCT00975195|453917711|FG000|Overall Study|Withdrawal by Subject|48|||
126172809|NCT00975195|453917712|FG001|Overall Study|Withdrawal by Subject|61|||
126172810|NCT00975195|453917711|FG000|Overall Study|Other reason not defined above|29|||
126172811|NCT00975195|453917712|FG001|Overall Study|Other reason not defined above|33|||
126172812|NCT00975195|453917711|FG000|Overall Study|Not treated|1|||
126172813|NCT00975195|453917712|FG001|Overall Study|Not treated|2|||
126172814|NCT00363246|453917713|FG000|Overall Study|Death|40|||
126172815|NCT00363246|453917713|FG000|Overall Study|Withdrawal by Subject|19|||
126172816|NCT00363246|453917713|FG000|Overall Study|Lost to Follow-up|14|||
126172817|NCT00363246|453917713|FG000|Overall Study|Bad health|6|||
126172818|NCT00363246|453917713|FG000|Overall Study|Stopped using wheelchair|11|||
126172819|NCT00363246|453917713|FG000|Overall Study|Subject expressed security concerns|2|||
126172820|NCT00363246|453917713|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
126172821|NCT01608724|453917714|FG000|Overall Study|Withdrawal by Subject|131|||
126172822|NCT01608724|453917714|FG000|Overall Study|Lost to Follow-up|41|||
126172823|NCT01608724|453917714|FG000|Overall Study|Study-specific discontinuation criteria|32|||
126172824|NCT01608724|453917714|FG000|Overall Study|Adverse Event|29|||
126172825|NCT01608724|453917714|FG000|Overall Study|Protocol Violation|6|||
126172826|NCT01608724|453917714|FG000|Overall Study|bood sugar too high, etc.|3|||
126172827|NCT01608724|453917714|FG000|Overall Study|Safety reasons|1|||
126172828|NCT00099359|453917719|FG000|Overall Study|Death|11|||
126172829|NCT00099359|453917720|FG001|Overall Study|Death|15|||
126172830|NCT00099359|453917721|FG002|Overall Study|Death|17|||
126172831|NCT00099359|453917719|FG000|Overall Study|Withdrawal by Subject|19|||
126172832|NCT00099359|453917720|FG001|Overall Study|Withdrawal by Subject|19|||
126172833|NCT00099359|453917721|FG002|Overall Study|Withdrawal by Subject|23|||
126172834|NCT00099359|453917719|FG000|Overall Study|Lost to Follow-up|15|||
126172835|NCT00099359|453917720|FG001|Overall Study|Lost to Follow-up|24|||
126172836|NCT00099359|453917721|FG002|Overall Study|Lost to Follow-up|24|||
126172837|NCT00099359|453917719|FG000|Overall Study|moved out of area|9|||
126172838|NCT00099359|453917720|FG001|Overall Study|moved out of area|7|||
126172839|NCT00099359|453917721|FG002|Overall Study|moved out of area|4|||
126172840|NCT02756650|453917722|FG000|Overall Study|Physician Decision|1|||
126172841|NCT02756650|453917722|FG000|Overall Study|Adverse Event|1|||
126172842|NCT01822691|453917723|FG000|Overall Study|Withdrawal by Subject|2|||
126172843|NCT02720016|453917727|FG000|Overall Study|Separation of couple|6|||
126172844|NCT02720016|453917728|FG001|Overall Study|Separation of couple|8|||
126172845|NCT02720016|453917729|FG002|Overall Study|Separation of couple|2|||
126172846|NCT02720016|453917727|FG000|Overall Study|Withdrawal by Subject|6|||
126172847|NCT02720016|453917728|FG001|Overall Study|Withdrawal by Subject|6|||
126172848|NCT02720016|453917729|FG002|Overall Study|Withdrawal by Subject|4|||
126172849|NCT02720016|453917727|FG000|Overall Study|Scheduling issues|2|||
126172850|NCT02720016|453917728|FG001|Overall Study|Scheduling issues|4|||
126172851|NCT02720016|453917729|FG002|Overall Study|Scheduling issues|7|||
126172852|NCT02720016|453917727|FG000|Overall Study|Childcare|2|||
126172853|NCT02720016|453917728|FG001|Overall Study|Childcare|0|||
126172854|NCT02720016|453917729|FG002|Overall Study|Childcare|2|||
126172855|NCT02720016|453917727|FG000|Overall Study|Withdrawal by PI|2|||
126172856|NCT02720016|453917728|FG001|Overall Study|Withdrawal by PI|2|||
126172857|NCT02720016|453917729|FG002|Overall Study|Withdrawal by PI|0|||
126172858|NCT02720016|453917727|FG000|Overall Study|Moved away|2|||
126172859|NCT02720016|453917728|FG001|Overall Study|Moved away|0|||
126172860|NCT02720016|453917729|FG002|Overall Study|Moved away|0|||
126172861|NCT02720016|453917727|FG000|Overall Study|Not Primary Health Concern|0|||
126172862|NCT02720016|453917728|FG001|Overall Study|Not Primary Health Concern|0|||
126172863|NCT02720016|453917729|FG002|Overall Study|Not Primary Health Concern|2|||
126172864|NCT02720016|453917727|FG000|Overall Study|Transportation issues|0|||
126172865|NCT02720016|453917728|FG001|Overall Study|Transportation issues|0|||
126172866|NCT02720016|453917729|FG002|Overall Study|Transportation issues|1|||
126172867|NCT02720016|453917727|FG000|Overall Study|Other|0|||
126172868|NCT02720016|453917728|FG001|Overall Study|Other|0|||
126172869|NCT02720016|453917729|FG002|Overall Study|Other|2|||
126172870|NCT04501679|453917732|FG000|Overall Study|Pregnancy|0|||
126172871|NCT04501679|453917733|FG001|Overall Study|Pregnancy|1|||
126172872|NCT04501679|453917732|FG000|Overall Study|Adverse Event|4|||
126172873|NCT04501679|453917733|FG001|Overall Study|Adverse Event|2|||
126172874|NCT04501679|453917732|FG000|Overall Study|Withdrawal by Subject|2|||
126172875|NCT04501679|453917733|FG001|Overall Study|Withdrawal by Subject|0|||
126172876|NCT04501679|453917732|FG000|Overall Study|Physician Decision|1|||
126172877|NCT04501679|453917733|FG001|Overall Study|Physician Decision|0|||
126172878|NCT04501679|453917732|FG000|Overall Study|Lost to Follow-up|2|||
126172879|NCT04501679|453917733|FG001|Overall Study|Lost to Follow-up|0|||
126172880|NCT00910429|453917736|FG000|Overall Study|Death|18|||
126172881|NCT00910429|453917737|FG001|Overall Study|Death|12|||
126172882|NCT00910429|453917736|FG000|Overall Study|Withdrawal by Subject|3|||
126172883|NCT00910429|453917737|FG001|Overall Study|Withdrawal by Subject|2|||
126172884|NCT00910429|453917736|FG000|Overall Study|Protocol Violation|1|||
126172885|NCT00910429|453917737|FG001|Overall Study|Protocol Violation|0|||
126172886|NCT00910429|453917736|FG000|Overall Study|Lost to Follow-up|2|||
126172887|NCT00910429|453917737|FG001|Overall Study|Lost to Follow-up|1|||
126172888|NCT00910429|453917736|FG000|Overall Study|Adverse Event|10|||
126172889|NCT00910429|453917737|FG001|Overall Study|Adverse Event|5|||
126172890|NCT00910429|453917736|FG000|Overall Study|Drug non-compliance|1|||
126172891|NCT00910429|453917737|FG001|Overall Study|Drug non-compliance|0|||
126172892|NCT00910429|453917736|FG000|Overall Study|Lack of Efficacy|4|||
126172893|NCT00910429|453917737|FG001|Overall Study|Lack of Efficacy|1|||
126172894|NCT02358369|453917741|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
126172895|NCT02358369|453917742|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
126172896|NCT02358369|453917743|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
126172897|NCT02358369|453917744|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
126172898|NCT02358369|453917745|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
126172899|NCT02358369|453917741|FG000|Treatment Period A/B|Adverse Event|0|||
126172900|NCT02358369|453917742|FG001|Treatment Period A/B|Adverse Event|0|||
126172901|NCT02358369|453917743|FG002|Treatment Period A/B|Adverse Event|1|||
126172902|NCT02358369|453917744|FG003|Treatment Period A/B|Adverse Event|2|||
126172903|NCT02358369|453917745|FG004|Treatment Period A/B|Adverse Event|0|||
126172904|NCT02358369|453917741|FG000|Treatment Period A/B|Death|0|||
126172905|NCT02358369|453917742|FG001|Treatment Period A/B|Death|0|||
126172906|NCT02358369|453917743|FG002|Treatment Period A/B|Death|1|||
126172907|NCT02358369|453917744|FG003|Treatment Period A/B|Death|0|||
126172908|NCT02358369|453917745|FG004|Treatment Period A/B|Death|0|||
126172909|NCT02358369|453917741|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
126172910|NCT02358369|453917742|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
126172911|NCT02358369|453917743|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
126172912|NCT02358369|453917744|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
126172913|NCT02358369|453917745|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
126172914|NCT02358369|453917741|FG000|Treatment Period C|Adverse Event|0|||
126172915|NCT02358369|453917742|FG001|Treatment Period C|Adverse Event|0|||
126172916|NCT02358369|453917743|FG002|Treatment Period C|Adverse Event|0|||
126172917|NCT02358369|453917744|FG003|Treatment Period C|Adverse Event|0|||
126172918|NCT02358369|453917745|FG004|Treatment Period C|Adverse Event|7|||
126172919|NCT04465396|453917746|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
126172920|NCT04465396|453917747|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
126172921|NCT04465396|453917748|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
126172922|NCT04465396|453917749|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
126172923|NCT00808249|453917756|FG000|Overall Study|Adverse Event|4|||
126172924|NCT00808249|453917757|FG001|Overall Study|Adverse Event|7|||
126172925|NCT00808249|453917758|FG002|Overall Study|Adverse Event|10|||
126172926|NCT00808249|453917759|FG003|Overall Study|Adverse Event|6|||
126172927|NCT00808249|453917756|FG000|Overall Study|Lost to Follow-up|2|||
126172928|NCT00808249|453917757|FG001|Overall Study|Lost to Follow-up|3|||
126172929|NCT00808249|453917758|FG002|Overall Study|Lost to Follow-up|3|||
126172930|NCT00808249|453917759|FG003|Overall Study|Lost to Follow-up|5|||
126172931|NCT00808249|453917756|FG000|Overall Study|Withdrawal by Subject|4|||
126172932|NCT00808249|453917757|FG001|Overall Study|Withdrawal by Subject|0|||
126172933|NCT00808249|453917758|FG002|Overall Study|Withdrawal by Subject|2|||
126172934|NCT00808249|453917759|FG003|Overall Study|Withdrawal by Subject|4|||
126172935|NCT00808249|453917756|FG000|Overall Study|Protocol Violation|3|||
126172936|NCT00808249|453917757|FG001|Overall Study|Protocol Violation|3|||
126172937|NCT00808249|453917758|FG002|Overall Study|Protocol Violation|3|||
126172938|NCT00808249|453917759|FG003|Overall Study|Protocol Violation|0|||
126172939|NCT00808249|453917756|FG000|Overall Study|Lack of Efficacy|1|||
126172940|NCT00808249|453917757|FG001|Overall Study|Lack of Efficacy|1|||
126172941|NCT00808249|453917758|FG002|Overall Study|Lack of Efficacy|0|||
126172942|NCT00808249|453917759|FG003|Overall Study|Lack of Efficacy|0|||
126172943|NCT00808249|453917756|FG000|Overall Study|study specific discontinuation criteria|1|||
126172944|NCT00808249|453917757|FG001|Overall Study|study specific discontinuation criteria|0|||
126172945|NCT00808249|453917758|FG002|Overall Study|study specific discontinuation criteria|1|||
126172946|NCT00808249|453917759|FG003|Overall Study|study specific discontinuation criteria|0|||
126172947|NCT00808249|453917756|FG000|Overall Study|All other reasons|2|||
126172948|NCT00808249|453917757|FG001|Overall Study|All other reasons|1|||
126172949|NCT00808249|453917758|FG002|Overall Study|All other reasons|3|||
126172950|NCT00808249|453917759|FG003|Overall Study|All other reasons|1|||
126172951|NCT00479557|453917762|FG000|Overall Study|Death|0|||
126172952|NCT00479557|453917763|FG001|Overall Study|Death|0|||
126172953|NCT00479557|453917764|FG002|Overall Study|Death|0|||
126172954|NCT00479557|453917765|FG003|Overall Study|Death|0|||
126172955|NCT00479557|453917766|FG004|Overall Study|Death|0|||
126172956|NCT00479557|453917767|FG005|Overall Study|Death|1|||
126172957|NCT00479557|453917768|FG006|Overall Study|Death|0|||
126172958|NCT00479557|453917762|FG000|Overall Study|Lack of Efficacy|1|||
126172959|NCT00479557|453917763|FG001|Overall Study|Lack of Efficacy|0|||
126172960|NCT00479557|453917764|FG002|Overall Study|Lack of Efficacy|0|||
126172961|NCT00479557|453917765|FG003|Overall Study|Lack of Efficacy|0|||
125973875|NCT02251990|453193186|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
126172962|NCT00479557|453917766|FG004|Overall Study|Lack of Efficacy|0|||
126172963|NCT00479557|453917767|FG005|Overall Study|Lack of Efficacy|0|||
126172964|NCT00479557|453917768|FG006|Overall Study|Lack of Efficacy|0|||
126172965|NCT00479557|453917762|FG000|Overall Study|Lost to Follow-up|0|||
126172966|NCT00479557|453917763|FG001|Overall Study|Lost to Follow-up|2|||
126172967|NCT00479557|453917764|FG002|Overall Study|Lost to Follow-up|0|||
126172968|NCT00479557|453917765|FG003|Overall Study|Lost to Follow-up|2|||
126172969|NCT00479557|453917766|FG004|Overall Study|Lost to Follow-up|0|||
126172970|NCT00479557|453917767|FG005|Overall Study|Lost to Follow-up|0|||
126172971|NCT00479557|453917768|FG006|Overall Study|Lost to Follow-up|0|||
126172972|NCT00479557|453917762|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
126172973|NCT00479557|453917763|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126172974|NCT00479557|453917764|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
126172975|NCT00479557|453917765|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
126172976|NCT00479557|453917766|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126172977|NCT00479557|453917767|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
126172978|NCT00479557|453917768|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126172979|NCT00479557|453917762|FG000|Overall Study|AE not related to Study Drug|1|||
126172980|NCT00479557|453917763|FG001|Overall Study|AE not related to Study Drug|3|||
126172981|NCT00479557|453917764|FG002|Overall Study|AE not related to Study Drug|0|||
126172982|NCT00479557|453917765|FG003|Overall Study|AE not related to Study Drug|0|||
126172983|NCT00479557|453917766|FG004|Overall Study|AE not related to Study Drug|2|||
126172984|NCT00479557|453917767|FG005|Overall Study|AE not related to Study Drug|2|||
126172985|NCT00479557|453917768|FG006|Overall Study|AE not related to Study Drug|1|||
126172986|NCT00479557|453917762|FG000|Overall Study|Caregiver Request|2|||
126172987|NCT00479557|453917763|FG001|Overall Study|Caregiver Request|2|||
126172988|NCT00479557|453917764|FG002|Overall Study|Caregiver Request|2|||
126172989|NCT00479557|453917765|FG003|Overall Study|Caregiver Request|0|||
126172990|NCT00479557|453917766|FG004|Overall Study|Caregiver Request|1|||
126172991|NCT00479557|453917767|FG005|Overall Study|Caregiver Request|2|||
126172992|NCT00479557|453917768|FG006|Overall Study|Caregiver Request|0|||
126172993|NCT00479557|453917762|FG000|Overall Study|Investigator Request|0|||
126172994|NCT00479557|453917763|FG001|Overall Study|Investigator Request|0|||
126172995|NCT00479557|453917764|FG002|Overall Study|Investigator Request|1|||
126172996|NCT00479557|453917765|FG003|Overall Study|Investigator Request|0|||
126172997|NCT00479557|453917766|FG004|Overall Study|Investigator Request|0|||
126172998|NCT00479557|453917767|FG005|Overall Study|Investigator Request|0|||
126172999|NCT00479557|453917768|FG006|Overall Study|Investigator Request|0|||
126173000|NCT00479557|453917762|FG000|Overall Study|Subject Request|3|||
126173001|NCT00479557|453917763|FG001|Overall Study|Subject Request|0|||
126173002|NCT00479557|453917764|FG002|Overall Study|Subject Request|1|||
126173003|NCT00479557|453917765|FG003|Overall Study|Subject Request|1|||
126173004|NCT00479557|453917766|FG004|Overall Study|Subject Request|1|||
126173005|NCT00479557|453917767|FG005|Overall Study|Subject Request|4|||
126173006|NCT00479557|453917768|FG006|Overall Study|Subject Request|1|||
126173007|NCT00479557|453917762|FG000|Overall Study|Other|2|||
126173008|NCT00479557|453917763|FG001|Overall Study|Other|3|||
126173009|NCT00479557|453917764|FG002|Overall Study|Other|1|||
126173010|NCT00479557|453917765|FG003|Overall Study|Other|0|||
126173011|NCT00479557|453917766|FG004|Overall Study|Other|0|||
126173012|NCT00479557|453917767|FG005|Overall Study|Other|3|||
126173013|NCT00479557|453917768|FG006|Overall Study|Other|0|||
126173014|NCT02509494|453917771|FG000|Overall Study|Lost to Follow-up|8|||
126173015|NCT02509494|453917772|FG001|Overall Study|Lost to Follow-up|47|||
126173016|NCT02509494|453917773|FG002|Overall Study|Lost to Follow-up|19|||
126173017|NCT02509494|453917774|FG003|Overall Study|Lost to Follow-up|6|||
126173018|NCT02509494|453917775|FG004|Overall Study|Lost to Follow-up|3|||
126173019|NCT02509494|453917776|FG005|Overall Study|Lost to Follow-up|3|||
126173020|NCT02509494|453917777|FG006|Overall Study|Lost to Follow-up|1|||
126173021|NCT02509494|453917778|FG007|Overall Study|Lost to Follow-up|3|||
126173022|NCT02509494|453917779|FG008|Overall Study|Lost to Follow-up|1|||
126173023|NCT02509494|453917771|FG000|Overall Study|Physician Decision|2|||
126173024|NCT02509494|453917772|FG001|Overall Study|Physician Decision|1|||
126173025|NCT02509494|453917773|FG002|Overall Study|Physician Decision|0|||
126173026|NCT02509494|453917774|FG003|Overall Study|Physician Decision|0|||
126173027|NCT02509494|453917775|FG004|Overall Study|Physician Decision|0|||
126173028|NCT02509494|453917776|FG005|Overall Study|Physician Decision|0|||
126173029|NCT02509494|453917777|FG006|Overall Study|Physician Decision|0|||
126173030|NCT02509494|453917778|FG007|Overall Study|Physician Decision|0|||
126173031|NCT02509494|453917779|FG008|Overall Study|Physician Decision|0|||
126173032|NCT02509494|453917771|FG000|Overall Study|Withdrawal by Subject|4|||
126173033|NCT02509494|453917772|FG001|Overall Study|Withdrawal by Subject|17|||
126173034|NCT02509494|453917773|FG002|Overall Study|Withdrawal by Subject|7|||
126173035|NCT02509494|453917774|FG003|Overall Study|Withdrawal by Subject|5|||
126173036|NCT02509494|453917775|FG004|Overall Study|Withdrawal by Subject|0|||
126173037|NCT02509494|453917776|FG005|Overall Study|Withdrawal by Subject|6|||
126173038|NCT02509494|453917777|FG006|Overall Study|Withdrawal by Subject|1|||
126173039|NCT02509494|453917778|FG007|Overall Study|Withdrawal by Subject|2|||
125973876|NCT02251990|453193185|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
126173040|NCT02509494|453917779|FG008|Overall Study|Withdrawal by Subject|1|||
126173041|NCT02509494|453917771|FG000|Overall Study|Death|0|||
126173042|NCT02509494|453917772|FG001|Overall Study|Death|1|||
126173043|NCT02509494|453917773|FG002|Overall Study|Death|0|||
126173044|NCT02509494|453917774|FG003|Overall Study|Death|0|||
126173045|NCT02509494|453917775|FG004|Overall Study|Death|1|||
126173046|NCT02509494|453917776|FG005|Overall Study|Death|0|||
126173047|NCT02509494|453917777|FG006|Overall Study|Death|0|||
126173048|NCT02509494|453917778|FG007|Overall Study|Death|1|||
126173049|NCT02509494|453917779|FG008|Overall Study|Death|0|||
126173050|NCT02509494|453917771|FG000|Overall Study|Other|0|||
126173051|NCT02509494|453917772|FG001|Overall Study|Other|4|||
126173052|NCT02509494|453917773|FG002|Overall Study|Other|5|||
126173053|NCT02509494|453917774|FG003|Overall Study|Other|0|||
126173054|NCT02509494|453917775|FG004|Overall Study|Other|0|||
126173055|NCT02509494|453917776|FG005|Overall Study|Other|0|||
126173056|NCT02509494|453917777|FG006|Overall Study|Other|0|||
126173057|NCT02509494|453917778|FG007|Overall Study|Other|0|||
126173058|NCT02509494|453917779|FG008|Overall Study|Other|0|||
126173059|NCT02509494|453917771|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126173060|NCT02509494|453917772|FG001|Overall Study|Non-Compliance With Study Drug|11|||
126173061|NCT02509494|453917773|FG002|Overall Study|Non-Compliance With Study Drug|7|||
126173062|NCT02509494|453917774|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126173063|NCT02509494|453917775|FG004|Overall Study|Non-Compliance With Study Drug|1|||
126173064|NCT02509494|453917776|FG005|Overall Study|Non-Compliance With Study Drug|2|||
126173065|NCT02509494|453917777|FG006|Overall Study|Non-Compliance With Study Drug|1|||
126173066|NCT02509494|453917778|FG007|Overall Study|Non-Compliance With Study Drug|1|||
126173067|NCT02509494|453917779|FG008|Overall Study|Non-Compliance With Study Drug|0|||
126173068|NCT03003403|453917780|FG000|Overall Study|Ineligible|8|||
126173069|NCT03003403|453917781|FG001|Overall Study|Ineligible|7|||
126173070|NCT03003403|453917780|FG000|Overall Study|Withdrawal by Subject|3|||
126173071|NCT03003403|453917781|FG001|Overall Study|Withdrawal by Subject|1|||
126173072|NCT03073213|453919258|FG000|Multiple Dose Period|Protocol Violation|0|||
126173073|NCT03073213|453919259|FG001|Multiple Dose Period|Protocol Violation|0|||
126173074|NCT03073213|453919260|FG002|Multiple Dose Period|Protocol Violation|1|||
126173075|NCT00280150|453919264|FG000|Overall Study|Adverse Event|0|||
126173076|NCT00280150|453919265|FG001|Overall Study|Adverse Event|1|||
126173077|NCT00280150|453919266|FG002|Overall Study|Adverse Event|2|||
126173078|NCT00280150|453919267|FG003|Overall Study|Adverse Event|3|||
126173079|NCT00280150|453919264|FG000|Overall Study|Lack of Efficacy|0|||
126173080|NCT00280150|453919265|FG001|Overall Study|Lack of Efficacy|0|||
126173081|NCT00280150|453919266|FG002|Overall Study|Lack of Efficacy|0|||
126173082|NCT00280150|453919267|FG003|Overall Study|Lack of Efficacy|3|||
126173083|NCT00280150|453919264|FG000|Overall Study|Physician Decision|0|||
126173084|NCT00280150|453919265|FG001|Overall Study|Physician Decision|0|||
126173085|NCT00280150|453919266|FG002|Overall Study|Physician Decision|0|||
126173086|NCT00280150|453919267|FG003|Overall Study|Physician Decision|1|||
126173087|NCT00280150|453919264|FG000|Overall Study|Protocol Violation|0|||
126173088|NCT00280150|453919265|FG001|Overall Study|Protocol Violation|0|||
126173089|NCT00280150|453919266|FG002|Overall Study|Protocol Violation|0|||
126173090|NCT00280150|453919267|FG003|Overall Study|Protocol Violation|1|||
126173091|NCT00280150|453919264|FG000|Overall Study|Withdrawal by Subject|0|||
126173092|NCT00280150|453919265|FG001|Overall Study|Withdrawal by Subject|0|||
126173093|NCT00280150|453919266|FG002|Overall Study|Withdrawal by Subject|0|||
126173094|NCT00280150|453919267|FG003|Overall Study|Withdrawal by Subject|1|||
126173095|NCT00280150|453919264|FG000|Overall Study|Did not get consolidation therapy|3|||
126173096|NCT00280150|453919265|FG001|Overall Study|Did not get consolidation therapy|0|||
126173097|NCT00280150|453919266|FG002|Overall Study|Did not get consolidation therapy|3|||
126173098|NCT00280150|453919267|FG003|Overall Study|Did not get consolidation therapy|0|||
126173099|NCT00280150|453919264|FG000|Overall Study|Declining Performance Status|0|||
126173100|NCT00280150|453919265|FG001|Overall Study|Declining Performance Status|0|||
126173101|NCT00280150|453919266|FG002|Overall Study|Declining Performance Status|0|||
126173102|NCT00280150|453919267|FG003|Overall Study|Declining Performance Status|1|||
126173103|NCT02871401|453919275|FG000|Overall Study|Adverse Event|1|||
126173104|NCT02871401|453919276|FG001|Overall Study|Adverse Event|0|||
126173105|NCT01120379|453919277|FG000|One Year Timepoint|Withdrawal by Subject|41|||
126173106|NCT01120379|453919277|FG000|One Year Timepoint|Lost to Follow-up|115|||
126173107|NCT01120379|453919277|FG000|One Year Timepoint|Death|108|||
126173108|NCT01120379|453919277|FG000|One Year Timepoint|Physician Decision|9|||
126173109|NCT01120379|453919277|FG000|One Year Timepoint|Any other reason for early termination|5|||
126173110|NCT01120379|453919277|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
126173111|NCT01120379|453919277|FG000|Two Year Timepoint|Lost to Follow-up|87|||
126173112|NCT01120379|453919277|FG000|Two Year Timepoint|Death|123|||
126173113|NCT01120379|453919277|FG000|Two Year Timepoint|Physician Decision|12|||
125973877|NCT02251990|453193186|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
125973878|NCT02251990|453193185|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
125973879|NCT02251990|453193186|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
126173114|NCT01120379|453919277|FG000|Two Year Timepoint|Any other reason for early termination|4|||
126173115|NCT01120379|453919277|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
126173116|NCT01120379|453919277|FG000|Three Year Timepoint|Lost to Follow-up|43|||
126173117|NCT01120379|453919277|FG000|Three Year Timepoint|Death|120|||
126173118|NCT01120379|453919277|FG000|Three Year Timepoint|Physician Decision|9|||
126173119|NCT01120379|453919277|FG000|Three Year Timepoint|Any other reason for early termination|17|||
126173120|NCT01120379|453919277|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
126173121|NCT01120379|453919277|FG000|Four Year Timepoint|Lost to Follow-up|10|||
126173122|NCT01120379|453919277|FG000|Four Year Timepoint|Death|131|||
126173123|NCT01120379|453919277|FG000|Four Year Timepoint|Physician Decision|5|||
126173124|NCT01120379|453919277|FG000|Four Year Timepoint|Any other reason for early termination|217|||
126173125|NCT03162055|453919278|FG000|Overall Study|Adverse Event|6|||
126173126|NCT03162055|453919279|FG001|Overall Study|Adverse Event|5|||
126173127|NCT03162055|453919278|FG000|Overall Study|Death|3|||
126173128|NCT03162055|453919279|FG001|Overall Study|Death|3|||
126173129|NCT03162055|453919278|FG000|Overall Study|Lost to Follow-up|0|||
126173130|NCT03162055|453919279|FG001|Overall Study|Lost to Follow-up|1|||
126173131|NCT03162055|453919278|FG000|Overall Study|Study-specific withdrawal criteria|22|||
126173132|NCT03162055|453919279|FG001|Overall Study|Study-specific withdrawal criteria|14|||
126173133|NCT03162055|453919278|FG000|Overall Study|Withdrawal by Subject|17|||
126173134|NCT03162055|453919279|FG001|Overall Study|Withdrawal by Subject|2|||
126173135|NCT03162055|453919278|FG000|Overall Study|Did not receive treatment|2|||
126173136|NCT03162055|453919279|FG001|Overall Study|Did not receive treatment|0|||
126173137|NCT03162055|453919278|FG000|Overall Study|Incorrect randomization|4|||
126173138|NCT03162055|453919279|FG001|Overall Study|Incorrect randomization|3|||
126173139|NCT03162055|453919278|FG000|Overall Study|Other|8|||
126173140|NCT03162055|453919279|FG001|Overall Study|Other|15|||
126173141|NCT02586077|453919280|FG000|Overall Study|Withdrawal by Subject|1|||
126173142|NCT02586077|453919280|FG000|Overall Study|Physician Decision|4|||
126173143|NCT02586077|453919280|FG000|Overall Study|Lost to Follow-up|3|||
126173144|NCT01993615|453919284|FG000|Overall Study|Death|1|||
126173145|NCT01993615|453919285|FG001|Overall Study|Death|0|||
126173146|NCT01617655|453919286|FG000|Overall Study|Adverse Event|2|||
126173147|NCT01617655|453919287|FG001|Overall Study|Adverse Event|3|||
126173148|NCT01617655|453919286|FG000|Overall Study|Poor compliance to protocol|1|||
126173149|NCT01617655|453919287|FG001|Overall Study|Poor compliance to protocol|4|||
126173150|NCT01617655|453919286|FG000|Overall Study|Participants moved|0|||
126173151|NCT01617655|453919287|FG001|Overall Study|Participants moved|4|||
126173152|NCT01617655|453919286|FG000|Overall Study|Consent withdrawn by participant|1|||
126173153|NCT01617655|453919287|FG001|Overall Study|Consent withdrawn by participant|1|||
126173154|NCT01617655|453919286|FG000|Overall Study|Last visit outside protocol visit window|1|||
126173155|NCT01617655|453919287|FG001|Overall Study|Last visit outside protocol visit window|10|||
126173156|NCT01617655|453919286|FG000|Overall Study|Site closure|3|||
126173157|NCT01617655|453919287|FG001|Overall Study|Site closure|5|||
126173158|NCT01617655|453919286|FG000|Overall Study|Other than specified above|1|||
126173159|NCT01617655|453919287|FG001|Overall Study|Other than specified above|2|||
126173160|NCT01175213|453919290|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
126173161|NCT01175213|453919291|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
126173162|NCT01175213|453919290|FG000|IGSC, 10%/rHuPH20|Death|1|||
126173163|NCT01175213|453919291|FG001|IGSC, 10%/rHuPH20|Death|0|||
126173164|NCT01175213|453919290|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
126173165|NCT01175213|453919291|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
126173166|NCT01175213|453919290|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
126173167|NCT01175213|453919291|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
126173168|NCT01175213|453919290|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
126173169|NCT01175213|453919291|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
126173170|NCT01175213|453919290|FG000|Safety Follow-up|Adverse Event|1|||
126173171|NCT01175213|453919291|FG001|Safety Follow-up|Adverse Event|0|||
126173172|NCT01245764|453919296|FG000|Study Phase A|Other|3|||
126173173|NCT01245764|453919297|FG001|Study Phase A|Other|2|||
126173174|NCT01245764|453919298|FG002|Study Phase A|Other|3|||
126173175|NCT01245764|453919299|FG003|Study Phase A|Other|1|||
126173176|NCT01245764|453919296|FG000|Study Phase A|Protocol Violation|6|||
126173177|NCT01245764|453919297|FG001|Study Phase A|Protocol Violation|3|||
126173178|NCT01245764|453919298|FG002|Study Phase A|Protocol Violation|2|||
126173179|NCT01245764|453919299|FG003|Study Phase A|Protocol Violation|2|||
126173180|NCT01245764|453919296|FG000|Study Phase A|Lost to Follow-up|0|||
126173181|NCT01245764|453919297|FG001|Study Phase A|Lost to Follow-up|0|||
126173182|NCT01245764|453919298|FG002|Study Phase A|Lost to Follow-up|5|||
126173183|NCT01245764|453919299|FG003|Study Phase A|Lost to Follow-up|0|||
126173184|NCT00003476|453919300|FG000|Overall Study|Not evaluable|1|||
126173185|NCT00781963|453919305|FG000|Overall Study|Death|3|||
126173186|NCT00781963|453919306|FG001|Overall Study|Death|0|||
126173187|NCT00781963|453919305|FG000|Overall Study|Lost to Follow-up|2|||
126173188|NCT00781963|453919306|FG001|Overall Study|Lost to Follow-up|1|||
126173189|NCT00781963|453919305|FG000|Overall Study|Withdrawal by Subject|3|||
126173190|NCT00781963|453919306|FG001|Overall Study|Withdrawal by Subject|1|||
126173191|NCT00781963|453919305|FG000|Overall Study|Refused follow-up|9|||
126173192|NCT00781963|453919306|FG001|Overall Study|Refused follow-up|0|||
126173193|NCT02064205|453919307|FG000|Overall Study|Withdrawal by Subject|1|||
126173194|NCT03057951|453919311|FG000|Overall Study|Adverse Event|553|||
126173195|NCT03057951|453919312|FG001|Overall Study|Adverse Event|575|||
126173196|NCT03057951|453919311|FG000|Overall Study|Protocol Violation|30|||
126173197|NCT03057951|453919312|FG001|Overall Study|Protocol Violation|24|||
126173198|NCT03057951|453919311|FG000|Overall Study|Lost to Follow-up|6|||
126173199|NCT03057951|453919312|FG001|Overall Study|Lost to Follow-up|16|||
126173200|NCT03057951|453919311|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
126173201|NCT03057951|453919312|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
126173202|NCT03057951|453919311|FG000|Overall Study|Study drug stopped, reason missing|6|||
126173203|NCT03057951|453919312|FG001|Overall Study|Study drug stopped, reason missing|1|||
126173204|NCT03057951|453919311|FG000|Overall Study|Medical advice|6|||
126173205|NCT03057951|453919312|FG001|Overall Study|Medical advice|2|||
126173206|NCT03057951|453919311|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
126173207|NCT03057951|453919312|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
126173208|NCT03057951|453919311|FG000|Overall Study|Investigator decision|2|||
126173209|NCT03057951|453919312|FG001|Overall Study|Investigator decision|0|||
126173210|NCT03057951|453919311|FG000|Overall Study|Patient decision|5|||
126173211|NCT03057951|453919312|FG001|Overall Study|Patient decision|2|||
126173212|NCT03057951|453919311|FG000|Overall Study|Not attending study visits|3|||
126173213|NCT03057951|453919312|FG001|Overall Study|Not attending study visits|0|||
126173214|NCT03057951|453919311|FG000|Overall Study|Patient moved away|3|||
126173215|NCT03057951|453919312|FG001|Overall Study|Patient moved away|4|||
126173216|NCT03057951|453919311|FG000|Overall Study|Other reason than stated above|23|||
126173217|NCT03057951|453919312|FG001|Overall Study|Other reason than stated above|29|||
126173218|NCT03057951|453919311|FG000|Overall Study|Not treated|2|||
126173219|NCT03057951|453919312|FG001|Overall Study|Not treated|1|||
126173220|NCT00696436|453919313|FG000|Overall Study|Adverse Event|7|||
126173221|NCT00696436|453919314|FG001|Overall Study|Adverse Event|9|||
126173222|NCT00696436|453919315|FG002|Overall Study|Adverse Event|8|||
126173223|NCT00696436|453919316|FG003|Overall Study|Adverse Event|6|||
126173224|NCT00696436|453919317|FG004|Overall Study|Adverse Event|4|||
126173225|NCT00696436|453919313|FG000|Overall Study|Protocol Violation|3|||
126173226|NCT00696436|453919314|FG001|Overall Study|Protocol Violation|2|||
126173227|NCT00696436|453919315|FG002|Overall Study|Protocol Violation|2|||
126173228|NCT00696436|453919316|FG003|Overall Study|Protocol Violation|0|||
126173229|NCT00696436|453919317|FG004|Overall Study|Protocol Violation|1|||
126173230|NCT00696436|453919313|FG000|Overall Study|Lost to Follow-up|1|||
126173231|NCT00696436|453919314|FG001|Overall Study|Lost to Follow-up|6|||
126173232|NCT00696436|453919315|FG002|Overall Study|Lost to Follow-up|2|||
126173233|NCT00696436|453919316|FG003|Overall Study|Lost to Follow-up|4|||
126173234|NCT00696436|453919317|FG004|Overall Study|Lost to Follow-up|3|||
126173235|NCT00696436|453919313|FG000|Overall Study|Withdrawal by Subject|4|||
126173236|NCT00696436|453919314|FG001|Overall Study|Withdrawal by Subject|11|||
126173237|NCT00696436|453919315|FG002|Overall Study|Withdrawal by Subject|5|||
126173238|NCT00696436|453919316|FG003|Overall Study|Withdrawal by Subject|7|||
126173239|NCT00696436|453919317|FG004|Overall Study|Withdrawal by Subject|1|||
126173240|NCT00696436|453919313|FG000|Overall Study|Lack of Efficacy|3|||
126173241|NCT00696436|453919314|FG001|Overall Study|Lack of Efficacy|1|||
126173242|NCT00696436|453919315|FG002|Overall Study|Lack of Efficacy|5|||
126173243|NCT00696436|453919316|FG003|Overall Study|Lack of Efficacy|2|||
126173244|NCT00696436|453919317|FG004|Overall Study|Lack of Efficacy|4|||
126173245|NCT00696436|453919313|FG000|Overall Study|Participant Unavailability|2|||
126173246|NCT00696436|453919314|FG001|Overall Study|Participant Unavailability|0|||
126173247|NCT00696436|453919315|FG002|Overall Study|Participant Unavailability|2|||
126173248|NCT00696436|453919316|FG003|Overall Study|Participant Unavailability|1|||
126173249|NCT00696436|453919317|FG004|Overall Study|Participant Unavailability|0|||
126173250|NCT00696436|453919313|FG000|Overall Study|Administrative Error|2|||
126173251|NCT00696436|453919314|FG001|Overall Study|Administrative Error|0|||
126173252|NCT00696436|453919315|FG002|Overall Study|Administrative Error|2|||
126173253|NCT00696436|453919316|FG003|Overall Study|Administrative Error|0|||
126173254|NCT00696436|453919317|FG004|Overall Study|Administrative Error|0|||
126173255|NCT00696436|453919313|FG000|Overall Study|Participant Non-compliance|0|||
126173256|NCT00696436|453919314|FG001|Overall Study|Participant Non-compliance|0|||
126173257|NCT00696436|453919315|FG002|Overall Study|Participant Non-compliance|1|||
126173258|NCT00696436|453919316|FG003|Overall Study|Participant Non-compliance|2|||
126173259|NCT00696436|453919317|FG004|Overall Study|Participant Non-compliance|0|||
126173260|NCT00696436|453919313|FG000|Overall Study|Administrative Decision|1|||
126173261|NCT00696436|453919314|FG001|Overall Study|Administrative Decision|0|||
126173262|NCT00696436|453919315|FG002|Overall Study|Administrative Decision|0|||
126173263|NCT00696436|453919316|FG003|Overall Study|Administrative Decision|0|||
126173264|NCT00696436|453919317|FG004|Overall Study|Administrative Decision|0|||
126173265|NCT00696436|453919313|FG000|Overall Study|Missing|0|||
126173266|NCT00696436|453919314|FG001|Overall Study|Missing|1|||
126173267|NCT00696436|453919315|FG002|Overall Study|Missing|1|||
126173268|NCT00696436|453919316|FG003|Overall Study|Missing|0|||
126173269|NCT00696436|453919317|FG004|Overall Study|Missing|0|||
126173270|NCT02282982|453919318|FG000|Overall Study|Lost to Follow-up|15|||
126173271|NCT02282982|453919318|FG000|Overall Study|Withdrew consent|2|||
126173272|NCT02282982|453919318|FG000|Overall Study|Death|4|||
126173273|NCT02282982|453919318|FG000|Overall Study|Lack of product|156|||
126173274|NCT02282982|453919318|FG000|Overall Study|Palivizumab is ended|11|||
126173275|NCT02282982|453919318|FG000|Overall Study|Other, not specified|18|||
126173276|NCT02062463|453919319|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
126200123|NCT02394028|454017878|FG001|Induction Phase|Lost to Follow-up|0|||
126173277|NCT02062463|453919320|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
126173278|NCT02062463|453919321|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
126173279|NCT02062463|453919322|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
126173280|NCT02062463|453919319|FG000|Stage 2|Adverse Event|0|||
126173281|NCT02062463|453919320|FG001|Stage 2|Adverse Event|0|||
126173282|NCT02062463|453919321|FG002|Stage 2|Adverse Event|12|||
126173283|NCT02062463|453919322|FG003|Stage 2|Adverse Event|20|||
126173284|NCT02062463|453919319|FG000|Stage 2|Lack of Efficacy|0|||
126173285|NCT02062463|453919320|FG001|Stage 2|Lack of Efficacy|0|||
126173286|NCT02062463|453919321|FG002|Stage 2|Lack of Efficacy|3|||
126173287|NCT02062463|453919322|FG003|Stage 2|Lack of Efficacy|4|||
126173288|NCT02062463|453919319|FG000|Stage 2|Lost to Follow-up|0|||
126173289|NCT02062463|453919320|FG001|Stage 2|Lost to Follow-up|0|||
126173290|NCT02062463|453919321|FG002|Stage 2|Lost to Follow-up|20|||
126173291|NCT02062463|453919322|FG003|Stage 2|Lost to Follow-up|20|||
126173292|NCT02062463|453919319|FG000|Stage 2|Non-Compliance|0|||
126173293|NCT02062463|453919320|FG001|Stage 2|Non-Compliance|0|||
126173294|NCT02062463|453919321|FG002|Stage 2|Non-Compliance|0|||
126173295|NCT02062463|453919322|FG003|Stage 2|Non-Compliance|1|||
126173296|NCT02062463|453919319|FG000|Stage 2|Other than specified|0|||
126173297|NCT02062463|453919320|FG001|Stage 2|Other than specified|0|||
126173298|NCT02062463|453919321|FG002|Stage 2|Other than specified|3|||
126173299|NCT02062463|453919322|FG003|Stage 2|Other than specified|1|||
126173300|NCT02062463|453919319|FG000|Stage 2|Withdrawal by Subject|0|||
126173301|NCT02062463|453919320|FG001|Stage 2|Withdrawal by Subject|0|||
126173302|NCT02062463|453919321|FG002|Stage 2|Withdrawal by Subject|15|||
126173303|NCT02062463|453919322|FG003|Stage 2|Withdrawal by Subject|10|||
126173304|NCT02394808|453919331|FG000|Period 1|Unsatisfactory lens fitting|0|||
126173305|NCT02394808|453919332|FG001|Period 1|Unsatisfactory lens fitting|1|||
126173306|NCT02394808|453919331|FG000|Period 2|Lost to Follow-up|1|||
126173307|NCT02394808|453919332|FG001|Period 2|Lost to Follow-up|0|||
126173308|NCT03341923|453919333|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
126173309|NCT03341923|453919334|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
126173310|NCT04580394|453919335|FG000|First Intervention|Incorrectly Randomized|1|||
126173311|NCT04580394|453919335|FG000|First Intervention|Physician Decision|1|||
126173312|NCT04580394|453919335|FG000|First Intervention|Lost to Follow-up|1|||
126173313|NCT04580394|453919335|FG000|Washout (One Week)|Withdrawal by Subject|1|||
126173314|NCT04580394|453919335|FG000|Washout (One Week)|Adverse Event|1|||
126173315|NCT04580394|453919335|FG000|Washout (One Week)|Withdrawal by Subject|2|||
126173316|NCT04580394|453919335|FG000|Third Intervention|Adverse Event|1|||
126173317|NCT04580394|453919335|FG000|Third Intervention|Withdrawal by Subject|1|||
126173318|NCT04580394|453919335|FG000|Washout (One Week)|Withdrawal by Subject|2|||
126173319|NCT03337152|453919338|FG000|Overall Study|Physician Decision|1|||
126173320|NCT03337152|453919339|FG001|Overall Study|Physician Decision|0|||
126173321|NCT03337152|453919338|FG000|Overall Study|Lost to Follow-up|1|||
126173322|NCT03337152|453919339|FG001|Overall Study|Lost to Follow-up|3|||
126173323|NCT03337152|453919338|FG000|Overall Study|Adverse Event|3|||
126173324|NCT03337152|453919339|FG001|Overall Study|Adverse Event|1|||
126173325|NCT03337152|453919338|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
126173326|NCT03337152|453919339|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
126173327|NCT02662985|453919340|FG000|Treatment Period 1|Adverse Event|0|||
126173328|NCT02662985|453919341|FG001|Treatment Period 1|Adverse Event|2|||
126173329|NCT02662985|453919340|FG000|Treatment Period 1|Protocol Violation|0|||
126173330|NCT02662985|453919341|FG001|Treatment Period 1|Protocol Violation|1|||
126173331|NCT02662985|453919340|FG000|Treatment Period 1|Physician Decision|1|||
126173332|NCT02662985|453919341|FG001|Treatment Period 1|Physician Decision|0|||
126173333|NCT02662985|453919340|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126173334|NCT02662985|453919341|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126173335|NCT02662985|453919340|FG000|Treatment Period 2|Lack of Efficacy|0|||
126173336|NCT02662985|453919341|FG001|Treatment Period 2|Lack of Efficacy|1|||
126173337|NCT02662985|453919340|FG000|Treatment Period 2|Lost to Follow-up|1|||
126173338|NCT02662985|453919341|FG001|Treatment Period 2|Lost to Follow-up|0|||
125973880|NCT03265600|453193187|FG000|Overall Study|Lost to Follow-up|17|||
125973881|NCT03265600|453193188|FG001|Overall Study|Lost to Follow-up|5|||
125973882|NCT03265600|453193187|FG000|Overall Study|Withdrawal by Subject|4|||
126173339|NCT02662985|453919340|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
126173340|NCT02662985|453919341|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
126173341|NCT02662985|453919340|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
126173342|NCT02662985|453919341|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
126173343|NCT02662985|453919340|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
126173344|NCT02662985|453919341|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
125973883|NCT03265600|453193188|FG001|Overall Study|Withdrawal by Subject|2|||
125973884|NCT03265600|453193187|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
125973885|NCT03265600|453193188|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
126173345|NCT02662985|453919340|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
126173346|NCT02662985|453919341|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
126173347|NCT02662985|453919340|FG000|Treatment Period 3 (Extension Period)|Death|0|||
126173348|NCT02662985|453919341|FG001|Treatment Period 3 (Extension Period)|Death|1|||
126173349|NCT02493426|453919342|FG000|Overall Study|Withdrawal by Subject|0|||
126173350|NCT02493426|453919343|FG001|Overall Study|Withdrawal by Subject|1|||
126173351|NCT01025817|453919346|FG000|Completed Study Medication|Adverse Event|66|||
126173352|NCT01025817|453919347|FG001|Completed Study Medication|Adverse Event|39|||
126173353|NCT01025817|453919346|FG000|Completed Study Medication|Protocol Deviation|9|||
126173354|NCT01025817|453919347|FG001|Completed Study Medication|Protocol Deviation|8|||
126173355|NCT01025817|453919346|FG000|Completed Study Medication|Withdrawal by Subject|8|||
126173356|NCT01025817|453919347|FG001|Completed Study Medication|Withdrawal by Subject|9|||
126173357|NCT01025817|453919346|FG000|Completed Study Medication|Administrative problems|7|||
126173358|NCT01025817|453919347|FG001|Completed Study Medication|Administrative problems|5|||
126173359|NCT01025817|453919346|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
126173360|NCT01025817|453919347|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
126173361|NCT01025817|453919346|FG000|Completed Study Medication|Abnormal test procedure|4|||
126173362|NCT01025817|453919347|FG001|Completed Study Medication|Abnormal test procedure|0|||
126173363|NCT01025817|453919346|FG000|Completed Study Medication|Graft loss|2|||
126173364|NCT01025817|453919347|FG001|Completed Study Medication|Graft loss|5|||
126173365|NCT01025817|453919346|FG000|Completed Study Medication|Death|2|||
126173366|NCT01025817|453919347|FG001|Completed Study Medication|Death|2|||
126173367|NCT01025817|453919346|FG000|Completed Study Medication|Abnormal lab values|0|||
126173368|NCT01025817|453919347|FG001|Completed Study Medication|Abnormal lab values|2|||
126173369|NCT01025817|453919346|FG000|Completed Study Medication|Subject no longer required study drug|0|||
126173370|NCT01025817|453919347|FG001|Completed Study Medication|Subject no longer required study drug|1|||
126173371|NCT01025817|453919346|FG000|Completed Study Medication|Lost to Follow-up|0|||
126173372|NCT01025817|453919347|FG001|Completed Study Medication|Lost to Follow-up|1|||
126173373|NCT01025817|453919346|FG000|Completed Study|Withdrawal by Subject|8|||
126173374|NCT01025817|453919347|FG001|Completed Study|Withdrawal by Subject|16|||
126173375|NCT01025817|453919346|FG000|Completed Study|Death|6|||
126173376|NCT01025817|453919347|FG001|Completed Study|Death|5|||
126173377|NCT01025817|453919346|FG000|Completed Study|Missing|2|||
126173378|NCT01025817|453919347|FG001|Completed Study|Missing|0|||
126173379|NCT01025817|453919346|FG000|Completed Study|Lost to Follow-up|0|||
126173380|NCT01025817|453919347|FG001|Completed Study|Lost to Follow-up|1|||
126173381|NCT01599754|453919349|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
126173382|NCT01599754|453919350|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
126173383|NCT01599754|453919349|FG000|Overall Study|Participant noncompliance|4|||
126173384|NCT01599754|453919350|FG001|Overall Study|Participant noncompliance|4|||
126173385|NCT01599754|453919349|FG000|Overall Study|Lost to Follow-up|13|||
126173386|NCT01599754|453919350|FG001|Overall Study|Lost to Follow-up|6|||
126173387|NCT01599754|453919349|FG000|Overall Study|Death|31|||
126173388|NCT01599754|453919350|FG001|Overall Study|Death|33|||
126173389|NCT01599754|453919349|FG000|Overall Study|Adverse Event|3|||
126173390|NCT01599754|453919350|FG001|Overall Study|Adverse Event|2|||
126173391|NCT01599754|453919349|FG000|Overall Study|Investigator decision|1|||
126173392|NCT01599754|453919350|FG001|Overall Study|Investigator decision|3|||
126173393|NCT01599754|453919349|FG000|Overall Study|Withdrawal by Subject|24|||
126173394|NCT01599754|453919350|FG001|Overall Study|Withdrawal by Subject|25|||
126173395|NCT01599754|453919349|FG000|Overall Study|Study terminated by sponsor|282|||
126173396|NCT01599754|453919350|FG001|Overall Study|Study terminated by sponsor|285|||
126173397|NCT01551758|453919351|FG000|Overall Study|Adverse Event|29|||
126173398|NCT01551758|453919352|FG001|Overall Study|Adverse Event|43|||
126173399|NCT01551758|453919351|FG000|Overall Study|Lack of Efficacy|0|||
126173400|NCT01551758|453919352|FG001|Overall Study|Lack of Efficacy|1|||
126173401|NCT01551758|453919351|FG000|Overall Study|Protocol Violation|5|||
126173402|NCT01551758|453919352|FG001|Overall Study|Protocol Violation|6|||
126173403|NCT01551758|453919351|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
126173404|NCT01551758|453919352|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
126173405|NCT01551758|453919351|FG000|Overall Study|Lost to Follow-up|29|||
126173406|NCT01551758|453919352|FG001|Overall Study|Lost to Follow-up|25|||
126173407|NCT01551758|453919351|FG000|Overall Study|Physician Decision|9|||
126173408|NCT01551758|453919352|FG001|Overall Study|Physician Decision|3|||
126173409|NCT01551758|453919351|FG000|Overall Study|Withdrawal by Subject|14|||
126173410|NCT01551758|453919352|FG001|Overall Study|Withdrawal by Subject|17|||
126173411|NCT00101192|453919353|FG000|Overall Study|Ineligible|6|||
126173412|NCT00101192|453919353|FG000|Overall Study|Inevaluable|1|||
126173413|NCT02618928|453919356|FG000|Overall Study|Failure to Return|28|||
126173414|NCT02618928|453919356|FG000|Overall Study|Insufficient Virological Response|1|||
125973886|NCT04330638|453193189|FG000|Overall Study|Adverse Event|9|||
126173415|NCT02618928|453919356|FG000|Overall Study|Withdrawal by Subject|2|||
126173416|NCT02618928|453919356|FG000|Overall Study|Death|3|||
126173417|NCT02618928|453919356|FG000|Overall Study|Other|11|||
126173418|NCT02618928|453919356|FG000|Overall Study|Missing|6|||
126173419|NCT02618928|453919356|FG000|Overall Study|Treatment Never Started|7|||
126173420|NCT03282357|453919361|FG000|Overall Study|Lost to Follow-up|3|||
126200124|NCT02394028|454017879|FG002|Induction Phase|Lost to Follow-up|0|||
126173421|NCT03282357|453919361|FG000|Overall Study|Withdrawal by Subject|4|||
126173422|NCT03282357|453919361|FG000|Overall Study|Adverse Event|1|||
126173423|NCT03282357|453919361|FG000|Overall Study|Other|9|||
126173424|NCT01586156|453919362|FG000|Overall Study|Pregnancy|0|||
126173425|NCT01586156|453919363|FG001|Overall Study|Pregnancy|1|||
126173426|NCT01586156|453919364|FG002|Overall Study|Pregnancy|0|||
126173427|NCT02121756|453919370|FG000|Overall Study|Adverse Event|3|||
126173428|NCT02121756|453919371|FG001|Overall Study|Adverse Event|0|||
126173429|NCT02121756|453919370|FG000|Overall Study|Protocol Violation|1|||
126173430|NCT02121756|453919371|FG001|Overall Study|Protocol Violation|1|||
126173431|NCT02121756|453919370|FG000|Overall Study|Physician Decision|2|||
126173432|NCT02121756|453919371|FG001|Overall Study|Physician Decision|1|||
126173433|NCT02365584|453919373|FG000|Overall Study|Adverse Event|2|||
126173434|NCT02365584|453919374|FG001|Overall Study|Adverse Event|2|||
126173435|NCT02365584|453919373|FG000|Overall Study|Withdrawal by Subject|1|||
126173436|NCT02365584|453919374|FG001|Overall Study|Withdrawal by Subject|0|||
126173437|NCT02365584|453919373|FG000|Overall Study|Disease Progression|9|||
126173438|NCT02365584|453919374|FG001|Overall Study|Disease Progression|12|||
126173439|NCT00349752|453919375|FG000|Overall Study|Adverse Event|8|||
126173440|NCT00349752|453919376|FG001|Overall Study|Adverse Event|12|||
126173441|NCT00349752|453919375|FG000|Overall Study|Lack of Efficacy|37|||
126173442|NCT00349752|453919376|FG001|Overall Study|Lack of Efficacy|42|||
126173443|NCT00349752|453919375|FG000|Overall Study|Lost to Follow-up|4|||
126173444|NCT00349752|453919376|FG001|Overall Study|Lost to Follow-up|2|||
126173445|NCT00349752|453919375|FG000|Overall Study|Personal reasons|6|||
126173446|NCT00349752|453919376|FG001|Overall Study|Personal reasons|5|||
126173447|NCT00349752|453919375|FG000|Overall Study|Other: Required exclusionary medication|0|||
126173448|NCT00349752|453919376|FG001|Overall Study|Other: Required exclusionary medication|1|||
126173449|NCT00349752|453919375|FG000|Overall Study|Other: Non compliance|0|||
126173450|NCT00349752|453919376|FG001|Overall Study|Other: Non compliance|1|||
126173451|NCT00349752|453919375|FG000|Overall Study|Other: Patient stopped steroids|0|||
126173452|NCT00349752|453919376|FG001|Overall Study|Other: Patient stopped steroids|1|||
126173453|NCT00349752|453919375|FG000|Overall Study|Other: Patient's steroid use|1|||
126173454|NCT00349752|453919376|FG001|Overall Study|Other: Patient's steroid use|0|||
126173455|NCT00349752|453919375|FG000|Overall Study|Other: Ineligible|1|||
126173456|NCT00349752|453919376|FG001|Overall Study|Other: Ineligible|0|||
126173457|NCT00349752|453919375|FG000|Overall Study|Other: Inadvertently unblinded|1|||
126173458|NCT00349752|453919376|FG001|Overall Study|Other: Inadvertently unblinded|0|||
126173459|NCT00349752|453919375|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
126173460|NCT00349752|453919376|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
126173461|NCT01973452|453919377|FG000|Overall Study|Lack of Efficacy|0|||
126173462|NCT01973452|453919378|FG001|Overall Study|Lack of Efficacy|1|||
126173463|NCT01973452|453919377|FG000|Overall Study|Lost to Follow-up|1|||
126173464|NCT01973452|453919378|FG001|Overall Study|Lost to Follow-up|0|||
126173465|NCT01973452|453919377|FG000|Overall Study|Withdrawal by Subject|10|||
126173466|NCT01973452|453919378|FG001|Overall Study|Withdrawal by Subject|9|||
126173467|NCT01973452|453919377|FG000|Overall Study|Ineligible|1|||
126173468|NCT01973452|453919378|FG001|Overall Study|Ineligible|1|||
126173469|NCT01973452|453919377|FG000|Overall Study|Surgery canceled by participant|5|||
126173470|NCT01973452|453919378|FG001|Overall Study|Surgery canceled by participant|3|||
126173471|NCT00632541|453919384|FG000|Overall Study|Adverse Event|7|||
126173472|NCT05294211|453919385|FG000|Overall Study|Withdrawal by Subject|3|||
126173473|NCT05294211|453919385|FG000|Overall Study|Physician Decision|2|||
126173474|NCT05294211|453919385|FG000|Overall Study|Progressed to active labor|1|||
126173475|NCT05294211|453919385|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
126173476|NCT05294211|453919385|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
126173477|NCT00064350|453919386|FG000|Induction Treatment|Disease Progression|5|||
126173478|NCT00064350|453919387|FG001|Induction Treatment|Disease Progression|1|||
126173479|NCT00064350|453919388|FG002|Induction Treatment|Disease Progression|110|||
126173480|NCT00064350|453919386|FG000|Induction Treatment|Adverse Event|0|||
126173481|NCT00064350|453919387|FG001|Induction Treatment|Adverse Event|2|||
126173482|NCT00064350|453919388|FG002|Induction Treatment|Adverse Event|49|||
126173483|NCT00064350|453919386|FG000|Induction Treatment|Death|0|||
126173484|NCT00064350|453919387|FG001|Induction Treatment|Death|0|||
126173485|NCT00064350|453919388|FG002|Induction Treatment|Death|9|||
126173486|NCT00064350|453919386|FG000|Induction Treatment|Withdrawal by Subject|0|||
126173487|NCT00064350|453919387|FG001|Induction Treatment|Withdrawal by Subject|0|||
126173488|NCT00064350|453919388|FG002|Induction Treatment|Withdrawal by Subject|21|||
126173489|NCT00064350|453919386|FG000|Induction Treatment|Ineligible or never started treatment|3|||
126173490|NCT00064350|453919387|FG001|Induction Treatment|Ineligible or never started treatment|6|||
126173491|NCT00064350|453919388|FG002|Induction Treatment|Ineligible or never started treatment|34|||
126173492|NCT00064350|453919386|FG000|Induction Treatment|Other|0|||
126173493|NCT00064350|453919387|FG001|Induction Treatment|Other|0|||
126173494|NCT00064350|453919388|FG002|Induction Treatment|Other|13|||
126173495|NCT00064350|453919386|FG000|Randomization|Adverse Event|8|||
126173496|NCT00064350|453919387|FG001|Randomization|Adverse Event|3|||
126173497|NCT00064350|453919388|FG002|Randomization|Adverse Event|0|||
126173498|NCT00064350|453919386|FG000|Randomization|Death|3|||
126173499|NCT00064350|453919387|FG001|Randomization|Death|0|||
126173500|NCT00064350|453919388|FG002|Randomization|Death|0|||
126173501|NCT00064350|453919386|FG000|Randomization|Withdrawal by Subject|1|||
126173502|NCT00064350|453919387|FG001|Randomization|Withdrawal by Subject|0|||
126173503|NCT00064350|453919388|FG002|Randomization|Withdrawal by Subject|0|||
126173504|NCT00064350|453919386|FG000|Randomization|Ineligible or never started treatment|9|||
126173505|NCT00064350|453919387|FG001|Randomization|Ineligible or never started treatment|15|||
126173506|NCT00064350|453919388|FG002|Randomization|Ineligible or never started treatment|0|||
126173507|NCT00064350|453919386|FG000|Randomization|Other|5|||
126173508|NCT00064350|453919387|FG001|Randomization|Other|0|||
126173509|NCT00064350|453919388|FG002|Randomization|Other|0|||
126173510|NCT00064350|453919386|FG000|Cross-Over|Adverse Event|0|||
126173511|NCT00064350|453919387|FG001|Cross-Over|Adverse Event|1|||
126173512|NCT00064350|453919388|FG002|Cross-Over|Adverse Event|0|||
126173513|NCT00064350|453919386|FG000|Cross-Over|Death|1|||
126173514|NCT00064350|453919387|FG001|Cross-Over|Death|3|||
126173515|NCT00064350|453919388|FG002|Cross-Over|Death|0|||
126173516|NCT00064350|453919386|FG000|Cross-Over|Withdrawal by Subject|2|||
126173517|NCT00064350|453919387|FG001|Cross-Over|Withdrawal by Subject|2|||
126173518|NCT00064350|453919388|FG002|Cross-Over|Withdrawal by Subject|0|||
126173519|NCT00064350|453919386|FG000|Cross-Over|Ineligible or never started treatment|3|||
126173520|NCT00064350|453919387|FG001|Cross-Over|Ineligible or never started treatment|6|||
126173521|NCT00064350|453919388|FG002|Cross-Over|Ineligible or never started treatment|0|||
126173522|NCT00064350|453919386|FG000|Cross-Over|Other|0|||
126173523|NCT00064350|453919387|FG001|Cross-Over|Other|2|||
126173524|NCT00064350|453919388|FG002|Cross-Over|Other|0|||
126173525|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
126173526|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
126173527|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
126173528|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
126173529|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
126173530|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
126173531|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
126173532|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
126173533|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
126173534|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
126173535|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
126173536|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
126173537|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
126173538|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
126173539|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
126173540|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
126173541|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Missing|3|||
126173542|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Missing|1|||
126173543|NCT00838916|453919389|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
126173544|NCT00838916|453919390|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
126173545|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
126173546|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
126173547|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
126173548|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
126173549|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
126173550|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
126173551|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
126173552|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
126173553|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
126173554|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
126173555|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
126173556|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
126173557|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
126173558|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
126173559|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
126173560|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
126173561|NCT00838916|453919389|FG000|Follow-up Period (8 Weeks)|Missing|3|||
126173562|NCT00838916|453919390|FG001|Follow-up Period (8 Weeks)|Missing|0|||
126173563|NCT01842607|453919392|FG000|Overall Study|Adverse Event|11|||
126173564|NCT01842607|453919392|FG000|Overall Study|Lack of Efficacy|19|||
126173565|NCT01842607|453919392|FG000|Overall Study|Protocol Violation|8|||
126173566|NCT01842607|453919392|FG000|Overall Study|Protocol defined stopping criteria|2|||
126173567|NCT01842607|453919392|FG000|Overall Study|Lost to Follow-up|3|||
126173568|NCT01842607|453919392|FG000|Overall Study|Physician Decision|9|||
126173569|NCT01842607|453919392|FG000|Overall Study|Withdrawal by Subject|14|||
126173570|NCT02034474|453919393|FG000|Overall Study|Adverse Event|3|||
126173571|NCT02034474|453919394|FG001|Overall Study|Adverse Event|2|||
126173572|NCT02034474|453919393|FG000|Overall Study|Withdrawal by Subject|1|||
126173573|NCT02034474|453919394|FG001|Overall Study|Withdrawal by Subject|2|||
126173574|NCT00675103|453919395|FG000|Overall Study|Lack of Efficacy|2|||
126173575|NCT00675103|453919395|FG000|Overall Study|Adverse Event|1|||
126173576|NCT03600714|453919396|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
126173577|NCT02164513|453919399|FG000|Overall Study|Adverse Event|162|||
126173578|NCT02164513|453919400|FG001|Overall Study|Adverse Event|180|||
126173579|NCT02164513|453919401|FG002|Overall Study|Adverse Event|111|||
126173580|NCT02164513|453919399|FG000|Overall Study|Other: Study Closed or terminated|5|||
126173581|NCT02164513|453919400|FG001|Overall Study|Other: Study Closed or terminated|2|||
126173582|NCT02164513|453919401|FG002|Overall Study|Other: Study Closed or terminated|4|||
126173583|NCT02164513|453919399|FG000|Overall Study|Lost to Follow-up|30|||
126173584|NCT02164513|453919400|FG001|Overall Study|Lost to Follow-up|36|||
126173585|NCT02164513|453919401|FG002|Overall Study|Lost to Follow-up|22|||
126173586|NCT02164513|453919399|FG000|Overall Study|Physician Decision|47|||
126173587|NCT02164513|453919400|FG001|Overall Study|Physician Decision|57|||
125973887|NCT04330638|453193190|FG001|Overall Study|Adverse Event|10|||
125973888|NCT04330638|453193191|FG002|Overall Study|Adverse Event|15|||
125973889|NCT04330638|453193192|FG003|Overall Study|Adverse Event|6|||
125973890|NCT04330638|453193193|FG004|Overall Study|Adverse Event|10|||
125973891|NCT04330638|453193194|FG005|Overall Study|Adverse Event|5|||
125973892|NCT04330638|453193189|FG000|Overall Study|Other|2|||
125973893|NCT04330638|453193190|FG001|Overall Study|Other|2|||
125973894|NCT04330638|453193191|FG002|Overall Study|Other|5|||
126173588|NCT02164513|453919401|FG002|Overall Study|Physician Decision|28|||
126173589|NCT02164513|453919399|FG000|Overall Study|Withdrawal by Subject|192|||
126173590|NCT02164513|453919400|FG001|Overall Study|Withdrawal by Subject|261|||
126173591|NCT02164513|453919401|FG002|Overall Study|Withdrawal by Subject|130|||
126173592|NCT02164513|453919399|FG000|Overall Study|Other: Reason not provided by site|1|||
126173593|NCT02164513|453919400|FG001|Overall Study|Other: Reason not provided by site|0|||
126173594|NCT02164513|453919401|FG002|Overall Study|Other: Reason not provided by site|0|||
126199878|NCT00405756|454017797|FG000|Double-blind Treatment|Protocol Violation|1|||
126199879|NCT00405756|454017798|FG001|Double-blind Treatment|Protocol Violation|0|||
126199880|NCT00405756|454017799|FG002|Double-blind Treatment|Protocol Violation|2|||
126199881|NCT00405756|454017797|FG000|Double-blind Treatment|Other|7|||
126199882|NCT00405756|454017798|FG001|Double-blind Treatment|Other|4|||
126199883|NCT00405756|454017799|FG002|Double-blind Treatment|Other|4|||
126199884|NCT00405756|454017797|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
126199885|NCT00405756|454017798|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
126199886|NCT00405756|454017799|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
126199887|NCT00405756|454017797|FG000|Open-label Extension|Adverse Event|1|||
126199888|NCT00405756|454017798|FG001|Open-label Extension|Adverse Event|3|||
126199889|NCT00405756|454017799|FG002|Open-label Extension|Adverse Event|7|||
126199890|NCT00405756|454017797|FG000|Open-label Extension|Disease Progression|8|||
126199891|NCT00405756|454017798|FG001|Open-label Extension|Disease Progression|23|||
126199892|NCT00405756|454017799|FG002|Open-label Extension|Disease Progression|26|||
126199893|NCT00405756|454017797|FG000|Open-label Extension|Withdrawal by Subject|2|||
126199894|NCT00405756|454017798|FG001|Open-label Extension|Withdrawal by Subject|3|||
126199895|NCT00405756|454017799|FG002|Open-label Extension|Withdrawal by Subject|3|||
126199896|NCT00405756|454017797|FG000|Open-label Extension|Death|1|||
126199897|NCT00405756|454017798|FG001|Open-label Extension|Death|2|||
126199898|NCT00405756|454017799|FG002|Open-label Extension|Death|4|||
126199899|NCT00405756|454017797|FG000|Open-label Extension|Other|0|||
126199900|NCT00405756|454017798|FG001|Open-label Extension|Other|1|||
126199901|NCT00405756|454017799|FG002|Open-label Extension|Other|7|||
126199902|NCT00405756|454017797|FG000|Follow-up|Ongoing in Follow-up Period|52|||
126199903|NCT00405756|454017798|FG001|Follow-up|Ongoing in Follow-up Period|51|||
126199904|NCT00405756|454017799|FG002|Follow-up|Ongoing in Follow-up Period|60|||
126199905|NCT00405756|454017797|FG000|Follow-up|Death|21|||
126199906|NCT00405756|454017798|FG001|Follow-up|Death|31|||
126199907|NCT00405756|454017799|FG002|Follow-up|Death|24|||
126199908|NCT00405756|454017797|FG000|Follow-up|Lost to Follow-up|2|||
126199909|NCT00405756|454017798|FG001|Follow-up|Lost to Follow-up|8|||
126199910|NCT00405756|454017799|FG002|Follow-up|Lost to Follow-up|4|||
126199911|NCT00089505|454017800|FG000|Overall Study|Death|4|||
126199912|NCT00089505|454017801|FG001|Overall Study|Death|1|||
125973895|NCT04330638|453193192|FG003|Overall Study|Other|1|||
125973896|NCT04330638|453193193|FG004|Overall Study|Other|3|||
125973897|NCT04330638|453193194|FG005|Overall Study|Other|2|||
125973898|NCT04330638|453193189|FG000|Overall Study|Withdrawal by Subject|4|||
126199913|NCT00089505|454017802|FG002|Overall Study|Death|5|||
126199914|NCT00089505|454017803|FG003|Overall Study|Death|8|||
126199915|NCT00089505|454017800|FG000|Overall Study|Withdrawal by Subject|3|||
126199916|NCT00089505|454017801|FG001|Overall Study|Withdrawal by Subject|0|||
126199917|NCT00089505|454017802|FG002|Overall Study|Withdrawal by Subject|6|||
126199918|NCT00089505|454017803|FG003|Overall Study|Withdrawal by Subject|6|||
126199919|NCT00089505|454017800|FG000|Overall Study|Lost to Follow-up|1|||
126199920|NCT00089505|454017801|FG001|Overall Study|Lost to Follow-up|1|||
126173595|NCT00363051|453921043|FG000|Overall Study|Adminstrative problems|1|||
126173596|NCT00363051|453921044|FG001|Overall Study|Adminstrative problems|1|||
126173597|NCT00363051|453921043|FG000|Overall Study|Adverse Event|21|||
126173598|NCT00363051|453921044|FG001|Overall Study|Adverse Event|12|||
126173599|NCT00363051|453921043|FG000|Overall Study|New Cancer Therapy|2|||
126173600|NCT00363051|453921044|FG001|Overall Study|New Cancer Therapy|1|||
126173601|NCT00363051|453921043|FG000|Overall Study|Withdrawal by Subject|11|||
126173602|NCT00363051|453921044|FG001|Overall Study|Withdrawal by Subject|3|||
126173603|NCT00363051|453921043|FG000|Overall Study|Lost to Follow-up|0|||
126173604|NCT00363051|453921044|FG001|Overall Study|Lost to Follow-up|1|||
126173605|NCT00363051|453921043|FG000|Overall Study|Protocol Violation|0|||
126173606|NCT00363051|453921044|FG001|Overall Study|Protocol Violation|2|||
126173607|NCT00363051|453921043|FG000|Overall Study|Death|3|||
126173608|NCT00363051|453921044|FG001|Overall Study|Death|2|||
126173609|NCT00205699|453921047|FG000|Overall Study|Lost to Follow-up|1|||
126173610|NCT00205699|453921048|FG001|Overall Study|Lost to Follow-up|3|||
126173611|NCT00205699|453921049|FG002|Overall Study|Lost to Follow-up|5|||
126173612|NCT00205699|453921047|FG000|Overall Study|Adverse Event|1|||
126173613|NCT00205699|453921048|FG001|Overall Study|Adverse Event|0|||
126173614|NCT00205699|453921049|FG002|Overall Study|Adverse Event|0|||
126173615|NCT00205699|453921047|FG000|Overall Study|Withdrawal by Subject|1|||
126173616|NCT00205699|453921048|FG001|Overall Study|Withdrawal by Subject|2|||
126173617|NCT00205699|453921049|FG002|Overall Study|Withdrawal by Subject|1|||
126173618|NCT00205699|453921047|FG000|Overall Study|Lack of Efficacy|0|||
126173619|NCT00205699|453921048|FG001|Overall Study|Lack of Efficacy|1|||
126173620|NCT00205699|453921049|FG002|Overall Study|Lack of Efficacy|0|||
126173621|NCT03225716|453921056|FG000|Overall Study|Withdrawal by Subject|2|||
126173622|NCT03225716|453921057|FG001|Overall Study|Withdrawal by Subject|2|||
126173623|NCT03225716|453921058|FG002|Overall Study|Withdrawal by Subject|0|||
126173624|NCT03225716|453921056|FG000|Overall Study|Lack of Efficacy|1|||
126173625|NCT03225716|453921057|FG001|Overall Study|Lack of Efficacy|0|||
126173626|NCT03225716|453921058|FG002|Overall Study|Lack of Efficacy|0|||
126173627|NCT03225716|453921056|FG000|Overall Study|Adverse Event|2|||
126173628|NCT03225716|453921057|FG001|Overall Study|Adverse Event|0|||
126173629|NCT03225716|453921058|FG002|Overall Study|Adverse Event|1|||
126173630|NCT03225716|453921056|FG000|Overall Study|Study early termination by Sponsor|0|||
126173631|NCT03225716|453921057|FG001|Overall Study|Study early termination by Sponsor|0|||
126173632|NCT03225716|453921058|FG002|Overall Study|Study early termination by Sponsor|2|||
126173633|NCT01114373|453921059|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
126173634|NCT01114373|453921060|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
126173635|NCT01114373|453921059|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
126173636|NCT01114373|453921060|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
126173637|NCT01114373|453921059|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
126173638|NCT01114373|453921060|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
126173639|NCT01114373|453921059|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
126173640|NCT01114373|453921060|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
126173641|NCT01653158|453921064|FG000|Overall Study|Death|0|||
126173642|NCT01653158|453921065|FG001|Overall Study|Death|0|||
126173643|NCT01653158|453921066|FG002|Overall Study|Death|0|||
126173644|NCT01653158|453921067|FG003|Overall Study|Death|1|||
126173645|NCT01653158|453921068|FG004|Overall Study|Death|0|||
126173646|NCT01653158|453921069|FG005|Overall Study|Death|0|||
126173647|NCT01653158|453921070|FG006|Overall Study|Death|0|||
126173648|NCT01653158|453921071|FG007|Overall Study|Death|2|||
126173649|NCT01653158|453921064|FG000|Overall Study|Adverse Event|0|||
126173650|NCT01653158|453921065|FG001|Overall Study|Adverse Event|0|||
126173651|NCT01653158|453921066|FG002|Overall Study|Adverse Event|0|||
126173652|NCT01653158|453921067|FG003|Overall Study|Adverse Event|1|||
126173653|NCT01653158|453921068|FG004|Overall Study|Adverse Event|0|||
126173654|NCT01653158|453921069|FG005|Overall Study|Adverse Event|0|||
126173655|NCT01653158|453921070|FG006|Overall Study|Adverse Event|0|||
126173656|NCT01653158|453921071|FG007|Overall Study|Adverse Event|3|||
126173657|NCT01653158|453921064|FG000|Overall Study|Other|0|||
126173658|NCT01653158|453921065|FG001|Overall Study|Other|0|||
126173659|NCT01653158|453921066|FG002|Overall Study|Other|0|||
126173660|NCT01653158|453921067|FG003|Overall Study|Other|0|||
126173661|NCT01653158|453921068|FG004|Overall Study|Other|0|||
126173662|NCT01653158|453921069|FG005|Overall Study|Other|0|||
126173663|NCT01653158|453921070|FG006|Overall Study|Other|0|||
126173664|NCT01653158|453921071|FG007|Overall Study|Other|1|||
126173665|NCT01653158|453921064|FG000|Overall Study|Progressive disease|0|||
126173666|NCT01653158|453921065|FG001|Overall Study|Progressive disease|0|||
126173667|NCT01653158|453921066|FG002|Overall Study|Progressive disease|0|||
126173668|NCT01653158|453921067|FG003|Overall Study|Progressive disease|0|||
126173669|NCT01653158|453921068|FG004|Overall Study|Progressive disease|1|||
126173670|NCT01653158|453921069|FG005|Overall Study|Progressive disease|1|||
126173671|NCT01653158|453921070|FG006|Overall Study|Progressive disease|2|||
126173672|NCT01653158|453921071|FG007|Overall Study|Progressive disease|9|||
126173673|NCT01653158|453921064|FG000|Overall Study|Withdrawal by Subject|1|||
126173674|NCT01653158|453921065|FG001|Overall Study|Withdrawal by Subject|0|||
126173675|NCT01653158|453921066|FG002|Overall Study|Withdrawal by Subject|0|||
126173676|NCT01653158|453921067|FG003|Overall Study|Withdrawal by Subject|0|||
126173677|NCT01653158|453921068|FG004|Overall Study|Withdrawal by Subject|0|||
126173678|NCT01653158|453921069|FG005|Overall Study|Withdrawal by Subject|0|||
126173679|NCT01653158|453921070|FG006|Overall Study|Withdrawal by Subject|0|||
126173680|NCT01653158|453921071|FG007|Overall Study|Withdrawal by Subject|0|||
126173681|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
126173682|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
126173683|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
126173684|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
126173685|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
126173686|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
126173687|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
126173688|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
126173689|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
126173690|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
126173691|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
126173692|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
126173693|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
126173694|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
126173695|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
126173696|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126173697|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126173698|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126173699|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
126173700|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
126173701|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
126173702|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
126173703|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
126173704|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
126173705|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
126173706|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
126173707|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
126173708|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
126173709|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
126173710|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
126173711|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
126173712|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126173713|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126173714|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126173715|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126173716|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126173717|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
126173718|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
126173719|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
126173720|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
126173721|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
126173722|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
126173723|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
126173724|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
126173725|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
126173726|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
126173727|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
126173728|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
126173729|NCT03444870|453921074|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
126173730|NCT03444870|453921075|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126173731|NCT03444870|453921076|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126173732|NCT03444870|453921077|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126173733|NCT03444870|453921078|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126173734|NCT03444870|453921079|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126173735|NCT03444870|453921074|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126173736|NCT03444870|453921075|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126173737|NCT03444870|453921076|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126173738|NCT03444870|453921077|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126173739|NCT03444870|453921078|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
126173740|NCT03444870|453921079|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
126173741|NCT03444870|453921074|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
126173742|NCT03444870|453921075|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
126173743|NCT03444870|453921076|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
126173744|NCT03444870|453921077|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
126173745|NCT03444870|453921078|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
126173746|NCT03444870|453921079|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
126173747|NCT03444870|453921074|FG000|Open-Label Extension (OLE) Period|Death|0|||
126173748|NCT03444870|453921075|FG001|Open-Label Extension (OLE) Period|Death|0|||
126173749|NCT03444870|453921076|FG002|Open-Label Extension (OLE) Period|Death|0|||
126173750|NCT03444870|453921077|FG003|Open-Label Extension (OLE) Period|Death|0|||
126173751|NCT03444870|453921078|FG004|Open-Label Extension (OLE) Period|Death|1|||
126173752|NCT03444870|453921079|FG005|Open-Label Extension (OLE) Period|Death|0|||
126173753|NCT01170702|453921082|FG000|Overall Study|Exclusion criteria met after consent|1|||
126173754|NCT01170702|453921083|FG001|Overall Study|Exclusion criteria met after consent|2|||
126173755|NCT01170702|453921084|FG002|Overall Study|Exclusion criteria met after consent|0|||
126173756|NCT01170702|453921085|FG003|Overall Study|Exclusion criteria met after consent|2|||
126173757|NCT01677507|453921086|FG000|Initial Assignment|Adverse Event|0|||
126173758|NCT01677507|453921087|FG001|Initial Assignment|Adverse Event|1|||
126173759|NCT01677507|453921086|FG000|Initial Assignment|Protocol Violation|0|||
126173760|NCT01677507|453921087|FG001|Initial Assignment|Protocol Violation|1|||
126173761|NCT01677507|453921086|FG000|Second Assigment|Withdrawal by Subject|2|||
126173762|NCT01677507|453921087|FG001|Second Assigment|Withdrawal by Subject|2|||
126173763|NCT01677507|453921086|FG000|Second Assigment|Adverse Event|1|||
126173764|NCT01677507|453921087|FG001|Second Assigment|Adverse Event|3|||
126173765|NCT00571688|453921088|FG000|Overall Study|Lost to Follow-up|3|||
126173766|NCT00571688|453921089|FG001|Overall Study|Lost to Follow-up|6|||
126173767|NCT00571688|453921088|FG000|Overall Study|subject did not tolerate Consta|1|||
126173768|NCT00571688|453921089|FG001|Overall Study|subject did not tolerate Consta|0|||
126173769|NCT00571688|453921088|FG000|Overall Study|subject moved out of the area|1|||
126173770|NCT00571688|453921089|FG001|Overall Study|subject moved out of the area|0|||
126173771|NCT00190983|453921092|FG000|Overall Study|Inevaluable (never treated)|2|||
126173772|NCT02287402|453921093|FG000|Treatment Period|Adverse Event|17|||
126173773|NCT02287402|453921093|FG000|Treatment Period|Voluntary Withdrawal|10|||
126173774|NCT02287402|453921093|FG000|Follow-up|Lost to Follow-up|1|||
126173775|NCT02287402|453921093|FG000|Follow-up|Voluntary Withdrawal|2|||
126173776|NCT01844830|453921094|FG000|Overall Study|Withdrawal by Subject|1|||
126173777|NCT01844830|453921095|FG001|Overall Study|Withdrawal by Subject|0|||
126173778|NCT04247815|453921096|FG000|Overall Study|Adverse Event|1|||
126173779|NCT04247815|453921097|FG001|Overall Study|Adverse Event|0|||
126173780|NCT04247815|453921096|FG000|Overall Study|Withdrawal by Subject|1|||
126173781|NCT04247815|453921097|FG001|Overall Study|Withdrawal by Subject|0|||
126173782|NCT04247815|453921096|FG000|Overall Study|Protocol Violation|0|||
126173783|NCT04247815|453921097|FG001|Overall Study|Protocol Violation|1|||
126173784|NCT00502320|453921099|FG000|Overall Study|Lost to Follow-up|1|||
126173785|NCT00502320|453921100|FG001|Overall Study|Lost to Follow-up|1|||
126173786|NCT00502320|453921099|FG000|Overall Study|Withdrew Consent|1|||
126173787|NCT00502320|453921100|FG001|Overall Study|Withdrew Consent|0|||
126173788|NCT00502320|453921099|FG000|Overall Study|No longer met criteria|1|||
126173789|NCT00502320|453921100|FG001|Overall Study|No longer met criteria|0|||
126173790|NCT00502320|453921099|FG000|Overall Study|Screen Failure|0|||
126173791|NCT00502320|453921100|FG001|Overall Study|Screen Failure|1|||
126173792|NCT00502320|453921099|FG000|Overall Study|Adverse Event|3|||
126173793|NCT00502320|453921100|FG001|Overall Study|Adverse Event|5|||
126173794|NCT03654755|453921101|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
126173795|NCT03654755|453921102|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
126173796|NCT03654755|453921103|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
126173797|NCT03654755|453921101|FG000|Overall Study|Withdrawal by Subject|2|||
126173798|NCT03654755|453921102|FG001|Overall Study|Withdrawal by Subject|4|||
126173799|NCT03654755|453921103|FG002|Overall Study|Withdrawal by Subject|8|||
126173800|NCT03654755|453921101|FG000|Overall Study|Lost to Follow-up|1|||
126173801|NCT03654755|453921102|FG001|Overall Study|Lost to Follow-up|3|||
126173802|NCT03654755|453921103|FG002|Overall Study|Lost to Follow-up|7|||
126173803|NCT03654755|453921101|FG000|Overall Study|Physician Decision|0|||
126173804|NCT03654755|453921102|FG001|Overall Study|Physician Decision|1|||
126173805|NCT03654755|453921103|FG002|Overall Study|Physician Decision|0|||
126173806|NCT03654755|453921101|FG000|Overall Study|Adverse Event|0|||
126173807|NCT03654755|453921102|FG001|Overall Study|Adverse Event|0|||
126173808|NCT03654755|453921103|FG002|Overall Study|Adverse Event|4|||
126173809|NCT03654755|453921101|FG000|Overall Study|Lack of Efficacy|0|||
126173810|NCT03654755|453921102|FG001|Overall Study|Lack of Efficacy|0|||
126173811|NCT03654755|453921103|FG002|Overall Study|Lack of Efficacy|1|||
126173812|NCT04724733|453921107|FG000|Overall Study|Lost to Follow-up|1|||
126173813|NCT04724733|453921108|FG001|Overall Study|Lost to Follow-up|1|||
126173814|NCT04724733|453921109|FG002|Overall Study|Lost to Follow-up|1|||
126173815|NCT01742078|453921110|FG000|Overall Study|Withdrawal by Subject|0|||
126173816|NCT01742078|453921111|FG001|Overall Study|Withdrawal by Subject|0|||
126173817|NCT01742078|453921112|FG002|Overall Study|Withdrawal by Subject|0|||
126173818|NCT01742078|453921113|FG003|Overall Study|Withdrawal by Subject|1|||
126173819|NCT01742078|453921114|FG004|Overall Study|Withdrawal by Subject|0|||
126173820|NCT01742078|453921115|FG005|Overall Study|Withdrawal by Subject|0|||
126173821|NCT01742078|453921116|FG006|Overall Study|Withdrawal by Subject|0|||
126173822|NCT01742078|453921117|FG007|Overall Study|Withdrawal by Subject|0|||
126173823|NCT01742078|453921118|FG008|Overall Study|Withdrawal by Subject|0|||
126173824|NCT00084929|453921119|FG000|Overall Study|ineligible - medical contraindication|1|||
126173825|NCT00084929|453921119|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
126173826|NCT00084929|453921119|FG000|Overall Study|Ineligible - Medical history|6|||
126173827|NCT00084929|453921119|FG000|Overall Study|Withdrawal by Subject|10|||
126173828|NCT00084929|453921119|FG000|Overall Study|Missing/incomplete CTC exam|9|||
126173829|NCT00084929|453921119|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
126173830|NCT00642746|453921121|FG000|Overall Study|Patient unevaluable|1|||
126173831|NCT00642746|453921122|FG001|Overall Study|Patient unevaluable|0|||
126173832|NCT00077610|453921123|FG000|Overall Study|Adverse Event|9|||
126173833|NCT00077610|453921124|FG001|Overall Study|Adverse Event|7|||
126173834|NCT00077610|453921125|FG002|Overall Study|Adverse Event|1|||
126173835|NCT00077610|453921123|FG000|Overall Study|Lost to Follow-up|0|||
126173836|NCT00077610|453921124|FG001|Overall Study|Lost to Follow-up|1|||
126173837|NCT00077610|453921125|FG002|Overall Study|Lost to Follow-up|2|||
126173838|NCT00077610|453921123|FG000|Overall Study|Withdrawal by Subject|4|||
126173839|NCT00077610|453921124|FG001|Overall Study|Withdrawal by Subject|10|||
126173840|NCT00077610|453921125|FG002|Overall Study|Withdrawal by Subject|6|||
126173841|NCT00077610|453921123|FG000|Overall Study|Death|17|||
126173842|NCT00077610|453921124|FG001|Overall Study|Death|13|||
126173843|NCT00077610|453921125|FG002|Overall Study|Death|13|||
126173844|NCT00077610|453921123|FG000|Overall Study|Renal transplant|12|||
126173845|NCT00077610|453921124|FG001|Overall Study|Renal transplant|15|||
126173846|NCT00077610|453921125|FG002|Overall Study|Renal transplant|11|||
126173847|NCT00077610|453921123|FG000|Overall Study|Withdrew from dialysis care|5|||
126173848|NCT00077610|453921124|FG001|Overall Study|Withdrew from dialysis care|0|||
126173849|NCT00077610|453921125|FG002|Overall Study|Withdrew from dialysis care|3|||
126173850|NCT00077610|453921123|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126173851|NCT00077610|453921124|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126173852|NCT00077610|453921125|FG002|Overall Study|Insufficient Therapeutic Response|0|||
126173853|NCT00077610|453921123|FG000|Overall Study|Multiple blood transfusions|0|||
126173854|NCT00077610|453921124|FG001|Overall Study|Multiple blood transfusions|0|||
126173855|NCT00077610|453921125|FG002|Overall Study|Multiple blood transfusions|1|||
126173856|NCT00077610|453921123|FG000|Overall Study|Principal Investigator's decision|1|||
126173857|NCT00077610|453921124|FG001|Overall Study|Principal Investigator's decision|0|||
126173858|NCT00077610|453921125|FG002|Overall Study|Principal Investigator's decision|1|||
126173859|NCT00077610|453921123|FG000|Overall Study|Worsening of health condition|1|||
126173860|NCT00077610|453921124|FG001|Overall Study|Worsening of health condition|1|||
126173861|NCT00077610|453921125|FG002|Overall Study|Worsening of health condition|0|||
126173862|NCT00077610|453921123|FG000|Overall Study|Given Epogen in hospital|1|||
126173863|NCT00077610|453921124|FG001|Overall Study|Given Epogen in hospital|0|||
126173864|NCT00077610|453921125|FG002|Overall Study|Given Epogen in hospital|0|||
126173865|NCT00077610|453921123|FG000|Overall Study|Transferred to other unit|0|||
126173866|NCT00077610|453921124|FG001|Overall Study|Transferred to other unit|0|||
126173867|NCT00077610|453921125|FG002|Overall Study|Transferred to other unit|1|||
126173868|NCT00077610|453921123|FG000|Overall Study|Transferred to nursing home|0|||
126173869|NCT00077610|453921124|FG001|Overall Study|Transferred to nursing home|0|||
126173870|NCT00077610|453921125|FG002|Overall Study|Transferred to nursing home|1|||
126173871|NCT00077610|453921123|FG000|Overall Study|Transfer to satellite unit|1|||
126173872|NCT00077610|453921124|FG001|Overall Study|Transfer to satellite unit|0|||
126173873|NCT00077610|453921125|FG002|Overall Study|Transfer to satellite unit|0|||
126173874|NCT00077610|453921123|FG000|Overall Study|Transfer to other center for surgery|1|||
126173875|NCT00077610|453921124|FG001|Overall Study|Transfer to other center for surgery|0|||
126173876|NCT00077610|453921125|FG002|Overall Study|Transfer to other center for surgery|0|||
126173877|NCT00077610|453921123|FG000|Overall Study|Change in dialysis modality|1|||
126173878|NCT00077610|453921124|FG001|Overall Study|Change in dialysis modality|0|||
126173879|NCT00077610|453921125|FG002|Overall Study|Change in dialysis modality|0|||
126173880|NCT00077610|453921123|FG000|Overall Study|Relocation|0|||
126173881|NCT00077610|453921124|FG001|Overall Study|Relocation|8|||
126173882|NCT00077610|453921125|FG002|Overall Study|Relocation|5|||
126173883|NCT00077610|453921123|FG000|Overall Study|Financial issues|0|||
126173884|NCT00077610|453921124|FG001|Overall Study|Financial issues|1|||
126173885|NCT00077610|453921125|FG002|Overall Study|Financial issues|0|||
126173886|NCT00077610|453921123|FG000|Overall Study|Sponsors decision to withdraw|0|||
126173887|NCT00077610|453921124|FG001|Overall Study|Sponsors decision to withdraw|0|||
126173888|NCT00077610|453921125|FG002|Overall Study|Sponsors decision to withdraw|1|||
126173889|NCT00976950|453921126|FG000|Overall Study|Adverse Event|3|||
126173890|NCT00976950|453921126|FG000|Overall Study|Events with no relationship to Aptivus|3|||
126173891|NCT00304915|453921127|FG000|Overall Study|Lost to Follow-up|11|||
126173892|NCT00304915|453921128|FG001|Overall Study|Lost to Follow-up|11|||
126173893|NCT00304915|453921127|FG000|Overall Study|Death|4|||
126173894|NCT00304915|453921128|FG001|Overall Study|Death|5|||
126173895|NCT00304915|453921127|FG000|Overall Study|Withdrawal by Subject|3|||
126173896|NCT00304915|453921128|FG001|Overall Study|Withdrawal by Subject|0|||
126173897|NCT03442829|453921137|FG000|Overall Study|Scheduling clash|3|||
126173898|NCT03442829|453921138|FG001|Overall Study|Scheduling clash|1|||
126173899|NCT03442829|453921137|FG000|Overall Study|Illness unrelated to study|1|||
126173900|NCT03442829|453921138|FG001|Overall Study|Illness unrelated to study|1|||
126173901|NCT01021852|453921141|FG000|Treatment Period 1|Adverse Event|3|||
126173902|NCT01021852|453921142|FG001|Treatment Period 1|Adverse Event|1|||
126173903|NCT01021852|453921143|FG002|Treatment Period 1|Adverse Event|1|||
126173904|NCT01021852|453921144|FG003|Treatment Period 1|Adverse Event|0|||
126173905|NCT01021852|453921145|FG004|Treatment Period 1|Adverse Event|2|||
126173906|NCT01021852|453921146|FG005|Treatment Period 1|Adverse Event|2|||
126173907|NCT01021852|453921147|FG006|Treatment Period 1|Adverse Event|0|||
126173908|NCT01021852|453921148|FG007|Treatment Period 1|Adverse Event|0|||
126173909|NCT01021852|453921141|FG000|Treatment Period 1|Pregnancy|0|||
126173910|NCT01021852|453921142|FG001|Treatment Period 1|Pregnancy|0|||
126173911|NCT01021852|453921143|FG002|Treatment Period 1|Pregnancy|1|||
126173912|NCT01021852|453921144|FG003|Treatment Period 1|Pregnancy|0|||
126173913|NCT01021852|453921145|FG004|Treatment Period 1|Pregnancy|0|||
126173914|NCT01021852|453921146|FG005|Treatment Period 1|Pregnancy|0|||
126173915|NCT01021852|453921147|FG006|Treatment Period 1|Pregnancy|0|||
126173916|NCT01021852|453921148|FG007|Treatment Period 1|Pregnancy|0|||
126173917|NCT01021852|453921141|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126173918|NCT01021852|453921142|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126173919|NCT01021852|453921143|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126173920|NCT01021852|453921144|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126173921|NCT01021852|453921145|FG004|Treatment Period 1|Withdrawal by Subject|1|||
126173922|NCT01021852|453921146|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126173923|NCT01021852|453921147|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126173924|NCT01021852|453921148|FG007|Treatment Period 1|Withdrawal by Subject|1|||
126173925|NCT01021852|453921141|FG000|Treatment Period 1|Not Treated|0|||
126173926|NCT01021852|453921142|FG001|Treatment Period 1|Not Treated|0|||
126173927|NCT01021852|453921143|FG002|Treatment Period 1|Not Treated|0|||
126173928|NCT01021852|453921144|FG003|Treatment Period 1|Not Treated|2|||
126173929|NCT01021852|453921145|FG004|Treatment Period 1|Not Treated|0|||
126173930|NCT01021852|453921146|FG005|Treatment Period 1|Not Treated|0|||
126173931|NCT01021852|453921147|FG006|Treatment Period 1|Not Treated|0|||
126173932|NCT01021852|453921148|FG007|Treatment Period 1|Not Treated|0|||
126173933|NCT01021852|453921141|FG000|Washout Period-Placebo|Adverse Event|0|||
126173934|NCT01021852|453921142|FG001|Washout Period-Placebo|Adverse Event|0|||
126173935|NCT01021852|453921143|FG002|Washout Period-Placebo|Adverse Event|0|||
126173936|NCT01021852|453921144|FG003|Washout Period-Placebo|Adverse Event|1|||
126173937|NCT01021852|453921145|FG004|Washout Period-Placebo|Adverse Event|0|||
126173938|NCT01021852|453921146|FG005|Washout Period-Placebo|Adverse Event|1|||
126173939|NCT01021852|453921147|FG006|Washout Period-Placebo|Adverse Event|0|||
126173940|NCT01021852|453921148|FG007|Washout Period-Placebo|Adverse Event|0|||
126173941|NCT01021852|453921141|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
126173942|NCT01021852|453921142|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
126173943|NCT01021852|453921143|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
126173944|NCT01021852|453921144|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
126173945|NCT01021852|453921145|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
126173946|NCT01021852|453921146|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
126173947|NCT01021852|453921147|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
126173948|NCT01021852|453921148|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
126173949|NCT01021852|453921141|FG000|Washout Period-Placebo|Protocol Violation|0|||
126173950|NCT01021852|453921142|FG001|Washout Period-Placebo|Protocol Violation|0|||
126173951|NCT01021852|453921143|FG002|Washout Period-Placebo|Protocol Violation|0|||
126173952|NCT01021852|453921144|FG003|Washout Period-Placebo|Protocol Violation|0|||
126173953|NCT01021852|453921145|FG004|Washout Period-Placebo|Protocol Violation|0|||
126173954|NCT01021852|453921146|FG005|Washout Period-Placebo|Protocol Violation|0|||
126173955|NCT01021852|453921147|FG006|Washout Period-Placebo|Protocol Violation|1|||
126173956|NCT01021852|453921148|FG007|Washout Period-Placebo|Protocol Violation|0|||
126173957|NCT01021852|453921141|FG000|Washout Period-No Drug|Adverse Event|1|||
126173958|NCT01021852|453921142|FG001|Washout Period-No Drug|Adverse Event|0|||
126173959|NCT01021852|453921143|FG002|Washout Period-No Drug|Adverse Event|0|||
126173960|NCT01021852|453921144|FG003|Washout Period-No Drug|Adverse Event|0|||
126173961|NCT01021852|453921145|FG004|Washout Period-No Drug|Adverse Event|0|||
126173962|NCT01021852|453921146|FG005|Washout Period-No Drug|Adverse Event|1|||
126173963|NCT01021852|453921147|FG006|Washout Period-No Drug|Adverse Event|0|||
126173964|NCT01021852|453921148|FG007|Washout Period-No Drug|Adverse Event|0|||
126173965|NCT01021852|453921141|FG000|Treatment Period 2|Adverse Event|0|||
126173966|NCT01021852|453921142|FG001|Treatment Period 2|Adverse Event|1|||
126173967|NCT01021852|453921143|FG002|Treatment Period 2|Adverse Event|0|||
126173968|NCT01021852|453921144|FG003|Treatment Period 2|Adverse Event|0|||
126173969|NCT01021852|453921145|FG004|Treatment Period 2|Adverse Event|1|||
126173970|NCT01021852|453921146|FG005|Treatment Period 2|Adverse Event|0|||
126173971|NCT01021852|453921147|FG006|Treatment Period 2|Adverse Event|1|||
126173972|NCT01021852|453921148|FG007|Treatment Period 2|Adverse Event|0|||
126173973|NCT01021852|453921141|FG000|Treatment Period 2|Lack of Efficacy|0|||
126173974|NCT01021852|453921142|FG001|Treatment Period 2|Lack of Efficacy|0|||
126173975|NCT01021852|453921143|FG002|Treatment Period 2|Lack of Efficacy|0|||
126173976|NCT01021852|453921144|FG003|Treatment Period 2|Lack of Efficacy|0|||
126173977|NCT01021852|453921145|FG004|Treatment Period 2|Lack of Efficacy|0|||
126173978|NCT01021852|453921146|FG005|Treatment Period 2|Lack of Efficacy|1|||
126173979|NCT01021852|453921147|FG006|Treatment Period 2|Lack of Efficacy|0|||
126173980|NCT01021852|453921148|FG007|Treatment Period 2|Lack of Efficacy|0|||
126173981|NCT01021852|453921141|FG000|Treatment Period 2|Physician Decision|0|||
126173982|NCT01021852|453921142|FG001|Treatment Period 2|Physician Decision|0|||
126173983|NCT01021852|453921143|FG002|Treatment Period 2|Physician Decision|1|||
126173984|NCT01021852|453921144|FG003|Treatment Period 2|Physician Decision|0|||
126173985|NCT01021852|453921145|FG004|Treatment Period 2|Physician Decision|0|||
126173986|NCT01021852|453921146|FG005|Treatment Period 2|Physician Decision|0|||
126173987|NCT01021852|453921147|FG006|Treatment Period 2|Physician Decision|0|||
126173988|NCT01021852|453921148|FG007|Treatment Period 2|Physician Decision|0|||
126173989|NCT01021852|453921141|FG000|Treatment Period 2|Protocol Violation|0|||
126173990|NCT01021852|453921142|FG001|Treatment Period 2|Protocol Violation|0|||
126173991|NCT01021852|453921143|FG002|Treatment Period 2|Protocol Violation|0|||
126173992|NCT01021852|453921144|FG003|Treatment Period 2|Protocol Violation|0|||
126173993|NCT01021852|453921145|FG004|Treatment Period 2|Protocol Violation|1|||
126173994|NCT01021852|453921146|FG005|Treatment Period 2|Protocol Violation|0|||
126173995|NCT01021852|453921147|FG006|Treatment Period 2|Protocol Violation|1|||
126173996|NCT01021852|453921148|FG007|Treatment Period 2|Protocol Violation|0|||
126173997|NCT01021852|453921141|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126173998|NCT01021852|453921142|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126173999|NCT01021852|453921143|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126174000|NCT01021852|453921144|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126174001|NCT01021852|453921145|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126174002|NCT01021852|453921146|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126174003|NCT01021852|453921147|FG006|Treatment Period 2|Withdrawal by Subject|1|||
126174004|NCT01021852|453921148|FG007|Treatment Period 2|Withdrawal by Subject|2|||
126174005|NCT00712322|453921149|FG000|Overall Study|Protocol deviation|0|||
126174006|NCT00712322|453921150|FG001|Overall Study|Protocol deviation|1|||
126174007|NCT00712322|453921151|FG002|Overall Study|Protocol deviation|0|||
126174008|NCT02802878|453921155|FG000|Overall Study|Withdrawal by Subject|3|||
126174009|NCT02802878|453921156|FG001|Overall Study|Withdrawal by Subject|3|||
126174010|NCT02802878|453921155|FG000|Overall Study|Protocol Violation|1|||
126174011|NCT02802878|453921156|FG001|Overall Study|Protocol Violation|0|||
126174012|NCT01029002|453921157|FG000|Overall Study|Lost to Follow-up|2|||
126174013|NCT01029002|453921158|FG001|Overall Study|Lost to Follow-up|4|||
126174014|NCT00702052|453921159|FG000|Overall Study|Adverse Event|23|||
126174015|NCT00702052|453921159|FG000|Overall Study|Disease Progression|30|||
126174016|NCT00702052|453921159|FG000|Overall Study|Withdrawal by Subject|5|||
126174017|NCT01577160|453921160|FG000|Overall Study|Adverse Event|9|||
126174018|NCT01577160|453921160|FG000|Overall Study|Lack of Efficacy|15|||
126174019|NCT01577160|453921160|FG000|Overall Study|Lost to Follow-up|40|||
126174020|NCT01577160|453921160|FG000|Overall Study|Withdrawal by Subject|18|||
126174021|NCT01577160|453921160|FG000|Overall Study|Subject Uncooperative|7|||
126174022|NCT01577160|453921160|FG000|Overall Study|Other|9|||
126174023|NCT00536978|453921161|FG000|Overall Study|Not eligible for Adback Infusion|22|||
126174024|NCT00916370|453921164|FG000|Overall Study|Death|3|||
126174025|NCT00916370|453921165|FG001|Overall Study|Death|1|||
126174026|NCT00916370|453921164|FG000|Overall Study|Withdrawal by Subject|2|||
126174027|NCT00916370|453921165|FG001|Overall Study|Withdrawal by Subject|0|||
126174028|NCT00916370|453921164|FG000|Overall Study|Physician Decision|0|||
126174029|NCT00916370|453921165|FG001|Overall Study|Physician Decision|1|||
126174030|NCT03550131|453921166|FG000|Overall Study|Lost to Follow-up|16|||
126174031|NCT03550131|453921167|FG001|Overall Study|Lost to Follow-up|24|||
126174032|NCT03550131|453921166|FG000|Overall Study|Withdrawal by Subject|36|||
126174033|NCT03550131|453921167|FG001|Overall Study|Withdrawal by Subject|28|||
126174034|NCT03550131|453921166|FG000|Overall Study|Illness of dyad member|10|||
126174035|NCT03550131|453921167|FG001|Overall Study|Illness of dyad member|2|||
126174036|NCT03550131|453921166|FG000|Overall Study|Death of person with dementia|4|||
126174037|NCT03550131|453921167|FG001|Overall Study|Death of person with dementia|8|||
126174038|NCT01318512|453921168|FG000|Maintenance Period (6 Months)|Death|2|||
126174039|NCT01318512|453921168|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
126174040|NCT00717366|453921169|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
126174041|NCT00717366|453921170|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
126174042|NCT00717366|453921169|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
126174043|NCT00717366|453921170|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
126174044|NCT00717366|453921169|FG000|Core Study Period (20 Weeks)|Death|0|||
126174045|NCT00717366|453921170|FG001|Core Study Period (20 Weeks)|Death|1|||
126174046|NCT00717366|453921169|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
126174047|NCT00717366|453921170|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
126174048|NCT00717366|453921169|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
126174049|NCT00717366|453921170|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
126174050|NCT00717366|453921169|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
126174051|NCT00717366|453921170|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
126174052|NCT00717366|453921169|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
126174053|NCT00717366|453921170|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
126174054|NCT01317615|453921173|FG000|Overall Study|Disease progression|25|||
126174055|NCT01317615|453921173|FG000|Overall Study|New cancer therapy|5|||
126174056|NCT01317615|453921173|FG000|Overall Study|Death|6|||
126174057|NCT01317615|453921173|FG000|Overall Study|Withdrawal by Subject|5|||
126174058|NCT01317615|453921173|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126174059|NCT01317615|453921173|FG000|Overall Study|Adverse Event|7|||
126174060|NCT00255086|453921174|FG000|Overall Study|Adverse Event|1|||
126174061|NCT00255086|453921175|FG001|Overall Study|Adverse Event|1|||
126174062|NCT00255086|453921174|FG000|Overall Study|Protocol Violation|1|||
126174063|NCT00255086|453921175|FG001|Overall Study|Protocol Violation|1|||
126174064|NCT00438399|453921178|FG000|Overall Study|Lost to Follow-up|2|||
126174065|NCT00438399|453921179|FG001|Overall Study|Lost to Follow-up|2|||
126174066|NCT00438399|453921180|FG002|Overall Study|Lost to Follow-up|1|||
126174067|NCT00438399|453921181|FG003|Overall Study|Lost to Follow-up|1|||
126174068|NCT00438399|453921182|FG004|Overall Study|Lost to Follow-up|1|||
126174069|NCT00438399|453921183|FG005|Overall Study|Lost to Follow-up|1|||
126174070|NCT00438399|453921178|FG000|Overall Study|Adverse Event|0|||
126174071|NCT00438399|453921179|FG001|Overall Study|Adverse Event|0|||
126174072|NCT00438399|453921180|FG002|Overall Study|Adverse Event|1|||
126174073|NCT00438399|453921181|FG003|Overall Study|Adverse Event|1|||
126174074|NCT00438399|453921182|FG004|Overall Study|Adverse Event|0|||
126174075|NCT00438399|453921183|FG005|Overall Study|Adverse Event|1|||
126174076|NCT00438399|453921178|FG000|Overall Study|Withdrawal by Subject|5|||
126174077|NCT00438399|453921179|FG001|Overall Study|Withdrawal by Subject|6|||
126174078|NCT00438399|453921180|FG002|Overall Study|Withdrawal by Subject|3|||
126174079|NCT00438399|453921181|FG003|Overall Study|Withdrawal by Subject|2|||
126174080|NCT00438399|453921182|FG004|Overall Study|Withdrawal by Subject|2|||
126174081|NCT00438399|453921183|FG005|Overall Study|Withdrawal by Subject|2|||
126174082|NCT00438399|453921178|FG000|Overall Study|Protocol Violation|0|||
126174083|NCT00438399|453921179|FG001|Overall Study|Protocol Violation|0|||
126174084|NCT00438399|453921180|FG002|Overall Study|Protocol Violation|1|||
126174085|NCT00438399|453921181|FG003|Overall Study|Protocol Violation|0|||
126174086|NCT00438399|453921182|FG004|Overall Study|Protocol Violation|0|||
126174087|NCT00438399|453921183|FG005|Overall Study|Protocol Violation|1|||
126174088|NCT00438399|453921178|FG000|Overall Study|Subje stopped study|0|||
126174089|NCT00438399|453921179|FG001|Overall Study|Subje stopped study|0|||
126174090|NCT00438399|453921180|FG002|Overall Study|Subje stopped study|1|||
126174091|NCT00438399|453921181|FG003|Overall Study|Subje stopped study|0|||
126174092|NCT00438399|453921182|FG004|Overall Study|Subje stopped study|0|||
126174093|NCT00438399|453921183|FG005|Overall Study|Subje stopped study|0|||
126174094|NCT00438399|453921178|FG000|Overall Study|Pregnancy|0|||
126174095|NCT00438399|453921179|FG001|Overall Study|Pregnancy|0|||
126174096|NCT00438399|453921180|FG002|Overall Study|Pregnancy|0|||
126174097|NCT00438399|453921181|FG003|Overall Study|Pregnancy|0|||
126174098|NCT00438399|453921182|FG004|Overall Study|Pregnancy|0|||
126174099|NCT00438399|453921183|FG005|Overall Study|Pregnancy|1|||
126174100|NCT00438399|453921178|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
126174101|NCT00438399|453921179|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
126174102|NCT00438399|453921180|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
126174103|NCT00438399|453921181|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
126174104|NCT00438399|453921182|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
126174105|NCT00438399|453921183|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
126174106|NCT03334396|453921186|FG000|Overall Study|Adverse Event|1|||
126174107|NCT03334396|453921187|FG001|Overall Study|Adverse Event|0|||
126174108|NCT03334396|453921188|FG002|Overall Study|Adverse Event|1|||
126174109|NCT03334396|453921189|FG003|Overall Study|Adverse Event|0|||
126174110|NCT03334396|453921190|FG004|Overall Study|Adverse Event|0|||
126174111|NCT03334396|453921191|FG005|Overall Study|Adverse Event|0|||
126174112|NCT03334396|453921192|FG006|Overall Study|Adverse Event|0|||
126174113|NCT03334396|453921193|FG007|Overall Study|Adverse Event|0|||
126174114|NCT03334396|453921186|FG000|Overall Study|Lack of Efficacy|10|||
126174115|NCT03334396|453921187|FG001|Overall Study|Lack of Efficacy|4|||
126174116|NCT03334396|453921188|FG002|Overall Study|Lack of Efficacy|1|||
126174117|NCT03334396|453921189|FG003|Overall Study|Lack of Efficacy|3|||
126174118|NCT03334396|453921190|FG004|Overall Study|Lack of Efficacy|1|||
126174119|NCT03334396|453921191|FG005|Overall Study|Lack of Efficacy|0|||
126174120|NCT03334396|453921192|FG006|Overall Study|Lack of Efficacy|0|||
126174121|NCT03334396|453921193|FG007|Overall Study|Lack of Efficacy|1|||
126174122|NCT03334396|453921186|FG000|Overall Study|Lost to Follow-up|0|||
126174123|NCT03334396|453921187|FG001|Overall Study|Lost to Follow-up|0|||
126174124|NCT03334396|453921188|FG002|Overall Study|Lost to Follow-up|1|||
126174125|NCT03334396|453921189|FG003|Overall Study|Lost to Follow-up|0|||
126174126|NCT03334396|453921190|FG004|Overall Study|Lost to Follow-up|0|||
126174127|NCT03334396|453921191|FG005|Overall Study|Lost to Follow-up|0|||
126174128|NCT03334396|453921192|FG006|Overall Study|Lost to Follow-up|1|||
126174129|NCT03334396|453921193|FG007|Overall Study|Lost to Follow-up|0|||
126174130|NCT03334396|453921186|FG000|Overall Study|Physician Decision|1|||
126174131|NCT03334396|453921187|FG001|Overall Study|Physician Decision|0|||
126174132|NCT03334396|453921188|FG002|Overall Study|Physician Decision|0|||
126174133|NCT03334396|453921189|FG003|Overall Study|Physician Decision|0|||
126174134|NCT03334396|453921190|FG004|Overall Study|Physician Decision|0|||
126174135|NCT03334396|453921191|FG005|Overall Study|Physician Decision|0|||
126174136|NCT03334396|453921192|FG006|Overall Study|Physician Decision|0|||
126174137|NCT03334396|453921193|FG007|Overall Study|Physician Decision|0|||
126174138|NCT03334396|453921186|FG000|Overall Study|Withdrawal by Subject|10|||
126174139|NCT03334396|453921187|FG001|Overall Study|Withdrawal by Subject|5|||
126174140|NCT03334396|453921188|FG002|Overall Study|Withdrawal by Subject|7|||
126174141|NCT03334396|453921189|FG003|Overall Study|Withdrawal by Subject|2|||
126174142|NCT03334396|453921190|FG004|Overall Study|Withdrawal by Subject|2|||
126174143|NCT03334396|453921191|FG005|Overall Study|Withdrawal by Subject|1|||
126174144|NCT03334396|453921192|FG006|Overall Study|Withdrawal by Subject|2|||
126174145|NCT03334396|453921193|FG007|Overall Study|Withdrawal by Subject|0|||
126174146|NCT03334396|453921186|FG000|Overall Study|Pregnancy|0|||
126174147|NCT03334396|453921187|FG001|Overall Study|Pregnancy|1|||
126174148|NCT03334396|453921188|FG002|Overall Study|Pregnancy|0|||
126174149|NCT03334396|453921189|FG003|Overall Study|Pregnancy|0|||
126174150|NCT03334396|453921190|FG004|Overall Study|Pregnancy|0|||
126174151|NCT03334396|453921191|FG005|Overall Study|Pregnancy|0|||
126174152|NCT03334396|453921192|FG006|Overall Study|Pregnancy|0|||
126174153|NCT03334396|453921193|FG007|Overall Study|Pregnancy|0|||
126174154|NCT03334396|453921186|FG000|Overall Study|Ineligible|0|||
126174155|NCT03334396|453921187|FG001|Overall Study|Ineligible|1|||
126174156|NCT03334396|453921188|FG002|Overall Study|Ineligible|0|||
126174157|NCT03334396|453921189|FG003|Overall Study|Ineligible|0|||
126174158|NCT03334396|453921190|FG004|Overall Study|Ineligible|0|||
126174159|NCT03334396|453921191|FG005|Overall Study|Ineligible|0|||
126174160|NCT03334396|453921192|FG006|Overall Study|Ineligible|0|||
126174161|NCT03334396|453921193|FG007|Overall Study|Ineligible|0|||
126174162|NCT03334396|453921186|FG000|Overall Study|Started New Job|1|||
126174163|NCT03334396|453921187|FG001|Overall Study|Started New Job|0|||
126174164|NCT03334396|453921188|FG002|Overall Study|Started New Job|0|||
126174165|NCT03334396|453921189|FG003|Overall Study|Started New Job|0|||
126174166|NCT03334396|453921190|FG004|Overall Study|Started New Job|0|||
126174167|NCT03334396|453921191|FG005|Overall Study|Started New Job|0|||
126174168|NCT03334396|453921192|FG006|Overall Study|Started New Job|0|||
126174169|NCT03334396|453921193|FG007|Overall Study|Started New Job|0|||
126174170|NCT01179347|453923210|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
126174171|NCT01179347|453923211|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
126174172|NCT01179347|453923210|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
126174173|NCT01179347|453923211|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
126174174|NCT01179347|453923210|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
126174175|NCT01179347|453923211|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
126174176|NCT01179347|453923210|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
126174177|NCT01179347|453923211|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
126174178|NCT01179347|453923210|FG000|Double-blind Period (12 Weeks)|Other|2|||
126174179|NCT01179347|453923211|FG001|Double-blind Period (12 Weeks)|Other|4|||
126174180|NCT01179347|453923210|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
126174181|NCT01179347|453923211|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
126174182|NCT01179347|453923210|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
126174183|NCT01179347|453923211|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
126174184|NCT01179347|453923210|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
126174185|NCT01179347|453923211|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
126174186|NCT01179347|453923210|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
126174187|NCT01179347|453923211|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
126174188|NCT01179347|453923210|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
126174189|NCT01179347|453923211|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
126174190|NCT01179347|453923210|FG000|Open-label Period (12 Weeks)|Other|7|||
126174191|NCT01179347|453923211|FG001|Open-label Period (12 Weeks)|Other|4|||
126174192|NCT00369967|453923213|FG000|Overall Study|Lost to Follow-up|23|||
126174193|NCT00369967|453923214|FG001|Overall Study|Lost to Follow-up|12|||
126174194|NCT01677624|453923215|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
126174195|NCT01830816|453923221|FG000|Overall Study|Progressive Disease|12|||
126174196|NCT01830816|453923222|FG001|Overall Study|Progressive Disease|7|||
126174197|NCT01830816|453923223|FG002|Overall Study|Progressive Disease|7|||
126174198|NCT01830816|453923221|FG000|Overall Study|Adverse Event|3|||
126174199|NCT01830816|453923222|FG001|Overall Study|Adverse Event|4|||
126174200|NCT01830816|453923223|FG002|Overall Study|Adverse Event|0|||
126174201|NCT01830816|453923221|FG000|Overall Study|Study Terminated by Sponsor|1|||
126174202|NCT01830816|453923222|FG001|Overall Study|Study Terminated by Sponsor|1|||
126174203|NCT01830816|453923223|FG002|Overall Study|Study Terminated by Sponsor|0|||
126174204|NCT01830816|453923221|FG000|Overall Study|Withdrawal by Subject|1|||
126174205|NCT01830816|453923222|FG001|Overall Study|Withdrawal by Subject|1|||
126174206|NCT01830816|453923223|FG002|Overall Study|Withdrawal by Subject|0|||
126174207|NCT01830816|453923221|FG000|Overall Study|Lost to Follow-up|0|||
126174208|NCT01830816|453923222|FG001|Overall Study|Lost to Follow-up|1|||
126174209|NCT01830816|453923223|FG002|Overall Study|Lost to Follow-up|0|||
126174210|NCT01830816|453923221|FG000|Overall Study|Symptomatic Deterioration|1|||
126174211|NCT01830816|453923222|FG001|Overall Study|Symptomatic Deterioration|0|||
126174212|NCT01830816|453923223|FG002|Overall Study|Symptomatic Deterioration|0|||
126174213|NCT01830816|453923221|FG000|Overall Study|Reason not Specified|2|||
126174214|NCT01830816|453923222|FG001|Overall Study|Reason not Specified|0|||
126174215|NCT01830816|453923223|FG002|Overall Study|Reason not Specified|0|||
126174216|NCT00830115|453923224|FG000|Overall Study|Adverse Event|2|||
126174217|NCT00830115|453923224|FG000|Overall Study|Improvement/recovery|1|||
126174218|NCT01207388|453923226|FG000|Overall Study|Death|67|||
126174219|NCT01207388|453923226|FG000|Overall Study|Withdrawal by Subject|1|||
126174220|NCT01885078|453923227|FG000|Treatment Period|Adverse Event|52|||
126174221|NCT01885078|453923228|FG001|Treatment Period|Adverse Event|136|||
126174222|NCT01885078|453923229|FG002|Treatment Period|Adverse Event|30|||
126174223|NCT01885078|453923230|FG003|Treatment Period|Adverse Event|73|||
126174224|NCT01885078|453923231|FG004|Treatment Period|Adverse Event|17|||
126174225|NCT01885078|453923232|FG005|Treatment Period|Adverse Event|72|||
125973899|NCT04330638|453193190|FG001|Overall Study|Withdrawal by Subject|0|||
125973900|NCT04330638|453193191|FG002|Overall Study|Withdrawal by Subject|0|||
125973901|NCT04330638|453193192|FG003|Overall Study|Withdrawal by Subject|0|||
125973902|NCT04330638|453193193|FG004|Overall Study|Withdrawal by Subject|0|||
125973903|NCT04330638|453193194|FG005|Overall Study|Withdrawal by Subject|0|||
125973904|NCT04330638|453193189|FG000|Overall Study|Lost to Follow-up|3|||
126174226|NCT01885078|453923233|FG006|Treatment Period|Adverse Event|24|||
126174227|NCT01885078|453923234|FG007|Treatment Period|Adverse Event|5|||
126174228|NCT01885078|453923235|FG008|Treatment Period|Adverse Event|0|||
126174229|NCT01885078|453923236|FG009|Treatment Period|Adverse Event|0|||
126174230|NCT01885078|453923227|FG000|Treatment Period|Death|13|||
126174231|NCT01885078|453923228|FG001|Treatment Period|Death|33|||
126174232|NCT01885078|453923229|FG002|Treatment Period|Death|5|||
126174233|NCT01885078|453923230|FG003|Treatment Period|Death|9|||
126174234|NCT01885078|453923231|FG004|Treatment Period|Death|2|||
126174235|NCT01885078|453923232|FG005|Treatment Period|Death|10|||
126174236|NCT01885078|453923233|FG006|Treatment Period|Death|3|||
126174237|NCT01885078|453923234|FG007|Treatment Period|Death|2|||
126174238|NCT01885078|453923235|FG008|Treatment Period|Death|0|||
126174239|NCT01885078|453923236|FG009|Treatment Period|Death|0|||
126174240|NCT01885078|453923227|FG000|Treatment Period|Lack of Efficacy|12|||
126174241|NCT01885078|453923228|FG001|Treatment Period|Lack of Efficacy|33|||
126174242|NCT01885078|453923229|FG002|Treatment Period|Lack of Efficacy|10|||
126174243|NCT01885078|453923230|FG003|Treatment Period|Lack of Efficacy|23|||
126174244|NCT01885078|453923231|FG004|Treatment Period|Lack of Efficacy|24|||
126174245|NCT01885078|453923232|FG005|Treatment Period|Lack of Efficacy|58|||
126174246|NCT01885078|453923233|FG006|Treatment Period|Lack of Efficacy|9|||
126174247|NCT01885078|453923234|FG007|Treatment Period|Lack of Efficacy|5|||
126174248|NCT01885078|453923235|FG008|Treatment Period|Lack of Efficacy|0|||
126174249|NCT01885078|453923236|FG009|Treatment Period|Lack of Efficacy|0|||
126174250|NCT01885078|453923227|FG000|Treatment Period|Lost to Follow-up|16|||
126174251|NCT01885078|453923228|FG001|Treatment Period|Lost to Follow-up|19|||
126174252|NCT01885078|453923229|FG002|Treatment Period|Lost to Follow-up|7|||
126174253|NCT01885078|453923230|FG003|Treatment Period|Lost to Follow-up|9|||
126174254|NCT01885078|453923231|FG004|Treatment Period|Lost to Follow-up|2|||
126174255|NCT01885078|453923232|FG005|Treatment Period|Lost to Follow-up|8|||
126174256|NCT01885078|453923233|FG006|Treatment Period|Lost to Follow-up|2|||
126174257|NCT01885078|453923234|FG007|Treatment Period|Lost to Follow-up|0|||
125973905|NCT04330638|453193190|FG001|Overall Study|Lost to Follow-up|2|||
126174258|NCT01885078|453923235|FG008|Treatment Period|Lost to Follow-up|0|||
126174259|NCT01885078|453923236|FG009|Treatment Period|Lost to Follow-up|0|||
126174260|NCT01885078|453923227|FG000|Treatment Period|Physician Decision|19|||
126174261|NCT01885078|453923228|FG001|Treatment Period|Physician Decision|21|||
126174262|NCT01885078|453923229|FG002|Treatment Period|Physician Decision|5|||
126174263|NCT01885078|453923230|FG003|Treatment Period|Physician Decision|12|||
126174264|NCT01885078|453923231|FG004|Treatment Period|Physician Decision|9|||
126174265|NCT01885078|453923232|FG005|Treatment Period|Physician Decision|24|||
126174266|NCT01885078|453923233|FG006|Treatment Period|Physician Decision|4|||
126174267|NCT01885078|453923234|FG007|Treatment Period|Physician Decision|3|||
126174268|NCT01885078|453923235|FG008|Treatment Period|Physician Decision|0|||
126174269|NCT01885078|453923236|FG009|Treatment Period|Physician Decision|0|||
126174270|NCT01885078|453923227|FG000|Treatment Period|Protocol Violation|3|||
126174271|NCT01885078|453923228|FG001|Treatment Period|Protocol Violation|5|||
126174272|NCT01885078|453923229|FG002|Treatment Period|Protocol Violation|0|||
126174273|NCT01885078|453923230|FG003|Treatment Period|Protocol Violation|3|||
126174274|NCT01885078|453923231|FG004|Treatment Period|Protocol Violation|1|||
126174275|NCT01885078|453923232|FG005|Treatment Period|Protocol Violation|6|||
126174276|NCT01885078|453923233|FG006|Treatment Period|Protocol Violation|0|||
126174277|NCT01885078|453923234|FG007|Treatment Period|Protocol Violation|0|||
126174278|NCT01885078|453923235|FG008|Treatment Period|Protocol Violation|0|||
126174279|NCT01885078|453923236|FG009|Treatment Period|Protocol Violation|0|||
126174280|NCT01885078|453923227|FG000|Treatment Period|Sponsor Decision|245|||
126174281|NCT01885078|453923228|FG001|Treatment Period|Sponsor Decision|648|||
126174282|NCT01885078|453923229|FG002|Treatment Period|Sponsor Decision|49|||
126174283|NCT01885078|453923230|FG003|Treatment Period|Sponsor Decision|90|||
126174284|NCT01885078|453923231|FG004|Treatment Period|Sponsor Decision|20|||
126174285|NCT01885078|453923232|FG005|Treatment Period|Sponsor Decision|38|||
126174286|NCT01885078|453923233|FG006|Treatment Period|Sponsor Decision|162|||
126174287|NCT01885078|453923234|FG007|Treatment Period|Sponsor Decision|3|||
126174288|NCT01885078|453923235|FG008|Treatment Period|Sponsor Decision|0|||
126174289|NCT01885078|453923236|FG009|Treatment Period|Sponsor Decision|0|||
126174290|NCT01885078|453923227|FG000|Treatment Period|Withdrawal by Subject|72|||
126174291|NCT01885078|453923228|FG001|Treatment Period|Withdrawal by Subject|132|||
126174292|NCT01885078|453923229|FG002|Treatment Period|Withdrawal by Subject|25|||
126174293|NCT01885078|453923230|FG003|Treatment Period|Withdrawal by Subject|63|||
126174294|NCT01885078|453923231|FG004|Treatment Period|Withdrawal by Subject|15|||
126174295|NCT01885078|453923232|FG005|Treatment Period|Withdrawal by Subject|34|||
126174296|NCT01885078|453923233|FG006|Treatment Period|Withdrawal by Subject|17|||
126174297|NCT01885078|453923234|FG007|Treatment Period|Withdrawal by Subject|10|||
126174298|NCT01885078|453923235|FG008|Treatment Period|Withdrawal by Subject|0|||
126174299|NCT01885078|453923236|FG009|Treatment Period|Withdrawal by Subject|0|||
126174300|NCT01885078|453923227|FG000|Treatment Period|Other|0|||
126174301|NCT01885078|453923228|FG001|Treatment Period|Other|0|||
126174302|NCT01885078|453923229|FG002|Treatment Period|Other|0|||
126174303|NCT01885078|453923230|FG003|Treatment Period|Other|1|||
126174304|NCT01885078|453923231|FG004|Treatment Period|Other|0|||
126174305|NCT01885078|453923232|FG005|Treatment Period|Other|0|||
126174306|NCT01885078|453923233|FG006|Treatment Period|Other|0|||
126174307|NCT01885078|453923234|FG007|Treatment Period|Other|0|||
126174308|NCT01885078|453923235|FG008|Treatment Period|Other|0|||
126174309|NCT01885078|453923236|FG009|Treatment Period|Other|0|||
126174310|NCT01885078|453923227|FG000|Step-down Period|Sponsor Decision|0|||
126174311|NCT01885078|453923228|FG001|Step-down Period|Sponsor Decision|0|||
126174312|NCT01885078|453923229|FG002|Step-down Period|Sponsor Decision|0|||
126174313|NCT01885078|453923230|FG003|Step-down Period|Sponsor Decision|0|||
126174314|NCT01885078|453923231|FG004|Step-down Period|Sponsor Decision|0|||
126174315|NCT01885078|453923232|FG005|Step-down Period|Sponsor Decision|0|||
126174316|NCT01885078|453923233|FG006|Step-down Period|Sponsor Decision|0|||
126174317|NCT01885078|453923234|FG007|Step-down Period|Sponsor Decision|0|||
126174318|NCT01885078|453923235|FG008|Step-down Period|Sponsor Decision|1|||
126174319|NCT01885078|453923236|FG009|Step-down Period|Sponsor Decision|1|||
126174320|NCT01885078|453923227|FG000|Step-down Period|Adverse Event|0|||
126174321|NCT01885078|453923228|FG001|Step-down Period|Adverse Event|0|||
126174322|NCT01885078|453923229|FG002|Step-down Period|Adverse Event|0|||
126174323|NCT01885078|453923230|FG003|Step-down Period|Adverse Event|0|||
126174324|NCT01885078|453923231|FG004|Step-down Period|Adverse Event|0|||
126174325|NCT01885078|453923232|FG005|Step-down Period|Adverse Event|0|||
126174326|NCT01885078|453923233|FG006|Step-down Period|Adverse Event|0|||
126174327|NCT01885078|453923234|FG007|Step-down Period|Adverse Event|0|||
126174328|NCT01885078|453923235|FG008|Step-down Period|Adverse Event|29|||
126174329|NCT01885078|453923236|FG009|Step-down Period|Adverse Event|38|||
126174330|NCT01885078|453923227|FG000|Step-down Period|Withdrawal by Subject|0|||
126174331|NCT01885078|453923228|FG001|Step-down Period|Withdrawal by Subject|0|||
126174332|NCT01885078|453923229|FG002|Step-down Period|Withdrawal by Subject|0|||
126174333|NCT01885078|453923230|FG003|Step-down Period|Withdrawal by Subject|0|||
126174334|NCT01885078|453923231|FG004|Step-down Period|Withdrawal by Subject|0|||
126174335|NCT01885078|453923232|FG005|Step-down Period|Withdrawal by Subject|0|||
126174336|NCT01885078|453923233|FG006|Step-down Period|Withdrawal by Subject|0|||
126174337|NCT01885078|453923234|FG007|Step-down Period|Withdrawal by Subject|0|||
126174338|NCT01885078|453923235|FG008|Step-down Period|Withdrawal by Subject|25|||
126174339|NCT01885078|453923236|FG009|Step-down Period|Withdrawal by Subject|15|||
126174340|NCT01885078|453923227|FG000|Step-down Period|Physician Decision|0|||
126174341|NCT01885078|453923228|FG001|Step-down Period|Physician Decision|0|||
126174342|NCT01885078|453923229|FG002|Step-down Period|Physician Decision|0|||
126174343|NCT01885078|453923230|FG003|Step-down Period|Physician Decision|0|||
126174344|NCT01885078|453923231|FG004|Step-down Period|Physician Decision|0|||
126174345|NCT01885078|453923232|FG005|Step-down Period|Physician Decision|0|||
126174346|NCT01885078|453923233|FG006|Step-down Period|Physician Decision|0|||
126174347|NCT01885078|453923234|FG007|Step-down Period|Physician Decision|0|||
126174348|NCT01885078|453923235|FG008|Step-down Period|Physician Decision|7|||
126174349|NCT01885078|453923236|FG009|Step-down Period|Physician Decision|2|||
126174350|NCT01885078|453923227|FG000|Step-down Period|Death|0|||
126174351|NCT01885078|453923228|FG001|Step-down Period|Death|0|||
126174352|NCT01885078|453923229|FG002|Step-down Period|Death|0|||
126174353|NCT01885078|453923230|FG003|Step-down Period|Death|0|||
126174354|NCT01885078|453923231|FG004|Step-down Period|Death|0|||
126174355|NCT01885078|453923232|FG005|Step-down Period|Death|0|||
126174356|NCT01885078|453923233|FG006|Step-down Period|Death|0|||
126174357|NCT01885078|453923234|FG007|Step-down Period|Death|0|||
126174358|NCT01885078|453923235|FG008|Step-down Period|Death|4|||
126174359|NCT01885078|453923236|FG009|Step-down Period|Death|3|||
126174360|NCT01885078|453923227|FG000|Step-down Period|Lost to Follow-up|0|||
126174361|NCT01885078|453923228|FG001|Step-down Period|Lost to Follow-up|0|||
126174362|NCT01885078|453923229|FG002|Step-down Period|Lost to Follow-up|0|||
126174363|NCT01885078|453923230|FG003|Step-down Period|Lost to Follow-up|0|||
126174364|NCT01885078|453923231|FG004|Step-down Period|Lost to Follow-up|0|||
126174365|NCT01885078|453923232|FG005|Step-down Period|Lost to Follow-up|0|||
126174366|NCT01885078|453923233|FG006|Step-down Period|Lost to Follow-up|0|||
126174367|NCT01885078|453923234|FG007|Step-down Period|Lost to Follow-up|0|||
126174368|NCT01885078|453923235|FG008|Step-down Period|Lost to Follow-up|1|||
126174369|NCT01885078|453923236|FG009|Step-down Period|Lost to Follow-up|1|||
126174370|NCT01885078|453923227|FG000|Step-down Period|Lack of Efficacy|0|||
126174371|NCT01885078|453923228|FG001|Step-down Period|Lack of Efficacy|0|||
126174372|NCT01885078|453923229|FG002|Step-down Period|Lack of Efficacy|0|||
126174373|NCT01885078|453923230|FG003|Step-down Period|Lack of Efficacy|0|||
126174374|NCT01885078|453923231|FG004|Step-down Period|Lack of Efficacy|0|||
126174375|NCT01885078|453923232|FG005|Step-down Period|Lack of Efficacy|0|||
126174376|NCT01885078|453923233|FG006|Step-down Period|Lack of Efficacy|0|||
126174377|NCT01885078|453923234|FG007|Step-down Period|Lack of Efficacy|0|||
126174378|NCT01885078|453923235|FG008|Step-down Period|Lack of Efficacy|1|||
126174379|NCT01885078|453923236|FG009|Step-down Period|Lack of Efficacy|0|||
126174380|NCT01885078|453923227|FG000|Step-down Period|Protocol Violation|0|||
126174381|NCT01885078|453923228|FG001|Step-down Period|Protocol Violation|0|||
126174382|NCT01885078|453923229|FG002|Step-down Period|Protocol Violation|0|||
126174383|NCT01885078|453923230|FG003|Step-down Period|Protocol Violation|0|||
126174384|NCT01885078|453923231|FG004|Step-down Period|Protocol Violation|0|||
126174385|NCT01885078|453923232|FG005|Step-down Period|Protocol Violation|0|||
126174386|NCT01885078|453923233|FG006|Step-down Period|Protocol Violation|0|||
126174387|NCT01885078|453923234|FG007|Step-down Period|Protocol Violation|0|||
126174388|NCT01885078|453923235|FG008|Step-down Period|Protocol Violation|1|||
126174389|NCT01885078|453923236|FG009|Step-down Period|Protocol Violation|1|||
126174390|NCT01895452|453923241|FG000|Overall Study|Adverse Event|1|||
126174391|NCT01895452|453923242|FG001|Overall Study|Adverse Event|4|||
126174392|NCT01895452|453923241|FG000|Overall Study|Lost to Follow-up|1|||
126174393|NCT01895452|453923242|FG001|Overall Study|Lost to Follow-up|5|||
126174394|NCT01895452|453923241|FG000|Overall Study|Pregnancy|0|||
126174395|NCT01895452|453923242|FG001|Overall Study|Pregnancy|1|||
126174396|NCT01895452|453923241|FG000|Overall Study|Withdrawal by Subject|2|||
126174397|NCT01895452|453923242|FG001|Overall Study|Withdrawal by Subject|14|||
126174398|NCT01895452|453923241|FG000|Overall Study|Underlying disease|0|||
126174399|NCT01895452|453923242|FG001|Overall Study|Underlying disease|3|||
126174400|NCT01895452|453923241|FG000|Overall Study|Noncompliance with study drug|0|||
126174401|NCT01895452|453923242|FG001|Overall Study|Noncompliance with study drug|1|||
126174402|NCT01204697|453923246|FG000|Overall Study|Death|26|||
126174403|NCT01204697|453923247|FG001|Overall Study|Death|27|||
126174404|NCT01204697|453923246|FG000|Overall Study|Lost to Follow-up|3|||
126174405|NCT01204697|453923247|FG001|Overall Study|Lost to Follow-up|4|||
126174406|NCT01204697|453923246|FG000|Overall Study|Withdrawal by Subject|2|||
126174407|NCT01204697|453923247|FG001|Overall Study|Withdrawal by Subject|4|||
126174408|NCT01204697|453923246|FG000|Overall Study|Randomized, but not treated|0|||
126174409|NCT01204697|453923247|FG001|Overall Study|Randomized, but not treated|1|||
126174410|NCT01205451|453923248|FG000|Overall Study|Lost to Follow-up|1|||
126174411|NCT01205451|453923249|FG001|Overall Study|Lost to Follow-up|1|||
126174412|NCT01205451|453923248|FG000|Overall Study|Withdrawal by Subject|5|||
126174413|NCT01205451|453923249|FG001|Overall Study|Withdrawal by Subject|9|||
126174414|NCT01194869|453923250|FG000|Overall Study|Disease Progression|2|||
126174415|NCT01194869|453923250|FG000|Overall Study|Toxicity|2|||
126174416|NCT04321252|453923251|FG000|Overall Study|Withdrawal by Subject|0|||
126174417|NCT04321252|453923252|FG001|Overall Study|Withdrawal by Subject|0|||
126174418|NCT04321252|453923253|FG002|Overall Study|Withdrawal by Subject|0|||
126174419|NCT04321252|453923254|FG003|Overall Study|Withdrawal by Subject|0|||
126174420|NCT04321252|453923255|FG004|Overall Study|Withdrawal by Subject|0|||
126174421|NCT04321252|453923256|FG005|Overall Study|Withdrawal by Subject|1|||
126174422|NCT04321252|453923257|FG006|Overall Study|Withdrawal by Subject|0|||
126174423|NCT04321252|453923258|FG007|Overall Study|Withdrawal by Subject|0|||
126174424|NCT04321252|453923259|FG008|Overall Study|Withdrawal by Subject|0|||
126174425|NCT03004469|453923260|FG000|Overall Study|Adverse Event|6|||
126174426|NCT03004469|453923261|FG001|Overall Study|Adverse Event|4|||
126174427|NCT03004469|453923262|FG002|Overall Study|Adverse Event|6|||
126174428|NCT03004469|453923260|FG000|Overall Study|Lack of Efficacy|1|||
126174429|NCT03004469|453923261|FG001|Overall Study|Lack of Efficacy|0|||
126174430|NCT03004469|453923262|FG002|Overall Study|Lack of Efficacy|1|||
126174431|NCT03004469|453923260|FG000|Overall Study|Lost to Follow-up|23|||
126174432|NCT03004469|453923261|FG001|Overall Study|Lost to Follow-up|14|||
126174433|NCT03004469|453923262|FG002|Overall Study|Lost to Follow-up|6|||
126174434|NCT03004469|453923260|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126174435|NCT03004469|453923261|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126174436|NCT03004469|453923262|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126174437|NCT03004469|453923260|FG000|Overall Study|Protocol Violation|0|||
126174438|NCT03004469|453923261|FG001|Overall Study|Protocol Violation|0|||
126174439|NCT03004469|453923262|FG002|Overall Study|Protocol Violation|1|||
126174440|NCT03004469|453923260|FG000|Overall Study|Withdrawal by Subject|29|||
126174441|NCT03004469|453923261|FG001|Overall Study|Withdrawal by Subject|27|||
126174442|NCT03004469|453923262|FG002|Overall Study|Withdrawal by Subject|10|||
126174443|NCT03004469|453923260|FG000|Overall Study|Other unspecified reason|0|||
126174444|NCT03004469|453923261|FG001|Overall Study|Other unspecified reason|4|||
126174445|NCT03004469|453923262|FG002|Overall Study|Other unspecified reason|1|||
126174446|NCT00259740|453923263|FG000|Overall Study|Physician Decision|1|||
126174447|NCT00259740|453923264|FG001|Overall Study|Physician Decision|1|||
126174448|NCT00259740|453923263|FG000|Overall Study|Adverse Event|0|||
126174449|NCT00259740|453923264|FG001|Overall Study|Adverse Event|2|||
126174450|NCT00259740|453923263|FG000|Overall Study|Withdrawal by Subject|2|||
126174451|NCT00259740|453923264|FG001|Overall Study|Withdrawal by Subject|6|||
126174452|NCT00259740|453923263|FG000|Overall Study|Death|1|||
126174453|NCT00259740|453923264|FG001|Overall Study|Death|1|||
126174454|NCT00259740|453923263|FG000|Overall Study|Disease progression|19|||
126174455|NCT00259740|453923264|FG001|Overall Study|Disease progression|36|||
126174456|NCT00259740|453923263|FG000|Overall Study|Ongoing|17|||
126174457|NCT00259740|453923264|FG001|Overall Study|Ongoing|3|||
126174458|NCT00259740|453923263|FG000|Overall Study|Other|3|||
126174459|NCT00259740|453923264|FG001|Overall Study|Other|0|||
126174460|NCT00259740|453923263|FG000|Overall Study|Requirement for alternative therapy|0|||
126174461|NCT00259740|453923264|FG001|Overall Study|Requirement for alternative therapy|4|||
126174462|NCT03495453|453923268|FG000|Overall Study|Withdrawal by Subject|0|||
126174463|NCT03495453|453923269|FG001|Overall Study|Withdrawal by Subject|1|||
126174464|NCT04511819|453923271|FG000|Overall Study|Non-compliance with study drug|5|||
126174465|NCT04511819|453923272|FG001|Overall Study|Non-compliance with study drug|1|||
126174466|NCT04511819|453923271|FG000|Overall Study|Withdrawal by Subject|0|||
126174467|NCT04511819|453923272|FG001|Overall Study|Withdrawal by Subject|3|||
126174468|NCT04511819|453923271|FG000|Overall Study|Adverse Event|0|||
126174469|NCT04511819|453923272|FG001|Overall Study|Adverse Event|1|||
126174470|NCT04511819|453923271|FG000|Overall Study|Protocol deviation|1|||
126174471|NCT04511819|453923272|FG001|Overall Study|Protocol deviation|0|||
126174472|NCT03247413|453923275|FG000|Overall Study|Lost to Follow-up|28|||
126174473|NCT00424294|453923276|FG000|Overall Study|Adverse Event|4|||
126174474|NCT00424294|453923277|FG001|Overall Study|Adverse Event|10|||
126174475|NCT00424294|453923276|FG000|Overall Study|Lack of Efficacy|2|||
126174476|NCT00424294|453923277|FG001|Overall Study|Lack of Efficacy|1|||
126174477|NCT00424294|453923276|FG000|Overall Study|Withdrawal by Subject|1|||
126174478|NCT00424294|453923277|FG001|Overall Study|Withdrawal by Subject|2|||
126174479|NCT00424294|453923276|FG000|Overall Study|Other|0|||
126174480|NCT00424294|453923277|FG001|Overall Study|Other|2|||
126174481|NCT00424294|453923276|FG000|Overall Study|Randomized but not Treated|1|||
126174482|NCT00424294|453923277|FG001|Overall Study|Randomized but not Treated|0|||
126174483|NCT04397718|453923278|FG000|Overall Study|Death|7|||
126174484|NCT04397718|453923279|FG001|Overall Study|Death|11|||
126174485|NCT04397718|453923278|FG000|Overall Study|Lost to Follow-up|0|||
126174486|NCT04397718|453923279|FG001|Overall Study|Lost to Follow-up|4|||
126174487|NCT01797965|453923280|FG000|Overall Study|Adverse Event|104|||
126174488|NCT01797965|453923281|FG001|Overall Study|Adverse Event|129|||
126174489|NCT01797965|453923282|FG002|Overall Study|Adverse Event|4|||
126174490|NCT01797965|453923283|FG003|Overall Study|Adverse Event|21|||
126174491|NCT01797965|453923280|FG000|Overall Study|Lost to Follow-up|9|||
126174492|NCT01797965|453923281|FG001|Overall Study|Lost to Follow-up|8|||
126174493|NCT01797965|453923282|FG002|Overall Study|Lost to Follow-up|1|||
126174494|NCT01797965|453923283|FG003|Overall Study|Lost to Follow-up|2|||
126174495|NCT01797965|453923280|FG000|Overall Study|Consent withdrawn|130|||
126174496|NCT01797965|453923281|FG001|Overall Study|Consent withdrawn|117|||
126174497|NCT01797965|453923282|FG002|Overall Study|Consent withdrawn|3|||
126174498|NCT01797965|453923283|FG003|Overall Study|Consent withdrawn|35|||
126174499|NCT01797965|453923280|FG000|Overall Study|Investigator decision|21|||
126174500|NCT01797965|453923281|FG001|Overall Study|Investigator decision|15|||
126174501|NCT01797965|453923282|FG002|Overall Study|Investigator decision|0|||
126174502|NCT01797965|453923283|FG003|Overall Study|Investigator decision|0|||
126174503|NCT01797965|453923280|FG000|Overall Study|Death|2|||
126174504|NCT01797965|453923281|FG001|Overall Study|Death|4|||
126174505|NCT01797965|453923282|FG002|Overall Study|Death|0|||
126174506|NCT01797965|453923283|FG003|Overall Study|Death|0|||
126174507|NCT01797965|453923280|FG000|Overall Study|Disease progression, defined by protocol|3|||
126174508|NCT01797965|453923281|FG001|Overall Study|Disease progression, defined by protocol|1|||
126174509|NCT01797965|453923282|FG002|Overall Study|Disease progression, defined by protocol|0|||
126174510|NCT01797965|453923283|FG003|Overall Study|Disease progression, defined by protocol|0|||
126174511|NCT01797965|453923280|FG000|Overall Study|Reason Not Specified|280|||
126199921|NCT00089505|454017802|FG002|Overall Study|Lost to Follow-up|9|||
126174512|NCT01797965|453923281|FG001|Overall Study|Reason Not Specified|295|||
126174513|NCT01797965|453923282|FG002|Overall Study|Reason Not Specified|0|||
126174514|NCT01797965|453923283|FG003|Overall Study|Reason Not Specified|15|||
126174515|NCT02670330|453923285|FG000|Overall Study|Protocol Deviation|1|||
126174516|NCT02670330|453923286|FG001|Overall Study|Protocol Deviation|0|||
126174517|NCT02670330|453923285|FG000|Overall Study|Study Terminated By Sponsor|36|||
126174518|NCT02670330|453923286|FG001|Overall Study|Study Terminated By Sponsor|43|||
126174519|NCT02670330|453923285|FG000|Overall Study|Adverse Event|1|||
126174520|NCT02670330|453923286|FG001|Overall Study|Adverse Event|3|||
126174521|NCT02670330|453923285|FG000|Overall Study|Withdrawal by Subject|34|||
126174522|NCT02670330|453923286|FG001|Overall Study|Withdrawal by Subject|29|||
126174523|NCT02670330|453923285|FG000|Overall Study|Lost to Follow-up|3|||
126174524|NCT02670330|453923286|FG001|Overall Study|Lost to Follow-up|2|||
126174525|NCT04404010|453923287|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
126174526|NCT04404010|453923288|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
126174527|NCT02120157|453923289|FG000|Overall Study|Death|8|||
126174528|NCT00441103|453923293|FG000|Overall Study|Adverse Event|2|||
126174529|NCT00441103|453923294|FG001|Overall Study|Adverse Event|1|||
126174530|NCT00441103|453923293|FG000|Overall Study|Death|1|||
126174531|NCT00441103|453923294|FG001|Overall Study|Death|0|||
126174532|NCT00441103|453923293|FG000|Overall Study|Disease Progression|2|||
126174533|NCT00441103|453923294|FG001|Overall Study|Disease Progression|0|||
126174534|NCT00441103|453923293|FG000|Overall Study|Lost to Follow-up|1|||
126174535|NCT00441103|453923294|FG001|Overall Study|Lost to Follow-up|0|||
126174536|NCT00441103|453923293|FG000|Overall Study|Protocol Violation|1|||
126174537|NCT00441103|453923294|FG001|Overall Study|Protocol Violation|0|||
126174538|NCT00441103|453923293|FG000|Overall Study|Participant unable to use Rebiject II|1|||
126174539|NCT00441103|453923294|FG001|Overall Study|Participant unable to use Rebiject II|0|||
126174540|NCT00441103|453923293|FG000|Overall Study|Participant refused MRI|1|||
126174541|NCT00441103|453923294|FG001|Overall Study|Participant refused MRI|0|||
126174542|NCT00441103|453923293|FG000|Overall Study|Inclusion criteria absent|1|||
126174543|NCT00441103|453923294|FG001|Overall Study|Inclusion criteria absent|0|||
126174544|NCT00441103|453923293|FG000|Overall Study|Non-compliant|0|||
126174545|NCT00441103|453923294|FG001|Overall Study|Non-compliant|1|||
126174546|NCT00441103|453923293|FG000|Overall Study|Participant decided to withdraw|1|||
126174547|NCT00441103|453923294|FG001|Overall Study|Participant decided to withdraw|0|||
126174548|NCT00441103|453923293|FG000|Overall Study|Participant's reason|0|||
126174549|NCT00441103|453923294|FG001|Overall Study|Participant's reason|1|||
126174550|NCT00441103|453923293|FG000|Overall Study|Participant decided to stop|0|||
126174551|NCT00441103|453923294|FG001|Overall Study|Participant decided to stop|1|||
126174552|NCT00239837|453923297|FG000|Overall Study|Lost to Follow-up|3|||
126174553|NCT00239837|453923298|FG001|Overall Study|Lost to Follow-up|7|||
126174554|NCT01153893|453923299|FG000|Overall Study|Adverse Event|1|||
126174555|NCT01153893|453923300|FG001|Overall Study|Adverse Event|0|||
126174556|NCT01838590|453923301|FG000|Overall Study|Lack of Efficacy|12|||
126174557|NCT01838590|453923302|FG001|Overall Study|Lack of Efficacy|4|||
126174558|NCT01838590|453923301|FG000|Overall Study|Lost to Follow-up|0|||
126174559|NCT01838590|453923302|FG001|Overall Study|Lost to Follow-up|1|||
126174560|NCT01354431|453923303|FG000|Pre-Treatment Period|Not reported|1|||
126174561|NCT01354431|453923304|FG001|Pre-Treatment Period|Not reported|0|||
126174562|NCT01354431|453923305|FG002|Pre-Treatment Period|Not reported|0|||
126174563|NCT01354431|453923303|FG000|Treatment Period|Disease Progression|50|||
126174564|NCT01354431|453923304|FG001|Treatment Period|Disease Progression|40|||
126174565|NCT01354431|453923305|FG002|Treatment Period|Disease Progression|44|||
126174566|NCT01354431|453923303|FG000|Treatment Period|Study Drug Toxicity|5|||
126174567|NCT01354431|453923304|FG001|Treatment Period|Study Drug Toxicity|8|||
126174568|NCT01354431|453923305|FG002|Treatment Period|Study Drug Toxicity|4|||
126174569|NCT01354431|453923303|FG000|Treatment Period|Death|0|||
126174570|NCT01354431|453923304|FG001|Treatment Period|Death|1|||
126174571|NCT01354431|453923305|FG002|Treatment Period|Death|0|||
126174572|NCT01354431|453923303|FG000|Treatment Period|AE unrelated to study drug|1|||
126174573|NCT01354431|453923304|FG001|Treatment Period|AE unrelated to study drug|2|||
126174574|NCT01354431|453923305|FG002|Treatment Period|AE unrelated to study drug|5|||
125973906|NCT04330638|453193191|FG002|Overall Study|Lost to Follow-up|3|||
125973907|NCT04330638|453193192|FG003|Overall Study|Lost to Follow-up|2|||
125973908|NCT04330638|453193193|FG004|Overall Study|Lost to Follow-up|3|||
125973909|NCT04330638|453193194|FG005|Overall Study|Lost to Follow-up|0|||
126174575|NCT01354431|453923303|FG000|Treatment Period|Participant request to discontinue|2|||
126174576|NCT01354431|453923304|FG001|Treatment Period|Participant request to discontinue|2|||
126174577|NCT01354431|453923305|FG002|Treatment Period|Participant request to discontinue|1|||
126174578|NCT01354431|453923303|FG000|Treatment Period|Participant withdrew consent|0|||
126174579|NCT01354431|453923304|FG001|Treatment Period|Participant withdrew consent|1|||
126174580|NCT01354431|453923305|FG002|Treatment Period|Participant withdrew consent|0|||
126174581|NCT01354431|453923303|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
126174582|NCT01354431|453923304|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
126174583|NCT01354431|453923305|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
126174584|NCT00878215|453923308|FG000|Overall Study|Determined to be ineligible|0|||
126174585|NCT00878215|453923309|FG001|Overall Study|Determined to be ineligible|10|||
126174586|NCT00878215|453923310|FG002|Overall Study|Determined to be ineligible|0|||
126174587|NCT00878215|453923311|FG003|Overall Study|Determined to be ineligible|0|||
126174588|NCT01364233|453923312|FG000|Overall Study|Lost to Follow-up|1|||
126174589|NCT00738374|453923314|FG000|Induction Treatment Phase|Adverse Event|14|||
126174590|NCT00738374|453923315|FG001|Induction Treatment Phase|Adverse Event|0|||
126174591|NCT00738374|453923316|FG002|Induction Treatment Phase|Adverse Event|0|||
126174592|NCT00738374|453923317|FG003|Induction Treatment Phase|Adverse Event|0|||
126174593|NCT00738374|453923314|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
126174594|NCT00738374|453923315|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
126174595|NCT00738374|453923316|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
126174596|NCT00738374|453923317|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
126174597|NCT00738374|453923314|FG000|Induction Treatment Phase|Physician Decision|2|||
126174598|NCT00738374|453923315|FG001|Induction Treatment Phase|Physician Decision|0|||
126174599|NCT00738374|453923316|FG002|Induction Treatment Phase|Physician Decision|0|||
126174600|NCT00738374|453923317|FG003|Induction Treatment Phase|Physician Decision|0|||
126174601|NCT00738374|453923314|FG000|Induction Treatment Phase|Protocol Violation|2|||
126174602|NCT00738374|453923315|FG001|Induction Treatment Phase|Protocol Violation|0|||
126174603|NCT00738374|453923316|FG002|Induction Treatment Phase|Protocol Violation|0|||
126174604|NCT00738374|453923317|FG003|Induction Treatment Phase|Protocol Violation|0|||
126174605|NCT00738374|453923314|FG000|Induction Treatment Phase|Non-compliance|1|||
126174606|NCT00738374|453923315|FG001|Induction Treatment Phase|Non-compliance|0|||
126174607|NCT00738374|453923316|FG002|Induction Treatment Phase|Non-compliance|0|||
126174608|NCT00738374|453923317|FG003|Induction Treatment Phase|Non-compliance|0|||
126174609|NCT00738374|453923314|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
126174610|NCT00738374|453923315|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
126174611|NCT00738374|453923316|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
126174612|NCT00738374|453923317|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
126174613|NCT00738374|453923314|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
126174614|NCT00738374|453923315|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
126174615|NCT00738374|453923316|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
126174616|NCT00738374|453923317|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
126174617|NCT00738374|453923314|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
126174618|NCT00738374|453923315|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
126174619|NCT00738374|453923316|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
126174620|NCT00738374|453923317|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
126174621|NCT00738374|453923314|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
126174622|NCT00738374|453923315|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
126174623|NCT00738374|453923316|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
126174624|NCT00738374|453923317|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
126174625|NCT00738374|453923314|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
126174626|NCT00738374|453923315|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
126174627|NCT00738374|453923316|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
126174628|NCT00738374|453923317|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
126174629|NCT00738374|453923314|FG000|Maintenance Treatment/Observation Phase|Other|0|||
126174630|NCT00738374|453923315|FG001|Maintenance Treatment/Observation Phase|Other|1|||
126174631|NCT00738374|453923316|FG002|Maintenance Treatment/Observation Phase|Other|0|||
126174632|NCT00738374|453923317|FG003|Maintenance Treatment/Observation Phase|Other|0|||
126174633|NCT01969799|453923318|FG000|Overall Study|Adverse Event|0|||
126174634|NCT01969799|453923319|FG001|Overall Study|Adverse Event|1|||
126174635|NCT01969799|453923318|FG000|Overall Study|Death|16|||
126174636|NCT01969799|453923319|FG001|Overall Study|Death|11|||
126174637|NCT01969799|453923318|FG000|Overall Study|Lost to Follow-up|0|||
126174638|NCT01969799|453923319|FG001|Overall Study|Lost to Follow-up|2|||
126174639|NCT01969799|453923318|FG000|Overall Study|Physician Decision|1|||
126174640|NCT01969799|453923319|FG001|Overall Study|Physician Decision|0|||
126174641|NCT02927873|453923322|FG000|Overall Study|Lost to Follow-up|0|||
126174642|NCT02927873|453923323|FG001|Overall Study|Lost to Follow-up|1|||
126174643|NCT02927873|453923324|FG002|Overall Study|Lost to Follow-up|0|||
126174644|NCT02927873|453923325|FG003|Overall Study|Lost to Follow-up|0|||
126174645|NCT02927873|453923326|FG004|Overall Study|Lost to Follow-up|0|||
126174646|NCT02927873|453923327|FG005|Overall Study|Lost to Follow-up|0|||
126174647|NCT02927873|453923322|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126174648|NCT02927873|453923323|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
126174649|NCT02927873|453923324|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126174650|NCT02927873|453923325|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126174651|NCT02927873|453923326|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126199922|NCT00089505|454017803|FG003|Overall Study|Lost to Follow-up|7|||
126174652|NCT02927873|453923327|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126174653|NCT02927873|453923322|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126174654|NCT02927873|453923323|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126174655|NCT02927873|453923324|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126174656|NCT02927873|453923325|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126174657|NCT02927873|453923326|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126174658|NCT02927873|453923327|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126174659|NCT02927873|453923322|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126174660|NCT02927873|453923323|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
126174661|NCT02927873|453923324|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126174662|NCT02927873|453923325|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126174663|NCT02927873|453923326|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126174664|NCT02927873|453923327|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126174665|NCT02927873|453923322|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
126174666|NCT02927873|453923323|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126174667|NCT02927873|453923324|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126174668|NCT02927873|453923325|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126174669|NCT02927873|453923326|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126174670|NCT02927873|453923327|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126174671|NCT02927873|453923322|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
126174672|NCT02927873|453923323|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126174673|NCT02927873|453923324|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126174674|NCT02927873|453923325|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126174675|NCT02927873|453923326|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126174676|NCT02927873|453923327|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126174677|NCT03629041|453923328|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
126174678|NCT03629041|453923329|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
126174679|NCT03629041|453923330|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
126174680|NCT03629041|453923331|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
126174681|NCT01927419|453923337|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126174682|NCT01927419|453923338|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
126174683|NCT01927419|453923337|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
126174684|NCT01927419|453923338|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
126174685|NCT01927419|453923337|FG000|Treatment Period|Disease progression|17|||
126174686|NCT01927419|453923338|FG001|Treatment Period|Disease progression|20|||
126174687|NCT01927419|453923337|FG000|Treatment Period|Study drug toxicity|48|||
126174688|NCT01927419|453923338|FG001|Treatment Period|Study drug toxicity|10|||
126174689|NCT01927419|453923337|FG000|Treatment Period|Death|0|||
126174690|NCT01927419|453923338|FG001|Treatment Period|Death|1|||
126174691|NCT01927419|453923337|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
126174692|NCT01927419|453923338|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
126174693|NCT01927419|453923337|FG000|Treatment Period|Participant request to discontinue|12|||
126174694|NCT01927419|453923338|FG001|Treatment Period|Participant request to discontinue|4|||
126174695|NCT01927419|453923337|FG000|Treatment Period|Withdrawal by Subject|1|||
126174696|NCT01927419|453923338|FG001|Treatment Period|Withdrawal by Subject|1|||
126174697|NCT01927419|453923337|FG000|Treatment Period|Maximum Clinical Benefit|6|||
126174698|NCT01927419|453923338|FG001|Treatment Period|Maximum Clinical Benefit|2|||
126174699|NCT01927419|453923337|FG000|Treatment Period|Other reasons|3|||
126174700|NCT01927419|453923338|FG001|Treatment Period|Other reasons|4|||
126174701|NCT01927419|453923337|FG000|Treatment Period|Not Reported|1|||
126174702|NCT01927419|453923338|FG001|Treatment Period|Not Reported|1|||
126174703|NCT00393913|453923339|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
126174704|NCT00393913|453923339|FG000|Initial Assessment|Withdrawal by Subject|16|||
126174705|NCT00393913|453923339|FG000|CPAP|Withdrawal by Subject|3|||
126174706|NCT00393913|453923339|FG000|CPAP|Physician Decision|1|||
126174707|NCT00393913|453923339|FG000|CPAP|TEchnical problem with CPAP|3|||
126174708|NCT03488251|453923340|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
126174709|NCT03488251|453923341|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
126174710|NCT03488251|453923342|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
126174711|NCT03488251|453923343|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
126174712|NCT03488251|453923340|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
126174713|NCT03488251|453923341|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
126174714|NCT03488251|453923342|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
126174715|NCT03488251|453923343|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
126174716|NCT03488251|453923340|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
125973910|NCT02293538|453193195|FG000|Overall Study|Adverse Event|0|||
126174717|NCT03488251|453923341|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
126174718|NCT03488251|453923342|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
126174719|NCT03488251|453923343|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
126174720|NCT03488251|453923340|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
126174721|NCT03488251|453923341|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
126174722|NCT03488251|453923342|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
126174723|NCT03488251|453923343|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
126174724|NCT03488251|453923340|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
126174725|NCT03488251|453923341|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
126174726|NCT03488251|453923342|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
126174727|NCT03488251|453923343|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
126174728|NCT00592553|453923349|FG000|Overall Study|Protocol Noncompliance|1|||
126174729|NCT00592553|453923350|FG001|Overall Study|Protocol Noncompliance|0|||
126174730|NCT00592553|453923351|FG002|Overall Study|Protocol Noncompliance|0|||
126174731|NCT02379390|453923352|FG000|Overall Study|Adverse Event|1|||
126174732|NCT02379390|453923353|FG001|Overall Study|Adverse Event|1|||
126174733|NCT02379390|453923352|FG000|Overall Study|Investigator's decision|1|||
126174734|NCT02379390|453923353|FG001|Overall Study|Investigator's decision|0|||
126174735|NCT02379390|453923352|FG000|Overall Study|Study Termination|0|||
126174736|NCT02379390|453923353|FG001|Overall Study|Study Termination|1|||
126174737|NCT01244191|453923354|FG000|Overall Study|Progressive disease|295|||
126174738|NCT01244191|453923355|FG001|Overall Study|Progressive disease|350|||
126174739|NCT01244191|453923354|FG000|Overall Study|Clinical disease progression|54|||
126174740|NCT01244191|453923355|FG001|Overall Study|Clinical disease progression|36|||
126174741|NCT01244191|453923354|FG000|Overall Study|Adverse Event|65|||
126174742|NCT01244191|453923355|FG001|Overall Study|Adverse Event|48|||
126174743|NCT01244191|453923354|FG000|Overall Study|Death|22|||
126174744|NCT01244191|453923355|FG001|Overall Study|Death|29|||
126174745|NCT01244191|453923354|FG000|Overall Study|Lost to Follow-up|0|||
126174746|NCT01244191|453923355|FG001|Overall Study|Lost to Follow-up|2|||
126174747|NCT01244191|453923354|FG000|Overall Study|Protocol Violation|1|||
126174748|NCT01244191|453923355|FG001|Overall Study|Protocol Violation|2|||
126174749|NCT01244191|453923354|FG000|Overall Study|Withdrawal by Subject|31|||
126174750|NCT01244191|453923355|FG001|Overall Study|Withdrawal by Subject|23|||
126174751|NCT01244191|453923354|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
126174752|NCT01244191|453923355|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
126174753|NCT01511107|453923357|FG000|Overall Study|Ineligible|3|||
126174754|NCT01511107|453923358|FG001|Overall Study|Ineligible|2|||
126174755|NCT01511107|453923357|FG000|Overall Study|Lost to Follow-up|10|||
126174756|NCT01511107|453923358|FG001|Overall Study|Lost to Follow-up|19|||
126174757|NCT01511107|453923357|FG000|Overall Study|Withdrawal by Subject|9|||
126174758|NCT01511107|453923358|FG001|Overall Study|Withdrawal by Subject|20|||
126174759|NCT01255306|453924856|FG000|Overall Study|Physician Decision|1|||
126174760|NCT01255306|453924857|FG001|Overall Study|Physician Decision|1|||
126174761|NCT01283997|453924858|FG000|Overall Study|Physician Decision|8|||
126174762|NCT01283997|453924859|FG001|Overall Study|Physician Decision|10|||
126174763|NCT01283997|453924858|FG000|Overall Study|Withdrawal by Subject|3|||
126174764|NCT01283997|453924859|FG001|Overall Study|Withdrawal by Subject|2|||
126174765|NCT01283997|453924858|FG000|Overall Study|Physically unable to continue|0|||
126174766|NCT01283997|453924859|FG001|Overall Study|Physically unable to continue|1|||
126174767|NCT01283997|453924858|FG000|Overall Study|Progressive disease|1|||
126174768|NCT01283997|453924859|FG001|Overall Study|Progressive disease|0|||
126174769|NCT01283997|453924858|FG000|Overall Study|Other|4|||
126174770|NCT01283997|453924859|FG001|Overall Study|Other|4|||
126174771|NCT02017899|453924860|FG000|Overall Study|Withdrawal by Subject|0|||
126174772|NCT02017899|453924861|FG001|Overall Study|Withdrawal by Subject|0|||
126174773|NCT02017899|453924862|FG002|Overall Study|Withdrawal by Subject|0|||
126174774|NCT02017899|453924863|FG003|Overall Study|Withdrawal by Subject|1|||
126174775|NCT02017899|453924864|FG004|Overall Study|Withdrawal by Subject|1|||
126174776|NCT02017899|453924865|FG005|Overall Study|Withdrawal by Subject|0|||
126174777|NCT01747811|453924869|FG000|Overall Study|Lack of Efficacy|2|||
126174778|NCT01747811|453924870|FG001|Overall Study|Lack of Efficacy|4|||
126174779|NCT01337167|453924871|FG000|Infant Series|Adverse Event|1|||
126174780|NCT01337167|453924872|FG001|Infant Series|Adverse Event|1|||
126174781|NCT01337167|453924871|FG000|Infant Series|Death|1|||
126174782|NCT01337167|453924872|FG001|Infant Series|Death|1|||
126174783|NCT01337167|453924871|FG000|Infant Series|Lost to Follow-up|13|||
126174784|NCT01337167|453924872|FG001|Infant Series|Lost to Follow-up|7|||
126174785|NCT01337167|453924871|FG000|Infant Series|Non-compliance with study drug|2|||
126174786|NCT01337167|453924872|FG001|Infant Series|Non-compliance with study drug|1|||
126174787|NCT01337167|453924871|FG000|Infant Series|Physician Decision|3|||
126174788|NCT01337167|453924872|FG001|Infant Series|Physician Decision|1|||
126174789|NCT01337167|453924871|FG000|Infant Series|Protocol Violation|22|||
126174790|NCT01337167|453924872|FG001|Infant Series|Protocol Violation|9|||
126174791|NCT01337167|453924871|FG000|Infant Series|Withdrawal by Subject|15|||
126174792|NCT01337167|453924872|FG001|Infant Series|Withdrawal by Subject|4|||
126174793|NCT01337167|453924871|FG000|Infant Series|Randomized but not vaccinated|5|||
126174794|NCT01337167|453924872|FG001|Infant Series|Randomized but not vaccinated|3|||
126174795|NCT01337167|453924871|FG000|Interim Period|Lost to Follow-up|51|||
126174796|NCT01337167|453924872|FG001|Interim Period|Lost to Follow-up|23|||
126174797|NCT01337167|453924871|FG000|Interim Period|Non-compliance with study drug|1|||
126174798|NCT01337167|453924872|FG001|Interim Period|Non-compliance with study drug|0|||
126174799|NCT01337167|453924871|FG000|Interim Period|Physician Decision|6|||
126174800|NCT01337167|453924872|FG001|Interim Period|Physician Decision|3|||
126174801|NCT01337167|453924871|FG000|Interim Period|Protocol Violation|5|||
126174802|NCT01337167|453924872|FG001|Interim Period|Protocol Violation|3|||
126174803|NCT01337167|453924871|FG000|Interim Period|Withdrawal by Subject|18|||
126174804|NCT01337167|453924872|FG001|Interim Period|Withdrawal by Subject|10|||
126174805|NCT01337167|453924871|FG000|Interim Period|Other protocol criterion not met|0|||
126174806|NCT01337167|453924872|FG001|Interim Period|Other protocol criterion not met|1|||
126174807|NCT01337167|453924871|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
126174808|NCT01337167|453924872|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
126174809|NCT01337167|453924871|FG000|Toddler Vaccinations|Protocol Violation|0|||
126174810|NCT01337167|453924872|FG001|Toddler Vaccinations|Protocol Violation|1|||
126174811|NCT01337167|453924871|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
126174812|NCT01337167|453924872|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
126174813|NCT03833817|453924873|FG000|Overall Study|Withdrawal by Subject|3|||
126174814|NCT03833817|453924874|FG001|Overall Study|Withdrawal by Subject|3|||
126174815|NCT03833817|453924873|FG000|Overall Study|Lost to Follow-up|3|||
126174816|NCT03833817|453924874|FG001|Overall Study|Lost to Follow-up|3|||
126174817|NCT00884221|453924877|FG000|Overall Study|Withdrawal by Subject|0|||
126174818|NCT00884221|453924878|FG001|Overall Study|Withdrawal by Subject|3|||
126174819|NCT00884221|453924877|FG000|Overall Study|Adverse Event|6|||
126174820|NCT00884221|453924878|FG001|Overall Study|Adverse Event|3|||
126174821|NCT00884221|453924877|FG000|Overall Study|Protocol Violation|16|||
126174822|NCT00884221|453924878|FG001|Overall Study|Protocol Violation|13|||
126174823|NCT00884221|453924877|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
126174824|NCT00884221|453924878|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
126174825|NCT03363919|453924881|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
126174826|NCT03363919|453924882|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
126174827|NCT03363919|453924881|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
126174828|NCT03363919|453924882|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
126174829|NCT01646398|453924883|FG000|Overall Study|Withdrawal by Subject|1|||
126174830|NCT01646398|453924884|FG001|Overall Study|Withdrawal by Subject|0|||
126174831|NCT00255034|453924885|FG000|Overall Study|Withdrawal by Subject|15|||
126174832|NCT00255034|453924886|FG001|Overall Study|Withdrawal by Subject|38|||
126174833|NCT00574119|453924887|FG000|Overall Study|Adverse Event|1|||
126174834|NCT00574119|453924887|FG000|Overall Study|Protocol Violation|1|||
126174835|NCT00574119|453924887|FG000|Overall Study|Withdrawal by Subject|1|||
126174836|NCT00574119|453924887|FG000|Overall Study|Physician Decision|1|||
126174837|NCT03434418|453924889|FG000|Overall Study|Disease Progression|11|||
126174838|NCT03434418|453924889|FG000|Overall Study|Adverse Event|2|||
126174839|NCT03434418|453924889|FG000|Overall Study|Physician Decision|1|||
126174840|NCT03434418|453924889|FG000|Overall Study|Decline in Performance Status (PS)|1|||
126174841|NCT00912340|453924892|FG000|Overall Study|Adverse Event|2|||
126174842|NCT00912340|453924893|FG001|Overall Study|Adverse Event|4|||
126174843|NCT00912340|453924894|FG002|Overall Study|Adverse Event|0|||
126174844|NCT00912340|453924892|FG000|Overall Study|Protocol revised to remove arm|0|||
126174845|NCT00912340|453924893|FG001|Overall Study|Protocol revised to remove arm|0|||
126174846|NCT00912340|453924894|FG002|Overall Study|Protocol revised to remove arm|4|||
126174847|NCT01517412|453924895|FG000|Overall Study|Adverse Event|10|||
126174848|NCT01517412|453924896|FG001|Overall Study|Adverse Event|11|||
125973911|NCT02293538|453193196|FG001|Overall Study|Adverse Event|1|||
125973912|NCT02293538|453193195|FG000|Overall Study|Lost to Follow-up|1|||
125973913|NCT02293538|453193196|FG001|Overall Study|Lost to Follow-up|0|||
125973914|NCT02293538|453193195|FG000|Overall Study|Withdrawal by Subject|0|||
125973915|NCT02293538|453193196|FG001|Overall Study|Withdrawal by Subject|1|||
125973916|NCT00322348|453193201|FG000|Overall Study|Adverse Event|0|||
125973917|NCT00322348|453193202|FG001|Overall Study|Adverse Event|1|||
126174849|NCT01517412|453924895|FG000|Overall Study|Lack of Efficacy|10|||
126174850|NCT01517412|453924896|FG001|Overall Study|Lack of Efficacy|5|||
126174851|NCT01517412|453924895|FG000|Overall Study|Poor compliance to protocol|8|||
126174852|NCT01517412|453924896|FG001|Overall Study|Poor compliance to protocol|3|||
126174853|NCT01517412|453924895|FG000|Overall Study|Other than specified above|8|||
126174854|NCT01517412|453924896|FG001|Overall Study|Other than specified above|5|||
126174855|NCT01956240|453924899|FG000|Overall Study|Lost to Follow-up|6|||
126174856|NCT01956240|453924900|FG001|Overall Study|Lost to Follow-up|20|||
126174857|NCT01956240|453924899|FG000|Overall Study|Adverse Event|17|||
126174858|NCT01956240|453924900|FG001|Overall Study|Adverse Event|4|||
126174859|NCT00600028|453924903|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126174860|NCT00600028|453924904|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
126174861|NCT00600028|453924903|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
126174862|NCT00600028|453924904|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
126174863|NCT00600028|453924903|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
126174864|NCT00600028|453924904|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
126174865|NCT03172481|453924905|FG000|Double-blind|Withdrawal by Subject|1|||
126174866|NCT03172481|453924906|FG001|Double-blind|Withdrawal by Subject|0|||
126174867|NCT01957709|453924907|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
126174868|NCT01149343|453924920|FG000|Overall Study|Withdrawal by Subject|1|||
126174869|NCT01149343|453924921|FG001|Overall Study|Withdrawal by Subject|1|||
126174870|NCT01149343|453924922|FG002|Overall Study|Withdrawal by Subject|1|||
126174871|NCT01149343|453924923|FG003|Overall Study|Withdrawal by Subject|5|||
126174872|NCT01149343|453924920|FG000|Overall Study|Death|10|||
126174873|NCT01149343|453924921|FG001|Overall Study|Death|13|||
126174874|NCT01149343|453924922|FG002|Overall Study|Death|18|||
126174875|NCT01149343|453924923|FG003|Overall Study|Death|18|||
126174876|NCT01149343|453924920|FG000|Overall Study|Lost to Follow-up|1|||
126174877|NCT01149343|453924921|FG001|Overall Study|Lost to Follow-up|0|||
126174878|NCT01149343|453924922|FG002|Overall Study|Lost to Follow-up|0|||
126174879|NCT01149343|453924923|FG003|Overall Study|Lost to Follow-up|1|||
126174880|NCT01149343|453924920|FG000|Overall Study|Other|8|||
126174881|NCT01149343|453924921|FG001|Overall Study|Other|10|||
126174882|NCT01149343|453924922|FG002|Overall Study|Other|2|||
126174883|NCT01149343|453924923|FG003|Overall Study|Other|14|||
126174884|NCT01149343|453924920|FG000|Overall Study|Sponsor study termination|0|||
126174885|NCT01149343|453924921|FG001|Overall Study|Sponsor study termination|0|||
126174886|NCT01149343|453924922|FG002|Overall Study|Sponsor study termination|0|||
126174887|NCT01149343|453924923|FG003|Overall Study|Sponsor study termination|2|||
126174888|NCT01149343|453924920|FG000|Overall Study|Recurrence / Progressive disease|0|||
126174889|NCT01149343|453924921|FG001|Overall Study|Recurrence / Progressive disease|0|||
126174890|NCT01149343|453924922|FG002|Overall Study|Recurrence / Progressive disease|1|||
126174891|NCT01149343|453924923|FG003|Overall Study|Recurrence / Progressive disease|0|||
126174892|NCT01061736|453924924|FG000|Overall Study|Dose regimen not selected|0|||
126174893|NCT01061736|453924925|FG001|Overall Study|Dose regimen not selected|0|||
126174894|NCT01061736|453924926|FG002|Overall Study|Dose regimen not selected|0|||
126174895|NCT01061736|453924927|FG003|Overall Study|Dose regimen not selected|0|||
126174896|NCT01061736|453924928|FG004|Overall Study|Dose regimen not selected|0|||
126174897|NCT01061736|453924929|FG005|Overall Study|Dose regimen not selected|0|||
126174898|NCT01061736|453924930|FG006|Overall Study|Dose regimen not selected|79|||
126174899|NCT01061736|453924931|FG007|Overall Study|Dose regimen not selected|0|||
126174900|NCT01061736|453924932|FG008|Overall Study|Dose regimen not selected|0|||
126174901|NCT01061736|453924933|FG009|Overall Study|Dose regimen not selected|0|||
126174902|NCT01061736|453924924|FG000|Overall Study|Adverse Event|13|||
126174903|NCT01061736|453924925|FG001|Overall Study|Adverse Event|1|||
126174904|NCT01061736|453924926|FG002|Overall Study|Adverse Event|3|||
126174905|NCT01061736|453924927|FG003|Overall Study|Adverse Event|2|||
126174906|NCT01061736|453924928|FG004|Overall Study|Adverse Event|4|||
126174907|NCT01061736|453924929|FG005|Overall Study|Adverse Event|1|||
126174908|NCT01061736|453924930|FG006|Overall Study|Adverse Event|4|||
126174909|NCT01061736|453924931|FG007|Overall Study|Adverse Event|63|||
126174910|NCT01061736|453924932|FG008|Overall Study|Adverse Event|67|||
126174911|NCT01061736|453924933|FG009|Overall Study|Adverse Event|34|||
126174912|NCT01061736|453924924|FG000|Overall Study|Lack of Efficacy|0|||
126174913|NCT01061736|453924925|FG001|Overall Study|Lack of Efficacy|2|||
126174914|NCT01061736|453924926|FG002|Overall Study|Lack of Efficacy|1|||
126174915|NCT01061736|453924927|FG003|Overall Study|Lack of Efficacy|1|||
126174916|NCT01061736|453924928|FG004|Overall Study|Lack of Efficacy|1|||
126174917|NCT01061736|453924929|FG005|Overall Study|Lack of Efficacy|2|||
126174918|NCT01061736|453924930|FG006|Overall Study|Lack of Efficacy|1|||
126174919|NCT01061736|453924931|FG007|Overall Study|Lack of Efficacy|9|||
126174920|NCT01061736|453924932|FG008|Overall Study|Lack of Efficacy|9|||
126174921|NCT01061736|453924933|FG009|Overall Study|Lack of Efficacy|10|||
126174922|NCT01061736|453924924|FG000|Overall Study|Poor compliance to protocol|0|||
126174923|NCT01061736|453924925|FG001|Overall Study|Poor compliance to protocol|0|||
126174924|NCT01061736|453924926|FG002|Overall Study|Poor compliance to protocol|0|||
126174925|NCT01061736|453924927|FG003|Overall Study|Poor compliance to protocol|0|||
126174926|NCT01061736|453924928|FG004|Overall Study|Poor compliance to protocol|0|||
126174927|NCT01061736|453924929|FG005|Overall Study|Poor compliance to protocol|0|||
125973918|NCT00322348|453193201|FG000|Overall Study|Withdrawal by Subject|1|||
126174928|NCT01061736|453924930|FG006|Overall Study|Poor compliance to protocol|0|||
126174929|NCT01061736|453924931|FG007|Overall Study|Poor compliance to protocol|2|||
126174930|NCT01061736|453924932|FG008|Overall Study|Poor compliance to protocol|5|||
126174931|NCT01061736|453924933|FG009|Overall Study|Poor compliance to protocol|9|||
126174932|NCT01061736|453924924|FG000|Overall Study|Not treated|0|||
126174933|NCT01061736|453924925|FG001|Overall Study|Not treated|0|||
126174934|NCT01061736|453924926|FG002|Overall Study|Not treated|0|||
126174935|NCT01061736|453924927|FG003|Overall Study|Not treated|0|||
126174936|NCT01061736|453924928|FG004|Overall Study|Not treated|1|||
126174937|NCT01061736|453924929|FG005|Overall Study|Not treated|0|||
126174938|NCT01061736|453924930|FG006|Overall Study|Not treated|0|||
126174939|NCT01061736|453924931|FG007|Overall Study|Not treated|2|||
126174940|NCT01061736|453924932|FG008|Overall Study|Not treated|1|||
126174941|NCT01061736|453924933|FG009|Overall Study|Not treated|0|||
126174942|NCT01061736|453924924|FG000|Overall Study|Other than specified above|0|||
126174943|NCT01061736|453924925|FG001|Overall Study|Other than specified above|1|||
126174944|NCT01061736|453924926|FG002|Overall Study|Other than specified above|2|||
126174945|NCT01061736|453924927|FG003|Overall Study|Other than specified above|0|||
126174946|NCT01061736|453924928|FG004|Overall Study|Other than specified above|1|||
126174947|NCT01061736|453924929|FG005|Overall Study|Other than specified above|0|||
126174948|NCT01061736|453924930|FG006|Overall Study|Other than specified above|0|||
126174949|NCT01061736|453924931|FG007|Overall Study|Other than specified above|18|||
126174950|NCT01061736|453924932|FG008|Overall Study|Other than specified above|15|||
126174951|NCT01061736|453924933|FG009|Overall Study|Other than specified above|21|||
126174952|NCT01093755|453924934|FG000|Overall Study|Withdrawal by Subject|3|||
126174953|NCT01093755|453924935|FG001|Overall Study|Withdrawal by Subject|4|||
126174954|NCT03115112|453924936|FG000|Overall Study|Adverse Event|5|||
126174955|NCT03115112|453924937|FG001|Overall Study|Adverse Event|1|||
126174956|NCT03115112|453924936|FG000|Overall Study|Withdrawal by Subject|4|||
126174957|NCT03115112|453924937|FG001|Overall Study|Withdrawal by Subject|2|||
126174958|NCT03115112|453924936|FG000|Overall Study|Lost to Follow-up|0|||
126174959|NCT03115112|453924937|FG001|Overall Study|Lost to Follow-up|1|||
126174960|NCT03115112|453924936|FG000|Overall Study|Death|1|||
126174961|NCT03115112|453924937|FG001|Overall Study|Death|0|||
126174962|NCT03115112|453924936|FG000|Overall Study|Pregnancy|1|||
126174963|NCT03115112|453924937|FG001|Overall Study|Pregnancy|0|||
126174964|NCT03115112|453924936|FG000|Overall Study|Site closure|1|||
126174965|NCT03115112|453924937|FG001|Overall Study|Site closure|1|||
126174966|NCT04019795|453924938|FG000|Overall Study|Withdrawal by Subject|1|||
126174967|NCT04019795|453924939|FG001|Overall Study|Withdrawal by Subject|2|||
126174968|NCT04019795|453924940|FG002|Overall Study|Withdrawal by Subject|2|||
126174969|NCT04019795|453924941|FG003|Overall Study|Withdrawal by Subject|1|||
126174970|NCT04019795|453924938|FG000|Overall Study|Lost to Follow-up|0|||
126174971|NCT04019795|453924939|FG001|Overall Study|Lost to Follow-up|1|||
126174972|NCT04019795|453924940|FG002|Overall Study|Lost to Follow-up|1|||
126174973|NCT04019795|453924941|FG003|Overall Study|Lost to Follow-up|2|||
126174974|NCT04019795|453924938|FG000|Overall Study|Treatment non-compliance|3|||
126174975|NCT04019795|453924939|FG001|Overall Study|Treatment non-compliance|1|||
126174976|NCT04019795|453924940|FG002|Overall Study|Treatment non-compliance|2|||
126174977|NCT04019795|453924941|FG003|Overall Study|Treatment non-compliance|0|||
126174978|NCT04019795|453924938|FG000|Overall Study|Physician Decision|0|||
126174979|NCT04019795|453924939|FG001|Overall Study|Physician Decision|0|||
126174980|NCT04019795|453924940|FG002|Overall Study|Physician Decision|1|||
126174981|NCT04019795|453924941|FG003|Overall Study|Physician Decision|0|||
126174982|NCT04019795|453924938|FG000|Overall Study|Adverse Event|1|||
126174983|NCT04019795|453924939|FG001|Overall Study|Adverse Event|0|||
126174984|NCT04019795|453924940|FG002|Overall Study|Adverse Event|0|||
126174985|NCT04019795|453924941|FG003|Overall Study|Adverse Event|0|||
126174986|NCT01610076|453924942|FG000|Overall Study|Technical issue with video|0|||
126174987|NCT01610076|453924943|FG001|Overall Study|Technical issue with video|1|||
126174988|NCT01610076|453924942|FG000|Overall Study|Lost to Follow-up|3|||
126174989|NCT01610076|453924943|FG001|Overall Study|Lost to Follow-up|4|||
126174990|NCT02168803|453924944|FG000|Overall Study|Lost to Follow-up|1|||
126174991|NCT02168803|453924945|FG001|Overall Study|Lost to Follow-up|0|||
126174992|NCT02168803|453924946|FG002|Overall Study|Lost to Follow-up|1|||
126174993|NCT02168803|453924944|FG000|Overall Study|Withdrawal by Subject|1|||
126174994|NCT02168803|453924945|FG001|Overall Study|Withdrawal by Subject|1|||
126174995|NCT02168803|453924946|FG002|Overall Study|Withdrawal by Subject|2|||
126174996|NCT02168803|453924944|FG000|Overall Study|Physician Decision|0|||
126174997|NCT02168803|453924945|FG001|Overall Study|Physician Decision|1|||
126174998|NCT02168803|453924946|FG002|Overall Study|Physician Decision|0|||
126174999|NCT02168803|453924944|FG000|Overall Study|Adverse Event|0|||
126175000|NCT02168803|453924945|FG001|Overall Study|Adverse Event|1|||
126175001|NCT02168803|453924946|FG002|Overall Study|Adverse Event|1|||
126175002|NCT02168803|453924944|FG000|Overall Study|Death|0|||
125973919|NCT00322348|453193202|FG001|Overall Study|Withdrawal by Subject|4|||
126175003|NCT02168803|453924945|FG001|Overall Study|Death|0|||
126175004|NCT02168803|453924946|FG002|Overall Study|Death|1|||
126175005|NCT02168803|453924944|FG000|Overall Study|Sponsor Decision|0|||
126175006|NCT02168803|453924945|FG001|Overall Study|Sponsor Decision|0|||
126175007|NCT02168803|453924946|FG002|Overall Study|Sponsor Decision|1|||
126175008|NCT01107405|453924947|FG000|Overall Study|Adverse Event|1|||
126175009|NCT01107405|453924948|FG001|Overall Study|Adverse Event|1|||
126175010|NCT01107405|453924949|FG002|Overall Study|Adverse Event|0|||
126175011|NCT01107405|453924950|FG003|Overall Study|Adverse Event|0|||
126175012|NCT01107405|453924951|FG004|Overall Study|Adverse Event|2|||
126175013|NCT01107405|453924947|FG000|Overall Study|Withdrawal by Subject|1|||
126175014|NCT01107405|453924948|FG001|Overall Study|Withdrawal by Subject|0|||
126175015|NCT01107405|453924949|FG002|Overall Study|Withdrawal by Subject|1|||
126175016|NCT01107405|453924950|FG003|Overall Study|Withdrawal by Subject|2|||
126175017|NCT01107405|453924951|FG004|Overall Study|Withdrawal by Subject|1|||
126175018|NCT01107405|453924947|FG000|Overall Study|Protocol Violation|0|||
126175019|NCT01107405|453924948|FG001|Overall Study|Protocol Violation|0|||
126175020|NCT01107405|453924949|FG002|Overall Study|Protocol Violation|1|||
126175021|NCT01107405|453924950|FG003|Overall Study|Protocol Violation|1|||
126175022|NCT01107405|453924951|FG004|Overall Study|Protocol Violation|0|||
126175023|NCT00980343|453924952|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
126175024|NCT00980343|453924953|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
126175025|NCT02310906|453924958|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
126175026|NCT02310906|453924959|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
126175027|NCT02310906|453924960|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
126175028|NCT02310906|453924961|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
126175029|NCT02310906|453924958|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
126175030|NCT02310906|453924959|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
126175031|NCT02310906|453924960|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
126175032|NCT02310906|453924961|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
126175033|NCT02310906|453924958|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
126175034|NCT02310906|453924959|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
126175035|NCT02310906|453924960|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
126175036|NCT02310906|453924961|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
126175037|NCT02310906|453924958|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
126175038|NCT02310906|453924959|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
126175039|NCT02310906|453924960|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
126175040|NCT02310906|453924961|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
126175041|NCT00098020|453924967|FG000|Overall Study|Adverse Event|2|||
126175042|NCT00098020|453924967|FG000|Overall Study|Lost to Follow-up|1|||
126175043|NCT00098020|453924967|FG000|Overall Study|elevated liver enzymes|1|||
126175044|NCT00098020|453924967|FG000|Overall Study|Low urine PCR|1|||
126175045|NCT00098020|453924967|FG000|Overall Study|Low epidermal growth factor receptor|1|||
126175046|NCT01840228|453924971|FG000|Overall Study|Lost to Follow-up|1|||
126175047|NCT01840228|453924972|FG001|Overall Study|Lost to Follow-up|1|||
126175048|NCT01879319|453924980|FG000|Overall Study|Withdrawal by Subject|1|||
126175049|NCT01879319|453924981|FG001|Overall Study|Withdrawal by Subject|0|||
126175050|NCT01879319|453924980|FG000|Overall Study|Lost to Follow-up|1|||
126175051|NCT01879319|453924981|FG001|Overall Study|Lost to Follow-up|5|||
126175052|NCT01360762|453924982|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
126175053|NCT01360762|453924982|FG000|Main Study Period (12-month Treatment)|Death|5|||
126175054|NCT01360762|453924982|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
126175055|NCT01360762|453924982|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
126175056|NCT01360762|453924982|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
126175057|NCT01360762|453924982|FG000|Whole Study Period|Lost to Follow-up|10|||
126175058|NCT01360762|453924982|FG000|Whole Study Period|Death|7|||
126175059|NCT01360762|453924982|FG000|Whole Study Period|Patient relapsed|18|||
126175060|NCT01360762|453924982|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
126175061|NCT03084718|453924983|FG000|Overall Study|Withdrawal by Subject|4|||
126175062|NCT03084718|453924984|FG001|Overall Study|Withdrawal by Subject|3|||
126175063|NCT03084718|453924985|FG002|Overall Study|Withdrawal by Subject|4|||
126175064|NCT03084718|453924986|FG003|Overall Study|Withdrawal by Subject|0|||
126175065|NCT03084718|453924987|FG004|Overall Study|Withdrawal by Subject|0|||
126175066|NCT03084718|453924983|FG000|Overall Study|Physician Decision|1|||
126175067|NCT03084718|453924984|FG001|Overall Study|Physician Decision|0|||
126175068|NCT03084718|453924985|FG002|Overall Study|Physician Decision|0|||
126175069|NCT03084718|453924986|FG003|Overall Study|Physician Decision|0|||
126175070|NCT03084718|453924987|FG004|Overall Study|Physician Decision|0|||
126175071|NCT03084718|453924983|FG000|Overall Study|Adverse Event|3|||
126175072|NCT03084718|453924984|FG001|Overall Study|Adverse Event|5|||
126175073|NCT03084718|453924985|FG002|Overall Study|Adverse Event|5|||
126175074|NCT03084718|453924986|FG003|Overall Study|Adverse Event|8|||
126175075|NCT03084718|453924987|FG004|Overall Study|Adverse Event|2|||
126175076|NCT03084718|453924983|FG000|Overall Study|Lack of Efficacy|2|||
125973920|NCT00322348|453193201|FG000|Overall Study|Lost to Follow-up|1|||
125973921|NCT00322348|453193202|FG001|Overall Study|Lost to Follow-up|0|||
125973922|NCT00322348|453193201|FG000|Overall Study|Death|0|||
126175077|NCT03084718|453924984|FG001|Overall Study|Lack of Efficacy|0|||
126175078|NCT03084718|453924985|FG002|Overall Study|Lack of Efficacy|1|||
126175079|NCT03084718|453924986|FG003|Overall Study|Lack of Efficacy|4|||
126175080|NCT03084718|453924987|FG004|Overall Study|Lack of Efficacy|0|||
126175081|NCT03084718|453924983|FG000|Overall Study|Lost to Follow-up|0|||
126175082|NCT03084718|453924984|FG001|Overall Study|Lost to Follow-up|1|||
126175083|NCT03084718|453924985|FG002|Overall Study|Lost to Follow-up|0|||
126175084|NCT03084718|453924986|FG003|Overall Study|Lost to Follow-up|0|||
126175085|NCT03084718|453924987|FG004|Overall Study|Lost to Follow-up|2|||
126175086|NCT03084718|453924983|FG000|Overall Study|Protocol Violation|0|||
126175087|NCT03084718|453924984|FG001|Overall Study|Protocol Violation|0|||
126175088|NCT03084718|453924985|FG002|Overall Study|Protocol Violation|1|||
126175089|NCT03084718|453924986|FG003|Overall Study|Protocol Violation|0|||
126175090|NCT03084718|453924987|FG004|Overall Study|Protocol Violation|0|||
126175091|NCT03084718|453924983|FG000|Overall Study|Death|0|||
126175092|NCT03084718|453924984|FG001|Overall Study|Death|1|||
126175093|NCT03084718|453924985|FG002|Overall Study|Death|0|||
126175094|NCT03084718|453924986|FG003|Overall Study|Death|0|||
126175095|NCT03084718|453924987|FG004|Overall Study|Death|0|||
126175096|NCT03084718|453924983|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
126175097|NCT03084718|453924984|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
126175098|NCT03084718|453924985|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
126175099|NCT03084718|453924986|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
126175100|NCT03084718|453924987|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
126175101|NCT00844649|453924988|FG000|Overall Study|Progressive Disease|196|||
126175102|NCT00844649|453924989|FG001|Overall Study|Progressive Disease|245|||
126175103|NCT00844649|453924988|FG000|Overall Study|Adverse Event|128|||
126175104|NCT00844649|453924989|FG001|Overall Study|Adverse Event|73|||
126175105|NCT00844649|453924988|FG000|Overall Study|Physician Decision|25|||
126175106|NCT00844649|453924989|FG001|Overall Study|Physician Decision|18|||
126175107|NCT00844649|453924988|FG000|Overall Study|Protocol Violation|10|||
126175108|NCT00844649|453924989|FG001|Overall Study|Protocol Violation|6|||
126175109|NCT00844649|453924988|FG000|Overall Study|Withdrawal by Subject|28|||
126175110|NCT00844649|453924989|FG001|Overall Study|Withdrawal by Subject|39|||
126175111|NCT00844649|453924988|FG000|Overall Study|Other|7|||
126175112|NCT00844649|453924989|FG001|Overall Study|Other|10|||
126175113|NCT00844649|453924988|FG000|Overall Study|Withdrew prior to starting treatment|11|||
126175114|NCT00844649|453924989|FG001|Overall Study|Withdrew prior to starting treatment|27|||
126175115|NCT02767856|453924990|FG000|Overall Study|Lost to Follow-up|9|||
126175116|NCT02767856|453924991|FG001|Overall Study|Lost to Follow-up|1|||
126175117|NCT02767856|453924990|FG000|Overall Study|Withdrawal by Subject|2|||
126175118|NCT02767856|453924991|FG001|Overall Study|Withdrawal by Subject|1|||
126175119|NCT00091026|453924992|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
126175120|NCT00091026|453924993|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
126175121|NCT00091026|453924992|FG000|Overall Study|Patient withdrew and never received trea|0|||
126175122|NCT00091026|453924993|FG001|Overall Study|Patient withdrew and never received trea|2|||
126175123|NCT00091026|453924992|FG000|Overall Study|Unknown-never received treatment|0|||
126175124|NCT00091026|453924993|FG001|Overall Study|Unknown-never received treatment|1|||
126175125|NCT00589979|453924994|FG000|Run-In Period|Adverse Event|5|||
126175126|NCT00589979|453924995|FG001|Run-In Period|Adverse Event|0|||
126175127|NCT00589979|453924996|FG002|Run-In Period|Adverse Event|0|||
126175128|NCT00589979|453924994|FG000|Run-In Period|Protocol Violation|3|||
126175129|NCT00589979|453924995|FG001|Run-In Period|Protocol Violation|0|||
126175130|NCT00589979|453924996|FG002|Run-In Period|Protocol Violation|0|||
126175131|NCT00589979|453924994|FG000|Run-In Period|Did not qualify for randomization|54|||
126175132|NCT00589979|453924995|FG001|Run-In Period|Did not qualify for randomization|0|||
126175133|NCT00589979|453924996|FG002|Run-In Period|Did not qualify for randomization|0|||
126175134|NCT00589979|453924994|FG000|Run-In Period|Withdrawal by Subject|10|||
126175135|NCT00589979|453924995|FG001|Run-In Period|Withdrawal by Subject|0|||
126175136|NCT00589979|453924996|FG002|Run-In Period|Withdrawal by Subject|0|||
126175137|NCT00589979|453924994|FG000|Run-In Period|Informed Consent Withdrawn|4|||
126175138|NCT00589979|453924995|FG001|Run-In Period|Informed Consent Withdrawn|0|||
126175139|NCT00589979|453924996|FG002|Run-In Period|Informed Consent Withdrawn|0|||
126175140|NCT00589979|453924994|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
126175141|NCT00589979|453924995|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
126175142|NCT00589979|453924996|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
126175143|NCT00589979|453924994|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
126175144|NCT00589979|453924995|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
126175145|NCT00589979|453924996|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
126175146|NCT00589979|453924994|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
126175147|NCT00589979|453924995|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
126175148|NCT00589979|453924996|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
126175149|NCT00589979|453924994|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
126175150|NCT00589979|453924995|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
126175151|NCT00589979|453924996|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
126175152|NCT00589979|453924994|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
126175153|NCT00589979|453924995|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
126175154|NCT00589979|453924996|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
126175155|NCT00589979|453924994|FG000|Double-Blind Treatment Period 2|Other|0|||
126175156|NCT00589979|453924995|FG001|Double-Blind Treatment Period 2|Other|0|||
126175157|NCT00589979|453924996|FG002|Double-Blind Treatment Period 2|Other|1|||
126199923|NCT00089505|454017800|FG000|Overall Study|Physician Decision|1|||
126175158|NCT00589979|453924994|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
126175159|NCT00589979|453924995|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
126175160|NCT00589979|453924996|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
126175161|NCT00589979|453924994|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
126175162|NCT00589979|453924995|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
126175163|NCT00589979|453924996|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
126175164|NCT00302718|453925008|FG000|Overall Study|Participant left the hospital|1|||
126175165|NCT00302718|453925009|FG001|Overall Study|Participant left the hospital|0|||
126175166|NCT00302718|453925010|FG002|Overall Study|Participant left the hospital|0|||
126175167|NCT00302718|453925011|FG003|Overall Study|Participant left the hospital|1|||
126175168|NCT00302718|453925008|FG000|Overall Study|Withdrawal by Subject|0|||
126175169|NCT00302718|453925009|FG001|Overall Study|Withdrawal by Subject|1|||
126175170|NCT00302718|453925010|FG002|Overall Study|Withdrawal by Subject|0|||
126175171|NCT00302718|453925011|FG003|Overall Study|Withdrawal by Subject|0|||
126175172|NCT00302718|453925008|FG000|Overall Study|Participant left primary care setting|0|||
126175173|NCT00302718|453925009|FG001|Overall Study|Participant left primary care setting|0|||
126175174|NCT00302718|453925010|FG002|Overall Study|Participant left primary care setting|2|||
126175175|NCT00302718|453925011|FG003|Overall Study|Participant left primary care setting|1|||
126175176|NCT00819585|453925012|FG000|Core Study|Adverse Event|2|||
126175177|NCT00819585|453925013|FG001|Core Study|Adverse Event|1|||
126175178|NCT00819585|453925014|FG002|Core Study|Adverse Event|1|||
126175179|NCT00819585|453925015|FG003|Core Study|Adverse Event|4|||
126175180|NCT00819585|453925016|FG004|Core Study|Adverse Event|1|||
126175181|NCT00819585|453925017|FG005|Core Study|Adverse Event|0|||
126175182|NCT00819585|453925018|FG006|Core Study|Adverse Event|2|||
126175183|NCT00819585|453925019|FG007|Core Study|Adverse Event|0|||
126175184|NCT00819585|453925020|FG008|Core Study|Adverse Event|0|||
126175185|NCT00819585|453925021|FG009|Core Study|Adverse Event|0|||
126175186|NCT00819585|453925022|FG010|Core Study|Adverse Event|0|||
126175187|NCT00819585|453925012|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
126175188|NCT00819585|453925013|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
126175189|NCT00819585|453925014|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
126175190|NCT00819585|453925015|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
126175191|NCT00819585|453925016|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
126175192|NCT00819585|453925017|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
126175193|NCT00819585|453925018|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
126175194|NCT00819585|453925019|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
126175195|NCT00819585|453925020|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
126175196|NCT00819585|453925021|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
126175197|NCT00819585|453925022|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
126175198|NCT00819585|453925012|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175199|NCT00819585|453925013|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
126175200|NCT00819585|453925014|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175201|NCT00819585|453925015|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175202|NCT00819585|453925016|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175203|NCT00819585|453925017|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175204|NCT00819585|453925018|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
126175205|NCT00819585|453925019|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175206|NCT00819585|453925020|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175207|NCT00819585|453925021|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175208|NCT00819585|453925022|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
126175209|NCT00819585|453925012|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
126175210|NCT00819585|453925013|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
126175211|NCT00819585|453925014|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
126175212|NCT00819585|453925015|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
126175213|NCT00819585|453925016|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
126175214|NCT00819585|453925017|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
126175215|NCT00819585|453925018|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
126175216|NCT00819585|453925019|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
126175217|NCT00819585|453925020|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
126175218|NCT00819585|453925021|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
126175219|NCT00819585|453925022|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
126175220|NCT00819585|453925012|FG000|Core Study|Subject Withdrew Consent|0|||
126175221|NCT00819585|453925013|FG001|Core Study|Subject Withdrew Consent|3|||
126175222|NCT00819585|453925014|FG002|Core Study|Subject Withdrew Consent|2|||
126175223|NCT00819585|453925015|FG003|Core Study|Subject Withdrew Consent|1|||
126175224|NCT00819585|453925016|FG004|Core Study|Subject Withdrew Consent|0|||
126175225|NCT00819585|453925017|FG005|Core Study|Subject Withdrew Consent|0|||
126175226|NCT00819585|453925018|FG006|Core Study|Subject Withdrew Consent|3|||
126175227|NCT00819585|453925019|FG007|Core Study|Subject Withdrew Consent|0|||
126175228|NCT00819585|453925020|FG008|Core Study|Subject Withdrew Consent|0|||
126175229|NCT00819585|453925021|FG009|Core Study|Subject Withdrew Consent|0|||
126175230|NCT00819585|453925022|FG010|Core Study|Subject Withdrew Consent|0|||
126175231|NCT00819585|453925012|FG000|Core Study|Lost to Follow-up|2|||
126175232|NCT00819585|453925013|FG001|Core Study|Lost to Follow-up|1|||
126175233|NCT00819585|453925014|FG002|Core Study|Lost to Follow-up|2|||
126175234|NCT00819585|453925015|FG003|Core Study|Lost to Follow-up|0|||
126175235|NCT00819585|453925016|FG004|Core Study|Lost to Follow-up|1|||
126175236|NCT00819585|453925017|FG005|Core Study|Lost to Follow-up|1|||
126175237|NCT00819585|453925018|FG006|Core Study|Lost to Follow-up|1|||
126175238|NCT00819585|453925019|FG007|Core Study|Lost to Follow-up|0|||
126175239|NCT00819585|453925020|FG008|Core Study|Lost to Follow-up|0|||
126175240|NCT00819585|453925021|FG009|Core Study|Lost to Follow-up|0|||
126175241|NCT00819585|453925022|FG010|Core Study|Lost to Follow-up|0|||
126175242|NCT00819585|453925012|FG000|Core Study|Administrative Problems|0|||
126175243|NCT00819585|453925013|FG001|Core Study|Administrative Problems|0|||
126175244|NCT00819585|453925014|FG002|Core Study|Administrative Problems|0|||
126175245|NCT00819585|453925015|FG003|Core Study|Administrative Problems|0|||
126175246|NCT00819585|453925016|FG004|Core Study|Administrative Problems|0|||
126175247|NCT00819585|453925017|FG005|Core Study|Administrative Problems|0|||
126175248|NCT00819585|453925018|FG006|Core Study|Administrative Problems|2|||
126175249|NCT00819585|453925019|FG007|Core Study|Administrative Problems|0|||
126175250|NCT00819585|453925020|FG008|Core Study|Administrative Problems|0|||
126175251|NCT00819585|453925021|FG009|Core Study|Administrative Problems|0|||
126175252|NCT00819585|453925022|FG010|Core Study|Administrative Problems|0|||
126175253|NCT00819585|453925012|FG000|Core Study|Death|0|||
126175254|NCT00819585|453925013|FG001|Core Study|Death|0|||
126175255|NCT00819585|453925014|FG002|Core Study|Death|0|||
126175256|NCT00819585|453925015|FG003|Core Study|Death|0|||
126175257|NCT00819585|453925016|FG004|Core Study|Death|0|||
126175258|NCT00819585|453925017|FG005|Core Study|Death|0|||
126175259|NCT00819585|453925018|FG006|Core Study|Death|1|||
126175260|NCT00819585|453925019|FG007|Core Study|Death|0|||
126175261|NCT00819585|453925020|FG008|Core Study|Death|0|||
126175262|NCT00819585|453925021|FG009|Core Study|Death|0|||
126175263|NCT00819585|453925022|FG010|Core Study|Death|0|||
126175264|NCT00819585|453925012|FG000|Core Study|Protocol Violation|0|||
126175265|NCT00819585|453925013|FG001|Core Study|Protocol Violation|0|||
126175266|NCT00819585|453925014|FG002|Core Study|Protocol Violation|1|||
126175267|NCT00819585|453925015|FG003|Core Study|Protocol Violation|0|||
126175268|NCT00819585|453925016|FG004|Core Study|Protocol Violation|0|||
126175269|NCT00819585|453925017|FG005|Core Study|Protocol Violation|1|||
126175270|NCT00819585|453925018|FG006|Core Study|Protocol Violation|3|||
126175271|NCT00819585|453925019|FG007|Core Study|Protocol Violation|0|||
126175272|NCT00819585|453925020|FG008|Core Study|Protocol Violation|0|||
126175273|NCT00819585|453925021|FG009|Core Study|Protocol Violation|0|||
126175274|NCT00819585|453925022|FG010|Core Study|Protocol Violation|0|||
126175275|NCT00819585|453925012|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
126175276|NCT00819585|453925013|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
126175277|NCT00819585|453925014|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
126175278|NCT00819585|453925015|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
126175279|NCT00819585|453925016|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
126175280|NCT00819585|453925017|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
126175281|NCT00819585|453925018|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
126175282|NCT00819585|453925019|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
126175283|NCT00819585|453925020|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
126175284|NCT00819585|453925021|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
126175285|NCT00819585|453925022|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
126175286|NCT00819585|453925012|FG000|Extension Study|Subject Withdrew Consent|0|||
126175287|NCT00819585|453925013|FG001|Extension Study|Subject Withdrew Consent|0|||
126175288|NCT00819585|453925014|FG002|Extension Study|Subject Withdrew Consent|0|||
126175289|NCT00819585|453925015|FG003|Extension Study|Subject Withdrew Consent|0|||
126175290|NCT00819585|453925016|FG004|Extension Study|Subject Withdrew Consent|0|||
126175291|NCT00819585|453925017|FG005|Extension Study|Subject Withdrew Consent|0|||
126175292|NCT00819585|453925018|FG006|Extension Study|Subject Withdrew Consent|0|||
126175293|NCT00819585|453925019|FG007|Extension Study|Subject Withdrew Consent|0|||
126175294|NCT00819585|453925020|FG008|Extension Study|Subject Withdrew Consent|3|||
126175295|NCT00819585|453925021|FG009|Extension Study|Subject Withdrew Consent|0|||
126175296|NCT00819585|453925022|FG010|Extension Study|Subject Withdrew Consent|1|||
126175297|NCT00819585|453925012|FG000|Extension Study|Lost to Follow-up|0|||
126175298|NCT00819585|453925013|FG001|Extension Study|Lost to Follow-up|0|||
126175299|NCT00819585|453925014|FG002|Extension Study|Lost to Follow-up|0|||
126175300|NCT00819585|453925015|FG003|Extension Study|Lost to Follow-up|0|||
126175301|NCT00819585|453925016|FG004|Extension Study|Lost to Follow-up|0|||
126175302|NCT00819585|453925017|FG005|Extension Study|Lost to Follow-up|0|||
126175303|NCT00819585|453925018|FG006|Extension Study|Lost to Follow-up|0|||
126175304|NCT00819585|453925019|FG007|Extension Study|Lost to Follow-up|0|||
126175305|NCT00819585|453925020|FG008|Extension Study|Lost to Follow-up|2|||
126175306|NCT00819585|453925021|FG009|Extension Study|Lost to Follow-up|1|||
126175307|NCT00819585|453925022|FG010|Extension Study|Lost to Follow-up|1|||
126175308|NCT00819585|453925012|FG000|Extension Study|Death|0|||
126175309|NCT00819585|453925013|FG001|Extension Study|Death|0|||
126175310|NCT00819585|453925014|FG002|Extension Study|Death|0|||
126175311|NCT00819585|453925015|FG003|Extension Study|Death|0|||
126175312|NCT00819585|453925016|FG004|Extension Study|Death|0|||
126175313|NCT00819585|453925017|FG005|Extension Study|Death|0|||
126175314|NCT00819585|453925018|FG006|Extension Study|Death|0|||
126175315|NCT00819585|453925019|FG007|Extension Study|Death|0|||
126175316|NCT00819585|453925020|FG008|Extension Study|Death|2|||
126175317|NCT00819585|453925021|FG009|Extension Study|Death|0|||
126175318|NCT00819585|453925022|FG010|Extension Study|Death|0|||
126175319|NCT02159469|453925023|FG000|Overall Study|Missing Completion status|1|||
126175320|NCT02159469|453925023|FG000|Overall Study|Adverse Event|5|||
126175321|NCT02159469|453925023|FG000|Overall Study|Non-compliance|2|||
126175322|NCT02159469|453925023|FG000|Overall Study|Withdrawal by Subject|9|||
126175323|NCT02159469|453925023|FG000|Overall Study|Lost to Follow-up|1|||
126175324|NCT02159469|453925023|FG000|Overall Study|Sponsor's request|2|||
126175325|NCT02159469|453925023|FG000|Overall Study|Met Stopping Criteria|3|||
126175326|NCT02159469|453925023|FG000|Overall Study|Other|1|||
126175327|NCT02159469|453925023|FG000|Overall Study|Multiple|29|||
126175328|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
126175329|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
126175330|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
126175331|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
126175332|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
126175333|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
126175334|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
126175335|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
126175336|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
126175337|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
126175338|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
126175339|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
126175340|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
126175341|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
126175342|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
126175343|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
126175344|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
126175345|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
126175346|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
126175347|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
126175348|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
126175349|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
126175350|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
126175351|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
126175352|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
126175353|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
126175354|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
126175355|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
126175356|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
126175357|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
126175358|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
126175359|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
126175360|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
126175361|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
126175362|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
126175363|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
126175364|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
126175365|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
126175366|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
126175367|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
125973923|NCT00322348|453193202|FG001|Overall Study|Death|2|||
125973924|NCT00322348|453193201|FG000|Overall Study|Disease Progression|30|||
126175368|NCT00383721|453925025|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
126175369|NCT00383721|453925026|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
126175370|NCT00383721|453925027|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
126175371|NCT00383721|453925028|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
126175372|NCT00383721|453925029|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
126175373|NCT00383721|453925025|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
126175374|NCT00383721|453925026|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
126175375|NCT00383721|453925027|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
126175376|NCT00383721|453925028|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
126175377|NCT00383721|453925029|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
126175378|NCT00383721|453925025|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
126175379|NCT00383721|453925026|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
126175380|NCT00383721|453925027|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
126175381|NCT00383721|453925028|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
126175382|NCT00383721|453925029|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
126175383|NCT00383721|453925025|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
126175384|NCT00383721|453925026|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
126175385|NCT00383721|453925027|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
126175386|NCT00383721|453925028|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
126175387|NCT00383721|453925029|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
126175388|NCT00383721|453925025|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
126175389|NCT00383721|453925026|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
126175390|NCT00383721|453925027|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
126175391|NCT00383721|453925028|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
126175392|NCT00383721|453925029|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
126175393|NCT00383721|453925025|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126175394|NCT00383721|453925026|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126175395|NCT00383721|453925027|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126175396|NCT00383721|453925028|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126175397|NCT00383721|453925029|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
126175398|NCT00383721|453925025|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
126175399|NCT00383721|453925026|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
126175400|NCT00383721|453925027|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
126175401|NCT00383721|453925028|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
126175402|NCT00383721|453925029|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
126175403|NCT00383721|453925025|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
126175404|NCT00383721|453925026|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
126175405|NCT00383721|453925027|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
126175406|NCT00383721|453925028|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
126175407|NCT00383721|453925029|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
126175408|NCT00383721|453925025|FG000|26-Week Treatment Safety Extension|Administrative|1|||
126175409|NCT00383721|453925026|FG001|26-Week Treatment Safety Extension|Administrative|2|||
126175410|NCT00383721|453925027|FG002|26-Week Treatment Safety Extension|Administrative|3|||
126175411|NCT00383721|453925028|FG003|26-Week Treatment Safety Extension|Administrative|1|||
126175412|NCT00383721|453925029|FG004|26-Week Treatment Safety Extension|Administrative|0|||
126175413|NCT01146951|453926867|FG000|Overall Study|Adverse Event|4|||
126175414|NCT01146951|453926868|FG001|Overall Study|Adverse Event|1|||
126175415|NCT00804843|453926872|FG000|Overall Study|Protocol Violation|1|||
126175416|NCT00804843|453926873|FG001|Overall Study|Protocol Violation|0|||
126175417|NCT00804843|453926872|FG000|Overall Study|Adverse Event|8|||
126175418|NCT00804843|453926873|FG001|Overall Study|Adverse Event|5|||
126175419|NCT00804843|453926872|FG000|Overall Study|Withdrawal by Subject|1|||
126175420|NCT00804843|453926873|FG001|Overall Study|Withdrawal by Subject|2|||
126175421|NCT02126670|453926882|FG000|Overall Study|Withdrawal by Subject|1|||
126175422|NCT02126670|453926883|FG001|Overall Study|Withdrawal by Subject|0|||
126175423|NCT02126670|453926884|FG002|Overall Study|Withdrawal by Subject|0|||
126175424|NCT02126670|453926885|FG003|Overall Study|Withdrawal by Subject|1|||
126175425|NCT01975246|453926886|FG000|Overall Study|Adverse Event|2|||
126175426|NCT01975246|453926887|FG001|Overall Study|Adverse Event|1|||
126175427|NCT01975246|453926886|FG000|Overall Study|Lack of Efficacy|1|||
126175428|NCT01975246|453926887|FG001|Overall Study|Lack of Efficacy|0|||
126175429|NCT01975246|453926886|FG000|Overall Study|Protocol Violation|1|||
126175430|NCT01975246|453926887|FG001|Overall Study|Protocol Violation|0|||
126175431|NCT01975246|453926886|FG000|Overall Study|Other than stated|0|||
126175432|NCT01975246|453926887|FG001|Overall Study|Other than stated|1|||
126175433|NCT01263093|453926888|FG000|Washout|Physician Decision|1|||
126175434|NCT01263093|453926889|FG001|Washout|Physician Decision|0|||
126175435|NCT01263093|453926888|FG000|Period 2|Adverse Event|1|||
126175436|NCT01263093|453926889|FG001|Period 2|Adverse Event|0|||
126175437|NCT00424346|453926890|FG000|Core Study|Adverse Event|5|||
126175438|NCT00424346|453926891|FG001|Core Study|Adverse Event|3|||
126175439|NCT00424346|453926892|FG002|Core Study|Adverse Event|1|||
126175440|NCT00424346|453926893|FG003|Core Study|Adverse Event|1|||
126175441|NCT00424346|453926890|FG000|Core Study|Abnormal Laboratory Values|0|||
126175442|NCT00424346|453926891|FG001|Core Study|Abnormal Laboratory Values|1|||
126175443|NCT00424346|453926892|FG002|Core Study|Abnormal Laboratory Values|0|||
126175444|NCT00424346|453926893|FG003|Core Study|Abnormal Laboratory Values|0|||
126175445|NCT00424346|453926890|FG000|Core Study|Lack of Efficacy|1|||
126175446|NCT00424346|453926891|FG001|Core Study|Lack of Efficacy|3|||
126175447|NCT00424346|453926892|FG002|Core Study|Lack of Efficacy|0|||
126175448|NCT00424346|453926893|FG003|Core Study|Lack of Efficacy|4|||
126175449|NCT00424346|453926890|FG000|Core Study|Withdrawal by Subject|1|||
126175450|NCT00424346|453926891|FG001|Core Study|Withdrawal by Subject|0|||
126175451|NCT00424346|453926892|FG002|Core Study|Withdrawal by Subject|0|||
126175452|NCT00424346|453926893|FG003|Core Study|Withdrawal by Subject|2|||
126175453|NCT00424346|453926890|FG000|Core Study|Lost to Follow-up|1|||
126175454|NCT00424346|453926891|FG001|Core Study|Lost to Follow-up|1|||
126175455|NCT00424346|453926892|FG002|Core Study|Lost to Follow-up|0|||
126175456|NCT00424346|453926893|FG003|Core Study|Lost to Follow-up|0|||
126175457|NCT00424346|453926890|FG000|Core Study|Administrative Problems|1|||
126175458|NCT00424346|453926891|FG001|Core Study|Administrative Problems|0|||
126175459|NCT00424346|453926892|FG002|Core Study|Administrative Problems|1|||
126175460|NCT00424346|453926893|FG003|Core Study|Administrative Problems|0|||
126175461|NCT00424346|453926890|FG000|Core Study|Protocol Violation|0|||
126175462|NCT00424346|453926891|FG001|Core Study|Protocol Violation|0|||
126175463|NCT00424346|453926892|FG002|Core Study|Protocol Violation|2|||
126175464|NCT00424346|453926893|FG003|Core Study|Protocol Violation|0|||
126175465|NCT00424346|453926890|FG000|Extension Phase|Adverse Event|0|||
126175466|NCT00424346|453926891|FG001|Extension Phase|Adverse Event|9|||
126175467|NCT00424346|453926892|FG002|Extension Phase|Adverse Event|5|||
126175468|NCT00424346|453926893|FG003|Extension Phase|Adverse Event|4|||
126175469|NCT00424346|453926890|FG000|Extension Phase|Lack of Efficacy|0|||
126175470|NCT00424346|453926891|FG001|Extension Phase|Lack of Efficacy|16|||
126175471|NCT00424346|453926892|FG002|Extension Phase|Lack of Efficacy|14|||
126175472|NCT00424346|453926893|FG003|Extension Phase|Lack of Efficacy|11|||
126175473|NCT00424346|453926890|FG000|Extension Phase|Withdrawal by Subject|0|||
126175474|NCT00424346|453926891|FG001|Extension Phase|Withdrawal by Subject|5|||
126175475|NCT00424346|453926892|FG002|Extension Phase|Withdrawal by Subject|3|||
126175476|NCT00424346|453926893|FG003|Extension Phase|Withdrawal by Subject|4|||
126175477|NCT00424346|453926890|FG000|Extension Phase|Lost to Follow-up|0|||
126175478|NCT00424346|453926891|FG001|Extension Phase|Lost to Follow-up|2|||
126175479|NCT00424346|453926892|FG002|Extension Phase|Lost to Follow-up|0|||
126175480|NCT00424346|453926893|FG003|Extension Phase|Lost to Follow-up|0|||
126175481|NCT00424346|453926890|FG000|Extension Phase|Administrative Problems|0|||
126175482|NCT00424346|453926891|FG001|Extension Phase|Administrative Problems|69|||
126175483|NCT00424346|453926892|FG002|Extension Phase|Administrative Problems|32|||
126175484|NCT00424346|453926893|FG003|Extension Phase|Administrative Problems|35|||
126175485|NCT00424346|453926890|FG000|Extension Phase|Death|0|||
126175486|NCT00424346|453926891|FG001|Extension Phase|Death|0|||
126175487|NCT00424346|453926892|FG002|Extension Phase|Death|0|||
126175488|NCT00424346|453926893|FG003|Extension Phase|Death|1|||
126175489|NCT00424346|453926890|FG000|Extension Phase|Protocol Violation|0|||
126175490|NCT00424346|453926891|FG001|Extension Phase|Protocol Violation|1|||
126175491|NCT00424346|453926892|FG002|Extension Phase|Protocol Violation|1|||
126175492|NCT00424346|453926893|FG003|Extension Phase|Protocol Violation|0|||
126175493|NCT01827319|453926894|FG000|Overall Study|Lost to Follow-up|3|||
126175494|NCT00571519|453926895|FG000|Overall Study|Subject withdrew consent|0|||
126175495|NCT00571519|453926896|FG001|Overall Study|Subject withdrew consent|1|||
126175496|NCT00571519|453926897|FG002|Overall Study|Subject withdrew consent|0|||
126175497|NCT00571519|453926898|FG003|Overall Study|Subject withdrew consent|2|||
126175498|NCT00571519|453926899|FG004|Overall Study|Subject withdrew consent|1|||
126175499|NCT00571519|453926900|FG005|Overall Study|Subject withdrew consent|1|||
126175500|NCT00571519|453926901|FG006|Overall Study|Subject withdrew consent|2|||
126175501|NCT00571519|453926895|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
126175502|NCT00571519|453926896|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
126175503|NCT00571519|453926897|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
126175504|NCT00571519|453926898|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
126175505|NCT00571519|453926899|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
126175506|NCT00571519|453926900|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
126175507|NCT00571519|453926901|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
126175508|NCT00571519|453926895|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
126175509|NCT00571519|453926896|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
126175510|NCT00571519|453926897|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
126175511|NCT00571519|453926898|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
126175512|NCT00571519|453926899|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
126175513|NCT00571519|453926900|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
126175514|NCT00571519|453926901|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
126175515|NCT00571519|453926895|FG000|Overall Study|Termination of study by Sponsor|2|||
126175516|NCT00571519|453926896|FG001|Overall Study|Termination of study by Sponsor|7|||
126175517|NCT00571519|453926897|FG002|Overall Study|Termination of study by Sponsor|10|||
126175518|NCT00571519|453926898|FG003|Overall Study|Termination of study by Sponsor|24|||
126175519|NCT00571519|453926899|FG004|Overall Study|Termination of study by Sponsor|8|||
126175520|NCT00571519|453926900|FG005|Overall Study|Termination of study by Sponsor|9|||
126175521|NCT00571519|453926901|FG006|Overall Study|Termination of study by Sponsor|22|||
126175522|NCT00571519|453926895|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126175523|NCT00571519|453926896|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126175524|NCT00571519|453926897|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
126175525|NCT00571519|453926898|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126175526|NCT00571519|453926899|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126175527|NCT00571519|453926900|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126175528|NCT00571519|453926901|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126175529|NCT00562640|453926903|FG000|Overall Study|Death|0|||
126175530|NCT00562640|453926904|FG001|Overall Study|Death|1|||
126175531|NCT00562640|453926905|FG002|Overall Study|Death|1|||
126175532|NCT00562640|453926906|FG003|Overall Study|Death|0|||
126175533|NCT05263921|453926907|FG000|Overall Study|Other: family emergency.|0|||
126175534|NCT05263921|453926908|FG001|Overall Study|Other: family emergency.|0|||
126175535|NCT05263921|453926909|FG002|Overall Study|Other: family emergency.|1|||
126175536|NCT05263921|453926910|FG003|Overall Study|Other: family emergency.|0|||
126175537|NCT02499575|453926911|FG000|Overall Study|Protocol Violation|0|||
126175538|NCT02499575|453926912|FG001|Overall Study|Protocol Violation|1|||
126175539|NCT02658968|453926913|FG000|Received Rituximab|Adverse Event|0|||
126175540|NCT02658968|453926914|FG001|Received Rituximab|Adverse Event|0|||
126175541|NCT02658968|453926915|FG002|Received Rituximab|Adverse Event|0|||
126175542|NCT02658968|453926916|FG003|Received Rituximab|Adverse Event|0|||
126175543|NCT02658968|453926917|FG004|Received Rituximab|Adverse Event|1|||
126175544|NCT02658968|453926913|FG000|Received Rituximab|Progressive disease|0|||
126175545|NCT02658968|453926914|FG001|Received Rituximab|Progressive disease|0|||
126175546|NCT02658968|453926915|FG002|Received Rituximab|Progressive disease|0|||
126175547|NCT02658968|453926916|FG003|Received Rituximab|Progressive disease|0|||
126175548|NCT02658968|453926917|FG004|Received Rituximab|Progressive disease|1|||
126175549|NCT02658968|453926913|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
126175550|NCT02658968|453926914|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
126175551|NCT02658968|453926915|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
126175552|NCT02658968|453926916|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
126175553|NCT02658968|453926917|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
126175554|NCT02658968|453926913|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
126175555|NCT02658968|453926914|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
126175556|NCT02658968|453926915|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
126175557|NCT02658968|453926916|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
126175558|NCT02658968|453926917|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
126175559|NCT02658968|453926913|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
126175560|NCT02658968|453926914|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
126175561|NCT02658968|453926915|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
126175562|NCT02658968|453926916|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
126175563|NCT02658968|453926917|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
126175564|NCT02658968|453926913|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
126175565|NCT02658968|453926914|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
126175566|NCT02658968|453926915|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
126175567|NCT02658968|453926916|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
126175568|NCT02658968|453926917|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
126175569|NCT02658968|453926913|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
126175570|NCT02658968|453926914|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
126175571|NCT02658968|453926915|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
126175572|NCT02658968|453926916|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
126175573|NCT02658968|453926917|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
126175574|NCT02667457|453926929|FG000|Overall Study|Withdrawal by Subject|1|||
126175575|NCT02667457|453926930|FG001|Overall Study|Withdrawal by Subject|0|||
126175576|NCT02667457|453926929|FG000|Overall Study|Other Reason|0|||
126175577|NCT02667457|453926930|FG001|Overall Study|Other Reason|2|||
126175578|NCT02475850|453926931|FG000|Overall Study|Death|155|||
126175579|NCT02475850|453926932|FG001|Overall Study|Death|141|||
126175580|NCT02475850|453926931|FG000|Overall Study|Lost to Follow-up|217|||
126175581|NCT02475850|453926932|FG001|Overall Study|Lost to Follow-up|188|||
126175582|NCT02475850|453926931|FG000|Overall Study|Withdrawal by Subject|221|||
126175583|NCT02475850|453926932|FG001|Overall Study|Withdrawal by Subject|155|||
126175584|NCT03297216|453926938|FG000|Overall Study|Death|0|||
126175585|NCT03297216|453926939|FG001|Overall Study|Death|1|||
126175586|NCT03297216|453926938|FG000|Overall Study|Miscarriage|0|||
126175587|NCT03297216|453926939|FG001|Overall Study|Miscarriage|2|||
126175588|NCT03297216|453926938|FG000|Overall Study|Lost to Follow-up|3|||
126175589|NCT03297216|453926939|FG001|Overall Study|Lost to Follow-up|2|||
126175590|NCT00603733|453926940|FG000|Active Phase ITT|Adverse Event|8|||
126175591|NCT00603733|453926941|FG001|Active Phase ITT|Adverse Event|7|||
126175592|NCT00603733|453926940|FG000|Active Phase ITT|Withdrawal by Subject|0|||
126175593|NCT00603733|453926941|FG001|Active Phase ITT|Withdrawal by Subject|3|||
126175594|NCT00603733|453926940|FG000|Active Phase ITT|Lost to Follow-up|0|||
126175595|NCT00603733|453926941|FG001|Active Phase ITT|Lost to Follow-up|1|||
126175596|NCT00603733|453926940|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
126175597|NCT00603733|453926941|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
126175598|NCT00603733|453926940|FG000|Active Phase ITT|Lack of Efficacy|1|||
126175599|NCT00603733|453926941|FG001|Active Phase ITT|Lack of Efficacy|2|||
126175600|NCT00603733|453926940|FG000|Active Phase ITT|Subject moved, site closed|1|||
126175601|NCT00603733|453926941|FG001|Active Phase ITT|Subject moved, site closed|1|||
126175602|NCT00603733|453926940|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
126175603|NCT00603733|453926941|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
126175604|NCT00603733|453926940|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
126175605|NCT00603733|453926941|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
126175606|NCT00603733|453926940|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
126175607|NCT00603733|453926941|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
126175608|NCT00603733|453926940|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
126175609|NCT00603733|453926941|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
126175610|NCT00603733|453926940|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
126175611|NCT00603733|453926941|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
126175612|NCT00603733|453926940|FG000|Maintenance Phase ITT|Adverse Event|3|||
126175613|NCT00603733|453926941|FG001|Maintenance Phase ITT|Adverse Event|6|||
126175614|NCT00603733|453926940|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
126175615|NCT00603733|453926941|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
126175616|NCT00603733|453926940|FG000|Maintenance Phase ITT|Protocol Violation|1|||
126175617|NCT00603733|453926941|FG001|Maintenance Phase ITT|Protocol Violation|1|||
126175618|NCT00603733|453926940|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
126175619|NCT00603733|453926941|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
126175620|NCT00603733|453926940|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
126175621|NCT00603733|453926941|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
126175622|NCT00603733|453926940|FG000|Maintenance Phase ITT|Physician Decision|0|||
126175623|NCT00603733|453926941|FG001|Maintenance Phase ITT|Physician Decision|1|||
126175624|NCT00603733|453926940|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
126175625|NCT00603733|453926941|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
126175626|NCT02700919|453926942|FG000|Overall Study|Physician Decision|1|||
126175627|NCT02700919|453926943|FG001|Overall Study|Physician Decision|0|||
126175628|NCT02700919|453926944|FG002|Overall Study|Physician Decision|0|||
126175629|NCT02700919|453926942|FG000|Overall Study|Protocol Violation|1|||
126175630|NCT02700919|453926943|FG001|Overall Study|Protocol Violation|0|||
126175631|NCT02700919|453926944|FG002|Overall Study|Protocol Violation|0|||
126175632|NCT02700919|453926942|FG000|Overall Study|Adverse Event|1|||
126175633|NCT02700919|453926943|FG001|Overall Study|Adverse Event|3|||
126175634|NCT02700919|453926944|FG002|Overall Study|Adverse Event|1|||
126175635|NCT02700919|453926942|FG000|Overall Study|Withdrawal by Subject|5|||
126175636|NCT02700919|453926943|FG001|Overall Study|Withdrawal by Subject|8|||
126175637|NCT02700919|453926944|FG002|Overall Study|Withdrawal by Subject|2|||
126175638|NCT02700919|453926942|FG000|Overall Study|Lost to Follow-up|2|||
126175639|NCT02700919|453926943|FG001|Overall Study|Lost to Follow-up|0|||
126175640|NCT02700919|453926944|FG002|Overall Study|Lost to Follow-up|0|||
126175641|NCT02700919|453926942|FG000|Overall Study|Other|2|||
126175642|NCT02700919|453926943|FG001|Overall Study|Other|1|||
126175643|NCT02700919|453926944|FG002|Overall Study|Other|1|||
126175644|NCT01253187|453926954|FG000|Period 2|Withdrawal by Subject|0|||
126175645|NCT01253187|453926955|FG001|Period 2|Withdrawal by Subject|0|||
126175646|NCT01253187|453926956|FG002|Period 2|Withdrawal by Subject|0|||
126175647|NCT01253187|453926957|FG003|Period 2|Withdrawal by Subject|0|||
126175648|NCT01253187|453926958|FG004|Period 2|Withdrawal by Subject|1|||
126175649|NCT01253187|453926959|FG005|Period 2|Withdrawal by Subject|0|||
126175650|NCT01253187|453926954|FG000|Period 3|Pregnancy|1|||
126175651|NCT01253187|453926955|FG001|Period 3|Pregnancy|0|||
126175652|NCT01253187|453926956|FG002|Period 3|Pregnancy|0|||
126175653|NCT01253187|453926957|FG003|Period 3|Pregnancy|0|||
126175654|NCT01253187|453926958|FG004|Period 3|Pregnancy|0|||
126175655|NCT01253187|453926959|FG005|Period 3|Pregnancy|0|||
126175656|NCT01253187|453926954|FG000|Period 3|difficulty with blood sampling|0|||
126175657|NCT01253187|453926955|FG001|Period 3|difficulty with blood sampling|1|||
126175658|NCT01253187|453926956|FG002|Period 3|difficulty with blood sampling|0|||
126175659|NCT01253187|453926957|FG003|Period 3|difficulty with blood sampling|0|||
125973925|NCT00322348|453193202|FG001|Overall Study|Disease Progression|25|||
126175660|NCT01253187|453926958|FG004|Period 3|difficulty with blood sampling|0|||
126175661|NCT01253187|453926959|FG005|Period 3|difficulty with blood sampling|0|||
126175662|NCT01253187|453926954|FG000|Period 3|non-compliance|0|||
126175663|NCT01253187|453926955|FG001|Period 3|non-compliance|0|||
126175664|NCT01253187|453926956|FG002|Period 3|non-compliance|0|||
126175665|NCT01253187|453926957|FG003|Period 3|non-compliance|0|||
125973926|NCT00322348|453193201|FG000|Overall Study|Reasons not specified|5|||
126175666|NCT01253187|453926958|FG004|Period 3|non-compliance|1|||
126175667|NCT01253187|453926959|FG005|Period 3|non-compliance|0|||
126175668|NCT02680587|453926962|FG000|Overall Study|Withdrawal by Subject|1|||
126175669|NCT02680587|453926963|FG001|Overall Study|Withdrawal by Subject|0|||
126175670|NCT02899377|453926964|FG000|Overall Study|Adverse Event|1|||
126175671|NCT02899377|453926965|FG001|Overall Study|Adverse Event|0|||
126175672|NCT00469209|453926966|FG000|Overall Study|Adverse Event|1|||
126175673|NCT00469209|453926967|FG001|Overall Study|Adverse Event|0|||
126175674|NCT00469209|453926968|FG002|Overall Study|Adverse Event|1|||
126175675|NCT00712933|453926971|FG000|Overall Study|Adverse Event|69|||
126175676|NCT00712933|453926971|FG000|Overall Study|Lack of Efficacy|6|||
126175677|NCT00712933|453926971|FG000|Overall Study|Lost to Follow-up|22|||
126175678|NCT00712933|453926971|FG000|Overall Study|Non-compliance with study drug|13|||
126175679|NCT00712933|453926971|FG000|Overall Study|Other Pregnancy|37|||
126175680|NCT00712933|453926971|FG000|Overall Study|Sponsor decision|14|||
126175681|NCT00712933|453926971|FG000|Overall Study|Withdrew consent|4|||
126175682|NCT00712933|453926971|FG000|Overall Study|Hip replacement surgery|1|||
126175683|NCT00712933|453926971|FG000|Overall Study|Involved in Clinical research|3|||
126175684|NCT00712933|453926971|FG000|Overall Study|Participant hospitalized|1|||
126175685|NCT00712933|453926971|FG000|Overall Study|Participant travelled overseas|2|||
126175686|NCT00712933|453926971|FG000|Overall Study|Death of patient|1|||
126175687|NCT00712933|453926971|FG000|Overall Study|Other Physician decision|1|||
126175688|NCT00712933|453926971|FG000|Overall Study|Not committed to contraception|1|||
126175689|NCT00712933|453926971|FG000|Overall Study|Participant received medication|1|||
126175690|NCT00712933|453926971|FG000|Overall Study|Physician Decision|36|||
126175691|NCT00712933|453926971|FG000|Overall Study|Protocol Violation|4|||
126175692|NCT00712933|453926971|FG000|Overall Study|Withdrawal by Subject|151|||
126175693|NCT01295580|453926974|FG000|Overall Study|Protocol Violation|4|||
126175694|NCT01295580|453926975|FG001|Overall Study|Protocol Violation|2|||
126175695|NCT01295580|453926974|FG000|Overall Study|Withdrawal by Subject|1|||
126175696|NCT01295580|453926975|FG001|Overall Study|Withdrawal by Subject|4|||
126175697|NCT01295580|453926974|FG000|Overall Study|Adverse Event|2|||
126175698|NCT01295580|453926975|FG001|Overall Study|Adverse Event|1|||
126175699|NCT01295580|453926974|FG000|Overall Study|Lost to Follow-up|1|||
126175700|NCT01295580|453926975|FG001|Overall Study|Lost to Follow-up|0|||
126175701|NCT01295580|453926974|FG000|Overall Study|Lack of Efficacy|1|||
126175702|NCT01295580|453926975|FG001|Overall Study|Lack of Efficacy|0|||
126175703|NCT01295580|453926974|FG000|Overall Study|Other: inconvenience|1|||
126175704|NCT01295580|453926975|FG001|Overall Study|Other: inconvenience|0|||
126175705|NCT01295580|453926974|FG000|Overall Study|Other: family objection|0|||
126175706|NCT01295580|453926975|FG001|Overall Study|Other: family objection|1|||
126175707|NCT02022033|453926979|FG000|Overall Study|Physician Decision|1|||
125973927|NCT00322348|453193202|FG001|Overall Study|Reasons not specified|1|||
125973928|NCT01090453|453193205|FG000|Overall Study|Withdrawal by Subject|1|||
125973929|NCT01090453|453193206|FG001|Overall Study|Withdrawal by Subject|2|||
125973930|NCT01090453|453193205|FG000|Overall Study|Lost to Follow-up|7|||
125973931|NCT01090453|453193206|FG001|Overall Study|Lost to Follow-up|7|||
125973932|NCT01090453|453193205|FG000|Overall Study|Non serious AEs|1|||
125973933|NCT01090453|453193206|FG001|Overall Study|Non serious AEs|0|||
125973934|NCT01090453|453193205|FG000|Overall Study|Protocol Violation|2|||
125973935|NCT01090453|453193206|FG001|Overall Study|Protocol Violation|0|||
125973936|NCT01090453|453193205|FG000|Overall Study|Other|2|||
125973937|NCT01090453|453193206|FG001|Overall Study|Other|4|||
125973938|NCT01090453|453193205|FG000|Overall Study|Eligibility Criteria|0|||
125973939|NCT01090453|453193206|FG001|Overall Study|Eligibility Criteria|1|||
125973940|NCT00989287|453193209|FG000|Overall Study|Adverse Event|1|||
125973941|NCT00989287|453193210|FG001|Overall Study|Adverse Event|0|||
125973942|NCT00989287|453193209|FG000|Overall Study|Lost to Follow-up|0|||
125973943|NCT00989287|453193210|FG001|Overall Study|Lost to Follow-up|1|||
125973944|NCT00729833|453193211|FG000|Overall Study|Death|5|||
125973945|NCT00729833|453193212|FG001|Overall Study|Death|1|||
125973946|NCT00729833|453193213|FG002|Overall Study|Death|3|||
125973947|NCT00729833|453193214|FG003|Overall Study|Death|5|||
125973948|NCT00729833|453193211|FG000|Overall Study|Study Terminated by Sponsor|0|||
125973949|NCT00729833|453193212|FG001|Overall Study|Study Terminated by Sponsor|0|||
125973950|NCT00729833|453193213|FG002|Overall Study|Study Terminated by Sponsor|1|||
125973951|NCT00729833|453193214|FG003|Overall Study|Study Terminated by Sponsor|0|||
125973952|NCT00729833|453193211|FG000|Overall Study|Lost to Follow-up|1|||
125973953|NCT00729833|453193212|FG001|Overall Study|Lost to Follow-up|0|||
125973954|NCT00729833|453193213|FG002|Overall Study|Lost to Follow-up|0|||
125973955|NCT00729833|453193214|FG003|Overall Study|Lost to Follow-up|0|||
125973956|NCT00729833|453193211|FG000|Overall Study|Withdrawal by Subject|3|||
125973957|NCT00729833|453193212|FG001|Overall Study|Withdrawal by Subject|1|||
125973958|NCT00729833|453193213|FG002|Overall Study|Withdrawal by Subject|3|||
126175708|NCT01103778|453926980|FG000|Overall Study|Lost to Follow-up|1|||
126175709|NCT01103778|453926980|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
125973959|NCT00729833|453193214|FG003|Overall Study|Withdrawal by Subject|0|||
125973960|NCT00729833|453193211|FG000|Overall Study|Unspecified Reasons|11|||
126175710|NCT01103778|453926980|FG000|Overall Study|Screen failure|1|||
126175711|NCT03067129|453926981|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
126175712|NCT03067129|453926982|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
126175713|NCT03067129|453926983|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
126175714|NCT03067129|453926984|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
126175715|NCT03067129|453926981|FG000|Overall Study|Withdrawal by Subject|0|||
126175716|NCT03067129|453926982|FG001|Overall Study|Withdrawal by Subject|0|||
126175717|NCT03067129|453926983|FG002|Overall Study|Withdrawal by Subject|1|||
126175718|NCT03067129|453926984|FG003|Overall Study|Withdrawal by Subject|2|||
126175719|NCT03067129|453926981|FG000|Overall Study|Lost to Follow-up|5|||
126175720|NCT03067129|453926982|FG001|Overall Study|Lost to Follow-up|5|||
126175721|NCT03067129|453926983|FG002|Overall Study|Lost to Follow-up|4|||
126175722|NCT03067129|453926984|FG003|Overall Study|Lost to Follow-up|3|||
126175723|NCT03986190|453926985|FG000|Overall Study|Withdrawal by Subject|12|||
126175724|NCT03986190|453926986|FG001|Overall Study|Withdrawal by Subject|0|||
126175725|NCT04929613|453926987|FG000|Overall Study|Withdrawal by Subject|12|||
126175726|NCT00865189|453926988|FG000|Overall Study|Other|1|||
126175727|NCT00865189|453926989|FG001|Overall Study|Other|2|||
126175728|NCT00865189|453926988|FG000|Overall Study|Death|4|||
126175729|NCT00865189|453926989|FG001|Overall Study|Death|11|||
126175730|NCT00865189|453926988|FG000|Overall Study|Lost to Follow-up|6|||
126175731|NCT00865189|453926989|FG001|Overall Study|Lost to Follow-up|6|||
126175732|NCT00865189|453926988|FG000|Overall Study|Withdrawal by Subject|1|||
126175733|NCT00865189|453926989|FG001|Overall Study|Withdrawal by Subject|0|||
126175734|NCT01464788|453927003|FG000|Overall Study|Lost to Follow-up|0|||
126175735|NCT01464788|453927004|FG001|Overall Study|Lost to Follow-up|1|||
126175736|NCT01464788|453927005|FG002|Overall Study|Lost to Follow-up|0|||
126175737|NCT01464788|453927003|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
126175738|NCT01464788|453927004|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
126175739|NCT01464788|453927005|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
126175740|NCT00418379|453927008|FG000|Year 1|Adverse Event|9|||
126175741|NCT00418379|453927009|FG001|Year 1|Adverse Event|15|||
126175742|NCT00418379|453927010|FG002|Year 1|Adverse Event|3|||
126175743|NCT00418379|453927008|FG000|Year 1|Withdrawal by Subject|7|||
126175744|NCT00418379|453927009|FG001|Year 1|Withdrawal by Subject|8|||
126175745|NCT00418379|453927010|FG002|Year 1|Withdrawal by Subject|5|||
126175746|NCT00418379|453927008|FG000|Year 1|Any other reason not above-mentioned|2|||
126175747|NCT00418379|453927009|FG001|Year 1|Any other reason not above-mentioned|5|||
126175748|NCT00418379|453927010|FG002|Year 1|Any other reason not above-mentioned|7|||
126175749|NCT00418379|453927008|FG000|Year 2|Adverse Event|5|||
126175750|NCT00418379|453927009|FG001|Year 2|Adverse Event|2|||
126175751|NCT00418379|453927010|FG002|Year 2|Adverse Event|1|||
126175752|NCT00418379|453927008|FG000|Year 2|Withdrawal by Subject|1|||
126175753|NCT00418379|453927009|FG001|Year 2|Withdrawal by Subject|1|||
126175754|NCT00418379|453927010|FG002|Year 2|Withdrawal by Subject|3|||
126175755|NCT00418379|453927008|FG000|Year 2|Any other reason not above-mentioned|2|||
126175756|NCT00418379|453927009|FG001|Year 2|Any other reason not above-mentioned|1|||
126175757|NCT00418379|453927010|FG002|Year 2|Any other reason not above-mentioned|6|||
126175758|NCT00418379|453927008|FG000|Year 3|Withdrawal by Subject|1|||
126175759|NCT00418379|453927009|FG001|Year 3|Withdrawal by Subject|1|||
126175760|NCT00418379|453927010|FG002|Year 3|Withdrawal by Subject|2|||
126175761|NCT00418379|453927008|FG000|Year 3|Any other reason not above-mentioned|2|||
126175762|NCT00418379|453927009|FG001|Year 3|Any other reason not above-mentioned|1|||
126175763|NCT00418379|453927010|FG002|Year 3|Any other reason not above-mentioned|1|||
126175764|NCT00418379|453927008|FG000|Year 4|Adverse Event|0|||
126175765|NCT00418379|453927009|FG001|Year 4|Adverse Event|1|||
126175766|NCT00418379|453927010|FG002|Year 4|Adverse Event|0|||
126175767|NCT00418379|453927008|FG000|Year 4|Withdrawal by Subject|2|||
126175768|NCT00418379|453927009|FG001|Year 4|Withdrawal by Subject|3|||
126175769|NCT00418379|453927010|FG002|Year 4|Withdrawal by Subject|2|||
126175770|NCT00418379|453927008|FG000|Year 4|Any other reason not above-mentioned|1|||
126175771|NCT00418379|453927009|FG001|Year 4|Any other reason not above-mentioned|1|||
126175772|NCT00418379|453927010|FG002|Year 4|Any other reason not above-mentioned|0|||
126175773|NCT00418379|453927008|FG000|Year 5|Adverse Event|0|||
126175774|NCT00418379|453927009|FG001|Year 5|Adverse Event|1|||
126175775|NCT00418379|453927010|FG002|Year 5|Adverse Event|0|||
126175776|NCT00418379|453927008|FG000|Year 5|Any other reason not above-mentioned|2|||
126175777|NCT00418379|453927009|FG001|Year 5|Any other reason not above-mentioned|4|||
125973961|NCT00729833|453193212|FG001|Overall Study|Unspecified Reasons|5|||
125973962|NCT00729833|453193213|FG002|Overall Study|Unspecified Reasons|5|||
126175778|NCT00418379|453927010|FG002|Year 5|Any other reason not above-mentioned|3|||
125973963|NCT00729833|453193214|FG003|Overall Study|Unspecified Reasons|1|||
126175779|NCT00843843|453927011|FG000|Overall Study|Physician Decision|1|||
126175780|NCT00843843|453927012|FG001|Overall Study|Physician Decision|1|||
126175781|NCT00843843|453927011|FG000|Overall Study|Protocol Violation|1|||
126175782|NCT00843843|453927012|FG001|Overall Study|Protocol Violation|1|||
126175783|NCT00565058|453927013|FG000|Overall Study|Adverse Event|1|||
126175784|NCT00565058|453927014|FG001|Overall Study|Adverse Event|0|||
126175785|NCT00830804|453927015|FG000|Overall Study|Lost to Follow-up|4|||
126175786|NCT00830804|453927015|FG000|Overall Study|Death|1|||
126175787|NCT00830804|453927015|FG000|Overall Study|Unable to get to clinic|7|||
126175788|NCT00830804|453927015|FG000|Overall Study|Consent withdrawn|2|||
126175789|NCT00830804|453927015|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
126175790|NCT00510068|453927016|FG000|Double-blind Period|Disease progression|98|||
126175791|NCT00510068|453927017|FG001|Double-blind Period|Disease progression|169|||
126175792|NCT00510068|453927016|FG000|Double-blind Period|Final primary analysis|52|||
126175793|NCT00510068|453927017|FG001|Double-blind Period|Final primary analysis|18|||
126175794|NCT00510068|453927016|FG000|Double-blind Period|Adverse Event|37|||
126175795|NCT00510068|453927017|FG001|Double-blind Period|Adverse Event|7|||
126175796|NCT00510068|453927016|FG000|Double-blind Period|Withdrawal by Subject|8|||
126175797|NCT00510068|453927017|FG001|Double-blind Period|Withdrawal by Subject|6|||
126175798|NCT00510068|453927016|FG000|Double-blind Period|Death|4|||
126175799|NCT00510068|453927017|FG001|Double-blind Period|Death|3|||
126175800|NCT00510068|453927016|FG000|Double-blind Period|Abnormal test result (s)|1|||
126175801|NCT00510068|453927017|FG001|Double-blind Period|Abnormal test result (s)|0|||
126175802|NCT00510068|453927016|FG000|Double-blind Period|Lost to Follow-up|1|||
126175803|NCT00510068|453927017|FG001|Double-blind Period|Lost to Follow-up|0|||
126175804|NCT00510068|453927016|FG000|Double-blind Period|Protocol Violation|6|||
126175805|NCT00510068|453927017|FG001|Double-blind Period|Protocol Violation|0|||
126175806|NCT00510068|453927016|FG000|Open-label Period|Disease Progression|124|||
126175807|NCT00510068|453927017|FG001|Open-label Period|Disease Progression|0|||
126175808|NCT00510068|453927016|FG000|Open-label Period|Adverse Event|46|||
126175809|NCT00510068|453927017|FG001|Open-label Period|Adverse Event|0|||
126175810|NCT00510068|453927016|FG000|Open-label Period|Withdrawal by Subject|21|||
126175811|NCT00510068|453927017|FG001|Open-label Period|Withdrawal by Subject|0|||
126175812|NCT00510068|453927016|FG000|Open-label Period|Administrative problems|17|||
126175813|NCT00510068|453927017|FG001|Open-label Period|Administrative problems|0|||
126175814|NCT00510068|453927016|FG000|Open-label Period|Death|7|||
126175815|NCT00510068|453927017|FG001|Open-label Period|Death|0|||
126175816|NCT00510068|453927016|FG000|Open-label Period|New cancer therapy|7|||
126175817|NCT00510068|453927017|FG001|Open-label Period|New cancer therapy|0|||
126175818|NCT00510068|453927016|FG000|Open-label Period|Protocol Violation|2|||
126175819|NCT00510068|453927017|FG001|Open-label Period|Protocol Violation|0|||
126175820|NCT00510068|453927016|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
126175821|NCT00510068|453927017|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
126175822|NCT01397448|453927018|FG000|Overall Study|Adverse Event|4|||
126175823|NCT01397448|453927019|FG001|Overall Study|Adverse Event|4|||
126175824|NCT01397448|453927020|FG002|Overall Study|Adverse Event|6|||
126175825|NCT01397448|453927018|FG000|Overall Study|Withdrawal by Subject|4|||
126175826|NCT01397448|453927019|FG001|Overall Study|Withdrawal by Subject|4|||
126175827|NCT01397448|453927020|FG002|Overall Study|Withdrawal by Subject|3|||
126175828|NCT01397448|453927018|FG000|Overall Study|Lack of Efficacy|2|||
126175829|NCT01397448|453927019|FG001|Overall Study|Lack of Efficacy|0|||
126175830|NCT01397448|453927020|FG002|Overall Study|Lack of Efficacy|5|||
126175831|NCT01397448|453927018|FG000|Overall Study|Other|8|||
126175832|NCT01397448|453927019|FG001|Overall Study|Other|7|||
126175833|NCT01397448|453927020|FG002|Overall Study|Other|4|||
126175834|NCT02180217|453927022|FG000|Overall Study|Adverse Event|3|||
126175835|NCT02180217|453927023|FG001|Overall Study|Adverse Event|2|||
126175836|NCT02180217|453927024|FG002|Overall Study|Adverse Event|22|||
126175837|NCT02180217|453927022|FG000|Overall Study|Death|1|||
126175838|NCT02180217|453927023|FG001|Overall Study|Death|1|||
126175839|NCT02180217|453927024|FG002|Overall Study|Death|0|||
126175840|NCT02180217|453927022|FG000|Overall Study|Withdrawal by Subject|1|||
126175841|NCT02180217|453927023|FG001|Overall Study|Withdrawal by Subject|1|||
126175842|NCT02180217|453927024|FG002|Overall Study|Withdrawal by Subject|4|||
126175843|NCT02180217|453927022|FG000|Overall Study|Subject/Guardian decision|5|||
126175844|NCT02180217|453927023|FG001|Overall Study|Subject/Guardian decision|3|||
126175845|NCT02180217|453927024|FG002|Overall Study|Subject/Guardian decision|6|||
126175846|NCT02180217|453927022|FG000|Overall Study|Physician Decision|1|||
126175847|NCT02180217|453927023|FG001|Overall Study|Physician Decision|1|||
126175848|NCT02180217|453927024|FG002|Overall Study|Physician Decision|6|||
126175849|NCT02180217|453927022|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126175850|NCT02180217|453927023|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126175851|NCT02180217|453927024|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126175852|NCT02475395|453927025|FG000|Overall Study|Protocol Violation|30|||
126175853|NCT02475395|453927026|FG001|Overall Study|Protocol Violation|3|||
126175854|NCT00995670|453927027|FG000|Overall Study|Failed arterial cannulation|1|||
126175855|NCT00995670|453927028|FG001|Overall Study|Failed arterial cannulation|0|||
126175856|NCT00995670|453927029|FG002|Overall Study|Failed arterial cannulation|3|||
126175857|NCT03784027|453927037|FG000|Period 1|Withdrawal by Subject|0|||
126175858|NCT03784027|453927038|FG001|Period 1|Withdrawal by Subject|1|||
126175859|NCT01297309|453929335|FG000|Overall Study|Eligibility failure|2|||
126175860|NCT01297309|453929335|FG000|Overall Study|Screen failure|2|||
126175861|NCT01297309|453929335|FG000|Overall Study|Withdrawal by Subject|5|||
126175862|NCT01297309|453929335|FG000|Overall Study|Adverse Event|1|||
126175863|NCT01297309|453929335|FG000|Overall Study|Investigator Decision|2|||
126175864|NCT01297309|453929335|FG000|Overall Study|Death|1|||
126175865|NCT01297309|453929335|FG000|Overall Study|Participant not entering extensionperiod|1|||
126175866|NCT03039738|453929336|FG000|Overall Study|Incomplete data sets|54|||
126175867|NCT03039738|453929337|FG001|Overall Study|Incomplete data sets|0|||
126175868|NCT03587584|453929338|FG000|Overall Study|SOC deviations|4|||
126175869|NCT03587584|453929339|FG001|Overall Study|SOC deviations|6|||
126175870|NCT03587584|453929338|FG000|Overall Study|Incomplete data|0|||
126175871|NCT03587584|453929339|FG001|Overall Study|Incomplete data|3|||
126175872|NCT00085917|453929345|FG000|Overall Study|Adverse Event|4|||
126175873|NCT00085917|453929346|FG001|Overall Study|Adverse Event|3|||
126175874|NCT01429077|453929347|FG000|Overall Study|Lost to Follow-up|0|||
126175875|NCT01429077|453929348|FG001|Overall Study|Lost to Follow-up|3|||
126175876|NCT03372603|453929349|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
126175877|NCT03372603|453929350|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
126175878|NCT03372603|453929349|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
126175879|NCT03372603|453929350|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
126175880|NCT02806947|453929351|FG000|Overall Study|Withdrawal by Subject|5|||
126175881|NCT02806947|453929352|FG001|Overall Study|Withdrawal by Subject|1|||
126175882|NCT01594333|453929360|FG000|Overall Study|Death|96|||
126175883|NCT01594333|453929361|FG001|Overall Study|Death|83|||
126175884|NCT01594333|453929360|FG000|Overall Study|Lost to Follow-up|5|||
126175885|NCT01594333|453929361|FG001|Overall Study|Lost to Follow-up|5|||
126175886|NCT01594333|453929360|FG000|Overall Study|Withdrawal by Subject|60|||
126175887|NCT01594333|453929361|FG001|Overall Study|Withdrawal by Subject|63|||
126175888|NCT03428997|453929371|FG000|Overall Study|Sponsor decision.|1|||
126175889|NCT03428997|453929371|FG000|Overall Study|Withdrawal by Subject|3|||
126175890|NCT03428997|453929371|FG000|Overall Study|Lost to Follow-up|4|||
126175891|NCT02563925|453929372|FG000|Overall Study|Withdrawal by Subject|2|||
126175892|NCT00400712|453929373|FG000|Overall Study|Death|1|||
126175893|NCT00400712|453929374|FG001|Overall Study|Death|0|||
126175894|NCT00400712|453929373|FG000|Overall Study|Withdrawal by Subject|11|||
126175895|NCT00400712|453929374|FG001|Overall Study|Withdrawal by Subject|12|||
126175896|NCT00400712|453929373|FG000|Overall Study|Physician Decision|5|||
126175897|NCT00400712|453929374|FG001|Overall Study|Physician Decision|4|||
126175898|NCT03691610|453929378|FG000|Overall Study|Adverse Event|0|||
126175899|NCT03691610|453929379|FG001|Overall Study|Adverse Event|1|||
126175900|NCT03691610|453929380|FG002|Overall Study|Adverse Event|0|||
126175901|NCT03691610|453929381|FG003|Overall Study|Adverse Event|0|||
126175902|NCT03691610|453929378|FG000|Overall Study|Protocol Deviation|15|||
126175903|NCT03691610|453929379|FG001|Overall Study|Protocol Deviation|8|||
126175904|NCT03691610|453929380|FG002|Overall Study|Protocol Deviation|1|||
126175905|NCT03691610|453929381|FG003|Overall Study|Protocol Deviation|2|||
126175906|NCT03691610|453929378|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
126175907|NCT03691610|453929379|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
126175908|NCT03691610|453929380|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
126175909|NCT03691610|453929381|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
126175910|NCT03691610|453929378|FG000|Overall Study|Lost to Follow-up|20|||
126175911|NCT03691610|453929379|FG001|Overall Study|Lost to Follow-up|11|||
126175912|NCT03691610|453929380|FG002|Overall Study|Lost to Follow-up|5|||
126175913|NCT03691610|453929381|FG003|Overall Study|Lost to Follow-up|2|||
126175914|NCT00622869|453929383|FG000|Overall Study|Subject Withdrew Consent|13|||
126175915|NCT00622869|453929384|FG001|Overall Study|Subject Withdrew Consent|17|||
126175916|NCT00622869|453929385|FG002|Overall Study|Subject Withdrew Consent|11|||
126175917|NCT00622869|453929383|FG000|Overall Study|Administrative Problems|11|||
126175918|NCT00622869|453929384|FG001|Overall Study|Administrative Problems|17|||
126175919|NCT00622869|453929385|FG002|Overall Study|Administrative Problems|13|||
126175920|NCT00622869|453929383|FG000|Overall Study|Death|12|||
126175921|NCT00622869|453929384|FG001|Overall Study|Death|15|||
126175922|NCT00622869|453929385|FG002|Overall Study|Death|10|||
126175923|NCT00622869|453929383|FG000|Overall Study|Lost to Follow-up|2|||
126175924|NCT00622869|453929384|FG001|Overall Study|Lost to Follow-up|4|||
126175925|NCT00622869|453929385|FG002|Overall Study|Lost to Follow-up|2|||
126175926|NCT00622869|453929383|FG000|Overall Study|Graft Loss|5|||
126175927|NCT00622869|453929384|FG001|Overall Study|Graft Loss|3|||
126175928|NCT00622869|453929385|FG002|Overall Study|Graft Loss|2|||
126175929|NCT00622869|453929383|FG000|Overall Study|Missing|0|||
126175930|NCT00622869|453929384|FG001|Overall Study|Missing|1|||
126175931|NCT00622869|453929385|FG002|Overall Study|Missing|1|||
126175932|NCT00645567|453929386|FG000|Overall Study|Adverse Event|1|||
126175933|NCT04664855|453929387|FG000|Overall Study|Withdrawal by Subject|0|||
126175934|NCT04664855|453929388|FG001|Overall Study|Withdrawal by Subject|2|||
126175935|NCT02219087|453929389|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
126175936|NCT02219087|453929390|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
126175937|NCT03454412|453929396|FG000|Baseline Assesment|Physician Decision|12|||
126175938|NCT03730194|453929397|FG000|First Stage Treatment|Withdrawal by Subject|1|||
126175939|NCT03730194|453929398|FG001|First Stage Treatment|Withdrawal by Subject|1|||
126175940|NCT03730194|453929399|FG002|First Stage Treatment|Withdrawal by Subject|0|||
126175941|NCT03730194|453929400|FG003|First Stage Treatment|Withdrawal by Subject|0|||
126175942|NCT03730194|453929401|FG004|First Stage Treatment|Withdrawal by Subject|0|||
126175943|NCT03730194|453929402|FG005|First Stage Treatment|Withdrawal by Subject|0|||
126175944|NCT03730194|453929397|FG000|First Stage Treatment|Protocol Violation|3|||
126175945|NCT03730194|453929398|FG001|First Stage Treatment|Protocol Violation|3|||
126175946|NCT03730194|453929399|FG002|First Stage Treatment|Protocol Violation|0|||
126175947|NCT03730194|453929400|FG003|First Stage Treatment|Protocol Violation|0|||
126175948|NCT03730194|453929401|FG004|First Stage Treatment|Protocol Violation|0|||
126175949|NCT03730194|453929402|FG005|First Stage Treatment|Protocol Violation|0|||
126175950|NCT00115765|453929403|FG000|Overall Study|Withdrawal by Subject|22|||
126175951|NCT00115765|453929404|FG001|Overall Study|Withdrawal by Subject|53|||
126175952|NCT00115765|453929405|FG002|Overall Study|Withdrawal by Subject|76|||
126175953|NCT00115765|453929406|FG003|Overall Study|Withdrawal by Subject|15|||
126175954|NCT00115765|453929403|FG000|Overall Study|Physician Decision|4|||
126175955|NCT00115765|453929404|FG001|Overall Study|Physician Decision|15|||
126175956|NCT00115765|453929405|FG002|Overall Study|Physician Decision|18|||
126175957|NCT00115765|453929406|FG003|Overall Study|Physician Decision|13|||
126175958|NCT00115765|453929403|FG000|Overall Study|Lost to Follow-up|3|||
126175959|NCT00115765|453929404|FG001|Overall Study|Lost to Follow-up|20|||
126175960|NCT00115765|453929405|FG002|Overall Study|Lost to Follow-up|18|||
126175961|NCT00115765|453929406|FG003|Overall Study|Lost to Follow-up|1|||
126175962|NCT00115765|453929403|FG000|Overall Study|Other|6|||
126175963|NCT00115765|453929404|FG001|Overall Study|Other|12|||
126175964|NCT00115765|453929405|FG002|Overall Study|Other|9|||
126175965|NCT00115765|453929406|FG003|Overall Study|Other|2|||
126175966|NCT03543358|453929407|FG000|Overall Study|Death|1|||
126175967|NCT03543358|453929408|FG001|Overall Study|Death|0|||
126175968|NCT03543358|453929407|FG000|Overall Study|Disease Progression|1|||
126175969|NCT03543358|453929408|FG001|Overall Study|Disease Progression|0|||
126175970|NCT03543358|453929407|FG000|Overall Study|Parent Study Closure|1|||
126175971|NCT03543358|453929408|FG001|Overall Study|Parent Study Closure|0|||
126175972|NCT00870818|453929411|FG000|Overall Study|Lost to Follow-up|3|||
126175973|NCT00870818|453929412|FG001|Overall Study|Lost to Follow-up|2|||
126175974|NCT00870818|453929413|FG002|Overall Study|Lost to Follow-up|1|||
126175975|NCT00870818|453929414|FG003|Overall Study|Lost to Follow-up|0|||
126175976|NCT00870818|453929415|FG004|Overall Study|Lost to Follow-up|0|||
126175977|NCT00870818|453929411|FG000|Overall Study|Withdrawal by Subject|0|||
126175978|NCT00870818|453929412|FG001|Overall Study|Withdrawal by Subject|0|||
126175979|NCT00870818|453929413|FG002|Overall Study|Withdrawal by Subject|1|||
126175980|NCT00870818|453929414|FG003|Overall Study|Withdrawal by Subject|2|||
126175981|NCT00870818|453929415|FG004|Overall Study|Withdrawal by Subject|0|||
126175982|NCT00870818|453929411|FG000|Overall Study|Terminated by sponsor|29|||
126175983|NCT00870818|453929412|FG001|Overall Study|Terminated by sponsor|70|||
126175984|NCT00870818|453929413|FG002|Overall Study|Terminated by sponsor|36|||
126175985|NCT00870818|453929414|FG003|Overall Study|Terminated by sponsor|36|||
126175986|NCT00870818|453929415|FG004|Overall Study|Terminated by sponsor|38|||
126175987|NCT00870818|453929411|FG000|Overall Study|Other|0|||
126175988|NCT00870818|453929412|FG001|Overall Study|Other|1|||
126175989|NCT00870818|453929413|FG002|Overall Study|Other|0|||
126175990|NCT00870818|453929414|FG003|Overall Study|Other|0|||
126175991|NCT00870818|453929415|FG004|Overall Study|Other|0|||
126175992|NCT00178464|453929416|FG000|Overall Study|Withdrawal by Subject|1|||
126175993|NCT00178464|453929416|FG000|Overall Study|Physician Decision|1|||
126175994|NCT02227108|453929417|FG000|Overall Study|Did not receive treatment|2|||
126175995|NCT02227108|453929417|FG000|Overall Study|Other|3|||
126175996|NCT02227108|453929417|FG000|Overall Study|Progressive disease|17|||
126175997|NCT02227108|453929417|FG000|Overall Study|Initiation of alternative therapy|2|||
126175998|NCT02227108|453929417|FG000|Overall Study|Investigator discretion|1|||
126175999|NCT02227108|453929417|FG000|Overall Study|Adverse Event|6|||
126176000|NCT04900038|453929418|FG000|Overall Study|Adverse Event|1|||
126176001|NCT04900038|453929419|FG001|Overall Study|Adverse Event|0|||
126176002|NCT04900038|453929420|FG002|Overall Study|Adverse Event|1|||
126176003|NCT04900038|453929421|FG003|Overall Study|Adverse Event|1|||
126176004|NCT04900038|453929418|FG000|Overall Study|Withdrawal by Subject|0|||
126176005|NCT04900038|453929419|FG001|Overall Study|Withdrawal by Subject|1|||
126176006|NCT04900038|453929420|FG002|Overall Study|Withdrawal by Subject|0|||
126176007|NCT04900038|453929421|FG003|Overall Study|Withdrawal by Subject|0|||
126176008|NCT04900038|453929418|FG000|Overall Study|Study terminated by sponsor|18|||
126176009|NCT04900038|453929419|FG001|Overall Study|Study terminated by sponsor|15|||
126176010|NCT04900038|453929420|FG002|Overall Study|Study terminated by sponsor|17|||
126176011|NCT04900038|453929421|FG003|Overall Study|Study terminated by sponsor|14|||
126176012|NCT04900038|453929418|FG000|Overall Study|Protocol Deviation|1|||
126176013|NCT04900038|453929419|FG001|Overall Study|Protocol Deviation|1|||
126176014|NCT04900038|453929420|FG002|Overall Study|Protocol Deviation|0|||
126176015|NCT04900038|453929421|FG003|Overall Study|Protocol Deviation|0|||
126176016|NCT04900038|453929418|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
126176017|NCT04900038|453929419|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
126176018|NCT04900038|453929420|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
126176019|NCT04900038|453929421|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
126176020|NCT04900038|453929418|FG000|Overall Study|Lost to Follow-up|0|||
126176021|NCT04900038|453929419|FG001|Overall Study|Lost to Follow-up|0|||
126176022|NCT04900038|453929420|FG002|Overall Study|Lost to Follow-up|0|||
126176023|NCT04900038|453929421|FG003|Overall Study|Lost to Follow-up|1|||
126176024|NCT02486952|453929422|FG000|Overall Study|Not Started Induction Therapy|3|||
126176025|NCT02486952|453929422|FG000|Overall Study|Adverse Event|1|||
126176026|NCT02486952|453929422|FG000|Overall Study|Death|15|||
126176027|NCT02486952|453929422|FG000|Overall Study|Lack of Efficacy|3|||
126176028|NCT02486952|453929422|FG000|Overall Study|Lost to Follow-up|26|||
126176029|NCT02486952|453929422|FG000|Overall Study|Other|2|||
126176030|NCT04111107|453929423|FG000|Overall Study|Withdrawal by Subject|6|||
126176031|NCT04111107|453929423|FG000|Overall Study|Declining Health|5|||
126176032|NCT01928485|453929424|FG000|Overall Study|Physician Decision|0|||
126176033|NCT01928485|453929425|FG001|Overall Study|Physician Decision|1|||
126176034|NCT03814590|453929426|FG000|Overall Study|Adverse Event|0|||
126176035|NCT03814590|453929427|FG001|Overall Study|Adverse Event|0|||
126176036|NCT03814590|453929428|FG002|Overall Study|Adverse Event|0|||
126176037|NCT03814590|453929429|FG003|Overall Study|Adverse Event|0|||
126176038|NCT03814590|453929430|FG004|Overall Study|Adverse Event|0|||
126176039|NCT03814590|453929431|FG005|Overall Study|Adverse Event|1|||
126176040|NCT03814590|453929432|FG006|Overall Study|Adverse Event|1|||
126176041|NCT03814590|453929433|FG007|Overall Study|Adverse Event|1|||
126176042|NCT03814590|453929434|FG008|Overall Study|Adverse Event|0|||
126176043|NCT03814590|453929435|FG009|Overall Study|Adverse Event|0|||
126176044|NCT03814590|453929436|FG010|Overall Study|Adverse Event|1|||
126176045|NCT03814590|453929437|FG011|Overall Study|Adverse Event|0|||
126176046|NCT03814590|453929438|FG012|Overall Study|Adverse Event|3|||
126176047|NCT03814590|453929439|FG013|Overall Study|Adverse Event|0|||
126176048|NCT03814590|453929426|FG000|Overall Study|Lost to Follow-up|0|||
126176049|NCT03814590|453929427|FG001|Overall Study|Lost to Follow-up|2|||
126176050|NCT03814590|453929428|FG002|Overall Study|Lost to Follow-up|1|||
126176051|NCT03814590|453929429|FG003|Overall Study|Lost to Follow-up|0|||
126176052|NCT03814590|453929430|FG004|Overall Study|Lost to Follow-up|1|||
126176053|NCT03814590|453929431|FG005|Overall Study|Lost to Follow-up|1|||
126176054|NCT03814590|453929432|FG006|Overall Study|Lost to Follow-up|1|||
126176055|NCT03814590|453929433|FG007|Overall Study|Lost to Follow-up|1|||
126176056|NCT03814590|453929434|FG008|Overall Study|Lost to Follow-up|0|||
126176057|NCT03814590|453929435|FG009|Overall Study|Lost to Follow-up|0|||
126176058|NCT03814590|453929436|FG010|Overall Study|Lost to Follow-up|1|||
126176059|NCT03814590|453929437|FG011|Overall Study|Lost to Follow-up|0|||
126176060|NCT03814590|453929438|FG012|Overall Study|Lost to Follow-up|0|||
126176061|NCT03814590|453929439|FG013|Overall Study|Lost to Follow-up|1|||
126176062|NCT03814590|453929426|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176063|NCT03814590|453929427|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176064|NCT03814590|453929428|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176065|NCT03814590|453929429|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176066|NCT03814590|453929430|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176067|NCT03814590|453929431|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176068|NCT03814590|453929432|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176069|NCT03814590|453929433|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176070|NCT03814590|453929434|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176071|NCT03814590|453929435|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
126176072|NCT03814590|453929436|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176073|NCT03814590|453929437|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176074|NCT03814590|453929438|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176075|NCT03814590|453929439|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126176076|NCT03814590|453929426|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126176077|NCT03814590|453929427|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126176078|NCT03814590|453929428|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126176079|NCT03814590|453929429|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126176080|NCT03814590|453929430|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126176081|NCT03814590|453929431|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
126176082|NCT03814590|453929432|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
126176083|NCT03814590|453929433|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
126176084|NCT03814590|453929434|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126176085|NCT03814590|453929435|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
126176086|NCT03814590|453929436|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
126176087|NCT03814590|453929437|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126176088|NCT03814590|453929438|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
126176089|NCT03814590|453929439|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
126176090|NCT03814590|453929426|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176091|NCT03814590|453929427|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176092|NCT03814590|453929428|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176093|NCT03814590|453929429|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176094|NCT03814590|453929430|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176095|NCT03814590|453929431|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176096|NCT03814590|453929432|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176097|NCT03814590|453929433|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126176098|NCT03814590|453929434|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176099|NCT03814590|453929435|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126176100|NCT03814590|453929436|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176101|NCT03814590|453929437|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176102|NCT03814590|453929438|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176103|NCT03814590|453929439|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126176104|NCT03814590|453929426|FG000|Overall Study|UNKNOWN REASON|0|||
126176105|NCT03814590|453929427|FG001|Overall Study|UNKNOWN REASON|0|||
126176106|NCT03814590|453929428|FG002|Overall Study|UNKNOWN REASON|0|||
126176107|NCT03814590|453929429|FG003|Overall Study|UNKNOWN REASON|0|||
126176108|NCT03814590|453929430|FG004|Overall Study|UNKNOWN REASON|0|||
126176109|NCT03814590|453929431|FG005|Overall Study|UNKNOWN REASON|0|||
126176110|NCT03814590|453929432|FG006|Overall Study|UNKNOWN REASON|0|||
126176111|NCT03814590|453929433|FG007|Overall Study|UNKNOWN REASON|1|||
126176112|NCT03814590|453929434|FG008|Overall Study|UNKNOWN REASON|0|||
126176113|NCT03814590|453929435|FG009|Overall Study|UNKNOWN REASON|0|||
126176114|NCT03814590|453929436|FG010|Overall Study|UNKNOWN REASON|0|||
126176115|NCT03814590|453929437|FG011|Overall Study|UNKNOWN REASON|0|||
126176116|NCT03814590|453929438|FG012|Overall Study|UNKNOWN REASON|0|||
126176117|NCT03814590|453929439|FG013|Overall Study|UNKNOWN REASON|0|||
126176118|NCT00567541|453929445|FG000|Overall Study|Adverse Event|0|||
126176119|NCT00567541|453929446|FG001|Overall Study|Adverse Event|1|||
126176120|NCT03519516|453929447|FG000|Overall Study|Adverse Event|0|||
126176121|NCT03519516|453929448|FG001|Overall Study|Adverse Event|1|||
126176122|NCT01890512|453929449|FG000|Overall Study|Physician Decision|1|||
126176123|NCT01890512|453929449|FG000|Overall Study|Withdrawal by Subject|1|||
126176124|NCT01890512|453929449|FG000|Overall Study|Protocol Violation|1|||
126176125|NCT01935336|453929450|FG000|Overall Study|Adverse Event|1|||
126176126|NCT01935336|453929451|FG001|Overall Study|Adverse Event|0|||
126176127|NCT01935336|453929452|FG002|Overall Study|Adverse Event|0|||
126176128|NCT01935336|453929453|FG003|Overall Study|Adverse Event|0|||
126176129|NCT01935336|453929450|FG000|Overall Study|Progressive disease|5|||
126176130|NCT01935336|453929451|FG001|Overall Study|Progressive disease|3|||
126176131|NCT01935336|453929452|FG002|Overall Study|Progressive disease|47|||
126176132|NCT01935336|453929453|FG003|Overall Study|Progressive disease|66|||
126176133|NCT01529385|453929454|FG000|Overall Study|Lost to Follow-up|2|||
126176134|NCT01529385|453929455|FG001|Overall Study|Lost to Follow-up|1|||
126176135|NCT00964158|453929458|FG000|Overall Study|Lost to Follow-up|0|||
126176136|NCT00964158|453929459|FG001|Overall Study|Lost to Follow-up|1|||
126176137|NCT00964158|453929460|FG002|Overall Study|Lost to Follow-up|2|||
126176138|NCT00964158|453929458|FG000|Overall Study|Withdrawal by Subject|0|||
126176139|NCT00964158|453929459|FG001|Overall Study|Withdrawal by Subject|0|||
126176140|NCT00964158|453929460|FG002|Overall Study|Withdrawal by Subject|6|||
126176141|NCT01763866|453929467|FG000|Overall Study|Withdrawal by Subject|2|||
126176142|NCT01763866|453929468|FG001|Overall Study|Withdrawal by Subject|1|||
125973964|NCT04403698|453193216|FG000|Overall Study|Adverse Event|1|||
125973965|NCT04403698|453193217|FG001|Overall Study|Adverse Event|1|||
125973966|NCT04403698|453193216|FG000|Overall Study|Lost to Follow-up|1|||
125973967|NCT04403698|453193217|FG001|Overall Study|Lost to Follow-up|0|||
125973968|NCT04403698|453193216|FG000|Overall Study|Protocol Violation|0|||
125973969|NCT04403698|453193217|FG001|Overall Study|Protocol Violation|1|||
125973970|NCT03152552|453193218|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
126176143|NCT01763866|453929469|FG002|Overall Study|Withdrawal by Subject|4|||
126176144|NCT01763866|453929470|FG003|Overall Study|Withdrawal by Subject|0|||
126176145|NCT01763866|453929471|FG004|Overall Study|Withdrawal by Subject|0|||
126176146|NCT01763866|453929472|FG005|Overall Study|Withdrawal by Subject|3|||
126176147|NCT01763866|453929473|FG006|Overall Study|Withdrawal by Subject|4|||
126176148|NCT01763866|453929474|FG007|Overall Study|Withdrawal by Subject|0|||
126176149|NCT01763866|453929475|FG008|Overall Study|Withdrawal by Subject|1|||
126176150|NCT01763866|453929476|FG009|Overall Study|Withdrawal by Subject|1|||
126176151|NCT01763866|453929477|FG010|Overall Study|Withdrawal by Subject|2|||
126176152|NCT01763866|453929478|FG011|Overall Study|Withdrawal by Subject|2|||
126176153|NCT01763866|453929479|FG012|Overall Study|Withdrawal by Subject|2|||
126176154|NCT01763866|453929480|FG013|Overall Study|Withdrawal by Subject|0|||
126176155|NCT01763866|453929481|FG014|Overall Study|Withdrawal by Subject|6|||
126176156|NCT01763866|453929482|FG015|Overall Study|Withdrawal by Subject|3|||
126176157|NCT01763866|453929483|FG016|Overall Study|Withdrawal by Subject|0|||
126176158|NCT01763866|453929484|FG017|Overall Study|Withdrawal by Subject|1|||
126176159|NCT01763866|453929485|FG018|Overall Study|Withdrawal by Subject|1|||
126176160|NCT01763866|453929486|FG019|Overall Study|Withdrawal by Subject|1|||
126176161|NCT01763866|453929487|FG020|Overall Study|Withdrawal by Subject|2|||
126176162|NCT01763866|453929488|FG021|Overall Study|Withdrawal by Subject|1|||
126176163|NCT01763866|453929489|FG022|Overall Study|Withdrawal by Subject|2|||
126176164|NCT01763866|453929490|FG023|Overall Study|Withdrawal by Subject|1|||
126176165|NCT01763866|453929467|FG000|Overall Study|Decision by sponsor|0|||
126176166|NCT01763866|453929468|FG001|Overall Study|Decision by sponsor|0|||
126176167|NCT01763866|453929469|FG002|Overall Study|Decision by sponsor|1|||
126176168|NCT01763866|453929470|FG003|Overall Study|Decision by sponsor|0|||
126176169|NCT01763866|453929471|FG004|Overall Study|Decision by sponsor|2|||
126176170|NCT01763866|453929472|FG005|Overall Study|Decision by sponsor|0|||
126176171|NCT01763866|453929473|FG006|Overall Study|Decision by sponsor|2|||
126176172|NCT01763866|453929474|FG007|Overall Study|Decision by sponsor|0|||
126176173|NCT01763866|453929475|FG008|Overall Study|Decision by sponsor|2|||
126176174|NCT01763866|453929476|FG009|Overall Study|Decision by sponsor|0|||
126176175|NCT01763866|453929477|FG010|Overall Study|Decision by sponsor|6|||
126176176|NCT01763866|453929478|FG011|Overall Study|Decision by sponsor|0|||
126176177|NCT01763866|453929479|FG012|Overall Study|Decision by sponsor|1|||
126176178|NCT01763866|453929480|FG013|Overall Study|Decision by sponsor|0|||
126176179|NCT01763866|453929481|FG014|Overall Study|Decision by sponsor|5|||
126176180|NCT01763866|453929482|FG015|Overall Study|Decision by sponsor|0|||
126176181|NCT01763866|453929483|FG016|Overall Study|Decision by sponsor|0|||
126176182|NCT01763866|453929484|FG017|Overall Study|Decision by sponsor|0|||
126176183|NCT01763866|453929485|FG018|Overall Study|Decision by sponsor|4|||
126176184|NCT01763866|453929486|FG019|Overall Study|Decision by sponsor|0|||
126176185|NCT01763866|453929487|FG020|Overall Study|Decision by sponsor|2|||
126176186|NCT01763866|453929488|FG021|Overall Study|Decision by sponsor|0|||
126176187|NCT01763866|453929489|FG022|Overall Study|Decision by sponsor|1|||
126176188|NCT01763866|453929490|FG023|Overall Study|Decision by sponsor|0|||
126176189|NCT01763866|453929467|FG000|Overall Study|Lost to Follow-up|0|||
126176190|NCT01763866|453929468|FG001|Overall Study|Lost to Follow-up|0|||
126176191|NCT01763866|453929469|FG002|Overall Study|Lost to Follow-up|0|||
126176192|NCT01763866|453929470|FG003|Overall Study|Lost to Follow-up|0|||
126176193|NCT01763866|453929471|FG004|Overall Study|Lost to Follow-up|0|||
126176194|NCT01763866|453929472|FG005|Overall Study|Lost to Follow-up|0|||
126176195|NCT01763866|453929473|FG006|Overall Study|Lost to Follow-up|1|||
126176196|NCT01763866|453929474|FG007|Overall Study|Lost to Follow-up|0|||
126176197|NCT01763866|453929475|FG008|Overall Study|Lost to Follow-up|0|||
126176198|NCT01763866|453929476|FG009|Overall Study|Lost to Follow-up|0|||
126176199|NCT01763866|453929477|FG010|Overall Study|Lost to Follow-up|0|||
126176200|NCT01763866|453929478|FG011|Overall Study|Lost to Follow-up|0|||
126176201|NCT01763866|453929479|FG012|Overall Study|Lost to Follow-up|1|||
126176202|NCT01763866|453929480|FG013|Overall Study|Lost to Follow-up|0|||
126176203|NCT01763866|453929481|FG014|Overall Study|Lost to Follow-up|1|||
126176204|NCT01763866|453929482|FG015|Overall Study|Lost to Follow-up|0|||
126176205|NCT01763866|453929483|FG016|Overall Study|Lost to Follow-up|0|||
126176206|NCT01763866|453929484|FG017|Overall Study|Lost to Follow-up|0|||
126176207|NCT01763866|453929485|FG018|Overall Study|Lost to Follow-up|1|||
126176208|NCT01763866|453929486|FG019|Overall Study|Lost to Follow-up|1|||
126176209|NCT01763866|453929487|FG020|Overall Study|Lost to Follow-up|0|||
126176210|NCT01763866|453929488|FG021|Overall Study|Lost to Follow-up|0|||
126176211|NCT01763866|453929489|FG022|Overall Study|Lost to Follow-up|0|||
126176212|NCT01763866|453929490|FG023|Overall Study|Lost to Follow-up|1|||
126176213|NCT01763866|453929467|FG000|Overall Study|Death|0|||
126176214|NCT01763866|453929468|FG001|Overall Study|Death|0|||
126176215|NCT01763866|453929469|FG002|Overall Study|Death|0|||
126176216|NCT01763866|453929470|FG003|Overall Study|Death|0|||
126176217|NCT01763866|453929471|FG004|Overall Study|Death|0|||
126176218|NCT01763866|453929472|FG005|Overall Study|Death|0|||
126176219|NCT01763866|453929473|FG006|Overall Study|Death|0|||
126176220|NCT01763866|453929474|FG007|Overall Study|Death|0|||
126176221|NCT01763866|453929475|FG008|Overall Study|Death|0|||
126176222|NCT01763866|453929476|FG009|Overall Study|Death|0|||
126176223|NCT01763866|453929477|FG010|Overall Study|Death|0|||
126176224|NCT01763866|453929478|FG011|Overall Study|Death|0|||
126176225|NCT01763866|453929479|FG012|Overall Study|Death|0|||
126176226|NCT01763866|453929480|FG013|Overall Study|Death|0|||
126176227|NCT01763866|453929481|FG014|Overall Study|Death|0|||
126176228|NCT01763866|453929482|FG015|Overall Study|Death|0|||
126176229|NCT01763866|453929483|FG016|Overall Study|Death|1|||
126176230|NCT01763866|453929484|FG017|Overall Study|Death|0|||
126176231|NCT01763866|453929485|FG018|Overall Study|Death|0|||
126176232|NCT01763866|453929486|FG019|Overall Study|Death|0|||
126176233|NCT01763866|453929487|FG020|Overall Study|Death|0|||
126176234|NCT01763866|453929488|FG021|Overall Study|Death|0|||
126176235|NCT01763866|453929489|FG022|Overall Study|Death|0|||
126176236|NCT01763866|453929490|FG023|Overall Study|Death|0|||
126176237|NCT03245723|453929493|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
126176238|NCT03245723|453929494|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
126176239|NCT03245723|453929493|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
126176240|NCT03245723|453929494|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
126176241|NCT03245723|453929493|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
126176242|NCT03245723|453929494|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
126176243|NCT03245723|453929493|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
126176244|NCT03245723|453929494|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
126176245|NCT03337139|453929495|FG000|Phase I|Withdrawal by Subject|10|||
126176246|NCT03337139|453929496|FG001|Phase I|Withdrawal by Subject|0|||
126176247|NCT02554253|453929497|FG000|Overall Study|ineligible after enrollment|1|||
126176248|NCT02554253|453929498|FG001|Overall Study|ineligible after enrollment|0|||
126176249|NCT02554253|453929497|FG000|Overall Study|converted to transcatheter procedure|0|||
126176250|NCT02554253|453929498|FG001|Overall Study|converted to transcatheter procedure|1|||
126176251|NCT02554253|453929497|FG000|Overall Study|received both drugs|0|||
126176252|NCT02554253|453929498|FG001|Overall Study|received both drugs|1|||
126176253|NCT03288493|453929499|FG000|Overall Study|Withdrawal by Subject|4|||
126176254|NCT03288493|453929500|FG001|Overall Study|Withdrawal by Subject|0|||
126176255|NCT03288493|453929501|FG002|Overall Study|Withdrawal by Subject|0|||
126176256|NCT03288493|453929502|FG003|Overall Study|Withdrawal by Subject|0|||
126176257|NCT03288493|453929503|FG004|Overall Study|Withdrawal by Subject|0|||
126176258|NCT03288493|453929504|FG005|Overall Study|Withdrawal by Subject|2|||
126176259|NCT03288493|453929505|FG006|Overall Study|Withdrawal by Subject|0|||
126176260|NCT03288493|453929499|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
126176261|NCT03288493|453929500|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
126176262|NCT03288493|453929501|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
126176263|NCT03288493|453929502|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
126176264|NCT03288493|453929503|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
126176265|NCT03288493|453929504|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
126176266|NCT03288493|453929505|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
126176267|NCT03288493|453929499|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
126176268|NCT03288493|453929500|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
126176269|NCT03288493|453929501|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
126176270|NCT03288493|453929502|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
126176271|NCT03288493|453929503|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
126176272|NCT03288493|453929504|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
126176273|NCT03288493|453929505|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
126176274|NCT03288493|453929499|FG000|Overall Study|Death|2|||
126176275|NCT03288493|453929500|FG001|Overall Study|Death|0|||
126176276|NCT03288493|453929501|FG002|Overall Study|Death|0|||
126176277|NCT03288493|453929502|FG003|Overall Study|Death|0|||
126176278|NCT03288493|453929503|FG004|Overall Study|Death|0|||
126176279|NCT03288493|453929504|FG005|Overall Study|Death|0|||
126176280|NCT03288493|453929505|FG006|Overall Study|Death|0|||
126176281|NCT03288493|453929499|FG000|Overall Study|other reason not listed above|2|||
126176282|NCT03288493|453929500|FG001|Overall Study|other reason not listed above|0|||
126176283|NCT03288493|453929501|FG002|Overall Study|other reason not listed above|0|||
126176284|NCT03288493|453929502|FG003|Overall Study|other reason not listed above|0|||
126176285|NCT03288493|453929503|FG004|Overall Study|other reason not listed above|0|||
126176286|NCT03288493|453929504|FG005|Overall Study|other reason not listed above|0|||
126176287|NCT03288493|453929505|FG006|Overall Study|other reason not listed above|0|||
126176288|NCT01736254|453929507|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
126176289|NCT01736254|453929507|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
126176290|NCT02559206|453929508|FG000|Overall Study|Adverse Event|0|||
126176291|NCT02559206|453929509|FG001|Overall Study|Adverse Event|4|||
126176292|NCT02559206|453929510|FG002|Overall Study|Adverse Event|1|||
126176293|NCT02559206|453929511|FG003|Overall Study|Adverse Event|5|||
126176294|NCT02559206|453929512|FG004|Overall Study|Adverse Event|3|||
126176295|NCT02559206|453929513|FG005|Overall Study|Adverse Event|0|||
126176296|NCT02559206|453929514|FG006|Overall Study|Adverse Event|1|||
126176297|NCT02559206|453929515|FG007|Overall Study|Adverse Event|0|||
126176298|NCT02559206|453929508|FG000|Overall Study|Protocol Violation|1|||
126176299|NCT02559206|453929509|FG001|Overall Study|Protocol Violation|0|||
126176300|NCT02559206|453929510|FG002|Overall Study|Protocol Violation|1|||
126176301|NCT02559206|453929511|FG003|Overall Study|Protocol Violation|0|||
126176302|NCT02559206|453929512|FG004|Overall Study|Protocol Violation|0|||
126176303|NCT02559206|453929513|FG005|Overall Study|Protocol Violation|2|||
126176304|NCT02559206|453929514|FG006|Overall Study|Protocol Violation|0|||
126176305|NCT02559206|453929515|FG007|Overall Study|Protocol Violation|0|||
126176306|NCT02559206|453929508|FG000|Overall Study|Withdrawal by Subject|3|||
126176307|NCT02559206|453929509|FG001|Overall Study|Withdrawal by Subject|3|||
126176308|NCT02559206|453929510|FG002|Overall Study|Withdrawal by Subject|1|||
126176309|NCT02559206|453929511|FG003|Overall Study|Withdrawal by Subject|3|||
126176310|NCT02559206|453929512|FG004|Overall Study|Withdrawal by Subject|5|||
126176311|NCT02559206|453929513|FG005|Overall Study|Withdrawal by Subject|4|||
126176312|NCT02559206|453929514|FG006|Overall Study|Withdrawal by Subject|1|||
126176313|NCT02559206|453929515|FG007|Overall Study|Withdrawal by Subject|2|||
126176314|NCT02559206|453929508|FG000|Overall Study|Lost to Follow-up|3|||
126176315|NCT02559206|453929509|FG001|Overall Study|Lost to Follow-up|5|||
126176316|NCT02559206|453929510|FG002|Overall Study|Lost to Follow-up|3|||
126176317|NCT02559206|453929511|FG003|Overall Study|Lost to Follow-up|3|||
126176318|NCT02559206|453929512|FG004|Overall Study|Lost to Follow-up|2|||
126176319|NCT02559206|453929513|FG005|Overall Study|Lost to Follow-up|5|||
126176320|NCT02559206|453929514|FG006|Overall Study|Lost to Follow-up|1|||
126176321|NCT02559206|453929515|FG007|Overall Study|Lost to Follow-up|4|||
126176322|NCT02559206|453929508|FG000|Overall Study|Lack of Efficacy|1|||
126176323|NCT02559206|453929509|FG001|Overall Study|Lack of Efficacy|0|||
126176324|NCT02559206|453929510|FG002|Overall Study|Lack of Efficacy|3|||
126176325|NCT02559206|453929511|FG003|Overall Study|Lack of Efficacy|2|||
126176326|NCT02559206|453929512|FG004|Overall Study|Lack of Efficacy|2|||
126176327|NCT02559206|453929513|FG005|Overall Study|Lack of Efficacy|3|||
126176328|NCT02559206|453929514|FG006|Overall Study|Lack of Efficacy|3|||
126176329|NCT02559206|453929515|FG007|Overall Study|Lack of Efficacy|3|||
126176330|NCT02559206|453929508|FG000|Overall Study|Other Not Specified|0|||
126176331|NCT02559206|453929509|FG001|Overall Study|Other Not Specified|0|||
126176332|NCT02559206|453929510|FG002|Overall Study|Other Not Specified|0|||
126176333|NCT02559206|453929511|FG003|Overall Study|Other Not Specified|1|||
126176334|NCT02559206|453929512|FG004|Overall Study|Other Not Specified|0|||
126176335|NCT02559206|453929513|FG005|Overall Study|Other Not Specified|0|||
126176336|NCT02559206|453929514|FG006|Overall Study|Other Not Specified|0|||
126176337|NCT02559206|453929515|FG007|Overall Study|Other Not Specified|0|||
126176338|NCT01561560|453929516|FG000|First Two Weeks of Wear|Time/job conflict|0|||
126176339|NCT01561560|453929517|FG001|First Two Weeks of Wear|Time/job conflict|1|||
126176340|NCT01561560|453929516|FG000|First Two Weeks of Wear|Adverse Event|0|||
126176341|NCT01561560|453929517|FG001|First Two Weeks of Wear|Adverse Event|1|||
126176342|NCT01561560|453929516|FG000|Second Two Weeks of Wear|Adverse Event|0|||
126176343|NCT01561560|453929517|FG001|Second Two Weeks of Wear|Adverse Event|1|||
126176344|NCT00646113|453930892|FG000|Overall Study|Lost to Follow-up|5|||
126176345|NCT00646113|453930892|FG000|Overall Study|Adverse Event|3|||
126176346|NCT02109744|453930893|FG000|Overall Study|Death|1|||
126176347|NCT02109744|453930894|FG001|Overall Study|Death|1|||
126176348|NCT02109744|453930893|FG000|Overall Study|no marrow exam|1|||
126176349|NCT02109744|453930894|FG001|Overall Study|no marrow exam|0|||
126176350|NCT04095442|453930895|FG000|Overall Study|Lost to Follow-up|0|||
126176351|NCT04095442|453930896|FG001|Overall Study|Lost to Follow-up|1|||
126176352|NCT04095442|453930895|FG000|Overall Study|Screen failure|1|||
126176353|NCT04095442|453930896|FG001|Overall Study|Screen failure|0|||
126176354|NCT03947255|453930899|FG000|Overall Study|Study Closure by Sponsor|2|||
126176355|NCT03947255|453930900|FG001|Overall Study|Study Closure by Sponsor|2|||
126176356|NCT03947255|453930899|FG000|Overall Study|Withdrawal by Subject|2|||
126176357|NCT03947255|453930900|FG001|Overall Study|Withdrawal by Subject|2|||
126176358|NCT03947255|453930899|FG000|Overall Study|Lost to Follow-up|2|||
126176359|NCT03947255|453930900|FG001|Overall Study|Lost to Follow-up|0|||
126176360|NCT03947255|453930899|FG000|Overall Study|Death|0|||
126176361|NCT03947255|453930900|FG001|Overall Study|Death|2|||
126176362|NCT04656418|453930901|FG000|Overall Study|Withdrawal by Subject|1|||
126176363|NCT04656418|453930902|FG001|Overall Study|Withdrawal by Subject|3|||
126176364|NCT03287245|453930903|FG000|Overall Study|Study terminated by sponsor|3|||
126176365|NCT03287245|453930904|FG001|Overall Study|Study terminated by sponsor|0|||
126176366|NCT03287245|453930905|FG002|Overall Study|Study terminated by sponsor|3|||
126176367|NCT03287245|453930906|FG003|Overall Study|Study terminated by sponsor|1|||
126176368|NCT03287245|453930903|FG000|Overall Study|Adverse Event|1|||
126176369|NCT03287245|453930904|FG001|Overall Study|Adverse Event|0|||
126176370|NCT03287245|453930905|FG002|Overall Study|Adverse Event|0|||
126176371|NCT03287245|453930906|FG003|Overall Study|Adverse Event|0|||
126176372|NCT03287245|453930903|FG000|Overall Study|Withdrawal by Subject|8|||
126176373|NCT03287245|453930904|FG001|Overall Study|Withdrawal by Subject|3|||
126176374|NCT03287245|453930905|FG002|Overall Study|Withdrawal by Subject|3|||
126176375|NCT03287245|453930906|FG003|Overall Study|Withdrawal by Subject|0|||
126176376|NCT03287245|453930903|FG000|Overall Study|Physician Decision|3|||
126176377|NCT03287245|453930904|FG001|Overall Study|Physician Decision|2|||
126176378|NCT03287245|453930905|FG002|Overall Study|Physician Decision|0|||
126176379|NCT03287245|453930906|FG003|Overall Study|Physician Decision|0|||
126176380|NCT02701192|453930907|FG000|Overall Study|Protocol Violation|2|||
126176381|NCT02701192|453930907|FG000|Overall Study|Lost to Follow-up|4|||
126176382|NCT00949910|453930908|FG000|Overall Study|Progressive Disease|3750|||
126176383|NCT00949910|453930908|FG000|Overall Study|Symptomatic Deterioration|1088|||
126176384|NCT00949910|453930908|FG000|Overall Study|Lost to Follow-up|100|||
126176385|NCT00949910|453930908|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
126176386|NCT00949910|453930908|FG000|Overall Study|Participant Refusal|390|||
126176387|NCT00949910|453930908|FG000|Overall Study|Death Due to Malignant Disease|456|||
126176388|NCT00949910|453930908|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
126176389|NCT00949910|453930908|FG000|Overall Study|Death Due to Adverse Event|115|||
126176390|NCT00949910|453930908|FG000|Overall Study|Death Due to Toxicity|3|||
126176391|NCT00949910|453930908|FG000|Overall Study|Death from Unknown Cause|5|||
126176392|NCT00949910|453930908|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
126176393|NCT00949910|453930908|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
126176394|NCT00949910|453930908|FG000|Overall Study|Switched to Commercial Treatment|4|||
126176395|NCT00949910|453930908|FG000|Overall Study|Violation of Eligibility|23|||
126176396|NCT00949910|453930908|FG000|Overall Study|Logistical Reasons|13|||
126176397|NCT00949910|453930908|FG000|Overall Study|Non-Compliance|10|||
126176398|NCT00949910|453930908|FG000|Overall Study|Prolonged Dosing Interruption|4|||
126176399|NCT00949910|453930908|FG000|Overall Study|Adverse Event|83|||
126176400|NCT00949910|453930908|FG000|Overall Study|Serious Adverse Event|6|||
126176401|NCT00949910|453930908|FG000|Overall Study|Physician/Participant Decision|7|||
126176402|NCT00949910|453930908|FG000|Overall Study|Other|4|||
126176403|NCT00949910|453930908|FG000|Overall Study|No Data|9|||
126176404|NCT03097614|453930909|FG000|Overall Study|Adverse Event|3|||
126176405|NCT02150213|453930910|FG000|Overall Study|Lost to Follow-up|1|||
126176406|NCT02150213|453930910|FG000|Overall Study|Withdrawal by Subject|1|||
126176407|NCT02678312|453930914|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
126176408|NCT02678312|453930915|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
126176409|NCT02678312|453930916|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
126176410|NCT02678312|453930917|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
126176411|NCT02678312|453930918|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
126176412|NCT02678312|453930914|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
126176413|NCT02678312|453930915|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
126176414|NCT02678312|453930916|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
126176415|NCT02678312|453930917|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
126176416|NCT02678312|453930918|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
126176417|NCT02678312|453930914|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
126176418|NCT02678312|453930915|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
126176419|NCT02678312|453930916|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
126176420|NCT02678312|453930917|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
126176421|NCT02678312|453930918|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
126176422|NCT02678312|453930914|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
126176423|NCT02678312|453930915|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
126176424|NCT02678312|453930916|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
126176425|NCT02678312|453930917|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
126176426|NCT02678312|453930918|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
126176427|NCT02678312|453930914|FG000|Part 2 Double Blind Epoch|Death|0|||
126176428|NCT02678312|453930915|FG001|Part 2 Double Blind Epoch|Death|0|||
126176429|NCT02678312|453930916|FG002|Part 2 Double Blind Epoch|Death|0|||
126176430|NCT02678312|453930917|FG003|Part 2 Double Blind Epoch|Death|8|||
126176431|NCT02678312|453930918|FG004|Part 2 Double Blind Epoch|Death|12|||
126176432|NCT02678312|453930914|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
126176433|NCT02678312|453930915|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
126176434|NCT02678312|453930916|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
126176435|NCT02678312|453930917|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
126176436|NCT02678312|453930918|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
126176437|NCT02678312|453930914|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
126176438|NCT02678312|453930915|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
126176439|NCT02678312|453930916|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
126176440|NCT02678312|453930917|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
126176441|NCT02678312|453930918|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
126176442|NCT02678312|453930914|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
126176443|NCT02678312|453930915|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
126176444|NCT02678312|453930916|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
126176445|NCT02678312|453930917|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
126176446|NCT02678312|453930918|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
126176447|NCT02254551|453930924|FG000|Dose Escalation|Physician Decision|1|||
126176448|NCT02254551|453930924|FG000|Dose Escalation|Dose-limiting toxicity|2|||
126176449|NCT02716194|453930927|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
126176450|NCT02716194|453930928|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
126176451|NCT02716194|453930929|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
126176452|NCT00971425|453930933|FG000|Overall Study|Adverse Event|1|||
126176453|NCT00971425|453930934|FG001|Overall Study|Adverse Event|1|||
126199924|NCT00089505|454017801|FG001|Overall Study|Physician Decision|0|||
126176454|NCT00971425|453930933|FG000|Overall Study|Withdrawal by Subject|0|||
126176455|NCT00971425|453930934|FG001|Overall Study|Withdrawal by Subject|1|||
126176456|NCT02759562|453930942|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
126176457|NCT02759562|453930943|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
126176458|NCT02759562|453930942|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
126176459|NCT02759562|453930943|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
126176460|NCT00387348|453930944|FG000|Overall Study|Death|1|||
126176461|NCT00387348|453930945|FG001|Overall Study|Death|1|||
126176462|NCT00387348|453930946|FG002|Overall Study|Death|0|||
126176463|NCT00387348|453930944|FG000|Overall Study|Physician Decision|1|||
126176464|NCT00387348|453930945|FG001|Overall Study|Physician Decision|0|||
126176465|NCT00387348|453930946|FG002|Overall Study|Physician Decision|1|||
126176466|NCT00387348|453930944|FG000|Overall Study|Withdrawal by Subject|0|||
126176467|NCT00387348|453930945|FG001|Overall Study|Withdrawal by Subject|2|||
126176468|NCT00387348|453930946|FG002|Overall Study|Withdrawal by Subject|2|||
126176469|NCT00387348|453930944|FG000|Overall Study|Adverse Event|1|||
126176470|NCT00387348|453930945|FG001|Overall Study|Adverse Event|0|||
126176471|NCT00387348|453930946|FG002|Overall Study|Adverse Event|1|||
126176472|NCT00225147|453930947|FG000|Open-label Phase|Lost to Follow-up|0|||
126176473|NCT00225147|453930948|FG001|Open-label Phase|Lost to Follow-up|0|||
126176474|NCT00225147|453930949|FG002|Open-label Phase|Lost to Follow-up|0|||
126176475|NCT00225147|453930950|FG003|Open-label Phase|Lost to Follow-up|4|||
126176476|NCT00225147|453930947|FG000|Open-label Phase|Withdrawal by Subject|0|||
126176477|NCT00225147|453930948|FG001|Open-label Phase|Withdrawal by Subject|0|||
126176478|NCT00225147|453930949|FG002|Open-label Phase|Withdrawal by Subject|0|||
126176479|NCT00225147|453930950|FG003|Open-label Phase|Withdrawal by Subject|6|||
126176480|NCT02685995|453930953|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
126176481|NCT02685995|453930954|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
126176482|NCT03625141|453930955|FG000|Overall Study|Adverse Event|0|||
126176483|NCT03625141|453930956|FG001|Overall Study|Adverse Event|2|||
126176484|NCT03625141|453930955|FG000|Overall Study|Study Terminated By Sponsor|1|||
126176485|NCT03625141|453930956|FG001|Overall Study|Study Terminated By Sponsor|13|||
126176486|NCT03625141|453930955|FG000|Overall Study|Withdrawal by Subject|3|||
126176487|NCT03625141|453930956|FG001|Overall Study|Withdrawal by Subject|0|||
126176488|NCT03625141|453930955|FG000|Overall Study|Withdrawal Of Consent|0|||
126176489|NCT03625141|453930956|FG001|Overall Study|Withdrawal Of Consent|1|||
126176490|NCT03625141|453930955|FG000|Overall Study|Death|11|||
126176491|NCT03625141|453930956|FG001|Overall Study|Death|47|||
126176492|NCT03625141|453930955|FG000|Overall Study|Progressive Disease|0|||
126176493|NCT03625141|453930956|FG001|Overall Study|Progressive Disease|2|||
126176494|NCT00868166|453930958|FG000|Overall Study|Death|58|||
126176495|NCT00868166|453930959|FG001|Overall Study|Death|65|||
126176496|NCT00868166|453930958|FG000|Overall Study|Withdrawal by Subject|33|||
126176497|NCT00868166|453930959|FG001|Overall Study|Withdrawal by Subject|25|||
126176498|NCT00868166|453930958|FG000|Overall Study|Protocol Violation|1|||
126176499|NCT00868166|453930959|FG001|Overall Study|Protocol Violation|0|||
126176500|NCT00868166|453930958|FG000|Overall Study|Lost to Follow-up|1|||
126176501|NCT00868166|453930959|FG001|Overall Study|Lost to Follow-up|3|||
126176502|NCT00868166|453930958|FG000|Overall Study|Adverse Event|9|||
126176503|NCT00868166|453930959|FG001|Overall Study|Adverse Event|10|||
126176504|NCT00868166|453930958|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
126176505|NCT00868166|453930959|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
126176506|NCT00868166|453930958|FG000|Overall Study|Non-compliance with IMP|1|||
126176507|NCT00868166|453930959|FG001|Overall Study|Non-compliance with IMP|1|||
126176508|NCT03819218|453930964|FG000|Overall Study|Protocol Violation|1|||
126176509|NCT02267278|453930965|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
126176510|NCT02267278|453930965|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
126176511|NCT02267278|453930965|FG000|Overall Study|Developed new cancer diagnoses|2|||
126176512|NCT02267278|453930965|FG000|Overall Study|prescribed prohibited medication|1|||
126176513|NCT00650091|453930966|FG000|Amended Study Design|Withdrawal by Subject|12|||
126176514|NCT00650091|453930967|FG001|Amended Study Design|Withdrawal by Subject|11|||
126176515|NCT00650091|453930968|FG002|Amended Study Design|Withdrawal by Subject|0|||
126176516|NCT00650091|453930966|FG000|Amended Study Design|Physician Decision|5|||
126176517|NCT00650091|453930967|FG001|Amended Study Design|Physician Decision|0|||
126176518|NCT00650091|453930968|FG002|Amended Study Design|Physician Decision|0|||
126176519|NCT00650091|453930966|FG000|Amended Study Design|Adverse Event|1|||
126176520|NCT00650091|453930967|FG001|Amended Study Design|Adverse Event|4|||
126176521|NCT00650091|453930968|FG002|Amended Study Design|Adverse Event|0|||
126176522|NCT00650091|453930966|FG000|Amended Study Design|Lung transplantation|4|||
126176523|NCT00650091|453930967|FG001|Amended Study Design|Lung transplantation|2|||
126176524|NCT00650091|453930968|FG002|Amended Study Design|Lung transplantation|0|||
126176525|NCT00650091|453930966|FG000|Amended Study Design|Other|1|||
126176526|NCT00650091|453930967|FG001|Amended Study Design|Other|3|||
126176527|NCT00650091|453930968|FG002|Amended Study Design|Other|0|||
126176528|NCT02988219|453930970|FG000|Overall Study|Lack of Efficacy|1|||
126176529|NCT02988219|453930971|FG001|Overall Study|Lack of Efficacy|1|||
126176530|NCT02988219|453930970|FG000|Overall Study|Withdrawal by Subject|0|||
126176531|NCT02988219|453930971|FG001|Overall Study|Withdrawal by Subject|2|||
126176532|NCT00664209|453930972|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
126176533|NCT00664209|453930972|FG000|Study Treatment Period|Physician Decision|4|||
126176534|NCT00664209|453930972|FG000|Study Treatment Period|Withdrawal by Subject|2|||
126176535|NCT00065442|453930973|FG000|Overall Study|Lost to Follow-up|1|||
125973971|NCT03152552|453193219|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
125973972|NCT03152552|453193220|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
125973973|NCT03152552|453193221|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
125973974|NCT03152552|453193222|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
125973975|NCT03152552|453193218|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
125973976|NCT03152552|453193219|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
125973977|NCT03152552|453193220|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
125973978|NCT03152552|453193221|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
125973979|NCT03152552|453193222|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
125973980|NCT03152552|453193218|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
125973981|NCT03152552|453193219|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
125973982|NCT03152552|453193220|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
125973983|NCT03152552|453193221|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
125973984|NCT03152552|453193222|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
125973985|NCT03152552|453193218|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125973986|NCT03152552|453193219|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125973987|NCT03152552|453193220|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125973988|NCT03152552|453193221|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125973989|NCT03152552|453193222|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125973990|NCT03152552|453193218|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
125973991|NCT03152552|453193219|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
125973992|NCT03152552|453193220|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
125973993|NCT03152552|453193221|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
125973994|NCT03152552|453193222|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
125973995|NCT03152552|453193218|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
125973996|NCT03152552|453193219|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
125973997|NCT03152552|453193220|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
125973998|NCT03152552|453193221|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
125973999|NCT03152552|453193222|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
125974000|NCT03152552|453193218|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
125974001|NCT03152552|453193219|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
125974002|NCT03152552|453193220|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
125974003|NCT03152552|453193221|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
125974004|NCT03152552|453193222|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
125974005|NCT01022762|453193223|FG000|Overall Study|Adverse Event|3|||
125974006|NCT01022762|453193224|FG001|Overall Study|Adverse Event|1|||
125974007|NCT01022762|453193223|FG000|Overall Study|Lack of Efficacy|0|||
125974008|NCT01022762|453193224|FG001|Overall Study|Lack of Efficacy|1|||
125974009|NCT01022762|453193223|FG000|Overall Study|Protocol Violation|7|||
125974010|NCT01022762|453193224|FG001|Overall Study|Protocol Violation|6|||
125974011|NCT01022762|453193223|FG000|Overall Study|Unclassified|12|||
125974012|NCT01022762|453193224|FG001|Overall Study|Unclassified|20|||
125974013|NCT01302119|453193225|FG000|Overall Study|Withdrawal by Subject|30|||
125974014|NCT01302119|453193226|FG001|Overall Study|Withdrawal by Subject|20|||
125974015|NCT01302119|453193225|FG000|Overall Study|Lost to Follow-up|10|||
125974016|NCT01302119|453193226|FG001|Overall Study|Lost to Follow-up|4|||
125974017|NCT01302119|453193225|FG000|Overall Study|Adverse Event|2|||
125974018|NCT01302119|453193226|FG001|Overall Study|Adverse Event|1|||
125974019|NCT01302119|453193225|FG000|Overall Study|Non-compliance|4|||
125974020|NCT01302119|453193226|FG001|Overall Study|Non-compliance|2|||
125974021|NCT01302119|453193225|FG000|Overall Study|Non-specific|4|||
125974022|NCT01302119|453193226|FG001|Overall Study|Non-specific|1|||
125974023|NCT03743038|453193227|FG000|Overall Study|Physician Decision|1|||
125974024|NCT03336619|453193228|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
125974025|NCT03336619|453193229|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
125974026|NCT03336619|453193228|FG000|Overall Study|Withdrawal by Subject|17|||
125974027|NCT03336619|453193229|FG001|Overall Study|Withdrawal by Subject|16|||
125974028|NCT03336619|453193228|FG000|Overall Study|Adverse Event|2|||
125974029|NCT03336619|453193229|FG001|Overall Study|Adverse Event|5|||
125974030|NCT03336619|453193228|FG000|Overall Study|Physician Decision|3|||
125974031|NCT03336619|453193229|FG001|Overall Study|Physician Decision|0|||
125974032|NCT01300546|453193230|FG000|Overall Study|Withdrawal by Subject|1|||
125974033|NCT01300546|453193231|FG001|Overall Study|Withdrawal by Subject|0|||
125974034|NCT01300546|453193230|FG000|Overall Study|Lost to Follow-up|0|||
126176536|NCT00065442|453930974|FG001|Overall Study|Lost to Follow-up|1|||
126176537|NCT00065442|453930973|FG000|Overall Study|Death|121|||
126176538|NCT00065442|453930974|FG001|Overall Study|Death|210|||
126176539|NCT00065442|453930973|FG000|Overall Study|Withdrawal by Subject|3|||
126176540|NCT00065442|453930974|FG001|Overall Study|Withdrawal by Subject|9|||
126176541|NCT01764256|453930975|FG000|Received All Vaccinations|Adverse Event|1|||
126176542|NCT01764256|453930976|FG001|Received All Vaccinations|Adverse Event|1|||
126176543|NCT01764256|453930977|FG002|Received All Vaccinations|Adverse Event|0|||
126176544|NCT01764256|453930978|FG003|Received All Vaccinations|Adverse Event|0|||
126176545|NCT01764256|453930975|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
126176546|NCT01764256|453930976|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
126176547|NCT01764256|453930977|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
126176548|NCT01764256|453930978|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
126176549|NCT01764256|453930975|FG000|Received All Vaccinations|Lost to Follow-up|1|||
126176550|NCT01764256|453930976|FG001|Received All Vaccinations|Lost to Follow-up|0|||
126176551|NCT01764256|453930977|FG002|Received All Vaccinations|Lost to Follow-up|0|||
126176552|NCT01764256|453930978|FG003|Received All Vaccinations|Lost to Follow-up|0|||
126176553|NCT01764256|453930975|FG000|Completed Study|Lost to Follow-up|0|||
126176554|NCT01764256|453930976|FG001|Completed Study|Lost to Follow-up|0|||
126176555|NCT01764256|453930977|FG002|Completed Study|Lost to Follow-up|0|||
126176556|NCT01764256|453930978|FG003|Completed Study|Lost to Follow-up|1|||
126176557|NCT02029638|453930979|FG000|Overall Study|Death|0|||
126176558|NCT02029638|453930980|FG001|Overall Study|Death|0|||
126176559|NCT02029638|453930981|FG002|Overall Study|Death|1|||
126176560|NCT02029638|453930979|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
126176561|NCT02029638|453930980|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
126176562|NCT02029638|453930981|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
126176563|NCT01153841|453930982|FG000|Overall Study|Adverse Event|1|||
125974035|NCT01300546|453193231|FG001|Overall Study|Lost to Follow-up|2|||
125974036|NCT01300546|453193230|FG000|Overall Study|Lack of Efficacy|0|||
125974037|NCT01300546|453193231|FG001|Overall Study|Lack of Efficacy|3|||
125974038|NCT01300546|453193230|FG000|Overall Study|Adverse Event|0|||
125974039|NCT01300546|453193231|FG001|Overall Study|Adverse Event|1|||
125974040|NCT02820623|453193232|FG000|Overall Study|Withdrawal by Subject|1|||
125974041|NCT02820623|453193233|FG001|Overall Study|Withdrawal by Subject|3|||
125974042|NCT02820623|453193234|FG002|Overall Study|Withdrawal by Subject|3|||
125974043|NCT02820623|453193232|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
125974044|NCT02820623|453193233|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
125974045|NCT02820623|453193234|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
125974046|NCT02820623|453193232|FG000|Overall Study|Therapist unable to enroll clients|1|||
125974047|NCT02820623|453193233|FG001|Overall Study|Therapist unable to enroll clients|1|||
125974048|NCT02820623|453193234|FG002|Overall Study|Therapist unable to enroll clients|3|||
125974049|NCT02820623|453193232|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
125974050|NCT02820623|453193233|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
125974051|NCT02820623|453193234|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
125974052|NCT01965834|453193235|FG000|Overall Study|Lack of Efficacy|4|||
125974053|NCT03943095|453193236|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
125974054|NCT03943095|453193237|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
125974055|NCT03943095|453193236|FG000|Overall Study|Withdrawal by Subject|1|||
125974056|NCT03943095|453193237|FG001|Overall Study|Withdrawal by Subject|0|||
125974057|NCT00744653|453193238|FG000|Overall Study|antineoplastic treatment|11|||
125974058|NCT00744653|453193238|FG000|Overall Study|Death|1|||
125974059|NCT00744653|453193238|FG000|Overall Study|Lost to Follow-up|1|||
125974060|NCT00744653|453193238|FG000|Overall Study|Physician Decision|3|||
125974061|NCT03826667|453193241|FG000|Overall Study|Protocol deviation|21|||
125974062|NCT01864564|453193246|FG000|Overall Study|Lost to Follow-up|17|||
125974063|NCT01864564|453193247|FG001|Overall Study|Lost to Follow-up|23|||
125974064|NCT01864564|453193246|FG000|Overall Study|Withdrawal by Subject|20|||
125974065|NCT01864564|453193247|FG001|Overall Study|Withdrawal by Subject|11|||
125974066|NCT01864564|453193246|FG000|Overall Study|Protocol Violation|0|||
125974067|NCT01864564|453193247|FG001|Overall Study|Protocol Violation|27|||
125974068|NCT01864564|453193246|FG000|Overall Study|not reported|0|||
125974069|NCT01864564|453193247|FG001|Overall Study|not reported|34|||
125974070|NCT02269670|453193248|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
125974071|NCT02693665|453193249|FG000|Overall Study|Death|3|||
125974072|NCT02693665|453193250|FG001|Overall Study|Death|2|||
125974073|NCT02693665|453193249|FG000|Overall Study|Lost to Follow-up|7|||
125974074|NCT02693665|453193250|FG001|Overall Study|Lost to Follow-up|3|||
125974075|NCT02693665|453193249|FG000|Overall Study|Protocol Violation|1|||
125974076|NCT02693665|453193250|FG001|Overall Study|Protocol Violation|0|||
125974077|NCT02693665|453193249|FG000|Overall Study|Withdrawal by Subject|2|||
125974078|NCT02693665|453193250|FG001|Overall Study|Withdrawal by Subject|0|||
125974079|NCT02693665|453193249|FG000|Overall Study|patient wanted to leave it behind|1|||
125974080|NCT02693665|453193250|FG001|Overall Study|patient wanted to leave it behind|0|||
125974081|NCT02693665|453193249|FG000|Overall Study|anxiety|1|||
126176564|NCT01153841|453930983|FG001|Overall Study|Adverse Event|0|||
125974082|NCT02693665|453193250|FG001|Overall Study|anxiety|0|||
126176565|NCT01153841|453930982|FG000|Overall Study|Withdrawal by Subject|1|||
126176566|NCT01153841|453930983|FG001|Overall Study|Withdrawal by Subject|0|||
126176567|NCT01153841|453930982|FG000|Overall Study|Protocol Violation|2|||
126176568|NCT01153841|453930983|FG001|Overall Study|Protocol Violation|0|||
126176569|NCT01153841|453930982|FG000|Overall Study|Lost to Follow-up|2|||
126176570|NCT01153841|453930983|FG001|Overall Study|Lost to Follow-up|0|||
126176571|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
125974083|NCT02693665|453193249|FG000|Overall Study|family issues|1|||
125974084|NCT02693665|453193250|FG001|Overall Study|family issues|0|||
125974085|NCT02693665|453193249|FG000|Overall Study|no reason given|1|||
125974086|NCT02693665|453193250|FG001|Overall Study|no reason given|0|||
125974087|NCT00710424|453193255|FG000|Overall Study|Adverse Event|30|||
125974088|NCT00710424|453193256|FG001|Overall Study|Adverse Event|12|||
125974089|NCT00710424|453193255|FG000|Overall Study|Lack of Efficacy|4|||
125974090|NCT00710424|453193256|FG001|Overall Study|Lack of Efficacy|5|||
125974091|NCT00710424|453193255|FG000|Overall Study|Withdrawal by Subject|5|||
125974092|NCT00710424|453193256|FG001|Overall Study|Withdrawal by Subject|3|||
125974093|NCT00710424|453193255|FG000|Overall Study|Lost to Follow-up|0|||
125974094|NCT00710424|453193256|FG001|Overall Study|Lost to Follow-up|1|||
125974095|NCT00710424|453193255|FG000|Overall Study|Refused medication, no side effects|1|||
125974096|NCT00710424|453193256|FG001|Overall Study|Refused medication, no side effects|0|||
125974097|NCT00710424|453193255|FG000|Overall Study|Non-compliance with stable analgesia|1|||
125974098|NCT00710424|453193256|FG001|Overall Study|Non-compliance with stable analgesia|0|||
125974099|NCT00710424|453193255|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
125974100|NCT00710424|453193256|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
125974101|NCT00710424|453193255|FG000|Overall Study|Subject thought medication changed|1|||
125974102|NCT00710424|453193256|FG001|Overall Study|Subject thought medication changed|0|||
125974103|NCT00710424|453193255|FG000|Overall Study|Ceased treatment due to travel|1|||
125974104|NCT00710424|453193256|FG001|Overall Study|Ceased treatment due to travel|0|||
125974105|NCT00710424|453193255|FG000|Overall Study|Subject preferred paracetamol|0|||
125974106|NCT00710424|453193256|FG001|Overall Study|Subject preferred paracetamol|1|||
125974107|NCT00710424|453193255|FG000|Overall Study|Felt good so stopped treatment|0|||
125974108|NCT00710424|453193256|FG001|Overall Study|Felt good so stopped treatment|1|||
125974109|NCT00655980|453193258|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
125974110|NCT00655980|453193259|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
125974111|NCT00655980|453193260|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
125974112|NCT04439110|453193261|FG000|Overall Study|Ineligible|2|||
125974113|NCT04439110|453193261|FG000|Overall Study|Adverse Event|4|||
125974114|NCT04439110|453193261|FG000|Overall Study|Death|2|||
125974115|NCT04439110|453193261|FG000|Overall Study|Disease proression|25|||
125974116|NCT04439110|453193261|FG000|Overall Study|Withdrawal by Subject|1|||
125974117|NCT04439110|453193261|FG000|Overall Study|Alternative therapy|1|||
125974118|NCT04439110|453193261|FG000|Overall Study|Other complicating disease|1|||
125974119|NCT04439110|453193261|FG000|Overall Study|Personal reasons|1|||
125974120|NCT04439110|453193261|FG000|Overall Study|Still on treatment|1|||
125974121|NCT00127608|453193264|FG000|Overall Study|VZV DNA negative|1|||
125974122|NCT05245864|453193265|FG000|Overall Study|Withdrawal by Subject|1|||
125974123|NCT05245864|453193266|FG001|Overall Study|Withdrawal by Subject|1|||
125974124|NCT00506493|453193272|FG000|Overall Study|Death|6|||
125974125|NCT00506493|453193272|FG000|Overall Study|Withdrawal by Subject|5|||
125974126|NCT00686166|453195093|FG000|Overall Study|Adverse Event|7|||
125974127|NCT00686166|453195093|FG000|Overall Study|Withdrawal by Subject|1|||
125974128|NCT00686166|453195093|FG000|Overall Study|Progression/Relapse|1|||
125974129|NCT00686166|453195093|FG000|Overall Study|Death|1|||
125974130|NCT00686166|453195093|FG000|Overall Study|Not Protocol Specified|1|||
125974131|NCT00686166|453195093|FG000|Overall Study|Ineligible|5|||
125974132|NCT00686166|453195093|FG000|Overall Study|Did not begin protocol therapy|4|||
125974133|NCT03912259|453195096|FG000|Overall Study|Adverse Event (AE)|2|||
125974134|NCT03912259|453195097|FG001|Overall Study|Adverse Event (AE)|4|||
125974135|NCT03912259|453195096|FG000|Overall Study|Lack of Efficacy|4|||
125974136|NCT03912259|453195097|FG001|Overall Study|Lack of Efficacy|1|||
125974137|NCT03912259|453195096|FG000|Overall Study|Withdrawal by Subject|11|||
125974138|NCT03912259|453195097|FG001|Overall Study|Withdrawal by Subject|1|||
125974139|NCT03647501|453195100|FG000|Overall Study|Lost to Follow-up|1|||
125974140|NCT03647501|453195101|FG001|Overall Study|Lost to Follow-up|1|||
125974141|NCT03647501|453195100|FG000|Overall Study|Withdrawal by Subject|0|||
125974142|NCT03647501|453195101|FG001|Overall Study|Withdrawal by Subject|1|||
125974143|NCT01613248|453195102|FG000|Overall Study|Adverse Event|0|||
125974144|NCT01613248|453195103|FG001|Overall Study|Adverse Event|0|||
125974145|NCT01613248|453195104|FG002|Overall Study|Adverse Event|0|||
125974146|NCT01613248|453195105|FG003|Overall Study|Adverse Event|1|||
125974147|NCT01613248|453195106|FG004|Overall Study|Adverse Event|0|||
125974148|NCT01613248|453195107|FG005|Overall Study|Adverse Event|0|||
125974149|NCT01613248|453195102|FG000|Overall Study|Withdrawal by Subject|3|||
125974150|NCT01613248|453195103|FG001|Overall Study|Withdrawal by Subject|2|||
125974151|NCT01613248|453195104|FG002|Overall Study|Withdrawal by Subject|2|||
126176572|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
126176573|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
126176574|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
126176575|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
126176576|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
126176577|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Death|1|||
126176578|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Death|3|||
126176579|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
126176580|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
126176581|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
126176582|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
126176583|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
126176584|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
126176585|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
126176586|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
126176587|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
126176588|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
126176589|NCT02553317|453930987|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
126176590|NCT02553317|453930988|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
126176591|NCT00585923|453930989|FG000|Overall Study|Physician decided not to continue|31|||
126176592|NCT00585923|453930990|FG001|Overall Study|Physician decided not to continue|33|||
126176593|NCT01766817|453930991|FG000|Overall Study|Drug-related adverse event|1|||
126176594|NCT01766817|453930992|FG001|Overall Study|Drug-related adverse event|2|||
126176595|NCT01766817|453930993|FG002|Overall Study|Drug-related adverse event|1|||
126176596|NCT01766817|453930991|FG000|Overall Study|Drug-unrelated adverse event|3|||
126176597|NCT01766817|453930992|FG001|Overall Study|Drug-unrelated adverse event|3|||
126176598|NCT01766817|453930993|FG002|Overall Study|Drug-unrelated adverse event|3|||
126176599|NCT01766817|453930991|FG000|Overall Study|Death|1|||
126176600|NCT01766817|453930992|FG001|Overall Study|Death|1|||
126176601|NCT01766817|453930993|FG002|Overall Study|Death|0|||
126176602|NCT01766817|453930991|FG000|Overall Study|Unable to take study drug|0|||
126176603|NCT01766817|453930992|FG001|Overall Study|Unable to take study drug|1|||
126176604|NCT01766817|453930993|FG002|Overall Study|Unable to take study drug|0|||
126176605|NCT01766817|453930991|FG000|Overall Study|Withdrawal by Subject|2|||
126176606|NCT01766817|453930992|FG001|Overall Study|Withdrawal by Subject|0|||
126176607|NCT01766817|453930993|FG002|Overall Study|Withdrawal by Subject|3|||
126176608|NCT01766817|453930991|FG000|Overall Study|Subject non-compliance|0|||
126176609|NCT01766817|453930992|FG001|Overall Study|Subject non-compliance|1|||
126176610|NCT01766817|453930993|FG002|Overall Study|Subject non-compliance|2|||
126176611|NCT01766817|453930991|FG000|Overall Study|Physician Decision|3|||
126176612|NCT01766817|453930992|FG001|Overall Study|Physician Decision|3|||
126176613|NCT01766817|453930993|FG002|Overall Study|Physician Decision|4|||
126176614|NCT01766817|453930991|FG000|Overall Study|Other|1|||
126176615|NCT01766817|453930992|FG001|Overall Study|Other|0|||
126176616|NCT01766817|453930993|FG002|Overall Study|Other|0|||
126176617|NCT03956225|453930995|FG000|Overall Study|Lack of Efficacy|1|||
126176618|NCT03956225|453930996|FG001|Overall Study|Lack of Efficacy|1|||
126176619|NCT03956225|453930995|FG000|Overall Study|Lost to Follow-up|0|||
126176620|NCT03956225|453930996|FG001|Overall Study|Lost to Follow-up|1|||
126176621|NCT03956225|453930995|FG000|Overall Study|Withdrawal by Subject|2|||
126176622|NCT03956225|453930996|FG001|Overall Study|Withdrawal by Subject|1|||
126176623|NCT03956225|453930995|FG000|Overall Study|Other Reasons|2|||
126176624|NCT03956225|453930996|FG001|Overall Study|Other Reasons|1|||
126176625|NCT02260648|453930997|FG000|Overall Study|Adverse Event|3|||
126176626|NCT02260648|453930998|FG001|Overall Study|Adverse Event|0|||
126176627|NCT02260648|453930999|FG002|Overall Study|Adverse Event|1|||
126176628|NCT02260648|453930997|FG000|Overall Study|Withdrawal by Subject|1|||
125974152|NCT01613248|453195105|FG003|Overall Study|Withdrawal by Subject|5|||
125974153|NCT01613248|453195106|FG004|Overall Study|Withdrawal by Subject|0|||
126176629|NCT02260648|453930998|FG001|Overall Study|Withdrawal by Subject|1|||
126176630|NCT02260648|453930999|FG002|Overall Study|Withdrawal by Subject|0|||
126176631|NCT02260648|453930997|FG000|Overall Study|Protocol Violation|1|||
126176632|NCT02260648|453930998|FG001|Overall Study|Protocol Violation|0|||
126176633|NCT02260648|453930999|FG002|Overall Study|Protocol Violation|0|||
126176634|NCT02260648|453930997|FG000|Overall Study|Discontinue Due to Study Termination|13|||
126176635|NCT02260648|453930998|FG001|Overall Study|Discontinue Due to Study Termination|12|||
126176636|NCT02260648|453930999|FG002|Overall Study|Discontinue Due to Study Termination|7|||
126176637|NCT04093258|453931000|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
126176638|NCT04093258|453931001|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
126176639|NCT00594204|453931002|FG000|Overall Study|Adverse Event|15|||
126176640|NCT00594204|453931003|FG001|Overall Study|Adverse Event|3|||
126176641|NCT00594204|453931002|FG000|Overall Study|Lost to Follow-up|9|||
126176642|NCT00594204|453931003|FG001|Overall Study|Lost to Follow-up|5|||
126176643|NCT00594204|453931002|FG000|Overall Study|Withdrawal by Subject|23|||
126176644|NCT00594204|453931003|FG001|Overall Study|Withdrawal by Subject|29|||
126176645|NCT00594204|453931002|FG000|Overall Study|Other|4|||
126176646|NCT00594204|453931003|FG001|Overall Study|Other|3|||
126176647|NCT00594204|453931002|FG000|Overall Study|Lack of Efficacy|3|||
126176648|NCT00594204|453931003|FG001|Overall Study|Lack of Efficacy|4|||
126176649|NCT00594204|453931002|FG000|Overall Study|Randomized but not treated|4|||
126176650|NCT00594204|453931003|FG001|Overall Study|Randomized but not treated|1|||
126176651|NCT01401465|453931004|FG000|Treatment Period 1|Adverse Event|4|||
126176652|NCT01401465|453931005|FG001|Treatment Period 1|Adverse Event|1|||
126176653|NCT01401465|453931004|FG000|Treatment Period 1|Pregnancy|0|||
126176654|NCT01401465|453931005|FG001|Treatment Period 1|Pregnancy|1|||
126176655|NCT01401465|453931004|FG000|Treatment Period 1|Protocol Violation|5|||
126176656|NCT01401465|453931005|FG001|Treatment Period 1|Protocol Violation|0|||
126176657|NCT01401465|453931004|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126176658|NCT01401465|453931005|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126176659|NCT01401465|453931004|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
126176660|NCT01401465|453931005|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
126176661|NCT01401465|453931004|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
126176662|NCT01401465|453931005|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
126176663|NCT01401465|453931004|FG000|Treatment Period 1|Scheduling Difficulties|1|||
126176664|NCT01401465|453931005|FG001|Treatment Period 1|Scheduling Difficulties|1|||
126176665|NCT01401465|453931004|FG000|Treatment Period 2|Lost to Follow-up|0|||
126176666|NCT01401465|453931005|FG001|Treatment Period 2|Lost to Follow-up|1|||
126176667|NCT01401465|453931004|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126176668|NCT01401465|453931005|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126176669|NCT00986427|453931006|FG000|Overall Study|Lost to Follow-up|2|||
126176670|NCT00986427|453931007|FG001|Overall Study|Lost to Follow-up|0|||
126176671|NCT00986427|453931006|FG000|Overall Study|Lack of Efficacy|1|||
126176672|NCT00986427|453931007|FG001|Overall Study|Lack of Efficacy|0|||
126176673|NCT00986427|453931006|FG000|Overall Study|Withdrawal by Subject|1|||
126176674|NCT00986427|453931007|FG001|Overall Study|Withdrawal by Subject|0|||
126176675|NCT01115738|453931008|FG000|Overall Study|Death|1|||
126176676|NCT01115738|453931009|FG001|Overall Study|Death|0|||
126176677|NCT01115738|453931010|FG002|Overall Study|Death|0|||
126176678|NCT01115738|453931008|FG000|Overall Study|Lost to Follow-up|0|||
126176679|NCT01115738|453931009|FG001|Overall Study|Lost to Follow-up|0|||
126176680|NCT01115738|453931010|FG002|Overall Study|Lost to Follow-up|1|||
126176681|NCT01115738|453931008|FG000|Overall Study|Physician Decision|18|||
126176682|NCT01115738|453931009|FG001|Overall Study|Physician Decision|15|||
126176683|NCT01115738|453931010|FG002|Overall Study|Physician Decision|17|||
126176684|NCT01115738|453931008|FG000|Overall Study|Withdrawal by Subject|6|||
126176685|NCT01115738|453931009|FG001|Overall Study|Withdrawal by Subject|6|||
126176686|NCT01115738|453931010|FG002|Overall Study|Withdrawal by Subject|9|||
126176687|NCT01054976|453931018|FG000|Overall Study|Adverse Event|16|||
126176688|NCT01054976|453931018|FG000|Overall Study|Uncooperative participations to study|7|||
126176689|NCT01054976|453931018|FG000|Overall Study|Withdrawal by Subject|4|||
126176690|NCT01054976|453931018|FG000|Overall Study|Other|8|||
126176691|NCT01669811|453931023|FG000|Overall Study|Investigator decision|0|||
126176692|NCT01669811|453931024|FG001|Overall Study|Investigator decision|1|||
126176693|NCT01669811|453931023|FG000|Overall Study|Withdrawal by Subject|1|||
126176694|NCT01669811|453931024|FG001|Overall Study|Withdrawal by Subject|2|||
126176695|NCT01669811|453931023|FG000|Overall Study|Adverse Event|2|||
126176696|NCT01669811|453931024|FG001|Overall Study|Adverse Event|6|||
126176697|NCT01669811|453931023|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126176698|NCT01669811|453931024|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
126176699|NCT00077376|453931025|FG000|Overall Study|Adverse Event|8|||
126176700|NCT00077376|453931025|FG000|Overall Study|Withdrawal by Subject|2|||
126176701|NCT00077376|453931025|FG000|Overall Study|Death|1|||
126176702|NCT00077376|453931025|FG000|Overall Study|Physician Decision|1|||
126176703|NCT00077376|453931025|FG000|Overall Study|Alternative therapy|5|||
126176704|NCT00077376|453931025|FG000|Overall Study|Complicating disease|1|||
126176705|NCT00077376|453931025|FG000|Overall Study|Still on treatment|1|||
126176706|NCT00077376|453931025|FG000|Overall Study|Symptomatic deterioration|1|||
126176707|NCT00077376|453931025|FG000|Overall Study|Surgery|1|||
126176708|NCT00077376|453931025|FG000|Overall Study|Insurance ran out|1|||
126176709|NCT00505752|453932812|FG000|Overall Study|Adverse Event|1|||
126176710|NCT00505752|453932813|FG001|Overall Study|Adverse Event|0|||
125974154|NCT01613248|453195107|FG005|Overall Study|Withdrawal by Subject|1|||
126176711|NCT00505752|453932814|FG002|Overall Study|Adverse Event|1|||
126176712|NCT00505752|453932815|FG003|Overall Study|Adverse Event|0|||
126176713|NCT00505752|453932812|FG000|Overall Study|Lost to Follow-up|1|||
126176714|NCT00505752|453932813|FG001|Overall Study|Lost to Follow-up|0|||
126176715|NCT00505752|453932814|FG002|Overall Study|Lost to Follow-up|0|||
126176716|NCT00505752|453932815|FG003|Overall Study|Lost to Follow-up|0|||
126176717|NCT00505752|453932812|FG000|Overall Study|Lack of ovarian response|1|||
126176718|NCT00505752|453932813|FG001|Overall Study|Lack of ovarian response|3|||
125974155|NCT01613248|453195102|FG000|Overall Study|Lost to Follow-up|5|||
125974156|NCT01613248|453195103|FG001|Overall Study|Lost to Follow-up|7|||
125974157|NCT01613248|453195104|FG002|Overall Study|Lost to Follow-up|4|||
125974158|NCT01613248|453195105|FG003|Overall Study|Lost to Follow-up|8|||
125974159|NCT01613248|453195106|FG004|Overall Study|Lost to Follow-up|4|||
125974160|NCT01613248|453195107|FG005|Overall Study|Lost to Follow-up|2|||
125974161|NCT01613248|453195102|FG000|Overall Study|Study Terminated by Sponsor|4|||
125974162|NCT01613248|453195103|FG001|Overall Study|Study Terminated by Sponsor|6|||
125974163|NCT01613248|453195104|FG002|Overall Study|Study Terminated by Sponsor|8|||
125974164|NCT01613248|453195105|FG003|Overall Study|Study Terminated by Sponsor|8|||
125974165|NCT01613248|453195106|FG004|Overall Study|Study Terminated by Sponsor|9|||
125974166|NCT01613248|453195107|FG005|Overall Study|Study Terminated by Sponsor|11|||
125974167|NCT01613248|453195102|FG000|Overall Study|Physician Decision|8|||
125974168|NCT01613248|453195103|FG001|Overall Study|Physician Decision|8|||
125974169|NCT01613248|453195104|FG002|Overall Study|Physician Decision|9|||
125974170|NCT01613248|453195105|FG003|Overall Study|Physician Decision|4|||
125974171|NCT01613248|453195106|FG004|Overall Study|Physician Decision|7|||
125974172|NCT01613248|453195107|FG005|Overall Study|Physician Decision|6|||
125974173|NCT01613248|453195102|FG000|Overall Study|Lack of Qualifying Event|9|||
125974174|NCT01613248|453195103|FG001|Overall Study|Lack of Qualifying Event|11|||
125974175|NCT01613248|453195104|FG002|Overall Study|Lack of Qualifying Event|10|||
125974176|NCT01613248|453195105|FG003|Overall Study|Lack of Qualifying Event|11|||
125974177|NCT01613248|453195106|FG004|Overall Study|Lack of Qualifying Event|15|||
125974178|NCT01613248|453195107|FG005|Overall Study|Lack of Qualifying Event|18|||
125974179|NCT01613248|453195102|FG000|Overall Study|Pregnancy|0|||
125974180|NCT01613248|453195103|FG001|Overall Study|Pregnancy|0|||
125974181|NCT01613248|453195104|FG002|Overall Study|Pregnancy|0|||
125974182|NCT01613248|453195105|FG003|Overall Study|Pregnancy|1|||
125974183|NCT01613248|453195106|FG004|Overall Study|Pregnancy|0|||
125974184|NCT01613248|453195107|FG005|Overall Study|Pregnancy|0|||
125974185|NCT01433354|453195109|FG000|Overall Study|Adverse Event|6|||
125974186|NCT01433354|453195109|FG000|Overall Study|Lost to Follow-up|1|||
125974187|NCT01433354|453195109|FG000|Overall Study|Administrative problems|90|||
125974188|NCT01433354|453195109|FG000|Overall Study|Protocol Violation|2|||
125974189|NCT01433354|453195109|FG000|Overall Study|Lack of Efficacy|17|||
125974190|NCT01433354|453195109|FG000|Overall Study|Subject Withdrew Consent|3|||
125974191|NCT02013622|453195121|FG000|Overall Study|Lost to Follow-up|10|||
125974192|NCT02013622|453195121|FG000|Overall Study|Adverse Event|3|||
125974193|NCT02013622|453195121|FG000|Overall Study|Met Withdrawal Criteria|3|||
125974194|NCT02013622|453195121|FG000|Overall Study|Withdrawal by Subject|6|||
125974195|NCT02013622|453195121|FG000|Overall Study|Protocol Deviation|1|||
125974196|NCT02013622|453195121|FG000|Overall Study|Lack of Efficacy|1|||
125974197|NCT04307004|453195129|FG000|Randomization 1|Withdrawal by Subject|25|||
125974198|NCT04307004|453195130|FG001|Randomization 1|Withdrawal by Subject|26|||
125974199|NCT04307004|453195131|FG002|Randomization 1|Withdrawal by Subject|0|||
125974200|NCT04307004|453195132|FG003|Randomization 1|Withdrawal by Subject|0|||
125974201|NCT04307004|453195129|FG000|Randomization 2|Withdrawal by Subject|0|||
125974202|NCT04307004|453195130|FG001|Randomization 2|Withdrawal by Subject|0|||
125974203|NCT04307004|453195131|FG002|Randomization 2|Withdrawal by Subject|28|||
125974204|NCT04307004|453195132|FG003|Randomization 2|Withdrawal by Subject|23|||
125974205|NCT01381692|453195133|FG000|Overall Study|Adverse Event|1|||
125974206|NCT01381692|453195134|FG001|Overall Study|Adverse Event|0|||
125974207|NCT01381692|453195135|FG002|Overall Study|Adverse Event|0|||
125974208|NCT01381692|453195136|FG003|Overall Study|Adverse Event|0|||
125974209|NCT01381692|453195137|FG004|Overall Study|Adverse Event|0|||
125974210|NCT01381692|453195138|FG005|Overall Study|Adverse Event|0|||
125974211|NCT04009291|453195139|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
125974212|NCT04009291|453195140|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
125974213|NCT04009291|453195141|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
125974214|NCT04009291|453195142|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
125974215|NCT04009291|453195143|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
125974216|NCT04009291|453195139|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
125974217|NCT04009291|453195140|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
125974218|NCT04009291|453195141|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
125974219|NCT04009291|453195142|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
125974220|NCT04009291|453195143|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
125974221|NCT01270347|453195144|FG000|Core Phase|Adverse Event|1|||
125974222|NCT01270347|453195145|FG001|Core Phase|Adverse Event|6|||
125974223|NCT01270347|453195144|FG000|Core Phase|Withdrawal by Subject|1|||
125974224|NCT01270347|453195145|FG001|Core Phase|Withdrawal by Subject|2|||
125974225|NCT01270347|453195144|FG000|Core Phase|Lost to Follow-up|0|||
125974226|NCT01270347|453195145|FG001|Core Phase|Lost to Follow-up|1|||
125974227|NCT01270347|453195144|FG000|Core Phase|Miscellaneous|8|||
125974228|NCT01270347|453195145|FG001|Core Phase|Miscellaneous|14|||
126176719|NCT00505752|453932814|FG002|Overall Study|Lack of ovarian response|0|||
125974229|NCT01270347|453195144|FG000|Extension Phase|Adverse Event|1|||
125974230|NCT01270347|453195145|FG001|Extension Phase|Adverse Event|3|||
125974231|NCT01270347|453195144|FG000|Extension Phase|Withdrawal by Subject|3|||
126176720|NCT00505752|453932815|FG003|Overall Study|Lack of ovarian response|0|||
126176721|NCT00505752|453932812|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126176722|NCT00505752|453932813|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126176723|NCT00505752|453932814|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
126176724|NCT00505752|453932815|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126176725|NCT00505752|453932812|FG000|Overall Study|No oocytes retrieved|0|||
126176726|NCT00505752|453932813|FG001|Overall Study|No oocytes retrieved|2|||
126176727|NCT00505752|453932814|FG002|Overall Study|No oocytes retrieved|0|||
126176728|NCT00505752|453932815|FG003|Overall Study|No oocytes retrieved|1|||
126176729|NCT00505752|453932812|FG000|Overall Study|No Fertilization|1|||
126176730|NCT00505752|453932813|FG001|Overall Study|No Fertilization|1|||
126176731|NCT00505752|453932814|FG002|Overall Study|No Fertilization|2|||
126176732|NCT00505752|453932815|FG003|Overall Study|No Fertilization|1|||
126176733|NCT00505752|453932812|FG000|Overall Study|All embryos/blastocysts discarded|0|||
126176734|NCT00505752|453932813|FG001|Overall Study|All embryos/blastocysts discarded|0|||
126176735|NCT00505752|453932814|FG002|Overall Study|All embryos/blastocysts discarded|1|||
126176736|NCT00505752|453932815|FG003|Overall Study|All embryos/blastocysts discarded|1|||
126176737|NCT00505752|453932812|FG000|Overall Study|Other|1|||
126176738|NCT00505752|453932813|FG001|Overall Study|Other|2|||
126176739|NCT00505752|453932814|FG002|Overall Study|Other|1|||
126176740|NCT00505752|453932815|FG003|Overall Study|Other|2|||
126176741|NCT01925612|453932818|FG000|Overall Study|Progressive Disease|1|||
126176742|NCT01925612|453932819|FG001|Overall Study|Progressive Disease|1|||
126176743|NCT01925612|453932820|FG002|Overall Study|Progressive Disease|1|||
126176744|NCT01925612|453932821|FG003|Overall Study|Progressive Disease|0|||
126176745|NCT01925612|453932822|FG004|Overall Study|Progressive Disease|0|||
126176746|NCT01925612|453932818|FG000|Overall Study|Adverse Event|3|||
126176747|NCT01925612|453932819|FG001|Overall Study|Adverse Event|3|||
126176748|NCT01925612|453932820|FG002|Overall Study|Adverse Event|0|||
126176749|NCT01925612|453932821|FG003|Overall Study|Adverse Event|1|||
126176750|NCT01925612|453932822|FG004|Overall Study|Adverse Event|2|||
126176751|NCT04624672|453932828|FG000|Overall Study|Early Study Closure|2|||
126176752|NCT04624672|453932829|FG001|Overall Study|Early Study Closure|1|||
126176753|NCT03472040|453932830|FG000|Overall Study|Physician Decision|0|||
126176754|NCT03472040|453932831|FG001|Overall Study|Physician Decision|3|||
126176755|NCT03472040|453932830|FG000|Overall Study|Withdrawal by Subject|10|||
126176756|NCT03472040|453932831|FG001|Overall Study|Withdrawal by Subject|23|||
126176757|NCT03472040|453932830|FG000|Overall Study|Perceived Lack of Efficacy|29|||
126176758|NCT03472040|453932831|FG001|Overall Study|Perceived Lack of Efficacy|30|||
126176759|NCT03472040|453932830|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
126176760|NCT03472040|453932831|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
126176761|NCT03472040|453932830|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
126176762|NCT03472040|453932831|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
126176763|NCT03472040|453932830|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
126176764|NCT03472040|453932831|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
126176765|NCT03472040|453932830|FG000|Overall Study|Subject Non-compliance|2|||
126176766|NCT03472040|453932831|FG001|Overall Study|Subject Non-compliance|5|||
126176767|NCT03472040|453932830|FG000|Overall Study|Discontinuation due to Rash|0|||
126176768|NCT03472040|453932831|FG001|Overall Study|Discontinuation due to Rash|1|||
126176769|NCT03472040|453932830|FG000|Overall Study|Subsequent Ineligibility|0|||
126176770|NCT03472040|453932831|FG001|Overall Study|Subsequent Ineligibility|2|||
126176771|NCT03472040|453932830|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
126176772|NCT03472040|453932831|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
126176773|NCT02769832|453932832|FG000|Overall Study|Death|30|||
126176774|NCT00433446|453932843|FG000|Overall Study|Adverse Event|4|||
126176775|NCT00433446|453932843|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126176776|NCT00433446|453932843|FG000|Overall Study|Progression|44|||
126176777|NCT00433446|453932843|FG000|Overall Study|Other - Not Protocol specified|3|||
126176778|NCT00433446|453932843|FG000|Overall Study|Ineligible|9|||
126176779|NCT01188538|453932844|FG000|Overall Study|Lost to Follow-up|0|||
126176780|NCT01188538|453932845|FG001|Overall Study|Lost to Follow-up|1|||
126176781|NCT01231607|453932849|FG000|Overall Study|Adverse Event|0|||
126176782|NCT01231607|453932850|FG001|Overall Study|Adverse Event|8|||
126176783|NCT01231607|453932851|FG002|Overall Study|Adverse Event|4|||
126176784|NCT01231607|453932852|FG003|Overall Study|Adverse Event|4|||
126176785|NCT01231607|453932853|FG004|Overall Study|Adverse Event|5|||
126176786|NCT01231607|453932849|FG000|Overall Study|Lost to Follow-up|13|||
126176787|NCT01231607|453932850|FG001|Overall Study|Lost to Follow-up|11|||
126176788|NCT01231607|453932851|FG002|Overall Study|Lost to Follow-up|10|||
126176789|NCT01231607|453932852|FG003|Overall Study|Lost to Follow-up|10|||
126176790|NCT01231607|453932853|FG004|Overall Study|Lost to Follow-up|4|||
126176791|NCT01231607|453932849|FG000|Overall Study|Physician Decision|4|||
126176792|NCT01231607|453932850|FG001|Overall Study|Physician Decision|4|||
126176793|NCT01231607|453932851|FG002|Overall Study|Physician Decision|3|||
126176794|NCT01231607|453932852|FG003|Overall Study|Physician Decision|5|||
126176795|NCT01231607|453932853|FG004|Overall Study|Physician Decision|4|||
126176796|NCT01231607|453932849|FG000|Overall Study|Protocol Violation|3|||
126176797|NCT01231607|453932850|FG001|Overall Study|Protocol Violation|2|||
126176798|NCT01231607|453932851|FG002|Overall Study|Protocol Violation|0|||
126176799|NCT01231607|453932852|FG003|Overall Study|Protocol Violation|2|||
126176800|NCT01231607|453932853|FG004|Overall Study|Protocol Violation|2|||
126176801|NCT01231607|453932849|FG000|Overall Study|Withdrawal by Subject|9|||
126176802|NCT01231607|453932850|FG001|Overall Study|Withdrawal by Subject|9|||
126176803|NCT01231607|453932851|FG002|Overall Study|Withdrawal by Subject|14|||
126176804|NCT01231607|453932852|FG003|Overall Study|Withdrawal by Subject|17|||
126176805|NCT01231607|453932853|FG004|Overall Study|Withdrawal by Subject|9|||
126176806|NCT02501902|453932854|FG000|Overall Study|Subject Refused Further Follow-up|0|||
126176807|NCT02501902|453932855|FG001|Overall Study|Subject Refused Further Follow-up|0|||
126176808|NCT02501902|453932856|FG002|Overall Study|Subject Refused Further Follow-up|0|||
126176809|NCT02501902|453932857|FG003|Overall Study|Subject Refused Further Follow-up|0|||
126176810|NCT02501902|453932858|FG004|Overall Study|Subject Refused Further Follow-up|0|||
126176811|NCT02501902|453932859|FG005|Overall Study|Subject Refused Further Follow-up|0|||
126176812|NCT02501902|453932860|FG006|Overall Study|Subject Refused Further Follow-up|0|||
126176813|NCT02501902|453932861|FG007|Overall Study|Subject Refused Further Follow-up|1|||
126176814|NCT02501902|453932854|FG000|Overall Study|Study Terminated by Sponsor|0|||
126176815|NCT02501902|453932855|FG001|Overall Study|Study Terminated by Sponsor|3|||
126176816|NCT02501902|453932856|FG002|Overall Study|Study Terminated by Sponsor|0|||
126176817|NCT02501902|453932857|FG003|Overall Study|Study Terminated by Sponsor|1|||
126176818|NCT02501902|453932858|FG004|Overall Study|Study Terminated by Sponsor|1|||
126176819|NCT02501902|453932859|FG005|Overall Study|Study Terminated by Sponsor|0|||
126176820|NCT02501902|453932860|FG006|Overall Study|Study Terminated by Sponsor|2|||
126176821|NCT02501902|453932861|FG007|Overall Study|Study Terminated by Sponsor|4|||
126176822|NCT02501902|453932854|FG000|Overall Study|Death|3|||
126176823|NCT02501902|453932855|FG001|Overall Study|Death|4|||
126176824|NCT02501902|453932856|FG002|Overall Study|Death|4|||
126176825|NCT02501902|453932857|FG003|Overall Study|Death|10|||
126176826|NCT02501902|453932858|FG004|Overall Study|Death|10|||
126176827|NCT02501902|453932859|FG005|Overall Study|Death|11|||
126176828|NCT02501902|453932860|FG006|Overall Study|Death|7|||
126176829|NCT02501902|453932861|FG007|Overall Study|Death|15|||
126176830|NCT02513771|453932862|FG000|Overall Study|Lost to Follow-up|1|||
126176831|NCT02513771|453932863|FG001|Overall Study|Lost to Follow-up|1|||
126176832|NCT02513771|453932862|FG000|Overall Study|Not being able to get to clinic|1|||
126176833|NCT02513771|453932863|FG001|Overall Study|Not being able to get to clinic|0|||
126176834|NCT01797445|453932866|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
126176835|NCT01797445|453932867|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
126176836|NCT01797445|453932866|FG000|Double-Blind Phase|Adverse Event|3|||
126176837|NCT01797445|453932867|FG001|Double-Blind Phase|Adverse Event|0|||
126176838|NCT01797445|453932866|FG000|Double-Blind Phase|Death|5|||
126176839|NCT01797445|453932867|FG001|Double-Blind Phase|Death|4|||
126176840|NCT01797445|453932866|FG000|Double-Blind Phase|Pregnancy|0|||
126176841|NCT01797445|453932867|FG001|Double-Blind Phase|Pregnancy|1|||
126176842|NCT01797445|453932866|FG000|Double-Blind Phase|Lack of Efficacy|1|||
126176843|NCT01797445|453932867|FG001|Double-Blind Phase|Lack of Efficacy|2|||
126176844|NCT01797445|453932866|FG000|Double-Blind Phase|Investigator's Discretion|15|||
126176845|NCT01797445|453932867|FG001|Double-Blind Phase|Investigator's Discretion|17|||
126176846|NCT01797445|453932866|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
126176847|NCT01797445|453932867|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
126176848|NCT01797445|453932866|FG000|Double-Blind Phase|Protocol Violation|0|||
126176849|NCT01797445|453932867|FG001|Double-Blind Phase|Protocol Violation|1|||
126176850|NCT01797445|453932866|FG000|Double-Blind Phase|Withdrew Consent|20|||
126176851|NCT01797445|453932867|FG001|Double-Blind Phase|Withdrew Consent|35|||
126176852|NCT01797445|453932866|FG000|Double-Blind Phase|Lost to Follow-up|34|||
126176853|NCT01797445|453932867|FG001|Double-Blind Phase|Lost to Follow-up|26|||
126176854|NCT01797445|453932866|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
126176855|NCT01797445|453932867|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
126176856|NCT01280266|453932876|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
126176857|NCT01280266|453932877|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
126176858|NCT01280266|453932876|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
126176859|NCT01280266|453932877|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
126176860|NCT04116073|453932884|FG000|Overall Study|Withdrawal by Subject|2|||
126176861|NCT04116073|453932884|FG000|Overall Study|failed to maintained eligibility|1|||
126176862|NCT00881361|453932889|FG000|Overall Study|Terminated prior to surgery|27|||
126176863|NCT00881361|453932890|FG001|Overall Study|Terminated prior to surgery|7|||
126176864|NCT00881361|453932891|FG002|Overall Study|Terminated prior to surgery|0|||
126176865|NCT00881361|453932889|FG000|Overall Study|Ineligible|17|||
126176866|NCT00881361|453932890|FG001|Overall Study|Ineligible|2|||
126176867|NCT00881361|453932891|FG002|Overall Study|Ineligible|2|||
126176868|NCT01413542|453932894|FG000|Overall Study|Physician Decision|1|||
126176869|NCT01413542|453932895|FG001|Overall Study|Physician Decision|0|||
126176870|NCT01413542|453932896|FG002|Overall Study|Physician Decision|3|||
126176871|NCT01413542|453932897|FG003|Overall Study|Physician Decision|0|||
126176872|NCT01413542|453932894|FG000|Overall Study|Adverse Event|0|||
126176873|NCT01413542|453932895|FG001|Overall Study|Adverse Event|0|||
126176874|NCT01413542|453932896|FG002|Overall Study|Adverse Event|0|||
126176875|NCT01413542|453932897|FG003|Overall Study|Adverse Event|1|||
126176876|NCT02505542|453932898|FG000|Part A: Open-Label Period|Adverse Event|31|||
126176877|NCT02505542|453932899|FG001|Part A: Open-Label Period|Adverse Event|0|||
126176878|NCT02505542|453932900|FG002|Part A: Open-Label Period|Adverse Event|0|||
126176879|NCT02505542|453932901|FG003|Part A: Open-Label Period|Adverse Event|0|||
126176880|NCT02505542|453932898|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
126176881|NCT02505542|453932899|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
126176882|NCT02505542|453932900|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
126176883|NCT02505542|453932901|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
126176884|NCT02505542|453932898|FG000|Part A: Open-Label Period|Protocol Violation|1|||
126176885|NCT02505542|453932899|FG001|Part A: Open-Label Period|Protocol Violation|0|||
126176886|NCT02505542|453932900|FG002|Part A: Open-Label Period|Protocol Violation|0|||
126176887|NCT02505542|453932901|FG003|Part A: Open-Label Period|Protocol Violation|0|||
126176888|NCT02505542|453932898|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
126176889|NCT02505542|453932899|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
126176890|NCT02505542|453932900|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
126176891|NCT02505542|453932901|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
126176892|NCT02505542|453932898|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
126176893|NCT02505542|453932899|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
126176894|NCT02505542|453932900|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
126176895|NCT02505542|453932901|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
126176896|NCT02505542|453932898|FG000|Part A: Open-Label Period|New medical history available|1|||
126176897|NCT02505542|453932899|FG001|Part A: Open-Label Period|New medical history available|0|||
126176898|NCT02505542|453932900|FG002|Part A: Open-Label Period|New medical history available|0|||
126176899|NCT02505542|453932901|FG003|Part A: Open-Label Period|New medical history available|0|||
126176900|NCT02505542|453932898|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
126176901|NCT02505542|453932899|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
126176902|NCT02505542|453932900|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
126176903|NCT02505542|453932901|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
126176904|NCT02505542|453932898|FG000|Part A: Open-Label Period|Pregnancy|2|||
126176905|NCT02505542|453932899|FG001|Part A: Open-Label Period|Pregnancy|0|||
126176906|NCT02505542|453932900|FG002|Part A: Open-Label Period|Pregnancy|0|||
126176907|NCT02505542|453932901|FG003|Part A: Open-Label Period|Pregnancy|0|||
126176908|NCT02505542|453932898|FG000|Part A: Open-Label Period|Sponsor directive|1|||
126176909|NCT02505542|453932899|FG001|Part A: Open-Label Period|Sponsor directive|0|||
126176910|NCT02505542|453932900|FG002|Part A: Open-Label Period|Sponsor directive|0|||
126176911|NCT02505542|453932901|FG003|Part A: Open-Label Period|Sponsor directive|0|||
126176912|NCT02505542|453932898|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
126176913|NCT02505542|453932899|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
126176914|NCT02505542|453932900|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
126176915|NCT02505542|453932901|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
126176916|NCT02505542|453932898|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
126176917|NCT02505542|453932899|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
126176918|NCT02505542|453932900|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
126176919|NCT02505542|453932901|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
126176920|NCT02505542|453932898|FG000|Part A: Open-Label Period|Non-compliance|1|||
126176921|NCT02505542|453932899|FG001|Part A: Open-Label Period|Non-compliance|0|||
126176922|NCT02505542|453932900|FG002|Part A: Open-Label Period|Non-compliance|0|||
126176923|NCT02505542|453932901|FG003|Part A: Open-Label Period|Non-compliance|0|||
126176924|NCT02505542|453932898|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
126176925|NCT02505542|453932899|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
126176926|NCT02505542|453932900|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
126176927|NCT02505542|453932901|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
126176928|NCT02505542|453932898|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
126176929|NCT02505542|453932899|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
126176930|NCT02505542|453932900|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
126176931|NCT02505542|453932901|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
126176932|NCT02505542|453932898|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
126176933|NCT02505542|453932899|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
126176934|NCT02505542|453932900|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
126176935|NCT02505542|453932901|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
126176936|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Adverse Event|0|||
126176937|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Adverse Event|0|||
126176938|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Adverse Event|1|||
126176939|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Adverse Event|3|||
125974232|NCT01270347|453195145|FG001|Extension Phase|Withdrawal by Subject|4|||
125974233|NCT01270347|453195144|FG000|Extension Phase|Miscellaneous|2|||
125974234|NCT01270347|453195145|FG001|Extension Phase|Miscellaneous|2|||
125974235|NCT02195986|453195148|FG000|Overall Study|Adverse Event|3|||
125974236|NCT02195986|453195149|FG001|Overall Study|Adverse Event|0|||
125974237|NCT02195986|453195150|FG002|Overall Study|Adverse Event|0|||
125974238|NCT02195986|453195148|FG000|Overall Study|Withdrawal by Subject|0|||
125974239|NCT02195986|453195149|FG001|Overall Study|Withdrawal by Subject|3|||
125974240|NCT02195986|453195150|FG002|Overall Study|Withdrawal by Subject|0|||
125974241|NCT02195986|453195148|FG000|Overall Study|Family Emergency|0|||
125974242|NCT02195986|453195149|FG001|Overall Study|Family Emergency|0|||
125974243|NCT02195986|453195150|FG002|Overall Study|Family Emergency|1|||
125974244|NCT02195986|453195148|FG000|Overall Study|Protocol Violation|0|||
125974245|NCT02195986|453195149|FG001|Overall Study|Protocol Violation|1|||
125974246|NCT02195986|453195150|FG002|Overall Study|Protocol Violation|1|||
125974247|NCT02195986|453195148|FG000|Overall Study|Non-compliance|0|||
125974248|NCT02195986|453195149|FG001|Overall Study|Non-compliance|1|||
125974249|NCT02195986|453195150|FG002|Overall Study|Non-compliance|0|||
125974250|NCT02834780|453195153|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
125974251|NCT02834780|453195154|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
125974252|NCT02834780|453195155|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
125974253|NCT02834780|453195156|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
125974254|NCT02834780|453195157|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
126176940|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
126176941|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
126176942|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
126176943|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
126176944|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
126176945|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
126176946|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
126176947|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
126176948|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
126176949|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
126176950|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
126176951|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
126176952|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
126176953|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
126176954|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
126176955|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
126176956|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
126176957|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
126176958|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
126176959|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
126176960|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
126176961|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
126176962|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
126176963|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
126176964|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Miscalculation|0|||
126176965|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Miscalculation|1|||
126176966|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Miscalculation|0|||
126176967|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Miscalculation|0|||
126176968|NCT02505542|453932898|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
126176969|NCT02505542|453932899|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
126176970|NCT02505542|453932900|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
126176971|NCT02505542|453932901|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
126176972|NCT00618995|453932904|FG000|Period 1|Adverse Event|0|||
126176973|NCT00618995|453932905|FG001|Period 1|Adverse Event|0|||
126176974|NCT00618995|453932906|FG002|Period 1|Adverse Event|1|||
126176975|NCT00618995|453932907|FG003|Period 1|Adverse Event|0|||
126176976|NCT00618995|453932904|FG000|Period 1|Protocol Violation|0|||
126176977|NCT00618995|453932905|FG001|Period 1|Protocol Violation|1|||
126176978|NCT00618995|453932906|FG002|Period 1|Protocol Violation|1|||
126176979|NCT00618995|453932907|FG003|Period 1|Protocol Violation|0|||
126176980|NCT00618995|453932904|FG000|Period 2|Protocol Violation|0|||
126176981|NCT00618995|453932905|FG001|Period 2|Protocol Violation|0|||
126176982|NCT00618995|453932906|FG002|Period 2|Protocol Violation|1|||
126176983|NCT00618995|453932907|FG003|Period 2|Protocol Violation|0|||
126176984|NCT00618995|453932904|FG000|Period 4|Adverse Event|1|||
126176985|NCT00618995|453932905|FG001|Period 4|Adverse Event|0|||
126176986|NCT00618995|453932906|FG002|Period 4|Adverse Event|0|||
126176987|NCT00618995|453932907|FG003|Period 4|Adverse Event|0|||
126176988|NCT01522443|453932908|FG000|Overall Study|No longer receiving clinical benefit|36|||
126176989|NCT01522443|453932909|FG001|Overall Study|No longer receiving clinical benefit|28|||
126176990|NCT01522443|453932908|FG000|Overall Study|Adverse Event|10|||
126176991|NCT01522443|453932909|FG001|Overall Study|Adverse Event|15|||
126176992|NCT01522443|453932908|FG000|Overall Study|Withdrawal by Subject|5|||
126176993|NCT01522443|453932909|FG001|Overall Study|Withdrawal by Subject|8|||
126176994|NCT01522443|453932908|FG000|Overall Study|No study treatment given|1|||
125974255|NCT02834780|453195158|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
125974256|NCT02834780|453195159|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
125974257|NCT02834780|453195160|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
125974258|NCT02834780|453195161|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
125974259|NCT02834780|453195162|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
125974260|NCT02834780|453195163|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
125974261|NCT02834780|453195164|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
125974262|NCT02834780|453195165|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
125974263|NCT02834780|453195153|FG000|Overall Study|Withdrawal by Subject|0|||
125974264|NCT02834780|453195154|FG001|Overall Study|Withdrawal by Subject|0|||
125974265|NCT02834780|453195155|FG002|Overall Study|Withdrawal by Subject|1|||
125974266|NCT02834780|453195156|FG003|Overall Study|Withdrawal by Subject|0|||
125974267|NCT02834780|453195157|FG004|Overall Study|Withdrawal by Subject|0|||
125974268|NCT02834780|453195158|FG005|Overall Study|Withdrawal by Subject|0|||
125974269|NCT02834780|453195159|FG006|Overall Study|Withdrawal by Subject|0|||
125974270|NCT02834780|453195160|FG007|Overall Study|Withdrawal by Subject|0|||
125974271|NCT02834780|453195161|FG008|Overall Study|Withdrawal by Subject|0|||
125974272|NCT02834780|453195162|FG009|Overall Study|Withdrawal by Subject|0|||
125974273|NCT02834780|453195163|FG010|Overall Study|Withdrawal by Subject|1|||
125974274|NCT02834780|453195164|FG011|Overall Study|Withdrawal by Subject|0|||
125974275|NCT02834780|453195165|FG012|Overall Study|Withdrawal by Subject|0|||
126176995|NCT01522443|453932909|FG001|Overall Study|No study treatment given|1|||
126176996|NCT01522443|453932908|FG000|Overall Study|Other|1|||
126176997|NCT01522443|453932909|FG001|Overall Study|Other|3|||
126176998|NCT00776555|453932910|FG000|Overall Study|Study terminated|3|||
126176999|NCT00776555|453932911|FG001|Overall Study|Study terminated|0|||
126177000|NCT04685499|453932912|FG000|Overall Study|Study Terminated Early|1|||
126177001|NCT03176277|453932913|FG000|Part A Dose Escalation Study|Adverse Event|1|||
126177002|NCT03176277|453932914|FG001|Part A Dose Escalation Study|Adverse Event|0|||
126177003|NCT03176277|453932915|FG002|Part A Dose Escalation Study|Adverse Event|1|||
126177004|NCT03176277|453932916|FG003|Part A Dose Escalation Study|Adverse Event|0|||
126177005|NCT03176277|453932913|FG000|Part A Dose Escalation Study|Physician Decision|1|||
126177006|NCT03176277|453932914|FG001|Part A Dose Escalation Study|Physician Decision|1|||
126177007|NCT03176277|453932915|FG002|Part A Dose Escalation Study|Physician Decision|2|||
126177008|NCT03176277|453932916|FG003|Part A Dose Escalation Study|Physician Decision|0|||
126177009|NCT03176277|453932913|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
126177010|NCT03176277|453932914|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
125974276|NCT02834780|453195153|FG000|Overall Study|Adverse Event|0|||
125974277|NCT02834780|453195154|FG001|Overall Study|Adverse Event|0|||
125974278|NCT02834780|453195155|FG002|Overall Study|Adverse Event|0|||
125974279|NCT02834780|453195156|FG003|Overall Study|Adverse Event|0|||
125974280|NCT02834780|453195157|FG004|Overall Study|Adverse Event|1|||
125974281|NCT02834780|453195158|FG005|Overall Study|Adverse Event|0|||
125974282|NCT02834780|453195159|FG006|Overall Study|Adverse Event|1|||
125974283|NCT02834780|453195160|FG007|Overall Study|Adverse Event|1|||
125974284|NCT02834780|453195161|FG008|Overall Study|Adverse Event|0|||
125974285|NCT02834780|453195162|FG009|Overall Study|Adverse Event|2|||
125974286|NCT02834780|453195163|FG010|Overall Study|Adverse Event|0|||
125974287|NCT02834780|453195164|FG011|Overall Study|Adverse Event|3|||
125974288|NCT02834780|453195165|FG012|Overall Study|Adverse Event|2|||
125974289|NCT02834780|453195153|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
125974290|NCT02834780|453195154|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
125974291|NCT02834780|453195155|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
125974292|NCT02834780|453195156|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
125974293|NCT02834780|453195157|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
125974294|NCT02834780|453195158|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
125974295|NCT02834780|453195159|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
125974296|NCT02834780|453195160|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
125974297|NCT02834780|453195161|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
125974298|NCT02834780|453195162|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
125974299|NCT02834780|453195163|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
125974300|NCT02834780|453195164|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
125974301|NCT02834780|453195165|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
125974302|NCT02834780|453195153|FG000|Overall Study|Other|1|||
125974303|NCT02834780|453195154|FG001|Overall Study|Other|0|||
125974304|NCT02834780|453195155|FG002|Overall Study|Other|1|||
125974305|NCT02834780|453195156|FG003|Overall Study|Other|2|||
125974306|NCT02834780|453195157|FG004|Overall Study|Other|0|||
125974307|NCT02834780|453195158|FG005|Overall Study|Other|0|||
125974308|NCT02834780|453195159|FG006|Overall Study|Other|0|||
125974309|NCT02834780|453195160|FG007|Overall Study|Other|0|||
125974310|NCT02834780|453195161|FG008|Overall Study|Other|0|||
125974311|NCT02834780|453195162|FG009|Overall Study|Other|0|||
125974312|NCT02834780|453195163|FG010|Overall Study|Other|0|||
125974313|NCT02834780|453195164|FG011|Overall Study|Other|0|||
125974314|NCT02834780|453195165|FG012|Overall Study|Other|1|||
125974315|NCT03449030|453195166|FG000|Overall Study|Withdrawal by Subject|0|||
125974316|NCT03449030|453195167|FG001|Overall Study|Withdrawal by Subject|0|||
125974317|NCT03449030|453195168|FG002|Overall Study|Withdrawal by Subject|0|||
125974318|NCT03449030|453195169|FG003|Overall Study|Withdrawal by Subject|1|||
125974319|NCT03449030|453195170|FG004|Overall Study|Withdrawal by Subject|1|||
125974320|NCT03449030|453195171|FG005|Overall Study|Withdrawal by Subject|1|||
125974321|NCT03449030|453195172|FG006|Overall Study|Withdrawal by Subject|1|||
125974322|NCT03449030|453195173|FG007|Overall Study|Withdrawal by Subject|2|||
125974323|NCT03449030|453195174|FG008|Overall Study|Withdrawal by Subject|0|||
125974324|NCT03449030|453195175|FG009|Overall Study|Withdrawal by Subject|0|||
125974325|NCT03449030|453195166|FG000|Overall Study|Symptomatic Deterioration|0|||
125974326|NCT03449030|453195167|FG001|Overall Study|Symptomatic Deterioration|1|||
125974327|NCT03449030|453195168|FG002|Overall Study|Symptomatic Deterioration|0|||
125974328|NCT03449030|453195169|FG003|Overall Study|Symptomatic Deterioration|0|||
125974329|NCT03449030|453195170|FG004|Overall Study|Symptomatic Deterioration|0|||
125974330|NCT03449030|453195171|FG005|Overall Study|Symptomatic Deterioration|1|||
125974331|NCT03449030|453195172|FG006|Overall Study|Symptomatic Deterioration|1|||
125974332|NCT03449030|453195173|FG007|Overall Study|Symptomatic Deterioration|0|||
125974333|NCT03449030|453195174|FG008|Overall Study|Symptomatic Deterioration|2|||
125974334|NCT03449030|453195175|FG009|Overall Study|Symptomatic Deterioration|0|||
125974335|NCT03449030|453195166|FG000|Overall Study|Progressive Disease|1|||
125974336|NCT03449030|453195167|FG001|Overall Study|Progressive Disease|0|||
125974337|NCT03449030|453195168|FG002|Overall Study|Progressive Disease|1|||
125974338|NCT03449030|453195169|FG003|Overall Study|Progressive Disease|4|||
125974339|NCT03449030|453195170|FG004|Overall Study|Progressive Disease|5|||
125974340|NCT03449030|453195171|FG005|Overall Study|Progressive Disease|3|||
125974341|NCT03449030|453195172|FG006|Overall Study|Progressive Disease|0|||
125974342|NCT03449030|453195173|FG007|Overall Study|Progressive Disease|1|||
125974343|NCT03449030|453195174|FG008|Overall Study|Progressive Disease|1|||
125974344|NCT03449030|453195175|FG009|Overall Study|Progressive Disease|1|||
125974345|NCT03449030|453195166|FG000|Overall Study|Adverse Event|0|||
125974346|NCT03449030|453195167|FG001|Overall Study|Adverse Event|0|||
125974347|NCT03449030|453195168|FG002|Overall Study|Adverse Event|0|||
125974348|NCT03449030|453195169|FG003|Overall Study|Adverse Event|0|||
125974349|NCT03449030|453195170|FG004|Overall Study|Adverse Event|0|||
125974350|NCT03449030|453195171|FG005|Overall Study|Adverse Event|2|||
125974351|NCT03449030|453195172|FG006|Overall Study|Adverse Event|0|||
125974352|NCT03449030|453195173|FG007|Overall Study|Adverse Event|0|||
125974353|NCT03449030|453195174|FG008|Overall Study|Adverse Event|0|||
125974354|NCT03449030|453195175|FG009|Overall Study|Adverse Event|0|||
125974355|NCT03449030|453195166|FG000|Overall Study|Death|0|||
125974356|NCT03449030|453195167|FG001|Overall Study|Death|0|||
125974357|NCT03449030|453195168|FG002|Overall Study|Death|0|||
125974358|NCT03449030|453195169|FG003|Overall Study|Death|0|||
125974359|NCT03449030|453195170|FG004|Overall Study|Death|1|||
125974360|NCT03449030|453195171|FG005|Overall Study|Death|0|||
125974361|NCT03449030|453195172|FG006|Overall Study|Death|0|||
125974362|NCT03449030|453195173|FG007|Overall Study|Death|0|||
125974363|NCT03449030|453195174|FG008|Overall Study|Death|0|||
125974364|NCT03449030|453195175|FG009|Overall Study|Death|0|||
125974365|NCT02491671|453195186|FG000|Overall Study|Adverse Event|6|||
125974366|NCT02491671|453195187|FG001|Overall Study|Adverse Event|8|||
125974367|NCT02491671|453195186|FG000|Overall Study|Death|0|||
125974368|NCT02491671|453195187|FG001|Overall Study|Death|2|||
125974369|NCT02491671|453195186|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
125974370|NCT02491671|453195187|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
125974371|NCT00535730|453195188|FG000|Overall Study|Adverse Event|1|||
126177011|NCT03176277|453932915|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
125974372|NCT00535730|453195189|FG001|Overall Study|Adverse Event|1|||
125974373|NCT00535730|453195188|FG000|Overall Study|Lost to Follow-up|0|||
125974374|NCT00535730|453195189|FG001|Overall Study|Lost to Follow-up|1|||
125974375|NCT00535730|453195188|FG000|Overall Study|Physician Decision|0|||
125974376|NCT00535730|453195189|FG001|Overall Study|Physician Decision|1|||
125974377|NCT00535730|453195188|FG000|Overall Study|Protocol Violation|1|||
125974378|NCT00535730|453195189|FG001|Overall Study|Protocol Violation|0|||
125974379|NCT00535730|453195188|FG000|Overall Study|Withdrawal by Subject|0|||
125974380|NCT00535730|453195189|FG001|Overall Study|Withdrawal by Subject|4|||
125974381|NCT04072159|453195200|FG000|Overall Study|Lost to Follow-up|6|||
125974382|NCT04072159|453195201|FG001|Overall Study|Lost to Follow-up|6|||
125974383|NCT04072159|453195200|FG000|Overall Study|Withdrawal by Subject|2|||
125974384|NCT04072159|453195201|FG001|Overall Study|Withdrawal by Subject|0|||
125974385|NCT00695669|453195205|FG000|Overall Study|Adverse Event|0|||
126177012|NCT03176277|453932916|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
126177013|NCT03176277|453932913|FG000|Part A Dose Escalation Study|Progressive disease|3|||
126177014|NCT03176277|453932914|FG001|Part A Dose Escalation Study|Progressive disease|1|||
126177015|NCT03176277|453932915|FG002|Part A Dose Escalation Study|Progressive disease|3|||
126177016|NCT03176277|453932916|FG003|Part A Dose Escalation Study|Progressive disease|0|||
126177017|NCT00634114|453932917|FG000|Overall Study|Adverse Event|6|||
126177018|NCT00634114|453932918|FG001|Overall Study|Adverse Event|8|||
126177019|NCT00634114|453932919|FG002|Overall Study|Adverse Event|3|||
126177020|NCT00634114|453932917|FG000|Overall Study|Withdrawal by Subject|9|||
126177021|NCT00634114|453932918|FG001|Overall Study|Withdrawal by Subject|6|||
126177022|NCT00634114|453932919|FG002|Overall Study|Withdrawal by Subject|11|||
126177023|NCT00634114|453932917|FG000|Overall Study|Lost to Follow-up|0|||
126177024|NCT00634114|453932918|FG001|Overall Study|Lost to Follow-up|0|||
126177025|NCT00634114|453932919|FG002|Overall Study|Lost to Follow-up|1|||
126177026|NCT00634114|453932917|FG000|Overall Study|Protocol Violation|3|||
126177027|NCT00634114|453932918|FG001|Overall Study|Protocol Violation|3|||
126177028|NCT00634114|453932919|FG002|Overall Study|Protocol Violation|1|||
126177029|NCT00634114|453932917|FG000|Overall Study|Pregnancy|1|||
126177030|NCT00634114|453932918|FG001|Overall Study|Pregnancy|0|||
126177031|NCT00634114|453932919|FG002|Overall Study|Pregnancy|0|||
126177032|NCT00634114|453932917|FG000|Overall Study|Incorrect enrolment|0|||
126177033|NCT00634114|453932918|FG001|Overall Study|Incorrect enrolment|1|||
126177034|NCT00634114|453932919|FG002|Overall Study|Incorrect enrolment|0|||
126177035|NCT00634114|453932917|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
126177036|NCT00634114|453932918|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
126177037|NCT00634114|453932919|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
126177038|NCT00634114|453932917|FG000|Overall Study|Difficult to continue|3|||
126177039|NCT00634114|453932918|FG001|Overall Study|Difficult to continue|1|||
126177040|NCT00634114|453932919|FG002|Overall Study|Difficult to continue|1|||
126177041|NCT00634114|453932917|FG000|Overall Study|Other reason|1|||
126177042|NCT00634114|453932918|FG001|Overall Study|Other reason|1|||
126177043|NCT00634114|453932919|FG002|Overall Study|Other reason|1|||
126177044|NCT03699631|453932920|FG000|Overall Study|Adverse Event|3|||
126177045|NCT02940626|453932921|FG000|Overall Study|Death|40|||
126177046|NCT02940626|453932922|FG001|Overall Study|Death|32|||
126177047|NCT02940626|453932921|FG000|Overall Study|Lost to Follow-up|5|||
126177048|NCT02940626|453932922|FG001|Overall Study|Lost to Follow-up|2|||
126177049|NCT02940626|453932921|FG000|Overall Study|Withdrawal by Subject|1|||
126177050|NCT02940626|453932922|FG001|Overall Study|Withdrawal by Subject|0|||
126177051|NCT02940626|453932921|FG000|Overall Study|Transfer to Hospice Care|1|||
126177052|NCT02940626|453932922|FG001|Overall Study|Transfer to Hospice Care|0|||
126177053|NCT02940626|453932921|FG000|Overall Study|Prohibited Concomitant Medication|0|||
126177054|NCT02940626|453932922|FG001|Overall Study|Prohibited Concomitant Medication|1|||
126177055|NCT01996904|453932923|FG000|Overall Study|Lost to Follow-up|38|||
126177056|NCT01996904|453932924|FG001|Overall Study|Lost to Follow-up|27|||
126177057|NCT01324622|453932925|FG000|Overall Study|Lost to Follow-up|7|||
126177058|NCT01324622|453932926|FG001|Overall Study|Lost to Follow-up|7|||
126177059|NCT01324622|453932925|FG000|Overall Study|Death|1|||
126177060|NCT01324622|453932926|FG001|Overall Study|Death|0|||
126177061|NCT01324622|453932925|FG000|Overall Study|Lack of Efficacy|1|||
126177062|NCT01324622|453932926|FG001|Overall Study|Lack of Efficacy|0|||
126177063|NCT00618449|453932927|FG000|Overall Study|Lost to Follow-up|98|||
126177064|NCT00618449|453932928|FG001|Overall Study|Lost to Follow-up|110|||
126177065|NCT05127421|453932929|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
126177066|NCT05127421|453932930|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
126177067|NCT05127421|453932931|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
126177068|NCT05127421|453932932|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
126177069|NCT05127421|453932929|FG000|4-Week Double-Blind Period|Physician Decision|1|||
126177070|NCT05127421|453932930|FG001|4-Week Double-Blind Period|Physician Decision|0|||
126177071|NCT05127421|453932931|FG002|4-Week Double-Blind Period|Physician Decision|0|||
126177072|NCT05127421|453932932|FG003|4-Week Double-Blind Period|Physician Decision|0|||
126177073|NCT05127421|453932929|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
126177074|NCT05127421|453932930|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
126177075|NCT05127421|453932931|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
126177076|NCT05127421|453932932|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
126177077|NCT05127421|453932929|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
126177078|NCT05127421|453932930|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
126177079|NCT05127421|453932931|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
126177080|NCT05127421|453932932|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
126177081|NCT05127421|453932929|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
126177082|NCT05127421|453932930|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
126177083|NCT05127421|453932931|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
125974386|NCT00695669|453195206|FG001|Overall Study|Adverse Event|0|||
126177084|NCT05127421|453932932|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
126177085|NCT05127421|453932929|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
126177086|NCT05127421|453932930|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
126177087|NCT05127421|453932931|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
126177088|NCT05127421|453932932|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
126177089|NCT05127421|453932929|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
126177090|NCT05127421|453932930|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
126177091|NCT05127421|453932931|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
126177092|NCT05127421|453932932|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
126177093|NCT05127421|453932929|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
126177094|NCT05127421|453932930|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
126177095|NCT05127421|453932931|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
126177096|NCT05127421|453932932|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
126177097|NCT01441115|453932933|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
126177098|NCT00138424|453932934|FG000|Overall Study|Physician Decision|0|||
126177099|NCT00138424|453932935|FG001|Overall Study|Physician Decision|1|||
126177100|NCT00138424|453932936|FG002|Overall Study|Physician Decision|0|||
126177101|NCT00138424|453932937|FG003|Overall Study|Physician Decision|0|||
126177102|NCT00574496|453932940|FG000|Overall Study|Withdrawal by Subject|1|||
126177103|NCT02176291|453932941|FG000|Overall Study|Death|1|||
126177104|NCT02176291|453932942|FG001|Overall Study|Death|0|||
126177105|NCT02176291|453932941|FG000|Overall Study|non compliance with protocol|2|||
126177106|NCT02176291|453932942|FG001|Overall Study|non compliance with protocol|0|||
126177107|NCT02176291|453932941|FG000|Overall Study|Withdrawal by Subject|2|||
126177108|NCT02176291|453932942|FG001|Overall Study|Withdrawal by Subject|0|||
126177109|NCT01056341|453932943|FG000|Overall Study|Treatment Intolerance|0|||
126177110|NCT01056341|453932944|FG001|Overall Study|Treatment Intolerance|2|||
126177111|NCT01056341|453932945|FG002|Overall Study|Treatment Intolerance|0|||
126177112|NCT01056341|453932946|FG003|Overall Study|Treatment Intolerance|2|||
126177113|NCT01056341|453932947|FG004|Overall Study|Treatment Intolerance|0|||
126177114|NCT01056341|453932943|FG000|Overall Study|Lack of Efficacy|32|||
126177115|NCT01056341|453932944|FG001|Overall Study|Lack of Efficacy|30|||
126177116|NCT01056341|453932945|FG002|Overall Study|Lack of Efficacy|7|||
126177117|NCT01056341|453932946|FG003|Overall Study|Lack of Efficacy|25|||
126177118|NCT01056341|453932947|FG004|Overall Study|Lack of Efficacy|9|||
126177119|NCT01056341|453932943|FG000|Overall Study|Other reasons|4|||
126177120|NCT01056341|453932944|FG001|Overall Study|Other reasons|4|||
126177121|NCT01056341|453932945|FG002|Overall Study|Other reasons|8|||
126177122|NCT01056341|453932946|FG003|Overall Study|Other reasons|9|||
126177123|NCT01056341|453932947|FG004|Overall Study|Other reasons|5|||
126177124|NCT01086150|453932948|FG000|Overall Study|Withdrawal by Subject|0|||
126177125|NCT01086150|453932949|FG001|Overall Study|Withdrawal by Subject|4|||
126177126|NCT01086150|453932950|FG002|Overall Study|Withdrawal by Subject|1|||
126177127|NCT01086150|453932948|FG000|Overall Study|Lost to Follow-up|0|||
126177128|NCT01086150|453932949|FG001|Overall Study|Lost to Follow-up|1|||
126177129|NCT01086150|453932950|FG002|Overall Study|Lost to Follow-up|0|||
126177130|NCT01086150|453932948|FG000|Overall Study|Screen Failure|0|||
126177131|NCT01086150|453932949|FG001|Overall Study|Screen Failure|1|||
126177132|NCT01086150|453932950|FG002|Overall Study|Screen Failure|0|||
126177133|NCT01167582|453932951|FG000|Overall Study|Lost to Follow-up|0|||
126177134|NCT01167582|453932952|FG001|Overall Study|Lost to Follow-up|1|||
126177135|NCT01681576|453932955|FG000|Period 1|Adverse Event|1|||
126177136|NCT01681576|453932956|FG001|Period 1|Adverse Event|0|||
126177137|NCT01681576|453932955|FG000|Period 1|Protocol Deviation|1|||
126177138|NCT01681576|453932956|FG001|Period 1|Protocol Deviation|0|||
126177139|NCT01681576|453932955|FG000|Period 2|subject/guardian decision|3|||
126177140|NCT01681576|453932956|FG001|Period 2|subject/guardian decision|1|||
126177141|NCT01681576|453932955|FG000|Period 2|Non-compliance with study treatment|1|||
126177142|NCT01681576|453932956|FG001|Period 2|Non-compliance with study treatment|0|||
126177143|NCT01518244|453932957|FG000|Overall Study|Adverse Event|3|||
126177144|NCT02721251|453932961|FG000|Overall Study|Withdrawal by Subject|8|||
126177145|NCT02721251|453932962|FG001|Overall Study|Withdrawal by Subject|7|||
126177146|NCT02721251|453932963|FG002|Overall Study|Withdrawal by Subject|9|||
126177147|NCT02721251|453932961|FG000|Overall Study|poor adherence|2|||
126177148|NCT02721251|453932962|FG001|Overall Study|poor adherence|2|||
126177149|NCT02721251|453932963|FG002|Overall Study|poor adherence|2|||
126177150|NCT01714817|453932964|FG000|Year 1 Period|Lack of Efficacy|11|||
126177151|NCT01714817|453932965|FG001|Year 1 Period|Lack of Efficacy|9|||
126177152|NCT01714817|453932964|FG000|Year 1 Period|Adverse Event|20|||
126177153|NCT01714817|453932965|FG001|Year 1 Period|Adverse Event|17|||
126177154|NCT01714817|453932964|FG000|Year 1 Period|Withdrawal by Subject|6|||
126177155|NCT01714817|453932965|FG001|Year 1 Period|Withdrawal by Subject|7|||
126177156|NCT01714817|453932964|FG000|Year 1 Period|Death|1|||
126177157|NCT01714817|453932965|FG001|Year 1 Period|Death|1|||
126177158|NCT01714817|453932964|FG000|Year 1 Period|Lost to Follow-up|0|||
126177159|NCT01714817|453932965|FG001|Year 1 Period|Lost to Follow-up|2|||
126177160|NCT01714817|453932964|FG000|Year 1 Period|Poor / non-compliance|0|||
126177161|NCT01714817|453932965|FG001|Year 1 Period|Poor / non-compliance|1|||
126177162|NCT01714817|453932964|FG000|Year 1 Period|Pregnancy|2|||
126177163|NCT01714817|453932965|FG001|Year 1 Period|Pregnancy|0|||
126177164|NCT01714817|453932964|FG000|Year 1 Period|Participant no longer meets criteria|6|||
126177165|NCT01714817|453932965|FG001|Year 1 Period|Participant no longer meets criteria|2|||
126177166|NCT01714817|453932964|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
126177167|NCT01714817|453932965|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
126177168|NCT01714817|453932964|FG000|Year 1 Period|Change in Concomitant Medication|0|||
126177169|NCT01714817|453932965|FG001|Year 1 Period|Change in Concomitant Medication|1|||
126177170|NCT01714817|453932964|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
126177171|NCT01714817|453932965|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
126177172|NCT01714817|453932964|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
126177173|NCT01714817|453932965|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
126177174|NCT01714817|453932964|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
126177175|NCT01714817|453932965|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
126177176|NCT01714817|453932964|FG000|Year 2 Period|Lack of Efficacy|4|||
126177177|NCT01714817|453932965|FG001|Year 2 Period|Lack of Efficacy|12|||
126177178|NCT01714817|453932964|FG000|Year 2 Period|Adverse Event|7|||
126177179|NCT01714817|453932965|FG001|Year 2 Period|Adverse Event|6|||
126177180|NCT01714817|453932964|FG000|Year 2 Period|Participant request to stop treatment|4|||
126177181|NCT01714817|453932965|FG001|Year 2 Period|Participant request to stop treatment|4|||
126177182|NCT01714817|453932964|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
126177183|NCT01714817|453932965|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
126177184|NCT01714817|453932964|FG000|Year 2 Period|Participant withdrew consent|1|||
126177185|NCT01714817|453932965|FG001|Year 2 Period|Participant withdrew consent|5|||
126177186|NCT01714817|453932964|FG000|Year 2 Period|Participant no longer meets criteria|1|||
126177187|NCT01714817|453932965|FG001|Year 2 Period|Participant no longer meets criteria|4|||
126177188|NCT01714817|453932964|FG000|Year 2 Period|Lost to Follow-up|2|||
126177189|NCT01714817|453932965|FG001|Year 2 Period|Lost to Follow-up|0|||
126177190|NCT01714817|453932964|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
126177191|NCT01714817|453932965|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
126177192|NCT01714817|453932964|FG000|Year 2 Period|Pregnancy|1|||
126177193|NCT01714817|453932965|FG001|Year 2 Period|Pregnancy|1|||
126177194|NCT01714817|453932964|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
126177195|NCT01714817|453932965|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
126177196|NCT01714817|453932964|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
126177197|NCT01714817|453932965|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
126177198|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
126177199|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
126177200|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
126177201|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
126177202|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
126177203|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
126177204|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
126177205|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
126177206|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
126177207|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
126177208|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
126177209|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
126177210|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126177211|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
126177212|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
126177213|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
126177214|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
126177215|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
126177216|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
126177217|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
126177218|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
126177219|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
126177220|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
126177221|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
126177222|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
126177223|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
126177224|NCT01714817|453932964|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
126177225|NCT01714817|453932965|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
126177226|NCT02921763|453932966|FG000|Overall Study|Adverse Event|4|||
126177227|NCT02921763|453932966|FG000|Overall Study|Lost to Follow-up|4|||
126177228|NCT02921763|453932966|FG000|Overall Study|Lack of Efficacy|3|||
126177229|NCT02921763|453932966|FG000|Overall Study|Protocol Violation|2|||
126177230|NCT02921763|453932966|FG000|Overall Study|Withdrawal by Subject|2|||
126177231|NCT02921763|453932966|FG000|Overall Study|Physician Decision|1|||
126177232|NCT02921763|453932966|FG000|Overall Study|No data obtained|2|||
126177233|NCT04142216|453932967|FG000|Overall Study|Hospitalization|0|||
126177234|NCT04142216|453932968|FG001|Overall Study|Hospitalization|2|||
126177235|NCT04142216|453932967|FG000|Overall Study|Death|3|||
126177236|NCT04142216|453932968|FG001|Overall Study|Death|1|||
126177237|NCT04142216|453932967|FG000|Overall Study|Referral to another hemodialysis unit|3|||
126177238|NCT04142216|453932968|FG001|Overall Study|Referral to another hemodialysis unit|2|||
126177239|NCT04142216|453932967|FG000|Overall Study|Use of clove|0|||
126177240|NCT04142216|453932968|FG001|Overall Study|Use of clove|1|||
126177241|NCT01582971|453932969|FG000|Overall Study|Death|2|||
126177242|NCT01582971|453932970|FG001|Overall Study|Death|1|||
126177243|NCT01582971|453932969|FG000|Overall Study|Lost to Follow-up|18|||
126177244|NCT01582971|453932970|FG001|Overall Study|Lost to Follow-up|21|||
126177245|NCT01582971|453932969|FG000|Overall Study|Withdrawal by Subject|4|||
126177246|NCT01582971|453932970|FG001|Overall Study|Withdrawal by Subject|2|||
126177247|NCT01582971|453932969|FG000|Overall Study|Other|15|||
126177248|NCT01582971|453932970|FG001|Overall Study|Other|13|||
126177249|NCT02007954|453932971|FG000|Overall Study|Received liver transplant|3|||
126177250|NCT02007954|453932971|FG000|Overall Study|Switch in treatment modality|2|||
126177251|NCT02007954|453932971|FG000|Overall Study|Disease progression and unrelated AE|1|||
126177252|NCT02007954|453932971|FG000|Overall Study|Death|1|||
126177253|NCT01195363|453932975|FG000|Overall Study|Lost to Follow-up|7|||
126177254|NCT01195363|453932976|FG001|Overall Study|Lost to Follow-up|4|||
126177255|NCT01195363|453932975|FG000|Overall Study|Adverse Event|3|||
126177256|NCT01195363|453932976|FG001|Overall Study|Adverse Event|1|||
126177257|NCT01195363|453932975|FG000|Overall Study|Lack of Efficacy|0|||
126177258|NCT01195363|453932976|FG001|Overall Study|Lack of Efficacy|4|||
126177259|NCT01195363|453932975|FG000|Overall Study|incarceration|1|||
126177260|NCT01195363|453932976|FG001|Overall Study|incarceration|0|||
126177261|NCT01871896|453932987|FG000|Overall Study|Lost to Follow-up|1|||
126177262|NCT06025396|453934734|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
126177263|NCT06025396|453934735|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
126177264|NCT06025396|453934736|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
126177265|NCT06025396|453934737|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
126177266|NCT06025396|453934738|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
126177267|NCT06025396|453934734|FG000|Overall Study|Withdrawal by Subject|0|||
126177268|NCT06025396|453934735|FG001|Overall Study|Withdrawal by Subject|1|||
126177269|NCT06025396|453934736|FG002|Overall Study|Withdrawal by Subject|1|||
126177270|NCT06025396|453934737|FG003|Overall Study|Withdrawal by Subject|0|||
126177271|NCT06025396|453934738|FG004|Overall Study|Withdrawal by Subject|0|||
126177272|NCT05691829|453934739|FG000|Overall Study|Physician Decision|2|||
126177273|NCT05691829|453934739|FG000|Overall Study|Eligibility criteria not met|3|||
126177274|NCT06422377|453934745|FG000|Overall Study|Study Terminated by Sponsor|1|||
126177275|NCT02843178|453934747|FG000|Overall Study|Lost to Follow-up|8|||
126177276|NCT02843178|453934748|FG001|Overall Study|Lost to Follow-up|8|||
126177277|NCT02843178|453934749|FG002|Overall Study|Lost to Follow-up|6|||
126177278|NCT02843178|453934750|FG003|Overall Study|Lost to Follow-up|3|||
126177279|NCT02843178|453934747|FG000|Overall Study|Withdrawal by Subject|0|||
126177280|NCT02843178|453934748|FG001|Overall Study|Withdrawal by Subject|0|||
126177281|NCT02843178|453934749|FG002|Overall Study|Withdrawal by Subject|1|||
126177282|NCT02843178|453934750|FG003|Overall Study|Withdrawal by Subject|1|||
126177283|NCT00453180|453934757|FG000|Overall Study|Lost to Follow-up|2|||
126177284|NCT00453180|453934758|FG001|Overall Study|Lost to Follow-up|1|||
126177285|NCT00453180|453934757|FG000|Overall Study|Adverse Event|1|||
126177286|NCT00453180|453934758|FG001|Overall Study|Adverse Event|2|||
126177287|NCT02420795|453934765|FG000|Overall Study|Withdrawal by Subject|1|||
126177288|NCT02420795|453934766|FG001|Overall Study|Withdrawal by Subject|0|||
126177289|NCT02420795|453934767|FG002|Overall Study|Withdrawal by Subject|0|||
126177290|NCT02420795|453934765|FG000|Overall Study|Adverse Event|1|||
126177291|NCT02420795|453934766|FG001|Overall Study|Adverse Event|0|||
126177292|NCT02420795|453934767|FG002|Overall Study|Adverse Event|0|||
126177293|NCT02420795|453934765|FG000|Overall Study|Progressive disease|2|||
126177294|NCT02420795|453934766|FG001|Overall Study|Progressive disease|2|||
126177295|NCT02420795|453934767|FG002|Overall Study|Progressive disease|4|||
126177296|NCT02420795|453934765|FG000|Overall Study|Death|0|||
126177297|NCT02420795|453934766|FG001|Overall Study|Death|0|||
126177298|NCT02420795|453934767|FG002|Overall Study|Death|1|||
126177299|NCT01002742|453934770|FG000|Overall Study|Determined to be ineligible|0|||
126177300|NCT01002742|453934771|FG001|Overall Study|Determined to be ineligible|1|||
126177301|NCT02862548|453934783|FG000|Randomized Phase (Up to Week 48)|Death|0|||
126177302|NCT02862548|453934784|FG001|Randomized Phase (Up to Week 48)|Death|1|||
126177303|NCT02862548|453934783|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
126177304|NCT02862548|453934784|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
126177305|NCT02862548|453934783|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
126177306|NCT02862548|453934784|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
126177307|NCT02862548|453934783|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
126177308|NCT02862548|453934784|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
126177309|NCT00880763|453934785|FG000|Extension Period (Part 2)|Adverse Event|0|||
126177310|NCT00880763|453934786|FG001|Extension Period (Part 2)|Adverse Event|0|||
126177311|NCT00880763|453934787|FG002|Extension Period (Part 2)|Adverse Event|1|||
126177312|NCT00880763|453934788|FG003|Extension Period (Part 2)|Adverse Event|1|||
126177313|NCT00880763|453934785|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
126177314|NCT00880763|453934786|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
126177315|NCT00880763|453934787|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
126177316|NCT00880763|453934788|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
126177317|NCT00880763|453934785|FG000|Extension Period (Part 2)|Physician Decision|0|||
126177318|NCT00880763|453934786|FG001|Extension Period (Part 2)|Physician Decision|1|||
126177319|NCT00880763|453934787|FG002|Extension Period (Part 2)|Physician Decision|1|||
126177320|NCT00880763|453934788|FG003|Extension Period (Part 2)|Physician Decision|0|||
126177321|NCT00880763|453934785|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
126177322|NCT00880763|453934786|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
126177323|NCT00880763|453934787|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
126177324|NCT00880763|453934788|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
126177325|NCT02670928|453934790|FG000|Overall Study|Adverse Event|3|||
126177326|NCT02670928|453934791|FG001|Overall Study|Adverse Event|1|||
126177327|NCT02670928|453934790|FG000|Overall Study|Withdrawal by Subject|4|||
126177328|NCT02670928|453934791|FG001|Overall Study|Withdrawal by Subject|0|||
126177329|NCT02670928|453934790|FG000|Overall Study|Lost to Follow-up|1|||
126177330|NCT02670928|453934791|FG001|Overall Study|Lost to Follow-up|0|||
126177331|NCT02670928|453934790|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
126177332|NCT02670928|453934791|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
126177333|NCT01293006|453934792|FG000|Period 2|Lost to Follow-up|1|||
126177334|NCT01293006|453934793|FG001|Period 2|Lost to Follow-up|0|||
126177335|NCT01293006|453934794|FG002|Period 2|Lost to Follow-up|0|||
126177336|NCT01293006|453934795|FG003|Period 2|Lost to Follow-up|0|||
126177337|NCT01494987|453934796|FG000|Overall Study|Adverse Event|6|||
126177338|NCT01494987|453934797|FG001|Overall Study|Adverse Event|5|||
126177339|NCT01494987|453934796|FG000|Overall Study|Hyperglycemia|6|||
126177340|NCT01494987|453934797|FG001|Overall Study|Hyperglycemia|4|||
126177341|NCT01494987|453934796|FG000|Overall Study|Investigator's Discretion|1|||
126177342|NCT01494987|453934797|FG001|Overall Study|Investigator's Discretion|2|||
126177343|NCT01494987|453934796|FG000|Overall Study|Lost to Follow-up|1|||
126177344|NCT01494987|453934797|FG001|Overall Study|Lost to Follow-up|1|||
126177345|NCT01494987|453934796|FG000|Overall Study|Protocol Violation|3|||
126177346|NCT01494987|453934797|FG001|Overall Study|Protocol Violation|3|||
126177347|NCT01494987|453934796|FG000|Overall Study|Subject Non-Compliance|9|||
126177348|NCT01494987|453934797|FG001|Overall Study|Subject Non-Compliance|10|||
126177349|NCT01494987|453934796|FG000|Overall Study|Subject Withdrew Consent|2|||
126177350|NCT01494987|453934797|FG001|Overall Study|Subject Withdrew Consent|3|||
125974387|NCT00695669|453195207|FG002|Overall Study|Adverse Event|2|||
125974388|NCT00695669|453195208|FG003|Overall Study|Adverse Event|0|||
125974389|NCT00695669|453195205|FG000|Overall Study|Lost to Follow-up|4|||
125974390|NCT00695669|453195206|FG001|Overall Study|Lost to Follow-up|4|||
125974391|NCT00695669|453195207|FG002|Overall Study|Lost to Follow-up|1|||
125974392|NCT00695669|453195208|FG003|Overall Study|Lost to Follow-up|4|||
125974393|NCT05045625|453195209|FG000|Overall Study|Lost to Follow-up|3|||
125974394|NCT00417079|453195210|FG000|Overall Study|Disease progression|267|||
125974395|NCT00417079|453195211|FG001|Overall Study|Disease progression|180|||
125974396|NCT00417079|453195210|FG000|Overall Study|Adverse Event|32|||
125974397|NCT00417079|453195211|FG001|Overall Study|Adverse Event|67|||
125974398|NCT00417079|453195210|FG000|Overall Study|Non-compliance to protocol|0|||
125974399|NCT00417079|453195211|FG001|Overall Study|Non-compliance to protocol|1|||
125974400|NCT00417079|453195210|FG000|Overall Study|Lost to Follow-up|2|||
126177351|NCT00436982|453934800|FG000|Overall Study|Withdrawal by Subject|3|||
126177352|NCT00436982|453934801|FG001|Overall Study|Withdrawal by Subject|1|||
126177353|NCT00436982|453934800|FG000|Overall Study|Did not receive allocated intervention|0|||
126177354|NCT00436982|453934801|FG001|Overall Study|Did not receive allocated intervention|1|||
126177355|NCT00436982|453934800|FG000|Overall Study|no RSA data|1|||
126177356|NCT00436982|453934801|FG001|Overall Study|no RSA data|2|||
126177357|NCT02215616|453934805|FG000|Overall Study|Sponsor requested to stop study drug|0|||
126177358|NCT02215616|453934806|FG001|Overall Study|Sponsor requested to stop study drug|0|||
125974401|NCT00417079|453195211|FG001|Overall Study|Lost to Follow-up|0|||
125974402|NCT00417079|453195210|FG000|Overall Study|Withdrawal by Subject|17|||
126177359|NCT02215616|453934807|FG002|Overall Study|Sponsor requested to stop study drug|1|||
126177360|NCT02215616|453934808|FG003|Overall Study|Sponsor requested to stop study drug|4|||
126177361|NCT02215616|453934805|FG000|Overall Study|Death|1|||
126177362|NCT02215616|453934806|FG001|Overall Study|Death|0|||
126177363|NCT02215616|453934807|FG002|Overall Study|Death|0|||
126177364|NCT02215616|453934808|FG003|Overall Study|Death|0|||
126177365|NCT02215616|453934805|FG000|Overall Study|Adverse Event|7|||
126177366|NCT02215616|453934806|FG001|Overall Study|Adverse Event|4|||
126177367|NCT02215616|453934807|FG002|Overall Study|Adverse Event|9|||
126177368|NCT02215616|453934808|FG003|Overall Study|Adverse Event|2|||
126177369|NCT02215616|453934805|FG000|Overall Study|Withdrawal by Subject|1|||
126177370|NCT02215616|453934806|FG001|Overall Study|Withdrawal by Subject|8|||
126177371|NCT02215616|453934807|FG002|Overall Study|Withdrawal by Subject|2|||
126177372|NCT02215616|453934808|FG003|Overall Study|Withdrawal by Subject|5|||
126177373|NCT02215616|453934805|FG000|Overall Study|Non-compliance|0|||
126177374|NCT02215616|453934806|FG001|Overall Study|Non-compliance|2|||
126177375|NCT02215616|453934807|FG002|Overall Study|Non-compliance|1|||
126177376|NCT02215616|453934808|FG003|Overall Study|Non-compliance|0|||
126177377|NCT02215616|453934805|FG000|Overall Study|Protocol Violation|0|||
126177378|NCT02215616|453934806|FG001|Overall Study|Protocol Violation|2|||
126177379|NCT02215616|453934807|FG002|Overall Study|Protocol Violation|0|||
126177380|NCT02215616|453934808|FG003|Overall Study|Protocol Violation|0|||
126177381|NCT02215616|453934805|FG000|Overall Study|Lost to Follow-up|1|||
126177382|NCT02215616|453934806|FG001|Overall Study|Lost to Follow-up|1|||
126177383|NCT02215616|453934807|FG002|Overall Study|Lost to Follow-up|0|||
126177384|NCT02215616|453934808|FG003|Overall Study|Lost to Follow-up|1|||
126177385|NCT02215616|453934805|FG000|Overall Study|Other than specified|1|||
126177386|NCT02215616|453934806|FG001|Overall Study|Other than specified|0|||
126177387|NCT02215616|453934807|FG002|Overall Study|Other than specified|1|||
126177388|NCT02215616|453934808|FG003|Overall Study|Other than specified|1|||
126177389|NCT01352845|453934811|FG000|Overall Study|Lost to Follow-up|313|||
126177390|NCT01352845|453934812|FG001|Overall Study|Lost to Follow-up|92|||
126177391|NCT01352845|453934811|FG000|Overall Study|No Longer Willing to Participate|205|||
126177392|NCT01352845|453934812|FG001|Overall Study|No Longer Willing to Participate|58|||
126177393|NCT01352845|453934811|FG000|Overall Study|Withdrawal by Subject|48|||
126177394|NCT01352845|453934812|FG001|Overall Study|Withdrawal by Subject|16|||
126177395|NCT01352845|453934811|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
126177396|NCT01352845|453934812|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
126177397|NCT01352845|453934811|FG000|Overall Study|Pregnancy|27|||
126177398|NCT01352845|453934812|FG001|Overall Study|Pregnancy|7|||
126177399|NCT01352845|453934811|FG000|Overall Study|Adverse Event|22|||
126177400|NCT01352845|453934812|FG001|Overall Study|Adverse Event|6|||
126177401|NCT01352845|453934811|FG000|Overall Study|Other|17|||
126177402|NCT01352845|453934812|FG001|Overall Study|Other|7|||
126177403|NCT01352845|453934811|FG000|Overall Study|Protocol Violation|12|||
126177404|NCT01352845|453934812|FG001|Overall Study|Protocol Violation|6|||
126177405|NCT01352845|453934811|FG000|Overall Study|Death|3|||
125974403|NCT00417079|453195211|FG001|Overall Study|Withdrawal by Subject|8|||
125974404|NCT00417079|453195210|FG000|Overall Study|Not treated|6|||
125974405|NCT00417079|453195211|FG001|Overall Study|Not treated|7|||
125974406|NCT00417079|453195210|FG000|Overall Study|Screened failure|2|||
125974407|NCT00417079|453195211|FG001|Overall Study|Screened failure|1|||
125974408|NCT00417079|453195210|FG000|Overall Study|Investigator's decision|1|||
125974409|NCT00417079|453195211|FG001|Overall Study|Investigator's decision|4|||
125974410|NCT00417079|453195210|FG000|Overall Study|Non-confirmed Disease progression|1|||
125974411|NCT00417079|453195211|FG001|Overall Study|Non-confirmed Disease progression|1|||
125974412|NCT00417079|453195210|FG000|Overall Study|Clinical deterioration|1|||
125974413|NCT00417079|453195211|FG001|Overall Study|Clinical deterioration|0|||
125974414|NCT00417079|453195210|FG000|Overall Study|Screening error|2|||
125974415|NCT00417079|453195211|FG001|Overall Study|Screening error|1|||
125974416|NCT00417079|453195210|FG000|Overall Study|Withdrawal by subject's family|0|||
125974417|NCT00417079|453195211|FG001|Overall Study|Withdrawal by subject's family|1|||
125974418|NCT00417079|453195210|FG000|Overall Study|Patient unable to come to the clinic|0|||
125974419|NCT00417079|453195211|FG001|Overall Study|Patient unable to come to the clinic|1|||
125974420|NCT00417079|453195210|FG000|Overall Study|abnormal liver function tests|0|||
125974421|NCT00417079|453195211|FG001|Overall Study|abnormal liver function tests|1|||
125974422|NCT03570619|453195222|FG000|Overall Study|Adverse Event|2|||
125974423|NCT03570619|453195223|FG001|Overall Study|Adverse Event|0|||
125974424|NCT03570619|453195224|FG002|Overall Study|Adverse Event|1|||
125974425|NCT03570619|453195222|FG000|Overall Study|new diagnosis of new malignancy|1|||
125974426|NCT03570619|453195223|FG001|Overall Study|new diagnosis of new malignancy|0|||
126177406|NCT01352845|453934812|FG001|Overall Study|Death|0|||
126177407|NCT01595438|453934818|FG000|Overall Study|Lost to Follow-up|20|||
126177408|NCT01595438|453934819|FG001|Overall Study|Lost to Follow-up|20|||
126177409|NCT01595438|453934818|FG000|Overall Study|Withdrawal by Subject|12|||
126177410|NCT01595438|453934819|FG001|Overall Study|Withdrawal by Subject|12|||
126177411|NCT01595438|453934818|FG000|Overall Study|Other Eligibility criteria|11|||
126177412|NCT01595438|453934819|FG001|Overall Study|Other Eligibility criteria|9|||
126177413|NCT05590767|453934822|FG000|Overall Study|Protocol Violation|1|||
126177414|NCT05590767|453934822|FG000|Overall Study|surgery canceled|1|||
126177415|NCT05590767|453934822|FG000|Overall Study|interscalene brachial block not performed|1|||
126177416|NCT02677220|453934832|FG000|Overall Study|Adverse Event|1|||
126177417|NCT00965146|453934833|FG000|Overall Study|Death|7|||
126177418|NCT00965146|453934833|FG000|Overall Study|Lost to Follow-up|22|||
126177419|NCT00965146|453934833|FG000|Overall Study|Withdrawal by Subject|17|||
126177420|NCT00965146|453934833|FG000|Overall Study|Unable to return|1|||
126177421|NCT00965146|453934833|FG000|Overall Study|Unwilling to return|11|||
126199925|NCT00089505|454017802|FG002|Overall Study|Physician Decision|0|||
126177422|NCT00965146|453934833|FG000|Overall Study|Intercurrent illness|1|||
126177423|NCT00965146|453934833|FG000|Overall Study|Revision / Removal of Study Implant|6|||
126177424|NCT00965146|453934833|FG000|Overall Study|Overall Study Termination|145|||
126177425|NCT01504971|453934836|FG000|Overall Study|Physician Decision|13|||
126177426|NCT03483116|453934837|FG000|Overall Study|Adverse Event|0|||
126177427|NCT03483116|453934838|FG001|Overall Study|Adverse Event|1|||
126177428|NCT03483116|453934839|FG002|Overall Study|Adverse Event|0|||
126177429|NCT03483116|453934840|FG003|Overall Study|Adverse Event|1|||
126177430|NCT03483116|453934837|FG000|Overall Study|Protocol Violation|1|||
126177431|NCT03483116|453934838|FG001|Overall Study|Protocol Violation|0|||
126177432|NCT03483116|453934839|FG002|Overall Study|Protocol Violation|0|||
126177433|NCT03483116|453934840|FG003|Overall Study|Protocol Violation|7|||
126177434|NCT03483116|453934837|FG000|Overall Study|Lost to Follow-up|9|||
126177435|NCT03483116|453934838|FG001|Overall Study|Lost to Follow-up|4|||
126177436|NCT03483116|453934839|FG002|Overall Study|Lost to Follow-up|9|||
126177437|NCT03483116|453934840|FG003|Overall Study|Lost to Follow-up|5|||
126177438|NCT03483116|453934837|FG000|Overall Study|Death|1|||
126177439|NCT03483116|453934838|FG001|Overall Study|Death|0|||
126177440|NCT03483116|453934839|FG002|Overall Study|Death|2|||
126177441|NCT03483116|453934840|FG003|Overall Study|Death|1|||
126177442|NCT03483116|453934837|FG000|Overall Study|Withdrawal by Subject|14|||
126177443|NCT03483116|453934838|FG001|Overall Study|Withdrawal by Subject|16|||
126177444|NCT03483116|453934839|FG002|Overall Study|Withdrawal by Subject|14|||
126177445|NCT03483116|453934840|FG003|Overall Study|Withdrawal by Subject|16|||
126177446|NCT03483116|453934837|FG000|Overall Study|Unknown other reason|3|||
126177447|NCT03483116|453934838|FG001|Overall Study|Unknown other reason|2|||
126177448|NCT03483116|453934839|FG002|Overall Study|Unknown other reason|1|||
126177449|NCT03483116|453934840|FG003|Overall Study|Unknown other reason|1|||
126177450|NCT01181102|453934841|FG000|Overall Study|Adverse Event|28|||
126177451|NCT01181102|453934842|FG001|Overall Study|Adverse Event|26|||
126177452|NCT01181102|453934841|FG000|Overall Study|Lack of Efficacy|3|||
126177453|NCT01181102|453934842|FG001|Overall Study|Lack of Efficacy|1|||
126177454|NCT01181102|453934841|FG000|Overall Study|Lost to Follow-up|2|||
126177455|NCT01181102|453934842|FG001|Overall Study|Lost to Follow-up|0|||
126177456|NCT01181102|453934841|FG000|Overall Study|Physician Decision|3|||
126177457|NCT01181102|453934842|FG001|Overall Study|Physician Decision|1|||
126177458|NCT01181102|453934841|FG000|Overall Study|Protocol Violation|5|||
126177459|NCT01181102|453934842|FG001|Overall Study|Protocol Violation|6|||
126177460|NCT01181102|453934841|FG000|Overall Study|Withdrawal by Subject|10|||
126177461|NCT01181102|453934842|FG001|Overall Study|Withdrawal by Subject|12|||
126177462|NCT00936117|453934845|FG000|Overall Study|Adverse Event|7|||
126177463|NCT00936117|453934845|FG000|Overall Study|Unable to continue oral medication|3|||
126177464|NCT00426556|453934854|FG000|Phase I - Core Phase|Disease Progression|0|||
126177465|NCT00426556|453934855|FG001|Phase I - Core Phase|Disease Progression|6|||
126177466|NCT00426556|453934856|FG002|Phase I - Core Phase|Disease Progression|2|||
126177467|NCT00426556|453934857|FG003|Phase I - Core Phase|Disease Progression|0|||
126177468|NCT00426556|453934854|FG000|Phase I - Core Phase|Adverse Event|1|||
126177469|NCT00426556|453934855|FG001|Phase I - Core Phase|Adverse Event|3|||
126177470|NCT00426556|453934856|FG002|Phase I - Core Phase|Adverse Event|1|||
126177471|NCT00426556|453934857|FG003|Phase I - Core Phase|Adverse Event|0|||
126177472|NCT00426556|453934854|FG000|Phase I - Core Phase|Death|0|||
126177473|NCT00426556|453934855|FG001|Phase I - Core Phase|Death|1|||
126177474|NCT00426556|453934856|FG002|Phase I - Core Phase|Death|0|||
125974427|NCT03570619|453195224|FG002|Overall Study|new diagnosis of new malignancy|0|||
125974428|NCT03570619|453195222|FG000|Overall Study|Physician Decision|1|||
125974429|NCT03570619|453195223|FG001|Overall Study|Physician Decision|1|||
125974430|NCT03570619|453195224|FG002|Overall Study|Physician Decision|0|||
125974431|NCT03570619|453195222|FG000|Overall Study|Withdrawal by Subject|0|||
126177475|NCT00426556|453934857|FG003|Phase I - Core Phase|Death|0|||
126177476|NCT00426556|453934854|FG000|Phase I - Extension Phase|Adverse Event|0|||
126177477|NCT00426556|453934855|FG001|Phase I - Extension Phase|Adverse Event|1|||
126177478|NCT00426556|453934856|FG002|Phase I - Extension Phase|Adverse Event|1|||
125974432|NCT03570619|453195223|FG001|Overall Study|Withdrawal by Subject|2|||
125974433|NCT03570619|453195224|FG002|Overall Study|Withdrawal by Subject|0|||
126177479|NCT00426556|453934857|FG003|Phase I - Extension Phase|Adverse Event|0|||
126177480|NCT00426556|453934854|FG000|Phase I - Extension Phase|Disease Progression|5|||
125974434|NCT04084314|453195229|FG000|Overall Study|Subject/guardian decision|91|||
126177481|NCT00426556|453934855|FG001|Phase I - Extension Phase|Disease Progression|5|||
126177482|NCT00426556|453934856|FG002|Phase I - Extension Phase|Disease Progression|6|||
126177483|NCT00426556|453934857|FG003|Phase I - Extension Phase|Disease Progression|0|||
126177484|NCT00426556|453934854|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
126177485|NCT00426556|453934855|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
126177486|NCT00426556|453934856|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
126177487|NCT00426556|453934857|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
126177488|NCT00426556|453934854|FG000|Phase II - Core Phase|Disease Progression|0|||
126177489|NCT00426556|453934855|FG001|Phase II - Core Phase|Disease Progression|0|||
126177490|NCT00426556|453934856|FG002|Phase II - Core Phase|Disease Progression|0|||
126177491|NCT00426556|453934857|FG003|Phase II - Core Phase|Disease Progression|16|||
126177492|NCT00426556|453934854|FG000|Phase II - Core Phase|Adverse Event|0|||
126177493|NCT00426556|453934855|FG001|Phase II - Core Phase|Adverse Event|0|||
126177494|NCT00426556|453934856|FG002|Phase II - Core Phase|Adverse Event|0|||
126177495|NCT00426556|453934857|FG003|Phase II - Core Phase|Adverse Event|8|||
126177496|NCT00426556|453934854|FG000|Phase II - Extension Phase|Disease Progression|0|||
126177497|NCT00426556|453934855|FG001|Phase II - Extension Phase|Disease Progression|0|||
126177498|NCT00426556|453934856|FG002|Phase II - Extension Phase|Disease Progression|0|||
126177499|NCT00426556|453934857|FG003|Phase II - Extension Phase|Disease Progression|21|||
126177500|NCT00426556|453934854|FG000|Phase II - Extension Phase|Adverse Event|0|||
126177501|NCT00426556|453934855|FG001|Phase II - Extension Phase|Adverse Event|0|||
126177502|NCT00426556|453934856|FG002|Phase II - Extension Phase|Adverse Event|0|||
126177503|NCT00426556|453934857|FG003|Phase II - Extension Phase|Adverse Event|2|||
126177504|NCT00225212|453934858|FG000|Overall Study|Disease progression|2|||
126177505|NCT00225212|453934858|FG000|Overall Study|Death|1|||
126177506|NCT00225212|453934858|FG000|Overall Study|Adverse Event|2|||
126177507|NCT00225212|453934858|FG000|Overall Study|Intercurrent illness|1|||
126177508|NCT01309841|453934863|FG000|Overall Study|Other|0|||
126177509|NCT01309841|453934864|FG001|Overall Study|Other|1|||
126177510|NCT01309841|453934865|FG002|Overall Study|Other|1|||
126177511|NCT01309841|453934863|FG000|Overall Study|Lost to Follow-up|7|||
126177512|NCT01309841|453934864|FG001|Overall Study|Lost to Follow-up|6|||
126177513|NCT01309841|453934865|FG002|Overall Study|Lost to Follow-up|4|||
126177514|NCT01309841|453934863|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
126177515|NCT01309841|453934864|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
126177516|NCT01309841|453934865|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
126177517|NCT01309841|453934863|FG000|Overall Study|Lack of Efficacy|0|||
126177518|NCT01309841|453934864|FG001|Overall Study|Lack of Efficacy|0|||
126177519|NCT01309841|453934865|FG002|Overall Study|Lack of Efficacy|2|||
126177520|NCT01309841|453934863|FG000|Overall Study|Adverse Event|9|||
126177521|NCT01309841|453934864|FG001|Overall Study|Adverse Event|22|||
126177522|NCT01309841|453934865|FG002|Overall Study|Adverse Event|11|||
126177523|NCT01309841|453934863|FG000|Overall Study|Death|1|||
126177524|NCT01309841|453934864|FG001|Overall Study|Death|0|||
126177525|NCT01309841|453934865|FG002|Overall Study|Death|0|||
126177526|NCT01309841|453934863|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126177527|NCT01309841|453934864|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126177528|NCT01309841|453934865|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
126177529|NCT01309841|453934863|FG000|Overall Study|Withdrawal by Subject|17|||
126177530|NCT01309841|453934864|FG001|Overall Study|Withdrawal by Subject|6|||
126177531|NCT01309841|453934865|FG002|Overall Study|Withdrawal by Subject|13|||
126177532|NCT01309841|453934863|FG000|Overall Study|Did Not Receive Treatment|2|||
126177533|NCT01309841|453934864|FG001|Overall Study|Did Not Receive Treatment|0|||
126177534|NCT01309841|453934865|FG002|Overall Study|Did Not Receive Treatment|1|||
126177535|NCT01309841|453934863|FG000|Overall Study|Severe non-compliance with protocol|0|||
126177536|NCT01309841|453934864|FG001|Overall Study|Severe non-compliance with protocol|5|||
126177537|NCT01309841|453934865|FG002|Overall Study|Severe non-compliance with protocol|2|||
126177538|NCT00050960|453934866|FG000|Overall Study|Progressive Disease|137|||
126177539|NCT00050960|453934867|FG001|Overall Study|Progressive Disease|93|||
126177540|NCT00050960|453934866|FG000|Overall Study|Stable Disease|19|||
126177541|NCT00050960|453934867|FG001|Overall Study|Stable Disease|48|||
126177542|NCT00050960|453934866|FG000|Overall Study|Partial Response|14|||
126177543|NCT00050960|453934867|FG001|Overall Study|Partial Response|19|||
126177544|NCT00050960|453934866|FG000|Overall Study|Complete Response|0|||
126177545|NCT00050960|453934867|FG001|Overall Study|Complete Response|2|||
126177546|NCT00050960|453934866|FG000|Overall Study|Adverse Event|62|||
126177547|NCT00050960|453934867|FG001|Overall Study|Adverse Event|61|||
126177548|NCT00050960|453934866|FG000|Overall Study|Lost to Follow-up|0|||
126177549|NCT00050960|453934867|FG001|Overall Study|Lost to Follow-up|1|||
126177550|NCT00050960|453934866|FG000|Overall Study|Withdrawal by Subject|23|||
126177551|NCT00050960|453934867|FG001|Overall Study|Withdrawal by Subject|18|||
126177552|NCT00050960|453934866|FG000|Overall Study|Administrative|31|||
126177553|NCT00050960|453934867|FG001|Overall Study|Administrative|46|||
126177554|NCT00050960|453934866|FG000|Overall Study|Non-compliance|3|||
126177555|NCT00050960|453934867|FG001|Overall Study|Non-compliance|1|||
126177556|NCT00050960|453934866|FG000|Overall Study|Death|13|||
126177557|NCT00050960|453934867|FG001|Overall Study|Death|15|||
126177558|NCT04311177|453934870|FG000|Overall Study|Adverse Event|3|||
126177559|NCT04311177|453934871|FG001|Overall Study|Adverse Event|1|||
126177560|NCT04311177|453934870|FG000|Overall Study|Physician Decision|4|||
126177561|NCT04311177|453934871|FG001|Overall Study|Physician Decision|3|||
126177562|NCT04311177|453934870|FG000|Overall Study|Withdrawal by Subject|1|||
126177563|NCT04311177|453934871|FG001|Overall Study|Withdrawal by Subject|0|||
126177564|NCT00413062|453934874|FG000|Overall Study|Adverse event/serious adverse event|289|||
126177565|NCT00413062|453934875|FG001|Overall Study|Adverse event/serious adverse event|56|||
126177566|NCT00413062|453934874|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
126177567|NCT00413062|453934875|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
126177568|NCT00413062|453934874|FG000|Overall Study|Withdrawal of informed consent|111|||
126177569|NCT00413062|453934875|FG001|Overall Study|Withdrawal of informed consent|36|||
126177570|NCT00413062|453934874|FG000|Overall Study|Pregnancy|15|||
126177571|NCT00413062|453934875|FG001|Overall Study|Pregnancy|5|||
126177572|NCT00413062|453934874|FG000|Overall Study|Pregnancy wish|17|||
126177573|NCT00413062|453934875|FG001|Overall Study|Pregnancy wish|6|||
126177574|NCT00413062|453934874|FG000|Overall Study|Lost to Follow-up|175|||
126177575|NCT00413062|453934875|FG001|Overall Study|Lost to Follow-up|73|||
126177576|NCT00413062|453934874|FG000|Overall Study|Other reason|70|||
126177577|NCT00413062|453934875|FG001|Overall Study|Other reason|34|||
126177578|NCT02815293|453934878|FG000|Overall Study|Study termination by sponsor|10|||
126177579|NCT02815293|453934879|FG001|Overall Study|Study termination by sponsor|7|||
126177580|NCT02815293|453934880|FG002|Overall Study|Study termination by sponsor|0|||
126177581|NCT02815293|453934878|FG000|Overall Study|Participants not randomized|0|||
126177582|NCT02815293|453934879|FG001|Overall Study|Participants not randomized|0|||
126177583|NCT02815293|453934880|FG002|Overall Study|Participants not randomized|18|||
126177584|NCT02815293|453934878|FG000|Overall Study|Adverse Event|0|||
126177585|NCT02815293|453934879|FG001|Overall Study|Adverse Event|1|||
126177586|NCT02815293|453934880|FG002|Overall Study|Adverse Event|0|||
126177587|NCT00006604|453934883|FG000|Overall Study|Met study objective - no further FU|1|||
126177588|NCT00006604|453934884|FG001|Overall Study|Met study objective - no further FU|0|||
126177589|NCT00006604|453934885|FG002|Overall Study|Met study objective - no further FU|0|||
126177590|NCT00006604|453934886|FG003|Overall Study|Met study objective - no further FU|0|||
126177591|NCT00006604|453934887|FG004|Overall Study|Met study objective - no further FU|0|||
126177592|NCT00006604|453934888|FG005|Overall Study|Met study objective - no further FU|0|||
126177593|NCT00006604|453934889|FG006|Overall Study|Met study objective - no further FU|0|||
126177594|NCT00006604|453934890|FG007|Overall Study|Met study objective - no further FU|0|||
126177595|NCT00006604|453934891|FG008|Overall Study|Met study objective - no further FU|0|||
126177596|NCT00006604|453934892|FG009|Overall Study|Met study objective - no further FU|0|||
125974435|NCT04084314|453195229|FG000|Overall Study|Adverse Event|24|||
125974436|NCT04084314|453195229|FG000|Overall Study|Lost to Follow-up|19|||
125974437|NCT04084314|453195229|FG000|Overall Study|New therapy for study indication|9|||
125974438|NCT04084314|453195229|FG000|Overall Study|Pregnancy|9|||
125974439|NCT04084314|453195229|FG000|Overall Study|Withdrawal of informed consent|8|||
125974440|NCT04084314|453195229|FG000|Overall Study|Physician Decision|4|||
125974441|NCT04084314|453195229|FG000|Overall Study|Protocol Deviation|3|||
125974442|NCT00802074|453195230|FG000|Overall Study|Adverse Event|1|||
125974443|NCT00802074|453195231|FG001|Overall Study|Adverse Event|1|||
125974444|NCT00802074|453195232|FG002|Overall Study|Adverse Event|1|||
125974445|NCT00802074|453195233|FG003|Overall Study|Adverse Event|0|||
125974446|NCT00802074|453195234|FG004|Overall Study|Adverse Event|0|||
125974447|NCT00802074|453195235|FG005|Overall Study|Adverse Event|0|||
125974448|NCT00802074|453195230|FG000|Overall Study|Withdrawal by Subject|1|||
125974449|NCT00802074|453195231|FG001|Overall Study|Withdrawal by Subject|0|||
125974450|NCT00802074|453195232|FG002|Overall Study|Withdrawal by Subject|0|||
125974451|NCT00802074|453195233|FG003|Overall Study|Withdrawal by Subject|0|||
125974452|NCT00802074|453195234|FG004|Overall Study|Withdrawal by Subject|0|||
125974453|NCT00802074|453195235|FG005|Overall Study|Withdrawal by Subject|0|||
125974454|NCT02298192|453195240|FG000|Overall Study|Unclassified|3|||
125974455|NCT02298192|453195241|FG001|Overall Study|Unclassified|2|||
125974456|NCT02298192|453195240|FG000|Overall Study|Withdrawal criteria|2|||
125974457|NCT02298192|453195241|FG001|Overall Study|Withdrawal criteria|0|||
125974458|NCT02298192|453195240|FG000|Overall Study|Withdrawal by Subject|6|||
125974459|NCT02298192|453195241|FG001|Overall Study|Withdrawal by Subject|1|||
125974460|NCT02298192|453195240|FG000|Overall Study|Lost to Follow-up|2|||
125974461|NCT02298192|453195241|FG001|Overall Study|Lost to Follow-up|1|||
125974462|NCT02298192|453195240|FG000|Overall Study|Adverse Event|6|||
125974463|NCT02298192|453195241|FG001|Overall Study|Adverse Event|2|||
125974464|NCT00679939|453195243|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
125974465|NCT00679939|453195244|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
125974466|NCT00679939|453195243|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
125974467|NCT00679939|453195244|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
125974468|NCT00679939|453195243|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
125974469|NCT00679939|453195244|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
125974470|NCT00679939|453195243|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
125974471|NCT00679939|453195244|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
125974472|NCT00679939|453195243|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
126177597|NCT00006604|453934893|FG010|Overall Study|Met study objective - no further FU|0|||
126177598|NCT00006604|453934894|FG011|Overall Study|Met study objective - no further FU|0|||
126177599|NCT00006604|453934895|FG012|Overall Study|Met study objective - no further FU|0|||
126177600|NCT00006604|453934896|FG013|Overall Study|Met study objective - no further FU|0|||
125974473|NCT00679939|453195244|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
125974474|NCT00679939|453195243|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
126177601|NCT00006604|453934897|FG014|Overall Study|Met study objective - no further FU|1|||
126177602|NCT00006604|453934898|FG015|Overall Study|Met study objective - no further FU|1|||
125974475|NCT00679939|453195244|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
125974476|NCT00679939|453195243|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
125974477|NCT00679939|453195244|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
125974478|NCT00679939|453195243|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
125974479|NCT00679939|453195244|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
125974480|NCT00679939|453195243|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
125974481|NCT00679939|453195244|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
125974482|NCT00679939|453195243|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
125974483|NCT00679939|453195244|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
125974484|NCT05608629|453195246|FG000|Overall Study|Lost to Follow-up|2|||
125974485|NCT01453595|453195247|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125974486|NCT01453595|453195248|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125974487|NCT01453595|453195249|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125974488|NCT00983073|453195250|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
125974489|NCT00983073|453195250|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
125974490|NCT00983073|453195250|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
125974491|NCT00983073|453195250|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
125974492|NCT00983073|453195250|FG000|Titration and Optimal Dose Period|Other reason|4|||
125974493|NCT00983073|453195250|FG000|Maintenance Period|Adverse Event|5|||
125974494|NCT00983073|453195250|FG000|Maintenance Period|Withdrawal by Subject|2|||
125974495|NCT00983073|453195250|FG000|Maintenance Period|Lack of Efficacy|2|||
125974496|NCT00983073|453195250|FG000|Maintenance Period|Other Reason|7|||
125974497|NCT02962908|453195253|FG000|Overall Study|Lost to Follow-up|0|||
125974498|NCT02962908|453195254|FG001|Overall Study|Lost to Follow-up|3|||
125974499|NCT02962908|453195255|FG002|Overall Study|Lost to Follow-up|0|||
125974500|NCT02962908|453195256|FG003|Overall Study|Lost to Follow-up|1|||
125974501|NCT02962908|453195253|FG000|Overall Study|Withdrawal by Subject|0|||
125974502|NCT02962908|453195254|FG001|Overall Study|Withdrawal by Subject|3|||
125974503|NCT02962908|453195255|FG002|Overall Study|Withdrawal by Subject|0|||
125974504|NCT02962908|453195256|FG003|Overall Study|Withdrawal by Subject|2|||
125974505|NCT02962908|453195253|FG000|Overall Study|Protocol Violation|0|||
125974506|NCT02962908|453195254|FG001|Overall Study|Protocol Violation|1|||
125974507|NCT02962908|453195255|FG002|Overall Study|Protocol Violation|0|||
125974508|NCT02962908|453195256|FG003|Overall Study|Protocol Violation|0|||
125974509|NCT02962908|453195253|FG000|Overall Study|Physician Decision|0|||
125974510|NCT02962908|453195254|FG001|Overall Study|Physician Decision|1|||
125974511|NCT02962908|453195255|FG002|Overall Study|Physician Decision|0|||
125974512|NCT02962908|453195256|FG003|Overall Study|Physician Decision|0|||
125974513|NCT05540522|453195259|FG000|Overall Study|Adverse Event|1|||
125974514|NCT05540522|453195260|FG001|Overall Study|Adverse Event|0|||
125974515|NCT05540522|453195261|FG002|Overall Study|Adverse Event|2|||
125974516|NCT05540522|453195262|FG003|Overall Study|Adverse Event|5|||
125974517|NCT05540522|453195259|FG000|Overall Study|Lost to Follow-up|487|||
125974518|NCT05540522|453195260|FG001|Overall Study|Lost to Follow-up|427|||
125974519|NCT05540522|453195261|FG002|Overall Study|Lost to Follow-up|146|||
125974520|NCT05540522|453195262|FG003|Overall Study|Lost to Follow-up|166|||
125974521|NCT05540522|453195259|FG000|Overall Study|Physician Decision|11|||
125974522|NCT05540522|453195260|FG001|Overall Study|Physician Decision|19|||
125974523|NCT05540522|453195261|FG002|Overall Study|Physician Decision|8|||
125974524|NCT05540522|453195262|FG003|Overall Study|Physician Decision|13|||
125974525|NCT05540522|453195259|FG000|Overall Study|Pregnancy|1|||
125974526|NCT05540522|453195260|FG001|Overall Study|Pregnancy|0|||
125974527|NCT05540522|453195261|FG002|Overall Study|Pregnancy|0|||
125974528|NCT05540522|453195262|FG003|Overall Study|Pregnancy|0|||
125974529|NCT05540522|453195259|FG000|Overall Study|Protocol Violation|3|||
125974530|NCT05540522|453195260|FG001|Overall Study|Protocol Violation|1|||
125974531|NCT05540522|453195261|FG002|Overall Study|Protocol Violation|9|||
125974532|NCT05540522|453195262|FG003|Overall Study|Protocol Violation|7|||
125974533|NCT05540522|453195259|FG000|Overall Study|Withdrawal by Subject|168|||
125974534|NCT05540522|453195260|FG001|Overall Study|Withdrawal by Subject|134|||
125974535|NCT05540522|453195261|FG002|Overall Study|Withdrawal by Subject|331|||
125974536|NCT05540522|453195262|FG003|Overall Study|Withdrawal by Subject|322|||
125974537|NCT05540522|453195259|FG000|Overall Study|Death|7|||
125974538|NCT05540522|453195260|FG001|Overall Study|Death|9|||
125974539|NCT05540522|453195261|FG002|Overall Study|Death|49|||
125974540|NCT05540522|453195262|FG003|Overall Study|Death|46|||
125974541|NCT05540522|453195259|FG000|Overall Study|Not vaccinated|34|||
125974542|NCT05540522|453195260|FG001|Overall Study|Not vaccinated|53|||
125974543|NCT05540522|453195261|FG002|Overall Study|Not vaccinated|57|||
125974544|NCT05540522|453195262|FG003|Overall Study|Not vaccinated|50|||
125974545|NCT05540522|453195259|FG000|Overall Study|No longer meets eligibility criteria|0|||
125974546|NCT05540522|453195260|FG001|Overall Study|No longer meets eligibility criteria|0|||
125974547|NCT05540522|453195261|FG002|Overall Study|No longer meets eligibility criteria|3|||
125974548|NCT05540522|453195262|FG003|Overall Study|No longer meets eligibility criteria|2|||
125974549|NCT05540522|453195259|FG000|Overall Study|Other (Unspecified)|8|||
125974550|NCT05540522|453195260|FG001|Overall Study|Other (Unspecified)|10|||
125974551|NCT05540522|453195261|FG002|Overall Study|Other (Unspecified)|4|||
126177603|NCT00006604|453934899|FG016|Overall Study|Met study objective - no further FU|0|||
126177604|NCT00006604|453934883|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
126177605|NCT00006604|453934884|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
126177606|NCT00006604|453934885|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
126177607|NCT00006604|453934886|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
126177608|NCT00006604|453934887|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
126177609|NCT00006604|453934888|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
126177610|NCT00006604|453934889|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
126177611|NCT00006604|453934890|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
126177612|NCT00006604|453934891|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
126177613|NCT00006604|453934892|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
126177614|NCT00006604|453934893|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
126177615|NCT00006604|453934894|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
126177616|NCT00006604|453934895|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
126177617|NCT00006604|453934896|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
126177618|NCT00006604|453934897|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
126177619|NCT00006604|453934898|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
126177620|NCT00006604|453934899|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
126177621|NCT00006604|453934883|FG000|Overall Study|Death|0|||
126177622|NCT00006604|453934884|FG001|Overall Study|Death|0|||
126177623|NCT00006604|453934885|FG002|Overall Study|Death|0|||
126177624|NCT00006604|453934886|FG003|Overall Study|Death|0|||
126177625|NCT00006604|453934887|FG004|Overall Study|Death|0|||
126177626|NCT00006604|453934888|FG005|Overall Study|Death|0|||
126177627|NCT00006604|453934889|FG006|Overall Study|Death|0|||
126177628|NCT00006604|453934890|FG007|Overall Study|Death|0|||
126177629|NCT00006604|453934891|FG008|Overall Study|Death|0|||
126177630|NCT00006604|453934892|FG009|Overall Study|Death|1|||
126177631|NCT00006604|453934893|FG010|Overall Study|Death|1|||
126177632|NCT00006604|453934894|FG011|Overall Study|Death|1|||
126177633|NCT00006604|453934895|FG012|Overall Study|Death|0|||
126177634|NCT00006604|453934896|FG013|Overall Study|Death|0|||
126177635|NCT00006604|453934897|FG014|Overall Study|Death|0|||
126177636|NCT00006604|453934898|FG015|Overall Study|Death|0|||
126177637|NCT00006604|453934899|FG016|Overall Study|Death|0|||
126177638|NCT00006604|453934883|FG000|Overall Study|Severe debilitation, unable to continue|0|||
126177639|NCT00006604|453934884|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126177640|NCT00006604|453934885|FG002|Overall Study|Severe debilitation, unable to continue|0|||
126177641|NCT00006604|453934886|FG003|Overall Study|Severe debilitation, unable to continue|0|||
126177642|NCT00006604|453934887|FG004|Overall Study|Severe debilitation, unable to continue|0|||
126177643|NCT00006604|453934888|FG005|Overall Study|Severe debilitation, unable to continue|0|||
126177644|NCT00006604|453934889|FG006|Overall Study|Severe debilitation, unable to continue|3|||
126177645|NCT00006604|453934890|FG007|Overall Study|Severe debilitation, unable to continue|0|||
126177646|NCT00006604|453934891|FG008|Overall Study|Severe debilitation, unable to continue|0|||
126177647|NCT00006604|453934892|FG009|Overall Study|Severe debilitation, unable to continue|5|||
126177648|NCT00006604|453934893|FG010|Overall Study|Severe debilitation, unable to continue|0|||
126177649|NCT00006604|453934894|FG011|Overall Study|Severe debilitation, unable to continue|2|||
126177650|NCT00006604|453934895|FG012|Overall Study|Severe debilitation, unable to continue|1|||
126177651|NCT00006604|453934896|FG013|Overall Study|Severe debilitation, unable to continue|0|||
126177652|NCT00006604|453934897|FG014|Overall Study|Severe debilitation, unable to continue|2|||
126177653|NCT00006604|453934898|FG015|Overall Study|Severe debilitation, unable to continue|0|||
126177654|NCT00006604|453934899|FG016|Overall Study|Severe debilitation, unable to continue|0|||
126177655|NCT00006604|453934883|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
126177656|NCT00006604|453934884|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
126177657|NCT00006604|453934885|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
126177658|NCT00006604|453934886|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
126177659|NCT00006604|453934887|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
126177660|NCT00006604|453934888|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
126177661|NCT00006604|453934889|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
126177662|NCT00006604|453934890|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
126177663|NCT00006604|453934891|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
126177664|NCT00006604|453934892|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
126177665|NCT00006604|453934893|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
126177666|NCT00006604|453934894|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
126177667|NCT00006604|453934895|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
126177668|NCT00006604|453934896|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
126177669|NCT00006604|453934897|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
126177670|NCT00006604|453934898|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
126177671|NCT00006604|453934899|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
126177672|NCT00006604|453934883|FG000|Overall Study|Site closing|0|||
126177673|NCT00006604|453934884|FG001|Overall Study|Site closing|0|||
126177674|NCT00006604|453934885|FG002|Overall Study|Site closing|1|||
126177675|NCT00006604|453934886|FG003|Overall Study|Site closing|1|||
126177676|NCT00006604|453934887|FG004|Overall Study|Site closing|0|||
126177677|NCT00006604|453934888|FG005|Overall Study|Site closing|0|||
126177678|NCT00006604|453934889|FG006|Overall Study|Site closing|0|||
126177679|NCT00006604|453934890|FG007|Overall Study|Site closing|1|||
126177680|NCT00006604|453934891|FG008|Overall Study|Site closing|0|||
126177681|NCT00006604|453934892|FG009|Overall Study|Site closing|0|||
126177682|NCT00006604|453934893|FG010|Overall Study|Site closing|0|||
126177683|NCT00006604|453934894|FG011|Overall Study|Site closing|1|||
126177684|NCT00006604|453934895|FG012|Overall Study|Site closing|1|||
126177685|NCT00006604|453934896|FG013|Overall Study|Site closing|1|||
126177686|NCT00006604|453934897|FG014|Overall Study|Site closing|0|||
126177687|NCT00006604|453934898|FG015|Overall Study|Site closing|0|||
126177688|NCT00006604|453934899|FG016|Overall Study|Site closing|1|||
126177689|NCT00006604|453934883|FG000|Overall Study|Withdrawal by Subject|1|||
126177690|NCT00006604|453934884|FG001|Overall Study|Withdrawal by Subject|0|||
126177691|NCT00006604|453934885|FG002|Overall Study|Withdrawal by Subject|2|||
125974552|NCT05540522|453195262|FG003|Overall Study|Other (Unspecified)|2|||
125974553|NCT03754803|453195263|FG000|Overall Study|Withdrawal by Subject|2|||
125974554|NCT05239039|453195264|FG000|Overall Study|Withdrawal by Subject|0|||
125974555|NCT05239039|453195265|FG001|Overall Study|Withdrawal by Subject|1|||
125974556|NCT02119260|453196826|FG000|Overall Study|Adverse Event|1|||
125974557|NCT02119260|453196827|FG001|Overall Study|Adverse Event|0|||
125974558|NCT02119260|453196828|FG002|Overall Study|Adverse Event|0|||
125974559|NCT02119260|453196829|FG003|Overall Study|Adverse Event|0|||
125974560|NCT02119260|453196830|FG004|Overall Study|Adverse Event|0|||
125974561|NCT02119260|453196831|FG005|Overall Study|Adverse Event|0|||
125974562|NCT02119260|453196832|FG006|Overall Study|Adverse Event|0|||
125974563|NCT02119260|453196826|FG000|Overall Study|Withdrew consent|0|||
125974564|NCT02119260|453196827|FG001|Overall Study|Withdrew consent|1|||
125974565|NCT02119260|453196828|FG002|Overall Study|Withdrew consent|1|||
125974566|NCT02119260|453196829|FG003|Overall Study|Withdrew consent|0|||
125974567|NCT02119260|453196830|FG004|Overall Study|Withdrew consent|0|||
125974568|NCT02119260|453196831|FG005|Overall Study|Withdrew consent|0|||
125974569|NCT02119260|453196832|FG006|Overall Study|Withdrew consent|0|||
125974570|NCT00857207|453196833|FG000|Overall Study|Withdrawal by Subject|13|||
125974571|NCT00857207|453196834|FG001|Overall Study|Withdrawal by Subject|0|||
125974572|NCT00857207|453196833|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
125974573|NCT00857207|453196834|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
125974574|NCT00857207|453196833|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
125974575|NCT00857207|453196834|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
125974576|NCT00955357|453196835|FG000|Titration Phase|Adverse Event|9|||
125974577|NCT00955357|453196836|FG001|Titration Phase|Adverse Event|46|||
125974578|NCT00955357|453196835|FG000|Titration Phase|Lack of Efficacy|0|||
125974579|NCT00955357|453196836|FG001|Titration Phase|Lack of Efficacy|2|||
125974580|NCT00955357|453196835|FG000|Titration Phase|Protocol Violation|3|||
125974581|NCT00955357|453196836|FG001|Titration Phase|Protocol Violation|7|||
125974582|NCT00955357|453196835|FG000|Titration Phase|Lost to Follow-up|1|||
125974583|NCT00955357|453196836|FG001|Titration Phase|Lost to Follow-up|3|||
125974584|NCT00955357|453196835|FG000|Titration Phase|Withdrawal by Subject|3|||
125974585|NCT00955357|453196836|FG001|Titration Phase|Withdrawal by Subject|5|||
125974586|NCT00955357|453196835|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
125974587|NCT00955357|453196836|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
125974588|NCT00955357|453196835|FG000|Titration Phase|Study medication not tolerated|0|||
125974589|NCT00955357|453196836|FG001|Titration Phase|Study medication not tolerated|1|||
125974590|NCT00955357|453196835|FG000|Titration Phase|Non compliance to study procedures|0|||
125974591|NCT00955357|453196836|FG001|Titration Phase|Non compliance to study procedures|1|||
125974592|NCT00955357|453196835|FG000|Maintenance Phase|Adverse Event|3|||
125974593|NCT00955357|453196836|FG001|Maintenance Phase|Adverse Event|23|||
125974594|NCT00955357|453196835|FG000|Maintenance Phase|Lack of Efficacy|0|||
125974595|NCT00955357|453196836|FG001|Maintenance Phase|Lack of Efficacy|4|||
125974596|NCT00955357|453196835|FG000|Maintenance Phase|Protocol Violation|2|||
125974597|NCT00955357|453196836|FG001|Maintenance Phase|Protocol Violation|6|||
125974598|NCT00955357|453196835|FG000|Maintenance Phase|Lost to Follow-up|2|||
125974599|NCT00955357|453196836|FG001|Maintenance Phase|Lost to Follow-up|7|||
126177692|NCT00006604|453934886|FG003|Overall Study|Withdrawal by Subject|0|||
126177693|NCT00006604|453934887|FG004|Overall Study|Withdrawal by Subject|1|||
126177694|NCT00006604|453934888|FG005|Overall Study|Withdrawal by Subject|2|||
126177695|NCT00006604|453934889|FG006|Overall Study|Withdrawal by Subject|2|||
126177696|NCT00006604|453934890|FG007|Overall Study|Withdrawal by Subject|0|||
126177697|NCT00006604|453934891|FG008|Overall Study|Withdrawal by Subject|1|||
126177698|NCT00006604|453934892|FG009|Overall Study|Withdrawal by Subject|3|||
126177699|NCT00006604|453934893|FG010|Overall Study|Withdrawal by Subject|2|||
126177700|NCT00006604|453934894|FG011|Overall Study|Withdrawal by Subject|0|||
126177701|NCT00006604|453934895|FG012|Overall Study|Withdrawal by Subject|1|||
126177702|NCT00006604|453934896|FG013|Overall Study|Withdrawal by Subject|2|||
126177703|NCT00006604|453934897|FG014|Overall Study|Withdrawal by Subject|1|||
126177704|NCT00006604|453934898|FG015|Overall Study|Withdrawal by Subject|0|||
126177705|NCT00006604|453934899|FG016|Overall Study|Withdrawal by Subject|1|||
126177706|NCT00006604|453934883|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
126177707|NCT00006604|453934884|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
126177708|NCT00006604|453934885|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
126177709|NCT00006604|453934886|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
126177710|NCT00006604|453934887|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
126177711|NCT00006604|453934888|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
126177712|NCT00006604|453934889|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
126177713|NCT00006604|453934890|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
126177714|NCT00006604|453934891|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
126177715|NCT00006604|453934892|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
126177716|NCT00006604|453934893|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
126177717|NCT00006604|453934894|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
126177718|NCT00006604|453934895|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
126177719|NCT00006604|453934896|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
126177720|NCT00006604|453934897|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
126177721|NCT00006604|453934898|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
126177722|NCT00006604|453934899|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
126177723|NCT00006604|453934883|FG000|Overall Study|Lost to Follow-up|0|||
126177724|NCT00006604|453934884|FG001|Overall Study|Lost to Follow-up|0|||
126177725|NCT00006604|453934885|FG002|Overall Study|Lost to Follow-up|0|||
126177726|NCT00006604|453934886|FG003|Overall Study|Lost to Follow-up|0|||
126177727|NCT00006604|453934887|FG004|Overall Study|Lost to Follow-up|0|||
126177728|NCT00006604|453934888|FG005|Overall Study|Lost to Follow-up|0|||
126177729|NCT00006604|453934889|FG006|Overall Study|Lost to Follow-up|0|||
126177730|NCT00006604|453934890|FG007|Overall Study|Lost to Follow-up|1|||
126177731|NCT00006604|453934891|FG008|Overall Study|Lost to Follow-up|0|||
126177732|NCT00006604|453934892|FG009|Overall Study|Lost to Follow-up|2|||
126177733|NCT00006604|453934893|FG010|Overall Study|Lost to Follow-up|0|||
126177734|NCT00006604|453934894|FG011|Overall Study|Lost to Follow-up|0|||
126177735|NCT00006604|453934895|FG012|Overall Study|Lost to Follow-up|0|||
126177736|NCT00006604|453934896|FG013|Overall Study|Lost to Follow-up|0|||
126177737|NCT00006604|453934897|FG014|Overall Study|Lost to Follow-up|0|||
126177738|NCT00006604|453934898|FG015|Overall Study|Lost to Follow-up|1|||
126177739|NCT00006604|453934899|FG016|Overall Study|Lost to Follow-up|3|||
126177740|NCT00006604|453934883|FG000|Overall Study|Other Reason|0|||
126177741|NCT00006604|453934884|FG001|Overall Study|Other Reason|0|||
126177742|NCT00006604|453934885|FG002|Overall Study|Other Reason|0|||
126177743|NCT00006604|453934886|FG003|Overall Study|Other Reason|0|||
126177744|NCT00006604|453934887|FG004|Overall Study|Other Reason|0|||
126177745|NCT00006604|453934888|FG005|Overall Study|Other Reason|1|||
126177746|NCT00006604|453934889|FG006|Overall Study|Other Reason|0|||
126177747|NCT00006604|453934890|FG007|Overall Study|Other Reason|0|||
126177748|NCT00006604|453934891|FG008|Overall Study|Other Reason|0|||
126177749|NCT00006604|453934892|FG009|Overall Study|Other Reason|1|||
126177750|NCT00006604|453934893|FG010|Overall Study|Other Reason|0|||
126177751|NCT00006604|453934894|FG011|Overall Study|Other Reason|0|||
126177752|NCT00006604|453934895|FG012|Overall Study|Other Reason|0|||
126177753|NCT00006604|453934896|FG013|Overall Study|Other Reason|0|||
126177754|NCT00006604|453934897|FG014|Overall Study|Other Reason|0|||
126177755|NCT00006604|453934898|FG015|Overall Study|Other Reason|0|||
126177756|NCT00006604|453934899|FG016|Overall Study|Other Reason|0|||
126177757|NCT01182337|453934902|FG000|Overall Study|Withdrawal by Subject|3|||
126177758|NCT01182337|453934903|FG001|Overall Study|Withdrawal by Subject|1|||
126177759|NCT01182337|453934902|FG000|Overall Study|Lost to Follow-up|0|||
126177760|NCT01182337|453934903|FG001|Overall Study|Lost to Follow-up|1|||
126177761|NCT03448224|453934904|FG000|Overall Study|Provided same answer to every question|1|||
126177762|NCT03448224|453934905|FG001|Overall Study|Provided same answer to every question|0|||
126177763|NCT03103906|453934906|FG000|Overall Study|Adverse Event|2|||
126177764|NCT03103906|453934907|FG001|Overall Study|Adverse Event|3|||
126177765|NCT03103906|453934906|FG000|Overall Study|Other|2|||
126177766|NCT03103906|453934907|FG001|Overall Study|Other|0|||
126177767|NCT03571256|453934908|FG000|Overall Study|Adverse Event|3|||
126177768|NCT03571256|453934909|FG001|Overall Study|Adverse Event|0|||
126177769|NCT03571256|453934910|FG002|Overall Study|Adverse Event|1|||
126177770|NCT03571256|453934908|FG000|Overall Study|Withdrawal by Subject|3|||
126177771|NCT03571256|453934909|FG001|Overall Study|Withdrawal by Subject|1|||
126177772|NCT03571256|453934910|FG002|Overall Study|Withdrawal by Subject|1|||
126177773|NCT03571256|453934908|FG000|Overall Study|Other than specified|0|||
126177774|NCT03571256|453934909|FG001|Overall Study|Other than specified|1|||
125974600|NCT00955357|453196835|FG000|Maintenance Phase|Withdrawal by Subject|4|||
126177775|NCT03571256|453934910|FG002|Overall Study|Other than specified|1|||
126177776|NCT03571256|453934908|FG000|Overall Study|Protocol Violation|0|||
126177777|NCT03571256|453934909|FG001|Overall Study|Protocol Violation|1|||
126177778|NCT03571256|453934910|FG002|Overall Study|Protocol Violation|1|||
126177779|NCT00575094|453934911|FG000|Overall Study|Adverse Event|2|||
126177780|NCT00575094|453934911|FG000|Overall Study|Withdrawal by Subject|1|||
126177781|NCT00772382|453934917|FG000|Overall Study|Adverse Event|19|||
126177782|NCT00772382|453934917|FG000|Overall Study|Death|6|||
126177783|NCT00772382|453934917|FG000|Overall Study|Lack of Efficacy|4|||
126177784|NCT00772382|453934917|FG000|Overall Study|Physician Decision|5|||
126177785|NCT00772382|453934917|FG000|Overall Study|Protocol Violation|1|||
126177786|NCT00772382|453934917|FG000|Overall Study|Withdrawal by Subject|10|||
126177787|NCT00772382|453934917|FG000|Overall Study|Other Reasons|10|||
126177788|NCT00643604|453934920|FG000|Overall Study|Death|1|||
126177789|NCT02702011|453934923|FG000|Overall Study|Withdrawal by Subject|0|||
126177790|NCT02702011|453934924|FG001|Overall Study|Withdrawal by Subject|1|||
126177791|NCT02702011|453934925|FG002|Overall Study|Withdrawal by Subject|0|||
126177792|NCT02702011|453934926|FG003|Overall Study|Withdrawal by Subject|0|||
126177793|NCT01512108|453936669|FG000|Overall Study|Adverse Event|9|||
125974601|NCT00955357|453196836|FG001|Maintenance Phase|Withdrawal by Subject|4|||
125974602|NCT00955357|453196835|FG000|Maintenance Phase|Patient moving out of area|0|||
125974603|NCT00955357|453196836|FG001|Maintenance Phase|Patient moving out of area|1|||
125974604|NCT00955357|453196835|FG000|Maintenance Phase|Non compliance to study procedures|1|||
125974605|NCT00955357|453196836|FG001|Maintenance Phase|Non compliance to study procedures|0|||
125974606|NCT00440531|453196843|FG000|Overall Study|Adverse Event|1|||
125974607|NCT00440531|453196844|FG001|Overall Study|Adverse Event|0|||
125974608|NCT00440531|453196845|FG002|Overall Study|Adverse Event|2|||
125974609|NCT00440531|453196843|FG000|Overall Study|Withdrawal by Subject|2|||
125974610|NCT00440531|453196844|FG001|Overall Study|Withdrawal by Subject|0|||
125974611|NCT00440531|453196845|FG002|Overall Study|Withdrawal by Subject|0|||
125974612|NCT00440531|453196843|FG000|Overall Study|Protocol Violation|1|||
125974613|NCT00440531|453196844|FG001|Overall Study|Protocol Violation|2|||
125974614|NCT00440531|453196845|FG002|Overall Study|Protocol Violation|0|||
125974615|NCT00440531|453196843|FG000|Overall Study|Lost to Follow-up|4|||
125974616|NCT00440531|453196844|FG001|Overall Study|Lost to Follow-up|3|||
125974617|NCT00440531|453196845|FG002|Overall Study|Lost to Follow-up|5|||
125974618|NCT00440531|453196843|FG000|Overall Study|see pre-assignment details|2|||
125974619|NCT00440531|453196844|FG001|Overall Study|see pre-assignment details|0|||
125974620|NCT00440531|453196845|FG002|Overall Study|see pre-assignment details|0|||
125974621|NCT02181803|453196852|FG000|Overall Study|Withdrawal by Subject|0|||
125974622|NCT02181803|453196853|FG001|Overall Study|Withdrawal by Subject|2|||
125974623|NCT02181803|453196854|FG002|Overall Study|Withdrawal by Subject|0|||
125974624|NCT02181803|453196855|FG003|Overall Study|Withdrawal by Subject|0|||
125974625|NCT02181803|453196856|FG004|Overall Study|Withdrawal by Subject|0|||
125974626|NCT02181803|453196857|FG005|Overall Study|Withdrawal by Subject|0|||
125974627|NCT02181803|453196858|FG006|Overall Study|Withdrawal by Subject|0|||
125974628|NCT02181803|453196859|FG007|Overall Study|Withdrawal by Subject|0|||
125974629|NCT02181803|453196860|FG008|Overall Study|Withdrawal by Subject|0|||
125974630|NCT02181803|453196852|FG000|Overall Study|Physician Decision|0|||
125974631|NCT02181803|453196853|FG001|Overall Study|Physician Decision|0|||
125974632|NCT02181803|453196854|FG002|Overall Study|Physician Decision|0|||
125974633|NCT02181803|453196855|FG003|Overall Study|Physician Decision|1|||
125974634|NCT02181803|453196856|FG004|Overall Study|Physician Decision|0|||
125974635|NCT02181803|453196857|FG005|Overall Study|Physician Decision|0|||
125974636|NCT02181803|453196858|FG006|Overall Study|Physician Decision|0|||
125974637|NCT02181803|453196859|FG007|Overall Study|Physician Decision|1|||
125974638|NCT02181803|453196860|FG008|Overall Study|Physician Decision|0|||
125974639|NCT02181803|453196852|FG000|Overall Study|Adverse Event|0|||
125974640|NCT02181803|453196853|FG001|Overall Study|Adverse Event|2|||
125974641|NCT02181803|453196854|FG002|Overall Study|Adverse Event|0|||
125974642|NCT02181803|453196855|FG003|Overall Study|Adverse Event|1|||
125974643|NCT02181803|453196856|FG004|Overall Study|Adverse Event|0|||
125974644|NCT02181803|453196857|FG005|Overall Study|Adverse Event|0|||
125974645|NCT02181803|453196858|FG006|Overall Study|Adverse Event|1|||
125974646|NCT02181803|453196859|FG007|Overall Study|Adverse Event|0|||
125974647|NCT02181803|453196860|FG008|Overall Study|Adverse Event|0|||
125974648|NCT04786444|453196861|FG000|Overall Study|Withdrawal by Subject|4|||
125974649|NCT04786444|453196862|FG001|Overall Study|Withdrawal by Subject|7|||
125974650|NCT04786444|453196863|FG002|Overall Study|Withdrawal by Subject|2|||
126177794|NCT01512108|453936670|FG001|Overall Study|Adverse Event|4|||
126177795|NCT01512108|453936669|FG000|Overall Study|Protocol Violation|1|||
126177796|NCT01512108|453936670|FG001|Overall Study|Protocol Violation|2|||
126177797|NCT01512108|453936669|FG000|Overall Study|Withdrawal Criteria|1|||
125974651|NCT04786444|453196861|FG000|Overall Study|Lost to Follow-up|11|||
125974652|NCT04786444|453196862|FG001|Overall Study|Lost to Follow-up|9|||
125974653|NCT04786444|453196863|FG002|Overall Study|Lost to Follow-up|10|||
126177798|NCT01512108|453936670|FG001|Overall Study|Withdrawal Criteria|0|||
126177799|NCT01512108|453936669|FG000|Overall Study|Unclassified|11|||
126177800|NCT01512108|453936670|FG001|Overall Study|Unclassified|3|||
126177801|NCT01824693|453936671|FG000|Overall Study|Death|0|||
126177802|NCT01824693|453936672|FG001|Overall Study|Death|1|||
126177803|NCT01824693|453936673|FG002|Overall Study|Death|0|||
126177804|NCT01824693|453936671|FG000|Overall Study|Physician Decision|1|||
126177805|NCT01824693|453936672|FG001|Overall Study|Physician Decision|1|||
126177806|NCT01824693|453936673|FG002|Overall Study|Physician Decision|1|||
126177807|NCT01824693|453936671|FG000|Overall Study|Withdrawal by Subject|0|||
126177808|NCT01824693|453936672|FG001|Overall Study|Withdrawal by Subject|0|||
126177809|NCT01824693|453936673|FG002|Overall Study|Withdrawal by Subject|1|||
126177810|NCT01824693|453936671|FG000|Overall Study|Progressive Disease|0|||
126177811|NCT01824693|453936672|FG001|Overall Study|Progressive Disease|5|||
126177812|NCT01824693|453936673|FG002|Overall Study|Progressive Disease|0|||
126177813|NCT01824693|453936671|FG000|Overall Study|Ineligible|0|||
126177814|NCT01824693|453936672|FG001|Overall Study|Ineligible|0|||
126177815|NCT01824693|453936673|FG002|Overall Study|Ineligible|3|||
126177816|NCT01824693|453936671|FG000|Overall Study|No Transplant Planned|0|||
126177817|NCT01824693|453936672|FG001|Overall Study|No Transplant Planned|0|||
125974654|NCT04786444|453196861|FG000|Overall Study|Subject would like to become pregnant|0|||
125974655|NCT04786444|453196862|FG001|Overall Study|Subject would like to become pregnant|1|||
125974656|NCT04786444|453196863|FG002|Overall Study|Subject would like to become pregnant|0|||
125974657|NCT01549613|453196864|FG000|Overall Study|Lost to Follow-up|11|||
125974658|NCT01549613|453196865|FG001|Overall Study|Lost to Follow-up|11|||
125974659|NCT02216123|453196866|FG000|Overall Study|Lost to Follow-up|4|||
125974660|NCT02216123|453196867|FG001|Overall Study|Lost to Follow-up|2|||
125974661|NCT02216123|453196866|FG000|Overall Study|Withdrawal by Subject|2|||
125974662|NCT02216123|453196867|FG001|Overall Study|Withdrawal by Subject|0|||
125974663|NCT02131272|453196868|FG000|Overall Study|Withdrawal by parent|0|||
125974664|NCT02131272|453196869|FG001|Overall Study|Withdrawal by parent|1|||
125974665|NCT02131272|453196868|FG000|Overall Study|Withdrawal by Subject|0|||
125974666|NCT02131272|453196869|FG001|Overall Study|Withdrawal by Subject|1|||
125974667|NCT02131272|453196868|FG000|Overall Study|Withdrawal Criteria|1|||
125974668|NCT02131272|453196869|FG001|Overall Study|Withdrawal Criteria|0|||
125974669|NCT02462876|453196870|FG000|Overall Study|Death|3|||
125974670|NCT02462876|453196870|FG000|Overall Study|Lost to Follow-up|7|||
125974671|NCT02462876|453196870|FG000|Overall Study|Surgical Bypass|9|||
125974672|NCT02462876|453196870|FG000|Overall Study|Amputation Above the Metatarsals|1|||
125974673|NCT02462876|453196870|FG000|Overall Study|36 months follow-up visit missed|1|||
125974674|NCT02462876|453196870|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
125974675|NCT02462876|453196870|FG000|Overall Study|Patient did not come back to the vascular department|1|||
125974676|NCT02462876|453196870|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
125974677|NCT02462876|453196870|FG000|Overall Study|Patient refused to come back|1|||
125974678|NCT02462876|453196870|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
125974679|NCT02462876|453196870|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
125974680|NCT01786512|453196875|FG000|Overall Study|Lost to Follow-up|0|||
125974681|NCT01786512|453196876|FG001|Overall Study|Lost to Follow-up|0|||
125974682|NCT01786512|453196877|FG002|Overall Study|Lost to Follow-up|0|||
125974683|NCT01786512|453196878|FG003|Overall Study|Lost to Follow-up|0|||
125974684|NCT01786512|453196879|FG004|Overall Study|Lost to Follow-up|0|||
125974685|NCT01786512|453196880|FG005|Overall Study|Lost to Follow-up|0|||
125974686|NCT01786512|453196881|FG006|Overall Study|Lost to Follow-up|0|||
125974687|NCT01786512|453196882|FG007|Overall Study|Lost to Follow-up|0|||
125974688|NCT01786512|453196883|FG008|Overall Study|Lost to Follow-up|0|||
125974689|NCT01786512|453196884|FG009|Overall Study|Lost to Follow-up|1|||
125974690|NCT01786512|453196885|FG010|Overall Study|Lost to Follow-up|0|||
125974691|NCT01786512|453196875|FG000|Overall Study|Decision by sponsor|0|||
125974692|NCT01786512|453196876|FG001|Overall Study|Decision by sponsor|0|||
125974693|NCT01786512|453196877|FG002|Overall Study|Decision by sponsor|0|||
125974694|NCT01786512|453196878|FG003|Overall Study|Decision by sponsor|0|||
125974695|NCT01786512|453196879|FG004|Overall Study|Decision by sponsor|0|||
125974696|NCT01786512|453196880|FG005|Overall Study|Decision by sponsor|0|||
125974697|NCT01786512|453196881|FG006|Overall Study|Decision by sponsor|0|||
125974698|NCT01786512|453196882|FG007|Overall Study|Decision by sponsor|0|||
125974699|NCT01786512|453196883|FG008|Overall Study|Decision by sponsor|0|||
125974700|NCT01786512|453196884|FG009|Overall Study|Decision by sponsor|0|||
125974701|NCT01786512|453196885|FG010|Overall Study|Decision by sponsor|2|||
125974702|NCT01786512|453196875|FG000|Overall Study|Withdrawal by Subject|0|||
125974703|NCT01786512|453196876|FG001|Overall Study|Withdrawal by Subject|1|||
125974704|NCT01786512|453196877|FG002|Overall Study|Withdrawal by Subject|0|||
125974705|NCT01786512|453196878|FG003|Overall Study|Withdrawal by Subject|0|||
125974706|NCT01786512|453196879|FG004|Overall Study|Withdrawal by Subject|0|||
125974707|NCT01786512|453196880|FG005|Overall Study|Withdrawal by Subject|0|||
125974708|NCT01786512|453196881|FG006|Overall Study|Withdrawal by Subject|1|||
126177818|NCT01824693|453936673|FG002|Overall Study|No Transplant Planned|10|||
126177819|NCT03287869|453936676|FG000|Overall Study|Adverse Event|14|||
126177820|NCT03287869|453936677|FG001|Overall Study|Adverse Event|12|||
126177821|NCT03287869|453936676|FG000|Overall Study|Lack of Efficacy|1|||
126177822|NCT03287869|453936677|FG001|Overall Study|Lack of Efficacy|0|||
126177823|NCT03287869|453936676|FG000|Overall Study|Lost to Follow-up|13|||
126177824|NCT03287869|453936677|FG001|Overall Study|Lost to Follow-up|19|||
126177825|NCT03287869|453936676|FG000|Overall Study|Non-Compliance With Study Drug|5|||
126177826|NCT03287869|453936677|FG001|Overall Study|Non-Compliance With Study Drug|9|||
125974709|NCT01786512|453196882|FG007|Overall Study|Withdrawal by Subject|0|||
126177827|NCT03287869|453936676|FG000|Overall Study|Progressive Disease|1|||
126177828|NCT03287869|453936677|FG001|Overall Study|Progressive Disease|0|||
126177829|NCT03287869|453936676|FG000|Overall Study|Protocol Deviation|2|||
126177830|NCT03287869|453936677|FG001|Overall Study|Protocol Deviation|1|||
125974710|NCT01786512|453196883|FG008|Overall Study|Withdrawal by Subject|0|||
125974711|NCT01786512|453196884|FG009|Overall Study|Withdrawal by Subject|3|||
125974712|NCT01786512|453196885|FG010|Overall Study|Withdrawal by Subject|7|||
125974713|NCT01786512|453196875|FG000|Overall Study|Death|0|||
125974714|NCT01786512|453196876|FG001|Overall Study|Death|0|||
125974715|NCT01786512|453196877|FG002|Overall Study|Death|0|||
125974716|NCT01786512|453196878|FG003|Overall Study|Death|0|||
125974717|NCT01786512|453196879|FG004|Overall Study|Death|0|||
125974718|NCT01786512|453196880|FG005|Overall Study|Death|0|||
125974719|NCT01786512|453196881|FG006|Overall Study|Death|0|||
125974720|NCT01786512|453196882|FG007|Overall Study|Death|0|||
125974721|NCT01786512|453196883|FG008|Overall Study|Death|4|||
125974722|NCT01786512|453196884|FG009|Overall Study|Death|1|||
125974723|NCT01786512|453196885|FG010|Overall Study|Death|3|||
125974724|NCT03166618|453196886|FG000|Overall Study|Study was Terminated|0|||
125974725|NCT03166618|453196887|FG001|Overall Study|Study was Terminated|1|||
125974726|NCT01925950|453196888|FG000|Part 2|Withdrawal by Subject|1|||
125974727|NCT01925950|453196889|FG001|Part 2|Withdrawal by Subject|0|||
125974728|NCT00381940|453196892|FG000|Overall Study|Lack of Efficacy|3|||
125974729|NCT00381940|453196892|FG000|Overall Study|Protocol Violation|1|||
125974730|NCT00381940|453196892|FG000|Overall Study|Ineligible|1|||
125974731|NCT03162224|453196894|FG000|Overall Study|Death|4|||
125974732|NCT03162224|453196895|FG001|Overall Study|Death|5|||
125974733|NCT03162224|453196896|FG002|Overall Study|Death|8|||
125974734|NCT03162224|453196894|FG000|Overall Study|Withdrawal by Subject|1|||
125974735|NCT03162224|453196895|FG001|Overall Study|Withdrawal by Subject|0|||
125974736|NCT03162224|453196896|FG002|Overall Study|Withdrawal by Subject|1|||
125974737|NCT03162224|453196894|FG000|Overall Study|Lost to Follow-up|0|||
125974738|NCT03162224|453196895|FG001|Overall Study|Lost to Follow-up|1|||
125974739|NCT03162224|453196896|FG002|Overall Study|Lost to Follow-up|0|||
125974740|NCT03162224|453196894|FG000|Overall Study|Other|6|||
125974741|NCT03162224|453196895|FG001|Overall Study|Other|2|||
125974742|NCT03162224|453196896|FG002|Overall Study|Other|1|||
125974743|NCT03137303|453196897|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
125974744|NCT03137303|453196898|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
125974745|NCT03137303|453196897|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
125974746|NCT03137303|453196898|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
125974747|NCT03137303|453196897|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
125974748|NCT03137303|453196898|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
125974749|NCT03137303|453196897|FG000|T3: 9-month Follow-up|Death|1|||
125974750|NCT03137303|453196898|FG001|T3: 9-month Follow-up|Death|0|||
125974751|NCT03137303|453196897|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
125974752|NCT03137303|453196898|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
125974753|NCT03137303|453196897|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
125974754|NCT03137303|453196898|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
125974755|NCT03137303|453196897|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
125974756|NCT03137303|453196898|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
125974757|NCT03561090|453196901|FG000|Overall Study|Adverse Event|11|||
125974758|NCT03561090|453196902|FG001|Overall Study|Adverse Event|7|||
125974759|NCT03561090|453196901|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125974760|NCT03561090|453196902|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125974761|NCT03561090|453196901|FG000|Overall Study|Protocol Violation|2|||
125974762|NCT03561090|453196902|FG001|Overall Study|Protocol Violation|2|||
125974763|NCT03561090|453196901|FG000|Overall Study|Withdrawal by Subject|7|||
125974764|NCT03561090|453196902|FG001|Overall Study|Withdrawal by Subject|7|||
125974765|NCT03561090|453196901|FG000|Overall Study|Lost to Follow-up|7|||
125974766|NCT03561090|453196902|FG001|Overall Study|Lost to Follow-up|2|||
125974767|NCT03561090|453196901|FG000|Overall Study|Study Terminated by Sponsor|10|||
125974768|NCT03561090|453196902|FG001|Overall Study|Study Terminated by Sponsor|15|||
125974769|NCT03561090|453196901|FG000|Overall Study|Randomized by Mistake|1|||
125974770|NCT03561090|453196902|FG001|Overall Study|Randomized by Mistake|1|||
126177831|NCT03287869|453936676|FG000|Overall Study|Withdrawal by Subject|36|||
126177832|NCT03287869|453936677|FG001|Overall Study|Withdrawal by Subject|43|||
126177833|NCT03287869|453936676|FG000|Overall Study|Early Closure of the Site|0|||
126177834|NCT03287869|453936677|FG001|Overall Study|Early Closure of the Site|1|||
126177835|NCT03287869|453936676|FG000|Overall Study|Physician Decision|5|||
126177836|NCT03287869|453936677|FG001|Overall Study|Physician Decision|5|||
126177837|NCT03287869|453936676|FG000|Overall Study|Reason not Specified|6|||
126177838|NCT03287869|453936677|FG001|Overall Study|Reason not Specified|3|||
126177839|NCT03488238|453936678|FG000|Overall Study|Equipment malfunction|1|||
126177840|NCT03488238|453936678|FG000|Overall Study|Adverse Event|1|||
126177841|NCT00656084|453936679|FG000|Overall Study|Adverse Event|4|||
126177842|NCT00656084|453936679|FG000|Overall Study|Withdrawal by Subject|1|||
126177843|NCT00656084|453936679|FG000|Overall Study|Patient Request|1|||
126177844|NCT00656084|453936679|FG000|Overall Study|Investigator Request|1|||
126177845|NCT02591238|453936680|FG000|Overall Study|Pregnancy|1|||
126177846|NCT02591238|453936681|FG001|Overall Study|Pregnancy|0|||
126177847|NCT02591238|453936682|FG002|Overall Study|Pregnancy|0|||
126177848|NCT02591238|453936683|FG003|Overall Study|Pregnancy|0|||
126177849|NCT02591238|453936680|FG000|Overall Study|Withdrawal by Subject|0|||
126177850|NCT02591238|453936681|FG001|Overall Study|Withdrawal by Subject|0|||
126177851|NCT02591238|453936682|FG002|Overall Study|Withdrawal by Subject|0|||
126177852|NCT02591238|453936683|FG003|Overall Study|Withdrawal by Subject|1|||
126177853|NCT02591238|453936680|FG000|Overall Study|influenza|0|||
126177854|NCT02591238|453936681|FG001|Overall Study|influenza|0|||
126177855|NCT02591238|453936682|FG002|Overall Study|influenza|0|||
126177856|NCT02591238|453936683|FG003|Overall Study|influenza|1|||
126177857|NCT02591238|453936680|FG000|Overall Study|personal circumstances|0|||
126177858|NCT02591238|453936681|FG001|Overall Study|personal circumstances|0|||
126177859|NCT02591238|453936682|FG002|Overall Study|personal circumstances|0|||
126177860|NCT02591238|453936683|FG003|Overall Study|personal circumstances|1|||
126177861|NCT02591238|453936680|FG000|Overall Study|personal circumstances|0|||
126177862|NCT02591238|453936681|FG001|Overall Study|personal circumstances|1|||
126177863|NCT02591238|453936682|FG002|Overall Study|personal circumstances|0|||
126177864|NCT02591238|453936683|FG003|Overall Study|personal circumstances|0|||
126177865|NCT00953225|453936684|FG000|Overall Study|Withdrawal by Subject|2|||
126177866|NCT00953225|453936685|FG001|Overall Study|Withdrawal by Subject|0|||
126177867|NCT00640146|453936689|FG000|Overall Study|Adverse Event|2|||
126177868|NCT00640146|453936690|FG001|Overall Study|Adverse Event|0|||
126177869|NCT00640146|453936689|FG000|Overall Study|Lost to Follow-up|0|||
126177870|NCT00640146|453936690|FG001|Overall Study|Lost to Follow-up|1|||
126177871|NCT00640146|453936689|FG000|Overall Study|Lack of Efficacy|0|||
126177872|NCT00640146|453936690|FG001|Overall Study|Lack of Efficacy|1|||
126177873|NCT00640146|453936689|FG000|Overall Study|Withdrawal by Subject|1|||
126177874|NCT00640146|453936690|FG001|Overall Study|Withdrawal by Subject|1|||
126177875|NCT00640146|453936689|FG000|Overall Study|Randomized but not treated|1|||
126177876|NCT00640146|453936690|FG001|Overall Study|Randomized but not treated|3|||
126177877|NCT00520299|453936691|FG000|Overall Study|Withdrawal by Subject|0|||
126177878|NCT00520299|453936692|FG001|Overall Study|Withdrawal by Subject|0|||
126177879|NCT00520299|453936693|FG002|Overall Study|Withdrawal by Subject|2|||
126177880|NCT00520299|453936691|FG000|Overall Study|Progressive disease|0|||
126177881|NCT00520299|453936692|FG001|Overall Study|Progressive disease|3|||
126177882|NCT00520299|453936693|FG002|Overall Study|Progressive disease|4|||
126177883|NCT01357980|453936697|FG000|Overall Study|Lack of Efficacy|0|||
126177884|NCT01357980|453936698|FG001|Overall Study|Lack of Efficacy|1|||
126177885|NCT01357980|453936699|FG002|Overall Study|Lack of Efficacy|0|||
126177886|NCT01357980|453936700|FG003|Overall Study|Lack of Efficacy|0|||
126177887|NCT01357980|453936697|FG000|Overall Study|Consent withdrawn|0|||
126177888|NCT01357980|453936698|FG001|Overall Study|Consent withdrawn|0|||
126177889|NCT01357980|453936699|FG002|Overall Study|Consent withdrawn|1|||
126177890|NCT01357980|453936700|FG003|Overall Study|Consent withdrawn|0|||
126177891|NCT02528253|453936701|FG000|Overall Study|Adverse Event|3|||
126177892|NCT02528253|453936702|FG001|Overall Study|Adverse Event|4|||
126177893|NCT02528253|453936703|FG002|Overall Study|Adverse Event|4|||
126177894|NCT02528253|453936704|FG003|Overall Study|Adverse Event|8|||
126177895|NCT02528253|453936705|FG004|Overall Study|Adverse Event|18|||
126177896|NCT02528253|453936701|FG000|Overall Study|Death|2|||
126177897|NCT02528253|453936702|FG001|Overall Study|Death|2|||
126177898|NCT02528253|453936703|FG002|Overall Study|Death|1|||
126177899|NCT02528253|453936704|FG003|Overall Study|Death|0|||
126177900|NCT02528253|453936705|FG004|Overall Study|Death|1|||
126177901|NCT02528253|453936701|FG000|Overall Study|Insufficient clinical response|7|||
126177902|NCT02528253|453936702|FG001|Overall Study|Insufficient clinical response|10|||
126177903|NCT02528253|453936703|FG002|Overall Study|Insufficient clinical response|13|||
126177904|NCT02528253|453936704|FG003|Overall Study|Insufficient clinical response|12|||
126177905|NCT02528253|453936705|FG004|Overall Study|Insufficient clinical response|16|||
126177906|NCT02528253|453936701|FG000|Overall Study|Lost to Follow-up|16|||
126177907|NCT02528253|453936702|FG001|Overall Study|Lost to Follow-up|9|||
126177908|NCT02528253|453936703|FG002|Overall Study|Lost to Follow-up|31|||
126177909|NCT02528253|453936704|FG003|Overall Study|Lost to Follow-up|16|||
126177910|NCT02528253|453936705|FG004|Overall Study|Lost to Follow-up|34|||
126177911|NCT02528253|453936701|FG000|Overall Study|Other|21|||
126177912|NCT02528253|453936702|FG001|Overall Study|Other|22|||
126177913|NCT02528253|453936703|FG002|Overall Study|Other|58|||
126177914|NCT02528253|453936704|FG003|Overall Study|Other|52|||
126177915|NCT02528253|453936705|FG004|Overall Study|Other|76|||
126177916|NCT02528253|453936701|FG000|Overall Study|Withdrawal by Subject|25|||
126177917|NCT02528253|453936702|FG001|Overall Study|Withdrawal by Subject|20|||
126177918|NCT02528253|453936703|FG002|Overall Study|Withdrawal by Subject|29|||
126177919|NCT02528253|453936704|FG003|Overall Study|Withdrawal by Subject|48|||
126177920|NCT02528253|453936705|FG004|Overall Study|Withdrawal by Subject|73|||
126177921|NCT02528253|453936701|FG000|Overall Study|Protocol Violation|1|||
126177922|NCT02528253|453936702|FG001|Overall Study|Protocol Violation|2|||
126177923|NCT02528253|453936703|FG002|Overall Study|Protocol Violation|4|||
126177924|NCT02528253|453936704|FG003|Overall Study|Protocol Violation|0|||
126177925|NCT02528253|453936705|FG004|Overall Study|Protocol Violation|4|||
126177926|NCT02528253|453936701|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
126177927|NCT02528253|453936702|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
126177928|NCT02528253|453936703|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
126177929|NCT02528253|453936704|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
126177930|NCT02528253|453936705|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
126177931|NCT02293993|453936707|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
126177932|NCT02293993|453936708|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
126177933|NCT02293993|453936709|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
126177934|NCT02293993|453936710|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
126177935|NCT02293993|453936707|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
126177936|NCT02293993|453936708|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
126177937|NCT02293993|453936709|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
126177938|NCT02293993|453936710|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
126177939|NCT02293993|453936707|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
126177940|NCT02293993|453936708|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
126177941|NCT02293993|453936709|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
126177942|NCT02293993|453936710|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
126177943|NCT02293993|453936707|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
126177944|NCT02293993|453936708|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
126177945|NCT02293993|453936709|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
126177946|NCT02293993|453936710|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
126177947|NCT02293993|453936707|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
126177948|NCT02293993|453936708|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
126177949|NCT02293993|453936709|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
126177950|NCT02293993|453936710|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
126177951|NCT00094835|453936711|FG000|Overall Study|Physician Decision|1|||
126177952|NCT00094835|453936712|FG001|Overall Study|Physician Decision|0|||
126177953|NCT00094835|453936713|FG002|Overall Study|Physician Decision|0|||
126177954|NCT00094835|453936714|FG003|Overall Study|Physician Decision|0|||
126177955|NCT00094835|453936715|FG004|Overall Study|Physician Decision|0|||
126177956|NCT00094835|453936716|FG005|Overall Study|Physician Decision|1|||
126177957|NCT00094835|453936717|FG006|Overall Study|Physician Decision|0|||
126177958|NCT00094835|453936711|FG000|Overall Study|Withdrawal by Subject|0|||
126177959|NCT00094835|453936712|FG001|Overall Study|Withdrawal by Subject|0|||
126177960|NCT00094835|453936713|FG002|Overall Study|Withdrawal by Subject|0|||
126177961|NCT00094835|453936714|FG003|Overall Study|Withdrawal by Subject|0|||
126177962|NCT00094835|453936715|FG004|Overall Study|Withdrawal by Subject|0|||
126177963|NCT00094835|453936716|FG005|Overall Study|Withdrawal by Subject|0|||
126177964|NCT00094835|453936717|FG006|Overall Study|Withdrawal by Subject|1|||
126177965|NCT00094835|453936711|FG000|Overall Study|Lost to Follow-up|0|||
126177966|NCT00094835|453936712|FG001|Overall Study|Lost to Follow-up|0|||
126177967|NCT00094835|453936713|FG002|Overall Study|Lost to Follow-up|0|||
126177968|NCT00094835|453936714|FG003|Overall Study|Lost to Follow-up|0|||
126177969|NCT00094835|453936715|FG004|Overall Study|Lost to Follow-up|1|||
126177970|NCT00094835|453936716|FG005|Overall Study|Lost to Follow-up|0|||
126177971|NCT00094835|453936717|FG006|Overall Study|Lost to Follow-up|0|||
126177972|NCT00094835|453936711|FG000|Overall Study|Death|1|||
126177973|NCT00094835|453936712|FG001|Overall Study|Death|0|||
126177974|NCT00094835|453936713|FG002|Overall Study|Death|0|||
126177975|NCT00094835|453936714|FG003|Overall Study|Death|0|||
126177976|NCT00094835|453936715|FG004|Overall Study|Death|1|||
126177977|NCT00094835|453936716|FG005|Overall Study|Death|0|||
126177978|NCT00094835|453936717|FG006|Overall Study|Death|0|||
126177979|NCT00094835|453936711|FG000|Overall Study|Non-compliance|1|||
126177980|NCT00094835|453936712|FG001|Overall Study|Non-compliance|2|||
126177981|NCT00094835|453936713|FG002|Overall Study|Non-compliance|2|||
126177982|NCT00094835|453936714|FG003|Overall Study|Non-compliance|0|||
126177983|NCT00094835|453936715|FG004|Overall Study|Non-compliance|2|||
126177984|NCT00094835|453936716|FG005|Overall Study|Non-compliance|2|||
126177985|NCT00094835|453936717|FG006|Overall Study|Non-compliance|1|||
126177986|NCT00094835|453936711|FG000|Overall Study|Other|1|||
126177987|NCT00094835|453936712|FG001|Overall Study|Other|1|||
126177988|NCT00094835|453936713|FG002|Overall Study|Other|1|||
126177989|NCT00094835|453936714|FG003|Overall Study|Other|1|||
126177990|NCT00094835|453936715|FG004|Overall Study|Other|0|||
126177991|NCT00094835|453936716|FG005|Overall Study|Other|0|||
126177992|NCT00094835|453936717|FG006|Overall Study|Other|0|||
126177993|NCT05905601|453936720|FG000|Overall Study|Lost to Follow-up|1|||
126177994|NCT05905601|453936721|FG001|Overall Study|Lost to Follow-up|3|||
126177995|NCT02514772|453936722|FG000|Overall Study|Adverse Event|1|||
126177996|NCT02514772|453936723|FG001|Overall Study|Adverse Event|0|||
126177997|NCT02514772|453936722|FG000|Overall Study|Death|0|||
126177998|NCT02514772|453936723|FG001|Overall Study|Death|1|||
126177999|NCT02514772|453936722|FG000|Overall Study|Withdrawal by Subject|2|||
126178000|NCT02514772|453936723|FG001|Overall Study|Withdrawal by Subject|1|||
126178001|NCT03024255|453936724|FG000|Overall Study|Adverse Event|1|||
126178002|NCT03024255|453936725|FG001|Overall Study|Adverse Event|4|||
126178003|NCT03024255|453936726|FG002|Overall Study|Adverse Event|8|||
126178004|NCT03024255|453936727|FG003|Overall Study|Adverse Event|0|||
126178005|NCT03024255|453936724|FG000|Overall Study|Withdrawal by Subject|3|||
126178006|NCT03024255|453936725|FG001|Overall Study|Withdrawal by Subject|1|||
126178007|NCT03024255|453936726|FG002|Overall Study|Withdrawal by Subject|0|||
126178008|NCT03024255|453936727|FG003|Overall Study|Withdrawal by Subject|3|||
126178009|NCT03024255|453936724|FG000|Overall Study|Protocol Violation|0|||
126178010|NCT03024255|453936725|FG001|Overall Study|Protocol Violation|0|||
126178011|NCT03024255|453936726|FG002|Overall Study|Protocol Violation|2|||
126178012|NCT03024255|453936727|FG003|Overall Study|Protocol Violation|0|||
126178013|NCT03024255|453936724|FG000|Overall Study|Lost to Follow-up|1|||
126178014|NCT03024255|453936725|FG001|Overall Study|Lost to Follow-up|2|||
126178015|NCT03024255|453936726|FG002|Overall Study|Lost to Follow-up|1|||
126178016|NCT03024255|453936727|FG003|Overall Study|Lost to Follow-up|1|||
126178017|NCT03024255|453936724|FG000|Overall Study|Lack of Efficacy|1|||
126178018|NCT03024255|453936725|FG001|Overall Study|Lack of Efficacy|0|||
126178019|NCT03024255|453936726|FG002|Overall Study|Lack of Efficacy|0|||
126178020|NCT03024255|453936727|FG003|Overall Study|Lack of Efficacy|0|||
126178021|NCT03024255|453936724|FG000|Overall Study|Protocol Noncompliance|1|||
126178022|NCT03024255|453936725|FG001|Overall Study|Protocol Noncompliance|1|||
126178023|NCT03024255|453936726|FG002|Overall Study|Protocol Noncompliance|0|||
126178024|NCT03024255|453936727|FG003|Overall Study|Protocol Noncompliance|1|||
126178025|NCT03583606|453936728|FG000|Overall Study|Lost to Follow-up|0|||
126178026|NCT03583606|453936729|FG001|Overall Study|Lost to Follow-up|1|||
126178027|NCT03583606|453936730|FG002|Overall Study|Lost to Follow-up|0|||
126178028|NCT03583606|453936728|FG000|Overall Study|Ineligible at baseline|1|||
126178029|NCT03583606|453936729|FG001|Overall Study|Ineligible at baseline|0|||
126178030|NCT03583606|453936730|FG002|Overall Study|Ineligible at baseline|0|||
126178031|NCT00817206|453936735|FG000|Overall Study|Adverse Event|10|||
126178032|NCT00817206|453936736|FG001|Overall Study|Adverse Event|3|||
126178033|NCT00817206|453936735|FG000|Overall Study|Protocol Violation|0|||
126178034|NCT00817206|453936736|FG001|Overall Study|Protocol Violation|2|||
126178035|NCT00817206|453936735|FG000|Overall Study|Lost to Follow-up|0|||
126178036|NCT00817206|453936736|FG001|Overall Study|Lost to Follow-up|1|||
126178037|NCT00817206|453936735|FG000|Overall Study|Death|2|||
126178038|NCT00817206|453936736|FG001|Overall Study|Death|0|||
126178039|NCT00817206|453936735|FG000|Overall Study|Withdrawal by Subject|7|||
126178040|NCT00817206|453936736|FG001|Overall Study|Withdrawal by Subject|3|||
126178041|NCT00817206|453936735|FG000|Overall Study|Physician Decision|2|||
126178042|NCT00817206|453936736|FG001|Overall Study|Physician Decision|0|||
126178043|NCT00126581|453936737|FG000|Overall Study|Adverse Event|3|||
126178044|NCT00126581|453936738|FG001|Overall Study|Adverse Event|7|||
126178045|NCT00126581|453936737|FG000|Overall Study|Death|3|||
126178046|NCT00126581|453936738|FG001|Overall Study|Death|2|||
126178047|NCT00126581|453936737|FG000|Overall Study|Withdrawal by Subject|1|||
125974771|NCT03561090|453196901|FG000|Overall Study|Other Not Specified|0|||
126178048|NCT00126581|453936738|FG001|Overall Study|Withdrawal by Subject|4|||
126178049|NCT00126581|453936737|FG000|Overall Study|Alternative therapy|3|||
126178050|NCT00126581|453936738|FG001|Overall Study|Alternative therapy|3|||
125974772|NCT03561090|453196902|FG001|Overall Study|Other Not Specified|2|||
125974773|NCT04162769|453196909|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
125974774|NCT04162769|453196910|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
126178051|NCT00126581|453936737|FG000|Overall Study|Other illness/MD discretion|3|||
126178052|NCT00126581|453936738|FG001|Overall Study|Other illness/MD discretion|4|||
126178053|NCT00793182|453936739|FG000|Overall Study|Adverse Event|0|||
126178054|NCT00793182|453936740|FG001|Overall Study|Adverse Event|1|||
126178055|NCT03728140|453936742|FG000|Overall Study|Abnormal embryo transfer operation|10|||
126178056|NCT03728140|453936743|FG001|Overall Study|Abnormal embryo transfer operation|7|||
126178057|NCT02197897|453936746|FG000|Overall Study|not eligible|1|||
126178058|NCT02384395|453936747|FG000|Overall Study|Physician Decision|4|||
126178059|NCT02384395|453936747|FG000|Overall Study|Withdrawal by Subject|3|||
126178060|NCT02384395|453936747|FG000|Overall Study|Lost to Follow-up|3|||
126178061|NCT04295356|453936749|FG000|Overall Study|Physician Decision|1|||
126178062|NCT04295356|453936750|FG001|Overall Study|Physician Decision|0|||
126178063|NCT04295356|453936749|FG000|Overall Study|Lost to Follow-up|0|||
126178064|NCT04295356|453936750|FG001|Overall Study|Lost to Follow-up|3|||
126178065|NCT04295356|453936749|FG000|Overall Study|Protocol Violation|0|||
126178066|NCT04295356|453936750|FG001|Overall Study|Protocol Violation|1|||
126178067|NCT01106391|453936751|FG000|Overall Study|Death|12|||
126178068|NCT01106391|453936751|FG000|Overall Study|Withdrawal by Subject|7|||
126178069|NCT04268004|453936754|FG000|Overall Study|Excluded from analyses|0|||
126178070|NCT04268004|453936755|FG001|Overall Study|Excluded from analyses|1|||
126178071|NCT03783442|453936756|FG000|Overall Study|Death|252|||
126178072|NCT03783442|453936757|FG001|Overall Study|Death|268|||
126178073|NCT03783442|453936756|FG000|Overall Study|Withdrawal by Subject|19|||
126178074|NCT03783442|453936757|FG001|Overall Study|Withdrawal by Subject|21|||
126178075|NCT03783442|453936756|FG000|Overall Study|Lost to Follow-up|7|||
126178076|NCT03783442|453936757|FG001|Overall Study|Lost to Follow-up|6|||
126178077|NCT03783442|453936756|FG000|Overall Study|Sponsor Ended Study|48|||
126178078|NCT03783442|453936757|FG001|Overall Study|Sponsor Ended Study|28|||
126178079|NCT04190186|453936758|FG000|Overall Study|ILR is no longer functioning|0|||
126178080|NCT04190186|453936759|FG001|Overall Study|ILR is no longer functioning|1|||
126178081|NCT04190186|453936758|FG000|Overall Study|Lost to Follow-up|0|||
126178082|NCT04190186|453936759|FG001|Overall Study|Lost to Follow-up|1|||
126178083|NCT04190186|453936758|FG000|Overall Study|Withdrawal by Subject|2|||
126178084|NCT04190186|453936759|FG001|Overall Study|Withdrawal by Subject|0|||
126178085|NCT04190186|453936758|FG000|Overall Study|Subject choice to explant|1|||
126178086|NCT04190186|453936759|FG001|Overall Study|Subject choice to explant|0|||
126178087|NCT04190186|453936758|FG000|Overall Study|Physician Decision|0|||
126178088|NCT04190186|453936759|FG001|Overall Study|Physician Decision|1|||
126178089|NCT04190186|453936758|FG000|Overall Study|Study was stopped|4|||
126178090|NCT04190186|453936759|FG001|Overall Study|Study was stopped|5|||
126178091|NCT01381718|453936760|FG000|Overall Study|Withdrawal by Subject|2|||
126178092|NCT01381718|453936761|FG001|Overall Study|Withdrawal by Subject|5|||
126178093|NCT01381718|453936760|FG000|Overall Study|Lost to Follow-up|3|||
126178094|NCT01381718|453936761|FG001|Overall Study|Lost to Follow-up|5|||
126178095|NCT01381718|453936760|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
126178096|NCT01381718|453936761|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
126178097|NCT02759861|453936764|FG000|Overall Study|Death|1|||
126178098|NCT00992186|453936767|FG000|Overall Study|Withdrawal by Subject|2|||
126178099|NCT00992186|453936767|FG000|Overall Study|Protocol Violation|1|||
126178100|NCT00992186|453936767|FG000|Overall Study|Physician Decision|1|||
126178101|NCT00992186|453936767|FG000|Overall Study|Adverse Event|9|||
126178102|NCT00992186|453936767|FG000|Overall Study|Progressive Disease|30|||
126178103|NCT00992186|453936767|FG000|Overall Study|Refusal To Receive Study Agent|3|||
126178104|NCT00830960|453936768|FG000|Overall Study|Death|5|||
126178105|NCT00830960|453936769|FG001|Overall Study|Death|4|||
126178106|NCT00830960|453936770|FG002|Overall Study|Death|3|||
126178107|NCT00830960|453936771|FG003|Overall Study|Death|2|||
126178108|NCT00830960|453936772|FG004|Overall Study|Death|6|||
126178109|NCT00830960|453936773|FG005|Overall Study|Death|1|||
126178110|NCT00830960|453936768|FG000|Overall Study|Lost to Follow-up|1|||
126178111|NCT00830960|453936769|FG001|Overall Study|Lost to Follow-up|1|||
126178112|NCT00830960|453936770|FG002|Overall Study|Lost to Follow-up|1|||
126178113|NCT00830960|453936771|FG003|Overall Study|Lost to Follow-up|0|||
126178114|NCT00830960|453936772|FG004|Overall Study|Lost to Follow-up|0|||
126178115|NCT00830960|453936773|FG005|Overall Study|Lost to Follow-up|1|||
126178116|NCT00830960|453936768|FG000|Overall Study|Withdrawal by Subject|19|||
126178117|NCT00830960|453936769|FG001|Overall Study|Withdrawal by Subject|19|||
126178118|NCT00830960|453936770|FG002|Overall Study|Withdrawal by Subject|18|||
126178119|NCT00830960|453936771|FG003|Overall Study|Withdrawal by Subject|23|||
126178120|NCT00830960|453936772|FG004|Overall Study|Withdrawal by Subject|16|||
126178121|NCT00830960|453936773|FG005|Overall Study|Withdrawal by Subject|21|||
126178122|NCT00830960|453936768|FG000|Overall Study|Sponsor Decision|1|||
125974775|NCT04162769|453196911|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
126178123|NCT00830960|453936769|FG001|Overall Study|Sponsor Decision|2|||
126178124|NCT00830960|453936770|FG002|Overall Study|Sponsor Decision|3|||
126178125|NCT00830960|453936771|FG003|Overall Study|Sponsor Decision|4|||
126178126|NCT00830960|453936772|FG004|Overall Study|Sponsor Decision|5|||
125974776|NCT04162769|453196912|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
126178127|NCT00830960|453936773|FG005|Overall Study|Sponsor Decision|7|||
126178128|NCT00830960|453936768|FG000|Overall Study|No study drug received|7|||
126178129|NCT00830960|453936769|FG001|Overall Study|No study drug received|2|||
126178130|NCT00830960|453936770|FG002|Overall Study|No study drug received|4|||
126178131|NCT00830960|453936771|FG003|Overall Study|No study drug received|3|||
126178132|NCT00830960|453936772|FG004|Overall Study|No study drug received|5|||
126178133|NCT00830960|453936773|FG005|Overall Study|No study drug received|7|||
126178134|NCT02855450|453936774|FG000|Overall Study|Adverse Event|1|||
126178135|NCT02855450|453936775|FG001|Overall Study|Adverse Event|0|||
126178136|NCT02855450|453936774|FG000|Overall Study|Lost to Follow-up|4|||
126178137|NCT02855450|453936775|FG001|Overall Study|Lost to Follow-up|0|||
126178138|NCT01374217|453936777|FG000|Overall Study|Lack of Efficacy|13|||
126178139|NCT01740388|453936778|FG000|Overall Study|Withdrawal by Subject|1|||
126178140|NCT01740388|453936779|FG001|Overall Study|Withdrawal by Subject|2|||
126178141|NCT01740388|453936778|FG000|Overall Study|Lost to Follow-up|2|||
126178142|NCT01740388|453936779|FG001|Overall Study|Lost to Follow-up|0|||
126178143|NCT01740388|453936778|FG000|Overall Study|Physician Decision|2|||
126178144|NCT01740388|453936779|FG001|Overall Study|Physician Decision|6|||
126178145|NCT01740388|453936778|FG000|Overall Study|Subjects missing data, completed|41|||
126178146|NCT01740388|453936779|FG001|Overall Study|Subjects missing data, completed|36|||
126178147|NCT00862121|453936782|FG000|Overall Study|Adverse Event|1|||
126178148|NCT00862121|453936783|FG001|Overall Study|Adverse Event|2|||
126178149|NCT00862121|453936782|FG000|Overall Study|Lack of Efficacy|0|||
126178150|NCT00862121|453936783|FG001|Overall Study|Lack of Efficacy|3|||
126178151|NCT00862121|453936782|FG000|Overall Study|Protocol Violation|0|||
126178152|NCT00862121|453936783|FG001|Overall Study|Protocol Violation|1|||
126178153|NCT00862121|453936782|FG000|Overall Study|Exclusion criterion violation|0|||
126178154|NCT00862121|453936783|FG001|Overall Study|Exclusion criterion violation|1|||
126178155|NCT00862121|453936782|FG000|Overall Study|Incorrect randomisation|0|||
126178156|NCT00862121|453936783|FG001|Overall Study|Incorrect randomisation|1|||
126178157|NCT01641991|453936784|FG000|Overall Study|Physician Decision|0|||
126178158|NCT01641991|453936785|FG001|Overall Study|Physician Decision|1|||
126178159|NCT01641991|453936786|FG002|Overall Study|Physician Decision|7|||
126178160|NCT01641991|453936787|FG003|Overall Study|Physician Decision|5|||
126178161|NCT01641991|453936784|FG000|Overall Study|Withdrawal by Subject|4|||
126178162|NCT01641991|453936785|FG001|Overall Study|Withdrawal by Subject|2|||
126178163|NCT01641991|453936786|FG002|Overall Study|Withdrawal by Subject|1|||
126178164|NCT01641991|453936787|FG003|Overall Study|Withdrawal by Subject|5|||
126178165|NCT01641991|453936784|FG000|Overall Study|Adverse Event|2|||
126178166|NCT01641991|453936785|FG001|Overall Study|Adverse Event|1|||
126178167|NCT01641991|453936786|FG002|Overall Study|Adverse Event|2|||
126178168|NCT01641991|453936787|FG003|Overall Study|Adverse Event|1|||
126178169|NCT01641991|453936784|FG000|Overall Study|Lost to Follow-up|0|||
126178170|NCT01641991|453936785|FG001|Overall Study|Lost to Follow-up|2|||
126178171|NCT01641991|453936786|FG002|Overall Study|Lost to Follow-up|3|||
126178172|NCT01641991|453936787|FG003|Overall Study|Lost to Follow-up|1|||
126178173|NCT01641991|453936784|FG000|Overall Study|Protocol Violation|1|||
126178174|NCT01641991|453936785|FG001|Overall Study|Protocol Violation|1|||
126178175|NCT01641991|453936786|FG002|Overall Study|Protocol Violation|3|||
126178176|NCT01641991|453936787|FG003|Overall Study|Protocol Violation|0|||
126178177|NCT01641991|453936784|FG000|Overall Study|Pregnancy|0|||
126178178|NCT01641991|453936785|FG001|Overall Study|Pregnancy|0|||
126178179|NCT01641991|453936786|FG002|Overall Study|Pregnancy|1|||
126178180|NCT01641991|453936787|FG003|Overall Study|Pregnancy|0|||
126178181|NCT01641991|453936784|FG000|Overall Study|no longer eligible|2|||
126178182|NCT01641991|453936785|FG001|Overall Study|no longer eligible|1|||
126178183|NCT01641991|453936786|FG002|Overall Study|no longer eligible|0|||
126178184|NCT01641991|453936787|FG003|Overall Study|no longer eligible|4|||
126178185|NCT03371732|453936792|FG000|Overall Study|Withdrawal by Subject|9|||
126178186|NCT03371732|453936793|FG001|Overall Study|Withdrawal by Subject|3|||
126178187|NCT03371732|453936792|FG000|Overall Study|Refusal to continue|3|||
126178188|NCT03371732|453936793|FG001|Overall Study|Refusal to continue|4|||
126178189|NCT00171314|453936794|FG000|Overall Study|Adverse Event|44|||
126178190|NCT00171314|453936795|FG001|Overall Study|Adverse Event|41|||
126178191|NCT00171314|453936794|FG000|Overall Study|Lack of Efficacy|19|||
126178192|NCT00171314|453936795|FG001|Overall Study|Lack of Efficacy|14|||
126178193|NCT00171314|453936794|FG000|Overall Study|Withdrawal by Subject|9|||
126178194|NCT00171314|453936795|FG001|Overall Study|Withdrawal by Subject|6|||
126178195|NCT00171314|453936794|FG000|Overall Study|Abnormal Test Procedure Results|9|||
126178196|NCT00171314|453936795|FG001|Overall Study|Abnormal Test Procedure Results|3|||
126178197|NCT00171314|453936794|FG000|Overall Study|Protocol Violation|3|||
125974777|NCT04162769|453196909|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
125974778|NCT04162769|453196910|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
126178198|NCT00171314|453936795|FG001|Overall Study|Protocol Violation|7|||
126178199|NCT00171314|453936794|FG000|Overall Study|Administrative Problems|4|||
126178200|NCT00171314|453936795|FG001|Overall Study|Administrative Problems|3|||
126178201|NCT00171314|453936794|FG000|Overall Study|Lost to Follow-up|1|||
126178202|NCT00171314|453936795|FG001|Overall Study|Lost to Follow-up|3|||
126178203|NCT00171314|453936794|FG000|Overall Study|Death|2|||
126178204|NCT00171314|453936795|FG001|Overall Study|Death|1|||
126178205|NCT00475540|453936796|FG000|36 Months|Lost to Follow-up|4|||
126178206|NCT00475540|453936797|FG001|36 Months|Lost to Follow-up|4|||
126178207|NCT00475540|453936796|FG000|36 Months|Death|1|||
126178208|NCT00475540|453936797|FG001|36 Months|Death|2|||
125974779|NCT04162769|453196911|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
126178209|NCT00475540|453936796|FG000|36 Months|Censored due to reoperation|3|||
126178210|NCT00475540|453936797|FG001|36 Months|Censored due to reoperation|0|||
126178211|NCT00377429|453936798|FG000|Overall Study|Withdrawal by Subject|5|||
126178212|NCT00377429|453936798|FG000|Overall Study|Adverse Event|8|||
126178213|NCT00377429|453936798|FG000|Overall Study|Physician Decision|1|||
126178214|NCT00377429|453936798|FG000|Overall Study|Patient non-compliance|1|||
126178215|NCT01033487|453936804|FG000|Fourth Intervention Period|Adverse Event|0|||
126178216|NCT01033487|453936805|FG001|Fourth Intervention Period|Adverse Event|0|||
126178217|NCT01033487|453936806|FG002|Fourth Intervention Period|Adverse Event|0|||
126178218|NCT01033487|453936807|FG003|Fourth Intervention Period|Adverse Event|0|||
126178219|NCT01033487|453936808|FG004|Fourth Intervention Period|Adverse Event|0|||
126178220|NCT01033487|453936809|FG005|Fourth Intervention Period|Adverse Event|0|||
126178221|NCT01033487|453936810|FG006|Fourth Intervention Period|Adverse Event|0|||
126178222|NCT01033487|453936811|FG007|Fourth Intervention Period|Adverse Event|0|||
126178223|NCT01033487|453936812|FG008|Fourth Intervention Period|Adverse Event|1|||
126178224|NCT01033487|453936813|FG009|Fourth Intervention Period|Adverse Event|0|||
126178225|NCT02939599|453936814|FG000|Overall Study|Adverse Event|1|||
126178226|NCT02939599|453936815|FG001|Overall Study|Adverse Event|0|||
126178227|NCT02939599|453936814|FG000|Overall Study|Study Terminated By Sponsor|2|||
126178228|NCT02939599|453936815|FG001|Overall Study|Study Terminated By Sponsor|2|||
126178229|NCT02148211|453936816|FG000|Overall Study|Lost to Follow-up|352|||
126178230|NCT02726113|453936817|FG000|Total Enrollment|Physician Decision|0|||
126178231|NCT02726113|453936818|FG001|Total Enrollment|Physician Decision|1|||
126178232|NCT02726113|453936817|FG000|Total Enrollment|Protocol Violation|1|||
126178233|NCT02726113|453936818|FG001|Total Enrollment|Protocol Violation|0|||
126178234|NCT02726113|453936817|FG000|Total Enrollment|Withdrawal by Subject|2|||
126178235|NCT02726113|453936818|FG001|Total Enrollment|Withdrawal by Subject|1|||
126178236|NCT02726113|453936817|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
126178237|NCT02726113|453936818|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
126178238|NCT02726113|453936817|FG000|Genomic Analysis|Protocol Violation|1|||
126178239|NCT02726113|453936818|FG001|Genomic Analysis|Protocol Violation|0|||
126178240|NCT02726113|453936817|FG000|Genomic Analysis|Withdrawal by Subject|2|||
126178241|NCT02726113|453936818|FG001|Genomic Analysis|Withdrawal by Subject|1|||
126178242|NCT02726113|453936817|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
126178243|NCT02726113|453936818|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
126178244|NCT03326869|453938707|FG000|Overall Study|Study data has been lost to natural disa|1|||
126178245|NCT03326869|453938708|FG001|Overall Study|Study data has been lost to natural disa|1|||
126178246|NCT03788967|453938709|FG000|Overall Study|Lost to Follow-up|14|||
126178247|NCT03788967|453938710|FG001|Overall Study|Lost to Follow-up|10|||
126178248|NCT03788967|453938709|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
126178249|NCT03788967|453938710|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
126178250|NCT03788967|453938709|FG000|Overall Study|Participant Withdrawal of Consent|13|||
126178251|NCT03788967|453938710|FG001|Overall Study|Participant Withdrawal of Consent|5|||
126178252|NCT03788967|453938709|FG000|Overall Study|Adverse Event|1|||
126178253|NCT03788967|453938710|FG001|Overall Study|Adverse Event|1|||
126178254|NCT03788967|453938709|FG000|Overall Study|COVID-19|1|||
126178255|NCT03788967|453938710|FG001|Overall Study|COVID-19|2|||
126178256|NCT03927911|453938711|FG000|Overall Study|problems with eDiary|0|||
126178257|NCT03927911|453938712|FG001|Overall Study|problems with eDiary|1|||
126178258|NCT03927911|453938713|FG002|Overall Study|problems with eDiary|0|||
126178259|NCT03927911|453938714|FG003|Overall Study|problems with eDiary|1|||
126178260|NCT03927911|453938715|FG004|Overall Study|problems with eDiary|0|||
126178261|NCT03927911|453938716|FG005|Overall Study|problems with eDiary|4|||
126178262|NCT03927911|453938711|FG000|Overall Study|Adverse Event|0|||
126178263|NCT03927911|453938712|FG001|Overall Study|Adverse Event|0|||
126178264|NCT03927911|453938713|FG002|Overall Study|Adverse Event|0|||
126178265|NCT03927911|453938714|FG003|Overall Study|Adverse Event|0|||
126178266|NCT03927911|453938715|FG004|Overall Study|Adverse Event|0|||
126178267|NCT03927911|453938716|FG005|Overall Study|Adverse Event|1|||
126178268|NCT03927911|453938711|FG000|Overall Study|not treated -study terminated by sponsor|0|||
126178269|NCT03927911|453938712|FG001|Overall Study|not treated -study terminated by sponsor|1|||
126178270|NCT03927911|453938713|FG002|Overall Study|not treated -study terminated by sponsor|0|||
126178271|NCT03927911|453938714|FG003|Overall Study|not treated -study terminated by sponsor|0|||
126178272|NCT03927911|453938715|FG004|Overall Study|not treated -study terminated by sponsor|0|||
126178273|NCT03927911|453938716|FG005|Overall Study|not treated -study terminated by sponsor|0|||
126178274|NCT03927911|453938711|FG000|Overall Study|Surgery cancelled|0|||
126178275|NCT03927911|453938712|FG001|Overall Study|Surgery cancelled|0|||
126178276|NCT03927911|453938713|FG002|Overall Study|Surgery cancelled|0|||
126178277|NCT03927911|453938714|FG003|Overall Study|Surgery cancelled|1|||
126178278|NCT03927911|453938715|FG004|Overall Study|Surgery cancelled|0|||
126178279|NCT03927911|453938716|FG005|Overall Study|Surgery cancelled|1|||
126178280|NCT03927911|453938711|FG000|Overall Study|Protocol Violation|0|||
126178281|NCT03927911|453938712|FG001|Overall Study|Protocol Violation|0|||
125974780|NCT04162769|453196912|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
125974781|NCT04162769|453196909|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
126178282|NCT03927911|453938713|FG002|Overall Study|Protocol Violation|0|||
126178283|NCT03927911|453938714|FG003|Overall Study|Protocol Violation|0|||
126178284|NCT03927911|453938715|FG004|Overall Study|Protocol Violation|0|||
126178285|NCT03927911|453938716|FG005|Overall Study|Protocol Violation|1|||
126178286|NCT04432376|453938717|FG000|Double-blind Treatment Period|Adverse Event|2|||
126178287|NCT04432376|453938718|FG001|Double-blind Treatment Period|Adverse Event|6|||
126178288|NCT04432376|453938719|FG002|Double-blind Treatment Period|Adverse Event|0|||
126178289|NCT04432376|453938717|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
126178290|NCT04432376|453938718|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
126178291|NCT04432376|453938719|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126178292|NCT04432376|453938717|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126178293|NCT04432376|453938718|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126178294|NCT04432376|453938719|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126178295|NCT04432376|453938717|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126178296|NCT04432376|453938718|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126178297|NCT04432376|453938719|FG002|Double-blind Treatment Period|Protocol Violation|0|||
126178298|NCT04432376|453938717|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
126178299|NCT04432376|453938718|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
126178300|NCT04432376|453938719|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
126178301|NCT04847141|453938720|FG000|Overall Study|Adverse Event|1|||
126178302|NCT04847141|453938721|FG001|Overall Study|Adverse Event|0|||
126178303|NCT04847141|453938722|FG002|Overall Study|Adverse Event|1|||
126178304|NCT04847141|453938720|FG000|Overall Study|Withdrawal by Subject|2|||
126178305|NCT04847141|453938721|FG001|Overall Study|Withdrawal by Subject|4|||
126178306|NCT04847141|453938722|FG002|Overall Study|Withdrawal by Subject|3|||
126178307|NCT04847141|453938720|FG000|Overall Study|Lost to Follow-up|7|||
126178308|NCT04847141|453938721|FG001|Overall Study|Lost to Follow-up|5|||
126178309|NCT04847141|453938722|FG002|Overall Study|Lost to Follow-up|7|||
126178310|NCT04847141|453938720|FG000|Overall Study|Reason not Specified|0|||
126178311|NCT04847141|453938721|FG001|Overall Study|Reason not Specified|1|||
126178312|NCT04847141|453938722|FG002|Overall Study|Reason not Specified|0|||
126178313|NCT04058158|453938723|FG000|Period 1|Death|1|||
126178314|NCT04058158|453938724|FG001|Period 1|Death|0|||
126178315|NCT04058158|453938723|FG000|Period 1|Adverse Event|1|||
126178316|NCT04058158|453938724|FG001|Period 1|Adverse Event|1|||
126178317|NCT04058158|453938723|FG000|Period 1|Pregnancy|0|||
126178318|NCT04058158|453938724|FG001|Period 1|Pregnancy|1|||
126178319|NCT01634113|453938725|FG000|Overall Study|Not treated|0|||
126178320|NCT01634113|453938726|FG001|Overall Study|Not treated|0|||
126178321|NCT01634113|453938727|FG002|Overall Study|Not treated|1|||
126178322|NCT00324740|453938728|FG000|Overall Study|Withdrawal by Subject|1|||
126178323|NCT00324740|453938729|FG001|Overall Study|Withdrawal by Subject|0|||
126178324|NCT00324740|453938730|FG002|Overall Study|Withdrawal by Subject|1|||
126178325|NCT04507776|453938731|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
126178326|NCT03628599|453938732|FG000|Overall Study|Adverse Event|0|||
126178327|NCT03628599|453938733|FG001|Overall Study|Adverse Event|1|||
126178328|NCT01624506|453938734|FG000|Overall Study|Lost to Follow-up|29|||
126178329|NCT01624506|453938735|FG001|Overall Study|Lost to Follow-up|15|||
125974782|NCT04162769|453196910|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
125974783|NCT04162769|453196911|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
125974784|NCT04162769|453196912|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
125974785|NCT04162769|453196909|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
125974786|NCT04162769|453196910|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
126178330|NCT01624506|453938734|FG000|Overall Study|Withdrawal by Subject|9|||
126178331|NCT01624506|453938735|FG001|Overall Study|Withdrawal by Subject|2|||
126178332|NCT01624506|453938734|FG000|Overall Study|Death|1|||
126178333|NCT01624506|453938735|FG001|Overall Study|Death|0|||
126178334|NCT01624506|453938734|FG000|Overall Study|LINX explants|23|||
126178335|NCT01624506|453938735|FG001|Overall Study|LINX explants|0|||
126178336|NCT01624506|453938734|FG000|Overall Study|Adverse Event|3|||
126178337|NCT01624506|453938735|FG001|Overall Study|Adverse Event|0|||
126178338|NCT00132314|453938738|FG000|Overall Study|Lost to Follow-up|70|||
126178339|NCT00132314|453938739|FG001|Overall Study|Lost to Follow-up|62|||
126178340|NCT00132314|453938738|FG000|Overall Study|Lacked SSN|1|||
126178341|NCT00132314|453938739|FG001|Overall Study|Lacked SSN|3|||
126178342|NCT00132314|453938738|FG000|Overall Study|Refused intervention at baseline|2|||
126178343|NCT00132314|453938739|FG001|Overall Study|Refused intervention at baseline|7|||
126178344|NCT03250377|453938740|FG000|Overall Study|Adverse Event|2|||
126178345|NCT03250377|453938741|FG001|Overall Study|Adverse Event|4|||
126178346|NCT03250377|453938742|FG002|Overall Study|Adverse Event|0|||
126178347|NCT03250377|453938743|FG003|Overall Study|Adverse Event|4|||
126178348|NCT03250377|453938740|FG000|Overall Study|Lack of Efficacy|5|||
126178349|NCT03250377|453938741|FG001|Overall Study|Lack of Efficacy|14|||
126178350|NCT03250377|453938742|FG002|Overall Study|Lack of Efficacy|1|||
126178351|NCT03250377|453938743|FG003|Overall Study|Lack of Efficacy|3|||
126178352|NCT03250377|453938740|FG000|Overall Study|Protocol Violation|0|||
126178353|NCT03250377|453938741|FG001|Overall Study|Protocol Violation|2|||
126178354|NCT03250377|453938742|FG002|Overall Study|Protocol Violation|0|||
126178355|NCT03250377|453938743|FG003|Overall Study|Protocol Violation|1|||
126178356|NCT03250377|453938740|FG000|Overall Study|Lost to Follow-up|0|||
126178357|NCT03250377|453938741|FG001|Overall Study|Lost to Follow-up|1|||
126178358|NCT03250377|453938742|FG002|Overall Study|Lost to Follow-up|0|||
126178359|NCT03250377|453938743|FG003|Overall Study|Lost to Follow-up|0|||
126178360|NCT03250377|453938740|FG000|Overall Study|Withdrawal by Subject|7|||
126178361|NCT03250377|453938741|FG001|Overall Study|Withdrawal by Subject|7|||
126178362|NCT03250377|453938742|FG002|Overall Study|Withdrawal by Subject|0|||
126178363|NCT03250377|453938743|FG003|Overall Study|Withdrawal by Subject|4|||
126178364|NCT03250377|453938740|FG000|Overall Study|Investigator's Judgment|1|||
126178365|NCT03250377|453938741|FG001|Overall Study|Investigator's Judgment|0|||
126178366|NCT03250377|453938742|FG002|Overall Study|Investigator's Judgment|0|||
126178367|NCT03250377|453938743|FG003|Overall Study|Investigator's Judgment|0|||
126178368|NCT03250377|453938740|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
126178369|NCT03250377|453938741|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
126178370|NCT03250377|453938742|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
126178371|NCT03250377|453938743|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
126178372|NCT03250377|453938740|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
126178373|NCT03250377|453938741|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
126178374|NCT03250377|453938742|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
126178375|NCT03250377|453938743|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
126178376|NCT03250377|453938740|FG000|Overall Study|Epilepsy Surgery|0|||
126178377|NCT03250377|453938741|FG001|Overall Study|Epilepsy Surgery|1|||
126178378|NCT03250377|453938742|FG002|Overall Study|Epilepsy Surgery|2|||
126178379|NCT03250377|453938743|FG003|Overall Study|Epilepsy Surgery|0|||
126178380|NCT03250377|453938740|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
126178381|NCT03250377|453938741|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
126178382|NCT03250377|453938742|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
126178383|NCT03250377|453938743|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
126178384|NCT03250377|453938740|FG000|Overall Study|Request From The Sponsor|0|||
126178385|NCT03250377|453938741|FG001|Overall Study|Request From The Sponsor|1|||
126178386|NCT03250377|453938742|FG002|Overall Study|Request From The Sponsor|0|||
126178387|NCT03250377|453938743|FG003|Overall Study|Request From The Sponsor|0|||
126178388|NCT03250377|453938740|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
126178389|NCT03250377|453938741|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
126178390|NCT03250377|453938742|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
126178391|NCT03250377|453938743|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
126178392|NCT03250377|453938740|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
126178393|NCT03250377|453938741|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
126178394|NCT03250377|453938742|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
126178395|NCT03250377|453938743|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
126178396|NCT03250377|453938740|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
126178397|NCT03250377|453938741|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
126178398|NCT03250377|453938742|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
126178399|NCT03250377|453938743|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
126178400|NCT03250377|453938740|FG000|Overall Study|Pregnancy Event|0|||
126178401|NCT03250377|453938741|FG001|Overall Study|Pregnancy Event|1|||
126178402|NCT03250377|453938742|FG002|Overall Study|Pregnancy Event|0|||
126178403|NCT03250377|453938743|FG003|Overall Study|Pregnancy Event|0|||
126178404|NCT03250377|453938740|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
126178405|NCT03250377|453938741|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
126178406|NCT03250377|453938742|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
126178407|NCT03250377|453938743|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
126178408|NCT03250377|453938740|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
126178409|NCT03250377|453938741|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
126178410|NCT03250377|453938742|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
126178411|NCT03250377|453938743|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
126178412|NCT03250377|453938740|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
126178413|NCT03250377|453938741|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
126178414|NCT03250377|453938742|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
126178415|NCT03250377|453938743|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
126178416|NCT03250377|453938740|FG000|Overall Study|Patient requested to change hospital|0|||
126178417|NCT03250377|453938741|FG001|Overall Study|Patient requested to change hospital|0|||
126178418|NCT03250377|453938742|FG002|Overall Study|Patient requested to change hospital|0|||
126178419|NCT03250377|453938743|FG003|Overall Study|Patient requested to change hospital|1|||
126178420|NCT03250377|453938740|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
126178421|NCT03250377|453938741|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
126178422|NCT03250377|453938742|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
126178423|NCT03250377|453938743|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
126178424|NCT03657810|453938744|FG000|Overall Study|Adverse Event|0|||
126178425|NCT03657810|453938745|FG001|Overall Study|Adverse Event|1|||
126178426|NCT03657810|453938746|FG002|Overall Study|Adverse Event|0|||
126178427|NCT03657810|453938744|FG000|Overall Study|Lack of Efficacy|4|||
126178428|NCT03657810|453938745|FG001|Overall Study|Lack of Efficacy|1|||
126178429|NCT03657810|453938746|FG002|Overall Study|Lack of Efficacy|3|||
126178430|NCT03657810|453938744|FG000|Overall Study|Protocol Violation|1|||
126178431|NCT03657810|453938745|FG001|Overall Study|Protocol Violation|0|||
126178432|NCT03657810|453938746|FG002|Overall Study|Protocol Violation|0|||
126178433|NCT03657810|453938744|FG000|Overall Study|Lost to Follow-up|0|||
126178434|NCT03657810|453938745|FG001|Overall Study|Lost to Follow-up|1|||
126178435|NCT03657810|453938746|FG002|Overall Study|Lost to Follow-up|0|||
126178436|NCT03657810|453938744|FG000|Overall Study|Not provided|0|||
126178437|NCT03657810|453938745|FG001|Overall Study|Not provided|1|||
126178438|NCT03657810|453938746|FG002|Overall Study|Not provided|0|||
126178439|NCT03939637|453938755|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
126178440|NCT03939637|453938756|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
126178441|NCT03939637|453938755|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
126178442|NCT03939637|453938756|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
126178443|NCT05224076|453938757|FG000|Overall Study|Lost to Follow-up|24|||
126178444|NCT01082367|453938758|FG000|Double-blind Period|Administrative problems|0|||
126178445|NCT01082367|453938759|FG001|Double-blind Period|Administrative problems|1|||
126178446|NCT01082367|453938758|FG000|Double-blind Period|Lack of Efficacy|5|||
126178447|NCT01082367|453938759|FG001|Double-blind Period|Lack of Efficacy|11|||
126178448|NCT01082367|453938758|FG000|Double-blind Period|Adverse Event|0|||
126178449|NCT01082367|453938759|FG001|Double-blind Period|Adverse Event|1|||
126178450|NCT01082367|453938758|FG000|Follow-up (F-U) Period|Administrative problems|1|||
126178451|NCT01082367|453938759|FG001|Follow-up (F-U) Period|Administrative problems|0|||
126178452|NCT01082367|453938758|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
126178453|NCT01082367|453938759|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
126178454|NCT01082367|453938758|FG000|Follow-up (F-U) Period|Adverse Event|0|||
126178455|NCT01082367|453938759|FG001|Follow-up (F-U) Period|Adverse Event|1|||
126178456|NCT02016898|453938760|FG000|Overall Study|Death|1|||
126178457|NCT02016898|453938761|FG001|Overall Study|Death|1|||
126178458|NCT02016898|453938760|FG000|Overall Study|Lost to Follow-up|4|||
126178459|NCT02016898|453938761|FG001|Overall Study|Lost to Follow-up|4|||
126178460|NCT01665768|453938762|FG000|Overall Study|Adverse Event|3|||
126178461|NCT01665768|453938762|FG000|Overall Study|Lack of Efficacy|19|||
126178462|NCT01665768|453938762|FG000|Overall Study|Withdrawal by Subject|1|||
126178463|NCT01329341|453938763|FG000|Overall Study|Withdrawal by Subject|44|||
126178464|NCT03017846|453938764|FG000|Overall Study|Lost to Follow-up|3|||
126178465|NCT03017846|453938764|FG000|Overall Study|Adverse Event|2|||
126178466|NCT04603391|453938765|FG000|First Intervention (4 Days)|Adverse Event|1|||
126178467|NCT04603391|453938766|FG001|First Intervention (4 Days)|Adverse Event|0|||
126178468|NCT04603391|453938765|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
126178469|NCT04603391|453938766|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
126178470|NCT02151682|453938767|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126178471|NCT02151682|453938768|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
126178472|NCT02151682|453938769|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126178473|NCT02151682|453938770|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126178474|NCT02151682|453938771|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126178475|NCT02151682|453938772|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126178476|NCT02151682|453938767|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126178477|NCT02151682|453938768|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
126178478|NCT02151682|453938769|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126178479|NCT02151682|453938770|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126178480|NCT02151682|453938771|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126178481|NCT02151682|453938772|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126178482|NCT02151682|453938767|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126178483|NCT02151682|453938768|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
126178484|NCT02151682|453938769|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126178485|NCT02151682|453938770|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126178486|NCT02151682|453938771|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126178487|NCT02151682|453938772|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126178488|NCT02151682|453938767|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
126178489|NCT02151682|453938768|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
126178490|NCT02151682|453938769|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
126178491|NCT02151682|453938770|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
126178492|NCT02151682|453938771|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
126178493|NCT02151682|453938772|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
126178494|NCT02151682|453938767|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
126178495|NCT02151682|453938768|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126178496|NCT02151682|453938769|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126178497|NCT02151682|453938770|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126178498|NCT02151682|453938771|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126178499|NCT02151682|453938772|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126178500|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126178501|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126178502|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
126178503|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126178504|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126178505|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126178506|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
126178507|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
126178508|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
126178509|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
126178510|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
126178511|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
126178512|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
126178513|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
126178514|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
126178515|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
126178516|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
126178517|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
126178518|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126178519|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126178520|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
126178521|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126178522|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126178523|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126178524|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126178525|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126178526|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
126178527|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126178528|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126178529|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126178530|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126178531|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126178532|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
126178533|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126178534|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126178535|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126178536|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
126178537|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
126178538|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
126178539|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
126178540|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
126178541|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
126178542|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
126178543|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
126178544|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
126178545|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
126178546|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
126178547|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
126178548|NCT02151682|453938767|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126178549|NCT02151682|453938768|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126178550|NCT02151682|453938769|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
126178551|NCT02151682|453938770|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126178552|NCT02151682|453938771|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126178553|NCT02151682|453938772|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126178554|NCT02151682|453938767|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126178555|NCT02151682|453938768|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126178556|NCT02151682|453938769|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126178557|NCT02151682|453938770|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126178558|NCT02151682|453938771|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126178559|NCT02151682|453938772|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
126178560|NCT02151682|453938767|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126178561|NCT02151682|453938768|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126178562|NCT02151682|453938769|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126178563|NCT02151682|453938770|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126178564|NCT02151682|453938771|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126178565|NCT02151682|453938772|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
126178566|NCT02151682|453938767|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126178567|NCT02151682|453938768|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126178568|NCT02151682|453938769|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126178569|NCT02151682|453938770|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126178570|NCT02151682|453938771|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126178571|NCT02151682|453938772|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
126178572|NCT02151682|453938767|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126178573|NCT02151682|453938768|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126178574|NCT02151682|453938769|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126178575|NCT02151682|453938770|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126178576|NCT02151682|453938771|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126178577|NCT02151682|453938772|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
126178578|NCT01306032|453938773|FG000|First Intervention|Adverse Event|1|||
126178579|NCT01306032|453938774|FG001|First Intervention|Adverse Event|0|||
126178580|NCT01306032|453938775|FG002|First Intervention|Adverse Event|1|||
126178581|NCT01306032|453938776|FG003|First Intervention|Adverse Event|0|||
126178582|NCT01306032|453938777|FG004|First Intervention|Adverse Event|0|||
126178583|NCT01306032|453938778|FG005|First Intervention|Adverse Event|1|||
126178584|NCT01306032|453938773|FG000|First Intervention|Withdrawal by Subject|0|||
126178585|NCT01306032|453938774|FG001|First Intervention|Withdrawal by Subject|2|||
126178586|NCT01306032|453938775|FG002|First Intervention|Withdrawal by Subject|0|||
126178587|NCT01306032|453938776|FG003|First Intervention|Withdrawal by Subject|1|||
126178588|NCT01306032|453938777|FG004|First Intervention|Withdrawal by Subject|0|||
126178589|NCT01306032|453938778|FG005|First Intervention|Withdrawal by Subject|0|||
126178590|NCT01306032|453938773|FG000|First Intervention|Death|0|||
126178591|NCT01306032|453938774|FG001|First Intervention|Death|0|||
126178592|NCT01306032|453938775|FG002|First Intervention|Death|1|||
126178593|NCT01306032|453938776|FG003|First Intervention|Death|0|||
126178594|NCT01306032|453938777|FG004|First Intervention|Death|0|||
126178595|NCT01306032|453938778|FG005|First Intervention|Death|0|||
126178596|NCT01306032|453938773|FG000|First Intervention|Ineligible|0|||
126178597|NCT01306032|453938774|FG001|First Intervention|Ineligible|0|||
126178598|NCT01306032|453938775|FG002|First Intervention|Ineligible|0|||
126178599|NCT01306032|453938776|FG003|First Intervention|Ineligible|0|||
126178600|NCT01306032|453938777|FG004|First Intervention|Ineligible|0|||
126178601|NCT01306032|453938778|FG005|First Intervention|Ineligible|1|||
126178602|NCT01306032|453938773|FG000|First Intervention|Progressive disease|0|||
126178603|NCT01306032|453938774|FG001|First Intervention|Progressive disease|0|||
126178604|NCT01306032|453938775|FG002|First Intervention|Progressive disease|0|||
126178605|NCT01306032|453938776|FG003|First Intervention|Progressive disease|0|||
126178606|NCT01306032|453938777|FG004|First Intervention|Progressive disease|2|||
126178607|NCT01306032|453938778|FG005|First Intervention|Progressive disease|0|||
126178608|NCT01306032|453938773|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
126178609|NCT01306032|453938774|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
126178610|NCT01306032|453938775|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
126178611|NCT01306032|453938776|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
126178612|NCT01306032|453938777|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
126178613|NCT01306032|453938778|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
126178614|NCT01306032|453938773|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
126178615|NCT01306032|453938774|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
126178616|NCT01306032|453938775|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
126178617|NCT01306032|453938776|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
126178618|NCT01306032|453938777|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
126178619|NCT01306032|453938778|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
126178620|NCT03260894|453938780|FG000|Overall Study|Death|6|||
126178621|NCT03260894|453938781|FG001|Overall Study|Death|8|||
126178622|NCT03260894|453938780|FG000|Overall Study|Withdrawal by Subject|4|||
126178623|NCT03260894|453938781|FG001|Overall Study|Withdrawal by Subject|11|||
126178624|NCT03260894|453938780|FG000|Overall Study|On-going at clinical cut off date|36|||
126178625|NCT03260894|453938781|FG001|Overall Study|On-going at clinical cut off date|31|||
126178626|NCT00168064|453938782|FG000|Overall Study|Adverse Event|26|||
126178627|NCT00168064|453938783|FG001|Overall Study|Adverse Event|22|||
126178628|NCT00168064|453938782|FG000|Overall Study|Withdrawal by Subject|3|||
126178629|NCT00168064|453938783|FG001|Overall Study|Withdrawal by Subject|4|||
126178630|NCT00168064|453938782|FG000|Overall Study|Lack of Efficacy|4|||
126178631|NCT00168064|453938783|FG001|Overall Study|Lack of Efficacy|4|||
126178632|NCT00168064|453938782|FG000|Overall Study|Lost to Follow-up|4|||
126178633|NCT00168064|453938783|FG001|Overall Study|Lost to Follow-up|3|||
126178634|NCT00168064|453938782|FG000|Overall Study|Non-compliance|2|||
126178635|NCT00168064|453938783|FG001|Overall Study|Non-compliance|3|||
126178636|NCT00168064|453938782|FG000|Overall Study|Concurrent Illness|4|||
126178637|NCT00168064|453938783|FG001|Overall Study|Concurrent Illness|3|||
126178638|NCT00168064|453938782|FG000|Overall Study|Subject's Best interest|2|||
126178639|NCT00168064|453938783|FG001|Overall Study|Subject's Best interest|2|||
126178640|NCT00168064|453938782|FG000|Overall Study|Various|4|||
126178641|NCT00168064|453938783|FG001|Overall Study|Various|3|||
126178642|NCT00290589|453938785|FG000|Overall Study|Lost to Follow-up|2|||
126178643|NCT00290589|453938786|FG001|Overall Study|Lost to Follow-up|2|||
126178644|NCT01376245|453938788|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
126178645|NCT01376245|453938789|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
126178646|NCT01376245|453938790|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
126178647|NCT01376245|453938791|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
126178648|NCT01376245|453938792|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
126178649|NCT01376245|453938788|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
126178650|NCT01376245|453938789|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
126178651|NCT01376245|453938790|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
126178652|NCT01376245|453938791|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
126178653|NCT01376245|453938792|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
126178654|NCT01376245|453938788|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
126178655|NCT01376245|453938789|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
126178656|NCT01376245|453938790|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
126178657|NCT01376245|453938791|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
126178658|NCT01376245|453938792|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
126178659|NCT01376245|453938788|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
126178660|NCT01376245|453938789|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
126178661|NCT01376245|453938790|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
126178662|NCT01376245|453938791|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
126178663|NCT01376245|453938792|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
126178664|NCT01376245|453938788|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
126178665|NCT01376245|453938789|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
126178666|NCT01376245|453938790|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
126178667|NCT01376245|453938791|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
126178668|NCT01376245|453938792|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
126178669|NCT01376245|453938788|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
126178670|NCT01376245|453938789|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
126178671|NCT01376245|453938790|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
126178672|NCT01376245|453938791|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
126178673|NCT01376245|453938792|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
126178674|NCT01376245|453938788|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
126178675|NCT01376245|453938789|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
126178676|NCT01376245|453938790|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
126178677|NCT01376245|453938791|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
126178678|NCT01376245|453938792|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
126178679|NCT01376245|453938788|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126178680|NCT01376245|453938789|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
126178681|NCT01376245|453938790|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126178682|NCT01376245|453938791|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
126178683|NCT01376245|453938792|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
126178684|NCT01376245|453938788|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126178685|NCT01376245|453938789|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
126178686|NCT01376245|453938790|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
126178687|NCT01376245|453938791|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
126178688|NCT01376245|453938792|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126178689|NCT01376245|453938788|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126178690|NCT01376245|453938789|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
126178691|NCT01376245|453938790|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126178692|NCT01376245|453938791|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126178693|NCT01376245|453938792|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126178694|NCT01376245|453938788|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
126178695|NCT01376245|453938789|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
126178696|NCT01376245|453938790|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
126178697|NCT01376245|453938791|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
126178698|NCT01376245|453938792|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
126178699|NCT01376245|453938788|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126178700|NCT01376245|453938789|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
126178701|NCT01376245|453938790|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
126178702|NCT01376245|453938791|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
126178703|NCT01376245|453938792|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
126178704|NCT05159362|453938793|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
126178705|NCT05159362|453938794|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
126178706|NCT05159362|453938795|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
126178707|NCT01335698|453938796|FG000|Treatment Stage 1|Lack of Efficacy|3|||
126178708|NCT01335698|453938797|FG001|Treatment Stage 1|Lack of Efficacy|1|||
126178709|NCT01335698|453938798|FG002|Treatment Stage 1|Lack of Efficacy|3|||
126178710|NCT01335698|453938799|FG003|Treatment Stage 1|Lack of Efficacy|3|||
126178711|NCT01335698|453938800|FG004|Treatment Stage 1|Lack of Efficacy|1|||
126178712|NCT01335698|453938796|FG000|Treatment Stage 1|Adverse Event|1|||
126178713|NCT01335698|453938797|FG001|Treatment Stage 1|Adverse Event|2|||
126178714|NCT01335698|453938798|FG002|Treatment Stage 1|Adverse Event|2|||
126178715|NCT01335698|453938799|FG003|Treatment Stage 1|Adverse Event|1|||
126178716|NCT01335698|453938800|FG004|Treatment Stage 1|Adverse Event|1|||
126178717|NCT01335698|453938796|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
126178718|NCT01335698|453938797|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
126178719|NCT01335698|453938798|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
126178720|NCT01335698|453938799|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
126178721|NCT01335698|453938800|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
126178722|NCT01335698|453938796|FG000|Treatment Stage 1|Lost to Follow-up|1|||
126178723|NCT01335698|453938797|FG001|Treatment Stage 1|Lost to Follow-up|1|||
126178724|NCT01335698|453938798|FG002|Treatment Stage 1|Lost to Follow-up|0|||
126178725|NCT01335698|453938799|FG003|Treatment Stage 1|Lost to Follow-up|0|||
126178726|NCT01335698|453938800|FG004|Treatment Stage 1|Lost to Follow-up|0|||
126178727|NCT01335698|453938796|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
126178728|NCT01335698|453938797|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
126178729|NCT01335698|453938798|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
126178730|NCT01335698|453938799|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
126178731|NCT01335698|453938800|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
126178732|NCT01335698|453938796|FG000|Treatment Stage 1|No longer meets study criteria|1|||
126178733|NCT01335698|453938797|FG001|Treatment Stage 1|No longer meets study criteria|1|||
126178734|NCT01335698|453938798|FG002|Treatment Stage 1|No longer meets study criteria|0|||
126178735|NCT01335698|453938799|FG003|Treatment Stage 1|No longer meets study criteria|1|||
126178736|NCT01335698|453938800|FG004|Treatment Stage 1|No longer meets study criteria|0|||
126178737|NCT01335698|453938796|FG000|Treatment Stage 1|Other|1|||
126178738|NCT01335698|453938797|FG001|Treatment Stage 1|Other|0|||
126178739|NCT01335698|453938798|FG002|Treatment Stage 1|Other|0|||
126178740|NCT01335698|453938799|FG003|Treatment Stage 1|Other|1|||
126178741|NCT01335698|453938800|FG004|Treatment Stage 1|Other|0|||
126178742|NCT01335698|453938796|FG000|Treatment Stage 2|Lack of Efficacy|2|||
126178743|NCT01335698|453938797|FG001|Treatment Stage 2|Lack of Efficacy|1|||
126178744|NCT01335698|453938798|FG002|Treatment Stage 2|Lack of Efficacy|3|||
126178745|NCT01335698|453938799|FG003|Treatment Stage 2|Lack of Efficacy|1|||
126178746|NCT01335698|453938800|FG004|Treatment Stage 2|Lack of Efficacy|0|||
126178747|NCT01335698|453938796|FG000|Treatment Stage 2|Adverse Event|2|||
126178748|NCT01335698|453938797|FG001|Treatment Stage 2|Adverse Event|0|||
126178749|NCT01335698|453938798|FG002|Treatment Stage 2|Adverse Event|0|||
126178750|NCT01335698|453938799|FG003|Treatment Stage 2|Adverse Event|3|||
126178751|NCT01335698|453938800|FG004|Treatment Stage 2|Adverse Event|0|||
126178752|NCT01335698|453938796|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
126178753|NCT01335698|453938797|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
126178754|NCT01335698|453938798|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
126178755|NCT01335698|453938799|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
126178756|NCT01335698|453938800|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
126178757|NCT01335698|453938796|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
126178758|NCT01335698|453938797|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
126178759|NCT01335698|453938798|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
126178760|NCT01335698|453938799|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
126178761|NCT01335698|453938800|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
126178762|NCT01335698|453938796|FG000|Treatment Stage 2|Lost to Follow-up|1|||
126178763|NCT01335698|453938797|FG001|Treatment Stage 2|Lost to Follow-up|0|||
126178764|NCT01335698|453938798|FG002|Treatment Stage 2|Lost to Follow-up|0|||
126178765|NCT01335698|453938799|FG003|Treatment Stage 2|Lost to Follow-up|0|||
126178766|NCT01335698|453938800|FG004|Treatment Stage 2|Lost to Follow-up|0|||
126178767|NCT01335698|453938796|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
126178768|NCT01335698|453938797|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
126178769|NCT01335698|453938798|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
126178770|NCT01335698|453938799|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
126178771|NCT01335698|453938800|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
126178772|NCT01335698|453938796|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
126178773|NCT01335698|453938797|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
126178774|NCT01335698|453938798|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
126178775|NCT01335698|453938799|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
126178776|NCT01335698|453938800|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
126178777|NCT01335698|453938796|FG000|Treatment Stage 2|Switched to another formulation|1|||
126178778|NCT01335698|453938797|FG001|Treatment Stage 2|Switched to another formulation|1|||
126178779|NCT01335698|453938798|FG002|Treatment Stage 2|Switched to another formulation|0|||
126178780|NCT01335698|453938799|FG003|Treatment Stage 2|Switched to another formulation|0|||
126178781|NCT01335698|453938800|FG004|Treatment Stage 2|Switched to another formulation|0|||
126178782|NCT01357889|453938801|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
126178783|NCT01357889|453938802|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
126178784|NCT01357889|453938801|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
126178785|NCT01357889|453938802|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
126178786|NCT01357889|453938801|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
126178787|NCT01357889|453938802|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
126178788|NCT01357889|453938801|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
126178789|NCT01357889|453938802|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
126178790|NCT01357889|453938801|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
126178791|NCT01357889|453938802|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
126178792|NCT01357889|453938801|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
126178793|NCT01357889|453938802|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
126178794|NCT01357889|453938801|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
126178795|NCT01357889|453938802|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
126178796|NCT01357889|453938801|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
126178797|NCT01357889|453938802|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
126178798|NCT01357889|453938801|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
126178799|NCT01357889|453938802|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
126178800|NCT01357889|453938801|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
126178801|NCT01357889|453938802|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
126178802|NCT01357889|453938801|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
126178803|NCT01357889|453938802|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
126178804|NCT01357889|453938801|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
126178805|NCT01357889|453938802|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
126178806|NCT01357889|453938801|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
126178807|NCT01357889|453938802|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
126178808|NCT03970824|453938803|FG000|Overall Study|Withdrawal by Subject|1|||
126178809|NCT03970824|453938804|FG001|Overall Study|Withdrawal by Subject|1|||
126178810|NCT03970824|453938805|FG002|Overall Study|Withdrawal by Subject|3|||
126178811|NCT03970824|453938803|FG000|Overall Study|Lost to Follow-up|0|||
126178812|NCT03970824|453938804|FG001|Overall Study|Lost to Follow-up|2|||
126178813|NCT03970824|453938805|FG002|Overall Study|Lost to Follow-up|1|||
126178814|NCT03970824|453938803|FG000|Overall Study|Adverse Event|1|||
126178815|NCT03970824|453938804|FG001|Overall Study|Adverse Event|0|||
126178816|NCT03970824|453938805|FG002|Overall Study|Adverse Event|0|||
126178817|NCT00416312|453938806|FG000|Overall Study|tumors not visible on imaging|2|||
126178818|NCT02727660|453938809|FG000|Overall Study|Lack of Efficacy|40|||
126178819|NCT02727660|453938810|FG001|Overall Study|Lack of Efficacy|40|||
126178820|NCT02727660|453938811|FG002|Overall Study|Lack of Efficacy|70|||
126178821|NCT02727660|453938809|FG000|Overall Study|Adverse Event|28|||
126178822|NCT02727660|453938810|FG001|Overall Study|Adverse Event|21|||
126178823|NCT02727660|453938811|FG002|Overall Study|Adverse Event|32|||
126178824|NCT02727660|453938809|FG000|Overall Study|Withdrawal by Subject|26|||
126178825|NCT02727660|453938810|FG001|Overall Study|Withdrawal by Subject|25|||
126178826|NCT02727660|453938811|FG002|Overall Study|Withdrawal by Subject|30|||
126178827|NCT02727660|453938809|FG000|Overall Study|Physician Decision|3|||
126178828|NCT02727660|453938810|FG001|Overall Study|Physician Decision|8|||
126178829|NCT02727660|453938811|FG002|Overall Study|Physician Decision|14|||
126178830|NCT02727660|453938809|FG000|Overall Study|Lost to Follow-up|5|||
126178831|NCT02727660|453938810|FG001|Overall Study|Lost to Follow-up|9|||
126178832|NCT02727660|453938811|FG002|Overall Study|Lost to Follow-up|8|||
126178833|NCT02727660|453938809|FG000|Overall Study|Protocol Violation|7|||
126178834|NCT02727660|453938810|FG001|Overall Study|Protocol Violation|5|||
126178835|NCT02727660|453938811|FG002|Overall Study|Protocol Violation|5|||
126178836|NCT02727660|453938809|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
126178837|NCT02727660|453938810|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
126178838|NCT02727660|453938811|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
126178839|NCT02727660|453938809|FG000|Overall Study|Administrative Reasons|2|||
126178840|NCT02727660|453938810|FG001|Overall Study|Administrative Reasons|3|||
126178841|NCT02727660|453938811|FG002|Overall Study|Administrative Reasons|4|||
126178842|NCT00105560|453938812|FG000|Overall Study|Lost to Follow-up|1|||
126178843|NCT00305604|453938813|FG000|Overall Study|Adverse Event|6|||
126178844|NCT00305604|453938814|FG001|Overall Study|Adverse Event|3|||
126178845|NCT00305604|453938813|FG000|Overall Study|Lack of Efficacy|11|||
126178846|NCT00305604|453938814|FG001|Overall Study|Lack of Efficacy|18|||
126178847|NCT00305604|453938813|FG000|Overall Study|Lost to Follow-up|0|||
126178848|NCT00305604|453938814|FG001|Overall Study|Lost to Follow-up|4|||
126178849|NCT00305604|453938813|FG000|Overall Study|Protocol Violation|2|||
126178850|NCT00305604|453938814|FG001|Overall Study|Protocol Violation|1|||
126178851|NCT00305604|453938813|FG000|Overall Study|Withdrawal by Subject|12|||
126178852|NCT00305604|453938814|FG001|Overall Study|Withdrawal by Subject|21|||
126178853|NCT00305604|453938813|FG000|Overall Study|Patient moved|1|||
126178854|NCT00305604|453938814|FG001|Overall Study|Patient moved|0|||
126178855|NCT01248364|453938818|FG000|Overall Study|Adverse Event|0|||
126178856|NCT01248364|453938819|FG001|Overall Study|Adverse Event|1|||
126178857|NCT01248364|453938820|FG002|Overall Study|Adverse Event|0|||
126178858|NCT01248364|453938821|FG003|Overall Study|Adverse Event|0|||
126178859|NCT00764946|453938824|FG000|Overall Study|Lack of Efficacy|1|||
126178860|NCT00764946|453938825|FG001|Overall Study|Lack of Efficacy|0|||
126178861|NCT00764946|453938826|FG002|Overall Study|Lack of Efficacy|0|||
126178862|NCT00764946|453938824|FG000|Overall Study|Lost to Follow-up|3|||
126178863|NCT00764946|453938825|FG001|Overall Study|Lost to Follow-up|4|||
126178864|NCT00764946|453938826|FG002|Overall Study|Lost to Follow-up|0|||
126178865|NCT00764946|453938824|FG000|Overall Study|Physician Decision|2|||
126178866|NCT00764946|453938825|FG001|Overall Study|Physician Decision|4|||
126178867|NCT00764946|453938826|FG002|Overall Study|Physician Decision|0|||
126178868|NCT00764946|453938824|FG000|Overall Study|Adverse Event|3|||
126178869|NCT00764946|453938825|FG001|Overall Study|Adverse Event|2|||
126178870|NCT00764946|453938826|FG002|Overall Study|Adverse Event|1|||
126178871|NCT00764946|453938824|FG000|Overall Study|Withdrawal by Subject|3|||
126178872|NCT00764946|453938825|FG001|Overall Study|Withdrawal by Subject|6|||
126178873|NCT00764946|453938826|FG002|Overall Study|Withdrawal by Subject|2|||
126178874|NCT00764946|453938824|FG000|Overall Study|Never Treated|1|||
126178875|NCT00764946|453938825|FG001|Overall Study|Never Treated|1|||
126178876|NCT00764946|453938826|FG002|Overall Study|Never Treated|1|||
126178877|NCT02431468|453938830|FG000|Overall Study|Adverse Event|2|||
126178878|NCT02431468|453938831|FG001|Overall Study|Adverse Event|4|||
126178879|NCT02431468|453938832|FG002|Overall Study|Adverse Event|5|||
126178880|NCT02431468|453938830|FG000|Overall Study|Withdrawal by Subject|4|||
126178881|NCT02431468|453938831|FG001|Overall Study|Withdrawal by Subject|12|||
126178882|NCT02431468|453938832|FG002|Overall Study|Withdrawal by Subject|2|||
126178883|NCT02431468|453938830|FG000|Overall Study|noncompliance, investigator termination,|2|||
126178884|NCT02431468|453938831|FG001|Overall Study|noncompliance, investigator termination,|2|||
126178885|NCT02431468|453938832|FG002|Overall Study|noncompliance, investigator termination,|2|||
126178886|NCT01361919|453938833|FG000|Overall Study|technical issues|10|||
126178887|NCT01361919|453938834|FG001|Overall Study|technical issues|12|||
126178888|NCT01361919|453938835|FG002|Overall Study|technical issues|10|||
126178889|NCT00039741|453938839|FG000|Overall Study|Death|0|||
126178890|NCT00039741|453938840|FG001|Overall Study|Death|1|||
126178891|NCT00039741|453938841|FG002|Overall Study|Death|0|||
126178892|NCT00039741|453938842|FG003|Overall Study|Death|0|||
126178893|NCT00039741|453938839|FG000|Overall Study|Lost to Follow-up|3|||
126178894|NCT00039741|453938840|FG001|Overall Study|Lost to Follow-up|1|||
126178895|NCT00039741|453938841|FG002|Overall Study|Lost to Follow-up|5|||
126178896|NCT00039741|453938842|FG003|Overall Study|Lost to Follow-up|2|||
126178897|NCT00039741|453938839|FG000|Overall Study|Confounding medical condition|1|||
126178898|NCT00039741|453938840|FG001|Overall Study|Confounding medical condition|0|||
126178899|NCT00039741|453938841|FG002|Overall Study|Confounding medical condition|0|||
126178900|NCT00039741|453938842|FG003|Overall Study|Confounding medical condition|0|||
125974787|NCT04162769|453196911|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
125974788|NCT04162769|453196912|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
126178901|NCT00039741|453938839|FG000|Overall Study|Not able to get to clinic|5|||
126178902|NCT00039741|453938840|FG001|Overall Study|Not able to get to clinic|2|||
126178903|NCT00039741|453938841|FG002|Overall Study|Not able to get to clinic|0|||
126178904|NCT00039741|453938842|FG003|Overall Study|Not able to get to clinic|3|||
126178905|NCT00039741|453938839|FG000|Overall Study|Moved|3|||
126178906|NCT00039741|453938840|FG001|Overall Study|Moved|2|||
126178907|NCT00039741|453938841|FG002|Overall Study|Moved|3|||
126178908|NCT00039741|453938842|FG003|Overall Study|Moved|6|||
126178909|NCT00039741|453938839|FG000|Overall Study|Non-compliance with protocol|1|||
126178910|NCT00039741|453938840|FG001|Overall Study|Non-compliance with protocol|0|||
126178911|NCT00039741|453938841|FG002|Overall Study|Non-compliance with protocol|1|||
126178912|NCT00039741|453938842|FG003|Overall Study|Non-compliance with protocol|0|||
126178913|NCT00039741|453938839|FG000|Overall Study|Withdrew consent|0|||
126178914|NCT00039741|453938840|FG001|Overall Study|Withdrew consent|5|||
126178915|NCT00039741|453938841|FG002|Overall Study|Withdrew consent|0|||
125974789|NCT04162769|453196909|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
126178916|NCT00039741|453938842|FG003|Overall Study|Withdrew consent|1|||
126178917|NCT00039741|453938839|FG000|Overall Study|Missed final visit|2|||
126178918|NCT00039741|453938840|FG001|Overall Study|Missed final visit|1|||
126178919|NCT00039741|453938841|FG002|Overall Study|Missed final visit|2|||
126178920|NCT00039741|453938842|FG003|Overall Study|Missed final visit|2|||
126178921|NCT01767519|453938843|FG000|Overall Study|Other Reasons|4|||
126178922|NCT01767519|453938844|FG001|Overall Study|Other Reasons|4|||
126178923|NCT01767519|453938845|FG002|Overall Study|Other Reasons|2|||
126178924|NCT01767519|453938843|FG000|Overall Study|Protocol Violation|0|||
126178925|NCT01767519|453938844|FG001|Overall Study|Protocol Violation|3|||
126178926|NCT01767519|453938845|FG002|Overall Study|Protocol Violation|0|||
126178927|NCT01767519|453938843|FG000|Overall Study|Personal Reasons|1|||
126178928|NCT01767519|453938844|FG001|Overall Study|Personal Reasons|0|||
126178929|NCT01767519|453938845|FG002|Overall Study|Personal Reasons|0|||
126178930|NCT01767519|453938843|FG000|Overall Study|Lost to Follow-up|3|||
126178931|NCT01767519|453938844|FG001|Overall Study|Lost to Follow-up|1|||
126178932|NCT01767519|453938845|FG002|Overall Study|Lost to Follow-up|2|||
126178933|NCT01767519|453938843|FG000|Overall Study|Lack of Efficacy|1|||
126178934|NCT01767519|453938844|FG001|Overall Study|Lack of Efficacy|0|||
126178935|NCT01767519|453938845|FG002|Overall Study|Lack of Efficacy|0|||
126178936|NCT01767519|453938843|FG000|Overall Study|Adverse Event|5|||
126178937|NCT01767519|453938844|FG001|Overall Study|Adverse Event|5|||
126178938|NCT01767519|453938845|FG002|Overall Study|Adverse Event|1|||
126178939|NCT00946881|453938846|FG000|First Treatment|Withdrawal by Subject|1|||
126178940|NCT00946881|453938846|FG000|First Treatment|Patient relocated to another state|1|||
126178941|NCT00946881|453938846|FG000|Retreatment|Withdrawal by Subject|1|||
126178942|NCT00293423|453938847|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
126178943|NCT00293423|453938848|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
126178944|NCT00293423|453938847|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
126178945|NCT00293423|453938848|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
126178946|NCT00293423|453938847|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
126178947|NCT00293423|453938848|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
126178948|NCT00293423|453938847|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
126178949|NCT00293423|453938848|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
126178950|NCT00293423|453938847|FG000|Surgical Resection|processing error during surgical resection|1|||
126178951|NCT00293423|453938848|FG001|Surgical Resection|processing error during surgical resection|0|||
126178952|NCT00293423|453938847|FG000|Surgical Resection|Withdrawal by Subject|4|||
126178953|NCT00293423|453938848|FG001|Surgical Resection|Withdrawal by Subject|0|||
126178954|NCT00293423|453938847|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
126178955|NCT00293423|453938848|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
126178956|NCT00805545|453938849|FG000|Overall Study|Protocol Violation|3|||
126178957|NCT00805545|453938850|FG001|Overall Study|Protocol Violation|2|||
126178958|NCT00805545|453938849|FG000|Overall Study|Protocol Violation|3|||
126178959|NCT00805545|453938850|FG001|Overall Study|Protocol Violation|1|||
126178960|NCT00507416|453938851|FG000|Overall Study|Adverse Event|58|||
126178961|NCT00507416|453938852|FG001|Overall Study|Adverse Event|67|||
126178962|NCT00507416|453938853|FG002|Overall Study|Adverse Event|65|||
126178963|NCT00507416|453938851|FG000|Overall Study|Protocol Violation|1|||
126178964|NCT00507416|453938852|FG001|Overall Study|Protocol Violation|2|||
126178965|NCT00507416|453938853|FG002|Overall Study|Protocol Violation|0|||
126178966|NCT00507416|453938851|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
126178967|NCT00507416|453938852|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
126178968|NCT00507416|453938853|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
126178969|NCT00507416|453938851|FG000|Overall Study|Progressive Disease|20|||
126178970|NCT00507416|453938852|FG001|Overall Study|Progressive Disease|10|||
126178971|NCT00507416|453938853|FG002|Overall Study|Progressive Disease|13|||
126178972|NCT00507416|453938851|FG000|Overall Study|Patient declined further treatment|18|||
126178973|NCT00507416|453938852|FG001|Overall Study|Patient declined further treatment|14|||
126178974|NCT00507416|453938853|FG002|Overall Study|Patient declined further treatment|11|||
126178975|NCT00507416|453938851|FG000|Overall Study|Other|11|||
126178976|NCT00507416|453938852|FG001|Overall Study|Other|16|||
126178977|NCT00507416|453938853|FG002|Overall Study|Other|13|||
126178978|NCT00507416|453938851|FG000|Overall Study|Did not Receive Study Treatment|3|||
126178979|NCT00507416|453938852|FG001|Overall Study|Did not Receive Study Treatment|9|||
126178980|NCT00507416|453938853|FG002|Overall Study|Did not Receive Study Treatment|4|||
126178981|NCT02157506|453938856|FG000|Overall Study|Adverse Event|0|||
126178982|NCT02157506|453938857|FG001|Overall Study|Adverse Event|1|||
126178983|NCT02157506|453938858|FG002|Overall Study|Adverse Event|0|||
126178984|NCT02157506|453938859|FG003|Overall Study|Adverse Event|0|||
126178985|NCT02157506|453938860|FG004|Overall Study|Adverse Event|0|||
126178986|NCT02157506|453938856|FG000|Overall Study|Lost to Follow-up|0|||
126178987|NCT02157506|453938857|FG001|Overall Study|Lost to Follow-up|0|||
126178988|NCT02157506|453938858|FG002|Overall Study|Lost to Follow-up|1|||
126178989|NCT02157506|453938859|FG003|Overall Study|Lost to Follow-up|0|||
126178990|NCT02157506|453938860|FG004|Overall Study|Lost to Follow-up|0|||
126178991|NCT03101514|453938861|FG000|Overall Study|Withdrawal by Subject|4|||
126178992|NCT03101514|453938861|FG000|Overall Study|Protocol Violation|2|||
126178993|NCT03101514|453938861|FG000|Overall Study|patient's information was incomplete|1|||
126178994|NCT01021813|453938862|FG000|DB Treatment Phase|Adverse Event|60|||
126178995|NCT01021813|453938863|FG001|DB Treatment Phase|Adverse Event|22|||
126178996|NCT01021813|453938864|FG002|DB Treatment Phase|Adverse Event|0|||
126178997|NCT01021813|453938865|FG003|DB Treatment Phase|Adverse Event|0|||
126178998|NCT01021813|453938866|FG004|DB Treatment Phase|Adverse Event|0|||
126178999|NCT01021813|453938862|FG000|DB Treatment Phase|Lack of Efficacy|44|||
126179000|NCT01021813|453938863|FG001|DB Treatment Phase|Lack of Efficacy|28|||
126179001|NCT01021813|453938864|FG002|DB Treatment Phase|Lack of Efficacy|0|||
126179002|NCT01021813|453938865|FG003|DB Treatment Phase|Lack of Efficacy|0|||
126179003|NCT01021813|453938866|FG004|DB Treatment Phase|Lack of Efficacy|0|||
126179004|NCT01021813|453938862|FG000|DB Treatment Phase|Lost to Follow-up|14|||
126179005|NCT01021813|453938863|FG001|DB Treatment Phase|Lost to Follow-up|12|||
126179006|NCT01021813|453938864|FG002|DB Treatment Phase|Lost to Follow-up|0|||
126179007|NCT01021813|453938865|FG003|DB Treatment Phase|Lost to Follow-up|0|||
126179008|NCT01021813|453938866|FG004|DB Treatment Phase|Lost to Follow-up|0|||
126179009|NCT01021813|453938862|FG000|DB Treatment Phase|Physician Decision|17|||
126179010|NCT01021813|453938863|FG001|DB Treatment Phase|Physician Decision|8|||
126179011|NCT01021813|453938864|FG002|DB Treatment Phase|Physician Decision|0|||
126179012|NCT01021813|453938865|FG003|DB Treatment Phase|Physician Decision|0|||
126179013|NCT01021813|453938866|FG004|DB Treatment Phase|Physician Decision|0|||
126179014|NCT01021813|453938862|FG000|DB Treatment Phase|Pregnancy|1|||
126179015|NCT01021813|453938863|FG001|DB Treatment Phase|Pregnancy|0|||
126179016|NCT01021813|453938864|FG002|DB Treatment Phase|Pregnancy|0|||
126179017|NCT01021813|453938865|FG003|DB Treatment Phase|Pregnancy|0|||
126179018|NCT01021813|453938866|FG004|DB Treatment Phase|Pregnancy|0|||
126179019|NCT01021813|453938862|FG000|DB Treatment Phase|Protocol Violation|4|||
126179020|NCT01021813|453938863|FG001|DB Treatment Phase|Protocol Violation|3|||
126179021|NCT01021813|453938864|FG002|DB Treatment Phase|Protocol Violation|0|||
126179022|NCT01021813|453938865|FG003|DB Treatment Phase|Protocol Violation|0|||
126179023|NCT01021813|453938866|FG004|DB Treatment Phase|Protocol Violation|0|||
126179024|NCT01021813|453938862|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
126179025|NCT01021813|453938863|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
126179026|NCT01021813|453938864|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
126179027|NCT01021813|453938865|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
126179028|NCT01021813|453938866|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
126179029|NCT01021813|453938862|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
126179030|NCT01021813|453938863|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
126179031|NCT01021813|453938864|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
126179032|NCT01021813|453938865|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
126179033|NCT01021813|453938866|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
126179034|NCT01021813|453938862|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
126179035|NCT01021813|453938863|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
126179036|NCT01021813|453938864|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
126179037|NCT01021813|453938865|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
126179038|NCT01021813|453938866|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
126179039|NCT01021813|453938862|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
126179040|NCT01021813|453938863|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
126179041|NCT01021813|453938864|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
126179042|NCT01021813|453938865|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
126179043|NCT01021813|453938866|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
126179044|NCT01021813|453938862|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
126179045|NCT01021813|453938863|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
126179046|NCT01021813|453938864|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
126179047|NCT01021813|453938865|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
126179048|NCT01021813|453938866|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
126179049|NCT01021813|453938862|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
126179050|NCT01021813|453938863|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
126179051|NCT01021813|453938864|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
126179052|NCT01021813|453938865|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
126179053|NCT01021813|453938866|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
126179054|NCT00764478|453938867|FG000|Overall Study|Adverse Event|1|||
126179055|NCT00764478|453938868|FG001|Overall Study|Adverse Event|1|||
126179056|NCT00764478|453938869|FG002|Overall Study|Adverse Event|1|||
125974790|NCT04162769|453196910|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
126179057|NCT00764478|453938867|FG000|Overall Study|Withdrawal by Subject|7|||
126179058|NCT00764478|453938868|FG001|Overall Study|Withdrawal by Subject|12|||
126179059|NCT00764478|453938869|FG002|Overall Study|Withdrawal by Subject|1|||
126179060|NCT00764478|453938867|FG000|Overall Study|Lost to Follow-up|7|||
126179061|NCT00764478|453938868|FG001|Overall Study|Lost to Follow-up|8|||
126179062|NCT00764478|453938869|FG002|Overall Study|Lost to Follow-up|5|||
126179063|NCT00764478|453938867|FG000|Overall Study|Protocol Violation|0|||
126179064|NCT00764478|453938868|FG001|Overall Study|Protocol Violation|1|||
126179065|NCT00764478|453938869|FG002|Overall Study|Protocol Violation|1|||
126179066|NCT02270684|453938870|FG000|Overall Study|Lost to Follow-up|0|||
125974791|NCT04162769|453196911|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
126179067|NCT02270684|453938871|FG001|Overall Study|Lost to Follow-up|3|||
126179068|NCT02270684|453938870|FG000|Overall Study|Study terminated|1|||
125974792|NCT04162769|453196912|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
126179069|NCT02270684|453938871|FG001|Overall Study|Study terminated|0|||
126179070|NCT03498287|453938878|FG000|Overall Study|Withdrawal by Subject|3|||
126179071|NCT03498287|453938879|FG001|Overall Study|Withdrawal by Subject|0|||
126179072|NCT03498287|453938878|FG000|Overall Study|Protocol Violation|0|||
126179073|NCT03498287|453938879|FG001|Overall Study|Protocol Violation|4|||
126179074|NCT03498287|453938878|FG000|Overall Study|Adverse Event|0|||
126179075|NCT03498287|453938879|FG001|Overall Study|Adverse Event|1|||
126179076|NCT02555657|453938882|FG000|Overall Study|Death|274|||
126179077|NCT02555657|453938883|FG001|Overall Study|Death|262|||
126179078|NCT02555657|453938882|FG000|Overall Study|Physician Decision|0|||
126179079|NCT02555657|453938883|FG001|Overall Study|Physician Decision|1|||
126179080|NCT02555657|453938882|FG000|Overall Study|Sponsor Decision|27|||
126179081|NCT02555657|453938883|FG001|Overall Study|Sponsor Decision|15|||
126179082|NCT02555657|453938882|FG000|Overall Study|Withdrawal by Subject|11|||
126179083|NCT02555657|453938883|FG001|Overall Study|Withdrawal by Subject|32|||
126179084|NCT01578785|453938884|FG000|Overall Study|Withdrawal by Subject|0|||
126179085|NCT01578785|453938885|FG001|Overall Study|Withdrawal by Subject|1|||
126179086|NCT01578785|453938884|FG000|Overall Study|Study terminated by sponsor|59|||
126179087|NCT01578785|453938885|FG001|Overall Study|Study terminated by sponsor|118|||
126179088|NCT00966693|453938886|FG000|Overall Study|Adverse Event|0|||
126179089|NCT00966693|453938887|FG001|Overall Study|Adverse Event|0|||
126179090|NCT00966693|453938888|FG002|Overall Study|Adverse Event|1|||
126179091|NCT00966693|453938889|FG003|Overall Study|Adverse Event|2|||
126179092|NCT00966693|453938886|FG000|Overall Study|Death|0|||
126179093|NCT00966693|453938887|FG001|Overall Study|Death|0|||
126179094|NCT00966693|453938888|FG002|Overall Study|Death|1|||
126179095|NCT00966693|453938889|FG003|Overall Study|Death|0|||
126179096|NCT00966693|453938886|FG000|Overall Study|Withdrawal by Subject|1|||
126179097|NCT00966693|453938887|FG001|Overall Study|Withdrawal by Subject|0|||
126179098|NCT00966693|453938888|FG002|Overall Study|Withdrawal by Subject|0|||
126179099|NCT00966693|453938889|FG003|Overall Study|Withdrawal by Subject|5|||
126179100|NCT00966693|453938886|FG000|Overall Study|Disease Progression|0|||
126179101|NCT00966693|453938887|FG001|Overall Study|Disease Progression|0|||
126179102|NCT00966693|453938888|FG002|Overall Study|Disease Progression|1|||
126179103|NCT00966693|453938889|FG003|Overall Study|Disease Progression|16|||
126179104|NCT02581982|453938890|FG000|Overall Study|Lack of Efficacy|12|||
126179105|NCT02581982|453938890|FG000|Overall Study|Adverse Event|3|||
126179106|NCT02581982|453938890|FG000|Overall Study|Physician Decision|1|||
126179107|NCT03479216|453938892|FG000|Overall Study|Withdrawal by Subject|3|||
126179108|NCT03479216|453938893|FG001|Overall Study|Withdrawal by Subject|2|||
126179109|NCT03479216|453938892|FG000|Overall Study|Physician Decision|2|||
126179110|NCT03479216|453938893|FG001|Overall Study|Physician Decision|3|||
126179111|NCT02332798|453940373|FG000|Overall Study|Unwilling to Participate in Study|0|||
126179112|NCT02332798|453940374|FG001|Overall Study|Unwilling to Participate in Study|1|||
126179113|NCT02332798|453940375|FG002|Overall Study|Unwilling to Participate in Study|1|||
126179114|NCT02332798|453940373|FG000|Overall Study|Positive Urine Drug Test|0|||
126179115|NCT02332798|453940374|FG001|Overall Study|Positive Urine Drug Test|1|||
126179116|NCT02332798|453940375|FG002|Overall Study|Positive Urine Drug Test|0|||
126179117|NCT02332798|453940373|FG000|Overall Study|Abnormal Laboratory Findings|1|||
126179118|NCT02332798|453940374|FG001|Overall Study|Abnormal Laboratory Findings|0|||
126179119|NCT02332798|453940375|FG002|Overall Study|Abnormal Laboratory Findings|0|||
126179120|NCT05406440|453940376|FG000|Overall Study|Lost to Follow-up|0|||
126179121|NCT05406440|453940377|FG001|Overall Study|Lost to Follow-up|0|||
126179122|NCT05406440|453940378|FG002|Overall Study|Lost to Follow-up|0|||
126179123|NCT05406440|453940379|FG003|Overall Study|Lost to Follow-up|0|||
126179124|NCT05406440|453940380|FG004|Overall Study|Lost to Follow-up|2|||
126179125|NCT05406440|453940381|FG005|Overall Study|Lost to Follow-up|0|||
126179126|NCT05406440|453940382|FG006|Overall Study|Lost to Follow-up|0|||
126179127|NCT05406440|453940376|FG000|Overall Study|Physician Decision|0|||
126179128|NCT05406440|453940377|FG001|Overall Study|Physician Decision|0|||
126179129|NCT05406440|453940378|FG002|Overall Study|Physician Decision|0|||
126179130|NCT05406440|453940379|FG003|Overall Study|Physician Decision|0|||
126179131|NCT05406440|453940380|FG004|Overall Study|Physician Decision|1|||
126179132|NCT05406440|453940381|FG005|Overall Study|Physician Decision|0|||
126179133|NCT05406440|453940382|FG006|Overall Study|Physician Decision|0|||
126179134|NCT05406440|453940376|FG000|Overall Study|Withdrawal by Subject|0|||
126179135|NCT05406440|453940377|FG001|Overall Study|Withdrawal by Subject|0|||
126179136|NCT05406440|453940378|FG002|Overall Study|Withdrawal by Subject|0|||
126179137|NCT05406440|453940379|FG003|Overall Study|Withdrawal by Subject|0|||
126179138|NCT05406440|453940380|FG004|Overall Study|Withdrawal by Subject|0|||
126179139|NCT05406440|453940381|FG005|Overall Study|Withdrawal by Subject|2|||
126179140|NCT05406440|453940382|FG006|Overall Study|Withdrawal by Subject|0|||
126179141|NCT02455388|453940383|FG000|Overall Study|Protocol Violation|1|||
126179142|NCT02455388|453940384|FG001|Overall Study|Protocol Violation|0|||
126179143|NCT02455388|453940385|FG002|Overall Study|Protocol Violation|4|||
126179144|NCT02455388|453940383|FG000|Overall Study|Withdrawal by Subject|0|||
126179145|NCT02455388|453940384|FG001|Overall Study|Withdrawal by Subject|0|||
126179146|NCT02455388|453940385|FG002|Overall Study|Withdrawal by Subject|7|||
126199926|NCT00089505|454017803|FG003|Overall Study|Physician Decision|0|||
126179147|NCT00525785|453940386|FG000|Overall Study|Withdrawal by Subject|1|||
126179148|NCT00525785|453940386|FG000|Overall Study|Lack of Efficacy|1|||
126179149|NCT00525785|453940386|FG000|Overall Study|Physician Decision|1|||
126179150|NCT01316939|453940387|FG000|Overall Study|Study closed/terminated|26|||
126179151|NCT01316939|453940388|FG001|Overall Study|Study closed/terminated|25|||
126179152|NCT01316939|453940389|FG002|Overall Study|Study closed/terminated|23|||
126179153|NCT01316939|453940387|FG000|Overall Study|Lack of Efficacy|24|||
126179154|NCT01316939|453940388|FG001|Overall Study|Lack of Efficacy|25|||
126179155|NCT01316939|453940389|FG002|Overall Study|Lack of Efficacy|25|||
126179156|NCT01316939|453940387|FG000|Overall Study|Adverse Event|9|||
126179157|NCT01316939|453940388|FG001|Overall Study|Adverse Event|12|||
126179158|NCT01316939|453940389|FG002|Overall Study|Adverse Event|11|||
126179159|NCT01316939|453940387|FG000|Overall Study|Withdrawal by Subject|1|||
126179160|NCT01316939|453940388|FG001|Overall Study|Withdrawal by Subject|3|||
126179161|NCT01316939|453940389|FG002|Overall Study|Withdrawal by Subject|6|||
126179162|NCT01316939|453940387|FG000|Overall Study|Physician Decision|2|||
126179163|NCT01316939|453940388|FG001|Overall Study|Physician Decision|2|||
126179164|NCT01316939|453940389|FG002|Overall Study|Physician Decision|1|||
126179165|NCT01316939|453940387|FG000|Overall Study|Lost to Follow-up|0|||
126179166|NCT01316939|453940388|FG001|Overall Study|Lost to Follow-up|0|||
126179167|NCT01316939|453940389|FG002|Overall Study|Lost to Follow-up|2|||
126179168|NCT01316939|453940387|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
126179169|NCT01316939|453940388|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
126179170|NCT01316939|453940389|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
126179171|NCT01316939|453940387|FG000|Overall Study|Protocol Violation|0|||
126179172|NCT01316939|453940388|FG001|Overall Study|Protocol Violation|1|||
126179173|NCT01316939|453940389|FG002|Overall Study|Protocol Violation|0|||
126179174|NCT00801892|453940390|FG000|Main Study Period|Withdrawal by Subject|0|||
126179175|NCT00801892|453940391|FG001|Main Study Period|Withdrawal by Subject|1|||
126179176|NCT00801892|453940390|FG000|Sham Crossover Period|Lost to Follow-up|0|||
126179177|NCT00801892|453940391|FG001|Sham Crossover Period|Lost to Follow-up|2|||
126179178|NCT01711541|453940400|FG000|Overall Study|Cancel prior to treatment|0|||
126179179|NCT01711541|453940401|FG001|Overall Study|Cancel prior to treatment|0|||
126179180|NCT01711541|453940402|FG002|Overall Study|Cancel prior to treatment|0|||
126179181|NCT01711541|453940403|FG003|Overall Study|Cancel prior to treatment|1|||
126179182|NCT01711541|453940404|FG004|Overall Study|Cancel prior to treatment|0|||
126179183|NCT01711541|453940400|FG000|Overall Study|Ineligible|0|||
126179184|NCT01711541|453940401|FG001|Overall Study|Ineligible|1|||
126179185|NCT01711541|453940402|FG002|Overall Study|Ineligible|0|||
126179186|NCT01711541|453940403|FG003|Overall Study|Ineligible|0|||
126179187|NCT01711541|453940404|FG004|Overall Study|Ineligible|0|||
126179188|NCT00728936|453940405|FG000|Overall Study|Withdrawal by Subject|0|||
126179189|NCT00728936|453940406|FG001|Overall Study|Withdrawal by Subject|0|||
126179190|NCT00728936|453940407|FG002|Overall Study|Withdrawal by Subject|0|||
126179191|NCT00728936|453940408|FG003|Overall Study|Withdrawal by Subject|0|||
126179192|NCT00728936|453940409|FG004|Overall Study|Withdrawal by Subject|0|||
126179193|NCT00728936|453940410|FG005|Overall Study|Withdrawal by Subject|1|||
126179194|NCT00728936|453940411|FG006|Overall Study|Withdrawal by Subject|0|||
126179195|NCT02966353|453940420|FG000|Overall Study|Withdrawal by Subject|7|||
126179196|NCT02966353|453940420|FG000|Overall Study|Adverse Event|4|||
126179197|NCT02966353|453940420|FG000|Overall Study|Death|4|||
126179198|NCT02966353|453940420|FG000|Overall Study|Physician Decision|3|||
126179199|NCT02966353|453940420|FG000|Overall Study|Progressive disease|2|||
126179200|NCT02966353|453940420|FG000|Overall Study|Protocol deviation|2|||
126179201|NCT00093470|453940423|FG000|Overall Study|Disease progression|39|||
126179202|NCT00093470|453940424|FG001|Overall Study|Disease progression|0|||
126179203|NCT00093470|453940423|FG000|Overall Study|Adverse Event|15|||
126179204|NCT00093470|453940424|FG001|Overall Study|Adverse Event|0|||
126179205|NCT00093470|453940423|FG000|Overall Study|Death|2|||
126179206|NCT00093470|453940424|FG001|Overall Study|Death|0|||
126179207|NCT00093470|453940423|FG000|Overall Study|Withdrawal by Subject|8|||
126179208|NCT00093470|453940424|FG001|Overall Study|Withdrawal by Subject|0|||
126179209|NCT00093470|453940423|FG000|Overall Study|Alternative therapy|2|||
126179210|NCT00093470|453940424|FG001|Overall Study|Alternative therapy|0|||
126179211|NCT00093470|453940423|FG000|Overall Study|Other complicating disease|3|||
126179212|NCT00093470|453940424|FG001|Overall Study|Other complicating disease|0|||
126179213|NCT00093470|453940423|FG000|Overall Study|Physician Decision|2|||
126179214|NCT00093470|453940424|FG001|Overall Study|Physician Decision|0|||
126179215|NCT00093470|453940423|FG000|Overall Study|Never started treatment|1|||
126179216|NCT00093470|453940424|FG001|Overall Study|Never started treatment|0|||
126179217|NCT00093470|453940423|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
126179218|NCT00093470|453940424|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
126179219|NCT00877006|453940425|FG000|Treatment Period|Death|2|||
126179220|NCT00877006|453940426|FG001|Treatment Period|Death|1|||
126179221|NCT00877006|453940425|FG000|Treatment Period|Adverse Event|10|||
126179222|NCT00877006|453940426|FG001|Treatment Period|Adverse Event|3|||
126179223|NCT00877006|453940425|FG000|Treatment Period|Withdrawal by Subject|2|||
126179224|NCT00877006|453940426|FG001|Treatment Period|Withdrawal by Subject|3|||
126179225|NCT00877006|453940425|FG000|Treatment Period|Protocol Violation|1|||
126179226|NCT00877006|453940426|FG001|Treatment Period|Protocol Violation|0|||
126179227|NCT00877006|453940425|FG000|Treatment Period|Lost to Follow-up|0|||
126179228|NCT00877006|453940426|FG001|Treatment Period|Lost to Follow-up|1|||
126179229|NCT00877006|453940425|FG000|Treatment Period|Disease Progression|1|||
126179230|NCT00877006|453940426|FG001|Treatment Period|Disease Progression|2|||
126179231|NCT00877006|453940425|FG000|Treatment Period|Started New Treatment Regimen|2|||
126179232|NCT00877006|453940426|FG001|Treatment Period|Started New Treatment Regimen|5|||
126179233|NCT00877006|453940425|FG000|Treatment Period|Other|4|||
126179234|NCT00877006|453940426|FG001|Treatment Period|Other|4|||
126179235|NCT00877006|453940425|FG000|Treatment Period|Randomized but Not Treated|3|||
126179236|NCT00877006|453940426|FG001|Treatment Period|Randomized but Not Treated|8|||
126179237|NCT00877006|453940425|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
126179238|NCT00877006|453940426|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
126179239|NCT00877006|453940425|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
126179240|NCT00877006|453940426|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
126179241|NCT00877006|453940425|FG000|Long-Term Follow-up Period|Death|26|||
126179242|NCT00877006|453940426|FG001|Long-Term Follow-up Period|Death|18|||
126179243|NCT00877006|453940425|FG000|Long-Term Follow-up Period|Other|7|||
126179244|NCT00877006|453940426|FG001|Long-Term Follow-up Period|Other|9|||
126179245|NCT01415908|453940427|FG000|Overall Study|Withdrawal by Subject|1|||
126179246|NCT01415908|453940428|FG001|Overall Study|Withdrawal by Subject|0|||
126179247|NCT02034552|453940429|FG000|Overall Study|Never treated|3|||
126179248|NCT02034552|453940430|FG001|Overall Study|Never treated|2|||
126179249|NCT02034552|453940431|FG002|Overall Study|Never treated|0|||
126179250|NCT02034552|453940429|FG000|Overall Study|Radiological progression|3|||
126179251|NCT02034552|453940430|FG001|Overall Study|Radiological progression|5|||
126179252|NCT02034552|453940431|FG002|Overall Study|Radiological progression|4|||
126179253|NCT02034552|453940429|FG000|Overall Study|AE not assoc. with disease progression|1|||
126179254|NCT02034552|453940430|FG001|Overall Study|AE not assoc. with disease progression|4|||
126179255|NCT02034552|453940431|FG002|Overall Study|AE not assoc. with disease progression|2|||
126179256|NCT02034552|453940429|FG000|Overall Study|AE associated with disease progression|0|||
126179257|NCT02034552|453940430|FG001|Overall Study|AE associated with disease progression|1|||
126179258|NCT02034552|453940431|FG002|Overall Study|AE associated with disease progression|0|||
126179259|NCT02034552|453940429|FG000|Overall Study|Withdrawal by Subject|2|||
126179260|NCT02034552|453940430|FG001|Overall Study|Withdrawal by Subject|1|||
126179261|NCT02034552|453940431|FG002|Overall Study|Withdrawal by Subject|1|||
126179262|NCT02034552|453940429|FG000|Overall Study|Non-compliance with study drug|0|||
126179263|NCT02034552|453940430|FG001|Overall Study|Non-compliance with study drug|0|||
126179264|NCT02034552|453940431|FG002|Overall Study|Non-compliance with study drug|1|||
126179265|NCT02034552|453940429|FG000|Overall Study|Clinical progression|5|||
126179266|NCT02034552|453940430|FG001|Overall Study|Clinical progression|7|||
126179267|NCT02034552|453940431|FG002|Overall Study|Clinical progression|9|||
126179268|NCT01188096|453940433|FG000|Overall Study|progression of disease|4|||
126179269|NCT01188096|453940433|FG000|Overall Study|Withdrawal by Subject|2|||
126179270|NCT00851253|453940437|FG000|Overall Study|Disease Progression|1|||
126179271|NCT00851253|453940438|FG001|Overall Study|Disease Progression|0|||
126179272|NCT02062398|453940439|FG000|Overall Study|Implant removal|1|||
126179273|NCT01779648|453940440|FG000|Overall Study|Protocol Violation|1|||
126179274|NCT01779648|453940441|FG001|Overall Study|Protocol Violation|0|||
126179275|NCT00415519|453940442|FG000|Overall Study|Adverse Event|1|||
126179276|NCT00415519|453940443|FG001|Overall Study|Adverse Event|0|||
126179277|NCT00415519|453940442|FG000|Overall Study|Withdrawal by Subject|2|||
126179278|NCT00415519|453940443|FG001|Overall Study|Withdrawal by Subject|0|||
126179279|NCT00415519|453940442|FG000|Overall Study|Patient's convenience|1|||
126179280|NCT00415519|453940443|FG001|Overall Study|Patient's convenience|0|||
126179281|NCT03485222|453940450|FG000|Overall Study|Death|0|||
126179282|NCT03485222|453940451|FG001|Overall Study|Death|1|||
126179283|NCT03485222|453940450|FG000|Overall Study|Lost to Follow-up|2|||
126179284|NCT03485222|453940451|FG001|Overall Study|Lost to Follow-up|1|||
126179285|NCT03325556|453940453|FG000|Open-label Period|Lack of Response in OL period|70|||
126179286|NCT03325556|453940454|FG001|Open-label Period|Lack of Response in OL period|0|||
126179287|NCT03325556|453940455|FG002|Open-label Period|Lack of Response in OL period|0|||
126179288|NCT03325556|453940453|FG000|Open-label Period|Adverse Event|27|||
126179289|NCT03325556|453940454|FG001|Open-label Period|Adverse Event|0|||
126179290|NCT03325556|453940455|FG002|Open-label Period|Adverse Event|0|||
126179291|NCT03325556|453940453|FG000|Open-label Period|Death|1|||
126179292|NCT03325556|453940454|FG001|Open-label Period|Death|0|||
126179293|NCT03325556|453940455|FG002|Open-label Period|Death|0|||
126179294|NCT03325556|453940453|FG000|Open-label Period|Lost to Follow-up|1|||
126179295|NCT03325556|453940454|FG001|Open-label Period|Lost to Follow-up|0|||
126179296|NCT03325556|453940455|FG002|Open-label Period|Lost to Follow-up|0|||
126179297|NCT03325556|453940453|FG000|Open-label Period|Non-compliance with study drug|5|||
126179298|NCT03325556|453940454|FG001|Open-label Period|Non-compliance with study drug|0|||
126179299|NCT03325556|453940455|FG002|Open-label Period|Non-compliance with study drug|0|||
126199927|NCT00089505|454017800|FG000|Overall Study|Protocol Violation|0|||
126179300|NCT03325556|453940453|FG000|Open-label Period|Use of prohibited medication|1|||
126179301|NCT03325556|453940454|FG001|Open-label Period|Use of prohibited medication|0|||
126179302|NCT03325556|453940455|FG002|Open-label Period|Use of prohibited medication|0|||
126179303|NCT03325556|453940453|FG000|Open-label Period|Protocol Violation|4|||
126179304|NCT03325556|453940454|FG001|Open-label Period|Protocol Violation|0|||
126179305|NCT03325556|453940455|FG002|Open-label Period|Protocol Violation|0|||
126179306|NCT03325556|453940453|FG000|Open-label Period|Withdrawal by Subject|17|||
126179307|NCT03325556|453940454|FG001|Open-label Period|Withdrawal by Subject|0|||
126179308|NCT03325556|453940455|FG002|Open-label Period|Withdrawal by Subject|0|||
126179309|NCT03325556|453940453|FG000|Open-label Period|Not otherwise specified|8|||
126179310|NCT03325556|453940454|FG001|Open-label Period|Not otherwise specified|0|||
126179311|NCT03325556|453940455|FG002|Open-label Period|Not otherwise specified|0|||
126179312|NCT03325556|453940453|FG000|Open-label Period|Administrative discont. at study termination|41|||
126179313|NCT03325556|453940454|FG001|Open-label Period|Administrative discont. at study termination|0|||
126179314|NCT03325556|453940455|FG002|Open-label Period|Administrative discont. at study termination|0|||
126179315|NCT03325556|453940453|FG000|Double-blind Period|Relapse|0|||
126179316|NCT03325556|453940454|FG001|Double-blind Period|Relapse|15|||
126179317|NCT03325556|453940455|FG002|Double-blind Period|Relapse|34|||
126179318|NCT03325556|453940453|FG000|Double-blind Period|Adverse Event|0|||
126179319|NCT03325556|453940454|FG001|Double-blind Period|Adverse Event|3|||
126179320|NCT03325556|453940455|FG002|Double-blind Period|Adverse Event|1|||
126179321|NCT03325556|453940453|FG000|Double-blind Period|Noncompliance with study drug|0|||
126179322|NCT03325556|453940454|FG001|Double-blind Period|Noncompliance with study drug|0|||
126179323|NCT03325556|453940455|FG002|Double-blind Period|Noncompliance with study drug|1|||
126179324|NCT03325556|453940453|FG000|Double-blind Period|Use of prohibited medication|0|||
126179325|NCT03325556|453940454|FG001|Double-blind Period|Use of prohibited medication|1|||
126179326|NCT03325556|453940455|FG002|Double-blind Period|Use of prohibited medication|0|||
126179327|NCT03325556|453940453|FG000|Double-blind Period|Physician Decision|0|||
126179328|NCT03325556|453940454|FG001|Double-blind Period|Physician Decision|0|||
126179329|NCT03325556|453940455|FG002|Double-blind Period|Physician Decision|1|||
126179330|NCT03325556|453940453|FG000|Double-blind Period|Withdrawal by Subject|0|||
126179331|NCT03325556|453940454|FG001|Double-blind Period|Withdrawal by Subject|6|||
126179332|NCT03325556|453940455|FG002|Double-blind Period|Withdrawal by Subject|4|||
126179333|NCT03325556|453940453|FG000|Double-blind Period|Not otherwise specified|0|||
126179334|NCT03325556|453940454|FG001|Double-blind Period|Not otherwise specified|1|||
126179335|NCT03325556|453940455|FG002|Double-blind Period|Not otherwise specified|5|||
126179336|NCT03325556|453940453|FG000|Double-blind Period|Administrative discont. at study termination|0|||
126179337|NCT03325556|453940454|FG001|Double-blind Period|Administrative discont. at study termination|35|||
126179338|NCT03325556|453940455|FG002|Double-blind Period|Administrative discont. at study termination|31|||
126179339|NCT01705587|453940456|FG000|Overall Study|Withdrawal by Subject|0|||
126179340|NCT01705587|453940457|FG001|Overall Study|Withdrawal by Subject|1|||
126179341|NCT02119026|453940460|FG000|1st-line Treatment|Adverse Event|9|||
126179342|NCT02119026|453940461|FG001|1st-line Treatment|Adverse Event|14|||
126179343|NCT02119026|453940460|FG000|1st-line Treatment|Physician Decision|3|||
126179344|NCT02119026|453940461|FG001|1st-line Treatment|Physician Decision|8|||
126179345|NCT02119026|453940460|FG000|1st-line Treatment|Withdrawal by Subject|4|||
126179346|NCT02119026|453940461|FG001|1st-line Treatment|Withdrawal by Subject|10|||
126179347|NCT02119026|453940460|FG000|1st-line Treatment|Patient condition or compliance|6|||
126179348|NCT02119026|453940461|FG001|1st-line Treatment|Patient condition or compliance|4|||
126179349|NCT02119026|453940460|FG000|1st-line Treatment|Surgery of metastases|2|||
126179350|NCT02119026|453940461|FG001|1st-line Treatment|Surgery of metastases|1|||
126179351|NCT02119026|453940460|FG000|1st-line Treatment|Death|2|||
126179352|NCT02119026|453940461|FG001|1st-line Treatment|Death|1|||
126179353|NCT02119026|453940460|FG000|2nd-line Treatment|Lost to Follow-up|2|||
126179354|NCT02119026|453940461|FG001|2nd-line Treatment|Lost to Follow-up|0|||
126179355|NCT02119026|453940460|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
126179356|NCT02119026|453940461|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
126179357|NCT02119026|453940460|FG000|2nd-line Treatment|Adverse Event|4|||
126179358|NCT02119026|453940461|FG001|2nd-line Treatment|Adverse Event|1|||
126179359|NCT01373918|453940462|FG000|Overall Study|Physician Decision|0|||
126179360|NCT01373918|453940463|FG001|Overall Study|Physician Decision|1|||
126179361|NCT00340834|453940465|FG000|Core Phase of Study|Adverse Event|26|||
126179362|NCT00340834|453940466|FG001|Core Phase of Study|Adverse Event|9|||
126179363|NCT00340834|453940467|FG002|Core Phase of Study|Adverse Event|9|||
126179364|NCT00340834|453940468|FG003|Core Phase of Study|Adverse Event|0|||
126179365|NCT00340834|453940469|FG004|Core Phase of Study|Adverse Event|0|||
126179366|NCT00340834|453940465|FG000|Core Phase of Study|Withdrawal by Subject|11|||
126179367|NCT00340834|453940466|FG001|Core Phase of Study|Withdrawal by Subject|9|||
126179368|NCT00340834|453940467|FG002|Core Phase of Study|Withdrawal by Subject|16|||
126179369|NCT00340834|453940468|FG003|Core Phase of Study|Withdrawal by Subject|0|||
126179370|NCT00340834|453940469|FG004|Core Phase of Study|Withdrawal by Subject|0|||
126179371|NCT00340834|453940465|FG000|Core Phase of Study|Administrative Problems|6|||
126179372|NCT00340834|453940466|FG001|Core Phase of Study|Administrative Problems|2|||
126179373|NCT00340834|453940467|FG002|Core Phase of Study|Administrative Problems|7|||
126179374|NCT00340834|453940468|FG003|Core Phase of Study|Administrative Problems|0|||
126179375|NCT00340834|453940469|FG004|Core Phase of Study|Administrative Problems|0|||
126179376|NCT00340834|453940465|FG000|Core Phase of Study|Lack of Efficacy|3|||
126179377|NCT00340834|453940466|FG001|Core Phase of Study|Lack of Efficacy|3|||
126179378|NCT00340834|453940467|FG002|Core Phase of Study|Lack of Efficacy|7|||
126179379|NCT00340834|453940468|FG003|Core Phase of Study|Lack of Efficacy|0|||
126179380|NCT00340834|453940469|FG004|Core Phase of Study|Lack of Efficacy|0|||
126179381|NCT00340834|453940465|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
126179382|NCT00340834|453940466|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
126179383|NCT00340834|453940467|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
126179384|NCT00340834|453940468|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
126179385|NCT00340834|453940469|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
126179386|NCT00340834|453940465|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
126179387|NCT00340834|453940466|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
126179388|NCT00340834|453940467|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
126179389|NCT00340834|453940468|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
126179390|NCT00340834|453940469|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
126179391|NCT00340834|453940465|FG000|Core Phase of Study|Lost to Follow-up|1|||
126179392|NCT00340834|453940466|FG001|Core Phase of Study|Lost to Follow-up|1|||
126179393|NCT00340834|453940467|FG002|Core Phase of Study|Lost to Follow-up|4|||
126179394|NCT00340834|453940468|FG003|Core Phase of Study|Lost to Follow-up|0|||
126179395|NCT00340834|453940469|FG004|Core Phase of Study|Lost to Follow-up|0|||
126179396|NCT00340834|453940465|FG000|Core Phase of Study|Death|2|||
126179397|NCT00340834|453940466|FG001|Core Phase of Study|Death|0|||
126179398|NCT00340834|453940467|FG002|Core Phase of Study|Death|0|||
126179399|NCT00340834|453940468|FG003|Core Phase of Study|Death|0|||
126179400|NCT00340834|453940469|FG004|Core Phase of Study|Death|0|||
126179401|NCT00340834|453940465|FG000|Core Phase of Study|Protocol Violation|0|||
126179402|NCT00340834|453940466|FG001|Core Phase of Study|Protocol Violation|0|||
126179403|NCT00340834|453940467|FG002|Core Phase of Study|Protocol Violation|2|||
126179404|NCT00340834|453940468|FG003|Core Phase of Study|Protocol Violation|0|||
126179405|NCT00340834|453940469|FG004|Core Phase of Study|Protocol Violation|0|||
126179406|NCT00340834|453940465|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
126179407|NCT00340834|453940466|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
126179408|NCT00340834|453940467|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
126179409|NCT00340834|453940468|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
126179410|NCT00340834|453940469|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
126179411|NCT00340834|453940465|FG000|Extension Phase of Study|Subject withdrew consent|26|||
126179412|NCT00340834|453940466|FG001|Extension Phase of Study|Subject withdrew consent|31|||
126179413|NCT00340834|453940467|FG002|Extension Phase of Study|Subject withdrew consent|0|||
126179414|NCT00340834|453940468|FG003|Extension Phase of Study|Subject withdrew consent|12|||
126179415|NCT00340834|453940469|FG004|Extension Phase of Study|Subject withdrew consent|15|||
126179416|NCT00340834|453940465|FG000|Extension Phase of Study|Adverse Event|21|||
126179417|NCT00340834|453940466|FG001|Extension Phase of Study|Adverse Event|22|||
126179418|NCT00340834|453940467|FG002|Extension Phase of Study|Adverse Event|0|||
126179419|NCT00340834|453940468|FG003|Extension Phase of Study|Adverse Event|19|||
126179420|NCT00340834|453940469|FG004|Extension Phase of Study|Adverse Event|7|||
126179421|NCT00340834|453940465|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
126179422|NCT00340834|453940466|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
126179423|NCT00340834|453940467|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
126179424|NCT00340834|453940468|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
126179425|NCT00340834|453940469|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
126179426|NCT00340834|453940465|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
126179427|NCT00340834|453940466|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
126179428|NCT00340834|453940467|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
126179429|NCT00340834|453940468|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
126179430|NCT00340834|453940469|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
126179431|NCT00340834|453940465|FG000|Extension Phase of Study|Lost to Follow-up|1|||
126179432|NCT00340834|453940466|FG001|Extension Phase of Study|Lost to Follow-up|1|||
126179433|NCT00340834|453940467|FG002|Extension Phase of Study|Lost to Follow-up|0|||
126179434|NCT00340834|453940468|FG003|Extension Phase of Study|Lost to Follow-up|2|||
126179435|NCT00340834|453940469|FG004|Extension Phase of Study|Lost to Follow-up|3|||
126179436|NCT00340834|453940465|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
126179437|NCT00340834|453940466|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
126179438|NCT00340834|453940467|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
126179439|NCT00340834|453940468|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
126179440|NCT00340834|453940469|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
126179441|NCT00340834|453940465|FG000|Extension Phase of Study|Administrative problems|3|||
126179442|NCT00340834|453940466|FG001|Extension Phase of Study|Administrative problems|0|||
126179443|NCT00340834|453940467|FG002|Extension Phase of Study|Administrative problems|0|||
126179444|NCT00340834|453940468|FG003|Extension Phase of Study|Administrative problems|1|||
126179445|NCT00340834|453940469|FG004|Extension Phase of Study|Administrative problems|1|||
126179446|NCT00340834|453940465|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
126179447|NCT00340834|453940466|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
126179448|NCT00340834|453940467|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
126179449|NCT00340834|453940468|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
126179450|NCT00340834|453940469|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
126179451|NCT00340834|453940465|FG000|Extension Phase of Study|Protocol Violation|3|||
126179452|NCT00340834|453940466|FG001|Extension Phase of Study|Protocol Violation|0|||
126179453|NCT00340834|453940467|FG002|Extension Phase of Study|Protocol Violation|0|||
126179454|NCT00340834|453940468|FG003|Extension Phase of Study|Protocol Violation|0|||
126179455|NCT00340834|453940469|FG004|Extension Phase of Study|Protocol Violation|0|||
126179456|NCT00340834|453940465|FG000|Extension Phase of Study|Death|0|||
126179457|NCT00340834|453940466|FG001|Extension Phase of Study|Death|0|||
126179458|NCT00340834|453940467|FG002|Extension Phase of Study|Death|0|||
126179459|NCT00340834|453940468|FG003|Extension Phase of Study|Death|0|||
126179460|NCT00340834|453940469|FG004|Extension Phase of Study|Death|1|||
126179461|NCT03004976|453940470|FG000|Overall Study|Lost to Follow-up|7|||
126179462|NCT03004976|453940471|FG001|Overall Study|Lost to Follow-up|5|||
126179463|NCT03004976|453940470|FG000|Overall Study|Physician Decision|1|||
126179464|NCT03004976|453940471|FG001|Overall Study|Physician Decision|0|||
126179465|NCT03004976|453940470|FG000|Overall Study|Withdrawal by Subject|1|||
126179466|NCT03004976|453940471|FG001|Overall Study|Withdrawal by Subject|0|||
126179467|NCT03004976|453940470|FG000|Overall Study|Death|4|||
126179468|NCT03004976|453940471|FG001|Overall Study|Death|1|||
126179469|NCT00291499|453940475|FG000|Overall Study|Adverse Event|3|||
126179470|NCT00291499|453940476|FG001|Overall Study|Adverse Event|8|||
126179471|NCT00291499|453940475|FG000|Overall Study|Change to other therapy|2|||
126179472|NCT00291499|453940476|FG001|Overall Study|Change to other therapy|1|||
126179473|NCT00291499|453940475|FG000|Overall Study|Intercurrent illness|1|||
126179474|NCT00291499|453940476|FG001|Overall Study|Intercurrent illness|0|||
126179475|NCT00291499|453940475|FG000|Overall Study|Protocol Violation|2|||
126179476|NCT00291499|453940476|FG001|Overall Study|Protocol Violation|2|||
126179477|NCT00291499|453940475|FG000|Overall Study|Other reasons|1|||
126179478|NCT00291499|453940476|FG001|Overall Study|Other reasons|4|||
126179479|NCT01532570|453940477|FG000|Overall Study|Lack of Efficacy|1|||
126179480|NCT01532570|453940478|FG001|Overall Study|Lack of Efficacy|0|||
126179481|NCT01532570|453940479|FG002|Overall Study|Lack of Efficacy|0|||
126179482|NCT01532570|453940480|FG003|Overall Study|Lack of Efficacy|0|||
126179483|NCT01532570|453940477|FG000|Overall Study|Withdrawal by Subject|0|||
126179484|NCT01532570|453940478|FG001|Overall Study|Withdrawal by Subject|1|||
126179485|NCT01532570|453940479|FG002|Overall Study|Withdrawal by Subject|0|||
126179486|NCT01532570|453940480|FG003|Overall Study|Withdrawal by Subject|0|||
126179487|NCT01807949|453940482|FG000|Overall Study|Adverse Event|1|||
126179488|NCT01807949|453940483|FG001|Overall Study|Adverse Event|2|||
126179489|NCT01807949|453940484|FG002|Overall Study|Adverse Event|2|||
126179490|NCT01807949|453940482|FG000|Overall Study|Withdrawal by Subject|1|||
126179491|NCT01807949|453940483|FG001|Overall Study|Withdrawal by Subject|2|||
126179492|NCT01807949|453940484|FG002|Overall Study|Withdrawal by Subject|2|||
126179493|NCT01807949|453940482|FG000|Overall Study|Non-Compliance|0|||
126179494|NCT01807949|453940483|FG001|Overall Study|Non-Compliance|0|||
126179495|NCT01807949|453940484|FG002|Overall Study|Non-Compliance|1|||
126179496|NCT01807949|453940482|FG000|Overall Study|Undefined|0|||
126179497|NCT01807949|453940483|FG001|Overall Study|Undefined|1|||
126179498|NCT01807949|453940484|FG002|Overall Study|Undefined|2|||
126179499|NCT01807949|453940482|FG000|Overall Study|Randomized But Not Treated|0|||
126179500|NCT01807949|453940483|FG001|Overall Study|Randomized But Not Treated|2|||
126179501|NCT01807949|453940484|FG002|Overall Study|Randomized But Not Treated|2|||
126179502|NCT04325906|453940485|FG000|Overall Study|Withdrawal by Subject|2|||
126179503|NCT04325906|453940486|FG001|Overall Study|Withdrawal by Subject|0|||
126179504|NCT05014542|453940487|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
126179505|NCT05014542|453940488|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
126179506|NCT05014542|453940487|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
126179507|NCT05014542|453940488|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
126179508|NCT05014542|453940487|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
126179509|NCT05014542|453940488|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
126179510|NCT05014542|453940487|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
126179511|NCT05014542|453940488|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
126179512|NCT06000501|453940489|FG000|Overall Study|Screen failure|3|||
126179513|NCT06000501|453940489|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
126179514|NCT06000501|453940489|FG000|Overall Study|Physician Decision|4|||
126179515|NCT06000501|453940489|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
126179516|NCT06000501|453940489|FG000|Overall Study|Scheduling issues|2|||
126179517|NCT00318565|453940490|FG000|Overall Study|Excluded per protocol|24|||
126179518|NCT01896856|453940492|FG000|Overall Study|Transportation issues / Non-compliance|0|||
126179519|NCT01896856|453940493|FG001|Overall Study|Transportation issues / Non-compliance|0|||
125974793|NCT04162769|453196909|FG000|Double-blind Treatment (12-Week)|Other|0|||
125974794|NCT04162769|453196910|FG001|Double-blind Treatment (12-Week)|Other|1|||
125974795|NCT04162769|453196911|FG002|Double-blind Treatment (12-Week)|Other|1|||
125974796|NCT04162769|453196912|FG003|Double-blind Treatment (12-Week)|Other|0|||
125974797|NCT04162769|453196909|FG000|OLE Period (52-Week)|Adverse Event|0|||
125974798|NCT04162769|453196910|FG001|OLE Period (52-Week)|Adverse Event|0|||
125974799|NCT04162769|453196911|FG002|OLE Period (52-Week)|Adverse Event|0|||
125974800|NCT04162769|453196912|FG003|OLE Period (52-Week)|Adverse Event|5|||
125974801|NCT04162769|453196909|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
125974802|NCT04162769|453196910|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
125974803|NCT04162769|453196911|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
125974804|NCT04162769|453196912|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
125974805|NCT04162769|453196909|FG000|OLE Period (52-Week)|Physician Decision|0|||
125974806|NCT04162769|453196910|FG001|OLE Period (52-Week)|Physician Decision|0|||
125974807|NCT04162769|453196911|FG002|OLE Period (52-Week)|Physician Decision|0|||
125974808|NCT04162769|453196912|FG003|OLE Period (52-Week)|Physician Decision|1|||
125974809|NCT04162769|453196909|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
125974810|NCT04162769|453196910|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
125974811|NCT04162769|453196911|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
125974812|NCT04162769|453196912|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
125974813|NCT04162769|453196909|FG000|OLE Period (52-Week)|Protocol deviation|0|||
125974814|NCT04162769|453196910|FG001|OLE Period (52-Week)|Protocol deviation|0|||
125974815|NCT04162769|453196911|FG002|OLE Period (52-Week)|Protocol deviation|0|||
125974816|NCT04162769|453196912|FG003|OLE Period (52-Week)|Protocol deviation|2|||
125974817|NCT04066114|453196916|FG000|Overall Study|Adverse Event|1|||
125974818|NCT04066114|453196917|FG001|Overall Study|Adverse Event|0|||
125974819|NCT04066114|453196918|FG002|Overall Study|Adverse Event|0|||
125974820|NCT04066114|453196916|FG000|Overall Study|Withdrawal by Subject|1|||
125974821|NCT04066114|453196917|FG001|Overall Study|Withdrawal by Subject|0|||
125974822|NCT04066114|453196918|FG002|Overall Study|Withdrawal by Subject|0|||
125974823|NCT04066114|453196916|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
125974824|NCT04066114|453196917|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
125974825|NCT04066114|453196918|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
125974826|NCT00254982|453196919|FG000|Overall Study|Other|2|||
125974827|NCT00254982|453196920|FG001|Overall Study|Other|1|||
125974828|NCT00254982|453196919|FG000|Overall Study|Lack of Efficacy|5|||
126179520|NCT01896856|453940494|FG002|Overall Study|Transportation issues / Non-compliance|1|||
126179521|NCT01896856|453940495|FG003|Overall Study|Transportation issues / Non-compliance|0|||
126179522|NCT01896856|453940496|FG004|Overall Study|Transportation issues / Non-compliance|0|||
126179523|NCT01896856|453940497|FG005|Overall Study|Transportation issues / Non-compliance|0|||
126179524|NCT00282867|453940498|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
126179525|NCT00282867|453940499|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
126179526|NCT00282867|453940500|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
126179527|NCT03589885|453940502|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
126179528|NCT03589885|453940503|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
126179529|NCT03589885|453940504|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
126179530|NCT03589885|453940505|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
126179531|NCT03589885|453940506|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
126179532|NCT03589885|453940502|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
126179533|NCT03589885|453940503|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
126179534|NCT03589885|453940504|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
126179535|NCT03589885|453940505|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
126179536|NCT03589885|453940506|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
126179537|NCT03589885|453940502|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
126179538|NCT03589885|453940503|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
125974829|NCT00254982|453196920|FG001|Overall Study|Lack of Efficacy|3|||
125974830|NCT00254982|453196919|FG000|Overall Study|Lost to Follow-up|5|||
125974831|NCT00254982|453196920|FG001|Overall Study|Lost to Follow-up|3|||
125974832|NCT00254982|453196919|FG000|Overall Study|Adverse Event|18|||
125974833|NCT00254982|453196920|FG001|Overall Study|Adverse Event|16|||
125974834|NCT00254982|453196919|FG000|Overall Study|Withdrawal by Subject|1|||
125974835|NCT00254982|453196920|FG001|Overall Study|Withdrawal by Subject|1|||
125974836|NCT00254982|453196919|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
125974837|NCT00254982|453196920|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
125974838|NCT00254982|453196919|FG000|Overall Study|Protocol deviation|1|||
125974839|NCT00254982|453196920|FG001|Overall Study|Protocol deviation|1|||
125974840|NCT00254982|453196919|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
125974841|NCT00254982|453196920|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
126179539|NCT03589885|453940504|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
126179540|NCT03589885|453940505|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
126179541|NCT03589885|453940506|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125974842|NCT00254982|453196919|FG000|Overall Study|Malignancy|0|||
125974843|NCT00254982|453196920|FG001|Overall Study|Malignancy|2|||
125974844|NCT00254982|453196919|FG000|Overall Study|Opportunistic infection|1|||
125974845|NCT00254982|453196920|FG001|Overall Study|Opportunistic infection|0|||
125974846|NCT00254982|453196919|FG000|Overall Study|Abnormal liver function tests|2|||
125974847|NCT00254982|453196920|FG001|Overall Study|Abnormal liver function tests|1|||
125974848|NCT03117738|453196922|FG000|Overall Study|Withdrawal by Subject|3|||
125974849|NCT03117738|453196923|FG001|Overall Study|Withdrawal by Subject|1|||
126179542|NCT03589885|453940502|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
126179543|NCT03589885|453940503|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
126179544|NCT03589885|453940504|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
126179545|NCT03589885|453940505|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
126179546|NCT03589885|453940506|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
126179547|NCT03589885|453940502|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
126179548|NCT03589885|453940503|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
126179549|NCT03589885|453940504|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
126179550|NCT03589885|453940505|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
126179551|NCT03589885|453940506|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
126179552|NCT03589885|453940502|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
126179553|NCT03589885|453940503|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
125974850|NCT03117738|453196922|FG000|Overall Study|Lost to Follow-up|1|||
125974851|NCT03117738|453196923|FG001|Overall Study|Lost to Follow-up|4|||
126179554|NCT03589885|453940504|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
126179555|NCT03589885|453940505|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
126179556|NCT03589885|453940506|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
126179557|NCT03589885|453940502|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
126179558|NCT03589885|453940503|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
126179559|NCT03589885|453940504|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
126179560|NCT03589885|453940505|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
126179561|NCT03589885|453940506|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
126179562|NCT03589885|453940502|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
126179563|NCT03589885|453940503|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
126179564|NCT03589885|453940504|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
126179565|NCT03589885|453940505|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
126179566|NCT03589885|453940506|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
126179567|NCT00493974|453940509|FG000|Overall Study|Death|1|||
125974852|NCT04004611|453196924|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125974853|NCT04004611|453196925|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125974854|NCT04004611|453196926|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125974855|NCT04004611|453196927|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125974856|NCT04004611|453196928|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125974857|NCT04004611|453196929|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125974858|NCT04004611|453196930|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125974859|NCT04004611|453196931|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125974860|NCT04004611|453196932|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
125974861|NCT04004611|453196924|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125974862|NCT04004611|453196925|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125974863|NCT04004611|453196926|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125974864|NCT04004611|453196927|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125974865|NCT04004611|453196928|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125974866|NCT04004611|453196929|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
125974867|NCT04004611|453196930|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
125974868|NCT04004611|453196931|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125974869|NCT04004611|453196932|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
125974870|NCT04004611|453196924|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125974871|NCT04004611|453196925|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125974872|NCT04004611|453196926|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125974873|NCT04004611|453196927|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125974874|NCT04004611|453196928|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
125974875|NCT04004611|453196929|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125974876|NCT04004611|453196930|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125974877|NCT04004611|453196931|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126179568|NCT00493974|453940510|FG001|Overall Study|Death|2|||
125974878|NCT04004611|453196932|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125974879|NCT04004611|453196924|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
125974880|NCT04004611|453196925|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
126179569|NCT00493974|453940509|FG000|Overall Study|Withdrawal by Subject|8|||
125974881|NCT04004611|453196926|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
125974882|NCT04004611|453196927|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
125974883|NCT04004611|453196928|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
125974884|NCT04004611|453196929|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
125974885|NCT04004611|453196930|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
125974886|NCT04004611|453196931|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
125974887|NCT04004611|453196932|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
125974888|NCT04004611|453196924|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
125974889|NCT04004611|453196925|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125974890|NCT04004611|453196926|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
125974891|NCT04004611|453196927|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125974892|NCT04004611|453196928|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125974893|NCT04004611|453196929|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125974894|NCT04004611|453196930|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125974895|NCT04004611|453196931|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125974896|NCT04004611|453196932|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125974897|NCT04004611|453196924|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125974898|NCT04004611|453196925|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
125974899|NCT04004611|453196926|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125974900|NCT04004611|453196927|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125974901|NCT04004611|453196928|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125974902|NCT04004611|453196929|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125974903|NCT04004611|453196930|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125974904|NCT04004611|453196931|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125974905|NCT04004611|453196932|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125974906|NCT04420689|453196933|FG000|Overall Study|COVID-19 related hospitalization|0|||
125974907|NCT04420689|453196934|FG001|Overall Study|COVID-19 related hospitalization|0|||
125974908|NCT04420689|453196935|FG002|Overall Study|COVID-19 related hospitalization|0|||
125974909|NCT04420689|453196936|FG003|Overall Study|COVID-19 related hospitalization|0|||
125974910|NCT04420689|453196937|FG004|Overall Study|COVID-19 related hospitalization|1|||
125974911|NCT04420689|453196938|FG005|Overall Study|COVID-19 related hospitalization|0|||
125974912|NCT04420689|453196939|FG006|Overall Study|COVID-19 related hospitalization|0|||
125974913|NCT04420689|453196933|FG000|Overall Study|Physician Decision|0|||
125974914|NCT04420689|453196934|FG001|Overall Study|Physician Decision|0|||
125974915|NCT04420689|453196935|FG002|Overall Study|Physician Decision|0|||
125974916|NCT04420689|453196936|FG003|Overall Study|Physician Decision|0|||
125974917|NCT04420689|453196937|FG004|Overall Study|Physician Decision|0|||
125974918|NCT04420689|453196938|FG005|Overall Study|Physician Decision|1|||
125974919|NCT04420689|453196939|FG006|Overall Study|Physician Decision|0|||
125974920|NCT00515502|453196940|FG000|Treatment Period 1|Adverse Event|0|||
125974921|NCT00515502|453196941|FG001|Treatment Period 1|Adverse Event|0|||
125974922|NCT00515502|453196942|FG002|Treatment Period 1|Adverse Event|0|||
125974923|NCT00515502|453196943|FG003|Treatment Period 1|Adverse Event|0|||
125974924|NCT00515502|453196944|FG004|Treatment Period 1|Adverse Event|0|||
125974925|NCT00515502|453196945|FG005|Treatment Period 1|Adverse Event|0|||
125974926|NCT00515502|453196946|FG006|Treatment Period 1|Adverse Event|1|||
125974927|NCT00515502|453196947|FG007|Treatment Period 1|Adverse Event|0|||
125974928|NCT00515502|453196948|FG008|Treatment Period 1|Adverse Event|1|||
125974929|NCT00515502|453196949|FG009|Treatment Period 1|Adverse Event|0|||
125974930|NCT00515502|453196950|FG010|Treatment Period 1|Adverse Event|0|||
125974931|NCT00515502|453196951|FG011|Treatment Period 1|Adverse Event|1|||
125974932|NCT00515502|453196940|FG000|Treatment Period 2|Adverse Event|0|||
125974933|NCT00515502|453196941|FG001|Treatment Period 2|Adverse Event|1|||
125974934|NCT00515502|453196942|FG002|Treatment Period 2|Adverse Event|0|||
125974935|NCT00515502|453196943|FG003|Treatment Period 2|Adverse Event|0|||
126179570|NCT00493974|453940510|FG001|Overall Study|Withdrawal by Subject|6|||
126179571|NCT00493974|453940509|FG000|Overall Study|Lost to Follow-up|4|||
126179572|NCT00493974|453940510|FG001|Overall Study|Lost to Follow-up|6|||
126179573|NCT02807363|453940511|FG000|Dosing Period|Adverse Event|0|||
125974936|NCT00515502|453196944|FG004|Treatment Period 2|Adverse Event|0|||
125974937|NCT00515502|453196945|FG005|Treatment Period 2|Adverse Event|0|||
125974938|NCT00515502|453196946|FG006|Treatment Period 2|Adverse Event|0|||
125974939|NCT00515502|453196947|FG007|Treatment Period 2|Adverse Event|0|||
125974940|NCT00515502|453196948|FG008|Treatment Period 2|Adverse Event|0|||
125974941|NCT00515502|453196949|FG009|Treatment Period 2|Adverse Event|0|||
125974942|NCT00515502|453196950|FG010|Treatment Period 2|Adverse Event|0|||
125974943|NCT00515502|453196951|FG011|Treatment Period 2|Adverse Event|0|||
125974944|NCT01324271|453196955|FG000|Overall Study|Lost to Follow-up|3|||
125974945|NCT01324271|453196956|FG001|Overall Study|Lost to Follow-up|0|||
125974946|NCT01324271|453196955|FG000|Overall Study|Physician Decision|1|||
125974947|NCT01324271|453196956|FG001|Overall Study|Physician Decision|0|||
125974948|NCT05130970|453196957|FG000|Overall Study|Adverse Event|1|||
125974949|NCT05130970|453196958|FG001|Overall Study|Adverse Event|1|||
125974950|NCT05130970|453196957|FG000|Overall Study|Death|0|||
126179574|NCT02807363|453940512|FG001|Dosing Period|Adverse Event|1|||
126179575|NCT02807363|453940513|FG002|Dosing Period|Adverse Event|0|||
125974951|NCT05130970|453196958|FG001|Overall Study|Death|1|||
125974952|NCT05130970|453196957|FG000|Overall Study|Lost to Follow-up|0|||
125974953|NCT05130970|453196958|FG001|Overall Study|Lost to Follow-up|1|||
125974954|NCT05130970|453196957|FG000|Overall Study|Physician Decision|0|||
125974955|NCT05130970|453196958|FG001|Overall Study|Physician Decision|1|||
125974956|NCT05130970|453196957|FG000|Overall Study|Withdrawal by Subject|1|||
125974957|NCT05130970|453196958|FG001|Overall Study|Withdrawal by Subject|1|||
125974958|NCT03644186|453196959|FG000|Overall Study|Withdrawal by Subject|1|||
125974959|NCT03644186|453196960|FG001|Overall Study|Withdrawal by Subject|1|||
125974960|NCT02192502|453196962|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
125974961|NCT02192502|453196963|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
125974962|NCT02192502|453196962|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
125974963|NCT02192502|453196963|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
125974964|NCT02192502|453196962|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
125974965|NCT02192502|453196963|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
125974966|NCT01869491|453196964|FG000|Overall Study|Adverse Event|3|||
125974967|NCT01869491|453196965|FG001|Overall Study|Adverse Event|5|||
125974968|NCT01869491|453196964|FG000|Overall Study|Lack of Efficacy|0|||
125974969|NCT01869491|453196965|FG001|Overall Study|Lack of Efficacy|3|||
125974970|NCT01869491|453196964|FG000|Overall Study|Withdrawal by Subject|6|||
125974971|NCT01869491|453196965|FG001|Overall Study|Withdrawal by Subject|7|||
125974972|NCT01869491|453196964|FG000|Overall Study|Lost to Follow-up|11|||
125974973|NCT01869491|453196965|FG001|Overall Study|Lost to Follow-up|9|||
125974974|NCT01869491|453196964|FG000|Overall Study|No further need of investigational product|1|||
125974975|NCT01869491|453196965|FG001|Overall Study|No further need of investigational product|0|||
125974976|NCT01371851|453196970|FG000|Overall Study|Lost to Follow-up|5|||
125974977|NCT01371851|453196971|FG001|Overall Study|Lost to Follow-up|8|||
125974978|NCT01371851|453196970|FG000|Overall Study|was arrested and put in jail|0|||
125974979|NCT01371851|453196971|FG001|Overall Study|was arrested and put in jail|1|||
125974980|NCT01371851|453196970|FG000|Overall Study|non study related adverse event|1|||
125974981|NCT01371851|453196971|FG001|Overall Study|non study related adverse event|0|||
125974982|NCT01371851|453196970|FG000|Overall Study|Blood Pressure outside study parameters|2|||
125974983|NCT01371851|453196971|FG001|Overall Study|Blood Pressure outside study parameters|0|||
125974984|NCT00833638|453196972|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
125974985|NCT00833638|453196973|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
125974986|NCT00833638|453196974|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
125974987|NCT00833638|453196972|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
125974988|NCT00833638|453196973|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
125974989|NCT00833638|453196974|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
125974990|NCT00833638|453196972|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
125974991|NCT00833638|453196973|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
125974992|NCT00833638|453196974|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
125974993|NCT00833638|453196972|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
125974994|NCT00833638|453196973|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
126179576|NCT02807363|453940514|FG003|Dosing Period|Adverse Event|0|||
126179577|NCT02188719|453940515|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
126179578|NCT02188719|453940516|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
126179579|NCT02188719|453940517|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
126179580|NCT02188719|453940518|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
126179581|NCT00599027|453940519|FG000|Overall Study|Withdrawal by Subject|1|||
126179582|NCT00599027|453940520|FG001|Overall Study|Withdrawal by Subject|1|||
126179583|NCT00599027|453940519|FG000|Overall Study|Adverse Event|0|||
126179584|NCT00599027|453940520|FG001|Overall Study|Adverse Event|1|||
126179585|NCT00599027|453940519|FG000|Overall Study|Treatment Failure|0|||
126179586|NCT00599027|453940520|FG001|Overall Study|Treatment Failure|1|||
126179587|NCT00476996|453940521|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
126179588|NCT00476996|453940522|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
126179589|NCT00476996|453940523|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
126179590|NCT00476996|453940524|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
126179591|NCT00476996|453940521|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
125974995|NCT00833638|453196974|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
125974996|NCT00833638|453196972|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
125974997|NCT00833638|453196973|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
125974998|NCT00833638|453196974|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
125974999|NCT00833638|453196972|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
126179592|NCT00476996|453940522|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
125975000|NCT00833638|453196973|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
125975001|NCT00833638|453196974|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
126179593|NCT00476996|453940523|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
126179594|NCT00476996|453940524|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
126179595|NCT00476996|453940521|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
126179596|NCT00476996|453940522|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
126179597|NCT00476996|453940523|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
126179598|NCT00476996|453940524|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
126179599|NCT00476996|453940521|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
126179600|NCT00476996|453940522|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
126179601|NCT00476996|453940523|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
126179602|NCT00476996|453940524|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
126179603|NCT00476996|453940521|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
126179604|NCT00476996|453940522|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
126179605|NCT00476996|453940523|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
126179606|NCT00476996|453940524|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
126179607|NCT00476996|453940521|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
126179608|NCT00476996|453940522|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
126179609|NCT00476996|453940523|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
126179610|NCT00476996|453940524|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
126179611|NCT00476996|453940521|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
126179612|NCT00476996|453940522|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
126179613|NCT00476996|453940523|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
126179614|NCT00476996|453940524|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
126179615|NCT00476996|453940521|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
126179616|NCT00476996|453940522|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
126179617|NCT00476996|453940523|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
126179618|NCT00476996|453940524|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
126179619|NCT00476996|453940521|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
126179620|NCT00476996|453940522|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
126179621|NCT00476996|453940523|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
126179622|NCT00476996|453940524|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
126179623|NCT00476996|453940521|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
126179624|NCT00476996|453940522|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
126179625|NCT00476996|453940523|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
126179626|NCT00476996|453940524|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
126179627|NCT00476996|453940521|FG000|OLE Phase (From Week 48)|Death|0|||
126179628|NCT00476996|453940522|FG001|OLE Phase (From Week 48)|Death|0|||
126179629|NCT00476996|453940523|FG002|OLE Phase (From Week 48)|Death|0|||
126179630|NCT00476996|453940524|FG003|OLE Phase (From Week 48)|Death|7|||
126179631|NCT00476996|453940521|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
126179632|NCT00476996|453940522|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
126179633|NCT00476996|453940523|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
126179634|NCT00476996|453940524|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
126179635|NCT00476996|453940521|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
126179636|NCT00476996|453940522|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
126179637|NCT00476996|453940523|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
126179638|NCT00476996|453940524|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
126179639|NCT00476996|453940521|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
126179640|NCT00476996|453940522|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
126179641|NCT00476996|453940523|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
126179642|NCT00476996|453940524|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
126179643|NCT00476996|453940521|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
126179644|NCT00476996|453940522|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
126179645|NCT00476996|453940523|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
126179646|NCT00476996|453940524|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
126179647|NCT01181778|453940535|FG000|Overall Study|Physician Decision|48|||
126179648|NCT01265420|453940536|FG000|Overall Study|Lost to Follow-up|1|||
126179649|NCT00595868|453942213|FG000|Overall Study|Lost to Follow-up|45|||
126179650|NCT00595868|453942214|FG001|Overall Study|Lost to Follow-up|50|||
126179651|NCT04268303|453942216|FG000|Overall Study|Lost to Follow-up|1|||
126179652|NCT04268303|453942217|FG001|Overall Study|Lost to Follow-up|1|||
126179653|NCT04268303|453942218|FG002|Overall Study|Lost to Follow-up|2|||
126179654|NCT04268303|453942216|FG000|Overall Study|Withdrawal by Subject|0|||
126179655|NCT04268303|453942217|FG001|Overall Study|Withdrawal by Subject|1|||
126179656|NCT04268303|453942218|FG002|Overall Study|Withdrawal by Subject|1|||
126179657|NCT04268303|453942216|FG000|Overall Study|Adverse Event|2|||
126179658|NCT04268303|453942217|FG001|Overall Study|Adverse Event|0|||
126179659|NCT04268303|453942218|FG002|Overall Study|Adverse Event|0|||
126179660|NCT05742841|453942223|FG000|Overall Study|Withdrawal by Subject|1|||
126179661|NCT05742841|453942223|FG000|Overall Study|Lost to Follow-up|1|||
126179662|NCT01175590|453942229|FG000|Overall Study|Lost to Follow-up|1|||
126179663|NCT01175590|453942230|FG001|Overall Study|Lost to Follow-up|0|||
125975002|NCT00833638|453196972|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
125975003|NCT00833638|453196973|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
125975004|NCT00833638|453196974|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
125975005|NCT00833638|453196972|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
125975006|NCT00833638|453196973|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
125975007|NCT00833638|453196974|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
125975008|NCT00833638|453196972|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
125975009|NCT00833638|453196973|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
125975010|NCT00833638|453196974|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
125975011|NCT01669122|453196975|FG000|Period I|Lost to Follow-up|1|||
125975012|NCT01669122|453196975|FG000|Washout Period II|Protocol Violation|2|||
125975013|NCT03543254|453196976|FG000|Overall Study|Lost to Follow-up|1|||
125975014|NCT01261338|453196977|FG000|Overall Study|Withdrawal by Subject|3|||
125975015|NCT01261338|453196978|FG001|Overall Study|Withdrawal by Subject|2|||
125975016|NCT00234065|453196979|FG000|Overall Study|Adverse Event|268|||
125975017|NCT00234065|453196980|FG001|Overall Study|Adverse Event|166|||
125975018|NCT00234065|453196979|FG000|Overall Study|Withdrawal by Subject|73|||
125975019|NCT00234065|453196980|FG001|Overall Study|Withdrawal by Subject|56|||
125975020|NCT00234065|453196979|FG000|Overall Study|Physician Decision|23|||
125975021|NCT00234065|453196980|FG001|Overall Study|Physician Decision|22|||
125975022|NCT00234065|453196979|FG000|Overall Study|Not Classified|111|||
125975023|NCT00234065|453196980|FG001|Overall Study|Not Classified|112|||
125975024|NCT05374421|453196981|FG000|Overall Study|Withdrawal by Subject|3|||
125975025|NCT05374421|453196982|FG001|Overall Study|Withdrawal by Subject|4|||
125975026|NCT05132699|453196983|FG000|Overall Study|Withdrawal by Subject|3|||
125975027|NCT05132699|453196984|FG001|Overall Study|Withdrawal by Subject|0|||
125975028|NCT02899728|453196985|FG000|Overall Study|Withdrawal by Subject|1|||
125975029|NCT02899728|453196986|FG001|Overall Study|Withdrawal by Subject|1|||
125975030|NCT05557942|453196987|FG000|Overall Study|Death|0|||
125975031|NCT05557942|453196988|FG001|Overall Study|Death|0|||
125975032|NCT05557942|453196989|FG002|Overall Study|Death|0|||
125975033|NCT05557942|453196990|FG003|Overall Study|Death|2|||
125975034|NCT05557942|453196991|FG004|Overall Study|Death|1|||
125975035|NCT05557942|453196992|FG005|Overall Study|Death|1|||
125975036|NCT05557942|453196987|FG000|Overall Study|Physician Decision|1|||
125975037|NCT05557942|453196988|FG001|Overall Study|Physician Decision|1|||
125975038|NCT05557942|453196989|FG002|Overall Study|Physician Decision|2|||
125975039|NCT05557942|453196990|FG003|Overall Study|Physician Decision|3|||
125975040|NCT05557942|453196991|FG004|Overall Study|Physician Decision|0|||
125975041|NCT05557942|453196992|FG005|Overall Study|Physician Decision|2|||
125975042|NCT05557942|453196987|FG000|Overall Study|Study terminated by sponsor|17|||
125975043|NCT05557942|453196988|FG001|Overall Study|Study terminated by sponsor|17|||
125975044|NCT05557942|453196989|FG002|Overall Study|Study terminated by sponsor|14|||
125975045|NCT05557942|453196990|FG003|Overall Study|Study terminated by sponsor|40|||
125975046|NCT05557942|453196991|FG004|Overall Study|Study terminated by sponsor|45|||
125975047|NCT05557942|453196992|FG005|Overall Study|Study terminated by sponsor|37|||
125975048|NCT05557942|453196987|FG000|Overall Study|Protocol Violation|0|||
125975049|NCT05557942|453196988|FG001|Overall Study|Protocol Violation|0|||
125975050|NCT05557942|453196989|FG002|Overall Study|Protocol Violation|0|||
125975051|NCT05557942|453196990|FG003|Overall Study|Protocol Violation|0|||
125975052|NCT05557942|453196991|FG004|Overall Study|Protocol Violation|0|||
125975053|NCT05557942|453196992|FG005|Overall Study|Protocol Violation|1|||
125975054|NCT05557942|453196987|FG000|Overall Study|Withdrawal by Subject|0|||
125975055|NCT05557942|453196988|FG001|Overall Study|Withdrawal by Subject|0|||
125975056|NCT05557942|453196989|FG002|Overall Study|Withdrawal by Subject|0|||
125975057|NCT05557942|453196990|FG003|Overall Study|Withdrawal by Subject|0|||
125975058|NCT05557942|453196991|FG004|Overall Study|Withdrawal by Subject|2|||
125975059|NCT05557942|453196992|FG005|Overall Study|Withdrawal by Subject|0|||
125975060|NCT02477618|453196993|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
125975061|NCT02477618|453196994|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
125975062|NCT02477618|453196993|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
125975063|NCT02477618|453196994|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
125975064|NCT02477618|453196993|FG000|Overall Study|Adverse Event|1|||
125975065|NCT02477618|453196994|FG001|Overall Study|Adverse Event|1|||
125975066|NCT02477618|453196993|FG000|Overall Study|Transferred Away from Study Site|1|||
125975067|NCT02477618|453196994|FG001|Overall Study|Transferred Away from Study Site|0|||
125975068|NCT02477618|453196993|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
125975069|NCT02477618|453196994|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
125975070|NCT00936390|453196996|FG000|Overall Study|Protocol Violation|21|||
125975071|NCT00936390|453196997|FG001|Overall Study|Protocol Violation|25|||
125975072|NCT04348604|453196998|FG000|Week 8|Withdrawal by Subject|1|||
125975073|NCT04348604|453196999|FG001|Week 8|Withdrawal by Subject|1|||
125975074|NCT04348604|453196998|FG000|Week 8|Lost to Follow-up|1|||
125975075|NCT04348604|453196999|FG001|Week 8|Lost to Follow-up|2|||
125975076|NCT04348604|453196998|FG000|Week 8|Suspended|0|||
125975077|NCT04348604|453196999|FG001|Week 8|Suspended|1|||
125975078|NCT04348604|453196998|FG000|Week 12|Lost to Follow-up|1|||
125975079|NCT04348604|453196999|FG001|Week 12|Lost to Follow-up|2|||
125975080|NCT04348604|453196998|FG000|Week 12|Withdrawal by Subject|1|||
125975081|NCT04348604|453196999|FG001|Week 12|Withdrawal by Subject|0|||
125975082|NCT04348604|453196998|FG000|Week 24|Lost to Follow-up|2|||
125975083|NCT04348604|453196999|FG001|Week 24|Lost to Follow-up|1|||
125975084|NCT02097108|453197000|FG000|Overall Study|Adverse Event|1|||
125975085|NCT02097108|453197000|FG000|Overall Study|patient was abroad for 6 months|1|||
125975086|NCT01738984|453198638|FG000|Overall Study|Pregnancy|4|||
125975087|NCT01738984|453198639|FG001|Overall Study|Pregnancy|0|||
125975088|NCT01738984|453198638|FG000|Overall Study|Withdrawal by Subject|1|||
125975089|NCT01738984|453198639|FG001|Overall Study|Withdrawal by Subject|0|||
125975090|NCT01738984|453198638|FG000|Overall Study|Lost to Follow-up|59|||
125975091|NCT01738984|453198639|FG001|Overall Study|Lost to Follow-up|39|||
125975092|NCT00725452|453198644|FG000|Overall Study|Adverse Event|3|||
125975093|NCT00725452|453198644|FG000|Overall Study|Lack of Efficacy|2|||
125975094|NCT00725452|453198644|FG000|Overall Study|Reason not specified|1|||
125975095|NCT00725452|453198644|FG000|Overall Study|Physician Decision|1|||
125975096|NCT00725452|453198644|FG000|Overall Study|Withdrawal by Subject|3|||
125975097|NCT00725452|453198644|FG000|Overall Study|Lost to Follow-up|1|||
125975098|NCT00620750|453198645|FG000|Overall Study|Lost to Follow-up|25|||
125975099|NCT02163733|453198646|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
125975100|NCT02163733|453198647|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
125975101|NCT02163733|453198648|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
125975102|NCT02163733|453198646|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
125975103|NCT02163733|453198647|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
125975104|NCT02163733|453198648|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
125975105|NCT04477187|453198649|FG000|Overall Study|Lost to Follow-up|2|||
125975106|NCT02633800|453198650|FG000|Overall Study|Death|3|||
125975107|NCT02633800|453198651|FG001|Overall Study|Death|3|||
125975108|NCT02633800|453198650|FG000|Overall Study|Reason not provided|1|||
125975109|NCT02633800|453198651|FG001|Overall Study|Reason not provided|0|||
125975110|NCT02633800|453198650|FG000|Overall Study|Radiologic(al) progression|23|||
125975111|NCT02633800|453198651|FG001|Overall Study|Radiologic(al) progression|23|||
125975112|NCT02633800|453198650|FG000|Overall Study|Clinical progression|3|||
125975113|NCT02633800|453198651|FG001|Overall Study|Clinical progression|6|||
125975114|NCT02633800|453198650|FG000|Overall Study|Study terminated by sponsor|6|||
125975115|NCT02633800|453198651|FG001|Overall Study|Study terminated by sponsor|5|||
125975116|NCT02633800|453198650|FG000|Overall Study|Adverse event, non-fatal|7|||
125975117|NCT02633800|453198651|FG001|Overall Study|Adverse event, non-fatal|2|||
125975118|NCT02633800|453198650|FG000|Overall Study|Withdrawal by Subject|0|||
125975119|NCT02633800|453198651|FG001|Overall Study|Withdrawal by Subject|3|||
125975120|NCT02633800|453198650|FG000|Overall Study|Patient Request|1|||
126179664|NCT01175590|453942229|FG000|Overall Study|Withdrawal by Subject|0|||
126179665|NCT01175590|453942230|FG001|Overall Study|Withdrawal by Subject|2|||
126179666|NCT01175590|453942229|FG000|Overall Study|Adverse Event|4|||
126179667|NCT01175590|453942230|FG001|Overall Study|Adverse Event|0|||
126179668|NCT01175590|453942229|FG000|Overall Study|Physician Decision|1|||
126179669|NCT01175590|453942230|FG001|Overall Study|Physician Decision|4|||
126179670|NCT01175590|453942229|FG000|Overall Study|Lack of Efficacy|1|||
126179671|NCT01175590|453942230|FG001|Overall Study|Lack of Efficacy|1|||
126179672|NCT01175590|453942229|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
126179673|NCT01175590|453942230|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
125975121|NCT02633800|453198651|FG001|Overall Study|Patient Request|1|||
125975122|NCT00082173|453198652|FG000|Overall Study|Withdrawal by Subject|3|||
125975123|NCT00082173|453198653|FG001|Overall Study|Withdrawal by Subject|5|||
125975124|NCT00082173|453198652|FG000|Overall Study|Lost to Follow-up|1|||
125975125|NCT00082173|453198653|FG001|Overall Study|Lost to Follow-up|0|||
125975126|NCT00082173|453198652|FG000|Overall Study|Adverse Event|1|||
125975127|NCT00082173|453198653|FG001|Overall Study|Adverse Event|0|||
125975128|NCT00082173|453198652|FG000|Overall Study|Culture negative or resistant at baselin|5|||
125975129|NCT00082173|453198653|FG001|Overall Study|Culture negative or resistant at baselin|6|||
125975130|NCT01733732|453198654|FG000|Overall Study|Adverse Event|1|||
125975131|NCT01733732|453198655|FG001|Overall Study|Adverse Event|0|||
126179674|NCT01175590|453942229|FG000|Overall Study|Treated not as randomized|3|||
125975132|NCT01733732|453198654|FG000|Overall Study|Did not attend all study visits|1|||
125975133|NCT01733732|453198655|FG001|Overall Study|Did not attend all study visits|0|||
125975134|NCT00746590|453198656|FG000|Overall Study|Death|1|||
125975135|NCT00464815|453198660|FG000|Overall Study|Withdrawal by Subject|6|||
126179675|NCT01175590|453942230|FG001|Overall Study|Treated not as randomized|2|||
125975136|NCT00464815|453198661|FG001|Overall Study|Withdrawal by Subject|3|||
125975137|NCT01358968|453198672|FG000|Period 2|Adverse Event|0|||
125975138|NCT01358968|453198673|FG001|Period 2|Adverse Event|1|||
125975139|NCT01358968|453198674|FG002|Period 2|Adverse Event|0|||
125975140|NCT01358968|453198675|FG003|Period 2|Adverse Event|0|||
125975141|NCT01358968|453198672|FG000|Continued Access Phase|Progression of Disease|0|||
125975142|NCT01358968|453198673|FG001|Continued Access Phase|Progression of Disease|0|||
125975143|NCT01358968|453198674|FG002|Continued Access Phase|Progression of Disease|8|||
125975144|NCT01358968|453198675|FG003|Continued Access Phase|Progression of Disease|4|||
125975145|NCT01358968|453198672|FG000|Continued Access Phase|Protocol Violation|0|||
125975146|NCT01358968|453198673|FG001|Continued Access Phase|Protocol Violation|0|||
125975147|NCT01358968|453198674|FG002|Continued Access Phase|Protocol Violation|0|||
125975148|NCT01358968|453198675|FG003|Continued Access Phase|Protocol Violation|2|||
125975149|NCT01358968|453198672|FG000|Continued Access Phase|Withdrawal by Subject|0|||
125975150|NCT01358968|453198673|FG001|Continued Access Phase|Withdrawal by Subject|0|||
125975151|NCT01358968|453198674|FG002|Continued Access Phase|Withdrawal by Subject|3|||
125975152|NCT01358968|453198675|FG003|Continued Access Phase|Withdrawal by Subject|0|||
125975153|NCT01358968|453198672|FG000|Continued Access Phase|Death|0|||
125975154|NCT01358968|453198673|FG001|Continued Access Phase|Death|0|||
125975155|NCT01358968|453198674|FG002|Continued Access Phase|Death|1|||
125975156|NCT01358968|453198675|FG003|Continued Access Phase|Death|1|||
125975157|NCT00868439|453198684|FG000|Overall Study|Adverse Event|4|||
125975158|NCT00868439|453198685|FG001|Overall Study|Adverse Event|3|||
125975159|NCT00868439|453198684|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
125975160|NCT00868439|453198685|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
125975161|NCT00868439|453198684|FG000|Overall Study|Death|0|||
125975162|NCT00868439|453198685|FG001|Overall Study|Death|1|||
125975163|NCT00868439|453198684|FG000|Overall Study|Protocol Violation|1|||
125975164|NCT00868439|453198685|FG001|Overall Study|Protocol Violation|1|||
125975165|NCT00868439|453198684|FG000|Overall Study|Physician Decision|1|||
125975166|NCT00868439|453198685|FG001|Overall Study|Physician Decision|0|||
125975167|NCT00868439|453198684|FG000|Overall Study|Withdrawal by Subject|0|||
125975168|NCT00868439|453198685|FG001|Overall Study|Withdrawal by Subject|1|||
125975169|NCT00476476|453198686|FG000|Overall Study|Adverse Event|2|||
125975170|NCT00476476|453198687|FG001|Overall Study|Adverse Event|7|||
125975171|NCT00476476|453198686|FG000|Overall Study|Progressive Disease|0|||
125975172|NCT00476476|453198687|FG001|Overall Study|Progressive Disease|17|||
125975173|NCT00971048|453198695|FG000|Overall Study|Protocol Violation|1|||
125975174|NCT00971048|453198696|FG001|Overall Study|Protocol Violation|2|||
125975175|NCT00971048|453198697|FG002|Overall Study|Protocol Violation|0|||
125975176|NCT00971048|453198698|FG003|Overall Study|Protocol Violation|1|||
125975177|NCT00971048|453198695|FG000|Overall Study|Adverse Event|0|||
125975178|NCT00971048|453198696|FG001|Overall Study|Adverse Event|0|||
125975179|NCT00971048|453198697|FG002|Overall Study|Adverse Event|1|||
125975180|NCT00971048|453198698|FG003|Overall Study|Adverse Event|0|||
125975181|NCT00971048|453198695|FG000|Overall Study|Physician Decision|0|||
125975182|NCT00971048|453198696|FG001|Overall Study|Physician Decision|0|||
125975183|NCT00971048|453198697|FG002|Overall Study|Physician Decision|0|||
125975184|NCT00971048|453198698|FG003|Overall Study|Physician Decision|1|||
125975185|NCT03321396|453198706|FG000|Overall Study|Physician Decision|1|||
125975186|NCT01540851|453198707|FG000|Overall Study|Lost to Follow-up|14|||
125975187|NCT01540851|453198708|FG001|Overall Study|Lost to Follow-up|15|||
125975188|NCT01540851|453198707|FG000|Overall Study|Withdrawal by Subject|7|||
125975189|NCT01540851|453198708|FG001|Overall Study|Withdrawal by Subject|3|||
125975190|NCT01654549|453198711|FG000|Overall Study|H.pylori eradication not successful|0|||
125975191|NCT01654549|453198712|FG001|Overall Study|H.pylori eradication not successful|1|||
125975192|NCT00937924|453198713|FG000|Overall Study|Lost to Follow-up|44|||
125975193|NCT00937924|453198714|FG001|Overall Study|Lost to Follow-up|44|||
125975194|NCT00937924|453198715|FG002|Overall Study|Lost to Follow-up|41|||
125975195|NCT00224874|453198716|FG000|Overall Study|Withdrawal by Subject|0|||
125975196|NCT00224874|453198717|FG001|Overall Study|Withdrawal by Subject|0|||
125975197|NCT00224874|453198718|FG002|Overall Study|Withdrawal by Subject|1|||
125975198|NCT00224874|453198719|FG003|Overall Study|Withdrawal by Subject|0|||
125975199|NCT05072080|453198722|FG000|Overall Study|Death|0|||
125975200|NCT05072080|453198723|FG001|Overall Study|Death|0|||
125975201|NCT05072080|453198724|FG002|Overall Study|Death|1|||
125975202|NCT05072080|453198725|FG003|Overall Study|Death|0|||
125975203|NCT05072080|453198722|FG000|Overall Study|Lost to Follow-up|65|||
125975204|NCT05072080|453198723|FG001|Overall Study|Lost to Follow-up|70|||
125975205|NCT05072080|453198724|FG002|Overall Study|Lost to Follow-up|58|||
126179676|NCT01175590|453942229|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
126179677|NCT01175590|453942230|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
125975206|NCT05072080|453198725|FG003|Overall Study|Lost to Follow-up|23|||
126179678|NCT01175590|453942229|FG000|Overall Study|Protocol Violation|0|||
125975207|NCT05072080|453198722|FG000|Overall Study|Physician Decision|2|||
125975208|NCT05072080|453198723|FG001|Overall Study|Physician Decision|1|||
125975209|NCT05072080|453198724|FG002|Overall Study|Physician Decision|1|||
125975210|NCT05072080|453198725|FG003|Overall Study|Physician Decision|0|||
125975211|NCT05072080|453198722|FG000|Overall Study|Withdrawal by Subject|45|||
125975212|NCT05072080|453198723|FG001|Overall Study|Withdrawal by Subject|30|||
125975213|NCT05072080|453198724|FG002|Overall Study|Withdrawal by Subject|27|||
125975214|NCT05072080|453198725|FG003|Overall Study|Withdrawal by Subject|7|||
125975215|NCT05072080|453198722|FG000|Overall Study|Sponsor Decision|0|||
125975216|NCT05072080|453198723|FG001|Overall Study|Sponsor Decision|1|||
125975217|NCT05072080|453198724|FG002|Overall Study|Sponsor Decision|0|||
125975218|NCT05072080|453198725|FG003|Overall Study|Sponsor Decision|0|||
125975219|NCT05072080|453198722|FG000|Overall Study|Subject moved|1|||
125975220|NCT05072080|453198723|FG001|Overall Study|Subject moved|3|||
125975221|NCT05072080|453198724|FG002|Overall Study|Subject moved|5|||
125975222|NCT05072080|453198725|FG003|Overall Study|Subject moved|2|||
125975223|NCT05072080|453198722|FG000|Overall Study|Withdrawal by parent|0|||
125975224|NCT05072080|453198723|FG001|Overall Study|Withdrawal by parent|0|||
125975225|NCT05072080|453198724|FG002|Overall Study|Withdrawal by parent|1|||
125975226|NCT05072080|453198725|FG003|Overall Study|Withdrawal by parent|0|||
125975227|NCT05072080|453198722|FG000|Overall Study|Subject was deployed|0|||
125975228|NCT05072080|453198723|FG001|Overall Study|Subject was deployed|1|||
125975229|NCT05072080|453198724|FG002|Overall Study|Subject was deployed|0|||
125975230|NCT05072080|453198725|FG003|Overall Study|Subject was deployed|0|||
125975231|NCT05072080|453198722|FG000|Overall Study|Subject left site without receiving dose|0|||
125975232|NCT05072080|453198723|FG001|Overall Study|Subject left site without receiving dose|1|||
125975233|NCT05072080|453198724|FG002|Overall Study|Subject left site without receiving dose|0|||
125975234|NCT05072080|453198725|FG003|Overall Study|Subject left site without receiving dose|0|||
125975235|NCT05072080|453198722|FG000|Overall Study|Subject incarcerated|0|||
125975236|NCT05072080|453198723|FG001|Overall Study|Subject incarcerated|1|||
125975237|NCT05072080|453198724|FG002|Overall Study|Subject incarcerated|0|||
125975238|NCT05072080|453198725|FG003|Overall Study|Subject incarcerated|1|||
125975239|NCT05072080|453198722|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
125975240|NCT05072080|453198723|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
125975241|NCT05072080|453198724|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
125975242|NCT05072080|453198725|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
125975243|NCT05072080|453198722|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
125975244|NCT05072080|453198723|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
125975245|NCT05072080|453198724|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
125975246|NCT05072080|453198725|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
125975247|NCT02633137|453198730|FG000|Overall Study|Adverse Event|1|||
125975248|NCT02633137|453198730|FG000|Overall Study|Lack of Efficacy|2|||
125975249|NCT02633137|453198730|FG000|Overall Study|Withdrawal by Subject|1|||
125975250|NCT03996473|453198733|FG000|Treatment Assignment|Withdrawal by Subject|1|||
125975251|NCT03996473|453198733|FG000|Treatment Assignment|Progressive disease|6|||
125975252|NCT03996473|453198733|FG000|Treatment Assignment|Study drug never administered|1|||
125975253|NCT03996473|453198733|FG000|Active Follow-up|Death|1|||
125975254|NCT03996473|453198733|FG000|Long-term Follow-up|Death|5|||
125975255|NCT06116591|453198734|FG000|Overall Study|No longer met eligibility criteria|0|||
125975256|NCT06116591|453198735|FG001|Overall Study|No longer met eligibility criteria|1|||
125975257|NCT06116591|453198734|FG000|Overall Study|Other: Change in life situation|0|||
125975258|NCT06116591|453198735|FG001|Overall Study|Other: Change in life situation|1|||
125975259|NCT01972841|453198736|FG000|Overall Study|Randomized but Never Received Treatment|2|||
125975260|NCT01972841|453198737|FG001|Overall Study|Randomized but Never Received Treatment|5|||
125975261|NCT01972841|453198738|FG002|Overall Study|Randomized but Never Received Treatment|4|||
125975262|NCT01972841|453198739|FG003|Overall Study|Randomized but Never Received Treatment|2|||
125975263|NCT01972841|453198740|FG004|Overall Study|Randomized but Never Received Treatment|6|||
125975264|NCT01972841|453198741|FG005|Overall Study|Randomized but Never Received Treatment|13|||
125975265|NCT01972841|453198736|FG000|Overall Study|Adverse Event|13|||
125975266|NCT01972841|453198737|FG001|Overall Study|Adverse Event|8|||
125975267|NCT01972841|453198738|FG002|Overall Study|Adverse Event|12|||
125975268|NCT01972841|453198739|FG003|Overall Study|Adverse Event|9|||
125975269|NCT01972841|453198740|FG004|Overall Study|Adverse Event|21|||
125975270|NCT01972841|453198741|FG005|Overall Study|Adverse Event|26|||
125975271|NCT01972841|453198736|FG000|Overall Study|Lack of Efficacy|1|||
125975272|NCT01972841|453198737|FG001|Overall Study|Lack of Efficacy|0|||
125975273|NCT01972841|453198738|FG002|Overall Study|Lack of Efficacy|0|||
125975274|NCT01972841|453198739|FG003|Overall Study|Lack of Efficacy|2|||
125975275|NCT01972841|453198740|FG004|Overall Study|Lack of Efficacy|4|||
125975276|NCT01972841|453198741|FG005|Overall Study|Lack of Efficacy|1|||
125975277|NCT01972841|453198736|FG000|Overall Study|Lost to Follow-up|4|||
125975278|NCT01972841|453198737|FG001|Overall Study|Lost to Follow-up|2|||
125975279|NCT01972841|453198738|FG002|Overall Study|Lost to Follow-up|4|||
125975280|NCT01972841|453198739|FG003|Overall Study|Lost to Follow-up|2|||
125975281|NCT01972841|453198740|FG004|Overall Study|Lost to Follow-up|9|||
125975282|NCT01972841|453198741|FG005|Overall Study|Lost to Follow-up|3|||
125975283|NCT01972841|453198736|FG000|Overall Study|Protocol Violation|2|||
125975284|NCT01972841|453198737|FG001|Overall Study|Protocol Violation|2|||
125975285|NCT01972841|453198738|FG002|Overall Study|Protocol Violation|3|||
125975286|NCT01972841|453198739|FG003|Overall Study|Protocol Violation|5|||
125975287|NCT01972841|453198740|FG004|Overall Study|Protocol Violation|9|||
125975288|NCT01972841|453198741|FG005|Overall Study|Protocol Violation|4|||
125975289|NCT01972841|453198736|FG000|Overall Study|Withdrawal by participants|21|||
125975290|NCT01972841|453198737|FG001|Overall Study|Withdrawal by participants|27|||
125975291|NCT01972841|453198738|FG002|Overall Study|Withdrawal by participants|23|||
125975292|NCT01972841|453198739|FG003|Overall Study|Withdrawal by participants|16|||
125975293|NCT01972841|453198740|FG004|Overall Study|Withdrawal by participants|33|||
125975294|NCT01972841|453198741|FG005|Overall Study|Withdrawal by participants|34|||
125975295|NCT01972841|453198736|FG000|Overall Study|Miscellaneous|0|||
125975296|NCT01972841|453198737|FG001|Overall Study|Miscellaneous|0|||
125975297|NCT01972841|453198738|FG002|Overall Study|Miscellaneous|4|||
125975298|NCT01972841|453198739|FG003|Overall Study|Miscellaneous|1|||
125975299|NCT01972841|453198740|FG004|Overall Study|Miscellaneous|0|||
125975300|NCT01972841|453198741|FG005|Overall Study|Miscellaneous|4|||
125975301|NCT01972841|453198736|FG000|Overall Study|Did not have end of treatment page|0|||
125975302|NCT01972841|453198737|FG001|Overall Study|Did not have end of treatment page|0|||
125975303|NCT01972841|453198738|FG002|Overall Study|Did not have end of treatment page|0|||
125975304|NCT01972841|453198739|FG003|Overall Study|Did not have end of treatment page|0|||
125975305|NCT01972841|453198740|FG004|Overall Study|Did not have end of treatment page|1|||
125975306|NCT01972841|453198741|FG005|Overall Study|Did not have end of treatment page|0|||
125975307|NCT04969198|453198744|FG000|Overall Study|Withdrawal by Subject|20|||
125975308|NCT04969198|453198744|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
125975309|NCT04969198|453198744|FG000|Overall Study|Lost to Follow-up|20|||
125975310|NCT05553808|453198748|FG000|Overall Study|Death|25|||
125975311|NCT05553808|453198749|FG001|Overall Study|Death|62|||
125975312|NCT05553808|453198748|FG000|Overall Study|Site Closed|6|||
125975313|NCT05553808|453198749|FG001|Overall Study|Site Closed|6|||
125975314|NCT05553808|453198748|FG000|Overall Study|Lost to Follow-up|1|||
125975315|NCT05553808|453198749|FG001|Overall Study|Lost to Follow-up|0|||
125975316|NCT05553808|453198748|FG000|Overall Study|Withdrawal by Subject|3|||
125975317|NCT05553808|453198749|FG001|Overall Study|Withdrawal by Subject|2|||
125975318|NCT02308748|453198757|FG000|Period 1|Withdrawal by Subject|0|||
125975319|NCT02308748|453198758|FG001|Period 1|Withdrawal by Subject|0|||
125975320|NCT02308748|453198759|FG002|Period 1|Withdrawal by Subject|1|||
125975321|NCT02308748|453198760|FG003|Period 1|Withdrawal by Subject|0|||
125975322|NCT02308748|453198761|FG004|Period 1|Withdrawal by Subject|0|||
125975323|NCT02308748|453198762|FG005|Period 1|Withdrawal by Subject|0|||
125975324|NCT02308748|453198763|FG006|Period 1|Withdrawal by Subject|0|||
125975325|NCT02308748|453198764|FG007|Period 1|Withdrawal by Subject|0|||
125975326|NCT02308748|453198765|FG008|Period 1|Withdrawal by Subject|0|||
125975327|NCT02308748|453198766|FG009|Period 1|Withdrawal by Subject|0|||
125975328|NCT02308748|453198757|FG000|Period 2|Adverse Event|0|||
125975329|NCT02308748|453198758|FG001|Period 2|Adverse Event|0|||
125975330|NCT02308748|453198759|FG002|Period 2|Adverse Event|0|||
125975331|NCT02308748|453198760|FG003|Period 2|Adverse Event|0|||
125975332|NCT02308748|453198761|FG004|Period 2|Adverse Event|0|||
125975333|NCT02308748|453198762|FG005|Period 2|Adverse Event|0|||
125975334|NCT02308748|453198763|FG006|Period 2|Adverse Event|0|||
125975335|NCT02308748|453198764|FG007|Period 2|Adverse Event|1|||
125975336|NCT02308748|453198765|FG008|Period 2|Adverse Event|0|||
125975337|NCT02308748|453198766|FG009|Period 2|Adverse Event|0|||
125975338|NCT02308748|453198757|FG000|Period 3|Protocol Violation|0|||
125975339|NCT02308748|453198758|FG001|Period 3|Protocol Violation|0|||
125975340|NCT02308748|453198759|FG002|Period 3|Protocol Violation|0|||
125975341|NCT02308748|453198760|FG003|Period 3|Protocol Violation|0|||
125975342|NCT02308748|453198761|FG004|Period 3|Protocol Violation|0|||
125975343|NCT02308748|453198762|FG005|Period 3|Protocol Violation|0|||
125975344|NCT02308748|453198763|FG006|Period 3|Protocol Violation|0|||
125975345|NCT02308748|453198764|FG007|Period 3|Protocol Violation|0|||
125975346|NCT02308748|453198765|FG008|Period 3|Protocol Violation|0|||
125975347|NCT02308748|453198766|FG009|Period 3|Protocol Violation|1|||
125975348|NCT02308748|453198757|FG000|Period 5|Adverse Event|1|||
125975349|NCT02308748|453198758|FG001|Period 5|Adverse Event|0|||
125975350|NCT02308748|453198759|FG002|Period 5|Adverse Event|0|||
125975351|NCT02308748|453198760|FG003|Period 5|Adverse Event|0|||
125975352|NCT02308748|453198761|FG004|Period 5|Adverse Event|0|||
125975353|NCT02308748|453198762|FG005|Period 5|Adverse Event|0|||
125975354|NCT02308748|453198763|FG006|Period 5|Adverse Event|0|||
125975355|NCT02308748|453198764|FG007|Period 5|Adverse Event|0|||
125975356|NCT02308748|453198765|FG008|Period 5|Adverse Event|1|||
125975357|NCT02308748|453198766|FG009|Period 5|Adverse Event|0|||
125975358|NCT05207813|453198769|FG000|Overall Study|Lost to Follow-up|2|||
125975359|NCT04988308|453198773|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
125975360|NCT04988308|453198774|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
125975361|NCT04988308|453198775|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
125975362|NCT04988308|453198776|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125975363|NCT04988308|453198777|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125975364|NCT04988308|453198778|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125975365|NCT04988308|453198773|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125975366|NCT04988308|453198774|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125975367|NCT04988308|453198775|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
125975368|NCT04988308|453198776|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125975369|NCT04988308|453198777|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
126179679|NCT01175590|453942230|FG001|Overall Study|Protocol Violation|1|||
125975370|NCT04988308|453198778|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125975371|NCT04988308|453198773|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
125975372|NCT04988308|453198774|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
125975373|NCT04988308|453198775|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
125975374|NCT04988308|453198776|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
125975375|NCT04988308|453198777|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
125975376|NCT04988308|453198778|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
125975377|NCT04988308|453198773|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
125975378|NCT04988308|453198774|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
125975379|NCT04988308|453198775|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
125975380|NCT04988308|453198776|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125975381|NCT04988308|453198777|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125975382|NCT04988308|453198778|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125975383|NCT04988308|453198773|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
125975384|NCT04988308|453198774|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
125975385|NCT04988308|453198775|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
125975386|NCT04988308|453198776|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
125975387|NCT04988308|453198777|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
125975388|NCT04988308|453198778|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
125975389|NCT04988308|453198773|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125975390|NCT04988308|453198774|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125975391|NCT04988308|453198775|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125975392|NCT04988308|453198776|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
125975393|NCT04988308|453198777|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
125975394|NCT04988308|453198778|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
125975395|NCT04988308|453198773|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125975396|NCT04988308|453198774|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125975397|NCT04988308|453198775|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125975398|NCT04988308|453198776|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
125975399|NCT04988308|453198777|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
125975400|NCT04988308|453198778|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
125975401|NCT04988308|453198773|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125975402|NCT04988308|453198774|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125975403|NCT04988308|453198775|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125975404|NCT04988308|453198776|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
125975405|NCT04988308|453198777|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
125975406|NCT04988308|453198778|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
125975407|NCT04988308|453198773|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
125975408|NCT04988308|453198774|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
125975409|NCT04988308|453198775|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
125975410|NCT04988308|453198776|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
125975411|NCT04988308|453198777|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
125975412|NCT04988308|453198778|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
125975413|NCT02625623|453198780|FG000|Overall Study|Participants randomized but not treated|9|||
125975414|NCT02625623|453198781|FG001|Overall Study|Participants randomized but not treated|1|||
125975415|NCT00808808|453198782|FG000|Overall Study|Vaccinated; survey not completed|131|||
125975416|NCT00808808|453198783|FG001|Overall Study|Vaccinated; survey not completed|169|||
125975417|NCT00808808|453198784|FG002|Overall Study|Vaccinated; survey not completed|302|||
125975418|NCT00808808|453198782|FG000|Overall Study|Employee was not vaccinated.|2686|||
125975419|NCT00808808|453198783|FG001|Overall Study|Employee was not vaccinated.|2268|||
125975420|NCT00808808|453198784|FG002|Overall Study|Employee was not vaccinated.|2255|||
125975421|NCT02352948|453198786|FG000|Overall Study|Death|47|||
125975422|NCT02352948|453198787|FG001|Overall Study|Death|48|||
125975423|NCT02352948|453198788|FG002|Overall Study|Death|114|||
125975424|NCT02352948|453198789|FG003|Overall Study|Death|74|||
125975425|NCT02352948|453198790|FG004|Overall Study|Death|77|||
125975426|NCT02352948|453198791|FG005|Overall Study|Death|44|||
125975427|NCT02352948|453198786|FG000|Overall Study|Lost to Follow-up|1|||
125975428|NCT02352948|453198787|FG001|Overall Study|Lost to Follow-up|0|||
125975429|NCT02352948|453198788|FG002|Overall Study|Lost to Follow-up|2|||
125975430|NCT02352948|453198789|FG003|Overall Study|Lost to Follow-up|1|||
125975431|NCT02352948|453198790|FG004|Overall Study|Lost to Follow-up|2|||
125975432|NCT02352948|453198791|FG005|Overall Study|Lost to Follow-up|1|||
125975433|NCT02352948|453198786|FG000|Overall Study|Withdrawal by Subject|1|||
126179680|NCT03911869|453942233|FG000|Safety Lead-in Phase|Death|7|||
125975434|NCT02352948|453198787|FG001|Overall Study|Withdrawal by Subject|10|||
125975435|NCT02352948|453198788|FG002|Overall Study|Withdrawal by Subject|11|||
126179681|NCT03911869|453942234|FG001|Safety Lead-in Phase|Death|0|||
125975436|NCT02352948|453198789|FG003|Overall Study|Withdrawal by Subject|23|||
125975437|NCT02352948|453198790|FG004|Overall Study|Withdrawal by Subject|9|||
125975438|NCT02352948|453198791|FG005|Overall Study|Withdrawal by Subject|4|||
125975439|NCT02352948|453198786|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125975440|NCT02352948|453198787|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125975441|NCT02352948|453198788|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125975442|NCT02352948|453198789|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125975443|NCT02352948|453198790|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125975444|NCT02352948|453198791|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
125975445|NCT02352948|453198786|FG000|Overall Study|Other|0|||
125975446|NCT02352948|453198787|FG001|Overall Study|Other|0|||
125975447|NCT02352948|453198788|FG002|Overall Study|Other|2|||
125975448|NCT02352948|453198789|FG003|Overall Study|Other|0|||
125975449|NCT02352948|453198790|FG004|Overall Study|Other|0|||
125975450|NCT02352948|453198791|FG005|Overall Study|Other|0|||
125975451|NCT00490646|453198792|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
125975452|NCT00490646|453198793|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
125975453|NCT00490646|453198792|FG000|Overall Study|Never Treated (had an adverse event)|1|||
125975454|NCT00490646|453198793|FG001|Overall Study|Never Treated (had an adverse event)|0|||
125975455|NCT00490646|453198792|FG000|Overall Study|Never Treated (withdrew consent)|0|||
125975456|NCT00490646|453198793|FG001|Overall Study|Never Treated (withdrew consent)|1|||
125975457|NCT01178086|453198794|FG000|Overall Study|Participant refusal|7|||
125975458|NCT01178086|453198794|FG000|Overall Study|Physician Decision|44|||
125975459|NCT01178086|453198794|FG000|Overall Study|Switch to other CLL therapy|113|||
125975460|NCT01178086|453198794|FG000|Overall Study|Death|59|||
125975461|NCT01178086|453198794|FG000|Overall Study|Other unspecified|89|||
125975462|NCT01178086|453198794|FG000|Overall Study|Excluded from EAS|20|||
125975463|NCT02313428|453198795|FG000|Overall Study|Lost to Follow-up|1|||
125975464|NCT02313428|453198796|FG001|Overall Study|Lost to Follow-up|1|||
125975465|NCT02057874|453201005|FG000|Overall Study|participant did not return for scan|1|||
125975466|NCT01258608|453201007|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
125975467|NCT01258608|453201008|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
125975468|NCT01258608|453201007|FG000|Overall Study|Clinical progression|1|||
125975469|NCT01258608|453201008|FG001|Overall Study|Clinical progression|0|||
125975470|NCT01258608|453201007|FG000|Overall Study|Sponsor decision|0|||
125975471|NCT01258608|453201008|FG001|Overall Study|Sponsor decision|1|||
125975472|NCT01258608|453201007|FG000|Overall Study|Physician Decision|6|||
125975473|NCT01258608|453201008|FG001|Overall Study|Physician Decision|1|||
125975474|NCT01258608|453201007|FG000|Overall Study|Lost to Follow-up|0|||
125975475|NCT01258608|453201008|FG001|Overall Study|Lost to Follow-up|1|||
125975476|NCT01258608|453201007|FG000|Overall Study|Lack of compliance|1|||
125975477|NCT01258608|453201008|FG001|Overall Study|Lack of compliance|0|||
125975478|NCT01258608|453201007|FG000|Overall Study|Lack of Efficacy|0|||
125975479|NCT01258608|453201008|FG001|Overall Study|Lack of Efficacy|1|||
125975480|NCT01258608|453201007|FG000|Overall Study|Adverse Event|6|||
125975481|NCT01258608|453201008|FG001|Overall Study|Adverse Event|10|||
125975482|NCT01258608|453201007|FG000|Overall Study|Withdrawal by Subject|6|||
125975483|NCT01258608|453201008|FG001|Overall Study|Withdrawal by Subject|5|||
125975484|NCT02943408|453201010|FG000|Overall Study|Lost to Follow-up|7|||
125975485|NCT02943408|453201011|FG001|Overall Study|Lost to Follow-up|1|||
125975486|NCT02943408|453201010|FG000|Overall Study|Withdrawal by Subject|0|||
125975487|NCT02943408|453201011|FG001|Overall Study|Withdrawal by Subject|1|||
125975488|NCT01621126|453201014|FG000|Overall Study|Physician Decision|6|||
125975489|NCT00886340|453201016|FG000|Overall Study|Withdrawal by Subject|0|||
125975490|NCT00886340|453201017|FG001|Overall Study|Withdrawal by Subject|7|||
125975491|NCT01949311|453201018|FG000|Overall Study|Lost to Follow-up|73|||
125975492|NCT01949311|453201018|FG000|Overall Study|Terminated by Sponsor|708|||
125975493|NCT01949311|453201018|FG000|Overall Study|Withdrawal by Subject|375|||
125975494|NCT01949311|453201018|FG000|Overall Study|Lack of Efficacy|50|||
125975495|NCT01949311|453201018|FG000|Overall Study|Protocol Deviation|34|||
125975496|NCT01949311|453201018|FG000|Overall Study|Pregnancy|20|||
125975497|NCT01949311|453201018|FG000|Overall Study|Physician Decision|9|||
125975498|NCT01949311|453201018|FG000|Overall Study|Other|4|||
126179682|NCT03911869|453942235|FG002|Safety Lead-in Phase|Death|0|||
126179683|NCT03911869|453942233|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
125975499|NCT01949311|453201018|FG000|Overall Study|Adverse Event|107|||
125975500|NCT02338154|453201019|FG000|Overall Study|Death|46|||
125975501|NCT02338154|453201019|FG000|Overall Study|Valve Implant Failure|17|||
125975502|NCT02338154|453201019|FG000|Overall Study|Valve Explant|11|||
125975503|NCT02338154|453201019|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
125975504|NCT02338154|453201019|FG000|Overall Study|Lost to Follow-up|8|||
125975505|NCT02338154|453201019|FG000|Overall Study|Other Reason|3|||
125975506|NCT02338154|453201019|FG000|Overall Study|Patients Without Exit Form|47|||
125975507|NCT02338154|453201019|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
125975508|NCT02120027|453201020|FG000|Overall Study|Adverse Event|4|||
125975509|NCT02120027|453201021|FG001|Overall Study|Adverse Event|5|||
126199928|NCT00089505|454017801|FG001|Overall Study|Protocol Violation|0|||
125975510|NCT02120027|453201020|FG000|Overall Study|Lack of Efficacy|3|||
125975511|NCT02120027|453201021|FG001|Overall Study|Lack of Efficacy|5|||
125975512|NCT02120027|453201020|FG000|Overall Study|Lost to Follow-up|5|||
125975513|NCT02120027|453201021|FG001|Overall Study|Lost to Follow-up|13|||
125975514|NCT02120027|453201020|FG000|Overall Study|Other|4|||
125975515|NCT02120027|453201021|FG001|Overall Study|Other|0|||
125975516|NCT02120027|453201020|FG000|Overall Study|Physician Decision|4|||
125975517|NCT02120027|453201021|FG001|Overall Study|Physician Decision|3|||
125975518|NCT02120027|453201020|FG000|Overall Study|Protocol Violation|18|||
125975519|NCT02120027|453201021|FG001|Overall Study|Protocol Violation|21|||
125975520|NCT02120027|453201020|FG000|Overall Study|Study terminated by Sponsor|45|||
125975521|NCT02120027|453201021|FG001|Overall Study|Study terminated by Sponsor|47|||
125975522|NCT02120027|453201020|FG000|Overall Study|Withdrawal by Subject|33|||
125975523|NCT02120027|453201021|FG001|Overall Study|Withdrawal by Subject|25|||
125975524|NCT00447057|453201026|FG000|Overall Study|Adverse Event|4|||
125975525|NCT00447057|453201027|FG001|Overall Study|Adverse Event|10|||
125975526|NCT00447057|453201028|FG002|Overall Study|Adverse Event|0|||
125975527|NCT00447057|453201029|FG003|Overall Study|Adverse Event|3|||
125975528|NCT00447057|453201026|FG000|Overall Study|Death due to study disease|6|||
125975529|NCT00447057|453201027|FG001|Overall Study|Death due to study disease|4|||
125975530|NCT00447057|453201028|FG002|Overall Study|Death due to study disease|1|||
125975531|NCT00447057|453201029|FG003|Overall Study|Death due to study disease|1|||
125975532|NCT00447057|453201026|FG000|Overall Study|Lost to Follow-up|0|||
125975533|NCT00447057|453201027|FG001|Overall Study|Lost to Follow-up|1|||
125975534|NCT00447057|453201028|FG002|Overall Study|Lost to Follow-up|0|||
125975535|NCT00447057|453201029|FG003|Overall Study|Lost to Follow-up|0|||
125975536|NCT00447057|453201026|FG000|Overall Study|Entry criteria not met|1|||
125975537|NCT00447057|453201027|FG001|Overall Study|Entry criteria not met|1|||
125975538|NCT00447057|453201028|FG002|Overall Study|Entry criteria not met|0|||
125975539|NCT00447057|453201029|FG003|Overall Study|Entry criteria not met|0|||
125975540|NCT00447057|453201026|FG000|Overall Study|Protocol Violation|0|||
125975541|NCT00447057|453201027|FG001|Overall Study|Protocol Violation|1|||
125975542|NCT00447057|453201028|FG002|Overall Study|Protocol Violation|0|||
125975543|NCT00447057|453201029|FG003|Overall Study|Protocol Violation|0|||
125975544|NCT00447057|453201026|FG000|Overall Study|Withdrawal by Subject|4|||
125975545|NCT00447057|453201027|FG001|Overall Study|Withdrawal by Subject|5|||
125975546|NCT00447057|453201028|FG002|Overall Study|Withdrawal by Subject|1|||
125975547|NCT00447057|453201029|FG003|Overall Study|Withdrawal by Subject|1|||
125975548|NCT00447057|453201026|FG000|Overall Study|Physician Decision|9|||
125975549|NCT00447057|453201027|FG001|Overall Study|Physician Decision|6|||
125975550|NCT00447057|453201028|FG002|Overall Study|Physician Decision|3|||
125975551|NCT00447057|453201029|FG003|Overall Study|Physician Decision|1|||
125975552|NCT00447057|453201026|FG000|Overall Study|Sponsor decision|1|||
125975553|NCT00447057|453201027|FG001|Overall Study|Sponsor decision|1|||
125975554|NCT00447057|453201028|FG002|Overall Study|Sponsor decision|0|||
125975555|NCT00447057|453201029|FG003|Overall Study|Sponsor decision|0|||
125975556|NCT00447057|453201026|FG000|Overall Study|Progressive disease|58|||
125975557|NCT00447057|453201027|FG001|Overall Study|Progressive disease|43|||
125975558|NCT00447057|453201028|FG002|Overall Study|Progressive disease|13|||
125975559|NCT00447057|453201029|FG003|Overall Study|Progressive disease|18|||
125975560|NCT00447057|453201026|FG000|Overall Study|Death due to adverse event|0|||
125975561|NCT00447057|453201027|FG001|Overall Study|Death due to adverse event|0|||
125975562|NCT00447057|453201028|FG002|Overall Study|Death due to adverse event|1|||
125975563|NCT00447057|453201029|FG003|Overall Study|Death due to adverse event|2|||
125975564|NCT00447057|453201026|FG000|Overall Study|Death, study drug related|0|||
125975565|NCT00447057|453201027|FG001|Overall Study|Death, study drug related|1|||
125975566|NCT00447057|453201028|FG002|Overall Study|Death, study drug related|0|||
125975567|NCT00447057|453201029|FG003|Overall Study|Death, study drug related|0|||
125975568|NCT01843192|453201030|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
125975569|NCT01843192|453201031|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
125975570|NCT01843192|453201032|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
125975571|NCT01559844|453201033|FG000|Overall Study|Consent Withdrawn|7|||
125975572|NCT01559844|453201033|FG000|Overall Study|Death|5|||
125975573|NCT01559844|453201033|FG000|Overall Study|Efficacy Failure|10|||
125975574|NCT01559844|453201033|FG000|Overall Study|No Longer A Transplant Candidate|3|||
125975575|NCT00951041|453201034|FG000|Overall Study|Withdrawal by Subject|1|||
125975576|NCT00951041|453201035|FG001|Overall Study|Withdrawal by Subject|1|||
125975577|NCT00951041|453201034|FG000|Overall Study|Lost to Follow-up|1|||
125975578|NCT00951041|453201035|FG001|Overall Study|Lost to Follow-up|0|||
125975579|NCT00951041|453201034|FG000|Overall Study|Other|3|||
125975580|NCT00951041|453201035|FG001|Overall Study|Other|0|||
125975581|NCT02314624|453201036|FG000|Overall Study|No participating patient|16|||
125975582|NCT02314624|453201037|FG001|Overall Study|No participating patient|13|||
125975583|NCT02314624|453201036|FG000|Overall Study|Participant withdrew|7|||
125975584|NCT02314624|453201037|FG001|Overall Study|Participant withdrew|2|||
125975585|NCT02314624|453201036|FG000|Overall Study|Lost to Follow-up|2|||
125975586|NCT02314624|453201037|FG001|Overall Study|Lost to Follow-up|5|||
125975587|NCT02314624|453201036|FG000|Overall Study|Dropped/Excluded by PI|6|||
125975588|NCT02314624|453201037|FG001|Overall Study|Dropped/Excluded by PI|6|||
125975589|NCT03151005|453201040|FG000|Overall Study|Lost to Follow-up|5|||
125975590|NCT03151005|453201041|FG001|Overall Study|Lost to Follow-up|5|||
125975591|NCT00605293|453201042|FG000|Overall Study|Death|2|||
125975592|NCT00605293|453201043|FG001|Overall Study|Death|1|||
125975593|NCT00605293|453201042|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125975594|NCT00605293|453201043|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125975595|NCT00605293|453201042|FG000|Overall Study|Adverse Event|1|||
125975596|NCT00605293|453201043|FG001|Overall Study|Adverse Event|0|||
125975597|NCT00605293|453201042|FG000|Overall Study|Holidays Dialysis Out|1|||
125975598|NCT00605293|453201043|FG001|Overall Study|Holidays Dialysis Out|0|||
125975599|NCT00605293|453201042|FG000|Overall Study|Blood Transfusion|7|||
125975600|NCT00605293|453201043|FG001|Overall Study|Blood Transfusion|1|||
125975601|NCT00605293|453201042|FG000|Overall Study|Renal Transplantation|3|||
125975602|NCT00605293|453201043|FG001|Overall Study|Renal Transplantation|1|||
125975603|NCT00605293|453201042|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
125975604|NCT00605293|453201043|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
125975605|NCT00605293|453201042|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
125975606|NCT00605293|453201043|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
125975607|NCT00605293|453201042|FG000|Overall Study|Principal Investigator Decision|0|||
125975608|NCT00605293|453201043|FG001|Overall Study|Principal Investigator Decision|1|||
125975609|NCT00713648|453201044|FG000|Overall Study|Adverse Event|1|||
125975610|NCT00713648|453201044|FG000|Overall Study|Unclassified|2|||
125975611|NCT00713648|453201044|FG000|Overall Study|According to Protocol|2|||
125975612|NCT00713648|453201044|FG000|Overall Study|Development of antibodies|3|||
125975613|NCT01260350|453201047|FG000|Overall Study|Lack of Efficacy|0|||
125975614|NCT01260350|453201048|FG001|Overall Study|Lack of Efficacy|0|||
125975615|NCT01260350|453201049|FG002|Overall Study|Lack of Efficacy|0|||
125975616|NCT01260350|453201050|FG003|Overall Study|Lack of Efficacy|0|||
125975617|NCT01260350|453201051|FG004|Overall Study|Lack of Efficacy|0|||
125975618|NCT01260350|453201052|FG005|Overall Study|Lack of Efficacy|0|||
125975619|NCT01260350|453201053|FG006|Overall Study|Lack of Efficacy|0|||
125975620|NCT01260350|453201054|FG007|Overall Study|Lack of Efficacy|0|||
125975621|NCT01260350|453201055|FG008|Overall Study|Lack of Efficacy|0|||
125975622|NCT01260350|453201056|FG009|Overall Study|Lack of Efficacy|0|||
125975623|NCT01260350|453201057|FG010|Overall Study|Lack of Efficacy|0|||
125975624|NCT01260350|453201058|FG011|Overall Study|Lack of Efficacy|0|||
125975625|NCT01260350|453201059|FG012|Overall Study|Lack of Efficacy|0|||
125975626|NCT01260350|453201060|FG013|Overall Study|Lack of Efficacy|0|||
125975627|NCT01260350|453201061|FG014|Overall Study|Lack of Efficacy|0|||
125975628|NCT01260350|453201062|FG015|Overall Study|Lack of Efficacy|0|||
125975629|NCT01260350|453201063|FG016|Overall Study|Lack of Efficacy|0|||
125975630|NCT01260350|453201064|FG017|Overall Study|Lack of Efficacy|1|||
125975631|NCT01260350|453201065|FG018|Overall Study|Lack of Efficacy|0|||
125975632|NCT01260350|453201066|FG019|Overall Study|Lack of Efficacy|0|||
125975633|NCT01260350|453201067|FG020|Overall Study|Lack of Efficacy|3|||
125975634|NCT01260350|453201068|FG021|Overall Study|Lack of Efficacy|0|||
125975635|NCT01260350|453201047|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975636|NCT01260350|453201048|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975637|NCT01260350|453201049|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975638|NCT01260350|453201050|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975639|NCT01260350|453201051|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975640|NCT01260350|453201052|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975641|NCT01260350|453201053|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975642|NCT01260350|453201054|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975643|NCT01260350|453201055|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
125975644|NCT01260350|453201056|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975645|NCT01260350|453201057|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975646|NCT01260350|453201058|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975647|NCT01260350|453201059|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975648|NCT01260350|453201060|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975649|NCT01260350|453201061|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975650|NCT01260350|453201062|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975651|NCT01260350|453201063|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975652|NCT01260350|453201064|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975653|NCT01260350|453201065|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975654|NCT01260350|453201066|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975655|NCT01260350|453201067|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975656|NCT01260350|453201068|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125975657|NCT04402866|453201069|FG000|Overall Study|Discontinued Prior to Treatment|0|||
125975658|NCT04402866|453201070|FG001|Overall Study|Discontinued Prior to Treatment|0|||
125975659|NCT04402866|453201071|FG002|Overall Study|Discontinued Prior to Treatment|0|||
125975660|NCT04402866|453201072|FG003|Overall Study|Discontinued Prior to Treatment|0|||
125975661|NCT04402866|453201073|FG004|Overall Study|Discontinued Prior to Treatment|2|||
125975662|NCT04402866|453201074|FG005|Overall Study|Discontinued Prior to Treatment|3|||
125975663|NCT04402866|453201069|FG000|Overall Study|Adverse Event|2|||
125975664|NCT04402866|453201070|FG001|Overall Study|Adverse Event|1|||
125975665|NCT04402866|453201071|FG002|Overall Study|Adverse Event|0|||
125975666|NCT04402866|453201072|FG003|Overall Study|Adverse Event|0|||
125975667|NCT04402866|453201073|FG004|Overall Study|Adverse Event|13|||
125975668|NCT04402866|453201074|FG005|Overall Study|Adverse Event|8|||
125975669|NCT04402866|453201069|FG000|Overall Study|Miscellaneous|0|||
125975670|NCT04402866|453201070|FG001|Overall Study|Miscellaneous|0|||
125975671|NCT04402866|453201071|FG002|Overall Study|Miscellaneous|1|||
125975672|NCT04402866|453201072|FG003|Overall Study|Miscellaneous|0|||
125975673|NCT04402866|453201073|FG004|Overall Study|Miscellaneous|0|||
125975674|NCT04402866|453201074|FG005|Overall Study|Miscellaneous|0|||
125975675|NCT04402866|453201069|FG000|Overall Study|Lost to Follow-up|0|||
125975676|NCT04402866|453201070|FG001|Overall Study|Lost to Follow-up|0|||
125975677|NCT04402866|453201071|FG002|Overall Study|Lost to Follow-up|0|||
125975678|NCT04402866|453201072|FG003|Overall Study|Lost to Follow-up|0|||
125975679|NCT04402866|453201073|FG004|Overall Study|Lost to Follow-up|0|||
125975680|NCT04402866|453201074|FG005|Overall Study|Lost to Follow-up|1|||
125975681|NCT04402866|453201069|FG000|Overall Study|Withdrawal by Subject|0|||
125975682|NCT04402866|453201070|FG001|Overall Study|Withdrawal by Subject|0|||
125975683|NCT04402866|453201071|FG002|Overall Study|Withdrawal by Subject|0|||
125975684|NCT04402866|453201072|FG003|Overall Study|Withdrawal by Subject|0|||
125975685|NCT04402866|453201073|FG004|Overall Study|Withdrawal by Subject|0|||
125975686|NCT04402866|453201074|FG005|Overall Study|Withdrawal by Subject|2|||
125975687|NCT01814371|453201075|FG000|Overall Study|Lost to Follow-up|30|||
125975688|NCT01814371|453201076|FG001|Overall Study|Lost to Follow-up|27|||
125975689|NCT02794285|453201077|FG000|Overall Study|Adverse Event|11|||
125975690|NCT02794285|453201078|FG001|Overall Study|Adverse Event|4|||
125975691|NCT02794285|453201079|FG002|Overall Study|Adverse Event|5|||
125975692|NCT02794285|453201080|FG003|Overall Study|Adverse Event|8|||
125975693|NCT02794285|453201077|FG000|Overall Study|Condition Under Investigation Improved|1|||
125975694|NCT02794285|453201078|FG001|Overall Study|Condition Under Investigation Improved|0|||
125975695|NCT02794285|453201079|FG002|Overall Study|Condition Under Investigation Improved|0|||
125975696|NCT02794285|453201080|FG003|Overall Study|Condition Under Investigation Improved|0|||
125975697|NCT02794285|453201077|FG000|Overall Study|Condition Under Investigation Worsened|0|||
125975698|NCT02794285|453201078|FG001|Overall Study|Condition Under Investigation Worsened|2|||
125975699|NCT02794285|453201079|FG002|Overall Study|Condition Under Investigation Worsened|1|||
125975700|NCT02794285|453201080|FG003|Overall Study|Condition Under Investigation Worsened|0|||
125975701|NCT02794285|453201077|FG000|Overall Study|Death|2|||
125975702|NCT02794285|453201078|FG001|Overall Study|Death|1|||
125975703|NCT02794285|453201079|FG002|Overall Study|Death|2|||
125975704|NCT02794285|453201080|FG003|Overall Study|Death|0|||
125975705|NCT02794285|453201077|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
125975706|NCT02794285|453201078|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
125975707|NCT02794285|453201079|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
125975708|NCT02794285|453201080|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
125975709|NCT02794285|453201077|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
125975710|NCT02794285|453201078|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
125975711|NCT02794285|453201079|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
125975712|NCT02794285|453201080|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
125975713|NCT02794285|453201077|FG000|Overall Study|Lack of Efficacy|10|||
125975714|NCT02794285|453201078|FG001|Overall Study|Lack of Efficacy|6|||
125975715|NCT02794285|453201079|FG002|Overall Study|Lack of Efficacy|3|||
125975716|NCT02794285|453201080|FG003|Overall Study|Lack of Efficacy|3|||
125975717|NCT02794285|453201077|FG000|Overall Study|Lost to Follow-up|5|||
125975718|NCT02794285|453201078|FG001|Overall Study|Lost to Follow-up|6|||
125975719|NCT02794285|453201079|FG002|Overall Study|Lost to Follow-up|3|||
125975720|NCT02794285|453201080|FG003|Overall Study|Lost to Follow-up|1|||
125975721|NCT02794285|453201077|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
125975722|NCT02794285|453201078|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
125975723|NCT02794285|453201079|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
126179684|NCT03911869|453942234|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
126179685|NCT03911869|453942235|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
126179686|NCT03911869|453942233|FG000|Safety Lead-in Phase|Other|1|||
125975724|NCT02794285|453201080|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
125975725|NCT02794285|453201077|FG000|Overall Study|Withdrawal by Subject|38|||
125975726|NCT02794285|453201078|FG001|Overall Study|Withdrawal by Subject|29|||
125975727|NCT02794285|453201079|FG002|Overall Study|Withdrawal by Subject|20|||
125975728|NCT02794285|453201080|FG003|Overall Study|Withdrawal by Subject|12|||
125975729|NCT02794285|453201077|FG000|Overall Study|Missing|1|||
125975730|NCT02794285|453201078|FG001|Overall Study|Missing|0|||
125975731|NCT02794285|453201079|FG002|Overall Study|Missing|0|||
125975732|NCT02794285|453201080|FG003|Overall Study|Missing|0|||
125975733|NCT02794285|453201077|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
125975734|NCT02794285|453201078|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
125975735|NCT02794285|453201079|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
125975736|NCT02794285|453201080|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
125975737|NCT02794285|453201077|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
125975738|NCT02794285|453201078|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
125975739|NCT02794285|453201079|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
125975740|NCT02794285|453201080|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
125975741|NCT03252587|453201081|FG000|Overall Study|Adverse Event|3|||
125975742|NCT03252587|453201082|FG001|Overall Study|Adverse Event|8|||
125975743|NCT03252587|453201083|FG002|Overall Study|Adverse Event|6|||
125975744|NCT03252587|453201084|FG003|Overall Study|Adverse Event|12|||
125975745|NCT03252587|453201081|FG000|Overall Study|Lack of Efficacy|7|||
125975746|NCT03252587|453201082|FG001|Overall Study|Lack of Efficacy|2|||
125975747|NCT03252587|453201083|FG002|Overall Study|Lack of Efficacy|2|||
125975748|NCT03252587|453201084|FG003|Overall Study|Lack of Efficacy|4|||
125975749|NCT03252587|453201081|FG000|Overall Study|Lost to Follow-up|2|||
125975750|NCT03252587|453201082|FG001|Overall Study|Lost to Follow-up|0|||
125975751|NCT03252587|453201083|FG002|Overall Study|Lost to Follow-up|0|||
125975752|NCT03252587|453201084|FG003|Overall Study|Lost to Follow-up|2|||
125975753|NCT03252587|453201081|FG000|Overall Study|Pregnancy|2|||
125975754|NCT03252587|453201082|FG001|Overall Study|Pregnancy|1|||
125975755|NCT03252587|453201083|FG002|Overall Study|Pregnancy|0|||
125975756|NCT03252587|453201084|FG003|Overall Study|Pregnancy|1|||
125975757|NCT03252587|453201081|FG000|Overall Study|Withdrawal by Subject|8|||
125975758|NCT03252587|453201082|FG001|Overall Study|Withdrawal by Subject|4|||
125975759|NCT03252587|453201083|FG002|Overall Study|Withdrawal by Subject|4|||
125975760|NCT03252587|453201084|FG003|Overall Study|Withdrawal by Subject|4|||
125975761|NCT03252587|453201081|FG000|Overall Study|Other Reasons|2|||
125975762|NCT03252587|453201082|FG001|Overall Study|Other Reasons|5|||
125975763|NCT03252587|453201083|FG002|Overall Study|Other Reasons|5|||
125975764|NCT03252587|453201084|FG003|Overall Study|Other Reasons|4|||
125975765|NCT04052204|453201085|FG000|Overall Study|Death|1|||
125975766|NCT04052204|453201086|FG001|Overall Study|Death|0|||
125975767|NCT04052204|453201087|FG002|Overall Study|Death|0|||
125975768|NCT04052204|453201085|FG000|Overall Study|Progressive disease|1|||
125975769|NCT04052204|453201086|FG001|Overall Study|Progressive disease|0|||
125975770|NCT04052204|453201087|FG002|Overall Study|Progressive disease|0|||
125975771|NCT04052204|453201085|FG000|Overall Study|Other|1|||
125975772|NCT04052204|453201086|FG001|Overall Study|Other|0|||
125975773|NCT04052204|453201087|FG002|Overall Study|Other|0|||
125975774|NCT00423176|453201100|FG000|Overall Study|Adverse Event|4|||
125975775|NCT00423176|453201101|FG001|Overall Study|Adverse Event|6|||
125975776|NCT00423176|453201100|FG000|Overall Study|Treatment Failure|1|||
125975777|NCT00423176|453201101|FG001|Overall Study|Treatment Failure|6|||
125975778|NCT00423176|453201100|FG000|Overall Study|Lost to Follow-up|4|||
125975779|NCT00423176|453201101|FG001|Overall Study|Lost to Follow-up|7|||
125975780|NCT00423176|453201100|FG000|Overall Study|Withdrawal by Subject|4|||
125975781|NCT00423176|453201101|FG001|Overall Study|Withdrawal by Subject|3|||
125975782|NCT00423176|453201100|FG000|Overall Study|Protocol Violation|1|||
125975783|NCT00423176|453201101|FG001|Overall Study|Protocol Violation|3|||
125975784|NCT00423176|453201100|FG000|Overall Study|Did not meet protocol eligibility|2|||
125975785|NCT00423176|453201101|FG001|Overall Study|Did not meet protocol eligibility|4|||
125975786|NCT05554237|453201102|FG000|Part 2 (7 Days)|Adverse Event|0|||
125975787|NCT05554237|453201103|FG001|Part 2 (7 Days)|Adverse Event|0|||
125975788|NCT05554237|453201104|FG002|Part 2 (7 Days)|Adverse Event|0|||
125975789|NCT05554237|453201105|FG003|Part 2 (7 Days)|Adverse Event|0|||
125975790|NCT05554237|453201106|FG004|Part 2 (7 Days)|Adverse Event|2|||
125975791|NCT05554237|453201107|FG005|Part 2 (7 Days)|Adverse Event|0|||
125975792|NCT05554237|453201108|FG006|Part 2 (7 Days)|Adverse Event|0|||
125975793|NCT05554237|453201109|FG007|Part 2 (7 Days)|Adverse Event|0|||
125975794|NCT05554237|453201110|FG008|Part 2 (7 Days)|Adverse Event|0|||
125975795|NCT05554237|453201111|FG009|Part 2 (7 Days)|Adverse Event|1|||
125975796|NCT05554237|453201112|FG010|Part 2 (7 Days)|Adverse Event|0|||
126179687|NCT03911869|453942234|FG001|Safety Lead-in Phase|Other|0|||
126179688|NCT03911869|453942235|FG002|Safety Lead-in Phase|Other|0|||
125975797|NCT05554237|453201113|FG011|Part 2 (7 Days)|Adverse Event|0|||
125975798|NCT05554237|453201114|FG012|Part 2 (7 Days)|Adverse Event|1|||
125975799|NCT05554237|453201115|FG013|Part 2 (7 Days)|Adverse Event|0|||
125975800|NCT02395042|453201116|FG000|Treatment 1 Period|Adverse Event|1|||
125975801|NCT02395042|453201117|FG001|Treatment 1 Period|Adverse Event|3|||
125975802|NCT02395042|453201118|FG002|Treatment 1 Period|Adverse Event|1|||
125975803|NCT02395042|453201116|FG000|Treatment 1 Period|Lack of Efficacy|1|||
125975804|NCT02395042|453201117|FG001|Treatment 1 Period|Lack of Efficacy|1|||
125975805|NCT02395042|453201118|FG002|Treatment 1 Period|Lack of Efficacy|0|||
125975806|NCT02395042|453201116|FG000|Treatment 1 Period|Lost to Follow-up|1|||
125975807|NCT02395042|453201117|FG001|Treatment 1 Period|Lost to Follow-up|0|||
125975808|NCT02395042|453201118|FG002|Treatment 1 Period|Lost to Follow-up|0|||
125975809|NCT02395042|453201116|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
125975810|NCT02395042|453201117|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
125975811|NCT02395042|453201118|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
126179689|NCT03911869|453942233|FG000|Phase 2|Death|0|||
125975812|NCT02395042|453201116|FG000|Treatment 2 Period|Lack of Efficacy|1|||
126179690|NCT03911869|453942234|FG001|Phase 2|Death|3|||
125975813|NCT02395042|453201117|FG001|Treatment 2 Period|Lack of Efficacy|1|||
125975814|NCT02395042|453201118|FG002|Treatment 2 Period|Lack of Efficacy|0|||
125975815|NCT02807558|453201119|FG000|Overall Study|Consent withdrawn by participant|4|||
125975816|NCT02807558|453201120|FG001|Overall Study|Consent withdrawn by participant|0|||
125975817|NCT02807558|453201121|FG002|Overall Study|Consent withdrawn by participant|4|||
125975818|NCT02807558|453201122|FG003|Overall Study|Consent withdrawn by participant|2|||
125975819|NCT02807558|453201123|FG004|Overall Study|Consent withdrawn by participant|1|||
125975820|NCT02807558|453201124|FG005|Overall Study|Consent withdrawn by participant|0|||
125975821|NCT02807558|453201119|FG000|Overall Study|Non-compliance with Study Drug|0|||
125975822|NCT02807558|453201120|FG001|Overall Study|Non-compliance with Study Drug|0|||
125975823|NCT02807558|453201121|FG002|Overall Study|Non-compliance with Study Drug|1|||
125975824|NCT02807558|453201122|FG003|Overall Study|Non-compliance with Study Drug|0|||
125975825|NCT02807558|453201123|FG004|Overall Study|Non-compliance with Study Drug|0|||
125975826|NCT02807558|453201124|FG005|Overall Study|Non-compliance with Study Drug|0|||
125975827|NCT02807558|453201119|FG000|Overall Study|Adverse Event|0|||
125975828|NCT02807558|453201120|FG001|Overall Study|Adverse Event|0|||
125975829|NCT02807558|453201121|FG002|Overall Study|Adverse Event|9|||
125975830|NCT02807558|453201122|FG003|Overall Study|Adverse Event|0|||
125975831|NCT02807558|453201123|FG004|Overall Study|Adverse Event|0|||
125975832|NCT02807558|453201124|FG005|Overall Study|Adverse Event|0|||
125975833|NCT02807558|453201119|FG000|Overall Study|Death|23|||
125975834|NCT02807558|453201120|FG001|Overall Study|Death|2|||
125975835|NCT02807558|453201121|FG002|Overall Study|Death|3|||
125975836|NCT02807558|453201122|FG003|Overall Study|Death|43|||
125975837|NCT02807558|453201123|FG004|Overall Study|Death|24|||
125975838|NCT02807558|453201124|FG005|Overall Study|Death|15|||
125975839|NCT02807558|453201119|FG000|Overall Study|Progressive Disease|0|||
125975840|NCT02807558|453201120|FG001|Overall Study|Progressive Disease|0|||
125975841|NCT02807558|453201121|FG002|Overall Study|Progressive Disease|1|||
125975842|NCT02807558|453201122|FG003|Overall Study|Progressive Disease|0|||
125975843|NCT02807558|453201123|FG004|Overall Study|Progressive Disease|0|||
125975844|NCT02807558|453201124|FG005|Overall Study|Progressive Disease|0|||
125975845|NCT02807558|453201119|FG000|Overall Study|Other than specified|1|||
125975846|NCT02807558|453201120|FG001|Overall Study|Other than specified|0|||
125975847|NCT02807558|453201121|FG002|Overall Study|Other than specified|2|||
125975848|NCT02807558|453201122|FG003|Overall Study|Other than specified|0|||
125975849|NCT02807558|453201123|FG004|Overall Study|Other than specified|1|||
125975850|NCT02807558|453201124|FG005|Overall Study|Other than specified|1|||
125975851|NCT02807558|453201119|FG000|Overall Study|Lack of Efficacy|0|||
125975852|NCT02807558|453201120|FG001|Overall Study|Lack of Efficacy|0|||
125975853|NCT02807558|453201121|FG002|Overall Study|Lack of Efficacy|9|||
125975854|NCT02807558|453201122|FG003|Overall Study|Lack of Efficacy|0|||
125975855|NCT02807558|453201123|FG004|Overall Study|Lack of Efficacy|0|||
125975856|NCT02807558|453201124|FG005|Overall Study|Lack of Efficacy|0|||
125975857|NCT04575467|453201128|FG000|Overall Study|Adverse Event|0|||
125975858|NCT04575467|453201129|FG001|Overall Study|Adverse Event|1|||
125975859|NCT04575467|453201130|FG002|Overall Study|Adverse Event|0|||
125975860|NCT04575467|453201131|FG003|Overall Study|Adverse Event|0|||
125975861|NCT01328574|453201132|FG000|Overall Study|Refused further treatment|1|||
125975862|NCT01483924|453201133|FG000|Overall Study|Withdrawal by Subject|2|||
125975863|NCT01483924|453201134|FG001|Overall Study|Withdrawal by Subject|0|||
125975864|NCT01483924|453201135|FG002|Overall Study|Withdrawal by Subject|0|||
125975865|NCT01483924|453201136|FG003|Overall Study|Withdrawal by Subject|1|||
125975866|NCT01483924|453201137|FG004|Overall Study|Withdrawal by Subject|1|||
125975867|NCT01483924|453201133|FG000|Overall Study|Adverse Event|0|||
125975868|NCT01483924|453201134|FG001|Overall Study|Adverse Event|0|||
125975869|NCT01483924|453201135|FG002|Overall Study|Adverse Event|1|||
125975870|NCT01483924|453201136|FG003|Overall Study|Adverse Event|1|||
125975871|NCT01483924|453201137|FG004|Overall Study|Adverse Event|0|||
125975872|NCT01483924|453201133|FG000|Overall Study|Non-compliance|0|||
125975873|NCT01483924|453201134|FG001|Overall Study|Non-compliance|0|||
125975874|NCT01483924|453201135|FG002|Overall Study|Non-compliance|0|||
125975875|NCT01483924|453201136|FG003|Overall Study|Non-compliance|1|||
125975876|NCT01483924|453201137|FG004|Overall Study|Non-compliance|1|||
125975877|NCT01483924|453201133|FG000|Overall Study|Sponsor concern over ECG result|0|||
125975878|NCT01483924|453201134|FG001|Overall Study|Sponsor concern over ECG result|0|||
125975879|NCT01483924|453201135|FG002|Overall Study|Sponsor concern over ECG result|0|||
125975880|NCT01483924|453201136|FG003|Overall Study|Sponsor concern over ECG result|1|||
126179691|NCT03911869|453942235|FG002|Phase 2|Death|0|||
126179692|NCT00688545|453942236|FG000|Overall Study|Lost to Follow-up|1|||
125975881|NCT01483924|453201137|FG004|Overall Study|Sponsor concern over ECG result|0|||
125975882|NCT00003298|453201138|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
125975883|NCT00003298|453201138|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
125975884|NCT00003298|453201138|FG000|Surgery|Unresectable at surgery|3|||
125975885|NCT00003298|453201138|FG000|Surgery|Progression before surgery|2|||
125975886|NCT00003298|453201138|FG000|Surgery|Unevaluable and off study|2|||
125975887|NCT00003298|453201138|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
125975888|NCT00003298|453201138|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
125975889|NCT00003298|453201138|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
125975890|NCT00003298|453201138|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
125975891|NCT00003298|453201138|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
125975892|NCT00003298|453201138|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
125975893|NCT00003298|453201138|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
125975894|NCT00003298|453201138|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
125975895|NCT00003298|453201138|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
125975896|NCT00003298|453201138|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
125975897|NCT03565887|453201148|FG000|Overall Study|Adverse Event|1|||
125975898|NCT03565887|453201149|FG001|Overall Study|Adverse Event|0|||
125975899|NCT03565887|453201148|FG000|Overall Study|Withdrawal by Subject|0|||
125975900|NCT03565887|453201149|FG001|Overall Study|Withdrawal by Subject|2|||
125975901|NCT01994954|453201151|FG000|Overall Study|Death|1|||
125975902|NCT01994954|453201152|FG001|Overall Study|Death|0|||
125975903|NCT01994954|453201151|FG000|Overall Study|Withdrawal by Subject|9|||
125975904|NCT01994954|453201152|FG001|Overall Study|Withdrawal by Subject|14|||
125975905|NCT01994954|453201151|FG000|Overall Study|Physician Decision|2|||
125975906|NCT01994954|453201152|FG001|Overall Study|Physician Decision|2|||
125975907|NCT01994954|453201151|FG000|Overall Study|Lost to Follow-up|8|||
125975908|NCT01994954|453201152|FG001|Overall Study|Lost to Follow-up|10|||
125975909|NCT01994954|453201151|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
125975910|NCT01994954|453201152|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
125975911|NCT00449176|453201153|FG000|Overall Study|Withdrawal by Subject|39|||
125975912|NCT00449176|453201154|FG001|Overall Study|Withdrawal by Subject|43|||
125975913|NCT00449176|453201155|FG002|Overall Study|Withdrawal by Subject|59|||
125975914|NCT00449176|453201153|FG000|Overall Study|Lost to Follow-up|13|||
125975915|NCT00449176|453201154|FG001|Overall Study|Lost to Follow-up|8|||
125975916|NCT00449176|453201155|FG002|Overall Study|Lost to Follow-up|12|||
125975917|NCT00449176|453201153|FG000|Overall Study|Adverse Event|51|||
125975918|NCT00449176|453201154|FG001|Overall Study|Adverse Event|107|||
125975919|NCT00449176|453201155|FG002|Overall Study|Adverse Event|15|||
125975920|NCT00449176|453201153|FG000|Overall Study|Lack of Efficacy|13|||
125975921|NCT00449176|453201154|FG001|Overall Study|Lack of Efficacy|7|||
125975922|NCT00449176|453201155|FG002|Overall Study|Lack of Efficacy|50|||
125975923|NCT00449176|453201153|FG000|Overall Study|Study drug non-compliant|14|||
125975924|NCT00449176|453201154|FG001|Overall Study|Study drug non-compliant|11|||
125975925|NCT00449176|453201155|FG002|Overall Study|Study drug non-compliant|11|||
125975926|NCT00449176|453201153|FG000|Overall Study|all other|22|||
125975927|NCT00449176|453201154|FG001|Overall Study|all other|19|||
125975928|NCT00449176|453201155|FG002|Overall Study|all other|20|||
125975929|NCT01967732|453201165|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
125975930|NCT01967732|453201166|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
125975931|NCT01967732|453201167|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
125975932|NCT01967732|453201168|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
125975933|NCT01967732|453201165|FG000|First Intervention (Day 1)|Poor venous access|0|||
125975934|NCT01967732|453201166|FG001|First Intervention (Day 1)|Poor venous access|1|||
125975935|NCT01967732|453201167|FG002|First Intervention (Day 1)|Poor venous access|0|||
125975936|NCT01967732|453201168|FG003|First Intervention (Day 1)|Poor venous access|0|||
125975937|NCT03342638|453201169|FG000|Overall Study|Withdrawal by Subject|1|||
125975938|NCT03342638|453201170|FG001|Overall Study|Withdrawal by Subject|0|||
125975939|NCT03342638|453201169|FG000|Overall Study|Physician Decision|0|||
125975940|NCT03342638|453201170|FG001|Overall Study|Physician Decision|1|||
125975941|NCT01292239|453201182|FG000|Overall Study|Other|1|||
125975942|NCT01292239|453201183|FG001|Overall Study|Other|1|||
125975943|NCT01292239|453201182|FG000|Overall Study|Withdrawal by Subject|3|||
126179693|NCT00688545|453942237|FG001|Overall Study|Lost to Follow-up|4|||
125975944|NCT01292239|453201183|FG001|Overall Study|Withdrawal by Subject|6|||
125975945|NCT00262821|453201184|FG000|Overall Study|Ineligible - wrong stage|0|||
125975946|NCT00262821|453201185|FG001|Overall Study|Ineligible - wrong stage|3|||
125975947|NCT00262821|453201184|FG000|Overall Study|Ineligible - wrong cell type|2|||
125975948|NCT00262821|453201185|FG001|Overall Study|Ineligible - wrong cell type|2|||
125975949|NCT00262821|453201184|FG000|Overall Study|Ineligible - wrong primary|0|||
125975950|NCT00262821|453201185|FG001|Overall Study|Ineligible - wrong primary|1|||
125975951|NCT00262821|453201184|FG000|Overall Study|Ineligible - inadequate pathology|1|||
126179694|NCT00688545|453942236|FG000|Overall Study|Insurance/cost of drug|0|||
126179695|NCT00688545|453942237|FG001|Overall Study|Insurance/cost of drug|1|||
126179696|NCT00688545|453942236|FG000|Overall Study|Withdrawal by Subject|2|||
125975952|NCT00262821|453201185|FG001|Overall Study|Ineligible - inadequate pathology|3|||
125975953|NCT00262821|453201184|FG000|Overall Study|Ineligible - elevated creatinine|0|||
125975954|NCT00262821|453201185|FG001|Overall Study|Ineligible - elevated creatinine|2|||
126179697|NCT00688545|453942237|FG001|Overall Study|Withdrawal by Subject|3|||
125975955|NCT00262821|453201184|FG000|Overall Study|Ineligible - required test not done|1|||
125975956|NCT00262821|453201185|FG001|Overall Study|Ineligible - required test not done|4|||
126199929|NCT00089505|454017802|FG002|Overall Study|Protocol Violation|1|||
125975957|NCT00262821|453201184|FG000|Overall Study|Inevaluable - inadequate data|0|||
125975958|NCT00262821|453201185|FG001|Overall Study|Inevaluable - inadequate data|4|||
125975959|NCT01988779|453201187|FG000|Overall Study|Withdrawal by Subject|2|||
125975960|NCT01988779|453201188|FG001|Overall Study|Withdrawal by Subject|2|||
125975961|NCT01988779|453201187|FG000|Overall Study|Protocol Violation|1|||
125975962|NCT01988779|453201188|FG001|Overall Study|Protocol Violation|0|||
125975963|NCT00377403|453201189|FG000|Overall Study|Unable to contact for telephone intervie|4|||
125975964|NCT00377403|453201190|FG001|Overall Study|Unable to contact for telephone intervie|7|||
125975965|NCT01041638|453201191|FG000|Overall Study|Adverse Event|4|||
125975966|NCT01041638|453201191|FG000|Overall Study|Death|1|||
125975967|NCT01041638|453201191|FG000|Overall Study|Lack of Efficacy|7|||
125975968|NCT01041638|453201191|FG000|Overall Study|Physician Decision|4|||
125975969|NCT01041638|453201191|FG000|Overall Study|Withdrawal by Subject|11|||
125975970|NCT01687257|453201193|FG000|Overall Study|Efficacy Failure|6|||
125975971|NCT01687257|453201194|FG001|Overall Study|Efficacy Failure|0|||
125975972|NCT01687257|453201195|FG002|Overall Study|Efficacy Failure|5|||
125975973|NCT01687257|453201193|FG000|Overall Study|Subject Withdrew Consent|1|||
125975974|NCT01687257|453201194|FG001|Overall Study|Subject Withdrew Consent|1|||
125975975|NCT01687257|453201195|FG002|Overall Study|Subject Withdrew Consent|1|||
125975976|NCT01687257|453201193|FG000|Overall Study|Adverse Event|1|||
125975977|NCT01687257|453201194|FG001|Overall Study|Adverse Event|0|||
125975978|NCT01687257|453201195|FG002|Overall Study|Adverse Event|0|||
125975979|NCT01687257|453201193|FG000|Overall Study|Investigator's Discretion|0|||
125975980|NCT01687257|453201194|FG001|Overall Study|Investigator's Discretion|3|||
125975981|NCT01687257|453201195|FG002|Overall Study|Investigator's Discretion|0|||
125975982|NCT01922076|453201197|FG000|Overall Study|Adverse Event|0|||
125975983|NCT01922076|453201198|FG001|Overall Study|Adverse Event|0|||
125975984|NCT01922076|453201199|FG002|Overall Study|Adverse Event|0|||
125975985|NCT01922076|453201200|FG003|Overall Study|Adverse Event|0|||
125975986|NCT01922076|453201201|FG004|Overall Study|Adverse Event|1|||
125975987|NCT01922076|453201202|FG005|Overall Study|Adverse Event|0|||
125975988|NCT01922076|453201203|FG006|Overall Study|Adverse Event|0|||
125975989|NCT01922076|453201197|FG000|Overall Study|Physician Decision|0|||
125975990|NCT01922076|453201198|FG001|Overall Study|Physician Decision|0|||
125975991|NCT01922076|453201199|FG002|Overall Study|Physician Decision|1|||
125975992|NCT01922076|453201200|FG003|Overall Study|Physician Decision|0|||
125975993|NCT01922076|453201201|FG004|Overall Study|Physician Decision|0|||
125975994|NCT01922076|453201202|FG005|Overall Study|Physician Decision|0|||
125975995|NCT01922076|453201203|FG006|Overall Study|Physician Decision|0|||
125975996|NCT01922076|453201197|FG000|Overall Study|Withdrawal by Subject|0|||
125975997|NCT01922076|453201198|FG001|Overall Study|Withdrawal by Subject|0|||
125975998|NCT01922076|453201199|FG002|Overall Study|Withdrawal by Subject|0|||
125975999|NCT01922076|453201200|FG003|Overall Study|Withdrawal by Subject|1|||
125976000|NCT01922076|453201201|FG004|Overall Study|Withdrawal by Subject|0|||
125976001|NCT01922076|453201202|FG005|Overall Study|Withdrawal by Subject|1|||
125976002|NCT01922076|453201203|FG006|Overall Study|Withdrawal by Subject|1|||
125976003|NCT01018394|453201206|FG000|Overall Study|Withdrawal by Subject|5|||
125976004|NCT01018394|453201207|FG001|Overall Study|Withdrawal by Subject|5|||
125976005|NCT01018394|453201206|FG000|Overall Study|Lost to Follow-up|4|||
125976006|NCT01018394|453201207|FG001|Overall Study|Lost to Follow-up|3|||
125976007|NCT00683644|453201208|FG000|Overall Study|Withdrawal by Subject|4|||
125976008|NCT00683644|453201209|FG001|Overall Study|Withdrawal by Subject|2|||
125976009|NCT00683644|453201208|FG000|Overall Study|Lost to Follow-up|1|||
125976010|NCT00683644|453201209|FG001|Overall Study|Lost to Follow-up|4|||
125976011|NCT00683644|453201208|FG000|Overall Study|Adverse Event|1|||
125976012|NCT00683644|453201209|FG001|Overall Study|Adverse Event|2|||
125976013|NCT00683644|453201208|FG000|Overall Study|Low copper, other health problems,|7|||
125976014|NCT00683644|453201209|FG001|Overall Study|Low copper, other health problems,|6|||
125976015|NCT01565707|453201210|FG000|Overall Study|Adverse Event|1|||
125976016|NCT01565707|453201211|FG001|Overall Study|Adverse Event|6|||
125976017|NCT01565707|453201212|FG002|Overall Study|Adverse Event|2|||
125976018|NCT01565707|453201213|FG003|Overall Study|Adverse Event|1|||
125976019|NCT01565707|453201210|FG000|Overall Study|Lost to Follow-up|1|||
125976020|NCT01565707|453201211|FG001|Overall Study|Lost to Follow-up|0|||
125976021|NCT01565707|453201212|FG002|Overall Study|Lost to Follow-up|0|||
125976022|NCT01565707|453201213|FG003|Overall Study|Lost to Follow-up|0|||
125976023|NCT01565707|453201210|FG000|Overall Study|Protocol Violation|1|||
125976024|NCT01565707|453201211|FG001|Overall Study|Protocol Violation|0|||
125976025|NCT01565707|453201212|FG002|Overall Study|Protocol Violation|0|||
125976026|NCT01565707|453201213|FG003|Overall Study|Protocol Violation|1|||
125976027|NCT01565707|453201210|FG000|Overall Study|Withdrawal by Subject|3|||
125976028|NCT01565707|453201211|FG001|Overall Study|Withdrawal by Subject|1|||
125976029|NCT01565707|453201212|FG002|Overall Study|Withdrawal by Subject|1|||
125976030|NCT01565707|453201213|FG003|Overall Study|Withdrawal by Subject|1|||
125976031|NCT01565707|453201210|FG000|Overall Study|Randomized but not evaluable|2|||
125976032|NCT01565707|453201211|FG001|Overall Study|Randomized but not evaluable|0|||
125976033|NCT01565707|453201212|FG002|Overall Study|Randomized but not evaluable|0|||
125976034|NCT01565707|453201213|FG003|Overall Study|Randomized but not evaluable|0|||
125976035|NCT01565707|453201210|FG000|Overall Study|Miscellaneous|1|||
125976036|NCT01565707|453201211|FG001|Overall Study|Miscellaneous|1|||
125976037|NCT01565707|453201212|FG002|Overall Study|Miscellaneous|0|||
125976038|NCT01565707|453201213|FG003|Overall Study|Miscellaneous|2|||
125976039|NCT03762473|453201214|FG000|Overall Study|Death|1|||
125976040|NCT03762473|453201215|FG001|Overall Study|Death|0|||
125976041|NCT00126438|453201216|FG000|Overall Study|Withdrawal due to adverse event|1|||
125976042|NCT00126438|453201217|FG001|Overall Study|Withdrawal due to adverse event|0|||
125976043|NCT00126438|453201216|FG000|Overall Study|Lost to Follow-up|22|||
125976044|NCT00126438|453201217|FG001|Overall Study|Lost to Follow-up|0|||
125976045|NCT00126438|453201216|FG000|Overall Study|Protocol Violation|8|||
125976046|NCT00126438|453201217|FG001|Overall Study|Protocol Violation|8|||
125976047|NCT00126438|453201216|FG000|Overall Study|Withdrawal by Subject|3|||
125976048|NCT00126438|453201217|FG001|Overall Study|Withdrawal by Subject|2|||
125976049|NCT02160314|453203295|FG000|Overall Study|Adverse Event|0|||
125976050|NCT02160314|453203296|FG001|Overall Study|Adverse Event|6|||
125976051|NCT02160314|453203295|FG000|Overall Study|Protocol Violation|0|||
125976052|NCT02160314|453203296|FG001|Overall Study|Protocol Violation|4|||
125976053|NCT02160314|453203295|FG000|Overall Study|Withdrawal by Subject|1|||
125976054|NCT02160314|453203296|FG001|Overall Study|Withdrawal by Subject|2|||
125976055|NCT02160314|453203295|FG000|Overall Study|Lost to Follow-up|0|||
125976056|NCT02160314|453203296|FG001|Overall Study|Lost to Follow-up|1|||
125976057|NCT04205630|453203304|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
125976058|NCT04205630|453203304|FG000|Overall Study|Disease clinical progression|7|||
125976059|NCT04205630|453203304|FG000|Overall Study|Withdrawal by Subject|2|||
125976060|NCT04205630|453203304|FG000|Overall Study|Adverse Event|17|||
125976061|NCT04205630|453203304|FG000|Overall Study|Other|1|||
125976062|NCT03393000|453203312|FG000|Overall Study|Death|11|||
125976063|NCT03393000|453203312|FG000|Overall Study|Withdrawal by Subject|2|||
125976064|NCT03393000|453203312|FG000|Overall Study|Physician Decision|1|||
125976065|NCT01773070|453203313|FG000|Overall Study|Withdrawal by Subject|24|||
125976066|NCT01773070|453203313|FG000|Overall Study|Lost to Follow-up|39|||
125976067|NCT01773070|453203313|FG000|Overall Study|Other|15|||
125976068|NCT01773070|453203313|FG000|Overall Study|Death (unrelated to study procedures)|3|||
125976069|NCT01471054|453203314|FG000|Overall Study|Study terminated prematurely|4|||
125976070|NCT01471054|453203315|FG001|Overall Study|Study terminated prematurely|0|||
125976071|NCT04493216|453203316|FG000|Overall Study|Study terminated by sponsor|30|||
125976072|NCT04493216|453203317|FG001|Overall Study|Study terminated by sponsor|33|||
125976073|NCT04493216|453203318|FG002|Overall Study|Study terminated by sponsor|28|||
125976074|NCT04493216|453203319|FG003|Overall Study|Study terminated by sponsor|27|||
125976075|NCT04493216|453203316|FG000|Overall Study|Withdrawal by Subject|2|||
125976076|NCT04493216|453203317|FG001|Overall Study|Withdrawal by Subject|1|||
125976077|NCT04493216|453203318|FG002|Overall Study|Withdrawal by Subject|1|||
125976078|NCT04493216|453203319|FG003|Overall Study|Withdrawal by Subject|2|||
125976079|NCT04493216|453203316|FG000|Overall Study|Protocol Violation|1|||
125976080|NCT04493216|453203317|FG001|Overall Study|Protocol Violation|2|||
125976081|NCT04493216|453203318|FG002|Overall Study|Protocol Violation|0|||
125976082|NCT04493216|453203319|FG003|Overall Study|Protocol Violation|2|||
125976083|NCT04493216|453203316|FG000|Overall Study|Physician Decision|0|||
125976084|NCT04493216|453203317|FG001|Overall Study|Physician Decision|0|||
125976085|NCT04493216|453203318|FG002|Overall Study|Physician Decision|1|||
125976086|NCT04493216|453203319|FG003|Overall Study|Physician Decision|0|||
125976087|NCT04493216|453203316|FG000|Overall Study|Lost to Follow-up|2|||
125976088|NCT04493216|453203317|FG001|Overall Study|Lost to Follow-up|1|||
125976089|NCT04493216|453203318|FG002|Overall Study|Lost to Follow-up|0|||
125976090|NCT04493216|453203319|FG003|Overall Study|Lost to Follow-up|1|||
125976091|NCT04493216|453203316|FG000|Overall Study|Adverse Event|1|||
125976092|NCT04493216|453203317|FG001|Overall Study|Adverse Event|4|||
125976093|NCT04493216|453203318|FG002|Overall Study|Adverse Event|5|||
125976094|NCT04493216|453203319|FG003|Overall Study|Adverse Event|2|||
125976095|NCT04493216|453203316|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
125976096|NCT04493216|453203317|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
125976097|NCT04493216|453203318|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
125976098|NCT04493216|453203319|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
125976099|NCT01514448|453203320|FG000|Overall Study|Death|7|||
125976100|NCT01514448|453203321|FG001|Overall Study|Death|8|||
125976101|NCT01514448|453203320|FG000|Overall Study|Withdrawal by Subject|2|||
125976102|NCT01514448|453203321|FG001|Overall Study|Withdrawal by Subject|0|||
125976103|NCT01514448|453203320|FG000|Overall Study|Lost to Follow-up|2|||
125976104|NCT01514448|453203321|FG001|Overall Study|Lost to Follow-up|0|||
125976105|NCT01514448|453203320|FG000|Overall Study|New Cancer Therapy|1|||
125976106|NCT01514448|453203321|FG001|Overall Study|New Cancer Therapy|0|||
125976107|NCT05224050|453203326|FG000|Overall Study|Withdrawal by Subject|9|||
125976108|NCT05224050|453203326|FG000|Overall Study|Lost to Follow-up|3|||
125976109|NCT01292876|453203327|FG000|Overall Study|Physician Decision|4|||
125976110|NCT01627327|453203328|FG000|Overall Study|Adverse Event|6|||
125976111|NCT01627327|453203329|FG001|Overall Study|Adverse Event|12|||
125976112|NCT01627327|453203328|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
125976113|NCT01627327|453203329|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
125976114|NCT01627327|453203328|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
125976115|NCT01627327|453203329|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
125976116|NCT01627327|453203328|FG000|Overall Study|Protocol Violation|4|||
125976117|NCT01627327|453203329|FG001|Overall Study|Protocol Violation|10|||
125976118|NCT01627327|453203328|FG000|Overall Study|Lost to Follow-up|1|||
125976119|NCT01627327|453203329|FG001|Overall Study|Lost to Follow-up|3|||
125976120|NCT01627327|453203328|FG000|Overall Study|Physician Decision|1|||
125976121|NCT01627327|453203329|FG001|Overall Study|Physician Decision|0|||
125976122|NCT01627327|453203328|FG000|Overall Study|Withdrawal by Subject|3|||
125976123|NCT01627327|453203329|FG001|Overall Study|Withdrawal by Subject|3|||
125976124|NCT04528069|453203335|FG000|Overall Study|Adverse Event|1|||
125976125|NCT04528069|453203335|FG000|Overall Study|Lost to Follow-up|1|||
125976126|NCT04528069|453203335|FG000|Overall Study|Patient Unable to Come|1|||
125976127|NCT04528069|453203335|FG000|Overall Study|Patient Unable to Attend|1|||
125976128|NCT02525874|453203338|FG000|Overall Study|Other|1|||
125976129|NCT02525874|453203338|FG000|Overall Study|Investigator Decision|1|||
125976130|NCT02525874|453203338|FG000|Overall Study|Consent withdrawn|22|||
125976131|NCT02525874|453203338|FG000|Overall Study|Non-compliance with study drug|3|||
125976132|NCT02525874|453203338|FG000|Overall Study|Adverse Event|17|||
125976133|NCT02525874|453203338|FG000|Overall Study|Lost to Follow-up|7|||
125976134|NCT02525874|453203338|FG000|Overall Study|Disease progression, defined by protocol|2|||
125976135|NCT02525874|453203338|FG000|Overall Study|Disease relapse|4|||
125976136|NCT02525874|453203338|FG000|Overall Study|Alternative Treatment for MS|2|||
125976137|NCT02525874|453203338|FG000|Overall Study|New lesions in Brain|1|||
125976138|NCT01692782|453203341|FG000|Overall Study|Adverse Event|12|||
125976139|NCT01692782|453203342|FG001|Overall Study|Adverse Event|32|||
125976140|NCT01692782|453203343|FG002|Overall Study|Adverse Event|2|||
125976141|NCT01692782|453203341|FG000|Overall Study|Lack of Efficacy|1|||
125976142|NCT01692782|453203342|FG001|Overall Study|Lack of Efficacy|2|||
125976143|NCT01692782|453203343|FG002|Overall Study|Lack of Efficacy|0|||
125976144|NCT01692782|453203341|FG000|Overall Study|Lost to Follow-up|2|||
125976145|NCT01692782|453203342|FG001|Overall Study|Lost to Follow-up|7|||
125976146|NCT01692782|453203343|FG002|Overall Study|Lost to Follow-up|1|||
125976147|NCT01692782|453203341|FG000|Overall Study|Pregnancy|1|||
125976148|NCT01692782|453203342|FG001|Overall Study|Pregnancy|0|||
125976149|NCT01692782|453203343|FG002|Overall Study|Pregnancy|0|||
125976150|NCT01692782|453203341|FG000|Overall Study|Protocol Violation|1|||
125976151|NCT01692782|453203342|FG001|Overall Study|Protocol Violation|0|||
125976152|NCT01692782|453203343|FG002|Overall Study|Protocol Violation|2|||
125976153|NCT01692782|453203341|FG000|Overall Study|Non-complance with study drug|0|||
125976154|NCT01692782|453203342|FG001|Overall Study|Non-complance with study drug|4|||
125976155|NCT01692782|453203343|FG002|Overall Study|Non-complance with study drug|1|||
125976156|NCT01692782|453203341|FG000|Overall Study|Non-compliant with study visits|0|||
125976157|NCT01692782|453203342|FG001|Overall Study|Non-compliant with study visits|0|||
125976158|NCT01692782|453203343|FG002|Overall Study|Non-compliant with study visits|1|||
125976159|NCT01692782|453203341|FG000|Overall Study|SAE not related to study drug|0|||
125976160|NCT01692782|453203342|FG001|Overall Study|SAE not related to study drug|1|||
125976161|NCT01692782|453203343|FG002|Overall Study|SAE not related to study drug|0|||
125976162|NCT01692782|453203341|FG000|Overall Study|Withdrawal by Subject|3|||
125976163|NCT01692782|453203342|FG001|Overall Study|Withdrawal by Subject|10|||
125976164|NCT01692782|453203343|FG002|Overall Study|Withdrawal by Subject|3|||
125976165|NCT03945188|453203344|FG000|Overall Study|Protocol Violation|1|||
125976166|NCT03945188|453203345|FG001|Overall Study|Protocol Violation|0|||
125976167|NCT03945188|453203344|FG000|Overall Study|Disease worsening|79|||
125976168|NCT03945188|453203345|FG001|Overall Study|Disease worsening|73|||
125976169|NCT03945188|453203344|FG000|Overall Study|Physician Decision|2|||
125976170|NCT03945188|453203345|FG001|Overall Study|Physician Decision|2|||
125976171|NCT03945188|453203344|FG000|Overall Study|Lack of Efficacy|7|||
125976172|NCT03945188|453203345|FG001|Overall Study|Lack of Efficacy|4|||
126179698|NCT00688545|453942236|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
126179699|NCT00688545|453942237|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
125976173|NCT03945188|453203344|FG000|Overall Study|Pregnancy|2|||
125976174|NCT03945188|453203345|FG001|Overall Study|Pregnancy|0|||
125976175|NCT03945188|453203344|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
125976176|NCT03945188|453203345|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
125976177|NCT03945188|453203344|FG000|Overall Study|Adverse Event|10|||
125976178|NCT03945188|453203345|FG001|Overall Study|Adverse Event|5|||
125976179|NCT03945188|453203344|FG000|Overall Study|Other|2|||
125976180|NCT03945188|453203345|FG001|Overall Study|Other|2|||
125976181|NCT03945188|453203344|FG000|Overall Study|Lost to Follow-up|1|||
125976182|NCT03945188|453203345|FG001|Overall Study|Lost to Follow-up|2|||
125976183|NCT01618162|453203364|FG000|Overall Study|Protocol Violation|13|||
125976184|NCT01618162|453203365|FG001|Overall Study|Protocol Violation|10|||
125976185|NCT01618162|453203364|FG000|Overall Study|Adverse Event|9|||
125976186|NCT01618162|453203365|FG001|Overall Study|Adverse Event|2|||
125976187|NCT01618162|453203364|FG000|Overall Study|Withdrawal Criteria|2|||
125976188|NCT01618162|453203365|FG001|Overall Study|Withdrawal Criteria|10|||
125976189|NCT01618162|453203364|FG000|Overall Study|Unclassified|14|||
125976190|NCT01618162|453203365|FG001|Overall Study|Unclassified|13|||
125976191|NCT04124926|453203366|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
125976192|NCT04124926|453203367|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
125976193|NCT04124926|453203368|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
125976194|NCT04124926|453203369|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
125976195|NCT04124926|453203370|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
125976196|NCT04124926|453203366|FG000|Healing Phase|Protocol Violation|0|||
125976197|NCT04124926|453203367|FG001|Healing Phase|Protocol Violation|1|||
125976198|NCT04124926|453203368|FG002|Healing Phase|Protocol Violation|0|||
125976199|NCT04124926|453203369|FG003|Healing Phase|Protocol Violation|0|||
125976200|NCT04124926|453203370|FG004|Healing Phase|Protocol Violation|0|||
125976201|NCT04124926|453203366|FG000|Healing Phase|Lost to Follow-up|5|||
125976202|NCT04124926|453203367|FG001|Healing Phase|Lost to Follow-up|4|||
125976203|NCT04124926|453203368|FG002|Healing Phase|Lost to Follow-up|0|||
125976204|NCT04124926|453203369|FG003|Healing Phase|Lost to Follow-up|0|||
125976205|NCT04124926|453203370|FG004|Healing Phase|Lost to Follow-up|0|||
125976206|NCT04124926|453203366|FG000|Healing Phase|Voluntary Withdrawal|10|||
125976207|NCT04124926|453203367|FG001|Healing Phase|Voluntary Withdrawal|7|||
125976208|NCT04124926|453203368|FG002|Healing Phase|Voluntary Withdrawal|0|||
125976209|NCT04124926|453203369|FG003|Healing Phase|Voluntary Withdrawal|0|||
125976210|NCT04124926|453203370|FG004|Healing Phase|Voluntary Withdrawal|0|||
125976211|NCT04124926|453203366|FG000|Healing Phase|Withdrawal of Consent|5|||
125976212|NCT04124926|453203367|FG001|Healing Phase|Withdrawal of Consent|3|||
125976213|NCT04124926|453203368|FG002|Healing Phase|Withdrawal of Consent|0|||
125976214|NCT04124926|453203369|FG003|Healing Phase|Withdrawal of Consent|0|||
125976215|NCT04124926|453203370|FG004|Healing Phase|Withdrawal of Consent|0|||
125976216|NCT04124926|453203366|FG000|Healing Phase|Miscellaneous|8|||
125976217|NCT04124926|453203367|FG001|Healing Phase|Miscellaneous|7|||
125976218|NCT04124926|453203368|FG002|Healing Phase|Miscellaneous|0|||
125976219|NCT04124926|453203369|FG003|Healing Phase|Miscellaneous|0|||
125976220|NCT04124926|453203370|FG004|Healing Phase|Miscellaneous|0|||
125976221|NCT04124926|453203366|FG000|Healing Phase|Randomized but not Treated|0|||
125976222|NCT04124926|453203367|FG001|Healing Phase|Randomized but not Treated|3|||
125976223|NCT04124926|453203368|FG002|Healing Phase|Randomized but not Treated|0|||
125976224|NCT04124926|453203369|FG003|Healing Phase|Randomized but not Treated|0|||
125976225|NCT04124926|453203370|FG004|Healing Phase|Randomized but not Treated|0|||
125976226|NCT04124926|453203366|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
125976227|NCT04124926|453203367|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
125976228|NCT04124926|453203368|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
125976229|NCT04124926|453203369|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
125976230|NCT04124926|453203370|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
125976231|NCT04124926|453203366|FG000|Maintenance Phase|Protocol Violation|0|||
125976232|NCT04124926|453203367|FG001|Maintenance Phase|Protocol Violation|0|||
125976233|NCT04124926|453203368|FG002|Maintenance Phase|Protocol Violation|3|||
125976234|NCT04124926|453203369|FG003|Maintenance Phase|Protocol Violation|0|||
125976235|NCT04124926|453203370|FG004|Maintenance Phase|Protocol Violation|0|||
125976236|NCT04124926|453203366|FG000|Maintenance Phase|Lost to Follow-up|0|||
125976237|NCT04124926|453203367|FG001|Maintenance Phase|Lost to Follow-up|0|||
125976238|NCT04124926|453203368|FG002|Maintenance Phase|Lost to Follow-up|7|||
125976239|NCT04124926|453203369|FG003|Maintenance Phase|Lost to Follow-up|8|||
125976240|NCT04124926|453203370|FG004|Maintenance Phase|Lost to Follow-up|9|||
125976241|NCT04124926|453203366|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
125976242|NCT04124926|453203367|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
125976243|NCT04124926|453203368|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
126179700|NCT01878097|453942238|FG000|Baseline|Surveys not fully completed|2497|||
126179701|NCT01878097|453942239|FG001|Baseline|Surveys not fully completed|1800|||
126179702|NCT01878097|453942238|FG000|Implementation Year 1|Surveys not fully completed|3202|||
125976244|NCT04124926|453203369|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
125976245|NCT04124926|453203370|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
125976246|NCT04124926|453203366|FG000|Maintenance Phase|Pregnancy|0|||
125976247|NCT04124926|453203367|FG001|Maintenance Phase|Pregnancy|0|||
125976248|NCT04124926|453203368|FG002|Maintenance Phase|Pregnancy|0|||
125976249|NCT04124926|453203369|FG003|Maintenance Phase|Pregnancy|1|||
125976250|NCT04124926|453203370|FG004|Maintenance Phase|Pregnancy|0|||
125976251|NCT04124926|453203366|FG000|Maintenance Phase|Lack of Efficacy|0|||
125976252|NCT04124926|453203367|FG001|Maintenance Phase|Lack of Efficacy|0|||
125976253|NCT04124926|453203368|FG002|Maintenance Phase|Lack of Efficacy|0|||
125976254|NCT04124926|453203369|FG003|Maintenance Phase|Lack of Efficacy|0|||
125976255|NCT04124926|453203370|FG004|Maintenance Phase|Lack of Efficacy|1|||
125976256|NCT04124926|453203366|FG000|Maintenance Phase|Withdrawal of Consent|0|||
125976257|NCT04124926|453203367|FG001|Maintenance Phase|Withdrawal of Consent|0|||
125976258|NCT04124926|453203368|FG002|Maintenance Phase|Withdrawal of Consent|5|||
126179703|NCT01878097|453942239|FG001|Implementation Year 1|Surveys not fully completed|2549|||
125976259|NCT04124926|453203369|FG003|Maintenance Phase|Withdrawal of Consent|5|||
125976260|NCT04124926|453203370|FG004|Maintenance Phase|Withdrawal of Consent|5|||
125976261|NCT04124926|453203366|FG000|Maintenance Phase|Miscellaneous|0|||
125976262|NCT04124926|453203367|FG001|Maintenance Phase|Miscellaneous|0|||
125976263|NCT04124926|453203368|FG002|Maintenance Phase|Miscellaneous|1|||
125976264|NCT04124926|453203369|FG003|Maintenance Phase|Miscellaneous|2|||
125976265|NCT04124926|453203370|FG004|Maintenance Phase|Miscellaneous|4|||
125976266|NCT04124926|453203366|FG000|Maintenance Phase|Randomized but not Treated|0|||
125976267|NCT04124926|453203367|FG001|Maintenance Phase|Randomized but not Treated|0|||
125976268|NCT04124926|453203368|FG002|Maintenance Phase|Randomized but not Treated|2|||
125976269|NCT04124926|453203369|FG003|Maintenance Phase|Randomized but not Treated|2|||
125976270|NCT04124926|453203370|FG004|Maintenance Phase|Randomized but not Treated|0|||
125976271|NCT04867369|453203373|FG000|Overall Study|Withdrawal by Subject|1|||
125976272|NCT04867369|453203374|FG001|Overall Study|Withdrawal by Subject|0|||
125976273|NCT04435366|453203375|FG000|Year 1 (12 Months)|Adverse Event|3|||
125976274|NCT04435366|453203376|FG001|Year 1 (12 Months)|Adverse Event|0|||
125976275|NCT04435366|453203377|FG002|Year 1 (12 Months)|Adverse Event|2|||
125976276|NCT04435366|453203375|FG000|Year 1 (12 Months)|Death|2|||
125976277|NCT04435366|453203376|FG001|Year 1 (12 Months)|Death|0|||
125976278|NCT04435366|453203377|FG002|Year 1 (12 Months)|Death|1|||
125976279|NCT04435366|453203375|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
125976280|NCT04435366|453203376|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
125976281|NCT04435366|453203377|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
125976282|NCT04435366|453203375|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
125976283|NCT04435366|453203376|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
125976284|NCT04435366|453203377|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
125976285|NCT04435366|453203375|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
125976286|NCT04435366|453203376|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
125976287|NCT04435366|453203377|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
125976288|NCT04435366|453203375|FG000|Year 1 (12 Months)|Not treated|0|||
125976289|NCT04435366|453203376|FG001|Year 1 (12 Months)|Not treated|0|||
125976290|NCT04435366|453203377|FG002|Year 1 (12 Months)|Not treated|1|||
125976291|NCT04435366|453203375|FG000|Year 2 (12 Months)|Death|1|||
125976292|NCT04435366|453203376|FG001|Year 2 (12 Months)|Death|4|||
125976293|NCT04435366|453203377|FG002|Year 2 (12 Months)|Death|6|||
125976294|NCT04435366|453203375|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
125976295|NCT04435366|453203376|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
125976296|NCT04435366|453203377|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
125976297|NCT04435366|453203375|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
125976298|NCT04435366|453203376|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
125976299|NCT04435366|453203377|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
125976300|NCT04435366|453203375|FG000|Year 2 (12 Months)|Adverse Event|2|||
125976301|NCT04435366|453203376|FG001|Year 2 (12 Months)|Adverse Event|1|||
125976302|NCT04435366|453203377|FG002|Year 2 (12 Months)|Adverse Event|6|||
125976303|NCT02477111|453203378|FG000|Overall Study|Death|28|||
125976304|NCT02477111|453203378|FG000|Overall Study|Withdrawal by Subject|19|||
125976305|NCT02477111|453203378|FG000|Overall Study|Lost to Follow-up|4|||
125976306|NCT03492281|453203383|FG000|Overall Study|Withdrawal by Subject|21|||
125976307|NCT03492281|453203384|FG001|Overall Study|Withdrawal by Subject|14|||
125976308|NCT03492281|453203385|FG002|Overall Study|Withdrawal by Subject|13|||
125976309|NCT03492281|453203383|FG000|Overall Study|Lost to Follow-up|14|||
125976310|NCT03492281|453203384|FG001|Overall Study|Lost to Follow-up|15|||
125976311|NCT03492281|453203385|FG002|Overall Study|Lost to Follow-up|10|||
125976312|NCT03492281|453203383|FG000|Overall Study|Adverse Event|6|||
125976313|NCT03492281|453203384|FG001|Overall Study|Adverse Event|8|||
125976314|NCT03492281|453203385|FG002|Overall Study|Adverse Event|13|||
125976315|NCT03492281|453203383|FG000|Overall Study|Lack of Efficacy|3|||
125976316|NCT03492281|453203384|FG001|Overall Study|Lack of Efficacy|0|||
125976317|NCT03492281|453203385|FG002|Overall Study|Lack of Efficacy|1|||
125976318|NCT03492281|453203383|FG000|Overall Study|Physician Decision|1|||
125976319|NCT03492281|453203384|FG001|Overall Study|Physician Decision|0|||
125976320|NCT03492281|453203385|FG002|Overall Study|Physician Decision|3|||
125976321|NCT03492281|453203383|FG000|Overall Study|Protocol Violation|0|||
125976322|NCT03492281|453203384|FG001|Overall Study|Protocol Violation|2|||
125976323|NCT03492281|453203385|FG002|Overall Study|Protocol Violation|1|||
125976324|NCT03492281|453203383|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
125976325|NCT03492281|453203384|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
125976326|NCT03492281|453203385|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
125976327|NCT03492281|453203383|FG000|Overall Study|Death|0|||
125976328|NCT03492281|453203384|FG001|Overall Study|Death|0|||
125976329|NCT03492281|453203385|FG002|Overall Study|Death|1|||
125976330|NCT03492281|453203383|FG000|Overall Study|Captured as Other in Database|8|||
125976331|NCT03492281|453203384|FG001|Overall Study|Captured as Other in Database|6|||
125976332|NCT03492281|453203385|FG002|Overall Study|Captured as Other in Database|3|||
125976333|NCT01506193|453203386|FG000|Overall Study|Protocol Violation|1|||
125976334|NCT01506193|453203387|FG001|Overall Study|Protocol Violation|0|||
125976335|NCT01506193|453203388|FG002|Overall Study|Protocol Violation|1|||
125976336|NCT01506193|453203386|FG000|Overall Study|Migrated/moved from study area|0|||
126179704|NCT01878097|453942238|FG000|Implementation Year 2|Surveys not fully completed|3281|||
126179705|NCT01878097|453942239|FG001|Implementation Year 2|Surveys not fully completed|2841|||
126179706|NCT01878097|453942238|FG000|Implementation Year 3|Surveys not fully completed|3494|||
126179707|NCT01878097|453942239|FG001|Implementation Year 3|Surveys not fully completed|2980|||
126179708|NCT01878097|453942238|FG000|Implementation Year 4|Surveys not fully completed|3604|||
126179709|NCT01878097|453942239|FG001|Implementation Year 4|Surveys not fully completed|3007|||
126179710|NCT00367341|453942240|FG000|Overall Study|Physician Decision|1|||
126179711|NCT00367341|453942241|FG001|Overall Study|Physician Decision|0|||
126179712|NCT00367341|453942240|FG000|Overall Study|Protocol Violation|1|||
126179713|NCT00367341|453942241|FG001|Overall Study|Protocol Violation|0|||
126179714|NCT02786836|453942245|FG000|Overall Study|Death|1|||
126179715|NCT02786836|453942245|FG000|Overall Study|Lack of Efficacy|2|||
126179716|NCT02786836|453942245|FG000|Overall Study|Protocol Violation|3|||
126179717|NCT02786836|453942245|FG000|Overall Study|Withdrawal by Subject|3|||
126179718|NCT02786836|453942245|FG000|Overall Study|Liver Transplantation|2|||
126179719|NCT02786836|453942245|FG000|Overall Study|Device or Pharmacy Issues|3|||
126179720|NCT01143714|453942247|FG000|Overall Study|Adverse Event|4|||
126179721|NCT01143714|453942248|FG001|Overall Study|Adverse Event|2|||
126179722|NCT01143714|453942247|FG000|Overall Study|Withdrawal by Subject|1|||
126179723|NCT01143714|453942248|FG001|Overall Study|Withdrawal by Subject|0|||
126179724|NCT01143714|453942247|FG000|Overall Study|Subject non-compliance|0|||
126179725|NCT01143714|453942248|FG001|Overall Study|Subject non-compliance|1|||
126179726|NCT01143714|453942247|FG000|Overall Study|wound closed = deemed healed|1|||
126179727|NCT01143714|453942248|FG001|Overall Study|wound closed = deemed healed|0|||
126179728|NCT01143714|453942247|FG000|Overall Study|wound size increased|1|||
126179729|NCT01143714|453942248|FG001|Overall Study|wound size increased|0|||
126179730|NCT01387074|453942249|FG000|Overall Study|Lost to Follow-up|7|||
126179731|NCT01387074|453942249|FG000|Overall Study|Lack of Efficacy|1|||
125976337|NCT01506193|453203387|FG001|Overall Study|Migrated/moved from study area|0|||
125976338|NCT01506193|453203388|FG002|Overall Study|Migrated/moved from study area|1|||
125976339|NCT01506193|453203386|FG000|Overall Study|Adverse event, non-fatal|0|||
125976340|NCT01506193|453203387|FG001|Overall Study|Adverse event, non-fatal|0|||
125976341|NCT01506193|453203388|FG002|Overall Study|Adverse event, non-fatal|1|||
125976342|NCT01506193|453203386|FG000|Overall Study|Withdrawal by Subject|5|||
125976343|NCT01506193|453203387|FG001|Overall Study|Withdrawal by Subject|1|||
125976344|NCT01506193|453203388|FG002|Overall Study|Withdrawal by Subject|8|||
125976345|NCT01506193|453203386|FG000|Overall Study|Lost to Follow-up|8|||
125976346|NCT01506193|453203387|FG001|Overall Study|Lost to Follow-up|3|||
125976347|NCT01506193|453203388|FG002|Overall Study|Lost to Follow-up|3|||
125976348|NCT01454583|453203389|FG000|1st Year|Lost to Follow-up|1057|||
125976349|NCT01454583|453203390|FG001|1st Year|Lost to Follow-up|318|||
125976350|NCT01454583|453203391|FG002|1st Year|Lost to Follow-up|180|||
125976351|NCT01454583|453203389|FG000|2nd Year|Lost to Follow-up|3965|||
125976352|NCT01454583|453203390|FG001|2nd Year|Lost to Follow-up|1049|||
125976353|NCT01454583|453203391|FG002|2nd Year|Lost to Follow-up|737|||
125976354|NCT01454583|453203389|FG000|3rd Year|Lost to Follow-up|1959|||
125976355|NCT01454583|453203390|FG001|3rd Year|Lost to Follow-up|512|||
125976356|NCT01454583|453203391|FG002|3rd Year|Lost to Follow-up|297|||
125976357|NCT02677116|453203392|FG000|Overall Study|Adverse Event|0|||
125976358|NCT02677116|453203393|FG001|Overall Study|Adverse Event|1|||
125976359|NCT02677116|453203394|FG002|Overall Study|Adverse Event|0|||
125976360|NCT02677116|453203395|FG003|Overall Study|Adverse Event|0|||
125976361|NCT02677116|453203396|FG004|Overall Study|Adverse Event|0|||
125976362|NCT02677116|453203397|FG005|Overall Study|Adverse Event|1|||
125976363|NCT02677116|453203398|FG006|Overall Study|Adverse Event|1|||
125976364|NCT02677116|453203399|FG007|Overall Study|Adverse Event|0|||
125976365|NCT02677116|453203400|FG008|Overall Study|Adverse Event|0|||
125976366|NCT02677116|453203392|FG000|Overall Study|Physician Decision|0|||
125976367|NCT02677116|453203393|FG001|Overall Study|Physician Decision|2|||
125976368|NCT02677116|453203394|FG002|Overall Study|Physician Decision|3|||
125976369|NCT02677116|453203395|FG003|Overall Study|Physician Decision|2|||
125976370|NCT02677116|453203396|FG004|Overall Study|Physician Decision|1|||
125976371|NCT02677116|453203397|FG005|Overall Study|Physician Decision|3|||
125976372|NCT02677116|453203398|FG006|Overall Study|Physician Decision|1|||
125976373|NCT02677116|453203399|FG007|Overall Study|Physician Decision|1|||
125976374|NCT02677116|453203400|FG008|Overall Study|Physician Decision|2|||
125976375|NCT02677116|453203392|FG000|Overall Study|Withdrawal by parent or guardian|2|||
125976376|NCT02677116|453203393|FG001|Overall Study|Withdrawal by parent or guardian|1|||
125976377|NCT02677116|453203394|FG002|Overall Study|Withdrawal by parent or guardian|0|||
125976378|NCT02677116|453203395|FG003|Overall Study|Withdrawal by parent or guardian|1|||
125976379|NCT02677116|453203396|FG004|Overall Study|Withdrawal by parent or guardian|0|||
125976380|NCT02677116|453203397|FG005|Overall Study|Withdrawal by parent or guardian|0|||
125976381|NCT02677116|453203398|FG006|Overall Study|Withdrawal by parent or guardian|2|||
126179732|NCT03892707|453942255|FG000|Overall Study|Screen failure|6|||
126179733|NCT03892707|453942256|FG001|Overall Study|Screen failure|0|||
126179734|NCT03892707|453942255|FG000|Overall Study|Pain resolution|0|||
126179735|NCT03892707|453942256|FG001|Overall Study|Pain resolution|4|||
125976382|NCT02677116|453203399|FG007|Overall Study|Withdrawal by parent or guardian|1|||
125976383|NCT02677116|453203400|FG008|Overall Study|Withdrawal by parent or guardian|0|||
125976384|NCT02677116|453203392|FG000|Overall Study|Withdrawal by Subject|1|||
125976385|NCT02677116|453203393|FG001|Overall Study|Withdrawal by Subject|0|||
125976386|NCT02677116|453203394|FG002|Overall Study|Withdrawal by Subject|0|||
125976387|NCT02677116|453203395|FG003|Overall Study|Withdrawal by Subject|0|||
125976388|NCT02677116|453203396|FG004|Overall Study|Withdrawal by Subject|0|||
125976389|NCT02677116|453203397|FG005|Overall Study|Withdrawal by Subject|0|||
125976390|NCT02677116|453203398|FG006|Overall Study|Withdrawal by Subject|0|||
125976391|NCT02677116|453203399|FG007|Overall Study|Withdrawal by Subject|0|||
125976392|NCT02677116|453203400|FG008|Overall Study|Withdrawal by Subject|0|||
125976393|NCT03182868|453203401|FG000|Overall Study|Protocol Violation|3|||
125976394|NCT03182868|453203402|FG001|Overall Study|Protocol Violation|0|||
125976395|NCT03182868|453203403|FG002|Overall Study|Protocol Violation|4|||
125976396|NCT03182868|453203404|FG003|Overall Study|Protocol Violation|1|||
125976397|NCT03182868|453203405|FG004|Overall Study|Protocol Violation|8|||
125976398|NCT02363946|453203406|FG000|Overall Study|Lost to Follow-up|0|||
125976399|NCT02363946|453203407|FG001|Overall Study|Lost to Follow-up|0|||
125976400|NCT02363946|453203408|FG002|Overall Study|Lost to Follow-up|0|||
125976401|NCT02363946|453203409|FG003|Overall Study|Lost to Follow-up|0|||
125976402|NCT02363946|453203410|FG004|Overall Study|Lost to Follow-up|0|||
125976403|NCT02363946|453203411|FG005|Overall Study|Lost to Follow-up|0|||
125976404|NCT02363946|453203412|FG006|Overall Study|Lost to Follow-up|0|||
125976405|NCT02363946|453203413|FG007|Overall Study|Lost to Follow-up|1|||
125976406|NCT02363946|453203414|FG008|Overall Study|Lost to Follow-up|0|||
125976407|NCT02363946|453203415|FG009|Overall Study|Lost to Follow-up|0|||
125976408|NCT02363946|453203416|FG010|Overall Study|Lost to Follow-up|0|||
125976409|NCT02363946|453203417|FG011|Overall Study|Lost to Follow-up|0|||
125976410|NCT02363946|453203418|FG012|Overall Study|Lost to Follow-up|0|||
125976411|NCT00113568|453203423|FG000|Overall Study|Adverse Event|97|||
125976412|NCT00113568|453203423|FG000|Overall Study|Death|1|||
125976413|NCT00113568|453203423|FG000|Overall Study|Lack of Efficacy|30|||
125976414|NCT00113568|453203423|FG000|Overall Study|Lost to Follow-up|156|||
125976415|NCT00113568|453203423|FG000|Overall Study|Protocol Violation|32|||
125976416|NCT00113568|453203423|FG000|Overall Study|Withdrawal by Subject|117|||
125976417|NCT00113568|453203423|FG000|Overall Study|Other|112|||
125976418|NCT00584727|453203424|FG000|First Intervention|Discontinuation|0|||
125976419|NCT00584727|453203425|FG001|First Intervention|Discontinuation|0|||
125976420|NCT00584727|453203426|FG002|First Intervention|Discontinuation|1|||
125976421|NCT00584727|453203427|FG003|First Intervention|Discontinuation|0|||
125976422|NCT00584727|453203428|FG004|First Intervention|Discontinuation|0|||
125976423|NCT00584727|453203429|FG005|First Intervention|Discontinuation|0|||
125976424|NCT00584727|453203424|FG000|Third Intervention|Protocol Violation|0|||
125976425|NCT00584727|453203425|FG001|Third Intervention|Protocol Violation|0|||
125976426|NCT00584727|453203426|FG002|Third Intervention|Protocol Violation|1|||
125976427|NCT00584727|453203427|FG003|Third Intervention|Protocol Violation|0|||
125976428|NCT00584727|453203428|FG004|Third Intervention|Protocol Violation|4|||
125976429|NCT00584727|453203429|FG005|Third Intervention|Protocol Violation|2|||
125976430|NCT00736645|453203431|FG000|Overall Study|Adverse Event|0|||
125976431|NCT00736645|453203432|FG001|Overall Study|Adverse Event|2|||
125976432|NCT00736645|453203433|FG002|Overall Study|Adverse Event|0|||
125976433|NCT00736645|453203434|FG003|Overall Study|Adverse Event|0|||
125976434|NCT00295022|453203437|FG000|Overall Study|Adverse Event|1|||
125976435|NCT00295022|453203438|FG001|Overall Study|Adverse Event|1|||
125976436|NCT00295022|453203439|FG002|Overall Study|Adverse Event|2|||
125976437|NCT00295022|453203437|FG000|Overall Study|Lost to Follow-up|0|||
125976438|NCT00295022|453203438|FG001|Overall Study|Lost to Follow-up|0|||
125976439|NCT00295022|453203439|FG002|Overall Study|Lost to Follow-up|1|||
126179736|NCT03892707|453942255|FG000|Overall Study|Withdrawal by Subject|0|||
125976440|NCT00295022|453203437|FG000|Overall Study|Withdrawal by Subject|0|||
125976441|NCT00295022|453203438|FG001|Overall Study|Withdrawal by Subject|0|||
125976442|NCT00295022|453203439|FG002|Overall Study|Withdrawal by Subject|2|||
125976443|NCT00734630|453203440|FG000|Overall Study|Lack of Efficacy|4|||
125976444|NCT00734630|453203441|FG001|Overall Study|Lack of Efficacy|4|||
125976445|NCT00734630|453203440|FG000|Overall Study|Withdrawal by Subject|7|||
125976446|NCT00734630|453203441|FG001|Overall Study|Withdrawal by Subject|9|||
125976447|NCT00734630|453203440|FG000|Overall Study|Lost to Follow-up|13|||
125976448|NCT00734630|453203441|FG001|Overall Study|Lost to Follow-up|7|||
125976449|NCT00734630|453203440|FG000|Overall Study|Protocol Violation|0|||
125976450|NCT00734630|453203441|FG001|Overall Study|Protocol Violation|3|||
125976451|NCT00734630|453203440|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
125976452|NCT00734630|453203441|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
126179737|NCT03892707|453942256|FG001|Overall Study|Withdrawal by Subject|1|||
126179738|NCT03892707|453942255|FG000|Overall Study|Other (long business trip)|0|||
125976453|NCT00734630|453203440|FG000|Overall Study|Adverse Event|3|||
125976454|NCT00734630|453203441|FG001|Overall Study|Adverse Event|6|||
125976455|NCT00734630|453203440|FG000|Overall Study|Randomized in Error|0|||
125976456|NCT00734630|453203441|FG001|Overall Study|Randomized in Error|1|||
125976457|NCT00734630|453203440|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
125976458|NCT00734630|453203441|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
125976459|NCT00734630|453203440|FG000|Overall Study|Poor Compliance|1|||
125976460|NCT00734630|453203441|FG001|Overall Study|Poor Compliance|1|||
125976461|NCT03240692|453203442|FG000|Overall Study|Physician Decision|1|||
125976462|NCT03240692|453203442|FG000|Overall Study|Withdrawal by Subject|1|||
125976463|NCT04123067|453203444|FG000|Overall Study|Lost to Follow-up|0|||
125976464|NCT04123067|453203445|FG001|Overall Study|Lost to Follow-up|1|||
125976465|NCT00827918|453203446|FG000|Overall Study|Adverse Event|4|||
125976466|NCT00827918|453203447|FG001|Overall Study|Adverse Event|0|||
125976467|NCT00827918|453203448|FG002|Overall Study|Adverse Event|0|||
125976468|NCT00827918|453203446|FG000|Overall Study|Lack of Efficacy|16|||
125976469|NCT00827918|453203447|FG001|Overall Study|Lack of Efficacy|4|||
125976470|NCT00827918|453203448|FG002|Overall Study|Lack of Efficacy|15|||
125976471|NCT00827918|453203446|FG000|Overall Study|Physician Decision|1|||
125976472|NCT00827918|453203447|FG001|Overall Study|Physician Decision|0|||
125976473|NCT00827918|453203448|FG002|Overall Study|Physician Decision|0|||
125976474|NCT00827918|453203446|FG000|Overall Study|Pregnancy|0|||
125976475|NCT00827918|453203447|FG001|Overall Study|Pregnancy|1|||
125976476|NCT00827918|453203448|FG002|Overall Study|Pregnancy|0|||
125976477|NCT00827918|453203446|FG000|Overall Study|Progressive Disease|1|||
125976478|NCT00827918|453203447|FG001|Overall Study|Progressive Disease|1|||
125976479|NCT00827918|453203448|FG002|Overall Study|Progressive Disease|0|||
125976480|NCT00827918|453203446|FG000|Overall Study|Protocol Violation|0|||
125976481|NCT00827918|453203447|FG001|Overall Study|Protocol Violation|1|||
125976482|NCT00827918|453203448|FG002|Overall Study|Protocol Violation|0|||
125976483|NCT00827918|453203446|FG000|Overall Study|Withdrawal by Subject|6|||
125976484|NCT00827918|453203447|FG001|Overall Study|Withdrawal by Subject|2|||
125976485|NCT00827918|453203448|FG002|Overall Study|Withdrawal by Subject|6|||
125976486|NCT00127101|453203451|FG000|Base Protocol|Adverse Event|0|||
125976487|NCT00127101|453203452|FG001|Base Protocol|Adverse Event|2|||
125976488|NCT00127101|453203453|FG002|Base Protocol|Adverse Event|1|||
125976489|NCT00127101|453203454|FG003|Base Protocol|Adverse Event|0|||
125976490|NCT00127101|453203455|FG004|Base Protocol|Adverse Event|0|||
125976491|NCT00127101|453203456|FG005|Base Protocol|Adverse Event|0|||
125976492|NCT00127101|453203451|FG000|Base Protocol|Lack of Efficacy|1|||
125976493|NCT00127101|453203452|FG001|Base Protocol|Lack of Efficacy|0|||
125976494|NCT00127101|453203453|FG002|Base Protocol|Lack of Efficacy|0|||
125976495|NCT00127101|453203454|FG003|Base Protocol|Lack of Efficacy|0|||
125976496|NCT00127101|453203455|FG004|Base Protocol|Lack of Efficacy|2|||
125976497|NCT00127101|453203456|FG005|Base Protocol|Lack of Efficacy|0|||
125976498|NCT00127101|453203451|FG000|Base Protocol|Withdrawal by Subject|1|||
125976499|NCT00127101|453203452|FG001|Base Protocol|Withdrawal by Subject|2|||
125976500|NCT00127101|453203453|FG002|Base Protocol|Withdrawal by Subject|1|||
125976501|NCT00127101|453203454|FG003|Base Protocol|Withdrawal by Subject|0|||
125976502|NCT00127101|453203455|FG004|Base Protocol|Withdrawal by Subject|0|||
125976503|NCT00127101|453203456|FG005|Base Protocol|Withdrawal by Subject|1|||
125976504|NCT00127101|453203451|FG000|Continuation Phase|Adverse Event|0|||
125976505|NCT00127101|453203452|FG001|Continuation Phase|Adverse Event|0|||
125976506|NCT00127101|453203453|FG002|Continuation Phase|Adverse Event|0|||
125976507|NCT00127101|453203454|FG003|Continuation Phase|Adverse Event|0|||
125976508|NCT00127101|453203455|FG004|Continuation Phase|Adverse Event|1|||
125976509|NCT00127101|453203456|FG005|Continuation Phase|Adverse Event|1|||
125976510|NCT00127101|453203451|FG000|Continuation Phase|Lack of Efficacy|0|||
125976511|NCT00127101|453203452|FG001|Continuation Phase|Lack of Efficacy|0|||
125976512|NCT00127101|453203453|FG002|Continuation Phase|Lack of Efficacy|0|||
125976513|NCT00127101|453203454|FG003|Continuation Phase|Lack of Efficacy|0|||
125976514|NCT00127101|453203455|FG004|Continuation Phase|Lack of Efficacy|0|||
125976515|NCT00127101|453203456|FG005|Continuation Phase|Lack of Efficacy|1|||
125976516|NCT00127101|453203451|FG000|Continuation Phase|Withdrawal by Subject|0|||
125976517|NCT00127101|453203452|FG001|Continuation Phase|Withdrawal by Subject|0|||
125976518|NCT00127101|453203453|FG002|Continuation Phase|Withdrawal by Subject|1|||
125976519|NCT00127101|453203454|FG003|Continuation Phase|Withdrawal by Subject|0|||
125976520|NCT00127101|453203455|FG004|Continuation Phase|Withdrawal by Subject|2|||
125976521|NCT00127101|453203456|FG005|Continuation Phase|Withdrawal by Subject|1|||
125976522|NCT00843167|453203457|FG000|Treatment Period|Adverse Event|1|||
125976523|NCT00843167|453203458|FG001|Treatment Period|Adverse Event|5|||
125976524|NCT00843167|453203457|FG000|Treatment Period|Withdrawal by Subject|2|||
125976525|NCT00843167|453203458|FG001|Treatment Period|Withdrawal by Subject|3|||
125976526|NCT02137369|453203459|FG000|Overall Study|Withdrawal by Subject|3|||
125976527|NCT02137369|453203460|FG001|Overall Study|Withdrawal by Subject|2|||
125976528|NCT02137369|453203459|FG000|Overall Study|Adverse Event|2|||
125976529|NCT02137369|453203460|FG001|Overall Study|Adverse Event|0|||
125976530|NCT02137369|453203459|FG000|Overall Study|Lost to Follow-up|1|||
125976531|NCT02137369|453203460|FG001|Overall Study|Lost to Follow-up|0|||
125976532|NCT02137369|453203459|FG000|Overall Study|Moved away|2|||
125976533|NCT02137369|453203460|FG001|Overall Study|Moved away|0|||
125976534|NCT01389973|453203466|FG000|Overall Study|Lost to Follow-up|1|||
125976535|NCT01389973|453203466|FG000|Overall Study|Trial Stopped by Sponsor|9|||
125976536|NCT01389973|453203466|FG000|Overall Study|Other|10|||
125976537|NCT02626780|453203467|FG000|Overall Study|Withdrawal by Subject|3|||
125976538|NCT03456700|453203468|FG000|Overall Study|Withdrawal by Subject|1|||
125976539|NCT04154787|453203469|FG000|Overall Study|Adverse Event|0|||
125976540|NCT04154787|453203470|FG001|Overall Study|Adverse Event|1|||
125976541|NCT04154787|453203471|FG002|Overall Study|Adverse Event|0|||
125976542|NCT04154787|453203469|FG000|Overall Study|Patient Requires Other Treatment|0|||
125976543|NCT04154787|453203470|FG001|Overall Study|Patient Requires Other Treatment|1|||
125976544|NCT04154787|453203471|FG002|Overall Study|Patient Requires Other Treatment|0|||
125976545|NCT04154787|453203469|FG000|Overall Study|Study Terminated By Sponsor|0|||
125976546|NCT04154787|453203470|FG001|Overall Study|Study Terminated By Sponsor|6|||
125976547|NCT04154787|453203471|FG002|Overall Study|Study Terminated By Sponsor|1|||
125976548|NCT04154787|453203469|FG000|Overall Study|Subject Decision|0|||
125976549|NCT04154787|453203470|FG001|Overall Study|Subject Decision|1|||
125976550|NCT04154787|453203471|FG002|Overall Study|Subject Decision|0|||
125976551|NCT04154787|453203469|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
125976552|NCT04154787|453203470|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
125976553|NCT04154787|453203471|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
125976554|NCT02858895|453203474|FG000|Overall Study|Disease progression|31|||
125976555|NCT02858895|453203474|FG000|Overall Study|Death|2|||
125976556|NCT02858895|453203474|FG000|Overall Study|Adverse Event|1|||
125976557|NCT02858895|453203474|FG000|Overall Study|Withdrawal by Subject|3|||
125976558|NCT02858895|453203474|FG000|Overall Study|hospice,|1|||
125976559|NCT02858895|453203474|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
125976560|NCT02277444|453203486|FG000|Overall Study|Adverse Event|10|||
125976561|NCT02277444|453203486|FG000|Overall Study|Withdrawal by Subject|3|||
125976562|NCT02277444|453203486|FG000|Overall Study|Other|1|||
125976563|NCT02277444|453203486|FG000|Overall Study|Enrolled and not Treated|3|||
125976564|NCT02277444|453203486|FG000|Overall Study|Ongoing|113|||
125976565|NCT04918784|453205796|FG000|Overall Study|Amputation - no longer eligible|1|||
125976566|NCT04918784|453205797|FG001|Overall Study|Amputation - no longer eligible|2|||
125976567|NCT04918784|453205796|FG000|Overall Study|Death|1|||
125976568|NCT04918784|453205797|FG001|Overall Study|Death|0|||
125976569|NCT04918784|453205796|FG000|Overall Study|patient non-compliance|3|||
125976570|NCT04918784|453205797|FG001|Overall Study|patient non-compliance|1|||
125976571|NCT04918784|453205796|FG000|Overall Study|Adverse Event|1|||
125976572|NCT04918784|453205797|FG001|Overall Study|Adverse Event|0|||
125976573|NCT01712009|453205798|FG000|Overall Study|Withdrawal by Subject|24|||
125976574|NCT01712009|453205799|FG001|Overall Study|Withdrawal by Subject|15|||
125976575|NCT01712009|453205800|FG002|Overall Study|Withdrawal by Subject|8|||
125976576|NCT01712009|453205798|FG000|Overall Study|Lost to Follow-up|2|||
125976577|NCT01712009|453205799|FG001|Overall Study|Lost to Follow-up|0|||
125976578|NCT01712009|453205800|FG002|Overall Study|Lost to Follow-up|1|||
125976579|NCT01712009|453205798|FG000|Overall Study|Decision by Sponsor|12|||
125976580|NCT01712009|453205799|FG001|Overall Study|Decision by Sponsor|14|||
125976581|NCT01712009|453205800|FG002|Overall Study|Decision by Sponsor|12|||
125976582|NCT00593567|453205801|FG000|Overall Study|Adverse Event|2|||
125976583|NCT00593567|453205802|FG001|Overall Study|Adverse Event|0|||
125976584|NCT00593567|453205801|FG000|Overall Study|Physician Decision|2|||
125976585|NCT00593567|453205802|FG001|Overall Study|Physician Decision|0|||
125976586|NCT00593567|453205801|FG000|Overall Study|Protocol Violation|13|||
125976587|NCT00593567|453205802|FG001|Overall Study|Protocol Violation|7|||
125976588|NCT00593567|453205801|FG000|Overall Study|Lack of Efficacy|2|||
125976589|NCT00593567|453205802|FG001|Overall Study|Lack of Efficacy|1|||
125976590|NCT00593567|453205801|FG000|Overall Study|Withdrawal by Subject|1|||
125976591|NCT00593567|453205802|FG001|Overall Study|Withdrawal by Subject|2|||
125976592|NCT00590902|453205805|FG000|Overall Study|Death|1|||
125976593|NCT00785291|453205807|FG000|Overall Study|Never began treatment|8|||
125976594|NCT00785291|453205808|FG001|Overall Study|Never began treatment|4|||
125976595|NCT00785291|453205809|FG002|Overall Study|Never began treatment|4|||
125976596|NCT00785291|453205807|FG000|Overall Study|Adverse Event|39|||
125976597|NCT00785291|453205808|FG001|Overall Study|Adverse Event|70|||
125976598|NCT00785291|453205809|FG002|Overall Study|Adverse Event|56|||
125976599|NCT00785291|453205807|FG000|Overall Study|Death|7|||
125976600|NCT00785291|453205808|FG001|Overall Study|Death|4|||
125976601|NCT00785291|453205809|FG002|Overall Study|Death|3|||
125976602|NCT00785291|453205807|FG000|Overall Study|Withdrawal by Subject|35|||
126179739|NCT03892707|453942256|FG001|Overall Study|Other (long business trip)|1|||
125976603|NCT00785291|453205808|FG001|Overall Study|Withdrawal by Subject|36|||
125976604|NCT00785291|453205809|FG002|Overall Study|Withdrawal by Subject|17|||
125976605|NCT00785291|453205807|FG000|Overall Study|Alternative Therapy|12|||
125976606|NCT00785291|453205808|FG001|Overall Study|Alternative Therapy|6|||
125976607|NCT00785291|453205809|FG002|Overall Study|Alternative Therapy|7|||
125976608|NCT00785291|453205807|FG000|Overall Study|Complicating illness|6|||
125976609|NCT00785291|453205808|FG001|Overall Study|Complicating illness|4|||
125976610|NCT00785291|453205809|FG002|Overall Study|Complicating illness|4|||
125976611|NCT00785291|453205807|FG000|Overall Study|Other Medical Reasons|29|||
125976612|NCT00785291|453205808|FG001|Overall Study|Other Medical Reasons|25|||
126179740|NCT02137837|453942259|FG000|Overall Study|Adverse Event|0|||
125976613|NCT00785291|453205809|FG002|Overall Study|Other Medical Reasons|15|||
125976614|NCT00844857|453205810|FG000|Overall Study|Adverse Event|24|||
125976615|NCT00844857|453205811|FG001|Overall Study|Adverse Event|5|||
125976616|NCT00844857|453205810|FG000|Overall Study|Sponsor Decision|1|||
125976617|NCT00844857|453205811|FG001|Overall Study|Sponsor Decision|1|||
125976618|NCT00844857|453205810|FG000|Overall Study|Physician Decision|2|||
125976619|NCT00844857|453205811|FG001|Overall Study|Physician Decision|0|||
125976620|NCT00844857|453205810|FG000|Overall Study|Parent/Caregiver Decision|6|||
125976621|NCT00844857|453205811|FG001|Overall Study|Parent/Caregiver Decision|2|||
125976622|NCT00844857|453205810|FG000|Overall Study|Withdrawal by Subject|8|||
125976623|NCT00844857|453205811|FG001|Overall Study|Withdrawal by Subject|7|||
125976624|NCT00844857|453205810|FG000|Overall Study|Protocol Violation|6|||
125976625|NCT00844857|453205811|FG001|Overall Study|Protocol Violation|0|||
125976626|NCT00844857|453205810|FG000|Overall Study|Lack of Efficacy|5|||
125976627|NCT00844857|453205811|FG001|Overall Study|Lack of Efficacy|5|||
125976628|NCT00844857|453205810|FG000|Overall Study|Clinical Relapse|0|||
125976629|NCT00844857|453205811|FG001|Overall Study|Clinical Relapse|1|||
125976630|NCT00844857|453205810|FG000|Overall Study|Entry Criteria Not Met|0|||
125976631|NCT00844857|453205811|FG001|Overall Study|Entry Criteria Not Met|1|||
125976632|NCT00844857|453205810|FG000|Overall Study|Lost to Follow-up|2|||
125976633|NCT00844857|453205811|FG001|Overall Study|Lost to Follow-up|3|||
125976634|NCT00844857|453205810|FG000|Overall Study|Did Not Take Study Drug|3|||
125976635|NCT00844857|453205811|FG001|Overall Study|Did Not Take Study Drug|1|||
125976636|NCT00844857|453205810|FG000|Overall Study|Good Clinical Practice Violations|21|||
125976637|NCT00844857|453205811|FG001|Overall Study|Good Clinical Practice Violations|11|||
125976638|NCT00570674|453205812|FG000|Overall Study|Withdrawal by Subject|0|||
125976639|NCT00570674|453205813|FG001|Overall Study|Withdrawal by Subject|0|||
125976640|NCT00570674|453205814|FG002|Overall Study|Withdrawal by Subject|1|||
125976641|NCT00570674|453205815|FG003|Overall Study|Withdrawal by Subject|0|||
125976642|NCT00570674|453205816|FG004|Overall Study|Withdrawal by Subject|0|||
125976643|NCT00570674|453205817|FG005|Overall Study|Withdrawal by Subject|0|||
125976644|NCT00570674|453205818|FG006|Overall Study|Withdrawal by Subject|0|||
125976645|NCT02979639|453205820|FG000|Overall Study|Withdrawal based on medical judgement|1|||
125976646|NCT02979639|453205820|FG000|Overall Study|Lost to Follow-up|8|||
125976647|NCT02979639|453205820|FG000|Overall Study|Withdrawal by Subject|3|||
125976648|NCT02979639|453205820|FG000|Overall Study|Adverse Event|2|||
125976649|NCT04050865|453205825|FG000|Overall Study|Adverse Event|1|||
125976650|NCT04050865|453205826|FG001|Overall Study|Adverse Event|0|||
125976651|NCT04050865|453205825|FG000|Overall Study|no insert|1|||
125976652|NCT04050865|453205826|FG001|Overall Study|no insert|0|||
125976653|NCT04050865|453205825|FG000|Overall Study|Only 1 insert|2|||
125976654|NCT04050865|453205826|FG001|Overall Study|Only 1 insert|3|||
125976655|NCT04050865|453205825|FG000|Overall Study|Physician Decision|0|||
125976656|NCT04050865|453205826|FG001|Overall Study|Physician Decision|1|||
125976657|NCT04050865|453205825|FG000|Overall Study|Withdrawal by Subject|0|||
125976658|NCT04050865|453205826|FG001|Overall Study|Withdrawal by Subject|1|||
125976659|NCT02586025|453205833|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
125976660|NCT02586025|453205834|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
125976661|NCT02586025|453205833|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
125976662|NCT02586025|453205834|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
125976663|NCT02586025|453205833|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
125976664|NCT02586025|453205834|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
125976665|NCT02586025|453205833|FG000|Neoadjuvant Treatment|Death|1|||
125976666|NCT02586025|453205834|FG001|Neoadjuvant Treatment|Death|0|||
125976667|NCT02586025|453205833|FG000|Neoadjuvant Treatment|Adverse Event|1|||
125976668|NCT02586025|453205834|FG001|Neoadjuvant Treatment|Adverse Event|0|||
125976669|NCT02586025|453205833|FG000|Neoadjuvant Treatment|Physician Decision|2|||
125976670|NCT02586025|453205834|FG001|Neoadjuvant Treatment|Physician Decision|1|||
125976671|NCT02586025|453205833|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
125976672|NCT02586025|453205834|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
125976673|NCT02586025|453205833|FG000|Adjuvant Treatment|Recurrent Disease|4|||
125976674|NCT02586025|453205834|FG001|Adjuvant Treatment|Recurrent Disease|5|||
125976675|NCT02586025|453205833|FG000|Adjuvant Treatment|Physician Decision|0|||
125976676|NCT02586025|453205834|FG001|Adjuvant Treatment|Physician Decision|1|||
125976677|NCT02586025|453205833|FG000|Adjuvant Treatment|Pregnancy|1|||
125976678|NCT02586025|453205834|FG001|Adjuvant Treatment|Pregnancy|0|||
125976679|NCT02586025|453205833|FG000|Treatment-Free Follow-Up|Death|11|||
125976680|NCT02586025|453205834|FG001|Treatment-Free Follow-Up|Death|11|||
125976681|NCT02586025|453205833|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
125976682|NCT02586025|453205834|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
125976683|NCT02586025|453205833|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
125976684|NCT02586025|453205834|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
125976685|NCT02586025|453205833|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
125976686|NCT02586025|453205834|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
125976687|NCT02586025|453205833|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
125976688|NCT02586025|453205834|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
125976689|NCT00175825|453205835|FG000|Overall Study|Adverse Event|3|||
125976690|NCT00175825|453205836|FG001|Overall Study|Adverse Event|2|||
125976691|NCT00175825|453205837|FG002|Overall Study|Adverse Event|1|||
125976692|NCT00175825|453205838|FG003|Overall Study|Adverse Event|1|||
125976693|NCT00175825|453205835|FG000|Overall Study|Lost to Follow-up|1|||
125976694|NCT00175825|453205836|FG001|Overall Study|Lost to Follow-up|2|||
125976695|NCT00175825|453205837|FG002|Overall Study|Lost to Follow-up|0|||
125976696|NCT00175825|453205838|FG003|Overall Study|Lost to Follow-up|0|||
125976697|NCT00175825|453205835|FG000|Overall Study|Withdrawal by Subject|1|||
125976698|NCT00175825|453205836|FG001|Overall Study|Withdrawal by Subject|0|||
125976699|NCT00175825|453205837|FG002|Overall Study|Withdrawal by Subject|0|||
125976700|NCT00175825|453205838|FG003|Overall Study|Withdrawal by Subject|0|||
125976701|NCT00608582|453205839|FG000|Overall Study|Lost to Follow-up|2|||
125976702|NCT00608582|453205840|FG001|Overall Study|Lost to Follow-up|0|||
125976703|NCT00608582|453205839|FG000|Overall Study|No Best Response in Phase 1 located|1|||
125976704|NCT00608582|453205840|FG001|Overall Study|No Best Response in Phase 1 located|1|||
125976705|NCT00608582|453205839|FG000|Overall Study|Illicit Drug Use|1|||
125976706|NCT00608582|453205840|FG001|Overall Study|Illicit Drug Use|0|||
125976707|NCT00608582|453205839|FG000|Overall Study|Early stage Design Change|0|||
125976708|NCT00608582|453205840|FG001|Overall Study|Early stage Design Change|3|||
125976709|NCT02450331|453205845|FG000|Overall Study|Death|162|||
125976710|NCT02450331|453205846|FG001|Overall Study|Death|171|||
125976711|NCT02450331|453205845|FG000|Overall Study|Lost to Follow-up|14|||
125976712|NCT02450331|453205846|FG001|Overall Study|Lost to Follow-up|12|||
125976713|NCT02450331|453205845|FG000|Overall Study|Withdrawal by Subject|55|||
125976714|NCT02450331|453205846|FG001|Overall Study|Withdrawal by Subject|44|||
125976715|NCT02450331|453205845|FG000|Overall Study|Non-specified other|1|||
125976716|NCT02450331|453205846|FG001|Overall Study|Non-specified other|1|||
125976717|NCT03232983|453205847|FG000|Period 1|Physician Decision|0|||
125976718|NCT03232983|453205848|FG001|Period 1|Physician Decision|0|||
125976719|NCT03232983|453205849|FG002|Period 1|Physician Decision|1|||
125976720|NCT03232983|453205850|FG003|Period 1|Physician Decision|0|||
125976721|NCT03232983|453205847|FG000|Washout Period 2|Physician Decision|0|||
125976722|NCT03232983|453205848|FG001|Washout Period 2|Physician Decision|0|||
125976723|NCT03232983|453205849|FG002|Washout Period 2|Physician Decision|1|||
125976724|NCT03232983|453205850|FG003|Washout Period 2|Physician Decision|0|||
125976725|NCT03232983|453205847|FG000|Washout Period 2|Withdrawal by Subject|0|||
125976726|NCT03232983|453205848|FG001|Washout Period 2|Withdrawal by Subject|0|||
125976727|NCT03232983|453205849|FG002|Washout Period 2|Withdrawal by Subject|0|||
125976728|NCT03232983|453205850|FG003|Washout Period 2|Withdrawal by Subject|1|||
125976729|NCT03232983|453205847|FG000|Period 4|Withdrawal by Subject|1|||
125976730|NCT03232983|453205848|FG001|Period 4|Withdrawal by Subject|0|||
125976731|NCT03232983|453205849|FG002|Period 4|Withdrawal by Subject|0|||
125976732|NCT03232983|453205850|FG003|Period 4|Withdrawal by Subject|0|||
125976733|NCT03643952|453205857|FG000|Overall Study|Lack of Efficacy|1|||
125976734|NCT01597050|453205858|FG000|Overall Study|Withdrawal by Subject|1|||
125976735|NCT01597050|453205859|FG001|Overall Study|Withdrawal by Subject|0|||
125976736|NCT00483184|453205860|FG000|Overall Study|Withdrawal by Subject|2|||
125976737|NCT00483184|453205861|FG001|Overall Study|Withdrawal by Subject|2|||
125976738|NCT00483184|453205862|FG002|Overall Study|Withdrawal by Subject|0|||
125976739|NCT00483184|453205860|FG000|Overall Study|Lost to Follow-up|1|||
125976740|NCT00483184|453205861|FG001|Overall Study|Lost to Follow-up|0|||
125976741|NCT00483184|453205862|FG002|Overall Study|Lost to Follow-up|0|||
125976742|NCT00483184|453205860|FG000|Overall Study|Adverse Event|1|||
125976743|NCT00483184|453205861|FG001|Overall Study|Adverse Event|2|||
125976744|NCT00483184|453205862|FG002|Overall Study|Adverse Event|2|||
125976745|NCT00483184|453205860|FG000|Overall Study|Protocol Violation|1|||
125976746|NCT00483184|453205861|FG001|Overall Study|Protocol Violation|0|||
125976747|NCT00483184|453205862|FG002|Overall Study|Protocol Violation|1|||
125976748|NCT00558428|453205863|FG000|Overall Study|Adverse Event|6|||
125976749|NCT00558428|453205864|FG001|Overall Study|Adverse Event|22|||
125976750|NCT00558428|453205865|FG002|Overall Study|Adverse Event|3|||
125976751|NCT00558428|453205866|FG003|Overall Study|Adverse Event|4|||
125976752|NCT00558428|453205863|FG000|Overall Study|Lost to Follow-up|0|||
125976753|NCT00558428|453205864|FG001|Overall Study|Lost to Follow-up|1|||
125976754|NCT00558428|453205865|FG002|Overall Study|Lost to Follow-up|0|||
125976755|NCT00558428|453205866|FG003|Overall Study|Lost to Follow-up|0|||
125976756|NCT00558428|453205863|FG000|Overall Study|Lack of Efficacy|0|||
125976757|NCT00558428|453205864|FG001|Overall Study|Lack of Efficacy|0|||
125976758|NCT00558428|453205865|FG002|Overall Study|Lack of Efficacy|1|||
125976759|NCT00558428|453205866|FG003|Overall Study|Lack of Efficacy|2|||
125976760|NCT00558428|453205863|FG000|Overall Study|Non compliant with protocol|1|||
125976761|NCT00558428|453205864|FG001|Overall Study|Non compliant with protocol|0|||
125976762|NCT00558428|453205865|FG002|Overall Study|Non compliant with protocol|0|||
125976763|NCT00558428|453205866|FG003|Overall Study|Non compliant with protocol|3|||
125976764|NCT00558428|453205863|FG000|Overall Study|Consent withdrawn|2|||
125976765|NCT00558428|453205864|FG001|Overall Study|Consent withdrawn|1|||
125976766|NCT00558428|453205865|FG002|Overall Study|Consent withdrawn|0|||
125976767|NCT00558428|453205866|FG003|Overall Study|Consent withdrawn|1|||
125976768|NCT00558428|453205863|FG000|Overall Study|Other|3|||
125976769|NCT00558428|453205864|FG001|Overall Study|Other|0|||
125976770|NCT00558428|453205865|FG002|Overall Study|Other|0|||
125976771|NCT00558428|453205866|FG003|Overall Study|Other|1|||
125976772|NCT00815295|453205867|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
125976773|NCT00815295|453205868|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
125976774|NCT00815295|453205869|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
125976775|NCT00530855|453205870|FG000|Overall Study|Lack of Efficacy|20|||
125976776|NCT00530855|453205870|FG000|Overall Study|Withdrawal by Subject|30|||
125976777|NCT00530855|453205870|FG000|Overall Study|Fatal Serious AE|3|||
125976778|NCT00530855|453205870|FG000|Overall Study|Non Fatal Serious AE|7|||
125976779|NCT00530855|453205870|FG000|Overall Study|Non Fatal Non Serious AE|12|||
125976780|NCT00530855|453205870|FG000|Overall Study|Protocol Violation|3|||
125976781|NCT00530855|453205870|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
125976782|NCT00530855|453205870|FG000|Overall Study|Lost to Follow-up|9|||
125976783|NCT00530855|453205870|FG000|Overall Study|Other reason for premature termination|17|||
125976784|NCT01137474|453205871|FG000|Overall Study|Adverse Event|3|||
125976785|NCT01137474|453205872|FG001|Overall Study|Adverse Event|5|||
125976786|NCT01137474|453205873|FG002|Overall Study|Adverse Event|1|||
125976787|NCT01137474|453205874|FG003|Overall Study|Adverse Event|3|||
125976788|NCT01137474|453205871|FG000|Overall Study|Withdrawal by Subject|7|||
125976789|NCT01137474|453205872|FG001|Overall Study|Withdrawal by Subject|2|||
125976790|NCT01137474|453205873|FG002|Overall Study|Withdrawal by Subject|6|||
125976791|NCT01137474|453205874|FG003|Overall Study|Withdrawal by Subject|9|||
125976792|NCT01137474|453205871|FG000|Overall Study|No longer met study criteria|6|||
125976793|NCT01137474|453205872|FG001|Overall Study|No longer met study criteria|1|||
125976794|NCT01137474|453205873|FG002|Overall Study|No longer met study criteria|0|||
125976795|NCT01137474|453205874|FG003|Overall Study|No longer met study criteria|5|||
125976796|NCT01137474|453205871|FG000|Overall Study|Lost to Follow-up|5|||
125976797|NCT01137474|453205872|FG001|Overall Study|Lost to Follow-up|1|||
125976798|NCT01137474|453205873|FG002|Overall Study|Lost to Follow-up|0|||
125976799|NCT01137474|453205874|FG003|Overall Study|Lost to Follow-up|2|||
125976800|NCT01137474|453205871|FG000|Overall Study|Lack of Efficacy|0|||
125976801|NCT01137474|453205872|FG001|Overall Study|Lack of Efficacy|0|||
125976802|NCT01137474|453205873|FG002|Overall Study|Lack of Efficacy|0|||
125976803|NCT01137474|453205874|FG003|Overall Study|Lack of Efficacy|2|||
125976804|NCT01137474|453205871|FG000|Overall Study|Other|3|||
125976805|NCT01137474|453205872|FG001|Overall Study|Other|1|||
125976806|NCT01137474|453205873|FG002|Overall Study|Other|0|||
125976807|NCT01137474|453205874|FG003|Overall Study|Other|0|||
125976808|NCT01137474|453205871|FG000|Overall Study|Pregnancy|0|||
125976809|NCT01137474|453205872|FG001|Overall Study|Pregnancy|1|||
125976810|NCT01137474|453205873|FG002|Overall Study|Pregnancy|0|||
125976811|NCT01137474|453205874|FG003|Overall Study|Pregnancy|0|||
125976812|NCT01137474|453205871|FG000|Overall Study|Administrative reason by sponsor|0|||
125976813|NCT01137474|453205872|FG001|Overall Study|Administrative reason by sponsor|1|||
125976814|NCT01137474|453205873|FG002|Overall Study|Administrative reason by sponsor|0|||
125976815|NCT01137474|453205874|FG003|Overall Study|Administrative reason by sponsor|0|||
125976816|NCT02219048|453205875|FG000|Overall Study|Adverse Event|2|||
125976817|NCT02219048|453205876|FG001|Overall Study|Adverse Event|5|||
125976818|NCT02219048|453205875|FG000|Overall Study|No longer meets eligibility criteria|1|||
125976819|NCT02219048|453205876|FG001|Overall Study|No longer meets eligibility criteria|0|||
125976820|NCT02219048|453205875|FG000|Overall Study|Study terminated by sponsor|16|||
125976821|NCT02219048|453205876|FG001|Overall Study|Study terminated by sponsor|15|||
125976822|NCT02219048|453205875|FG000|Overall Study|Withdrawal by Subject|2|||
125976823|NCT02219048|453205876|FG001|Overall Study|Withdrawal by Subject|0|||
125976824|NCT02219048|453205875|FG000|Overall Study|Other|0|||
125976825|NCT02219048|453205876|FG001|Overall Study|Other|1|||
125976826|NCT04794803|453205877|FG000|Overall Study|Death|1|||
125976827|NCT04794803|453205878|FG001|Overall Study|Death|3|||
125976828|NCT04794803|453205877|FG000|Overall Study|Lost to Follow-up|2|||
126179741|NCT02137837|453942260|FG001|Overall Study|Adverse Event|2|||
126179742|NCT02137837|453942261|FG002|Overall Study|Adverse Event|1|||
126179743|NCT02137837|453942259|FG000|Overall Study|Refusal unrelated to adverse event|2|||
125976829|NCT04794803|453205878|FG001|Overall Study|Lost to Follow-up|2|||
125976830|NCT04794803|453205877|FG000|Overall Study|Withdrawal by Subject|1|||
125976831|NCT04794803|453205878|FG001|Overall Study|Withdrawal by Subject|0|||
125976832|NCT04794803|453205877|FG000|Overall Study|Physician Decision|1|||
125976833|NCT04794803|453205878|FG001|Overall Study|Physician Decision|1|||
125976834|NCT04794803|453205877|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
125976835|NCT04794803|453205878|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
125976836|NCT04794803|453205877|FG000|Overall Study|Refused to continue the treatment|1|||
125976837|NCT04794803|453205878|FG001|Overall Study|Refused to continue the treatment|0|||
125976838|NCT04794803|453205877|FG000|Overall Study|Patient admitted to ICU|0|||
125976839|NCT04794803|453205878|FG001|Overall Study|Patient admitted to ICU|1|||
125976840|NCT00911534|453205881|FG000|Overall Study|Adverse Event|4|||
125976841|NCT00911534|453205882|FG001|Overall Study|Adverse Event|4|||
125976842|NCT00911534|453205881|FG000|Overall Study|Lost to Follow-up|2|||
125976843|NCT00911534|453205882|FG001|Overall Study|Lost to Follow-up|4|||
125976844|NCT00911534|453205881|FG000|Overall Study|Withdrawal by Subject|2|||
125976845|NCT00911534|453205882|FG001|Overall Study|Withdrawal by Subject|1|||
125976846|NCT00911534|453205881|FG000|Overall Study|Lack of Efficacy|4|||
125976847|NCT00911534|453205882|FG001|Overall Study|Lack of Efficacy|1|||
125976848|NCT00911534|453205881|FG000|Overall Study|Withdrawal of consent|1|||
125976849|NCT00911534|453205882|FG001|Overall Study|Withdrawal of consent|4|||
125976850|NCT00911534|453205881|FG000|Overall Study|Other|2|||
125976851|NCT00911534|453205882|FG001|Overall Study|Other|2|||
125976852|NCT03152526|453205883|FG000|Overall Study|Withdrawal by Subject|0|||
125976853|NCT03152526|453205884|FG001|Overall Study|Withdrawal by Subject|1|||
125976854|NCT03792126|453205892|FG000|Overall Study|Adverse Event|1|||
125976855|NCT03792126|453205893|FG001|Overall Study|Adverse Event|2|||
125976856|NCT03792126|453205892|FG000|Overall Study|Death|0|||
125976857|NCT03792126|453205893|FG001|Overall Study|Death|1|||
125976858|NCT03792126|453205892|FG000|Overall Study|Lost to Follow-up|1|||
125976859|NCT03792126|453205893|FG001|Overall Study|Lost to Follow-up|0|||
125976860|NCT03792126|453205892|FG000|Overall Study|Withdrawal by Subject|0|||
125976861|NCT03792126|453205893|FG001|Overall Study|Withdrawal by Subject|1|||
125976862|NCT03792126|453205892|FG000|Overall Study|COVID-19 Restrictions|1|||
125976863|NCT03792126|453205893|FG001|Overall Study|COVID-19 Restrictions|3|||
125976864|NCT03792126|453205892|FG000|Overall Study|Symptoms resolved|0|||
125976865|NCT03792126|453205893|FG001|Overall Study|Symptoms resolved|3|||
125976866|NCT02300220|453205894|FG000|Overall Study|Lost to Follow-up|1|||
125976867|NCT02300220|453205895|FG001|Overall Study|Lost to Follow-up|2|||
125976868|NCT02300220|453205894|FG000|Overall Study|Death|1|||
125976869|NCT02300220|453205895|FG001|Overall Study|Death|1|||
125976870|NCT02300220|453205894|FG000|Overall Study|Adverse Event|1|||
125976871|NCT02300220|453205895|FG001|Overall Study|Adverse Event|1|||
125976872|NCT02300220|453205894|FG000|Overall Study|Protocol Violation|1|||
125976873|NCT02300220|453205895|FG001|Overall Study|Protocol Violation|0|||
125976874|NCT02300220|453205894|FG000|Overall Study|Withdrawal by Subject|0|||
125976875|NCT02300220|453205895|FG001|Overall Study|Withdrawal by Subject|2|||
125976876|NCT02300220|453205894|FG000|Overall Study|Did not tolerate IMP|0|||
125976877|NCT02300220|453205895|FG001|Overall Study|Did not tolerate IMP|1|||
125976878|NCT04322682|453205896|FG000|Overall Study|Withdrawal by Subject|33|||
125976879|NCT04322682|453205897|FG001|Overall Study|Withdrawal by Subject|47|||
125976880|NCT04322682|453205896|FG000|Overall Study|Death|5|||
125976881|NCT04322682|453205897|FG001|Overall Study|Death|9|||
125976882|NCT04322682|453205896|FG000|Overall Study|Lost to Follow-up|4|||
125976883|NCT04322682|453205897|FG001|Overall Study|Lost to Follow-up|8|||
125976884|NCT04322682|453205896|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
125976885|NCT04322682|453205897|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
125976886|NCT02238379|453205898|FG000|Overall Study|Lost to Follow-up|1|||
125976887|NCT02238379|453205899|FG001|Overall Study|Lost to Follow-up|0|||
125976888|NCT00441090|453205900|FG000|Overall Study|Adverse Event|0|||
125976889|NCT00441090|453205901|FG001|Overall Study|Adverse Event|1|||
125976890|NCT00441090|453205902|FG002|Overall Study|Adverse Event|1|||
125976891|NCT00441090|453205903|FG003|Overall Study|Adverse Event|0|||
125976892|NCT00441090|453205904|FG004|Overall Study|Adverse Event|0|||
125976893|NCT00441090|453205900|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
125976894|NCT00441090|453205901|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
125976895|NCT00441090|453205902|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
125976896|NCT00441090|453205903|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
125976897|NCT00441090|453205904|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
125976898|NCT00441090|453205900|FG000|Overall Study|Withdrawal by Subject|1|||
125976899|NCT00441090|453205901|FG001|Overall Study|Withdrawal by Subject|0|||
125976900|NCT00441090|453205902|FG002|Overall Study|Withdrawal by Subject|1|||
125976901|NCT00441090|453205903|FG003|Overall Study|Withdrawal by Subject|0|||
125976902|NCT00441090|453205904|FG004|Overall Study|Withdrawal by Subject|0|||
125976903|NCT00441090|453205900|FG000|Overall Study|Lack of Efficacy|1|||
125976904|NCT00441090|453205901|FG001|Overall Study|Lack of Efficacy|0|||
125976905|NCT00441090|453205902|FG002|Overall Study|Lack of Efficacy|0|||
125976906|NCT00441090|453205903|FG003|Overall Study|Lack of Efficacy|0|||
125976907|NCT00441090|453205904|FG004|Overall Study|Lack of Efficacy|0|||
125976908|NCT01441102|453205905|FG000|Overall Study|Adverse Event|1|||
125976909|NCT01441102|453205905|FG000|Overall Study|Withdrawal by Subject|2|||
125976910|NCT03085485|453205906|FG000|Overall Study|Death|1|||
126179744|NCT02137837|453942260|FG001|Overall Study|Refusal unrelated to adverse event|2|||
125976911|NCT03085485|453205907|FG001|Overall Study|Death|0|||
125976912|NCT03085485|453205906|FG000|Overall Study|Lost to Follow-up|1|||
125976913|NCT03085485|453205907|FG001|Overall Study|Lost to Follow-up|0|||
125976914|NCT00605280|453205908|FG000|Year 1|Protocol Violation|0|||
126179745|NCT02137837|453942261|FG002|Overall Study|Refusal unrelated to adverse event|1|||
125976915|NCT00605280|453205909|FG001|Year 1|Protocol Violation|0|||
125976916|NCT00605280|453205910|FG002|Year 1|Protocol Violation|0|||
125976917|NCT00605280|453205911|FG003|Year 1|Protocol Violation|1|||
125976918|NCT00605280|453205908|FG000|Year 1|Adverse Event|3|||
125976919|NCT00605280|453205909|FG001|Year 1|Adverse Event|1|||
125976920|NCT00605280|453205910|FG002|Year 1|Adverse Event|1|||
125976921|NCT00605280|453205911|FG003|Year 1|Adverse Event|5|||
125976922|NCT00605280|453205908|FG000|Year 1|Physician Decision|7|||
125976923|NCT00605280|453205909|FG001|Year 1|Physician Decision|4|||
125976924|NCT00605280|453205910|FG002|Year 1|Physician Decision|0|||
125976925|NCT00605280|453205911|FG003|Year 1|Physician Decision|6|||
125976926|NCT00605280|453205908|FG000|Year 1|Withdrawal by Subject|2|||
125976927|NCT00605280|453205909|FG001|Year 1|Withdrawal by Subject|4|||
125976928|NCT00605280|453205910|FG002|Year 1|Withdrawal by Subject|0|||
125976929|NCT00605280|453205911|FG003|Year 1|Withdrawal by Subject|4|||
125976930|NCT00605280|453205908|FG000|Year 1|Other|2|||
125976931|NCT00605280|453205909|FG001|Year 1|Other|1|||
125976932|NCT00605280|453205910|FG002|Year 1|Other|0|||
125976933|NCT00605280|453205911|FG003|Year 1|Other|1|||
125976934|NCT00605280|453205908|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
125976935|NCT00605280|453205909|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
125976936|NCT00605280|453205910|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
125976937|NCT00605280|453205911|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
125976938|NCT00605280|453205908|FG000|Year 2|Adverse Event|4|||
125976939|NCT00605280|453205909|FG001|Year 2|Adverse Event|0|||
125976940|NCT00605280|453205910|FG002|Year 2|Adverse Event|2|||
125976941|NCT00605280|453205911|FG003|Year 2|Adverse Event|4|||
125976942|NCT00605280|453205908|FG000|Year 2|Physician Decision|11|||
125976943|NCT00605280|453205909|FG001|Year 2|Physician Decision|6|||
125976944|NCT00605280|453205910|FG002|Year 2|Physician Decision|4|||
125976945|NCT00605280|453205911|FG003|Year 2|Physician Decision|11|||
125976946|NCT00605280|453205908|FG000|Year 2|Withdrawal by Subject|4|||
125976947|NCT00605280|453205909|FG001|Year 2|Withdrawal by Subject|0|||
125976948|NCT00605280|453205910|FG002|Year 2|Withdrawal by Subject|0|||
125976949|NCT00605280|453205911|FG003|Year 2|Withdrawal by Subject|4|||
125976950|NCT00605280|453205908|FG000|Year 2|Other|1|||
125976951|NCT00605280|453205909|FG001|Year 2|Other|0|||
125976952|NCT00605280|453205910|FG002|Year 2|Other|0|||
125976953|NCT00605280|453205911|FG003|Year 2|Other|1|||
125976954|NCT00605280|453205908|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
125976955|NCT00605280|453205909|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
125976956|NCT00605280|453205910|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
125976957|NCT00605280|453205911|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
125976958|NCT00605280|453205908|FG000|Year 3 Extension|Adverse Event|2|||
125976959|NCT00605280|453205909|FG001|Year 3 Extension|Adverse Event|0|||
125976960|NCT00605280|453205910|FG002|Year 3 Extension|Adverse Event|0|||
125976961|NCT00605280|453205911|FG003|Year 3 Extension|Adverse Event|2|||
125976962|NCT00605280|453205908|FG000|Year 3 Extension|Physician Decision|0|||
125976963|NCT00605280|453205909|FG001|Year 3 Extension|Physician Decision|0|||
125976964|NCT00605280|453205910|FG002|Year 3 Extension|Physician Decision|0|||
125976965|NCT00605280|453205911|FG003|Year 3 Extension|Physician Decision|2|||
125976966|NCT00605280|453205908|FG000|Year 3 Extension|Withdrawal by Subject|2|||
125976967|NCT00605280|453205909|FG001|Year 3 Extension|Withdrawal by Subject|0|||
125976968|NCT00605280|453205910|FG002|Year 3 Extension|Withdrawal by Subject|0|||
125976969|NCT00605280|453205911|FG003|Year 3 Extension|Withdrawal by Subject|5|||
125976970|NCT00605280|453205908|FG000|Year 3 Extension|Other|2|||
125976971|NCT00605280|453205909|FG001|Year 3 Extension|Other|0|||
125976972|NCT00605280|453205910|FG002|Year 3 Extension|Other|0|||
125976973|NCT00605280|453205911|FG003|Year 3 Extension|Other|0|||
125976974|NCT00605280|453205908|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
125976975|NCT00605280|453205909|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
125976976|NCT00605280|453205910|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
125976977|NCT00605280|453205911|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
125976978|NCT01775904|453205915|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
125976979|NCT01775904|453205915|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
125976980|NCT00518115|453205916|FG000|Overall Study|Adverse Event|6|||
125976981|NCT00518115|453205917|FG001|Overall Study|Adverse Event|1|||
125976982|NCT00518115|453205918|FG002|Overall Study|Adverse Event|5|||
125976983|NCT00518115|453205919|FG003|Overall Study|Adverse Event|6|||
125976984|NCT00518115|453205920|FG004|Overall Study|Adverse Event|5|||
125976985|NCT00518115|453205921|FG005|Overall Study|Adverse Event|5|||
125976986|NCT00518115|453205922|FG006|Overall Study|Adverse Event|5|||
125976987|NCT00518115|453205923|FG007|Overall Study|Adverse Event|10|||
125976988|NCT00518115|453205924|FG008|Overall Study|Adverse Event|2|||
125976989|NCT00518115|453205925|FG009|Overall Study|Adverse Event|9|||
125976990|NCT00518115|453205916|FG000|Overall Study|Lost to Follow-up|0|||
125976991|NCT00518115|453205917|FG001|Overall Study|Lost to Follow-up|0|||
125976992|NCT00518115|453205918|FG002|Overall Study|Lost to Follow-up|2|||
125976993|NCT00518115|453205919|FG003|Overall Study|Lost to Follow-up|3|||
125976994|NCT00518115|453205920|FG004|Overall Study|Lost to Follow-up|1|||
125976995|NCT00518115|453205921|FG005|Overall Study|Lost to Follow-up|3|||
125976996|NCT00518115|453205922|FG006|Overall Study|Lost to Follow-up|0|||
125976997|NCT00518115|453205923|FG007|Overall Study|Lost to Follow-up|1|||
125976998|NCT00518115|453205924|FG008|Overall Study|Lost to Follow-up|1|||
125976999|NCT00518115|453205925|FG009|Overall Study|Lost to Follow-up|1|||
125977000|NCT00518115|453205916|FG000|Overall Study|Protocol Violation|1|||
125977001|NCT00518115|453205917|FG001|Overall Study|Protocol Violation|3|||
125977002|NCT00518115|453205918|FG002|Overall Study|Protocol Violation|1|||
125977003|NCT00518115|453205919|FG003|Overall Study|Protocol Violation|0|||
125977004|NCT00518115|453205920|FG004|Overall Study|Protocol Violation|0|||
125977005|NCT00518115|453205921|FG005|Overall Study|Protocol Violation|0|||
125977006|NCT00518115|453205922|FG006|Overall Study|Protocol Violation|0|||
125977007|NCT00518115|453205923|FG007|Overall Study|Protocol Violation|0|||
125977008|NCT00518115|453205924|FG008|Overall Study|Protocol Violation|0|||
125977009|NCT00518115|453205925|FG009|Overall Study|Protocol Violation|0|||
125977010|NCT00518115|453205916|FG000|Overall Study|Withdrawal by Subject|1|||
125977011|NCT00518115|453205917|FG001|Overall Study|Withdrawal by Subject|1|||
125977012|NCT00518115|453205918|FG002|Overall Study|Withdrawal by Subject|5|||
125977013|NCT00518115|453205919|FG003|Overall Study|Withdrawal by Subject|0|||
125977014|NCT00518115|453205920|FG004|Overall Study|Withdrawal by Subject|2|||
125977015|NCT00518115|453205921|FG005|Overall Study|Withdrawal by Subject|1|||
125977016|NCT00518115|453205922|FG006|Overall Study|Withdrawal by Subject|0|||
125977017|NCT00518115|453205923|FG007|Overall Study|Withdrawal by Subject|2|||
125977018|NCT00518115|453205924|FG008|Overall Study|Withdrawal by Subject|1|||
125977019|NCT00518115|453205925|FG009|Overall Study|Withdrawal by Subject|3|||
125977020|NCT00518115|453205916|FG000|Overall Study|Lack of Efficacy|1|||
125977021|NCT00518115|453205917|FG001|Overall Study|Lack of Efficacy|0|||
125977022|NCT00518115|453205918|FG002|Overall Study|Lack of Efficacy|1|||
125977023|NCT00518115|453205919|FG003|Overall Study|Lack of Efficacy|1|||
125977024|NCT00518115|453205920|FG004|Overall Study|Lack of Efficacy|0|||
125977025|NCT00518115|453205921|FG005|Overall Study|Lack of Efficacy|0|||
125977026|NCT00518115|453205922|FG006|Overall Study|Lack of Efficacy|0|||
125977027|NCT00518115|453205923|FG007|Overall Study|Lack of Efficacy|1|||
125977028|NCT00518115|453205924|FG008|Overall Study|Lack of Efficacy|0|||
125977029|NCT00518115|453205925|FG009|Overall Study|Lack of Efficacy|0|||
125977030|NCT00518115|453205916|FG000|Overall Study|Non-Compliance|1|||
125977031|NCT00518115|453205917|FG001|Overall Study|Non-Compliance|0|||
125977032|NCT00518115|453205918|FG002|Overall Study|Non-Compliance|1|||
125977033|NCT00518115|453205919|FG003|Overall Study|Non-Compliance|0|||
125977034|NCT00518115|453205920|FG004|Overall Study|Non-Compliance|1|||
125977035|NCT00518115|453205921|FG005|Overall Study|Non-Compliance|1|||
125977036|NCT00518115|453205922|FG006|Overall Study|Non-Compliance|1|||
125977037|NCT00518115|453205923|FG007|Overall Study|Non-Compliance|1|||
125977038|NCT00518115|453205924|FG008|Overall Study|Non-Compliance|0|||
125977039|NCT00518115|453205925|FG009|Overall Study|Non-Compliance|1|||
125977040|NCT00518115|453205916|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
125977041|NCT00518115|453205917|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
125977042|NCT00518115|453205918|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125977043|NCT00518115|453205919|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125977044|NCT00518115|453205920|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125977045|NCT00518115|453205921|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
125977046|NCT00518115|453205922|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125977047|NCT00518115|453205923|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125977048|NCT00518115|453205924|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125977049|NCT00518115|453205925|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125977050|NCT00518115|453205916|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
125977051|NCT00518115|453205917|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977052|NCT00518115|453205918|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977053|NCT00518115|453205919|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977054|NCT00518115|453205920|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977055|NCT00518115|453205921|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977056|NCT00518115|453205922|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977057|NCT00518115|453205923|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977058|NCT00518115|453205924|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977059|NCT00518115|453205925|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125977060|NCT00518115|453205916|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
125977061|NCT00518115|453205917|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
125977062|NCT00518115|453205918|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
125977063|NCT00518115|453205919|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
125977064|NCT00518115|453205920|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
125977065|NCT00518115|453205921|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
125977066|NCT00518115|453205922|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
125977067|NCT00518115|453205923|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
125977068|NCT00518115|453205924|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
125977069|NCT00518115|453205925|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
125977070|NCT00518115|453205916|FG000|Overall Study|Wrong Monotherapy Administered|0|||
125977071|NCT00518115|453205917|FG001|Overall Study|Wrong Monotherapy Administered|0|||
126179746|NCT02137837|453942259|FG000|Overall Study|Progression/relapse|9|||
126179747|NCT02137837|453942260|FG001|Overall Study|Progression/relapse|7|||
125977072|NCT00518115|453205918|FG002|Overall Study|Wrong Monotherapy Administered|1|||
125977073|NCT00518115|453205919|FG003|Overall Study|Wrong Monotherapy Administered|0|||
125977074|NCT00518115|453205920|FG004|Overall Study|Wrong Monotherapy Administered|0|||
125977075|NCT00518115|453205921|FG005|Overall Study|Wrong Monotherapy Administered|0|||
125977076|NCT00518115|453205922|FG006|Overall Study|Wrong Monotherapy Administered|1|||
125977077|NCT00518115|453205923|FG007|Overall Study|Wrong Monotherapy Administered|0|||
125977078|NCT00518115|453205924|FG008|Overall Study|Wrong Monotherapy Administered|0|||
125977079|NCT00518115|453205925|FG009|Overall Study|Wrong Monotherapy Administered|0|||
125977080|NCT00518115|453205916|FG000|Overall Study|Violation of Exclusion Criteria|0|||
125977081|NCT00518115|453205917|FG001|Overall Study|Violation of Exclusion Criteria|0|||
125977082|NCT00518115|453205918|FG002|Overall Study|Violation of Exclusion Criteria|0|||
125977083|NCT00518115|453205919|FG003|Overall Study|Violation of Exclusion Criteria|1|||
125977084|NCT00518115|453205920|FG004|Overall Study|Violation of Exclusion Criteria|0|||
125977085|NCT00518115|453205921|FG005|Overall Study|Violation of Exclusion Criteria|0|||
125977086|NCT00518115|453205922|FG006|Overall Study|Violation of Exclusion Criteria|1|||
125977087|NCT00518115|453205923|FG007|Overall Study|Violation of Exclusion Criteria|0|||
125977088|NCT00518115|453205924|FG008|Overall Study|Violation of Exclusion Criteria|0|||
125977089|NCT00518115|453205925|FG009|Overall Study|Violation of Exclusion Criteria|0|||
125977090|NCT00518115|453205916|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
125977091|NCT00518115|453205917|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
125977092|NCT00518115|453205918|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
125977093|NCT00518115|453205919|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
125977094|NCT00518115|453205920|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
125977095|NCT00518115|453205921|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
125977096|NCT00518115|453205922|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
125977097|NCT00518115|453205923|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
125977098|NCT00518115|453205924|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
125977099|NCT00518115|453205925|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
125977100|NCT00518115|453205916|FG000|Overall Study|Withdrew Consent|0|||
125977101|NCT00518115|453205917|FG001|Overall Study|Withdrew Consent|0|||
125977102|NCT00518115|453205918|FG002|Overall Study|Withdrew Consent|0|||
125977103|NCT00518115|453205919|FG003|Overall Study|Withdrew Consent|0|||
125977104|NCT00518115|453205920|FG004|Overall Study|Withdrew Consent|0|||
125977105|NCT00518115|453205921|FG005|Overall Study|Withdrew Consent|1|||
125977106|NCT00518115|453205922|FG006|Overall Study|Withdrew Consent|0|||
125977107|NCT00518115|453205923|FG007|Overall Study|Withdrew Consent|0|||
125977108|NCT00518115|453205924|FG008|Overall Study|Withdrew Consent|0|||
125977109|NCT00518115|453205925|FG009|Overall Study|Withdrew Consent|0|||
125977110|NCT00518115|453205916|FG000|Overall Study|Moved Out of State|0|||
125977111|NCT00518115|453205917|FG001|Overall Study|Moved Out of State|0|||
125977112|NCT00518115|453205918|FG002|Overall Study|Moved Out of State|0|||
125977113|NCT00518115|453205919|FG003|Overall Study|Moved Out of State|0|||
125977114|NCT00518115|453205920|FG004|Overall Study|Moved Out of State|0|||
125977115|NCT00518115|453205921|FG005|Overall Study|Moved Out of State|0|||
125977116|NCT00518115|453205922|FG006|Overall Study|Moved Out of State|0|||
125977117|NCT00518115|453205923|FG007|Overall Study|Moved Out of State|0|||
125977118|NCT00518115|453205924|FG008|Overall Study|Moved Out of State|0|||
125977119|NCT00518115|453205925|FG009|Overall Study|Moved Out of State|1|||
125977120|NCT04891419|453205926|FG000|Overall Study|Withdrawal by Subject|4|||
125977121|NCT04891419|453205927|FG001|Overall Study|Withdrawal by Subject|0|||
125977122|NCT04891419|453205926|FG000|Overall Study|Lost to Follow-up|1|||
125977123|NCT04891419|453205927|FG001|Overall Study|Lost to Follow-up|3|||
125977124|NCT02291614|453205928|FG000|Overall Study|Lost to Follow-up|0|||
125977125|NCT02291614|453205929|FG001|Overall Study|Lost to Follow-up|0|||
125977126|NCT02291614|453205930|FG002|Overall Study|Lost to Follow-up|0|||
125977127|NCT02291614|453205931|FG003|Overall Study|Lost to Follow-up|0|||
125977128|NCT02291614|453205932|FG004|Overall Study|Lost to Follow-up|0|||
125977129|NCT02291614|453205933|FG005|Overall Study|Lost to Follow-up|0|||
125977130|NCT02291614|453205934|FG006|Overall Study|Lost to Follow-up|0|||
125977131|NCT02291614|453205935|FG007|Overall Study|Lost to Follow-up|1|||
125977132|NCT02291614|453205936|FG008|Overall Study|Lost to Follow-up|0|||
125977133|NCT02291614|453205937|FG009|Overall Study|Lost to Follow-up|0|||
125977134|NCT02291614|453205938|FG010|Overall Study|Lost to Follow-up|0|||
125977135|NCT02291614|453205928|FG000|Overall Study|Withdrawal by Subject|0|||
125977136|NCT02291614|453205929|FG001|Overall Study|Withdrawal by Subject|1|||
125977137|NCT02291614|453205930|FG002|Overall Study|Withdrawal by Subject|0|||
125977138|NCT02291614|453205931|FG003|Overall Study|Withdrawal by Subject|0|||
125977139|NCT02291614|453205932|FG004|Overall Study|Withdrawal by Subject|0|||
125977140|NCT02291614|453205933|FG005|Overall Study|Withdrawal by Subject|0|||
125977141|NCT02291614|453205934|FG006|Overall Study|Withdrawal by Subject|0|||
125977142|NCT02291614|453205935|FG007|Overall Study|Withdrawal by Subject|0|||
125977143|NCT02291614|453205936|FG008|Overall Study|Withdrawal by Subject|0|||
125977144|NCT02291614|453205937|FG009|Overall Study|Withdrawal by Subject|2|||
125977145|NCT02291614|453205938|FG010|Overall Study|Withdrawal by Subject|2|||
125977146|NCT02291614|453205928|FG000|Overall Study|Decision by sponsor|0|||
125977147|NCT02291614|453205929|FG001|Overall Study|Decision by sponsor|0|||
125977148|NCT02291614|453205930|FG002|Overall Study|Decision by sponsor|0|||
125977149|NCT02291614|453205931|FG003|Overall Study|Decision by sponsor|1|||
125977150|NCT02291614|453205932|FG004|Overall Study|Decision by sponsor|0|||
125977151|NCT02291614|453205933|FG005|Overall Study|Decision by sponsor|0|||
125977152|NCT02291614|453205934|FG006|Overall Study|Decision by sponsor|0|||
125977153|NCT02291614|453205935|FG007|Overall Study|Decision by sponsor|0|||
125977154|NCT02291614|453205936|FG008|Overall Study|Decision by sponsor|0|||
125977155|NCT02291614|453205937|FG009|Overall Study|Decision by sponsor|0|||
125977156|NCT02291614|453205938|FG010|Overall Study|Decision by sponsor|0|||
125977157|NCT02291614|453205928|FG000|Overall Study|Death|0|||
125977158|NCT02291614|453205929|FG001|Overall Study|Death|0|||
125977159|NCT02291614|453205930|FG002|Overall Study|Death|1|||
125977160|NCT02291614|453205931|FG003|Overall Study|Death|0|||
125977161|NCT02291614|453205932|FG004|Overall Study|Death|1|||
125977162|NCT02291614|453205933|FG005|Overall Study|Death|1|||
125977163|NCT02291614|453205934|FG006|Overall Study|Death|1|||
125977164|NCT02291614|453205935|FG007|Overall Study|Death|0|||
125977165|NCT02291614|453205936|FG008|Overall Study|Death|0|||
125977166|NCT02291614|453205937|FG009|Overall Study|Death|0|||
125977167|NCT02291614|453205938|FG010|Overall Study|Death|0|||
125977168|NCT01662310|453205939|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
125977169|NCT01662310|453205940|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
125977170|NCT01662310|453205941|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
125977171|NCT01662310|453205942|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
125977172|NCT01662310|453205943|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
125977173|NCT01662310|453205939|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
125977174|NCT01662310|453205940|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
125977175|NCT01662310|453205941|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
125977176|NCT01662310|453205942|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
125977177|NCT01662310|453205943|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
125977178|NCT01662310|453205939|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
125977179|NCT01662310|453205940|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125977180|NCT01662310|453205941|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125977181|NCT01662310|453205942|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125977182|NCT01662310|453205943|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125977183|NCT01662310|453205939|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
125977184|NCT01662310|453205940|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
125977185|NCT01662310|453205941|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
125977186|NCT01662310|453205942|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
125977187|NCT01662310|453205943|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
125977188|NCT01662310|453205939|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
125977189|NCT01662310|453205940|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125977190|NCT01662310|453205941|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125977191|NCT01662310|453205942|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125977192|NCT01662310|453205943|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125977193|NCT01662310|453205939|FG000|Run-In or Stabilization Phase|Other|1|||
125977194|NCT01662310|453205940|FG001|Run-In or Stabilization Phase|Other|0|||
125977195|NCT01662310|453205941|FG002|Run-In or Stabilization Phase|Other|0|||
125977196|NCT01662310|453205942|FG003|Run-In or Stabilization Phase|Other|0|||
125977197|NCT01662310|453205943|FG004|Run-In or Stabilization Phase|Other|0|||
125977198|NCT01662310|453205939|FG000|Double-Blind Phase|Adverse Event|0|||
125977199|NCT01662310|453205940|FG001|Double-Blind Phase|Adverse Event|0|||
125977200|NCT01662310|453205941|FG002|Double-Blind Phase|Adverse Event|1|||
125977201|NCT01662310|453205942|FG003|Double-Blind Phase|Adverse Event|0|||
125977202|NCT01662310|453205943|FG004|Double-Blind Phase|Adverse Event|0|||
125977203|NCT01662310|453205939|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125977204|NCT01662310|453205940|FG001|Double-Blind Phase|Lost to Follow-up|3|||
125977205|NCT01662310|453205941|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125977206|NCT01662310|453205942|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125977207|NCT01662310|453205943|FG004|Double-Blind Phase|Lost to Follow-up|0|||
125977208|NCT01662310|453205939|FG000|Double-Blind Phase|Pregnancy|0|||
125977209|NCT01662310|453205940|FG001|Double-Blind Phase|Pregnancy|2|||
125977210|NCT01662310|453205941|FG002|Double-Blind Phase|Pregnancy|0|||
125977211|NCT01662310|453205942|FG003|Double-Blind Phase|Pregnancy|0|||
125977212|NCT01662310|453205943|FG004|Double-Blind Phase|Pregnancy|0|||
125977213|NCT01662310|453205939|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125977214|NCT01662310|453205940|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
125977215|NCT01662310|453205941|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
125977216|NCT01662310|453205942|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125977217|NCT01662310|453205943|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125977218|NCT01662310|453205939|FG000|Double-Blind Phase|Other|0|||
125977219|NCT01662310|453205940|FG001|Double-Blind Phase|Other|0|||
125977220|NCT01662310|453205941|FG002|Double-Blind Phase|Other|1|||
125977221|NCT01662310|453205942|FG003|Double-Blind Phase|Other|0|||
125977222|NCT01662310|453205943|FG004|Double-Blind Phase|Other|0|||
125977223|NCT01662310|453205939|FG000|Double-Blind Phase|Randomized but not treated|0|||
125977224|NCT01662310|453205940|FG001|Double-Blind Phase|Randomized but not treated|1|||
125977225|NCT01662310|453205941|FG002|Double-Blind Phase|Randomized but not treated|0|||
125977226|NCT01662310|453205942|FG003|Double-Blind Phase|Randomized but not treated|0|||
125977227|NCT01662310|453205943|FG004|Double-Blind Phase|Randomized but not treated|0|||
125977228|NCT01662310|453205939|FG000|Open-Label Extension Phase|Adverse Event|0|||
125977229|NCT01662310|453205940|FG001|Open-Label Extension Phase|Adverse Event|0|||
125977230|NCT01662310|453205941|FG002|Open-Label Extension Phase|Adverse Event|0|||
125977231|NCT01662310|453205942|FG003|Open-Label Extension Phase|Adverse Event|3|||
125977232|NCT01662310|453205943|FG004|Open-Label Extension Phase|Adverse Event|0|||
125977233|NCT01662310|453205939|FG000|Open-Label Extension Phase|Death|0|||
125977234|NCT01662310|453205940|FG001|Open-Label Extension Phase|Death|0|||
125977235|NCT01662310|453205941|FG002|Open-Label Extension Phase|Death|0|||
125977236|NCT01662310|453205942|FG003|Open-Label Extension Phase|Death|1|||
125977237|NCT01662310|453205943|FG004|Open-Label Extension Phase|Death|0|||
125977238|NCT01662310|453205939|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
125977239|NCT01662310|453205940|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
125977240|NCT01662310|453205941|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
125977241|NCT01662310|453205942|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
125977242|NCT01662310|453205943|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
125977243|NCT01662310|453205939|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125977244|NCT01662310|453205940|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125977245|NCT01662310|453205941|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125977246|NCT01662310|453205942|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
125977247|NCT01662310|453205943|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
125977248|NCT01662310|453205939|FG000|Open-Label Extension Phase|Pregnancy|0|||
125977249|NCT01662310|453205940|FG001|Open-Label Extension Phase|Pregnancy|0|||
125977250|NCT01662310|453205941|FG002|Open-Label Extension Phase|Pregnancy|0|||
125977251|NCT01662310|453205942|FG003|Open-Label Extension Phase|Pregnancy|1|||
125977252|NCT01662310|453205943|FG004|Open-Label Extension Phase|Pregnancy|0|||
125977253|NCT01662310|453205939|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
125977254|NCT01662310|453205940|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
125977255|NCT01662310|453205941|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
125977256|NCT01662310|453205942|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
125977257|NCT01662310|453205943|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
125977258|NCT01302847|453205947|FG000|Overall Study|Death|0|||
125977259|NCT01302847|453205948|FG001|Overall Study|Death|1|||
125977260|NCT01302847|453205949|FG002|Overall Study|Death|0|||
125977261|NCT01302847|453205950|FG003|Overall Study|Death|0|||
125977262|NCT01302847|453205951|FG004|Overall Study|Death|0|||
125977263|NCT01302847|453205952|FG005|Overall Study|Death|1|||
125977264|NCT01302847|453205953|FG006|Overall Study|Death|1|||
125977265|NCT01302847|453205954|FG007|Overall Study|Death|0|||
125977266|NCT01302847|453205947|FG000|Overall Study|Pregnancy|2|||
125977267|NCT01302847|453205948|FG001|Overall Study|Pregnancy|0|||
125977268|NCT01302847|453205949|FG002|Overall Study|Pregnancy|0|||
125977269|NCT01302847|453205950|FG003|Overall Study|Pregnancy|0|||
125977270|NCT01302847|453205951|FG004|Overall Study|Pregnancy|0|||
125977271|NCT01302847|453205952|FG005|Overall Study|Pregnancy|0|||
125977272|NCT01302847|453205953|FG006|Overall Study|Pregnancy|0|||
125977273|NCT01302847|453205954|FG007|Overall Study|Pregnancy|0|||
125977274|NCT01302847|453205947|FG000|Overall Study|Virologic failure|0|||
125977275|NCT01302847|453205948|FG001|Overall Study|Virologic failure|2|||
125977276|NCT01302847|453205949|FG002|Overall Study|Virologic failure|0|||
125977277|NCT01302847|453205950|FG003|Overall Study|Virologic failure|2|||
125977278|NCT01302847|453205951|FG004|Overall Study|Virologic failure|1|||
125977279|NCT01302847|453205952|FG005|Overall Study|Virologic failure|3|||
125977280|NCT01302847|453205953|FG006|Overall Study|Virologic failure|1|||
125977281|NCT01302847|453205954|FG007|Overall Study|Virologic failure|2|||
125977282|NCT01302847|453205947|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125977283|NCT01302847|453205948|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125977284|NCT01302847|453205949|FG002|Overall Study|Severe debilitation, unable to continue|0|||
125977285|NCT01302847|453205950|FG003|Overall Study|Severe debilitation, unable to continue|0|||
125977286|NCT01302847|453205951|FG004|Overall Study|Severe debilitation, unable to continue|0|||
125977287|NCT01302847|453205952|FG005|Overall Study|Severe debilitation, unable to continue|1|||
125977288|NCT01302847|453205953|FG006|Overall Study|Severe debilitation, unable to continue|1|||
125977289|NCT01302847|453205954|FG007|Overall Study|Severe debilitation, unable to continue|0|||
125977290|NCT01302847|453205947|FG000|Overall Study|Not able to get to clinic|1|||
125977291|NCT01302847|453205948|FG001|Overall Study|Not able to get to clinic|1|||
125977292|NCT01302847|453205949|FG002|Overall Study|Not able to get to clinic|0|||
125977293|NCT01302847|453205950|FG003|Overall Study|Not able to get to clinic|0|||
125977294|NCT01302847|453205951|FG004|Overall Study|Not able to get to clinic|0|||
125977295|NCT01302847|453205952|FG005|Overall Study|Not able to get to clinic|0|||
125977296|NCT01302847|453205953|FG006|Overall Study|Not able to get to clinic|0|||
125977297|NCT01302847|453205954|FG007|Overall Study|Not able to get to clinic|0|||
125977298|NCT01302847|453205947|FG000|Overall Study|Site closing|2|||
126179748|NCT02137837|453942261|FG002|Overall Study|Progression/relapse|7|||
125977299|NCT01302847|453205948|FG001|Overall Study|Site closing|2|||
125977300|NCT01302847|453205949|FG002|Overall Study|Site closing|0|||
125977301|NCT01302847|453205950|FG003|Overall Study|Site closing|0|||
125977302|NCT01302847|453205951|FG004|Overall Study|Site closing|0|||
125977303|NCT01302847|453205952|FG005|Overall Study|Site closing|0|||
125977304|NCT01302847|453205953|FG006|Overall Study|Site closing|0|||
125977305|NCT01302847|453205954|FG007|Overall Study|Site closing|0|||
125977306|NCT01302847|453205947|FG000|Overall Study|Withdrawal by Subject|1|||
125977307|NCT01302847|453205948|FG001|Overall Study|Withdrawal by Subject|0|||
125977308|NCT01302847|453205949|FG002|Overall Study|Withdrawal by Subject|0|||
125977309|NCT01302847|453205950|FG003|Overall Study|Withdrawal by Subject|0|||
125977310|NCT01302847|453205951|FG004|Overall Study|Withdrawal by Subject|1|||
125977311|NCT01302847|453205952|FG005|Overall Study|Withdrawal by Subject|0|||
125977312|NCT01302847|453205953|FG006|Overall Study|Withdrawal by Subject|0|||
125977313|NCT01302847|453205954|FG007|Overall Study|Withdrawal by Subject|1|||
125977314|NCT01302847|453205947|FG000|Overall Study|Not willing to adhere to requirements|5|||
125977315|NCT01302847|453205948|FG001|Overall Study|Not willing to adhere to requirements|0|||
125977316|NCT01302847|453205949|FG002|Overall Study|Not willing to adhere to requirements|1|||
125977317|NCT01302847|453205950|FG003|Overall Study|Not willing to adhere to requirements|0|||
125977318|NCT01302847|453205951|FG004|Overall Study|Not willing to adhere to requirements|0|||
125977319|NCT01302847|453205952|FG005|Overall Study|Not willing to adhere to requirements|0|||
125977320|NCT01302847|453205953|FG006|Overall Study|Not willing to adhere to requirements|0|||
125977321|NCT01302847|453205954|FG007|Overall Study|Not willing to adhere to requirements|2|||
125977322|NCT01302847|453205947|FG000|Overall Study|Site unable to contact participant|2|||
125977323|NCT01302847|453205948|FG001|Overall Study|Site unable to contact participant|1|||
125977324|NCT01302847|453205949|FG002|Overall Study|Site unable to contact participant|0|||
125977325|NCT01302847|453205950|FG003|Overall Study|Site unable to contact participant|0|||
125977326|NCT01302847|453205951|FG004|Overall Study|Site unable to contact participant|0|||
125977327|NCT01302847|453205952|FG005|Overall Study|Site unable to contact participant|0|||
125977328|NCT01302847|453205953|FG006|Overall Study|Site unable to contact participant|2|||
125977329|NCT01302847|453205954|FG007|Overall Study|Site unable to contact participant|0|||
125977330|NCT04302350|453205957|FG000|Overall Study|Physician Decision|1|||
125977331|NCT04302350|453205958|FG001|Overall Study|Physician Decision|1|||
125977332|NCT04302350|453205959|FG002|Overall Study|Physician Decision|2|||
125977333|NCT04302350|453205957|FG000|Overall Study|Lack of Efficacy|1|||
125977334|NCT04302350|453205958|FG001|Overall Study|Lack of Efficacy|1|||
125977335|NCT04302350|453205959|FG002|Overall Study|Lack of Efficacy|4|||
125977336|NCT04302350|453205957|FG000|Overall Study|Adverse Event|0|||
125977337|NCT04302350|453205958|FG001|Overall Study|Adverse Event|1|||
125977338|NCT04302350|453205959|FG002|Overall Study|Adverse Event|2|||
125977339|NCT00374322|453205962|FG000|Overall Study|Lost to Follow-up|92|||
125977340|NCT00374322|453205963|FG001|Overall Study|Lost to Follow-up|90|||
125977341|NCT00374322|453205962|FG000|Overall Study|Protocol Violation|8|||
125977342|NCT00374322|453205963|FG001|Overall Study|Protocol Violation|3|||
125977343|NCT00374322|453205962|FG000|Overall Study|Withdrawal by Subject|235|||
125977344|NCT00374322|453205963|FG001|Overall Study|Withdrawal by Subject|167|||
125977345|NCT00374322|453205962|FG000|Overall Study|Sponsor Terminated Study|866|||
125977346|NCT00374322|453205963|FG001|Overall Study|Sponsor Terminated Study|990|||
125977347|NCT00374322|453205962|FG000|Overall Study|Physician Decision|36|||
125977348|NCT00374322|453205963|FG001|Overall Study|Physician Decision|32|||
125977349|NCT00374322|453205962|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
125977350|NCT00374322|453205963|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
125977351|NCT00374322|453205962|FG000|Overall Study|Sponsor Decision|2|||
125977352|NCT00374322|453205963|FG001|Overall Study|Sponsor Decision|3|||
125977353|NCT00374322|453205962|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
125977354|NCT00374322|453205963|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
125977355|NCT00374322|453205962|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
125977356|NCT00374322|453205963|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
125977357|NCT00374322|453205962|FG000|Overall Study|Severe Toxicity|1|||
125977358|NCT00374322|453205963|FG001|Overall Study|Severe Toxicity|0|||
125977359|NCT00374322|453205962|FG000|Overall Study|Site Closed|2|||
125977360|NCT00374322|453205963|FG001|Overall Study|Site Closed|2|||
125977361|NCT00374322|453205962|FG000|Overall Study|Participant Changed Physician|1|||
125977362|NCT00374322|453205963|FG001|Overall Study|Participant Changed Physician|0|||
125977363|NCT00374322|453205962|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
125977364|NCT00374322|453205963|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
125977365|NCT00374322|453205962|FG000|Overall Study|Noncompliance with Study Requirements|0|||
126179749|NCT02137837|453942259|FG000|Overall Study|Not protocol specified|2|||
125977366|NCT00374322|453205963|FG001|Overall Study|Noncompliance with Study Requirements|1|||
125977367|NCT00374322|453205962|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
125977368|NCT00374322|453205963|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
125977369|NCT00374322|453205962|FG000|Overall Study|Did Not Receive Study Medication|8|||
125977370|NCT00374322|453205963|FG001|Overall Study|Did Not Receive Study Medication|6|||
126179750|NCT02137837|453942260|FG001|Overall Study|Not protocol specified|1|||
125977371|NCT02012491|453205964|FG000|Overall Study|Lost to Follow-up|1|||
125977372|NCT02012491|453205965|FG001|Overall Study|Lost to Follow-up|0|||
125977373|NCT02012491|453205964|FG000|Overall Study|Protocol Violation|0|||
125977374|NCT02012491|453205965|FG001|Overall Study|Protocol Violation|1|||
125977375|NCT02012491|453205964|FG000|Overall Study|Withdrawal by Subject|1|||
125977376|NCT02012491|453205965|FG001|Overall Study|Withdrawal by Subject|0|||
125977377|NCT00450411|453205966|FG000|Overall Study|Protocol Violation|6|||
125977378|NCT00450411|453205966|FG000|Overall Study|No protocol treatment|2|||
125977379|NCT03969719|453205977|FG000|Overall Study|Other reasons not specified|1|||
125977380|NCT03969719|453205978|FG001|Overall Study|Other reasons not specified|1|||
125977381|NCT03969719|453205979|FG002|Overall Study|Other reasons not specified|3|||
125977382|NCT03969719|453205977|FG000|Overall Study|Withdrawal by Subject|2|||
125977383|NCT03969719|453205978|FG001|Overall Study|Withdrawal by Subject|3|||
125977384|NCT03969719|453205979|FG002|Overall Study|Withdrawal by Subject|2|||
125977385|NCT03969719|453205977|FG000|Overall Study|Protocol Violation|1|||
125977386|NCT03969719|453205978|FG001|Overall Study|Protocol Violation|2|||
125977387|NCT03969719|453205979|FG002|Overall Study|Protocol Violation|0|||
125977388|NCT03969719|453205977|FG000|Overall Study|Adverse Event|0|||
125977389|NCT03969719|453205978|FG001|Overall Study|Adverse Event|2|||
125977390|NCT03969719|453205979|FG002|Overall Study|Adverse Event|0|||
125977391|NCT03969719|453205977|FG000|Overall Study|Lost to Follow-up|0|||
125977392|NCT03969719|453205978|FG001|Overall Study|Lost to Follow-up|1|||
125977393|NCT03969719|453205979|FG002|Overall Study|Lost to Follow-up|0|||
125977394|NCT02130193|453205983|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
125977395|NCT02130193|453205984|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
125977396|NCT02130193|453205985|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
125977397|NCT02130193|453205983|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
125977398|NCT02130193|453205984|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
125977399|NCT02130193|453205985|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
125977400|NCT02130193|453205983|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
125977401|NCT02130193|453205984|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
125977402|NCT02130193|453205985|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
125977403|NCT02130193|453205983|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
125977404|NCT02130193|453205984|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
125977405|NCT02130193|453205985|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
125977406|NCT01297959|453205986|FG000|Overall Study|Adverse Event|0|||
125977407|NCT01297959|453205987|FG001|Overall Study|Adverse Event|1|||
125977408|NCT01297959|453205986|FG000|Overall Study|Protocol Violation|2|||
125977409|NCT01297959|453205987|FG001|Overall Study|Protocol Violation|1|||
125977410|NCT01297959|453205986|FG000|Overall Study|Withdrawal by Subject|5|||
125977411|NCT01297959|453205987|FG001|Overall Study|Withdrawal by Subject|4|||
125977412|NCT01297959|453205986|FG000|Overall Study|Physician Decision|0|||
125977413|NCT01297959|453205987|FG001|Overall Study|Physician Decision|1|||
125977414|NCT01297959|453205986|FG000|Overall Study|Unrelated medical illness / complication|0|||
125977415|NCT01297959|453205987|FG001|Overall Study|Unrelated medical illness / complication|2|||
125977416|NCT01297959|453205986|FG000|Overall Study|Other|13|||
125977417|NCT01297959|453205987|FG001|Overall Study|Other|7|||
125977418|NCT01667432|453205990|FG000|Overall Study|Premature Study Termination|26|||
125977419|NCT01667432|453205990|FG000|Overall Study|Failure to Return|10|||
125977420|NCT01667432|453205990|FG000|Overall Study|Moved to Another Center|3|||
125977421|NCT01667432|453205990|FG000|Overall Study|Lost to Follow-up|3|||
125977422|NCT01667432|453205990|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
125977423|NCT01667432|453205990|FG000|Overall Study|Insufficient Therapeutic Response|4|||
125977424|NCT01667432|453205990|FG000|Overall Study|Adverse Event|1|||
125977425|NCT01667432|453205990|FG000|Overall Study|Protocol Deviation|2|||
125977426|NCT01667432|453205990|FG000|Overall Study|Principal Investigator Decision|1|||
125977427|NCT01667432|453205990|FG000|Overall Study|Reason Not Specified|2|||
125977428|NCT01667432|453205990|FG000|Overall Study|Missing Information|4|||
125977429|NCT02077166|453205993|FG000|Overall Study|Death|6|||
125977430|NCT02077166|453205994|FG001|Overall Study|Death|7|||
126179751|NCT02137837|453942261|FG002|Overall Study|Not protocol specified|3|||
126179752|NCT02141217|453942262|FG000|Overall Study|Adverse Event|1|||
125977431|NCT02077166|453205995|FG002|Overall Study|Death|5|||
125977432|NCT02077166|453205996|FG003|Overall Study|Death|6|||
125977433|NCT02077166|453205997|FG004|Overall Study|Death|4|||
125977434|NCT02077166|453205998|FG005|Overall Study|Death|32|||
126179753|NCT02141217|453942263|FG001|Overall Study|Adverse Event|2|||
125977435|NCT02077166|453205999|FG006|Overall Study|Death|22|||
125977436|NCT02077166|453205993|FG000|Overall Study|Study Closure by Sponsor|3|||
125977437|NCT02077166|453205994|FG001|Overall Study|Study Closure by Sponsor|0|||
125977438|NCT02077166|453205995|FG002|Overall Study|Study Closure by Sponsor|2|||
125977439|NCT02077166|453205996|FG003|Overall Study|Study Closure by Sponsor|2|||
126179754|NCT02141217|453942262|FG000|Overall Study|Protocol Violation|1|||
125977440|NCT02077166|453205997|FG004|Overall Study|Study Closure by Sponsor|2|||
125977441|NCT02077166|453205998|FG005|Overall Study|Study Closure by Sponsor|12|||
126179755|NCT02141217|453942263|FG001|Overall Study|Protocol Violation|4|||
126179756|NCT02141217|453942262|FG000|Overall Study|Withdrawal by Subject|6|||
125977442|NCT02077166|453205999|FG006|Overall Study|Study Closure by Sponsor|4|||
125977443|NCT02077166|453205993|FG000|Overall Study|Lost to Follow-up|0|||
125977444|NCT02077166|453205994|FG001|Overall Study|Lost to Follow-up|0|||
125977445|NCT02077166|453205995|FG002|Overall Study|Lost to Follow-up|0|||
125977446|NCT02077166|453205996|FG003|Overall Study|Lost to Follow-up|0|||
125977447|NCT02077166|453205997|FG004|Overall Study|Lost to Follow-up|0|||
125977448|NCT02077166|453205998|FG005|Overall Study|Lost to Follow-up|1|||
125977449|NCT02077166|453205999|FG006|Overall Study|Lost to Follow-up|0|||
125977450|NCT02077166|453205993|FG000|Overall Study|Withdrawal by Subject|3|||
125977451|NCT02077166|453205994|FG001|Overall Study|Withdrawal by Subject|0|||
125977452|NCT02077166|453205995|FG002|Overall Study|Withdrawal by Subject|1|||
125977453|NCT02077166|453205996|FG003|Overall Study|Withdrawal by Subject|1|||
125977454|NCT02077166|453205997|FG004|Overall Study|Withdrawal by Subject|1|||
125977455|NCT02077166|453205998|FG005|Overall Study|Withdrawal by Subject|3|||
125977456|NCT02077166|453205999|FG006|Overall Study|Withdrawal by Subject|0|||
125977457|NCT02077166|453205993|FG000|Overall Study|Other, Not Specified|0|||
125977458|NCT02077166|453205994|FG001|Overall Study|Other, Not Specified|0|||
125977459|NCT02077166|453205995|FG002|Overall Study|Other, Not Specified|1|||
125977460|NCT02077166|453205996|FG003|Overall Study|Other, Not Specified|0|||
125977461|NCT02077166|453205997|FG004|Overall Study|Other, Not Specified|1|||
125977462|NCT02077166|453205998|FG005|Overall Study|Other, Not Specified|7|||
125977463|NCT02077166|453205999|FG006|Overall Study|Other, Not Specified|8|||
125977464|NCT00707031|453206000|FG000|Overall Study|Adverse Event|45|||
125977465|NCT00707031|453206001|FG001|Overall Study|Adverse Event|45|||
125977466|NCT00707031|453206000|FG000|Overall Study|Lack of Efficacy|19|||
125977467|NCT00707031|453206001|FG001|Overall Study|Lack of Efficacy|6|||
125977468|NCT00707031|453206000|FG000|Overall Study|Lost to Follow-up|2|||
125977469|NCT00707031|453206001|FG001|Overall Study|Lost to Follow-up|1|||
125977470|NCT00707031|453206000|FG000|Overall Study|Protocol Violation|1|||
125977471|NCT00707031|453206001|FG001|Overall Study|Protocol Violation|0|||
125977472|NCT00707031|453206000|FG000|Overall Study|Withdrawal by Subject|7|||
125977473|NCT00707031|453206001|FG001|Overall Study|Withdrawal by Subject|8|||
125977474|NCT00707031|453206000|FG000|Overall Study|Poor Compliance to Protocol|7|||
125977475|NCT00707031|453206001|FG001|Overall Study|Poor Compliance to Protocol|13|||
125977476|NCT00707031|453206000|FG000|Overall Study|Familial or Personal Reasons|12|||
125977477|NCT00707031|453206001|FG001|Overall Study|Familial or Personal Reasons|15|||
125977478|NCT00707031|453206000|FG000|Overall Study|Serious Noncompliance|2|||
125977479|NCT00707031|453206001|FG001|Overall Study|Serious Noncompliance|3|||
125977480|NCT00707031|453206000|FG000|Overall Study|Sponsor Decision|9|||
125977481|NCT00707031|453206001|FG001|Overall Study|Sponsor Decision|8|||
125977482|NCT03519854|453206002|FG000|Overall Study|Technical Error|0|||
125977483|NCT03519854|453206003|FG001|Overall Study|Technical Error|0|||
125977484|NCT03519854|453206004|FG002|Overall Study|Technical Error|1|||
125977485|NCT03519854|453206005|FG003|Overall Study|Technical Error|0|||
125977486|NCT03519854|453206006|FG004|Overall Study|Technical Error|0|||
125977487|NCT03519854|453206007|FG005|Overall Study|Technical Error|0|||
125977488|NCT03519854|453206008|FG006|Overall Study|Technical Error|0|||
125977489|NCT03519854|453206009|FG007|Overall Study|Technical Error|0|||
125977490|NCT03519854|453206010|FG008|Overall Study|Technical Error|0|||
125977491|NCT03519854|453206011|FG009|Overall Study|Technical Error|0|||
125977492|NCT03519854|453206012|FG010|Overall Study|Technical Error|0|||
125977493|NCT03519854|453206013|FG011|Overall Study|Technical Error|0|||
125977494|NCT03519854|453206014|FG012|Overall Study|Technical Error|0|||
125977495|NCT03519854|453206015|FG013|Overall Study|Technical Error|0|||
125977496|NCT03519854|453206016|FG014|Overall Study|Technical Error|0|||
125977497|NCT03519854|453206017|FG015|Overall Study|Technical Error|0|||
125977498|NCT03519854|453206018|FG016|Overall Study|Technical Error|0|||
125977499|NCT03519854|453206019|FG017|Overall Study|Technical Error|0|||
125977500|NCT00818753|453206025|FG000|Overall Study|Protocol Violation|1|||
125977501|NCT00818753|453206026|FG001|Overall Study|Protocol Violation|0|||
125977502|NCT00818753|453206027|FG002|Overall Study|Protocol Violation|0|||
125977503|NCT00818753|453206025|FG000|Overall Study|Other reason (not specified)|0|||
125977504|NCT00818753|453206026|FG001|Overall Study|Other reason (not specified)|0|||
126179757|NCT02141217|453942263|FG001|Overall Study|Withdrawal by Subject|0|||
125977505|NCT00818753|453206027|FG002|Overall Study|Other reason (not specified)|1|||
125977506|NCT00818753|453206025|FG000|Overall Study|Randomised and not treated|2|||
125977507|NCT00818753|453206026|FG001|Overall Study|Randomised and not treated|0|||
125977508|NCT00818753|453206027|FG002|Overall Study|Randomised and not treated|0|||
126179758|NCT02141217|453942262|FG000|Overall Study|Lost to Follow-up|1|||
126179759|NCT02141217|453942263|FG001|Overall Study|Lost to Follow-up|1|||
126179760|NCT02141217|453942262|FG000|Overall Study|Physician Decision|1|||
126179761|NCT02141217|453942263|FG001|Overall Study|Physician Decision|0|||
126179762|NCT02141217|453942262|FG000|Overall Study|Surgical Intervention|1|||
126179763|NCT02141217|453942263|FG001|Overall Study|Surgical Intervention|1|||
126179764|NCT01181141|453942268|FG000|Overall Study|Adverse Event|2|||
126179765|NCT01181141|453942269|FG001|Overall Study|Adverse Event|1|||
126179766|NCT01181141|453942268|FG000|Overall Study|Lack of Efficacy|1|||
126179767|NCT01181141|453942269|FG001|Overall Study|Lack of Efficacy|0|||
126179768|NCT01181141|453942268|FG000|Overall Study|Lost to Follow-up|1|||
126179769|NCT01181141|453942269|FG001|Overall Study|Lost to Follow-up|1|||
126179770|NCT01181141|453942268|FG000|Overall Study|Physician Decision|2|||
126179771|NCT01181141|453942269|FG001|Overall Study|Physician Decision|0|||
126179772|NCT01181141|453942268|FG000|Overall Study|Protocol Violation|3|||
126179773|NCT01181141|453942269|FG001|Overall Study|Protocol Violation|1|||
126179774|NCT01181141|453942268|FG000|Overall Study|Withdrawal by Subject|3|||
126179775|NCT01181141|453942269|FG001|Overall Study|Withdrawal by Subject|1|||
126179776|NCT00448760|453942270|FG000|Overall Study|Death|3|||
126179777|NCT01213264|453942276|FG000|Overall Study|Adverse Event|1|||
126179778|NCT01213264|453942277|FG001|Overall Study|Adverse Event|0|||
126179779|NCT01213264|453942278|FG002|Overall Study|Adverse Event|0|||
126179780|NCT01213264|453942276|FG000|Overall Study|Lost to Follow-up|1|||
126179781|NCT01213264|453942277|FG001|Overall Study|Lost to Follow-up|2|||
126179782|NCT01213264|453942278|FG002|Overall Study|Lost to Follow-up|6|||
126179783|NCT00118911|453942279|FG000|Overall Study|Withdrawal by Subject|2|||
126179784|NCT00118911|453942280|FG001|Overall Study|Withdrawal by Subject|5|||
126179785|NCT05507580|453942281|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126179786|NCT05507580|453942282|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126179787|NCT05507580|453942283|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
126179788|NCT05507580|453942284|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
126179789|NCT05507580|453942285|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
126179790|NCT05507580|453942286|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
126179791|NCT05507580|453942281|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
126179792|NCT05507580|453942282|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126179793|NCT05507580|453942283|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126179794|NCT05507580|453942284|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126179795|NCT05507580|453942285|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126179796|NCT05507580|453942286|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126179797|NCT05507580|453942281|FG000|Double-Blind Treatment Period|Other, not specified|5|||
126179798|NCT05507580|453942282|FG001|Double-Blind Treatment Period|Other, not specified|4|||
126179799|NCT05507580|453942283|FG002|Double-Blind Treatment Period|Other, not specified|0|||
126179800|NCT05507580|453942284|FG003|Double-Blind Treatment Period|Other, not specified|0|||
126179801|NCT05507580|453942285|FG004|Double-Blind Treatment Period|Other, not specified|0|||
126179802|NCT05507580|453942286|FG005|Double-Blind Treatment Period|Other, not specified|0|||
126179803|NCT05507580|453942281|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
126179804|NCT05507580|453942282|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
126179805|NCT05507580|453942283|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
126179806|NCT05507580|453942284|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
126179807|NCT05507580|453942285|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
126179808|NCT05507580|453942286|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
126179809|NCT05507580|453942281|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
126179810|NCT05507580|453942282|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
126179811|NCT05507580|453942283|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
126179812|NCT05507580|453942284|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
126179813|NCT05507580|453942285|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
126179814|NCT05507580|453942286|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
126179815|NCT05507580|453942281|FG000|Single-Blind Treatment Period|Other, not specified|0|||
126179816|NCT05507580|453942282|FG001|Single-Blind Treatment Period|Other, not specified|0|||
126179817|NCT05507580|453942283|FG002|Single-Blind Treatment Period|Other, not specified|2|||
126179818|NCT05507580|453942284|FG003|Single-Blind Treatment Period|Other, not specified|7|||
126179819|NCT05507580|453942285|FG004|Single-Blind Treatment Period|Other, not specified|3|||
126179820|NCT05507580|453942286|FG005|Single-Blind Treatment Period|Other, not specified|5|||
126179821|NCT04702984|453942287|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
126179822|NCT03496662|453942288|FG000|Overall Study|Adverse Event|0|||
126179823|NCT03496662|453942289|FG001|Overall Study|Adverse Event|0|||
126179824|NCT03496662|453942290|FG002|Overall Study|Adverse Event|4|||
126179825|NCT03496662|453942288|FG000|Overall Study|Withdrawal by Subject|1|||
126179826|NCT03496662|453942289|FG001|Overall Study|Withdrawal by Subject|0|||
126179827|NCT03496662|453942290|FG002|Overall Study|Withdrawal by Subject|2|||
126179828|NCT03496662|453942288|FG000|Overall Study|Death|0|||
126179829|NCT03496662|453942289|FG001|Overall Study|Death|0|||
126179830|NCT03496662|453942290|FG002|Overall Study|Death|2|||
126179831|NCT03496662|453942288|FG000|Overall Study|Noncompliance|0|||
126179832|NCT03496662|453942289|FG001|Overall Study|Noncompliance|0|||
126179833|NCT03496662|453942290|FG002|Overall Study|Noncompliance|1|||
126179834|NCT03037307|453942291|FG000|Period 1|Did Not Meet Study Criteria|0|||
126179835|NCT03037307|453942292|FG001|Period 1|Did Not Meet Study Criteria|0|||
126179836|NCT03037307|453942293|FG002|Period 1|Did Not Meet Study Criteria|0|||
126179837|NCT03037307|453942294|FG003|Period 1|Did Not Meet Study Criteria|1|||
126179838|NCT03037307|453942295|FG004|Period 1|Did Not Meet Study Criteria|0|||
126179839|NCT03037307|453942296|FG005|Period 1|Did Not Meet Study Criteria|0|||
126179840|NCT00691093|453942297|FG000|Overall Study|Adverse Event|1|||
126179841|NCT00691093|453942297|FG000|Overall Study|Lost to Follow-up|1|||
126179842|NCT00691093|453942297|FG000|Overall Study|Lack of Efficacy|1|||
126179843|NCT00691093|453942297|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
126179844|NCT01588353|453942298|FG000|Step2|Withdrawal by Subject|0|||
126179845|NCT01588353|453942299|FG001|Step2|Withdrawal by Subject|1|||
126179846|NCT01588353|453942300|FG002|Step2|Withdrawal by Subject|0|||
126179847|NCT01588353|453942298|FG000|Step3|Adverse Event|0|||
126179848|NCT01588353|453942299|FG001|Step3|Adverse Event|0|||
126179849|NCT01588353|453942300|FG002|Step3|Adverse Event|2|||
126179850|NCT05489081|453942302|FG000|Overall Study|student left classroom|0|||
126179851|NCT05489081|453942303|FG001|Overall Study|student left classroom|1|||
126179852|NCT05489081|453942302|FG000|Overall Study|teacher left school|0|||
126179853|NCT05489081|453942303|FG001|Overall Study|teacher left school|2|||
126179854|NCT00810810|453942304|FG000|Overall Study|Withdrawal by Subject|0|||
126179855|NCT00810810|453942305|FG001|Overall Study|Withdrawal by Subject|8|||
126179856|NCT00810810|453942306|FG002|Overall Study|Withdrawal by Subject|10|||
126179857|NCT00810810|453942307|FG003|Overall Study|Withdrawal by Subject|8|||
126179858|NCT00810810|453942304|FG000|Overall Study|Physician Decision|0|||
126179859|NCT00810810|453942305|FG001|Overall Study|Physician Decision|3|||
126179860|NCT00810810|453942306|FG002|Overall Study|Physician Decision|1|||
126179861|NCT00810810|453942307|FG003|Overall Study|Physician Decision|5|||
126179862|NCT01409993|453942308|FG000|Overall Study|Adverse Event|4|||
126179863|NCT01409993|453942309|FG001|Overall Study|Adverse Event|4|||
126179864|NCT01409993|453942310|FG002|Overall Study|Adverse Event|3|||
126179865|NCT01409993|453942311|FG003|Overall Study|Adverse Event|1|||
126179866|NCT01409993|453942308|FG000|Overall Study|Withdrawal by Subject|0|||
126179867|NCT01409993|453942309|FG001|Overall Study|Withdrawal by Subject|0|||
126179868|NCT01409993|453942310|FG002|Overall Study|Withdrawal by Subject|0|||
126179869|NCT01409993|453942311|FG003|Overall Study|Withdrawal by Subject|4|||
126179870|NCT01409993|453942308|FG000|Overall Study|Lost to Follow-up|0|||
126179871|NCT01409993|453942309|FG001|Overall Study|Lost to Follow-up|1|||
126179872|NCT01409993|453942310|FG002|Overall Study|Lost to Follow-up|0|||
126179873|NCT01409993|453942311|FG003|Overall Study|Lost to Follow-up|0|||
126179874|NCT01700985|453942312|FG000|Overall Study|Incarcerated|0|||
126179875|NCT01700985|453942313|FG001|Overall Study|Incarcerated|1|||
126179876|NCT05067452|453942314|FG000|Overall Study|Lost to Follow-up|0|||
126179877|NCT05067452|453942315|FG001|Overall Study|Lost to Follow-up|4|||
126179878|NCT00067470|453942318|FG000|Overall Study|Withdrawal by Subject|0|||
126179879|NCT00067470|453942319|FG001|Overall Study|Withdrawal by Subject|1|||
126179880|NCT03074149|453942320|FG000|Overall Study|Reason unknown|22|||
126179881|NCT03074149|453942321|FG001|Overall Study|Reason unknown|35|||
126179882|NCT03074149|453942320|FG000|Overall Study|Death|10|||
126179883|NCT03074149|453942321|FG001|Overall Study|Death|45|||
126179884|NCT00050622|453942322|FG000|Overall Study|Adverse Event|1|||
126179885|NCT01192204|453942323|FG000|Overall Study|could not keep recall appointments|1|||
126179886|NCT01192204|453942324|FG001|Overall Study|could not keep recall appointments|0|||
126179887|NCT02146248|453942325|FG000|Overall Study|Withdrawal by Subject|2|||
126179888|NCT01315847|453942326|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
126179889|NCT01315847|453942327|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
126179890|NCT01315847|453942326|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
126179891|NCT01315847|453942327|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
126179892|NCT02247401|453942328|FG000|Overall Study|Adverse Event|1|||
126179893|NCT02247401|453942329|FG001|Overall Study|Adverse Event|0|||
126179894|NCT02247401|453942330|FG002|Overall Study|Adverse Event|0|||
126179895|NCT02247401|453942328|FG000|Overall Study|Withdrawal by Subject|4|||
126179896|NCT02247401|453942329|FG001|Overall Study|Withdrawal by Subject|1|||
126179897|NCT02247401|453942330|FG002|Overall Study|Withdrawal by Subject|1|||
126179898|NCT02247401|453942328|FG000|Overall Study|Lost to Follow-up|1|||
126179899|NCT02247401|453942329|FG001|Overall Study|Lost to Follow-up|1|||
126179900|NCT02247401|453942330|FG002|Overall Study|Lost to Follow-up|1|||
126179901|NCT01117012|453942332|FG000|Overall Study|Adverse Event|0|||
126179902|NCT01117012|453942333|FG001|Overall Study|Adverse Event|1|||
126179903|NCT01117012|453942332|FG000|Overall Study|Death|1|||
126179904|NCT01117012|453942333|FG001|Overall Study|Death|1|||
126179905|NCT01117012|453942332|FG000|Overall Study|Withdrawal by Subject|3|||
126179906|NCT01117012|453942333|FG001|Overall Study|Withdrawal by Subject|0|||
126179907|NCT01117012|453942332|FG000|Overall Study|Undefined|4|||
126179908|NCT01117012|453942333|FG001|Overall Study|Undefined|3|||
126179909|NCT03695393|453942334|FG000|Overall Study|Death|3|||
126179910|NCT03695393|453942335|FG001|Overall Study|Death|1|||
126179911|NCT03695393|453942334|FG000|Overall Study|Lost to Follow-up|0|||
126179912|NCT03695393|453942335|FG001|Overall Study|Lost to Follow-up|1|||
126179913|NCT00673894|453942336|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
126179914|NCT00673894|453942337|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
126179915|NCT00673894|453942336|FG000|First Intervention 4 Weeks|Adverse Event|1|||
126179916|NCT00673894|453942337|FG001|First Intervention 4 Weeks|Adverse Event|0|||
126179917|NCT01164865|453942338|FG000|Overall Study|Lost to Follow-up|2|||
126179918|NCT01164865|453942339|FG001|Overall Study|Lost to Follow-up|1|||
126179919|NCT00405821|453942344|FG000|Overall Study|Death|5|||
126179920|NCT00405821|453942345|FG001|Overall Study|Death|7|||
126179921|NCT00405821|453942344|FG000|Overall Study|Lost to Follow-up|7|||
126179922|NCT00405821|453942345|FG001|Overall Study|Lost to Follow-up|7|||
126179923|NCT00405821|453942344|FG000|Overall Study|Protocol Violation|1|||
126179924|NCT00405821|453942345|FG001|Overall Study|Protocol Violation|0|||
126179925|NCT00405821|453942344|FG000|Overall Study|initiated ART|9|||
126179926|NCT00405821|453942345|FG001|Overall Study|initiated ART|8|||
126179927|NCT01586806|453942347|FG000|Overall Study|Protocol Violation|0|||
126179928|NCT01586806|453942348|FG001|Overall Study|Protocol Violation|1|||
126179929|NCT01586806|453942349|FG002|Overall Study|Protocol Violation|0|||
126179930|NCT01586806|453942347|FG000|Overall Study|Withdrawal by Subject|1|||
126179931|NCT01586806|453942348|FG001|Overall Study|Withdrawal by Subject|0|||
126179932|NCT01586806|453942349|FG002|Overall Study|Withdrawal by Subject|0|||
126179933|NCT01586806|453942347|FG000|Overall Study|Lost to Follow-up|2|||
126179934|NCT01586806|453942348|FG001|Overall Study|Lost to Follow-up|3|||
126179935|NCT01586806|453942349|FG002|Overall Study|Lost to Follow-up|2|||
126179936|NCT01769469|453942351|FG000|Overall Study|Consent Withdrawn|5|||
126179937|NCT01769469|453942351|FG000|Overall Study|Moved Out Of Area|3|||
126179938|NCT01769469|453942351|FG000|Overall Study|Lost to Follow-up|17|||
126179939|NCT01769469|453942351|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
126179940|NCT01769469|453942351|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
126179941|NCT02031432|453942352|FG000|Overall Study|Protocol Violation|1|||
126179942|NCT02031432|453942352|FG000|Overall Study|Lack of Efficacy|5|||
126179943|NCT02031432|453942352|FG000|Overall Study|Cancer Progression|2|||
126179944|NCT02031432|453942352|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
126179945|NCT02031432|453942352|FG000|Overall Study|Adverse Event|8|||
126179946|NCT02031432|453942352|FG000|Overall Study|Withdrawal by Subject|5|||
126179947|NCT02031432|453942352|FG000|Overall Study|Lost to Follow-up|1|||
126179948|NCT02031432|453942352|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
126179949|NCT02031432|453942352|FG000|Overall Study|Death|10|||
126179950|NCT01617187|453942353|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
126179951|NCT01617187|453942354|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
126179952|NCT01617187|453942355|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
126179953|NCT01617187|453942356|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
126179954|NCT01617187|453942353|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
126179955|NCT01617187|453942354|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
126179956|NCT01617187|453942355|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
126179957|NCT01617187|453942356|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
126179958|NCT01617187|453942353|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
126179959|NCT01617187|453942354|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
126179960|NCT01617187|453942355|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
126179961|NCT01617187|453942356|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
126179962|NCT01617187|453942353|FG000|Treatment Through Study Completion|Adverse Event|1|||
126179963|NCT01617187|453942354|FG001|Treatment Through Study Completion|Adverse Event|1|||
126179964|NCT01617187|453942355|FG002|Treatment Through Study Completion|Adverse Event|0|||
126179965|NCT01617187|453942356|FG003|Treatment Through Study Completion|Adverse Event|1|||
126179966|NCT01617187|453942353|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
126179967|NCT01617187|453942354|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
126179968|NCT01617187|453942355|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
126179969|NCT01617187|453942356|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
126179970|NCT01617187|453942353|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
126179971|NCT01617187|453942354|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
126179972|NCT01617187|453942355|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
126179973|NCT01617187|453942356|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
126179974|NCT01617187|453942353|FG000|Treatment Through Study Completion|Protocol Violation|1|||
126179975|NCT01617187|453942354|FG001|Treatment Through Study Completion|Protocol Violation|0|||
126179976|NCT01617187|453942355|FG002|Treatment Through Study Completion|Protocol Violation|0|||
126179977|NCT01617187|453942356|FG003|Treatment Through Study Completion|Protocol Violation|1|||
126179978|NCT03862131|453942360|FG000|Overall Study|Lost to Follow-up|1|||
126179979|NCT03862131|453942361|FG001|Overall Study|Lost to Follow-up|0|||
126179980|NCT03862131|453942362|FG002|Overall Study|Lost to Follow-up|1|||
126179981|NCT03862131|453942360|FG000|Overall Study|Determined to be ineligible|0|||
126179982|NCT03862131|453942361|FG001|Overall Study|Determined to be ineligible|0|||
126179983|NCT03862131|453942362|FG002|Overall Study|Determined to be ineligible|5|||
126179984|NCT03862131|453942360|FG000|Overall Study|Death|4|||
126179985|NCT03862131|453942361|FG001|Overall Study|Death|4|||
126179986|NCT03862131|453942362|FG002|Overall Study|Death|0|||
126179987|NCT03862131|453942360|FG000|Overall Study|Withdrawal by Subject|5|||
126179988|NCT03862131|453942361|FG001|Overall Study|Withdrawal by Subject|3|||
126179989|NCT03862131|453942362|FG002|Overall Study|Withdrawal by Subject|0|||
126179990|NCT03862131|453942360|FG000|Overall Study|Physician Decision|0|||
126179991|NCT03862131|453942361|FG001|Overall Study|Physician Decision|1|||
126179992|NCT03862131|453942362|FG002|Overall Study|Physician Decision|0|||
126179993|NCT01770145|453943991|FG000|Baseline|Adverse Event|20|||
126179994|NCT01770145|453943991|FG000|Baseline|Withdrawal by Subject|1|||
126179995|NCT01770145|453943991|FG000|Baseline|Lost to Follow-up|1|||
126179996|NCT01770145|453943991|FG000|Baseline|Unable to define optimal dose|4|||
126179997|NCT01770145|453943991|FG000|Treatment|Adverse Event|3|||
126179998|NCT01770145|453943991|FG000|Treatment|Withdrawal by Subject|1|||
126179999|NCT00510484|453943992|FG000|Wash-out Period|Adverse Event|0|||
126180000|NCT00510484|453943993|FG001|Wash-out Period|Adverse Event|1|||
126180001|NCT02533401|453943996|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
126180002|NCT02533401|453943996|FG000|Overall Study|Death|5|||
126180003|NCT02533401|453943996|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
126180004|NCT02533401|453943996|FG000|Overall Study|Lost to Follow-up|1|||
126180005|NCT02533401|453943996|FG000|Overall Study|Violation of Selection Criteria|1|||
126180006|NCT01438307|453944000|FG000|Overall Study|Death|1|||
126180007|NCT01438307|453944001|FG001|Overall Study|Death|1|||
126180008|NCT00973622|453944003|FG000|Overall Study|did not attend MRI|14|||
126180009|NCT00973622|453944004|FG001|Overall Study|did not attend MRI|3|||
126180010|NCT00973622|453944003|FG000|Overall Study|did not pass MRI screen|6|||
126180011|NCT00973622|453944004|FG001|Overall Study|did not pass MRI screen|0|||
126180012|NCT00973622|453944003|FG000|Overall Study|did not complete rTMS sessions|11|||
126180013|NCT00973622|453944004|FG001|Overall Study|did not complete rTMS sessions|2|||
126180014|NCT00555568|453944005|FG000|Overall Study|Lost to Follow-up|26|||
126180015|NCT00555568|453944006|FG001|Overall Study|Lost to Follow-up|16|||
126180016|NCT00555568|453944007|FG002|Overall Study|Lost to Follow-up|16|||
126180017|NCT02378883|453944010|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
126180018|NCT02378883|453944010|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
126180019|NCT02378883|453944010|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
126180020|NCT02378883|453944010|FG000|30 Day Follow-Up|Physician Decision|2|||
126180021|NCT02378883|453944010|FG000|30 Day Follow-Up|Missed Visit|2|||
126180022|NCT02378883|453944010|FG000|30 Day Follow-Up|Death|1|||
126180023|NCT02378883|453944010|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
126180024|NCT02378883|453944010|FG000|12 Months Follow-Up|Death|2|||
126180025|NCT00493467|453944014|FG000|Overall Study|Death|1|||
126180026|NCT03814005|453944017|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
126180027|NCT03814005|453944018|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
126180028|NCT03814005|453944019|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
126180029|NCT03814005|453944017|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
126180030|NCT03814005|453944018|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
126180031|NCT03814005|453944019|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
126180032|NCT03814005|453944017|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
126180033|NCT03814005|453944018|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
126180034|NCT03814005|453944019|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
126180035|NCT03814005|453944017|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
126180036|NCT03814005|453944018|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
126180037|NCT03814005|453944019|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
126180038|NCT03814005|453944017|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
126180039|NCT03814005|453944018|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
126180040|NCT03814005|453944019|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
126180041|NCT03814005|453944017|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
126180042|NCT03814005|453944018|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
126180043|NCT03814005|453944019|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
126180044|NCT03395223|453944020|FG000|Overall Study|Lost to Follow-up|3|||
126180045|NCT03395223|453944020|FG000|Overall Study|Other|1|||
126180046|NCT01855945|453944026|FG000|Overall Study|Adverse Event|0|||
126180047|NCT01855945|453944027|FG001|Overall Study|Adverse Event|0|||
126180048|NCT01855945|453944028|FG002|Overall Study|Adverse Event|0|||
126180049|NCT01855945|453944029|FG003|Overall Study|Adverse Event|0|||
126180050|NCT01855945|453944030|FG004|Overall Study|Adverse Event|0|||
126180051|NCT01855945|453944031|FG005|Overall Study|Adverse Event|0|||
126180052|NCT01855945|453944032|FG006|Overall Study|Adverse Event|1|||
126180053|NCT01855945|453944033|FG007|Overall Study|Adverse Event|0|||
126180054|NCT01855945|453944034|FG008|Overall Study|Adverse Event|0|||
126180055|NCT01855945|453944035|FG009|Overall Study|Adverse Event|0|||
126180056|NCT01855945|453944036|FG010|Overall Study|Adverse Event|0|||
126180057|NCT01855945|453944037|FG011|Overall Study|Adverse Event|0|||
126180058|NCT01855945|453944026|FG000|Overall Study|Death|0|||
126180059|NCT01855945|453944027|FG001|Overall Study|Death|0|||
126180060|NCT01855945|453944028|FG002|Overall Study|Death|0|||
126180061|NCT01855945|453944029|FG003|Overall Study|Death|0|||
126180062|NCT01855945|453944030|FG004|Overall Study|Death|0|||
126180063|NCT01855945|453944031|FG005|Overall Study|Death|0|||
126180064|NCT01855945|453944032|FG006|Overall Study|Death|2|||
126180065|NCT01855945|453944033|FG007|Overall Study|Death|0|||
126180066|NCT01855945|453944034|FG008|Overall Study|Death|0|||
126180067|NCT01855945|453944035|FG009|Overall Study|Death|0|||
126180068|NCT01855945|453944036|FG010|Overall Study|Death|0|||
126180069|NCT01855945|453944037|FG011|Overall Study|Death|0|||
126180070|NCT01855945|453944026|FG000|Overall Study|Lost to Follow-up|11|||
126180071|NCT01855945|453944027|FG001|Overall Study|Lost to Follow-up|10|||
126180072|NCT01855945|453944028|FG002|Overall Study|Lost to Follow-up|7|||
126180073|NCT01855945|453944029|FG003|Overall Study|Lost to Follow-up|3|||
126180074|NCT01855945|453944030|FG004|Overall Study|Lost to Follow-up|0|||
126180075|NCT01855945|453944031|FG005|Overall Study|Lost to Follow-up|3|||
126180076|NCT01855945|453944032|FG006|Overall Study|Lost to Follow-up|4|||
126180077|NCT01855945|453944033|FG007|Overall Study|Lost to Follow-up|7|||
126180078|NCT01855945|453944034|FG008|Overall Study|Lost to Follow-up|2|||
126180079|NCT01855945|453944035|FG009|Overall Study|Lost to Follow-up|0|||
126180080|NCT01855945|453944036|FG010|Overall Study|Lost to Follow-up|0|||
126180081|NCT01855945|453944037|FG011|Overall Study|Lost to Follow-up|2|||
126180082|NCT01855945|453944026|FG000|Overall Study|Other - Unclassified|1|||
126180083|NCT01855945|453944027|FG001|Overall Study|Other - Unclassified|1|||
126180084|NCT01855945|453944028|FG002|Overall Study|Other - Unclassified|1|||
126180085|NCT01855945|453944029|FG003|Overall Study|Other - Unclassified|0|||
126180086|NCT01855945|453944030|FG004|Overall Study|Other - Unclassified|0|||
126180087|NCT01855945|453944031|FG005|Overall Study|Other - Unclassified|0|||
126180088|NCT01855945|453944032|FG006|Overall Study|Other - Unclassified|2|||
126180089|NCT01855945|453944033|FG007|Overall Study|Other - Unclassified|1|||
126180090|NCT01855945|453944034|FG008|Overall Study|Other - Unclassified|0|||
126180091|NCT01855945|453944035|FG009|Overall Study|Other - Unclassified|0|||
126180092|NCT01855945|453944036|FG010|Overall Study|Other - Unclassified|1|||
126180093|NCT01855945|453944037|FG011|Overall Study|Other - Unclassified|0|||
126180094|NCT01855945|453944026|FG000|Overall Study|Withdrawal by Subject|4|||
126180095|NCT01855945|453944027|FG001|Overall Study|Withdrawal by Subject|0|||
126180096|NCT01855945|453944028|FG002|Overall Study|Withdrawal by Subject|4|||
126180097|NCT01855945|453944029|FG003|Overall Study|Withdrawal by Subject|1|||
126180098|NCT01855945|453944030|FG004|Overall Study|Withdrawal by Subject|1|||
126180099|NCT01855945|453944031|FG005|Overall Study|Withdrawal by Subject|0|||
126180100|NCT01855945|453944032|FG006|Overall Study|Withdrawal by Subject|1|||
126180101|NCT01855945|453944033|FG007|Overall Study|Withdrawal by Subject|0|||
126180102|NCT01855945|453944034|FG008|Overall Study|Withdrawal by Subject|0|||
126180103|NCT01855945|453944035|FG009|Overall Study|Withdrawal by Subject|2|||
126180104|NCT01855945|453944036|FG010|Overall Study|Withdrawal by Subject|4|||
126180105|NCT01855945|453944037|FG011|Overall Study|Withdrawal by Subject|1|||
126180106|NCT01148693|453944038|FG000|Overall Study|Attempts for cannulation were failed|13|||
126180107|NCT01148693|453944039|FG001|Overall Study|Attempts for cannulation were failed|10|||
126180108|NCT01135017|453944040|FG000|Overall Study|Adverse Event|3|||
126180109|NCT01135017|453944041|FG001|Overall Study|Adverse Event|8|||
126180110|NCT01135017|453944040|FG000|Overall Study|Other than above|3|||
126180111|NCT01135017|453944041|FG001|Overall Study|Other than above|4|||
126180112|NCT03228394|453944043|FG000|Overall Study|Lost to Follow-up|0|||
126180113|NCT03228394|453944044|FG001|Overall Study|Lost to Follow-up|0|||
126180114|NCT03228394|453944045|FG002|Overall Study|Lost to Follow-up|1|||
126180115|NCT03228394|453944046|FG003|Overall Study|Lost to Follow-up|1|||
126180116|NCT03228394|453944047|FG004|Overall Study|Lost to Follow-up|0|||
126180117|NCT03228394|453944048|FG005|Overall Study|Lost to Follow-up|0|||
126180118|NCT03228394|453944049|FG006|Overall Study|Lost to Follow-up|2|||
126180119|NCT03228394|453944050|FG007|Overall Study|Lost to Follow-up|0|||
126180120|NCT03228394|453944043|FG000|Overall Study|Withdrawal by Subject|0|||
126180121|NCT03228394|453944044|FG001|Overall Study|Withdrawal by Subject|0|||
126180122|NCT03228394|453944045|FG002|Overall Study|Withdrawal by Subject|1|||
126180123|NCT03228394|453944046|FG003|Overall Study|Withdrawal by Subject|0|||
126180124|NCT03228394|453944047|FG004|Overall Study|Withdrawal by Subject|0|||
126180125|NCT03228394|453944048|FG005|Overall Study|Withdrawal by Subject|0|||
126180126|NCT03228394|453944049|FG006|Overall Study|Withdrawal by Subject|1|||
126180127|NCT03228394|453944050|FG007|Overall Study|Withdrawal by Subject|3|||
126180128|NCT03228394|453944043|FG000|Overall Study|Protocol Violation|0|||
126180129|NCT03228394|453944044|FG001|Overall Study|Protocol Violation|0|||
126180130|NCT03228394|453944045|FG002|Overall Study|Protocol Violation|0|||
126180131|NCT03228394|453944046|FG003|Overall Study|Protocol Violation|1|||
126180132|NCT03228394|453944047|FG004|Overall Study|Protocol Violation|0|||
126180133|NCT03228394|453944048|FG005|Overall Study|Protocol Violation|0|||
126180134|NCT03228394|453944049|FG006|Overall Study|Protocol Violation|0|||
126180135|NCT03228394|453944050|FG007|Overall Study|Protocol Violation|0|||
126180136|NCT03228394|453944043|FG000|Overall Study|Physician Decision|0|||
126180137|NCT03228394|453944044|FG001|Overall Study|Physician Decision|0|||
126180138|NCT03228394|453944045|FG002|Overall Study|Physician Decision|0|||
126180139|NCT03228394|453944046|FG003|Overall Study|Physician Decision|0|||
126180140|NCT03228394|453944047|FG004|Overall Study|Physician Decision|0|||
126180141|NCT03228394|453944048|FG005|Overall Study|Physician Decision|0|||
126180142|NCT03228394|453944049|FG006|Overall Study|Physician Decision|1|||
126180143|NCT03228394|453944050|FG007|Overall Study|Physician Decision|0|||
126180144|NCT03228394|453944043|FG000|Overall Study|Noncompliance|0|||
126180145|NCT03228394|453944044|FG001|Overall Study|Noncompliance|0|||
126180146|NCT03228394|453944045|FG002|Overall Study|Noncompliance|0|||
126180147|NCT03228394|453944046|FG003|Overall Study|Noncompliance|0|||
126180148|NCT03228394|453944047|FG004|Overall Study|Noncompliance|0|||
126180149|NCT03228394|453944048|FG005|Overall Study|Noncompliance|0|||
126180150|NCT03228394|453944049|FG006|Overall Study|Noncompliance|1|||
126180151|NCT03228394|453944050|FG007|Overall Study|Noncompliance|0|||
126180152|NCT01170221|453944055|FG000|Overall Study|Lost to Follow-up|22|||
126180153|NCT01170221|453944056|FG001|Overall Study|Lost to Follow-up|21|||
126180154|NCT01170221|453944055|FG000|Overall Study|Withdrawal by Subject|9|||
126180155|NCT01170221|453944056|FG001|Overall Study|Withdrawal by Subject|7|||
126180156|NCT01170221|453944055|FG000|Overall Study|Subject completed only screening and LFU|1|||
126180157|NCT01170221|453944056|FG001|Overall Study|Subject completed only screening and LFU|0|||
126180158|NCT01170221|453944055|FG000|Overall Study|Randomized but not treated|1|||
126180159|NCT01170221|453944056|FG001|Overall Study|Randomized but not treated|0|||
126180160|NCT04169061|453944059|FG000|Overall Study|Adverse Event|2|||
126180161|NCT04169061|453944059|FG000|Overall Study|Death|1|||
126180162|NCT04169061|453944059|FG000|Overall Study|Withdrawal by Subject|1|||
126180163|NCT04169061|453944059|FG000|Overall Study|Protocol Violation|1|||
126180164|NCT00192036|453944063|FG000|Overall Study|Protocol Violation|3|||
126180165|NCT00192036|453944063|FG000|Overall Study|Adverse Event|6|||
126180166|NCT00192036|453944063|FG000|Overall Study|Patient/Physician Perception|1|||
126180167|NCT00192036|453944063|FG000|Overall Study|Objective Tumor Progression|4|||
126180168|NCT00192036|453944063|FG000|Overall Study|Clinical Disease Progression|1|||
126180169|NCT00192036|453944063|FG000|Overall Study|Death|1|||
126180170|NCT00192036|453944063|FG000|Overall Study|Unknown or Not Specified|5|||
126180171|NCT05425719|453944064|FG000|Overall Study|Lost to Follow-up|4|||
126180172|NCT05425719|453944065|FG001|Overall Study|Lost to Follow-up|0|||
126180173|NCT05425719|453944064|FG000|Overall Study|Withdrew consent|1|||
126180174|NCT05425719|453944065|FG001|Overall Study|Withdrew consent|1|||
126180175|NCT04682353|453944066|FG000|Overall Study|Lost to Follow-up|0|||
126180176|NCT04682353|453944067|FG001|Overall Study|Lost to Follow-up|1|||
126180177|NCT04682353|453944068|FG002|Overall Study|Lost to Follow-up|0|||
126180178|NCT04682353|453944069|FG003|Overall Study|Lost to Follow-up|1|||
126180179|NCT04682353|453944066|FG000|Overall Study|Personal reasons|0|||
126180180|NCT04682353|453944067|FG001|Overall Study|Personal reasons|1|||
126180181|NCT04682353|453944068|FG002|Overall Study|Personal reasons|0|||
126180182|NCT04682353|453944069|FG003|Overall Study|Personal reasons|0|||
126180183|NCT00862654|453944070|FG000|Overall Study|Lack of Efficacy|1|||
126180184|NCT00862654|453944071|FG001|Overall Study|Lack of Efficacy|0|||
126180185|NCT00862654|453944072|FG002|Overall Study|Lack of Efficacy|1|||
126180186|NCT00862654|453944073|FG003|Overall Study|Lack of Efficacy|0|||
126180187|NCT00862654|453944070|FG000|Overall Study|Lost to Follow-up|1|||
126180188|NCT00862654|453944071|FG001|Overall Study|Lost to Follow-up|2|||
126180189|NCT00862654|453944072|FG002|Overall Study|Lost to Follow-up|1|||
126180190|NCT00862654|453944073|FG003|Overall Study|Lost to Follow-up|3|||
126180191|NCT00862654|453944070|FG000|Overall Study|Adverse Event|0|||
126180192|NCT00862654|453944071|FG001|Overall Study|Adverse Event|1|||
126180193|NCT00862654|453944072|FG002|Overall Study|Adverse Event|1|||
126180194|NCT00862654|453944073|FG003|Overall Study|Adverse Event|0|||
126180195|NCT00862654|453944070|FG000|Overall Study|Pregnancy|1|||
126180196|NCT00862654|453944071|FG001|Overall Study|Pregnancy|1|||
126180197|NCT00862654|453944072|FG002|Overall Study|Pregnancy|0|||
126180198|NCT00862654|453944073|FG003|Overall Study|Pregnancy|0|||
126180199|NCT00862654|453944070|FG000|Overall Study|Withdrawal by Subject|2|||
126180200|NCT00862654|453944071|FG001|Overall Study|Withdrawal by Subject|2|||
126180201|NCT00862654|453944072|FG002|Overall Study|Withdrawal by Subject|2|||
126180202|NCT00862654|453944073|FG003|Overall Study|Withdrawal by Subject|3|||
126180203|NCT00862654|453944070|FG000|Overall Study|Subject mistake|0|||
126180204|NCT00862654|453944071|FG001|Overall Study|Subject mistake|1|||
126180205|NCT00862654|453944072|FG002|Overall Study|Subject mistake|0|||
126180206|NCT00862654|453944073|FG003|Overall Study|Subject mistake|0|||
126180207|NCT00862654|453944070|FG000|Overall Study|Familly constraint|0|||
126180208|NCT00862654|453944071|FG001|Overall Study|Familly constraint|1|||
126180209|NCT00862654|453944072|FG002|Overall Study|Familly constraint|0|||
126180210|NCT00862654|453944073|FG003|Overall Study|Familly constraint|0|||
126180211|NCT00862654|453944070|FG000|Overall Study|Never used study drugs|1|||
126180212|NCT00862654|453944071|FG001|Overall Study|Never used study drugs|0|||
126180213|NCT00862654|453944072|FG002|Overall Study|Never used study drugs|0|||
126180214|NCT00862654|453944073|FG003|Overall Study|Never used study drugs|0|||
126180215|NCT00862654|453944070|FG000|Overall Study|Included after end of inclusions|0|||
126180216|NCT00862654|453944071|FG001|Overall Study|Included after end of inclusions|0|||
126180217|NCT00862654|453944072|FG002|Overall Study|Included after end of inclusions|1|||
126180218|NCT00862654|453944073|FG003|Overall Study|Included after end of inclusions|0|||
126180219|NCT03219567|453944079|FG000|Overall Study|Withdrawal by Subject|0|||
126180220|NCT03219567|453944080|FG001|Overall Study|Withdrawal by Subject|1|||
126180221|NCT02394795|453944081|FG000|Overall Study|Adverse Event|92|||
126180222|NCT02394795|453944082|FG001|Overall Study|Adverse Event|70|||
126180223|NCT02394795|453944081|FG000|Overall Study|Lost to Follow-up|0|||
126180224|NCT02394795|453944082|FG001|Overall Study|Lost to Follow-up|1|||
126180225|NCT02394795|453944081|FG000|Overall Study|Withdrawal by Subject|17|||
126180226|NCT02394795|453944082|FG001|Overall Study|Withdrawal by Subject|26|||
126180227|NCT02394795|453944081|FG000|Overall Study|Lack of Efficacy|181|||
126180228|NCT02394795|453944082|FG001|Overall Study|Lack of Efficacy|211|||
126180229|NCT02394795|453944081|FG000|Overall Study|Death|4|||
126180230|NCT02394795|453944082|FG001|Overall Study|Death|5|||
126180231|NCT02394795|453944081|FG000|Overall Study|Physician Decision|109|||
126180232|NCT02394795|453944082|FG001|Overall Study|Physician Decision|93|||
126180233|NCT04377672|453944089|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
126180234|NCT03954444|453944092|FG000|Overall Study|Withdrawal by Subject|5|||
126180235|NCT03954444|453944093|FG001|Overall Study|Withdrawal by Subject|5|||
126180236|NCT03954444|453944094|FG002|Overall Study|Withdrawal by Subject|5|||
126180237|NCT03954444|453944092|FG000|Overall Study|Adverse Event|1|||
126180238|NCT03954444|453944093|FG001|Overall Study|Adverse Event|3|||
126180239|NCT03954444|453944094|FG002|Overall Study|Adverse Event|2|||
126180240|NCT03954444|453944092|FG000|Overall Study|Protocol Violation|0|||
126180241|NCT03954444|453944093|FG001|Overall Study|Protocol Violation|3|||
126180242|NCT03954444|453944094|FG002|Overall Study|Protocol Violation|5|||
126180243|NCT03954444|453944092|FG000|Overall Study|Use of prohibited therapy|1|||
126180244|NCT03954444|453944093|FG001|Overall Study|Use of prohibited therapy|1|||
126180245|NCT03954444|453944094|FG002|Overall Study|Use of prohibited therapy|2|||
126180246|NCT03954444|453944092|FG000|Overall Study|Lost to Follow-up|1|||
126180247|NCT03954444|453944093|FG001|Overall Study|Lost to Follow-up|0|||
126180248|NCT03954444|453944094|FG002|Overall Study|Lost to Follow-up|1|||
126180249|NCT03954444|453944092|FG000|Overall Study|Non-compliant with study drug application|2|||
126180250|NCT03954444|453944093|FG001|Overall Study|Non-compliant with study drug application|2|||
126180251|NCT03954444|453944094|FG002|Overall Study|Non-compliant with study drug application|0|||
126180252|NCT03954444|453944092|FG000|Overall Study|Administrative reasons|0|||
126180253|NCT03954444|453944093|FG001|Overall Study|Administrative reasons|0|||
126180254|NCT03954444|453944094|FG002|Overall Study|Administrative reasons|1|||
126180255|NCT03954444|453944092|FG000|Overall Study|Miscellaneous|3|||
126180256|NCT03954444|453944093|FG001|Overall Study|Miscellaneous|2|||
126180257|NCT03954444|453944094|FG002|Overall Study|Miscellaneous|1|||
126180258|NCT02447458|453944095|FG000|Overall Study|Other|0|||
126180259|NCT02447458|453944096|FG001|Overall Study|Other|0|||
126180260|NCT02447458|453944097|FG002|Overall Study|Other|1|||
126180261|NCT02447458|453944098|FG003|Overall Study|Other|0|||
126180262|NCT02447458|453944099|FG004|Overall Study|Other|0|||
126180263|NCT02447458|453944100|FG005|Overall Study|Other|0|||
126180264|NCT02133742|453944101|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
126180265|NCT02133742|453944101|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
126180266|NCT02133742|453944101|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
126180267|NCT02133742|453944101|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
126180268|NCT02133742|453944101|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
126180269|NCT03505749|453944102|FG000|Overall Study|Lost to Follow-up|7|||
126180270|NCT03505749|453944103|FG001|Overall Study|Lost to Follow-up|11|||
126180271|NCT03505749|453944102|FG000|Overall Study|Withdrawal by Subject|6|||
126180272|NCT03505749|453944103|FG001|Overall Study|Withdrawal by Subject|0|||
126180273|NCT03505749|453944102|FG000|Overall Study|Discharged from treatment|3|||
126180274|NCT03505749|453944103|FG001|Overall Study|Discharged from treatment|6|||
126180275|NCT03846219|453944105|FG000|Overall Study|Withdrawal by Subject|3|||
126180276|NCT03846219|453944106|FG001|Overall Study|Withdrawal by Subject|2|||
126180277|NCT03846219|453944107|FG002|Overall Study|Withdrawal by Subject|2|||
126180278|NCT03846219|453944105|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
126180279|NCT03846219|453944106|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
126180280|NCT03846219|453944107|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
126180281|NCT03846219|453944105|FG000|Overall Study|Physician Decision|0|||
126180282|NCT03846219|453944106|FG001|Overall Study|Physician Decision|0|||
126180283|NCT03846219|453944107|FG002|Overall Study|Physician Decision|2|||
126180284|NCT01688635|453944108|FG000|Washout 1|Withdrawal by Subject|1|||
126180285|NCT01688635|453944109|FG001|Washout 1|Withdrawal by Subject|0|||
126180286|NCT01688635|453944108|FG000|Washout 1|Adverse Event|0|||
126180287|NCT01688635|453944109|FG001|Washout 1|Adverse Event|1|||
126180288|NCT01688635|453944108|FG000|Washout 1|Physician Decision|0|||
126180289|NCT01688635|453944109|FG001|Washout 1|Physician Decision|1|||
126180290|NCT01688635|453944108|FG000|Washout 2|Physician Decision|1|||
126180291|NCT01688635|453944109|FG001|Washout 2|Physician Decision|0|||
126180292|NCT01688635|453944108|FG000|Washout 2|Withdrawal by Subject|1|||
126180293|NCT01688635|453944109|FG001|Washout 2|Withdrawal by Subject|0|||
126180294|NCT01688635|453944108|FG000|Washout 2|Sponsor Decision|1|||
126180295|NCT01688635|453944109|FG001|Washout 2|Sponsor Decision|2|||
126180296|NCT01688635|453944108|FG000|Washout 3|Withdrawal by Subject|1|||
126180297|NCT01688635|453944109|FG001|Washout 3|Withdrawal by Subject|0|||
126180298|NCT03549117|453944113|FG000|Overall Study|Withdrawal by Subject|1|||
126180299|NCT03549117|453944114|FG001|Overall Study|Withdrawal by Subject|0|||
126180300|NCT01924299|453944115|FG000|Period 2|Withdrawal by Subject|1|||
126180301|NCT01924299|453944116|FG001|Period 2|Withdrawal by Subject|0|||
126180302|NCT01924299|453944115|FG000|Period 2|Adverse Event|0|||
126180303|NCT01924299|453944116|FG001|Period 2|Adverse Event|1|||
126180304|NCT00888615|453944121|FG000|Overall Study|No treatment|2|||
126180305|NCT02293902|453944124|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
126180306|NCT02293902|453944125|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
126180307|NCT02293902|453944126|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
126180308|NCT02293902|453944127|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
126180309|NCT02293902|453944128|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
126180310|NCT02293902|453944124|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
126180311|NCT02293902|453944125|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
126180312|NCT02293902|453944126|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
126180313|NCT02293902|453944127|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
126180314|NCT02293902|453944128|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
126180315|NCT02293902|453944124|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
126180316|NCT02293902|453944125|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
126180317|NCT02293902|453944126|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
126180318|NCT02293902|453944127|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
126180319|NCT02293902|453944128|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
126180320|NCT02293902|453944124|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
126180321|NCT02293902|453944125|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
126180322|NCT02293902|453944126|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
126180323|NCT02293902|453944127|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
126180324|NCT02293902|453944128|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
126180325|NCT02293902|453944124|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
126180326|NCT02293902|453944125|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
126180327|NCT02293902|453944126|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
126180328|NCT02293902|453944127|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
126180329|NCT02293902|453944128|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
126180330|NCT02947022|453944129|FG000|Overall Study|Study Stopped|1|||
126180331|NCT02905825|453945822|FG000|Overall Study|Protocol Violation|11|||
126180332|NCT02905825|453945822|FG000|Overall Study|Device Malfunction|1|||
126180333|NCT01281189|453945823|FG000|Overall Study|Adverse Event|7|||
126180334|NCT01281189|453945824|FG001|Overall Study|Adverse Event|9|||
126180335|NCT01281189|453945823|FG000|Overall Study|Lost to Follow-up|6|||
126180336|NCT01281189|453945824|FG001|Overall Study|Lost to Follow-up|4|||
126180337|NCT01281189|453945823|FG000|Overall Study|Withdrawal by Subject|21|||
126180338|NCT01281189|453945824|FG001|Overall Study|Withdrawal by Subject|24|||
126180339|NCT01281189|453945823|FG000|Overall Study|Physician Decision|2|||
126180340|NCT01281189|453945824|FG001|Overall Study|Physician Decision|3|||
126180341|NCT01281189|453945823|FG000|Overall Study|Death|103|||
126180342|NCT01281189|453945824|FG001|Overall Study|Death|91|||
126180343|NCT01281189|453945823|FG000|Overall Study|Other|8|||
126180344|NCT01281189|453945824|FG001|Overall Study|Other|12|||
126180345|NCT05355818|453945825|FG000|Overall Study|Adverse Event|1|||
126180346|NCT05355818|453945826|FG001|Overall Study|Adverse Event|1|||
126180347|NCT05355818|453945825|FG000|Overall Study|Lack of Efficacy|2|||
126180348|NCT05355818|453945826|FG001|Overall Study|Lack of Efficacy|1|||
126180349|NCT05355818|453945825|FG000|Overall Study|Lost to Follow-up|0|||
126180350|NCT05355818|453945826|FG001|Overall Study|Lost to Follow-up|1|||
126180351|NCT00092677|453945831|FG000|Overall Study|Lost to Follow-up|0|||
126180352|NCT00092677|453945832|FG001|Overall Study|Lost to Follow-up|2|||
126180353|NCT00092677|453945831|FG000|Overall Study|Adminstrative|5|||
126180354|NCT00092677|453945832|FG001|Overall Study|Adminstrative|9|||
126180355|NCT00010803|453945836|FG000|Overall Study|Withdrawal by Subject|97|||
126180356|NCT00010803|453945837|FG001|Overall Study|Withdrawal by Subject|98|||
126180357|NCT01019252|453945838|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
126180358|NCT01019252|453945839|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
126180359|NCT01019252|453945838|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
126180360|NCT01019252|453945839|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
126180361|NCT01019252|453945838|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
126180362|NCT01019252|453945839|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
126180363|NCT01019252|453945838|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
126180364|NCT01019252|453945839|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
126180365|NCT04671342|453945840|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
126180366|NCT04671342|453945840|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
126180367|NCT04671342|453945840|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
126180368|NCT04671342|453945840|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
126180369|NCT04671342|453945840|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
126180370|NCT04671342|453945840|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
126180371|NCT02273037|453945841|FG000|Overall Study|Lost to Follow-up|1|||
126180372|NCT02273037|453945842|FG001|Overall Study|Lost to Follow-up|0|||
126180373|NCT02273037|453945841|FG000|Overall Study|Delivered before monitoring initiated|1|||
126180374|NCT02273037|453945842|FG001|Overall Study|Delivered before monitoring initiated|3|||
126180375|NCT02273037|453945841|FG000|Overall Study|Breech delivery|2|||
126180376|NCT02273037|453945842|FG001|Overall Study|Breech delivery|3|||
126180377|NCT02273037|453945841|FG000|Overall Study|Multiple delivery|2|||
126180378|NCT02273037|453945842|FG001|Overall Study|Multiple delivery|2|||
126180379|NCT02273037|453945841|FG000|Overall Study|Other complication|2|||
126180380|NCT02273037|453945842|FG001|Overall Study|Other complication|0|||
126180381|NCT03351478|453945845|FG000|Overall Study|At the subject's own request|11|||
126180382|NCT03351478|453945846|FG001|Overall Study|At the subject's own request|12|||
126180383|NCT03351478|453945847|FG002|Overall Study|At the subject's own request|5|||
126180384|NCT03351478|453945845|FG000|Overall Study|Adverse Event|1|||
126180385|NCT03351478|453945846|FG001|Overall Study|Adverse Event|2|||
126180386|NCT03351478|453945847|FG002|Overall Study|Adverse Event|1|||
126180387|NCT03351478|453945845|FG000|Overall Study|Poor compliance to protocol|1|||
126180388|NCT03351478|453945846|FG001|Overall Study|Poor compliance to protocol|0|||
126180389|NCT03351478|453945847|FG002|Overall Study|Poor compliance to protocol|0|||
126180390|NCT03351478|453945845|FG000|Overall Study|Reason not Specified|1|||
126180391|NCT03351478|453945846|FG001|Overall Study|Reason not Specified|3|||
126180392|NCT03351478|453945847|FG002|Overall Study|Reason not Specified|0|||
126180393|NCT03351478|453945845|FG000|Overall Study|Lost to Follow-up|0|||
126180394|NCT03351478|453945846|FG001|Overall Study|Lost to Follow-up|0|||
126180395|NCT03351478|453945847|FG002|Overall Study|Lost to Follow-up|1|||
126180396|NCT00762268|453945851|FG000|Overall Study|Withdrawal by Subject|3|||
126180397|NCT00762268|453945852|FG001|Overall Study|Withdrawal by Subject|3|||
126180398|NCT01074658|453945857|FG000|Overall Study|No implant attempted|19|||
126180399|NCT01342952|453945858|FG000|Overall Study|Adverse Event|0|||
126180400|NCT01342952|453945859|FG001|Overall Study|Adverse Event|5|||
126180401|NCT01342952|453945860|FG002|Overall Study|Adverse Event|1|||
126180402|NCT01342952|453945861|FG003|Overall Study|Adverse Event|0|||
126180403|NCT01342952|453945858|FG000|Overall Study|Lost to Follow-up|0|||
126180404|NCT01342952|453945859|FG001|Overall Study|Lost to Follow-up|2|||
126180405|NCT01342952|453945860|FG002|Overall Study|Lost to Follow-up|0|||
126180406|NCT01342952|453945861|FG003|Overall Study|Lost to Follow-up|0|||
126180407|NCT01342952|453945858|FG000|Overall Study|Withdrawal by Subject|1|||
126180408|NCT01342952|453945859|FG001|Overall Study|Withdrawal by Subject|1|||
126180409|NCT01342952|453945860|FG002|Overall Study|Withdrawal by Subject|0|||
126180410|NCT01342952|453945861|FG003|Overall Study|Withdrawal by Subject|0|||
126180411|NCT01342952|453945858|FG000|Overall Study|Physician Decision|3|||
126180412|NCT01342952|453945859|FG001|Overall Study|Physician Decision|3|||
126180413|NCT01342952|453945860|FG002|Overall Study|Physician Decision|1|||
126180414|NCT01342952|453945861|FG003|Overall Study|Physician Decision|0|||
126180415|NCT02156804|453945862|FG000|Overall Study|Withdrawal by Subject|1|||
126180416|NCT04581863|453945863|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
126180417|NCT04581863|453945864|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
126180418|NCT01803711|453945865|FG000|Overall Study|Adverse Event|1|||
126180419|NCT01803711|453945866|FG001|Overall Study|Adverse Event|1|||
126180420|NCT00432562|453945870|FG000|Overall Study|Death|3|||
126180421|NCT00432562|453945871|FG001|Overall Study|Death|0|||
126180422|NCT02693691|453945872|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
126180423|NCT02693691|453945872|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
126180424|NCT02693691|453945872|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
126180425|NCT02693691|453945872|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
126180426|NCT02693691|453945872|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
126180427|NCT02693691|453945872|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
126180428|NCT02693691|453945872|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
126180429|NCT00636441|453945874|FG000|Overall Study|Adverse Event|0|||
126180430|NCT00636441|453945875|FG001|Overall Study|Adverse Event|1|||
126180431|NCT00636441|453945876|FG002|Overall Study|Adverse Event|1|||
126180432|NCT00636441|453945877|FG003|Overall Study|Adverse Event|0|||
126180433|NCT00636441|453945878|FG004|Overall Study|Adverse Event|0|||
126180434|NCT00636441|453945879|FG005|Overall Study|Adverse Event|1|||
126180435|NCT00636441|453945880|FG006|Overall Study|Adverse Event|0|||
126180436|NCT00636441|453945874|FG000|Overall Study|Late, ineligible|0|||
126180437|NCT00636441|453945875|FG001|Overall Study|Late, ineligible|0|||
126180438|NCT00636441|453945876|FG002|Overall Study|Late, ineligible|0|||
126180439|NCT00636441|453945877|FG003|Overall Study|Late, ineligible|0|||
126180440|NCT00636441|453945878|FG004|Overall Study|Late, ineligible|0|||
126180441|NCT00636441|453945879|FG005|Overall Study|Late, ineligible|0|||
126180442|NCT00636441|453945880|FG006|Overall Study|Late, ineligible|1|||
126180443|NCT00636441|453945874|FG000|Overall Study|Screen Failure|0|||
126180444|NCT00636441|453945875|FG001|Overall Study|Screen Failure|0|||
126180445|NCT00636441|453945876|FG002|Overall Study|Screen Failure|0|||
126180446|NCT00636441|453945877|FG003|Overall Study|Screen Failure|0|||
126180447|NCT00636441|453945878|FG004|Overall Study|Screen Failure|0|||
126180448|NCT00636441|453945879|FG005|Overall Study|Screen Failure|0|||
126180449|NCT00636441|453945880|FG006|Overall Study|Screen Failure|17|||
126180450|NCT01162304|453945881|FG000|Overall Study|Beck scale to high|11|||
126180451|NCT00844285|453945883|FG000|Overall Study|Other|0|||
126180452|NCT00844285|453945884|FG001|Overall Study|Other|1|||
126180453|NCT00844285|453945885|FG002|Overall Study|Other|0|||
126180454|NCT00844285|453945883|FG000|Overall Study|Other than specified|95|||
126180455|NCT00844285|453945884|FG001|Overall Study|Other than specified|129|||
126180456|NCT00844285|453945885|FG002|Overall Study|Other than specified|12|||
126180457|NCT00844285|453945883|FG000|Overall Study|Site closure|256|||
126180458|NCT00844285|453945884|FG001|Overall Study|Site closure|450|||
126180459|NCT00844285|453945885|FG002|Overall Study|Site closure|50|||
126180460|NCT00844285|453945883|FG000|Overall Study|Follow-up < 8 years|16|||
126180461|NCT00844285|453945884|FG001|Overall Study|Follow-up < 8 years|23|||
126180462|NCT00844285|453945885|FG002|Overall Study|Follow-up < 8 years|4|||
126180463|NCT00844285|453945883|FG000|Overall Study|Protocol Violation|26|||
126180464|NCT00844285|453945884|FG001|Overall Study|Protocol Violation|28|||
126180465|NCT00844285|453945885|FG002|Overall Study|Protocol Violation|54|||
126180466|NCT00844285|453945883|FG000|Overall Study|Death|22|||
126180467|NCT00844285|453945884|FG001|Overall Study|Death|21|||
126180468|NCT00844285|453945885|FG002|Overall Study|Death|8|||
126180469|NCT00844285|453945883|FG000|Overall Study|Withdrew Consent|344|||
126180470|NCT00844285|453945884|FG001|Overall Study|Withdrew Consent|466|||
126180471|NCT00844285|453945885|FG002|Overall Study|Withdrew Consent|70|||
126180472|NCT00844285|453945883|FG000|Overall Study|Lost to Follow-up|330|||
126180473|NCT00844285|453945884|FG001|Overall Study|Lost to Follow-up|486|||
126180474|NCT00844285|453945885|FG002|Overall Study|Lost to Follow-up|74|||
126180475|NCT02849626|453945890|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
126180476|NCT02849626|453945891|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
126180477|NCT02849626|453945892|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
126180478|NCT02849626|453945893|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
126180479|NCT02849626|453945890|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
126180480|NCT02849626|453945891|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
126180481|NCT02849626|453945892|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
126180482|NCT02849626|453945893|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
126180483|NCT02849626|453945890|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
126180484|NCT02849626|453945891|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
126180485|NCT02849626|453945892|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
126180486|NCT02849626|453945893|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
126180487|NCT02849626|453945890|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
126180488|NCT02849626|453945891|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
126180489|NCT02849626|453945892|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
126180490|NCT02849626|453945893|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
126180491|NCT02849626|453945890|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
126180492|NCT02849626|453945891|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
126180493|NCT02849626|453945892|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
126180494|NCT02849626|453945893|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
126180495|NCT02849626|453945890|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
126180496|NCT02849626|453945891|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
126180497|NCT02849626|453945892|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
126180498|NCT02849626|453945893|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
126180499|NCT02849626|453945890|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
126180500|NCT02849626|453945891|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
126180501|NCT02849626|453945892|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
126180502|NCT02849626|453945893|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
126180503|NCT02849626|453945890|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
126180504|NCT02849626|453945891|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
126180505|NCT02849626|453945892|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
126180506|NCT02849626|453945893|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
126180507|NCT02849626|453945890|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
126180508|NCT02849626|453945891|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
126180509|NCT02849626|453945892|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
126180510|NCT02849626|453945893|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
126180511|NCT02849626|453945890|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
126180512|NCT02849626|453945891|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
126180513|NCT02849626|453945892|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
126180514|NCT02849626|453945893|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
126180515|NCT02849626|453945890|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
126180516|NCT02849626|453945891|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
126180517|NCT02849626|453945892|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
126180518|NCT02849626|453945893|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
126180519|NCT01313208|453945894|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
126180520|NCT01313208|453945895|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
126180521|NCT01313208|453945894|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
126180522|NCT01313208|453945895|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
126180523|NCT01313208|453945894|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
126180524|NCT01313208|453945895|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
126180525|NCT01313208|453945894|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
126180526|NCT01313208|453945895|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
126180527|NCT01313208|453945894|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
126180528|NCT01313208|453945895|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
126180529|NCT01313208|453945894|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
126180530|NCT01313208|453945895|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
126180531|NCT01313208|453945894|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
126180532|NCT01313208|453945895|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
126180533|NCT01313208|453945894|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
126180534|NCT01313208|453945895|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
126180535|NCT01313208|453945894|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
126180536|NCT01313208|453945895|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
126180537|NCT01654523|453945896|FG000|Overall Study|Withdrawal by Subject|1|||
126180538|NCT01957787|453945897|FG000|Overall Study|Death|18|||
126180539|NCT01957787|453945897|FG000|Overall Study|Lost to Follow-up|3|||
126180540|NCT01957787|453945897|FG000|Overall Study|Withdrawal by Subject|3|||
126180541|NCT01957787|453945897|FG000|Overall Study|Entered Hospice or Similar Program|2|||
126180542|NCT01957787|453945897|FG000|Overall Study|Index Tumor(s) Resected|2|||
126180543|NCT01957787|453945897|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
126180544|NCT01957787|453945897|FG000|Overall Study|Local therapy, not cryoablation|6|||
126180545|NCT04176445|453945898|FG000|Overall Study|Adverse Event|0|||
126180546|NCT04176445|453945899|FG001|Overall Study|Adverse Event|1|||
126180547|NCT04176445|453945898|FG000|Overall Study|change plans weaning after first intervention|0|||
126180548|NCT04176445|453945899|FG001|Overall Study|change plans weaning after first intervention|1|||
126180549|NCT00405652|453945902|FG000|Overall Study|Adverse Event|4|||
126180550|NCT00435994|453945903|FG000|Overall Study|Lost to Follow-up|7|||
126180551|NCT00435994|453945904|FG001|Overall Study|Lost to Follow-up|0|||
126180552|NCT00435994|453945905|FG002|Overall Study|Lost to Follow-up|0|||
126180553|NCT05109702|453945909|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
126180554|NCT05109702|453945910|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
126180555|NCT05109702|453945911|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
126180556|NCT05109702|453945909|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
126180557|NCT05109702|453945910|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
126180558|NCT05109702|453945911|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
126180559|NCT05109702|453945909|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
126180560|NCT05109702|453945910|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
126180561|NCT05109702|453945911|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
126180562|NCT05109702|453945909|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
126180563|NCT05109702|453945910|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
126180564|NCT05109702|453945911|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
126180565|NCT05109702|453945909|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
126180566|NCT05109702|453945910|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
126180567|NCT05109702|453945911|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
126180568|NCT01392378|453945918|FG000|Infant Series|Adverse Event|0|||
126180569|NCT01392378|453945919|FG001|Infant Series|Adverse Event|0|||
126180570|NCT01392378|453945920|FG002|Infant Series|Adverse Event|0|||
126180571|NCT01392378|453945921|FG003|Infant Series|Adverse Event|1|||
126180572|NCT01392378|453945922|FG004|Infant Series|Adverse Event|0|||
126180573|NCT01392378|453945918|FG000|Infant Series|Lost to Follow-up|0|||
126180574|NCT01392378|453945919|FG001|Infant Series|Lost to Follow-up|0|||
126180575|NCT01392378|453945920|FG002|Infant Series|Lost to Follow-up|0|||
126180576|NCT01392378|453945921|FG003|Infant Series|Lost to Follow-up|1|||
126180577|NCT01392378|453945922|FG004|Infant Series|Lost to Follow-up|0|||
126180578|NCT01392378|453945918|FG000|Infant Series|Protocol Violation|0|||
126180579|NCT01392378|453945919|FG001|Infant Series|Protocol Violation|1|||
126180580|NCT01392378|453945920|FG002|Infant Series|Protocol Violation|0|||
126180581|NCT01392378|453945921|FG003|Infant Series|Protocol Violation|0|||
126180582|NCT01392378|453945922|FG004|Infant Series|Protocol Violation|0|||
126180583|NCT01392378|453945918|FG000|Infant Series|Withdrawal by Parent|4|||
126180584|NCT01392378|453945919|FG001|Infant Series|Withdrawal by Parent|1|||
126180585|NCT01392378|453945920|FG002|Infant Series|Withdrawal by Parent|0|||
126180586|NCT01392378|453945921|FG003|Infant Series|Withdrawal by Parent|0|||
126180587|NCT01392378|453945922|FG004|Infant Series|Withdrawal by Parent|0|||
126180588|NCT01392378|453945918|FG000|After Infant Series|Lost to Follow-up|0|||
126180589|NCT01392378|453945919|FG001|After Infant Series|Lost to Follow-up|0|||
126180590|NCT01392378|453945920|FG002|After Infant Series|Lost to Follow-up|1|||
126180591|NCT01392378|453945921|FG003|After Infant Series|Lost to Follow-up|0|||
126180592|NCT01392378|453945922|FG004|After Infant Series|Lost to Follow-up|0|||
126180593|NCT01392378|453945918|FG000|After Infant Series|Withdrawal by Parent|0|||
126180594|NCT01392378|453945919|FG001|After Infant Series|Withdrawal by Parent|1|||
126180595|NCT01392378|453945920|FG002|After Infant Series|Withdrawal by Parent|1|||
126180596|NCT01392378|453945921|FG003|After Infant Series|Withdrawal by Parent|0|||
126180597|NCT01392378|453945922|FG004|After Infant Series|Withdrawal by Parent|1|||
126180598|NCT01392378|453945918|FG000|Toddler Dose|Lost to Follow-up|0|||
126180599|NCT01392378|453945919|FG001|Toddler Dose|Lost to Follow-up|0|||
126180600|NCT01392378|453945920|FG002|Toddler Dose|Lost to Follow-up|0|||
126180601|NCT01392378|453945921|FG003|Toddler Dose|Lost to Follow-up|1|||
126180602|NCT01392378|453945922|FG004|Toddler Dose|Lost to Follow-up|0|||
126180603|NCT01392378|453945918|FG000|Toddler Dose|Withdrawal by Parent|0|||
126180604|NCT01392378|453945919|FG001|Toddler Dose|Withdrawal by Parent|1|||
126180605|NCT01392378|453945920|FG002|Toddler Dose|Withdrawal by Parent|0|||
126180606|NCT01392378|453945921|FG003|Toddler Dose|Withdrawal by Parent|1|||
126180607|NCT01392378|453945922|FG004|Toddler Dose|Withdrawal by Parent|1|||
126180608|NCT02322411|453945925|FG000|Overall Study|Lost to Follow-up|4|||
126180609|NCT02322411|453945926|FG001|Overall Study|Lost to Follow-up|7|||
126180610|NCT02322411|453945925|FG000|Overall Study|Withdrawal by Subject|1|||
126180611|NCT02322411|453945926|FG001|Overall Study|Withdrawal by Subject|0|||
126180612|NCT02261883|453945928|FG000|Overall Study|Death|3|||
126180613|NCT02261883|453945929|FG001|Overall Study|Death|2|||
126180614|NCT02261883|453945928|FG000|Overall Study|Physician Decision|1|||
126180615|NCT02261883|453945929|FG001|Overall Study|Physician Decision|0|||
126180616|NCT02261883|453945928|FG000|Overall Study|Protocol Violation|1|||
126180617|NCT02261883|453945929|FG001|Overall Study|Protocol Violation|0|||
126180618|NCT02261883|453945928|FG000|Overall Study|Withdrawal by Subject|0|||
126180619|NCT02261883|453945929|FG001|Overall Study|Withdrawal by Subject|1|||
126180620|NCT02261883|453945928|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
126180621|NCT02261883|453945929|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
126180622|NCT02713789|453945931|FG000|Overall Study|Lost to Follow-up|0|||
126180623|NCT02713789|453945932|FG001|Overall Study|Lost to Follow-up|1|||
126180624|NCT02713789|453945933|FG002|Overall Study|Lost to Follow-up|1|||
126180625|NCT00367432|453945934|FG000|First Period (16 Weeks)|Adverse Event|6|||
126180626|NCT00367432|453945935|FG001|First Period (16 Weeks)|Adverse Event|0|||
126180627|NCT00367432|453945934|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
126180628|NCT00367432|453945935|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
126180629|NCT00367432|453945934|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
126180630|NCT00367432|453945935|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
126180631|NCT00367432|453945934|FG000|First Period (16 Weeks)|Other Reason|2|||
126180632|NCT00367432|453945935|FG001|First Period (16 Weeks)|Other Reason|0|||
126180633|NCT00367432|453945934|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
126180634|NCT00367432|453945935|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
126180635|NCT00367432|453945934|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
126180636|NCT00367432|453945935|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
126180637|NCT00367432|453945934|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
126180638|NCT00367432|453945935|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
126180639|NCT00367432|453945934|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
126180640|NCT00367432|453945935|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
126180641|NCT00367432|453945934|FG000|Second Period (up to 54 Months)|Other Reason|6|||
126180642|NCT00367432|453945935|FG001|Second Period (up to 54 Months)|Other Reason|2|||
126180643|NCT00903370|453945936|FG000|Overall Study|Death|13|||
126180644|NCT00903370|453945937|FG001|Overall Study|Death|10|||
126180645|NCT00903370|453945936|FG000|Overall Study|Withdrawal by Subject|9|||
126180646|NCT00903370|453945937|FG001|Overall Study|Withdrawal by Subject|6|||
126180647|NCT00903370|453945936|FG000|Overall Study|Lost to Follow-up|6|||
126180648|NCT00903370|453945937|FG001|Overall Study|Lost to Follow-up|8|||
126180649|NCT00014911|453945938|FG000|Overall Study|Adverse Event|1|||
126180650|NCT00014911|453945938|FG000|Overall Study|Lost to Follow-up|1|||
126180651|NCT00014911|453945938|FG000|Overall Study|Withdrawal by Subject|6|||
126180652|NCT00014911|453945938|FG000|Overall Study|Unknown Reasons|2|||
126180653|NCT00014911|453945938|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
126180654|NCT01999946|453945939|FG000|Overall Study|Participant not released from jail|2|||
126180655|NCT01999946|453945940|FG001|Overall Study|Participant not released from jail|2|||
126180656|NCT01999946|453945941|FG002|Overall Study|Participant not released from jail|0|||
126180657|NCT01999946|453945939|FG000|Overall Study|Not included in primary outcome analysis|0|||
126180658|NCT01999946|453945940|FG001|Overall Study|Not included in primary outcome analysis|0|||
126180659|NCT01999946|453945941|FG002|Overall Study|Not included in primary outcome analysis|79|||
126180660|NCT02091921|453945942|FG000|Overall Study|Adverse Event|3|||
126180661|NCT03307629|453945943|FG000|Overall Study|Withdrawal by Subject|0|||
126180662|NCT03307629|453945944|FG001|Overall Study|Withdrawal by Subject|0|||
126180663|NCT03307629|453945945|FG002|Overall Study|Withdrawal by Subject|0|||
126180664|NCT03307629|453945946|FG003|Overall Study|Withdrawal by Subject|2|||
126180665|NCT03307629|453945943|FG000|Overall Study|Disease Progression|0|||
126180666|NCT03307629|453945944|FG001|Overall Study|Disease Progression|0|||
126180667|NCT03307629|453945945|FG002|Overall Study|Disease Progression|0|||
126180668|NCT03307629|453945946|FG003|Overall Study|Disease Progression|3|||
126180669|NCT03307629|453945943|FG000|Overall Study|Death|0|||
126180670|NCT03307629|453945944|FG001|Overall Study|Death|3|||
126180671|NCT03307629|453945945|FG002|Overall Study|Death|0|||
126180672|NCT03307629|453945946|FG003|Overall Study|Death|1|||
126180673|NCT00719953|453945951|FG000|Overall Study|Adverse Event|4|||
126180674|NCT01626989|453945952|FG000|Screening Period|Screen Failure|15|||
126180675|NCT01626989|453945953|FG001|Screening Period|Screen Failure|0|||
126180676|NCT01626989|453945954|FG002|Screening Period|Screen Failure|0|||
126180677|NCT01626989|453945952|FG000|Screening Period|Withdrawal by Subject|2|||
126180678|NCT01626989|453945953|FG001|Screening Period|Withdrawal by Subject|0|||
126180679|NCT01626989|453945954|FG002|Screening Period|Withdrawal by Subject|0|||
126180680|NCT00642018|453945962|FG000|Overall Study|Adverse Event|11|||
126180681|NCT00642018|453945963|FG001|Overall Study|Adverse Event|36|||
126180682|NCT00642018|453945962|FG000|Overall Study|Withdrawal by Subject|4|||
126180683|NCT00642018|453945963|FG001|Overall Study|Withdrawal by Subject|10|||
126180684|NCT00642018|453945962|FG000|Overall Study|Progressive Disease|13|||
126180685|NCT00642018|453945963|FG001|Overall Study|Progressive Disease|18|||
126180686|NCT00642018|453945962|FG000|Overall Study|Physician Decision|0|||
126180687|NCT00642018|453945963|FG001|Overall Study|Physician Decision|10|||
126180688|NCT00642018|453945962|FG000|Overall Study|Protocol Violation|0|||
126180689|NCT00642018|453945963|FG001|Overall Study|Protocol Violation|1|||
126180690|NCT00642018|453945962|FG000|Overall Study|Death|0|||
126180691|NCT00642018|453945963|FG001|Overall Study|Death|3|||
126180692|NCT00642018|453945962|FG000|Overall Study|Entry Criteria Not Met|0|||
126180693|NCT00642018|453945963|FG001|Overall Study|Entry Criteria Not Met|1|||
126180694|NCT01230749|453945964|FG000|Overall Study|Adverse Event|0|||
126180695|NCT01230749|453945965|FG001|Overall Study|Adverse Event|0|||
126180696|NCT01230749|453945966|FG002|Overall Study|Adverse Event|0|||
126180697|NCT01230749|453945967|FG003|Overall Study|Adverse Event|1|||
126180698|NCT01230749|453945964|FG000|Overall Study|Physician Decision|0|||
126180699|NCT01230749|453945965|FG001|Overall Study|Physician Decision|0|||
126180700|NCT01230749|453945966|FG002|Overall Study|Physician Decision|1|||
126180701|NCT01230749|453945967|FG003|Overall Study|Physician Decision|0|||
126180702|NCT01230749|453945964|FG000|Overall Study|Withdrawal by Subject|0|||
126180703|NCT01230749|453945965|FG001|Overall Study|Withdrawal by Subject|1|||
126180704|NCT01230749|453945966|FG002|Overall Study|Withdrawal by Subject|0|||
126180705|NCT01230749|453945967|FG003|Overall Study|Withdrawal by Subject|0|||
126180706|NCT01230749|453945964|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
126180707|NCT01230749|453945965|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
126180708|NCT01230749|453945966|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
126180709|NCT01230749|453945967|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
126180710|NCT04021706|453947926|FG000|Overall Study|Adverse Event|2|||
126180711|NCT04021706|453947927|FG001|Overall Study|Adverse Event|0|||
126180712|NCT04021706|453947926|FG000|Overall Study|Withdrawal by Subject|1|||
126180713|NCT04021706|453947927|FG001|Overall Study|Withdrawal by Subject|2|||
126180714|NCT04021706|453947926|FG000|Overall Study|Physician Decision|1|||
126180715|NCT04021706|453947927|FG001|Overall Study|Physician Decision|0|||
126180716|NCT00355134|453947930|FG000|Core Phase|Withdrawal by Subject|35|||
126180717|NCT00355134|453947931|FG001|Core Phase|Withdrawal by Subject|24|||
126180718|NCT00355134|453947932|FG002|Core Phase|Withdrawal by Subject|35|||
126180719|NCT00355134|453947933|FG003|Core Phase|Withdrawal by Subject|0|||
126180720|NCT00355134|453947934|FG004|Core Phase|Withdrawal by Subject|0|||
126180721|NCT00355134|453947930|FG000|Core Phase|Adverse Event|28|||
126180722|NCT00355134|453947931|FG001|Core Phase|Adverse Event|22|||
126180723|NCT00355134|453947932|FG002|Core Phase|Adverse Event|16|||
126180724|NCT00355134|453947933|FG003|Core Phase|Adverse Event|0|||
126180725|NCT00355134|453947934|FG004|Core Phase|Adverse Event|0|||
126180726|NCT00355134|453947930|FG000|Core Phase|Lost to Follow-up|17|||
126180727|NCT00355134|453947931|FG001|Core Phase|Lost to Follow-up|13|||
126180728|NCT00355134|453947932|FG002|Core Phase|Lost to Follow-up|21|||
126180729|NCT00355134|453947933|FG003|Core Phase|Lost to Follow-up|0|||
126180730|NCT00355134|453947934|FG004|Core Phase|Lost to Follow-up|0|||
126180731|NCT00355134|453947930|FG000|Core Phase|Abnormal laboratory value(s)|19|||
126180732|NCT00355134|453947931|FG001|Core Phase|Abnormal laboratory value(s)|14|||
126180733|NCT00355134|453947932|FG002|Core Phase|Abnormal laboratory value(s)|2|||
126180734|NCT00355134|453947933|FG003|Core Phase|Abnormal laboratory value(s)|0|||
126180735|NCT00355134|453947934|FG004|Core Phase|Abnormal laboratory value(s)|0|||
126180736|NCT00355134|453947930|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
126180737|NCT00355134|453947931|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
126180738|NCT00355134|453947932|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
126180739|NCT00355134|453947933|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
126180740|NCT00355134|453947934|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
126180741|NCT00355134|453947930|FG000|Core Phase|Administrative problems|5|||
126180742|NCT00355134|453947931|FG001|Core Phase|Administrative problems|3|||
126180743|NCT00355134|453947932|FG002|Core Phase|Administrative problems|5|||
126180744|NCT00355134|453947933|FG003|Core Phase|Administrative problems|0|||
126180745|NCT00355134|453947934|FG004|Core Phase|Administrative problems|0|||
126180746|NCT00355134|453947930|FG000|Core Phase|Protocol Violation|3|||
126180747|NCT00355134|453947931|FG001|Core Phase|Protocol Violation|2|||
126180748|NCT00355134|453947932|FG002|Core Phase|Protocol Violation|2|||
126180749|NCT00355134|453947933|FG003|Core Phase|Protocol Violation|0|||
126180750|NCT00355134|453947934|FG004|Core Phase|Protocol Violation|0|||
126180751|NCT00355134|453947930|FG000|Core Phase|Abnormal test procedure result(s)|1|||
126180752|NCT00355134|453947931|FG001|Core Phase|Abnormal test procedure result(s)|2|||
126180753|NCT00355134|453947932|FG002|Core Phase|Abnormal test procedure result(s)|1|||
126180754|NCT00355134|453947933|FG003|Core Phase|Abnormal test procedure result(s)|0|||
126180755|NCT00355134|453947934|FG004|Core Phase|Abnormal test procedure result(s)|0|||
126180756|NCT00355134|453947930|FG000|Core Phase|Condition no longer requires study drug|1|||
126180757|NCT00355134|453947931|FG001|Core Phase|Condition no longer requires study drug|0|||
126180758|NCT00355134|453947932|FG002|Core Phase|Condition no longer requires study drug|1|||
126180759|NCT00355134|453947933|FG003|Core Phase|Condition no longer requires study drug|0|||
126180760|NCT00355134|453947934|FG004|Core Phase|Condition no longer requires study drug|0|||
126180761|NCT00355134|453947930|FG000|Extension Phase|Withdrawal by Subject|7|||
126180762|NCT00355134|453947931|FG001|Extension Phase|Withdrawal by Subject|11|||
126180763|NCT00355134|453947932|FG002|Extension Phase|Withdrawal by Subject|0|||
126180764|NCT00355134|453947933|FG003|Extension Phase|Withdrawal by Subject|7|||
126180765|NCT00355134|453947934|FG004|Extension Phase|Withdrawal by Subject|5|||
126180766|NCT00355134|453947930|FG000|Extension Phase|Adverse Event|13|||
126180767|NCT00355134|453947931|FG001|Extension Phase|Adverse Event|9|||
126180768|NCT00355134|453947932|FG002|Extension Phase|Adverse Event|0|||
126180769|NCT00355134|453947933|FG003|Extension Phase|Adverse Event|3|||
126180770|NCT00355134|453947934|FG004|Extension Phase|Adverse Event|5|||
126180771|NCT00355134|453947930|FG000|Extension Phase|Lost to Follow-up|2|||
126180772|NCT00355134|453947931|FG001|Extension Phase|Lost to Follow-up|6|||
126180773|NCT00355134|453947932|FG002|Extension Phase|Lost to Follow-up|0|||
126180774|NCT00355134|453947933|FG003|Extension Phase|Lost to Follow-up|2|||
126180775|NCT00355134|453947934|FG004|Extension Phase|Lost to Follow-up|4|||
126180776|NCT00355134|453947930|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
126180777|NCT00355134|453947931|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
126180778|NCT00355134|453947932|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
126180779|NCT00355134|453947933|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
126180780|NCT00355134|453947934|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
126180781|NCT00355134|453947930|FG000|Extension Phase|Administrative problems|2|||
126180782|NCT00355134|453947931|FG001|Extension Phase|Administrative problems|4|||
126180783|NCT00355134|453947932|FG002|Extension Phase|Administrative problems|0|||
126180784|NCT00355134|453947933|FG003|Extension Phase|Administrative problems|1|||
126180785|NCT00355134|453947934|FG004|Extension Phase|Administrative problems|1|||
126180786|NCT00355134|453947930|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
126180787|NCT00355134|453947931|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
126180788|NCT00355134|453947932|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
126180789|NCT00355134|453947933|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
126180790|NCT00355134|453947934|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
126180791|NCT00355134|453947930|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
126180792|NCT00355134|453947931|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
126180793|NCT00355134|453947932|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
126180794|NCT00355134|453947933|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
126180795|NCT00355134|453947934|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
126180796|NCT00355134|453947930|FG000|Extension Phase|Protocol Violation|0|||
126180797|NCT00355134|453947931|FG001|Extension Phase|Protocol Violation|0|||
126180798|NCT00355134|453947932|FG002|Extension Phase|Protocol Violation|0|||
126180799|NCT00355134|453947933|FG003|Extension Phase|Protocol Violation|1|||
126180800|NCT00355134|453947934|FG004|Extension Phase|Protocol Violation|0|||
126180801|NCT01412151|453947935|FG000|Week 0 - 306 - Treatment Period|Death|1|||
126180802|NCT01412151|453947935|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
126180803|NCT01412151|453947935|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
126180804|NCT01412151|453947935|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
126180805|NCT03127852|453947937|FG000|Overall Study|Withdrawal by Subject|4|||
126180806|NCT03127852|453947938|FG001|Overall Study|Withdrawal by Subject|1|||
126180807|NCT03127852|453947937|FG000|Overall Study|Death|1|||
126180808|NCT03127852|453947938|FG001|Overall Study|Death|1|||
126180809|NCT00859573|453947940|FG000|Overall Study|Withdrawal by Subject|4|||
126180810|NCT00859573|453947941|FG001|Overall Study|Withdrawal by Subject|1|||
126180811|NCT00859573|453947940|FG000|Overall Study|Physician Decision|1|||
126180812|NCT00859573|453947941|FG001|Overall Study|Physician Decision|1|||
126180813|NCT03077243|453947942|FG000|Overall Study|Death|1|||
126180814|NCT03077243|453947943|FG001|Overall Study|Death|2|||
126180815|NCT03077243|453947944|FG002|Overall Study|Death|0|||
126180816|NCT03077243|453947945|FG003|Overall Study|Death|0|||
126180817|NCT03077243|453947942|FG000|Overall Study|Withdrawal by Subject|1|||
126180818|NCT03077243|453947943|FG001|Overall Study|Withdrawal by Subject|3|||
126180819|NCT03077243|453947944|FG002|Overall Study|Withdrawal by Subject|0|||
126180820|NCT03077243|453947945|FG003|Overall Study|Withdrawal by Subject|0|||
126180821|NCT03077243|453947942|FG000|Overall Study|Physician Decision|1|||
126180822|NCT03077243|453947943|FG001|Overall Study|Physician Decision|0|||
126180823|NCT03077243|453947944|FG002|Overall Study|Physician Decision|0|||
126180824|NCT03077243|453947945|FG003|Overall Study|Physician Decision|0|||
126180825|NCT03077243|453947942|FG000|Overall Study|Research at two study sites terminated early|0|||
126180826|NCT03077243|453947943|FG001|Overall Study|Research at two study sites terminated early|0|||
126180827|NCT03077243|453947944|FG002|Overall Study|Research at two study sites terminated early|0|||
126180828|NCT03077243|453947945|FG003|Overall Study|Research at two study sites terminated early|69|||
126180829|NCT02848313|453947946|FG000|Overall Study|Adverse Event|1|||
126180830|NCT02848313|453947947|FG001|Overall Study|Adverse Event|2|||
126180831|NCT02848313|453947946|FG000|Overall Study|Lack of Efficacy|0|||
126180832|NCT02848313|453947947|FG001|Overall Study|Lack of Efficacy|1|||
126180833|NCT02848313|453947946|FG000|Overall Study|Withdrawal by Subject|1|||
126180834|NCT02848313|453947947|FG001|Overall Study|Withdrawal by Subject|1|||
126180835|NCT02848313|453947946|FG000|Overall Study|Lost to follow up|1|||
126180836|NCT02848313|453947947|FG001|Overall Study|Lost to follow up|0|||
126180837|NCT01432457|453947948|FG000|Overall Study|Adverse Event|7|||
126180838|NCT01432457|453947949|FG001|Overall Study|Adverse Event|10|||
126180839|NCT01432457|453947950|FG002|Overall Study|Adverse Event|16|||
126180840|NCT01432457|453947948|FG000|Overall Study|Lack of Efficacy|2|||
126180841|NCT01432457|453947949|FG001|Overall Study|Lack of Efficacy|1|||
126180842|NCT01432457|453947950|FG002|Overall Study|Lack of Efficacy|1|||
126180843|NCT01432457|453947948|FG000|Overall Study|Lost to Follow-up|11|||
126180844|NCT01432457|453947949|FG001|Overall Study|Lost to Follow-up|15|||
126180845|NCT01432457|453947950|FG002|Overall Study|Lost to Follow-up|20|||
126180846|NCT01432457|453947948|FG000|Overall Study|Protocol Violation|3|||
126180847|NCT01432457|453947949|FG001|Overall Study|Protocol Violation|2|||
126180848|NCT01432457|453947950|FG002|Overall Study|Protocol Violation|6|||
126180849|NCT01432457|453947948|FG000|Overall Study|Withdrawal by Subject|6|||
126180850|NCT01432457|453947949|FG001|Overall Study|Withdrawal by Subject|11|||
126180851|NCT01432457|453947950|FG002|Overall Study|Withdrawal by Subject|9|||
126180852|NCT01432457|453947948|FG000|Overall Study|Reasons not defined|2|||
126180853|NCT01432457|453947949|FG001|Overall Study|Reasons not defined|3|||
126180854|NCT01432457|453947950|FG002|Overall Study|Reasons not defined|4|||
126180855|NCT01432457|453947948|FG000|Overall Study|Did not take study drug|6|||
126180856|NCT01432457|453947949|FG001|Overall Study|Did not take study drug|6|||
126180857|NCT01432457|453947950|FG002|Overall Study|Did not take study drug|3|||
126180858|NCT01544478|453947951|FG000|Overall Study|Adverse Event|1|||
126180859|NCT01544478|453947951|FG000|Overall Study|Death|1|||
126180860|NCT01544478|453947951|FG000|Overall Study|Lost to Follow-up|48|||
126180861|NCT01544478|453947951|FG000|Overall Study|Physician Decision|15|||
126180862|NCT01544478|453947951|FG000|Overall Study|Pregnancy|1|||
126180863|NCT01544478|453947951|FG000|Overall Study|Withdrawal by Subject|52|||
126180864|NCT02574481|453947952|FG000|Overall Study|Withdrawal by Subject|29|||
126180865|NCT02574481|453947953|FG001|Overall Study|Withdrawal by Subject|15|||
126180866|NCT02574481|453947954|FG002|Overall Study|Withdrawal by Subject|4|||
126180867|NCT02574481|453947955|FG003|Overall Study|Withdrawal by Subject|1|||
126180868|NCT02574481|453947952|FG000|Overall Study|Adverse Event|5|||
126180869|NCT02574481|453947953|FG001|Overall Study|Adverse Event|1|||
126180870|NCT02574481|453947954|FG002|Overall Study|Adverse Event|1|||
126180871|NCT02574481|453947955|FG003|Overall Study|Adverse Event|0|||
126180872|NCT02574481|453947952|FG000|Overall Study|Visit Missed|15|||
126180873|NCT02574481|453947953|FG001|Overall Study|Visit Missed|7|||
126180874|NCT02574481|453947954|FG002|Overall Study|Visit Missed|5|||
126180875|NCT02574481|453947955|FG003|Overall Study|Visit Missed|0|||
126180876|NCT02574481|453947952|FG000|Overall Study|Other|7|||
126180877|NCT02574481|453947953|FG001|Overall Study|Other|2|||
126180878|NCT02574481|453947954|FG002|Overall Study|Other|0|||
126180879|NCT02574481|453947955|FG003|Overall Study|Other|0|||
126180880|NCT02574481|453947952|FG000|Overall Study|Death|48|||
126180881|NCT02574481|453947953|FG001|Overall Study|Death|26|||
126180882|NCT02574481|453947954|FG002|Overall Study|Death|12|||
126180883|NCT02574481|453947955|FG003|Overall Study|Death|4|||
126180884|NCT02574481|453947952|FG000|Overall Study|Physician Decision|5|||
126180885|NCT02574481|453947953|FG001|Overall Study|Physician Decision|2|||
126180886|NCT02574481|453947954|FG002|Overall Study|Physician Decision|0|||
126180887|NCT02574481|453947955|FG003|Overall Study|Physician Decision|0|||
126180888|NCT02574481|453947952|FG000|Overall Study|Lost to Follow-up|5|||
126180889|NCT02574481|453947953|FG001|Overall Study|Lost to Follow-up|1|||
126180890|NCT02574481|453947954|FG002|Overall Study|Lost to Follow-up|3|||
126180891|NCT02574481|453947955|FG003|Overall Study|Lost to Follow-up|0|||
126180892|NCT04134728|453947959|FG000|Overall Study|Adverse Event|3|||
126180893|NCT04134728|453947960|FG001|Overall Study|Adverse Event|2|||
126180894|NCT04134728|453947961|FG002|Overall Study|Adverse Event|9|||
126180895|NCT04134728|453947962|FG003|Overall Study|Adverse Event|0|||
126180896|NCT04134728|453947963|FG004|Overall Study|Adverse Event|0|||
126180897|NCT04134728|453947964|FG005|Overall Study|Adverse Event|0|||
126180898|NCT04134728|453947959|FG000|Overall Study|Lack of Efficacy|3|||
126180899|NCT04134728|453947960|FG001|Overall Study|Lack of Efficacy|3|||
126180900|NCT04134728|453947961|FG002|Overall Study|Lack of Efficacy|1|||
126180901|NCT04134728|453947962|FG003|Overall Study|Lack of Efficacy|2|||
126180902|NCT04134728|453947963|FG004|Overall Study|Lack of Efficacy|0|||
126180903|NCT04134728|453947964|FG005|Overall Study|Lack of Efficacy|0|||
126180904|NCT04134728|453947959|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126180905|NCT04134728|453947960|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126180906|NCT04134728|453947961|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
126180907|NCT04134728|453947962|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126180908|NCT04134728|453947963|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126180909|NCT04134728|453947964|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126180910|NCT04134728|453947959|FG000|Overall Study|Protocol Deviation|0|||
126180911|NCT04134728|453947960|FG001|Overall Study|Protocol Deviation|0|||
126180912|NCT04134728|453947961|FG002|Overall Study|Protocol Deviation|1|||
126180913|NCT04134728|453947962|FG003|Overall Study|Protocol Deviation|0|||
126180914|NCT04134728|453947963|FG004|Overall Study|Protocol Deviation|0|||
126180915|NCT04134728|453947964|FG005|Overall Study|Protocol Deviation|0|||
126180916|NCT04134728|453947959|FG000|Overall Study|Informed Consent Withdrawn|3|||
126180917|NCT04134728|453947960|FG001|Overall Study|Informed Consent Withdrawn|6|||
126180918|NCT04134728|453947961|FG002|Overall Study|Informed Consent Withdrawn|8|||
126180919|NCT04134728|453947962|FG003|Overall Study|Informed Consent Withdrawn|1|||
126180920|NCT04134728|453947963|FG004|Overall Study|Informed Consent Withdrawn|1|||
126180921|NCT04134728|453947964|FG005|Overall Study|Informed Consent Withdrawn|0|||
126180922|NCT04134728|453947959|FG000|Overall Study|Physician Decision|2|||
126180923|NCT04134728|453947960|FG001|Overall Study|Physician Decision|0|||
126180924|NCT04134728|453947961|FG002|Overall Study|Physician Decision|0|||
126180925|NCT04134728|453947962|FG003|Overall Study|Physician Decision|0|||
126180926|NCT04134728|453947963|FG004|Overall Study|Physician Decision|0|||
126180927|NCT04134728|453947964|FG005|Overall Study|Physician Decision|0|||
126180928|NCT04134728|453947959|FG000|Overall Study|Lost to Follow-up|1|||
126180929|NCT04134728|453947960|FG001|Overall Study|Lost to Follow-up|2|||
126180930|NCT04134728|453947961|FG002|Overall Study|Lost to Follow-up|1|||
126180931|NCT04134728|453947962|FG003|Overall Study|Lost to Follow-up|0|||
126180932|NCT04134728|453947963|FG004|Overall Study|Lost to Follow-up|0|||
126180933|NCT04134728|453947964|FG005|Overall Study|Lost to Follow-up|1|||
126180934|NCT04134728|453947959|FG000|Overall Study|Investigator Site Closed|0|||
126180935|NCT04134728|453947960|FG001|Overall Study|Investigator Site Closed|1|||
126180936|NCT04134728|453947961|FG002|Overall Study|Investigator Site Closed|1|||
126180937|NCT04134728|453947962|FG003|Overall Study|Investigator Site Closed|0|||
126180938|NCT04134728|453947963|FG004|Overall Study|Investigator Site Closed|0|||
126180939|NCT04134728|453947964|FG005|Overall Study|Investigator Site Closed|0|||
126180940|NCT03382262|453947965|FG000|Overall Study|Physician Decision|0|||
126180941|NCT03382262|453947966|FG001|Overall Study|Physician Decision|0|||
126180942|NCT03382262|453947967|FG002|Overall Study|Physician Decision|1|||
126180943|NCT03382262|453947968|FG003|Overall Study|Physician Decision|0|||
126180944|NCT03382262|453947965|FG000|Overall Study|Withdrawal by Subject|0|||
126180945|NCT03382262|453947966|FG001|Overall Study|Withdrawal by Subject|0|||
126180946|NCT03382262|453947967|FG002|Overall Study|Withdrawal by Subject|0|||
126180947|NCT03382262|453947968|FG003|Overall Study|Withdrawal by Subject|1|||
126180948|NCT02038790|453947970|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
126180949|NCT02038790|453947971|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
126180950|NCT00438464|453947979|FG000|Overall Study|Terminated Early|14|||
126180951|NCT00438464|453947980|FG001|Overall Study|Terminated Early|5|||
126180952|NCT00438464|453947979|FG000|Overall Study|Incomplete data submission|0|||
126180953|NCT00438464|453947980|FG001|Overall Study|Incomplete data submission|2|||
126180954|NCT03943446|453947982|FG000|Overall Study|Lost to Follow-up|0|||
126180955|NCT03943446|453947983|FG001|Overall Study|Lost to Follow-up|0|||
126180956|NCT03943446|453947984|FG002|Overall Study|Lost to Follow-up|1|||
126180957|NCT03943446|453947982|FG000|Overall Study|Withdrawal by Subject|1|||
126180958|NCT03943446|453947983|FG001|Overall Study|Withdrawal by Subject|1|||
126180959|NCT03943446|453947984|FG002|Overall Study|Withdrawal by Subject|2|||
126180960|NCT03943446|453947982|FG000|Overall Study|Study Terminated by Sponsor|1|||
126180961|NCT03943446|453947983|FG001|Overall Study|Study Terminated by Sponsor|2|||
126180962|NCT03943446|453947984|FG002|Overall Study|Study Terminated by Sponsor|1|||
126180963|NCT03943446|453947982|FG000|Overall Study|Reason not Specified|5|||
126180964|NCT03943446|453947983|FG001|Overall Study|Reason not Specified|1|||
126180965|NCT03943446|453947984|FG002|Overall Study|Reason not Specified|3|||
126180966|NCT01136746|453947987|FG000|Overall Study|Lost to Follow-up|0|||
126180967|NCT01136746|453947988|FG001|Overall Study|Lost to Follow-up|2|||
126180968|NCT01136746|453947987|FG000|Overall Study|Protocol Violation|2|||
126180969|NCT01136746|453947988|FG001|Overall Study|Protocol Violation|1|||
126180970|NCT01136746|453947987|FG000|Overall Study|Death|1|||
126180971|NCT01136746|453947988|FG001|Overall Study|Death|0|||
126180972|NCT01601704|453947998|FG000|Overall Study|Randomized but not dispensed study med|1|||
126180973|NCT01601704|453947999|FG001|Overall Study|Randomized but not dispensed study med|4|||
126180974|NCT01090102|453948000|FG000|First 12 Weeks|Withdrawal by Subject|1|||
126180975|NCT01090102|453948001|FG001|First 12 Weeks|Withdrawal by Subject|1|||
126180976|NCT01090102|453948000|FG000|First 12 Weeks|Adverse Event|2|||
126180977|NCT01090102|453948001|FG001|First 12 Weeks|Adverse Event|0|||
126180978|NCT01090102|453948000|FG000|First 12 Weeks|Death|1|||
126180979|NCT01090102|453948001|FG001|First 12 Weeks|Death|1|||
126180980|NCT01090102|453948000|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
126180981|NCT01090102|453948001|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
126180982|NCT03518034|453948002|FG000|Overall Study|Not Treated|5|||
126180983|NCT03518034|453948003|FG001|Overall Study|Not Treated|1|||
126180984|NCT03518034|453948002|FG000|Overall Study|Withdrawal by Subject|309|||
126180985|NCT03518034|453948003|FG001|Overall Study|Withdrawal by Subject|351|||
126180986|NCT03518034|453948002|FG000|Overall Study|Lost to Follow-up|446|||
126180987|NCT03518034|453948003|FG001|Overall Study|Lost to Follow-up|458|||
126180988|NCT03518034|453948002|FG000|Overall Study|Adverse Event|138|||
126180989|NCT03518034|453948003|FG001|Overall Study|Adverse Event|130|||
126180990|NCT03518034|453948002|FG000|Overall Study|Lack of Efficacy|11|||
126180991|NCT03518034|453948003|FG001|Overall Study|Lack of Efficacy|23|||
126180992|NCT03518034|453948002|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
126180993|NCT03518034|453948003|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
126180994|NCT03518034|453948002|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
126180995|NCT03518034|453948003|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
126180996|NCT03518034|453948002|FG000|Overall Study|Other, Not Specified|84|||
126180997|NCT03518034|453948003|FG001|Overall Study|Other, Not Specified|53|||
126180998|NCT03518034|453948002|FG000|Overall Study|Reason Missing|2|||
126180999|NCT03518034|453948003|FG001|Overall Study|Reason Missing|3|||
126181000|NCT00985738|453948011|FG000|Overall Study|Study closed prematurely|8|||
126181001|NCT00985738|453948012|FG001|Overall Study|Study closed prematurely|8|||
126181002|NCT02227849|453948014|FG000|Overall Study|Adverse Event|4|||
126181003|NCT02227849|453948014|FG000|Overall Study|Physician Decision|1|||
126181004|NCT02227849|453948014|FG000|Overall Study|Withdrawal by Subject|3|||
126181005|NCT01590212|453948017|FG000|Overall Study|Withdrawal by Subject|2|||
126181006|NCT01590212|453948018|FG001|Overall Study|Withdrawal by Subject|2|||
126181007|NCT01590212|453948019|FG002|Overall Study|Withdrawal by Subject|2|||
126181008|NCT01590212|453948017|FG000|Overall Study|Lost to Follow-up|1|||
126181009|NCT01590212|453948018|FG001|Overall Study|Lost to Follow-up|2|||
126181010|NCT01590212|453948019|FG002|Overall Study|Lost to Follow-up|3|||
126181011|NCT04897594|453948021|FG000|Overall Study|Lost to Follow-up|0|||
126181012|NCT04897594|453948022|FG001|Overall Study|Lost to Follow-up|1|||
126181013|NCT04897594|453948023|FG002|Overall Study|Lost to Follow-up|1|||
126181014|NCT04897594|453948021|FG000|Overall Study|Sponsor Decision|0|||
126181015|NCT04897594|453948022|FG001|Overall Study|Sponsor Decision|0|||
126181016|NCT04897594|453948023|FG002|Overall Study|Sponsor Decision|1|||
126181017|NCT04897594|453948021|FG000|Overall Study|Withdrawal by Subject|1|||
126181018|NCT04897594|453948022|FG001|Overall Study|Withdrawal by Subject|0|||
126181019|NCT04897594|453948023|FG002|Overall Study|Withdrawal by Subject|1|||
126181020|NCT00150345|453948026|FG000|Overall Study|Death|5|||
126181021|NCT00150345|453948027|FG001|Overall Study|Death|2|||
126181022|NCT00150345|453948026|FG000|Overall Study|Adverse Event|8|||
126181023|NCT00150345|453948027|FG001|Overall Study|Adverse Event|6|||
126181024|NCT00150345|453948026|FG000|Overall Study|Lack of Efficacy|5|||
126181025|NCT00150345|453948027|FG001|Overall Study|Lack of Efficacy|4|||
126181026|NCT00150345|453948026|FG000|Overall Study|Withdrawal by Subject|3|||
126181027|NCT00150345|453948027|FG001|Overall Study|Withdrawal by Subject|4|||
126181028|NCT00150345|453948026|FG000|Overall Study|Laboratory abnormality|1|||
126181029|NCT00150345|453948027|FG001|Overall Study|Laboratory abnormality|2|||
126181030|NCT00150345|453948026|FG000|Overall Study|Other|12|||
126181031|NCT00150345|453948027|FG001|Overall Study|Other|14|||
126181032|NCT01457924|453948030|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
126181033|NCT01457924|453948031|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
126181034|NCT01457924|453948032|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
126181035|NCT01457924|453948033|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
126181036|NCT01457924|453948034|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
126181037|NCT01457924|453948030|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
126181038|NCT01457924|453948031|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
126181039|NCT01457924|453948032|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
126181040|NCT01457924|453948033|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
126181041|NCT01457924|453948034|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
126181042|NCT01457924|453948030|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
126181043|NCT01457924|453948031|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
126181044|NCT01457924|453948032|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
126181045|NCT01457924|453948033|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
126181046|NCT01457924|453948034|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
126181047|NCT01457924|453948030|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
126181048|NCT01457924|453948031|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
126181049|NCT01457924|453948032|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
126181050|NCT01457924|453948033|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
126181051|NCT01457924|453948034|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
126181052|NCT01457924|453948030|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
126181053|NCT01457924|453948031|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
126181054|NCT01457924|453948032|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
126181055|NCT01457924|453948033|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
126181056|NCT01457924|453948034|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
126181057|NCT01457924|453948030|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
126181058|NCT01457924|453948031|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
126181059|NCT01457924|453948032|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
126181060|NCT01457924|453948033|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
126181061|NCT01457924|453948034|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
126181062|NCT01457924|453948030|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
126181063|NCT01457924|453948031|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
126181064|NCT01457924|453948032|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
126181065|NCT01457924|453948033|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
126181066|NCT01457924|453948034|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
126181067|NCT01457924|453948030|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
126181068|NCT01457924|453948031|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
126181069|NCT01457924|453948032|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
126181070|NCT01457924|453948033|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
126181071|NCT01457924|453948034|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
126181072|NCT01457924|453948030|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
126181073|NCT01457924|453948031|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
126181074|NCT01457924|453948032|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
126181075|NCT01457924|453948033|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
126181076|NCT01457924|453948034|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
126181077|NCT01457924|453948030|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
126181078|NCT01457924|453948031|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
126181079|NCT01457924|453948032|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
126181080|NCT01457924|453948033|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
126181081|NCT01457924|453948034|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
126181082|NCT01457924|453948030|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
126181083|NCT01457924|453948031|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
126181084|NCT01457924|453948032|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
126181085|NCT01457924|453948033|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
126181086|NCT01457924|453948034|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
126181087|NCT01457924|453948030|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
126181088|NCT01457924|453948031|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
126181089|NCT01457924|453948032|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
126181090|NCT01457924|453948033|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
126181091|NCT01457924|453948034|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
126181092|NCT01457924|453948030|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
126181093|NCT01457924|453948031|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
126181094|NCT01457924|453948032|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
126181095|NCT01457924|453948033|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
126181096|NCT01457924|453948034|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
126181097|NCT00792701|453948036|FG000|Overall Study|Adverse Event|0|||
126181098|NCT00792701|453948037|FG001|Overall Study|Adverse Event|22|||
126181099|NCT00792701|453948036|FG000|Overall Study|Ineligible|1|||
126181100|NCT00792701|453948037|FG001|Overall Study|Ineligible|3|||
126181101|NCT00792701|453948036|FG000|Overall Study|Withdrawal by Subject|1|||
126181102|NCT00792701|453948037|FG001|Overall Study|Withdrawal by Subject|19|||
126181103|NCT00792701|453948036|FG000|Overall Study|Not protocol specified|17|||
126181104|NCT00792701|453948037|FG001|Overall Study|Not protocol specified|0|||
126181105|NCT02143141|453948046|FG000|Overall Study|pain scores at 24 hours not collected|1|||
126181106|NCT02143141|453948047|FG001|Overall Study|pain scores at 24 hours not collected|0|||
126181107|NCT03862495|453948048|FG000|Overall Study|Lost to Follow-up|37|||
126181108|NCT03862495|453948049|FG001|Overall Study|Lost to Follow-up|35|||
126181109|NCT00615914|453948050|FG000|Overall Study|Adverse Event|274|||
126181110|NCT00615914|453948050|FG000|Overall Study|Death|20|||
126181111|NCT00615914|453948050|FG000|Overall Study|Lack of Efficacy|59|||
126181112|NCT00615914|453948050|FG000|Overall Study|Lost to Follow-up|187|||
126181113|NCT00615914|453948050|FG000|Overall Study|Withdrawal by Subject|16|||
126181114|NCT00615914|453948050|FG000|Overall Study|Physician Decision|4|||
126181115|NCT00615914|453948050|FG000|Overall Study|No data was collected.|65|||
126181116|NCT00615914|453948050|FG000|Overall Study|No treatment|2|||
126181117|NCT00615914|453948050|FG000|Overall Study|Irregularly enrolled patients|10|||
126181118|NCT01467661|453948051|FG000|Overall Study|Adverse Event|16|||
126181119|NCT01467661|453948051|FG000|Overall Study|Withdrawal by Subject|1|||
126181120|NCT01467661|453948051|FG000|Overall Study|Lack of Efficacy|3|||
126181121|NCT01467661|453948051|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
126181122|NCT03673956|453948052|FG000|Overall Study|Lost to Follow-up|1|||
126181123|NCT03673956|453948053|FG001|Overall Study|Lost to Follow-up|0|||
126181124|NCT03673956|453948054|FG002|Overall Study|Lost to Follow-up|0|||
126181125|NCT03673956|453948055|FG003|Overall Study|Lost to Follow-up|0|||
126181126|NCT03673956|453948052|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
126181127|NCT03673956|453948053|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
126181128|NCT03673956|453948054|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
126181129|NCT03673956|453948055|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
126181130|NCT00270998|453948056|FG000|3 Month Follow-up|Adverse Event|1|||
126181131|NCT00270998|453948057|FG001|3 Month Follow-up|Adverse Event|0|||
126181132|NCT00270998|453948058|FG002|3 Month Follow-up|Adverse Event|0|||
126181133|NCT00270998|453948056|FG000|3 Month Follow-up|Lack of Efficacy|1|||
126181134|NCT00270998|453948057|FG001|3 Month Follow-up|Lack of Efficacy|2|||
126181135|NCT00270998|453948058|FG002|3 Month Follow-up|Lack of Efficacy|1|||
126181136|NCT00270998|453948056|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
126181137|NCT00270998|453948057|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
126181138|NCT00270998|453948058|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
126181139|NCT00270998|453948056|FG000|3 Month Follow-up|Pessary did not fit|12|||
126181140|NCT00270998|453948057|FG001|3 Month Follow-up|Pessary did not fit|0|||
126181141|NCT00270998|453948058|FG002|3 Month Follow-up|Pessary did not fit|0|||
126181142|NCT00270998|453948056|FG000|3 Month Follow-up|Personal/family health|1|||
126181143|NCT00270998|453948057|FG001|3 Month Follow-up|Personal/family health|1|||
126181144|NCT00270998|453948058|FG002|3 Month Follow-up|Personal/family health|0|||
126181145|NCT00270998|453948056|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
126181146|NCT00270998|453948057|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
126181147|NCT00270998|453948058|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
126181148|NCT00270998|453948056|FG000|12 Month Follow-up|Lack of Efficacy|5|||
126181149|NCT00270998|453948057|FG001|12 Month Follow-up|Lack of Efficacy|4|||
126181150|NCT00270998|453948058|FG002|12 Month Follow-up|Lack of Efficacy|3|||
126181151|NCT00270998|453948056|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
126181152|NCT00270998|453948057|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
126181153|NCT00270998|453948058|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
126181154|NCT00270998|453948056|FG000|12 Month Follow-up|Pessary did not fit|1|||
126181155|NCT00270998|453948057|FG001|12 Month Follow-up|Pessary did not fit|0|||
126181156|NCT00270998|453948058|FG002|12 Month Follow-up|Pessary did not fit|0|||
126181157|NCT00270998|453948056|FG000|12 Month Follow-up|Personal/family health|0|||
126181158|NCT00270998|453948057|FG001|12 Month Follow-up|Personal/family health|5|||
126181159|NCT00270998|453948058|FG002|12 Month Follow-up|Personal/family health|1|||
126181160|NCT00270998|453948056|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
126181161|NCT00270998|453948057|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
126181162|NCT00270998|453948058|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
126181163|NCT00563368|453948059|FG000|Overall Study|Lost to Follow-up|14|||
126181164|NCT00563368|453948060|FG001|Overall Study|Lost to Follow-up|14|||
126181165|NCT00563368|453948061|FG002|Overall Study|Lost to Follow-up|12|||
126181166|NCT00563368|453948062|FG003|Overall Study|Lost to Follow-up|6|||
126181167|NCT00563368|453948063|FG004|Overall Study|Lost to Follow-up|9|||
126181168|NCT00563368|453948064|FG005|Overall Study|Lost to Follow-up|8|||
126181169|NCT00563368|453948065|FG006|Overall Study|Lost to Follow-up|9|||
126181170|NCT00563368|453948059|FG000|Overall Study|Adverse Event|3|||
126181171|NCT00563368|453948060|FG001|Overall Study|Adverse Event|4|||
126181172|NCT00563368|453948061|FG002|Overall Study|Adverse Event|5|||
126181173|NCT00563368|453948062|FG003|Overall Study|Adverse Event|9|||
126181174|NCT00563368|453948063|FG004|Overall Study|Adverse Event|6|||
126181175|NCT00563368|453948064|FG005|Overall Study|Adverse Event|10|||
126181176|NCT00563368|453948065|FG006|Overall Study|Adverse Event|17|||
126181177|NCT00563368|453948059|FG000|Overall Study|Withdrawal by Subject|11|||
126181178|NCT00563368|453948060|FG001|Overall Study|Withdrawal by Subject|6|||
126181179|NCT00563368|453948061|FG002|Overall Study|Withdrawal by Subject|5|||
126181180|NCT00563368|453948062|FG003|Overall Study|Withdrawal by Subject|7|||
126181181|NCT00563368|453948063|FG004|Overall Study|Withdrawal by Subject|8|||
126181182|NCT00563368|453948064|FG005|Overall Study|Withdrawal by Subject|5|||
126181183|NCT00563368|453948065|FG006|Overall Study|Withdrawal by Subject|4|||
126181184|NCT00563368|453948059|FG000|Overall Study|protocol non-compliance|1|||
126181185|NCT00563368|453948060|FG001|Overall Study|protocol non-compliance|1|||
126181186|NCT00563368|453948061|FG002|Overall Study|protocol non-compliance|2|||
126181187|NCT00563368|453948062|FG003|Overall Study|protocol non-compliance|1|||
126181188|NCT00563368|453948063|FG004|Overall Study|protocol non-compliance|0|||
126181189|NCT00563368|453948064|FG005|Overall Study|protocol non-compliance|1|||
126181190|NCT00563368|453948065|FG006|Overall Study|protocol non-compliance|3|||
126181191|NCT00563368|453948059|FG000|Overall Study|Pregnancy|1|||
126181192|NCT00563368|453948060|FG001|Overall Study|Pregnancy|0|||
126181193|NCT00563368|453948061|FG002|Overall Study|Pregnancy|1|||
126181194|NCT00563368|453948062|FG003|Overall Study|Pregnancy|2|||
126181195|NCT00563368|453948063|FG004|Overall Study|Pregnancy|1|||
126181196|NCT00563368|453948064|FG005|Overall Study|Pregnancy|2|||
126181197|NCT00563368|453948065|FG006|Overall Study|Pregnancy|0|||
126181198|NCT00563368|453948059|FG000|Overall Study|requirement for restricted medication|0|||
126181199|NCT00563368|453948060|FG001|Overall Study|requirement for restricted medication|0|||
126181200|NCT00563368|453948061|FG002|Overall Study|requirement for restricted medication|2|||
126181201|NCT00563368|453948062|FG003|Overall Study|requirement for restricted medication|0|||
126181202|NCT00563368|453948063|FG004|Overall Study|requirement for restricted medication|0|||
126181203|NCT00563368|453948064|FG005|Overall Study|requirement for restricted medication|0|||
126181204|NCT00563368|453948065|FG006|Overall Study|requirement for restricted medication|0|||
126181205|NCT00563368|453948059|FG000|Overall Study|Other|5|||
126181206|NCT00563368|453948060|FG001|Overall Study|Other|5|||
126181207|NCT00563368|453948061|FG002|Overall Study|Other|3|||
126181208|NCT00563368|453948062|FG003|Overall Study|Other|4|||
126181209|NCT00563368|453948063|FG004|Overall Study|Other|4|||
126181210|NCT00563368|453948064|FG005|Overall Study|Other|4|||
126181211|NCT00563368|453948065|FG006|Overall Study|Other|0|||
126181212|NCT00425113|453948066|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
126181213|NCT00425113|453948067|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
126181214|NCT00425113|453948066|FG000|Overall Study|diagnosis of abdominal TB|0|||
126181215|NCT00425113|453948067|FG001|Overall Study|diagnosis of abdominal TB|1|||
126181216|NCT00425113|453948066|FG000|Overall Study|missing study drug more than 14 days|0|||
126181217|NCT00425113|453948067|FG001|Overall Study|missing study drug more than 14 days|1|||
126181218|NCT00425113|453948066|FG000|Overall Study|Withdrawal by Subject|1|||
126181219|NCT00425113|453948067|FG001|Overall Study|Withdrawal by Subject|0|||
126181220|NCT03495817|453948074|FG000|26 Week Open Label|Adverse Event|3|||
126181221|NCT03495817|453948074|FG000|26 Week Open Label|Withdrawal by Subject|4|||
126181222|NCT03495817|453948074|FG000|26 Week Open Label|Lost to Follow-up|1|||
126181223|NCT03495817|453948074|FG000|26 Week Extension|Lost to Follow-up|2|||
126181224|NCT04585451|453948079|FG000|Overall Study|Withdrawal by Subject|26|||
126181225|NCT04585451|453948080|FG001|Overall Study|Withdrawal by Subject|0|||
126181226|NCT00326417|453948081|FG000|Overall Study|Withdrawal by Subject|0|||
126181227|NCT00326417|453948082|FG001|Overall Study|Withdrawal by Subject|0|||
126181228|NCT00326417|453948083|FG002|Overall Study|Withdrawal by Subject|1|||
126181229|NCT00326417|453948084|FG003|Overall Study|Withdrawal by Subject|0|||
126181230|NCT00326417|453948081|FG000|Overall Study|Arm Closed|7|||
126181231|NCT00326417|453948082|FG001|Overall Study|Arm Closed|0|||
126181232|NCT00326417|453948083|FG002|Overall Study|Arm Closed|0|||
126181233|NCT00326417|453948084|FG003|Overall Study|Arm Closed|3|||
126181234|NCT00326417|453948081|FG000|Overall Study|Death|7|||
126181235|NCT00326417|453948082|FG001|Overall Study|Death|0|||
126181236|NCT00326417|453948083|FG002|Overall Study|Death|0|||
126181237|NCT00326417|453948084|FG003|Overall Study|Death|0|||
126181238|NCT04046341|453948091|FG000|Overall Study|Lost to Follow-up|2|||
126181239|NCT04046341|453948091|FG000|Overall Study|Withdrawal by Subject|1|||
126181240|NCT02248857|453948092|FG000|3 Month|Withdrawal by Subject|9|||
126181241|NCT02248857|453948093|FG001|3 Month|Withdrawal by Subject|3|||
126181242|NCT02248857|453948094|FG002|3 Month|Withdrawal by Subject|4|||
126181243|NCT02248857|453948092|FG000|3 Month|Unable to reach for 3 month|35|||
126181244|NCT02248857|453948093|FG001|3 Month|Unable to reach for 3 month|29|||
126181245|NCT02248857|453948094|FG002|3 Month|Unable to reach for 3 month|26|||
126181246|NCT02248857|453948092|FG000|3 Month|Partially completed, unable to finish|2|||
126181247|NCT02248857|453948093|FG001|3 Month|Partially completed, unable to finish|2|||
126181248|NCT02248857|453948094|FG002|3 Month|Partially completed, unable to finish|1|||
126181249|NCT02248857|453948092|FG000|6 Month|Lost to Follow-up|27|||
126181250|NCT02248857|453948093|FG001|6 Month|Lost to Follow-up|26|||
126181251|NCT02248857|453948094|FG002|6 Month|Lost to Follow-up|15|||
126181252|NCT02248857|453948092|FG000|6 Month|Partially completed, unable to finish|0|||
126181253|NCT02248857|453948093|FG001|6 Month|Partially completed, unable to finish|1|||
126181254|NCT02248857|453948094|FG002|6 Month|Partially completed, unable to finish|0|||
126181255|NCT02248857|453948092|FG000|6 Month|Withdrawal by Subject|0|||
126181256|NCT02248857|453948093|FG001|6 Month|Withdrawal by Subject|2|||
126181257|NCT02248857|453948094|FG002|6 Month|Withdrawal by Subject|2|||
126181258|NCT02248857|453948092|FG000|6 Month|Death|1|||
126181259|NCT02248857|453948093|FG001|6 Month|Death|0|||
126181260|NCT02248857|453948094|FG002|6 Month|Death|0|||
126181261|NCT01412060|453948095|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
126181262|NCT01412060|453948096|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
126181263|NCT01412060|453948097|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
126181264|NCT01412060|453948095|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
126181265|NCT01412060|453948096|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
126181266|NCT01412060|453948097|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
126181267|NCT01412060|453948095|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
126181268|NCT01412060|453948096|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
126181269|NCT01412060|453948097|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
126181270|NCT01412060|453948095|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
126181271|NCT01412060|453948096|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
126181272|NCT01412060|453948097|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
126181273|NCT01412060|453948095|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
126181274|NCT01412060|453948096|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
126181275|NCT01412060|453948097|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
126181276|NCT01412060|453948095|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
126181277|NCT01412060|453948096|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
126181278|NCT01412060|453948097|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
126181279|NCT01412060|453948095|FG000|Period Between RIP and SP|Adverse Event|4|||
126181280|NCT01412060|453948096|FG001|Period Between RIP and SP|Adverse Event|0|||
126181281|NCT01412060|453948097|FG002|Period Between RIP and SP|Adverse Event|0|||
126181282|NCT01412060|453948095|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
126181283|NCT01412060|453948096|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
126181284|NCT01412060|453948097|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
126181285|NCT01412060|453948095|FG000|Period Between RIP and SP|Protocol Violation|2|||
126181286|NCT01412060|453948096|FG001|Period Between RIP and SP|Protocol Violation|0|||
126181287|NCT01412060|453948097|FG002|Period Between RIP and SP|Protocol Violation|0|||
126181288|NCT01412060|453948095|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
126181289|NCT01412060|453948096|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
126181290|NCT01412060|453948097|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
126181291|NCT01412060|453948095|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
126181292|NCT01412060|453948096|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
126181293|NCT01412060|453948097|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
126181294|NCT01412060|453948095|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
126181295|NCT01412060|453948096|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
126181296|NCT01412060|453948097|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
126181297|NCT01412060|453948095|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
126181298|NCT01412060|453948096|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
126181299|NCT01412060|453948097|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
126181300|NCT01412060|453948095|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
126181301|NCT01412060|453948096|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
126181302|NCT01412060|453948097|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
126181303|NCT01412060|453948095|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
126181304|NCT01412060|453948096|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
126181305|NCT01412060|453948097|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
126181306|NCT01412060|453948095|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
126181307|NCT01412060|453948096|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
126181308|NCT01412060|453948097|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
126181309|NCT01412060|453948095|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
126181310|NCT01412060|453948096|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
126181311|NCT01412060|453948097|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
126181312|NCT01412060|453948095|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
126181313|NCT01412060|453948096|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
126181314|NCT01412060|453948097|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
126181315|NCT01412060|453948095|FG000|Period Between SP and DBP|Protocol Violation|2|||
126181316|NCT01412060|453948096|FG001|Period Between SP and DBP|Protocol Violation|0|||
126181317|NCT01412060|453948097|FG002|Period Between SP and DBP|Protocol Violation|0|||
126181318|NCT01412060|453948095|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
126181319|NCT01412060|453948096|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
126181320|NCT01412060|453948097|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
126181321|NCT01412060|453948095|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
126181322|NCT01412060|453948096|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
126181323|NCT01412060|453948097|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
126181324|NCT01412060|453948095|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
126181325|NCT01412060|453948096|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
126181326|NCT01412060|453948097|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
126181327|NCT01412060|453948095|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
126181328|NCT01412060|453948096|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
126181329|NCT01412060|453948097|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
126181330|NCT01412060|453948095|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
126181331|NCT01412060|453948096|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
126181332|NCT01412060|453948097|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
126181333|NCT01412060|453948095|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
126181334|NCT01412060|453948096|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
126181335|NCT01412060|453948097|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
126181336|NCT01412060|453948095|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
126181337|NCT01412060|453948096|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
126181338|NCT01412060|453948097|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
126181339|NCT01412060|453948095|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
126181340|NCT01412060|453948096|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
126181341|NCT01412060|453948097|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
126181342|NCT01412060|453948095|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
126181343|NCT01412060|453948096|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
126181344|NCT01412060|453948097|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
126181345|NCT01412060|453948095|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
126181346|NCT01412060|453948096|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
126199930|NCT00089505|454017803|FG003|Overall Study|Protocol Violation|0|||
126181347|NCT01412060|453948097|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
126181348|NCT00004732|453948098|FG000|Overall Study|Withdrawal by Subject|36|||
126181349|NCT00004732|453948099|FG001|Overall Study|Withdrawal by Subject|64|||
126181350|NCT00004732|453948098|FG000|Overall Study|Lost to Follow-up|33|||
126181351|NCT00004732|453948099|FG001|Overall Study|Lost to Follow-up|47|||
126181352|NCT02674685|453948103|FG000|Overall Study|Withdrawal by Subject|4|||
126181353|NCT05567393|453948104|FG000|Overall Study|Voluntary Withdrawal|0|||
126181354|NCT05567393|453948105|FG001|Overall Study|Voluntary Withdrawal|0|||
126181355|NCT05567393|453948106|FG002|Overall Study|Voluntary Withdrawal|0|||
126181356|NCT05567393|453948107|FG003|Overall Study|Voluntary Withdrawal|0|||
126181357|NCT05567393|453948108|FG004|Overall Study|Voluntary Withdrawal|0|||
126181358|NCT05567393|453948109|FG005|Overall Study|Voluntary Withdrawal|0|||
126181359|NCT05567393|453948110|FG006|Overall Study|Voluntary Withdrawal|0|||
126181360|NCT05567393|453948111|FG007|Overall Study|Voluntary Withdrawal|0|||
126181361|NCT05567393|453948112|FG008|Overall Study|Voluntary Withdrawal|0|||
126181362|NCT05567393|453948113|FG009|Overall Study|Voluntary Withdrawal|0|||
126181363|NCT05567393|453948114|FG010|Overall Study|Voluntary Withdrawal|0|||
126181364|NCT05567393|453948115|FG011|Overall Study|Voluntary Withdrawal|0|||
126181365|NCT05567393|453948116|FG012|Overall Study|Voluntary Withdrawal|0|||
126181366|NCT05567393|453948117|FG013|Overall Study|Voluntary Withdrawal|1|||
126181367|NCT05567393|453948118|FG014|Overall Study|Voluntary Withdrawal|0|||
126181368|NCT05567393|453948119|FG015|Overall Study|Voluntary Withdrawal|0|||
126181369|NCT05567393|453948120|FG016|Overall Study|Voluntary Withdrawal|0|||
126181370|NCT05567393|453948121|FG017|Overall Study|Voluntary Withdrawal|0|||
126181371|NCT04199793|453948122|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
126181372|NCT04199793|453948123|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
126181373|NCT04199793|453948122|FG000|Overall Study|Withdrawal by Subject|1|||
126181374|NCT04199793|453948123|FG001|Overall Study|Withdrawal by Subject|1|||
126181375|NCT00719862|453948130|FG000|Overall Study|Adverse Event|1|||
126181376|NCT00719862|453948131|FG001|Overall Study|Adverse Event|2|||
126181377|NCT00719862|453948130|FG000|Overall Study|Lack of Efficacy|3|||
126181378|NCT00719862|453948131|FG001|Overall Study|Lack of Efficacy|0|||
126181379|NCT00719862|453948130|FG000|Overall Study|Non-Compliance|1|||
126181380|NCT00719862|453948131|FG001|Overall Study|Non-Compliance|0|||
126181381|NCT00719862|453948130|FG000|Overall Study|Withdrawal by Subject|1|||
126181382|NCT00719862|453948131|FG001|Overall Study|Withdrawal by Subject|0|||
126181383|NCT00719862|453948130|FG000|Overall Study|Lost to Follow-up|0|||
126181384|NCT00719862|453948131|FG001|Overall Study|Lost to Follow-up|1|||
126181385|NCT00719862|453948130|FG000|Overall Study|Other|2|||
126181386|NCT00719862|453948131|FG001|Overall Study|Other|3|||
126181387|NCT02687711|453950195|FG000|Overall Study|Adverse Event|89|||
126181388|NCT02687711|453950195|FG000|Overall Study|Lack of Efficacy|70|||
126181389|NCT02687711|453950195|FG000|Overall Study|Lost to Follow-up|20|||
126181390|NCT02687711|453950195|FG000|Overall Study|Consent withdrawn|15|||
126181391|NCT02687711|453950195|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
126181392|NCT02687711|453950195|FG000|Overall Study|Too expensive|4|||
126181393|NCT02687711|453950195|FG000|Overall Study|Participant moved abroad|1|||
126181394|NCT02687711|453950195|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
126181395|NCT02687711|453950195|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
126181396|NCT02687711|453950195|FG000|Overall Study|Disliked taste|1|||
126181397|NCT02687711|453950195|FG000|Overall Study|Low mood|1|||
126181398|NCT02687711|453950195|FG000|Overall Study|Side effects|1|||
126181399|NCT02687711|453950195|FG000|Overall Study|Change of Hospital|1|||
126181400|NCT02687711|453950195|FG000|Overall Study|Liver Encephalopathy|1|||
126181401|NCT02687711|453950195|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
126181402|NCT02687711|453950195|FG000|Overall Study|Withdrawn due to intake interruption|1|||
126181403|NCT02687711|453950195|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
126181404|NCT02687711|453950195|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
126181405|NCT02687711|453950195|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
126181406|NCT03621189|453950196|FG000|Overall Study|Withdrawal by Subject|0|||
126181407|NCT03621189|453950197|FG001|Overall Study|Withdrawal by Subject|3|||
126181408|NCT03621189|453950196|FG000|Overall Study|Physician Decision|0|||
126181409|NCT03621189|453950197|FG001|Overall Study|Physician Decision|2|||
126181410|NCT00247273|453950198|FG000|Overall Study|Adverse Event|85|||
126181411|NCT00247273|453950199|FG001|Overall Study|Adverse Event|80|||
126181412|NCT00247273|453950198|FG000|Overall Study|Physician Decision|6|||
126181413|NCT00247273|453950199|FG001|Overall Study|Physician Decision|3|||
126181414|NCT00247273|453950198|FG000|Overall Study|Lost to Follow-up|7|||
126181415|NCT00247273|453950199|FG001|Overall Study|Lost to Follow-up|7|||
126181416|NCT00247273|453950198|FG000|Overall Study|Withdrawal by Subject|46|||
126181417|NCT00247273|453950199|FG001|Overall Study|Withdrawal by Subject|47|||
126181418|NCT00247273|453950198|FG000|Overall Study|Did not take any study drug|2|||
126181419|NCT00247273|453950199|FG001|Overall Study|Did not take any study drug|0|||
126181420|NCT01419015|453950200|FG000|Overall Study|Death|2|||
126181421|NCT04209530|453950201|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
126181422|NCT04209530|453950202|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
126181423|NCT04209530|453950201|FG000|Overall Study|Withdrawal by Subject|0|||
126181424|NCT04209530|453950202|FG001|Overall Study|Withdrawal by Subject|1|||
126181425|NCT02580240|453950203|FG000|Overall Study|Physician Decision|2|||
126181426|NCT02580240|453950204|FG001|Overall Study|Physician Decision|0|||
126181427|NCT00607919|453950205|FG000|Acute Phase|Adverse Event|9|||
126181428|NCT00607919|453950206|FG001|Acute Phase|Adverse Event|2|||
126181429|NCT00607919|453950205|FG000|Acute Phase|Entry Criteria Not Met|1|||
126181430|NCT00607919|453950206|FG001|Acute Phase|Entry Criteria Not Met|1|||
126181431|NCT00607919|453950205|FG000|Acute Phase|Lack of Efficacy|1|||
126181432|NCT00607919|453950206|FG001|Acute Phase|Lack of Efficacy|2|||
126181433|NCT00607919|453950205|FG000|Acute Phase|Lost to Follow-up|9|||
126181434|NCT00607919|453950206|FG001|Acute Phase|Lost to Follow-up|3|||
126181435|NCT00607919|453950205|FG000|Acute Phase|Parent/Caregiver Decision|6|||
126181436|NCT00607919|453950206|FG001|Acute Phase|Parent/Caregiver Decision|4|||
126181437|NCT00607919|453950205|FG000|Acute Phase|Protocol Violation|5|||
126181438|NCT00607919|453950206|FG001|Acute Phase|Protocol Violation|1|||
126181439|NCT00607919|453950205|FG000|Acute Phase|Withdrawal by Subject|3|||
126181440|NCT00607919|453950206|FG001|Acute Phase|Withdrawal by Subject|3|||
126181441|NCT00607919|453950205|FG000|Open-Label Phase|Adverse Event|1|||
126181442|NCT00607919|453950206|FG001|Open-Label Phase|Adverse Event|5|||
126181443|NCT00607919|453950205|FG000|Open-Label Phase|Lost to Follow-up|4|||
126181444|NCT00607919|453950206|FG001|Open-Label Phase|Lost to Follow-up|1|||
126181445|NCT00607919|453950205|FG000|Open-Label Phase|Protocol Violation|2|||
126181446|NCT00607919|453950206|FG001|Open-Label Phase|Protocol Violation|2|||
126181447|NCT00607919|453950205|FG000|Open-Label Phase|Withdrawal by Subject|2|||
126181448|NCT00607919|453950206|FG001|Open-Label Phase|Withdrawal by Subject|2|||
126181449|NCT00607919|453950205|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
126181450|NCT00607919|453950206|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
126181451|NCT01527110|453950219|FG000|Overall Study|Adverse Event|1|||
126181452|NCT02007252|453950222|FG000|Overall Study|Administrative problems|3|||
126181453|NCT02007252|453950223|FG001|Overall Study|Administrative problems|7|||
126181454|NCT02007252|453950222|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126181455|NCT02007252|453950223|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126181456|NCT02007252|453950222|FG000|Overall Study|Adverse Event|7|||
126181457|NCT02007252|453950223|FG001|Overall Study|Adverse Event|4|||
126181458|NCT01628393|453950224|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
126181459|NCT01628393|453950225|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126181460|NCT01628393|453950226|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126181461|NCT01628393|453950227|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126181462|NCT01628393|453950228|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126181463|NCT01628393|453950224|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
126181464|NCT01628393|453950225|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
126181465|NCT01628393|453950226|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
126181466|NCT01628393|453950227|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
126181467|NCT01628393|453950228|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
126181468|NCT01628393|453950224|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
126181469|NCT01628393|453950225|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
126181470|NCT01628393|453950226|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
126181471|NCT01628393|453950227|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
126181472|NCT01628393|453950228|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
126181473|NCT01628393|453950224|FG000|Blinded Active Extension Period|Adverse Event|0|||
126181474|NCT01628393|453950225|FG001|Blinded Active Extension Period|Adverse Event|1|||
126181475|NCT01628393|453950226|FG002|Blinded Active Extension Period|Adverse Event|0|||
126181476|NCT01628393|453950227|FG003|Blinded Active Extension Period|Adverse Event|2|||
126181477|NCT01628393|453950228|FG004|Blinded Active Extension Period|Adverse Event|2|||
126181478|NCT01628393|453950224|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
126181479|NCT01628393|453950225|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
126181480|NCT01628393|453950226|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
126181481|NCT01628393|453950227|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
126181482|NCT01628393|453950228|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
126181483|NCT01628393|453950224|FG000|Blinded Active Extension Period|Physician Decision|0|||
126181484|NCT01628393|453950225|FG001|Blinded Active Extension Period|Physician Decision|3|||
126181485|NCT01628393|453950226|FG002|Blinded Active Extension Period|Physician Decision|0|||
126181486|NCT01628393|453950227|FG003|Blinded Active Extension Period|Physician Decision|1|||
126181487|NCT01628393|453950228|FG004|Blinded Active Extension Period|Physician Decision|0|||
126181488|NCT01628393|453950224|FG000|Blinded Active Extension Period|Protocol Violation|0|||
126181489|NCT01628393|453950225|FG001|Blinded Active Extension Period|Protocol Violation|0|||
126181490|NCT01628393|453950226|FG002|Blinded Active Extension Period|Protocol Violation|2|||
126181491|NCT01628393|453950227|FG003|Blinded Active Extension Period|Protocol Violation|1|||
126181492|NCT01628393|453950228|FG004|Blinded Active Extension Period|Protocol Violation|0|||
126181493|NCT01628393|453950224|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
126181494|NCT01628393|453950225|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
126181495|NCT01628393|453950226|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
126181496|NCT01628393|453950227|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
126181497|NCT01628393|453950228|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
126181498|NCT02001688|453950229|FG000|Overall Study|Withdrawal by Subject|0|||
126181499|NCT02001688|453950230|FG001|Overall Study|Withdrawal by Subject|0|||
126181500|NCT02001688|453950231|FG002|Overall Study|Withdrawal by Subject|1|||
126181501|NCT02001688|453950229|FG000|Overall Study|Adverse Event|0|||
126181502|NCT02001688|453950230|FG001|Overall Study|Adverse Event|1|||
126181503|NCT02001688|453950231|FG002|Overall Study|Adverse Event|0|||
126181504|NCT05441540|453950235|FG000|Overall Study|Withdrawal by Subject|2|||
126181505|NCT00813917|453950236|FG000|Overall Study|Adverse Event|0|||
126181506|NCT00813917|453950237|FG001|Overall Study|Adverse Event|1|||
126181507|NCT00813917|453950236|FG000|Overall Study|Withdrawal by Subject|3|||
126181508|NCT00813917|453950237|FG001|Overall Study|Withdrawal by Subject|4|||
126181509|NCT00813917|453950236|FG000|Overall Study|Lost to Follow-up|3|||
126181510|NCT00813917|453950237|FG001|Overall Study|Lost to Follow-up|1|||
126181511|NCT00879437|453950241|FG000|Overall Study|Protocol Violation|0|||
126181512|NCT00879437|453950242|FG001|Overall Study|Protocol Violation|1|||
126181513|NCT00879437|453950241|FG000|Overall Study|Death|1|||
126181514|NCT00879437|453950242|FG001|Overall Study|Death|0|||
126181515|NCT01112982|453950243|FG000|Overall Study|Withdrawal by Subject|1|||
126181516|NCT01112982|453950243|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
126181517|NCT01001234|453950251|FG000|Overall Study|Withdrawal by Subject|2|||
126181518|NCT01001234|453950252|FG001|Overall Study|Withdrawal by Subject|0|||
126181519|NCT01001234|453950253|FG002|Overall Study|Withdrawal by Subject|3|||
126181520|NCT01001234|453950254|FG003|Overall Study|Withdrawal by Subject|0|||
126181521|NCT01001234|453950255|FG004|Overall Study|Withdrawal by Subject|0|||
126181522|NCT01001234|453950251|FG000|Overall Study|Protocol Violation|34|||
126181523|NCT01001234|453950252|FG001|Overall Study|Protocol Violation|3|||
126181524|NCT01001234|453950253|FG002|Overall Study|Protocol Violation|19|||
126181525|NCT01001234|453950254|FG003|Overall Study|Protocol Violation|18|||
126181526|NCT01001234|453950255|FG004|Overall Study|Protocol Violation|0|||
126181527|NCT01001234|453950251|FG000|Overall Study|Lost to Follow-up|0|||
126181528|NCT01001234|453950252|FG001|Overall Study|Lost to Follow-up|0|||
126181529|NCT01001234|453950253|FG002|Overall Study|Lost to Follow-up|1|||
126181530|NCT01001234|453950254|FG003|Overall Study|Lost to Follow-up|2|||
126181531|NCT01001234|453950255|FG004|Overall Study|Lost to Follow-up|0|||
126181532|NCT01001234|453950251|FG000|Overall Study|Physician Decision|1|||
126181533|NCT01001234|453950252|FG001|Overall Study|Physician Decision|0|||
126181534|NCT01001234|453950253|FG002|Overall Study|Physician Decision|0|||
126181535|NCT01001234|453950254|FG003|Overall Study|Physician Decision|0|||
126181536|NCT01001234|453950255|FG004|Overall Study|Physician Decision|0|||
126181537|NCT01001234|453950251|FG000|Overall Study|Not Treated: Adverse Event|1|||
126181538|NCT01001234|453950252|FG001|Overall Study|Not Treated: Adverse Event|0|||
126181539|NCT01001234|453950253|FG002|Overall Study|Not Treated: Adverse Event|0|||
126181540|NCT01001234|453950254|FG003|Overall Study|Not Treated: Adverse Event|0|||
126181541|NCT01001234|453950255|FG004|Overall Study|Not Treated: Adverse Event|0|||
126181542|NCT01001234|453950251|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
126181543|NCT01001234|453950252|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
126181544|NCT01001234|453950253|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
126181545|NCT01001234|453950254|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
126181546|NCT01001234|453950255|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
126181547|NCT01001234|453950251|FG000|Overall Study|Not Treated: Protocol Violation|3|||
126181548|NCT01001234|453950252|FG001|Overall Study|Not Treated: Protocol Violation|0|||
126181549|NCT01001234|453950253|FG002|Overall Study|Not Treated: Protocol Violation|0|||
126181550|NCT01001234|453950254|FG003|Overall Study|Not Treated: Protocol Violation|0|||
126181551|NCT01001234|453950255|FG004|Overall Study|Not Treated: Protocol Violation|0|||
126181552|NCT01001234|453950251|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
126181553|NCT01001234|453950252|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
126181554|NCT01001234|453950253|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
126181555|NCT01001234|453950254|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
126181556|NCT01001234|453950255|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
126181557|NCT01001234|453950251|FG000|Overall Study|Not Treated: Pregnancy|3|||
126181558|NCT01001234|453950252|FG001|Overall Study|Not Treated: Pregnancy|0|||
126181559|NCT01001234|453950253|FG002|Overall Study|Not Treated: Pregnancy|0|||
126181560|NCT01001234|453950254|FG003|Overall Study|Not Treated: Pregnancy|0|||
126181561|NCT01001234|453950255|FG004|Overall Study|Not Treated: Pregnancy|0|||
126181562|NCT01001234|453950251|FG000|Overall Study|Not Treated: Physician Decision|37|||
126181563|NCT01001234|453950252|FG001|Overall Study|Not Treated: Physician Decision|4|||
126181564|NCT01001234|453950253|FG002|Overall Study|Not Treated: Physician Decision|0|||
126181565|NCT01001234|453950254|FG003|Overall Study|Not Treated: Physician Decision|0|||
126181566|NCT01001234|453950255|FG004|Overall Study|Not Treated: Physician Decision|0|||
126181567|NCT01001234|453950251|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
126181568|NCT01001234|453950252|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
126181569|NCT01001234|453950253|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
126181570|NCT01001234|453950254|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
126181571|NCT01001234|453950255|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
126181572|NCT01611298|453950256|FG000|Overall Study|Relapsed|2|||
126181573|NCT00753623|453950257|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
126181574|NCT00753623|453950258|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
126181575|NCT00753623|453950257|FG000|Phase I (14 Days)|Physician Decision|1|||
126181576|NCT00753623|453950258|FG001|Phase I (14 Days)|Physician Decision|2|||
126181577|NCT00753623|453950257|FG000|Phase I (14 Days)|Adverse Event|0|||
126181578|NCT00753623|453950258|FG001|Phase I (14 Days)|Adverse Event|1|||
126181579|NCT00753623|453950257|FG000|Washout (7 Days)|Physician Decision|1|||
126181580|NCT00753623|453950258|FG001|Washout (7 Days)|Physician Decision|0|||
126181581|NCT00753623|453950257|FG000|Phase II (14 Days)|Physician Decision|0|||
126181582|NCT00753623|453950258|FG001|Phase II (14 Days)|Physician Decision|1|||
126181583|NCT03332303|453950259|FG000|Overall Study|Participant did not dose|1|||
126181584|NCT03332303|453950260|FG001|Overall Study|Participant did not dose|2|||
126181585|NCT03332303|453950261|FG002|Overall Study|Participant did not dose|0|||
126181586|NCT03332303|453950259|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
126181587|NCT03332303|453950260|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
126181588|NCT03332303|453950261|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
126181589|NCT03332303|453950259|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
126181590|NCT03332303|453950260|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
126181591|NCT03332303|453950261|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
126181592|NCT03332303|453950259|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
126181593|NCT03332303|453950260|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
126181594|NCT03332303|453950261|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
126181595|NCT03332303|453950259|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
126181596|NCT03332303|453950260|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
126181597|NCT03332303|453950261|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
126181598|NCT03332303|453950259|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
126181599|NCT03332303|453950260|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
126181600|NCT03332303|453950261|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
126181601|NCT03332303|453950259|FG000|Overall Study|Participant had a significant protocol deviation|0|||
126181602|NCT03332303|453950260|FG001|Overall Study|Participant had a significant protocol deviation|1|||
126181603|NCT03332303|453950261|FG002|Overall Study|Participant had a significant protocol deviation|0|||
126181604|NCT03639987|453950262|FG000|Overall Study|Study terminated by sponsor|26|||
126181605|NCT03639987|453950263|FG001|Overall Study|Study terminated by sponsor|25|||
126181606|NCT03639987|453950262|FG000|Overall Study|Lost to Follow-up|0|||
126181607|NCT03639987|453950263|FG001|Overall Study|Lost to Follow-up|1|||
126181608|NCT00425100|453950264|FG000|Overall Study|Adverse Event|36|||
126181609|NCT00425100|453950264|FG000|Overall Study|Lack of Efficacy|4|||
126181610|NCT00425100|453950264|FG000|Overall Study|Lost to Follow-up|2|||
126181611|NCT00425100|453950264|FG000|Overall Study|Protocol Violation|4|||
126181612|NCT00425100|453950264|FG000|Overall Study|Withdrawal by Subject|7|||
126181613|NCT00555906|453950265|FG000|Phase 1|Objective Progression or Relapse|3|||
126181614|NCT00555906|453950266|FG001|Phase 1|Objective Progression or Relapse|5|||
126181615|NCT00555906|453950267|FG002|Phase 1|Objective Progression or Relapse|3|||
126181616|NCT00555906|453950268|FG003|Phase 1|Objective Progression or Relapse|1|||
126181617|NCT00555906|453950269|FG004|Phase 1|Objective Progression or Relapse|0|||
126181618|NCT00555906|453950265|FG000|Phase 1|Global Deterioration of Health Status|0|||
126181619|NCT00555906|453950266|FG001|Phase 1|Global Deterioration of Health Status|1|||
126181620|NCT00555906|453950267|FG002|Phase 1|Global Deterioration of Health Status|1|||
126181621|NCT00555906|453950268|FG003|Phase 1|Global Deterioration of Health Status|1|||
126181622|NCT00555906|453950269|FG004|Phase 1|Global Deterioration of Health Status|0|||
126181623|NCT00555906|453950265|FG000|Phase 1|Adverse Event|0|||
126181624|NCT00555906|453950266|FG001|Phase 1|Adverse Event|0|||
126181625|NCT00555906|453950267|FG002|Phase 1|Adverse Event|3|||
126181626|NCT00555906|453950268|FG003|Phase 1|Adverse Event|2|||
126181627|NCT00555906|453950269|FG004|Phase 1|Adverse Event|0|||
126181628|NCT00555906|453950265|FG000|Phase 1|Withdrawal by Subject|0|||
126181629|NCT00555906|453950266|FG001|Phase 1|Withdrawal by Subject|0|||
126181630|NCT00555906|453950267|FG002|Phase 1|Withdrawal by Subject|0|||
126181631|NCT00555906|453950268|FG003|Phase 1|Withdrawal by Subject|1|||
126181632|NCT00555906|453950269|FG004|Phase 1|Withdrawal by Subject|0|||
126181633|NCT00555906|453950265|FG000|Phase 2|Adverse Event|0|||
126181634|NCT00555906|453950266|FG001|Phase 2|Adverse Event|0|||
126181635|NCT00555906|453950267|FG002|Phase 2|Adverse Event|0|||
126181636|NCT00555906|453950268|FG003|Phase 2|Adverse Event|0|||
126181637|NCT00555906|453950269|FG004|Phase 2|Adverse Event|4|||
126181638|NCT00555906|453950265|FG000|Phase 2|Global Deterioration of Health Status|0|||
126181639|NCT00555906|453950266|FG001|Phase 2|Global Deterioration of Health Status|0|||
126181640|NCT00555906|453950267|FG002|Phase 2|Global Deterioration of Health Status|0|||
126181641|NCT00555906|453950268|FG003|Phase 2|Global Deterioration of Health Status|0|||
126181642|NCT00555906|453950269|FG004|Phase 2|Global Deterioration of Health Status|2|||
126181643|NCT00555906|453950265|FG000|Phase 2|Objective Progression or Relapse|0|||
126181644|NCT00555906|453950266|FG001|Phase 2|Objective Progression or Relapse|0|||
126181645|NCT00555906|453950267|FG002|Phase 2|Objective Progression or Relapse|0|||
126181646|NCT00555906|453950268|FG003|Phase 2|Objective Progression or Relapse|0|||
126181647|NCT00555906|453950269|FG004|Phase 2|Objective Progression or Relapse|16|||
126181648|NCT00555906|453950265|FG000|Phase 2|Withdrawal by Subject|0|||
126181649|NCT00555906|453950266|FG001|Phase 2|Withdrawal by Subject|0|||
126181650|NCT00555906|453950267|FG002|Phase 2|Withdrawal by Subject|0|||
126181651|NCT00555906|453950268|FG003|Phase 2|Withdrawal by Subject|0|||
126181652|NCT00555906|453950269|FG004|Phase 2|Withdrawal by Subject|2|||
126181653|NCT00555906|453950265|FG000|Phase 2|Other|0|||
126181654|NCT00555906|453950266|FG001|Phase 2|Other|0|||
126181655|NCT00555906|453950267|FG002|Phase 2|Other|0|||
126181656|NCT00555906|453950268|FG003|Phase 2|Other|0|||
126181657|NCT00555906|453950269|FG004|Phase 2|Other|6|||
126181658|NCT00555906|453950265|FG000|Phase 2|Randomized but not Treated|0|||
126181659|NCT00555906|453950266|FG001|Phase 2|Randomized but not Treated|0|||
126181660|NCT00555906|453950267|FG002|Phase 2|Randomized but not Treated|0|||
126181661|NCT00555906|453950268|FG003|Phase 2|Randomized but not Treated|0|||
126181662|NCT00555906|453950269|FG004|Phase 2|Randomized but not Treated|2|||
126181663|NCT02193828|453950270|FG000|Overall Study|Withdrawal by Subject|0|||
126181664|NCT02193828|453950271|FG001|Overall Study|Withdrawal by Subject|0|||
126181665|NCT02193828|453950272|FG002|Overall Study|Withdrawal by Subject|1|||
126181666|NCT02193828|453950273|FG003|Overall Study|Withdrawal by Subject|1|||
126181667|NCT00889681|453950274|FG000|Overall Study|Not meeting qualification Criteria|2|||
126181668|NCT00889681|453950274|FG000|Overall Study|Insurance disapproval|1|||
126181669|NCT01185704|453950275|FG000|Overall Study|Randomized but not treated|3|||
126181670|NCT01185704|453950276|FG001|Overall Study|Randomized but not treated|3|||
126181671|NCT01185704|453950275|FG000|Overall Study|Lack of ovarian response|5|||
126181672|NCT01185704|453950276|FG001|Overall Study|Lack of ovarian response|1|||
126181673|NCT01185704|453950275|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
126181674|NCT01185704|453950276|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
126181675|NCT01185704|453950275|FG000|Overall Study|Ectopic pregnancy|0|||
126181676|NCT01185704|453950276|FG001|Overall Study|Ectopic pregnancy|1|||
126181677|NCT01686958|453950279|FG000|Overall Study|Withdrawal by Subject|1|||
126181678|NCT00187889|453950280|FG000|Overall Study|Withdrawal by Subject|6|||
126181679|NCT00187889|453950281|FG001|Overall Study|Withdrawal by Subject|4|||
126181680|NCT01151540|453950284|FG000|Overall Study|Other|2|||
126181681|NCT01151540|453950284|FG000|Overall Study|Adverse event, non-fatal|4|||
126181682|NCT01151540|453950284|FG000|Overall Study|Withdrawal by Subject|7|||
126181683|NCT03094832|453950287|FG000|Overall Study|Lost to Follow-up|0|||
126181684|NCT03094832|453950288|FG001|Overall Study|Lost to Follow-up|0|||
126181685|NCT03094832|453950289|FG002|Overall Study|Lost to Follow-up|0|||
126181686|NCT03094832|453950290|FG003|Overall Study|Lost to Follow-up|1|||
126181687|NCT03094832|453950291|FG004|Overall Study|Lost to Follow-up|1|||
126181688|NCT03094832|453950287|FG000|Overall Study|Death|1|||
126181689|NCT03094832|453950288|FG001|Overall Study|Death|0|||
126181690|NCT03094832|453950289|FG002|Overall Study|Death|0|||
126181691|NCT03094832|453950290|FG003|Overall Study|Death|0|||
126181692|NCT03094832|453950291|FG004|Overall Study|Death|0|||
126181693|NCT03094832|453950287|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126181694|NCT03094832|453950288|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126181695|NCT03094832|453950289|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126181696|NCT03094832|453950290|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126181697|NCT03094832|453950291|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126181698|NCT03094832|453950287|FG000|Overall Study|Other|13|||
126181699|NCT03094832|453950288|FG001|Overall Study|Other|20|||
126181700|NCT03094832|453950289|FG002|Overall Study|Other|1|||
126181701|NCT03094832|453950290|FG003|Overall Study|Other|7|||
126181702|NCT03094832|453950291|FG004|Overall Study|Other|1|||
126181703|NCT00788697|453950295|FG000|Overall Study|No study drug administered|12|||
126181704|NCT00788697|453950295|FG000|Overall Study|Training Patients|74|||
126181705|NCT00788697|453950295|FG000|Overall Study|no truth standard procedure available|5|||
126181706|NCT00788697|453950295|FG000|Overall Study|Technically inadequate truth standard|1|||
126181707|NCT00788697|453950295|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
126181708|NCT01575899|453950296|FG000|Overall Study|Lost to Follow-up|3|||
126181709|NCT01575899|453950297|FG001|Overall Study|Lost to Follow-up|4|||
126181710|NCT01575899|453950298|FG002|Overall Study|Lost to Follow-up|2|||
126181711|NCT01575899|453950296|FG000|Overall Study|Protocol Violation|2|||
126181712|NCT01575899|453950297|FG001|Overall Study|Protocol Violation|1|||
126181713|NCT01575899|453950298|FG002|Overall Study|Protocol Violation|0|||
126181714|NCT02671461|453950299|FG000|Treatment|Adverse Event|0|||
126181715|NCT02671461|453950300|FG001|Treatment|Adverse Event|0|||
126181716|NCT02671461|453950301|FG002|Treatment|Adverse Event|1|||
126181717|NCT02671461|453950299|FG000|Treatment|Administrative Reason by Sponsor|1|||
126181718|NCT02671461|453950300|FG001|Treatment|Administrative Reason by Sponsor|3|||
126181719|NCT02671461|453950301|FG002|Treatment|Administrative Reason by Sponsor|4|||
126181720|NCT02671461|453950299|FG000|Treatment|Randomized, not treated|1|||
126181721|NCT02671461|453950300|FG001|Treatment|Randomized, not treated|0|||
126181722|NCT02671461|453950301|FG002|Treatment|Randomized, not treated|0|||
126181723|NCT02671461|453950299|FG000|Follow-up|Withdrawal by Subject|1|||
126181724|NCT02671461|453950300|FG001|Follow-up|Withdrawal by Subject|0|||
126181725|NCT02671461|453950301|FG002|Follow-up|Withdrawal by Subject|0|||
126181726|NCT02671461|453950299|FG000|Follow-up|Lost to Follow-up|0|||
126181727|NCT02671461|453950300|FG001|Follow-up|Lost to Follow-up|0|||
126181728|NCT02671461|453950301|FG002|Follow-up|Lost to Follow-up|1|||
126181729|NCT02671461|453950299|FG000|Follow-up|Administrative Reason by Sponsor|0|||
126181730|NCT02671461|453950300|FG001|Follow-up|Administrative Reason by Sponsor|1|||
126181731|NCT02671461|453950301|FG002|Follow-up|Administrative Reason by Sponsor|0|||
126181732|NCT02807844|453950302|FG000|Overall Study|Physician Decision|0|||
126181733|NCT02807844|453950303|FG001|Overall Study|Physician Decision|0|||
126181734|NCT02807844|453950304|FG002|Overall Study|Physician Decision|0|||
126181735|NCT02807844|453950305|FG003|Overall Study|Physician Decision|0|||
126181736|NCT02807844|453950306|FG004|Overall Study|Physician Decision|0|||
126181737|NCT02807844|453950307|FG005|Overall Study|Physician Decision|0|||
126181738|NCT02807844|453950308|FG006|Overall Study|Physician Decision|3|||
126181739|NCT02807844|453950309|FG007|Overall Study|Physician Decision|0|||
126181740|NCT02807844|453950310|FG008|Overall Study|Physician Decision|1|||
126181741|NCT02807844|453950311|FG009|Overall Study|Physician Decision|2|||
126181742|NCT02807844|453950302|FG000|Overall Study|Death|0|||
126181743|NCT02807844|453950303|FG001|Overall Study|Death|0|||
126181744|NCT02807844|453950304|FG002|Overall Study|Death|2|||
126181745|NCT02807844|453950305|FG003|Overall Study|Death|4|||
126181746|NCT02807844|453950306|FG004|Overall Study|Death|1|||
126181747|NCT02807844|453950307|FG005|Overall Study|Death|2|||
126181748|NCT02807844|453950308|FG006|Overall Study|Death|1|||
126181749|NCT02807844|453950309|FG007|Overall Study|Death|2|||
126181750|NCT02807844|453950310|FG008|Overall Study|Death|0|||
126181751|NCT02807844|453950311|FG009|Overall Study|Death|1|||
126181752|NCT02807844|453950302|FG000|Overall Study|Withdrawal by Subject|0|||
126181753|NCT02807844|453950303|FG001|Overall Study|Withdrawal by Subject|0|||
126181754|NCT02807844|453950304|FG002|Overall Study|Withdrawal by Subject|2|||
126181755|NCT02807844|453950305|FG003|Overall Study|Withdrawal by Subject|1|||
126181756|NCT02807844|453950306|FG004|Overall Study|Withdrawal by Subject|1|||
126181757|NCT02807844|453950307|FG005|Overall Study|Withdrawal by Subject|0|||
126181758|NCT02807844|453950308|FG006|Overall Study|Withdrawal by Subject|1|||
126181759|NCT02807844|453950309|FG007|Overall Study|Withdrawal by Subject|0|||
126181760|NCT02807844|453950310|FG008|Overall Study|Withdrawal by Subject|0|||
126181761|NCT02807844|453950311|FG009|Overall Study|Withdrawal by Subject|0|||
126181762|NCT02807844|453950302|FG000|Overall Study|Progressive disease|5|||
126181763|NCT02807844|453950303|FG001|Overall Study|Progressive disease|12|||
126181764|NCT02807844|453950304|FG002|Overall Study|Progressive disease|8|||
126181765|NCT02807844|453950305|FG003|Overall Study|Progressive disease|8|||
126181766|NCT02807844|453950306|FG004|Overall Study|Progressive disease|3|||
126181767|NCT02807844|453950307|FG005|Overall Study|Progressive disease|8|||
126181768|NCT02807844|453950308|FG006|Overall Study|Progressive disease|14|||
126181769|NCT02807844|453950309|FG007|Overall Study|Progressive disease|17|||
126181770|NCT02807844|453950310|FG008|Overall Study|Progressive disease|19|||
126181771|NCT02807844|453950311|FG009|Overall Study|Progressive disease|15|||
126181772|NCT02807844|453950302|FG000|Overall Study|Adverse Event|1|||
126181773|NCT02807844|453950303|FG001|Overall Study|Adverse Event|0|||
126181774|NCT02807844|453950304|FG002|Overall Study|Adverse Event|0|||
126181775|NCT02807844|453950305|FG003|Overall Study|Adverse Event|0|||
126181776|NCT02807844|453950306|FG004|Overall Study|Adverse Event|1|||
126181777|NCT02807844|453950307|FG005|Overall Study|Adverse Event|1|||
126181778|NCT02807844|453950308|FG006|Overall Study|Adverse Event|1|||
126181779|NCT02807844|453950309|FG007|Overall Study|Adverse Event|1|||
126181780|NCT02807844|453950310|FG008|Overall Study|Adverse Event|1|||
126181781|NCT02807844|453950311|FG009|Overall Study|Adverse Event|2|||
126181782|NCT00709124|453950312|FG000|Overall Study|Death|3|||
126181783|NCT00709124|453950313|FG001|Overall Study|Death|1|||
126181784|NCT00709124|453950312|FG000|Overall Study|encephalopathy; can't do assessment|1|||
126181785|NCT00709124|453950313|FG001|Overall Study|encephalopathy; can't do assessment|0|||
126181786|NCT00373490|453950314|FG000|Overall Study|Adverse Event|0|||
126181787|NCT00373490|453950315|FG001|Overall Study|Adverse Event|1|||
126181788|NCT00373490|453950314|FG000|Overall Study|Lack of Efficacy|9|||
126181789|NCT00373490|453950315|FG001|Overall Study|Lack of Efficacy|4|||
126181790|NCT00373490|453950314|FG000|Overall Study|Withdrawal by Subject|0|||
126181791|NCT00373490|453950315|FG001|Overall Study|Withdrawal by Subject|1|||
126181792|NCT04179786|453950321|FG000|Overall Study|Withdrawal by Subject|8|||
126181793|NCT03310580|453950322|FG000|Overall Study|Adverse Event|0|||
126181794|NCT03310580|453950323|FG001|Overall Study|Adverse Event|1|||
126181795|NCT03310580|453950324|FG002|Overall Study|Adverse Event|0|||
126181796|NCT02762708|453950327|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
126181797|NCT02762708|453950328|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
126181798|NCT02762708|453950329|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
126181799|NCT02762708|453950330|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
126181800|NCT01468701|453950337|FG000|Overall Study|Not eligible|91|||
126181801|NCT01468701|453950338|FG001|Overall Study|Not eligible|140|||
126181802|NCT01468701|453950339|FG002|Overall Study|Not eligible|29|||
126181803|NCT01468701|453950340|FG003|Overall Study|Not eligible|12|||
126181804|NCT01468701|453950341|FG004|Overall Study|Not eligible|22|||
126181805|NCT01468701|453950342|FG005|Overall Study|Not eligible|2|||
126181806|NCT01468701|453950343|FG006|Overall Study|Not eligible|39|||
126181807|NCT01468701|453950344|FG007|Overall Study|Not eligible|1|||
126181808|NCT01468701|453950345|FG008|Overall Study|Not eligible|40|||
126181809|NCT01468701|453950346|FG009|Overall Study|Not eligible|126|||
126181810|NCT01468701|453950347|FG010|Overall Study|Not eligible|39|||
126181811|NCT01468701|453950348|FG011|Overall Study|Not eligible|33|||
126181812|NCT01468701|453950349|FG012|Overall Study|Not eligible|1|||
126181813|NCT01468701|453950350|FG013|Overall Study|Not eligible|19|||
126181814|NCT01468701|453950351|FG014|Overall Study|Not eligible|1|||
126181815|NCT01468701|453950352|FG015|Overall Study|Not eligible|32|||
126181816|NCT01468701|453950353|FG016|Overall Study|Not eligible|0|||
126181817|NCT01468701|453950337|FG000|Overall Study|Lost to Follow-up|306|||
126181818|NCT01468701|453950338|FG001|Overall Study|Lost to Follow-up|0|||
126181819|NCT01468701|453950339|FG002|Overall Study|Lost to Follow-up|0|||
126181820|NCT01468701|453950340|FG003|Overall Study|Lost to Follow-up|0|||
126181821|NCT01468701|453950341|FG004|Overall Study|Lost to Follow-up|0|||
126181822|NCT01468701|453950342|FG005|Overall Study|Lost to Follow-up|0|||
126181823|NCT01468701|453950343|FG006|Overall Study|Lost to Follow-up|0|||
126181824|NCT01468701|453950344|FG007|Overall Study|Lost to Follow-up|0|||
126181825|NCT01468701|453950345|FG008|Overall Study|Lost to Follow-up|215|||
126181826|NCT01468701|453950346|FG009|Overall Study|Lost to Follow-up|309|||
126181827|NCT01468701|453950347|FG010|Overall Study|Lost to Follow-up|224|||
126181828|NCT01468701|453950348|FG011|Overall Study|Lost to Follow-up|212|||
126181829|NCT01468701|453950349|FG012|Overall Study|Lost to Follow-up|11|||
126181830|NCT01468701|453950350|FG013|Overall Study|Lost to Follow-up|164|||
126181831|NCT01468701|453950351|FG014|Overall Study|Lost to Follow-up|17|||
126181832|NCT01468701|453950352|FG015|Overall Study|Lost to Follow-up|127|||
126181833|NCT01468701|453950353|FG016|Overall Study|Lost to Follow-up|1|||
126181834|NCT01468701|453950337|FG000|Overall Study|Withdrawal by Subject|165|||
126181835|NCT01468701|453950338|FG001|Overall Study|Withdrawal by Subject|0|||
126181836|NCT01468701|453950339|FG002|Overall Study|Withdrawal by Subject|0|||
126181837|NCT01468701|453950340|FG003|Overall Study|Withdrawal by Subject|0|||
126181838|NCT01468701|453950341|FG004|Overall Study|Withdrawal by Subject|0|||
126181839|NCT01468701|453950342|FG005|Overall Study|Withdrawal by Subject|0|||
126181840|NCT01468701|453950343|FG006|Overall Study|Withdrawal by Subject|0|||
126181841|NCT01468701|453950344|FG007|Overall Study|Withdrawal by Subject|0|||
126181842|NCT01468701|453950345|FG008|Overall Study|Withdrawal by Subject|83|||
126181843|NCT01468701|453950346|FG009|Overall Study|Withdrawal by Subject|88|||
126181844|NCT01468701|453950347|FG010|Overall Study|Withdrawal by Subject|100|||
126181845|NCT01468701|453950348|FG011|Overall Study|Withdrawal by Subject|114|||
126181846|NCT01468701|453950349|FG012|Overall Study|Withdrawal by Subject|9|||
126181847|NCT01468701|453950350|FG013|Overall Study|Withdrawal by Subject|47|||
126181848|NCT01468701|453950351|FG014|Overall Study|Withdrawal by Subject|6|||
126181849|NCT01468701|453950352|FG015|Overall Study|Withdrawal by Subject|31|||
126181850|NCT01468701|453950353|FG016|Overall Study|Withdrawal by Subject|0|||
126181851|NCT01468701|453950337|FG000|Overall Study|Other reasons than listed|437|||
126181852|NCT01468701|453950338|FG001|Overall Study|Other reasons than listed|0|||
126181853|NCT01468701|453950339|FG002|Overall Study|Other reasons than listed|0|||
126181854|NCT01468701|453950340|FG003|Overall Study|Other reasons than listed|0|||
126181855|NCT01468701|453950341|FG004|Overall Study|Other reasons than listed|0|||
126181856|NCT01468701|453950342|FG005|Overall Study|Other reasons than listed|0|||
126181857|NCT01468701|453950343|FG006|Overall Study|Other reasons than listed|0|||
126181858|NCT01468701|453950344|FG007|Overall Study|Other reasons than listed|0|||
126181859|NCT01468701|453950345|FG008|Overall Study|Other reasons than listed|318|||
126181860|NCT01468701|453950346|FG009|Overall Study|Other reasons than listed|658|||
126181861|NCT01468701|453950347|FG010|Overall Study|Other reasons than listed|433|||
126181862|NCT01468701|453950348|FG011|Overall Study|Other reasons than listed|504|||
126181863|NCT01468701|453950349|FG012|Overall Study|Other reasons than listed|28|||
126181864|NCT01468701|453950350|FG013|Overall Study|Other reasons than listed|239|||
126181865|NCT01468701|453950351|FG014|Overall Study|Other reasons than listed|39|||
126181866|NCT01468701|453950352|FG015|Overall Study|Other reasons than listed|172|||
126181867|NCT01468701|453950353|FG016|Overall Study|Other reasons than listed|0|||
126181868|NCT01468701|453950337|FG000|Overall Study|No end of study case report form|0|||
126181869|NCT01468701|453950338|FG001|Overall Study|No end of study case report form|0|||
126181870|NCT01468701|453950339|FG002|Overall Study|No end of study case report form|0|||
126181871|NCT01468701|453950340|FG003|Overall Study|No end of study case report form|0|||
126199931|NCT01117428|454017804|FG000|Overall Study|Lack of Efficacy|1|||
126181872|NCT01468701|453950341|FG004|Overall Study|No end of study case report form|0|||
126181873|NCT01468701|453950342|FG005|Overall Study|No end of study case report form|0|||
126181874|NCT01468701|453950343|FG006|Overall Study|No end of study case report form|0|||
126181875|NCT01468701|453950344|FG007|Overall Study|No end of study case report form|0|||
126181876|NCT01468701|453950345|FG008|Overall Study|No end of study case report form|4|||
126181877|NCT01468701|453950346|FG009|Overall Study|No end of study case report form|1|||
126181878|NCT01468701|453950347|FG010|Overall Study|No end of study case report form|2|||
126181879|NCT01468701|453950348|FG011|Overall Study|No end of study case report form|3|||
126181880|NCT01468701|453950349|FG012|Overall Study|No end of study case report form|0|||
126181881|NCT01468701|453950350|FG013|Overall Study|No end of study case report form|1|||
126181882|NCT01468701|453950351|FG014|Overall Study|No end of study case report form|0|||
126181883|NCT01468701|453950352|FG015|Overall Study|No end of study case report form|0|||
126181884|NCT01468701|453950353|FG016|Overall Study|No end of study case report form|0|||
126181885|NCT01468701|453950337|FG000|Overall Study|Not being followed up|0|||
126181886|NCT01468701|453950338|FG001|Overall Study|Not being followed up|4963|||
126181887|NCT01468701|453950339|FG002|Overall Study|Not being followed up|1755|||
126181888|NCT01468701|453950340|FG003|Overall Study|Not being followed up|703|||
126181889|NCT01468701|453950341|FG004|Overall Study|Not being followed up|1714|||
126181890|NCT01468701|453950342|FG005|Overall Study|Not being followed up|126|||
126181891|NCT01468701|453950343|FG006|Overall Study|Not being followed up|1170|||
126181892|NCT01468701|453950344|FG007|Overall Study|Not being followed up|4|||
126181893|NCT01468701|453950345|FG008|Overall Study|Not being followed up|0|||
126181894|NCT01468701|453950346|FG009|Overall Study|Not being followed up|0|||
126181895|NCT01468701|453950347|FG010|Overall Study|Not being followed up|0|||
126181896|NCT01468701|453950348|FG011|Overall Study|Not being followed up|0|||
126181897|NCT01468701|453950349|FG012|Overall Study|Not being followed up|0|||
126181898|NCT01468701|453950350|FG013|Overall Study|Not being followed up|0|||
126181899|NCT01468701|453950351|FG014|Overall Study|Not being followed up|0|||
126181900|NCT01468701|453950352|FG015|Overall Study|Not being followed up|0|||
126181901|NCT01468701|453950353|FG016|Overall Study|Not being followed up|0|||
126181902|NCT01068717|453950354|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
126181903|NCT01068717|453950355|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
126181904|NCT01068717|453950356|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
126181905|NCT01068717|453950357|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
126181906|NCT04186663|453950358|FG000|Overall Study|Lost to Follow-up|1|||
126181907|NCT04186663|453950358|FG000|Overall Study|Unable to complete blood draw|3|||
126181908|NCT01602549|453950362|FG000|Overall Study|Protocol Violation|0|||
126181909|NCT01602549|453950363|FG001|Overall Study|Protocol Violation|1|||
126181910|NCT01602549|453950362|FG000|Overall Study|Withdrawal by Subject|1|||
126181911|NCT01602549|453950363|FG001|Overall Study|Withdrawal by Subject|0|||
126181912|NCT05200455|453950364|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
126181913|NCT01184846|453950368|FG000|Overall Study|Adverse Event|2|||
126181914|NCT01184846|453950368|FG000|Overall Study|Insufficient response|1|||
126181915|NCT00892957|453950369|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
126181916|NCT00892957|453950370|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
126181917|NCT00892957|453950369|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
126181918|NCT00892957|453950370|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
126181919|NCT02853032|453950371|FG000|Overall Study|Adverse Event|4|||
126181920|NCT02853032|453950372|FG001|Overall Study|Adverse Event|0|||
126181921|NCT02853032|453950371|FG000|Overall Study|Withdrawal by Subject|3|||
126181922|NCT02853032|453950372|FG001|Overall Study|Withdrawal by Subject|1|||
126181923|NCT02853032|453950371|FG000|Overall Study|Requested to withdraw from all treatment|2|||
126181924|NCT02853032|453950372|FG001|Overall Study|Requested to withdraw from all treatment|2|||
126181925|NCT03700736|453950375|FG000|Overall Study|Pregnancy|1|||
126181926|NCT03700736|453950376|FG001|Overall Study|Pregnancy|1|||
126181927|NCT03700736|453950375|FG000|Overall Study|Withdrawal by Subject|2|||
126181928|NCT03700736|453950376|FG001|Overall Study|Withdrawal by Subject|6|||
126181929|NCT03366844|453953064|FG000|Overall Study|Physician Decision|1|||
126181930|NCT03366844|453953064|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
126181931|NCT00107172|453953065|FG000|Overall Study|Withdrawal by Subject|1|||
126181932|NCT00107172|453953066|FG001|Overall Study|Withdrawal by Subject|0|||
126181933|NCT00107172|453953065|FG000|Overall Study|Death|0|||
126181934|NCT00107172|453953066|FG001|Overall Study|Death|2|||
126181935|NCT00107172|453953065|FG000|Overall Study|Other Reason|4|||
126181936|NCT00107172|453953066|FG001|Overall Study|Other Reason|3|||
126181937|NCT01102140|453953069|FG000|Overall Study|Lost to Follow-up|1|||
126181938|NCT01102140|453953070|FG001|Overall Study|Lost to Follow-up|0|||
126181939|NCT01102140|453953069|FG000|Overall Study|Investigator terminated study|2|||
126181940|NCT01102140|453953070|FG001|Overall Study|Investigator terminated study|2|||
126181941|NCT00191386|453953071|FG000|Overall Study|Adverse Event|16|||
126181942|NCT00191386|453953071|FG000|Overall Study|Lost to Follow-up|1|||
126181943|NCT00191386|453953071|FG000|Overall Study|Entry Criteria Exclusion|3|||
126181944|NCT00191386|453953071|FG000|Overall Study|Protocol Violation|18|||
126181945|NCT00191386|453953071|FG000|Overall Study|Withdrawal by Subject|96|||
126181946|NCT00191386|453953071|FG000|Overall Study|Physician Decision|11|||
126181947|NCT00191386|453953071|FG000|Overall Study|Lack of Efficacy|15|||
126181948|NCT01742091|453953076|FG000|Overall Study|Adverse Event|0|||
126181949|NCT01742091|453953077|FG001|Overall Study|Adverse Event|0|||
126181950|NCT01742091|453953078|FG002|Overall Study|Adverse Event|0|||
126181951|NCT01742091|453953079|FG003|Overall Study|Adverse Event|0|||
126181952|NCT01742091|453953080|FG004|Overall Study|Adverse Event|1|||
126181953|NCT01742091|453953081|FG005|Overall Study|Adverse Event|0|||
126181954|NCT01742091|453953076|FG000|Overall Study|Physician Decision|0|||
126181955|NCT01742091|453953077|FG001|Overall Study|Physician Decision|0|||
126181956|NCT01742091|453953078|FG002|Overall Study|Physician Decision|0|||
126181957|NCT01742091|453953079|FG003|Overall Study|Physician Decision|0|||
126181958|NCT01742091|453953080|FG004|Overall Study|Physician Decision|0|||
126181959|NCT01742091|453953081|FG005|Overall Study|Physician Decision|1|||
126181960|NCT01742091|453953076|FG000|Overall Study|Withdrawal by Subject|0|||
126181961|NCT01742091|453953077|FG001|Overall Study|Withdrawal by Subject|0|||
126181962|NCT01742091|453953078|FG002|Overall Study|Withdrawal by Subject|0|||
126181963|NCT01742091|453953079|FG003|Overall Study|Withdrawal by Subject|1|||
126181964|NCT01742091|453953080|FG004|Overall Study|Withdrawal by Subject|0|||
126181965|NCT01742091|453953081|FG005|Overall Study|Withdrawal by Subject|0|||
126181966|NCT01742091|453953076|FG000|Overall Study|Lost to Follow-up|0|||
126181967|NCT01742091|453953077|FG001|Overall Study|Lost to Follow-up|0|||
126181968|NCT01742091|453953078|FG002|Overall Study|Lost to Follow-up|0|||
126181969|NCT01742091|453953079|FG003|Overall Study|Lost to Follow-up|0|||
126181970|NCT01742091|453953080|FG004|Overall Study|Lost to Follow-up|0|||
126181971|NCT01742091|453953081|FG005|Overall Study|Lost to Follow-up|1|||
126181972|NCT03750240|453953082|FG000|Overall Study|Technical Difficulties|2|||
126181973|NCT03706040|453953083|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
126181974|NCT03706040|453953084|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
126181975|NCT03706040|453953085|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
126181976|NCT03706040|453953086|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
126181977|NCT03706040|453953087|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
126181978|NCT03706040|453953088|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
126181979|NCT03706040|453953089|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
126181980|NCT03706040|453953083|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
126181981|NCT03706040|453953084|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
126181982|NCT03706040|453953085|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
126181983|NCT03706040|453953086|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
126181984|NCT03706040|453953087|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
126181985|NCT03706040|453953088|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
126181986|NCT03706040|453953089|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
126181987|NCT03706040|453953083|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
126181988|NCT03706040|453953084|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
126181989|NCT03706040|453953085|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
126181990|NCT03706040|453953086|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
126181991|NCT03706040|453953087|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
126181992|NCT03706040|453953088|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
126181993|NCT03706040|453953089|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
126181994|NCT03706040|453953083|FG000|Period A (Week 0 to Week 16)|Other|2|||
126181995|NCT03706040|453953084|FG001|Period A (Week 0 to Week 16)|Other|0|||
126181996|NCT03706040|453953085|FG002|Period A (Week 0 to Week 16)|Other|2|||
126181997|NCT03706040|453953086|FG003|Period A (Week 0 to Week 16)|Other|0|||
126181998|NCT03706040|453953087|FG004|Period A (Week 0 to Week 16)|Other|0|||
126181999|NCT03706040|453953088|FG005|Period A (Week 0 to Week 16)|Other|0|||
126182000|NCT03706040|453953089|FG006|Period A (Week 0 to Week 16)|Other|0|||
126182001|NCT03706040|453953083|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
126182002|NCT03706040|453953084|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
126182003|NCT03706040|453953085|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
126182004|NCT03706040|453953086|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
126182005|NCT03706040|453953087|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
126182006|NCT03706040|453953088|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
126182007|NCT03706040|453953089|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
126182008|NCT03706040|453953083|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
126182009|NCT03706040|453953084|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
126182010|NCT03706040|453953085|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
126182011|NCT03706040|453953086|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
126182012|NCT03706040|453953087|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
126182013|NCT03706040|453953088|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
126182014|NCT03706040|453953089|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
126182015|NCT03706040|453953083|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126182016|NCT03706040|453953084|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126182017|NCT03706040|453953085|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126182018|NCT03706040|453953086|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126182019|NCT03706040|453953087|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126182020|NCT03706040|453953088|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
126182021|NCT03706040|453953089|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
126182022|NCT03706040|453953083|FG000|Period B (Week 16 to Week 52)|Other|0|||
126182023|NCT03706040|453953084|FG001|Period B (Week 16 to Week 52)|Other|0|||
126182024|NCT03706040|453953085|FG002|Period B (Week 16 to Week 52)|Other|0|||
126182025|NCT03706040|453953086|FG003|Period B (Week 16 to Week 52)|Other|4|||
126182026|NCT03706040|453953087|FG004|Period B (Week 16 to Week 52)|Other|5|||
126182027|NCT03706040|453953088|FG005|Period B (Week 16 to Week 52)|Other|23|||
126182028|NCT03706040|453953089|FG006|Period B (Week 16 to Week 52)|Other|17|||
126182029|NCT00927758|453953090|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
126182030|NCT00927758|453953091|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
126182031|NCT00927758|453953092|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
126182032|NCT00927758|453953093|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
126182033|NCT00927758|453953094|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
126182034|NCT00927758|453953095|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
126182035|NCT00927758|453953090|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
126182036|NCT00927758|453953091|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
126182037|NCT00927758|453953092|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
126182038|NCT00927758|453953093|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
126182039|NCT00927758|453953094|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
126182040|NCT00927758|453953095|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
126182041|NCT00439725|453953097|FG000|Treatment Period|Withdrawal by Subject|22|||
126182042|NCT00439725|453953098|FG001|Treatment Period|Withdrawal by Subject|19|||
126182043|NCT00439725|453953097|FG000|Treatment Period|Study terminated by sponsor|156|||
126182044|NCT00439725|453953098|FG001|Treatment Period|Study terminated by sponsor|148|||
126182045|NCT00439725|453953097|FG000|Treatment Period|Site closed by investigator|1|||
126182046|NCT00439725|453953098|FG001|Treatment Period|Site closed by investigator|2|||
126182047|NCT00439725|453953097|FG000|Treatment Period|Adverse Event|39|||
126182048|NCT00439725|453953098|FG001|Treatment Period|Adverse Event|18|||
126182049|NCT00439725|453953097|FG000|Treatment Period|Physician Decision|1|||
126182050|NCT00439725|453953098|FG001|Treatment Period|Physician Decision|1|||
126182051|NCT00439725|453953097|FG000|Treatment Period|Protocol Violation|2|||
126182052|NCT00439725|453953098|FG001|Treatment Period|Protocol Violation|1|||
126182053|NCT00439725|453953097|FG000|Treatment Period|Clinical endpoint reached|6|||
126182054|NCT00439725|453953098|FG001|Treatment Period|Clinical endpoint reached|50|||
126182055|NCT00439725|453953097|FG000|Treatment Period|Technical problems|1|||
126182056|NCT00439725|453953098|FG001|Treatment Period|Technical problems|0|||
126182057|NCT00439725|453953097|FG000|Treatment Period|Lost to Follow-up|1|||
126182058|NCT00439725|453953098|FG001|Treatment Period|Lost to Follow-up|1|||
126182059|NCT00439725|453953097|FG000|Treatment Period|Participant convenience|1|||
126182060|NCT00439725|453953098|FG001|Treatment Period|Participant convenience|0|||
126182061|NCT00439725|453953097|FG000|Treatment Period|Protocol driven decision point|1|||
126182062|NCT00439725|453953098|FG001|Treatment Period|Protocol driven decision point|1|||
126182063|NCT00439725|453953097|FG000|Treatment Period|Death|1|||
126182064|NCT00439725|453953098|FG001|Treatment Period|Death|1|||
126182065|NCT00439725|453953097|FG000|Treatment Period|Participant did not receive treatment|4|||
126182066|NCT00439725|453953098|FG001|Treatment Period|Participant did not receive treatment|4|||
126182067|NCT00439725|453953097|FG000|Observational Period|Withdrawal by Subject|2|||
126182068|NCT00439725|453953098|FG001|Observational Period|Withdrawal by Subject|2|||
126182069|NCT00439725|453953097|FG000|Observational Period|Lost to Follow-up|0|||
126182070|NCT00439725|453953098|FG001|Observational Period|Lost to Follow-up|1|||
126182071|NCT00439725|453953097|FG000|Observational Period|Death|0|||
126182072|NCT00439725|453953098|FG001|Observational Period|Death|2|||
126182073|NCT00439725|453953097|FG000|Observational Period|Study termination by sponsor|1|||
126182074|NCT00439725|453953098|FG001|Observational Period|Study termination by sponsor|1|||
126182075|NCT00439725|453953097|FG000|Observational Period|Clinical endpoint reached|3|||
126182076|NCT00439725|453953098|FG001|Observational Period|Clinical endpoint reached|1|||
126182077|NCT00439725|453953097|FG000|Observational Period|Technical problems|1|||
126182078|NCT00439725|453953098|FG001|Observational Period|Technical problems|0|||
126182079|NCT00439725|453953097|FG000|Observational Period|Participant convenience|1|||
126182080|NCT00439725|453953098|FG001|Observational Period|Participant convenience|0|||
126182081|NCT00212758|453953102|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
126182082|NCT00212758|453953103|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
126182083|NCT00212758|453953102|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
126182084|NCT00212758|453953103|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
126182085|NCT03510910|453953104|FG000|Overall Study|Incomplete Survey|2|||
126182086|NCT03510910|453953105|FG001|Overall Study|Incomplete Survey|3|||
126182087|NCT01673490|453953106|FG000|Overall Study|Lost to Follow-up|1|||
126182088|NCT01673490|453953106|FG000|Overall Study|Adverse Event|3|||
126182089|NCT01673490|453953106|FG000|Overall Study|Withdrawal by Subject|3|||
126182090|NCT00379236|453953107|FG000|Double-blind|Adverse Event|11|||
126182091|NCT00379236|453953108|FG001|Double-blind|Adverse Event|6|||
126182092|NCT00379236|453953109|FG002|Double-blind|Adverse Event|0|||
126182093|NCT00379236|453953107|FG000|Double-blind|Protocol Violation|3|||
126182094|NCT00379236|453953108|FG001|Double-blind|Protocol Violation|3|||
126182095|NCT00379236|453953109|FG002|Double-blind|Protocol Violation|0|||
126182096|NCT00379236|453953107|FG000|Double-blind|Withdrawal by Subject|12|||
126182097|NCT00379236|453953108|FG001|Double-blind|Withdrawal by Subject|13|||
126182098|NCT00379236|453953109|FG002|Double-blind|Withdrawal by Subject|0|||
126182099|NCT00379236|453953107|FG000|Double-blind|Lost to Follow-up|4|||
126182100|NCT00379236|453953108|FG001|Double-blind|Lost to Follow-up|3|||
126182101|NCT00379236|453953109|FG002|Double-blind|Lost to Follow-up|0|||
126182102|NCT00379236|453953107|FG000|Double-blind|Use of exclusionary medication|1|||
126182103|NCT00379236|453953108|FG001|Double-blind|Use of exclusionary medication|2|||
126182104|NCT00379236|453953109|FG002|Double-blind|Use of exclusionary medication|0|||
126182105|NCT00379236|453953107|FG000|Double-blind|Other|3|||
126182106|NCT00379236|453953108|FG001|Double-blind|Other|7|||
126182107|NCT00379236|453953109|FG002|Double-blind|Other|0|||
126182108|NCT00379236|453953107|FG000|Double-blind|Data could not be retrieved|2|||
126182109|NCT00379236|453953108|FG001|Double-blind|Data could not be retrieved|2|||
126182110|NCT00379236|453953109|FG002|Double-blind|Data could not be retrieved|0|||
126182111|NCT00379236|453953107|FG000|Open-label Extension|Adverse Event|0|||
126182112|NCT00379236|453953108|FG001|Open-label Extension|Adverse Event|0|||
126182113|NCT00379236|453953109|FG002|Open-label Extension|Adverse Event|13|||
126182114|NCT00379236|453953107|FG000|Open-label Extension|Protocol Violation|0|||
126182115|NCT00379236|453953108|FG001|Open-label Extension|Protocol Violation|0|||
126182116|NCT00379236|453953109|FG002|Open-label Extension|Protocol Violation|7|||
126182117|NCT00379236|453953107|FG000|Open-label Extension|Withdrawal by Subject|0|||
126182118|NCT00379236|453953108|FG001|Open-label Extension|Withdrawal by Subject|0|||
126182119|NCT00379236|453953109|FG002|Open-label Extension|Withdrawal by Subject|13|||
126182120|NCT00379236|453953107|FG000|Open-label Extension|Lost to Follow-up|0|||
126182121|NCT00379236|453953108|FG001|Open-label Extension|Lost to Follow-up|0|||
126182122|NCT00379236|453953109|FG002|Open-label Extension|Lost to Follow-up|12|||
126182123|NCT00379236|453953107|FG000|Open-label Extension|Use of exclusionary medication|0|||
126182124|NCT00379236|453953108|FG001|Open-label Extension|Use of exclusionary medication|0|||
126182125|NCT00379236|453953109|FG002|Open-label Extension|Use of exclusionary medication|3|||
126182126|NCT00379236|453953107|FG000|Open-label Extension|Other|0|||
126182127|NCT00379236|453953108|FG001|Open-label Extension|Other|0|||
126182128|NCT00379236|453953109|FG002|Open-label Extension|Other|7|||
126182129|NCT03276572|453953116|FG000|Overall Study|In follow-up|0|||
126182130|NCT03276572|453953117|FG001|Overall Study|In follow-up|0|||
126182131|NCT03276572|453953118|FG002|Overall Study|In follow-up|0|||
126182132|NCT03276572|453953119|FG003|Overall Study|In follow-up|0|||
126182133|NCT03276572|453953120|FG004|Overall Study|In follow-up|0|||
126182134|NCT03276572|453953121|FG005|Overall Study|In follow-up|1|||
126182135|NCT03276572|453953122|FG006|Overall Study|In follow-up|1|||
126182136|NCT03276572|453953116|FG000|Overall Study|Lost to Follow-up|0|||
126182137|NCT03276572|453953117|FG001|Overall Study|Lost to Follow-up|0|||
126182138|NCT03276572|453953118|FG002|Overall Study|Lost to Follow-up|0|||
126182139|NCT03276572|453953119|FG003|Overall Study|Lost to Follow-up|0|||
126182140|NCT03276572|453953120|FG004|Overall Study|Lost to Follow-up|0|||
126182141|NCT03276572|453953121|FG005|Overall Study|Lost to Follow-up|0|||
126182142|NCT03276572|453953122|FG006|Overall Study|Lost to Follow-up|1|||
126182143|NCT01709708|453953123|FG000|Overall Study|Protocol Violation|1|||
126182144|NCT01709708|453953124|FG001|Overall Study|Protocol Violation|2|||
126182145|NCT00527072|453953125|FG000|Overall Study|Adverse Event|13|||
126182146|NCT00527072|453953125|FG000|Overall Study|Lack of Efficacy|11|||
126182147|NCT00527072|453953125|FG000|Overall Study|Lost to Follow-up|3|||
126182148|NCT00527072|453953125|FG000|Overall Study|Protocol Violation|2|||
126182149|NCT00527072|453953125|FG000|Overall Study|Withdrawal by Subject|7|||
126182150|NCT00810043|453953126|FG000|Overall Study|Withdrawal by Subject|1|||
126182151|NCT00810043|453953127|FG001|Overall Study|Withdrawal by Subject|0|||
126182152|NCT00810043|453953128|FG002|Overall Study|Withdrawal by Subject|2|||
126182153|NCT00810043|453953126|FG000|Overall Study|Lost to Follow-up|1|||
126182154|NCT00810043|453953127|FG001|Overall Study|Lost to Follow-up|0|||
126182155|NCT00810043|453953128|FG002|Overall Study|Lost to Follow-up|0|||
126182156|NCT00810043|453953126|FG000|Overall Study|Physician Decision|0|||
126182157|NCT00810043|453953127|FG001|Overall Study|Physician Decision|0|||
126182158|NCT00810043|453953128|FG002|Overall Study|Physician Decision|2|||
126182159|NCT00810043|453953126|FG000|Overall Study|Death|2|||
126182160|NCT00810043|453953127|FG001|Overall Study|Death|0|||
126182161|NCT00810043|453953128|FG002|Overall Study|Death|0|||
126182162|NCT00810043|453953126|FG000|Overall Study|Unrelated medical problem|0|||
126182163|NCT00810043|453953127|FG001|Overall Study|Unrelated medical problem|1|||
126182164|NCT00810043|453953128|FG002|Overall Study|Unrelated medical problem|0|||
126182165|NCT00810043|453953126|FG000|Overall Study|Non-medical problem|0|||
126182166|NCT00810043|453953127|FG001|Overall Study|Non-medical problem|0|||
126182167|NCT00810043|453953128|FG002|Overall Study|Non-medical problem|1|||
126182168|NCT00810043|453953126|FG000|Overall Study|No longer met enrollment criteria|0|||
126182169|NCT00810043|453953127|FG001|Overall Study|No longer met enrollment criteria|0|||
126182170|NCT00810043|453953128|FG002|Overall Study|No longer met enrollment criteria|3|||
126182171|NCT01989754|453953129|FG000|Overall Study|Withdrawal by Subject|10|||
126182172|NCT01989754|453953130|FG001|Overall Study|Withdrawal by Subject|14|||
126182173|NCT01989754|453953129|FG000|Overall Study|Lost to Follow-up|28|||
126182174|NCT01989754|453953130|FG001|Overall Study|Lost to Follow-up|20|||
126182175|NCT01989754|453953129|FG000|Overall Study|Closed Site|1|||
126182176|NCT01989754|453953130|FG001|Overall Study|Closed Site|1|||
126182177|NCT01369225|453953134|FG000|Overall Study|Withdrawal by Subject|1|||
126182178|NCT01369225|453953135|FG001|Overall Study|Withdrawal by Subject|0|||
126182179|NCT01369225|453953136|FG002|Overall Study|Withdrawal by Subject|2|||
126182180|NCT01369225|453953137|FG003|Overall Study|Withdrawal by Subject|1|||
126182181|NCT01369225|453953138|FG004|Overall Study|Withdrawal by Subject|0|||
126182182|NCT01369225|453953139|FG005|Overall Study|Withdrawal by Subject|0|||
126182183|NCT01369225|453953134|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
126182184|NCT01369225|453953135|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
126182185|NCT01369225|453953136|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
126182186|NCT01369225|453953137|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
126182187|NCT01369225|453953138|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
126182188|NCT01369225|453953139|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
126182189|NCT01369225|453953134|FG000|Overall Study|Other|1|||
126182190|NCT01369225|453953135|FG001|Overall Study|Other|0|||
126182191|NCT01369225|453953136|FG002|Overall Study|Other|0|||
126182192|NCT01369225|453953137|FG003|Overall Study|Other|0|||
126182193|NCT01369225|453953138|FG004|Overall Study|Other|1|||
126182194|NCT01369225|453953139|FG005|Overall Study|Other|0|||
126182195|NCT01369225|453953134|FG000|Overall Study|Adverse Event|0|||
126182196|NCT01369225|453953135|FG001|Overall Study|Adverse Event|0|||
126182197|NCT01369225|453953136|FG002|Overall Study|Adverse Event|0|||
126182198|NCT01369225|453953137|FG003|Overall Study|Adverse Event|1|||
126182199|NCT01369225|453953138|FG004|Overall Study|Adverse Event|1|||
126182200|NCT01369225|453953139|FG005|Overall Study|Adverse Event|0|||
126182201|NCT02980692|453953142|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
126182202|NCT02980692|453953143|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
126182203|NCT02980692|453953144|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
126182204|NCT02980692|453953145|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
126182205|NCT02980692|453953146|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
126182206|NCT02980692|453953142|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
126182207|NCT02980692|453953143|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
126182208|NCT02980692|453953144|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
126182209|NCT02980692|453953145|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
126182210|NCT02980692|453953146|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
126182211|NCT02980692|453953142|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
126182212|NCT02980692|453953143|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
126182213|NCT02980692|453953144|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
126182214|NCT02980692|453953145|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
126182215|NCT02980692|453953146|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
126182216|NCT02980692|453953142|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
126182217|NCT02980692|453953143|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
126182218|NCT02980692|453953144|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
126182219|NCT02980692|453953145|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
126182220|NCT02980692|453953146|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
126182221|NCT02980692|453953142|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
126182222|NCT02980692|453953143|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
126182223|NCT02980692|453953144|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
126182224|NCT02980692|453953145|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
126182225|NCT02980692|453953146|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
126182226|NCT02980692|453953142|FG000|Double Blind Placebo Controlled Period|Other|1|||
126182227|NCT02980692|453953143|FG001|Double Blind Placebo Controlled Period|Other|0|||
126182228|NCT02980692|453953144|FG002|Double Blind Placebo Controlled Period|Other|0|||
126182229|NCT02980692|453953145|FG003|Double Blind Placebo Controlled Period|Other|0|||
126182230|NCT02980692|453953146|FG004|Double Blind Placebo Controlled Period|Other|1|||
126182231|NCT02980692|453953142|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
126182232|NCT02980692|453953143|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
126182233|NCT02980692|453953144|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
126182234|NCT02980692|453953145|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
126182235|NCT02980692|453953146|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
126199932|NCT01117428|454017805|FG001|Overall Study|Lack of Efficacy|0|||
126182236|NCT02980692|453953142|FG000|Double-blind Follow-up Period|Adverse Event|0|||
126182237|NCT02980692|453953143|FG001|Double-blind Follow-up Period|Adverse Event|0|||
126182238|NCT02980692|453953144|FG002|Double-blind Follow-up Period|Adverse Event|0|||
126182239|NCT02980692|453953145|FG003|Double-blind Follow-up Period|Adverse Event|1|||
126182240|NCT02980692|453953146|FG004|Double-blind Follow-up Period|Adverse Event|1|||
126182241|NCT02980692|453953142|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
126182242|NCT02980692|453953143|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
126182243|NCT02980692|453953144|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
126182244|NCT02980692|453953145|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
126182245|NCT02980692|453953146|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
126182246|NCT02980692|453953142|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
126182247|NCT02980692|453953143|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
126182248|NCT02980692|453953144|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
126182249|NCT02980692|453953145|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
126182250|NCT02980692|453953146|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
126182251|NCT02980692|453953142|FG000|Double-blind Follow-up Period|Pregnancy|0|||
126182252|NCT02980692|453953143|FG001|Double-blind Follow-up Period|Pregnancy|0|||
126182253|NCT02980692|453953144|FG002|Double-blind Follow-up Period|Pregnancy|1|||
126182254|NCT02980692|453953145|FG003|Double-blind Follow-up Period|Pregnancy|1|||
126182255|NCT02980692|453953146|FG004|Double-blind Follow-up Period|Pregnancy|0|||
126182256|NCT02980692|453953142|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
126182257|NCT02980692|453953143|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
126182258|NCT02980692|453953144|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
126182259|NCT02980692|453953145|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
126182260|NCT02980692|453953146|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
126182261|NCT02980692|453953142|FG000|Double-blind Follow-up Period|Other|0|||
126182262|NCT02980692|453953143|FG001|Double-blind Follow-up Period|Other|0|||
126182263|NCT02980692|453953144|FG002|Double-blind Follow-up Period|Other|1|||
126182264|NCT02980692|453953145|FG003|Double-blind Follow-up Period|Other|1|||
126182265|NCT02980692|453953146|FG004|Double-blind Follow-up Period|Other|3|||
126182266|NCT00064077|453953149|FG000|Overall Study|Improper prior treatment|1|||
126182267|NCT00064077|453953150|FG001|Overall Study|Improper prior treatment|0|||
126182268|NCT00064077|453953151|FG002|Overall Study|Improper prior treatment|0|||
126182269|NCT00064077|453953152|FG003|Overall Study|Improper prior treatment|0|||
126182270|NCT00064077|453953149|FG000|Overall Study|Poor risk|2|||
126182271|NCT00064077|453953150|FG001|Overall Study|Poor risk|0|||
126182272|NCT00064077|453953151|FG002|Overall Study|Poor risk|1|||
126182273|NCT00064077|453953152|FG003|Overall Study|Poor risk|1|||
126182274|NCT00064077|453953149|FG000|Overall Study|Pathology|10|||
126182275|NCT00064077|453953150|FG001|Overall Study|Pathology|7|||
126182276|NCT00064077|453953151|FG002|Overall Study|Pathology|3|||
126182277|NCT00064077|453953152|FG003|Overall Study|Pathology|4|||
126182278|NCT00064077|453953149|FG000|Overall Study|No surgery|0|||
126182279|NCT00064077|453953150|FG001|Overall Study|No surgery|0|||
126182280|NCT00064077|453953151|FG002|Overall Study|No surgery|1|||
126182281|NCT00064077|453953152|FG003|Overall Study|No surgery|0|||
126182282|NCT00064077|453953149|FG000|Overall Study|No tumor|0|||
126182283|NCT00064077|453953150|FG001|Overall Study|No tumor|0|||
126182284|NCT00064077|453953151|FG002|Overall Study|No tumor|1|||
126182285|NCT00064077|453953152|FG003|Overall Study|No tumor|0|||
126182286|NCT00064077|453953149|FG000|Overall Study|Other reasons|2|||
126182287|NCT00064077|453953150|FG001|Overall Study|Other reasons|2|||
126182288|NCT00064077|453953151|FG002|Overall Study|Other reasons|1|||
126182289|NCT00064077|453953152|FG003|Overall Study|Other reasons|2|||
126182290|NCT01819506|453953153|FG000|Overall Study|Physician Decision|5|||
126182291|NCT01819506|453953154|FG001|Overall Study|Physician Decision|2|||
126182292|NCT01819506|453953153|FG000|Overall Study|Withdrawal by Subject|3|||
126182293|NCT01819506|453953154|FG001|Overall Study|Withdrawal by Subject|3|||
126182294|NCT03000686|453953155|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
126182295|NCT03000686|453953156|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
126182296|NCT03000686|453953157|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
126182297|NCT03000686|453953158|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
126182298|NCT03379376|453953162|FG000|Overall Study|Lost to Follow-up|2|||
126182299|NCT03379376|453953162|FG000|Overall Study|Did not wish to complete follow up|1|||
126182300|NCT03379376|453953162|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
126182301|NCT03379376|453953162|FG000|Overall Study|Death|1|||
126182302|NCT00928512|453953163|FG000|Overall Study|Adverse Event|4|||
126182303|NCT00928512|453953164|FG001|Overall Study|Adverse Event|3|||
126182304|NCT00928512|453953165|FG002|Overall Study|Adverse Event|2|||
126182305|NCT00928512|453953166|FG003|Overall Study|Adverse Event|8|||
126182306|NCT00928512|453953167|FG004|Overall Study|Adverse Event|6|||
126182307|NCT00928512|453953163|FG000|Overall Study|Lack of Efficacy|2|||
126182308|NCT00928512|453953164|FG001|Overall Study|Lack of Efficacy|0|||
126182309|NCT00928512|453953165|FG002|Overall Study|Lack of Efficacy|4|||
126182310|NCT00928512|453953166|FG003|Overall Study|Lack of Efficacy|7|||
126182311|NCT00928512|453953167|FG004|Overall Study|Lack of Efficacy|3|||
126182312|NCT00928512|453953163|FG000|Overall Study|Protocol Violation|0|||
126182313|NCT00928512|453953164|FG001|Overall Study|Protocol Violation|1|||
126182314|NCT00928512|453953165|FG002|Overall Study|Protocol Violation|0|||
126182315|NCT00928512|453953166|FG003|Overall Study|Protocol Violation|1|||
126182316|NCT00928512|453953167|FG004|Overall Study|Protocol Violation|3|||
126182317|NCT00928512|453953163|FG000|Overall Study|Withdrawal by Subject|3|||
126182318|NCT00928512|453953164|FG001|Overall Study|Withdrawal by Subject|0|||
126182319|NCT00928512|453953165|FG002|Overall Study|Withdrawal by Subject|3|||
126182320|NCT00928512|453953166|FG003|Overall Study|Withdrawal by Subject|4|||
126182321|NCT00928512|453953167|FG004|Overall Study|Withdrawal by Subject|0|||
126182322|NCT00928512|453953163|FG000|Overall Study|Lost to Follow-up|1|||
126182323|NCT00928512|453953164|FG001|Overall Study|Lost to Follow-up|1|||
126182324|NCT00928512|453953165|FG002|Overall Study|Lost to Follow-up|2|||
126182325|NCT00928512|453953166|FG003|Overall Study|Lost to Follow-up|1|||
126182326|NCT00928512|453953167|FG004|Overall Study|Lost to Follow-up|3|||
126182327|NCT00928512|453953163|FG000|Overall Study|Administrative Problems|0|||
126182328|NCT00928512|453953164|FG001|Overall Study|Administrative Problems|1|||
126182329|NCT00928512|453953165|FG002|Overall Study|Administrative Problems|0|||
126182330|NCT00928512|453953166|FG003|Overall Study|Administrative Problems|0|||
126182331|NCT00928512|453953167|FG004|Overall Study|Administrative Problems|0|||
126182332|NCT04153929|453953168|FG000|Overall Study|Other than listed|2|||
126182333|NCT04153929|453953169|FG001|Overall Study|Other than listed|2|||
126182334|NCT04153929|453953170|FG002|Overall Study|Other than listed|0|||
126182335|NCT04153929|453953171|FG003|Overall Study|Other than listed|1|||
126182336|NCT04153929|453953172|FG004|Overall Study|Other than listed|0|||
126182337|NCT04153929|453953173|FG005|Overall Study|Other than listed|2|||
126182338|NCT04153929|453953174|FG006|Overall Study|Other than listed|2|||
126182339|NCT04153929|453953175|FG007|Overall Study|Other than listed|1|||
126182340|NCT04153929|453953168|FG000|Overall Study|Lost to Follow-up|2|||
126182341|NCT04153929|453953169|FG001|Overall Study|Lost to Follow-up|1|||
126182342|NCT04153929|453953170|FG002|Overall Study|Lost to Follow-up|0|||
126182343|NCT04153929|453953171|FG003|Overall Study|Lost to Follow-up|1|||
126182344|NCT04153929|453953172|FG004|Overall Study|Lost to Follow-up|1|||
126182345|NCT04153929|453953173|FG005|Overall Study|Lost to Follow-up|0|||
126182346|NCT04153929|453953174|FG006|Overall Study|Lost to Follow-up|0|||
126182347|NCT04153929|453953175|FG007|Overall Study|Lost to Follow-up|0|||
126182348|NCT04153929|453953168|FG000|Overall Study|Withdrawal by Subject|3|||
126182349|NCT04153929|453953169|FG001|Overall Study|Withdrawal by Subject|1|||
126182350|NCT04153929|453953170|FG002|Overall Study|Withdrawal by Subject|0|||
126182351|NCT04153929|453953171|FG003|Overall Study|Withdrawal by Subject|3|||
126182352|NCT04153929|453953172|FG004|Overall Study|Withdrawal by Subject|1|||
126182353|NCT04153929|453953173|FG005|Overall Study|Withdrawal by Subject|0|||
126182354|NCT04153929|453953174|FG006|Overall Study|Withdrawal by Subject|1|||
126182355|NCT04153929|453953175|FG007|Overall Study|Withdrawal by Subject|0|||
126182356|NCT04153929|453953168|FG000|Overall Study|Protocol Violation|0|||
126182357|NCT04153929|453953169|FG001|Overall Study|Protocol Violation|0|||
126182358|NCT04153929|453953170|FG002|Overall Study|Protocol Violation|0|||
126182359|NCT04153929|453953171|FG003|Overall Study|Protocol Violation|0|||
126182360|NCT04153929|453953172|FG004|Overall Study|Protocol Violation|0|||
126182361|NCT04153929|453953173|FG005|Overall Study|Protocol Violation|0|||
126182362|NCT04153929|453953174|FG006|Overall Study|Protocol Violation|1|||
126182363|NCT04153929|453953175|FG007|Overall Study|Protocol Violation|2|||
126182364|NCT04153929|453953168|FG000|Overall Study|Adverse Event|3|||
126182365|NCT04153929|453953169|FG001|Overall Study|Adverse Event|5|||
126182366|NCT04153929|453953170|FG002|Overall Study|Adverse Event|5|||
126182367|NCT04153929|453953171|FG003|Overall Study|Adverse Event|11|||
126182368|NCT04153929|453953172|FG004|Overall Study|Adverse Event|15|||
126182369|NCT04153929|453953173|FG005|Overall Study|Adverse Event|4|||
126182370|NCT04153929|453953174|FG006|Overall Study|Adverse Event|8|||
126182371|NCT04153929|453953175|FG007|Overall Study|Adverse Event|2|||
126182372|NCT04153929|453953168|FG000|Overall Study|Not treated|1|||
126182373|NCT04153929|453953169|FG001|Overall Study|Not treated|0|||
126182374|NCT04153929|453953170|FG002|Overall Study|Not treated|0|||
126182375|NCT04153929|453953171|FG003|Overall Study|Not treated|0|||
126182376|NCT04153929|453953172|FG004|Overall Study|Not treated|0|||
126182377|NCT04153929|453953173|FG005|Overall Study|Not treated|0|||
126182378|NCT04153929|453953174|FG006|Overall Study|Not treated|1|||
126182379|NCT04153929|453953175|FG007|Overall Study|Not treated|0|||
126182380|NCT01963780|453953176|FG000|Overall Study|Death|7|||
126182381|NCT03383614|453953177|FG000|Overall Study|Withdrawal by Subject|0|||
126182382|NCT03383614|453953178|FG001|Overall Study|Withdrawal by Subject|1|||
126182383|NCT03383614|453953179|FG002|Overall Study|Withdrawal by Subject|0|||
126182384|NCT03383614|453953180|FG003|Overall Study|Withdrawal by Subject|0|||
126182385|NCT00729326|453953187|FG000|Overall Study|Lost to Follow-up|2|||
126182386|NCT00729326|453953188|FG001|Overall Study|Lost to Follow-up|0|||
126182387|NCT00729326|453953187|FG000|Overall Study|Physician Decision|0|||
126182388|NCT00729326|453953188|FG001|Overall Study|Physician Decision|1|||
126182389|NCT00729326|453953187|FG000|Overall Study|Protocol Violation|3|||
126182390|NCT00729326|453953188|FG001|Overall Study|Protocol Violation|2|||
126182391|NCT00729326|453953187|FG000|Overall Study|Subject Decision|4|||
126182392|NCT00729326|453953188|FG001|Overall Study|Subject Decision|4|||
126182393|NCT00729326|453953187|FG000|Overall Study|Sponsor Decision|1|||
126182394|NCT00729326|453953188|FG001|Overall Study|Sponsor Decision|2|||
126182395|NCT01235728|453953189|FG000|Overall Study|Protocol Violation|0|||
126182396|NCT01235728|453953190|FG001|Overall Study|Protocol Violation|0|||
126182397|NCT01235728|453953191|FG002|Overall Study|Protocol Violation|0|||
126182398|NCT01235728|453953192|FG003|Overall Study|Protocol Violation|1|||
126182399|NCT01235728|453953193|FG004|Overall Study|Protocol Violation|0|||
126182400|NCT01235728|453953194|FG005|Overall Study|Protocol Violation|0|||
126182401|NCT01235728|453953195|FG006|Overall Study|Protocol Violation|0|||
126182402|NCT01235728|453953196|FG007|Overall Study|Protocol Violation|0|||
126182403|NCT02559713|453953197|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
126182404|NCT01419080|453953201|FG000|Overall Study|Withdrawal by Subject|75|||
126182405|NCT01419080|453953201|FG000|Overall Study|Death|30|||
126182406|NCT01419080|453953201|FG000|Overall Study|Lost to Follow-up|23|||
126182407|NCT01419080|453953201|FG000|Overall Study|Too Ill|3|||
126182408|NCT01998880|453953202|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
126182409|NCT01998880|453953203|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
126182410|NCT01998880|453953202|FG000|Overall Study|Disease Progression|1|||
126182411|NCT01998880|453953203|FG001|Overall Study|Disease Progression|8|||
126182412|NCT01998880|453953202|FG000|Overall Study|Withdrew Consent|2|||
126182413|NCT01998880|453953203|FG001|Overall Study|Withdrew Consent|1|||
126182414|NCT01998880|453953202|FG000|Overall Study|Death|3|||
126182415|NCT01998880|453953203|FG001|Overall Study|Death|6|||
126182416|NCT01998880|453953202|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126182417|NCT01998880|453953203|FG001|Overall Study|Insufficient Therapeutic Response|5|||
126182418|NCT01998880|453953202|FG000|Overall Study|Administrative/Other|1|||
126182419|NCT01998880|453953203|FG001|Overall Study|Administrative/Other|1|||
126182420|NCT01998880|453953202|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
126182421|NCT01998880|453953203|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
126182422|NCT01998880|453953202|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
126182423|NCT01998880|453953203|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126182424|NCT01998880|453953202|FG000|Overall Study|Did Not Receive Treatment|3|||
126182425|NCT01998880|453953203|FG001|Overall Study|Did Not Receive Treatment|2|||
126182426|NCT03199638|453953207|FG000|Overall Study|inability to drink glutamine during regularly|0|||
126182427|NCT03199638|453953208|FG001|Overall Study|inability to drink glutamine during regularly|2|||
126182428|NCT04294095|453953209|FG000|Overall Study|Adverse Event|1|||
126182429|NCT04294095|453953210|FG001|Overall Study|Adverse Event|0|||
126182430|NCT02661464|453953211|FG000|Overall Study|Lost to Follow-up|28|||
126182431|NCT02661464|453953212|FG001|Overall Study|Lost to Follow-up|0|||
126182432|NCT02661464|453953213|FG002|Overall Study|Lost to Follow-up|0|||
126182433|NCT02661464|453953214|FG003|Overall Study|Lost to Follow-up|0|||
126182434|NCT02661464|453953211|FG000|Overall Study|Withdrawal by Subject|3|||
126182435|NCT02661464|453953212|FG001|Overall Study|Withdrawal by Subject|1|||
126182436|NCT02661464|453953213|FG002|Overall Study|Withdrawal by Subject|0|||
126182437|NCT02661464|453953214|FG003|Overall Study|Withdrawal by Subject|0|||
126182438|NCT02661464|453953211|FG000|Overall Study|Participants terminated prematurely|288|||
126182439|NCT02661464|453953212|FG001|Overall Study|Participants terminated prematurely|52|||
126182440|NCT02661464|453953213|FG002|Overall Study|Participants terminated prematurely|1|||
126182441|NCT02661464|453953214|FG003|Overall Study|Participants terminated prematurely|1|||
126182442|NCT02661464|453953211|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
126182443|NCT02661464|453953212|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
126182444|NCT02661464|453953213|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
126182445|NCT02661464|453953214|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
126182446|NCT03148756|453953215|FG000|Overall Study|Study Terminated|0|||
126182447|NCT03148756|453953216|FG001|Overall Study|Study Terminated|1|||
126182448|NCT02177175|453953219|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
126182449|NCT02177175|453953220|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
126182450|NCT03820726|453953225|FG000|Overall Study|Other than listed|23|||
126182451|NCT03820726|453953225|FG000|Overall Study|Withdrawal by Subject|37|||
126182452|NCT03820726|453953225|FG000|Overall Study|Lost to Follow-up|3|||
126182453|NCT03820726|453953225|FG000|Overall Study|Protocol deviation|1|||
126182454|NCT03820726|453953225|FG000|Overall Study|Adverse Event|146|||
126182455|NCT03820726|453953225|FG000|Overall Study|Not treated|1|||
126182456|NCT00345540|453953226|FG000|Overall Study|Withdrawal by Subject|1|||
126182457|NCT01406652|453953227|FG000|Overall Study|Lost-to-follow-up|3|||
126182458|NCT01406652|453953228|FG001|Overall Study|Lost-to-follow-up|4|||
126182459|NCT01406652|453953227|FG000|Overall Study|Withdrawal by Subject|2|||
126182460|NCT01406652|453953228|FG001|Overall Study|Withdrawal by Subject|2|||
126182461|NCT01406652|453953227|FG000|Overall Study|Insufficient follow-up|5|||
126182462|NCT01406652|453953228|FG001|Overall Study|Insufficient follow-up|4|||
126182463|NCT01406652|453953227|FG000|Overall Study|Infection not sure|10|||
126182464|NCT01406652|453953228|FG001|Overall Study|Infection not sure|10|||
126182465|NCT00141037|453953229|FG000|Overall Study|Physician Decision|1|||
126182466|NCT00141037|453953230|FG001|Overall Study|Physician Decision|2|||
126182467|NCT00141037|453953229|FG000|Overall Study|Lost to Follow-up|3|||
126182468|NCT00141037|453953230|FG001|Overall Study|Lost to Follow-up|1|||
126182469|NCT00141037|453953229|FG000|Overall Study|Protocol Violation|0|||
126182470|NCT00141037|453953230|FG001|Overall Study|Protocol Violation|2|||
126182471|NCT00141037|453953229|FG000|Overall Study|Withdrawal by Subject|2|||
126182472|NCT00141037|453953230|FG001|Overall Study|Withdrawal by Subject|1|||
126182473|NCT00141037|453953229|FG000|Overall Study|Other|0|||
126182474|NCT00141037|453953230|FG001|Overall Study|Other|1|||
126182475|NCT00141037|453953229|FG000|Overall Study|Moved from area|1|||
126182476|NCT00141037|453953230|FG001|Overall Study|Moved from area|7|||
126182477|NCT00141037|453953229|FG000|Overall Study|Graft Failure|3|||
126182478|NCT00141037|453953230|FG001|Overall Study|Graft Failure|4|||
126182479|NCT00260429|453953231|FG000|Overall Study|failure to follow appointments|1|||
126182480|NCT00260429|453953232|FG001|Overall Study|failure to follow appointments|0|||
126182481|NCT00260429|453953231|FG000|Overall Study|scheduled hand surgery|1|||
126182482|NCT00260429|453953232|FG001|Overall Study|scheduled hand surgery|0|||
126182483|NCT00861380|453953233|FG000|Overall Study|Withdrawal Information not recorded|8427|||
126182484|NCT00861380|453953234|FG001|Overall Study|Withdrawal Information not recorded|9112|||
126182485|NCT00861380|453953235|FG002|Overall Study|Withdrawal Information not recorded|8872|||
126182486|NCT00861380|453953236|FG003|Overall Study|Withdrawal Information not recorded|3689|||
126182487|NCT00861380|453953237|FG004|Overall Study|Withdrawal Information not recorded|1812|||
126182488|NCT00861380|453953238|FG005|Overall Study|Withdrawal Information not recorded|6249|||
126182489|NCT00861380|453953239|FG006|Overall Study|Withdrawal Information not recorded|3020|||
126182490|NCT00628758|453953240|FG000|Overall Study|Adverse Event|2|||
126182491|NCT00628758|453953241|FG001|Overall Study|Adverse Event|3|||
126182492|NCT00628758|453953240|FG000|Overall Study|Withdrawal by Subject|6|||
126182493|NCT00628758|453953241|FG001|Overall Study|Withdrawal by Subject|3|||
126182494|NCT00628758|453953240|FG000|Overall Study|Death|1|||
126182495|NCT00628758|453953241|FG001|Overall Study|Death|0|||
126182496|NCT00628758|453953240|FG000|Overall Study|Protocol Violation|5|||
126182497|NCT00628758|453953241|FG001|Overall Study|Protocol Violation|1|||
126182498|NCT00628758|453953240|FG000|Overall Study|Lost to Follow-up|25|||
126182499|NCT00628758|453953241|FG001|Overall Study|Lost to Follow-up|31|||
126182500|NCT00628758|453953240|FG000|Overall Study|Pregnancy|2|||
126182501|NCT00628758|453953241|FG001|Overall Study|Pregnancy|2|||
126182502|NCT00628758|453953240|FG000|Overall Study|Investigator Moved|3|||
126182503|NCT00628758|453953241|FG001|Overall Study|Investigator Moved|0|||
126182504|NCT00628758|453953240|FG000|Overall Study|Treatment Failure|0|||
126182505|NCT00628758|453953241|FG001|Overall Study|Treatment Failure|2|||
126182506|NCT00637377|453953242|FG000|Overall Study|Adverse Event|2|||
126182507|NCT00637377|453953243|FG001|Overall Study|Adverse Event|6|||
126182508|NCT00637377|453953244|FG002|Overall Study|Adverse Event|8|||
126182509|NCT00637377|453953245|FG003|Overall Study|Adverse Event|9|||
126182510|NCT00637377|453953242|FG000|Overall Study|Death|1|||
126182511|NCT00637377|453953243|FG001|Overall Study|Death|3|||
126182512|NCT00637377|453953244|FG002|Overall Study|Death|2|||
126182513|NCT00637377|453953245|FG003|Overall Study|Death|1|||
126182514|NCT00637377|453953242|FG000|Overall Study|Lack of Efficacy|0|||
126182515|NCT00637377|453953243|FG001|Overall Study|Lack of Efficacy|0|||
126182516|NCT00637377|453953244|FG002|Overall Study|Lack of Efficacy|1|||
126182517|NCT00637377|453953245|FG003|Overall Study|Lack of Efficacy|1|||
126182518|NCT00637377|453953242|FG000|Overall Study|Lost to Follow-up|4|||
126182519|NCT00637377|453953243|FG001|Overall Study|Lost to Follow-up|1|||
126182520|NCT00637377|453953244|FG002|Overall Study|Lost to Follow-up|2|||
126182521|NCT00637377|453953245|FG003|Overall Study|Lost to Follow-up|2|||
126182522|NCT00637377|453953242|FG000|Overall Study|Protocol Violation|2|||
126182523|NCT00637377|453953243|FG001|Overall Study|Protocol Violation|1|||
126182524|NCT00637377|453953244|FG002|Overall Study|Protocol Violation|1|||
126182525|NCT00637377|453953245|FG003|Overall Study|Protocol Violation|0|||
126182526|NCT00637377|453953242|FG000|Overall Study|Withdrawal by Subject|11|||
126182527|NCT00637377|453953243|FG001|Overall Study|Withdrawal by Subject|15|||
126182528|NCT00637377|453953244|FG002|Overall Study|Withdrawal by Subject|13|||
126182529|NCT00637377|453953245|FG003|Overall Study|Withdrawal by Subject|11|||
126182530|NCT00637377|453953242|FG000|Overall Study|Other (no further information available)|7|||
126182531|NCT00637377|453953243|FG001|Overall Study|Other (no further information available)|6|||
126182532|NCT00637377|453953244|FG002|Overall Study|Other (no further information available)|10|||
126182533|NCT00637377|453953245|FG003|Overall Study|Other (no further information available)|5|||
126182534|NCT01938001|453953246|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
126182535|NCT01938001|453953247|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
126182536|NCT01938001|453953246|FG000|Pre-Treatment|Death|1|||
126182537|NCT01938001|453953247|FG001|Pre-Treatment|Death|0|||
126182538|NCT01938001|453953246|FG000|Treatment|Death|2|||
126182539|NCT01938001|453953247|FG001|Treatment|Death|0|||
126182540|NCT01938001|453953246|FG000|Treatment|Adverse Event|14|||
126182541|NCT01938001|453953247|FG001|Treatment|Adverse Event|8|||
126182542|NCT01938001|453953246|FG000|Treatment|Progressive Disease|21|||
126182543|NCT01938001|453953247|FG001|Treatment|Progressive Disease|54|||
126182544|NCT01938001|453953246|FG000|Treatment|Withdrawal by Subject|13|||
126182545|NCT01938001|453953247|FG001|Treatment|Withdrawal by Subject|7|||
126182546|NCT01938001|453953246|FG000|Treatment|Other reasons|2|||
126182547|NCT01938001|453953247|FG001|Treatment|Other reasons|1|||
126182548|NCT01822223|453953248|FG000|Overall Study|Death|0|||
126182549|NCT01822223|453953249|FG001|Overall Study|Death|1|||
126182550|NCT02483078|453953256|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
126182551|NCT02483078|453953257|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
126182552|NCT02483078|453953256|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
126182553|NCT02483078|453953257|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
126182554|NCT02483078|453953256|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
126182555|NCT02483078|453953257|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
126182556|NCT02483078|453953256|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
126182557|NCT02483078|453953257|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
126182558|NCT02483078|453953256|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
126182559|NCT02483078|453953257|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
126182560|NCT02483078|453953256|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
126182561|NCT02483078|453953257|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
126182562|NCT04876599|453953258|FG000|Overall Study|Missed|2|||
126182563|NCT04876599|453953259|FG001|Overall Study|Missed|0|||
126182564|NCT04876599|453953258|FG000|Overall Study|Declined|2|||
126182565|NCT04876599|453953259|FG001|Overall Study|Declined|3|||
126182566|NCT03175562|453953260|FG000|Overall Study|Adverse Event|1|||
126182567|NCT03175562|453953260|FG000|Overall Study|Lost to Follow-up|3|||
126182568|NCT03175562|453953260|FG000|Overall Study|Withdrawal by Subject|7|||
126182569|NCT03175562|453953260|FG000|Overall Study|Other (Not Specified)|5|||
126182570|NCT02146833|453953261|FG000|Overall Study|Death|10|||
126182571|NCT02146833|453953261|FG000|Overall Study|No longer consented to study treatment|1|||
126182572|NCT01410799|453953263|FG000|Overall Study|PI decision|13|||
126182573|NCT04126031|453953265|FG000|Part A|Withdrawal by Subject|0|||
126182574|NCT04126031|453953266|FG001|Part A|Withdrawal by Subject|0|||
126182575|NCT04126031|453953267|FG002|Part A|Withdrawal by Subject|1|||
126182576|NCT04126031|453953268|FG003|Part A|Withdrawal by Subject|0|||
126182577|NCT04126031|453953269|FG004|Part A|Withdrawal by Subject|0|||
126182578|NCT04126031|453953270|FG005|Part A|Withdrawal by Subject|0|||
126182579|NCT04126031|453953265|FG000|Part A|Other|1|||
126182580|NCT04126031|453953266|FG001|Part A|Other|0|||
126182581|NCT04126031|453953267|FG002|Part A|Other|0|||
126182582|NCT04126031|453953268|FG003|Part A|Other|0|||
126182583|NCT04126031|453953269|FG004|Part A|Other|0|||
126182584|NCT04126031|453953270|FG005|Part A|Other|0|||
126182585|NCT04126031|453953265|FG000|Part B|Adverse Event|0|||
126182586|NCT04126031|453953266|FG001|Part B|Adverse Event|0|||
126182587|NCT04126031|453953267|FG002|Part B|Adverse Event|0|||
126182588|NCT04126031|453953268|FG003|Part B|Adverse Event|0|||
126182589|NCT04126031|453953269|FG004|Part B|Adverse Event|0|||
126182590|NCT04126031|453953270|FG005|Part B|Adverse Event|2|||
126182591|NCT04126031|453953265|FG000|Part B|Pre-existing hypertransaminasemia|0|||
126182592|NCT04126031|453953266|FG001|Part B|Pre-existing hypertransaminasemia|0|||
126182593|NCT04126031|453953267|FG002|Part B|Pre-existing hypertransaminasemia|0|||
126182594|NCT04126031|453953268|FG003|Part B|Pre-existing hypertransaminasemia|0|||
126182595|NCT04126031|453953269|FG004|Part B|Pre-existing hypertransaminasemia|1|||
126182596|NCT04126031|453953270|FG005|Part B|Pre-existing hypertransaminasemia|0|||
126182597|NCT00617656|453953271|FG000|Overall Study|Inclusion error|4|||
126182598|NCT00617656|453953272|FG001|Overall Study|Inclusion error|4|||
126182599|NCT00617656|453953273|FG002|Overall Study|Inclusion error|0|||
126182600|NCT00617656|453953274|FG003|Overall Study|Inclusion error|0|||
126182601|NCT00617656|453953271|FG000|Overall Study|Missing data|44|||
126182602|NCT00617656|453953272|FG001|Overall Study|Missing data|30|||
126182603|NCT00617656|453953273|FG002|Overall Study|Missing data|13|||
126182604|NCT00617656|453953274|FG003|Overall Study|Missing data|6|||
126182605|NCT00617656|453953271|FG000|Overall Study|Withdrawal by Subject|0|||
126182606|NCT00617656|453953272|FG001|Overall Study|Withdrawal by Subject|2|||
126182607|NCT00617656|453953273|FG002|Overall Study|Withdrawal by Subject|0|||
126182608|NCT00617656|453953274|FG003|Overall Study|Withdrawal by Subject|0|||
126182609|NCT00131664|453953275|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
126182610|NCT00131664|453953276|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
126182611|NCT00131664|453953277|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
126182612|NCT00131664|453953278|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
126182613|NCT00131664|453953279|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
126182614|NCT00131664|453953280|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
126182615|NCT00131664|453953275|FG000|First Period (First 6 Months)|Death|0|||
126182616|NCT00131664|453953276|FG001|First Period (First 6 Months)|Death|1|||
126182617|NCT00131664|453953277|FG002|First Period (First 6 Months)|Death|0|||
126182618|NCT00131664|453953278|FG003|First Period (First 6 Months)|Death|0|||
126182619|NCT00131664|453953279|FG004|First Period (First 6 Months)|Death|0|||
126182620|NCT00131664|453953280|FG005|First Period (First 6 Months)|Death|0|||
126182621|NCT00131664|453953275|FG000|First Period (First 6 Months)|Protocol Violation|2|||
126182622|NCT00131664|453953276|FG001|First Period (First 6 Months)|Protocol Violation|2|||
126182623|NCT00131664|453953277|FG002|First Period (First 6 Months)|Protocol Violation|1|||
126182624|NCT00131664|453953278|FG003|First Period (First 6 Months)|Protocol Violation|0|||
126182625|NCT00131664|453953279|FG004|First Period (First 6 Months)|Protocol Violation|0|||
126182626|NCT00131664|453953280|FG005|First Period (First 6 Months)|Protocol Violation|0|||
126182627|NCT00131664|453953275|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
126182628|NCT00131664|453953276|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
126182629|NCT00131664|453953277|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
126182630|NCT00131664|453953278|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
126182631|NCT00131664|453953279|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
126182632|NCT00131664|453953280|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
126182633|NCT00131664|453953275|FG000|First Period (First 6 Months)|Adverse Event|9|||
126182634|NCT00131664|453953276|FG001|First Period (First 6 Months)|Adverse Event|4|||
126182635|NCT00131664|453953277|FG002|First Period (First 6 Months)|Adverse Event|5|||
126182636|NCT00131664|453953278|FG003|First Period (First 6 Months)|Adverse Event|0|||
126182637|NCT00131664|453953279|FG004|First Period (First 6 Months)|Adverse Event|0|||
126182638|NCT00131664|453953280|FG005|First Period (First 6 Months)|Adverse Event|0|||
126182639|NCT00131664|453953275|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
126182640|NCT00131664|453953276|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
126182641|NCT00131664|453953277|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
126182642|NCT00131664|453953278|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
126182643|NCT00131664|453953279|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
126182644|NCT00131664|453953280|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
126182645|NCT00131664|453953275|FG000|First Period (First 6 Months)|Administrative reasons|2|||
126182646|NCT00131664|453953276|FG001|First Period (First 6 Months)|Administrative reasons|0|||
126182647|NCT00131664|453953277|FG002|First Period (First 6 Months)|Administrative reasons|5|||
126182648|NCT00131664|453953278|FG003|First Period (First 6 Months)|Administrative reasons|0|||
126182649|NCT00131664|453953279|FG004|First Period (First 6 Months)|Administrative reasons|0|||
126182650|NCT00131664|453953280|FG005|First Period (First 6 Months)|Administrative reasons|0|||
126182651|NCT00131664|453953275|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
126182652|NCT00131664|453953276|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
126182653|NCT00131664|453953277|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
126182654|NCT00131664|453953278|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
126182655|NCT00131664|453953279|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
126182656|NCT00131664|453953280|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
126182657|NCT00131664|453953275|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
126182658|NCT00131664|453953276|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
126182659|NCT00131664|453953277|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
126182660|NCT00131664|453953278|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
126182661|NCT00131664|453953279|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
126182662|NCT00131664|453953280|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
126182663|NCT00131664|453953275|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
126182664|NCT00131664|453953276|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126182665|NCT00131664|453953277|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126182666|NCT00131664|453953278|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126182667|NCT00131664|453953279|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126182668|NCT00131664|453953280|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126182669|NCT00131664|453953275|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
126182670|NCT00131664|453953276|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
126182671|NCT00131664|453953277|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
126182672|NCT00131664|453953278|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
126182673|NCT00131664|453953279|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
126182674|NCT00131664|453953280|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
126182675|NCT00131664|453953275|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126182676|NCT00131664|453953276|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126182677|NCT00131664|453953277|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126182678|NCT00131664|453953278|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
126182679|NCT00131664|453953279|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126182680|NCT00131664|453953280|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126182681|NCT00131664|453953275|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
126182682|NCT00131664|453953276|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
126182683|NCT00131664|453953277|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
126182684|NCT00131664|453953278|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
126182685|NCT00131664|453953279|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
126182686|NCT00131664|453953280|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
126182687|NCT02688153|453954919|FG000|Overall Study|Death|7|||
126182688|NCT02688153|453954920|FG001|Overall Study|Death|5|||
126182689|NCT02688153|453954919|FG000|Overall Study|Withdrawal by Subject|4|||
126182690|NCT02688153|453954920|FG001|Overall Study|Withdrawal by Subject|2|||
126182691|NCT02688153|453954919|FG000|Overall Study|Valve Explant|1|||
126182692|NCT02688153|453954920|FG001|Overall Study|Valve Explant|0|||
126182693|NCT02688153|453954919|FG000|Overall Study|Conversion to Commercial Valve|3|||
126182694|NCT02688153|453954920|FG001|Overall Study|Conversion to Commercial Valve|0|||
126182695|NCT03682055|453954921|FG000|Overall Study|Lack of Efficacy|1|||
126182696|NCT03682055|453954922|FG001|Overall Study|Lack of Efficacy|2|||
126182697|NCT03682055|453954923|FG002|Overall Study|Lack of Efficacy|1|||
126182698|NCT03682055|453954924|FG003|Overall Study|Lack of Efficacy|2|||
126182699|NCT03682055|453954925|FG004|Overall Study|Lack of Efficacy|1|||
126182700|NCT03682055|453954926|FG005|Overall Study|Lack of Efficacy|3|||
126182701|NCT03682055|453954921|FG000|Overall Study|Withdrawal by Subject|0|||
126182702|NCT03682055|453954922|FG001|Overall Study|Withdrawal by Subject|0|||
126182703|NCT03682055|453954923|FG002|Overall Study|Withdrawal by Subject|0|||
126182704|NCT03682055|453954924|FG003|Overall Study|Withdrawal by Subject|0|||
126182705|NCT03682055|453954925|FG004|Overall Study|Withdrawal by Subject|0|||
126182706|NCT03682055|453954926|FG005|Overall Study|Withdrawal by Subject|1|||
126182707|NCT03682055|453954921|FG000|Overall Study|Termination of Study by Sponsor|0|||
126182708|NCT03682055|453954922|FG001|Overall Study|Termination of Study by Sponsor|0|||
126182709|NCT03682055|453954923|FG002|Overall Study|Termination of Study by Sponsor|0|||
126182710|NCT03682055|453954924|FG003|Overall Study|Termination of Study by Sponsor|0|||
126182711|NCT03682055|453954925|FG004|Overall Study|Termination of Study by Sponsor|0|||
126182712|NCT03682055|453954926|FG005|Overall Study|Termination of Study by Sponsor|3|||
126182713|NCT01135394|453954927|FG000|Screening|Lost to Follow-up|2|||
126182714|NCT01135394|453954927|FG000|Screening|Withdrawal by Subject|10|||
126182715|NCT01135394|453954927|FG000|Screening|Screening failure|16|||
126182716|NCT01135394|453954927|FG000|Screening|Physician Decision|5|||
126182717|NCT01135394|453954927|FG000|Baseline Assessment|Withdrawal by Subject|9|||
126182718|NCT01135394|453954927|FG000|Baseline Assessment|Physician Decision|3|||
126182719|NCT01135394|453954927|FG000|Baseline Assessment|Lost to Follow-up|2|||
126182720|NCT01135394|453954927|FG000|Baseline Assessment|Adverse Event|1|||
126182721|NCT01135394|453954927|FG000|Study Treatment|Withdrawal by Subject|1|||
126182722|NCT01135394|453954927|FG000|Study Treatment|Physician Decision|1|||
126182723|NCT01135394|453954927|FG000|Study Treatment|Adverse Event|2|||
126182724|NCT00462488|453954928|FG000|Overall Study|Protocol Violation|1|||
126182725|NCT00462488|453954929|FG001|Overall Study|Protocol Violation|0|||
126182726|NCT00462488|453954928|FG000|Overall Study|Lack of Efficacy|19|||
126182727|NCT00462488|453954929|FG001|Overall Study|Lack of Efficacy|17|||
126182728|NCT02940860|453954935|FG000|Overall Study|Non-serious AE|1|||
126182729|NCT02940860|453954936|FG001|Overall Study|Non-serious AE|2|||
126182730|NCT02940860|453954935|FG000|Overall Study|Serious AE|7|||
126182731|NCT02940860|453954936|FG001|Overall Study|Serious AE|3|||
126182732|NCT02940860|453954935|FG000|Overall Study|Withdrawal by Subject|19|||
126182733|NCT02940860|453954936|FG001|Overall Study|Withdrawal by Subject|9|||
126182734|NCT02940860|453954935|FG000|Overall Study|Lost to Follow-up|13|||
126182735|NCT02940860|453954936|FG001|Overall Study|Lost to Follow-up|7|||
126182736|NCT02940860|453954935|FG000|Overall Study|Physician Decision|5|||
126182737|NCT02940860|453954936|FG001|Overall Study|Physician Decision|3|||
126182738|NCT02940860|453954935|FG000|Overall Study|Sponsor Decision|0|||
126182739|NCT02940860|453954936|FG001|Overall Study|Sponsor Decision|1|||
126182740|NCT02940860|453954935|FG000|Overall Study|Protocol Violation|0|||
126182741|NCT02940860|453954936|FG001|Overall Study|Protocol Violation|2|||
126182742|NCT02940860|453954935|FG000|Overall Study|Death|3|||
126182743|NCT02940860|453954936|FG001|Overall Study|Death|2|||
126182744|NCT02940860|453954935|FG000|Overall Study|Moved, poor venous access, transport|6|||
126182745|NCT02940860|453954936|FG001|Overall Study|Moved, poor venous access, transport|4|||
126182746|NCT02940860|453954935|FG000|Overall Study|Not treated|2|||
126182747|NCT02940860|453954936|FG001|Overall Study|Not treated|2|||
126182748|NCT04914819|453954937|FG000|Overall Study|Pregnancy|3|||
126182749|NCT04914819|453954938|FG001|Overall Study|Pregnancy|1|||
126182750|NCT04914819|453954937|FG000|Overall Study|Discontinued study|4|||
126182751|NCT04914819|453954938|FG001|Overall Study|Discontinued study|1|||
126182752|NCT04914819|453954937|FG000|Overall Study|Lost to Follow-up|7|||
126182753|NCT04914819|453954938|FG001|Overall Study|Lost to Follow-up|0|||
126182754|NCT02715804|453954939|FG000|Overall Study|Death|222|||
126182755|NCT02715804|453954940|FG001|Overall Study|Death|106|||
126182756|NCT02715804|453954939|FG000|Overall Study|Withdrawal by Subject|5|||
126182757|NCT02715804|453954940|FG001|Overall Study|Withdrawal by Subject|4|||
126182758|NCT02715804|453954939|FG000|Overall Study|Other than specified|2|||
126182759|NCT02715804|453954940|FG001|Overall Study|Other than specified|3|||
126182760|NCT04038385|453954941|FG000|Overall Study|Completed baseline assessment only|7|||
126182761|NCT04038385|453954942|FG001|Overall Study|Completed baseline assessment only|4|||
126182762|NCT04038385|453954941|FG000|Overall Study|Moved out of area|4|||
126182763|NCT04038385|453954942|FG001|Overall Study|Moved out of area|2|||
126182764|NCT04038385|453954941|FG000|Overall Study|Discontinued study involvement|6|||
126182765|NCT04038385|453954942|FG001|Overall Study|Discontinued study involvement|1|||
126182766|NCT00948194|453954945|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
126182767|NCT00948194|453954946|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
126182768|NCT00233324|453954947|FG000|Main Study|Death|68|||
126182769|NCT00233324|453954948|FG001|Main Study|Death|60|||
126182770|NCT00233324|453954949|FG002|Main Study|Death|62|||
126182771|NCT00233324|453954950|FG003|Main Study|Death|47|||
126182772|NCT00233324|453954947|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
126182773|NCT00233324|453954948|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
126182774|NCT00233324|453954949|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
126182775|NCT00233324|453954950|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
126182776|NCT00233324|453954947|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
126182777|NCT00233324|453954948|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
126182778|NCT00233324|453954949|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
126182779|NCT00233324|453954950|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
126182780|NCT02657434|453954957|FG000|Overall Study|Study Terminated By Sponsor|64|||
126182781|NCT02657434|453954958|FG001|Overall Study|Study Terminated By Sponsor|82|||
126182782|NCT02657434|453954957|FG000|Overall Study|Death|189|||
126182783|NCT02657434|453954958|FG001|Overall Study|Death|190|||
126182784|NCT02657434|453954957|FG000|Overall Study|Lost to Follow-up|2|||
126182785|NCT02657434|453954958|FG001|Overall Study|Lost to Follow-up|2|||
126182786|NCT02657434|453954957|FG000|Overall Study|Randomization by Error|2|||
126182787|NCT02657434|453954958|FG001|Overall Study|Randomization by Error|0|||
126182788|NCT02657434|453954957|FG000|Overall Study|Withdrawal by Subject|28|||
126182789|NCT02657434|453954958|FG001|Overall Study|Withdrawal by Subject|17|||
126182790|NCT02657434|453954957|FG000|Overall Study|Protocol Violation|1|||
126182791|NCT02657434|453954958|FG001|Overall Study|Protocol Violation|0|||
126182792|NCT02657434|453954957|FG000|Overall Study|Physician Decision|0|||
126182793|NCT02657434|453954958|FG001|Overall Study|Physician Decision|1|||
126182794|NCT00608881|453954959|FG000|Overall Study|Death|22|||
126182795|NCT00608881|453954960|FG001|Overall Study|Death|13|||
126182796|NCT00608881|453954959|FG000|Overall Study|Adverse Event|5|||
126182797|NCT00608881|453954960|FG001|Overall Study|Adverse Event|3|||
126182798|NCT00608881|453954959|FG000|Overall Study|Lost to Follow-up|28|||
126182799|NCT00608881|453954960|FG001|Overall Study|Lost to Follow-up|14|||
126182800|NCT00608881|453954959|FG000|Overall Study|Withdrawal by Subject|18|||
126182801|NCT00608881|453954960|FG001|Overall Study|Withdrawal by Subject|29|||
126182802|NCT00608881|453954959|FG000|Overall Study|Physician Decision|5|||
126182803|NCT00608881|453954960|FG001|Overall Study|Physician Decision|5|||
126182804|NCT00608881|453954959|FG000|Overall Study|Institutionalized|1|||
126182805|NCT00608881|453954960|FG001|Overall Study|Institutionalized|2|||
126182806|NCT01998958|453954963|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182807|NCT01998958|453954964|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
126182808|NCT01998958|453954965|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182809|NCT01998958|453954966|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182810|NCT01998958|453954967|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182811|NCT01998958|453954968|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182812|NCT01998958|453954969|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182813|NCT01998958|453954970|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182814|NCT01998958|453954971|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182815|NCT01998958|453954972|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182816|NCT01998958|453954973|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182817|NCT01998958|453954974|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182818|NCT01998958|453954975|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182819|NCT01998958|453954976|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182820|NCT01998958|453954977|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182821|NCT01998958|453954978|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182822|NCT01998958|453954979|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182823|NCT01998958|453954980|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182824|NCT01998958|453954981|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182825|NCT01998958|453954982|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182826|NCT01998958|453954983|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182827|NCT01998958|453954984|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182828|NCT01998958|453954985|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182829|NCT01998958|453954986|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182830|NCT01998958|453954987|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182831|NCT01998958|453954988|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182832|NCT01998958|453954989|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182833|NCT01998958|453954990|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182834|NCT01998958|453954991|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182835|NCT01998958|453954992|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182836|NCT01998958|453954993|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182837|NCT01998958|453954994|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126182838|NCT01998958|453954963|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182839|NCT01998958|453954964|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
126182840|NCT01998958|453954965|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182841|NCT01998958|453954966|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182842|NCT01998958|453954967|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182843|NCT01998958|453954968|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182844|NCT01998958|453954969|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182845|NCT01998958|453954970|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182846|NCT01998958|453954971|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182847|NCT01998958|453954972|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182848|NCT01998958|453954973|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182849|NCT01998958|453954974|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182850|NCT01998958|453954975|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182851|NCT01998958|453954976|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182852|NCT01998958|453954977|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182853|NCT01998958|453954978|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182854|NCT01998958|453954979|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182855|NCT01998958|453954980|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182856|NCT01998958|453954981|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182857|NCT01998958|453954982|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182858|NCT01998958|453954983|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182859|NCT01998958|453954984|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182860|NCT01998958|453954985|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182861|NCT01998958|453954986|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182862|NCT01998958|453954987|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182863|NCT01998958|453954988|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182864|NCT01998958|453954989|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182865|NCT01998958|453954990|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182866|NCT01998958|453954991|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182867|NCT01998958|453954992|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182868|NCT01998958|453954993|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182869|NCT01998958|453954994|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126182870|NCT01998958|453954963|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
126182871|NCT01998958|453954964|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
126182872|NCT01998958|453954965|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
126182873|NCT01998958|453954966|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
126182874|NCT01998958|453954967|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
126182875|NCT01998958|453954968|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
126182876|NCT01998958|453954969|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
126182877|NCT01998958|453954970|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
126182878|NCT01998958|453954971|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
126182879|NCT01998958|453954972|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
126182880|NCT01998958|453954973|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
126182881|NCT01998958|453954974|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
126182882|NCT01998958|453954975|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
126182883|NCT01998958|453954976|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
126182884|NCT01998958|453954977|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
126182885|NCT01998958|453954978|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
126182886|NCT01998958|453954979|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
126182887|NCT01998958|453954980|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
126182888|NCT01998958|453954981|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
126182889|NCT01998958|453954982|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
126182890|NCT01998958|453954983|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
126182891|NCT01998958|453954984|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
126182892|NCT01998958|453954985|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
126182893|NCT01998958|453954986|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
126182894|NCT01998958|453954987|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
126182895|NCT01998958|453954988|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
126182896|NCT01998958|453954989|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
126182897|NCT01998958|453954990|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
126182898|NCT01998958|453954991|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
126182899|NCT01998958|453954992|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
126182900|NCT01998958|453954993|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
126182901|NCT01998958|453954994|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
126182902|NCT01998958|453954963|FG000|Period 1 (Panel A and B)|Other|1|||
126182903|NCT01998958|453954964|FG001|Period 1 (Panel A and B)|Other|0|||
126182904|NCT01998958|453954965|FG002|Period 1 (Panel A and B)|Other|0|||
126182905|NCT01998958|453954966|FG003|Period 1 (Panel A and B)|Other|0|||
126182906|NCT01998958|453954967|FG004|Period 1 (Panel A and B)|Other|0|||
126182907|NCT01998958|453954968|FG005|Period 1 (Panel A and B)|Other|0|||
126182908|NCT01998958|453954969|FG006|Period 1 (Panel A and B)|Other|0|||
126182909|NCT01998958|453954970|FG007|Period 1 (Panel A and B)|Other|0|||
126182910|NCT01998958|453954971|FG008|Period 1 (Panel A and B)|Other|0|||
126182911|NCT01998958|453954972|FG009|Period 1 (Panel A and B)|Other|0|||
126182912|NCT01998958|453954973|FG010|Period 1 (Panel A and B)|Other|0|||
126182913|NCT01998958|453954974|FG011|Period 1 (Panel A and B)|Other|0|||
126182914|NCT01998958|453954975|FG012|Period 1 (Panel A and B)|Other|0|||
126182915|NCT01998958|453954976|FG013|Period 1 (Panel A and B)|Other|0|||
126182916|NCT01998958|453954977|FG014|Period 1 (Panel A and B)|Other|0|||
126182917|NCT01998958|453954978|FG015|Period 1 (Panel A and B)|Other|0|||
126182918|NCT01998958|453954979|FG016|Period 1 (Panel A and B)|Other|0|||
126182919|NCT01998958|453954980|FG017|Period 1 (Panel A and B)|Other|0|||
126182920|NCT01998958|453954981|FG018|Period 1 (Panel A and B)|Other|0|||
126182921|NCT01998958|453954982|FG019|Period 1 (Panel A and B)|Other|0|||
126182922|NCT01998958|453954983|FG020|Period 1 (Panel A and B)|Other|0|||
126182923|NCT01998958|453954984|FG021|Period 1 (Panel A and B)|Other|0|||
126182924|NCT01998958|453954985|FG022|Period 1 (Panel A and B)|Other|0|||
126182925|NCT01998958|453954986|FG023|Period 1 (Panel A and B)|Other|0|||
126182926|NCT01998958|453954987|FG024|Period 1 (Panel A and B)|Other|0|||
126182927|NCT01998958|453954988|FG025|Period 1 (Panel A and B)|Other|0|||
126182928|NCT01998958|453954989|FG026|Period 1 (Panel A and B)|Other|0|||
126182929|NCT01998958|453954990|FG027|Period 1 (Panel A and B)|Other|0|||
126182930|NCT01998958|453954991|FG028|Period 1 (Panel A and B)|Other|0|||
126182931|NCT01998958|453954992|FG029|Period 1 (Panel A and B)|Other|0|||
126182932|NCT01998958|453954993|FG030|Period 1 (Panel A and B)|Other|0|||
126182933|NCT01998958|453954994|FG031|Period 1 (Panel A and B)|Other|0|||
126182934|NCT01998958|453954963|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
126182935|NCT01998958|453954964|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
126182936|NCT01998958|453954965|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
126182937|NCT01998958|453954966|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
126182938|NCT01998958|453954967|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
126182939|NCT01998958|453954968|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
126182940|NCT01998958|453954969|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
126182941|NCT01998958|453954970|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
126182942|NCT01998958|453954971|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
126182943|NCT01998958|453954972|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
126182944|NCT01998958|453954973|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
126182945|NCT01998958|453954974|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
126182946|NCT01998958|453954975|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
126182947|NCT01998958|453954976|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
126182948|NCT01998958|453954977|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
126182949|NCT01998958|453954978|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
126182950|NCT01998958|453954979|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
126182951|NCT01998958|453954980|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
126182952|NCT01998958|453954981|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
126182953|NCT01998958|453954982|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
126182954|NCT01998958|453954983|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
126182955|NCT01998958|453954984|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
126182956|NCT01998958|453954985|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
126182957|NCT01998958|453954986|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
126182958|NCT01998958|453954987|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
126182959|NCT01998958|453954988|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
126182960|NCT01998958|453954989|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
126182961|NCT01998958|453954990|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
126182962|NCT01998958|453954991|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
126182963|NCT01998958|453954992|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
126182964|NCT01998958|453954993|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
126182965|NCT01998958|453954994|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
126182966|NCT01998958|453954963|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182967|NCT01998958|453954964|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182968|NCT01998958|453954965|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182969|NCT01998958|453954966|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182970|NCT01998958|453954967|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182971|NCT01998958|453954968|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182972|NCT01998958|453954969|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182973|NCT01998958|453954970|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182974|NCT01998958|453954971|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182975|NCT01998958|453954972|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182976|NCT01998958|453954973|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182977|NCT01998958|453954974|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182978|NCT01998958|453954975|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182979|NCT01998958|453954976|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182980|NCT01998958|453954977|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
126182981|NCT01998958|453954978|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182982|NCT01998958|453954979|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182983|NCT01998958|453954980|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182984|NCT01998958|453954981|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
126182985|NCT01998958|453954982|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182986|NCT01998958|453954983|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182987|NCT01998958|453954984|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182988|NCT01998958|453954985|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182989|NCT01998958|453954986|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182990|NCT01998958|453954987|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182991|NCT01998958|453954988|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182992|NCT01998958|453954989|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182993|NCT01998958|453954990|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182994|NCT01998958|453954991|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182995|NCT01998958|453954992|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182996|NCT01998958|453954993|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182997|NCT01998958|453954994|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126182998|NCT01998958|453954963|FG000|Open Label Phase (Optional)|Adverse Event|0|||
126182999|NCT01998958|453954964|FG001|Open Label Phase (Optional)|Adverse Event|0|||
126183000|NCT01998958|453954965|FG002|Open Label Phase (Optional)|Adverse Event|0|||
126183001|NCT01998958|453954966|FG003|Open Label Phase (Optional)|Adverse Event|0|||
126183002|NCT01998958|453954967|FG004|Open Label Phase (Optional)|Adverse Event|0|||
126183003|NCT01998958|453954968|FG005|Open Label Phase (Optional)|Adverse Event|0|||
126183004|NCT01998958|453954969|FG006|Open Label Phase (Optional)|Adverse Event|0|||
126183005|NCT01998958|453954970|FG007|Open Label Phase (Optional)|Adverse Event|0|||
126183006|NCT01998958|453954971|FG008|Open Label Phase (Optional)|Adverse Event|0|||
126183007|NCT01998958|453954972|FG009|Open Label Phase (Optional)|Adverse Event|0|||
126183008|NCT01998958|453954973|FG010|Open Label Phase (Optional)|Adverse Event|0|||
126183009|NCT01998958|453954974|FG011|Open Label Phase (Optional)|Adverse Event|0|||
126183010|NCT01998958|453954975|FG012|Open Label Phase (Optional)|Adverse Event|0|||
126183011|NCT01998958|453954976|FG013|Open Label Phase (Optional)|Adverse Event|0|||
126183012|NCT01998958|453954977|FG014|Open Label Phase (Optional)|Adverse Event|0|||
126183013|NCT01998958|453954978|FG015|Open Label Phase (Optional)|Adverse Event|0|||
126183014|NCT01998958|453954979|FG016|Open Label Phase (Optional)|Adverse Event|0|||
126183015|NCT01998958|453954980|FG017|Open Label Phase (Optional)|Adverse Event|0|||
126183016|NCT01998958|453954981|FG018|Open Label Phase (Optional)|Adverse Event|0|||
126183017|NCT01998958|453954982|FG019|Open Label Phase (Optional)|Adverse Event|0|||
126183018|NCT01998958|453954983|FG020|Open Label Phase (Optional)|Adverse Event|0|||
126183019|NCT01998958|453954984|FG021|Open Label Phase (Optional)|Adverse Event|0|||
126183020|NCT01998958|453954985|FG022|Open Label Phase (Optional)|Adverse Event|0|||
126183021|NCT01998958|453954986|FG023|Open Label Phase (Optional)|Adverse Event|1|||
126183022|NCT01998958|453954987|FG024|Open Label Phase (Optional)|Adverse Event|0|||
126183023|NCT01998958|453954988|FG025|Open Label Phase (Optional)|Adverse Event|0|||
126183024|NCT01998958|453954989|FG026|Open Label Phase (Optional)|Adverse Event|0|||
126183025|NCT01998958|453954990|FG027|Open Label Phase (Optional)|Adverse Event|0|||
126183026|NCT01998958|453954991|FG028|Open Label Phase (Optional)|Adverse Event|0|||
126183027|NCT01998958|453954992|FG029|Open Label Phase (Optional)|Adverse Event|0|||
126183028|NCT01998958|453954993|FG030|Open Label Phase (Optional)|Adverse Event|0|||
126183029|NCT01998958|453954994|FG031|Open Label Phase (Optional)|Adverse Event|0|||
126183030|NCT01998958|453954963|FG000|Open Label Phase (Optional)|Other|0|||
126183031|NCT01998958|453954964|FG001|Open Label Phase (Optional)|Other|0|||
126183032|NCT01998958|453954965|FG002|Open Label Phase (Optional)|Other|0|||
126183033|NCT01998958|453954966|FG003|Open Label Phase (Optional)|Other|0|||
126183034|NCT01998958|453954967|FG004|Open Label Phase (Optional)|Other|0|||
126183035|NCT01998958|453954968|FG005|Open Label Phase (Optional)|Other|0|||
126183036|NCT01998958|453954969|FG006|Open Label Phase (Optional)|Other|0|||
126183037|NCT01998958|453954970|FG007|Open Label Phase (Optional)|Other|0|||
126183038|NCT01998958|453954971|FG008|Open Label Phase (Optional)|Other|0|||
126183039|NCT01998958|453954972|FG009|Open Label Phase (Optional)|Other|0|||
126183040|NCT01998958|453954973|FG010|Open Label Phase (Optional)|Other|0|||
126183041|NCT01998958|453954974|FG011|Open Label Phase (Optional)|Other|0|||
126183042|NCT01998958|453954975|FG012|Open Label Phase (Optional)|Other|0|||
126183043|NCT01998958|453954976|FG013|Open Label Phase (Optional)|Other|0|||
126183044|NCT01998958|453954977|FG014|Open Label Phase (Optional)|Other|0|||
126183045|NCT01998958|453954978|FG015|Open Label Phase (Optional)|Other|0|||
126183046|NCT01998958|453954979|FG016|Open Label Phase (Optional)|Other|0|||
126183047|NCT01998958|453954980|FG017|Open Label Phase (Optional)|Other|0|||
126183048|NCT01998958|453954981|FG018|Open Label Phase (Optional)|Other|0|||
126183049|NCT01998958|453954982|FG019|Open Label Phase (Optional)|Other|0|||
126183050|NCT01998958|453954983|FG020|Open Label Phase (Optional)|Other|0|||
126183051|NCT01998958|453954984|FG021|Open Label Phase (Optional)|Other|0|||
126183052|NCT01998958|453954985|FG022|Open Label Phase (Optional)|Other|5|||
126183053|NCT01998958|453954986|FG023|Open Label Phase (Optional)|Other|1|||
126183054|NCT01998958|453954987|FG024|Open Label Phase (Optional)|Other|0|||
126183055|NCT01998958|453954988|FG025|Open Label Phase (Optional)|Other|0|||
126183056|NCT01998958|453954989|FG026|Open Label Phase (Optional)|Other|0|||
126183057|NCT01998958|453954990|FG027|Open Label Phase (Optional)|Other|0|||
126183058|NCT01998958|453954991|FG028|Open Label Phase (Optional)|Other|0|||
126183059|NCT01998958|453954992|FG029|Open Label Phase (Optional)|Other|0|||
126183060|NCT01998958|453954993|FG030|Open Label Phase (Optional)|Other|0|||
126183061|NCT01998958|453954994|FG031|Open Label Phase (Optional)|Other|0|||
126183062|NCT01998958|453954963|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183063|NCT01998958|453954964|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183064|NCT01998958|453954965|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183065|NCT01998958|453954966|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183066|NCT01998958|453954967|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183067|NCT01998958|453954968|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183068|NCT01998958|453954969|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183069|NCT01998958|453954970|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183070|NCT01998958|453954971|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183071|NCT01998958|453954972|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183072|NCT01998958|453954973|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183073|NCT01998958|453954974|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183074|NCT01998958|453954975|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183075|NCT01998958|453954976|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183076|NCT01998958|453954977|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183077|NCT01998958|453954978|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183078|NCT01998958|453954979|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183079|NCT01998958|453954980|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183080|NCT01998958|453954981|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183081|NCT01998958|453954982|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183082|NCT01998958|453954983|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183083|NCT01998958|453954984|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183084|NCT01998958|453954985|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
126183085|NCT01998958|453954986|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183086|NCT01998958|453954987|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183087|NCT01998958|453954988|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183088|NCT01998958|453954989|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183089|NCT01998958|453954990|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183090|NCT01998958|453954991|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183091|NCT01998958|453954992|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183092|NCT01998958|453954993|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183093|NCT01998958|453954994|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
126183094|NCT01998958|453954963|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183095|NCT01998958|453954964|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183096|NCT01998958|453954965|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183097|NCT01998958|453954966|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183098|NCT01998958|453954967|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183099|NCT01998958|453954968|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183100|NCT01998958|453954969|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183101|NCT01998958|453954970|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183102|NCT01998958|453954971|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183103|NCT01998958|453954972|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183104|NCT01998958|453954973|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183105|NCT01998958|453954974|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183106|NCT01998958|453954975|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183107|NCT01998958|453954976|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183108|NCT01998958|453954977|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183109|NCT01998958|453954978|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183110|NCT01998958|453954979|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183111|NCT01998958|453954980|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183112|NCT01998958|453954981|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183113|NCT01998958|453954982|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183114|NCT01998958|453954983|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183115|NCT01998958|453954984|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
126183116|NCT01998958|453954985|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
126183117|NCT01998958|453954986|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183118|NCT01998958|453954987|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183119|NCT01998958|453954988|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183120|NCT01998958|453954989|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183121|NCT01998958|453954990|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183122|NCT01998958|453954991|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183123|NCT01998958|453954992|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183124|NCT01998958|453954993|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183125|NCT01998958|453954994|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
126183126|NCT01998958|453954963|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183127|NCT01998958|453954964|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183128|NCT01998958|453954965|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183129|NCT01998958|453954966|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183130|NCT01998958|453954967|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183131|NCT01998958|453954968|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183132|NCT01998958|453954969|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183133|NCT01998958|453954970|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183134|NCT01998958|453954971|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183135|NCT01998958|453954972|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183136|NCT01998958|453954973|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183137|NCT01998958|453954974|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183138|NCT01998958|453954975|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183139|NCT01998958|453954976|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183140|NCT01998958|453954977|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183141|NCT01998958|453954978|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183142|NCT01998958|453954979|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183143|NCT01998958|453954980|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183144|NCT01998958|453954981|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183145|NCT01998958|453954982|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183146|NCT01998958|453954983|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183147|NCT01998958|453954984|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
126183148|NCT01998958|453954985|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
126183149|NCT01998958|453954986|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
126183150|NCT01998958|453954987|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183151|NCT01998958|453954988|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183152|NCT01998958|453954989|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183153|NCT01998958|453954990|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183154|NCT01998958|453954991|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183155|NCT01998958|453954992|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183156|NCT01998958|453954993|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183157|NCT01998958|453954994|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126183158|NCT00724815|453954995|FG000|Overall Study|Randomized, not treated|31|||
126183159|NCT00724815|453954996|FG001|Overall Study|Randomized, not treated|30|||
126183160|NCT00724815|453954995|FG000|Overall Study|Adverse Event|5|||
126183161|NCT00724815|453954996|FG001|Overall Study|Adverse Event|3|||
126183162|NCT00724815|453954995|FG000|Overall Study|Lost to Follow-up|4|||
126183163|NCT00724815|453954996|FG001|Overall Study|Lost to Follow-up|1|||
126183164|NCT00724815|453954995|FG000|Overall Study|Other Various|3|||
126183165|NCT00724815|453954996|FG001|Overall Study|Other Various|5|||
126183166|NCT00105183|453955001|FG000|Overall Study|Death|19|||
126183167|NCT00105183|453955002|FG001|Overall Study|Death|13|||
126183168|NCT00105183|453955003|FG002|Overall Study|Death|15|||
126183169|NCT00105183|453955001|FG000|Overall Study|Withdrawal by Subject|1|||
126183170|NCT00105183|453955002|FG001|Overall Study|Withdrawal by Subject|1|||
126183171|NCT00105183|453955003|FG002|Overall Study|Withdrawal by Subject|4|||
126183172|NCT00105183|453955001|FG000|Overall Study|Physician Decision|1|||
126183173|NCT00105183|453955002|FG001|Overall Study|Physician Decision|2|||
126183174|NCT00105183|453955003|FG002|Overall Study|Physician Decision|3|||
126183175|NCT00105183|453955001|FG000|Overall Study|Lost to Follow-up|0|||
126183176|NCT00105183|453955002|FG001|Overall Study|Lost to Follow-up|1|||
126183177|NCT00105183|453955003|FG002|Overall Study|Lost to Follow-up|1|||
126183178|NCT00105183|453955001|FG000|Overall Study|Other reason|1|||
126183179|NCT00105183|453955002|FG001|Overall Study|Other reason|2|||
126183180|NCT00105183|453955003|FG002|Overall Study|Other reason|0|||
126183181|NCT00294684|453955004|FG000|Overall Study|Lost to Follow-up|5|||
126183182|NCT00294684|453955005|FG001|Overall Study|Lost to Follow-up|8|||
126183183|NCT00389441|453955006|FG000|Overall Study|Adverse Event|7|||
126183184|NCT00389441|453955006|FG000|Overall Study|Death|4|||
126183185|NCT00389441|453955006|FG000|Overall Study|Lost to Follow-up|2|||
126183186|NCT00389441|453955006|FG000|Overall Study|Withdrawal by Subject|4|||
126183187|NCT00389441|453955006|FG000|Overall Study|Physician Decision|1|||
126183188|NCT00389441|453955006|FG000|Overall Study|Protocol Violation|1|||
126183189|NCT00389441|453955006|FG000|Overall Study|Global deterioration of health status|4|||
126183190|NCT00389441|453955006|FG000|Overall Study|Objective progression or relapse|26|||
126183191|NCT00389441|453955006|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
126183192|NCT00389441|453955006|FG000|Overall Study|Clinical progression|1|||
126183193|NCT01981109|453955007|FG000|Overall Study|Death|36|||
126183194|NCT01981109|453955007|FG000|Overall Study|Withdrawal by Subject|40|||
126183195|NCT01981109|453955007|FG000|Overall Study|Lost to Follow-up|9|||
126183196|NCT01981109|453955007|FG000|Overall Study|No Discontinuation Documentation|37|||
126183197|NCT01981109|453955007|FG000|Overall Study|Study Termination|100|||
126183198|NCT01981109|453955007|FG000|Overall Study|No data available|2|||
126183199|NCT03407170|453955008|FG000|Overall Study|Adverse Event|1|||
126183200|NCT00126672|453955011|FG000|Overall Study|Adverse Event|4|||
126183201|NCT00126672|453955011|FG000|Overall Study|Lost to Follow-up|4|||
126183202|NCT00615459|453955012|FG000|Period I|Adverse Event|2|||
126183203|NCT00615459|453955013|FG001|Period I|Adverse Event|0|||
126183204|NCT00615459|453955014|FG002|Period I|Adverse Event|1|||
126183205|NCT00615459|453955015|FG003|Period I|Adverse Event|0|||
126183206|NCT00615459|453955012|FG000|Period I|Subject withdrew consent|1|||
126183207|NCT00615459|453955013|FG001|Period I|Subject withdrew consent|0|||
126183208|NCT00615459|453955014|FG002|Period I|Subject withdrew consent|0|||
126183209|NCT00615459|453955015|FG003|Period I|Subject withdrew consent|1|||
126183210|NCT00615459|453955012|FG000|Period I|Abnormal test procedure results|1|||
126183211|NCT00615459|453955013|FG001|Period I|Abnormal test procedure results|1|||
126183212|NCT00615459|453955014|FG002|Period I|Abnormal test procedure results|1|||
126183213|NCT00615459|453955015|FG003|Period I|Abnormal test procedure results|0|||
126183214|NCT00615459|453955012|FG000|Period II|Adverse Event|1|||
126183215|NCT00615459|453955013|FG001|Period II|Adverse Event|0|||
126183216|NCT00615459|453955014|FG002|Period II|Adverse Event|0|||
126183217|NCT00615459|453955015|FG003|Period II|Adverse Event|0|||
126183218|NCT00615459|453955012|FG000|Period II|Lost to Follow-up|0|||
126183219|NCT00615459|453955013|FG001|Period II|Lost to Follow-up|0|||
126183220|NCT00615459|453955014|FG002|Period II|Lost to Follow-up|0|||
126183221|NCT00615459|453955015|FG003|Period II|Lost to Follow-up|1|||
126183222|NCT00615459|453955012|FG000|Period III|Adverse Event|0|||
126183223|NCT00615459|453955013|FG001|Period III|Adverse Event|1|||
126183224|NCT00615459|453955014|FG002|Period III|Adverse Event|0|||
126183225|NCT00615459|453955015|FG003|Period III|Adverse Event|0|||
126183226|NCT00615459|453955012|FG000|Period III|Administrative problems|0|||
126183227|NCT00615459|453955013|FG001|Period III|Administrative problems|1|||
126183228|NCT00615459|453955014|FG002|Period III|Administrative problems|1|||
126183229|NCT00615459|453955015|FG003|Period III|Administrative problems|0|||
126183230|NCT00615459|453955012|FG000|Period III|Unsatisfactory therapeutic effect|0|||
126183231|NCT00615459|453955013|FG001|Period III|Unsatisfactory therapeutic effect|1|||
126183232|NCT00615459|453955014|FG002|Period III|Unsatisfactory therapeutic effect|0|||
126183233|NCT00615459|453955015|FG003|Period III|Unsatisfactory therapeutic effect|0|||
126183234|NCT01851863|453955018|FG000|Overall Study|Did not receive study medication|2|||
126183235|NCT01851863|453955019|FG001|Overall Study|Did not receive study medication|5|||
126183236|NCT01851863|453955020|FG002|Overall Study|Did not receive study medication|3|||
126183237|NCT01851863|453955021|FG003|Overall Study|Did not receive study medication|0|||
126183238|NCT01851863|453955018|FG000|Overall Study|Lost to Follow-up|3|||
126183239|NCT01851863|453955019|FG001|Overall Study|Lost to Follow-up|4|||
126183240|NCT01851863|453955020|FG002|Overall Study|Lost to Follow-up|2|||
126183241|NCT01851863|453955021|FG003|Overall Study|Lost to Follow-up|3|||
126183242|NCT02076334|453955022|FG000|Overall Study|Protocol Violation|1|||
126183243|NCT02076334|453955023|FG001|Overall Study|Protocol Violation|0|||
126183244|NCT02076334|453955024|FG002|Overall Study|Protocol Violation|0|||
126183245|NCT02076334|453955025|FG003|Overall Study|Protocol Violation|0|||
126183246|NCT02076334|453955022|FG000|Overall Study|Lost to Follow-up|0|||
126183247|NCT02076334|453955023|FG001|Overall Study|Lost to Follow-up|1|||
126183248|NCT02076334|453955024|FG002|Overall Study|Lost to Follow-up|1|||
126183249|NCT02076334|453955025|FG003|Overall Study|Lost to Follow-up|0|||
126183250|NCT02076334|453955022|FG000|Overall Study|muscle soreness|0|||
126183251|NCT02076334|453955023|FG001|Overall Study|muscle soreness|0|||
126183252|NCT02076334|453955024|FG002|Overall Study|muscle soreness|0|||
126183253|NCT02076334|453955025|FG003|Overall Study|muscle soreness|1|||
126183254|NCT03238352|453955026|FG000|Overall Study|Lost to Follow-up|0|||
126183255|NCT03238352|453955027|FG001|Overall Study|Lost to Follow-up|2|||
126183256|NCT03238352|453955028|FG002|Overall Study|Lost to Follow-up|1|||
126183257|NCT03238352|453955026|FG000|Overall Study|Withdrawal by Subject|0|||
126183258|NCT03238352|453955027|FG001|Overall Study|Withdrawal by Subject|1|||
126183259|NCT03238352|453955028|FG002|Overall Study|Withdrawal by Subject|0|||
126183260|NCT04083794|453955029|FG000|Overall Study|Lost to Follow-up|9|||
126183261|NCT01296698|453955030|FG000|Overall Study|Adverse Event|1|||
126183262|NCT01296698|453955031|FG001|Overall Study|Adverse Event|0|||
126183263|NCT01296698|453955030|FG000|Overall Study|Death|1|||
126183264|NCT01296698|453955031|FG001|Overall Study|Death|0|||
126183265|NCT01296698|453955030|FG000|Overall Study|Lost to Follow-up|19|||
126183266|NCT01296698|453955031|FG001|Overall Study|Lost to Follow-up|1|||
126183267|NCT01296698|453955030|FG000|Overall Study|Withdrawal by Subject|12|||
126183268|NCT01296698|453955031|FG001|Overall Study|Withdrawal by Subject|0|||
126183269|NCT01296698|453955030|FG000|Overall Study|Difficulty Contacting Subject|2|||
126183270|NCT01296698|453955031|FG001|Overall Study|Difficulty Contacting Subject|0|||
126183271|NCT01296698|453955030|FG000|Overall Study|Study Terminated by Sponsor|209|||
126183272|NCT01296698|453955031|FG001|Overall Study|Study Terminated by Sponsor|12|||
126183273|NCT03097029|453955034|FG000|Overall Study|Withdrawal by Subject|1|||
126183274|NCT00108953|453955042|FG000|Follow-up|Death|18|||
126183275|NCT00108953|453955043|FG001|Follow-up|Death|26|||
126183276|NCT00108953|453955042|FG000|Follow-up|Lost to Follow-up|1|||
126183277|NCT00108953|453955043|FG001|Follow-up|Lost to Follow-up|1|||
126183278|NCT00108953|453955042|FG000|Follow-up|Study terminated by sponsor|10|||
126183279|NCT00108953|453955043|FG001|Follow-up|Study terminated by sponsor|6|||
126183280|NCT03803202|453955046|FG000|Overall Study|Other|0|||
126183281|NCT03803202|453955047|FG001|Overall Study|Other|1|||
126183282|NCT03803202|453955048|FG002|Overall Study|Other|0|||
126183283|NCT03803202|453955049|FG003|Overall Study|Other|0|||
126183284|NCT03803202|453955050|FG004|Overall Study|Other|0|||
126183285|NCT03803202|453955051|FG005|Overall Study|Other|0|||
126183286|NCT03803202|453955052|FG006|Overall Study|Other|0|||
126183287|NCT03803202|453955053|FG007|Overall Study|Other|0|||
126183288|NCT03803202|453955054|FG008|Overall Study|Other|0|||
126183289|NCT03803202|453955046|FG000|Overall Study|Death|0|||
126183290|NCT03803202|453955047|FG001|Overall Study|Death|0|||
126183291|NCT03803202|453955048|FG002|Overall Study|Death|0|||
126183292|NCT03803202|453955049|FG003|Overall Study|Death|0|||
126183293|NCT03803202|453955050|FG004|Overall Study|Death|0|||
126183294|NCT03803202|453955051|FG005|Overall Study|Death|1|||
126183295|NCT03803202|453955052|FG006|Overall Study|Death|0|||
126183296|NCT03803202|453955053|FG007|Overall Study|Death|0|||
126183297|NCT03803202|453955054|FG008|Overall Study|Death|0|||
126183298|NCT03803202|453955046|FG000|Overall Study|Withdrawal by Subject|0|||
126183299|NCT03803202|453955047|FG001|Overall Study|Withdrawal by Subject|0|||
126183300|NCT03803202|453955048|FG002|Overall Study|Withdrawal by Subject|1|||
126183301|NCT03803202|453955049|FG003|Overall Study|Withdrawal by Subject|0|||
126183302|NCT03803202|453955050|FG004|Overall Study|Withdrawal by Subject|0|||
126183303|NCT03803202|453955051|FG005|Overall Study|Withdrawal by Subject|0|||
126183304|NCT03803202|453955052|FG006|Overall Study|Withdrawal by Subject|0|||
126183305|NCT03803202|453955053|FG007|Overall Study|Withdrawal by Subject|1|||
126183306|NCT03803202|453955054|FG008|Overall Study|Withdrawal by Subject|0|||
126183307|NCT03803202|453955046|FG000|Overall Study|Lost to Follow-up|0|||
126183308|NCT03803202|453955047|FG001|Overall Study|Lost to Follow-up|0|||
126183309|NCT03803202|453955048|FG002|Overall Study|Lost to Follow-up|0|||
126183310|NCT03803202|453955049|FG003|Overall Study|Lost to Follow-up|1|||
126183311|NCT03803202|453955050|FG004|Overall Study|Lost to Follow-up|1|||
126183312|NCT03803202|453955051|FG005|Overall Study|Lost to Follow-up|0|||
126183313|NCT03803202|453955052|FG006|Overall Study|Lost to Follow-up|1|||
126183314|NCT03803202|453955053|FG007|Overall Study|Lost to Follow-up|0|||
126183315|NCT03803202|453955054|FG008|Overall Study|Lost to Follow-up|0|||
126183316|NCT01125293|453955055|FG000|Overall Study|Disease Progression|1|||
126183317|NCT01125293|453955056|FG001|Overall Study|Disease Progression|3|||
126183318|NCT01125293|453955057|FG002|Overall Study|Disease Progression|4|||
126183319|NCT01125293|453955058|FG003|Overall Study|Disease Progression|3|||
126183320|NCT01125293|453955059|FG004|Overall Study|Disease Progression|5|||
126183321|NCT01125293|453955060|FG005|Overall Study|Disease Progression|12|||
126183322|NCT01125293|453955055|FG000|Overall Study|Adverse Event|1|||
126183323|NCT01125293|453955056|FG001|Overall Study|Adverse Event|0|||
126183324|NCT01125293|453955057|FG002|Overall Study|Adverse Event|0|||
126183325|NCT01125293|453955058|FG003|Overall Study|Adverse Event|0|||
126183326|NCT01125293|453955059|FG004|Overall Study|Adverse Event|2|||
126183327|NCT01125293|453955060|FG005|Overall Study|Adverse Event|8|||
126183328|NCT01125293|453955055|FG000|Overall Study|Symptomatic Deterioration|1|||
126183329|NCT01125293|453955056|FG001|Overall Study|Symptomatic Deterioration|0|||
126183330|NCT01125293|453955057|FG002|Overall Study|Symptomatic Deterioration|0|||
126183331|NCT01125293|453955058|FG003|Overall Study|Symptomatic Deterioration|0|||
126183332|NCT01125293|453955059|FG004|Overall Study|Symptomatic Deterioration|0|||
126183333|NCT01125293|453955060|FG005|Overall Study|Symptomatic Deterioration|0|||
126183334|NCT01125293|453955055|FG000|Overall Study|Death|0|||
126183335|NCT01125293|453955056|FG001|Overall Study|Death|0|||
126183336|NCT01125293|453955057|FG002|Overall Study|Death|0|||
126183337|NCT01125293|453955058|FG003|Overall Study|Death|0|||
126183338|NCT01125293|453955059|FG004|Overall Study|Death|1|||
126183339|NCT01125293|453955060|FG005|Overall Study|Death|0|||
126183340|NCT01125293|453955055|FG000|Overall Study|Withdrawal by Subject|0|||
126183341|NCT01125293|453955056|FG001|Overall Study|Withdrawal by Subject|0|||
126183342|NCT01125293|453955057|FG002|Overall Study|Withdrawal by Subject|0|||
126183343|NCT01125293|453955058|FG003|Overall Study|Withdrawal by Subject|0|||
126183344|NCT01125293|453955059|FG004|Overall Study|Withdrawal by Subject|2|||
126183345|NCT01125293|453955060|FG005|Overall Study|Withdrawal by Subject|1|||
126183346|NCT01125293|453955055|FG000|Overall Study|Physician Decision|0|||
126183347|NCT01125293|453955056|FG001|Overall Study|Physician Decision|0|||
126183348|NCT01125293|453955057|FG002|Overall Study|Physician Decision|0|||
126183349|NCT01125293|453955058|FG003|Overall Study|Physician Decision|0|||
126183350|NCT01125293|453955059|FG004|Overall Study|Physician Decision|0|||
126183351|NCT01125293|453955060|FG005|Overall Study|Physician Decision|2|||
126183352|NCT02925312|453955066|FG000|Overall Study|Lost to Follow-up|25|||
126183353|NCT02925312|453955067|FG001|Overall Study|Lost to Follow-up|0|||
126183354|NCT02925312|453955066|FG000|Overall Study|Adverse Event|2|||
126183355|NCT02925312|453955067|FG001|Overall Study|Adverse Event|0|||
126183356|NCT03205982|453955075|FG000|Overall Study|Lost to Follow-up|20|||
126183357|NCT03205982|453955076|FG001|Overall Study|Lost to Follow-up|19|||
126183358|NCT03205982|453955075|FG000|Overall Study|Withdrawal by Subject|4|||
126183359|NCT03205982|453955076|FG001|Overall Study|Withdrawal by Subject|3|||
126183360|NCT03205982|453955075|FG000|Overall Study|Withdrawal by PI|0|||
126183361|NCT03205982|453955076|FG001|Overall Study|Withdrawal by PI|1|||
126183362|NCT00994162|453955077|FG000|Overall Study|Withdrawal by Subject|1|||
126183363|NCT00994162|453955077|FG000|Overall Study|Lost to Follow-up|2|||
126183364|NCT00994162|453955077|FG000|Overall Study|Product Complaint|1|||
126183365|NCT00994162|453955077|FG000|Overall Study|Poor Compliance|5|||
126183366|NCT00994162|453955077|FG000|Overall Study|Lack of Response|3|||
126183367|NCT00994162|453955077|FG000|Overall Study|Discharged from Hospital|4|||
126183368|NCT00994162|453955077|FG000|Overall Study|Death|2|||
126183369|NCT00994162|453955077|FG000|Overall Study|Care Transferred to Another Physician|2|||
126183370|NCT00994162|453955077|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
126183371|NCT00994162|453955077|FG000|Overall Study|Physician Decision|2|||
126183372|NCT00994162|453955077|FG000|Overall Study|Surrounding Wound Erythematous|1|||
126183373|NCT00994162|453955077|FG000|Overall Study|Machine Losing Vaccum|1|||
126183374|NCT00994162|453955077|FG000|Overall Study|Patient Lived Too Far Away|1|||
126183375|NCT00994162|453955077|FG000|Overall Study|Above Knee Amputation|1|||
126183376|NCT00994162|453955077|FG000|Overall Study|Reason Not Reported By Site|1|||
126183377|NCT00631540|453955082|FG000|Overall Study|Withdrawal by Subject|5|||
126183378|NCT00631540|453955082|FG000|Overall Study|Death|4|||
126183379|NCT00631540|453955082|FG000|Overall Study|Lost to Follow-up|2|||
126183380|NCT00631540|453955082|FG000|Overall Study|Core Lab Data Unavailable|3|||
126183381|NCT03136367|453955084|FG000|T1 Consultation|discontinued mistakenly included|2|||
126183382|NCT03136367|453955085|FG001|T1 Consultation|discontinued mistakenly included|6|||
126183383|NCT03136367|453955086|FG002|T1 Consultation|discontinued mistakenly included|1|||
126183384|NCT03136367|453955084|FG000|T1 Consultation|Discontinued other|0|||
126183385|NCT03136367|453955085|FG001|T1 Consultation|Discontinued other|1|||
126183386|NCT03136367|453955086|FG002|T1 Consultation|Discontinued other|0|||
126183387|NCT03136367|453955084|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
126183388|NCT03136367|453955085|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
126183389|NCT03136367|453955086|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
126183390|NCT03136367|453955084|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
126183391|NCT03136367|453955085|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
126183392|NCT03136367|453955086|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
126183393|NCT03136367|453955084|FG000|T2 Post-consultation|Discontinued other|0|||
126183394|NCT03136367|453955085|FG001|T2 Post-consultation|Discontinued other|2|||
126183395|NCT03136367|453955086|FG002|T2 Post-consultation|Discontinued other|6|||
126183396|NCT03136367|453955084|FG000|T2 Post-consultation|Discontinued transferred care|0|||
126183397|NCT03136367|453955085|FG001|T2 Post-consultation|Discontinued transferred care|0|||
126183398|NCT03136367|453955086|FG002|T2 Post-consultation|Discontinued transferred care|3|||
126183399|NCT03136367|453955084|FG000|T2 Post-consultation|Discontinued lost contact|0|||
126183400|NCT03136367|453955085|FG001|T2 Post-consultation|Discontinued lost contact|1|||
126183401|NCT03136367|453955086|FG002|T2 Post-consultation|Discontinued lost contact|0|||
126183402|NCT03136367|453955084|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
126183403|NCT03136367|453955085|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
126183404|NCT03136367|453955086|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
126183405|NCT03136367|453955084|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
126183406|NCT03136367|453955085|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
126183407|NCT03136367|453955086|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
126183408|NCT03136367|453955084|FG000|T3 1 Week After Surgery|other discontinued|2|||
126183409|NCT03136367|453955085|FG001|T3 1 Week After Surgery|other discontinued|4|||
126183410|NCT03136367|453955086|FG002|T3 1 Week After Surgery|other discontinued|3|||
126183411|NCT03136367|453955084|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
126183412|NCT03136367|453955085|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
126183413|NCT03136367|453955086|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
126183414|NCT03136367|453955084|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
126183415|NCT03136367|453955085|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
126183416|NCT03136367|453955086|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
126183417|NCT03136367|453955084|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
126183418|NCT03136367|453955085|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
126183419|NCT03136367|453955086|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
126183420|NCT03136367|453955084|FG000|T4 12 Weeks After Surgery|Death|0|||
126183421|NCT03136367|453955085|FG001|T4 12 Weeks After Surgery|Death|1|||
126183422|NCT03136367|453955086|FG002|T4 12 Weeks After Surgery|Death|3|||
126183423|NCT03136367|453955084|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
126183424|NCT03136367|453955085|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
126183425|NCT03136367|453955086|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
126183426|NCT03136367|453955084|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
126183427|NCT03136367|453955085|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
126183428|NCT03136367|453955086|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
126183429|NCT03136367|453955084|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
126183430|NCT03136367|453955085|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
126183431|NCT03136367|453955086|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
126183432|NCT03136367|453955084|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
126183433|NCT03136367|453955085|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
126183434|NCT03136367|453955086|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
126183435|NCT03136367|453955084|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
126183436|NCT03136367|453955085|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
126183437|NCT03136367|453955086|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
126183438|NCT03136367|453955084|FG000|T5 1 Year After Surgery|Death|0|||
126183439|NCT03136367|453955085|FG001|T5 1 Year After Surgery|Death|0|||
126183440|NCT03136367|453955086|FG002|T5 1 Year After Surgery|Death|1|||
126183441|NCT03136367|453955084|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
126183442|NCT03136367|453955085|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
126183443|NCT03136367|453955086|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
126183444|NCT03136367|453955084|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
126183445|NCT03136367|453955085|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
126183446|NCT03136367|453955086|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
126183447|NCT03136367|453955084|FG000|T5 1 Year After Surgery|study ended before due|31|||
126183448|NCT03136367|453955085|FG001|T5 1 Year After Surgery|study ended before due|103|||
126183449|NCT03136367|453955086|FG002|T5 1 Year After Surgery|study ended before due|110|||
126183450|NCT03136367|453955084|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
126183451|NCT03136367|453955085|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
126183452|NCT03136367|453955086|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
126183453|NCT00676208|453955090|FG000|Overall Study|Lost to Follow-up|0|||
126183454|NCT00676208|453955091|FG001|Overall Study|Lost to Follow-up|2|||
126183455|NCT00676208|453955090|FG000|Overall Study|Incomplete data|2|||
126183456|NCT00676208|453955091|FG001|Overall Study|Incomplete data|4|||
126183457|NCT03726333|453955092|FG000|Overall Study|Progressive Disease|0|||
126183458|NCT03726333|453955093|FG001|Overall Study|Progressive Disease|0|||
126183459|NCT03726333|453955094|FG002|Overall Study|Progressive Disease|1|||
126183460|NCT03726333|453955095|FG003|Overall Study|Progressive Disease|0|||
126183461|NCT03726333|453955096|FG004|Overall Study|Progressive Disease|0|||
126183462|NCT01946412|453955097|FG000|Overall Study|Adverse Event|1|||
126183463|NCT01946412|453955097|FG000|Overall Study|Non-Compliance|1|||
126183464|NCT01946412|453955097|FG000|Overall Study|Continued with commercial Kalydeco|2|||
126183465|NCT01946412|453955097|FG000|Overall Study|Difficulty in swallowing|1|||
126183466|NCT02088541|453957059|FG000|Overall Study|Adverse Event|3|||
126183467|NCT02088541|453957060|FG001|Overall Study|Adverse Event|0|||
126183468|NCT02088541|453957061|FG002|Overall Study|Adverse Event|3|||
126183469|NCT02088541|453957062|FG003|Overall Study|Adverse Event|3|||
126183470|NCT02088541|453957063|FG004|Overall Study|Adverse Event|0|||
126183471|NCT02088541|453957059|FG000|Overall Study|Death|51|||
126183472|NCT02088541|453957060|FG001|Overall Study|Death|21|||
126183473|NCT02088541|453957061|FG002|Overall Study|Death|85|||
126183474|NCT02088541|453957062|FG003|Overall Study|Death|28|||
126183475|NCT02088541|453957063|FG004|Overall Study|Death|38|||
126183476|NCT02088541|453957059|FG000|Overall Study|Lost to Follow-up|2|||
126183477|NCT02088541|453957060|FG001|Overall Study|Lost to Follow-up|0|||
126183478|NCT02088541|453957061|FG002|Overall Study|Lost to Follow-up|1|||
126183479|NCT02088541|453957062|FG003|Overall Study|Lost to Follow-up|0|||
126183480|NCT02088541|453957063|FG004|Overall Study|Lost to Follow-up|0|||
126183481|NCT02088541|453957059|FG000|Overall Study|Physician Decision|2|||
126183482|NCT02088541|453957060|FG001|Overall Study|Physician Decision|1|||
126183483|NCT02088541|453957061|FG002|Overall Study|Physician Decision|2|||
126183484|NCT02088541|453957062|FG003|Overall Study|Physician Decision|0|||
126183485|NCT02088541|453957063|FG004|Overall Study|Physician Decision|2|||
126183486|NCT02088541|453957059|FG000|Overall Study|Disease progression|7|||
126183487|NCT02088541|453957060|FG001|Overall Study|Disease progression|1|||
126183488|NCT02088541|453957061|FG002|Overall Study|Disease progression|2|||
126183489|NCT02088541|453957062|FG003|Overall Study|Disease progression|3|||
126183490|NCT02088541|453957063|FG004|Overall Study|Disease progression|1|||
126183491|NCT02088541|453957059|FG000|Overall Study|Study terminated by sponsor|1|||
126183492|NCT02088541|453957060|FG001|Overall Study|Study terminated by sponsor|1|||
126183493|NCT02088541|453957061|FG002|Overall Study|Study terminated by sponsor|12|||
126183494|NCT02088541|453957062|FG003|Overall Study|Study terminated by sponsor|2|||
126183495|NCT02088541|453957063|FG004|Overall Study|Study terminated by sponsor|6|||
126183496|NCT02088541|453957059|FG000|Overall Study|Withdrawal by Subject|3|||
126183497|NCT02088541|453957060|FG001|Overall Study|Withdrawal by Subject|2|||
126183498|NCT02088541|453957061|FG002|Overall Study|Withdrawal by Subject|9|||
126183499|NCT02088541|453957062|FG003|Overall Study|Withdrawal by Subject|7|||
126183500|NCT02088541|453957063|FG004|Overall Study|Withdrawal by Subject|10|||
126183501|NCT02088541|453957059|FG000|Overall Study|Other|2|||
126183502|NCT02088541|453957060|FG001|Overall Study|Other|1|||
126183503|NCT02088541|453957061|FG002|Overall Study|Other|3|||
126183504|NCT02088541|453957062|FG003|Overall Study|Other|1|||
126183505|NCT02088541|453957063|FG004|Overall Study|Other|1|||
126183506|NCT01105936|453957065|FG000|Period 1|Adverse Event|0|||
126183507|NCT01105936|453957066|FG001|Period 1|Adverse Event|0|||
126183508|NCT01105936|453957067|FG002|Period 1|Adverse Event|0|||
126183509|NCT01105936|453957068|FG003|Period 1|Adverse Event|1|||
126183510|NCT01105936|453957065|FG000|Period 2|Adverse Event|1|||
126183511|NCT01105936|453957066|FG001|Period 2|Adverse Event|0|||
126183512|NCT01105936|453957067|FG002|Period 2|Adverse Event|0|||
126183513|NCT01105936|453957068|FG003|Period 2|Adverse Event|0|||
126183514|NCT01105936|453957065|FG000|Period 3|Protocol Violation|0|||
126183515|NCT01105936|453957066|FG001|Period 3|Protocol Violation|2|||
126183516|NCT01105936|453957067|FG002|Period 3|Protocol Violation|0|||
126183517|NCT01105936|453957068|FG003|Period 3|Protocol Violation|0|||
126183518|NCT01625611|453957071|FG000|Overall Study|No adlib drinks Lab 1|3|||
126183519|NCT01625611|453957072|FG001|Overall Study|No adlib drinks Lab 1|0|||
126183520|NCT01625611|453957071|FG000|Overall Study|Technical issues with PET|1|||
126183521|NCT01625611|453957072|FG001|Overall Study|Technical issues with PET|0|||
126183522|NCT01625611|453957071|FG000|Overall Study|Unable to complete study procedures|1|||
126183523|NCT01625611|453957072|FG001|Overall Study|Unable to complete study procedures|0|||
126183524|NCT01625611|453957071|FG000|Overall Study|Withdrawal by Subject|3|||
126183525|NCT01625611|453957072|FG001|Overall Study|Withdrawal by Subject|0|||
126183526|NCT02431793|453957073|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
126183527|NCT02431793|453957074|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
126183528|NCT02431793|453957075|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
126183529|NCT02431793|453957073|FG000|Overall Study|Withdrawal by Subject|7|||
126183530|NCT02431793|453957074|FG001|Overall Study|Withdrawal by Subject|5|||
126183531|NCT02431793|453957075|FG002|Overall Study|Withdrawal by Subject|5|||
126183532|NCT02431793|453957073|FG000|Overall Study|Lost to Follow-up|101|||
126183533|NCT02431793|453957074|FG001|Overall Study|Lost to Follow-up|122|||
126183534|NCT02431793|453957075|FG002|Overall Study|Lost to Follow-up|104|||
126183535|NCT03170258|453957079|FG000|Overall Study|Physician Decision|4|||
126183536|NCT03170258|453957080|FG001|Overall Study|Physician Decision|0|||
126183537|NCT03170258|453957079|FG000|Overall Study|Equipment issues|1|||
126183538|NCT03170258|453957080|FG001|Overall Study|Equipment issues|0|||
126183539|NCT03170258|453957079|FG000|Overall Study|Medication|1|||
126183540|NCT03170258|453957080|FG001|Overall Study|Medication|0|||
126183541|NCT03170258|453957079|FG000|Overall Study|Sleep issues|1|||
126183542|NCT03170258|453957080|FG001|Overall Study|Sleep issues|0|||
126183543|NCT01563107|453957081|FG000|Overall Study|Physician Decision|0|||
126183544|NCT01563107|453957082|FG001|Overall Study|Physician Decision|1|||
126183545|NCT01563107|453957083|FG002|Overall Study|Physician Decision|1|||
126183546|NCT01563107|453957084|FG003|Overall Study|Physician Decision|3|||
126183547|NCT01563107|453957081|FG000|Overall Study|Withdrawal by Subject|1|||
126183548|NCT01563107|453957082|FG001|Overall Study|Withdrawal by Subject|2|||
126183549|NCT01563107|453957083|FG002|Overall Study|Withdrawal by Subject|1|||
126183550|NCT01563107|453957084|FG003|Overall Study|Withdrawal by Subject|2|||
126183551|NCT03907969|453957085|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
126183552|NCT03907969|453957086|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
126183553|NCT03907969|453957087|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
126183554|NCT03907969|453957088|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
126183555|NCT03907969|453957089|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
126183556|NCT03907969|453957090|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
126183557|NCT03907969|453957091|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
126183558|NCT03907969|453957092|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
126183559|NCT03907969|453957093|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
126183560|NCT03907969|453957094|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
126183561|NCT03907969|453957095|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
126183562|NCT03907969|453957085|FG000|Monotherapy Part A|Progressive Disease|0|||
126183563|NCT03907969|453957086|FG001|Monotherapy Part A|Progressive Disease|1|||
126183564|NCT03907969|453957087|FG002|Monotherapy Part A|Progressive Disease|0|||
126183565|NCT03907969|453957088|FG003|Monotherapy Part A|Progressive Disease|0|||
126183566|NCT03907969|453957089|FG004|Monotherapy Part A|Progressive Disease|0|||
126183567|NCT03907969|453957090|FG005|Monotherapy Part A|Progressive Disease|1|||
126183568|NCT03907969|453957091|FG006|Monotherapy Part A|Progressive Disease|2|||
126183569|NCT03907969|453957092|FG007|Monotherapy Part A|Progressive Disease|0|||
126183570|NCT03907969|453957093|FG008|Monotherapy Part A|Progressive Disease|0|||
126183571|NCT03907969|453957094|FG009|Monotherapy Part A|Progressive Disease|0|||
126183572|NCT03907969|453957095|FG010|Monotherapy Part A|Progressive Disease|0|||
126183573|NCT03907969|453957085|FG000|Monotherapy Part A|Death|0|||
126183574|NCT03907969|453957086|FG001|Monotherapy Part A|Death|0|||
126183575|NCT03907969|453957087|FG002|Monotherapy Part A|Death|1|||
126183576|NCT03907969|453957088|FG003|Monotherapy Part A|Death|1|||
126183577|NCT03907969|453957089|FG004|Monotherapy Part A|Death|0|||
126183578|NCT03907969|453957090|FG005|Monotherapy Part A|Death|1|||
126183579|NCT03907969|453957091|FG006|Monotherapy Part A|Death|0|||
126183580|NCT03907969|453957092|FG007|Monotherapy Part A|Death|0|||
126183581|NCT03907969|453957093|FG008|Monotherapy Part A|Death|0|||
126183582|NCT03907969|453957094|FG009|Monotherapy Part A|Death|0|||
126183583|NCT03907969|453957095|FG010|Monotherapy Part A|Death|0|||
126183584|NCT03907969|453957085|FG000|Combination Therapy Part A|Adverse Event|0|||
126183585|NCT03907969|453957086|FG001|Combination Therapy Part A|Adverse Event|0|||
126183586|NCT03907969|453957087|FG002|Combination Therapy Part A|Adverse Event|0|||
126183587|NCT03907969|453957088|FG003|Combination Therapy Part A|Adverse Event|0|||
126183588|NCT03907969|453957089|FG004|Combination Therapy Part A|Adverse Event|0|||
126183589|NCT03907969|453957090|FG005|Combination Therapy Part A|Adverse Event|0|||
126183590|NCT03907969|453957091|FG006|Combination Therapy Part A|Adverse Event|0|||
126183591|NCT03907969|453957092|FG007|Combination Therapy Part A|Adverse Event|0|||
126183592|NCT03907969|453957093|FG008|Combination Therapy Part A|Adverse Event|0|||
126183593|NCT03907969|453957094|FG009|Combination Therapy Part A|Adverse Event|1|||
126183594|NCT03907969|453957095|FG010|Combination Therapy Part A|Adverse Event|1|||
126183595|NCT03907969|453957085|FG000|Combination Therapy Part A|Progressive disease|0|||
126183596|NCT03907969|453957086|FG001|Combination Therapy Part A|Progressive disease|0|||
126183597|NCT03907969|453957087|FG002|Combination Therapy Part A|Progressive disease|0|||
126183598|NCT03907969|453957088|FG003|Combination Therapy Part A|Progressive disease|0|||
126183599|NCT03907969|453957089|FG004|Combination Therapy Part A|Progressive disease|0|||
126183600|NCT03907969|453957090|FG005|Combination Therapy Part A|Progressive disease|0|||
126183601|NCT03907969|453957091|FG006|Combination Therapy Part A|Progressive disease|0|||
126183602|NCT03907969|453957092|FG007|Combination Therapy Part A|Progressive disease|1|||
126183603|NCT03907969|453957093|FG008|Combination Therapy Part A|Progressive disease|0|||
126183604|NCT03907969|453957094|FG009|Combination Therapy Part A|Progressive disease|2|||
126183605|NCT03907969|453957095|FG010|Combination Therapy Part A|Progressive disease|3|||
126183606|NCT03907969|453957085|FG000|Combination Therapy Part A|Death|0|||
126183607|NCT03907969|453957086|FG001|Combination Therapy Part A|Death|0|||
126183608|NCT03907969|453957087|FG002|Combination Therapy Part A|Death|0|||
126183609|NCT03907969|453957088|FG003|Combination Therapy Part A|Death|0|||
126183610|NCT03907969|453957089|FG004|Combination Therapy Part A|Death|0|||
126183611|NCT03907969|453957090|FG005|Combination Therapy Part A|Death|0|||
126183612|NCT03907969|453957091|FG006|Combination Therapy Part A|Death|0|||
126183613|NCT03907969|453957092|FG007|Combination Therapy Part A|Death|0|||
126183614|NCT03907969|453957093|FG008|Combination Therapy Part A|Death|1|||
126183615|NCT03907969|453957094|FG009|Combination Therapy Part A|Death|0|||
126183616|NCT03907969|453957095|FG010|Combination Therapy Part A|Death|1|||
126183617|NCT03907969|453957085|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
126183618|NCT03907969|453957086|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
126183619|NCT03907969|453957087|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
126183620|NCT03907969|453957088|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
126183621|NCT03907969|453957089|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
126183622|NCT03907969|453957090|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
126183623|NCT03907969|453957091|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
126183624|NCT03907969|453957092|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
126183625|NCT03907969|453957093|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
126183626|NCT03907969|453957094|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
126183627|NCT03907969|453957095|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
126183628|NCT03907969|453957085|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
126183629|NCT03907969|453957086|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
126183630|NCT03907969|453957087|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
126183631|NCT03907969|453957088|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
126183632|NCT03907969|453957089|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
126183633|NCT03907969|453957090|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
126183634|NCT03907969|453957091|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
126183635|NCT03907969|453957092|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
126183636|NCT03907969|453957093|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
126183637|NCT03907969|453957094|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
126183638|NCT03907969|453957095|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
126183639|NCT03907969|453957085|FG000|Combination Therapy Part A|Physician Decision|0|||
126183640|NCT03907969|453957086|FG001|Combination Therapy Part A|Physician Decision|0|||
126183641|NCT03907969|453957087|FG002|Combination Therapy Part A|Physician Decision|0|||
126183642|NCT03907969|453957088|FG003|Combination Therapy Part A|Physician Decision|0|||
126183643|NCT03907969|453957089|FG004|Combination Therapy Part A|Physician Decision|0|||
126183644|NCT03907969|453957090|FG005|Combination Therapy Part A|Physician Decision|0|||
126183645|NCT03907969|453957091|FG006|Combination Therapy Part A|Physician Decision|0|||
126183646|NCT03907969|453957092|FG007|Combination Therapy Part A|Physician Decision|1|||
126183647|NCT03907969|453957093|FG008|Combination Therapy Part A|Physician Decision|0|||
126183648|NCT03907969|453957094|FG009|Combination Therapy Part A|Physician Decision|0|||
126183649|NCT03907969|453957095|FG010|Combination Therapy Part A|Physician Decision|1|||
126183650|NCT00666536|453957096|FG000|Overall Study|Adverse Event|9|||
126183651|NCT00666536|453957097|FG001|Overall Study|Adverse Event|19|||
126183652|NCT00666536|453957096|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126183653|NCT00666536|453957097|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126183654|NCT00666536|453957096|FG000|Overall Study|Protocol deviation(s)|8|||
126183655|NCT00666536|453957097|FG001|Overall Study|Protocol deviation(s)|6|||
126183656|NCT00666536|453957096|FG000|Overall Study|Withdrawal by Subject|10|||
126183657|NCT00666536|453957097|FG001|Overall Study|Withdrawal by Subject|9|||
126183658|NCT00666536|453957096|FG000|Overall Study|Lost to Follow-up|4|||
126183659|NCT00666536|453957097|FG001|Overall Study|Lost to Follow-up|3|||
126183660|NCT00511108|453957101|FG000|Overall Study|Adverse Event|2|||
126183661|NCT00511108|453957102|FG001|Overall Study|Adverse Event|0|||
126183662|NCT00511108|453957103|FG002|Overall Study|Adverse Event|1|||
126183663|NCT00511108|453957104|FG003|Overall Study|Adverse Event|2|||
126183664|NCT00511108|453957101|FG000|Overall Study|Lost to Follow-up|0|||
126183665|NCT00511108|453957102|FG001|Overall Study|Lost to Follow-up|2|||
126183666|NCT00511108|453957103|FG002|Overall Study|Lost to Follow-up|1|||
126183667|NCT00511108|453957104|FG003|Overall Study|Lost to Follow-up|0|||
126183668|NCT00511108|453957101|FG000|Overall Study|Physician Decision|0|||
126183669|NCT00511108|453957102|FG001|Overall Study|Physician Decision|0|||
126183670|NCT00511108|453957103|FG002|Overall Study|Physician Decision|0|||
126183671|NCT00511108|453957104|FG003|Overall Study|Physician Decision|1|||
126199933|NCT01117428|454017806|FG002|Overall Study|Lack of Efficacy|0|||
126183672|NCT00511108|453957101|FG000|Overall Study|Withdrawal by Subject|4|||
126183673|NCT00511108|453957102|FG001|Overall Study|Withdrawal by Subject|0|||
126183674|NCT00511108|453957103|FG002|Overall Study|Withdrawal by Subject|3|||
126183675|NCT00511108|453957104|FG003|Overall Study|Withdrawal by Subject|2|||
126183676|NCT01831804|453957111|FG000|Overall Study|Adverse Event|0|||
126183677|NCT01831804|453957112|FG001|Overall Study|Adverse Event|0|||
126183678|NCT01831804|453957113|FG002|Overall Study|Adverse Event|0|||
126183679|NCT01831804|453957114|FG003|Overall Study|Adverse Event|0|||
126183680|NCT01831804|453957115|FG004|Overall Study|Adverse Event|0|||
126183681|NCT01831804|453957116|FG005|Overall Study|Adverse Event|0|||
126183682|NCT01831804|453957117|FG006|Overall Study|Adverse Event|1|||
126183683|NCT01831804|453957118|FG007|Overall Study|Adverse Event|0|||
126183684|NCT01831804|453957119|FG008|Overall Study|Adverse Event|1|||
126183685|NCT01831804|453957111|FG000|Overall Study|Protocol Violation|0|||
126183686|NCT01831804|453957112|FG001|Overall Study|Protocol Violation|0|||
126183687|NCT01831804|453957113|FG002|Overall Study|Protocol Violation|2|||
126183688|NCT01831804|453957114|FG003|Overall Study|Protocol Violation|0|||
126183689|NCT01831804|453957115|FG004|Overall Study|Protocol Violation|0|||
126183690|NCT01831804|453957116|FG005|Overall Study|Protocol Violation|0|||
126183691|NCT01831804|453957117|FG006|Overall Study|Protocol Violation|0|||
126183692|NCT01831804|453957118|FG007|Overall Study|Protocol Violation|0|||
126183693|NCT01831804|453957119|FG008|Overall Study|Protocol Violation|0|||
126183694|NCT01831804|453957111|FG000|Overall Study|Protocol defined stopping criteria|1|||
126183695|NCT01831804|453957112|FG001|Overall Study|Protocol defined stopping criteria|1|||
126183696|NCT01831804|453957113|FG002|Overall Study|Protocol defined stopping criteria|3|||
126183697|NCT01831804|453957114|FG003|Overall Study|Protocol defined stopping criteria|0|||
126183698|NCT01831804|453957115|FG004|Overall Study|Protocol defined stopping criteria|1|||
126183699|NCT01831804|453957116|FG005|Overall Study|Protocol defined stopping criteria|0|||
126183700|NCT01831804|453957117|FG006|Overall Study|Protocol defined stopping criteria|0|||
126183701|NCT01831804|453957118|FG007|Overall Study|Protocol defined stopping criteria|0|||
126183702|NCT01831804|453957119|FG008|Overall Study|Protocol defined stopping criteria|0|||
126183703|NCT01831804|453957111|FG000|Overall Study|Lost to Follow-up|0|||
126183704|NCT01831804|453957112|FG001|Overall Study|Lost to Follow-up|0|||
126183705|NCT01831804|453957113|FG002|Overall Study|Lost to Follow-up|1|||
126183706|NCT01831804|453957114|FG003|Overall Study|Lost to Follow-up|0|||
126183707|NCT01831804|453957115|FG004|Overall Study|Lost to Follow-up|0|||
126183708|NCT01831804|453957116|FG005|Overall Study|Lost to Follow-up|0|||
126183709|NCT01831804|453957117|FG006|Overall Study|Lost to Follow-up|0|||
126183710|NCT01831804|453957118|FG007|Overall Study|Lost to Follow-up|0|||
126183711|NCT01831804|453957119|FG008|Overall Study|Lost to Follow-up|1|||
126183712|NCT01831804|453957111|FG000|Overall Study|Investigator discretion|0|||
126183713|NCT01831804|453957112|FG001|Overall Study|Investigator discretion|0|||
126183714|NCT01831804|453957113|FG002|Overall Study|Investigator discretion|0|||
126183715|NCT01831804|453957114|FG003|Overall Study|Investigator discretion|0|||
126183716|NCT01831804|453957115|FG004|Overall Study|Investigator discretion|1|||
126183717|NCT01831804|453957116|FG005|Overall Study|Investigator discretion|0|||
126183718|NCT01831804|453957117|FG006|Overall Study|Investigator discretion|0|||
126183719|NCT01831804|453957118|FG007|Overall Study|Investigator discretion|1|||
126183720|NCT01831804|453957119|FG008|Overall Study|Investigator discretion|0|||
126183721|NCT01831804|453957111|FG000|Overall Study|Withdrew Consent|0|||
126183722|NCT01831804|453957112|FG001|Overall Study|Withdrew Consent|1|||
126183723|NCT01831804|453957113|FG002|Overall Study|Withdrew Consent|0|||
126183724|NCT01831804|453957114|FG003|Overall Study|Withdrew Consent|0|||
126183725|NCT01831804|453957115|FG004|Overall Study|Withdrew Consent|0|||
126183726|NCT01831804|453957116|FG005|Overall Study|Withdrew Consent|0|||
126183727|NCT01831804|453957117|FG006|Overall Study|Withdrew Consent|0|||
126183728|NCT01831804|453957118|FG007|Overall Study|Withdrew Consent|2|||
126183729|NCT01831804|453957119|FG008|Overall Study|Withdrew Consent|0|||
126183730|NCT00268463|453957122|FG000|Overall Study|study terminated due to low accrual|10|||
126183731|NCT00268463|453957123|FG001|Overall Study|study terminated due to low accrual|12|||
126183732|NCT02920450|453957124|FG000|Overall Study|Death|1|||
126183733|NCT02920450|453957125|FG001|Overall Study|Death|0|||
126183734|NCT02920450|453957126|FG002|Overall Study|Death|0|||
126183735|NCT02920450|453957127|FG003|Overall Study|Death|0|||
126183736|NCT02920450|453957124|FG000|Overall Study|Withdrawal by Subject|1|||
126183737|NCT02920450|453957125|FG001|Overall Study|Withdrawal by Subject|0|||
126183738|NCT02920450|453957126|FG002|Overall Study|Withdrawal by Subject|0|||
126183739|NCT02920450|453957127|FG003|Overall Study|Withdrawal by Subject|0|||
126183740|NCT00968708|453957130|FG000|Overall Study|Adverse Event|169|||
126183741|NCT00968708|453957131|FG001|Overall Study|Adverse Event|150|||
126183742|NCT00968708|453957130|FG000|Overall Study|Major Protocol Deviation|0|||
126183743|NCT00968708|453957131|FG001|Overall Study|Major Protocol Deviation|1|||
126183744|NCT00968708|453957130|FG000|Overall Study|Lost to Follow-up|19|||
126183745|NCT00968708|453957131|FG001|Overall Study|Lost to Follow-up|11|||
126183746|NCT00968708|453957130|FG000|Overall Study|Voluntary Withdrawal|104|||
126183747|NCT00968708|453957131|FG001|Overall Study|Voluntary Withdrawal|101|||
126183748|NCT00968708|453957130|FG000|Overall Study|Investigator Discretion|0|||
126183749|NCT00968708|453957131|FG001|Overall Study|Investigator Discretion|1|||
126183750|NCT00968708|453957130|FG000|Overall Study|Other|26|||
126183751|NCT00968708|453957131|FG001|Overall Study|Other|34|||
126183752|NCT01732107|453957132|FG000|Overall Study|Adverse Event|2|||
126183753|NCT01732107|453957132|FG000|Overall Study|Disease Progression|8|||
126183754|NCT01732107|453957132|FG000|Overall Study|Physician Decision|1|||
126183755|NCT01732107|453957132|FG000|Overall Study|Withdrawal by Subject|2|||
126183756|NCT01975675|453957135|FG000|Overall Study|Death|0|||
126183757|NCT01975675|453957136|FG001|Overall Study|Death|1|||
126183758|NCT01975675|453957137|FG002|Overall Study|Death|0|||
126183759|NCT01975675|453957138|FG003|Overall Study|Death|0|||
126183760|NCT00224003|453957139|FG000|Overall Study|Adverse Event|1|||
126183761|NCT00224003|453957139|FG000|Overall Study|Protocol Violation|2|||
126183762|NCT00224003|453957139|FG000|Overall Study|Withdrawal by Subject|1|||
126183763|NCT00224003|453957139|FG000|Overall Study|unk|3|||
126183764|NCT01202760|453957140|FG000|Overall Study|Entry Criteria Not Met|0|||
126183765|NCT01202760|453957141|FG001|Overall Study|Entry Criteria Not Met|3|||
126183766|NCT01202760|453957142|FG002|Overall Study|Entry Criteria Not Met|1|||
126183767|NCT01202760|453957140|FG000|Overall Study|Adverse Event|11|||
126183768|NCT01202760|453957141|FG001|Overall Study|Adverse Event|9|||
126183769|NCT01202760|453957142|FG002|Overall Study|Adverse Event|10|||
126183770|NCT01202760|453957140|FG000|Overall Study|Death|2|||
126183771|NCT01202760|453957141|FG001|Overall Study|Death|1|||
126183772|NCT01202760|453957142|FG002|Overall Study|Death|0|||
126183773|NCT01202760|453957140|FG000|Overall Study|Lack of Efficacy|6|||
126183774|NCT01202760|453957141|FG001|Overall Study|Lack of Efficacy|8|||
126183775|NCT01202760|453957142|FG002|Overall Study|Lack of Efficacy|7|||
126183776|NCT01202760|453957140|FG000|Overall Study|Lost to Follow-up|0|||
126183777|NCT01202760|453957141|FG001|Overall Study|Lost to Follow-up|2|||
126183778|NCT01202760|453957142|FG002|Overall Study|Lost to Follow-up|1|||
126183779|NCT01202760|453957140|FG000|Overall Study|Parent / Caregiver Decision|0|||
126183780|NCT01202760|453957141|FG001|Overall Study|Parent / Caregiver Decision|1|||
126183781|NCT01202760|453957142|FG002|Overall Study|Parent / Caregiver Decision|0|||
126183782|NCT01202760|453957140|FG000|Overall Study|Withdrawal by Subject|17|||
126183783|NCT01202760|453957141|FG001|Overall Study|Withdrawal by Subject|18|||
126183784|NCT01202760|453957142|FG002|Overall Study|Withdrawal by Subject|14|||
126183785|NCT01202760|453957140|FG000|Overall Study|Physician Decision|0|||
126183786|NCT01202760|453957141|FG001|Overall Study|Physician Decision|1|||
126183787|NCT01202760|453957142|FG002|Overall Study|Physician Decision|0|||
126183788|NCT01202760|453957140|FG000|Overall Study|Protocol Violation|7|||
126183789|NCT01202760|453957141|FG001|Overall Study|Protocol Violation|5|||
126183790|NCT01202760|453957142|FG002|Overall Study|Protocol Violation|2|||
126183791|NCT01202760|453957140|FG000|Overall Study|Sponsor Decision|4|||
126183792|NCT01202760|453957141|FG001|Overall Study|Sponsor Decision|4|||
126183793|NCT01202760|453957142|FG002|Overall Study|Sponsor Decision|0|||
126183794|NCT00871572|453957143|FG000|Overall Study|Adverse Event|0|||
126183795|NCT00871572|453957144|FG001|Overall Study|Adverse Event|2|||
126183796|NCT00871572|453957145|FG002|Overall Study|Adverse Event|0|||
126183797|NCT00871572|453957146|FG003|Overall Study|Adverse Event|3|||
126183798|NCT00871572|453957143|FG000|Overall Study|Investigator Decision|0|||
126183799|NCT00871572|453957144|FG001|Overall Study|Investigator Decision|1|||
126183800|NCT00871572|453957145|FG002|Overall Study|Investigator Decision|0|||
126183801|NCT00871572|453957146|FG003|Overall Study|Investigator Decision|1|||
126183802|NCT00871572|453957143|FG000|Overall Study|Lost to Follow-up|0|||
126183803|NCT00871572|453957144|FG001|Overall Study|Lost to Follow-up|1|||
126183804|NCT00871572|453957145|FG002|Overall Study|Lost to Follow-up|0|||
126183805|NCT00871572|453957146|FG003|Overall Study|Lost to Follow-up|1|||
126183806|NCT00871572|453957143|FG000|Overall Study|Protocol Violation|0|||
126183807|NCT00871572|453957144|FG001|Overall Study|Protocol Violation|0|||
126183808|NCT00871572|453957145|FG002|Overall Study|Protocol Violation|1|||
126183809|NCT00871572|453957146|FG003|Overall Study|Protocol Violation|1|||
126183810|NCT00871572|453957143|FG000|Overall Study|Sponsor Decision|1|||
126183811|NCT00871572|453957144|FG001|Overall Study|Sponsor Decision|0|||
126183812|NCT00871572|453957145|FG002|Overall Study|Sponsor Decision|0|||
126183813|NCT00871572|453957146|FG003|Overall Study|Sponsor Decision|0|||
126183814|NCT00871572|453957143|FG000|Overall Study|Withdrawal by Subject|1|||
126183815|NCT00871572|453957144|FG001|Overall Study|Withdrawal by Subject|2|||
126183816|NCT00871572|453957145|FG002|Overall Study|Withdrawal by Subject|3|||
126183817|NCT00871572|453957146|FG003|Overall Study|Withdrawal by Subject|1|||
126183818|NCT04354155|453957149|FG000|Overall Study|Withdrawal by Subject|1|||
126183819|NCT04354155|453957149|FG000|Overall Study|Did not meet criteria for study intervention|1|||
126183820|NCT02565615|453957152|FG000|Overall Study|Death|0|||
126183821|NCT02565615|453957153|FG001|Overall Study|Death|1|||
126183822|NCT02565615|453957154|FG002|Overall Study|Death|0|||
126183823|NCT02565615|453957155|FG003|Overall Study|Death|0|||
126183824|NCT02565615|453957156|FG004|Overall Study|Death|4|||
126183825|NCT02565615|453957152|FG000|Overall Study|Not willing to participate in study|2|||
126183826|NCT02565615|453957153|FG001|Overall Study|Not willing to participate in study|21|||
126183827|NCT02565615|453957154|FG002|Overall Study|Not willing to participate in study|0|||
126183828|NCT02565615|453957155|FG003|Overall Study|Not willing to participate in study|1|||
126183829|NCT02565615|453957156|FG004|Overall Study|Not willing to participate in study|169|||
126183830|NCT02565615|453957152|FG000|Overall Study|Lost to Follow-up|0|||
126183831|NCT02565615|453957153|FG001|Overall Study|Lost to Follow-up|4|||
126183832|NCT02565615|453957154|FG002|Overall Study|Lost to Follow-up|0|||
126183833|NCT02565615|453957155|FG003|Overall Study|Lost to Follow-up|1|||
126183834|NCT02565615|453957156|FG004|Overall Study|Lost to Follow-up|765|||
126183835|NCT02565615|453957152|FG000|Overall Study|Not meeting eligibility criteria|0|||
126183836|NCT02565615|453957153|FG001|Overall Study|Not meeting eligibility criteria|7|||
126183837|NCT02565615|453957154|FG002|Overall Study|Not meeting eligibility criteria|0|||
126183838|NCT02565615|453957155|FG003|Overall Study|Not meeting eligibility criteria|0|||
126183839|NCT02565615|453957156|FG004|Overall Study|Not meeting eligibility criteria|25|||
126183840|NCT02565615|453957152|FG000|Overall Study|Reason not defined|0|||
126183841|NCT02565615|453957153|FG001|Overall Study|Reason not defined|2|||
126183842|NCT02565615|453957154|FG002|Overall Study|Reason not defined|0|||
126183843|NCT02565615|453957155|FG003|Overall Study|Reason not defined|1|||
126183844|NCT02565615|453957156|FG004|Overall Study|Reason not defined|62|||
126183845|NCT02565615|453957152|FG000|Overall Study|Adverse Event|1|||
126183846|NCT02565615|453957153|FG001|Overall Study|Adverse Event|1|||
126183847|NCT02565615|453957154|FG002|Overall Study|Adverse Event|0|||
126183848|NCT02565615|453957155|FG003|Overall Study|Adverse Event|0|||
126183849|NCT02565615|453957156|FG004|Overall Study|Adverse Event|9|||
126183850|NCT02565615|453957152|FG000|Overall Study|Untreated|0|||
126183851|NCT02565615|453957153|FG001|Overall Study|Untreated|0|||
126183852|NCT02565615|453957154|FG002|Overall Study|Untreated|0|||
126183853|NCT02565615|453957155|FG003|Overall Study|Untreated|0|||
126183854|NCT02565615|453957156|FG004|Overall Study|Untreated|567|||
126183855|NCT00753688|453957162|FG000|Overall Study|Death|102|||
126183856|NCT00753688|453957163|FG001|Overall Study|Death|203|||
126183857|NCT00753688|453957162|FG000|Overall Study|Missing|4|||
126183858|NCT00753688|453957163|FG001|Overall Study|Missing|9|||
126183859|NCT00753688|453957162|FG000|Overall Study|Participant Withdrew Consent|2|||
126183860|NCT00753688|453957163|FG001|Overall Study|Participant Withdrew Consent|2|||
126183861|NCT00753688|453957162|FG000|Overall Study|Ongoing - in Follow-up|15|||
126183862|NCT00753688|453957163|FG001|Overall Study|Ongoing - in Follow-up|31|||
126183863|NCT00753688|453957162|FG000|Overall Study|Adverse Event|0|||
126183864|NCT00753688|453957163|FG001|Overall Study|Adverse Event|1|||
126183865|NCT02999100|453957167|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
126183866|NCT02999100|453957168|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
126183867|NCT02999100|453957169|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
126183868|NCT02999100|453957170|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
126183869|NCT02999100|453957171|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
126183870|NCT02999100|453957172|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
126183871|NCT02999100|453957167|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126183872|NCT02999100|453957168|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126183873|NCT02999100|453957169|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126183874|NCT02999100|453957170|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126183875|NCT02999100|453957171|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126183876|NCT02999100|453957172|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
126183877|NCT02999100|453957167|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126183878|NCT02999100|453957168|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126183879|NCT02999100|453957169|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
126183880|NCT02999100|453957170|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126183881|NCT02999100|453957171|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126183882|NCT02999100|453957172|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126183883|NCT03595384|453957176|FG000|Overall Study|Other time commitments|8|||
126183884|NCT03595384|453957176|FG000|Overall Study|Changes to session time|7|||
126183885|NCT03595384|453957176|FG000|Overall Study|Relocation out of country|1|||
126183886|NCT00293241|453957177|FG000|Overall Study|Lost to Follow-up|9|||
126183887|NCT00293241|453957178|FG001|Overall Study|Lost to Follow-up|16|||
126183888|NCT00293241|453957177|FG000|Overall Study|Physician Decision|23|||
126183889|NCT00293241|453957178|FG001|Overall Study|Physician Decision|17|||
126183890|NCT00293241|453957177|FG000|Overall Study|Withdrawal by Subject|4|||
126183891|NCT00293241|453957178|FG001|Overall Study|Withdrawal by Subject|8|||
126183892|NCT02224638|453957179|FG000|Overall Study|Adverse Event|1|||
126183893|NCT02224638|453957180|FG001|Overall Study|Adverse Event|1|||
126183894|NCT01270958|453957181|FG000|Overall Study|Lost to Follow-up|2|||
126183895|NCT01270958|453957181|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
126183896|NCT00659126|453957188|FG000|Overall Study|Adverse Event|2|||
126183897|NCT00659126|453957189|FG001|Overall Study|Adverse Event|2|||
126183898|NCT00659126|453957188|FG000|Overall Study|Screen failure|1|||
126183899|NCT00659126|453957189|FG001|Overall Study|Screen failure|1|||
126183900|NCT00659126|453957188|FG000|Overall Study|Technical problems with MRI|0|||
126183901|NCT00659126|453957189|FG001|Overall Study|Technical problems with MRI|1|||
126183902|NCT02633046|453957192|FG000|Overall Study|Adverse Event|8|||
126183903|NCT02633046|453957192|FG000|Overall Study|Physician Decision|7|||
126183904|NCT02633046|453957192|FG000|Overall Study|Withdrawal by Subject|8|||
126183905|NCT02633046|453957192|FG000|Overall Study|Increased proteinuria|2|||
126183906|NCT02633046|453957192|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
126183907|NCT02633046|453957192|FG000|Overall Study|Mutual decision patient and physician|1|||
126183908|NCT01455415|453957202|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
126183909|NCT01455415|453957203|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
126183910|NCT01455415|453957202|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
126183911|NCT01455415|453957203|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
126183912|NCT01455415|453957202|FG000|Period 1|Drug Error not Associated to AE|0|||
126183913|NCT01455415|453957203|FG001|Period 1|Drug Error not Associated to AE|1|||
126183914|NCT01455415|453957202|FG000|Period 1|AE Not Related to Study Drug|2|||
126183915|NCT01455415|453957203|FG001|Period 1|AE Not Related to Study Drug|6|||
126183916|NCT01455415|453957202|FG000|Period 1|Withdrawal by Subject|4|||
126183917|NCT01455415|453957203|FG001|Period 1|Withdrawal by Subject|5|||
126183918|NCT01455415|453957202|FG000|Period 1|Unspecified Reason|1|||
126183919|NCT01455415|453957203|FG001|Period 1|Unspecified Reason|1|||
126183920|NCT01455415|453957202|FG000|Period 1|Protocol Violation|0|||
126183921|NCT01455415|453957203|FG001|Period 1|Protocol Violation|2|||
126183922|NCT01455415|453957202|FG000|Washout|AE Related to Study Drug|2|||
126183923|NCT01455415|453957203|FG001|Washout|AE Related to Study Drug|0|||
126183924|NCT01455415|453957202|FG000|Washout|Lost to Follow-up|1|||
126183925|NCT01455415|453957203|FG001|Washout|Lost to Follow-up|0|||
126183926|NCT01455415|453957202|FG000|Washout|Drug Error not Associated to AE|2|||
126183927|NCT01455415|453957203|FG001|Washout|Drug Error not Associated to AE|1|||
126183928|NCT01455415|453957202|FG000|Washout|AE Not Related to Study Drug|2|||
126183929|NCT01455415|453957203|FG001|Washout|AE Not Related to Study Drug|3|||
126183930|NCT01455415|453957202|FG000|Washout|Unspecified Reason|1|||
126183931|NCT01455415|453957203|FG001|Washout|Unspecified Reason|2|||
126183932|NCT01455415|453957202|FG000|Washout|Protocol Violation|0|||
126183933|NCT01455415|453957203|FG001|Washout|Protocol Violation|1|||
126183934|NCT01455415|453957202|FG000|Period 2|AE Related to Study Drug|1|||
126183935|NCT01455415|453957203|FG001|Period 2|AE Related to Study Drug|2|||
126183936|NCT01455415|453957202|FG000|Period 2|Lost to Follow-up|2|||
126183937|NCT01455415|453957203|FG001|Period 2|Lost to Follow-up|1|||
126183938|NCT01455415|453957202|FG000|Period 2|AE Not Related to Study Drug|2|||
126183939|NCT01455415|453957203|FG001|Period 2|AE Not Related to Study Drug|1|||
126183940|NCT01455415|453957202|FG000|Period 2|Lack of Efficacy|2|||
126183941|NCT01455415|453957203|FG001|Period 2|Lack of Efficacy|0|||
126183942|NCT01455415|453957202|FG000|Period 2|Withdrawal by Subject|2|||
126183943|NCT01455415|453957203|FG001|Period 2|Withdrawal by Subject|3|||
126183944|NCT01455415|453957202|FG000|Period 2|Unspecified Reason|2|||
126183945|NCT01455415|453957203|FG001|Period 2|Unspecified Reason|3|||
126183946|NCT01455415|453957202|FG000|Period 2|Protocol Violation|2|||
126183947|NCT01455415|453957203|FG001|Period 2|Protocol Violation|0|||
126183948|NCT01455415|453957202|FG000|Follow-up|AE Related to Study Drug|0|||
126183949|NCT01455415|453957203|FG001|Follow-up|AE Related to Study Drug|1|||
126183950|NCT01455415|453957202|FG000|Follow-up|Lack of Efficacy|0|||
126183951|NCT01455415|453957203|FG001|Follow-up|Lack of Efficacy|1|||
126183952|NCT01455415|453957202|FG000|Follow-up|Withdrawal by Subject|2|||
126183953|NCT01455415|453957203|FG001|Follow-up|Withdrawal by Subject|0|||
126183954|NCT01455415|453957202|FG000|Follow-up|Unspecified Reason|1|||
126183955|NCT01455415|453957203|FG001|Follow-up|Unspecified Reason|0|||
126183956|NCT00587301|453957204|FG000|Overall Study|Screen Failure|9|||
126183957|NCT00587301|453957204|FG000|Overall Study|Lost to Follow-up|22|||
126183958|NCT00587301|453957204|FG000|Overall Study|Withdrawal by Subject|7|||
126183959|NCT00587301|453957204|FG000|Overall Study|Protocol Violation|7|||
126183960|NCT01496274|453957206|FG000|Overall Study|Protocol Violation|0|||
126183961|NCT01496274|453957207|FG001|Overall Study|Protocol Violation|1|||
126183962|NCT01496274|453957206|FG000|Overall Study|Adverse Event|1|||
126183963|NCT01496274|453957207|FG001|Overall Study|Adverse Event|1|||
126183964|NCT01496274|453957206|FG000|Overall Study|Withdrawal by Subject|2|||
126183965|NCT01496274|453957207|FG001|Overall Study|Withdrawal by Subject|0|||
126183966|NCT01496274|453957206|FG000|Overall Study|Lost to Follow-up|0|||
126183967|NCT01496274|453957207|FG001|Overall Study|Lost to Follow-up|3|||
126183968|NCT02758613|453957208|FG000|Treatment|Physician and Sponsor Decision|1|||
126183969|NCT02758613|453957209|FG001|Treatment|Physician and Sponsor Decision|0|||
126183970|NCT02758613|453957210|FG002|Treatment|Physician and Sponsor Decision|0|||
126183971|NCT02758613|453957211|FG003|Treatment|Physician and Sponsor Decision|0|||
126183972|NCT02758613|453957208|FG000|Treatment|Withdrawal by Subject|1|||
126183973|NCT02758613|453957209|FG001|Treatment|Withdrawal by Subject|0|||
126183974|NCT02758613|453957210|FG002|Treatment|Withdrawal by Subject|1|||
126183975|NCT02758613|453957211|FG003|Treatment|Withdrawal by Subject|0|||
126183976|NCT00351819|453957212|FG000|Overall Study|Lost to Follow-up|4|||
126183977|NCT00351819|453957213|FG001|Overall Study|Lost to Follow-up|4|||
126183978|NCT00351819|453957212|FG000|Overall Study|Withdrawal by Subject|0|||
126183979|NCT00351819|453957213|FG001|Overall Study|Withdrawal by Subject|4|||
126183980|NCT00351819|453957212|FG000|Overall Study|Elevated PSA|1|||
126183981|NCT00351819|453957213|FG001|Overall Study|Elevated PSA|1|||
126183982|NCT00351819|453957212|FG000|Overall Study|Traumatic ankle fracture|1|||
126183983|NCT00351819|453957213|FG001|Overall Study|Traumatic ankle fracture|0|||
126183984|NCT00351819|453957212|FG000|Overall Study|Unprofessional behavior|1|||
126183985|NCT00351819|453957213|FG001|Overall Study|Unprofessional behavior|0|||
126183986|NCT00351819|453957212|FG000|Overall Study|Non-compliance|0|||
126183987|NCT00351819|453957213|FG001|Overall Study|Non-compliance|1|||
126183988|NCT00351819|453957212|FG000|Overall Study|Incarcerated|0|||
126183989|NCT00351819|453957213|FG001|Overall Study|Incarcerated|1|||
126183990|NCT00351819|453957212|FG000|Overall Study|Enrolled in another trial|0|||
126183991|NCT00351819|453957213|FG001|Overall Study|Enrolled in another trial|1|||
126183992|NCT01425749|453957214|FG000|Overall Study|progression of melanoma|0|||
126183993|NCT01425749|453957215|FG001|Overall Study|progression of melanoma|1|||
126183994|NCT01293084|453957216|FG000|Overall Study|Physician Decision|3|||
126183995|NCT01293084|453957216|FG000|Overall Study|Withdrawal by Subject|2|||
126183996|NCT02096042|453957217|FG000|Overall Study|Disease Progression|1|||
126183997|NCT02096042|453957218|FG001|Overall Study|Disease Progression|0|||
126183998|NCT02096042|453957219|FG002|Overall Study|Disease Progression|0|||
126183999|NCT02983799|453957220|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
126184000|NCT02983799|453957221|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
126184001|NCT02983799|453957222|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
126184002|NCT02983799|453957223|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
126184003|NCT02983799|453957224|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
126184004|NCT02983799|453957220|FG000|Overall Study|Death|20|||
126184005|NCT02983799|453957221|FG001|Overall Study|Death|5|||
126184006|NCT02983799|453957222|FG002|Overall Study|Death|23|||
126184007|NCT02983799|453957223|FG003|Overall Study|Death|47|||
126184008|NCT02983799|453957224|FG004|Overall Study|Death|7|||
126184009|NCT02983799|453957220|FG000|Overall Study|Withdrawal by Subject|1|||
126184010|NCT02983799|453957221|FG001|Overall Study|Withdrawal by Subject|0|||
126184011|NCT02983799|453957222|FG002|Overall Study|Withdrawal by Subject|3|||
126184012|NCT02983799|453957223|FG003|Overall Study|Withdrawal by Subject|4|||
126184013|NCT02983799|453957224|FG004|Overall Study|Withdrawal by Subject|1|||
126184014|NCT02983799|453957220|FG000|Overall Study|Protocol Violation|0|||
126184015|NCT02983799|453957221|FG001|Overall Study|Protocol Violation|1|||
126184016|NCT02983799|453957222|FG002|Overall Study|Protocol Violation|0|||
126184017|NCT02983799|453957223|FG003|Overall Study|Protocol Violation|0|||
126184018|NCT02983799|453957224|FG004|Overall Study|Protocol Violation|1|||
126184019|NCT02983799|453957220|FG000|Overall Study|Lost to Follow-up|1|||
126184020|NCT02983799|453957221|FG001|Overall Study|Lost to Follow-up|0|||
126184021|NCT02983799|453957222|FG002|Overall Study|Lost to Follow-up|1|||
126184022|NCT02983799|453957223|FG003|Overall Study|Lost to Follow-up|0|||
126184023|NCT02983799|453957224|FG004|Overall Study|Lost to Follow-up|0|||
126184024|NCT01313078|453957231|FG000|Overall Study|Death|1|||
126184025|NCT01313078|453957231|FG000|Overall Study|Discontinued study drug|1|||
126184026|NCT01313078|453957231|FG000|Overall Study|Withdrawal by Subject|1|||
126184027|NCT01225172|453957235|FG000|Overall Study|Subject decision to stop|1|||
126184028|NCT01225172|453957236|FG001|Overall Study|Subject decision to stop|0|||
126184029|NCT01225172|453957235|FG000|Overall Study|Subject request to discontinue treatment|3|||
126184030|NCT01225172|453957236|FG001|Overall Study|Subject request to discontinue treatment|1|||
126184031|NCT01225172|453957235|FG000|Overall Study|Subject no longer meets study criteria|1|||
126184032|NCT01225172|453957236|FG001|Overall Study|Subject no longer meets study criteria|0|||
126184033|NCT01225172|453957235|FG000|Overall Study|Withdrawal by Subject|1|||
126184034|NCT01225172|453957236|FG001|Overall Study|Withdrawal by Subject|0|||
126184035|NCT00795509|453957240|FG000|Overall Study|Protocol Violation|31|||
126184036|NCT01601470|453957241|FG000|Period 2 - LCZ696|Physician Decision|1|||
126184037|NCT01079195|453957242|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
126184038|NCT01079195|453957242|FG000|Overall Study|No Documentation Available|437|||
126184039|NCT01079195|453957242|FG000|Overall Study|Adverse Event|157|||
126184040|NCT01079195|453957242|FG000|Overall Study|Reason Unknown|39|||
126184041|NCT01079195|453957242|FG000|Overall Study|Withdrawal by Subject|18|||
126184042|NCT01079195|453957242|FG000|Overall Study|Financial Reasons|15|||
126184043|NCT01079195|453957242|FG000|Overall Study|Lack of Effectiveness|12|||
126184044|NCT01079195|453957242|FG000|Overall Study|Physician Decision|4|||
126184045|NCT01079195|453957242|FG000|Overall Study|Improved Status of Participant|4|||
126184046|NCT01079195|453957242|FG000|Overall Study|No Follow-up Documentation Available|4|||
126184047|NCT01079195|453957242|FG000|Overall Study|Non-compliance|2|||
126184048|NCT01041404|453957245|FG000|Overall Study|Adverse Event|45|||
126184049|NCT01041404|453957246|FG001|Overall Study|Adverse Event|35|||
126184050|NCT01041404|453957245|FG000|Overall Study|Lack of Efficacy|200|||
126184051|NCT01041404|453957246|FG001|Overall Study|Lack of Efficacy|210|||
126184052|NCT01041404|453957245|FG000|Overall Study|Violation of Selection Criteria|0|||
126184053|NCT01041404|453957246|FG001|Overall Study|Violation of Selection Criteria|1|||
126184054|NCT01041404|453957245|FG000|Overall Study|Protocol Violation|4|||
126184055|NCT01041404|453957246|FG001|Overall Study|Protocol Violation|0|||
126184056|NCT01041404|453957245|FG000|Overall Study|Withdrawal by Subject|29|||
126184057|NCT01041404|453957246|FG001|Overall Study|Withdrawal by Subject|23|||
126184058|NCT01041404|453957245|FG000|Overall Study|Failure to Return|1|||
126184059|NCT01041404|453957246|FG001|Overall Study|Failure to Return|2|||
126184060|NCT01041404|453957245|FG000|Overall Study|Other|11|||
126184061|NCT01041404|453957246|FG001|Overall Study|Other|23|||
126184062|NCT01607073|453957247|FG000|Overall Study|Adverse Event|1|||
126184063|NCT01375647|453959038|FG000|Overall Study|Lost to Follow-up|3|||
126184064|NCT01375647|453959039|FG001|Overall Study|Lost to Follow-up|3|||
126184065|NCT01375647|453959040|FG002|Overall Study|Lost to Follow-up|7|||
126184066|NCT01375647|453959041|FG003|Overall Study|Lost to Follow-up|10|||
126184067|NCT01375647|453959038|FG000|Overall Study|Death|1|||
126184068|NCT01375647|453959039|FG001|Overall Study|Death|2|||
126184069|NCT01375647|453959040|FG002|Overall Study|Death|1|||
126184070|NCT01375647|453959041|FG003|Overall Study|Death|0|||
126184071|NCT01375647|453959038|FG000|Overall Study|Withdrawal by Subject|17|||
126184072|NCT01375647|453959039|FG001|Overall Study|Withdrawal by Subject|20|||
126184073|NCT01375647|453959040|FG002|Overall Study|Withdrawal by Subject|26|||
126184074|NCT01375647|453959041|FG003|Overall Study|Withdrawal by Subject|14|||
126184075|NCT01375647|453959038|FG000|Overall Study|Physician Decision|1|||
126184076|NCT01375647|453959039|FG001|Overall Study|Physician Decision|0|||
126184077|NCT01375647|453959040|FG002|Overall Study|Physician Decision|0|||
126184078|NCT01375647|453959041|FG003|Overall Study|Physician Decision|0|||
126184079|NCT02147691|453959042|FG000|Overall Study|Withdrawal by Subject|2|||
126184080|NCT02147691|453959043|FG001|Overall Study|Withdrawal by Subject|0|||
126184081|NCT02147691|453959042|FG000|Overall Study|Adverse Event|2|||
126184082|NCT02147691|453959043|FG001|Overall Study|Adverse Event|0|||
126184083|NCT02147691|453959042|FG000|Overall Study|Lost to Follow-up|0|||
126184084|NCT02147691|453959043|FG001|Overall Study|Lost to Follow-up|1|||
126184085|NCT02954952|453959044|FG000|Overall Study|Withdrawal by Subject|1|||
126184086|NCT02954952|453959045|FG001|Overall Study|Withdrawal by Subject|0|||
126184087|NCT02954952|453959046|FG002|Overall Study|Withdrawal by Subject|0|||
126184088|NCT02954952|453959044|FG000|Overall Study|No data collected|0|||
126184089|NCT02954952|453959045|FG001|Overall Study|No data collected|1|||
126184090|NCT02954952|453959046|FG002|Overall Study|No data collected|0|||
126184091|NCT01392742|453959049|FG000|Overall Study|Premature study termination|42|||
126184092|NCT01392742|453959049|FG000|Overall Study|Failure to return|35|||
126184093|NCT01392742|453959049|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
126184094|NCT01392742|453959049|FG000|Overall Study|Lost to Follow-up|34|||
126184095|NCT01392742|453959049|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
126184096|NCT01392742|453959049|FG000|Overall Study|ITR and Protocol deviation|1|||
126184097|NCT01392742|453959049|FG000|Overall Study|Adverse event/intercurrent illness|17|||
126184098|NCT01392742|453959049|FG000|Overall Study|Protocol Violation|14|||
126184099|NCT01392742|453959049|FG000|Overall Study|Other|3|||
126184100|NCT01392742|453959049|FG000|Overall Study|Missing information|13|||
126184101|NCT04179032|453959050|FG000|Part B (Up to Week 52)|Adverse Event|1|||
126184102|NCT04179032|453959050|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
126184103|NCT04179032|453959050|FG000|Access Extension Phase|Ongoing|11|||
126184104|NCT02432703|453959051|FG000|Overall Study|Adverse Event|1|||
126184105|NCT02432703|453959052|FG001|Overall Study|Adverse Event|4|||
126184106|NCT02432703|453959051|FG000|Overall Study|Lack of Efficacy|1|||
126184107|NCT02432703|453959052|FG001|Overall Study|Lack of Efficacy|0|||
126184108|NCT02432703|453959051|FG000|Overall Study|Lost to Follow-up|5|||
126184109|NCT02432703|453959052|FG001|Overall Study|Lost to Follow-up|3|||
126184110|NCT02432703|453959051|FG000|Overall Study|Withdrawal by Subject|9|||
126184111|NCT02432703|453959052|FG001|Overall Study|Withdrawal by Subject|6|||
126184112|NCT02432703|453959051|FG000|Overall Study|Other|6|||
126184113|NCT02432703|453959052|FG001|Overall Study|Other|5|||
126184114|NCT03210220|453959053|FG000|Overall Study|Physician Decision|1|||
126184115|NCT03210220|453959054|FG001|Overall Study|Physician Decision|0|||
126184116|NCT00653328|453959055|FG000|Overall Study|Withdrawal by Subject|1|||
126184117|NCT00653328|453959055|FG000|Overall Study|Adverse Event|2|||
126184118|NCT00653328|453959055|FG000|Overall Study|Disease progression|10|||
126184119|NCT00653328|453959055|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
126184120|NCT02911519|453959056|FG000|Overall Study|Lost to Follow-up|2|||
126184121|NCT02911519|453959057|FG001|Overall Study|Lost to Follow-up|2|||
126184122|NCT02911519|453959056|FG000|Overall Study|Death|0|||
126184123|NCT02911519|453959057|FG001|Overall Study|Death|2|||
126184124|NCT00839436|453959060|FG000|Overall Study|Developed exclusionary condition|1|||
126184125|NCT00839436|453959061|FG001|Overall Study|Developed exclusionary condition|0|||
126184126|NCT00839436|453959062|FG002|Overall Study|Developed exclusionary condition|0|||
126184127|NCT00839436|453959060|FG000|Overall Study|Withdrawal by Subject|0|||
126184128|NCT00839436|453959061|FG001|Overall Study|Withdrawal by Subject|1|||
126184129|NCT00839436|453959062|FG002|Overall Study|Withdrawal by Subject|0|||
126184130|NCT00839436|453959060|FG000|Overall Study|Study drug no longer available|0|||
126184131|NCT00839436|453959061|FG001|Overall Study|Study drug no longer available|0|||
126184132|NCT00839436|453959062|FG002|Overall Study|Study drug no longer available|1|||
126184133|NCT01444898|453959064|FG000|Overall Study|Withdrawal by Subject|1|||
126184134|NCT02580591|453959066|FG000|Overall Study|Adverse Event|0|||
126184135|NCT02580591|453959067|FG001|Overall Study|Adverse Event|1|||
126184136|NCT02580591|453959068|FG002|Overall Study|Adverse Event|2|||
126184137|NCT02580591|453959069|FG003|Overall Study|Adverse Event|5|||
126184138|NCT02580591|453959066|FG000|Overall Study|Protocol Violation|3|||
126184139|NCT02580591|453959067|FG001|Overall Study|Protocol Violation|2|||
126184140|NCT02580591|453959068|FG002|Overall Study|Protocol Violation|1|||
126184141|NCT02580591|453959069|FG003|Overall Study|Protocol Violation|1|||
126184142|NCT02580591|453959066|FG000|Overall Study|Lost to Follow-up|5|||
126184143|NCT02580591|453959067|FG001|Overall Study|Lost to Follow-up|3|||
126184144|NCT02580591|453959068|FG002|Overall Study|Lost to Follow-up|3|||
126184145|NCT02580591|453959069|FG003|Overall Study|Lost to Follow-up|1|||
126184146|NCT02580591|453959066|FG000|Overall Study|Withdrawal by Subject|6|||
126184147|NCT02580591|453959067|FG001|Overall Study|Withdrawal by Subject|1|||
126184148|NCT02580591|453959068|FG002|Overall Study|Withdrawal by Subject|2|||
126184149|NCT02580591|453959069|FG003|Overall Study|Withdrawal by Subject|3|||
126184150|NCT02580591|453959066|FG000|Overall Study|Not treated|1|||
126184151|NCT02580591|453959067|FG001|Overall Study|Not treated|1|||
126184152|NCT02580591|453959068|FG002|Overall Study|Not treated|0|||
126184153|NCT02580591|453959069|FG003|Overall Study|Not treated|0|||
126184154|NCT02580591|453959066|FG000|Overall Study|Other than specified|3|||
126184155|NCT02580591|453959067|FG001|Overall Study|Other than specified|2|||
126184156|NCT02580591|453959068|FG002|Overall Study|Other than specified|5|||
126184157|NCT02580591|453959069|FG003|Overall Study|Other than specified|2|||
126184158|NCT00561340|453959073|FG000|Overall Study|refused to drink pediasure|6|||
126184159|NCT00561340|453959074|FG001|Overall Study|refused to drink pediasure|0|||
126184160|NCT00445341|453959075|FG000|Overall Study|refused further treatment|1|||
126184161|NCT00445341|453959075|FG000|Overall Study|taken off treatment too early|1|||
126184162|NCT03051217|453959076|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
126184163|NCT03051217|453959077|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126184164|NCT03051217|453959078|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
126184165|NCT03051217|453959079|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126184166|NCT03051217|453959080|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126184167|NCT03051217|453959081|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126184168|NCT03051217|453959082|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126184169|NCT03051217|453959076|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126184170|NCT03051217|453959077|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
126184171|NCT03051217|453959078|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126184172|NCT03051217|453959079|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126184173|NCT03051217|453959080|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126184174|NCT03051217|453959081|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126184175|NCT03051217|453959082|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126184176|NCT03051217|453959076|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
126184177|NCT03051217|453959077|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
126184178|NCT03051217|453959078|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
126184179|NCT03051217|453959079|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126184180|NCT03051217|453959080|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126184181|NCT03051217|453959081|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126184182|NCT03051217|453959082|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126184183|NCT03051217|453959076|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
126184184|NCT03051217|453959077|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
126184185|NCT03051217|453959078|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
126184186|NCT03051217|453959079|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
126184187|NCT03051217|453959080|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
126184188|NCT03051217|453959081|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
126184189|NCT03051217|453959082|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
126184190|NCT03051217|453959076|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126184191|NCT03051217|453959077|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126184192|NCT03051217|453959078|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126184193|NCT03051217|453959079|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
126184194|NCT03051217|453959080|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126184195|NCT03051217|453959081|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126184196|NCT03051217|453959082|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126184197|NCT03051217|453959076|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126184198|NCT03051217|453959077|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126184199|NCT03051217|453959078|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126184200|NCT03051217|453959079|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
126184201|NCT03051217|453959080|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126184202|NCT03051217|453959081|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126184203|NCT03051217|453959082|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126184204|NCT03051217|453959076|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126184205|NCT03051217|453959077|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126184206|NCT03051217|453959078|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126184207|NCT03051217|453959079|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126184208|NCT03051217|453959080|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
126184209|NCT03051217|453959081|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126184210|NCT03051217|453959082|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126184211|NCT03051217|453959076|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126184212|NCT03051217|453959077|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126184213|NCT03051217|453959078|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126184214|NCT03051217|453959079|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126184215|NCT03051217|453959080|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126184216|NCT03051217|453959081|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
126184217|NCT03051217|453959082|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126184218|NCT00109772|453959083|FG000|Double-blind Treatment|Adverse Event|14|||
126184219|NCT00109772|453959084|FG001|Double-blind Treatment|Adverse Event|5|||
126184220|NCT00109772|453959083|FG000|Double-blind Treatment|Lack of Efficacy|1|||
126184221|NCT00109772|453959084|FG001|Double-blind Treatment|Lack of Efficacy|0|||
126184222|NCT00109772|453959083|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
126184223|NCT00109772|453959084|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
126184224|NCT00109772|453959083|FG000|Double-blind Treatment|Lost to Follow-up|2|||
126184225|NCT00109772|453959084|FG001|Double-blind Treatment|Lost to Follow-up|3|||
126184226|NCT00109772|453959083|FG000|Double-blind Treatment|Protocol Violation|0|||
126184227|NCT00109772|453959084|FG001|Double-blind Treatment|Protocol Violation|1|||
126184228|NCT00109772|453959083|FG000|Double-blind Treatment|Other|0|||
126184229|NCT00109772|453959084|FG001|Double-blind Treatment|Other|4|||
126184230|NCT00109772|453959083|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
126184231|NCT00109772|453959084|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
126184232|NCT00109772|453959083|FG000|Open-label Extension|Adverse Event|10|||
126184233|NCT00109772|453959084|FG001|Open-label Extension|Adverse Event|19|||
126184234|NCT00109772|453959083|FG000|Open-label Extension|Lack of Efficacy|19|||
126184235|NCT00109772|453959084|FG001|Open-label Extension|Lack of Efficacy|11|||
126184236|NCT00109772|453959083|FG000|Open-label Extension|Withdrawal by Subject|9|||
126184237|NCT00109772|453959084|FG001|Open-label Extension|Withdrawal by Subject|6|||
126184238|NCT00109772|453959083|FG000|Open-label Extension|Lost to Follow-up|1|||
126184239|NCT00109772|453959084|FG001|Open-label Extension|Lost to Follow-up|0|||
126184240|NCT00109772|453959083|FG000|Open-label Extension|Death|0|||
126184241|NCT00109772|453959084|FG001|Open-label Extension|Death|1|||
126184242|NCT00109772|453959083|FG000|Open-label Extension|Protocol Violation|2|||
126184243|NCT00109772|453959084|FG001|Open-label Extension|Protocol Violation|2|||
126184244|NCT00109772|453959083|FG000|Open-label Extension|Other|4|||
126184245|NCT00109772|453959084|FG001|Open-label Extension|Other|10|||
126184246|NCT01359046|453959087|FG000|Overall Study|Did not receive allocated intervention|6|||
126184247|NCT01359046|453959088|FG001|Overall Study|Did not receive allocated intervention|6|||
126184248|NCT01359046|453959087|FG000|Overall Study|Physician Decision|1|||
126184249|NCT01359046|453959088|FG001|Overall Study|Physician Decision|11|||
126184250|NCT04539262|453959089|FG000|Overall Study|Adverse Event|0|||
126184251|NCT04539262|453959090|FG001|Overall Study|Adverse Event|0|||
126184252|NCT04539262|453959091|FG002|Overall Study|Adverse Event|1|||
126184253|NCT04539262|453959092|FG003|Overall Study|Adverse Event|0|||
126184254|NCT04539262|453959093|FG004|Overall Study|Adverse Event|0|||
126184255|NCT04539262|453959094|FG005|Overall Study|Adverse Event|0|||
126184256|NCT04539262|453959095|FG006|Overall Study|Adverse Event|0|||
126184257|NCT04539262|453959096|FG007|Overall Study|Adverse Event|0|||
126184258|NCT04539262|453959089|FG000|Overall Study|Withdrew Consent|0|||
126184259|NCT04539262|453959090|FG001|Overall Study|Withdrew Consent|0|||
126184260|NCT04539262|453959091|FG002|Overall Study|Withdrew Consent|0|||
126184261|NCT04539262|453959092|FG003|Overall Study|Withdrew Consent|1|||
126184262|NCT04539262|453959093|FG004|Overall Study|Withdrew Consent|0|||
126184263|NCT04539262|453959094|FG005|Overall Study|Withdrew Consent|0|||
126184264|NCT04539262|453959095|FG006|Overall Study|Withdrew Consent|0|||
126184265|NCT04539262|453959096|FG007|Overall Study|Withdrew Consent|0|||
126184266|NCT04539262|453959089|FG000|Overall Study|Randomized, Not treated|0|||
126184267|NCT04539262|453959090|FG001|Overall Study|Randomized, Not treated|1|||
126184268|NCT04539262|453959091|FG002|Overall Study|Randomized, Not treated|0|||
126184269|NCT04539262|453959092|FG003|Overall Study|Randomized, Not treated|0|||
126184270|NCT04539262|453959093|FG004|Overall Study|Randomized, Not treated|0|||
126184271|NCT04539262|453959094|FG005|Overall Study|Randomized, Not treated|0|||
126184272|NCT04539262|453959095|FG006|Overall Study|Randomized, Not treated|1|||
126184273|NCT04539262|453959096|FG007|Overall Study|Randomized, Not treated|0|||
126184274|NCT03725293|453959099|FG000|Overall Study|Physician Decision|9|||
126184275|NCT03725293|453959100|FG001|Overall Study|Physician Decision|6|||
126184276|NCT03725293|453959099|FG000|Overall Study|alternative vascular access needs|1|||
126184277|NCT03725293|453959100|FG001|Overall Study|alternative vascular access needs|2|||
126184278|NCT03725293|453959099|FG000|Overall Study|venous anatomy screen failures|2|||
126184279|NCT03725293|453959100|FG001|Overall Study|venous anatomy screen failures|1|||
126184280|NCT04397796|453959105|FG000|Overall Study|Death|3|||
126184281|NCT04397796|453959106|FG001|Overall Study|Death|1|||
126184282|NCT00802867|453959107|FG000|Overall Study|Lost to Follow-up|6|||
126184283|NCT00802867|453959107|FG000|Overall Study|Protocol Violation|6|||
126184284|NCT00802867|453959107|FG000|Overall Study|Withdrawal by Subject|1|||
126184285|NCT01061567|453959108|FG000|Overall Study|Adverse Event|32|||
126184286|NCT01061567|453959108|FG000|Overall Study|Death|2|||
126184287|NCT01061567|453959108|FG000|Overall Study|Lack of Efficacy|3|||
126184288|NCT01061567|453959108|FG000|Overall Study|Lost to Follow-up|24|||
126184289|NCT01061567|453959108|FG000|Overall Study|Protocol Violation|1|||
126184290|NCT01061567|453959108|FG000|Overall Study|Withdrawal by Subject|11|||
126184291|NCT01061567|453959108|FG000|Overall Study|Other reason than stated above|3|||
126184292|NCT01156532|453959115|FG000|Overall Study|Family Reasons|1|||
126184293|NCT01156532|453959115|FG000|Overall Study|Lost to Follow-up|1|||
126184294|NCT02443805|453959118|FG000|Overall Study|Adverse Event|100|||
126184295|NCT02443805|453959119|FG001|Overall Study|Adverse Event|18|||
126184296|NCT02443805|453959118|FG000|Overall Study|Withdrawal by Subject|73|||
126184297|NCT02443805|453959119|FG001|Overall Study|Withdrawal by Subject|74|||
126184298|NCT02443805|453959118|FG000|Overall Study|Lost to Follow-up|19|||
126184299|NCT02443805|453959119|FG001|Overall Study|Lost to Follow-up|14|||
126184300|NCT02443805|453959118|FG000|Overall Study|Pregnancy|6|||
126184301|NCT02443805|453959119|FG001|Overall Study|Pregnancy|5|||
126184302|NCT02443805|453959118|FG000|Overall Study|Protocol Violation|2|||
126184303|NCT02443805|453959119|FG001|Overall Study|Protocol Violation|4|||
126184304|NCT02443805|453959118|FG000|Overall Study|Lack of Efficacy|1|||
126184305|NCT02443805|453959119|FG001|Overall Study|Lack of Efficacy|1|||
126184306|NCT02443805|453959118|FG000|Overall Study|Non-compliance with study drug|6|||
126184307|NCT02443805|453959119|FG001|Overall Study|Non-compliance with study drug|4|||
126184308|NCT02443805|453959118|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126184309|NCT02443805|453959119|FG001|Overall Study|Withdrawal by parent/guardian|5|||
126184310|NCT02443805|453959118|FG000|Overall Study|Any other reason not above-mentioned|3|||
126184311|NCT02443805|453959119|FG001|Overall Study|Any other reason not above-mentioned|2|||
126184312|NCT04362813|453959120|FG000|Overall Study|Death|12|||
126184313|NCT04362813|453959121|FG001|Overall Study|Death|16|||
126184314|NCT04362813|453959120|FG000|Overall Study|Withdrawal by Subject|3|||
126184315|NCT04362813|453959121|FG001|Overall Study|Withdrawal by Subject|1|||
126184316|NCT04362813|453959120|FG000|Overall Study|Protocol Violation|0|||
126184317|NCT04362813|453959121|FG001|Overall Study|Protocol Violation|3|||
126184318|NCT04362813|453959120|FG000|Overall Study|Lost to Follow-up|1|||
126184319|NCT04362813|453959121|FG001|Overall Study|Lost to Follow-up|1|||
126184320|NCT04362813|453959120|FG000|Overall Study|Enrolled but did not receive treatment|2|||
126184321|NCT04362813|453959121|FG001|Overall Study|Enrolled but did not receive treatment|4|||
126184322|NCT00961116|453959122|FG000|Washout Period of 7 Days|Adverse Event|1|||
126184323|NCT00961116|453959123|FG001|Washout Period of 7 Days|Adverse Event|1|||
126184324|NCT00961116|453959122|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
126184325|NCT00961116|453959123|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126184326|NCT00961116|453959122|FG000|Washout Period of 7 Days|Protocol Violation|0|||
126184327|NCT00961116|453959123|FG001|Washout Period of 7 Days|Protocol Violation|1|||
126184328|NCT00719537|453959130|FG000|Overall Study|Withdrawal by Subject|1|||
126184329|NCT00719537|453959131|FG001|Overall Study|Withdrawal by Subject|0|||
126184330|NCT00719537|453959130|FG000|Overall Study|Lost to Follow-up|0|||
126184331|NCT00719537|453959131|FG001|Overall Study|Lost to Follow-up|1|||
126184332|NCT01142193|453959132|FG000|Overall Study|Adverse Event|12|||
126184333|NCT01142193|453959133|FG001|Overall Study|Adverse Event|4|||
126184334|NCT01142193|453959132|FG000|Overall Study|Lack of Efficacy|2|||
126184335|NCT01142193|453959133|FG001|Overall Study|Lack of Efficacy|1|||
126184336|NCT01142193|453959132|FG000|Overall Study|Physician Decision|1|||
126184337|NCT01142193|453959133|FG001|Overall Study|Physician Decision|1|||
126184338|NCT01142193|453959132|FG000|Overall Study|Withdrawal by Subject|4|||
126184339|NCT01142193|453959133|FG001|Overall Study|Withdrawal by Subject|3|||
126184340|NCT01142193|453959132|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
126184341|NCT01142193|453959133|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
126184342|NCT01142193|453959132|FG000|Overall Study|Other|1|||
126184343|NCT01142193|453959133|FG001|Overall Study|Other|2|||
126184344|NCT01459068|453959134|FG000|Overall Study|Withdrawal by Subject|8|||
126184345|NCT01459068|453959135|FG001|Overall Study|Withdrawal by Subject|18|||
126184346|NCT01459068|453959134|FG000|Overall Study|Lost to Follow-up|31|||
126184347|NCT01459068|453959135|FG001|Overall Study|Lost to Follow-up|15|||
126184348|NCT01459068|453959134|FG000|Overall Study|Death|0|||
126184349|NCT01459068|453959135|FG001|Overall Study|Death|1|||
126184350|NCT00196196|453959138|FG000|Overall Study|Withdrawal by Subject|2|||
126184351|NCT00196196|453959138|FG000|Overall Study|Did not have required condition (hydroce|5|||
126184352|NCT02910219|453959139|FG000|Overall Study|Withdrawal by Subject|1|||
126184353|NCT02910219|453959140|FG001|Overall Study|Withdrawal by Subject|1|||
126184354|NCT01015820|453959141|FG000|Overall Study|Suboptimal measurements|1|||
126184355|NCT01015820|453959142|FG001|Overall Study|Suboptimal measurements|0|||
126184356|NCT00701441|453959143|FG000|Overall Study|failure in cpap compliance|0|||
126184357|NCT00701441|453959144|FG001|Overall Study|failure in cpap compliance|4|||
126184358|NCT02679781|453959148|FG000|Overall Study|Lost to Follow-up|1|||
126184359|NCT02679781|453959149|FG001|Overall Study|Lost to Follow-up|2|||
126184360|NCT02679781|453959148|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
126184361|NCT02679781|453959149|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
126184362|NCT04209400|453959150|FG000|Overall Study|Withdrawal by Subject|0|||
126184363|NCT04209400|453959151|FG001|Overall Study|Withdrawal by Subject|1|||
126184364|NCT00970268|453959157|FG000|Overall Study|Withdrawal by Subject|12|||
126184365|NCT00970268|453959158|FG001|Overall Study|Withdrawal by Subject|19|||
126184366|NCT00970268|453959157|FG000|Overall Study|Adverse Event|15|||
126184367|NCT00970268|453959158|FG001|Overall Study|Adverse Event|12|||
126184368|NCT00970268|453959157|FG000|Overall Study|Lack of Efficacy|3|||
126184369|NCT00970268|453959158|FG001|Overall Study|Lack of Efficacy|6|||
126184370|NCT00970268|453959157|FG000|Overall Study|Protocol Violation|4|||
126184371|NCT00970268|453959158|FG001|Overall Study|Protocol Violation|7|||
126184372|NCT00970268|453959157|FG000|Overall Study|Other Reason|3|||
126184373|NCT00970268|453959158|FG001|Overall Study|Other Reason|1|||
126184374|NCT00970268|453959157|FG000|Overall Study|COPD Exacerbation|4|||
126184375|NCT00970268|453959158|FG001|Overall Study|COPD Exacerbation|2|||
126184376|NCT00970268|453959157|FG000|Overall Study|Lost to Follow-up|1|||
126184377|NCT00970268|453959158|FG001|Overall Study|Lost to Follow-up|2|||
126184378|NCT00970268|453959157|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
126184379|NCT00970268|453959158|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
126184380|NCT01203787|453959159|FG000|Overall Study|Death|12|||
126184381|NCT01203787|453959160|FG001|Overall Study|Death|10|||
126184382|NCT01203787|453959159|FG000|Overall Study|Withdrawal by Subject|6|||
126184383|NCT01203787|453959160|FG001|Overall Study|Withdrawal by Subject|2|||
126184384|NCT01203787|453959159|FG000|Overall Study|Lost to Follow-up|2|||
126184385|NCT01203787|453959160|FG001|Overall Study|Lost to Follow-up|0|||
126184386|NCT01203787|453959159|FG000|Overall Study|Adverse Event|11|||
126184387|NCT01203787|453959160|FG001|Overall Study|Adverse Event|15|||
126184388|NCT03404518|453959161|FG000|Overall Study|Lost to Follow-up|28|||
126184389|NCT03404518|453959162|FG001|Overall Study|Lost to Follow-up|30|||
126184390|NCT03404518|453959161|FG000|Overall Study|Protocol Violation|13|||
126184391|NCT03404518|453959162|FG001|Overall Study|Protocol Violation|6|||
126184392|NCT03693404|453959167|FG000|Overall Study|Withdrawal by Subject|1|||
126184393|NCT03693404|453959168|FG001|Overall Study|Withdrawal by Subject|0|||
126184394|NCT03693404|453959167|FG000|Overall Study|Lost to Follow-up|0|||
126184395|NCT03693404|453959168|FG001|Overall Study|Lost to Follow-up|5|||
126184396|NCT03693404|453959167|FG000|Overall Study|Excluded from Analysis|0|||
126184397|NCT03693404|453959168|FG001|Overall Study|Excluded from Analysis|1|||
126184398|NCT02079519|453959169|FG000|Overall Study|Disease Progression|9|||
126184399|NCT02079519|453959169|FG000|Overall Study|Adverse Event|1|||
126184400|NCT01685203|453959174|FG000|Overall Study|Lost to Follow-up|3|||
126184401|NCT01685203|453959175|FG001|Overall Study|Lost to Follow-up|3|||
126184402|NCT01685203|453959176|FG002|Overall Study|Lost to Follow-up|0|||
126184403|NCT01685203|453959177|FG003|Overall Study|Lost to Follow-up|1|||
126184404|NCT01685203|453959178|FG004|Overall Study|Lost to Follow-up|0|||
126184405|NCT01685203|453959179|FG005|Overall Study|Lost to Follow-up|0|||
126184406|NCT01685203|453959180|FG006|Overall Study|Lost to Follow-up|0|||
126184407|NCT01685203|453959174|FG000|Overall Study|Adverse Event|0|||
126184408|NCT01685203|453959175|FG001|Overall Study|Adverse Event|0|||
126184409|NCT01685203|453959176|FG002|Overall Study|Adverse Event|0|||
126184410|NCT01685203|453959177|FG003|Overall Study|Adverse Event|0|||
126184411|NCT01685203|453959178|FG004|Overall Study|Adverse Event|0|||
126184412|NCT01685203|453959179|FG005|Overall Study|Adverse Event|2|||
126184413|NCT01685203|453959180|FG006|Overall Study|Adverse Event|0|||
126184414|NCT01685203|453959174|FG000|Overall Study|Adverse event and withdrew consent|1|||
126184415|NCT01685203|453959175|FG001|Overall Study|Adverse event and withdrew consent|0|||
126184416|NCT01685203|453959176|FG002|Overall Study|Adverse event and withdrew consent|0|||
126184417|NCT01685203|453959177|FG003|Overall Study|Adverse event and withdrew consent|0|||
126184418|NCT01685203|453959178|FG004|Overall Study|Adverse event and withdrew consent|0|||
126184419|NCT01685203|453959179|FG005|Overall Study|Adverse event and withdrew consent|0|||
126184420|NCT01685203|453959180|FG006|Overall Study|Adverse event and withdrew consent|0|||
126184421|NCT01685203|453959174|FG000|Overall Study|Patient's decision|0|||
126184422|NCT01685203|453959175|FG001|Overall Study|Patient's decision|0|||
126184423|NCT01685203|453959176|FG002|Overall Study|Patient's decision|0|||
126184424|NCT01685203|453959177|FG003|Overall Study|Patient's decision|0|||
126184425|NCT01685203|453959178|FG004|Overall Study|Patient's decision|0|||
126184426|NCT01685203|453959179|FG005|Overall Study|Patient's decision|1|||
126184427|NCT01685203|453959180|FG006|Overall Study|Patient's decision|0|||
126184428|NCT00383708|453959181|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
126184429|NCT00383708|453959181|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
126184430|NCT00383708|453959181|FG000|Run-in Period|Protocol Violation|4|||
126184431|NCT00383708|453959181|FG000|Run-in Period|Adverse Event|2|||
126184432|NCT00383708|453959181|FG000|Run-in Period|Claustrophobia|1|||
126184433|NCT00383708|453959181|FG000|Co-administration Period|Adverse Event|5|||
126184434|NCT00318370|453959182|FG000|Period 1|Lack of Efficacy|5|||
126184435|NCT00318370|453959183|FG001|Period 1|Lack of Efficacy|0|||
126184436|NCT00318370|453959184|FG002|Period 1|Lack of Efficacy|0|||
126184437|NCT00318370|453959182|FG000|Period 1|Physician Decision|1|||
126184438|NCT00318370|453959183|FG001|Period 1|Physician Decision|0|||
126184439|NCT00318370|453959184|FG002|Period 1|Physician Decision|0|||
126184440|NCT00318370|453959182|FG000|Period 1|Withdrawal by Subject|1|||
126184441|NCT00318370|453959183|FG001|Period 1|Withdrawal by Subject|0|||
126184442|NCT00318370|453959184|FG002|Period 1|Withdrawal by Subject|0|||
126184443|NCT00318370|453959182|FG000|Period 2|Adverse Event|0|||
126184444|NCT00318370|453959183|FG001|Period 2|Adverse Event|3|||
126184445|NCT00318370|453959184|FG002|Period 2|Adverse Event|0|||
126184446|NCT00318370|453959182|FG000|Period 2|Lack of Efficacy|0|||
126184447|NCT00318370|453959183|FG001|Period 2|Lack of Efficacy|5|||
126184448|NCT00318370|453959184|FG002|Period 2|Lack of Efficacy|0|||
126184449|NCT00318370|453959182|FG000|Period 2|Physician Decision|0|||
126184450|NCT00318370|453959183|FG001|Period 2|Physician Decision|1|||
126184451|NCT00318370|453959184|FG002|Period 2|Physician Decision|0|||
126184452|NCT00318370|453959182|FG000|Period 2|Withdrawal by Subject|0|||
126184453|NCT00318370|453959183|FG001|Period 2|Withdrawal by Subject|1|||
126184454|NCT00318370|453959184|FG002|Period 2|Withdrawal by Subject|0|||
126184455|NCT00318370|453959182|FG000|Period 2|Other|0|||
126184456|NCT00318370|453959183|FG001|Period 2|Other|1|||
126184457|NCT00318370|453959184|FG002|Period 2|Other|0|||
126184458|NCT00318370|453959182|FG000|Period 3|Adverse Event|0|||
126184459|NCT00318370|453959183|FG001|Period 3|Adverse Event|0|||
126184460|NCT00318370|453959184|FG002|Period 3|Adverse Event|1|||
126184461|NCT00318370|453959182|FG000|Period 3|Lack of Efficacy|0|||
126184462|NCT00318370|453959183|FG001|Period 3|Lack of Efficacy|0|||
126184463|NCT00318370|453959184|FG002|Period 3|Lack of Efficacy|24|||
126184464|NCT00318370|453959182|FG000|Period 3|Death|0|||
126184465|NCT00318370|453959183|FG001|Period 3|Death|0|||
126184466|NCT00318370|453959184|FG002|Period 3|Death|1|||
126184467|NCT00318370|453959182|FG000|Period 3|Physician Decision|0|||
126184468|NCT00318370|453959183|FG001|Period 3|Physician Decision|0|||
126184469|NCT00318370|453959184|FG002|Period 3|Physician Decision|1|||
126184470|NCT00318370|453959182|FG000|Period 3|Withdrawal by Subject|0|||
126184471|NCT00318370|453959183|FG001|Period 3|Withdrawal by Subject|0|||
126184472|NCT00318370|453959184|FG002|Period 3|Withdrawal by Subject|3|||
126184473|NCT00318370|453959182|FG000|Period 3|Other|0|||
126184474|NCT00318370|453959183|FG001|Period 3|Other|0|||
126184475|NCT00318370|453959184|FG002|Period 3|Other|3|||
126184476|NCT01750840|453959185|FG000|Overall Study|Lost to Follow-up|4|||
126184477|NCT01576406|453959187|FG000|Overall Study|Lost to Follow-up|1|||
126184478|NCT01576406|453959188|FG001|Overall Study|Lost to Follow-up|2|||
126184479|NCT01576406|453959189|FG002|Overall Study|Lost to Follow-up|0|||
126184480|NCT01576406|453959190|FG003|Overall Study|Lost to Follow-up|0|||
126184481|NCT01576406|453959191|FG004|Overall Study|Lost to Follow-up|0|||
126184482|NCT01576406|453959192|FG005|Overall Study|Lost to Follow-up|0|||
126184483|NCT01576406|453959187|FG000|Overall Study|Death|3|||
126184484|NCT01576406|453959188|FG001|Overall Study|Death|4|||
126184485|NCT01576406|453959189|FG002|Overall Study|Death|8|||
126184486|NCT01576406|453959190|FG003|Overall Study|Death|5|||
126184487|NCT01576406|453959191|FG004|Overall Study|Death|7|||
126184488|NCT01576406|453959192|FG005|Overall Study|Death|9|||
126184489|NCT01576406|453959187|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
126184490|NCT01576406|453959188|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
126184491|NCT01576406|453959189|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
126184492|NCT01576406|453959190|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
126184493|NCT01576406|453959191|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
126184494|NCT01576406|453959192|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
126184495|NCT01576406|453959187|FG000|Overall Study|Withdrawal the consent|2|||
126184496|NCT01576406|453959188|FG001|Overall Study|Withdrawal the consent|2|||
126184497|NCT01576406|453959189|FG002|Overall Study|Withdrawal the consent|5|||
126184498|NCT01576406|453959190|FG003|Overall Study|Withdrawal the consent|1|||
126184499|NCT01576406|453959191|FG004|Overall Study|Withdrawal the consent|1|||
126184500|NCT01576406|453959192|FG005|Overall Study|Withdrawal the consent|3|||
126184501|NCT01576406|453959187|FG000|Overall Study|Other|0|||
126184502|NCT01576406|453959188|FG001|Overall Study|Other|0|||
126184503|NCT01576406|453959189|FG002|Overall Study|Other|2|||
126184504|NCT01576406|453959190|FG003|Overall Study|Other|2|||
126184505|NCT01576406|453959191|FG004|Overall Study|Other|0|||
126184506|NCT01576406|453959192|FG005|Overall Study|Other|0|||
126184507|NCT00669032|453959197|FG000|Overall Study|Lost to Follow-up|6|||
126184508|NCT00669032|453959198|FG001|Overall Study|Lost to Follow-up|5|||
126184509|NCT00669032|453959197|FG000|Overall Study|Lack of Efficacy|8|||
126184510|NCT00669032|453959198|FG001|Overall Study|Lack of Efficacy|19|||
126184511|NCT00669032|453959197|FG000|Overall Study|Withdrawal by Subject|12|||
126184512|NCT00669032|453959198|FG001|Overall Study|Withdrawal by Subject|13|||
126184513|NCT00669032|453959197|FG000|Overall Study|Adverse Event|12|||
126184514|NCT00669032|453959198|FG001|Overall Study|Adverse Event|16|||
126184515|NCT00669032|453959197|FG000|Overall Study|Physician Decision|1|||
126184516|NCT00669032|453959198|FG001|Overall Study|Physician Decision|1|||
126184517|NCT00669032|453959197|FG000|Overall Study|No fulfilment of the selection criteria|5|||
126184518|NCT00669032|453959198|FG001|Overall Study|No fulfilment of the selection criteria|5|||
126184519|NCT03627494|453959199|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
126184520|NCT03627494|453959200|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184521|NCT03627494|453959201|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
126184522|NCT03627494|453959202|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184523|NCT03627494|453959203|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184524|NCT03627494|453959204|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184525|NCT03627494|453959205|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184526|NCT03627494|453959206|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184527|NCT03627494|453959207|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184528|NCT03627494|453959208|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184529|NCT03627494|453959209|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184530|NCT03627494|453959210|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
126184531|NCT03627494|453959199|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184532|NCT03627494|453959200|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184533|NCT03627494|453959201|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184534|NCT03627494|453959202|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184535|NCT03627494|453959203|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184536|NCT03627494|453959204|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184537|NCT03627494|453959205|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184538|NCT03627494|453959206|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184539|NCT03627494|453959207|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
126184540|NCT03627494|453959208|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184541|NCT03627494|453959209|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184542|NCT03627494|453959210|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
126184543|NCT03627494|453959199|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184544|NCT03627494|453959200|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184545|NCT03627494|453959201|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184546|NCT03627494|453959202|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184547|NCT03627494|453959203|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184548|NCT03627494|453959204|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184549|NCT03627494|453959205|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184550|NCT03627494|453959206|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184551|NCT03627494|453959207|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184552|NCT03627494|453959208|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
126184553|NCT03627494|453959209|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
126184554|NCT03627494|453959210|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
126184555|NCT03906136|453961702|FG000|Overall Study|Adverse Event|1|||
126184556|NCT03906136|453961703|FG001|Overall Study|Adverse Event|0|||
126184557|NCT03906136|453961702|FG000|Overall Study|Lost to Follow-up|7|||
126184558|NCT03906136|453961703|FG001|Overall Study|Lost to Follow-up|4|||
126184559|NCT03906136|453961702|FG000|Overall Study|Physician Decision|1|||
126184560|NCT03906136|453961703|FG001|Overall Study|Physician Decision|0|||
126184561|NCT03906136|453961702|FG000|Overall Study|Withdrawal by Subject|3|||
126184562|NCT03906136|453961703|FG001|Overall Study|Withdrawal by Subject|7|||
126184563|NCT00323310|453961706|FG000|Overall Study|Withdrawal by Subject|1|||
126184564|NCT00323310|453961706|FG000|Overall Study|a parent refused blood draw|1|||
126184565|NCT00323310|453961706|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
126184566|NCT03984812|453961707|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184567|NCT03984812|453961708|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184568|NCT03984812|453961709|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
126184569|NCT03984812|453961710|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184570|NCT03984812|453961711|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184571|NCT03984812|453961712|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184572|NCT03984812|453961713|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184573|NCT03984812|453961714|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184574|NCT03984812|453961715|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184575|NCT03984812|453961716|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184576|NCT03984812|453961717|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126184577|NCT00446641|453961718|FG000|Overall Study|Withdrawal by Subject|8|||
126184578|NCT00446641|453961719|FG001|Overall Study|Withdrawal by Subject|3|||
126184579|NCT00446641|453961718|FG000|Overall Study|poor compliance|8|||
126184580|NCT00446641|453961719|FG001|Overall Study|poor compliance|6|||
126184581|NCT00446641|453961718|FG000|Overall Study|Lost to Follow-up|1|||
126184582|NCT00446641|453961719|FG001|Overall Study|Lost to Follow-up|1|||
126184583|NCT03565991|453961721|FG000|Overall Study|Other|11|||
126184584|NCT03565991|453961722|FG001|Overall Study|Other|0|||
126184585|NCT03565991|453961721|FG000|Overall Study|Global deterioration of health status|14|||
126184586|NCT03565991|453961722|FG001|Overall Study|Global deterioration of health status|4|||
126184587|NCT03565991|453961721|FG000|Overall Study|Withdrawal by Subject|2|||
126184588|NCT03565991|453961722|FG001|Overall Study|Withdrawal by Subject|6|||
126184589|NCT03565991|453961721|FG000|Overall Study|Progressive disease|121|||
126184590|NCT03565991|453961722|FG001|Overall Study|Progressive disease|29|||
126184591|NCT03565991|453961721|FG000|Overall Study|Death|3|||
126184592|NCT03565991|453961722|FG001|Overall Study|Death|0|||
126184593|NCT03565991|453961721|FG000|Overall Study|Adverse Event|7|||
126184594|NCT03565991|453961722|FG001|Overall Study|Adverse Event|2|||
126184595|NCT03424044|453961724|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126184596|NCT03424044|453961725|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126184597|NCT03424044|453961726|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
126184598|NCT03424044|453961727|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126184599|NCT03424044|453961728|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126184600|NCT03424044|453961729|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126184601|NCT03424044|453961730|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126184602|NCT03424044|453961731|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126184603|NCT03424044|453961732|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126184604|NCT03424044|453961724|FG000|First Intervention (76 Hours)|Adverse Event|0|||
126184605|NCT03424044|453961725|FG001|First Intervention (76 Hours)|Adverse Event|0|||
126184606|NCT03424044|453961726|FG002|First Intervention (76 Hours)|Adverse Event|0|||
126184607|NCT03424044|453961727|FG003|First Intervention (76 Hours)|Adverse Event|0|||
126184608|NCT03424044|453961728|FG004|First Intervention (76 Hours)|Adverse Event|1|||
126184609|NCT03424044|453961729|FG005|First Intervention (76 Hours)|Adverse Event|0|||
126184610|NCT03424044|453961730|FG006|First Intervention (76 Hours)|Adverse Event|0|||
126184611|NCT03424044|453961731|FG007|First Intervention (76 Hours)|Adverse Event|0|||
126184612|NCT03424044|453961732|FG008|First Intervention (76 Hours)|Adverse Event|0|||
126184613|NCT03424044|453961724|FG000|First Intervention (76 Hours)|device issues|0|||
126184614|NCT03424044|453961725|FG001|First Intervention (76 Hours)|device issues|0|||
126184615|NCT03424044|453961726|FG002|First Intervention (76 Hours)|device issues|0|||
126184616|NCT03424044|453961727|FG003|First Intervention (76 Hours)|device issues|0|||
126184617|NCT03424044|453961728|FG004|First Intervention (76 Hours)|device issues|0|||
126184618|NCT03424044|453961729|FG005|First Intervention (76 Hours)|device issues|0|||
126184619|NCT03424044|453961730|FG006|First Intervention (76 Hours)|device issues|1|||
126184620|NCT03424044|453961731|FG007|First Intervention (76 Hours)|device issues|1|||
126184621|NCT03424044|453961732|FG008|First Intervention (76 Hours)|device issues|1|||
126184622|NCT03424044|453961724|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
126184623|NCT03424044|453961725|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
126184624|NCT03424044|453961726|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
126184625|NCT03424044|453961727|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
126184626|NCT03424044|453961728|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
126184627|NCT03424044|453961729|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
126184628|NCT03424044|453961730|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
126184629|NCT03424044|453961731|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
126184630|NCT03424044|453961732|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
126184631|NCT03424044|453961724|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126184632|NCT03424044|453961725|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126184633|NCT03424044|453961726|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126184634|NCT03424044|453961727|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
126184635|NCT03424044|453961728|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126184636|NCT03424044|453961729|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126184637|NCT03424044|453961730|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126184638|NCT03424044|453961731|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126184639|NCT03424044|453961732|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126184640|NCT02971007|453961733|FG000|Overall Study|Adverse Event|1|||
126184641|NCT02971007|453961734|FG001|Overall Study|Adverse Event|0|||
126184642|NCT02971007|453961735|FG002|Overall Study|Adverse Event|0|||
126184643|NCT02971007|453961733|FG000|Overall Study|Lost to Follow-up|0|||
126184644|NCT02971007|453961734|FG001|Overall Study|Lost to Follow-up|1|||
126184645|NCT02971007|453961735|FG002|Overall Study|Lost to Follow-up|1|||
126184646|NCT02971007|453961733|FG000|Overall Study|Withdrawal by Subject|0|||
126184647|NCT02971007|453961734|FG001|Overall Study|Withdrawal by Subject|1|||
126184648|NCT02971007|453961735|FG002|Overall Study|Withdrawal by Subject|0|||
126184649|NCT02971007|453961733|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
126184650|NCT02971007|453961734|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
126184651|NCT02971007|453961735|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
126184652|NCT02971007|453961733|FG000|Overall Study|Patient discontinued study drug|0|||
126184653|NCT02971007|453961734|FG001|Overall Study|Patient discontinued study drug|1|||
126184654|NCT02971007|453961735|FG002|Overall Study|Patient discontinued study drug|0|||
126184655|NCT00402285|453961738|FG000|Overall Study|insufficient RNA quality|7|||
126184656|NCT00402285|453961739|FG001|Overall Study|insufficient RNA quality|6|||
126184657|NCT00402285|453961740|FG002|Overall Study|insufficient RNA quality|2|||
126184658|NCT00784459|453961741|FG000|Overall Study|Adverse Event|0|||
126184659|NCT00784459|453961742|FG001|Overall Study|Adverse Event|2|||
126184660|NCT02707601|453961743|FG000|Overall Study|Death|0|||
126184661|NCT02707601|453961744|FG001|Overall Study|Death|1|||
126184662|NCT02707601|453961743|FG000|Overall Study|Lack of Efficacy|0|||
126184663|NCT02707601|453961744|FG001|Overall Study|Lack of Efficacy|1|||
126184664|NCT02707601|453961743|FG000|Overall Study|Investigator's Discretion|1|||
126184665|NCT02707601|453961744|FG001|Overall Study|Investigator's Discretion|0|||
126184666|NCT02707601|453961743|FG000|Overall Study|Withdrew Consent|0|||
126184667|NCT02707601|453961744|FG001|Overall Study|Withdrew Consent|1|||
126184668|NCT02707601|453961743|FG000|Overall Study|Lost to Follow-up|1|||
126184669|NCT02707601|453961744|FG001|Overall Study|Lost to Follow-up|1|||
126184670|NCT02707601|453961743|FG000|Overall Study|Participants Randomized but Not Treated|2|||
126184671|NCT02707601|453961744|FG001|Overall Study|Participants Randomized but Not Treated|0|||
126184672|NCT02009930|453961745|FG000|Overall Study|withdrawn|5|||
126184673|NCT02959970|453961747|FG000|Overall Study|Adverse Event|1|||
126184674|NCT02959970|453961748|FG001|Overall Study|Adverse Event|0|||
126184675|NCT02959970|453961747|FG000|Overall Study|Withdrawal by Subject|0|||
126184676|NCT02959970|453961748|FG001|Overall Study|Withdrawal by Subject|2|||
126184677|NCT02959970|453961747|FG000|Overall Study|Lost to Follow-up|1|||
126184678|NCT02959970|453961748|FG001|Overall Study|Lost to Follow-up|5|||
126184679|NCT00693420|453961749|FG000|Overall Study|Adverse Event|4|||
126184680|NCT00693420|453961750|FG001|Overall Study|Adverse Event|4|||
126184681|NCT00693420|453961749|FG000|Overall Study|Lost to Follow-up|0|||
126184682|NCT00693420|453961750|FG001|Overall Study|Lost to Follow-up|3|||
126184683|NCT00693420|453961749|FG000|Overall Study|Withdrawal by Subject|1|||
126184684|NCT00693420|453961750|FG001|Overall Study|Withdrawal by Subject|0|||
126184685|NCT00693420|453961749|FG000|Overall Study|Protocol Violation|0|||
126184686|NCT00693420|453961750|FG001|Overall Study|Protocol Violation|2|||
126184687|NCT00693420|453961749|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
126184688|NCT00693420|453961750|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
126184689|NCT00693420|453961749|FG000|Overall Study|Personal Reasons|1|||
126184690|NCT00693420|453961750|FG001|Overall Study|Personal Reasons|4|||
126184691|NCT00063986|453961758|FG000|Overall Study|Withdrawal by Subject|1|||
126184692|NCT00063986|453961758|FG000|Overall Study|Ineligible|1|||
126184693|NCT00063986|453961758|FG000|Overall Study|Intra-operatively ineligible|4|||
126184694|NCT01235338|453961759|FG000|Overall Study|Adverse Event|3|||
126184695|NCT01235338|453961760|FG001|Overall Study|Adverse Event|2|||
126184696|NCT01235338|453961759|FG000|Overall Study|Protocol Violation|1|||
126184697|NCT01235338|453961760|FG001|Overall Study|Protocol Violation|1|||
126184698|NCT01235338|453961759|FG000|Overall Study|Withdrawal by Subject|5|||
126184699|NCT01235338|453961760|FG001|Overall Study|Withdrawal by Subject|0|||
126184700|NCT01235338|453961759|FG000|Overall Study|Exclusion criteria violations|1|||
126184701|NCT01235338|453961760|FG001|Overall Study|Exclusion criteria violations|1|||
126184702|NCT01235338|453961759|FG000|Overall Study|Positive drug screen|0|||
126184703|NCT01235338|453961760|FG001|Overall Study|Positive drug screen|1|||
126184704|NCT01235338|453961759|FG000|Overall Study|Prohibited meds|1|||
126184705|NCT01235338|453961760|FG001|Overall Study|Prohibited meds|0|||
126184706|NCT00948428|453961764|FG000|Overall Study|Withdrawal by Subject|6|||
126184707|NCT00948428|453961765|FG001|Overall Study|Withdrawal by Subject|12|||
126184708|NCT00948428|453961766|FG002|Overall Study|Withdrawal by Subject|7|||
126184709|NCT00948428|453961764|FG000|Overall Study|Adverse Event|6|||
126184710|NCT00948428|453961765|FG001|Overall Study|Adverse Event|3|||
126184711|NCT00948428|453961766|FG002|Overall Study|Adverse Event|0|||
126184712|NCT00948428|453961764|FG000|Overall Study|Lost to Follow-up|2|||
126184713|NCT00948428|453961765|FG001|Overall Study|Lost to Follow-up|1|||
126184714|NCT00948428|453961766|FG002|Overall Study|Lost to Follow-up|1|||
126184715|NCT00948428|453961764|FG000|Overall Study|Death|2|||
126184716|NCT00948428|453961765|FG001|Overall Study|Death|0|||
126184717|NCT00948428|453961766|FG002|Overall Study|Death|0|||
126184718|NCT00948428|453961764|FG000|Overall Study|Intercurrent Illness|1|||
126184719|NCT00948428|453961765|FG001|Overall Study|Intercurrent Illness|0|||
126184720|NCT00948428|453961766|FG002|Overall Study|Intercurrent Illness|0|||
126184721|NCT00948428|453961764|FG000|Overall Study|Non-compliance|1|||
126184722|NCT00948428|453961765|FG001|Overall Study|Non-compliance|2|||
126184723|NCT00948428|453961766|FG002|Overall Study|Non-compliance|0|||
126184724|NCT00509028|453961767|FG000|Overall Study|Adverse Event|2|||
126184725|NCT00509028|453961768|FG001|Overall Study|Adverse Event|0|||
126184726|NCT00509028|453961767|FG000|Overall Study|Withdrawal by Subject|4|||
126184727|NCT00509028|453961768|FG001|Overall Study|Withdrawal by Subject|3|||
126184728|NCT00509028|453961767|FG000|Overall Study|Lost to Follow-up|0|||
126184729|NCT00509028|453961768|FG001|Overall Study|Lost to Follow-up|1|||
126184730|NCT00509028|453961767|FG000|Overall Study|Protocol Violation|4|||
126184731|NCT00509028|453961768|FG001|Overall Study|Protocol Violation|2|||
126184732|NCT00509028|453961767|FG000|Overall Study|Non-compliance|2|||
126184733|NCT00509028|453961768|FG001|Overall Study|Non-compliance|1|||
126184734|NCT04839393|453961772|FG000|Overall Study|Adverse Event|0|||
126184735|NCT04839393|453961773|FG001|Overall Study|Adverse Event|0|||
126184736|NCT04839393|453961774|FG002|Overall Study|Adverse Event|2|||
126184737|NCT04839393|453961772|FG000|Overall Study|Withdrawal by participant|0|||
126184738|NCT04839393|453961773|FG001|Overall Study|Withdrawal by participant|0|||
126184739|NCT04839393|453961774|FG002|Overall Study|Withdrawal by participant|1|||
126184740|NCT00633893|453961777|FG000|Overall Study|Death|1|||
126184741|NCT00633893|453961778|FG001|Overall Study|Death|3|||
126184742|NCT00633893|453961779|FG002|Overall Study|Death|9|||
126184743|NCT00633893|453961777|FG000|Overall Study|Adverse Event|65|||
126184744|NCT00633893|453961778|FG001|Overall Study|Adverse Event|58|||
126184745|NCT00633893|453961779|FG002|Overall Study|Adverse Event|126|||
126184746|NCT00633893|453961777|FG000|Overall Study|Withdrawal by Subject|7|||
126184747|NCT00633893|453961778|FG001|Overall Study|Withdrawal by Subject|12|||
126184748|NCT00633893|453961779|FG002|Overall Study|Withdrawal by Subject|6|||
126184749|NCT00633893|453961777|FG000|Overall Study|Lost to Follow-up|2|||
126184750|NCT00633893|453961778|FG001|Overall Study|Lost to Follow-up|4|||
126184751|NCT00633893|453961779|FG002|Overall Study|Lost to Follow-up|8|||
126184752|NCT00633893|453961777|FG000|Overall Study|Poor/non-compliance|5|||
126184753|NCT00633893|453961778|FG001|Overall Study|Poor/non-compliance|12|||
126184754|NCT00633893|453961779|FG002|Overall Study|Poor/non-compliance|3|||
126184755|NCT00633893|453961777|FG000|Overall Study|Pregnancy|2|||
126184756|NCT00633893|453961778|FG001|Overall Study|Pregnancy|1|||
126184757|NCT00633893|453961779|FG002|Overall Study|Pregnancy|1|||
126184758|NCT00633893|453961777|FG000|Overall Study|Not meet/no longer meets criteria|4|||
126184759|NCT00633893|453961778|FG001|Overall Study|Not meet/no longer meets criteria|6|||
126184760|NCT00633893|453961779|FG002|Overall Study|Not meet/no longer meets criteria|4|||
126184761|NCT00633893|453961777|FG000|Overall Study|Other|28|||
126184762|NCT00633893|453961778|FG001|Overall Study|Other|33|||
126184763|NCT00633893|453961779|FG002|Overall Study|Other|31|||
126184764|NCT02741310|453961780|FG000|Overall Study|Sponsor Decision|2|||
126184765|NCT02741310|453961781|FG001|Overall Study|Sponsor Decision|2|||
126184766|NCT05091918|453961782|FG000|Overall Study|Adverse Event|1|||
126184767|NCT05091918|453961782|FG000|Overall Study|Withdrawal by Subject|81|||
126184768|NCT00239356|453961783|FG000|Overall Study|Lack of Efficacy|1|||
126184769|NCT00239356|453961784|FG001|Overall Study|Lack of Efficacy|0|||
126184770|NCT00239356|453961783|FG000|Overall Study|Adverse Event|6|||
126184771|NCT00239356|453961784|FG001|Overall Study|Adverse Event|0|||
126184772|NCT00239356|453961783|FG000|Overall Study|Withdrawal by Subject|15|||
126184773|NCT00239356|453961784|FG001|Overall Study|Withdrawal by Subject|6|||
126184774|NCT00239356|453961783|FG000|Overall Study|Lost to Follow-up|3|||
126184775|NCT00239356|453961784|FG001|Overall Study|Lost to Follow-up|0|||
126184776|NCT00239356|453961783|FG000|Overall Study|poor/non-compliance|2|||
126184777|NCT00239356|453961784|FG001|Overall Study|poor/non-compliance|0|||
126184778|NCT00239356|453961783|FG000|Overall Study|Pregnancy|1|||
126184779|NCT00239356|453961784|FG001|Overall Study|Pregnancy|0|||
126184780|NCT00239356|453961783|FG000|Overall Study|Administrative reason|0|||
126184781|NCT00239356|453961784|FG001|Overall Study|Administrative reason|1|||
126184782|NCT00239356|453961783|FG000|Overall Study|Drug available on market|11|||
126184783|NCT00239356|453961784|FG001|Overall Study|Drug available on market|2|||
126184784|NCT02044822|453961785|FG000|Overall Study|Study Terminated by Sponsor|77|||
126184785|NCT02044822|453961785|FG000|Overall Study|Investigator's Discretion|10|||
126184786|NCT02044822|453961785|FG000|Overall Study|Withdrew Consent|3|||
126184787|NCT02044822|453961785|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
126184788|NCT02044822|453961785|FG000|Overall Study|Lost to Follow-up|1|||
126184789|NCT03417505|453961788|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
126184790|NCT03417505|453961789|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
126184791|NCT00282568|453961792|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
126184792|NCT00282568|453961792|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
126184793|NCT00282568|453961792|FG000|Extended Treatment Period|Adverse Event|17|||
126184794|NCT00282568|453961792|FG000|Extended Treatment Period|Non-compliance|4|||
126184795|NCT00282568|453961792|FG000|Extended Treatment Period|Physician Decision|1|||
126184796|NCT00282568|453961792|FG000|Extended Treatment Period|Lost to Follow-up|2|||
126184797|NCT03006926|453961793|FG000|Overall Study|Adverse Event|0|||
126184798|NCT03006926|453961794|FG001|Overall Study|Adverse Event|27|||
126184799|NCT03006926|453961793|FG000|Overall Study|Withdrawal by Subject|0|||
126184800|NCT03006926|453961794|FG001|Overall Study|Withdrawal by Subject|1|||
126184801|NCT03006926|453961793|FG000|Overall Study|Radiological Disease Progression|0|||
126184802|NCT03006926|453961794|FG001|Overall Study|Radiological Disease Progression|52|||
126184803|NCT03006926|453961793|FG000|Overall Study|Clinical Disease Progression|0|||
126184804|NCT03006926|453961794|FG001|Overall Study|Clinical Disease Progression|10|||
126184805|NCT03006926|453961793|FG000|Overall Study|Other|0|||
126184806|NCT03006926|453961794|FG001|Overall Study|Other|8|||
126184807|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
126184808|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
126184809|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
126184810|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
126184811|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
126184812|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
126184813|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
126184814|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
126184815|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
126184816|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
126184817|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
126184818|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
126184819|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
126184820|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
126184821|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
126184822|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
126184823|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
126184824|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
126184825|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
126184826|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
126184827|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
126184828|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
126184829|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
126184830|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
126184831|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
126184832|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
126184833|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
126184834|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
126184835|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
126184836|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
126184837|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
126184838|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
126184839|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
126184840|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
126184841|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
126184842|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
126184843|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
126184844|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
126184845|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
126184846|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
126184847|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
126184848|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
126184849|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
126184850|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
126184851|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
126184852|NCT03689972|453961795|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
126184853|NCT03689972|453961796|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
126184854|NCT03689972|453961797|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
126184855|NCT03689972|453961798|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
126184856|NCT03689972|453961799|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
126184857|NCT03689972|453961795|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
126184858|NCT03689972|453961796|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
126184859|NCT03689972|453961797|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
126184860|NCT03689972|453961798|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
126184861|NCT03689972|453961799|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
126184862|NCT03689972|453961795|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
126184863|NCT03689972|453961796|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
126184864|NCT03689972|453961797|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
126184865|NCT03689972|453961798|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
126184866|NCT03689972|453961799|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
126184867|NCT03689972|453961795|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
126184868|NCT03689972|453961796|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
126184869|NCT03689972|453961797|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
126184870|NCT03689972|453961798|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
126184871|NCT03689972|453961799|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
126184872|NCT03689972|453961795|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
126184873|NCT03689972|453961796|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
126184874|NCT03689972|453961797|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
126184875|NCT03689972|453961798|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
126184876|NCT03689972|453961799|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
126184877|NCT03689972|453961795|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
126184878|NCT03689972|453961796|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
126184879|NCT03689972|453961797|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
126184880|NCT03689972|453961798|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
126184881|NCT03689972|453961799|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
126184882|NCT03689972|453961795|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
126184883|NCT03689972|453961796|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
126184884|NCT03689972|453961797|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
126184885|NCT03689972|453961798|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
126184886|NCT03689972|453961799|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
126184887|NCT03689972|453961795|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
126184888|NCT03689972|453961796|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
126184889|NCT03689972|453961797|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
126184890|NCT03689972|453961798|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
126184891|NCT03689972|453961799|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
126184892|NCT03689972|453961795|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
126184893|NCT03689972|453961796|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
126184894|NCT03689972|453961797|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
126184895|NCT03689972|453961798|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
126184896|NCT03689972|453961799|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
126184897|NCT03689972|453961795|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
126184898|NCT03689972|453961796|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
126184899|NCT03689972|453961797|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
126184900|NCT03689972|453961798|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
126184901|NCT03689972|453961799|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
126184902|NCT01838213|453961800|FG000|Overall Study|Ineligible|166|||
126184903|NCT01838213|453961801|FG001|Overall Study|Ineligible|191|||
126184904|NCT02417064|453961806|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
126184905|NCT02417064|453961807|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
126184906|NCT02417064|453961808|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
126184907|NCT02417064|453961806|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
126184908|NCT02417064|453961807|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
126184909|NCT02417064|453961808|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
126184910|NCT02417064|453961806|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
126184911|NCT02417064|453961807|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
126184912|NCT02417064|453961808|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
126184913|NCT02417064|453961806|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
126184914|NCT02417064|453961807|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
126184915|NCT02417064|453961808|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
126184916|NCT02417064|453961806|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
126184917|NCT02417064|453961807|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
126184918|NCT02417064|453961808|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
126184919|NCT02417064|453961806|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
126184920|NCT02417064|453961807|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
126184921|NCT02417064|453961808|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
126184922|NCT02417064|453961806|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
126184923|NCT02417064|453961807|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
126184924|NCT02417064|453961808|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
126184925|NCT02417064|453961806|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
126184926|NCT02417064|453961807|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
126184927|NCT02417064|453961808|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
126184928|NCT02417064|453961806|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
126184929|NCT02417064|453961807|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
126184930|NCT02417064|453961808|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
126184931|NCT02417064|453961806|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
126184932|NCT02417064|453961807|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
126184933|NCT02417064|453961808|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
126184934|NCT02417064|453961806|FG000|Follow-up Phase (24 Weeks)|Other|2|||
126184935|NCT02417064|453961807|FG001|Follow-up Phase (24 Weeks)|Other|2|||
126184936|NCT02417064|453961808|FG002|Follow-up Phase (24 Weeks)|Other|3|||
126184937|NCT00990249|453961811|FG000|Overall Study|Disease Progression|8|||
126184938|NCT00990249|453961811|FG000|Overall Study|Non-Compliance|1|||
126184939|NCT00990249|453961811|FG000|Overall Study|Death|2|||
126184940|NCT00990249|453961811|FG000|Overall Study|Not treated|2|||
126184941|NCT01548417|453961812|FG000|Overall Study|Withdrawal by Subject|0|||
126184942|NCT01548417|453961813|FG001|Overall Study|Withdrawal by Subject|2|||
126184943|NCT04583969|453961814|FG000|Overall Study|Death|31|||
126184944|NCT04583969|453961815|FG001|Overall Study|Death|38|||
126184945|NCT04583969|453961814|FG000|Overall Study|Lost to Follow-up|16|||
126184946|NCT04583969|453961815|FG001|Overall Study|Lost to Follow-up|13|||
126184947|NCT04583969|453961814|FG000|Overall Study|Protocol Violation|1|||
126184948|NCT04583969|453961815|FG001|Overall Study|Protocol Violation|0|||
126184949|NCT04583969|453961814|FG000|Overall Study|Withdrawal by Subject|3|||
126184950|NCT04583969|453961815|FG001|Overall Study|Withdrawal by Subject|3|||
126184951|NCT04583969|453961814|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
126184952|NCT04583969|453961815|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
126184953|NCT04583969|453961814|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
126184954|NCT04583969|453961815|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
126184955|NCT04583969|453961814|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
126184956|NCT04583969|453961815|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
126184957|NCT04583969|453961814|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
126184958|NCT04583969|453961815|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
126184959|NCT04583969|453961814|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
126184960|NCT04583969|453961815|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
126184961|NCT01057862|453961816|FG000|Overall Study|Withdrawal by Subject|1|||
126184962|NCT01057862|453961817|FG001|Overall Study|Withdrawal by Subject|2|||
126184963|NCT00415584|453961818|FG000|Overall Study|Withdrawal by Subject|1|||
126184964|NCT02640755|453961819|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
126184965|NCT02640755|453961820|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
126184966|NCT02640755|453961819|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
126184967|NCT02640755|453961820|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
126184968|NCT02640755|453961819|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
126184969|NCT02640755|453961820|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
126184970|NCT04075396|453961821|FG000|Overall Study|Death|11|||
126184971|NCT04075396|453961822|FG001|Overall Study|Death|9|||
126184972|NCT04075396|453961821|FG000|Overall Study|Withdrawal by Subject|1|||
126184973|NCT04075396|453961822|FG001|Overall Study|Withdrawal by Subject|2|||
126184974|NCT04075396|453961821|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
126184975|NCT04075396|453961822|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
126184976|NCT04075396|453961821|FG000|Overall Study|Enrolled but not-treated|0|||
126184977|NCT04075396|453961822|FG001|Overall Study|Enrolled but not-treated|1|||
126184978|NCT03434041|453961823|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
126184979|NCT03434041|453961824|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
126184980|NCT03434041|453961823|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
126184981|NCT03434041|453961824|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
126184982|NCT03434041|453961823|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
126184983|NCT03434041|453961824|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
126184984|NCT03434041|453961823|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
126184985|NCT03434041|453961824|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
126184986|NCT03434041|453961823|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
126184987|NCT03434041|453961824|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
126184988|NCT03434041|453961823|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
126184989|NCT03434041|453961824|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
126184990|NCT03434041|453961823|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
126184991|NCT03434041|453961824|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
126184992|NCT03434041|453961823|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
126184993|NCT03434041|453961824|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
126184994|NCT03434041|453961823|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
126184995|NCT03434041|453961824|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
126184996|NCT03434041|453961823|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
126184997|NCT03434041|453961824|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
126184998|NCT03434041|453961823|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
126184999|NCT03434041|453961824|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
126185000|NCT03363165|453961825|FG000|3-month Follow-up|Death|0|||
126185001|NCT03363165|453961826|FG001|3-month Follow-up|Death|1|||
126185002|NCT03363165|453961825|FG000|6-month Follow-up|Death|0|||
126185003|NCT03363165|453961826|FG001|6-month Follow-up|Death|1|||
126185004|NCT03363165|453961825|FG000|6-month Follow-up|Withdrawal by Subject|1|||
126185005|NCT03363165|453961826|FG001|6-month Follow-up|Withdrawal by Subject|1|||
126185006|NCT03363165|453961825|FG000|12-month Follow-up|Death|1|||
126185007|NCT03363165|453961826|FG001|12-month Follow-up|Death|1|||
126185008|NCT03363165|453961825|FG000|12-month Follow-up|Withdrawal by Subject|1|||
126185009|NCT03363165|453961826|FG001|12-month Follow-up|Withdrawal by Subject|1|||
126185010|NCT02255760|453961827|FG000|Overall Study|Lost to Follow-up|0|||
126185011|NCT02255760|453961828|FG001|Overall Study|Lost to Follow-up|1|||
126185012|NCT02255760|453961829|FG002|Overall Study|Lost to Follow-up|0|||
126185013|NCT02255760|453961830|FG003|Overall Study|Lost to Follow-up|0|||
126185014|NCT02255760|453961831|FG004|Overall Study|Lost to Follow-up|0|||
126185015|NCT00618813|453961832|FG000|Overall Study|Lack of Efficacy|1|||
126185016|NCT00618813|453961832|FG000|Overall Study|Physician Decision|2|||
126185017|NCT00618813|453961832|FG000|Overall Study|Withdrawal by Subject|1|||
126185018|NCT00003838|453961833|FG000|Overall Study|Death|0|||
126185019|NCT00003838|453961834|FG001|Overall Study|Death|12|||
126185020|NCT00003838|453961835|FG002|Overall Study|Death|7|||
126185021|NCT00003838|453961833|FG000|Overall Study|Lost to Follow-up|0|||
126185022|NCT00003838|453961834|FG001|Overall Study|Lost to Follow-up|1|||
126185023|NCT00003838|453961835|FG002|Overall Study|Lost to Follow-up|1|||
126185024|NCT00003838|453961833|FG000|Overall Study|Disease Progression|0|||
126185025|NCT00003838|453961834|FG001|Overall Study|Disease Progression|12|||
126185026|NCT00003838|453961835|FG002|Overall Study|Disease Progression|0|||
126185027|NCT01809197|453961836|FG000|Overall Study|Lost to Follow-up|4|||
126185028|NCT01809197|453961837|FG001|Overall Study|Lost to Follow-up|2|||
126185029|NCT01809197|453961836|FG000|Overall Study|Adverse Event|2|||
126185030|NCT01809197|453961837|FG001|Overall Study|Adverse Event|3|||
126185031|NCT01809197|453961836|FG000|Overall Study|Failed slit lamp exam|1|||
126185032|NCT01809197|453961837|FG001|Overall Study|Failed slit lamp exam|0|||
126185033|NCT01809197|453961836|FG000|Overall Study|Non-Compliance|1|||
126185034|NCT01809197|453961837|FG001|Overall Study|Non-Compliance|1|||
126185035|NCT01809197|453961836|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
126185036|NCT01809197|453961837|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
126185037|NCT01809197|453961836|FG000|Overall Study|Withdrawal by Subject|1|||
126185038|NCT01809197|453961837|FG001|Overall Study|Withdrawal by Subject|1|||
126185039|NCT01809197|453961836|FG000|Overall Study|Product not available|0|||
126185040|NCT01809197|453961837|FG001|Overall Study|Product not available|1|||
126185041|NCT01484561|453961842|FG000|Overall Study|Lack of Efficacy|3|||
126185042|NCT01484561|453961843|FG001|Overall Study|Lack of Efficacy|1|||
126185043|NCT01484561|453961842|FG000|Overall Study|Lost to Follow-up|1|||
126185044|NCT01484561|453961843|FG001|Overall Study|Lost to Follow-up|0|||
126185045|NCT01484561|453961842|FG000|Overall Study|Withdrawal by Subject|3|||
126185046|NCT01484561|453961843|FG001|Overall Study|Withdrawal by Subject|0|||
126185047|NCT01484561|453961842|FG000|Overall Study|Other|1|||
126185048|NCT01484561|453961843|FG001|Overall Study|Other|1|||
126185049|NCT01484561|453961842|FG000|Overall Study|Adverse Event|1|||
126185050|NCT01484561|453961843|FG001|Overall Study|Adverse Event|4|||
126185051|NCT03371251|453961844|FG000|Overall Study|Withdrawal by Subject|1|||
126185052|NCT03371251|453961845|FG001|Overall Study|Withdrawal by Subject|0|||
126185053|NCT03371251|453961846|FG002|Overall Study|Withdrawal by Subject|1|||
126185054|NCT03371251|453961847|FG003|Overall Study|Withdrawal by Subject|0|||
126185055|NCT03371251|453961848|FG004|Overall Study|Withdrawal by Subject|2|||
126185056|NCT03371251|453961849|FG005|Overall Study|Withdrawal by Subject|2|||
126185057|NCT03371251|453961844|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
126185058|NCT03371251|453961845|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
126185059|NCT03371251|453961846|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
126185060|NCT03371251|453961847|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
126185061|NCT03371251|453961848|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
126185062|NCT03371251|453961849|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
126185063|NCT03371251|453961844|FG000|Overall Study|Adverse Event|0|||
126185064|NCT03371251|453961845|FG001|Overall Study|Adverse Event|0|||
126185065|NCT03371251|453961846|FG002|Overall Study|Adverse Event|0|||
126185066|NCT03371251|453961847|FG003|Overall Study|Adverse Event|0|||
126185067|NCT03371251|453961848|FG004|Overall Study|Adverse Event|1|||
126185068|NCT03371251|453961849|FG005|Overall Study|Adverse Event|0|||
126185069|NCT03371251|453961844|FG000|Overall Study|Decision by Sponsor|0|||
126185070|NCT03371251|453961845|FG001|Overall Study|Decision by Sponsor|0|||
126185071|NCT03371251|453961846|FG002|Overall Study|Decision by Sponsor|0|||
126185072|NCT03371251|453961847|FG003|Overall Study|Decision by Sponsor|0|||
126185073|NCT03371251|453961848|FG004|Overall Study|Decision by Sponsor|2|||
126185074|NCT03371251|453961849|FG005|Overall Study|Decision by Sponsor|0|||
126185075|NCT00291187|453961850|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
126185076|NCT00291187|453961851|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
126185077|NCT00291187|453961852|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
126185078|NCT00291187|453961853|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
126185079|NCT00114218|453961854|FG000|Overall Study|Wrong Cell Type|2|||
126185080|NCT00114218|453961854|FG000|Overall Study|Wrong Primary|1|||
126185081|NCT00114218|453961854|FG000|Overall Study|Never Treated|1|||
126185082|NCT03168555|453961856|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
126185083|NCT03168555|453961856|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
126185084|NCT03168555|453961856|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
126185085|NCT03168555|453961856|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
126185086|NCT01040845|453961857|FG000|Overall Study|Withdrawal by Subject|1|||
126185087|NCT01040845|453961858|FG001|Overall Study|Withdrawal by Subject|1|||
126185088|NCT01040845|453961857|FG000|Overall Study|Physician Decision|1|||
126185089|NCT01040845|453961858|FG001|Overall Study|Physician Decision|0|||
126185090|NCT02708966|453961862|FG000|Overall Study|Lost to Follow-up|2|||
126185091|NCT02708966|453961863|FG001|Overall Study|Lost to Follow-up|2|||
126185092|NCT02959190|453961867|FG000|Open Label|Adverse Event|5|||
126185093|NCT02959190|453961868|FG001|Open Label|Adverse Event|7|||
126185094|NCT02959190|453961869|FG002|Open Label|Adverse Event|3|||
126185095|NCT02959190|453961870|FG003|Open Label|Adverse Event|4|||
126185096|NCT02959190|453961867|FG000|Open Label|Pregnancy|0|||
126185097|NCT02959190|453961868|FG001|Open Label|Pregnancy|1|||
126185098|NCT02959190|453961869|FG002|Open Label|Pregnancy|0|||
126185099|NCT02959190|453961870|FG003|Open Label|Pregnancy|0|||
126185100|NCT02959190|453961867|FG000|Open Label|Withdrawal by Subject|2|||
126185101|NCT02959190|453961868|FG001|Open Label|Withdrawal by Subject|8|||
126185102|NCT02959190|453961869|FG002|Open Label|Withdrawal by Subject|0|||
126185103|NCT02959190|453961870|FG003|Open Label|Withdrawal by Subject|0|||
126185104|NCT02959190|453961867|FG000|Open Label|Physician Decision|0|||
126185105|NCT02959190|453961868|FG001|Open Label|Physician Decision|0|||
126185106|NCT02959190|453961869|FG002|Open Label|Physician Decision|1|||
126185107|NCT02959190|453961870|FG003|Open Label|Physician Decision|0|||
126185108|NCT02959190|453961867|FG000|Open Label|Protocol Violation|0|||
126185109|NCT02959190|453961868|FG001|Open Label|Protocol Violation|0|||
126185110|NCT02959190|453961869|FG002|Open Label|Protocol Violation|0|||
126185111|NCT02959190|453961870|FG003|Open Label|Protocol Violation|2|||
126185112|NCT02959190|453961867|FG000|Post Treatment Follow Up|Adverse Event|1|||
126185113|NCT02959190|453961868|FG001|Post Treatment Follow Up|Adverse Event|1|||
126185114|NCT02959190|453961869|FG002|Post Treatment Follow Up|Adverse Event|0|||
126185115|NCT02959190|453961870|FG003|Post Treatment Follow Up|Adverse Event|0|||
126185116|NCT02959190|453961867|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
126185117|NCT02959190|453961868|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
126185118|NCT02959190|453961869|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
126185119|NCT02959190|453961870|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
126185120|NCT02023268|453961871|FG000|Overall Study|Lack of Efficacy|0|||
126185121|NCT02023268|453961872|FG001|Overall Study|Lack of Efficacy|1|||
126185122|NCT02023268|453961871|FG000|Overall Study|Adverse Event|0|||
126185123|NCT02023268|453961872|FG001|Overall Study|Adverse Event|2|||
126185124|NCT02023268|453961871|FG000|Overall Study|Withdrawal by Subject|0|||
126185125|NCT02023268|453961872|FG001|Overall Study|Withdrawal by Subject|1|||
126185126|NCT04445688|453961873|FG000|Washout (One Week)|Adverse Event|2|||
126185127|NCT04445688|453961873|FG000|Washout (One Week)|Withdrawal by Subject|1|||
126185128|NCT01998399|453961877|FG000|Overall Study|Lost to Follow-up|1|||
126185129|NCT01998399|453961878|FG001|Overall Study|Lost to Follow-up|3|||
126185130|NCT01998399|453961877|FG000|Overall Study|Death|4|||
126185131|NCT01998399|453961878|FG001|Overall Study|Death|2|||
126185132|NCT01998399|453961877|FG000|Overall Study|Study stopped before dosing completed|3|||
126185133|NCT01998399|453961878|FG001|Overall Study|Study stopped before dosing completed|3|||
126185134|NCT01998399|453961877|FG000|Overall Study|Withdrawal by Subject|0|||
126185135|NCT01998399|453961878|FG001|Overall Study|Withdrawal by Subject|1|||
126185136|NCT04114539|453961882|FG000|Overall Study|Adverse Event|14|||
126185137|NCT04114539|453961882|FG000|Overall Study|Lost to Follow-up|2|||
126185138|NCT04114539|453961882|FG000|Overall Study|Non-compliance with Protocol|2|||
126185139|NCT04114539|453961882|FG000|Overall Study|Non-compliance with Study Drug|1|||
126185140|NCT04114539|453961882|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
126185141|NCT04114539|453961882|FG000|Overall Study|Withdrew consent|10|||
126185142|NCT04114539|453961882|FG000|Overall Study|Others not specified|5|||
126185143|NCT04114539|453961882|FG000|Overall Study|Investigator Decision|2|||
126185144|NCT00617591|453961883|FG000|Overall Study|Withdrew consent during Induction|4|||
126185145|NCT00617591|453961883|FG000|Overall Study|Withdrew consent during Maintenance|6|||
126185146|NCT00376246|453961884|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
126185147|NCT00376246|453961885|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
126185148|NCT00376246|453961884|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126185149|NCT00376246|453961885|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
126185150|NCT00376246|453961884|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
126185151|NCT00376246|453961885|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126185152|NCT01072448|453961894|FG000|Overall Study|Adverse Event|9|||
126185153|NCT01072448|453961895|FG001|Overall Study|Adverse Event|10|||
126185154|NCT01072448|453961894|FG000|Overall Study|Subject withdrew consent|4|||
126185155|NCT01072448|453961895|FG001|Overall Study|Subject withdrew consent|9|||
126185156|NCT01072448|453961894|FG000|Overall Study|Protocol deviation|3|||
126185157|NCT01072448|453961895|FG001|Overall Study|Protocol deviation|4|||
126185158|NCT01072448|453961894|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126185159|NCT01072448|453961895|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126185160|NCT01072448|453961894|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126185161|NCT01072448|453961895|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126185162|NCT01072448|453961894|FG000|Overall Study|Lost to Follow-up|1|||
126185163|NCT01072448|453961895|FG001|Overall Study|Lost to Follow-up|1|||
126185164|NCT01072448|453961894|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126185165|NCT01072448|453961895|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126185166|NCT01072448|453961894|FG000|Overall Study|Death|0|||
126185167|NCT01072448|453961895|FG001|Overall Study|Death|2|||
126185168|NCT00418717|453961898|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
126185169|NCT00418717|453961898|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
126185170|NCT01400139|453961899|FG000|HYD Core Study|Adverse Event|210|||
126185171|NCT01400139|453961899|FG000|HYD Core Study|Lack of Efficacy|59|||
126185172|NCT01400139|453961899|FG000|HYD Core Study|Withdrawal by Subject|114|||
126185173|NCT01400139|453961899|FG000|HYD Core Study|Lost to Follow-up|39|||
126185174|NCT01400139|453961899|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
126185175|NCT01400139|453961899|FG000|HYD Core Study|Administrative|56|||
126185176|NCT01400139|453961899|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
126185177|NCT01400139|453961899|FG000|HYD Extension Period|Adverse Event|8|||
126185178|NCT01400139|453961899|FG000|HYD Extension Period|Withdrawal by Subject|5|||
126185179|NCT01400139|453961899|FG000|HYD Extension Period|Administrative|10|||
126185180|NCT00249795|453961900|FG000|Overall Study|Not treated|16|||
126185181|NCT00249795|453961901|FG001|Overall Study|Not treated|14|||
126185182|NCT00249795|453961900|FG000|Overall Study|Symptomatic hypotension|127|||
126185183|NCT00249795|453961901|FG001|Overall Study|Symptomatic hypotension|64|||
126185184|NCT00249795|453961900|FG000|Overall Study|Other Serious Adverse Event|84|||
126185185|NCT00249795|453961901|FG001|Overall Study|Other Serious Adverse Event|93|||
126185186|NCT00249795|453961900|FG000|Overall Study|Qualifying condition not present|26|||
126185187|NCT00249795|453961901|FG001|Overall Study|Qualifying condition not present|29|||
126185188|NCT00249795|453961900|FG000|Overall Study|Withdrawal by Subject|678|||
126185189|NCT00249795|453961901|FG001|Overall Study|Withdrawal by Subject|742|||
126185190|NCT00249795|453961900|FG000|Overall Study|Thromboembolic / outcome event|39|||
126185191|NCT00249795|453961901|FG001|Overall Study|Thromboembolic / outcome event|45|||
126185192|NCT00249795|453961900|FG000|Overall Study|Oral anticoagulant required|2|||
126185193|NCT00249795|453961901|FG001|Overall Study|Oral anticoagulant required|0|||
126185194|NCT00249795|453961900|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
126185195|NCT00249795|453961901|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
126185196|NCT00249795|453961900|FG000|Overall Study|Non-compliance|71|||
126185197|NCT00249795|453961901|FG001|Overall Study|Non-compliance|69|||
126185198|NCT00249795|453961900|FG000|Overall Study|Study drug intolerance|3|||
126185199|NCT00249795|453961901|FG001|Overall Study|Study drug intolerance|3|||
126185200|NCT00249795|453961900|FG000|Overall Study|Other adverse events (non-serious)|188|||
126185201|NCT00249795|453961901|FG001|Overall Study|Other adverse events (non-serious)|159|||
126185202|NCT00249795|453961900|FG000|Overall Study|Physician withdrew consent|71|||
126185203|NCT00249795|453961901|FG001|Overall Study|Physician withdrew consent|63|||
126185204|NCT00249795|453961900|FG000|Overall Study|Surgery / procedure|4|||
126185205|NCT00249795|453961901|FG001|Overall Study|Surgery / procedure|5|||
126185206|NCT00249795|453961900|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
126185207|NCT00249795|453961901|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
126185208|NCT00249795|453961900|FG000|Overall Study|Lightheadedness / dizziness|15|||
126185209|NCT00249795|453961901|FG001|Overall Study|Lightheadedness / dizziness|11|||
126185210|NCT00249795|453961900|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
126185211|NCT00249795|453961901|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
126185212|NCT00249795|453961900|FG000|Overall Study|Other contraindicated medication|1|||
126185213|NCT00249795|453961901|FG001|Overall Study|Other contraindicated medication|1|||
126185214|NCT00249795|453961900|FG000|Overall Study|Event related to cardiac condition|17|||
126185215|NCT00249795|453961901|FG001|Overall Study|Event related to cardiac condition|16|||
126185216|NCT00249795|453961900|FG000|Overall Study|Patient not wish to continue after May08|4|||
126185217|NCT00249795|453961901|FG001|Overall Study|Patient not wish to continue after May08|6|||
126185218|NCT00249795|453961900|FG000|Overall Study|Site not agree to continue after May08|1|||
126185219|NCT00249795|453961901|FG001|Overall Study|Site not agree to continue after May08|1|||
126185220|NCT00249795|453961900|FG000|Overall Study|Lost to Follow-up|0|||
126185221|NCT00249795|453961901|FG001|Overall Study|Lost to Follow-up|2|||
126185222|NCT00249795|453961900|FG000|Overall Study|Missing|0|||
126185223|NCT00249795|453961901|FG001|Overall Study|Missing|1|||
126185224|NCT01826448|453963754|FG000|Overall Study|Adverse Event|1|||
126185225|NCT01826448|453963755|FG001|Overall Study|Adverse Event|3|||
126185226|NCT01826448|453963754|FG000|Overall Study|Disease progression|2|||
126185227|NCT01826448|453963755|FG001|Overall Study|Disease progression|4|||
126185228|NCT01826448|453963754|FG000|Overall Study|Withdrawal by Subject|1|||
126185229|NCT01826448|453963755|FG001|Overall Study|Withdrawal by Subject|0|||
126185230|NCT01826448|453963754|FG000|Overall Study|Physician Decision|0|||
126185231|NCT01826448|453963755|FG001|Overall Study|Physician Decision|1|||
126185232|NCT01826448|453963754|FG000|Overall Study|2 active cancers|0|||
126185233|NCT01826448|453963755|FG001|Overall Study|2 active cancers|1|||
126185234|NCT02431702|453963760|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
126185235|NCT02431702|453963761|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126185236|NCT02431702|453963762|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126185237|NCT02431702|453963763|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126185238|NCT02431702|453963764|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126185239|NCT02431702|453963765|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126185240|NCT02431702|453963766|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126185241|NCT02431702|453963760|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
126185242|NCT02431702|453963761|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126185243|NCT02431702|453963762|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126185244|NCT02431702|453963763|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126199934|NCT01117428|454017807|FG003|Overall Study|Lack of Efficacy|0|||
126185245|NCT02431702|453963764|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126185246|NCT02431702|453963765|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126185247|NCT02431702|453963766|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
126185248|NCT02431702|453963760|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
126185249|NCT02431702|453963761|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126185250|NCT02431702|453963762|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126185251|NCT02431702|453963763|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126185252|NCT02431702|453963764|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126185253|NCT02431702|453963765|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126185254|NCT02431702|453963766|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
126185255|NCT02431702|453963760|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
126185256|NCT02431702|453963761|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126185257|NCT02431702|453963762|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126185258|NCT02431702|453963763|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126185259|NCT02431702|453963764|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126185260|NCT02431702|453963765|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126185261|NCT02431702|453963766|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
126185262|NCT02431702|453963760|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
126185263|NCT02431702|453963761|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126185264|NCT02431702|453963762|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126185265|NCT02431702|453963763|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126185266|NCT02431702|453963764|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126185267|NCT02431702|453963765|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126185268|NCT02431702|453963766|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126185269|NCT02431702|453963760|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126185270|NCT02431702|453963761|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
126185271|NCT02431702|453963762|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
126185272|NCT02431702|453963763|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126185273|NCT02431702|453963764|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126185274|NCT02431702|453963765|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126185275|NCT02431702|453963766|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126185276|NCT02431702|453963760|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126185277|NCT02431702|453963761|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
126185278|NCT02431702|453963762|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
126185279|NCT02431702|453963763|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126185280|NCT02431702|453963764|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126185281|NCT02431702|453963765|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126185282|NCT02431702|453963766|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126185283|NCT02431702|453963760|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126185284|NCT02431702|453963761|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
126185285|NCT02431702|453963762|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
126185286|NCT02431702|453963763|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126185287|NCT02431702|453963764|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126185288|NCT02431702|453963765|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126185289|NCT02431702|453963766|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126185290|NCT02431702|453963760|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126185291|NCT02431702|453963761|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
126185292|NCT02431702|453963762|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126185293|NCT02431702|453963763|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126185294|NCT02431702|453963764|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126185295|NCT02431702|453963765|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126185296|NCT02431702|453963766|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126185297|NCT02431702|453963760|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
126185298|NCT02431702|453963761|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
126185299|NCT02431702|453963762|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
126185300|NCT02431702|453963763|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
126185301|NCT02431702|453963764|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
126185302|NCT02431702|453963765|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
126185303|NCT02431702|453963766|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
126185304|NCT02431702|453963760|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126185305|NCT02431702|453963761|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126185306|NCT02431702|453963762|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
126185307|NCT02431702|453963763|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126199935|NCT01117428|454017808|FG004|Overall Study|Lack of Efficacy|0|||
126185308|NCT02431702|453963764|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126185309|NCT02431702|453963765|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126185310|NCT02431702|453963766|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126185311|NCT02431702|453963760|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126185312|NCT02431702|453963761|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126185313|NCT02431702|453963762|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126185314|NCT02431702|453963763|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
126185315|NCT02431702|453963764|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
126185316|NCT02431702|453963765|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126185317|NCT02431702|453963766|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126185318|NCT02431702|453963760|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126185319|NCT02431702|453963761|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126185320|NCT02431702|453963762|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126185321|NCT02431702|453963763|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
126185322|NCT02431702|453963764|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126185323|NCT02431702|453963765|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
126185324|NCT02431702|453963766|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126185325|NCT02431702|453963760|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
126185326|NCT02431702|453963761|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
126185327|NCT02431702|453963762|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
126185328|NCT02431702|453963763|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
126185329|NCT02431702|453963764|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
126185330|NCT02431702|453963765|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
126185331|NCT02431702|453963766|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
126185332|NCT02431702|453963760|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
126185333|NCT02431702|453963761|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
126185334|NCT02431702|453963762|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
126185335|NCT02431702|453963763|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
126185336|NCT02431702|453963764|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
126185337|NCT02431702|453963765|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
126185338|NCT02431702|453963766|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
126185339|NCT03250624|453963773|FG000|Overall Study|Lack of Efficacy|1|||
126185340|NCT03250624|453963774|FG001|Overall Study|Lack of Efficacy|4|||
126185341|NCT03250624|453963773|FG000|Overall Study|Adverse Event|0|||
126185342|NCT03250624|453963774|FG001|Overall Study|Adverse Event|1|||
126185343|NCT03250624|453963773|FG000|Overall Study|Other|1|||
126185344|NCT03250624|453963774|FG001|Overall Study|Other|2|||
126185345|NCT02809118|453963777|FG000|Overall Study|Withdrawal by Subject|0|||
126185346|NCT02809118|453963778|FG001|Overall Study|Withdrawal by Subject|1|||
126185347|NCT02809118|453963779|FG002|Overall Study|Withdrawal by Subject|1|||
126185348|NCT02408484|453963782|FG000|Overall Study|Withdrawal by Subject|3|||
126185349|NCT02408484|453963782|FG000|Overall Study|Not treated during study period|1|||
126185350|NCT03805971|453963793|FG000|Overall Study|Withdrawal by Subject|1|||
126185351|NCT03805971|453963793|FG000|Overall Study|Protocol Violation|2|||
126185352|NCT00517413|453963799|FG000|Overall Study|Adverse Event|7|||
126185353|NCT00517413|453963799|FG000|Overall Study|Death|13|||
126185354|NCT00517413|453963799|FG000|Overall Study|Protocol Violation|15|||
126185355|NCT00517413|453963799|FG000|Overall Study|Withdrawal by Subject|2|||
126185356|NCT00517413|453963799|FG000|Overall Study|Failure to return|1|||
126185357|NCT00517413|453963799|FG000|Overall Study|Other-Reasons|23|||
126185358|NCT01510028|453963800|FG000|Overall Study|Lack of Efficacy|1|||
126185359|NCT01510028|453963801|FG001|Overall Study|Lack of Efficacy|0|||
126185360|NCT01510028|453963802|FG002|Overall Study|Lack of Efficacy|0|||
126185361|NCT01510028|453963803|FG003|Overall Study|Lack of Efficacy|0|||
126185362|NCT01355497|453963804|FG000|Overall Study|Death|19|||
126185363|NCT01355497|453963805|FG001|Overall Study|Death|18|||
126185364|NCT01355497|453963804|FG000|Overall Study|Lost to Follow-up|3|||
126185365|NCT01355497|453963805|FG001|Overall Study|Lost to Follow-up|0|||
126185366|NCT01355497|453963804|FG000|Overall Study|Protocol Violation|0|||
126185367|NCT01355497|453963805|FG001|Overall Study|Protocol Violation|1|||
126185368|NCT01355497|453963804|FG000|Overall Study|other-not provided|9|||
126185369|NCT01355497|453963805|FG001|Overall Study|other-not provided|4|||
126185370|NCT01355497|453963804|FG000|Overall Study|Withdrawal by Subject|12|||
126185371|NCT01355497|453963805|FG001|Overall Study|Withdrawal by Subject|20|||
126185372|NCT01355497|453963804|FG000|Overall Study|noncompliance|1|||
126185373|NCT01355497|453963805|FG001|Overall Study|noncompliance|2|||
126185374|NCT01355497|453963804|FG000|Overall Study|progressive disease|11|||
126185375|NCT01355497|453963805|FG001|Overall Study|progressive disease|8|||
126185376|NCT01355497|453963804|FG000|Overall Study|Adverse Event|11|||
126185377|NCT01355497|453963805|FG001|Overall Study|Adverse Event|10|||
126185378|NCT00441727|453963812|FG000|Overall Study|Protocol Violation|19|||
126185379|NCT00441727|453963813|FG001|Overall Study|Protocol Violation|28|||
126185380|NCT00441727|453963814|FG002|Overall Study|Protocol Violation|32|||
126185381|NCT00441727|453963812|FG000|Overall Study|Adverse Event|26|||
126185382|NCT00441727|453963813|FG001|Overall Study|Adverse Event|33|||
126185383|NCT00441727|453963814|FG002|Overall Study|Adverse Event|28|||
126185384|NCT00441727|453963812|FG000|Overall Study|Lack of Efficacy|7|||
126185385|NCT00441727|453963813|FG001|Overall Study|Lack of Efficacy|8|||
126185386|NCT00441727|453963814|FG002|Overall Study|Lack of Efficacy|48|||
126185387|NCT00441727|453963812|FG000|Overall Study|Withdrawal by Subject|40|||
126185388|NCT00441727|453963813|FG001|Overall Study|Withdrawal by Subject|34|||
126185389|NCT00441727|453963814|FG002|Overall Study|Withdrawal by Subject|47|||
126185390|NCT00441727|453963812|FG000|Overall Study|Lost to Follow-up|5|||
126185391|NCT00441727|453963813|FG001|Overall Study|Lost to Follow-up|6|||
126185392|NCT00441727|453963814|FG002|Overall Study|Lost to Follow-up|5|||
126185393|NCT00441727|453963812|FG000|Overall Study|Safety Reasons|3|||
126185394|NCT00441727|453963813|FG001|Overall Study|Safety Reasons|1|||
126185395|NCT00441727|453963814|FG002|Overall Study|Safety Reasons|3|||
126185396|NCT00441727|453963812|FG000|Overall Study|Various reason specified|6|||
126185397|NCT00441727|453963813|FG001|Overall Study|Various reason specified|8|||
126185398|NCT00441727|453963814|FG002|Overall Study|Various reason specified|5|||
126185399|NCT01237223|453963821|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
126185400|NCT01237223|453963822|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126185401|NCT01237223|453963823|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126185402|NCT01237223|453963824|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126185403|NCT01237223|453963825|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126185404|NCT01237223|453963826|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126185405|NCT01237223|453963821|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
126185406|NCT01237223|453963822|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126185407|NCT01237223|453963823|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126185408|NCT01237223|453963824|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126185409|NCT01237223|453963825|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126185410|NCT01237223|453963826|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126185411|NCT01237223|453963821|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
126185412|NCT01237223|453963822|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126185413|NCT01237223|453963823|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126185414|NCT01237223|453963824|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126185415|NCT01237223|453963825|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126185416|NCT01237223|453963826|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126185417|NCT01237223|453963821|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
126185418|NCT01237223|453963822|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126185419|NCT01237223|453963823|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126185420|NCT01237223|453963824|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126185421|NCT01237223|453963825|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126185422|NCT01237223|453963826|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126185423|NCT01237223|453963821|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
126185424|NCT01237223|453963822|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126185425|NCT01237223|453963823|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126185426|NCT01237223|453963824|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126185427|NCT01237223|453963825|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126185428|NCT01237223|453963826|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126185429|NCT01237223|453963821|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
126185430|NCT01237223|453963822|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
126185431|NCT01237223|453963823|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
126185432|NCT01237223|453963824|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
126185433|NCT01237223|453963825|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
126185434|NCT01237223|453963826|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
126185435|NCT01237223|453963821|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
126185436|NCT01237223|453963822|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
126185437|NCT01237223|453963823|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
126185438|NCT01237223|453963824|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
126185439|NCT01237223|453963825|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
126185440|NCT01237223|453963826|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
126185441|NCT01237223|453963821|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
126185442|NCT01237223|453963822|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
126185443|NCT01237223|453963823|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
126185444|NCT01237223|453963824|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
126185445|NCT01237223|453963825|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
126185446|NCT01237223|453963826|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
126185447|NCT01237223|453963821|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126185448|NCT01237223|453963822|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126185449|NCT01237223|453963823|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126185450|NCT01237223|453963824|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126185451|NCT01237223|453963825|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126185452|NCT01237223|453963826|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
126185453|NCT01237223|453963821|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
126185454|NCT01237223|453963822|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
126185455|NCT01237223|453963823|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
126185456|NCT01237223|453963824|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
126185457|NCT01237223|453963825|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
126185458|NCT01237223|453963826|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
126185459|NCT00407550|453963833|FG000|Overall Study|Adverse Event|0|||
126185460|NCT00407550|453963834|FG001|Overall Study|Adverse Event|1|||
126185461|NCT00407550|453963833|FG000|Overall Study|Withdrawal by Subject|0|||
126185462|NCT00407550|453963834|FG001|Overall Study|Withdrawal by Subject|2|||
126185463|NCT00407550|453963833|FG000|Overall Study|Death|1|||
126185464|NCT00407550|453963834|FG001|Overall Study|Death|0|||
126185465|NCT00407550|453963833|FG000|Overall Study|Insurance or Other medical condition|2|||
126185466|NCT00407550|453963834|FG001|Overall Study|Insurance or Other medical condition|1|||
126185467|NCT03235726|453963835|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185468|NCT03235726|453963836|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185469|NCT03235726|453963837|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185470|NCT03235726|453963838|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185471|NCT03235726|453963839|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
126185472|NCT03235726|453963840|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185473|NCT03235726|453963841|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185474|NCT03235726|453963842|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185475|NCT03235726|453963843|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185476|NCT03235726|453963844|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126185477|NCT03235726|453963835|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185478|NCT03235726|453963836|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185479|NCT03235726|453963837|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185480|NCT03235726|453963838|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185481|NCT03235726|453963839|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
126185482|NCT03235726|453963840|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185483|NCT03235726|453963841|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185484|NCT03235726|453963842|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185485|NCT03235726|453963843|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185486|NCT03235726|453963844|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126185487|NCT00443846|453963845|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
126185488|NCT00443846|453963846|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
126185489|NCT00443846|453963845|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
126185490|NCT00443846|453963846|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
126185491|NCT00443846|453963845|FG000|Overall Study|Adverse Event|0|||
126185492|NCT00443846|453963846|FG001|Overall Study|Adverse Event|1|||
126185493|NCT00443846|453963845|FG000|Overall Study|Personal reason|8|||
126185494|NCT00443846|453963846|FG001|Overall Study|Personal reason|3|||
126185495|NCT00443846|453963845|FG000|Overall Study|Lost to Follow-up|1|||
126185496|NCT00443846|453963846|FG001|Overall Study|Lost to Follow-up|2|||
126185497|NCT00641706|453963848|FG000|Overall Study|Adverse Event|2|||
126185498|NCT00641706|453963849|FG001|Overall Study|Adverse Event|1|||
126185499|NCT00641706|453963848|FG000|Overall Study|Withdrawal by Subject|6|||
126185500|NCT00641706|453963849|FG001|Overall Study|Withdrawal by Subject|1|||
126185501|NCT00641706|453963848|FG000|Overall Study|Clinical Decline|1|||
126185502|NCT00641706|453963849|FG001|Overall Study|Clinical Decline|0|||
126185503|NCT00641706|453963848|FG000|Overall Study|Lead Investigator Decision|0|||
126185504|NCT00641706|453963849|FG001|Overall Study|Lead Investigator Decision|1|||
126185505|NCT01599806|453963852|FG000|Overall Study|Lost to Follow-up|20|||
126185506|NCT01599806|453963853|FG001|Overall Study|Lost to Follow-up|20|||
126185507|NCT01599806|453963852|FG000|Overall Study|Withdrawal by Subject|12|||
126185508|NCT01599806|453963853|FG001|Overall Study|Withdrawal by Subject|12|||
126185509|NCT01599806|453963852|FG000|Overall Study|Other Eligibility criteria|11|||
126185510|NCT01599806|453963853|FG001|Overall Study|Other Eligibility criteria|9|||
126185511|NCT00391807|453963855|FG000|Overall Study|Did not receive study medication|23|||
126185512|NCT00391807|453963855|FG000|Overall Study|Adverse Event|177|||
126185513|NCT00391807|453963855|FG000|Overall Study|Pregnancy|25|||
126185514|NCT00391807|453963855|FG000|Overall Study|Lost to Follow-up|227|||
126185515|NCT00391807|453963855|FG000|Overall Study|Withdrawal by Subject|147|||
126185516|NCT00391807|453963855|FG000|Overall Study|Protocol Violation|20|||
126185517|NCT00391807|453963855|FG000|Overall Study|Various|96|||
126185518|NCT01266070|453963865|FG000|Overall Study|Adverse Event|3|||
126185519|NCT01266070|453963865|FG000|Overall Study|Protocol Violation|1|||
126185520|NCT01585168|453963866|FG000|Overall Study|Lost to Follow-up|3|||
126185521|NCT01585168|453963867|FG001|Overall Study|Lost to Follow-up|1|||
126185522|NCT01585168|453963868|FG002|Overall Study|Lost to Follow-up|1|||
126185523|NCT01585168|453963869|FG003|Overall Study|Lost to Follow-up|1|||
126185524|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
126185525|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
126185526|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
126185527|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
126185528|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
126185529|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
126185530|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
126185531|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
126185532|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
126185533|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
126185534|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
126185535|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
126185536|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
126185537|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
126185538|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
126185539|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
126185540|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
126185541|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
126185542|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
126185543|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
126185544|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
126185545|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
126185546|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
126185547|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
126185548|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Other|0|||
126185549|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Other|1|||
126185550|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Other|0|||
126185551|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Other|0|||
126185552|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
126185553|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
126185554|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
126185555|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
126185556|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
126185557|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
126185558|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
126185559|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
126185560|NCT01194414|453963870|FG000|24 Weeks Double Blind Period|Death|0|||
126185561|NCT01194414|453963871|FG001|24 Weeks Double Blind Period|Death|1|||
126185562|NCT01194414|453963872|FG002|24 Weeks Double Blind Period|Death|0|||
126185563|NCT01194414|453963873|FG003|24 Weeks Double Blind Period|Death|0|||
126185564|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
126185565|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
126185566|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
126185567|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
126185568|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
126185569|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
126185570|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
126185571|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
126185572|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
126185573|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
126185574|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
126185575|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
126185576|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
126185577|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
126185578|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
126185579|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
126185580|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
126185581|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
126185582|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
126185583|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
126185584|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
126185585|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
126185586|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
126185587|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
126185588|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Other|2|||
126185589|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Other|1|||
126185590|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Other|0|||
126185591|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Other|0|||
126185592|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
126185593|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
126185594|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
126185595|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
126185596|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
126185597|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
126185598|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
126185599|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
126185600|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
126185601|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
126185602|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
126185603|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
126185604|NCT01194414|453963870|FG000|72 Weeks Open Label Extension|Death|1|||
126185605|NCT01194414|453963871|FG001|72 Weeks Open Label Extension|Death|2|||
126185606|NCT01194414|453963872|FG002|72 Weeks Open Label Extension|Death|0|||
126185607|NCT01194414|453963873|FG003|72 Weeks Open Label Extension|Death|2|||
126185608|NCT04685538|453963880|FG000|Overall Study|Adverse Event|0|||
126185609|NCT04685538|453963881|FG001|Overall Study|Adverse Event|1|||
126185610|NCT04685538|453963880|FG000|Overall Study|Lost to Follow-up|0|||
126185611|NCT04685538|453963881|FG001|Overall Study|Lost to Follow-up|2|||
126185612|NCT00770224|453963886|FG000|Step 1: Induction|Adverse Event|3|||
126185613|NCT00770224|453963887|FG001|Step 1: Induction|Adverse Event|0|||
126185614|NCT00770224|453963886|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
126185615|NCT00770224|453963887|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
126185616|NCT00770224|453963886|FG000|Step 1: Induction|Other reason not protocol specified|2|||
126185617|NCT00770224|453963887|FG001|Step 1: Induction|Other reason not protocol specified|0|||
126185618|NCT00770224|453963886|FG000|Step 1: Induction|Ineligible|2|||
126185619|NCT00770224|453963887|FG001|Step 1: Induction|Ineligible|0|||
126185620|NCT00770224|453963886|FG000|Step 1: Induction|No protocol treatment given|1|||
126185621|NCT00770224|453963887|FG001|Step 1: Induction|No protocol treatment given|0|||
126185622|NCT00770224|453963886|FG000|Step 2: Maintenance|Adverse Event|0|||
126185623|NCT00770224|453963887|FG001|Step 2: Maintenance|Adverse Event|10|||
126185624|NCT00770224|453963886|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
126185625|NCT00770224|453963887|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
126185626|NCT00770224|453963886|FG000|Step 2: Maintenance|Progression/relapse|0|||
126185627|NCT00770224|453963887|FG001|Step 2: Maintenance|Progression/relapse|1|||
126185628|NCT00770224|453963886|FG000|Step 2: Maintenance|Death|0|||
126185629|NCT00770224|453963887|FG001|Step 2: Maintenance|Death|2|||
126185630|NCT00770224|453963886|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
126185631|NCT00770224|453963887|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
126185632|NCT00770224|453963886|FG000|Step 2: Maintenance|Ineligible|0|||
126185633|NCT00770224|453963887|FG001|Step 2: Maintenance|Ineligible|2|||
126185634|NCT01505114|453963896|FG000|Overall Study|Withdrawal by Subject|5|||
126185635|NCT01505114|453963897|FG001|Overall Study|Withdrawal by Subject|4|||
126185636|NCT01505114|453963898|FG002|Overall Study|Withdrawal by Subject|4|||
126185637|NCT01505114|453963899|FG003|Overall Study|Withdrawal by Subject|7|||
126185638|NCT01505114|453963896|FG000|Overall Study|Death|1|||
126185639|NCT01505114|453963897|FG001|Overall Study|Death|0|||
126185640|NCT01505114|453963898|FG002|Overall Study|Death|0|||
126185641|NCT01505114|453963899|FG003|Overall Study|Death|1|||
126185642|NCT01505114|453963896|FG000|Overall Study|unable to adhere to visit schedule|3|||
126185643|NCT01505114|453963897|FG001|Overall Study|unable to adhere to visit schedule|2|||
126185644|NCT01505114|453963898|FG002|Overall Study|unable to adhere to visit schedule|3|||
126185645|NCT01505114|453963899|FG003|Overall Study|unable to adhere to visit schedule|3|||
126185646|NCT01505114|453963896|FG000|Overall Study|Lost to Follow-up|11|||
126185647|NCT01505114|453963897|FG001|Overall Study|Lost to Follow-up|5|||
126185648|NCT01505114|453963898|FG002|Overall Study|Lost to Follow-up|8|||
126185649|NCT01505114|453963899|FG003|Overall Study|Lost to Follow-up|7|||
126185650|NCT01505114|453963896|FG000|Overall Study|relocated|4|||
126185651|NCT01505114|453963897|FG001|Overall Study|relocated|2|||
126185652|NCT01505114|453963898|FG002|Overall Study|relocated|2|||
126185653|NCT01505114|453963899|FG003|Overall Study|relocated|3|||
126185654|NCT01505114|453963896|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
126185655|NCT01505114|453963897|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
126185656|NCT01505114|453963898|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
126185657|NCT01505114|453963899|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
126185658|NCT01505114|453963896|FG000|Overall Study|staff safety concerns|0|||
126185659|NCT01505114|453963897|FG001|Overall Study|staff safety concerns|0|||
126185660|NCT01505114|453963898|FG002|Overall Study|staff safety concerns|0|||
126185661|NCT01505114|453963899|FG003|Overall Study|staff safety concerns|1|||
126185662|NCT01505114|453963896|FG000|Overall Study|investigator decision|1|||
126185663|NCT01505114|453963897|FG001|Overall Study|investigator decision|0|||
126185664|NCT01505114|453963898|FG002|Overall Study|investigator decision|1|||
126185665|NCT01505114|453963899|FG003|Overall Study|investigator decision|0|||
126185666|NCT01235507|453963900|FG000|Overall Study|Adverse Event|1|||
126185667|NCT01235507|453963900|FG000|Overall Study|Withdrawal by Subject|1|||
126185668|NCT01587274|453963904|FG000|Overall Study|Lost to Follow-up|4|||
126185669|NCT01587274|453963905|FG001|Overall Study|Lost to Follow-up|5|||
126185670|NCT01587274|453963906|FG002|Overall Study|Lost to Follow-up|3|||
126185671|NCT02475629|453963907|FG000|Overall Study|Adverse Event|1|||
126185672|NCT02475629|453963907|FG000|Overall Study|Death|4|||
126185673|NCT02475629|453963907|FG000|Overall Study|Physician Decision|1|||
126185674|NCT02475629|453963907|FG000|Overall Study|Withdrawal by Subject|1|||
126185675|NCT02475629|453963907|FG000|Overall Study|Lost to Follow-up|1|||
126185676|NCT02475629|453963907|FG000|Overall Study|Subject non-compliance|1|||
126185677|NCT04423757|453963918|FG000|Overall Study|Adverse Event|2|||
126185678|NCT04423757|453963919|FG001|Overall Study|Adverse Event|0|||
126185679|NCT04423757|453963918|FG000|Overall Study|Not treated|1|||
126185680|NCT04423757|453963919|FG001|Overall Study|Not treated|1|||
126185681|NCT02709109|453963920|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
126185682|NCT02709109|453963921|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
126185683|NCT02709109|453963922|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
126185684|NCT02709109|453963923|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
126185685|NCT02709109|453963920|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
126185686|NCT02709109|453963921|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
126185687|NCT02709109|453963922|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
126185688|NCT02709109|453963923|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
126185689|NCT02709109|453963920|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
126185690|NCT02709109|453963921|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
126185691|NCT02709109|453963922|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
126185692|NCT02709109|453963923|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
126185693|NCT02709109|453963920|FG000|Washout Period (28 Days)|Other|2|||
126185694|NCT02709109|453963921|FG001|Washout Period (28 Days)|Other|2|||
126185695|NCT02709109|453963922|FG002|Washout Period (28 Days)|Other|3|||
126185696|NCT02709109|453963923|FG003|Washout Period (28 Days)|Other|0|||
126185697|NCT02709109|453963920|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
126185698|NCT02709109|453963921|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
126185699|NCT02709109|453963922|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
126185700|NCT02709109|453963923|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
126185701|NCT02709109|453963920|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
126185702|NCT02709109|453963921|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
126185703|NCT02709109|453963922|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
126185704|NCT02709109|453963923|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
126185705|NCT02709109|453963920|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
126185706|NCT02709109|453963921|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
126185707|NCT02709109|453963922|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
126185708|NCT02709109|453963923|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
126185709|NCT02709109|453963920|FG000|Treatment Period 2 (28 Days)|Other|0|||
126185710|NCT02709109|453963921|FG001|Treatment Period 2 (28 Days)|Other|0|||
126185711|NCT02709109|453963922|FG002|Treatment Period 2 (28 Days)|Other|1|||
126185712|NCT02709109|453963923|FG003|Treatment Period 2 (28 Days)|Other|0|||
126185713|NCT05563714|453963924|FG000|Overall Study|Death|2|||
126185714|NCT05563714|453963925|FG001|Overall Study|Death|2|||
126185715|NCT05563714|453963926|FG002|Overall Study|Death|0|||
126185716|NCT05563714|453963927|FG003|Overall Study|Death|0|||
126185717|NCT05563714|453963924|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
126185718|NCT05563714|453963925|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
126185719|NCT05563714|453963926|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
126185720|NCT05563714|453963927|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
126185721|NCT05563714|453963924|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
126185722|NCT05563714|453963925|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
126185723|NCT05563714|453963926|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
126185724|NCT05563714|453963927|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
126185725|NCT05563714|453963924|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
126185726|NCT05563714|453963925|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
126185727|NCT05563714|453963926|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
126185728|NCT05563714|453963927|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
126185729|NCT05563714|453963924|FG000|Overall Study|Lost to Follow-up|22|||
126185730|NCT05563714|453963925|FG001|Overall Study|Lost to Follow-up|19|||
126185731|NCT05563714|453963926|FG002|Overall Study|Lost to Follow-up|0|||
126185732|NCT05563714|453963927|FG003|Overall Study|Lost to Follow-up|0|||
126185733|NCT01815580|453963928|FG000|Overall Study|Lost to Follow-up|4|||
126185734|NCT01815580|453963929|FG001|Overall Study|Lost to Follow-up|7|||
126185735|NCT01815580|453963928|FG000|Overall Study|Withdrawal by Subject|3|||
126185736|NCT01815580|453963929|FG001|Overall Study|Withdrawal by Subject|4|||
126185737|NCT01815580|453963928|FG000|Overall Study|Excluded from analysis|5|||
126185738|NCT01815580|453963929|FG001|Overall Study|Excluded from analysis|4|||
126185739|NCT02228564|453963930|FG000|Overall Study|Withdrawal by Subject|10|||
126185740|NCT02228564|453963930|FG000|Overall Study|Death|11|||
126185741|NCT02228564|453963930|FG000|Overall Study|Physician Decision|5|||
126185742|NCT02228564|453963930|FG000|Overall Study|Lost to Follow-up|17|||
126185743|NCT02228564|453963930|FG000|Overall Study|Other|6|||
126185744|NCT02460978|453963931|FG000|Overall Study|Adverse Event|17|||
126185745|NCT02460978|453963932|FG001|Overall Study|Adverse Event|11|||
126185746|NCT02460978|453963933|FG002|Overall Study|Adverse Event|11|||
126185747|NCT02460978|453963931|FG000|Overall Study|Withdrawal by Subject|5|||
126185748|NCT02460978|453963932|FG001|Overall Study|Withdrawal by Subject|5|||
126185749|NCT02460978|453963933|FG002|Overall Study|Withdrawal by Subject|14|||
126185750|NCT02460978|453963931|FG000|Overall Study|Lost to Follow-up|2|||
126185751|NCT02460978|453963932|FG001|Overall Study|Lost to Follow-up|3|||
126185752|NCT02460978|453963933|FG002|Overall Study|Lost to Follow-up|1|||
126185753|NCT02460978|453963931|FG000|Overall Study|Protocol Violation|1|||
126185754|NCT02460978|453963932|FG001|Overall Study|Protocol Violation|1|||
126185755|NCT02460978|453963933|FG002|Overall Study|Protocol Violation|1|||
126185756|NCT02460978|453963931|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
126185757|NCT02460978|453963932|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
126185758|NCT02460978|453963933|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
126185759|NCT02460978|453963931|FG000|Overall Study|Pregnancy|0|||
126185760|NCT02460978|453963932|FG001|Overall Study|Pregnancy|0|||
126185761|NCT02460978|453963933|FG002|Overall Study|Pregnancy|2|||
126185762|NCT03549429|453963936|FG000|Overall Study|Protocol Violation|5|||
126185763|NCT03549429|453963937|FG001|Overall Study|Protocol Violation|3|||
126185764|NCT00588523|453963941|FG000|Overall Study|Not treated|3|||
126185765|NCT03032510|453963942|FG000|Overall Study|Adverse Event|5|||
126185766|NCT03032510|453963943|FG001|Overall Study|Adverse Event|2|||
126185767|NCT03032510|453963942|FG000|Overall Study|Lost to Follow-up|8|||
126185768|NCT03032510|453963943|FG001|Overall Study|Lost to Follow-up|7|||
126185769|NCT03032510|453963942|FG000|Overall Study|Withdrawal by Subject|8|||
126185770|NCT03032510|453963943|FG001|Overall Study|Withdrawal by Subject|7|||
126185771|NCT03032510|453963942|FG000|Overall Study|Subject noncompliance|4|||
126185772|NCT03032510|453963943|FG001|Overall Study|Subject noncompliance|2|||
126185773|NCT03032510|453963942|FG000|Overall Study|Physician Decision|2|||
126185774|NCT03032510|453963943|FG001|Overall Study|Physician Decision|0|||
126185775|NCT02371980|453965700|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
126185776|NCT02371980|453965701|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
126185777|NCT02371980|453965702|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
126185778|NCT02371980|453965703|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
126185779|NCT02371980|453965704|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
126185780|NCT02371980|453965700|FG000|Open-label Period|Significant Protocol Deviation|19|||
126185781|NCT02371980|453965701|FG001|Open-label Period|Significant Protocol Deviation|0|||
126185782|NCT02371980|453965702|FG002|Open-label Period|Significant Protocol Deviation|0|||
126185783|NCT02371980|453965703|FG003|Open-label Period|Significant Protocol Deviation|0|||
126185784|NCT02371980|453965704|FG004|Open-label Period|Significant Protocol Deviation|0|||
126185785|NCT02371980|453965700|FG000|Open-label Period|Noncompliance with Study Drug|10|||
126185786|NCT02371980|453965701|FG001|Open-label Period|Noncompliance with Study Drug|0|||
126185787|NCT02371980|453965702|FG002|Open-label Period|Noncompliance with Study Drug|0|||
126185788|NCT02371980|453965703|FG003|Open-label Period|Noncompliance with Study Drug|0|||
126185789|NCT02371980|453965704|FG004|Open-label Period|Noncompliance with Study Drug|0|||
126185790|NCT02371980|453965700|FG000|Open-label Period|Lost to Follow-up|55|||
126185791|NCT02371980|453965701|FG001|Open-label Period|Lost to Follow-up|0|||
126185792|NCT02371980|453965702|FG002|Open-label Period|Lost to Follow-up|0|||
126185793|NCT02371980|453965703|FG003|Open-label Period|Lost to Follow-up|0|||
126185794|NCT02371980|453965704|FG004|Open-label Period|Lost to Follow-up|0|||
126185795|NCT02371980|453965700|FG000|Open-label Period|Voluntary Withdrawal|91|||
126185796|NCT02371980|453965701|FG001|Open-label Period|Voluntary Withdrawal|0|||
126185797|NCT02371980|453965702|FG002|Open-label Period|Voluntary Withdrawal|0|||
126185798|NCT02371980|453965703|FG003|Open-label Period|Voluntary Withdrawal|0|||
126185799|NCT02371980|453965704|FG004|Open-label Period|Voluntary Withdrawal|0|||
126185800|NCT02371980|453965700|FG000|Open-label Period|Pregnancy|1|||
126185801|NCT02371980|453965701|FG001|Open-label Period|Pregnancy|0|||
126185802|NCT02371980|453965702|FG002|Open-label Period|Pregnancy|0|||
126185803|NCT02371980|453965703|FG003|Open-label Period|Pregnancy|0|||
126185804|NCT02371980|453965704|FG004|Open-label Period|Pregnancy|0|||
126185805|NCT02371980|453965700|FG000|Open-label Period|Lack of Efficacy|116|||
126185806|NCT02371980|453965701|FG001|Open-label Period|Lack of Efficacy|0|||
126185807|NCT02371980|453965702|FG002|Open-label Period|Lack of Efficacy|0|||
126185808|NCT02371980|453965703|FG003|Open-label Period|Lack of Efficacy|0|||
126185809|NCT02371980|453965704|FG004|Open-label Period|Lack of Efficacy|0|||
126185810|NCT02371980|453965700|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
126185811|NCT02371980|453965701|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
126185812|NCT02371980|453965702|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
126185813|NCT02371980|453965703|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
126185814|NCT02371980|453965704|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
126185815|NCT02371980|453965700|FG000|Open-label Period|Reason not Specified|9|||
126185816|NCT02371980|453965701|FG001|Open-label Period|Reason not Specified|0|||
126185817|NCT02371980|453965702|FG002|Open-label Period|Reason not Specified|0|||
126185818|NCT02371980|453965703|FG003|Open-label Period|Reason not Specified|0|||
126185819|NCT02371980|453965704|FG004|Open-label Period|Reason not Specified|0|||
126185820|NCT02371980|453965700|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
126185821|NCT02371980|453965701|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
126185822|NCT02371980|453965702|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
126185823|NCT02371980|453965703|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
126185824|NCT02371980|453965704|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
126185825|NCT02371980|453965700|FG000|Double-blind Period|Significant Protocol Deviation|0|||
126185826|NCT02371980|453965701|FG001|Double-blind Period|Significant Protocol Deviation|2|||
126185827|NCT02371980|453965702|FG002|Double-blind Period|Significant Protocol Deviation|7|||
126185828|NCT02371980|453965703|FG003|Double-blind Period|Significant Protocol Deviation|3|||
126185829|NCT02371980|453965704|FG004|Double-blind Period|Significant Protocol Deviation|3|||
126185830|NCT02371980|453965700|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
126185831|NCT02371980|453965701|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
126185832|NCT02371980|453965702|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
126185833|NCT02371980|453965703|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
126185834|NCT02371980|453965704|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
126185835|NCT02371980|453965700|FG000|Double-blind Period|Lost to Follow-up|0|||
126185836|NCT02371980|453965701|FG001|Double-blind Period|Lost to Follow-up|8|||
126185837|NCT02371980|453965702|FG002|Double-blind Period|Lost to Follow-up|8|||
126185838|NCT02371980|453965703|FG003|Double-blind Period|Lost to Follow-up|6|||
126185839|NCT02371980|453965704|FG004|Double-blind Period|Lost to Follow-up|5|||
126185840|NCT02371980|453965700|FG000|Double-blind Period|Voluntary Withdrawal|0|||
126185841|NCT02371980|453965701|FG001|Double-blind Period|Voluntary Withdrawal|12|||
126185842|NCT02371980|453965702|FG002|Double-blind Period|Voluntary Withdrawal|8|||
126185843|NCT02371980|453965703|FG003|Double-blind Period|Voluntary Withdrawal|9|||
126185844|NCT02371980|453965704|FG004|Double-blind Period|Voluntary Withdrawal|11|||
126185845|NCT02371980|453965700|FG000|Double-blind Period|Relapse|0|||
126185846|NCT02371980|453965701|FG001|Double-blind Period|Relapse|50|||
126185847|NCT02371980|453965702|FG002|Double-blind Period|Relapse|25|||
126185848|NCT02371980|453965703|FG003|Double-blind Period|Relapse|25|||
126185849|NCT02371980|453965704|FG004|Double-blind Period|Relapse|26|||
126185850|NCT02371980|453965700|FG000|Double-blind Period|Reason not Specified|0|||
126185851|NCT02371980|453965701|FG001|Double-blind Period|Reason not Specified|3|||
126185852|NCT02371980|453965702|FG002|Double-blind Period|Reason not Specified|3|||
126185853|NCT02371980|453965703|FG003|Double-blind Period|Reason not Specified|2|||
126185854|NCT02371980|453965704|FG004|Double-blind Period|Reason not Specified|1|||
126185855|NCT02371980|453965700|FG000|Double-blind Period|Missing|0|||
126185856|NCT02371980|453965701|FG001|Double-blind Period|Missing|1|||
126185857|NCT02371980|453965702|FG002|Double-blind Period|Missing|0|||
126185858|NCT02371980|453965703|FG003|Double-blind Period|Missing|0|||
126185859|NCT02371980|453965704|FG004|Double-blind Period|Missing|0|||
126185860|NCT01731990|453965705|FG000|Overall Study|Adverse Event|1|||
126185861|NCT01731990|453965706|FG001|Overall Study|Adverse Event|5|||
126185862|NCT01731990|453965705|FG000|Overall Study|Withdrawal by Subject|1|||
126185863|NCT01731990|453965706|FG001|Overall Study|Withdrawal by Subject|1|||
126185864|NCT01731990|453965705|FG000|Overall Study|Protocol deviation|1|||
126185865|NCT01731990|453965706|FG001|Overall Study|Protocol deviation|2|||
126185866|NCT01731990|453965705|FG000|Overall Study|Death|1|||
126185867|NCT01731990|453965706|FG001|Overall Study|Death|0|||
126185868|NCT01280812|453965707|FG000|Overall Study|Withdrawal by Subject|2|||
126185869|NCT01280812|453965708|FG001|Overall Study|Withdrawal by Subject|1|||
126185870|NCT01280812|453965709|FG002|Overall Study|Withdrawal by Subject|0|||
126185871|NCT01280812|453965707|FG000|Overall Study|Lost to Follow-up|1|||
126185872|NCT01280812|453965708|FG001|Overall Study|Lost to Follow-up|1|||
126185873|NCT01280812|453965709|FG002|Overall Study|Lost to Follow-up|1|||
126185874|NCT04483544|453965710|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
126185875|NCT04483544|453965710|FG000|Post-Treatment|Admitted to hospice|2|||
126185876|NCT04483544|453965710|FG000|Post-Treatment|Study terminated|3|||
126185877|NCT01131078|453965713|FG000|Overall Study|Adverse Event|22|||
126185878|NCT01131078|453965714|FG001|Overall Study|Adverse Event|12|||
126185879|NCT01131078|453965715|FG002|Overall Study|Adverse Event|17|||
126185880|NCT01131078|453965713|FG000|Overall Study|Progressive Disease|58|||
126185881|NCT01131078|453965714|FG001|Overall Study|Progressive Disease|77|||
126185882|NCT01131078|453965715|FG002|Overall Study|Progressive Disease|71|||
126185883|NCT01131078|453965713|FG000|Overall Study|Protocol Violation|1|||
126185884|NCT01131078|453965714|FG001|Overall Study|Protocol Violation|0|||
126185885|NCT01131078|453965715|FG002|Overall Study|Protocol Violation|0|||
126185886|NCT01131078|453965713|FG000|Overall Study|Lost to Follow-up|1|||
126185887|NCT01131078|453965714|FG001|Overall Study|Lost to Follow-up|1|||
126185888|NCT01131078|453965715|FG002|Overall Study|Lost to Follow-up|1|||
126185889|NCT01131078|453965713|FG000|Overall Study|Withdrawal by Subject|2|||
126185890|NCT01131078|453965714|FG001|Overall Study|Withdrawal by Subject|4|||
126185891|NCT01131078|453965715|FG002|Overall Study|Withdrawal by Subject|3|||
126185892|NCT01131078|453965713|FG000|Overall Study|Non-compliance|3|||
126185893|NCT01131078|453965714|FG001|Overall Study|Non-compliance|0|||
126185894|NCT01131078|453965715|FG002|Overall Study|Non-compliance|0|||
126185895|NCT01131078|453965713|FG000|Overall Study|Physician Decision|10|||
126185896|NCT01131078|453965714|FG001|Overall Study|Physician Decision|6|||
126185897|NCT01131078|453965715|FG002|Overall Study|Physician Decision|8|||
126185898|NCT01131078|453965713|FG000|Overall Study|Death|4|||
126185899|NCT01131078|453965714|FG001|Overall Study|Death|0|||
126185900|NCT01131078|453965715|FG002|Overall Study|Death|2|||
126185901|NCT01131078|453965713|FG000|Overall Study|Other|0|||
126185902|NCT01131078|453965714|FG001|Overall Study|Other|1|||
126185903|NCT01131078|453965715|FG002|Overall Study|Other|0|||
126185904|NCT00790218|453965717|FG000|Overall Study|Death|1|||
126185905|NCT00790218|453965718|FG001|Overall Study|Death|0|||
126185906|NCT00790218|453965719|FG002|Overall Study|Death|0|||
126185907|NCT05283499|453965722|FG000|Overall Study|Did not receive intervention|1|||
126185908|NCT05283499|453965723|FG001|Overall Study|Did not receive intervention|2|||
126185909|NCT05516134|453965724|FG000|Overall Study|Lost to Follow-up|1|||
126185910|NCT05516134|453965725|FG001|Overall Study|Lost to Follow-up|0|||
126185911|NCT05516134|453965726|FG002|Overall Study|Lost to Follow-up|0|||
126185912|NCT01094808|453965728|FG000|Overall Study|Withdrawal by Subject|1|||
126185913|NCT01094808|453965729|FG001|Overall Study|Withdrawal by Subject|1|||
126185914|NCT01094808|453965730|FG002|Overall Study|Withdrawal by Subject|0|||
126185915|NCT00369278|453965731|FG000|Overall Study|Adverse Event|14|||
126185916|NCT00369278|453965732|FG001|Overall Study|Adverse Event|11|||
126185917|NCT00369278|453965731|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126185918|NCT00369278|453965732|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
126185919|NCT00369278|453965731|FG000|Overall Study|Protocol Violation|2|||
126185920|NCT00369278|453965732|FG001|Overall Study|Protocol Violation|1|||
126185921|NCT00369278|453965731|FG000|Overall Study|Withdrawal by Subject|2|||
126185922|NCT00369278|453965732|FG001|Overall Study|Withdrawal by Subject|2|||
126185923|NCT00369278|453965731|FG000|Overall Study|Lost to Follow-up|1|||
126185924|NCT00369278|453965732|FG001|Overall Study|Lost to Follow-up|0|||
126185925|NCT00369278|453965731|FG000|Overall Study|Graft loss|1|||
126185926|NCT00369278|453965732|FG001|Overall Study|Graft loss|2|||
126185927|NCT01224106|453965733|FG000|Double-Blind Treatment Phase|Death|3|||
126185928|NCT01224106|453965734|FG001|Double-Blind Treatment Phase|Death|0|||
126185929|NCT01224106|453965735|FG002|Double-Blind Treatment Phase|Death|0|||
126185930|NCT01224106|453965736|FG003|Double-Blind Treatment Phase|Death|0|||
126185931|NCT01224106|453965737|FG004|Double-Blind Treatment Phase|Death|0|||
126185932|NCT01224106|453965733|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
126185933|NCT01224106|453965734|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
126185934|NCT01224106|453965735|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
126185935|NCT01224106|453965736|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
126185936|NCT01224106|453965737|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
126185937|NCT01224106|453965733|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126185938|NCT01224106|453965734|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
126185939|NCT01224106|453965735|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
126185940|NCT01224106|453965736|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126185941|NCT01224106|453965737|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
126185942|NCT01224106|453965733|FG000|Double-Blind Treatment Phase|Other|0|||
126185943|NCT01224106|453965734|FG001|Double-Blind Treatment Phase|Other|0|||
126185944|NCT01224106|453965735|FG002|Double-Blind Treatment Phase|Other|1|||
126185945|NCT01224106|453965736|FG003|Double-Blind Treatment Phase|Other|0|||
126185946|NCT01224106|453965737|FG004|Double-Blind Treatment Phase|Other|0|||
126185947|NCT01224106|453965733|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
126185948|NCT01224106|453965734|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
126185949|NCT01224106|453965735|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
126185950|NCT01224106|453965736|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
126185951|NCT01224106|453965737|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
126185952|NCT01224106|453965733|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
126185953|NCT01224106|453965734|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
126185954|NCT01224106|453965735|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
126185955|NCT01224106|453965736|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
126185956|NCT01224106|453965737|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
126185957|NCT01224106|453965733|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126185958|NCT01224106|453965734|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126185959|NCT01224106|453965735|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126185960|NCT01224106|453965736|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126185961|NCT01224106|453965737|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126185962|NCT01224106|453965733|FG000|Open-Label Extension (OLE) Phase|Death|0|||
126185963|NCT01224106|453965734|FG001|Open-Label Extension (OLE) Phase|Death|0|||
126185964|NCT01224106|453965735|FG002|Open-Label Extension (OLE) Phase|Death|0|||
126185965|NCT01224106|453965736|FG003|Open-Label Extension (OLE) Phase|Death|1|||
126185966|NCT01224106|453965737|FG004|Open-Label Extension (OLE) Phase|Death|3|||
126185967|NCT01224106|453965733|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
126185968|NCT01224106|453965734|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
126185969|NCT01224106|453965735|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
126185970|NCT01224106|453965736|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
126185971|NCT01224106|453965737|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
126185972|NCT01224106|453965733|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
126185973|NCT01224106|453965734|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
126185974|NCT01224106|453965735|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
126185975|NCT01224106|453965736|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
126185976|NCT01224106|453965737|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
126185977|NCT01224106|453965733|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
126185978|NCT01224106|453965734|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
126185979|NCT01224106|453965735|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
126185980|NCT01224106|453965736|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
126185981|NCT01224106|453965737|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
126185982|NCT01224106|453965733|FG000|Open-Label Extension (OLE) Phase|Other|0|||
126185983|NCT01224106|453965734|FG001|Open-Label Extension (OLE) Phase|Other|0|||
126185984|NCT01224106|453965735|FG002|Open-Label Extension (OLE) Phase|Other|0|||
126185985|NCT01224106|453965736|FG003|Open-Label Extension (OLE) Phase|Other|5|||
126185986|NCT01224106|453965737|FG004|Open-Label Extension (OLE) Phase|Other|3|||
126185987|NCT00446797|453965738|FG000|Overall Study|Lack of Efficacy|0|||
126185988|NCT00446797|453965739|FG001|Overall Study|Lack of Efficacy|2|||
126185989|NCT00446797|453965738|FG000|Overall Study|Lost to Follow-up|5|||
126185990|NCT00446797|453965739|FG001|Overall Study|Lost to Follow-up|3|||
126185991|NCT00446797|453965738|FG000|Overall Study|Withdrawal by Subject|2|||
126185992|NCT00446797|453965739|FG001|Overall Study|Withdrawal by Subject|2|||
126185993|NCT00446797|453965738|FG000|Overall Study|Protocol Violation|1|||
126185994|NCT00446797|453965739|FG001|Overall Study|Protocol Violation|3|||
126185995|NCT00446797|453965738|FG000|Overall Study|subject entered at another site|0|||
126185996|NCT00446797|453965739|FG001|Overall Study|subject entered at another site|1|||
126185997|NCT00446797|453965738|FG000|Overall Study|did not meet entrance criteria|0|||
126185998|NCT00446797|453965739|FG001|Overall Study|did not meet entrance criteria|1|||
126185999|NCT02133001|453965740|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
126186000|NCT02133001|453965741|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
126186001|NCT02133001|453965740|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
126186002|NCT02133001|453965741|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
126186003|NCT02133001|453965740|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
126186004|NCT02133001|453965741|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
126186005|NCT02133001|453965740|FG000|Double Blind (Day 1-25)|Other|2|||
126186006|NCT02133001|453965741|FG001|Double Blind (Day 1-25)|Other|2|||
126186007|NCT02133001|453965740|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
126186008|NCT02133001|453965741|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
126186009|NCT02133001|453965740|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
126186010|NCT02133001|453965741|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
126186011|NCT02133001|453965740|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
126186012|NCT02133001|453965741|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
126186013|NCT02133001|453965740|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
126186014|NCT02133001|453965741|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
126186015|NCT02498392|453965746|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
126186016|NCT02498392|453965747|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
126186017|NCT02498392|453965746|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
126186018|NCT02498392|453965747|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
126186019|NCT02498392|453965746|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
126186020|NCT02498392|453965747|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
126186021|NCT02498392|453965746|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
126186022|NCT02498392|453965747|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
126186023|NCT02498392|453965746|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
126186024|NCT02498392|453965747|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
126186025|NCT02498392|453965746|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
126186026|NCT02498392|453965747|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
126186027|NCT03135262|453965750|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
126186028|NCT03135262|453965751|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
126186029|NCT03135262|453965752|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
126186030|NCT03135262|453965753|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
126186031|NCT03135262|453965754|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
126186032|NCT03135262|453965750|FG000|Overall Study|Progression of disease|0|||
126186033|NCT03135262|453965751|FG001|Overall Study|Progression of disease|0|||
126186034|NCT03135262|453965752|FG002|Overall Study|Progression of disease|0|||
126186035|NCT03135262|453965753|FG003|Overall Study|Progression of disease|1|||
126186036|NCT03135262|453965754|FG004|Overall Study|Progression of disease|0|||
126186037|NCT03135262|453965750|FG000|Overall Study|Death|6|||
126186038|NCT03135262|453965751|FG001|Overall Study|Death|2|||
126186039|NCT03135262|453965752|FG002|Overall Study|Death|2|||
126186040|NCT03135262|453965753|FG003|Overall Study|Death|2|||
126186041|NCT03135262|453965754|FG004|Overall Study|Death|0|||
126186042|NCT03135262|453965750|FG000|Overall Study|Withdrawal by Subject|0|||
126186043|NCT03135262|453965751|FG001|Overall Study|Withdrawal by Subject|0|||
126186044|NCT03135262|453965752|FG002|Overall Study|Withdrawal by Subject|1|||
126186045|NCT03135262|453965753|FG003|Overall Study|Withdrawal by Subject|0|||
126186046|NCT03135262|453965754|FG004|Overall Study|Withdrawal by Subject|1|||
126186047|NCT03135262|453965750|FG000|Overall Study|Study terminated by sponsor|2|||
126186048|NCT03135262|453965751|FG001|Overall Study|Study terminated by sponsor|4|||
126186049|NCT03135262|453965752|FG002|Overall Study|Study terminated by sponsor|4|||
126186050|NCT03135262|453965753|FG003|Overall Study|Study terminated by sponsor|3|||
126186051|NCT03135262|453965754|FG004|Overall Study|Study terminated by sponsor|0|||
126186052|NCT01675141|453965755|FG000|Overall Study|Lenalidomide outside NIH|3|||
126186053|NCT01675141|453965755|FG000|Overall Study|Withdrawal by Subject|3|||
126186054|NCT01675141|453965755|FG000|Overall Study|Physician Decision|4|||
126186055|NCT01675141|453965755|FG000|Overall Study|No treatment, per protocol|1|||
126186056|NCT03097133|453965758|FG000|Overall Study|Lost to Follow-up|3|||
126186057|NCT03097133|453965759|FG001|Overall Study|Lost to Follow-up|2|||
126186058|NCT03097133|453965758|FG000|Overall Study|Withdrawal by Subject|2|||
126186059|NCT03097133|453965759|FG001|Overall Study|Withdrawal by Subject|5|||
126186060|NCT03097133|453965758|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
126186061|NCT03097133|453965759|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
126186062|NCT03097133|453965758|FG000|Overall Study|Other|3|||
126186063|NCT03097133|453965759|FG001|Overall Study|Other|2|||
126186064|NCT03097133|453965758|FG000|Overall Study|Adverse Event|1|||
126186065|NCT03097133|453965759|FG001|Overall Study|Adverse Event|0|||
126186066|NCT02873208|453965760|FG000|Overall Study|Withdrawal by Subject|36|||
126186067|NCT02873208|453965760|FG000|Overall Study|Lost to Follow-up|22|||
126186068|NCT02873208|453965760|FG000|Overall Study|Adverse Event|15|||
126186069|NCT02873208|453965760|FG000|Overall Study|Non-compliance with study drug|12|||
126186070|NCT02873208|453965760|FG000|Overall Study|Protocol Violation|8|||
126186071|NCT02873208|453965760|FG000|Overall Study|Pregnancy|2|||
126186072|NCT02873208|453965760|FG000|Overall Study|Incarceration|1|||
126186073|NCT02873208|453965760|FG000|Overall Study|Lack of Efficacy|1|||
126186074|NCT02873208|453965760|FG000|Overall Study|Physician Decision|1|||
126186075|NCT04080752|453965761|FG000|Overall Study|Adverse Event|2|||
126186076|NCT04080752|453965762|FG001|Overall Study|Adverse Event|3|||
126186077|NCT04080752|453965761|FG000|Overall Study|Lack of Efficacy|1|||
126186078|NCT04080752|453965762|FG001|Overall Study|Lack of Efficacy|0|||
126186079|NCT04080752|453965761|FG000|Overall Study|Lost to Follow-up|1|||
126186080|NCT04080752|453965762|FG001|Overall Study|Lost to Follow-up|0|||
126186081|NCT04080752|453965761|FG000|Overall Study|Pregnancy|0|||
126186082|NCT04080752|453965762|FG001|Overall Study|Pregnancy|1|||
126186083|NCT04080752|453965761|FG000|Overall Study|Withdrawal by Subject|7|||
126186084|NCT04080752|453965762|FG001|Overall Study|Withdrawal by Subject|0|||
126186085|NCT04080752|453965761|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126186086|NCT04080752|453965762|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126186087|NCT04080752|453965761|FG000|Overall Study|Other|2|||
126186088|NCT04080752|453965762|FG001|Overall Study|Other|1|||
126186089|NCT01192100|453965763|FG000|Overall Study|Withdrawal by Subject|0|||
126186090|NCT01192100|453965764|FG001|Overall Study|Withdrawal by Subject|0|||
126186091|NCT01192100|453965765|FG002|Overall Study|Withdrawal by Subject|0|||
126186092|NCT01192100|453965766|FG003|Overall Study|Withdrawal by Subject|0|||
126186093|NCT01192100|453965767|FG004|Overall Study|Withdrawal by Subject|1|||
126186094|NCT01192100|453965768|FG005|Overall Study|Withdrawal by Subject|0|||
126186095|NCT01192100|453965763|FG000|Overall Study|Protocol Violation|0|||
126186096|NCT01192100|453965764|FG001|Overall Study|Protocol Violation|0|||
126186097|NCT01192100|453965765|FG002|Overall Study|Protocol Violation|0|||
126186098|NCT01192100|453965766|FG003|Overall Study|Protocol Violation|1|||
126186099|NCT01192100|453965767|FG004|Overall Study|Protocol Violation|0|||
126186100|NCT01192100|453965768|FG005|Overall Study|Protocol Violation|0|||
126186101|NCT04737759|453965769|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
126186102|NCT04737759|453965770|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
126186103|NCT04737759|453965769|FG000|Overall Study|Death|2|||
126186104|NCT04737759|453965770|FG001|Overall Study|Death|0|||
126186105|NCT04737759|453965769|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
126186106|NCT04737759|453965770|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
126186107|NCT04737759|453965769|FG000|Overall Study|Lost to Follow-up|4|||
126186108|NCT04737759|453965770|FG001|Overall Study|Lost to Follow-up|12|||
126186109|NCT02260388|453965771|FG000|Overall Study|Lost to Follow-up|2|||
126186110|NCT02260388|453965772|FG001|Overall Study|Lost to Follow-up|8|||
126186111|NCT02260388|453965773|FG002|Overall Study|Lost to Follow-up|3|||
126186112|NCT02260388|453965774|FG003|Overall Study|Lost to Follow-up|4|||
126186113|NCT02017704|453965778|FG000|Overall Study|Withdrawal by Subject|2|||
126186114|NCT02017704|453965779|FG001|Overall Study|Withdrawal by Subject|0|||
126186115|NCT00918346|453965780|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
126186116|NCT00918346|453965781|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
126186117|NCT01421069|453965782|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
126186118|NCT01421069|453965782|FG000|Parent Study|Failed to return|3|||
126186119|NCT01421069|453965782|FG000|Parent Study|Withdrawal by Subject|1|||
126186120|NCT01421069|453965782|FG000|Parent Study|Lost to Follow-up|2|||
126186121|NCT01421069|453965782|FG000|Parent Study|Lack of Efficacy|1|||
126186122|NCT01421069|453965782|FG000|Overall Period for Extension Study|Other|2|||
126186123|NCT01421069|453965782|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
126186124|NCT01421069|453965782|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
126186125|NCT01421069|453965782|FG000|Overall Period for Extension Study|Pregnancy|1|||
126186126|NCT01421069|453965782|FG000|Overall Period for Extension Study|Adverse Event|1|||
126186127|NCT01421069|453965782|FG000|Overall Period for Extension Study|Protocol Violation|1|||
126186128|NCT01421069|453965782|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
126186129|NCT01421069|453965782|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
126186130|NCT01421069|453965782|FG000|Active Treatment Period|Other|1|||
126186131|NCT01421069|453965782|FG000|Active Treatment Period|No longer willing to participate in study|8|||
126186132|NCT01421069|453965782|FG000|Active Treatment Period|Insufficient clinical response|1|||
126186133|NCT01421069|453965782|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
126186134|NCT01421069|453965782|FG000|Active Treatment Period|Pregnancy|1|||
126186135|NCT01421069|453965782|FG000|Active Treatment Period|Adverse Event|1|||
126186136|NCT01421069|453965782|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
126186137|NCT01421069|453965782|FG000|Active Treatment Period|Enrolled in observational period|29|||
126186138|NCT01421069|453965782|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
126186139|NCT01421069|453965782|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
126186140|NCT01421069|453965782|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
126186141|NCT01421069|453965782|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
126186142|NCT01421069|453965782|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
126186143|NCT01421069|453965782|FG000|2b. Retreatment Period|Protocol Violation|1|||
126186144|NCT01421069|453965782|FG000|Observational Period|Other|1|||
126186145|NCT01421069|453965782|FG000|Observational Period|No longer willing to participate in study|4|||
126186146|NCT01421069|453965782|FG000|Observational Period|Lost to Follow-up|3|||
126186147|NCT01641081|453965783|FG000|Period 1|Sponsor request (potential unblinding)|0|||
126186148|NCT01641081|453965784|FG001|Period 1|Sponsor request (potential unblinding)|0|||
126186149|NCT01641081|453965785|FG002|Period 1|Sponsor request (potential unblinding)|0|||
126186150|NCT01641081|453965786|FG003|Period 1|Sponsor request (potential unblinding)|0|||
126186151|NCT01641081|453965787|FG004|Period 1|Sponsor request (potential unblinding)|0|||
126186152|NCT01641081|453965788|FG005|Period 1|Sponsor request (potential unblinding)|0|||
126186153|NCT01641081|453965789|FG006|Period 1|Sponsor request (potential unblinding)|1|||
126186154|NCT01641081|453965790|FG007|Period 1|Sponsor request (potential unblinding)|0|||
126186155|NCT01641081|453965791|FG008|Period 1|Sponsor request (potential unblinding)|0|||
126186156|NCT01641081|453965792|FG009|Period 1|Sponsor request (potential unblinding)|0|||
126186157|NCT01641081|453965783|FG000|Period 1|Protocol Violation|0|||
126186158|NCT01641081|453965784|FG001|Period 1|Protocol Violation|0|||
126186159|NCT01641081|453965785|FG002|Period 1|Protocol Violation|0|||
126186160|NCT01641081|453965786|FG003|Period 1|Protocol Violation|0|||
126186161|NCT01641081|453965787|FG004|Period 1|Protocol Violation|1|||
126186162|NCT01641081|453965788|FG005|Period 1|Protocol Violation|0|||
126186163|NCT01641081|453965789|FG006|Period 1|Protocol Violation|0|||
126186164|NCT01641081|453965790|FG007|Period 1|Protocol Violation|1|||
126186165|NCT01641081|453965791|FG008|Period 1|Protocol Violation|0|||
126186166|NCT01641081|453965792|FG009|Period 1|Protocol Violation|0|||
126186167|NCT01641081|453965783|FG000|Period 1|Adverse Event|1|||
126186168|NCT01641081|453965784|FG001|Period 1|Adverse Event|0|||
126186169|NCT01641081|453965785|FG002|Period 1|Adverse Event|0|||
126186170|NCT01641081|453965786|FG003|Period 1|Adverse Event|0|||
126186171|NCT01641081|453965787|FG004|Period 1|Adverse Event|0|||
126186172|NCT01641081|453965788|FG005|Period 1|Adverse Event|0|||
126186173|NCT01641081|453965789|FG006|Period 1|Adverse Event|0|||
126186174|NCT01641081|453965790|FG007|Period 1|Adverse Event|2|||
126186175|NCT01641081|453965791|FG008|Period 1|Adverse Event|0|||
126186176|NCT01641081|453965792|FG009|Period 1|Adverse Event|0|||
126186177|NCT01641081|453965783|FG000|Period 2|Adverse Event|0|||
126186178|NCT01641081|453965784|FG001|Period 2|Adverse Event|0|||
126186179|NCT01641081|453965785|FG002|Period 2|Adverse Event|0|||
126186180|NCT01641081|453965786|FG003|Period 2|Adverse Event|0|||
126186181|NCT01641081|453965787|FG004|Period 2|Adverse Event|0|||
126186182|NCT01641081|453965788|FG005|Period 2|Adverse Event|1|||
126186183|NCT01641081|453965789|FG006|Period 2|Adverse Event|0|||
126186184|NCT01641081|453965790|FG007|Period 2|Adverse Event|0|||
126186185|NCT01641081|453965791|FG008|Period 2|Adverse Event|0|||
126186186|NCT01641081|453965792|FG009|Period 2|Adverse Event|0|||
126186187|NCT01641081|453965783|FG000|Period 2|Withdrawal by Subject|0|||
126186188|NCT01641081|453965784|FG001|Period 2|Withdrawal by Subject|0|||
126186189|NCT01641081|453965785|FG002|Period 2|Withdrawal by Subject|0|||
126186190|NCT01641081|453965786|FG003|Period 2|Withdrawal by Subject|1|||
126186191|NCT01641081|453965787|FG004|Period 2|Withdrawal by Subject|0|||
126186192|NCT01641081|453965788|FG005|Period 2|Withdrawal by Subject|0|||
126186193|NCT01641081|453965789|FG006|Period 2|Withdrawal by Subject|2|||
126186194|NCT01641081|453965790|FG007|Period 2|Withdrawal by Subject|0|||
126186195|NCT01641081|453965791|FG008|Period 2|Withdrawal by Subject|0|||
126186196|NCT01641081|453965792|FG009|Period 2|Withdrawal by Subject|0|||
126186197|NCT01641081|453965783|FG000|Period 2|Protocol Violation|1|||
126186198|NCT01641081|453965784|FG001|Period 2|Protocol Violation|0|||
126186199|NCT01641081|453965785|FG002|Period 2|Protocol Violation|0|||
126186200|NCT01641081|453965786|FG003|Period 2|Protocol Violation|0|||
126186201|NCT01641081|453965787|FG004|Period 2|Protocol Violation|0|||
126186202|NCT01641081|453965788|FG005|Period 2|Protocol Violation|0|||
126186203|NCT01641081|453965789|FG006|Period 2|Protocol Violation|0|||
126186204|NCT01641081|453965790|FG007|Period 2|Protocol Violation|0|||
126186205|NCT01641081|453965791|FG008|Period 2|Protocol Violation|0|||
126186206|NCT01641081|453965792|FG009|Period 2|Protocol Violation|0|||
126186207|NCT01641081|453965783|FG000|Period 3|Adverse Event|0|||
126186208|NCT01641081|453965784|FG001|Period 3|Adverse Event|0|||
126186209|NCT01641081|453965785|FG002|Period 3|Adverse Event|1|||
126186210|NCT01641081|453965786|FG003|Period 3|Adverse Event|0|||
126186211|NCT01641081|453965787|FG004|Period 3|Adverse Event|0|||
126186212|NCT01641081|453965788|FG005|Period 3|Adverse Event|0|||
126186213|NCT01641081|453965789|FG006|Period 3|Adverse Event|0|||
126186214|NCT01641081|453965790|FG007|Period 3|Adverse Event|0|||
126186215|NCT01641081|453965791|FG008|Period 3|Adverse Event|0|||
126186216|NCT01641081|453965792|FG009|Period 3|Adverse Event|0|||
126186217|NCT01641081|453965783|FG000|Period 3|Withdrawal by Subject|0|||
126186218|NCT01641081|453965784|FG001|Period 3|Withdrawal by Subject|0|||
126186219|NCT01641081|453965785|FG002|Period 3|Withdrawal by Subject|0|||
126186220|NCT01641081|453965786|FG003|Period 3|Withdrawal by Subject|0|||
126186221|NCT01641081|453965787|FG004|Period 3|Withdrawal by Subject|0|||
126186222|NCT01641081|453965788|FG005|Period 3|Withdrawal by Subject|0|||
126186223|NCT01641081|453965789|FG006|Period 3|Withdrawal by Subject|0|||
126186224|NCT01641081|453965790|FG007|Period 3|Withdrawal by Subject|0|||
126186225|NCT01641081|453965791|FG008|Period 3|Withdrawal by Subject|1|||
126186226|NCT01641081|453965792|FG009|Period 3|Withdrawal by Subject|0|||
126186227|NCT01641081|453965783|FG000|Period 4|Adverse Event|0|||
126186228|NCT01641081|453965784|FG001|Period 4|Adverse Event|1|||
126186229|NCT01641081|453965785|FG002|Period 4|Adverse Event|0|||
126186230|NCT01641081|453965786|FG003|Period 4|Adverse Event|1|||
126186231|NCT01641081|453965787|FG004|Period 4|Adverse Event|0|||
126186232|NCT01641081|453965788|FG005|Period 4|Adverse Event|0|||
126186233|NCT01641081|453965789|FG006|Period 4|Adverse Event|0|||
126186234|NCT01641081|453965790|FG007|Period 4|Adverse Event|0|||
126186235|NCT01641081|453965791|FG008|Period 4|Adverse Event|0|||
126186236|NCT01641081|453965792|FG009|Period 4|Adverse Event|0|||
126186237|NCT01641081|453965783|FG000|Period 5|Adverse Event|0|||
126186238|NCT01641081|453965784|FG001|Period 5|Adverse Event|0|||
126186239|NCT01641081|453965785|FG002|Period 5|Adverse Event|2|||
126186240|NCT01641081|453965786|FG003|Period 5|Adverse Event|0|||
126186241|NCT01641081|453965787|FG004|Period 5|Adverse Event|0|||
126186242|NCT01641081|453965788|FG005|Period 5|Adverse Event|0|||
126186243|NCT01641081|453965789|FG006|Period 5|Adverse Event|0|||
126186244|NCT01641081|453965790|FG007|Period 5|Adverse Event|0|||
126186245|NCT01641081|453965791|FG008|Period 5|Adverse Event|0|||
126186246|NCT01641081|453965792|FG009|Period 5|Adverse Event|0|||
126186247|NCT01095666|453965793|FG000|Overall Study|Lack of Efficacy|0|||
126186248|NCT01095666|453965794|FG001|Overall Study|Lack of Efficacy|0|||
126186249|NCT01095666|453965795|FG002|Overall Study|Lack of Efficacy|1|||
126186250|NCT01095666|453965793|FG000|Overall Study|Adverse Event|2|||
126186251|NCT01095666|453965794|FG001|Overall Study|Adverse Event|1|||
126186252|NCT01095666|453965795|FG002|Overall Study|Adverse Event|3|||
126186253|NCT01095666|453965793|FG000|Overall Study|Lost to Follow-up|2|||
126186254|NCT01095666|453965794|FG001|Overall Study|Lost to Follow-up|2|||
126186255|NCT01095666|453965795|FG002|Overall Study|Lost to Follow-up|0|||
126186256|NCT01095666|453965793|FG000|Overall Study|Withdrawal by Subject|6|||
126186257|NCT01095666|453965794|FG001|Overall Study|Withdrawal by Subject|6|||
126186258|NCT01095666|453965795|FG002|Overall Study|Withdrawal by Subject|1|||
126186259|NCT01095666|453965793|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
126186260|NCT01095666|453965794|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
126186261|NCT01095666|453965795|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
126186262|NCT01749800|453965799|FG000|Overall Study|not meeting inclusion criteria|3|||
126186263|NCT01749800|453965800|FG001|Overall Study|not meeting inclusion criteria|0|||
126186264|NCT01749800|453965801|FG002|Overall Study|not meeting inclusion criteria|0|||
126186265|NCT01749800|453965799|FG000|Overall Study|Withdrawal by Subject|0|||
126186266|NCT01749800|453965800|FG001|Overall Study|Withdrawal by Subject|1|||
126186267|NCT01749800|453965801|FG002|Overall Study|Withdrawal by Subject|0|||
126186268|NCT01000025|453965804|FG000|Overall Study|Adverse Event|43|||
126186269|NCT01000025|453965805|FG001|Overall Study|Adverse Event|2|||
126186270|NCT01000025|453965804|FG000|Overall Study|Withdrawal by Subject|13|||
126186271|NCT01000025|453965805|FG001|Overall Study|Withdrawal by Subject|8|||
126186272|NCT01000025|453965804|FG000|Overall Study|Death|23|||
126186273|NCT01000025|453965805|FG001|Overall Study|Death|13|||
126186274|NCT01000025|453965804|FG000|Overall Study|Lack of Efficacy|363|||
126186275|NCT01000025|453965805|FG001|Overall Study|Lack of Efficacy|208|||
126186276|NCT01000025|453965804|FG000|Overall Study|Intercurrent Illness|26|||
126186277|NCT01000025|453965805|FG001|Overall Study|Intercurrent Illness|7|||
126186278|NCT00422669|453965806|FG000|Overall Study|The study was terminated early.|98|||
126186279|NCT00422669|453965807|FG001|Overall Study|The study was terminated early.|100|||
126186280|NCT00422669|453965808|FG002|Overall Study|The study was terminated early.|7|||
126186281|NCT02738580|453965809|FG000|Overall Study|Adverse Event|1|||
126186282|NCT02738580|453965810|FG001|Overall Study|Adverse Event|0|||
126186283|NCT02738580|453965809|FG000|Overall Study|Lack of Efficacy|3|||
126186284|NCT02738580|453965810|FG001|Overall Study|Lack of Efficacy|2|||
126186285|NCT02738580|453965809|FG000|Overall Study|Withdrawal by Subject|0|||
126186286|NCT02738580|453965810|FG001|Overall Study|Withdrawal by Subject|1|||
126186287|NCT02738580|453965809|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
126186288|NCT02738580|453965810|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
126186289|NCT00996593|453965812|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
126186290|NCT00996593|453965812|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
126186291|NCT00996593|453965812|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
126186292|NCT00996593|453965812|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
126186293|NCT00996593|453965812|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
126186294|NCT00996593|453965812|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
126186295|NCT00996593|453965812|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
126186296|NCT00996593|453965812|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
126186297|NCT00996593|453965812|FG000|Long-Term Follow-Up|Site Closed|1|||
126186298|NCT00741260|453965813|FG000|Overall Study|Disease Progression|3|||
126186299|NCT00741260|453965814|FG001|Overall Study|Disease Progression|5|||
126186300|NCT00741260|453965815|FG002|Overall Study|Disease Progression|3|||
126186301|NCT00741260|453965816|FG003|Overall Study|Disease Progression|3|||
126186302|NCT00741260|453965817|FG004|Overall Study|Disease Progression|5|||
126186303|NCT00741260|453965818|FG005|Overall Study|Disease Progression|37|||
126186304|NCT00741260|453965819|FG006|Overall Study|Disease Progression|4|||
126186305|NCT00741260|453965813|FG000|Overall Study|Death|0|||
126186306|NCT00741260|453965814|FG001|Overall Study|Death|1|||
126186307|NCT00741260|453965815|FG002|Overall Study|Death|0|||
126186308|NCT00741260|453965816|FG003|Overall Study|Death|1|||
126186309|NCT00741260|453965817|FG004|Overall Study|Death|2|||
126186310|NCT00741260|453965818|FG005|Overall Study|Death|2|||
126186311|NCT00741260|453965819|FG006|Overall Study|Death|1|||
126186312|NCT00741260|453965813|FG000|Overall Study|Withdrawal by Subject|0|||
126186313|NCT00741260|453965814|FG001|Overall Study|Withdrawal by Subject|0|||
126186314|NCT00741260|453965815|FG002|Overall Study|Withdrawal by Subject|0|||
126186315|NCT00741260|453965816|FG003|Overall Study|Withdrawal by Subject|0|||
126186316|NCT00741260|453965817|FG004|Overall Study|Withdrawal by Subject|1|||
126186317|NCT00741260|453965818|FG005|Overall Study|Withdrawal by Subject|3|||
126186318|NCT00741260|453965819|FG006|Overall Study|Withdrawal by Subject|1|||
126186319|NCT00741260|453965813|FG000|Overall Study|Physician Decision|1|||
126186320|NCT00741260|453965814|FG001|Overall Study|Physician Decision|1|||
126186321|NCT00741260|453965815|FG002|Overall Study|Physician Decision|0|||
126186322|NCT00741260|453965816|FG003|Overall Study|Physician Decision|0|||
126186323|NCT00741260|453965817|FG004|Overall Study|Physician Decision|0|||
126186324|NCT00741260|453965818|FG005|Overall Study|Physician Decision|0|||
126186325|NCT00741260|453965819|FG006|Overall Study|Physician Decision|0|||
126186326|NCT00741260|453965813|FG000|Overall Study|Other|2|||
126186327|NCT00741260|453965814|FG001|Overall Study|Other|1|||
126186328|NCT00741260|453965815|FG002|Overall Study|Other|1|||
126186329|NCT00741260|453965816|FG003|Overall Study|Other|2|||
126186330|NCT00741260|453965817|FG004|Overall Study|Other|1|||
126186331|NCT00741260|453965818|FG005|Overall Study|Other|3|||
126186332|NCT00741260|453965819|FG006|Overall Study|Other|1|||
126186333|NCT02810951|453965820|FG000|Overall Study|Adverse Event|1|||
126186334|NCT01250756|453965821|FG000|Infant Series|Withdrawal by Subject|4|||
126186335|NCT01250756|453965822|FG001|Infant Series|Withdrawal by Subject|5|||
126186336|NCT01250756|453965821|FG000|Infant Series|Randomized, Not Vaccinated|2|||
126186337|NCT01250756|453965822|FG001|Infant Series|Randomized, Not Vaccinated|2|||
126186338|NCT01250756|453965821|FG000|Infant Series|Other|22|||
126186339|NCT01250756|453965822|FG001|Infant Series|Other|0|||
126186340|NCT01250756|453965821|FG000|After Infant Series|Adverse Event|5|||
126186341|NCT01250756|453965822|FG001|After Infant Series|Adverse Event|2|||
126186342|NCT01250756|453965821|FG000|After Infant Series|Withdrawal by Subject|4|||
126186343|NCT01250756|453965822|FG001|After Infant Series|Withdrawal by Subject|1|||
126186344|NCT01250756|453965821|FG000|After Infant Series|Other|2|||
126186345|NCT01250756|453965822|FG001|After Infant Series|Other|1|||
126186346|NCT01250756|453965821|FG000|Toddler Dose|Adverse Event|0|||
126186347|NCT01250756|453965822|FG001|Toddler Dose|Adverse Event|1|||
126186348|NCT01250756|453965821|FG000|After Toddler Dose|Adverse Event|0|||
126186349|NCT01250756|453965822|FG001|After Toddler Dose|Adverse Event|1|||
126186350|NCT01928082|453965823|FG000|Overall Study|Study terminated.|1|||
126186351|NCT02142504|453965829|FG000|Overall Study|Protocol Violation|2|||
126186352|NCT02142504|453965830|FG001|Overall Study|Protocol Violation|1|||
126186353|NCT02142504|453965831|FG002|Overall Study|Protocol Violation|2|||
126186354|NCT02142504|453965829|FG000|Overall Study|Adverse Event|2|||
126186355|NCT02142504|453965830|FG001|Overall Study|Adverse Event|3|||
126186356|NCT02142504|453965831|FG002|Overall Study|Adverse Event|4|||
126186357|NCT02142504|453965829|FG000|Overall Study|Lost to Follow-up|12|||
126186358|NCT02142504|453965830|FG001|Overall Study|Lost to Follow-up|19|||
126186359|NCT02142504|453965831|FG002|Overall Study|Lost to Follow-up|17|||
126186360|NCT02142504|453965829|FG000|Overall Study|Withdrawal by Subject|7|||
126186361|NCT02142504|453965830|FG001|Overall Study|Withdrawal by Subject|9|||
126186362|NCT02142504|453965831|FG002|Overall Study|Withdrawal by Subject|11|||
126186363|NCT02142504|453965829|FG000|Overall Study|Pregnancy|4|||
126186364|NCT02142504|453965830|FG001|Overall Study|Pregnancy|4|||
126186365|NCT02142504|453965831|FG002|Overall Study|Pregnancy|2|||
126186366|NCT02142504|453965829|FG000|Overall Study|Physician Decision|0|||
126186367|NCT02142504|453965830|FG001|Overall Study|Physician Decision|1|||
126186368|NCT02142504|453965831|FG002|Overall Study|Physician Decision|3|||
126186369|NCT02142504|453965829|FG000|Overall Study|Reason Not Specified|4|||
126186370|NCT02142504|453965830|FG001|Overall Study|Reason Not Specified|5|||
126186371|NCT02142504|453965831|FG002|Overall Study|Reason Not Specified|4|||
126186372|NCT02120352|453965832|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
126186373|NCT02120352|453965833|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
126186374|NCT02120352|453965834|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
126186375|NCT02120352|453965835|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
126186376|NCT02120352|453965836|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
126186377|NCT02120352|453965837|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
126186378|NCT02120352|453965838|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
126186379|NCT02120352|453965832|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
126186380|NCT02120352|453965833|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126186381|NCT02120352|453965834|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126186382|NCT02120352|453965835|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126186383|NCT02120352|453965836|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126186384|NCT02120352|453965837|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126186385|NCT02120352|453965838|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126186386|NCT02120352|453965832|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
126186387|NCT02120352|453965833|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
126186388|NCT02120352|453965834|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
126186389|NCT02120352|453965835|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
126186390|NCT02120352|453965836|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
126186391|NCT02120352|453965837|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
126186392|NCT02120352|453965838|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
126186393|NCT02120352|453965832|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
126186394|NCT02120352|453965833|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126186395|NCT02120352|453965834|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126186396|NCT02120352|453965835|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126186397|NCT02120352|453965836|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126186398|NCT02120352|453965837|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126186399|NCT02120352|453965838|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126186400|NCT02120352|453965832|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
126186401|NCT02120352|453965833|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126186402|NCT02120352|453965834|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126186403|NCT02120352|453965835|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126186404|NCT02120352|453965836|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126186405|NCT02120352|453965837|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126186406|NCT02120352|453965838|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126186407|NCT02120352|453965832|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
126186408|NCT02120352|453965833|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126186409|NCT02120352|453965834|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126186410|NCT02120352|453965835|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126186411|NCT02120352|453965836|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126186412|NCT02120352|453965837|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126186413|NCT02120352|453965838|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126186414|NCT02120352|453965832|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
126186415|NCT02120352|453965833|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
126186416|NCT02120352|453965834|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
126186417|NCT02120352|453965835|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
126186418|NCT02120352|453965836|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
126186419|NCT02120352|453965837|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
126186420|NCT02120352|453965838|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
126186421|NCT02120352|453965832|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
126186422|NCT02120352|453965833|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
126186423|NCT02120352|453965834|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
126186424|NCT02120352|453965835|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
126186425|NCT02120352|453965836|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
126186426|NCT02120352|453965837|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
126186427|NCT02120352|453965838|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
126186428|NCT02120352|453965832|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126186429|NCT02120352|453965833|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
126186430|NCT02120352|453965834|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126186431|NCT02120352|453965835|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
126186432|NCT02120352|453965836|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126186433|NCT02120352|453965837|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126186434|NCT02120352|453965838|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126186435|NCT02120352|453965832|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126186436|NCT02120352|453965833|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
126186437|NCT02120352|453965834|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
126186438|NCT02120352|453965835|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126186439|NCT02120352|453965836|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126186440|NCT02120352|453965837|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126186441|NCT02120352|453965838|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126186442|NCT02120352|453965832|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126186443|NCT02120352|453965833|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126186444|NCT02120352|453965834|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
126186445|NCT02120352|453965835|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
126186446|NCT02120352|453965836|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126186447|NCT02120352|453965837|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126186448|NCT02120352|453965838|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126186449|NCT02120352|453965832|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126186450|NCT02120352|453965833|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126186451|NCT02120352|453965834|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126186452|NCT02120352|453965835|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
126186453|NCT02120352|453965836|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126186454|NCT02120352|453965837|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126186455|NCT02120352|453965838|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126186456|NCT02120352|453965832|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
126186457|NCT02120352|453965833|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
126186458|NCT02120352|453965834|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
126186459|NCT02120352|453965835|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
126186460|NCT02120352|453965836|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
126186461|NCT02120352|453965837|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
126186462|NCT02120352|453965838|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
126186463|NCT02120352|453965832|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126186464|NCT02120352|453965833|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
126186465|NCT02120352|453965834|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126186466|NCT02120352|453965835|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126186467|NCT02120352|453965836|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126186468|NCT02120352|453965837|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126186469|NCT02120352|453965838|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126186470|NCT02120352|453965832|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
126186471|NCT02120352|453965833|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
126186472|NCT02120352|453965834|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
126186473|NCT02120352|453965835|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
126186474|NCT02120352|453965836|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
126186475|NCT02120352|453965837|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
126186476|NCT02120352|453965838|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
126186477|NCT02120352|453965832|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126186478|NCT02120352|453965833|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126186479|NCT02120352|453965834|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126186480|NCT02120352|453965835|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126186481|NCT02120352|453965836|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
126186482|NCT02120352|453965837|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126186483|NCT02120352|453965838|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126186484|NCT02120352|453965832|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
126186485|NCT02120352|453965833|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
126186486|NCT02120352|453965834|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
126186487|NCT02120352|453965835|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
126186488|NCT02120352|453965836|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
126186489|NCT02120352|453965837|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
126186490|NCT02120352|453965838|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
126186491|NCT02120352|453965832|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
126186492|NCT02120352|453965833|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
126186493|NCT02120352|453965834|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
126186494|NCT02120352|453965835|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
126186495|NCT02120352|453965836|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
126186496|NCT02120352|453965837|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
126186497|NCT02120352|453965838|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
126186498|NCT02120352|453965832|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
126186499|NCT02120352|453965833|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
126186500|NCT02120352|453965834|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
126186501|NCT02120352|453965835|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
126186502|NCT02120352|453965836|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
126186503|NCT02120352|453965837|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
126186504|NCT02120352|453965838|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
126186505|NCT02120352|453965832|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126186506|NCT02120352|453965833|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
126186507|NCT02120352|453965834|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
126186508|NCT02120352|453965835|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126186509|NCT02120352|453965836|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126186510|NCT02120352|453965837|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126186511|NCT02120352|453965838|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126186512|NCT02120352|453965832|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
126186513|NCT02120352|453965833|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
126186514|NCT02120352|453965834|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
126186515|NCT02120352|453965835|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
126186516|NCT02120352|453965836|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
126186517|NCT02120352|453965837|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
126186518|NCT02120352|453965838|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
126186519|NCT02120352|453965832|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126186520|NCT02120352|453965833|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126186521|NCT02120352|453965834|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126186522|NCT02120352|453965835|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126186523|NCT02120352|453965836|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126186524|NCT02120352|453965837|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126186525|NCT02120352|453965838|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
126186526|NCT01610206|453965841|FG000|Overall Study|Adverse Event|10|||
126186527|NCT01610206|453965842|FG001|Overall Study|Adverse Event|30|||
126186528|NCT00166517|453965844|FG000|Overall Study|Lost to Follow-up|1|||
126186529|NCT00166517|453965845|FG001|Overall Study|Lost to Follow-up|0|||
126186530|NCT00166517|453965844|FG000|Overall Study|Protocol Violation|4|||
126186531|NCT00166517|453965845|FG001|Overall Study|Protocol Violation|1|||
126186532|NCT00166517|453965844|FG000|Overall Study|Withdrawal by Subject|0|||
126186533|NCT00166517|453965845|FG001|Overall Study|Withdrawal by Subject|1|||
126186534|NCT02186561|453965846|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
126186535|NCT02186561|453965846|FG000|Enrollment|Enrollment Cap Reached|5|||
126186536|NCT02186561|453965846|FG000|Enrollment|Insurance Denial|2|||
126186537|NCT02186561|453965846|FG000|Enrollment|Withdrawal by Subject|2|||
126186538|NCT02186561|453965846|FG000|Enrollment|Investigator Withdrew Consent|1|||
126186539|NCT02186561|453965846|FG000|30-Day Post Index Procedure Visit|Death|1|||
126186540|NCT02186561|453965846|FG000|1- Year Post Index Procedure Visit|Death|1|||
126186541|NCT02186561|453965846|FG000|1- Year Post Index Procedure Visit|Missed|1|||
126186542|NCT04285853|453965847|FG000|Overall Study|Withdrawal by Subject|1|||
126186543|NCT04285853|453965848|FG001|Overall Study|Withdrawal by Subject|0|||
126186544|NCT04285853|453965847|FG000|Overall Study|Lost to Follow-up|9|||
126186545|NCT04285853|453965848|FG001|Overall Study|Lost to Follow-up|5|||
126186546|NCT00653068|453967851|FG000|Overall Study|Death|9|||
126186547|NCT00653068|453967851|FG000|Overall Study|Lack of Efficacy|34|||
126186548|NCT00653068|453967851|FG000|Overall Study|Physician Decision|4|||
126186549|NCT00653068|453967851|FG000|Overall Study|Withdrawal by Subject|1|||
126186550|NCT00653068|453967851|FG000|Overall Study|Ineligible|2|||
126186551|NCT01685060|453967856|FG000|Overall Study|Rollover patients|16|||
126186552|NCT01685060|453967856|FG000|Overall Study|Adverse Event|12|||
126186553|NCT01685060|453967856|FG000|Overall Study|Progressive disease|69|||
126186554|NCT01685060|453967856|FG000|Overall Study|Physician Decision|14|||
126186555|NCT01685060|453967856|FG000|Overall Study|Subject/guardian decision|20|||
126186556|NCT01685060|453967856|FG000|Overall Study|Lost to Follow-up|1|||
126186557|NCT01685060|453967856|FG000|Overall Study|Death|8|||
126186558|NCT03597503|453967857|FG000|Overall Study|Withdrawal by Subject|0|||
126186559|NCT03597503|453967858|FG001|Overall Study|Withdrawal by Subject|2|||
126186560|NCT03597503|453967857|FG000|Overall Study|Lost to Follow-up|1|||
126186561|NCT03597503|453967858|FG001|Overall Study|Lost to Follow-up|2|||
126186562|NCT03597503|453967857|FG000|Overall Study|Protocol Violation|1|||
126186563|NCT03597503|453967858|FG001|Overall Study|Protocol Violation|0|||
126186564|NCT02944513|453967859|FG000|Overall Study|Withdrawal by Subject|4|||
126186565|NCT02944513|453967860|FG001|Overall Study|Withdrawal by Subject|1|||
126186566|NCT00937326|453967864|FG000|Overall Study|Adverse Event|0|||
126186567|NCT00937326|453967865|FG001|Overall Study|Adverse Event|3|||
126186568|NCT00937326|453967866|FG002|Overall Study|Adverse Event|1|||
126186569|NCT00937326|453967867|FG003|Overall Study|Adverse Event|1|||
126186570|NCT00937326|453967868|FG004|Overall Study|Adverse Event|2|||
126186571|NCT00937326|453967864|FG000|Overall Study|Death|0|||
126186572|NCT00937326|453967865|FG001|Overall Study|Death|0|||
126186573|NCT00937326|453967866|FG002|Overall Study|Death|1|||
126186574|NCT00937326|453967867|FG003|Overall Study|Death|0|||
126186575|NCT00937326|453967868|FG004|Overall Study|Death|0|||
126186576|NCT00937326|453967864|FG000|Overall Study|Withdrawal by Subject|3|||
126186577|NCT00937326|453967865|FG001|Overall Study|Withdrawal by Subject|4|||
126186578|NCT00937326|453967866|FG002|Overall Study|Withdrawal by Subject|1|||
126186579|NCT00937326|453967867|FG003|Overall Study|Withdrawal by Subject|4|||
126186580|NCT00937326|453967868|FG004|Overall Study|Withdrawal by Subject|3|||
126186581|NCT00937326|453967864|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
126186582|NCT00937326|453967865|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
126186583|NCT00937326|453967866|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
126186584|NCT00937326|453967867|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
126186585|NCT00937326|453967868|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
126186586|NCT02578992|453967869|FG000|Overall Study|equipment not available or malfunction|3|||
126186587|NCT02578992|453967870|FG001|Overall Study|equipment not available or malfunction|3|||
126186588|NCT00086385|453967873|FG000|Overall Study|Death|2|||
126186589|NCT00086385|453967874|FG001|Overall Study|Death|2|||
126186590|NCT00086385|453967875|FG002|Overall Study|Death|1|||
126186591|NCT00086385|453967876|FG003|Overall Study|Death|1|||
126186592|NCT00880100|453967879|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
126186593|NCT00880100|453967879|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
126186594|NCT00880100|453967879|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
126186595|NCT00405275|453967881|FG000|Overall Study|Death|1|||
126186596|NCT00405275|453967882|FG001|Overall Study|Death|0|||
126186597|NCT00405275|453967881|FG000|Overall Study|Lost to Follow-up|5|||
126186598|NCT00405275|453967882|FG001|Overall Study|Lost to Follow-up|1|||
126186599|NCT00405275|453967881|FG000|Overall Study|Withdrawal by Subject|7|||
126186600|NCT00405275|453967882|FG001|Overall Study|Withdrawal by Subject|9|||
126186601|NCT00405275|453967881|FG000|Overall Study|Unwilling to continue|10|||
126186602|NCT00405275|453967882|FG001|Overall Study|Unwilling to continue|9|||
126186603|NCT00731666|453967883|FG000|Overall Study|Adverse Event|2|||
126186604|NCT00731666|453967883|FG000|Overall Study|Lost to Follow-up|8|||
126186605|NCT00731666|453967883|FG000|Overall Study|Withdrawal by Subject|2|||
126186606|NCT02853123|453967886|FG000|Treatment Period 1|Adverse Event|0|||
126186607|NCT02853123|453967887|FG001|Treatment Period 1|Adverse Event|3|||
126186608|NCT02853123|453967886|FG000|Washout Period|Worsening of COPD|0|||
126186609|NCT02853123|453967887|FG001|Washout Period|Worsening of COPD|3|||
126186610|NCT02853123|453967886|FG000|Washout Period|Adverse Event|1|||
126186611|NCT02853123|453967887|FG001|Washout Period|Adverse Event|0|||
126186612|NCT02471586|453967888|FG000|Overall Study|Lost to Follow-up|3|||
126186613|NCT02471586|453967889|FG001|Overall Study|Lost to Follow-up|8|||
126186614|NCT02471586|453967890|FG002|Overall Study|Lost to Follow-up|4|||
126186615|NCT02471586|453967888|FG000|Overall Study|Death|2|||
126186616|NCT02471586|453967889|FG001|Overall Study|Death|2|||
126186617|NCT02471586|453967890|FG002|Overall Study|Death|0|||
126186618|NCT00841672|453967899|FG000|Overall Study|Adverse Event|7|||
126186619|NCT00841672|453967900|FG001|Overall Study|Adverse Event|16|||
126186620|NCT00841672|453967899|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126186621|NCT00841672|453967900|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126186622|NCT00841672|453967899|FG000|Overall Study|Subject withdrew consent|2|||
126186623|NCT00841672|453967900|FG001|Overall Study|Subject withdrew consent|4|||
126186624|NCT00841672|453967899|FG000|Overall Study|Lost to Follow-up|1|||
126186625|NCT00841672|453967900|FG001|Overall Study|Lost to Follow-up|1|||
126186626|NCT00841672|453967899|FG000|Overall Study|Administrative problems|9|||
126186627|NCT00841672|453967900|FG001|Overall Study|Administrative problems|9|||
126186628|NCT00841672|453967899|FG000|Overall Study|Misrandomized|1|||
126186629|NCT00841672|453967900|FG001|Overall Study|Misrandomized|0|||
126186630|NCT00841672|453967899|FG000|Overall Study|Protocol Deviation|0|||
126186631|NCT00841672|453967900|FG001|Overall Study|Protocol Deviation|1|||
126186632|NCT01451398|453967904|FG000|Overall Study|Adverse Event|7|||
126186633|NCT01451398|453967905|FG001|Overall Study|Adverse Event|9|||
126186634|NCT01451398|453967904|FG000|Overall Study|Protocol Violation|1|||
126186635|NCT01451398|453967905|FG001|Overall Study|Protocol Violation|2|||
126186636|NCT01451398|453967904|FG000|Overall Study|Physician Decision|1|||
126186637|NCT01451398|453967905|FG001|Overall Study|Physician Decision|1|||
126186638|NCT01451398|453967904|FG000|Overall Study|Withdrawal by Subject|10|||
126186639|NCT01451398|453967905|FG001|Overall Study|Withdrawal by Subject|14|||
126186640|NCT01451398|453967904|FG000|Overall Study|Lost to Follow-up|6|||
126186641|NCT01451398|453967905|FG001|Overall Study|Lost to Follow-up|4|||
126186642|NCT01451398|453967904|FG000|Overall Study|Non-compliance with study drug|1|||
126186643|NCT01451398|453967905|FG001|Overall Study|Non-compliance with study drug|3|||
126186644|NCT01451398|453967904|FG000|Overall Study|Non-compliance with protocol|1|||
126186645|NCT01451398|453967905|FG001|Overall Study|Non-compliance with protocol|1|||
126186646|NCT01451398|453967904|FG000|Overall Study|Moved out of country|0|||
126186647|NCT01451398|453967905|FG001|Overall Study|Moved out of country|1|||
126186648|NCT01451398|453967904|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
126186649|NCT01451398|453967905|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
126186650|NCT01451398|453967904|FG000|Overall Study|Lack of Efficacy|0|||
126186651|NCT01451398|453967905|FG001|Overall Study|Lack of Efficacy|1|||
126186652|NCT02427100|453967909|FG000|Overall Study|Lost to Follow-up|0|||
126186653|NCT02427100|453967910|FG001|Overall Study|Lost to Follow-up|2|||
126186654|NCT03094611|453967911|FG000|Overall Study|Lack of Efficacy|1|||
126186655|NCT03094611|453967911|FG000|Overall Study|Stem Cell Transplant|1|||
126186656|NCT00842361|453967912|FG000|Overall Study|Protocol Violation|1|||
126186657|NCT00842361|453967913|FG001|Overall Study|Protocol Violation|0|||
126186658|NCT00842361|453967912|FG000|Overall Study|Unclassified|0|||
126186659|NCT00842361|453967913|FG001|Overall Study|Unclassified|2|||
126186660|NCT00924729|453967921|FG000|Overall Study|insufficient volume for analysis|1|||
126186661|NCT00924729|453967922|FG001|Overall Study|insufficient volume for analysis|0|||
126186662|NCT00924729|453967921|FG000|Overall Study|Protocol Violation|1|||
126186663|NCT00924729|453967922|FG001|Overall Study|Protocol Violation|0|||
126186664|NCT00981747|453967925|FG000|Losartan|Withdrawal by Subject|1|||
126186665|NCT00981747|453967925|FG000|Losartan|Death|1|||
126186666|NCT00981747|453967925|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
126186667|NCT01814826|453967926|FG000|Overall Study|Other|3|||
126186668|NCT01814826|453967927|FG001|Overall Study|Other|5|||
126186669|NCT01814826|453967928|FG002|Overall Study|Other|0|||
126186670|NCT01814826|453967926|FG000|Overall Study|Death|29|||
126186671|NCT01814826|453967927|FG001|Overall Study|Death|24|||
126186672|NCT01814826|453967928|FG002|Overall Study|Death|3|||
126186673|NCT02917629|453967929|FG000|Overall Study|Withdrawal by Subject|0|||
126186674|NCT02917629|453967930|FG001|Overall Study|Withdrawal by Subject|1|||
126186675|NCT03339401|453967931|FG000|Overall Study|Death|2|||
126186676|NCT03339401|453967932|FG001|Overall Study|Death|1|||
126186677|NCT03339401|453967931|FG000|Overall Study|Withdrawal by Subject|2|||
126186678|NCT03339401|453967932|FG001|Overall Study|Withdrawal by Subject|0|||
126186679|NCT03339401|453967931|FG000|Overall Study|Study terminated|4|||
126186680|NCT03339401|453967932|FG001|Overall Study|Study terminated|3|||
126186681|NCT03339401|453967931|FG000|Overall Study|Investigator Decision|1|||
126186682|NCT03339401|453967932|FG001|Overall Study|Investigator Decision|0|||
126186683|NCT00718523|453967933|FG000|Overall Study|Withdrawal by Subject|5|||
126186684|NCT00718523|453967934|FG001|Overall Study|Withdrawal by Subject|7|||
126186685|NCT00718523|453967933|FG000|Overall Study|Death|13|||
126186686|NCT00718523|453967934|FG001|Overall Study|Death|17|||
126186687|NCT03271307|453967935|FG000|Overall Study|Lost to Follow-up|0|||
126186688|NCT03271307|453967936|FG001|Overall Study|Lost to Follow-up|0|||
126186689|NCT03271307|453967937|FG002|Overall Study|Lost to Follow-up|0|||
126186690|NCT03271307|453967938|FG003|Overall Study|Lost to Follow-up|28|||
126186691|NCT03271307|453967939|FG004|Overall Study|Lost to Follow-up|91|||
126186692|NCT03365947|453967940|FG000|Overall Study|Lost to Follow-up|0|||
126186693|NCT03365947|453967941|FG001|Overall Study|Lost to Follow-up|0|||
126186694|NCT03365947|453967942|FG002|Overall Study|Lost to Follow-up|0|||
126186695|NCT03365947|453967943|FG003|Overall Study|Lost to Follow-up|0|||
126186696|NCT03365947|453967944|FG004|Overall Study|Lost to Follow-up|0|||
126186697|NCT03365947|453967945|FG005|Overall Study|Lost to Follow-up|1|||
126186698|NCT03365947|453967946|FG006|Overall Study|Lost to Follow-up|0|||
126186699|NCT03365947|453967947|FG007|Overall Study|Lost to Follow-up|0|||
126186700|NCT03365947|453967948|FG008|Overall Study|Lost to Follow-up|0|||
126186701|NCT03365947|453967949|FG009|Overall Study|Lost to Follow-up|0|||
126186702|NCT03365947|453967950|FG010|Overall Study|Lost to Follow-up|0|||
126186703|NCT03365947|453967951|FG011|Overall Study|Lost to Follow-up|0|||
126186704|NCT03365947|453967952|FG012|Overall Study|Lost to Follow-up|0|||
126186705|NCT03365947|453967953|FG013|Overall Study|Lost to Follow-up|0|||
126186706|NCT03365947|453967954|FG014|Overall Study|Lost to Follow-up|0|||
126186707|NCT03365947|453967955|FG015|Overall Study|Lost to Follow-up|0|||
126186708|NCT03365947|453967956|FG016|Overall Study|Lost to Follow-up|0|||
126186709|NCT03365947|453967957|FG017|Overall Study|Lost to Follow-up|0|||
126186710|NCT03365947|453967958|FG018|Overall Study|Lost to Follow-up|0|||
126186711|NCT01042938|453967959|FG000|Overall Study|Withdrawal by Subject|1|||
126186712|NCT01042938|453967960|FG001|Overall Study|Withdrawal by Subject|1|||
126186713|NCT01042938|453967959|FG000|Overall Study|Protocol Violation|1|||
126186714|NCT01042938|453967960|FG001|Overall Study|Protocol Violation|1|||
126186715|NCT01042938|453967959|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
126186716|NCT01042938|453967960|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
126186717|NCT03136484|453967961|FG000|Overall Study|Withdrawal by Subject|19|||
126186718|NCT03136484|453967962|FG001|Overall Study|Withdrawal by Subject|14|||
126186719|NCT03136484|453967961|FG000|Overall Study|Lost to Follow-up|7|||
126186720|NCT03136484|453967962|FG001|Overall Study|Lost to Follow-up|8|||
126186721|NCT03136484|453967961|FG000|Overall Study|Death|1|||
126186722|NCT03136484|453967962|FG001|Overall Study|Death|0|||
126186723|NCT03997760|453967967|FG000|Overall Study|Protocol Deviation|0|||
126186724|NCT03997760|453967968|FG001|Overall Study|Protocol Deviation|1|||
126186725|NCT03997760|453967969|FG002|Overall Study|Protocol Deviation|0|||
126186726|NCT03997760|453967970|FG003|Overall Study|Protocol Deviation|0|||
126186727|NCT00856986|453967971|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
126186728|NCT00856986|453967972|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
126186729|NCT00856986|453967973|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
126186730|NCT00856986|453967974|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
126186731|NCT00856986|453967975|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
126186732|NCT00856986|453967971|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
126186733|NCT00856986|453967972|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
126186734|NCT00856986|453967973|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
126186735|NCT00856986|453967974|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
126186736|NCT00856986|453967975|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
126186737|NCT00856986|453967971|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
126186738|NCT00856986|453967972|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
126186739|NCT00856986|453967973|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
126186740|NCT00856986|453967974|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
126186741|NCT00856986|453967975|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
126186742|NCT00856986|453967971|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
126186743|NCT00856986|453967972|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
126186744|NCT00856986|453967973|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
126186745|NCT00856986|453967974|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
126186746|NCT00856986|453967975|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
126186747|NCT00856986|453967971|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
126186748|NCT00856986|453967972|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
126186749|NCT00856986|453967973|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
126186750|NCT00856986|453967974|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
126186751|NCT00856986|453967975|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
126186752|NCT00856986|453967971|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
126186753|NCT00856986|453967972|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
126186754|NCT00856986|453967973|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
126186755|NCT00856986|453967974|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
126186756|NCT00856986|453967975|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
126186757|NCT00856986|453967971|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
126186758|NCT00856986|453967972|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
126186759|NCT00856986|453967973|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
126186760|NCT00856986|453967974|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
126186761|NCT00856986|453967975|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
126186762|NCT00856986|453967971|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
126186763|NCT00856986|453967972|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
126186764|NCT00856986|453967973|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
126186765|NCT00856986|453967974|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
126186766|NCT00856986|453967975|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
126186767|NCT00856986|453967971|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
126186768|NCT00856986|453967972|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
126186769|NCT00856986|453967973|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
126186770|NCT00856986|453967974|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
126186771|NCT00856986|453967975|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
126186772|NCT00856986|453967971|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
126186773|NCT00856986|453967972|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
126186774|NCT00856986|453967973|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
126186775|NCT00856986|453967974|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
126186776|NCT00856986|453967975|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
126186777|NCT00856986|453967971|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
126186778|NCT00856986|453967972|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
126186779|NCT00856986|453967973|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
126186780|NCT00856986|453967974|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
126186781|NCT00856986|453967975|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
126186782|NCT00856986|453967971|FG000|Main Period, Weeks 0-26|Unclassified|7|||
126186783|NCT00856986|453967972|FG001|Main Period, Weeks 0-26|Unclassified|6|||
126186784|NCT00856986|453967973|FG002|Main Period, Weeks 0-26|Unclassified|7|||
126186785|NCT00856986|453967974|FG003|Main Period, Weeks 0-26|Unclassified|0|||
126186786|NCT00856986|453967975|FG004|Main Period, Weeks 0-26|Unclassified|0|||
126186787|NCT00856986|453967971|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
126186788|NCT00856986|453967972|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
126186789|NCT00856986|453967973|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
126186790|NCT00856986|453967974|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
126186791|NCT00856986|453967975|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
126186792|NCT00856986|453967971|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
126186793|NCT00856986|453967972|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
126186794|NCT00856986|453967973|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
126186795|NCT00856986|453967974|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
126186796|NCT00856986|453967975|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
126186797|NCT00856986|453967971|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
126186798|NCT00856986|453967972|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
126186799|NCT00856986|453967973|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
126186800|NCT00856986|453967974|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
126186801|NCT00856986|453967975|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
126186802|NCT00856986|453967971|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
126186803|NCT00856986|453967972|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
126186804|NCT00856986|453967973|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
126186805|NCT00856986|453967974|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
126186806|NCT00856986|453967975|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
126186807|NCT00856986|453967971|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
126186808|NCT00856986|453967972|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
126186809|NCT00856986|453967973|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
126186810|NCT00856986|453967974|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
126186811|NCT00856986|453967975|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
126186812|NCT00856986|453967971|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
126186813|NCT00856986|453967972|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
126186814|NCT00856986|453967973|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
126186815|NCT00856986|453967974|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
126186816|NCT00856986|453967975|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
126186817|NCT05041062|453967976|FG000|Overall Study|Adverse Event|2|||
126186818|NCT01915095|453967977|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
126186819|NCT01915095|453967978|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
126186820|NCT01915095|453967979|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
126186821|NCT01915095|453967980|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
126186822|NCT01915095|453967981|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
126186823|NCT04018612|453967982|FG000|Overall Study|Withdrawal by Subject|1|||
126186824|NCT04018612|453967983|FG001|Overall Study|Withdrawal by Subject|0|||
126186825|NCT04018612|453967984|FG002|Overall Study|Withdrawal by Subject|1|||
126186826|NCT02671760|453967988|FG000|Overall Study|Lost to Follow-up|0|||
126186827|NCT02671760|453967989|FG001|Overall Study|Lost to Follow-up|1|||
126186828|NCT02671760|453967990|FG002|Overall Study|Lost to Follow-up|0|||
126186829|NCT02999191|453967991|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
126186830|NCT02999191|453967992|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
126186831|NCT02999191|453967993|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
126186832|NCT01802515|453968000|FG000|Overall Study|Withdrawal by Subject|3|||
126186833|NCT01802515|453968001|FG001|Overall Study|Withdrawal by Subject|0|||
126186834|NCT01802515|453968002|FG002|Overall Study|Withdrawal by Subject|0|||
126186835|NCT01176240|453968005|FG000|Study 306A|Lack of Efficacy|2|||
126186836|NCT01176240|453968006|FG001|Study 306A|Lack of Efficacy|1|||
126186837|NCT01176240|453968005|FG000|Study 306A|Protocol Violation|0|||
126186838|NCT01176240|453968006|FG001|Study 306A|Protocol Violation|1|||
126186839|NCT01176240|453968005|FG000|Study 306A|Withdrawal by Subject|0|||
126186840|NCT01176240|453968006|FG001|Study 306A|Withdrawal by Subject|1|||
126186841|NCT01176240|453968005|FG000|Study 306A|Stop due to diverse problems|1|||
126186842|NCT01176240|453968006|FG001|Study 306A|Stop due to diverse problems|0|||
126186843|NCT01176240|453968005|FG000|Study 306B|Lack of Efficacy|5|||
126186844|NCT01176240|453968006|FG001|Study 306B|Lack of Efficacy|3|||
126186845|NCT01176240|453968005|FG000|Study 306B|Adverse Event|10|||
126186846|NCT01176240|453968006|FG001|Study 306B|Adverse Event|5|||
126186847|NCT01176240|453968005|FG000|Study 306B|Protocol Violation|2|||
126186848|NCT01176240|453968006|FG001|Study 306B|Protocol Violation|3|||
126186849|NCT01176240|453968005|FG000|Study 306B|Withdrawal by Subject|4|||
126186850|NCT01176240|453968006|FG001|Study 306B|Withdrawal by Subject|1|||
126186851|NCT01176240|453968005|FG000|Study 306B|Physician Decision|2|||
126186852|NCT01176240|453968006|FG001|Study 306B|Physician Decision|1|||
126186853|NCT01176240|453968005|FG000|Study 306B|Supine Hypertension|1|||
126186854|NCT01176240|453968006|FG001|Study 306B|Supine Hypertension|2|||
126186855|NCT01176240|453968005|FG000|Study 306B|Lost to Follow-up|0|||
126186856|NCT01176240|453968006|FG001|Study 306B|Lost to Follow-up|1|||
126186857|NCT01176240|453968005|FG000|Study 306B|withdrew prior to dosing|2|||
126186858|NCT01176240|453968006|FG001|Study 306B|withdrew prior to dosing|1|||
126186859|NCT01931150|453968007|FG000|Overall Study|Withdrawal by Subject|1|||
126186860|NCT01931150|453968008|FG001|Overall Study|Withdrawal by Subject|2|||
126186861|NCT02896192|453968012|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
126186862|NCT02896192|453968012|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
126186863|NCT02896192|453968012|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
126186864|NCT00479167|453968019|FG000|Overall Study|Withdrawal by Subject|1|||
126186865|NCT01390038|453968020|FG000|Overall Study|Death|1|||
126186866|NCT01390038|453968020|FG000|Overall Study|Lost to Follow-up|1|||
126186867|NCT01390038|453968020|FG000|Overall Study|Withdrawal by Subject|4|||
126186868|NCT01390038|453968020|FG000|Overall Study|Simpliciti System Removal|2|||
126186869|NCT03619837|453968026|FG000|Screening|received organs from HCV-negative donors|47|||
126186870|NCT03619837|453968026|FG000|Screening|died on the wait-list|2|||
126186871|NCT03619837|453968026|FG000|Screening|remained on the wait list|40|||
126186872|NCT03619837|453968026|FG000|Screening|didn't meet eligibility criteria|3|||
126186873|NCT03619837|453968026|FG000|Screening|withdrew consent|2|||
126186874|NCT03619837|453968026|FG000|Screening|never listed for HCV-viremic donor|1|||
126186875|NCT03619837|453968026|FG000|Screening|developed exclusion criteria|2|||
126186876|NCT03619837|453968026|FG000|Screening|excluded by the investigator due to non-compliance|1|||
126186877|NCT00807014|453968030|FG000|Overall Study|Participant Considered Disease Cured|13|||
126186878|NCT00807014|453968031|FG001|Overall Study|Participant Considered Disease Cured|2|||
126186879|NCT00807014|453968030|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
126186880|NCT00807014|453968031|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
126186881|NCT00807014|453968030|FG000|Overall Study|Protocol Violation|2|||
126186882|NCT00807014|453968031|FG001|Overall Study|Protocol Violation|8|||
126186883|NCT00807014|453968030|FG000|Overall Study|Adverse Event|0|||
126186884|NCT00807014|453968031|FG001|Overall Study|Adverse Event|2|||
126186885|NCT00807014|453968030|FG000|Overall Study|Lost to Follow-up|9|||
126186886|NCT00807014|453968031|FG001|Overall Study|Lost to Follow-up|7|||
126186887|NCT00807014|453968030|FG000|Overall Study|Recovery|1|||
126186888|NCT00807014|453968031|FG001|Overall Study|Recovery|0|||
126186889|NCT00807014|453968030|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
126186890|NCT00807014|453968031|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
126186891|NCT02650895|453968032|FG000|Overall Study|Withdrawal by Subject|0|||
126186892|NCT02650895|453968033|FG001|Overall Study|Withdrawal by Subject|1|||
126186893|NCT02650895|453968034|FG002|Overall Study|Withdrawal by Subject|0|||
126186894|NCT02650895|453968035|FG003|Overall Study|Withdrawal by Subject|0|||
126186895|NCT02650895|453968036|FG004|Overall Study|Withdrawal by Subject|0|||
126186896|NCT02650895|453968037|FG005|Overall Study|Withdrawal by Subject|0|||
126186897|NCT03038672|453969421|FG000|Initial Treatment|Unacceptable chemistry|0|||
126186898|NCT03038672|453969422|FG001|Initial Treatment|Unacceptable chemistry|1|||
126186899|NCT03038672|453969421|FG000|Initial Treatment|Progression prior to treatment|1|||
126186900|NCT03038672|453969422|FG001|Initial Treatment|Progression prior to treatment|0|||
126186901|NCT03038672|453969421|FG000|Initial Treatment|No treatment per protocol|1|||
126186902|NCT03038672|453969422|FG001|Initial Treatment|No treatment per protocol|0|||
126186903|NCT00959894|453969423|FG000|Overall Study|Lost to Follow-up|10|||
126186904|NCT00959894|453969423|FG000|Overall Study|Adverse Event|3|||
126186905|NCT00959894|453969423|FG000|Overall Study|Withdrawal by Subject|1|||
126186906|NCT00959894|453969423|FG000|Overall Study|Need for contraindicated medication|1|||
126186907|NCT00959894|453969423|FG000|Overall Study|Subject moved out of town|1|||
126186908|NCT01305941|453969424|FG000|Overall Study|Adverse Event|6|||
126186909|NCT01305941|453969424|FG000|Overall Study|Clinical decline|2|||
126186910|NCT01305941|453969424|FG000|Overall Study|Withdrawal by Subject|1|||
126186911|NCT01305941|453969424|FG000|Overall Study|Death|1|||
126186912|NCT02892734|453969425|FG000|Treatment on Study|Progressive Disease|2|||
126186913|NCT02892734|453969425|FG000|Follow up for 2 Years|Death|2|||
126186914|NCT02892734|453969425|FG000|Follow up for 2 Years|Study closed early|1|||
126186915|NCT02043509|453969426|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
126186916|NCT02043509|453969427|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
126186917|NCT02043509|453969426|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
126186918|NCT02043509|453969427|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
126186919|NCT02043509|453969426|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
126186920|NCT02043509|453969427|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
126186921|NCT02043509|453969426|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
126186922|NCT02043509|453969427|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
126186923|NCT00608244|453969432|FG000|Overall Study|Adverse Event|1|||
126186924|NCT00608244|453969432|FG000|Overall Study|Low trough levels|1|||
126186925|NCT01957215|453969437|FG000|Overall Study|Adverse Event|2|||
126186926|NCT01957215|453969438|FG001|Overall Study|Adverse Event|2|||
126186927|NCT01957215|453969437|FG000|Overall Study|Lost to Follow-up|3|||
126186928|NCT01957215|453969438|FG001|Overall Study|Lost to Follow-up|3|||
126186929|NCT01957215|453969437|FG000|Overall Study|Protocol Violation|1|||
126186930|NCT01957215|453969438|FG001|Overall Study|Protocol Violation|2|||
126186931|NCT01957215|453969437|FG000|Overall Study|Withdrawal by Subject|7|||
126186932|NCT01957215|453969438|FG001|Overall Study|Withdrawal by Subject|5|||
126186933|NCT01495689|453969449|FG000|Overall Study|Death|0|||
126186934|NCT01495689|453969450|FG001|Overall Study|Death|1|||
126186935|NCT01495689|453969449|FG000|Overall Study|Withdrawal by Subject|3|||
126186936|NCT01495689|453969450|FG001|Overall Study|Withdrawal by Subject|0|||
126186937|NCT01495689|453969449|FG000|Overall Study|Lost to Follow-up|7|||
126186938|NCT01495689|453969450|FG001|Overall Study|Lost to Follow-up|6|||
126186939|NCT00254163|453969451|FG000|Overall Study|Adverse Event|29|||
126186940|NCT00254163|453969452|FG001|Overall Study|Adverse Event|26|||
126186941|NCT00254163|453969451|FG000|Overall Study|Patient request/withdrew consent|6|||
126186942|NCT00254163|453969452|FG001|Overall Study|Patient request/withdrew consent|4|||
126186943|NCT00254163|453969451|FG000|Overall Study|Investigator request|1|||
126186944|NCT00254163|453969452|FG001|Overall Study|Investigator request|3|||
126186945|NCT00254163|453969451|FG000|Overall Study|Failed entry|1|||
126186946|NCT00254163|453969452|FG001|Overall Study|Failed entry|3|||
126186947|NCT00254163|453969451|FG000|Overall Study|Progressive disease|0|||
126186948|NCT00254163|453969452|FG001|Overall Study|Progressive disease|1|||
126186949|NCT00254163|453969451|FG000|Overall Study|Death|0|||
126186950|NCT00254163|453969452|FG001|Overall Study|Death|1|||
126186951|NCT00254163|453969451|FG000|Overall Study|Other|8|||
126186952|NCT00254163|453969452|FG001|Overall Study|Other|8|||
126186953|NCT00524043|453969453|FG000|Overall Study|Lack of Efficacy|15|||
126186954|NCT00524043|453969454|FG001|Overall Study|Lack of Efficacy|13|||
126186955|NCT00524043|453969455|FG002|Overall Study|Lack of Efficacy|14|||
126186956|NCT00524043|453969453|FG000|Overall Study|Withdrawal by Subject|5|||
126186957|NCT00524043|453969454|FG001|Overall Study|Withdrawal by Subject|7|||
126186958|NCT00524043|453969455|FG002|Overall Study|Withdrawal by Subject|7|||
126186959|NCT00524043|453969453|FG000|Overall Study|Adverse Event|5|||
126186960|NCT00524043|453969454|FG001|Overall Study|Adverse Event|2|||
126186961|NCT00524043|453969455|FG002|Overall Study|Adverse Event|7|||
126186962|NCT00524043|453969453|FG000|Overall Study|Lost to Follow-up|3|||
126186963|NCT00524043|453969454|FG001|Overall Study|Lost to Follow-up|5|||
126186964|NCT00524043|453969455|FG002|Overall Study|Lost to Follow-up|3|||
126186965|NCT00524043|453969453|FG000|Overall Study|Various (eg, incarceration)|2|||
126186966|NCT00524043|453969454|FG001|Overall Study|Various (eg, incarceration)|1|||
126186967|NCT00524043|453969455|FG002|Overall Study|Various (eg, incarceration)|0|||
126186968|NCT00606177|453969458|FG000|Overall Study|Adverse Event|9|||
126186969|NCT00606177|453969459|FG001|Overall Study|Adverse Event|5|||
126186970|NCT00606177|453969458|FG000|Overall Study|Lack of Efficacy|3|||
126186971|NCT00606177|453969459|FG001|Overall Study|Lack of Efficacy|7|||
126186972|NCT00606177|453969458|FG000|Overall Study|Physician Decision|1|||
126186973|NCT00606177|453969459|FG001|Overall Study|Physician Decision|0|||
126186974|NCT00606177|453969458|FG000|Overall Study|Protocol Violation|1|||
126186975|NCT00606177|453969459|FG001|Overall Study|Protocol Violation|4|||
126186976|NCT00606177|453969458|FG000|Overall Study|Withdrawal by Subject|5|||
126186977|NCT00606177|453969459|FG001|Overall Study|Withdrawal by Subject|6|||
126186978|NCT00606177|453969458|FG000|Overall Study|Progression to depressive phase|6|||
126186979|NCT00606177|453969459|FG001|Overall Study|Progression to depressive phase|1|||
126186980|NCT00606177|453969458|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
126186981|NCT00606177|453969459|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
126186982|NCT00606177|453969458|FG000|Overall Study|Change of residence or other commitments|1|||
126186983|NCT00606177|453969459|FG001|Overall Study|Change of residence or other commitments|1|||
126186984|NCT00136357|453969460|FG000|Overall Study|Withdrawal by Subject|3|||
126186985|NCT00136357|453969461|FG001|Overall Study|Withdrawal by Subject|2|||
126186986|NCT00216086|453969469|FG000|Overall Study|Protocol Violation|1|||
126186987|NCT00216086|453969469|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
126186988|NCT00216086|453969469|FG000|Overall Study|Social Reasons|2|||
126186989|NCT01784211|453969470|FG000|Part A (Days 1-15)|Adverse Event|1|||
126186990|NCT01784211|453969471|FG001|Part A (Days 1-15)|Adverse Event|1|||
126186991|NCT01784211|453969472|FG002|Part A (Days 1-15)|Adverse Event|0|||
126186992|NCT01784211|453969473|FG003|Part A (Days 1-15)|Adverse Event|0|||
126186993|NCT01784211|453969474|FG004|Part A (Days 1-15)|Adverse Event|0|||
126186994|NCT01784211|453969475|FG005|Part A (Days 1-15)|Adverse Event|0|||
126186995|NCT01784211|453969470|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
126186996|NCT01784211|453969471|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
126186997|NCT01784211|453969472|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
126186998|NCT01784211|453969473|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
126186999|NCT01784211|453969474|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
126187000|NCT01784211|453969475|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
126187001|NCT01001572|453969476|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
126187002|NCT01001572|453969477|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
126187003|NCT01001572|453969478|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
126187004|NCT01001572|453969476|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
126187005|NCT01001572|453969477|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
126187006|NCT01001572|453969478|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
126187007|NCT01001572|453969476|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
126187008|NCT01001572|453969477|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
126187009|NCT01001572|453969478|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
126187010|NCT01001572|453969476|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
126187011|NCT01001572|453969477|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
126187012|NCT01001572|453969478|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
126187013|NCT01001572|453969476|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
126187014|NCT01001572|453969477|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
126187015|NCT01001572|453969478|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
126187016|NCT01001572|453969476|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
126187017|NCT01001572|453969477|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
126187018|NCT01001572|453969478|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
126187019|NCT01001572|453969476|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
126187020|NCT01001572|453969477|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
126187021|NCT01001572|453969478|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
126187022|NCT01001572|453969476|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
126187023|NCT01001572|453969477|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
126187024|NCT01001572|453969478|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
126187025|NCT01001572|453969476|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126187026|NCT01001572|453969477|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
126187027|NCT01001572|453969478|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
126187028|NCT01001572|453969476|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126187029|NCT01001572|453969477|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
126187030|NCT01001572|453969478|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
126187031|NCT01001572|453969476|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
126187032|NCT01001572|453969477|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
126187033|NCT01001572|453969478|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
126187034|NCT01001572|453969476|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
126187035|NCT01001572|453969477|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
126187036|NCT01001572|453969478|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
126187037|NCT01001572|453969476|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
126187038|NCT01001572|453969477|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
126187039|NCT01001572|453969478|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
126187040|NCT01001572|453969476|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126187041|NCT01001572|453969477|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126187042|NCT01001572|453969478|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126187043|NCT02025530|453969481|FG000|Overall Study|No longer met elligibility criteria|5|||
126187044|NCT02025530|453969482|FG001|Overall Study|No longer met elligibility criteria|1|||
126187045|NCT03551626|453969489|FG000|Overall Study|Adverse Event|88|||
126187046|NCT03551626|453969489|FG000|Overall Study|Disease relapse|18|||
126187047|NCT03551626|453969489|FG000|Overall Study|Withdrawal of informed consent|6|||
126187048|NCT03551626|453969489|FG000|Overall Study|Patient decision|5|||
126187049|NCT03551626|453969489|FG000|Overall Study|Physician Decision|4|||
126187050|NCT03551626|453969489|FG000|Overall Study|Lost to Follow-up|3|||
126187051|NCT03551626|453969489|FG000|Overall Study|Pregnancy|1|||
126187052|NCT03551626|453969489|FG000|Overall Study|Protocol deviation|1|||
126187053|NCT03551626|453969489|FG000|Overall Study|Technical problems|1|||
126187054|NCT04211961|453969490|FG000|Overall Study|Death|0|||
126187055|NCT04211961|453969491|FG001|Overall Study|Death|1|||
126187056|NCT04211961|453969490|FG000|Overall Study|Lost to Follow-up|0|||
126187057|NCT04211961|453969491|FG001|Overall Study|Lost to Follow-up|1|||
126187058|NCT04211961|453969490|FG000|Overall Study|Withdrawal by Subject|0|||
126187059|NCT04211961|453969491|FG001|Overall Study|Withdrawal by Subject|1|||
126187060|NCT05784129|453969492|FG000|Overall Study|Study terminated by sponsor|2|||
126187061|NCT05784129|453969493|FG001|Overall Study|Study terminated by sponsor|2|||
126187062|NCT01156363|453969494|FG000|Overall Study|Adverse Event|6|||
126187063|NCT01156363|453969494|FG000|Overall Study|Insufficient Therapeutic Response|5|||
126187064|NCT01156363|453969494|FG000|Overall Study|Failure to Return|1|||
126187065|NCT01156363|453969494|FG000|Overall Study|Refused Treatment|4|||
126187066|NCT01156363|453969494|FG000|Overall Study|Other|6|||
126187067|NCT04882072|453969501|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
126187068|NCT04882072|453969502|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
126187069|NCT04882072|453969501|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
126187070|NCT04882072|453969502|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
126187071|NCT04882072|453969501|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
126187072|NCT04882072|453969502|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
126187073|NCT02918318|453969503|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
126187074|NCT02918318|453969504|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
126187075|NCT02918318|453969505|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
126187076|NCT02918318|453969506|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
126187077|NCT02918318|453969507|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
126187078|NCT02918318|453969503|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
126187079|NCT02918318|453969504|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
126187080|NCT02918318|453969505|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
126187081|NCT02918318|453969506|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
126187082|NCT02918318|453969507|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
126187083|NCT02918318|453969503|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
126187084|NCT02918318|453969504|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
126187085|NCT02918318|453969505|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
126187086|NCT02918318|453969506|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
126187087|NCT02918318|453969507|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
126187088|NCT02918318|453969503|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
126187089|NCT02918318|453969504|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
126187090|NCT02918318|453969505|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
126187091|NCT02918318|453969506|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
126187092|NCT02918318|453969507|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
126187093|NCT02918318|453969503|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
126187094|NCT02918318|453969504|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
126187095|NCT02918318|453969505|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
126187096|NCT02918318|453969506|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
126187097|NCT02918318|453969507|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
126187098|NCT02918318|453969503|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
126187099|NCT02918318|453969504|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
126187100|NCT02918318|453969505|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
126187101|NCT02918318|453969506|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
126187102|NCT02918318|453969507|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
126187103|NCT02918318|453969503|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
126187104|NCT02918318|453969504|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
126187105|NCT02918318|453969505|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
126187106|NCT02918318|453969506|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
126187107|NCT02918318|453969507|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
126187108|NCT02918318|453969503|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
126187109|NCT02918318|453969504|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
126187110|NCT02918318|453969505|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
126187111|NCT02918318|453969506|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
126187112|NCT02918318|453969507|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
126187113|NCT02918318|453969503|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
126187114|NCT02918318|453969504|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
126187115|NCT02918318|453969505|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
126187116|NCT02918318|453969506|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
126187117|NCT02918318|453969507|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
126187118|NCT02918318|453969503|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
126187119|NCT02918318|453969504|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
126187120|NCT02918318|453969505|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
126187121|NCT02918318|453969506|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
126187122|NCT02918318|453969507|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
126187123|NCT02918318|453969503|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
126187124|NCT02918318|453969504|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
126187125|NCT02918318|453969505|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
126187126|NCT02918318|453969506|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
126187127|NCT02918318|453969507|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
126187128|NCT02918318|453969503|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
126187129|NCT02918318|453969504|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
126187130|NCT02918318|453969505|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
126187131|NCT02918318|453969506|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
126187132|NCT02918318|453969507|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
126187133|NCT00045630|453969509|FG000|Overall Study|Adverse Event|1|||
126187134|NCT00045630|453969509|FG000|Overall Study|Refusal unrelated to adverse event|1|||
126187135|NCT00045630|453969509|FG000|Overall Study|Progression/relapse|1|||
126187136|NCT00045630|453969509|FG000|Overall Study|Death|1|||
126187137|NCT00045630|453969509|FG000|Overall Study|Ineligible|2|||
126187138|NCT02023112|453969514|FG000|Overall Study|Withdrawal by Subject|2|||
126187139|NCT02023112|453969515|FG001|Overall Study|Withdrawal by Subject|1|||
126187140|NCT02067533|453969519|FG000|Overall Study|Lost to Follow-up|4|||
126187141|NCT02067533|453969520|FG001|Overall Study|Lost to Follow-up|2|||
126187142|NCT02566109|453969521|FG000|Overall Study|Withdrawal by Subject|1|||
126187143|NCT01906476|453969522|FG000|Overall Study|Lost to Follow-up|17|||
126187144|NCT01906476|453969523|FG001|Overall Study|Lost to Follow-up|16|||
126187145|NCT01993667|453969524|FG000|Overall Study|Insufficient data to analyze|16|||
126187146|NCT01993667|453969525|FG001|Overall Study|Insufficient data to analyze|16|||
126187147|NCT01993667|453969524|FG000|Overall Study|Insufficient altitude reached|3|||
126187148|NCT01993667|453969525|FG001|Overall Study|Insufficient altitude reached|1|||
126187149|NCT01993667|453969524|FG000|Overall Study|Lost to Follow-up|2|||
126187150|NCT01993667|453969525|FG001|Overall Study|Lost to Follow-up|2|||
126187151|NCT01997281|453969530|FG000|Overall Study|Withdrawal by Subject|1|||
126187152|NCT01997281|453969531|FG001|Overall Study|Withdrawal by Subject|0|||
126187153|NCT00560794|453969532|FG000|Overall Study|Adverse Event|2|||
126187154|NCT00560794|453969532|FG000|Overall Study|Patient was not Compliant|1|||
126187155|NCT00560794|453969532|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
126187156|NCT00560794|453969532|FG000|Overall Study|Hematological Relapse|1|||
126187157|NCT00560794|453969532|FG000|Overall Study|Received Bone Marrow Transplant|6|||
126187158|NCT04857892|453969533|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
126187159|NCT04857892|453969534|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
126187160|NCT04857892|453969535|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
126187161|NCT04857892|453969536|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
126187162|NCT04857892|453969537|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
126187163|NCT04857892|453969533|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
126187164|NCT04857892|453969534|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
126187165|NCT04857892|453969535|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
126187166|NCT04857892|453969536|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
126187167|NCT04857892|453969537|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
126187168|NCT04857892|453969533|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
126187169|NCT04857892|453969534|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
126187170|NCT04857892|453969535|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
126187171|NCT04857892|453969536|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
126187172|NCT04857892|453969537|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
126187173|NCT00368472|453969542|FG000|Overall Study|Adverse Event|22|||
126187174|NCT00368472|453969542|FG000|Overall Study|Medication non-compliance|4|||
126187175|NCT00368472|453969542|FG000|Overall Study|Protocol Violation|2|||
126187176|NCT00368472|453969542|FG000|Overall Study|Request of Investigator or Sponsor|3|||
126187177|NCT00368472|453969542|FG000|Overall Study|Withdrawal by Subject|40|||
126187178|NCT00368472|453969542|FG000|Overall Study|Diary non-compliance|1|||
126187179|NCT00368472|453969542|FG000|Overall Study|Other|32|||
126187180|NCT00368472|453969542|FG000|Overall Study|Missing Final Disposition Date|1|||
126187181|NCT04095793|453969543|FG000|Overall Study|Adverse Event|3|||
126187182|NCT04095793|453969543|FG000|Overall Study|Study Terminated by Sponsor|103|||
126187183|NCT04095793|453969543|FG000|Overall Study|Withdrawal by Subject|4|||
126187184|NCT02384993|453969544|FG000|Overall Study|Adverse Event|0|||
126187185|NCT02384993|453969545|FG001|Overall Study|Adverse Event|1|||
126187186|NCT00651313|453969546|FG000|Overall Study|Adverse Event|0|||
126187187|NCT00651313|453969547|FG001|Overall Study|Adverse Event|1|||
126187188|NCT00651313|453969546|FG000|Overall Study|Withdrawal by Subject|3|||
126187189|NCT00651313|453969547|FG001|Overall Study|Withdrawal by Subject|1|||
126187190|NCT00651313|453969546|FG000|Overall Study|Lost to Follow-up|1|||
126187191|NCT00651313|453969547|FG001|Overall Study|Lost to Follow-up|1|||
126187192|NCT00651313|453969546|FG000|Overall Study|Adminstrative Discontinuation|2|||
126187193|NCT00651313|453969547|FG001|Overall Study|Adminstrative Discontinuation|3|||
126187194|NCT00981682|453969548|FG000|Overall Study|Adverse Event|48|||
126187195|NCT00981682|453969548|FG000|Overall Study|Withdrawal by Subject|52|||
126187196|NCT00981682|453969548|FG000|Overall Study|Lost to Follow-up|14|||
126187197|NCT00981682|453969548|FG000|Overall Study|Lack of Efficacy|13|||
126187198|NCT00981682|453969548|FG000|Overall Study|Protocol Violation|6|||
126187199|NCT00981682|453969548|FG000|Overall Study|administrative|9|||
126187200|NCT01696396|453971851|FG000|Overall Study|Withdrawal by Subject|19|||
126187201|NCT01696396|453971852|FG001|Overall Study|Withdrawal by Subject|5|||
126187202|NCT01696396|453971853|FG002|Overall Study|Withdrawal by Subject|19|||
126187203|NCT01696396|453971854|FG003|Overall Study|Withdrawal by Subject|11|||
126187204|NCT01696396|453971851|FG000|Overall Study|Decision by Sponsor|3|||
126187205|NCT01696396|453971852|FG001|Overall Study|Decision by Sponsor|1|||
126187206|NCT01696396|453971853|FG002|Overall Study|Decision by Sponsor|2|||
126187207|NCT01696396|453971854|FG003|Overall Study|Decision by Sponsor|2|||
126187208|NCT01696396|453971851|FG000|Overall Study|Lost to Follow-up|9|||
126187209|NCT01696396|453971852|FG001|Overall Study|Lost to Follow-up|1|||
126187210|NCT01696396|453971853|FG002|Overall Study|Lost to Follow-up|4|||
126187211|NCT01696396|453971854|FG003|Overall Study|Lost to Follow-up|1|||
126187212|NCT01696396|453971851|FG000|Overall Study|Death|0|||
126187213|NCT01696396|453971852|FG001|Overall Study|Death|0|||
126187214|NCT01696396|453971853|FG002|Overall Study|Death|1|||
126187215|NCT01696396|453971854|FG003|Overall Study|Death|0|||
126187216|NCT02712008|453971861|FG000|Baseline (Day 1) up to Week 12|Death|3|||
126187217|NCT02712008|453971862|FG001|Baseline (Day 1) up to Week 12|Death|0|||
126187218|NCT02712008|453971863|FG002|Baseline (Day 1) up to Week 12|Death|0|||
126187219|NCT02712008|453971864|FG003|Baseline (Day 1) up to Week 12|Death|0|||
126187220|NCT02712008|453971865|FG004|Baseline (Day 1) up to Week 12|Death|0|||
126187221|NCT02712008|453971866|FG005|Baseline (Day 1) up to Week 12|Death|0|||
126187222|NCT02712008|453971867|FG006|Baseline (Day 1) up to Week 12|Death|0|||
126187223|NCT02712008|453971868|FG007|Baseline (Day 1) up to Week 12|Death|0|||
126187224|NCT02712008|453971861|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126187225|NCT02712008|453971862|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
126187226|NCT02712008|453971863|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
126187227|NCT02712008|453971864|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126187228|NCT02712008|453971865|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126187229|NCT02712008|453971866|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126187230|NCT02712008|453971867|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126187231|NCT02712008|453971868|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126187232|NCT02712008|453971861|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
126187233|NCT02712008|453971862|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126187234|NCT02712008|453971863|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
126187235|NCT02712008|453971864|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126187236|NCT02712008|453971865|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126187237|NCT02712008|453971866|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126187238|NCT02712008|453971867|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126187239|NCT02712008|453971868|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126187240|NCT02712008|453971861|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126187241|NCT02712008|453971862|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126187242|NCT02712008|453971863|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
126187243|NCT02712008|453971864|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126187244|NCT02712008|453971865|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126187245|NCT02712008|453971866|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126187246|NCT02712008|453971867|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126187247|NCT02712008|453971868|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126187248|NCT02712008|453971861|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126187249|NCT02712008|453971862|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
126187250|NCT02712008|453971863|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126187251|NCT02712008|453971864|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126187252|NCT02712008|453971865|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126187253|NCT02712008|453971866|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126187254|NCT02712008|453971867|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126187255|NCT02712008|453971868|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126187256|NCT02712008|453971861|FG000|From Week 12 up to Week 36|Adverse Event|0|||
126187257|NCT02712008|453971862|FG001|From Week 12 up to Week 36|Adverse Event|0|||
126187258|NCT02712008|453971863|FG002|From Week 12 up to Week 36|Adverse Event|0|||
126187259|NCT02712008|453971864|FG003|From Week 12 up to Week 36|Adverse Event|0|||
126187260|NCT02712008|453971865|FG004|From Week 12 up to Week 36|Adverse Event|1|||
126187261|NCT02712008|453971866|FG005|From Week 12 up to Week 36|Adverse Event|0|||
126187262|NCT02712008|453971867|FG006|From Week 12 up to Week 36|Adverse Event|0|||
126187263|NCT02712008|453971868|FG007|From Week 12 up to Week 36|Adverse Event|2|||
126187264|NCT02712008|453971861|FG000|From Week 12 up to Week 36|Death|1|||
126187265|NCT02712008|453971862|FG001|From Week 12 up to Week 36|Death|0|||
126187266|NCT02712008|453971863|FG002|From Week 12 up to Week 36|Death|0|||
126187267|NCT02712008|453971864|FG003|From Week 12 up to Week 36|Death|0|||
126187268|NCT02712008|453971865|FG004|From Week 12 up to Week 36|Death|0|||
126187269|NCT02712008|453971866|FG005|From Week 12 up to Week 36|Death|0|||
126187270|NCT02712008|453971867|FG006|From Week 12 up to Week 36|Death|1|||
126187271|NCT02712008|453971868|FG007|From Week 12 up to Week 36|Death|0|||
126187272|NCT02712008|453971861|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
126187273|NCT02712008|453971862|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
126187274|NCT02712008|453971863|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
126187275|NCT02712008|453971864|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
126187276|NCT02712008|453971865|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
126187277|NCT02712008|453971866|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
126199936|NCT01117428|454017809|FG005|Overall Study|Lack of Efficacy|0|||
126187278|NCT02712008|453971867|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
126187279|NCT02712008|453971868|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
126187280|NCT02712008|453971861|FG000|From Week 12 up to Week 36|Physician Decision|0|||
126187281|NCT02712008|453971862|FG001|From Week 12 up to Week 36|Physician Decision|0|||
126187282|NCT02712008|453971863|FG002|From Week 12 up to Week 36|Physician Decision|0|||
126187283|NCT02712008|453971864|FG003|From Week 12 up to Week 36|Physician Decision|1|||
126187284|NCT02712008|453971865|FG004|From Week 12 up to Week 36|Physician Decision|1|||
126187285|NCT02712008|453971866|FG005|From Week 12 up to Week 36|Physician Decision|0|||
126187286|NCT02712008|453971867|FG006|From Week 12 up to Week 36|Physician Decision|0|||
126187287|NCT02712008|453971868|FG007|From Week 12 up to Week 36|Physician Decision|0|||
126187288|NCT02712008|453971861|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126187289|NCT02712008|453971862|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126187290|NCT02712008|453971863|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126187291|NCT02712008|453971864|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126187292|NCT02712008|453971865|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126187293|NCT02712008|453971866|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126187294|NCT02712008|453971867|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
126187295|NCT02712008|453971868|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
126187296|NCT01199198|453971869|FG000|Overall Study|Adverse Event|3|||
126187297|NCT01199198|453971870|FG001|Overall Study|Adverse Event|0|||
126187298|NCT01199198|453971869|FG000|Overall Study|Lost to Follow-up|1|||
126187299|NCT01199198|453971870|FG001|Overall Study|Lost to Follow-up|5|||
126187300|NCT01199198|453971869|FG000|Overall Study|Withdrawal by Subject|1|||
126187301|NCT01199198|453971870|FG001|Overall Study|Withdrawal by Subject|2|||
126187302|NCT01199198|453971869|FG000|Overall Study|ICU Transfer|1|||
126187303|NCT01199198|453971870|FG001|Overall Study|ICU Transfer|2|||
126187304|NCT01199198|453971869|FG000|Overall Study|Hospice-care transfer|1|||
126187305|NCT01199198|453971870|FG001|Overall Study|Hospice-care transfer|2|||
126187306|NCT00922974|453971871|FG000|Phase II Component|Protocol Violation|2|||
126187307|NCT00922974|453971872|FG001|Phase II Component|Protocol Violation|0|||
126187308|NCT00922974|453971871|FG000|Phase II Component|Not evaluable for treatment review|5|||
126187309|NCT00922974|453971872|FG001|Phase II Component|Not evaluable for treatment review|0|||
126187310|NCT00922974|453971871|FG000|Phase III Component|Protocol Violation|8|||
126187311|NCT00922974|453971872|FG001|Phase III Component|Protocol Violation|6|||
126187312|NCT03950440|453971873|FG000|Overall Study|Death|8|||
126187313|NCT03950440|453971874|FG001|Overall Study|Death|2|||
126187314|NCT03950440|453971875|FG002|Overall Study|Death|1|||
126187315|NCT00430027|453971876|FG000|Overall Study|Study terminated|8|||
126187316|NCT02443155|453971879|FG000|Overall Study|Adverse Event|3|||
126187317|NCT02443155|453971880|FG001|Overall Study|Adverse Event|4|||
126187318|NCT02443155|453971881|FG002|Overall Study|Adverse Event|1|||
126187319|NCT02443155|453971882|FG003|Overall Study|Adverse Event|2|||
126187320|NCT02443155|453971879|FG000|Overall Study|Unclassified|0|||
126187321|NCT02443155|453971880|FG001|Overall Study|Unclassified|0|||
126187322|NCT02443155|453971881|FG002|Overall Study|Unclassified|2|||
126187323|NCT02443155|453971882|FG003|Overall Study|Unclassified|1|||
126187324|NCT02443155|453971879|FG000|Overall Study|Withdrawal by Subject|4|||
126187325|NCT02443155|453971880|FG001|Overall Study|Withdrawal by Subject|7|||
126187326|NCT02443155|453971881|FG002|Overall Study|Withdrawal by Subject|3|||
126187327|NCT02443155|453971882|FG003|Overall Study|Withdrawal by Subject|9|||
126187328|NCT02443155|453971879|FG000|Overall Study|Pregnancy|3|||
126187329|NCT02443155|453971880|FG001|Overall Study|Pregnancy|1|||
126187330|NCT02443155|453971881|FG002|Overall Study|Pregnancy|1|||
126187331|NCT02443155|453971882|FG003|Overall Study|Pregnancy|2|||
126187332|NCT02443155|453971879|FG000|Overall Study|Lost to Follow-up|1|||
126187333|NCT02443155|453971880|FG001|Overall Study|Lost to Follow-up|2|||
126187334|NCT02443155|453971881|FG002|Overall Study|Lost to Follow-up|0|||
126187335|NCT02443155|453971882|FG003|Overall Study|Lost to Follow-up|1|||
126187336|NCT02443155|453971879|FG000|Overall Study|Protocol Violation|1|||
126187337|NCT02443155|453971880|FG001|Overall Study|Protocol Violation|0|||
126187338|NCT02443155|453971881|FG002|Overall Study|Protocol Violation|1|||
126187339|NCT02443155|453971882|FG003|Overall Study|Protocol Violation|1|||
126187340|NCT02443155|453971879|FG000|Overall Study|Death|0|||
126187341|NCT02443155|453971880|FG001|Overall Study|Death|0|||
126187342|NCT02443155|453971881|FG002|Overall Study|Death|1|||
126187343|NCT02443155|453971882|FG003|Overall Study|Death|0|||
126187344|NCT02000219|453971883|FG000|14-Week Study Period|Physician Decision|1|||
126187345|NCT02000219|453971883|FG000|14-Week Study Period|Adverse Event|1|||
126187346|NCT02000219|453971883|FG000|14-Week Study Period|Underwent transplantation|1|||
126187347|NCT02000219|453971883|FG000|Continuation Period|Withdrawal by Subject|1|||
126187348|NCT02000219|453971883|FG000|Continuation Period|Had liver transplant|2|||
126187349|NCT02000219|453971883|FG000|Continuation Period|Non-compliance with study drug|2|||
126187350|NCT00088595|453971887|FG000|Overall Study|Adverse Event|11|||
126187351|NCT00088595|453971887|FG000|Overall Study|Withdrawal by Subject|8|||
126187352|NCT00088595|453971887|FG000|Overall Study|Ongoing (After Core)|7|||
126187353|NCT00088595|453971887|FG000|Overall Study|New Cancer Therapy|2|||
126187354|NCT00608894|453971888|FG000|Overall Study|Withdrawal by Subject|0|||
126187355|NCT00608894|453971889|FG001|Overall Study|Withdrawal by Subject|2|||
126187356|NCT01376388|453971894|FG000|Overall Study|Adverse Event|13|||
126187357|NCT01376388|453971894|FG000|Overall Study|Lack of Efficacy|2|||
126187358|NCT01376388|453971894|FG000|Overall Study|Withdrawal by Subject|3|||
126187359|NCT00106249|453971903|FG000|Overall Study|Lost to Follow-up|3|||
126187360|NCT00106249|453971904|FG001|Overall Study|Lost to Follow-up|2|||
126187361|NCT01119963|453971905|FG000|Overall Study|Lost to Follow-up|1|||
126187362|NCT01119963|453971906|FG001|Overall Study|Lost to Follow-up|1|||
126187363|NCT01843205|453971911|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
126187364|NCT01843205|453971912|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
126187365|NCT03938636|453971913|FG000|Overall Study|Protocol Violation|0|||
126187366|NCT03938636|453971914|FG001|Overall Study|Protocol Violation|1|||
126187367|NCT03938636|453971915|FG002|Overall Study|Protocol Violation|1|||
126187368|NCT03938636|453971913|FG000|Overall Study|Subject withdrew due to death in family|0|||
126187369|NCT03938636|453971914|FG001|Overall Study|Subject withdrew due to death in family|1|||
126187370|NCT03938636|453971915|FG002|Overall Study|Subject withdrew due to death in family|0|||
126187371|NCT03938636|453971913|FG000|Overall Study|Missed visit|0|||
126187372|NCT03938636|453971914|FG001|Overall Study|Missed visit|1|||
126187373|NCT03938636|453971915|FG002|Overall Study|Missed visit|0|||
126187374|NCT03938636|453971913|FG000|Overall Study|Adverse Event|0|||
126187375|NCT03938636|453971914|FG001|Overall Study|Adverse Event|0|||
126187376|NCT03938636|453971915|FG002|Overall Study|Adverse Event|1|||
126187377|NCT03938636|453971913|FG000|Overall Study|Lost to Follow-up|0|||
126187378|NCT03938636|453971914|FG001|Overall Study|Lost to Follow-up|0|||
126187379|NCT03938636|453971915|FG002|Overall Study|Lost to Follow-up|1|||
126187380|NCT02728206|453971916|FG000|Overall Study|Death|1|||
126187381|NCT00429572|453971917|FG000|Overall Study|Disease progression|1|||
126187382|NCT02773368|453971918|FG000|Overall Study|Lost to Follow-up|4|||
126187383|NCT02773368|453971919|FG001|Overall Study|Lost to Follow-up|1|||
126187384|NCT02773368|453971918|FG000|Overall Study|Withdrawal by Subject|5|||
126187385|NCT02773368|453971919|FG001|Overall Study|Withdrawal by Subject|1|||
126187386|NCT02773368|453971918|FG000|Overall Study|Unclassified|1|||
126187387|NCT02773368|453971919|FG001|Overall Study|Unclassified|1|||
126187388|NCT02773368|453971918|FG000|Overall Study|Missing|0|||
126187389|NCT02773368|453971919|FG001|Overall Study|Missing|1|||
126187390|NCT01929018|453971923|FG000|Overall Study|Lost to Follow-up|1|||
126187391|NCT01929018|453971924|FG001|Overall Study|Lost to Follow-up|0|||
126187392|NCT01929018|453971923|FG000|Overall Study|Hospitalization|0|||
126187393|NCT01929018|453971924|FG001|Overall Study|Hospitalization|1|||
126187394|NCT01366534|453971927|FG000|Overall Study|Lost to Follow-up|1|||
126187395|NCT01366534|453971928|FG001|Overall Study|Lost to Follow-up|0|||
126187396|NCT01366534|453971929|FG002|Overall Study|Lost to Follow-up|0|||
126187397|NCT01366534|453971927|FG000|Overall Study|Migrated|1|||
126187398|NCT01366534|453971928|FG001|Overall Study|Migrated|1|||
126187399|NCT01366534|453971929|FG002|Overall Study|Migrated|0|||
126187400|NCT01366534|453971927|FG000|Overall Study|Declined challenged|0|||
126187401|NCT01366534|453971928|FG001|Overall Study|Declined challenged|1|||
126187402|NCT01366534|453971929|FG002|Overall Study|Declined challenged|0|||
126187403|NCT02635867|453971934|FG000|Overall Study|Lost to Follow-up|4|||
126187404|NCT02635867|453971935|FG001|Overall Study|Lost to Follow-up|3|||
126187405|NCT02635867|453971936|FG002|Overall Study|Lost to Follow-up|3|||
126187406|NCT02635867|453971937|FG003|Overall Study|Lost to Follow-up|4|||
126187407|NCT02635867|453971938|FG004|Overall Study|Lost to Follow-up|1|||
126187408|NCT02565576|453971939|FG000|Overall Study|abnormal lab value|2|||
126187409|NCT02565576|453971940|FG001|Overall Study|abnormal lab value|0|||
126187410|NCT02565576|453971939|FG000|Overall Study|subject / guardian decision|1|||
126187411|NCT02565576|453971940|FG001|Overall Study|subject / guardian decision|3|||
126187412|NCT02565576|453971939|FG000|Overall Study|Lost to Follow-up|1|||
126187413|NCT02565576|453971940|FG001|Overall Study|Lost to Follow-up|0|||
126187414|NCT02565576|453971939|FG000|Overall Study|Death|0|||
126187415|NCT02565576|453971940|FG001|Overall Study|Death|2|||
126187416|NCT02565576|453971939|FG000|Overall Study|Adverse Event|1|||
126187417|NCT02565576|453971940|FG001|Overall Study|Adverse Event|0|||
126187418|NCT03377452|453971941|FG000|Overall Study|Refused assessment|0|||
126187419|NCT03377452|453971942|FG001|Overall Study|Refused assessment|2|||
126187420|NCT03377452|453971941|FG000|Overall Study|Lost to Follow-up|5|||
126187421|NCT03377452|453971942|FG001|Overall Study|Lost to Follow-up|4|||
126187422|NCT03345342|453971943|FG000|Open-Label Phase|Adverse Event|30|||
126187423|NCT03345342|453971944|FG001|Open-Label Phase|Adverse Event|0|||
126187424|NCT03345342|453971945|FG002|Open-Label Phase|Adverse Event|0|||
126187425|NCT03345342|453971946|FG003|Open-Label Phase|Adverse Event|0|||
126187426|NCT03345342|453971947|FG004|Open-Label Phase|Adverse Event|0|||
126187427|NCT03345342|453971943|FG000|Open-Label Phase|Death|1|||
126187428|NCT03345342|453971944|FG001|Open-Label Phase|Death|0|||
126187429|NCT03345342|453971945|FG002|Open-Label Phase|Death|0|||
126187430|NCT03345342|453971946|FG003|Open-Label Phase|Death|0|||
126187431|NCT03345342|453971947|FG004|Open-Label Phase|Death|0|||
126187432|NCT03345342|453971943|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
126187433|NCT03345342|453971944|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
126187434|NCT03345342|453971945|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
126187435|NCT03345342|453971946|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
126187436|NCT03345342|453971947|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
126187437|NCT03345342|453971943|FG000|Open-Label Phase|Lack of Efficacy|6|||
126187438|NCT03345342|453971944|FG001|Open-Label Phase|Lack of Efficacy|0|||
126187439|NCT03345342|453971945|FG002|Open-Label Phase|Lack of Efficacy|0|||
126187440|NCT03345342|453971946|FG003|Open-Label Phase|Lack of Efficacy|0|||
126187441|NCT03345342|453971947|FG004|Open-Label Phase|Lack of Efficacy|0|||
126187442|NCT03345342|453971943|FG000|Open-Label Phase|Lost to Follow-up|9|||
126187443|NCT03345342|453971944|FG001|Open-Label Phase|Lost to Follow-up|0|||
126187444|NCT03345342|453971945|FG002|Open-Label Phase|Lost to Follow-up|0|||
126187445|NCT03345342|453971946|FG003|Open-Label Phase|Lost to Follow-up|0|||
126187446|NCT03345342|453971947|FG004|Open-Label Phase|Lost to Follow-up|0|||
126187447|NCT03345342|453971943|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
126187448|NCT03345342|453971944|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
126187449|NCT03345342|453971945|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
126187450|NCT03345342|453971946|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
126187451|NCT03345342|453971947|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
126187452|NCT03345342|453971943|FG000|Open-Label Phase|Physician Decision|4|||
126187453|NCT03345342|453971944|FG001|Open-Label Phase|Physician Decision|0|||
126187454|NCT03345342|453971945|FG002|Open-Label Phase|Physician Decision|0|||
126187455|NCT03345342|453971946|FG003|Open-Label Phase|Physician Decision|0|||
126187456|NCT03345342|453971947|FG004|Open-Label Phase|Physician Decision|0|||
126187457|NCT03345342|453971943|FG000|Open-Label Phase|Protocol Violation|8|||
126187458|NCT03345342|453971944|FG001|Open-Label Phase|Protocol Violation|0|||
126187459|NCT03345342|453971945|FG002|Open-Label Phase|Protocol Violation|0|||
126187460|NCT03345342|453971946|FG003|Open-Label Phase|Protocol Violation|0|||
126187461|NCT03345342|453971947|FG004|Open-Label Phase|Protocol Violation|0|||
126187462|NCT03345342|453971943|FG000|Open-Label Phase|Withdrawal by Subject|57|||
126187463|NCT03345342|453971944|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126187464|NCT03345342|453971945|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126187465|NCT03345342|453971946|FG003|Open-Label Phase|Withdrawal by Subject|0|||
126187466|NCT03345342|453971947|FG004|Open-Label Phase|Withdrawal by Subject|0|||
126187467|NCT03345342|453971943|FG000|Open-Label Phase|Other|15|||
126187468|NCT03345342|453971944|FG001|Open-Label Phase|Other|0|||
126187469|NCT03345342|453971945|FG002|Open-Label Phase|Other|0|||
126187470|NCT03345342|453971946|FG003|Open-Label Phase|Other|0|||
126187471|NCT03345342|453971947|FG004|Open-Label Phase|Other|0|||
126187472|NCT03345342|453971943|FG000|Double-Blind Phase|Adverse Event|0|||
126187473|NCT03345342|453971944|FG001|Double-Blind Phase|Adverse Event|1|||
126187474|NCT03345342|453971945|FG002|Double-Blind Phase|Adverse Event|6|||
126187475|NCT03345342|453971946|FG003|Double-Blind Phase|Adverse Event|0|||
126187476|NCT03345342|453971947|FG004|Double-Blind Phase|Adverse Event|0|||
126187477|NCT03345342|453971943|FG000|Double-Blind Phase|Death|0|||
126187478|NCT03345342|453971944|FG001|Double-Blind Phase|Death|2|||
126187479|NCT03345342|453971945|FG002|Double-Blind Phase|Death|1|||
126187480|NCT03345342|453971946|FG003|Double-Blind Phase|Death|0|||
126187481|NCT03345342|453971947|FG004|Double-Blind Phase|Death|0|||
126187482|NCT03345342|453971943|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
126187483|NCT03345342|453971944|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
126187484|NCT03345342|453971945|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
126187485|NCT03345342|453971946|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
126187486|NCT03345342|453971947|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
126187487|NCT03345342|453971943|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126187488|NCT03345342|453971944|FG001|Double-Blind Phase|Lost to Follow-up|1|||
126187489|NCT03345342|453971945|FG002|Double-Blind Phase|Lost to Follow-up|7|||
126187490|NCT03345342|453971946|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126187491|NCT03345342|453971947|FG004|Double-Blind Phase|Lost to Follow-up|0|||
126187492|NCT03345342|453971943|FG000|Double-Blind Phase|Physician Decision|0|||
126187493|NCT03345342|453971944|FG001|Double-Blind Phase|Physician Decision|1|||
126187494|NCT03345342|453971945|FG002|Double-Blind Phase|Physician Decision|4|||
126187495|NCT03345342|453971946|FG003|Double-Blind Phase|Physician Decision|0|||
126187496|NCT03345342|453971947|FG004|Double-Blind Phase|Physician Decision|0|||
126187497|NCT03345342|453971943|FG000|Double-Blind Phase|Protocol Violation|0|||
126187498|NCT03345342|453971944|FG001|Double-Blind Phase|Protocol Violation|0|||
126187499|NCT03345342|453971945|FG002|Double-Blind Phase|Protocol Violation|1|||
126187500|NCT03345342|453971946|FG003|Double-Blind Phase|Protocol Violation|0|||
126187501|NCT03345342|453971947|FG004|Double-Blind Phase|Protocol Violation|0|||
126187502|NCT03345342|453971943|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126187503|NCT03345342|453971944|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
126187504|NCT03345342|453971945|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
126187505|NCT03345342|453971946|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126187506|NCT03345342|453971947|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
126187507|NCT03345342|453971943|FG000|Double-Blind Phase|Other|0|||
126187508|NCT03345342|453971944|FG001|Double-Blind Phase|Other|1|||
126187509|NCT03345342|453971945|FG002|Double-Blind Phase|Other|3|||
126187510|NCT03345342|453971946|FG003|Double-Blind Phase|Other|0|||
126187511|NCT03345342|453971947|FG004|Double-Blind Phase|Other|0|||
126187512|NCT03345342|453971943|FG000|Follow-Up Phase|Adverse Event|0|||
126187513|NCT03345342|453971944|FG001|Follow-Up Phase|Adverse Event|0|||
126187514|NCT03345342|453971945|FG002|Follow-Up Phase|Adverse Event|0|||
126187515|NCT03345342|453971946|FG003|Follow-Up Phase|Adverse Event|0|||
126187516|NCT03345342|453971947|FG004|Follow-Up Phase|Adverse Event|4|||
126187517|NCT03345342|453971943|FG000|Follow-Up Phase|Lost to Follow-up|0|||
126187518|NCT03345342|453971944|FG001|Follow-Up Phase|Lost to Follow-up|0|||
126187519|NCT03345342|453971945|FG002|Follow-Up Phase|Lost to Follow-up|0|||
126187520|NCT03345342|453971946|FG003|Follow-Up Phase|Lost to Follow-up|0|||
126187521|NCT03345342|453971947|FG004|Follow-Up Phase|Lost to Follow-up|6|||
126187522|NCT03345342|453971943|FG000|Follow-Up Phase|Physician Decision|0|||
126187523|NCT03345342|453971944|FG001|Follow-Up Phase|Physician Decision|0|||
126187524|NCT03345342|453971945|FG002|Follow-Up Phase|Physician Decision|0|||
126187525|NCT03345342|453971946|FG003|Follow-Up Phase|Physician Decision|0|||
126187526|NCT03345342|453971947|FG004|Follow-Up Phase|Physician Decision|5|||
126187527|NCT03345342|453971943|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
126187528|NCT03345342|453971944|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
126187529|NCT03345342|453971945|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
126187530|NCT03345342|453971946|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
126187531|NCT03345342|453971947|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
126187532|NCT03345342|453971943|FG000|Follow-Up Phase|Other|0|||
126187533|NCT03345342|453971944|FG001|Follow-Up Phase|Other|0|||
126187534|NCT03345342|453971945|FG002|Follow-Up Phase|Other|0|||
126187535|NCT03345342|453971946|FG003|Follow-Up Phase|Other|3|||
126187536|NCT03345342|453971947|FG004|Follow-Up Phase|Other|1|||
126187537|NCT02782104|453971952|FG000|Overall Study|Other|215|||
126187538|NCT02782104|453971952|FG000|Overall Study|Induction Day 28 Non Responder|9|||
126187539|NCT02782104|453971952|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126187540|NCT02782104|453971952|FG000|Overall Study|Death|8|||
126187541|NCT02782104|453971952|FG000|Overall Study|Pregnancy|6|||
126187542|NCT02782104|453971952|FG000|Overall Study|Withdrawal by Subject|63|||
126187543|NCT02782104|453971952|FG000|Overall Study|Protocol Violation|7|||
126187544|NCT02782104|453971952|FG000|Overall Study|Lack of Efficacy|61|||
126187545|NCT02782104|453971952|FG000|Overall Study|Lost to Follow-up|23|||
126187546|NCT02782104|453971952|FG000|Overall Study|Adverse Event|74|||
126187547|NCT03185819|453971953|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
126187548|NCT03185819|453971954|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
126187549|NCT03185819|453971955|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
126187550|NCT03185819|453971956|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
126187551|NCT03185819|453971953|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
126187552|NCT03185819|453971954|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
126187553|NCT03185819|453971955|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
126187554|NCT03185819|453971956|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
126187555|NCT03185819|453971953|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
126187556|NCT03185819|453971954|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
126187557|NCT03185819|453971955|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
126187558|NCT03185819|453971956|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
126187559|NCT03185819|453971953|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
126187560|NCT03185819|453971954|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
126187561|NCT03185819|453971955|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
126187562|NCT03185819|453971956|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
126187563|NCT03185819|453971953|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
126187564|NCT03185819|453971954|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
126187565|NCT03185819|453971955|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
126187566|NCT03185819|453971956|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
126187567|NCT03185819|453971953|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
126187568|NCT03185819|453971954|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
126187569|NCT03185819|453971955|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
126187570|NCT03185819|453971956|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
126187571|NCT03185819|453971953|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
126187572|NCT03185819|453971954|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
126187573|NCT03185819|453971955|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
126187574|NCT03185819|453971956|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
126187575|NCT03185819|453971953|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
126187576|NCT03185819|453971954|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
126187577|NCT03185819|453971955|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
126187578|NCT03185819|453971956|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
126187579|NCT03185819|453971953|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
126187580|NCT03185819|453971954|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
126199937|NCT01117428|454017804|FG000|Overall Study|Adverse Event|4|||
126187581|NCT03185819|453971955|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
126187582|NCT03185819|453971956|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
126187583|NCT03185819|453971953|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
126187584|NCT03185819|453971954|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
126187585|NCT03185819|453971955|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
126187586|NCT03185819|453971956|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
126187587|NCT03185819|453971953|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
126187588|NCT03185819|453971954|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
126187589|NCT03185819|453971955|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
126187590|NCT03185819|453971956|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
126187591|NCT03185819|453971953|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
126187592|NCT03185819|453971954|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
126187593|NCT03185819|453971955|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
126187594|NCT03185819|453971956|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
126187595|NCT03185819|453971953|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
126187596|NCT03185819|453971954|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
126187597|NCT03185819|453971955|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
126187598|NCT03185819|453971956|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
126187599|NCT02438787|453971957|FG000|Overall Study|Adverse Event|1|||
126187600|NCT02438787|453971958|FG001|Overall Study|Adverse Event|0|||
126187601|NCT02438787|453971959|FG002|Overall Study|Adverse Event|2|||
126187602|NCT02438787|453971957|FG000|Overall Study|Lack of Efficacy|1|||
126187603|NCT02438787|453971958|FG001|Overall Study|Lack of Efficacy|2|||
126187604|NCT02438787|453971959|FG002|Overall Study|Lack of Efficacy|0|||
126187605|NCT02438787|453971957|FG000|Overall Study|Lost to Follow-up|0|||
126187606|NCT02438787|453971958|FG001|Overall Study|Lost to Follow-up|1|||
126187607|NCT02438787|453971959|FG002|Overall Study|Lost to Follow-up|0|||
126187608|NCT02438787|453971957|FG000|Overall Study|Protocol Violation|0|||
126187609|NCT02438787|453971958|FG001|Overall Study|Protocol Violation|0|||
126187610|NCT02438787|453971959|FG002|Overall Study|Protocol Violation|1|||
126187611|NCT02438787|453971957|FG000|Overall Study|Withdrawal by Subject|15|||
126187612|NCT02438787|453971958|FG001|Overall Study|Withdrawal by Subject|7|||
126187613|NCT02438787|453971959|FG002|Overall Study|Withdrawal by Subject|10|||
126187614|NCT02438787|453971957|FG000|Overall Study|Study discontinued by sponsor|64|||
126187615|NCT02438787|453971958|FG001|Overall Study|Study discontinued by sponsor|72|||
126187616|NCT02438787|453971959|FG002|Overall Study|Study discontinued by sponsor|69|||
126187617|NCT02438787|453971957|FG000|Overall Study|Other|0|||
126187618|NCT02438787|453971958|FG001|Overall Study|Other|1|||
126187619|NCT02438787|453971959|FG002|Overall Study|Other|0|||
126187620|NCT02438787|453971957|FG000|Overall Study|Site terminated by sponsor|0|||
126187621|NCT02438787|453971958|FG001|Overall Study|Site terminated by sponsor|0|||
126187622|NCT02438787|453971959|FG002|Overall Study|Site terminated by sponsor|1|||
126187623|NCT03375203|453971960|FG000|Overall Study|Protocol Violation|0|||
126187624|NCT03375203|453971961|FG001|Overall Study|Protocol Violation|0|||
126187625|NCT03375203|453971962|FG002|Overall Study|Protocol Violation|1|||
126187626|NCT03375203|453971963|FG003|Overall Study|Protocol Violation|0|||
126187627|NCT03375203|453971964|FG004|Overall Study|Protocol Violation|0|||
126187628|NCT03375203|453971960|FG000|Overall Study|Adverse Event|2|||
126187629|NCT03375203|453971961|FG001|Overall Study|Adverse Event|3|||
126187630|NCT03375203|453971962|FG002|Overall Study|Adverse Event|0|||
126187631|NCT03375203|453971963|FG003|Overall Study|Adverse Event|2|||
126187632|NCT03375203|453971964|FG004|Overall Study|Adverse Event|2|||
126187633|NCT03375203|453971960|FG000|Overall Study|Withdrawal by Subject|3|||
126187634|NCT03375203|453971961|FG001|Overall Study|Withdrawal by Subject|0|||
126187635|NCT03375203|453971962|FG002|Overall Study|Withdrawal by Subject|1|||
126187636|NCT03375203|453971963|FG003|Overall Study|Withdrawal by Subject|0|||
126187637|NCT03375203|453971964|FG004|Overall Study|Withdrawal by Subject|2|||
126187638|NCT03375203|453971960|FG000|Overall Study|Non-compliance with study drug|1|||
126187639|NCT03375203|453971961|FG001|Overall Study|Non-compliance with study drug|0|||
126187640|NCT03375203|453971962|FG002|Overall Study|Non-compliance with study drug|0|||
126187641|NCT03375203|453971963|FG003|Overall Study|Non-compliance with study drug|0|||
126187642|NCT03375203|453971964|FG004|Overall Study|Non-compliance with study drug|0|||
126187643|NCT03375203|453971960|FG000|Overall Study|Randomized, not treated.|0|||
126187644|NCT03375203|453971961|FG001|Overall Study|Randomized, not treated.|1|||
126187645|NCT03375203|453971962|FG002|Overall Study|Randomized, not treated.|0|||
126187646|NCT03375203|453971963|FG003|Overall Study|Randomized, not treated.|0|||
126187647|NCT03375203|453971964|FG004|Overall Study|Randomized, not treated.|0|||
126187648|NCT03321526|453971965|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
126187649|NCT03321526|453971966|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
126187650|NCT03321526|453971965|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
126187651|NCT03321526|453971966|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
126187652|NCT03321526|453971965|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
126187653|NCT03321526|453971966|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
126187654|NCT03321526|453971965|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
126187655|NCT03321526|453971966|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
126187656|NCT03321526|453971965|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
126187657|NCT03321526|453971966|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
126187658|NCT03321526|453971965|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
126187659|NCT03321526|453971966|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
126187660|NCT03321526|453971965|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
126187661|NCT03321526|453971966|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
126187662|NCT03321526|453971965|FG000|Follow-up Phase (2 Weeks)|Other|24|||
126187663|NCT03321526|453971966|FG001|Follow-up Phase (2 Weeks)|Other|24|||
126187664|NCT00732641|453971967|FG000|Overall Study|Relapse or Progressive Disease|65|||
126187665|NCT00732641|453971968|FG001|Overall Study|Relapse or Progressive Disease|101|||
126187666|NCT00732641|453971967|FG000|Overall Study|Serious Adverse Events|12|||
126187667|NCT00732641|453971968|FG001|Overall Study|Serious Adverse Events|3|||
126187668|NCT00732641|453971967|FG000|Overall Study|Physician Decision|6|||
126187669|NCT00732641|453971968|FG001|Overall Study|Physician Decision|0|||
126187670|NCT00732641|453971967|FG000|Overall Study|Withdrawal by Subject|4|||
126187671|NCT00732641|453971968|FG001|Overall Study|Withdrawal by Subject|2|||
126187672|NCT00732641|453971967|FG000|Overall Study|Unable to Complete|1|||
126187673|NCT00732641|453971968|FG001|Overall Study|Unable to Complete|1|||
126187674|NCT00732641|453971967|FG000|Overall Study|Other|18|||
126187675|NCT00732641|453971968|FG001|Overall Study|Other|5|||
126187676|NCT02910089|453971969|FG000|Overall Study|Lost insurance eligibility|22|||
126187677|NCT02910089|453971970|FG001|Overall Study|Lost insurance eligibility|16|||
126187678|NCT01782885|453971973|FG000|Overall Study|Lost to Follow-up|4|||
126187679|NCT01782885|453971974|FG001|Overall Study|Lost to Follow-up|6|||
126187680|NCT03447821|453971975|FG000|Overall Study|Withdrawal by Subject|1|||
126187681|NCT03447821|453971976|FG001|Overall Study|Withdrawal by Subject|1|||
126187682|NCT03447821|453971977|FG002|Overall Study|Withdrawal by Subject|0|||
126187683|NCT03447821|453971975|FG000|Overall Study|Lost to Follow-up|0|||
126187684|NCT03447821|453971976|FG001|Overall Study|Lost to Follow-up|0|||
126187685|NCT03447821|453971977|FG002|Overall Study|Lost to Follow-up|1|||
126187686|NCT00329784|453971980|FG000|Overall Study|Lost to Follow-up|0|||
126187687|NCT00329784|453971981|FG001|Overall Study|Lost to Follow-up|1|||
126187688|NCT00329784|453971982|FG002|Overall Study|Lost to Follow-up|0|||
126187689|NCT00329784|453971983|FG003|Overall Study|Lost to Follow-up|0|||
126187690|NCT00329784|453971980|FG000|Overall Study|Withdrawal by Subject|4|||
126187691|NCT00329784|453971981|FG001|Overall Study|Withdrawal by Subject|2|||
126187692|NCT00329784|453971982|FG002|Overall Study|Withdrawal by Subject|0|||
126187693|NCT00329784|453971983|FG003|Overall Study|Withdrawal by Subject|0|||
126187694|NCT00329784|453971980|FG000|Overall Study|Other|1|||
126187695|NCT00329784|453971981|FG001|Overall Study|Other|2|||
126187696|NCT00329784|453971982|FG002|Overall Study|Other|0|||
126187697|NCT00329784|453971983|FG003|Overall Study|Other|0|||
126187698|NCT01098032|453971984|FG000|Overall Study|Withdrawal by Subject|1|||
126187699|NCT01098032|453971985|FG001|Overall Study|Withdrawal by Subject|1|||
126187700|NCT00481988|453971986|FG000|Overall Study|Withdrawal by Subject|1|||
126187701|NCT00481988|453971987|FG001|Overall Study|Withdrawal by Subject|1|||
126187702|NCT00654420|453971988|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
126187703|NCT00654420|453971989|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
126187704|NCT00654420|453971990|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
126187705|NCT00654420|453971991|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
126187706|NCT00654420|453971988|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
126187707|NCT00654420|453971989|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
126187708|NCT00654420|453971990|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
126187709|NCT00654420|453971991|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
126187710|NCT00654420|453971988|FG000|Phase II|Adverse Event|0|||
126187711|NCT00654420|453971989|FG001|Phase II|Adverse Event|0|||
126187712|NCT00654420|453971990|FG002|Phase II|Adverse Event|3|||
126187713|NCT00654420|453971991|FG003|Phase II|Adverse Event|3|||
126187714|NCT00654420|453971988|FG000|Phase II|Lost to Follow-up|0|||
126187715|NCT00654420|453971989|FG001|Phase II|Lost to Follow-up|0|||
126187716|NCT00654420|453971990|FG002|Phase II|Lost to Follow-up|0|||
126187717|NCT00654420|453971991|FG003|Phase II|Lost to Follow-up|1|||
126187718|NCT00654420|453971988|FG000|Phase II|Physician Decision|0|||
126187719|NCT00654420|453971989|FG001|Phase II|Physician Decision|0|||
126187720|NCT00654420|453971990|FG002|Phase II|Physician Decision|0|||
126187721|NCT00654420|453971991|FG003|Phase II|Physician Decision|4|||
126187722|NCT00654420|453971988|FG000|Phase II|Progressive Disease|0|||
126187723|NCT00654420|453971989|FG001|Phase II|Progressive Disease|0|||
126187724|NCT00654420|453971990|FG002|Phase II|Progressive Disease|29|||
126187725|NCT00654420|453971991|FG003|Phase II|Progressive Disease|29|||
126187726|NCT00654420|453971988|FG000|Phase II|Withdrawal by Subject|0|||
126187727|NCT00654420|453971989|FG001|Phase II|Withdrawal by Subject|0|||
126187728|NCT00654420|453971990|FG002|Phase II|Withdrawal by Subject|4|||
126187729|NCT00654420|453971991|FG003|Phase II|Withdrawal by Subject|1|||
126187730|NCT00654420|453971988|FG000|Phase II|Missing Disposition Record|0|||
126187731|NCT00654420|453971989|FG001|Phase II|Missing Disposition Record|0|||
126187732|NCT00654420|453971990|FG002|Phase II|Missing Disposition Record|1|||
126187733|NCT00654420|453971991|FG003|Phase II|Missing Disposition Record|0|||
126187734|NCT01594411|453971994|FG000|Overall Study|Lost to Follow-up|2|||
126187735|NCT03034057|453972000|FG000|Overall Study|Withdrawal by Subject|10|||
126187736|NCT03034057|453972000|FG000|Overall Study|Protocol Violation|1|||
126187737|NCT03034057|453972000|FG000|Overall Study|Not defined|2|||
126187738|NCT03034057|453972000|FG000|Overall Study|Lost to Follow-up|19|||
126187739|NCT03034057|453972000|FG000|Overall Study|Adverse Event|22|||
126187740|NCT03034057|453972000|FG000|Overall Study|Medication error without associated AE|1|||
126187741|NCT00701103|453972004|FG000|Overall Study|Adverse Event|0|||
126187742|NCT00701103|453972005|FG001|Overall Study|Adverse Event|0|||
126187743|NCT00701103|453972006|FG002|Overall Study|Adverse Event|1|||
126187744|NCT00701103|453972007|FG003|Overall Study|Adverse Event|1|||
126187745|NCT00701103|453972008|FG004|Overall Study|Adverse Event|0|||
126187746|NCT00701103|453972009|FG005|Overall Study|Adverse Event|1|||
126187747|NCT00701103|453972010|FG006|Overall Study|Adverse Event|1|||
126187748|NCT00701103|453972011|FG007|Overall Study|Adverse Event|0|||
126187749|NCT00701103|453972012|FG008|Overall Study|Adverse Event|0|||
126187750|NCT00701103|453972013|FG009|Overall Study|Adverse Event|2|||
126187751|NCT00701103|453972014|FG010|Overall Study|Adverse Event|0|||
126187752|NCT00701103|453972004|FG000|Overall Study|Progressive Disease|5|||
126187753|NCT00701103|453972005|FG001|Overall Study|Progressive Disease|2|||
126187754|NCT00701103|453972006|FG002|Overall Study|Progressive Disease|6|||
126187755|NCT00701103|453972007|FG003|Overall Study|Progressive Disease|5|||
126187756|NCT00701103|453972008|FG004|Overall Study|Progressive Disease|6|||
126187757|NCT00701103|453972009|FG005|Overall Study|Progressive Disease|5|||
126187758|NCT00701103|453972010|FG006|Overall Study|Progressive Disease|7|||
126187759|NCT00701103|453972011|FG007|Overall Study|Progressive Disease|7|||
126187760|NCT00701103|453972012|FG008|Overall Study|Progressive Disease|8|||
126187761|NCT00701103|453972013|FG009|Overall Study|Progressive Disease|8|||
126187762|NCT00701103|453972014|FG010|Overall Study|Progressive Disease|11|||
126187763|NCT00701103|453972004|FG000|Overall Study|Withdrawal by Subject|0|||
126187764|NCT00701103|453972005|FG001|Overall Study|Withdrawal by Subject|1|||
126187765|NCT00701103|453972006|FG002|Overall Study|Withdrawal by Subject|1|||
126187766|NCT00701103|453972007|FG003|Overall Study|Withdrawal by Subject|0|||
126187767|NCT00701103|453972008|FG004|Overall Study|Withdrawal by Subject|0|||
126187768|NCT00701103|453972009|FG005|Overall Study|Withdrawal by Subject|0|||
126187769|NCT00701103|453972010|FG006|Overall Study|Withdrawal by Subject|0|||
126187770|NCT00701103|453972011|FG007|Overall Study|Withdrawal by Subject|0|||
126187771|NCT00701103|453972012|FG008|Overall Study|Withdrawal by Subject|0|||
126187772|NCT00701103|453972013|FG009|Overall Study|Withdrawal by Subject|0|||
126187773|NCT00701103|453972014|FG010|Overall Study|Withdrawal by Subject|0|||
126187774|NCT00701103|453972004|FG000|Overall Study|Other|0|||
126187775|NCT00701103|453972005|FG001|Overall Study|Other|0|||
126187776|NCT00701103|453972006|FG002|Overall Study|Other|0|||
126187777|NCT00701103|453972007|FG003|Overall Study|Other|0|||
126187778|NCT00701103|453972008|FG004|Overall Study|Other|0|||
126187779|NCT00701103|453972009|FG005|Overall Study|Other|0|||
126187780|NCT00701103|453972010|FG006|Overall Study|Other|0|||
126187781|NCT00701103|453972011|FG007|Overall Study|Other|0|||
126187782|NCT00701103|453972012|FG008|Overall Study|Other|1|||
126187783|NCT00701103|453972013|FG009|Overall Study|Other|1|||
126187784|NCT00701103|453972014|FG010|Overall Study|Other|0|||
126187785|NCT01929707|453972015|FG000|Intervention Period 1|Lost to Follow-up|0|||
126187786|NCT01929707|453972016|FG001|Intervention Period 1|Lost to Follow-up|0|||
126187787|NCT01929707|453972017|FG002|Intervention Period 1|Lost to Follow-up|0|||
126187788|NCT01929707|453972018|FG003|Intervention Period 1|Lost to Follow-up|1|||
126187789|NCT01929707|453972019|FG004|Intervention Period 1|Lost to Follow-up|0|||
126187790|NCT01929707|453972020|FG005|Intervention Period 1|Lost to Follow-up|0|||
126187791|NCT01929707|453972021|FG006|Intervention Period 1|Lost to Follow-up|0|||
126187792|NCT01929707|453972022|FG007|Intervention Period 1|Lost to Follow-up|0|||
126187793|NCT01929707|453972015|FG000|Intervention Period 1|Withdrawal by Subject|0|||
126187794|NCT01929707|453972016|FG001|Intervention Period 1|Withdrawal by Subject|0|||
126187795|NCT01929707|453972017|FG002|Intervention Period 1|Withdrawal by Subject|0|||
126187796|NCT01929707|453972018|FG003|Intervention Period 1|Withdrawal by Subject|2|||
126187797|NCT01929707|453972019|FG004|Intervention Period 1|Withdrawal by Subject|0|||
126187798|NCT01929707|453972020|FG005|Intervention Period 1|Withdrawal by Subject|0|||
126187799|NCT01929707|453972021|FG006|Intervention Period 1|Withdrawal by Subject|0|||
126187800|NCT01929707|453972022|FG007|Intervention Period 1|Withdrawal by Subject|0|||
126187801|NCT01929707|453972015|FG000|Intervention Period 2|Withdrawal by Subject|0|||
126187802|NCT01929707|453972016|FG001|Intervention Period 2|Withdrawal by Subject|0|||
126187803|NCT01929707|453972017|FG002|Intervention Period 2|Withdrawal by Subject|0|||
126187804|NCT01929707|453972018|FG003|Intervention Period 2|Withdrawal by Subject|0|||
126187805|NCT01929707|453972019|FG004|Intervention Period 2|Withdrawal by Subject|0|||
126187806|NCT01929707|453972020|FG005|Intervention Period 2|Withdrawal by Subject|2|||
126187807|NCT01929707|453972021|FG006|Intervention Period 2|Withdrawal by Subject|0|||
126187808|NCT01929707|453972022|FG007|Intervention Period 2|Withdrawal by Subject|0|||
126187809|NCT00179517|453972023|FG000|Overall Study|Withdrawal by Subject|2|||
126187810|NCT00179517|453972024|FG001|Overall Study|Withdrawal by Subject|1|||
126187811|NCT00437203|453972025|FG000|Overall Study|Death|0|||
126187812|NCT00437203|453972026|FG001|Overall Study|Death|0|||
126187813|NCT00437203|453972027|FG002|Overall Study|Death|1|||
126187814|NCT00437203|453972028|FG003|Overall Study|Death|0|||
126187815|NCT00437203|453972029|FG004|Overall Study|Death|0|||
126187816|NCT00437203|453972030|FG005|Overall Study|Death|0|||
126187817|NCT00437203|453972031|FG006|Overall Study|Death|0|||
126187818|NCT00437203|453972032|FG007|Overall Study|Death|1|||
126187819|NCT00437203|453972033|FG008|Overall Study|Death|0|||
126187820|NCT00437203|453972034|FG009|Overall Study|Death|1|||
126187821|NCT00437203|453972025|FG000|Overall Study|Adverse Event|1|||
126187822|NCT00437203|453972026|FG001|Overall Study|Adverse Event|1|||
126187823|NCT00437203|453972027|FG002|Overall Study|Adverse Event|0|||
126187824|NCT00437203|453972028|FG003|Overall Study|Adverse Event|0|||
126187825|NCT00437203|453972029|FG004|Overall Study|Adverse Event|0|||
126187826|NCT00437203|453972030|FG005|Overall Study|Adverse Event|0|||
126187827|NCT00437203|453972031|FG006|Overall Study|Adverse Event|0|||
126187828|NCT00437203|453972032|FG007|Overall Study|Adverse Event|1|||
126187829|NCT00437203|453972033|FG008|Overall Study|Adverse Event|0|||
126187830|NCT00437203|453972034|FG009|Overall Study|Adverse Event|1|||
126187831|NCT00437203|453972025|FG000|Overall Study|Study terminated by sponsor|0|||
126187832|NCT00437203|453972026|FG001|Overall Study|Study terminated by sponsor|0|||
126187833|NCT00437203|453972027|FG002|Overall Study|Study terminated by sponsor|0|||
126187834|NCT00437203|453972028|FG003|Overall Study|Study terminated by sponsor|0|||
126187835|NCT00437203|453972029|FG004|Overall Study|Study terminated by sponsor|0|||
126187836|NCT00437203|453972030|FG005|Overall Study|Study terminated by sponsor|0|||
126187837|NCT00437203|453972031|FG006|Overall Study|Study terminated by sponsor|0|||
126187838|NCT00437203|453972032|FG007|Overall Study|Study terminated by sponsor|0|||
126187839|NCT00437203|453972033|FG008|Overall Study|Study terminated by sponsor|1|||
126187840|NCT00437203|453972034|FG009|Overall Study|Study terminated by sponsor|0|||
126187841|NCT00437203|453972025|FG000|Overall Study|Objective progression or relapse|5|||
126187842|NCT00437203|453972026|FG001|Overall Study|Objective progression or relapse|6|||
126187843|NCT00437203|453972027|FG002|Overall Study|Objective progression or relapse|2|||
126187844|NCT00437203|453972028|FG003|Overall Study|Objective progression or relapse|3|||
126187845|NCT00437203|453972029|FG004|Overall Study|Objective progression or relapse|3|||
126187846|NCT00437203|453972030|FG005|Overall Study|Objective progression or relapse|3|||
126187847|NCT00437203|453972031|FG006|Overall Study|Objective progression or relapse|6|||
126187848|NCT00437203|453972032|FG007|Overall Study|Objective progression or relapse|1|||
126187849|NCT00437203|453972033|FG008|Overall Study|Objective progression or relapse|2|||
126187850|NCT00437203|453972034|FG009|Overall Study|Objective progression or relapse|2|||
126187851|NCT00437203|453972025|FG000|Overall Study|Other|0|||
126187852|NCT00437203|453972026|FG001|Overall Study|Other|1|||
126187853|NCT00437203|453972027|FG002|Overall Study|Other|0|||
126187854|NCT00437203|453972028|FG003|Overall Study|Other|0|||
126187855|NCT00437203|453972029|FG004|Overall Study|Other|0|||
126187856|NCT00437203|453972030|FG005|Overall Study|Other|0|||
126187857|NCT00437203|453972031|FG006|Overall Study|Other|1|||
126187858|NCT00437203|453972032|FG007|Overall Study|Other|0|||
126187859|NCT00437203|453972033|FG008|Overall Study|Other|0|||
126187860|NCT00437203|453972034|FG009|Overall Study|Other|0|||
126187861|NCT01449955|453972035|FG000|Overall Study|Withdrawal by Subject|1|||
126187862|NCT01449955|453972036|FG001|Overall Study|Withdrawal by Subject|2|||
126187863|NCT00431496|453972043|FG000|Overall Study|Adverse Event|3|||
126187864|NCT00431496|453972043|FG000|Overall Study|Lost to Follow-up|1|||
126187865|NCT00431496|453972043|FG000|Overall Study|Withdrawal by Subject|2|||
126187866|NCT00431496|453972043|FG000|Overall Study|Protocol-specified criteria|5|||
126187867|NCT00361218|453972044|FG000|Overall Study|Lost to Follow-up|11|||
126187868|NCT00361218|453972044|FG000|Overall Study|Personal Reasons|7|||
126187869|NCT00361218|453972044|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
126187870|NCT01570309|453972047|FG000|Overall Study|Withdrawal by Subject|3|||
126187871|NCT01570309|453972048|FG001|Overall Study|Withdrawal by Subject|3|||
126187872|NCT01594749|453973957|FG000|Overall Study|Adverse Event|2|||
126187873|NCT01594749|453973958|FG001|Overall Study|Adverse Event|1|||
126187874|NCT01594749|453973957|FG000|Overall Study|Withdrawal by Subject|2|||
126187875|NCT01594749|453973958|FG001|Overall Study|Withdrawal by Subject|2|||
126187876|NCT01594749|453973957|FG000|Overall Study|Protocol Violation|2|||
126187877|NCT01594749|453973958|FG001|Overall Study|Protocol Violation|0|||
126187878|NCT01594749|453973957|FG000|Overall Study|Physician Decision|1|||
126187879|NCT01594749|453973958|FG001|Overall Study|Physician Decision|1|||
126187880|NCT01594749|453973957|FG000|Overall Study|Non-compliance with Protocol|0|||
126187881|NCT01594749|453973958|FG001|Overall Study|Non-compliance with Protocol|1|||
126187882|NCT01594749|453973957|FG000|Overall Study|Lost to Follow-up|1|||
126187883|NCT01594749|453973958|FG001|Overall Study|Lost to Follow-up|0|||
126187884|NCT01594749|453973957|FG000|Overall Study|Death|9|||
126187885|NCT01594749|453973958|FG001|Overall Study|Death|3|||
126187886|NCT01594749|453973957|FG000|Overall Study|Not Treated|4|||
126187887|NCT01594749|453973958|FG001|Overall Study|Not Treated|10|||
126187888|NCT01594749|453973957|FG000|Overall Study|Lost Source Documentation|1|||
126187889|NCT01594749|453973958|FG001|Overall Study|Lost Source Documentation|0|||
126187890|NCT02177786|453973959|FG000|Overall Study|Withdrew Consent|2|||
126187891|NCT02177786|453973960|FG001|Overall Study|Withdrew Consent|6|||
126187892|NCT02177786|453973961|FG002|Overall Study|Withdrew Consent|9|||
126187893|NCT02177786|453973962|FG003|Overall Study|Withdrew Consent|5|||
126187894|NCT02177786|453973959|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
126187895|NCT02177786|453973960|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
126187896|NCT02177786|453973961|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
126187897|NCT02177786|453973962|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
126187898|NCT02177786|453973959|FG000|Overall Study|Adverse Event|1|||
126187899|NCT02177786|453973960|FG001|Overall Study|Adverse Event|1|||
126187900|NCT02177786|453973961|FG002|Overall Study|Adverse Event|2|||
126187901|NCT02177786|453973962|FG003|Overall Study|Adverse Event|3|||
126187902|NCT02177786|453973959|FG000|Overall Study|Death|1|||
126187903|NCT02177786|453973960|FG001|Overall Study|Death|1|||
126187904|NCT02177786|453973961|FG002|Overall Study|Death|1|||
126187905|NCT02177786|453973962|FG003|Overall Study|Death|1|||
126187906|NCT02177786|453973959|FG000|Overall Study|Lost to Follow-up|0|||
126187907|NCT02177786|453973960|FG001|Overall Study|Lost to Follow-up|0|||
126187908|NCT02177786|453973961|FG002|Overall Study|Lost to Follow-up|2|||
126187909|NCT02177786|453973962|FG003|Overall Study|Lost to Follow-up|2|||
126187910|NCT02177786|453973959|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126187911|NCT02177786|453973960|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126187912|NCT02177786|453973961|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126187913|NCT02177786|453973962|FG003|Overall Study|Non-Compliance with Study Drug|1|||
126187914|NCT02177786|453973959|FG000|Overall Study|Protocol Violation|0|||
126187915|NCT02177786|453973960|FG001|Overall Study|Protocol Violation|0|||
126187916|NCT02177786|453973961|FG002|Overall Study|Protocol Violation|2|||
126187917|NCT02177786|453973962|FG003|Overall Study|Protocol Violation|0|||
126187918|NCT02177786|453973959|FG000|Overall Study|Progressive Disease|0|||
126187919|NCT02177786|453973960|FG001|Overall Study|Progressive Disease|1|||
126187920|NCT02177786|453973961|FG002|Overall Study|Progressive Disease|0|||
126187921|NCT02177786|453973962|FG003|Overall Study|Progressive Disease|0|||
126187922|NCT02177786|453973959|FG000|Overall Study|Missing study completion status|0|||
126187923|NCT02177786|453973960|FG001|Overall Study|Missing study completion status|1|||
126187924|NCT02177786|453973961|FG002|Overall Study|Missing study completion status|0|||
126187925|NCT02177786|453973962|FG003|Overall Study|Missing study completion status|0|||
126187926|NCT00439309|453973963|FG000|Follow-Up|Death|1|||
126187927|NCT00439309|453973964|FG001|Follow-Up|Death|0|||
126187928|NCT00439309|453973963|FG000|Follow-Up|Lost to Follow-up|2|||
126187929|NCT00439309|453973964|FG001|Follow-Up|Lost to Follow-up|0|||
126187930|NCT00439309|453973963|FG000|Follow-Up|Withdrawal by Subject|0|||
126187931|NCT00439309|453973964|FG001|Follow-Up|Withdrawal by Subject|1|||
126187932|NCT00439309|453973963|FG000|Follow-Up|Late response by subject|0|||
126187933|NCT00439309|453973964|FG001|Follow-Up|Late response by subject|1|||
126187934|NCT01977040|453973965|FG000|Overall Study|Vasa previa not confirmed|2|||
126187935|NCT00634751|453973970|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
126187936|NCT00634751|453973971|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
126187937|NCT00634751|453973972|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
126187938|NCT00634751|453973973|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
126187939|NCT00634751|453973970|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
126187940|NCT00634751|453973971|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
126187941|NCT00634751|453973972|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
126187942|NCT00634751|453973973|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
126187943|NCT00634751|453973970|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
126187944|NCT00634751|453973971|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
126187945|NCT00634751|453973972|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
126187946|NCT00634751|453973973|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
126187947|NCT02204410|453973977|FG000|Overall Study|Lost to Follow-up|5|||
126187948|NCT02204410|453973977|FG000|Overall Study|Physician Decision|2|||
126187949|NCT02204410|453973977|FG000|Overall Study|Protocol Violation|1|||
126187950|NCT02204410|453973977|FG000|Overall Study|Withdrawal by Subject|3|||
126187951|NCT03654560|453973978|FG000|Overall Study|Death|3|||
126187952|NCT03654560|453973979|FG001|Overall Study|Death|1|||
126187953|NCT03654560|453973978|FG000|Overall Study|Lost to Follow-up|1|||
126187954|NCT03654560|453973979|FG001|Overall Study|Lost to Follow-up|0|||
126187955|NCT01473355|453973980|FG000|Overall Study|Protocol Violation|2|||
126187956|NCT01473355|453973980|FG000|Overall Study|Adverse Event|2|||
126187957|NCT01473355|453973980|FG000|Overall Study|Lost to Follow-up|2|||
126187958|NCT02603172|453973981|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126187959|NCT02603172|453973982|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126187960|NCT02603172|453973983|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
126187961|NCT02603172|453973984|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126187962|NCT02603172|453973985|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126187963|NCT02603172|453973986|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126187964|NCT02603172|453973987|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126187965|NCT02603172|453973988|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126187966|NCT01100658|453973989|FG000|Overall Study|Withdrawal by Subject|1|||
126187967|NCT00711412|453973990|FG000|Induction Treatment|Death|2|||
126187968|NCT00711412|453973990|FG000|Induction Treatment|Adverse Event|1|||
126187969|NCT00711412|453973990|FG000|Induction Treatment|Other|1|||
126187970|NCT00711412|453973990|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
126187971|NCT00711412|453973990|FG000|Evaluated for Combination Treatment|Death|1|||
126187972|NCT00711412|453973990|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
126187973|NCT00711412|453973990|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
126187974|NCT00711412|453973990|FG000|Combination Treatment|Progressive Disease|1|||
126187975|NCT00711412|453973990|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
126187976|NCT00711412|453973990|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
126187977|NCT00711412|453973990|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
126187978|NCT00711412|453973990|FG000|Evaluation for Response and Surgery|Death|1|||
126187979|NCT00711412|453973990|FG000|Survival Follow up Until Death|Other|12|||
126187980|NCT00420342|453973994|FG000|Overall Study|Lost to Follow-up|1|||
126187981|NCT00420342|453973995|FG001|Overall Study|Lost to Follow-up|0|||
126187982|NCT00420342|453973996|FG002|Overall Study|Lost to Follow-up|1|||
126187983|NCT00420342|453973994|FG000|Overall Study|Withdrawal by Subject|0|||
126187984|NCT00420342|453973995|FG001|Overall Study|Withdrawal by Subject|2|||
126187985|NCT00420342|453973996|FG002|Overall Study|Withdrawal by Subject|0|||
126187986|NCT01017549|453973997|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
126187987|NCT01017549|453973997|FG000|One-year Follow-up|Lost to Follow-up|2|||
126187988|NCT01017549|453973997|FG000|One-year Follow-up|Withdrawal by Subject|5|||
126187989|NCT01017549|453973997|FG000|5 Year Follow-up|Lost to Follow-up|9|||
126187990|NCT01017549|453973997|FG000|5 Year Follow-up|Mastectomy|3|||
126187991|NCT04072575|453973998|FG000|Overall Study|Physician Decision|1|||
126187992|NCT04072575|453973998|FG000|Overall Study|Adverse Event|7|||
126187993|NCT04072575|453973998|FG000|Overall Study|Withdrawal by Subject|14|||
126187994|NCT04072575|453973998|FG000|Overall Study|Other|2|||
126187995|NCT02473289|453973999|FG000|Overall Study|Adverse Event|2|||
126187996|NCT02473289|453974000|FG001|Overall Study|Adverse Event|3|||
126187997|NCT02473289|453973999|FG000|Overall Study|Lost to Follow-up|1|||
126187998|NCT02473289|453974000|FG001|Overall Study|Lost to Follow-up|1|||
126187999|NCT02473289|453973999|FG000|Overall Study|Protocol Violation|0|||
126188000|NCT02473289|453974000|FG001|Overall Study|Protocol Violation|1|||
126188001|NCT02473289|453973999|FG000|Overall Study|Withdrawal of consent|6|||
126188002|NCT02473289|453974000|FG001|Overall Study|Withdrawal of consent|7|||
126188003|NCT02473289|453973999|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
126188004|NCT02473289|453974000|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
126188005|NCT02473289|453973999|FG000|Overall Study|Other|2|||
126188006|NCT02473289|453974000|FG001|Overall Study|Other|0|||
126188007|NCT02244619|453974001|FG000|Overall Study|Did not receive study intervention|8|||
126188008|NCT02244619|453974002|FG001|Overall Study|Did not receive study intervention|21|||
126188009|NCT03285490|453974004|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
126188010|NCT03285490|453974005|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
126188011|NCT03285490|453974004|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
126188012|NCT03285490|453974005|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
126188013|NCT03745989|453974006|FG000|Overall Study|Death|3|||
126188014|NCT03745989|453974007|FG001|Overall Study|Death|7|||
126188015|NCT03745989|453974008|FG002|Overall Study|Death|4|||
126188016|NCT03745989|453974006|FG000|Overall Study|Lost to Follow-up|0|||
126188017|NCT03745989|453974007|FG001|Overall Study|Lost to Follow-up|2|||
126188018|NCT03745989|453974008|FG002|Overall Study|Lost to Follow-up|0|||
126188019|NCT03745989|453974006|FG000|Overall Study|Sponsor Decision|0|||
126188020|NCT03745989|453974007|FG001|Overall Study|Sponsor Decision|2|||
126188021|NCT03745989|453974008|FG002|Overall Study|Sponsor Decision|8|||
126188022|NCT03745989|453974006|FG000|Overall Study|Withdrawal by Subject|0|||
126188023|NCT03745989|453974007|FG001|Overall Study|Withdrawal by Subject|1|||
126188024|NCT03745989|453974008|FG002|Overall Study|Withdrawal by Subject|3|||
126188025|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
126188026|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
126188027|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
126188028|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
126188029|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
126188030|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
126188031|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
126188032|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
126188033|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
126188034|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
126188035|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
126188036|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
126188037|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
126188038|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
126188039|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
126188040|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
126188041|NCT01291511|453974009|FG000|Cross-Titration and Stabilization Phase|Death|1|||
126188042|NCT01291511|453974010|FG001|Cross-Titration and Stabilization Phase|Death|0|||
126188043|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
126188044|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
126188045|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
126188046|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
126188047|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
126188048|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
126188049|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
126188050|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
126188051|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
126188052|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
126188053|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
126188054|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
126188055|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
126188056|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
126188057|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
126188058|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
126188059|NCT01291511|453974009|FG000|Double-blind Relapse Prevention Phase|Death|1|||
126188060|NCT01291511|453974010|FG001|Double-blind Relapse Prevention Phase|Death|0|||
126188061|NCT00047008|453974012|FG000|Overall Study|Withdrawn consent|2|||
126188062|NCT00047008|453974013|FG001|Overall Study|Withdrawn consent|3|||
126188063|NCT00047008|453974012|FG000|Overall Study|Ineligible|9|||
126188064|NCT00047008|453974013|FG001|Overall Study|Ineligible|8|||
126188065|NCT01047436|453974015|FG000|Overall Study|Protocol Violation|1|||
126188066|NCT01047436|453974016|FG001|Overall Study|Protocol Violation|0|||
126188067|NCT00939341|453974017|FG000|Overall Study|Adverse Event|15|||
126188068|NCT00939341|453974017|FG000|Overall Study|Pregnancy|1|||
126188069|NCT00939341|453974017|FG000|Overall Study|Lost to Follow-up|23|||
126188070|NCT00939341|453974017|FG000|Overall Study|Withdrawal by Subject|13|||
126188071|NCT00939341|453974017|FG000|Overall Study|Protocol Violation|6|||
126188072|NCT00939341|453974017|FG000|Overall Study|Incorrect enrolment|8|||
126188073|NCT00424099|453974018|FG000|Overall Study|Adverse Event|0|||
126188074|NCT00424099|453974019|FG001|Overall Study|Adverse Event|1|||
126188075|NCT00424099|453974020|FG002|Overall Study|Adverse Event|1|||
126188076|NCT00424099|453974021|FG003|Overall Study|Adverse Event|0|||
126188077|NCT00424099|453974018|FG000|Overall Study|Death|0|||
126188078|NCT00424099|453974019|FG001|Overall Study|Death|1|||
126188079|NCT00424099|453974020|FG002|Overall Study|Death|0|||
126188080|NCT00424099|453974021|FG003|Overall Study|Death|0|||
126188081|NCT00424099|453974018|FG000|Overall Study|Illness|2|||
126188082|NCT00424099|453974019|FG001|Overall Study|Illness|0|||
126188083|NCT00424099|453974020|FG002|Overall Study|Illness|1|||
126188084|NCT00424099|453974021|FG003|Overall Study|Illness|4|||
126188085|NCT00424099|453974018|FG000|Overall Study|Lost to Follow-up|0|||
126188086|NCT00424099|453974019|FG001|Overall Study|Lost to Follow-up|0|||
126188087|NCT00424099|453974020|FG002|Overall Study|Lost to Follow-up|3|||
126188088|NCT00424099|453974021|FG003|Overall Study|Lost to Follow-up|0|||
126188089|NCT00424099|453974018|FG000|Overall Study|Hospitalized|1|||
126188090|NCT00424099|453974019|FG001|Overall Study|Hospitalized|2|||
126188091|NCT00424099|453974020|FG002|Overall Study|Hospitalized|1|||
126188092|NCT00424099|453974021|FG003|Overall Study|Hospitalized|3|||
126188093|NCT00424099|453974018|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
126188094|NCT00424099|453974019|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
126188095|NCT00424099|453974020|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
126188096|NCT00424099|453974021|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
126188097|NCT00424099|453974018|FG000|Overall Study|Withdrawal by Subject|1|||
126188098|NCT00424099|453974019|FG001|Overall Study|Withdrawal by Subject|9|||
126188099|NCT00424099|453974020|FG002|Overall Study|Withdrawal by Subject|4|||
126188100|NCT00424099|453974021|FG003|Overall Study|Withdrawal by Subject|6|||
126188101|NCT00424099|453974018|FG000|Overall Study|Physician Decision|0|||
126188102|NCT00424099|453974019|FG001|Overall Study|Physician Decision|0|||
126188103|NCT00424099|453974020|FG002|Overall Study|Physician Decision|1|||
126188104|NCT00424099|453974021|FG003|Overall Study|Physician Decision|0|||
126188105|NCT00424099|453974018|FG000|Overall Study|Missing|0|||
126188106|NCT00424099|453974019|FG001|Overall Study|Missing|0|||
126188107|NCT00424099|453974020|FG002|Overall Study|Missing|1|||
126188108|NCT00424099|453974021|FG003|Overall Study|Missing|0|||
126188109|NCT01408732|453974022|FG000|Overall Study|Withdrawal by Subject|2|||
126188110|NCT01408732|453974023|FG001|Overall Study|Withdrawal by Subject|2|||
126188111|NCT00796003|453974025|FG000|Overall Study|Disease Progression|2|||
126188112|NCT00796003|453974026|FG001|Overall Study|Disease Progression|13|||
126188113|NCT00796003|453974025|FG000|Overall Study|Adverse Event|1|||
126188114|NCT00796003|453974026|FG001|Overall Study|Adverse Event|7|||
126188115|NCT00796003|453974025|FG000|Overall Study|Specified organ function not met|0|||
126188116|NCT00796003|453974026|FG001|Overall Study|Specified organ function not met|1|||
126188117|NCT00796003|453974025|FG000|Overall Study|Physician Decision|0|||
126188118|NCT00796003|453974026|FG001|Overall Study|Physician Decision|4|||
126188119|NCT00796003|453974025|FG000|Overall Study|Withdrawal by Subject|0|||
126188120|NCT00796003|453974026|FG001|Overall Study|Withdrawal by Subject|1|||
126188121|NCT00796003|453974025|FG000|Overall Study|Other|0|||
126188122|NCT00796003|453974026|FG001|Overall Study|Other|1|||
126188123|NCT00796003|453974025|FG000|Overall Study|Participants Not treated|0|||
126188124|NCT00796003|453974026|FG001|Overall Study|Participants Not treated|2|||
126188125|NCT05179057|453974027|FG000|Overall Study|Adverse Event|3|||
126188126|NCT05179057|453974028|FG001|Overall Study|Adverse Event|2|||
126188127|NCT05179057|453974027|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
126188128|NCT05179057|453974028|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
126188129|NCT05179057|453974027|FG000|Overall Study|Study terminated|13|||
126188130|NCT05179057|453974028|FG001|Overall Study|Study terminated|7|||
126188131|NCT05179057|453974027|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
126188132|NCT05179057|453974028|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
126188133|NCT05179057|453974027|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
126188134|NCT05179057|453974028|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
126188135|NCT02437162|453974029|FG000|Overall Study|Protocol Violation|0|||
126188136|NCT02437162|453974030|FG001|Overall Study|Protocol Violation|1|||
126188137|NCT02437162|453974031|FG002|Overall Study|Protocol Violation|0|||
126188138|NCT02437162|453974029|FG000|Overall Study|Randomized but not treated|0|||
126188139|NCT02437162|453974030|FG001|Overall Study|Randomized but not treated|0|||
126188140|NCT02437162|453974031|FG002|Overall Study|Randomized but not treated|1|||
126188141|NCT02437162|453974029|FG000|Overall Study|Study discontinued by Sponsor|93|||
126188142|NCT02437162|453974030|FG001|Overall Study|Study discontinued by Sponsor|98|||
126188143|NCT02437162|453974031|FG002|Overall Study|Study discontinued by Sponsor|97|||
126188144|NCT02437162|453974029|FG000|Overall Study|Withdrawal by Subject|13|||
126188145|NCT02437162|453974030|FG001|Overall Study|Withdrawal by Subject|7|||
126188146|NCT02437162|453974031|FG002|Overall Study|Withdrawal by Subject|9|||
126188147|NCT02437162|453974029|FG000|Overall Study|Adverse Event|0|||
126188148|NCT02437162|453974030|FG001|Overall Study|Adverse Event|1|||
126188149|NCT02437162|453974031|FG002|Overall Study|Adverse Event|0|||
126188150|NCT02437162|453974029|FG000|Overall Study|Lost to Follow-up|1|||
126188151|NCT02437162|453974030|FG001|Overall Study|Lost to Follow-up|0|||
126188152|NCT02437162|453974031|FG002|Overall Study|Lost to Follow-up|1|||
126188153|NCT02437162|453974029|FG000|Overall Study|Death|0|||
126188154|NCT02437162|453974030|FG001|Overall Study|Death|1|||
126188155|NCT02437162|453974031|FG002|Overall Study|Death|0|||
126188156|NCT02437162|453974029|FG000|Overall Study|Other|0|||
126188157|NCT02437162|453974030|FG001|Overall Study|Other|0|||
126188158|NCT02437162|453974031|FG002|Overall Study|Other|1|||
126188159|NCT04338321|453974032|FG000|Overall Study|Adverse Event|4|||
126188160|NCT04338321|453974033|FG001|Overall Study|Adverse Event|10|||
126188161|NCT04338321|453974032|FG000|Overall Study|Death|1|||
126188162|NCT04338321|453974033|FG001|Overall Study|Death|1|||
126188163|NCT04338321|453974032|FG000|Overall Study|Lost to Follow-up|4|||
126188164|NCT04338321|453974033|FG001|Overall Study|Lost to Follow-up|9|||
126188165|NCT04338321|453974032|FG000|Overall Study|Withdrawal by Subject|45|||
126188166|NCT04338321|453974033|FG001|Overall Study|Withdrawal by Subject|69|||
126188167|NCT04338321|453974032|FG000|Overall Study|Physician Decision|5|||
126188168|NCT04338321|453974033|FG001|Overall Study|Physician Decision|9|||
126188169|NCT04338321|453974032|FG000|Overall Study|Other|3|||
126188170|NCT04338321|453974033|FG001|Overall Study|Other|10|||
126188171|NCT03107793|453974034|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
126188172|NCT03107793|453974035|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
126188173|NCT03107793|453974036|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
126188174|NCT03107793|453974037|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
126188175|NCT03107793|453974038|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
126188176|NCT03107793|453974034|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
126188177|NCT03107793|453974035|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
126188178|NCT03107793|453974036|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
126188179|NCT03107793|453974037|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
126188180|NCT03107793|453974038|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
126188181|NCT03107793|453974034|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
126188182|NCT03107793|453974035|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
126188183|NCT03107793|453974036|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
126188184|NCT03107793|453974037|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
126188185|NCT03107793|453974038|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
126199938|NCT01117428|454017805|FG001|Overall Study|Adverse Event|0|||
126188186|NCT03107793|453974034|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
126188187|NCT03107793|453974035|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126188188|NCT03107793|453974036|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126188189|NCT03107793|453974037|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126188190|NCT03107793|453974038|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126188191|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126188192|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
126188193|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
126188194|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126188195|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126188196|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126188197|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
126188198|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
126188199|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126188200|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126188201|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
126188202|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
126188203|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
126188204|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
126188205|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
126188206|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126188207|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
126188208|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
126188209|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126188210|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126188211|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
126188212|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
126188213|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
126188214|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
126188215|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
126188216|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
126188217|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
126188218|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
126188219|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
126188220|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
126188221|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126188222|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126188223|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126188224|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126188225|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126188226|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
126188227|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
126188228|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
126188229|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
126188230|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
126188231|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
126188232|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
126188233|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
126188234|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
126188235|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
126188236|NCT03107793|453974034|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126188237|NCT03107793|453974035|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
126188238|NCT03107793|453974036|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
126188239|NCT03107793|453974037|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126188240|NCT03107793|453974038|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126188241|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
126188242|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
126188243|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
126188244|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
126188245|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
126188246|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
126188247|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
126188248|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
126188249|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
126188250|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
126188251|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
126188252|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
126188253|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
126188254|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
126188255|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
126188256|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Death|0|||
126188257|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Death|0|||
126188258|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Death|0|||
126188259|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Death|0|||
126188260|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Death|1|||
126188261|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
126188262|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
126188263|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
126188264|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
126188265|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
126188266|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
126188267|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
126188268|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
126188269|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
126188270|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
126188271|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
126188272|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
126188273|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
126188274|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
126188275|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
126188276|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
126188277|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
126188278|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
126188279|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
126188280|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
126188281|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
126188282|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
126188283|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
126188284|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
126188285|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
126188286|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Other|0|||
126188287|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Other|0|||
126188288|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Other|0|||
126188289|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Other|1|||
126188290|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Other|3|||
126188291|NCT03107793|453974034|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
126188292|NCT03107793|453974035|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
126188293|NCT03107793|453974036|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
126188294|NCT03107793|453974037|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
126188295|NCT03107793|453974038|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
126188296|NCT01989572|453974042|FG000|Overall Study|Lack of Efficacy|35|||
126188297|NCT01989572|453974043|FG001|Overall Study|Lack of Efficacy|48|||
126188298|NCT01989572|453974044|FG002|Overall Study|Lack of Efficacy|48|||
126188299|NCT01989572|453974045|FG003|Overall Study|Lack of Efficacy|43|||
126188300|NCT01989572|453974046|FG004|Overall Study|Lack of Efficacy|71|||
126188301|NCT01989572|453974047|FG005|Overall Study|Lack of Efficacy|79|||
126188302|NCT01989572|453974042|FG000|Overall Study|Adverse Event|2|||
126188303|NCT01989572|453974043|FG001|Overall Study|Adverse Event|1|||
126188304|NCT01989572|453974044|FG002|Overall Study|Adverse Event|3|||
126188305|NCT01989572|453974045|FG003|Overall Study|Adverse Event|0|||
126188306|NCT01989572|453974046|FG004|Overall Study|Adverse Event|3|||
126188307|NCT01989572|453974047|FG005|Overall Study|Adverse Event|0|||
126188308|NCT01989572|453974042|FG000|Overall Study|Death|0|||
126188309|NCT01989572|453974043|FG001|Overall Study|Death|0|||
126188310|NCT01989572|453974044|FG002|Overall Study|Death|0|||
126188311|NCT01989572|453974045|FG003|Overall Study|Death|0|||
126188312|NCT01989572|453974046|FG004|Overall Study|Death|1|||
126188313|NCT01989572|453974047|FG005|Overall Study|Death|0|||
126188314|NCT01989572|453974042|FG000|Overall Study|Withdrawal by Subject|4|||
126188315|NCT01989572|453974043|FG001|Overall Study|Withdrawal by Subject|1|||
126188316|NCT01989572|453974044|FG002|Overall Study|Withdrawal by Subject|5|||
126188317|NCT01989572|453974045|FG003|Overall Study|Withdrawal by Subject|1|||
126188318|NCT01989572|453974046|FG004|Overall Study|Withdrawal by Subject|12|||
126188319|NCT01989572|453974047|FG005|Overall Study|Withdrawal by Subject|4|||
126188320|NCT01989572|453974042|FG000|Overall Study|complicating disease|1|||
126188321|NCT01989572|453974043|FG001|Overall Study|complicating disease|1|||
126188322|NCT01989572|453974044|FG002|Overall Study|complicating disease|2|||
126188323|NCT01989572|453974045|FG003|Overall Study|complicating disease|0|||
126188324|NCT01989572|453974046|FG004|Overall Study|complicating disease|1|||
126188325|NCT01989572|453974047|FG005|Overall Study|complicating disease|0|||
126188326|NCT01989572|453974042|FG000|Overall Study|error|2|||
126188327|NCT01989572|453974043|FG001|Overall Study|error|1|||
126188328|NCT01989572|453974044|FG002|Overall Study|error|1|||
126188329|NCT01989572|453974045|FG003|Overall Study|error|1|||
126188330|NCT01989572|453974046|FG004|Overall Study|error|1|||
126188331|NCT01989572|453974047|FG005|Overall Study|error|1|||
126188332|NCT01989572|453974042|FG000|Overall Study|maximum dose reached|0|||
126188333|NCT01989572|453974043|FG001|Overall Study|maximum dose reached|1|||
126188334|NCT01989572|453974044|FG002|Overall Study|maximum dose reached|0|||
126188335|NCT01989572|453974045|FG003|Overall Study|maximum dose reached|0|||
126188336|NCT01989572|453974046|FG004|Overall Study|maximum dose reached|1|||
126188337|NCT01989572|453974047|FG005|Overall Study|maximum dose reached|0|||
126188338|NCT01989572|453974042|FG000|Overall Study|unknown/not specify|3|||
126188339|NCT01989572|453974043|FG001|Overall Study|unknown/not specify|4|||
126188340|NCT01989572|453974044|FG002|Overall Study|unknown/not specify|1|||
126188341|NCT01989572|453974045|FG003|Overall Study|unknown/not specify|3|||
126188342|NCT01989572|453974046|FG004|Overall Study|unknown/not specify|3|||
126188343|NCT01989572|453974047|FG005|Overall Study|unknown/not specify|5|||
126188344|NCT01989572|453974042|FG000|Overall Study|not start protocol therapy|5|||
126188345|NCT01989572|453974043|FG001|Overall Study|not start protocol therapy|1|||
126188346|NCT01989572|453974044|FG002|Overall Study|not start protocol therapy|2|||
126188347|NCT01989572|453974045|FG003|Overall Study|not start protocol therapy|3|||
126188348|NCT01989572|453974046|FG004|Overall Study|not start protocol therapy|4|||
126188349|NCT01989572|453974047|FG005|Overall Study|not start protocol therapy|18|||
126188350|NCT01989572|453974042|FG000|Overall Study|alternative therapy|3|||
126188351|NCT01989572|453974043|FG001|Overall Study|alternative therapy|0|||
126188352|NCT01989572|453974044|FG002|Overall Study|alternative therapy|0|||
126188353|NCT01989572|453974045|FG003|Overall Study|alternative therapy|0|||
126188354|NCT01989572|453974046|FG004|Overall Study|alternative therapy|1|||
126188355|NCT01989572|453974047|FG005|Overall Study|alternative therapy|3|||
126188356|NCT02280096|453974048|FG000|Overall Study|Pregnancy|1|||
126188357|NCT02280096|453974049|FG001|Overall Study|Pregnancy|0|||
126188358|NCT02280096|453974048|FG000|Overall Study|Functional neurological disorder|1|||
126188359|NCT02280096|453974049|FG001|Overall Study|Functional neurological disorder|0|||
126188360|NCT02280096|453974048|FG000|Overall Study|Lack of attachment|0|||
126188361|NCT02280096|453974049|FG001|Overall Study|Lack of attachment|1|||
126188362|NCT02939976|453974050|FG000|Overall Study|Lost to Follow-up|7|||
126188363|NCT02939976|453974051|FG001|Overall Study|Lost to Follow-up|1|||
126188364|NCT02939976|453974052|FG002|Overall Study|Lost to Follow-up|1|||
126188365|NCT02939976|453974053|FG003|Overall Study|Lost to Follow-up|2|||
126188366|NCT02939976|453974050|FG000|Overall Study|Withdrawal by Subject|4|||
126188367|NCT02939976|453974051|FG001|Overall Study|Withdrawal by Subject|0|||
126188368|NCT02939976|453974052|FG002|Overall Study|Withdrawal by Subject|2|||
126188369|NCT02939976|453974053|FG003|Overall Study|Withdrawal by Subject|4|||
126188370|NCT02939976|453974050|FG000|Overall Study|Due to early study closure|4|||
126188371|NCT02939976|453974051|FG001|Overall Study|Due to early study closure|3|||
126188372|NCT02939976|453974052|FG002|Overall Study|Due to early study closure|2|||
126188373|NCT02939976|453974053|FG003|Overall Study|Due to early study closure|3|||
126188374|NCT01872897|453974054|FG000|Overall Study|Withdrawal by Subject|1|||
126188375|NCT01872897|453974055|FG001|Overall Study|Withdrawal by Subject|0|||
126188376|NCT02418585|453974056|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
126188377|NCT02418585|453974057|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
126188378|NCT02418585|453974056|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
126188379|NCT02418585|453974057|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
126188380|NCT02418585|453974056|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
126188381|NCT02418585|453974057|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
126188382|NCT02418585|453974056|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
126188383|NCT02418585|453974057|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
126188384|NCT02418585|453974056|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
126188385|NCT02418585|453974057|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
126188386|NCT02418585|453974056|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
126188387|NCT02418585|453974057|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
126188388|NCT02418585|453974056|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
126188389|NCT02418585|453974057|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
126188390|NCT02418585|453974056|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
126188391|NCT02418585|453974057|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
126188392|NCT02418585|453974056|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
126188393|NCT02418585|453974057|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
126188394|NCT02418585|453974056|FG000|Follow-up Phase (24 Weeks)|Other|3|||
126188395|NCT02418585|453974057|FG001|Follow-up Phase (24 Weeks)|Other|2|||
126188396|NCT02040857|453974058|FG000|Overall Study|Adverse Event|14|||
126188397|NCT02040857|453974058|FG000|Overall Study|Physician Decision|5|||
126188398|NCT02040857|453974058|FG000|Overall Study|Withdrawal by Subject|31|||
126188399|NCT02040857|453974058|FG000|Overall Study|patient non-compliance|3|||
126188400|NCT02040857|453974058|FG000|Overall Study|Lost to Follow-up|2|||
126188401|NCT02040857|453974058|FG000|Overall Study|recurrence|4|||
126188402|NCT02040857|453974058|FG000|Overall Study|ineligible|1|||
126188403|NCT04159701|453974059|FG000|Period 1: Treatment Period|Pregnancy|1|||
126188404|NCT04159701|453974060|FG001|Period 1: Treatment Period|Pregnancy|0|||
126188405|NCT04159701|453974059|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
126188406|NCT04159701|453974060|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
126188407|NCT04159701|453974059|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
126188408|NCT04159701|453974060|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
126188409|NCT04159701|453974059|FG000|Washout Period|site terminated by sponsor|0|||
126188410|NCT04159701|453974060|FG001|Washout Period|site terminated by sponsor|1|||
126188411|NCT04159701|453974059|FG000|Washout Period|study terminated by sponsor|10|||
126188412|NCT04159701|453974060|FG001|Washout Period|study terminated by sponsor|3|||
126188413|NCT04159701|453974059|FG000|Washout Period|Withdrawal by Subject|1|||
126188414|NCT04159701|453974060|FG001|Washout Period|Withdrawal by Subject|0|||
126188415|NCT04159701|453974059|FG000|Washout Period|Inadvertent Enrollment|1|||
126188416|NCT04159701|453974060|FG001|Washout Period|Inadvertent Enrollment|0|||
126188417|NCT04159701|453974059|FG000|Washout Period|Miscellaneous|1|||
126188418|NCT04159701|453974060|FG001|Washout Period|Miscellaneous|0|||
126188419|NCT04159701|453974059|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
126188420|NCT04159701|453974060|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
126188421|NCT04159701|453974059|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
126188422|NCT04159701|453974060|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
126188423|NCT04159701|453974059|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
126188424|NCT04159701|453974060|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
126188425|NCT04159701|453974059|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
126188426|NCT04159701|453974060|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
126188427|NCT04159701|453974059|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
126188428|NCT04159701|453974060|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
126188429|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
126188430|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
126188431|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
126188432|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
126188433|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
126188434|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
126188435|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
126188436|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
126188437|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
126188438|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
126188439|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
126188440|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
126188441|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
126188442|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
126188443|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
126188444|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
126188445|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
126188446|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
126188447|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
126188448|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
126188449|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
126188450|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
126188451|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
126188452|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
126188453|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
126188454|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
126188455|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
126188456|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
126188457|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
126188458|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
126188459|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
126188460|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
126188461|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
126188462|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
126188463|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
126188464|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
126188465|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
126188466|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
126188467|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
126188468|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
126188469|NCT03605836|453974061|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
126188470|NCT03605836|453974062|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
126188471|NCT03605836|453974063|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
126188472|NCT03605836|453974064|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
126188473|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
126188474|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
126188475|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
126188476|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
126188477|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
126188478|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
126188479|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
126188480|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
126188481|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
126188482|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
126188483|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
126188484|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
126188485|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
126188486|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
126188487|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
126188488|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
126188489|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
126188490|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
126188491|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
126188492|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
126188493|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
126188494|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
126188495|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
126188496|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
126188497|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
126188498|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
126188499|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
126188500|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
126188501|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
126188502|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
126188503|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
126188504|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
126188505|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
126188506|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
126188507|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
126188508|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
126188509|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
126188510|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
126188511|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
126188512|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
126188513|NCT03605836|453974061|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
126188514|NCT03605836|453974062|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
126188515|NCT03605836|453974063|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
126188516|NCT03605836|453974064|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
126188517|NCT02057068|453974071|FG000|Overall Study|Withdrawal by Subject|2|||
126188518|NCT02057068|453974072|FG001|Overall Study|Withdrawal by Subject|2|||
126188519|NCT02057068|453974071|FG000|Overall Study|Caregiver (CG) Health|0|||
126188520|NCT02057068|453974072|FG001|Overall Study|Caregiver (CG) Health|2|||
126188521|NCT02057068|453974071|FG000|Overall Study|Carepartner (CP) Health|4|||
126188522|NCT02057068|453974072|FG001|Overall Study|Carepartner (CP) Health|2|||
126188523|NCT02057068|453974071|FG000|Overall Study|Lost to Follow-up|2|||
126188524|NCT02057068|453974072|FG001|Overall Study|Lost to Follow-up|2|||
126188525|NCT00865046|453974073|FG000|Overall Study|Lost to Follow-up|1|||
126188526|NCT00865046|453974074|FG001|Overall Study|Lost to Follow-up|4|||
126188527|NCT00865046|453974075|FG002|Overall Study|Lost to Follow-up|0|||
126188528|NCT00865046|453974073|FG000|Overall Study|Death|0|||
126188529|NCT00865046|453974074|FG001|Overall Study|Death|1|||
126188530|NCT00865046|453974075|FG002|Overall Study|Death|1|||
126188531|NCT00865046|453974073|FG000|Overall Study|Withdrawal by Subject|5|||
126188532|NCT00865046|453974074|FG001|Overall Study|Withdrawal by Subject|0|||
126188533|NCT00865046|453974075|FG002|Overall Study|Withdrawal by Subject|0|||
126188534|NCT01024920|453974078|FG000|Overall Study|Progressive disease|47|||
126188535|NCT01024920|453974079|FG001|Overall Study|Progressive disease|25|||
126188536|NCT01024920|453974078|FG000|Overall Study|Adverse Event|8|||
126188537|NCT01024920|453974079|FG001|Overall Study|Adverse Event|4|||
126188538|NCT01024920|453974078|FG000|Overall Study|Lost to Follow-up|0|||
126188539|NCT01024920|453974079|FG001|Overall Study|Lost to Follow-up|1|||
126188540|NCT01024920|453974078|FG000|Overall Study|Patient refusal to continue|4|||
126188541|NCT01024920|453974079|FG001|Overall Study|Patient refusal to continue|0|||
126188542|NCT01024920|453974078|FG000|Overall Study|Other than listed|5|||
126188543|NCT01024920|453974079|FG001|Overall Study|Other than listed|1|||
126188544|NCT01024920|453974078|FG000|Overall Study|Not treated|3|||
126188545|NCT01024920|453974079|FG001|Overall Study|Not treated|0|||
126188546|NCT01024920|453974078|FG000|Overall Study|Protocol Violation|0|||
126188547|NCT01024920|453974079|FG001|Overall Study|Protocol Violation|1|||
126188548|NCT02977507|453974080|FG000|Overall Study|Protocol Deviation|1|||
126188549|NCT02977507|453974081|FG001|Overall Study|Protocol Deviation|0|||
126188550|NCT02977507|453974080|FG000|Overall Study|Lost to Follow-up|1|||
126188551|NCT02977507|453974081|FG001|Overall Study|Lost to Follow-up|0|||
126188552|NCT00633360|453974082|FG000|Overall Study|Lost to Follow-up|1|||
126188553|NCT00633360|453974083|FG001|Overall Study|Lost to Follow-up|1|||
126188554|NCT00633360|453974082|FG000|Overall Study|Adverse Event|3|||
126188555|NCT00633360|453974083|FG001|Overall Study|Adverse Event|1|||
126188556|NCT00633360|453974082|FG000|Overall Study|Protocol Violation|0|||
126188557|NCT00633360|453974083|FG001|Overall Study|Protocol Violation|1|||
126188558|NCT00471276|453974087|FG000|Overall Study|Death|2|||
126188559|NCT00471276|453974087|FG000|Overall Study|Adverse Event|16|||
126188560|NCT00471276|453974087|FG000|Overall Study|Protocol Violation|1|||
126188561|NCT00471276|453974087|FG000|Overall Study|Objective progression or relapse|54|||
126188562|NCT00471276|453974087|FG000|Overall Study|Global deterioration of health status|1|||
126188563|NCT00471276|453974087|FG000|Overall Study|Other|3|||
126188564|NCT00471276|453974087|FG000|Overall Study|Refused treatment|6|||
126188565|NCT00910728|453974088|FG000|Overall Study|Lack of Efficacy|2|||
126188566|NCT00910728|453974089|FG001|Overall Study|Lack of Efficacy|3|||
126188567|NCT00910728|453974090|FG002|Overall Study|Lack of Efficacy|1|||
126188568|NCT00910728|453974091|FG003|Overall Study|Lack of Efficacy|2|||
126188569|NCT00910728|453974092|FG004|Overall Study|Lack of Efficacy|1|||
126188570|NCT00910728|453974093|FG005|Overall Study|Lack of Efficacy|0|||
126188571|NCT00910728|453974094|FG006|Overall Study|Lack of Efficacy|2|||
126188572|NCT00910728|453974095|FG007|Overall Study|Lack of Efficacy|2|||
126188573|NCT00910728|453974096|FG008|Overall Study|Lack of Efficacy|2|||
126188574|NCT00910728|453974088|FG000|Overall Study|Withdrawal by Subject|0|||
126188575|NCT00910728|453974089|FG001|Overall Study|Withdrawal by Subject|0|||
126188576|NCT00910728|453974090|FG002|Overall Study|Withdrawal by Subject|0|||
126188577|NCT00910728|453974091|FG003|Overall Study|Withdrawal by Subject|0|||
126188578|NCT00910728|453974092|FG004|Overall Study|Withdrawal by Subject|3|||
126188579|NCT00910728|453974093|FG005|Overall Study|Withdrawal by Subject|1|||
126188580|NCT00910728|453974094|FG006|Overall Study|Withdrawal by Subject|2|||
126188581|NCT00910728|453974095|FG007|Overall Study|Withdrawal by Subject|0|||
126188582|NCT00910728|453974096|FG008|Overall Study|Withdrawal by Subject|0|||
126188583|NCT00910728|453974088|FG000|Overall Study|(not specified)|2|||
126188584|NCT00910728|453974089|FG001|Overall Study|(not specified)|0|||
126188585|NCT00910728|453974090|FG002|Overall Study|(not specified)|1|||
126188586|NCT00910728|453974091|FG003|Overall Study|(not specified)|0|||
126188587|NCT00910728|453974092|FG004|Overall Study|(not specified)|1|||
126188588|NCT00910728|453974093|FG005|Overall Study|(not specified)|0|||
126188589|NCT00910728|453974094|FG006|Overall Study|(not specified)|0|||
126188590|NCT00910728|453974095|FG007|Overall Study|(not specified)|0|||
126188591|NCT00910728|453974096|FG008|Overall Study|(not specified)|0|||
126188592|NCT00910728|453974088|FG000|Overall Study|Adverse Event|2|||
126188593|NCT00910728|453974089|FG001|Overall Study|Adverse Event|0|||
126188594|NCT00910728|453974090|FG002|Overall Study|Adverse Event|1|||
126188595|NCT00910728|453974091|FG003|Overall Study|Adverse Event|1|||
126188596|NCT00910728|453974092|FG004|Overall Study|Adverse Event|0|||
126188597|NCT00910728|453974093|FG005|Overall Study|Adverse Event|0|||
126188598|NCT00910728|453974094|FG006|Overall Study|Adverse Event|2|||
126188599|NCT00910728|453974095|FG007|Overall Study|Adverse Event|1|||
126188600|NCT00910728|453974096|FG008|Overall Study|Adverse Event|1|||
126188601|NCT00044213|453974097|FG000|Overall Study|Withdrawal by Subject|50|||
126188602|NCT00044213|453974098|FG001|Overall Study|Withdrawal by Subject|65|||
126188603|NCT00044213|453974099|FG002|Overall Study|Withdrawal by Subject|91|||
126188604|NCT00044213|453974100|FG003|Overall Study|Withdrawal by Subject|83|||
126188605|NCT00044213|453974097|FG000|Overall Study|Death|42|||
126188606|NCT00044213|453974098|FG001|Overall Study|Death|42|||
126188607|NCT00044213|453974099|FG002|Overall Study|Death|42|||
126188608|NCT00044213|453974100|FG003|Overall Study|Death|49|||
126188609|NCT00044213|453974097|FG000|Overall Study|Lost to Follow-up|8|||
126188610|NCT00044213|453974098|FG001|Overall Study|Lost to Follow-up|5|||
126188611|NCT00044213|453974099|FG002|Overall Study|Lost to Follow-up|5|||
126188612|NCT00044213|453974100|FG003|Overall Study|Lost to Follow-up|4|||
126188613|NCT01927068|453974102|FG000|Overall Study|Death|37|||
126188614|NCT01927068|453974103|FG001|Overall Study|Death|3|||
126188615|NCT01927068|453974102|FG000|Overall Study|Withdrawal by Subject|50|||
126188616|NCT01927068|453974103|FG001|Overall Study|Withdrawal by Subject|3|||
126188617|NCT01927068|453974102|FG000|Overall Study|Lost to Follow-up|10|||
126188618|NCT01927068|453974103|FG001|Overall Study|Lost to Follow-up|2|||
126188619|NCT01927068|453974102|FG000|Overall Study|Physician Decision|9|||
126188620|NCT01927068|453974103|FG001|Overall Study|Physician Decision|0|||
126188621|NCT01927068|453974102|FG000|Overall Study|Missed last follow-up visit|2|||
126188622|NCT01927068|453974103|FG001|Overall Study|Missed last follow-up visit|0|||
126188623|NCT00880607|453974104|FG000|Overall Study|Physician Decision|2|||
126188624|NCT00880607|453974105|FG001|Overall Study|Physician Decision|2|||
126188625|NCT00880607|453974104|FG000|Overall Study|Protocol Violation|2|||
126188626|NCT00880607|453974105|FG001|Overall Study|Protocol Violation|1|||
126188627|NCT00880607|453974104|FG000|Overall Study|surgery did not extend past L1 level|3|||
126188628|NCT00880607|453974105|FG001|Overall Study|surgery did not extend past L1 level|0|||
126188629|NCT02963766|453974107|FG000|Double-Blind Period|Adverse Event|1|||
126188630|NCT02963766|453974108|FG001|Double-Blind Period|Adverse Event|0|||
126188631|NCT02963766|453974109|FG002|Double-Blind Period|Adverse Event|1|||
126188632|NCT02963766|453974107|FG000|Double-Blind Period|Physician Decision|1|||
126188633|NCT02963766|453974108|FG001|Double-Blind Period|Physician Decision|0|||
126188634|NCT02963766|453974109|FG002|Double-Blind Period|Physician Decision|0|||
126188635|NCT02963766|453974107|FG000|Double-Blind Period|Withdrawal by Subject|1|||
126188636|NCT02963766|453974108|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126188637|NCT02963766|453974109|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126188638|NCT02963766|453974107|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
126188639|NCT02963766|453974108|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
126188640|NCT02963766|453974109|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
126188641|NCT02963766|453974107|FG000|Double-Blind Period|Protocol Violation|1|||
126188642|NCT02963766|453974108|FG001|Double-Blind Period|Protocol Violation|0|||
126188643|NCT02963766|453974109|FG002|Double-Blind Period|Protocol Violation|0|||
126188644|NCT02963766|453974107|FG000|Double-Blind Period|Lost to Follow-up|0|||
126188645|NCT02963766|453974108|FG001|Double-Blind Period|Lost to Follow-up|1|||
126188646|NCT02963766|453974109|FG002|Double-Blind Period|Lost to Follow-up|0|||
126188647|NCT02963766|453974107|FG000|Open Label Extension (OLE)|Physician Decision|1|||
126188648|NCT02963766|453974108|FG001|Open Label Extension (OLE)|Physician Decision|2|||
126188649|NCT02963766|453974109|FG002|Open Label Extension (OLE)|Physician Decision|2|||
126188650|NCT02963766|453974107|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
126188651|NCT02963766|453974108|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
126188652|NCT02963766|453974109|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
126188653|NCT00499460|453974110|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
126188654|NCT00499460|453974111|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
126188655|NCT00499460|453974110|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
126188656|NCT00499460|453974111|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
126188657|NCT00499460|453974110|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
126188658|NCT00499460|453974111|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
126188659|NCT00814307|453974112|FG000|Overall Study|Randomized but not treated|1|||
126188660|NCT00814307|453974113|FG001|Overall Study|Randomized but not treated|0|||
126188661|NCT00814307|453974114|FG002|Overall Study|Randomized but not treated|0|||
126188662|NCT00814307|453974115|FG003|Overall Study|Randomized but not treated|0|||
126188663|NCT00814307|453974112|FG000|Overall Study|Adverse Event|3|||
126188664|NCT00814307|453974113|FG001|Overall Study|Adverse Event|9|||
126188665|NCT00814307|453974114|FG002|Overall Study|Adverse Event|3|||
126188666|NCT00814307|453974115|FG003|Overall Study|Adverse Event|2|||
126188667|NCT00814307|453974112|FG000|Overall Study|Lack of Efficacy|1|||
126188668|NCT00814307|453974113|FG001|Overall Study|Lack of Efficacy|1|||
126188669|NCT00814307|453974114|FG002|Overall Study|Lack of Efficacy|3|||
126188670|NCT00814307|453974115|FG003|Overall Study|Lack of Efficacy|4|||
126188671|NCT00814307|453974112|FG000|Overall Study|Other|1|||
126188672|NCT00814307|453974113|FG001|Overall Study|Other|2|||
126188673|NCT00814307|453974114|FG002|Overall Study|Other|0|||
126188674|NCT00814307|453974115|FG003|Overall Study|Other|1|||
126188675|NCT00814307|453974112|FG000|Overall Study|Protocol Violation|2|||
126188676|NCT00814307|453974113|FG001|Overall Study|Protocol Violation|8|||
126188677|NCT00814307|453974114|FG002|Overall Study|Protocol Violation|1|||
126188678|NCT00814307|453974115|FG003|Overall Study|Protocol Violation|1|||
126188679|NCT00814307|453974112|FG000|Overall Study|Withdrawal by Subject|4|||
126188680|NCT00814307|453974113|FG001|Overall Study|Withdrawal by Subject|6|||
126188681|NCT00814307|453974114|FG002|Overall Study|Withdrawal by Subject|0|||
126188682|NCT00814307|453974115|FG003|Overall Study|Withdrawal by Subject|2|||
126188683|NCT00814307|453974112|FG000|Overall Study|Death|0|||
126188684|NCT00814307|453974113|FG001|Overall Study|Death|1|||
126188685|NCT00814307|453974114|FG002|Overall Study|Death|0|||
126188686|NCT00814307|453974115|FG003|Overall Study|Death|0|||
126188687|NCT02290340|453974117|FG000|Overall Study|Lost to Follow-up|0|||
126188688|NCT02290340|453974118|FG001|Overall Study|Lost to Follow-up|0|||
126188689|NCT02290340|453974119|FG002|Overall Study|Lost to Follow-up|0|||
126188690|NCT02290340|453974120|FG003|Overall Study|Lost to Follow-up|1|||
126188691|NCT02290340|453974117|FG000|Overall Study|Withdrawal by Subject|1|||
126188692|NCT02290340|453974118|FG001|Overall Study|Withdrawal by Subject|0|||
126188693|NCT02290340|453974119|FG002|Overall Study|Withdrawal by Subject|0|||
126188694|NCT02290340|453974120|FG003|Overall Study|Withdrawal by Subject|0|||
126188695|NCT02290340|453974117|FG000|Overall Study|Other|1|||
126188696|NCT02290340|453974118|FG001|Overall Study|Other|0|||
126188697|NCT02290340|453974119|FG002|Overall Study|Other|0|||
126188698|NCT02290340|453974120|FG003|Overall Study|Other|1|||
126188699|NCT04402385|453976312|FG000|Overall Study|Withdrawal by Subject|4|||
126188700|NCT04402385|453976313|FG001|Overall Study|Withdrawal by Subject|4|||
126188701|NCT04402385|453976312|FG000|Overall Study|Lost to Follow-up|1|||
126188702|NCT04402385|453976313|FG001|Overall Study|Lost to Follow-up|1|||
126188703|NCT04402385|453976312|FG000|Overall Study|Physician Decision|0|||
126188704|NCT04402385|453976313|FG001|Overall Study|Physician Decision|1|||
126188705|NCT01308853|453976319|FG000|Overall Study|Adverse Event|1|||
126188706|NCT01308853|453976319|FG000|Overall Study|Lost to Follow-up|2|||
126188707|NCT01308853|453976319|FG000|Overall Study|Insertion of permanent implants|1|||
126188708|NCT00863317|453976324|FG000|Overall Study|Lost to Follow-up|8|||
126188709|NCT00863317|453976325|FG001|Overall Study|Lost to Follow-up|9|||
126188710|NCT00735072|453976329|FG000|Overall Study|interrupted study med during ARV change|1|||
126188711|NCT00735072|453976330|FG001|Overall Study|interrupted study med during ARV change|0|||
126188712|NCT00735072|453976329|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
126188713|NCT00735072|453976330|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
126188714|NCT00911144|453976331|FG000|Overall Study|Withdrawal by Subject|16|||
126188715|NCT00911144|453976332|FG001|Overall Study|Withdrawal by Subject|5|||
126188716|NCT03981744|453976333|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
126188717|NCT03981744|453976334|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
126188718|NCT03981744|453976335|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
126188719|NCT03981744|453976336|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
126188720|NCT03981744|453976333|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
126188721|NCT03981744|453976334|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
126188722|NCT03981744|453976335|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
126188723|NCT03981744|453976336|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
126188724|NCT03981744|453976333|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
126188725|NCT03981744|453976334|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
126188726|NCT03981744|453976335|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
126188727|NCT03981744|453976336|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
126188728|NCT00732238|453976337|FG000|Overall Study|Bacteremia|4|||
126188729|NCT00732238|453976338|FG001|Overall Study|Bacteremia|1|||
126188730|NCT00732238|453976337|FG000|Overall Study|Asymptomatic bacteriuria|1|||
126188731|NCT00732238|453976338|FG001|Overall Study|Asymptomatic bacteriuria|0|||
126188732|NCT00246376|453976341|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
126188733|NCT00246376|453976342|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
126188734|NCT00246376|453976343|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
126188735|NCT00246376|453976344|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
126188736|NCT00246376|453976345|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
126188737|NCT00246376|453976341|FG000|Overall Study|Adverse Event|2|||
126188738|NCT00246376|453976342|FG001|Overall Study|Adverse Event|3|||
126188739|NCT00246376|453976343|FG002|Overall Study|Adverse Event|1|||
126188740|NCT00246376|453976344|FG003|Overall Study|Adverse Event|3|||
126188741|NCT00246376|453976345|FG004|Overall Study|Adverse Event|1|||
126188742|NCT00246376|453976341|FG000|Overall Study|Lost to Follow-up|2|||
126188743|NCT00246376|453976342|FG001|Overall Study|Lost to Follow-up|11|||
126188744|NCT00246376|453976343|FG002|Overall Study|Lost to Follow-up|11|||
126188745|NCT00246376|453976344|FG003|Overall Study|Lost to Follow-up|16|||
126188746|NCT00246376|453976345|FG004|Overall Study|Lost to Follow-up|13|||
126188747|NCT00610207|453976349|FG000|Overall Study|Lost to Follow-up|3|||
126188748|NCT02465489|453976350|FG000|Overall Study|Adverse Event|5|||
126188749|NCT00693693|453976353|FG000|Overall Study|Lost to Follow-up|1|||
126188750|NCT00693693|453976354|FG001|Overall Study|Lost to Follow-up|1|||
126188751|NCT00693693|453976355|FG002|Overall Study|Lost to Follow-up|2|||
126188752|NCT02972593|453976356|FG000|Overall Study|Lost to Follow-up|19|||
126188753|NCT02972593|453976357|FG001|Overall Study|Lost to Follow-up|15|||
126188754|NCT02972593|453976356|FG000|Overall Study|Protocol Violation|1|||
126188755|NCT02972593|453976357|FG001|Overall Study|Protocol Violation|0|||
126188756|NCT04599972|453976358|FG000|Overall Study|Withdrawal by Subject|6|||
126188757|NCT04599972|453976359|FG001|Overall Study|Withdrawal by Subject|1|||
126188758|NCT04599972|453976358|FG000|Overall Study|Adverse Event|1|||
126188759|NCT04599972|453976359|FG001|Overall Study|Adverse Event|1|||
126188760|NCT04599972|453976358|FG000|Overall Study|Lost to Follow-up|1|||
126188761|NCT04599972|453976359|FG001|Overall Study|Lost to Follow-up|6|||
126188762|NCT04599972|453976358|FG000|Overall Study|Protocol Violation|1|||
126188763|NCT04599972|453976359|FG001|Overall Study|Protocol Violation|0|||
126188764|NCT04599972|453976358|FG000|Overall Study|Other reason|1|||
126188765|NCT04599972|453976359|FG001|Overall Study|Other reason|0|||
126188766|NCT00621244|453976361|FG000|Overall Study|Withdrawal by Subject|7|||
126188767|NCT00621244|453976362|FG001|Overall Study|Withdrawal by Subject|3|||
126188768|NCT00621244|453976363|FG002|Overall Study|Withdrawal by Subject|3|||
126188769|NCT00621244|453976364|FG003|Overall Study|Withdrawal by Subject|3|||
126188770|NCT00621244|453976361|FG000|Overall Study|Disease progression|44|||
126188771|NCT00621244|453976362|FG001|Overall Study|Disease progression|20|||
126188772|NCT00621244|453976363|FG002|Overall Study|Disease progression|20|||
126188773|NCT00621244|453976364|FG003|Overall Study|Disease progression|15|||
126188774|NCT00621244|453976361|FG000|Overall Study|Death|3|||
126188775|NCT00621244|453976362|FG001|Overall Study|Death|3|||
126188776|NCT00621244|453976363|FG002|Overall Study|Death|1|||
126188777|NCT00621244|453976364|FG003|Overall Study|Death|1|||
126188778|NCT00621244|453976361|FG000|Overall Study|Adverse Event|27|||
126188779|NCT00621244|453976362|FG001|Overall Study|Adverse Event|7|||
126188780|NCT00621244|453976363|FG002|Overall Study|Adverse Event|9|||
126188781|NCT00621244|453976364|FG003|Overall Study|Adverse Event|2|||
126188782|NCT00621244|453976361|FG000|Overall Study|Administrative problems|5|||
126188783|NCT00621244|453976362|FG001|Overall Study|Administrative problems|1|||
126188784|NCT00621244|453976363|FG002|Overall Study|Administrative problems|0|||
126188785|NCT00621244|453976364|FG003|Overall Study|Administrative problems|2|||
126188786|NCT04449276|453976370|FG000|Overall Study|Adverse Event|1|||
126188787|NCT04449276|453976371|FG001|Overall Study|Adverse Event|2|||
126188788|NCT04449276|453976372|FG002|Overall Study|Adverse Event|0|||
126188789|NCT04449276|453976373|FG003|Overall Study|Adverse Event|0|||
126188790|NCT04449276|453976374|FG004|Overall Study|Adverse Event|2|||
126188791|NCT04449276|453976375|FG005|Overall Study|Adverse Event|0|||
126188792|NCT04449276|453976376|FG006|Overall Study|Adverse Event|0|||
126188793|NCT04449276|453976377|FG007|Overall Study|Adverse Event|1|||
126188794|NCT04449276|453976370|FG000|Overall Study|Withdrawal by Subject|2|||
126188795|NCT04449276|453976371|FG001|Overall Study|Withdrawal by Subject|0|||
126188796|NCT04449276|453976372|FG002|Overall Study|Withdrawal by Subject|0|||
126188797|NCT04449276|453976373|FG003|Overall Study|Withdrawal by Subject|1|||
126188798|NCT04449276|453976374|FG004|Overall Study|Withdrawal by Subject|0|||
126188799|NCT04449276|453976375|FG005|Overall Study|Withdrawal by Subject|0|||
126188800|NCT04449276|453976376|FG006|Overall Study|Withdrawal by Subject|0|||
126188801|NCT04449276|453976377|FG007|Overall Study|Withdrawal by Subject|0|||
126188802|NCT04449276|453976370|FG000|Overall Study|Other|0|||
126188803|NCT04449276|453976371|FG001|Overall Study|Other|2|||
126188804|NCT04449276|453976372|FG002|Overall Study|Other|3|||
126188805|NCT04449276|453976373|FG003|Overall Study|Other|2|||
126188806|NCT04449276|453976374|FG004|Overall Study|Other|0|||
126188807|NCT04449276|453976375|FG005|Overall Study|Other|0|||
126188808|NCT04449276|453976376|FG006|Overall Study|Other|0|||
126188809|NCT04449276|453976377|FG007|Overall Study|Other|1|||
126188810|NCT01614795|453976378|FG000|Overall Study|Adverse Event|0|||
126188811|NCT01614795|453976379|FG001|Overall Study|Adverse Event|0|||
126188812|NCT01614795|453976380|FG002|Overall Study|Adverse Event|1|||
126188813|NCT01614795|453976381|FG003|Overall Study|Adverse Event|1|||
126188814|NCT01614795|453976378|FG000|Overall Study|Lack of Efficacy|10|||
126188815|NCT01614795|453976379|FG001|Overall Study|Lack of Efficacy|10|||
126188816|NCT01614795|453976380|FG002|Overall Study|Lack of Efficacy|9|||
126188817|NCT01614795|453976381|FG003|Overall Study|Lack of Efficacy|8|||
126188818|NCT01614795|453976378|FG000|Overall Study|Physician Decision|1|||
126188819|NCT01614795|453976379|FG001|Overall Study|Physician Decision|0|||
126188820|NCT01614795|453976380|FG002|Overall Study|Physician Decision|1|||
126188821|NCT01614795|453976381|FG003|Overall Study|Physician Decision|1|||
126188822|NCT01614795|453976378|FG000|Overall Study|Withdrawal by Subject|0|||
126188823|NCT01614795|453976379|FG001|Overall Study|Withdrawal by Subject|1|||
126188824|NCT01614795|453976380|FG002|Overall Study|Withdrawal by Subject|0|||
126188825|NCT01614795|453976381|FG003|Overall Study|Withdrawal by Subject|2|||
126188826|NCT01614795|453976378|FG000|Overall Study|Ineligible|0|||
126188827|NCT01614795|453976379|FG001|Overall Study|Ineligible|1|||
126188828|NCT01614795|453976380|FG002|Overall Study|Ineligible|0|||
126188829|NCT01614795|453976381|FG003|Overall Study|Ineligible|0|||
126188830|NCT00023712|453976382|FG000|Overall Study|Not platinum sensitive|1|||
126188831|NCT00023712|453976383|FG001|Overall Study|Not platinum sensitive|0|||
126188832|NCT00023712|453976382|FG000|Overall Study|Never treated|1|||
126188833|NCT00023712|453976383|FG001|Overall Study|Never treated|1|||
126188834|NCT00565812|453976386|FG000|Overall Study|Death|2|||
126188835|NCT00565812|453976387|FG001|Overall Study|Death|1|||
126188836|NCT00565812|453976388|FG002|Overall Study|Death|3|||
126188837|NCT00565812|453976386|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
126188838|NCT00565812|453976387|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
126188839|NCT00565812|453976388|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
126188840|NCT00565812|453976386|FG000|Overall Study|Lost to Follow-up|10|||
126188841|NCT00565812|453976387|FG001|Overall Study|Lost to Follow-up|8|||
126188842|NCT00565812|453976388|FG002|Overall Study|Lost to Follow-up|8|||
126188843|NCT00565812|453976386|FG000|Overall Study|Withdrawal by Subject|58|||
126188844|NCT00565812|453976387|FG001|Overall Study|Withdrawal by Subject|47|||
126188845|NCT00565812|453976388|FG002|Overall Study|Withdrawal by Subject|48|||
126188846|NCT00565812|453976386|FG000|Overall Study|Work Schedule|5|||
126188847|NCT00565812|453976387|FG001|Overall Study|Work Schedule|3|||
126188848|NCT00565812|453976388|FG002|Overall Study|Work Schedule|1|||
126188849|NCT00565812|453976386|FG000|Overall Study|Protocol Violation|2|||
126188850|NCT00565812|453976387|FG001|Overall Study|Protocol Violation|6|||
126188851|NCT00565812|453976388|FG002|Overall Study|Protocol Violation|4|||
126188852|NCT00565812|453976386|FG000|Overall Study|Adverse Event|41|||
126188853|NCT00565812|453976387|FG001|Overall Study|Adverse Event|54|||
126188854|NCT00565812|453976388|FG002|Overall Study|Adverse Event|40|||
126188855|NCT00565812|453976386|FG000|Overall Study|Jury Duty|1|||
126188856|NCT00565812|453976387|FG001|Overall Study|Jury Duty|0|||
126188857|NCT00565812|453976388|FG002|Overall Study|Jury Duty|0|||
126188858|NCT00565812|453976386|FG000|Overall Study|Relocated Out of Area|5|||
126188859|NCT00565812|453976387|FG001|Overall Study|Relocated Out of Area|8|||
126188860|NCT00565812|453976388|FG002|Overall Study|Relocated Out of Area|9|||
126188861|NCT00565812|453976386|FG000|Overall Study|Sponsor Decision|1|||
126188862|NCT00565812|453976387|FG001|Overall Study|Sponsor Decision|5|||
126188863|NCT00565812|453976388|FG002|Overall Study|Sponsor Decision|1|||
126188864|NCT00565812|453976386|FG000|Overall Study|Domestic Reasons|7|||
126188865|NCT00565812|453976387|FG001|Overall Study|Domestic Reasons|1|||
126188866|NCT00565812|453976388|FG002|Overall Study|Domestic Reasons|3|||
126188867|NCT00565812|453976386|FG000|Overall Study|Research Site Closure|6|||
126188868|NCT00565812|453976387|FG001|Overall Study|Research Site Closure|1|||
126188869|NCT00565812|453976388|FG002|Overall Study|Research Site Closure|8|||
126188870|NCT00565812|453976386|FG000|Overall Study|Surgical Intervention|0|||
126188871|NCT00565812|453976387|FG001|Overall Study|Surgical Intervention|1|||
126188872|NCT00565812|453976388|FG002|Overall Study|Surgical Intervention|2|||
126188873|NCT00565812|453976386|FG000|Overall Study|Low Compliance|1|||
126188874|NCT00565812|453976387|FG001|Overall Study|Low Compliance|0|||
126188875|NCT00565812|453976388|FG002|Overall Study|Low Compliance|1|||
126188876|NCT00565812|453976386|FG000|Overall Study|Follow-up Visit Not Completed|2|||
126188877|NCT00565812|453976387|FG001|Overall Study|Follow-up Visit Not Completed|0|||
126188878|NCT00565812|453976388|FG002|Overall Study|Follow-up Visit Not Completed|1|||
126188879|NCT00565812|453976386|FG000|Overall Study|Physician Decision|2|||
126188880|NCT00565812|453976387|FG001|Overall Study|Physician Decision|0|||
126188881|NCT00565812|453976388|FG002|Overall Study|Physician Decision|0|||
126188882|NCT04968353|453976389|FG000|Overall Study|Non-compliance|1|||
126188883|NCT04968353|453976390|FG001|Overall Study|Non-compliance|0|||
126188884|NCT04968353|453976391|FG002|Overall Study|Non-compliance|2|||
126188885|NCT04968353|453976392|FG003|Overall Study|Non-compliance|0|||
126188886|NCT00845845|453976393|FG000|Overall Study|Lost to Follow-up|0|||
126188887|NCT00845845|453976394|FG001|Overall Study|Lost to Follow-up|4|||
126188888|NCT02033850|453976400|FG000|Overall Study|Death|1|||
126188889|NCT02033850|453976401|FG001|Overall Study|Death|0|||
126188890|NCT02033850|453976400|FG000|Overall Study|unrelated medical reason|1|||
126188891|NCT02033850|453976401|FG001|Overall Study|unrelated medical reason|1|||
126188892|NCT02820038|453976402|FG000|Overall Study|Lost to Follow-up|7|||
126188893|NCT02820038|453976403|FG001|Overall Study|Lost to Follow-up|11|||
126188894|NCT02820038|453976404|FG002|Overall Study|Lost to Follow-up|2|||
126188895|NCT02820038|453976405|FG003|Overall Study|Lost to Follow-up|9|||
126188896|NCT02820038|453976402|FG000|Overall Study|Withdrawal by Subject|3|||
126188897|NCT02820038|453976403|FG001|Overall Study|Withdrawal by Subject|14|||
126188898|NCT02820038|453976404|FG002|Overall Study|Withdrawal by Subject|3|||
126188899|NCT02820038|453976405|FG003|Overall Study|Withdrawal by Subject|13|||
126188900|NCT03215667|453976406|FG000|Overall Study|Physician Decision|4|||
126188901|NCT01810380|453976409|FG000|Overall Study|Randomised not treated|2|||
126188902|NCT01810380|453976410|FG001|Overall Study|Randomised not treated|1|||
126188903|NCT01810380|453976411|FG002|Overall Study|Randomised not treated|1|||
126188904|NCT01810380|453976409|FG000|Overall Study|Adverse Event|11|||
126188905|NCT01810380|453976410|FG001|Overall Study|Adverse Event|14|||
126188906|NCT01810380|453976411|FG002|Overall Study|Adverse Event|4|||
126188907|NCT01810380|453976409|FG000|Overall Study|Lack of Efficacy|24|||
126188908|NCT01810380|453976410|FG001|Overall Study|Lack of Efficacy|10|||
126188909|NCT01810380|453976411|FG002|Overall Study|Lack of Efficacy|11|||
126188910|NCT01810380|453976409|FG000|Overall Study|Protocol Violation|1|||
126188911|NCT01810380|453976410|FG001|Overall Study|Protocol Violation|0|||
126188912|NCT01810380|453976411|FG002|Overall Study|Protocol Violation|1|||
126188913|NCT01810380|453976409|FG000|Overall Study|Withdrawal by Subject|6|||
126188914|NCT01810380|453976410|FG001|Overall Study|Withdrawal by Subject|0|||
126188915|NCT01810380|453976411|FG002|Overall Study|Withdrawal by Subject|6|||
126188916|NCT01810380|453976409|FG000|Overall Study|Administrative or other reasons|11|||
126188917|NCT01810380|453976410|FG001|Overall Study|Administrative or other reasons|13|||
126188918|NCT01810380|453976411|FG002|Overall Study|Administrative or other reasons|9|||
126188919|NCT00614991|453976412|FG000|Overall Study|Adverse Event|3|||
126188920|NCT00614991|453976413|FG001|Overall Study|Adverse Event|3|||
126188921|NCT00614991|453976414|FG002|Overall Study|Adverse Event|0|||
126188922|NCT00614991|453976415|FG003|Overall Study|Adverse Event|0|||
126188923|NCT00614991|453976416|FG004|Overall Study|Adverse Event|1|||
126188924|NCT00614991|453976417|FG005|Overall Study|Adverse Event|0|||
126188925|NCT03148795|453976418|FG000|Overall Study|Progressive Disease|1|||
126188926|NCT03209362|453976423|FG000|Overall Study|Adverse Event|0|||
126188927|NCT03209362|453976424|FG001|Overall Study|Adverse Event|1|||
126188928|NCT03209362|453976423|FG000|Overall Study|Lost to Follow-up|0|||
126188929|NCT03209362|453976424|FG001|Overall Study|Lost to Follow-up|1|||
126188930|NCT03209362|453976423|FG000|Overall Study|Withdrawal by Subject|2|||
126188931|NCT03209362|453976424|FG001|Overall Study|Withdrawal by Subject|0|||
126188932|NCT03209362|453976423|FG000|Overall Study|Other|0|||
126188933|NCT03209362|453976424|FG001|Overall Study|Other|1|||
126188934|NCT00251589|453976429|FG000|Overall Study|Adverse Event|5|||
126188935|NCT00251589|453976430|FG001|Overall Study|Adverse Event|1|||
126188936|NCT00251589|453976431|FG002|Overall Study|Adverse Event|2|||
126188937|NCT00251589|453976432|FG003|Overall Study|Adverse Event|1|||
126188938|NCT00251589|453976429|FG000|Overall Study|Withdrawal by Subject|1|||
126188939|NCT00251589|453976430|FG001|Overall Study|Withdrawal by Subject|1|||
126188940|NCT00251589|453976431|FG002|Overall Study|Withdrawal by Subject|0|||
126188941|NCT00251589|453976432|FG003|Overall Study|Withdrawal by Subject|0|||
126188942|NCT00251589|453976429|FG000|Overall Study|Discontinued due to progressive disease|9|||
126188943|NCT00251589|453976430|FG001|Overall Study|Discontinued due to progressive disease|1|||
126188944|NCT00251589|453976431|FG002|Overall Study|Discontinued due to progressive disease|0|||
126188945|NCT00251589|453976432|FG003|Overall Study|Discontinued due to progressive disease|1|||
126188946|NCT02571972|453976435|FG000|Overall Study|Protocol Violation|2|||
126188947|NCT02571972|453976435|FG000|Overall Study|Withdrawal by Subject|2|||
126188948|NCT03039192|453976436|FG000|Overall Study|Lost to Follow-up|4|||
126188949|NCT03039192|453976437|FG001|Overall Study|Lost to Follow-up|4|||
126188950|NCT03039192|453976436|FG000|Overall Study|Adverse event, serious fatal|0|||
126188951|NCT03039192|453976437|FG001|Overall Study|Adverse event, serious fatal|1|||
126188952|NCT03039192|453976436|FG000|Overall Study|Adverse event, non-fatal|0|||
126188953|NCT03039192|453976437|FG001|Overall Study|Adverse event, non-fatal|2|||
126188954|NCT03039192|453976436|FG000|Overall Study|Withdrawal by Subject|6|||
126188955|NCT03039192|453976437|FG001|Overall Study|Withdrawal by Subject|9|||
126188956|NCT03039192|453976436|FG000|Overall Study|Discontinued from treatment phase|19|||
126188957|NCT03039192|453976437|FG001|Overall Study|Discontinued from treatment phase|12|||
126188958|NCT03039192|453976436|FG000|Overall Study|Other|3|||
126188959|NCT03039192|453976437|FG001|Overall Study|Other|2|||
126188960|NCT02493868|453976438|FG000|Induction Phase: DE Participants|Adverse Event|22|||
126188961|NCT02493868|453976439|FG001|Induction Phase: DE Participants|Adverse Event|0|||
126188962|NCT02493868|453976438|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
126188963|NCT02493868|453976439|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
126188964|NCT02493868|453976438|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
126188965|NCT02493868|453976439|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
126188966|NCT02493868|453976438|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
126188967|NCT02493868|453976439|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
126188968|NCT02493868|453976438|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
126188969|NCT02493868|453976439|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
126188970|NCT02493868|453976438|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
126188971|NCT02493868|453976439|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
126188972|NCT02493868|453976438|FG000|Induction Phase: DE Participants|Other|8|||
126188973|NCT02493868|453976439|FG001|Induction Phase: DE Participants|Other|0|||
126188974|NCT02493868|453976438|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
126188975|NCT02493868|453976439|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
126188976|NCT02493868|453976438|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
126188977|NCT02493868|453976439|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
126188978|NCT02493868|453976438|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
126188979|NCT02493868|453976439|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
126188980|NCT02493868|453976438|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
126188981|NCT02493868|453976439|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
126188982|NCT02493868|453976438|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
126188983|NCT02493868|453976439|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
126188984|NCT02493868|453976438|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
126188985|NCT02493868|453976439|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
126188986|NCT02493868|453976438|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
126188987|NCT02493868|453976439|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
126188988|NCT02493868|453976438|FG000|Optimization Phase: DE+TE Participants|Other|10|||
126188989|NCT02493868|453976439|FG001|Optimization Phase: DE+TE Participants|Other|2|||
126188990|NCT02493868|453976438|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
126188991|NCT02493868|453976439|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
126188992|NCT02493868|453976438|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
126188993|NCT02493868|453976439|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
126188994|NCT02493868|453976438|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
126188995|NCT02493868|453976439|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
126188996|NCT02493868|453976438|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
126188997|NCT02493868|453976439|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
126188998|NCT02493868|453976438|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
126188999|NCT02493868|453976439|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
126189000|NCT02493868|453976438|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
126189001|NCT02493868|453976439|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
126189002|NCT02493868|453976438|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
126189003|NCT02493868|453976439|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
126189004|NCT02493868|453976438|FG000|Follow-up Phase|Lost to Follow-up|1|||
126189005|NCT02493868|453976439|FG001|Follow-up Phase|Lost to Follow-up|0|||
126189006|NCT02493868|453976438|FG000|Follow-up Phase|Withdrawal by Subject|3|||
126189007|NCT02493868|453976439|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126189008|NCT02493868|453976438|FG000|Follow-up Phase|Investigator Decision|5|||
126189009|NCT02493868|453976439|FG001|Follow-up Phase|Investigator Decision|1|||
126189010|NCT02493868|453976438|FG000|Follow-up Phase|Other|2|||
126189011|NCT02493868|453976439|FG001|Follow-up Phase|Other|1|||
126189012|NCT02407236|453976440|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
126189013|NCT02407236|453976441|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
126189014|NCT02407236|453976442|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
126189015|NCT02407236|453976443|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
126189016|NCT02407236|453976444|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
126189017|NCT02407236|453976445|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
126189018|NCT02407236|453976446|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
126189019|NCT02407236|453976447|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
126189020|NCT02407236|453976448|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
126189021|NCT02407236|453976449|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
126189022|NCT02407236|453976450|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
126189023|NCT02407236|453976451|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
126189024|NCT02407236|453976452|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
126189025|NCT02407236|453976440|FG000|Induction Study (8 Weeks)|Death|0|||
126189026|NCT02407236|453976441|FG001|Induction Study (8 Weeks)|Death|0|||
126189027|NCT02407236|453976442|FG002|Induction Study (8 Weeks)|Death|1|||
126189028|NCT02407236|453976443|FG003|Induction Study (8 Weeks)|Death|0|||
126189029|NCT02407236|453976444|FG004|Induction Study (8 Weeks)|Death|0|||
126189030|NCT02407236|453976445|FG005|Induction Study (8 Weeks)|Death|0|||
126189031|NCT02407236|453976446|FG006|Induction Study (8 Weeks)|Death|0|||
126189032|NCT02407236|453976447|FG007|Induction Study (8 Weeks)|Death|0|||
126189033|NCT02407236|453976448|FG008|Induction Study (8 Weeks)|Death|0|||
126189034|NCT02407236|453976449|FG009|Induction Study (8 Weeks)|Death|0|||
126189035|NCT02407236|453976450|FG010|Induction Study (8 Weeks)|Death|0|||
126189036|NCT02407236|453976451|FG011|Induction Study (8 Weeks)|Death|0|||
126189037|NCT02407236|453976452|FG012|Induction Study (8 Weeks)|Death|0|||
126189038|NCT02407236|453976440|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
126189039|NCT02407236|453976441|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
126189040|NCT02407236|453976442|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
126189041|NCT02407236|453976443|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189042|NCT02407236|453976444|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189043|NCT02407236|453976445|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189044|NCT02407236|453976446|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189045|NCT02407236|453976447|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189046|NCT02407236|453976448|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189047|NCT02407236|453976449|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189048|NCT02407236|453976450|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189049|NCT02407236|453976451|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189050|NCT02407236|453976452|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126189051|NCT02407236|453976440|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189052|NCT02407236|453976441|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189053|NCT02407236|453976442|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
126189054|NCT02407236|453976443|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189055|NCT02407236|453976444|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189056|NCT02407236|453976445|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189057|NCT02407236|453976446|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189058|NCT02407236|453976447|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189059|NCT02407236|453976448|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189060|NCT02407236|453976449|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189061|NCT02407236|453976450|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126199939|NCT01117428|454017806|FG002|Overall Study|Adverse Event|0|||
126189062|NCT02407236|453976451|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189063|NCT02407236|453976452|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126189064|NCT02407236|453976440|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
126189065|NCT02407236|453976441|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
126189066|NCT02407236|453976442|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
126189067|NCT02407236|453976443|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
126189068|NCT02407236|453976444|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
126189069|NCT02407236|453976445|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
126189070|NCT02407236|453976446|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
126189071|NCT02407236|453976447|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
126189072|NCT02407236|453976448|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
126189073|NCT02407236|453976449|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
126189074|NCT02407236|453976450|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
126189075|NCT02407236|453976451|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
126189076|NCT02407236|453976452|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
126189077|NCT02407236|453976440|FG000|Induction Study (8 Weeks)|Other|2|||
126189078|NCT02407236|453976441|FG001|Induction Study (8 Weeks)|Other|1|||
126189079|NCT02407236|453976442|FG002|Induction Study (8 Weeks)|Other|5|||
126189080|NCT02407236|453976443|FG003|Induction Study (8 Weeks)|Other|0|||
126189081|NCT02407236|453976444|FG004|Induction Study (8 Weeks)|Other|0|||
126189082|NCT02407236|453976445|FG005|Induction Study (8 Weeks)|Other|0|||
126189083|NCT02407236|453976446|FG006|Induction Study (8 Weeks)|Other|0|||
126189084|NCT02407236|453976447|FG007|Induction Study (8 Weeks)|Other|0|||
126189085|NCT02407236|453976448|FG008|Induction Study (8 Weeks)|Other|0|||
126189086|NCT02407236|453976449|FG009|Induction Study (8 Weeks)|Other|0|||
126189087|NCT02407236|453976450|FG010|Induction Study (8 Weeks)|Other|0|||
126189088|NCT02407236|453976451|FG011|Induction Study (8 Weeks)|Other|0|||
126189089|NCT02407236|453976452|FG012|Induction Study (8 Weeks)|Other|0|||
126189090|NCT02407236|453976440|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
126189091|NCT02407236|453976441|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
126189092|NCT02407236|453976442|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
126189093|NCT02407236|453976443|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
126189094|NCT02407236|453976444|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
126189095|NCT02407236|453976445|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
126189096|NCT02407236|453976446|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
126189097|NCT02407236|453976447|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
126189098|NCT02407236|453976448|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
126189099|NCT02407236|453976449|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
126189100|NCT02407236|453976450|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
126189101|NCT02407236|453976451|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
126189102|NCT02407236|453976452|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
126189103|NCT02407236|453976440|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126189104|NCT02407236|453976441|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126189105|NCT02407236|453976442|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126189106|NCT02407236|453976443|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
126189107|NCT02407236|453976444|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
126189108|NCT02407236|453976445|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
126189109|NCT02407236|453976446|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
126189110|NCT02407236|453976447|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
126189111|NCT02407236|453976448|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126189112|NCT02407236|453976449|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126189113|NCT02407236|453976450|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126189114|NCT02407236|453976451|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126189115|NCT02407236|453976452|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126189116|NCT02407236|453976440|FG000|Maintenance Study (44 Weeks)|Other|0|||
126189117|NCT02407236|453976441|FG001|Maintenance Study (44 Weeks)|Other|0|||
126189118|NCT02407236|453976442|FG002|Maintenance Study (44 Weeks)|Other|0|||
126189119|NCT02407236|453976443|FG003|Maintenance Study (44 Weeks)|Other|5|||
126189120|NCT02407236|453976444|FG004|Maintenance Study (44 Weeks)|Other|7|||
126189121|NCT02407236|453976445|FG005|Maintenance Study (44 Weeks)|Other|8|||
126189122|NCT02407236|453976446|FG006|Maintenance Study (44 Weeks)|Other|4|||
126189123|NCT02407236|453976447|FG007|Maintenance Study (44 Weeks)|Other|6|||
126189124|NCT02407236|453976448|FG008|Maintenance Study (44 Weeks)|Other|0|||
126189125|NCT02407236|453976449|FG009|Maintenance Study (44 Weeks)|Other|0|||
126189126|NCT02407236|453976450|FG010|Maintenance Study (44 Weeks)|Other|0|||
126189127|NCT02407236|453976451|FG011|Maintenance Study (44 Weeks)|Other|0|||
126189128|NCT02407236|453976452|FG012|Maintenance Study (44 Weeks)|Other|0|||
126189129|NCT02407236|453976440|FG000|Maintenance Study (44 Weeks)|Death|0|||
126189130|NCT02407236|453976441|FG001|Maintenance Study (44 Weeks)|Death|0|||
126189131|NCT02407236|453976442|FG002|Maintenance Study (44 Weeks)|Death|0|||
126189132|NCT02407236|453976443|FG003|Maintenance Study (44 Weeks)|Death|0|||
126189133|NCT02407236|453976444|FG004|Maintenance Study (44 Weeks)|Death|0|||
126189134|NCT02407236|453976445|FG005|Maintenance Study (44 Weeks)|Death|0|||
126189135|NCT02407236|453976446|FG006|Maintenance Study (44 Weeks)|Death|0|||
126189136|NCT02407236|453976447|FG007|Maintenance Study (44 Weeks)|Death|1|||
126189137|NCT02407236|453976448|FG008|Maintenance Study (44 Weeks)|Death|0|||
126189138|NCT02407236|453976449|FG009|Maintenance Study (44 Weeks)|Death|0|||
126189139|NCT02407236|453976450|FG010|Maintenance Study (44 Weeks)|Death|0|||
126189140|NCT02407236|453976451|FG011|Maintenance Study (44 Weeks)|Death|0|||
126189141|NCT02407236|453976452|FG012|Maintenance Study (44 Weeks)|Death|0|||
126189142|NCT02407236|453976440|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126189143|NCT02407236|453976441|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126189144|NCT02407236|453976442|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126189145|NCT02407236|453976443|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126189146|NCT02407236|453976444|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126189147|NCT02407236|453976445|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126189148|NCT02407236|453976446|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126189149|NCT02407236|453976447|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126189150|NCT02407236|453976448|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
126189151|NCT02407236|453976449|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
126189152|NCT02407236|453976450|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
126189153|NCT02407236|453976451|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
126189154|NCT02407236|453976452|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
126189155|NCT02407236|453976440|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189156|NCT02407236|453976441|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189157|NCT02407236|453976442|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189158|NCT02407236|453976443|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189159|NCT02407236|453976444|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189160|NCT02407236|453976445|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189161|NCT02407236|453976446|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189162|NCT02407236|453976447|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189163|NCT02407236|453976448|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189164|NCT02407236|453976449|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189165|NCT02407236|453976450|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
126189166|NCT02407236|453976451|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189167|NCT02407236|453976452|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126189168|NCT02407236|453976440|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126189169|NCT02407236|453976441|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126189170|NCT02407236|453976442|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126189171|NCT02407236|453976443|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126189172|NCT02407236|453976444|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126189173|NCT02407236|453976445|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126189174|NCT02407236|453976446|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126189175|NCT02407236|453976447|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126189176|NCT02407236|453976448|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
126189177|NCT02407236|453976449|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
126189178|NCT02407236|453976450|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
126189179|NCT02407236|453976451|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
126189180|NCT02407236|453976452|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
126189181|NCT02407236|453976440|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
126189182|NCT02407236|453976441|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
126189183|NCT02407236|453976442|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
126189184|NCT02407236|453976443|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
126189185|NCT02407236|453976444|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
126189186|NCT02407236|453976445|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
126189187|NCT02407236|453976446|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
126189188|NCT02407236|453976447|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
126189189|NCT02407236|453976448|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
126189190|NCT02407236|453976449|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
126189191|NCT02407236|453976450|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
126189192|NCT02407236|453976451|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
126189193|NCT02407236|453976452|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
126189194|NCT03074318|453976453|FG000|Overall Study|Adverse Event|0|||
126189195|NCT03074318|453976454|FG001|Overall Study|Adverse Event|1|||
126189196|NCT03074318|453976455|FG002|Overall Study|Adverse Event|1|||
126189197|NCT03074318|453976456|FG003|Overall Study|Adverse Event|1|||
126189198|NCT03074318|453976453|FG000|Overall Study|Death|1|||
126189199|NCT03074318|453976454|FG001|Overall Study|Death|0|||
126189200|NCT03074318|453976455|FG002|Overall Study|Death|0|||
126189201|NCT03074318|453976456|FG003|Overall Study|Death|0|||
126189202|NCT03074318|453976453|FG000|Overall Study|Withdrawal by Subject|1|||
126189203|NCT03074318|453976454|FG001|Overall Study|Withdrawal by Subject|2|||
126189204|NCT03074318|453976455|FG002|Overall Study|Withdrawal by Subject|2|||
126189205|NCT03074318|453976456|FG003|Overall Study|Withdrawal by Subject|4|||
126189206|NCT03074318|453976453|FG000|Overall Study|Trial Closure|2|||
126189207|NCT03074318|453976454|FG001|Overall Study|Trial Closure|2|||
126189208|NCT03074318|453976455|FG002|Overall Study|Trial Closure|3|||
126189209|NCT03074318|453976456|FG003|Overall Study|Trial Closure|11|||
126189210|NCT00643448|453976459|FG000|Overall Study|Lack of Efficacy|2|||
126189211|NCT00643448|453976460|FG001|Overall Study|Lack of Efficacy|0|||
126189212|NCT00643448|453976461|FG002|Overall Study|Lack of Efficacy|4|||
126189213|NCT00643448|453976459|FG000|Overall Study|Adverse Event|2|||
126189214|NCT00643448|453976460|FG001|Overall Study|Adverse Event|2|||
126189215|NCT00643448|453976461|FG002|Overall Study|Adverse Event|2|||
126189216|NCT00643448|453976459|FG000|Overall Study|QTcF>550 ms|0|||
126189217|NCT00643448|453976460|FG001|Overall Study|QTcF>550 ms|3|||
126189218|NCT00643448|453976461|FG002|Overall Study|QTcF>550 ms|0|||
126189219|NCT02177812|453976463|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126189220|NCT02177812|453976464|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126189221|NCT02177812|453976465|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126189222|NCT02177812|453976466|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126189223|NCT02177812|453976467|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126189224|NCT02177812|453976468|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
126189225|NCT02177812|453976469|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
126189226|NCT02177812|453976470|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
126189227|NCT02177812|453976471|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126189228|NCT02177812|453976463|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126189229|NCT02177812|453976464|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126189230|NCT02177812|453976465|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126189231|NCT02177812|453976466|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126189232|NCT02177812|453976467|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126189233|NCT02177812|453976468|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
126189234|NCT02177812|453976469|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
126189235|NCT02177812|453976470|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126189236|NCT02177812|453976471|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126189237|NCT02177812|453976463|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
126189238|NCT02177812|453976464|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
126189239|NCT02177812|453976465|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
126189240|NCT02177812|453976466|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
126189241|NCT02177812|453976467|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
126189242|NCT02177812|453976468|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
126189243|NCT02177812|453976469|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
126189244|NCT02177812|453976470|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
126189245|NCT02177812|453976471|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
126189246|NCT00089999|453976472|FG000|Overall Study|Adverse Event|4|||
126189247|NCT00089999|453976473|FG001|Overall Study|Adverse Event|7|||
126189248|NCT00089999|453976472|FG000|Overall Study|Withdrawal by Subject|0|||
126189249|NCT00089999|453976473|FG001|Overall Study|Withdrawal by Subject|4|||
126189250|NCT00089999|453976472|FG000|Overall Study|Lost to Follow-up|2|||
126189251|NCT00089999|453976473|FG001|Overall Study|Lost to Follow-up|1|||
126189252|NCT00089999|453976472|FG000|Overall Study|Radiological Progression of Cancer|52|||
126189253|NCT00089999|453976473|FG001|Overall Study|Radiological Progression of Cancer|44|||
126189254|NCT00089999|453976472|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
126189255|NCT00089999|453976473|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
126189256|NCT00089999|453976472|FG000|Overall Study|Death|3|||
126189257|NCT00089999|453976473|FG001|Overall Study|Death|3|||
126189258|NCT00089999|453976472|FG000|Overall Study|Poor General Condition|1|||
126189259|NCT00089999|453976473|FG001|Overall Study|Poor General Condition|0|||
126189260|NCT00089999|453976472|FG000|Overall Study|Clinical Progression|1|||
126189261|NCT00089999|453976473|FG001|Overall Study|Clinical Progression|2|||
126189262|NCT00089999|453976472|FG000|Overall Study|Physician Decision|2|||
126189263|NCT00089999|453976473|FG001|Overall Study|Physician Decision|2|||
126189264|NCT00089999|453976472|FG000|Overall Study|Patient Underwent Surgery|2|||
126189265|NCT00089999|453976473|FG001|Overall Study|Patient Underwent Surgery|0|||
126189266|NCT00089999|453976472|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
126189267|NCT00089999|453976473|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
126189268|NCT01167153|453976474|FG000|Overall Study|Non-effective therapy|1|||
126189269|NCT01167153|453976475|FG001|Overall Study|Non-effective therapy|4|||
126189270|NCT01167153|453976474|FG000|Overall Study|AE including clinical laboratory AE|2|||
126189271|NCT01167153|453976475|FG001|Overall Study|AE including clinical laboratory AE|8|||
126189272|NCT01167153|453976474|FG000|Overall Study|Hypotension|1|||
126189273|NCT01167153|453976475|FG001|Overall Study|Hypotension|0|||
126189274|NCT01167153|453976474|FG000|Overall Study|Lost to Follow-up|7|||
126189275|NCT01167153|453976475|FG001|Overall Study|Lost to Follow-up|9|||
126189276|NCT01167153|453976474|FG000|Overall Study|Non-compliance to concomitant medication|0|||
126189277|NCT01167153|453976475|FG001|Overall Study|Non-compliance to concomitant medication|2|||
126189278|NCT01167153|453976474|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
126189279|NCT01167153|453976475|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
126189280|NCT01167153|453976474|FG000|Overall Study|Withdrawal consent|1|||
126189281|NCT01167153|453976475|FG001|Overall Study|Withdrawal consent|1|||
126189282|NCT01167153|453976474|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
126189283|NCT01167153|453976475|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
126189284|NCT00464620|453977932|FG000|Overall Study|Physician Decision|1|||
126189285|NCT00464620|453977933|FG001|Overall Study|Physician Decision|0|||
126189286|NCT00464620|453977934|FG002|Overall Study|Physician Decision|0|||
126189287|NCT00464620|453977932|FG000|Overall Study|Withdrawal by Subject|1|||
126189288|NCT00464620|453977933|FG001|Overall Study|Withdrawal by Subject|0|||
126189289|NCT00464620|453977934|FG002|Overall Study|Withdrawal by Subject|3|||
126189290|NCT00464620|453977932|FG000|Overall Study|Ineligible sarcoma subtype|0|||
126189291|NCT00464620|453977933|FG001|Overall Study|Ineligible sarcoma subtype|2|||
126189292|NCT00464620|453977934|FG002|Overall Study|Ineligible sarcoma subtype|2|||
126189293|NCT00464620|453977932|FG000|Overall Study|Use of prohibited concomitant medication|0|||
126189294|NCT00464620|453977933|FG001|Overall Study|Use of prohibited concomitant medication|0|||
126189295|NCT00464620|453977934|FG002|Overall Study|Use of prohibited concomitant medication|2|||
126189296|NCT04984876|453977935|FG000|Overall Study|Subject decision|2|||
126189297|NCT04984876|453977936|FG001|Overall Study|Subject decision|10|||
126189298|NCT04984876|453977937|FG002|Overall Study|Subject decision|3|||
126189299|NCT04984876|453977938|FG003|Overall Study|Subject decision|3|||
126189300|NCT04984876|453977939|FG004|Overall Study|Subject decision|3|||
126189301|NCT04984876|453977940|FG005|Overall Study|Subject decision|0|||
126189302|NCT04984876|453977935|FG000|Overall Study|Guardian decision|0|||
126189303|NCT04984876|453977936|FG001|Overall Study|Guardian decision|1|||
126189304|NCT04984876|453977937|FG002|Overall Study|Guardian decision|0|||
126189305|NCT04984876|453977938|FG003|Overall Study|Guardian decision|2|||
126189306|NCT04984876|453977939|FG004|Overall Study|Guardian decision|0|||
126189307|NCT04984876|453977940|FG005|Overall Study|Guardian decision|1|||
126189308|NCT04984876|453977935|FG000|Overall Study|Lost to Follow-up|0|||
126189309|NCT04984876|453977936|FG001|Overall Study|Lost to Follow-up|0|||
126189310|NCT04984876|453977937|FG002|Overall Study|Lost to Follow-up|1|||
126189311|NCT04984876|453977938|FG003|Overall Study|Lost to Follow-up|1|||
126189312|NCT04984876|453977939|FG004|Overall Study|Lost to Follow-up|0|||
126189313|NCT04984876|453977940|FG005|Overall Study|Lost to Follow-up|0|||
126189314|NCT04984876|453977935|FG000|Overall Study|Physician Decision|1|||
126189315|NCT04984876|453977936|FG001|Overall Study|Physician Decision|0|||
126189316|NCT04984876|453977937|FG002|Overall Study|Physician Decision|0|||
126189317|NCT04984876|453977938|FG003|Overall Study|Physician Decision|1|||
126189318|NCT04984876|453977939|FG004|Overall Study|Physician Decision|0|||
126189319|NCT04984876|453977940|FG005|Overall Study|Physician Decision|0|||
126189320|NCT04984876|453977935|FG000|Overall Study|Adverse Event|0|||
126189321|NCT04984876|453977936|FG001|Overall Study|Adverse Event|0|||
126189322|NCT04984876|453977937|FG002|Overall Study|Adverse Event|1|||
126189323|NCT04984876|453977938|FG003|Overall Study|Adverse Event|0|||
126189324|NCT04984876|453977939|FG004|Overall Study|Adverse Event|0|||
126189325|NCT04984876|453977940|FG005|Overall Study|Adverse Event|0|||
126189326|NCT00209092|453977943|FG000|Overall Study|Progression of disease|7|||
126189327|NCT00209092|453977944|FG001|Overall Study|Progression of disease|1|||
126189328|NCT00209092|453977943|FG000|Overall Study|Adverse Event|0|||
126189329|NCT00209092|453977944|FG001|Overall Study|Adverse Event|1|||
126189330|NCT00209092|453977943|FG000|Overall Study|Withdrawal by Subject|1|||
126189331|NCT00209092|453977944|FG001|Overall Study|Withdrawal by Subject|0|||
126189332|NCT01462045|453977947|FG000|Overall Study|Family matter|0|||
126189333|NCT01462045|453977948|FG001|Overall Study|Family matter|1|||
126189334|NCT01462045|453977949|FG002|Overall Study|Family matter|0|||
126189335|NCT02828644|453977952|FG000|Overall Study|Lost to Follow-up|23|||
126189336|NCT02828644|453977953|FG001|Overall Study|Lost to Follow-up|22|||
126189337|NCT02436915|453977954|FG000|Overall Study|Withdrawal by Subject|0|||
126189338|NCT02436915|453977955|FG001|Overall Study|Withdrawal by Subject|1|||
126189339|NCT01117181|453977962|FG000|Overall Study|Lost to Follow-up|1|||
126189340|NCT01117181|453977963|FG001|Overall Study|Lost to Follow-up|0|||
126189341|NCT01117181|453977962|FG000|Overall Study|Withdrawal by Subject|0|||
126189342|NCT01117181|453977963|FG001|Overall Study|Withdrawal by Subject|2|||
126189343|NCT02158728|453977964|FG000|Overall Study|no procedure according to CIP done|3|||
126189344|NCT02158728|453977964|FG000|Overall Study|no qualified dataset|24|||
126189345|NCT01518309|453977965|FG000|Overall Study|Adverse Event|6|||
126189346|NCT01518309|453977965|FG000|Overall Study|Death|6|||
126189347|NCT01518309|453977965|FG000|Overall Study|Lack of Efficacy|7|||
126189348|NCT01518309|453977965|FG000|Overall Study|Withdrawal by Subject|6|||
126189349|NCT01518309|453977965|FG000|Overall Study|Physician Decision|3|||
126189350|NCT01518309|453977965|FG000|Overall Study|Sponsor Decision|2|||
126189351|NCT01518309|453977965|FG000|Overall Study|Not in Predefined Categories|9|||
126189352|NCT02579863|453977966|FG000|Overall Study|Final Disposition Unknown|2|||
126189353|NCT02579863|453977967|FG001|Overall Study|Final Disposition Unknown|1|||
126189354|NCT02579863|453977966|FG000|Overall Study|Adverse Event|18|||
126189355|NCT02579863|453977967|FG001|Overall Study|Adverse Event|11|||
126189356|NCT02579863|453977966|FG000|Overall Study|Death|31|||
126189357|NCT02579863|453977967|FG001|Overall Study|Death|29|||
126189358|NCT02579863|453977966|FG000|Overall Study|Lost to Follow-up|2|||
126189359|NCT02579863|453977967|FG001|Overall Study|Lost to Follow-up|1|||
126189360|NCT02579863|453977966|FG000|Overall Study|Physician Decision|1|||
126189361|NCT02579863|453977967|FG001|Overall Study|Physician Decision|2|||
126189362|NCT02579863|453977966|FG000|Overall Study|Screen Failure|0|||
126189363|NCT02579863|453977967|FG001|Overall Study|Screen Failure|2|||
126189364|NCT02579863|453977966|FG000|Overall Study|Study Terminated at Selected Sites|82|||
126189365|NCT02579863|453977967|FG001|Overall Study|Study Terminated at Selected Sites|88|||
126189366|NCT02579863|453977966|FG000|Overall Study|Withdrawal by Subject|20|||
126189367|NCT02579863|453977967|FG001|Overall Study|Withdrawal by Subject|20|||
126189368|NCT03878160|453977973|FG000|Overall Study|Lost to Follow-up|1|||
126189369|NCT03878160|453977974|FG001|Overall Study|Lost to Follow-up|1|||
126189370|NCT03878160|453977975|FG002|Overall Study|Lost to Follow-up|1|||
126189371|NCT03878160|453977973|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
126189372|NCT03878160|453977974|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
126189373|NCT03878160|453977975|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
126189374|NCT00038142|453977978|FG000|Overall Study|Ineligible|1|||
126189375|NCT00038142|453977979|FG001|Overall Study|Ineligible|0|||
126189376|NCT00038142|453977978|FG000|Overall Study|Progressive Disease|11|||
126189377|NCT00038142|453977979|FG001|Overall Study|Progressive Disease|7|||
126189378|NCT00038142|453977978|FG000|Overall Study|Death|1|||
126189379|NCT00038142|453977979|FG001|Overall Study|Death|0|||
126189380|NCT00038142|453977978|FG000|Overall Study|Adverse Event|1|||
126189381|NCT00038142|453977979|FG001|Overall Study|Adverse Event|0|||
126189382|NCT00038142|453977978|FG000|Overall Study|Unknown Reason|8|||
126189383|NCT00038142|453977979|FG001|Overall Study|Unknown Reason|0|||
126189384|NCT00809614|453977986|FG000|Overall Study|Lack of Efficacy|2|||
126189385|NCT00809614|453977987|FG001|Overall Study|Lack of Efficacy|3|||
126189386|NCT00809614|453977986|FG000|Overall Study|Withdrawal by Subject|1|||
126189387|NCT00809614|453977987|FG001|Overall Study|Withdrawal by Subject|1|||
126189388|NCT01080625|453977988|FG000|Overall Study|Physician Decision|0|||
126189389|NCT01080625|453977989|FG001|Overall Study|Physician Decision|2|||
126189390|NCT01080625|453977990|FG002|Overall Study|Physician Decision|1|||
126189391|NCT00364832|453977994|FG000|Core Period|Early Withdrawals|2|||
126189392|NCT00364832|453977995|FG001|Core Period|Early Withdrawals|2|||
126189393|NCT00364832|453977996|FG002|Core Period|Early Withdrawals|1|||
126189394|NCT00364832|453977997|FG003|Core Period|Early Withdrawals|1|||
126189395|NCT00364832|453977998|FG004|Core Period|Early Withdrawals|0|||
126189396|NCT00364832|453977999|FG005|Core Period|Early Withdrawals|0|||
126189397|NCT00364832|453978000|FG006|Core Period|Early Withdrawals|4|||
126189398|NCT00364832|453978001|FG007|Core Period|Early Withdrawals|1|||
126189399|NCT00364832|453978002|FG008|Core Period|Early Withdrawals|0|||
126189400|NCT00364832|453978003|FG009|Core Period|Early Withdrawals|0|||
126189401|NCT00364832|453978004|FG010|Core Period|Early Withdrawals|0|||
126189402|NCT00364832|453978005|FG011|Core Period|Early Withdrawals|0|||
126189403|NCT00364832|453977994|FG000|Extension Year 1|Early Withdrawals|0|||
126189404|NCT00364832|453977995|FG001|Extension Year 1|Early Withdrawals|0|||
126189405|NCT00364832|453977996|FG002|Extension Year 1|Early Withdrawals|0|||
126189406|NCT00364832|453977997|FG003|Extension Year 1|Early Withdrawals|0|||
126189407|NCT00364832|453977998|FG004|Extension Year 1|Early Withdrawals|0|||
126189408|NCT00364832|453977999|FG005|Extension Year 1|Early Withdrawals|0|||
126189409|NCT00364832|453978000|FG006|Extension Year 1|Early Withdrawals|0|||
126189410|NCT00364832|453978001|FG007|Extension Year 1|Early Withdrawals|0|||
126189411|NCT00364832|453978002|FG008|Extension Year 1|Early Withdrawals|0|||
126189412|NCT00364832|453978003|FG009|Extension Year 1|Early Withdrawals|4|||
126189413|NCT00364832|453978004|FG010|Extension Year 1|Early Withdrawals|2|||
126189414|NCT00364832|453978005|FG011|Extension Year 1|Early Withdrawals|10|||
126189415|NCT00364832|453977994|FG000|Extension Year 2|Early Withdrawals|0|||
126189416|NCT00364832|453977995|FG001|Extension Year 2|Early Withdrawals|0|||
126189417|NCT00364832|453977996|FG002|Extension Year 2|Early Withdrawals|0|||
126189418|NCT00364832|453977997|FG003|Extension Year 2|Early Withdrawals|0|||
126189419|NCT00364832|453977998|FG004|Extension Year 2|Early Withdrawals|0|||
126189420|NCT00364832|453977999|FG005|Extension Year 2|Early Withdrawals|0|||
126189421|NCT00364832|453978000|FG006|Extension Year 2|Early Withdrawals|0|||
126189422|NCT00364832|453978001|FG007|Extension Year 2|Early Withdrawals|0|||
126189423|NCT00364832|453978002|FG008|Extension Year 2|Early Withdrawals|0|||
126189424|NCT00364832|453978003|FG009|Extension Year 2|Early Withdrawals|5|||
126189425|NCT00364832|453978004|FG010|Extension Year 2|Early Withdrawals|5|||
126189426|NCT00364832|453978005|FG011|Extension Year 2|Early Withdrawals|3|||
126189427|NCT00589602|453978009|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
126189428|NCT02658149|453978011|FG000|Overall Study|Physician Decision|1|||
126189429|NCT02658149|453978012|FG001|Overall Study|Physician Decision|0|||
126189430|NCT01804842|453978020|FG000|Overall Study|Adverse Event|1|||
126189431|NCT01804842|453978021|FG001|Overall Study|Adverse Event|1|||
126189432|NCT01804842|453978022|FG002|Overall Study|Adverse Event|0|||
126189433|NCT01804842|453978020|FG000|Overall Study|Lost to Follow-up|1|||
126189434|NCT01804842|453978021|FG001|Overall Study|Lost to Follow-up|0|||
126189435|NCT01804842|453978022|FG002|Overall Study|Lost to Follow-up|0|||
126189436|NCT01804842|453978020|FG000|Overall Study|Non-Compliance|1|||
126189437|NCT01804842|453978021|FG001|Overall Study|Non-Compliance|1|||
126189438|NCT01804842|453978022|FG002|Overall Study|Non-Compliance|0|||
126189439|NCT01804842|453978020|FG000|Overall Study|Personal Reason|0|||
126189440|NCT01804842|453978021|FG001|Overall Study|Personal Reason|0|||
126189441|NCT01804842|453978022|FG002|Overall Study|Personal Reason|1|||
126189442|NCT01440972|453978023|FG000|Overall Study|Withdrawal by Subject|3|||
126189443|NCT01440972|453978024|FG001|Overall Study|Withdrawal by Subject|2|||
126189444|NCT03933215|453978025|FG000|Overall Study|Other|6|||
126189445|NCT03933215|453978025|FG000|Overall Study|Sponsor decision|5|||
126189446|NCT03933215|453978025|FG000|Overall Study|Protocol Violation|5|||
126189447|NCT03933215|453978025|FG000|Overall Study|Withdrawal by Subject|6|||
126189448|NCT03933215|453978025|FG000|Overall Study|Lost to Follow-up|6|||
126189449|NCT03933215|453978025|FG000|Overall Study|Enrolled but not treated|38|||
126189450|NCT04222673|453978026|FG000|Overall Study|Lost to Follow-up|5|||
126189451|NCT04097028|453978027|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
126189452|NCT04097028|453978027|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
126189453|NCT04097028|453978027|FG000|Overall Study|Disease Progression prior to Surgery|2|||
126189454|NCT04097028|453978027|FG000|Overall Study|Adverse Event prior to Surgery|1|||
126189455|NCT02352090|453978028|FG000|Overall Study|general malaise|1|||
126189456|NCT02352090|453978029|FG001|Overall Study|general malaise|0|||
126189457|NCT02352090|453978030|FG002|Overall Study|general malaise|0|||
126189458|NCT02352090|453978028|FG000|Overall Study|non-specified mild side-effects|0|||
126189459|NCT02352090|453978029|FG001|Overall Study|non-specified mild side-effects|0|||
126189460|NCT02352090|453978030|FG002|Overall Study|non-specified mild side-effects|2|||
126189461|NCT00068822|453978032|FG000|First Randomized Intervention|Lost to Follow-up|1|||
126189462|NCT00068822|453978033|FG001|First Randomized Intervention|Lost to Follow-up|2|||
126189463|NCT03146403|453978034|FG000|Overall Study|Withdrawal by Subject|0|||
126189464|NCT03146403|453978035|FG001|Overall Study|Withdrawal by Subject|3|||
126189465|NCT03146403|453978034|FG000|Overall Study|Lost to Follow-up|2|||
126189466|NCT03146403|453978035|FG001|Overall Study|Lost to Follow-up|0|||
126189467|NCT02252588|453978039|FG000|Overall Study|Withdrawal by Subject|4|||
126189468|NCT02252588|453978040|FG001|Overall Study|Withdrawal by Subject|0|||
126189469|NCT02266004|453978048|FG000|Overall Study|unrelated adverse event|1|||
126189470|NCT02266004|453978048|FG000|Overall Study|Physician Decision|1|||
126189471|NCT00537771|453978052|FG000|Overall Study|Withdrawal by Subject|6|||
126189472|NCT00537771|453978053|FG001|Overall Study|Withdrawal by Subject|23|||
126189473|NCT00537771|453978052|FG000|Overall Study|Adverse Event|8|||
126189474|NCT00537771|453978053|FG001|Overall Study|Adverse Event|15|||
126189475|NCT00537771|453978052|FG000|Overall Study|Lost to Follow-up|9|||
126189476|NCT00537771|453978053|FG001|Overall Study|Lost to Follow-up|15|||
126189477|NCT00537771|453978052|FG000|Overall Study|Protocol Violation|2|||
126189478|NCT00537771|453978053|FG001|Overall Study|Protocol Violation|6|||
126189479|NCT00537771|453978052|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
126189480|NCT00537771|453978053|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
126189481|NCT01855425|453978066|FG000|Overall Study|Physician Decision|20|||
126189482|NCT00638690|453978067|FG000|Overall Study|Death|655|||
126189483|NCT00638690|453978068|FG001|Overall Study|Death|335|||
126189484|NCT00638690|453978067|FG000|Overall Study|Withdrawal by Subject|22|||
126189485|NCT00638690|453978068|FG001|Overall Study|Withdrawal by Subject|5|||
126189486|NCT00638690|453978067|FG000|Overall Study|Lost to Follow-up|4|||
126189487|NCT00638690|453978068|FG001|Overall Study|Lost to Follow-up|2|||
126189488|NCT01347073|453978078|FG000|Overall Study|Adverse Event|1|||
126189489|NCT01347073|453978078|FG000|Overall Study|Liver Transplant|1|||
126189490|NCT00372489|453978085|FG000|Overall Study|Adverse Event|18|||
126189491|NCT00372489|453978085|FG000|Overall Study|Lack of Efficacy|1|||
126189492|NCT00372489|453978085|FG000|Overall Study|Lost to Follow-up|3|||
126189493|NCT00372489|453978085|FG000|Overall Study|Physician Decision|3|||
126189494|NCT00372489|453978085|FG000|Overall Study|Withdrawal by Subject|5|||
126189495|NCT00372489|453978085|FG000|Overall Study|Patient Relocation|2|||
126189496|NCT00372489|453978085|FG000|Overall Study|Renal transplant|6|||
126189497|NCT00372489|453978085|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
126189498|NCT00552344|453978090|FG000|Overall Study|Lack of Efficacy|55|||
126189499|NCT00552344|453978090|FG000|Overall Study|Loss of efficacy|75|||
126189500|NCT00552344|453978090|FG000|Overall Study|Lost to Follow-up|8|||
126189501|NCT00552344|453978090|FG000|Overall Study|Withdrawal by Subject|48|||
126189502|NCT00552344|453978090|FG000|Overall Study|SAE, non-fatal|6|||
126189503|NCT00552344|453978090|FG000|Overall Study|AE, non-serious non-fatal|38|||
126189504|NCT00552344|453978090|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
126189505|NCT00552344|453978090|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
126189506|NCT00552344|453978090|FG000|Overall Study|Other Reason|22|||
126189507|NCT01448707|453978092|FG000|Overall Study|Adverse Event|3|||
126189508|NCT01448707|453978093|FG001|Overall Study|Adverse Event|1|||
126189509|NCT01448707|453978092|FG000|Overall Study|Lost to Follow-up|2|||
126189510|NCT01448707|453978093|FG001|Overall Study|Lost to Follow-up|6|||
126189511|NCT01448707|453978092|FG000|Overall Study|Withdrawal by Subject|6|||
126189512|NCT01448707|453978093|FG001|Overall Study|Withdrawal by Subject|7|||
126189513|NCT01448707|453978092|FG000|Overall Study|Other|7|||
126189514|NCT01448707|453978093|FG001|Overall Study|Other|4|||
126189515|NCT02623699|453978094|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189516|NCT02623699|453978095|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
126189517|NCT02623699|453978096|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189518|NCT02623699|453978097|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189519|NCT02623699|453978098|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189520|NCT02623699|453978099|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189521|NCT02623699|453978100|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189522|NCT02623699|453978101|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189523|NCT02623699|453978102|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189524|NCT02623699|453978103|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189525|NCT02623699|453978104|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189526|NCT02623699|453978105|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126189527|NCT02623699|453978094|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189528|NCT02623699|453978095|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189529|NCT02623699|453978096|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189530|NCT02623699|453978097|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189531|NCT02623699|453978098|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189532|NCT02623699|453978099|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189533|NCT02623699|453978100|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
126189534|NCT02623699|453978101|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189535|NCT02623699|453978102|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189536|NCT02623699|453978103|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189537|NCT02623699|453978104|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189538|NCT02623699|453978105|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126189539|NCT02623699|453978094|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189540|NCT02623699|453978095|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189541|NCT02623699|453978096|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189542|NCT02623699|453978097|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189543|NCT02623699|453978098|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189544|NCT02623699|453978099|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
126189545|NCT02623699|453978100|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189546|NCT02623699|453978101|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189547|NCT02623699|453978102|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189548|NCT02623699|453978103|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189549|NCT02623699|453978104|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189550|NCT02623699|453978105|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126189551|NCT02623699|453978094|FG000|Part B (Up to 289 Days)|Death|0|||
126189552|NCT02623699|453978095|FG001|Part B (Up to 289 Days)|Death|0|||
126189553|NCT02623699|453978096|FG002|Part B (Up to 289 Days)|Death|0|||
126189554|NCT02623699|453978097|FG003|Part B (Up to 289 Days)|Death|0|||
126189555|NCT02623699|453978098|FG004|Part B (Up to 289 Days)|Death|0|||
126189556|NCT02623699|453978099|FG005|Part B (Up to 289 Days)|Death|1|||
126189557|NCT02623699|453978100|FG006|Part B (Up to 289 Days)|Death|1|||
126189558|NCT02623699|453978101|FG007|Part B (Up to 289 Days)|Death|0|||
126189559|NCT02623699|453978102|FG008|Part B (Up to 289 Days)|Death|1|||
126189560|NCT02623699|453978103|FG009|Part B (Up to 289 Days)|Death|0|||
126189561|NCT02623699|453978104|FG010|Part B (Up to 289 Days)|Death|0|||
126189562|NCT02623699|453978105|FG011|Part B (Up to 289 Days)|Death|0|||
126189563|NCT02623699|453978094|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
126189564|NCT02623699|453978095|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
126189565|NCT02623699|453978096|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
126189566|NCT02623699|453978097|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
126189567|NCT02623699|453978098|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
126189568|NCT02623699|453978099|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
126189569|NCT02623699|453978100|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
126189570|NCT02623699|453978101|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
126189571|NCT02623699|453978102|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
126189572|NCT02623699|453978103|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
126189573|NCT02623699|453978104|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
126189574|NCT02623699|453978105|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
126189575|NCT02623699|453978094|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189576|NCT02623699|453978095|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189577|NCT02623699|453978096|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189578|NCT02623699|453978097|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189579|NCT02623699|453978098|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189580|NCT02623699|453978099|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189581|NCT02623699|453978100|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189582|NCT02623699|453978101|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189583|NCT02623699|453978102|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189584|NCT02623699|453978103|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126189585|NCT02623699|453978104|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
126189586|NCT02623699|453978105|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
126189587|NCT02623699|453978094|FG000|Part C (Up to 236 Days)|Death|0|||
126189588|NCT02623699|453978095|FG001|Part C (Up to 236 Days)|Death|0|||
126189589|NCT02623699|453978096|FG002|Part C (Up to 236 Days)|Death|0|||
126189590|NCT02623699|453978097|FG003|Part C (Up to 236 Days)|Death|0|||
126189591|NCT02623699|453978098|FG004|Part C (Up to 236 Days)|Death|0|||
126189592|NCT02623699|453978099|FG005|Part C (Up to 236 Days)|Death|0|||
126189593|NCT02623699|453978100|FG006|Part C (Up to 236 Days)|Death|0|||
126189594|NCT02623699|453978101|FG007|Part C (Up to 236 Days)|Death|0|||
126189595|NCT02623699|453978102|FG008|Part C (Up to 236 Days)|Death|0|||
126189596|NCT02623699|453978103|FG009|Part C (Up to 236 Days)|Death|0|||
126189597|NCT02623699|453978104|FG010|Part C (Up to 236 Days)|Death|0|||
126189598|NCT02623699|453978105|FG011|Part C (Up to 236 Days)|Death|1|||
126189599|NCT02623699|453978094|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
126189600|NCT02623699|453978095|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
126189601|NCT02623699|453978096|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
126189602|NCT02623699|453978097|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
126189603|NCT02623699|453978098|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
126189604|NCT02623699|453978099|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
126189605|NCT02623699|453978100|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
126189606|NCT02623699|453978101|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
126189607|NCT02623699|453978102|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
126189608|NCT02623699|453978103|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
126189609|NCT02623699|453978104|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
126189610|NCT02623699|453978105|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
126189611|NCT03796195|453978108|FG000|Overall Study|Study closed early|1|||
126189612|NCT01190020|453978109|FG000|Overall Study|Adverse Event|2|||
126189613|NCT01190020|453978110|FG001|Overall Study|Adverse Event|0|||
126189614|NCT01190020|453978109|FG000|Overall Study|Lost to Follow-up|2|||
126189615|NCT01190020|453978110|FG001|Overall Study|Lost to Follow-up|0|||
126189616|NCT01190020|453978109|FG000|Overall Study|Withdrawal by Subject|3|||
126189617|NCT01190020|453978110|FG001|Overall Study|Withdrawal by Subject|0|||
126189618|NCT01627782|453978113|FG000|Overall Study|Adverse Event|1|||
126189619|NCT01627782|453978114|FG001|Overall Study|Adverse Event|2|||
126189620|NCT01627782|453978115|FG002|Overall Study|Adverse Event|0|||
126189621|NCT01627782|453978116|FG003|Overall Study|Adverse Event|1|||
126189622|NCT01627782|453978113|FG000|Overall Study|Lack of Efficacy|11|||
126189623|NCT01627782|453978114|FG001|Overall Study|Lack of Efficacy|1|||
126189624|NCT01627782|453978115|FG002|Overall Study|Lack of Efficacy|15|||
126189625|NCT01627782|453978116|FG003|Overall Study|Lack of Efficacy|2|||
126189626|NCT01627782|453978113|FG000|Overall Study|Protocol Violation|1|||
126189627|NCT01627782|453978114|FG001|Overall Study|Protocol Violation|0|||
126189628|NCT01627782|453978115|FG002|Overall Study|Protocol Violation|0|||
126189629|NCT01627782|453978116|FG003|Overall Study|Protocol Violation|0|||
126189630|NCT01627782|453978113|FG000|Overall Study|Withdrawal by Subject|2|||
126189631|NCT01627782|453978114|FG001|Overall Study|Withdrawal by Subject|1|||
126189632|NCT01627782|453978115|FG002|Overall Study|Withdrawal by Subject|0|||
126189633|NCT01627782|453978116|FG003|Overall Study|Withdrawal by Subject|0|||
126189634|NCT01627782|453978113|FG000|Overall Study|Other|0|||
126189635|NCT01627782|453978114|FG001|Overall Study|Other|2|||
126189636|NCT01627782|453978115|FG002|Overall Study|Other|0|||
126189637|NCT01627782|453978116|FG003|Overall Study|Other|3|||
126189638|NCT01627782|453978113|FG000|Overall Study|Randomized But Not Treated|1|||
126189639|NCT01627782|453978114|FG001|Overall Study|Randomized But Not Treated|0|||
126189640|NCT01627782|453978115|FG002|Overall Study|Randomized But Not Treated|0|||
126189641|NCT01627782|453978116|FG003|Overall Study|Randomized But Not Treated|0|||
126189642|NCT03573401|453978117|FG000|Overall Study|Withdrawal by Subject|2|||
126189643|NCT03573401|453978118|FG001|Overall Study|Withdrawal by Subject|0|||
126189644|NCT03573401|453978117|FG000|Overall Study|Subject non-compliance with study schedule|1|||
126189645|NCT03573401|453978118|FG001|Overall Study|Subject non-compliance with study schedule|0|||
126189646|NCT03573401|453978117|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
126189647|NCT03573401|453978118|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
126189648|NCT03573401|453978117|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
126189649|NCT03573401|453978118|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
126189650|NCT05166603|453978121|FG000|Overall Study|Withdrawal by Subject|68|||
126189651|NCT05166603|453978122|FG001|Overall Study|Withdrawal by Subject|0|||
126189652|NCT00777257|453980356|FG000|Overall Study|Adverse Event|3|||
126189653|NCT00777257|453980357|FG001|Overall Study|Adverse Event|1|||
126189654|NCT00777257|453980358|FG002|Overall Study|Adverse Event|0|||
126189655|NCT00777257|453980356|FG000|Overall Study|Lost to Follow-up|3|||
126189656|NCT00777257|453980357|FG001|Overall Study|Lost to Follow-up|3|||
126189657|NCT00777257|453980358|FG002|Overall Study|Lost to Follow-up|2|||
126189658|NCT00777257|453980356|FG000|Overall Study|Protocol Violation|2|||
126189659|NCT00777257|453980357|FG001|Overall Study|Protocol Violation|2|||
126189660|NCT00777257|453980358|FG002|Overall Study|Protocol Violation|2|||
126189661|NCT00777257|453980356|FG000|Overall Study|Withdrawal by Subject|3|||
126189662|NCT00777257|453980357|FG001|Overall Study|Withdrawal by Subject|6|||
126189663|NCT00777257|453980358|FG002|Overall Study|Withdrawal by Subject|5|||
126189664|NCT04315298|453980359|FG000|Overall Study|Withdrawal by Subject|0|||
126189665|NCT04315298|453980360|FG001|Overall Study|Withdrawal by Subject|0|||
126189666|NCT04315298|453980361|FG002|Overall Study|Withdrawal by Subject|0|||
126189667|NCT04315298|453980362|FG003|Overall Study|Withdrawal by Subject|2|||
126189668|NCT04315298|453980363|FG004|Overall Study|Withdrawal by Subject|2|||
126189669|NCT04315298|453980364|FG005|Overall Study|Withdrawal by Subject|2|||
126189670|NCT04315298|453980365|FG006|Overall Study|Withdrawal by Subject|0|||
126189671|NCT04315298|453980366|FG007|Overall Study|Withdrawal by Subject|1|||
126189672|NCT04315298|453980367|FG008|Overall Study|Withdrawal by Subject|1|||
126189673|NCT04315298|453980368|FG009|Overall Study|Withdrawal by Subject|1|||
126189674|NCT04315298|453980369|FG010|Overall Study|Withdrawal by Subject|0|||
126189675|NCT04315298|453980370|FG011|Overall Study|Withdrawal by Subject|0|||
126189676|NCT04315298|453980371|FG012|Overall Study|Withdrawal by Subject|0|||
126189677|NCT04315298|453980372|FG013|Overall Study|Withdrawal by Subject|0|||
126189678|NCT04315298|453980373|FG014|Overall Study|Withdrawal by Subject|0|||
126189679|NCT04315298|453980374|FG015|Overall Study|Withdrawal by Subject|0|||
126189680|NCT04315298|453980375|FG016|Overall Study|Withdrawal by Subject|0|||
126189681|NCT04315298|453980376|FG017|Overall Study|Withdrawal by Subject|0|||
126189682|NCT04315298|453980377|FG018|Overall Study|Withdrawal by Subject|0|||
126189683|NCT04315298|453980359|FG000|Overall Study|Physician Decision|0|||
126189684|NCT04315298|453980360|FG001|Overall Study|Physician Decision|0|||
126189685|NCT04315298|453980361|FG002|Overall Study|Physician Decision|0|||
126189686|NCT04315298|453980362|FG003|Overall Study|Physician Decision|0|||
126189687|NCT04315298|453980363|FG004|Overall Study|Physician Decision|1|||
126189688|NCT04315298|453980364|FG005|Overall Study|Physician Decision|0|||
126189689|NCT04315298|453980365|FG006|Overall Study|Physician Decision|0|||
126189690|NCT04315298|453980366|FG007|Overall Study|Physician Decision|0|||
126189691|NCT04315298|453980367|FG008|Overall Study|Physician Decision|0|||
126189692|NCT04315298|453980368|FG009|Overall Study|Physician Decision|0|||
126189693|NCT04315298|453980369|FG010|Overall Study|Physician Decision|0|||
126189694|NCT04315298|453980370|FG011|Overall Study|Physician Decision|0|||
126189695|NCT04315298|453980371|FG012|Overall Study|Physician Decision|0|||
126189696|NCT04315298|453980372|FG013|Overall Study|Physician Decision|0|||
126189697|NCT04315298|453980373|FG014|Overall Study|Physician Decision|0|||
126189698|NCT04315298|453980374|FG015|Overall Study|Physician Decision|0|||
126189699|NCT04315298|453980375|FG016|Overall Study|Physician Decision|0|||
126189700|NCT04315298|453980376|FG017|Overall Study|Physician Decision|0|||
126189701|NCT04315298|453980377|FG018|Overall Study|Physician Decision|0|||
126189702|NCT04315298|453980359|FG000|Overall Study|Lost to Follow-up|5|||
126189703|NCT04315298|453980360|FG001|Overall Study|Lost to Follow-up|10|||
126189704|NCT04315298|453980361|FG002|Overall Study|Lost to Follow-up|6|||
126189705|NCT04315298|453980362|FG003|Overall Study|Lost to Follow-up|8|||
126189706|NCT04315298|453980363|FG004|Overall Study|Lost to Follow-up|12|||
126189707|NCT04315298|453980364|FG005|Overall Study|Lost to Follow-up|13|||
126189708|NCT04315298|453980365|FG006|Overall Study|Lost to Follow-up|9|||
126189709|NCT04315298|453980366|FG007|Overall Study|Lost to Follow-up|16|||
126189710|NCT04315298|453980367|FG008|Overall Study|Lost to Follow-up|14|||
126189711|NCT04315298|453980368|FG009|Overall Study|Lost to Follow-up|0|||
126189712|NCT04315298|453980369|FG010|Overall Study|Lost to Follow-up|2|||
126189713|NCT04315298|453980370|FG011|Overall Study|Lost to Follow-up|1|||
126189714|NCT04315298|453980371|FG012|Overall Study|Lost to Follow-up|0|||
126189715|NCT04315298|453980372|FG013|Overall Study|Lost to Follow-up|0|||
126189716|NCT04315298|453980373|FG014|Overall Study|Lost to Follow-up|0|||
126189717|NCT04315298|453980374|FG015|Overall Study|Lost to Follow-up|2|||
126189718|NCT04315298|453980375|FG016|Overall Study|Lost to Follow-up|0|||
126189719|NCT04315298|453980376|FG017|Overall Study|Lost to Follow-up|0|||
126189720|NCT04315298|453980377|FG018|Overall Study|Lost to Follow-up|0|||
126189721|NCT04315298|453980359|FG000|Overall Study|Death|24|||
126189722|NCT04315298|453980360|FG001|Overall Study|Death|60|||
126189723|NCT04315298|453980361|FG002|Overall Study|Death|49|||
126189724|NCT04315298|453980362|FG003|Overall Study|Death|59|||
126189725|NCT04315298|453980363|FG004|Overall Study|Death|70|||
126189726|NCT04315298|453980364|FG005|Overall Study|Death|114|||
126189727|NCT04315298|453980365|FG006|Overall Study|Death|9|||
126189728|NCT04315298|453980366|FG007|Overall Study|Death|12|||
126189729|NCT04315298|453980367|FG008|Overall Study|Death|21|||
126189730|NCT04315298|453980368|FG009|Overall Study|Death|16|||
126189731|NCT04315298|453980369|FG010|Overall Study|Death|40|||
126189732|NCT04315298|453980370|FG011|Overall Study|Death|40|||
126189733|NCT04315298|453980371|FG012|Overall Study|Death|3|||
126189734|NCT04315298|453980372|FG013|Overall Study|Death|4|||
126189735|NCT04315298|453980373|FG014|Overall Study|Death|6|||
126189736|NCT04315298|453980374|FG015|Overall Study|Death|4|||
126189737|NCT04315298|453980375|FG016|Overall Study|Death|3|||
126189738|NCT04315298|453980376|FG017|Overall Study|Death|1|||
126189739|NCT04315298|453980377|FG018|Overall Study|Death|0|||
126189740|NCT00736385|453980378|FG000|Overall Study|Withdrawal by Subject|2|||
126189741|NCT00736385|453980379|FG001|Overall Study|Withdrawal by Subject|2|||
126189742|NCT00736385|453980378|FG000|Overall Study|Adverse Event|0|||
126189743|NCT00736385|453980379|FG001|Overall Study|Adverse Event|1|||
126189744|NCT00098865|453980380|FG000|Overall Study|Progressive Disease|6|||
126189745|NCT00098865|453980380|FG000|Overall Study|Adverse Event|2|||
126189746|NCT00098865|453980380|FG000|Overall Study|Alternative Therapy|1|||
126189747|NCT01183104|453980381|FG000|Overall Study|Adverse Event|8|||
126189748|NCT01183104|453980382|FG001|Overall Study|Adverse Event|6|||
126189749|NCT01183104|453980381|FG000|Overall Study|Death|0|||
126189750|NCT01183104|453980382|FG001|Overall Study|Death|1|||
126189751|NCT01183104|453980381|FG000|Overall Study|Lost to Follow-up|14|||
126189752|NCT01183104|453980382|FG001|Overall Study|Lost to Follow-up|7|||
126189753|NCT01183104|453980381|FG000|Overall Study|Physician Decision|5|||
126189754|NCT01183104|453980382|FG001|Overall Study|Physician Decision|8|||
126189755|NCT01183104|453980381|FG000|Overall Study|Withdrawal by Subject|6|||
126189756|NCT01183104|453980382|FG001|Overall Study|Withdrawal by Subject|11|||
126189757|NCT01183104|453980381|FG000|Overall Study|Nonparticipation in Extension Study|39|||
126189758|NCT01183104|453980382|FG001|Overall Study|Nonparticipation in Extension Study|50|||
126189759|NCT01183104|453980381|FG000|Overall Study|Did not receive study drug|5|||
126189760|NCT01183104|453980382|FG001|Overall Study|Did not receive study drug|9|||
126189761|NCT03267511|453980383|FG000|Overall Study|Lost to Follow-up|0|||
126189762|NCT03267511|453980384|FG001|Overall Study|Lost to Follow-up|0|||
126189763|NCT03267511|453980385|FG002|Overall Study|Lost to Follow-up|0|||
126189764|NCT03267511|453980386|FG003|Overall Study|Lost to Follow-up|1|||
126189765|NCT00364351|453980387|FG000|Overall Study|Adverse Event|90|||
126189766|NCT00364351|453980388|FG001|Overall Study|Adverse Event|44|||
126189767|NCT00364351|453980387|FG000|Overall Study|Condition under investigation worsened|469|||
126189768|NCT00364351|453980388|FG001|Overall Study|Condition under investigation worsened|497|||
126189769|NCT00364351|453980387|FG000|Overall Study|Prohibited concomitant medication|0|||
126189770|NCT00364351|453980388|FG001|Overall Study|Prohibited concomitant medication|2|||
126189771|NCT00364351|453980387|FG000|Overall Study|Lost to Follow-up|1|||
126189772|NCT00364351|453980388|FG001|Overall Study|Lost to Follow-up|1|||
126189773|NCT00364351|453980387|FG000|Overall Study|Withdrawal by Subject|30|||
126189774|NCT00364351|453980388|FG001|Overall Study|Withdrawal by Subject|29|||
126189775|NCT00364351|453980387|FG000|Overall Study|Incorrect enrollment|1|||
126189776|NCT00364351|453980388|FG001|Overall Study|Incorrect enrollment|1|||
126189777|NCT00364351|453980387|FG000|Overall Study|Sponsor decision|1|||
126189778|NCT00364351|453980388|FG001|Overall Study|Sponsor decision|0|||
126189779|NCT00364351|453980387|FG000|Overall Study|Poor treatment compliance|0|||
126189780|NCT00364351|453980388|FG001|Overall Study|Poor treatment compliance|3|||
126189781|NCT00364351|453980387|FG000|Overall Study|Investigator error|0|||
126189782|NCT00364351|453980388|FG001|Overall Study|Investigator error|2|||
126189783|NCT00364351|453980387|FG000|Overall Study|Patient could not travel to site|0|||
126189784|NCT00364351|453980388|FG001|Overall Study|Patient could not travel to site|1|||
126189785|NCT00364351|453980387|FG000|Overall Study|Randomised treatment not started|0|||
126189786|NCT00364351|453980388|FG001|Overall Study|Randomised treatment not started|3|||
126189787|NCT00688623|453980390|FG000|Overall Study|Adverse Event|22|||
126189788|NCT00688623|453980390|FG000|Overall Study|abnormal lab value|1|||
126189789|NCT00688623|453980390|FG000|Overall Study|Withdrawal by Subject|4|||
126189790|NCT00688623|453980390|FG000|Overall Study|Death|3|||
126189791|NCT00688623|453980390|FG000|Overall Study|disease progression|23|||
126189792|NCT00688623|453980390|FG000|Overall Study|Protocol Violation|2|||
126189793|NCT02667236|453980391|FG000|Overall Study|Adverse Event|1|||
126189794|NCT02667236|453980392|FG001|Overall Study|Adverse Event|1|||
126189795|NCT02667236|453980391|FG000|Overall Study|Withdrawal by Subject|2|||
126189796|NCT02667236|453980392|FG001|Overall Study|Withdrawal by Subject|0|||
126189797|NCT03887052|453980398|FG000|Overall Study|Adverse Event|2|||
126189798|NCT03887052|453980398|FG000|Overall Study|Physician Decision|2|||
126189799|NCT03887052|453980398|FG000|Overall Study|Withdrawal by Subject|3|||
126189800|NCT03887052|453980398|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
126189801|NCT03887052|453980398|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
126189802|NCT03687827|453980402|FG000|Treatment Period 1|Death|0|||
126189803|NCT03687827|453980403|FG001|Treatment Period 1|Death|1|||
126189804|NCT03687827|453980402|FG000|Treatment Period 1|Lost to Follow-up|2|||
126189805|NCT03687827|453980403|FG001|Treatment Period 1|Lost to Follow-up|2|||
126189806|NCT03687827|453980402|FG000|Treatment Period 1|Physician Decision|5|||
126189807|NCT03687827|453980403|FG001|Treatment Period 1|Physician Decision|2|||
126189808|NCT03687827|453980402|FG000|Treatment Period 1|Withdrawal by Subject|7|||
126189809|NCT03687827|453980403|FG001|Treatment Period 1|Withdrawal by Subject|3|||
126189810|NCT03687827|453980402|FG000|Treatment Period 2|Physician Decision|4|||
126189811|NCT03687827|453980403|FG001|Treatment Period 2|Physician Decision|1|||
126189812|NCT03687827|453980402|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126189813|NCT03687827|453980403|FG001|Treatment Period 2|Withdrawal by Subject|2|||
126189814|NCT01678313|453980404|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
126189815|NCT01678313|453980405|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
126189816|NCT01678313|453980404|FG000|Completed the 3-month Therapy|Physician Decision|3|||
126189817|NCT01678313|453980405|FG001|Completed the 3-month Therapy|Physician Decision|4|||
126189818|NCT01678313|453980404|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
126189819|NCT01678313|453980405|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
126189820|NCT01678313|453980404|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
126189821|NCT01678313|453980405|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
126189822|NCT00981292|453980408|FG000|Day 1|Protocol Violation|1|||
126189823|NCT00981292|453980409|FG001|Day 1|Protocol Violation|0|||
126189824|NCT00981292|453980410|FG002|Day 1|Protocol Violation|0|||
126189825|NCT00981292|453980411|FG003|Day 1|Protocol Violation|0|||
126189826|NCT00981292|453980412|FG004|Day 1|Protocol Violation|0|||
126189827|NCT00981292|453980413|FG005|Day 1|Protocol Violation|2|||
126189828|NCT00981292|453980408|FG000|Day 2|Protocol Violation|2|||
126189829|NCT00981292|453980409|FG001|Day 2|Protocol Violation|0|||
126189830|NCT00981292|453980410|FG002|Day 2|Protocol Violation|0|||
126189831|NCT00981292|453980411|FG003|Day 2|Protocol Violation|0|||
126189832|NCT00981292|453980412|FG004|Day 2|Protocol Violation|0|||
126189833|NCT00981292|453980413|FG005|Day 2|Protocol Violation|0|||
126189834|NCT00981292|453980408|FG000|Day 3|Protocol Violation|0|||
126189835|NCT00981292|453980409|FG001|Day 3|Protocol Violation|0|||
126189836|NCT00981292|453980410|FG002|Day 3|Protocol Violation|0|||
126189837|NCT00981292|453980411|FG003|Day 3|Protocol Violation|0|||
126189838|NCT00981292|453980412|FG004|Day 3|Protocol Violation|0|||
126189839|NCT00981292|453980413|FG005|Day 3|Protocol Violation|1|||
126189840|NCT01131130|453980414|FG000|Period 1 - Baseline|Pregnancy|1|||
126189841|NCT01131130|453980414|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
126189842|NCT03464136|453980415|FG000|Overall Study|Lost to Follow-up|5|||
126189843|NCT03464136|453980416|FG001|Overall Study|Lost to Follow-up|8|||
126189844|NCT03464136|453980415|FG000|Overall Study|Withdrawal by Subject|16|||
126189845|NCT03464136|453980416|FG001|Overall Study|Withdrawal by Subject|13|||
126189846|NCT03464136|453980415|FG000|Overall Study|Death|1|||
126189847|NCT03464136|453980416|FG001|Overall Study|Death|0|||
126189848|NCT03464136|453980415|FG000|Overall Study|Other|8|||
126189849|NCT03464136|453980416|FG001|Overall Study|Other|4|||
126189850|NCT03412565|453980417|FG000|Overall Study|Lost to Follow-up|0|||
126189851|NCT03412565|453980418|FG001|Overall Study|Lost to Follow-up|0|||
126189852|NCT03412565|453980419|FG002|Overall Study|Lost to Follow-up|1|||
126189853|NCT03412565|453980420|FG003|Overall Study|Lost to Follow-up|0|||
126189854|NCT03412565|453980417|FG000|Overall Study|Physician Decision|0|||
126189855|NCT03412565|453980418|FG001|Overall Study|Physician Decision|0|||
126189856|NCT03412565|453980419|FG002|Overall Study|Physician Decision|0|||
126189857|NCT03412565|453980420|FG003|Overall Study|Physician Decision|1|||
126189858|NCT03412565|453980417|FG000|Overall Study|Withdrawal by Subject|0|||
126189859|NCT03412565|453980418|FG001|Overall Study|Withdrawal by Subject|4|||
126189860|NCT03412565|453980419|FG002|Overall Study|Withdrawal by Subject|5|||
126189861|NCT03412565|453980420|FG003|Overall Study|Withdrawal by Subject|5|||
126189862|NCT03412565|453980417|FG000|Overall Study|Death|1|||
126189863|NCT03412565|453980418|FG001|Overall Study|Death|3|||
126189864|NCT03412565|453980419|FG002|Overall Study|Death|4|||
126189865|NCT03412565|453980420|FG003|Overall Study|Death|5|||
126189866|NCT03412565|453980417|FG000|Overall Study|Data collection ended|0|||
126189867|NCT03412565|453980418|FG001|Overall Study|Data collection ended|41|||
126189868|NCT03412565|453980419|FG002|Overall Study|Data collection ended|41|||
126189869|NCT03412565|453980420|FG003|Overall Study|Data collection ended|40|||
126189870|NCT03277105|453980421|FG000|Overall Study|Death|129|||
126189871|NCT03277105|453980422|FG001|Overall Study|Death|124|||
126189872|NCT03277105|453980421|FG000|Overall Study|Lost to Follow-up|2|||
126189873|NCT03277105|453980422|FG001|Overall Study|Lost to Follow-up|4|||
126189874|NCT03277105|453980421|FG000|Overall Study|Withdrawal by Subject|10|||
126189875|NCT03277105|453980422|FG001|Overall Study|Withdrawal by Subject|10|||
126189876|NCT03277105|453980421|FG000|Overall Study|Other|118|||
126189877|NCT03277105|453980422|FG001|Overall Study|Other|125|||
126189878|NCT01849562|453980429|FG000|Overall Study|Lost to Follow-up|1|||
126189879|NCT01849562|453980430|FG001|Overall Study|Lost to Follow-up|0|||
126189880|NCT01849562|453980431|FG002|Overall Study|Lost to Follow-up|0|||
126189881|NCT01849562|453980429|FG000|Overall Study|Non-compliance with Study Drug|1|||
126189882|NCT01849562|453980430|FG001|Overall Study|Non-compliance with Study Drug|0|||
126189883|NCT01849562|453980431|FG002|Overall Study|Non-compliance with Study Drug|0|||
126189884|NCT02182999|453980432|FG000|Overall Study|Adverse Event|4|||
126189885|NCT02182999|453980433|FG001|Overall Study|Adverse Event|3|||
126189886|NCT02182999|453980432|FG000|Overall Study|Physician Decision|1|||
126189887|NCT02182999|453980433|FG001|Overall Study|Physician Decision|0|||
126189888|NCT03039790|453980434|FG000|Overall Study|Lost to Follow-up|2|||
126189889|NCT03039790|453980435|FG001|Overall Study|Lost to Follow-up|0|||
126189890|NCT03039790|453980436|FG002|Overall Study|Lost to Follow-up|1|||
126189891|NCT03039790|453980437|FG003|Overall Study|Lost to Follow-up|1|||
126189892|NCT03039790|453980438|FG004|Overall Study|Lost to Follow-up|0|||
126189893|NCT03039790|453980439|FG005|Overall Study|Lost to Follow-up|1|||
126189894|NCT03039790|453980440|FG006|Overall Study|Lost to Follow-up|1|||
126189895|NCT03039790|453980441|FG007|Overall Study|Lost to Follow-up|1|||
126189896|NCT03039790|453980442|FG008|Overall Study|Lost to Follow-up|0|||
126189897|NCT03039790|453980443|FG009|Overall Study|Lost to Follow-up|1|||
126189898|NCT03039790|453980444|FG010|Overall Study|Lost to Follow-up|1|||
126189899|NCT03039790|453980445|FG011|Overall Study|Lost to Follow-up|0|||
126189900|NCT03039790|453980446|FG012|Overall Study|Lost to Follow-up|1|||
126189901|NCT03039790|453980447|FG013|Overall Study|Lost to Follow-up|0|||
126189902|NCT03039790|453980448|FG014|Overall Study|Lost to Follow-up|3|||
126189903|NCT03039790|453980449|FG015|Overall Study|Lost to Follow-up|1|||
126189904|NCT03039790|453980450|FG016|Overall Study|Lost to Follow-up|2|||
126189905|NCT03039790|453980451|FG017|Overall Study|Lost to Follow-up|2|||
126189906|NCT03039790|453980452|FG018|Overall Study|Lost to Follow-up|1|||
126189907|NCT03039790|453980453|FG019|Overall Study|Lost to Follow-up|3|||
126189908|NCT03039790|453980434|FG000|Overall Study|Withdrawal of Consent|1|||
126189909|NCT03039790|453980435|FG001|Overall Study|Withdrawal of Consent|0|||
126189910|NCT03039790|453980436|FG002|Overall Study|Withdrawal of Consent|0|||
126189911|NCT03039790|453980437|FG003|Overall Study|Withdrawal of Consent|1|||
126189912|NCT03039790|453980438|FG004|Overall Study|Withdrawal of Consent|0|||
126189913|NCT03039790|453980439|FG005|Overall Study|Withdrawal of Consent|0|||
126189914|NCT03039790|453980440|FG006|Overall Study|Withdrawal of Consent|0|||
126189915|NCT03039790|453980441|FG007|Overall Study|Withdrawal of Consent|0|||
126189916|NCT03039790|453980442|FG008|Overall Study|Withdrawal of Consent|0|||
126189917|NCT03039790|453980443|FG009|Overall Study|Withdrawal of Consent|1|||
126189918|NCT03039790|453980444|FG010|Overall Study|Withdrawal of Consent|0|||
126189919|NCT03039790|453980445|FG011|Overall Study|Withdrawal of Consent|0|||
126189920|NCT03039790|453980446|FG012|Overall Study|Withdrawal of Consent|2|||
126189921|NCT03039790|453980447|FG013|Overall Study|Withdrawal of Consent|0|||
126189922|NCT03039790|453980448|FG014|Overall Study|Withdrawal of Consent|1|||
126189923|NCT03039790|453980449|FG015|Overall Study|Withdrawal of Consent|5|||
126189924|NCT03039790|453980450|FG016|Overall Study|Withdrawal of Consent|3|||
126189925|NCT03039790|453980451|FG017|Overall Study|Withdrawal of Consent|0|||
126189926|NCT03039790|453980452|FG018|Overall Study|Withdrawal of Consent|2|||
126189927|NCT03039790|453980453|FG019|Overall Study|Withdrawal of Consent|5|||
126189928|NCT03039790|453980434|FG000|Overall Study|Death|0|||
126189929|NCT03039790|453980435|FG001|Overall Study|Death|0|||
126189930|NCT03039790|453980436|FG002|Overall Study|Death|0|||
126189931|NCT03039790|453980437|FG003|Overall Study|Death|0|||
126189932|NCT03039790|453980438|FG004|Overall Study|Death|0|||
126189933|NCT03039790|453980439|FG005|Overall Study|Death|0|||
126189934|NCT03039790|453980440|FG006|Overall Study|Death|0|||
126189935|NCT03039790|453980441|FG007|Overall Study|Death|0|||
126189936|NCT03039790|453980442|FG008|Overall Study|Death|0|||
126189937|NCT03039790|453980443|FG009|Overall Study|Death|0|||
126189938|NCT03039790|453980444|FG010|Overall Study|Death|0|||
126189939|NCT03039790|453980445|FG011|Overall Study|Death|0|||
126189940|NCT03039790|453980446|FG012|Overall Study|Death|0|||
126189941|NCT03039790|453980447|FG013|Overall Study|Death|0|||
126189942|NCT03039790|453980448|FG014|Overall Study|Death|0|||
126189943|NCT03039790|453980449|FG015|Overall Study|Death|1|||
126189944|NCT03039790|453980450|FG016|Overall Study|Death|3|||
126189945|NCT03039790|453980451|FG017|Overall Study|Death|0|||
126189946|NCT03039790|453980452|FG018|Overall Study|Death|2|||
126189947|NCT03039790|453980453|FG019|Overall Study|Death|0|||
126189948|NCT03039790|453980434|FG000|Overall Study|Reason, not Specified|1|||
126189949|NCT03039790|453980435|FG001|Overall Study|Reason, not Specified|0|||
126189950|NCT03039790|453980436|FG002|Overall Study|Reason, not Specified|0|||
126189951|NCT03039790|453980437|FG003|Overall Study|Reason, not Specified|0|||
126189952|NCT03039790|453980438|FG004|Overall Study|Reason, not Specified|0|||
126189953|NCT03039790|453980439|FG005|Overall Study|Reason, not Specified|0|||
126189954|NCT03039790|453980440|FG006|Overall Study|Reason, not Specified|0|||
126189955|NCT03039790|453980441|FG007|Overall Study|Reason, not Specified|0|||
126189956|NCT03039790|453980442|FG008|Overall Study|Reason, not Specified|0|||
126189957|NCT03039790|453980443|FG009|Overall Study|Reason, not Specified|0|||
126189958|NCT03039790|453980444|FG010|Overall Study|Reason, not Specified|0|||
126189959|NCT03039790|453980445|FG011|Overall Study|Reason, not Specified|0|||
126189960|NCT03039790|453980446|FG012|Overall Study|Reason, not Specified|0|||
126189961|NCT03039790|453980447|FG013|Overall Study|Reason, not Specified|0|||
126189962|NCT03039790|453980448|FG014|Overall Study|Reason, not Specified|0|||
126189963|NCT03039790|453980449|FG015|Overall Study|Reason, not Specified|0|||
126189964|NCT03039790|453980450|FG016|Overall Study|Reason, not Specified|2|||
126189965|NCT03039790|453980451|FG017|Overall Study|Reason, not Specified|0|||
126189966|NCT03039790|453980452|FG018|Overall Study|Reason, not Specified|1|||
126189967|NCT03039790|453980453|FG019|Overall Study|Reason, not Specified|0|||
126189968|NCT00498368|453980456|FG000|Overall Study|Withdrawal by Subject|3|||
126189969|NCT00498368|453980457|FG001|Overall Study|Withdrawal by Subject|2|||
126189970|NCT02736929|453980460|FG000|Main Study|Lost to Follow-up|7|||
126189971|NCT02736929|453980461|FG001|Main Study|Lost to Follow-up|1|||
126189972|NCT02736929|453980462|FG002|Main Study|Lost to Follow-up|0|||
126189973|NCT02736929|453980460|FG000|Main Study|Withdrawal by Subject|1|||
126189974|NCT02736929|453980461|FG001|Main Study|Withdrawal by Subject|1|||
126189975|NCT02736929|453980462|FG002|Main Study|Withdrawal by Subject|0|||
126189976|NCT02736929|453980460|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
126189977|NCT02736929|453980461|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
126189978|NCT02736929|453980462|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
126189979|NCT00285649|453980465|FG000|Overall Study|Lost to Follow-up|6|||
126189980|NCT00285649|453980466|FG001|Overall Study|Lost to Follow-up|4|||
126189981|NCT00285649|453980467|FG002|Overall Study|Lost to Follow-up|4|||
126189982|NCT00285649|453980465|FG000|Overall Study|Withdrawal by Subject|3|||
126189983|NCT00285649|453980466|FG001|Overall Study|Withdrawal by Subject|2|||
126189984|NCT00285649|453980467|FG002|Overall Study|Withdrawal by Subject|2|||
126189985|NCT03342404|453980468|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
126189986|NCT03342404|453980469|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
126189987|NCT03342404|453980468|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
126189988|NCT03342404|453980469|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
126189989|NCT03342404|453980468|FG000|Blinded Treatment Phase|Adverse Event|5|||
126189990|NCT03342404|453980469|FG001|Blinded Treatment Phase|Adverse Event|4|||
126189991|NCT03342404|453980468|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
126189992|NCT03342404|453980469|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
126189993|NCT03342404|453980468|FG000|Blinded Treatment Phase|Other reasons|1|||
126189994|NCT03342404|453980469|FG001|Blinded Treatment Phase|Other reasons|0|||
126189995|NCT03342404|453980468|FG000|Blinded Treatment Phase|Physician Decision|1|||
126189996|NCT03342404|453980469|FG001|Blinded Treatment Phase|Physician Decision|0|||
126189997|NCT03342404|453980468|FG000|Blinded Treatment Phase|Death|1|||
126189998|NCT03342404|453980469|FG001|Blinded Treatment Phase|Death|0|||
126189999|NCT03342404|453980468|FG000|Open-Label Phase|Lost to Follow-up|0|||
126190000|NCT03342404|453980469|FG001|Open-Label Phase|Lost to Follow-up|1|||
126190001|NCT03342404|453980468|FG000|Open-Label Phase|Other reasons|0|||
126190002|NCT03342404|453980469|FG001|Open-Label Phase|Other reasons|1|||
126190003|NCT03342404|453980468|FG000|Open-Label Phase|Adverse Event|0|||
126190004|NCT03342404|453980469|FG001|Open-Label Phase|Adverse Event|3|||
126190005|NCT03342404|453980468|FG000|Open-Label Phase|Withdrawal by Subject|0|||
126190006|NCT03342404|453980469|FG001|Open-Label Phase|Withdrawal by Subject|6|||
126190007|NCT01690988|453980470|FG000|Overall Study|Withdrawal by Subject|2|||
126190008|NCT01690988|453980471|FG001|Overall Study|Withdrawal by Subject|2|||
126190009|NCT01690988|453980472|FG002|Overall Study|Withdrawal by Subject|3|||
126190010|NCT01690988|453980470|FG000|Overall Study|Physician Decision|0|||
126190011|NCT01690988|453980471|FG001|Overall Study|Physician Decision|0|||
126190012|NCT01690988|453980472|FG002|Overall Study|Physician Decision|1|||
126190013|NCT01690988|453980470|FG000|Overall Study|Operation Cancelled|1|||
126190014|NCT01690988|453980471|FG001|Overall Study|Operation Cancelled|1|||
126190015|NCT01690988|453980472|FG002|Overall Study|Operation Cancelled|0|||
126190016|NCT01690988|453980470|FG000|Overall Study|Determined ineligible|1|||
126190017|NCT01690988|453980471|FG001|Overall Study|Determined ineligible|0|||
126190018|NCT01690988|453980472|FG002|Overall Study|Determined ineligible|0|||
126190019|NCT01690988|453980470|FG000|Overall Study|Death|1|||
126190020|NCT01690988|453980471|FG001|Overall Study|Death|1|||
126190021|NCT01690988|453980472|FG002|Overall Study|Death|1|||
126190022|NCT01690988|453980470|FG000|Overall Study|Sedated|1|||
126190023|NCT01690988|453980471|FG001|Overall Study|Sedated|1|||
126190024|NCT01690988|453980472|FG002|Overall Study|Sedated|2|||
126190025|NCT01634100|453980475|FG000|Overall Study|Withdrawal by Subject|1|||
126190026|NCT01634100|453980476|FG001|Overall Study|Withdrawal by Subject|0|||
126190027|NCT01634100|453980477|FG002|Overall Study|Withdrawal by Subject|1|||
126190028|NCT01634100|453980478|FG003|Overall Study|Withdrawal by Subject|0|||
126190029|NCT01634100|453980479|FG004|Overall Study|Withdrawal by Subject|0|||
126190030|NCT01634100|453980480|FG005|Overall Study|Withdrawal by Subject|0|||
126190031|NCT01662986|453980481|FG000|Overall Study|Adverse Event|5|||
126190032|NCT01662986|453980482|FG001|Overall Study|Adverse Event|4|||
126190033|NCT01662986|453980481|FG000|Overall Study|Protocol Violation|2|||
126190034|NCT01662986|453980482|FG001|Overall Study|Protocol Violation|3|||
126190035|NCT01662986|453980481|FG000|Overall Study|Lost to Follow-up|5|||
126190036|NCT01662986|453980482|FG001|Overall Study|Lost to Follow-up|4|||
126190037|NCT01662986|453980481|FG000|Overall Study|Withdrawal by Subject|2|||
126190038|NCT01662986|453980482|FG001|Overall Study|Withdrawal by Subject|2|||
126190039|NCT01662986|453980481|FG000|Overall Study|Not Treated|1|||
126190040|NCT01662986|453980482|FG001|Overall Study|Not Treated|0|||
126190041|NCT01662986|453980481|FG000|Overall Study|Other than stated above|3|||
126190042|NCT01662986|453980482|FG001|Overall Study|Other than stated above|0|||
126190043|NCT01512693|453980488|FG000|Overall Study|Withdrawal by Subject|0|||
126190044|NCT01512693|453980489|FG001|Overall Study|Withdrawal by Subject|1|||
126190045|NCT01975376|453980490|FG000|Overall Study|Adverse Event|5|||
126190046|NCT01975376|453980491|FG001|Overall Study|Adverse Event|5|||
126190047|NCT01975376|453980490|FG000|Overall Study|Death|65|||
126190048|NCT01975376|453980491|FG001|Overall Study|Death|72|||
126190049|NCT01975376|453980490|FG000|Overall Study|Lost to Follow-up|70|||
126190050|NCT01975376|453980491|FG001|Overall Study|Lost to Follow-up|66|||
126190051|NCT01975376|453980490|FG000|Overall Study|Withdrew consent|68|||
126190052|NCT01975376|453980491|FG001|Overall Study|Withdrew consent|62|||
126190053|NCT01975376|453980490|FG000|Overall Study|Other|2|||
126190054|NCT01975376|453980491|FG001|Overall Study|Other|4|||
126190055|NCT01975376|453980490|FG000|Overall Study|Randomized, Not Treated|16|||
126190056|NCT01975376|453980491|FG001|Overall Study|Randomized, Not Treated|8|||
126190057|NCT04731922|453980492|FG000|Overall Study|Adverse Event|0|||
126190058|NCT04731922|453980493|FG001|Overall Study|Adverse Event|0|||
126190059|NCT04731922|453980494|FG002|Overall Study|Adverse Event|0|||
126190060|NCT04731922|453980495|FG003|Overall Study|Adverse Event|0|||
126190061|NCT04731922|453980496|FG004|Overall Study|Adverse Event|0|||
126190062|NCT04731922|453980497|FG005|Overall Study|Adverse Event|0|||
126190063|NCT04731922|453980498|FG006|Overall Study|Adverse Event|0|||
126190064|NCT04731922|453980499|FG007|Overall Study|Adverse Event|0|||
126190065|NCT04731922|453980500|FG008|Overall Study|Adverse Event|0|||
126190066|NCT04731922|453980501|FG009|Overall Study|Adverse Event|0|||
126190067|NCT04731922|453980502|FG010|Overall Study|Adverse Event|1|||
126190068|NCT04731922|453980503|FG011|Overall Study|Adverse Event|0|||
126190069|NCT04731922|453980504|FG012|Overall Study|Adverse Event|0|||
126190070|NCT04731922|453980505|FG013|Overall Study|Adverse Event|0|||
126190071|NCT04731922|453980506|FG014|Overall Study|Adverse Event|0|||
126190072|NCT04731922|453980507|FG015|Overall Study|Adverse Event|0|||
126190073|NCT04731922|453980508|FG016|Overall Study|Adverse Event|0|||
126190074|NCT04731922|453980492|FG000|Overall Study|Lost to Follow-up|0|||
126190075|NCT04731922|453980493|FG001|Overall Study|Lost to Follow-up|0|||
126190076|NCT04731922|453980494|FG002|Overall Study|Lost to Follow-up|0|||
126190077|NCT04731922|453980495|FG003|Overall Study|Lost to Follow-up|1|||
126190078|NCT04731922|453980496|FG004|Overall Study|Lost to Follow-up|0|||
126190079|NCT04731922|453980497|FG005|Overall Study|Lost to Follow-up|1|||
126190080|NCT04731922|453980498|FG006|Overall Study|Lost to Follow-up|0|||
126190081|NCT04731922|453980499|FG007|Overall Study|Lost to Follow-up|0|||
126190082|NCT04731922|453980500|FG008|Overall Study|Lost to Follow-up|0|||
126190083|NCT04731922|453980501|FG009|Overall Study|Lost to Follow-up|0|||
126190084|NCT04731922|453980502|FG010|Overall Study|Lost to Follow-up|0|||
126190085|NCT04731922|453980503|FG011|Overall Study|Lost to Follow-up|0|||
126190086|NCT04731922|453980504|FG012|Overall Study|Lost to Follow-up|0|||
126190087|NCT04731922|453980505|FG013|Overall Study|Lost to Follow-up|0|||
126190088|NCT04731922|453980506|FG014|Overall Study|Lost to Follow-up|0|||
126190089|NCT04731922|453980507|FG015|Overall Study|Lost to Follow-up|0|||
126190090|NCT04731922|453980508|FG016|Overall Study|Lost to Follow-up|0|||
126190091|NCT04731922|453980492|FG000|Overall Study|Withdrawal by Subject|1|||
126190092|NCT04731922|453980493|FG001|Overall Study|Withdrawal by Subject|0|||
126190093|NCT04731922|453980494|FG002|Overall Study|Withdrawal by Subject|0|||
126190094|NCT04731922|453980495|FG003|Overall Study|Withdrawal by Subject|0|||
126190095|NCT04731922|453980496|FG004|Overall Study|Withdrawal by Subject|1|||
126190096|NCT04731922|453980497|FG005|Overall Study|Withdrawal by Subject|0|||
126190097|NCT04731922|453980498|FG006|Overall Study|Withdrawal by Subject|1|||
126190098|NCT04731922|453980499|FG007|Overall Study|Withdrawal by Subject|0|||
126190099|NCT04731922|453980500|FG008|Overall Study|Withdrawal by Subject|0|||
126190100|NCT04731922|453980501|FG009|Overall Study|Withdrawal by Subject|0|||
126190101|NCT04731922|453980502|FG010|Overall Study|Withdrawal by Subject|0|||
126190102|NCT04731922|453980503|FG011|Overall Study|Withdrawal by Subject|0|||
126190103|NCT04731922|453980504|FG012|Overall Study|Withdrawal by Subject|0|||
126190104|NCT04731922|453980505|FG013|Overall Study|Withdrawal by Subject|1|||
126190105|NCT04731922|453980506|FG014|Overall Study|Withdrawal by Subject|0|||
126190106|NCT04731922|453980507|FG015|Overall Study|Withdrawal by Subject|0|||
126190107|NCT04731922|453980508|FG016|Overall Study|Withdrawal by Subject|0|||
126190108|NCT04731922|453980492|FG000|Overall Study|Other|0|||
126190109|NCT04731922|453980493|FG001|Overall Study|Other|0|||
126190110|NCT04731922|453980494|FG002|Overall Study|Other|0|||
126190111|NCT04731922|453980495|FG003|Overall Study|Other|0|||
126190112|NCT04731922|453980496|FG004|Overall Study|Other|0|||
126190113|NCT04731922|453980497|FG005|Overall Study|Other|0|||
126190114|NCT04731922|453980498|FG006|Overall Study|Other|1|||
126190115|NCT04731922|453980499|FG007|Overall Study|Other|0|||
126190116|NCT04731922|453980500|FG008|Overall Study|Other|0|||
126190117|NCT04731922|453980501|FG009|Overall Study|Other|0|||
126190118|NCT04731922|453980502|FG010|Overall Study|Other|0|||
126190119|NCT04731922|453980503|FG011|Overall Study|Other|0|||
126190120|NCT04731922|453980504|FG012|Overall Study|Other|0|||
126190121|NCT04731922|453980505|FG013|Overall Study|Other|0|||
126190122|NCT04731922|453980506|FG014|Overall Study|Other|0|||
126190123|NCT04731922|453980507|FG015|Overall Study|Other|0|||
126190124|NCT04731922|453980508|FG016|Overall Study|Other|0|||
126190125|NCT01819194|453980510|FG000|Overall Study|Loss of study articles|2|||
126190126|NCT02343952|453980515|FG000|Study Treatment|Disease Progression|23|||
126190127|NCT02343952|453980515|FG000|Study Treatment|Death|3|||
126190128|NCT02343952|453980515|FG000|Study Treatment|Adverse Event|19|||
126190129|NCT02343952|453980515|FG000|Study Treatment|Withdrawal by Subject|7|||
126190130|NCT02343952|453980515|FG000|Study Treatment|other complicating Diseases|1|||
126190131|NCT02343952|453980515|FG000|Follow up|Withdrawal by Subject|3|||
126190132|NCT02343952|453980515|FG000|Follow up|Death|33|||
126190133|NCT02343952|453980515|FG000|Follow up|Patient does not meet eligibility for study.|1|||
126190134|NCT02343952|453980515|FG000|Follow up|Research department closed by the practice.|5|||
126190135|NCT02343952|453980515|FG000|Follow up|Patient went home to Russia|1|||
126190136|NCT02343952|453980515|FG000|Follow up|Disease Progression|1|||
126190137|NCT02343952|453980515|FG000|Follow up|study terminated|1|||
126190138|NCT00899678|453980519|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
126190139|NCT00899678|453980520|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
126190140|NCT00899678|453980521|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
126190141|NCT00899678|453980519|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
126190142|NCT00899678|453980520|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
126190143|NCT00899678|453980521|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
126190144|NCT00899678|453980519|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
126190145|NCT00899678|453980520|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
126190146|NCT00899678|453980521|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
126190147|NCT00899678|453980519|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
126190148|NCT00899678|453980520|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
126190149|NCT00899678|453980521|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
126190150|NCT00899678|453980519|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
126190151|NCT00899678|453980520|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
126190152|NCT00899678|453980521|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
126190153|NCT00899678|453980519|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
126190154|NCT00899678|453980520|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
126190155|NCT00899678|453980521|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
126190156|NCT00899678|453980519|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
126190157|NCT00899678|453980520|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
126190158|NCT00899678|453980521|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
126190159|NCT00899678|453980519|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
126190160|NCT00899678|453980520|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
126190161|NCT00899678|453980521|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
126190162|NCT00899678|453980519|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
126190163|NCT00899678|453980520|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
126190164|NCT00899678|453980521|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
126190165|NCT00033371|453980522|FG000|Overall Study|Adverse Event|1|||
126190166|NCT00033371|453980523|FG001|Overall Study|Adverse Event|5|||
126190167|NCT00033371|453980522|FG000|Overall Study|Lost to Follow-up|2|||
126190168|NCT00033371|453980523|FG001|Overall Study|Lost to Follow-up|1|||
126190169|NCT00033371|453980522|FG000|Overall Study|Withdrawal by Subject|3|||
126190170|NCT00033371|453980523|FG001|Overall Study|Withdrawal by Subject|3|||
126190171|NCT00033371|453980522|FG000|Overall Study|Disease Progression|0|||
126190172|NCT00033371|453980523|FG001|Overall Study|Disease Progression|1|||
126190173|NCT02699125|453980524|FG000|Placebo|Lost to Follow-up|2|||
126190174|NCT02699125|453980525|FG001|Placebo|Lost to Follow-up|0|||
126190175|NCT02699125|453980524|FG000|Placebo|Protocol Violation|1|||
126190176|NCT02699125|453980525|FG001|Placebo|Protocol Violation|0|||
126190177|NCT02699125|453980524|FG000|Placebo|Withdrawal by Subject|0|||
126190178|NCT02699125|453980525|FG001|Placebo|Withdrawal by Subject|4|||
126190179|NCT02699125|453980524|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
126190180|NCT02699125|453980525|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
126190181|NCT03799627|453980530|FG000|Overall Study|Adverse Event|1|||
126190182|NCT03799627|453980531|FG001|Overall Study|Adverse Event|2|||
126190183|NCT03799627|453980532|FG002|Overall Study|Adverse Event|0|||
126190184|NCT03799627|453980533|FG003|Overall Study|Adverse Event|0|||
126190185|NCT03799627|453980534|FG004|Overall Study|Adverse Event|2|||
126190186|NCT03799627|453980535|FG005|Overall Study|Adverse Event|5|||
126190187|NCT03799627|453980536|FG006|Overall Study|Adverse Event|0|||
126190188|NCT03799627|453980537|FG007|Overall Study|Adverse Event|2|||
126190189|NCT03799627|453980538|FG008|Overall Study|Adverse Event|0|||
126190190|NCT03799627|453980530|FG000|Overall Study|Physician Decision|2|||
126190191|NCT03799627|453980531|FG001|Overall Study|Physician Decision|2|||
126190192|NCT03799627|453980532|FG002|Overall Study|Physician Decision|0|||
126190193|NCT03799627|453980533|FG003|Overall Study|Physician Decision|0|||
126190194|NCT03799627|453980534|FG004|Overall Study|Physician Decision|2|||
126190195|NCT03799627|453980535|FG005|Overall Study|Physician Decision|2|||
126190196|NCT03799627|453980536|FG006|Overall Study|Physician Decision|0|||
126190197|NCT03799627|453980537|FG007|Overall Study|Physician Decision|0|||
126190198|NCT03799627|453980538|FG008|Overall Study|Physician Decision|0|||
126190199|NCT03799627|453980530|FG000|Overall Study|Withdrawal by Subject|1|||
126190200|NCT03799627|453980531|FG001|Overall Study|Withdrawal by Subject|1|||
126190201|NCT03799627|453980532|FG002|Overall Study|Withdrawal by Subject|0|||
126190202|NCT03799627|453980533|FG003|Overall Study|Withdrawal by Subject|2|||
126190203|NCT03799627|453980534|FG004|Overall Study|Withdrawal by Subject|0|||
126190204|NCT03799627|453980535|FG005|Overall Study|Withdrawal by Subject|3|||
126190205|NCT03799627|453980536|FG006|Overall Study|Withdrawal by Subject|0|||
126190206|NCT03799627|453980537|FG007|Overall Study|Withdrawal by Subject|0|||
126190207|NCT03799627|453980538|FG008|Overall Study|Withdrawal by Subject|0|||
126190208|NCT03799627|453980530|FG000|Overall Study|Lack of Efficacy|0|||
126190209|NCT03799627|453980531|FG001|Overall Study|Lack of Efficacy|0|||
126190210|NCT03799627|453980532|FG002|Overall Study|Lack of Efficacy|0|||
126190211|NCT03799627|453980533|FG003|Overall Study|Lack of Efficacy|1|||
126190212|NCT03799627|453980534|FG004|Overall Study|Lack of Efficacy|0|||
126190213|NCT03799627|453980535|FG005|Overall Study|Lack of Efficacy|0|||
126190214|NCT03799627|453980536|FG006|Overall Study|Lack of Efficacy|0|||
126190215|NCT03799627|453980537|FG007|Overall Study|Lack of Efficacy|0|||
126190216|NCT03799627|453980538|FG008|Overall Study|Lack of Efficacy|0|||
126190217|NCT03799627|453980530|FG000|Overall Study|Lost to Follow-up|0|||
126190218|NCT03799627|453980531|FG001|Overall Study|Lost to Follow-up|0|||
126190219|NCT03799627|453980532|FG002|Overall Study|Lost to Follow-up|0|||
126190220|NCT03799627|453980533|FG003|Overall Study|Lost to Follow-up|0|||
126190221|NCT03799627|453980534|FG004|Overall Study|Lost to Follow-up|0|||
126190222|NCT03799627|453980535|FG005|Overall Study|Lost to Follow-up|0|||
126190223|NCT03799627|453980536|FG006|Overall Study|Lost to Follow-up|1|||
126190224|NCT03799627|453980537|FG007|Overall Study|Lost to Follow-up|0|||
126190225|NCT03799627|453980538|FG008|Overall Study|Lost to Follow-up|1|||
126190226|NCT03799627|453980530|FG000|Overall Study|Death|0|||
126190227|NCT03799627|453980531|FG001|Overall Study|Death|0|||
126190228|NCT03799627|453980532|FG002|Overall Study|Death|0|||
126190229|NCT03799627|453980533|FG003|Overall Study|Death|1|||
126190230|NCT03799627|453980534|FG004|Overall Study|Death|0|||
126190231|NCT03799627|453980535|FG005|Overall Study|Death|0|||
126190232|NCT03799627|453980536|FG006|Overall Study|Death|0|||
126190233|NCT03799627|453980537|FG007|Overall Study|Death|0|||
126190234|NCT03799627|453980538|FG008|Overall Study|Death|0|||
126190235|NCT03799627|453980530|FG000|Overall Study|Study Drug Put on Hold|1|||
126190236|NCT03799627|453980531|FG001|Overall Study|Study Drug Put on Hold|0|||
126190237|NCT03799627|453980532|FG002|Overall Study|Study Drug Put on Hold|0|||
126190238|NCT03799627|453980533|FG003|Overall Study|Study Drug Put on Hold|0|||
126190239|NCT03799627|453980534|FG004|Overall Study|Study Drug Put on Hold|0|||
126190240|NCT03799627|453980535|FG005|Overall Study|Study Drug Put on Hold|0|||
126190241|NCT03799627|453980536|FG006|Overall Study|Study Drug Put on Hold|0|||
126190242|NCT03799627|453980537|FG007|Overall Study|Study Drug Put on Hold|0|||
126190243|NCT03799627|453980538|FG008|Overall Study|Study Drug Put on Hold|0|||
126190244|NCT03799627|453980530|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
126190245|NCT03799627|453980531|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
126190246|NCT03799627|453980532|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
126190247|NCT03799627|453980533|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
126190248|NCT03799627|453980534|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
126190249|NCT03799627|453980535|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
126190250|NCT03799627|453980536|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
126190251|NCT03799627|453980537|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
126190252|NCT03799627|453980538|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
126190253|NCT03799627|453980530|FG000|Overall Study|Kidney Transplantation|1|||
126190254|NCT03799627|453980531|FG001|Overall Study|Kidney Transplantation|0|||
126190255|NCT03799627|453980532|FG002|Overall Study|Kidney Transplantation|0|||
126190256|NCT03799627|453980533|FG003|Overall Study|Kidney Transplantation|1|||
126190257|NCT03799627|453980534|FG004|Overall Study|Kidney Transplantation|1|||
126190258|NCT03799627|453980535|FG005|Overall Study|Kidney Transplantation|0|||
126190259|NCT03799627|453980536|FG006|Overall Study|Kidney Transplantation|0|||
126190260|NCT03799627|453980537|FG007|Overall Study|Kidney Transplantation|0|||
126190261|NCT03799627|453980538|FG008|Overall Study|Kidney Transplantation|0|||
126190262|NCT03799627|453980530|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
126190263|NCT03799627|453980531|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
126190264|NCT03799627|453980532|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
126190265|NCT03799627|453980533|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
126190266|NCT03799627|453980534|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
126190267|NCT03799627|453980535|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
126190268|NCT03799627|453980536|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
126190269|NCT03799627|453980537|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
126190270|NCT03799627|453980538|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
126190271|NCT03799627|453980530|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126190272|NCT03799627|453980531|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
126190273|NCT03799627|453980532|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126190274|NCT03799627|453980533|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126190275|NCT03799627|453980534|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126190276|NCT03799627|453980535|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126190277|NCT03799627|453980536|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126190278|NCT03799627|453980537|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126190279|NCT03799627|453980538|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126190280|NCT03799627|453980530|FG000|Overall Study|Met Exclusion Criteria|0|||
126190281|NCT03799627|453980531|FG001|Overall Study|Met Exclusion Criteria|0|||
126190282|NCT03799627|453980532|FG002|Overall Study|Met Exclusion Criteria|0|||
126190283|NCT03799627|453980533|FG003|Overall Study|Met Exclusion Criteria|1|||
126190284|NCT03799627|453980534|FG004|Overall Study|Met Exclusion Criteria|0|||
126190285|NCT03799627|453980535|FG005|Overall Study|Met Exclusion Criteria|0|||
126190286|NCT03799627|453980536|FG006|Overall Study|Met Exclusion Criteria|0|||
126190287|NCT03799627|453980537|FG007|Overall Study|Met Exclusion Criteria|0|||
126190288|NCT03799627|453980538|FG008|Overall Study|Met Exclusion Criteria|0|||
126190289|NCT03799627|453980530|FG000|Overall Study|Investigational Product Noncompliance|0|||
126190290|NCT03799627|453980531|FG001|Overall Study|Investigational Product Noncompliance|0|||
126190291|NCT03799627|453980532|FG002|Overall Study|Investigational Product Noncompliance|0|||
126190292|NCT03799627|453980533|FG003|Overall Study|Investigational Product Noncompliance|1|||
126190293|NCT03799627|453980534|FG004|Overall Study|Investigational Product Noncompliance|0|||
126190294|NCT03799627|453980535|FG005|Overall Study|Investigational Product Noncompliance|0|||
126190295|NCT03799627|453980536|FG006|Overall Study|Investigational Product Noncompliance|0|||
126190296|NCT03799627|453980537|FG007|Overall Study|Investigational Product Noncompliance|0|||
126190297|NCT03799627|453980538|FG008|Overall Study|Investigational Product Noncompliance|0|||
126190298|NCT03799627|453980530|FG000|Overall Study|Participant Relocation|0|||
126190299|NCT03799627|453980531|FG001|Overall Study|Participant Relocation|0|||
126190300|NCT03799627|453980532|FG002|Overall Study|Participant Relocation|0|||
126190301|NCT03799627|453980533|FG003|Overall Study|Participant Relocation|1|||
126190302|NCT03799627|453980534|FG004|Overall Study|Participant Relocation|0|||
126190303|NCT03799627|453980535|FG005|Overall Study|Participant Relocation|1|||
126190304|NCT03799627|453980536|FG006|Overall Study|Participant Relocation|0|||
126190305|NCT03799627|453980537|FG007|Overall Study|Participant Relocation|0|||
126190306|NCT03799627|453980538|FG008|Overall Study|Participant Relocation|0|||
126190307|NCT03799627|453980530|FG000|Overall Study|Eurofin Issue|0|||
126190308|NCT03799627|453980531|FG001|Overall Study|Eurofin Issue|0|||
126190309|NCT03799627|453980532|FG002|Overall Study|Eurofin Issue|0|||
126190310|NCT03799627|453980533|FG003|Overall Study|Eurofin Issue|0|||
126190311|NCT03799627|453980534|FG004|Overall Study|Eurofin Issue|1|||
126190312|NCT03799627|453980535|FG005|Overall Study|Eurofin Issue|0|||
126190313|NCT03799627|453980536|FG006|Overall Study|Eurofin Issue|0|||
126190314|NCT03799627|453980537|FG007|Overall Study|Eurofin Issue|0|||
126190315|NCT03799627|453980538|FG008|Overall Study|Eurofin Issue|0|||
126190316|NCT03799627|453980530|FG000|Overall Study|Noncompliance with Site Instructions|0|||
126190317|NCT03799627|453980531|FG001|Overall Study|Noncompliance with Site Instructions|0|||
126190318|NCT03799627|453980532|FG002|Overall Study|Noncompliance with Site Instructions|0|||
126190319|NCT03799627|453980533|FG003|Overall Study|Noncompliance with Site Instructions|0|||
126190320|NCT03799627|453980534|FG004|Overall Study|Noncompliance with Site Instructions|1|||
126190321|NCT03799627|453980535|FG005|Overall Study|Noncompliance with Site Instructions|0|||
126190322|NCT03799627|453980536|FG006|Overall Study|Noncompliance with Site Instructions|0|||
126190323|NCT03799627|453980537|FG007|Overall Study|Noncompliance with Site Instructions|0|||
126190324|NCT03799627|453980538|FG008|Overall Study|Noncompliance with Site Instructions|0|||
126190325|NCT03799627|453980530|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126190326|NCT03799627|453980531|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126190327|NCT03799627|453980532|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126190328|NCT03799627|453980533|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126190329|NCT03799627|453980534|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
126190330|NCT03799627|453980535|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126190331|NCT03799627|453980536|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126190332|NCT03799627|453980537|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126190333|NCT03799627|453980538|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126190334|NCT03799627|453980530|FG000|Overall Study|Changes In Hemoglobin Values|1|||
126190335|NCT03799627|453980531|FG001|Overall Study|Changes In Hemoglobin Values|2|||
126190336|NCT03799627|453980532|FG002|Overall Study|Changes In Hemoglobin Values|1|||
126190337|NCT03799627|453980533|FG003|Overall Study|Changes In Hemoglobin Values|0|||
126190338|NCT03799627|453980534|FG004|Overall Study|Changes In Hemoglobin Values|0|||
126190339|NCT03799627|453980535|FG005|Overall Study|Changes In Hemoglobin Values|2|||
126190340|NCT03799627|453980536|FG006|Overall Study|Changes In Hemoglobin Values|1|||
126190341|NCT03799627|453980537|FG007|Overall Study|Changes In Hemoglobin Values|0|||
126190342|NCT03799627|453980538|FG008|Overall Study|Changes In Hemoglobin Values|1|||
126190343|NCT02092324|453980541|FG000|Overall Study|Adverse Event|1|||
126190344|NCT02092324|453980541|FG000|Overall Study|Lack of Efficacy|6|||
126190345|NCT02092324|453980541|FG000|Overall Study|Proceed to Transplant|3|||
126190346|NCT02092324|453980541|FG000|Overall Study|Physician Decision|7|||
126190347|NCT02092324|453980541|FG000|Overall Study|Misdiagnosis|2|||
126190348|NCT01922739|453980548|FG000|Titration/Adjustment Period|Adverse Event|3|||
126190349|NCT01922739|453980548|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
126190350|NCT01922739|453980548|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
126190351|NCT01922739|453980548|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
126190352|NCT01922739|453980548|FG000|Open-label Treatment Period|Adverse Event|6|||
126190353|NCT01922739|453980548|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
126190354|NCT01922739|453980548|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
126190355|NCT01922739|453980548|FG000|Open-label Treatment Period|Protocol Violation|5|||
126190356|NCT01922739|453980548|FG000|Open-label Treatment Period|Pregnancy|1|||
126190357|NCT01922739|453980548|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
126190358|NCT01922739|453980548|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
126190359|NCT01922739|453980548|FG000|Open-label Treatment Period|Physician Decision|1|||
126190360|NCT01922739|453980548|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
126190361|NCT04498468|453980551|FG000|Overall Study|Lost to Follow-up|3|||
126190362|NCT02725268|453980552|FG000|Overall Study|Death|58|||
126190363|NCT02725268|453980553|FG001|Overall Study|Death|59|||
126190364|NCT02725268|453980554|FG002|Overall Study|Death|30|||
126190365|NCT02725268|453980555|FG003|Overall Study|Death|16|||
126190366|NCT02725268|453980552|FG000|Overall Study|Lost to Follow-up|4|||
126190367|NCT02725268|453980553|FG001|Overall Study|Lost to Follow-up|3|||
126190368|NCT02725268|453980554|FG002|Overall Study|Lost to Follow-up|0|||
126190369|NCT02725268|453980555|FG003|Overall Study|Lost to Follow-up|1|||
126190370|NCT02725268|453980552|FG000|Overall Study|Site Terminated by Sponsor|0|||
126190371|NCT02725268|453980553|FG001|Overall Study|Site Terminated by Sponsor|1|||
126190372|NCT02725268|453980554|FG002|Overall Study|Site Terminated by Sponsor|0|||
126190373|NCT02725268|453980555|FG003|Overall Study|Site Terminated by Sponsor|0|||
126190374|NCT02725268|453980552|FG000|Overall Study|Withdrawal by Subject|8|||
126190375|NCT02725268|453980553|FG001|Overall Study|Withdrawal by Subject|6|||
126190376|NCT02725268|453980554|FG002|Overall Study|Withdrawal by Subject|8|||
126190377|NCT02725268|453980555|FG003|Overall Study|Withdrawal by Subject|1|||
126190378|NCT02725268|453980552|FG000|Overall Study|Reason not Specified|2|||
126190379|NCT02725268|453980553|FG001|Overall Study|Reason not Specified|1|||
126190380|NCT02725268|453980554|FG002|Overall Study|Reason not Specified|0|||
126190381|NCT02725268|453980555|FG003|Overall Study|Reason not Specified|0|||
126190382|NCT02224274|453980557|FG000|Overall Study|Death|1|||
126190383|NCT02224274|453980558|FG001|Overall Study|Death|0|||
126190384|NCT01976624|453980559|FG000|Overall Study|Participants contraindicated|2|||
126190385|NCT01976624|453980559|FG000|Overall Study|Participants age less than 19 years|12|||
126190386|NCT04350372|453980560|FG000|Overall Study|Death|1|||
126190387|NCT00412113|453980562|FG000|Overall Study|Adverse Event|11|||
126190388|NCT00412113|453980563|FG001|Overall Study|Adverse Event|15|||
126190389|NCT00412113|453980562|FG000|Overall Study|did not receive treatment|1|||
126190390|NCT00412113|453980563|FG001|Overall Study|did not receive treatment|0|||
126190391|NCT01998906|453982117|FG000|Overall Study|Participants ongoing in follow-up|77|||
126190392|NCT01998906|453982118|FG001|Overall Study|Participants ongoing in follow-up|60|||
126190393|NCT01998906|453982119|FG002|Overall Study|Participants ongoing in follow-up|58|||
126190394|NCT01998906|453982117|FG000|Overall Study|Death|21|||
126190395|NCT01998906|453982118|FG001|Overall Study|Death|30|||
126190396|NCT01998906|453982119|FG002|Overall Study|Death|17|||
126190397|NCT01998906|453982117|FG000|Overall Study|Lack of Efficacy|10|||
126190398|NCT01998906|453982118|FG001|Overall Study|Lack of Efficacy|9|||
126190399|NCT01998906|453982119|FG002|Overall Study|Lack of Efficacy|8|||
126190400|NCT01998906|453982117|FG000|Overall Study|Failure to return|0|||
126190401|NCT01998906|453982118|FG001|Overall Study|Failure to return|2|||
126190402|NCT01998906|453982119|FG002|Overall Study|Failure to return|4|||
126190403|NCT01998906|453982117|FG000|Overall Study|Violation of Selection Criteria|0|||
126190404|NCT01998906|453982118|FG001|Overall Study|Violation of Selection Criteria|0|||
126190405|NCT01998906|453982119|FG002|Overall Study|Violation of Selection Criteria|1|||
126190406|NCT01998906|453982117|FG000|Overall Study|Withdrawal by Subject|1|||
126190407|NCT01998906|453982118|FG001|Overall Study|Withdrawal by Subject|4|||
126190408|NCT01998906|453982119|FG002|Overall Study|Withdrawal by Subject|3|||
126190409|NCT01998906|453982117|FG000|Overall Study|Administrative/Other|2|||
126190410|NCT01998906|453982118|FG001|Overall Study|Administrative/Other|1|||
126190411|NCT01998906|453982119|FG002|Overall Study|Administrative/Other|3|||
126190412|NCT01998906|453982117|FG000|Overall Study|Other|3|||
126190413|NCT01998906|453982118|FG001|Overall Study|Other|8|||
126190414|NCT01998906|453982119|FG002|Overall Study|Other|4|||
126190415|NCT02996110|453982120|FG000|Pre-Treatment|Other Reasons|0|||
126190416|NCT02996110|453982121|FG001|Pre-Treatment|Other Reasons|1|||
126190417|NCT02996110|453982122|FG002|Pre-Treatment|Other Reasons|0|||
126190418|NCT02996110|453982123|FG003|Pre-Treatment|Other Reasons|0|||
126190419|NCT02996110|453982124|FG004|Pre-Treatment|Other Reasons|1|||
126190420|NCT02996110|453982120|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
126190421|NCT02996110|453982121|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
126190422|NCT02996110|453982122|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
126190423|NCT02996110|453982123|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
126190424|NCT02996110|453982124|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
126190425|NCT02996110|453982120|FG000|Track 1|Disease Progression|15|||
126190426|NCT02996110|453982121|FG001|Track 1|Disease Progression|17|||
126190427|NCT02996110|453982122|FG002|Track 1|Disease Progression|0|||
126190428|NCT02996110|453982123|FG003|Track 1|Disease Progression|0|||
126190429|NCT02996110|453982124|FG004|Track 1|Disease Progression|0|||
126190430|NCT02996110|453982120|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
126190431|NCT02996110|453982121|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
126190432|NCT02996110|453982122|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
126190433|NCT02996110|453982123|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
126190434|NCT02996110|453982124|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
126190435|NCT02996110|453982120|FG000|Track 1|Study Drug Toxicity|5|||
126190436|NCT02996110|453982121|FG001|Track 1|Study Drug Toxicity|3|||
126190437|NCT02996110|453982122|FG002|Track 1|Study Drug Toxicity|0|||
126190438|NCT02996110|453982123|FG003|Track 1|Study Drug Toxicity|0|||
126190439|NCT02996110|453982124|FG004|Track 1|Study Drug Toxicity|0|||
126190440|NCT02996110|453982120|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
126190441|NCT02996110|453982121|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
126190442|NCT02996110|453982122|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
126190443|NCT02996110|453982123|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
126190444|NCT02996110|453982124|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
126190445|NCT02996110|453982120|FG000|Track 1|Administrative Reason by Sponsor|0|||
126190446|NCT02996110|453982121|FG001|Track 1|Administrative Reason by Sponsor|1|||
126190447|NCT02996110|453982122|FG002|Track 1|Administrative Reason by Sponsor|0|||
126190448|NCT02996110|453982123|FG003|Track 1|Administrative Reason by Sponsor|0|||
126190449|NCT02996110|453982124|FG004|Track 1|Administrative Reason by Sponsor|0|||
126190450|NCT02996110|453982120|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
126190451|NCT02996110|453982121|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
126190452|NCT02996110|453982122|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
126190453|NCT02996110|453982123|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
126190454|NCT02996110|453982124|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
126190455|NCT02996110|453982120|FG000|Track 2|Disease Progression|33|||
126190456|NCT02996110|453982121|FG001|Track 2|Disease Progression|26|||
126190457|NCT02996110|453982122|FG002|Track 2|Disease Progression|19|||
126190458|NCT02996110|453982123|FG003|Track 2|Disease Progression|16|||
126190459|NCT02996110|453982124|FG004|Track 2|Disease Progression|15|||
126190460|NCT02996110|453982120|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
126190461|NCT02996110|453982121|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
126190462|NCT02996110|453982122|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
126190463|NCT02996110|453982123|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
126190464|NCT02996110|453982124|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
126190465|NCT02996110|453982120|FG000|Track 2|Death|0|||
126190466|NCT02996110|453982121|FG001|Track 2|Death|0|||
126190467|NCT02996110|453982122|FG002|Track 2|Death|1|||
126190468|NCT02996110|453982123|FG003|Track 2|Death|0|||
126190469|NCT02996110|453982124|FG004|Track 2|Death|1|||
126190470|NCT02996110|453982120|FG000|Track 2|Study Drug Toxicity|4|||
126190471|NCT02996110|453982121|FG001|Track 2|Study Drug Toxicity|1|||
126190472|NCT02996110|453982122|FG002|Track 2|Study Drug Toxicity|4|||
126190473|NCT02996110|453982123|FG003|Track 2|Study Drug Toxicity|1|||
126190474|NCT02996110|453982124|FG004|Track 2|Study Drug Toxicity|0|||
126190475|NCT02996110|453982120|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
126190476|NCT02996110|453982121|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
126190477|NCT02996110|453982122|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
126190478|NCT02996110|453982123|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
126190479|NCT02996110|453982124|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
126190480|NCT02996110|453982120|FG000|Track 2|Participant Withdrew Consent|1|||
126190481|NCT02996110|453982121|FG001|Track 2|Participant Withdrew Consent|2|||
126190482|NCT02996110|453982122|FG002|Track 2|Participant Withdrew Consent|3|||
126190483|NCT02996110|453982123|FG003|Track 2|Participant Withdrew Consent|1|||
126190484|NCT02996110|453982124|FG004|Track 2|Participant Withdrew Consent|1|||
126190485|NCT02996110|453982120|FG000|Track 2|Other Reasons|0|||
126190486|NCT02996110|453982121|FG001|Track 2|Other Reasons|0|||
126190487|NCT02996110|453982122|FG002|Track 2|Other Reasons|1|||
126190488|NCT02996110|453982123|FG003|Track 2|Other Reasons|0|||
126190489|NCT02996110|453982124|FG004|Track 2|Other Reasons|1|||
126190490|NCT01077193|453982125|FG000|Overall Study|Lost to Follow-up|1|||
126190491|NCT01077193|453982125|FG000|Overall Study|Withdrawal by Subject|2|||
126190492|NCT01077193|453982125|FG000|Overall Study|Lack of Efficacy|1|||
126190493|NCT01077193|453982125|FG000|Overall Study|Study Terminated by Sponsor|40|||
126190494|NCT06048809|453982130|FG000|Overall Study|Adverse Event|2|||
126190495|NCT06048809|453982131|FG001|Overall Study|Adverse Event|0|||
126190496|NCT06048809|453982130|FG000|Overall Study|Withdrawal by Subject|1|||
126190497|NCT06048809|453982131|FG001|Overall Study|Withdrawal by Subject|1|||
126190498|NCT00373880|453982137|FG000|Overall Study|Physician Decision|3|||
126190499|NCT00373880|453982137|FG000|Overall Study|Arrested|1|||
126190500|NCT00373880|453982137|FG000|Overall Study|Protocol Violation|14|||
126190501|NCT03748420|453982138|FG000|Overall Study|No 12 month medication adherence data available|0|||
126190502|NCT03748420|453982139|FG001|Overall Study|No 12 month medication adherence data available|1|||
126190503|NCT03748420|453982138|FG000|Overall Study|Death|24|||
126190504|NCT03748420|453982139|FG001|Overall Study|Death|28|||
126190505|NCT03748420|453982138|FG000|Overall Study|Lost to Follow-up|231|||
126190506|NCT03748420|453982139|FG001|Overall Study|Lost to Follow-up|230|||
126190507|NCT01925014|453982140|FG000|Overall Study|Inappropriate enrollment|4|||
126190508|NCT01925014|453982141|FG001|Overall Study|Inappropriate enrollment|6|||
126190509|NCT01925014|453982140|FG000|Overall Study|Withdrawal by Subject|5|||
126190510|NCT01925014|453982141|FG001|Overall Study|Withdrawal by Subject|13|||
126190511|NCT00312728|453982152|FG000|Overall Study|Progressive disease|53|||
126190512|NCT00312728|453982152|FG000|Overall Study|Adverse Event|32|||
126190513|NCT00312728|453982152|FG000|Overall Study|Withdrawal by Subject|10|||
126190514|NCT00312728|453982152|FG000|Overall Study|Required non-protocol cancer treatment|2|||
126190515|NCT00312728|453982152|FG000|Overall Study|Protocol Violation|2|||
126190516|NCT00312728|453982152|FG000|Overall Study|Other|10|||
126190517|NCT00312728|453982152|FG000|Overall Study|Other|1|||
126190518|NCT00850135|453982153|FG000|Overall Study|Physician Decision|1|||
126190519|NCT00744991|453982154|FG000|Overall Study|Progressive Disease|11|||
126190520|NCT00744991|453982154|FG000|Overall Study|Withdrawal by Subject|8|||
126190521|NCT00744991|453982154|FG000|Overall Study|Physician Decision|3|||
126190522|NCT00744991|453982154|FG000|Overall Study|Adverse Event|2|||
126190523|NCT00744991|453982154|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
126190524|NCT02139280|453982158|FG000|Overall Study|No longer eligible|2|||
126190525|NCT02139280|453982159|FG001|Overall Study|No longer eligible|0|||
126190526|NCT00422903|453982172|FG000|Overall Study|Disease Progression|3|||
126190527|NCT00422903|453982173|FG001|Overall Study|Disease Progression|1|||
126190528|NCT00422903|453982172|FG000|Overall Study|Adverse Event|0|||
126190529|NCT00422903|453982173|FG001|Overall Study|Adverse Event|2|||
126190530|NCT00422903|453982172|FG000|Overall Study|Informed Consent Withdrawn|1|||
126190531|NCT00422903|453982173|FG001|Overall Study|Informed Consent Withdrawn|2|||
126190532|NCT01302691|453982174|FG000|Overall Study|Adverse Event|2|||
126190533|NCT01302691|453982175|FG001|Overall Study|Adverse Event|0|||
126190534|NCT01302691|453982174|FG000|Overall Study|Death|0|||
126190535|NCT01302691|453982175|FG001|Overall Study|Death|1|||
126190536|NCT01302691|453982174|FG000|Overall Study|Lost to Follow-up|1|||
126190537|NCT01302691|453982175|FG001|Overall Study|Lost to Follow-up|0|||
126190538|NCT01302691|453982174|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
126190539|NCT01302691|453982175|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
126190540|NCT01302691|453982174|FG000|Overall Study|Physician Decision|0|||
126190541|NCT01302691|453982175|FG001|Overall Study|Physician Decision|1|||
126190542|NCT01302691|453982174|FG000|Overall Study|Protocol Violation|1|||
126190543|NCT01302691|453982175|FG001|Overall Study|Protocol Violation|0|||
126190544|NCT00423592|453982176|FG000|Overall Study|Adverse Event (through Week 12)|2|||
126190545|NCT00423592|453982176|FG000|Overall Study|Adverse Event (post Week 12)|5|||
126190546|NCT03446612|453982177|FG000|Overall Study|Protocol defined stopping criteria|0|||
126190547|NCT03446612|453982178|FG001|Overall Study|Protocol defined stopping criteria|1|||
126190548|NCT01437267|453982179|FG000|Overall Study|Withdrawal by Subject|0|||
126190549|NCT01437267|453982180|FG001|Overall Study|Withdrawal by Subject|0|||
126190550|NCT01437267|453982181|FG002|Overall Study|Withdrawal by Subject|0|||
126190551|NCT01437267|453982182|FG003|Overall Study|Withdrawal by Subject|1|||
126190552|NCT01437267|453982183|FG004|Overall Study|Withdrawal by Subject|0|||
126190553|NCT01437267|453982184|FG005|Overall Study|Withdrawal by Subject|0|||
126190554|NCT01437267|453982179|FG000|Overall Study|Protocol Violation|0|||
126190555|NCT01437267|453982180|FG001|Overall Study|Protocol Violation|1|||
126190556|NCT01437267|453982181|FG002|Overall Study|Protocol Violation|0|||
126190557|NCT01437267|453982182|FG003|Overall Study|Protocol Violation|0|||
126190558|NCT01437267|453982183|FG004|Overall Study|Protocol Violation|0|||
126190559|NCT01437267|453982184|FG005|Overall Study|Protocol Violation|0|||
126190560|NCT03934203|453982187|FG000|Overall Study|Adverse Event|0|||
126190561|NCT03934203|453982188|FG001|Overall Study|Adverse Event|0|||
126190562|NCT03934203|453982189|FG002|Overall Study|Adverse Event|1|||
126190563|NCT03934203|453982190|FG003|Overall Study|Adverse Event|0|||
126190564|NCT03934203|453982191|FG004|Overall Study|Adverse Event|1|||
126190565|NCT03934203|453982192|FG005|Overall Study|Adverse Event|0|||
126190566|NCT03934203|453982193|FG006|Overall Study|Adverse Event|2|||
126190567|NCT03934203|453982194|FG007|Overall Study|Adverse Event|0|||
126190568|NCT03934203|453982195|FG008|Overall Study|Adverse Event|0|||
126190569|NCT03934203|453982196|FG009|Overall Study|Adverse Event|0|||
126190570|NCT03934203|453982197|FG010|Overall Study|Adverse Event|0|||
126190571|NCT03934203|453982198|FG011|Overall Study|Adverse Event|0|||
126190572|NCT03934203|453982199|FG012|Overall Study|Adverse Event|0|||
126190573|NCT03934203|453982200|FG013|Overall Study|Adverse Event|1|||
126190574|NCT03934203|453982201|FG014|Overall Study|Adverse Event|0|||
126190575|NCT00441480|453982204|FG000|Overall Study|Protocol Violation|1|||
126190576|NCT00441480|453982205|FG001|Overall Study|Protocol Violation|1|||
126190577|NCT00441480|453982204|FG000|Overall Study|Withdrawal by Subject|2|||
126190578|NCT00441480|453982205|FG001|Overall Study|Withdrawal by Subject|3|||
126190579|NCT00608842|453982206|FG000|Overall Study|Participant's Request|0|||
126190580|NCT00608842|453982207|FG001|Overall Study|Participant's Request|1|||
126190581|NCT00608842|453982208|FG002|Overall Study|Participant's Request|2|||
126190582|NCT00608842|453982209|FG003|Overall Study|Participant's Request|1|||
126190583|NCT00608842|453982206|FG000|Overall Study|Lost to Follow-up|1|||
126190584|NCT00608842|453982207|FG001|Overall Study|Lost to Follow-up|0|||
126190585|NCT00608842|453982208|FG002|Overall Study|Lost to Follow-up|0|||
126190586|NCT00608842|453982209|FG003|Overall Study|Lost to Follow-up|0|||
126190587|NCT01039428|453982212|FG000|Overall Study|Protocol Violation|1|||
126190588|NCT01039428|453982213|FG001|Overall Study|Protocol Violation|0|||
126190589|NCT01039428|453982212|FG000|Overall Study|Withdrawal by Subject|1|||
126190590|NCT01039428|453982213|FG001|Overall Study|Withdrawal by Subject|0|||
126190591|NCT00422240|453982216|FG000|Overall Study|Lack of Efficacy|1|||
126190592|NCT00422240|453982217|FG001|Overall Study|Lack of Efficacy|2|||
126190593|NCT00422240|453982218|FG002|Overall Study|Lack of Efficacy|0|||
126190594|NCT00422240|453982219|FG003|Overall Study|Lack of Efficacy|1|||
126190595|NCT00422240|453982216|FG000|Overall Study|Adverse Event|11|||
126190596|NCT00422240|453982217|FG001|Overall Study|Adverse Event|4|||
126190597|NCT00422240|453982218|FG002|Overall Study|Adverse Event|5|||
126190598|NCT00422240|453982219|FG003|Overall Study|Adverse Event|2|||
126190599|NCT00422240|453982216|FG000|Overall Study|Subject request|21|||
126190600|NCT00422240|453982217|FG001|Overall Study|Subject request|17|||
126190601|NCT00422240|453982218|FG002|Overall Study|Subject request|18|||
126190602|NCT00422240|453982219|FG003|Overall Study|Subject request|30|||
126190603|NCT00422240|453982216|FG000|Overall Study|Protocol Violation|0|||
126190604|NCT00422240|453982217|FG001|Overall Study|Protocol Violation|1|||
126190605|NCT00422240|453982218|FG002|Overall Study|Protocol Violation|0|||
126190606|NCT00422240|453982219|FG003|Overall Study|Protocol Violation|1|||
126190607|NCT00422240|453982216|FG000|Overall Study|Lost to Follow-up|31|||
126190608|NCT00422240|453982217|FG001|Overall Study|Lost to Follow-up|32|||
126190609|NCT00422240|453982218|FG002|Overall Study|Lost to Follow-up|19|||
126190610|NCT00422240|453982219|FG003|Overall Study|Lost to Follow-up|34|||
126190611|NCT00422240|453982216|FG000|Overall Study|Other|1|||
126190612|NCT00422240|453982217|FG001|Overall Study|Other|0|||
126190613|NCT00422240|453982218|FG002|Overall Study|Other|0|||
126190614|NCT00422240|453982219|FG003|Overall Study|Other|1|||
126190615|NCT00422240|453982216|FG000|Overall Study|Pregnancy|3|||
126190616|NCT00422240|453982217|FG001|Overall Study|Pregnancy|1|||
126190617|NCT00422240|453982218|FG002|Overall Study|Pregnancy|1|||
126190618|NCT00422240|453982219|FG003|Overall Study|Pregnancy|2|||
126190619|NCT00441012|453982220|FG000|Overall Study|Adverse Event|0|||
126190620|NCT00441012|453982221|FG001|Overall Study|Adverse Event|1|||
126190621|NCT00441012|453982220|FG000|Overall Study|Lost to Follow-up|3|||
126190622|NCT00441012|453982221|FG001|Overall Study|Lost to Follow-up|3|||
126190623|NCT00441012|453982220|FG000|Overall Study|Protocol Violation|10|||
126190624|NCT00441012|453982221|FG001|Overall Study|Protocol Violation|9|||
126190625|NCT00441012|453982220|FG000|Overall Study|Withdrawal by Subject|4|||
126190626|NCT00441012|453982221|FG001|Overall Study|Withdrawal by Subject|0|||
126190627|NCT00441012|453982220|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
126190628|NCT00441012|453982221|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
126190629|NCT04489940|453982222|FG000|Overall Study|Other|2|||
126190630|NCT04489940|453982222|FG000|Overall Study|Withdrawal by Subject|2|||
126190631|NCT04489940|453982222|FG000|Overall Study|Death|5|||
126190632|NCT04489940|453982222|FG000|Overall Study|Lost to Follow-up|1|||
126190633|NCT01624467|453982223|FG000|Overall Study|Withdrawal by Subject|2|||
126190634|NCT01624467|453982223|FG000|Overall Study|Lost to Follow-up|1|||
126190635|NCT01624467|453982223|FG000|Overall Study|Adverse Event|7|||
126190636|NCT01624467|453982223|FG000|Overall Study|Progressive Disease|19|||
126190637|NCT01624467|453982223|FG000|Overall Study|Per Sponsor Requirement|1|||
126190638|NCT01624467|453982223|FG000|Overall Study|Subject Withdrew from Treatment|1|||
126190639|NCT02201472|453982226|FG000|Overall Study|Lack of Efficacy|2|||
126190640|NCT00262314|453982229|FG000|Overall Study|Changing physicians|38|||
126190641|NCT00262314|453982229|FG000|Overall Study|Death|12|||
126190642|NCT00262314|453982229|FG000|Overall Study|Patient's decision|92|||
126190643|NCT00262314|453982229|FG000|Overall Study|Other|95|||
126190644|NCT00262314|453982229|FG000|Overall Study|Lost to Follow-up|70|||
126190645|NCT00262314|453982229|FG000|Overall Study|Administrative withdrawal|30|||
126190646|NCT05104749|453982230|FG000|Overall Study|Lost to Follow-up|2|||
126190647|NCT05104749|453982231|FG001|Overall Study|Lost to Follow-up|3|||
126190648|NCT03964493|453982232|FG000|Overall Study|Withdrawal by Subject|4|||
126190649|NCT03964493|453982233|FG001|Overall Study|Withdrawal by Subject|1|||
126190650|NCT03964493|453982232|FG000|Overall Study|Lost to Follow-up|13|||
126190651|NCT03964493|453982233|FG001|Overall Study|Lost to Follow-up|4|||
126190652|NCT02470429|453982234|FG000|Overall Study|Adverse Event|1|||
126190653|NCT02470429|453982235|FG001|Overall Study|Adverse Event|0|||
126190654|NCT02470429|453982234|FG000|Overall Study|Withdrawal by Subject|1|||
126190655|NCT02470429|453982235|FG001|Overall Study|Withdrawal by Subject|0|||
126190656|NCT01300767|453982236|FG000|Overall Study|Discomfort|2|||
126190657|NCT01300767|453982236|FG000|Overall Study|Biomicroscopy|1|||
126190658|NCT01300767|453982236|FG000|Overall Study|Unacceptable fit|1|||
126190659|NCT00398138|453982237|FG000|Overall Study|Adverse Event|2|||
126190660|NCT00117572|453982240|FG000|Overall Study|Site withdrew before starting treatment|2|||
126190661|NCT00117572|453982241|FG001|Overall Study|Site withdrew before starting treatment|3|||
126190662|NCT00117572|453982240|FG000|Overall Study|Withdrawal by Subject|3|||
126190663|NCT00117572|453982241|FG001|Overall Study|Withdrawal by Subject|3|||
126190664|NCT00117572|453982240|FG000|Overall Study|Protocol Violation|1|||
126190665|NCT00117572|453982241|FG001|Overall Study|Protocol Violation|0|||
126190666|NCT04973085|453982246|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
126190667|NCT04973085|453982247|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
126190668|NCT00887068|453982248|FG000|Overall Study|Withdrawal by Subject|2|||
126190669|NCT00887068|453982249|FG001|Overall Study|Withdrawal by Subject|0|||
126199940|NCT01117428|454017807|FG003|Overall Study|Adverse Event|0|||
126190670|NCT00887068|453982248|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
126190671|NCT00887068|453982249|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
126190672|NCT01188811|453982255|FG000|Overall Study|Withdrawal by Subject|0|||
126190673|NCT01188811|453982256|FG001|Overall Study|Withdrawal by Subject|2|||
126190674|NCT01188811|453982255|FG000|Overall Study|Adverse Event|6|||
126190675|NCT01188811|453982256|FG001|Overall Study|Adverse Event|0|||
126190676|NCT01602744|453982257|FG000|Overall Study|Death|17|||
126190677|NCT01602744|453982258|FG001|Overall Study|Death|15|||
126190678|NCT01602744|453982257|FG000|Overall Study|Lost to Follow-up|13|||
126190679|NCT01602744|453982258|FG001|Overall Study|Lost to Follow-up|8|||
126190680|NCT03418376|453982259|FG000|Overall Study|Musculoskeletal injury|1|||
126190681|NCT03418376|453982260|FG001|Overall Study|Musculoskeletal injury|2|||
126190682|NCT03418376|453982261|FG002|Overall Study|Musculoskeletal injury|1|||
126190683|NCT03418376|453982262|FG003|Overall Study|Musculoskeletal injury|0|||
126190684|NCT03418376|453982259|FG000|Overall Study|Personal reasons|0|||
126190685|NCT03418376|453982260|FG001|Overall Study|Personal reasons|2|||
126190686|NCT03418376|453982261|FG002|Overall Study|Personal reasons|2|||
126190687|NCT03418376|453982262|FG003|Overall Study|Personal reasons|1|||
126190688|NCT03418376|453982259|FG000|Overall Study|Exacerbation|0|||
126190689|NCT03418376|453982260|FG001|Overall Study|Exacerbation|1|||
126190690|NCT03418376|453982261|FG002|Overall Study|Exacerbation|0|||
126190691|NCT03418376|453982262|FG003|Overall Study|Exacerbation|0|||
126190692|NCT01387594|453982267|FG000|Overall Study|Withdrawal by Subject|0|||
126190693|NCT01387594|453982268|FG001|Overall Study|Withdrawal by Subject|2|||
126190694|NCT01387594|453982267|FG000|Overall Study|Lost to Follow-up|0|||
126190695|NCT01387594|453982268|FG001|Overall Study|Lost to Follow-up|1|||
126190696|NCT03573804|453982280|FG000|Overall Study|claustrophobia or MRI table problems|10|||
126190697|NCT04507360|453984064|FG000|Week 1|Lost to Follow-up|0|||
126190698|NCT04507360|453984065|FG001|Week 1|Lost to Follow-up|0|||
126190699|NCT04507360|453984066|FG002|Week 1|Lost to Follow-up|0|||
126190700|NCT04507360|453984067|FG003|Week 1|Lost to Follow-up|0|||
126190701|NCT04507360|453984068|FG004|Week 1|Lost to Follow-up|0|||
126190702|NCT04507360|453984069|FG005|Week 1|Lost to Follow-up|0|||
126190703|NCT04507360|453984070|FG006|Week 1|Lost to Follow-up|0|||
126190704|NCT04507360|453984071|FG007|Week 1|Lost to Follow-up|0|||
126190705|NCT04507360|453984072|FG008|Week 1|Lost to Follow-up|72|||
126190706|NCT04507360|453984073|FG009|Week 1|Lost to Follow-up|22|||
126190707|NCT04507360|453984074|FG010|Week 1|Lost to Follow-up|10|||
126190708|NCT04507360|453984064|FG000|Week 2|Lost to Follow-up|0|||
126190709|NCT04507360|453984065|FG001|Week 2|Lost to Follow-up|0|||
126190710|NCT04507360|453984066|FG002|Week 2|Lost to Follow-up|0|||
126190711|NCT04507360|453984067|FG003|Week 2|Lost to Follow-up|0|||
126190712|NCT04507360|453984068|FG004|Week 2|Lost to Follow-up|0|||
126190713|NCT04507360|453984069|FG005|Week 2|Lost to Follow-up|0|||
126190714|NCT04507360|453984070|FG006|Week 2|Lost to Follow-up|0|||
126190715|NCT04507360|453984071|FG007|Week 2|Lost to Follow-up|0|||
126190716|NCT04507360|453984072|FG008|Week 2|Lost to Follow-up|121|||
126190717|NCT04507360|453984073|FG009|Week 2|Lost to Follow-up|85|||
126190718|NCT04507360|453984074|FG010|Week 2|Lost to Follow-up|82|||
126190719|NCT04507360|453984064|FG000|Week 3|Lost to Follow-up|0|||
126190720|NCT04507360|453984065|FG001|Week 3|Lost to Follow-up|0|||
126190721|NCT04507360|453984066|FG002|Week 3|Lost to Follow-up|0|||
126190722|NCT04507360|453984067|FG003|Week 3|Lost to Follow-up|0|||
126190723|NCT04507360|453984068|FG004|Week 3|Lost to Follow-up|0|||
126190724|NCT04507360|453984069|FG005|Week 3|Lost to Follow-up|0|||
126190725|NCT04507360|453984070|FG006|Week 3|Lost to Follow-up|0|||
126190726|NCT04507360|453984071|FG007|Week 3|Lost to Follow-up|0|||
126190727|NCT04507360|453984072|FG008|Week 3|Lost to Follow-up|123|||
126190728|NCT04507360|453984073|FG009|Week 3|Lost to Follow-up|92|||
126190729|NCT04507360|453984074|FG010|Week 3|Lost to Follow-up|84|||
126190730|NCT04507360|453984064|FG000|Week 4|Lost to Follow-up|0|||
126190731|NCT04507360|453984065|FG001|Week 4|Lost to Follow-up|0|||
126190732|NCT04507360|453984066|FG002|Week 4|Lost to Follow-up|0|||
126190733|NCT04507360|453984067|FG003|Week 4|Lost to Follow-up|0|||
126190734|NCT04507360|453984068|FG004|Week 4|Lost to Follow-up|0|||
126190735|NCT04507360|453984069|FG005|Week 4|Lost to Follow-up|0|||
126190736|NCT04507360|453984070|FG006|Week 4|Lost to Follow-up|0|||
126190737|NCT04507360|453984071|FG007|Week 4|Lost to Follow-up|0|||
126190738|NCT04507360|453984072|FG008|Week 4|Lost to Follow-up|131|||
126190739|NCT04507360|453984073|FG009|Week 4|Lost to Follow-up|115|||
126190740|NCT04507360|453984074|FG010|Week 4|Lost to Follow-up|102|||
126190741|NCT04507360|453984064|FG000|Week 5|Lost to Follow-up|0|||
126190742|NCT04507360|453984065|FG001|Week 5|Lost to Follow-up|0|||
126190743|NCT04507360|453984066|FG002|Week 5|Lost to Follow-up|0|||
126190744|NCT04507360|453984067|FG003|Week 5|Lost to Follow-up|0|||
126190745|NCT04507360|453984068|FG004|Week 5|Lost to Follow-up|0|||
126190746|NCT04507360|453984069|FG005|Week 5|Lost to Follow-up|0|||
126190747|NCT04507360|453984070|FG006|Week 5|Lost to Follow-up|0|||
126190748|NCT04507360|453984071|FG007|Week 5|Lost to Follow-up|0|||
126190749|NCT04507360|453984072|FG008|Week 5|Lost to Follow-up|103|||
126190750|NCT04507360|453984073|FG009|Week 5|Lost to Follow-up|135|||
126190751|NCT04507360|453984074|FG010|Week 5|Lost to Follow-up|143|||
126190752|NCT04507360|453984064|FG000|Week 8|Lost to Follow-up|0|||
126190753|NCT04507360|453984065|FG001|Week 8|Lost to Follow-up|0|||
126190754|NCT04507360|453984066|FG002|Week 8|Lost to Follow-up|0|||
126190755|NCT04507360|453984067|FG003|Week 8|Lost to Follow-up|0|||
126190756|NCT04507360|453984068|FG004|Week 8|Lost to Follow-up|0|||
126190757|NCT04507360|453984069|FG005|Week 8|Lost to Follow-up|0|||
126190758|NCT04507360|453984070|FG006|Week 8|Lost to Follow-up|0|||
126190759|NCT04507360|453984071|FG007|Week 8|Lost to Follow-up|0|||
126190760|NCT04507360|453984072|FG008|Week 8|Lost to Follow-up|139|||
126190761|NCT04507360|453984073|FG009|Week 8|Lost to Follow-up|145|||
126190762|NCT04507360|453984074|FG010|Week 8|Lost to Follow-up|152|||
126190763|NCT00636155|453984075|FG000|Overall Study|Adverse Event|8|||
126190764|NCT00636155|453984075|FG000|Overall Study|Lack of Efficacy|1|||
126190765|NCT00636155|453984075|FG000|Overall Study|Withdrawal by Subject|3|||
126190766|NCT00636155|453984075|FG000|Overall Study|Stem cell transplant|1|||
126190767|NCT00636155|453984075|FG000|Overall Study|Physician Decision|5|||
126190768|NCT01432756|453984076|FG000|Overall Study|Lost to Follow-up|1|||
126190769|NCT01432756|453984077|FG001|Overall Study|Lost to Follow-up|0|||
126190770|NCT01432756|453984078|FG002|Overall Study|Lost to Follow-up|2|||
126190771|NCT01432756|453984079|FG003|Overall Study|Lost to Follow-up|1|||
126190772|NCT01004159|453984087|FG000|Overall Study|Adverse Event|2|||
126190773|NCT01004159|453984087|FG000|Overall Study|Disease Progression|18|||
126190774|NCT03050307|453984096|FG000|Overall Study|Adverse Event|4|||
126190775|NCT03050307|453984097|FG001|Overall Study|Adverse Event|2|||
126190776|NCT03050307|453984096|FG000|Overall Study|Significant Protocol Deviation|0|||
126190777|NCT03050307|453984097|FG001|Overall Study|Significant Protocol Deviation|1|||
126190778|NCT03050307|453984096|FG000|Overall Study|Lost to Follow-up|0|||
126190779|NCT03050307|453984097|FG001|Overall Study|Lost to Follow-up|1|||
126190780|NCT03050307|453984096|FG000|Overall Study|Voluntary Withdrawal|3|||
126190781|NCT03050307|453984097|FG001|Overall Study|Voluntary Withdrawal|4|||
126190782|NCT03050307|453984096|FG000|Overall Study|Reason not Specified|1|||
126190783|NCT03050307|453984097|FG001|Overall Study|Reason not Specified|1|||
126190784|NCT02973997|453984098|FG000|Overall Study|Withdrawal by Subject|4|||
126190785|NCT02973997|453984099|FG001|Overall Study|Withdrawal by Subject|0|||
126190786|NCT02973997|453984098|FG000|Overall Study|Adverse Event|4|||
126190787|NCT02973997|453984099|FG001|Overall Study|Adverse Event|1|||
126190788|NCT02973997|453984098|FG000|Overall Study|Disease Progression|11|||
126190789|NCT02973997|453984099|FG001|Overall Study|Disease Progression|20|||
126190790|NCT02973997|453984098|FG000|Overall Study|Alternative Therapy|3|||
126190791|NCT02973997|453984099|FG001|Overall Study|Alternative Therapy|0|||
126190792|NCT02973997|453984098|FG000|Overall Study|Other complicating disease|0|||
126190793|NCT02973997|453984099|FG001|Overall Study|Other complicating disease|1|||
126190794|NCT02973997|453984098|FG000|Overall Study|Death|0|||
126190795|NCT02973997|453984099|FG001|Overall Study|Death|1|||
126190796|NCT00444951|453984100|FG000|Overall Study|Lost to Follow-up|1|||
126190797|NCT00444951|453984101|FG001|Overall Study|Lost to Follow-up|1|||
126190798|NCT00444951|453984102|FG002|Overall Study|Lost to Follow-up|0|||
126190799|NCT00444951|453984100|FG000|Overall Study|Withdrawal by Subject|4|||
126190800|NCT00444951|453984101|FG001|Overall Study|Withdrawal by Subject|5|||
126190801|NCT00444951|453984102|FG002|Overall Study|Withdrawal by Subject|3|||
126190802|NCT01938391|453984109|FG000|6 Month Follow up|Withdrawal by Subject|1|||
126190803|NCT01938391|453984109|FG000|12 Month Follow up|Physician Decision|1|||
126190804|NCT01938391|453984109|FG000|12 Month Follow up|Withdrawal by Subject|1|||
126190805|NCT01536418|453984120|FG000|Overall Study|Protocol Violation|2|||
126190806|NCT01536418|453984121|FG001|Overall Study|Protocol Violation|3|||
126190807|NCT01536418|453984120|FG000|Overall Study|Physician Decision|1|||
126190808|NCT01536418|453984121|FG001|Overall Study|Physician Decision|3|||
126190809|NCT01536418|453984120|FG000|Overall Study|Study closed/terminated|41|||
126190810|NCT01536418|453984121|FG001|Overall Study|Study closed/terminated|37|||
126190811|NCT01536418|453984120|FG000|Overall Study|Lack of Efficacy|10|||
126190812|NCT01536418|453984121|FG001|Overall Study|Lack of Efficacy|16|||
126190813|NCT01536418|453984120|FG000|Overall Study|Adverse Event|9|||
126190814|NCT01536418|453984121|FG001|Overall Study|Adverse Event|4|||
126190815|NCT01536418|453984120|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
126190816|NCT01536418|453984121|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
126190817|NCT01536418|453984120|FG000|Overall Study|Withdrawal by Subject|5|||
126190818|NCT01536418|453984121|FG001|Overall Study|Withdrawal by Subject|3|||
126190819|NCT01680991|453984122|FG000|Overall Study|Adverse Event|1|||
126190820|NCT01680991|453984123|FG001|Overall Study|Adverse Event|0|||
126190821|NCT01680991|453984124|FG002|Overall Study|Adverse Event|0|||
126190822|NCT01680991|453984122|FG000|Overall Study|Death|1|||
126190823|NCT01680991|453984123|FG001|Overall Study|Death|0|||
126190824|NCT01680991|453984124|FG002|Overall Study|Death|1|||
126190825|NCT01680991|453984122|FG000|Overall Study|Protocol Violation|0|||
126190826|NCT01680991|453984123|FG001|Overall Study|Protocol Violation|1|||
126190827|NCT01680991|453984124|FG002|Overall Study|Protocol Violation|0|||
126190828|NCT01680991|453984122|FG000|Overall Study|Withdrawal by Subject|5|||
126190829|NCT01680991|453984123|FG001|Overall Study|Withdrawal by Subject|1|||
126190830|NCT01680991|453984124|FG002|Overall Study|Withdrawal by Subject|0|||
126190831|NCT01680991|453984122|FG000|Overall Study|Progressive disease (PD)|0|||
126190832|NCT01680991|453984123|FG001|Overall Study|Progressive disease (PD)|10|||
126190833|NCT01680991|453984124|FG002|Overall Study|Progressive disease (PD)|0|||
126190834|NCT01680991|453984122|FG000|Overall Study|Physician Decision|0|||
126190835|NCT01680991|453984123|FG001|Overall Study|Physician Decision|7|||
126190836|NCT01680991|453984124|FG002|Overall Study|Physician Decision|2|||
126190837|NCT01680991|453984122|FG000|Overall Study|Bad physical condition|0|||
126190838|NCT01680991|453984123|FG001|Overall Study|Bad physical condition|0|||
126190839|NCT01680991|453984124|FG002|Overall Study|Bad physical condition|1|||
126190840|NCT01680991|453984122|FG000|Overall Study|PD confirmed in other hospital|1|||
126190841|NCT01680991|453984123|FG001|Overall Study|PD confirmed in other hospital|0|||
126190842|NCT01680991|453984124|FG002|Overall Study|PD confirmed in other hospital|0|||
126190843|NCT02148952|453984129|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
126190844|NCT02148952|453984130|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
126190845|NCT02148952|453984129|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
126190846|NCT02148952|453984130|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
126190847|NCT02148952|453984129|FG000|Follow-Up|Lost to Follow-up|219|||
126190848|NCT02148952|453984130|FG001|Follow-Up|Lost to Follow-up|231|||
126190849|NCT02148952|453984129|FG000|Follow-Up|Withdrawal by Subject|46|||
126190850|NCT02148952|453984130|FG001|Follow-Up|Withdrawal by Subject|48|||
126190851|NCT01600105|453984131|FG000|Total Participants|Withdrawal by Subject|1|||
126190852|NCT01600105|453984132|FG001|Total Participants|Withdrawal by Subject|0|||
126190853|NCT01600105|453984131|FG000|Total Participants|No images in PACS|10|||
126190854|NCT01600105|453984132|FG001|Total Participants|No images in PACS|0|||
126190855|NCT01600105|453984131|FG000|Total Participants|Insufficient image quality|30|||
126190856|NCT01600105|453984132|FG001|Total Participants|Insufficient image quality|10|||
126190857|NCT01600105|453984131|FG000|Sub Study I|Insufficient image quality|0|||
126190858|NCT01600105|453984132|FG001|Sub Study I|Insufficient image quality|10|||
126190859|NCT01600105|453984131|FG000|Sub Study II|Withdrawal by Subject|1|||
126190860|NCT01600105|453984132|FG001|Sub Study II|Withdrawal by Subject|0|||
126190861|NCT01600105|453984131|FG000|Sub Study II|No images in PACS|1|||
126190862|NCT01600105|453984132|FG001|Sub Study II|No images in PACS|0|||
126190863|NCT01600105|453984131|FG000|Sub Study II|Insufficient image quality|3|||
126190864|NCT01600105|453984132|FG001|Sub Study II|Insufficient image quality|0|||
126190865|NCT01600105|453984131|FG000|Sub Study III|Insufficient image quality|5|||
126190866|NCT01600105|453984132|FG001|Sub Study III|Insufficient image quality|0|||
126190867|NCT01600105|453984131|FG000|Sub Study V|Poor Image Quality|2|||
126190868|NCT01600105|453984132|FG001|Sub Study V|Poor Image Quality|0|||
126190869|NCT04007367|453984133|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
126190870|NCT04007367|453984134|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
126190871|NCT04007367|453984135|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
126190872|NCT04007367|453984133|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
126190873|NCT04007367|453984134|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
126190874|NCT04007367|453984135|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
126190875|NCT04007367|453984133|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
126190876|NCT04007367|453984134|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
126190877|NCT04007367|453984135|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
126190878|NCT04007367|453984133|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
126190879|NCT04007367|453984134|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
126190880|NCT04007367|453984135|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
126190881|NCT04007367|453984133|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
126190882|NCT04007367|453984134|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
126190883|NCT04007367|453984135|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
126190884|NCT01764022|453984136|FG000|Overall Study|Death|3|||
126190885|NCT01764022|453984137|FG001|Overall Study|Death|5|||
126190886|NCT01764022|453984136|FG000|Overall Study|Withdrawal by Subject|2|||
126190887|NCT01764022|453984137|FG001|Overall Study|Withdrawal by Subject|6|||
126190888|NCT01764022|453984136|FG000|Overall Study|Lack of Efficacy|0|||
126190889|NCT01764022|453984137|FG001|Overall Study|Lack of Efficacy|1|||
126190890|NCT01764022|453984136|FG000|Overall Study|Physician Decision|0|||
126190891|NCT01764022|453984137|FG001|Overall Study|Physician Decision|2|||
126190892|NCT01764022|453984136|FG000|Overall Study|Lost to Follow-up|2|||
126190893|NCT01764022|453984137|FG001|Overall Study|Lost to Follow-up|0|||
126190894|NCT01764022|453984136|FG000|Overall Study|Protocol Violation|1|||
126190895|NCT01764022|453984137|FG001|Overall Study|Protocol Violation|0|||
126190896|NCT01899768|453984139|FG000|Part A|Adverse Event|2|||
126190897|NCT01899768|453984139|FG000|Part A|Withdrawal by Subject|1|||
126190898|NCT01899768|453984139|FG000|Part B|Adverse Event|1|||
126190899|NCT01899768|453984139|FG000|Part B|Withdrawal by Subject|1|||
126190900|NCT04043416|453984141|FG000|Washout|Change in health condition|0|||
126190901|NCT04043416|453984142|FG001|Washout|Change in health condition|1|||
126190902|NCT00338806|453984152|FG000|Acute Phase|Withdrawal by Subject|0|||
126190903|NCT00338806|453984153|FG001|Acute Phase|Withdrawal by Subject|1|||
126190904|NCT00338806|453984152|FG000|Follow-up|Lost to Follow-up|1|||
126190905|NCT00338806|453984153|FG001|Follow-up|Lost to Follow-up|3|||
126190906|NCT01487863|453984160|FG000|Overall Study|Death|19|||
126190907|NCT01487863|453984161|FG001|Overall Study|Death|19|||
126190908|NCT04259346|453984162|FG000|Overall Study|Lost to Follow-up|1|||
126190909|NCT04259346|453984163|FG001|Overall Study|Lost to Follow-up|3|||
126190910|NCT04259346|453984162|FG000|Overall Study|Protocol Violation|1|||
126190911|NCT04259346|453984163|FG001|Overall Study|Protocol Violation|0|||
126190912|NCT04259346|453984162|FG000|Overall Study|Withdrawal by Subject|1|||
126190913|NCT04259346|453984163|FG001|Overall Study|Withdrawal by Subject|0|||
126190914|NCT04259346|453984162|FG000|Overall Study|Adverse Event|1|||
126190915|NCT04259346|453984163|FG001|Overall Study|Adverse Event|1|||
126190916|NCT03330106|453984164|FG000|Part A|Withdrawal by Subject|1|||
126190917|NCT03330106|453984165|FG001|Part A|Withdrawal by Subject|1|||
126190918|NCT03330106|453984166|FG002|Part A|Withdrawal by Subject|0|||
126190919|NCT03330106|453984167|FG003|Part A|Withdrawal by Subject|0|||
126190920|NCT03330106|453984164|FG000|Part A|Death|2|||
126190921|NCT03330106|453984165|FG001|Part A|Death|1|||
126190922|NCT03330106|453984166|FG002|Part A|Death|0|||
126190923|NCT03330106|453984167|FG003|Part A|Death|0|||
126190924|NCT03330106|453984164|FG000|Part A|Adverse Event|0|||
126190925|NCT03330106|453984165|FG001|Part A|Adverse Event|1|||
126190926|NCT03330106|453984166|FG002|Part A|Adverse Event|0|||
126190927|NCT03330106|453984167|FG003|Part A|Adverse Event|0|||
126190928|NCT03330106|453984164|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
126190929|NCT03330106|453984165|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
126190930|NCT03330106|453984166|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
126190931|NCT03330106|453984167|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
126190932|NCT03330106|453984164|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
126190933|NCT03330106|453984165|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
126190934|NCT03330106|453984166|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
126190935|NCT03330106|453984167|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
126190936|NCT03330106|453984164|FG000|Part A|Progressive Disease|0|||
126190937|NCT03330106|453984165|FG001|Part A|Progressive Disease|1|||
126190938|NCT03330106|453984166|FG002|Part A|Progressive Disease|0|||
126190939|NCT03330106|453984167|FG003|Part A|Progressive Disease|0|||
126190940|NCT03330106|453984164|FG000|Part B|Lost to Follow-up|0|||
126190941|NCT03330106|453984165|FG001|Part B|Lost to Follow-up|0|||
126190942|NCT03330106|453984166|FG002|Part B|Lost to Follow-up|0|||
126190943|NCT03330106|453984167|FG003|Part B|Lost to Follow-up|1|||
126190944|NCT03330106|453984164|FG000|Part B|Withdrawal by Subject|0|||
126190945|NCT03330106|453984165|FG001|Part B|Withdrawal by Subject|0|||
126190946|NCT03330106|453984166|FG002|Part B|Withdrawal by Subject|4|||
126190947|NCT03330106|453984167|FG003|Part B|Withdrawal by Subject|0|||
126190948|NCT03330106|453984164|FG000|Part B|Death|0|||
126190949|NCT03330106|453984165|FG001|Part B|Death|0|||
126190950|NCT03330106|453984166|FG002|Part B|Death|2|||
126190951|NCT03330106|453984167|FG003|Part B|Death|0|||
126190952|NCT03330106|453984164|FG000|Part B|Clinical Progression|0|||
126190953|NCT03330106|453984165|FG001|Part B|Clinical Progression|0|||
126190954|NCT03330106|453984166|FG002|Part B|Clinical Progression|1|||
126190955|NCT03330106|453984167|FG003|Part B|Clinical Progression|1|||
126190956|NCT03330106|453984164|FG000|Part B|Symptomatic Deterioration|0|||
126190957|NCT03330106|453984165|FG001|Part B|Symptomatic Deterioration|0|||
126190958|NCT03330106|453984166|FG002|Part B|Symptomatic Deterioration|0|||
126190959|NCT03330106|453984167|FG003|Part B|Symptomatic Deterioration|1|||
126190960|NCT03330106|453984164|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
126190961|NCT03330106|453984165|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
126190962|NCT03330106|453984166|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
126190963|NCT03330106|453984167|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
126190964|NCT03330106|453984164|FG000|Part B|Progressive Disease|0|||
126190965|NCT03330106|453984165|FG001|Part B|Progressive Disease|0|||
126190966|NCT03330106|453984166|FG002|Part B|Progressive Disease|11|||
126190967|NCT03330106|453984167|FG003|Part B|Progressive Disease|4|||
126190968|NCT00623766|453984171|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
126190969|NCT00623766|453984172|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
126190970|NCT00623766|453984171|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
126190971|NCT00623766|453984172|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
126190972|NCT00623766|453984171|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
126190973|NCT00623766|453984172|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
126190974|NCT00623766|453984171|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
126190975|NCT00623766|453984172|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
126190976|NCT00623766|453984171|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
126190977|NCT00623766|453984172|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
126190978|NCT00486889|453984174|FG000|Overall Study|Death|3|||
126190979|NCT00486889|453984174|FG000|Overall Study|Non-compliant|2|||
126190980|NCT00486889|453984174|FG000|Overall Study|Withdrawal by Subject|6|||
126190981|NCT00893763|453984175|FG000|Overall Study|extubated|110|||
126190982|NCT00893763|453984176|FG001|Overall Study|extubated|110|||
126190983|NCT04157751|453984177|FG000|Overall Study|Withdrawal by Subject|12|||
126190984|NCT04157751|453984178|FG001|Overall Study|Withdrawal by Subject|17|||
126190985|NCT04157751|453984177|FG000|Overall Study|Lost to Follow-up|6|||
126190986|NCT04157751|453984178|FG001|Overall Study|Lost to Follow-up|2|||
126190987|NCT04157751|453984177|FG000|Overall Study|Adverse Event|34|||
126190988|NCT04157751|453984178|FG001|Overall Study|Adverse Event|23|||
126190989|NCT04157751|453984177|FG000|Overall Study|Not treated|1|||
126190990|NCT04157751|453984178|FG001|Overall Study|Not treated|5|||
126190991|NCT04157751|453984177|FG000|Overall Study|Other reason not stated above|10|||
126190992|NCT04157751|453984178|FG001|Overall Study|Other reason not stated above|10|||
126190993|NCT04445051|453984181|FG000|Overall Study|Adverse Event|0|||
126190994|NCT04445051|453984182|FG001|Overall Study|Adverse Event|0|||
126190995|NCT04445051|453984183|FG002|Overall Study|Adverse Event|1|||
126190996|NCT04445051|453984184|FG003|Overall Study|Adverse Event|0|||
126190997|NCT04445051|453984185|FG004|Overall Study|Adverse Event|0|||
126190998|NCT04445051|453984186|FG005|Overall Study|Adverse Event|0|||
126190999|NCT00901394|453984194|FG000|Overall Study|Physician Decision|1|||
126191000|NCT00901394|453984195|FG001|Overall Study|Physician Decision|1|||
126191001|NCT00901394|453984196|FG002|Overall Study|Physician Decision|2|||
126191002|NCT00796224|453984199|FG000|Overall Study|Adverse Event|1|||
126191003|NCT00796224|453984200|FG001|Overall Study|Adverse Event|0|||
126191004|NCT00796224|453984199|FG000|Overall Study|Protocol Violation|0|||
126191005|NCT00796224|453984200|FG001|Overall Study|Protocol Violation|1|||
126191006|NCT02569398|453984201|FG000|Overall Study|Adverse Event|0|||
126191007|NCT02569398|453984202|FG001|Overall Study|Adverse Event|1|||
126191008|NCT02569398|453984203|FG002|Overall Study|Adverse Event|6|||
126191009|NCT02569398|453984201|FG000|Overall Study|Withdrawal by Subject|43|||
126191010|NCT02569398|453984202|FG001|Overall Study|Withdrawal by Subject|43|||
126191011|NCT02569398|453984203|FG002|Overall Study|Withdrawal by Subject|30|||
126191012|NCT02569398|453984201|FG000|Overall Study|Study terminated by sponsor|130|||
126191013|NCT02569398|453984202|FG001|Overall Study|Study terminated by sponsor|131|||
126191014|NCT02569398|453984203|FG002|Overall Study|Study terminated by sponsor|134|||
126191015|NCT02569398|453984201|FG000|Overall Study|Other|12|||
126191016|NCT02569398|453984202|FG001|Overall Study|Other|14|||
126191017|NCT02569398|453984203|FG002|Overall Study|Other|13|||
126191018|NCT02116361|453984204|FG000|Overall Study|Pregnancy|0|||
126191019|NCT02116361|453984205|FG001|Overall Study|Pregnancy|0|||
126191020|NCT02116361|453984206|FG002|Overall Study|Pregnancy|0|||
126191021|NCT02116361|453984207|FG003|Overall Study|Pregnancy|1|||
126191022|NCT02116361|453984204|FG000|Overall Study|Protocol Violation|1|||
126191023|NCT02116361|453984205|FG001|Overall Study|Protocol Violation|0|||
126191024|NCT02116361|453984206|FG002|Overall Study|Protocol Violation|0|||
126191025|NCT02116361|453984207|FG003|Overall Study|Protocol Violation|2|||
126191026|NCT02116361|453984204|FG000|Overall Study|Physician Decision|2|||
126191027|NCT02116361|453984205|FG001|Overall Study|Physician Decision|3|||
126191028|NCT02116361|453984206|FG002|Overall Study|Physician Decision|0|||
126191029|NCT02116361|453984207|FG003|Overall Study|Physician Decision|0|||
126191030|NCT02116361|453984204|FG000|Overall Study|Adverse Event|1|||
126191031|NCT02116361|453984205|FG001|Overall Study|Adverse Event|0|||
126191032|NCT02116361|453984206|FG002|Overall Study|Adverse Event|0|||
126191033|NCT02116361|453984207|FG003|Overall Study|Adverse Event|3|||
126191034|NCT02116361|453984204|FG000|Overall Study|Other Reasons|3|||
126191035|NCT02116361|453984205|FG001|Overall Study|Other Reasons|3|||
126191036|NCT02116361|453984206|FG002|Overall Study|Other Reasons|3|||
126191037|NCT02116361|453984207|FG003|Overall Study|Other Reasons|3|||
126191038|NCT02116361|453984204|FG000|Overall Study|Lack of Efficacy|5|||
126191039|NCT02116361|453984205|FG001|Overall Study|Lack of Efficacy|7|||
126191040|NCT02116361|453984206|FG002|Overall Study|Lack of Efficacy|4|||
126191041|NCT02116361|453984207|FG003|Overall Study|Lack of Efficacy|3|||
126191042|NCT02116361|453984204|FG000|Overall Study|Lost to Follow-up|4|||
126191043|NCT02116361|453984205|FG001|Overall Study|Lost to Follow-up|5|||
126191044|NCT02116361|453984206|FG002|Overall Study|Lost to Follow-up|7|||
126191045|NCT02116361|453984207|FG003|Overall Study|Lost to Follow-up|5|||
126191046|NCT02116361|453984204|FG000|Overall Study|Personal Reasons|6|||
126191047|NCT02116361|453984205|FG001|Overall Study|Personal Reasons|6|||
126191048|NCT02116361|453984206|FG002|Overall Study|Personal Reasons|4|||
126191049|NCT02116361|453984207|FG003|Overall Study|Personal Reasons|9|||
126191050|NCT02116361|453984204|FG000|Overall Study|Investigator Decision - Relapse|9|||
126191051|NCT02116361|453984205|FG001|Overall Study|Investigator Decision - Relapse|7|||
126191052|NCT02116361|453984206|FG002|Overall Study|Investigator Decision - Relapse|8|||
126191053|NCT02116361|453984207|FG003|Overall Study|Investigator Decision - Relapse|5|||
126191054|NCT03227224|453984208|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
126191055|NCT03227224|453984209|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
126191056|NCT03227224|453984210|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
126191057|NCT03227224|453984211|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
126191058|NCT03227224|453984208|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
126191059|NCT03227224|453984209|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
126191060|NCT03227224|453984210|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
126191061|NCT03227224|453984211|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
126191062|NCT03227224|453984208|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
126191063|NCT03227224|453984209|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
126191064|NCT03227224|453984210|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
126191065|NCT03227224|453984211|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
126191066|NCT03227224|453984208|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
126191067|NCT03227224|453984209|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126191068|NCT03227224|453984210|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126191069|NCT03227224|453984211|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126191070|NCT03227224|453984208|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
126191071|NCT03227224|453984209|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
126191072|NCT03227224|453984210|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
126191073|NCT03227224|453984211|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
126191074|NCT03227224|453984208|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
126191075|NCT03227224|453984209|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
126191076|NCT03227224|453984210|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
126191077|NCT03227224|453984211|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
126191078|NCT03227224|453984208|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
126191079|NCT03227224|453984209|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
126191080|NCT03227224|453984210|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
126191081|NCT03227224|453984211|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
126191082|NCT03227224|453984208|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
126191083|NCT03227224|453984209|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
126191084|NCT03227224|453984210|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
126191085|NCT03227224|453984211|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
126191086|NCT03227224|453984208|FG000|Follow-up Phase (2 Weeks)|Other|4|||
126191087|NCT03227224|453984209|FG001|Follow-up Phase (2 Weeks)|Other|4|||
126191088|NCT03227224|453984210|FG002|Follow-up Phase (2 Weeks)|Other|6|||
126191089|NCT03227224|453984211|FG003|Follow-up Phase (2 Weeks)|Other|3|||
126191090|NCT04195750|453984212|FG000|Overall Study|Death|245|||
126191091|NCT04195750|453984213|FG001|Overall Study|Death|253|||
126191092|NCT04195750|453984214|FG002|Overall Study|Death|5|||
126191093|NCT04195750|453984212|FG000|Overall Study|Physician Decision|0|||
126191094|NCT04195750|453984213|FG001|Overall Study|Physician Decision|1|||
126191095|NCT04195750|453984214|FG002|Overall Study|Physician Decision|0|||
126191096|NCT04195750|453984212|FG000|Overall Study|Withdrawal by Subject|9|||
126191097|NCT04195750|453984213|FG001|Overall Study|Withdrawal by Subject|8|||
126191098|NCT04195750|453984214|FG002|Overall Study|Withdrawal by Subject|0|||
126191099|NCT04195750|453984212|FG000|Overall Study|Ongoing|120|||
126191100|NCT04195750|453984213|FG001|Overall Study|Ongoing|110|||
126191101|NCT04195750|453984214|FG002|Overall Study|Ongoing|4|||
126191102|NCT02406027|453984215|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126191103|NCT02406027|453984216|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
126191104|NCT02406027|453984217|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
126191105|NCT02406027|453984218|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126191106|NCT02406027|453984219|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126191107|NCT02406027|453984220|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126191108|NCT02406027|453984221|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126191109|NCT02406027|453984215|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
126191110|NCT02406027|453984216|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126191111|NCT02406027|453984217|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
126191112|NCT02406027|453984218|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126191113|NCT02406027|453984219|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126191114|NCT02406027|453984220|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126191115|NCT02406027|453984221|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126191116|NCT02406027|453984215|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
126191117|NCT02406027|453984216|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
126191118|NCT02406027|453984217|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
126191119|NCT02406027|453984218|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
126191120|NCT02406027|453984219|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
126191121|NCT02406027|453984220|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
126191122|NCT02406027|453984221|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
126191123|NCT02406027|453984215|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
126191124|NCT02406027|453984216|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126191125|NCT02406027|453984217|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
126191126|NCT02406027|453984218|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126199941|NCT01117428|454017808|FG004|Overall Study|Adverse Event|1|||
126191127|NCT02406027|453984219|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126191128|NCT02406027|453984220|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126191129|NCT02406027|453984221|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126191130|NCT02406027|453984215|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
126191131|NCT02406027|453984216|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
126191132|NCT02406027|453984217|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
126191133|NCT02406027|453984218|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
126191134|NCT02406027|453984219|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
126191135|NCT02406027|453984220|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
126191136|NCT02406027|453984221|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
126191137|NCT02406027|453984215|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
126191138|NCT02406027|453984216|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
126191139|NCT02406027|453984217|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
126191140|NCT02406027|453984218|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
126191141|NCT02406027|453984219|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
126191142|NCT02406027|453984220|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
126191143|NCT02406027|453984221|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
126191144|NCT02406027|453984215|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
126191145|NCT02406027|453984216|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
126191146|NCT02406027|453984217|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
126191147|NCT02406027|453984218|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
126191148|NCT02406027|453984219|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
126191149|NCT02406027|453984220|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
126191150|NCT02406027|453984221|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
126191151|NCT02406027|453984215|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
126191152|NCT02406027|453984216|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
126191153|NCT02406027|453984217|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
126191154|NCT02406027|453984218|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
126191155|NCT02406027|453984219|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
126191156|NCT02406027|453984220|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
126191157|NCT02406027|453984221|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
126191158|NCT02406027|453984215|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126191159|NCT02406027|453984216|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126191160|NCT02406027|453984217|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126191161|NCT02406027|453984218|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126191162|NCT02406027|453984219|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126191163|NCT02406027|453984220|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
126191164|NCT02406027|453984221|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126191165|NCT02406027|453984215|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126191166|NCT02406027|453984216|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126191167|NCT02406027|453984217|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126191168|NCT02406027|453984218|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126191169|NCT02406027|453984219|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
126191170|NCT02406027|453984220|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126191171|NCT02406027|453984221|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126191172|NCT02497287|453984222|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
126191173|NCT02497287|453984222|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
126191174|NCT02497287|453984222|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
126191175|NCT02497287|453984222|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
126191176|NCT02497287|453984222|FG000|Induction Phase (4 Weeks)|Other|13|||
126191177|NCT02497287|453984222|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
126191178|NCT02497287|453984222|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
126191179|NCT02497287|453984222|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
126191180|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
126191181|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
126191182|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
126191183|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
126191184|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
126191185|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
126191186|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
126191187|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
126191188|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
126191189|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
126191190|NCT02497287|453984222|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
126191191|NCT02497287|453984222|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
126191192|NCT02497287|453984222|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
126191193|NCT02497287|453984222|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
126191194|NCT02497287|453984222|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
126191195|NCT02497287|453984222|FG000|Follow-up Phase (4 Week)|Other|1|||
126191196|NCT03782376|453984223|FG000|Overall Study|Lost to Follow-up|2|||
126191197|NCT03782376|453984224|FG001|Overall Study|Lost to Follow-up|2|||
126191198|NCT03782376|453984223|FG000|Overall Study|Withdrawal by Subject|7|||
126191199|NCT03782376|453984224|FG001|Overall Study|Withdrawal by Subject|11|||
126191200|NCT03782376|453984223|FG000|Overall Study|Death|1|||
126191201|NCT03782376|453984224|FG001|Overall Study|Death|0|||
126191202|NCT03782376|453984223|FG000|Overall Study|Other|16|||
126191203|NCT03782376|453984224|FG001|Overall Study|Other|17|||
126191204|NCT03559192|453984225|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
126191205|NCT03559192|453984226|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
126191206|NCT03559192|453984227|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
126191207|NCT03559192|453984225|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
126191208|NCT03559192|453984226|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
126191209|NCT03559192|453984227|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
126191210|NCT03559192|453984225|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
126191211|NCT03559192|453984226|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
126191212|NCT03559192|453984227|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
126191213|NCT03559192|453984225|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
126191214|NCT03559192|453984226|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
126191215|NCT03559192|453984227|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
126191216|NCT03559192|453984225|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
126191217|NCT03559192|453984226|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
126191218|NCT03559192|453984227|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
126191219|NCT03559192|453984225|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
126191220|NCT03559192|453984226|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
126191221|NCT03559192|453984227|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
126191222|NCT03559192|453984225|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
126191223|NCT03559192|453984226|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
126191224|NCT03559192|453984227|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
126191225|NCT03559192|453984225|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
126191226|NCT03559192|453984226|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
126191227|NCT03559192|453984227|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
126191228|NCT03559192|453984225|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
126191229|NCT03559192|453984226|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
126191230|NCT03559192|453984227|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
126191231|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
126191232|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
126191233|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Death|0|||
126191234|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Death|4|||
126191235|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
126191236|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
126191237|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
126191238|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
126191239|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
126191240|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
126191241|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
126191242|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
126191243|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
126191244|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
126191245|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Other|4|||
126191246|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Other|3|||
126191247|NCT03517722|453984228|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
126191248|NCT03517722|453984229|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
126191249|NCT03517722|453984228|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
126191250|NCT03517722|453984229|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
126191251|NCT03517722|453984228|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
126191252|NCT03517722|453984229|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
126191253|NCT03517722|453984228|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
126191254|NCT03517722|453984229|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
126191255|NCT03517722|453984228|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
126191256|NCT03517722|453984229|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
126191257|NCT02422186|453984230|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
126191258|NCT02422186|453984231|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
126191259|NCT02422186|453984230|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
126191260|NCT02422186|453984231|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
126191261|NCT02422186|453984230|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
126191262|NCT02422186|453984231|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
126191263|NCT02422186|453984230|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
126191264|NCT02422186|453984231|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
126191265|NCT02422186|453984230|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
126191266|NCT02422186|453984231|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
126191267|NCT02422186|453984230|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
126191268|NCT02422186|453984231|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
126191269|NCT02422186|453984230|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
126191270|NCT02422186|453984231|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
126191271|NCT02422186|453984230|FG000|Follow-up Phase (2 Weeks)|Other|3|||
126191272|NCT02422186|453984231|FG001|Follow-up Phase (2 Weeks)|Other|0|||
126191273|NCT03277794|453984236|FG000|Overall Study|Lost to Follow-up|2|||
126191274|NCT03277794|453984237|FG001|Overall Study|Lost to Follow-up|4|||
126191275|NCT03277794|453984236|FG000|Overall Study|Withdrew due to high acuity|1|||
126191276|NCT03277794|453984237|FG001|Overall Study|Withdrew due to high acuity|0|||
126191277|NCT03039569|453984241|FG000|Overall Study|Lost to Follow-up|5|||
126191278|NCT03039569|453984242|FG001|Overall Study|Lost to Follow-up|4|||
126191279|NCT02254304|453984243|FG000|Overall Study|Adverse Event|2|||
126191280|NCT02254304|453984244|FG001|Overall Study|Adverse Event|1|||
126191281|NCT02254304|453984243|FG000|Overall Study|Lost to Follow-up|2|||
126191282|NCT02254304|453984244|FG001|Overall Study|Lost to Follow-up|2|||
126191283|NCT02254304|453984243|FG000|Overall Study|Protocol Violation|1|||
126191284|NCT02254304|453984244|FG001|Overall Study|Protocol Violation|0|||
126191285|NCT02254304|453984243|FG000|Overall Study|Withdrawal by Subject|3|||
126191286|NCT02254304|453984244|FG001|Overall Study|Withdrawal by Subject|0|||
126191287|NCT02254304|453984243|FG000|Overall Study|Injection site pain and Injection fear|1|||
126191288|NCT02254304|453984244|FG001|Overall Study|Injection site pain and Injection fear|0|||
126191289|NCT02254304|453984243|FG000|Overall Study|Personal causes|4|||
126191290|NCT02254304|453984244|FG001|Overall Study|Personal causes|1|||
126191291|NCT02254304|453984243|FG000|Overall Study|Personal decision|1|||
126191292|NCT02254304|453984244|FG001|Overall Study|Personal decision|0|||
126191293|NCT01226472|453984245|FG000|Overall Study|Progressive Disease|1|||
126191294|NCT00952419|453984246|FG000|Overall Study|Adverse Event|2|||
126191295|NCT00952419|453984247|FG001|Overall Study|Adverse Event|0|||
126191296|NCT00952419|453984248|FG002|Overall Study|Adverse Event|0|||
126191297|NCT00952419|453984246|FG000|Overall Study|Protocol Violation|3|||
126191298|NCT00952419|453984247|FG001|Overall Study|Protocol Violation|7|||
126191299|NCT00952419|453984248|FG002|Overall Study|Protocol Violation|0|||
126191300|NCT00952419|453984246|FG000|Overall Study|Withdrawal by Subject|1|||
126191301|NCT00952419|453984247|FG001|Overall Study|Withdrawal by Subject|3|||
126191302|NCT00952419|453984248|FG002|Overall Study|Withdrawal by Subject|0|||
126191303|NCT03399786|453984249|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
126191304|NCT03399786|453984250|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126191305|NCT03399786|453984251|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126191306|NCT03399786|453984252|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126191307|NCT03399786|453984249|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
126191308|NCT03399786|453984250|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
126191309|NCT03399786|453984251|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
126191310|NCT03399786|453984252|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
126191311|NCT03399786|453984249|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
126191312|NCT03399786|453984250|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
126191313|NCT03399786|453984251|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
126191314|NCT03399786|453984252|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
126191315|NCT04888507|453986537|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
126191316|NCT00400946|453986538|FG000|Overall Study|Ineligible|0|||
126191317|NCT00400946|453986539|FG001|Overall Study|Ineligible|0|||
126191318|NCT00400946|453986540|FG002|Overall Study|Ineligible|0|||
126191319|NCT00400946|453986541|FG003|Overall Study|Ineligible|5|||
126191320|NCT00400946|453986542|FG004|Overall Study|Ineligible|1|||
126191321|NCT00400946|453986538|FG000|Overall Study|Induction Failure|0|||
126191322|NCT00400946|453986539|FG001|Overall Study|Induction Failure|0|||
126191323|NCT00400946|453986540|FG002|Overall Study|Induction Failure|0|||
126191324|NCT00400946|453986541|FG003|Overall Study|Induction Failure|11|||
126191325|NCT00400946|453986542|FG004|Overall Study|Induction Failure|8|||
126191326|NCT00400946|453986538|FG000|Overall Study|Induction Death|0|||
126191327|NCT00400946|453986539|FG001|Overall Study|Induction Death|0|||
126191328|NCT00400946|453986540|FG002|Overall Study|Induction Death|0|||
126191329|NCT00400946|453986541|FG003|Overall Study|Induction Death|13|||
126191330|NCT00400946|453986542|FG004|Overall Study|Induction Death|3|||
126191331|NCT00400946|453986538|FG000|Overall Study|Lost to Follow-up|1|||
126191332|NCT00400946|453986539|FG001|Overall Study|Lost to Follow-up|1|||
126191333|NCT00400946|453986540|FG002|Overall Study|Lost to Follow-up|0|||
126191334|NCT00400946|453986541|FG003|Overall Study|Lost to Follow-up|0|||
126191335|NCT00400946|453986542|FG004|Overall Study|Lost to Follow-up|1|||
126191336|NCT00400946|453986538|FG000|Overall Study|Remission Death|1|||
126191337|NCT00400946|453986539|FG001|Overall Study|Remission Death|1|||
126191338|NCT00400946|453986540|FG002|Overall Study|Remission Death|0|||
126191339|NCT00400946|453986541|FG003|Overall Study|Remission Death|0|||
126191340|NCT00400946|453986542|FG004|Overall Study|Remission Death|1|||
126191341|NCT00400946|453986538|FG000|Overall Study|Relapse|9|||
126191342|NCT00400946|453986539|FG001|Overall Study|Relapse|2|||
126191343|NCT00400946|453986540|FG002|Overall Study|Relapse|1|||
126191344|NCT00400946|453986541|FG003|Overall Study|Relapse|1|||
126191345|NCT00400946|453986542|FG004|Overall Study|Relapse|5|||
126191346|NCT00400946|453986538|FG000|Overall Study|Transplant in CR1|0|||
126191347|NCT00400946|453986539|FG001|Overall Study|Transplant in CR1|0|||
126191348|NCT00400946|453986540|FG002|Overall Study|Transplant in CR1|0|||
126191349|NCT00400946|453986541|FG003|Overall Study|Transplant in CR1|10|||
126191350|NCT00400946|453986542|FG004|Overall Study|Transplant in CR1|1|||
126191351|NCT00400946|453986538|FG000|Overall Study|Withdrawal by Subject|2|||
126191352|NCT00400946|453986539|FG001|Overall Study|Withdrawal by Subject|5|||
126191353|NCT00400946|453986540|FG002|Overall Study|Withdrawal by Subject|1|||
126191354|NCT00400946|453986541|FG003|Overall Study|Withdrawal by Subject|5|||
126191355|NCT00400946|453986542|FG004|Overall Study|Withdrawal by Subject|8|||
126191356|NCT00400946|453986538|FG000|Overall Study|Clinical|1|||
126191357|NCT00400946|453986539|FG001|Overall Study|Clinical|2|||
126191358|NCT00400946|453986540|FG002|Overall Study|Clinical|0|||
126191359|NCT00400946|453986541|FG003|Overall Study|Clinical|2|||
126191360|NCT00400946|453986542|FG004|Overall Study|Clinical|9|||
126191361|NCT00400946|453986538|FG000|Overall Study|Other|0|||
126191362|NCT00400946|453986539|FG001|Overall Study|Other|0|||
126191363|NCT00400946|453986540|FG002|Overall Study|Other|0|||
126191364|NCT00400946|453986541|FG003|Overall Study|Other|0|||
126191365|NCT00400946|453986542|FG004|Overall Study|Other|1|||
126191366|NCT05643170|453986543|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
126191367|NCT05643170|453986543|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
126191368|NCT01673373|453986545|FG000|Overall Study|Death|2|||
126191369|NCT05426460|453986546|FG000|Overall Study|Protocol Violation|1|||
126191370|NCT05426460|453986547|FG001|Overall Study|Protocol Violation|1|||
126191371|NCT05426460|453986548|FG002|Overall Study|Protocol Violation|1|||
126191372|NCT05426460|453986549|FG003|Overall Study|Protocol Violation|0|||
126191373|NCT01431521|453986555|FG000|Overall Study|Withdrawal by Subject|0|||
126191374|NCT01431521|453986556|FG001|Overall Study|Withdrawal by Subject|0|||
126191375|NCT01431521|453986557|FG002|Overall Study|Withdrawal by Subject|1|||
126191376|NCT01431521|453986558|FG003|Overall Study|Withdrawal by Subject|0|||
126191377|NCT02531633|453986559|FG000|Part A (52 Weeks)|Sponsor request|24|||
126191378|NCT02531633|453986560|FG001|Part A (52 Weeks)|Sponsor request|24|||
126191379|NCT02531633|453986561|FG002|Part A (52 Weeks)|Sponsor request|18|||
126191380|NCT02531633|453986562|FG003|Part A (52 Weeks)|Sponsor request|18|||
126191381|NCT02531633|453986563|FG004|Part A (52 Weeks)|Sponsor request|19|||
126191382|NCT02531633|453986564|FG005|Part A (52 Weeks)|Sponsor request|0|||
126191383|NCT02531633|453986565|FG006|Part A (52 Weeks)|Sponsor request|0|||
126191384|NCT02531633|453986566|FG007|Part A (52 Weeks)|Sponsor request|0|||
126191385|NCT02531633|453986567|FG008|Part A (52 Weeks)|Sponsor request|0|||
126191386|NCT02531633|453986568|FG009|Part A (52 Weeks)|Sponsor request|0|||
126191387|NCT02531633|453986559|FG000|Part A (52 Weeks)|Protocol Violation|1|||
126191388|NCT02531633|453986560|FG001|Part A (52 Weeks)|Protocol Violation|0|||
126191389|NCT02531633|453986561|FG002|Part A (52 Weeks)|Protocol Violation|0|||
126191390|NCT02531633|453986562|FG003|Part A (52 Weeks)|Protocol Violation|0|||
126191391|NCT02531633|453986563|FG004|Part A (52 Weeks)|Protocol Violation|0|||
126191392|NCT02531633|453986564|FG005|Part A (52 Weeks)|Protocol Violation|0|||
126191393|NCT02531633|453986565|FG006|Part A (52 Weeks)|Protocol Violation|0|||
126191394|NCT02531633|453986566|FG007|Part A (52 Weeks)|Protocol Violation|0|||
126191395|NCT02531633|453986567|FG008|Part A (52 Weeks)|Protocol Violation|0|||
126191396|NCT02531633|453986568|FG009|Part A (52 Weeks)|Protocol Violation|0|||
126191397|NCT02531633|453986559|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
126191398|NCT02531633|453986560|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
126191399|NCT02531633|453986561|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
126191400|NCT02531633|453986562|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
126191401|NCT02531633|453986563|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
126191402|NCT02531633|453986564|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
126191403|NCT02531633|453986565|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
126191404|NCT02531633|453986566|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
126191405|NCT02531633|453986567|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
126191406|NCT02531633|453986568|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
126191407|NCT02531633|453986559|FG000|Part A (52 Weeks)|Physician Decision|1|||
126191408|NCT02531633|453986560|FG001|Part A (52 Weeks)|Physician Decision|4|||
126191409|NCT02531633|453986561|FG002|Part A (52 Weeks)|Physician Decision|3|||
126191410|NCT02531633|453986562|FG003|Part A (52 Weeks)|Physician Decision|1|||
126191411|NCT02531633|453986563|FG004|Part A (52 Weeks)|Physician Decision|0|||
126191412|NCT02531633|453986564|FG005|Part A (52 Weeks)|Physician Decision|0|||
126191413|NCT02531633|453986565|FG006|Part A (52 Weeks)|Physician Decision|0|||
126191414|NCT02531633|453986566|FG007|Part A (52 Weeks)|Physician Decision|0|||
126191415|NCT02531633|453986567|FG008|Part A (52 Weeks)|Physician Decision|0|||
126191416|NCT02531633|453986568|FG009|Part A (52 Weeks)|Physician Decision|0|||
126191417|NCT02531633|453986559|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
126191418|NCT02531633|453986560|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
126191419|NCT02531633|453986561|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
126191420|NCT02531633|453986562|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
126191421|NCT02531633|453986563|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
126191422|NCT02531633|453986564|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
126191423|NCT02531633|453986565|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
126191424|NCT02531633|453986566|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
126191425|NCT02531633|453986567|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
126191426|NCT02531633|453986568|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
126191427|NCT02531633|453986559|FG000|Part A (52 Weeks)|Other|2|||
126191428|NCT02531633|453986560|FG001|Part A (52 Weeks)|Other|0|||
126191429|NCT02531633|453986561|FG002|Part A (52 Weeks)|Other|0|||
126191430|NCT02531633|453986562|FG003|Part A (52 Weeks)|Other|0|||
126191431|NCT02531633|453986563|FG004|Part A (52 Weeks)|Other|0|||
126191432|NCT02531633|453986564|FG005|Part A (52 Weeks)|Other|0|||
126191433|NCT02531633|453986565|FG006|Part A (52 Weeks)|Other|0|||
126191434|NCT02531633|453986566|FG007|Part A (52 Weeks)|Other|0|||
126191435|NCT02531633|453986567|FG008|Part A (52 Weeks)|Other|0|||
126191436|NCT02531633|453986568|FG009|Part A (52 Weeks)|Other|0|||
126191437|NCT02531633|453986559|FG000|Part B (104 Weeks)|Sponsor request|0|||
126191438|NCT02531633|453986560|FG001|Part B (104 Weeks)|Sponsor request|0|||
126191439|NCT02531633|453986561|FG002|Part B (104 Weeks)|Sponsor request|0|||
126191440|NCT02531633|453986562|FG003|Part B (104 Weeks)|Sponsor request|0|||
126191441|NCT02531633|453986563|FG004|Part B (104 Weeks)|Sponsor request|0|||
126191442|NCT02531633|453986564|FG005|Part B (104 Weeks)|Sponsor request|8|||
126191443|NCT02531633|453986565|FG006|Part B (104 Weeks)|Sponsor request|5|||
126191444|NCT02531633|453986566|FG007|Part B (104 Weeks)|Sponsor request|3|||
126191445|NCT02531633|453986567|FG008|Part B (104 Weeks)|Sponsor request|5|||
126191446|NCT02531633|453986568|FG009|Part B (104 Weeks)|Sponsor request|4|||
126191447|NCT02531633|453986559|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
126191448|NCT02531633|453986560|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
126191449|NCT02531633|453986561|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
126191450|NCT02531633|453986562|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
126191451|NCT02531633|453986563|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
126191452|NCT02531633|453986564|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
126191453|NCT02531633|453986565|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
126191454|NCT02531633|453986566|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
126191455|NCT02531633|453986567|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
126191456|NCT02531633|453986568|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
126191457|NCT01572844|453986569|FG000|Overall Study|Physician Decision|1|||
126191458|NCT01572844|453986570|FG001|Overall Study|Physician Decision|1|||
126191459|NCT00366444|453986572|FG000|Overall Study|Withdrawal by Subject|1|||
126191460|NCT00366444|453986573|FG001|Overall Study|Withdrawal by Subject|1|||
126191461|NCT00366444|453986572|FG000|Overall Study|Lack of Efficacy|0|||
126191462|NCT00366444|453986573|FG001|Overall Study|Lack of Efficacy|1|||
126191463|NCT05171816|453986574|FG000|Overall Study|Death|18|||
126191464|NCT05171816|453986575|FG001|Overall Study|Death|16|||
126191465|NCT04667949|453986576|FG000|Overall Study|Adverse Event|0|||
126191466|NCT04667949|453986577|FG001|Overall Study|Adverse Event|2|||
126191467|NCT04667949|453986576|FG000|Overall Study|Lost to Follow-up|0|||
126191468|NCT04667949|453986577|FG001|Overall Study|Lost to Follow-up|1|||
126191469|NCT04667949|453986576|FG000|Overall Study|Physician Decision|0|||
126191470|NCT04667949|453986577|FG001|Overall Study|Physician Decision|2|||
126191471|NCT04667949|453986576|FG000|Overall Study|Subject decision|1|||
126191472|NCT04667949|453986577|FG001|Overall Study|Subject decision|7|||
126191473|NCT02000622|453986580|FG000|Overall Study|Withdrawal by Subject|5|||
126191474|NCT02000622|453986581|FG001|Overall Study|Withdrawal by Subject|7|||
126191475|NCT02000622|453986580|FG000|Overall Study|Lost to Follow-up|4|||
126191476|NCT02000622|453986581|FG001|Overall Study|Lost to Follow-up|0|||
126191477|NCT02000622|453986580|FG000|Overall Study|Death|159|||
126191478|NCT02000622|453986581|FG001|Overall Study|Death|73|||
126191479|NCT02000622|453986580|FG000|Overall Study|Withdrawn due to site closure|1|||
126191480|NCT02000622|453986581|FG001|Overall Study|Withdrawn due to site closure|0|||
126191481|NCT01405027|453986582|FG000|Overall Study|Withdrawn consent|3|||
126191482|NCT01405027|453986583|FG001|Overall Study|Withdrawn consent|0|||
126191483|NCT01405027|453986582|FG000|Overall Study|Lost to Follow-up|16|||
126191484|NCT01405027|453986583|FG001|Overall Study|Lost to Follow-up|24|||
126191485|NCT01405027|453986582|FG000|Overall Study|Investigator judgement|0|||
126191486|NCT01405027|453986583|FG001|Overall Study|Investigator judgement|2|||
126191487|NCT01405027|453986582|FG000|Overall Study|Death|1|||
126191488|NCT01405027|453986583|FG001|Overall Study|Death|0|||
126191489|NCT01405027|453986582|FG000|Overall Study|Other or Unknown|12|||
126191490|NCT01405027|453986583|FG001|Overall Study|Other or Unknown|25|||
126191491|NCT01320033|453986588|FG000|Overall Study|Lack of Efficacy|0|||
126191492|NCT01320033|453986589|FG001|Overall Study|Lack of Efficacy|0|||
126191493|NCT01320033|453986590|FG002|Overall Study|Lack of Efficacy|1|||
126191494|NCT01320033|453986588|FG000|Overall Study|Adverse Event|9|||
126191495|NCT01320033|453986589|FG001|Overall Study|Adverse Event|7|||
126191496|NCT01320033|453986590|FG002|Overall Study|Adverse Event|8|||
126191497|NCT01320033|453986588|FG000|Overall Study|Withdrawal by Subject|22|||
126191498|NCT01320033|453986589|FG001|Overall Study|Withdrawal by Subject|23|||
126191499|NCT01320033|453986590|FG002|Overall Study|Withdrawal by Subject|23|||
126191500|NCT01320033|453986588|FG000|Overall Study|Protocol Violation|3|||
126191501|NCT01320033|453986589|FG001|Overall Study|Protocol Violation|5|||
126191502|NCT01320033|453986590|FG002|Overall Study|Protocol Violation|3|||
126191503|NCT01320033|453986588|FG000|Overall Study|Lost to Follow-up|22|||
126191504|NCT01320033|453986589|FG001|Overall Study|Lost to Follow-up|26|||
126191505|NCT01320033|453986590|FG002|Overall Study|Lost to Follow-up|17|||
126191506|NCT01320033|453986588|FG000|Overall Study|Other|2|||
126191507|NCT01320033|453986589|FG001|Overall Study|Other|3|||
126191508|NCT01320033|453986590|FG002|Overall Study|Other|1|||
126191509|NCT00963469|453986591|FG000|Overall Study|Adverse Event|15|||
126191510|NCT00963469|453986592|FG001|Overall Study|Adverse Event|11|||
126191511|NCT00963469|453986593|FG002|Overall Study|Adverse Event|1|||
126191512|NCT00963469|453986591|FG000|Overall Study|Lack of Efficacy|10|||
126191513|NCT00963469|453986592|FG001|Overall Study|Lack of Efficacy|7|||
126191514|NCT00963469|453986593|FG002|Overall Study|Lack of Efficacy|2|||
126191515|NCT00963469|453986591|FG000|Overall Study|Lost to Follow-up|1|||
126191516|NCT00963469|453986592|FG001|Overall Study|Lost to Follow-up|1|||
126191517|NCT00963469|453986593|FG002|Overall Study|Lost to Follow-up|0|||
126191518|NCT00963469|453986591|FG000|Overall Study|Protocol Violation|5|||
126191519|NCT00963469|453986592|FG001|Overall Study|Protocol Violation|5|||
126191520|NCT00963469|453986593|FG002|Overall Study|Protocol Violation|3|||
126191521|NCT00963469|453986591|FG000|Overall Study|Withdrawal by Subject|4|||
126191522|NCT00963469|453986592|FG001|Overall Study|Withdrawal by Subject|1|||
126191523|NCT00963469|453986593|FG002|Overall Study|Withdrawal by Subject|1|||
126191524|NCT00963469|453986591|FG000|Overall Study|Pre-randomization Adverse Event|1|||
126191525|NCT00963469|453986592|FG001|Overall Study|Pre-randomization Adverse Event|2|||
126191526|NCT00963469|453986593|FG002|Overall Study|Pre-randomization Adverse Event|0|||
126191527|NCT00963469|453986591|FG000|Overall Study|Moved|1|||
126191528|NCT00963469|453986592|FG001|Overall Study|Moved|0|||
126191529|NCT00963469|453986593|FG002|Overall Study|Moved|0|||
126191530|NCT00963469|453986591|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
126191531|NCT00963469|453986592|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
126191532|NCT00963469|453986593|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
126191533|NCT00673816|453986605|FG000|Overall Study|Adverse Event|1|||
126191534|NCT00673816|453986605|FG000|Overall Study|Withdrawal by Subject|1|||
126191535|NCT02234050|453986607|FG000|Overall Study|Lack of Efficacy|38|||
126191536|NCT02234050|453986608|FG001|Overall Study|Lack of Efficacy|22|||
126191537|NCT02234050|453986607|FG000|Overall Study|Adverse Event|13|||
126191538|NCT02234050|453986608|FG001|Overall Study|Adverse Event|1|||
126191539|NCT02234050|453986607|FG000|Overall Study|Withdrawal by Subject|4|||
126191540|NCT02234050|453986608|FG001|Overall Study|Withdrawal by Subject|2|||
126191541|NCT02234050|453986607|FG000|Overall Study|Sponsor's decision|6|||
126191542|NCT02234050|453986608|FG001|Overall Study|Sponsor's decision|0|||
126191543|NCT02365506|453986609|FG000|Overall Study|Investigator's Discretion|0|||
126191544|NCT02365506|453986610|FG001|Overall Study|Investigator's Discretion|0|||
126191545|NCT02365506|453986611|FG002|Overall Study|Investigator's Discretion|1|||
126191546|NCT01852591|453986613|FG000|Overall Study|Withdrawal by Subject|2|||
126191547|NCT01852591|453986613|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
126191548|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
126191549|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
126191550|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|Death|1|||
126191551|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|Death|1|||
126191552|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
126191553|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
126191554|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
126191555|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
126191556|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
126191557|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
126191558|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
126191559|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
126191560|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
126191561|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
126191562|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
126191563|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
126191564|NCT03728881|453986614|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
126191565|NCT03728881|453986615|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
126191566|NCT03728881|453986614|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
126191567|NCT03728881|453986615|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
126191568|NCT03728881|453986614|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
126191569|NCT03728881|453986615|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
126191570|NCT06073054|453986616|FG000|Overall Study|Withdrawal by Subject|2|||
126191571|NCT00413777|453986621|FG000|Fixed-dose Period|Lost to Follow-up|1|||
126191572|NCT00413777|453986622|FG001|Fixed-dose Period|Lost to Follow-up|1|||
126191573|NCT00413777|453986621|FG000|Fixed-dose Period|Adverse Event|2|||
126191574|NCT00413777|453986622|FG001|Fixed-dose Period|Adverse Event|1|||
126191575|NCT00413777|453986621|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
126191576|NCT00413777|453986622|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
126191577|NCT00413777|453986621|FG000|Fixed-dose Period|Withdrew Consent|0|||
126191578|NCT00413777|453986622|FG001|Fixed-dose Period|Withdrew Consent|1|||
126191579|NCT04088331|453986623|FG000|Overall Study|Lost to Follow-up|3|||
126191580|NCT04088331|453986623|FG000|Overall Study|Withdrawal by Subject|7|||
126191581|NCT04088331|453986623|FG000|Overall Study|Adverse Event|4|||
126191582|NCT05505734|453986624|FG000|Overall Study|Withdrawal by Subject|51|||
126191583|NCT05505734|453986625|FG001|Overall Study|Withdrawal by Subject|64|||
126191584|NCT05505734|453986624|FG000|Overall Study|Adverse Event|6|||
126191585|NCT05505734|453986625|FG001|Overall Study|Adverse Event|20|||
126191586|NCT05505734|453986624|FG000|Overall Study|Protocol Violation|8|||
126191587|NCT05505734|453986625|FG001|Overall Study|Protocol Violation|15|||
126191588|NCT05505734|453986624|FG000|Overall Study|Lack of therapeutic response|0|||
126191589|NCT05505734|453986625|FG001|Overall Study|Lack of therapeutic response|1|||
126191590|NCT05505734|453986624|FG000|Overall Study|Lost to Follow-up|247|||
126191591|NCT05505734|453986625|FG001|Overall Study|Lost to Follow-up|237|||
126191592|NCT05505734|453986624|FG000|Overall Study|Physician Decision|22|||
126191593|NCT05505734|453986625|FG001|Overall Study|Physician Decision|13|||
126191594|NCT05505734|453986624|FG000|Overall Study|Death|2|||
126191595|NCT05505734|453986625|FG001|Overall Study|Death|1|||
126191596|NCT05505734|453986624|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126191597|NCT05505734|453986625|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126191598|NCT05505734|453986624|FG000|Overall Study|Pregnancy|1|||
126191599|NCT05505734|453986625|FG001|Overall Study|Pregnancy|0|||
126191600|NCT05505734|453986624|FG000|Overall Study|Other|17|||
126191601|NCT05505734|453986625|FG001|Overall Study|Other|13|||
126191602|NCT00764322|453986626|FG000|Overall Study|Withdrawal by Subject|11|||
126191603|NCT00764322|453986626|FG000|Overall Study|No CYP2D6 genotyping|9|||
126191604|NCT00976963|453986632|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
126191605|NCT00976963|453986633|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
126191606|NCT00976963|453986632|FG000|Overall Study|administrative error|1|||
126191607|NCT00976963|453986633|FG001|Overall Study|administrative error|0|||
126191608|NCT00976963|453986632|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
126191609|NCT00976963|453986633|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
126191610|NCT02756845|453986636|FG000|Overall Study|Death|12|||
126191611|NCT02756845|453986637|FG001|Overall Study|Death|2|||
126191612|NCT02756845|453986636|FG000|Overall Study|Withdrawal by Subject|1|||
126191613|NCT02756845|453986637|FG001|Overall Study|Withdrawal by Subject|0|||
126191614|NCT02768103|453986640|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
126191615|NCT03369704|453986644|FG000|Treatment Epoch|technical problems|1|||
126191616|NCT03369704|453986645|FG001|Treatment Epoch|technical problems|0|||
126191617|NCT03369704|453986644|FG000|Treatment Epoch|Protocol Violation|1|||
126191618|NCT03369704|453986645|FG001|Treatment Epoch|Protocol Violation|0|||
126191619|NCT03369704|453986644|FG000|Treatment Epoch|Lost to Follow-up|0|||
126191620|NCT03369704|453986645|FG001|Treatment Epoch|Lost to Follow-up|1|||
126191621|NCT03369704|453986644|FG000|Treatment Epoch|Lack of Efficacy|0|||
126191622|NCT03369704|453986645|FG001|Treatment Epoch|Lack of Efficacy|2|||
126191623|NCT03369704|453986644|FG000|Treatment Epoch|Adverse Event|2|||
126191624|NCT03369704|453986645|FG001|Treatment Epoch|Adverse Event|0|||
126191625|NCT03369704|453986644|FG000|Follow-up Epoch|Lost to Follow-up|1|||
126191626|NCT03369704|453986645|FG001|Follow-up Epoch|Lost to Follow-up|0|||
126191627|NCT02348840|453986646|FG000|Overall Study|Withdrawal by Subject|2|||
126191628|NCT02348840|453986647|FG001|Overall Study|Withdrawal by Subject|1|||
126191629|NCT02348840|453986648|FG002|Overall Study|Withdrawal by Subject|0|||
126191630|NCT02348840|453986649|FG003|Overall Study|Withdrawal by Subject|0|||
126191631|NCT01025232|453986650|FG000|Overall Study|Study drug no longer available|3|||
126191632|NCT01025232|453986651|FG001|Overall Study|Study drug no longer available|6|||
126191633|NCT01263444|453986652|FG000|Overall Study|Adverse Event|8|||
126191634|NCT01263444|453986652|FG000|Overall Study|Withdrawal by Subject|1|||
126191635|NCT01263444|453986652|FG000|Overall Study|Protocol Violation|1|||
126191636|NCT02203916|453986654|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126191637|NCT02203916|453986655|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
126191638|NCT02203916|453986656|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
126191639|NCT02203916|453986654|FG000|Overall Study|Major Protocol Deviation|1|||
126191640|NCT02203916|453986655|FG001|Overall Study|Major Protocol Deviation|1|||
126191641|NCT02203916|453986656|FG002|Overall Study|Major Protocol Deviation|0|||
126191642|NCT02203916|453986654|FG000|Overall Study|Lost to Follow-up|0|||
126191643|NCT02203916|453986655|FG001|Overall Study|Lost to Follow-up|1|||
126191644|NCT02203916|453986656|FG002|Overall Study|Lost to Follow-up|0|||
126191645|NCT02203916|453986654|FG000|Overall Study|Voluntary Withdrawal|3|||
126191646|NCT02203916|453986655|FG001|Overall Study|Voluntary Withdrawal|3|||
126191647|NCT02203916|453986656|FG002|Overall Study|Voluntary Withdrawal|8|||
126191648|NCT02203916|453986654|FG000|Overall Study|Lack of Efficacy|3|||
126191649|NCT02203916|453986655|FG001|Overall Study|Lack of Efficacy|0|||
126191650|NCT02203916|453986656|FG002|Overall Study|Lack of Efficacy|0|||
126191651|NCT02203916|453986654|FG000|Overall Study|Reason Not Specified|0|||
126191652|NCT02203916|453986655|FG001|Overall Study|Reason Not Specified|2|||
126191653|NCT02203916|453986656|FG002|Overall Study|Reason Not Specified|1|||
126191654|NCT00414973|453986657|FG000|Overall Study|Withdrawal by Subject|14|||
126191655|NCT00414973|453986658|FG001|Overall Study|Withdrawal by Subject|4|||
126191656|NCT00414973|453986659|FG002|Overall Study|Withdrawal by Subject|1|||
126191657|NCT00414973|453986660|FG003|Overall Study|Withdrawal by Subject|0|||
126191658|NCT00414973|453986657|FG000|Overall Study|Adverse Event|10|||
126191659|NCT00414973|453986658|FG001|Overall Study|Adverse Event|0|||
126191660|NCT00414973|453986659|FG002|Overall Study|Adverse Event|1|||
126191661|NCT00414973|453986660|FG003|Overall Study|Adverse Event|0|||
126191662|NCT00414973|453986657|FG000|Overall Study|Protocol Violation|3|||
126191663|NCT00414973|453986658|FG001|Overall Study|Protocol Violation|4|||
126191664|NCT00414973|453986659|FG002|Overall Study|Protocol Violation|0|||
126191665|NCT00414973|453986660|FG003|Overall Study|Protocol Violation|0|||
126191666|NCT00414973|453986657|FG000|Overall Study|Lost to Follow-up|0|||
126191667|NCT00414973|453986658|FG001|Overall Study|Lost to Follow-up|2|||
126191668|NCT00414973|453986659|FG002|Overall Study|Lost to Follow-up|0|||
126191669|NCT00414973|453986660|FG003|Overall Study|Lost to Follow-up|0|||
126191670|NCT00414973|453986657|FG000|Overall Study|Sponsor Decision|1|||
126191671|NCT00414973|453986658|FG001|Overall Study|Sponsor Decision|0|||
126191672|NCT00414973|453986659|FG002|Overall Study|Sponsor Decision|0|||
126191673|NCT00414973|453986660|FG003|Overall Study|Sponsor Decision|0|||
126191674|NCT00414973|453986657|FG000|Overall Study|Death|0|||
126191675|NCT00414973|453986658|FG001|Overall Study|Death|0|||
126191676|NCT00414973|453986659|FG002|Overall Study|Death|1|||
126191677|NCT00414973|453986660|FG003|Overall Study|Death|0|||
126191678|NCT03236506|453986661|FG000|Overall Study|Death|1|||
126191679|NCT03236506|453986662|FG001|Overall Study|Death|1|||
126191680|NCT03236506|453986663|FG002|Overall Study|Death|1|||
126191681|NCT03236506|453986661|FG000|Overall Study|Withdrawal by Subject|3|||
126191682|NCT03236506|453986662|FG001|Overall Study|Withdrawal by Subject|3|||
126191683|NCT03236506|453986663|FG002|Overall Study|Withdrawal by Subject|4|||
126191684|NCT03236506|453986661|FG000|Overall Study|Did not initiate treatment|2|||
126191685|NCT03236506|453986662|FG001|Overall Study|Did not initiate treatment|1|||
126191686|NCT03236506|453986663|FG002|Overall Study|Did not initiate treatment|2|||
126191687|NCT01466062|453986664|FG000|Overall Study|Adverse Event|1|||
126191688|NCT01466062|453986664|FG000|Overall Study|Withdrawal by Subject|1|||
126191689|NCT02865928|453986665|FG000|Overall Study|Withdrawal by Subject|1|||
126191690|NCT02865928|453986666|FG001|Overall Study|Withdrawal by Subject|0|||
126191691|NCT02865928|453986665|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
126191692|NCT02865928|453986666|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
126191693|NCT02865928|453986665|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
126191694|NCT02865928|453986666|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
126191695|NCT03152110|453986667|FG000|Overall Study|Withdrawal by Subject|3|||
126191696|NCT03696576|453986668|FG000|Overall Study|Soreness of throat after therapy|1|||
126191697|NCT03696576|453986669|FG001|Overall Study|Soreness of throat after therapy|1|||
126191698|NCT03696576|453986668|FG000|Overall Study|Lost to Follow-up|2|||
126191699|NCT03696576|453986669|FG001|Overall Study|Lost to Follow-up|4|||
126191700|NCT00085644|453986672|FG000|Double-Blind Period|Adverse Event|5|||
126191701|NCT00085644|453986673|FG001|Double-Blind Period|Adverse Event|2|||
126191702|NCT00085644|453986674|FG002|Double-Blind Period|Adverse Event|0|||
126191703|NCT00085644|453986672|FG000|Double-Blind Period|Withdrawal by Subject|3|||
126191704|NCT00085644|453986673|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126191705|NCT00085644|453986674|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126191706|NCT00085644|453986672|FG000|Double-Blind Period|Lost to Follow-up|2|||
126191707|NCT00085644|453986673|FG001|Double-Blind Period|Lost to Follow-up|1|||
126191708|NCT00085644|453986674|FG002|Double-Blind Period|Lost to Follow-up|0|||
126191709|NCT00085644|453986672|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
126191710|NCT00085644|453986673|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
126191711|NCT00085644|453986674|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
126191712|NCT00085644|453986672|FG000|Double-Blind Period|Contemplating pregnancy|1|||
126191713|NCT00085644|453986673|FG001|Double-Blind Period|Contemplating pregnancy|0|||
126191714|NCT00085644|453986674|FG002|Double-Blind Period|Contemplating pregnancy|0|||
126191715|NCT00085644|453986672|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
126191716|NCT00085644|453986673|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
126191717|NCT00085644|453986674|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
126191718|NCT00085644|453986672|FG000|Open-Label Period|Adverse Event|0|||
126191719|NCT00085644|453986673|FG001|Open-Label Period|Adverse Event|0|||
126191720|NCT00085644|453986674|FG002|Open-Label Period|Adverse Event|38|||
126191721|NCT00085644|453986672|FG000|Open-Label Period|Withdrawal by Subject|0|||
126191722|NCT00085644|453986673|FG001|Open-Label Period|Withdrawal by Subject|0|||
126191723|NCT00085644|453986674|FG002|Open-Label Period|Withdrawal by Subject|29|||
126191724|NCT00085644|453986672|FG000|Open-Label Period|Lost to Follow-up|0|||
126191725|NCT00085644|453986673|FG001|Open-Label Period|Lost to Follow-up|0|||
126191726|NCT00085644|453986674|FG002|Open-Label Period|Lost to Follow-up|13|||
126191727|NCT00085644|453986672|FG000|Open-Label Period|Lack of Efficacy|0|||
126191728|NCT00085644|453986673|FG001|Open-Label Period|Lack of Efficacy|0|||
126191729|NCT00085644|453986674|FG002|Open-Label Period|Lack of Efficacy|15|||
126191730|NCT00085644|453986672|FG000|Open-Label Period|Pregnancy|0|||
126191731|NCT00085644|453986673|FG001|Open-Label Period|Pregnancy|0|||
126191732|NCT00085644|453986674|FG002|Open-Label Period|Pregnancy|3|||
126191733|NCT00085644|453986672|FG000|Open-Label Period|Contemplating pregnancy|0|||
126191734|NCT00085644|453986673|FG001|Open-Label Period|Contemplating pregnancy|0|||
126191735|NCT00085644|453986674|FG002|Open-Label Period|Contemplating pregnancy|3|||
126191736|NCT00085644|453986672|FG000|Open-Label Period|Protocol Violation|0|||
126191737|NCT00085644|453986673|FG001|Open-Label Period|Protocol Violation|0|||
126191738|NCT00085644|453986674|FG002|Open-Label Period|Protocol Violation|4|||
126191739|NCT00085644|453986672|FG000|Open-Label Period|Personal reason|0|||
126191740|NCT00085644|453986673|FG001|Open-Label Period|Personal reason|0|||
126191741|NCT00085644|453986674|FG002|Open-Label Period|Personal reason|4|||
126191742|NCT02324049|453986675|FG000|Part C|Study terminated|11|||
126191743|NCT03198728|453986676|FG000|Overall Study|Adverse Event|10|||
126191744|NCT03198728|453986677|FG001|Overall Study|Adverse Event|5|||
126191745|NCT03198728|453986676|FG000|Overall Study|Lost to Follow-up|21|||
126191746|NCT03198728|453986677|FG001|Overall Study|Lost to Follow-up|7|||
126191747|NCT03198728|453986676|FG000|Overall Study|Physician Decision|7|||
126191748|NCT03198728|453986677|FG001|Overall Study|Physician Decision|2|||
126191749|NCT03198728|453986676|FG000|Overall Study|Withdrawal by Subject|14|||
126191750|NCT03198728|453986677|FG001|Overall Study|Withdrawal by Subject|10|||
126191751|NCT02829775|453986688|FG000|Overall Study|Death|1|||
126191752|NCT02829775|453986688|FG000|Overall Study|Withdrawal by Subject|3|||
126191753|NCT02829775|453986688|FG000|Overall Study|Disease remission|1|||
126191754|NCT01249157|453986689|FG000|Overall Study|Withdrawal by Subject|1|||
126191755|NCT00062647|453986690|FG000|Overall Study|Death|2|||
126191756|NCT00062647|453986691|FG001|Overall Study|Death|2|||
126191757|NCT00062647|453986690|FG000|Overall Study|Adverse Event|1|||
126191758|NCT00062647|453986691|FG001|Overall Study|Adverse Event|1|||
126191759|NCT00062647|453986690|FG000|Overall Study|Withdrawal by Subject|2|||
126191760|NCT00062647|453986691|FG001|Overall Study|Withdrawal by Subject|1|||
126191761|NCT00062647|453986690|FG000|Overall Study|Protocol Violation|1|||
126191762|NCT00062647|453986691|FG001|Overall Study|Protocol Violation|0|||
126191763|NCT00062647|453986690|FG000|Overall Study|Lost to Follow-up|1|||
126191764|NCT00062647|453986691|FG001|Overall Study|Lost to Follow-up|2|||
126191765|NCT00062647|453986690|FG000|Overall Study|Failed continuation criteria|4|||
126191766|NCT00062647|453986691|FG001|Overall Study|Failed continuation criteria|2|||
126191767|NCT00062647|453986690|FG000|Overall Study|Other|4|||
126191768|NCT00062647|453986691|FG001|Overall Study|Other|4|||
126191769|NCT00062647|453986690|FG000|Overall Study|Never received study treatment|1|||
126191770|NCT00062647|453986691|FG001|Overall Study|Never received study treatment|1|||
126191771|NCT02392468|453986699|FG000|Overall Study|Adverse Event|0|||
126191772|NCT02392468|453986700|FG001|Overall Study|Adverse Event|1|||
126191773|NCT02392468|453986701|FG002|Overall Study|Adverse Event|0|||
126191774|NCT02392468|453986702|FG003|Overall Study|Adverse Event|0|||
126191775|NCT02392468|453986703|FG004|Overall Study|Adverse Event|0|||
126191776|NCT02392468|453986704|FG005|Overall Study|Adverse Event|1|||
126191777|NCT01313039|453986705|FG000|Overall Study|Physician Decision|1|||
126191778|NCT01313039|453986705|FG000|Overall Study|Adverse Event|1|||
126191779|NCT04228445|453986709|FG000|Overall Study|Lost to Follow-up|1|||
126191780|NCT04228445|453986710|FG001|Overall Study|Lost to Follow-up|1|||
126191781|NCT04228445|453986709|FG000|Overall Study|Physician Decision|1|||
126191782|NCT04228445|453986710|FG001|Overall Study|Physician Decision|2|||
126191783|NCT04228445|453986709|FG000|Overall Study|Withdrawal by Subject|0|||
126191784|NCT04228445|453986710|FG001|Overall Study|Withdrawal by Subject|1|||
126191785|NCT04228445|453986709|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
126191786|NCT04228445|453986710|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
126191787|NCT03864627|453986711|FG000|Overall Study|Adverse Event|0|||
126191788|NCT03864627|453986712|FG001|Overall Study|Adverse Event|1|||
126191789|NCT03864627|453986711|FG000|Overall Study|Lack of Efficacy|0|||
126191790|NCT03864627|453986712|FG001|Overall Study|Lack of Efficacy|1|||
126191791|NCT03864627|453986711|FG000|Overall Study|Lost to Follow-up|0|||
126191792|NCT03864627|453986712|FG001|Overall Study|Lost to Follow-up|1|||
126191793|NCT03864627|453986711|FG000|Overall Study|Withdrawal by Subject|4|||
126191794|NCT03864627|453986712|FG001|Overall Study|Withdrawal by Subject|8|||
126191795|NCT03864627|453986711|FG000|Overall Study|Study terminated by sponsor|0|||
126191796|NCT03864627|453986712|FG001|Overall Study|Study terminated by sponsor|1|||
126191797|NCT01388491|453986713|FG000|Overall Study|Adverse Event|10|||
126191798|NCT01388491|453986714|FG001|Overall Study|Adverse Event|9|||
126191799|NCT01388491|453986713|FG000|Overall Study|Sponsor Request|9|||
126191800|NCT01388491|453986714|FG001|Overall Study|Sponsor Request|7|||
126191801|NCT01388491|453986713|FG000|Overall Study|Withdrawal by Subject|6|||
126191802|NCT01388491|453986714|FG001|Overall Study|Withdrawal by Subject|10|||
126191803|NCT01388491|453986713|FG000|Overall Study|Lost to Follow-up|4|||
126191804|NCT01388491|453986714|FG001|Overall Study|Lost to Follow-up|3|||
126191805|NCT01388491|453986713|FG000|Overall Study|Protocol Violation|2|||
126191806|NCT01388491|453986714|FG001|Overall Study|Protocol Violation|0|||
126191807|NCT01388491|453986713|FG000|Overall Study|Noncompliance|2|||
126191808|NCT01388491|453986714|FG001|Overall Study|Noncompliance|0|||
126191809|NCT01388491|453986713|FG000|Overall Study|Pregnancy|1|||
126191810|NCT01388491|453986714|FG001|Overall Study|Pregnancy|0|||
126191811|NCT00397891|453986715|FG000|Overall Study|Withdrawal by Subject|1|||
126191812|NCT00397891|453986716|FG001|Overall Study|Withdrawal by Subject|0|||
126191813|NCT00397891|453986717|FG002|Overall Study|Withdrawal by Subject|0|||
126191814|NCT00397891|453986718|FG003|Overall Study|Withdrawal by Subject|0|||
126191815|NCT00397891|453986719|FG004|Overall Study|Withdrawal by Subject|1|||
126191816|NCT04960202|453988316|FG000|Overall Study|Other|5|||
126191817|NCT04960202|453988317|FG001|Overall Study|Other|0|||
126191818|NCT04960202|453988316|FG000|Overall Study|Withdrawal by Subject|37|||
126191819|NCT04960202|453988317|FG001|Overall Study|Withdrawal by Subject|43|||
126191820|NCT04960202|453988316|FG000|Overall Study|Lost to Follow-up|20|||
126191821|NCT04960202|453988317|FG001|Overall Study|Lost to Follow-up|16|||
126191822|NCT04960202|453988316|FG000|Overall Study|Death|0|||
126191823|NCT04960202|453988317|FG001|Overall Study|Death|15|||
126191824|NCT03558828|453988321|FG000|Overall Study|Lost to Follow-up|4|||
126191825|NCT03558828|453988322|FG001|Overall Study|Lost to Follow-up|3|||
126191826|NCT03558828|453988323|FG002|Overall Study|Lost to Follow-up|3|||
126191827|NCT03558828|453988324|FG003|Overall Study|Lost to Follow-up|5|||
126191828|NCT03558828|453988325|FG004|Overall Study|Lost to Follow-up|2|||
126191829|NCT03558828|453988326|FG005|Overall Study|Lost to Follow-up|3|||
126191830|NCT03558828|453988321|FG000|Overall Study|dropped before the intervention|1|||
126191831|NCT03558828|453988322|FG001|Overall Study|dropped before the intervention|1|||
126191832|NCT03558828|453988323|FG002|Overall Study|dropped before the intervention|0|||
126191833|NCT03558828|453988324|FG003|Overall Study|dropped before the intervention|0|||
126191834|NCT03558828|453988325|FG004|Overall Study|dropped before the intervention|0|||
126191835|NCT03558828|453988326|FG005|Overall Study|dropped before the intervention|0|||
126191836|NCT03671148|453988332|FG000|Overall Study|Adverse Event|3|||
126191837|NCT03671148|453988333|FG001|Overall Study|Adverse Event|2|||
126191838|NCT03671148|453988332|FG000|Overall Study|Withdrawal by Subject|8|||
126191839|NCT03671148|453988333|FG001|Overall Study|Withdrawal by Subject|2|||
126191840|NCT03671148|453988332|FG000|Overall Study|Lost to Follow-up|1|||
126191841|NCT03671148|453988333|FG001|Overall Study|Lost to Follow-up|2|||
126191842|NCT03671148|453988332|FG000|Overall Study|Lack of Efficacy|7|||
126191843|NCT03671148|453988333|FG001|Overall Study|Lack of Efficacy|2|||
126191844|NCT03671148|453988332|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
126191845|NCT03671148|453988333|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
126191846|NCT03671148|453988332|FG000|Overall Study|Other|1|||
126191847|NCT03671148|453988333|FG001|Overall Study|Other|0|||
126191848|NCT03671148|453988332|FG000|Overall Study|Incomplete Randomization Visit|1|||
126191849|NCT03671148|453988333|FG001|Overall Study|Incomplete Randomization Visit|0|||
126191850|NCT02155712|453988340|FG000|Overall Study|Death|12|||
126191851|NCT02155712|453988341|FG001|Overall Study|Death|0|||
126191852|NCT02155712|453988340|FG000|Overall Study|Lost to Follow-up|37|||
126191853|NCT02155712|453988341|FG001|Overall Study|Lost to Follow-up|22|||
126191854|NCT02155712|453988340|FG000|Overall Study|Revision of device|4|||
126191855|NCT02155712|453988341|FG001|Overall Study|Revision of device|3|||
126191856|NCT02155712|453988340|FG000|Overall Study|Withdrawal by Subject|39|||
126191857|NCT02155712|453988341|FG001|Overall Study|Withdrawal by Subject|21|||
126191858|NCT02155712|453988340|FG000|Overall Study|Site termination|77|||
126191859|NCT02155712|453988341|FG001|Overall Study|Site termination|19|||
126191860|NCT02155712|453988340|FG000|Overall Study|Sponsor terminated study early|150|||
126191861|NCT02155712|453988341|FG001|Overall Study|Sponsor terminated study early|0|||
126191862|NCT02155712|453988340|FG000|Overall Study|Missed final 5-year protocol visit|0|||
126191863|NCT02155712|453988341|FG001|Overall Study|Missed final 5-year protocol visit|32|||
126191864|NCT02155712|453988340|FG000|Overall Study|Censored because surgery cancelled|6|||
126191865|NCT02155712|453988341|FG001|Overall Study|Censored because surgery cancelled|10|||
126191866|NCT02155712|453988340|FG000|Overall Study|Censored because study device was not implanted|61|||
126191867|NCT02155712|453988341|FG001|Overall Study|Censored because study device was not implanted|66|||
126191868|NCT02155712|453988340|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
126191869|NCT02155712|453988341|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
126191870|NCT01688999|453988345|FG000|Overall Study|Withdrawal by Subject|5|||
126191871|NCT01688999|453988346|FG001|Overall Study|Withdrawal by Subject|1|||
126191872|NCT01688999|453988347|FG002|Overall Study|Withdrawal by Subject|1|||
126191873|NCT01688999|453988345|FG000|Overall Study|Adverse Event|2|||
126191874|NCT01688999|453988346|FG001|Overall Study|Adverse Event|0|||
126191875|NCT01688999|453988347|FG002|Overall Study|Adverse Event|2|||
126191876|NCT01688999|453988345|FG000|Overall Study|Ineligible/Not treated|1|||
126191877|NCT01688999|453988346|FG001|Overall Study|Ineligible/Not treated|0|||
126191878|NCT01688999|453988347|FG002|Overall Study|Ineligible/Not treated|0|||
126191879|NCT04051944|453988365|FG000|Overall Study|Study ending|1|||
126191880|NCT04051944|453988366|FG001|Overall Study|Study ending|1|||
126191881|NCT04051944|453988365|FG000|Overall Study|Early study termination by participant|1|||
126191882|NCT04051944|453988366|FG001|Overall Study|Early study termination by participant|0|||
126191883|NCT04051944|453988365|FG000|Overall Study|Withdrawal by Subject|2|||
126191884|NCT04051944|453988366|FG001|Overall Study|Withdrawal by Subject|2|||
126191885|NCT04051944|453988365|FG000|Overall Study|Lack of Efficacy|3|||
126191886|NCT04051944|453988366|FG001|Overall Study|Lack of Efficacy|0|||
126191887|NCT04051944|453988365|FG000|Overall Study|Adverse event, non- fatal|1|||
126191888|NCT04051944|453988366|FG001|Overall Study|Adverse event, non- fatal|1|||
126191889|NCT00736450|453988367|FG000|Overall Study|Not ABC gene eligible|19|||
126191890|NCT00736450|453988367|FG000|Overall Study|Withdrawal by Subject|5|||
126191891|NCT00736450|453988367|FG000|Overall Study|Physician Decision|1|||
126191892|NCT01947894|453988369|FG000|Overall Study|Other|3|||
126191893|NCT01947894|453988370|FG001|Overall Study|Other|4|||
126191894|NCT01947894|453988371|FG002|Overall Study|Other|3|||
126191895|NCT01947894|453988369|FG000|Overall Study|Withdrawal by Subject|12|||
126191896|NCT01947894|453988370|FG001|Overall Study|Withdrawal by Subject|4|||
126191897|NCT01947894|453988371|FG002|Overall Study|Withdrawal by Subject|1|||
126191898|NCT01947894|453988369|FG000|Overall Study|Death|12|||
126191899|NCT01947894|453988370|FG001|Overall Study|Death|1|||
126191900|NCT01947894|453988371|FG002|Overall Study|Death|0|||
126191901|NCT01947894|453988369|FG000|Overall Study|Physician Decision|2|||
126191902|NCT01947894|453988370|FG001|Overall Study|Physician Decision|0|||
126191903|NCT01947894|453988371|FG002|Overall Study|Physician Decision|0|||
126191904|NCT01947894|453988369|FG000|Overall Study|Adverse Event|5|||
126191905|NCT01947894|453988370|FG001|Overall Study|Adverse Event|1|||
126191906|NCT01947894|453988371|FG002|Overall Study|Adverse Event|0|||
126191907|NCT01947894|453988369|FG000|Overall Study|Switched to other growth hormone brand|53|||
126191908|NCT01947894|453988370|FG001|Overall Study|Switched to other growth hormone brand|8|||
126191909|NCT01947894|453988371|FG002|Overall Study|Switched to other growth hormone brand|23|||
126191910|NCT00333970|453988372|FG000|Overall Study|Withdrawal by Subject|13|||
126191911|NCT00333970|453988373|FG001|Overall Study|Withdrawal by Subject|7|||
126191912|NCT05083949|453988379|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
126191913|NCT05083949|453988380|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
126191914|NCT05083949|453988379|FG000|Period 1|Adverse Event|1|||
126191915|NCT05083949|453988380|FG001|Period 1|Adverse Event|1|||
126191916|NCT05083949|453988379|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
126191917|NCT05083949|453988380|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
126191918|NCT05083949|453988379|FG000|Period 2|Adverse Event|0|||
126191919|NCT05083949|453988380|FG001|Period 2|Adverse Event|2|||
126191920|NCT01678560|453988381|FG000|Overall Study|Physician Decision|4|||
126191921|NCT01678560|453988382|FG001|Overall Study|Physician Decision|4|||
126191922|NCT01678560|453988381|FG000|Overall Study|Death|0|||
126191923|NCT01678560|453988382|FG001|Overall Study|Death|1|||
126191924|NCT01678560|453988381|FG000|Overall Study|Withdrawal by Subject|0|||
126191925|NCT01678560|453988382|FG001|Overall Study|Withdrawal by Subject|1|||
126191926|NCT00322387|453988386|FG000|Treatment Period|Adverse Event|0|||
126191927|NCT00322387|453988387|FG001|Treatment Period|Adverse Event|1|||
126191928|NCT00322387|453988386|FG000|Follow-up Period|Final assessment not done|1|||
126191929|NCT00322387|453988387|FG001|Follow-up Period|Final assessment not done|3|||
126191930|NCT00322387|453988386|FG000|Follow-up Period|Death|1|||
126191931|NCT00322387|453988387|FG001|Follow-up Period|Death|0|||
126191932|NCT00090766|453988392|FG000|Overall Study|Nephrectomy Planned|0|||
126191933|NCT00090766|453988393|FG001|Overall Study|Nephrectomy Planned|0|||
126191934|NCT00090766|453988394|FG002|Overall Study|Nephrectomy Planned|1|||
126191935|NCT00090766|453988392|FG000|Overall Study|Death|1|||
126191936|NCT00090766|453988393|FG001|Overall Study|Death|0|||
126191937|NCT00090766|453988394|FG002|Overall Study|Death|0|||
126191938|NCT00090766|453988392|FG000|Overall Study|Admin|0|||
126191939|NCT00090766|453988393|FG001|Overall Study|Admin|2|||
126191940|NCT00090766|453988394|FG002|Overall Study|Admin|0|||
126191941|NCT00090766|453988392|FG000|Overall Study|Lost to Follow-up|2|||
126191942|NCT00090766|453988393|FG001|Overall Study|Lost to Follow-up|0|||
126191943|NCT00090766|453988394|FG002|Overall Study|Lost to Follow-up|2|||
126191944|NCT00804986|453988401|FG000|Overall Study|Adverse Event|0|||
126191945|NCT00804986|453988402|FG001|Overall Study|Adverse Event|1|||
126191946|NCT00804986|453988403|FG002|Overall Study|Adverse Event|2|||
126191947|NCT00804986|453988404|FG003|Overall Study|Adverse Event|1|||
126191948|NCT00804986|453988405|FG004|Overall Study|Adverse Event|3|||
126191949|NCT00804986|453988406|FG005|Overall Study|Adverse Event|0|||
126191950|NCT00804986|453988401|FG000|Overall Study|Lack of Efficacy|0|||
126191951|NCT00804986|453988402|FG001|Overall Study|Lack of Efficacy|0|||
126191952|NCT00804986|453988403|FG002|Overall Study|Lack of Efficacy|0|||
126191953|NCT00804986|453988404|FG003|Overall Study|Lack of Efficacy|1|||
126191954|NCT00804986|453988405|FG004|Overall Study|Lack of Efficacy|0|||
126191955|NCT00804986|453988406|FG005|Overall Study|Lack of Efficacy|3|||
126191956|NCT00804986|453988401|FG000|Overall Study|Lost to Follow-up|0|||
126191957|NCT00804986|453988402|FG001|Overall Study|Lost to Follow-up|0|||
126191958|NCT00804986|453988403|FG002|Overall Study|Lost to Follow-up|0|||
126191959|NCT00804986|453988404|FG003|Overall Study|Lost to Follow-up|1|||
126191960|NCT00804986|453988405|FG004|Overall Study|Lost to Follow-up|1|||
126191961|NCT00804986|453988406|FG005|Overall Study|Lost to Follow-up|3|||
126191962|NCT00804986|453988401|FG000|Overall Study|Protocol Violation|0|||
126191963|NCT00804986|453988402|FG001|Overall Study|Protocol Violation|1|||
126191964|NCT00804986|453988403|FG002|Overall Study|Protocol Violation|0|||
126191965|NCT00804986|453988404|FG003|Overall Study|Protocol Violation|1|||
126191966|NCT00804986|453988405|FG004|Overall Study|Protocol Violation|0|||
126191967|NCT00804986|453988406|FG005|Overall Study|Protocol Violation|0|||
126191968|NCT00804986|453988401|FG000|Overall Study|Withdrawal by Subject|0|||
126191969|NCT00804986|453988402|FG001|Overall Study|Withdrawal by Subject|3|||
126191970|NCT00804986|453988403|FG002|Overall Study|Withdrawal by Subject|0|||
126191971|NCT00804986|453988404|FG003|Overall Study|Withdrawal by Subject|3|||
126191972|NCT00804986|453988405|FG004|Overall Study|Withdrawal by Subject|5|||
126191973|NCT00804986|453988406|FG005|Overall Study|Withdrawal by Subject|3|||
126191974|NCT00804986|453988401|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
126191975|NCT00804986|453988402|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
126191976|NCT00804986|453988403|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
126191977|NCT00804986|453988404|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
126191978|NCT00804986|453988405|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
126191979|NCT00804986|453988406|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
126191980|NCT00804986|453988401|FG000|Overall Study|Sponsor Decision|0|||
126191981|NCT00804986|453988402|FG001|Overall Study|Sponsor Decision|1|||
126191982|NCT00804986|453988403|FG002|Overall Study|Sponsor Decision|0|||
126191983|NCT00804986|453988404|FG003|Overall Study|Sponsor Decision|0|||
126191984|NCT00804986|453988405|FG004|Overall Study|Sponsor Decision|0|||
126191985|NCT00804986|453988406|FG005|Overall Study|Sponsor Decision|0|||
126191986|NCT00804986|453988401|FG000|Overall Study|Physician Decision|1|||
126191987|NCT00804986|453988402|FG001|Overall Study|Physician Decision|0|||
126191988|NCT00804986|453988403|FG002|Overall Study|Physician Decision|0|||
126191989|NCT00804986|453988404|FG003|Overall Study|Physician Decision|0|||
126191990|NCT00804986|453988405|FG004|Overall Study|Physician Decision|0|||
126191991|NCT00804986|453988406|FG005|Overall Study|Physician Decision|0|||
126191992|NCT00654368|453988407|FG000|Overall Study|Ineligibility determined|6|||
126191993|NCT00654368|453988408|FG001|Overall Study|Ineligibility determined|0|||
126191994|NCT00654368|453988409|FG002|Overall Study|Ineligibility determined|0|||
126191995|NCT00654368|453988407|FG000|Overall Study|Protocol deviation|3|||
126191996|NCT00654368|453988408|FG001|Overall Study|Protocol deviation|2|||
126191997|NCT00654368|453988409|FG002|Overall Study|Protocol deviation|1|||
126191998|NCT00654368|453988407|FG000|Overall Study|Non-compliance|2|||
126191999|NCT00654368|453988408|FG001|Overall Study|Non-compliance|1|||
126192000|NCT00654368|453988409|FG002|Overall Study|Non-compliance|2|||
126192001|NCT00654368|453988407|FG000|Overall Study|Withdrawal by Subject|5|||
126192002|NCT00654368|453988408|FG001|Overall Study|Withdrawal by Subject|2|||
126192003|NCT00654368|453988409|FG002|Overall Study|Withdrawal by Subject|2|||
126192004|NCT00654368|453988407|FG000|Overall Study|Disease progression|21|||
126192005|NCT00654368|453988408|FG001|Overall Study|Disease progression|31|||
126192006|NCT00654368|453988409|FG002|Overall Study|Disease progression|13|||
126192007|NCT00654368|453988407|FG000|Overall Study|Requirement for alternative therapy|1|||
126192008|NCT00654368|453988408|FG001|Overall Study|Requirement for alternative therapy|1|||
126192009|NCT00654368|453988409|FG002|Overall Study|Requirement for alternative therapy|1|||
126192010|NCT00654368|453988407|FG000|Overall Study|Physician Decision|0|||
126192011|NCT00654368|453988408|FG001|Overall Study|Physician Decision|0|||
126192012|NCT00654368|453988409|FG002|Overall Study|Physician Decision|2|||
126192013|NCT00654368|453988407|FG000|Overall Study|Death|1|||
126192014|NCT00654368|453988408|FG001|Overall Study|Death|0|||
126192015|NCT00654368|453988409|FG002|Overall Study|Death|0|||
126192016|NCT00654368|453988407|FG000|Overall Study|Pregnancy|0|||
126192017|NCT00654368|453988408|FG001|Overall Study|Pregnancy|0|||
126192018|NCT00654368|453988409|FG002|Overall Study|Pregnancy|2|||
126192019|NCT00654368|453988407|FG000|Overall Study|Other|0|||
126192020|NCT00654368|453988408|FG001|Overall Study|Other|2|||
126192021|NCT00654368|453988409|FG002|Overall Study|Other|3|||
126192022|NCT00654368|453988407|FG000|Overall Study|Adverse Event|14|||
126192023|NCT00654368|453988408|FG001|Overall Study|Adverse Event|9|||
126192024|NCT00654368|453988409|FG002|Overall Study|Adverse Event|6|||
126192025|NCT00959699|453988411|FG000|Treatment Period|Adverse Event|3|||
126192026|NCT00959699|453988412|FG001|Treatment Period|Adverse Event|13|||
126192027|NCT00959699|453988411|FG000|Treatment Period|Lack of Efficacy|15|||
126192028|NCT00959699|453988412|FG001|Treatment Period|Lack of Efficacy|6|||
126192029|NCT00959699|453988411|FG000|Treatment Period|Lost to Follow-up|0|||
126192030|NCT00959699|453988412|FG001|Treatment Period|Lost to Follow-up|1|||
126192031|NCT00959699|453988411|FG000|Treatment Period|Withdrawal by Subject|1|||
126192032|NCT00959699|453988412|FG001|Treatment Period|Withdrawal by Subject|3|||
126192033|NCT00959699|453988411|FG000|Treatment Period|Non-Compliance with Protocol|0|||
126192034|NCT00959699|453988412|FG001|Treatment Period|Non-Compliance with Protocol|1|||
126192035|NCT00959699|453988411|FG000|Treatment Period|Did not receive treatment|0|||
126192036|NCT00959699|453988412|FG001|Treatment Period|Did not receive treatment|1|||
126192037|NCT00959699|453988411|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
126192038|NCT00959699|453988412|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
126192039|NCT00959699|453988411|FG000|Follow-up Period|Lost to Follow-up|3|||
126192040|NCT00959699|453988412|FG001|Follow-up Period|Lost to Follow-up|2|||
126192041|NCT00959699|453988411|FG000|Follow-up Period|Withdrawal by Subject|3|||
126192042|NCT00959699|453988412|FG001|Follow-up Period|Withdrawal by Subject|4|||
126192043|NCT00606294|453988419|FG000|Overall Study|Withdrawal by Subject|36|||
126192044|NCT00606294|453988420|FG001|Overall Study|Withdrawal by Subject|0|||
126192045|NCT03924427|453988421|FG000|Overall Study|Adverse Event|4|||
126192046|NCT03924427|453988421|FG000|Overall Study|Lack of Efficacy|1|||
126192047|NCT03924427|453988421|FG000|Overall Study|Withdrawal by Subject|1|||
126192048|NCT02774291|453988427|FG000|Overall Study|Lost to Follow-up|1|||
126192049|NCT00126425|453988428|FG000|Overall Study|Withdrawal by Subject|17|||
126192050|NCT00126425|453988429|FG001|Overall Study|Withdrawal by Subject|1|||
126192051|NCT00126425|453988428|FG000|Overall Study|Lost to Follow-up|8|||
126192052|NCT00126425|453988429|FG001|Overall Study|Lost to Follow-up|4|||
126192053|NCT00126425|453988428|FG000|Overall Study|Protocol Violation|9|||
126192054|NCT00126425|453988429|FG001|Overall Study|Protocol Violation|6|||
126192055|NCT00126425|453988428|FG000|Overall Study|Adverse Event|1|||
126192056|NCT00126425|453988429|FG001|Overall Study|Adverse Event|0|||
126192057|NCT00126425|453988428|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
126192058|NCT00126425|453988429|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
126192059|NCT00126425|453988428|FG000|Overall Study|Other|5|||
126192060|NCT00126425|453988429|FG001|Overall Study|Other|0|||
126192061|NCT01316380|453988433|FG000|Overall Study|Adverse Event|0|||
126192062|NCT01316380|453988434|FG001|Overall Study|Adverse Event|2|||
126192063|NCT01316380|453988435|FG002|Overall Study|Adverse Event|1|||
126192064|NCT01316380|453988433|FG000|Overall Study|Protocol Violation|0|||
126192065|NCT01316380|453988434|FG001|Overall Study|Protocol Violation|0|||
126192066|NCT01316380|453988435|FG002|Overall Study|Protocol Violation|1|||
126192067|NCT01316380|453988433|FG000|Overall Study|Withdrawal by Subject|1|||
126192068|NCT01316380|453988434|FG001|Overall Study|Withdrawal by Subject|2|||
126192069|NCT01316380|453988435|FG002|Overall Study|Withdrawal by Subject|0|||
126192070|NCT01316380|453988433|FG000|Overall Study|Other|0|||
126192071|NCT01316380|453988434|FG001|Overall Study|Other|1|||
126192072|NCT01316380|453988435|FG002|Overall Study|Other|1|||
126192073|NCT01316380|453988433|FG000|Overall Study|Not treated|1|||
126192074|NCT01316380|453988434|FG001|Overall Study|Not treated|0|||
126192075|NCT01316380|453988435|FG002|Overall Study|Not treated|0|||
126192076|NCT00149890|453988436|FG000|Overall Study|Adverse Event|1|||
126192077|NCT00149890|453988437|FG001|Overall Study|Adverse Event|8|||
126192078|NCT00149890|453988436|FG000|Overall Study|Lack of Efficacy|8|||
126192079|NCT00149890|453988437|FG001|Overall Study|Lack of Efficacy|9|||
126192080|NCT00149890|453988436|FG000|Overall Study|Protocol Violation|1|||
126192081|NCT00149890|453988437|FG001|Overall Study|Protocol Violation|0|||
126192082|NCT00149890|453988436|FG000|Overall Study|Lost to Follow-up|1|||
126192083|NCT00149890|453988437|FG001|Overall Study|Lost to Follow-up|0|||
126192084|NCT00149890|453988436|FG000|Overall Study|Graft Loss|2|||
126192085|NCT00149890|453988437|FG001|Overall Study|Graft Loss|1|||
126192086|NCT01894776|453988438|FG000|Overall Study|Withdrawal by Subject|1|||
126192087|NCT02332876|453988439|FG000|Overall Study|Lost to Follow-up|1|||
126192088|NCT02332876|453988440|FG001|Overall Study|Lost to Follow-up|1|||
126192089|NCT02415595|453988442|FG000|Overall Study|Administrative reason by sponsor|39|||
126192090|NCT02415595|453988443|FG001|Overall Study|Administrative reason by sponsor|40|||
126192091|NCT02415595|453988444|FG002|Overall Study|Administrative reason by sponsor|41|||
126192092|NCT02415595|453988445|FG003|Overall Study|Administrative reason by sponsor|39|||
126192093|NCT02415595|453988442|FG000|Overall Study|Adverse Event|1|||
126192094|NCT02415595|453988443|FG001|Overall Study|Adverse Event|3|||
126192095|NCT02415595|453988444|FG002|Overall Study|Adverse Event|5|||
126192096|NCT02415595|453988445|FG003|Overall Study|Adverse Event|10|||
126192097|NCT02415595|453988442|FG000|Overall Study|Lack of Efficacy|4|||
126192098|NCT02415595|453988443|FG001|Overall Study|Lack of Efficacy|4|||
126192099|NCT02415595|453988444|FG002|Overall Study|Lack of Efficacy|0|||
126192100|NCT02415595|453988445|FG003|Overall Study|Lack of Efficacy|0|||
126192101|NCT02415595|453988442|FG000|Overall Study|Lost to Follow-up|1|||
126192102|NCT02415595|453988443|FG001|Overall Study|Lost to Follow-up|3|||
126192103|NCT02415595|453988444|FG002|Overall Study|Lost to Follow-up|1|||
126192104|NCT02415595|453988445|FG003|Overall Study|Lost to Follow-up|1|||
126192105|NCT02415595|453988442|FG000|Overall Study|Poor/Non-compliance|1|||
126192106|NCT02415595|453988443|FG001|Overall Study|Poor/Non-compliance|0|||
126192107|NCT02415595|453988444|FG002|Overall Study|Poor/Non-compliance|1|||
126192108|NCT02415595|453988445|FG003|Overall Study|Poor/Non-compliance|0|||
126192109|NCT02415595|453988442|FG000|Overall Study|Reached stopping criteria|0|||
126192110|NCT02415595|453988443|FG001|Overall Study|Reached stopping criteria|1|||
126192111|NCT02415595|453988444|FG002|Overall Study|Reached stopping criteria|1|||
126192112|NCT02415595|453988445|FG003|Overall Study|Reached stopping criteria|0|||
126192113|NCT02415595|453988442|FG000|Overall Study|Withdrawal by Subject|4|||
126192114|NCT02415595|453988443|FG001|Overall Study|Withdrawal by Subject|0|||
126192115|NCT02415595|453988444|FG002|Overall Study|Withdrawal by Subject|1|||
126192116|NCT02415595|453988445|FG003|Overall Study|Withdrawal by Subject|3|||
126192117|NCT02415595|453988442|FG000|Overall Study|Other|0|||
126192118|NCT02415595|453988443|FG001|Overall Study|Other|1|||
126192119|NCT02415595|453988444|FG002|Overall Study|Other|1|||
126192120|NCT02415595|453988445|FG003|Overall Study|Other|0|||
126192121|NCT02614261|453988446|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
126192122|NCT02614261|453988447|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
126192123|NCT02614261|453988448|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
126192124|NCT02614261|453988449|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126192125|NCT02614261|453988446|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
126192126|NCT02614261|453988447|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126192127|NCT02614261|453988448|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126192128|NCT02614261|453988449|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126192129|NCT02614261|453988446|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
126192130|NCT02614261|453988447|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
126192131|NCT02614261|453988448|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126192132|NCT02614261|453988449|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126192133|NCT02614261|453988446|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
126192134|NCT02614261|453988447|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
126192135|NCT02614261|453988448|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
126192136|NCT02614261|453988449|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
126192137|NCT02614261|453988446|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
126192138|NCT02614261|453988447|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
126192139|NCT02614261|453988448|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
126192140|NCT02614261|453988449|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
126192141|NCT02614261|453988446|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
126192142|NCT02614261|453988447|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
126192143|NCT02614261|453988448|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
126192144|NCT02614261|453988449|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
126192145|NCT02614261|453988446|FG000|Double-Blind Treatment Phase|Screen failure|0|||
126192146|NCT02614261|453988447|FG001|Double-Blind Treatment Phase|Screen failure|1|||
126192147|NCT02614261|453988448|FG002|Double-Blind Treatment Phase|Screen failure|2|||
126192148|NCT02614261|453988449|FG003|Double-Blind Treatment Phase|Screen failure|0|||
126192149|NCT02614261|453988446|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
126192150|NCT02614261|453988447|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
126192151|NCT02614261|453988448|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
126192152|NCT02614261|453988449|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126192153|NCT02614261|453988446|FG000|Open-Label Extension Phase|Adverse Event|23|||
126192154|NCT02614261|453988447|FG001|Open-Label Extension Phase|Adverse Event|12|||
126192155|NCT02614261|453988448|FG002|Open-Label Extension Phase|Adverse Event|11|||
126192156|NCT02614261|453988449|FG003|Open-Label Extension Phase|Adverse Event|0|||
126192157|NCT02614261|453988446|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
126192158|NCT02614261|453988447|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
126192159|NCT02614261|453988448|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
126192160|NCT02614261|453988449|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
126192161|NCT02614261|453988446|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
126192162|NCT02614261|453988447|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
126192163|NCT02614261|453988448|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
126192164|NCT02614261|453988449|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
126192165|NCT02614261|453988446|FG000|Open-Label Extension Phase|Physician Decision|2|||
126192166|NCT02614261|453988447|FG001|Open-Label Extension Phase|Physician Decision|0|||
126192167|NCT02614261|453988448|FG002|Open-Label Extension Phase|Physician Decision|0|||
126192168|NCT02614261|453988449|FG003|Open-Label Extension Phase|Physician Decision|0|||
126192169|NCT02614261|453988446|FG000|Open-Label Extension Phase|Pregnancy|1|||
126192170|NCT02614261|453988447|FG001|Open-Label Extension Phase|Pregnancy|2|||
126192171|NCT02614261|453988448|FG002|Open-Label Extension Phase|Pregnancy|1|||
126192172|NCT02614261|453988449|FG003|Open-Label Extension Phase|Pregnancy|0|||
126192173|NCT02614261|453988446|FG000|Open-Label Extension Phase|Protocol Violation|3|||
126192174|NCT02614261|453988447|FG001|Open-Label Extension Phase|Protocol Violation|4|||
126192175|NCT02614261|453988448|FG002|Open-Label Extension Phase|Protocol Violation|1|||
126192176|NCT02614261|453988449|FG003|Open-Label Extension Phase|Protocol Violation|0|||
126192177|NCT02614261|453988446|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
126192178|NCT02614261|453988447|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
126192179|NCT02614261|453988448|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
126192180|NCT02614261|453988449|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
126192181|NCT02614261|453988446|FG000|Follow-up Phase|Adverse Event|2|||
126192182|NCT02614261|453988447|FG001|Follow-up Phase|Adverse Event|0|||
126192183|NCT02614261|453988448|FG002|Follow-up Phase|Adverse Event|1|||
126192184|NCT02614261|453988449|FG003|Follow-up Phase|Adverse Event|0|||
126192185|NCT02614261|453988446|FG000|Follow-up Phase|Lost to Follow-up|12|||
126192186|NCT02614261|453988447|FG001|Follow-up Phase|Lost to Follow-up|5|||
126192187|NCT02614261|453988448|FG002|Follow-up Phase|Lost to Follow-up|2|||
126192188|NCT02614261|453988449|FG003|Follow-up Phase|Lost to Follow-up|0|||
126192189|NCT02614261|453988446|FG000|Follow-up Phase|Physician Decision|5|||
126192190|NCT02614261|453988447|FG001|Follow-up Phase|Physician Decision|1|||
126192191|NCT02614261|453988448|FG002|Follow-up Phase|Physician Decision|0|||
126192192|NCT02614261|453988449|FG003|Follow-up Phase|Physician Decision|0|||
126192193|NCT02614261|453988446|FG000|Follow-up Phase|Pregnancy|0|||
126192194|NCT02614261|453988447|FG001|Follow-up Phase|Pregnancy|1|||
126192195|NCT02614261|453988448|FG002|Follow-up Phase|Pregnancy|0|||
126192196|NCT02614261|453988449|FG003|Follow-up Phase|Pregnancy|0|||
126192197|NCT02614261|453988446|FG000|Follow-up Phase|Protocol Violation|1|||
126192198|NCT02614261|453988447|FG001|Follow-up Phase|Protocol Violation|0|||
126192199|NCT02614261|453988448|FG002|Follow-up Phase|Protocol Violation|0|||
126192200|NCT02614261|453988449|FG003|Follow-up Phase|Protocol Violation|0|||
126192201|NCT02614261|453988446|FG000|Follow-up Phase|Withdrawal by Subject|12|||
126192202|NCT02614261|453988447|FG001|Follow-up Phase|Withdrawal by Subject|4|||
126192203|NCT02614261|453988448|FG002|Follow-up Phase|Withdrawal by Subject|11|||
126192204|NCT02614261|453988449|FG003|Follow-up Phase|Withdrawal by Subject|0|||
126192205|NCT02614261|453988446|FG000|Israel Addendum|Withdrawal by Subject|0|||
126192206|NCT02614261|453988447|FG001|Israel Addendum|Withdrawal by Subject|0|||
126192207|NCT02614261|453988448|FG002|Israel Addendum|Withdrawal by Subject|0|||
126192208|NCT02614261|453988449|FG003|Israel Addendum|Withdrawal by Subject|4|||
126192209|NCT03512275|453988452|FG000|Overall Study|Withdrawal by Subject|1|||
126192210|NCT03512275|453988453|FG001|Overall Study|Withdrawal by Subject|3|||
126192211|NCT03512275|453988452|FG000|Overall Study|Physician Decision|0|||
126192212|NCT03512275|453988453|FG001|Overall Study|Physician Decision|1|||
126192213|NCT03512275|453988452|FG000|Overall Study|Lost to Follow-up|0|||
126192214|NCT03512275|453988453|FG001|Overall Study|Lost to Follow-up|3|||
126192215|NCT03512275|453988452|FG000|Overall Study|Other|1|||
126192216|NCT03512275|453988453|FG001|Overall Study|Other|0|||
126192217|NCT01307046|453988454|FG000|Overall Study|Adverse Event|3|||
126192218|NCT01307046|453988455|FG001|Overall Study|Adverse Event|3|||
126192219|NCT01307046|453988454|FG000|Overall Study|Lack of Efficacy|0|||
126192220|NCT01307046|453988455|FG001|Overall Study|Lack of Efficacy|2|||
126192221|NCT01307046|453988454|FG000|Overall Study|Physician Decision|2|||
126192222|NCT01307046|453988455|FG001|Overall Study|Physician Decision|0|||
126192223|NCT01307046|453988454|FG000|Overall Study|Withdrawal by Subject|1|||
126192224|NCT01307046|453988455|FG001|Overall Study|Withdrawal by Subject|1|||
126192225|NCT01307046|453988454|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
126192226|NCT01307046|453988455|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
126192227|NCT01307046|453988454|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
126192228|NCT01307046|453988455|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
126192229|NCT00609167|453988456|FG000|Overall Study|Withdrawal by Subject|1|||
126192230|NCT00609167|453988457|FG001|Overall Study|Withdrawal by Subject|0|||
126192231|NCT00609167|453988456|FG000|Overall Study|Lack of Efficacy|1|||
126192232|NCT00609167|453988457|FG001|Overall Study|Lack of Efficacy|0|||
126192233|NCT00609167|453988456|FG000|Overall Study|Adverse Event|5|||
126192234|NCT00609167|453988457|FG001|Overall Study|Adverse Event|1|||
126192235|NCT00609167|453988456|FG000|Overall Study|Disease Progression|1|||
126192236|NCT00609167|453988457|FG001|Overall Study|Disease Progression|0|||
126192237|NCT00609167|453988456|FG000|Overall Study|Stem Cell Transplant|0|||
126192238|NCT00609167|453988457|FG001|Overall Study|Stem Cell Transplant|6|||
126192239|NCT02574520|453988458|FG000|Overall Study|Not dosed|2|||
126192240|NCT02574520|453988459|FG001|Overall Study|Not dosed|0|||
126192241|NCT02574520|453988460|FG002|Overall Study|Not dosed|5|||
126192242|NCT02574520|453988461|FG003|Overall Study|Not dosed|4|||
126192243|NCT02574520|453988458|FG000|Overall Study|Adverse Event|0|||
126192244|NCT02574520|453988459|FG001|Overall Study|Adverse Event|0|||
126192245|NCT02574520|453988460|FG002|Overall Study|Adverse Event|0|||
126192246|NCT02574520|453988461|FG003|Overall Study|Adverse Event|1|||
126192247|NCT02574520|453988458|FG000|Overall Study|Withdrawal by Subject|0|||
126192248|NCT02574520|453988459|FG001|Overall Study|Withdrawal by Subject|0|||
126192249|NCT02574520|453988460|FG002|Overall Study|Withdrawal by Subject|0|||
126192250|NCT02574520|453988461|FG003|Overall Study|Withdrawal by Subject|1|||
126192251|NCT02574520|453988458|FG000|Overall Study|Other|0|||
126192252|NCT02574520|453988459|FG001|Overall Study|Other|0|||
126192253|NCT02574520|453988460|FG002|Overall Study|Other|0|||
126192254|NCT02574520|453988461|FG003|Overall Study|Other|2|||
126192255|NCT01365091|453988464|FG000|Period 1|Adverse Event|1|||
126192256|NCT01365091|453988465|FG001|Period 1|Adverse Event|0|||
126192257|NCT01365091|453988466|FG002|Period 1|Adverse Event|2|||
126192258|NCT01365091|453988467|FG003|Period 1|Adverse Event|3|||
126192259|NCT01365091|453988464|FG000|Period 1|Positive test result for drugs of abuse|1|||
126192260|NCT01365091|453988465|FG001|Period 1|Positive test result for drugs of abuse|0|||
126192261|NCT01365091|453988466|FG002|Period 1|Positive test result for drugs of abuse|0|||
126192262|NCT01365091|453988467|FG003|Period 1|Positive test result for drugs of abuse|0|||
126192263|NCT01365091|453988464|FG000|Period 1|No longer met study criteria|0|||
126192264|NCT01365091|453988465|FG001|Period 1|No longer met study criteria|1|||
126192265|NCT01365091|453988466|FG002|Period 1|No longer met study criteria|0|||
126192266|NCT01365091|453988467|FG003|Period 1|No longer met study criteria|0|||
126192267|NCT01365091|453988464|FG000|Period 1|Withdrawal by Subject|0|||
126192268|NCT01365091|453988465|FG001|Period 1|Withdrawal by Subject|1|||
126192269|NCT01365091|453988466|FG002|Period 1|Withdrawal by Subject|0|||
126192270|NCT01365091|453988467|FG003|Period 1|Withdrawal by Subject|0|||
126192271|NCT01365091|453988464|FG000|Period 1|Personal reasons|0|||
126192272|NCT01365091|453988465|FG001|Period 1|Personal reasons|0|||
126192273|NCT01365091|453988466|FG002|Period 1|Personal reasons|1|||
126192274|NCT01365091|453988467|FG003|Period 1|Personal reasons|0|||
126192275|NCT01365091|453988464|FG000|Period 2|Withdrawal by Subject|1|||
126192276|NCT01365091|453988465|FG001|Period 2|Withdrawal by Subject|0|||
126192277|NCT01365091|453988466|FG002|Period 2|Withdrawal by Subject|0|||
126192278|NCT01365091|453988467|FG003|Period 2|Withdrawal by Subject|0|||
126192279|NCT01365091|453988464|FG000|Period 2|Adverse Event|0|||
126192280|NCT01365091|453988465|FG001|Period 2|Adverse Event|0|||
126192281|NCT01365091|453988466|FG002|Period 2|Adverse Event|1|||
126192282|NCT01365091|453988467|FG003|Period 2|Adverse Event|0|||
126192283|NCT05116683|453988469|FG000|Overall Study|Physician Decision|4|||
126192284|NCT01474889|453988470|FG000|Overall Study|Physician Decision|1|||
126192285|NCT01474889|453988471|FG001|Overall Study|Physician Decision|0|||
126192286|NCT01474889|453988472|FG002|Overall Study|Physician Decision|0|||
126192287|NCT01474889|453988470|FG000|Overall Study|Did not meet inclusion|1|||
126192288|NCT01474889|453988471|FG001|Overall Study|Did not meet inclusion|0|||
126192289|NCT01474889|453988472|FG002|Overall Study|Did not meet inclusion|0|||
126192290|NCT01474889|453988470|FG000|Overall Study|Withdrawal by Subject|0|||
126192291|NCT01474889|453988471|FG001|Overall Study|Withdrawal by Subject|1|||
126192292|NCT01474889|453988472|FG002|Overall Study|Withdrawal by Subject|0|||
126192293|NCT03935594|453988476|FG000|Overall Study|Physician Decision|3|||
126192294|NCT01435122|453988477|FG000|Overall Study|Early withdrawal due to toxicity|8|||
126192295|NCT04412668|453988478|FG000|Overall Study|Death - multiple comorbidities|2|||
126192296|NCT04412668|453988479|FG001|Overall Study|Death - multiple comorbidities|0|||
126192297|NCT04412668|453988480|FG002|Overall Study|Death - multiple comorbidities|0|||
126192298|NCT04412668|453988478|FG000|Overall Study|Withdrawal by Subject|3|||
126192299|NCT04412668|453988479|FG001|Overall Study|Withdrawal by Subject|0|||
126192300|NCT04412668|453988480|FG002|Overall Study|Withdrawal by Subject|0|||
126192301|NCT04412668|453988478|FG000|Overall Study|Other than Specified|2|||
126192302|NCT04412668|453988479|FG001|Overall Study|Other than Specified|0|||
126192303|NCT04412668|453988480|FG002|Overall Study|Other than Specified|0|||
126192304|NCT04964557|453988482|FG000|Overall Study|Withdrawal by Subject|3|||
126192305|NCT04964557|453988483|FG001|Overall Study|Withdrawal by Subject|2|||
126192306|NCT04964557|453988482|FG000|Overall Study|Lost to Follow-up|1|||
126192307|NCT04964557|453988483|FG001|Overall Study|Lost to Follow-up|2|||
126192308|NCT04964557|453988482|FG000|Overall Study|Physician Decision|2|||
126192309|NCT04964557|453988483|FG001|Overall Study|Physician Decision|0|||
126192310|NCT04964557|453988482|FG000|Overall Study|Death|3|||
126192311|NCT04964557|453988483|FG001|Overall Study|Death|0|||
126192312|NCT04964557|453988482|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
126192313|NCT04964557|453988483|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
126192314|NCT02358863|453990023|FG000|Overall Study|Physician Decision|3|||
126192315|NCT03793010|453990030|FG000|Overall Study|Withdrawal by Subject|5|||
126192316|NCT03793010|453990031|FG001|Overall Study|Withdrawal by Subject|7|||
126192317|NCT03793010|453990030|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
126192318|NCT03793010|453990031|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
126192319|NCT03793010|453990030|FG000|Overall Study|Lost to Follow-up|1|||
126192320|NCT03793010|453990031|FG001|Overall Study|Lost to Follow-up|2|||
126192321|NCT03793010|453990030|FG000|Overall Study|Patient couldn't sit still for injection|1|||
126192322|NCT03793010|453990031|FG001|Overall Study|Patient couldn't sit still for injection|0|||
126192323|NCT03793010|453990030|FG000|Overall Study|Withdrew to pursue other treatment|1|||
126192324|NCT03793010|453990031|FG001|Overall Study|Withdrew to pursue other treatment|0|||
126192325|NCT03793010|453990030|FG000|Overall Study|Did not meet eligibility criteria|1|||
126192326|NCT03793010|453990031|FG001|Overall Study|Did not meet eligibility criteria|0|||
126192327|NCT04924114|453990033|FG000|Overall Study|Withdrawal by Subject|0|||
126192328|NCT04924114|453990034|FG001|Overall Study|Withdrawal by Subject|2|||
126192329|NCT04924114|453990035|FG002|Overall Study|Withdrawal by Subject|2|||
126192330|NCT04924114|453990036|FG003|Overall Study|Withdrawal by Subject|0|||
126192331|NCT04924114|453990037|FG004|Overall Study|Withdrawal by Subject|2|||
126192332|NCT00378534|453990038|FG000|Overall Study|Participants did not receive transplant|3|||
126192333|NCT00378534|453990039|FG001|Overall Study|Participants did not receive transplant|0|||
126192334|NCT04969900|453990040|FG000|Overall Study|Physician Decision|1|||
126192335|NCT04969900|453990041|FG001|Overall Study|Physician Decision|1|||
126192336|NCT04969900|453990040|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
126192337|NCT04969900|453990041|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
126192338|NCT04423718|453990042|FG000|Main Study|Adverse Event|9|||
126192339|NCT04423718|453990043|FG001|Main Study|Adverse Event|5|||
126192340|NCT04423718|453990044|FG002|Main Study|Adverse Event|8|||
126192341|NCT04423718|453990042|FG000|Main Study|Physician Decision|3|||
126192342|NCT04423718|453990043|FG001|Main Study|Physician Decision|3|||
126192343|NCT04423718|453990044|FG002|Main Study|Physician Decision|2|||
126192344|NCT04423718|453990042|FG000|Main Study|Protocol Violation|0|||
126192345|NCT04423718|453990043|FG001|Main Study|Protocol Violation|0|||
126192346|NCT04423718|453990044|FG002|Main Study|Protocol Violation|1|||
126192347|NCT04423718|453990042|FG000|Main Study|Lost to Follow-up|3|||
126192348|NCT04423718|453990043|FG001|Main Study|Lost to Follow-up|3|||
126192349|NCT04423718|453990044|FG002|Main Study|Lost to Follow-up|4|||
126192350|NCT04423718|453990042|FG000|Main Study|Lack of Efficacy|2|||
126192351|NCT04423718|453990043|FG001|Main Study|Lack of Efficacy|1|||
126192352|NCT04423718|453990044|FG002|Main Study|Lack of Efficacy|0|||
126192353|NCT04423718|453990042|FG000|Main Study|Withdrawal by Subject|14|||
126192354|NCT04423718|453990043|FG001|Main Study|Withdrawal by Subject|20|||
126192355|NCT04423718|453990044|FG002|Main Study|Withdrawal by Subject|20|||
126192356|NCT04423718|453990042|FG000|Main Study|Death|10|||
126192357|NCT04423718|453990043|FG001|Main Study|Death|7|||
126192358|NCT04423718|453990044|FG002|Main Study|Death|7|||
126192359|NCT04423718|453990042|FG000|Main Study|COVID-19 pandemic|2|||
126192360|NCT04423718|453990043|FG001|Main Study|COVID-19 pandemic|2|||
126192361|NCT04423718|453990044|FG002|Main Study|COVID-19 pandemic|2|||
126192362|NCT04423718|453990042|FG000|Main Study|Other|7|||
126192363|NCT04423718|453990043|FG001|Main Study|Other|3|||
126192364|NCT04423718|453990044|FG002|Main Study|Other|2|||
126192365|NCT04423718|453990042|FG000|Extension Phase|Other|1|||
126192366|NCT04423718|453990043|FG001|Extension Phase|Other|0|||
126192367|NCT04423718|453990044|FG002|Extension Phase|Other|0|||
126192368|NCT04423718|453990042|FG000|Extension Phase|Logistical problems|0|||
126192369|NCT04423718|453990043|FG001|Extension Phase|Logistical problems|1|||
126192370|NCT04423718|453990044|FG002|Extension Phase|Logistical problems|1|||
126192371|NCT04423718|453990042|FG000|Extension Phase|Physician Decision|1|||
126192372|NCT04423718|453990043|FG001|Extension Phase|Physician Decision|0|||
126192373|NCT04423718|453990044|FG002|Extension Phase|Physician Decision|1|||
126192374|NCT04423718|453990042|FG000|Extension Phase|Lack of Efficacy|2|||
126192375|NCT04423718|453990043|FG001|Extension Phase|Lack of Efficacy|0|||
126192376|NCT04423718|453990044|FG002|Extension Phase|Lack of Efficacy|1|||
126192377|NCT04423718|453990042|FG000|Extension Phase|Lost to Follow-up|0|||
126192378|NCT04423718|453990043|FG001|Extension Phase|Lost to Follow-up|2|||
126192379|NCT04423718|453990044|FG002|Extension Phase|Lost to Follow-up|3|||
126192380|NCT04423718|453990042|FG000|Extension Phase|Adverse Event|2|||
126192381|NCT04423718|453990043|FG001|Extension Phase|Adverse Event|3|||
126192382|NCT04423718|453990044|FG002|Extension Phase|Adverse Event|1|||
126192383|NCT04423718|453990042|FG000|Extension Phase|Death|4|||
126192384|NCT04423718|453990043|FG001|Extension Phase|Death|7|||
126192385|NCT04423718|453990044|FG002|Extension Phase|Death|2|||
126192386|NCT04423718|453990042|FG000|Extension Phase|Withdrawal by Subject|11|||
126192387|NCT04423718|453990043|FG001|Extension Phase|Withdrawal by Subject|11|||
126192388|NCT04423718|453990044|FG002|Extension Phase|Withdrawal by Subject|7|||
126192389|NCT00425945|453990045|FG000|Overall Study|Concern about Supplement|2|||
126192390|NCT00425945|453990046|FG001|Overall Study|Concern about Supplement|0|||
126192391|NCT00425945|453990045|FG000|Overall Study|Inconvenience|0|||
126192392|NCT00425945|453990046|FG001|Overall Study|Inconvenience|2|||
126192393|NCT00425945|453990045|FG000|Overall Study|Lost to Follow-up|0|||
126192394|NCT00425945|453990046|FG001|Overall Study|Lost to Follow-up|2|||
126192395|NCT00425945|453990045|FG000|Overall Study|Began hypertension medication|1|||
126192396|NCT00425945|453990046|FG001|Overall Study|Began hypertension medication|0|||
126192397|NCT00425945|453990045|FG000|Overall Study|Began cancer treatments|1|||
126192398|NCT00425945|453990046|FG001|Overall Study|Began cancer treatments|0|||
126192399|NCT00425945|453990045|FG000|Overall Study|Moved from area|0|||
126192400|NCT00425945|453990046|FG001|Overall Study|Moved from area|1|||
126192401|NCT03657576|453990051|FG000|Overall Study|Death|0|||
126192402|NCT03657576|453990052|FG001|Overall Study|Death|1|||
126192403|NCT03657576|453990053|FG002|Overall Study|Death|1|||
126192404|NCT03657576|453990054|FG003|Overall Study|Death|0|||
126192405|NCT03657576|453990055|FG004|Overall Study|Death|0|||
126192406|NCT03657576|453990056|FG005|Overall Study|Death|0|||
126192407|NCT03657576|453990051|FG000|Overall Study|Withdrawal by Subject|0|||
126192408|NCT03657576|453990052|FG001|Overall Study|Withdrawal by Subject|0|||
126192409|NCT03657576|453990053|FG002|Overall Study|Withdrawal by Subject|0|||
126192410|NCT03657576|453990054|FG003|Overall Study|Withdrawal by Subject|1|||
126192411|NCT03657576|453990055|FG004|Overall Study|Withdrawal by Subject|0|||
126192412|NCT03657576|453990056|FG005|Overall Study|Withdrawal by Subject|0|||
126192413|NCT03657576|453990051|FG000|Overall Study|Screen Fail|0|||
126192414|NCT03657576|453990052|FG001|Overall Study|Screen Fail|0|||
126192415|NCT03657576|453990053|FG002|Overall Study|Screen Fail|0|||
126192416|NCT03657576|453990054|FG003|Overall Study|Screen Fail|0|||
126192417|NCT03657576|453990055|FG004|Overall Study|Screen Fail|0|||
126192418|NCT03657576|453990056|FG005|Overall Study|Screen Fail|5|||
126192419|NCT03657576|453990051|FG000|Overall Study|Disease Progression|1|||
126192420|NCT03657576|453990052|FG001|Overall Study|Disease Progression|1|||
126192421|NCT03657576|453990053|FG002|Overall Study|Disease Progression|0|||
126192422|NCT03657576|453990054|FG003|Overall Study|Disease Progression|5|||
126192423|NCT03657576|453990055|FG004|Overall Study|Disease Progression|0|||
126192424|NCT03657576|453990056|FG005|Overall Study|Disease Progression|0|||
126192425|NCT03657576|453990051|FG000|Overall Study|Insurance Coverage|0|||
126192426|NCT03657576|453990052|FG001|Overall Study|Insurance Coverage|0|||
126192427|NCT03657576|453990053|FG002|Overall Study|Insurance Coverage|0|||
126192428|NCT03657576|453990054|FG003|Overall Study|Insurance Coverage|1|||
126192429|NCT03657576|453990055|FG004|Overall Study|Insurance Coverage|0|||
126192430|NCT03657576|453990056|FG005|Overall Study|Insurance Coverage|0|||
126192431|NCT05618808|453990059|FG000|Overall Study|Withdrawal by Subject|3|||
126192432|NCT05618808|453990060|FG001|Overall Study|Withdrawal by Subject|1|||
126192433|NCT05618808|453990061|FG002|Overall Study|Withdrawal by Subject|3|||
126192434|NCT04284787|453990062|FG000|Overall Study|Disease Progression|9|||
126192435|NCT04284787|453990063|FG001|Overall Study|Disease Progression|12|||
126192436|NCT04284787|453990062|FG000|Overall Study|Physician Decision|12|||
126192437|NCT04284787|453990063|FG001|Overall Study|Physician Decision|7|||
126192438|NCT04284787|453990062|FG000|Overall Study|Transplant|5|||
126192439|NCT04284787|453990063|FG001|Overall Study|Transplant|4|||
126192440|NCT04284787|453990062|FG000|Overall Study|Death|1|||
126192441|NCT04284787|453990063|FG001|Overall Study|Death|2|||
126192442|NCT04284787|453990062|FG000|Overall Study|Adverse Event|0|||
126192443|NCT04284787|453990063|FG001|Overall Study|Adverse Event|4|||
126192444|NCT04284787|453990062|FG000|Overall Study|Non-adherence|2|||
126192445|NCT04284787|453990063|FG001|Overall Study|Non-adherence|0|||
126192446|NCT04284787|453990062|FG000|Overall Study|Lack of Efficacy|2|||
126192447|NCT04284787|453990063|FG001|Overall Study|Lack of Efficacy|0|||
126192448|NCT01874353|453990064|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
126192449|NCT01874353|453990065|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
126192450|NCT01874353|453990066|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
126192451|NCT01874353|453990067|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
126192452|NCT01874353|453990064|FG000|Overall Study|Lost to Follow-up|2|||
126192453|NCT01874353|453990065|FG001|Overall Study|Lost to Follow-up|2|||
126192454|NCT01874353|453990066|FG002|Overall Study|Lost to Follow-up|2|||
126192455|NCT01874353|453990067|FG003|Overall Study|Lost to Follow-up|0|||
126192456|NCT01874353|453990064|FG000|Overall Study|Death|110|||
126192457|NCT01874353|453990065|FG001|Overall Study|Death|60|||
126192458|NCT01874353|453990066|FG002|Overall Study|Death|13|||
126192459|NCT01874353|453990067|FG003|Overall Study|Death|7|||
126192460|NCT01874353|453990064|FG000|Overall Study|Withdrawal by Subject|13|||
126192461|NCT01874353|453990065|FG001|Overall Study|Withdrawal by Subject|11|||
126192462|NCT01874353|453990066|FG002|Overall Study|Withdrawal by Subject|0|||
126192463|NCT01874353|453990067|FG003|Overall Study|Withdrawal by Subject|0|||
126192464|NCT04392154|453990068|FG000|Overall Study|Adverse Event|3|||
126192465|NCT04392154|453990069|FG001|Overall Study|Adverse Event|46|||
126192466|NCT04392154|453990068|FG000|Overall Study|Due to epidemic/pandemic|0|||
126192467|NCT04392154|453990069|FG001|Overall Study|Due to epidemic/pandemic|1|||
126192468|NCT04392154|453990068|FG000|Overall Study|Lack of Efficacy|1|||
126192469|NCT04392154|453990069|FG001|Overall Study|Lack of Efficacy|47|||
126192470|NCT04392154|453990068|FG000|Overall Study|Lost to Follow-up|11|||
126192471|NCT04392154|453990069|FG001|Overall Study|Lost to Follow-up|61|||
126192472|NCT04392154|453990068|FG000|Overall Study|Geopolitical conflict|1|||
126192473|NCT04392154|453990069|FG001|Overall Study|Geopolitical conflict|1|||
126192474|NCT04392154|453990068|FG000|Overall Study|Physician Decision|1|||
126192475|NCT04392154|453990069|FG001|Overall Study|Physician Decision|5|||
126192476|NCT04392154|453990068|FG000|Overall Study|Pregnancy|1|||
126192477|NCT04392154|453990069|FG001|Overall Study|Pregnancy|8|||
126192478|NCT04392154|453990068|FG000|Overall Study|Protocol deviation|1|||
126192479|NCT04392154|453990069|FG001|Overall Study|Protocol deviation|12|||
126192480|NCT04392154|453990068|FG000|Overall Study|Withdrawal by Subject|18|||
126192481|NCT04392154|453990069|FG001|Overall Study|Withdrawal by Subject|138|||
126192482|NCT04392154|453990068|FG000|Overall Study|Sponsor Decision|1|||
126192483|NCT04392154|453990069|FG001|Overall Study|Sponsor Decision|14|||
126192484|NCT04392154|453990068|FG000|Overall Study|Site Closure|0|||
126192485|NCT04392154|453990069|FG001|Overall Study|Site Closure|4|||
126192486|NCT04992507|453990072|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
126192487|NCT04992507|453990073|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
126192488|NCT04992507|453990072|FG000|Overall Study|Death|0|||
126192489|NCT04992507|453990073|FG001|Overall Study|Death|1|||
126192490|NCT03774875|453990074|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
126192491|NCT03774875|453990075|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
126192492|NCT03774875|453990074|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
126192493|NCT03774875|453990075|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
126192494|NCT03774875|453990074|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
126192495|NCT03774875|453990075|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
126192496|NCT03774875|453990074|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
126192497|NCT03774875|453990075|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
126192498|NCT03774875|453990074|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
126192499|NCT03774875|453990075|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
126192500|NCT03774875|453990074|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
126192501|NCT03774875|453990075|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
126192502|NCT03774875|453990074|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
126192503|NCT03774875|453990075|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
126192504|NCT03774875|453990074|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
126192505|NCT03774875|453990075|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
126192506|NCT03774875|453990074|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
126192507|NCT03774875|453990075|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
126192508|NCT03774875|453990074|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
126192509|NCT03774875|453990075|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
126192510|NCT03774875|453990074|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
126192511|NCT03774875|453990075|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
126192512|NCT03774875|453990074|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
126192513|NCT03774875|453990075|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
126192514|NCT03774875|453990074|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
126192515|NCT03774875|453990075|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
126192516|NCT03149029|453990078|FG000|Overall Study|Adverse Event|2|||
126192517|NCT03149029|453990079|FG001|Overall Study|Adverse Event|0|||
126192518|NCT03233308|453990080|FG000|Overall Study|Adverse Event|1|||
126192519|NCT03233308|453990080|FG000|Overall Study|Protocol Violation|1|||
126192520|NCT03287830|453990081|FG000|Overall Study|Withdrawal by Subject|1|||
126192521|NCT03287830|453990082|FG001|Overall Study|Withdrawal by Subject|1|||
126192522|NCT03287830|453990081|FG000|Overall Study|not meeting inclusion criteria|5|||
126192523|NCT03287830|453990082|FG001|Overall Study|not meeting inclusion criteria|12|||
126192524|NCT02974621|453990083|FG000|Overall Study|Didn't receive study treatment|1|||
126192525|NCT02974621|453990084|FG001|Overall Study|Didn't receive study treatment|10|||
126192526|NCT05016037|453990085|FG000|Overall Study|Lost to Follow-up|2|||
126192527|NCT00129376|453990090|FG000|Overall Study|Adverse Event|1|||
126192528|NCT00129376|453990090|FG000|Overall Study|Lack of Efficacy|1|||
126192529|NCT03218826|453990092|FG000|Overall Study|Non-compliance with protocol|1|||
126192530|NCT03218826|453990093|FG001|Overall Study|Non-compliance with protocol|0|||
126192531|NCT03218826|453990094|FG002|Overall Study|Non-compliance with protocol|2|||
126192532|NCT03218826|453990095|FG003|Overall Study|Non-compliance with protocol|1|||
126192533|NCT03218826|453990096|FG004|Overall Study|Non-compliance with protocol|1|||
126192534|NCT01426009|453990097|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
126192535|NCT01426009|453990097|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
126192536|NCT01426009|453990097|FG000|Washout 1|Withdrawal by Subject|1|||
126192537|NCT01426009|453990097|FG000|Washout 1|Personal Reasons|1|||
126192538|NCT01426009|453990097|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
126192539|NCT01426009|453990097|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
126192540|NCT01426009|453990097|FG000|Washout 2|electrive surgery|1|||
126192541|NCT01426009|453990097|FG000|Washout 3|personal reasons|1|||
126192542|NCT01426009|453990097|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
126192543|NCT01426009|453990097|FG000|Washout 4|Lost to Follow-up|1|||
126192544|NCT00557323|453990101|FG000|Overall Study|Death|3|||
126192545|NCT00557323|453990101|FG000|Overall Study|Withdrawal by Subject|2|||
126192546|NCT00557323|453990101|FG000|Overall Study|Administrative change|2|||
126192547|NCT01196091|453990106|FG000|Overall Study|Adverse Event|22|||
126192548|NCT01196091|453990107|FG001|Overall Study|Adverse Event|27|||
126192549|NCT01196091|453990108|FG002|Overall Study|Adverse Event|26|||
126192550|NCT01196091|453990106|FG000|Overall Study|Death|3|||
126192551|NCT01196091|453990107|FG001|Overall Study|Death|2|||
126192552|NCT01196091|453990108|FG002|Overall Study|Death|2|||
126192553|NCT01196091|453990106|FG000|Overall Study|Entry Criteria Not Met|11|||
126192554|NCT01196091|453990107|FG001|Overall Study|Entry Criteria Not Met|11|||
126192555|NCT01196091|453990108|FG002|Overall Study|Entry Criteria Not Met|10|||
126192556|NCT01196091|453990106|FG000|Overall Study|Lack of Efficacy|15|||
126192557|NCT01196091|453990107|FG001|Overall Study|Lack of Efficacy|12|||
126192558|NCT01196091|453990108|FG002|Overall Study|Lack of Efficacy|17|||
126192559|NCT01196091|453990106|FG000|Overall Study|Lost to Follow-up|5|||
126192560|NCT01196091|453990107|FG001|Overall Study|Lost to Follow-up|5|||
126192561|NCT01196091|453990108|FG002|Overall Study|Lost to Follow-up|6|||
126192562|NCT01196091|453990106|FG000|Overall Study|Parent/Caregiver Decision|0|||
126192563|NCT01196091|453990107|FG001|Overall Study|Parent/Caregiver Decision|0|||
126192564|NCT01196091|453990108|FG002|Overall Study|Parent/Caregiver Decision|1|||
126192565|NCT01196091|453990106|FG000|Overall Study|Withdrawal by Subject|16|||
126192566|NCT01196091|453990107|FG001|Overall Study|Withdrawal by Subject|19|||
126192567|NCT01196091|453990108|FG002|Overall Study|Withdrawal by Subject|22|||
126192568|NCT01196091|453990106|FG000|Overall Study|Physician Decision|3|||
126192569|NCT01196091|453990107|FG001|Overall Study|Physician Decision|3|||
126192570|NCT01196091|453990108|FG002|Overall Study|Physician Decision|4|||
126192571|NCT01196091|453990106|FG000|Overall Study|Protocol Violation|1|||
126192572|NCT01196091|453990107|FG001|Overall Study|Protocol Violation|3|||
126192573|NCT01196091|453990108|FG002|Overall Study|Protocol Violation|3|||
126192574|NCT01196091|453990106|FG000|Overall Study|Sponsor Decision|6|||
126192575|NCT01196091|453990107|FG001|Overall Study|Sponsor Decision|5|||
126192576|NCT01196091|453990108|FG002|Overall Study|Sponsor Decision|4|||
126192577|NCT01196091|453990106|FG000|Overall Study|Excluded Site|5|||
126192578|NCT01196091|453990107|FG001|Overall Study|Excluded Site|11|||
126192579|NCT01196091|453990108|FG002|Overall Study|Excluded Site|8|||
126192580|NCT01196091|453990106|FG000|Overall Study|Randomized, No Study Drug Received|1|||
126192581|NCT01196091|453990107|FG001|Overall Study|Randomized, No Study Drug Received|0|||
126192582|NCT01196091|453990108|FG002|Overall Study|Randomized, No Study Drug Received|1|||
126192583|NCT03797144|453990109|FG000|Enrollment|Protocol Violation|4|||
126192584|NCT03797144|453990110|FG001|Enrollment|Protocol Violation|1|||
126192585|NCT03797144|453990109|FG000|Surgery|Protocol Violation|1|||
126192586|NCT03797144|453990110|FG001|Surgery|Protocol Violation|0|||
126192587|NCT03797144|453990109|FG000|3 Month|Early termination cut-off date|2|||
126192588|NCT03797144|453990110|FG001|3 Month|Early termination cut-off date|0|||
126192589|NCT03797144|453990109|FG000|12 Month|Early termination cut-off date|8|||
126192590|NCT03797144|453990110|FG001|12 Month|Early termination cut-off date|9|||
126192591|NCT03797144|453990109|FG000|24 Month|Early termination cut-off date|1|||
126192592|NCT03797144|453990110|FG001|24 Month|Early termination cut-off date|1|||
126192593|NCT03077711|453990111|FG000|Overall Study|Lost to Follow-up|2|||
126192594|NCT03077711|453990112|FG001|Overall Study|Lost to Follow-up|2|||
126192595|NCT03077711|453990111|FG000|Overall Study|noncompliant taking medication|2|||
126192596|NCT03077711|453990112|FG001|Overall Study|noncompliant taking medication|0|||
126192597|NCT00376675|453990113|FG000|Overall Study|Withdrawal by Subject|9|||
126192598|NCT00376675|453990114|FG001|Overall Study|Withdrawal by Subject|2|||
126192599|NCT00376675|453990113|FG000|Overall Study|Adverse Event|10|||
126192600|NCT00376675|453990114|FG001|Overall Study|Adverse Event|5|||
126192601|NCT00376675|453990113|FG000|Overall Study|Other Reason|1|||
126192602|NCT00376675|453990114|FG001|Overall Study|Other Reason|7|||
126192603|NCT02943668|453990116|FG000|Overall Study|Disease Progression|1|||
126192604|NCT02201251|453990117|FG000|Overall Study|Adverse Event|1|||
126192605|NCT02201251|453990118|FG001|Overall Study|Adverse Event|1|||
126192606|NCT02201251|453990117|FG000|Overall Study|Protocol Violation|1|||
126192607|NCT02201251|453990118|FG001|Overall Study|Protocol Violation|0|||
126192608|NCT02201251|453990117|FG000|Overall Study|Noncompliance with Study Drug|0|||
126192609|NCT02201251|453990118|FG001|Overall Study|Noncompliance with Study Drug|1|||
126192610|NCT02201251|453990117|FG000|Overall Study|Withdrawal by Subject|2|||
126192611|NCT02201251|453990118|FG001|Overall Study|Withdrawal by Subject|1|||
126192612|NCT01332851|453990119|FG000|Overall Study|Withdrawal by Subject|4|||
126192613|NCT01332851|453990120|FG001|Overall Study|Withdrawal by Subject|2|||
126192614|NCT01332851|453990119|FG000|Overall Study|Lost to Follow-up|7|||
126192615|NCT01332851|453990120|FG001|Overall Study|Lost to Follow-up|11|||
126192616|NCT00255008|453990121|FG000|Overall Study|Adverse Event|1|||
126192617|NCT00255008|453990122|FG001|Overall Study|Adverse Event|1|||
126192618|NCT00255008|453990123|FG002|Overall Study|Adverse Event|2|||
126192619|NCT00255008|453990124|FG003|Overall Study|Adverse Event|0|||
126192620|NCT00255008|453990121|FG000|Overall Study|Lost to Follow-up|1|||
126192621|NCT00255008|453990122|FG001|Overall Study|Lost to Follow-up|0|||
126192622|NCT00255008|453990123|FG002|Overall Study|Lost to Follow-up|1|||
126192623|NCT00255008|453990124|FG003|Overall Study|Lost to Follow-up|2|||
126192624|NCT00255008|453990121|FG000|Overall Study|Did not meet viral reduction criteria|4|||
126192625|NCT00255008|453990122|FG001|Overall Study|Did not meet viral reduction criteria|5|||
126192626|NCT00255008|453990123|FG002|Overall Study|Did not meet viral reduction criteria|0|||
126192627|NCT00255008|453990124|FG003|Overall Study|Did not meet viral reduction criteria|1|||
126192628|NCT00255008|453990121|FG000|Overall Study|Withdrew consent|0|||
126192629|NCT00255008|453990122|FG001|Overall Study|Withdrew consent|0|||
126192630|NCT00255008|453990123|FG002|Overall Study|Withdrew consent|2|||
126192631|NCT00255008|453990124|FG003|Overall Study|Withdrew consent|0|||
126192632|NCT00255008|453990121|FG000|Overall Study|Sponsor request|18|||
126192633|NCT00255008|453990122|FG001|Overall Study|Sponsor request|3|||
126192634|NCT00255008|453990123|FG002|Overall Study|Sponsor request|8|||
126192635|NCT00255008|453990124|FG003|Overall Study|Sponsor request|17|||
126192636|NCT00255008|453990121|FG000|Overall Study|Adverse lab experience|1|||
126192637|NCT00255008|453990122|FG001|Overall Study|Adverse lab experience|0|||
126192638|NCT00255008|453990123|FG002|Overall Study|Adverse lab experience|0|||
126192639|NCT00255008|453990124|FG003|Overall Study|Adverse lab experience|0|||
126192640|NCT00255008|453990121|FG000|Overall Study|Other|7|||
126192641|NCT00255008|453990122|FG001|Overall Study|Other|0|||
126192642|NCT00255008|453990123|FG002|Overall Study|Other|3|||
126192643|NCT00255008|453990124|FG003|Overall Study|Other|2|||
126192644|NCT01833806|453990125|FG000|Overall Study|Alternative treatment|2|||
126192645|NCT01833806|453990125|FG000|Overall Study|Death|5|||
126192646|NCT01833806|453990125|FG000|Overall Study|Physician Decision|1|||
126192647|NCT01833806|453990125|FG000|Overall Study|Lost to Follow-up|1|||
126192648|NCT02724111|453990126|FG000|Overall Study|Protocol Violation|2|||
126192649|NCT02724111|453990127|FG001|Overall Study|Protocol Violation|5|||
126192650|NCT02996500|453990128|FG000|Overall Study|Adverse Event|1|||
126192651|NCT02996500|453990129|FG001|Overall Study|Adverse Event|1|||
126192652|NCT02996500|453990130|FG002|Overall Study|Adverse Event|4|||
126192653|NCT02996500|453990131|FG003|Overall Study|Adverse Event|3|||
126192654|NCT02996500|453990132|FG004|Overall Study|Adverse Event|1|||
126192655|NCT02996500|453990133|FG005|Overall Study|Adverse Event|2|||
126192656|NCT02996500|453990128|FG000|Overall Study|Lack of Efficacy|0|||
126192657|NCT02996500|453990129|FG001|Overall Study|Lack of Efficacy|0|||
126192658|NCT02996500|453990130|FG002|Overall Study|Lack of Efficacy|0|||
126192659|NCT02996500|453990131|FG003|Overall Study|Lack of Efficacy|0|||
126192660|NCT02996500|453990132|FG004|Overall Study|Lack of Efficacy|2|||
126192661|NCT02996500|453990133|FG005|Overall Study|Lack of Efficacy|0|||
126192662|NCT02996500|453990128|FG000|Overall Study|Lost to Follow-up|1|||
126192663|NCT02996500|453990129|FG001|Overall Study|Lost to Follow-up|0|||
126192664|NCT02996500|453990130|FG002|Overall Study|Lost to Follow-up|0|||
126192665|NCT02996500|453990131|FG003|Overall Study|Lost to Follow-up|0|||
126192666|NCT02996500|453990132|FG004|Overall Study|Lost to Follow-up|0|||
126192667|NCT02996500|453990133|FG005|Overall Study|Lost to Follow-up|1|||
126192668|NCT02996500|453990128|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126192669|NCT02996500|453990129|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126192670|NCT02996500|453990130|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
126192671|NCT02996500|453990131|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
126192672|NCT02996500|453990132|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
126192673|NCT02996500|453990133|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
126192674|NCT02996500|453990128|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126192675|NCT02996500|453990129|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126192676|NCT02996500|453990130|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126192677|NCT02996500|453990131|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126192678|NCT02996500|453990132|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126192679|NCT02996500|453990133|FG005|Overall Study|Non-Compliance With Study Drug|1|||
126192680|NCT02996500|453990128|FG000|Overall Study|Progressive Disease|1|||
126192681|NCT02996500|453990129|FG001|Overall Study|Progressive Disease|0|||
126192682|NCT02996500|453990130|FG002|Overall Study|Progressive Disease|0|||
126192683|NCT02996500|453990131|FG003|Overall Study|Progressive Disease|0|||
126192684|NCT02996500|453990132|FG004|Overall Study|Progressive Disease|0|||
126192685|NCT02996500|453990133|FG005|Overall Study|Progressive Disease|0|||
126192686|NCT02996500|453990128|FG000|Overall Study|Other|2|||
126192687|NCT02996500|453990129|FG001|Overall Study|Other|0|||
126192688|NCT02996500|453990130|FG002|Overall Study|Other|2|||
126192689|NCT02996500|453990131|FG003|Overall Study|Other|0|||
126192690|NCT02996500|453990132|FG004|Overall Study|Other|0|||
126192691|NCT02996500|453990133|FG005|Overall Study|Other|0|||
126192692|NCT02996500|453990128|FG000|Overall Study|Protocol Violation|0|||
126192693|NCT02996500|453990129|FG001|Overall Study|Protocol Violation|0|||
126192694|NCT02996500|453990130|FG002|Overall Study|Protocol Violation|0|||
126192695|NCT02996500|453990131|FG003|Overall Study|Protocol Violation|1|||
126192696|NCT02996500|453990132|FG004|Overall Study|Protocol Violation|0|||
126192697|NCT02996500|453990133|FG005|Overall Study|Protocol Violation|0|||
126192698|NCT02996500|453990128|FG000|Overall Study|Withdrawal by Subject|3|||
126192699|NCT02996500|453990129|FG001|Overall Study|Withdrawal by Subject|0|||
126192700|NCT02996500|453990130|FG002|Overall Study|Withdrawal by Subject|3|||
126192701|NCT02996500|453990131|FG003|Overall Study|Withdrawal by Subject|0|||
126192702|NCT02996500|453990132|FG004|Overall Study|Withdrawal by Subject|2|||
126192703|NCT02996500|453990133|FG005|Overall Study|Withdrawal by Subject|0|||
126192704|NCT01828567|453990134|FG000|Overall Study|Lost to Follow-up|27|||
126192705|NCT01828567|453990135|FG001|Overall Study|Lost to Follow-up|9|||
126192706|NCT01828567|453990134|FG000|Overall Study|Excluded - did not meet criteria|4|||
126192707|NCT01828567|453990135|FG001|Overall Study|Excluded - did not meet criteria|1|||
126192708|NCT00707486|453990136|FG000|Overall Study|Withdrawal by Subject|1|||
126192709|NCT02485860|453990137|FG000|Overall Study|Lost to Follow-up|4|||
126192710|NCT02485860|453990138|FG001|Overall Study|Lost to Follow-up|1|||
126192711|NCT02485860|453990137|FG000|Overall Study|Physician Decision|1|||
126192712|NCT02485860|453990138|FG001|Overall Study|Physician Decision|2|||
126192713|NCT02485860|453990137|FG000|Overall Study|Health context (COVID-19)|1|||
126192714|NCT02485860|453990138|FG001|Overall Study|Health context (COVID-19)|0|||
126192715|NCT03325010|453990139|FG000|Overall Study|Adverse Event|3|||
126192716|NCT03325010|453990140|FG001|Overall Study|Adverse Event|8|||
126192717|NCT03325010|453990139|FG000|Overall Study|Protocol Violation|1|||
126192718|NCT03325010|453990140|FG001|Overall Study|Protocol Violation|8|||
126192719|NCT03325010|453990139|FG000|Overall Study|Withdrawal by Subject|1|||
126192720|NCT03325010|453990140|FG001|Overall Study|Withdrawal by Subject|3|||
126192721|NCT03325010|453990139|FG000|Overall Study|Lost to Follow-up|1|||
126192722|NCT03325010|453990140|FG001|Overall Study|Lost to Follow-up|0|||
126192723|NCT03325010|453990139|FG000|Overall Study|Physician Decision|1|||
126192724|NCT03325010|453990140|FG001|Overall Study|Physician Decision|1|||
126192725|NCT03325010|453990139|FG000|Overall Study|Lack of Efficacy|2|||
126192726|NCT03325010|453990140|FG001|Overall Study|Lack of Efficacy|0|||
126192727|NCT00471315|453990143|FG000|Overall Study|Adverse Event|7|||
126192728|NCT00471315|453990143|FG000|Overall Study|Withdrawal by Subject|1|||
126192729|NCT03073200|453990150|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126192730|NCT03073200|453990151|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126192731|NCT03073200|453990152|FG002|Double Blind Treatment Period|Protocol Violation|0|||
126192732|NCT03073200|453990153|FG003|Double Blind Treatment Period|Protocol Violation|0|||
126192733|NCT03073200|453990154|FG004|Double Blind Treatment Period|Protocol Violation|0|||
126192734|NCT03073200|453990155|FG005|Double Blind Treatment Period|Protocol Violation|0|||
126192735|NCT03073200|453990156|FG006|Double Blind Treatment Period|Protocol Violation|0|||
126192736|NCT03073200|453990157|FG007|Double Blind Treatment Period|Protocol Violation|0|||
126192737|NCT03073200|453990158|FG008|Double Blind Treatment Period|Protocol Violation|0|||
126192738|NCT03073200|453990159|FG009|Double Blind Treatment Period|Protocol Violation|0|||
126192739|NCT03073200|453990160|FG010|Double Blind Treatment Period|Protocol Violation|0|||
126192740|NCT03073200|453990161|FG011|Double Blind Treatment Period|Protocol Violation|0|||
126192741|NCT03073200|453990162|FG012|Double Blind Treatment Period|Protocol Violation|0|||
126192742|NCT03073200|453990163|FG013|Double Blind Treatment Period|Protocol Violation|0|||
126192743|NCT03073200|453990164|FG014|Double Blind Treatment Period|Protocol Violation|0|||
126192744|NCT03073200|453990150|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192745|NCT03073200|453990151|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
126192746|NCT03073200|453990152|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192747|NCT03073200|453990153|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192748|NCT03073200|453990154|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192749|NCT03073200|453990155|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192750|NCT03073200|453990156|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192751|NCT03073200|453990157|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192752|NCT03073200|453990158|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192753|NCT03073200|453990159|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192754|NCT03073200|453990160|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192755|NCT03073200|453990161|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192756|NCT03073200|453990162|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192757|NCT03073200|453990163|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192758|NCT03073200|453990164|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126192759|NCT03073200|453990150|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
126192760|NCT03073200|453990151|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192761|NCT03073200|453990152|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192762|NCT03073200|453990153|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192763|NCT03073200|453990154|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192764|NCT03073200|453990155|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192765|NCT03073200|453990156|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192766|NCT03073200|453990157|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192767|NCT03073200|453990158|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192768|NCT03073200|453990159|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192769|NCT03073200|453990160|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192770|NCT03073200|453990161|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192771|NCT03073200|453990162|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192772|NCT03073200|453990163|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192773|NCT03073200|453990164|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
126192774|NCT03073200|453990150|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192775|NCT03073200|453990151|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192776|NCT03073200|453990152|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192777|NCT03073200|453990153|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
126192778|NCT03073200|453990154|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
126192779|NCT03073200|453990155|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192780|NCT03073200|453990156|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192781|NCT03073200|453990157|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192782|NCT03073200|453990158|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192783|NCT03073200|453990159|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192784|NCT03073200|453990160|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192785|NCT03073200|453990161|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192786|NCT03073200|453990162|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192787|NCT03073200|453990163|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192788|NCT03073200|453990164|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
126192789|NCT03073200|453990150|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
126192790|NCT03073200|453990151|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
126192791|NCT03073200|453990152|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
126192792|NCT03073200|453990153|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
126192793|NCT03073200|453990154|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
126192794|NCT03073200|453990155|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
126192795|NCT03073200|453990156|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
126192796|NCT03073200|453990157|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
126192797|NCT03073200|453990158|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
126192798|NCT03073200|453990159|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
126192799|NCT03073200|453990160|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
126192800|NCT03073200|453990161|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
126192801|NCT03073200|453990162|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
126192802|NCT03073200|453990163|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
126192803|NCT03073200|453990164|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
126192804|NCT03073200|453990150|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192805|NCT03073200|453990151|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192806|NCT03073200|453990152|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192807|NCT03073200|453990153|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192808|NCT03073200|453990154|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
126192809|NCT03073200|453990155|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192810|NCT03073200|453990156|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192811|NCT03073200|453990157|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192812|NCT03073200|453990158|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192813|NCT03073200|453990159|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192814|NCT03073200|453990160|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192815|NCT03073200|453990161|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192816|NCT03073200|453990162|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192817|NCT03073200|453990163|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192818|NCT03073200|453990164|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
126192819|NCT03073200|453990150|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192820|NCT03073200|453990151|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192821|NCT03073200|453990152|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192822|NCT03073200|453990153|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
126192823|NCT03073200|453990154|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
126192824|NCT03073200|453990155|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192825|NCT03073200|453990156|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192826|NCT03073200|453990157|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192827|NCT03073200|453990158|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192828|NCT03073200|453990159|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192829|NCT03073200|453990160|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192830|NCT03073200|453990161|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192831|NCT03073200|453990162|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192832|NCT03073200|453990163|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192833|NCT03073200|453990164|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126192834|NCT03073200|453990150|FG000|Extension Period|Lost to Follow-up|0|||
126192835|NCT03073200|453990151|FG001|Extension Period|Lost to Follow-up|0|||
126192836|NCT03073200|453990152|FG002|Extension Period|Lost to Follow-up|0|||
126192837|NCT03073200|453990153|FG003|Extension Period|Lost to Follow-up|0|||
126192838|NCT03073200|453990154|FG004|Extension Period|Lost to Follow-up|0|||
126192839|NCT03073200|453990155|FG005|Extension Period|Lost to Follow-up|0|||
126192840|NCT03073200|453990156|FG006|Extension Period|Lost to Follow-up|1|||
126192841|NCT03073200|453990157|FG007|Extension Period|Lost to Follow-up|1|||
126192842|NCT03073200|453990158|FG008|Extension Period|Lost to Follow-up|0|||
126192843|NCT03073200|453990159|FG009|Extension Period|Lost to Follow-up|0|||
126192844|NCT03073200|453990160|FG010|Extension Period|Lost to Follow-up|0|||
126192845|NCT03073200|453990161|FG011|Extension Period|Lost to Follow-up|0|||
126192846|NCT03073200|453990162|FG012|Extension Period|Lost to Follow-up|0|||
126192847|NCT03073200|453990163|FG013|Extension Period|Lost to Follow-up|0|||
126192848|NCT03073200|453990164|FG014|Extension Period|Lost to Follow-up|0|||
126192849|NCT03073200|453990150|FG000|Extension Period|Sponsor Decision|0|||
126192850|NCT03073200|453990151|FG001|Extension Period|Sponsor Decision|0|||
126192851|NCT03073200|453990152|FG002|Extension Period|Sponsor Decision|0|||
126192852|NCT03073200|453990153|FG003|Extension Period|Sponsor Decision|0|||
126192853|NCT03073200|453990154|FG004|Extension Period|Sponsor Decision|0|||
126192854|NCT03073200|453990155|FG005|Extension Period|Sponsor Decision|0|||
126192855|NCT03073200|453990156|FG006|Extension Period|Sponsor Decision|0|||
126192856|NCT03073200|453990157|FG007|Extension Period|Sponsor Decision|0|||
126192857|NCT03073200|453990158|FG008|Extension Period|Sponsor Decision|1|||
126192858|NCT03073200|453990159|FG009|Extension Period|Sponsor Decision|0|||
126192859|NCT03073200|453990160|FG010|Extension Period|Sponsor Decision|0|||
126192860|NCT03073200|453990161|FG011|Extension Period|Sponsor Decision|0|||
126192861|NCT03073200|453990162|FG012|Extension Period|Sponsor Decision|0|||
126192862|NCT03073200|453990163|FG013|Extension Period|Sponsor Decision|0|||
126192863|NCT03073200|453990164|FG014|Extension Period|Sponsor Decision|0|||
126192864|NCT03073200|453990150|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
126192865|NCT03073200|453990151|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
126192866|NCT03073200|453990152|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
126192867|NCT03073200|453990153|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
126192868|NCT03073200|453990154|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
126192869|NCT03073200|453990155|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
126192870|NCT03073200|453990156|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
126192871|NCT03073200|453990157|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
126192872|NCT03073200|453990158|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
126192873|NCT03073200|453990159|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
126192874|NCT03073200|453990160|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
126192875|NCT03073200|453990161|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
126192876|NCT03073200|453990162|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
126192877|NCT03073200|453990163|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
126192878|NCT03073200|453990164|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
126192879|NCT03073200|453990150|FG000|Extension Period|Withdrawal by Subject|0|||
126192880|NCT03073200|453990151|FG001|Extension Period|Withdrawal by Subject|0|||
126192881|NCT03073200|453990152|FG002|Extension Period|Withdrawal by Subject|0|||
126192882|NCT03073200|453990153|FG003|Extension Period|Withdrawal by Subject|0|||
126192883|NCT03073200|453990154|FG004|Extension Period|Withdrawal by Subject|0|||
126192884|NCT03073200|453990155|FG005|Extension Period|Withdrawal by Subject|0|||
126192885|NCT03073200|453990156|FG006|Extension Period|Withdrawal by Subject|1|||
126192886|NCT03073200|453990157|FG007|Extension Period|Withdrawal by Subject|2|||
126192887|NCT03073200|453990158|FG008|Extension Period|Withdrawal by Subject|0|||
126192888|NCT03073200|453990159|FG009|Extension Period|Withdrawal by Subject|0|||
126192889|NCT03073200|453990160|FG010|Extension Period|Withdrawal by Subject|0|||
126192890|NCT03073200|453990161|FG011|Extension Period|Withdrawal by Subject|0|||
126192891|NCT03073200|453990162|FG012|Extension Period|Withdrawal by Subject|0|||
126192892|NCT03073200|453990163|FG013|Extension Period|Withdrawal by Subject|0|||
126192893|NCT03073200|453990164|FG014|Extension Period|Withdrawal by Subject|0|||
126192894|NCT03073200|453990150|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192895|NCT03073200|453990151|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192896|NCT03073200|453990152|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192897|NCT03073200|453990153|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192898|NCT03073200|453990154|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192899|NCT03073200|453990155|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192900|NCT03073200|453990156|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192901|NCT03073200|453990157|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192902|NCT03073200|453990158|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192903|NCT03073200|453990159|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192904|NCT03073200|453990160|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192905|NCT03073200|453990161|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
126192906|NCT03073200|453990162|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192907|NCT03073200|453990163|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192908|NCT03073200|453990164|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
126192909|NCT03073200|453990150|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192910|NCT03073200|453990151|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192911|NCT03073200|453990152|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192912|NCT03073200|453990153|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192913|NCT03073200|453990154|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192914|NCT03073200|453990155|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192915|NCT03073200|453990156|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192916|NCT03073200|453990157|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192917|NCT03073200|453990158|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192918|NCT03073200|453990159|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192919|NCT03073200|453990160|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192920|NCT03073200|453990161|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
126192921|NCT03073200|453990162|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192922|NCT03073200|453990163|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192923|NCT03073200|453990164|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126192924|NCT03073200|453990150|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192925|NCT03073200|453990151|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192926|NCT03073200|453990152|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192927|NCT03073200|453990153|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192928|NCT03073200|453990154|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192929|NCT03073200|453990155|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192930|NCT03073200|453990156|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192931|NCT03073200|453990157|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192932|NCT03073200|453990158|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192933|NCT03073200|453990159|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192934|NCT03073200|453990160|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
126192935|NCT03073200|453990161|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
126192936|NCT03073200|453990162|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192937|NCT03073200|453990163|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192938|NCT03073200|453990164|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126192939|NCT03073200|453990150|FG000|Randomized Withdrawal Period|Adverse Event|0|||
126192940|NCT03073200|453990151|FG001|Randomized Withdrawal Period|Adverse Event|0|||
126192941|NCT03073200|453990152|FG002|Randomized Withdrawal Period|Adverse Event|0|||
126192942|NCT03073200|453990153|FG003|Randomized Withdrawal Period|Adverse Event|0|||
126192943|NCT03073200|453990154|FG004|Randomized Withdrawal Period|Adverse Event|0|||
126192944|NCT03073200|453990155|FG005|Randomized Withdrawal Period|Adverse Event|0|||
126192945|NCT03073200|453990156|FG006|Randomized Withdrawal Period|Adverse Event|0|||
126192946|NCT03073200|453990157|FG007|Randomized Withdrawal Period|Adverse Event|0|||
126192947|NCT03073200|453990158|FG008|Randomized Withdrawal Period|Adverse Event|0|||
126192948|NCT03073200|453990159|FG009|Randomized Withdrawal Period|Adverse Event|0|||
126192949|NCT03073200|453990160|FG010|Randomized Withdrawal Period|Adverse Event|1|||
126192950|NCT03073200|453990161|FG011|Randomized Withdrawal Period|Adverse Event|0|||
126192951|NCT03073200|453990162|FG012|Randomized Withdrawal Period|Adverse Event|0|||
126192952|NCT03073200|453990163|FG013|Randomized Withdrawal Period|Adverse Event|0|||
126192953|NCT03073200|453990164|FG014|Randomized Withdrawal Period|Adverse Event|0|||
126192954|NCT03073200|453990150|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192955|NCT03073200|453990151|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192956|NCT03073200|453990152|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192957|NCT03073200|453990153|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192958|NCT03073200|453990154|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192959|NCT03073200|453990155|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192960|NCT03073200|453990156|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192961|NCT03073200|453990157|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192962|NCT03073200|453990158|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192963|NCT03073200|453990159|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192964|NCT03073200|453990160|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192965|NCT03073200|453990161|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192966|NCT03073200|453990162|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192967|NCT03073200|453990163|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
126192968|NCT03073200|453990164|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
126192969|NCT03073200|453990150|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192970|NCT03073200|453990151|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192971|NCT03073200|453990152|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192972|NCT03073200|453990153|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192973|NCT03073200|453990154|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192974|NCT03073200|453990155|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192975|NCT03073200|453990156|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192976|NCT03073200|453990157|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192977|NCT03073200|453990158|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192978|NCT03073200|453990159|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192979|NCT03073200|453990160|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192980|NCT03073200|453990161|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192981|NCT03073200|453990162|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192982|NCT03073200|453990163|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
126192983|NCT03073200|453990164|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126192984|NCT03073200|453990150|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192985|NCT03073200|453990151|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192986|NCT03073200|453990152|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192987|NCT03073200|453990153|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192988|NCT03073200|453990154|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192989|NCT03073200|453990155|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192990|NCT03073200|453990156|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192991|NCT03073200|453990157|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192992|NCT03073200|453990158|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192993|NCT03073200|453990159|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192994|NCT03073200|453990160|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192995|NCT03073200|453990161|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192996|NCT03073200|453990162|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192997|NCT03073200|453990163|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
126192998|NCT03073200|453990164|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126192999|NCT03073200|453990150|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193000|NCT03073200|453990151|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193001|NCT03073200|453990152|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193002|NCT03073200|453990153|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193003|NCT03073200|453990154|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193004|NCT03073200|453990155|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193005|NCT03073200|453990156|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193006|NCT03073200|453990157|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193007|NCT03073200|453990158|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193008|NCT03073200|453990159|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193009|NCT03073200|453990160|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193010|NCT03073200|453990161|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193011|NCT03073200|453990162|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193012|NCT03073200|453990163|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
126193013|NCT03073200|453990164|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126193014|NCT03073200|453990150|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193015|NCT03073200|453990151|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193016|NCT03073200|453990152|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193017|NCT03073200|453990153|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193018|NCT03073200|453990154|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193019|NCT03073200|453990155|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193020|NCT03073200|453990156|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193021|NCT03073200|453990157|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193022|NCT03073200|453990158|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193023|NCT03073200|453990159|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193024|NCT03073200|453990160|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193025|NCT03073200|453990161|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193026|NCT03073200|453990162|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193027|NCT03073200|453990163|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126193028|NCT03073200|453990164|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
126193029|NCT03073200|453990150|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193030|NCT03073200|453990151|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193031|NCT03073200|453990152|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193032|NCT03073200|453990153|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193033|NCT03073200|453990154|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193034|NCT03073200|453990155|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193035|NCT03073200|453990156|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193036|NCT03073200|453990157|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193037|NCT03073200|453990158|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193038|NCT03073200|453990159|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193039|NCT03073200|453990160|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193040|NCT03073200|453990161|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193041|NCT03073200|453990162|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193042|NCT03073200|453990163|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
126193043|NCT03073200|453990164|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126193044|NCT03073200|453990150|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193045|NCT03073200|453990151|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193046|NCT03073200|453990152|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193047|NCT03073200|453990153|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193048|NCT03073200|453990154|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193049|NCT03073200|453990155|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193050|NCT03073200|453990156|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193051|NCT03073200|453990157|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193052|NCT03073200|453990158|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193053|NCT03073200|453990159|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193054|NCT03073200|453990160|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193055|NCT03073200|453990161|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193056|NCT03073200|453990162|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193057|NCT03073200|453990163|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
126193058|NCT03073200|453990164|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126193059|NCT03073200|453990150|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193060|NCT03073200|453990151|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193061|NCT03073200|453990152|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193062|NCT03073200|453990153|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193063|NCT03073200|453990154|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193064|NCT03073200|453990155|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193065|NCT03073200|453990156|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193066|NCT03073200|453990157|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193067|NCT03073200|453990158|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193068|NCT03073200|453990159|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193069|NCT03073200|453990160|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193070|NCT03073200|453990161|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193071|NCT03073200|453990162|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193072|NCT03073200|453990163|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
126193073|NCT03073200|453990164|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126193074|NCT04757376|453990165|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
126193075|NCT04757376|453990166|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
126193076|NCT04757376|453990167|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
126193077|NCT04757376|453990168|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
126193078|NCT04757376|453990169|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
126193079|NCT04757376|453990165|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
126193080|NCT04757376|453990166|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
126193081|NCT04757376|453990167|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
126193082|NCT04757376|453990168|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
126193083|NCT04757376|453990169|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
126193084|NCT04757376|453990165|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
126193085|NCT04757376|453990166|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
126193086|NCT04757376|453990167|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
126193087|NCT04757376|453990168|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
126193088|NCT04757376|453990169|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
126193089|NCT04757376|453990165|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
126193090|NCT04757376|453990166|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
126193091|NCT04757376|453990167|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
126193092|NCT04757376|453990168|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
126193093|NCT04757376|453990169|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
126193094|NCT04757376|453990165|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
126193095|NCT04757376|453990166|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
126193096|NCT04757376|453990167|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
126193097|NCT04757376|453990168|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
126193098|NCT04757376|453990169|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
126193099|NCT04757376|453990165|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
126193100|NCT04757376|453990166|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
126193101|NCT04757376|453990167|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
126193102|NCT04757376|453990168|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
126193103|NCT04757376|453990169|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
126193104|NCT04757376|453990165|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
126193105|NCT04757376|453990166|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
126193106|NCT04757376|453990167|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
126193107|NCT04757376|453990168|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
126193108|NCT04757376|453990169|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
126193109|NCT04757376|453990165|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
126193110|NCT04757376|453990166|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
126193111|NCT04757376|453990167|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
126193112|NCT04757376|453990168|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
126193113|NCT04757376|453990169|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
126193114|NCT04474366|453990170|FG000|Overall Study|Lost to Follow-up|2|||
126193115|NCT04474366|453990171|FG001|Overall Study|Lost to Follow-up|5|||
126193116|NCT03695471|453991953|FG000|Overall Study|Cancellation|1|||
126193117|NCT02859558|453991954|FG000|Step 1|Not Eligible|0|||
126193118|NCT02859558|453991955|FG001|Step 1|Not Eligible|0|||
126193119|NCT02859558|453991956|FG002|Step 1|Not Eligible|0|||
126193120|NCT02859558|453991957|FG003|Step 1|Not Eligible|0|||
126193121|NCT02859558|453991958|FG004|Step 1|Not Eligible|3|||
126193122|NCT02859558|453991954|FG000|Step 1|Lost to Follow-up|1|||
126193123|NCT02859558|453991955|FG001|Step 1|Lost to Follow-up|3|||
126193124|NCT02859558|453991956|FG002|Step 1|Lost to Follow-up|3|||
126193125|NCT02859558|453991957|FG003|Step 1|Lost to Follow-up|0|||
126193126|NCT02859558|453991958|FG004|Step 1|Lost to Follow-up|0|||
126193127|NCT02859558|453991954|FG000|Step 1|Did Not Return to Clinic|2|||
126193128|NCT02859558|453991955|FG001|Step 1|Did Not Return to Clinic|3|||
126193129|NCT02859558|453991956|FG002|Step 1|Did Not Return to Clinic|4|||
126193130|NCT02859558|453991957|FG003|Step 1|Did Not Return to Clinic|0|||
126193131|NCT02859558|453991958|FG004|Step 1|Did Not Return to Clinic|0|||
126193132|NCT02859558|453991954|FG000|Step 1|Moved|0|||
126193133|NCT02859558|453991955|FG001|Step 1|Moved|1|||
126193134|NCT02859558|453991956|FG002|Step 1|Moved|1|||
126193135|NCT02859558|453991957|FG003|Step 1|Moved|0|||
126193136|NCT02859558|453991958|FG004|Step 1|Moved|0|||
126193137|NCT02859558|453991954|FG000|Step 1|Withdrawal By Participant|1|||
126193138|NCT02859558|453991955|FG001|Step 1|Withdrawal By Participant|2|||
126193139|NCT02859558|453991956|FG002|Step 1|Withdrawal By Participant|1|||
126193140|NCT02859558|453991957|FG003|Step 1|Withdrawal By Participant|0|||
126193141|NCT02859558|453991958|FG004|Step 1|Withdrawal By Participant|0|||
126193142|NCT02859558|453991954|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
126193143|NCT02859558|453991955|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
126193144|NCT02859558|453991956|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
126193145|NCT02859558|453991957|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
126193146|NCT02859558|453991958|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
126193147|NCT02859558|453991954|FG000|Step 1|Incarceration|0|||
126193148|NCT02859558|453991955|FG001|Step 1|Incarceration|1|||
126193149|NCT02859558|453991956|FG002|Step 1|Incarceration|0|||
126193150|NCT02859558|453991957|FG003|Step 1|Incarceration|0|||
126193151|NCT02859558|453991958|FG004|Step 1|Incarceration|0|||
126193152|NCT02859558|453991954|FG000|Step 1|Non-Adherence to Study Drug|2|||
126193153|NCT02859558|453991955|FG001|Step 1|Non-Adherence to Study Drug|0|||
126193154|NCT02859558|453991956|FG002|Step 1|Non-Adherence to Study Drug|1|||
126193155|NCT02859558|453991957|FG003|Step 1|Non-Adherence to Study Drug|0|||
126193156|NCT02859558|453991958|FG004|Step 1|Non-Adherence to Study Drug|0|||
126193157|NCT02859558|453991954|FG000|Step 1|Non-Adherence to Study Requirements|3|||
126193158|NCT02859558|453991955|FG001|Step 1|Non-Adherence to Study Requirements|1|||
126193159|NCT02859558|453991956|FG002|Step 1|Non-Adherence to Study Requirements|0|||
126193160|NCT02859558|453991957|FG003|Step 1|Non-Adherence to Study Requirements|0|||
126193161|NCT02859558|453991958|FG004|Step 1|Non-Adherence to Study Requirements|0|||
126193162|NCT02859558|453991954|FG000|Step 1|Virologic Failure|2|||
126193163|NCT02859558|453991955|FG001|Step 1|Virologic Failure|1|||
126193164|NCT02859558|453991956|FG002|Step 1|Virologic Failure|1|||
126193165|NCT02859558|453991957|FG003|Step 1|Virologic Failure|0|||
126193166|NCT02859558|453991958|FG004|Step 1|Virologic Failure|0|||
126193167|NCT02859558|453991954|FG000|Step 2|Lost to Follow-up|3|||
126193168|NCT02859558|453991955|FG001|Step 2|Lost to Follow-up|3|||
126193169|NCT02859558|453991956|FG002|Step 2|Lost to Follow-up|1|||
126193170|NCT02859558|453991957|FG003|Step 2|Lost to Follow-up|0|||
126193171|NCT02859558|453991958|FG004|Step 2|Lost to Follow-up|0|||
126193172|NCT02859558|453991954|FG000|Step 2|Withdrawal by Subject|0|||
126193173|NCT02859558|453991955|FG001|Step 2|Withdrawal by Subject|1|||
126193174|NCT02859558|453991956|FG002|Step 2|Withdrawal by Subject|1|||
126193175|NCT02859558|453991957|FG003|Step 2|Withdrawal by Subject|0|||
126193176|NCT02859558|453991958|FG004|Step 2|Withdrawal by Subject|0|||
126193177|NCT02859558|453991954|FG000|Step 2|Unexpected Closure of Site|0|||
126193178|NCT02859558|453991955|FG001|Step 2|Unexpected Closure of Site|1|||
126193179|NCT02859558|453991956|FG002|Step 2|Unexpected Closure of Site|1|||
126193180|NCT02859558|453991957|FG003|Step 2|Unexpected Closure of Site|0|||
126193181|NCT02859558|453991958|FG004|Step 2|Unexpected Closure of Site|0|||
126193182|NCT02859558|453991954|FG000|Step 2|Death|1|||
126193183|NCT02859558|453991955|FG001|Step 2|Death|0|||
126193184|NCT02859558|453991956|FG002|Step 2|Death|0|||
126193185|NCT02859558|453991957|FG003|Step 2|Death|0|||
126193186|NCT02859558|453991958|FG004|Step 2|Death|0|||
126193187|NCT02859558|453991954|FG000|Step 2|Incarceration|0|||
126193188|NCT02859558|453991955|FG001|Step 2|Incarceration|0|||
126193189|NCT02859558|453991956|FG002|Step 2|Incarceration|1|||
126193190|NCT02859558|453991957|FG003|Step 2|Incarceration|0|||
126193191|NCT02859558|453991958|FG004|Step 2|Incarceration|0|||
126193192|NCT05665595|453991959|FG000|Overall Study|Ongoing|692|||
126193193|NCT05665595|453991960|FG001|Overall Study|Ongoing|698|||
126193194|NCT05665595|453991959|FG000|Overall Study|Withdrawal by Subject|2|||
126193195|NCT05665595|453991960|FG001|Overall Study|Withdrawal by Subject|2|||
126193196|NCT05665595|453991959|FG000|Overall Study|Lost to Follow-up|1|||
126193197|NCT05665595|453991960|FG001|Overall Study|Lost to Follow-up|0|||
126193198|NCT05665595|453991959|FG000|Overall Study|Death|6|||
126193199|NCT05665595|453991960|FG001|Overall Study|Death|1|||
126193200|NCT00766142|453991961|FG000|Overall Study|Protocol Violation|4|||
126193201|NCT02903966|453991966|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
126193202|NCT02903966|453991967|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
126193203|NCT02903966|453991966|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
126193204|NCT02903966|453991967|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
126193205|NCT02903966|453991966|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
126193206|NCT02903966|453991967|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
126193207|NCT03381274|453991968|FG000|Overall Study|Death|2|||
126193208|NCT03381274|453991969|FG001|Overall Study|Death|9|||
126193209|NCT03381274|453991970|FG002|Overall Study|Death|3|||
126193210|NCT03381274|453991971|FG003|Overall Study|Death|2|||
126193211|NCT03381274|453991972|FG004|Overall Study|Death|3|||
126193212|NCT03381274|453991968|FG000|Overall Study|Lost to Follow-up|0|||
126193213|NCT03381274|453991969|FG001|Overall Study|Lost to Follow-up|0|||
126193214|NCT03381274|453991970|FG002|Overall Study|Lost to Follow-up|0|||
126193215|NCT03381274|453991971|FG003|Overall Study|Lost to Follow-up|1|||
126193216|NCT03381274|453991972|FG004|Overall Study|Lost to Follow-up|0|||
126193217|NCT03381274|453991968|FG000|Overall Study|Withdrawal by Subject|2|||
126193218|NCT03381274|453991969|FG001|Overall Study|Withdrawal by Subject|1|||
126193219|NCT03381274|453991970|FG002|Overall Study|Withdrawal by Subject|3|||
126193220|NCT03381274|453991971|FG003|Overall Study|Withdrawal by Subject|1|||
126193221|NCT03381274|453991972|FG004|Overall Study|Withdrawal by Subject|0|||
126193222|NCT03381274|453991968|FG000|Overall Study|Other|1|||
126193223|NCT03381274|453991969|FG001|Overall Study|Other|11|||
126193224|NCT03381274|453991970|FG002|Overall Study|Other|0|||
126193225|NCT03381274|453991971|FG003|Overall Study|Other|2|||
126193226|NCT03381274|453991972|FG004|Overall Study|Other|2|||
126193227|NCT06048367|453991973|FG000|Overall Study|Withdrawal by Subject|0|||
126193228|NCT06048367|453991974|FG001|Overall Study|Withdrawal by Subject|1|||
126193229|NCT06048367|453991975|FG002|Overall Study|Withdrawal by Subject|0|||
126193230|NCT06048367|453991976|FG003|Overall Study|Withdrawal by Subject|0|||
126193231|NCT06048367|453991977|FG004|Overall Study|Withdrawal by Subject|0|||
126193232|NCT06048367|453991973|FG000|Overall Study|Withdrawal by Subject|0|||
126193233|NCT06048367|453991974|FG001|Overall Study|Withdrawal by Subject|0|||
126193234|NCT06048367|453991975|FG002|Overall Study|Withdrawal by Subject|1|||
126193235|NCT06048367|453991976|FG003|Overall Study|Withdrawal by Subject|0|||
126193236|NCT06048367|453991977|FG004|Overall Study|Withdrawal by Subject|0|||
126193237|NCT06048367|453991973|FG000|Overall Study|Withdrawal by Subject|0|||
126193238|NCT06048367|453991974|FG001|Overall Study|Withdrawal by Subject|0|||
126193239|NCT06048367|453991975|FG002|Overall Study|Withdrawal by Subject|0|||
126193240|NCT06048367|453991976|FG003|Overall Study|Withdrawal by Subject|1|||
126193241|NCT06048367|453991977|FG004|Overall Study|Withdrawal by Subject|0|||
126193242|NCT06048367|453991973|FG000|Overall Study|Withdrawal by Subject|0|||
126193243|NCT06048367|453991974|FG001|Overall Study|Withdrawal by Subject|0|||
126193244|NCT06048367|453991975|FG002|Overall Study|Withdrawal by Subject|0|||
126193245|NCT06048367|453991976|FG003|Overall Study|Withdrawal by Subject|1|||
126193246|NCT06048367|453991977|FG004|Overall Study|Withdrawal by Subject|0|||
126193247|NCT00796549|453991985|FG000|Overall Study|Adverse Event|11|||
126193248|NCT00796549|453991985|FG000|Overall Study|not entered|149|||
126193249|NCT00796549|453991985|FG000|Overall Study|Other|2|||
126193250|NCT00796549|453991985|FG000|Overall Study|Progressive disease|56|||
126193251|NCT01878175|453991987|FG000|Overall Study|Developed contraindicated health problem|2|||
126193252|NCT03083470|453991988|FG000|Overall Study|Lost to Follow-up|0|||
126193253|NCT03083470|453991989|FG001|Overall Study|Lost to Follow-up|0|||
126193254|NCT03083470|453991990|FG002|Overall Study|Lost to Follow-up|0|||
126193255|NCT03083470|453991991|FG003|Overall Study|Lost to Follow-up|0|||
126193256|NCT03083470|453991992|FG004|Overall Study|Lost to Follow-up|1|||
126193257|NCT03083470|453991988|FG000|Overall Study|Withdrawal by Subject|0|||
126193258|NCT03083470|453991989|FG001|Overall Study|Withdrawal by Subject|0|||
126193259|NCT03083470|453991990|FG002|Overall Study|Withdrawal by Subject|0|||
126193260|NCT03083470|453991991|FG003|Overall Study|Withdrawal by Subject|0|||
126193261|NCT03083470|453991992|FG004|Overall Study|Withdrawal by Subject|1|||
126193262|NCT00606229|453991993|FG000|Overall Study|Adverse Event|11|||
126193263|NCT00606229|453991993|FG000|Overall Study|Lack of Efficacy|1|||
126193264|NCT00606229|453991993|FG000|Overall Study|Withdrawal by Subject|4|||
126193265|NCT00606229|453991993|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
126193266|NCT00606229|453991993|FG000|Overall Study|change of residence or other commitments|2|||
126193267|NCT01526928|453991994|FG000|Overall Study|Progressive Disease|35|||
126193268|NCT01526928|453991995|FG001|Overall Study|Progressive Disease|17|||
126193269|NCT01526928|453991996|FG002|Overall Study|Progressive Disease|150|||
126193270|NCT01526928|453991997|FG003|Overall Study|Progressive Disease|182|||
126193271|NCT01526928|453991998|FG004|Overall Study|Progressive Disease|76|||
126193272|NCT01526928|453991999|FG005|Overall Study|Progressive Disease|4|||
126193273|NCT01526928|453991994|FG000|Overall Study|Adverse Event|2|||
126193274|NCT01526928|453991995|FG001|Overall Study|Adverse Event|1|||
126193275|NCT01526928|453991996|FG002|Overall Study|Adverse Event|29|||
126193276|NCT01526928|453991997|FG003|Overall Study|Adverse Event|40|||
126193277|NCT01526928|453991998|FG004|Overall Study|Adverse Event|13|||
126193278|NCT01526928|453991999|FG005|Overall Study|Adverse Event|2|||
126193279|NCT01526928|453991994|FG000|Overall Study|Death|0|||
126193280|NCT01526928|453991995|FG001|Overall Study|Death|0|||
126193281|NCT01526928|453991996|FG002|Overall Study|Death|3|||
126193282|NCT01526928|453991997|FG003|Overall Study|Death|0|||
126193283|NCT01526928|453991998|FG004|Overall Study|Death|0|||
126193284|NCT01526928|453991999|FG005|Overall Study|Death|0|||
126193285|NCT01526928|453991994|FG000|Overall Study|Withdrawal by Subject|1|||
126193286|NCT01526928|453991995|FG001|Overall Study|Withdrawal by Subject|0|||
126193287|NCT01526928|453991996|FG002|Overall Study|Withdrawal by Subject|13|||
126193288|NCT01526928|453991997|FG003|Overall Study|Withdrawal by Subject|11|||
126193289|NCT01526928|453991998|FG004|Overall Study|Withdrawal by Subject|3|||
126193290|NCT01526928|453991999|FG005|Overall Study|Withdrawal by Subject|0|||
126193291|NCT01526928|453991994|FG000|Overall Study|Physician Decision|0|||
126193292|NCT01526928|453991995|FG001|Overall Study|Physician Decision|0|||
126193293|NCT01526928|453991996|FG002|Overall Study|Physician Decision|2|||
126193294|NCT01526928|453991997|FG003|Overall Study|Physician Decision|5|||
126193295|NCT01526928|453991998|FG004|Overall Study|Physician Decision|0|||
126193296|NCT01526928|453991999|FG005|Overall Study|Physician Decision|0|||
126193297|NCT01526928|453991994|FG000|Overall Study|Other Reason|0|||
126193298|NCT01526928|453991995|FG001|Overall Study|Other Reason|1|||
126193299|NCT01526928|453991996|FG002|Overall Study|Other Reason|11|||
126193300|NCT01526928|453991997|FG003|Overall Study|Other Reason|4|||
126193301|NCT01526928|453991998|FG004|Overall Study|Other Reason|1|||
126193302|NCT01526928|453991999|FG005|Overall Study|Other Reason|0|||
126193303|NCT01526928|453991994|FG000|Overall Study|Lost to Follow-up|0|||
126193304|NCT01526928|453991995|FG001|Overall Study|Lost to Follow-up|0|||
126193305|NCT01526928|453991996|FG002|Overall Study|Lost to Follow-up|0|||
126193306|NCT01526928|453991997|FG003|Overall Study|Lost to Follow-up|1|||
126193307|NCT01526928|453991998|FG004|Overall Study|Lost to Follow-up|0|||
126193308|NCT01526928|453991999|FG005|Overall Study|Lost to Follow-up|0|||
126193309|NCT01526928|453991994|FG000|Overall Study|Protocol Deviation|0|||
126193310|NCT01526928|453991995|FG001|Overall Study|Protocol Deviation|0|||
126193311|NCT01526928|453991996|FG002|Overall Study|Protocol Deviation|0|||
126193312|NCT01526928|453991997|FG003|Overall Study|Protocol Deviation|2|||
126193313|NCT01526928|453991998|FG004|Overall Study|Protocol Deviation|0|||
126193314|NCT01526928|453991999|FG005|Overall Study|Protocol Deviation|0|||
126193315|NCT01526928|453991994|FG000|Overall Study|Missing|0|||
126193316|NCT01526928|453991995|FG001|Overall Study|Missing|0|||
126193317|NCT01526928|453991996|FG002|Overall Study|Missing|1|||
126193318|NCT01526928|453991997|FG003|Overall Study|Missing|0|||
126193319|NCT01526928|453991998|FG004|Overall Study|Missing|2|||
126193320|NCT01526928|453991999|FG005|Overall Study|Missing|0|||
126193321|NCT01108068|453992000|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
126193322|NCT01108068|453992001|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
126193323|NCT00836953|453992002|FG000|Overall Study|Withdrawal by Subject|1|||
126193324|NCT00836953|453992002|FG000|Overall Study|Lost to Follow-up|1|||
126193325|NCT02877134|453992006|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193326|NCT02877134|453992007|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
126193327|NCT02877134|453992008|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193328|NCT02877134|453992009|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193329|NCT02877134|453992010|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193330|NCT02877134|453992011|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
126193331|NCT02877134|453992012|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193332|NCT02877134|453992013|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193333|NCT02877134|453992014|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193334|NCT02877134|453992015|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193335|NCT02877134|453992016|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193336|NCT02877134|453992017|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
126193337|NCT02877134|453992006|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193338|NCT02877134|453992007|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
126193339|NCT02877134|453992008|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193340|NCT02877134|453992009|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
126193341|NCT02877134|453992010|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193342|NCT02877134|453992011|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193343|NCT02877134|453992012|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
126193344|NCT02877134|453992013|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193345|NCT02877134|453992014|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193346|NCT02877134|453992015|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193347|NCT02877134|453992016|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193348|NCT02877134|453992017|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126193349|NCT02877134|453992006|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
126193350|NCT02877134|453992007|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
126193351|NCT02877134|453992008|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
126193352|NCT02877134|453992009|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
126193353|NCT02877134|453992010|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
126193354|NCT02877134|453992011|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
126193355|NCT02877134|453992012|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
126193356|NCT02877134|453992013|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126193357|NCT02877134|453992014|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126193358|NCT02877134|453992015|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126193359|NCT02877134|453992016|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126193360|NCT02877134|453992017|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126193361|NCT02877134|453992006|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
126193362|NCT02877134|453992007|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
126193363|NCT02877134|453992008|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
126193364|NCT02877134|453992009|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
126193365|NCT02877134|453992010|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
126193366|NCT02877134|453992011|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
126193367|NCT02877134|453992012|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
126193368|NCT02877134|453992013|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
126193369|NCT02877134|453992014|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
126193370|NCT02877134|453992015|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
126193371|NCT02877134|453992016|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
126193372|NCT02877134|453992017|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
126193373|NCT02877134|453992006|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193374|NCT02877134|453992007|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193375|NCT02877134|453992008|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193376|NCT02877134|453992009|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193377|NCT02877134|453992010|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193378|NCT02877134|453992011|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193379|NCT02877134|453992012|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193380|NCT02877134|453992013|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193381|NCT02877134|453992014|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
126193382|NCT02877134|453992015|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193383|NCT02877134|453992016|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193384|NCT02877134|453992017|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126193385|NCT02877134|453992006|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126193386|NCT02877134|453992007|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126193387|NCT02877134|453992008|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126193388|NCT02877134|453992009|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126193389|NCT02877134|453992010|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126193390|NCT02877134|453992011|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126193391|NCT02877134|453992012|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126193392|NCT02877134|453992013|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
126193393|NCT02877134|453992014|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
126193394|NCT02877134|453992015|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
126193395|NCT02877134|453992016|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
126193396|NCT02877134|453992017|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
126193397|NCT02877134|453992006|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193398|NCT02877134|453992007|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193399|NCT02877134|453992008|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193400|NCT02877134|453992009|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193401|NCT02877134|453992010|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193402|NCT02877134|453992011|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193403|NCT02877134|453992012|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193404|NCT02877134|453992013|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
126193405|NCT02877134|453992014|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
126193406|NCT02877134|453992015|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
126193407|NCT02877134|453992016|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193408|NCT02877134|453992017|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126193409|NCT02877134|453992006|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
126193410|NCT02877134|453992007|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
126193411|NCT02877134|453992008|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
126193412|NCT02877134|453992009|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
126193413|NCT02877134|453992010|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
126193414|NCT02877134|453992011|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
126193415|NCT02877134|453992012|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
126193416|NCT02877134|453992013|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
126193417|NCT02877134|453992014|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
126193418|NCT02877134|453992015|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
126193419|NCT02877134|453992016|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
126193420|NCT02877134|453992017|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
126193421|NCT01197794|453992020|FG000|Overall Study|Adverse Event|3|||
126193422|NCT01197794|453992021|FG001|Overall Study|Adverse Event|2|||
126193423|NCT01197794|453992022|FG002|Overall Study|Adverse Event|4|||
126193424|NCT01197794|453992023|FG003|Overall Study|Adverse Event|4|||
126193425|NCT01197794|453992024|FG004|Overall Study|Adverse Event|4|||
126193426|NCT01197794|453992025|FG005|Overall Study|Adverse Event|2|||
126193427|NCT01197794|453992026|FG006|Overall Study|Adverse Event|3|||
126193428|NCT01197794|453992020|FG000|Overall Study|Protocol Violation|0|||
126193429|NCT01197794|453992021|FG001|Overall Study|Protocol Violation|0|||
126193430|NCT01197794|453992022|FG002|Overall Study|Protocol Violation|0|||
126193431|NCT01197794|453992023|FG003|Overall Study|Protocol Violation|0|||
126193432|NCT01197794|453992024|FG004|Overall Study|Protocol Violation|2|||
126193433|NCT01197794|453992025|FG005|Overall Study|Protocol Violation|0|||
126193434|NCT01197794|453992026|FG006|Overall Study|Protocol Violation|1|||
126193435|NCT01197794|453992020|FG000|Overall Study|Development of study withdrawal criteria|3|||
126193436|NCT01197794|453992021|FG001|Overall Study|Development of study withdrawal criteria|0|||
126193437|NCT01197794|453992022|FG002|Overall Study|Development of study withdrawal criteria|0|||
126193438|NCT01197794|453992023|FG003|Overall Study|Development of study withdrawal criteria|1|||
126193439|NCT01197794|453992024|FG004|Overall Study|Development of study withdrawal criteria|0|||
126193440|NCT01197794|453992025|FG005|Overall Study|Development of study withdrawal criteria|0|||
126193441|NCT01197794|453992026|FG006|Overall Study|Development of study withdrawal criteria|1|||
126193442|NCT01197794|453992020|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
126193443|NCT01197794|453992021|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
126193444|NCT01197794|453992022|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
126193445|NCT01197794|453992023|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
126193446|NCT01197794|453992024|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
126193447|NCT01197794|453992025|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
126193448|NCT01197794|453992026|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
126193449|NCT01197794|453992020|FG000|Overall Study|Withdrawal by Subject|3|||
126193450|NCT01197794|453992021|FG001|Overall Study|Withdrawal by Subject|3|||
126193451|NCT01197794|453992022|FG002|Overall Study|Withdrawal by Subject|4|||
126193452|NCT01197794|453992023|FG003|Overall Study|Withdrawal by Subject|1|||
126193453|NCT01197794|453992024|FG004|Overall Study|Withdrawal by Subject|1|||
126193454|NCT01197794|453992025|FG005|Overall Study|Withdrawal by Subject|5|||
126193455|NCT01197794|453992026|FG006|Overall Study|Withdrawal by Subject|6|||
126193456|NCT01197794|453992020|FG000|Overall Study|Lost to Follow-up|1|||
126193457|NCT01197794|453992021|FG001|Overall Study|Lost to Follow-up|1|||
126193458|NCT01197794|453992022|FG002|Overall Study|Lost to Follow-up|0|||
126193459|NCT01197794|453992023|FG003|Overall Study|Lost to Follow-up|1|||
126193460|NCT01197794|453992024|FG004|Overall Study|Lost to Follow-up|0|||
126193461|NCT01197794|453992025|FG005|Overall Study|Lost to Follow-up|1|||
126193462|NCT01197794|453992026|FG006|Overall Study|Lost to Follow-up|0|||
126193463|NCT01197794|453992020|FG000|Overall Study|Other|1|||
126193464|NCT01197794|453992021|FG001|Overall Study|Other|1|||
126193465|NCT01197794|453992022|FG002|Overall Study|Other|3|||
126193466|NCT01197794|453992023|FG003|Overall Study|Other|0|||
126193467|NCT01197794|453992024|FG004|Overall Study|Other|2|||
126193468|NCT01197794|453992025|FG005|Overall Study|Other|2|||
126193469|NCT01197794|453992026|FG006|Overall Study|Other|4|||
126193470|NCT01055457|453992027|FG000|Overall Study|Lost to Follow-up|0|||
126193471|NCT01055457|453992028|FG001|Overall Study|Lost to Follow-up|1|||
126193472|NCT01055457|453992029|FG002|Overall Study|Lost to Follow-up|0|||
126193473|NCT01055457|453992030|FG003|Overall Study|Lost to Follow-up|0|||
126193474|NCT01055457|453992031|FG004|Overall Study|Lost to Follow-up|0|||
126193475|NCT01055457|453992032|FG005|Overall Study|Lost to Follow-up|1|||
126193476|NCT01055457|453992033|FG006|Overall Study|Lost to Follow-up|0|||
126193477|NCT01055457|453992034|FG007|Overall Study|Lost to Follow-up|0|||
126193478|NCT01055457|453992035|FG008|Overall Study|Lost to Follow-up|0|||
126193479|NCT01055457|453992036|FG009|Overall Study|Lost to Follow-up|0|||
126193480|NCT01055457|453992027|FG000|Overall Study|Protocol Violation|0|||
126193481|NCT01055457|453992028|FG001|Overall Study|Protocol Violation|0|||
126193482|NCT01055457|453992029|FG002|Overall Study|Protocol Violation|1|||
126193483|NCT01055457|453992030|FG003|Overall Study|Protocol Violation|1|||
126193484|NCT01055457|453992031|FG004|Overall Study|Protocol Violation|1|||
126193485|NCT01055457|453992032|FG005|Overall Study|Protocol Violation|2|||
126193486|NCT01055457|453992033|FG006|Overall Study|Protocol Violation|1|||
126193487|NCT01055457|453992034|FG007|Overall Study|Protocol Violation|0|||
126193488|NCT01055457|453992035|FG008|Overall Study|Protocol Violation|0|||
126193489|NCT01055457|453992036|FG009|Overall Study|Protocol Violation|1|||
126193490|NCT01055457|453992027|FG000|Overall Study|Subject Disinterest|0|||
126193491|NCT01055457|453992028|FG001|Overall Study|Subject Disinterest|0|||
126193492|NCT01055457|453992029|FG002|Overall Study|Subject Disinterest|0|||
126193493|NCT01055457|453992030|FG003|Overall Study|Subject Disinterest|0|||
126193494|NCT01055457|453992031|FG004|Overall Study|Subject Disinterest|0|||
126193495|NCT01055457|453992032|FG005|Overall Study|Subject Disinterest|0|||
126193496|NCT01055457|453992033|FG006|Overall Study|Subject Disinterest|0|||
126193497|NCT01055457|453992034|FG007|Overall Study|Subject Disinterest|1|||
126193498|NCT01055457|453992035|FG008|Overall Study|Subject Disinterest|0|||
126193499|NCT01055457|453992036|FG009|Overall Study|Subject Disinterest|0|||
126193500|NCT01055457|453992027|FG000|Overall Study|Subject Ineligible|1|||
126193501|NCT01055457|453992028|FG001|Overall Study|Subject Ineligible|0|||
126193502|NCT01055457|453992029|FG002|Overall Study|Subject Ineligible|1|||
126193503|NCT01055457|453992030|FG003|Overall Study|Subject Ineligible|0|||
126193504|NCT01055457|453992031|FG004|Overall Study|Subject Ineligible|1|||
126193505|NCT01055457|453992032|FG005|Overall Study|Subject Ineligible|0|||
126193506|NCT01055457|453992033|FG006|Overall Study|Subject Ineligible|0|||
126193507|NCT01055457|453992034|FG007|Overall Study|Subject Ineligible|0|||
126193508|NCT01055457|453992035|FG008|Overall Study|Subject Ineligible|0|||
126193509|NCT01055457|453992036|FG009|Overall Study|Subject Ineligible|0|||
126193510|NCT01055457|453992027|FG000|Overall Study|Discomfort|0|||
126193511|NCT01055457|453992028|FG001|Overall Study|Discomfort|0|||
126193512|NCT01055457|453992029|FG002|Overall Study|Discomfort|0|||
126193513|NCT01055457|453992030|FG003|Overall Study|Discomfort|0|||
126193514|NCT01055457|453992031|FG004|Overall Study|Discomfort|1|||
126193515|NCT01055457|453992032|FG005|Overall Study|Discomfort|0|||
126193516|NCT01055457|453992033|FG006|Overall Study|Discomfort|0|||
126193517|NCT01055457|453992034|FG007|Overall Study|Discomfort|0|||
126193518|NCT01055457|453992035|FG008|Overall Study|Discomfort|0|||
126193519|NCT01055457|453992036|FG009|Overall Study|Discomfort|0|||
126193520|NCT01055457|453992027|FG000|Overall Study|Pregnancy|0|||
126193521|NCT01055457|453992028|FG001|Overall Study|Pregnancy|0|||
126193522|NCT01055457|453992029|FG002|Overall Study|Pregnancy|0|||
126193523|NCT01055457|453992030|FG003|Overall Study|Pregnancy|1|||
126193524|NCT01055457|453992031|FG004|Overall Study|Pregnancy|0|||
126193525|NCT01055457|453992032|FG005|Overall Study|Pregnancy|0|||
126193526|NCT01055457|453992033|FG006|Overall Study|Pregnancy|0|||
126193527|NCT01055457|453992034|FG007|Overall Study|Pregnancy|0|||
126193528|NCT01055457|453992035|FG008|Overall Study|Pregnancy|0|||
126193529|NCT01055457|453992036|FG009|Overall Study|Pregnancy|0|||
126193530|NCT01055457|453992027|FG000|Overall Study|Adverse Event|0|||
126193531|NCT01055457|453992028|FG001|Overall Study|Adverse Event|0|||
126193532|NCT01055457|453992029|FG002|Overall Study|Adverse Event|0|||
126193533|NCT01055457|453992030|FG003|Overall Study|Adverse Event|1|||
126193534|NCT01055457|453992031|FG004|Overall Study|Adverse Event|0|||
126193535|NCT01055457|453992032|FG005|Overall Study|Adverse Event|0|||
126193536|NCT01055457|453992033|FG006|Overall Study|Adverse Event|0|||
126193537|NCT01055457|453992034|FG007|Overall Study|Adverse Event|0|||
126193538|NCT01055457|453992035|FG008|Overall Study|Adverse Event|0|||
126193539|NCT01055457|453992036|FG009|Overall Study|Adverse Event|0|||
126193540|NCT04055844|453992037|FG000|Overall Study|Adverse Event|12|||
126193541|NCT04055844|453992037|FG000|Overall Study|Poor Performance|1|||
126193542|NCT04055844|453992037|FG000|Overall Study|Death|1|||
126193543|NCT03630016|453992046|FG000|Overall Study|Poor Sensor Placement|1|||
126193544|NCT04063865|453992047|FG000|Overall Study|Physician Decision|1|||
126193545|NCT04063865|453992048|FG001|Overall Study|Physician Decision|3|||
126193546|NCT04063865|453992047|FG000|Overall Study|Study Closed Prior to Completion|4|||
126193547|NCT04063865|453992048|FG001|Overall Study|Study Closed Prior to Completion|4|||
126193548|NCT04063865|453992047|FG000|Overall Study|Withdrawal by Subject|1|||
126193549|NCT04063865|453992048|FG001|Overall Study|Withdrawal by Subject|1|||
126193550|NCT03898323|453992049|FG000|Overall Study|Physician Decision|1|||
126193551|NCT00320190|453992051|FG000|First 12 Months|Completed but did not enter extension|5|||
126193552|NCT00320190|453992052|FG001|First 12 Months|Completed but did not enter extension|3|||
126193553|NCT00320190|453992051|FG000|First 12 Months|Sponsor terminated study|2|||
126193554|NCT00320190|453992052|FG001|First 12 Months|Sponsor terminated study|2|||
126193555|NCT00320190|453992051|FG000|First 12 Months|Lost to Follow-up|0|||
126193556|NCT00320190|453992052|FG001|First 12 Months|Lost to Follow-up|1|||
126193557|NCT00320190|453992051|FG000|First 12 Months|Enrollment failure|0|||
126193558|NCT00320190|453992052|FG001|First 12 Months|Enrollment failure|1|||
126193559|NCT00320190|453992051|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
126193560|NCT00320190|453992052|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
126193561|NCT00320190|453992051|FG000|First 12 Months|Investigator request|0|||
126193562|NCT00320190|453992052|FG001|First 12 Months|Investigator request|1|||
126193563|NCT00320190|453992051|FG000|First 12 Months|Study drug toxicity|0|||
126193564|NCT00320190|453992052|FG001|First 12 Months|Study drug toxicity|1|||
126193565|NCT00320190|453992051|FG000|First 12 Months|Withdrawal by Subject|0|||
126193566|NCT00320190|453992052|FG001|First 12 Months|Withdrawal by Subject|1|||
126193567|NCT00320190|453992051|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
126193568|NCT00320190|453992052|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
126193569|NCT00320190|453992051|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
126193570|NCT00320190|453992052|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
126193571|NCT00320190|453992051|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
126193572|NCT00320190|453992052|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
126193573|NCT00712270|453992053|FG000|Overall Study|Withdrawal by Subject|11|||
126193574|NCT00712270|453992053|FG000|Overall Study|Screen Failure|3|||
126193575|NCT03954704|453992066|FG000|Overall Study|Death|1|||
126193576|NCT03954704|453992067|FG001|Overall Study|Death|1|||
126193577|NCT03954704|453992068|FG002|Overall Study|Death|1|||
126193578|NCT03954704|453992069|FG003|Overall Study|Death|3|||
126193579|NCT03954704|453992070|FG004|Overall Study|Death|2|||
126193580|NCT03954704|453992071|FG005|Overall Study|Death|2|||
126193581|NCT03954704|453992072|FG006|Overall Study|Death|0|||
126193582|NCT03954704|453992066|FG000|Overall Study|Withdrew Consent|0|||
126193583|NCT03954704|453992067|FG001|Overall Study|Withdrew Consent|0|||
126193584|NCT03954704|453992068|FG002|Overall Study|Withdrew Consent|1|||
126193585|NCT03954704|453992069|FG003|Overall Study|Withdrew Consent|0|||
126193586|NCT03954704|453992070|FG004|Overall Study|Withdrew Consent|0|||
126193587|NCT03954704|453992071|FG005|Overall Study|Withdrew Consent|1|||
126193588|NCT03954704|453992072|FG006|Overall Study|Withdrew Consent|0|||
126193589|NCT03954704|453992066|FG000|Overall Study|Lost to Follow-up|0|||
126193590|NCT03954704|453992067|FG001|Overall Study|Lost to Follow-up|0|||
126193591|NCT03954704|453992068|FG002|Overall Study|Lost to Follow-up|0|||
126193592|NCT03954704|453992069|FG003|Overall Study|Lost to Follow-up|0|||
126193593|NCT03954704|453992070|FG004|Overall Study|Lost to Follow-up|0|||
126193594|NCT03954704|453992071|FG005|Overall Study|Lost to Follow-up|0|||
126193595|NCT03954704|453992072|FG006|Overall Study|Lost to Follow-up|1|||
126193596|NCT03954704|453992066|FG000|Overall Study|Study Terminated by Sponsor|0|||
126193597|NCT03954704|453992067|FG001|Overall Study|Study Terminated by Sponsor|0|||
126193598|NCT03954704|453992068|FG002|Overall Study|Study Terminated by Sponsor|1|||
126193599|NCT03954704|453992069|FG003|Overall Study|Study Terminated by Sponsor|0|||
126193600|NCT03954704|453992070|FG004|Overall Study|Study Terminated by Sponsor|1|||
126193601|NCT03954704|453992071|FG005|Overall Study|Study Terminated by Sponsor|4|||
126193602|NCT03954704|453992072|FG006|Overall Study|Study Terminated by Sponsor|2|||
126193603|NCT03954704|453992066|FG000|Overall Study|Enrolled but not Treated|0|||
126193604|NCT03954704|453992067|FG001|Overall Study|Enrolled but not Treated|0|||
126193605|NCT03954704|453992068|FG002|Overall Study|Enrolled but not Treated|0|||
126193606|NCT03954704|453992069|FG003|Overall Study|Enrolled but not Treated|0|||
126193607|NCT03954704|453992070|FG004|Overall Study|Enrolled but not Treated|0|||
126193608|NCT03954704|453992071|FG005|Overall Study|Enrolled but not Treated|1|||
126193609|NCT03954704|453992072|FG006|Overall Study|Enrolled but not Treated|0|||
126193610|NCT00102804|453992073|FG000|Overall Study|Progressive Disease (PD)|307|||
126193611|NCT00102804|453992074|FG001|Overall Study|Progressive Disease (PD)|196|||
126193612|NCT00102804|453992073|FG000|Overall Study|Withdrawal by Subject|46|||
126193613|NCT00102804|453992074|FG001|Overall Study|Withdrawal by Subject|7|||
126193614|NCT00102804|453992073|FG000|Overall Study|Adverse Event|37|||
126193615|NCT00102804|453992074|FG001|Overall Study|Adverse Event|3|||
126193616|NCT00102804|453992073|FG000|Overall Study|Physician Decision|24|||
126193617|NCT00102804|453992074|FG001|Overall Study|Physician Decision|6|||
126193618|NCT00102804|453992073|FG000|Overall Study|Death|5|||
126193619|NCT00102804|453992074|FG001|Overall Study|Death|6|||
126193620|NCT00102804|453992073|FG000|Overall Study|Enrollment Criteria Not Met|6|||
126193621|NCT00102804|453992074|FG001|Overall Study|Enrollment Criteria Not Met|0|||
126193622|NCT00102804|453992073|FG000|Overall Study|Lost to Follow-up|4|||
126193623|NCT00102804|453992074|FG001|Overall Study|Lost to Follow-up|1|||
126193624|NCT00102804|453992073|FG000|Overall Study|Protocol Violation|2|||
126193625|NCT00102804|453992074|FG001|Overall Study|Protocol Violation|1|||
126193626|NCT00102804|453992073|FG000|Overall Study|Satisfactory Response|2|||
126193627|NCT00102804|453992074|FG001|Overall Study|Satisfactory Response|0|||
126193628|NCT00102804|453992073|FG000|Overall Study|Sponsor Decision|1|||
126193629|NCT00102804|453992074|FG001|Overall Study|Sponsor Decision|0|||
126193630|NCT00102804|453992073|FG000|Overall Study|Alive, Receiving Treatment|7|||
126193631|NCT00102804|453992074|FG001|Overall Study|Alive, Receiving Treatment|2|||
126193632|NCT00374127|453992078|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
126193633|NCT00374127|453992078|FG000|Overall Study|Blood could not be drawn.|2|||
126193634|NCT00374127|453992078|FG000|Overall Study|Protocol Violation|5|||
126193635|NCT00374127|453992078|FG000|Overall Study|Pregnancy|1|||
126193636|NCT04035473|453992083|FG000|Screening/Baseline|Death|0|||
126193637|NCT04035473|453992084|FG001|Screening/Baseline|Death|1|||
126193638|NCT04035473|453992083|FG000|Screening/Baseline|Adverse Event|0|||
126193639|NCT04035473|453992084|FG001|Screening/Baseline|Adverse Event|1|||
126193640|NCT04035473|453992083|FG000|Follow-up Period|Adverse Event|2|||
126193641|NCT04035473|453992084|FG001|Follow-up Period|Adverse Event|0|||
126193642|NCT00112840|453992085|FG000|Overall Study|Physician Decision|1|||
126193643|NCT00112840|453992086|FG001|Overall Study|Physician Decision|0|||
126193644|NCT00112840|453992087|FG002|Overall Study|Physician Decision|0|||
126193645|NCT00112840|453992085|FG000|Overall Study|Withdrawal by Subject|1|||
126193646|NCT00112840|453992086|FG001|Overall Study|Withdrawal by Subject|0|||
126193647|NCT00112840|453992087|FG002|Overall Study|Withdrawal by Subject|1|||
126193648|NCT00112840|453992085|FG000|Overall Study|Protocol Violation|0|||
126193649|NCT00112840|453992086|FG001|Overall Study|Protocol Violation|0|||
126193650|NCT00112840|453992087|FG002|Overall Study|Protocol Violation|5|||
126193651|NCT02299206|453992088|FG000|Overall Study|Lost to Follow-up|1|||
126193652|NCT02299206|453992088|FG000|Overall Study|Withdrawal by Subject|1|||
126193653|NCT02875366|453992089|FG000|Overall Study|Adverse Event|0|||
126193654|NCT02875366|453992090|FG001|Overall Study|Adverse Event|2|||
126193655|NCT02875366|453992089|FG000|Overall Study|Noncompliance|0|||
126193656|NCT02875366|453992090|FG001|Overall Study|Noncompliance|1|||
126193657|NCT00683774|453992091|FG000|Overall Study|Withdrawal by Subject|0|||
126193658|NCT00683774|453992092|FG001|Overall Study|Withdrawal by Subject|1|||
126193659|NCT00683774|453992091|FG000|Overall Study|Physician Decision|3|||
126193660|NCT00683774|453992092|FG001|Overall Study|Physician Decision|0|||
126193661|NCT00691054|453992093|FG000|Overall Study|Withdrawal by Subject|1|||
126193662|NCT03595176|453992094|FG000|Overall Study|Death|0|||
126193663|NCT03595176|453992095|FG001|Overall Study|Death|2|||
126193664|NCT03595176|453992094|FG000|Overall Study|Lost to Follow-up|0|||
126193665|NCT03595176|453992095|FG001|Overall Study|Lost to Follow-up|1|||
126193666|NCT02735044|453992098|FG000|Overall Study|Adverse Event|3|||
126193667|NCT02735044|453992099|FG001|Overall Study|Adverse Event|3|||
126193668|NCT02735044|453992098|FG000|Overall Study|Lack of Efficacy|1|||
126193669|NCT02735044|453992099|FG001|Overall Study|Lack of Efficacy|0|||
126193670|NCT02735044|453992098|FG000|Overall Study|Poor compliance to protocol|7|||
126193671|NCT02735044|453992099|FG001|Overall Study|Poor compliance to protocol|7|||
126193672|NCT02735044|453992098|FG000|Overall Study|Randomized and not treated|0|||
126193673|NCT02735044|453992099|FG001|Overall Study|Randomized and not treated|2|||
126193674|NCT02735044|453992098|FG000|Overall Study|Other, not specified above|5|||
126193675|NCT02735044|453992099|FG001|Overall Study|Other, not specified above|11|||
126193676|NCT01682759|453992102|FG000|Overall Study|Death|2|||
126193677|NCT01682759|453992103|FG001|Overall Study|Death|1|||
126193678|NCT01682759|453992102|FG000|Overall Study|Lost to Follow-up|10|||
126193679|NCT01682759|453992103|FG001|Overall Study|Lost to Follow-up|13|||
126193680|NCT01682759|453992102|FG000|Overall Study|Physician Decision|1|||
126193681|NCT01682759|453992103|FG001|Overall Study|Physician Decision|1|||
126193682|NCT01682759|453992102|FG000|Overall Study|Withdrawal by Subject|56|||
126193683|NCT01682759|453992103|FG001|Overall Study|Withdrawal by Subject|55|||
126193684|NCT02141854|453992104|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
126193685|NCT02141854|453992105|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126193686|NCT02141854|453992106|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126193687|NCT02141854|453992107|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126193688|NCT02141854|453992108|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126193689|NCT02141854|453992109|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126193690|NCT02141854|453992104|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
126193691|NCT02141854|453992105|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126193692|NCT02141854|453992106|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126193693|NCT02141854|453992107|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126193694|NCT02141854|453992108|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126193695|NCT02141854|453992109|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126193696|NCT02141854|453992104|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
126193697|NCT02141854|453992105|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126193698|NCT02141854|453992106|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126193699|NCT02141854|453992107|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126193700|NCT02141854|453992108|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126193701|NCT02141854|453992109|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126193702|NCT02141854|453992104|FG000|Run-In Period (Pre-assignment)|Other|14|||
126193703|NCT02141854|453992105|FG001|Run-In Period (Pre-assignment)|Other|0|||
126193704|NCT02141854|453992106|FG002|Run-In Period (Pre-assignment)|Other|0|||
126193705|NCT02141854|453992107|FG003|Run-In Period (Pre-assignment)|Other|0|||
126193706|NCT02141854|453992108|FG004|Run-In Period (Pre-assignment)|Other|0|||
126193707|NCT02141854|453992109|FG005|Run-In Period (Pre-assignment)|Other|0|||
126193708|NCT02141854|453992104|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
126193709|NCT02141854|453992105|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
126193710|NCT02141854|453992106|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
126193711|NCT02141854|453992107|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
126193712|NCT02141854|453992108|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
126193713|NCT02141854|453992109|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
126193714|NCT02141854|453992104|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
126193715|NCT02141854|453992105|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126193716|NCT02141854|453992106|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126193717|NCT02141854|453992107|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126193718|NCT02141854|453992108|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126193719|NCT02141854|453992109|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126193720|NCT02141854|453992104|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
126193721|NCT02141854|453992105|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126193722|NCT02141854|453992106|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126193723|NCT02141854|453992107|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126193724|NCT02141854|453992108|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126193725|NCT02141854|453992109|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126193726|NCT02141854|453992104|FG000|Treatment Period|Protocol Violation|0|||
126193727|NCT02141854|453992105|FG001|Treatment Period|Protocol Violation|1|||
126193728|NCT02141854|453992106|FG002|Treatment Period|Protocol Violation|0|||
126193729|NCT02141854|453992107|FG003|Treatment Period|Protocol Violation|2|||
126193730|NCT02141854|453992108|FG004|Treatment Period|Protocol Violation|2|||
126193731|NCT02141854|453992109|FG005|Treatment Period|Protocol Violation|1|||
126193732|NCT02141854|453992104|FG000|Treatment Period|Noncompliance|0|||
126193733|NCT02141854|453992105|FG001|Treatment Period|Noncompliance|0|||
126193734|NCT02141854|453992106|FG002|Treatment Period|Noncompliance|0|||
126193735|NCT02141854|453992107|FG003|Treatment Period|Noncompliance|1|||
126193736|NCT02141854|453992108|FG004|Treatment Period|Noncompliance|0|||
126193737|NCT02141854|453992109|FG005|Treatment Period|Noncompliance|0|||
126193738|NCT02141854|453992104|FG000|Treatment Period|Lack of Efficacy|0|||
126193739|NCT02141854|453992105|FG001|Treatment Period|Lack of Efficacy|0|||
126193740|NCT02141854|453992106|FG002|Treatment Period|Lack of Efficacy|0|||
126193741|NCT02141854|453992107|FG003|Treatment Period|Lack of Efficacy|1|||
126193742|NCT02141854|453992108|FG004|Treatment Period|Lack of Efficacy|1|||
126193743|NCT02141854|453992109|FG005|Treatment Period|Lack of Efficacy|7|||
126193744|NCT02141854|453992104|FG000|Treatment Period|Pregnancy|0|||
126193745|NCT02141854|453992105|FG001|Treatment Period|Pregnancy|1|||
126193746|NCT02141854|453992106|FG002|Treatment Period|Pregnancy|0|||
126193747|NCT02141854|453992107|FG003|Treatment Period|Pregnancy|0|||
126193748|NCT02141854|453992108|FG004|Treatment Period|Pregnancy|0|||
126193749|NCT02141854|453992109|FG005|Treatment Period|Pregnancy|0|||
126193750|NCT02141854|453992104|FG000|Treatment Period|Other|0|||
126193751|NCT02141854|453992105|FG001|Treatment Period|Other|1|||
126193752|NCT02141854|453992106|FG002|Treatment Period|Other|2|||
126193753|NCT02141854|453992107|FG003|Treatment Period|Other|0|||
126193754|NCT02141854|453992108|FG004|Treatment Period|Other|1|||
126193755|NCT02141854|453992109|FG005|Treatment Period|Other|2|||
126193756|NCT02141854|453992104|FG000|Treatment Period|Adverse Event|0|||
126193757|NCT02141854|453992105|FG001|Treatment Period|Adverse Event|2|||
126193758|NCT02141854|453992106|FG002|Treatment Period|Adverse Event|2|||
126193759|NCT02141854|453992107|FG003|Treatment Period|Adverse Event|0|||
126193760|NCT02141854|453992108|FG004|Treatment Period|Adverse Event|2|||
126193761|NCT02141854|453992109|FG005|Treatment Period|Adverse Event|2|||
126193762|NCT02141854|453992104|FG000|Treatment Period|Withdrawal by Subject|0|||
126193763|NCT02141854|453992105|FG001|Treatment Period|Withdrawal by Subject|2|||
126193764|NCT02141854|453992106|FG002|Treatment Period|Withdrawal by Subject|3|||
126193765|NCT02141854|453992107|FG003|Treatment Period|Withdrawal by Subject|3|||
126193766|NCT02141854|453992108|FG004|Treatment Period|Withdrawal by Subject|4|||
126193767|NCT02141854|453992109|FG005|Treatment Period|Withdrawal by Subject|7|||
126193768|NCT02141854|453992104|FG000|Treatment Period|Disease progression|0|||
126193769|NCT02141854|453992105|FG001|Treatment Period|Disease progression|2|||
126193770|NCT02141854|453992106|FG002|Treatment Period|Disease progression|1|||
126193771|NCT02141854|453992107|FG003|Treatment Period|Disease progression|3|||
126193772|NCT02141854|453992108|FG004|Treatment Period|Disease progression|0|||
126193773|NCT02141854|453992109|FG005|Treatment Period|Disease progression|18|||
126193774|NCT02141854|453992104|FG000|Treatment Period|Lost to Follow-up|0|||
126193775|NCT02141854|453992105|FG001|Treatment Period|Lost to Follow-up|1|||
126193776|NCT02141854|453992106|FG002|Treatment Period|Lost to Follow-up|1|||
126193777|NCT02141854|453992107|FG003|Treatment Period|Lost to Follow-up|1|||
126193778|NCT02141854|453992108|FG004|Treatment Period|Lost to Follow-up|0|||
126193779|NCT02141854|453992109|FG005|Treatment Period|Lost to Follow-up|1|||
126193780|NCT01868594|453992112|FG000|Overall Study|Do not meet inclusion criteria|4|||
126193781|NCT01868594|453992113|FG001|Overall Study|Do not meet inclusion criteria|3|||
126193782|NCT01201967|453992116|FG000|Overall Study|Lost to Follow-up|6|||
126193783|NCT01201967|453992117|FG001|Overall Study|Lost to Follow-up|5|||
126193784|NCT02659098|453992120|FG000|Overall Study|Withdrawal by Subject|7|||
126193785|NCT04363944|453992121|FG000|Overall Study|Withdrawal by Subject|2|||
126193786|NCT04363944|453992122|FG001|Overall Study|Withdrawal by Subject|0|||
126193787|NCT02632344|453993689|FG000|Overall Study|Adverse Event|3|||
126193788|NCT02632344|453993689|FG000|Overall Study|Lack of Efficacy|3|||
126193789|NCT02632344|453993689|FG000|Overall Study|Withdrawal by Subject|2|||
126193790|NCT04076579|453993691|FG000|Overall Study|Adverse Event|2|||
126193791|NCT04076579|453993692|FG001|Overall Study|Adverse Event|0|||
126193792|NCT04076579|453993691|FG000|Overall Study|discontinued due to toxicity|1|||
126193793|NCT04076579|453993692|FG001|Overall Study|discontinued due to toxicity|0|||
126193794|NCT04076579|453993691|FG000|Overall Study|Physician Decision|1|||
126193795|NCT04076579|453993692|FG001|Overall Study|Physician Decision|0|||
126193796|NCT04076579|453993691|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
126193797|NCT04076579|453993692|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
126193798|NCT04076579|453993691|FG000|Overall Study|Noncompliance|0|||
126193799|NCT04076579|453993692|FG001|Overall Study|Noncompliance|1|||
126193800|NCT04076579|453993691|FG000|Overall Study|Withdrawal by Subject|0|||
126193801|NCT04076579|453993692|FG001|Overall Study|Withdrawal by Subject|2|||
126193802|NCT03991936|453993695|FG000|Overall Study|Lost to Follow-up|1|||
126193803|NCT03991936|453993696|FG001|Overall Study|Lost to Follow-up|1|||
126193804|NCT03991936|453993697|FG002|Overall Study|Lost to Follow-up|1|||
126193805|NCT03991936|453993698|FG003|Overall Study|Lost to Follow-up|1|||
126193806|NCT03991936|453993699|FG004|Overall Study|Lost to Follow-up|1|||
126193807|NCT00939055|453993700|FG000|Overall Study|Discontinuation prior to procedure|4|||
126193808|NCT00939055|453993701|FG001|Overall Study|Discontinuation prior to procedure|0|||
126193809|NCT00584987|453993704|FG000|Overall Study|Protocol Violation|1|||
126193810|NCT00584987|453993705|FG001|Overall Study|Protocol Violation|1|||
126193811|NCT00584987|453993706|FG002|Overall Study|Protocol Violation|1|||
126193812|NCT00584987|453993707|FG003|Overall Study|Protocol Violation|0|||
126193813|NCT00584987|453993704|FG000|Overall Study|Adverse Event|0|||
126193814|NCT00584987|453993705|FG001|Overall Study|Adverse Event|0|||
126193815|NCT00584987|453993706|FG002|Overall Study|Adverse Event|0|||
126193816|NCT00584987|453993707|FG003|Overall Study|Adverse Event|1|||
126193817|NCT02881151|453993708|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
126193818|NCT03225833|453993709|FG000|Overall Study|Adverse Event|0|||
126193819|NCT03225833|453993710|FG001|Overall Study|Adverse Event|1|||
126193820|NCT03225833|453993711|FG002|Overall Study|Adverse Event|2|||
126193821|NCT03225833|453993712|FG003|Overall Study|Adverse Event|0|||
126193822|NCT03225833|453993713|FG004|Overall Study|Adverse Event|0|||
126193823|NCT03225833|453993714|FG005|Overall Study|Adverse Event|2|||
126193824|NCT03225833|453993709|FG000|Overall Study|Withdrawal by Subject|1|||
126193825|NCT03225833|453993710|FG001|Overall Study|Withdrawal by Subject|0|||
126193826|NCT03225833|453993711|FG002|Overall Study|Withdrawal by Subject|0|||
126193827|NCT03225833|453993712|FG003|Overall Study|Withdrawal by Subject|0|||
126193828|NCT03225833|453993713|FG004|Overall Study|Withdrawal by Subject|1|||
126193829|NCT03225833|453993714|FG005|Overall Study|Withdrawal by Subject|0|||
126193830|NCT03225833|453993709|FG000|Overall Study|Termination of Study by Sponsor|4|||
126193831|NCT03225833|453993710|FG001|Overall Study|Termination of Study by Sponsor|0|||
126193832|NCT03225833|453993711|FG002|Overall Study|Termination of Study by Sponsor|0|||
126193833|NCT03225833|453993712|FG003|Overall Study|Termination of Study by Sponsor|0|||
126193834|NCT03225833|453993713|FG004|Overall Study|Termination of Study by Sponsor|0|||
126193835|NCT03225833|453993714|FG005|Overall Study|Termination of Study by Sponsor|7|||
126193836|NCT03225833|453993709|FG000|Overall Study|Sponsor Decision|0|||
126193837|NCT03225833|453993710|FG001|Overall Study|Sponsor Decision|0|||
126193838|NCT03225833|453993711|FG002|Overall Study|Sponsor Decision|0|||
126193839|NCT03225833|453993712|FG003|Overall Study|Sponsor Decision|0|||
126193840|NCT03225833|453993713|FG004|Overall Study|Sponsor Decision|0|||
126193841|NCT03225833|453993714|FG005|Overall Study|Sponsor Decision|1|||
126193842|NCT03258593|453993715|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
126193843|NCT03258593|453993716|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
126193844|NCT03258593|453993717|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
126193845|NCT03258593|453993718|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
126193846|NCT03258593|453993715|FG000|Run-In Maintenance Phase|Disease progression|3|||
126193847|NCT03258593|453993716|FG001|Run-In Maintenance Phase|Disease progression|0|||
126193848|NCT03258593|453993717|FG002|Run-In Maintenance Phase|Disease progression|0|||
126193849|NCT03258593|453993718|FG003|Run-In Maintenance Phase|Disease progression|0|||
126193850|NCT03258593|453993715|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
126193851|NCT03258593|453993716|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
126193852|NCT03258593|453993717|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
126193853|NCT03258593|453993718|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
126193854|NCT03258593|453993715|FG000|Expansion Maintenance Phase|Physician Decision|0|||
126193855|NCT03258593|453993716|FG001|Expansion Maintenance Phase|Physician Decision|1|||
126193856|NCT03258593|453993717|FG002|Expansion Maintenance Phase|Physician Decision|0|||
126193857|NCT03258593|453993718|FG003|Expansion Maintenance Phase|Physician Decision|0|||
126193858|NCT05318183|453993719|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
126193859|NCT05318183|453993720|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
126193860|NCT05318183|453993719|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
126193861|NCT05318183|453993720|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126193862|NCT05298774|453993727|FG000|Overall Study|Physician Decision|3|||
126193863|NCT05298774|453993727|FG000|Overall Study|Withdrawal by Subject|2|||
126193864|NCT05298774|453993727|FG000|Overall Study|Lost to Follow-up|3|||
126193865|NCT05298774|453993727|FG000|Overall Study|Screen failure|1|||
126193866|NCT01263470|453993736|FG000|Overall Study|Adverse Event|2|||
126193867|NCT01263470|453993737|FG001|Overall Study|Adverse Event|2|||
126193868|NCT01263470|453993738|FG002|Overall Study|Adverse Event|1|||
126193869|NCT01263470|453993739|FG003|Overall Study|Adverse Event|1|||
126193870|NCT01263470|453993740|FG004|Overall Study|Adverse Event|2|||
126193871|NCT01263470|453993741|FG005|Overall Study|Adverse Event|2|||
126193872|NCT01263470|453993736|FG000|Overall Study|Protocol Violation|0|||
126193873|NCT01263470|453993737|FG001|Overall Study|Protocol Violation|1|||
126193874|NCT01263470|453993738|FG002|Overall Study|Protocol Violation|0|||
126193875|NCT01263470|453993739|FG003|Overall Study|Protocol Violation|0|||
126193876|NCT01263470|453993740|FG004|Overall Study|Protocol Violation|0|||
126193877|NCT01263470|453993741|FG005|Overall Study|Protocol Violation|1|||
126193878|NCT01263470|453993736|FG000|Overall Study|Withdrawal by Subject|0|||
126193879|NCT01263470|453993737|FG001|Overall Study|Withdrawal by Subject|1|||
126193880|NCT01263470|453993738|FG002|Overall Study|Withdrawal by Subject|1|||
126199942|NCT01117428|454017809|FG005|Overall Study|Adverse Event|2|||
126193881|NCT01263470|453993739|FG003|Overall Study|Withdrawal by Subject|2|||
126193882|NCT01263470|453993740|FG004|Overall Study|Withdrawal by Subject|0|||
126193883|NCT01263470|453993741|FG005|Overall Study|Withdrawal by Subject|2|||
126193884|NCT01263470|453993736|FG000|Overall Study|Lack of Efficacy|0|||
126193885|NCT01263470|453993737|FG001|Overall Study|Lack of Efficacy|0|||
126193886|NCT01263470|453993738|FG002|Overall Study|Lack of Efficacy|2|||
126193887|NCT01263470|453993739|FG003|Overall Study|Lack of Efficacy|0|||
126193888|NCT01263470|453993740|FG004|Overall Study|Lack of Efficacy|0|||
126193889|NCT01263470|453993741|FG005|Overall Study|Lack of Efficacy|0|||
126193890|NCT01263470|453993736|FG000|Overall Study|Participant Unavailability|0|||
126193891|NCT01263470|453993737|FG001|Overall Study|Participant Unavailability|1|||
126193892|NCT01263470|453993738|FG002|Overall Study|Participant Unavailability|0|||
126193893|NCT01263470|453993739|FG003|Overall Study|Participant Unavailability|0|||
126193894|NCT01263470|453993740|FG004|Overall Study|Participant Unavailability|0|||
126193895|NCT01263470|453993741|FG005|Overall Study|Participant Unavailability|0|||
126193896|NCT01263470|453993736|FG000|Overall Study|Study Drug Non-compliance|0|||
126193897|NCT01263470|453993737|FG001|Overall Study|Study Drug Non-compliance|0|||
126193898|NCT01263470|453993738|FG002|Overall Study|Study Drug Non-compliance|0|||
126193899|NCT01263470|453993739|FG003|Overall Study|Study Drug Non-compliance|0|||
126193900|NCT01263470|453993740|FG004|Overall Study|Study Drug Non-compliance|1|||
126193901|NCT01263470|453993741|FG005|Overall Study|Study Drug Non-compliance|0|||
126193902|NCT01327573|453993742|FG000|Overall Study|Physician Decision|3|||
126193903|NCT01327573|453993743|FG001|Overall Study|Physician Decision|1|||
126193904|NCT00712712|453993744|FG000|Overall Study|Protocol Violation|11|||
126193905|NCT00712712|453993744|FG000|Overall Study|Radiofrequency not done|3|||
126193906|NCT00712712|453993744|FG000|Overall Study|Death|8|||
126193907|NCT00712712|453993744|FG000|Overall Study|Withdrawal by Subject|1|||
126193908|NCT02136134|453993745|FG000|Overall Study|Death|170|||
126193909|NCT02136134|453993746|FG001|Overall Study|Death|148|||
126193910|NCT02136134|453993745|FG000|Overall Study|Withdrawal by Subject|19|||
126193911|NCT02136134|453993746|FG001|Overall Study|Withdrawal by Subject|10|||
126193912|NCT02136134|453993745|FG000|Overall Study|Lost to Follow-up|3|||
126193913|NCT02136134|453993746|FG001|Overall Study|Lost to Follow-up|3|||
126193914|NCT02136134|453993745|FG000|Overall Study|Uspecified|55|||
126193915|NCT02136134|453993746|FG001|Overall Study|Uspecified|90|||
126193916|NCT03070119|453993749|FG000|Overall Study|Adverse Event|0|||
126193917|NCT03070119|453993750|FG001|Overall Study|Adverse Event|0|||
126193918|NCT03070119|453993751|FG002|Overall Study|Adverse Event|1|||
126193919|NCT03070119|453993749|FG000|Overall Study|Lost to Follow-up|0|||
126193920|NCT03070119|453993750|FG001|Overall Study|Lost to Follow-up|1|||
126193921|NCT03070119|453993751|FG002|Overall Study|Lost to Follow-up|0|||
126193922|NCT03070119|453993749|FG000|Overall Study|Consent Withdrawn|6|||
126193923|NCT03070119|453993750|FG001|Overall Study|Consent Withdrawn|5|||
126193924|NCT03070119|453993751|FG002|Overall Study|Consent Withdrawn|3|||
126193925|NCT03070119|453993749|FG000|Overall Study|Investigator Decision|0|||
126193926|NCT03070119|453993750|FG001|Overall Study|Investigator Decision|0|||
126193927|NCT03070119|453993751|FG002|Overall Study|Investigator Decision|1|||
126193928|NCT03070119|453993749|FG000|Overall Study|Death|7|||
126193929|NCT03070119|453993750|FG001|Overall Study|Death|14|||
126193930|NCT03070119|453993751|FG002|Overall Study|Death|5|||
126193931|NCT03070119|453993749|FG000|Overall Study|Disease Progression|5|||
126193932|NCT03070119|453993750|FG001|Overall Study|Disease Progression|7|||
126193933|NCT03070119|453993751|FG002|Overall Study|Disease Progression|7|||
126193934|NCT03070119|453993749|FG000|Overall Study|Reason not Specified|2|||
126193935|NCT03070119|453993750|FG001|Overall Study|Reason not Specified|2|||
126193936|NCT03070119|453993751|FG002|Overall Study|Reason not Specified|1|||
126193937|NCT00732472|453993752|FG000|Overall Study|Adverse Event|0|||
126193938|NCT00732472|453993753|FG001|Overall Study|Adverse Event|1|||
126193939|NCT00732472|453993754|FG002|Overall Study|Adverse Event|1|||
126193940|NCT00732472|453993755|FG003|Overall Study|Adverse Event|1|||
126193941|NCT00732472|453993752|FG000|Overall Study|Protocol Violation|0|||
126193942|NCT00732472|453993753|FG001|Overall Study|Protocol Violation|0|||
126193943|NCT00732472|453993754|FG002|Overall Study|Protocol Violation|0|||
126193944|NCT00732472|453993755|FG003|Overall Study|Protocol Violation|1|||
126193945|NCT00732472|453993752|FG000|Overall Study|Withdrawal by Subject|0|||
126193946|NCT00732472|453993753|FG001|Overall Study|Withdrawal by Subject|2|||
126193947|NCT00732472|453993754|FG002|Overall Study|Withdrawal by Subject|0|||
126193948|NCT00732472|453993755|FG003|Overall Study|Withdrawal by Subject|1|||
126193949|NCT01266876|453993758|FG000|Overall Study|Adverse Event|0|||
126193950|NCT01266876|453993759|FG001|Overall Study|Adverse Event|0|||
126193951|NCT01266876|453993760|FG002|Overall Study|Adverse Event|0|||
126193952|NCT01266876|453993761|FG003|Overall Study|Adverse Event|1|||
126193953|NCT01266876|453993762|FG004|Overall Study|Adverse Event|0|||
126193954|NCT05180721|453993763|FG000|Overall Study|Lost to Follow-up|4|||
126193955|NCT01996865|453993765|FG000|Induction Period|Protocol Violation|1|||
126193956|NCT01996865|453993766|FG001|Induction Period|Protocol Violation|0|||
126193957|NCT01996865|453993767|FG002|Induction Period|Protocol Violation|0|||
126193958|NCT01996865|453993765|FG000|Induction Period|Progressive Disease|4|||
126193959|NCT01996865|453993766|FG001|Induction Period|Progressive Disease|0|||
126193960|NCT01996865|453993767|FG002|Induction Period|Progressive Disease|0|||
126193961|NCT01996865|453993765|FG000|Induction Period|Lost to Follow-up|10|||
126193962|NCT01996865|453993766|FG001|Induction Period|Lost to Follow-up|0|||
126193963|NCT01996865|453993767|FG002|Induction Period|Lost to Follow-up|0|||
126193964|NCT01996865|453993765|FG000|Induction Period|Other Reasons|13|||
126193965|NCT01996865|453993766|FG001|Induction Period|Other Reasons|0|||
126193966|NCT01996865|453993767|FG002|Induction Period|Other Reasons|0|||
126193967|NCT01996865|453993765|FG000|Induction Period|Adverse Event|20|||
126193968|NCT01996865|453993766|FG001|Induction Period|Adverse Event|0|||
126193969|NCT01996865|453993767|FG002|Induction Period|Adverse Event|0|||
126193970|NCT01996865|453993765|FG000|Induction Period|Withdrawal by Subject|60|||
126193971|NCT01996865|453993766|FG001|Induction Period|Withdrawal by Subject|0|||
126193972|NCT01996865|453993767|FG002|Induction Period|Withdrawal by Subject|0|||
126193973|NCT01996865|453993765|FG000|Induction Period|Death|111|||
126193974|NCT01996865|453993766|FG001|Induction Period|Death|0|||
126193975|NCT01996865|453993767|FG002|Induction Period|Death|0|||
126193976|NCT01996865|453993765|FG000|Maintenance Period|Protocol Violation|0|||
126193977|NCT01996865|453993766|FG001|Maintenance Period|Protocol Violation|1|||
126193978|NCT01996865|453993767|FG002|Maintenance Period|Protocol Violation|1|||
126193979|NCT01996865|453993765|FG000|Maintenance Period|Other reasons|0|||
126193980|NCT01996865|453993766|FG001|Maintenance Period|Other reasons|8|||
126193981|NCT01996865|453993767|FG002|Maintenance Period|Other reasons|5|||
126193982|NCT01996865|453993765|FG000|Maintenance Period|Progressive Disease|0|||
126193983|NCT01996865|453993766|FG001|Maintenance Period|Progressive Disease|6|||
126193984|NCT01996865|453993767|FG002|Maintenance Period|Progressive Disease|23|||
126193985|NCT01996865|453993765|FG000|Maintenance Period|Withdrawal by Subject|0|||
126193986|NCT01996865|453993766|FG001|Maintenance Period|Withdrawal by Subject|18|||
126193987|NCT01996865|453993767|FG002|Maintenance Period|Withdrawal by Subject|4|||
126193988|NCT01996865|453993765|FG000|Maintenance Period|Adverse Event|0|||
126193989|NCT01996865|453993766|FG001|Maintenance Period|Adverse Event|7|||
126193990|NCT01996865|453993767|FG002|Maintenance Period|Adverse Event|7|||
126193991|NCT01996865|453993765|FG000|Maintenance Period|Death|0|||
126193992|NCT01996865|453993766|FG001|Maintenance Period|Death|15|||
126193993|NCT01996865|453993767|FG002|Maintenance Period|Death|3|||
126193994|NCT01996865|453993765|FG000|Maintenance Period|Lost to Follow-up|0|||
126193995|NCT01996865|453993766|FG001|Maintenance Period|Lost to Follow-up|2|||
126193996|NCT01996865|453993767|FG002|Maintenance Period|Lost to Follow-up|0|||
126193997|NCT03575351|453993770|FG000|Overall Study|Adverse Event|1|||
126193998|NCT03575351|453993771|FG001|Overall Study|Adverse Event|0|||
126193999|NCT03575351|453993770|FG000|Overall Study|Death|2|||
126194000|NCT03575351|453993771|FG001|Overall Study|Death|2|||
126194001|NCT03575351|453993770|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
126194002|NCT03575351|453993771|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
126194003|NCT03575351|453993770|FG000|Overall Study|Lack of Efficacy|28|||
126194004|NCT03575351|453993771|FG001|Overall Study|Lack of Efficacy|0|||
126194005|NCT03575351|453993770|FG000|Overall Study|Withdrawal by Subject|1|||
126194006|NCT03575351|453993771|FG001|Overall Study|Withdrawal by Subject|1|||
126194007|NCT03575351|453993770|FG000|Overall Study|Physician Decision|3|||
126194008|NCT03575351|453993771|FG001|Overall Study|Physician Decision|0|||
126194009|NCT03575351|453993770|FG000|Overall Study|Disease relapse|15|||
126194010|NCT03575351|453993771|FG001|Overall Study|Disease relapse|6|||
126194011|NCT03575351|453993770|FG000|Overall Study|Study drug manufacturing failure|0|||
126194012|NCT03575351|453993771|FG001|Overall Study|Study drug manufacturing failure|1|||
126194013|NCT03575351|453993770|FG000|Overall Study|other reasons|5|||
126194014|NCT03575351|453993771|FG001|Overall Study|other reasons|0|||
126194015|NCT04288089|453993777|FG000|Overall Study|Ongoing Treatment|2|||
126194016|NCT04288089|453993778|FG001|Overall Study|Ongoing Treatment|1|||
126194017|NCT04288089|453993779|FG002|Overall Study|Ongoing Treatment|1|||
126194018|NCT04288089|453993780|FG003|Overall Study|Ongoing Treatment|4|||
126194019|NCT03715205|453993781|FG000|Overall Study|Death|13|||
126194020|NCT03715205|453993781|FG000|Overall Study|Lost to Follow-up|2|||
126194021|NCT03715205|453993781|FG000|Overall Study|Physician Decision|93|||
126194022|NCT03715205|453993781|FG000|Overall Study|Withdrawal by Subject|26|||
126194023|NCT05492877|453993784|FG000|Overall Study|Adverse Event|11|||
126194024|NCT05492877|453993785|FG001|Overall Study|Adverse Event|7|||
126194025|NCT05492877|453993784|FG000|Overall Study|Death|1|||
126194026|NCT05492877|453993785|FG001|Overall Study|Death|0|||
126194027|NCT05492877|453993784|FG000|Overall Study|Lost to Follow-up|1|||
126194028|NCT05492877|453993785|FG001|Overall Study|Lost to Follow-up|1|||
126194029|NCT05492877|453993784|FG000|Overall Study|Physician Decision|1|||
126194030|NCT05492877|453993785|FG001|Overall Study|Physician Decision|2|||
126194031|NCT05492877|453993784|FG000|Overall Study|Protocol Violation|1|||
126194032|NCT05492877|453993785|FG001|Overall Study|Protocol Violation|1|||
126194033|NCT05492877|453993784|FG000|Overall Study|Withdrawal by Subject|3|||
126194034|NCT05492877|453993785|FG001|Overall Study|Withdrawal by Subject|7|||
126194035|NCT05492877|453993784|FG000|Overall Study|Reason not specified|6|||
126194036|NCT05492877|453993785|FG001|Overall Study|Reason not specified|4|||
126194037|NCT02286089|453993786|FG000|Overall Study|Ongoing in Study|1|||
126194038|NCT02286089|453993787|FG001|Overall Study|Ongoing in Study|1|||
126194039|NCT02286089|453993788|FG002|Overall Study|Ongoing in Study|4|||
126194040|NCT02286089|453993789|FG003|Overall Study|Ongoing in Study|10|||
126194041|NCT02286089|453993786|FG000|Overall Study|Withdrawal by Subject|0|||
126194042|NCT02286089|453993787|FG001|Overall Study|Withdrawal by Subject|0|||
126194043|NCT02286089|453993788|FG002|Overall Study|Withdrawal by Subject|2|||
126194044|NCT02286089|453993789|FG003|Overall Study|Withdrawal by Subject|2|||
126194045|NCT03733249|453993796|FG000|Overall Study|Death|7|||
126194046|NCT03733249|453993796|FG000|Overall Study|Disease relapse|16|||
126194047|NCT03733249|453993796|FG000|Overall Study|Lost to Follow-up|4|||
126194048|NCT03733249|453993796|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
126194049|NCT03733249|453993796|FG000|Overall Study|Withdrawal by Subject|1|||
126194050|NCT04476108|453993797|FG000|Overall Study|Adverse Event|4|||
126194051|NCT04476108|453993798|FG001|Overall Study|Adverse Event|1|||
126194052|NCT04476108|453993797|FG000|Overall Study|Lost to Follow-up|1|||
126194053|NCT04476108|453993798|FG001|Overall Study|Lost to Follow-up|0|||
126194054|NCT04476108|453993797|FG000|Overall Study|Inadvertent Enrollment|1|||
126194055|NCT04476108|453993798|FG001|Overall Study|Inadvertent Enrollment|0|||
126194056|NCT04476108|453993797|FG000|Overall Study|Protocol Violation|1|||
126194057|NCT04476108|453993798|FG001|Overall Study|Protocol Violation|1|||
126194058|NCT04476108|453993797|FG000|Overall Study|Withdrawal by Subject|1|||
126194059|NCT04476108|453993798|FG001|Overall Study|Withdrawal by Subject|1|||
126194060|NCT02253992|453993799|FG000|Overall Study|Study drug toxicity|1|||
126194061|NCT02253992|453993800|FG001|Overall Study|Study drug toxicity|0|||
126194062|NCT02253992|453993801|FG002|Overall Study|Study drug toxicity|10|||
126194063|NCT02253992|453993799|FG000|Overall Study|Disease progression|4|||
126194064|NCT02253992|453993800|FG001|Overall Study|Disease progression|3|||
126194065|NCT02253992|453993801|FG002|Overall Study|Disease progression|98|||
126194066|NCT02253992|453993799|FG000|Overall Study|Withdrawal by Subject|0|||
126194067|NCT02253992|453993800|FG001|Overall Study|Withdrawal by Subject|0|||
126194068|NCT02253992|453993801|FG002|Overall Study|Withdrawal by Subject|3|||
126194069|NCT02253992|453993799|FG000|Overall Study|Adverse Event|0|||
126194070|NCT02253992|453993800|FG001|Overall Study|Adverse Event|0|||
126194071|NCT02253992|453993801|FG002|Overall Study|Adverse Event|8|||
126194072|NCT02253992|453993799|FG000|Overall Study|Death|0|||
126194073|NCT02253992|453993800|FG001|Overall Study|Death|0|||
126194074|NCT02253992|453993801|FG002|Overall Study|Death|1|||
126194075|NCT02253992|453993799|FG000|Overall Study|Subject discontinued study drug|1|||
126194076|NCT02253992|453993800|FG001|Overall Study|Subject discontinued study drug|0|||
126194077|NCT02253992|453993801|FG002|Overall Study|Subject discontinued study drug|1|||
126194078|NCT02253992|453993799|FG000|Overall Study|Completed treatment as per protocol|0|||
126194079|NCT02253992|453993800|FG001|Overall Study|Completed treatment as per protocol|1|||
126194080|NCT02253992|453993801|FG002|Overall Study|Completed treatment as per protocol|22|||
126194081|NCT02253992|453993799|FG000|Overall Study|Other|0|||
126194082|NCT02253992|453993800|FG001|Overall Study|Other|0|||
126194083|NCT02253992|453993801|FG002|Overall Study|Other|1|||
126194084|NCT00772889|453993802|FG000|Overall Study|Adverse Event|7|||
126194085|NCT00772889|453993803|FG001|Overall Study|Adverse Event|4|||
126194086|NCT00772889|453993804|FG002|Overall Study|Adverse Event|0|||
126194087|NCT00772889|453993802|FG000|Overall Study|Withdrawal by Subject|9|||
126194088|NCT00772889|453993803|FG001|Overall Study|Withdrawal by Subject|8|||
126194089|NCT00772889|453993804|FG002|Overall Study|Withdrawal by Subject|9|||
126194090|NCT00772889|453993802|FG000|Overall Study|Lost to Follow-up|6|||
126194091|NCT00772889|453993803|FG001|Overall Study|Lost to Follow-up|6|||
126194092|NCT00772889|453993804|FG002|Overall Study|Lost to Follow-up|7|||
126194093|NCT03323086|453993805|FG000|Overall Study|Lost to Follow-up|3|||
126194094|NCT03323086|453993806|FG001|Overall Study|Lost to Follow-up|2|||
126194095|NCT00355615|453993807|FG000|Randomized Double Blind Period|Adverse Event|1|||
126194096|NCT00355615|453993808|FG001|Randomized Double Blind Period|Adverse Event|0|||
126194097|NCT00355615|453993809|FG002|Randomized Double Blind Period|Adverse Event|0|||
126194098|NCT00355615|453993810|FG003|Randomized Double Blind Period|Adverse Event|0|||
126194099|NCT00355615|453993811|FG004|Randomized Double Blind Period|Adverse Event|0|||
126194100|NCT00355615|453993807|FG000|Randomized Double Blind Period|Protocol Violation|0|||
126194101|NCT00355615|453993808|FG001|Randomized Double Blind Period|Protocol Violation|0|||
126194102|NCT00355615|453993809|FG002|Randomized Double Blind Period|Protocol Violation|1|||
126194103|NCT00355615|453993810|FG003|Randomized Double Blind Period|Protocol Violation|1|||
126194104|NCT00355615|453993811|FG004|Randomized Double Blind Period|Protocol Violation|0|||
126194105|NCT00355615|453993807|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
126194106|NCT00355615|453993808|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
126194107|NCT00355615|453993809|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
126194108|NCT00355615|453993810|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
126194109|NCT00355615|453993811|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
126194110|NCT00355615|453993807|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
126194111|NCT00355615|453993808|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
126194112|NCT00355615|453993809|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
126194113|NCT00355615|453993810|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
126199943|NCT01117428|454017804|FG000|Overall Study|Death|0|||
126194114|NCT00355615|453993811|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
126194115|NCT00355615|453993807|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
126194116|NCT00355615|453993808|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
126194117|NCT00355615|453993809|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
126194118|NCT00355615|453993810|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
126194119|NCT00355615|453993811|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
126194120|NCT00355615|453993807|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
126194121|NCT00355615|453993808|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
126194122|NCT00355615|453993809|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
126194123|NCT00355615|453993810|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
126194124|NCT00355615|453993811|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
126194125|NCT04247828|453993815|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
126194126|NCT02159365|453993816|FG000|Overall Study|Disease Progression|23|||
126194127|NCT02159365|453993816|FG000|Overall Study|Other reasons|11|||
126194128|NCT02159365|453993816|FG000|Overall Study|Administrative reason by Sponsor|9|||
126194129|NCT02159365|453993816|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
126194130|NCT02159365|453993816|FG000|Overall Study|Study drug toxicity|7|||
126194131|NCT02159365|453993816|FG000|Overall Study|Maximum clinical benefit|3|||
126194132|NCT02159365|453993816|FG000|Overall Study|Subject request to discontinue treatment|3|||
126194133|NCT02159365|453993816|FG000|Overall Study|Subject withdrew consent|3|||
126194134|NCT02159365|453993816|FG000|Overall Study|Death|1|||
126194135|NCT02159365|453993816|FG000|Overall Study|Lost to Follow-up|1|||
126194136|NCT03523715|453993817|FG000|Overall Study|Lost to Follow-up|11|||
126194137|NCT03523715|453993818|FG001|Overall Study|Lost to Follow-up|14|||
126194138|NCT03523715|453993817|FG000|Overall Study|Did not meet inclusion criteria|1|||
126194139|NCT03523715|453993818|FG001|Overall Study|Did not meet inclusion criteria|0|||
126194140|NCT03523715|453993817|FG000|Overall Study|Internally inconsistent reporting|0|||
126194141|NCT03523715|453993818|FG001|Overall Study|Internally inconsistent reporting|2|||
126194142|NCT03299166|453993819|FG000|Overall Study|Adverse Event|9|||
126194143|NCT03299166|453993820|FG001|Overall Study|Adverse Event|4|||
126194144|NCT03299166|453993819|FG000|Overall Study|Withdrawal by Subject|6|||
126194145|NCT03299166|453993820|FG001|Overall Study|Withdrawal by Subject|5|||
126194146|NCT03299166|453993819|FG000|Overall Study|Physician Decision|1|||
126194147|NCT03299166|453993820|FG001|Overall Study|Physician Decision|1|||
126194148|NCT03299166|453993819|FG000|Overall Study|Sponsor Decision|3|||
126194149|NCT03299166|453993820|FG001|Overall Study|Sponsor Decision|0|||
126194150|NCT03299166|453993819|FG000|Overall Study|Lost to Follow-up|2|||
126194151|NCT03299166|453993820|FG001|Overall Study|Lost to Follow-up|4|||
126194152|NCT03299166|453993819|FG000|Overall Study|Randomization Error|0|||
126194153|NCT03299166|453993820|FG001|Overall Study|Randomization Error|1|||
126194154|NCT03299166|453993819|FG000|Overall Study|Subject unable to return due to COVID|1|||
126194155|NCT03299166|453993820|FG001|Overall Study|Subject unable to return due to COVID|0|||
126194156|NCT03299166|453993819|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
126194157|NCT03299166|453993820|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
126194158|NCT00572728|453993821|FG000|Overall Study|Withdrawal by Subject|10|||
126194159|NCT00572728|453993821|FG000|Overall Study|Ineligible|3|||
126194160|NCT00572728|453993821|FG000|Overall Study|Enrolled under Amendment 4|5|||
126194161|NCT00572728|453993821|FG000|Overall Study|Offstudy due to complicating disease|1|||
126194162|NCT00572728|453993821|FG000|Overall Study|FLT1 not completed|4|||
126194163|NCT00572728|453993821|FG000|Overall Study|First Chemotherapy not initiated|2|||
126194164|NCT00572728|453993821|FG000|Overall Study|FLT2 not completed|5|||
126194165|NCT00572728|453993821|FG000|Overall Study|Second chemotherapy not initiated|1|||
126194166|NCT00572728|453993821|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
126194167|NCT00572728|453993821|FG000|Overall Study|Pathology missing|1|||
126194168|NCT00002981|453993822|FG000|Overall Study|Inevaluable|6|||
126194169|NCT03457636|453993825|FG000|Overall Study|Lost to Follow-up|2|||
126194170|NCT03128307|453993837|FG000|Overall Study|Lost to Follow-up|29|||
126194171|NCT03128307|453993837|FG000|Overall Study|Withdrawal by Subject|5|||
126194172|NCT01693562|453995473|FG000|Escalation Phase|Withdrawal by Subject|0|||
126194173|NCT01693562|453995474|FG001|Escalation Phase|Withdrawal by Subject|1|||
126194174|NCT01693562|453995475|FG002|Escalation Phase|Withdrawal by Subject|0|||
126194175|NCT01693562|453995476|FG003|Escalation Phase|Withdrawal by Subject|0|||
126194176|NCT01693562|453995477|FG004|Escalation Phase|Withdrawal by Subject|0|||
126194177|NCT01693562|453995478|FG005|Escalation Phase|Withdrawal by Subject|2|||
126194178|NCT01693562|453995479|FG006|Escalation Phase|Withdrawal by Subject|0|||
126194179|NCT01693562|453995480|FG007|Escalation Phase|Withdrawal by Subject|0|||
126194180|NCT01693562|453995481|FG008|Escalation Phase|Withdrawal by Subject|0|||
126194181|NCT01693562|453995482|FG009|Escalation Phase|Withdrawal by Subject|0|||
126194182|NCT01693562|453995483|FG010|Escalation Phase|Withdrawal by Subject|0|||
126194183|NCT01693562|453995484|FG011|Escalation Phase|Withdrawal by Subject|0|||
126194184|NCT01693562|453995485|FG012|Escalation Phase|Withdrawal by Subject|0|||
126194185|NCT01693562|453995486|FG013|Escalation Phase|Withdrawal by Subject|0|||
126199944|NCT01117428|454017805|FG001|Overall Study|Death|1|||
126194186|NCT01693562|453995487|FG014|Escalation Phase|Withdrawal by Subject|0|||
126194187|NCT01693562|453995488|FG015|Escalation Phase|Withdrawal by Subject|0|||
126194188|NCT01693562|453995489|FG016|Escalation Phase|Withdrawal by Subject|0|||
126194189|NCT01693562|453995490|FG017|Escalation Phase|Withdrawal by Subject|0|||
126194190|NCT01693562|453995491|FG018|Escalation Phase|Withdrawal by Subject|0|||
126194191|NCT01693562|453995492|FG019|Escalation Phase|Withdrawal by Subject|0|||
126194192|NCT01693562|453995493|FG020|Escalation Phase|Withdrawal by Subject|0|||
126194193|NCT01693562|453995494|FG021|Escalation Phase|Withdrawal by Subject|0|||
126194194|NCT01693562|453995495|FG022|Escalation Phase|Withdrawal by Subject|0|||
126194195|NCT01693562|453995473|FG000|Escalation Phase|Death|4|||
126194196|NCT01693562|453995474|FG001|Escalation Phase|Death|2|||
126194197|NCT01693562|453995475|FG002|Escalation Phase|Death|0|||
126194198|NCT01693562|453995476|FG003|Escalation Phase|Death|3|||
126194199|NCT01693562|453995477|FG004|Escalation Phase|Death|6|||
126194200|NCT01693562|453995478|FG005|Escalation Phase|Death|4|||
126194201|NCT01693562|453995479|FG006|Escalation Phase|Death|0|||
126194202|NCT01693562|453995480|FG007|Escalation Phase|Death|0|||
126194203|NCT01693562|453995481|FG008|Escalation Phase|Death|0|||
126194204|NCT01693562|453995482|FG009|Escalation Phase|Death|0|||
126194205|NCT01693562|453995483|FG010|Escalation Phase|Death|0|||
126194206|NCT01693562|453995484|FG011|Escalation Phase|Death|0|||
126194207|NCT01693562|453995485|FG012|Escalation Phase|Death|0|||
126194208|NCT01693562|453995486|FG013|Escalation Phase|Death|0|||
126194209|NCT01693562|453995487|FG014|Escalation Phase|Death|0|||
126194210|NCT01693562|453995488|FG015|Escalation Phase|Death|0|||
126194211|NCT01693562|453995489|FG016|Escalation Phase|Death|0|||
126194212|NCT01693562|453995490|FG017|Escalation Phase|Death|0|||
126194213|NCT01693562|453995491|FG018|Escalation Phase|Death|0|||
126194214|NCT01693562|453995492|FG019|Escalation Phase|Death|0|||
126194215|NCT01693562|453995493|FG020|Escalation Phase|Death|0|||
126194216|NCT01693562|453995494|FG021|Escalation Phase|Death|0|||
126194217|NCT01693562|453995495|FG022|Escalation Phase|Death|0|||
126194218|NCT01693562|453995473|FG000|Escalation Phase|Lost to Follow-up|0|||
126194219|NCT01693562|453995474|FG001|Escalation Phase|Lost to Follow-up|1|||
126194220|NCT01693562|453995475|FG002|Escalation Phase|Lost to Follow-up|1|||
126194221|NCT01693562|453995476|FG003|Escalation Phase|Lost to Follow-up|0|||
126194222|NCT01693562|453995477|FG004|Escalation Phase|Lost to Follow-up|0|||
126194223|NCT01693562|453995478|FG005|Escalation Phase|Lost to Follow-up|0|||
126194224|NCT01693562|453995479|FG006|Escalation Phase|Lost to Follow-up|0|||
126194225|NCT01693562|453995480|FG007|Escalation Phase|Lost to Follow-up|0|||
126194226|NCT01693562|453995481|FG008|Escalation Phase|Lost to Follow-up|0|||
126194227|NCT01693562|453995482|FG009|Escalation Phase|Lost to Follow-up|0|||
126194228|NCT01693562|453995483|FG010|Escalation Phase|Lost to Follow-up|0|||
126194229|NCT01693562|453995484|FG011|Escalation Phase|Lost to Follow-up|0|||
126194230|NCT01693562|453995485|FG012|Escalation Phase|Lost to Follow-up|0|||
126194231|NCT01693562|453995486|FG013|Escalation Phase|Lost to Follow-up|0|||
126194232|NCT01693562|453995487|FG014|Escalation Phase|Lost to Follow-up|0|||
126194233|NCT01693562|453995488|FG015|Escalation Phase|Lost to Follow-up|0|||
126194234|NCT01693562|453995489|FG016|Escalation Phase|Lost to Follow-up|0|||
126194235|NCT01693562|453995490|FG017|Escalation Phase|Lost to Follow-up|0|||
126194236|NCT01693562|453995491|FG018|Escalation Phase|Lost to Follow-up|0|||
126194237|NCT01693562|453995492|FG019|Escalation Phase|Lost to Follow-up|0|||
126194238|NCT01693562|453995493|FG020|Escalation Phase|Lost to Follow-up|0|||
126194239|NCT01693562|453995494|FG021|Escalation Phase|Lost to Follow-up|0|||
126194240|NCT01693562|453995495|FG022|Escalation Phase|Lost to Follow-up|0|||
126194241|NCT01693562|453995473|FG000|Escalation Phase|Other|0|||
126194242|NCT01693562|453995474|FG001|Escalation Phase|Other|0|||
126194243|NCT01693562|453995475|FG002|Escalation Phase|Other|2|||
126194244|NCT01693562|453995476|FG003|Escalation Phase|Other|0|||
126194245|NCT01693562|453995477|FG004|Escalation Phase|Other|0|||
126194246|NCT01693562|453995478|FG005|Escalation Phase|Other|1|||
126194247|NCT01693562|453995479|FG006|Escalation Phase|Other|0|||
126194248|NCT01693562|453995480|FG007|Escalation Phase|Other|0|||
126194249|NCT01693562|453995481|FG008|Escalation Phase|Other|0|||
126194250|NCT01693562|453995482|FG009|Escalation Phase|Other|0|||
126194251|NCT01693562|453995483|FG010|Escalation Phase|Other|0|||
126194252|NCT01693562|453995484|FG011|Escalation Phase|Other|0|||
126194253|NCT01693562|453995485|FG012|Escalation Phase|Other|0|||
126194254|NCT01693562|453995486|FG013|Escalation Phase|Other|0|||
126194255|NCT01693562|453995487|FG014|Escalation Phase|Other|0|||
126194256|NCT01693562|453995488|FG015|Escalation Phase|Other|0|||
126194257|NCT01693562|453995489|FG016|Escalation Phase|Other|0|||
126194258|NCT01693562|453995490|FG017|Escalation Phase|Other|0|||
126194259|NCT01693562|453995491|FG018|Escalation Phase|Other|0|||
126194260|NCT01693562|453995492|FG019|Escalation Phase|Other|0|||
126194261|NCT01693562|453995493|FG020|Escalation Phase|Other|0|||
126194262|NCT01693562|453995494|FG021|Escalation Phase|Other|0|||
126194263|NCT01693562|453995495|FG022|Escalation Phase|Other|0|||
126194264|NCT01693562|453995473|FG000|Exploration Phase|Withdrawal by Subject|0|||
126194265|NCT01693562|453995474|FG001|Exploration Phase|Withdrawal by Subject|0|||
126194266|NCT01693562|453995475|FG002|Exploration Phase|Withdrawal by Subject|0|||
126194267|NCT01693562|453995476|FG003|Exploration Phase|Withdrawal by Subject|0|||
126194268|NCT01693562|453995477|FG004|Exploration Phase|Withdrawal by Subject|0|||
126194269|NCT01693562|453995478|FG005|Exploration Phase|Withdrawal by Subject|0|||
126194270|NCT01693562|453995479|FG006|Exploration Phase|Withdrawal by Subject|2|||
126194271|NCT01693562|453995480|FG007|Exploration Phase|Withdrawal by Subject|0|||
126194272|NCT01693562|453995481|FG008|Exploration Phase|Withdrawal by Subject|0|||
126194273|NCT01693562|453995482|FG009|Exploration Phase|Withdrawal by Subject|0|||
126194274|NCT01693562|453995483|FG010|Exploration Phase|Withdrawal by Subject|0|||
126194275|NCT01693562|453995484|FG011|Exploration Phase|Withdrawal by Subject|0|||
126194276|NCT01693562|453995485|FG012|Exploration Phase|Withdrawal by Subject|0|||
126194277|NCT01693562|453995486|FG013|Exploration Phase|Withdrawal by Subject|0|||
126194278|NCT01693562|453995487|FG014|Exploration Phase|Withdrawal by Subject|0|||
126194279|NCT01693562|453995488|FG015|Exploration Phase|Withdrawal by Subject|0|||
126194280|NCT01693562|453995489|FG016|Exploration Phase|Withdrawal by Subject|0|||
126194281|NCT01693562|453995490|FG017|Exploration Phase|Withdrawal by Subject|0|||
126194282|NCT01693562|453995491|FG018|Exploration Phase|Withdrawal by Subject|0|||
126194283|NCT01693562|453995492|FG019|Exploration Phase|Withdrawal by Subject|0|||
126194284|NCT01693562|453995493|FG020|Exploration Phase|Withdrawal by Subject|0|||
126194285|NCT01693562|453995494|FG021|Exploration Phase|Withdrawal by Subject|0|||
126194286|NCT01693562|453995495|FG022|Exploration Phase|Withdrawal by Subject|0|||
126194287|NCT01693562|453995473|FG000|Exploration Phase|Death|0|||
126194288|NCT01693562|453995474|FG001|Exploration Phase|Death|0|||
126194289|NCT01693562|453995475|FG002|Exploration Phase|Death|0|||
126194290|NCT01693562|453995476|FG003|Exploration Phase|Death|0|||
126194291|NCT01693562|453995477|FG004|Exploration Phase|Death|0|||
126194292|NCT01693562|453995478|FG005|Exploration Phase|Death|0|||
126194293|NCT01693562|453995479|FG006|Exploration Phase|Death|17|||
126194294|NCT01693562|453995480|FG007|Exploration Phase|Death|0|||
126194295|NCT01693562|453995481|FG008|Exploration Phase|Death|0|||
126194296|NCT01693562|453995482|FG009|Exploration Phase|Death|0|||
126194297|NCT01693562|453995483|FG010|Exploration Phase|Death|0|||
126194298|NCT01693562|453995484|FG011|Exploration Phase|Death|0|||
126194299|NCT01693562|453995485|FG012|Exploration Phase|Death|0|||
126194300|NCT01693562|453995486|FG013|Exploration Phase|Death|0|||
126194301|NCT01693562|453995487|FG014|Exploration Phase|Death|0|||
126194302|NCT01693562|453995488|FG015|Exploration Phase|Death|0|||
126194303|NCT01693562|453995489|FG016|Exploration Phase|Death|0|||
126194304|NCT01693562|453995490|FG017|Exploration Phase|Death|0|||
126194305|NCT01693562|453995491|FG018|Exploration Phase|Death|0|||
126194306|NCT01693562|453995492|FG019|Exploration Phase|Death|0|||
126194307|NCT01693562|453995493|FG020|Exploration Phase|Death|0|||
126194308|NCT01693562|453995494|FG021|Exploration Phase|Death|0|||
126194309|NCT01693562|453995495|FG022|Exploration Phase|Death|0|||
126194310|NCT01693562|453995473|FG000|Exploration Phase|Other|0|||
126194311|NCT01693562|453995474|FG001|Exploration Phase|Other|0|||
126194312|NCT01693562|453995475|FG002|Exploration Phase|Other|0|||
126194313|NCT01693562|453995476|FG003|Exploration Phase|Other|0|||
126194314|NCT01693562|453995477|FG004|Exploration Phase|Other|0|||
126194315|NCT01693562|453995478|FG005|Exploration Phase|Other|0|||
126194316|NCT01693562|453995479|FG006|Exploration Phase|Other|2|||
126194317|NCT01693562|453995480|FG007|Exploration Phase|Other|0|||
126194318|NCT01693562|453995481|FG008|Exploration Phase|Other|0|||
126194319|NCT01693562|453995482|FG009|Exploration Phase|Other|0|||
126194320|NCT01693562|453995483|FG010|Exploration Phase|Other|0|||
126194321|NCT01693562|453995484|FG011|Exploration Phase|Other|0|||
126194322|NCT01693562|453995485|FG012|Exploration Phase|Other|0|||
126194323|NCT01693562|453995486|FG013|Exploration Phase|Other|0|||
126194324|NCT01693562|453995487|FG014|Exploration Phase|Other|0|||
126194325|NCT01693562|453995488|FG015|Exploration Phase|Other|0|||
126194326|NCT01693562|453995489|FG016|Exploration Phase|Other|0|||
126194327|NCT01693562|453995490|FG017|Exploration Phase|Other|0|||
126194328|NCT01693562|453995491|FG018|Exploration Phase|Other|0|||
126194329|NCT01693562|453995492|FG019|Exploration Phase|Other|0|||
126194330|NCT01693562|453995493|FG020|Exploration Phase|Other|0|||
126194331|NCT01693562|453995494|FG021|Exploration Phase|Other|0|||
126194332|NCT01693562|453995495|FG022|Exploration Phase|Other|0|||
126194333|NCT01693562|453995473|FG000|Expansion Phase|Withdrawal by Subject|0|||
126194334|NCT01693562|453995474|FG001|Expansion Phase|Withdrawal by Subject|0|||
126194335|NCT01693562|453995475|FG002|Expansion Phase|Withdrawal by Subject|0|||
126194336|NCT01693562|453995476|FG003|Expansion Phase|Withdrawal by Subject|0|||
126194337|NCT01693562|453995477|FG004|Expansion Phase|Withdrawal by Subject|0|||
126194338|NCT01693562|453995478|FG005|Expansion Phase|Withdrawal by Subject|0|||
126194339|NCT01693562|453995479|FG006|Expansion Phase|Withdrawal by Subject|0|||
126194340|NCT01693562|453995480|FG007|Expansion Phase|Withdrawal by Subject|16|||
126194341|NCT01693562|453995481|FG008|Expansion Phase|Withdrawal by Subject|2|||
126194342|NCT01693562|453995482|FG009|Expansion Phase|Withdrawal by Subject|54|||
126194343|NCT01693562|453995483|FG010|Expansion Phase|Withdrawal by Subject|2|||
126194344|NCT01693562|453995484|FG011|Expansion Phase|Withdrawal by Subject|2|||
126194345|NCT01693562|453995485|FG012|Expansion Phase|Withdrawal by Subject|3|||
126194346|NCT01693562|453995486|FG013|Expansion Phase|Withdrawal by Subject|5|||
126194347|NCT01693562|453995487|FG014|Expansion Phase|Withdrawal by Subject|16|||
126194348|NCT01693562|453995488|FG015|Expansion Phase|Withdrawal by Subject|7|||
126194349|NCT01693562|453995489|FG016|Expansion Phase|Withdrawal by Subject|40|||
126194350|NCT01693562|453995490|FG017|Expansion Phase|Withdrawal by Subject|4|||
126194351|NCT01693562|453995491|FG018|Expansion Phase|Withdrawal by Subject|8|||
126194352|NCT01693562|453995492|FG019|Expansion Phase|Withdrawal by Subject|3|||
126194353|NCT01693562|453995493|FG020|Expansion Phase|Withdrawal by Subject|1|||
126194354|NCT01693562|453995494|FG021|Expansion Phase|Withdrawal by Subject|8|||
126194355|NCT01693562|453995495|FG022|Expansion Phase|Withdrawal by Subject|1|||
126194356|NCT01693562|453995473|FG000|Expansion Phase|Death|0|||
126194357|NCT01693562|453995474|FG001|Expansion Phase|Death|0|||
126194358|NCT01693562|453995475|FG002|Expansion Phase|Death|0|||
126194359|NCT01693562|453995476|FG003|Expansion Phase|Death|0|||
126194360|NCT01693562|453995477|FG004|Expansion Phase|Death|0|||
126194361|NCT01693562|453995478|FG005|Expansion Phase|Death|0|||
126194362|NCT01693562|453995479|FG006|Expansion Phase|Death|0|||
126194363|NCT01693562|453995480|FG007|Expansion Phase|Death|42|||
126194364|NCT01693562|453995481|FG008|Expansion Phase|Death|17|||
126194365|NCT01693562|453995482|FG009|Expansion Phase|Death|208|||
126194366|NCT01693562|453995483|FG010|Expansion Phase|Death|30|||
126194367|NCT01693562|453995484|FG011|Expansion Phase|Death|8|||
126194368|NCT01693562|453995485|FG012|Expansion Phase|Death|19|||
126194369|NCT01693562|453995486|FG013|Expansion Phase|Death|42|||
126194370|NCT01693562|453995487|FG014|Expansion Phase|Death|23|||
126194371|NCT01693562|453995488|FG015|Expansion Phase|Death|23|||
126194372|NCT01693562|453995489|FG016|Expansion Phase|Death|128|||
126194373|NCT01693562|453995490|FG017|Expansion Phase|Death|16|||
126194374|NCT01693562|453995491|FG018|Expansion Phase|Death|36|||
126194375|NCT01693562|453995492|FG019|Expansion Phase|Death|16|||
126194376|NCT01693562|453995493|FG020|Expansion Phase|Death|17|||
126194377|NCT01693562|453995494|FG021|Expansion Phase|Death|35|||
126194378|NCT01693562|453995495|FG022|Expansion Phase|Death|7|||
126194379|NCT01693562|453995473|FG000|Expansion Phase|Lost to Follow-up|0|||
126194380|NCT01693562|453995474|FG001|Expansion Phase|Lost to Follow-up|0|||
126194381|NCT01693562|453995475|FG002|Expansion Phase|Lost to Follow-up|0|||
126194382|NCT01693562|453995476|FG003|Expansion Phase|Lost to Follow-up|0|||
126194383|NCT01693562|453995477|FG004|Expansion Phase|Lost to Follow-up|0|||
126194384|NCT01693562|453995478|FG005|Expansion Phase|Lost to Follow-up|0|||
126194385|NCT01693562|453995479|FG006|Expansion Phase|Lost to Follow-up|0|||
126194386|NCT01693562|453995480|FG007|Expansion Phase|Lost to Follow-up|1|||
126194387|NCT01693562|453995481|FG008|Expansion Phase|Lost to Follow-up|2|||
126194388|NCT01693562|453995482|FG009|Expansion Phase|Lost to Follow-up|10|||
126194389|NCT01693562|453995483|FG010|Expansion Phase|Lost to Follow-up|4|||
126194390|NCT01693562|453995484|FG011|Expansion Phase|Lost to Follow-up|4|||
126194391|NCT01693562|453995485|FG012|Expansion Phase|Lost to Follow-up|1|||
126194392|NCT01693562|453995486|FG013|Expansion Phase|Lost to Follow-up|3|||
126194393|NCT01693562|453995487|FG014|Expansion Phase|Lost to Follow-up|0|||
126194394|NCT01693562|453995488|FG015|Expansion Phase|Lost to Follow-up|1|||
126194395|NCT01693562|453995489|FG016|Expansion Phase|Lost to Follow-up|1|||
126194396|NCT01693562|453995490|FG017|Expansion Phase|Lost to Follow-up|0|||
126194397|NCT01693562|453995491|FG018|Expansion Phase|Lost to Follow-up|2|||
126194398|NCT01693562|453995492|FG019|Expansion Phase|Lost to Follow-up|1|||
126194399|NCT01693562|453995493|FG020|Expansion Phase|Lost to Follow-up|2|||
126194400|NCT01693562|453995494|FG021|Expansion Phase|Lost to Follow-up|2|||
126194401|NCT01693562|453995495|FG022|Expansion Phase|Lost to Follow-up|1|||
126194402|NCT01693562|453995473|FG000|Expansion Phase|Other|0|||
126194403|NCT01693562|453995474|FG001|Expansion Phase|Other|0|||
126194404|NCT01693562|453995475|FG002|Expansion Phase|Other|0|||
126194405|NCT01693562|453995476|FG003|Expansion Phase|Other|0|||
126194406|NCT01693562|453995477|FG004|Expansion Phase|Other|0|||
126194407|NCT01693562|453995478|FG005|Expansion Phase|Other|0|||
126194408|NCT01693562|453995479|FG006|Expansion Phase|Other|0|||
126194409|NCT01693562|453995480|FG007|Expansion Phase|Other|3|||
126194410|NCT01693562|453995481|FG008|Expansion Phase|Other|1|||
126194411|NCT01693562|453995482|FG009|Expansion Phase|Other|28|||
126194412|NCT01693562|453995483|FG010|Expansion Phase|Other|4|||
126194413|NCT01693562|453995484|FG011|Expansion Phase|Other|7|||
126194414|NCT01693562|453995485|FG012|Expansion Phase|Other|0|||
126194415|NCT01693562|453995486|FG013|Expansion Phase|Other|1|||
126194416|NCT01693562|453995487|FG014|Expansion Phase|Other|1|||
126194417|NCT01693562|453995488|FG015|Expansion Phase|Other|0|||
126194418|NCT01693562|453995489|FG016|Expansion Phase|Other|28|||
126194419|NCT01693562|453995490|FG017|Expansion Phase|Other|0|||
126194420|NCT01693562|453995491|FG018|Expansion Phase|Other|1|||
126194421|NCT01693562|453995492|FG019|Expansion Phase|Other|0|||
126194422|NCT01693562|453995493|FG020|Expansion Phase|Other|1|||
126194423|NCT01693562|453995494|FG021|Expansion Phase|Other|17|||
126194424|NCT01693562|453995495|FG022|Expansion Phase|Other|1|||
126194425|NCT05815758|453995500|FG000|Overall Study|Adverse Event|6|||
126194426|NCT05815758|453995501|FG001|Overall Study|Adverse Event|2|||
126194427|NCT05815758|453995500|FG000|Overall Study|Lost to Follow-up|14|||
126194428|NCT05815758|453995501|FG001|Overall Study|Lost to Follow-up|1|||
126194429|NCT05815758|453995500|FG000|Overall Study|Withdrawal by Subject|6|||
126194430|NCT05815758|453995501|FG001|Overall Study|Withdrawal by Subject|6|||
126194431|NCT05815758|453995500|FG000|Overall Study|Protocol Violation|1|||
126194432|NCT05815758|453995501|FG001|Overall Study|Protocol Violation|1|||
126194433|NCT05815758|453995500|FG000|Overall Study|Discontinued|4|||
126194434|NCT05815758|453995501|FG001|Overall Study|Discontinued|4|||
126194435|NCT02987205|453995502|FG000|Overall Study|Adverse Event|1|||
126194436|NCT02987205|453995502|FG000|Overall Study|Withdrawal by Subject|3|||
126194437|NCT04167514|453995505|FG000|Overall Study|Adverse event, not serious|0|||
126194438|NCT04167514|453995506|FG001|Overall Study|Adverse event, not serious|1|||
126194439|NCT04167514|453995505|FG000|Overall Study|Lost to Follow-up|1|||
126194440|NCT04167514|453995506|FG001|Overall Study|Lost to Follow-up|0|||
126194441|NCT04167514|453995505|FG000|Overall Study|Participant Decision|2|||
126194442|NCT04167514|453995506|FG001|Overall Study|Participant Decision|4|||
126194443|NCT04167514|453995505|FG000|Overall Study|Physician Decision|3|||
126194444|NCT04167514|453995506|FG001|Overall Study|Physician Decision|2|||
126194445|NCT04167514|453995505|FG000|Overall Study|Death|14|||
126194446|NCT04167514|453995506|FG001|Overall Study|Death|18|||
126194447|NCT04167514|453995505|FG000|Overall Study|Enrolled but treatment not administered|2|||
126194448|NCT04167514|453995506|FG001|Overall Study|Enrolled but treatment not administered|0|||
126194449|NCT04167514|453995505|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
126194450|NCT04167514|453995506|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
126194451|NCT04167514|453995505|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
126194452|NCT04167514|453995506|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
126194453|NCT04437511|453995509|FG000|Overall Study|Adverse Event|50|||
126194454|NCT04437511|453995510|FG001|Overall Study|Adverse Event|21|||
126194455|NCT04437511|453995509|FG000|Overall Study|Death|15|||
126194456|NCT04437511|453995510|FG001|Overall Study|Death|10|||
126194457|NCT04437511|453995509|FG000|Overall Study|Lost to Follow-up|11|||
126194458|NCT04437511|453995510|FG001|Overall Study|Lost to Follow-up|11|||
126194459|NCT04437511|453995509|FG000|Overall Study|Physician Decision|19|||
126194460|NCT04437511|453995510|FG001|Overall Study|Physician Decision|10|||
126194461|NCT04437511|453995509|FG000|Overall Study|Progressive Disease|4|||
126194462|NCT04437511|453995510|FG001|Overall Study|Progressive Disease|7|||
126194463|NCT04437511|453995509|FG000|Overall Study|Withdrawal by Subject|111|||
126194464|NCT04437511|453995510|FG001|Overall Study|Withdrawal by Subject|94|||
126194465|NCT04437511|453995509|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
126194466|NCT04437511|453995510|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
126194467|NCT04437511|453995509|FG000|Overall Study|Continuing Study|7|||
126194468|NCT04437511|453995510|FG001|Overall Study|Continuing Study|5|||
126194469|NCT05564039|453995528|FG000|Overall Study|Adverse Event|1|||
126194470|NCT05564039|453995529|FG001|Overall Study|Adverse Event|0|||
126194471|NCT05564039|453995528|FG000|Overall Study|Death|1|||
126194472|NCT05564039|453995529|FG001|Overall Study|Death|1|||
126194473|NCT05564039|453995528|FG000|Overall Study|Lost to Follow-up|3|||
126194474|NCT05564039|453995529|FG001|Overall Study|Lost to Follow-up|2|||
126194475|NCT05564039|453995528|FG000|Overall Study|Withdrawal by Subject|2|||
126194476|NCT05564039|453995529|FG001|Overall Study|Withdrawal by Subject|0|||
126194477|NCT05564039|453995528|FG000|Overall Study|Inadvertent enrollment|3|||
126194478|NCT05564039|453995529|FG001|Overall Study|Inadvertent enrollment|6|||
126194479|NCT00610714|453995532|FG000|Overall Study|Adverse Event|3|||
126194480|NCT00610714|453995533|FG001|Overall Study|Adverse Event|1|||
126194481|NCT00610714|453995532|FG000|Overall Study|Death|12|||
126194482|NCT00610714|453995533|FG001|Overall Study|Death|18|||
126194483|NCT00610714|453995532|FG000|Overall Study|Withdrawal by Subject|9|||
126194484|NCT00610714|453995533|FG001|Overall Study|Withdrawal by Subject|3|||
126194485|NCT00610714|453995532|FG000|Overall Study|Study completion at 120 PFS events|2|||
126194486|NCT00610714|453995533|FG001|Overall Study|Study completion at 120 PFS events|2|||
126194487|NCT03598140|453995534|FG000|Overall Study|enrolled but didn't start|1|||
126194488|NCT03598140|453995535|FG001|Overall Study|enrolled but didn't start|0|||
126194489|NCT01058395|453995536|FG000|Overall Study|Death|2|||
126194490|NCT01058395|453995537|FG001|Overall Study|Death|1|||
126194491|NCT01058395|453995536|FG000|Overall Study|Lost to Follow-up|1|||
126194492|NCT01058395|453995537|FG001|Overall Study|Lost to Follow-up|0|||
126194493|NCT04083781|453995538|FG000|Main Part|Physician Decision|0|||
126194494|NCT04083781|453995539|FG001|Main Part|Physician Decision|1|||
126194495|NCT04083781|453995540|FG002|Main Part|Physician Decision|2|||
126194496|NCT04083781|453995541|FG003|Main Part|Physician Decision|0|||
126194497|NCT04083781|453995538|FG000|Main Part|Death|1|||
126194498|NCT04083781|453995539|FG001|Main Part|Death|3|||
126194499|NCT04083781|453995540|FG002|Main Part|Death|1|||
126194500|NCT04083781|453995541|FG003|Main Part|Death|0|||
126194501|NCT04083781|453995538|FG000|Main Part|Withdrawal by Subject|5|||
126194502|NCT04083781|453995539|FG001|Main Part|Withdrawal by Subject|2|||
126194503|NCT04083781|453995540|FG002|Main Part|Withdrawal by Subject|3|||
126194504|NCT04083781|453995541|FG003|Main Part|Withdrawal by Subject|7|||
126194505|NCT04083781|453995538|FG000|Extension Part|Physician Decision|0|||
126194506|NCT04083781|453995539|FG001|Extension Part|Physician Decision|0|||
126194507|NCT04083781|453995540|FG002|Extension Part|Physician Decision|0|||
126194508|NCT04083781|453995541|FG003|Extension Part|Physician Decision|1|||
126194509|NCT04083781|453995538|FG000|Extension Part|Death|0|||
126194510|NCT04083781|453995539|FG001|Extension Part|Death|1|||
126194511|NCT04083781|453995540|FG002|Extension Part|Death|0|||
126194512|NCT04083781|453995541|FG003|Extension Part|Death|1|||
126194513|NCT04083781|453995538|FG000|Extension Part|Withdrawal by Subject|0|||
126194514|NCT04083781|453995539|FG001|Extension Part|Withdrawal by Subject|1|||
126194515|NCT04083781|453995540|FG002|Extension Part|Withdrawal by Subject|0|||
126194516|NCT04083781|453995541|FG003|Extension Part|Withdrawal by Subject|0|||
126194517|NCT04083781|453995538|FG000|Extension Part|Ongoing|13|||
126194518|NCT04083781|453995539|FG001|Extension Part|Ongoing|25|||
126194519|NCT04083781|453995540|FG002|Extension Part|Ongoing|15|||
126194520|NCT04083781|453995541|FG003|Extension Part|Ongoing|51|||
126194521|NCT05304611|453995543|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194522|NCT05304611|453995544|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194523|NCT05304611|453995545|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194524|NCT05304611|453995546|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194525|NCT05304611|453995547|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194526|NCT05304611|453995548|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194527|NCT05304611|453995549|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
126194528|NCT05304611|453995550|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194529|NCT05304611|453995551|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
126194530|NCT05304611|453995552|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194531|NCT05304611|453995553|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194532|NCT05304611|453995554|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
126194533|NCT05304611|453995543|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
126194534|NCT05304611|453995544|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
126194535|NCT05304611|453995545|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
126194536|NCT05304611|453995546|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
126194537|NCT05304611|453995547|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
126194538|NCT05304611|453995548|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
126194539|NCT05304611|453995549|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
126194540|NCT05304611|453995550|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
126194541|NCT05304611|453995551|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
126194542|NCT05304611|453995552|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
126194543|NCT05304611|453995553|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
126194544|NCT05304611|453995554|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
126194545|NCT05304611|453995543|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
126194546|NCT05304611|453995544|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
126194547|NCT05304611|453995545|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
126194548|NCT05304611|453995546|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
126194549|NCT05304611|453995547|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
126194550|NCT05304611|453995548|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
126194551|NCT05304611|453995549|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
126194552|NCT05304611|453995550|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
126194553|NCT05304611|453995551|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
126194554|NCT05304611|453995552|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
126194555|NCT05304611|453995553|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
126194556|NCT05304611|453995554|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
126194557|NCT02354690|453995555|FG000|Overall Study|Physician Decision|1|||
126194558|NCT00963820|453995556|FG000|Dose Escalation Phase|Progressive Disease|3|||
126194559|NCT00963820|453995557|FG001|Dose Escalation Phase|Progressive Disease|3|||
126194560|NCT00963820|453995558|FG002|Dose Escalation Phase|Progressive Disease|3|||
126194561|NCT00963820|453995559|FG003|Dose Escalation Phase|Progressive Disease|3|||
126194562|NCT00963820|453995560|FG004|Dose Escalation Phase|Progressive Disease|4|||
126194563|NCT00963820|453995561|FG005|Dose Escalation Phase|Progressive Disease|3|||
126194564|NCT00963820|453995562|FG006|Dose Escalation Phase|Progressive Disease|3|||
126194565|NCT00963820|453995563|FG007|Dose Escalation Phase|Progressive Disease|2|||
126194566|NCT00963820|453995564|FG008|Dose Escalation Phase|Progressive Disease|0|||
126194567|NCT00963820|453995565|FG009|Dose Escalation Phase|Progressive Disease|0|||
126194568|NCT00963820|453995566|FG010|Dose Escalation Phase|Progressive Disease|0|||
126194569|NCT00963820|453995567|FG011|Dose Escalation Phase|Progressive Disease|0|||
126194570|NCT00963820|453995556|FG000|Dose Escalation Phase|Adverse Event|0|||
126194571|NCT00963820|453995557|FG001|Dose Escalation Phase|Adverse Event|0|||
126194572|NCT00963820|453995558|FG002|Dose Escalation Phase|Adverse Event|0|||
126194573|NCT00963820|453995559|FG003|Dose Escalation Phase|Adverse Event|0|||
126194574|NCT00963820|453995560|FG004|Dose Escalation Phase|Adverse Event|0|||
126194575|NCT00963820|453995561|FG005|Dose Escalation Phase|Adverse Event|0|||
126194576|NCT00963820|453995562|FG006|Dose Escalation Phase|Adverse Event|3|||
126194577|NCT00963820|453995563|FG007|Dose Escalation Phase|Adverse Event|1|||
126194578|NCT00963820|453995564|FG008|Dose Escalation Phase|Adverse Event|0|||
126194579|NCT00963820|453995565|FG009|Dose Escalation Phase|Adverse Event|0|||
126194580|NCT00963820|453995566|FG010|Dose Escalation Phase|Adverse Event|0|||
126194581|NCT00963820|453995567|FG011|Dose Escalation Phase|Adverse Event|0|||
126194582|NCT00963820|453995556|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126194583|NCT00963820|453995557|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126194584|NCT00963820|453995558|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126194585|NCT00963820|453995559|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126194586|NCT00963820|453995560|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
126194587|NCT00963820|453995561|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
126194588|NCT00963820|453995562|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
126194589|NCT00963820|453995563|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
126194590|NCT00963820|453995564|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
126194591|NCT00963820|453995565|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
126194592|NCT00963820|453995566|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
126194593|NCT00963820|453995567|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
126194594|NCT00963820|453995556|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194595|NCT00963820|453995557|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194596|NCT00963820|453995558|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194597|NCT00963820|453995559|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194598|NCT00963820|453995560|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194599|NCT00963820|453995561|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194600|NCT00963820|453995562|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
126194601|NCT00963820|453995563|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194602|NCT00963820|453995564|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194603|NCT00963820|453995565|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194604|NCT00963820|453995566|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194605|NCT00963820|453995567|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126194606|NCT00963820|453995556|FG000|Expansion Phase|Progressive Disease|0|||
126194607|NCT00963820|453995557|FG001|Expansion Phase|Progressive Disease|0|||
126194608|NCT00963820|453995558|FG002|Expansion Phase|Progressive Disease|0|||
126194609|NCT00963820|453995559|FG003|Expansion Phase|Progressive Disease|0|||
126194610|NCT00963820|453995560|FG004|Expansion Phase|Progressive Disease|0|||
126194611|NCT00963820|453995561|FG005|Expansion Phase|Progressive Disease|0|||
126194612|NCT00963820|453995562|FG006|Expansion Phase|Progressive Disease|0|||
126194613|NCT00963820|453995563|FG007|Expansion Phase|Progressive Disease|0|||
126194614|NCT00963820|453995564|FG008|Expansion Phase|Progressive Disease|8|||
126194615|NCT00963820|453995565|FG009|Expansion Phase|Progressive Disease|6|||
126194616|NCT00963820|453995566|FG010|Expansion Phase|Progressive Disease|4|||
126194617|NCT00963820|453995567|FG011|Expansion Phase|Progressive Disease|2|||
126194618|NCT00963820|453995556|FG000|Expansion Phase|Adverse Event|0|||
126194619|NCT00963820|453995557|FG001|Expansion Phase|Adverse Event|0|||
126194620|NCT00963820|453995558|FG002|Expansion Phase|Adverse Event|0|||
126194621|NCT00963820|453995559|FG003|Expansion Phase|Adverse Event|0|||
126194622|NCT00963820|453995560|FG004|Expansion Phase|Adverse Event|0|||
126194623|NCT00963820|453995561|FG005|Expansion Phase|Adverse Event|0|||
126194624|NCT00963820|453995562|FG006|Expansion Phase|Adverse Event|0|||
126194625|NCT00963820|453995563|FG007|Expansion Phase|Adverse Event|0|||
126194626|NCT00963820|453995564|FG008|Expansion Phase|Adverse Event|1|||
126194627|NCT00963820|453995565|FG009|Expansion Phase|Adverse Event|3|||
126194628|NCT00963820|453995566|FG010|Expansion Phase|Adverse Event|0|||
126194629|NCT00963820|453995567|FG011|Expansion Phase|Adverse Event|0|||
126194630|NCT00963820|453995556|FG000|Expansion Phase|Withdrawal by Subject|0|||
126194631|NCT00963820|453995557|FG001|Expansion Phase|Withdrawal by Subject|0|||
126194632|NCT00963820|453995558|FG002|Expansion Phase|Withdrawal by Subject|0|||
126194633|NCT00963820|453995559|FG003|Expansion Phase|Withdrawal by Subject|0|||
126194634|NCT00963820|453995560|FG004|Expansion Phase|Withdrawal by Subject|0|||
126194635|NCT00963820|453995561|FG005|Expansion Phase|Withdrawal by Subject|0|||
126194636|NCT00963820|453995562|FG006|Expansion Phase|Withdrawal by Subject|0|||
126194637|NCT00963820|453995563|FG007|Expansion Phase|Withdrawal by Subject|0|||
126194638|NCT00963820|453995564|FG008|Expansion Phase|Withdrawal by Subject|1|||
126194639|NCT00963820|453995565|FG009|Expansion Phase|Withdrawal by Subject|0|||
126194640|NCT00963820|453995566|FG010|Expansion Phase|Withdrawal by Subject|1|||
126194641|NCT00963820|453995567|FG011|Expansion Phase|Withdrawal by Subject|1|||
126194642|NCT00963820|453995556|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194643|NCT00963820|453995557|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194644|NCT00963820|453995558|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194645|NCT00963820|453995559|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194646|NCT00963820|453995560|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194647|NCT00963820|453995561|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194648|NCT00963820|453995562|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194649|NCT00963820|453995563|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194650|NCT00963820|453995564|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194651|NCT00963820|453995565|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194652|NCT00963820|453995566|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126194653|NCT00963820|453995567|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
126194654|NCT04556175|453995575|FG000|Overall Study|Study terminated due to COVID-19|8|||
126194655|NCT04556175|453995576|FG001|Overall Study|Study terminated due to COVID-19|8|||
126194656|NCT05549505|453995578|FG000|Overall Study|Lost to Follow-up|2|||
126194657|NCT05549505|453995579|FG001|Overall Study|Lost to Follow-up|0|||
126194658|NCT05549505|453995578|FG000|Overall Study|Withdrawal by Subject|3|||
126194659|NCT05549505|453995579|FG001|Overall Study|Withdrawal by Subject|3|||
126194660|NCT05549505|453995578|FG000|Overall Study|Other: Miscellaneous|3|||
126194661|NCT05549505|453995579|FG001|Overall Study|Other: Miscellaneous|6|||
126194662|NCT01602822|453995582|FG000|Overall Study|Adverse Event|11|||
126194663|NCT02871791|453995584|FG000|Phase 1b|Death|0|||
126194664|NCT02871791|453995585|FG001|Phase 1b|Death|1|||
126194665|NCT02871791|453995584|FG000|Phase 1b|progressive disease|6|||
126194666|NCT02871791|453995585|FG001|Phase 1b|progressive disease|2|||
126194667|NCT02871791|453995584|FG000|Phase 2|Death|1|||
126194668|NCT02871791|453995585|FG001|Phase 2|Death|0|||
126194669|NCT02871791|453995584|FG000|Phase 2|Lost to Follow-up|2|||
126194670|NCT02871791|453995585|FG001|Phase 2|Lost to Follow-up|0|||
126194671|NCT04005755|453995586|FG000|Overall Study|Adverse Event|6|||
126194672|NCT04005755|453995586|FG000|Overall Study|Physician Decision|3|||
126194673|NCT04005755|453995586|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
126194674|NCT04005755|453995586|FG000|Overall Study|Withdrawal by Subject|3|||
126194675|NCT04005755|453995586|FG000|Overall Study|Lost to Follow-up|1|||
126194676|NCT02723019|453995587|FG000|Overall Study|Death|17|||
126194677|NCT02723019|453995588|FG001|Overall Study|Death|13|||
126194678|NCT02723019|453995587|FG000|Overall Study|Withdrawal by Subject|11|||
126194679|NCT02723019|453995588|FG001|Overall Study|Withdrawal by Subject|7|||
126194680|NCT02723019|453995587|FG000|Overall Study|Lost to Follow-up|57|||
126194681|NCT02723019|453995588|FG001|Overall Study|Lost to Follow-up|70|||
126194682|NCT00515099|453995592|FG000|Overall Study|Lost to Follow-up|0|||
126194683|NCT00515099|453995593|FG001|Overall Study|Lost to Follow-up|4|||
126194684|NCT00515099|453995592|FG000|Overall Study|Withdrawal by Subject|2|||
126194685|NCT00515099|453995593|FG001|Overall Study|Withdrawal by Subject|0|||
126194686|NCT00515099|453995592|FG000|Overall Study|IRB Recommendation|1|||
126194687|NCT00515099|453995593|FG001|Overall Study|IRB Recommendation|0|||
126194688|NCT05333289|453995594|FG000|Overall Study|Other|1|||
126194689|NCT05333289|453995595|FG001|Overall Study|Other|0|||
126194690|NCT05333289|453995596|FG002|Overall Study|Other|0|||
126194691|NCT05333289|453995597|FG003|Overall Study|Other|1|||
126194692|NCT05333289|453995598|FG004|Overall Study|Other|1|||
126194693|NCT05333289|453995599|FG005|Overall Study|Other|2|||
126194694|NCT05333289|453995600|FG006|Overall Study|Other|2|||
126194695|NCT05333289|453995601|FG007|Overall Study|Other|0|||
126194696|NCT05333289|453995594|FG000|Overall Study|Withdrawal by Subject|1|||
126194697|NCT05333289|453995595|FG001|Overall Study|Withdrawal by Subject|2|||
126194698|NCT05333289|453995596|FG002|Overall Study|Withdrawal by Subject|2|||
126194699|NCT05333289|453995597|FG003|Overall Study|Withdrawal by Subject|1|||
126194700|NCT05333289|453995598|FG004|Overall Study|Withdrawal by Subject|1|||
126194701|NCT05333289|453995599|FG005|Overall Study|Withdrawal by Subject|2|||
126194702|NCT05333289|453995600|FG006|Overall Study|Withdrawal by Subject|1|||
126194703|NCT05333289|453995601|FG007|Overall Study|Withdrawal by Subject|3|||
126194704|NCT05333289|453995594|FG000|Overall Study|Protocol Violation|1|||
126194705|NCT05333289|453995595|FG001|Overall Study|Protocol Violation|0|||
126194706|NCT05333289|453995596|FG002|Overall Study|Protocol Violation|0|||
126194707|NCT05333289|453995597|FG003|Overall Study|Protocol Violation|0|||
126194708|NCT05333289|453995598|FG004|Overall Study|Protocol Violation|0|||
126194709|NCT05333289|453995599|FG005|Overall Study|Protocol Violation|0|||
126194710|NCT05333289|453995600|FG006|Overall Study|Protocol Violation|0|||
126194711|NCT05333289|453995601|FG007|Overall Study|Protocol Violation|0|||
126194712|NCT05333289|453995594|FG000|Overall Study|Physician Decision|0|||
126194713|NCT05333289|453995595|FG001|Overall Study|Physician Decision|0|||
126194714|NCT05333289|453995596|FG002|Overall Study|Physician Decision|1|||
126194715|NCT05333289|453995597|FG003|Overall Study|Physician Decision|0|||
126194716|NCT05333289|453995598|FG004|Overall Study|Physician Decision|0|||
126194717|NCT05333289|453995599|FG005|Overall Study|Physician Decision|2|||
126194718|NCT05333289|453995600|FG006|Overall Study|Physician Decision|0|||
126194719|NCT05333289|453995601|FG007|Overall Study|Physician Decision|0|||
126194720|NCT05333289|453995594|FG000|Overall Study|Lost to Follow-up|6|||
126194721|NCT05333289|453995595|FG001|Overall Study|Lost to Follow-up|0|||
126194722|NCT05333289|453995596|FG002|Overall Study|Lost to Follow-up|1|||
126194723|NCT05333289|453995597|FG003|Overall Study|Lost to Follow-up|6|||
126194724|NCT05333289|453995598|FG004|Overall Study|Lost to Follow-up|3|||
126194725|NCT05333289|453995599|FG005|Overall Study|Lost to Follow-up|3|||
126194726|NCT05333289|453995600|FG006|Overall Study|Lost to Follow-up|2|||
126194727|NCT05333289|453995601|FG007|Overall Study|Lost to Follow-up|1|||
126194728|NCT05333289|453995594|FG000|Overall Study|Death|1|||
126194729|NCT05333289|453995595|FG001|Overall Study|Death|0|||
126194730|NCT05333289|453995596|FG002|Overall Study|Death|0|||
126194731|NCT05333289|453995597|FG003|Overall Study|Death|0|||
126194732|NCT05333289|453995598|FG004|Overall Study|Death|0|||
126194733|NCT05333289|453995599|FG005|Overall Study|Death|0|||
126194734|NCT05333289|453995600|FG006|Overall Study|Death|0|||
126194735|NCT05333289|453995601|FG007|Overall Study|Death|0|||
126194736|NCT03685643|453995602|FG000|Overall Study|Lost to Follow-up|14|||
126194737|NCT03685643|453995603|FG001|Overall Study|Lost to Follow-up|22|||
126199945|NCT01117428|454017806|FG002|Overall Study|Death|2|||
126194738|NCT04430036|453995604|FG000|Safety Run in Phase|Progression of disease|2|||
126194739|NCT01842334|453995605|FG000|Overall Study|Withdrawal by Subject|3|||
126194740|NCT01842334|453995606|FG001|Overall Study|Withdrawal by Subject|3|||
126194741|NCT01842334|453995605|FG000|Overall Study|Moved away mid-study|0|||
126194742|NCT01842334|453995606|FG001|Overall Study|Moved away mid-study|1|||
126194743|NCT01885104|453995616|FG000|Overall Study|Withdrawal of Consent|1|||
126194744|NCT01885104|453995617|FG001|Overall Study|Withdrawal of Consent|0|||
126194745|NCT01885104|453995616|FG000|Overall Study|Lost to Follow-up|0|||
126194746|NCT01885104|453995617|FG001|Overall Study|Lost to Follow-up|1|||
126194747|NCT01885104|453995616|FG000|Overall Study|Physician Decision|1|||
126194748|NCT01885104|453995617|FG001|Overall Study|Physician Decision|0|||
126194749|NCT00113555|453995619|FG000|Overall Study|Baseline Failure|59|||
126194750|NCT00113555|453995619|FG000|Overall Study|Permanently Explanted|7|||
126194751|NCT00113555|453995619|FG000|Overall Study|Death|1|||
126194752|NCT00113555|453995619|FG000|Overall Study|Missed Followup|4|||
126194753|NCT00113555|453995619|FG000|Overall Study|Lost to Follow-up|8|||
126194754|NCT01060124|453995622|FG000|Overall Study|Other|16|||
126194755|NCT01060124|453995622|FG000|Overall Study|Adverse Event|14|||
126194756|NCT01060124|453995622|FG000|Overall Study|Withdrawal by Subject|7|||
126194757|NCT03858686|453995625|FG000|Period 1|Adverse Event|1|||
126194758|NCT03858686|453995626|FG001|Period 1|Adverse Event|1|||
126194759|NCT03858686|453995625|FG000|Period 1|Lack of compliance|0|||
126194760|NCT03858686|453995626|FG001|Period 1|Lack of compliance|1|||
126194761|NCT03858686|453995625|FG000|Period 1|Adverse Event|0|||
126194762|NCT03858686|453995626|FG001|Period 1|Adverse Event|1|||
126194763|NCT03858686|453995625|FG000|Period 2|Adverse Event|0|||
126194764|NCT03858686|453995626|FG001|Period 2|Adverse Event|1|||
126194765|NCT01432938|453995627|FG000|First Intervention|Protocol Violation|1|||
126194766|NCT01432938|453995628|FG001|First Intervention|Protocol Violation|0|||
126194767|NCT01432938|453995627|FG000|First Intervention|Physician Decision|1|||
126194768|NCT01432938|453995628|FG001|First Intervention|Physician Decision|0|||
126194769|NCT01432938|453995627|FG000|Second Intervention|Adverse Event|1|||
126194770|NCT01432938|453995628|FG001|Second Intervention|Adverse Event|0|||
126194771|NCT03231228|453995629|FG000|Overall Study|Lost to Follow-up|2|||
126194772|NCT03231228|453995630|FG001|Overall Study|Lost to Follow-up|0|||
126194773|NCT03231228|453995629|FG000|Overall Study|Physician Decision|1|||
126194774|NCT03231228|453995630|FG001|Overall Study|Physician Decision|0|||
126194775|NCT04191096|453995632|FG000|Overall Study|Death|102|||
126194776|NCT04191096|453995633|FG001|Overall Study|Death|89|||
126194777|NCT04191096|453995632|FG000|Overall Study|Lost to Follow-up|1|||
126194778|NCT04191096|453995633|FG001|Overall Study|Lost to Follow-up|1|||
126194779|NCT04191096|453995632|FG000|Overall Study|Withdrawal by Subject|5|||
126194780|NCT04191096|453995633|FG001|Overall Study|Withdrawal by Subject|5|||
126194781|NCT04191096|453995632|FG000|Overall Study|Participants Ongoing|518|||
126194782|NCT04191096|453995633|FG001|Overall Study|Participants Ongoing|530|||
126194783|NCT02683668|453995635|FG000|Period 2|Withdrawal by Subject|0|||
126194784|NCT02683668|453995636|FG001|Period 2|Withdrawal by Subject|1|||
126194785|NCT02683668|453995637|FG002|Period 2|Withdrawal by Subject|0|||
126194786|NCT04418427|453997159|FG000|Overall Study|Death|0|||
126194787|NCT04418427|453997160|FG001|Overall Study|Death|1|||
126194788|NCT04418427|453997161|FG002|Overall Study|Death|0|||
126194789|NCT04418427|453997159|FG000|Overall Study|Lost to Follow-up|0|||
126194790|NCT04418427|453997160|FG001|Overall Study|Lost to Follow-up|2|||
126194791|NCT04418427|453997161|FG002|Overall Study|Lost to Follow-up|2|||
126194792|NCT04418427|453997159|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
126194793|NCT04418427|453997160|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
126194794|NCT04418427|453997161|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
126194795|NCT04418427|453997159|FG000|Overall Study|Pre-existing medical condition|0|||
126194796|NCT04418427|453997160|FG001|Overall Study|Pre-existing medical condition|1|||
126194797|NCT04418427|453997161|FG002|Overall Study|Pre-existing medical condition|0|||
126194798|NCT02554721|453997166|FG000|Overall Study|Adverse Event|1|||
126194799|NCT02554721|453997167|FG001|Overall Study|Adverse Event|0|||
126194800|NCT02554721|453997168|FG002|Overall Study|Adverse Event|0|||
126194801|NCT02554721|453997169|FG003|Overall Study|Adverse Event|0|||
126194802|NCT02554721|453997170|FG004|Overall Study|Adverse Event|1|||
126194803|NCT02554721|453997166|FG000|Overall Study|Noncompliance|0|||
126194804|NCT02554721|453997167|FG001|Overall Study|Noncompliance|0|||
126194805|NCT02554721|453997168|FG002|Overall Study|Noncompliance|0|||
126194806|NCT02554721|453997169|FG003|Overall Study|Noncompliance|0|||
126194807|NCT02554721|453997170|FG004|Overall Study|Noncompliance|1|||
126194808|NCT01888965|453997172|FG000|Overall Study|Adverse Event|5|||
126194809|NCT01888965|453997172|FG000|Overall Study|Lack of Efficacy|4|||
126194810|NCT00908895|453997173|FG000|Overall Study|Lost to Follow-up|1|||
126194811|NCT00908895|453997174|FG001|Overall Study|Lost to Follow-up|3|||
126194812|NCT00908895|453997173|FG000|Overall Study|algodystrophy|2|||
126194813|NCT00908895|453997174|FG001|Overall Study|algodystrophy|2|||
126194814|NCT00908895|453997173|FG000|Overall Study|Adverse Event|1|||
126194815|NCT00908895|453997174|FG001|Overall Study|Adverse Event|1|||
126194816|NCT03661983|453997176|FG000|Open Label Stabilization Phase|Adverse Event|5|||
126194817|NCT03661983|453997177|FG001|Open Label Stabilization Phase|Adverse Event|0|||
126194818|NCT03661983|453997178|FG002|Open Label Stabilization Phase|Adverse Event|0|||
126194819|NCT03661983|453997179|FG003|Open Label Stabilization Phase|Adverse Event|0|||
126194820|NCT03661983|453997176|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
126194821|NCT03661983|453997177|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
126194822|NCT03661983|453997178|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
126194823|NCT03661983|453997179|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
126194824|NCT03661983|453997176|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
126194825|NCT03661983|453997177|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
126194826|NCT03661983|453997178|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
126194827|NCT03661983|453997179|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
126194828|NCT03661983|453997176|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
126194829|NCT03661983|453997177|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
126194830|NCT03661983|453997178|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
126194831|NCT03661983|453997179|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
126194832|NCT03661983|453997176|FG000|Double-blind Randomized Phase|Adverse Event|0|||
126194833|NCT03661983|453997177|FG001|Double-blind Randomized Phase|Adverse Event|1|||
126194834|NCT03661983|453997178|FG002|Double-blind Randomized Phase|Adverse Event|0|||
126194835|NCT03661983|453997179|FG003|Double-blind Randomized Phase|Adverse Event|0|||
126194836|NCT03661983|453997176|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
126194837|NCT03661983|453997177|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
126194838|NCT03661983|453997178|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
126194839|NCT03661983|453997179|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
126194840|NCT03661983|453997176|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
126194841|NCT03661983|453997177|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
126194842|NCT03661983|453997178|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
126194843|NCT03661983|453997179|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
126194844|NCT03661983|453997176|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
126194845|NCT03661983|453997177|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
126194846|NCT03661983|453997178|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
126194847|NCT03661983|453997179|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
126194848|NCT04124952|453997180|FG000|Overall Study|Lost to Follow-up|1|||
126194849|NCT01654224|453997184|FG000|Overall Study|Lost to Follow-up|2|||
126194850|NCT01654224|453997185|FG001|Overall Study|Lost to Follow-up|2|||
126194851|NCT01654224|453997184|FG000|Overall Study|Did not receive allocation|1|||
126194852|NCT01654224|453997185|FG001|Overall Study|Did not receive allocation|8|||
126194853|NCT01654224|453997184|FG000|Overall Study|Insufficient blood sample|3|||
126194854|NCT01654224|453997185|FG001|Overall Study|Insufficient blood sample|2|||
126194855|NCT00166504|453997186|FG000|Overall Study|Adverse Event|3|||
126194856|NCT00166504|453997187|FG001|Overall Study|Adverse Event|3|||
126194857|NCT00166504|453997186|FG000|Overall Study|Lost to Follow-up|1|||
126194858|NCT00166504|453997187|FG001|Overall Study|Lost to Follow-up|1|||
126194859|NCT00166504|453997186|FG000|Overall Study|Withdrawal by Subject|1|||
126194860|NCT00166504|453997187|FG001|Overall Study|Withdrawal by Subject|0|||
126194861|NCT02094612|453997188|FG000|Overall Study|Lost to Follow-up|47|||
126194862|NCT02094612|453997189|FG001|Overall Study|Lost to Follow-up|47|||
126194863|NCT02094612|453997188|FG000|Overall Study|Never started ADHD medication|32|||
126194864|NCT02094612|453997189|FG001|Overall Study|Never started ADHD medication|23|||
126194865|NCT03345849|453997190|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
126194866|NCT03345849|453997191|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
126194867|NCT03345849|453997192|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
126194868|NCT03345849|453997193|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
126194869|NCT03345849|453997190|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
126194870|NCT03345849|453997191|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
126194871|NCT03345849|453997192|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
126194872|NCT03345849|453997193|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
126194873|NCT03345849|453997190|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
126194874|NCT03345849|453997191|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
126194875|NCT03345849|453997192|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
126194876|NCT03345849|453997193|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
126194877|NCT03345849|453997190|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
126194878|NCT03345849|453997191|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
126194879|NCT03345849|453997192|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
126194880|NCT03345849|453997193|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
126194881|NCT03345849|453997190|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
126194882|NCT03345849|453997191|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
126194883|NCT03345849|453997192|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
126194884|NCT03345849|453997193|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
126194885|NCT03345849|453997190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
126194886|NCT03345849|453997191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
126194887|NCT03345849|453997192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
126194888|NCT03345849|453997193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
126194889|NCT03345849|453997190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
126194890|NCT03345849|453997191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
126194891|NCT03345849|453997192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
126194892|NCT03345849|453997193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
126194893|NCT03345849|453997190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
126194894|NCT03345849|453997191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
126194895|NCT03345849|453997192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
126194896|NCT03345849|453997193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
126194897|NCT03345849|453997190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126194898|NCT03345849|453997191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126194899|NCT03345849|453997192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126194900|NCT03345849|453997193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
126194901|NCT03345849|453997190|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
126194902|NCT03345849|453997191|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
126194903|NCT03345849|453997192|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
126194904|NCT03345849|453997193|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
126194905|NCT03345849|453997190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
126194906|NCT03345849|453997191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
126194907|NCT03345849|453997192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
126194908|NCT03345849|453997193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
126194909|NCT03261037|453997194|FG000|Overall Study|Withdrawal by Subject|2|||
126194910|NCT03261037|453997195|FG001|Overall Study|Withdrawal by Subject|13|||
126194911|NCT03261037|453997196|FG002|Overall Study|Withdrawal by Subject|0|||
126194912|NCT03261037|453997197|FG003|Overall Study|Withdrawal by Subject|18|||
126194913|NCT03261037|453997194|FG000|Overall Study|Non-compliance with study procedures|0|||
126194914|NCT03261037|453997195|FG001|Overall Study|Non-compliance with study procedures|2|||
126194915|NCT03261037|453997196|FG002|Overall Study|Non-compliance with study procedures|0|||
126194916|NCT03261037|453997197|FG003|Overall Study|Non-compliance with study procedures|6|||
126194917|NCT03261037|453997194|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
126194918|NCT03261037|453997195|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
126194919|NCT03261037|453997196|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
126194920|NCT03261037|453997197|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
126194921|NCT03261037|453997194|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
126194922|NCT03261037|453997195|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
126194923|NCT03261037|453997196|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
126194924|NCT03261037|453997197|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
126194925|NCT03261037|453997194|FG000|Overall Study|Diagnosed but protocol deviation|1|||
126194926|NCT03261037|453997195|FG001|Overall Study|Diagnosed but protocol deviation|0|||
126194927|NCT03261037|453997196|FG002|Overall Study|Diagnosed but protocol deviation|0|||
126194928|NCT03261037|453997197|FG003|Overall Study|Diagnosed but protocol deviation|0|||
126194929|NCT03261037|453997194|FG000|Overall Study|Participant did not want to continue the study|0|||
126194930|NCT03261037|453997195|FG001|Overall Study|Participant did not want to continue the study|1|||
126194931|NCT03261037|453997196|FG002|Overall Study|Participant did not want to continue the study|0|||
126194932|NCT03261037|453997197|FG003|Overall Study|Participant did not want to continue the study|0|||
126194933|NCT03261037|453997194|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
126194934|NCT03261037|453997195|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
126194935|NCT03261037|453997196|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
126194936|NCT03261037|453997197|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
126194937|NCT03261037|453997194|FG000|Overall Study|Participant presented clinical improvement|0|||
126194938|NCT03261037|453997195|FG001|Overall Study|Participant presented clinical improvement|2|||
126194939|NCT03261037|453997196|FG002|Overall Study|Participant presented clinical improvement|0|||
126194940|NCT03261037|453997197|FG003|Overall Study|Participant presented clinical improvement|0|||
126194941|NCT03261037|453997194|FG000|Overall Study|Technical difficulties|0|||
126194942|NCT03261037|453997195|FG001|Overall Study|Technical difficulties|0|||
126194943|NCT03261037|453997196|FG002|Overall Study|Technical difficulties|0|||
126194944|NCT03261037|453997197|FG003|Overall Study|Technical difficulties|1|||
126194945|NCT03261037|453997194|FG000|Overall Study|Equipment failed to work|0|||
126194946|NCT03261037|453997195|FG001|Overall Study|Equipment failed to work|0|||
126194947|NCT03261037|453997196|FG002|Overall Study|Equipment failed to work|0|||
126194948|NCT03261037|453997197|FG003|Overall Study|Equipment failed to work|1|||
126199946|NCT01117428|454017807|FG003|Overall Study|Death|0|||
126194949|NCT03261037|453997194|FG000|Overall Study|End of study for participant and no follow up|0|||
126194950|NCT03261037|453997195|FG001|Overall Study|End of study for participant and no follow up|0|||
126194951|NCT03261037|453997196|FG002|Overall Study|End of study for participant and no follow up|0|||
126194952|NCT03261037|453997197|FG003|Overall Study|End of study for participant and no follow up|1|||
126194953|NCT03261037|453997194|FG000|Overall Study|Participant was too weak to continue in study|1|||
126194954|NCT03261037|453997195|FG001|Overall Study|Participant was too weak to continue in study|0|||
126194955|NCT03261037|453997196|FG002|Overall Study|Participant was too weak to continue in study|0|||
126194956|NCT03261037|453997197|FG003|Overall Study|Participant was too weak to continue in study|0|||
126194957|NCT02943577|453997198|FG000|Overall Study|Protocol Violation|0|||
126194958|NCT02943577|453997199|FG001|Overall Study|Protocol Violation|1|||
126194959|NCT02943577|453997198|FG000|Overall Study|Adverse Event|3|||
126194960|NCT02943577|453997199|FG001|Overall Study|Adverse Event|2|||
126194961|NCT02943577|453997198|FG000|Overall Study|Lost to Follow-up|0|||
126194962|NCT02943577|453997199|FG001|Overall Study|Lost to Follow-up|1|||
126194963|NCT02943577|453997198|FG000|Overall Study|Withdrawal by Subject|1|||
126194964|NCT02943577|453997199|FG001|Overall Study|Withdrawal by Subject|1|||
126194965|NCT02943577|453997198|FG000|Overall Study|Pregnancy|1|||
126194966|NCT02943577|453997199|FG001|Overall Study|Pregnancy|0|||
126194967|NCT04654468|453997206|FG000|Overall Study|Death|1|||
126194968|NCT04654468|453997206|FG000|Overall Study|Ongoing in the Study|50|||
126194969|NCT03093350|453997211|FG000|Overall Study|Death|1|||
126194970|NCT03093350|453997211|FG000|Overall Study|Signed consent, never began treartment|1|||
126194971|NCT04564027|453997216|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
126194972|NCT04564027|453997217|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
126194973|NCT04564027|453997218|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
126194974|NCT04564027|453997219|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
126194975|NCT00777036|453997220|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
126194976|NCT00777036|453997221|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
126194977|NCT00777036|453997222|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
126194978|NCT00777036|453997223|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
126194979|NCT00777036|453997220|FG000|On Treatment|Administrative Reason By Sponsor|1|||
126194980|NCT00777036|453997221|FG001|On Treatment|Administrative Reason By Sponsor|0|||
126194981|NCT00777036|453997222|FG002|On Treatment|Administrative Reason By Sponsor|9|||
126194982|NCT00777036|453997223|FG003|On Treatment|Administrative Reason By Sponsor|0|||
126194983|NCT00777036|453997220|FG000|On Treatment|Failure to Meet Study Criteria|0|||
126194984|NCT00777036|453997221|FG001|On Treatment|Failure to Meet Study Criteria|1|||
126194985|NCT00777036|453997222|FG002|On Treatment|Failure to Meet Study Criteria|4|||
126194986|NCT00777036|453997223|FG003|On Treatment|Failure to Meet Study Criteria|0|||
126194987|NCT00777036|453997220|FG000|On Treatment|Pregnancy|1|||
126194988|NCT00777036|453997221|FG001|On Treatment|Pregnancy|0|||
126194989|NCT00777036|453997222|FG002|On Treatment|Pregnancy|1|||
126194990|NCT00777036|453997223|FG003|On Treatment|Pregnancy|0|||
126194991|NCT00777036|453997220|FG000|On Treatment|Non-compliance with Study Drug|1|||
126194992|NCT00777036|453997221|FG001|On Treatment|Non-compliance with Study Drug|0|||
126194993|NCT00777036|453997222|FG002|On Treatment|Non-compliance with Study Drug|1|||
126194994|NCT00777036|453997223|FG003|On Treatment|Non-compliance with Study Drug|0|||
126194995|NCT00777036|453997220|FG000|On Treatment|Maximum Clinical Benefit|2|||
126194996|NCT00777036|453997221|FG001|On Treatment|Maximum Clinical Benefit|0|||
126194997|NCT00777036|453997222|FG002|On Treatment|Maximum Clinical Benefit|5|||
126194998|NCT00777036|453997223|FG003|On Treatment|Maximum Clinical Benefit|0|||
126194999|NCT00777036|453997220|FG000|On Treatment|Withdrawal by Subject|0|||
126195000|NCT00777036|453997221|FG001|On Treatment|Withdrawal by Subject|2|||
126195001|NCT00777036|453997222|FG002|On Treatment|Withdrawal by Subject|2|||
126195002|NCT00777036|453997223|FG003|On Treatment|Withdrawal by Subject|0|||
126195003|NCT00777036|453997220|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
126195004|NCT00777036|453997221|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
126195005|NCT00777036|453997222|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
126195006|NCT00777036|453997223|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
126195007|NCT00777036|453997220|FG000|On Treatment|Death|0|||
126195008|NCT00777036|453997221|FG001|On Treatment|Death|2|||
126195009|NCT00777036|453997222|FG002|On Treatment|Death|0|||
126195010|NCT00777036|453997223|FG003|On Treatment|Death|0|||
126195011|NCT00777036|453997220|FG000|On Treatment|Study Drug Toxicity|1|||
126195012|NCT00777036|453997221|FG001|On Treatment|Study Drug Toxicity|0|||
126195013|NCT00777036|453997222|FG002|On Treatment|Study Drug Toxicity|4|||
126195014|NCT00777036|453997223|FG003|On Treatment|Study Drug Toxicity|0|||
126195015|NCT00777036|453997220|FG000|On Treatment|Progressive Disease|6|||
126195016|NCT00777036|453997221|FG001|On Treatment|Progressive Disease|4|||
126195017|NCT00777036|453997222|FG002|On Treatment|Progressive Disease|7|||
126195018|NCT00777036|453997223|FG003|On Treatment|Progressive Disease|0|||
126195019|NCT00777036|453997220|FG000|On Treatment|Not Reported|0|||
126195020|NCT00777036|453997221|FG001|On Treatment|Not Reported|0|||
126195021|NCT00777036|453997222|FG002|On Treatment|Not Reported|2|||
126195022|NCT00777036|453997223|FG003|On Treatment|Not Reported|0|||
126195023|NCT00777036|453997220|FG000|On Treatment|Site Closed|0|||
126195024|NCT00777036|453997221|FG001|On Treatment|Site Closed|1|||
126195025|NCT00777036|453997222|FG002|On Treatment|Site Closed|1|||
126195026|NCT00777036|453997223|FG003|On Treatment|Site Closed|0|||
126195027|NCT00777036|453997220|FG000|Follow-Up|Withdrawal by Subject|0|||
126195028|NCT00777036|453997221|FG001|Follow-Up|Withdrawal by Subject|0|||
126195029|NCT00777036|453997222|FG002|Follow-Up|Withdrawal by Subject|5|||
126195030|NCT00777036|453997223|FG003|Follow-Up|Withdrawal by Subject|0|||
126195031|NCT00777036|453997220|FG000|Follow-Up|Death|1|||
126195032|NCT00777036|453997221|FG001|Follow-Up|Death|9|||
126195033|NCT00777036|453997222|FG002|Follow-Up|Death|0|||
126195034|NCT00777036|453997223|FG003|Follow-Up|Death|0|||
126195035|NCT00777036|453997220|FG000|Follow-Up|Lost to Follow-up|3|||
126195036|NCT00777036|453997221|FG001|Follow-Up|Lost to Follow-up|0|||
126195037|NCT00777036|453997222|FG002|Follow-Up|Lost to Follow-up|0|||
126195038|NCT00777036|453997223|FG003|Follow-Up|Lost to Follow-up|0|||
126195039|NCT00777036|453997220|FG000|Follow-Up|Reason Not Specified|4|||
126195040|NCT00777036|453997221|FG001|Follow-Up|Reason Not Specified|0|||
126195041|NCT00777036|453997222|FG002|Follow-Up|Reason Not Specified|13|||
126195042|NCT00777036|453997223|FG003|Follow-Up|Reason Not Specified|0|||
126195043|NCT00777036|453997220|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
126195044|NCT00777036|453997221|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
126195045|NCT00777036|453997222|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
126195046|NCT00777036|453997223|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
126195047|NCT01267955|453997224|FG000|Stage 1 (6 Months)|Death|3|||
126195048|NCT01267955|453997224|FG000|Stage 2 (6 Months)|Death|5|||
126195049|NCT01267955|453997224|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
126195050|NCT04517253|453997225|FG000|Primary Treatment Period|Adverse Event|1|||
126195051|NCT04517253|453997226|FG001|Primary Treatment Period|Adverse Event|0|||
126195052|NCT04517253|453997227|FG002|Primary Treatment Period|Adverse Event|0|||
126195053|NCT04517253|453997225|FG000|Primary Treatment Period|Death|0|||
126195054|NCT04517253|453997226|FG001|Primary Treatment Period|Death|1|||
126195055|NCT04517253|453997227|FG002|Primary Treatment Period|Death|0|||
126195056|NCT04517253|453997225|FG000|Maintenance Period|Withdrawal by Subject|1|||
126195057|NCT04517253|453997226|FG001|Maintenance Period|Withdrawal by Subject|0|||
126195058|NCT04517253|453997227|FG002|Maintenance Period|Withdrawal by Subject|0|||
126195059|NCT04517253|453997225|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
126195060|NCT04517253|453997226|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
126195061|NCT04517253|453997227|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
126195062|NCT04651777|453997228|FG000|Overall Study|Adverse Event|1|||
126195063|NCT04651777|453997228|FG000|Overall Study|Withdrawal by Subject|2|||
126195064|NCT04566445|453997229|FG000|Overall Study|Death|4|||
126195065|NCT04566445|453997230|FG001|Overall Study|Death|1|||
126195066|NCT04566445|453997231|FG002|Overall Study|Death|1|||
126195067|NCT04566445|453997229|FG000|Overall Study|Lost to Follow-up|3|||
126195068|NCT04566445|453997230|FG001|Overall Study|Lost to Follow-up|1|||
126195069|NCT04566445|453997231|FG002|Overall Study|Lost to Follow-up|1|||
126195070|NCT04566445|453997229|FG000|Overall Study|Study terminated by sponsor|11|||
126195071|NCT04566445|453997230|FG001|Overall Study|Study terminated by sponsor|17|||
126195072|NCT04566445|453997231|FG002|Overall Study|Study terminated by sponsor|32|||
126195073|NCT04566445|453997229|FG000|Overall Study|Withdrawal by Subject|12|||
126195074|NCT04566445|453997230|FG001|Overall Study|Withdrawal by Subject|14|||
126195075|NCT04566445|453997231|FG002|Overall Study|Withdrawal by Subject|13|||
126195076|NCT04566445|453997229|FG000|Overall Study|Randomized but not treated due to AE|2|||
126195077|NCT04566445|453997230|FG001|Overall Study|Randomized but not treated due to AE|1|||
126195078|NCT04566445|453997231|FG002|Overall Study|Randomized but not treated due to AE|0|||
126195079|NCT04566445|453997229|FG000|Overall Study|Adverse Event|1|||
126195080|NCT04566445|453997230|FG001|Overall Study|Adverse Event|1|||
126195081|NCT04566445|453997231|FG002|Overall Study|Adverse Event|0|||
126195082|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
126195083|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
126195084|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
126195085|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
126195086|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Death|38|||
126195087|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Death|10|||
126195088|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
126195089|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
126195090|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
126195091|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
126195092|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
126195093|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
126195094|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
126195095|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
126195096|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
126195097|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
126195098|NCT02421939|453997232|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
126195099|NCT02421939|453997233|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
126195100|NCT02421939|453997232|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
126195101|NCT02421939|453997233|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
126195102|NCT02421939|453997232|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
126195103|NCT02421939|453997233|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
126195104|NCT02421939|453997232|FG000|Long Term Follow up: up to 3 Years|Death|118|||
126195105|NCT02421939|453997233|FG001|Long Term Follow up: up to 3 Years|Death|65|||
126195106|NCT02421939|453997232|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
126195107|NCT02421939|453997233|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
126195108|NCT04785144|453997234|FG000|Overall Study|Withdrawal by Subject|4|||
126195109|NCT04785144|453997235|FG001|Overall Study|Withdrawal by Subject|1|||
126195110|NCT04785144|453997236|FG002|Overall Study|Withdrawal by Subject|0|||
126195111|NCT04785144|453997237|FG003|Overall Study|Withdrawal by Subject|0|||
126195112|NCT04785144|453997238|FG004|Overall Study|Withdrawal by Subject|0|||
126195113|NCT04785144|453997239|FG005|Overall Study|Withdrawal by Subject|2|||
126195114|NCT04785144|453997240|FG006|Overall Study|Withdrawal by Subject|2|||
126195115|NCT04785144|453997241|FG007|Overall Study|Withdrawal by Subject|0|||
126195116|NCT04785144|453997242|FG008|Overall Study|Withdrawal by Subject|1|||
126195117|NCT04785144|453997243|FG009|Overall Study|Withdrawal by Subject|0|||
126195118|NCT04785144|453997234|FG000|Overall Study|Lost to Follow-up|1|||
126195119|NCT04785144|453997235|FG001|Overall Study|Lost to Follow-up|0|||
126195120|NCT04785144|453997236|FG002|Overall Study|Lost to Follow-up|0|||
126195121|NCT04785144|453997237|FG003|Overall Study|Lost to Follow-up|0|||
126195122|NCT04785144|453997238|FG004|Overall Study|Lost to Follow-up|1|||
126195123|NCT04785144|453997239|FG005|Overall Study|Lost to Follow-up|2|||
126195124|NCT04785144|453997240|FG006|Overall Study|Lost to Follow-up|1|||
126195125|NCT04785144|453997241|FG007|Overall Study|Lost to Follow-up|2|||
126195126|NCT04785144|453997242|FG008|Overall Study|Lost to Follow-up|4|||
126195127|NCT04785144|453997243|FG009|Overall Study|Lost to Follow-up|1|||
126195128|NCT04785144|453997234|FG000|Overall Study|Protocol Violation|0|||
126195129|NCT04785144|453997235|FG001|Overall Study|Protocol Violation|0|||
126195130|NCT04785144|453997236|FG002|Overall Study|Protocol Violation|0|||
126195131|NCT04785144|453997237|FG003|Overall Study|Protocol Violation|0|||
126195132|NCT04785144|453997238|FG004|Overall Study|Protocol Violation|0|||
126195133|NCT04785144|453997239|FG005|Overall Study|Protocol Violation|0|||
126195134|NCT04785144|453997240|FG006|Overall Study|Protocol Violation|1|||
126195135|NCT04785144|453997241|FG007|Overall Study|Protocol Violation|0|||
126195136|NCT04785144|453997242|FG008|Overall Study|Protocol Violation|0|||
126195137|NCT04785144|453997243|FG009|Overall Study|Protocol Violation|0|||
126195138|NCT04785144|453997234|FG000|Overall Study|Physician Decision|0|||
126195139|NCT04785144|453997235|FG001|Overall Study|Physician Decision|0|||
126195140|NCT04785144|453997236|FG002|Overall Study|Physician Decision|0|||
126195141|NCT04785144|453997237|FG003|Overall Study|Physician Decision|0|||
126195142|NCT04785144|453997238|FG004|Overall Study|Physician Decision|0|||
126195143|NCT04785144|453997239|FG005|Overall Study|Physician Decision|0|||
126195144|NCT04785144|453997240|FG006|Overall Study|Physician Decision|0|||
126195145|NCT04785144|453997241|FG007|Overall Study|Physician Decision|0|||
126195146|NCT04785144|453997242|FG008|Overall Study|Physician Decision|0|||
126195147|NCT04785144|453997243|FG009|Overall Study|Physician Decision|1|||
126195148|NCT04785144|453997234|FG000|Overall Study|Unable to continue due to work schedule|0|||
126195149|NCT04785144|453997235|FG001|Overall Study|Unable to continue due to work schedule|0|||
126195150|NCT04785144|453997236|FG002|Overall Study|Unable to continue due to work schedule|0|||
126195151|NCT04785144|453997237|FG003|Overall Study|Unable to continue due to work schedule|0|||
126195152|NCT04785144|453997238|FG004|Overall Study|Unable to continue due to work schedule|0|||
126195153|NCT04785144|453997239|FG005|Overall Study|Unable to continue due to work schedule|0|||
126195154|NCT04785144|453997240|FG006|Overall Study|Unable to continue due to work schedule|0|||
126195155|NCT04785144|453997241|FG007|Overall Study|Unable to continue due to work schedule|0|||
126195156|NCT04785144|453997242|FG008|Overall Study|Unable to continue due to work schedule|0|||
126195157|NCT04785144|453997243|FG009|Overall Study|Unable to continue due to work schedule|1|||
126195158|NCT02559115|453997244|FG000|Overall Study|Withdrawal by Subject|3|||
126195159|NCT02060903|453997247|FG000|Overall Study|Lost to Follow-up|4|||
126195160|NCT02060903|453997248|FG001|Overall Study|Lost to Follow-up|0|||
126195161|NCT02060903|453997247|FG000|Overall Study|Withdrawal by Subject|0|||
126195162|NCT02060903|453997248|FG001|Overall Study|Withdrawal by Subject|7|||
126195163|NCT05245071|453997249|FG000|Overall Study|Progressive disease|18|||
126195164|NCT05245071|453997249|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
126195165|NCT05245071|453997249|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
126195166|NCT00592072|453997252|FG000|Wash Out Period|Lost to Follow-up|1|||
126195167|NCT00592072|453997253|FG001|Wash Out Period|Lost to Follow-up|1|||
126195168|NCT00118040|453997259|FG000|Overall Study|Adverse Event|0|||
126195169|NCT00118040|453997260|FG001|Overall Study|Adverse Event|1|||
126195170|NCT00118040|453997261|FG002|Overall Study|Adverse Event|0|||
126195171|NCT00118040|453997259|FG000|Overall Study|Withdrawal by Subject|0|||
126195172|NCT00118040|453997260|FG001|Overall Study|Withdrawal by Subject|0|||
126195173|NCT00118040|453997261|FG002|Overall Study|Withdrawal by Subject|2|||
126195174|NCT00118040|453997259|FG000|Overall Study|Medical Contraindication|0|||
126195175|NCT00118040|453997260|FG001|Overall Study|Medical Contraindication|0|||
126195176|NCT00118040|453997261|FG002|Overall Study|Medical Contraindication|1|||
126195177|NCT00118040|453997259|FG000|Overall Study|Non-Compliant Participant|1|||
126195178|NCT00118040|453997260|FG001|Overall Study|Non-Compliant Participant|1|||
126195179|NCT00118040|453997261|FG002|Overall Study|Non-Compliant Participant|2|||
126195180|NCT00118040|453997259|FG000|Overall Study|Other|0|||
126195181|NCT00118040|453997260|FG001|Overall Study|Other|0|||
126195182|NCT00118040|453997261|FG002|Overall Study|Other|1|||
126195183|NCT02750501|453997262|FG000|Overall Study|Adverse Event|4|||
126195184|NCT02750501|453997262|FG000|Overall Study|Physician Decision|1|||
126195185|NCT02750501|453997262|FG000|Overall Study|Protocol Violation|1|||
126195186|NCT02750501|453997262|FG000|Overall Study|G-tube came out|1|||
126195187|NCT02750501|453997262|FG000|Overall Study|Non-compliant use of PERT|1|||
126195188|NCT01738594|453997263|FG000|Registration and Treatment Start|Adverse Event|0|||
126195189|NCT01738594|453997264|FG001|Registration and Treatment Start|Adverse Event|1|||
126195190|NCT01738594|453997265|FG002|Registration and Treatment Start|Adverse Event|0|||
126195191|NCT01738594|453997266|FG003|Registration and Treatment Start|Adverse Event|0|||
126195192|NCT01738594|453997267|FG004|Registration and Treatment Start|Adverse Event|0|||
126195193|NCT01738594|453997268|FG005|Registration and Treatment Start|Adverse Event|0|||
126195194|NCT01738594|453997269|FG006|Registration and Treatment Start|Adverse Event|0|||
126195195|NCT01738594|453997270|FG007|Registration and Treatment Start|Adverse Event|0|||
126195196|NCT01738594|453997263|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126195197|NCT01738594|453997264|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126195198|NCT01738594|453997265|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126195199|NCT01738594|453997266|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126195200|NCT01738594|453997267|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126195201|NCT01738594|453997268|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
126195202|NCT01738594|453997269|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126195203|NCT01738594|453997270|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126195204|NCT01738594|453997263|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
126195205|NCT01738594|453997264|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
126195206|NCT01738594|453997265|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
126195207|NCT01738594|453997266|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
126195208|NCT01738594|453997267|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
126195209|NCT01738594|453997268|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
126195210|NCT01738594|453997269|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
126195211|NCT01738594|453997270|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
126195212|NCT01738594|453997263|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126195213|NCT01738594|453997264|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126195214|NCT01738594|453997265|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126195215|NCT01738594|453997266|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126195216|NCT01738594|453997267|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126195217|NCT01738594|453997268|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
126195218|NCT01738594|453997269|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126195219|NCT01738594|453997270|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126195220|NCT01738594|453997263|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126195221|NCT01738594|453997264|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126195222|NCT01738594|453997265|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126195223|NCT01738594|453997266|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126195224|NCT01738594|453997267|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126195225|NCT01738594|453997268|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
126195226|NCT01738594|453997269|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126195227|NCT01738594|453997270|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126195228|NCT01738594|453997263|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126195229|NCT01738594|453997264|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126195230|NCT01738594|453997265|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126195231|NCT01738594|453997266|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126195232|NCT01738594|453997267|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
126195233|NCT01738594|453997268|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126195234|NCT01738594|453997269|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126195235|NCT01738594|453997270|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126195236|NCT01738594|453997263|FG000|Follow up for 1 Year|Death|0|||
126195237|NCT01738594|453997264|FG001|Follow up for 1 Year|Death|0|||
126195238|NCT01738594|453997265|FG002|Follow up for 1 Year|Death|0|||
126195239|NCT01738594|453997266|FG003|Follow up for 1 Year|Death|0|||
126195240|NCT01738594|453997267|FG004|Follow up for 1 Year|Death|0|||
126195241|NCT01738594|453997268|FG005|Follow up for 1 Year|Death|1|||
126195242|NCT01738594|453997269|FG006|Follow up for 1 Year|Death|0|||
126195243|NCT01738594|453997270|FG007|Follow up for 1 Year|Death|0|||
126195244|NCT01738594|453997263|FG000|Follow up for 1 Year|Other|0|||
126195245|NCT01738594|453997264|FG001|Follow up for 1 Year|Other|0|||
126195246|NCT01738594|453997265|FG002|Follow up for 1 Year|Other|0|||
126195247|NCT01738594|453997266|FG003|Follow up for 1 Year|Other|0|||
126195248|NCT01738594|453997267|FG004|Follow up for 1 Year|Other|0|||
126195249|NCT01738594|453997268|FG005|Follow up for 1 Year|Other|2|||
126195250|NCT01738594|453997269|FG006|Follow up for 1 Year|Other|0|||
126195251|NCT01738594|453997270|FG007|Follow up for 1 Year|Other|0|||
126195252|NCT00403390|453997271|FG000|Overall Study|Withdrawal by Subject|1|||
126195253|NCT00403390|453997272|FG001|Overall Study|Withdrawal by Subject|0|||
126195254|NCT00403390|453997271|FG000|Overall Study|samples lost|1|||
126195255|NCT00403390|453997272|FG001|Overall Study|samples lost|0|||
126195256|NCT00403390|453997271|FG000|Overall Study|non-compliant|1|||
126195257|NCT00403390|453997272|FG001|Overall Study|non-compliant|0|||
126195258|NCT01347840|453997281|FG000|Overall Study|Withdrawal by Subject|1|||
126195259|NCT05307523|453997282|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
126195260|NCT05307523|453997283|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
126195261|NCT05307523|453997282|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
126195262|NCT05307523|453997283|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
126195263|NCT01708915|453997288|FG000|Overall Study|Adverse Event|1|||
126195264|NCT01708915|453997289|FG001|Overall Study|Adverse Event|0|||
126195265|NCT01708915|453997290|FG002|Overall Study|Adverse Event|9|||
126195266|NCT01708915|453997291|FG003|Overall Study|Adverse Event|13|||
126195267|NCT01708915|453997288|FG000|Overall Study|Lack of Efficacy|84|||
126195268|NCT01708915|453997289|FG001|Overall Study|Lack of Efficacy|60|||
126195269|NCT01708915|453997290|FG002|Overall Study|Lack of Efficacy|35|||
126195270|NCT01708915|453997291|FG003|Overall Study|Lack of Efficacy|15|||
126195271|NCT01708915|453997288|FG000|Overall Study|Protocol Violation|0|||
126195272|NCT01708915|453997289|FG001|Overall Study|Protocol Violation|0|||
126195273|NCT01708915|453997290|FG002|Overall Study|Protocol Violation|0|||
126195274|NCT01708915|453997291|FG003|Overall Study|Protocol Violation|1|||
126195275|NCT01708915|453997288|FG000|Overall Study|Withdrawal by Subject|0|||
126195276|NCT01708915|453997289|FG001|Overall Study|Withdrawal by Subject|1|||
126195277|NCT01708915|453997290|FG002|Overall Study|Withdrawal by Subject|2|||
126195278|NCT01708915|453997291|FG003|Overall Study|Withdrawal by Subject|2|||
126195279|NCT01708915|453997288|FG000|Overall Study|Other reasons than stated above|1|||
126195280|NCT01708915|453997289|FG001|Overall Study|Other reasons than stated above|1|||
126195281|NCT01708915|453997290|FG002|Overall Study|Other reasons than stated above|0|||
126195282|NCT01708915|453997291|FG003|Overall Study|Other reasons than stated above|2|||
126195283|NCT04223778|453997293|FG000|Overall Study|Death|1|||
126195284|NCT04223778|453997294|FG001|Overall Study|Death|1|||
126195285|NCT04223778|453997293|FG000|Overall Study|Lost to Follow-up|4|||
126195286|NCT04223778|453997294|FG001|Overall Study|Lost to Follow-up|5|||
126195287|NCT04223778|453997293|FG000|Overall Study|Physician Decision|10|||
126195288|NCT04223778|453997294|FG001|Overall Study|Physician Decision|6|||
126195289|NCT04223778|453997293|FG000|Overall Study|Withdrawal by Subject|35|||
126195290|NCT04223778|453997294|FG001|Overall Study|Withdrawal by Subject|17|||
126195291|NCT04223778|453997293|FG000|Overall Study|Not Reported|7|||
126195292|NCT04223778|453997294|FG001|Overall Study|Not Reported|8|||
126195293|NCT03893630|453997295|FG000|Overall Study|Lost to Follow-up|5|||
126195294|NCT03893630|453997296|FG001|Overall Study|Lost to Follow-up|4|||
126195295|NCT03893630|453997297|FG002|Overall Study|Lost to Follow-up|2|||
126195296|NCT03893630|453997295|FG000|Overall Study|Withdrawal by Subject|3|||
126195297|NCT03893630|453997296|FG001|Overall Study|Withdrawal by Subject|6|||
126195298|NCT03893630|453997297|FG002|Overall Study|Withdrawal by Subject|3|||
126195299|NCT03893630|453997295|FG000|Overall Study|Discontinued Intervention|0|||
126195300|NCT03893630|453997296|FG001|Overall Study|Discontinued Intervention|4|||
126195301|NCT03893630|453997297|FG002|Overall Study|Discontinued Intervention|2|||
126195302|NCT00887822|453999305|FG000|Overall Study|Insufficient therapeutic response|53|||
126195303|NCT00887822|453999306|FG001|Overall Study|Insufficient therapeutic response|55|||
126195304|NCT00887822|453999305|FG000|Overall Study|Adverse Event|14|||
126195305|NCT00887822|453999306|FG001|Overall Study|Adverse Event|17|||
126195306|NCT00887822|453999305|FG000|Overall Study|Failure to return|11|||
126195307|NCT00887822|453999306|FG001|Overall Study|Failure to return|11|||
126195308|NCT00887822|453999305|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
126195309|NCT00887822|453999306|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
126195310|NCT00887822|453999305|FG000|Overall Study|Administrative/Other than specified|5|||
126195311|NCT00887822|453999306|FG001|Overall Study|Administrative/Other than specified|4|||
126195312|NCT00887822|453999305|FG000|Overall Study|Death|2|||
126195313|NCT00887822|453999306|FG001|Overall Study|Death|3|||
126195314|NCT00887822|453999305|FG000|Overall Study|Protocol Violation|0|||
126195315|NCT00887822|453999306|FG001|Overall Study|Protocol Violation|1|||
126195316|NCT00887822|453999305|FG000|Overall Study|Randomized but not treated|0|||
126195317|NCT00887822|453999306|FG001|Overall Study|Randomized but not treated|1|||
126195318|NCT02045979|453999307|FG000|Overall Study|Informed Consent Withdrawn|2|||
126195319|NCT02045979|453999308|FG001|Overall Study|Informed Consent Withdrawn|0|||
126195320|NCT02045979|453999309|FG002|Overall Study|Informed Consent Withdrawn|1|||
126195321|NCT02045979|453999307|FG000|Overall Study|not specified above|0|||
126195322|NCT02045979|453999308|FG001|Overall Study|not specified above|1|||
126195323|NCT02045979|453999309|FG002|Overall Study|not specified above|0|||
126195324|NCT02425891|453999310|FG000|Overall Study|Death|333|||
126195325|NCT02425891|453999311|FG001|Overall Study|Death|314|||
126195326|NCT02425891|453999310|FG000|Overall Study|Lost to Follow-up|4|||
126195327|NCT02425891|453999311|FG001|Overall Study|Lost to Follow-up|6|||
126195328|NCT02425891|453999310|FG000|Overall Study|Non-Compliance|1|||
126195329|NCT02425891|453999311|FG001|Overall Study|Non-Compliance|1|||
126195330|NCT02425891|453999310|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
126195331|NCT02425891|453999311|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
126195332|NCT02425891|453999310|FG000|Overall Study|Physician Decision|0|||
126195333|NCT02425891|453999311|FG001|Overall Study|Physician Decision|1|||
126195334|NCT02425891|453999310|FG000|Overall Study|Protocol Violation|1|||
126195335|NCT02425891|453999311|FG001|Overall Study|Protocol Violation|1|||
126195336|NCT02425891|453999310|FG000|Overall Study|Study Terminated By Sponsor|85|||
126195337|NCT02425891|453999311|FG001|Overall Study|Study Terminated By Sponsor|95|||
126195338|NCT02425891|453999310|FG000|Overall Study|Withdrawal by Subject|27|||
126195339|NCT02425891|453999311|FG001|Overall Study|Withdrawal by Subject|32|||
126195340|NCT02145429|453999313|FG000|Overall Study|Death|4|||
126195341|NCT02145429|453999314|FG001|Overall Study|Death|5|||
126195342|NCT02145429|453999313|FG000|Overall Study|Lost to Follow-up|4|||
126195343|NCT02145429|453999314|FG001|Overall Study|Lost to Follow-up|3|||
126195344|NCT02145429|453999313|FG000|Overall Study|Withdrawal by Subject|8|||
126195345|NCT02145429|453999314|FG001|Overall Study|Withdrawal by Subject|3|||
126195346|NCT01944462|453999315|FG000|PPPP Educational Program|Lost to Follow-up|60|||
126195347|NCT01222767|453999316|FG000|Overall Study|Progressive disease|13|||
126195348|NCT01222767|453999316|FG000|Overall Study|Adverse Event|2|||
126195349|NCT01222767|453999316|FG000|Overall Study|Surgical resection|1|||
126195350|NCT01222767|453999316|FG000|Overall Study|Never treated|1|||
126195351|NCT00723489|453999317|FG000|Overall Study|Physician Decision|0|||
126195352|NCT00723489|453999318|FG001|Overall Study|Physician Decision|1|||
126195353|NCT00723489|453999319|FG002|Overall Study|Physician Decision|0|||
126195354|NCT00723489|453999320|FG003|Overall Study|Physician Decision|0|||
126195355|NCT00723489|453999317|FG000|Overall Study|Pregnancy|0|||
126195356|NCT00723489|453999318|FG001|Overall Study|Pregnancy|0|||
126195357|NCT00723489|453999319|FG002|Overall Study|Pregnancy|0|||
126195358|NCT00723489|453999320|FG003|Overall Study|Pregnancy|1|||
126195359|NCT00723489|453999317|FG000|Overall Study|Withdrawal by Subject|0|||
126195360|NCT00723489|453999318|FG001|Overall Study|Withdrawal by Subject|0|||
126195361|NCT00723489|453999319|FG002|Overall Study|Withdrawal by Subject|0|||
126195362|NCT00723489|453999320|FG003|Overall Study|Withdrawal by Subject|1|||
126195363|NCT00723489|453999317|FG000|Overall Study|Seropositive at baseline|1|||
126195364|NCT00723489|453999318|FG001|Overall Study|Seropositive at baseline|0|||
126195365|NCT00723489|453999319|FG002|Overall Study|Seropositive at baseline|0|||
126195366|NCT00723489|453999320|FG003|Overall Study|Seropositive at baseline|0|||
126195367|NCT00723489|453999317|FG000|Overall Study|Prohibited Medication|0|||
126195368|NCT00723489|453999318|FG001|Overall Study|Prohibited Medication|0|||
126195369|NCT00723489|453999319|FG002|Overall Study|Prohibited Medication|0|||
126195370|NCT00723489|453999320|FG003|Overall Study|Prohibited Medication|1|||
126195371|NCT00723489|453999317|FG000|Overall Study|Samples Collected Out of Window|0|||
126195372|NCT00723489|453999318|FG001|Overall Study|Samples Collected Out of Window|3|||
126195373|NCT00723489|453999319|FG002|Overall Study|Samples Collected Out of Window|0|||
126195374|NCT00723489|453999320|FG003|Overall Study|Samples Collected Out of Window|0|||
126195375|NCT01599585|453999321|FG000|Overall Study|Withdrawal by Subject|16|||
126195376|NCT01599585|453999322|FG001|Overall Study|Withdrawal by Subject|9|||
126195377|NCT01599585|453999321|FG000|Overall Study|Lost to Follow-up|3|||
126195378|NCT01599585|453999322|FG001|Overall Study|Lost to Follow-up|5|||
126195379|NCT01599585|453999321|FG000|Overall Study|randomized did not start treatment|3|||
126195380|NCT01599585|453999322|FG001|Overall Study|randomized did not start treatment|3|||
126195381|NCT00081263|453999323|FG000|Overall Study|clerical error|1|||
126195382|NCT00081263|453999324|FG001|Overall Study|clerical error|0|||
126195383|NCT00081263|453999323|FG000|Overall Study|wrong cell type|7|||
126195384|NCT00081263|453999324|FG001|Overall Study|wrong cell type|5|||
126195385|NCT00081263|453999323|FG000|Overall Study|improper pre-protocol therapy|0|||
126195386|NCT00081263|453999324|FG001|Overall Study|improper pre-protocol therapy|1|||
126195387|NCT00081263|453999323|FG000|Overall Study|Inadequate pathology|0|||
126195388|NCT00081263|453999324|FG001|Overall Study|Inadequate pathology|1|||
126195389|NCT00081263|453999323|FG000|Overall Study|Never treated|4|||
126195390|NCT00081263|453999324|FG001|Overall Study|Never treated|5|||
126195391|NCT00081263|453999323|FG000|Overall Study|Inadequate data|5|||
126195392|NCT00081263|453999324|FG001|Overall Study|Inadequate data|10|||
126195393|NCT05827978|453999325|FG000|Overall Study|Adverse Event|1|||
126195394|NCT05827978|453999326|FG001|Overall Study|Adverse Event|0|||
126195395|NCT05827978|453999327|FG002|Overall Study|Adverse Event|0|||
126195396|NCT05827978|453999328|FG003|Overall Study|Adverse Event|1|||
126195397|NCT05827978|453999329|FG004|Overall Study|Adverse Event|0|||
126195398|NCT05827978|453999330|FG005|Overall Study|Adverse Event|0|||
126195399|NCT05827978|453999325|FG000|Overall Study|Death|1|||
126195400|NCT05827978|453999326|FG001|Overall Study|Death|5|||
126195401|NCT05827978|453999327|FG002|Overall Study|Death|2|||
126195402|NCT05827978|453999328|FG003|Overall Study|Death|3|||
126195403|NCT05827978|453999329|FG004|Overall Study|Death|1|||
126195404|NCT05827978|453999330|FG005|Overall Study|Death|3|||
126195405|NCT05827978|453999325|FG000|Overall Study|Lost to Follow-up|57|||
126195406|NCT05827978|453999326|FG001|Overall Study|Lost to Follow-up|88|||
126195407|NCT05827978|453999327|FG002|Overall Study|Lost to Follow-up|54|||
126195408|NCT05827978|453999328|FG003|Overall Study|Lost to Follow-up|47|||
126195409|NCT05827978|453999329|FG004|Overall Study|Lost to Follow-up|25|||
126195410|NCT05827978|453999330|FG005|Overall Study|Lost to Follow-up|10|||
126195411|NCT05827978|453999325|FG000|Overall Study|Noncompliance with Study Procedures|0|||
126195412|NCT05827978|453999326|FG001|Overall Study|Noncompliance with Study Procedures|1|||
126195413|NCT05827978|453999327|FG002|Overall Study|Noncompliance with Study Procedures|1|||
126195414|NCT05827978|453999328|FG003|Overall Study|Noncompliance with Study Procedures|1|||
126195415|NCT05827978|453999329|FG004|Overall Study|Noncompliance with Study Procedures|1|||
126195416|NCT05827978|453999330|FG005|Overall Study|Noncompliance with Study Procedures|0|||
126195417|NCT05827978|453999325|FG000|Overall Study|Physician Decision|2|||
126195418|NCT05827978|453999326|FG001|Overall Study|Physician Decision|0|||
126195419|NCT05827978|453999327|FG002|Overall Study|Physician Decision|1|||
126195420|NCT05827978|453999328|FG003|Overall Study|Physician Decision|2|||
126195421|NCT05827978|453999329|FG004|Overall Study|Physician Decision|1|||
126195422|NCT05827978|453999330|FG005|Overall Study|Physician Decision|1|||
126195423|NCT05827978|453999325|FG000|Overall Study|Protocol Violation|5|||
126195424|NCT05827978|453999326|FG001|Overall Study|Protocol Violation|2|||
126195425|NCT05827978|453999327|FG002|Overall Study|Protocol Violation|0|||
126195426|NCT05827978|453999328|FG003|Overall Study|Protocol Violation|0|||
126195427|NCT05827978|453999329|FG004|Overall Study|Protocol Violation|0|||
126195428|NCT05827978|453999330|FG005|Overall Study|Protocol Violation|0|||
126195429|NCT05827978|453999325|FG000|Overall Study|Withdrawal by Subject|17|||
126195430|NCT05827978|453999326|FG001|Overall Study|Withdrawal by Subject|16|||
126195431|NCT05827978|453999327|FG002|Overall Study|Withdrawal by Subject|10|||
126195432|NCT05827978|453999328|FG003|Overall Study|Withdrawal by Subject|12|||
126195433|NCT05827978|453999329|FG004|Overall Study|Withdrawal by Subject|10|||
126195434|NCT05827978|453999330|FG005|Overall Study|Withdrawal by Subject|9|||
126195435|NCT05827978|453999325|FG000|Overall Study|Other Than Specified|0|||
126195436|NCT05827978|453999326|FG001|Overall Study|Other Than Specified|0|||
126195437|NCT05827978|453999327|FG002|Overall Study|Other Than Specified|1|||
126195438|NCT05827978|453999328|FG003|Overall Study|Other Than Specified|0|||
126195439|NCT05827978|453999329|FG004|Overall Study|Other Than Specified|2|||
126195440|NCT05827978|453999330|FG005|Overall Study|Other Than Specified|0|||
126195441|NCT00729560|453999331|FG000|Overall Study|Withdrawal by Subject|3|||
126195442|NCT00103207|453999332|FG000|Overall Study|Adverse Event|3|||
126195443|NCT00103207|453999332|FG000|Overall Study|Death|1|||
126195444|NCT00103207|453999332|FG000|Overall Study|Withdrawal by Subject|2|||
126195445|NCT00103207|453999332|FG000|Overall Study|Other complicating disease|1|||
126195446|NCT00103207|453999332|FG000|Overall Study|Ineligible|4|||
126195447|NCT00103207|453999332|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
126195448|NCT03662789|453999333|FG000|Overall Study|Lost to Follow-up|1|||
126195449|NCT03662789|453999334|FG001|Overall Study|Lost to Follow-up|2|||
126195450|NCT03662789|453999333|FG000|Overall Study|Could not perform treadmill test|4|||
126195451|NCT03662789|453999334|FG001|Overall Study|Could not perform treadmill test|4|||
126195452|NCT03662789|453999333|FG000|Overall Study|Death|0|||
126195453|NCT03662789|453999334|FG001|Overall Study|Death|1|||
126195454|NCT01029691|453999335|FG000|Continued APAP to Delivery|Death|0|||
126195455|NCT01029691|453999336|FG001|Continued APAP to Delivery|Death|0|||
126195456|NCT01029691|453999337|FG002|Continued APAP to Delivery|Death|1|||
126195457|NCT01023516|453999338|FG000|Overall Study|Voluntary discontinuation|7|||
126195458|NCT01023516|453999339|FG001|Overall Study|Voluntary discontinuation|5|||
126195459|NCT01023516|453999338|FG000|Overall Study|Adverse Event|9|||
126195460|NCT01023516|453999339|FG001|Overall Study|Adverse Event|6|||
126195461|NCT01023516|453999338|FG000|Overall Study|Safety reason|0|||
126195462|NCT01023516|453999339|FG001|Overall Study|Safety reason|3|||
126195463|NCT01023516|453999338|FG000|Overall Study|Study-specific criteria|4|||
126195464|NCT01023516|453999339|FG001|Overall Study|Study-specific criteria|2|||
126195465|NCT01023516|453999338|FG000|Overall Study|Incorrect enrolment|4|||
126195466|NCT01023516|453999339|FG001|Overall Study|Incorrect enrolment|2|||
126195467|NCT00137267|453999342|FG000|Overall Study|Lost to Follow-up|15|||
126195468|NCT00137267|453999343|FG001|Overall Study|Lost to Follow-up|21|||
126195469|NCT00638989|453999344|FG000|Overall Study|Lost to Follow-up|0|||
126195470|NCT00638989|453999345|FG001|Overall Study|Lost to Follow-up|0|||
126195471|NCT00638989|453999346|FG002|Overall Study|Lost to Follow-up|1|||
126195472|NCT00853112|453999351|FG000|Overall Study|Randomized but not treated|0|||
126195473|NCT00853112|453999352|FG001|Overall Study|Randomized but not treated|1|||
126195474|NCT00853112|453999353|FG002|Overall Study|Randomized but not treated|0|||
126195475|NCT00853112|453999354|FG003|Overall Study|Randomized but not treated|2|||
126195476|NCT00853112|453999355|FG004|Overall Study|Randomized but not treated|0|||
126195477|NCT00853112|453999356|FG005|Overall Study|Randomized but not treated|0|||
126195478|NCT00853112|453999357|FG006|Overall Study|Randomized but not treated|1|||
126195479|NCT01553591|453999358|FG000|Overall Study|Voluntarily withdrew|94|||
126195480|NCT01553591|453999359|FG001|Overall Study|Voluntarily withdrew|79|||
126195481|NCT01553591|453999360|FG002|Overall Study|Voluntarily withdrew|96|||
126195482|NCT01553591|453999358|FG000|Overall Study|Adverse Event|36|||
126195483|NCT01553591|453999359|FG001|Overall Study|Adverse Event|45|||
126195484|NCT01553591|453999360|FG002|Overall Study|Adverse Event|16|||
126195485|NCT01553591|453999358|FG000|Overall Study|Lost to Follow-up|25|||
126195486|NCT01553591|453999359|FG001|Overall Study|Lost to Follow-up|23|||
126195487|NCT01553591|453999360|FG002|Overall Study|Lost to Follow-up|16|||
126195488|NCT01553591|453999358|FG000|Overall Study|Physician decision: other|11|||
126195489|NCT01553591|453999359|FG001|Overall Study|Physician decision: other|14|||
126195490|NCT01553591|453999360|FG002|Overall Study|Physician decision: other|16|||
126195491|NCT01553591|453999358|FG000|Overall Study|Physician decision: lack of efficacy|2|||
126195492|NCT01553591|453999359|FG001|Overall Study|Physician decision: lack of efficacy|3|||
126195493|NCT01553591|453999360|FG002|Overall Study|Physician decision: lack of efficacy|7|||
126195494|NCT01553591|453999358|FG000|Overall Study|Protocol Violation|3|||
126195495|NCT01553591|453999359|FG001|Overall Study|Protocol Violation|4|||
126195496|NCT01553591|453999360|FG002|Overall Study|Protocol Violation|4|||
126195497|NCT01553591|453999358|FG000|Overall Study|Sponsor decision|1|||
126195498|NCT01553591|453999359|FG001|Overall Study|Sponsor decision|0|||
126195499|NCT01553591|453999360|FG002|Overall Study|Sponsor decision|3|||
126195500|NCT01553591|453999358|FG000|Overall Study|Randomized and never dispensed drug|0|||
126195501|NCT01553591|453999359|FG001|Overall Study|Randomized and never dispensed drug|1|||
126195502|NCT01553591|453999360|FG002|Overall Study|Randomized and never dispensed drug|0|||
126195503|NCT00958191|453999363|FG000|Overall Study|Death|4|||
126195504|NCT00958191|453999363|FG000|Overall Study|Lost to Follow-up|5|||
126195505|NCT00958191|453999363|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
126195506|NCT00958191|453999363|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
126195507|NCT00958191|453999363|FG000|Overall Study|Revision of study device|4|||
126195508|NCT00958191|453999363|FG000|Overall Study|Site termination|11|||
126195509|NCT00958191|453999363|FG000|Overall Study|No 5 yr x-rays|56|||
126195510|NCT00611767|453999364|FG000|Overall Study|Withdrawal by Subject|4|||
126195511|NCT00611767|453999365|FG001|Overall Study|Withdrawal by Subject|1|||
126195512|NCT00611767|453999364|FG000|Overall Study|Thiopental not available|3|||
126195513|NCT00611767|453999365|FG001|Overall Study|Thiopental not available|0|||
126195514|NCT00611767|453999364|FG000|Overall Study|didn't like the medication|1|||
126195515|NCT00611767|453999365|FG001|Overall Study|didn't like the medication|1|||
126195516|NCT00611767|453999364|FG000|Overall Study|Physician Decision|1|||
126195517|NCT00611767|453999365|FG001|Overall Study|Physician Decision|0|||
126195518|NCT01818765|453999366|FG000|Overall Study|Death|2|||
126195519|NCT02010567|453999367|FG000|Overall Study|Adverse Event|0|||
126195520|NCT02010567|453999368|FG001|Overall Study|Adverse Event|0|||
126195521|NCT02010567|453999369|FG002|Overall Study|Adverse Event|1|||
126195522|NCT02010567|453999370|FG003|Overall Study|Adverse Event|0|||
126195523|NCT02010567|453999371|FG004|Overall Study|Adverse Event|1|||
126195524|NCT02005211|453999372|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126195525|NCT02005211|453999373|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126195526|NCT02005211|453999374|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126195527|NCT02005211|453999375|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126195528|NCT02005211|453999376|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
126195529|NCT02005211|453999377|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126195530|NCT02005211|453999378|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126195531|NCT00397631|453999380|FG000|Overall Study|Adverse Event|5|||
126195532|NCT00397631|453999381|FG001|Overall Study|Adverse Event|6|||
126195533|NCT00397631|453999380|FG000|Overall Study|Lack of Efficacy|7|||
126195534|NCT00397631|453999381|FG001|Overall Study|Lack of Efficacy|10|||
126195535|NCT00397631|453999380|FG000|Overall Study|Lost to Follow-up|8|||
126195536|NCT00397631|453999381|FG001|Overall Study|Lost to Follow-up|9|||
126195537|NCT00397631|453999380|FG000|Overall Study|Physician Decision|2|||
126195538|NCT00397631|453999381|FG001|Overall Study|Physician Decision|0|||
126195539|NCT00397631|453999380|FG000|Overall Study|Protocol Violation|0|||
126195540|NCT00397631|453999381|FG001|Overall Study|Protocol Violation|1|||
126195541|NCT00397631|453999380|FG000|Overall Study|Withdrawal by Subject|7|||
126195542|NCT00397631|453999381|FG001|Overall Study|Withdrawal by Subject|14|||
126195543|NCT00397631|453999380|FG000|Overall Study|protocol discontinuation criteria|1|||
126195544|NCT00397631|453999381|FG001|Overall Study|protocol discontinuation criteria|4|||
126195545|NCT02202161|453999382|FG000|Overall Study|Adverse Event|1|||
126195546|NCT02202161|453999383|FG001|Overall Study|Adverse Event|1|||
126195547|NCT02202161|453999384|FG002|Overall Study|Adverse Event|0|||
126195548|NCT02202161|453999385|FG003|Overall Study|Adverse Event|0|||
126195549|NCT02202161|453999386|FG004|Overall Study|Adverse Event|0|||
126195550|NCT02202161|453999387|FG005|Overall Study|Adverse Event|1|||
126195551|NCT02202161|453999388|FG006|Overall Study|Adverse Event|0|||
126195552|NCT02202161|453999389|FG007|Overall Study|Adverse Event|0|||
126195553|NCT02202161|453999382|FG000|Overall Study|Did not meet continuation criteria|0|||
126195554|NCT02202161|453999383|FG001|Overall Study|Did not meet continuation criteria|0|||
126195555|NCT02202161|453999384|FG002|Overall Study|Did not meet continuation criteria|0|||
126195556|NCT02202161|453999385|FG003|Overall Study|Did not meet continuation criteria|0|||
126195557|NCT02202161|453999386|FG004|Overall Study|Did not meet continuation criteria|0|||
126195558|NCT02202161|453999387|FG005|Overall Study|Did not meet continuation criteria|0|||
126195559|NCT02202161|453999388|FG006|Overall Study|Did not meet continuation criteria|0|||
126195560|NCT02202161|453999389|FG007|Overall Study|Did not meet continuation criteria|3|||
126195561|NCT02202161|453999382|FG000|Overall Study|Physician Decision|0|||
126195562|NCT02202161|453999383|FG001|Overall Study|Physician Decision|0|||
126195563|NCT02202161|453999384|FG002|Overall Study|Physician Decision|0|||
126195564|NCT02202161|453999385|FG003|Overall Study|Physician Decision|0|||
126195565|NCT02202161|453999386|FG004|Overall Study|Physician Decision|0|||
126195566|NCT02202161|453999387|FG005|Overall Study|Physician Decision|0|||
126195567|NCT02202161|453999388|FG006|Overall Study|Physician Decision|0|||
126195568|NCT02202161|453999389|FG007|Overall Study|Physician Decision|3|||
126195569|NCT02202161|453999382|FG000|Overall Study|Withdrawal by Subject|0|||
126195570|NCT02202161|453999383|FG001|Overall Study|Withdrawal by Subject|0|||
126195571|NCT02202161|453999384|FG002|Overall Study|Withdrawal by Subject|0|||
126195572|NCT02202161|453999385|FG003|Overall Study|Withdrawal by Subject|0|||
126195573|NCT02202161|453999386|FG004|Overall Study|Withdrawal by Subject|1|||
126195574|NCT02202161|453999387|FG005|Overall Study|Withdrawal by Subject|0|||
126195575|NCT02202161|453999388|FG006|Overall Study|Withdrawal by Subject|0|||
126195576|NCT02202161|453999389|FG007|Overall Study|Withdrawal by Subject|0|||
126195577|NCT00832091|453999390|FG000|Overall Study|Adverse Event|1|||
126195578|NCT00832091|453999391|FG001|Overall Study|Adverse Event|1|||
126195579|NCT00832091|453999390|FG000|Overall Study|Protocol Violation|1|||
126195580|NCT00832091|453999391|FG001|Overall Study|Protocol Violation|0|||
126195581|NCT00832091|453999390|FG000|Overall Study|Withdrawal by Subject|2|||
126195582|NCT00832091|453999391|FG001|Overall Study|Withdrawal by Subject|1|||
126195583|NCT00832091|453999390|FG000|Overall Study|Prohibited Medication|1|||
126195584|NCT00832091|453999391|FG001|Overall Study|Prohibited Medication|0|||
126195585|NCT00942422|453999397|FG000|Overall Study|Withdrawal by Subject|1|||
126195586|NCT00942422|453999397|FG000|Overall Study|Death|1|||
126195587|NCT00942422|453999397|FG000|Overall Study|Progressive diease|1|||
126195588|NCT02711553|453999400|FG000|Overall Study|Withdrawal by Subject|2|||
126195589|NCT02711553|453999401|FG001|Overall Study|Withdrawal by Subject|1|||
126195590|NCT02711553|453999402|FG002|Overall Study|Withdrawal by Subject|1|||
126195591|NCT02711553|453999403|FG003|Overall Study|Withdrawal by Subject|0|||
126195592|NCT02711553|453999400|FG000|Overall Study|Lost to Follow-up|3|||
126195593|NCT02711553|453999401|FG001|Overall Study|Lost to Follow-up|3|||
126195594|NCT02711553|453999402|FG002|Overall Study|Lost to Follow-up|6|||
126195595|NCT02711553|453999403|FG003|Overall Study|Lost to Follow-up|3|||
126195596|NCT02711553|453999400|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
126195597|NCT02711553|453999401|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
126195598|NCT02711553|453999402|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
126195599|NCT02711553|453999403|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
126195600|NCT05559203|453999404|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
126195601|NCT03117309|453999405|FG000|Overall Study|Not meeting inclusion criteria|0|||
126195602|NCT03117309|453999406|FG001|Overall Study|Not meeting inclusion criteria|1|||
126195603|NCT04048876|453999407|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
126195604|NCT04048876|453999408|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
126195605|NCT04048876|453999409|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
126195606|NCT04048876|453999410|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
126195607|NCT04048876|453999407|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
126195608|NCT04048876|453999408|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
126195609|NCT04048876|453999409|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
126195610|NCT04048876|453999410|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
126195611|NCT04048876|453999407|FG000|Placebo Controlled Phase|Adverse Event|0|||
126195612|NCT04048876|453999408|FG001|Placebo Controlled Phase|Adverse Event|1|||
126195613|NCT04048876|453999409|FG002|Placebo Controlled Phase|Adverse Event|0|||
126195614|NCT04048876|453999410|FG003|Placebo Controlled Phase|Adverse Event|0|||
126195615|NCT04048876|453999407|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
126195616|NCT04048876|453999408|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
126195617|NCT04048876|453999409|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
126195618|NCT04048876|453999410|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
126195619|NCT02187224|453999411|FG000|Overall Study|Did not show up for test day|1|||
126195620|NCT02187224|453999412|FG001|Overall Study|Did not show up for test day|0|||
126195621|NCT01010776|453999415|FG000|Main Phase|Withdrawal by Subject|14|||
126195622|NCT01010776|453999415|FG000|Main Phase|Lack of Efficacy|8|||
126195623|NCT01010776|453999415|FG000|Main Phase|Adverse Event|7|||
126195624|NCT01010776|453999415|FG000|Main Phase|Lost to Follow-up|6|||
126195625|NCT01010776|453999415|FG000|Main Phase|Non-compliance to study medication|5|||
126195626|NCT01010776|453999415|FG000|Main Phase|Selection failure|2|||
126195627|NCT01010776|453999415|FG000|Main Phase|Inform consent withdrawal|1|||
126195628|NCT01010776|453999415|FG000|Main Phase|Other|1|||
126195629|NCT01010776|453999415|FG000|Main Phase|Did not received study medication|5|||
126195630|NCT01010776|453999415|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
126195631|NCT01010776|453999415|FG000|Extension Phase|Other|3|||
126195632|NCT01012037|453999419|FG000|Overall Study|Adverse Event|0|||
126195633|NCT01012037|453999420|FG001|Overall Study|Adverse Event|8|||
126195634|NCT01012037|453999421|FG002|Overall Study|Adverse Event|3|||
126195635|NCT01012037|453999419|FG000|Overall Study|Protocol Violation|0|||
126195636|NCT01012037|453999420|FG001|Overall Study|Protocol Violation|3|||
126195637|NCT01012037|453999421|FG002|Overall Study|Protocol Violation|5|||
126195638|NCT01012037|453999419|FG000|Overall Study|Withdrawal by Subject|0|||
126195639|NCT01012037|453999420|FG001|Overall Study|Withdrawal by Subject|4|||
126195640|NCT01012037|453999421|FG002|Overall Study|Withdrawal by Subject|1|||
126195641|NCT01012037|453999419|FG000|Overall Study|Other reason (not specified)|1|||
126195642|NCT01012037|453999420|FG001|Overall Study|Other reason (not specified)|1|||
126195643|NCT01012037|453999421|FG002|Overall Study|Other reason (not specified)|1|||
126195644|NCT02583711|453999422|FG000|Overall Study|Withdrawal by Subject|0|||
126195645|NCT02583711|453999423|FG001|Overall Study|Withdrawal by Subject|10|||
126195646|NCT02583711|453999424|FG002|Overall Study|Withdrawal by Subject|0|||
126195647|NCT00415623|453999426|FG000|Overall Study|Adverse Event|3|||
126195648|NCT00415623|453999427|FG001|Overall Study|Adverse Event|4|||
126195649|NCT00415623|453999426|FG000|Overall Study|Death|1|||
126195650|NCT00415623|453999427|FG001|Overall Study|Death|0|||
126195651|NCT00415623|453999426|FG000|Overall Study|Withdrawal by Subject|1|||
126195652|NCT00415623|453999427|FG001|Overall Study|Withdrawal by Subject|1|||
126195653|NCT00542425|453999428|FG000|Initial 24 Weeks|Administrative reasons|0|||
126195654|NCT00542425|453999429|FG001|Initial 24 Weeks|Administrative reasons|0|||
126195655|NCT00542425|453999430|FG002|Initial 24 Weeks|Administrative reasons|1|||
126195656|NCT00542425|453999431|FG003|Initial 24 Weeks|Administrative reasons|1|||
126195657|NCT00542425|453999432|FG004|Initial 24 Weeks|Administrative reasons|0|||
126195658|NCT00542425|453999428|FG000|Initial 24 Weeks|Adverse Event|0|||
126195659|NCT00542425|453999429|FG001|Initial 24 Weeks|Adverse Event|1|||
126195660|NCT00542425|453999430|FG002|Initial 24 Weeks|Adverse Event|1|||
126195661|NCT00542425|453999431|FG003|Initial 24 Weeks|Adverse Event|3|||
126195662|NCT00542425|453999432|FG004|Initial 24 Weeks|Adverse Event|2|||
126195663|NCT00542425|453999428|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
126195664|NCT00542425|453999429|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
126195665|NCT00542425|453999430|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
126195666|NCT00542425|453999431|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
126195667|NCT00542425|453999432|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
126195668|NCT00542425|453999428|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
126195669|NCT00542425|453999429|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
126195670|NCT00542425|453999430|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
126195671|NCT00542425|453999431|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
126195672|NCT00542425|453999432|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
126195673|NCT00542425|453999428|FG000|Initial 24 Weeks|Non-compliance|0|||
126195674|NCT00542425|453999429|FG001|Initial 24 Weeks|Non-compliance|0|||
126195675|NCT00542425|453999430|FG002|Initial 24 Weeks|Non-compliance|0|||
126195676|NCT00542425|453999431|FG003|Initial 24 Weeks|Non-compliance|1|||
126195677|NCT00542425|453999432|FG004|Initial 24 Weeks|Non-compliance|1|||
126195678|NCT00542425|453999428|FG000|Initial 24 Weeks|Protocol Violation|0|||
126195679|NCT00542425|453999429|FG001|Initial 24 Weeks|Protocol Violation|0|||
126195680|NCT00542425|453999430|FG002|Initial 24 Weeks|Protocol Violation|0|||
126195681|NCT00542425|453999431|FG003|Initial 24 Weeks|Protocol Violation|1|||
126195682|NCT00542425|453999432|FG004|Initial 24 Weeks|Protocol Violation|0|||
126195683|NCT00542425|453999428|FG000|Initial 24 Weeks|Refusal of treatment|2|||
126195684|NCT00542425|453999429|FG001|Initial 24 Weeks|Refusal of treatment|2|||
126195685|NCT00542425|453999430|FG002|Initial 24 Weeks|Refusal of treatment|1|||
126195686|NCT00542425|453999431|FG003|Initial 24 Weeks|Refusal of treatment|4|||
126195687|NCT00542425|453999432|FG004|Initial 24 Weeks|Refusal of treatment|1|||
126195688|NCT00542425|453999428|FG000|Initial 24 Weeks|Other|0|||
126195689|NCT00542425|453999429|FG001|Initial 24 Weeks|Other|2|||
126195690|NCT00542425|453999430|FG002|Initial 24 Weeks|Other|1|||
126195691|NCT00542425|453999431|FG003|Initial 24 Weeks|Other|0|||
126195692|NCT00542425|453999432|FG004|Initial 24 Weeks|Other|0|||
126195693|NCT00542425|453999428|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
126195694|NCT00542425|453999429|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
126195695|NCT00542425|453999430|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
126195696|NCT00542425|453999431|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
126195697|NCT00542425|453999432|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
126195698|NCT00542425|453999428|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
126195699|NCT00542425|453999429|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
126195700|NCT00542425|453999430|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
126195701|NCT00542425|453999431|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
126195702|NCT00542425|453999432|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
126195703|NCT00542425|453999428|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
126195704|NCT00542425|453999429|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
126195705|NCT00542425|453999430|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
126195706|NCT00542425|453999431|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
126195707|NCT00542425|453999432|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
126195708|NCT00542425|453999428|FG000|Extended 24 Weeks of Treatment|Other|1|||
126195709|NCT00542425|453999429|FG001|Extended 24 Weeks of Treatment|Other|1|||
126195710|NCT00542425|453999430|FG002|Extended 24 Weeks of Treatment|Other|0|||
126195711|NCT00542425|453999431|FG003|Extended 24 Weeks of Treatment|Other|0|||
126195712|NCT00542425|453999432|FG004|Extended 24 Weeks of Treatment|Other|1|||
126195713|NCT02096471|453999433|FG000|Overall Study|Adverse Event|1|||
126195714|NCT02096471|453999433|FG000|Overall Study|Lack of Efficacy|7|||
126195715|NCT02096471|453999433|FG000|Overall Study|Withdrawal by Subject|3|||
126195716|NCT02096471|453999433|FG000|Overall Study|Non-Compliant|2|||
126195717|NCT01610414|453999434|FG000|Study Start - Month 13|Serious Adverse Event|65|||
126195718|NCT01610414|453999435|FG001|Study Start - Month 13|Serious Adverse Event|67|||
126195719|NCT01610414|453999434|FG000|Study Start - Month 13|Adverse Event|14|||
126195720|NCT01610414|453999435|FG001|Study Start - Month 13|Adverse Event|14|||
126195721|NCT01610414|453999434|FG000|Study Start - Month 13|Protocol Violation|3|||
126195722|NCT01610414|453999435|FG001|Study Start - Month 13|Protocol Violation|1|||
126195723|NCT01610414|453999434|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
126195724|NCT01610414|453999435|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
126195725|NCT01610414|453999434|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
126195726|NCT01610414|453999435|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
126195727|NCT01610414|453999434|FG000|Study Start - Month 13|Lost to Follow-up|4|||
126195728|NCT01610414|453999435|FG001|Study Start - Month 13|Lost to Follow-up|6|||
126195729|NCT01610414|453999434|FG000|Study Start - Month 13|Suspected HZ episode|1|||
126195730|NCT01610414|453999435|FG001|Study Start - Month 13|Suspected HZ episode|3|||
126195731|NCT01610414|453999434|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
126195732|NCT01610414|453999435|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
126195733|NCT01610414|453999434|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
126195734|NCT01610414|453999435|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
126195735|NCT01610414|453999434|FG000|Month 13 - Month 25|Adverse Event|8|||
126195736|NCT01610414|453999435|FG001|Month 13 - Month 25|Adverse Event|4|||
126195737|NCT01610414|453999434|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
126195738|NCT01610414|453999435|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
126195739|NCT01610414|453999434|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
126195740|NCT01610414|453999435|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
126195741|NCT01610414|453999434|FG000|Month 13 - Month 25|Protocol Violation|0|||
126195742|NCT01610414|453999435|FG001|Month 13 - Month 25|Protocol Violation|2|||
126195743|NCT01610414|453999434|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
126195744|NCT01610414|453999435|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
126195745|NCT01610414|453999434|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
126195746|NCT01610414|453999435|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
126195747|NCT01610414|453999434|FG000|After Month 25|Study end not reached|48|||
126195748|NCT01610414|453999435|FG001|After Month 25|Study end not reached|53|||
126195749|NCT02736474|453999436|FG000|Overall Study|Lost to Follow-up|0|||
126195750|NCT02736474|453999437|FG001|Overall Study|Lost to Follow-up|1|||
126195751|NCT02483611|453999438|FG000|Overall Study|Protocol Violation|0|||
126195752|NCT02483611|453999439|FG001|Overall Study|Protocol Violation|0|||
126195753|NCT02483611|453999440|FG002|Overall Study|Protocol Violation|1|||
126195754|NCT02382276|453999441|FG000|Overall Study|Withdrawal by Subject|4|||
126195755|NCT02382276|453999442|FG001|Overall Study|Withdrawal by Subject|8|||
126195756|NCT02382276|453999443|FG002|Overall Study|Withdrawal by Subject|5|||
126195757|NCT02382276|453999441|FG000|Overall Study|Adverse Event|7|||
126195758|NCT02382276|453999442|FG001|Overall Study|Adverse Event|2|||
126195759|NCT02382276|453999443|FG002|Overall Study|Adverse Event|32|||
126195760|NCT02382276|453999441|FG000|Overall Study|Physician Decision|0|||
126195761|NCT02382276|453999442|FG001|Overall Study|Physician Decision|0|||
126195762|NCT02382276|453999443|FG002|Overall Study|Physician Decision|2|||
126195763|NCT04610827|454000606|FG000|Overall Study|Withdrawal by Subject|1|||
126195764|NCT04610827|454000607|FG001|Overall Study|Withdrawal by Subject|1|||
126195765|NCT04610827|454000608|FG002|Overall Study|Withdrawal by Subject|0|||
126195766|NCT02059174|454000631|FG000|Period 1|Withdrawal by Subject|0|||
126195767|NCT02059174|454000632|FG001|Period 1|Withdrawal by Subject|2|||
126195768|NCT02059174|454000631|FG000|Period 2|Withdrawal by Subject|0|||
126195769|NCT02059174|454000632|FG001|Period 2|Withdrawal by Subject|2|||
126195770|NCT02059174|454000631|FG000|Period 2|Protocol Violation|1|||
126195771|NCT02059174|454000632|FG001|Period 2|Protocol Violation|0|||
126195772|NCT02059174|454000631|FG000|Period 3|Physician Decision|1|||
126195773|NCT02059174|454000632|FG001|Period 3|Physician Decision|0|||
126195774|NCT02306148|454000633|FG000|Overall Study|Adverse Event|12|||
126195775|NCT02306148|454000634|FG001|Overall Study|Adverse Event|6|||
126195776|NCT02306148|454000633|FG000|Overall Study|Lost to Follow-up|1|||
126195777|NCT02306148|454000634|FG001|Overall Study|Lost to Follow-up|4|||
126195778|NCT00087594|454000635|FG000|Overall Study|Adverse Event|2|||
126195779|NCT00087594|454000636|FG001|Overall Study|Adverse Event|3|||
126195780|NCT00087594|454000635|FG000|Overall Study|Lost to Follow-up|0|||
126195781|NCT00087594|454000636|FG001|Overall Study|Lost to Follow-up|2|||
126195782|NCT00087594|454000635|FG000|Overall Study|Withdrawal by Subject|4|||
126195783|NCT00087594|454000636|FG001|Overall Study|Withdrawal by Subject|2|||
126195784|NCT00087594|454000635|FG000|Overall Study|Lack of Efficacy|2|||
126195785|NCT00087594|454000636|FG001|Overall Study|Lack of Efficacy|5|||
126195786|NCT01952041|454000643|FG000|Overall Study|Lost to Follow-up|9|||
126195787|NCT01952041|454000644|FG001|Overall Study|Lost to Follow-up|16|||
126195788|NCT01952041|454000643|FG000|Overall Study|Withdrawal by Subject|7|||
126195789|NCT01952041|454000644|FG001|Overall Study|Withdrawal by Subject|5|||
126195790|NCT01952041|454000643|FG000|Overall Study|Death|1|||
126195791|NCT01952041|454000644|FG001|Overall Study|Death|0|||
126195792|NCT00186121|454000645|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
126195793|NCT00186121|454000645|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
126195794|NCT00186121|454000645|FG000|Overall Study|Not eligible (no treatment)|1|||
126195795|NCT03650387|454000646|FG000|Overall Study|Withdrawal by Subject|13|||
126195796|NCT03650387|454000646|FG000|Overall Study|Lost to Follow-up|12|||
126195797|NCT03650387|454000646|FG000|Overall Study|Adverse Event (Not related)|1|||
126195798|NCT03650387|454000646|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
126195799|NCT01569568|454000647|FG000|Overall Study|Physician Decision|0|||
126195800|NCT01569568|454000648|FG001|Overall Study|Physician Decision|2|||
126195801|NCT01370499|454000649|FG000|Overall Study|Adverse Event|38|||
126195802|NCT01370499|454000650|FG001|Overall Study|Adverse Event|12|||
126195803|NCT01370499|454000649|FG000|Overall Study|Lack of Efficacy|4|||
126195804|NCT01370499|454000650|FG001|Overall Study|Lack of Efficacy|2|||
126195805|NCT01370499|454000649|FG000|Overall Study|Lost to Follow-up|2|||
126195806|NCT01370499|454000650|FG001|Overall Study|Lost to Follow-up|1|||
126195807|NCT01370499|454000649|FG000|Overall Study|Physician Decision|3|||
126195808|NCT01370499|454000650|FG001|Overall Study|Physician Decision|3|||
126195809|NCT01370499|454000649|FG000|Overall Study|Protocol Violation|5|||
126195810|NCT01370499|454000650|FG001|Overall Study|Protocol Violation|4|||
126195811|NCT01370499|454000649|FG000|Overall Study|Withdrawal by Subject|18|||
126195812|NCT01370499|454000650|FG001|Overall Study|Withdrawal by Subject|7|||
126195813|NCT01370499|454000649|FG000|Overall Study|Sponsor Decision|41|||
126195814|NCT01370499|454000650|FG001|Overall Study|Sponsor Decision|15|||
126195815|NCT00934791|454000651|FG000|Overall Study|Withdrawal by Subject|1|||
126195816|NCT00934791|454000652|FG001|Overall Study|Withdrawal by Subject|0|||
126195817|NCT03763942|454000654|FG000|Overall Study|Lost to Follow-up|114|||
126195818|NCT03763942|454000655|FG001|Overall Study|Lost to Follow-up|54|||
126195819|NCT03763942|454000654|FG000|Overall Study|Protocol Violation|1|||
126195820|NCT03763942|454000655|FG001|Overall Study|Protocol Violation|0|||
126195821|NCT03763942|454000654|FG000|Overall Study|Withdrawal by Subject|2|||
126195822|NCT03763942|454000655|FG001|Overall Study|Withdrawal by Subject|0|||
126195823|NCT03763942|454000654|FG000|Overall Study|Other|2|||
126195824|NCT03763942|454000655|FG001|Overall Study|Other|3|||
126195825|NCT03558503|454000656|FG000|Overall Study|Adverse Event|1|||
126195826|NCT03558503|454000656|FG000|Overall Study|Death|1|||
126195827|NCT03558503|454000656|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
126195828|NCT02646891|454000657|FG000|Overall Study|Adverse Event|0|||
126195829|NCT02646891|454000658|FG001|Overall Study|Adverse Event|1|||
126195830|NCT02646891|454000659|FG002|Overall Study|Adverse Event|0|||
126195831|NCT02646891|454000660|FG003|Overall Study|Adverse Event|0|||
126195832|NCT02646891|454000661|FG004|Overall Study|Adverse Event|0|||
126195833|NCT02646891|454000662|FG005|Overall Study|Adverse Event|0|||
126195834|NCT02646891|454000663|FG006|Overall Study|Adverse Event|0|||
126195835|NCT02646891|454000664|FG007|Overall Study|Adverse Event|0|||
126195836|NCT02646891|454000665|FG008|Overall Study|Adverse Event|0|||
126195837|NCT02646891|454000666|FG009|Overall Study|Adverse Event|0|||
126195838|NCT02646891|454000657|FG000|Overall Study|Lost to Follow-up|0|||
126195839|NCT02646891|454000658|FG001|Overall Study|Lost to Follow-up|0|||
126195840|NCT02646891|454000659|FG002|Overall Study|Lost to Follow-up|0|||
126195841|NCT02646891|454000660|FG003|Overall Study|Lost to Follow-up|0|||
126195842|NCT02646891|454000661|FG004|Overall Study|Lost to Follow-up|0|||
126195843|NCT02646891|454000662|FG005|Overall Study|Lost to Follow-up|0|||
126195844|NCT02646891|454000663|FG006|Overall Study|Lost to Follow-up|2|||
126195845|NCT02646891|454000664|FG007|Overall Study|Lost to Follow-up|2|||
126195846|NCT02646891|454000665|FG008|Overall Study|Lost to Follow-up|2|||
126195847|NCT02646891|454000666|FG009|Overall Study|Lost to Follow-up|2|||
126195848|NCT02646891|454000657|FG000|Overall Study|Protocol Violation|0|||
126195849|NCT02646891|454000658|FG001|Overall Study|Protocol Violation|0|||
126195850|NCT02646891|454000659|FG002|Overall Study|Protocol Violation|0|||
126195851|NCT02646891|454000660|FG003|Overall Study|Protocol Violation|0|||
126195852|NCT02646891|454000661|FG004|Overall Study|Protocol Violation|0|||
126195853|NCT02646891|454000662|FG005|Overall Study|Protocol Violation|0|||
126195854|NCT02646891|454000663|FG006|Overall Study|Protocol Violation|1|||
126195855|NCT02646891|454000664|FG007|Overall Study|Protocol Violation|1|||
126195856|NCT02646891|454000665|FG008|Overall Study|Protocol Violation|0|||
126195857|NCT02646891|454000666|FG009|Overall Study|Protocol Violation|0|||
126195858|NCT02646891|454000657|FG000|Overall Study|Withdrawal by Subject|2|||
126195859|NCT02646891|454000658|FG001|Overall Study|Withdrawal by Subject|0|||
126195860|NCT02646891|454000659|FG002|Overall Study|Withdrawal by Subject|1|||
126195861|NCT02646891|454000660|FG003|Overall Study|Withdrawal by Subject|0|||
126195862|NCT02646891|454000661|FG004|Overall Study|Withdrawal by Subject|0|||
126195863|NCT02646891|454000662|FG005|Overall Study|Withdrawal by Subject|0|||
126195864|NCT02646891|454000663|FG006|Overall Study|Withdrawal by Subject|5|||
126195865|NCT02646891|454000664|FG007|Overall Study|Withdrawal by Subject|9|||
126195866|NCT02646891|454000665|FG008|Overall Study|Withdrawal by Subject|7|||
126195867|NCT02646891|454000666|FG009|Overall Study|Withdrawal by Subject|3|||
126195868|NCT02646891|454000657|FG000|Overall Study|Death|0|||
126195869|NCT02646891|454000658|FG001|Overall Study|Death|0|||
126195870|NCT02646891|454000659|FG002|Overall Study|Death|0|||
126195871|NCT02646891|454000660|FG003|Overall Study|Death|0|||
126195872|NCT02646891|454000661|FG004|Overall Study|Death|0|||
126195873|NCT02646891|454000662|FG005|Overall Study|Death|0|||
126195874|NCT02646891|454000663|FG006|Overall Study|Death|1|||
126195875|NCT02646891|454000664|FG007|Overall Study|Death|1|||
126195876|NCT02646891|454000665|FG008|Overall Study|Death|1|||
126195877|NCT02646891|454000666|FG009|Overall Study|Death|0|||
126195878|NCT02274311|454000667|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
126195879|NCT02477800|454000669|FG000|Placebo-Controlled Period|Adverse Event|16|||
126195880|NCT02477800|454000670|FG001|Placebo-Controlled Period|Adverse Event|25|||
126195881|NCT02477800|454000671|FG002|Placebo-Controlled Period|Adverse Event|28|||
126195882|NCT02477800|454000672|FG003|Placebo-Controlled Period|Adverse Event|0|||
126195883|NCT02477800|454000673|FG004|Placebo-Controlled Period|Adverse Event|0|||
126195884|NCT02477800|454000674|FG005|Placebo-Controlled Period|Adverse Event|0|||
126195885|NCT02477800|454000675|FG006|Placebo-Controlled Period|Adverse Event|0|||
126195886|NCT02477800|454000669|FG000|Placebo-Controlled Period|Change of Treatment|1|||
126195887|NCT02477800|454000670|FG001|Placebo-Controlled Period|Change of Treatment|2|||
126195888|NCT02477800|454000671|FG002|Placebo-Controlled Period|Change of Treatment|1|||
126195889|NCT02477800|454000672|FG003|Placebo-Controlled Period|Change of Treatment|0|||
126195890|NCT02477800|454000673|FG004|Placebo-Controlled Period|Change of Treatment|0|||
126195891|NCT02477800|454000674|FG005|Placebo-Controlled Period|Change of Treatment|0|||
126195892|NCT02477800|454000675|FG006|Placebo-Controlled Period|Change of Treatment|0|||
126195893|NCT02477800|454000669|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
126195894|NCT02477800|454000670|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
126195895|NCT02477800|454000671|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
126195896|NCT02477800|454000672|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
126195897|NCT02477800|454000673|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
126195898|NCT02477800|454000674|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
126195899|NCT02477800|454000675|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
126195900|NCT02477800|454000669|FG000|Placebo-Controlled Period|Death|0|||
126195901|NCT02477800|454000670|FG001|Placebo-Controlled Period|Death|3|||
126195902|NCT02477800|454000671|FG002|Placebo-Controlled Period|Death|2|||
126195903|NCT02477800|454000672|FG003|Placebo-Controlled Period|Death|0|||
126195904|NCT02477800|454000673|FG004|Placebo-Controlled Period|Death|0|||
126195905|NCT02477800|454000674|FG005|Placebo-Controlled Period|Death|0|||
126195906|NCT02477800|454000675|FG006|Placebo-Controlled Period|Death|0|||
126195907|NCT02477800|454000669|FG000|Placebo-Controlled Period|Disease Progression|1|||
126195908|NCT02477800|454000670|FG001|Placebo-Controlled Period|Disease Progression|0|||
126195909|NCT02477800|454000671|FG002|Placebo-Controlled Period|Disease Progression|1|||
126195910|NCT02477800|454000672|FG003|Placebo-Controlled Period|Disease Progression|0|||
126195911|NCT02477800|454000673|FG004|Placebo-Controlled Period|Disease Progression|0|||
126195912|NCT02477800|454000674|FG005|Placebo-Controlled Period|Disease Progression|0|||
126195913|NCT02477800|454000675|FG006|Placebo-Controlled Period|Disease Progression|0|||
126195914|NCT02477800|454000669|FG000|Placebo-Controlled Period|Investigator Decision|3|||
126195915|NCT02477800|454000670|FG001|Placebo-Controlled Period|Investigator Decision|2|||
126195916|NCT02477800|454000671|FG002|Placebo-Controlled Period|Investigator Decision|1|||
126195917|NCT02477800|454000672|FG003|Placebo-Controlled Period|Investigator Decision|0|||
126195918|NCT02477800|454000673|FG004|Placebo-Controlled Period|Investigator Decision|0|||
126195919|NCT02477800|454000674|FG005|Placebo-Controlled Period|Investigator Decision|0|||
126195920|NCT02477800|454000675|FG006|Placebo-Controlled Period|Investigator Decision|0|||
126195921|NCT02477800|454000669|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
126195922|NCT02477800|454000670|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
126195923|NCT02477800|454000671|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
126195924|NCT02477800|454000672|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
126195925|NCT02477800|454000673|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
126195926|NCT02477800|454000674|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
126195927|NCT02477800|454000675|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
126195928|NCT02477800|454000669|FG000|Placebo-Controlled Period|Relocation|2|||
126195929|NCT02477800|454000670|FG001|Placebo-Controlled Period|Relocation|0|||
126195930|NCT02477800|454000671|FG002|Placebo-Controlled Period|Relocation|0|||
126199947|NCT01117428|454017808|FG004|Overall Study|Death|0|||
126195931|NCT02477800|454000672|FG003|Placebo-Controlled Period|Relocation|0|||
126195932|NCT02477800|454000673|FG004|Placebo-Controlled Period|Relocation|0|||
126195933|NCT02477800|454000674|FG005|Placebo-Controlled Period|Relocation|0|||
126195934|NCT02477800|454000675|FG006|Placebo-Controlled Period|Relocation|0|||
126195935|NCT02477800|454000669|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
126195936|NCT02477800|454000670|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
126195937|NCT02477800|454000671|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
126195938|NCT02477800|454000672|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
126195939|NCT02477800|454000673|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
126195940|NCT02477800|454000674|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
126195941|NCT02477800|454000675|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
126195942|NCT02477800|454000669|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
126195943|NCT02477800|454000670|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
126195944|NCT02477800|454000671|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126195945|NCT02477800|454000672|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126195946|NCT02477800|454000673|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126195947|NCT02477800|454000674|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126195948|NCT02477800|454000675|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126195949|NCT02477800|454000669|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
126195950|NCT02477800|454000670|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
126195951|NCT02477800|454000671|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
126195952|NCT02477800|454000672|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
126195953|NCT02477800|454000673|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
126195954|NCT02477800|454000674|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
126195955|NCT02477800|454000675|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
126195956|NCT02477800|454000669|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
126195957|NCT02477800|454000670|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
126195958|NCT02477800|454000671|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
126195959|NCT02477800|454000672|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126195960|NCT02477800|454000673|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126195961|NCT02477800|454000674|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126195962|NCT02477800|454000675|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126195963|NCT02477800|454000669|FG000|Placebo-Controlled Period|Reason not Specified|161|||
126195964|NCT02477800|454000670|FG001|Placebo-Controlled Period|Reason not Specified|161|||
126195965|NCT02477800|454000671|FG002|Placebo-Controlled Period|Reason not Specified|189|||
126195966|NCT02477800|454000672|FG003|Placebo-Controlled Period|Reason not Specified|0|||
126195967|NCT02477800|454000673|FG004|Placebo-Controlled Period|Reason not Specified|0|||
126195968|NCT02477800|454000674|FG005|Placebo-Controlled Period|Reason not Specified|0|||
126195969|NCT02477800|454000675|FG006|Placebo-Controlled Period|Reason not Specified|0|||
126195970|NCT02477800|454000669|FG000|Long Term Extension Period|Adverse Event|0|||
126195971|NCT02477800|454000670|FG001|Long Term Extension Period|Adverse Event|0|||
126195972|NCT02477800|454000671|FG002|Long Term Extension Period|Adverse Event|0|||
126195973|NCT02477800|454000672|FG003|Long Term Extension Period|Adverse Event|6|||
126195974|NCT02477800|454000673|FG004|Long Term Extension Period|Adverse Event|2|||
126195975|NCT02477800|454000674|FG005|Long Term Extension Period|Adverse Event|4|||
126195976|NCT02477800|454000675|FG006|Long Term Extension Period|Adverse Event|3|||
126195977|NCT02477800|454000669|FG000|Long Term Extension Period|Death|0|||
126195978|NCT02477800|454000670|FG001|Long Term Extension Period|Death|0|||
126195979|NCT02477800|454000671|FG002|Long Term Extension Period|Death|0|||
126195980|NCT02477800|454000672|FG003|Long Term Extension Period|Death|1|||
126195981|NCT02477800|454000673|FG004|Long Term Extension Period|Death|1|||
126195982|NCT02477800|454000674|FG005|Long Term Extension Period|Death|1|||
126195983|NCT02477800|454000675|FG006|Long Term Extension Period|Death|2|||
126195984|NCT02477800|454000669|FG000|Long Term Extension Period|Consent Withdrawn|0|||
126195985|NCT02477800|454000670|FG001|Long Term Extension Period|Consent Withdrawn|0|||
126195986|NCT02477800|454000671|FG002|Long Term Extension Period|Consent Withdrawn|0|||
126195987|NCT02477800|454000672|FG003|Long Term Extension Period|Consent Withdrawn|10|||
126195988|NCT02477800|454000673|FG004|Long Term Extension Period|Consent Withdrawn|4|||
126195989|NCT02477800|454000674|FG005|Long Term Extension Period|Consent Withdrawn|13|||
126195990|NCT02477800|454000675|FG006|Long Term Extension Period|Consent Withdrawn|16|||
126195991|NCT02477800|454000669|FG000|Long Term Extension Period|Disease Progression|0|||
126195992|NCT02477800|454000670|FG001|Long Term Extension Period|Disease Progression|0|||
126195993|NCT02477800|454000671|FG002|Long Term Extension Period|Disease Progression|0|||
126195994|NCT02477800|454000672|FG003|Long Term Extension Period|Disease Progression|3|||
126195995|NCT02477800|454000673|FG004|Long Term Extension Period|Disease Progression|1|||
126195996|NCT02477800|454000674|FG005|Long Term Extension Period|Disease Progression|1|||
126195997|NCT02477800|454000675|FG006|Long Term Extension Period|Disease Progression|0|||
126195998|NCT02477800|454000669|FG000|Long Term Extension Period|Investigator Decision|0|||
126195999|NCT02477800|454000670|FG001|Long Term Extension Period|Investigator Decision|0|||
126196000|NCT02477800|454000671|FG002|Long Term Extension Period|Investigator Decision|0|||
126196001|NCT02477800|454000672|FG003|Long Term Extension Period|Investigator Decision|0|||
126196002|NCT02477800|454000673|FG004|Long Term Extension Period|Investigator Decision|0|||
126196003|NCT02477800|454000674|FG005|Long Term Extension Period|Investigator Decision|0|||
126196004|NCT02477800|454000675|FG006|Long Term Extension Period|Investigator Decision|2|||
126196005|NCT02477800|454000669|FG000|Long Term Extension Period|Lost to Follow-up|0|||
126196006|NCT02477800|454000670|FG001|Long Term Extension Period|Lost to Follow-up|0|||
126196007|NCT02477800|454000671|FG002|Long Term Extension Period|Lost to Follow-up|0|||
126196008|NCT02477800|454000672|FG003|Long Term Extension Period|Lost to Follow-up|0|||
126196009|NCT02477800|454000673|FG004|Long Term Extension Period|Lost to Follow-up|1|||
126196010|NCT02477800|454000674|FG005|Long Term Extension Period|Lost to Follow-up|3|||
126196011|NCT02477800|454000675|FG006|Long Term Extension Period|Lost to Follow-up|0|||
126196012|NCT02477800|454000669|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
126196013|NCT02477800|454000670|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
126196014|NCT02477800|454000671|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
126196015|NCT02477800|454000672|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
126196016|NCT02477800|454000673|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
126196017|NCT02477800|454000674|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
126196018|NCT02477800|454000675|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
126196019|NCT02477800|454000669|FG000|Long Term Extension Period|Study Visit Burden|0|||
126196020|NCT02477800|454000670|FG001|Long Term Extension Period|Study Visit Burden|0|||
126196021|NCT02477800|454000671|FG002|Long Term Extension Period|Study Visit Burden|0|||
126196022|NCT02477800|454000672|FG003|Long Term Extension Period|Study Visit Burden|3|||
126196023|NCT02477800|454000673|FG004|Long Term Extension Period|Study Visit Burden|0|||
126196024|NCT02477800|454000674|FG005|Long Term Extension Period|Study Visit Burden|2|||
126196025|NCT02477800|454000675|FG006|Long Term Extension Period|Study Visit Burden|2|||
126196026|NCT02477800|454000669|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
126196027|NCT02477800|454000670|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
126196028|NCT02477800|454000671|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
126196029|NCT02477800|454000672|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
126196030|NCT02477800|454000673|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
126196031|NCT02477800|454000674|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
126196032|NCT02477800|454000675|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
126196033|NCT02477800|454000669|FG000|Long Term Extension Period|Reason not Specified|0|||
126196034|NCT02477800|454000670|FG001|Long Term Extension Period|Reason not Specified|0|||
126196035|NCT02477800|454000671|FG002|Long Term Extension Period|Reason not Specified|0|||
126196036|NCT02477800|454000672|FG003|Long Term Extension Period|Reason not Specified|126|||
126196037|NCT02477800|454000673|FG004|Long Term Extension Period|Reason not Specified|140|||
126196038|NCT02477800|454000674|FG005|Long Term Extension Period|Reason not Specified|270|||
126196039|NCT02477800|454000675|FG006|Long Term Extension Period|Reason not Specified|224|||
126196040|NCT00170846|454000680|FG000|Overall Study|Subject withdrew Informed Consent|5|||
126196041|NCT00170846|454000681|FG001|Overall Study|Subject withdrew Informed Consent|12|||
126196042|NCT00170846|454000682|FG002|Overall Study|Subject withdrew Informed Consent|8|||
126196043|NCT00170846|454000680|FG000|Overall Study|Lost to Follow-up|6|||
126196044|NCT00170846|454000681|FG001|Overall Study|Lost to Follow-up|3|||
126196045|NCT00170846|454000682|FG002|Overall Study|Lost to Follow-up|2|||
126196046|NCT00170846|454000680|FG000|Overall Study|Death|0|||
126196047|NCT00170846|454000681|FG001|Overall Study|Death|3|||
126196048|NCT00170846|454000682|FG002|Overall Study|Death|3|||
126196049|NCT00170846|454000680|FG000|Overall Study|Reason Missing|0|||
126196050|NCT00170846|454000681|FG001|Overall Study|Reason Missing|1|||
126196051|NCT00170846|454000682|FG002|Overall Study|Reason Missing|0|||
126196052|NCT01756833|454000684|FG000|Overall Study|Withdrawal by Subject|4|||
126196053|NCT01756833|454000685|FG001|Overall Study|Withdrawal by Subject|3|||
126196054|NCT01700140|454000688|FG000|Overall Study|Use of rescue drugs|3|||
126196055|NCT01700140|454000689|FG001|Overall Study|Use of rescue drugs|3|||
126196056|NCT01700140|454000690|FG002|Overall Study|Use of rescue drugs|1|||
126196057|NCT01700140|454000688|FG000|Overall Study|Discontinuation of radiotherapy|1|||
126196058|NCT01700140|454000689|FG001|Overall Study|Discontinuation of radiotherapy|0|||
126196059|NCT01700140|454000690|FG002|Overall Study|Discontinuation of radiotherapy|0|||
126196060|NCT01700140|454000688|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
126196061|NCT01700140|454000689|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
126196062|NCT01700140|454000690|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
126196063|NCT01700140|454000688|FG000|Overall Study|Aggravation of symptoms|1|||
126196064|NCT01700140|454000689|FG001|Overall Study|Aggravation of symptoms|0|||
126196065|NCT01700140|454000690|FG002|Overall Study|Aggravation of symptoms|0|||
126196066|NCT01700140|454000688|FG000|Overall Study|Adverse Event|0|||
126196067|NCT01700140|454000689|FG001|Overall Study|Adverse Event|1|||
126196068|NCT01700140|454000690|FG002|Overall Study|Adverse Event|0|||
126196069|NCT01700140|454000688|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
126196070|NCT01700140|454000689|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
126196071|NCT01700140|454000690|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
126196072|NCT02573012|454000691|FG000|Overall Study|Adverse Event|5|||
126196073|NCT02573012|454000692|FG001|Overall Study|Adverse Event|5|||
126196074|NCT02573012|454000691|FG000|Overall Study|Lack of Efficacy|5|||
126196075|NCT02573012|454000692|FG001|Overall Study|Lack of Efficacy|4|||
126196076|NCT02573012|454000691|FG000|Overall Study|Non-compliance|1|||
126196077|NCT02573012|454000692|FG001|Overall Study|Non-compliance|2|||
126196078|NCT02573012|454000691|FG000|Overall Study|Withdrawal by Subject|2|||
126196079|NCT02573012|454000692|FG001|Overall Study|Withdrawal by Subject|2|||
126196080|NCT02573012|454000691|FG000|Overall Study|Study Ended per Protocol|1|||
126196081|NCT02573012|454000692|FG001|Overall Study|Study Ended per Protocol|0|||
126196082|NCT02573012|454000691|FG000|Overall Study|Physician Decision|1|||
126196083|NCT02573012|454000692|FG001|Overall Study|Physician Decision|2|||
126196084|NCT01601873|454000693|FG000|Overall Study|Lost to Follow-up|2|||
126196085|NCT01601873|454000694|FG001|Overall Study|Lost to Follow-up|3|||
126196086|NCT01222416|454000695|FG000|Overall Study|ineligible;metastasis|3|||
126196087|NCT01222416|454000696|FG001|Overall Study|ineligible;metastasis|0|||
126196088|NCT01222416|454000695|FG000|Overall Study|Adverse Event|4|||
126196089|NCT01222416|454000696|FG001|Overall Study|Adverse Event|0|||
126196090|NCT01222416|454000695|FG000|Overall Study|Withdrawal by Subject|5|||
126196091|NCT01222416|454000696|FG001|Overall Study|Withdrawal by Subject|0|||
126196092|NCT01222416|454000695|FG000|Overall Study|scheduling|6|||
126196093|NCT01222416|454000696|FG001|Overall Study|scheduling|0|||
126196094|NCT01222416|454000695|FG000|Overall Study|missed view/scan|1|||
126196095|NCT01222416|454000696|FG001|Overall Study|missed view/scan|0|||
126196096|NCT01222416|454000695|FG000|Overall Study|Death|1|||
126196097|NCT01222416|454000696|FG001|Overall Study|Death|0|||
126196098|NCT00518336|454000697|FG000|Year 7|Lost to Follow-up|2|||
126196099|NCT00518336|454000698|FG001|Year 7|Lost to Follow-up|0|||
126196100|NCT00518336|454000697|FG000|Year 7|Could not attend in time|0|||
126196101|NCT00518336|454000698|FG001|Year 7|Could not attend in time|3|||
126196102|NCT00518336|454000697|FG000|Year 8|Lost to Follow-up|1|||
126196103|NCT00518336|454000698|FG001|Year 8|Lost to Follow-up|1|||
126196104|NCT00518336|454000697|FG000|Year 8|Could not attend in time|0|||
126196105|NCT00518336|454000698|FG001|Year 8|Could not attend in time|1|||
126196106|NCT00518336|454000697|FG000|Year 9|Migrated/moved from study area|1|||
126196107|NCT00518336|454000698|FG001|Year 9|Migrated/moved from study area|1|||
126196108|NCT00518336|454000697|FG000|Year 9|Lost to Follow-up|3|||
126196109|NCT00518336|454000698|FG001|Year 9|Lost to Follow-up|0|||
126196110|NCT00518336|454000697|FG000|Year 9|Personal reasons|1|||
126196111|NCT00518336|454000698|FG001|Year 9|Personal reasons|0|||
126196112|NCT00125268|454000699|FG000|Overall Study|Withdrawal by Subject|1|||
126196113|NCT00125268|454000700|FG001|Overall Study|Withdrawal by Subject|1|||
126196114|NCT00286156|454000701|FG000|Overall Study|Missed 12 month visit|0|||
126196115|NCT00286156|454000702|FG001|Overall Study|Missed 12 month visit|0|||
126196116|NCT00286156|454000703|FG002|Overall Study|Missed 12 month visit|1|||
126196117|NCT00286156|454000701|FG000|Overall Study|AE: pulmonary embolus|0|||
126196118|NCT00286156|454000702|FG001|Overall Study|AE: pulmonary embolus|1|||
126196119|NCT00286156|454000703|FG002|Overall Study|AE: pulmonary embolus|0|||
126196120|NCT00286156|454000701|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
126196121|NCT00286156|454000702|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
126196122|NCT00286156|454000703|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
126196123|NCT00286156|454000701|FG000|Overall Study|AE: pneumonia|1|||
126196124|NCT00286156|454000702|FG001|Overall Study|AE: pneumonia|0|||
126196125|NCT00286156|454000703|FG002|Overall Study|AE: pneumonia|0|||
126196126|NCT02449915|454000705|FG000|Overall Study|Exclusion criteria - drug use|1|||
126196127|NCT02449915|454000706|FG001|Overall Study|Exclusion criteria - drug use|0|||
126196128|NCT02449915|454000705|FG000|Overall Study|Withdrawal by Subject|0|||
126196129|NCT02449915|454000706|FG001|Overall Study|Withdrawal by Subject|2|||
126196130|NCT02449915|454000705|FG000|Overall Study|Intraoperative surgical findings|1|||
126196131|NCT02449915|454000706|FG001|Overall Study|Intraoperative surgical findings|1|||
126196132|NCT02449915|454000705|FG000|Overall Study|Abnormal preop lab|0|||
126196133|NCT02449915|454000706|FG001|Overall Study|Abnormal preop lab|1|||
126196134|NCT01855919|454002313|FG000|Overall Study|Adverse Event|16|||
126196135|NCT01855919|454002314|FG001|Overall Study|Adverse Event|8|||
126196136|NCT01855919|454002313|FG000|Overall Study|Lack of Efficacy|1|||
126196137|NCT01855919|454002314|FG001|Overall Study|Lack of Efficacy|3|||
126196138|NCT01855919|454002313|FG000|Overall Study|Withdrawal by Subject|4|||
126196139|NCT01855919|454002314|FG001|Overall Study|Withdrawal by Subject|10|||
126196140|NCT01855919|454002313|FG000|Overall Study|Entry Criteria Not Met|1|||
126196141|NCT01855919|454002314|FG001|Overall Study|Entry Criteria Not Met|1|||
126196142|NCT01855919|454002313|FG000|Overall Study|Protocol Violation|1|||
126196143|NCT01855919|454002314|FG001|Overall Study|Protocol Violation|4|||
126196144|NCT04459416|454002315|FG000|Overall Study|Lost to Follow-up|2|||
126196145|NCT04459416|454002316|FG001|Overall Study|Lost to Follow-up|0|||
126196146|NCT04459416|454002315|FG000|Overall Study|Withdrawal by Subject|8|||
126196147|NCT04459416|454002316|FG001|Overall Study|Withdrawal by Subject|10|||
126196148|NCT04459416|454002315|FG000|Overall Study|Disease progression|0|||
126196149|NCT04459416|454002316|FG001|Overall Study|Disease progression|3|||
126196150|NCT03455530|454002317|FG000|Overall Study|Withdrawal by Subject|9|||
126196151|NCT03455530|454002318|FG001|Overall Study|Withdrawal by Subject|1|||
126196152|NCT03455530|454002319|FG002|Overall Study|Withdrawal by Subject|3|||
126196153|NCT03455530|454002320|FG003|Overall Study|Withdrawal by Subject|3|||
126196154|NCT01592773|454002321|FG000|Overall Study|Study Terminated by Sponsor|582|||
126196155|NCT01592773|454002321|FG000|Overall Study|Withdrawal by Subject|35|||
126196156|NCT01592773|454002321|FG000|Overall Study|Lost to Follow-up|19|||
126196157|NCT01592773|454002321|FG000|Overall Study|Adverse Event|17|||
126196158|NCT01592773|454002321|FG000|Overall Study|Lack of Efficacy|9|||
126196159|NCT01592773|454002321|FG000|Overall Study|Protocol Violation|2|||
126196160|NCT01592773|454002321|FG000|Overall Study|Inclusion/exclusion not meet|1|||
126196161|NCT01592773|454002321|FG000|Overall Study|Other Reason|1|||
126196162|NCT00740116|454002325|FG000|Overall Study|Withdrawal by Subject|1|||
126196163|NCT00740116|454002326|FG001|Overall Study|Withdrawal by Subject|1|||
126196164|NCT00740116|454002325|FG000|Overall Study|Protocol Violation|1|||
126196165|NCT00740116|454002326|FG001|Overall Study|Protocol Violation|4|||
126196166|NCT03037489|454002327|FG000|Overall Study|Adverse Event|4|||
126196167|NCT03037489|454002328|FG001|Overall Study|Adverse Event|0|||
126196168|NCT03037489|454002327|FG000|Overall Study|Withdrawal by Subject|3|||
126196169|NCT03037489|454002328|FG001|Overall Study|Withdrawal by Subject|0|||
126196170|NCT00121485|454002329|FG000|Overall Study|Not implanted|1|||
126196171|NCT00121485|454002330|FG001|Overall Study|Not implanted|5|||
126196172|NCT00121485|454002329|FG000|Overall Study|Crossover|0|||
126196173|NCT00121485|454002330|FG001|Overall Study|Crossover|2|||
126196174|NCT00724243|454002333|FG000|Overall Study|Lack of Efficacy|10|||
126196175|NCT00724243|454002333|FG000|Overall Study|Adverse Event|5|||
126196176|NCT03031327|454002334|FG000|Overall Study|Withdrawal by Subject|0|||
126196177|NCT03031327|454002335|FG001|Overall Study|Withdrawal by Subject|1|||
126196178|NCT03031327|454002336|FG002|Overall Study|Withdrawal by Subject|1|||
126196179|NCT01004861|454002337|FG000|Overall Study|Disease progression|3|||
126196180|NCT01004861|454002338|FG001|Overall Study|Disease progression|4|||
126196181|NCT01004861|454002339|FG002|Overall Study|Disease progression|5|||
126196182|NCT01004861|454002340|FG003|Overall Study|Disease progression|4|||
126196183|NCT01004861|454002341|FG004|Overall Study|Disease progression|4|||
126196184|NCT01004861|454002342|FG005|Overall Study|Disease progression|4|||
126196185|NCT01004861|454002343|FG006|Overall Study|Disease progression|5|||
126196186|NCT01004861|454002344|FG007|Overall Study|Disease progression|1|||
126196187|NCT01004861|454002345|FG008|Overall Study|Disease progression|4|||
126196188|NCT01004861|454002346|FG009|Overall Study|Disease progression|7|||
126196189|NCT01004861|454002347|FG010|Overall Study|Disease progression|6|||
126196190|NCT01004861|454002348|FG011|Overall Study|Disease progression|3|||
126196191|NCT01004861|454002349|FG012|Overall Study|Disease progression|8|||
126196192|NCT01004861|454002337|FG000|Overall Study|Physician Decision|0|||
126196193|NCT01004861|454002338|FG001|Overall Study|Physician Decision|2|||
126196194|NCT01004861|454002339|FG002|Overall Study|Physician Decision|1|||
126196195|NCT01004861|454002340|FG003|Overall Study|Physician Decision|1|||
126196196|NCT01004861|454002341|FG004|Overall Study|Physician Decision|1|||
126196197|NCT01004861|454002342|FG005|Overall Study|Physician Decision|0|||
126196198|NCT01004861|454002343|FG006|Overall Study|Physician Decision|0|||
126196199|NCT01004861|454002344|FG007|Overall Study|Physician Decision|1|||
126196200|NCT01004861|454002345|FG008|Overall Study|Physician Decision|0|||
126196201|NCT01004861|454002346|FG009|Overall Study|Physician Decision|0|||
126196202|NCT01004861|454002347|FG010|Overall Study|Physician Decision|0|||
126196203|NCT01004861|454002348|FG011|Overall Study|Physician Decision|0|||
126196204|NCT01004861|454002349|FG012|Overall Study|Physician Decision|3|||
126196205|NCT01004861|454002337|FG000|Overall Study|Adverse Event|0|||
126196206|NCT01004861|454002338|FG001|Overall Study|Adverse Event|0|||
126196207|NCT01004861|454002339|FG002|Overall Study|Adverse Event|0|||
126196208|NCT01004861|454002340|FG003|Overall Study|Adverse Event|1|||
126196209|NCT01004861|454002341|FG004|Overall Study|Adverse Event|0|||
126196210|NCT01004861|454002342|FG005|Overall Study|Adverse Event|2|||
126196211|NCT01004861|454002343|FG006|Overall Study|Adverse Event|1|||
126196212|NCT01004861|454002344|FG007|Overall Study|Adverse Event|1|||
126196213|NCT01004861|454002345|FG008|Overall Study|Adverse Event|13|||
126196214|NCT01004861|454002346|FG009|Overall Study|Adverse Event|1|||
126196215|NCT01004861|454002347|FG010|Overall Study|Adverse Event|1|||
126196216|NCT01004861|454002348|FG011|Overall Study|Adverse Event|0|||
126196217|NCT01004861|454002349|FG012|Overall Study|Adverse Event|2|||
126196218|NCT01004861|454002337|FG000|Overall Study|Protocol Violation|0|||
126196219|NCT01004861|454002338|FG001|Overall Study|Protocol Violation|0|||
126196220|NCT01004861|454002339|FG002|Overall Study|Protocol Violation|0|||
126196221|NCT01004861|454002340|FG003|Overall Study|Protocol Violation|0|||
126196222|NCT01004861|454002341|FG004|Overall Study|Protocol Violation|1|||
126196223|NCT01004861|454002342|FG005|Overall Study|Protocol Violation|0|||
126196224|NCT01004861|454002343|FG006|Overall Study|Protocol Violation|0|||
126196225|NCT01004861|454002344|FG007|Overall Study|Protocol Violation|0|||
126196226|NCT01004861|454002345|FG008|Overall Study|Protocol Violation|0|||
126196227|NCT01004861|454002346|FG009|Overall Study|Protocol Violation|0|||
126196228|NCT01004861|454002347|FG010|Overall Study|Protocol Violation|0|||
126196229|NCT01004861|454002348|FG011|Overall Study|Protocol Violation|0|||
126196230|NCT01004861|454002349|FG012|Overall Study|Protocol Violation|0|||
126196231|NCT01004861|454002337|FG000|Overall Study|Lost to Follow-up|0|||
126196232|NCT01004861|454002338|FG001|Overall Study|Lost to Follow-up|0|||
126196233|NCT01004861|454002339|FG002|Overall Study|Lost to Follow-up|0|||
126196234|NCT01004861|454002340|FG003|Overall Study|Lost to Follow-up|0|||
126196235|NCT01004861|454002341|FG004|Overall Study|Lost to Follow-up|0|||
126196236|NCT01004861|454002342|FG005|Overall Study|Lost to Follow-up|0|||
126196237|NCT01004861|454002343|FG006|Overall Study|Lost to Follow-up|0|||
126196238|NCT01004861|454002344|FG007|Overall Study|Lost to Follow-up|1|||
126196239|NCT01004861|454002345|FG008|Overall Study|Lost to Follow-up|3|||
126196240|NCT01004861|454002346|FG009|Overall Study|Lost to Follow-up|0|||
126196241|NCT01004861|454002347|FG010|Overall Study|Lost to Follow-up|0|||
126196242|NCT01004861|454002348|FG011|Overall Study|Lost to Follow-up|1|||
126196243|NCT01004861|454002349|FG012|Overall Study|Lost to Follow-up|0|||
126196244|NCT01004861|454002337|FG000|Overall Study|Non-compliance|0|||
126196245|NCT01004861|454002338|FG001|Overall Study|Non-compliance|0|||
126196246|NCT01004861|454002339|FG002|Overall Study|Non-compliance|0|||
126196247|NCT01004861|454002340|FG003|Overall Study|Non-compliance|0|||
126196248|NCT01004861|454002341|FG004|Overall Study|Non-compliance|0|||
126196249|NCT01004861|454002342|FG005|Overall Study|Non-compliance|0|||
126196250|NCT01004861|454002343|FG006|Overall Study|Non-compliance|0|||
126196251|NCT01004861|454002344|FG007|Overall Study|Non-compliance|0|||
126196252|NCT01004861|454002345|FG008|Overall Study|Non-compliance|5|||
126196253|NCT01004861|454002346|FG009|Overall Study|Non-compliance|0|||
126196254|NCT01004861|454002347|FG010|Overall Study|Non-compliance|0|||
126196255|NCT01004861|454002348|FG011|Overall Study|Non-compliance|0|||
126196256|NCT01004861|454002349|FG012|Overall Study|Non-compliance|1|||
126196257|NCT01004861|454002337|FG000|Overall Study|Other|0|||
126196258|NCT01004861|454002338|FG001|Overall Study|Other|0|||
126196259|NCT01004861|454002339|FG002|Overall Study|Other|0|||
126196260|NCT01004861|454002340|FG003|Overall Study|Other|0|||
126196261|NCT01004861|454002341|FG004|Overall Study|Other|0|||
126196262|NCT01004861|454002342|FG005|Overall Study|Other|0|||
126196263|NCT01004861|454002343|FG006|Overall Study|Other|0|||
126196264|NCT01004861|454002344|FG007|Overall Study|Other|0|||
126196265|NCT01004861|454002345|FG008|Overall Study|Other|0|||
126196266|NCT01004861|454002346|FG009|Overall Study|Other|2|||
126196267|NCT01004861|454002347|FG010|Overall Study|Other|1|||
126196268|NCT01004861|454002348|FG011|Overall Study|Other|2|||
126196269|NCT01004861|454002349|FG012|Overall Study|Other|3|||
126196270|NCT01004861|454002337|FG000|Overall Study|Patient decision|0|||
126196271|NCT01004861|454002338|FG001|Overall Study|Patient decision|0|||
126196272|NCT01004861|454002339|FG002|Overall Study|Patient decision|0|||
126196273|NCT01004861|454002340|FG003|Overall Study|Patient decision|0|||
126196274|NCT01004861|454002341|FG004|Overall Study|Patient decision|1|||
126196275|NCT01004861|454002342|FG005|Overall Study|Patient decision|0|||
126196276|NCT01004861|454002343|FG006|Overall Study|Patient decision|1|||
126196277|NCT01004861|454002344|FG007|Overall Study|Patient decision|0|||
126196278|NCT01004861|454002345|FG008|Overall Study|Patient decision|7|||
126196279|NCT01004861|454002346|FG009|Overall Study|Patient decision|1|||
126196280|NCT01004861|454002347|FG010|Overall Study|Patient decision|1|||
126196281|NCT01004861|454002348|FG011|Overall Study|Patient decision|2|||
126196282|NCT01004861|454002349|FG012|Overall Study|Patient decision|3|||
126196283|NCT01004861|454002337|FG000|Overall Study|Transitioned to Phase 4 study|0|||
126196284|NCT01004861|454002338|FG001|Overall Study|Transitioned to Phase 4 study|0|||
126196285|NCT01004861|454002339|FG002|Overall Study|Transitioned to Phase 4 study|0|||
126196286|NCT01004861|454002340|FG003|Overall Study|Transitioned to Phase 4 study|0|||
126196287|NCT01004861|454002341|FG004|Overall Study|Transitioned to Phase 4 study|0|||
126196288|NCT01004861|454002342|FG005|Overall Study|Transitioned to Phase 4 study|0|||
126196289|NCT01004861|454002343|FG006|Overall Study|Transitioned to Phase 4 study|0|||
126196290|NCT01004861|454002344|FG007|Overall Study|Transitioned to Phase 4 study|0|||
126196291|NCT01004861|454002345|FG008|Overall Study|Transitioned to Phase 4 study|2|||
126196292|NCT01004861|454002346|FG009|Overall Study|Transitioned to Phase 4 study|0|||
126196293|NCT01004861|454002347|FG010|Overall Study|Transitioned to Phase 4 study|0|||
126196294|NCT01004861|454002348|FG011|Overall Study|Transitioned to Phase 4 study|0|||
126196295|NCT01004861|454002349|FG012|Overall Study|Transitioned to Phase 4 study|0|||
126196296|NCT01004861|454002337|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196297|NCT01004861|454002338|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196298|NCT01004861|454002339|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196299|NCT01004861|454002340|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196300|NCT01004861|454002341|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196301|NCT01004861|454002342|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196302|NCT01004861|454002343|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196303|NCT01004861|454002344|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196304|NCT01004861|454002345|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
126196305|NCT01004861|454002346|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196306|NCT01004861|454002347|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196307|NCT01004861|454002348|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196308|NCT01004861|454002349|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126196309|NCT01004861|454002337|FG000|Overall Study|Patient withdrew|0|||
126196310|NCT01004861|454002338|FG001|Overall Study|Patient withdrew|0|||
126196311|NCT01004861|454002339|FG002|Overall Study|Patient withdrew|0|||
126196312|NCT01004861|454002340|FG003|Overall Study|Patient withdrew|0|||
126196313|NCT01004861|454002341|FG004|Overall Study|Patient withdrew|0|||
126196314|NCT01004861|454002342|FG005|Overall Study|Patient withdrew|0|||
126196315|NCT01004861|454002343|FG006|Overall Study|Patient withdrew|0|||
126196316|NCT01004861|454002344|FG007|Overall Study|Patient withdrew|0|||
126196317|NCT01004861|454002345|FG008|Overall Study|Patient withdrew|1|||
126196318|NCT01004861|454002346|FG009|Overall Study|Patient withdrew|0|||
126196319|NCT01004861|454002347|FG010|Overall Study|Patient withdrew|0|||
126196320|NCT01004861|454002348|FG011|Overall Study|Patient withdrew|0|||
126196321|NCT01004861|454002349|FG012|Overall Study|Patient withdrew|0|||
126196322|NCT01004861|454002337|FG000|Overall Study|Surgical resection|0|||
126196323|NCT01004861|454002338|FG001|Overall Study|Surgical resection|0|||
126196324|NCT01004861|454002339|FG002|Overall Study|Surgical resection|0|||
126196325|NCT01004861|454002340|FG003|Overall Study|Surgical resection|0|||
126196326|NCT01004861|454002341|FG004|Overall Study|Surgical resection|0|||
126196327|NCT01004861|454002342|FG005|Overall Study|Surgical resection|0|||
126196328|NCT01004861|454002343|FG006|Overall Study|Surgical resection|0|||
126196329|NCT01004861|454002344|FG007|Overall Study|Surgical resection|0|||
126196330|NCT01004861|454002345|FG008|Overall Study|Surgical resection|1|||
126196331|NCT01004861|454002346|FG009|Overall Study|Surgical resection|0|||
126196332|NCT01004861|454002347|FG010|Overall Study|Surgical resection|0|||
126196333|NCT01004861|454002348|FG011|Overall Study|Surgical resection|0|||
126196334|NCT01004861|454002349|FG012|Overall Study|Surgical resection|0|||
126196335|NCT01004861|454002337|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196336|NCT01004861|454002338|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196337|NCT01004861|454002339|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196338|NCT01004861|454002340|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196339|NCT01004861|454002341|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196340|NCT01004861|454002342|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196341|NCT01004861|454002343|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196342|NCT01004861|454002344|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196343|NCT01004861|454002345|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
126196344|NCT01004861|454002346|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196345|NCT01004861|454002347|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196346|NCT01004861|454002348|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196347|NCT01004861|454002349|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126196348|NCT01004861|454002337|FG000|Overall Study|Study termination by Sponsor|0|||
126196349|NCT01004861|454002338|FG001|Overall Study|Study termination by Sponsor|0|||
126196350|NCT01004861|454002339|FG002|Overall Study|Study termination by Sponsor|0|||
126196351|NCT01004861|454002340|FG003|Overall Study|Study termination by Sponsor|0|||
126196352|NCT01004861|454002341|FG004|Overall Study|Study termination by Sponsor|0|||
126196353|NCT01004861|454002342|FG005|Overall Study|Study termination by Sponsor|0|||
126196354|NCT01004861|454002343|FG006|Overall Study|Study termination by Sponsor|0|||
126196355|NCT01004861|454002344|FG007|Overall Study|Study termination by Sponsor|0|||
126196356|NCT01004861|454002345|FG008|Overall Study|Study termination by Sponsor|1|||
126196357|NCT01004861|454002346|FG009|Overall Study|Study termination by Sponsor|0|||
126196358|NCT01004861|454002347|FG010|Overall Study|Study termination by Sponsor|0|||
126196359|NCT01004861|454002348|FG011|Overall Study|Study termination by Sponsor|0|||
126196360|NCT01004861|454002349|FG012|Overall Study|Study termination by Sponsor|0|||
126196361|NCT00686699|454002350|FG000|Treatment Period 1|Adverse Event|0|||
126196362|NCT00686699|454002351|FG001|Treatment Period 1|Adverse Event|2|||
126196363|NCT02608099|454002355|FG000|Overall Study|Ablation procedure not initiated|3|||
126196364|NCT02608099|454002356|FG001|Overall Study|Ablation procedure not initiated|2|||
126196365|NCT04657003|454002360|FG000|Overall Study|Adverse Event|5|||
126196366|NCT04657003|454002361|FG001|Overall Study|Adverse Event|1|||
126196367|NCT04657003|454002362|FG002|Overall Study|Adverse Event|5|||
126196368|NCT04657003|454002360|FG000|Overall Study|Death|0|||
126196369|NCT04657003|454002361|FG001|Overall Study|Death|2|||
126196370|NCT04657003|454002362|FG002|Overall Study|Death|0|||
126196371|NCT04657003|454002360|FG000|Overall Study|Lost to Follow-up|8|||
126196372|NCT04657003|454002361|FG001|Overall Study|Lost to Follow-up|4|||
126196373|NCT04657003|454002362|FG002|Overall Study|Lost to Follow-up|10|||
126196374|NCT04657003|454002360|FG000|Overall Study|Other - As Reported by Investigator|3|||
126196375|NCT04657003|454002361|FG001|Overall Study|Other - As Reported by Investigator|2|||
126196376|NCT04657003|454002362|FG002|Overall Study|Other - As Reported by Investigator|2|||
126196377|NCT04657003|454002360|FG000|Overall Study|Pregnancy|2|||
126196378|NCT04657003|454002361|FG001|Overall Study|Pregnancy|0|||
126196379|NCT04657003|454002362|FG002|Overall Study|Pregnancy|2|||
126196380|NCT04657003|454002360|FG000|Overall Study|Withdrawal by Subject|16|||
126196381|NCT04657003|454002361|FG001|Overall Study|Withdrawal by Subject|7|||
126196382|NCT04657003|454002362|FG002|Overall Study|Withdrawal by Subject|10|||
126196383|NCT01736176|454002363|FG000|Overall Study|Adverse Event|3|||
126196384|NCT01736176|454002363|FG000|Overall Study|Withdrawal by Subject|4|||
126196385|NCT01736176|454002363|FG000|Overall Study|Lack of Efficacy|3|||
126196386|NCT01736176|454002363|FG000|Overall Study|Unable to Complete PEG Placement|1|||
126196387|NCT00811395|454002366|FG000|Extension Treatment|Adverse Event|1|||
126196388|NCT00811395|454002367|FG001|Extension Treatment|Adverse Event|2|||
126196389|NCT00811395|454002368|FG002|Extension Treatment|Adverse Event|2|||
126196390|NCT00811395|454002369|FG003|Extension Treatment|Adverse Event|2|||
126196391|NCT00811395|454002370|FG004|Extension Treatment|Adverse Event|0|||
126196392|NCT00811395|454002371|FG005|Extension Treatment|Adverse Event|1|||
126196393|NCT00811395|454002366|FG000|Extension Treatment|Progressive disease|1|||
126196394|NCT00811395|454002367|FG001|Extension Treatment|Progressive disease|1|||
126196395|NCT00811395|454002368|FG002|Extension Treatment|Progressive disease|0|||
126196396|NCT00811395|454002369|FG003|Extension Treatment|Progressive disease|0|||
126196397|NCT00811395|454002370|FG004|Extension Treatment|Progressive disease|0|||
126196398|NCT00811395|454002371|FG005|Extension Treatment|Progressive disease|0|||
126196399|NCT00811395|454002366|FG000|Extension Treatment|Participant did not wish to continue|0|||
126196400|NCT00811395|454002367|FG001|Extension Treatment|Participant did not wish to continue|3|||
126196401|NCT00811395|454002368|FG002|Extension Treatment|Participant did not wish to continue|0|||
126196402|NCT00811395|454002369|FG003|Extension Treatment|Participant did not wish to continue|1|||
126196403|NCT00811395|454002370|FG004|Extension Treatment|Participant did not wish to continue|0|||
126196404|NCT00811395|454002371|FG005|Extension Treatment|Participant did not wish to continue|1|||
126196405|NCT00811395|454002366|FG000|Extension Treatment|Other than above|0|||
126196406|NCT00811395|454002367|FG001|Extension Treatment|Other than above|0|||
126196407|NCT00811395|454002368|FG002|Extension Treatment|Other than above|1|||
126196408|NCT00811395|454002369|FG003|Extension Treatment|Other than above|0|||
126196409|NCT00811395|454002370|FG004|Extension Treatment|Other than above|0|||
126196410|NCT00811395|454002371|FG005|Extension Treatment|Other than above|0|||
126196411|NCT02607865|454002374|FG000|Overall Study|Lost to Follow-up|9|||
126196412|NCT02607865|454002375|FG001|Overall Study|Lost to Follow-up|7|||
126196413|NCT02607865|454002376|FG002|Overall Study|Lost to Follow-up|7|||
126196414|NCT02607865|454002377|FG003|Overall Study|Lost to Follow-up|5|||
126196415|NCT02607865|454002374|FG000|Overall Study|Withdrawal by Subject|18|||
126196416|NCT02607865|454002375|FG001|Overall Study|Withdrawal by Subject|18|||
126196417|NCT02607865|454002376|FG002|Overall Study|Withdrawal by Subject|17|||
126196418|NCT02607865|454002377|FG003|Overall Study|Withdrawal by Subject|8|||
126196419|NCT02607865|454002374|FG000|Overall Study|Death|5|||
126196420|NCT02607865|454002375|FG001|Overall Study|Death|4|||
126196421|NCT02607865|454002376|FG002|Overall Study|Death|1|||
126196422|NCT02607865|454002377|FG003|Overall Study|Death|3|||
126196423|NCT02607865|454002374|FG000|Overall Study|Unclassified|1|||
126196424|NCT02607865|454002375|FG001|Overall Study|Unclassified|1|||
126196425|NCT02607865|454002376|FG002|Overall Study|Unclassified|2|||
126196426|NCT02607865|454002377|FG003|Overall Study|Unclassified|0|||
126196427|NCT00528840|454002378|FG000|Overall Study|Lost to Follow-up|10|||
126196428|NCT00528840|454002378|FG000|Overall Study|Adverse Event|1|||
126196429|NCT00528840|454002378|FG000|Overall Study|Withdrawal by Subject|17|||
126196430|NCT00528840|454002378|FG000|Overall Study|Death|2|||
126196431|NCT00528840|454002378|FG000|Overall Study|Administrative Reasons|1|||
126196432|NCT00528840|454002378|FG000|Overall Study|Other|2|||
126196433|NCT02447952|454002379|FG000|Overall Study|Adverse Event|2|||
126196434|NCT02447952|454002379|FG000|Overall Study|Physician Decision|1|||
126196435|NCT02447952|454002379|FG000|Overall Study|Withdrawal by Subject|4|||
126196436|NCT01766401|454002384|FG000|Overall Study|Adverse Event|7|||
126196437|NCT01766401|454002385|FG001|Overall Study|Adverse Event|22|||
126196438|NCT01766401|454002384|FG000|Overall Study|Lack of Efficacy|1|||
126196439|NCT01766401|454002385|FG001|Overall Study|Lack of Efficacy|2|||
126196440|NCT01766401|454002384|FG000|Overall Study|Protocol Violation|3|||
126196441|NCT01766401|454002385|FG001|Overall Study|Protocol Violation|8|||
126196442|NCT01766401|454002384|FG000|Overall Study|Withdrawal by Subject|15|||
126196443|NCT01766401|454002385|FG001|Overall Study|Withdrawal by Subject|12|||
126196444|NCT01766401|454002384|FG000|Overall Study|Lost to Follow-up|10|||
126196445|NCT01766401|454002385|FG001|Overall Study|Lost to Follow-up|11|||
126196446|NCT01766401|454002384|FG000|Overall Study|Pregnancy|1|||
126196447|NCT01766401|454002385|FG001|Overall Study|Pregnancy|1|||
126196448|NCT00398086|454002389|FG000|Overall Study|Unacceptable Toxicity|2|||
126196449|NCT00398086|454002390|FG001|Overall Study|Unacceptable Toxicity|8|||
126196450|NCT00398086|454002391|FG002|Overall Study|Unacceptable Toxicity|2|||
126196451|NCT00398086|454002389|FG000|Overall Study|Adverse Event|1|||
126196452|NCT00398086|454002390|FG001|Overall Study|Adverse Event|4|||
126196453|NCT00398086|454002391|FG002|Overall Study|Adverse Event|0|||
126196454|NCT00398086|454002389|FG000|Overall Study|Physician Decision|1|||
126196455|NCT00398086|454002390|FG001|Overall Study|Physician Decision|4|||
126196456|NCT00398086|454002391|FG002|Overall Study|Physician Decision|0|||
126196457|NCT00398086|454002389|FG000|Overall Study|Withdrawal by Subject|5|||
126196458|NCT00398086|454002390|FG001|Overall Study|Withdrawal by Subject|7|||
126196459|NCT00398086|454002391|FG002|Overall Study|Withdrawal by Subject|0|||
126196460|NCT01950364|454002392|FG000|Overall Study|Adverse Event|3|||
126196461|NCT01950364|454002393|FG001|Overall Study|Adverse Event|0|||
126196462|NCT01950364|454002392|FG000|Overall Study|Stem Cell Transplant|2|||
126196463|NCT01950364|454002393|FG001|Overall Study|Stem Cell Transplant|6|||
126196464|NCT01950364|454002392|FG000|Overall Study|Disease Progression|5|||
126196465|NCT01950364|454002393|FG001|Overall Study|Disease Progression|2|||
126196466|NCT01950364|454002392|FG000|Overall Study|Withdrawal by Subject|0|||
126196467|NCT01950364|454002393|FG001|Overall Study|Withdrawal by Subject|1|||
126196468|NCT01950364|454002392|FG000|Overall Study|Protocol Violation|0|||
126196469|NCT01950364|454002393|FG001|Overall Study|Protocol Violation|1|||
126196470|NCT00998985|454002397|FG000|Overall Study|Withdrawal by Subject|0|||
126196471|NCT00998985|454002398|FG001|Overall Study|Withdrawal by Subject|0|||
126196472|NCT00998985|454002399|FG002|Overall Study|Withdrawal by Subject|0|||
126196473|NCT00998985|454002400|FG003|Overall Study|Withdrawal by Subject|0|||
126196474|NCT00998985|454002401|FG004|Overall Study|Withdrawal by Subject|0|||
126196475|NCT00998985|454002402|FG005|Overall Study|Withdrawal by Subject|0|||
126196476|NCT00998985|454002403|FG006|Overall Study|Withdrawal by Subject|0|||
126196477|NCT00998985|454002404|FG007|Overall Study|Withdrawal by Subject|0|||
126196478|NCT00998985|454002405|FG008|Overall Study|Withdrawal by Subject|1|||
126196479|NCT00998985|454002406|FG009|Overall Study|Withdrawal by Subject|0|||
126196480|NCT00998985|454002407|FG010|Overall Study|Withdrawal by Subject|0|||
126196481|NCT00998985|454002408|FG011|Overall Study|Withdrawal by Subject|0|||
126196482|NCT00998985|454002409|FG012|Overall Study|Withdrawal by Subject|0|||
126196483|NCT00998985|454002410|FG013|Overall Study|Withdrawal by Subject|0|||
126196484|NCT00998985|454002397|FG000|Overall Study|Protocol Violation|0|||
126196485|NCT00998985|454002398|FG001|Overall Study|Protocol Violation|0|||
126196486|NCT00998985|454002399|FG002|Overall Study|Protocol Violation|0|||
126196487|NCT00998985|454002400|FG003|Overall Study|Protocol Violation|0|||
126196488|NCT00998985|454002401|FG004|Overall Study|Protocol Violation|0|||
126196489|NCT00998985|454002402|FG005|Overall Study|Protocol Violation|1|||
126196490|NCT00998985|454002403|FG006|Overall Study|Protocol Violation|0|||
126196491|NCT00998985|454002404|FG007|Overall Study|Protocol Violation|0|||
126196492|NCT00998985|454002405|FG008|Overall Study|Protocol Violation|0|||
126196493|NCT00998985|454002406|FG009|Overall Study|Protocol Violation|0|||
126196494|NCT00998985|454002407|FG010|Overall Study|Protocol Violation|0|||
126196495|NCT00998985|454002408|FG011|Overall Study|Protocol Violation|0|||
126196496|NCT00998985|454002409|FG012|Overall Study|Protocol Violation|0|||
126196497|NCT00998985|454002410|FG013|Overall Study|Protocol Violation|0|||
126196498|NCT01040728|454002412|FG000|Overall Study|Adverse Event|4|||
126196499|NCT01040728|454002413|FG001|Overall Study|Adverse Event|8|||
126196500|NCT01040728|454002414|FG002|Overall Study|Adverse Event|0|||
126196501|NCT01040728|454002415|FG003|Overall Study|Adverse Event|4|||
126196502|NCT01040728|454002412|FG000|Overall Study|Withdrawal by Subject|0|||
126196503|NCT01040728|454002413|FG001|Overall Study|Withdrawal by Subject|1|||
126196504|NCT01040728|454002414|FG002|Overall Study|Withdrawal by Subject|1|||
126196505|NCT01040728|454002415|FG003|Overall Study|Withdrawal by Subject|0|||
126196506|NCT01040728|454002412|FG000|Overall Study|Protocol Violation|0|||
126196507|NCT01040728|454002413|FG001|Overall Study|Protocol Violation|0|||
126196508|NCT01040728|454002414|FG002|Overall Study|Protocol Violation|0|||
126196509|NCT01040728|454002415|FG003|Overall Study|Protocol Violation|1|||
126196510|NCT01040728|454002412|FG000|Overall Study|Lack of Efficacy|0|||
126196511|NCT01040728|454002413|FG001|Overall Study|Lack of Efficacy|1|||
126196512|NCT01040728|454002414|FG002|Overall Study|Lack of Efficacy|0|||
126196513|NCT01040728|454002415|FG003|Overall Study|Lack of Efficacy|1|||
126196514|NCT01040728|454002412|FG000|Overall Study|Other reasons not listed above|0|||
126196515|NCT01040728|454002413|FG001|Overall Study|Other reasons not listed above|1|||
126196516|NCT01040728|454002414|FG002|Overall Study|Other reasons not listed above|0|||
126196517|NCT01040728|454002415|FG003|Overall Study|Other reasons not listed above|0|||
126196518|NCT01875874|454002418|FG000|Overall Study|Death|3|||
126196519|NCT00590031|454002419|FG000|Overall Study|Adverse Event|3|||
126196520|NCT00590031|454002419|FG000|Overall Study|Withdrawal by Subject|1|||
126196521|NCT00590031|454002419|FG000|Overall Study|Metastatic Disease|1|||
126196522|NCT00590031|454002419|FG000|Overall Study|Admin Hold|1|||
126196523|NCT02463331|454002433|FG000|Overall Study|Adverse Event|4|||
126196524|NCT02463331|454002434|FG001|Overall Study|Adverse Event|2|||
126196525|NCT02463331|454002433|FG000|Overall Study|Lost to Follow-up|1|||
126196526|NCT02463331|454002434|FG001|Overall Study|Lost to Follow-up|1|||
126196527|NCT02463331|454002433|FG000|Overall Study|Pregnancy|2|||
126196528|NCT02463331|454002434|FG001|Overall Study|Pregnancy|3|||
126196529|NCT02463331|454002433|FG000|Overall Study|Lack of Efficacy|6|||
126196530|NCT02463331|454002434|FG001|Overall Study|Lack of Efficacy|0|||
126196531|NCT02463331|454002433|FG000|Overall Study|Physician Decision|3|||
126196532|NCT02463331|454002434|FG001|Overall Study|Physician Decision|0|||
126196533|NCT00826540|454002435|FG000|Overall Study|ineligible|3|||
126196534|NCT00826540|454002435|FG000|Overall Study|Withdrawal by Subject|1|||
126196535|NCT01166386|454002436|FG000|Overall Study|Withdrawal by Subject|3|||
126196536|NCT01166386|454002437|FG001|Overall Study|Withdrawal by Subject|5|||
126196537|NCT02274766|454002438|FG000|Overall Study|Withdrawal by Subject|3|||
126196538|NCT02274766|454002439|FG001|Overall Study|Withdrawal by Subject|6|||
126196539|NCT02274766|454002438|FG000|Overall Study|Did Not Receive Study Drug|1|||
126196540|NCT02274766|454002439|FG001|Overall Study|Did Not Receive Study Drug|1|||
126196541|NCT02274766|454002438|FG000|Overall Study|Subject Unwilling to Proceed|0|||
126196542|NCT02274766|454002439|FG001|Overall Study|Subject Unwilling to Proceed|1|||
126196543|NCT02274766|454002438|FG000|Overall Study|Adverse Event|0|||
126196544|NCT02274766|454002439|FG001|Overall Study|Adverse Event|1|||
126196545|NCT02178592|454002442|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
126196546|NCT02178592|454002443|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
126196547|NCT02178592|454002442|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
126196548|NCT02178592|454002443|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
126196549|NCT02178592|454002442|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
126196550|NCT02178592|454002443|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
126196551|NCT02178592|454002442|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
126196552|NCT02178592|454002443|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
126196553|NCT02178592|454002442|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
126196554|NCT02178592|454002443|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
126196555|NCT02178592|454002442|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
126196556|NCT02178592|454002443|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
126196557|NCT02178592|454002442|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
126196558|NCT02178592|454002443|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
126196559|NCT02178592|454002442|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
126196560|NCT02178592|454002443|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
126196561|NCT02178592|454002442|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
126196562|NCT02178592|454002443|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
126196563|NCT02178592|454002442|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
126196564|NCT02178592|454002443|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
126196565|NCT02178592|454002442|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
126196566|NCT02178592|454002443|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
126196567|NCT02178592|454002442|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
126196568|NCT02178592|454002443|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
126196569|NCT02520141|454002446|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
126196570|NCT00703781|454002447|FG000|Overall Study|Withdrawal by Subject|1|||
126196571|NCT00703781|454002448|FG001|Overall Study|Withdrawal by Subject|2|||
126196572|NCT00703781|454002447|FG000|Overall Study|Cancelled surgery|1|||
126196573|NCT00703781|454002448|FG001|Overall Study|Cancelled surgery|0|||
126196574|NCT03452397|454002451|FG000|Overall Study|Adverse Event|1|||
126196575|NCT03452397|454002452|FG001|Overall Study|Adverse Event|0|||
126196576|NCT03452397|454002453|FG002|Overall Study|Adverse Event|0|||
126196577|NCT03452397|454002454|FG003|Overall Study|Adverse Event|0|||
126196578|NCT03452397|454002451|FG000|Overall Study|Administrative reason|0|||
126196579|NCT03452397|454002452|FG001|Overall Study|Administrative reason|0|||
126196580|NCT03452397|454002453|FG002|Overall Study|Administrative reason|1|||
126196581|NCT03452397|454002454|FG003|Overall Study|Administrative reason|1|||
126196582|NCT03452397|454002451|FG000|Overall Study|Withdrawal by Subject|0|||
126196583|NCT03452397|454002452|FG001|Overall Study|Withdrawal by Subject|0|||
126196584|NCT03452397|454002453|FG002|Overall Study|Withdrawal by Subject|1|||
126196585|NCT03452397|454002454|FG003|Overall Study|Withdrawal by Subject|0|||
126196586|NCT02691468|454002455|FG000|Overall Study|Bronchial blocker use|2|||
126196587|NCT02691468|454002456|FG001|Overall Study|Bronchial blocker use|1|||
126196588|NCT02691468|454002455|FG000|Overall Study|Lost to Follow-up|2|||
126196589|NCT02691468|454002456|FG001|Overall Study|Lost to Follow-up|1|||
126196590|NCT02691468|454002455|FG000|Overall Study|Failure to advance FOB|2|||
126196591|NCT02691468|454002456|FG001|Overall Study|Failure to advance FOB|0|||
126196592|NCT06334055|454002458|FG000|Overall Study|Adverse Event|4|||
126196593|NCT06334055|454002458|FG000|Overall Study|Disqualified|72|||
126196594|NCT02545049|454002459|FG000|Overall Study|Withdrawal by Subject|1|||
126196595|NCT02545049|454002460|FG001|Overall Study|Withdrawal by Subject|7|||
126196596|NCT02545049|454002459|FG000|Overall Study|Lost to Follow-up|4|||
126196597|NCT02545049|454002460|FG001|Overall Study|Lost to Follow-up|6|||
126196598|NCT02545049|454002459|FG000|Overall Study|GCP violations|37|||
126196599|NCT02545049|454002460|FG001|Overall Study|GCP violations|48|||
126196600|NCT02972658|454004317|FG000|Overall Study|Adverse Event|0|||
126196601|NCT02972658|454004318|FG001|Overall Study|Adverse Event|3|||
126196602|NCT02972658|454004319|FG002|Overall Study|Adverse Event|0|||
126196603|NCT02972658|454004320|FG003|Overall Study|Adverse Event|2|||
126196604|NCT02972658|454004317|FG000|Overall Study|Other-determined by Investigator|1|||
126196605|NCT02972658|454004318|FG001|Overall Study|Other-determined by Investigator|1|||
126196606|NCT02972658|454004319|FG002|Overall Study|Other-determined by Investigator|0|||
126196607|NCT02972658|454004320|FG003|Overall Study|Other-determined by Investigator|0|||
126196608|NCT02972658|454004317|FG000|Overall Study|Death|0|||
126196609|NCT02972658|454004318|FG001|Overall Study|Death|0|||
126196610|NCT02972658|454004319|FG002|Overall Study|Death|0|||
126196611|NCT02972658|454004320|FG003|Overall Study|Death|1|||
126196612|NCT02972658|454004317|FG000|Overall Study|Lost to Follow-up|0|||
126196613|NCT02972658|454004318|FG001|Overall Study|Lost to Follow-up|1|||
126196614|NCT02972658|454004319|FG002|Overall Study|Lost to Follow-up|1|||
126196615|NCT02972658|454004320|FG003|Overall Study|Lost to Follow-up|2|||
126196616|NCT02972658|454004317|FG000|Overall Study|Progressive Disease|0|||
126196617|NCT02972658|454004318|FG001|Overall Study|Progressive Disease|1|||
126196618|NCT02972658|454004319|FG002|Overall Study|Progressive Disease|0|||
126196619|NCT02972658|454004320|FG003|Overall Study|Progressive Disease|1|||
126196620|NCT02972658|454004317|FG000|Overall Study|Withdrawal by Subject|4|||
126196621|NCT02972658|454004318|FG001|Overall Study|Withdrawal by Subject|4|||
126196622|NCT02972658|454004319|FG002|Overall Study|Withdrawal by Subject|1|||
126196623|NCT02972658|454004320|FG003|Overall Study|Withdrawal by Subject|6|||
126196624|NCT02972658|454004317|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
126196625|NCT02972658|454004318|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
126196626|NCT02972658|454004319|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
126196627|NCT02972658|454004320|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
126196628|NCT02972658|454004317|FG000|Overall Study|Sponsor Decision|70|||
126196629|NCT02972658|454004318|FG001|Overall Study|Sponsor Decision|127|||
126196630|NCT02972658|454004319|FG002|Overall Study|Sponsor Decision|72|||
126196631|NCT02972658|454004320|FG003|Overall Study|Sponsor Decision|119|||
126196632|NCT03958149|454004321|FG000|Overall Study|Withdrawal by Subject|0|||
126196633|NCT03958149|454004322|FG001|Overall Study|Withdrawal by Subject|1|||
126196634|NCT02785588|454004323|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
126196635|NCT02785588|454004323|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
126196636|NCT00621764|454004325|FG000|Overall Study|Protocol Violation|0|||
126196637|NCT00621764|454004326|FG001|Overall Study|Protocol Violation|0|||
126196638|NCT00621764|454004327|FG002|Overall Study|Protocol Violation|0|||
126196639|NCT00621764|454004328|FG003|Overall Study|Protocol Violation|1|||
126196640|NCT02499172|454004329|FG000|Overall Study|Financial reason|0|||
126196641|NCT02499172|454004330|FG001|Overall Study|Financial reason|0|||
126196642|NCT02499172|454004331|FG002|Overall Study|Financial reason|523|||
126196643|NCT02499172|454004332|FG003|Overall Study|Financial reason|436|||
126196644|NCT02499172|454004329|FG000|Overall Study|Lost to Follow-up|65|||
126196645|NCT02499172|454004330|FG001|Overall Study|Lost to Follow-up|64|||
126196646|NCT02499172|454004331|FG002|Overall Study|Lost to Follow-up|0|||
126196647|NCT02499172|454004332|FG003|Overall Study|Lost to Follow-up|0|||
126196648|NCT01293123|454004333|FG000|Overall Study|Lost to Follow-up|0|||
126196649|NCT01293123|454004334|FG001|Overall Study|Lost to Follow-up|1|||
126196650|NCT00211536|454004337|FG000|Overall Study|Withdrawal by Subject|2|||
126196651|NCT00211536|454004338|FG001|Overall Study|Withdrawal by Subject|2|||
126196652|NCT00211536|454004337|FG000|Overall Study|Physician Decision|0|||
126196653|NCT00211536|454004338|FG001|Overall Study|Physician Decision|5|||
126196654|NCT00211536|454004337|FG000|Overall Study|Adverse Event|2|||
126196655|NCT00211536|454004338|FG001|Overall Study|Adverse Event|0|||
126196656|NCT00003389|454004339|FG000|Overall Study|Disease progression|6|||
126196657|NCT00003389|454004340|FG001|Overall Study|Disease progression|1|||
126196658|NCT00003389|454004339|FG000|Overall Study|Adverse Event|13|||
126196659|NCT00003389|454004340|FG001|Overall Study|Adverse Event|2|||
126196660|NCT00003389|454004339|FG000|Overall Study|Death|0|||
126196661|NCT00003389|454004340|FG001|Overall Study|Death|3|||
126196662|NCT00003389|454004339|FG000|Overall Study|Withdrawal by Subject|12|||
126196663|NCT00003389|454004340|FG001|Overall Study|Withdrawal by Subject|5|||
126196664|NCT00003389|454004339|FG000|Overall Study|Alternative therapy|2|||
126196665|NCT00003389|454004340|FG001|Overall Study|Alternative therapy|1|||
126196666|NCT00003389|454004339|FG000|Overall Study|Complicating disease|1|||
126196667|NCT00003389|454004340|FG001|Overall Study|Complicating disease|0|||
126196668|NCT00003389|454004339|FG000|Overall Study|Off-treatment reason missing|31|||
126196669|NCT00003389|454004340|FG001|Overall Study|Off-treatment reason missing|21|||
126196670|NCT00003389|454004339|FG000|Overall Study|Ineligible|33|||
126196671|NCT00003389|454004340|FG001|Overall Study|Ineligible|27|||
126196672|NCT01997892|454004343|FG000|Overall Study|Physician Decision|2|||
126196673|NCT01997892|454004343|FG000|Overall Study|Lost to Follow-up|6|||
126196674|NCT01997892|454004343|FG000|Overall Study|Death|14|||
126196675|NCT01997892|454004343|FG000|Overall Study|Renal transplant|8|||
126196676|NCT01997892|454004343|FG000|Overall Study|Other|3|||
126196677|NCT01997892|454004343|FG000|Overall Study|Study completion data not recorded|35|||
126196678|NCT02710422|454004344|FG000|Overall Study|Termination of study|9|||
126196679|NCT02710422|454004345|FG001|Overall Study|Termination of study|9|||
126196680|NCT00768040|454004348|FG000|Overall Study|Adverse Event|3|||
126196681|NCT00768040|454004349|FG001|Overall Study|Adverse Event|2|||
126196682|NCT00768040|454004348|FG000|Overall Study|Abnormal laboratory value|1|||
126196683|NCT00768040|454004349|FG001|Overall Study|Abnormal laboratory value|1|||
126196684|NCT00417248|454004351|FG000|Overall Study|Study Terminated|6|||
126196685|NCT00417248|454004351|FG000|Overall Study|Death|1|||
126196686|NCT00417248|454004351|FG000|Overall Study|Lack of Efficacy|1|||
126196687|NCT02185040|454004352|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
126196688|NCT02185040|454004353|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
126196689|NCT02185040|454004354|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
126196690|NCT02185040|454004355|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
126196691|NCT02185040|454004356|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
126196692|NCT02185040|454004357|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
126196693|NCT02185040|454004358|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
126196694|NCT02185040|454004352|FG000|Part 1 Treatment Phase|Adverse Event|1|||
126196695|NCT02185040|454004353|FG001|Part 1 Treatment Phase|Adverse Event|0|||
126196696|NCT02185040|454004354|FG002|Part 1 Treatment Phase|Adverse Event|0|||
126196697|NCT02185040|454004355|FG003|Part 1 Treatment Phase|Adverse Event|2|||
126196698|NCT02185040|454004356|FG004|Part 1 Treatment Phase|Adverse Event|3|||
126196699|NCT02185040|454004357|FG005|Part 1 Treatment Phase|Adverse Event|0|||
126196700|NCT02185040|454004358|FG006|Part 1 Treatment Phase|Adverse Event|0|||
126196701|NCT02185040|454004352|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126196702|NCT02185040|454004353|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
126196703|NCT02185040|454004354|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126196704|NCT02185040|454004355|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126196705|NCT02185040|454004356|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126196706|NCT02185040|454004357|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126196707|NCT02185040|454004358|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126196708|NCT02185040|454004352|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
126196709|NCT02185040|454004353|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
126196710|NCT02185040|454004354|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
126196711|NCT02185040|454004355|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
126196712|NCT02185040|454004356|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
126196713|NCT02185040|454004357|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
126196714|NCT02185040|454004358|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
126196715|NCT02185040|454004352|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
126196716|NCT02185040|454004353|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
126196717|NCT02185040|454004354|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
126196718|NCT02185040|454004355|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
126196719|NCT02185040|454004356|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
126196720|NCT02185040|454004357|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
126196721|NCT02185040|454004358|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
126196722|NCT02185040|454004352|FG000|Active Treatment Extension Phase|Adverse Event|0|||
126196723|NCT02185040|454004353|FG001|Active Treatment Extension Phase|Adverse Event|0|||
126196724|NCT02185040|454004354|FG002|Active Treatment Extension Phase|Adverse Event|0|||
126196725|NCT02185040|454004355|FG003|Active Treatment Extension Phase|Adverse Event|0|||
126196726|NCT02185040|454004356|FG004|Active Treatment Extension Phase|Adverse Event|0|||
126196727|NCT02185040|454004357|FG005|Active Treatment Extension Phase|Adverse Event|1|||
126196728|NCT02185040|454004358|FG006|Active Treatment Extension Phase|Adverse Event|4|||
126196729|NCT02185040|454004352|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126196730|NCT02185040|454004353|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126196731|NCT02185040|454004354|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126196732|NCT02185040|454004355|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126196733|NCT02185040|454004356|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126196734|NCT02185040|454004357|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
126196735|NCT02185040|454004358|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
126196736|NCT02185040|454004352|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
126196737|NCT02185040|454004353|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
126196738|NCT02185040|454004354|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
126196739|NCT02185040|454004355|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
126196740|NCT02185040|454004356|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
126196741|NCT02185040|454004357|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
126196742|NCT02185040|454004358|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
126196743|NCT03347279|454004359|FG000|Overall Study|Withdrawal by Subject|8|||
126196744|NCT03347279|454004360|FG001|Overall Study|Withdrawal by Subject|15|||
126196745|NCT03347279|454004359|FG000|Overall Study|Death|0|||
126196746|NCT03347279|454004360|FG001|Overall Study|Death|2|||
126196747|NCT03347279|454004359|FG000|Overall Study|Lost to Follow-up|5|||
126196748|NCT03347279|454004360|FG001|Overall Study|Lost to Follow-up|2|||
126196749|NCT03347279|454004359|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
126196750|NCT03347279|454004360|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
126196751|NCT03818399|454004365|FG000|Overall Study|Lost to Follow-up|11|||
126196752|NCT03818399|454004365|FG000|Overall Study|Withdrawal by Subject|1|||
126196753|NCT03818399|454004365|FG000|Overall Study|Protocol Violation|2|||
126196754|NCT03557801|454004368|FG000|Overall Study|Protocol Violation|1|||
126196755|NCT03557801|454004369|FG001|Overall Study|Protocol Violation|0|||
126196756|NCT03557801|454004370|FG002|Overall Study|Protocol Violation|0|||
126196757|NCT03557801|454004368|FG000|Overall Study|Withdrawal by Subject|1|||
126196758|NCT03557801|454004369|FG001|Overall Study|Withdrawal by Subject|0|||
126196759|NCT03557801|454004370|FG002|Overall Study|Withdrawal by Subject|3|||
126196760|NCT03557801|454004368|FG000|Overall Study|Lost to Follow-up|0|||
126196761|NCT03557801|454004369|FG001|Overall Study|Lost to Follow-up|1|||
126196762|NCT03557801|454004370|FG002|Overall Study|Lost to Follow-up|0|||
126196763|NCT00535236|454004371|FG000|Overall Study|Adverse Event|1|||
126196764|NCT00535236|454004372|FG001|Overall Study|Adverse Event|0|||
126196765|NCT00535236|454004373|FG002|Overall Study|Adverse Event|9|||
126196766|NCT00535236|454004374|FG003|Overall Study|Adverse Event|3|||
126196767|NCT00535236|454004375|FG004|Overall Study|Adverse Event|3|||
126196768|NCT00535236|454004376|FG005|Overall Study|Adverse Event|0|||
126196769|NCT00535236|454004377|FG006|Overall Study|Adverse Event|5|||
126196770|NCT00535236|454004378|FG007|Overall Study|Adverse Event|1|||
126196771|NCT00535236|454004379|FG008|Overall Study|Adverse Event|2|||
126196772|NCT00535236|454004380|FG009|Overall Study|Adverse Event|1|||
126196773|NCT00535236|454004371|FG000|Overall Study|Lost to Follow-up|1|||
126196774|NCT00535236|454004372|FG001|Overall Study|Lost to Follow-up|2|||
126196775|NCT00535236|454004373|FG002|Overall Study|Lost to Follow-up|0|||
126196776|NCT00535236|454004374|FG003|Overall Study|Lost to Follow-up|0|||
126196777|NCT00535236|454004375|FG004|Overall Study|Lost to Follow-up|2|||
126196778|NCT00535236|454004376|FG005|Overall Study|Lost to Follow-up|0|||
126196779|NCT00535236|454004377|FG006|Overall Study|Lost to Follow-up|0|||
126196780|NCT00535236|454004378|FG007|Overall Study|Lost to Follow-up|0|||
126196781|NCT00535236|454004379|FG008|Overall Study|Lost to Follow-up|6|||
126196782|NCT00535236|454004380|FG009|Overall Study|Lost to Follow-up|1|||
126196783|NCT00535236|454004371|FG000|Overall Study|Physician Decision|0|||
126196784|NCT00535236|454004372|FG001|Overall Study|Physician Decision|0|||
126196785|NCT00535236|454004373|FG002|Overall Study|Physician Decision|0|||
126196786|NCT00535236|454004374|FG003|Overall Study|Physician Decision|0|||
126196787|NCT00535236|454004375|FG004|Overall Study|Physician Decision|1|||
126196788|NCT00535236|454004376|FG005|Overall Study|Physician Decision|0|||
126196789|NCT00535236|454004377|FG006|Overall Study|Physician Decision|1|||
126196790|NCT00535236|454004378|FG007|Overall Study|Physician Decision|0|||
126196791|NCT00535236|454004379|FG008|Overall Study|Physician Decision|0|||
126196792|NCT00535236|454004380|FG009|Overall Study|Physician Decision|0|||
126196793|NCT00535236|454004371|FG000|Overall Study|Protocol Violation|2|||
126196794|NCT00535236|454004372|FG001|Overall Study|Protocol Violation|0|||
126196795|NCT00535236|454004373|FG002|Overall Study|Protocol Violation|1|||
126196796|NCT00535236|454004374|FG003|Overall Study|Protocol Violation|0|||
126196797|NCT00535236|454004375|FG004|Overall Study|Protocol Violation|0|||
126196798|NCT00535236|454004376|FG005|Overall Study|Protocol Violation|0|||
126196799|NCT00535236|454004377|FG006|Overall Study|Protocol Violation|0|||
126196800|NCT00535236|454004378|FG007|Overall Study|Protocol Violation|0|||
126196801|NCT00535236|454004379|FG008|Overall Study|Protocol Violation|1|||
126196802|NCT00535236|454004380|FG009|Overall Study|Protocol Violation|0|||
126196803|NCT00535236|454004371|FG000|Overall Study|Withdrawal by Subject|3|||
126196804|NCT00535236|454004372|FG001|Overall Study|Withdrawal by Subject|0|||
126196805|NCT00535236|454004373|FG002|Overall Study|Withdrawal by Subject|2|||
126196806|NCT00535236|454004374|FG003|Overall Study|Withdrawal by Subject|1|||
126196807|NCT00535236|454004375|FG004|Overall Study|Withdrawal by Subject|6|||
126196808|NCT00535236|454004376|FG005|Overall Study|Withdrawal by Subject|1|||
126196809|NCT00535236|454004377|FG006|Overall Study|Withdrawal by Subject|5|||
126196810|NCT00535236|454004378|FG007|Overall Study|Withdrawal by Subject|0|||
126196811|NCT00535236|454004379|FG008|Overall Study|Withdrawal by Subject|4|||
126196812|NCT00535236|454004380|FG009|Overall Study|Withdrawal by Subject|2|||
126196813|NCT00141297|454004382|FG000|Overall Study|Adverse Event|0|||
126196814|NCT00141297|454004383|FG001|Overall Study|Adverse Event|0|||
126196815|NCT00141297|454004384|FG002|Overall Study|Adverse Event|1|||
126196816|NCT00141297|454004385|FG003|Overall Study|Adverse Event|0|||
126196817|NCT00141297|454004386|FG004|Overall Study|Adverse Event|1|||
126196818|NCT00141297|454004387|FG005|Overall Study|Adverse Event|1|||
126196819|NCT00141297|454004388|FG006|Overall Study|Adverse Event|0|||
126196820|NCT00141297|454004389|FG007|Overall Study|Adverse Event|1|||
126196821|NCT00141297|454004390|FG008|Overall Study|Adverse Event|1|||
126196822|NCT00141297|454004391|FG009|Overall Study|Adverse Event|0|||
126196823|NCT00141297|454004382|FG000|Overall Study|Death|1|||
126196824|NCT00141297|454004383|FG001|Overall Study|Death|0|||
126196825|NCT00141297|454004384|FG002|Overall Study|Death|0|||
126196826|NCT00141297|454004385|FG003|Overall Study|Death|0|||
126196827|NCT00141297|454004386|FG004|Overall Study|Death|0|||
126196828|NCT00141297|454004387|FG005|Overall Study|Death|0|||
126196829|NCT00141297|454004388|FG006|Overall Study|Death|0|||
126196830|NCT00141297|454004389|FG007|Overall Study|Death|0|||
126196831|NCT00141297|454004390|FG008|Overall Study|Death|1|||
126196832|NCT00141297|454004391|FG009|Overall Study|Death|0|||
126196833|NCT00141297|454004382|FG000|Overall Study|Withdrawal by Subject|0|||
126196834|NCT00141297|454004383|FG001|Overall Study|Withdrawal by Subject|0|||
126196835|NCT00141297|454004384|FG002|Overall Study|Withdrawal by Subject|0|||
126196836|NCT00141297|454004385|FG003|Overall Study|Withdrawal by Subject|0|||
126196837|NCT00141297|454004386|FG004|Overall Study|Withdrawal by Subject|0|||
126196838|NCT00141297|454004387|FG005|Overall Study|Withdrawal by Subject|0|||
126196839|NCT00141297|454004388|FG006|Overall Study|Withdrawal by Subject|0|||
126196840|NCT00141297|454004389|FG007|Overall Study|Withdrawal by Subject|0|||
126196841|NCT00141297|454004390|FG008|Overall Study|Withdrawal by Subject|1|||
126196842|NCT00141297|454004391|FG009|Overall Study|Withdrawal by Subject|0|||
126196843|NCT00141297|454004382|FG000|Overall Study|Other|0|||
126196844|NCT00141297|454004383|FG001|Overall Study|Other|0|||
126196845|NCT00141297|454004384|FG002|Overall Study|Other|0|||
126196846|NCT00141297|454004385|FG003|Overall Study|Other|1|||
126196847|NCT00141297|454004386|FG004|Overall Study|Other|5|||
126196848|NCT00141297|454004387|FG005|Overall Study|Other|0|||
126196849|NCT00141297|454004388|FG006|Overall Study|Other|0|||
126196850|NCT00141297|454004389|FG007|Overall Study|Other|0|||
126196851|NCT00141297|454004390|FG008|Overall Study|Other|2|||
126196852|NCT00141297|454004391|FG009|Overall Study|Other|0|||
126196853|NCT00141297|454004382|FG000|Overall Study|Progressive Disease|2|||
126196854|NCT00141297|454004383|FG001|Overall Study|Progressive Disease|3|||
126196855|NCT00141297|454004384|FG002|Overall Study|Progressive Disease|6|||
126196856|NCT00141297|454004385|FG003|Overall Study|Progressive Disease|2|||
126196857|NCT00141297|454004386|FG004|Overall Study|Progressive Disease|15|||
126196858|NCT00141297|454004387|FG005|Overall Study|Progressive Disease|2|||
126196859|NCT00141297|454004388|FG006|Overall Study|Progressive Disease|3|||
126196860|NCT00141297|454004389|FG007|Overall Study|Progressive Disease|3|||
126196861|NCT00141297|454004390|FG008|Overall Study|Progressive Disease|15|||
126196862|NCT00141297|454004391|FG009|Overall Study|Progressive Disease|6|||
126196863|NCT00141297|454004382|FG000|Overall Study|Transitioned|0|||
126196864|NCT00141297|454004383|FG001|Overall Study|Transitioned|0|||
126196865|NCT00141297|454004384|FG002|Overall Study|Transitioned|0|||
126196866|NCT00141297|454004385|FG003|Overall Study|Transitioned|0|||
126196867|NCT00141297|454004386|FG004|Overall Study|Transitioned|1|||
126196868|NCT00141297|454004387|FG005|Overall Study|Transitioned|0|||
126196869|NCT00141297|454004388|FG006|Overall Study|Transitioned|0|||
126196870|NCT00141297|454004389|FG007|Overall Study|Transitioned|0|||
126196871|NCT00141297|454004390|FG008|Overall Study|Transitioned|0|||
126196872|NCT00141297|454004391|FG009|Overall Study|Transitioned|0|||
126196873|NCT02200510|454004392|FG000|Overall Study|Death|1|||
126196874|NCT02200510|454004393|FG001|Overall Study|Death|1|||
126196875|NCT02200510|454004392|FG000|Overall Study|Protocol Violation|0|||
126196876|NCT02200510|454004393|FG001|Overall Study|Protocol Violation|1|||
126196877|NCT02200510|454004392|FG000|Overall Study|Lost to Follow-up|7|||
126196878|NCT02200510|454004393|FG001|Overall Study|Lost to Follow-up|1|||
126196879|NCT02200510|454004392|FG000|Overall Study|potential COI - joined study team|1|||
126196880|NCT02200510|454004393|FG001|Overall Study|potential COI - joined study team|0|||
126196881|NCT00290355|454004394|FG000|Overall Study|Serious adverse event|7|||
126196882|NCT00290355|454004395|FG001|Overall Study|Serious adverse event|4|||
126196883|NCT00290355|454004394|FG000|Overall Study|Study product reactogenicity|1|||
126196884|NCT00290355|454004395|FG001|Overall Study|Study product reactogenicity|0|||
126196885|NCT00290355|454004394|FG000|Overall Study|Protocol Violation|1|||
126196886|NCT00290355|454004395|FG001|Overall Study|Protocol Violation|0|||
126196887|NCT00290355|454004394|FG000|Overall Study|Withdrawal by Subject|2|||
126196888|NCT00290355|454004395|FG001|Overall Study|Withdrawal by Subject|0|||
126196889|NCT00290355|454004394|FG000|Overall Study|Migrated / moved from the study area|1|||
126196890|NCT00290355|454004395|FG001|Overall Study|Migrated / moved from the study area|0|||
126196891|NCT00290355|454004394|FG000|Overall Study|Lost to Follow-up|3|||
126196892|NCT00290355|454004395|FG001|Overall Study|Lost to Follow-up|1|||
126196893|NCT00290355|454004394|FG000|Overall Study|Other|2|||
126196894|NCT00290355|454004395|FG001|Overall Study|Other|0|||
126196895|NCT01542632|454004396|FG000|Overall Study|Withdrawal of Consent|0|||
126196896|NCT01542632|454004397|FG001|Overall Study|Withdrawal of Consent|0|||
126196897|NCT01542632|454004398|FG002|Overall Study|Withdrawal of Consent|0|||
126196898|NCT01542632|454004399|FG003|Overall Study|Withdrawal of Consent|2|||
126196899|NCT01542632|454004400|FG004|Overall Study|Withdrawal of Consent|3|||
126196900|NCT01542632|454004401|FG005|Overall Study|Withdrawal of Consent|0|||
126196901|NCT01542632|454004396|FG000|Overall Study|Adverse Event|0|||
126196902|NCT01542632|454004397|FG001|Overall Study|Adverse Event|0|||
126196903|NCT01542632|454004398|FG002|Overall Study|Adverse Event|1|||
126196904|NCT01542632|454004399|FG003|Overall Study|Adverse Event|0|||
126196905|NCT01542632|454004400|FG004|Overall Study|Adverse Event|0|||
126196906|NCT01542632|454004401|FG005|Overall Study|Adverse Event|0|||
126196907|NCT01542632|454004396|FG000|Overall Study|Lost to Follow-up|0|||
126196908|NCT01542632|454004397|FG001|Overall Study|Lost to Follow-up|1|||
126196909|NCT01542632|454004398|FG002|Overall Study|Lost to Follow-up|0|||
126196910|NCT01542632|454004399|FG003|Overall Study|Lost to Follow-up|0|||
126196911|NCT01542632|454004400|FG004|Overall Study|Lost to Follow-up|0|||
126196912|NCT01542632|454004401|FG005|Overall Study|Lost to Follow-up|0|||
126196913|NCT01542632|454004396|FG000|Overall Study|Sponsor/Investigator Decision|0|||
126199948|NCT01117428|454017809|FG005|Overall Study|Death|1|||
126196914|NCT01542632|454004397|FG001|Overall Study|Sponsor/Investigator Decision|0|||
126196915|NCT01542632|454004398|FG002|Overall Study|Sponsor/Investigator Decision|0|||
126196916|NCT01542632|454004399|FG003|Overall Study|Sponsor/Investigator Decision|0|||
126196917|NCT01542632|454004400|FG004|Overall Study|Sponsor/Investigator Decision|1|||
126196918|NCT01542632|454004401|FG005|Overall Study|Sponsor/Investigator Decision|0|||
126196919|NCT00033514|454004402|FG000|Overall Study|Lost to Follow-up|1|||
126196920|NCT00033514|454004403|FG001|Overall Study|Lost to Follow-up|1|||
126196921|NCT00033514|454004402|FG000|Overall Study|Withdrawal by Subject|0|||
126196922|NCT00033514|454004403|FG001|Overall Study|Withdrawal by Subject|3|||
126196923|NCT01108263|454004415|FG000|Overall Study|Adverse Event|0|||
126196924|NCT01108263|454004416|FG001|Overall Study|Adverse Event|1|||
126196925|NCT01685372|454004417|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
126196926|NCT01685372|454004418|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
126196927|NCT01488994|454004419|FG000|Overall Study|Withdrawal by Subject|0|||
126196928|NCT01488994|454004420|FG001|Overall Study|Withdrawal by Subject|1|||
126196929|NCT01072500|454004423|FG000|Overall Study|Death|2|||
126196930|NCT01072500|454004424|FG001|Overall Study|Death|2|||
126196931|NCT01072500|454004423|FG000|Overall Study|Lost to Follow-up|5|||
126196932|NCT01072500|454004424|FG001|Overall Study|Lost to Follow-up|2|||
126196933|NCT01072500|454004423|FG000|Overall Study|Withdrawal by Subject|17|||
126196934|NCT01072500|454004424|FG001|Overall Study|Withdrawal by Subject|10|||
126196935|NCT00829010|454004425|FG000|Overall Study|Adverse Event|1|||
126196936|NCT00829010|454004426|FG001|Overall Study|Adverse Event|0|||
126196937|NCT00829010|454004427|FG002|Overall Study|Adverse Event|0|||
126196938|NCT00829010|454004428|FG003|Overall Study|Adverse Event|0|||
126196939|NCT00829010|454004429|FG004|Overall Study|Adverse Event|0|||
126196940|NCT00829010|454004425|FG000|Overall Study|Withdrawal by Subject|0|||
126196941|NCT00829010|454004426|FG001|Overall Study|Withdrawal by Subject|1|||
126196942|NCT00829010|454004427|FG002|Overall Study|Withdrawal by Subject|1|||
126196943|NCT00829010|454004428|FG003|Overall Study|Withdrawal by Subject|0|||
126196944|NCT00829010|454004429|FG004|Overall Study|Withdrawal by Subject|2|||
126196945|NCT00829010|454004425|FG000|Overall Study|Lost to Follow-up|1|||
126196946|NCT00829010|454004426|FG001|Overall Study|Lost to Follow-up|0|||
126196947|NCT00829010|454004427|FG002|Overall Study|Lost to Follow-up|2|||
126196948|NCT00829010|454004428|FG003|Overall Study|Lost to Follow-up|0|||
126196949|NCT00829010|454004429|FG004|Overall Study|Lost to Follow-up|0|||
126196950|NCT00829010|454004425|FG000|Overall Study|Fatality|5|||
126196951|NCT00829010|454004426|FG001|Overall Study|Fatality|4|||
126196952|NCT00829010|454004427|FG002|Overall Study|Fatality|0|||
126196953|NCT00829010|454004428|FG003|Overall Study|Fatality|3|||
126196954|NCT00829010|454004429|FG004|Overall Study|Fatality|0|||
126196955|NCT00829010|454004425|FG000|Overall Study|Migrated/Moved from study area|3|||
126196956|NCT00829010|454004426|FG001|Overall Study|Migrated/Moved from study area|4|||
126196957|NCT00829010|454004427|FG002|Overall Study|Migrated/Moved from study area|0|||
126196958|NCT00829010|454004428|FG003|Overall Study|Migrated/Moved from study area|5|||
126196959|NCT00829010|454004429|FG004|Overall Study|Migrated/Moved from study area|0|||
126196960|NCT03798366|454004430|FG000|Overall Study|Lost to Follow-up|0|||
126196961|NCT03798366|454004431|FG001|Overall Study|Lost to Follow-up|1|||
126196962|NCT00474539|454004434|FG000|Infant Series|Withdrawal by Subject|3|||
126196963|NCT00474539|454004435|FG001|Infant Series|Withdrawal by Subject|4|||
126196964|NCT00474539|454004434|FG000|Infant Series|Randomization error|5|||
126196965|NCT00474539|454004435|FG001|Infant Series|Randomization error|0|||
126196966|NCT00474539|454004434|FG000|Infant Series|Lost to Follow-up|2|||
126196967|NCT00474539|454004435|FG001|Infant Series|Lost to Follow-up|1|||
126196968|NCT00474539|454004434|FG000|Infant Series|Protocol Violation|0|||
126196969|NCT00474539|454004435|FG001|Infant Series|Protocol Violation|1|||
126196970|NCT00474539|454004434|FG000|After Infant Series|Lost to Follow-up|3|||
126196971|NCT00474539|454004435|FG001|After Infant Series|Lost to Follow-up|0|||
126196972|NCT00474539|454004434|FG000|After Infant Series|Withdrawal by Subject|1|||
126196973|NCT00474539|454004435|FG001|After Infant Series|Withdrawal by Subject|0|||
126196974|NCT00474539|454004434|FG000|Toddler Dose|Protocol Violation|1|||
126196975|NCT00474539|454004435|FG001|Toddler Dose|Protocol Violation|0|||
126196976|NCT02061540|454004436|FG000|Overall Study|Adverse Event|2|||
126196977|NCT02061540|454004436|FG000|Overall Study|Withdrawal by Subject|2|||
126196978|NCT02289833|454004438|FG000|Overall Study|Study discontinuation|0|||
126196979|NCT02289833|454004439|FG001|Overall Study|Study discontinuation|1|||
126196980|NCT02289833|454004438|FG000|Overall Study|Lost to Follow-up|4|||
126196981|NCT02289833|454004439|FG001|Overall Study|Lost to Follow-up|0|||
126196982|NCT02289833|454004438|FG000|Overall Study|Death|23|||
126196983|NCT02289833|454004439|FG001|Overall Study|Death|16|||
126196984|NCT01227252|454004440|FG000|Overall Study|Sponsor Decision|0|||
126196985|NCT01227252|454004441|FG001|Overall Study|Sponsor Decision|1|||
126196986|NCT01227252|454004442|FG002|Overall Study|Sponsor Decision|0|||
126196987|NCT01227252|454004443|FG003|Overall Study|Sponsor Decision|0|||
126196988|NCT01227252|454004440|FG000|Overall Study|Lost to Follow-up|0|||
126196989|NCT01227252|454004441|FG001|Overall Study|Lost to Follow-up|1|||
126196990|NCT01227252|454004442|FG002|Overall Study|Lost to Follow-up|0|||
126196991|NCT01227252|454004443|FG003|Overall Study|Lost to Follow-up|0|||
126196992|NCT01227252|454004440|FG000|Overall Study|Withdrawal by Subject|0|||
126196993|NCT01227252|454004441|FG001|Overall Study|Withdrawal by Subject|1|||
126196994|NCT01227252|454004442|FG002|Overall Study|Withdrawal by Subject|0|||
126196995|NCT01227252|454004443|FG003|Overall Study|Withdrawal by Subject|0|||
126196996|NCT02561273|454004450|FG000|Overall Study|Protocol Violation|1|||
126196997|NCT02561273|454004451|FG001|Overall Study|Protocol Violation|0|||
126196998|NCT03442595|454004452|FG000|Overall Study|Lost to Follow-up|94|||
126196999|NCT03442595|454004453|FG001|Overall Study|Lost to Follow-up|0|||
126197000|NCT01642004|454004454|FG000|Randomization|Adverse Event unrelated to study drug|1|||
126197001|NCT01642004|454004455|FG001|Randomization|Adverse Event unrelated to study drug|0|||
126197002|NCT01642004|454004454|FG000|Randomization|Participant withdrew consent|1|||
126197003|NCT01642004|454004455|FG001|Randomization|Participant withdrew consent|6|||
126197004|NCT01642004|454004454|FG000|Randomization|No longer meets study criteria|2|||
126197005|NCT01642004|454004455|FG001|Randomization|No longer meets study criteria|2|||
126197006|NCT01642004|454004454|FG000|Treatment|Disease progression|95|||
126197007|NCT01642004|454004455|FG001|Treatment|Disease progression|79|||
126197008|NCT01642004|454004454|FG000|Treatment|Study drug toxicity|10|||
126197009|NCT01642004|454004455|FG001|Treatment|Study drug toxicity|13|||
126197010|NCT01642004|454004454|FG000|Treatment|Death|1|||
126197011|NCT01642004|454004455|FG001|Treatment|Death|1|||
126197012|NCT01642004|454004454|FG000|Treatment|Adverse event unrelated to study drug|9|||
126197013|NCT01642004|454004455|FG001|Treatment|Adverse event unrelated to study drug|13|||
126197014|NCT01642004|454004454|FG000|Treatment|Maximum clinical benefit|1|||
126197015|NCT01642004|454004455|FG001|Treatment|Maximum clinical benefit|9|||
126197016|NCT01642004|454004454|FG000|Treatment|Poor/non-compliance|1|||
126197017|NCT01642004|454004455|FG001|Treatment|Poor/non-compliance|0|||
126197018|NCT01642004|454004454|FG000|Treatment|No longer meets study criteria|1|||
126197019|NCT01642004|454004455|FG001|Treatment|No longer meets study criteria|2|||
126197020|NCT01642004|454004454|FG000|Treatment|Other reasons|2|||
126197021|NCT01642004|454004455|FG001|Treatment|Other reasons|0|||
126197022|NCT01642004|454004454|FG000|Treatment|Not reported|0|||
126197023|NCT01642004|454004455|FG001|Treatment|Not reported|3|||
126197024|NCT01642004|454004454|FG000|Treatment|Participant request to discontinue study treatment|6|||
126197025|NCT01642004|454004455|FG001|Treatment|Participant request to discontinue study treatment|4|||
126197026|NCT01642004|454004454|FG000|Treatment|Participant withdrew consent|5|||
126197027|NCT01642004|454004455|FG001|Treatment|Participant withdrew consent|5|||
126197028|NCT02192190|454004464|FG000|Overall Study|Adverse Event|1|||
126197029|NCT02192190|454004465|FG001|Overall Study|Adverse Event|1|||
126197030|NCT02192190|454004466|FG002|Overall Study|Adverse Event|0|||
126197031|NCT02192190|454004467|FG003|Overall Study|Adverse Event|0|||
126197032|NCT02192190|454004468|FG004|Overall Study|Adverse Event|0|||
126197033|NCT02192190|454004469|FG005|Overall Study|Adverse Event|0|||
126197034|NCT02192190|454004464|FG000|Overall Study|Lost to Follow-up|3|||
126197035|NCT02192190|454004465|FG001|Overall Study|Lost to Follow-up|3|||
126197036|NCT02192190|454004466|FG002|Overall Study|Lost to Follow-up|2|||
126197037|NCT02192190|454004467|FG003|Overall Study|Lost to Follow-up|1|||
126197038|NCT02192190|454004468|FG004|Overall Study|Lost to Follow-up|4|||
126197039|NCT02192190|454004469|FG005|Overall Study|Lost to Follow-up|3|||
126197040|NCT02192190|454004464|FG000|Overall Study|Physician Decision|2|||
126197041|NCT02192190|454004465|FG001|Overall Study|Physician Decision|0|||
126197042|NCT02192190|454004466|FG002|Overall Study|Physician Decision|0|||
126197043|NCT02192190|454004467|FG003|Overall Study|Physician Decision|0|||
126197044|NCT02192190|454004468|FG004|Overall Study|Physician Decision|0|||
126197045|NCT02192190|454004469|FG005|Overall Study|Physician Decision|0|||
126197046|NCT02192190|454004464|FG000|Overall Study|Terminated by Sponsor|43|||
126197047|NCT02192190|454004465|FG001|Overall Study|Terminated by Sponsor|23|||
126197048|NCT02192190|454004466|FG002|Overall Study|Terminated by Sponsor|20|||
126197049|NCT02192190|454004467|FG003|Overall Study|Terminated by Sponsor|23|||
126197050|NCT02192190|454004468|FG004|Overall Study|Terminated by Sponsor|21|||
126197051|NCT02192190|454004469|FG005|Overall Study|Terminated by Sponsor|23|||
126197052|NCT02192190|454004464|FG000|Overall Study|Withdrawal by Subject|4|||
126197053|NCT02192190|454004465|FG001|Overall Study|Withdrawal by Subject|1|||
126197054|NCT02192190|454004466|FG002|Overall Study|Withdrawal by Subject|2|||
126197055|NCT02192190|454004467|FG003|Overall Study|Withdrawal by Subject|1|||
126197056|NCT02192190|454004468|FG004|Overall Study|Withdrawal by Subject|5|||
126197057|NCT02192190|454004469|FG005|Overall Study|Withdrawal by Subject|3|||
126197058|NCT02192190|454004464|FG000|Overall Study|Could not Keep Visit Schedule|1|||
126197059|NCT02192190|454004465|FG001|Overall Study|Could not Keep Visit Schedule|0|||
126197060|NCT02192190|454004466|FG002|Overall Study|Could not Keep Visit Schedule|0|||
126197061|NCT02192190|454004467|FG003|Overall Study|Could not Keep Visit Schedule|0|||
126197062|NCT02192190|454004468|FG004|Overall Study|Could not Keep Visit Schedule|0|||
126197063|NCT02192190|454004469|FG005|Overall Study|Could not Keep Visit Schedule|0|||
126197064|NCT02192190|454004464|FG000|Overall Study|Positive Drug Screen|0|||
126197065|NCT02192190|454004465|FG001|Overall Study|Positive Drug Screen|0|||
126197066|NCT02192190|454004466|FG002|Overall Study|Positive Drug Screen|0|||
126197067|NCT02192190|454004467|FG003|Overall Study|Positive Drug Screen|1|||
126197068|NCT02192190|454004468|FG004|Overall Study|Positive Drug Screen|0|||
126197069|NCT02192190|454004469|FG005|Overall Study|Positive Drug Screen|0|||
126197070|NCT02192190|454004464|FG000|Overall Study|Inadequate Pain Relief|0|||
126197071|NCT02192190|454004465|FG001|Overall Study|Inadequate Pain Relief|1|||
126197072|NCT02192190|454004466|FG002|Overall Study|Inadequate Pain Relief|1|||
126197073|NCT02192190|454004467|FG003|Overall Study|Inadequate Pain Relief|0|||
126197074|NCT02192190|454004468|FG004|Overall Study|Inadequate Pain Relief|0|||
126197075|NCT02192190|454004469|FG005|Overall Study|Inadequate Pain Relief|0|||
126197076|NCT03227692|454004470|FG000|Overall Study|Protocol Violation|1|||
126197077|NCT03227692|454004471|FG001|Overall Study|Protocol Violation|1|||
126197078|NCT03227692|454004470|FG000|Overall Study|Lost to Follow-up|4|||
126197079|NCT03227692|454004471|FG001|Overall Study|Lost to Follow-up|2|||
126197080|NCT03227692|454004470|FG000|Overall Study|Adverse Event|0|||
126197081|NCT03227692|454004471|FG001|Overall Study|Adverse Event|2|||
126197082|NCT01657253|454004472|FG000|Overall Study|Lost to Follow-up|6|||
126197083|NCT01657253|454004473|FG001|Overall Study|Lost to Follow-up|5|||
126197084|NCT01657253|454004472|FG000|Overall Study|Withdrawal by Subject|11|||
126197085|NCT01657253|454004473|FG001|Overall Study|Withdrawal by Subject|12|||
126197086|NCT01657253|454004472|FG000|Overall Study|Adverse Event|0|||
126197087|NCT01657253|454004473|FG001|Overall Study|Adverse Event|1|||
126197088|NCT01970540|454004476|FG000|Overall Study|Non-treatment-related AE|0|||
126197089|NCT01970540|454004477|FG001|Overall Study|Non-treatment-related AE|0|||
126197090|NCT01970540|454004478|FG002|Overall Study|Non-treatment-related AE|1|||
126197091|NCT01970540|454004476|FG000|Overall Study|Progressive disease|55|||
126197092|NCT01970540|454004477|FG001|Overall Study|Progressive disease|23|||
126197093|NCT01970540|454004478|FG002|Overall Study|Progressive disease|10|||
126197094|NCT01970540|454004476|FG000|Overall Study|Treatment delay over protocol|0|||
126197095|NCT01970540|454004477|FG001|Overall Study|Treatment delay over protocol|0|||
126197096|NCT01970540|454004478|FG002|Overall Study|Treatment delay over protocol|1|||
126197097|NCT01970540|454004476|FG000|Overall Study|Physician Decision|7|||
126197098|NCT01970540|454004477|FG001|Overall Study|Physician Decision|2|||
126197099|NCT01970540|454004478|FG002|Overall Study|Physician Decision|0|||
126197100|NCT01970540|454004476|FG000|Overall Study|Clinical progression|0|||
126197101|NCT01970540|454004477|FG001|Overall Study|Clinical progression|1|||
126197102|NCT01970540|454004478|FG002|Overall Study|Clinical progression|1|||
126197103|NCT01970540|454004476|FG000|Overall Study|End of study|2|||
126197104|NCT01970540|454004477|FG001|Overall Study|End of study|0|||
126197105|NCT01970540|454004478|FG002|Overall Study|End of study|2|||
126197106|NCT01970540|454004476|FG000|Overall Study|Adverse Event|0|||
126197107|NCT01970540|454004477|FG001|Overall Study|Adverse Event|2|||
126197108|NCT01970540|454004478|FG002|Overall Study|Adverse Event|1|||
126197109|NCT01970540|454004476|FG000|Overall Study|Treatment-related AE|4|||
126197110|NCT01970540|454004477|FG001|Overall Study|Treatment-related AE|0|||
126197111|NCT01970540|454004478|FG002|Overall Study|Treatment-related AE|2|||
126197112|NCT01970540|454004476|FG000|Overall Study|Withdrawal by Subject|4|||
126197113|NCT01970540|454004477|FG001|Overall Study|Withdrawal by Subject|0|||
126197114|NCT01970540|454004478|FG002|Overall Study|Withdrawal by Subject|1|||
126197115|NCT01970540|454004476|FG000|Overall Study|Clinical deterioration|1|||
126197116|NCT01970540|454004477|FG001|Overall Study|Clinical deterioration|0|||
126197117|NCT01970540|454004478|FG002|Overall Study|Clinical deterioration|0|||
126197118|NCT01603628|454004479|FG000|Overall Study|Personal Reasons|1|||
126197119|NCT01603628|454004480|FG001|Overall Study|Personal Reasons|1|||
126197120|NCT01603628|454004481|FG002|Overall Study|Personal Reasons|2|||
126197121|NCT01603628|454004479|FG000|Overall Study|Protocol Violation|1|||
126197122|NCT01603628|454004480|FG001|Overall Study|Protocol Violation|1|||
126197123|NCT01603628|454004481|FG002|Overall Study|Protocol Violation|0|||
126197124|NCT01603628|454004479|FG000|Overall Study|Lost to Follow-up|0|||
126197125|NCT01603628|454004480|FG001|Overall Study|Lost to Follow-up|1|||
126197126|NCT01603628|454004481|FG002|Overall Study|Lost to Follow-up|0|||
126197127|NCT01603628|454004479|FG000|Overall Study|Other Miscellaneous Reason|1|||
126197128|NCT01603628|454004480|FG001|Overall Study|Other Miscellaneous Reason|0|||
126197129|NCT01603628|454004481|FG002|Overall Study|Other Miscellaneous Reason|0|||
126197130|NCT00952588|454004483|FG000|Overall Study|Death|28|||
126197131|NCT00952588|454004484|FG001|Overall Study|Death|13|||
126197132|NCT00952588|454004483|FG000|Overall Study|Withdrawal by Subject|2|||
126197133|NCT00952588|454004484|FG001|Overall Study|Withdrawal by Subject|5|||
126197134|NCT00952588|454004483|FG000|Overall Study|Adverse Event|2|||
126197135|NCT00952588|454004484|FG001|Overall Study|Adverse Event|3|||
126197136|NCT00952588|454004483|FG000|Overall Study|Lost to Follow-up|2|||
126197137|NCT00952588|454004484|FG001|Overall Study|Lost to Follow-up|0|||
126197138|NCT00952588|454004483|FG000|Overall Study|Physician Decision|0|||
126197139|NCT00952588|454004484|FG001|Overall Study|Physician Decision|1|||
126197140|NCT00952588|454004483|FG000|Overall Study|Lack of Efficacy|2|||
126197141|NCT00952588|454004484|FG001|Overall Study|Lack of Efficacy|2|||
126197142|NCT01796106|454004485|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
126197143|NCT01796106|454004486|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
126197144|NCT02795182|454004487|FG000|Overall Study|Death|5|||
126197145|NCT02795182|454004488|FG001|Overall Study|Death|4|||
126197146|NCT02795182|454004489|FG002|Overall Study|Death|4|||
126197147|NCT02795182|454004490|FG003|Overall Study|Death|18|||
126197148|NCT02795182|454004487|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
126197149|NCT02795182|454004488|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
126197150|NCT02795182|454004489|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
126197151|NCT02795182|454004490|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
126197152|NCT02795182|454004487|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
126197153|NCT02795182|454004488|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
126197154|NCT02795182|454004489|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
126197155|NCT02795182|454004490|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
126197156|NCT02795182|454004487|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
126197157|NCT02795182|454004488|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
126197158|NCT02795182|454004489|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
126197159|NCT02795182|454004490|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
126197160|NCT02795182|454004487|FG000|Overall Study|Withdrawal by Subject|4|||
126197161|NCT02795182|454004488|FG001|Overall Study|Withdrawal by Subject|0|||
126197162|NCT02795182|454004489|FG002|Overall Study|Withdrawal by Subject|0|||
126197163|NCT02795182|454004490|FG003|Overall Study|Withdrawal by Subject|3|||
126197164|NCT02795182|454004487|FG000|Overall Study|Lost to Follow-up|0|||
126197165|NCT02795182|454004488|FG001|Overall Study|Lost to Follow-up|0|||
126197166|NCT02795182|454004489|FG002|Overall Study|Lost to Follow-up|1|||
126197167|NCT02795182|454004490|FG003|Overall Study|Lost to Follow-up|1|||
126197168|NCT02795182|454004487|FG000|Overall Study|Roll Over to Long Term Extension|3|||
126197169|NCT02795182|454004488|FG001|Overall Study|Roll Over to Long Term Extension|3|||
126197170|NCT02795182|454004489|FG002|Overall Study|Roll Over to Long Term Extension|2|||
126197171|NCT02795182|454004490|FG003|Overall Study|Roll Over to Long Term Extension|5|||
126197172|NCT02795182|454004487|FG000|Overall Study|Progressive Disease|0|||
126197173|NCT02795182|454004488|FG001|Overall Study|Progressive Disease|1|||
126197174|NCT02795182|454004489|FG002|Overall Study|Progressive Disease|0|||
126197175|NCT02795182|454004490|FG003|Overall Study|Progressive Disease|4|||
126197176|NCT02795182|454004487|FG000|Overall Study|Physician Decision|0|||
126197177|NCT02795182|454004488|FG001|Overall Study|Physician Decision|0|||
126197178|NCT02795182|454004489|FG002|Overall Study|Physician Decision|0|||
126197179|NCT02795182|454004490|FG003|Overall Study|Physician Decision|1|||
126197180|NCT04107935|454004491|FG000|Overall Study|Death|1|||
126197181|NCT04107935|454004492|FG001|Overall Study|Death|0|||
126197182|NCT01021553|454004493|FG000|Overall Study|Adverse Event|1|||
126197183|NCT01021553|454004494|FG001|Overall Study|Adverse Event|0|||
126197184|NCT01021553|454004495|FG002|Overall Study|Adverse Event|0|||
126197185|NCT01021553|454004493|FG000|Overall Study|Lack of Efficacy|2|||
126197186|NCT01021553|454004494|FG001|Overall Study|Lack of Efficacy|2|||
126197187|NCT01021553|454004495|FG002|Overall Study|Lack of Efficacy|0|||
126197188|NCT01021553|454004493|FG000|Overall Study|Protocol Violation|0|||
126197189|NCT01021553|454004494|FG001|Overall Study|Protocol Violation|2|||
126197190|NCT01021553|454004495|FG002|Overall Study|Protocol Violation|2|||
126197191|NCT01021553|454004493|FG000|Overall Study|Lost to Follow-up|0|||
126197192|NCT01021553|454004494|FG001|Overall Study|Lost to Follow-up|0|||
126197193|NCT01021553|454004495|FG002|Overall Study|Lost to Follow-up|1|||
126197194|NCT01021553|454004493|FG000|Overall Study|Withdrawal by Subject|1|||
126197195|NCT01021553|454004494|FG001|Overall Study|Withdrawal by Subject|1|||
126197196|NCT01021553|454004495|FG002|Overall Study|Withdrawal by Subject|0|||
126197197|NCT00033293|454004496|FG000|Overall Study|Death|0|||
126197198|NCT00033293|454004497|FG001|Overall Study|Death|1|||
126197199|NCT00033293|454004496|FG000|Overall Study|Lack of Efficacy|5|||
126197200|NCT00033293|454004497|FG001|Overall Study|Lack of Efficacy|8|||
126197201|NCT00033293|454004496|FG000|Overall Study|Lost to Follow-up|0|||
126197202|NCT00033293|454004497|FG001|Overall Study|Lost to Follow-up|1|||
126197203|NCT00033293|454004496|FG000|Overall Study|Physician Decision|3|||
126197204|NCT00033293|454004497|FG001|Overall Study|Physician Decision|1|||
126197205|NCT00033293|454004496|FG000|Overall Study|Withdrawal by Subject|1|||
126197206|NCT00033293|454004497|FG001|Overall Study|Withdrawal by Subject|0|||
126197207|NCT00033293|454004496|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
126197208|NCT00033293|454004497|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
126197209|NCT00033293|454004496|FG000|Overall Study|Treatment refused|0|||
126197210|NCT00033293|454004497|FG001|Overall Study|Treatment refused|6|||
126197211|NCT00890201|454004498|FG000|Overall Study|Protocol Violation|5|||
126197212|NCT00890201|454004499|FG001|Overall Study|Protocol Violation|56|||
126197213|NCT00935701|454004500|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
126197214|NCT02087241|454004501|FG000|Overall Study|Death|2|||
126197215|NCT02087241|454004502|FG001|Overall Study|Death|1|||
126197216|NCT02087241|454004503|FG002|Overall Study|Death|1|||
126197217|NCT02087241|454004504|FG003|Overall Study|Death|1|||
126197218|NCT02087241|454004501|FG000|Overall Study|Withdrawal by Subject|1|||
126197219|NCT02087241|454004502|FG001|Overall Study|Withdrawal by Subject|0|||
126197220|NCT02087241|454004503|FG002|Overall Study|Withdrawal by Subject|0|||
126197221|NCT02087241|454004504|FG003|Overall Study|Withdrawal by Subject|1|||
126197222|NCT02087241|454004501|FG000|Overall Study|Progressive Disease|0|||
126197223|NCT02087241|454004502|FG001|Overall Study|Progressive Disease|0|||
126197224|NCT02087241|454004503|FG002|Overall Study|Progressive Disease|0|||
126197225|NCT02087241|454004504|FG003|Overall Study|Progressive Disease|1|||
126197226|NCT02087241|454004501|FG000|Overall Study|Study Terminated by Sponsor|0|||
126197227|NCT02087241|454004502|FG001|Overall Study|Study Terminated by Sponsor|2|||
126197228|NCT02087241|454004503|FG002|Overall Study|Study Terminated by Sponsor|0|||
126197229|NCT02087241|454004504|FG003|Overall Study|Study Terminated by Sponsor|4|||
126197230|NCT02181504|454004505|FG000|Overall Study|Adverse Event|1|||
126197231|NCT02181504|454004506|FG001|Overall Study|Adverse Event|1|||
126197232|NCT02181504|454004507|FG002|Overall Study|Adverse Event|1|||
126197233|NCT02583399|454006081|FG000|Overall Study|Able to be discharged|3|||
126197234|NCT02583399|454006081|FG000|Overall Study|Wanted to use a restricted medication|3|||
126197235|NCT00887913|454006082|FG000|Overall Study|Withdrawal by Subject|6|||
126197236|NCT01200758|454006083|FG000|Stage I|Death|0|||
126197237|NCT01200758|454006084|FG001|Stage I|Death|1|||
126197238|NCT01200758|454006085|FG002|Stage I|Death|0|||
126197239|NCT01200758|454006086|FG003|Stage I|Death|0|||
126197240|NCT01200758|454006083|FG000|Stage I|Physician Decision|1|||
126197241|NCT01200758|454006084|FG001|Stage I|Physician Decision|1|||
126197242|NCT01200758|454006085|FG002|Stage I|Physician Decision|0|||
126197243|NCT01200758|454006086|FG003|Stage I|Physician Decision|0|||
126197244|NCT01200758|454006083|FG000|Stage I|Lack of Efficacy|2|||
126197245|NCT01200758|454006084|FG001|Stage I|Lack of Efficacy|1|||
126197246|NCT01200758|454006085|FG002|Stage I|Lack of Efficacy|0|||
126197247|NCT01200758|454006086|FG003|Stage I|Lack of Efficacy|0|||
126197248|NCT01200758|454006083|FG000|Stage I|Adverse Event|5|||
126197249|NCT01200758|454006084|FG001|Stage I|Adverse Event|5|||
126197250|NCT01200758|454006085|FG002|Stage I|Adverse Event|0|||
126197251|NCT01200758|454006086|FG003|Stage I|Adverse Event|0|||
126197252|NCT01200758|454006083|FG000|Stage I|Withdrawal by Subject|1|||
126197253|NCT01200758|454006084|FG001|Stage I|Withdrawal by Subject|2|||
126197254|NCT01200758|454006085|FG002|Stage I|Withdrawal by Subject|0|||
126197255|NCT01200758|454006086|FG003|Stage I|Withdrawal by Subject|0|||
126197256|NCT01200758|454006083|FG000|Stage I|Disease Progression|9|||
126197257|NCT01200758|454006084|FG001|Stage I|Disease Progression|7|||
126197258|NCT01200758|454006085|FG002|Stage I|Disease Progression|0|||
126197259|NCT01200758|454006086|FG003|Stage I|Disease Progression|0|||
126197260|NCT01200758|454006083|FG000|Stage 2|Disease Progression|0|||
126197261|NCT01200758|454006084|FG001|Stage 2|Disease Progression|0|||
126197262|NCT01200758|454006085|FG002|Stage 2|Disease Progression|16|||
126197263|NCT01200758|454006086|FG003|Stage 2|Disease Progression|21|||
126197264|NCT01200758|454006083|FG000|Stage 2|Lack of Efficacy|0|||
126197265|NCT01200758|454006084|FG001|Stage 2|Lack of Efficacy|0|||
126197266|NCT01200758|454006085|FG002|Stage 2|Lack of Efficacy|4|||
126197267|NCT01200758|454006086|FG003|Stage 2|Lack of Efficacy|2|||
126197268|NCT01200758|454006083|FG000|Stage 2|Physician Decision|0|||
126197269|NCT01200758|454006084|FG001|Stage 2|Physician Decision|0|||
126197270|NCT01200758|454006085|FG002|Stage 2|Physician Decision|5|||
126197271|NCT01200758|454006086|FG003|Stage 2|Physician Decision|7|||
126197272|NCT01200758|454006083|FG000|Stage 2|Adverse Event|0|||
126197273|NCT01200758|454006084|FG001|Stage 2|Adverse Event|0|||
126197274|NCT01200758|454006085|FG002|Stage 2|Adverse Event|5|||
126197275|NCT01200758|454006086|FG003|Stage 2|Adverse Event|9|||
126197276|NCT01200758|454006083|FG000|Stage 2|Withdrawal by Subject|0|||
126197277|NCT01200758|454006084|FG001|Stage 2|Withdrawal by Subject|0|||
126197278|NCT01200758|454006085|FG002|Stage 2|Withdrawal by Subject|4|||
126197279|NCT01200758|454006086|FG003|Stage 2|Withdrawal by Subject|1|||
126197280|NCT01200758|454006083|FG000|Stage 2|Lost to Follow-up|0|||
126197281|NCT01200758|454006084|FG001|Stage 2|Lost to Follow-up|0|||
126197282|NCT01200758|454006085|FG002|Stage 2|Lost to Follow-up|3|||
126197283|NCT01200758|454006086|FG003|Stage 2|Lost to Follow-up|1|||
126197284|NCT01200758|454006083|FG000|Stage 2|Protocol Violation|0|||
126197285|NCT01200758|454006084|FG001|Stage 2|Protocol Violation|0|||
126197286|NCT01200758|454006085|FG002|Stage 2|Protocol Violation|1|||
126197287|NCT01200758|454006086|FG003|Stage 2|Protocol Violation|4|||
126197288|NCT01200758|454006083|FG000|Stage 2|Death|0|||
126197289|NCT01200758|454006084|FG001|Stage 2|Death|0|||
126197290|NCT01200758|454006085|FG002|Stage 2|Death|3|||
126197291|NCT01200758|454006086|FG003|Stage 2|Death|5|||
126197292|NCT00545584|454006087|FG000|Overall Study|Only one reason for discontinuation|62|||
126197293|NCT00545584|454006088|FG001|Overall Study|Only one reason for discontinuation|61|||
126197294|NCT00545584|454006089|FG002|Overall Study|Only one reason for discontinuation|48|||
126197295|NCT00545584|454006087|FG000|Overall Study|Two or more reasons for discontinuation|17|||
126197296|NCT00545584|454006088|FG001|Overall Study|Two or more reasons for discontinuation|19|||
126197297|NCT00545584|454006089|FG002|Overall Study|Two or more reasons for discontinuation|8|||
126197298|NCT03525613|454006092|FG000|Overall Study|Adverse Event|11|||
126197299|NCT03525613|454006093|FG001|Overall Study|Adverse Event|8|||
126197300|NCT03525613|454006094|FG002|Overall Study|Adverse Event|3|||
126197301|NCT03525613|454006095|FG003|Overall Study|Adverse Event|3|||
126197302|NCT03525613|454006092|FG000|Overall Study|Lost to Follow-up|4|||
126197303|NCT03525613|454006093|FG001|Overall Study|Lost to Follow-up|5|||
126197304|NCT03525613|454006094|FG002|Overall Study|Lost to Follow-up|3|||
126197305|NCT03525613|454006095|FG003|Overall Study|Lost to Follow-up|2|||
126197306|NCT03525613|454006092|FG000|Overall Study|Physician Decision|0|||
126197307|NCT03525613|454006093|FG001|Overall Study|Physician Decision|1|||
126197308|NCT03525613|454006094|FG002|Overall Study|Physician Decision|0|||
126197309|NCT03525613|454006095|FG003|Overall Study|Physician Decision|1|||
126197310|NCT03525613|454006092|FG000|Overall Study|Consent Withdrawal|25|||
126197311|NCT03525613|454006093|FG001|Overall Study|Consent Withdrawal|16|||
126197312|NCT03525613|454006094|FG002|Overall Study|Consent Withdrawal|12|||
126197313|NCT03525613|454006095|FG003|Overall Study|Consent Withdrawal|9|||
126197314|NCT03525613|454006092|FG000|Overall Study|Death|20|||
126197315|NCT03525613|454006093|FG001|Overall Study|Death|9|||
126197316|NCT03525613|454006094|FG002|Overall Study|Death|7|||
126197317|NCT03525613|454006095|FG003|Overall Study|Death|1|||
126197318|NCT03525613|454006092|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
126197319|NCT03525613|454006093|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
126197320|NCT03525613|454006094|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
126197321|NCT03525613|454006095|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
126197322|NCT02584660|454006096|FG000|Overall Study|Adverse Event|4|||
126197323|NCT02584660|454006097|FG001|Overall Study|Adverse Event|0|||
126197324|NCT02584660|454006096|FG000|Overall Study|Lost to Follow-up|3|||
126197325|NCT02584660|454006097|FG001|Overall Study|Lost to Follow-up|4|||
126197326|NCT02584660|454006096|FG000|Overall Study|Protocol Violation|0|||
126197327|NCT02584660|454006097|FG001|Overall Study|Protocol Violation|1|||
126197328|NCT02584660|454006096|FG000|Overall Study|Withdrawal by Subject|0|||
126197329|NCT02584660|454006097|FG001|Overall Study|Withdrawal by Subject|2|||
126197330|NCT02584660|454006096|FG000|Overall Study|Other|0|||
126197331|NCT02584660|454006097|FG001|Overall Study|Other|1|||
126197332|NCT00461552|454006100|FG000|Overall Study|Drug Dispensing error|0|||
126197333|NCT00461552|454006101|FG001|Overall Study|Drug Dispensing error|2|||
126197334|NCT01289028|454006104|FG000|Overall Study|Progressive Disease|49|||
126197335|NCT01289028|454006104|FG000|Overall Study|Adverse Event|14|||
126197336|NCT01289028|454006104|FG000|Overall Study|Withdrawal by Subject|6|||
126197337|NCT01289028|454006104|FG000|Overall Study|Death|4|||
126197338|NCT01289028|454006104|FG000|Overall Study|Lack of Efficacy|2|||
126197339|NCT01289028|454006104|FG000|Overall Study|No longer required|2|||
126197340|NCT01289028|454006104|FG000|Overall Study|Lost to Follow-up|2|||
126197341|NCT01289028|454006104|FG000|Overall Study|New Cancer Therapy|2|||
126197342|NCT01289028|454006104|FG000|Overall Study|Abnormal Lab Value|1|||
126197343|NCT01289028|454006104|FG000|Overall Study|Missing reason for discon|1|||
126197344|NCT02120469|454006105|FG000|Overall Study|HER-2/neu-amplified|1|||
126197345|NCT02120469|454006106|FG001|Overall Study|HER-2/neu-amplified|0|||
126197346|NCT02120469|454006107|FG002|Overall Study|HER-2/neu-amplified|1|||
126197347|NCT03267576|454006112|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
126197348|NCT03267576|454006113|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
126197349|NCT03267576|454006112|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
126197350|NCT03267576|454006113|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
126197351|NCT01369069|454006114|FG000|Overall Study|Lost to Follow-up|8|||
126197352|NCT01369069|454006115|FG001|Overall Study|Lost to Follow-up|9|||
126197353|NCT01369069|454006114|FG000|Overall Study|Withdrawal by Subject|9|||
126197354|NCT01369069|454006115|FG001|Overall Study|Withdrawal by Subject|7|||
126197355|NCT00882362|454006116|FG000|Overall Study|Adverse Event|13|||
126197356|NCT00882362|454006117|FG001|Overall Study|Adverse Event|10|||
126197357|NCT00882362|454006116|FG000|Overall Study|Withdrawal by Subject|13|||
126197358|NCT00882362|454006117|FG001|Overall Study|Withdrawal by Subject|10|||
126197359|NCT00882362|454006116|FG000|Overall Study|Lack of Efficacy|3|||
126197360|NCT00882362|454006117|FG001|Overall Study|Lack of Efficacy|0|||
126197361|NCT00882362|454006116|FG000|Overall Study|Protocol Violation|7|||
126197362|NCT00882362|454006117|FG001|Overall Study|Protocol Violation|2|||
126197363|NCT00882362|454006116|FG000|Overall Study|Pregnancy|1|||
126197364|NCT00882362|454006117|FG001|Overall Study|Pregnancy|0|||
126197365|NCT00882362|454006116|FG000|Overall Study|Physician Decision|5|||
126197366|NCT00882362|454006117|FG001|Overall Study|Physician Decision|1|||
126197367|NCT00882362|454006116|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
126197368|NCT00882362|454006117|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
126197369|NCT00882362|454006116|FG000|Overall Study|change of residence or other commitments|5|||
126197370|NCT00882362|454006117|FG001|Overall Study|change of residence or other commitments|0|||
126197371|NCT01268514|454006118|FG000|Overall Study|Adverse Event|20|||
126197372|NCT01268514|454006118|FG000|Overall Study|Death|8|||
126197373|NCT01268514|454006118|FG000|Overall Study|Lost to Follow-up|5|||
126197374|NCT01268514|454006118|FG000|Overall Study|Withdrawal by Subject|3|||
126197375|NCT01268514|454006118|FG000|Overall Study|Withdrawal by Surgeon|5|||
126197376|NCT01846208|454006119|FG000|Overall Study|Withdrew prior to treatment|1|||
126197377|NCT01846208|454006120|FG001|Overall Study|Withdrew prior to treatment|1|||
126197378|NCT01846208|454006121|FG002|Overall Study|Withdrew prior to treatment|1|||
126197379|NCT01846208|454006119|FG000|Overall Study|Dosing Symptoms|1|||
126197380|NCT01846208|454006120|FG001|Overall Study|Dosing Symptoms|2|||
126197381|NCT01846208|454006121|FG002|Overall Study|Dosing Symptoms|6|||
126197382|NCT01846208|454006119|FG000|Overall Study|Withdrawal by Subject|5|||
126197383|NCT01846208|454006120|FG001|Overall Study|Withdrawal by Subject|0|||
126197384|NCT01846208|454006121|FG002|Overall Study|Withdrawal by Subject|0|||
126197385|NCT01846208|454006119|FG000|Overall Study|Non-compliance|1|||
126197386|NCT01846208|454006120|FG001|Overall Study|Non-compliance|1|||
126197387|NCT01846208|454006121|FG002|Overall Study|Non-compliance|0|||
126197388|NCT01846208|454006119|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
126197389|NCT01846208|454006120|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
126197390|NCT01846208|454006121|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
126197391|NCT01846208|454006119|FG000|Overall Study|Refused SU OFC|0|||
126197392|NCT01846208|454006120|FG001|Overall Study|Refused SU OFC|0|||
126197393|NCT01846208|454006121|FG002|Overall Study|Refused SU OFC|1|||
126197394|NCT01424306|454006122|FG000|Overall Study|Protocol Violation|0|||
126197395|NCT01424306|454006123|FG001|Overall Study|Protocol Violation|0|||
126197396|NCT01424306|454006124|FG002|Overall Study|Protocol Violation|0|||
126197397|NCT01424306|454006125|FG003|Overall Study|Protocol Violation|0|||
126197398|NCT01424306|454006126|FG004|Overall Study|Protocol Violation|1|||
126197399|NCT01424306|454006127|FG005|Overall Study|Protocol Violation|0|||
126197400|NCT03196973|454006135|FG000|Overall Study|Adverse Event|1|||
126197401|NCT03196973|454006136|FG001|Overall Study|Adverse Event|1|||
126197402|NCT03196973|454006137|FG002|Overall Study|Adverse Event|2|||
126197403|NCT03196973|454006135|FG000|Overall Study|Lack of Efficacy|2|||
126197404|NCT03196973|454006136|FG001|Overall Study|Lack of Efficacy|6|||
126197405|NCT03196973|454006137|FG002|Overall Study|Lack of Efficacy|1|||
126197406|NCT03196973|454006135|FG000|Overall Study|Lost to Follow-up|4|||
126197407|NCT03196973|454006136|FG001|Overall Study|Lost to Follow-up|3|||
126197408|NCT03196973|454006137|FG002|Overall Study|Lost to Follow-up|2|||
126197409|NCT03196973|454006135|FG000|Overall Study|Consent withdrawn|2|||
126197410|NCT03196973|454006136|FG001|Overall Study|Consent withdrawn|1|||
126197411|NCT03196973|454006137|FG002|Overall Study|Consent withdrawn|0|||
126197412|NCT03196973|454006135|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
126197413|NCT03196973|454006136|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
126197414|NCT03196973|454006137|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
126197415|NCT01809327|454006138|FG000|Overall Study|Lost to Follow-up|5|||
126197416|NCT01809327|454006139|FG001|Overall Study|Lost to Follow-up|2|||
126197417|NCT01809327|454006140|FG002|Overall Study|Lost to Follow-up|4|||
126197418|NCT01809327|454006141|FG003|Overall Study|Lost to Follow-up|2|||
126197419|NCT01809327|454006142|FG004|Overall Study|Lost to Follow-up|3|||
126197420|NCT01809327|454006138|FG000|Overall Study|Withdrawal by Subject|6|||
126197421|NCT01809327|454006139|FG001|Overall Study|Withdrawal by Subject|4|||
126197422|NCT01809327|454006140|FG002|Overall Study|Withdrawal by Subject|4|||
126197423|NCT01809327|454006141|FG003|Overall Study|Withdrawal by Subject|2|||
126197424|NCT01809327|454006142|FG004|Overall Study|Withdrawal by Subject|5|||
126197425|NCT01809327|454006138|FG000|Overall Study|Adverse Event|4|||
126197426|NCT01809327|454006139|FG001|Overall Study|Adverse Event|3|||
126197427|NCT01809327|454006140|FG002|Overall Study|Adverse Event|7|||
126197428|NCT01809327|454006141|FG003|Overall Study|Adverse Event|4|||
126197429|NCT01809327|454006142|FG004|Overall Study|Adverse Event|8|||
126197430|NCT01809327|454006138|FG000|Overall Study|Death|1|||
126197431|NCT01809327|454006139|FG001|Overall Study|Death|0|||
126197432|NCT01809327|454006140|FG002|Overall Study|Death|0|||
126197433|NCT01809327|454006141|FG003|Overall Study|Death|0|||
126197434|NCT01809327|454006142|FG004|Overall Study|Death|0|||
126197435|NCT01809327|454006138|FG000|Overall Study|Protocol Violation|0|||
126197436|NCT01809327|454006139|FG001|Overall Study|Protocol Violation|1|||
126197437|NCT01809327|454006140|FG002|Overall Study|Protocol Violation|0|||
126197438|NCT01809327|454006141|FG003|Overall Study|Protocol Violation|0|||
126197439|NCT01809327|454006142|FG004|Overall Study|Protocol Violation|0|||
126197440|NCT01809327|454006138|FG000|Overall Study|Physician Decision|1|||
126197441|NCT01809327|454006139|FG001|Overall Study|Physician Decision|1|||
126197442|NCT01809327|454006140|FG002|Overall Study|Physician Decision|0|||
126197443|NCT01809327|454006141|FG003|Overall Study|Physician Decision|0|||
126197444|NCT01809327|454006142|FG004|Overall Study|Physician Decision|0|||
126197445|NCT01809327|454006138|FG000|Overall Study|Pregnancy|1|||
126197446|NCT01809327|454006139|FG001|Overall Study|Pregnancy|0|||
126197447|NCT01809327|454006140|FG002|Overall Study|Pregnancy|0|||
126197448|NCT01809327|454006141|FG003|Overall Study|Pregnancy|0|||
126197449|NCT01809327|454006142|FG004|Overall Study|Pregnancy|0|||
126197450|NCT01809327|454006138|FG000|Overall Study|Other|14|||
126197451|NCT01809327|454006139|FG001|Overall Study|Other|15|||
126197452|NCT01809327|454006140|FG002|Overall Study|Other|7|||
126197453|NCT01809327|454006141|FG003|Overall Study|Other|4|||
126197454|NCT01809327|454006142|FG004|Overall Study|Other|9|||
126197455|NCT03344562|454006143|FG000|Overall Study|Withdrawal by Subject|2|||
126197456|NCT03344562|454006144|FG001|Overall Study|Withdrawal by Subject|0|||
126197457|NCT02390362|454006151|FG000|Overall Study|Withdrawal by Subject|0|||
126197458|NCT02390362|454006152|FG001|Overall Study|Withdrawal by Subject|1|||
126197459|NCT04009824|454006153|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
126197460|NCT04009824|454006154|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
126197461|NCT04009824|454006155|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
126197462|NCT04009824|454006156|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
126197463|NCT04009824|454006157|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
126197464|NCT01142791|454006169|FG000|Overall Study|Alternative Treatment|1|||
126197465|NCT01142791|454006170|FG001|Overall Study|Alternative Treatment|0|||
126197466|NCT01142791|454006169|FG000|Overall Study|Lost to Follow-up|1|||
126197467|NCT01142791|454006170|FG001|Overall Study|Lost to Follow-up|0|||
126197468|NCT01142791|454006169|FG000|Overall Study|Withdrawal by Subject|5|||
126197469|NCT01142791|454006170|FG001|Overall Study|Withdrawal by Subject|0|||
126197470|NCT01142791|454006169|FG000|Overall Study|Received only 1 sonication|0|||
126197471|NCT01142791|454006170|FG001|Overall Study|Received only 1 sonication|6|||
126197472|NCT02608892|454006171|FG000|Overall Study|Lost to Follow-up|1|||
126197473|NCT02608892|454006172|FG001|Overall Study|Lost to Follow-up|0|||
126197474|NCT03032523|454006173|FG000|Overall Study|Withdrawal by Subject|2|||
126197475|NCT03032523|454006174|FG001|Overall Study|Withdrawal by Subject|2|||
126197476|NCT03032523|454006173|FG000|Overall Study|Physician Decision|1|||
126197477|NCT03032523|454006174|FG001|Overall Study|Physician Decision|0|||
126197478|NCT02590406|454006177|FG000|Overall Study|Adverse Event|1|||
126197479|NCT02590406|454006178|FG001|Overall Study|Adverse Event|0|||
126197480|NCT02590406|454006177|FG000|Overall Study|Saturometer malfunction|0|||
126197481|NCT02590406|454006178|FG001|Overall Study|Saturometer malfunction|1|||
126197482|NCT00957723|454006179|FG000|Overall Study|Death|3|||
126197483|NCT00957723|454006179|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
126197484|NCT00957723|454006179|FG000|Overall Study|Lost to Follow-up|8|||
126197485|NCT00957723|454006179|FG000|Overall Study|Withdrawal by Subject|24|||
126197486|NCT00957723|454006179|FG000|Overall Study|Investigative Site Terminated|61|||
126197487|NCT00957723|454006179|FG000|Overall Study|Intercurrent Illness|2|||
126197488|NCT00957723|454006179|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
126197489|NCT00984009|454006180|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
126197490|NCT00281528|454006181|FG000|Overall Study|Progressive Disease|28|||
126197491|NCT00281528|454006182|FG001|Overall Study|Progressive Disease|18|||
126197492|NCT00281528|454006183|FG002|Overall Study|Progressive Disease|27|||
126197493|NCT00281528|454006181|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
126197494|NCT00281528|454006182|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
126197495|NCT00281528|454006183|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
126197496|NCT00281528|454006181|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
126197497|NCT00281528|454006182|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
126197498|NCT00281528|454006183|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
126197499|NCT00281528|454006181|FG000|Overall Study|Physician Decision|11|||
126197500|NCT00281528|454006182|FG001|Overall Study|Physician Decision|4|||
126197501|NCT00281528|454006183|FG002|Overall Study|Physician Decision|5|||
126197502|NCT00281528|454006181|FG000|Overall Study|Protocol Violation|1|||
126197503|NCT00281528|454006182|FG001|Overall Study|Protocol Violation|0|||
126197504|NCT00281528|454006183|FG002|Overall Study|Protocol Violation|1|||
126197505|NCT00281528|454006181|FG000|Overall Study|Withdrawal by Subject|5|||
126197506|NCT00281528|454006182|FG001|Overall Study|Withdrawal by Subject|5|||
126197507|NCT00281528|454006183|FG002|Overall Study|Withdrawal by Subject|7|||
126197508|NCT00281528|454006181|FG000|Overall Study|Other|6|||
126197509|NCT00281528|454006182|FG001|Overall Study|Other|3|||
126197510|NCT00281528|454006183|FG002|Overall Study|Other|5|||
126197511|NCT02036476|454006193|FG000|Overall Study|Withdrawal by Subject|2|||
126197512|NCT02036476|454006193|FG000|Overall Study|Progressive Disease|4|||
126197513|NCT02036476|454006193|FG000|Overall Study|Unacceptable Toxicity|2|||
126197514|NCT02168816|454006194|FG000|Overall Study|Lost to Follow-up|2|||
126197515|NCT02168816|454006195|FG001|Overall Study|Lost to Follow-up|2|||
126197516|NCT01984294|454006196|FG000|Overall Study|Randomized but Never Treated|0|||
126197517|NCT01984294|454006197|FG001|Overall Study|Randomized but Never Treated|0|||
126197518|NCT01984294|454006198|FG002|Overall Study|Randomized but Never Treated|1|||
126197519|NCT01984294|454006196|FG000|Overall Study|Lack of Efficacy|4|||
126197520|NCT01984294|454006197|FG001|Overall Study|Lack of Efficacy|2|||
126197521|NCT01984294|454006198|FG002|Overall Study|Lack of Efficacy|6|||
126197522|NCT01984294|454006196|FG000|Overall Study|Adverse Event|0|||
126197523|NCT01984294|454006197|FG001|Overall Study|Adverse Event|1|||
126197524|NCT01984294|454006198|FG002|Overall Study|Adverse Event|0|||
126197525|NCT01987609|454006201|FG000|Overall Study|Adverse Event|1|||
126197526|NCT02610231|454006202|FG000|Overall Study|Withdrawal by Subject|27|||
126197527|NCT02610231|454006202|FG000|Overall Study|Adverse Event|20|||
126197528|NCT02610231|454006202|FG000|Overall Study|Death|5|||
126197529|NCT02610231|454006202|FG000|Overall Study|Surgery|2|||
126197530|NCT02610231|454006202|FG000|Overall Study|Physician Decision|1|||
126197531|NCT02610231|454006202|FG000|Overall Study|Non Compliance|2|||
126197532|NCT02610231|454006202|FG000|Overall Study|Other|3|||
126197533|NCT00806494|454006203|FG000|Overall Study|Adverse Event|29|||
126197534|NCT00806494|454006203|FG000|Overall Study|Lack of Efficacy|6|||
126197535|NCT00806494|454006203|FG000|Overall Study|Lost to Follow-up|10|||
126197536|NCT00806494|454006203|FG000|Overall Study|Other|30|||
126197537|NCT00806494|454006203|FG000|Overall Study|Withdrawal by Subject|5|||
126197538|NCT01279954|454006204|FG000|Overall Study|Lack of Efficacy|3|||
126197539|NCT01279954|454006205|FG001|Overall Study|Lack of Efficacy|4|||
126197540|NCT02709889|454006206|FG000|Overall Study|Withdrawal by Subject|11|||
126197541|NCT02709889|454006207|FG001|Overall Study|Withdrawal by Subject|10|||
126197542|NCT02709889|454006208|FG002|Overall Study|Withdrawal by Subject|2|||
126197543|NCT02709889|454006209|FG003|Overall Study|Withdrawal by Subject|12|||
126197544|NCT02709889|454006206|FG000|Overall Study|Death|25|||
126197545|NCT02709889|454006207|FG001|Overall Study|Death|38|||
126197546|NCT02709889|454006208|FG002|Overall Study|Death|4|||
126197547|NCT02709889|454006209|FG003|Overall Study|Death|44|||
126197548|NCT02709889|454006206|FG000|Overall Study|Physician Decision|1|||
126197549|NCT02709889|454006207|FG001|Overall Study|Physician Decision|2|||
126197550|NCT02709889|454006208|FG002|Overall Study|Physician Decision|3|||
126197551|NCT02709889|454006209|FG003|Overall Study|Physician Decision|5|||
126197552|NCT02709889|454006206|FG000|Overall Study|Lost to Follow-up|2|||
126197553|NCT02709889|454006207|FG001|Overall Study|Lost to Follow-up|0|||
126197554|NCT02709889|454006208|FG002|Overall Study|Lost to Follow-up|0|||
126197555|NCT02709889|454006209|FG003|Overall Study|Lost to Follow-up|4|||
126197556|NCT02709889|454006206|FG000|Overall Study|Study Terminated by Sponsor|4|||
126197557|NCT02709889|454006207|FG001|Overall Study|Study Terminated by Sponsor|6|||
126197558|NCT02709889|454006208|FG002|Overall Study|Study Terminated by Sponsor|2|||
126197559|NCT02709889|454006209|FG003|Overall Study|Study Terminated by Sponsor|17|||
126197560|NCT02709889|454006206|FG000|Overall Study|Other, Not Specified|0|||
126197561|NCT02709889|454006207|FG001|Overall Study|Other, Not Specified|1|||
126197562|NCT02709889|454006208|FG002|Overall Study|Other, Not Specified|1|||
126197563|NCT02709889|454006209|FG003|Overall Study|Other, Not Specified|6|||
126197564|NCT00537810|454006210|FG000|Overall Study|Withdrawal by Subject|4|||
126197565|NCT00537810|454006211|FG001|Overall Study|Withdrawal by Subject|11|||
126197566|NCT00537810|454006212|FG002|Overall Study|Withdrawal by Subject|4|||
126197567|NCT00537810|454006213|FG003|Overall Study|Withdrawal by Subject|3|||
126197568|NCT00537810|454006210|FG000|Overall Study|Medically withdrawn|2|||
126197569|NCT00537810|454006211|FG001|Overall Study|Medically withdrawn|2|||
126197570|NCT00537810|454006212|FG002|Overall Study|Medically withdrawn|0|||
126197571|NCT00537810|454006213|FG003|Overall Study|Medically withdrawn|1|||
126197572|NCT01066546|454006214|FG000|Overall Study|Study terminated by sponsor|5|||
126197573|NCT03258762|454006215|FG000|Overall Study|Lost to Follow-up|0|||
126197574|NCT03258762|454006216|FG001|Overall Study|Lost to Follow-up|1|||
126197575|NCT01711359|454006217|FG000|Treatment Period|Withdrawal by Subject|18|||
126197576|NCT01711359|454006218|FG001|Treatment Period|Withdrawal by Subject|7|||
126197577|NCT01711359|454006219|FG002|Treatment Period|Withdrawal by Subject|13|||
126197578|NCT01711359|454006217|FG000|Treatment Period|Lack of Efficacy|13|||
126197579|NCT01711359|454006218|FG001|Treatment Period|Lack of Efficacy|2|||
126197580|NCT01711359|454006219|FG002|Treatment Period|Lack of Efficacy|2|||
126197581|NCT01711359|454006217|FG000|Treatment Period|Adverse Event|8|||
126197582|NCT01711359|454006218|FG001|Treatment Period|Adverse Event|10|||
126197583|NCT01711359|454006219|FG002|Treatment Period|Adverse Event|24|||
126197584|NCT01711359|454006217|FG000|Treatment Period|Physician Decision|4|||
126197585|NCT01711359|454006218|FG001|Treatment Period|Physician Decision|3|||
126197586|NCT01711359|454006219|FG002|Treatment Period|Physician Decision|2|||
126197587|NCT01711359|454006217|FG000|Treatment Period|Death|3|||
126197588|NCT01711359|454006218|FG001|Treatment Period|Death|0|||
126197589|NCT01711359|454006219|FG002|Treatment Period|Death|0|||
126197590|NCT01711359|454006217|FG000|Treatment Period|Entry Criteria Not Met|1|||
126197591|NCT01711359|454006218|FG001|Treatment Period|Entry Criteria Not Met|0|||
126197592|NCT01711359|454006219|FG002|Treatment Period|Entry Criteria Not Met|0|||
126197593|NCT01711359|454006217|FG000|Treatment Period|Sponsor Decision|1|||
126197594|NCT01711359|454006218|FG001|Treatment Period|Sponsor Decision|0|||
126197595|NCT01711359|454006219|FG002|Treatment Period|Sponsor Decision|0|||
126197596|NCT01711359|454006217|FG000|Treatment Period|Lost to Follow-up|1|||
126197597|NCT01711359|454006218|FG001|Treatment Period|Lost to Follow-up|1|||
126197598|NCT01711359|454006219|FG002|Treatment Period|Lost to Follow-up|1|||
126197599|NCT01711359|454006217|FG000|Treatment Period|Randomized, Not Treated|3|||
126197600|NCT01711359|454006218|FG001|Treatment Period|Randomized, Not Treated|1|||
126197601|NCT01711359|454006219|FG002|Treatment Period|Randomized, Not Treated|0|||
126197602|NCT02698176|454006220|FG000|Overall Study|Progressive disease|4|||
126197603|NCT02698176|454006221|FG001|Overall Study|Progressive disease|3|||
126197604|NCT02698176|454006222|FG002|Overall Study|Progressive disease|1|||
126197605|NCT02698176|454006223|FG003|Overall Study|Progressive disease|0|||
126197606|NCT02698176|454006220|FG000|Overall Study|Adverse Event|2|||
126197607|NCT02698176|454006221|FG001|Overall Study|Adverse Event|0|||
126197608|NCT02698176|454006222|FG002|Overall Study|Adverse Event|0|||
126197609|NCT02698176|454006223|FG003|Overall Study|Adverse Event|0|||
126197610|NCT02698176|454006220|FG000|Overall Study|Clinical progression|3|||
126197611|NCT02698176|454006221|FG001|Overall Study|Clinical progression|0|||
126197612|NCT02698176|454006222|FG002|Overall Study|Clinical progression|0|||
126197613|NCT02698176|454006223|FG003|Overall Study|Clinical progression|0|||
126197614|NCT02561572|454006226|FG000|Overall Study|Inadequate time before surgery|2|||
126199949|NCT01117428|454017804|FG000|Overall Study|Physician Decision|0|||
126197615|NCT02561572|454006227|FG001|Overall Study|Inadequate time before surgery|1|||
126197616|NCT02561572|454006226|FG000|Overall Study|Protocol Violation|0|||
126197617|NCT02561572|454006227|FG001|Overall Study|Protocol Violation|1|||
126197618|NCT00795717|454006228|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
126197619|NCT00795717|454006229|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
126197620|NCT00795717|454006228|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
126197621|NCT00795717|454006229|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
126197622|NCT00795717|454006228|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
126197623|NCT00795717|454006229|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
126197624|NCT00795717|454006228|FG000|Phase II|too busy|0|||
126197625|NCT00795717|454006229|FG001|Phase II|too busy|1|||
126197626|NCT02985684|454006235|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
126197627|NCT02985684|454006235|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
126197628|NCT02985684|454006235|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
126197629|NCT00424463|454006236|FG000|Overall Study|Adverse Event|2|||
126197630|NCT00424463|454006237|FG001|Overall Study|Adverse Event|3|||
126197631|NCT00424463|454006238|FG002|Overall Study|Adverse Event|2|||
126197632|NCT00424463|454006236|FG000|Overall Study|Physician Decision|0|||
126197633|NCT00424463|454006237|FG001|Overall Study|Physician Decision|2|||
126197634|NCT00424463|454006238|FG002|Overall Study|Physician Decision|2|||
126197635|NCT00424463|454006236|FG000|Overall Study|Withdrawal by Subject|4|||
126197636|NCT00424463|454006237|FG001|Overall Study|Withdrawal by Subject|2|||
126197637|NCT00424463|454006238|FG002|Overall Study|Withdrawal by Subject|5|||
126197638|NCT00424463|454006236|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
126197639|NCT00424463|454006237|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
126197640|NCT00424463|454006238|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
126197641|NCT00424463|454006236|FG000|Overall Study|Patient's convenience|0|||
126197642|NCT00424463|454006237|FG001|Overall Study|Patient's convenience|0|||
126197643|NCT00424463|454006238|FG002|Overall Study|Patient's convenience|1|||
126197644|NCT01436357|454006239|FG000|Overall Study|Death|5|||
126197645|NCT01436357|454006240|FG001|Overall Study|Death|1|||
126197646|NCT01436357|454006239|FG000|Overall Study|Enrolled but not vaccinated|1|||
126197647|NCT01436357|454006240|FG001|Overall Study|Enrolled but not vaccinated|1|||
126197648|NCT01436357|454006239|FG000|Overall Study|Incarceration|18|||
126197649|NCT01436357|454006240|FG001|Overall Study|Incarceration|20|||
126197650|NCT01436357|454006239|FG000|Overall Study|Lost to Follow-up|67|||
126197651|NCT01436357|454006240|FG001|Overall Study|Lost to Follow-up|61|||
126197652|NCT01436357|454006239|FG000|Overall Study|Protocol Violation|1|||
126197653|NCT01436357|454006240|FG001|Overall Study|Protocol Violation|0|||
126197654|NCT01436357|454006239|FG000|Overall Study|Withdrawal by Subject|26|||
126197655|NCT01436357|454006240|FG001|Overall Study|Withdrawal by Subject|38|||
126197656|NCT01436357|454006239|FG000|Overall Study|Physician Decision|3|||
126197657|NCT01436357|454006240|FG001|Overall Study|Physician Decision|4|||
126197658|NCT01436357|454006239|FG000|Overall Study|Moved out of area|1|||
126197659|NCT01436357|454006240|FG001|Overall Study|Moved out of area|2|||
126197660|NCT01436357|454006239|FG000|Overall Study|Subject in rehab|0|||
126197661|NCT01436357|454006240|FG001|Overall Study|Subject in rehab|1|||
126197662|NCT05281094|454006241|FG000|Overall Study|Adverse Event|1|||
126197663|NCT05281094|454006242|FG001|Overall Study|Adverse Event|0|||
126197664|NCT05281094|454006241|FG000|Overall Study|Lost to Follow-up|29|||
126197665|NCT05281094|454006242|FG001|Overall Study|Lost to Follow-up|22|||
126197666|NCT05281094|454006241|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
126197667|NCT05281094|454006242|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
126197668|NCT05281094|454006241|FG000|Overall Study|Death|1|||
126197669|NCT05281094|454006242|FG001|Overall Study|Death|2|||
126197670|NCT05281094|454006241|FG000|Overall Study|Not pre-specified reason|8|||
126197671|NCT05281094|454006242|FG001|Overall Study|Not pre-specified reason|5|||
126197672|NCT05315297|454006243|FG000|Overall Study|Lost to Follow-up|6|||
126197673|NCT05315297|454006244|FG001|Overall Study|Lost to Follow-up|4|||
126197674|NCT05315297|454006243|FG000|Overall Study|Withdrawal by Subject|0|||
126197675|NCT05315297|454006244|FG001|Overall Study|Withdrawal by Subject|1|||
126197676|NCT02759939|454008076|FG000|Overall Study|Missing data on first outcome assessed|11|||
126197677|NCT02759939|454008077|FG001|Overall Study|Missing data on first outcome assessed|2|||
126197678|NCT02759939|454008078|FG002|Overall Study|Missing data on first outcome assessed|5|||
126197679|NCT02759939|454008079|FG003|Overall Study|Missing data on first outcome assessed|2|||
126197680|NCT02759939|454008076|FG000|Overall Study|Ineligible for T2 and T3|310|||
126197681|NCT02759939|454008077|FG001|Overall Study|Ineligible for T2 and T3|179|||
126197682|NCT02759939|454008078|FG002|Overall Study|Ineligible for T2 and T3|366|||
126197683|NCT02759939|454008079|FG003|Overall Study|Ineligible for T2 and T3|391|||
126197684|NCT02759939|454008076|FG000|Overall Study|Lost to Follow-up|735|||
126197685|NCT02759939|454008077|FG001|Overall Study|Lost to Follow-up|791|||
126197686|NCT02759939|454008078|FG002|Overall Study|Lost to Follow-up|783|||
126197687|NCT02759939|454008079|FG003|Overall Study|Lost to Follow-up|650|||
126197688|NCT03288987|454008080|FG000|Overall Study|Protocol Violation|10|||
126197689|NCT03288987|454008081|FG001|Overall Study|Protocol Violation|4|||
126197690|NCT04905563|454008084|FG000|Overall Study|Withdrawal by Subject|1|||
126197691|NCT04905563|454008085|FG001|Overall Study|Withdrawal by Subject|0|||
126197692|NCT04905563|454008084|FG000|Overall Study|Standard of care orders entered by resident|1|||
126197693|NCT04905563|454008085|FG001|Overall Study|Standard of care orders entered by resident|0|||
126197694|NCT04905563|454008084|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
126197695|NCT04905563|454008085|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
126197696|NCT04905563|454008084|FG000|Overall Study|Withdrawal by Subject|0|||
126197697|NCT04905563|454008085|FG001|Overall Study|Withdrawal by Subject|1|||
126197698|NCT04652102|454008097|FG000|Overall Study|Adverse Event|14|||
126197699|NCT04652102|454008098|FG001|Overall Study|Adverse Event|13|||
126197700|NCT04652102|454008097|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
126197701|NCT04652102|454008098|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
126197702|NCT04652102|454008097|FG000|Overall Study|Physician Decision|78|||
126197703|NCT04652102|454008098|FG001|Overall Study|Physician Decision|40|||
126197704|NCT04652102|454008097|FG000|Overall Study|Study Ended by Sponsor|64|||
126197705|NCT04652102|454008098|FG001|Overall Study|Study Ended by Sponsor|17|||
126197706|NCT04652102|454008097|FG000|Overall Study|Withdrawal by Subject|4625|||
126197707|NCT04652102|454008098|FG001|Overall Study|Withdrawal by Subject|5594|||
126197708|NCT04652102|454008097|FG000|Overall Study|Lost to Follow-up|2019|||
126197709|NCT04652102|454008098|FG001|Overall Study|Lost to Follow-up|1082|||
126197710|NCT04652102|454008097|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
126197711|NCT04652102|454008098|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
126197712|NCT04652102|454008097|FG000|Overall Study|Miscellaneous|80|||
126197713|NCT04652102|454008098|FG001|Overall Study|Miscellaneous|64|||
126197714|NCT04554394|454008099|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
126197715|NCT04554394|454008100|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
126197716|NCT04554394|454008099|FG000|Overall Study|Withdrawal by Subject|2|||
126197717|NCT04554394|454008100|FG001|Overall Study|Withdrawal by Subject|2|||
126197718|NCT04554394|454008099|FG000|Overall Study|Lost to Follow-up|2|||
126197719|NCT04554394|454008100|FG001|Overall Study|Lost to Follow-up|2|||
126197720|NCT04554394|454008099|FG000|Overall Study|Physician Decision|1|||
126197721|NCT04554394|454008100|FG001|Overall Study|Physician Decision|1|||
126197722|NCT00886587|454008104|FG000|Overall Study|Adverse Event|2|||
126197723|NCT00886587|454008105|FG001|Overall Study|Adverse Event|1|||
126197724|NCT00886587|454008104|FG000|Overall Study|Protocol Violation|2|||
126197725|NCT00886587|454008105|FG001|Overall Study|Protocol Violation|0|||
126197726|NCT00886587|454008104|FG000|Overall Study|Withdrawal by Subject|0|||
126197727|NCT00886587|454008105|FG001|Overall Study|Withdrawal by Subject|1|||
126197728|NCT00696774|454008111|FG000|Period II|Adverse Event|0|||
126197729|NCT00696774|454008112|FG001|Period II|Adverse Event|0|||
126197730|NCT00696774|454008113|FG002|Period II|Adverse Event|15|||
126197731|NCT00696774|454008111|FG000|Period II|Lost to Follow-up|0|||
126197732|NCT00696774|454008112|FG001|Period II|Lost to Follow-up|0|||
126197733|NCT00696774|454008113|FG002|Period II|Lost to Follow-up|4|||
126197734|NCT00696774|454008111|FG000|Period II|Protocol Violation|0|||
126197735|NCT00696774|454008112|FG001|Period II|Protocol Violation|0|||
126197736|NCT00696774|454008113|FG002|Period II|Protocol Violation|11|||
126197737|NCT00696774|454008111|FG000|Period II|Withdrawal by Subject|0|||
126197738|NCT00696774|454008112|FG001|Period II|Withdrawal by Subject|0|||
126197739|NCT00696774|454008113|FG002|Period II|Withdrawal by Subject|4|||
126197740|NCT00696774|454008111|FG000|Period II|Sponsor Decision|0|||
126197741|NCT00696774|454008112|FG001|Period II|Sponsor Decision|0|||
126197742|NCT00696774|454008113|FG002|Period II|Sponsor Decision|0|||
126197743|NCT00696774|454008111|FG000|Period II|Lack of Efficacy|0|||
126197744|NCT00696774|454008112|FG001|Period II|Lack of Efficacy|0|||
126197745|NCT00696774|454008113|FG002|Period II|Lack of Efficacy|2|||
126197746|NCT00696774|454008111|FG000|Period III|Adverse Event|1|||
126197747|NCT00696774|454008112|FG001|Period III|Adverse Event|1|||
126197748|NCT00696774|454008113|FG002|Period III|Adverse Event|0|||
126197749|NCT00696774|454008111|FG000|Period III|Lost to Follow-up|2|||
126197750|NCT00696774|454008112|FG001|Period III|Lost to Follow-up|1|||
126197751|NCT00696774|454008113|FG002|Period III|Lost to Follow-up|0|||
126197752|NCT00696774|454008111|FG000|Period III|Protocol Violation|1|||
126197753|NCT00696774|454008112|FG001|Period III|Protocol Violation|1|||
126197754|NCT00696774|454008113|FG002|Period III|Protocol Violation|0|||
126197755|NCT00696774|454008111|FG000|Period III|Withdrawal by Subject|1|||
126197756|NCT00696774|454008112|FG001|Period III|Withdrawal by Subject|2|||
126197757|NCT00696774|454008113|FG002|Period III|Withdrawal by Subject|0|||
126197758|NCT00696774|454008111|FG000|Period III|Sponsor Decision|2|||
126197759|NCT00696774|454008112|FG001|Period III|Sponsor Decision|0|||
126197760|NCT00696774|454008113|FG002|Period III|Sponsor Decision|0|||
126197761|NCT00696774|454008111|FG000|Period III|Lack of Efficacy|0|||
126197762|NCT00696774|454008112|FG001|Period III|Lack of Efficacy|2|||
126197763|NCT00696774|454008113|FG002|Period III|Lack of Efficacy|0|||
126197764|NCT03490734|454008121|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
126197765|NCT03490734|454008122|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
126197766|NCT03490734|454008123|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
126197767|NCT03490734|454008124|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
126197768|NCT03490734|454008121|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
126197769|NCT03490734|454008122|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
126197770|NCT03490734|454008123|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
126197771|NCT03490734|454008124|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
126197772|NCT03490734|454008121|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
126197773|NCT03490734|454008122|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
126197774|NCT03490734|454008123|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
126197775|NCT03490734|454008124|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
126197776|NCT03490734|454008121|FG000|Post-intervention Scan Visit|Adverse Event|2|||
126197777|NCT03490734|454008122|FG001|Post-intervention Scan Visit|Adverse Event|0|||
126197778|NCT03490734|454008123|FG002|Post-intervention Scan Visit|Adverse Event|0|||
126197779|NCT03490734|454008124|FG003|Post-intervention Scan Visit|Adverse Event|0|||
126197780|NCT03490734|454008121|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
126197781|NCT03490734|454008122|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
126197782|NCT03490734|454008123|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
126197783|NCT03490734|454008124|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
126197784|NCT03490734|454008121|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
126197785|NCT03490734|454008122|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
126197786|NCT03490734|454008123|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
126197787|NCT03490734|454008124|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
126197788|NCT02442765|454008127|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
126197789|NCT02442765|454008128|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
126197790|NCT02442765|454008129|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
126197791|NCT02442765|454008130|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
126197792|NCT02442765|454008131|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
126197793|NCT02442765|454008132|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
126197794|NCT02442765|454008133|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
126197795|NCT02442765|454008134|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
126197796|NCT02442765|454008127|FG000|Stage 2- (Days 43 to 85)|Death|0|||
126197797|NCT02442765|454008128|FG001|Stage 2- (Days 43 to 85)|Death|0|||
126197798|NCT02442765|454008129|FG002|Stage 2- (Days 43 to 85)|Death|0|||
126197799|NCT02442765|454008130|FG003|Stage 2- (Days 43 to 85)|Death|1|||
126197800|NCT02442765|454008131|FG004|Stage 2- (Days 43 to 85)|Death|1|||
126197801|NCT02442765|454008132|FG005|Stage 2- (Days 43 to 85)|Death|0|||
126197802|NCT02442765|454008133|FG006|Stage 2- (Days 43 to 85)|Death|2|||
126197803|NCT02442765|454008134|FG007|Stage 2- (Days 43 to 85)|Death|0|||
126197804|NCT02442765|454008127|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126197805|NCT02442765|454008128|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126197806|NCT02442765|454008129|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126197807|NCT02442765|454008130|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
126197808|NCT02442765|454008131|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126197809|NCT02442765|454008132|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126197810|NCT02442765|454008133|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126197811|NCT02442765|454008134|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126197812|NCT02442765|454008127|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126197813|NCT02442765|454008128|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126197814|NCT02442765|454008129|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126197815|NCT02442765|454008130|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
126197816|NCT02442765|454008131|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126197817|NCT02442765|454008132|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126197818|NCT02442765|454008133|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126197819|NCT02442765|454008134|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126197820|NCT02442765|454008127|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126197821|NCT02442765|454008128|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126197822|NCT02442765|454008129|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126197823|NCT02442765|454008130|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
126197824|NCT02442765|454008131|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126197825|NCT02442765|454008132|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
126197826|NCT02442765|454008133|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126197827|NCT02442765|454008134|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
126197828|NCT02442765|454008127|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126197829|NCT02442765|454008128|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126197830|NCT02442765|454008129|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126197831|NCT02442765|454008130|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
126197832|NCT02442765|454008131|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126197833|NCT02442765|454008132|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
126197834|NCT02442765|454008133|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
126197835|NCT02442765|454008134|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126197836|NCT02442765|454008127|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126197837|NCT02442765|454008128|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126197838|NCT02442765|454008129|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126197839|NCT02442765|454008130|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126197840|NCT02442765|454008131|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
126197841|NCT02442765|454008132|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126197842|NCT02442765|454008133|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
126197843|NCT02442765|454008134|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
126197844|NCT02442765|454008127|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126197845|NCT02442765|454008128|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126197846|NCT02442765|454008129|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126197847|NCT02442765|454008130|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126197848|NCT02442765|454008131|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
126197849|NCT02442765|454008132|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126197850|NCT02442765|454008133|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126197851|NCT02442765|454008134|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
126197852|NCT01371721|454008135|FG000|Overall Study|Adverse Event|5|||
126197853|NCT01371721|454008136|FG001|Overall Study|Adverse Event|4|||
126197854|NCT01371721|454008137|FG002|Overall Study|Adverse Event|5|||
126197855|NCT01371721|454008135|FG000|Overall Study|Protocol Violation|6|||
126197856|NCT01371721|454008136|FG001|Overall Study|Protocol Violation|4|||
126197857|NCT01371721|454008137|FG002|Overall Study|Protocol Violation|5|||
126197858|NCT01371721|454008135|FG000|Overall Study|Lost to Follow-up|8|||
126197859|NCT01371721|454008136|FG001|Overall Study|Lost to Follow-up|2|||
126197860|NCT01371721|454008137|FG002|Overall Study|Lost to Follow-up|6|||
126197861|NCT01371721|454008135|FG000|Overall Study|Withdrawal by Subject|5|||
126197862|NCT01371721|454008136|FG001|Overall Study|Withdrawal by Subject|7|||
126197863|NCT01371721|454008137|FG002|Overall Study|Withdrawal by Subject|11|||
126197864|NCT01371721|454008135|FG000|Overall Study|Other|2|||
126197865|NCT01371721|454008136|FG001|Overall Study|Other|3|||
126197866|NCT01371721|454008137|FG002|Overall Study|Other|0|||
126197867|NCT01371721|454008135|FG000|Overall Study|Lack of Efficacy|2|||
126197868|NCT01371721|454008136|FG001|Overall Study|Lack of Efficacy|4|||
126197869|NCT01371721|454008137|FG002|Overall Study|Lack of Efficacy|3|||
126197870|NCT01371721|454008135|FG000|Overall Study|Randomized but not treated|1|||
126197871|NCT01371721|454008136|FG001|Overall Study|Randomized but not treated|0|||
126197872|NCT01371721|454008137|FG002|Overall Study|Randomized but not treated|0|||
126197873|NCT00374452|454008141|FG000|Overall Study|Left clinic before intervention started|4|||
126197874|NCT00374452|454008142|FG001|Overall Study|Left clinic before intervention started|1|||
126197875|NCT00374452|454008141|FG000|Overall Study|Change in job role before intervention|0|||
126197876|NCT00374452|454008142|FG001|Overall Study|Change in job role before intervention|1|||
126197877|NCT00374452|454008141|FG000|Overall Study|Left clinic after intervention started|1|||
126197878|NCT00374452|454008142|FG001|Overall Study|Left clinic after intervention started|1|||
126197879|NCT00374452|454008141|FG000|Overall Study|Withdrawal by Subject|0|||
126197880|NCT00374452|454008142|FG001|Overall Study|Withdrawal by Subject|2|||
126197881|NCT00523744|454008144|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
126197882|NCT00523744|454008144|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
126197883|NCT00523744|454008144|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
126197884|NCT00523744|454008144|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
126197885|NCT00523744|454008144|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
126197886|NCT00523744|454008144|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
126197887|NCT03099304|454008147|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
126197888|NCT03099304|454008148|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
126197889|NCT03099304|454008149|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
126197890|NCT03099304|454008150|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
126197891|NCT03099304|454008151|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
126197892|NCT03099304|454008152|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
126197893|NCT03099304|454008147|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
126197894|NCT03099304|454008148|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
126197895|NCT03099304|454008149|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
126197896|NCT03099304|454008150|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
126197897|NCT03099304|454008151|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
126197898|NCT03099304|454008152|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
126197899|NCT03099304|454008147|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
126197900|NCT03099304|454008148|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
126197901|NCT03099304|454008149|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
126197902|NCT03099304|454008150|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
126197903|NCT03099304|454008151|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
126197904|NCT03099304|454008152|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
126197905|NCT03099304|454008147|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
126197906|NCT03099304|454008148|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
126197907|NCT03099304|454008149|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
126197908|NCT03099304|454008150|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
126197909|NCT03099304|454008151|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
126197910|NCT03099304|454008152|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
126197911|NCT03099304|454008147|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
126197912|NCT03099304|454008148|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
126197913|NCT03099304|454008149|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
126197914|NCT03099304|454008150|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
126197915|NCT03099304|454008151|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
126197916|NCT03099304|454008152|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
126197917|NCT03099304|454008147|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126197918|NCT03099304|454008148|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126197919|NCT03099304|454008149|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
126197920|NCT03099304|454008150|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126197921|NCT03099304|454008151|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126197922|NCT03099304|454008152|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126197923|NCT03099304|454008147|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
126197924|NCT03099304|454008148|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
126197925|NCT03099304|454008149|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
126197926|NCT03099304|454008150|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
126197927|NCT03099304|454008151|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
126197928|NCT03099304|454008152|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
126197929|NCT03099304|454008147|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
126197930|NCT03099304|454008148|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
126197931|NCT03099304|454008149|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
126197932|NCT03099304|454008150|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
126197933|NCT03099304|454008151|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
126197934|NCT03099304|454008152|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
126197935|NCT03099304|454008147|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
126197936|NCT03099304|454008148|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
126197937|NCT03099304|454008149|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
126197938|NCT03099304|454008150|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
126197939|NCT03099304|454008151|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
126197940|NCT03099304|454008152|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
126197941|NCT03099304|454008147|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
126197942|NCT03099304|454008148|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
126197943|NCT03099304|454008149|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
126197944|NCT03099304|454008150|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
126197945|NCT03099304|454008151|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
126197946|NCT03099304|454008152|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
126197947|NCT03099304|454008147|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
126197948|NCT03099304|454008148|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
126197949|NCT03099304|454008149|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
126197950|NCT03099304|454008150|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
126197951|NCT03099304|454008151|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
126197952|NCT03099304|454008152|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
126197953|NCT03099304|454008147|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
126197954|NCT03099304|454008148|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
126197955|NCT03099304|454008149|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
126197956|NCT03099304|454008150|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
126197957|NCT03099304|454008151|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
126197958|NCT03099304|454008152|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
126197959|NCT03099304|454008147|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
126197960|NCT03099304|454008148|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
126197961|NCT03099304|454008149|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
126197962|NCT03099304|454008150|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
126197963|NCT03099304|454008151|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
126197964|NCT03099304|454008152|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
126197965|NCT03099304|454008147|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
126197966|NCT03099304|454008148|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
126197967|NCT03099304|454008149|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
126197968|NCT03099304|454008150|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
126197969|NCT03099304|454008151|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
126197970|NCT03099304|454008152|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
126197971|NCT03099304|454008147|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
126197972|NCT03099304|454008148|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
126197973|NCT03099304|454008149|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
126197974|NCT03099304|454008150|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
126197975|NCT03099304|454008151|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
126197976|NCT03099304|454008152|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
126197977|NCT03099304|454008147|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
126197978|NCT03099304|454008148|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
126199950|NCT01117428|454017805|FG001|Overall Study|Physician Decision|1|||
126197979|NCT03099304|454008149|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
126197980|NCT03099304|454008150|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
126197981|NCT03099304|454008151|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
126197982|NCT03099304|454008152|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
126197983|NCT03099304|454008147|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
126197984|NCT03099304|454008148|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
126197985|NCT03099304|454008149|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
126197986|NCT03099304|454008150|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
126197987|NCT03099304|454008151|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
126197988|NCT03099304|454008152|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
126197989|NCT00715949|454008155|FG000|Overall Study|could not finish first test|4|||
126197990|NCT01024946|454008156|FG000|Overall Study|Screen Failure|3|||
126197991|NCT01024946|454008156|FG000|Overall Study|Withdrawal by Subject|1|||
126197992|NCT01024946|454008156|FG000|Overall Study|Adverse Event|1|||
126197993|NCT05375838|454008157|FG000|Overall Study|Other|0|||
126197994|NCT05375838|454008158|FG001|Overall Study|Other|0|||
126197995|NCT05375838|454008159|FG002|Overall Study|Other|0|||
126197996|NCT05375838|454008160|FG003|Overall Study|Other|1|||
126197997|NCT05375838|454008161|FG004|Overall Study|Other|1|||
126197998|NCT05375838|454008162|FG005|Overall Study|Other|0|||
126197999|NCT05375838|454008157|FG000|Overall Study|Withdrawal by Subject|2|||
126198000|NCT05375838|454008158|FG001|Overall Study|Withdrawal by Subject|1|||
126198001|NCT05375838|454008159|FG002|Overall Study|Withdrawal by Subject|3|||
126198002|NCT05375838|454008160|FG003|Overall Study|Withdrawal by Subject|2|||
126198003|NCT05375838|454008161|FG004|Overall Study|Withdrawal by Subject|2|||
126198004|NCT05375838|454008162|FG005|Overall Study|Withdrawal by Subject|0|||
126198005|NCT05375838|454008157|FG000|Overall Study|Protocol Violation|0|||
126198006|NCT05375838|454008158|FG001|Overall Study|Protocol Violation|0|||
126198007|NCT05375838|454008159|FG002|Overall Study|Protocol Violation|0|||
126198008|NCT05375838|454008160|FG003|Overall Study|Protocol Violation|0|||
126198009|NCT05375838|454008161|FG004|Overall Study|Protocol Violation|1|||
126198010|NCT05375838|454008162|FG005|Overall Study|Protocol Violation|0|||
126198011|NCT05375838|454008157|FG000|Overall Study|Physician Decision|0|||
126198012|NCT05375838|454008158|FG001|Overall Study|Physician Decision|1|||
126198013|NCT05375838|454008159|FG002|Overall Study|Physician Decision|0|||
126198014|NCT05375838|454008160|FG003|Overall Study|Physician Decision|0|||
126198015|NCT05375838|454008161|FG004|Overall Study|Physician Decision|0|||
126198016|NCT05375838|454008162|FG005|Overall Study|Physician Decision|1|||
126198017|NCT05375838|454008157|FG000|Overall Study|Lost to Follow-up|2|||
126198018|NCT05375838|454008158|FG001|Overall Study|Lost to Follow-up|7|||
126198019|NCT05375838|454008159|FG002|Overall Study|Lost to Follow-up|0|||
126198020|NCT05375838|454008160|FG003|Overall Study|Lost to Follow-up|4|||
126198021|NCT05375838|454008161|FG004|Overall Study|Lost to Follow-up|2|||
126198022|NCT05375838|454008162|FG005|Overall Study|Lost to Follow-up|3|||
126198023|NCT02993783|454008171|FG000|Overall Study|Reason not Specified|6|||
126198024|NCT02993783|454008172|FG001|Overall Study|Reason not Specified|9|||
126198025|NCT03049852|454008176|FG000|Overall Study|Lost to Follow-up|0|||
126198026|NCT03049852|454008177|FG001|Overall Study|Lost to Follow-up|1|||
126198027|NCT03049852|454008178|FG002|Overall Study|Lost to Follow-up|0|||
126198028|NCT02067104|454008179|FG000|Overall Study|Study termination due to low accrual|4|||
126198029|NCT02067104|454008180|FG001|Overall Study|Study termination due to low accrual|5|||
126198030|NCT00554840|454008194|FG000|Overall Study|Physician Decision|0|||
126198031|NCT00554840|454008195|FG001|Overall Study|Physician Decision|1|||
126198032|NCT01385098|454008196|FG000|Overall Study|Adverse Event|10|||
126198033|NCT01385098|454008196|FG000|Overall Study|Lost to Follow-up|4|||
126198034|NCT00925522|454008197|FG000|Overall Study|study closed -- business decision|20|||
126198035|NCT00410514|454008202|FG000|Overall Study|Adverse Event|2|||
126198036|NCT00410514|454008203|FG001|Overall Study|Adverse Event|2|||
126198037|NCT00410514|454008204|FG002|Overall Study|Adverse Event|2|||
126198038|NCT00410514|454008202|FG000|Overall Study|Protocol Violation|0|||
126198039|NCT00410514|454008203|FG001|Overall Study|Protocol Violation|1|||
126198040|NCT00410514|454008204|FG002|Overall Study|Protocol Violation|1|||
126198041|NCT00410514|454008202|FG000|Overall Study|Lost to Follow-up|0|||
126198042|NCT00410514|454008203|FG001|Overall Study|Lost to Follow-up|0|||
126198043|NCT00410514|454008204|FG002|Overall Study|Lost to Follow-up|2|||
126198044|NCT00410514|454008202|FG000|Overall Study|Non-compliant with study procedures|0|||
126198045|NCT00410514|454008203|FG001|Overall Study|Non-compliant with study procedures|0|||
126198046|NCT00410514|454008204|FG002|Overall Study|Non-compliant with study procedures|2|||
126198047|NCT00656799|454008207|FG000|Overall Study|Death|2|||
126198048|NCT04728815|454008215|FG000|Overall Study|Lost to Follow-up|3|||
126198049|NCT04728815|454008216|FG001|Overall Study|Lost to Follow-up|0|||
126198050|NCT04728815|454008217|FG002|Overall Study|Lost to Follow-up|0|||
126198051|NCT04728815|454008218|FG003|Overall Study|Lost to Follow-up|1|||
126198052|NCT04728815|454008219|FG004|Overall Study|Lost to Follow-up|1|||
126198053|NCT04728815|454008220|FG005|Overall Study|Lost to Follow-up|0|||
126198054|NCT04728815|454008221|FG006|Overall Study|Lost to Follow-up|2|||
126198055|NCT04728815|454008222|FG007|Overall Study|Lost to Follow-up|0|||
126198056|NCT04728815|454008215|FG000|Overall Study|Physician Decision|0|||
126198057|NCT04728815|454008216|FG001|Overall Study|Physician Decision|0|||
126198058|NCT04728815|454008217|FG002|Overall Study|Physician Decision|1|||
126198059|NCT04728815|454008218|FG003|Overall Study|Physician Decision|0|||
126198060|NCT04728815|454008219|FG004|Overall Study|Physician Decision|0|||
126198061|NCT04728815|454008220|FG005|Overall Study|Physician Decision|0|||
126198062|NCT04728815|454008221|FG006|Overall Study|Physician Decision|0|||
126198063|NCT04728815|454008222|FG007|Overall Study|Physician Decision|0|||
126198064|NCT04728815|454008215|FG000|Overall Study|Treatment drop|0|||
126198065|NCT04728815|454008216|FG001|Overall Study|Treatment drop|2|||
126198066|NCT04728815|454008217|FG002|Overall Study|Treatment drop|1|||
126198067|NCT04728815|454008218|FG003|Overall Study|Treatment drop|0|||
126198068|NCT04728815|454008219|FG004|Overall Study|Treatment drop|3|||
126198069|NCT04728815|454008220|FG005|Overall Study|Treatment drop|1|||
126198070|NCT04728815|454008221|FG006|Overall Study|Treatment drop|3|||
126198071|NCT04728815|454008222|FG007|Overall Study|Treatment drop|0|||
126198072|NCT04728815|454008215|FG000|Overall Study|Study drop|0|||
126198073|NCT04728815|454008216|FG001|Overall Study|Study drop|3|||
126198074|NCT04728815|454008217|FG002|Overall Study|Study drop|3|||
126198075|NCT04728815|454008218|FG003|Overall Study|Study drop|0|||
126198076|NCT04728815|454008219|FG004|Overall Study|Study drop|0|||
126198077|NCT04728815|454008220|FG005|Overall Study|Study drop|0|||
126198078|NCT04728815|454008221|FG006|Overall Study|Study drop|7|||
126198079|NCT04728815|454008222|FG007|Overall Study|Study drop|0|||
126198080|NCT00631969|454008225|FG000|Overall Study|Adverse Event|3|||
126198081|NCT00631969|454008226|FG001|Overall Study|Adverse Event|1|||
126198082|NCT00631969|454008225|FG000|Overall Study|Lack of Efficacy|2|||
126198083|NCT00631969|454008226|FG001|Overall Study|Lack of Efficacy|8|||
126198084|NCT00631969|454008225|FG000|Overall Study|Lost to Follow-up|2|||
126198085|NCT00631969|454008226|FG001|Overall Study|Lost to Follow-up|1|||
126198086|NCT00631969|454008225|FG000|Overall Study|Protocol Violation|1|||
126198087|NCT00631969|454008226|FG001|Overall Study|Protocol Violation|1|||
126198088|NCT00631969|454008225|FG000|Overall Study|Consent Withdrawn|5|||
126198089|NCT00631969|454008226|FG001|Overall Study|Consent Withdrawn|7|||
126198090|NCT00631969|454008225|FG000|Overall Study|Noncompliant With Study Medication|0|||
126198091|NCT00631969|454008226|FG001|Overall Study|Noncompliant With Study Medication|1|||
126198092|NCT00631969|454008225|FG000|Overall Study|No Drug Exposure|2|||
126198093|NCT00631969|454008226|FG001|Overall Study|No Drug Exposure|2|||
126198094|NCT00957034|454008227|FG000|Overall Study|Adverse Event|0|||
126198095|NCT00957034|454008228|FG001|Overall Study|Adverse Event|1|||
126198096|NCT00957034|454008229|FG002|Overall Study|Adverse Event|1|||
126198097|NCT00957034|454008227|FG000|Overall Study|Sponsor Terminated Study|6|||
126198098|NCT00957034|454008228|FG001|Overall Study|Sponsor Terminated Study|1|||
126198099|NCT00957034|454008229|FG002|Overall Study|Sponsor Terminated Study|5|||
126198100|NCT00957034|454008227|FG000|Overall Study|Withdrawal by Subject|0|||
126198101|NCT00957034|454008228|FG001|Overall Study|Withdrawal by Subject|2|||
126198102|NCT00957034|454008229|FG002|Overall Study|Withdrawal by Subject|0|||
126198103|NCT03053180|454010001|FG000|Overall Study|Failure to Return|1|||
126198104|NCT04144140|454010006|FG000|Overall Study|Other|0|||
126198105|NCT04144140|454010007|FG001|Overall Study|Other|0|||
126198106|NCT04144140|454010008|FG002|Overall Study|Other|0|||
126198107|NCT04144140|454010009|FG003|Overall Study|Other|0|||
126198108|NCT04144140|454010010|FG004|Overall Study|Other|0|||
126198109|NCT04144140|454010011|FG005|Overall Study|Other|1|||
126198110|NCT04144140|454010012|FG006|Overall Study|Other|0|||
126198111|NCT01465958|454010013|FG000|Run-in Phase|Protocol Violation|1|||
126198112|NCT01465958|454010014|FG001|Run-in Phase|Protocol Violation|0|||
126198113|NCT01465958|454010013|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
126198114|NCT01465958|454010014|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
126198115|NCT00669240|454010023|FG000|Overall Study|Lack of Efficacy|33|||
126198116|NCT00669240|454010023|FG000|Overall Study|Withdrawal by Subject|42|||
126198117|NCT00669240|454010023|FG000|Overall Study|Lost to Follow-up|34|||
126198118|NCT00669240|454010023|FG000|Overall Study|Adverse Event|21|||
126198119|NCT00669240|454010023|FG000|Overall Study|Other|19|||
126198120|NCT00669240|454010023|FG000|Overall Study|Enrolled but not treated|15|||
126198121|NCT00669240|454010023|FG000|Overall Study|Enrolled but no dosing record|1|||
126198122|NCT00959192|454010026|FG000|Overall Study|Adverse Event|1|||
126198123|NCT00959192|454010027|FG001|Overall Study|Adverse Event|1|||
126198124|NCT00959192|454010028|FG002|Overall Study|Adverse Event|1|||
126198125|NCT00959192|454010029|FG003|Overall Study|Adverse Event|0|||
126198126|NCT00959192|454010026|FG000|Overall Study|Investigator Request|1|||
126198127|NCT00959192|454010027|FG001|Overall Study|Investigator Request|0|||
126198128|NCT00959192|454010028|FG002|Overall Study|Investigator Request|0|||
126198129|NCT00959192|454010029|FG003|Overall Study|Investigator Request|0|||
126198130|NCT00959192|454010026|FG000|Overall Study|Caregiver Request|0|||
126198131|NCT00959192|454010027|FG001|Overall Study|Caregiver Request|0|||
126198132|NCT00959192|454010028|FG002|Overall Study|Caregiver Request|2|||
126198133|NCT00959192|454010029|FG003|Overall Study|Caregiver Request|1|||
126198134|NCT00532441|454010030|FG000|Overall Study|Death|1|||
126198135|NCT00532441|454010031|FG001|Overall Study|Death|0|||
126198136|NCT01967134|454010032|FG000|Overall Study|Lost to Follow-up|0|||
126198137|NCT01967134|454010033|FG001|Overall Study|Lost to Follow-up|1|||
126198138|NCT01967134|454010034|FG002|Overall Study|Lost to Follow-up|0|||
126198139|NCT00443534|454010035|FG000|Overall Study|Lack of Efficacy|67|||
126198140|NCT00443534|454010035|FG000|Overall Study|Adverse Event|16|||
126198141|NCT00443534|454010035|FG000|Overall Study|Death|9|||
126198142|NCT00443534|454010035|FG000|Overall Study|Withdrawal by Subject|8|||
126198143|NCT00443534|454010035|FG000|Overall Study|Study Terminated by Sponsor|12|||
126198144|NCT00443534|454010035|FG000|Overall Study|Other|10|||
126198145|NCT00443534|454010035|FG000|Overall Study|Enrolled, Not Treated|1|||
126198146|NCT00364611|454010036|FG000|Overall Study|Did not receive study medication|0|||
126198147|NCT00364611|454010037|FG001|Overall Study|Did not receive study medication|1|||
126198148|NCT00364611|454010036|FG000|Overall Study|Adverse Event|7|||
126198149|NCT00364611|454010037|FG001|Overall Study|Adverse Event|4|||
126198150|NCT00364611|454010036|FG000|Overall Study|Participant's Request|3|||
126198151|NCT00364611|454010037|FG001|Overall Study|Participant's Request|4|||
126198152|NCT00364611|454010036|FG000|Overall Study|Disease Progression|38|||
126198153|NCT00364611|454010037|FG001|Overall Study|Disease Progression|8|||
126198154|NCT00364611|454010036|FG000|Overall Study|Investigator decision|2|||
126198155|NCT00364611|454010037|FG001|Overall Study|Investigator decision|2|||
126198156|NCT00364611|454010036|FG000|Overall Study|Found Ineligible|1|||
126198157|NCT00364611|454010037|FG001|Overall Study|Found Ineligible|0|||
126198158|NCT00364611|454010036|FG000|Overall Study|Presumed CR on Study|0|||
126198159|NCT00364611|454010037|FG001|Overall Study|Presumed CR on Study|1|||
126198160|NCT00364611|454010036|FG000|Overall Study|Receiving Liver Ablation|0|||
126198161|NCT00364611|454010037|FG001|Overall Study|Receiving Liver Ablation|1|||
126198162|NCT05466240|454010038|FG000|Overall Study|Adverse Event|1|||
126198163|NCT05466240|454010039|FG001|Overall Study|Adverse Event|0|||
126198164|NCT05466240|454010038|FG000|Overall Study|Withdrawal by Subject|1|||
126198165|NCT05466240|454010039|FG001|Overall Study|Withdrawal by Subject|0|||
126198166|NCT00305773|454010040|FG000|Overall Study|Death|3|||
126198167|NCT00305773|454010041|FG001|Overall Study|Death|2|||
126198168|NCT00305773|454010040|FG000|Overall Study|Adverse Event|1|||
126198169|NCT00305773|454010041|FG001|Overall Study|Adverse Event|2|||
126198170|NCT00305773|454010040|FG000|Overall Study|Alternative Treatment|4|||
126198171|NCT00305773|454010041|FG001|Overall Study|Alternative Treatment|4|||
126198172|NCT00305773|454010040|FG000|Overall Study|Physician Decision|1|||
126198173|NCT00305773|454010041|FG001|Overall Study|Physician Decision|1|||
126198174|NCT00305773|454010040|FG000|Overall Study|Withdrawal by Subject|1|||
126198175|NCT00305773|454010041|FG001|Overall Study|Withdrawal by Subject|4|||
126198176|NCT00305773|454010040|FG000|Overall Study|Disease Progression|1|||
126198177|NCT00305773|454010041|FG001|Overall Study|Disease Progression|3|||
126198178|NCT00305773|454010040|FG000|Overall Study|All other reasons|3|||
126198179|NCT00305773|454010041|FG001|Overall Study|All other reasons|2|||
126198180|NCT02679222|454010042|FG000|Overall Study|No time for project|1|||
126198181|NCT04097925|454010043|FG000|Overall Study|Withdrawal by Subject|1|||
126198182|NCT04735432|454010048|FG000|Overall Study|Other - due to personal reason|1|||
126198183|NCT04735432|454010049|FG001|Overall Study|Other - due to personal reason|0|||
126198184|NCT04735432|454010048|FG000|Overall Study|Adverse Event|2|||
126198185|NCT04735432|454010049|FG001|Overall Study|Adverse Event|0|||
126198186|NCT04397757|454010050|FG000|Overall Study|Death|3|||
126198187|NCT04397757|454010051|FG001|Overall Study|Death|11|||
126198188|NCT04397757|454010050|FG000|Overall Study|Withdrawal by Subject|2|||
126198189|NCT04397757|454010051|FG001|Overall Study|Withdrawal by Subject|0|||
126198190|NCT04397757|454010050|FG000|Overall Study|Lost to Follow-up|4|||
126198191|NCT04397757|454010051|FG001|Overall Study|Lost to Follow-up|3|||
126198192|NCT00413231|454010052|FG000|0 to 30-day Post Treatment|Death|5|||
126198193|NCT00413231|454010052|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
126198194|NCT00413231|454010052|FG000|30-day to 365-day Post Treatment|Death|13|||
126198195|NCT00413231|454010052|FG000|365-day to 60-month Post Treatment|Death|36|||
126198196|NCT00413231|454010052|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
126198197|NCT00413231|454010052|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
126198198|NCT00413231|454010052|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
126198199|NCT00945945|454010057|FG000|Overall Study|Adverse Event|15|||
126198200|NCT00945945|454010058|FG001|Overall Study|Adverse Event|35|||
126198201|NCT00945945|454010057|FG000|Overall Study|Withdrawal by Subject|7|||
126198202|NCT00945945|454010058|FG001|Overall Study|Withdrawal by Subject|10|||
126198203|NCT00945945|454010057|FG000|Overall Study|Lost to Follow-up|4|||
126198204|NCT00945945|454010058|FG001|Overall Study|Lost to Follow-up|5|||
126198205|NCT00945945|454010057|FG000|Overall Study|Lack of Efficacy|6|||
126198206|NCT00945945|454010058|FG001|Overall Study|Lack of Efficacy|2|||
126198207|NCT00945945|454010057|FG000|Overall Study|Protocol Violation|4|||
126198208|NCT00945945|454010058|FG001|Overall Study|Protocol Violation|2|||
126198209|NCT00945945|454010057|FG000|Overall Study|Entry Criteria Not Met|0|||
126198210|NCT00945945|454010058|FG001|Overall Study|Entry Criteria Not Met|1|||
126198211|NCT00626327|454010059|FG000|Overall Study|Withdrawal by Subject|21|||
126198212|NCT00626327|454010060|FG001|Overall Study|Withdrawal by Subject|29|||
126198213|NCT00626327|454010061|FG002|Overall Study|Withdrawal by Subject|30|||
126198214|NCT00626327|454010059|FG000|Overall Study|Adverse Event|1|||
126198215|NCT00626327|454010060|FG001|Overall Study|Adverse Event|0|||
126198216|NCT00626327|454010061|FG002|Overall Study|Adverse Event|0|||
126198217|NCT00626327|454010059|FG000|Overall Study|Lost to Follow-up|24|||
126198218|NCT00626327|454010060|FG001|Overall Study|Lost to Follow-up|21|||
126198219|NCT00626327|454010061|FG002|Overall Study|Lost to Follow-up|23|||
126198220|NCT00626327|454010059|FG000|Overall Study|Inappropriate enrollment|4|||
126198221|NCT00626327|454010060|FG001|Overall Study|Inappropriate enrollment|5|||
126198222|NCT00626327|454010061|FG002|Overall Study|Inappropriate enrollment|3|||
126198223|NCT00626327|454010059|FG000|Overall Study|Administrative Reason|2|||
126198224|NCT00626327|454010060|FG001|Overall Study|Administrative Reason|0|||
126198225|NCT00626327|454010061|FG002|Overall Study|Administrative Reason|6|||
126198226|NCT00626327|454010059|FG000|Overall Study|Protocol Violation|26|||
126198227|NCT00626327|454010060|FG001|Overall Study|Protocol Violation|4|||
126198228|NCT00626327|454010061|FG002|Overall Study|Protocol Violation|26|||
126198229|NCT01823991|454010062|FG000|Overall Study|Withdrawal by Subject|8|||
126198230|NCT01823991|454010063|FG001|Overall Study|Withdrawal by Subject|5|||
126198231|NCT05158244|454010064|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
126198232|NCT05158244|454010065|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
126198233|NCT05158244|454010066|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
126198234|NCT05158244|454010067|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
126198235|NCT05158244|454010068|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
126198236|NCT05158244|454010064|FG000|Overall Study|Withdrawal by Subject|0|||
126198237|NCT05158244|454010065|FG001|Overall Study|Withdrawal by Subject|0|||
126198238|NCT05158244|454010066|FG002|Overall Study|Withdrawal by Subject|1|||
126198239|NCT05158244|454010067|FG003|Overall Study|Withdrawal by Subject|0|||
126198240|NCT05158244|454010068|FG004|Overall Study|Withdrawal by Subject|0|||
126198241|NCT01066819|454010069|FG000|Overall Study|Adverse Event|18|||
126198242|NCT01066819|454010070|FG001|Overall Study|Adverse Event|1|||
126198243|NCT01066819|454010071|FG002|Overall Study|Adverse Event|6|||
126198244|NCT01066819|454010072|FG003|Overall Study|Adverse Event|0|||
126198245|NCT01066819|454010073|FG004|Overall Study|Adverse Event|0|||
126198246|NCT01066819|454010074|FG005|Overall Study|Adverse Event|0|||
126198247|NCT01066819|454010069|FG000|Overall Study|Death|5|||
126198248|NCT01066819|454010070|FG001|Overall Study|Death|0|||
126198249|NCT01066819|454010071|FG002|Overall Study|Death|1|||
126198250|NCT01066819|454010072|FG003|Overall Study|Death|0|||
126198251|NCT01066819|454010073|FG004|Overall Study|Death|0|||
126198252|NCT01066819|454010074|FG005|Overall Study|Death|0|||
126198253|NCT01066819|454010069|FG000|Overall Study|Lack of Efficacy|22|||
126198254|NCT01066819|454010070|FG001|Overall Study|Lack of Efficacy|1|||
126198255|NCT01066819|454010071|FG002|Overall Study|Lack of Efficacy|2|||
126198256|NCT01066819|454010072|FG003|Overall Study|Lack of Efficacy|1|||
126198257|NCT01066819|454010073|FG004|Overall Study|Lack of Efficacy|0|||
126198258|NCT01066819|454010074|FG005|Overall Study|Lack of Efficacy|0|||
126198259|NCT01066819|454010069|FG000|Overall Study|Physician Decision|6|||
126198260|NCT01066819|454010070|FG001|Overall Study|Physician Decision|2|||
126198261|NCT01066819|454010071|FG002|Overall Study|Physician Decision|3|||
126198262|NCT01066819|454010072|FG003|Overall Study|Physician Decision|0|||
126198263|NCT01066819|454010073|FG004|Overall Study|Physician Decision|0|||
126198264|NCT01066819|454010074|FG005|Overall Study|Physician Decision|0|||
126198265|NCT01066819|454010069|FG000|Overall Study|Protocol Violation|12|||
126198266|NCT01066819|454010070|FG001|Overall Study|Protocol Violation|6|||
126198267|NCT01066819|454010071|FG002|Overall Study|Protocol Violation|0|||
126198268|NCT01066819|454010072|FG003|Overall Study|Protocol Violation|0|||
126198269|NCT01066819|454010073|FG004|Overall Study|Protocol Violation|0|||
126198270|NCT01066819|454010074|FG005|Overall Study|Protocol Violation|0|||
126198271|NCT01066819|454010069|FG000|Overall Study|Withdrawal by Subject|29|||
126198272|NCT01066819|454010070|FG001|Overall Study|Withdrawal by Subject|11|||
126198273|NCT01066819|454010071|FG002|Overall Study|Withdrawal by Subject|6|||
126198274|NCT01066819|454010072|FG003|Overall Study|Withdrawal by Subject|0|||
126198275|NCT01066819|454010073|FG004|Overall Study|Withdrawal by Subject|0|||
126198276|NCT01066819|454010074|FG005|Overall Study|Withdrawal by Subject|0|||
126198277|NCT01066819|454010069|FG000|Overall Study|Administrative|6|||
126198278|NCT01066819|454010070|FG001|Overall Study|Administrative|4|||
126198279|NCT01066819|454010071|FG002|Overall Study|Administrative|2|||
126198280|NCT01066819|454010072|FG003|Overall Study|Administrative|0|||
126198281|NCT01066819|454010073|FG004|Overall Study|Administrative|0|||
126198282|NCT01066819|454010074|FG005|Overall Study|Administrative|0|||
126198283|NCT01066819|454010069|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
126198284|NCT01066819|454010070|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
126198285|NCT01066819|454010071|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
126198286|NCT01066819|454010072|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
126198287|NCT01066819|454010073|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
126198288|NCT01066819|454010074|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
126198289|NCT01066819|454010069|FG000|Overall Study|Early termination|2|||
126198290|NCT01066819|454010070|FG001|Overall Study|Early termination|0|||
126198291|NCT01066819|454010071|FG002|Overall Study|Early termination|0|||
126198292|NCT01066819|454010072|FG003|Overall Study|Early termination|0|||
126198293|NCT01066819|454010073|FG004|Overall Study|Early termination|0|||
126198294|NCT01066819|454010074|FG005|Overall Study|Early termination|0|||
126198295|NCT01066819|454010069|FG000|Overall Study|Failed to return|298|||
126198296|NCT01066819|454010070|FG001|Overall Study|Failed to return|107|||
126198297|NCT01066819|454010071|FG002|Overall Study|Failed to return|68|||
126198298|NCT01066819|454010072|FG003|Overall Study|Failed to return|7|||
126198299|NCT01066819|454010073|FG004|Overall Study|Failed to return|2|||
126198300|NCT01066819|454010074|FG005|Overall Study|Failed to return|3|||
126198301|NCT01066819|454010069|FG000|Overall Study|Lab test not done|9|||
126198302|NCT01066819|454010070|FG001|Overall Study|Lab test not done|0|||
126198303|NCT01066819|454010071|FG002|Overall Study|Lab test not done|2|||
126198304|NCT01066819|454010072|FG003|Overall Study|Lab test not done|1|||
126198305|NCT01066819|454010073|FG004|Overall Study|Lab test not done|0|||
126198306|NCT01066819|454010074|FG005|Overall Study|Lab test not done|0|||
126198307|NCT01066819|454010069|FG000|Overall Study|Miscellaneous|28|||
126198308|NCT01066819|454010070|FG001|Overall Study|Miscellaneous|10|||
126198309|NCT01066819|454010071|FG002|Overall Study|Miscellaneous|18|||
126198310|NCT01066819|454010072|FG003|Overall Study|Miscellaneous|1|||
126198311|NCT01066819|454010073|FG004|Overall Study|Miscellaneous|0|||
126198312|NCT01066819|454010074|FG005|Overall Study|Miscellaneous|0|||
126198313|NCT01066819|454010069|FG000|Overall Study|Non responders|123|||
126198314|NCT01066819|454010070|FG001|Overall Study|Non responders|2|||
126198315|NCT01066819|454010071|FG002|Overall Study|Non responders|7|||
126198316|NCT01066819|454010072|FG003|Overall Study|Non responders|2|||
126198317|NCT01066819|454010073|FG004|Overall Study|Non responders|0|||
126198318|NCT01066819|454010074|FG005|Overall Study|Non responders|1|||
126198319|NCT01066819|454010069|FG000|Overall Study|Not categorised|9|||
126198320|NCT01066819|454010070|FG001|Overall Study|Not categorised|2|||
126198321|NCT01066819|454010071|FG002|Overall Study|Not categorised|6|||
126198322|NCT01066819|454010072|FG003|Overall Study|Not categorised|1|||
126198323|NCT01066819|454010073|FG004|Overall Study|Not categorised|0|||
126198324|NCT01066819|454010074|FG005|Overall Study|Not categorised|0|||
126198325|NCT01066819|454010069|FG000|Overall Study|Relapse|16|||
126198326|NCT01066819|454010070|FG001|Overall Study|Relapse|4|||
126198327|NCT01066819|454010071|FG002|Overall Study|Relapse|3|||
126198328|NCT01066819|454010072|FG003|Overall Study|Relapse|0|||
126198329|NCT01066819|454010073|FG004|Overall Study|Relapse|0|||
126198330|NCT01066819|454010074|FG005|Overall Study|Relapse|0|||
126198331|NCT01066819|454010069|FG000|Overall Study|Results not available|1|||
126198332|NCT01066819|454010070|FG001|Overall Study|Results not available|0|||
126198333|NCT01066819|454010071|FG002|Overall Study|Results not available|0|||
126198334|NCT01066819|454010072|FG003|Overall Study|Results not available|0|||
126198335|NCT01066819|454010073|FG004|Overall Study|Results not available|0|||
126198336|NCT01066819|454010074|FG005|Overall Study|Results not available|0|||
126198337|NCT01066819|454010069|FG000|Overall Study|Screen failure|1|||
126198338|NCT01066819|454010070|FG001|Overall Study|Screen failure|0|||
126198339|NCT01066819|454010071|FG002|Overall Study|Screen failure|0|||
126198340|NCT01066819|454010072|FG003|Overall Study|Screen failure|0|||
126198341|NCT01066819|454010073|FG004|Overall Study|Screen failure|0|||
126198342|NCT01066819|454010074|FG005|Overall Study|Screen failure|0|||
126198343|NCT01066819|454010069|FG000|Overall Study|Spontaneous cure|1|||
126198344|NCT01066819|454010070|FG001|Overall Study|Spontaneous cure|0|||
126198345|NCT01066819|454010071|FG002|Overall Study|Spontaneous cure|0|||
126198346|NCT01066819|454010072|FG003|Overall Study|Spontaneous cure|0|||
126198347|NCT01066819|454010073|FG004|Overall Study|Spontaneous cure|0|||
126198348|NCT01066819|454010074|FG005|Overall Study|Spontaneous cure|0|||
126198349|NCT01066819|454010069|FG000|Overall Study|Treatment never started|85|||
126198350|NCT01066819|454010070|FG001|Overall Study|Treatment never started|19|||
126198351|NCT01066819|454010071|FG002|Overall Study|Treatment never started|19|||
126198352|NCT01066819|454010072|FG003|Overall Study|Treatment never started|3|||
126198353|NCT01066819|454010073|FG004|Overall Study|Treatment never started|2|||
126198354|NCT01066819|454010074|FG005|Overall Study|Treatment never started|2|||
126198355|NCT01066819|454010069|FG000|Overall Study|Treatment stopped|12|||
126198356|NCT01066819|454010070|FG001|Overall Study|Treatment stopped|1|||
126198357|NCT01066819|454010071|FG002|Overall Study|Treatment stopped|2|||
126198358|NCT01066819|454010072|FG003|Overall Study|Treatment stopped|1|||
126198359|NCT01066819|454010073|FG004|Overall Study|Treatment stopped|0|||
126198360|NCT01066819|454010074|FG005|Overall Study|Treatment stopped|0|||
126198361|NCT01066819|454010069|FG000|Overall Study|Other|5|||
126198362|NCT01066819|454010070|FG001|Overall Study|Other|1|||
126198363|NCT01066819|454010071|FG002|Overall Study|Other|1|||
126198364|NCT01066819|454010072|FG003|Overall Study|Other|0|||
126198365|NCT01066819|454010073|FG004|Overall Study|Other|0|||
126198366|NCT01066819|454010074|FG005|Overall Study|Other|0|||
126198367|NCT00805194|454010076|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
126198368|NCT00805194|454010077|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
126198369|NCT00805194|454010076|FG000|Overall Study|Worsening or AE of underlying disease|64|||
126198370|NCT00805194|454010077|FG001|Overall Study|Worsening or AE of underlying disease|70|||
126198371|NCT00805194|454010076|FG000|Overall Study|Other AE|84|||
126198372|NCT00805194|454010077|FG001|Overall Study|Other AE|73|||
126198373|NCT00805194|454010076|FG000|Overall Study|Protocol Violation|9|||
126198374|NCT00805194|454010077|FG001|Overall Study|Protocol Violation|9|||
126198375|NCT00805194|454010076|FG000|Overall Study|Lost to Follow-up|5|||
126198376|NCT00805194|454010077|FG001|Overall Study|Lost to Follow-up|5|||
126198377|NCT00805194|454010076|FG000|Overall Study|Withdrawal by Subject|60|||
126198378|NCT00805194|454010077|FG001|Overall Study|Withdrawal by Subject|42|||
126198379|NCT00805194|454010076|FG000|Overall Study|Not treated|3|||
126198380|NCT00805194|454010077|FG001|Overall Study|Not treated|4|||
126198381|NCT00805194|454010076|FG000|Overall Study|Reasons other than stated above|20|||
126198382|NCT00805194|454010077|FG001|Overall Study|Reasons other than stated above|16|||
126198383|NCT02275052|454010084|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126198384|NCT02275052|454010085|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126198385|NCT02275052|454010086|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126198386|NCT02275052|454010087|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126198387|NCT02275052|454010084|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
126198388|NCT02275052|454010085|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
126198389|NCT02275052|454010086|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
126198390|NCT02275052|454010087|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
126198391|NCT02275052|454010084|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
126198392|NCT02275052|454010085|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
126198393|NCT02275052|454010086|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126198394|NCT02275052|454010087|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126198395|NCT02275052|454010084|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
126198396|NCT02275052|454010085|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
126198397|NCT02275052|454010086|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
126198398|NCT02275052|454010087|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
126198399|NCT02275052|454010084|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
126198400|NCT02275052|454010085|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
126198401|NCT02275052|454010086|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
126198402|NCT02275052|454010087|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
126198403|NCT02275052|454010084|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
126198404|NCT02275052|454010085|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
126198405|NCT02275052|454010086|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
126198406|NCT02275052|454010087|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
126198407|NCT02275052|454010084|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
126198408|NCT02275052|454010085|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
126198409|NCT02275052|454010086|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
126198410|NCT02275052|454010087|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
126198411|NCT02275052|454010084|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126198412|NCT02275052|454010085|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126198413|NCT02275052|454010086|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
126198414|NCT02275052|454010087|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
126198415|NCT02275052|454010084|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126198416|NCT02275052|454010085|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126198417|NCT02275052|454010086|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126198418|NCT02275052|454010087|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
126198419|NCT02275052|454010084|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126198420|NCT02275052|454010085|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126198421|NCT02275052|454010086|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
126198422|NCT02275052|454010087|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
126198423|NCT02275052|454010084|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126198424|NCT02275052|454010085|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126198425|NCT02275052|454010086|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126198426|NCT02275052|454010087|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
126198427|NCT02807376|454010090|FG000|Overall Study|Intra-operative exclusion criteria|3|||
126198428|NCT02807376|454010091|FG001|Overall Study|Intra-operative exclusion criteria|0|||
126198429|NCT02807376|454010090|FG000|Overall Study|Lost to Follow-up|0|||
126198430|NCT02807376|454010091|FG001|Overall Study|Lost to Follow-up|1|||
126198431|NCT00846027|454010092|FG000|Overall Study|Death|3|||
126198432|NCT00846027|454010092|FG000|Overall Study|Disease Progression|30|||
126198433|NCT00846027|454010092|FG000|Overall Study|Toxicity|12|||
126198434|NCT00846027|454010092|FG000|Overall Study|Patient Decision|7|||
126198435|NCT00846027|454010092|FG000|Overall Study|Investigator Discretion|29|||
126198436|NCT00846027|454010092|FG000|Overall Study|Protocol Violation|2|||
126198437|NCT00846027|454010092|FG000|Overall Study|Subject Not Treated|7|||
126198438|NCT00808028|454010095|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
126198439|NCT00808028|454010096|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
126198440|NCT00808028|454010097|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
126198441|NCT00808028|454010098|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
126198442|NCT00808028|454010095|FG000|Stage 1 (6 Months)|Other|1|||
126198443|NCT00808028|454010096|FG001|Stage 1 (6 Months)|Other|0|||
126198444|NCT00808028|454010097|FG002|Stage 1 (6 Months)|Other|2|||
126198445|NCT00808028|454010098|FG003|Stage 1 (6 Months)|Other|4|||
126198446|NCT00808028|454010095|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
126198447|NCT00808028|454010096|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
126198448|NCT00808028|454010097|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
126198449|NCT00808028|454010098|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
126198450|NCT00808028|454010095|FG000|Stage 1 (6 Months)|Adverse Event|0|||
126198451|NCT00808028|454010096|FG001|Stage 1 (6 Months)|Adverse Event|0|||
126198452|NCT00808028|454010097|FG002|Stage 1 (6 Months)|Adverse Event|1|||
126198453|NCT00808028|454010098|FG003|Stage 1 (6 Months)|Adverse Event|2|||
126198454|NCT00808028|454010095|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
126198455|NCT00808028|454010096|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
126198456|NCT00808028|454010097|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
126198457|NCT00808028|454010098|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
126198458|NCT00808028|454010095|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
126198459|NCT00808028|454010096|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
126198460|NCT00808028|454010097|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
126198461|NCT00808028|454010098|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
126198462|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
126198463|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
126198464|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
126198465|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
126198466|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
126198467|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
126198468|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
126198469|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
126198470|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
126198471|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
126198472|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
126198473|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
126198474|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
126198475|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
126198476|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
126198477|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
126198478|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
126198479|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
126198480|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
126198481|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
126198482|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
126198483|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
126198484|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
126198485|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
126198486|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
126198487|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
126198488|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
126198489|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
126198490|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
126198491|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
126198492|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
126198493|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
126198494|NCT00808028|454010095|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
126198495|NCT00808028|454010096|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
126198496|NCT00808028|454010097|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
126198497|NCT00808028|454010098|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
126198498|NCT01797302|454010099|FG000|Overall Study|Lost to Follow-up|16|||
126198499|NCT01797302|454010100|FG001|Overall Study|Lost to Follow-up|23|||
126198500|NCT01797302|454010101|FG002|Overall Study|Lost to Follow-up|22|||
126198501|NCT01797302|454010099|FG000|Overall Study|Withdrawal by Subject|1|||
126198502|NCT01797302|454010100|FG001|Overall Study|Withdrawal by Subject|3|||
126198503|NCT01797302|454010101|FG002|Overall Study|Withdrawal by Subject|4|||
126198504|NCT03228836|454010102|FG000|Overall Study|Adverse Event|3|||
126198505|NCT03228836|454010102|FG000|Overall Study|Withdrawal by Subject|1|||
126198506|NCT03228836|454010102|FG000|Overall Study|Death|1|||
126198507|NCT03228836|454010102|FG000|Overall Study|Physician Decision|1|||
126198508|NCT03228836|454010102|FG000|Overall Study|Disease Progression|7|||
126198509|NCT03228836|454010102|FG000|Overall Study|Other|4|||
126198510|NCT02773849|454010104|FG000|Overall Study|Lost to Follow-up|11|||
126198511|NCT02773849|454010104|FG000|Overall Study|Death|26|||
126198512|NCT02773849|454010104|FG000|Overall Study|Withdrawal by Subject|5|||
126198513|NCT02773849|454010104|FG000|Overall Study|Withdrawal of Consent|9|||
126198514|NCT02773849|454010104|FG000|Overall Study|Other: not due to lack of tolerability|11|||
126198515|NCT00948389|454010105|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
126198516|NCT00948389|454010106|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
126198517|NCT00948389|454010107|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
126198518|NCT00948389|454010108|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
126198519|NCT00948389|454010109|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
126198520|NCT00948389|454010105|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
126198521|NCT00948389|454010106|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
126198522|NCT00948389|454010107|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
126198523|NCT00948389|454010108|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
126198524|NCT00948389|454010109|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
126198525|NCT00948389|454010105|FG000|Overall Study|Both Progression and Toxicity|1|||
126198526|NCT00948389|454010106|FG001|Overall Study|Both Progression and Toxicity|0|||
126198527|NCT00948389|454010107|FG002|Overall Study|Both Progression and Toxicity|0|||
126198528|NCT00948389|454010108|FG003|Overall Study|Both Progression and Toxicity|0|||
126198529|NCT00948389|454010109|FG004|Overall Study|Both Progression and Toxicity|0|||
126198530|NCT02418000|454010110|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
126198531|NCT02418000|454010111|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
126198532|NCT02418000|454010112|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
126198533|NCT02418000|454010113|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
126198534|NCT02418000|454010114|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
126198535|NCT02418000|454010110|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
126198536|NCT02418000|454010111|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
126198537|NCT02418000|454010112|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
126198538|NCT02418000|454010113|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
126198539|NCT02418000|454010114|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
126198540|NCT02418000|454010110|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
126198541|NCT02418000|454010111|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
126198542|NCT02418000|454010112|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
126198543|NCT02418000|454010113|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
126198544|NCT02418000|454010114|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
126198545|NCT02418000|454010110|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
126198546|NCT02418000|454010111|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
126198547|NCT02418000|454010112|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
126198548|NCT02418000|454010113|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
126198549|NCT02418000|454010114|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
126198550|NCT02418000|454010110|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
126198551|NCT02418000|454010111|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
126198552|NCT02418000|454010112|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
126198553|NCT02418000|454010113|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
126198554|NCT02418000|454010114|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
126198555|NCT02418000|454010110|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198556|NCT02418000|454010111|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198557|NCT02418000|454010112|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
126198558|NCT02418000|454010113|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198559|NCT02418000|454010114|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198560|NCT02418000|454010110|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198561|NCT02418000|454010111|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198562|NCT02418000|454010112|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198563|NCT02418000|454010113|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
126198564|NCT02418000|454010114|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198565|NCT02418000|454010110|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
126198566|NCT02418000|454010111|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
126198567|NCT02418000|454010112|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
126198568|NCT02418000|454010113|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
126198569|NCT02418000|454010114|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
126198570|NCT02418000|454010110|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198571|NCT02418000|454010111|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198572|NCT02418000|454010112|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198573|NCT02418000|454010113|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126198574|NCT02418000|454010114|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
126198575|NCT00508001|454010115|FG000|Overall Study|Adverse Event|2|||
126198576|NCT00508001|454010116|FG001|Overall Study|Adverse Event|0|||
126198577|NCT00508001|454010117|FG002|Overall Study|Adverse Event|4|||
126198578|NCT00508001|454010115|FG000|Overall Study|condition under investigation worsened|13|||
126198579|NCT00508001|454010116|FG001|Overall Study|condition under investigation worsened|7|||
126198580|NCT00508001|454010117|FG002|Overall Study|condition under investigation worsened|1|||
126198581|NCT00508001|454010115|FG000|Overall Study|Death|0|||
126198582|NCT00508001|454010116|FG001|Overall Study|Death|1|||
126198583|NCT00508001|454010117|FG002|Overall Study|Death|1|||
126198584|NCT00508001|454010115|FG000|Overall Study|Withdrawal by Subject|4|||
126198585|NCT00508001|454010116|FG001|Overall Study|Withdrawal by Subject|4|||
126198586|NCT00508001|454010117|FG002|Overall Study|Withdrawal by Subject|1|||
126198587|NCT02381795|454010125|FG000|Overall Study|Withdrawal by Subject|1|||
126198588|NCT02381795|454010125|FG000|Overall Study|Study Terminated|2|||
126198589|NCT02176226|454010126|FG000|Overall Study|Lost to Follow-up|3|||
126198590|NCT02176226|454010126|FG000|Overall Study|Withdrew prior to treatment|6|||
126198591|NCT02908841|454010131|FG000|Overall Study|Physician Decision|4|||
126198592|NCT02908841|454010132|FG001|Overall Study|Physician Decision|0|||
126198593|NCT01611558|454010133|FG000|Induction Phase|Study drug toxicity|15|||
126198594|NCT01611558|454010133|FG000|Induction Phase|Disease progression|18|||
126198595|NCT01611558|454010133|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
126198596|NCT01611558|454010133|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
126198597|NCT01611558|454010133|FG000|Induction Phase|Death|1|||
126198598|NCT01611558|454010133|FG000|Maintenance Phase|Withdrawal by Subject|1|||
126198599|NCT01611558|454010133|FG000|Maintenance Phase|Elevated Uric acid|1|||
126198600|NCT04005885|454010135|FG000|First Intervention|Withdrawal by Subject|1|||
126198601|NCT04005885|454010136|FG001|First Intervention|Withdrawal by Subject|1|||
126198602|NCT04005885|454010135|FG000|Second Intervention|Withdrawal by Subject|0|||
126198603|NCT04005885|454010136|FG001|Second Intervention|Withdrawal by Subject|2|||
126198604|NCT00750867|454010137|FG000|Overall Study|Adverse Event|2|||
126198605|NCT02718625|454010138|FG000|Overall Study|Adverse Event|0|||
126198606|NCT02718625|454010139|FG001|Overall Study|Adverse Event|1|||
126198607|NCT02718625|454010138|FG000|Overall Study|Termination of Study by Sponsor|0|||
126198608|NCT02718625|454010139|FG001|Overall Study|Termination of Study by Sponsor|1|||
126198609|NCT01947127|454010144|FG000|Overall Study|Protocol Violation|18|||
126198610|NCT01947127|454010145|FG001|Overall Study|Protocol Violation|38|||
126198611|NCT01947127|454010144|FG000|Overall Study|Withdrawal by Subject|1|||
126198612|NCT01947127|454010145|FG001|Overall Study|Withdrawal by Subject|1|||
126198613|NCT01947127|454010144|FG000|Overall Study|Data loss|4|||
126198614|NCT01947127|454010145|FG001|Overall Study|Data loss|4|||
126198615|NCT01836549|454010146|FG000|Overall Study|Did not receive study drug|0|||
126198616|NCT01836549|454010147|FG001|Overall Study|Did not receive study drug|0|||
126198617|NCT01836549|454010148|FG002|Overall Study|Did not receive study drug|1|||
126198618|NCT01836549|454010149|FG003|Overall Study|Did not receive study drug|0|||
126198619|NCT01836549|454010150|FG004|Overall Study|Did not receive study drug|0|||
126198620|NCT01836549|454010151|FG005|Overall Study|Did not receive study drug|0|||
126198621|NCT01836549|454010152|FG006|Overall Study|Did not receive study drug|0|||
126198622|NCT01836549|454010146|FG000|Overall Study|Patient declared ineligible|0|||
126198623|NCT01836549|454010147|FG001|Overall Study|Patient declared ineligible|0|||
126198624|NCT01836549|454010148|FG002|Overall Study|Patient declared ineligible|0|||
126198625|NCT01836549|454010149|FG003|Overall Study|Patient declared ineligible|1|||
126198626|NCT01836549|454010150|FG004|Overall Study|Patient declared ineligible|0|||
126198627|NCT01836549|454010151|FG005|Overall Study|Patient declared ineligible|0|||
126198628|NCT01836549|454010152|FG006|Overall Study|Patient declared ineligible|0|||
126198629|NCT01836549|454010146|FG000|Overall Study|Patient inevaluable to start therapy|0|||
126198630|NCT01836549|454010147|FG001|Overall Study|Patient inevaluable to start therapy|0|||
126198631|NCT01836549|454010148|FG002|Overall Study|Patient inevaluable to start therapy|0|||
126198632|NCT01836549|454010149|FG003|Overall Study|Patient inevaluable to start therapy|0|||
126198633|NCT01836549|454010150|FG004|Overall Study|Patient inevaluable to start therapy|0|||
126198634|NCT01836549|454010151|FG005|Overall Study|Patient inevaluable to start therapy|0|||
126198635|NCT01836549|454010152|FG006|Overall Study|Patient inevaluable to start therapy|1|||
126198636|NCT02516306|454010153|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
126198637|NCT02516306|454010154|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
126198638|NCT01969565|454010158|FG000|Overall Study|Withdrawal by Subject|1|||
126198639|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Adverse Event|30|||
126198640|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Adverse Event|25|||
126198641|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Adverse Event|23|||
126198642|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Adverse Event|14|||
126198643|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Death|0|||
126198644|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Death|0|||
126198645|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Death|1|||
126198646|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Death|0|||
126198647|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Physician Decision|0|||
126198648|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Physician Decision|1|||
126198649|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Physician Decision|0|||
126198650|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Physician Decision|1|||
126198651|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
126198652|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
126198653|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
126198654|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
126198655|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Other|6|||
126198656|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Other|1|||
126198657|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Other|0|||
126198658|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Other|2|||
126198659|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
126198660|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
126198661|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
126198662|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
126198663|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
126198664|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
126198665|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
126198666|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
126198667|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
126198668|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
126198669|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
126198670|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
126198671|NCT00242710|454010159|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
126198672|NCT00242710|454010160|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
126198673|NCT00242710|454010161|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
126198674|NCT00242710|454010162|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
126198675|NCT00242710|454010159|FG000|Period Between Core Study and Extension|Adverse Event|2|||
126198676|NCT00242710|454010160|FG001|Period Between Core Study and Extension|Adverse Event|3|||
126198677|NCT00242710|454010161|FG002|Period Between Core Study and Extension|Adverse Event|5|||
126198678|NCT00242710|454010162|FG003|Period Between Core Study and Extension|Adverse Event|2|||
126198679|NCT00242710|454010159|FG000|Period Between Core Study and Extension|Physician Decision|1|||
126198680|NCT00242710|454010160|FG001|Period Between Core Study and Extension|Physician Decision|1|||
126198681|NCT00242710|454010161|FG002|Period Between Core Study and Extension|Physician Decision|0|||
126198682|NCT00242710|454010162|FG003|Period Between Core Study and Extension|Physician Decision|0|||
126198683|NCT00242710|454010159|FG000|Period Between Core Study and Extension|Other|24|||
126198684|NCT00242710|454010160|FG001|Period Between Core Study and Extension|Other|24|||
126198685|NCT00242710|454010161|FG002|Period Between Core Study and Extension|Other|9|||
126198686|NCT00242710|454010162|FG003|Period Between Core Study and Extension|Other|11|||
126198687|NCT00242710|454010159|FG000|Period Between Core Study and Extension|Extension not Available|17|||
126198688|NCT00242710|454010160|FG001|Period Between Core Study and Extension|Extension not Available|21|||
126198689|NCT00242710|454010161|FG002|Period Between Core Study and Extension|Extension not Available|8|||
126198690|NCT00242710|454010162|FG003|Period Between Core Study and Extension|Extension not Available|7|||
126198691|NCT00242710|454010159|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
126198692|NCT00242710|454010160|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
126198693|NCT00242710|454010161|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
126198694|NCT00242710|454010162|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
126198695|NCT00242710|454010159|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
126198696|NCT00242710|454010160|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
126198697|NCT00242710|454010161|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
126198698|NCT00242710|454010162|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
126198699|NCT00242710|454010159|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
126198700|NCT00242710|454010160|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
126198701|NCT00242710|454010161|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
126198702|NCT00242710|454010162|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
126198703|NCT00242710|454010159|FG000|Study Extension (up to Year 2)|Death|0|||
126198704|NCT00242710|454010160|FG001|Study Extension (up to Year 2)|Death|0|||
126198705|NCT00242710|454010161|FG002|Study Extension (up to Year 2)|Death|0|||
126198706|NCT00242710|454010162|FG003|Study Extension (up to Year 2)|Death|1|||
126198707|NCT00242710|454010159|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
126198708|NCT00242710|454010160|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
126198709|NCT00242710|454010161|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
126198710|NCT00242710|454010162|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
126198711|NCT00242710|454010159|FG000|Study Extension (up to Year 2)|Other|3|||
126198712|NCT00242710|454010160|FG001|Study Extension (up to Year 2)|Other|5|||
126198713|NCT00242710|454010161|FG002|Study Extension (up to Year 2)|Other|4|||
126198714|NCT00242710|454010162|FG003|Study Extension (up to Year 2)|Other|3|||
126198715|NCT00242710|454010159|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
126198716|NCT00242710|454010160|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
126198717|NCT00242710|454010161|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
126198718|NCT00242710|454010162|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
126198719|NCT00242710|454010159|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
126198720|NCT00242710|454010160|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
126198721|NCT00242710|454010161|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
126198722|NCT00242710|454010162|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
126198723|NCT00579527|454010163|FG000|Overall Study|Death|4|||
126198724|NCT03961529|454010164|FG000|Overall Study|Adverse Event|13|||
126198725|NCT03961529|454010165|FG001|Overall Study|Adverse Event|5|||
126198726|NCT03961529|454010166|FG002|Overall Study|Adverse Event|2|||
126198727|NCT03961529|454010164|FG000|Overall Study|Withdrawal by Subject|17|||
126198728|NCT03961529|454010165|FG001|Overall Study|Withdrawal by Subject|2|||
126198729|NCT03961529|454010166|FG002|Overall Study|Withdrawal by Subject|1|||
126198730|NCT03961529|454010164|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126198731|NCT03961529|454010165|FG001|Overall Study|Withdrawal by parent/guardian|7|||
126198732|NCT03961529|454010166|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126198733|NCT03961529|454010164|FG000|Overall Study|Physician Decision|2|||
126198734|NCT03961529|454010165|FG001|Overall Study|Physician Decision|1|||
126198735|NCT03961529|454010166|FG002|Overall Study|Physician Decision|1|||
126198736|NCT03961529|454010164|FG000|Overall Study|Lost to Follow-up|2|||
126198737|NCT03961529|454010165|FG001|Overall Study|Lost to Follow-up|1|||
126198738|NCT03961529|454010166|FG002|Overall Study|Lost to Follow-up|0|||
126198739|NCT03961529|454010164|FG000|Overall Study|Lack of Efficacy|2|||
126198740|NCT03961529|454010165|FG001|Overall Study|Lack of Efficacy|0|||
126198741|NCT03961529|454010166|FG002|Overall Study|Lack of Efficacy|1|||
126198742|NCT03961529|454010164|FG000|Overall Study|Other|6|||
126198743|NCT03961529|454010165|FG001|Overall Study|Other|1|||
126198744|NCT03961529|454010166|FG002|Overall Study|Other|0|||
126198745|NCT03644173|454010167|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
126198746|NCT03644173|454010167|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
126198747|NCT03644173|454010167|FG000|Participants at the 1-month Follow up|Death|2|||
126198748|NCT03644173|454010167|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
126198749|NCT00381706|454010170|FG000|Overall Study|Never treated|7|||
126198750|NCT00381706|454010171|FG001|Overall Study|Never treated|2|||
126198751|NCT00381706|454010172|FG002|Overall Study|Never treated|1|||
126198752|NCT02390167|454012507|FG000|Overall Study|Lost to Follow-up|1|||
126198753|NCT02033369|454012508|FG000|Overall Study|Physician Decision|1|||
126198754|NCT02033369|454012509|FG001|Overall Study|Physician Decision|2|||
126198755|NCT02033369|454012508|FG000|Overall Study|Not a good demographic match|0|||
126198756|NCT02033369|454012509|FG001|Overall Study|Not a good demographic match|2|||
126198757|NCT02033369|454012508|FG000|Overall Study|Withdrawal by Subject|1|||
126198758|NCT02033369|454012509|FG001|Overall Study|Withdrawal by Subject|1|||
126198759|NCT02033369|454012508|FG000|Overall Study|Lost to Follow-up|1|||
126198760|NCT02033369|454012509|FG001|Overall Study|Lost to Follow-up|0|||
126198761|NCT02033369|454012508|FG000|Overall Study|Protocol Violation|2|||
126198762|NCT02033369|454012509|FG001|Overall Study|Protocol Violation|0|||
126198763|NCT01265719|454012515|FG000|Overall Study|Does not meet entrance criteria|0|||
126198764|NCT01265719|454012516|FG001|Overall Study|Does not meet entrance criteria|3|||
126198765|NCT01265719|454012515|FG000|Overall Study|Other reasons|2|||
126198766|NCT01265719|454012516|FG001|Overall Study|Other reasons|0|||
126198767|NCT01265719|454012515|FG000|Overall Study|Withdrawal by Subject|8|||
126198768|NCT01265719|454012516|FG001|Overall Study|Withdrawal by Subject|3|||
126198769|NCT01265719|454012515|FG000|Overall Study|Lost to Follow-up|2|||
126198770|NCT01265719|454012516|FG001|Overall Study|Lost to Follow-up|7|||
126198771|NCT01265719|454012515|FG000|Overall Study|Adverse Event|2|||
126198772|NCT01265719|454012516|FG001|Overall Study|Adverse Event|0|||
126198773|NCT04335929|454012517|FG000|Overall Study|Lost to Follow-up|10|||
126198774|NCT00732199|454012526|FG000|Overall Study|Withdrawal by Subject|25|||
126198775|NCT00732199|454012527|FG001|Overall Study|Withdrawal by Subject|18|||
126198776|NCT00732199|454012526|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
126198777|NCT00732199|454012527|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
126198778|NCT02870348|454012538|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
126198779|NCT01051856|454012539|FG000|Overall Study|Withdrawal by Subject|1|||
126198780|NCT01051856|454012540|FG001|Overall Study|Withdrawal by Subject|0|||
126198781|NCT00672139|454012541|FG000|Overall Study|Death|14|||
126198782|NCT00672139|454012542|FG001|Overall Study|Death|23|||
126198783|NCT00672139|454012541|FG000|Overall Study|Withdrawal by Subject|2|||
126198784|NCT00672139|454012542|FG001|Overall Study|Withdrawal by Subject|11|||
126198785|NCT00672139|454012541|FG000|Overall Study|Adverse Event|4|||
126198786|NCT00672139|454012542|FG001|Overall Study|Adverse Event|7|||
126198787|NCT00672139|454012541|FG000|Overall Study|Physician Decision|2|||
126198788|NCT00672139|454012542|FG001|Overall Study|Physician Decision|0|||
126198789|NCT00672139|454012541|FG000|Overall Study|Lack of Efficacy|4|||
126198790|NCT00672139|454012542|FG001|Overall Study|Lack of Efficacy|1|||
126198791|NCT00672139|454012541|FG000|Overall Study|Protocol Violation|1|||
126198792|NCT00672139|454012542|FG001|Overall Study|Protocol Violation|1|||
126198793|NCT00672139|454012541|FG000|Overall Study|hospice discharge, caregiver requests|3|||
126198794|NCT00672139|454012542|FG001|Overall Study|hospice discharge, caregiver requests|2|||
126198795|NCT01412333|454012553|FG000|Overall Study|Adverse Event|40|||
126198796|NCT01412333|454012554|FG001|Overall Study|Adverse Event|42|||
126198797|NCT01412333|454012553|FG000|Overall Study|Death|5|||
126198798|NCT01412333|454012554|FG001|Overall Study|Death|6|||
126198799|NCT01412333|454012553|FG000|Overall Study|Lack of Efficacy|22|||
126198800|NCT01412333|454012554|FG001|Overall Study|Lack of Efficacy|10|||
126198801|NCT01412333|454012553|FG000|Overall Study|Lost to Follow-up|15|||
126198802|NCT01412333|454012554|FG001|Overall Study|Lost to Follow-up|12|||
126198803|NCT01412333|454012553|FG000|Overall Study|Non-Compliance|3|||
126198804|NCT01412333|454012554|FG001|Overall Study|Non-Compliance|7|||
126198805|NCT01412333|454012553|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126198806|NCT01412333|454012554|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126198807|NCT01412333|454012553|FG000|Overall Study|Other|30|||
126198808|NCT01412333|454012554|FG001|Overall Study|Other|33|||
126198809|NCT01412333|454012553|FG000|Overall Study|Physician Decision|11|||
126198810|NCT01412333|454012554|FG001|Overall Study|Physician Decision|16|||
126198811|NCT01412333|454012553|FG000|Overall Study|Pregnancy|6|||
126198812|NCT01412333|454012554|FG001|Overall Study|Pregnancy|4|||
126198813|NCT01412333|454012553|FG000|Overall Study|Protocol Violation|1|||
126198814|NCT01412333|454012554|FG001|Overall Study|Protocol Violation|2|||
126198815|NCT01412333|454012553|FG000|Overall Study|Study Terminated By Sponsor|3|||
126198816|NCT01412333|454012554|FG001|Overall Study|Study Terminated By Sponsor|2|||
126198817|NCT01412333|454012553|FG000|Overall Study|Withdrawal by Subject|51|||
126198818|NCT01412333|454012554|FG001|Overall Study|Withdrawal by Subject|54|||
126198819|NCT01412333|454012553|FG000|Overall Study|Missing|1|||
126198820|NCT01412333|454012554|FG001|Overall Study|Missing|3|||
126198821|NCT01060150|454012555|FG000|Overall Study|Adverse Event|6|||
126198822|NCT01060150|454012555|FG000|Overall Study|Lost to Follow-up|1|||
126198823|NCT01060150|454012555|FG000|Overall Study|Protocol Violation|6|||
126198824|NCT01060150|454012555|FG000|Overall Study|Withdrawal by Subject|8|||
126198825|NCT01060150|454012555|FG000|Overall Study|Enrolled, but not treated|2|||
126198826|NCT01683058|454012556|FG000|Overall Study|Lost to Follow-up|9|||
126198827|NCT01683058|454012556|FG000|Overall Study|Adverse Event|6|||
126198828|NCT01683058|454012556|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
126198829|NCT01683058|454012556|FG000|Overall Study|Withdrawal by Subject|7|||
126198830|NCT01683058|454012556|FG000|Overall Study|Lack of Efficacy|2|||
126198831|NCT04062240|454012557|FG000|Overall Study|equipment malfunction|1|||
126198832|NCT01957111|454012558|FG000|Overall Study|Withdrawal by Subject|1|||
126198833|NCT01957111|454012559|FG001|Overall Study|Withdrawal by Subject|1|||
126198834|NCT01057394|454012560|FG000|Overall Study|Not eligible|0|||
126198835|NCT01057394|454012561|FG001|Overall Study|Not eligible|2|||
126198836|NCT03500419|454012562|FG000|Overall Study|Withdrawal by Subject|2|||
126198837|NCT03500419|454012563|FG001|Overall Study|Withdrawal by Subject|25|||
126198838|NCT00256204|454012564|FG000|Overall Study|Adverse Event|10|||
126198839|NCT00256204|454012565|FG001|Overall Study|Adverse Event|14|||
126198840|NCT00256204|454012566|FG002|Overall Study|Adverse Event|16|||
126198841|NCT00256204|454012567|FG003|Overall Study|Adverse Event|14|||
126198842|NCT00256204|454012564|FG000|Overall Study|Death|0|||
126198843|NCT00256204|454012565|FG001|Overall Study|Death|1|||
126198844|NCT00256204|454012566|FG002|Overall Study|Death|0|||
126198845|NCT00256204|454012567|FG003|Overall Study|Death|0|||
126198846|NCT00256204|454012564|FG000|Overall Study|Lost to Follow-up|1|||
126198847|NCT00256204|454012565|FG001|Overall Study|Lost to Follow-up|1|||
126198848|NCT00256204|454012566|FG002|Overall Study|Lost to Follow-up|1|||
126198849|NCT00256204|454012567|FG003|Overall Study|Lost to Follow-up|2|||
126198850|NCT00256204|454012564|FG000|Overall Study|Protocol Violation|1|||
126198851|NCT00256204|454012565|FG001|Overall Study|Protocol Violation|0|||
126198852|NCT00256204|454012566|FG002|Overall Study|Protocol Violation|2|||
126198853|NCT00256204|454012567|FG003|Overall Study|Protocol Violation|1|||
126198854|NCT00256204|454012564|FG000|Overall Study|Physician Decision|0|||
126198855|NCT00256204|454012565|FG001|Overall Study|Physician Decision|0|||
126198856|NCT00256204|454012566|FG002|Overall Study|Physician Decision|1|||
126198857|NCT00256204|454012567|FG003|Overall Study|Physician Decision|2|||
126198858|NCT00256204|454012564|FG000|Overall Study|Withdrawal by Subject|17|||
126198859|NCT00256204|454012565|FG001|Overall Study|Withdrawal by Subject|6|||
126198860|NCT00256204|454012566|FG002|Overall Study|Withdrawal by Subject|7|||
126198861|NCT00256204|454012567|FG003|Overall Study|Withdrawal by Subject|5|||
126198862|NCT00256204|454012564|FG000|Overall Study|Need for additional prohibited treatment|38|||
126198863|NCT00256204|454012565|FG001|Overall Study|Need for additional prohibited treatment|28|||
126198864|NCT00256204|454012566|FG002|Overall Study|Need for additional prohibited treatment|27|||
126198865|NCT00256204|454012567|FG003|Overall Study|Need for additional prohibited treatment|25|||
126198866|NCT00808132|454012571|FG000|Overall Study|Adverse Event|34|||
126198867|NCT00808132|454012572|FG001|Overall Study|Adverse Event|33|||
126198868|NCT00808132|454012573|FG002|Overall Study|Adverse Event|16|||
126198869|NCT00808132|454012574|FG003|Overall Study|Adverse Event|31|||
126198870|NCT00808132|454012575|FG004|Overall Study|Adverse Event|33|||
126198871|NCT00808132|454012571|FG000|Overall Study|Death|0|||
126198872|NCT00808132|454012572|FG001|Overall Study|Death|0|||
126198873|NCT00808132|454012573|FG002|Overall Study|Death|0|||
126198874|NCT00808132|454012574|FG003|Overall Study|Death|0|||
126198875|NCT00808132|454012575|FG004|Overall Study|Death|1|||
126198876|NCT00808132|454012571|FG000|Overall Study|Physician Decision|0|||
126198877|NCT00808132|454012572|FG001|Overall Study|Physician Decision|1|||
126198878|NCT00808132|454012573|FG002|Overall Study|Physician Decision|0|||
126198879|NCT00808132|454012574|FG003|Overall Study|Physician Decision|0|||
126198880|NCT00808132|454012575|FG004|Overall Study|Physician Decision|0|||
126198881|NCT00808132|454012571|FG000|Overall Study|Lost to Follow-up|8|||
126198882|NCT00808132|454012572|FG001|Overall Study|Lost to Follow-up|10|||
126198883|NCT00808132|454012573|FG002|Overall Study|Lost to Follow-up|11|||
126198884|NCT00808132|454012574|FG003|Overall Study|Lost to Follow-up|8|||
126198885|NCT00808132|454012575|FG004|Overall Study|Lost to Follow-up|9|||
126198886|NCT00808132|454012571|FG000|Overall Study|Protocol Violation|8|||
126198887|NCT00808132|454012572|FG001|Overall Study|Protocol Violation|9|||
126198888|NCT00808132|454012573|FG002|Overall Study|Protocol Violation|4|||
126198889|NCT00808132|454012574|FG003|Overall Study|Protocol Violation|9|||
126198890|NCT00808132|454012575|FG004|Overall Study|Protocol Violation|5|||
126198891|NCT00808132|454012571|FG000|Overall Study|Withdrawal by Subject|27|||
126198892|NCT00808132|454012572|FG001|Overall Study|Withdrawal by Subject|18|||
126198893|NCT00808132|454012573|FG002|Overall Study|Withdrawal by Subject|2|||
126198894|NCT00808132|454012574|FG003|Overall Study|Withdrawal by Subject|7|||
126198895|NCT00808132|454012575|FG004|Overall Study|Withdrawal by Subject|16|||
126198896|NCT00808132|454012571|FG000|Overall Study|Other|6|||
126198897|NCT00808132|454012572|FG001|Overall Study|Other|4|||
126198898|NCT00808132|454012573|FG002|Overall Study|Other|6|||
126198899|NCT00808132|454012574|FG003|Overall Study|Other|2|||
126198900|NCT00808132|454012575|FG004|Overall Study|Other|15|||
126198901|NCT00808132|454012571|FG000|Overall Study|Randomized, but not treated|10|||
126198902|NCT00808132|454012572|FG001|Overall Study|Randomized, but not treated|7|||
126198903|NCT00808132|454012573|FG002|Overall Study|Randomized, but not treated|9|||
126198904|NCT00808132|454012574|FG003|Overall Study|Randomized, but not treated|8|||
126198905|NCT00808132|454012575|FG004|Overall Study|Randomized, but not treated|9|||
126198906|NCT00808132|454012571|FG000|Overall Study|Unsatisfactory response|5|||
126198907|NCT00808132|454012572|FG001|Overall Study|Unsatisfactory response|6|||
126198908|NCT00808132|454012573|FG002|Overall Study|Unsatisfactory response|6|||
126198909|NCT00808132|454012574|FG003|Overall Study|Unsatisfactory response|4|||
126198910|NCT00808132|454012575|FG004|Overall Study|Unsatisfactory response|12|||
126198911|NCT00550615|454012576|FG000|Overall Study|Withdrawal by Subject|0|||
126198912|NCT00550615|454012577|FG001|Overall Study|Withdrawal by Subject|0|||
126198913|NCT00550615|454012578|FG002|Overall Study|Withdrawal by Subject|2|||
126198914|NCT00550615|454012579|FG003|Overall Study|Withdrawal by Subject|3|||
126198915|NCT00550615|454012576|FG000|Overall Study|Not evaluable|0|||
126198916|NCT00550615|454012577|FG001|Overall Study|Not evaluable|0|||
126198917|NCT00550615|454012578|FG002|Overall Study|Not evaluable|2|||
126198918|NCT00550615|454012579|FG003|Overall Study|Not evaluable|7|||
126198919|NCT02405091|454012582|FG000|Overall Study|Adverse Event|16|||
126198920|NCT02405091|454012583|FG001|Overall Study|Adverse Event|10|||
126198921|NCT02405091|454012584|FG002|Overall Study|Adverse Event|0|||
126198922|NCT02405091|454012582|FG000|Overall Study|Protocol Violation|1|||
126198923|NCT02405091|454012583|FG001|Overall Study|Protocol Violation|0|||
126198924|NCT02405091|454012584|FG002|Overall Study|Protocol Violation|0|||
126198925|NCT02405091|454012582|FG000|Overall Study|Noncompliance|1|||
126198926|NCT02405091|454012583|FG001|Overall Study|Noncompliance|6|||
126198927|NCT02405091|454012584|FG002|Overall Study|Noncompliance|2|||
126198928|NCT02405091|454012582|FG000|Overall Study|Withdrawal by Subject|4|||
126198929|NCT02405091|454012583|FG001|Overall Study|Withdrawal by Subject|8|||
126198930|NCT02405091|454012584|FG002|Overall Study|Withdrawal by Subject|0|||
126198931|NCT02405091|454012582|FG000|Overall Study|Death|0|||
126198932|NCT02405091|454012583|FG001|Overall Study|Death|1|||
126198933|NCT02405091|454012584|FG002|Overall Study|Death|0|||
126198934|NCT02405091|454012582|FG000|Overall Study|Lost to Follow-up|5|||
126198935|NCT02405091|454012583|FG001|Overall Study|Lost to Follow-up|6|||
126198936|NCT02405091|454012584|FG002|Overall Study|Lost to Follow-up|0|||
126198937|NCT02405091|454012582|FG000|Overall Study|Physician Decision|2|||
126198938|NCT02405091|454012583|FG001|Overall Study|Physician Decision|2|||
126198939|NCT02405091|454012584|FG002|Overall Study|Physician Decision|0|||
126198940|NCT01948791|454012591|FG000|Overall Study|Adverse Event|12|||
126198941|NCT01948791|454012591|FG000|Overall Study|Lack of Efficacy|3|||
126198942|NCT01948791|454012591|FG000|Overall Study|Protocol Violation|2|||
126198943|NCT01948791|454012591|FG000|Overall Study|Withdrawal by Subject|5|||
126198944|NCT01948791|454012591|FG000|Overall Study|Lost to Follow-up|6|||
126198945|NCT01948791|454012591|FG000|Overall Study|Management issues|1|||
126198946|NCT01948791|454012591|FG000|Overall Study|Others|7|||
126198947|NCT01948791|454012591|FG000|Overall Study|Screening failure|35|||
126198948|NCT03481634|454012594|FG000|Overall Study|Withdrawal by Subject|16|||
126198949|NCT03481634|454012595|FG001|Overall Study|Withdrawal by Subject|19|||
126198950|NCT03481634|454012596|FG002|Overall Study|Withdrawal by Subject|14|||
126198951|NCT03481634|454012594|FG000|Overall Study|Protocol Violation|1|||
126198952|NCT03481634|454012595|FG001|Overall Study|Protocol Violation|0|||
126198953|NCT03481634|454012596|FG002|Overall Study|Protocol Violation|1|||
126198954|NCT03481634|454012594|FG000|Overall Study|Progressive disease|0|||
126198955|NCT03481634|454012595|FG001|Overall Study|Progressive disease|1|||
126198956|NCT03481634|454012596|FG002|Overall Study|Progressive disease|0|||
126198957|NCT03481634|454012594|FG000|Overall Study|Physician Decision|3|||
126198958|NCT03481634|454012595|FG001|Overall Study|Physician Decision|0|||
126198959|NCT03481634|454012596|FG002|Overall Study|Physician Decision|1|||
126198960|NCT03481634|454012594|FG000|Overall Study|Lost to Follow-up|3|||
126198961|NCT03481634|454012595|FG001|Overall Study|Lost to Follow-up|4|||
126198962|NCT03481634|454012596|FG002|Overall Study|Lost to Follow-up|4|||
126198963|NCT03481634|454012594|FG000|Overall Study|Death|4|||
126198964|NCT03481634|454012595|FG001|Overall Study|Death|8|||
126198965|NCT03481634|454012596|FG002|Overall Study|Death|7|||
126198966|NCT03481634|454012594|FG000|Overall Study|Adverse Event|6|||
126198967|NCT03481634|454012595|FG001|Overall Study|Adverse Event|3|||
126198968|NCT03481634|454012596|FG002|Overall Study|Adverse Event|7|||
126198969|NCT00994890|454012600|FG000|Overall Study|Adverse Event|13|||
126198970|NCT00994890|454012601|FG001|Overall Study|Adverse Event|9|||
126198971|NCT00994890|454012602|FG002|Overall Study|Adverse Event|11|||
126198972|NCT00994890|454012600|FG000|Overall Study|Lack of Efficacy|0|||
126198973|NCT00994890|454012601|FG001|Overall Study|Lack of Efficacy|0|||
126198974|NCT00994890|454012602|FG002|Overall Study|Lack of Efficacy|1|||
126198975|NCT00994890|454012600|FG000|Overall Study|Lost to Follow-up|6|||
126198976|NCT00994890|454012601|FG001|Overall Study|Lost to Follow-up|1|||
126198977|NCT00994890|454012602|FG002|Overall Study|Lost to Follow-up|3|||
126198978|NCT00994890|454012600|FG000|Overall Study|No longer willing to participate|8|||
126198979|NCT00994890|454012601|FG001|Overall Study|No longer willing to participate|5|||
126198980|NCT00994890|454012602|FG002|Overall Study|No longer willing to participate|13|||
126198981|NCT00994890|454012600|FG000|Overall Study|Protocol Violation|2|||
126198982|NCT00994890|454012601|FG001|Overall Study|Protocol Violation|4|||
126198983|NCT00994890|454012602|FG002|Overall Study|Protocol Violation|0|||
126198984|NCT00994890|454012600|FG000|Overall Study|Study terminated by sponsor|199|||
126198985|NCT00994890|454012601|FG001|Overall Study|Study terminated by sponsor|201|||
126198986|NCT00994890|454012602|FG002|Overall Study|Study terminated by sponsor|197|||
126198987|NCT00994890|454012600|FG000|Overall Study|Randomized, but not treated|1|||
126198988|NCT00994890|454012601|FG001|Overall Study|Randomized, but not treated|0|||
126198989|NCT00994890|454012602|FG002|Overall Study|Randomized, but not treated|0|||
126198990|NCT00994890|454012600|FG000|Overall Study|Other|2|||
126198991|NCT00994890|454012601|FG001|Overall Study|Other|2|||
126198992|NCT00994890|454012602|FG002|Overall Study|Other|1|||
126198993|NCT01955005|454012609|FG000|Overall Study|Withdrawal by Subject|3|||
126198994|NCT01955005|454012610|FG001|Overall Study|Withdrawal by Subject|5|||
126198995|NCT02555722|454012615|FG000|Week 2|Adverse Event|0|||
126198996|NCT02555722|454012616|FG001|Week 2|Adverse Event|1|||
126198997|NCT02555722|454012615|FG000|Week 2|Withdrawal by Subject|1|||
126198998|NCT02555722|454012616|FG001|Week 2|Withdrawal by Subject|0|||
126198999|NCT02555722|454012615|FG000|Month 1|Lens Discomfort|1|||
126199000|NCT02555722|454012616|FG001|Month 1|Lens Discomfort|0|||
126199001|NCT02555722|454012615|FG000|Month 2|Withdrawal by Subject|3|||
126199002|NCT02555722|454012616|FG001|Month 2|Withdrawal by Subject|0|||
126199003|NCT02555722|454012615|FG000|Month 2|Lost to Follow-up|1|||
126199004|NCT02555722|454012616|FG001|Month 2|Lost to Follow-up|0|||
126199005|NCT00352027|454012617|FG000|Overall Study|Progressive disease|3|||
126199006|NCT00702949|454012618|FG000|Overall Study|Refusal|3|||
126199007|NCT00702949|454012619|FG001|Overall Study|Refusal|2|||
126199008|NCT00702949|454012620|FG002|Overall Study|Refusal|2|||
126199009|NCT00702949|454012618|FG000|Overall Study|Adverse Event|1|||
126199010|NCT00702949|454012619|FG001|Overall Study|Adverse Event|6|||
126199011|NCT00702949|454012620|FG002|Overall Study|Adverse Event|3|||
126199012|NCT00702949|454012618|FG000|Overall Study|Other Medical Reason/unknown|1|||
126199013|NCT00702949|454012619|FG001|Overall Study|Other Medical Reason/unknown|1|||
126199014|NCT00702949|454012620|FG002|Overall Study|Other Medical Reason/unknown|3|||
126199015|NCT01469637|454012621|FG000|First Intervention|Unacceptable behavior|0|||
126199016|NCT01469637|454012622|FG001|First Intervention|Unacceptable behavior|1|||
126199017|NCT01469637|454012621|FG000|Second Intervention|Incarcerated|1|||
126199018|NCT01469637|454012622|FG001|Second Intervention|Incarcerated|0|||
126199019|NCT00598585|454012623|FG000|Overall Study|Lost to Follow-up|1|||
126199020|NCT00598585|454012624|FG001|Overall Study|Lost to Follow-up|0|||
126199021|NCT04491591|454012626|FG000|Overall Study|Accidently randomized|3|||
126199022|NCT04491591|454012627|FG001|Overall Study|Accidently randomized|1|||
126199023|NCT04491591|454012628|FG002|Overall Study|Accidently randomized|0|||
126199024|NCT04491591|454012626|FG000|Overall Study|Did not complete survey|28|||
126199025|NCT04491591|454012627|FG001|Overall Study|Did not complete survey|20|||
126199026|NCT04491591|454012628|FG002|Overall Study|Did not complete survey|3|||
126199027|NCT00135694|454012629|FG000|Overall Study|Adverse Event|17|||
126199028|NCT00135694|454012630|FG001|Overall Study|Adverse Event|4|||
126199029|NCT00135694|454012631|FG002|Overall Study|Adverse Event|0|||
126199030|NCT00135694|454012629|FG000|Overall Study|Death|14|||
126199031|NCT00135694|454012630|FG001|Overall Study|Death|1|||
126199032|NCT00135694|454012631|FG002|Overall Study|Death|2|||
126199033|NCT00135694|454012629|FG000|Overall Study|Lost to Follow-up|8|||
126199034|NCT00135694|454012630|FG001|Overall Study|Lost to Follow-up|7|||
126199035|NCT00135694|454012631|FG002|Overall Study|Lost to Follow-up|1|||
126199036|NCT00135694|454012629|FG000|Overall Study|Withdrawal by Subject|41|||
126199037|NCT00135694|454012630|FG001|Overall Study|Withdrawal by Subject|7|||
126199038|NCT00135694|454012631|FG002|Overall Study|Withdrawal by Subject|4|||
126199039|NCT00135694|454012629|FG000|Overall Study|Protocol Violation|19|||
126199040|NCT00135694|454012630|FG001|Overall Study|Protocol Violation|1|||
126199041|NCT00135694|454012631|FG002|Overall Study|Protocol Violation|0|||
126199042|NCT00135694|454012629|FG000|Overall Study|Hepatitis C related reasons|39|||
126199043|NCT00135694|454012630|FG001|Overall Study|Hepatitis C related reasons|1|||
126199044|NCT00135694|454012631|FG002|Overall Study|Hepatitis C related reasons|0|||
126199045|NCT00135694|454012629|FG000|Overall Study|Ineligible for Random assignment|42|||
126199046|NCT00135694|454012630|FG001|Overall Study|Ineligible for Random assignment|0|||
126199047|NCT00135694|454012631|FG002|Overall Study|Ineligible for Random assignment|0|||
126199048|NCT00472043|454012633|FG000|Overall Study|Withdrawal by Subject|1|||
126199049|NCT00472043|454012634|FG001|Overall Study|Withdrawal by Subject|0|||
126199050|NCT00472043|454012633|FG000|Overall Study|Death|1|||
126199051|NCT00472043|454012634|FG001|Overall Study|Death|0|||
126199052|NCT02802735|454012635|FG000|Overall Study|Withdrawal by Subject|0|||
126199053|NCT02802735|454012636|FG001|Overall Study|Withdrawal by Subject|1|||
126199054|NCT02802735|454012637|FG002|Overall Study|Withdrawal by Subject|0|||
126199055|NCT02802735|454012638|FG003|Overall Study|Withdrawal by Subject|0|||
126199056|NCT02802735|454012639|FG004|Overall Study|Withdrawal by Subject|0|||
126199057|NCT03922711|454012640|FG000|Overall Study|Adverse Event|3|||
126199058|NCT03922711|454012641|FG001|Overall Study|Adverse Event|2|||
126199059|NCT03922711|454012642|FG002|Overall Study|Adverse Event|2|||
126199060|NCT03922711|454012640|FG000|Overall Study|Protocol Violation|1|||
126199061|NCT03922711|454012641|FG001|Overall Study|Protocol Violation|0|||
126199062|NCT03922711|454012642|FG002|Overall Study|Protocol Violation|0|||
126199063|NCT03922711|454012640|FG000|Overall Study|Withdrawal by Subject|0|||
126199064|NCT03922711|454012641|FG001|Overall Study|Withdrawal by Subject|3|||
126199065|NCT03922711|454012642|FG002|Overall Study|Withdrawal by Subject|1|||
126199066|NCT03922711|454012640|FG000|Overall Study|Not further specified|0|||
126199067|NCT03922711|454012641|FG001|Overall Study|Not further specified|0|||
126199068|NCT03922711|454012642|FG002|Overall Study|Not further specified|1|||
126199069|NCT03147495|454012645|FG000|Overall Study|Physician Decision|0|||
126199070|NCT03147495|454012646|FG001|Overall Study|Physician Decision|6|||
126199071|NCT00877890|454012651|FG000|Overall Study|Adverse Event|6|||
126199072|NCT00877890|454012652|FG001|Overall Study|Adverse Event|6|||
126199073|NCT00877890|454012651|FG000|Overall Study|Lost to Follow-up|5|||
126199074|NCT00877890|454012652|FG001|Overall Study|Lost to Follow-up|5|||
126199075|NCT00877890|454012651|FG000|Overall Study|Protocol Violation|0|||
126199076|NCT00877890|454012652|FG001|Overall Study|Protocol Violation|1|||
126199077|NCT00877890|454012651|FG000|Overall Study|Withdrawal of Consent|6|||
126199078|NCT00877890|454012652|FG001|Overall Study|Withdrawal of Consent|12|||
126199079|NCT00877890|454012651|FG000|Overall Study|Investigator Decision|0|||
126199080|NCT00877890|454012652|FG001|Overall Study|Investigator Decision|2|||
126199081|NCT00877890|454012651|FG000|Overall Study|Loss of Glucose Control|3|||
126199082|NCT00877890|454012652|FG001|Overall Study|Loss of Glucose Control|4|||
126199083|NCT02975206|454012654|FG000|Overall Study|Withdrawal by Subject|14|||
126199084|NCT02975206|454012655|FG001|Overall Study|Withdrawal by Subject|11|||
126199085|NCT02975206|454012656|FG002|Overall Study|Withdrawal by Subject|11|||
126199086|NCT02975206|454012654|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
126199087|NCT02975206|454012655|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
126199088|NCT02975206|454012656|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
126199089|NCT00866606|454012657|FG000|Overall Study|Lost to Follow-up|3|||
126199090|NCT00866606|454012657|FG000|Overall Study|Adverse Event|1|||
126199091|NCT01058356|454012670|FG000|Overall Study|Adverse Event|5|||
126199092|NCT01058356|454012670|FG000|Overall Study|Administration of contraindicated drugs|12|||
126199093|NCT01058356|454012670|FG000|Overall Study|Withdrawal by Subject|21|||
126199094|NCT01058356|454012670|FG000|Overall Study|Lost to Follow-up|4|||
126199095|NCT00606021|454012673|FG000|Induction Phase|Death|73|||
126199096|NCT00606021|454012674|FG001|Induction Phase|Death|0|||
126199097|NCT00606021|454012675|FG002|Induction Phase|Death|0|||
126199098|NCT00606021|454012673|FG000|Induction Phase|Physician Decision|2|||
126199099|NCT00606021|454012674|FG001|Induction Phase|Physician Decision|0|||
126199100|NCT00606021|454012675|FG002|Induction Phase|Physician Decision|0|||
126199101|NCT00606021|454012673|FG000|Induction Phase|Withdrawal by Subject|2|||
126199102|NCT00606021|454012674|FG001|Induction Phase|Withdrawal by Subject|0|||
126199103|NCT00606021|454012675|FG002|Induction Phase|Withdrawal by Subject|0|||
126199104|NCT00606021|454012673|FG000|Induction Phase|Lost to Follow-up|10|||
126199105|NCT00606021|454012674|FG001|Induction Phase|Lost to Follow-up|0|||
126199106|NCT00606021|454012675|FG002|Induction Phase|Lost to Follow-up|0|||
126199107|NCT00606021|454012673|FG000|Maintenance Phase|Death|0|||
126199108|NCT00606021|454012674|FG001|Maintenance Phase|Death|17|||
126199109|NCT00606021|454012675|FG002|Maintenance Phase|Death|15|||
126199110|NCT00606021|454012673|FG000|Maintenance Phase|Physician Decision|0|||
126199111|NCT00606021|454012674|FG001|Maintenance Phase|Physician Decision|1|||
126199112|NCT00606021|454012675|FG002|Maintenance Phase|Physician Decision|0|||
126199113|NCT00606021|454012673|FG000|Maintenance Phase|Lost to Follow-up|0|||
126199114|NCT00606021|454012674|FG001|Maintenance Phase|Lost to Follow-up|5|||
126199115|NCT00606021|454012675|FG002|Maintenance Phase|Lost to Follow-up|2|||
126199116|NCT02363322|454012683|FG000|Overall Study|Lost to Follow-up|1|||
126199117|NCT02363322|454012684|FG001|Overall Study|Lost to Follow-up|0|||
126199118|NCT01230827|454012685|FG000|Overall Study|Lost to Follow-up|0|||
126199119|NCT01230827|454012686|FG001|Overall Study|Lost to Follow-up|0|||
126199120|NCT01230827|454012687|FG002|Overall Study|Lost to Follow-up|1|||
126199121|NCT01230827|454012688|FG003|Overall Study|Lost to Follow-up|3|||
126199122|NCT01230827|454012685|FG000|Overall Study|Withdrawal by Subject|1|||
126199123|NCT01230827|454012686|FG001|Overall Study|Withdrawal by Subject|0|||
126199124|NCT01230827|454012687|FG002|Overall Study|Withdrawal by Subject|3|||
126199125|NCT01230827|454012688|FG003|Overall Study|Withdrawal by Subject|2|||
126199126|NCT01230827|454012685|FG000|Overall Study|Lack of Efficacy|14|||
126199127|NCT01230827|454012686|FG001|Overall Study|Lack of Efficacy|1|||
126199128|NCT01230827|454012687|FG002|Overall Study|Lack of Efficacy|2|||
126199129|NCT01230827|454012688|FG003|Overall Study|Lack of Efficacy|3|||
126199130|NCT01230827|454012685|FG000|Overall Study|Adverse Event|4|||
126199131|NCT01230827|454012686|FG001|Overall Study|Adverse Event|2|||
126199132|NCT01230827|454012687|FG002|Overall Study|Adverse Event|3|||
126199133|NCT01230827|454012688|FG003|Overall Study|Adverse Event|7|||
126199134|NCT01230827|454012685|FG000|Overall Study|Recovery|0|||
126199135|NCT01230827|454012686|FG001|Overall Study|Recovery|6|||
126199136|NCT01230827|454012687|FG002|Overall Study|Recovery|0|||
126199137|NCT01230827|454012688|FG003|Overall Study|Recovery|0|||
126199138|NCT01230827|454012685|FG000|Overall Study|Study terminated by Sponsor|0|||
126199139|NCT01230827|454012686|FG001|Overall Study|Study terminated by Sponsor|2|||
126199140|NCT01230827|454012687|FG002|Overall Study|Study terminated by Sponsor|56|||
126199141|NCT01230827|454012688|FG003|Overall Study|Study terminated by Sponsor|63|||
126199142|NCT00805142|454012689|FG000|Titration Period|Adverse Event|3|||
126199143|NCT00805142|454012690|FG001|Titration Period|Adverse Event|3|||
126199144|NCT00805142|454012689|FG000|Titration Period|Lack of Efficacy|1|||
126199145|NCT00805142|454012690|FG001|Titration Period|Lack of Efficacy|1|||
126199146|NCT00805142|454012689|FG000|Titration Period|Lost to Follow-up|0|||
126199147|NCT00805142|454012690|FG001|Titration Period|Lost to Follow-up|1|||
126199148|NCT00805142|454012689|FG000|Titration Period|Disease Progression|2|||
126199149|NCT00805142|454012690|FG001|Titration Period|Disease Progression|1|||
126199150|NCT00805142|454012689|FG000|Titration Period|Withdrawal of consent|0|||
126199151|NCT00805142|454012690|FG001|Titration Period|Withdrawal of consent|1|||
126199152|NCT00805142|454012689|FG000|Titration Period|Other|0|||
126199153|NCT00805142|454012690|FG001|Titration Period|Other|3|||
126199154|NCT00805142|454012689|FG000|Maintenance Period|Adverse Event|0|||
126199155|NCT00805142|454012690|FG001|Maintenance Period|Adverse Event|1|||
126199156|NCT00805142|454012689|FG000|Maintenance Period|Other|0|||
126199157|NCT00805142|454012690|FG001|Maintenance Period|Other|1|||
126199158|NCT01021423|454012692|FG000|Overall Study|Study terminated|4|||
126199159|NCT01021423|454012693|FG001|Overall Study|Study terminated|5|||
126199160|NCT01021293|454012697|FG000|Overall Study|Serious Adverse Event|2|||
126199161|NCT01021293|454012698|FG001|Overall Study|Serious Adverse Event|1|||
126199162|NCT01021293|454012697|FG000|Overall Study|Adverse Event|2|||
126199163|NCT01021293|454012698|FG001|Overall Study|Adverse Event|1|||
126199164|NCT01021293|454012697|FG000|Overall Study|Withdrawal by Subject|1|||
126199165|NCT01021293|454012698|FG001|Overall Study|Withdrawal by Subject|3|||
126199166|NCT01021293|454012697|FG000|Overall Study|Migrated/moved from study area|6|||
126199167|NCT01021293|454012698|FG001|Overall Study|Migrated/moved from study area|18|||
126199168|NCT01021293|454012697|FG000|Overall Study|Lost to Follow-up|1|||
126199169|NCT01021293|454012698|FG001|Overall Study|Lost to Follow-up|1|||
126199170|NCT01084096|454015078|FG000|Overall Study|Lost to Follow-up|1501|||
126199171|NCT01084096|454015079|FG001|Overall Study|Lost to Follow-up|1833|||
126199172|NCT01084096|454015078|FG000|Overall Study|Withdrawal by Subject|3|||
126199173|NCT01084096|454015079|FG001|Overall Study|Withdrawal by Subject|0|||
126199174|NCT01084096|454015078|FG000|Overall Study|Woman had a miscarriage|21|||
126199175|NCT01084096|454015079|FG001|Overall Study|Woman had a miscarriage|17|||
126199176|NCT00027846|454015080|FG000|Overall Study|Lost to Follow-up|0|||
126199177|NCT00027846|454015081|FG001|Overall Study|Lost to Follow-up|41|||
126199178|NCT00027846|454015082|FG002|Overall Study|Lost to Follow-up|9|||
126199179|NCT00027846|454015080|FG000|Overall Study|Withdrawal by Subject|0|||
126199180|NCT00027846|454015081|FG001|Overall Study|Withdrawal by Subject|14|||
126199181|NCT00027846|454015082|FG002|Overall Study|Withdrawal by Subject|7|||
126199182|NCT00027846|454015080|FG000|Overall Study|Ineligible for study|2|||
126199183|NCT00027846|454015081|FG001|Overall Study|Ineligible for study|6|||
126199184|NCT00027846|454015082|FG002|Overall Study|Ineligible for study|14|||
126199185|NCT00027846|454015080|FG000|Overall Study|Entry into another COG therapeutic study|0|||
126199186|NCT00027846|454015081|FG001|Overall Study|Entry into another COG therapeutic study|5|||
126199187|NCT00027846|454015082|FG002|Overall Study|Entry into another COG therapeutic study|2|||
126199188|NCT00027846|454015080|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
126199189|NCT00027846|454015081|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
126199190|NCT00027846|454015082|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
126199191|NCT01354964|454015083|FG000|Overall Study|Lost to Follow-up|2|||
126199192|NCT01354964|454015084|FG001|Overall Study|Lost to Follow-up|0|||
126199193|NCT01354964|454015083|FG000|Overall Study|IV access issues|1|||
126199194|NCT01354964|454015084|FG001|Overall Study|IV access issues|1|||
126199195|NCT01354964|454015083|FG000|Overall Study|Physician Decision|1|||
126199196|NCT01354964|454015084|FG001|Overall Study|Physician Decision|0|||
126199197|NCT05604781|454015089|FG000|Overall Study|Lost to Follow-up|3|||
126199198|NCT05604781|454015089|FG000|Overall Study|Adverse Event|1|||
126199199|NCT02889861|454015100|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
126199200|NCT01864746|454015101|FG000|Overall Study|Disease recurrence|25|||
126199201|NCT01864746|454015102|FG001|Overall Study|Disease recurrence|40|||
126199202|NCT01864746|454015101|FG000|Overall Study|Second primary invasive nonbreast|2|||
126199203|NCT01864746|454015102|FG001|Overall Study|Second primary invasive nonbreast|3|||
126199204|NCT01864746|454015101|FG000|Overall Study|Death|2|||
126199205|NCT01864746|454015102|FG001|Overall Study|Death|1|||
126199206|NCT01864746|454015101|FG000|Overall Study|Adverse Event|33|||
126199207|NCT01864746|454015102|FG001|Overall Study|Adverse Event|5|||
126199208|NCT01864746|454015101|FG000|Overall Study|Withdrawal by Subject|56|||
126199209|NCT01864746|454015102|FG001|Overall Study|Withdrawal by Subject|41|||
126199210|NCT01864746|454015101|FG000|Overall Study|Physician Decision|5|||
126199211|NCT01864746|454015102|FG001|Overall Study|Physician Decision|6|||
126199212|NCT01005966|454015103|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
126199213|NCT01005966|454015104|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
126199214|NCT01005966|454015105|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
126199215|NCT01005966|454015106|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
126199216|NCT01005966|454015107|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
126199217|NCT01005966|454015103|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
126199218|NCT01005966|454015104|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
126199219|NCT01005966|454015105|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
126199220|NCT01005966|454015106|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
126199221|NCT01005966|454015107|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
126199222|NCT01005966|454015103|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
126199223|NCT01005966|454015104|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
126199224|NCT01005966|454015105|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
126199225|NCT01005966|454015106|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
126199226|NCT01005966|454015107|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
126199227|NCT01005966|454015103|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
126199228|NCT01005966|454015104|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
126199229|NCT01005966|454015105|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
126199230|NCT01005966|454015106|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
126199231|NCT01005966|454015107|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
126199232|NCT01005966|454015103|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126199233|NCT01005966|454015104|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126199234|NCT01005966|454015105|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126199235|NCT01005966|454015106|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126199236|NCT01005966|454015107|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126199237|NCT01005966|454015103|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126199238|NCT01005966|454015104|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126199239|NCT01005966|454015105|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
126199240|NCT01005966|454015106|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126199241|NCT01005966|454015107|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126199242|NCT01005966|454015103|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
126199243|NCT01005966|454015104|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
126199244|NCT01005966|454015105|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
126199245|NCT01005966|454015106|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
126199246|NCT01005966|454015107|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
126199247|NCT01005966|454015103|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
126199248|NCT01005966|454015104|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
126199249|NCT01005966|454015105|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
126199250|NCT01005966|454015106|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
126199251|NCT01005966|454015107|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
126199252|NCT01005966|454015103|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
126199253|NCT01005966|454015104|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
126199254|NCT01005966|454015105|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
126199255|NCT01005966|454015106|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
126199256|NCT01005966|454015107|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
126199257|NCT01451203|454015108|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
126199258|NCT01451203|454015109|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
126199259|NCT01451203|454015108|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
126199260|NCT01451203|454015109|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
126199261|NCT01451203|454015108|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
126199262|NCT01451203|454015109|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
126199263|NCT01451203|454015108|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
126199264|NCT01451203|454015109|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
126199265|NCT01451203|454015108|FG000|Double-blind Treatment Period|Adverse Event|6|||
126199266|NCT01451203|454015109|FG001|Double-blind Treatment Period|Adverse Event|9|||
126199267|NCT01451203|454015108|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
126199268|NCT01451203|454015109|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
126199269|NCT01451203|454015108|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
126199270|NCT01451203|454015109|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
126199271|NCT01451203|454015108|FG000|Double-blind Treatment Period|Investigator decision|2|||
126199272|NCT01451203|454015109|FG001|Double-blind Treatment Period|Investigator decision|0|||
126199273|NCT01451203|454015108|FG000|Post-treatment Period|Consent withdrawn|2|||
126199274|NCT01451203|454015109|FG001|Post-treatment Period|Consent withdrawn|4|||
126199275|NCT01451203|454015108|FG000|Post-treatment Period|Lack of Efficacy|12|||
126199276|NCT01451203|454015109|FG001|Post-treatment Period|Lack of Efficacy|28|||
126199277|NCT01451203|454015108|FG000|Post-treatment Period|Adverse Event|0|||
126199278|NCT01451203|454015109|FG001|Post-treatment Period|Adverse Event|1|||
126199279|NCT01451203|454015108|FG000|Post-treatment Period|Investigator decision|0|||
126199280|NCT01451203|454015109|FG001|Post-treatment Period|Investigator decision|1|||
126199281|NCT03890731|454015110|FG000|Overall Study|Progressive disease|1|||
126199282|NCT03890731|454015110|FG000|Overall Study|Patient's decision|1|||
126199283|NCT03890731|454015110|FG000|Overall Study|Adverse Event|4|||
126199284|NCT00027027|454015114|FG000|Overall Study|Adverse Event|0|||
126199285|NCT00027027|454015115|FG001|Overall Study|Adverse Event|0|||
126199286|NCT00027027|454015116|FG002|Overall Study|Adverse Event|1|||
126199287|NCT00027027|454015117|FG003|Overall Study|Adverse Event|0|||
126199288|NCT00027027|454015118|FG004|Overall Study|Adverse Event|1|||
126199289|NCT00027027|454015114|FG000|Overall Study|Admitted for Signs of PD|0|||
126199290|NCT00027027|454015115|FG001|Overall Study|Admitted for Signs of PD|0|||
126199291|NCT00027027|454015116|FG002|Overall Study|Admitted for Signs of PD|0|||
126199292|NCT00027027|454015117|FG003|Overall Study|Admitted for Signs of PD|0|||
126199293|NCT00027027|454015118|FG004|Overall Study|Admitted for Signs of PD|1|||
126199294|NCT00027027|454015114|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
126199295|NCT00027027|454015115|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
126199296|NCT00027027|454015116|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
126199297|NCT00027027|454015117|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
126199298|NCT00027027|454015118|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
126199299|NCT00027027|454015114|FG000|Overall Study|PD Requiring Surgery|0|||
126199300|NCT00027027|454015115|FG001|Overall Study|PD Requiring Surgery|0|||
126199301|NCT00027027|454015116|FG002|Overall Study|PD Requiring Surgery|1|||
126199302|NCT00027027|454015117|FG003|Overall Study|PD Requiring Surgery|0|||
126199303|NCT00027027|454015118|FG004|Overall Study|PD Requiring Surgery|0|||
126199304|NCT00027027|454015114|FG000|Overall Study|Physician Decision Due To PD|2|||
126199305|NCT00027027|454015115|FG001|Overall Study|Physician Decision Due To PD|3|||
126199306|NCT00027027|454015116|FG002|Overall Study|Physician Decision Due To PD|2|||
126199307|NCT00027027|454015117|FG003|Overall Study|Physician Decision Due To PD|3|||
126199308|NCT00027027|454015118|FG004|Overall Study|Physician Decision Due To PD|5|||
126199309|NCT00027027|454015114|FG000|Overall Study|Withdrawal by Subject|0|||
126199310|NCT00027027|454015115|FG001|Overall Study|Withdrawal by Subject|0|||
126199311|NCT00027027|454015116|FG002|Overall Study|Withdrawal by Subject|0|||
126199312|NCT00027027|454015117|FG003|Overall Study|Withdrawal by Subject|0|||
126199313|NCT00027027|454015118|FG004|Overall Study|Withdrawal by Subject|1|||
126199314|NCT02039687|454015124|FG000|Overall Study|Adverse Event|0|||
126199315|NCT02039687|454015125|FG001|Overall Study|Adverse Event|0|||
126199316|NCT02039687|454015126|FG002|Overall Study|Adverse Event|1|||
126199317|NCT02039687|454015127|FG003|Overall Study|Adverse Event|0|||
126199318|NCT02039687|454015124|FG000|Overall Study|Withdrawal by Subject|0|||
126199319|NCT02039687|454015125|FG001|Overall Study|Withdrawal by Subject|1|||
126199320|NCT02039687|454015126|FG002|Overall Study|Withdrawal by Subject|0|||
126199321|NCT02039687|454015127|FG003|Overall Study|Withdrawal by Subject|0|||
126199322|NCT02039687|454015124|FG000|Overall Study|treatment assignment could not be confir|0|||
126199323|NCT02039687|454015125|FG001|Overall Study|treatment assignment could not be confir|0|||
126199324|NCT02039687|454015126|FG002|Overall Study|treatment assignment could not be confir|2|||
126199325|NCT02039687|454015127|FG003|Overall Study|treatment assignment could not be confir|0|||
126199326|NCT00303329|454015137|FG000|Overall Study|Adverse Event|7|||
126199327|NCT00303329|454015138|FG001|Overall Study|Adverse Event|14|||
126199328|NCT00303329|454015137|FG000|Overall Study|Abnormal Laboratory Values|0|||
126199329|NCT00303329|454015138|FG001|Overall Study|Abnormal Laboratory Values|1|||
126199330|NCT00303329|454015137|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
126199331|NCT00303329|454015138|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126199332|NCT00303329|454015137|FG000|Overall Study|Condition no longer requires study drug|0|||
126199333|NCT00303329|454015138|FG001|Overall Study|Condition no longer requires study drug|8|||
126199334|NCT00303329|454015137|FG000|Overall Study|Protocol Violation|3|||
126199335|NCT00303329|454015138|FG001|Overall Study|Protocol Violation|0|||
126199336|NCT00303329|454015137|FG000|Overall Study|Withdrawal by Subject|9|||
126199337|NCT00303329|454015138|FG001|Overall Study|Withdrawal by Subject|15|||
126199338|NCT00303329|454015137|FG000|Overall Study|Lost to Follow-up|0|||
126199339|NCT00303329|454015138|FG001|Overall Study|Lost to Follow-up|1|||
126199340|NCT00303329|454015137|FG000|Overall Study|Administrative problems|1|||
126199341|NCT00303329|454015138|FG001|Overall Study|Administrative problems|0|||
126199342|NCT00303329|454015137|FG000|Overall Study|Death|2|||
126199343|NCT00303329|454015138|FG001|Overall Study|Death|12|||
126199344|NCT00303329|454015137|FG000|Overall Study|Stopped at end of core|3|||
126199345|NCT00303329|454015138|FG001|Overall Study|Stopped at end of core|9|||
126199346|NCT00303329|454015137|FG000|Overall Study|Stopped at end of extension 1|1|||
126199347|NCT00303329|454015138|FG001|Overall Study|Stopped at end of extension 1|0|||
126199348|NCT02408016|454015141|FG000|Overall Study|Death|6|||
126199349|NCT02408016|454015142|FG001|Overall Study|Death|1|||
126199350|NCT02408016|454015143|FG002|Overall Study|Death|0|||
126199351|NCT02408016|454015141|FG000|Overall Study|Physician Decision|0|||
126199352|NCT02408016|454015142|FG001|Overall Study|Physician Decision|2|||
126199353|NCT02408016|454015143|FG002|Overall Study|Physician Decision|0|||
126199354|NCT02967562|454015145|FG000|Overall Study|Consent not obtained|1|||
126199355|NCT02967562|454015146|FG001|Overall Study|Consent not obtained|0|||
126199356|NCT02967562|454015145|FG000|Overall Study|High leak precluding analysis|1|||
126199357|NCT02967562|454015146|FG001|Overall Study|High leak precluding analysis|1|||
126199358|NCT00106626|454015147|FG000|Overall Study|Adverse Event|5|||
126199359|NCT00106626|454015148|FG001|Overall Study|Adverse Event|4|||
126199360|NCT00106626|454015149|FG002|Overall Study|Adverse Event|3|||
126199361|NCT00106626|454015150|FG003|Overall Study|Adverse Event|3|||
126199362|NCT00106626|454015147|FG000|Overall Study|Progressive Disease|4|||
126199363|NCT00106626|454015148|FG001|Overall Study|Progressive Disease|1|||
126199364|NCT00106626|454015149|FG002|Overall Study|Progressive Disease|9|||
126199365|NCT00106626|454015150|FG003|Overall Study|Progressive Disease|10|||
126199366|NCT00106626|454015147|FG000|Overall Study|Received radiation on new therapy|1|||
126199367|NCT00106626|454015148|FG001|Overall Study|Received radiation on new therapy|0|||
126199368|NCT00106626|454015149|FG002|Overall Study|Received radiation on new therapy|0|||
126199369|NCT00106626|454015150|FG003|Overall Study|Received radiation on new therapy|0|||
126199370|NCT00106626|454015147|FG000|Overall Study|> 14 day delay in therapy start|0|||
126199371|NCT00106626|454015148|FG001|Overall Study|> 14 day delay in therapy start|1|||
126199372|NCT00106626|454015149|FG002|Overall Study|> 14 day delay in therapy start|0|||
126199373|NCT00106626|454015150|FG003|Overall Study|> 14 day delay in therapy start|0|||
126199374|NCT01038635|454015158|FG000|Overall Study|Disease Progression|2|||
126199375|NCT01038635|454015159|FG001|Overall Study|Disease Progression|0|||
126199376|NCT01038635|454015160|FG002|Overall Study|Disease Progression|0|||
126199377|NCT01038635|454015161|FG003|Overall Study|Disease Progression|0|||
126199378|NCT01038635|454015162|FG004|Overall Study|Disease Progression|0|||
126199379|NCT01038635|454015163|FG005|Overall Study|Disease Progression|0|||
126199380|NCT01038635|454015164|FG006|Overall Study|Disease Progression|1|||
126199381|NCT01038635|454015165|FG007|Overall Study|Disease Progression|4|||
126199382|NCT01038635|454015166|FG008|Overall Study|Disease Progression|0|||
126199383|NCT01038635|454015158|FG000|Overall Study|Death|0|||
126199384|NCT01038635|454015159|FG001|Overall Study|Death|0|||
126199385|NCT01038635|454015160|FG002|Overall Study|Death|0|||
126199386|NCT01038635|454015161|FG003|Overall Study|Death|0|||
126199387|NCT01038635|454015162|FG004|Overall Study|Death|1|||
126199388|NCT01038635|454015163|FG005|Overall Study|Death|0|||
126199389|NCT01038635|454015164|FG006|Overall Study|Death|1|||
126199390|NCT01038635|454015165|FG007|Overall Study|Death|1|||
126199391|NCT01038635|454015166|FG008|Overall Study|Death|2|||
126199392|NCT01034709|454015167|FG000|Overall Study|Protocol Violation|9|||
126199393|NCT01034709|454015168|FG001|Overall Study|Protocol Violation|16|||
126199394|NCT01562327|454015171|FG000|Overall Study|Adverse Event|2|||
126199395|NCT01562327|454015171|FG000|Overall Study|Lack of Efficacy|1|||
126199396|NCT01562327|454015171|FG000|Overall Study|Participant drop-out|1|||
126199397|NCT01562327|454015171|FG000|Overall Study|Infusion not received at 6 month window|4|||
126199398|NCT03018340|454015172|FG000|Overall Study|Adverse Event|1|||
126199399|NCT03018340|454015173|FG001|Overall Study|Adverse Event|2|||
126199400|NCT03018340|454015172|FG000|Overall Study|Withdrawal by Subject|0|||
126199401|NCT03018340|454015173|FG001|Overall Study|Withdrawal by Subject|8|||
126199402|NCT03018340|454015172|FG000|Overall Study|Lack of Efficacy|0|||
126199403|NCT03018340|454015173|FG001|Overall Study|Lack of Efficacy|1|||
126199404|NCT03018340|454015172|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
126199405|NCT03018340|454015173|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
126199406|NCT03018340|454015172|FG000|Overall Study|Lost to Follow-up|1|||
126199407|NCT03018340|454015173|FG001|Overall Study|Lost to Follow-up|7|||
126199408|NCT03018340|454015172|FG000|Overall Study|Protocol Violation|3|||
126199409|NCT03018340|454015173|FG001|Overall Study|Protocol Violation|7|||
126199410|NCT03018340|454015172|FG000|Overall Study|Not further specified|0|||
126199411|NCT03018340|454015173|FG001|Overall Study|Not further specified|1|||
126199412|NCT01195636|454015178|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
126199413|NCT01195636|454015179|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
126199414|NCT01195636|454015178|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
126199415|NCT01195636|454015179|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
126199416|NCT01195636|454015178|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126199417|NCT01195636|454015179|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
126199418|NCT01195636|454015178|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
126199419|NCT01195636|454015179|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
126199420|NCT01195636|454015178|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
126199421|NCT01195636|454015179|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
126199422|NCT01195636|454015178|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
126199423|NCT01195636|454015179|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
126199424|NCT01195636|454015178|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
126199425|NCT01195636|454015179|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
126199426|NCT01195636|454015178|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126199427|NCT01195636|454015179|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
126199428|NCT00203294|454015180|FG000|Overall Study|Withdrawal by Subject|8|||
126199429|NCT00203294|454015181|FG001|Overall Study|Withdrawal by Subject|13|||
126199430|NCT00247962|454015182|FG000|Overall Study|Adverse Event|15|||
126199431|NCT00247962|454015183|FG001|Overall Study|Adverse Event|12|||
126199432|NCT00247962|454015182|FG000|Overall Study|Lost to Follow-up|3|||
126199433|NCT00247962|454015183|FG001|Overall Study|Lost to Follow-up|1|||
126199434|NCT00247962|454015182|FG000|Overall Study|Physician Decision|0|||
126199435|NCT00247962|454015183|FG001|Overall Study|Physician Decision|1|||
126199436|NCT00247962|454015182|FG000|Overall Study|Protocol Violation|1|||
126199437|NCT00247962|454015183|FG001|Overall Study|Protocol Violation|1|||
126199438|NCT00247962|454015182|FG000|Overall Study|Withdrawal by Subject|3|||
126199439|NCT00247962|454015183|FG001|Overall Study|Withdrawal by Subject|2|||
126199440|NCT00247962|454015182|FG000|Overall Study|Lack of Efficacy|4|||
126199441|NCT00247962|454015183|FG001|Overall Study|Lack of Efficacy|2|||
126199442|NCT02607735|454015184|FG000|Primary Study|Randomized but Never Treated|1|||
126199443|NCT02607735|454015185|FG001|Primary Study|Randomized but Never Treated|0|||
126199444|NCT02607735|454015186|FG002|Primary Study|Randomized but Never Treated|0|||
126199445|NCT02607735|454015184|FG000|Primary Study|Lost to Follow-up|4|||
126199446|NCT02607735|454015185|FG001|Primary Study|Lost to Follow-up|0|||
126199447|NCT02607735|454015186|FG002|Primary Study|Lost to Follow-up|0|||
126199448|NCT02607735|454015184|FG000|Primary Study|Withdrew Consent|2|||
126199449|NCT02607735|454015185|FG001|Primary Study|Withdrew Consent|0|||
126199450|NCT02607735|454015186|FG002|Primary Study|Withdrew Consent|0|||
126199451|NCT02607735|454015184|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
126199452|NCT02607735|454015185|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
126199453|NCT02607735|454015186|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
126199454|NCT02607735|454015184|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
126199455|NCT02607735|454015185|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
126199456|NCT02607735|454015186|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
126199457|NCT00742391|454015187|FG000|Overall Study|Adverse Event|2|||
126199458|NCT00742391|454015188|FG001|Overall Study|Adverse Event|1|||
126199459|NCT00742391|454015187|FG000|Overall Study|Lost to Follow-up|1|||
126199460|NCT00742391|454015188|FG001|Overall Study|Lost to Follow-up|0|||
126199461|NCT00742391|454015187|FG000|Overall Study|Protocol Violation|1|||
126199462|NCT00742391|454015188|FG001|Overall Study|Protocol Violation|0|||
126199463|NCT01981096|454015195|FG000|Overall Study|Parent illness|1|||
126199464|NCT01981096|454015196|FG001|Overall Study|Parent illness|0|||
126199465|NCT01981096|454015195|FG000|Overall Study|Withdrawal by Subject|0|||
126199466|NCT01981096|454015196|FG001|Overall Study|Withdrawal by Subject|1|||
126199467|NCT01981096|454015195|FG000|Overall Study|Lost to Follow-up|2|||
126199468|NCT01981096|454015196|FG001|Overall Study|Lost to Follow-up|0|||
126199469|NCT01225211|454015197|FG000|Overall Study|Adverse Event|0|||
126199470|NCT01225211|454015198|FG001|Overall Study|Adverse Event|0|||
126199471|NCT01225211|454015199|FG002|Overall Study|Adverse Event|1|||
126199472|NCT01225211|454015200|FG003|Overall Study|Adverse Event|0|||
126199473|NCT01225211|454015201|FG004|Overall Study|Adverse Event|0|||
126199474|NCT01225211|454015202|FG005|Overall Study|Adverse Event|0|||
126199475|NCT01225211|454015203|FG006|Overall Study|Adverse Event|0|||
126199476|NCT01225211|454015204|FG007|Overall Study|Adverse Event|0|||
126199477|NCT01225211|454015205|FG008|Overall Study|Adverse Event|0|||
126199478|NCT01225211|454015206|FG009|Overall Study|Adverse Event|1|||
126199479|NCT01225211|454015197|FG000|Overall Study|Withdrawal by Subject|0|||
126199480|NCT01225211|454015198|FG001|Overall Study|Withdrawal by Subject|0|||
126199481|NCT01225211|454015199|FG002|Overall Study|Withdrawal by Subject|0|||
126199482|NCT01225211|454015200|FG003|Overall Study|Withdrawal by Subject|0|||
126199483|NCT01225211|454015201|FG004|Overall Study|Withdrawal by Subject|0|||
126199484|NCT01225211|454015202|FG005|Overall Study|Withdrawal by Subject|0|||
126199485|NCT01225211|454015203|FG006|Overall Study|Withdrawal by Subject|1|||
126199486|NCT01225211|454015204|FG007|Overall Study|Withdrawal by Subject|0|||
126199487|NCT01225211|454015205|FG008|Overall Study|Withdrawal by Subject|1|||
126199488|NCT01225211|454015206|FG009|Overall Study|Withdrawal by Subject|3|||
126199489|NCT01225211|454015197|FG000|Overall Study|Other|0|||
126199490|NCT01225211|454015198|FG001|Overall Study|Other|0|||
126199491|NCT01225211|454015199|FG002|Overall Study|Other|0|||
126199492|NCT01225211|454015200|FG003|Overall Study|Other|0|||
126199493|NCT01225211|454015201|FG004|Overall Study|Other|0|||
126199494|NCT01225211|454015202|FG005|Overall Study|Other|0|||
126199495|NCT01225211|454015203|FG006|Overall Study|Other|0|||
126199496|NCT01225211|454015204|FG007|Overall Study|Other|0|||
126199497|NCT01225211|454015205|FG008|Overall Study|Other|0|||
126199498|NCT01225211|454015206|FG009|Overall Study|Other|1|||
126199499|NCT01241318|454015211|FG000|Overall Study|Woman: false pregnancies|27|||
126199500|NCT01241318|454015212|FG001|Overall Study|Woman: false pregnancies|15|||
126199501|NCT01241318|454015211|FG000|Overall Study|Woman: miscarriage/abortion|46|||
126199502|NCT01241318|454015212|FG001|Overall Study|Woman: miscarriage/abortion|38|||
126199503|NCT01241318|454015211|FG000|Overall Study|Withdrawal by Subject|175|||
126199504|NCT01241318|454015212|FG001|Overall Study|Withdrawal by Subject|46|||
126199505|NCT01241318|454015211|FG000|Overall Study|Lost to Follow-up|740|||
126199506|NCT01241318|454015212|FG001|Overall Study|Lost to Follow-up|455|||
126199507|NCT01241318|454015211|FG000|Overall Study|Death|2|||
126199508|NCT01241318|454015212|FG001|Overall Study|Death|4|||
126199509|NCT01241318|454015211|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
126199510|NCT01241318|454015212|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
126199511|NCT01241318|454015211|FG000|Overall Study|Woman: Stillborn infant|129|||
126199512|NCT01241318|454015212|FG001|Overall Study|Woman: Stillborn infant|146|||
126199513|NCT02355665|454015218|FG000|Overall Study|Adverse Event|16|||
126199514|NCT02355665|454015219|FG001|Overall Study|Adverse Event|24|||
126199515|NCT02355665|454015218|FG000|Overall Study|Protocol Violation|2|||
126199516|NCT02355665|454015219|FG001|Overall Study|Protocol Violation|0|||
126199517|NCT02355665|454015218|FG000|Overall Study|Withdrawal by Subject|90|||
126199518|NCT02355665|454015219|FG001|Overall Study|Withdrawal by Subject|100|||
126199519|NCT02355665|454015218|FG000|Overall Study|Lost to Follow-up|131|||
126199520|NCT02355665|454015219|FG001|Overall Study|Lost to Follow-up|103|||
126199521|NCT02355665|454015218|FG000|Overall Study|Death|4|||
126199522|NCT02355665|454015219|FG001|Overall Study|Death|2|||
126199523|NCT02355665|454015218|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
126199524|NCT02355665|454015219|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
126199525|NCT04129242|454015220|FG000|Overall Study|Physician Decision|1|||
126199526|NCT04129242|454015221|FG001|Overall Study|Physician Decision|1|||
126199527|NCT04129242|454015220|FG000|Overall Study|Protocol Violation|0|||
126199528|NCT04129242|454015221|FG001|Overall Study|Protocol Violation|1|||
126199529|NCT00392210|454015225|FG000|First Voiding Trial|Physician Decision|2|||
126199530|NCT00392210|454015226|FG001|First Voiding Trial|Physician Decision|2|||
126199531|NCT04815291|454015227|FG000|Overall Study|Lost to Follow-up|1|||
126199532|NCT04815291|454015227|FG000|Overall Study|Physician Decision|4|||
126199533|NCT04815291|454015227|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
126199534|NCT02140762|454015228|FG000|Overall Study|Adverse Event|1|||
126199535|NCT02140762|454015229|FG001|Overall Study|Adverse Event|1|||
126199536|NCT02140762|454015228|FG000|Overall Study|Lost to Follow-up|9|||
126199537|NCT02140762|454015229|FG001|Overall Study|Lost to Follow-up|5|||
126199538|NCT02140762|454015228|FG000|Overall Study|Protocol Violation|1|||
126199539|NCT02140762|454015229|FG001|Overall Study|Protocol Violation|1|||
126199540|NCT02140762|454015228|FG000|Overall Study|Withdrawal by Subject|6|||
126199541|NCT02140762|454015229|FG001|Overall Study|Withdrawal by Subject|4|||
126199542|NCT02140762|454015228|FG000|Overall Study|Other|0|||
126199543|NCT02140762|454015229|FG001|Overall Study|Other|1|||
126199544|NCT00989664|454015230|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
126199545|NCT00989664|454015230|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
126199546|NCT00989664|454015230|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
126199547|NCT00989664|454015230|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
126199548|NCT00989664|454015230|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
126199549|NCT00989664|454015230|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
126199550|NCT00989664|454015230|FG000|Long-Term Follow-Up|Death|3|||
126199551|NCT00095836|454015231|FG000|Overall Study|Lost to Follow-up|1|||
126199552|NCT00095836|454015231|FG000|Overall Study|Adverse Event|1|||
126199553|NCT00095836|454015231|FG000|Overall Study|Death|2|||
126199554|NCT00962780|454015235|FG000|Overall Study|Death|0|||
126199555|NCT00962780|454015236|FG001|Overall Study|Death|1|||
126199556|NCT00962780|454015235|FG000|Overall Study|Protocol Violation|9|||
126199557|NCT00962780|454015236|FG001|Overall Study|Protocol Violation|4|||
126199558|NCT00962780|454015235|FG000|Overall Study|Withdrawal by Subject|1|||
126199559|NCT00962780|454015236|FG001|Overall Study|Withdrawal by Subject|8|||
126199560|NCT00962780|454015235|FG000|Overall Study|Other|0|||
126199561|NCT00962780|454015236|FG001|Overall Study|Other|1|||
126199562|NCT01775995|454015237|FG000|Overall Study|Lost to Follow-up|1|||
126199563|NCT01775995|454015238|FG001|Overall Study|Lost to Follow-up|1|||
126199564|NCT02055976|454015239|FG000|Overall Study|Other|0|||
126199565|NCT02055976|454015240|FG001|Overall Study|Other|0|||
126199566|NCT02055976|454015241|FG002|Overall Study|Other|1|||
126199567|NCT02055976|454015242|FG003|Overall Study|Other|0|||
126199568|NCT02055976|454015243|FG004|Overall Study|Other|0|||
126199569|NCT02055976|454015244|FG005|Overall Study|Other|0|||
126199570|NCT02055976|454015245|FG006|Overall Study|Other|0|||
126199571|NCT02055976|454015246|FG007|Overall Study|Other|0|||
126199572|NCT02055976|454015247|FG008|Overall Study|Other|0|||
126199573|NCT02055976|454015239|FG000|Overall Study|Adverse Event|0|||
126199574|NCT02055976|454015240|FG001|Overall Study|Adverse Event|0|||
126199575|NCT02055976|454015241|FG002|Overall Study|Adverse Event|0|||
126199576|NCT02055976|454015242|FG003|Overall Study|Adverse Event|0|||
126199577|NCT02055976|454015243|FG004|Overall Study|Adverse Event|0|||
126199578|NCT02055976|454015244|FG005|Overall Study|Adverse Event|1|||
126199579|NCT02055976|454015245|FG006|Overall Study|Adverse Event|1|||
126199580|NCT02055976|454015246|FG007|Overall Study|Adverse Event|0|||
126199581|NCT02055976|454015247|FG008|Overall Study|Adverse Event|0|||
126199582|NCT02055976|454015239|FG000|Overall Study|Does not meet entrance criteria|0|||
126199583|NCT02055976|454015240|FG001|Overall Study|Does not meet entrance criteria|0|||
126199584|NCT02055976|454015241|FG002|Overall Study|Does not meet entrance criteria|0|||
126199585|NCT02055976|454015242|FG003|Overall Study|Does not meet entrance criteria|0|||
126199586|NCT02055976|454015243|FG004|Overall Study|Does not meet entrance criteria|0|||
126199587|NCT02055976|454015244|FG005|Overall Study|Does not meet entrance criteria|0|||
126199588|NCT02055976|454015245|FG006|Overall Study|Does not meet entrance criteria|1|||
126199589|NCT02055976|454015246|FG007|Overall Study|Does not meet entrance criteria|0|||
126199590|NCT02055976|454015247|FG008|Overall Study|Does not meet entrance criteria|0|||
126199591|NCT02055976|454015239|FG000|Overall Study|Lost to Follow-up|0|||
126199592|NCT02055976|454015240|FG001|Overall Study|Lost to Follow-up|0|||
126199593|NCT02055976|454015241|FG002|Overall Study|Lost to Follow-up|0|||
126199594|NCT02055976|454015242|FG003|Overall Study|Lost to Follow-up|1|||
126199595|NCT02055976|454015243|FG004|Overall Study|Lost to Follow-up|0|||
126199596|NCT02055976|454015244|FG005|Overall Study|Lost to Follow-up|0|||
126199597|NCT02055976|454015245|FG006|Overall Study|Lost to Follow-up|0|||
126199598|NCT02055976|454015246|FG007|Overall Study|Lost to Follow-up|0|||
126199599|NCT02055976|454015247|FG008|Overall Study|Lost to Follow-up|0|||
126199600|NCT00394654|454015248|FG000|Overall Study|Lost to Follow-up|1|||
126199601|NCT00394654|454015249|FG001|Overall Study|Lost to Follow-up|0|||
126199602|NCT00394654|454015248|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
126199603|NCT00394654|454015249|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
126199604|NCT00122317|454015250|FG000|Overall Study|Death|3|||
126199605|NCT00122317|454015250|FG000|Overall Study|Adverse Event|4|||
126199606|NCT00122317|454015250|FG000|Overall Study|Physician Decision|2|||
126199607|NCT00122317|454015250|FG000|Overall Study|patient non-compliance|1|||
126199608|NCT00122317|454015250|FG000|Overall Study|Withdrawal by Subject|1|||
126199609|NCT02886338|454015251|FG000|Overall Study|Withdrawal by Subject|1|||
126199610|NCT03756285|454015252|FG000|Overall Study|Lost to Follow-up|0|||
126199611|NCT03756285|454015253|FG001|Overall Study|Lost to Follow-up|1|||
126199612|NCT03756285|454015252|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
126199613|NCT03756285|454015253|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
126199614|NCT03756285|454015252|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
126199615|NCT03756285|454015253|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
126199616|NCT02705755|454015254|FG000|Part A (6 Days)|Adverse Event|1|||
126199617|NCT02705755|454015255|FG001|Part A (6 Days)|Adverse Event|0|||
126199618|NCT02705755|454015256|FG002|Part A (6 Days)|Adverse Event|0|||
126199619|NCT02705755|454015257|FG003|Part A (6 Days)|Adverse Event|0|||
126199620|NCT02705755|454015254|FG000|Part A (6 Days)|Physician Decision|3|||
126199621|NCT02705755|454015255|FG001|Part A (6 Days)|Physician Decision|0|||
126199622|NCT02705755|454015256|FG002|Part A (6 Days)|Physician Decision|0|||
126199623|NCT02705755|454015257|FG003|Part A (6 Days)|Physician Decision|0|||
126199624|NCT02705755|454015254|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
126199625|NCT02705755|454015255|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
126199626|NCT02705755|454015256|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
126199627|NCT02705755|454015257|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
126199628|NCT02705755|454015254|FG000|Part C (20 Weeks)|Physician Decision|0|||
126199629|NCT02705755|454015255|FG001|Part C (20 Weeks)|Physician Decision|0|||
126199630|NCT02705755|454015256|FG002|Part C (20 Weeks)|Physician Decision|0|||
126199631|NCT02705755|454015257|FG003|Part C (20 Weeks)|Physician Decision|2|||
126199632|NCT02705755|454015254|FG000|Part C (20 Weeks)|Adverse Event|0|||
126199633|NCT02705755|454015255|FG001|Part C (20 Weeks)|Adverse Event|0|||
126199634|NCT02705755|454015256|FG002|Part C (20 Weeks)|Adverse Event|0|||
126199635|NCT02705755|454015257|FG003|Part C (20 Weeks)|Adverse Event|6|||
126199636|NCT02705755|454015254|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
126199637|NCT02705755|454015255|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
126199638|NCT02705755|454015256|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
126199639|NCT02705755|454015257|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
126199640|NCT04450394|454017686|FG000|Overall Study|Adverse Event|2|||
126199641|NCT04450394|454017687|FG001|Overall Study|Adverse Event|0|||
126199642|NCT04450394|454017688|FG002|Overall Study|Adverse Event|0|||
126199643|NCT04450394|454017686|FG000|Overall Study|Death|0|||
126199644|NCT04450394|454017687|FG001|Overall Study|Death|1|||
126199645|NCT04450394|454017688|FG002|Overall Study|Death|0|||
126199646|NCT04450394|454017686|FG000|Overall Study|Lost to Follow-up|0|||
126199647|NCT04450394|454017687|FG001|Overall Study|Lost to Follow-up|3|||
126199648|NCT04450394|454017688|FG002|Overall Study|Lost to Follow-up|0|||
126199649|NCT04450394|454017686|FG000|Overall Study|Physician Decision|0|||
126199650|NCT04450394|454017687|FG001|Overall Study|Physician Decision|1|||
126199651|NCT04450394|454017688|FG002|Overall Study|Physician Decision|0|||
126199652|NCT04450394|454017686|FG000|Overall Study|Protocol Violation|2|||
126199653|NCT04450394|454017687|FG001|Overall Study|Protocol Violation|0|||
126199654|NCT04450394|454017688|FG002|Overall Study|Protocol Violation|0|||
126199655|NCT04450394|454017686|FG000|Overall Study|Withdrawal by Subject|6|||
126199656|NCT04450394|454017687|FG001|Overall Study|Withdrawal by Subject|9|||
126199657|NCT04450394|454017688|FG002|Overall Study|Withdrawal by Subject|0|||
126199658|NCT02155660|454017693|FG000|Overall Study|Other Reason|8|||
126199659|NCT02155660|454017694|FG001|Overall Study|Other Reason|6|||
126199660|NCT02155660|454017695|FG002|Overall Study|Other Reason|10|||
126199661|NCT02155660|454017696|FG003|Overall Study|Other Reason|10|||
126199662|NCT02155660|454017693|FG000|Overall Study|Study-specific withdrawal criteria|0|||
126199663|NCT02155660|454017694|FG001|Overall Study|Study-specific withdrawal criteria|1|||
126199664|NCT02155660|454017695|FG002|Overall Study|Study-specific withdrawal criteria|1|||
126199665|NCT02155660|454017696|FG003|Overall Study|Study-specific withdrawal criteria|1|||
126199666|NCT02155660|454017693|FG000|Overall Study|Severe non-compliance|0|||
126199667|NCT02155660|454017694|FG001|Overall Study|Severe non-compliance|4|||
126199668|NCT02155660|454017695|FG002|Overall Study|Severe non-compliance|0|||
126199669|NCT02155660|454017696|FG003|Overall Study|Severe non-compliance|1|||
126199670|NCT02155660|454017693|FG000|Overall Study|Adverse Event|2|||
126199671|NCT02155660|454017694|FG001|Overall Study|Adverse Event|6|||
126199672|NCT02155660|454017695|FG002|Overall Study|Adverse Event|3|||
126199673|NCT02155660|454017696|FG003|Overall Study|Adverse Event|1|||
126199674|NCT02155660|454017693|FG000|Overall Study|Lost to Follow-up|3|||
126199675|NCT02155660|454017694|FG001|Overall Study|Lost to Follow-up|6|||
126199676|NCT02155660|454017695|FG002|Overall Study|Lost to Follow-up|5|||
126199677|NCT02155660|454017696|FG003|Overall Study|Lost to Follow-up|8|||
126199678|NCT02155660|454017693|FG000|Overall Study|Death|17|||
126199679|NCT02155660|454017694|FG001|Overall Study|Death|19|||
126199680|NCT02155660|454017695|FG002|Overall Study|Death|17|||
126199681|NCT02155660|454017696|FG003|Overall Study|Death|19|||
126199682|NCT02155660|454017693|FG000|Overall Study|Withdrawal by Subject|28|||
126199683|NCT02155660|454017694|FG001|Overall Study|Withdrawal by Subject|31|||
126199684|NCT02155660|454017695|FG002|Overall Study|Withdrawal by Subject|24|||
126199685|NCT02155660|454017696|FG003|Overall Study|Withdrawal by Subject|21|||
126199686|NCT03812224|454017703|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
126199687|NCT03812224|454017704|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126199688|NCT03812224|454017703|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
126199689|NCT03812224|454017704|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
126199690|NCT03812224|454017703|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
126199691|NCT03812224|454017704|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
126199692|NCT03812224|454017703|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
126199693|NCT03812224|454017704|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
126199694|NCT00303719|454017705|FG000|Overall Study|Not evaluable, prior therapies|0|||
126199695|NCT00303719|454017706|FG001|Overall Study|Not evaluable, prior therapies|30|||
126199696|NCT00303719|454017705|FG000|Overall Study|Lost to Follow-up|0|||
126199697|NCT00303719|454017706|FG001|Overall Study|Lost to Follow-up|7|||
126199698|NCT01641952|454017707|FG000|Overall Study|Lost to Follow-up|28|||
126199699|NCT01641952|454017707|FG000|Overall Study|Adverse Event|6|||
126199700|NCT02500901|454017708|FG000|Overall Study|Disease ProgressionDD|2|||
126199701|NCT00561912|454017726|FG000|Overall Study|ineligible|1|||
126199702|NCT02643420|454017730|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
126199703|NCT02643420|454017731|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
126199704|NCT02643420|454017730|FG000|Overall Study|Withdrawal by Subject|25|||
126199705|NCT02643420|454017731|FG001|Overall Study|Withdrawal by Subject|19|||
126199706|NCT02643420|454017730|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
126199707|NCT02643420|454017731|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
126199708|NCT02643420|454017730|FG000|Overall Study|Lost to Follow-up|6|||
126199709|NCT02643420|454017731|FG001|Overall Study|Lost to Follow-up|10|||
126199710|NCT02643420|454017730|FG000|Overall Study|Investigator Decision|2|||
126199711|NCT02643420|454017731|FG001|Overall Study|Investigator Decision|4|||
126199712|NCT02643420|454017730|FG000|Overall Study|Sponsor decision|1|||
126199713|NCT02643420|454017731|FG001|Overall Study|Sponsor decision|1|||
126199714|NCT02643420|454017730|FG000|Overall Study|Death|0|||
126199715|NCT02643420|454017731|FG001|Overall Study|Death|2|||
126199716|NCT02643420|454017730|FG000|Overall Study|Reason not Specified|8|||
126199717|NCT02643420|454017731|FG001|Overall Study|Reason not Specified|7|||
126199718|NCT02127970|454017732|FG000|Overall Study|Adverse Event|2|||
126199719|NCT02127970|454017733|FG001|Overall Study|Adverse Event|1|||
126199720|NCT02127970|454017732|FG000|Overall Study|Death|1|||
126199721|NCT02127970|454017733|FG001|Overall Study|Death|1|||
126199722|NCT02127970|454017732|FG000|Overall Study|Lost to Follow-up|14|||
126199723|NCT02127970|454017733|FG001|Overall Study|Lost to Follow-up|14|||
126199724|NCT02127970|454017732|FG000|Overall Study|Reason not Specified|4|||
126199725|NCT02127970|454017733|FG001|Overall Study|Reason not Specified|7|||
126199726|NCT02127970|454017732|FG000|Overall Study|Pregnancy|0|||
126199727|NCT02127970|454017733|FG001|Overall Study|Pregnancy|1|||
126199728|NCT02127970|454017732|FG000|Overall Study|Subject Withdrew Consent|5|||
126199729|NCT02127970|454017733|FG001|Overall Study|Subject Withdrew Consent|3|||
126199730|NCT01710709|454017734|FG000|Overall Study|Lost to Follow-up|29|||
126199731|NCT01710709|454017734|FG000|Overall Study|Adverse Event|48|||
126199732|NCT01710709|454017734|FG000|Overall Study|Participant met withdrawal criteria|33|||
126199733|NCT01710709|454017734|FG000|Overall Study|Participant withdrawn by investigator|2|||
126199734|NCT01710709|454017734|FG000|Overall Study|Withdrawal by Subject|53|||
126199735|NCT01710709|454017734|FG000|Overall Study|Protocol Violation|5|||
126199736|NCT01710709|454017734|FG000|Overall Study|Lack of Efficacy|3|||
126199737|NCT01398176|454017736|FG000|Overall Study|Lost to Follow-up|1|||
126199738|NCT01398176|454017737|FG001|Overall Study|Lost to Follow-up|3|||
126199739|NCT01398176|454017736|FG000|Overall Study|Physician Decision|2|||
126199740|NCT01398176|454017737|FG001|Overall Study|Physician Decision|3|||
126199741|NCT00542321|454017738|FG000|Overall Study|Death|0|||
126199742|NCT00542321|454017739|FG001|Overall Study|Death|1|||
126199743|NCT00718887|454017752|FG000|Overall Study|Withdrawal by Subject|3|||
126199744|NCT00718887|454017753|FG001|Overall Study|Withdrawal by Subject|2|||
126199745|NCT00718887|454017752|FG000|Overall Study|Not identified|2|||
126199746|NCT00718887|454017753|FG001|Overall Study|Not identified|7|||
126199747|NCT05102734|454017754|FG000|Overall Study|Did not require vasopressors|1|||
126199748|NCT05102734|454017755|FG001|Overall Study|Did not require vasopressors|0|||
126199749|NCT05102734|454017754|FG000|Overall Study|Did not have functioning PA catheter|1|||
126199750|NCT05102734|454017755|FG001|Overall Study|Did not have functioning PA catheter|0|||
126199751|NCT05102734|454017754|FG000|Overall Study|Inadequate video quality|2|||
126199752|NCT05102734|454017755|FG001|Overall Study|Inadequate video quality|0|||
126199753|NCT03055806|454017756|FG000|Overall Study|Adverse Event|0|||
126199754|NCT03055806|454017757|FG001|Overall Study|Adverse Event|0|||
126199755|NCT03055806|454017758|FG002|Overall Study|Adverse Event|1|||
126199756|NCT03055806|454017759|FG003|Overall Study|Adverse Event|1|||
126199757|NCT03055806|454017756|FG000|Overall Study|Lost to Follow-up|0|||
126199758|NCT03055806|454017757|FG001|Overall Study|Lost to Follow-up|3|||
126199759|NCT03055806|454017758|FG002|Overall Study|Lost to Follow-up|6|||
126199760|NCT03055806|454017759|FG003|Overall Study|Lost to Follow-up|7|||
126199761|NCT03055806|454017756|FG000|Overall Study|Physician Decision|1|||
126199762|NCT03055806|454017757|FG001|Overall Study|Physician Decision|0|||
126199763|NCT03055806|454017758|FG002|Overall Study|Physician Decision|0|||
126199764|NCT03055806|454017759|FG003|Overall Study|Physician Decision|1|||
126199765|NCT03055806|454017756|FG000|Overall Study|Protocol Violation|1|||
126199766|NCT03055806|454017757|FG001|Overall Study|Protocol Violation|0|||
126199767|NCT03055806|454017758|FG002|Overall Study|Protocol Violation|0|||
126199768|NCT03055806|454017759|FG003|Overall Study|Protocol Violation|0|||
126199769|NCT03055806|454017756|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
126199770|NCT03055806|454017757|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
126199771|NCT03055806|454017758|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
126199772|NCT03055806|454017759|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
126199773|NCT03055806|454017756|FG000|Overall Study|Withdrawal of consent to continue study|2|||
126199774|NCT03055806|454017757|FG001|Overall Study|Withdrawal of consent to continue study|3|||
126199775|NCT03055806|454017758|FG002|Overall Study|Withdrawal of consent to continue study|4|||
126199776|NCT03055806|454017759|FG003|Overall Study|Withdrawal of consent to continue study|6|||
126199777|NCT03055806|454017756|FG000|Overall Study|Partner not willing to try intercourse|1|||
126199778|NCT03055806|454017757|FG001|Overall Study|Partner not willing to try intercourse|0|||
126199779|NCT03055806|454017758|FG002|Overall Study|Partner not willing to try intercourse|0|||
126199780|NCT03055806|454017759|FG003|Overall Study|Partner not willing to try intercourse|0|||
126199781|NCT00125138|454017760|FG000|Overall Study|Adverse Event|1|||
126199782|NCT00125138|454017761|FG001|Overall Study|Adverse Event|0|||
126199783|NCT00125138|454017762|FG002|Overall Study|Adverse Event|3|||
126199784|NCT00125138|454017763|FG003|Overall Study|Adverse Event|2|||
126199785|NCT00125138|454017760|FG000|Overall Study|Withdrawal by Subject|2|||
126199786|NCT00125138|454017761|FG001|Overall Study|Withdrawal by Subject|3|||
126199787|NCT00125138|454017762|FG002|Overall Study|Withdrawal by Subject|1|||
126199788|NCT00125138|454017763|FG003|Overall Study|Withdrawal by Subject|1|||
126199789|NCT00125138|454017760|FG000|Overall Study|Lack of Efficacy|0|||
126199790|NCT00125138|454017761|FG001|Overall Study|Lack of Efficacy|0|||
126199791|NCT00125138|454017762|FG002|Overall Study|Lack of Efficacy|0|||
126199792|NCT00125138|454017763|FG003|Overall Study|Lack of Efficacy|1|||
126199793|NCT00125138|454017760|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
126199794|NCT00125138|454017761|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
126199795|NCT00125138|454017762|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
126199796|NCT00125138|454017763|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
126199797|NCT00348686|454017768|FG000|Overall Study|Withdrawal by Subject|45|||
126199798|NCT00348686|454017768|FG000|Overall Study|Adverse Event|5|||
126199799|NCT00348686|454017768|FG000|Overall Study|Protocol Violation|6|||
126199800|NCT00348686|454017768|FG000|Overall Study|Lost to Follow-up|2|||
126199801|NCT00348686|454017768|FG000|Overall Study|Multiple Reasons|8|||
126199802|NCT01258738|454017769|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
126199803|NCT01258738|454017770|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
126199804|NCT01258738|454017769|FG000|Double-blind Period|Withdrawal by Subject|2|||
126199805|NCT01258738|454017770|FG001|Double-blind Period|Withdrawal by Subject|2|||
126199806|NCT01258738|454017769|FG000|Double-blind Period|Protocol Violation|1|||
126199807|NCT01258738|454017770|FG001|Double-blind Period|Protocol Violation|1|||
126199808|NCT01258738|454017769|FG000|Double-blind Period|Adverse Event|3|||
126199809|NCT01258738|454017770|FG001|Double-blind Period|Adverse Event|1|||
126199810|NCT01258738|454017769|FG000|Open-label Period|Did not meet inclusion criteria|0|||
126199811|NCT01258738|454017770|FG001|Open-label Period|Did not meet inclusion criteria|1|||
126199812|NCT01258738|454017769|FG000|Open-label Period|Insufficient clinical response|5|||
126199813|NCT01258738|454017770|FG001|Open-label Period|Insufficient clinical response|3|||
126199814|NCT01258738|454017769|FG000|Open-label Period|Lost to Follow-up|0|||
126199815|NCT01258738|454017770|FG001|Open-label Period|Lost to Follow-up|2|||
126199816|NCT01258738|454017769|FG000|Open-label Period|Withdrawal by Subject|5|||
126199817|NCT01258738|454017770|FG001|Open-label Period|Withdrawal by Subject|6|||
126199818|NCT01258738|454017769|FG000|Open-label Period|Protocol Violation|2|||
126199819|NCT01258738|454017770|FG001|Open-label Period|Protocol Violation|2|||
126199820|NCT01258738|454017769|FG000|Open-label Period|Adverse Event|4|||
126199821|NCT01258738|454017770|FG001|Open-label Period|Adverse Event|5|||
126199822|NCT01258738|454017769|FG000|Open-label Period|Other Reasons|0|||
126199823|NCT01258738|454017770|FG001|Open-label Period|Other Reasons|1|||
126199824|NCT01258738|454017769|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
126199825|NCT01258738|454017770|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
126199826|NCT00689611|454017771|FG000|Overall Study|Death|6|||
126199827|NCT00689611|454017772|FG001|Overall Study|Death|9|||
126199828|NCT00689611|454017771|FG000|Overall Study|Withdrawal by Subject|8|||
126199829|NCT00689611|454017772|FG001|Overall Study|Withdrawal by Subject|9|||
126199830|NCT00689611|454017771|FG000|Overall Study|Lost to Follow-up|27|||
126199831|NCT00689611|454017772|FG001|Overall Study|Lost to Follow-up|28|||
126199832|NCT00568399|454017773|FG000|Overall Study|Death|2|||
126199833|NCT00568399|454017773|FG000|Overall Study|Adverse Event|5|||
126199834|NCT00568399|454017773|FG000|Overall Study|Withdrawal by Subject|8|||
126199835|NCT01904760|454017780|FG000|Overall Study|Protocol Violation|1|||
126199836|NCT01904760|454017781|FG001|Overall Study|Protocol Violation|0|||
126199837|NCT04249076|454017791|FG000|Overall Study|Adverse Event|1|||
126199838|NCT04249076|454017792|FG001|Overall Study|Adverse Event|1|||
126199839|NCT04249076|454017791|FG000|Overall Study|Protocol Violation|1|||
126199840|NCT04249076|454017792|FG001|Overall Study|Protocol Violation|2|||
126199841|NCT04249076|454017791|FG000|Overall Study|Lack of Efficacy|0|||
126199842|NCT04249076|454017792|FG001|Overall Study|Lack of Efficacy|1|||
126199843|NCT04249076|454017791|FG000|Overall Study|Withdrawal by Subject|0|||
126199844|NCT04249076|454017792|FG001|Overall Study|Withdrawal by Subject|1|||
126199845|NCT00783263|454017793|FG000|Overall Study|Adverse Event|3|||
126199846|NCT00783263|454017794|FG001|Overall Study|Adverse Event|0|||
126199847|NCT00783263|454017795|FG002|Overall Study|Adverse Event|2|||
126199848|NCT00783263|454017796|FG003|Overall Study|Adverse Event|1|||
126199849|NCT00783263|454017793|FG000|Overall Study|Lost to Follow-up|1|||
126199850|NCT00783263|454017794|FG001|Overall Study|Lost to Follow-up|1|||
126199851|NCT00783263|454017795|FG002|Overall Study|Lost to Follow-up|0|||
126199852|NCT00783263|454017796|FG003|Overall Study|Lost to Follow-up|0|||
126199853|NCT00783263|454017793|FG000|Overall Study|Withdrawal by Subject|0|||
126199854|NCT00783263|454017794|FG001|Overall Study|Withdrawal by Subject|1|||
126199855|NCT00783263|454017795|FG002|Overall Study|Withdrawal by Subject|1|||
126199856|NCT00783263|454017796|FG003|Overall Study|Withdrawal by Subject|2|||
126199857|NCT00405756|454017797|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
126199858|NCT00405756|454017798|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
126199859|NCT00405756|454017799|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
126199860|NCT00405756|454017797|FG000|Double-blind Treatment|Adverse Event|31|||
126199861|NCT00405756|454017798|FG001|Double-blind Treatment|Adverse Event|27|||
126199862|NCT00405756|454017799|FG002|Double-blind Treatment|Adverse Event|12|||
126199863|NCT00405756|454017797|FG000|Double-blind Treatment|Disease Progression|47|||
126199864|NCT00405756|454017798|FG001|Double-blind Treatment|Disease Progression|81|||
126199865|NCT00405756|454017799|FG002|Double-blind Treatment|Disease Progression|102|||
126199866|NCT00405756|454017797|FG000|Double-blind Treatment|Lack of Efficacy|1|||
126199867|NCT00405756|454017798|FG001|Double-blind Treatment|Lack of Efficacy|4|||
126199868|NCT00405756|454017799|FG002|Double-blind Treatment|Lack of Efficacy|2|||
126199869|NCT00405756|454017797|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
126199870|NCT00405756|454017798|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
126199871|NCT00405756|454017799|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
126199872|NCT00405756|454017797|FG000|Double-blind Treatment|Lost to Follow-up|1|||
126199873|NCT00405756|454017798|FG001|Double-blind Treatment|Lost to Follow-up|0|||
126199874|NCT00405756|454017799|FG002|Double-blind Treatment|Lost to Follow-up|0|||
126199875|NCT00405756|454017797|FG000|Double-blind Treatment|Death|4|||
126199876|NCT00405756|454017798|FG001|Double-blind Treatment|Death|4|||
126199877|NCT00405756|454017799|FG002|Double-blind Treatment|Death|4|||
126199956|NCT01117428|454017805|FG001|Overall Study|Withdrawal by Subject|0|||
126199957|NCT01117428|454017806|FG002|Overall Study|Withdrawal by Subject|1|||
126199958|NCT01117428|454017807|FG003|Overall Study|Withdrawal by Subject|0|||
126199959|NCT01117428|454017808|FG004|Overall Study|Withdrawal by Subject|0|||
126199960|NCT01117428|454017809|FG005|Overall Study|Withdrawal by Subject|0|||
126199961|NCT01117428|454017804|FG000|Overall Study|Progressive disease|15|||
126199962|NCT01117428|454017805|FG001|Overall Study|Progressive disease|27|||
126199963|NCT01117428|454017806|FG002|Overall Study|Progressive disease|10|||
126199964|NCT01117428|454017807|FG003|Overall Study|Progressive disease|12|||
126199965|NCT01117428|454017808|FG004|Overall Study|Progressive disease|16|||
126199966|NCT01117428|454017809|FG005|Overall Study|Progressive disease|17|||
126199967|NCT03018028|454017810|FG000|Overall Study|Withdrawal by Subject|3|||
126199968|NCT03018028|454017811|FG001|Overall Study|Withdrawal by Subject|0|||
126199969|NCT03018028|454017812|FG002|Overall Study|Withdrawal by Subject|1|||
126199970|NCT03018028|454017813|FG003|Overall Study|Withdrawal by Subject|2|||
126199971|NCT03018028|454017814|FG004|Overall Study|Withdrawal by Subject|0|||
126199972|NCT02519777|454017817|FG000|Overall Study|Death|1|||
126199973|NCT02519777|454017818|FG001|Overall Study|Death|0|||
126199974|NCT02519777|454017819|FG002|Overall Study|Death|0|||
126199975|NCT02519777|454017817|FG000|Overall Study|Lost to Follow-up|0|||
126199976|NCT02519777|454017818|FG001|Overall Study|Lost to Follow-up|4|||
126199977|NCT02519777|454017819|FG002|Overall Study|Lost to Follow-up|2|||
126199978|NCT02519777|454017817|FG000|Overall Study|Withdrawal by Subject|3|||
126199979|NCT02519777|454017818|FG001|Overall Study|Withdrawal by Subject|1|||
126199980|NCT02519777|454017819|FG002|Overall Study|Withdrawal by Subject|0|||
126199981|NCT02519777|454017817|FG000|Overall Study|Severe Debilitation|1|||
126199982|NCT02519777|454017818|FG001|Overall Study|Severe Debilitation|1|||
126199983|NCT02519777|454017819|FG002|Overall Study|Severe Debilitation|1|||
126199984|NCT02519777|454017817|FG000|Overall Study|Not able to get to clinic|1|||
126199985|NCT02519777|454017818|FG001|Overall Study|Not able to get to clinic|2|||
126199986|NCT02519777|454017819|FG002|Overall Study|Not able to get to clinic|1|||
126199987|NCT02195531|454017820|FG000|Overall Study|Withdrawal by Subject|1|||
126199988|NCT02195531|454017821|FG001|Overall Study|Withdrawal by Subject|1|||
126199989|NCT02195531|454017822|FG002|Overall Study|Withdrawal by Subject|1|||
126199990|NCT02543801|454017824|FG000|Overall Study|Protocol Violation|1|||
126199991|NCT02543801|454017825|FG001|Overall Study|Protocol Violation|2|||
126199992|NCT02543801|454017826|FG002|Overall Study|Protocol Violation|0|||
126199993|NCT02543801|454017827|FG003|Overall Study|Protocol Violation|0|||
126199994|NCT00082628|454017842|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
126199995|NCT00082628|454017843|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
126199996|NCT00082628|454017844|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
126199997|NCT00082628|454017845|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
126199998|NCT00082628|454017846|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
126199999|NCT00082628|454017842|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
126200000|NCT00082628|454017843|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
126200001|NCT00082628|454017844|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
126200002|NCT00082628|454017845|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
126200003|NCT00082628|454017846|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
126200004|NCT00082628|454017842|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
126200005|NCT00082628|454017843|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
126200006|NCT00082628|454017844|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
126200007|NCT00082628|454017845|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
126200008|NCT00082628|454017846|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
126200009|NCT00082628|454017842|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
126200010|NCT00082628|454017843|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
126200011|NCT00082628|454017844|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
126200012|NCT00082628|454017845|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
126200013|NCT00082628|454017846|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
126200014|NCT00082628|454017842|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
126200015|NCT00082628|454017843|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
126200016|NCT00082628|454017844|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
126200017|NCT00082628|454017845|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
126200018|NCT00082628|454017846|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
126200019|NCT00082628|454017842|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
126200020|NCT00082628|454017843|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
126200021|NCT00082628|454017844|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
126200022|NCT00082628|454017845|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
126200023|NCT00082628|454017846|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
126200024|NCT00082628|454017842|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
126200025|NCT00082628|454017843|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
126200026|NCT00082628|454017844|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
126200027|NCT00082628|454017845|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
126200028|NCT00082628|454017846|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
126200029|NCT02364999|454017847|FG000|Overall Study|Death|136|||
126200030|NCT02364999|454017848|FG001|Overall Study|Death|138|||
126200031|NCT02364999|454017847|FG000|Overall Study|Lost to Follow-up|10|||
126200032|NCT02364999|454017848|FG001|Overall Study|Lost to Follow-up|15|||
126200033|NCT02364999|454017847|FG000|Overall Study|Protocol Violation|3|||
126200034|NCT02364999|454017848|FG001|Overall Study|Protocol Violation|2|||
126200035|NCT02364999|454017847|FG000|Overall Study|Withdrawal by Subject|14|||
126200036|NCT02364999|454017848|FG001|Overall Study|Withdrawal by Subject|14|||
126200037|NCT02364999|454017847|FG000|Overall Study|Other|0|||
126200038|NCT02364999|454017848|FG001|Overall Study|Other|1|||
126200039|NCT02364999|454017847|FG000|Overall Study|Randomized but did not receive treatment|2|||
126200040|NCT02364999|454017848|FG001|Overall Study|Randomized but did not receive treatment|3|||
126200041|NCT01566981|454017849|FG000|Overall Study|Lost to Follow-up|5|||
126200042|NCT01566981|454017850|FG001|Overall Study|Lost to Follow-up|8|||
126200043|NCT03323385|454017857|FG000|Overall Study|Withdrawal by Subject|1|||
126200044|NCT03323385|454017858|FG001|Overall Study|Withdrawal by Subject|2|||
126200045|NCT03323385|454017857|FG000|Overall Study|Noncompliance|0|||
126200046|NCT03323385|454017858|FG001|Overall Study|Noncompliance|1|||
126200047|NCT01849289|454017859|FG000|Overall Study|Adverse Event|3|||
126200048|NCT01849289|454017860|FG001|Overall Study|Adverse Event|3|||
126200049|NCT01849289|454017859|FG000|Overall Study|Protocol Violation|3|||
126200050|NCT01849289|454017860|FG001|Overall Study|Protocol Violation|3|||
126200051|NCT01849289|454017859|FG000|Overall Study|Withdrawal criteria|1|||
126200052|NCT01849289|454017860|FG001|Overall Study|Withdrawal criteria|0|||
126200053|NCT01849289|454017859|FG000|Overall Study|Unclassified|25|||
126200054|NCT01849289|454017860|FG001|Overall Study|Unclassified|18|||
126200055|NCT00660816|454017864|FG000|Overall Study|Adverse Event|1|||
126200056|NCT00660816|454017865|FG001|Overall Study|Adverse Event|2|||
126200057|NCT00660816|454017864|FG000|Overall Study|Withdrawal by Subject|1|||
126200058|NCT00660816|454017865|FG001|Overall Study|Withdrawal by Subject|0|||
126200059|NCT00660816|454017864|FG000|Overall Study|Death|0|||
126200060|NCT00660816|454017865|FG001|Overall Study|Death|2|||
126200061|NCT00660816|454017864|FG000|Overall Study|Lack of Efficacy|1|||
126200062|NCT00660816|454017865|FG001|Overall Study|Lack of Efficacy|0|||
126200063|NCT00660816|454017864|FG000|Overall Study|Physician Decision|0|||
126200064|NCT00660816|454017865|FG001|Overall Study|Physician Decision|2|||
126200065|NCT00660816|454017864|FG000|Overall Study|Protocol Violation|1|||
126200066|NCT00660816|454017865|FG001|Overall Study|Protocol Violation|0|||
126200067|NCT00660816|454017864|FG000|Overall Study|Disease Progression|16|||
126200068|NCT00660816|454017865|FG001|Overall Study|Disease Progression|12|||
126200069|NCT00660816|454017864|FG000|Overall Study|Complicating Disease|0|||
126200070|NCT00660816|454017865|FG001|Overall Study|Complicating Disease|1|||
126200071|NCT02692560|454017866|FG000|Overall Study|Withdrawal by Subject|0|||
126200072|NCT02692560|454017867|FG001|Overall Study|Withdrawal by Subject|6|||
126200073|NCT00420212|454017870|FG000|Overall Study|Adverse Event|22|||
126200074|NCT00420212|454017871|FG001|Overall Study|Adverse Event|40|||
126200075|NCT00420212|454017872|FG002|Overall Study|Adverse Event|36|||
126200076|NCT00420212|454017870|FG000|Overall Study|Lost to Follow-up|9|||
126200077|NCT00420212|454017871|FG001|Overall Study|Lost to Follow-up|11|||
126200078|NCT00420212|454017872|FG002|Overall Study|Lost to Follow-up|11|||
126200079|NCT00420212|454017870|FG000|Overall Study|Withdrawal by Subject|31|||
126200080|NCT00420212|454017871|FG001|Overall Study|Withdrawal by Subject|22|||
126200081|NCT00420212|454017872|FG002|Overall Study|Withdrawal by Subject|19|||
126200082|NCT00420212|454017870|FG000|Overall Study|Physician Decision|4|||
126200083|NCT00420212|454017871|FG001|Overall Study|Physician Decision|4|||
126200084|NCT00420212|454017872|FG002|Overall Study|Physician Decision|3|||
126200085|NCT00420212|454017870|FG000|Overall Study|Protocol Violation|4|||
126200086|NCT00420212|454017871|FG001|Overall Study|Protocol Violation|4|||
126200087|NCT00420212|454017872|FG002|Overall Study|Protocol Violation|8|||
126200088|NCT00420212|454017870|FG000|Overall Study|Death|0|||
126200089|NCT00420212|454017871|FG001|Overall Study|Death|0|||
126200090|NCT00420212|454017872|FG002|Overall Study|Death|1|||
126200091|NCT00420212|454017870|FG000|Overall Study|Other-Unspecified|21|||
126200092|NCT00420212|454017871|FG001|Overall Study|Other-Unspecified|14|||
126200093|NCT00420212|454017872|FG002|Overall Study|Other-Unspecified|18|||
126200094|NCT01326910|454017873|FG000|Overall Study|Withdrawal by Subject|3|||
126200095|NCT01326910|454017874|FG001|Overall Study|Withdrawal by Subject|2|||
126200096|NCT01326910|454017873|FG000|Overall Study|Protocol Violation|1|||
126200097|NCT01326910|454017874|FG001|Overall Study|Protocol Violation|1|||
126200098|NCT01681836|454017875|FG000|Second Intervention|Withdrawal by Subject|0|||
126200099|NCT01681836|454017876|FG001|Second Intervention|Withdrawal by Subject|1|||
126200100|NCT02394028|454017877|FG000|Induction Phase|Adverse Event|2|||
126200101|NCT02394028|454017878|FG001|Induction Phase|Adverse Event|4|||
126200175|NCT02394028|454017886|FG009|Induction Phase|Withdrawal by Subject|0|||
126200176|NCT02394028|454017887|FG010|Induction Phase|Withdrawal by Subject|0|||
126200177|NCT02394028|454017877|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200178|NCT02394028|454017878|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200179|NCT02394028|454017879|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200180|NCT02394028|454017880|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200181|NCT02394028|454017881|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200182|NCT02394028|454017882|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200183|NCT02394028|454017883|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
126200184|NCT02394028|454017884|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200185|NCT02394028|454017885|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200186|NCT02394028|454017886|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200187|NCT02394028|454017887|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
126200188|NCT02394028|454017877|FG000|Induction Phase|Sponsor decision|0|||
126200189|NCT02394028|454017878|FG001|Induction Phase|Sponsor decision|1|||
126200190|NCT02394028|454017879|FG002|Induction Phase|Sponsor decision|2|||
126200191|NCT02394028|454017880|FG003|Induction Phase|Sponsor decision|0|||
126200192|NCT02394028|454017881|FG004|Induction Phase|Sponsor decision|0|||
126200193|NCT02394028|454017882|FG005|Induction Phase|Sponsor decision|0|||
126200194|NCT02394028|454017883|FG006|Induction Phase|Sponsor decision|0|||
126200195|NCT02394028|454017884|FG007|Induction Phase|Sponsor decision|0|||
126200196|NCT02394028|454017885|FG008|Induction Phase|Sponsor decision|0|||
126200197|NCT02394028|454017886|FG009|Induction Phase|Sponsor decision|0|||
126200198|NCT02394028|454017887|FG010|Induction Phase|Sponsor decision|0|||
126200199|NCT02394028|454017877|FG000|Induction Phase|Technical reason|0|||
126200200|NCT02394028|454017878|FG001|Induction Phase|Technical reason|0|||
126200201|NCT02394028|454017879|FG002|Induction Phase|Technical reason|0|||
126200202|NCT02394028|454017880|FG003|Induction Phase|Technical reason|1|||
126200203|NCT02394028|454017881|FG004|Induction Phase|Technical reason|0|||
126200204|NCT02394028|454017882|FG005|Induction Phase|Technical reason|0|||
126200205|NCT02394028|454017883|FG006|Induction Phase|Technical reason|0|||
126200206|NCT02394028|454017884|FG007|Induction Phase|Technical reason|0|||
126200207|NCT02394028|454017885|FG008|Induction Phase|Technical reason|0|||
126200208|NCT02394028|454017886|FG009|Induction Phase|Technical reason|0|||
126200209|NCT02394028|454017887|FG010|Induction Phase|Technical reason|0|||
126200210|NCT02394028|454017877|FG000|Induction Phase|:ack of calculation|0|||
126200211|NCT02394028|454017878|FG001|Induction Phase|:ack of calculation|0|||
126200212|NCT02394028|454017879|FG002|Induction Phase|:ack of calculation|0|||
126200213|NCT02394028|454017880|FG003|Induction Phase|:ack of calculation|0|||
126200214|NCT02394028|454017881|FG004|Induction Phase|:ack of calculation|0|||
126200215|NCT02394028|454017882|FG005|Induction Phase|:ack of calculation|0|||
126200216|NCT02394028|454017883|FG006|Induction Phase|:ack of calculation|0|||
126200217|NCT02394028|454017884|FG007|Induction Phase|:ack of calculation|1|||
126200218|NCT02394028|454017885|FG008|Induction Phase|:ack of calculation|0|||
126200219|NCT02394028|454017886|FG009|Induction Phase|:ack of calculation|0|||
126200220|NCT02394028|454017887|FG010|Induction Phase|:ack of calculation|0|||
126200221|NCT02394028|454017877|FG000|Maintenance Phase|Protocol Violation|0|||
126200222|NCT02394028|454017878|FG001|Maintenance Phase|Protocol Violation|0|||
126200223|NCT02394028|454017879|FG002|Maintenance Phase|Protocol Violation|0|||
126200224|NCT02394028|454017880|FG003|Maintenance Phase|Protocol Violation|0|||
126200225|NCT02394028|454017881|FG004|Maintenance Phase|Protocol Violation|0|||
126200226|NCT02394028|454017882|FG005|Maintenance Phase|Protocol Violation|0|||
126200227|NCT02394028|454017883|FG006|Maintenance Phase|Protocol Violation|0|||
126200228|NCT02394028|454017884|FG007|Maintenance Phase|Protocol Violation|0|||
126200229|NCT02394028|454017885|FG008|Maintenance Phase|Protocol Violation|0|||
126200230|NCT02394028|454017886|FG009|Maintenance Phase|Protocol Violation|0|||
126200231|NCT02394028|454017887|FG010|Maintenance Phase|Protocol Violation|1|||
126200232|NCT02394028|454017877|FG000|Maintenance Phase|Physician Decision|0|||
126200233|NCT02394028|454017878|FG001|Maintenance Phase|Physician Decision|0|||
126200234|NCT02394028|454017879|FG002|Maintenance Phase|Physician Decision|0|||
126200235|NCT02394028|454017880|FG003|Maintenance Phase|Physician Decision|0|||
126200236|NCT02394028|454017881|FG004|Maintenance Phase|Physician Decision|0|||
126200237|NCT02394028|454017882|FG005|Maintenance Phase|Physician Decision|0|||
126200238|NCT02394028|454017883|FG006|Maintenance Phase|Physician Decision|0|||
126200239|NCT02394028|454017884|FG007|Maintenance Phase|Physician Decision|0|||
126200240|NCT02394028|454017885|FG008|Maintenance Phase|Physician Decision|1|||
126200241|NCT02394028|454017886|FG009|Maintenance Phase|Physician Decision|3|||
126200242|NCT02394028|454017887|FG010|Maintenance Phase|Physician Decision|2|||
126200243|NCT02394028|454017877|FG000|Maintenance Phase|Lack of Efficacy|0|||
126200244|NCT02394028|454017878|FG001|Maintenance Phase|Lack of Efficacy|0|||
126200245|NCT02394028|454017879|FG002|Maintenance Phase|Lack of Efficacy|0|||
126200246|NCT02394028|454017880|FG003|Maintenance Phase|Lack of Efficacy|0|||
126200247|NCT02394028|454017881|FG004|Maintenance Phase|Lack of Efficacy|0|||
126200248|NCT02394028|454017882|FG005|Maintenance Phase|Lack of Efficacy|0|||
126200249|NCT02394028|454017883|FG006|Maintenance Phase|Lack of Efficacy|0|||
126200250|NCT02394028|454017884|FG007|Maintenance Phase|Lack of Efficacy|0|||
126200251|NCT02394028|454017885|FG008|Maintenance Phase|Lack of Efficacy|7|||
126200252|NCT02394028|454017886|FG009|Maintenance Phase|Lack of Efficacy|25|||
126200253|NCT02394028|454017887|FG010|Maintenance Phase|Lack of Efficacy|33|||
126200254|NCT02394028|454017877|FG000|Maintenance Phase|Death|0|||
126200255|NCT02394028|454017878|FG001|Maintenance Phase|Death|0|||
126200256|NCT02394028|454017879|FG002|Maintenance Phase|Death|0|||
126200257|NCT02394028|454017880|FG003|Maintenance Phase|Death|0|||
126200258|NCT02394028|454017881|FG004|Maintenance Phase|Death|0|||
126200259|NCT02394028|454017882|FG005|Maintenance Phase|Death|0|||
126200260|NCT02394028|454017883|FG006|Maintenance Phase|Death|0|||
126200261|NCT02394028|454017884|FG007|Maintenance Phase|Death|0|||
126200262|NCT02394028|454017885|FG008|Maintenance Phase|Death|0|||
126200263|NCT02394028|454017886|FG009|Maintenance Phase|Death|0|||
126200264|NCT02394028|454017887|FG010|Maintenance Phase|Death|1|||
126200265|NCT02394028|454017877|FG000|Maintenance Phase|Adverse Event|0|||
126200266|NCT02394028|454017878|FG001|Maintenance Phase|Adverse Event|0|||
126200267|NCT02394028|454017879|FG002|Maintenance Phase|Adverse Event|0|||
126200268|NCT02394028|454017880|FG003|Maintenance Phase|Adverse Event|0|||
126200269|NCT02394028|454017881|FG004|Maintenance Phase|Adverse Event|0|||
126200270|NCT02394028|454017882|FG005|Maintenance Phase|Adverse Event|0|||
126200271|NCT02394028|454017883|FG006|Maintenance Phase|Adverse Event|0|||
126200272|NCT02394028|454017884|FG007|Maintenance Phase|Adverse Event|0|||
126200273|NCT02394028|454017885|FG008|Maintenance Phase|Adverse Event|1|||
126200274|NCT02394028|454017886|FG009|Maintenance Phase|Adverse Event|1|||
126200275|NCT02394028|454017887|FG010|Maintenance Phase|Adverse Event|3|||
126200276|NCT02394028|454017877|FG000|Maintenance Phase|Site closure|0|||
126200277|NCT02394028|454017878|FG001|Maintenance Phase|Site closure|0|||
126200278|NCT02394028|454017879|FG002|Maintenance Phase|Site closure|0|||
126200279|NCT02394028|454017880|FG003|Maintenance Phase|Site closure|0|||
126200280|NCT02394028|454017881|FG004|Maintenance Phase|Site closure|0|||
126200281|NCT02394028|454017882|FG005|Maintenance Phase|Site closure|0|||
126200282|NCT02394028|454017883|FG006|Maintenance Phase|Site closure|0|||
126200283|NCT02394028|454017884|FG007|Maintenance Phase|Site closure|0|||
126200284|NCT02394028|454017885|FG008|Maintenance Phase|Site closure|0|||
126200285|NCT02394028|454017886|FG009|Maintenance Phase|Site closure|1|||
126200286|NCT02394028|454017887|FG010|Maintenance Phase|Site closure|0|||
126200287|NCT02394028|454017877|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126200288|NCT02394028|454017878|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126200289|NCT02394028|454017879|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126200290|NCT02394028|454017880|FG003|Maintenance Phase|Withdrawal by Subject|0|||
126200291|NCT02394028|454017881|FG004|Maintenance Phase|Withdrawal by Subject|0|||
126200292|NCT02394028|454017882|FG005|Maintenance Phase|Withdrawal by Subject|0|||
126200293|NCT02394028|454017883|FG006|Maintenance Phase|Withdrawal by Subject|0|||
126200294|NCT02394028|454017884|FG007|Maintenance Phase|Withdrawal by Subject|0|||
126200295|NCT02394028|454017885|FG008|Maintenance Phase|Withdrawal by Subject|3|||
126200296|NCT02394028|454017886|FG009|Maintenance Phase|Withdrawal by Subject|12|||
126200297|NCT02394028|454017887|FG010|Maintenance Phase|Withdrawal by Subject|12|||
126200298|NCT02142712|454017890|FG000|Overall Study|Lost to Follow-up|1|||
126200299|NCT02142712|454017891|FG001|Overall Study|Lost to Follow-up|1|||
126200300|NCT02142712|454017892|FG002|Overall Study|Lost to Follow-up|1|||
126200301|NCT02142712|454017893|FG003|Overall Study|Lost to Follow-up|0|||
126200302|NCT03458234|454017901|FG000|Overall Study|Withdrawal by Subject|1|||
126200303|NCT01640353|454019407|FG000|Overall Study|Withdrew prior to treatment|10|||
126200304|NCT01640353|454019407|FG000|Overall Study|Withdrawn from analysis at term site|12|||
126200305|NCT01640353|454019407|FG000|Overall Study|Withdrawal by Subject|5|||
126200306|NCT01640353|454019407|FG000|Overall Study|Death|2|||
126200307|NCT01640353|454019407|FG000|Overall Study|Early site termination|3|||
126200308|NCT01640353|454019407|FG000|Overall Study|Lost to Follow-up|12|||
126200309|NCT01640353|454019407|FG000|Overall Study|Physician Decision|1|||
126200310|NCT03758612|454019408|FG000|Washout Period|Withdrawal by Subject|0|||
126200311|NCT03758612|454019409|FG001|Washout Period|Withdrawal by Subject|0|||
126200312|NCT03758612|454019410|FG002|Washout Period|Withdrawal by Subject|2|||
126200313|NCT03758612|454019411|FG003|Washout Period|Withdrawal by Subject|0|||
126200314|NCT03758612|454019412|FG004|Washout Period|Withdrawal by Subject|0|||
126200315|NCT03758612|454019413|FG005|Washout Period|Withdrawal by Subject|0|||
126200316|NCT03758612|454019414|FG006|Washout Period|Withdrawal by Subject|0|||
126200317|NCT03758612|454019415|FG007|Washout Period|Withdrawal by Subject|0|||
126200318|NCT03758612|454019416|FG008|Washout Period|Withdrawal by Subject|0|||
126200319|NCT03758612|454019417|FG009|Washout Period|Withdrawal by Subject|0|||
126200320|NCT03758612|454019418|FG010|Washout Period|Withdrawal by Subject|0|||
126200321|NCT03758612|454019419|FG011|Washout Period|Withdrawal by Subject|0|||
126200322|NCT03758612|454019408|FG000|Period 2|Protocol Violation|0|||
126200323|NCT03758612|454019409|FG001|Period 2|Protocol Violation|0|||
126200324|NCT03758612|454019410|FG002|Period 2|Protocol Violation|0|||
126200325|NCT03758612|454019411|FG003|Period 2|Protocol Violation|0|||
126200326|NCT03758612|454019412|FG004|Period 2|Protocol Violation|1|||
126200327|NCT03758612|454019413|FG005|Period 2|Protocol Violation|0|||
126200351|NCT02194699|454019438|FG001|Randomised|Did not receive treatment|5|||
126200352|NCT02194699|454019437|FG000|Randomised|Without potential for 52 weeks of IP|5|||
126200353|NCT02194699|454019438|FG001|Randomised|Without potential for 52 weeks of IP|5|||
126200354|NCT02194699|454019437|FG000|Randomised|Duplicate patient|2|||
126200355|NCT02194699|454019438|FG001|Randomised|Duplicate patient|1|||
126200356|NCT02194699|454019437|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
126200357|NCT02194699|454019438|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
126200358|NCT02194699|454019437|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
126200359|NCT02194699|454019438|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
126200360|NCT02194699|454019437|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
126200361|NCT02194699|454019438|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
126200362|NCT02194699|454019437|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
126200363|NCT02194699|454019438|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
126200364|NCT02194699|454019437|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
126200365|NCT02194699|454019438|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
126200366|NCT02194699|454019437|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
126200367|NCT02194699|454019438|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
126200368|NCT04601194|454019439|FG000|Overall Study|Lost to Follow-up|7|||
126200369|NCT00545740|454019442|FG000|Overall Study|Lack of Efficacy|34|||
126200370|NCT00545740|454019443|FG001|Overall Study|Lack of Efficacy|35|||
126200371|NCT00545740|454019444|FG002|Overall Study|Lack of Efficacy|47|||
126200372|NCT00545740|454019445|FG003|Overall Study|Lack of Efficacy|36|||
126200373|NCT00545740|454019442|FG000|Overall Study|Withdrawal by Subject|17|||
126200374|NCT00545740|454019443|FG001|Overall Study|Withdrawal by Subject|15|||
126200375|NCT00545740|454019444|FG002|Overall Study|Withdrawal by Subject|16|||
126200376|NCT00545740|454019445|FG003|Overall Study|Withdrawal by Subject|18|||
126200377|NCT00545740|454019442|FG000|Overall Study|Adverse Event|10|||
126200378|NCT00545740|454019443|FG001|Overall Study|Adverse Event|18|||
126200379|NCT00545740|454019444|FG002|Overall Study|Adverse Event|19|||
126200380|NCT00545740|454019445|FG003|Overall Study|Adverse Event|9|||
126200381|NCT00545740|454019442|FG000|Overall Study|Lost to Follow-up|7|||
126200382|NCT00545740|454019443|FG001|Overall Study|Lost to Follow-up|5|||
126200383|NCT00545740|454019444|FG002|Overall Study|Lost to Follow-up|5|||
126200384|NCT00545740|454019445|FG003|Overall Study|Lost to Follow-up|6|||
126200385|NCT00545740|454019442|FG000|Overall Study|Protocol Violation|1|||
126200386|NCT00545740|454019443|FG001|Overall Study|Protocol Violation|3|||
126200387|NCT00545740|454019444|FG002|Overall Study|Protocol Violation|1|||
126200388|NCT00545740|454019445|FG003|Overall Study|Protocol Violation|0|||
126200389|NCT00545740|454019442|FG000|Overall Study|Non-compliance|0|||
126200390|NCT00545740|454019443|FG001|Overall Study|Non-compliance|2|||
126200391|NCT00545740|454019444|FG002|Overall Study|Non-compliance|1|||
126200392|NCT00545740|454019445|FG003|Overall Study|Non-compliance|0|||
126200393|NCT00545740|454019442|FG000|Overall Study|Moved|2|||
126200394|NCT00545740|454019443|FG001|Overall Study|Moved|0|||
126200395|NCT00545740|454019444|FG002|Overall Study|Moved|1|||
126200396|NCT00545740|454019445|FG003|Overall Study|Moved|0|||
126200397|NCT00545740|454019442|FG000|Overall Study|Diverticulitis attack|0|||
126200398|NCT00545740|454019443|FG001|Overall Study|Diverticulitis attack|0|||
126200399|NCT00545740|454019444|FG002|Overall Study|Diverticulitis attack|1|||
126200400|NCT00545740|454019445|FG003|Overall Study|Diverticulitis attack|1|||
126200401|NCT00545740|454019442|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
126200402|NCT00545740|454019443|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
126200403|NCT00545740|454019444|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
126200404|NCT00545740|454019445|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
126200405|NCT00545740|454019442|FG000|Overall Study|Site closure|1|||
126200406|NCT00545740|454019443|FG001|Overall Study|Site closure|0|||
126200407|NCT00545740|454019444|FG002|Overall Study|Site closure|0|||
126200408|NCT00545740|454019445|FG003|Overall Study|Site closure|0|||
126200409|NCT00545740|454019442|FG000|Overall Study|Missed visit|1|||
126200410|NCT00545740|454019443|FG001|Overall Study|Missed visit|0|||
126200411|NCT00545740|454019444|FG002|Overall Study|Missed visit|0|||
126200412|NCT00545740|454019445|FG003|Overall Study|Missed visit|0|||
126200413|NCT00545740|454019442|FG000|Overall Study|Physician Decision|0|||
126200414|NCT00545740|454019443|FG001|Overall Study|Physician Decision|0|||
126200415|NCT00545740|454019444|FG002|Overall Study|Physician Decision|3|||
126200416|NCT00545740|454019445|FG003|Overall Study|Physician Decision|0|||
126200417|NCT00545740|454019442|FG000|Overall Study|Accepted only monthly telephone calls|1|||
126200418|NCT00545740|454019443|FG001|Overall Study|Accepted only monthly telephone calls|0|||
126200419|NCT00545740|454019444|FG002|Overall Study|Accepted only monthly telephone calls|0|||
126200420|NCT00545740|454019445|FG003|Overall Study|Accepted only monthly telephone calls|0|||
126200421|NCT00545740|454019442|FG000|Overall Study|Sponsor decision|0|||
126200422|NCT00545740|454019443|FG001|Overall Study|Sponsor decision|1|||
126200423|NCT00545740|454019444|FG002|Overall Study|Sponsor decision|0|||
126200424|NCT00545740|454019445|FG003|Overall Study|Sponsor decision|0|||
126200425|NCT00545740|454019442|FG000|Overall Study|Lack of time|0|||
126200426|NCT00545740|454019443|FG001|Overall Study|Lack of time|1|||
126200451|NCT01351415|454019452|FG000|Overall Study|Trial termination by the Sponsor|28|||
126200452|NCT01351415|454019453|FG001|Overall Study|Trial termination by the Sponsor|19|||
126200453|NCT01351415|454019452|FG000|Overall Study|Lost to Follow-up|5|||
126200454|NCT01351415|454019453|FG001|Overall Study|Lost to Follow-up|7|||
126200455|NCT01351415|454019452|FG000|Overall Study|Death|190|||
126200456|NCT01351415|454019453|FG001|Overall Study|Death|187|||
126200457|NCT01351415|454019452|FG000|Overall Study|Physician Decision|2|||
126200458|NCT01351415|454019453|FG001|Overall Study|Physician Decision|3|||
126200459|NCT01351415|454019452|FG000|Overall Study|Reason unknown|0|||
126200460|NCT01351415|454019453|FG001|Overall Study|Reason unknown|2|||
126200461|NCT01351415|454019452|FG000|Overall Study|Never Started|5|||
126200462|NCT01351415|454019453|FG001|Overall Study|Never Started|5|||
126200463|NCT01234337|454019454|FG000|Overall Study|Adverse Event|58|||
126200464|NCT01234337|454019455|FG001|Overall Study|Adverse Event|21|||
126200465|NCT01234337|454019454|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
126200466|NCT01234337|454019455|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
126200467|NCT01234337|454019454|FG000|Overall Study|Investi. decision not protocol driven|5|||
126200468|NCT01234337|454019455|FG001|Overall Study|Investi. decision not protocol driven|6|||
126200469|NCT01234337|454019454|FG000|Overall Study|Non-compliant with study medication|3|||
126200470|NCT01234337|454019455|FG001|Overall Study|Non-compliant with study medication|2|||
126200471|NCT01234337|454019454|FG000|Overall Study|Randomized but not treated|6|||
126200472|NCT01234337|454019455|FG001|Overall Study|Randomized but not treated|4|||
126200473|NCT01234337|454019454|FG000|Overall Study|Lost to Follow-up|0|||
126200474|NCT01234337|454019455|FG001|Overall Study|Lost to Follow-up|1|||
126200475|NCT01234337|454019454|FG000|Overall Study|Protocol Violation|2|||
126200476|NCT01234337|454019455|FG001|Overall Study|Protocol Violation|3|||
126200477|NCT01234337|454019454|FG000|Overall Study|Withdrawal by Subject|11|||
126200478|NCT01234337|454019455|FG001|Overall Study|Withdrawal by Subject|9|||
126200479|NCT01234337|454019454|FG000|Overall Study|Death|0|||
126200480|NCT01234337|454019455|FG001|Overall Study|Death|1|||
126200481|NCT01234337|454019454|FG000|Overall Study|Switch to commercial drug|0|||
126200482|NCT01234337|454019455|FG001|Overall Study|Switch to commercial drug|1|||
126200483|NCT04118127|454019460|FG000|Overall Study|Trial terminated by sponsor|0|||
126200484|NCT04118127|454019461|FG001|Overall Study|Trial terminated by sponsor|12|||
126200485|NCT04118127|454019460|FG000|Overall Study|Adverse Event|1|||
126200486|NCT04118127|454019461|FG001|Overall Study|Adverse Event|2|||
126200487|NCT04118127|454019460|FG000|Overall Study|Physician Decision|0|||
126200488|NCT04118127|454019461|FG001|Overall Study|Physician Decision|1|||
126200489|NCT04118127|454019460|FG000|Overall Study|Withdrawal by Subject|2|||
126200490|NCT04118127|454019461|FG001|Overall Study|Withdrawal by Subject|1|||
126200491|NCT03480360|454019462|FG000|Overall Study|Death|2|||
126200492|NCT01376908|454019467|FG000|Overall Study|Protocol Violation|1|||
126200493|NCT01376908|454019468|FG001|Overall Study|Protocol Violation|1|||
126200494|NCT01376908|454019467|FG000|Overall Study|Withdrawal by Subject|1|||
126200495|NCT01376908|454019468|FG001|Overall Study|Withdrawal by Subject|2|||
126200496|NCT01646255|454019469|FG000|Overall Study|Adverse Event|7|||
126200497|NCT01646255|454019470|FG001|Overall Study|Adverse Event|8|||
126200498|NCT01646255|454019469|FG000|Overall Study|Lack of Efficacy|2|||
126200499|NCT01646255|454019470|FG001|Overall Study|Lack of Efficacy|0|||
126200500|NCT01646255|454019469|FG000|Overall Study|Withdrawal by Subject|10|||
126200501|NCT01646255|454019470|FG001|Overall Study|Withdrawal by Subject|6|||
126200502|NCT01646255|454019469|FG000|Overall Study|Compliance is not well|1|||
126200503|NCT01646255|454019470|FG001|Overall Study|Compliance is not well|0|||
126200504|NCT01646255|454019469|FG000|Overall Study|Inclusion Criteria Deviation|1|||
126200505|NCT01646255|454019470|FG001|Overall Study|Inclusion Criteria Deviation|0|||
126200506|NCT01468844|454019473|FG000|Overall Study|Adverse Event|1|||
126200507|NCT01468844|454019474|FG001|Overall Study|Adverse Event|0|||
126200508|NCT01468844|454019473|FG000|Overall Study|Withdrawal by Subject|1|||
126200509|NCT01468844|454019474|FG001|Overall Study|Withdrawal by Subject|0|||
126200510|NCT02380703|454019477|FG000|Overall Study|Withdrawal by Subject|12|||
126200511|NCT02380703|454019478|FG001|Overall Study|Withdrawal by Subject|9|||
126200512|NCT02380703|454019477|FG000|Overall Study|Lost to Follow-up|12|||
126200513|NCT02380703|454019478|FG001|Overall Study|Lost to Follow-up|12|||
126200514|NCT02380703|454019477|FG000|Overall Study|Caregiver death|1|||
126200515|NCT02380703|454019478|FG001|Overall Study|Caregiver death|0|||
126200516|NCT02380703|454019477|FG000|Overall Study|Person with dementia (PWD) death|7|||
126200517|NCT02380703|454019478|FG001|Overall Study|Person with dementia (PWD) death|8|||
126200518|NCT02380703|454019477|FG000|Overall Study|Entered Long-term Care|4|||
126200519|NCT02380703|454019478|FG001|Overall Study|Entered Long-term Care|7|||
126200520|NCT00266695|454019479|FG000|Overall Study|Adverse Event|1|||
126200521|NCT00266695|454019479|FG000|Overall Study|Death|9|||
126200522|NCT00266695|454019479|FG000|Overall Study|Physician Decision|1|||
126200523|NCT00266695|454019479|FG000|Overall Study|Lost to Follow-up|3|||
126200524|NCT00266695|454019479|FG000|Overall Study|Withdrawal by Subject|15|||
126200525|NCT03480841|454019480|FG000|Overall Study|Lost to Follow-up|2|||
126200526|NCT01362049|454019481|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
126200527|NCT01362049|454019482|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
126200528|NCT01362049|454019483|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
126200529|NCT01362049|454019484|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
126200530|NCT01362049|454019481|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
126200531|NCT01362049|454019482|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
126200532|NCT01362049|454019483|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
126200533|NCT01362049|454019484|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
126200534|NCT03607994|454019485|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
126200535|NCT03607994|454019486|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
126200536|NCT02417935|454019487|FG000|Treatment Period|Adverse Event|12|||
126200537|NCT02417935|454019488|FG001|Treatment Period|Adverse Event|10|||
126200538|NCT02417935|454019487|FG000|Treatment Period|Lost to Follow-up|1|||
126200539|NCT02417935|454019488|FG001|Treatment Period|Lost to Follow-up|0|||
126200540|NCT02417935|454019487|FG000|Treatment Period|Entry Criteria not met|0|||
126200541|NCT02417935|454019488|FG001|Treatment Period|Entry Criteria not met|1|||
126200542|NCT02417935|454019487|FG000|Treatment Period|Protocol Violation|2|||
126200543|NCT02417935|454019488|FG001|Treatment Period|Protocol Violation|1|||
126200544|NCT02417935|454019487|FG000|Treatment Period|Withdrawal by Subject|3|||
126200545|NCT02417935|454019488|FG001|Treatment Period|Withdrawal by Subject|3|||
126200546|NCT02417935|454019487|FG000|Treatment Period|Physician Decision|3|||
126200547|NCT02417935|454019488|FG001|Treatment Period|Physician Decision|1|||
126200548|NCT02850276|454019493|FG000|Overall Study|screen failure|43|||
126200549|NCT02850276|454019493|FG000|Overall Study|Withdrawal by Subject|14|||
126200550|NCT02850276|454019493|FG000|Overall Study|Physician Decision|2|||
126200551|NCT02850276|454019493|FG000|Overall Study|Lost to Follow-up|2|||
126200552|NCT01899729|454019494|FG000|Overall Study|Adverse Event|1|||
126200553|NCT01899729|454019495|FG001|Overall Study|Adverse Event|0|||
126200554|NCT01899729|454019496|FG002|Overall Study|Adverse Event|0|||
126200555|NCT01899729|454019497|FG003|Overall Study|Adverse Event|0|||
126200556|NCT01899729|454019498|FG004|Overall Study|Adverse Event|1|||
126200557|NCT01899729|454019494|FG000|Overall Study|Withdrawal by Subject|1|||
126200558|NCT01899729|454019495|FG001|Overall Study|Withdrawal by Subject|2|||
126200559|NCT01899729|454019496|FG002|Overall Study|Withdrawal by Subject|0|||
126200560|NCT01899729|454019497|FG003|Overall Study|Withdrawal by Subject|0|||
126200561|NCT01899729|454019498|FG004|Overall Study|Withdrawal by Subject|0|||
126200562|NCT01899729|454019494|FG000|Overall Study|Lack of Efficacy|0|||
126200563|NCT01899729|454019495|FG001|Overall Study|Lack of Efficacy|0|||
126200564|NCT01899729|454019496|FG002|Overall Study|Lack of Efficacy|2|||
126200565|NCT01899729|454019497|FG003|Overall Study|Lack of Efficacy|0|||
126200566|NCT01899729|454019498|FG004|Overall Study|Lack of Efficacy|1|||
126200567|NCT01454531|454019501|FG000|Overall Study|Adverse Event|14|||
126200568|NCT01454531|454019501|FG000|Overall Study|Withdrawal by Subject|5|||
126200569|NCT01454531|454019501|FG000|Overall Study|Lost to Follow-up|1|||
126200570|NCT01454531|454019501|FG000|Overall Study|Physician Decision|1|||
126200571|NCT01454531|454019501|FG000|Overall Study|Delay in IMP administration|1|||
126200572|NCT01454531|454019501|FG000|Overall Study|Other|1|||
126200573|NCT02504424|454019507|FG000|Overall Study|Withdrawal by Subject|2|||
126200574|NCT00440232|454019508|FG000|Overall Study|Lost to Follow-up|1|||
126200575|NCT00440232|454019509|FG001|Overall Study|Lost to Follow-up|1|||
126200576|NCT00440232|454019508|FG000|Overall Study|Unable to treat within allowed time|0|||
126200577|NCT00440232|454019509|FG001|Overall Study|Unable to treat within allowed time|1|||
126200578|NCT00440232|454019508|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
126200579|NCT00440232|454019509|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
126200580|NCT00426842|454019510|FG000|Overall Study|Lost to Follow-up|1|||
126200581|NCT00362297|454019511|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
126200582|NCT00362297|454019512|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
126200583|NCT01070381|454019513|FG000|Period 2, 1 Week of Wear|Handling|0|||
126200584|NCT01070381|454019514|FG001|Period 2, 1 Week of Wear|Handling|1|||
126200585|NCT01070381|454019513|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
126200586|NCT01070381|454019514|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
126200587|NCT01259388|454019516|FG000|Overall Study|Adverse Event|3|||
126200588|NCT01259388|454019517|FG001|Overall Study|Adverse Event|0|||
126200589|NCT01259388|454019516|FG000|Overall Study|Withdrawal by Subject|1|||
126200590|NCT01259388|454019517|FG001|Overall Study|Withdrawal by Subject|1|||
126200591|NCT01259388|454019516|FG000|Overall Study|Physician Decision|1|||
126200592|NCT01259388|454019517|FG001|Overall Study|Physician Decision|0|||
126200593|NCT03512028|454019518|FG000|Overall Study|Withdrawal by Subject|2|||
126200594|NCT03512028|454019519|FG001|Overall Study|Withdrawal by Subject|0|||
126200595|NCT03512028|454019518|FG000|Overall Study|Protocol Violation|2|||
126200596|NCT03512028|454019519|FG001|Overall Study|Protocol Violation|0|||
126200597|NCT02743494|454019522|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
126200598|NCT02743494|454019523|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
126200599|NCT02743494|454019522|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
126200600|NCT02743494|454019523|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
126200601|NCT02743494|454019522|FG000|Treatment Period|Completed treatment|229|||
126200602|NCT02743494|454019523|FG001|Treatment Period|Completed treatment|99|||
126200603|NCT02743494|454019522|FG000|Treatment Period|Disease recurrence|149|||
126200604|NCT02743494|454019523|FG001|Treatment Period|Disease recurrence|113|||
126200605|NCT02743494|454019522|FG000|Treatment Period|Study drug toxicity|57|||
126200606|NCT02743494|454019523|FG001|Treatment Period|Study drug toxicity|8|||
126200607|NCT02743494|454019522|FG000|Treatment Period|Death|1|||
126200608|NCT02743494|454019523|FG001|Treatment Period|Death|0|||
126200609|NCT02743494|454019522|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
126200610|NCT02743494|454019523|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
126200611|NCT02743494|454019522|FG000|Treatment Period|Participant request to discontinue treatment|30|||
126200612|NCT02743494|454019523|FG001|Treatment Period|Participant request to discontinue treatment|5|||
126200613|NCT02743494|454019522|FG000|Treatment Period|Participant withdrew consent|12|||
126200614|NCT02743494|454019523|FG001|Treatment Period|Participant withdrew consent|4|||
126200615|NCT02743494|454019522|FG000|Treatment Period|Lost to Follow-up|0|||
126200616|NCT02743494|454019523|FG001|Treatment Period|Lost to Follow-up|1|||
126200617|NCT02743494|454019522|FG000|Treatment Period|Poor/Non-compliance|1|||
126200618|NCT02743494|454019523|FG001|Treatment Period|Poor/Non-compliance|0|||
126200619|NCT02743494|454019522|FG000|Treatment Period|Other reasons|7|||
126200620|NCT02743494|454019523|FG001|Treatment Period|Other reasons|2|||
126200621|NCT03529162|454019524|FG000|Overall Study|Lost to Follow-up|2|||
126200622|NCT03529162|454019525|FG001|Overall Study|Lost to Follow-up|2|||
126200623|NCT00983827|454019526|FG000|Overall Study|Withdrawal by Subject|1|||
126200624|NCT01521494|454019527|FG000|Overall Study|Adverse Event|1|||
126200625|NCT01521494|454019528|FG001|Overall Study|Adverse Event|2|||
126200626|NCT01521494|454019529|FG002|Overall Study|Adverse Event|9|||
126200627|NCT01521494|454019530|FG003|Overall Study|Adverse Event|6|||
126200628|NCT01521494|454019531|FG004|Overall Study|Adverse Event|2|||
126200629|NCT01521494|454019527|FG000|Overall Study|Lack of Efficacy|0|||
126200630|NCT01521494|454019528|FG001|Overall Study|Lack of Efficacy|0|||
126200631|NCT01521494|454019529|FG002|Overall Study|Lack of Efficacy|0|||
126200632|NCT01521494|454019530|FG003|Overall Study|Lack of Efficacy|0|||
126200633|NCT01521494|454019531|FG004|Overall Study|Lack of Efficacy|2|||
126200634|NCT01521494|454019527|FG000|Overall Study|Withdrawal by Subject|1|||
126200635|NCT01521494|454019528|FG001|Overall Study|Withdrawal by Subject|1|||
126200636|NCT01521494|454019529|FG002|Overall Study|Withdrawal by Subject|0|||
126200637|NCT01521494|454019530|FG003|Overall Study|Withdrawal by Subject|2|||
126200638|NCT01521494|454019531|FG004|Overall Study|Withdrawal by Subject|0|||
126200639|NCT01521494|454019527|FG000|Overall Study|Decrease in serum phosphate|0|||
126200640|NCT01521494|454019528|FG001|Overall Study|Decrease in serum phosphate|2|||
126200641|NCT01521494|454019529|FG002|Overall Study|Decrease in serum phosphate|3|||
126200642|NCT01521494|454019530|FG003|Overall Study|Decrease in serum phosphate|12|||
126200643|NCT01521494|454019531|FG004|Overall Study|Decrease in serum phosphate|0|||
126200644|NCT01521494|454019527|FG000|Overall Study|Decrease in serum calcium|0|||
126200645|NCT01521494|454019528|FG001|Overall Study|Decrease in serum calcium|0|||
126200646|NCT01521494|454019529|FG002|Overall Study|Decrease in serum calcium|0|||
126200647|NCT01521494|454019530|FG003|Overall Study|Decrease in serum calcium|1|||
126200648|NCT01521494|454019531|FG004|Overall Study|Decrease in serum calcium|1|||
126200649|NCT01521494|454019527|FG000|Overall Study|Physician Decision|0|||
126200650|NCT01521494|454019528|FG001|Overall Study|Physician Decision|0|||
126200651|NCT01521494|454019529|FG002|Overall Study|Physician Decision|0|||
126200652|NCT01521494|454019530|FG003|Overall Study|Physician Decision|0|||
126200653|NCT01521494|454019531|FG004|Overall Study|Physician Decision|2|||
126200654|NCT02728804|454019539|FG000|Overall Study|Ineligible|3|||
126200655|NCT02728804|454019539|FG000|Overall Study|Did not complete baseline questionnaire|9|||
126200656|NCT02728804|454019539|FG000|Overall Study|Death|99|||
126200657|NCT01854918|454019540|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
126200658|NCT01854918|454019541|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
126200659|NCT01854918|454019540|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
126200660|NCT01854918|454019541|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
126200661|NCT01854918|454019540|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
126200662|NCT01854918|454019541|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
126200663|NCT01854918|454019540|FG000|SOC-controlled Period (Year 1)|Death|5|||
126200664|NCT01854918|454019541|FG001|SOC-controlled Period (Year 1)|Death|5|||
126200665|NCT01854918|454019540|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
126200666|NCT01854918|454019541|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
126200667|NCT01854918|454019540|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
126200668|NCT01854918|454019541|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
126200669|NCT01854918|454019540|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
126200670|NCT01854918|454019541|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
126200671|NCT01854918|454019540|FG000|All-IP Period (Years 2 and 3)|Death|5|||
126200672|NCT01854918|454019541|FG001|All-IP Period (Years 2 and 3)|Death|16|||
126200673|NCT02146352|454019546|FG000|Overall Study|Death|1|||
126200674|NCT02146352|454019546|FG000|Overall Study|Patient entered hospice care|1|||
126200675|NCT02918006|454019547|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
126200676|NCT02918006|454019548|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
126200677|NCT02918006|454019549|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
126200678|NCT02918006|454019547|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
126200679|NCT02918006|454019548|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
126200680|NCT02918006|454019549|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
126200681|NCT02918006|454019547|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
126200682|NCT02918006|454019548|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
126200683|NCT02918006|454019549|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
126200684|NCT02918006|454019547|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
126200685|NCT02918006|454019548|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
126200686|NCT02918006|454019549|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
126200687|NCT02918006|454019547|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
126200688|NCT02918006|454019548|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
126200689|NCT02918006|454019549|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
126200690|NCT02918006|454019547|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
126200691|NCT02918006|454019548|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
126200692|NCT02918006|454019549|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
126200693|NCT02918006|454019547|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
126200694|NCT02918006|454019548|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
126200695|NCT02918006|454019549|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
126200696|NCT02918006|454019547|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
126200697|NCT02918006|454019548|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
126200698|NCT02918006|454019549|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
126200699|NCT02918006|454019547|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
126200700|NCT02918006|454019548|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
126200701|NCT02918006|454019549|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
126200702|NCT02475564|454019551|FG000|Overall Study|Withdrawal by Subject|1|||
126200703|NCT02475564|454019552|FG001|Overall Study|Withdrawal by Subject|0|||
126200704|NCT02475564|454019551|FG000|Overall Study|Lost to Follow-up|2|||
126200705|NCT02475564|454019552|FG001|Overall Study|Lost to Follow-up|1|||
126200706|NCT02475564|454019551|FG000|Overall Study|Intense Menstrual bleeding|1|||
126200707|NCT02475564|454019552|FG001|Overall Study|Intense Menstrual bleeding|0|||
126200708|NCT01156012|454019553|FG000|Overall Study|Adverse Event|3|||
126200709|NCT01156012|454019554|FG001|Overall Study|Adverse Event|1|||
126200710|NCT01156012|454019553|FG000|Overall Study|Lost to Follow-up|1|||
126200711|NCT01156012|454019554|FG001|Overall Study|Lost to Follow-up|0|||
126200712|NCT01156012|454019553|FG000|Overall Study|Withdrawal by Subject|1|||
126200713|NCT01156012|454019554|FG001|Overall Study|Withdrawal by Subject|0|||
126200714|NCT01156012|454019553|FG000|Overall Study|use of commercial drug instead of study|0|||
126200715|NCT01156012|454019554|FG001|Overall Study|use of commercial drug instead of study|1|||
126200716|NCT01156012|454019553|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
126200717|NCT01156012|454019554|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
126200718|NCT00939094|454019556|FG000|Overall Study|Adverse Event|9|||
126200719|NCT00939094|454019557|FG001|Overall Study|Adverse Event|0|||
126200720|NCT00939094|454019556|FG000|Overall Study|Withdrawal by Subject|1|||
126200721|NCT00939094|454019557|FG001|Overall Study|Withdrawal by Subject|6|||
126200722|NCT00939094|454019556|FG000|Overall Study|Lost to Follow-up|1|||
126200723|NCT00939094|454019557|FG001|Overall Study|Lost to Follow-up|1|||
126200724|NCT00939094|454019556|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126200725|NCT00939094|454019557|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126200726|NCT00939094|454019556|FG000|Overall Study|Severe non-compliance to protocol|0|||
126200727|NCT00939094|454019557|FG001|Overall Study|Severe non-compliance to protocol|1|||
126200728|NCT00939094|454019556|FG000|Overall Study|Study stopped by sponsor|0|||
126200729|NCT00939094|454019557|FG001|Overall Study|Study stopped by sponsor|2|||
126200730|NCT00939094|454019556|FG000|Overall Study|Abnormal ECG findings|1|||
126200731|NCT00939094|454019557|FG001|Overall Study|Abnormal ECG findings|0|||
126200732|NCT01906489|454019558|FG000|Overall Study|Adverse Event|10|||
126200733|NCT01906489|454019559|FG001|Overall Study|Adverse Event|3|||
126200734|NCT01906489|454019558|FG000|Overall Study|Worsening of CKD|6|||
126200735|NCT01906489|454019559|FG001|Overall Study|Worsening of CKD|4|||
126200736|NCT01906489|454019558|FG000|Overall Study|Withdrawal by Subject|5|||
126200737|NCT01906489|454019559|FG001|Overall Study|Withdrawal by Subject|0|||
126200738|NCT01906489|454019558|FG000|Overall Study|Worsening of Anemia|1|||
126200739|NCT01906489|454019559|FG001|Overall Study|Worsening of Anemia|0|||
126200740|NCT01906489|454019558|FG000|Overall Study|Protocol Violation|0|||
126200741|NCT01906489|454019559|FG001|Overall Study|Protocol Violation|1|||
126200742|NCT01906489|454019558|FG000|Overall Study|Non- Compliance|1|||
126200743|NCT01906489|454019559|FG001|Overall Study|Non- Compliance|0|||
126200744|NCT01906489|454019558|FG000|Overall Study|Sponsor Decision|1|||
126200745|NCT01906489|454019559|FG001|Overall Study|Sponsor Decision|0|||
126200746|NCT01906489|454019558|FG000|Overall Study|Lost to Follow-up|1|||
126200747|NCT01906489|454019559|FG001|Overall Study|Lost to Follow-up|1|||
126200748|NCT01906489|454019558|FG000|Overall Study|Other|1|||
126200749|NCT01906489|454019559|FG001|Overall Study|Other|0|||
